PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Konishi, Y; Setou, M				Konishi, Yoshiyuki; Setou, Mitsutoshi			Tubulin tyrosination navigates the kinesin-1 motor domain to axons	NATURE NEUROSCIENCE			English	Article							HIPPOCAMPAL-NEURONS; INTERMEDIATE-FILAMENTS; MOLECULAR MOTORS; IN-VITRO; PROTEIN; MICROTUBULES; TRANSPORT; POLARITY; BINDING; POLARIZATION	Neurons form distinctive axonal and dendritic compartments that are important for directional signaling, but the mechanisms that discriminate between axons and dendrites remain elusive. Previous studies have demonstrated that the kinesin-1 motor domain is capable of distinguishing the axon from dendrites. Here we found that the amino acid substitutions in the beta5-loop8 region transformed truncated kinesin-1 from a uni-destination (that is, the axon-specific destination) to a bi-destination (that is, axons and dendrites) state. Furthermore, tyrosinated tubulins that are abundant in somatodendrites prevent the wild-type kinesin-1 from binding to microtubules, whereas the bi-destination-type kinesin-1 does not have this inhibition. Consistently, inhibition of tubulin tyrosination in rat hippocampal neurons resulted in the distribution of truncated kinesin-1 in both axons and dendrites. Our study identifies a molecular mechanism that discriminates the axonal microtubules from somatodendritic microtubules, as well as a previously unknown linkage between tubulin modification and polarized trafficking in neurons.	[Konishi, Yoshiyuki; Setou, Mitsutoshi] Hamamatsu Univ Sch Med, Dept Mol Anat, Shizuoka, Japan; [Konishi, Yoshiyuki; Setou, Mitsutoshi] Mitsubishi Kagaku Inst Life Sci, Tokyo, Japan	Hamamatsu University School of Medicine; Mitsubishi Kagaku Institute of Life Sciences (MITILS)	Konishi, Y (corresponding author), Hamamatsu Univ Sch Med, Dept Mol Anat, Shizuoka, Japan.	ykonishi@hama-med.ac.jp; setou@hama-med.ac.jp			Mitsubishi Kagaku Institute of Life Sciences	Mitsubishi Kagaku Institute of Life Sciences	We are grateful to M. Kikkawa for his help with the electron microscopy and for valuable discussions. We also thank A. Bonni and N. Ohkawa for critical reading of the manuscript, T. Funatsu, S. Uemura and M. Tsunoda for valuable discussions, K. Yasutake and M. Arai for help with primary cultures, Y. Hatanaka and M. Takamatsu for help with preparing constructs, and the Department of Molecular Anatomy, Hamamatsu University School of Medicine and the Molecular Gerontology Group at the Mitsubishi Kagaku Institute of Life Sciences for various forms of help. This work was supported in part by Grants-In-Aid for Young Scientists S (M.S.) and B (Y.K.) and by a grant from the Mitsubishi Kagaku Institute of Life Sciences.	ANDREWS SB, 1993, P NATL ACAD SCI USA, V90, P6503, DOI 10.1073/pnas.90.14.6503; Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; BAAS PW, 1988, P NATL ACAD SCI USA, V85, P8335, DOI 10.1073/pnas.85.21.8335; Barnes AP, 2007, CELL, V129, P549, DOI 10.1016/j.cell.2007.03.025; Bi GQ, 1997, J CELL BIOL, V138, P999, DOI 10.1083/jcb.138.5.999; CACERES A, 1986, J NEUROSCI, V6, P714; Cai Q, 2007, J NEUROSCI, V27, P7284, DOI 10.1523/JNEUROSCI.0731-07.2007; CHAPIN SJ, 1991, METHOD ENZYMOL, V196, P254; Coy DL, 1999, NAT CELL BIOL, V1, P288, DOI 10.1038/13001; Cross R, 1999, NAT CELL BIOL, V1, pE119, DOI 10.1038/12947; DOTTI CG, 1987, NATURE, V330, P254, DOI 10.1038/330254a0; Dunn S, 2008, J CELL SCI, V121, P1085, DOI 10.1242/jcs.026492; Endow SA, 2000, NATURE, V406, P913, DOI 10.1038/35022617; Erck C, 2005, P NATL ACAD SCI USA, V102, P7853, DOI 10.1073/pnas.0409626102; ERSFELD K, 1993, J CELL BIOL, V120, P725, DOI 10.1083/jcb.120.3.725; FERREIRA A, 1992, J CELL BIOL, V117, P595, DOI 10.1083/jcb.117.3.595; Goldberg JL, 2002, SCIENCE, V296, P1860, DOI 10.1126/science.1068428; Goldstein LSB, 2001, P NATL ACAD SCI USA, V98, P6999, DOI 10.1073/pnas.111145298; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; Horiguchi K, 2006, J CELL BIOL, V174, P425, DOI 10.1083/jcb.200604031; Ikegami K, 2007, P NATL ACAD SCI USA, V104, P3213, DOI 10.1073/pnas.0611547104; Jacobson C, 2006, NEURON, V49, P797, DOI 10.1016/j.neuron.2006.02.005; Janke C, 2005, SCIENCE, V308, P1758, DOI 10.1126/science.1113010; Kanai Y, 2000, J NEUROSCI, V20, P6374, DOI 10.1523/JNEUROSCI.20-17-06374.2000; KIKKAWA M, 1994, J CELL BIOL, V127, P1965, DOI 10.1083/jcb.127.6.1965; Kikkawa M, 2001, NATURE, V411, P439, DOI 10.1038/35078000; Kimura T, 2005, J NEUROCHEM, V93, P1371, DOI 10.1111/j.1471-4159.2005.03063.x; Konishi Y, 2004, SCIENCE, V303, P1026, DOI 10.1126/science.1093712; Kozielski F, 1997, CELL, V91, P985, DOI 10.1016/S0092-8674(00)80489-4; Kreitzer G, 1999, MOL BIOL CELL, V10, P1105, DOI 10.1091/mbc.10.4.1105; Levy-Strumpf N, 2007, NAT NEUROSCI, V10, P161, DOI 10.1038/nn1835; Liao GJ, 1998, J BIOL CHEM, V273, P9797, DOI 10.1074/jbc.273.16.9797; Miki H, 2001, P NATL ACAD SCI USA, V98, P7004, DOI 10.1073/pnas.111145398; Nakata T, 2003, J CELL BIOL, V162, P1045, DOI 10.1083/jcb.200302175; Peris L, 2006, J CELL BIOL, V174, P839, DOI 10.1083/jcb.200512058; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Setou M, 2002, NATURE, V417, P83, DOI 10.1038/nature743; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Shelly M, 2007, CELL, V129, P565, DOI 10.1016/j.cell.2007.04.012; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Skiniotis G, 2004, EMBO J, V23, P989, DOI 10.1038/sj.emboj.7600118; VALE RD, 1985, CELL, V42, P39, DOI 10.1016/S0092-8674(85)80099-4; Verhey KJ, 2001, J CELL BIOL, V152, P959, DOI 10.1083/jcb.152.5.959; Watari-Goshima N, 2007, NAT NEUROSCI, V10, P169, DOI 10.1038/nn1834; Westermann S, 2003, NAT REV MOL CELL BIO, V4, P938, DOI 10.1038/nrm1260; Witte H, 2008, J CELL BIOL, V180, P619, DOI 10.1083/jcb.200707042; Woehlke G, 1997, CELL, V90, P207, DOI 10.1016/S0092-8674(00)80329-3; YANG JT, 1989, CELL, V56, P879, DOI 10.1016/0092-8674(89)90692-2; Zhai RG, 2001, NEURON, V29, P131, DOI 10.1016/S0896-6273(01)00185-4	50	273	277	1	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2009	12	5					559	567		10.1038/nn.2314	http://dx.doi.org/10.1038/nn.2314			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	438SJ	19377471				2022-12-17	WOS:000265575400012
J	Janzen, G; van Turennout, M				Janzen, G; van Turennout, M			Selective neural representation of objects relevant for navigation	NATURE NEUROSCIENCE			English	Article							ATTENTION; MEMORY; BRAIN; NETWORKS; HIPPOCAMPUS; ACTIVATION	As people find their way through their environment, objects at navigationally relevant locations can serve as crucial landmarks. The parahippocampal gyrus has previously been shown to be involved in object and scene recognition. In the present study, we investigated the neural representation of navigationally relevant locations. Healthy human adults viewed a route through a virtual museum with objects placed at intersections (decision points) or at simple turns (non-decision points). Event-related functional magnetic resonance imaging (fMRI) data were acquired during subsequent recognition of the objects in isolation. Neural activity in the parahippocampal gyrus reflected the navigational relevance of an object's location in the museum. Parahippocampal responses were selectively increased for objects that occurred at decision points, independent of attentional demands. This increase occurred for forgotten as well as remembered objects, showing implicit retrieval of navigational information. The automatic storage of relevant object location in the parahippocampal gyrus provides a part of the neural mechanism underlying successful navigation.	Max Planck Inst Psycholinguist, NL-6500 AH Nijmegen, Netherlands; FC Donders Ctr Cognit Neuroimaging, NL-6500 HB Nijmegen, Netherlands	Max Planck Society	Janzen, G (corresponding author), Max Planck Inst Psycholinguist, Postbus 310, NL-6500 AH Nijmegen, Netherlands.	gabriele.janzen@mpi.nl	Janzen, Gabriele/G-2058-2012					Aguirre GK, 1996, CEREB CORTEX, V6, P823, DOI 10.1093/cercor/6.6.823; Bar M, 2003, NEURON, V38, P347, DOI 10.1016/S0896-6273(03)00167-3; BLADES M, 1992, J ENVIRON PSYCHOL, V12, P175, DOI 10.1016/S0272-4944(05)80069-6; Brewer JB, 1998, SCIENCE, V281, P1185, DOI 10.1126/science.281.5380.1185; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; BURGESS N, 1999, HIPPOCAMPAL PARIETAL; Caldwell JI, 2001, MEM COGNITION, V29, P285, DOI 10.3758/BF03194922; DANIEL MP, 1998, KOGNITIONSWISSENSCHA, V7, P45, DOI DOI 10.1007/S001970050050; Dragoi G, 2003, NEURON, V39, P843, DOI 10.1016/S0896-6273(03)00465-3; Duzel E, 2003, J NEUROSCI, V23, P9439; Ekstrom AD, 2003, NATURE, V425, P184, DOI 10.1038/nature01964; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Gabrieli JDE, 1997, SCIENCE, V276, P264, DOI 10.1126/science.276.5310.264; Golledge R, 1999, WAYFINDING BEHAV; Gron G, 2000, NAT NEUROSCI, V3, P404, DOI 10.1038/73980; HASHER L, 1979, J EXP PSYCHOL GEN, V108, P356, DOI 10.1037/0096-3445.108.3.356; Henson R, 2000, SCIENCE, V287, P1269, DOI 10.1126/science.287.5456.1269; HYDE JS, 1981, AM PSYCHOL, V36, P892, DOI 10.1037/0003-066X.36.8.892; Johnsrude IS, 1999, NEUROPSYCHOLOGIA, V37, P829, DOI 10.1016/S0028-3932(98)00136-5; Kanwisher N, 2000, NAT REV NEUROSCI, V1, P91, DOI 10.1038/35039043; LAWTON CA, 1994, SEX ROLES, V30, P765, DOI 10.1007/BF01544230; Maccoby E.E., 1978, PSYCHOL SEX DIFFEREN, V2; Maguire EA, 1998, SCIENCE, V280, P921, DOI 10.1126/science.280.5365.921; Maguire EA, 1998, J COGNITIVE NEUROSCI, V10, P61, DOI 10.1162/089892998563789; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Owen AM, 1996, J COGNITIVE NEUROSCI, V8, P588, DOI 10.1162/jocn.1996.8.6.588; Saenz M, 2002, NAT NEUROSCI, V5, P631, DOI 10.1038/nn876; Sandstrom NJ, 1998, COGNITIVE BRAIN RES, V6, P351, DOI 10.1016/S0926-6410(98)00002-0; Talairach J., 1988, COPLANAR STEREOTAXIC; Ungerleider LG, 1982, ANAL VISUAL BEHAV, P549; van Turennout M, 2000, NAT NEUROSCI, V3, P1329, DOI 10.1038/81873; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Wood ER, 2000, NEURON, V27, P623, DOI 10.1016/S0896-6273(00)00071-4; Yantis S, 2002, NAT NEUROSCI, V5, P995, DOI 10.1038/nn921	36	273	276	1	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2004	7	6					673	677		10.1038/nn1257	http://dx.doi.org/10.1038/nn1257			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	823VA	15146191	Green Published			2022-12-17	WOS:000221640300023
J	Flanagan, JR; Beltzner, MA				Flanagan, JR; Beltzner, MA			Independence of perceptual and sensorimotor predictions in the size-weight illusion	NATURE NEUROSCIENCE			English	Article							PRECISION GRIP; GRASP STABILITY; TANGENTIAL TORQUE; FINGERTIP FORCES; INTERNAL MODELS; MOTOR CONTROL; OBJECT SHAPE; MOVEMENTS; INTEGRATION; INFORMATION	The smaller of two equally weighted objects is judged to be heavier when lifted. Here we disproved a leading hypothesis that this size-weight illusion is caused by a mismatch between predicted and actual sensory feedback. We showed that when subjects repeatedly lifted equally heavy large and small objects in alternation, they learned to scale their fingertip forces precisely for the true object weights and thus exhibited accurate sensorimotor prediction. The size-weight. illusion nevertheless persisted, suggesting that the illusion can be caused by high-level cognitive and perceptual factors and indicating that the sensorimotor system can operate independently of the cognitive/perceptual system.	Queens Univ, Dept Psychol, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Flanagan, JR (corresponding author), Queens Univ, Dept Psychol, Kingston, ON K7L 3N6, Canada.							Amazeen EL, 1996, J EXP PSYCHOL HUMAN, V22, P213, DOI 10.1037/0096-1523.22.1.213; Amazeen EL, 1997, ECOL PSYCHOL, V9, P245, DOI 10.1207/s15326969eco0904_1; Blakemore SJ, 1998, NAT NEUROSCI, V1, P635, DOI 10.1038/2870; Brenner E, 1996, EXP BRAIN RES, V111, P473; Charpentier A., 1891, ARCHIVE PHYSIOLOGIE, V3, P122; DAVIS CM, 1976, PERCEPT PSYCHOPHYS, V20, P33, DOI 10.3758/BF03198701; Ellis RR, 1998, PERCEPTION, V27, P193, DOI 10.1068/p270193; ELLIS RR, 1993, PERCEPT PSYCHOPHYS, V53, P315, DOI 10.3758/BF03205186; FLANAGAN JR, 1993, EXP BRAIN RES, V95, P131; Flanagan JR, 1997, J NEUROSCI, V17, P1519; Flanagan JR, 1999, J NEUROPHYSIOL, V81, P1706, DOI 10.1152/jn.1999.81.4.1706; Flournoy, 1894, ANN PSYCHOL, V1, P198, DOI [DOI 10.3406/PSY.1894.1051, 10.3406/psy.1894.1051]; GOODALE MA, 1994, CURR BIOL, V4, P604, DOI 10.1016/S0960-9822(00)00132-9; GOODALE MA, 1991, NATURE, V349, P154, DOI 10.1038/349154a0; Goodwin AW, 1998, J NEUROSCI, V18, P10724; GORDON AM, 1991, EXP BRAIN RES, V85, P226; GORDON AM, 1991, EXP BRAIN RES, V83, P477; GORDON AM, 1991, EXP BRAIN RES, V83, P483; GORDON AM, 1993, J NEUROPHYSIOL, V69, P1789, DOI 10.1152/jn.1993.69.6.1789; GRANIT R, 1972, BRAIN, V95, P451; Jenmalm P, 1998, J NEUROPHYSIOL, V79, P1643, DOI 10.1152/jn.1998.79.4.1643; Jenmalm P, 1997, J NEUROSCI, V17, P4486; Johansson RS, 1999, EXP BRAIN RES, V128, P20, DOI 10.1007/s002210050813; JOHANSSON RS, 1984, EXP BRAIN RES, V56, P550; JOHANSSON RS, 1988, EXP BRAIN RES, V71, P59; JOHANSSON RS, 1994, CAN J PHYSIOL PHARM, V72, P511, DOI 10.1139/y94-075; JORDAN MI, 1992, COGNITIVE SCI, V16, P307, DOI 10.1207/s15516709cog1603_1; Kawato M, 1999, CURR OPIN NEUROBIOL, V9, P718, DOI 10.1016/S0959-4388(99)00028-8; Kinoshita H, 1997, J NEUROPHYSIOL, V78, P1619, DOI 10.1152/jn.1997.78.3.1619; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; Milner A. D., 1995, VISUAL BRAIN ACTION; Murray DJ, 1999, PERCEPT PSYCHOPHYS, V61, P1681, DOI 10.3758/BF03213127; Nyssen R, 1955, ACTA PSYCHOL, V11, P467; ROSS HE, 1969, Q J EXP PSYCHOL, V21, P346, DOI 10.1080/14640746908400230; Seashore CE, 1899, U IOWA STUDIES PSYCH, V2, P36; SPERRY RW, 1950, J COMP PHYSIOL PSYCH, V43, P482, DOI 10.1037/h0055479; von Holst E, 1954, BRIT J ANIM BEHAV, V2, P89, DOI DOI 10.1016/S0950-5601(54)80044-X; WESTLING G, 1987, EXP BRAIN RES, V66, P128; Wing AM, 1998, J EXP PSYCHOL HUMAN, V24, P1571, DOI 10.1037/0096-1523.24.6.1571; Wolfe H. K., 1898, PSYCHOL REV, V5, P25, DOI [DOI 10.1037/H0073342, 10.1037/h0073342]; Wolpert DM, 1997, TRENDS COGN SCI, V1, P209, DOI 10.1016/S1364-6613(97)01070-X; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; ZWISLOCKI JJ, 1980, PERCEPT PSYCHOPHYS, V28, P28, DOI 10.3758/BF03204312	43	273	278	3	26	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2000	3	7					737	741		10.1038/76701	http://dx.doi.org/10.1038/76701			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TT	10862708				2022-12-17	WOS:000167177200022
J	Whitmore, D; Foulkes, NS; Strahle, U; Sassone-Corsi, P				Whitmore, D; Foulkes, NS; Strahle, U; Sassone-Corsi, P			Zebrafish Clock rhythmic expression reveals independent peripheral circadian oscillators	NATURE NEUROSCIENCE			English	Article							DROSOPHILA PERIOD GENE; MESSENGER-RNA LEVELS; TRANSCRIPTION; ANTAGONISTS; TIMELESS; BEHAVIOR; CLONING; LESIONS; PROTEIN; RETINA	The only vertebrate clock gene identified by mutagenesis is mouse Clock, which encodes a bHLH-PAS transcription factor. We have cloned Clock in zebrafish and show that, in contrast to its mouse homologue, it is expressed with a pronounced circadian rhythm in the brain and in two defined pacemaker structures, the eye and the pineal gland. Clock oscillation was also found in other tissues, including kidney and heart. In these tissues, expression of Clock continues to oscillate in vitro. This demonstrates that self-sustaining circadian oscillators exist in several vertebrate organs, as was previously reported for invertebrates.	ULP, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Sassone-Corsi, P (corresponding author), ULP, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, 1 Rue Laurent Fries, F-67404 Illkirch Graffenstaden, France.		Foulkes, Nicholas S/K-7003-2013; Sassone-Corsi, Paolo/H-6182-2011; Straehle, Uwe/K-7054-2013	Foulkes, Nicholas S/0000-0002-1794-9891; Whitmore, David/0000-0003-2420-8220				Albrecht U, 1997, CELL, V91, P1055, DOI 10.1016/S0092-8674(00)80495-X; Allada R, 1998, CELL, V93, P791, DOI 10.1016/S0092-8674(00)81440-3; Antoch MP, 1997, CELL, V89, P655, DOI 10.1016/S0092-8674(00)80246-9; Bae K, 1998, MOL CELL BIOL, V18, P6142, DOI 10.1128/MCB.18.10.6142; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Cahill GM, 1996, BRAIN RES, V708, P177, DOI 10.1016/0006-8993(95)01365-2; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; Dunlap JC, 1996, ANNU REV GENET, V30, P579, DOI 10.1146/annurev.genet.30.1.579; Fonjallaz P, 1996, EMBO J, V15, P351, DOI 10.1002/j.1460-2075.1996.tb00365.x; Foulkes NS, 1996, BBA-REV CANCER, V1288, pF101, DOI 10.1016/S0304-419X(96)00025-X; FOULKES NS, 1991, CELL, V64, P739, DOI 10.1016/0092-8674(91)90503-Q; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; HARDIN PE, 1990, NATURE, V343, P536, DOI 10.1038/343536a0; HARDIN PE, 1992, P NATL ACAD SCI USA, V89, P11711, DOI 10.1073/pnas.89.24.11711; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Klein D.C., 1991, SUPRACHIASMATIC NUCL; MELLSTROM B, 1993, NEURON, V10, P655, DOI 10.1016/0896-6273(93)90167-P; Miyamoto Y, 1998, P NATL ACAD SCI USA, V95, P6097, DOI 10.1073/pnas.95.11.6097; MOORE RY, 1972, BRAIN RES, V42, P201, DOI 10.1016/0006-8993(72)90054-6; Plautz JD, 1997, SCIENCE, V278, P1632, DOI 10.1126/science.278.5343.1632; Rajendran RR, 1996, J EXP BIOL, V199, P2775; REPPERT SM, 1995, NEURON, V15, P983, DOI 10.1016/0896-6273(95)90086-1; Reppert SM, 1997, CELL, V89, P487, DOI 10.1016/S0092-8674(00)80229-9; Reppert SM, 1995, CELL, V83, P1059, DOI 10.1016/0092-8674(95)90131-0; Rutila JE, 1998, CELL, V93, P805, DOI 10.1016/S0092-8674(00)81441-5; Sassone-Corsi P, 1998, NATURE, V392, P871, DOI 10.1038/31821; SEHGAL A, 1995, SCIENCE, V270, P808, DOI 10.1126/science.270.5237.808; SERVILLO G, 1991, BIOCHEM BIOPH RES CO, V175, P104, DOI 10.1016/S0006-291X(05)81206-9; Shearman LP, 1997, NEURON, V19, P1261, DOI 10.1016/S0896-6273(00)80417-1; Shigeyoshi Y, 1997, CELL, V91, P1043, DOI 10.1016/S0092-8674(00)80494-8; STEPHAN FK, 1972, P NATL ACAD SCI USA, V69, P1583, DOI 10.1073/pnas.69.6.1583; Sun ZS, 1997, CELL, V90, P1003, DOI 10.1016/S0092-8674(00)80366-9; TAKAHASHI JS, 1995, ANNU REV NEUROSCI, V18, P531, DOI 10.1146/annurev.neuro.18.1.531; Tei H, 1997, NATURE, V389, P512, DOI 10.1038/39086; Tosini G, 1996, SCIENCE, V272, P419, DOI 10.1126/science.272.5260.419; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; ZERR DM, 1990, J NEUROSCI, V10, P2749; Zylka MJ, 1998, NEURON, V20, P1103, DOI 10.1016/S0896-6273(00)80492-4	41	273	279	0	37	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	1998	1	8					701	707		10.1038/3703	http://dx.doi.org/10.1038/3703			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	144PR	10196586				2022-12-17	WOS:000077323400014
J	Epstein, RA; Patai, EZ; Julian, JB; Spiers, HJ				Epstein, Russell A.; Patai, Eva Zita; Julian, Joshua B.; Spiers, Hugo J.			The cognitive map in humans: spatial navigation and beyond	NATURE NEUROSCIENCE			English	Review							HEAD-DIRECTION CELLS; OCCIPITAL PLACE AREA; PATH-INTEGRATION; RETROSPLENIAL CORTEX; REFERENCE FRAMES; HIPPOCAMPAL REPRESENTATION; PARAHIPPOCAMPAL CORTEX; GEOMETRIC DETERMINANTS; NEURAL REPRESENTATION; ATTRACTOR DYNAMICS	The 'cognitive map' hypothesis proposes that brain builds a unified representation of the spatial environment to support memory and guide future action. Forty years of electrophysiological research in rodents suggest that cognitive maps are neurally instantiated by place, grid, border and head direction cells in the hippocampal formation and related structures. Here we review recent work that suggests a similar functional organization in the human brain and yields insights into how cognitive maps are used during spatial navigation. Specifically, these studies indicate that (i) the human hippocampus and entorhinal cortex support map-like spatial codes, (ii) posterior brain regions such as parahippocampal and retrosplenial cortices provide critical inputs that allow cognitive maps to be anchored to fixed environmental landmarks, and (iii) hippocampal and entorhinal spatial codes are used in conjunction with frontal lobe mechanisms to plan routes during navigation. We also discuss how these three basic elements of cognitive map based navigation-spatial coding, landmark anchoring and route planning-might be applied to nonspatial domains to provide the building blocks for many core elements of human thought.	[Epstein, Russell A.; Julian, Joshua B.] Univ Penn, Dept Psychol, 3815 Walnut St, Philadelphia, PA 19104 USA; [Patai, Eva Zita; Spiers, Hugo J.] UCL, Inst Behav Neurosci, Div Psychol & Language Sci, Dept Expt Psychol, London, England	University of Pennsylvania; University of London; University College London	Epstein, RA (corresponding author), Univ Penn, Dept Psychol, 3815 Walnut St, Philadelphia, PA 19104 USA.; Spiers, HJ (corresponding author), UCL, Inst Behav Neurosci, Div Psychol & Language Sci, Dept Expt Psychol, London, England.	epstein@psych.upenn.edu; h.spiers@ucl.ac.uk		Julian, Joshua/0000-0001-6944-5479	US National Institutes of Health [EY022350, EY027047]; National Science Foundation (GRFP); JSMF; Wellcome Trust [094850/Z/10/Z]; NATIONAL EYE INSTITUTE [R01EY022350, R21EY027047] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (GRFP)(National Science Foundation (NSF)); JSMF; Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank K. Jeffery for comments on the manuscript. This work was supported by the US National Institutes of Health (EY022350 and EY027047 to R.A.E.), National Science Foundation (GRFP to J.B.J.), JSMF (to H.J.S.) and Wellcome Trust (094850/Z/10/Z to H.J.S.).	Aguirre GK, 1999, BRAIN, V122, P1613, DOI 10.1093/brain/122.9.1613; Aguirre GK, 1996, CEREB CORTEX, V6, P823, DOI 10.1093/cercor/6.6.823; Alexander AS, 2015, NAT NEUROSCI, V18, P1143, DOI 10.1038/nn.4058; Aminoff EM, 2013, TRENDS COGN SCI, V17, P379, DOI 10.1016/j.tics.2013.06.009; Anderson MI, 2003, J NEUROSCI, V23, P8827; Aronov D, 2017, NATURE, V543, P719, DOI 10.1038/nature21692; Auger SD, 2015, ELIFE, V4, DOI 10.7554/eLife.09031; Auger SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043620; Balaguer J, 2016, NEURON, V90, P893, DOI 10.1016/j.neuron.2016.03.037; Bar M, 2003, NEURON, V38, P347, DOI 10.1016/S0896-6273(03)00167-3; Barry C, 2007, NAT NEUROSCI, V10, P682, DOI 10.1038/nn1905; Baumann O, 2010, J NEUROSCI, V30, P12897, DOI 10.1523/JNEUROSCI.3077-10.2010; Bicanski A, 2016, J NEUROSCI, V36, P11601, DOI 10.1523/JNEUROSCI.0516-16.2016; BIEGLER R, 1993, NATURE, V361, P631, DOI 10.1038/361631a0; Bird CM, 2010, J NEUROSCI, V30, P11688, DOI 10.1523/JNEUROSCI.0723-10.2010; Bonner MF, 2017, P NATL ACAD SCI USA, V114, P4793, DOI 10.1073/pnas.1618228114; Brown TI, 2016, SCIENCE, V352, P1323, DOI 10.1126/science.aaf0784; Buckner RL, 2010, ANNU REV PSYCHOL, V61, P27, DOI 10.1146/annurev.psych.60.110707.163508; Bush D, 2015, NEURON, V87, P507, DOI 10.1016/j.neuron.2015.07.006; Buzsaki G, 2017, NAT NEUROSCI, V20, P1434; Buzsaki G, 2013, NAT NEUROSCI, V16, P130, DOI 10.1038/nn.3304; Byrne P, 2007, PSYCHOL REV, V114, P340, DOI 10.1037/0033-295X.114.2.340; Chadwick MJ, 2015, CURR BIOL, V25, P87, DOI 10.1016/j.cub.2014.11.001; Chanales AJH, 2017, CURR BIOL, V27, P2307, DOI 10.1016/j.cub.2017.06.057; CHEN LL, 1994, EXP BRAIN RES, V101, P8, DOI 10.1007/BF00243212; CHENG K, 1986, COGNITION, V23, P149, DOI 10.1016/0010-0277(86)90041-7; Cheng K, 2013, PSYCHON B REV, V20, P1033, DOI 10.3758/s13423-013-0416-1; Cho JW, 2001, BEHAV NEUROSCI, V115, P3, DOI 10.1037//0735-7044.115.1.3; Clark RE, 2013, P NATL ACAD SCI USA, V110, P10365, DOI 10.1073/pnas.1301225110; Colgin LL, 2008, TRENDS NEUROSCI, V31, P469, DOI 10.1016/j.tins.2008.06.008; Committeri G, 2004, J COGNITIVE NEUROSCI, V16, P1517, DOI 10.1162/0898929042568550; Constantinescu AO, 2016, SCIENCE, V352, P1464, DOI 10.1126/science.aaf0941; Dabaghian Y, 2014, ELIFE, V3, DOI 10.7554/eLife.03476; Deuker L, 2016, ELIFE, V5, DOI 10.7554/eLife.16534; Doeller CF, 2008, P NATL ACAD SCI USA, V105, P5915, DOI 10.1073/pnas.0801489105; Doeller CF, 2010, NATURE, V463, P657, DOI 10.1038/nature08704; Eichenbaum H, 2014, NEURON, V83, P764, DOI 10.1016/j.neuron.2014.07.032; Ekstrom AD, 2003, NATURE, V425, P184, DOI 10.1038/nature01964; Ekstrom AD, 2017, HIPPOCAMPUS; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Epstein RA, 2008, TRENDS COGN SCI, V12, P388, DOI 10.1016/j.tics.2008.07.004; Epstein RA, 2007, J NEUROSCI, V27, P6141, DOI 10.1523/JNEUROSCI.0799-07.2007; Epstein RA, 2014, SCENE VISION: MAKING SENSE OF WHAT WE SEE, P105; Epstein RA, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2012.0533; Erdem UM, 2012, EUR J NEUROSCI, V35, P916, DOI 10.1111/j.1460-9568.2012.08015.x; Etienne AS, 2004, HIPPOCAMPUS, V14, P180, DOI 10.1002/hipo.10173; Ezzyat Y, 2014, NEURON, V81, P1179, DOI 10.1016/j.neuron.2014.01.042; Fairhall SL, 2013, J NEUROSCI, V33, P10552, DOI 10.1523/JNEUROSCI.0051-13.2013; Gallistel CR, 1990, ORG LEARNING; Garvert MM, 2017, ELIFE, V6, DOI 10.7554/eLife.17086; Ghaem O, 1997, NEUROREPORT, V8, P739, DOI 10.1097/00001756-199702100-00032; Grieves RM, 2017, BEHAV PROCESS, V135, P113, DOI 10.1016/j.beproc.2016.12.012; Hamilton DA, 2007, J EXP PSYCHOL-ANIM B, V33, P100, DOI 10.1037/0097-7403.33.2.100; Hartley T, 2004, COGNITION, V94, P39, DOI 10.1016/j.cognition.2003.12.001; Hartley T, 2003, NEURON, V37, P877, DOI 10.1016/S0896-6273(03)00095-3; Hartley T, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00338; Hassabis D, 2007, TRENDS COGN SCI, V11, P299, DOI 10.1016/j.tics.2007.05.001; Hassabis D, 2009, CURR BIOL, V19, P546, DOI 10.1016/j.cub.2009.02.033; Hasselmo M.E, 2011, WE REMEMBER BRAIN ME; Horner AJ, 2016, COGNITION, V154, P151, DOI 10.1016/j.cognition.2016.05.013; Horner AJ, 2016, CURR BIOL, V26, P842, DOI 10.1016/j.cub.2016.01.042; Howard LR, 2014, CURR BIOL, V24, P1331, DOI 10.1016/j.cub.2014.05.001; Iaria G, 2003, J NEUROSCI, V23, P5945; Jacobs J, 2013, NAT NEUROSCI, V16, P1188, DOI 10.1038/nn.3466; Jacobs PY, 2017, NAT NEUROSCI, V20, P173, DOI 10.1038/nn.4465; Janzen G, 2004, NAT NEUROSCI, V7, P673, DOI 10.1038/nn1257; Javadi AH, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14652; Jeffery KJ, 2004, NEUROSCI BIOBEHAV R, V28, P201, DOI 10.1016/j.neubiorev.2003.12.002; Johnson A, 2007, J NEUROSCI, V27, P12176, DOI 10.1523/JNEUROSCI.3761-07.2007; Julian JB, 2012, NEUROIMAGE, V60, P2357, DOI 10.1016/j.neuroimage.2012.02.055; Julian JB, 2016, CURR BIOL, V26, P1104, DOI 10.1016/j.cub.2016.02.066; Julian JB, 2015, P NATL ACAD SCI USA, V112, P6503, DOI 10.1073/pnas.1424194112; Kamps FS, 2016, CORTEX, V83, P17, DOI 10.1016/j.cortex.2016.06.022; Kaplan R, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.1002588; Keinath AT, 2017, CURR BIOL, V27, P309, DOI 10.1016/j.cub.2016.11.046; Knierim JJ, 2011, PHYSIOL REV, V91, P1245, DOI 10.1152/physrev.00021.2010; KNIERIM JJ, 1995, J NEUROSCI, V15, P1648, DOI 10.1523/JNEUROSCI.15-03-01648.1995; Knight R, 2011, J NEUROSCI, V31, P15681, DOI 10.1523/JNEUROSCI.2257-11.2011; Kolarik BS, 2016, NEUROPSYCHOLOGIA, V80, P90, DOI 10.1016/j.neuropsychologia.2015.11.013; Kornblith S, 2013, NEURON, V79, P766, DOI 10.1016/j.neuron.2013.06.015; Krupic J, 2015, NATURE, V518, P232, DOI 10.1038/nature14153; Kubie JL, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00020; Kyle CT, 2015, ELIFE, V4, DOI 10.7554/eLife.10499; Lehn H, 2009, J NEUROSCI, V29, P3475, DOI 10.1523/JNEUROSCI.5370-08.2009; Lever C, 2002, NATURE, V416, P90, DOI 10.1038/416090a; MacDonald CJ, 2011, NEURON, V71, P737, DOI 10.1016/j.neuron.2011.07.012; Maguire EA, 1998, SCIENCE, V280, P921, DOI 10.1126/science.280.5365.921; Maguire EA, 2001, SCAND J PSYCHOL, V42, P225, DOI 10.1111/1467-9450.00233; Maguire EA, 2006, BRAIN, V129, P2894, DOI 10.1093/brain/awl286; Marchette SA, 2017, COGNITION, V158, P68, DOI 10.1016/j.cognition.2016.10.005; Marchette SA, 2015, J NEUROSCI, V35, P14896, DOI 10.1523/JNEUROSCI.2270-15.2015; Marchette SA, 2014, NAT NEUROSCI, V17, P1598, DOI 10.1038/nn.3834; Marchette SA, 2011, J NEUROSCI, V31, P15264, DOI 10.1523/JNEUROSCI.3634-11.2011; McKenzie S, 2014, NEURON, V83, P202, DOI 10.1016/j.neuron.2014.05.019; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Meilinger T, 2008, LECT NOTES ARTIF INT, V5248, P344, DOI 10.1007/978-3-540-87601-4_25; Milivojevic B, 2016, J NEUROSCI, V36, P12412, DOI 10.1523/JNEUROSCI.2889-15.2016; Miller JF, 2015, CURR BIOL, V25, P1080, DOI 10.1016/j.cub.2015.02.045; Miller KJ, 2017, NAT NEUROSCI, V20, P1269, DOI 10.1038/nn.4613; Morgan LK, 2011, J NEUROSCI, V31, P1238, DOI 10.1523/JNEUROSCI.4667-10.2011; Nasr S, 2011, J NEUROSCI, V31, P13771, DOI 10.1523/JNEUROSCI.2792-11.2011; Nielson DM, 2015, P NATL ACAD SCI USA, V112, P11078, DOI 10.1073/pnas.1507104112; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKeefe J, 1996, NATURE, V381, P425, DOI 10.1038/381425a0; Patai E.Z., 2017, LONG TERM CONSOLIDAT; Pfeiffer BE, 2013, NATURE, V497, P74, DOI 10.1038/nature12112; Quiroga RQ, 2005, NATURE, V435, P1102, DOI 10.1038/nature03687; Ranganath C, 2012, NAT REV NEUROSCI, V13, P713, DOI 10.1038/nrn3338; Redish A. D., 1999, COGNITIVE MAP PLACE, DOI DOI 10.1038/nature14445; Ribas-Fernandes JJF, 2011, NEURON, V71, P370, DOI 10.1016/j.neuron.2011.05.042; Rosenbaum RS, 2004, HIPPOCAMPUS, V14, P826, DOI 10.1002/hipo.10218; Sarel A, 2017, SCIENCE, V355, P176, DOI 10.1126/science.aak9589; Sato N, 2006, P NATL ACAD SCI USA, V103, P17001, DOI 10.1073/pnas.0604277103; Schapiro AC, 2016, HIPPOCAMPUS, V26, P3, DOI 10.1002/hipo.22523; Schiller D, 2015, J NEUROSCI, V35, P13904, DOI 10.1523/JNEUROSCI.2618-15.2015; Schinazi VR, 2013, HIPPOCAMPUS, V23, P515, DOI 10.1002/hipo.22111; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Shelton AL, 2001, COGNITIVE PSYCHOL, V43, P274, DOI 10.1006/cogp.2001.0758; Sherrill KR, 2013, J NEUROSCI, V33, P19304, DOI 10.1523/JNEUROSCI.1825-13.2013; Shine JP, 2016, J NEUROSCI, V36, P6371, DOI 10.1523/JNEUROSCI.1268-15.2016; SHOLL MJ, 1987, J EXP PSYCHOL LEARN, V13, P615, DOI 10.1037/0278-7393.13.4.615; Simon DA, 2011, J NEUROSCI, V31, P5526, DOI 10.1523/JNEUROSCI.4647-10.2011; Spiers HJ, 2007, HIPPOCAMPUS, V17, P618, DOI 10.1002/hipo.20298; Spiers HJ, 2006, NEUROIMAGE, V31, P1826, DOI 10.1016/j.neuroimage.2006.01.037; Spiers HJ, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00125; Steemers B, 2016, CURR BIOL, V26, P1750, DOI 10.1016/j.cub.2016.04.063; Stensola T, 2015, NATURE, V518, P207, DOI 10.1038/nature14151; Sulpizio V, 2013, BEHAV BRAIN RES, V242, P62, DOI 10.1016/j.bbr.2012.12.031; Suthana NA, 2009, J NEUROSCI, V29, P10512, DOI 10.1523/JNEUROSCI.0621-09.2009; Taube JS, 2007, ANNU REV NEUROSCI, V30, P181, DOI 10.1146/annurev.neuro.29.051605.112854; Tavares RM, 2015, NEURON, V87, P231, DOI 10.1016/j.neuron.2015.06.011; Teng E, 1999, NATURE, V400, P675, DOI 10.1038/23276; TOLMAN EC, 1948, PSYCHOL REV, V55, P189, DOI 10.1037/h0061626; Troiani V, 2014, CEREB CORTEX, V24, P883, DOI 10.1093/cercor/bhs364; Turk-Browne NB, 2012, J NEUROSCI, V32, P7202, DOI 10.1523/JNEUROSCI.0942-12.2012; Vass LK, 2017, CEREB CORTEX, V27, P1457, DOI 10.1093/cercor/bhv343; Vass LK, 2013, J NEUROSCI, V33, P6133, DOI 10.1523/JNEUROSCI.3873-12.2013; Viard A, 2011, J NEUROSCI, V31, P4613, DOI 10.1523/JNEUROSCI.4640-10.2011; Wikenheiser AM, 2015, NAT NEUROSCI, V18, P289, DOI 10.1038/nn.3909; Wilber AA, 2014, J NEUROSCI, V34, P5431, DOI 10.1523/JNEUROSCI.0511-14.2014; Wills TJ, 2005, SCIENCE, V308, P873, DOI 10.1126/science.1108905; Wolbers T, 2005, J NEUROSCI, V25, P3333, DOI 10.1523/JNEUROSCI.4705-04.2005; Wolbers T, 2007, J NEUROSCI, V27, P9408, DOI 10.1523/JNEUROSCI.2146-07.2007; Wood ER, 1999, NATURE, V397, P613, DOI 10.1038/17605; Woollett K, 2011, CURR BIOL, V21, P2109, DOI 10.1016/j.cub.2011.11.018; Wu XJ, 2014, J NEUROSCI, V34, P6459, DOI 10.1523/JNEUROSCI.3414-13.2014; Yarkoni T, 2011, NAT METHODS, V8, P665, DOI [10.1038/NMETH.1635, 10.1038/nmeth.1635]; Yassa MA, 2011, TRENDS NEUROSCI, V34, P515, DOI 10.1016/j.tins.2011.06.006; Yoder RM, 2011, TRENDS NEUROSCI, V34, P561, DOI 10.1016/j.tins.2011.08.004	150	272	277	35	183	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2017	20	11					1504	1513		10.1038/nn.4656	http://dx.doi.org/10.1038/nn.4656			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FL0QV	29073650	Green Submitted, Green Accepted			2022-12-17	WOS:000413916800009
J	Yu, TW; Bargmann, CI				Yu, TW; Bargmann, CI			Dynamic regulation of axon guidance	NATURE NEUROSCIENCE			English	Review							GROWTH CONE GUIDANCE; RECEPTOR TYROSINE KINASES; CHEMOREPELLENT SEMAPHORIN-III; GANGLION-CELL AXONS; C-ELEGANS; CAENORHABDITIS-ELEGANS; PATHWAY SELECTION; EPH RECEPTOR; CNS MIDLINE; SAM DOMAIN	To reach their proper targets, axons rely upon the actions of highly conserved families of attractive and repulsive guidance molecules, including the netrins, Slits, semaphorins and ephrins. These guidance systems are used to generate an astonishingly varied set of neuronal circuits. Here we consider the mechanisms by which a few guidance systems can be used to generate diverse outcomes. Recent studies have revealed extensive transcriptional and post-transcriptional regulation of guidance cues and their receptors, as well as combinatorial mechanisms that integrate information from different families of guidance cues.	Univ Calif San Francisco, Howard Hughes Med Inst, Program Neurosci, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Program Neurosci, Dept Biochem & Biophys, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Bargmann, CI (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Program Neurosci, Dept Anat, San Francisco, CA 94143 USA.		Yu, Timothy W./AAF-5738-2019	Yu, Timothy W./0000-0003-2988-7701; Bargmann, Cornelia/0000-0002-8484-0618				Ackerman SL, 1997, NATURE, V386, P838, DOI 10.1038/386838a0; Baran R, 1999, DEVELOPMENT, V126, P2241; Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; Behar O, 1996, NATURE, V383, P525, DOI 10.1038/383525a0; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Brown A, 2000, CELL, V102, P77, DOI 10.1016/S0092-8674(00)00012-X; Bruckner K, 1998, CURR OPIN NEUROBIOL, V8, P375, DOI 10.1016/S0959-4388(98)80064-0; Castellani V, 2000, NEURON, V27, P237, DOI 10.1016/S0896-6273(00)00033-7; Castellani V, 1998, J NEUROSCI, V18, P4663; Chan SSY, 1996, CELL, V87, P187, DOI 10.1016/S0092-8674(00)81337-9; Chen H, 1997, NEURON, V19, P547, DOI 10.1016/S0896-6273(00)80371-2; Colavita A, 1998, DEV BIOL, V194, P72, DOI 10.1006/dbio.1997.8790; Corset V, 2000, NATURE, V407, P747, DOI 10.1038/35037600; Culotti JG, 1998, CURR OPIN CELL BIOL, V10, P609, DOI 10.1016/S0955-0674(98)80036-7; DAVIS S, 1994, SCIENCE, V266, P816, DOI 10.1126/science.7973638; Dutting D, 1999, DEV BIOL, V216, P297, DOI 10.1006/dbio.1999.9489; Erkman L, 2000, NEURON, V28, P779, DOI 10.1016/S0896-6273(00)00153-7; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Galko MJ, 2000, SCIENCE, V289, P1365, DOI 10.1126/science.289.5483.1365; Giger RJ, 1998, J NEUROSCI RES, V52, P27, DOI 10.1002/(SICI)1097-4547(19980401)52:1<27::AID-JNR4>3.0.CO;2-M; Guthrie S, 1999, CURR BIOL, V9, pR432, DOI 10.1016/S0960-9822(99)80274-7; HAMELIN M, 1993, NATURE, V364, P327, DOI 10.1038/364327a0; Hartmann B, 2000, MECH DEVELOP, V90, P143, DOI 10.1016/S0925-4773(99)00237-3; Hattori M, 2000, SCIENCE, V289, P1360, DOI 10.1126/science.289.5483.1360; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Hiramoto M, 2000, NATURE, V406, P886, DOI 10.1038/35022571; Holmberg J, 2000, NATURE, V408, P203, DOI 10.1038/35041577; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; Hopker VH, 1999, NATURE, V401, P69, DOI 10.1038/43441; Hornberger MR, 1999, NEURON, V22, P731, DOI 10.1016/S0896-6273(00)80732-1; Itoh A, 1998, MOL BRAIN RES, V62, P175, DOI 10.1016/S0169-328X(98)00224-1; Kania A, 2000, CELL, V102, P161, DOI 10.1016/S0092-8674(00)00022-2; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kidd T, 1998, NEURON, V20, P25, DOI 10.1016/S0896-6273(00)80431-6; Kitsukawa T, 1997, NEURON, V19, P995, DOI 10.1016/S0896-6273(00)80392-X; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; Kramer SG, 2001, SCIENCE, V292, P737, DOI 10.1126/science.1058766; Kullander K, 2001, NEURON, V29, P73, DOI 10.1016/S0896-6273(01)00181-7; Lander AD, 1990, CURR OPIN CELL BIOL, V2, P907, DOI 10.1016/0955-0674(90)90091-R; Landgraf M, 1999, NEURON, V22, P43, DOI 10.1016/S0896-6273(00)80677-7; Leonardo ED, 1997, NATURE, V386, P833, DOI 10.1038/386833a0; LEUNGHAGESTEIJN CY, 1992, CELL, V71, P289, DOI 10.1016/0092-8674(92)90357-I; Lu Q, 2001, CELL, V105, P69, DOI 10.1016/S0092-8674(01)00297-5; LUNDGREN SE, 1995, DEVELOPMENT, V121, P1769; Luo LQ, 2000, NEURON, V26, P1, DOI 10.1016/S0896-6273(00)81129-0; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; LUO YL, 1995, NEURON, V14, P1131, DOI 10.1016/0896-6273(95)90261-9; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Much JW, 2000, DEVELOPMENT, V127, P703; Mueller BK, 1999, ANNU REV NEUROSCI, V22, P351, DOI 10.1146/annurev.neuro.22.1.351; Nakagawa S, 2000, NEURON, V25, P599, DOI 10.1016/S0896-6273(00)81063-6; Nakamura F, 1998, NEURON, V21, P1093, DOI 10.1016/S0896-6273(00)80626-1; Nash B, 2000, GENE DEV, V14, P2486, DOI 10.1101/gad.831500; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Polleux F, 1998, SCIENCE, V282, P1904, DOI 10.1126/science.282.5395.1904; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; Rajagopalan S, 2000, CELL, V103, P1033, DOI 10.1016/S0092-8674(00)00207-5; Rajan TV, 2000, TROP MED SCI PRACT, V1, P1; Raper JA, 2000, CURR OPIN NEUROBIOL, V10, P88, DOI 10.1016/S0959-4388(99)00057-4; Retaux S, 1996, TRENDS NEUROSCI, V19, P542, DOI 10.1016/S0166-2236(96)10062-X; Rhinn M, 1999, DEVELOPMENT, V126, P4295; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schulte D, 2000, DEVELOPMENT, V127, P5033; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Simpson JH, 2000, CELL, V103, P1019, DOI 10.1016/S0092-8674(00)00206-3; Simpson JH, 2000, NEURON, V28, P753, DOI 10.1016/S0896-6273(00)00151-3; Smalla M, 1999, PROTEIN SCI, V8, P1954, DOI 10.1110/ps.8.10.1954; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Song HJ, 2001, NAT CELL BIOL, V3, pE81, DOI 10.1038/35060164; Stapleton D, 1999, NAT STRUCT BIOL, V6, P44; Stein E, 2001, SCIENCE, V291, P1976, DOI 10.1126/science.1059391; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; Steven R, 1998, CELL, V92, P785, DOI 10.1016/S0092-8674(00)81406-3; Su MW, 2000, DEVELOPMENT, V127, P585; Sun Q, 2000, DEVELOPMENT, V127, P801; Takahashi T, 2001, NEURON, V29, P429, DOI 10.1016/S0896-6273(01)00216-1; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Tamagnone L, 2000, TRENDS CELL BIOL, V10, P377, DOI 10.1016/S0962-8924(00)01816-X; TANAKA E, 1995, CELL, V83, P171, DOI 10.1016/0092-8674(95)90158-2; Tear G, 1996, NEURON, V16, P501, DOI 10.1016/S0896-6273(00)80070-7; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Thanos CD, 1999, SCIENCE, V283, P833, DOI 10.1126/science.283.5403.833; Thor S, 1999, NATURE, V397, P76, DOI 10.1038/16275; Thor S, 1997, NEURON, V18, P397, DOI 10.1016/S0896-6273(00)81241-6; Van Vactor D, 1999, NEURON, V22, P649, DOI 10.1016/S0896-6273(00)80723-0; Wadsworth WG, 1996, NEURON, V16, P35, DOI 10.1016/S0896-6273(00)80021-5; Whitaker GB, 2001, J BIOL CHEM, V276, P25520, DOI 10.1074/jbc.M102315200; Wightman B, 1996, DEVELOPMENT, V122, P671; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; Wolf FW, 1998, NEURON, V20, P655, DOI 10.1016/S0896-6273(00)81006-5; Yuan WL, 1999, DEV BIOL, V212, P290, DOI 10.1006/dbio.1999.9371; Zallen JA, 1999, DEVELOPMENT, V126, P3679; Zheng JQ, 2000, NATURE, V403, P89, DOI 10.1038/47501; Zipkin ID, 1997, CELL, V90, P883, DOI 10.1016/S0092-8674(00)80353-0	101	272	293	0	27	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2001	4			S			1169	1176		10.1038/nn748	http://dx.doi.org/10.1038/nn748			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	490GF	11687826				2022-12-17	WOS:000172041500008
J	Shenhav, A; Cohen, JD; Botvinick, MM				Shenhav, Amitai; Cohen, Jonathan D.; Botvinick, Matthew M.			Dorsal anterior cingulate cortex and the value of control	NATURE NEUROSCIENCE			English	Article							DECISION-MAKING TASK; COGNITIVE CONTROL; PREFRONTAL CORTEX; NEGATIVE AFFECT; ATTENTIONAL CONTROL; NONHUMAN-PRIMATES; NEURONAL-ACTIVITY; ADAPTIVE-CONTROL; HUMAN BRAIN; CONFLICT	Debates over the function(s) of dorsal anterior cingulate cortex (dACC) have persisted for decades. So too have demonstrations of the region's association with cognitive control. Researchers have struggled to account for this association and, simultaneously, dACC's involvement in phenomena related to evaluation and motivation. We describe a recent integrative theory that achieves this goal. It proposes that dACC serves to specify the currently optimal allocation of control by determining the overall expected value of control (EVC), thereby licensing the associated cognitive effort. The EVC theory accounts for dACC's sensitivity to a wide array of experimental variables, and their relationship to subsequent control adjustments. Finally, we contrast our theory with a recent theory proposing a primary role for dACC in foraging-like decisions. We describe why the EVC theory offers a more comprehensive and coherent account of dACC function, including dACC's particular involvement in decisions regarding foraging or otherwise altering one's behavior.	[Shenhav, Amitai; Cohen, Jonathan D.; Botvinick, Matthew M.] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA; [Shenhav, Amitai] Brown Univ, Dept Cognit Linguist & Psychol Sci, Providence, RI 02912 USA; [Shenhav, Amitai] Brown Univ, Brown Inst Brain Sci, Providence, RI 02912 USA; [Cohen, Jonathan D.; Botvinick, Matthew M.] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; [Botvinick, Matthew M.] Google DeepMind, London, England; [Botvinick, Matthew M.] UCL, Gatsby Computat Neurosci Unit, London, England	Princeton University; Brown University; Brown University; Princeton University; Google Incorporated; University of London; University College London	Shenhav, A (corresponding author), Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA.	amitai_shenhav@brown.edu			C.V. Starr Foundation; John Templeton Foundation	C.V. Starr Foundation; John Templeton Foundation	The authors would like to thank J. Cavanagh for his feedback on an earlier draft of the manuscript. This work was supported by the C.V. Starr Foundation (A.S.) and the John Templeton Foundation. The opinions expressed in this publication are those of the authors and do not necessarily reflect the views of the John Templeton Foundation.	Alexander WH, 2015, NEURAL COMPUT, V27, P2354, DOI 10.1162/NECO_a_00779; Amiez C, 2012, NEUROIMAGE, V63, P1078, DOI 10.1016/j.neuroimage.2012.06.023; Botvinick M, 2015, ANNU REV PSYCHOL, V66, P83, DOI 10.1146/annurev-psych-010814-015044; Botvinick MM, 2014, COGNITIVE SCI, V38, P1249, DOI 10.1111/cogs.12126; Botvinick MM, 2009, COGN AFFECT BEHAV NE, V9, P16, DOI 10.3758/CABN.9.1.16; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Cavanagh JF, 2015, J PHYSIOL-PARIS, V109, P3, DOI 10.1016/j.jphysparis.2014.04.003; Cavanagh JF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6394; Cavanagh JF, 2014, TRENDS COGN SCI, V18, P414, DOI 10.1016/j.tics.2014.04.012; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Chudasama Y, 2013, CEREB CORTEX, V23, P2884, DOI 10.1093/cercor/bhs266; COHEN JD, 1990, PSYCHOL REV, V97, P332, DOI 10.1037/0033-295X.97.3.332; Cole MW, 2009, TRENDS NEUROSCI, V32, P566, DOI 10.1016/j.tins.2009.07.001; de Wit S, 2012, J NEUROSCI, V32, P12066, DOI 10.1523/JNEUROSCI.1088-12.2012; Ebitz RB, 2015, NEURON, V85, P628, DOI 10.1016/j.neuron.2014.12.053; Fellows LK, 2005, BRAIN, V128, P788, DOI 10.1093/brain/awh405; Gaymard B, 1998, EXP BRAIN RES, V120, P173, DOI 10.1007/s002210050391; Glascher J, 2012, P NATL ACAD SCI USA, V109, P14681, DOI 10.1073/pnas.1206608109; Hare TA, 2011, P NATL ACAD SCI USA, V108, P18120, DOI 10.1073/pnas.1109322108; Heilbronner SR, 2016, ANNU REV NEUROSCI, V39, P149, DOI 10.1146/annurev-neuro-070815-013952; Hillman KL, 2010, J NEUROSCI, V30, P7705, DOI 10.1523/JNEUROSCI.1273-10.2010; Hochman EY, 2015, NEUROPSYCHOLOGIA, V69, P130, DOI 10.1016/j.neuropsychologia.2015.01.023; Holroyd CB, 2012, TRENDS COGN SCI, V16, P122, DOI 10.1016/j.tics.2011.12.008; Hosking JG, 2014, NEUROPSYCHOPHARMACOL, V39, P1558, DOI 10.1038/npp.2014.27; Ito S, 2003, SCIENCE, V302, P120, DOI 10.1126/science.1087847; Johnston K, 2007, NEURON, V53, P453, DOI 10.1016/j.neuron.2006.12.023; Kaping D, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001224; Kennerley SW, 2006, NAT NEUROSCI, V9, P940, DOI 10.1038/nn1724; Kolling N, 2016, CURR OPIN NEUROBIOL, V37, P36, DOI 10.1016/j.conb.2015.12.007; Kolling N, 2012, SCIENCE, V336, P95, DOI 10.1126/science.1216930; Kouneiher F, 2009, NAT NEUROSCI, V12, P939, DOI 10.1038/nn.2321; Ma LY, 2014, J NEUROSCI, V34, P2244, DOI 10.1523/JNEUROSCI.3834-13.2014; Magno E, 2006, J NEUROSCI, V26, P4769, DOI 10.1523/JNEUROSCI.0369-06.2006; Manohar SG, 2015, CURR BIOL, V25, P1707, DOI 10.1016/j.cub.2015.05.038; McGuire JT, 2014, NEURON, V84, P870, DOI 10.1016/j.neuron.2014.10.013; McGuire JT, 2010, P NATL ACAD SCI USA, V107, P7922, DOI 10.1073/pnas.0910662107; Metzler-Baddeley C, 2012, J NEUROSCI, V32, P17612, DOI 10.1523/JNEUROSCI.3299-12.2012; Michelet T, 2016, CEREB CORTEX, V26, P1684, DOI 10.1093/cercor/bhv004; Mulder MJ, 2012, J NEUROSCI, V32, P2335, DOI 10.1523/JNEUROSCI.4156-11.2012; Musslick S., 2015, REINFORCEMENT LEARNI, P6; Nakamura K, 2005, J NEUROPHYSIOL, V93, P884, DOI 10.1152/jn.00305.2004; Narayanan NS, 2013, NAT NEUROSCI, V16, P1888, DOI 10.1038/nn.3549; Newman LA, 2015, J PHYSIOL-PARIS, V109, P95, DOI 10.1016/j.jphysparis.2014.06.004; O'Reilly JX, 2013, P NATL ACAD SCI USA, V110, pE3660, DOI 10.1073/pnas.1305373110; Oehrn CR, 2014, J NEUROSCI, V34, P10438, DOI 10.1523/JNEUROSCI.3099-13.2014; Parvizi J, 2013, NEURON, V80, P1359, DOI 10.1016/j.neuron.2013.10.057; Payzan-LeNestour E, 2013, NEURON, V79, P191, DOI 10.1016/j.neuron.2013.04.037; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; Phillips JM, 2014, NEUROIMAGE, V97, P308, DOI 10.1016/j.neuroimage.2014.04.028; Phillips JM, 2011, J COGNITIVE NEUROSCI, V23, P481, DOI 10.1162/jocn.2010.21482; Procyk E, 2016, CEREB CORTEX, V26, P467, DOI 10.1093/cercor/bhu213; Quilodran R, 2008, NEURON, V57, P314, DOI 10.1016/j.neuron.2007.11.031; Reinhart RMG, 2015, P NATL ACAD SCI USA, V112, P9448, DOI 10.1073/pnas.1504196112; Reinhart RMG, 2014, J NEUROSCI, V34, P4214, DOI 10.1523/JNEUROSCI.5421-13.2014; Rushworth MFS, 2012, CURR OPIN NEUROBIOL, V22, P946, DOI 10.1016/j.conb.2012.04.011; Schall JD, 2010, BRAIN BEHAV EVOLUT, V75, P237, DOI 10.1159/000313862; Schlund MW, 2016, NEUROIMAGE, V136, P94, DOI 10.1016/j.neuroimage.2016.04.070; Shackman AJ, 2011, NAT REV NEUROSCI, V12, P154, DOI 10.1038/nrn2994; Shen C, 2015, CEREB CORTEX, V25, P2213, DOI 10.1093/cercor/bhu028; Shenhav A., 2016, COGN AFFECT BEHAV NE; Shenhav A, 2014, NAT NEUROSCI, V17, P1249, DOI 10.1038/nn.3771; Shenhav A, 2013, NEURON, V79, P217, DOI 10.1016/j.neuron.2013.07.007; Sheth SA, 2012, NATURE, V488, P218, DOI 10.1038/nature11239; Spunt RP, 2012, J COGNITIVE NEUROSCI, V24, P1753, DOI 10.1162/jocn_a_00242; Stuss DT, 2007, PHILOS T R SOC B, V362, P901, DOI 10.1098/rstb.2007.2096; Tang H., 2016, ELIFE, V5, P4671; Tolomeo S, 2016, BRAIN, V139, P1844, DOI 10.1093/brain/aww069; Ullsperger M, 2014, PHYSIOL REV, V94, P35, DOI 10.1152/physrev.00041.2012; Venkatraman V, 2012, EUR J NEUROSCI, V35, P1075, DOI 10.1111/j.1460-9568.2012.08009.x; Vogt BA, 2016, J CHEM NEUROANAT, V74, P28, DOI 10.1016/j.jchemneu.2016.01.010; Wallis JD, 2011, ANN NY ACAD SCI, V1239, P33, DOI 10.1111/j.1749-6632.2011.06277.x; Warren CM, 2015, J PHYSIOL-PARIS, V109, P87, DOI 10.1016/j.jphysparis.2014.08.008; Westbrook A, 2016, NEURON, V89, P695, DOI [10.1016/j.neuron.2015.12.029, 10.1016/j.neuron.2016.07.020]; Westbrook A, 2015, COGN AFFECT BEHAV NE, V15, P395, DOI 10.3758/s13415-015-0334-y; Womelsdorf T, 2010, P NATL ACAD SCI USA, V107, P5248, DOI 10.1073/pnas.0906194107	75	271	271	6	94	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2016	19	10					1286	1291		10.1038/nn.4384	http://dx.doi.org/10.1038/nn.4384			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DX7ER	27669989				2022-12-17	WOS:000384549900008
J	Posthuma, D; De Geus, EJC; Baare, WFC; Pol, HEH; Kahn, RS; Boomsma, DI				Posthuma, D; De Geus, EJC; Baare, WFC; Pol, HEH; Kahn, RS; Boomsma, DI			The association between brain volume and intelligence is of genetic origin	NATURE NEUROSCIENCE			English	Letter									Free Univ Amsterdam, Dept Biol Psychol, NL-1081 BT Amsterdam, Netherlands; Univ Med Ctr, Dept Psychiat, NL-3584 CX Utrecht, Netherlands	Vrije Universiteit Amsterdam; Utrecht University; Utrecht University Medical Center	Posthuma, D (corresponding author), Free Univ Amsterdam, Dept Biol Psychol, van der Goechorststr 1, NL-1081 BT Amsterdam, Netherlands.	d.posthuma@psy.vu.nl	de Geus, Eco J.C./M-9318-2015; Hulshoff Pol, Hilleke Evertje/B-4795-2014; Baare, William/GPK-7674-2022; Boomsma, Dorret I/AAX-4470-2020	de Geus, Eco J.C./0000-0001-6022-2666; Hulshoff Pol, Hilleke Evertje/0000-0002-2038-5281; Posthuma, Danielle/0000-0001-7582-2365; Baare, William Frans Christiaan/0000-0002-1810-7266				[Anonymous], 1999, MOL CELL ENDOCRINOL; Baare WFC, 2001, CEREB CORTEX, V11, P816, DOI 10.1093/cercor/11.9.816; Daneman M, 1996, PSYCHON B REV, V3, P422, DOI 10.3758/BF03214546; GoldmanRakic PS, 1996, P NATL ACAD SCI USA, V93, P13473, DOI 10.1073/pnas.93.24.13473; NEALE MC, 1992, NATO ASI SERIES D, V67; Pennington BF, 2000, J COGNITIVE NEUROSCI, V12, P223, DOI 10.1162/089892900561850; Plomin R, 2001, NAT NEUROSCI, V4, P1153, DOI 10.1038/nn1201-1153; PLOMIN R, IN PRESS BEHAV GENET; Posthuma D, 2001, BEHAV GENET, V31, P593, DOI 10.1023/A:1013349512683; Thompson PM, 2001, NAT NEUROSCI, V4, P1253, DOI 10.1038/nn758; Vernon PA., 2000, HDB INTELLIGENCE, P245, DOI DOI 10.1017/CBO9780511807947.013	11	271	275	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2002	5	2					83	84		10.1038/nn0202-83	http://dx.doi.org/10.1038/nn0202-83			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	516NB	11818967	Green Published			2022-12-17	WOS:000173558400002
J	Tsunoda, K; Yamane, Y; Nishizaki, M; Tanifuji, M				Tsunoda, K; Yamane, Y; Nishizaki, M; Tanifuji, M			Complex objects are represented in macaque inferotemporal cortex by the combination of feature columns	NATURE NEUROSCIENCE			English	Article							SUPERIOR TEMPORAL SULCUS; VENTRAL VISUAL PATHWAY; FUNCTIONAL ARCHITECTURE; MONKEY; NEURONS; ORGANIZATION; SELECTIVITY; RECOGNITION; RESPONSES; FACES	Intrinsic signal imaging from inferotemporal (IT) cortex, a visual area essential for object perception and recognition, revealed that visually presented objects activated patches in a distributed manner. When visual features of these objects were partially removed, the simplified stimuli activated only a subset of the patches elicited by the originals. This result, in conjunction with extracellular recording, suggests that an object is represented by a combination of cortical columns, each of which represents a visual feature (feature column). Simplification of an object occasionally caused the appearance of columns that were not active when viewing the more complex form. Thus, not all the columns related to a particular feature were necessarily activated by the original objects. Taken together, these results suggest that objects may be represented not only by simply combining feature columns but also by using a variety of combinations of active and inactive columns for individual features.	RIKEN, Inst Phys & Chem Res, Brain Sci Inst, Lab Integrat Neural Syst, Wako, Saitama 3510198, Japan; Hokkaido Univ, Grad Sch Sci, Div Biol Sci, Sapporo, Hokkaido 0600810, Japan	RIKEN; Hokkaido University	Tanifuji, M (corresponding author), RIKEN, Inst Phys & Chem Res, Brain Sci Inst, Lab Integrat Neural Syst, Hirosawa 2-1, Wako, Saitama 3510198, Japan.		Tanifuji, Manabu/H-1744-2019	Tanifuji, Manabu/0000-0001-7754-7774; yamane, yukako/0000-0002-3348-1942				BAYLIS GC, 1985, BRAIN RES, V342, P91, DOI 10.1016/0006-8993(85)91356-3; BIEDERMAN I, 1987, PSYCHOL REV, V94, P115, DOI 10.1037/0033-295X.94.2.115; BLASDEL GG, 1992, J NEUROSCI, V12, P3139, DOI 10.1523/JNEUROSCI.12-08-03139.1992; DAS A, 1995, NATURE, V375, P780, DOI 10.1038/375780a0; DESIMONE R, 1984, J NEUROSCI, V4, P2051; Edelman S, 1998, PSYCHOBIOLOGY, V26, P309; Erickson CA, 1999, J NEUROSCI, V19, P10404; FUJITA I, 1992, NATURE, V360, P343, DOI 10.1038/360343a0; Ghose GM, 1997, J NEUROPHYSIOL, V77, P2191, DOI 10.1152/jn.1997.77.4.2191; GOCHIN PM, 1991, EXP BRAIN RES, V84, P505; GROSS CG, 1972, J NEUROPHYSIOL, V35, P96, DOI 10.1152/jn.1972.35.1.96; HASSELMO ME, 1989, EXP BRAIN RES, V75, P417; Ishai A, 1999, P NATL ACAD SCI USA, V96, P9379, DOI 10.1073/pnas.96.16.9379; KOBATAKE E, 1994, J NEUROPHYSIOL, V71, P856, DOI 10.1152/jn.1994.71.3.856; MALONEK D, 1994, P ROY SOC B-BIOL SCI, V258, P109, DOI 10.1098/rspb.1994.0150; MARR D, 1978, PROC R SOC SER B-BIO, V200, P269, DOI 10.1098/rspb.1978.0020; PERRETT DI, 1982, EXP BRAIN RES, V47, P329; ROE AW, 1995, J NEUROSCI, V15, P3689; SAKAI K, 1991, NATURE, V354, P152, DOI 10.1038/354152a0; Shtoyerman E, 2000, J NEUROSCI, V20, P8111; TANAKA K, 1991, J NEUROPHYSIOL, V66, P170, DOI 10.1152/jn.1991.66.1.170; TSO DY, 1990, SCIENCE, V249, P417, DOI 10.1126/science.2165630; Uchida N, 2000, NAT NEUROSCI, V3, P1035, DOI 10.1038/79857; Ullman S, 1999, NEURAL NETWORKS, V12, P1021, DOI 10.1016/S0893-6080(99)00048-9; Wang G, 1998, NEUROSCI RES, V32, P33, DOI 10.1016/S0168-0102(98)00062-5; Wang G, 1996, SCIENCE, V272, P1665, DOI 10.1126/science.272.5268.1665; Wang Y, 2000, NAT NEUROSCI, V3, P807, DOI 10.1038/77712; YAMANE S, 1988, EXP BRAIN RES, V73, P209, DOI 10.1007/BF00279674	28	271	277	0	14	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2001	4	8					832	838		10.1038/90547	http://dx.doi.org/10.1038/90547			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	457KY	11477430				2022-12-17	WOS:000170137300017
J	Amedi, A; Stern, WM; Camprodon, JA; Bermpohl, F; Merabet, L; Rotman, S; Hemond, C; Meijer, P; Pascual-Leone, A				Amedi, Amir; Stern, William M.; Camprodon, Joan A.; Bermpohl, Felix; Merabet, Lotfi; Rotman, Stephen; Hemond, Christopher; Meijer, Peter; Pascual-Leone, Alvaro			Shape conveyed by visual-to-auditory sensory substitution activates the lateral occipital complex	NATURE NEUROSCIENCE			English	Article							CORTEX; PERCEPTION; PATHWAY; VISION	The lateral-occipital tactile-visual area (LOtv) is activated when objects are recognized by vision or touch. We report here that the LOtv is also activated in sighted and blind humans who recognize objects by extracting shape information from visual-to-auditory sensory substitution soundscapes. Recognizing objects by their typical sounds or learning to associate specific soundscapes with specific objects do not activate this region. This suggests that LOtv is driven by the presence of shape information.	Harvard Univ, Sch Med, Dept Neurol, Berenson Allen Ctr Noninvas Brain Stimulat, Boston, MA 02115 USA; Hebrew Univ Jerusalem, Dept Physiol, IL-91220 Jerusalem, Israel; Hebrew Univ Jerusalem, Program Cognit Sci, IL-91220 Jerusalem, Israel; Charite Univ Med Berlin, Dept Psychiat, D-10117 Berlin, Germany; NXP Semicond, NL-5656 AE Eindhoven, Netherlands	Harvard University; Harvard Medical School; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; NXP Semiconductors	Amedi, A (corresponding author), Harvard Univ, Sch Med, Dept Neurol, Berenson Allen Ctr Noninvas Brain Stimulat, 330 Brookline Ave, Boston, MA 02115 USA.	aamedi@bidmc.harvard.edu; apleone@bidmc.harvard.edu	Pascual-Leone, Alvaro/G-6566-2011; Merabet, Lotfi B./V-2735-2017; Hemond, Christopher/AAJ-7568-2020; merabet, lotfi/AAU-8259-2020; Pascual-Leone, Alvaro/AAC-5101-2019; Camprodon, Joan Albert/M-9093-2017	Merabet, Lotfi B./0000-0002-8094-9536; Hemond, Christopher/0000-0002-2408-4638; merabet, lotfi/0000-0002-8094-9536; Pascual-Leone, Alvaro/0000-0001-8975-0382; Camprodon, Joan Albert/0000-0003-1282-9257; Bermpohl, Felix/0000-0002-3260-6328; Amedi, Amir/0000-0001-5042-2533	NATIONAL CENTER FOR RESEARCH RESOURCES [K24RR018875] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY012091] Funding Source: NIH RePORTER; NCRR NIH HHS [K24-RR018875] Funding Source: Medline; NEI NIH HHS [R21-EY0116168, R01-EY12091] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Amedi A, 2005, EXP BRAIN RES, V166, P559, DOI 10.1007/s00221-005-2396-5; Amedi A, 2001, NAT NEUROSCI, V4, P324, DOI 10.1038/85201; Bach-y-Rita P, 2003, TRENDS COGN SCI, V7, P541, DOI 10.1016/j.tics.2003.10.013; Beauchamp MS, 2005, CURR OPIN NEUROBIOL, V15, P145, DOI 10.1016/j.conb.2005.03.011; Buchel C, 1998, NATURE, V394, P274, DOI 10.1038/28389; Collignon O, 2007, CEREB CORTEX, V17, P457, DOI 10.1093/cercor/bhj162; Hull J.M., 1992, TOUCHING ROCK EXPERI; MEIJER PBL, 1992, IEEE T BIO-MED ENG, V39, P112, DOI 10.1109/10.121642; Pascual-Leone A, 2005, ANNU REV NEUROSCI, V28, P377, DOI 10.1146/annurev.neuro.27.070203.144216; PASCUALLEONE A, 2001, VISION NEURONS COGNI, pCH27; RAUSCHECKER JP, 1995, TRENDS NEUROSCI, V18, P36, DOI 10.1016/0166-2236(95)93948-W; Renier L, 2005, NEUROIMAGE, V26, P573, DOI 10.1016/j.neuroimage.2005.01.047; RICCIARDI E, 2007, CEREB, DOI DOI 10.1098/CERC3R/BH7018; Sathian K, 2005, DEV PSYCHOBIOL, V46, P279, DOI 10.1002/dev.20056; Zangaladze A, 1999, NATURE, V401, P587, DOI 10.1038/44139	15	270	272	1	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2007	10	6					687	689		10.1038/nn1912	http://dx.doi.org/10.1038/nn1912			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	172JI	17515898				2022-12-17	WOS:000246799800010
J	Schoenemann, PT; Sheehan, MJ; Glotzer, LD				Schoenemann, PT; Sheehan, MJ; Glotzer, LD			Prefrontal white matter volume is disproportionately larger in humans than in other primates	NATURE NEUROSCIENCE			English	Article							BRAIN SIZE; FRONTAL-CORTEX; COMPARATIVE PERSPECTIVE; SEX-DIFFERENCES; MR-IMAGES; EVOLUTION; LANGUAGE; STEREOLOGY; NEOCORTEX; MAMMALS	Determining how the human brain differs from nonhuman primate brains is central to understanding human behavioral evolution. There is currently dispute over whether the prefrontal cortex, which mediates evolutionarily interesting behaviors, has increased disproportionately. Using magnetic resonance imaging brain scans from 11 primate species, we measured gray, white and total volumes for both prefrontal and the entire cerebrum on each specimen (n = 46). In relative terms, prefrontal white matter shows the largest difference between human and nonhuman, whereas gray matter shows no significant difference. This suggests that connectional elaboration (as gauged by white matter volume) played a key role in human brain evolution.	Univ Penn, Dept Anthropol, Philadelphia, PA 19104 USA	University of Pennsylvania	Schoenemann, PT (corresponding author), Univ Penn, Dept Anthropol, 3260 South St, Philadelphia, PA 19104 USA.	ptschoen@sas.upenn.edu	Sheehan, Michael/F-5612-2012	Sheehan, Michael/0000-0002-3949-7873				Aboitiz F, 1997, BRAIN RES REV, V25, P381, DOI 10.1016/S0165-0173(97)00053-2; ANKNEY CD, 1992, INTELLIGENCE, V16, P329; ARMSTRONG E, 1991, J HUM EVOL, V20, P341, DOI 10.1016/0047-2484(91)90014-M; Blinkov SM., 1968, HUMAN BRAIN FIGURES; Brodmann K., 1909, VERGLEICHENDE LOKALI; Brodmann Karl, 1912, Anatomischer Anzeiger, V41; Bush EC, 2004, P NATL ACAD SCI USA, V101, P3962, DOI 10.1073/pnas.0305760101; Changizi MA, 2001, BIOL CYBERN, V84, P207, DOI 10.1007/s004220000205; Damasio A.R., 1985, INT J CLIN NEUROPSYC, P339; Deacon TW., 1997, SYMBOLIC SPECIES COE; DEBRUIN JPC, 1990, PROG BRAIN RES, V85, P485; Dunbar RIM, 1996, GROOMING GOSSIP EVOL; ELIAS H, 1971, PHYSIOL REV, V51, P158, DOI 10.1152/physrev.1971.51.1.158; Falk D, 1999, J HUM EVOL, V36, P233, DOI 10.1006/jhev.1998.0273; Fuster J., 1989, DISSERT ABSTRACTS IN, V60, P255; FUSTER JM, 1985, HUM NEUROBIOL, V4, P169; Gabrieli JDE, 1998, P NATL ACAD SCI USA, V95, P906, DOI 10.1073/pnas.95.3.906; GoldmanRakic PS, 1996, PHILOS T ROY SOC B, V351, P1445, DOI 10.1098/rstb.1996.0129; Gray JR, 2004, NAT REV NEUROSCI, V5, P471, DOI 10.1038/nrn1405; Guillemaud R, 1997, IEEE T MED IMAGING, V16, P238, DOI 10.1109/42.585758; HARVEY PH, 1985, EVOLUTION, V39, P559, DOI 10.1111/j.1558-5646.1985.tb00395.x; HOFMAN MA, 1983, Q REV BIOL, V58, P495, DOI 10.1086/413544; HOLLOWAY RALPH L., 1968, BRAIN RES, V7, P121, DOI 10.1016/0006-8993(68)90094-2; Holloway Ralph L., 1995, P42; Holloway RL, 2002, AM J PHYS ANTHROPOL, V118, P399, DOI 10.1002/ajpa.10090; HOLLOWAY RL, 1992, J HUM EVOL, V22, P163, DOI 10.1016/S0047-2484(05)80005-3; Humphrey N., 1984, CONSCIOUSNESS REGAIN, P14, DOI DOI 10.1126/SCIENCE.860134; Jerison H.J., 1982, P77; KRUBITZER L, 1995, TRENDS NEUROSCI, V18, P408, DOI 10.1016/0166-2236(95)93938-T; Lieberman P, 2002, YEARB PHYS ANTHROPOL, V45, P36, DOI 10.1002/ajpa.10171; McBride T, 1999, BRAIN BEHAV EVOLUT, V54, P159, DOI 10.1159/000006620; Melhem ER, 2002, AM J ROENTGENOL, V178, P3, DOI 10.2214/ajr.178.1.1780003; Rilling JK, 1999, J HUM EVOL, V37, P191, DOI 10.1006/jhev.1999.0313; RINGO JL, 1991, BRAIN BEHAV EVOLUT, V38, P1, DOI 10.1159/000114375; Roberts N, 2000, BRIT J RADIOL, V73, P679, DOI 10.1259/bjr.73.871.11089458; Rumbaugh DM, 1996, JPN PSYCHOL RES, V38, P113, DOI 10.1111/j.1468-5884.1996.tb00016.x; SAVAGERUMBAUGH ES, 1993, TOOLS, LANGUAGE AND COGNITION IN HUMAN EVOLUTION, P86; Schoenemann PT, 2000, P NATL ACAD SCI USA, V97, P4932, DOI 10.1073/pnas.97.9.4932; Schoenemann PT, 1999, MIND MACH, V9, P309, DOI 10.1023/A:1008360020568; Semendeferi K, 2002, NAT NEUROSCI, V5, P272, DOI 10.1038/nn814; Semendeferi K, 2001, AM J PHYS ANTHROPOL, V114, P224, DOI 10.1002/1096-8644(200103)114:3<224::AID-AJPA1022>3.0.CO;2-I; Semendeferi K, 1998, AM J PHYS ANTHROPOL, V106, P129, DOI 10.1002/(SICI)1096-8644(199806)106:2<129::AID-AJPA3>3.0.CO;2-L; STEPHAN H, 1981, FOLIA PRIMATOL, V35, P1, DOI 10.1159/000155963; Thompson PM, 2001, NAT NEUROSCI, V4, P1253, DOI 10.1038/nn758; Thompson-Schill SL, 1998, P NATL ACAD SCI USA, V95, P15855, DOI 10.1073/pnas.95.26.15855; UYLINGS HBM, 1990, PROG BRAIN RES, V85, P31; VENDRELL P, 1995, NEUROPSYCHOLOGIA, V33, P341, DOI 10.1016/0028-3932(94)00116-7; VONBONIN G, 1948, FRONT LOB P ASS RES; Wynn T, 2002, BEHAV BRAIN SCI, V25, P389, DOI 10.1017/S0140525X02000079; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	50	270	274	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2005	8	2					242	252		10.1038/nn1394	http://dx.doi.org/10.1038/nn1394			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	892GN	15665874				2022-12-17	WOS:000226638200025
J	Ahmed, SH; Kenny, PJ; Koob, GF; Markou, A				Ahmed, SH; Kenny, PJ; Koob, GF; Markou, A			Neurobiological evidence for hedonic allostasis associated with escalating cocaine use	NATURE NEUROSCIENCE			English	Article							DRUG-ADDICTION; REWARD; BRAIN; WITHDRAWAL; DEPRESSION		Univ Bordeaux 2, CNRS, UMR 5541, Lab Neuropsychobiol Desadaptat, F-33076 Bordeaux, France; Scripps Res Inst, Res Inst, Dept Neuropharmacol, La Jolla, CA 92037 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Scripps Research Institute	Ahmed, SH (corresponding author), Univ Bordeaux 2, CNRS, UMR 5541, Lab Neuropsychobiol Desadaptat, 146 Rue Leo Saignat, F-33076 Bordeaux, France.		AHMED, Serge H/D-5236-2014	Ahmed, Serge/0000-0002-1225-9234	NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011946, R01DA004398, R56DA011946] Funding Source: NIH RePORTER; NIDA NIH HHS [DA11946, R56 DA011946, DA04398] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Ahmed SH, 1998, SCIENCE, V282, P298, DOI 10.1126/science.282.5387.298; Ahmed SH, 2000, NEUROPSYCHOPHARMACOL, V22, P413, DOI 10.1016/S0893-133X(99)00133-5; Epping-Jordan MP, 1998, NATURE, V393, P76, DOI 10.1038/30001; Koob GF, 2001, NEUROPSYCHOPHARMACOL, V24, P97, DOI 10.1016/S0893-133X(00)00195-0; Koob GF, 1996, NEURON, V16, P893, DOI 10.1016/S0896-6273(00)80109-9; KORNETSKY C, 1979, FED PROC, V38, P2473; LEITH NJ, 1976, PSYCHOPHARMACOLOGIA, V46, P19, DOI 10.1007/BF00421544; MARKOU A, 1992, PHYSIOL BEHAV, V51, P111, DOI 10.1016/0031-9384(92)90211-J; MARKOU A, 1991, NEUROPSYCHOPHARMACOL, V4, P17; Markou A, 1998, NEUROPSYCHOPHARMACOL, V18, P135, DOI 10.1016/S0893-133X(97)00113-9; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; SCHULTEIS G, 1995, P NATL ACAD SCI USA, V92, P5880, DOI 10.1073/pnas.92.13.5880; Wise RA, 1996, ANNU REV NEUROSCI, V19, P319, DOI 10.1146/annurev.ne.19.030196.001535	13	270	279	0	16	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2002	5	7					625	626		10.1038/nn872	http://dx.doi.org/10.1038/nn872			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	566EP	12055635				2022-12-17	WOS:000176414300007
J	Cossart, R; Esclapez, M; Hirsch, JC; Bernard, C; Ben-Ari, Y				Cossart, R; Esclapez, M; Hirsch, JC; Bernard, C; Ben-Ari, Y			GluR5 kainate receptor activation in interneurons increases tonic inhibition of pyramidal cells	NATURE NEUROSCIENCE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; TEMPORAL-LOBE EPILEPSY; KAINIC ACID; SYNAPTIC TRANSMISSION; EPILEPTIFORM ACTIVITY; GABAERGIC INHIBITION; HIPPOCAMPAL-NEURONS; MONKEY HIPPOCAMPUS; RAT HIPPOCAMPUS; K+ CONDUCTANCE	We studied the modulation of GABAergic inhibition by glutamate and kainate acting on GluR5-containing kainate receptors in the CA1 hippocampal region. Glutamate, kainate or ATPA, a selective agonist of GluR5-containing receptors, generates an inward current in inhibitory interneurons and cause repetitive action potential firing. This results in a massive increase of tonic GABAergic inhibition in the somata and apical dendrites of pyramidal neurons. These effects are prevented by the GluR5 antagonist LY 293558. Electrical stimulation of excitatory afferents generates kainate receptor-mediated excitatory postsynaptic currents (EPSCs) and action potentials in identified interneurons that project to the dendrites and somata of pyramidal neurons. Therefore glutamate acting on kainate receptors containing the GluR5 subunit may provide a protective mechanism against hyperexcitability.	Hop Port Royal, INSERM, U29, F-75014 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Ben-Ari, Y (corresponding author), Hop Port Royal, INSERM, U29, 123 Bld Port Royal, F-75014 Paris, France.		Cossart, Rosa/E-7674-2014; bernard, christophe/S-5937-2016; Cossart, Rosa/AAT-7934-2020; Esclapez, Monique/O-6509-2016; bernard, christophe/A-4929-2012	Cossart, Rosa/0000-0003-2111-6638; bernard, christophe/0000-0003-3014-1966; Cossart, Rosa/0000-0003-2111-6638; Esclapez, Monique/0000-0002-8558-1363; bernard, christophe/0000-0003-3014-1966; Ben-Ari, Yehezkel/0000-0001-6208-8480				BAHN S, 1994, J NEUROSCI, V14, P5525; BATCHELOR AM, 1994, NEUROSCIENCE, V63, P911, DOI 10.1016/0306-4522(94)90558-4; BENARI Y, 1985, NEUROSCIENCE, V14, P375, DOI 10.1016/0306-4522(85)90299-4; BENARI Y, 1988, J PHYSIOL-LONDON, V404, P365, DOI 10.1113/jphysiol.1988.sp017294; Bergles DE, 1996, J NEUROSCI, V16, P572; BETTLER B, 1990, NEURON, V5, P583, DOI 10.1016/0896-6273(90)90213-Y; Castillo PE, 1997, NATURE, V388, P182, DOI 10.1038/40645; Clarke VRJ, 1997, NATURE, V389, P599, DOI 10.1038/39315; Congar P, 1997, J NEUROSCI, V17, P5366; Esclapez M, 1997, P NATL ACAD SCI USA, V94, P12151, DOI 10.1073/pnas.94.22.12151; FISHER RS, 1984, J NEUROSCI, V4, P1312; Frazier CJ, 1998, J NEUROSCI, V18, P1187; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; GAIARSA JL, 1994, J NEUROPHYSIOL, V71, P204, DOI 10.1152/jn.1994.71.1.204; GAIARSA JL, 1992, J COMP NEUROL, V321, P612, DOI 10.1002/cne.903210408; GOOD PF, 1993, BRAIN RES, V624, P347, DOI 10.1016/0006-8993(93)90102-S; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; Houser CR, 1996, EPILEPSY RES, V26, P207, DOI 10.1016/S0920-1211(96)00054-X; HUNTLEY GW, 1993, J NEUROSCI, V13, P2965; Kondo S, 1998, J PHYSIOL-LONDON, V509, P221, DOI 10.1111/j.1469-7793.1998.221bo.x; Kondo S, 1998, J PHYSIOL-LONDON, V509, P233, DOI 10.1111/j.1469-7793.1998.233bo.x; Lerma J, 1997, NEURON, V19, P1155, DOI 10.1016/S0896-6273(00)80407-9; Lerma J, 1997, TRENDS NEUROSCI, V20, P9, DOI 10.1016/S0166-2236(96)20055-4; Miller KK, 1997, J NEUROSCI, V17, P4994; Mulle C, 1998, NATURE, V392, P601, DOI 10.1038/33408; NADLER JV, 1981, LIFE SCI, V29, P2031; PONCER JC, 1995, J PHYSIOL-LONDON, V485, P121, DOI 10.1113/jphysiol.1995.sp020717; Radnikow G, 1998, J NEUROSCI, V18, P2009; REPRESA A, 1992, EXP BRAIN RES, V92, P69; ROBINSON JH, 1981, BRAIN RES, V221, P117, DOI 10.1016/0006-8993(81)91067-2; Rodriguez-Moreno A, 1998, NEURON, V20, P1211, DOI 10.1016/S0896-6273(00)80501-2; RodriguezMoreno A, 1997, NEURON, V19, P893, DOI 10.1016/S0896-6273(00)80970-8; ROVIRA C, 1990, PFLUG ARCH EUR J PHY, V415, P471, DOI 10.1007/BF00373625; SIEGEL SJ, 1995, J NEUROSCI, V15, P2707; Vida I, 1998, J PHYSIOL-LONDON, V506, P755, DOI 10.1111/j.1469-7793.1998.755bv.x; Vignes M, 1997, NATURE, V388, P179, DOI 10.1038/40639; Wang HL, 1997, BRAIN RES, V746, P294, DOI 10.1016/S0006-8993(96)00772-X; WESTBROOK GL, 1983, BRAIN RES, V273, P97, DOI 10.1016/0006-8993(83)91098-3	38	270	274	0	17	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	1998	1	6					470	478		10.1038/2185	http://dx.doi.org/10.1038/2185			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	128LE	10196544				2022-12-17	WOS:000076406900011
J	Sellgren, CM; Gracias, J; Watmuff, B; Biag, JD; Thanos, JM; Whittredge, PB; Fu, T; Worringer, K; Brown, HE; Wang, J; Kaykas, A; Karmacharya, R; Goold, CP; Sheridan, SD; Perlis, RH				Sellgren, Carl M.; Gracias, Jessica; Watmuff, Bradley; Biag, Jonathan D.; Thanos, Jessica M.; Whittredge, Paul B.; Fu, Ting; Worringer, Kathleen; Brown, Hannah E.; Wang, Jennifer; Kaykas, Ajamete; Karmacharya, Rakesh; Goold, Carleton P.; Sheridan, Steven D.; Perlis, Roy H.			Increased synapse elimination by microglia in schizophrenia patient-derived models of synaptic pruning	NATURE NEUROSCIENCE			English	Article							DENDRITIC SPINE PATHOLOGY; PLURIPOTENT STEM-CELLS; FUNCTIONAL CONNECTIVITY; MINOCYCLINE; BRAIN; ONSET; RISK; DIFFERENTIATION; PHAGOCYTOSIS; SYNAPTOSOMES	Synapse density is reduced in postmortem cortical tissue from schizophrenia patients, which is suggestive of increased synapse elimination. Using a reprogrammed in vitro model of microglia-mediated synapse engulfment, we demonstrate increased synapse elimination in patient-derived neural cultures and isolated synaptosomes. This excessive synaptic pruning reflects abnormalities in both microglia-like cells and synaptic structures. Further, we find that schizophrenia risk-associated variants within the human complement component 4 locus are associated with increased neuronal complement deposition and synapse uptake; however, they do not fully explain the observed increase in synapse uptake. Finally, we demonstrate that the antibiotic minocycline reduces microglia-mediated synapse uptake in vitro and its use is associated with a modest decrease in incident schizophrenia risk compared to other antibiotics in a cohort of young adults drawn from electronic health records. These findings point to excessive pruning as a potential target for delaying or preventing the onset of schizophrenia in high-risk individuals.	[Sellgren, Carl M.; Gracias, Jessica; Watmuff, Bradley; Thanos, Jessica M.; Fu, Ting; Brown, Hannah E.; Wang, Jennifer; Karmacharya, Rakesh; Sheridan, Steven D.; Perlis, Roy H.] Massachusetts Gen Hosp, Ctr Genom Med, Ctr Quantitat Hlth, Boston, MA 02114 USA; [Sellgren, Carl M.; Gracias, Jessica; Watmuff, Bradley; Thanos, Jessica M.; Fu, Ting; Brown, Hannah E.; Wang, Jennifer; Karmacharya, Rakesh; Sheridan, Steven D.; Perlis, Roy H.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Sellgren, Carl M.; Gracias, Jessica; Watmuff, Bradley; Thanos, Jessica M.; Fu, Ting; Brown, Hannah E.; Wang, Jennifer; Karmacharya, Rakesh; Sheridan, Steven D.; Perlis, Roy H.] Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA; [Sellgren, Carl M.; Gracias, Jessica] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; [Biag, Jonathan D.; Whittredge, Paul B.; Worringer, Kathleen; Kaykas, Ajamete; Goold, Carleton P.] Novartis Inst BioMed Res, Cambridge, MA USA; [Karmacharya, Rakesh] McLean Hosp, Schizophrenia & Bipolar Disorder Program, 115 Mill St, Belmont, MA 02178 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Karolinska Institutet; Novartis; Harvard University; McLean Hospital	Sellgren, CM; Perlis, RH (corresponding author), Massachusetts Gen Hosp, Ctr Genom Med, Ctr Quantitat Hlth, Boston, MA 02114 USA.; Sellgren, CM; Perlis, RH (corresponding author), Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA.; Sellgren, CM; Perlis, RH (corresponding author), Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA.; Sellgren, CM (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden.	carl.sellgren@ki.se; rperlis@mgh.harvard.edu		Sellgren, Carl/0000-0001-9103-2785; Karmacharya, Rakesh/0000-0002-0565-5482; Thanos, Jessica/0000-0001-7984-5361	National Institute of Mental Health [P50-MH106933]; National Human Genome Research Institute [P50-MH106933]; Swedish Research Council [2017-02559]; Marianne and Marcus Wallenberg Foundation [MMW 2017.0118]; National Institute of Mental Health Biobehavioral Research Award for Innovative New Scientists (BRAINS) [R01MH113858]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH106933, R01MH113858] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Marianne and Marcus Wallenberg Foundation; National Institute of Mental Health Biobehavioral Research Award for Innovative New Scientists (BRAINS); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank the study participants. We are also grateful to J. Ruiliera (MGH) for technical assistance with isolating buffy coats, D. Fletcher and S. Kommineni (Novartis) for stem cell reprogramming and automated neural differentiation assistance. This work was supported by grant no. P50-MH106933 (National Institute of Mental Health and National Human Genome Research Institute) and an anonymous donor to R.H.P., grant nos. 2017-02559 (Swedish Research Council) and MMW 2017.0118 (Marianne and Marcus Wallenberg Foundation) to C.M.S., and a National Institute of Mental Health Biobehavioral Research Award for Innovative New Scientists (BRAINS) no. R01MH113858 to R.K.	Abud EM, 2017, NEURON, V94, P278, DOI 10.1016/j.neuron.2017.03.042; Balekian DS, 2016, PEDIAT ALLERG IMM-UK, V27, P413, DOI 10.1111/pai.12532; Beletskii A, 2005, BIOTECHNIQUES, V39, P894, DOI 10.2144/000112001; Bennett ML, 2016, P NATL ACAD SCI USA, V113, pE1738, DOI 10.1073/pnas.1525528113; Bienenfeld A, 2017, AM J CLIN DERMATOL, V18, P469, DOI 10.1007/s40257-017-0267-z; Birur B, 2017, NPJ SCHIZOPHR, V3, DOI 10.1038/s41537-017-0013-9; Borgwardt SJ, 2008, SCHIZOPHR RES, V106, P108, DOI 10.1016/j.schres.2008.08.007; Cannon TD, 2015, TRENDS COGN SCI, V19, P744, DOI 10.1016/j.tics.2015.09.009; Cannon TD, 2015, BIOL PSYCHIAT, V77, P147, DOI 10.1016/j.biopsych.2014.05.023; Castro VM, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2015.190; Castro VM, 2016, NEUROPSYCHOPHARMACOL, V41, P1138, DOI 10.1038/npp.2015.254; Castro VM, 2015, AM J PSYCHIAT, V172, P363, DOI 10.1176/appi.ajp.2014.14030423; Chung WS, 2013, NATURE, V504, P394, DOI 10.1038/nature12776; Daniel JA, 2012, NAT PROTOC, V7, P1439, DOI 10.1038/nprot.2012.070; Danielson E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115298; Del Rosso James Q, 2015, J Clin Aesthet Dermatol, V8, P19; Dhara SK, 2008, DIFFERENTIATION, V76, P454, DOI 10.1111/j.1432-0436.2007.00256.x; DODD PR, 1986, NEUROCHEM PATHOL, V4, P177, DOI 10.1007/BF02834357; Fagan SC, 2004, EXP NEUROL, V186, P248, DOI 10.1016/j.expneurol.2003.12.006; Familian A, 2007, NEUROSCI LETT, V416, P87, DOI 10.1016/j.neulet.2007.01.052; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Gainer VS, 2016, J PERS MED, V6, pE11; Gallagher PJ, 2012, AM J PSYCHIAT, V169, P1065, DOI 10.1176/appi.ajp.2012.11091325; Giovanoli S, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.38; Glantz LA, 2000, ARCH GEN PSYCHIAT, V57, P65, DOI 10.1001/archpsyc.57.1.65; Glausier JR, 2013, NEUROSCIENCE, V251, P90, DOI 10.1016/j.neuroscience.2012.04.044; Gosselin D, 2017, SCIENCE, V356, DOI 10.1126/science.aal3222; Habela CW, 2016, MOL CELL NEUROSCI, V73, P52, DOI 10.1016/j.mcn.2015.12.002; Haneuse Sebastien, 2016, EGEMS (Wash DC), V4, P1203, DOI 10.13063/2327-9214.1203; Hersch S, 2003, ANN NEUROL, V54, P841, DOI 10.1002/ana.21891; Inta D, 2017, SCHIZOPHRENIA BULL, V43, P493, DOI 10.1093/schbul/sbw088; Kirwan P, 2015, DEVELOPMENT, V142, P3178, DOI 10.1242/dev.123851; Konopaske GT, 2014, JAMA PSYCHIAT, V71, P1323, DOI 10.1001/jamapsychiatry.2014.1582; Lawrie SM, 2002, BIOL PSYCHIAT, V51, P1008, DOI 10.1016/S0006-3223(02)01316-1; Li WL, 2011, P NATL ACAD SCI USA, V108, P8299, DOI 10.1073/pnas.1014041108; Luo C, 2016, GLIA, V64, P1508, DOI 10.1002/glia.23018; Meyer-Lindenberg AS, 2005, ARCH GEN PSYCHIAT, V62, P379, DOI 10.1001/archpsyc.62.4.379; Miksa M, 2009, J IMMUNOL METHODS, V342, P71, DOI 10.1016/j.jim.2008.11.019; Muffat J, 2016, NAT MED, V22, P1358, DOI 10.1038/nm.4189; Nutile-McMenemy N, 2007, J NEUROCHEM, V103, P2035, DOI 10.1111/j.1471-4159.2007.04889.x; Oceguera-Yanez F, 2016, METHODS, V101, P43, DOI 10.1016/j.ymeth.2015.12.012; Pandya H, 2017, NAT NEUROSCI, V20, P753, DOI 10.1038/nn.4534; Pantelis C, 2003, LANCET, V361, P281, DOI 10.1016/S0140-6736(03)12323-9; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Perlis RH, 2012, PSYCHOL MED, V42, P41, DOI 10.1017/S0033291711000997; Petanjek Z, 2011, P NATL ACAD SCI USA, V108, P13281, DOI 10.1073/pnas.1105108108; Pivovarov R, 2014, J BIOMED INFORM, V51, P24, DOI 10.1016/j.jbi.2014.03.016; Raghavendra V, 2003, J PHARMACOL EXP THER, V306, P624, DOI 10.1124/jpet.103.052407; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Roberson AM, 2016, J CLIN PSYCHIAT, V77, P359, DOI 10.4088/JCP.14m09612; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Sekar A, 2016, NATURE, V530, P177, DOI 10.1038/nature16549; Sellgren CM, 2017, MOL PSYCHIATR, V22, P170, DOI 10.1038/mp.2016.220; Selvaraj S, 2018, SCHIZOPHR RES, V195, P206, DOI 10.1016/j.schres.2017.08.063; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Sheridan SD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026203; Solmi M, 2017, CNS SPECTRUMS, V22, P415, DOI 10.1017/S1092852916000638; Stephan KE, 2009, SCHIZOPHRENIA BULL, V35, P509, DOI 10.1093/schbul/sbn176; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Sun D, 2009, SCHIZOPHR RES, V108, P85, DOI 10.1016/j.schres.2008.11.026; Takahashi T, 2009, ARCH GEN PSYCHIAT, V66, P366, DOI 10.1001/archgenpsychiatry.2009.12; Wang C, 2017, STEM CELL REP, V9, P1221, DOI 10.1016/j.stemcr.2017.08.019; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Wu YL, 2007, J IMMUNOL, V179, P3012, DOI 10.4049/jimmunol.179.5.3012; Ziermans TB, 2012, SCHIZOPHRENIA BULL, V38, P519, DOI 10.1093/schbul/sbq113	66	269	272	9	112	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2019	22	3					374	+		10.1038/s41593-018-0334-7	http://dx.doi.org/10.1038/s41593-018-0334-7			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	HM4DL	30718903	Green Accepted			2022-12-17	WOS:000459423800009
J	Lin, CCJ; Yu, K; Hatcher, A; Huang, TW; Lee, HK; Carlson, J; Weston, MC; Chen, FJ; Zhang, YQ; Zhu, WY; Mohila, CA; Ahnied, N; Patel, AJ; Arenkiel, BR; Noebels, JL; Creighton, CJ; Deneen, B				Lin, Chia-Ching John; Yu, Kwanha; Hatcher, Asante; Huang, Teng-Wei; Lee, Hyun Kyoung; Carlson, Jeffrey; Weston, Matthew C.; Chen, Fengju; Zhang, Yiqun; Zhu, Wenyi; Mohila, Carrie A.; Ahnied, Nabil; Patel, Akash J.; Arenkiel, Benjamin R.; Noebels, Jeffrey L.; Creighton, Chad J.; Deneen, Benjamin			Identification of diverse astrocyte populations and their malignant analogs	NATURE NEUROSCIENCE			English	Article							BRAIN; HETEROGENEITY; SUBTYPES; GLIA; CNS; TRANSCRIPTOME; PERSPECTIVE; RESOURCE; NEURONS; LINEAGE	Astrocytes are the most abundant cell type in the brain, where they perform a wide array of functions, yet the nature of their cellular heterogeneity and how it oversees these diverse roles remains shrouded in mystery. Using an intersectional fluorescence-activated cell sorting-based strategy, we identified five distinct astrocyte subpopulations present across three brain regions that show extensive molecular diversity. Application of this molecular insight toward function revealed that these populations differentially support synaptogenesis between neurons. We identified correlative populations in mouse and human glioma and found that the emergence of specific subpopulations during tumor progression corresponded with the onset of seizures and tumor invasion. In sum, we have identified subpopulations of astrocytes in the adult brain and their correlates in glioma that are endowed with diverse cellular, molecular and functional properties. These populations selectively contribute to synaptogenesis and tumor pathophysiology, providing a blueprint for understanding diverse astrocyte contributions to neurological disease.	[Lin, Chia-Ching John; Yu, Kwanha; Huang, Teng-Wei; Carlson, Jeffrey; Zhu, Wenyi; Ahnied, Nabil; Deneen, Benjamin] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA; [Yu, Kwanha; Lee, Hyun Kyoung; Arenkiel, Benjamin R.; Noebels, Jeffrey L.; Deneen, Benjamin] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Lee, Hyun Kyoung; Patel, Akash J.; Arenkiel, Benjamin R.; Deneen, Benjamin] Texas Childrens Hosp, Baylor Coll Med, Neurol Res Inst, Houston, TX 77030 USA; [Lee, Hyun Kyoung] Texas Childrens Hosp, Div Neurol, Dept Pediat, Houston, TX 77030 USA; [Carlson, Jeffrey; Arenkiel, Benjamin R.; Deneen, Benjamin] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Weston, Matthew C.] Univ Vermont, Dept Neurol Sci, Burlington, VT 05405 USA; [Chen, Fengju; Zhang, Yiqun; Creighton, Chad J.] Baylor Coll Med, Dept Biostat, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Mohila, Carrie A.] Texas Childrens Hosp, Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Patel, Akash J.] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; [Arenkiel, Benjamin R.; Noebels, Jeffrey L.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Noebels, Jeffrey L.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Creighton, Chad J.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Vermont; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Deneen, B (corresponding author), Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA.; Deneen, B (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.; Deneen, B (corresponding author), Texas Childrens Hosp, Baylor Coll Med, Neurol Res Inst, Houston, TX 77030 USA.; Deneen, B (corresponding author), Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA.; Creighton, CJ (corresponding author), Baylor Coll Med, Dept Biostat, Dan L Duncan Canc Ctr, Houston, TX 77030 USA.; Creighton, CJ (corresponding author), Baylor Coll Med, Dept Med, Houston, TX 77030 USA.	creighto@bcm.edu; deneen@bcm.edu	Zhang, YiQun/HCI-2427-2022	Lee, Hyun Kyoung/0000-0001-5793-4398; Deneen, Benjmain/0000-0002-6335-1081; Huang, Teng-Wei/0000-0002-8604-1262; Arenkiel, Benjamin/0000-0001-9047-2420	Sontag Foundation; National Multiple Sclerosis Society [RG-1501-02756]; Cancer Prevention Research Institute of Texas [RP510334, RP160192]; American Cancer Society [PF-15-220]; US National Institutes of Health (NIH) [NS071153, AG054111, NS089366, NS29709, T32HL902332]; NIH-NCI [P30CA125123]; NIH [P30 AI036211, P30 CA125123, S10 RR024574]; IDDRC from the Eunice Kennedy Shriver National Institute of Child Health and Human Development [1U54 HD083092]; Genomic and RNA Profiling Core at Baylor College of Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083092] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL092332] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK109934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM056929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS087095, R01NS029709, R01NS071153, R21NS089366] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RF1AG054111] Funding Source: NIH RePORTER	Sontag Foundation; National Multiple Sclerosis Society(National Multiple Sclerosis Society); Cancer Prevention Research Institute of Texas; American Cancer Society(American Cancer Society); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH-NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); IDDRC from the Eunice Kennedy Shriver National Institute of Child Health and Human Development; Genomic and RNA Profiling Core at Baylor College of Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank M. Brenner and M. Goodell for assistance with our cell-surface-marker antibody screen. This work was supported by grants from the Sontag Foundation (B.D.), the National Multiple Sclerosis Society (RG-1501-02756; B.D.), the Cancer Prevention Research Institute of Texas (RP510334 and RP160192 awarded to both B.D. and C.J.C.), the American Cancer Society (PF-15-220; K.Y.) and the US National Institutes of Health (NIH) (NS071153 and AG054111 (B.D.), NS089366 (B.D.), NS29709 (J.L.N.) and T32HL902332 (K.Y. and J.C.)). This project was also supported in part by the Genomic and RNA Profiling Core at Baylor College of Medicine with funding from the NIH-NCI grant (P30CA125123) and the expert assistance of L. White, the Cytometry and Cell Sorting Core at Baylor College of Medicine with funding from the NIH (P30 AI036211, P30 CA125123 and S10 RR024574), the expert assistance of J. Sederstrom and by IDDRC grant number 1U54 HD083092 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Andriezen W L, 1893, Br Med J, V2, P227; Anthony TE, 2007, J COMP NEUROL, V500, P368, DOI 10.1002/cne.21179; BAILEY MS, 1993, J COMP NEUROL, V328, P501, DOI 10.1002/cne.903280405; Bakheit AMO, 2013, NEUROCASE, V19, P36, DOI 10.1080/13554794.2011.654213; Barres BA, 2008, NEURON, V60, P430, DOI 10.1016/j.neuron.2008.10.013; Bayraktar OA, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020362; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; CAMERON RS, 1991, GLIA, V4, P124, DOI 10.1002/glia.440040204; Campbell SL, 2015, GLIA, V63, P23, DOI 10.1002/glia.22730; Chen FY, 2015, DEVELOPMENT, V142, P3601, DOI 10.1242/dev.118836; Chung WS, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020370; Cuddapah VA, 2014, NAT REV NEUROSCI, V15, P455, DOI 10.1038/nrn3765; Dallas NA, 2008, CLIN CANCER RES, V14, P1931, DOI 10.1158/1078-0432.CCR-07-4478; de la Iglesia N, 2008, GENE DEV, V22, P449, DOI 10.1101/gad.1606508; Dudek F Edward, 2002, Epilepsy Curr, V2, P137, DOI 10.1046/j.1535-7597.2002.t01-1-00052.x; Farmer WT, 2016, SCIENCE, V351, P849, DOI 10.1126/science.aab3103; Ge WP, 2012, NATURE, V484, P376, DOI 10.1038/nature10959; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hochstim C, 2008, CELL, V133, P510, DOI 10.1016/j.cell.2008.02.046; Iwai Y, 1997, NEURON, V19, P77, DOI 10.1016/S0896-6273(00)80349-9; Jiang XN, 2016, NEUROBIOL DIS, V92, P3, DOI 10.1016/j.nbd.2015.07.007; Jiang XL, 2015, SCIENCE, V350, DOI 10.1126/science.aac9462; Kepecs A, 2014, NATURE, V505, P318, DOI 10.1038/nature12983; Kolliker A, 1889, HDB GEWEBELEHRE MENS; Ligon KL, 2006, GLIA, V54, P1, DOI 10.1002/glia.20273; Lovatt D, 2007, J NEUROSCI, V27, P12255, DOI 10.1523/JNEUROSCI.3404-07.2007; Miyoshi G, 2015, J NEUROSCI, V35, P12869, DOI 10.1523/JNEUROSCI.1164-15.2015; Molofsky AV, 2012, GENE DEV, V26, P891, DOI 10.1101/gad.188326.112; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Paw I, 2015, CANCER LETT, V362, P1, DOI 10.1016/j.canlet.2015.03.015; Ramon, 1897, HISTOLOGY NERVOUS SY; Ran X, 2015, NUCLEIC ACIDS RES, V43, pD893, DOI 10.1093/nar/gku943; RANSOM BR, 1992, J CLIN NEUROPHYSIOL, V9, P224, DOI 10.1097/00004691-199204010-00005; Robel S, 2016, NAT NEUROSCI, V19, P28, DOI 10.1038/nn.4184; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Stiles CD, 2008, NEURON, V58, P832, DOI 10.1016/j.neuron.2008.05.031; Tau GZ, 2010, NEUROPSYCHOPHARMACOL, V35, P147, DOI 10.1038/npp.2009.115; Tsai HH, 2012, SCIENCE, V337, P358, DOI 10.1126/science.1222381; Venkatesh HS, 2015, CELL, V161, P803, DOI 10.1016/j.cell.2015.04.012; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang J, 2008, INT J CANCER, V122, P761, DOI 10.1002/ijc.23130; Xue W, 2014, NATURE, V514, P380, DOI 10.1038/nature13589; Yeh TH, 2009, GLIA, V57, P1239, DOI 10.1002/glia.20845	44	269	270	3	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2017	20	3					396	405		10.1038/nn.4493	http://dx.doi.org/10.1038/nn.4493			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EL9DU	28166219	Green Accepted			2022-12-17	WOS:000394920400017
J	Vassoler, FM; White, SL; Schmidt, HD; Sadri-Vakili, G; Pierce, RC				Vassoler, Fair M.; White, Samantha L.; Schmidt, Heath D.; Sadri-Vakili, Ghazaleh; Pierce, R Christopher			Epigenetic inheritance of a cocaine-resistance phenotype	NATURE NEUROSCIENCE			English	Article							MEDIAL PREFRONTAL CORTEX; HUNTINGTONS-DISEASE; OFFSPRING VIABILITY; DNA METHYLATION; GENE-EXPRESSION; FEMALE RATS; DRUG-ABUSE; BDNF; BRAIN; MICE	We delineated a heritable phenotype resulting from the self-administration of cocaine in rats. We observed delayed acquisition and reduced maintenance of cocaine self-administration in male, but not female, offspring of sires that self-administered cocaine. Brain-derived neurotrophic factor (Bdnf) mRNA and BDNF protein were increased in the medial prefrontal cortex (mPFC), and there was an increased association of acetylated histone H3 with Bdnf promoters in only the male offspring of cocaine-experienced sires. Administration of a BDNF receptor antagonist (the TrkB receptor antagonist ANA-12) reversed the diminished cocaine self-administration in male cocaine-sired rats. In addition, the association of acetylated histone H3 with Bdnf promoters was increased in the sperm of sires that self-administered cocaine. Collectively, these findings indicate that voluntary paternal ingestion of cocaine results in epigenetic reprogramming of the germline, having profound effects on mPFC gene expression and resistance to cocaine reinforcement in male offspring.	[Vassoler, Fair M.; White, Samantha L.; Schmidt, Heath D.; Pierce, R Christopher] Univ Penn, Dept Psychiat, Perelman Sch Med, Ctr Neurobiol & Behav, Philadelphia, PA 19104 USA; [Sadri-Vakili, Ghazaleh] Massachusetts Gen Hosp, MassGen Inst Neurodegenerat Dis, Boston, MA 02114 USA	University of Pennsylvania; Pennsylvania Medicine; Harvard University; Massachusetts General Hospital	Pierce, RC (corresponding author), Univ Penn, Dept Psychiat, Perelman Sch Med, Ctr Neurobiol & Behav, Philadelphia, PA 19104 USA.	rcpierce@mail.med.upenn.edu		Vassoler, Fair/0000-0001-5317-7174	US National Institutes of Health [R01s DA15214, DA22339, DA33641, K02 DA18678, K01 DA30445, F31 DA31535, T32s DA28874, MH86599]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086599, R56MH086599] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA028874, K02DA018678, R01DA015214, F31DA031535, R01DA033641, R01DA022339, K01DA030445] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank R. Schassburger, T. Hopkins, B. Kimmey, S. Friedman, A. Lee, S. Darnell and G. Sangrey for technical assistance, and L. Briand for advice on experimental design. This work was supported by grants from the US National Institutes of Health (R01s DA15214, DA22339, DA33641, K02 DA18678, K01 DA30445, F31 DA31535, T32s DA28874 and MH86599).	ABEL EL, 1989, J ANDROL, V10, P17; Alter MD, 2009, BIOL PSYCHIAT, V66, P1061, DOI 10.1016/j.biopsych.2009.05.026; Anker JJ, 2011, CURR TOP BEHAV NEURO, V8, P73, DOI 10.1007/7854_2010_93; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Becker JB, 2008, FRONT NEUROENDOCRIN, V29, P36, DOI 10.1016/j.yfrne.2007.07.003; Berglind WJ, 2007, EUR J NEUROSCI, V26, P757, DOI 10.1111/j.1460-9568.2007.05692.x; Braveman Melissa W., 2004, V277, P261; BURLEY N, 1988, AM NAT, V132, P611, DOI 10.1086/284877; Byrnes EM, 2005, PSYCHOPHARMACOLOGY, V182, P537, DOI 10.1007/s00213-005-0122-4; Byrnes JJ, 2011, BEHAV BRAIN RES, V218, P200, DOI 10.1016/j.bbr.2010.11.059; Carone BR, 2010, CELL, V143, P1084, DOI 10.1016/j.cell.2010.12.008; Cazorla M, 2011, J CLIN INVEST, V121, P1846, DOI 10.1172/JCI43992; Champagne DL, 2008, J NEUROSCI, V28, P6037, DOI 10.1523/JNEUROSCI.0526-08.2008; Champagne FA, 2010, DEV PSYCHOBIOL, V52, P299, DOI 10.1002/dev.20436; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Chen-Plotkin AS, 2006, NEUROBIOL DIS, V22, P233, DOI 10.1016/j.nbd.2005.11.001; Chung WCJ, 2000, J NEUROBIOL, V43, P234, DOI 10.1002/(SICI)1097-4695(20000605)43:3<234::AID-NEU2>3.3.CO;2-V; Drickamer LC, 2000, ANIM BEHAV, V59, P371, DOI 10.1006/anbe.1999.1316; Dunn GA, 2009, ENDOCRINOLOGY, V150, P4999, DOI 10.1210/en.2009-0500; Goldman D, 2005, NAT REV GENET, V6, P521, DOI 10.1038/nrg1635; Gowaty PA, 2007, P NATL ACAD SCI USA, V104, P15023, DOI 10.1073/pnas.0706622104; Graham DL, 2007, NAT NEUROSCI, V10, P1029, DOI 10.1038/nn1929; Guerrero-Bosagna C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013100; He F, 2006, NEUROTOXICOL TERATOL, V28, P198, DOI 10.1016/j.ntt.2005.12.003; Kaati G, 2002, EUR J HUM GENET, V10, P682, DOI 10.1038/sj.ejhg.5200859; Kendler KS, 2003, AM J PSYCHIAT, V160, P687, DOI 10.1176/appi.ajp.160.4.687; Koob GF, 2010, BRAIN RES, V1314, P3, DOI 10.1016/j.brainres.2009.11.008; Li HK, 1997, J UROLOGY, V158, P962, DOI 10.1016/S0022-5347(01)64371-4; Martini M, 2012, PSYCHOPHARMACOLOGY, V219, P149, DOI 10.1007/s00213-011-2385-2; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Maze I, 2011, ANN NY ACAD SCI, V1216, P99, DOI 10.1111/j.1749-6632.2010.05893.x; McElligott ZA, 2009, PROG NEURO-PSYCHOPH, V33, P1329, DOI 10.1016/j.pnpbp.2009.05.022; Merikangas KR, 1998, ARCH GEN PSYCHIAT, V55, P973, DOI 10.1001/archpsyc.55.11.973; MISRA AL, 1977, DRUG ALCOHOL DEPEN, V2, P261, DOI 10.1016/0376-8716(77)90004-7; Morgan CP, 2011, J NEUROSCI, V31, P11748, DOI 10.1523/JNEUROSCI.1887-11.2011; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Novikova SI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001919; Pembrey ME, 2006, EUR J HUM GENET, V14, P159, DOI 10.1038/sj.ejhg.5201538; Pierce RC, 2001, REV NEUROSCIENCE, V12, P95; Quinones-Jenab V, 2010, HORM BEHAV, V58, P22, DOI 10.1016/j.yhbeh.2009.10.002; Sadri-Vakili G, 2007, HUM MOL GENET, V16, P1293, DOI 10.1093/hmg/ddm078; Sadri-Vakili G, 2010, J NEUROSCI, V30, P11735, DOI 10.1523/JNEUROSCI.2328-10.2010; Sakuma Y, 2009, J NEUROENDOCRINOL, V21, P410, DOI 10.1111/j.1365-2826.2009.01856.x; Sheldon TA, 2000, HEALTH ECON, V9, P571, DOI 10.1002/1099-1050(200010)9:7<571::AID-HEC555>3.0.CO;2-8; Steger K, 2011, INT J ANDROL, V34, P513, DOI 10.1111/j.1365-2605.2010.01129.x; Tsuang MT, 1998, ARCH GEN PSYCHIAT, V55, P967, DOI 10.1001/archpsyc.55.11.967; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Whitfield TW, 2011, J NEUROSCI, V31, P834, DOI 10.1523/JNEUROSCI.4986-10.2011	48	269	280	0	94	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2013	16	1					42	U67		10.1038/nn.3280	http://dx.doi.org/10.1038/nn.3280			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	058KZ	23242310	Green Accepted, Green Submitted			2022-12-17	WOS:000312633900011
J	Hayden, BY; Pearson, JM; Platt, ML				Hayden, Benjamin Y.; Pearson, John M.; Platt, Michael L.			Neuronal basis of sequential foraging decisions in a patchy environment	NATURE NEUROSCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; REWARD SIGNALS; PREDICTION ERRORS; UNCERTAINTY; DOPAMINE; STRATEGY; CHOICE; BRAIN; DELAY; AREA	Deciding when to leave a depleting resource to exploit another is a fundamental problem for all decision makers. The neuronal mechanisms mediating patch-leaving decisions remain unknown. We found that neurons in primate (Macaca mulatta) dorsal anterior cingulate cortex, an area that is linked to reward monitoring and executive control, encode a decision variable signaling the relative value of leaving a depleting resource for a new one. Neurons fired during each sequential decision to stay in a patch and, for each travel time, these responses reached a fixed threshold for patch-leaving. Longer travel times reduced the gain of neural responses for choosing to stay in a patch and increased the firing rate threshold mandating patch-leaving. These modulations more closely matched behavioral decisions than any single task variable. These findings portend an understanding of the neural basis of foraging decisions and endorse the unification of theoretical and experimental work in ecology and neuroscience.	[Hayden, Benjamin Y.; Pearson, John M.; Platt, Michael L.] Duke Univ, Sch Med, Dept Neurobiol, Durham, NC 27710 USA; [Hayden, Benjamin Y.; Pearson, John M.; Platt, Michael L.] Duke Univ, Ctr Cognit Neurosci, Durham, NC USA; [Platt, Michael L.] Duke Univ, Dept Evolutionary Anthropol, Durham, NC USA	Duke University; Duke University; Duke University	Hayden, BY (corresponding author), Duke Univ, Sch Med, Dept Neurobiol, Durham, NC 27710 USA.	benhayden@gmail.com	Hayden, Benjamin/J-7994-2013	Hayden, Benjamin/0000-0002-7678-4281; Pearson, John/0000-0002-9876-7837	US National Institutes of Health [R01EY013496, K99 DA027718-01]; Tourette Syndrome Association; NATIONAL EYE INSTITUTE [R01EY013496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K99DA027718] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tourette Syndrome Association; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank S. Heilbronner for comments on design, analysis and writing. This research was supported by US National Institutes of Health grant R01EY013496 (M. L. P.), a Fellowship from the Tourette Syndrome Association (B.Y.H.) and US National Institutes of Health grant K99 DA027718-01 (B.Y.H.).	Agetsuma N, 1998, J ETHOL, V16, P49, DOI 10.1007/BF02769282; Amiez C, 2006, CEREB CORTEX, V16, P1040, DOI 10.1093/cercor/bhj046; Baler RD, 2006, TRENDS MOL MED, V12, P559, DOI 10.1016/j.molmed.2006.10.005; Bendesky A, 2011, NATURE, V472, P313, DOI 10.1038/nature09821; Bonser R, 1998, ECOL ENTOMOL, V23, P15, DOI 10.1046/j.1365-2311.1998.00103.x; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Carpenter RHS, 1988, MOVEMENTS EYES; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Cornelissen FW, 2002, BEHAV RES METH INS C, V34, P613, DOI 10.3758/BF03195489; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Evans TA, 2007, J GEN PSYCHOL, V134, P199, DOI 10.3200/GENP.134.2.199-216; Gold JI, 2002, NEURON, V36, P299, DOI 10.1016/S0896-6273(02)00971-6; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Hanes DP, 1996, SCIENCE, V274, P427, DOI 10.1126/science.274.5286.427; Hayden BY, 2011, J NEUROSCI, V31, P4178, DOI 10.1523/JNEUROSCI.4652-10.2011; Hayden BY, 2010, J NEUROSCI, V30, P3339, DOI 10.1523/JNEUROSCI.4874-09.2010; Hayden BY, 2009, SCIENCE, V324, P948, DOI 10.1126/science.1168488; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI [10.1037//0033-295X.109.4.679, 10.1037/0033-295X.109.4.679]; Horwitz GD, 2004, J NEUROPHYSIOL, V91, P2281, DOI 10.1152/jn.00872.2003; Ito S, 2003, SCIENCE, V302, P120, DOI 10.1126/science.1087847; KAHNEMAN D, 1991, J ECON PERSPECT, V5, P193, DOI 10.1257/jep.5.1.193; Kennerley SW, 2006, NAT NEUROSCI, V9, P940, DOI 10.1038/nn1724; Kennerley SW, 2009, J COGNITIVE NEUROSCI, V21, P1162, DOI 10.1162/jocn.2009.21100; Kim S, 2008, NEURON, V59, P161, DOI 10.1016/j.neuron.2008.05.010; Latty T, 2009, BEHAV ECOL, V20, P1160, DOI 10.1093/beheco/arp111; Louie K, 2010, J NEUROSCI, V30, P5498, DOI 10.1523/JNEUROSCI.5742-09.2010; Marr D., 1982, VISION COMPUTATIONAL; Matsumoto M, 2007, NAT NEUROSCI, V10, P647, DOI 10.1038/nn1890; Mazur J.E., 1987, QUANTITATIVE ANAL BE, V5; McNickle GG, 2009, P NATL ACAD SCI USA, V106, P4747, DOI 10.1073/pnas.0807971106; Prins HHT, 1996, ECOLOGY BEHAV AFRICA; Quilodran R, 2008, NEURON, V57, P314, DOI 10.1016/j.neuron.2007.11.031; Roitman JD, 2002, J NEUROSCI, V22, P9475; Rushworth MFS, 2008, NAT NEUROSCI, V11, P389, DOI 10.1038/nn2066; Sallet J, 2007, COGN AFFECT BEHAV NE, V7, P327, DOI 10.3758/CABN.7.4.327; Schall JD, 2004, ANNU REV PSYCHOL, V55, P23, DOI 10.1146/annurev.psych.55.090902.141907; Seo H, 2007, J NEUROSCI, V27, P8366, DOI 10.1523/JNEUROSCI.2369-07.2007; Shidara M, 2002, SCIENCE, V296, P1709, DOI 10.1126/science.1069504; Shima K, 1998, SCIENCE, V282, P1335, DOI 10.1126/science.282.5392.1335; Smith E.A., 1992, EVOL ECOL; Stephens D.W., 1986, pi; Stephens D.W., 2006, FORAGING BEHAV ECOLO; Stephens DW, 2001, BEHAV ECOL, V12, P330, DOI 10.1093/beheco/12.3.330; Stern E, 2000, ARCH GEN PSYCHIAT, V57, P741, DOI 10.1001/archpsyc.57.8.741; Thompson D, 2001, ANIM BEHAV, V61, P287, DOI 10.1006/anbe.2000.1539; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370; Wallis JD, 2010, CURR OPIN NEUROBIOL, V20, P191, DOI 10.1016/j.conb.2010.02.009; Williams ZM, 2004, NAT NEUROSCI, V7, P1370, DOI 10.1038/nn1354; Wilson E.O., 1999, CONSILIENCE UNITY KN; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026	50	269	271	0	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2011	14	7					933	U165		10.1038/nn.2856	http://dx.doi.org/10.1038/nn.2856			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	783KR	21642973	Green Accepted			2022-12-17	WOS:000292081700023
J	Mameli, M; Halbout, B; Creton, C; Engblom, D; Parkitna, JR; Spanagel, R; Luscher, C				Mameli, Manuel; Halbout, Briac; Creton, Cyril; Engblom, David; Parkitna, Jan Rodriguez; Spanagel, Rainer; Luescher, Christian			Cocaine-evoked synaptic plasticity: persistence in the VTA triggers adaptations in the NAc	NATURE NEUROSCIENCE			English	Article							VENTRAL TEGMENTAL AREA; LONG-TERM POTENTIATION; NUCLEUS-ACCUMBENS; DOPAMINE NEURONS; BEHAVIORAL SENSITIZATION; GLUTAMATE SYSTEMS; NMDA-RECEPTORS; AMPA RECEPTORS; IN-VIVO; MIDBRAIN	Addictive drugs hijack mechanisms of learning and memory that normally underlie reinforcement of natural rewards and induce synaptic plasticity of glutamatergic transmission in the mesolimbic dopamine (DA) system. In the ventral tegmental area (VTA), a single exposure to cocaine efficiently triggers NMDA receptor-dependent synaptic plasticity in DA neurons, whereas plasticity in the nucleus accumbens (NAc) occurs only after repeated injections. Whether these two forms of plasticity are independent or hierarchically organized remains unknown. We combined ex vivo electrophysiology in acute brain slices with behavioral assays modeling drug relapse in mice and found that the duration of the cocaine-evoked synaptic plasticity in the VTA is gated by mGluR1. Overriding mGluR1 in vivo made the potentiation in the VTA persistent. This led to synaptic plasticity in the NAc, which contributes to cocaine-seeking behavior after protracted withdrawal. Impaired mGluR1 function in vulnerable individuals could represent a first step in the recruitment of the neuronal network that underlies drug addiction.	[Mameli, Manuel; Creton, Cyril; Luescher, Christian] Univ Geneva, Fac Med, Dept Basic Neurosci, Geneva, Switzerland; [Halbout, Briac; Spanagel, Rainer] Cent Inst Mental Hlth, Dept Psychopharmacol, D-6800 Mannheim, Germany; [Engblom, David; Parkitna, Jan Rodriguez] German Canc Res Ctr, Div Mol Biol Cell 1, D-6900 Heidelberg, Germany; [Luescher, Christian] Univ Hosp Geneva, Dept Clin Neurosci, Neurol Clin, Geneva, Switzerland; [Luescher, Christian] Geneva Neurosci Ctr, Geneva, Switzerland	University of Geneva; Central Institute of Mental Health; Helmholtz Association; German Cancer Research Center (DKFZ); University of Geneva	Luscher, C (corresponding author), Univ Geneva, Fac Med, Dept Basic Neurosci, Geneva, Switzerland.	christian.luscher@unige.ch	Rodriguez, Jan/I-2910-2012; Lüscher, Christian/A-2496-2011; Halbout, Briac/I-4646-2019	Rodriguez, Jan/0000-0003-0367-2331; Lüscher, Christian/0000-0001-7917-4596; Mameli, Manuel/0000-0002-0570-6964	Swiss National Science Foundation; Swiss initiative in system biology; Nationales Genomforschungsnetz; Deutsche Forschungsgemeinschaft	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss initiative in system biology; Nationales Genomforschungsnetz; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank members of the Luscher laboratory, as well as B. J. Everitt, M. Frerking, A. Luthi, M. Serafin, M. Carta and C. F. Valenzuela for helpful discussions and suggestions regarding the manuscript. R. Sprengel (Max Planck Institute Heidelberg) generated the NR12<SUP>loxP/loxP</SUP> mouse line and G. Schutz (Deutsches Krebsforschungszentrum Heidelberg) provided the NR1<SUP>DAT-CreERT2</SUP> mouse line. C. L. is supported by grants from the Swiss National Science Foundation and the Swiss initiative in system biology (SystemsX: neurochoice). R. S. is supported by Nationales Genomforschungsnetz and Deutsche Forschungsgemeinschaft.	Anderson SM, 2008, NAT NEUROSCI, V11, P344, DOI 10.1038/nn2054; Argilli E, 2008, J NEUROSCI, V28, P9092, DOI 10.1523/JNEUROSCI.1001-08.2008; Bellone C, 2006, NAT NEUROSCI, V9, P636, DOI 10.1038/nn1682; Borgland SL, 2004, J NEUROSCI, V24, P7482, DOI 10.1523/JNEUROSCI.1312-04.2004; Boudreau AC, 2005, J NEUROSCI, V25, P9144, DOI 10.1523/JNEUROSCI.2252-05.2005; Carlezon WA, 2002, TRENDS NEUROSCI, V25, P610, DOI 10.1016/S0166-2236(02)02289-0; Chen BT, 2008, NEURON, V59, P288, DOI 10.1016/j.neuron.2008.05.024; Churchill L, 1999, J NEUROCHEM, V72, P2397, DOI 10.1046/j.1471-4159.1999.0722397.x; Conrad KL, 2008, NATURE, V454, P118, DOI 10.1038/nature06995; Dong Y, 2004, P NATL ACAD SCI USA, V101, P14282, DOI 10.1073/pnas.0401553101; Engblom D, 2008, NEURON, V59, P497, DOI 10.1016/j.neuron.2008.07.010; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Grimm JW, 2001, NATURE, V412, P141, DOI 10.1038/35084134; Haber SN, 2000, J NEUROSCI, V20, P2369; Harris GC, 2004, NEUROSCIENCE, V129, P841, DOI 10.1016/j.neuroscience.2004.09.018; Ikemoto S, 2007, BRAIN RES REV, V56, P27, DOI 10.1016/j.brainresrev.2007.05.004; Kalivas PW, 2004, CURR OPIN PHARMACOL, V4, P23, DOI 10.1016/j.coph.2003.11.002; Kauer JA, 2007, NAT REV NEUROSCI, V8, P844, DOI 10.1038/nrn2234; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Kourrich S, 2007, J NEUROSCI, V27, P7921, DOI 10.1523/JNEUROSCI.1859-07.2007; Lammel S, 2008, NEURON, V57, P760, DOI 10.1016/j.neuron.2008.01.022; Luscher C, 2008, NAT NEUROSCI, V11, P737, DOI 10.1038/nn0708-737; Mameli M, 2007, SCIENCE, V317, P530, DOI 10.1126/science.1142365; Mao LM, 2005, J NEUROSCI, V25, P2741, DOI 10.1523/JNEUROSCI.4360-04.2005; Mead AN, 2005, PSYCHOPHARMACOLOGY, V179, P164, DOI 10.1007/s00213-004-2071-8; Moroni F, 1997, J PHARMACOL EXP THER, V281, P721; Ping AS, 2008, BRAIN RES, V1215, P173, DOI 10.1016/j.brainres.2008.03.088; Ronesi JA, 2008, J NEUROSCI, V28, P543, DOI 10.1523/JNEUROSCI.5019-07.2008; Saal D, 2003, NEURON, V37, P577, DOI 10.1016/S0896-6273(03)00021-7; Thomas MJ, 2008, BRIT J PHARMACOL, V154, P327, DOI 10.1038/bjp.2008.77; Thomas MJ, 2001, NAT NEUROSCI, V4, P1217, DOI 10.1038/nn757; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Vezina P, 2000, PSYCHOPHARMACOLOGY, V151, P184, DOI 10.1007/s002130000463; Zhao SL, 2004, EUR J NEUROSCI, V19, P1133, DOI 10.1111/j.1460-9568.2004.03206.x; Zweifel LS, 2008, NEURON, V59, P486, DOI 10.1016/j.neuron.2008.05.028	35	269	276	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2009	12	8					1036	U108		10.1038/nn.2367	http://dx.doi.org/10.1038/nn.2367			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	475WS	19597494				2022-12-17	WOS:000268396300018
J	Francis, DD; Szegda, K; Campbell, G; Martin, WD; Insel, TR				Francis, DD; Szegda, K; Campbell, G; Martin, WD; Insel, TR			Epigenetic sources of behavioral differences in mice	NATURE NEUROSCIENCE			English	Article							PREPULSE INHIBITION; MATERNAL-BEHAVIOR; MOUSE; RESPONSES; GENETICS; STRAIN; STRESS; CARE		NIMH, Bethesda, MD 20892 USA; Emory Univ, Ctr Behav Neurosci, Yerkes Res Ctr, Atlanta, GA 30329 USA; Emory Univ, Transgen Mouse Core, Sch Med, Atlanta, GA 30329 USA; Emory Univ, Dept Psychiat & Behav Sci, Sch Med, Atlanta, GA 30329 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Emory University; Emory University; Emory University	Insel, TR (corresponding author), NIMH, 6001 Execut Blvd,Room 8235,MSC 9669, Bethesda, MD 20892 USA.	insel@mail.nih.gov						Brown RE, 1999, PHYSIOL BEHAV, V67, P599, DOI 10.1016/S0031-9384(99)00109-2; Bucan M, 2002, NAT REV GENET, V3, P114, DOI 10.1038/nrg728; CARLIER M, 1983, PHYSIOL BEHAV, V30, P837, DOI 10.1016/0031-9384(83)90245-7; Crabbe JC, 1999, SCIENCE, V284, P1670, DOI 10.1126/science.284.5420.1670; DeFries J. C., 1967, PSYCHON SCI, V8, P207; Dulawa SC, 2000, NEUROPHARMACOLOGY, V39, P2170, DOI 10.1016/S0028-3908(00)00030-7; Francis D, 1999, SCIENCE, V286, P1155, DOI 10.1126/science.286.5442.1155; Le Isabelle R, 2001, BEHAV BRAIN RES, V125, P57, DOI 10.1016/S0166-4328(01)00279-0; Liu D, 2000, NAT NEUROSCI, V3, P799, DOI 10.1038/77702; Liu D, 1997, SCIENCE, V277, P1659, DOI 10.1126/science.277.5332.1659; Paylor R, 1997, PSYCHOPHARMACOLOGY, V132, P169, DOI 10.1007/s002130050333; Rhees BK, 1999, GENETICS, V153, P905; Zaharia MD, 1996, PSYCHOPHARMACOLOGY, V128, P227, DOI 10.1007/s002130050130	13	269	273	0	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2003	6	5					445	446		10.1038/nn1038	http://dx.doi.org/10.1038/nn1038			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	672ZD	12665797				2022-12-17	WOS:000182553200007
J	Kay, LM; Laurent, G				Kay, LM; Laurent, G			Odor- and context-dependent modulation of mitral cell activity in behaving rats	NATURE NEUROSCIENCE			English	Article							RABBIT OLFACTORY-BULB; TUFTED CELLS; HORSERADISH-PEROXIDASE; UNIT-ACTIVITY; CONNECTIONS; RESPONSES; MOLECULES; SYSTEM; DISCRIMINATION; HIPPOCAMPUS	The projections and odor responses of mammalian olfactory receptor neurons, as well as the physiology of the bulb's principal neurons-the mitral cells (MCs)-are known from studies in slices and anesthetized animals. In behaving rats trained to discriminate between two odors associated with different reinforcers, we examined MC responses following alternated odor-reinforcer pairings. Whereas only 11% of the recorded MCs showed changes in odor-selective firing rate during the odor-sampling phase, 94% of MCs modulated activity during specific behaviors surrounding odor sampling. These cell- and odor-selective responses were not primary sensory responses; rather, they depended (reversibly) on the predictive value of each odor. MC activity thus depends critically on efferent influences linked to the animal's experience and behavior.	CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Laurent, G (corresponding author), CALTECH, Div Biol, 139-74, Pasadena, CA 91125 USA.		Laurent, Gilles/A-4583-2012	Laurent, Gilles/0000-0002-2296-114X; Kay, Leslie/0000-0003-3049-477X	NCRR NIH HHS [P41-RR09754] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR009754] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Bhalla US, 1997, J COMPUT NEUROSCI, V4, P221, DOI 10.1023/A:1008819818970; BRAGIN A, 1995, J NEUROSCI, V15, P47; BUONVISO N, 1990, J NEUROPHYSIOL, V63, P447, DOI 10.1152/jn.1990.63.3.447; CARMICHAEL ST, 1994, J COMP NEUROL, V346, P403, DOI 10.1002/cne.903460306; CHAPUT MA, 1985, PHYSIOL BEHAV, V34, P249, DOI 10.1016/0031-9384(85)90113-1; DARLING FMC, 1994, PHYSIOL BEHAV, V55, P817, DOI 10.1016/0031-9384(94)90065-5; Dave AS, 1998, SCIENCE, V282, P2250, DOI 10.1126/science.282.5397.2250; DEOLMOS J, 1978, J COMP NEUROL, V181, P213, DOI 10.1002/cne.901810202; DIPRISCO GV, 1985, BEHAV NEUROSCI, V99, P964; FREEMAN WJ, 1983, J COMP PSYCHOL, V97, P12, DOI 10.1037/0735-7036.97.1.12; GRAY CM, 1988, EXP BRAIN RES, V73, P189, DOI 10.1007/BF00279672; GRAY CM, 1988, EXP BRAIN RES, V69, P378; IMAMURA K, 1992, J NEUROPHYSIOL, V68, P1986, DOI 10.1152/jn.1992.68.6.1986; Jansen HT, 1998, BRAIN RES BULL, V45, P27, DOI 10.1016/S0361-9230(97)00279-7; Johnson BA, 1998, J COMP NEUROL, V393, P457, DOI 10.1002/(SICI)1096-9861(19980420)393:4<457::AID-CNE5>3.0.CO;2-#; KATOH K, 1993, J NEUROPHYSIOL, V70, P2161, DOI 10.1152/jn.1993.70.5.2161; Kay LM, 1998, BEHAV NEUROSCI, V112, P541, DOI 10.1037/0735-7044.112.3.541; Kay LM, 1996, INT J NEURAL SYST, V7, P489, DOI 10.1142/S0129065796000476; KLINGBERG F, 1965, ACTA BIOL MED GER, V14, P593; MACRIDES F, 1972, SCIENCE, V175, P84, DOI 10.1126/science.175.4017.84; MILLER SD, 1966, PHYSIOL BEHAV, V1, P145, DOI 10.1016/0031-9384(66)90059-X; MORI K, 1992, J NEUROPHYSIOL, V67, P786, DOI 10.1152/jn.1992.67.3.786; Motokizawa F, 1996, EXP BRAIN RES, V112, P24; PAGER J, 1985, BEHAV BRAIN RES, V16, P81, DOI 10.1016/0166-4328(85)90084-1; PAGER J, 1983, BRAIN RES, V289, P87, DOI 10.1016/0006-8993(83)90009-4; Paxinos G, 1986, RAT BRAIN STEREOTAXI; RHINEHARTDOTY JA, 1994, CHEM SENSES, V19, P425, DOI 10.1093/chemse/19.5.425; Schmidt MF, 1998, NAT NEUROSCI, V1, P513, DOI 10.1038/2232; Schoenbaum G, 1998, NAT NEUROSCI, V1, P155, DOI 10.1038/407; Schoenbaum G, 1999, J NEUROSCI, V19, P1876; SHIPLEY MT, 1984, BRAIN RES BULL, V12, P669, DOI 10.1016/0361-9230(84)90148-5; SOBEL EC, 1993, J NEUROPHYSIOL, V69, P1331, DOI 10.1152/jn.1993.69.4.1331; STEWART WB, 1979, J COMP NEUROL, V185, P715, DOI 10.1002/cne.901850407; VANGROEN T, 1990, J COMP NEUROL, V302, P515, DOI 10.1002/cne.903020308; Wehr M, 1996, NATURE, V384, P162, DOI 10.1038/384162a0	35	269	273	2	24	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	1999	2	11					1003	1009		10.1038/14801	http://dx.doi.org/10.1038/14801			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259FF	10526340				2022-12-17	WOS:000083883300018
J	Jaffe, AE; Gao, Y; Deep-Soboslay, A; Tao, R; Hyde, TM; Weinberger, DR; Kleinman, JE				Jaffe, Andrew E.; Gao, Yuan; Deep-Soboslay, Amy; Tao, Ran; Hyde, Thomas M.; Weinberger, Daniel R.; Kleinman, Joel E.			Mapping DNA methylation across development, genotype and schizophrenia in the human frontal cortex	NATURE NEUROSCIENCE			English	Article							EPIGENOME-WIDE ASSOCIATION; HUMAN PREFRONTAL CORTEX; HUMAN BRAIN; EPIGENETIC EPIDEMIOLOGY; CELLULAR HETEROGENEITY; PRENATAL EXPOSURE; GENE-EXPRESSION; METAANALYSIS; DISEASE; IDENTIFICATION	DNA methylation (DNAm) is important in brain development and is potentially important in schizophrenia. We characterized DNAm in prefrontal cortex from 335 non-psychiatric controls across the lifespan and 191 patients with schizophrenia and identified widespread changes in the transition from prenatal to postnatal life. These DNAm changes manifest in the transcriptome, correlate strongly with a shifting cellular landscape and overlap regions of genetic risk for schizophrenia. A quarter of published genome-wide association studies (GWAS)-suggestive loci (4,208 of 15,930, P < 10(-100)) manifest as significant methylation quantitative trait loci (meQTLs), including 59.6% of GWAS-positive schizophrenia loci. We identified 2,104 CpGs that differ between schizophrenia patients and controls that were enriched for genes related to development and neurodifferentiation. The schizophrenia-associated CpGs strongly correlate with changes related to the prenatal-postnatal transition and show slight enrichment for GWAS risk loci while not corresponding to CpGs differentiating adolescence from later adult life. These data implicate an epigenetic component to the developmental origins of this disorder.	[Jaffe, Andrew E.; Gao, Yuan; Deep-Soboslay, Amy; Tao, Ran; Hyde, Thomas M.; Weinberger, Daniel R.; Kleinman, Joel E.] Lieber Inst Brain Dev, Baltimore, MD 21205 USA; [Jaffe, Andrew E.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD USA; [Jaffe, Andrew E.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [Hyde, Thomas M.; Weinberger, Daniel R.] Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD USA; [Hyde, Thomas M.] Johns Hopkins Sch Med, Dept Psychiat, Baltimore, MD USA; [Weinberger, Daniel R.] Johns Hopkins Sch Med, Dept Neurosci, Baltimore, MD USA; [Weinberger, Daniel R.] Johns Hopkins Sch Med, Inst Med Genet, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Jaffe, AE (corresponding author), Lieber Inst Brain Dev, Johns Hopkins Med Campus, Baltimore, MD 21205 USA.	andrew.jaffe@libd.org	Jaffe, Andrew/GPF-5693-2022; Jaffe, Andrew/L-3089-2016	Jaffe, Andrew/0000-0001-6886-1454; Jaffe, Andrew/0000-0001-6886-1454	Lieber Institute for Brain Development;  [1R21MH102791]; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH102791] Funding Source: NIH RePORTER	Lieber Institute for Brain Development; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We are grateful for the vision and generosity of the Lieber and Maltz Families who made this work possible. We thank the families who donated to this research and we thank A. Feinberg for helpful input on data analyses. This work was supported by the Lieber Institute for Brain Development. A.E.J. was partially supported by 1R21MH102791.	Abdolmaleky HM, 2004, AM J MED GENET B, V127B, P51, DOI 10.1002/ajmg.b.20142; Akbarian S, 2015, NAT NEUROSCI, V18, P1707, DOI 10.1038/nn.4156; Anderson CA, 2010, NAT PROTOC, V5, P1564, DOI 10.1038/nprot.2010.116; Aryee MJ, 2014, BIOINFORMATICS, V30, P1363, DOI 10.1093/bioinformatics/btu049; Bird A, 2011, NAT GENET, V43, P1050, DOI 10.1038/ng.987; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; BrainSpan, 2011, ATL DEV HUM BRAIN; Breitling LP, 2011, AM J HUM GENET, V88, P450, DOI 10.1016/j.ajhg.2011.03.003; Colantuoni C, 2011, NATURE, V478, P519, DOI 10.1038/nature10524; Cortessis VK, 2012, HUM GENET, V131, P1565, DOI 10.1007/s00439-012-1189-8; Darmanis S, 2015, P NATL ACAD SCI USA, V112, P7285, DOI 10.1073/pnas.1507125112; Deep-Soboslay A, 2005, BIOL PSYCHIAT, V57, P96, DOI 10.1016/j.biopsych.2004.10.016; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Farrell CM, 2014, NUCLEIC ACIDS RES, V42, pD865, DOI 10.1093/nar/gkt1059; Gavin DP, 2010, NEUROSCI BIOBEHAV R, V34, P882, DOI 10.1016/j.neubiorev.2009.10.010; Grayson DR, 2013, NEUROPSYCHOPHARMACOL, V38, P138, DOI 10.1038/npp.2012.125; Guintivano J, 2013, EPIGENETICS-US, V8, P290, DOI 10.4161/epi.23924; Gulsuner S, 2013, CELL, V154, P518, DOI 10.1016/j.cell.2013.06.049; Hannon E, 2016, NAT NEUROSCI, V19, P48, DOI 10.1038/nn.4182; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; Houseman EA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-86; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Irizarry RA, 2008, GENOME RES, V18, P780, DOI 10.1101/gr.7301508; Jaffe AE, 2015, NAT NEUROSCI, V18, P154, DOI 10.1038/nn.3898; Jaffe AE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r31; Jaffe AE, 2012, INT J EPIDEMIOL, V41, P200, DOI 10.1093/ije/dyr238; Jakovcevski M, 2012, NAT MED, V18, P1194, DOI 10.1038/nm.2828; Kim M, 2014, HUM MOL GENET, V23, P657, DOI 10.1093/hmg/ddt453; Kleinman JE, 2011, BIOL PSYCHIAT, V69, P140, DOI 10.1016/j.biopsych.2010.10.032; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Lienert F, 2011, NAT GENET, V43, P1091, DOI 10.1038/ng.946; Lipska BK, 2006, BIOL PSYCHIAT, V60, P650, DOI 10.1016/j.biopsych.2006.06.019; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; Liu Y, 2013, NAT BIOTECHNOL, V31, P142, DOI 10.1038/nbt.2487; Mill J, 2008, AM J HUM GENET, V82, P696, DOI 10.1016/j.ajhg.2008.01.008; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Nalls MA, 2011, LANCET, V377, P641, DOI 10.1016/S0140-6736(10)62345-8; Nichols L, 2014, BIOL PSYCHIAT, V75, pE21, DOI 10.1016/j.biopsych.2013.07.039; Numata S, 2012, AM J HUM GENET, V90, P260, DOI 10.1016/j.ajhg.2011.12.020; Parikshak NN, 2013, CELL, V155, P1008, DOI 10.1016/j.cell.2013.10.031; Pidsley R, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0483-2; Reichard JF, 2007, BIOCHEM BIOPH RES CO, V352, P188, DOI 10.1016/j.bbrc.2006.11.001; Relton CL, 2012, INT J EPIDEMIOL, V41, P5, DOI 10.1093/ije/dys006; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Sandoval J, 2011, EPIGENETICS-US, V6, P692, DOI 10.4161/epi.6.6.16196; Scharpf RB, 2011, J STAT SOFTW, V40, P1; Schilling E, 2009, GENOME RES, V19, P2028, DOI 10.1101/gr.095562.109; Shabalin AA, 2012, BIOINFORMATICS, V28, P1353, DOI 10.1093/bioinformatics/bts163; Smyth G. K., 2004, STAT APPL GENET MOL, V3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027/MACHINEREADABLECITATION/RIS]; Spiers H, 2015, GENOME RES, V25, P338, DOI 10.1101/gr.180273.114; SUSSER ES, 1992, ARCH GEN PSYCHIAT, V49, P983; Timp W, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0061-y; Verreault A, 1998, CURR BIOL, V8, P96, DOI 10.1016/S0960-9822(98)70040-5; Waterland RA, 2007, ANNU REV NUTR, V27, P363, DOI 10.1146/annurev.nutr.27.061406.093705; Weinberger D.R., 2011, SCHIZOPHRENIA; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Wiliams AL, 2012, AM J HUM GENET, V91, P238, DOI 10.1016/j.ajhg.2012.06.013; Zoubarev A, 2012, BIOINFORMATICS, V28, P2272, DOI 10.1093/bioinformatics/bts430	61	268	270	1	72	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2016	19	1					40	+		10.1038/nn.4181	http://dx.doi.org/10.1038/nn.4181			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CZ7BH	26619358	Green Submitted, Green Accepted			2022-12-17	WOS:000367254400011
J	Frost, B; Hemberg, M; Lewis, J; Feany, MB				Frost, Bess; Hemberg, Martin; Lewis, Jada; Feany, Mel B.			Tau promotes neurodegeneration through global chromatin relaxation	NATURE NEUROSCIENCE			English	Article							ALZHEIMERS-DISEASE; DNA-DAMAGE; NEUROFIBRILLARY TANGLES; DROSOPHILA-MELANOGASTER; PROTEIN BINDS; PIWI PROTEINS; HUMAN GENOME; IN-VIVO; GENE; CELL	The microtubule-associated protein tau is involved in a number of neurodegenerative disorders, including Alzheimer's disease. Previous studies have linked oxidative stress and subsequent DNA damage to neuronal death in Alzheimer's disease and related tauopathies. Given that DNA damage can substantially alter chromatin structure, we examined epigenetic changes in tau-induced neurodegeneration. We found widespread loss of heterochromatin in tau transgenic Drosophila and mice and in human Alzheimer's disease. Notably, genetic rescue of tau-induced heterochromatin loss substantially reduced neurodegeneration in Drosophila. We identified oxidative stress and subsequent DNA damage as a mechanistic link between transgenic tau expression and heterochromatin relaxation, and found that heterochromatin loss permitted aberrant gene expression in tauopathies. Furthermore, large-scale analyses from the brains of individuals with Alzheimer's disease revealed a widespread transcriptional increase in genes that were heterochromatically silenced in controls. Our results establish heterochromatin loss as a toxic effector of tau-induced neurodegeneration and identify chromatin structure as a potential therapeutic target in Alzheimer's disease.	[Frost, Bess; Feany, Mel B.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Hemberg, Martin] Boston Childrens Hosp, Dept Ophthalmol, Boston, MA USA; [Hemberg, Martin] Boston Childrens Hosp, Program Neurobiol, Boston, MA USA; [Lewis, Jada] Univ Florida, Dept Neurosci, Gainesville, FL 32610 USA; [Lewis, Jada] Univ Florida, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Feany, MB (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA.	mel_feany@hms.harvard.edu		Feany, Mel/0000-0003-0315-7970; Frost, Bess/0000-0002-1212-8138	NIH [U24NS050606]; Ruth L. Kirschstein National Research Service Award [F32AG039193, R01AG33518]; Ellison Medical Foundation; American Health Assistance Foundation/BrightFocus; US National Institutes of Health [1R21NS070250]; National Science Foundation [0954570]; University of Florida Department of Neuroscience; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS070250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG044113, R01AG033518, F32AG039193] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); American Health Assistance Foundation/BrightFocus(BrightFocus Foundation); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); University of Florida Department of Neuroscience; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	A. Alekseyenko, N. Riddle and A. Minoda provided critical advice for the H3K9me2 ChIP experiments. J. Eissenberg (Saint Louis University School of Medicine), K. Maggert (Texas A&M University), J. Brennecke (Austrian Academy of Science) and F. Missirlis (National Polytechnic Institute) provided Drosophila stocks. We thank C. Lemere (Brigham and Women's Hospital), D. Borchelt and G. Xu (University of Florida) for generously providing important reagents. We performed confocal imaging at the Harvard NeuroDiscovery Center Enhanced Neuroimaging Core Facility. The TRiP at Harvard Medical School (NIH/HIGMS R01-GM084947) and the Vienna Drosophila RNAi Center provided transgenic RNAi fly stocks. Antibodies obtained from the Developmental Studies Hybridoma Bank were developed under the auspices of the National Institute of Child Health and Human Development and maintained by the University of Iowa. Antibodies obtained from the University of California Davis/US National Institutes of Health NeuroMab facility are supported by NIH grant U24NS050606 and maintained by the University of California Davis. This work was supported by a Ruth L. Kirschstein National Research Service Award F32AG039193 (B. F.), R01AG33518, a Senior Scholar Award from the Ellison Medical Foundation and a grant from the American Health Assistance Foundation/BrightFocus (M. B. F.), and US National Institutes of Health (1R21NS070250) and National Science Foundation grants (0954570) in support of M. H. Support was provided to J. L. through the University of Florida Department of Neuroscience.	Ambegaokar SS, 2011, HUM MOL GENET, V20, P4947, DOI 10.1093/hmg/ddr432; Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Beisel C, 2002, NATURE, V419, P857, DOI 10.1038/nature01126; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Berzsenyi MD, 2011, J HEPATOL, V55, P536, DOI 10.1016/j.jhep.2010.12.021; Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; Blard O, 2007, HUM MOL GENET, V16, P555, DOI 10.1093/hmg/ddm011; Bosch-Presegue L, 2011, MOL CELL, V42, P210, DOI 10.1016/j.molcel.2011.02.034; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; Cooper-Knock J, 2012, NAT REV NEUROL, V8, P518, DOI 10.1038/nrneurol.2012.156; De Lucia F, 2005, NUCLEIC ACIDS RES, V33, P2852, DOI 10.1093/nar/gki584; Dias-Santagata D, 2007, J CLIN INVEST, V117, P236, DOI 10.1172/JCI28769; Dillon N, 2004, BIOL CELL, V96, P631, DOI 10.1016/j.biolcel.2004.06.003; DuBoff B, 2012, NEURON, V75, P618, DOI 10.1016/j.neuron.2012.06.026; Edwards TN, 2010, PROG NEUROBIOL, V90, P471, DOI 10.1016/j.pneurobio.2010.01.001; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Faghihi MA, 2008, NAT MED, V14, P723, DOI 10.1038/nm1784; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Fulga TA, 2007, NAT CELL BIOL, V9, P139, DOI 10.1038/ncb1528; Gelbart ME, 2009, NAT STRUCT MOL BIOL, V16, P825, DOI 10.1038/nsmb.1644; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Hensley K, 1998, J NEUROSCI, V18, P8126; HITTELMAN WN, 1984, CARCINOGENESIS, V5, P1277, DOI 10.1093/carcin/5.10.1277; Holtzman DM, 2012, COLD SPRING HARB PER, V2, P11; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Ittner LM, 2011, NAT REV NEUROSCI, V12, P67, DOI 10.1038/nrn2967; Jiang Y, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-42; Juliano C, 2011, ANNU REV GENET, V45, P447, DOI 10.1146/annurev-genet-110410-132541; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Khurana V, 2006, CURR BIOL, V16, P230, DOI 10.1016/j.cub.2005.12.042; Khurana V, 2012, AGING CELL, V11, P360, DOI 10.1111/j.1474-9726.2011.00778.x; Kruman II, 2004, NEURON, V41, P549, DOI 10.1016/S0896-6273(04)00017-0; Krylova SM, 2005, FEBS LETT, V579, P1371, DOI 10.1016/j.febslet.2005.01.032; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Lu BY, 1998, DEVELOPMENT, V125, P2223; Maes OC, 2007, NEUROBIOL AGING, V28, P1795, DOI 10.1016/j.neurobiolaging.2006.08.004; Martens GA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024134; Marygold SJ, 2013, NUCLEIC ACIDS RES, V41, pD751, DOI 10.1093/nar/gks1024; Missirlis F, 2002, J BIOL CHEM, V277, P11521, DOI 10.1074/jbc.M111692200; MULLAART E, 1990, NEUROBIOL AGING, V11, P169, DOI 10.1016/0197-4580(90)90542-8; Paredes S, 2009, P NATL ACAD SCI USA, V106, P17829, DOI 10.1073/pnas.0906811106; Peng JC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000435; Penna I, 2011, INT J MOL SCI, V12, P5461, DOI 10.3390/ijms12095461; Poorkaj P, 1998, ANN NEUROL, V43, P815, DOI 10.1002/ana.410430617; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Rubbi CP, 2003, EMBO J, V22, P975, DOI 10.1093/emboj/cdg082; Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817; Sjoberg MK, 2006, J CELL SCI, V119, P2025, DOI 10.1242/jcs.02907; Smith KT, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001371; Spillantini MG, 1998, AM J PATHOL, V153, P1359, DOI 10.1016/S0002-9440(10)65721-5; Steinhilb ML, 2007, MOL BIOL CELL, V18, P5060, DOI 10.1091/mbc.E07-04-0327; TSUKIYAMA T, 1995, CELL, V83, P1011, DOI 10.1016/0092-8674(95)90216-3; Wei Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002600; Williams DW, 2006, NAT NEUROSCI, V9, P1234, DOI 10.1038/nn1774; Wittmann CW, 2001, SCIENCE, V293, P711, DOI 10.1126/science.1062382; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033	59	268	270	1	65	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2014	17	3					357	U48		10.1038/nn.3639	http://dx.doi.org/10.1038/nn.3639			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AB8CA	24464041	Green Accepted, Green Submitted			2022-12-17	WOS:000332016500008
J	Lovett-Barron, M; Turi, GF; Kaifosh, P; Lee, PH; Bolze, F; Sun, XH; Nicoud, JF; Zemelman, BV; Sternson, SM; Losonczy, A				Lovett-Barron, Matthew; Turi, Gergely F.; Kaifosh, Patrick; Lee, Peter H.; Bolze, Frederic; Sun, Xiao-Hua; Nicoud, Jean-Francois; Zemelman, Boris V.; Sternson, Scott M.; Losonczy, Attila			Regulation of neuronal input transformations by tunable dendritic inhibition	NATURE NEUROSCIENCE			English	Article							CA1 PYRAMIDAL NEURONS; HIPPOCAMPAL INTERNEURONS; RAT HIPPOCAMPUS; GABAERGIC INTERNEURONS; PLACE CELLS; IN-VIVO; NETWORK; PLASTICITY; OSCILLATIONS; POTENTIALS	Transforming synaptic input into action potential output is a fundamental function of neurons. The pattern of action potential output from principal cells of the mammalian hippocampus encodes spatial and nonspatial information, but the cellular and circuit mechanisms by which neurons transform their synaptic input into a given output are unknown. Using a combination of optical activation and cell type-specific pharmacogenetic silencing in vitro, we found that dendritic inhibition is the primary regulator of input-output transformations in mouse hippocampal CA1 pyramidal cells, and acts by gating the dendritic electrogenesis driving burst spiking. Dendrite-targeting interneurons are themselves modulated by interneurons targeting pyramidal cell somata, providing a synaptic substrate for tuning pyramidal cell output through interactions in the local inhibitory network. These results provide evidence for a division of labor in cortical circuits, where distinct computational functions are implemented by subtypes of local inhibitory neurons.	[Lovett-Barron, Matthew; Turi, Gergely F.; Kaifosh, Patrick; Losonczy, Attila] Columbia Univ, Dept Neurosci, New York, NY 10027 USA; [Lee, Peter H.; Sternson, Scott M.] Howard Hughes Med Inst, Ashburn, VA USA; [Bolze, Frederic; Sun, Xiao-Hua; Nicoud, Jean-Francois] Univ Strasbourg, Lab Biophoton & Pharmacol, Ctr Natl Rech Sci, UMR 7213, Strasbourg, France; [Zemelman, Boris V.] Univ Texas Austin, Ctr Learning & Memory, Austin, TX 78712 USA	Columbia University; Howard Hughes Medical Institute; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Texas System; University of Texas Austin	Losonczy, A (corresponding author), Columbia Univ, Dept Neurosci, New York, NY 10027 USA.	al2856@columbia.edu	Bolze, Frederic/AAX-9871-2021; Turi, Gergely/E-7631-2013; Turi, Gergely/G-5054-2019	Turi, Gergely/0000-0001-5651-9459; Zemelman, Boris/0000-0003-2463-4887; Lovett-Barron, Matthew/0000-0003-1425-5277; Lee, Peter H/0000-0003-4177-4099; Sternson, Scott/0000-0002-0835-444X; Kaifosh, Patrick/0000-0002-1470-5701	Natural Sciences and Engineering Research Council of Canada; Searle Scholar Program; Gatsby Foundation; Kavli Institute at Columbia University; Howard Hughes Medical Institute; Agence Nationale pour la Recherche (France) [ANR PCV 07 10035]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Searle Scholar Program; Gatsby Foundation; Kavli Institute at Columbia University; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Agence Nationale pour la Recherche (France)(French National Research Agency (ANR))	We thank R. Nyilas, R. Field, A. Qureshi, J.K. Baruni and A. Villacis for help with histology. We thank J.C. Magee, L. F. Abbott, G. Buzsaki, S. A. Siegelbaum and T. M. Jessell for discussions and comments on a previous version of the manuscript. This work was supported by Natural Sciences and Engineering Research Council of Canada Postgraduate Scholarships (M.L.-B. and P. K.), the Searle Scholar Program, the Gatsby Foundation and Kavli Institute at Columbia University (A. L.) and the Howard Hughes Medical Institute (S. M. S.). F. B. thanks the Agence Nationale pour la Recherche (France) for financial support (ANR PCV 07 10035).	Ahmed OJ, 2009, TRENDS NEUROSCI, V32, P329, DOI 10.1016/j.tins.2009.01.009; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Branco T, 2010, CURR OPIN NEUROBIOL, V20, P494, DOI 10.1016/j.conb.2010.07.009; BUHL EH, 1994, NATURE, V368, P823, DOI 10.1038/368823a0; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Cobb SR, 1997, NEUROSCIENCE, V79, P629, DOI 10.1016/S0306-4522(97)00055-9; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; Colgin LL, 2008, TRENDS NEUROSCI, V31, P469, DOI 10.1016/j.tins.2008.06.008; Collingridge G.L., 1988, J PHYSIOL-LONDON, V399, P282; Cope DW, 2002, NEUROSCIENCE, V109, P63, DOI 10.1016/S0306-4522(01)00440-7; Epsztein J, 2011, NEURON, V70, P109, DOI 10.1016/j.neuron.2011.03.006; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Fuentealba P, 2008, NEURON, V57, P917, DOI 10.1016/j.neuron.2008.01.034; Gasparini S, 2006, J NEUROSCI, V26, P2088, DOI 10.1523/JNEUROSCI.4428-05.2006; Golding NL, 1999, J NEUROSCI, V19, P8789, DOI 10.1523/JNEUROSCI.19-20-08789.1999; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027; Jarsky T, 2005, NAT NEUROSCI, V8, P1667, DOI 10.1038/nn1599; KANDEL ER, 1961, J NEUROPHYSIOL, V24, P243, DOI 10.1152/jn.1961.24.3.243; Katona I, 1999, J NEUROSCI, V19, P4544; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Klausberger T, 2004, NAT NEUROSCI, V7, P41, DOI 10.1038/nn1159; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Klausberger T, 2009, EUR J NEUROSCI, V30, P947, DOI 10.1111/j.1460-9568.2009.06913.x; KNOWLES WD, 1981, J NEUROSCI, V1, P1236; Larkum ME, 2009, SCIENCE, V325, P756, DOI 10.1126/science.1171958; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Losonczy A, 2006, NEURON, V50, P291, DOI 10.1016/j.neuron.2006.03.016; Losonczy A, 2002, J PHYSIOL-LONDON, V542, P193, DOI 10.1113/jphysiol.2002.020024; Losonczy A, 2008, NATURE, V452, P436, DOI 10.1038/nature06725; Losonczy A, 2010, NAT NEUROSCI, V13, P967, DOI 10.1038/nn.2597; Maccaferri G, 2000, J PHYSIOL-LONDON, V524, P91, DOI 10.1111/j.1469-7793.2000.t01-3-00091.x; Magee JC, 1999, J NEUROPHYSIOL, V82, P1895, DOI 10.1152/jn.1999.82.4.1895; Magnus CJ, 2011, SCIENCE, V333, P1292, DOI 10.1126/science.1206606; Megias M, 2001, NEUROSCIENCE, V102, P527, DOI 10.1016/S0306-4522(00)00496-6; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; MULLIGAN KA, 1988, J COMP NEUROL, V270, P86, DOI 10.1002/cne.902700108; Murayama M, 2009, NATURE, V457, P1137, DOI 10.1038/nature07663; Nevian T, 2007, NAT NEUROSCI, V10, P206, DOI 10.1038/nn1826; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Poirazi P, 2003, NEURON, V37, P977, DOI 10.1016/S0896-6273(03)00148-X; Poirazi P, 2003, NEURON, V37, P989, DOI 10.1016/S0896-6273(03)00149-1; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Takahashi H, 2009, NEURON, V62, P102, DOI 10.1016/j.neuron.2009.03.007; THOMPSON LT, 1989, J NEUROSCI, V9, P2382; Varga V, 2009, SCIENCE, V326, P449, DOI 10.1126/science.1178307; Verde EMR, 2008, FRONT NEURAL CIRCUIT, V2, DOI 10.3389/neuro.04.002.2008; Williams SR, 2004, NAT NEUROSCI, V7, P961, DOI 10.1038/nn1305; Williams SR, 2002, SCIENCE, V295, P1907, DOI 10.1126/science.1067903	50	268	268	0	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2012	15	3					423	U111		10.1038/nn.3024	http://dx.doi.org/10.1038/nn.3024			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	899CY	22246433				2022-12-17	WOS:000300793100016
J	Loffler, G; Yourganov, G; Wilkinson, F; Wilson, HR				Loffler, G; Yourganov, G; Wilkinson, F; Wilson, HR			fMRI evidence for the neural representation of faces	NATURE NEUROSCIENCE			English	Article							INFERIOR TEMPORAL CORTEX; STRIATE CORTEX; RECOGNITION; PERCEPTION; CONTRAST; MONKEY; AREA; IDENTIFICATION; POTENTIALS; RESPONSES	fMRI ( functional magnetic resonance imaging) studies on humans have shown a cortical area, the fusiform face area, that is specialized for face processing. An important question is how faces are represented within this area. This study provides direct evidence for a representation in which individual faces are encoded by their direction ( facial identity) and distance ( distinctiveness) from a prototypical ( mean) face. When facial geometry ( head shape, hair line, internal feature size and placement) was varied, the fMRI signal increased with increasing distance from the mean face. Furthermore, adaptation of the fMRI signal showed that the same neural population responds to faces falling along single identity axes within this space.	Glasgow Caledonian Univ, Dept Vis Sci, Glasgow G4 0BA, Lanark, Scotland; York Univ, Ctr Vis Res, N York, ON M3J 1P3, Canada	Glasgow Caledonian University; York University - Canada	Loffler, G (corresponding author), Glasgow Caledonian Univ, Dept Vis Sci, Cowcaddens Rd, Glasgow G4 0BA, Lanark, Scotland.	gloe@gcal.ac.uk		Loffler, Gunter/0000-0002-8359-9033	NATIONAL EYE INSTITUTE [R01EY002158] Funding Source: NIH RePORTER; NEI NIH HHS [EY002158] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALBRECHT DG, 1982, J NEUROPHYSIOL, V48, P217, DOI 10.1152/jn.1982.48.1.217; Boynton GM, 1999, VISION RES, V39, P257, DOI 10.1016/S0042-6989(98)00113-8; BRUCE V, 1991, COGNITION, V38, P109, DOI 10.1016/0010-0277(91)90049-A; Bruce V., 1998, EYE BEHOLDER SCI FAC; DESIMONE R, 1991, J COGNITIVE NEUROSCI, V3, P1, DOI 10.1162/jocn.1991.3.1.1; Duchaine BC, 2004, NEURON, V43, P469, DOI 10.1016/j.neuron.2004.08.006; Gauthier I, 1999, NAT NEUROSCI, V2, P568, DOI 10.1038/9224; Gold J, 1999, VISION RES, V39, P3537, DOI 10.1016/S0042-6989(99)00080-2; Grill-Spector K, 2004, NAT NEUROSCI, V7, P555, DOI 10.1038/nn1224; Grill-Spector K, 2001, ACTA PSYCHOL, V107, P293, DOI 10.1016/S0001-6918(01)00019-1; GROSS CG, 1992, PHILOS T ROY SOC B, V335, P3, DOI 10.1098/rstb.1992.0001; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kayaert G, 2003, J NEUROSCI, V23, P3016; Leopold DA, 2001, NAT NEUROSCI, V4, P89, DOI 10.1038/82947; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; McCarthy G, 1999, CEREB CORTEX, V9, P431, DOI 10.1093/cercor/9.5.431; NAKA KI, 1966, J PHYSIOL-LONDON, V185, P536, DOI 10.1113/jphysiol.1966.sp008001; Nasanen R, 1999, VISION RES, V39, P3824, DOI 10.1016/S0042-6989(99)00096-6; SCLAR G, 1990, VISION RES, V30, P1, DOI 10.1016/0042-6989(90)90123-3; Sheth SA, 2004, NEURON, V42, P347, DOI 10.1016/S0896-6273(04)00221-1; Tanaka J, 1998, COGNITION, V68, P199, DOI 10.1016/S0010-0277(98)00048-1; VALENTINE T, 1991, Q J EXP PSYCHOL-A, V43, P161, DOI 10.1080/14640749108400966; Wilson HR, 2002, VISION RES, V42, P2909, DOI 10.1016/S0042-6989(02)00362-0	25	268	271	2	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2005	8	10					1386	1390		10.1038/nn1538	http://dx.doi.org/10.1038/nn1538			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	968EY	16136037				2022-12-17	WOS:000232145900024
J	Butler, AA; Marks, DL; Fan, W; Kuhn, CM; Bartolome, M; Cone, RD				Butler, AA; Marks, DL; Fan, W; Kuhn, CM; Bartolome, M; Cone, RD			Melanocortin-4 receptor is required for acute homeostatic responses to increased dietary fat	NATURE NEUROSCIENCE			English	Article							BROWN ADIPOSE-TISSUE; FOOD-INTAKE; ENERGY-BALANCE; LEPTIN; THERMOGENESIS; OBESE; MICE; INSULIN; WEIGHT; SYSTEM	In response to moderately increased dietary fat content, melanocortin-4 receptor-null mutant (MC4R(-/-)) mice exhibit hyperphagia and accelerated weight gain compared to wild-type mice. An increased feed efficiency (weight gain/kcal consumed) argues that mechanisms in addition to hyperphagia are instrumental in causing weight gain. We report two specific defects in coordinating energy expenditure with food intake in MC4R(-/-) mice. Wild-type mice respond to an increase in the fat content of the diet by rapidly increasing diet-induced thermogenesis and by increasing physical activity, neither of which are observed in MC4R(-/-) mice. Leptin-deficient and MC3R(-/-) mice regulate metabolic rate similarly to wild-type mice in this protocol. Melanocortinergic pathways involving MC4-R-regulated neurons, which rapidly respond to signals not requiring changes in leptin, thus seem to be important in regulating metabolic and behavioral responses to dietary fat.	Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA; Oregon Hlth & Sci Univ, CDRCP, Dept Pediat Endocrinol, Portland, OR 97201 USA; Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	Oregon Health & Science University; Oregon Health & Science University; Duke University	Cone, RD (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.	cone@ohsu.edu		Butler, Andrew/0000-0001-7196-0170	OAPP OPHS HHS [PPGDK55819] Funding Source: Medline	OAPP OPHS HHS		Baskin DG, 1999, BRAIN RES, V848, P114, DOI 10.1016/S0006-8993(99)01974-5; Boston BA, 1997, SCIENCE, V278, P1641, DOI 10.1126/science.278.5343.1641; Butler AA, 2000, ENDOCRINOLOGY, V141, P3518, DOI 10.1210/en.141.9.3518; Cheung CC, 1997, ENDOCRINOLOGY, V138, P4489, DOI 10.1210/en.138.10.4489; Collins S, 1996, NATURE, V380, P677, DOI 10.1038/380677a0; Cowley MA, 1999, NEURON, V24, P155, DOI 10.1016/S0896-6273(00)80829-6; De Souza J, 2000, NEUROENDOCRINOLOGY, V72, P126, DOI 10.1159/000054579; Eckel LA, 1998, AM J PHYSIOL-REG I, V275, pR186, DOI 10.1152/ajpregu.1998.275.1.R186; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; FERRANNINI E, 1988, METABOLISM, V37, P287, DOI 10.1016/0026-0495(88)90110-2; FRIGERI LG, 1988, INT J OBESITY, V12, P305; Hagan MM, 1999, J NEUROSCI, V19, P2362; Halaas JL, 1997, P NATL ACAD SCI USA, V94, P8878, DOI 10.1073/pnas.94.16.8878; Haynes WG, 1999, HYPERTENSION, V33, P542, DOI 10.1161/01.HYP.33.1.542; HIMMSHAGEN J, 1986, AM J PHYSIOL, V250, pE274, DOI 10.1152/ajpendo.1986.250.3.E274; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Leibel RL, 1997, J BIOL CHEM, V272, P31937, DOI 10.1074/jbc.272.51.31937; Levine James A., 1999, Science (Washington D C), V283, P212, DOI 10.1126/science.283.5399.212; Loftus TM, 2000, SCIENCE, V288, P2379, DOI 10.1126/science.288.5475.2379; Low M.J., 1994, CURR OPIN ENDOCRINOL, V1, P79; Marsh DJ, 1999, NAT GENET, V21, P119, DOI 10.1038/5070; MERCER SW, 1987, J NUTR, V117, P2147; Nakaya Y, 1998, ANN NUTR METAB, V42, P333, DOI 10.1159/000012753; SALADIN R, 1995, NATURE, V377, P527, DOI 10.1038/377527a0; Satoh N, 1998, NEUROSCI LETT, V249, P107, DOI 10.1016/S0304-3940(98)00401-7; SCHUTZ Y, 1984, AM J CLIN NUTR, V40, P542, DOI 10.1093/ajcn/40.3.542; Seeley RJ, 1997, NATURE, V390, P349, DOI 10.1038/37016; SMITH AI, 1988, ENDOCR REV, V9, P159, DOI 10.1210/edrv-9-1-159; Ste Marie L, 2000, P NATL ACAD SCI USA, V97, P12339, DOI 10.1073/pnas.220409497; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; TRAYHURN P, 1982, NATURE, V295, P323, DOI 10.1038/295323a0; YEN TT, 1984, INT J OBESITY, V8, P65; Ziotopoulou M, 2000, AM J PHYSIOL-ENDOC M, V279, pE838, DOI 10.1152/ajpendo.2000.279.4.E838; ZURLO F, 1990, AM J PHYSIOL, V259, pE650	34	268	275	4	14	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2001	4	6					605	611		10.1038/88423	http://dx.doi.org/10.1038/88423			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	438PG	11369941				2022-12-17	WOS:000169061800013
J	Busche, MA; Hyman, BT				Busche, Marc Aurel; Hyman, Bradley T.			Synergy between amyloid-beta and tau in Alzheimer's disease	NATURE NEUROSCIENCE			English	Review							TRANSGENIC MICE; A-BETA; HYPERPHOSPHORYLATED-TAU; MOUSE MODEL; NEUROFIBRILLARY DEGENERATION; ABNORMAL INTERACTION; CEREBROSPINAL-FLUID; COGNITIVE DECLINE; AXONAL-TRANSPORT; PATHOLOGICAL TAU	Patients with Alzheimer's disease (AD) present with both extracellular amyloid-beta (A beta) plaques and intracellular tau-containing neurofibrillary tangles in the brain. For many years, the prevailing view of AD pathogenesis has been that changes in A beta precipitate the disease process and initiate a deleterious cascade involving tau pathology and neurodegeneration. Beyond this 'triggering' function, it has been typically presumed that A beta and tau act independently and in the absence of specific interaction. However, accumulating evidence now suggests otherwise and contends that both pathologies have synergistic effects. This could not only help explain negative results from anti-A beta clinical trials but also suggest that trials directed solely at tau may need to be reconsidered. Here, drawing from extensive human and disease model data, we highlight the latest evidence base pertaining to the complex A beta-tau interaction and underscore its crucial importance to elucidating disease pathogenesis and the design of next-generation AD therapeutic trials. Busche and Hyman review emerging evidence for an interaction between A beta and tau during Alzheimer's disease (AD) progression that challenges the classical linear trajectory model and offers a new perspective on AD pathophysiology and therapy.	[Busche, Marc Aurel] UCL, UK Dementia Res Inst UCL, London, England; [Hyman, Bradley T.] Harvard Med Sch, Massachusetts Gen Hosp, MassGen Inst Neurodegenerat Dis, Boston, MA 02115 USA	University of London; University College London; Harvard University; Harvard Medical School; Massachusetts General Hospital	Busche, MA (corresponding author), UCL, UK Dementia Res Inst UCL, London, England.	m.busche@ucl.ac.uk		Busche, Marc Aurel/0000-0002-4416-7553; Hyman, Bradley/0000-0002-7959-9401	Alzheimer's Disease Research (ADR), a program of BrightFocus Foundation [A2019112S]; UK Dementia Research Institute - DRI Ltd.; Medical Research Council; Alzheimer's Society; Alzheimer Research UK; UKRI Future Leaders Fellowship [MR/S017003/1]; Massachusetts Alzheimer's Disease Research Center [P30AG062421]; JPB foundation; National Institutes of Health [R01AG058674]; Tau Consortium; MRC [UKDRI-1010] Funding Source: UKRI; UKRI [MR/S017003/1] Funding Source: UKRI	Alzheimer's Disease Research (ADR), a program of BrightFocus Foundation(BrightFocus Foundation); UK Dementia Research Institute - DRI Ltd.; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimer's Society; Alzheimer Research UK(Alzheimer's Research UK (ARUK)); UKRI Future Leaders Fellowship(UK Research & Innovation (UKRI)); Massachusetts Alzheimer's Disease Research Center; JPB foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tau Consortium; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UKRI	We are grateful to S. S. Harris for his support preparing this manuscript, and we thank B. I. Lee for help with the figures. We acknowledge the donors of Alzheimer's Disease Research (ADR), a program of BrightFocus Foundation, for the generous support of this research (grant number: A2019112S). M.A.B. is further supported by the UK Dementia Research Institute, which receives its funding from DRI Ltd., funded by the Medical Research Council, Alzheimer's Society and Alzheimer Research UK and by a UKRI Future Leaders Fellowship (grant number: MR/S017003/1). B.T.H. is supported by the Massachusetts Alzheimer's Disease Research Center (P30AG062421), the JPB foundation, the National Institutes of Health (R01AG058674) and the Tau Consortium.	Adalbert R, 2018, NEUROBIOL AGING, V68, P68, DOI 10.1016/j.neurobiolaging.2018.03.033; Adams JN, 2019, ELIFE, V8, DOI 10.7554/eLife.49132; Angulo SL, 2017, NEUROBIOL DIS, V108, P261, DOI 10.1016/j.nbd.2017.08.015; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; Asai H, 2015, NAT NEUROSCI, V18, P1584, DOI 10.1038/nn.4132; Bassil F, 2020, NEURON, V105, P260, DOI 10.1016/j.neuron.2019.10.010; Benbow SJ, 2020, HUM MOL GENET, V29, P495, DOI 10.1093/hmg/ddz319; Bennett RE, 2018, P NATL ACAD SCI USA, V115, pE1289, DOI 10.1073/pnas.1710329115; Bennett RE, 2017, AM J PATHOL, V187, P1601, DOI 10.1016/j.ajpath.2017.03.011; Bezprozvanny I, 2008, TRENDS NEUROSCI, V31, P454, DOI 10.1016/j.tins.2008.06.005; Bhaskar K, 2010, NEURON, V68, P19, DOI 10.1016/j.neuron.2010.08.023; Blair LJ, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0186-2; Bodea LG, 2017, AGING CELL, V16, P377, DOI 10.1111/acel.12565; Bolmont T, 2007, AM J PATHOL, V171, P2012, DOI 10.2353/ajpath.2007.070403; Bolos M, 2016, J ALZHEIMERS DIS, V50, P77, DOI 10.3233/JAD-150704; Braak H, 1997, NEUROBIOL AGING, V18, P351, DOI 10.1016/S0197-4580(97)00056-0; Braak H, 2011, J NEUROPATH EXP NEUR, V70, P960, DOI 10.1097/NEN.0b013e318232a379; Brawek B, 2014, ACTA NEUROPATHOL, V127, P495, DOI 10.1007/s00401-013-1242-2; Busche MA, 2019, NAT NEUROSCI, V22, P57, DOI 10.1038/s41593-018-0289-8; Bussian TJ, 2018, NATURE, V562, P578, DOI 10.1038/s41586-018-0543-y; Chabrier MA, 2014, NEUROBIOL DIS, V64, P107, DOI 10.1016/j.nbd.2014.01.007; Chen W, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0336-1; Choi SH, 2014, NATURE, V515, P274, DOI 10.1038/nature13800; Corbett GT, 2020, ACTA NEUROPATHOL, V139, P503, DOI 10.1007/s00401-019-02114-9; Crary JF, 2014, ACTA NEUROPATHOL, V128, P755, DOI 10.1007/s00401-014-1349-0; Cserep C, 2020, SCIENCE, V367, P528, DOI 10.1126/science.aax6752; Das M, 2018, NEUROBIOL DIS, V117, P181, DOI 10.1016/j.nbd.2018.05.020; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; Dejanovic B, 2018, NEURON, V100, P1322, DOI 10.1016/j.neuron.2018.10.014; Desikan RS, 2011, ANN NEUROL, V70, P657, DOI 10.1002/ana.22509; DeVos SL, 2018, BRAIN, V141, P2194, DOI 10.1093/brain/awy117; Duan LH, 2018, NEURON, V100, P183, DOI 10.1016/j.neuron.2018.08.030; Eftekharzadeh B, 2018, NEURON, V99, P925, DOI 10.1016/j.neuron.2018.07.039; Evans HT, 2019, EMBO J, V38, DOI 10.15252/embj.2018101174; Fang EF, 2019, NAT NEUROSCI, V22, P401, DOI 10.1038/s41593-018-0332-9; Ferrari A, 2003, J BIOL CHEM, V278, P40162, DOI 10.1074/jbc.M308243200; Fortea J, 2014, ANN NEUROL, V76, P223, DOI 10.1002/ana.24186; Fu HJ, 2019, NAT NEUROSCI, V22, P47, DOI 10.1038/s41593-018-0298-7; Gamache J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10428-1; Gomes LA, 2019, ACTA NEUROPATHOL, V138, P913, DOI 10.1007/s00401-019-02053-5; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Green C, 2019, MOL NEURODEGENER, V14, DOI 10.1186/s13024-019-0316-6; Griner SL, 2019, ELIFE, V8, DOI 10.7554/eLife.46924; Guo JL, 2013, CELL, V154, P103, DOI 10.1016/j.cell.2013.05.057; Hanseeuw BJ, 2019, JAMA NEUROL, V76, P915, DOI 10.1001/jamaneurol.2019.1424; Hanseeuw BJ, 2017, ANN NEUROL, V81, P583, DOI 10.1002/ana.24910; Hatch RJ, 2017, ACTA NEUROPATHOL, V133, P717, DOI 10.1007/s00401-017-1674-1; He ZH, 2018, NAT MED, V24, P29, DOI 10.1038/nm.4443; Hoppe SC, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1309-z; Hou YJ, 2019, NAT REV NEUROL, V15, P565, DOI 10.1038/s41582-019-0244-7; Huijbers W, 2019, J NEUROSCI, V39, P548, DOI 10.1523/JNEUROSCI.1397-18.2018; Hyman BT, 2011, ARCH NEUROL-CHICAGO, V68, P1062, DOI 10.1001/archneurol.2011.70; Ingelsson M, 2004, NEUROLOGY, V62, P925, DOI 10.1212/01.WNL.0000115115.98960.37; Israel MA, 2012, NATURE, V482, P216, DOI 10.1038/nature10821; Ittner A, 2016, SCIENCE, V354, P904, DOI 10.1126/science.aah6205; Ittner LM, 2008, P NATL ACAD SCI USA, V105, P15997, DOI 10.1073/pnas.0808084105; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Iturria-Medina Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11934; Jackson RJ, 2016, EUR J NEUROSCI, V44, P3056, DOI 10.1111/ejn.13442; Jacobs HIL, 2018, NAT NEUROSCI, V21, P424, DOI 10.1038/s41593-018-0070-z; Jagust W, 2018, NAT REV NEUROSCI, V19, P687, DOI 10.1038/s41583-018-0067-3; Jansen WJ, 2015, JAMA-J AM MED ASSOC, V313, P1924, DOI 10.1001/jama.2015.4668; Perez MJ, 2018, MOL NEUROBIOL, V55, P1004, DOI 10.1007/s12035-017-0385-x; Jucker M, 2018, NAT NEUROSCI, V21, P1341, DOI 10.1038/s41593-018-0238-6; Ke YZD, 2019, J BIOL CHEM, V294, P14149, DOI 10.1074/jbc.RA118.005263; Kitaguchi H, 2009, BRAIN RES, V1294, P202, DOI 10.1016/j.brainres.2009.07.078; KOUNNAS MZ, 1995, CELL, V82, P331, DOI 10.1016/0092-8674(95)90320-8; Kuchibhotla KV, 2014, P NATL ACAD SCI USA, V111, P510, DOI 10.1073/pnas.1318807111; Lasagna-Reeves CA, 2010, BIOCHEMISTRY-US, V49, P10039, DOI 10.1021/bi1016233; Lee HK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163072; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Leyns CEG, 2019, NAT NEUROSCI, V22, P1217, DOI 10.1038/s41593-019-0433-0; Lippi SLP, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00382; Lleo A, 2004, AM J GERIAT PSYCHIAT, V12, P146, DOI 10.1176/appi.ajgp.12.2.146; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Maia LF, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006446; Mancuso R, 2019, BRAIN, V142, P3243, DOI 10.1093/brain/awz241; Manczak M, 2013, J ALZHEIMERS DIS, V36, P285, DOI 10.3233/JAD-130275; Manczak M, 2012, HUM MOL GENET, V21, P5131, DOI 10.1093/hmg/dds360; Maphis N, 2015, BRAIN, V138, P1738, DOI 10.1093/brain/awv081; Marinkovic P, 2019, BRAIN, V142, P1051, DOI 10.1093/brain/awz035; Marschallinger J, 2020, NAT NEUROSCI, V23, P194, DOI 10.1038/s41593-019-0566-1; Martini-Stoica H, 2018, J EXP MED, V215, P2355, DOI 10.1084/jem.20172158; Mattson MP, 2018, CELL METAB, V27, P1176, DOI 10.1016/j.cmet.2018.05.011; McInnes J, 2018, NEURON, V97, P823, DOI 10.1016/j.neuron.2018.01.022; Menkes-Caspi N, 2015, NEURON, V85, P959, DOI 10.1016/j.neuron.2015.01.025; Merlini M, 2016, ACTA NEUROPATHOL, V131, P737, DOI 10.1007/s00401-016-1560-2; Milikovsky DZ, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aaw8954; Musi N, 2018, AGING CELL, V17, DOI 10.1111/acel.12840; Nation DA, 2019, NAT MED, V25, P270, DOI 10.1038/s41591-018-0297-y; Nortley R, 2019, SCIENCE, V365, P250, DOI 10.1126/science.aav9518; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Oddo S, 2004, NEURON, V43, P321, DOI 10.1016/j.neuron.2004.07.003; Ondrejcak T, 2019, NEUROBIOL DIS, V127, P582, DOI 10.1016/j.nbd.2019.03.022; Palop JJ, 2016, NAT REV NEUROSCI, V17, P777, DOI 10.1038/nrn.2016.141; Pascoal TA, 2017, MOL PSYCHIATR, V22, P306, DOI 10.1038/mp.2016.37; Peng C, 2020, NAT REV NEUROL, V16, P199, DOI 10.1038/s41582-020-0333-7; Perez-Nievas BG, 2013, BRAIN, V136, P2510, DOI 10.1093/brain/awt171; Pickett EK, 2019, CELL REP, V29, P3592, DOI 10.1016/j.celrep.2019.11.044; Pluvinage JV, 2020, NAT REV NEUROSCI, V21, P93, DOI 10.1038/s41583-019-0255-9; Pontecorvo MJ, 2017, BRAIN, V140, P748, DOI 10.1093/brain/aww334; Pooler AM, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0199-x; Prinz M, 2019, CELL, V179, P292, DOI 10.1016/j.cell.2019.08.053; Qiu LF, 2016, SCI REP-UK, V6, DOI 10.1038/srep23964; Rabin JS, 2019, ANN NEUROL, V85, P272, DOI 10.1002/ana.25399; Rasool S, 2013, J NEUROCHEM, V126, P473, DOI 10.1111/jnc.12305; Rauch JN, 2020, NATURE, V580, P381, DOI 10.1038/s41586-020-2156-5; Rhein V, 2009, P NATL ACAD SCI USA, V106, P20057, DOI 10.1073/pnas.0905529106; Ribe EM, 2005, NEUROBIOL DIS, V20, P814, DOI 10.1016/j.nbd.2005.05.027; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Roberson ED, 2011, J NEUROSCI, V31, P700, DOI 10.1523/JNEUROSCI.4152-10.2011; Rodriguez G.A., 2019, ATTENUATION ENTORHIN, DOI [10.1101/487405, DOI 10.1101/487405]; Rosenberg RN, 2018, ALZHEIMERS RES THER, V10, DOI 10.1186/s13195-018-0441-4; Ryan NS, 2016, LANCET NEUROL, V15, P1326, DOI 10.1016/S1474-4422(16)30193-4; Sagare AP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3932; Saito T, 2019, J BIOL CHEM, V294, P12754, DOI 10.1074/jbc.RA119.009487; Schelle J, 2017, ALZHEIMERS DEMENT, V13, P701, DOI 10.1016/j.jalz.2016.09.005; Schultz AP, 2017, J NEUROSCI, V37, P4323, DOI 10.1523/JNEUROSCI.3263-16.2017; Schultz MK, 2018, NEUROBIOL DIS, V118, P161, DOI 10.1016/j.nbd.2018.07.003; Senatorov VV, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aaw8283; Sepulcre J, 2018, NAT MED, V24, P1910, DOI 10.1038/s41591-018-0206-4; Shi Y, 2019, J EXP MED, V216, P2546, DOI 10.1084/jem.20190980; Sierksma A, 2020, EMBO MOL MED, V12, DOI 10.15252/emmm.201910606; Sohn PD, 2019, NEURON, V104, P458, DOI 10.1016/j.neuron.2019.08.008; Sperling RA, 2019, ANN NEUROL, V85, P181, DOI 10.1002/ana.25395; Suberbielle E, 2013, NAT NEUROSCI, V16, P613, DOI 10.1038/nn.3356; Sun WY, 2018, NAT NEUROSCI, V21, P1038, DOI 10.1038/s41593-018-0194-1; Sykora P, 2015, NUCLEIC ACIDS RES, V43, P943, DOI 10.1093/nar/gku1356; Tai XY, 2016, BRAIN, V139, P2441, DOI 10.1093/brain/aww187; Takeda S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9490; Therriault J, 2021, MOL PSYCHIATR, V26, P5977, DOI 10.1038/s41380-020-0688-6; Timmers M, 2019, NEUROBIOL AGING, V79, P131, DOI 10.1016/j.neurobiolaging.2019.03.016; Tracy TE, 2016, NEURON, V90, P245, DOI 10.1016/j.neuron.2016.03.005; Umeda T, 2014, ACTA NEUROPATHOL, V127, P685, DOI 10.1007/s00401-014-1259-1; Usenovic M, 2015, J NEUROSCI, V35, P14234, DOI 10.1523/JNEUROSCI.1523-15.2015; Vasconcelos B, 2016, ACTA NEUROPATHOL, V131, P549, DOI 10.1007/s00401-015-1525-x; Vergara C, 2019, ACTA NEUROPATHOL, V137, P397, DOI 10.1007/s00401-018-1953-5; Villeneuve S, 2015, BRAIN, V138, P2020, DOI 10.1093/brain/awv112; Vossel KA, 2015, J CELL BIOL, V209, P419, DOI 10.1083/jcb.201407065; Wang CY, 2018, NEUROBIOL DIS, V109, P88, DOI 10.1016/j.nbd.2017.10.003; Wang L, 2016, JAMA NEUROL, V73, P1070, DOI 10.1001/jamaneurol.2016.2078; Wang XJ, 2010, J ALZHEIMERS DIS, V21, P813, DOI 10.3233/JAD-2010-100216; Warmus BA, 2014, J NEUROSCI, V34, P16482, DOI 10.1523/JNEUROSCI.3418-14.2014; Wu JW, 2016, NAT NEUROSCI, V19, P1085, DOI 10.1038/nn.4328; Yap EL, 2018, NEURON, V100, P330, DOI 10.1016/j.neuron.2018.10.013; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Zhang F, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aay6931; Zhang PS, 2019, NAT NEUROSCI, V22, P719, DOI 10.1038/s41593-019-0372-9; Zott B, 2019, SCIENCE, V365, P559, DOI 10.1126/science.aay0198; Zullo JM, 2019, NATURE, V574, P359, DOI 10.1038/s41586-019-1647-8	150	267	273	59	198	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2020	23	10					1183	1193		10.1038/s41593-020-0687-6	http://dx.doi.org/10.1038/s41593-020-0687-6		AUG 2020	11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NS9AA	32778792	Green Submitted			2022-12-17	WOS:000558142300005
J	Shimogori, T; Lee, DA; Miranda-Angulo, A; Yang, YQ; Wang, H; Jiang, LZ; Yoshida, AC; Kataoka, A; Mashiko, H; Avetisyan, M; Qi, LX; Qian, J; Blackshaw, S				Shimogori, Tomomi; Lee, Daniel A.; Miranda-Angulo, Ana; Yang, Yanqin; Wang, Hong; Jiang, Lizhi; Yoshida, Aya C.; Kataoka, Ayane; Mashiko, Hiromi; Avetisyan, Marina; Qi, Lixin; Qian, Jiang; Blackshaw, Seth			A genomic atlas of mouse hypothalamic development	NATURE NEUROSCIENCE			English	Article							AREA ANTERIOR HYPOTHALAMUS; SONIC-HEDGEHOG; SEX-DIFFERENCES; CIRCADIAN-RHYTHMS; REGIONAL IDENTITY; GENE-EXPRESSION; MICE LACKING; BRAIN; DIENCEPHALON; FOREBRAIN	The hypothalamus is a central regulator of many behaviors that are essential for survival, such as temperature regulation, food intake and circadian rhythms. However, the molecular pathways that mediate hypothalamic development are largely unknown. To identify genes expressed in developing mouse hypothalamus, we performed microarray analysis at 12 different developmental time points. We then conducted developmental in situ hybridization for 1,045 genes that were dynamically expressed over the course of hypothalamic neurogenesis. We identified markers that stably labeled each major hypothalamic nucleus over the entire course of neurogenesis and constructed a detailed molecular atlas of the developing hypothalamus. As a proof of concept of the utility of these data, we used these markers to analyze the phenotype of mice in which Sonic Hedgehog (Shh) was selectively deleted from hypothalamic neuroepithelium and found that Shh is essential for anterior hypothalamic patterning. Our results serve as a resource for functional investigations of hypothalamic development, connectivity, physiology and dysfunction.	[Shimogori, Tomomi; Yoshida, Aya C.; Kataoka, Ayane; Mashiko, Hiromi] RIKEN BSI, Wako, Saitama, Japan; [Lee, Daniel A.; Miranda-Angulo, Ana; Wang, Hong; Jiang, Lizhi; Avetisyan, Marina; Qi, Lixin; Blackshaw, Seth] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD USA; [Yang, Yanqin; Qian, Jiang; Blackshaw, Seth] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; [Blackshaw, Seth] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Blackshaw, Seth] Johns Hopkins Univ, Sch Med, Ctr High Throughput Biol, Baltimore, MD USA; [Blackshaw, Seth] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD USA	RIKEN; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Shimogori, T (corresponding author), RIKEN BSI, 2-1 Hirosawa, Wako, Saitama, Japan.	tshimogori@brain.riken.jp; sblack@jhmi.edu	Shimogori, Tomomi/L-2893-2013	Shimogori, Tomomi/0000-0002-6931-5401; Miranda-Angulo, Ana L./0000-0003-4938-3033; Lee, Daniel/0000-0001-7411-2740; Avetisyan, Marina/0000-0001-9836-5005	RIKEN Brain Science Institute and Human Frontier Science Project; National Science Foundation; March of Dimes; Klingenstein Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS067393] Funding Source: NIH RePORTER	RIKEN Brain Science Institute and Human Frontier Science Project; National Science Foundation(National Science Foundation (NSF)); March of Dimes(March of Dimes); Klingenstein Fund(Klingenstein Philanthropies); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank C.-M. Fan for guidance concerning dissection of embryonic hypothalamus and S. Hattar, A. Moore and B. Nelson for comments on the manuscript. This work was supported by the RIKEN Brain Science Institute and Human Frontier Science Project (T.S.), a National Science Foundation Predoctoral Fellowship (D.A L.), a Basil O'Connor Starter Scholar Award from the March of Dimes (S.B.) and an award from the Klingenstein Fund (S.B.). S.B. is a W.M. Keck Distinguished Young Investigator in Medical Science.	Acampora D, 1999, GENE DEV, V13, P2787, DOI 10.1101/gad.13.21.2787; Alvarez-Bolado G, 2006, J PHYSIOL-LONDON, V575, P347, DOI 10.1113/jphysiol.2006.112763; Blackshaw S, 2004, PLOS BIOL, V2, P1411, DOI 10.1371/journal.pbio.0020247; Brown AE, 1999, DEV BRAIN RES, V115, P171, DOI 10.1016/S0165-3806(99)00061-9; Budefeld T, 2008, DEV NEUROBIOL, V68, P981, DOI 10.1002/dneu.20638; Caqueret A, 2005, HORM RES, V64, P222, DOI 10.1159/000088977; Charlton H, 2008, J NEUROENDOCRINOL, V20, P641, DOI 10.1111/j.1365-2826.2008.01718.x; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Dale JK, 1997, CELL, V90, P257, DOI 10.1016/S0092-8674(00)80334-7; Dassule HR, 2000, DEVELOPMENT, V127, P4775; Davis AM, 2004, J NEUROBIOL, V60, P424, DOI 10.1002/neu.20030; Elmquist JK, 1999, NEURON, V22, P221, DOI 10.1016/S0896-6273(00)81084-3; Fuller PM, 2008, SCIENCE, V320, P1074, DOI 10.1126/science.1153277; Fyffe SL, 2008, NEURON, V59, P947, DOI 10.1016/j.neuron.2008.07.030; Goshu E, 2004, MOL ENDOCRINOL, V18, P1251, DOI 10.1210/me.2003-0372; Gray PA, 2004, SCIENCE, V306, P2255, DOI 10.1126/science.1104935; Grove EA, 1998, DEVELOPMENT, V125, P2315; HATINI V, 1994, J NEUROBIOL, V25, P1293, DOI 10.1002/neu.480251010; Herrera E, 2004, DEVELOPMENT, V131, P5727, DOI 10.1242/dev.01431; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Ino H, 2004, J HISTOCHEM CYTOCHEM, V52, P311, DOI 10.1177/002215540405200302; Kataoka A, 2008, DEVELOPMENT, V135, P2873, DOI 10.1242/dev.021618; Kiecker C, 2004, NAT NEUROSCI, V7, P1242, DOI 10.1038/nn1338; Kruk MR, 1998, NEUROSCI BIOBEHAV R, V23, P163, DOI 10.1016/S0149-7634(98)00018-9; Labosky PA, 1997, DEVELOPMENT, V124, P1263; Lee JE, 2006, DEVELOPMENT, V133, P4451, DOI 10.1242/dev.02613; Manning L, 2006, DEV CELL, V11, P873, DOI 10.1016/j.devcel.2006.09.021; Mathieu J, 2002, DEVELOPMENT, V129, P3055; McGill BE, 2006, P NATL ACAD SCI USA, V103, P18267, DOI 10.1073/pnas.0608702103; Michaud JL, 1998, GENE DEV, V12, P3264, DOI 10.1101/gad.12.20.3264; Miura H, 1997, MECH DEVELOP, V65, P99, DOI 10.1016/S0925-4773(97)00062-2; Moga MM, 1997, J COMP NEUROL, V389, P508, DOI 10.1002/(SICI)1096-9861(19971222)389:3<508::AID-CNE11>3.0.CO;2-H; O'Rahilly S, 2009, NATURE, V462, P307, DOI 10.1038/nature08532; Ohyama K, 2008, DEVELOPMENT, V135, P3325, DOI 10.1242/dev.027078; Peinado JR, 2005, ENDOCRINOLOGY, V146, P3438, DOI 10.1210/en.2004-1289; Pera EM, 1998, DEV GENES EVOL, V208, P168, DOI 10.1007/s004270050170; PORTEUS MH, 1994, J NEUROSCI, V14, P6370; Rinn JL, 2005, TRENDS GENET, V21, P298, DOI 10.1016/j.tig.2005.03.005; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Scholpp S, 2006, DEVELOPMENT, V133, P855, DOI 10.1242/dev.02248; Schonemann MD, 1995, GENE DEV, V9, P3122, DOI 10.1101/gad.9.24.3122; SHIMADA M, 1973, EXP NEUROL, V41, P163, DOI 10.1016/0014-4886(73)90187-8; Szabo NE, 2009, J NEUROSCI, V29, P6989, DOI 10.1523/JNEUROSCI.1089-09.2009; Szabo NE, 2009, J NEUROSCI, V29, P2453, DOI 10.1523/JNEUROSCI.4524-08.2009; Tobet S, 2009, J NEUROENDOCRINOL, V21, P387, DOI 10.1111/j.1365-2826.2009.01834.x; TOBET SA, 1995, J NEUROBIOL, V26, P75, DOI 10.1002/neu.480260107; Ulrich-Lai YM, 2009, NAT REV NEUROSCI, V10, P397, DOI 10.1038/nrn2647; WATSON SJ, 1977, P NATL ACAD SCI USA, V74, P5155, DOI 10.1073/pnas.74.11.5155; Wehr R, 1997, DEVELOPMENT, V124, P4447; Xu Q, 2008, J COMP NEUROL, V506, P16, DOI 10.1002/cne.21529	50	267	270	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2010	13	6					767	U153		10.1038/nn.2545	http://dx.doi.org/10.1038/nn.2545			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	600QY	20436479	Green Accepted			2022-12-17	WOS:000278003300023
J	Mante, V; Frazor, RA; Bonin, V; Geisler, WS; Carandini, M				Mante, V; Frazor, RA; Bonin, V; Geisler, WS; Carandini, M			Independence of luminance and contrast in natural scenes and in the early visual system	NATURE NEUROSCIENCE			English	Article							RETINAL GANGLION-CELLS; LATERAL GENICULATE-NUCLEUS; LIGHT ADAPTATION; RECEPTIVE-FIELD; IMAGE-CONTRAST; SPATIAL SCALE; GAIN-CONTROL; CAT; NEURONS; STATISTICS	The early visual system is endowed with adaptive mechanisms that rapidly adjust gain and integration time based on the local luminance ( mean intensity) and contrast ( standard deviation of intensity relative to the mean). Here we show that these mechanisms are matched to the statistics of the environment. First, we measured the joint distribution of luminance and contrast in patches selected from natural images and found that luminance and contrast were statistically independent of each other. This independence did not hold for artificial images with matched spectral characteristics. Second, we characterized the effects of the adaptive mechanisms in lateral geniculate nucleus (LGN), the direct recipient of retinal outputs. We found that luminance gain control had the same effect at all contrasts and that contrast gain control had the same effect at all mean luminances. Thus, the adaptive mechanisms for luminance and contrast operate independently, reflecting the very independence encountered in natural images.	Smith Kettlewell Eye Res Inst, San Francisco, CA 94115 USA; Univ Texas, Dept Psychol, Austin, TX 78712 USA; Univ Texas, Ctr Perceptual Syst, Austin, TX 78712 USA	The Smith-Kettlewell Eye Research Institute; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Carandini, M (corresponding author), Smith Kettlewell Eye Res Inst, 2232 Webster St, San Francisco, CA 94115 USA.	matteo@ski.org	Carandini, Matteo/C-1922-2008; Carandini, Matteo/ABD-8296-2021; Bonin, Vincent/AAQ-3833-2020	Carandini, Matteo/0000-0003-4880-7682; Carandini, Matteo/0000-0003-4880-7682; Geisler, Wilson/0000-0003-4630-6614; Bonin, Vincent/0000-0002-9437-8092	NEI NIH HHS [R01EY11747] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011747] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Baccus SA, 2002, NEURON, V36, P909, DOI 10.1016/S0896-6273(02)01050-4; BONIN V, IN PRESS J NEUROSCI; Brown SP, 2001, NAT NEUROSCI, V4, P44, DOI 10.1038/82888; Chander D, 2001, J NEUROSCI, V21, P9904, DOI 10.1523/JNEUROSCI.21-24-09904.2001; Demb JB, 2002, NEURON, V36, P781, DOI 10.1016/S0896-6273(02)01100-5; DERRINGTON AM, 1982, J PHYSIOL-LONDON, V333, P343, DOI 10.1113/jphysiol.1982.sp014457; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; Freeman TCB, 2002, NEURON, V35, P759, DOI 10.1016/S0896-6273(02)00819-X; HOCHSTEIN S, 1976, J PHYSIOL-LONDON, V262, P237, DOI 10.1113/jphysiol.1976.sp011594; KAPLAN E, 1987, J PHYSIOL-LONDON, V391, P267, DOI 10.1113/jphysiol.1987.sp016737; LANKHEET MJM, 1993, VISION RES, V33, P1153, DOI 10.1016/0042-6989(93)90205-B; LANKHEET MJM, 1991, VISION RES, V31, P1129, DOI 10.1016/0042-6989(91)90039-8; LAUGHLIN S, 1981, Z NATURFORSCH C, V36, P910; Lee BB, 2003, J VISION, V3, P513, DOI 10.1167/3.7.5; LENNIE P, 1980, VISION RES, V20, P561, DOI 10.1016/0042-6989(80)90115-7; Machens CK, 2004, J NEUROSCI, V24, P1089, DOI 10.1523/JNEUROSCI.4445-03.2004; Najemnik J, 2005, NATURE, V434, P387, DOI 10.1038/nature03390; Nolt MJ, 2004, J NEUROPHYSIOL, V92, P1708, DOI 10.1152/jn.00176.2004; OPPENHEIM AV, 1981, P IEEE, V69, P529, DOI 10.1109/PROC.1981.12022; REID RC, 1992, VISUAL NEUROSCI, V9, P39, DOI 10.1017/S0952523800006350; Rodieck RW., 1998, 1 STEPS SEEING, V1; RUDERMAN DL, 1994, NETWORK-COMP NEURAL, V5, P517, DOI 10.1088/0954-898X/5/4/006; Sahani M, 2003, ADV NEURAL INFORM PR, P125; SAITO H, 1986, VISION RES, V26, P391, DOI 10.1016/0042-6989(86)90182-3; Schwartz O, 2001, NAT NEUROSCI, V4, P819, DOI 10.1038/90526; SCLAR G, 1990, VISION RES, V30, P1, DOI 10.1016/0042-6989(90)90123-3; SHAPLEY R, 1986, VISION RES, V26, P45, DOI 10.1016/0042-6989(86)90070-2; Shapley R., 1984, PROG RETIN RES, V3, P263, DOI [10.1016/0278-4327(84)90011-7, DOI 10.1016/0278-4327(84)90011-7]; SHAPLEY RM, 1978, J PHYSIOL-LONDON, V285, P275, DOI 10.1113/jphysiol.1978.sp012571; Shapley RM, 1993, CONTRAST SENSITIVITY; Sherman SM, 2001, TRENDS NEUROSCI, V24, P122, DOI 10.1016/S0166-2236(00)01714-8; Smirnakis SM, 1997, NATURE, V386, P69, DOI 10.1038/386069a0; Solomon SG, 2004, NEURON, V42, P155, DOI 10.1016/S0896-6273(04)00178-3; Tadmor Y, 2000, VISION RES, V40, P3145, DOI 10.1016/S0042-6989(00)00166-8; TRANCHINA D, 1984, NATURE, V310, P314, DOI 10.1038/310314a0; TROY JB, 1993, EXP BRAIN RES, V93, P383; Troy JB, 1999, VISUAL NEUROSCI, V16, P1089, DOI 10.1017/S0952523899166094; van Hateren JH, 1998, P ROY SOC B-BIOL SCI, V265, P359, DOI 10.1098/rspb.1998.0303; VANHATEREN JH, 1993, VISION RES, V33, P257, DOI 10.1016/0042-6989(93)90163-Q; VICTOR JD, 1987, J PHYSIOL-LONDON, V386, P219, DOI 10.1113/jphysiol.1987.sp016531; Yeh TY, 1996, VISION RES, V36, P913, DOI 10.1016/0042-6989(95)00332-0; Zaghloul KA, 2005, J NEUROSCI, V25, P860, DOI 10.1523/JNEUROSCI.2782-04.2005	42	267	268	2	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2005	8	12					1690	1697		10.1038/nn1556	http://dx.doi.org/10.1038/nn1556			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	988FC	16286933				2022-12-17	WOS:000233576200017
J	McLaughlin, J; Osterhout, L; Kim, A				McLaughlin, J; Osterhout, L; Kim, A			Neural correlates of second-language word learning: minimal instruction produces rapid change	NATURE NEUROSCIENCE			English	Article							POTENTIALS	Adult second-language (L2) learning is often claimed to be slow and laborious compared to native language (L1) acquisition, but little is known about the rate of L2 word learning. Here we report that adult second-language learners' brain activity, as measured by event-related potentials (ERPs), discriminated between L2 words and L2 'pseudowords' (word-like letter strings) after just 14 h of classroom instruction. This occurred even while the learners performed at chance levels when making overt L2 word-nonword judgments, indicating that the early acquisition of some aspects of a new language may be overlooked by current behavioral assessments.	Univ Washington, Dept Psychol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	McLaughlin, J (corresponding author), Univ Washington, Dept Psychol, Guthrie Hall,Box 351525, Seattle, WA 98195 USA.	giuditta@u.washington.edu			NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R29DC001947, F32DC005756, R01DC001947] Funding Source: NIH RePORTER; NIDCD NIH HHS [P30DC04661, F32DC005756, R01 DC001947, R01DC01947] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BENTIN S, 1987, BRAIN LANG, V31, P308, DOI 10.1016/0093-934X(87)90077-0; CHWILLA DJ, 1995, PSYCHOPHYSIOLOGY, V32, P274, DOI 10.1111/j.1469-8986.1995.tb02956.x; GREEN RM, 1974, SIGNAL DETECTION THE; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Kutas M., 1994, HDB PSYCHOLINGUISTIC, P83, DOI DOI 10.1016/8978-012369374-7/50018-3; Miller J, 1996, PERCEPT PSYCHOPHYS, V58, P65, DOI 10.3758/BF03205476; Osterhout L, 1997, TRENDS COGN SCI, V1, P203, DOI 10.1016/S1364-6613(97)01073-5; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926	8	267	270	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2004	7	7					703	704		10.1038/nn1264	http://dx.doi.org/10.1038/nn1264			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	832NO	15195094				2022-12-17	WOS:000222274400010
J	Cruz, HG; Ivanova, T; Lunn, ML; Stoffel, M; Slesinger, PA; Luscher, C				Cruz, HG; Ivanova, T; Lunn, ML; Stoffel, M; Slesinger, PA; Luscher, C			Bi-directional effects of GABA(B) receptor agonists on the mesolimbic dopamine system	NATURE NEUROSCIENCE			English	Article							RECTIFYING K+ CHANNELS; GAMMA-HYDROXYBUTYRIC ACID; MUSCARINIC POTASSIUM CHANNEL; VENTRAL TEGMENTAL AREA; FUNCTIONAL EXPRESSION; MOLECULAR-PROPERTIES; INWARD RECTIFIER; SYNAPTIC INPUTS; DRUG-ADDICTION; BETA-GAMMA	The rewarding effect of drugs of abuse is mediated by activation of the mesolimbic dopamine system, which is inhibited by putative anti-craving compounds. Interestingly, different GABA(B) receptor agonists can exert similarly opposing effects on the reward pathway, but the cellular mechanisms involved are unknown. Here we found that the coupling efficacy (EC50) of G-protein-gated inwardly rectifying potassium (GIRK, Kir3) channels to GABA(B) receptor was much lower in dopamine neurons than in GABA neurons of the ventral tegmental area (VTA), depending on the differential expression of GIRK subunits. Consequently, in rodent VTA slices, a low concentration of the canonical agonist baclofen caused increased activity, whereas higher doses eventually inhibited dopamine neurons. At behaviorally relevant dosages, baclofen activated GIRK channels in both cell types, but the drug of abuse gamma-hydroxy-butyric acid (GHB) activated GIRK channels only in GABAergic neurons. Thus GABA(B) receptor agonists exert parallel cellular and behavioral effects due to the cell- specific expression of GIRK subunits.	Univ Geneva, Dept Basic Neurosci, CH-1211 Geneva 4, Switzerland; Univ Geneva, Neurol Clin, CH-1211 Geneva 4, Switzerland; Salk Inst Biol Studies, Peptide Biol Lab, San Diego, CA 92186 USA; Rockefeller Univ, Lab Metab Dis, New York, NY 10021 USA	University of Geneva; University of Geneva; Salk Institute; Rockefeller University	Luscher, C (corresponding author), Univ Geneva, Dept Basic Neurosci, 1 Michel Servet, CH-1211 Geneva 4, Switzerland.	Slesinger@salk.edu; Christian.Luscher@medecine.unige.ch	Lüscher, Christian/A-2496-2011	Lüscher, Christian/0000-0001-7917-4596; Stoffel, Markus/0000-0003-1304-5817				Andriamampandry C, 2003, FASEB J, V17, P1691, DOI 10.1096/fj.02-0846fje; Billinton A, 1999, BRIT J PHARMACOL, V126, P1387, DOI 10.1038/sj.bjp.0702460; Brauner-Osborne H, 1999, BRIT J PHARMACOL, V128, P1370, DOI 10.1038/sj.bjp.0702914; Brebner K, 2002, ALCOHOL ALCOHOLISM, V37, P478, DOI 10.1093/alcalc/37.5.478; Carter LP, 2003, J PHARMACOL EXP THER, V305, P668, DOI 10.1124/jpet.102.047860; Cousins MS, 2002, DRUG ALCOHOL DEPEN, V65, P209, DOI 10.1016/S0376-8716(01)00163-6; DASCAL N, 1993, P NATL ACAD SCI USA, V90, P10235, DOI 10.1073/pnas.90.21.10235; Feigenbaum JJ, 1996, INT J NEUROSCI, V88, P53, DOI 10.3109/00207459608999812; GALLIMBERTI L, 1989, LANCET, V2, P787; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Inanobe A, 1999, J NEUROSCI, V19, P1006; Jelacic TM, 2000, J BIOL CHEM, V275, P36211, DOI 10.1074/jbc.M007087200; Jelacic TM, 1999, J MEMBRANE BIOL, V169, P123, DOI 10.1007/s002329900524; Jeong SW, 2000, J NEUROSCI, V20, P4489, DOI 10.1523/JNEUROSCI.20-12-04489.2000; JOHNSON SW, 1992, J NEUROSCI, V12, P483; JOHNSON SW, 1992, J PHYSIOL-LONDON, V450, P455, DOI 10.1113/jphysiol.1992.sp019136; KALIVAS PW, 1990, J PHARMACOL EXP THER, V253, P858; KALIVAS PW, 1993, BRAIN RES REV, V18, P75, DOI 10.1016/0165-0173(93)90008-N; Karschin C, 1996, J NEUROSCI, V16, P3559; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Kaupmann K, 2003, EUR J NEUROSCI, V18, P2722, DOI 10.1111/j.1460-9568.2003.03013.x; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; KUBO Y, 1993, NATURE, V364, P802, DOI 10.1038/364802a0; LESAGE F, 1995, J BIOL CHEM, V270, P28660, DOI 10.1074/jbc.270.48.28660; LESAGE F, 1994, FEBS LETT, V353, P37, DOI 10.1016/0014-5793(94)01007-2; Liao YJ, 1996, J NEUROSCI, V16, P7137; Lingenhoehl K, 1999, NEUROPHARMACOLOGY, V38, P1667, DOI 10.1016/S0028-3908(99)00131-8; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; Luscher C, 1997, NEURON, V19, P687, DOI 10.1016/S0896-6273(00)80381-5; Ma D, 2002, NEURON, V33, P715, DOI 10.1016/S0896-6273(02)00614-1; Madden TE, 1998, J PHARMACOL EXP THER, V287, P261; Martellotta MC, 1998, EUR NEUROPSYCHOPHARM, V8, P293, DOI 10.1016/S0924-977X(97)00087-4; McFarland K, 2001, J NEUROSCI, V21, P8655; Nicholson KL, 2001, DRUG ALCOHOL DEPEN, V63, P1, DOI 10.1016/S0376-8716(00)00191-5; Patel AJ, 2001, TRENDS NEUROSCI, V24, P339, DOI 10.1016/S0166-2236(00)01810-5; Pfaff T, 1999, EUR J NEUROSCI, V11, P2874, DOI 10.1046/j.1460-9568.1999.00704.x; Queva S, 2003, BRIT J PHARMACOL, V140, P315, DOI 10.1038/sj.bjp.0705447; REUVENY E, 1994, NATURE, V370, P143, DOI 10.1038/370143a0; Robbins TW, 1999, NATURE, V398, P567, DOI 10.1038/19208; Schoots O, 1999, CELL SIGNAL, V11, P871, DOI 10.1016/S0898-6568(99)00059-5; Schuler V, 2001, NEURON, V31, P47, DOI 10.1016/S0896-6273(01)00345-2; Slesinger PA, 1996, NEURON, V16, P321, DOI 10.1016/S0896-6273(00)80050-1; Snead OC, 2000, J NEUROCHEM, V75, P1986, DOI 10.1046/j.1471-4159.2000.0751986.x; SUGITA S, 1992, NEUROSCI LETT, V134, P207, DOI 10.1016/0304-3940(92)90518-C; Torrecilla M, 2002, J NEUROSCI, V22, P4328, DOI 10.1523/JNEUROSCI.22-11-04328.2002; Wei JJ, 1998, GENOMICS, V51, P379, DOI 10.1006/geno.1998.5369; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; Wickman K, 2000, J NEUROSCI, V20, P5608, DOI 10.1523/JNEUROSCI.20-15-05608.2000; Wickman K, 2002, GENE, V284, P241, DOI 10.1016/S0378-1119(01)00884-8; 2002, MATINDALE COMPLETE D, P2496	50	267	273	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2004	7	2					153	159		10.1038/nn1181	http://dx.doi.org/10.1038/nn1181			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	767TJ	14745451				2022-12-17	WOS:000188468500013
J	Sundstrom-Poromaa, I; Smith, DH; Gong, QH; Sabado, TN; Li, XS; Light, A; Wiedmann, M; Williams, K; Smith, SS				Sundstrom-Poromaa, I; Smith, DH; Gong, QH; Sabado, TN; Li, XS; Light, A; Wiedmann, M; Williams, K; Smith, SS			Hormonally regulated alpha(4)beta(2)delta GABA(A) receptors are a target for alcohol	NATURE NEUROSCIENCE			English	Article							PREMENSTRUAL-SYNDROME; ETHANOL		SUNY Downstate Med Ctr, Dept Physiol & Pharmacol, Brooklyn, NY 11203 USA; Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, New York, NY 10021 USA; MCP Hahnemann Univ, Dept Neurobiol & Anat, Philadelphia, PA 19129 USA; Univ Chicago, Dept Neurol, Chicago, IL 60637 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Memorial Sloan Kettering Cancer Center; Drexel University; University of Chicago	Smith, SS (corresponding author), SUNY Downstate Med Ctr, Dept Physiol & Pharmacol, 450 Clarkson Ave, Brooklyn, NY 11203 USA.			Sundstrom Poromaa, Inger/0000-0002-2491-2042; Smith, Sheryl/0000-0003-4308-3267	NIAAA NIH HHS [R01 AA012958-02, R01 AA012958, R01 AA012958-01, AA12958] Funding Source: Medline; NIDA NIH HHS [R01 DA009618-04, DA09618, R01 DA009618, R01 DA009618-05A2] Funding Source: Medline; NINDS NIH HHS [R01 NS035047, NS35047] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035047] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA012958] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA009618] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Adkins CE, 2001, J BIOL CHEM, V276, P38934, DOI 10.1074/jbc.M104318200; Brickley SG, 2001, NATURE, V409, P88, DOI 10.1038/35051086; COHEN HL, 1993, ELECTROEN CLIN NEURO, V86, P368, DOI 10.1016/0013-4694(93)90132-F; HOLFORD NHG, 1987, CLIN PHARMACOKINET, V13, P273, DOI 10.2165/00003088-198713050-00001; KALANT H, 1975, CAN MED ASSOC J, V112, P953; KOOB GF, 1988, ALCOHOL, V5, P437, DOI 10.1016/0741-8329(88)90079-1; Mahmoudi M, 1997, J NEUROCHEM, V68, P2485; MCLEOD DR, 1994, ALCOHOL CLIN EXP RES, V18, P664, DOI 10.1111/j.1530-0277.1994.tb00928.x; Mihalek RM, 2001, ALCOHOL CLIN EXP RES, V25, P1708, DOI 10.1111/j.1530-0277.2001.tb02179.x; Mihic SJ, 1997, NATURE, V389, P385, DOI 10.1038/38738; Nusser Z, 1998, J NEUROSCI, V18, P1693; Smith SS, 1998, NATURE, V392, P926, DOI 10.1038/31948; Sundstrom I, 1998, NEUROENDOCRINOLOGY, V67, P126, DOI 10.1159/000054307; Ueno S, 2001, ALCOHOL CLIN EXP RES, V25, p76S, DOI 10.1097/00000374-200105051-00014; Wan FJ, 1996, P NATL ACAD SCI USA, V93, P5049, DOI 10.1073/pnas.93.10.5049	15	267	272	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2002	5	8					721	722		10.1038/nn888	http://dx.doi.org/10.1038/nn888			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	577XT	12118257	Green Accepted			2022-12-17	WOS:000177088900010
J	Crist, RE; Li, W; Gilbert, CD				Crist, RE; Li, W; Gilbert, CD			Learning to see: experience and attention in primary visual cortex	NATURE NEUROSCIENCE			English	Article							STRIATE CORTEX; HORIZONTAL CONNECTIONS; MACAQUE MONKEY; ALERT MONKEYS; FUNCTIONAL ARCHITECTURE; VERNIER ACUITY; OWL MONKEYS; ORIENTATION; REPRESENTATION; DISCRIMINATION	The response properties of neurons in primary sensory cortices remain malleable throughout life. The existence of such plasticity, and the characteristics of a form of implicit learning known as perceptual learning, suggest that changes in primary sensory cortex may mediate learning. We explored whether modification of the functional properties of primary visual cortex (V1) accompanies perceptual learning. Basic receptive field properties, such as location, size and orientation selectivity, were unaffected by perceptual training, and visual topography (as measured by magnification factor) was indistinguishable between trained and untrained animals. On the other hand, the influence of contextual stimuli placed outside the receptive field showed a change consistent with the trained discrimination. Furthermore, this property showed task dependence, only being manifest when the animal was performing the trained discrimination.	Rockefeller Univ, New York, NY 10021 USA	Rockefeller University	Gilbert, CD (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.		Li, Wu/AHA-4320-2022; Li, Wu/G-9415-2011	Li, Wu/0000-0002-2175-4579	NATIONAL EYE INSTITUTE [R01EY007968] Funding Source: NIH RePORTER; NEI NIH HHS [EY07968] Funding Source: Medline; NIGMS NIH HHS [GM07524] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Crist RE, 1997, J NEUROPHYSIOL, V78, P2889, DOI 10.1152/jn.1997.78.6.2889; DAS A, 1995, J NEUROPHYSIOL, V74, P779, DOI 10.1152/jn.1995.74.2.779; Dill M, 1998, PERCEPT PSYCHOPHYS, V60, P65, DOI 10.3758/BF03211918; DOW BM, 1981, EXP BRAIN RES, V44, P213; FAHLE M, 1993, VISION RES, V33, P397, DOI 10.1016/0042-6989(93)90094-D; GILBERT CD, 1989, J NEUROSCI, V9, P2432; GILBERT CD, 1990, COLD SPRING HARB SYM, V55, P663; Gilbert CD, 1998, PHYSIOL REV, V78, P467, DOI 10.1152/physrev.1998.78.2.467; GILBERT CD, 1994, P NATL ACAD SCI USA, V91, P1195, DOI 10.1073/pnas.91.4.1195; HEINEN SJ, 1991, EXP BRAIN RES, V83, P670; HIRSCH JA, 1991, J NEUROSCI, V11, P1800; HUBEL DH, 1977, PROC R SOC SER B-BIO, V198, P1, DOI 10.1098/rspb.1977.0085; Ito M, 1999, NEURON, V22, P593, DOI 10.1016/S0896-6273(00)80713-8; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; KAAS JH, 1990, SCIENCE, V248, P229, DOI 10.1126/science.2326637; Kapadia MK, 2000, J NEUROPHYSIOL, V84, P2048, DOI 10.1152/jn.2000.84.4.2048; Kapadia MK, 1999, P NATL ACAD SCI USA, V96, P12073, DOI 10.1073/pnas.96.21.12073; KAPADIA MK, 1995, NEURON, V15, P843, DOI 10.1016/0896-6273(95)90175-2; KAPADIA MK, 1994, J NEUROSCI, V14, P451; KNIERIM JJ, 1992, J NEUROPHYSIOL, V67, P961, DOI 10.1152/jn.1992.67.4.961; Levi DM, 1996, P NATL ACAD SCI USA, V93, P6830, DOI 10.1073/pnas.93.13.6830; MCGUIRE BA, 1991, J COMP NEUROL, V305, P370, DOI 10.1002/cne.903050303; MCKEE SP, 1978, PERCEPT PSYCHOPHYS, V24, P258, DOI 10.3758/BF03206097; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; POGGIO T, 1992, SCIENCE, V256, P1018, DOI 10.1126/science.1589770; RECANZONE GH, 1993, J NEUROSCI, V13, P87; RECANZONE GH, 1992, J NEUROPHYSIOL, V67, P1031, DOI 10.1152/jn.1992.67.5.1031; SNODDERLY DM, 1995, J NEUROPHYSIOL, V74, P2100, DOI 10.1152/jn.1995.74.5.2100; TSO DY, 1988, J NEUROSCI, V8, P1712; TSO DY, 1986, J NEUROSCI, V6, P1160; VANESSEN DC, 1984, VISION RES, V24, P429, DOI 10.1016/0042-6989(84)90041-5; VOGELS R, 1994, J NEUROPHYSIOL, V71, P1428, DOI 10.1152/jn.1994.71.4.1428; VONDERHEYDT R, 1989, J NEUROSCI, V9, P1731; WEINBERGER NM, 1990, CONCEPTS NEUROSCIENC, V1, P91; WELIKY M, 1995, NEURON, V15, P541, DOI 10.1016/0896-6273(95)90143-4; WOLBARSHT ML, 1960, SCIENCE, V132, P1309, DOI 10.1126/science.132.3436.1309	36	267	273	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2001	4	5					519	525		10.1038/87470	http://dx.doi.org/10.1038/87470			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	427NN	11319561				2022-12-17	WOS:000168412600016
J	Hofman, PM; Van Riswick, JGA; Van Opstal, AJ				Hofman, PM; Van Riswick, JGA; Van Opstal, AJ			Relearning sound localization with new ears	NATURE NEUROSCIENCE			English	Article							BARN OWLS; AUDITORY SPACE; EYE-MOVEMENTS; OPTIC TECTUM; PLASTICITY; CUES; ADJUSTMENT; AGE; MAP	Because the inner ear is not organized spatially, sound localization relies on the neural processing of implicit acoustic cues. To determine a sound's position, the brain must learn and calibrate these cues, using accurate spatial feedback from other sensorimotor systems. Experimental evidence for such a system has been demonstrated in barn owls, but not in humans. Here, we demonstrate the existence of ongoing spatial calibration in the adult human auditory system. The spectral elevation cues of human subjects were disrupted by modifying their outer ears (pinnae) with molds. Although localization of sound elevation was dramatically degraded immediately after the modification, accurate performance was steadily reacquired. Interestingly, learning the new spectral cues did not interfere with the neural representation of the original cues, as subjects could localize sounds with both normal and modified pinnae.	Univ Nijmegen, Dept Med Phys & Biophys, NL-6525 EZ Nijmegen, Netherlands	Radboud University Nijmegen	Van Opstal, AJ (corresponding author), Univ Nijmegen, Dept Med Phys & Biophys, Geert Grooteplein 21, NL-6525 EZ Nijmegen, Netherlands.	johnvo@mbfys.kun.nl	Hofman, Paul/P-7654-2018; van Opstal, John/D-1907-2010	Hofman, Paul/0000-0003-0431-9353; van Opstal, John/0000-0001-5957-5712				BATTEAU DW, 1967, PROC R SOC SER B-BIO, V168, P158, DOI 10.1098/rspb.1967.0058; Blauert J, 1996, SPATIAL HEARING PSYC; BRAINARD MS, 1993, J NEUROSCI, V13, P4590; COLLEWIJN H, 1975, VISION RES, V15, P447, DOI 10.1016/0042-6989(75)90098-X; EFRON B, 1991, SCIENCE, V253, P390, DOI 10.1126/science.253.5018.390; FRENS MA, 1995, EXP BRAIN RES, V107, P103, DOI 10.1007/BF00228022; Hofman PM, 1998, J ACOUST SOC AM, V103, P2634, DOI 10.1121/1.422784; JAVER AR, 1995, J OTOLARYNGOL, V24, P111; KING AJ, 1991, TRENDS NEUROSCI, V14, P31, DOI 10.1016/0166-2236(91)90181-S; KING AJ, 1988, NATURE, V332, P73, DOI 10.1038/332073a0; Knudsen EI, 1998, SCIENCE, V279, P1531, DOI 10.1126/science.279.5356.1531; KNUDSEN EI, 1979, J COMP PHYSIOL, V133, P13, DOI 10.1007/BF00663106; KNUDSEN EI, 1994, J NEUROPHYSIOL, V71, P79, DOI 10.1152/jn.1994.71.1.79; KNUDSEN EI, 1989, J NEUROSCI, V9, P3306; KNUDSEN EI, 1992, J NEUROSCI, V12, P3485; KNUDSEN EI, 1986, J NEUROSCI, V6, P1918; KNUDSEN EI, 1985, SCIENCE, V230, P545, DOI 10.1126/science.4048948; LopezPoveda EA, 1996, J ACOUST SOC AM, V100, P3248, DOI 10.1121/1.417208; MIDDLEBROOKS JC, 1992, J ACOUST SOC AM, V92, P2607, DOI 10.1121/1.404400; OLDFIELD SR, 1984, PERCEPTION, V13, P581, DOI 10.1068/p130581; OLDFIELD SR, 1984, PERCEPTION, V13, P601, DOI 10.1068/p130601; Perrett S, 1997, PERCEPT PSYCHOPHYS, V59, P1018, DOI 10.3758/BF03205517; Press W. H., 2007, NUMERICAL RECIPES C, V3rd; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; SCHROEDER MR, 1970, IEEE T INFORM THEORY, V16, P85, DOI 10.1109/TIT.1970.1054411; Stein BE., 1993, MERGING SENSES; TERANISHI R, 1968, J ACOUST SOC AM, V44, P257, DOI 10.1121/1.1911061; WENZEL EM, 1993, J ACOUST SOC AM, V94, P111, DOI 10.1121/1.407089; WIGHTMAN FL, 1989, J ACOUST SOC AM, V85, P858, DOI 10.1121/1.397557; WITHINGTONWRAY DJ, 1990, EUR J NEUROSCI, V2, P682, DOI 10.1111/j.1460-9568.1990.tb00458.x; ZAKARAUSKAS P, 1993, J ACOUST SOC AM, V94, P1323, DOI 10.1121/1.408160	31	267	301	1	93	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	1998	1	5					417	421		10.1038/1633	http://dx.doi.org/10.1038/1633			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QE	10196533				2022-12-17	WOS:000076361400021
J	Woo, SH; Lukacs, V; de Nooij, JC; Zaytseva, D; Criddle, CR; Francisco, A; Jessell, TM; Wilkinson, KA; Patapoutian, A				Woo, Seung-Hyun; Lukacs, Viktor; de Nooij, Joriene C.; Zaytseva, Dasha; Criddle, Connor R.; Francisco, Allain; Jessell, Thomas M.; Wilkinson, Katherine A.; Patapoutian, Ardem			Piezo2 is the principal mechanotransduction channel for proprioception	NATURE NEUROSCIENCE			English	Article							MAMMALIAN MUSCLE-SPINDLES; ACTIVATED ION-CHANNEL; TOUCH RECEPTORS; MOTOR-NEURONS; MICE; TRANSDUCTION; LOCOMOTION; ADULT; FORCE	Proprioception, the perception of body and limb position, is mediated by proprioceptors, specialized mechanosensory neurons that convey information about the stretch and tension experienced by muscles, tendons, skin and joints. In mammals, the molecular identity of the stretch-sensitive channel that mediates proprioception is unknown. We found that the mechanically activated nonselective cation channel Piezo2 was expressed in sensory endings of proprioceptors innervating muscle spindles and Golgi tendon organs in mice. Two independent mouse lines that lack Piezo2 in proprioceptive neurons showed severely uncoordinated body movements and abnormal limb positions. Moreover, the mechanosensitivity of parvalbumin-expressing neurons that predominantly mark proprioceptors was dependent on Piezo2 expression in vitro, and the stretch-induced firing of proprioceptors in muscle-nerve recordings was markedly reduced in Piezo2-deficient mice. Together, our results indicate that Piezo2 is the major mechanotransducer of mammalian proprioceptors.	[Woo, Seung-Hyun; Lukacs, Viktor; Francisco, Allain; Patapoutian, Ardem] Scripps Res Inst, Dorris Neurosci Ctr, Mol & Cellular Neurosci, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [de Nooij, Joriene C.; Jessell, Thomas M.] Columbia Univ, Howard Hughes Med Inst, Dept Neurosci, New York, NY 10032 USA; [de Nooij, Joriene C.; Jessell, Thomas M.] Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Zaytseva, Dasha; Criddle, Connor R.; Wilkinson, Katherine A.] San Jose State Univ, Dept Biol Sci, San Jose, CA 95192 USA	Howard Hughes Medical Institute; Scripps Research Institute; Columbia University; Howard Hughes Medical Institute; Columbia University; Howard Hughes Medical Institute; California State University System; San Jose State University	Patapoutian, A (corresponding author), Scripps Res Inst, Dorris Neurosci Ctr, Mol & Cellular Neurosci, Howard Hughes Med Inst, La Jolla, CA 92037 USA.	ardem@scripps.edu		Lukacs, Viktor/0000-0003-3652-5469; Wilkinson, Katherine A./0000-0002-2692-5533	Howard Hughes Medical Institute; US National Institutes of Health [R01DE022358]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022358] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank B. Costs (Aix Marseille Universite) for suggestions and H.U. Zeilhofer (University of Zurich) and R. Seal (University of Pittsburgh) for providing HoxB8-Cre mice. This work was supported by the Howard Hughes Medical Institute and US National Institutes of Health grant R01DE022358.	Adrian ED, 1926, J PHYSIOL-LONDON, V61, P151, DOI 10.1113/jphysiol.1926.sp002281; Akay T, 2014, P NATL ACAD SCI USA, V111, P16877, DOI 10.1073/pnas.1419045111; Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; Bewick GS, 2015, PFLUG ARCH EUR J PHY, V467, P175, DOI 10.1007/s00424-014-1536-9; BROOKS SV, 1988, J PHYSIOL-LONDON, V404, P71, DOI 10.1113/jphysiol.1988.sp017279; Cahalan SM, 2015, ELIFE, V4, DOI 10.7554/eLife.07370; Cheng LE, 2010, NEURON, V67, P373, DOI 10.1016/j.neuron.2010.07.004; Coste B, 2013, P NATL ACAD SCI USA, V110, P4667, DOI 10.1073/pnas.1221400110; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; de Nooij JC, 2015, J NEUROSCI, V35, P3073, DOI 10.1523/JNEUROSCI.3699-14.2015; de Nooij JC, 2013, NEURON, V77, P1055, DOI 10.1016/j.neuron.2013.01.015; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; HUNT CC, 1978, J GEN PHYSIOL, V71, P683, DOI 10.1085/jgp.71.6.683; Li J, 2014, NATURE, V515, P279, DOI 10.1038/nature13701; Li W, 2006, NATURE, V440, P684, DOI 10.1038/nature04538; Lu W, 2013, NEURON, V78, P433, DOI 10.1016/j.neuron.2013.02.030; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Maksimovic S, 2014, NATURE, V509, P617, DOI 10.1038/nature13250; McCarter GC, 1999, NEUROSCI LETT, V273, P179, DOI 10.1016/S0304-3940(99)00665-5; Proske U, 2012, PHYSIOL REV, V92, P1651, DOI 10.1152/physrev.00048.2011; Ranade SS, 2014, NATURE, V516, P121, DOI 10.1038/nature13980; Ranade SS, 2014, P NATL ACAD SCI USA, V111, P10347, DOI 10.1073/pnas.1409233111; Sherrington CS, 1906, BRAIN, V29, P467; Simon A, 2010, J PHYSIOL-LONDON, V588, P171, DOI 10.1113/jphysiol.2009.182683; Suslak TJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130969; Tavernarakis N, 1997, NEURON, V18, P107, DOI 10.1016/S0896-6273(01)80050-7; Vrieseling E, 2006, CELL, V127, P1439, DOI 10.1016/j.cell.2006.10.042; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; Wilkinson KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039140; Witschi R, 2010, GENESIS, V48, P596, DOI 10.1002/dvg.20656; Woo SH, 2014, NATURE, V509, P622, DOI 10.1038/nature13251; Zimmerman A, 2014, SCIENCE, V346, P950, DOI 10.1126/science.1254229	32	266	277	17	109	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2015	18	12					1756	1762		10.1038/nn.4162	http://dx.doi.org/10.1038/nn.4162			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CX1LV	26551544	Green Accepted			2022-12-17	WOS:000365458600013
J	Hines, JH; Ravanelli, AM; Schwindt, R; Scott, EK; Appel, B				Hines, Jacob H.; Ravanelli, Andrew M.; Schwindt, Rani; Scott, Ethan K.; Appel, Bruce			Neuronal activity biases axon selection for myelination in vivo	NATURE NEUROSCIENCE			English	Article							CRITICAL PERIOD; WHITE; MATURATION; ZEBRAFISH; GROWTH; OLIGODENDROCYTES; SPECIFICATION; GLUTAMATE; RELEASE; SYSTEM	An essential feature of vertebrate neural development is ensheathment of axons with myelin, an insulating membrane formed by oligodendrocytes. Not all axons are myelinated, but mechanisms directing myelination of specific axons are unknown. Using zebrafish, we found that activity-dependent secretion stabilized myelin sheath formation on select axons. When VAMP2-dependent exocytosis was silenced in single axons, oligodendrocytes preferentially ensheathed neighboring axons. Nascent sheaths formed on silenced axons were shorter in length, but when activity of neighboring axons was also suppressed, inhibition of sheath growth was relieved. Using in vivo time-lapse microscopy, we found that only 25% of oligodendrocyte processes that initiated axon wrapping were stabilized during normal development and that initiation did not require activity. Instead, oligodendrocyte processes wrapping silenced axons retracted more frequently. We propose that axon selection for myelination results from excessive and indiscriminate initiation of wrapping followed by refinement that is biased by activity-dependent secretion from axons.	[Hines, Jacob H.; Ravanelli, Andrew M.; Schwindt, Rani; Appel, Bruce] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA; [Scott, Ethan K.] Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Queensland	Hines, JH (corresponding author), Winona State Univ, Dept Biol, Winona, MN 55987 USA.	jhhines@winona.edu; bruce.appel@ucdenver.edu	Appel, Bruce/X-6418-2019	Appel, Bruce/0000-0003-4500-0672; Scott, Ethan/0000-0003-3150-9216; Hines, Jacob/0000-0003-1557-3795; Ravanelli, Andrew/0000-0001-8138-3880	US National Institutes of Health (NIH) [R01 NS046668]; National Multiple Sclerosis Postdoctoral Fellowship [FG 2024-A-1]; NIH (NIMH) fellowship [T32 MN015442]; NIH (NCI) fellowship [T32 5T32CA08208613]; NIH [P30 NS048154]; NATIONAL CANCER INSTITUTE [T32CA082086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH015442] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS048154, R01NS046668] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Postdoctoral Fellowship; NIH (NIMH) fellowship; NIH (NCI) fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to A.J. Treichel (Winona State University) for help with image analysis. We thank A. Nechiporuk (Oregon Health Sciences University) for Tg(phox2b:EGFP) zebrafish, H. Yawo (Tohoku University) and the National BioResource Zebrafish Project for Tg(UAS:ChRWR-EGFP) zebrafish, M. Meyer (King's College London) for the pCS2-TeNT-EGFP plasmid and J. Fetcho (Cornell University) for the UAS: Kir2.1-2A-EGFP plasmid. We thank M. Goll (Memorial Sloan-Kettering Cancer Center), M. Nonet (Washington University), C.-B. Chien (University of Utah) and K. Kwan (University of Utah) for Gateway plasmids. For critical feedback on the project, we thank M. Rasband, J. Triplett, S. Henle, A. Ribera and W. Macklin, and all members of the Appel, Ribera and Macklin laboratories. We also thank J. Costabile and the University of Colorado Anschutz Medical Campus Optogenetics Core Facility for assistance with UAS: ChRWR-EGFP experiments. This work was supported by US National Institutes of Health (NIH) grant R01 NS046668 and a gift from the Gates Frontiers Fund to B.A., a National Multiple Sclerosis Postdoctoral Fellowship (FG 2024-A-1) and NIH (NIMH) fellowship T32 MN015442 to J.H.H. and NIH (NCI) fellowship T32 5T32CA08208613 to A.M.R. The University of Colorado Anschutz Medical Campus Zebrafish Core Facility is supported by NIH grant P30 NS048154. All DNA plasmids and transgenic zebrafish used in this study are available by request.	Agetsuma M, 2010, NAT NEUROSCI, V13, P1354, DOI 10.1038/nn.2654; Almeida RG, 2014, NEUROSCIENCE, V276, P98, DOI 10.1016/j.neuroscience.2013.08.062; BARRES BA, 1993, NATURE, V361, P258, DOI 10.1038/361258a0; Ben Fredj N, 2010, J NEUROSCI, V30, P10939, DOI 10.1523/JNEUROSCI.1556-10.2010; Chittajallu R, 2004, J PHYSIOL-LONDON, V561, P109, DOI 10.1113/jphysiol.2004.074252; COLELLO RJ, 1994, J NEUROSCI, V14, P2594; Czopka T, 2013, DEV CELL, V25, P599, DOI 10.1016/j.devcel.2013.05.013; De Biase LM, 2011, J NEUROSCI, V31, P12650, DOI 10.1523/JNEUROSCI.2455-11.2011; Demerens C, 1996, P NATL ACAD SCI USA, V93, P9887, DOI 10.1073/pnas.93.18.9887; Fields RD, 2008, TRENDS NEUROSCI, V31, P361, DOI 10.1016/j.tins.2008.04.001; Gibson EM, 2014, SCIENCE, V344, P487, DOI 10.1126/science.1252304; GYLLENSTEN L, 1963, J EMBRYOL EXP MORPH, V11, P255; Heap LA, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00053; Hua JY, 2005, NATURE, V434, P1022, DOI 10.1038/nature03409; Jung SH, 2010, DEV DYNAM, V239, P592, DOI 10.1002/dvdy.22166; Karadottir R, 2007, NEUROSCIENCE, V145, P1426, DOI 10.1016/j.neuroscience.2006.08.070; Karadottir R, 2008, NAT NEUROSCI, V11, P450, DOI 10.1038/nn2060; Kishore S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3086; Kucenas S, 2008, NAT NEUROSCI, V11, P143, DOI 10.1038/nn2025; Kucenas S, 2009, J NEUROSCI, V29, P15187, DOI 10.1523/JNEUROSCI.4193-09.2009; Kukley M, 2007, NAT NEUROSCI, V10, P311, DOI 10.1038/nn1850; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Lee S, 2012, NAT METHODS, V9, P917, DOI 10.1038/nmeth.2105; Liu J, 2012, NAT NEUROSCI, V15, P1621, DOI 10.1038/nn.3263; Makinodan M, 2012, SCIENCE, V337, P1357, DOI 10.1126/science.1220845; McKenzie IA, 2014, SCIENCE, V346, P318, DOI 10.1126/science.1254960; McLaughlin T, 2003, NEURON, V40, P1147, DOI 10.1016/S0896-6273(03)00790-6; Mensch S, 2015, NAT NEUROSCI, V18, P628, DOI 10.1038/nn.3991; Mo WK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027146; Nechiporuk A, 2007, DEVELOPMENT, V134, P611, DOI 10.1242/dev.02749; Ng BK, 2007, J NEUROSCI, V27, P7597, DOI 10.1523/JNEUROSCI.0563-07.2007; Nicol X, 2007, NAT NEUROSCI, V10, P340, DOI 10.1038/nn1842; Park HC, 2005, J NEUROSCI, V25, P6836, DOI 10.1523/JNEUROSCI.0981-05.2005; Plazas PV, 2013, P NATL ACAD SCI USA, V110, P1524, DOI 10.1073/pnas.1213048110; Rosenberg SS, 2008, P NATL ACAD SCI USA, V105, P14662, DOI 10.1073/pnas.0805640105; Sanchez I, 1996, J NEUROSCI, V16, P5095; SHRAGER P, 1995, DEV BRAIN RES, V88, P68, DOI 10.1016/0165-3806(95)00081-N; STURROCK RR, 1980, NEUROPATH APPL NEURO, V6, P415, DOI 10.1111/j.1365-2990.1980.tb00219.x; TAUBER H, 1980, NEUROSCI LETT, V16, P235, DOI 10.1016/0304-3940(80)90003-8; Umeda K, 2013, NEUROSCI RES, V75, P69, DOI 10.1016/j.neures.2012.08.010; Wake H, 2011, SCIENCE, V333, P1647, DOI 10.1126/science.1206998; Ziskin JL, 2007, NAT NEUROSCI, V10, P321, DOI 10.1038/nn1854	42	266	271	1	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2015	18	5					683	+		10.1038/nn.3992	http://dx.doi.org/10.1038/nn.3992			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CG9LN	25849987	Green Accepted			2022-12-17	WOS:000353636900015
J	Aguirre, A; Dupree, JL; Mangin, JM; Gallo, V				Aguirre, Adan; Dupree, Jeff L.; Mangin, J. M.; Gallo, Vittorio			A functional role for EGFR signaling in myelination and remyelination	NATURE NEUROSCIENCE			English	Article							GROWTH-FACTOR-RECEPTOR; SUBVENTRICULAR ZONE; PROGENITOR CELLS; OLIGODENDROCYTE LINEAGE; MULTIPLE-SCLEROSIS; NEURAL PROGENITORS; TYROSINE KINASE; ADULT FOREBRAIN; NERVOUS-SYSTEM; WHITE-MATTER	Cellular strategies for oligodendrocyte regeneration and remyelination involve characterizing endogenous neural progenitors that are capable of generating oligodendrocytes during normal development and after demyelination, and identifying the molecular signals that enhance oligodendrogenesis from these progenitors. Using both gain- and loss-of-function approaches, we explored the role of epidermal growth factor receptor (EGFR) signaling in adult myelin repair and in oligodendrogenesis. We show that 2 ',3 '-cyclic nucleotide 3 '-phosphodiesterase (CNP) promoter-driven overexpression of human EGFR (hEGFR) accelerated remyelination and functional recovery following focal demyelination of mouse corpus callosum. Lesion repopulation by Cspg(4+) (also known as NG2) Ascl1(+) (also known as Mash1) Olig2(+) progenitors and functional remyelination were accelerated in CNP-hEGFR mice compared with wild-type mice. EGFR overexpression in subventricular zone (SVZ) and corpus callosum during early postnatal development also expanded this NG2(+)Mash1(+)Olig2(+) progenitor population and promoted SVZ-to-lesion migration, enhancing oligodendrocyte generation and axonal myelination. Analysis of hypomorphic EGFR-mutant mice confirmed that EGFR signaling regulates oligodendrogenesis and remyelination by NG2(+)Mash1(+)Olig2(+) progenitors. EGFR targeting holds promise for enhancing oligodendrocyte regeneration and myelin repair.	Childrens Natl Med Ctr, Neurosci Res Ctr, Washington, DC 20010 USA; Virginia Commonwealth Univ, Dept Anat & Neurobiol, Richmond, VA 23298 USA	Children's National Health System; Virginia Commonwealth University	Gallo, V (corresponding author), Childrens Natl Med Ctr, Neurosci Res Ctr, 111 Michigan Ave,NW, Washington, DC 20010 USA.	vgallo@cnmcresearch.org	Messier, Claude/A-2322-2008	Messier, Claude/0000-0002-4791-1763	NICHD NIH HHS [P30HD40677] Funding Source: Medline; NINDS NIH HHS [R01NS045702, R21NS050463, 5P30NS047463] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD040677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS050463, P30NS047463, R01NS045702] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aguirre A, 2005, J NEUROSCI, V25, P11092, DOI 10.1523/JNEUROSCI.2981-05.2005; Aguirre A, 2004, J NEUROSCI, V24, P10530, DOI 10.1523/JNEUROSCI.3572-04.2004; Aguirre AA, 2004, J CELL BIOL, V165, P575, DOI 10.1083/jcb.200311141; Anton ES, 2004, NAT NEUROSCI, V7, P1319, DOI 10.1038/nn1345; Armstrong RC, 2002, J NEUROSCI, V22, P8574; Armstrong RC, 2006, J NEUROPATH EXP NEUR, V65, P245, DOI 10.1097/01.jnen.0000205142.08716.7e; Arnett HA, 2004, SCIENCE, V306, P2111, DOI 10.1126/science.1103709; Belachew S, 2003, J CELL BIOL, V161, P169, DOI 10.1083/jcb.200210110; Buffo A, 2005, P NATL ACAD SCI USA, V102, P18183, DOI 10.1073/pnas.0506535102; Burrows RC, 1997, NEURON, V19, P251, DOI 10.1016/S0896-6273(00)80937-X; Cassiani-Ingoni R, 2006, EXP NEUROL, V201, P349, DOI 10.1016/j.expneurol.2006.04.030; Chang A, 2000, J NEUROSCI, V20, P6404, DOI 10.1523/JNEUROSCI.20-17-06404.2000; Coskun V, 2002, J NEUROSCI RES, V69, P795, DOI 10.1002/jnr.10336; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Ferrer I, 1996, PROG NEUROBIOL, V49, P99; Gensert JM, 1997, NEURON, V19, P197, DOI 10.1016/S0896-6273(00)80359-1; Goddard DR, 2001, MOL CELL NEUROSCI, V18, P557, DOI 10.1006/mcne.2001.1025; Hidalgo A, 2002, TRENDS NEUROSCI, V25, P365, DOI 10.1016/S0166-2236(02)02186-0; Irvin DK, 2003, DEV NEUROSCI-BASEL, V25, P162, DOI 10.1159/000072265; Jin KL, 2002, J NEUROSCI, V22, P5365; Kakita A, 1999, NEURON, V23, P461, DOI 10.1016/S0896-6273(00)80800-4; Karimi-Abdolrezaee S, 2006, J NEUROSCI, V26, P3377, DOI 10.1523/JNEUROSCI.4184-05.2006; Kessaris N, 2006, NAT NEUROSCI, V9, P173, DOI 10.1038/nn1620; Kessaris N, 2004, DEVELOPMENT, V131, P1289, DOI 10.1242/dev.01027; Knapp PE, 2004, EXP CELL RES, V296, P135, DOI 10.1016/j.yexcr.2004.02.007; Kornblum HI, 2000, DEV NEUROSCI-BASEL, V22, P16, DOI 10.1159/000017423; Levine JM, 2001, TRENDS NEUROSCI, V24, P39, DOI 10.1016/S0166-2236(00)01691-X; Ling BC, 2005, CANCER CELL, V7, P65, DOI 10.1016/j.ccr.2004.10.016; Lisovoski F, 1997, J NEUROPATH EXP NEUR, V56, P459, DOI 10.1097/00005072-199705000-00001; LUETTEKE NC, 1994, GENE DEV, V8, P399, DOI 10.1101/gad.8.4.399; Marcus J, 2006, GLIA, V53, P372, DOI 10.1002/glia.20292; Marshall CAG, 2003, GLIA, V43, P52, DOI 10.1002/glia.10213; Martens DJ, 2002, EUR J NEUROSCI, V16, P1045, DOI 10.1046/j.1460-9568.2002.02181.x; Mason JL, 2003, J NEUROSCI, V23, P7710; Mason JL, 2002, MOL CELL NEUROSCI, V20, P30, DOI 10.1006/mcne.2002.1114; Mason JL, 2001, NEUROPATH APPL NEURO, V27, P50, DOI 10.1046/j.0305-1846.2001.00301.x; MATTHIEU JM, 1992, J NEUROIMMUNOL, V40, P231, DOI 10.1016/0165-5728(92)90138-B; Menn B, 2006, J NEUROSCI, V26, P7907, DOI 10.1523/JNEUROSCI.1299-06.2006; Moreau-Fauvarque C, 2003, J NEUROSCI, V23, P9229; Murtie JC, 2005, NEUROBIOL DIS, V19, P171, DOI 10.1016/j.nbd.2004.12.006; Nait-Oumesmar B, 1999, EUR J NEUROSCI, V11, P4357, DOI 10.1046/j.1460-9568.1999.00873.x; NIETOSAMPEDRO M, 1988, NEUROSCI LETT, V91, P276, DOI 10.1016/0304-3940(88)90693-3; Parras CM, 2004, EMBO J, V23, P4495, DOI 10.1038/sj.emboj.7600447; PRESTON RJ, 1983, EXP NEUROL, V79, P808, DOI 10.1016/0014-4886(83)90044-4; Reynolds R, 2002, J NEUROCYTOL, V31, P523, DOI 10.1023/A:1025747832215; Shields SA, 1999, GLIA, V28, P77, DOI 10.1002/(SICI)1098-1136(199910)28:1<77::AID-GLIA9>3.0.CO;2-F; Stangel M, 2002, PROG NEUROBIOL, V68, P361, DOI 10.1016/S0301-0082(02)00105-3; Suzuki SO, 2003, J NEUROSCI, V23, P4240; Xin M, 2005, J NEUROSCI, V25, P1354, DOI 10.1523/JNEUROSCI.3034-04.2005; Yuan XQ, 2002, J NEUROSCI RES, V70, P529, DOI 10.1002/jnr.10368	50	266	271	3	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2007	10	8					990	1002		10.1038/nn1938	http://dx.doi.org/10.1038/nn1938			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	194PY	17618276				2022-12-17	WOS:000248357500013
J	Zatorre, RJ; Bouffard, M; Ahad, P; Belin, P				Zatorre, RJ; Bouffard, M; Ahad, P; Belin, P			Where is 'where' in the human auditory cortex?	NATURE NEUROSCIENCE			English	Article							CORTICAL-NEURONS; SPATIAL LOCALIZATION; PARIETAL CORTEX; MACAQUE MONKEY; NEARBY SOURCES; HUMAN BRAIN; LOCATION; MOVEMENT; AREAS; ATTENTION	We examine the functional characteristics of auditory cortical areas that are sensitive to spatial cues in the human brain, and determine whether they can be dissociated from parietal lobe mechanisms. Three positron emission tomography (PET) experiments were conducted using a speaker array permitting quasi free-field sound presentation within the scanner. Posterior auditory cortex responded to sounds that varied in their spatial distribution, but only when multiple complex stimuli were presented simultaneously, implicating this cortical system in disambiguation of overlapping auditory sources. We also found that the right inferior parietal cortex is specifically recruited in localization tasks, and that its activity predicts behavioral performance, consistent with its involvement in sensorimotor integration and spatial transformation. These findings clarify the functional roles of posterior auditory and parietal cortices, and help to reconcile competing models of auditory cortical organization.	McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada	McGill University	Zatorre, RJ (corresponding author), McGill Univ, Montreal Neurol Inst, 3801 Univ St, Montreal, PQ H3A 2B4, Canada.	robert.zatorre@mcgill.ca	Belin, Pascal/C-6247-2009	Belin, Pascal/0000-0002-7578-6365				Alain C, 2001, P NATL ACAD SCI USA, V98, P12301, DOI 10.1073/pnas.211209098; ANDERSEN RA, 1995, CEREB CORTEX, V5, P457, DOI 10.1093/cercor/5.5.457; Baumgart F, 1999, NATURE, V400, P724, DOI 10.1038/23390; Belin P, 2000, NAT NEUROSCI, V3, P965, DOI 10.1038/79890; Bregman A. S., 1990, AUDITORY SCENE ANAL; Brugge JF, 2001, AUDIOL NEURO-OTOL, V6, P173, DOI 10.1159/000046827; Brungart DS, 1999, J ACOUST SOC AM, V106, P1465, DOI 10.1121/1.427180; Brungart DS, 1999, J ACOUST SOC AM, V106, P1956, DOI 10.1121/1.427943; Bushara KO, 1999, NAT NEUROSCI, V2, P759, DOI 10.1038/11239; Clarke S, 2000, NEUROPSYCHOLOGIA, V38, P797, DOI 10.1016/S0028-3932(99)00141-4; Cohen YE, 1999, NEURON, V24, P769, DOI 10.1016/S0896-6273(00)81024-7; EFRON R, 1983, BRAIN LANG, V19, P254, DOI 10.1016/0093-934X(83)90069-X; Furukawa S, 2000, J NEUROSCI, V20, P1216, DOI 10.1523/JNEUROSCI.20-03-01216.2000; GALABURDA A, 1980, J COMP NEUROL, V190, P597, DOI 10.1002/cne.901900312; Griffiths TD, 1998, NAT NEUROSCI, V1, P74, DOI 10.1038/276; Griffiths TD, 2000, HUM BRAIN MAPP, V9, P72, DOI 10.1002/(SICI)1097-0193(200002)9:2<72::AID-HBM2>3.0.CO;2-9; Grill-Spector K, 2001, ACTA PSYCHOL, V107, P293, DOI 10.1016/S0001-6918(01)00019-1; Lewis JW, 2000, J COMP NEUROL, V428, P112, DOI 10.1002/1096-9861(20001204)428:1<112::AID-CNE8>3.0.CO;2-9; Maeder PP, 2001, NEUROIMAGE, V14, P802, DOI 10.1006/nimg.2001.0888; Mesulam MM, 1999, PHILOS T R SOC B, V354, P1325, DOI 10.1098/rstb.1999.0482; Middlebrooks JC, 1999, J ACOUST SOC AM, V106, P1493, DOI 10.1121/1.427147; MIDDLEBROOKS JC, 1994, SCIENCE, V264, P842, DOI 10.1126/science.8171339; Mondor TA, 1998, J EXP PSYCHOL HUMAN, V24, P66, DOI 10.1037/0096-1523.24.1.66; Mrsic-Flogel TD, 2001, J NEUROPHYSIOL, V86, P1043, DOI 10.1152/jn.2001.86.2.1043; Paus T, 1996, EUR J NEUROSCI, V8, P2236, DOI 10.1111/j.1460-9568.1996.tb01187.x; Penhune VB, 1996, CEREB CORTEX, V6, P661, DOI 10.1093/cercor/6.5.661; Rauschecker JP, 1997, J COMP NEUROL, V382, P89; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; RAUSCHECKER JP, 1995, SCIENCE, V268, P111, DOI 10.1126/science.7701330; Recanzone GH, 2000, J NEUROPHYSIOL, V83, P2723, DOI 10.1152/jn.2000.83.5.2723; Romanski LM, 1999, NAT NEUROSCI, V2, P1131, DOI 10.1038/16056; Sereno AB, 1998, NATURE, V395, P500, DOI 10.1038/26752; Talairach J., 1988, COPLANAR STEREOTAXIC; Thivard L, 2000, NEUROREPORT, V11, P2969, DOI 10.1097/00001756-200009110-00028; Tian B, 2001, SCIENCE, V292, P290, DOI 10.1126/science.1058911; Ungerleider Leslie G., 1994, Current Opinion in Neurobiology, V4, P157, DOI 10.1016/0959-4388(94)90066-3; Warren JD, 2002, NEURON, V34, P139, DOI 10.1016/S0896-6273(02)00637-2; Weeks R, 2000, J NEUROSCI, V20, P2664; Westbury CF, 1999, CEREB CORTEX, V9, P392, DOI 10.1093/cercor/9.4.392; WHITFIELD IC, 1985, CEREB CORTEX, V4, P329; WIGHTMAN FL, 1989, J ACOUST SOC AM, V85, P868, DOI 10.1121/1.397558; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127; Zatorre RJ, 2001, J NEUROSCI, V21, P6321, DOI 10.1523/JNEUROSCI.21-16-06321.2001; Zatorre RJ, 1999, NEUROIMAGE, V10, P544, DOI 10.1006/nimg.1999.0491	44	266	270	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2002	5	9					905	909		10.1038/nn904	http://dx.doi.org/10.1038/nn904			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	587RL	12195426				2022-12-17	WOS:000177656300022
J	Siclari, F; Baird, B; Perogamvros, L; Bernardi, G; LaRocque, JJ; Riedner, B; Boly, M; Postle, BR; Tononi, G				Siclari, Francesca; Baird, Benjamin; Perogamvros, Lampros; Bernardi, Giulio; LaRocque, Joshua J.; Riedner, Brady; Boly, Melanie; Postle, Bradley R.; Tononi, Giulio			The neural correlates of dreaming	NATURE NEUROSCIENCE			English	Article							CURRENT STIMULATION; BRAIN ACTIVITY; SLOW WAVES; REM-SLEEP; CONSCIOUSNESS; CORTEX; WAKING; STATES; AREAS; OSCILLATIONS	Consciousness never fades during waking. However, when awakened from sleep, we sometimes recall dreams and sometimes recall no experiences. Traditionally, dreaming has been identified with rapid eye-movement (REM) sleep, characterized by wake-like, globally 'activated', high-frequency electroencephalographic activity. However, dreaming also occurs in non-REM (NREM) sleep, characterized by prominent low-frequency activity. This challenges our understanding of the neural correlates of conscious experiences in sleep. Using high-density electroencephalography, we contrasted the presence and absence of dreaming in NREM and REM sleep. In both NREM and REM sleep, reports of dream experience were associated with local decreases in low-frequency activity in posterior cortical regions. High-frequency activity in these regions correlated with specific dream contents. Monitoring this posterior 'hot zone' in real time predicted whether an individual reported dreaming or the absence of dream experiences during NREM sleep, suggesting that it may constitute a core correlate of conscious experiences in sleep.	[Siclari, Francesca; Baird, Benjamin; Perogamvros, Lampros; Bernardi, Giulio; Riedner, Brady; Boly, Melanie; Postle, Bradley R.; Tononi, Giulio] Univ Wisconsin, Dept Psychiat, Madison, WI 53706 USA; [Siclari, Francesca; Bernardi, Giulio] Lausanne Univ Hosp CHUV, Ctr Res & Invest Sleep CIRS, Lausanne, Switzerland; [Siclari, Francesca; Bernardi, Giulio] Univ Lausanne, Lausanne, Switzerland; [Perogamvros, Lampros] Geneva Univ Hosp HUG, Div Pneumol, Sleep Lab, Geneva, Switzerland; [Perogamvros, Lampros] Univ Geneva, Dept Neurosci, Geneva, Switzerland; [Bernardi, Giulio] IMT Sch Adv Studies, Lucca, Italy; [LaRocque, Joshua J.] Univ Wisconsin, Med Scientist Training Program, Madison, WI USA; [LaRocque, Joshua J.] Univ Wisconsin, Neurosci Training Program, Madison, WI USA; [Boly, Melanie] Univ Wisconsin, Dept Neurol, Madison, WI 53706 USA; [Postle, Bradley R.] Univ Wisconsin, Dept Psychol, 1202 W Johnson St, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; University of Geneva; University of Geneva; IMT School for Advanced Studies Lucca; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Tononi, G (corresponding author), Univ Wisconsin, Dept Psychiat, Madison, WI 53706 USA.	gtononi@wisc.edu	Bernardi, Giulio/B-1452-2012; Siclari, Francesca/AFO-9175-2022; Perogamvros, Lampros/AAC-4931-2019	Bernardi, Giulio/0000-0003-4045-7075; Siclari, Francesca/0000-0003-2061-9719; Boly, Melanie/0000-0001-9584-0907	NIH/NCCAM [P01AT004952]; NIH/NIMH [5P20MH077967]; Tiny Blue Dot Inc. [MSN196438/AAC1335]; Swiss National Science Foundation [139778, 145571, 155120]; Swiss Foundation for Medical Biological Grants [151743, 145763]; NIH/NINDS [F32NS089348]; UW Medical Scientist Training Program Grant [T32 GM008692]; NIH [MH064498, MH095984]; National Center for Complementary & Integrative Health [P01AT004952] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008692] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P20MH077967, R01MH095984, R01MH064498] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS089348] Funding Source: NIH RePORTER	NIH/NCCAM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NIH/NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Tiny Blue Dot Inc.; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Foundation for Medical Biological Grants; NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); UW Medical Scientist Training Program Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank D. Bachhuber, L. Barbosa, R. Benca, E. Carrera, A. Castelnovo, A. Cayo, C. Cirelli, R. Davidson, C. Funk, M. Gevelinger, J. Harris, A. Mensen, P. Nori, R. Smith, L. Vuillaume, S. Yu, C. Zennig and our undergraduate research assistants for help with data collection, sleep scoring, technical assistance and discussions. This work was supported by NIH/NCCAM P01AT004952 (to G. T.), NIH/NIMH 5P20MH077967 (to G. T.), Tiny Blue Dot Inc. grant MSN196438/AAC1335 (to G. T.), Swiss National Science Foundation Grants 139778 (to F.S.), 145571 (to F.S.) and 155120 (to L. P.), Swiss Foundation for Medical Biological Grants 151743 and 145763 (to F. S.), NIH/NINDS F32NS089348 (to B.B.), UW Medical Scientist Training Program Grant T32 GM008692 (to J. J. L.), NIH Grants MH064498 and MH095984 (to B.R.P.).	Andrillon T, 2011, J NEUROSCI, V31, P17821, DOI 10.1523/JNEUROSCI.2604-11.2011; Aru J, 2012, J NEUROSCI, V32, P14909, DOI 10.1523/JNEUROSCI.2051-12.2012; ASERINSKY E, 1953, SCIENCE, V118, P273, DOI 10.1126/science.118.3062.273; Baars BJ, 2003, TRENDS NEUROSCI, V26, P671, DOI 10.1016/j.tins.2003.09.015; Balestrini S, 2016, BRAIN, V139, DOI 10.1093/brain/awv382; CAVALLERO C, 1992, SLEEP, V15, P562, DOI 10.1093/sleep/15.6.562; Chow HM, 2013, P NATL ACAD SCI USA, V110, P10300, DOI 10.1073/pnas.1217691110; Christoff K, 2009, P NATL ACAD SCI USA, V106, P8719, DOI 10.1073/pnas.0900234106; Christophel TB, 2012, J NEUROSCI, V32, P12983, DOI 10.1523/JNEUROSCI.0184-12.2012; Chumbley J, 2010, NEUROIMAGE, V49, P3057, DOI 10.1016/j.neuroimage.2009.10.090; CORBETTA M, 1993, J NEUROSCI, V13, P1202; Dehaene S, 2001, NAT NEUROSCI, V4, P752, DOI 10.1038/89551; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; DENNETT DC, 1976, PHILOS REV, V85, P151, DOI 10.2307/2183728; Dresler M, 2012, SLEEP, V35, P1017, DOI 10.5665/sleep.1974; Fleming SM, 2012, PHILOS T R SOC B, V367, P1338, DOI 10.1098/rstb.2011.0417; FOULKES WD, 1962, J ABNORM PSYCHOL, V65, P14, DOI 10.1037/h0040431; Frasle S, 2014, J NEUROSCI, V34, P1738, DOI 10.1523/JNEUROSCI.4403-13.2014; Funk CM, 2016, CURR BIOL, V26, P396, DOI 10.1016/j.cub.2015.11.062; GOKYIGIT A, 1995, EPILEPSIA, V36, P210, DOI 10.1111/j.1528-1157.1995.tb00982.x; Gross DW, 1999, NEUROSCIENCE, V94, P1005, DOI 10.1016/S0306-4522(99)00343-7; Grossman E, 2000, J COGNITIVE NEUROSCI, V12, P711, DOI 10.1162/089892900562417; Hebb DO, 1940, ARCH NEURO PSYCHIATR, V44, P421, DOI 10.1001/archneurpsyc.1940.02280080181011; Herbet G, 2014, NEUROPSYCHOLOGIA, V56, P239, DOI 10.1016/j.neuropsychologia.2014.01.020; Hohwy J, 2009, CONSCIOUS COGN, V18, P428, DOI 10.1016/j.concog.2009.02.006; Horikawa T, 2013, SCIENCE, V340, P639, DOI 10.1126/science.1234330; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Huber R, 2006, NAT NEUROSCI, V9, P1169, DOI 10.1038/nn1758; Iber C., 2007, AASM MANUAL SCORING; Jones BE, 2005, TRENDS PHARMACOL SCI, V26, P578, DOI 10.1016/j.tips.2005.09.009; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Kamphuisen A, 2008, J VISION, V8, DOI 10.1167/8.5.4; Keren AS, 2010, NEUROIMAGE, V49, P2248, DOI 10.1016/j.neuroimage.2009.10.057; Koch C, 2016, NAT REV NEUROSCI, V17, P307, DOI 10.1038/nrn.2016.22; Le Van Quyen M, 2010, J NEUROSCI, V30, P7770, DOI 10.1523/JNEUROSCI.5049-09.2010; MALCOLM N, 1956, PHILOS REV, V65, P14, DOI 10.2307/2182186; Malhotra P, 2009, BRAIN, V132, P645, DOI 10.1093/brain/awn350; Maquet P, 2000, J SLEEP RES, V9, P207; MORUZZI G, 1949, ELECTROEN CLIN NEURO, V1, P455, DOI 10.1016/0013-4694(49)90219-9; Murphy M, 2011, SLEEP, V34, P283, DOI 10.1093/sleep/34.3.283; Muthukumaraswamy SD, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00138; Narain C, 2003, CEREB CORTEX, V13, P1362, DOI 10.1093/cercor/bhg083; Naro A, 2016, BRAIN TOPOGR, V29, P623, DOI 10.1007/s10548-016-0489-z; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Nielsen T. A., 1999, HDB BEHAV STATE CONT, P101; Nielsen T. A., 2000, BEHAV BRAIN SCI, V23, P904, DOI DOI 10.1017/S0140525X0000399X; Nielsen TA, 2000, BEHAV BRAIN SCI, V23, P851, DOI 10.1017/S0140525X0000399X; Nir Y, 2011, NEURON, V70, P153, DOI 10.1016/j.neuron.2011.02.043; Nir Y, 2010, TRENDS COGN SCI, V14, P88, DOI 10.1016/j.tics.2009.12.001; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Perogamvros L, 2012, NEUROSCI BIOBEHAV R, V36, P1934, DOI 10.1016/j.neubiorev.2012.05.010; Pigorini A, 2015, NEUROIMAGE, V112, P105, DOI 10.1016/j.neuroimage.2015.02.056; Postle BR, 2015, CURR OPIN BEHAV SCI, V1, P40, DOI 10.1016/j.cobeha.2014.08.004; Puce A, 1998, J NEUROSCI, V18, P2188; Purdon PL, 2013, P NATL ACAD SCI USA, V110, pE1142, DOI 10.1073/pnas.1221180110; Renard Y, 2010, PRESENCE-TELEOP VIRT, V19, P35, DOI 10.1162/pres.19.1.35; Revonsuo A, 2000, BEHAV BRAIN SCI, V23, P995, DOI 10.1017/S0140525X00814028; Rossion B, 2003, NEUROIMAGE, V19, P877, DOI 10.1016/S1053-8119(03)00105-8; Schiff ND, 2014, CURR OPIN NEUROBIOL, V25, P7, DOI 10.1016/j.conb.2013.10.007; Schwartz S, 2002, TRENDS COGN SCI, V6, P23, DOI 10.1016/S1364-6613(00)01818-0; Seghier ML, 2008, MAGN RESON IMAGING, V26, P594, DOI 10.1016/j.mri.2007.10.010; Siclari F, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00542; Sirota A, 2003, P NATL ACAD SCI USA, V100, P2065, DOI 10.1073/pnas.0437938100; Sitt JD, 2014, BRAIN, V137, P2258, DOI 10.1093/brain/awu141; Steriade M, 1996, J NEUROSCI, V16, P2788; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; Stickgold R, 2001, SLEEP, V24, P171, DOI 10.1093/sleep/24.2.171; Tadel F, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/879716; Tononi G, 2008, ANN NY ACAD SCI, V1129, P330, DOI 10.1196/annals.1417.024; Voss U, 2014, NAT NEUROSCI, V17, P810, DOI 10.1038/nn.3719; Voss U, 2009, SLEEP, V32, P1191, DOI 10.1093/sleep/32.9.1191; WIKLER A, 1952, P SOC EXP BIOL MED, V79, P261, DOI 10.3181/00379727-79-19345; Windt JM, 2015, DREAMING: A CONCEPTUAL FRAMEWORK FOR PHILOSOPHY OF MIND AND EMPIRICAL RESEARCH, P1, DOI 10.7551/mitpress/9780262028677.001.0001	73	265	269	19	198	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2017	20	6					872	+		10.1038/nn.4545	http://dx.doi.org/10.1038/nn.4545			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EV8FU	28394322	Green Accepted, Green Submitted			2022-12-17	WOS:000402016900017
J	Schaal, S; Sternad, D; Osu, R; Kawato, M				Schaal, S; Sternad, D; Osu, R; Kawato, M			Rhythmic arm movement is not discrete	NATURE NEUROSCIENCE			English	Article							POSTERIOR PARIETAL CORTEX; CENTRAL PATTERN GENERATOR; REACHING MOVEMENTS; SEGMENTED-CONTROL; MOTOR AREAS; POWER-LAW; COORDINATION; HUMANS; MODEL; SPACE	Rhythmic movements, such as walking, chewing or scratching, are phylogenetically old motor behaviors found in many organisms, ranging from insects to primates. In contrast, discrete movements, such as reaching, grasping or kicking, are behaviors that have reached sophistication primarily in younger species, particularly primates. Neurophysiological and computational research on arm motor control has focused almost exclusively on discrete movements, essentially assuming similar neural circuitry for rhythmic tasks. In contrast, many behavioral studies have focused on rhythmic models, subsuming discrete movement as a special case. Here, using a human functional neuroimaging experiment, we show that in addition to areas activated in rhythmic movement, discrete movement involves several higher cortical planning areas, even when both movement conditions are confined to the same single wrist joint. These results provide neuroscientific evidence that rhythmic arm movement cannot be part of a more general discrete movement system and may require separate neurophysiological and theoretical treatment.	Univ So Calif, Los Angeles, CA 90089 USA; Penn State Univ, Dept Kinesiol, University Pk, PA 16802 USA; ATR Computat Neurosci Labs, Seika, Kyoto 6190288, Japan	University of Southern California; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Schaal, S (corresponding author), Univ So Calif, Los Angeles, CA 90089 USA.	sschaal@usc.edu	Sternad, Dagmar/D-8341-2013					ABEND W, 1982, BRAIN, V105, P331, DOI 10.1093/brain/105.2.331; Andersen RA, 1997, ANNU REV NEUROSCI, V20, P303, DOI 10.1146/annurev.neuro.20.1.303; Brett M, 2001, NEUROIMAGE, V13, pS85; Brett M., 2002, 8 INT C FUNC MAPP HU; Brown TG, 1914, J PHYSIOL-LONDON, V48, P18; de Rugy A, 2003, BRAIN RES, V994, P160, DOI 10.1016/j.brainres.2003.09.031; Debaere F, 2001, NEUROIMAGE, V14, P947, DOI 10.1006/nimg.2001.0892; Deiber MP, 1999, J NEUROPHYSIOL, V81, P3065, DOI 10.1152/jn.1999.81.6.3065; Dimitrijevic MR, 1998, ANN NY ACAD SCI, V860, P360, DOI 10.1111/j.1749-6632.1998.tb09062.x; FELDMAN AG, 1980, NEUROSCIENCE, V5, P81, DOI 10.1016/0306-4522(80)90073-1; Fink GR, 1997, J NEUROPHYSIOL, V77, P2164, DOI 10.1152/jn.1997.77.4.2164; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; Flash T, 2001, CURR OPIN NEUROBIOL, V11, P655, DOI 10.1016/S0959-4388(01)00265-3; FRISTON KJ, 1991, J CEREBR BLOOD F MET, V11, P690, DOI 10.1038/jcbfm.1991.122; Gordon AM, 1998, EXP BRAIN RES, V121, P153, DOI 10.1007/s002210050447; Grafton ST, 1996, CEREB CORTEX, V6, P226, DOI 10.1093/cercor/6.2.226; Ijspeert AJ, 2003, ADV NEURAL INFORM PR, V2003, P1547; Kalaska JF, 1997, CURR OPIN NEUROBIOL, V7, P849, DOI 10.1016/S0959-4388(97)80146-8; Kawagoe A, 1999, IEEE T APPL SUPERCON, V9, P727, DOI 10.1109/77.783398; Kelso J.A.S., 1995, DYNAMIC PATTERNS SEL; Kertzman C, 1997, EXP BRAIN RES, V114, P170, DOI 10.1007/PL00005617; Kugler P.N., 1987, INFORM NATURAL LAW S; Lam T, 2000, J NEUROPHYSIOL, V83, P2814, DOI 10.1152/jn.2000.83.5.2814; Latash M., 1993, CONTROL HUMAN MOVEME; Lewis PA, 2003, CURR OPIN NEUROBIOL, V13, P250, DOI 10.1016/S0959-4388(03)00036-9; Marder E, 2000, CURR OPIN NEUROBIOL, V10, P691, DOI 10.1016/S0959-4388(00)00157-4; MORASSO P, 1981, EXP BRAIN RES, V42, P223; Picard N, 2001, CURR OPIN NEUROBIOL, V11, P663, DOI 10.1016/S0959-4388(01)00266-5; Pinter MM, 1999, SPINAL CORD, V37, P531, DOI 10.1038/sj.sc.3100886; Richardson MJE, 2002, J NEUROSCI, V22, P8201; Rizzolatti G, 1998, TRENDS NEUROSCI, V21, P188, DOI 10.1016/S0166-2236(98)01260-0; Sabes PN, 2000, CURR OPIN NEUROBIOL, V10, P740, DOI 10.1016/S0959-4388(00)00149-5; Schaal S, 2001, EXP BRAIN RES, V136, P60, DOI 10.1007/s002210000505; Seitz RJ, 2000, EXP BRAIN RES, V133, P71, DOI 10.1007/s002210000402; Smits-Engelsman BCM, 2002, EXP BRAIN RES, V145, P222, DOI 10.1007/s00221-002-1115-8; SOECHTING JF, 1987, NEUROSCIENCE, V23, P53, DOI 10.1016/0306-4522(87)90270-3; Sternad D, 2003, BRAIN RES, V989, P152, DOI 10.1016/S0006-8993(03)03292-X; Sternad D, 2002, EXP BRAIN RES, V147, P162, DOI 10.1007/s00221-002-1219-1; Sternad D, 2000, HUM MOVEMENT SCI, V19, P627, DOI 10.1016/S0167-9457(00)00028-2; Sternad D, 1999, EXP BRAIN RES, V124, P118, DOI 10.1007/s002210050606; Talairach J., 1988, COPLANAR STEREOTAXIC; Thickbroom GW, 1999, EXP BRAIN RES, V126, P431, DOI 10.1007/s002210050749; Turner R, 1998, EXP BRAIN RES, V123, P5, DOI 10.1007/s002210050538; TURVEY MT, 1990, AM PSYCHOL, V45, P938, DOI 10.1037/0003-066X.45.8.938; UNO Y, 1989, BIOL CYBERN, V61, P89, DOI 10.1007/BF00204593; Wei KL, 2003, MOTOR CONTROL, V7, P134, DOI 10.1123/mcj.7.2.134	46	265	265	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2004	7	10					1137	1144		10.1038/nn1322	http://dx.doi.org/10.1038/nn1322			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	857YQ	15452580				2022-12-17	WOS:000224156900024
J	Reisel, D; Bannerman, DM; Schmitt, WB; Deacon, RMJ; Flint, J; Borchardt, T; Seeburg, PH; Rawlins, JNP				Reisel, D; Bannerman, DM; Schmitt, WB; Deacon, RMJ; Flint, J; Borchardt, T; Seeburg, PH; Rawlins, JNP			Spatial memory dissociations in mice lacking GluR1	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; HIPPOCAMPUS; IMPAIRMENT; ANTAGONIST; LESIONS; COMPONENTS; BLOCKADE; RATS; AP5	Gene-targeted mice lacking the AMPA receptor subunit GluR1 (GluR-A) have deficits in hippocampal CA3-CA1 long-term potentiation. We now report that they showed normal spatial reference learning and memory, both on the hidden platform watermaze task and on an appetitively motivated Y-maze task. In contrast, they showed a specific spatial working memory impairment during tests of non-matching to place on both the Y-maze and an elevated T-maze. In addition, successful watermaze and Y-maze reference memory performance depended on hippocampal function in both wild-type and mutant mice; bilateral hippocampal lesions profoundly impaired performance on both tasks, to a similar extent in both groups. These results suggest that different forms of hippocampus-dependent spatial memory involve different aspects of neural processing within the hippocampus.	Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Max Planck Inst Med Res, Dept Mol Neurobiol, D-69120 Heidelberg, Germany	University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; Max Planck Society	Bannerman, DM (corresponding author), Univ Oxford, Dept Expt Psychol, S Parks Rd, Oxford OX1 3UD, England.		Borchardt, Thilo/E-7844-2011	Borchardt, Thilo/0000-0002-2960-0267; Bannerman, David/0000-0002-3024-7595; Flint, Jonathan/0000-0002-9427-4429; Reisel, Dan/0000-0001-9018-4621				BANNERMAN DM, 1995, NATURE, V378, P182, DOI 10.1038/378182a0; Bannerman DM, 1999, BEHAV NEUROSCI, V113, P1170, DOI 10.1037/0735-7044.113.6.1170; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Chen C, 1997, ANNU REV NEUROSCI, V20, P157, DOI 10.1146/annurev.neuro.20.1.157; Deacon RMJ, 2002, BEHAV BRAIN RES, V133, P57, DOI 10.1016/S0166-4328(01)00451-X; Hoffman DA, 2002, P NATL ACAD SCI USA, V99, P7740, DOI 10.1073/pnas.092157999; Logue SE, 1997, BEHAV NEUROSCI, V111, P104, DOI 10.1037/0735-7044.111.1.104; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MORRIS RGM, 1990, EUR J NEUROSCI, V2, P1016, DOI 10.1111/j.1460-9568.1990.tb00014.x; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MORRIS RGM, 1981, LEARN MOTIV, V12, P239, DOI 10.1016/0023-9690(81)90020-5; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OLTON DS, 1979, BEHAV BRAIN SCI, V2, P313, DOI 10.1017/S0140525X00062713; Paulsen O, 2000, CURR OPIN NEUROBIOL, V10, P172, DOI 10.1016/S0959-4388(00)00076-3; Pike FG, 1999, J PHYSIOL-LONDON, V518, P571, DOI 10.1111/j.1469-7793.1999.0571p.x; RAWLINS JNP, 1982, BEHAV BRAIN RES, V5, P331, DOI 10.1016/0166-4328(82)90039-0; SAUCIER D, 1995, NATURE, V378, P186, DOI 10.1038/378186a0; Steele RJ, 1999, HIPPOCAMPUS, V9, P118, DOI 10.1002/(SICI)1098-1063(1999)9:2<118::AID-HIPO4>3.0.CO;2-8; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; TONKISS J, 1991, EXP BRAIN RES, V85, P349; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805	26	265	276	0	20	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2002	5	9					868	873		10.1038/nn910	http://dx.doi.org/10.1038/nn910			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	587RL	12195431				2022-12-17	WOS:000177656300017
J	Chi, P; Greengard, P; Ryan, TA				Chi, P; Greengard, P; Ryan, TA			Synapsin dispersion and reclustering during synaptic activity	NATURE NEUROSCIENCE			English	Article							TERMINAL-SPECIFIC PHOSPHOPROTEIN; SQUID GIANT SYNAPSE; PROTEIN-KINASE-II; F-ACTIN; NEUROTRANSMITTER RELEASE; VESICLE PHOSPHOPROTEINS; NERVE-TERMINALS; GENE FAMILY; ASSOCIATION; SITES	Presynaptic modulation of synaptic transmission provides an important basis for control of synaptic function. The synapsins, a family of highly conserved proteins associated with synaptic vesicles, have long been implicated in the regulation of neurotransmitter release. However, direct physiological measurements of the molecular mechanisms have been lacking. Here we show that in living hippocampal terminals, green fluorescent protein (GFP)-labeled synapsin la dissociates from synaptic vesicles, disperses into axons during action potential (AP) firing, and reclusters to synapses after the cessation of synaptic activity. Using various mutated forms of synapsin la that prevent phosphorylation at specific sites, we performed simultaneous FM 4-64 measurements of vesicle pool mobilization along with synapsin dispersion kinetics. These studies indicate that the rate of synapsin dispersion is controlled by phosphorylation, which in turn controls the kinetics of vesicle pool turnover. Thus synapsin acts as a phosphorylation-state-dependent regulator of synaptic vesicle mobilization, and hence, neurotransmitter release.	Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA; Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA	Cornell University; Rockefeller University	Ryan, TA (corresponding author), Cornell Univ, Weill Med Coll, Dept Biochem, 1300 York Ave, New York, NY 10021 USA.	taryan@med.cornell.edu	Ryan, Timothy/AAO-8286-2020	Ryan, Timothy/0000-0003-2533-9548	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM061925] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH039327, R37MH039327] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM61925-01] Funding Source: Medline; NIMH NIH HHS [MH39327] Funding Source: Medline; NINDS NIH HHS [NS24692] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BAHLER M, 1987, NATURE, V326, P704, DOI 10.1038/326704a0; BAHLER M, 1989, J CELL BIOL, V108, P1841, DOI 10.1083/jcb.108.5.1841; BENFENATI F, 1989, J CELL BIOL, V108, P1863, DOI 10.1083/jcb.108.5.1863; BENFENATI F, 1989, J CELL BIOL, V108, P1851, DOI 10.1083/jcb.108.5.1851; BENFENATI F, 1993, J CELL BIOL, V123, P1845, DOI 10.1083/jcb.123.6.1845; BENFENATI F, 1989, CELL BIOL INT REP, V13, P1007, DOI 10.1016/0309-1651(89)90016-7; BENFENATI F, 1992, NEURON, V8, P377, DOI 10.1016/0896-6273(92)90303-U; CECCALDI PE, 1995, J CELL BIOL, V128, P905, DOI 10.1083/jcb.128.5.905; CHILCOTE TJ, 1994, J NEUROCHEM, V63, P1568; CZERNIK AJ, 1987, P NATL ACAD SCI USA, V84, P7518, DOI 10.1073/pnas.84.21.7518; DECAMILLI P, 1990, ANNU REV CELL BIOL, V6, P433, DOI 10.1146/annurev.cellbio.6.1.433; DECAMILLI P, 1983, J CELL BIOL, V96, P1355, DOI 10.1083/jcb.96.5.1355; Esser L, 1998, EMBO J, V17, P977, DOI 10.1093/emboj/17.4.977; Ferreira A, 1998, MOL MED, V4, P22, DOI 10.1007/BF03401726; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; Greengard P., 1987, Advances in Experimental Medicine and Biology, V221, P135; Henkel AW, 1995, J NEUROSCI, V15, P8246; Hilfiker S, 1998, NAT NEUROSCI, V1, P29, DOI 10.1038/229; Hosaka M, 1999, J BIOL CHEM, V274, P16747, DOI 10.1074/jbc.274.24.16747; Hosaka M, 1999, NEURON, V24, P377, DOI 10.1016/S0896-6273(00)80851-X; Hosaka M, 1998, J BIOL CHEM, V273, P13371, DOI 10.1074/jbc.273.22.13371; Hosaka M, 1998, J BIOL CHEM, V273, P1425, DOI 10.1074/jbc.273.3.1425; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Kao HT, 1999, J EXP ZOOL, V285, P360, DOI 10.1002/(SICI)1097-010X(19991215)285:4<360::AID-JEZ4>3.3.CO;2-V; Kao HT, 1998, P NATL ACAD SCI USA, V95, P4667, DOI 10.1073/pnas.95.8.4667; LI L, 1995, P NATL ACAD SCI USA, V92, P9235, DOI 10.1073/pnas.92.20.9235; LLINAS R, 1985, P NATL ACAD SCI USA, V82, P3035, DOI 10.1073/pnas.82.9.3035; LLINAS R, 1991, J PHYSIOL-LONDON, V436, P257, DOI 10.1113/jphysiol.1991.sp018549; MANDELL JW, 1992, J NEUROSCI, V12, P1736; MANDELL JW, 1990, NEURON, V5, P19, DOI 10.1016/0896-6273(90)90030-J; ROSAHL TW, 1995, NATURE, V375, P488, DOI 10.1038/375488a0; ROSAHL TW, 1993, CELL, V75, P661, DOI 10.1016/0092-8674(93)90487-B; Ryan TA, 1999, J NEUROSCI, V19, P1317; Ryan TA, 1996, J CELL BIOL, V134, P1219, DOI 10.1083/jcb.134.5.1219; SCHIEBLER W, 1986, J BIOL CHEM, V261, P8383; SIHRA TS, 1989, P NATL ACAD SCI USA, V86, P8108, DOI 10.1073/pnas.86.20.8108; Stefani G, 1997, J PHYSIOL-LONDON, V504, P501, DOI 10.1111/j.1469-7793.1997.501bd.x; SUDHOF TC, 1989, SCIENCE, V245, P1474, DOI 10.1126/science.2506642; Tanaka H, 2000, NEURON, V25, P93, DOI 10.1016/S0896-6273(00)80874-0; TARELLI FT, 1992, NEURON, V9, P1143, DOI 10.1016/0896-6273(92)90072-L; THIEL G, 1990, J BIOL CHEM, V265, P16527; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1	43	265	274	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2001	4	12					1187	1193		10.1038/nn756	http://dx.doi.org/10.1038/nn756			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	498RV	11685225				2022-12-17	WOS:000172525000014
J	Heeger, DJ; Huk, AC; Geisler, WS; Albrecht, DG				Heeger, DJ; Huk, AC; Geisler, WS; Albrecht, DG			Spikes versus BOLD: what does neuroimaging tell us about neuronal activity?	NATURE NEUROSCIENCE			English	News Item							VISUAL-CORTEX; DISCRIMINATION; SIGNALS; MT	By demonstrating that fMRI responses in human MT+ increase linearly with motion coherence and comparing these responses with slopes of single-neuron firing rates in monkey MT, a new paper provides that the best evidence so far that fMRI responses are proportional to firing rates.	Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; Univ Texas, Dept Psychol, Austin, TX 78712 USA	Stanford University; University of Texas System; University of Texas Austin	Heeger, DJ (corresponding author), Stanford Univ, Dept Psychol, Stanford, CA 94305 USA.		Huk, Alexander/A-8031-2016	Huk, Alexander/0000-0003-1430-6935; Geisler, Wilson/0000-0003-4630-6614				Boynton GM, 1999, VISION RES, V39, P257, DOI 10.1016/S0042-6989(98)00113-8; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Braitenberg V, 1991, ANATOMY CORTEX; BRITTEN KH, 1993, VISUAL NEUROSCI, V10, P1157, DOI 10.1017/S0952523800010269; Britten KH, 1998, J NEUROPHYSIOL, V80, P762, DOI 10.1152/jn.1998.80.2.762; Buxton RB, 1998, MAGNET RESON MED, V39, P855, DOI 10.1002/mrm.1910390602; Geisler WS, 1997, VISUAL NEUROSCI, V14, P897, DOI 10.1017/S0952523800011627; Heeger DJ, 1999, J NEUROSCI, V19, P7162, DOI 10.1523/JNEUROSCI.19-16-07162.1999; PETERS A, 1991, J COMP NEUROL, V306, P1, DOI 10.1002/cne.903060102; Rees G, 2000, NAT NEUROSCI, V3, P716, DOI 10.1038/76673; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Shulman RG, 1998, P NATL ACAD SCI USA, V95, P11993, DOI 10.1073/pnas.95.20.11993; Vanzetta I, 1999, SCIENCE, V286, P1555, DOI 10.1126/science.286.5444.1555; Wandell BA, 1999, NEURON, V24, P901, DOI 10.1016/S0896-6273(00)81037-5; Wong-Riley Margaret T.T., 1994, Cerebral Cortex, V10, P141	15	265	270	1	22	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2000	3	7					631	633		10.1038/76572	http://dx.doi.org/10.1038/76572			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TT	10862687				2022-12-17	WOS:000167177200002
J	Redmond, L; Oh, SR; Hicks, C; Weinmaster, G; Ghosh, A				Redmond, L; Oh, SR; Hicks, C; Weinmaster, G; Ghosh, A			Nuclear Notch1 signaling and the regulation of dendritic development	NATURE NEUROSCIENCE			English	Article							NEURON-SPECIFIC ENOLASE; DROSOPHILA-NOTCH; CELL-DIFFERENTIATION; INTRACELLULAR DOMAIN; XENOPUS-EMBRYOS; MAMMALIAN NOTCH; EXPRESSION; RECEPTOR; HOMOLOG; GENE	To understand the function of Notch in the mammalian brain, we examined Notch1 signaling and its cellular consequences in developing cortical neurons. We found that the cytoplasmic domain of endogenous Notch1 translocated to the nucleus during neuronal differentiation. Notch1 cytoplasmic-domain constructs transfected into cortical neurons were present in multiple phosphorylated forms, localized to the nucleus and could induce CBF1-mediated transactivation. Molecular perturbation experiments suggested that Notch1 signaling in cortical neurons promoted dendritic branching and inhibited dendritic growth. These observations show that Notch1 signaling to the nucleus exerts an important regulatory influence on the specification of dendritic morphology in neurons.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Univ Calif Los Angeles, Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA	Johns Hopkins University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Ghosh, A (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.	aghosh@jhmi.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036176] Funding Source: NIH RePORTER; NINDS NIH HHS [NS36176] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; AUSTIN CP, 1995, DEVELOPMENT, V121, P3637; Berezovska O, 1999, NEUROSCIENCE, V93, P433, DOI 10.1016/S0306-4522(99)00157-8; BETTENHAUSEN B, 1995, DEVELOPMENT, V121, P2407; Blaumueller CM, 1997, CELL, V90, P281, DOI 10.1016/S0092-8674(00)80336-0; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; CHITNIS A, 1995, NATURE, V375, P761, DOI 10.1038/375761a0; COFFMAN C, 1990, SCIENCE, V249, P1438, DOI 10.1126/science.2402639; COFFMAN CR, 1993, CELL, V73, P659, DOI 10.1016/0092-8674(93)90247-N; CONLON RA, 1995, DEVELOPMENT, V121, P1533; DELAMO FF, 1992, DEVELOPMENT, V115, P737; DORSKY RI, 1995, NEURON, V14, P487, DOI 10.1016/0896-6273(95)90305-4; Fambrough D, 1996, P NATL ACAD SCI USA, V93, P13233, DOI 10.1073/pnas.93.23.13233; FORSSPETTER S, 1990, NEURON, V5, P187, DOI 10.1016/0896-6273(90)90308-3; FORTINI ME, 1994, CELL, V79, P273, DOI 10.1016/0092-8674(94)90196-1; GHYSEN A, 1993, GENE DEV, V7, P723, DOI 10.1101/gad.7.5.723; GINIGER E, 1993, DEVELOPMENT, V117, P431; Giniger E, 1998, NEURON, V20, P667, DOI 10.1016/S0896-6273(00)81007-7; GONATAS JO, 1985, J NEUROCHEM, V45, P497, DOI 10.1111/j.1471-4159.1985.tb04016.x; GREENWALD I, 1992, CELL, V68, P271, DOI 10.1016/0092-8674(92)90470-W; Greenwald I, 1998, GENE DEV, V12, P1751, DOI 10.1101/gad.12.12.1751; Hsieh JJD, 1996, MOL CELL BIOL, V16, P952; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Kidd S, 1998, GENE DEV, V12, P3728, DOI 10.1101/gad.12.23.3728; Kimble J, 1997, ANNU REV CELL DEV BI, V13, P333, DOI 10.1146/annurev.cellbio.13.1.333; Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683; Lardelli M, 1996, MECH DEVELOP, V59, P177, DOI 10.1016/0925-4773(96)00589-8; LARDELLI M, 1994, MECH DEVELOP, V46, P123, DOI 10.1016/0925-4773(94)90081-7; Lecourtois M, 1998, CURR BIOL, V8, P771, DOI 10.1016/S0960-9822(98)70300-8; LECOURTOIS M, 1995, GENE DEV, V9, P2598, DOI 10.1101/gad.9.21.2598; LINDSELL CE, 1995, CELL, V80, P909, DOI 10.1016/0092-8674(95)90294-5; Lindsell CE, 1996, MOL CELL NEUROSCI, V8, P14, DOI 10.1006/mcne.1996.0040; Logeat F, 1998, P NATL ACAD SCI USA, V95, P8108, DOI 10.1073/pnas.95.14.8108; Lu FM, 1996, P NATL ACAD SCI USA, V93, P5663, DOI 10.1073/pnas.93.11.5663; Pan DJ, 1997, CELL, V90, P271, DOI 10.1016/S0092-8674(00)80335-9; Qi HL, 1999, SCIENCE, V283, P91, DOI 10.1126/science.283.5398.91; REAUME AG, 1992, DEV BIOL, V154, P377, DOI 10.1016/0012-1606(92)90076-S; REBAY I, 1993, CELL, V74, P319, DOI 10.1016/0092-8674(93)90423-N; SCHMECHEL DE, 1980, BRAIN RES, V190, P195, DOI 10.1016/0006-8993(80)91169-5; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Sestan N, 1999, SCIENCE, V286, P741, DOI 10.1126/science.286.5440.741; Shawber C, 1996, DEV BIOL, V180, P370, DOI 10.1006/dbio.1996.0310; Shawber C, 1996, DEVELOPMENT, V122, P3765; Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9; SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707; Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X; THORMODSSON FR, 1995, J NEUROCHEM, V64, P1919; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; WEINMASTER G, 1991, DEVELOPMENT, V113, P199; WEINMASTER G, 1992, DEVELOPMENT, V116, P931	50	265	272	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2000	3	1					30	40		10.1038/71104	http://dx.doi.org/10.1038/71104			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292TB	10607392				2022-12-17	WOS:000085810200009
J	Jacobs, J; Weidemann, CT; Miller, JF; Solway, A; Burke, JF; Wei, XX; Suthana, N; Sperling, MR; Sharan, AD; Fried, I; Kahana, MJ				Jacobs, Joshua; Weidemann, Christoph T.; Miller, Jonathan F.; Solway, Alec; Burke, John F.; Wei, Xue-Xin; Suthana, Nanthia; Sperling, Michael R.; Sharan, Ashwini D.; Fried, Itzhak; Kahana, Michael J.			Direct recordings of grid-like neuronal activity in human spatial navigation	NATURE NEUROSCIENCE			English	Article							ENTORHINAL CORTEX; CELLS; HIPPOCAMPUS; REPRESENTATION; MEMORY; MAP; EXPERIENCE; NETWORK; PLACE; SPACE	Grid cells in the entorhinal cortex appear to represent spatial location via a triangular coordinate system. Such cells, which have been identified in rats, bats and monkeys, are believed to support a wide range of spatial behaviors. Recording neuronal activity from neurosurgical patients performing a virtual-navigation task, we identified cells exhibiting grid-like spiking patterns in the human brain, suggesting that humans and simpler animals rely on homologous spatial-coding schemes.	[Jacobs, Joshua; Miller, Jonathan F.] Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA; [Weidemann, Christoph T.] Swansea Univ, Dept Psychol, Swansea, W Glam, Wales; [Solway, Alec] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA; [Burke, John F.; Wei, Xue-Xin; Kahana, Michael J.] Univ Penn, Dept Psychol, Philadelphia, PA 19104 USA; [Suthana, Nanthia; Fried, Itzhak] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA; [Suthana, Nanthia; Fried, Itzhak] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90024 USA; [Sperling, Michael R.] Thomas Jefferson Univ, Dept Neurol, Philadelphia, PA 19107 USA; [Sharan, Ashwini D.] Thomas Jefferson Univ, Dept Neurosurg, Philadelphia, PA 19107 USA; [Fried, Itzhak] Tel Aviv Univ, Tel Aviv Med Ctr, Funct Neurosurg Unit, IL-69978 Tel Aviv, Israel; [Fried, Itzhak] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel	Drexel University; Swansea University; Princeton University; University of Pennsylvania; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; Jefferson University; Jefferson University; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine	Jacobs, J (corresponding author), Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA.	joshua.jacobs@drexel.edu; ifried@mednet.ucla.edu	Weidemann, Christoph T./E-8857-2011; Jacobs, Joshua/E-9500-2013	Weidemann, Christoph T./0000-0002-4280-2744; Jacobs, Joshua/0000-0003-1807-6882; Burke, John/0000-0002-6190-5116; Suthana, Nanthia/0000-0002-8796-3277	US National Institutes of Health [MH061975, NS033221]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033221, R56NS033221, R01NS084017] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to the patients for participating in our study. We thank K. Lee, D. Wyeth, E. Wyeth, D. Pourshaban, E. Behnke and T. Fields for technical assistance. This work was supported by US National Institutes of Health grants MH061975 and NS033221.	Bird CM, 2008, NAT REV NEUROSCI, V9, P182, DOI 10.1038/nrn2335; Buzsaki G, 2013, NAT NEUROSCI, V16, P130, DOI 10.1038/nn.3304; Doeller CF, 2010, NATURE, V463, P657, DOI 10.1038/nature08704; Ekstrom AD, 2003, NATURE, V425, P184, DOI 10.1038/nature01964; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hargreaves EL, 2005, SCIENCE, V308, P1792, DOI 10.1126/science.1110449; Hill DN, 2011, J NEUROSCI, V31, P8699, DOI 10.1523/JNEUROSCI.0971-11.2011; Jacobs J, 2010, TRENDS COGN SCI, V14, P162, DOI 10.1016/j.tics.2010.01.005; Jacobs J, 2010, P NATL ACAD SCI USA, V107, P6487, DOI 10.1073/pnas.0911213107; Killian NJ, 2012, NATURE, V491, P761, DOI 10.1038/nature11587; Krupic J, 2012, SCIENCE, V337, P853, DOI 10.1126/science.1222403; McHugh TJ, 1996, CELL, V87, P1339, DOI 10.1016/S0092-8674(00)81828-0; MULLER RU, 1987, J NEUROSCI, V7, P1935; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; QUIRK GJ, 1990, J NEUROSCI, V10, P2008; Quiroga RQ, 2004, NEURAL COMPUT, V16, P1661, DOI 10.1162/089976604774201631; Rolls ET, 1999, HIPPOCAMPUS, V9, P467; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Terrazas A, 2005, J NEUROSCI, V25, P8085, DOI 10.1523/JNEUROSCI.0693-05.2005; Tsao A, 2013, CURR BIOL, V23, P399, DOI 10.1016/j.cub.2013.01.036; Ulanovsky N, 2007, NAT NEUROSCI, V10, P224, DOI 10.1038/nn1829; Yartsev MM, 2011, NATURE, V479, P103, DOI 10.1038/nature10583	22	264	272	1	88	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2013	16	9					1188	1190		10.1038/nn.3466	http://dx.doi.org/10.1038/nn.3466			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	207KN	23912946	Green Accepted			2022-12-17	WOS:000323597500009
J	Ziemann, AE; Schnizler, MK; Albert, GW; Severson, MA; Howard, MA; Welsh, MJ; Wemmie, JA				Ziemann, Adam E.; Schnizler, Mikael K.; Albert, Gregory W.; Severson, Meryl A.; Howard, Matthew A., III; Welsh, Michael J.; Wemmie, John A.			Seizure termination by acidosis depends on ASIC1a	NATURE NEUROSCIENCE			English	Article							SENSING ION CHANNELS; CENTRAL-NERVOUS-SYSTEM; SPREADING DEPRESSION; HIPPOCAMPAL SLICES; CARBON DIOXIDE; NEURONS; EPILEPSY; BRAIN; RAT; CONTRIBUTES	Most seizures stop spontaneously; however, the molecular mechanisms that terminate seizures remain unknown. Observations that seizures reduced brain pH and that acidosis inhibited seizures indicate that acidosis halts epileptic activity. Because acid-sensing ion channel 1a (ASIC1a) is exquisitely sensitive to extracellular pH and regulates neuron excitability, we hypothesized that acidosis might activate ASIC1a, which would terminate seizures. Disrupting mouse ASIC1a increased the severity of chemoconvulsant-induced seizures, whereas overexpressing ASIC1a had the opposite effect. ASIC1a did not affect seizure threshold or onset, but shortened seizure duration and prevented seizure progression. CO2 inhalation, long known to lower brain pH and inhibit seizures, required ASIC1a to interrupt tonic-clonic seizures. Acidosis activated inhibitory interneurons through ASIC1a, suggesting that ASIC1a might limit seizures by increasing inhibitory tone. Our results identify ASIC1a as an important element in seizure termination when brain pH falls and suggest both a molecular mechanism for how the brain stops seizures and new therapeutic strategies.	[Ziemann, Adam E.; Welsh, Michael J.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Med Sci Training Program, Iowa City, IA 52242 USA; [Ziemann, Adam E.; Welsh, Michael J.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Schnizler, Mikael K.; Welsh, Michael J.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; [Albert, Gregory W.; Severson, Meryl A.; Howard, Matthew A., III] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Neurosurg, Iowa City, IA 52242 USA; [Howard, Matthew A., III; Welsh, Michael J.; Wemmie, John A.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Neurosci Program, Iowa City, IA 52242 USA; [Welsh, Michael J.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Howard Hughes Med Inst, Iowa City, IA 52242 USA; [Wemmie, John A.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Psychiat, Iowa City, IA 52242 USA; [Wemmie, John A.] Dept Vet Affairs Med Ctr, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; Howard Hughes Medical Institute; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Welsh, MJ (corresponding author), Univ Iowa, Roy J & Lucille A Carver Coll Med, Med Sci Training Program, Iowa City, IA 52242 USA.	michael-welsh@uiowa.edu; john-wemmie@uiowa.edu		Welsh, Michael/0000-0002-1646-6206; Howard, Matthew/0000-0003-3935-8889; Wemmie, John/0000-0001-7531-9065	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS058309, T32NS045549] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [T32 GM007337] Funding Source: Medline; NIMH NIH HHS [R01 MH085724] Funding Source: Medline; NINDS NIH HHS [R21 NS058309, T32 NS045549, 1R21NS058309-01A1, T32NS045549, R21 NS058309-01A1, T32 NS045549-04] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSON WW, 1987, J NEUROPHYSIOL, V57, P1; Benson CJ, 2002, P NATL ACAD SCI USA, V99, P2338, DOI 10.1073/pnas.032678399; Bernard C, 2006, MODELS OF SEIZURES AND EPILEPSY, P59, DOI 10.1016/B978-012088554-1/50008-6; Bolshakov KV, 2002, NEUROSCIENCE, V110, P723, DOI 10.1016/S0306-4522(01)00582-6; Bragin A, 1997, J NEUROSCI, V17, P2567; Buckmaster PS, 2002, J NEUROPHYSIOL, V88, P783, DOI 10.1152/jn.2002.88.2.783; CHAPMAN AG, 1977, J NEUROCHEM, V28, P1025, DOI 10.1111/j.1471-4159.1977.tb10665.x; Cole TB, 2000, EPILEPSY RES, V39, P153, DOI 10.1016/S0920-1211(99)00121-7; Coryell MW, 2007, BIOL PSYCHIAT, V62, P1140, DOI 10.1016/j.biopsych.2007.05.008; de la Rosa DA, 2003, J PHYSIOL-LONDON, V546, P77, DOI 10.1113/jphysiol.2002.030692; Dubberke R, 1998, PFLUG ARCH EUR J PHY, V437, P79, DOI 10.1007/s004240050750; Dulla CG, 2005, NEURON, V48, P1011, DOI 10.1016/j.neuron.2005.11.009; Escoubas P, 2000, J BIOL CHEM, V275, P25116, DOI 10.1074/jbc.M003643200; FISHER RS, 1989, BRAIN RES REV, V14, P245, DOI 10.1016/0165-0173(89)90003-9; FREUND TF, 1989, NEUROSCIENCE, V28, P539, DOI 10.1016/0306-4522(89)90003-1; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Friese MA, 2007, NAT MED, V13, P1483, DOI 10.1038/nm1668; GarciaAnoveros J, 1997, P NATL ACAD SCI USA, V94, P1459, DOI 10.1073/pnas.94.4.1459; GRUOL DL, 1980, BRAIN RES, V183, P247, DOI 10.1016/0006-8993(80)90138-9; HAGLUND MM, 1990, J NEUROPHYSIOL, V63, P225, DOI 10.1152/jn.1990.63.2.225; Immke DC, 2001, NAT NEUROSCI, V4, P869, DOI 10.1038/nn0901-869; Kaila Kai, 1998, P309; KAY AR, 1986, J NEUROSCI METH, V16, P227, DOI 10.1016/0165-0270(86)90040-3; Kirchner A, 2006, EUR J NEUROSCI, V23, P1512, DOI 10.1111/j.1460-9568.2006.04665.x; KLOIBER O, 1993, NMR BIOMED, V6, P333, DOI 10.1002/nbm.1940060509; LENNOX WG, 1929, J CLIN INVEST, V4, P23; Lingueglia E, 1997, J BIOL CHEM, V272, P29778, DOI 10.1074/jbc.272.47.29778; Mares P, 2006, MODELS OF SEIZURES AND EPILEPSY, P153, DOI 10.1016/B978-012088554-1/50014-1; MEDUNA LJ, 1958, CARBON DIOXIDE THERA, P3; MITCHELL WG, 1956, SCIENCE, V123, P223, DOI 10.1126/science.123.3189.223; Noebels JL, 2003, ANNU REV NEUROSCI, V26, P599, DOI 10.1146/annurev.neuro.26.010302.081210; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Somjen George G., 1998, P373; SOMJEN GG, 1984, BRAIN RES, V311, P186, DOI 10.1016/0006-8993(84)91416-1; Spencer SS, 1996, EPILEPSIA, V37, P455, DOI 10.1111/j.1528-1157.1996.tb00591.x; TRAYNELIS SF, 1990, NATURE, V345, P347, DOI 10.1038/345347a0; TSCHIRGI RD, 1958, AM J PHYSIOL, V195, P7, DOI 10.1152/ajplegacy.1958.195.1.7; VELISEK L, 1994, EXP BRAIN RES, V101, P44, DOI 10.1007/BF00243215; Vukicevic M, 2004, AM J PHYSIOL-CELL PH, V287, pC682, DOI 10.1152/ajpcell.00127.2004; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; WANG RIH, 1955, J NEUROPHYSIOL, V18, P130, DOI 10.1152/jn.1955.18.2.130; Waxman SG, 2007, NAT NEUROSCI, V10, P405, DOI 10.1038/nn1857; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2004, P NATL ACAD SCI USA, V101, P3621, DOI 10.1073/pnas.0308753101; Wemmie JA, 2003, J NEUROSCI, V23, P5496; WOODBURY DM, 1956, AM J PHYSIOL, V184, P202, DOI 10.1152/ajplegacy.1955.184.1.202; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Yamada K, 2001, SCIENCE, V292, P1543, DOI 10.1126/science.1059829; Yermolaieva O, 2004, P NATL ACAD SCI USA, V101, P6752, DOI 10.1073/pnas.0308636100; Zha XM, 2006, P NATL ACAD SCI USA, V103, P16556, DOI 10.1073/pnas.0608018103	50	264	276	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2008	11	7					816	822		10.1038/nn.2132	http://dx.doi.org/10.1038/nn.2132			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	318KD	18536711	Green Accepted			2022-12-17	WOS:000257089400019
J	Johansen, JP; Fields, HL				Johansen, JP; Fields, HL			Glutamatergic activation of anterior cingulate cortex produces an aversive teaching signal	NATURE NEUROSCIENCE			English	Article							MEDIAL PREFRONTAL CORTEX; NOCICEPTIVE NEURONS; PAIN; RAT; RESPONSES; STIMULATION; AMYGDALA; BRAIN; PROJECTIONS; MODULATION	Noxious stimuli have motivational power and can support associative learning, but the neural circuitry mediating such avoidance learning is poorly understood. The anterior cingulate cortex (ACC) is implicated in the affective response to noxious stimuli and the motivational properties of conditioned stimuli that predict noxious stimulation. Using conditioned place aversion (CPA) in rats, we found that excitatory amino acid microinjection into the ACC during conditioning produces avoidance learning in the absence of a peripheral noxious stimulus. Furthermore, microinjection of an excitatory amino acid antagonist into the ACC during conditioning blocked learning elicited by a noxious stimulus. ACC lesions made after conditioning did not impair expression of CPA. Thus, ACC neuronal activity is necessary and sufficient for noxious stimuli to produce an aversive teaching signal. Our results support the idea that a shared ACC pathway mediates both pain-induced negative affect and a nociceptor-driven aversive teaching signal.	Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, WM Keck Fdn Ctr Integrat Neurosci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Fields, HL (corresponding author), Univ Calif San Francisco, Dept Neurol, 513 Parnassus Ave,S-784, San Francisco, CA 94143 USA.	hlf@itsa.ucsf.edu	Johansen, Joshua/N-8010-2015; Fields, Howard/ABG-9073-2020	Johansen, Joshua/0000-0003-4240-1550; 	NINDS NIH HHS [NS 21445] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS021445, P50NS021445] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALLEN GV, 1989, J COMP NEUROL, V286, P311, DOI 10.1002/cne.902860303; Barros DM, 2000, BEHAV BRAIN RES, V114, P183, DOI 10.1016/S0166-4328(00)00226-6; BERENDSE HW, 1991, NEUROSCIENCE, V42, P73, DOI 10.1016/0306-4522(91)90151-D; BUCHANAN SL, 1982, J COMP PHYSIOL PSYCH, V96, P755, DOI 10.1037/h0077925; Calejesan AA, 2000, EUR J PAIN, V4, P83, DOI 10.1053/eujp.1999.0158; Casey KL, 1999, P NATL ACAD SCI USA, V96, P7668, DOI 10.1073/pnas.96.14.7668; CASSELL MD, 1986, BRAIN RES BULL, V17, P321, DOI 10.1016/0361-9230(86)90237-6; CHRISTIE MJ, 1987, NEUROSCIENCE, V22, P425, DOI 10.1016/0306-4522(87)90345-9; CLIFFER KD, 1991, J NEUROSCI, V11, P852; Craig AD, 2003, ANNU REV NEUROSCI, V26, P1, DOI 10.1146/annurev.neuro.26.041002.131022; Donahue RR, 2001, BRAIN RES, V897, P131, DOI 10.1016/S0006-8993(01)02103-5; DUBUISSON D, 1977, PAIN, V4, P161, DOI 10.1016/0304-3959(77)90130-0; Fields H. L., 1999, PAIN S, P61; FOLTZ EL, 1962, J NEUROSURG, V19, P89, DOI 10.3171/jns.1962.19.2.0089; GABRIEL M, 1991, EXP BRAIN RES, V86, P585; GIGG J, 1992, CEREB CORTEX, V2, P477, DOI 10.1093/cercor/2.6.477; HARDY SGP, 1985, BRAIN RES, V339, P285; HARDY SGP, 1985, BRAIN RES, V339, P281; Hsu MM, 1997, NEUROREPORT, V8, P2701, DOI 10.1097/00001756-199708180-00013; Hurt R W, 1974, Clin Neurosurg, V21, P334; Hutchison WD, 1999, NAT NEUROSCI, V2, P403, DOI 10.1038/8065; Johansen JP, 2001, P NATL ACAD SCI USA, V98, P8077, DOI 10.1073/pnas.141218998; Kandel E.R., 2000, PRINCIPLES NEURAL SC; Koyama T, 1998, NEUROREPORT, V9, P2663, DOI 10.1097/00001756-199808030-00044; Kung JC, 2003, BRAIN RES, V970, P58, DOI 10.1016/S0006-8993(02)04276-2; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lee DE, 1999, BRAIN RES, V845, P117, DOI 10.1016/S0006-8993(99)01956-3; Manning BH, 1998, J NEUROSCI, V18, P9453; MAO JR, 1993, J NEUROSCI, V13, P2689, DOI 10.1523/JNEUROSCI.13-06-02689.1993; MORGAN MA, 1995, BEHAV NEUROSCI, V109, P681, DOI 10.1037/0735-7044.109.4.681; Nishijo H, 1997, NEUROSCI LETT, V227, P79, DOI 10.1016/S0304-3940(97)00310-8; Pastoriza LN, 1996, PAIN, V64, P11, DOI 10.1016/0304-3959(95)00070-4; PERETZ E, 1960, J COMP PHYSIOL PSYCH, V53, P540, DOI 10.1037/h0040297; PESCHANSKI M, 1985, J COMP NEUROL, V236, P29, DOI 10.1002/cne.902360104; Ploghaus A, 1999, SCIENCE, V284, P1979, DOI 10.1126/science.284.5422.1979; Price DD, 2000, SCIENCE, V288, P1769, DOI 10.1126/science.288.5472.1769; Puig S, 1996, PAIN, V64, P345, DOI 10.1016/0304-3959(95)00121-2; QUIRK GJ, 1995, NEURON, V15, P1029, DOI 10.1016/0896-6273(95)90092-6; Rainville P, 1997, SCIENCE, V277, P968, DOI 10.1126/science.277.5328.968; Reep RL, 1999, BRAIN RES, V841, P43, DOI 10.1016/S0006-8993(99)01779-5; Rosenkranz JA, 2002, NATURE, V417, P282, DOI 10.1038/417282a; SALAS PJ, 1997, J CELL BIOL, V21, P359; SIKES RW, 1992, J NEUROPHYSIOL, V68, P1720, DOI 10.1152/jn.1992.68.5.1720; Takenouchi K, 1999, NEUROSCIENCE, V93, P1271, DOI 10.1016/S0306-4522(99)00216-X; Treede RD, 1999, PAIN, V79, P105, DOI 10.1016/S0304-3959(98)00184-5; VACCARINO AL, 1989, PAIN, V39, P213, DOI 10.1016/0304-3959(89)90008-0; Vogt BA, 2000, PROG BRAIN RES, V122, P223; Wei F, 1999, J NEUROSCI, V19, P9346; Wei F, 2001, J PHYSIOL-LONDON, V532, P823, DOI 10.1111/j.1469-7793.2001.0823e.x; Yamamura H, 1996, BRAIN RES, V735, P83	50	264	274	0	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2004	7	4					398	403		10.1038/nn1207	http://dx.doi.org/10.1038/nn1207			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	807DP	15004562				2022-12-17	WOS:000220482500019
J	Constantinidis, C; Williams, GV; Goldman-Rakic, PS				Constantinidis, C; Williams, GV; Goldman-Rakic, PS			A role for inhibition in shaping the temporal flow of information in prefrontal cortex	NATURE NEUROSCIENCE			English	Article							WORKING-MEMORY; VISUAL-CORTEX; ORIENTATION SELECTIVITY; NEURONAL-ACTIVITY; NETWORK MODEL; DYNAMICS; MONKEY; SYNCHRONIZATION; CONNECTIVITY; ASSOCIATION	The prefrontal cortex is important in guiding or inhibiting future responses, which requires the temporal integration of events and which provides continuity to the thought process. No cellular mechanism has been proposed to explain how the mental representation of a response or idea is linked to the next. Using simultaneous recordings in monkeys, we revealed inhibitory interactions between neurons active at different time points relative to the cue presentation, delay interval and response period of a working memory task. These findings suggest an important role of inhibition in the cerebral cortex-controlling the timing of neuronal activities during cognitive operations and thereby shaping the temporal flow of information.	Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA	Yale University	Goldman-Rakic, PS (corresponding author), Yale Univ, Sch Med, Dept Neurobiol, POB 208001,333 Cedar St,SHM B404, New Haven, CT 06520 USA.	patricia.goldman-rakic@yale.edu	Constantinidis, Christos/ABB-5760-2021	Constantinidis, Christos/0000-0001-7441-022X	NIMH NIH HHS [MH38546] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH038546, R37MH038546] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AERTSEN AMHJ, 1989, J NEUROPHYSIOL, V61, P900, DOI 10.1152/jn.1989.61.5.900; Amit DJ, 1997, CEREB CORTEX, V7, P237, DOI 10.1093/cercor/7.3.237; Beierlein M, 2000, NAT NEUROSCI, V3, P904, DOI 10.1038/78809; BENYISHAI R, 1995, P NATL ACAD SCI USA, V92, P3844, DOI 10.1073/pnas.92.9.3844; Camperi M, 1998, J COMPUT NEUROSCI, V5, P383, DOI 10.1023/A:1008837311948; Changeux JP, 2000, INT J PSYCHOPHYSIOL, V35, P179, DOI 10.1016/S0167-8760(99)00052-5; Compte A, 2000, CEREB CORTEX, V10, P910, DOI 10.1093/cercor/10.9.910; Constantinidis C, 2001, NAT NEUROSCI, V4, P311, DOI 10.1038/85179; Constantinidis C, 2001, J NEUROSCI, V21, P3646, DOI 10.1523/JNEUROSCI.21-10-03646.2001; Dehaene S, 1997, P NATL ACAD SCI USA, V94, P13293, DOI 10.1073/pnas.94.24.13293; ELHANANY E, 1990, J COMP NEUROL, V291, P43, DOI 10.1002/cne.902910105; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; FETZ E, 1991, CEREB CORTEX, V9, P1; FUNAHASHI S, 1990, J NEUROPHYSIOL, V63, P814, DOI 10.1152/jn.1990.63.4.814; FUNAHASHI S, 1993, NATURE, V365, P753, DOI 10.1038/365753a0; FUNAHASHI S, 1991, J NEUROPHYSIOL, V65, P1464, DOI 10.1152/jn.1991.65.6.1464; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; Fuster JM, 2000, NATURE, V405, P347, DOI 10.1038/35012613; FUSTER JM, 1990, ANN NY ACAD SCI, V608, P318, DOI 10.1111/j.1749-6632.1990.tb48901.x; FUSTER JM, 1991, PROG BRAIN RES, V87, P201; FUSTER JM, 1985, HUM NEUROBIOL, V4, P169; Gao WJ, 2001, P NATL ACAD SCI USA, V98, P295, DOI 10.1073/pnas.011524298; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; GOLDMANRAKIC PS, 1988, ANNU REV NEUROSCI, V11, P137, DOI 10.1146/annurev.neuro.11.1.137; GUIGON E, 1995, CEREB CORTEX, V5, P135, DOI 10.1093/cercor/5.2.135; Krimer LS, 2001, J NEUROSCI, V21, P3788, DOI 10.1523/JNEUROSCI.21-11-03788.2001; Lisman JE, 1998, NAT NEUROSCI, V1, P273, DOI 10.1038/1086; McLaughlin D, 2000, P NATL ACAD SCI USA, V97, P8087, DOI 10.1073/pnas.110135097; Melchitzky DS, 1998, J COMP NEUROL, V390, P211, DOI 10.1002/(SICI)1096-9861(19980112)390:2<211::AID-CNE4>3.0.CO;2-4; Nowak LG, 1995, J NEUROPHYSIOL, V74, P2379, DOI 10.1152/jn.1995.74.6.2379; Oram MW, 2001, J NEUROPHYSIOL, V86, P1700, DOI 10.1152/jn.2001.86.4.1700; PERKEL DH, 1967, BIOPHYS J, V7, P419, DOI 10.1016/S0006-3495(67)86597-4; Rao SG, 2000, J NEUROSCI, V20, P485, DOI 10.1523/JNEUROSCI.20-01-00485.2000; Rao SG, 1999, J NEUROPHYSIOL, V81, P1903, DOI 10.1152/jn.1999.81.4.1903; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Riehle A, 1997, SCIENCE, V278, P1950, DOI 10.1126/science.278.5345.1950; SOMERS DC, 1995, J NEUROSCI, V15, P5448; Troyer TW, 1998, J NEUROSCI, V18, P5908; VAADIA E, 1995, NATURE, V373, P515, DOI 10.1038/373515a0; Wang Y, 2000, NAT NEUROSCI, V3, P807, DOI 10.1038/77712; WILSON FAW, 1993, SCIENCE, V260, P1955, DOI 10.1126/science.8316836	42	264	271	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2002	5	2					175	180		10.1038/nn799	http://dx.doi.org/10.1038/nn799			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	516NB	11802172				2022-12-17	WOS:000173558400021
J	Eban-Rothschild, A; Rothschild, G; Giardino, WJ; Jones, JR; de Lecea, L				Eban-Rothschild, Ada; Rothschild, Gideon; Giardino, William J.; Jones, Jeff R.; de Lecea, Luis			VTA dopaminergic neurons regulate ethologically relevant sleep-wake behaviors	NATURE NEUROSCIENCE			English	Article							VENTRAL TEGMENTAL AREA; FREELY MOVING CATS; NUCLEUS-ACCUMBENS; MESENCEPHALIC DOPAMINE; WAKING CYCLE; WAKEFULNESS; MICE; MODULATION; AROUSAL; IDENTIFICATION	Dopaminergic ventral tegmental area (VTA) neurons are critically involved in a variety of behaviors that rely on heightened arousal, but whether they directly and causally control the generation and maintenance of wakefulness is unknown. We recorded calcium activity using fiber photometry in freely behaving mice and found arousal-state-dependent alterations in VTA dopaminergic neurons. We used chemogenetic and optogenetic manipulations together with polysomnographic recordings to demonstrate that VTA dopaminergic neurons are necessary for arousal and that their inhibition suppresses wakefulness, even in the face of ethologically relevant salient stimuli. Nevertheless, before inducing sleep, inhibition of VTA dopaminergic neurons promoted goal-directed and sleep-related nesting behavior. Optogenetic stimulation, in contrast, initiated and maintained wakefulness and suppressed sleep and sleep-related nesting behavior. We further found that different projections of VTA dopaminergic neurons differentially modulate arousal. Collectively, our findings uncover a fundamental role for VTA dopaminergic circuitry in the maintenance of the awake state and ethologically relevant sleep-related behaviors.	[Eban-Rothschild, Ada; Giardino, William J.; Jones, Jeff R.; de Lecea, Luis] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Rothschild, Gideon] Univ Calif San Francisco, Dept Physiol, Box 0444, San Francisco, CA USA; [Rothschild, Gideon] Univ Calif San Francisco, Ctr Integrat Neurosci, San Francisco, CA 94143 USA	Stanford University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	de Lecea, L (corresponding author), Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA.	llecea@stanford.edu	Eban-Rothschild, Ada/Q-5440-2018; Core, Vector/CAF-4832-2022; de Lecea, Luis/ABE-4005-2021; Giardino, William/AAD-3030-2019	Eban-Rothschild, Ada/0000-0001-5816-1315; de Lecea, Luis/0000-0002-8921-5942; Giardino, William/0000-0001-7474-7914	National Institutes of Health (NIH) [RO1-MH087592, RO1-MH102638, RO1-AG04767]; Brain and Behavior Research Foundation (NARSAD) grant; US Israel Binational Science Foundation; Klarman Family Foundation; Edmond and Lily Safra Center of Brain Science (ELSC); NIH [F32 AA022832, NS069375]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH087592, R01MH102638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS069375] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [F32AA022832] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brain and Behavior Research Foundation (NARSAD) grant; US Israel Binational Science Foundation(US-Israel Binational Science Foundation); Klarman Family Foundation; Edmond and Lily Safra Center of Brain Science (ELSC); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank T. Davidson for assistance in the set-up of the fiber photometry rig, A. Whittle for assistance in core body temperature measurements and for feedback on the manuscript, A. Rolls and P. Bonnavion for early training in sleep-wake recording and viral manipulations and discussion and J. Garner for discussion. This work was supported by National Institutes of Health (NIH) grants RO1-MH087592, RO1-MH102638 and RO1-AG04767 (L.d.L.), a Brain and Behavior Research Foundation (NARSAD) grant (L.d.L.), the US Israel Binational Science Foundation and the Klarman Family Foundation (L.d.L.), Edmond and Lily Safra Center of Brain Science (ELSC) postdoctoral fellowships (A.E.-R.) and NIH F32 AA022832 (W.J.G.). We thank the Stanford Neuroscience Microscopy Service, supported by NIH NS069375.	Adamantidis AR, 2011, J NEUROSCI, V31, P10829, DOI 10.1523/JNEUROSCI.2246-11.2011; Alexander GM, 2009, NEURON, V63, P27, DOI 10.1016/j.neuron.2009.06.014; Anaclet C, 2014, NAT NEUROSCI, V17, P1217, DOI 10.1038/nn.3789; Andretic R, 2005, CURR BIOL, V15, P1165, DOI 10.1016/j.cub.2005.05.025; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Boutrel B, 2004, SLEEP, V27, P1181, DOI 10.1093/sleep/27.6.1181; Brown RE, 2012, PHYSIOL REV, V92, P1087, DOI 10.1152/physrev.00032.2011; Burgess CR, 2010, SLEEP, V33, P1295, DOI 10.1093/sleep/33.10.1295; Carter ME, 2010, NAT NEUROSCI, V13, P1526, DOI 10.1038/nn.2682; Chaudhury D, 2013, NATURE, V493, P532, DOI 10.1038/nature11713; Cousins DA, 2009, BIPOLAR DISORD, V11, P787, DOI 10.1111/j.1399-5618.2009.00760.x; Curie T, 2013, SLEEP, V36, P311, DOI 10.5665/sleep.2440; Dahan L, 2007, NEUROPSYCHOPHARMACOL, V32, P1232, DOI 10.1038/sj.npp.1301251; Danjo T, 2014, P NATL ACAD SCI USA, V111, P6455, DOI 10.1073/pnas.1404323111; Deacon RMJ, 2006, NAT PROTOC, V1, P1117, DOI 10.1038/nprot.2006.170; Dzirasa K, 2006, J NEUROSCI, V26, P10577, DOI 10.1523/JNEUROSCI.1767-06.2006; Espana RA, 2011, SLEEP, V34, P845, DOI 10.5665/SLEEP.1112; Gaskill BN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032799; Gunaydin LA, 2014, CELL, V157, P1535, DOI 10.1016/j.cell.2014.05.017; Hall ZJ, 2015, J NEUROENDOCRINOL, V27, P158, DOI 10.1111/jne.12250; HEDIGER H, 1969, P ROY SOC MED, V62, P153, DOI 10.1177/003591576906200213; Holst SC, 2014, J NEUROSCI, V34, P566, DOI 10.1523/JNEUROSCI.4128-13.2014; Jego S, 2013, NAT NEUROSCI, V16, P1637, DOI 10.1038/nn.3522; JONES BE, 1973, BRAIN RES, V58, P157, DOI 10.1016/0006-8993(73)90830-5; Kume K, 2005, J NEUROSCI, V25, P7377, DOI 10.1523/JNEUROSCI.2048-05.2005; Lazarus M, 2013, CURR OPIN NEUROBIOL, V23, P780, DOI 10.1016/j.conb.2013.02.001; Lena I, 2005, J NEUROSCI RES, V81, P891, DOI 10.1002/jnr.20602; Lerner TN, 2015, CELL, V162, P635, DOI 10.1016/j.cell.2015.07.014; Lu J, 2006, J NEUROSCI, V26, P193, DOI 10.1523/JNEUROSCI.2244-05.2006; MEDDIS R, 1975, ANIM BEHAV, V23, P676, DOI 10.1016/0003-3472(75)90144-X; MILLR JD, 1983, BRAIN RES, V273, P133, DOI 10.1016/0006-8993(83)91101-0; Monti JM, 2007, SLEEP MED REV, V11, P113, DOI 10.1016/j.smrv.2006.08.003; MORUZZI G, 1969, ARCH ITAL BIOL, V107, P175; Palchykova S, 2006, NEUROBIOL LEARN MEM, V85, P263, DOI 10.1016/j.nlm.2005.11.005; Parekh PK, 2015, ALCOHOL, V49, P341, DOI 10.1016/j.alcohol.2014.09.034; Pimentel D., 2016, NATURE; Qiu MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045471; Qu WM, 2008, J NEUROSCI, V28, P8462, DOI 10.1523/JNEUROSCI.1819-08.2008; Qu WM, 2010, J NEUROSCI, V30, P4382, DOI 10.1523/JNEUROSCI.4936-09.2010; Robbins TW, 2007, PSYCHOPHARMACOLOGY, V191, P433, DOI 10.1007/s00213-006-0528-7; Salamone JD, 1997, NEUROSCI BIOBEHAV R, V21, P341, DOI 10.1016/S0149-7634(96)00017-6; Salamone JD, 2012, NEURON, V76, P470, DOI 10.1016/j.neuron.2012.10.021; Saper CB, 2010, NEURON, V68, P1023, DOI 10.1016/j.neuron.2010.11.032; Schultz W, 2007, ANNU REV NEUROSCI, V30, P259, DOI 10.1146/annurev.neuro.28.061604.135722; STEINFELS GF, 1983, BRAIN RES, V258, P217, DOI 10.1016/0006-8993(83)91145-9; TRULSON ME, 1984, EXP NEUROL, V83, P367, DOI 10.1016/S0014-4886(84)90105-5; TRULSON ME, 1981, NEUROSCI LETT, V26, P183, DOI 10.1016/0304-3940(81)90346-3; Tye KM, 2013, NATURE, V493, P537, DOI 10.1038/nature11740; UNGERSTEDT U, 1971, ACTA PHYSIOL SCAND, P95; Winton-Brown TT, 2014, TRENDS NEUROSCI, V37, P85, DOI 10.1016/j.tins.2013.11.003; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Wisor JP, 2001, J NEUROSCI, V21, P1787, DOI 10.1523/JNEUROSCI.21-05-01787.2001; Wulff K, 2010, NAT REV NEUROSCI, V11, P589, DOI 10.1038/nrn2868; Zhang F., 2015, COLD SPRING HARB PRO; Zhou QY, 1995, CELL, V83, P1197, DOI 10.1016/0092-8674(95)90145-0	55	263	270	6	65	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2016	19	10					1356	+		10.1038/nn.4377	http://dx.doi.org/10.1038/nn.4377			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DX7ER	27595385	Green Accepted			2022-12-17	WOS:000384549900016
J	Moreno-Bote, R; Beck, J; Kanitscheider, I; Pitkow, X; Latham, P; Pouget, A				Moreno-Bote, Ruben; Beck, Jeffrey; Kanitscheider, Ingmar; Pitkow, Xaq; Latham, Peter; Pouget, Alexandre			Information-limiting correlations	NATURE NEUROSCIENCE			English	Article							PRIMARY VISUAL-CORTEX; NOISE CORRELATIONS; CODING EFFICIENCY; INTERNEURONAL CORRELATIONS; FISHER INFORMATION; POPULATION CODES; VARIABILITY; MACAQUE; NEURONS; ORIENTATION	Computational strategies used by the brain strongly depend on the amount of information that can be stored in population activity, which in turn strongly depends on the pattern of noise correlations. In vivo, noise correlations tend to be positive and proportional to the similarity in tuning properties. Such correlations are thought to limit information, which has led to the suggestion that decorrelation increases information. In contrast, we found, analytically and numerically, that decorrelation does not imply an increase in information. Instead, the only information-limiting correlations are what we refer to as differential correlations: correlations proportional to the product of the derivatives of the tuning curves. Unfortunately, differential correlations are likely to be very small and buried under correlations that do not limit information, making them particularly difficult to detect. We found, however, that the effect of differential correlations on information can be detected with relatively simple decoders.	[Moreno-Bote, Ruben] Parc Sanitari St Joan De Deu, Res Unit, Barcelona, Spain; [Moreno-Bote, Ruben] Univ Barcelona, Barcelona, Spain; [Moreno-Bote, Ruben] Ctr Invest Biomed Red Salud Mental CIBERSAM, Barcelona, Spain; [Beck, Jeffrey; Pitkow, Xaq; Pouget, Alexandre] Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA; [Kanitscheider, Ingmar; Pouget, Alexandre] Univ Geneva, Dept Basic Neurosci, Geneva, Switzerland; [Pitkow, Xaq] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Pitkow, Xaq] Rice Univ, Dept Elect & Comp Engn, Houston, TX 77251 USA; [Latham, Peter; Pouget, Alexandre] UCL, Gatsby Computat Neurosci Unit, London, England	University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Rochester; University of Geneva; Baylor College of Medicine; Rice University; University of London; University College London	Pouget, A (corresponding author), Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA.	alexandre.pouget@unige.ch	Kanitscheider, Ingmar/C-6213-2018	Kanitscheider, Ingmar/0000-0002-6144-9659; Moreno-Bote, Ruben/0000-0003-0398-014X; Pouget, Alexandre/0000-0003-3054-6365	Ramon y Cajal Spanish Award [RYC-2010-05952]; Marie Curie FP7-PEOPLE-IRG grant [PIRG08-GA-2010-276795]; US National Institutes of Health [T32DC009974]; Gatsby Charitable Foundation; Swiss National Science Foundation [31003A_143707]; Human Frontier Science Program; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC009974] Funding Source: NIH RePORTER	Ramon y Cajal Spanish Award; Marie Curie FP7-PEOPLE-IRG grant; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gatsby Charitable Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Human Frontier Science Program(Human Frontier Science Program); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	R.M.-B. was supported by the Ramon y Cajal Spanish Award RYC-2010-05952 and by the Marie Curie FP7-PEOPLE-2010-IRG grant PIRG08-GA-2010-276795. X.P. was supported in part by US National Institutes of Health grant T32DC009974. P.L. was supported by the Gatsby Charitable Foundation. A.P. was supported by a grant from the Swiss National Science Foundation (#31003A_143707), and a grant from the Human Frontier Science Program.	Abbott LF, 1999, NEURAL COMPUT, V11, P91, DOI 10.1162/089976699300016827; Adibi M, 2013, J NEUROSCI, V33, P2108, DOI 10.1523/JNEUROSCI.3449-12.2013; Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; Averbeck BB, 2003, J NEUROSCI, V23, P7630; Barlow H, 2001, NETWORK-COMP NEURAL, V12, P241, DOI 10.1088/0954-898X/12/3/301; Beck J, 2011, NEURAL COMPUT, V23, P1484, DOI 10.1162/NECO_a_00125; Beck JM, 2012, NEURON, V74, P30, DOI 10.1016/j.neuron.2012.03.016; Berens P, 2012, J NEUROSCI, V32, P10618, DOI 10.1523/JNEUROSCI.1335-12.2012; Berens P, 2011, P NATL ACAD SCI USA, V108, P4423, DOI 10.1073/pnas.1015904108; Churchland MM, 2007, J NEUROPHYSIOL, V97, P4235, DOI 10.1152/jn.00095.2007; Churchland MM, 2010, NAT NEUROSCI, V13, P369, DOI 10.1038/nn.2501; Cohen MR, 2009, NAT NEUROSCI, V12, P1594, DOI 10.1038/nn.2439; Ecker AS, 2014, NEURON, V82, P235, DOI 10.1016/j.neuron.2014.02.006; Ecker AS, 2011, J NEUROSCI, V31, P14272, DOI 10.1523/JNEUROSCI.2539-11.2011; Ecker AS, 2010, SCIENCE, V327, P584, DOI 10.1126/science.1179867; Gershon ED, 1998, J NEUROPHYSIOL, V79, P1135, DOI 10.1152/jn.1998.79.3.1135; Goris RLT, 2014, NAT NEUROSCI, V17, P858, DOI 10.1038/nn.3711; Graf ABA, 2011, NAT NEUROSCI, V14, P239, DOI 10.1038/nn.2733; Gu Y, 2011, NEURON, V71, P750, DOI 10.1016/j.neuron.2011.06.015; Huang X, 2009, J NEUROPHYSIOL, V101, P3012, DOI 10.1152/jn.00010.2009; Kohn A, 2005, J NEUROSCI, V25, P3661, DOI 10.1523/JNEUROSCI.5106-04.2005; Maimon G, 2009, NEURON, V62, P426, DOI 10.1016/j.neuron.2009.03.021; Maynard EM, 1999, J NEUROSCI, V19, P8083; Mitchell JF, 2009, NEURON, V63, P879, DOI 10.1016/j.neuron.2009.09.013; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; Papoulis A., 1991, COMMUNICATIONS SIGNA, V3; PARADISO MA, 1988, BIOL CYBERN, V58, P35, DOI 10.1007/BF00363954; Ponce-Alvarez A, 2013, P NATL ACAD SCI USA, V110, P13162, DOI 10.1073/pnas.1300098110; Qi XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041053; Renart A, 2010, SCIENCE, V327, P587, DOI 10.1126/science.1179850; Romo R, 2003, NEURON, V38, P649, DOI 10.1016/S0896-6273(03)00287-3; Series P, 2004, NAT NEUROSCI, V7, P1129, DOI 10.1038/nn1321; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Shamir M, 2006, NEURAL COMPUT, V18, P1951, DOI 10.1162/neco.2006.18.8.1951; Sompolinsky H, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.051904; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; Wimmer K, 2014, NAT NEUROSCI, V17, P431, DOI 10.1038/nn.3645; Yoon H, 1999, ADV NEUR IN, V11, P167; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	40	263	263	2	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2014	17	10					1410	1417		10.1038/nn.3807	http://dx.doi.org/10.1038/nn.3807			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AP8KD	25195105	Green Accepted			2022-12-17	WOS:000342327000022
J	Goris, RLT; Movshon, JA; Simoncelli, EP				Goris, Robbe L. T.; Movshon, J. Anthony; Simoncelli, Eero P.			Partitioning neuronal variability	NATURE NEUROSCIENCE			English	Article							PRIMARY VISUAL-CORTEX; NEURAL SPIKING ACTIVITY; CORTICAL-NEURONS; PSYCHOPHYSICAL PERFORMANCE; RESPONSE VARIABILITY; POPULATION; MECHANISMS; DISCHARGE; TRAINS; V1	Responses of sensory neurons differ across repeated measurements. This variability is usually treated as stochasticity arising within neurons or neural circuits. However, some portion of the variability arises from fluctuations in excitability due to factors that are not purely sensory, such as arousal, attention and adaptation. To isolate these fluctuations, we developed a model in which spikes are generated by a Poisson process whose rate is the product of a drive that is sensory in origin and a gain summarizing stimulus-independent modulatory influences on excitability. This model provides an accurate account of response distributions of visual neurons in macaque lateral geniculate nucleus and cortical areas V1, V2 and MT, revealing that variability originates in large part from excitability fluctuations that are correlated over time and between neurons, and that increase in strength along the visual pathway. The model provides a parsimonious explanation for observed systematic dependencies of response variability and covariability on firing rate.	[Goris, Robbe L. T.; Movshon, J. Anthony; Simoncelli, Eero P.] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Simoncelli, Eero P.] NYU, Howard Hughes Med Inst, New York, NY USA	New York University; Howard Hughes Medical Institute; New York University	Simoncelli, EP (corresponding author), NYU, Ctr Neural Sci, New York, NY 10003 USA.	eero.simoncelli@nyu.edu		Goris, Robbe/0000-0002-2218-3720; Simoncelli, Eero/0000-0002-1206-527X	US National Institutes of Health [EY04440, EY022428]; Howard Hughes Medical Institute; Fund for Scientific Research of Flanders; Belgian American Educational Foundation; NATIONAL EYE INSTITUTE [R01EY004440, R01EY022428, R37EY004440] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Fund for Scientific Research of Flanders(FWO); Belgian American Educational Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We are grateful to R. Kumbhani and N. Rabinowitz for discussions and to members of the Movshon laboratory for sharing their data. This work was supported by US National Institutes of Health grants EY04440, EY022428, the Howard Hughes Medical Institute and postdoctoral fellowships from the Fund for Scientific Research of Flanders and the Belgian American Educational Foundation awarded to R.L.T.G.	ALLEN C, 1994, P NATL ACAD SCI USA, V91, P10380, DOI 10.1073/pnas.91.22.10380; Amarasingham A, 2006, J NEUROSCI, V26, P801, DOI 10.1523/JNEUROSCI.2948-05.2006; Barbieri R, 2001, J NEUROSCI METH, V105, P25, DOI 10.1016/S0165-0270(00)00344-7; Benucci A, 2013, NAT NEUROSCI, V16, P724, DOI 10.1038/nn.3382; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Brody CD, 1999, NEURAL COMPUT, V11, P1537, DOI 10.1162/089976699300016133; Churchland AK, 2011, NEURON, V69, P818, DOI 10.1016/j.neuron.2010.12.037; Churchland MM, 2010, NAT NEUROSCI, V13, P369, DOI 10.1038/nn.2501; Cohen MR, 2011, NAT NEUROSCI, V14, P811, DOI 10.1038/nn.2842; Cohen MR, 2009, NAT NEUROSCI, V12, P1594, DOI 10.1038/nn.2439; de la Rocha J, 2007, NATURE, V448, P802, DOI 10.1038/nature06028; Dorn JD, 2003, J NEUROPHYSIOL, V89, P2271, DOI 10.1152/jn.000889.2002; Ecker AS, 2014, NEURON, V82, P235, DOI 10.1016/j.neuron.2014.02.006; Ecker AS, 2010, SCIENCE, V327, P584, DOI 10.1126/science.1179867; GEISLER WS, 1995, VISION RES, V35, P2723, DOI 10.1016/0042-6989(95)00029-Y; Gershon ED, 1998, J NEUROPHYSIOL, V79, P1135, DOI 10.1152/jn.1998.79.3.1135; Goris RLT, 2013, PSYCHOL REV, V120, P472, DOI 10.1037/a0033136; Graf ABA, 2011, NAT NEUROSCI, V14, P239, DOI 10.1038/nn.2733; GROSSMAN RG, 1961, SCIENCE, V134, P99, DOI 10.1126/science.134.3472.99; Gur M, 1997, J NEUROSCI, V17, P2914; Kara P, 2000, NEURON, V27, P635, DOI 10.1016/S0896-6273(00)00072-6; Kato HK, 2012, NEURON, V76, P962, DOI 10.1016/j.neuron.2012.09.037; KUFFLER SW, 1957, J GEN PHYSIOL, V40, P683, DOI 10.1085/jgp.40.5.683; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Oram MW, 1999, J NEUROPHYSIOL, V81, P3021, DOI 10.1152/jn.1999.81.6.3021; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; Pillow JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062123; Pillow JW., 2012, ADV NEURAL INFORM PR, V3, P1898, DOI [10.5555/2999325.2999347, DOI 10.5555/2999325.2999347]; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Sherman SM, 1998, P NATL ACAD SCI USA, V95, P7121, DOI 10.1073/pnas.95.12.7121; SIEBERT WM, 1970, PR INST ELECTR ELECT, V58, P723, DOI 10.1109/PROC.1970.7727; Smith MA, 2008, J NEUROSCI, V28, P12591, DOI 10.1523/JNEUROSCI.2929-08.2008; SOFTKY WR, 1993, J NEUROSCI, V13, P334; Stevens CF, 1996, ADV NEUR IN, V8, P103; TOLHURST DJ, 1981, EXP BRAIN RES, V41, P414; TOMKO GJ, 1974, BRAIN RES, V79, P405, DOI 10.1016/0006-8993(74)90438-7; Truccolo W, 2005, J NEUROPHYSIOL, V93, P1074, DOI 10.1152/jn.00697.2004; van den Berg R, 2012, P NATL ACAD SCI USA, V109, P8780, DOI 10.1073/pnas.1117465109; vanVreeswijk C, 1996, SCIENCE, V274, P1724, DOI 10.1126/science.274.5293.1724; Vidne M, 2012, J COMPUT NEUROSCI, V33, P97, DOI 10.1007/s10827-011-0376-2; Vogels TP, 2005, J NEUROSCI, V25, P10786, DOI 10.1523/JNEUROSCI.3508-05.2005; Wiener MC, 2003, J NEUROSCI, V23, P2394; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	44	263	265	0	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2014	17	6					858	865		10.1038/nn.3711	http://dx.doi.org/10.1038/nn.3711			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AI1TO	24777419	Green Accepted			2022-12-17	WOS:000336638000022
J	Matsumoto, T; Rauskolb, S; Polack, M; Klose, J; Kolbeck, R; Korte, M; Barde, YA				Matsumoto, Tomoya; Rauskolb, Stefanie; Polack, Martin; Klose, Johannes; Kolbeck, Roland; Korte, Martin; Barde, Yves-Alain			Biosynthesis and processing of endogenous BDNF: CNS neurons store and secrete BDNF, not pro-BDNF	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; NEUROTROPHIC FACTOR; BRAIN; P75(NTR); ACTIVATION; GENE; MICE	Pro- and mature BDNF activate very different receptors and intracellular pathways, potentially leading to either neuronal death or survival. Here we examined the biochemistry of endogenous BDNF in mouse neurons using sensitive reagents and found that pro-BDNF is rapidly converted intracellularly to mature BDNF, the latter being stored and released by excitatory input.	[Matsumoto, Tomoya; Rauskolb, Stefanie; Barde, Yves-Alain] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; [Polack, Martin; Korte, Martin] Tech Univ Carolo Wilhelmina Braunschweig, D-38106 Braunschweig, Germany; [Klose, Johannes; Kolbeck, Roland; Barde, Yves-Alain] Max Planck Inst Neurobiol, D-82152 Martinsried, Germany; [Kolbeck, Roland] Medimmune Inc, Gaithersburg, MD 20878 USA	University of Basel; Braunschweig University of Technology; Max Planck Society; AstraZeneca; Medimmune	Barde, YA (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.	yves.barde@unibas.ch	Barde, Yves/F-6019-2011	Barde, Yves/0000-0002-7627-461X; Rauskolb, Stefanie/0000-0002-8936-5414				BARDE YA, 1982, EMBO J, V1, P549, DOI 10.1002/j.1460-2075.1982.tb01207.x; Chen ZY, 2006, SCIENCE, V314, P140, DOI 10.1126/science.1129663; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Gray J, 2006, DIABETES, V55, P3366, DOI 10.2337/db06-0550; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Harrington AW, 2004, P NATL ACAD SCI USA, V101, P6226, DOI 10.1073/pnas.0305755101; Kolbeck R, 1999, J NEUROCHEM, V72, P1930, DOI 10.1046/j.1471-4159.1999.0721930.x; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; Mowla SJ, 2001, J BIOL CHEM, V276, P12660, DOI 10.1074/jbc.M008104200; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Rosch H, 2005, P NATL ACAD SCI USA, V102, P7362, DOI 10.1073/pnas.0502460102; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; Woo NH, 2005, NAT NEUROSCI, V8, P1069, DOI 10.1038/nn1510; Zagrebelsky M, 2005, J NEUROSCI, V25, P9989, DOI 10.1523/JNEUROSCI.2492-05.2005	15	263	272	1	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2008	11	2					131	133		10.1038/nn2038	http://dx.doi.org/10.1038/nn2038			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	256FC	18204444				2022-12-17	WOS:000252712100006
J	Yoshimura, Y; Callaway, EM				Yoshimura, Y; Callaway, EM			Fine-scale specificity of cortical networks depends on inhibitory cell type and connectivity	NATURE NEUROSCIENCE			English	Article							PRIMARY VISUAL-CORTEX; INTRINSIC FIRING PATTERNS; RAT FRONTAL-CORTEX; PYRAMIDAL CELLS; LOCAL CIRCUITS; MACAQUE MONKEY; BARREL CORTEX; NEURONS; INTERNEURONS; NEOCORTEX	Excitatory cortical neurons form fine-scale networks of precisely interconnected neurons. Here we tested whether inhibitory cortical neurons in rat visual cortex might also be connected with fine-scale specificity. Using paired intracellular recordings and cross-correlation analyses of photostimulation-evoked synaptic currents, we found that fast-spiking interneurons preferentially connected to neighboring pyramids that provided them with reciprocal excitation. Furthermore, they shared common fine-scale excitatory input with neighboring pyramidal neurons only when the two cells were reciprocally connected, and not when there was no connection or a one-way, inhibitory-to-excitatory connection. Adapting inhibitory neurons shared little or no common input with neighboring pyramids, regardless of their direct connectivity. We conclude that inhibitory connections and also excitatory connections to inhibitory neurons can both be precise on a fine scale. Furthermore, fine-scale specificity depends on the type of inhibitory neuron and on direct connectivity between neighboring pyramidal-inhibitory neuron pairs.	Salk Inst Biol Studies, Syst Neurobiol Labs, La Jolla, CA 92037 USA; Nagoya Univ, Environm Med Res Inst, Dept Visual Neurosci, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Salk Institute; Nagoya University	Callaway, EM (corresponding author), Salk Inst Biol Studies, Syst Neurobiol Labs, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	callaway@salk.edu	Callaway, Edward/D-4336-2011	Callaway, Edward/0000-0002-6366-5267; Yoshimura, Yumiko/0000-0002-7526-4153	NEI NIH HHS [EY010742] Funding Source: Medline; NIMH NIH HHS [MH063912, R01 MH063912] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY010742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063912] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AERTSEN AMHJ, 1989, J NEUROPHYSIOL, V61, P900, DOI 10.1152/jn.1989.61.5.900; AGMON A, 1992, J NEUROSCI, V12, P319; Blatow M, 2005, J PHYSIOL-LONDON, V562, P99, DOI 10.1113/jphysiol.2004.078584; Briggs F, 2001, J NEUROSCI, V21, P3600, DOI 10.1523/JNEUROSCI.21-10-03600.2001; Callaway EM, 1998, ANNU REV NEUROSCI, V21, P47, DOI 10.1146/annurev.neuro.21.1.47; CONNORS BW, 1990, TRENDS NEUROSCI, V13, P99, DOI 10.1016/0166-2236(90)90185-D; Dantzker JL, 2000, NAT NEUROSCI, V3, P701, DOI 10.1038/76656; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; Dragoi V, 2000, J NEUROPHYSIOL, V83, P1019, DOI 10.1152/jn.2000.83.2.1019; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Fitzpatrick D, 1996, CEREB CORTEX, V6, P329, DOI 10.1093/cercor/6.3.329; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; GILBERT CD, 1989, J NEUROSCI, V9, P2432; GILBERT CD, 1983, ANNU REV NEUROSCI, V6, P217, DOI 10.1146/annurev.ne.06.030183.001245; Gonchar Y, 2003, J NEUROSCI, V23, P10904; Gonchar Y, 1999, CEREB CORTEX, V9, P683, DOI 10.1093/cercor/9.7.683; Holmgren C, 2003, J PHYSIOL-LONDON, V551, P139, DOI 10.1113/jphysiol.2003.044784; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KAWAGUCHI Y, 1993, J NEUROPHYSIOL, V69, P416, DOI 10.1152/jn.1993.69.2.416; Kawaguchi Y, 2002, J NEUROCYTOL, V31, P277, DOI 10.1023/A:1024126110356; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Lauritzen TZ, 2003, J NEUROSCI, V23, P10201; LUND JS, 1988, ANNU REV NEUROSCI, V11, P253, DOI 10.1146/annurev.neuro.11.1.253; Martin K. A. C., 1984, CEREB CORTEX, V2, P241; Martin KAC, 2002, CURR OPIN NEUROBIOL, V12, P418, DOI 10.1016/S0959-4388(02)00343-4; Meskenaite V, 1997, J COMP NEUROL, V379, P113; Mooser F, 2004, NAT NEUROSCI, V7, P872, DOI 10.1038/nn1287; Sawatari A, 2000, NEURON, V25, P459, DOI 10.1016/S0896-6273(00)80908-3; Schubert D, 2001, J NEUROSCI, V21, P3580, DOI 10.1523/JNEUROSCI.21-10-03580.2001; Schubert D, 2003, J NEUROSCI, V23, P2961; SHEPHERD GM, 2005, NAT NEUROSCI; Somogyi P, 2005, J PHYSIOL-LONDON, V562, P9, DOI 10.1113/jphysiol.2004.078915; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Staiger JF, 2002, EUR J NEUROSCI, V16, P11, DOI 10.1046/j.1460-9568.2002.02048.x; Swadlow HA, 2003, CEREB CORTEX, V13, P25, DOI 10.1093/cercor/13.1.25; Tamas G, 2000, NAT NEUROSCI, V3, P366, DOI 10.1038/73936; Yabuta NH, 2001, SCIENCE, V292, P297, DOI 10.1126/science.1057916; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252	40	263	265	0	15	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2005	8	11					1552	1559		10.1038/nn1565	http://dx.doi.org/10.1038/nn1565			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	979TB	16222228				2022-12-17	WOS:000232966600030
J	Goel, V; Dolan, RJ				Goel, V; Dolan, RJ			The functional anatomy of humor: segregating cognitive and affective components	NATURE NEUROSCIENCE			English	Article							BRAIN-DAMAGED PATIENTS; ORBITOFRONTAL CORTEX; LEXICAL AMBIGUITY; RIGHT-HEMISPHERE; APPRECIATION; ARTICULATION; RESOLUTION; REWARD		Inst Neurol, Wellcome Dept Cognit Neurol, London WC1N 3BG, England; York Univ, Dept Psychol, N York, ON M3J 1P3, Canada; Royal Free Hosp, Sch Med, London NW3, England	University of London; University College London; York University - Canada; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Goel, V (corresponding author), Inst Neurol, Wellcome Dept Cognit Neurol, Queen Sq, London WC1N 3BG, England.			Dolan, Ray/0000-0001-9356-761X				Anderson SW, 1999, NAT NEUROSCI, V2, P1032, DOI 10.1038/14833; BROWNELL HH, 1984, BRAIN LANG, V22, P253, DOI 10.1016/0093-934X(84)90093-2; BROWNELL HH, 1990, NEUROPSYCHOLOGIA, V28, P375, DOI 10.1016/0028-3932(90)90063-T; Coney J, 2000, NEUROPSYCHOLOGIA, V38, P272, DOI 10.1016/S0028-3932(99)00076-7; Dronkers NF, 1996, NATURE, V384, P159, DOI 10.1038/384159a0; Faust M, 1998, NEUROPSYCHOLOGIA, V36, P827, DOI 10.1016/S0028-3932(98)00042-6; Federmeier KD, 1999, COGNITIVE BRAIN RES, V8, P373, DOI 10.1016/S0926-6410(99)00036-1; Friston K.J., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; GARDNER H, 1975, BRAIN, V98, P399, DOI 10.1093/brain/98.3.399; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; Schultz W, 2000, CEREB CORTEX, V10, P272, DOI 10.1093/cercor/10.3.272; Shammi P, 1999, BRAIN, V122, P657, DOI 10.1093/brain/122.4.657; St George M, 1999, BRAIN, V122, P1317, DOI 10.1093/brain/122.7.1317; WAPNER W, 1981, BRAIN LANG, V14, P15, DOI 10.1016/0093-934X(81)90061-4; Wise RJS, 1999, LANCET, V353, P1057, DOI 10.1016/S0140-6736(98)07491-1	15	263	270	3	47	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2001	4	3					237	238		10.1038/85076	http://dx.doi.org/10.1038/85076			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UE	11224538	Green Published			2022-12-17	WOS:000167178300009
J	Krimer, LS; Muly, EC; Williams, GV; Goldman-Rakic, PS				Krimer, LS; Muly, EC; Williams, GV; Goldman-Rakic, PS			Dopaminergic regulation of cerebral cortical microcirculation	NATURE NEUROSCIENCE			English	Article							BLOOD-FLOW; PREFRONTAL CORTEX; VASOMOTOR RESPONSES; BETA-HYDROXYLASE; NEURONS PROJECT; BASAL FOREBRAIN; BRAIN-SLICES; NITRIC-OXIDE; RAT-BRAIN; MICROVESSELS	Functional variations in cerebral cortical activity are accompanied by local changes in blood flow, but the mechanisms underlying this physiological coupling are not well understood. Here we report that dopamine, a neurotransmitter normally associated with neuromodulatory actions, may directly affect local cortical blood flow. Using light and electron-microscopic immunocytochemistry, we show that dopaminergic axons innervate the intraparenchymal microvessels. We also provide evidence in an in vitro slice preparation that dopamine produces vasomotor responses in the cortical vasculature. These anatomical and physiological observations reveal a previously unknown source of regulation of the microvasculature by dopamine. The findings may be relevant to the mechanisms underlying changes in blood flow observed in circulatory and neuropsychiatric disorders.	Yale Univ, Sch Med, Neurobiol Sect, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06510 USA	Yale University; Yale University	Goldman-Rakic, PS (corresponding author), Yale Univ, Sch Med, Neurobiol Sect, 333 Cedar St, New Haven, CT 06510 USA.	patricia.goldman-rakic@yale.edu			NIMH NIH HHS [MH44866] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH044866] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		CEPEDA C, 1992, SYNAPSE, V11, P330, DOI 10.1002/syn.890110408; Cohen Z, 1997, J CEREBR BLOOD F MET, V17, P894, DOI 10.1097/00004647-199708000-00008; COHEN Z, 1995, NEUROSCIENCE, V66, P555, DOI 10.1016/0306-4522(94)00625-F; COX SB, 1993, J CEREBR BLOOD F MET, V13, P899, DOI 10.1038/jcbfm.1993.113; DACEY RG, 1988, J CEREBR BLOOD F MET, V8, P254, DOI 10.1038/jcbfm.1988.56; EDVINSSON L, 1985, BRIT J PHARMACOL, V85, P403, DOI 10.1111/j.1476-5381.1985.tb08875.x; Farber NE, 1997, ANESTHESIOLOGY, V87, P1191, DOI 10.1097/00000542-199711000-00024; FAVARD C, 1990, BRAIN RES, V523, P127, DOI 10.1016/0006-8993(90)91645-W; GEIJOBARRIENTOS E, 1995, EUR J NEUROSCI, V7, P358, DOI 10.1111/j.1460-9568.1995.tb00331.x; GOLDBERG LI, 1984, AM J MED, V77, P37, DOI 10.1016/S0002-9343(84)80036-4; GOLDMANRAKIC PS, 1992, J NEURAL TRANSM-GEN, P163; HAEFLIGER IO, 1994, INVEST OPHTH VIS SCI, V35, P991; HARTMAN BK, 1972, P NATL ACAD SCI USA, V69, P2722, DOI 10.1073/pnas.69.9.2722; IADECOLA C, 1993, TRENDS NEUROSCI, V16, P206, DOI 10.1016/0166-2236(93)90156-G; LOU HC, 1987, ANN NEUROL, V22, P289, DOI 10.1002/ana.410220302; MACKENZIE ET, 1987, CRC CR REV CL NEUROB, V2, P357; Magistretti PJ, 1997, NEUROSCIENTIST, V3, P361, DOI 10.1177/107385849700300608; MORRISON JH, 1982, BRAIN RES BULL, V9, P309, DOI 10.1016/0361-9230(82)90144-7; RAICHLE ME, 1975, P NATL ACAD SCI USA, V72, P3726, DOI 10.1073/pnas.72.9.3726; REINHARD JF, 1979, SCIENCE, V206, P85, DOI 10.1126/science.482930; SAGHER O, 1993, J CEREBR BLOOD F MET, V13, P676, DOI 10.1038/jcbfm.1993.86; SATO A, 1992, NEUROSCI RES, V14, P242, DOI 10.1016/0168-0102(92)90071-J; SHEPRO D, 1993, FASEB J, V7, P1031, DOI 10.1096/fasebj.7.11.8370472; VAUCHER E, 1995, J NEUROSCI, V15, P7427; WAHL M, 1993, ACTA NEUROCHIR, P3; WEILFUGAZZA J, 1993, NEUROCHEM RES, V18, P965, DOI 10.1007/BF00966754; WEINBERGER DR, 1988, ARCH GEN PSYCHIAT, V45, P609; WILLIAMS GV, 1995, NATURE, V376, P572, DOI 10.1038/376572a0; WILLIAMS SM, 1993, CEREB CORTEX, V3, P199, DOI 10.1093/cercor/3.3.199	29	263	267	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	1998	1	4					286	289		10.1038/1099	http://dx.doi.org/10.1038/1099			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QD	10195161				2022-12-17	WOS:000076361300011
J	Kisler, K; Nelson, AR; Rege, SV; Ramanathan, A; Wang, YM; Ahuja, A; Lazic, D; Tsai, PS; Zhao, Z; Zhou, Y; Boas, DA; Sakadzic, S; Zlokovic, BV				Kisler, Kassandra; Nelson, Amy R.; Rege, Sanket V.; Ramanathan, Anita; Wang, Yaoming; Ahuja, Ashim; Lazic, Divna; Tsai, Philbert S.; Zhao, Zhen; Zhou, Yi; Boas, David A.; Sakadzic, Sava; Zlokovic, Berislav V.			Pericyte degeneration leads to neurovascular uncoupling and limits oxygen supply to brain	NATURE NEUROSCIENCE			English	Article							CEREBRAL-BLOOD-FLOW; PDGF BETA-RECEPTOR; CAPILLARY PERICYTES; ALZHEIMERS-DISEASE; BARRIER BREAKDOWN; DYSFUNCTION; HEALTH; CONTRACTION	Pericytes are perivascular mural cells of brain capillaries. They are positioned centrally in the neurovascular unit between endothelial cells, astrocytes and neurons. This position allows them to regulate key neurovascular functions of the brain. The role of pericytes in the regulation of cerebral blood flow (CBF) and neurovascular coupling remains, however, under debate. Using loss-of-function pericyte-deficient mice, here we show that pericyte degeneration diminishes global and individual capillary CBF responses to neuronal stimuli, resulting in neurovascular uncoupling, reduced oxygen supply to the brain and metabolic stress. Neurovascular deficits lead over time to impaired neuronal excitability and neurodegenerative changes. Thus, pericyte degeneration as seen in neurological disorders such as Alzheimer's disease may contribute to neurovascular dysfunction and neurodegeneration associated with human disease.	[Kisler, Kassandra; Nelson, Amy R.; Rege, Sanket V.; Ramanathan, Anita; Wang, Yaoming; Ahuja, Ashim; Lazic, Divna; Zhao, Zhen; Zlokovic, Berislav V.] Univ Southern Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA 90033 USA; [Kisler, Kassandra; Nelson, Amy R.; Rege, Sanket V.; Ramanathan, Anita; Wang, Yaoming; Ahuja, Ashim; Lazic, Divna; Zhao, Zhen; Zlokovic, Berislav V.] Univ Southern Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA; [Lazic, Divna] Univ Belgrade, Inst Biol Res, Dept Neurobiol, Belgrade, Serbia; [Tsai, Philbert S.] Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; [Zhou, Yi] Third Mil Med Univ, Chongqing Key Lab Neurobiol, Dept Neurobiol, Chongqing, Peoples R China; [Boas, David A.; Sakadzic, Sava] Massachusetts Gen Hosp, Dept Radiol, Athinoula A Martinos Ctr Biomed Imaging, Opt Div, Charlestown, MA USA; [Boas, David A.; Sakadzic, Sava] Harvard Med Sch, Charlestown, MA USA	University of Southern California; University of Southern California; University of Belgrade; University of California System; University of California San Diego; Army Medical University; Harvard University; Massachusetts General Hospital	Zlokovic, BV (corresponding author), Univ Southern Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA 90033 USA.; Zlokovic, BV (corresponding author), Univ Southern Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA.	zlokovic@usc.edu	Nelson, Amy R./HCH-3772-2022; zhao, zhen/A-2080-2012; Zhou, Yi/B-3854-2012	Nelson, Amy R./0000-0003-2025-1408; zhao, zhen/0000-0001-8967-5570; Kisler, Kassandra/0000-0002-4161-2498; Zhou, Yi/0000-0002-2623-8960	National Institutes of Health [R01 AG023084, R01 AG039452, R01 NS034467, R01 NS100459, R01 NS091230, R01 EB000790, R24 NS092986, P01 NS055104]; National Natural Science Foundation of China [31371116]; American Heart Association [SDG7600037]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH111359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS091230, R24NS092986, R01NS100459, R01NS034467, P01NS055104] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005142, R01AG023084, R01AG039452, RF1AG039452, P01AG052350] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We would like to thank R. Angus for statistical discussions. This research was supported by National Institutes of Health grants R01 AG023084, R01 AG039452, R01 NS034467 and R01 NS100459 to B.V.Z.; R01 NS091230 to S.S.; and R01 EB000790, R24 NS092986 and P01 NS055104 to D.A.B.; National Natural Science Foundation of China grant 31371116 to Y.Z.; and American Heart Association grant SDG7600037 to S.S.	Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Attwell D, 2016, J CEREBR BLOOD F MET, V36, P451, DOI 10.1177/0271678X15610340; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Baloyannis SJ, 2012, J NEUROL SCI, V322, P117, DOI 10.1016/j.jns.2012.07.010; Baraghis E, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3633339; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Blinder P, 2013, NAT NEUROSCI, V16, P889, DOI 10.1038/nn.3426; Chow N, 2007, P NATL ACAD SCI USA, V104, P823, DOI 10.1073/pnas.0608251104; Dai M, 2009, HEARING RES, V254, P100, DOI 10.1016/j.heares.2009.04.018; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Dromparis P, 2013, ANNU REV PHYSIOL, V75, P95, DOI 10.1146/annurev-physiol-030212-183804; Farkas E, 2001, PROG NEUROBIOL, V64, P575, DOI 10.1016/S0301-0082(00)00068-X; Barros LF, 2013, TRENDS NEUROSCI, V36, P396, DOI 10.1016/j.tins.2013.04.002; Fernandez-Klett F, 2010, P NATL ACAD SCI USA, V107, P22290, DOI 10.1073/pnas.1011321108; Hall CN, 2014, NATURE, V508, P55, DOI 10.1038/nature13165; Halliday MR, 2016, J CEREBR BLOOD F MET, V36, P216, DOI 10.1038/jcbfm.2015.44; Hartmann DA, 2015, NEUROPHOTONICS, V2, DOI 10.1117/1.NPh.2.4.041402; Hill RA, 2015, NEURON, V87, P95, DOI 10.1016/j.neuron.2015.06.001; Hillman EMC, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2789693; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Iadecola C, 1999, NAT NEUROSCI, V2, P157, DOI 10.1038/5715; Iadecola C, 2007, NAT NEUROSCI, V10, P1369, DOI 10.1038/nn2003; Iadecola C, 2013, NEURON, V80, P844, DOI 10.1016/j.neuron.2013.10.008; Ishii Y, 2008, MOL CELL NEUROSCI, V37, P507, DOI 10.1016/j.mcn.2007.11.006; Kasischke KA, 2011, J CEREBR BLOOD F MET, V31, P68, DOI 10.1038/jcbfm.2010.158; Kawamura H, 2004, J PHYSIOL-LONDON, V561, P671, DOI 10.1113/jphysiol.2004.073098; Kim TN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038590; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; MacVicar BA, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020388; Mishra A, 2016, NAT NEUROSCI, V19, P1619, DOI 10.1038/nn.4428; Montagne A, 2016, ACTA NEUROPATHOL, V131, P687, DOI 10.1007/s00401-016-1570-0; Montagne A, 2015, NEURON, V85, P296, DOI 10.1016/j.neuron.2014.12.032; Oishi K, 2007, MICROVASC RES, V73, P20, DOI 10.1016/j.mvr.2006.08.004; Peppiatt CM, 2006, NATURE, V443, P700, DOI 10.1038/nature05193; Rouget C, 1873, ARCH PHYSIOL NORM P, V5, P603; Sakadzic S, 2010, NAT METHODS, V7, P755, DOI 10.1038/nmeth.1490; Sengillo JD, 2013, BRAIN PATHOL, V23, P303, DOI 10.1111/bpa.12004; Sirotin YB, 2009, P NATL ACAD SCI USA, V106, P18390, DOI 10.1073/pnas.0905509106; Sweeney MD, 2016, NAT NEUROSCI, V19, P771, DOI 10.1038/nn.4288; Winkler EA, 2014, BRAIN PATHOL, V24, P371, DOI 10.1111/bpa.12152; Winkler EA, 2013, ACTA NEUROPATHOL, V125, P111, DOI 10.1007/s00401-012-1039-8; Winkler EA, 2011, NAT NEUROSCI, V14, P1398, DOI 10.1038/nn.2946; Winkler EA, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-32; Wu ZH, 2005, NAT MED, V11, P959, DOI 10.1038/nm1287; Yamanishi S, 2006, AM J PHYSIOL-HEART C, V290, pH925, DOI 10.1152/ajpheart.01012.2005; Yemisci M, 2009, NAT MED, V15, P1031, DOI 10.1038/nm.2022; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114	48	262	268	9	107	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2017	20	3					406	416		10.1038/nn.4489	http://dx.doi.org/10.1038/nn.4489			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EL9DU	28135240	Green Accepted			2022-12-17	WOS:000394920400018
J	Cheng, LP; Arata, A; Mizuguchi, R; Qian, Y; Karunaratne, A; Gray, PA; Arata, S; Shirasawa, S; Bouchard, M; Luo, P; Chen, CL; Busslinger, M; Goulding, M; Onimaru, H; Ma, QF				Cheng, LP; Arata, A; Mizuguchi, R; Qian, Y; Karunaratne, A; Gray, PA; Arata, S; Shirasawa, S; Bouchard, M; Luo, P; Chen, CL; Busslinger, M; Goulding, M; Onimaru, H; Ma, QF			Tlx3 and Tlx1 are post-mitotic selector genes determining glutamatergic over GABAergic cell fates	NATURE NEUROSCIENCE			English	Article							DORSAL SPINAL-CORD; RESPIRATORY RHYTHM GENERATION; PRESYNAPTIC REGULATION; DEVELOPMENTAL SWITCH; SENSORY NEURONS; HOMEOBOX GENES; RAT; EXPRESSION; BRAIN; INTERNEURONS	Glutamatergic and GABAergic neurons mediate much of the excitatory and inhibitory neurotransmission, respectively, in the vertebrate nervous system. The process by which developing neurons select between these two cell fates is poorly understood. Here we show that the homeobox genes Tlx3 and Tlx1 determine excitatory over inhibitory cell fates in the mouse dorsal spinal cord. First, we found that Tlx3 was required for specification of, and expressed in, glutamatergic neurons. Both generic and region-specific glutamatergic markers, including VGLUT2 and the AMPA receptor Gria2, were absent in Tlx mutant dorsal horn. Second, spinal GABAergic markers were derepressed in Tlx mutants, including Pax2 that is necessary for GABAergic differentiation, Gad1/2 and Viaat that regulate GABA synthesis and transport, and the kainate receptors Grik2/3. Third, ectopic expression of Tlx3 was sufficient to suppress GABAergic differentiation and induce formation of glutamatergic neurons. Finally, excess GABA-mediated inhibition caused dysfunction of central respiratory circuits in Tlx3 mutant mice.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; RIKEN, Brain Sci Inst, Lab Memory & Learning, Wako, Saitama 3510198, Japan; Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA; Showa Univ, Ctr Biotechnol, Tokyo 1428555, Japan; Int Med Ctr Japan, Dept Pathol, Shinjuku Ku, Tokyo 1628655, Japan; Res Inst Mol Pathol, A-1030 Vienna, Austria; Showa Univ, Sch Med, Dept Physiol, Tokyo 1428555, Japan	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; RIKEN; Salk Institute; Showa University; National Center for Global Health & Medicine - Japan; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Showa University	Ma, QF (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, 1 Jimmy Fund Way, Boston, MA 02115 USA.	Qiufu_Ma@dfci.harvard.edu	Karunaratne, Asanka/B-5808-2008; Busslinger, Meinrad J./J-1249-2016	Busslinger, Meinrad J./0000-0002-9111-9351; Arata, Akiko/0000-0001-7418-8294; Bouchard, Maxime/0000-0002-7619-9680				Anderson SA, 2002, CEREB CORTEX, V12, P702, DOI 10.1093/cercor/12.7.702; Azkue JJ, 1998, BRAIN RES, V790, P74, DOI 10.1016/S0006-8993(98)00050-X; Bellocchio EE, 2000, SCIENCE, V289, P957, DOI 10.1126/science.289.5481.957; Bennett MR, 1999, NEUROCHEM INT, V35, P269, DOI 10.1016/S0197-0186(99)00068-6; BIRREN SJ, 1993, DEVELOPMENT, V119, P597; Blessing WW, 1997, LOWER BRAINSTEM BODY; Bouchard M, 2000, DEVELOPMENT, V127, P3703; Caspary T, 2003, NAT REV NEUROSCI, V4, P289, DOI 10.1038/nrn1073; Chen ZF, 2001, NEURON, V31, P59, DOI 10.1016/S0896-6273(01)00341-5; Dickenson AH, 2002, BRIT J ANAESTH, V88, P755, DOI 10.1093/bja/88.6.755; ERLANDER MG, 1991, NEURON, V7, P91, DOI 10.1016/0896-6273(91)90077-D; Feldman JL, 2003, ANNU REV NEUROSCI, V26, P239, DOI 10.1146/annurev.neuro.26.041002.131103; Fode C, 2000, GENE DEV, V14, P67; Fremeau RT, 2001, NEURON, V31, P247, DOI 10.1016/S0896-6273(01)00344-0; GARCIABELLIDO A, 1975, CIBA F SYMP, P161, DOI DOI 10.1002/9780470720110.CH8; Goulding M, 2002, CURR OPIN NEUROBIOL, V12, P508, DOI 10.1016/S0959-4388(02)00371-9; Gross MK, 2002, NEURON, V34, P535, DOI 10.1016/S0896-6273(02)00690-6; Helms AW, 2003, CURR OPIN NEUROBIOL, V13, P42, DOI 10.1016/S0959-4388(03)00010-2; Kaneko T, 2002, NEUROSCI RES, V42, P243, DOI 10.1016/S0168-0102(02)00009-3; Kerchner GA, 2002, J NEUROSCI, V22, P8010; Kerchner GA, 2001, NEURON, V32, P477, DOI 10.1016/S0896-6273(01)00479-2; Kullander K, 2003, SCIENCE, V299, P1889, DOI 10.1126/science.1079641; LANDIS SC, 1990, TRENDS NEUROSCI, V13, P344, DOI 10.1016/0166-2236(90)90147-3; Logan C, 1998, J NEUROSCI, V18, P5389, DOI 10.1523/JNEUROSCI.18-14-05389.1998; Lu Y, 2003, J NEUROSCI, V23, P8752; MA W, 1992, J COMP NEUROL, V325, P271, DOI 10.1002/cne.903250210; Malcangio M, 1996, TRENDS PHARMACOL SCI, V17, P457; Mann RS, 2002, CURR OPIN GENET DEV, V12, P592, DOI 10.1016/S0959-437X(02)00344-1; Maricich SM, 1999, J NEUROBIOL, V41, P281, DOI 10.1002/(SICI)1097-4695(19991105)41:2<281::AID-NEU10>3.0.CO;2-5; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; MELZACK R, 1965, SCIENCE, V150, P971, DOI 10.1126/science.150.3699.971; Morgan BA, 1996, METHOD CELL BIOL, V51, P185, DOI 10.1016/S0091-679X(08)60629-9; Muller T, 2002, NEURON, V34, P551, DOI 10.1016/S0896-6273(02)00689-X; Muzio L, 2002, NAT NEUROSCI, V5, P737, DOI 10.1038/nn892; Nabekura J, 2004, NAT NEUROSCI, V7, P17, DOI 10.1038/nn1170; ONIMARU H, 1992, PFLUG ARCH EUR J PHY, V420, P399, DOI 10.1007/BF00374476; ONIMARU H, 1988, BRAIN RES, V445, P314, DOI 10.1016/0006-8993(88)91194-8; Onimaru H, 1997, JPN J PHYSIOL, V47, P385, DOI 10.2170/jjphysiol.47.385; Panganiban G, 2002, DEVELOPMENT, V129, P4371; Polgar E, 1999, BRAIN RES, V833, P71, DOI 10.1016/S0006-8993(99)01500-0; Qian Y, 2002, GENE DEV, V16, P1220, DOI 10.1101/gad.982802; Qian Y, 2001, GENE DEV, V15, P2533, DOI 10.1101/gad.921501; Ritter B, 2000, EUR J NEUROSCI, V12, P2975, DOI 10.1046/j.1460-9568.2000.00152.x; ROBERTS CWM, 1994, NATURE, V368, P747, DOI 10.1038/368747a0; SCHAFFNER AE, 1993, DEV BRAIN RES, V72, P265, DOI 10.1016/0165-3806(93)90192-D; Shirasawa S, 2000, NAT GENET, V24, P287, DOI 10.1038/73516; Spike RC, 1998, EUR J NEUROSCI, V10, P324, DOI 10.1046/j.1460-9568.1998.00048.x; STEIN R, 1988, DEV BIOL, V127, P316, DOI 10.1016/0012-1606(88)90318-1; SUZUE T, 1984, J PHYSIOL-LONDON, V354, P173, DOI 10.1113/jphysiol.1984.sp015370	49	262	263	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2004	7	5					510	517		10.1038/nn1221	http://dx.doi.org/10.1038/nn1221			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	816HP	15064766				2022-12-17	WOS:000221101300028
J	Chou, CC; Zhang, Y; Umoh, ME; Vaughan, SW; Lorenzini, I; Liu, F; Sayegh, M; Donlin-Asp, PG; Chen, YH; Duong, DM; Seyfried, NT; Powers, MA; Kukar, T; Hales, CM; Gearing, M; Cairns, NJ; Boylan, KB; Dickson, DW; Rademakers, R; Zhang, YJ; Petrucelli, L; Sattler, R; Zarnescu, DC; Glass, JD; Rossoll, W				Chou, Ching-Chieh; Zhang, Yi; Umoh, Mfon E.; Vaughan, Spencer W.; Lorenzini, Ileana; Liu, Feilin; Sayegh, Melissa; Donlin-Asp, Paul G.; Chen, Yu Han; Duong, Duc M.; Seyfried, Nicholas T.; Powers, Maureen A.; Kukar, Thomas; Hales, Chadwick M.; Gearing, Maria; Cairns, Nigel J.; Boylan, Kevin B.; Dickson, Dennis W.; Rademakers, Rosa; Zhang, Yong-Jie; Petrucelli, Leonard; Sattler, Rita; Zarnescu, Daniela C.; Glass, Jonathan D.; Rossoll, Wilfried			TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD	NATURE NEUROSCIENCE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; MOTOR-NEURON DISEASE; RNA-BINDING PROTEIN; MESSENGER-RNA; DROSOPHILA MODEL; REPEAT EXPANSION; A315T MUTATION; ALS; EXPRESSION	The cytoplasmic mislocalization and aggregation of TAR DNA-binding protein-43 (TDP-43) is a common histopathological hallmark of the amyotrophic lateral sclerosis and frontotemporal dementia disease spectrum (ALS/FTD). However, the composition of aggregates and their contribution to the disease process remain unknown. Here we used proximity-dependent biotin identification (BioID) to interrogate the interactome of detergent-insoluble TDP-43 aggregates and found them enriched for components of the nuclear pore complex and nucleocytoplasmic transport machinery. Aggregated and disease-linked mutant TDP-43 triggered the sequestration and/or mislocalization of nucleoporins and transport factors, and interfered with nuclear protein import and RNA export in mouse primary cortical neurons, human fibroblasts and induced pluripotent stem cell-derived neurons. Nuclear pore pathology is present in brain tissue in cases of sporadic ALS and those involving genetic mutations in TARDBP and C9orf72. Our data strongly implicate TDP-43-mediated nucleocytoplasmic transport defects as a common disease mechanism in ALS/FTD.	[Chou, Ching-Chieh; Zhang, Yi; Donlin-Asp, Paul G.; Chen, Yu Han; Powers, Maureen A.; Rossoll, Wilfried] Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA; [Chou, Ching-Chieh; Umoh, Mfon E.; Duong, Duc M.; Seyfried, Nicholas T.; Kukar, Thomas; Hales, Chadwick M.; Gearing, Maria; Glass, Jonathan D.; Rossoll, Wilfried] Emory Univ, Sch Med, Ctr Neurodegenerat Dis, Atlanta, GA 30322 USA; [Zhang, Yi] Cent S Univ, Xiangya Hosp, Changsha, Hunan, Peoples R China; [Zhang, Yi] Cent S Univ, Xiangya Sch Med, Changsha, Hunan, Peoples R China; [Umoh, Mfon E.; Seyfried, Nicholas T.; Kukar, Thomas; Hales, Chadwick M.; Gearing, Maria; Glass, Jonathan D.] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; [Vaughan, Spencer W.; Sayegh, Melissa] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA; [Lorenzini, Ileana; Sattler, Rita] Barrow Neurol Inst, Dept Neurobiol, Phoenix, AZ 85013 USA; [Liu, Feilin; Dickson, Dennis W.; Rademakers, Rosa; Zhang, Yong-Jie; Petrucelli, Leonard; Rossoll, Wilfried] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Liu, Feilin] Jilin Univ, Hosp 2, Dept Ophthalmol, Changchun, Jilin, Peoples R China; [Duong, Duc M.; Seyfried, Nicholas T.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Kukar, Thomas] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA; [Gearing, Maria] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Cairns, Nigel J.] Washington Univ, Dept Pathol & Immunol, St Louis, MO USA; [Boylan, Kevin B.] Mayo Clin, Dept Neurol, Jacksonville, FL 32224 USA; [Glass, Jonathan D.] Emory Univ, Sch Med, Emory ALS Ctr, Atlanta, GA USA; [Chou, Ching-Chieh] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Zhang, Yi] Cent S Univ, Xiangya Hosp 2, Dept Resp Med, Changsha, Hunan, Peoples R China; [Donlin-Asp, Paul G.] Max Planck Inst Brain Res, Frankfurt, Germany	Emory University; Emory University; Central South University; Central South University; Emory University; University of Arizona; Barrow Neurological Institute; Mayo Clinic; Jilin University; Emory University; Emory University; Emory University; Washington University (WUSTL); Mayo Clinic; Emory University; Stanford University; Central South University; Max Planck Society	Rossoll, W (corresponding author), Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA.; Rossoll, W (corresponding author), Emory Univ, Sch Med, Ctr Neurodegenerat Dis, Atlanta, GA 30322 USA.; Rossoll, W (corresponding author), Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA.	rossoll.wilfried@mayo.edu	Kukar, Thomas/AAW-2612-2021; Cairns, Nigel/AAB-9713-2020; zhang, lixun/AAG-6923-2021	Cairns, Nigel/0000-0001-9858-3344; Kukar, Thomas/0000-0002-3750-6262; Duong, Duc/0000-0001-5880-1888; Donlin-Asp, Paul/0000-0002-6309-6535; Vaughan, Spencer/0000-0003-1662-2982; Zhang, Yi/0000-0003-4813-414X; Rossoll, Wilfried/0000-0002-9622-541X	ALS Association [17-IIP-353, 16-IIP-278]; Emory Medicine Catalyst Funding Program; Muscular Dystrophy Association [MDA348086]; NIH [K08-NS087121, P30-NS055077, AG025688, R01-NS091299, R35-NS097261, R01-NS085207, R01NS091749, R01-NS093362, R01-AG053960]; The Bluefield Project to Cure FTD; Alzheimers Drug Discovery Foundation; Alzheimers Association (ALZ); Alzheimers Research UK (ARUK); The Michael J. Fox Foundation for Parkinsons Research (MJFF); Weston Brain Institute Biomarkers Across Neurodegenerative Diseases Grant [11060]; UBRP; UA Provosts Office; ARCS Fellowship Roche Foundation Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS091749, R01NS085207, R35NS097261, R01NS091299, K08NS087121, P30NS055077, R01NS093362] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG025688, R01AG053960] Funding Source: NIH RePORTER	ALS Association; Emory Medicine Catalyst Funding Program; Muscular Dystrophy Association(Muscular Dystrophy Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Bluefield Project to Cure FTD; Alzheimers Drug Discovery Foundation; Alzheimers Association (ALZ); Alzheimers Research UK (ARUK); The Michael J. Fox Foundation for Parkinsons Research (MJFF); Weston Brain Institute Biomarkers Across Neurodegenerative Diseases Grant; UBRP; UA Provosts Office; ARCS Fellowship Roche Foundation Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank K. R. Moss and K. T. Thomas for help with the preparation of primary cortical neurons, G. J. Bassell for logistical support and M. Castanedes-Casey for expert staining of human brain tissue. For numerous expression plasmids used in this study (Supplementary Table 3), we thank M. Hetzer (The Salk Institute for Biological Studies), J. Ellenberg (EMBL Heidelberg), V. Doye (Institut Jacques Monod, Universite Paris Diderot/CNRS), J. Teodoro (McGill University) and J. Joseph (National Centre for Cell Science, S.P. Pune University), L. Gerace (The Scripps Research Institute), B. Paschal (University of Virginia School of Medicine) and M. Dasso (Eunice Kennedy Shriver National Institute of Child Health and Human Development). We thank the Bloomington Drosophila Stock Center for fly lines and Emory Integrated Proteomics Core, Neuropathology/Histochemistry Core and Robert P. Apkarian Integrated Electron Microscopy Core for technical support. This work was supported by grants from the ALS Association (17-IIP-353) to W.R. and (16-IIP-278) to R.S.; the Emory Medicine Catalyst Funding Program to W.R.; Muscular Dystrophy Association (MDA348086) to R.S.; NIH grants K08-NS087121 to C.M.H., P30-NS055077 to the Neuropathology/Histochemistry core of the Emory NINDS Neurosciences Core Facility, AG025688 to Emorys Alzheimers Disease Research Center, NIH R01-NS091299 to D.C.Z., R35-NS097261 to R.R., R01-NS085207 to R.S., R01NS091749 to W.R. and R01-NS093362 to W.R. and T.K., who is also supported by The Bluefield Project to Cure FTD; the Alzheimers Drug Discovery Foundation to N.J.C; and NIH R01-AG053960 to N.T.S., who is also supported in part by the Alzheimers Association (ALZ), Alzheimers Research UK (ARUK), The Michael J. Fox Foundation for Parkinsons Research (MJFF) and a Weston Brain Institute Biomarkers Across Neurodegenerative Diseases Grant (11060). S.V. was partially funded by UBRP with funds from the UA Provosts Office. P.G.D.-A. was funded by an ARCS Fellowship Roche Foundation Award.	Alami NH, 2014, NEURON, V81, P536, DOI 10.1016/j.neuron.2013.12.018; Amlie-Wolf A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141836; Ayala YM, 2008, J CELL SCI, V121, P3778, DOI 10.1242/jcs.038950; Ayala YM, 2008, P NATL ACAD SCI USA, V105, P3785, DOI 10.1073/pnas.0800546105; Broers JLV, 2006, PHYSIOL REV, V86, P967, DOI 10.1152/physrev.00047.2005; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; Caballero-Benitez A, 2003, J NEUROSCI RES, V71, P383, DOI 10.1002/jnr.10493; Cairns NJ, 2010, NEUROPATH APPL NEURO, V36, P673, DOI 10.1111/j.1365-2990.2010.01121.x; Chou CC, 2015, HUM MOL GENET, V24, P5154, DOI 10.1093/hmg/ddv238; Coyne AN, 2014, J NEUROSCI, V34, P15962, DOI 10.1523/JNEUROSCI.2526-14.2014; Crisp M, 2006, J CELL BIOL, V172, P41, DOI 10.1083/jcb.200509124; D'Angelo MA, 2009, CELL, V136, P284, DOI 10.1016/j.cell.2008.11.037; Donnelly CJ, 2013, NEURON, V80, P415, DOI 10.1016/j.neuron.2013.10.015; Estes PS, 2013, DIS MODEL MECH, V6, P721, DOI 10.1242/dmm.010710; Estes PS, 2011, HUM MOL GENET, V20, P2308, DOI 10.1093/hmg/ddr124; Fallini C, 2012, HUM MOL GENET, V21, P3703, DOI 10.1093/hmg/dds205; Fallini C, 2011, J NEUROSCI, V31, P3914, DOI 10.1523/JNEUROSCI.3631-10.2011; Fallini C, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-17; Freibaum BD, 2015, NATURE, V525, P129, DOI 10.1038/nature14974; Frey S, 2007, CELL, V130, P512, DOI 10.1016/j.cell.2007.06.024; Frost B, 2016, CURR BIOL, V26, P129, DOI 10.1016/j.cub.2015.11.039; Gasset-Rosa F, 2017, NEURON, V94, P48, DOI 10.1016/j.neuron.2017.03.027; Gitcho MA, 2008, ANN NEUROL, V63, P535, DOI 10.1002/ana.21344; Grima JC, 2017, NEURON, V94, P93, DOI 10.1016/j.neuron.2017.03.023; Guo WR, 2011, NAT STRUCT MOL BIOL, V18, P822, DOI 10.1038/nsmb.2053; Halfmann R, 2012, PRION, V6, P391, DOI 10.4161/pri.20199; Hatch EM, 2013, CELL, V154, P47, DOI 10.1016/j.cell.2013.06.007; Igaz LM, 2008, AM J PATHOL, V173, P182, DOI 10.2353/ajpath.2008.080003; Igaz LM, 2009, J BIOL CHEM, V284, P8516, DOI 10.1074/jbc.M809462200; Joardar A, 2015, HUM MOL GENET, V24, P1741, DOI 10.1093/hmg/ddu587; Jovicic A, 2015, NAT NEUROSCI, V18, P1226, DOI 10.1038/nn.4085; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Kaneb HM, 2015, HUM MOL GENET, V24, P1363, DOI 10.1093/hmg/ddu545; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kim DI, 2014, P NATL ACAD SCI USA, V111, pE2453, DOI 10.1073/pnas.1406459111; Kinoshita Y, 2009, J NEUROPATH EXP NEUR, V68, P1184, DOI 10.1097/NEN.0b013e3181bc3bec; Kuo LJ, 2008, IN VIVO, V22, P305; Lam SS, 2015, NAT METHODS, V12, P51, DOI 10.1038/nmeth.3179; Lee KH, 2016, CELL, V167, P774, DOI 10.1016/j.cell.2016.10.002; Li YR, 2013, J CELL BIOL, V201, P361, DOI 10.1083/jcb.201302044; Lim LZ, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002338; Ling SC, 2013, NEURON, V79, P416, DOI 10.1016/j.neuron.2013.07.033; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nishimura AL, 2010, BRAIN, V133, P1763, DOI 10.1093/brain/awq111; Nofrini V, 2016, EUR J HUM GENET, V24, P1388, DOI 10.1038/ejhg.2016.25; Nonaka T, 2009, HUM MOL GENET, V18, P3353, DOI 10.1093/hmg/ddp275; Perwitasari O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167221; Pujol G, 2002, BIOCHEM BIOPH RES CO, V294, P354, DOI 10.1016/S0006-291X(02)00492-8; Rha J, 2017, HUM MOL GENET, V26, P3663, DOI 10.1093/hmg/ddx248; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; Soderholm JF, 2011, ACS CHEM BIOL, V6, P700, DOI 10.1021/cb2000296; Soo KY, 2015, ACTA NEUROPATHOL, V130, P679, DOI 10.1007/s00401-015-1468-2; Tajiri N, 2016, CNS NEUROSCI THER, V22, P306, DOI 10.1111/cns.12501; Ward ME, 2014, J EXP MED, V211, P1937, DOI 10.1084/jem.20140214; Williams KR, 2016, MOL BIOL CELL, V27, P518, DOI 10.1091/mbc.E15-07-0504; Woerner AC, 2016, SCIENCE, V351, P173, DOI 10.1126/science.aad2033; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920; Yamashita T, 2017, SCI REP-UK, V7, DOI 10.1038/srep39994; Zhan LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057214; Zhang K, 2015, NATURE, V525, P56, DOI 10.1038/nature14973; Zhang QP, 2007, HUM MOL GENET, V16, P2816, DOI 10.1093/hmg/ddm238; Zhang YJ, 2016, NAT NEUROSCI, V19, P668, DOI 10.1038/nn.4272	64	261	263	5	75	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2018	21	2					228	+		10.1038/s41593-017-0047-3	http://dx.doi.org/10.1038/s41593-017-0047-3			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FV0TB	29311743	Green Accepted, hybrid			2022-12-17	WOS:000424269900014
J	Nugent, BM; Wright, CL; Shetty, AC; Hodes, GE; Lenz, KM; Mahurkar, A; Russo, SJ; Devine, SE; McCarthy, MM				Nugent, Bridget M.; Wright, Christopher L.; Shetty, Amol C.; Hodes, Georgia E.; Lenz, Kathryn M.; Mahurkar, Anup; Russo, Scott J.; Devine, Scott E.; McCarthy, Margaret M.			Brain feminization requires active repression of masculinization via DNA methylation	NATURE NEUROSCIENCE			English	Article							SEXUAL-DIFFERENTIATION; SPINE PLASTICITY; MAST-CELLS; ESTRADIOL; BEHAVIOR; ESTROGEN; RAT; EXPRESSION; FEMALE; PROSTAGLANDIN-E2	The developing mammalian brain is destined for a female phenotype unless exposed to gonadal hormones during a perinatal sensitive period. It has been assumed that the undifferentiated brain is masculinized by direct induction of transcription by ligand-activated nuclear steroid receptors. We found that a primary effect of gonadal steroids in the highly sexually dimorphic preoptic area (POA) is to reduce activity of DNA methyltransferase (Dnmt) enzymes, thereby decreasing DNA methylation and releasing masculinizing genes from epigenetic repression. Pharmacological inhibition of Dnmts mimicked gonadal steroids, resulting in masculinized neuronal markers and male sexual behavior in female rats. Conditional knockout of the de novo Dnmt isoform, Dnmt3a, also masculinized sexual behavior in female mice. RNA sequencing revealed gene and isoform variants modulated by methylation that may underlie the divergent reproductive behaviors of males versus females. Our data show that brain feminization is maintained by the active suppression of masculinization via DNA methylation.	[Nugent, Bridget M.; McCarthy, Margaret M.] Univ Maryland, Sch Med, Program Neurosci, Baltimore, MD 21201 USA; [Nugent, Bridget M.; Wright, Christopher L.; Lenz, Kathryn M.; McCarthy, Margaret M.] Univ Maryland, Sch Med, Dept Pharmacol, Baltimore, MD 21201 USA; [Shetty, Amol C.; Mahurkar, Anup; Devine, Scott E.] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [Hodes, Georgia E.; Russo, Scott J.] Mt Sinai Sch Med, Dept Neurosci, New York, NY USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Icahn School of Medicine at Mount Sinai	Nugent, BM (corresponding author), Univ Maryland, Sch Med, Program Neurosci, Baltimore, MD 21201 USA.	bnugent@vet.upenn.edu	McCarthy, Margaret/O-2059-2017; Hodes, Georgia/L-8022-2016; Shetty, Amol Carl/W-7121-2019; Russo, Scott/R-7107-2019	McCarthy, Margaret/0000-0003-2243-4726; Hodes, Georgia/0000-0002-1551-2178; Russo, Scott/0000-0002-6470-1805; Nugent, Bridget/0000-0001-8450-0843; Shetty, Amol/0000-0001-8790-7649	 [R01 MH052716];  [F31NS073545-01];  [R21 MH099562]; NATIONAL CANCER INSTITUTE [R01CA166661] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002898] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH096890, R21MH099562, R01MH052716] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS073545] Funding Source: NIH RePORTER	; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank B.K. Krueger and S.M. Thompson for their helpful input on this manuscript. We thank G. Fan (University of California, Los Angeles) for kindly providing the Dnmt3a<SUP>loxP/loxP</SUP> mice. This work was supported by grant R01 MH052716 to M.M.M. and F31NS073545-01 to B.M.N., and R21 MH099562 to S.J.R. This work was conducted as part of the doctoral thesis requirements of B.M.N.	Akalin A, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-r87, 10.1186/gb-2012-13-10-R87]; Amateau SK, 2004, NAT NEUROSCI, V7, P643, DOI 10.1038/nn1254; Amateau SK, 2002, J NEUROSCI, V22, P8586; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bakker J, 2002, J NEUROSCI, V22, P9104; Bowers JM, 2013, J NEUROSCI, V33, P3276, DOI 10.1523/JNEUROSCI.0425-12.2013; Cardoso MC, 1999, J CELL BIOL, V147, P25, DOI 10.1083/jcb.147.1.25; Champion C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012388; Dodge JE, 2005, J BIOL CHEM, V280, P17986, DOI 10.1074/jbc.M413246200; EVERITT BJ, 1990, NEUROSCI BIOBEHAV R, V14, P217, DOI 10.1016/S0149-7634(05)80222-2; Gavin DP, 2012, NEUROPSYCHOPHARMACOL, V37, P531, DOI 10.1038/npp.2011.221; GLASER EM, 1981, J NEUROSCI METH, V4, P117, DOI 10.1016/0165-0270(81)90045-5; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Guo JU, 2014, NAT NEUROSCI, V17, P215, DOI 10.1038/nn.3607; Guo JJU, 2011, NAT NEUROSCI, V14, P1345, DOI 10.1038/nn.2900; Jeltsch A, 2014, TRENDS BIOCHEM SCI, V39, P310, DOI 10.1016/j.tibs.2014.05.002; Kimchi T, 2007, NATURE, V448, P1009, DOI 10.1038/nature06089; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Kudwa AE, 2006, NEUROSCIENCE, V138, P921, DOI 10.1016/j.neuroscience.2005.10.018; LaPlant Q, 2010, NAT NEUROSCI, V13, P1137, DOI 10.1038/nn.2619; Lauber ME, 1997, NEUROENDOCRINOLOGY, V66, P173, DOI 10.1159/000127235; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; Luco RF, 2011, CELL, V144, P16, DOI 10.1016/j.cell.2010.11.056; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Mccarthy MM, 2008, PHYSIOL REV, V88, P91, DOI 10.1152/physrev.00010.2007; McCarthy MM, 2012, J NEUROSCI, V32, P2241, DOI 10.1523/JNEUROSCI.5372-11.2012; McCarthy MM, 2011, NAT NEUROSCI, V14, P677, DOI 10.1038/nn.2834; MCCARTHY MM, 1993, ENDOCRINOLOGY, V133, P433, DOI 10.1210/en.133.2.433; Miller CA, 2010, NAT NEUROSCI, V13, P664, DOI 10.1038/nn.2560; Moeller S., GPLOTS VARIOUS R PRO; Morris JA, 2004, NAT NEUROSCI, V7, P1034, DOI 10.1038/nn1325; Niehrs C, 2012, TRENDS CELL BIOL, V22, P220, DOI 10.1016/j.tcb.2012.01.002; Park JH, 2009, HORM BEHAV, V56, P254, DOI 10.1016/j.yhbeh.2009.05.007; R Core Team, R LANG ENV STAT COMP; Roth TL, 2009, CURR OPIN NEUROBIOL, V19, P336, DOI 10.1016/j.conb.2009.05.011; Sabatino MA, 2013, EPIGENETICS-US, V8, P656, DOI 10.4161/epi.24916; Sato T, 2004, P NATL ACAD SCI USA, V101, P1673, DOI 10.1073/pnas.0305303101; Satoh A, 1998, J BIOL CHEM, V273, P3470, DOI 10.1074/jbc.273.6.3470; Siedlecki P, 2006, J MED CHEM, V49, P678, DOI 10.1021/jm050844z; Silverman AJ, 2002, PROG BRAIN RES, V141, P315; Simerly RB, 2002, ANNU REV NEUROSCI, V25, P507, DOI 10.1146/annurev.neuro.25.112701.142745; SODERSTEN P, 1972, HORM BEHAV, V3, P307, DOI 10.1016/0018-506X(72)90020-7; Takahashi H, 2003, J NEUROSCI, V23, P6586; Tan L, 2012, DEVELOPMENT, V139, P1895, DOI 10.1242/dev.070771; Todd BJ, 2005, HORM BEHAV, V48, P512, DOI 10.1016/j.yhbeh.2005.07.011; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Uhlenhaut NH, 2009, CELL, V139, P1130, DOI 10.1016/j.cell.2009.11.021; Wedemeyer J, 2000, BRIT MED BULL, V56, P936, DOI 10.1258/0007142001903616; Williams K, 2012, EMBO REP, V13, P28, DOI 10.1038/embor.2011.233; Wright CL, 2008, DEV NEUROBIOL, V68, P1406, DOI 10.1002/dneu.20665; Xu XH, 2012, CELL, V148, P596, DOI 10.1016/j.cell.2011.12.018; Yoo CB, 2004, BIOCHEM SOC T, V32, P910, DOI 10.1042/BST0320910	54	261	264	4	88	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2015	18	5					690	+		10.1038/nn.3988	http://dx.doi.org/10.1038/nn.3988			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CG9LN	25821913	Green Accepted			2022-12-17	WOS:000353636900016
J	Proulx, CD; Hikosaka, O; Malinow, R				Proulx, Christophe D.; Hikosaka, Okihide; Malinow, Roberto			Reward processing by the lateral habenula in normal and depressive behaviors	NATURE NEUROSCIENCE			English	Review							VENTRAL TEGMENTAL AREA; MIDBRAIN DOPAMINE NEURONS; DORSAL RAPHE NUCLEUS; BASAL GANGLIA; CRE-RECOMBINASE; GABA NEURONS; SEROTONIN; RAT; PROJECTIONS; RESPONSES	The brain reward circuit has a central role in reinforcing behaviors that are rewarding and preventing behaviors that lead to punishment. Recent work has shown that the lateral habenula is an important part of the reward circuit by providing 'negative value' signals to the dopaminergic and serotonergic systems. Studies have also suggested that dysfunction of the lateral habenula is associated with psychiatric disorders, including major depression. Here, we discuss insights gained from neuronal recordings in monkeys regarding how the lateral habenula processes reward-related information. We then highlight recent optogenetic experiments in rodents addressing normal and abnormal functions of the habenula. Finally, we discuss how deregulation of the lateral habenula may be involved in depressive behaviors.	[Proulx, Christophe D.; Malinow, Roberto] Univ Calif San Diego, Dept Neurosci, Neurobiol Sect, Ctr Neural Circuits & Behav, San Diego, CA 92103 USA; [Hikosaka, Okihide] NEI, Sensorimotor Res Lab, Bethesda, MD 20892 USA	University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Proulx, CD (corresponding author), Univ Calif San Diego, Dept Neurosci, Neurobiol Sect, Ctr Neural Circuits & Behav, San Diego, CA 92103 USA.	cproulx@ucsd.edu		Proulx, Christophe/0000-0001-6484-9677	Institutions de Recherche en Sante du Canada; NARSAD Young Investigator Grant from the Brain and Behavior Research Foundation [21367]; Intramural Research Program at the US National Institutes of Health, National Eye Institute [EY000415-09]; US National Institutes of Health [R01MH091119]; NATIONAL EYE INSTITUTE [ZIAEY000415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH091119] Funding Source: NIH RePORTER	Institutions de Recherche en Sante du Canada; NARSAD Young Investigator Grant from the Brain and Behavior Research Foundation(NARSAD); Intramural Research Program at the US National Institutes of Health, National Eye Institute; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	C.D.P. received support from the Institutions de Recherche en Sante du Canada and a NARSAD Young Investigator Grant from the Brain and Behavior Research Foundation (21367). O.H. received support by the Intramural Research Program at the US National Institutes of Health, National Eye Institute (EY000415-09), and R.M. received support from the US National Institutes of Health (R01MH091119).	Agetsuma M, 2010, NAT NEUROSCI, V13, P1354, DOI 10.1038/nn.2654; Aizawa H, 2013, J NEUROSCI, V33, P8909, DOI 10.1523/JNEUROSCI.4369-12.2013; Aizawa H, 2012, J COMP NEUROL, V520, P4051, DOI 10.1002/cne.23167; Amat J, 2001, BRAIN RES, V917, P118, DOI 10.1016/S0006-8993(01)02934-1; Belova MA, 2008, J NEUROSCI, V28, P10023, DOI 10.1523/JNEUROSCI.1400-08.2008; Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; Brischoux F, 2009, P NATL ACAD SCI USA, V106, P4894, DOI 10.1073/pnas.0811507106; Bromberg-Martin ES, 2011, NAT NEUROSCI, V14, P1209, DOI 10.1038/nn.2902; Bromberg-Martin ES, 2010, J NEUROSCI, V30, P6262, DOI 10.1523/JNEUROSCI.0015-10.2010; Bromberg-Martin ES, 2009, NEURON, V63, P119, DOI 10.1016/j.neuron.2009.06.009; Coizet V, 2006, NEUROSCIENCE, V139, P1479, DOI 10.1016/j.neuroscience.2006.01.030; Concha ML, 2001, J ANAT, V199, P63, DOI 10.1046/j.1469-7580.2001.19910063.x; CONTESTABILE A, 1987, NEUROSCIENCE, V21, P253, DOI 10.1016/0306-4522(87)90337-X; Cools R, 2008, TRENDS COGN SCI, V12, P31, DOI 10.1016/j.tics.2007.10.011; Cools R, 2011, NEUROPSYCHOPHARMACOL, V36, P98, DOI 10.1038/npp.2010.121; Dayan P, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040004; de Jong TR, 2010, NEUROSCIENCE, V169, P1094, DOI 10.1016/j.neuroscience.2010.06.012; FANSELOW MS, 1994, PSYCHON B REV, V1, P429, DOI 10.3758/BF03210947; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Fowler CD, 2011, NATURE, V471, P597, DOI 10.1038/nature09797; Frahm S, 2011, NEURON, V70, P522, DOI 10.1016/j.neuron.2011.04.013; Friedman A, 2011, NEUROPHARMACOLOGY, V60, P381, DOI 10.1016/j.neuropharm.2010.10.006; Geisler S, 2003, J COMP NEUROL, V458, P78, DOI 10.1002/cne.10566; Gerfen CR, 2013, NEURON, V80, P1368, DOI 10.1016/j.neuron.2013.10.016; Goncalves L, 2012, J COMP NEUROL, V520, P1278, DOI 10.1002/cne.22787; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; Goutagny R, 2013, NEUROPSYCHOPHARMACOL, V38, P2418, DOI 10.1038/npp.2013.142; HABER SN, 1993, J COMP NEUROL, V329, P111, DOI 10.1002/cne.903290108; Pobbe RLH, 2010, NEUROSCI LETT, V479, P87, DOI 10.1016/j.neulet.2010.05.021; HERKENHAM M, 1979, J COMP NEUROL, V187, P19, DOI 10.1002/cne.901870103; HERKENHAM M, 1977, J COMP NEUROL, V173, P123, DOI 10.1002/cne.901730107; Hikosaka O, 2008, J NEUROSCI, V28, P11825, DOI 10.1523/JNEUROSCI.3463-08.2008; Hikosaka O, 2010, NAT REV NEUROSCI, V11, P503, DOI 10.1038/nrn2866; Hong S, 2014, NEUROSCIENCE, V282, P139, DOI 10.1016/j.neuroscience.2014.07.002; Hong S, 2011, J NEUROSCI, V31, P11457, DOI 10.1523/JNEUROSCI.1384-11.2011; Hong S, 2008, NEURON, V60, P720, DOI 10.1016/j.neuron.2008.09.035; Horvitz JC, 2000, NEUROSCIENCE, V96, P651, DOI 10.1016/S0306-4522(00)00019-1; Hsu YWA, 2013, J NEUROSCI, V33, P18022, DOI 10.1523/JNEUROSCI.2927-13.2013; IIango A., 2013, PLOS ONE, V8; Jhou TC, 2009, NEURON, V61, P786, DOI 10.1016/j.neuron.2009.02.001; KALEN P, 1989, BRAIN RES, V492, P187, DOI 10.1016/0006-8993(89)90901-3; Kaufling J, 2009, J COMP NEUROL, V513, P597, DOI 10.1002/cne.21983; Kazi JA, 2004, NEUROSIGNALS, V13, P130, DOI 10.1159/000076566; Kim U, 2009, J COMP NEUROL, V513, P173, DOI 10.1002/cne.21951; Kobayashi Y, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00017; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Lammel S, 2012, NATURE, V491, P212, DOI 10.1038/nature11527; Lammel S, 2011, NEURON, V70, P855, DOI 10.1016/j.neuron.2011.03.025; Lecca S, 2014, EUR J NEUROSCI, V39, P1170, DOI 10.1111/ejn.12480; Lecourtier L, 2007, NEUROSCI BIOBEHAV R, V31, P658, DOI 10.1016/j.neubiorev.2007.01.004; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Li B, 2011, NATURE, V470, P535, DOI 10.1038/nature09742; Li K, 2013, SCIENCE, V341, P1016, DOI 10.1126/science.1240729; Matsumoto M, 2007, NATURE, V447, P1111, DOI 10.1038/nature05860; Matsumoto M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026701; Matsumoto M, 2009, NATURE, V459, P837, DOI 10.1038/nature08028; Matsumoto M, 2009, NAT NEUROSCI, V12, P77, DOI 10.1038/nn.2233; McCallum SE, 2012, NEUROPHARMACOLOGY, V63, P434, DOI 10.1016/j.neuropharm.2012.04.015; Mizoguchi K, 2000, J NEUROSCI, V20, P1568; MOORE RY, 1978, J COMP NEUROL, V180, P417, DOI 10.1002/cne.901800302; Morris JS, 1999, NEUROIMAGE, V10, P163, DOI 10.1006/nimg.1999.0455; Nair SG, 2013, BRAIN RES, V1511, P93, DOI 10.1016/j.brainres.2012.10.011; Nakamura K, 2008, J NEUROSCI, V28, P5331, DOI 10.1523/JNEUROSCI.0021-08.2008; Nakamura K, 2006, J NEUROSCI, V26, P5360, DOI 10.1523/JNEUROSCI.4853-05.2006; Omelchenko N, 2009, EUR J NEUROSCI, V30, P1239, DOI 10.1111/j.1460-9568.2009.06924.x; PARENT A, 1981, BRAIN RES BULL, V6, P23, DOI 10.1016/S0361-9230(81)80066-4; Parent M, 2001, J COMP NEUROL, V439, P162, DOI 10.1002/cne.1340; Qin C, 2009, NEUROSCIENCE, V161, P827, DOI 10.1016/j.neuroscience.2009.03.085; Ranft K, 2010, PSYCHOL MED, V40, P557, DOI 10.1017/S0033291709990821; REISINE TD, 1984, BRAIN RES, V308, P281, DOI 10.1016/0006-8993(84)91067-9; REISINE TD, 1982, J NEUROSCI, V2, P1062; Russo SJ, 2013, NAT REV NEUROSCI, V14, P609, DOI 10.1038/nrn3381; Salas R, 2009, J NEUROSCI, V29, P3014, DOI 10.1523/JNEUROSCI.4934-08.2009; Sartorius A, 2010, BIOL PSYCHIAT, V67, pE9, DOI 10.1016/j.biopsych.2009.08.027; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Seymour B, 2007, NAT REV NEUROSCI, V8, P300, DOI 10.1038/nrn2119; Seymour B, 2012, J NEUROSCI, V32, P5833, DOI 10.1523/JNEUROSCI.0053-12.2012; Shabel SJ, 2012, NEURON, V74, P475, DOI 10.1016/j.neuron.2012.02.037; Shumake J, 2003, BRAIN RES, V963, P274, DOI 10.1016/S0006-8993(02)04048-9; Signore IA, 2009, PHILOS T R SOC B, V364, P991, DOI 10.1098/rstb.2008.0260; Stamatakis AM, 2013, NEURON, V80, P1039, DOI 10.1016/j.neuron.2013.08.023; Stamatakis AM, 2012, NAT NEUROSCI, V15, P1105, DOI 10.1038/nn.3145; Stephenson-Jones M, 2012, P NATL ACAD SCI USA, V109, pE164, DOI 10.1073/pnas.1119348109; Stopper CM, 2014, NAT NEUROSCI, V17, P33, DOI 10.1038/nn.3587; Sugama S, 2008, BRAIN RES REV, V58, P85, DOI 10.1016/j.brainresrev.2007.11.003; SUTHERLAND RJ, 1982, NEUROSCI BIOBEHAV R, V6, P1, DOI 10.1016/0149-7634(82)90003-3; Tachibana Y, 2012, NEURON, V76, P826, DOI 10.1016/j.neuron.2012.09.030; Tripathi A, 2013, BRAIN STRUCT FUNCT, V218, P1133, DOI 10.1007/s00429-012-0451-0; van Zessen R, 2012, NEURON, V73, P1184, DOI 10.1016/j.neuron.2012.02.016; WILCOX KS, 1986, PHYSIOL BEHAV, V36, P413, DOI 10.1016/0031-9384(86)90307-0; WIRTSHAFTER D, 1994, BRAIN RES, V633, P21, DOI 10.1016/0006-8993(94)91517-2; Wise RA, 2005, J COMP NEUROL, V493, P115, DOI 10.1002/cne.20689; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Yang LM, 2008, BEHAV BRAIN RES, V188, P84, DOI 10.1016/j.bbr.2007.10.022; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004	96	261	273	10	91	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2014	17	9					1146	1152		10.1038/nn.3779	http://dx.doi.org/10.1038/nn.3779			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AO2DJ	25157511	Green Accepted			2022-12-17	WOS:000341125400006
J	Bardehle, S; Kruger, M; Buggenthin, F; Schwausch, J; Ninkovic, J; Clevers, H; Snippert, HJ; Theis, FJ; Meyer-Luehmann, M; Bechmann, I; Dimou, L; Gotz, M				Bardehle, Sophia; Krueger, Martin; Buggenthin, Felix; Schwausch, Julia; Ninkovic, Jovica; Clevers, Hans; Snippert, Hugo J.; Theis, Fabian J.; Meyer-Luehmann, Melanie; Bechmann, Ingo; Dimou, Leda; Goetz, Magdalena			Live imaging of astrocyte responses to acute injury reveals selective juxtavascular proliferation	NATURE NEUROSCIENCE			English	Article							IN-VITRO; MOUSE MODEL; RHO-GTPASE; GLIA; CELLS; CDC42; TOOL; REGENERATION; EXPRESSION; DELETION	Astrocytes are thought to have important roles after brain injury, but their behavior has largely been inferred from postmortem analysis. To examine the mechanisms that recruit astrocytes to sites of injury, we used in vivo two-photon laser-scanning microscopy to follow the response of GFP-labeled astrocytes in the adult mouse cerebral cortex over several weeks after acute injury. Live imaging revealed a marked heterogeneity in the reaction of individual astrocytes, with one subset retaining their initial morphology, another directing their processes toward the lesion, and a distinct subset located at juxtavascular sites proliferating. Although no astrocytes actively migrated toward the injury site, selective proliferation of juxtavascular astrocytes was observed after the introduction of a lesion and was still the case, even though the extent was reduced, after astrocyte-specific deletion of the RhoGTPase Cdc42. Thus, astrocyte recruitment after injury relies solely on proliferation in a specific niche.	[Bardehle, Sophia; Dimou, Leda; Goetz, Magdalena] Univ Munich, Inst Physiol, D-80539 Munich, Germany; [Bardehle, Sophia; Schwausch, Julia; Ninkovic, Jovica; Dimou, Leda; Goetz, Magdalena] Helmholtz Zentrum Munich, Inst Stem Cell Res, Neuherberg, Germany; [Krueger, Martin; Bechmann, Ingo] Univ Leipzig, Inst Anat, D-04109 Leipzig, Germany; [Buggenthin, Felix; Theis, Fabian J.] Helmholtz Zentrum Munich, Inst Bioinformat & Syst Biol, Neuherberg, Germany; [Buggenthin, Felix; Theis, Fabian J.] Tech Univ Munich, Dept Math, D-80290 Munich, Germany; [Clevers, Hans; Snippert, Hugo J.] Koninklijke Nederlandse Akad Wetenschappen, Hubrecht Inst, Connecticut Utrecht, Netherlands; [Clevers, Hans; Snippert, Hugo J.] Univ Med Ctr Utrecht, Connecticut Utrecht, Netherlands; [Meyer-Luehmann, Melanie] Univ Munich, Dept Biochem, Adolf Butenandt Inst, Munich, Germany; [Meyer-Luehmann, Melanie] Univ Freiburg, Dept Neurol, Neuroctr, Freiburg, Germany; [Goetz, Magdalena] Munich Cluster Syst Neurol SyNergy, Munich, Germany	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Leipzig University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; University of Munich; University of Freiburg; University of Munich	Gotz, M (corresponding author), Univ Munich, Inst Physiol, Pettenkoferstr 12, D-80539 Munich, Germany.	magdalena.goetz@helmholtz-muenchen.de	Dimou, Leda/E-7968-2012; Ninkovic, Jovica/AAH-5220-2019; Theis, Fabian J/ABD-5212-2021	Ninkovic, Jovica/0000-0002-4381-0041; Theis, Fabian J/0000-0002-2419-1943; Meyer-Luehmann, Melanie/0000-0003-3661-2220	DFG (German Research foundation) [SFB 870, SPP1356, DFG-FOR 1336]; BMBF (Ministry of Science and Education); Helmholtz Association (Helmholtz Alliance ICEMED); Helmholtz Association (Helmholtz Alliance on Systems Biology); Emmy Noether Program of the DFG [ME 3542/1-1]; European Research Council; Munich Cluster for Systems Neurology; European Commission under the Seventh Framework Program (FP7)	DFG (German Research foundation)(German Research Foundation (DFG)); BMBF (Ministry of Science and Education); Helmholtz Association (Helmholtz Alliance ICEMED); Helmholtz Association (Helmholtz Alliance on Systems Biology); Emmy Noether Program of the DFG(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); Munich Cluster for Systems Neurology; European Commission under the Seventh Framework Program (FP7)	We are indebted to C. Brakebusch for the Cdc42<SUP>loxP/loxP</SUP> mice, S. Robel for initial help in setting up the two-photon live-imaging procedure, and C. Straube and S. Falkner for sharing their imaging expertise. We would also like to thank R. Waberer, C. Meyer, D. Franzen, I. Muhlhahn and G. Jager for technical assistance, and M. Hubener, D.E. Bergles, J. McCarter and P. Hardy for critical comments on the manuscript. We thank the DFG (German Research foundation) whose support (particularly via the Leibniz Prize and SFB 870) allowed us to invest into this new experimental area and for funding M.G. and F.J.T. by SPP1356 and I.B. by DFG-FOR 1336. In addition, this work was supported by the BMBF (Ministry of Science and Education) to M.G. and F.J.T., the Helmholtz Association (Helmholtz Alliance ICEMED to M.G., I.B. and F.J.T.; Helmholtz Alliance on Systems Biology to M.G. and F.J.T.), the Emmy Noether Program of the DFG (ME 3542/1-1 to M.M.-L.), the European Research Council (starting grant 'LatentCauses' to F.J.T.) and Munich Cluster for Systems Neurology. The Initial Training Network Edu-GLIA (PITN-GA-2009-237956) funded by the European Commission under the Seventh Framework Program (FP7) provided a wonderful discussion platform for glial research.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Davalos D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2230; Dibaj P, 2011, NEUROSCI LETT, V497, P148, DOI 10.1016/j.neulet.2011.04.049; Erturk A, 2012, NAT MED, V18, P166, DOI 10.1038/nm.2600; Etienne-Manneville S, 2006, METHOD ENZYMOL, V406, P565, DOI 10.1016/S0076-6879(06)06044-7; Fuchs S, 2009, CELL STEM CELL, V4, P236, DOI 10.1016/j.stem.2009.01.017; Fuhrmann M, 2010, NAT NEUROSCI, V13, P411, DOI 10.1038/nn.2511; Ge WP, 2012, NATURE, V484, P376, DOI 10.1038/nature10959; Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165; Heintz N, 2004, NAT NEUROSCI, V7, P483, DOI 10.1038/nn0504-483; Hellal F, 2011, SCIENCE, V331, P928, DOI 10.1126/science.1201148; Holtje M, 2005, J NEUROCHEM, V95, P1237, DOI 10.1111/j.1471-4159.2005.03443.x; Holtmaat A, 2009, NAT PROTOC, V4, P1128, DOI 10.1038/nprot.2009.89; Klein S, 2007, IEEE T IMAGE PROCESS, V16, P2879, DOI 10.1109/TIP.2007.909412; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Krueger M, 2010, GLIA, V58, P1, DOI 10.1002/glia.20898; Mathiisen TM, 2010, GLIA, V58, P1094, DOI 10.1002/glia.20990; McCaslin AFH, 2011, J CEREBR BLOOD F MET, V31, P795, DOI 10.1038/jcbfm.2010.204; Metz CT, 2011, MED IMAGE ANAL, V15, P238, DOI 10.1016/j.media.2010.10.003; Meyer-Luehmann M, 2008, NATURE, V451, P720, DOI 10.1038/nature06616; Middeldorp J, 2011, PROG NEUROBIOL, V93, P421, DOI 10.1016/j.pneurobio.2011.01.005; Misgeld T, 2007, NAT PROTOC, V2, P263, DOI 10.1038/nprot.2007.24; Mori T, 2006, GLIA, V54, P21, DOI 10.1002/glia.20350; Nakamura T, 2006, CIRC RES, V98, P1547, DOI 10.1161/01.RES.0000227505.19472.69; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Nolte C, 2001, GLIA, V33, P72; Oberheim NA, 2008, J NEUROSCI, V28, P3264, DOI 10.1523/JNEUROSCI.4980-07.2008; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Prodinger C, 2011, ACTA NEUROPATHOL, V121, P445, DOI 10.1007/s00401-010-0774-y; Regan MR, 2007, J NEUROSCI, V27, P6607, DOI 10.1523/JNEUROSCI.0790-07.2007; Robel S, 2011, J NEUROSCI, V31, P12471, DOI 10.1523/JNEUROSCI.2696-11.2011; Robel S, 2011, NAT REV NEUROSCI, V12, P88, DOI 10.1038/nrn2978; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Simon C, 2011, GLIA, V59, P869, DOI 10.1002/glia.21156; Sirko S., 2013, CELL STEM C IN PRESS; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Tsai HH, 2012, SCIENCE, V337, P358, DOI 10.1126/science.1222381; Warner SJ, 2010, CURR BIOL, V20, P677, DOI 10.1016/j.cub.2010.03.025; Wolburg H, 2005, NEUROGLIA, V2, P19, DOI [10.1093/acprof:oso/9780195152227.001.0001/acprof-9780195152227-chapter-2, DOI 10.1093/ACPROF:OSO/9780195152227.003]; Wu XW, 2006, GENE DEV, V20, P571, DOI 10.1101/gad.361406; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012	46	261	266	2	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2013	16	5					580	+		10.1038/nn.3371	http://dx.doi.org/10.1038/nn.3371			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	131WT	23542688				2022-12-17	WOS:000318029300014
J	Klausberger, T; Marton, LF; Baude, A; Roberts, JDB; Magill, PJ; Somogyi, P				Klausberger, T; Marton, LF; Baude, A; Roberts, JDB; Magill, PJ; Somogyi, P			Spike timing of dendrite-targeting bistratified cells during hippocampal network oscillations in vivo	NATURE NEUROSCIENCE			English	Article							CA1 PYRAMIDAL NEURONS; RAT HIPPOCAMPUS; GAP-JUNCTIONS; INTACT HIPPOCAMPUS; ACTION-POTENTIALS; PHASE-PRECESSION; NEUROPEPTIDE-Y; INTERNEURONS; INHIBITION; RECEPTOR	Behavior-contingent network oscillations bring about transient, functionally coherent neuronal assemblies in the cerebral cortex, including the hippocampus. Inhibitory input on and close to the soma is believed to phase intrinsic oscillations and output of pyramidal cells, but the function of GABA release to pyramidal cell dendrites remains unknown. We recorded the oscillation-locked spike timing of identified bistratified interneurons in rats. These cells mainly innervated small dendritic shafts of pyramidal cells co-aligned with the glutamatergic Schaffer collateral/commissural input. During theta oscillations, bistratified cells fired at a phase when, on average, pyramidal cell dendrites are most hyperpolarized. Interneurons targeting the perisomatic domain discharge at an earlier phase. During sharp wave-associated ripples, bistratified cells fired with high frequency and in-phase with basket cells, on average 1-2 ms after the discharges in pyramidal cell somata and dendrites. Our results indicate that bistratified cells rhythmically modulate glutamatergic input to the dendrites of pyramidal cells to actively promote the precise input/output transformation during network oscillations.	Univ Oxford, Dept Pharmacol, MRC, Anat Neuropharmacol Unit, Oxford OX1 3TH, England; IFR Jean Roche, Fac Med, CNRS, UMR 6150, F-13916 Marseille 20, France	University of Oxford; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Klausberger, T (corresponding author), Univ Oxford, Dept Pharmacol, MRC, Anat Neuropharmacol Unit, Mansfield Rd, Oxford OX1 3TH, England.		Baude, Agnès/M-7356-2016	Baude, Agnès/0000-0002-7025-364X; Magill, Peter/0000-0001-7141-7071				ALLEN YS, 1983, SCIENCE, V221, P877, DOI 10.1126/science.6136091; ANDERSEN P, 1962, NATURE, V196, P645, DOI 10.1038/196645a0; ANDERSEN P, 1980, J PHYSIOL-LONDON, V305, P279, DOI 10.1113/jphysiol.1980.sp013363; ANDERSEN P, 1963, NATURE, V198, P540, DOI 10.1038/198540a0; Bland BH, 2002, J NEUROPHYSIOL, V88, P3046, DOI 10.1152/jn.00315.2002; BUHL EH, 1994, NATURE, V368, P823, DOI 10.1038/368823a0; BUZSAKI G, 1984, PROG NEUROBIOL, V22, P131, DOI 10.1016/0301-0082(84)90023-6; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Chen WR, 1997, SCIENCE, V278, P463, DOI 10.1126/science.278.5337.463; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; Colbert CM, 1997, J NEUROSCI, V17, P6512; CRUNELLI V, 1991, TRENDS NEUROSCI, V14, P16, DOI 10.1016/0166-2236(91)90178-W; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; FERRAGUTI F, IN PRESS HIPPOCAMPUS; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Frick A, 2003, J NEUROSCI, V23, P3243; Fricker D, 2001, NEURON, V32, P771, DOI 10.1016/S0896-6273(01)00528-1; Gulledge AT, 2003, NEURON, V37, P299, DOI 10.1016/S0896-6273(02)01146-7; Halasy K, 1996, HIPPOCAMPUS, V6, P306, DOI 10.1002/(SICI)1098-1063(1996)6:3<306::AID-HIPO8>3.0.CO;2-K; Harris KD, 2001, NEURON, V32, P141, DOI 10.1016/S0896-6273(01)00447-0; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; JAHNSEN H, 1984, J PHYSIOL-LONDON, V349, P205, DOI 10.1113/jphysiol.1984.sp015153; Kamondi A, 1998, HIPPOCAMPUS, V8, P244, DOI 10.1002/(SICI)1098-1063(1998)8:3<244::AID-HIPO7>3.0.CO;2-J; Kamondi A, 1998, J NEUROSCI, V18, P3919; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; KOSAKA T, 1985, J COMP NEUROL, V231, P150, DOI 10.1002/cne.902310203; LEVEY AI, 1995, J COMP NEUROL, V351, P339, DOI 10.1002/cne.903510303; Lorincz A, 2002, NAT NEUROSCI, V5, P1185, DOI 10.1038/nn962; Losonczy A, 2002, J PHYSIOL-LONDON, V542, P193, DOI 10.1113/jphysiol.2002.020024; Maccaferri G, 2002, J NEUROSCI, V22, P5462; MAGEE JC, 1995, J NEUROPHYSIOL, V74, P1335, DOI 10.1152/jn.1995.74.3.1335; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MCBAIN CJ, 1994, J NEUROSCI, V14, P4433; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; MOORE SD, 1988, SCIENCE, V239, P278, DOI 10.1126/science.2892268; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Pawelzik H, 2002, J COMP NEUROL, V443, P346, DOI 10.1002/cne.10118; Pinault D, 1996, J NEUROSCI METH, V65, P113, DOI 10.1016/0165-0270(95)00144-1; ROY JP, 1984, J NEUROPHYSIOL, V51, P1220, DOI 10.1152/jn.1984.51.6.1220; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; Szabadics J, 2001, J NEUROSCI, V21, P5824, DOI 10.1523/JNEUROSCI.21-15-05824.2001; Traub RD, 2002, REV NEUROSCIENCE, V13, P1; Tsubokawa H, 1996, J NEUROPHYSIOL, V76, P2896, DOI 10.1152/jn.1996.76.5.2896; Vezzani A, 1999, TRENDS NEUROSCI, V22, P25, DOI 10.1016/S0166-2236(98)01284-3; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; YLINEN A, 1995, J NEUROSCI, V15, P30; ZEZULA J, 1991, BRAIN RES, V563, P325, DOI 10.1016/0006-8993(91)91556-G	50	261	268	0	14	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2004	7	1					41	47		10.1038/nn1159	http://dx.doi.org/10.1038/nn1159			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	758LN	14634650				2022-12-17	WOS:000187636000011
J	Yeckel, MF; Kapur, A; Johnston, D				Yeckel, MF; Kapur, A; Johnston, D			Multiple forms of LTP in hippocampal CA3 neurons use a common postsynaptic mechanism	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; MOSSY-FIBER SYNAPSES; DEPENDENT LATE-PHASE; RAT HIPPOCAMPUS; PYRAMIDAL NEURONS; SYNAPTIC TRANSMISSION; KAINATE RECEPTORS; ACTIVATION; INDUCTION; CHANNELS	We investigated long-term potentiation (LTP) at mossy fiber synapses on CA3 pyramidal neurons in the hippocampus. Using Ca2+ imaging techniques, we show here that when postsynaptic Ca2+ was sufficiently buffered so that [Ca2+](i) did not rise during synaptic stimulation, the induction of mossy fiber LTP was prevented. In addition, induction of mossy fiber LTP was suppressed by postsynaptic injection of a peptide inhibitor of cAMP-dependent protein kinase. Finally, when ionotropic glutamate receptors were blocked, LTP depended on the postsynaptic release of Ca2+ from internal stores triggered by activation of metabotropic glutamate receptors. These results support the conclusion that mossy fiber LTP and LTP at other hippocampal synapses share a common induction mechanism involving an initial rise in postsynaptic [Ca2+].	Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA	Baylor College of Medicine	Johnston, D (corresponding author), Baylor Coll Med, Div Neurosci, 1 Baylor Plaza, Houston, TX 77030 USA.				NIMH NIH HHS [MH44754, R01 MH048432, R37 MH044754, MH11390, F32 MH011390, MH48432, F32 MH011390-03] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH044754, R01MH048432, F32MH011390] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Acsady L, 1998, J NEUROSCI, V18, P3386; Amaral D.G., 1990, PROG BRAIN RES, P1; Bao JX, 1998, J NEUROSCI, V18, P458; BASHIR ZI, 1993, NATURE, V363, P347, DOI 10.1038/363347a0; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; BLISS T V P, 1988, P3; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bolshakov VY, 1997, NEURON, V19, P635, DOI 10.1016/S0896-6273(00)80377-3; Castillo PE, 1997, NATURE, V388, P590, DOI 10.1038/41574; CASTILLO PE, 1994, NEURON, V12, P261, DOI 10.1016/0896-6273(94)90269-0; Castillo PE, 1997, NATURE, V388, P182, DOI 10.1038/40645; CHICUREL ME, 1992, J COMP NEUROL, V325, P169, DOI 10.1002/cne.903250204; CLAIBORNE BJ, 1993, HIPPOCAMPUS, V3, P115, DOI 10.1002/hipo.450030202; CLAIBORNE BJ, 1986, J COMP NEUROL, V246, P435, DOI 10.1002/cne.902460403; Davis GW, 1998, NEURON, V20, P305, DOI 10.1016/S0896-6273(00)80458-4; GROVER LM, 1992, NEUROSCIENCE, V49, P7, DOI 10.1016/0306-4522(92)90072-A; HOPKINS WF, 1988, J NEUROPHYSIOL, V59, P667, DOI 10.1152/jn.1988.59.2.667; Huang YY, 1996, NEURON, V16, P611, DOI 10.1016/S0896-6273(00)80080-X; HUANG YY, 1994, CELL, V79, P69, DOI 10.1016/0092-8674(94)90401-4; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; JAFFE D, 1990, J NEUROPHYSIOL, V64, P948, DOI 10.1152/jn.1990.64.3.948; Jaffe DB, 1997, J NEUROPHYSIOL, V78, P10, DOI 10.1152/jn.1997.78.1.10; JOHNSTON D, 1992, ANNU REV PHYSIOL, V54, P489; JUNG MW, 1993, HIPPOCAMPUS, V3, P165, DOI 10.1002/hipo.450030209; Kamiya H, 1996, J PHYSIOL-LONDON, V493, P447, DOI 10.1113/jphysiol.1996.sp021395; Kapur A, 1998, J NEUROPHYSIOL, V79, P2181, DOI 10.1152/jn.1998.79.4.2181; KATSUKI H, 1991, NEUROSCI RES, V12, P393, DOI 10.1016/0168-0102(91)90070-F; Kobayashi K, 1996, SCIENCE, V273, P648, DOI 10.1126/science.273.5275.648; LANGDON RB, 1995, J NEUROBIOL, V26, P370, DOI 10.1002/neu.480260309; LASSERROSS N, 1991, J NEUROSCI METH, V36, P253, DOI 10.1016/0165-0270(91)90051-Z; LLANO I, 1991, NEURON, V6, P565, DOI 10.1016/0896-6273(91)90059-9; LopezGarcia JC, 1996, P NATL ACAD SCI USA, V93, P4712, DOI 10.1073/pnas.93.10.4712; Miller LDP, 1996, J NEUROPHYSIOL, V76, P554, DOI 10.1152/jn.1996.76.1.554; Murphy GG, 1997, SCIENCE, V278, P467, DOI 10.1126/science.278.5337.467; Shigemoto R, 1997, J NEUROSCI, V17, P7503, DOI 10.1523/jneurosci.17-19-07503.1997; STAUBLI U, 1990, SYNAPSE, V5, P333, DOI 10.1002/syn.890050410; STEVENS CF, 1994, NATURE, V371, P704, DOI 10.1038/371704a0; Tong G, 1996, NEURON, V16, P1147, DOI 10.1016/S0896-6273(00)80141-5; Urban NN, 1996, J NEUROSCI, V16, P4293; Vignes M, 1997, NATURE, V388, P179, DOI 10.1038/40639; Villacres EC, 1998, J NEUROSCI, V18, P3186; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482; WESTENBROEK RE, 1990, NATURE, V347, P281, DOI 10.1038/347281a0; WILLIAMS S, 1989, NEURON, V3, P583, DOI 10.1016/0896-6273(89)90268-7; Wilsch VW, 1998, J NEUROSCI, V18, P6071; XIANG ZX, 1994, J NEUROPHYSIOL, V71, P2552, DOI 10.1152/jn.1994.71.6.2552; Yang SN, 1999, J NEUROPHYSIOL, V81, P781, DOI 10.1152/jn.1999.81.2.781; Yeckel MF, 1998, J NEUROSCI, V18, P438; ZALUTSKY RA, 1990, SCIENCE, V248, P1619, DOI 10.1126/science.2114039; ZALUTSKY RA, 1992, NEUROSCI LETT, V138, P193, DOI 10.1016/0304-3940(92)90503-Y	50	261	265	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	1999	2	7					625	633		10.1038/10180	http://dx.doi.org/10.1038/10180			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259EY	10404192	Green Accepted			2022-12-17	WOS:000083882600013
J	Herry, C; Johansen, JP				Herry, Cyril; Johansen, Joshua P.			Encoding of fear learning and memory in distributed neuronal circuits	NATURE NEUROSCIENCE			English	Review							MEDIAL PREFRONTAL CORTEX; ANTERIOR-CINGULATE-CORTEX; AMYGDALA INHIBITORY CIRCUITS; PERIAQUEDUCTAL GRAY; CONDITIONED FEAR; LATERAL AMYGDALA; BASOLATERAL AMYGDALA; PYRAMIDAL CELLS; GENICULATE-BODY; CENTRAL NUCLEUS	How sensory information is transformed by learning into adaptive behaviors is a fundamental question in neuroscience. Studies of auditory fear conditioning have revealed much about the formation and expression of emotional memories and have provided important insights into this question. Classical work focused on the amygdala as a central structure for fear conditioning. Recent advances, however, have identified new circuits and neural coding strategies mediating fear learning and the expression of fear behaviors. One area of research has identified key brain regions and neuronal coding mechanisms that regulate the formation, specificity and strength of fear memories. Other work has discovered critical circuits and neuronal dynamics by which fear memories are expressed through a medial prefrontal cortex pathway and coordinated activity across interconnected brain regions. Here we review these recent advances alongside prior work to provide a working model of the extended circuits and neuronal coding mechanisms mediating fear learning and memory.	[Herry, Cyril] INSERM, Neuroctr Magendie, U862, Bordeaux, France; [Johansen, Joshua P.] RIKEN Brain Sci Inst, Lab Neural Circuitry Memory, Wako, Saitama, Japan; [Johansen, Joshua P.] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo, Japan	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; RIKEN; University of Tokyo	Johansen, JP (corresponding author), RIKEN Brain Sci Inst, Lab Neural Circuitry Memory, Wako, Saitama, Japan.	cyril.herry@inserm.fr; jjohans@brain.riken.jp	Johansen, Joshua/N-8010-2015; Herry, Cyril/AAP-9902-2020	Johansen, Joshua/0000-0003-4240-1550; Herry, Cyril/0000-0003-2973-0843	French National Research Agency [ANR-2010-BLAN-1442-01, ANR-10-EQPX-08 OPTOPATH, LABEX BRAIN ANR 10-LABX-43]; European Research Council under the European Union's Seventh Framework Program (FP7)/ERC [281168]; Conseil Regional d'Aquitaine; MEXT (Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS)); Strategic Research Program for Brain Sciences [11041047];  [25710003];  [25116531]	French National Research Agency(French National Research Agency (ANR)); European Research Council under the European Union's Seventh Framework Program (FP7)/ERC; Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine); MEXT (Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS)); Strategic Research Program for Brain Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; 	We thank T.C. Bienvenu, R.R. Rozeske and J. Ormond for helpful comments on the manuscript. This work was supported by grants to C.H. from the French National Research Agency (ANR-2010-BLAN-1442-01; ANR-10-EQPX-08 OPTOPATH; LABEX BRAIN ANR 10-LABX-43), the European Research Council under the European Union's Seventh Framework Program (FP7/2007-2013)/ERC grant agreement no. 281168, the Conseil Regional d'Aquitaine, and by grants to J.P.J. from MEXT (Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS)), Strategic Research Program for Brain Sciences (11041047) and Grants-in-Aid for Scientific Research (25710003, 25116531).	Adhikari A, 2011, NEURON, V71, P898, DOI 10.1016/j.neuron.2011.07.027; AITKIN LM, 1973, J NEUROPHYSIOL, V36, P275, DOI 10.1152/jn.1973.36.2.275; Amano T, 2011, J NEUROSCI, V31, P15481, DOI 10.1523/JNEUROSCI.3410-11.2011; Antunes R, 2010, J NEUROSCI, V30, P9782, DOI 10.1523/JNEUROSCI.1037-10.2010; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Baeg EH, 2001, CEREB CORTEX, V11, P441, DOI 10.1093/cercor/11.5.441; Bajic D, 1999, J COMP NEUROL, V405, P359; Belova MA, 2007, NEURON, V55, P970, DOI 10.1016/j.neuron.2007.08.004; Benchenane K, 2010, NEURON, V66, P921, DOI 10.1016/j.neuron.2010.05.013; Bienvenu TCM, 2012, NEURON, V74, P1059, DOI 10.1016/j.neuron.2012.04.022; Bissiere S, 2003, NAT NEUROSCI, V6, P587, DOI 10.1038/nn1058; Boatman JA, 2006, EUR J NEUROSCI, V24, P894, DOI 10.1111/j.1460-9568.2006.04965.x; BOLLES RC, 1980, BEHAV BRAIN SCI, V3, P291, DOI 10.1017/S0140525X0000491X; Brunzell DH, 2001, BEHAV NEUROSCI, V115, P365, DOI 10.1037//0735-7044.115.2.365; Burgos-Robles A, 2009, J NEUROSCI, V29, P8474, DOI 10.1523/JNEUROSCI.0378-09.2009; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; CALFORD MB, 1981, J NEUROPHYSIOL, V45, P1013, DOI 10.1152/jn.1981.45.6.1013; CAMPEAU S, 1995, J NEUROSCI, V15, P2312, DOI 10.1523/JNEUROSCI.15-03-02312.1995; Carlen M, 2012, MOL PSYCHIATR, V17, P537, DOI 10.1038/mp.2011.31; Ciocchi S, 2010, NATURE, V468, P277, DOI 10.1038/nature09559; Corcoran KA, 2007, J NEUROSCI, V27, P840, DOI 10.1523/JNEUROSCI.5327-06.2007; Courtin J, 2014, NATURE, V505, P92, DOI 10.1038/nature12755; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; DISCALA G, 1987, PHYSIOL BEHAV, V40, P55, DOI 10.1016/0031-9384(87)90185-5; Duvarci S, 2014, NEURON, V82, P966, DOI 10.1016/j.neuron.2014.04.042; Ehrlich I, 2009, NEURON, V62, P757, DOI 10.1016/j.neuron.2009.05.026; Fanselow MS, 1998, NEURON, V20, P625, DOI 10.1016/S0896-6273(00)81002-8; Fanselow MS, 2005, ANNU REV PSYCHOL, V56, P207, DOI 10.1146/annurev.psych.56.091103.070213; Furlong TM, 2010, BEHAV NEUROSCI, V124, P574, DOI 10.1037/a0020739; Goosens KA, 2003, NEURON, V40, P1013, DOI 10.1016/S0896-6273(03)00728-1; Goosens KA, 2003, BEHAV NEUROSCI, V117, P738, DOI 10.1037/0735-7044.117.4.738; Grace AA, 2002, PHYSIOL BEHAV, V77, P489, DOI 10.1016/S0031-9384(02)00909-5; Gross CT, 2012, NAT REV NEUROSCI, V13, P651, DOI 10.1038/nrn3301; Han JH, 2008, LEARN MEMORY, V15, P443, DOI 10.1101/lm.993608; Haubensak W, 2010, NATURE, V468, P270, DOI 10.1038/nature09553; Heidbreder CA, 2003, NEUROSCI BIOBEHAV R, V27, P555, DOI 10.1016/j.neubiorev.2003.09.003; HELMSTETTER FJ, 1994, J NEUROSCI, V14, P7099; Herry C, 2008, NATURE, V454, P600, DOI 10.1038/nature07166; Huxter J, 2003, NATURE, V425, P828, DOI 10.1038/nature02058; Huxter JR, 2008, NAT NEUROSCI, V11, P587, DOI 10.1038/nn.2106; Johansen J, 2010, SOC NEUR ABSTR, V914, P15; Johansen J.P., P NATL ACAD IN PRESS; Johansen JP, 2012, BIOL PSYCHIAT, V71, P1053, DOI 10.1016/j.biopsych.2011.10.023; Johansen JP, 2011, CELL, V147, P509, DOI 10.1016/j.cell.2011.10.009; Johansen JP, 2010, NAT NEUROSCI, V13, P979, DOI 10.1038/nn.2594; Johansen JP, 2010, P NATL ACAD SCI USA, V107, P12692, DOI 10.1073/pnas.1002418107; Johansen JP, 2004, NAT NEUROSCI, V7, P398, DOI 10.1038/nn1207; Kayser C, 2009, NEURON, V61, P597, DOI 10.1016/j.neuron.2009.01.008; Kholodar-Smith DB, 2008, BEHAV NEUROSCI, V122, P1178, DOI 10.1037/a0012902; Kim EJ, 2013, P NATL ACAD SCI USA, V110, P14795, DOI 10.1073/pnas.1310845110; Klavir O, 2013, NEURON, V80, P1290, DOI 10.1016/j.neuron.2013.09.035; Klavir O, 2012, J NEUROSCI, V32, P8589, DOI 10.1523/JNEUROSCI.6481-11.2012; Lanuza E, 2004, NEUROSCIENCE, V125, P305, DOI 10.1016/j.neuroscience.2003.12.034; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; LEDOUX JE, 1988, J NEUROSCI, V8, P2517; LeDoux JE, 2014, P NATL ACAD SCI USA, V111, P2871, DOI 10.1073/pnas.1400335111; Letzkus JJ, 2011, NATURE, V480, P331, DOI 10.1038/nature10674; Li HH, 2013, NAT NEUROSCI, V16, P332, DOI 10.1038/nn.3322; Likhtik E, 2005, J NEUROSCI, V25, P7429, DOI 10.1523/JNEUROSCI.2314-05.2005; Likhtik E, 2014, NAT NEUROSCI, V17, P106, DOI 10.1038/nn.3582; Lima SQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006099; Linke R, 2000, CEREB CORTEX, V10, P753, DOI 10.1093/cercor/10.8.753; Livneh U, 2012, NEURON, V75, P133, DOI 10.1016/j.neuron.2012.05.016; Lovett-Barron M, 2012, NAT NEUROSCI, V15, P423, DOI 10.1038/nn.3024; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Maren S, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-06-j0001.2001; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Maroun M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035853; Massi L, 2012, J NEUROSCI, V32, P16496, DOI 10.1523/JNEUROSCI.3475-12.2012; McDonald AJ, 2005, BRAIN RES, V1035, P32, DOI 10.1016/j.brainres.2004.11.052; McHugh SB, 2014, J NEUROSCI, V34, P9024, DOI 10.1523/JNEUROSCI.4465-13.2014; McNally GP, 2011, TRENDS NEUROSCI, V34, P283, DOI 10.1016/j.tins.2011.03.005; McNally GP, 2006, BEHAV NEUROSCI, V120, P313, DOI 10.1037/0735-7044.120.2.313; Morrison SE, 2010, CURR OPIN NEUROBIOL, V20, P221, DOI 10.1016/j.conb.2010.02.007; Pape HC, 2010, PHYSIOL REV, V90, P419, DOI 10.1152/physrev.00037.2009; Parsons RG, 2006, NEUROSCIENCE, V141, P1163, DOI 10.1016/j.neuroscience.2006.04.078; Pastalkova E, 2008, SCIENCE, V321, P1322, DOI 10.1126/science.1159775; PEARCE JM, 1980, PSYCHOL REV, V87, P532, DOI 10.1037/0033-295X.87.6.532; Penzo MA, 2014, J NEUROSCI, V34, P2432, DOI 10.1523/JNEUROSCI.4166-13.2014; Petrovich GD, 1997, BRAIN RES, V763, P247, DOI 10.1016/S0006-8993(96)01361-3; Pezze MA, 2004, PROG NEUROBIOL, V74, P301, DOI 10.1016/j.pneurobio.2004.09.004; Pi HJ, 2013, NATURE, V503, P521, DOI 10.1038/nature12676; Pitkanen A, 1997, TRENDS NEUROSCI, V20, P517, DOI 10.1016/S0166-2236(97)01125-9; Popa D, 2010, P NATL ACAD SCI USA, V107, P6516, DOI 10.1073/pnas.0913016107; Quirk GJ, 2003, J NEUROSCI, V23, P8800, DOI 10.1523/jneurosci.23-25-08800.2003; QUIRK GJ, 1995, NEURON, V15, P1029, DOI 10.1016/0896-6273(95)90092-6; Repa JC, 2001, NAT NEUROSCI, V4, P724, DOI 10.1038/89512; Rescorla R.A., 1972, CLASSICAL CONDITIONI; Roesch MR, 2010, J NEUROSCI, V30, P2464, DOI 10.1523/JNEUROSCI.5781-09.2010; ROMANSKI LM, 1992, J NEUROSCI, V12, P4501; ROMANSKI LM, 1993, BEHAV NEUROSCI, V107, P444, DOI 10.1037/0735-7044.107.3.444; Roy M, 2014, NAT NEUROSCI, V17, P1607, DOI 10.1038/nn.3832; RYUGO DK, 1978, BEHAV BIOL, V22, P275, DOI 10.1016/S0091-6773(78)92351-9; Sacco T, 2010, SCIENCE, V329, P649, DOI 10.1126/science.1183165; Sah P, 2003, PHYSIOL REV, V83, P803, DOI 10.1152/physrev.00002.2003; Sara SJ, 2009, NAT REV NEUROSCI, V10, P211, DOI 10.1038/nrn2573; Schafe GE, 2005, J NEUROSCI, V25, P10010, DOI 10.1523/JNEUROSCI.3307-05.2005; Schoenbaum G, 1999, J NEUROSCI, V19, P1876; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2013, CURR OPIN NEUROBIOL, V23, P229, DOI 10.1016/j.conb.2012.11.012; Senn V, 2014, NEURON, V81, P428, DOI 10.1016/j.neuron.2013.11.006; Shabel SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027797; Shi CJ, 1999, J NEUROSCI, V19, P420, DOI 10.1523/JNEUROSCI.19-01-00420.1999; Sotres-Bayon F, 2012, NEURON, V76, P804, DOI 10.1016/j.neuron.2012.09.028; SUTTON RS, 1981, PSYCHOL REV, V88, P135, DOI 10.1037/0033-295X.88.2.135; Tang JR, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-6; Tully K, 2007, P NATL ACAD SCI USA, V104, P14146, DOI 10.1073/pnas.0704621104; Tye KM, 2012, NAT REV NEUROSCI, V13, P251, DOI 10.1038/nrn3171; Tye KM, 2010, J NEUROSCI, V30, P116, DOI 10.1523/JNEUROSCI.4240-09.2010; UWANO T, 1995, NEUROSCIENCE, V68, P339, DOI 10.1016/0306-4522(95)00125-3; Viviani D, 2011, SCIENCE, V333, P104, DOI 10.1126/science.1201043; Watabe AM, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-11; Watabe-Uchida M, 2012, NEURON, V74, P858, DOI 10.1016/j.neuron.2012.03.017; Weinberger NM, 2007, LEARN MEMORY, V14, P1, DOI 10.1101/lm.421807; Weinberger NM, 2011, HEARING RES, V274, P61, DOI 10.1016/j.heares.2010.03.093; Wilensky AE, 2006, J NEUROSCI, V26, P12387, DOI 10.1523/JNEUROSCI.4316-06.2006; Wolff SBE, 2014, NATURE, V509, P453, DOI 10.1038/nature13258; YOUNG SL, 1992, J EXP PSYCHOL ANIM B, V18, P400, DOI 10.1037/0097-7403.18.4.400; Zimmerman JM, 2007, LEARN MEMORY, V14, P634, DOI 10.1101/lm.607207	119	260	266	7	146	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2014	17	12					1644	1654		10.1038/nn.3869	http://dx.doi.org/10.1038/nn.3869			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AU2ZY	25413091				2022-12-17	WOS:000345484000009
J	Ress, D; Heeger, DJ				Ress, D; Heeger, DJ			Neuronal correlates of perception in early visual cortex	NATURE NEUROSCIENCE			English	Article							SIMPLE CELLS; RESPONSES; VARIABILITY; PERFORMANCE; ACTIVATION; ATTENTION; DISCHARGE; MONKEYS; HUMANS; TARGET	We used functional magnetic resonance imaging (fMRI) to measure activity in human early visual cortex (areas V1, V2 and V3) during a challenging contrast-detection task. Subjects attempted to detect the presence of slight contrast increments added to two kinds of background patterns. Behavioral responses were recorded so that the corresponding cortical activity could be grouped into the usual signal detection categories: hits, false alarms, misses and correct rejects. For both kinds of background patterns, the measured cortical activity was retinotopically specific. Hits and false alarms were associated with significantly more cortical activity than were correct rejects and misses. That false alarms evoked more activity than misses indicates that activity in early visual cortex corresponded to the subjects' percepts, rather than to the physically presented stimulus.	Stanford Univ, Dept Psychol, Stanford, CA 94309 USA; NYU, Dept Psychol, New York, NY 10003 USA; NYU, Ctr Neural Sci, New York, NY 10003 USA	Stanford University; New York University; New York University	Ress, D (corresponding author), Stanford Univ, Dept Psychol, 450 Serra Mall,Bldg 420-400, Stanford, CA 94309 USA.	ress@stanford.edu			NATIONAL EYE INSTITUTE [R01EY011794] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY011794-09, R01 EY011794, R01-EY11794] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Aguirre GK, 1998, NEUROIMAGE, V8, P360, DOI 10.1006/nimg.1998.0369; Ahumada AJ, 1996, PERCEPTION, V25, P18; Blake R, 2002, NAT REV NEUROSCI, V3, P13, DOI 10.1038/nrn701; Brefczynski JA, 1999, NAT NEUROSCI, V2, P370, DOI 10.1038/7280; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; CAMPBELL FW, 1971, J PHYSIOL-LONDON, V217, pP54; Carandini M, 1997, J NEUROSCI, V17, P8621; Chawla D, 1999, NAT NEUROSCI, V2, P671, DOI 10.1038/10230; Clark VP, 2000, J NEUROPHYSIOL, V83, P3133, DOI 10.1152/jn.2000.83.5.3133; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; DEAN AF, 1981, EXP BRAIN RES, V44, P437; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; Foxe JJ, 2002, EXP BRAIN RES, V142, P139, DOI 10.1007/s00221-001-0906-7; Gandhi SP, 1999, P NATL ACAD SCI USA, V96, P3314, DOI 10.1073/pnas.96.6.3314; Geisler WS, 1997, VISUAL NEUROSCI, V14, P897, DOI 10.1017/S0952523800011627; Glover GH, 1998, MAGN RESON MED, V39, P361, DOI 10.1002/mrm.1910390305; Glover GH, 1999, MAGNET RESON MED, V42, P412, DOI 10.1002/(SICI)1522-2594(199908)42:2<412::AID-MRM25>3.0.CO;2-U; Graham N., 1989, VISUAL PATTERN ANAL; Grill-Spector K, 2000, NAT NEUROSCI, V3, P837, DOI 10.1038/77754; GRILLSPECTOR K, IN PRESS ATTENTION P, V20; HILLYARD SA, 1971, SCIENCE, V172, P1357, DOI 10.1126/science.172.3990.1357; Hunter M, 2001, BRAIN COGNITION, V46, P342, DOI 10.1006/brcg.2001.1290; Hupe JM, 2001, J NEUROPHYSIOL, V85, P134, DOI 10.1152/jn.2001.85.1.134; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; Lamme VAF, 1998, CURR OPIN NEUROBIOL, V8, P529, DOI 10.1016/S0959-4388(98)80042-1; Leopold DA, 1996, NATURE, V379, P549, DOI 10.1038/379549a0; Liang HL, 2000, NEUROREPORT, V11, P2875, DOI 10.1097/00001756-200009110-00009; Nestares O, 2000, MAGNET RESON MED, V43, P705, DOI 10.1002/(SICI)1522-2594(200005)43:5<705::AID-MRM13>3.0.CO;2-R; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; PASHLER HE, 1998, PSYCHOL ATTENTION; Polonsky A, 2000, NAT NEUROSCI, V3, P1153, DOI 10.1038/80676; Ress D, 2000, NAT NEUROSCI, V3, P940, DOI 10.1038/78856; Schmolesky MT, 1998, J NEUROPHYSIOL, V79, P3272, DOI 10.1152/jn.1998.79.6.3272; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Shulman GL, 1999, J NEUROSCI, V19, P9480; Shulman GL, 2001, P NATL ACAD SCI USA, V98, P313, DOI 10.1073/pnas.021381198; Smith AM, 1999, NEUROIMAGE, V9, P526, DOI 10.1006/nimg.1999.0435; SOFTKY WR, 1993, J NEUROSCI, V13, P334; Solomon JA, 2002, J VISION, V2, P105, DOI 10.1167/2.1.7; SQUIRES KC, 1975, BEHAV BIOL, V13, P21, DOI 10.1016/S0091-6773(75)90748-8; Super H, 2001, NAT NEUROSCI, V4, P304, DOI 10.1038/85170; Thompson KG, 1999, NAT NEUROSCI, V2, P283, DOI 10.1038/6398; Thompson KG, 2000, VISION RES, V40, P1523, DOI 10.1016/S0042-6989(99)00250-3; Tong F, 2001, NATURE, V411, P195, DOI 10.1038/35075583; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; Vogel EK, 1998, J EXP PSYCHOL HUMAN, V24, P1656, DOI 10.1037/0096-1523.24.6.1656	49	260	269	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2003	6	4					414	420		10.1038/nn1024	http://dx.doi.org/10.1038/nn1024			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	660KV	12627164	Green Accepted			2022-12-17	WOS:000181833100020
J	Paul, S; Nairn, AC; Wang, P; Lombroso, PJ				Paul, S; Nairn, AC; Wang, P; Lombroso, PJ			NMDA-mediated activation of the tyrosine phosphatase STEP regulates the duration of ERK signaling	NATURE NEUROSCIENCE			English	Article							PROTEIN-KINASE CASCADE; DUAL-SPECIFICITY PHOSPHATASES; LONG-TERM POTENTIATION; MAP KINASE; DEPENDENT PATHWAY; STRIATAL NEURONS; IN-VIVO; PHOSPHORYLATION; RECEPTOR; HIPPOCAMPAL	The intracellular mechanism(s) by which a cell determines the duration of extracellular signal-regulated kinase (ERK) activation is not well understood. We have investigated the role of STEP, a striatal-enriched tyrosine phosphatase, in the regulation of ERK activity in rat neurons. Glutamate-mediated activation of NMDA receptors leads to the rapid but transient phosphorylation of ERK in cultured neurons. Here we show that activation of NMDA receptors led to activation of STEP, which limited the duration of ERK activity as well as its translocation to the nucleus and its subsequent downstream nuclear signaling. In neurons, STEP is phosphorylated and inactive under basal conditions. NMDA-mediated influx of Ca2+, but not increased intracellular Ca2+ from other sources, leads to activation of the Ca2+-dependent phosphatase calcineurin and the dephosphorylation and activation of STEP. We have identified an important mechanism involved in the regulation of ERK activity in neurons that highlights the complex interplay between serine/threonine and tyrosine kinases and phosphatases.	Yale Univ, Sch Med, Ctr Child Study, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06520 USA; Rockefeller Univ, New York, NY 10021 USA	Yale University; Yale University; Rockefeller University	Lombroso, PJ (corresponding author), Yale Univ, Sch Med, Ctr Child Study, 230 S Frontage Rd, New Haven, CT 06520 USA.			Nairn, Angus/0000-0002-7075-0195	NIDA NIH HHS [DA10044, P01 DA010044] Funding Source: Medline; NIMH NIH HHS [MH52711, MH40899, MH01527] Funding Source: Medline; NINDS NIH HHS [NS35989] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH040899, R01MH052711, R29MH052711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035989] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010044] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Abe K, 2000, NEUROSCI LETT, V292, P1, DOI 10.1016/S0304-3940(00)01415-4; ALESSI DR, 1995, CURR BIOL, V5, P283, DOI 10.1016/S0960-9822(95)00059-5; ANDERSON NG, 1990, NATURE, V343, P651, DOI 10.1038/343651a0; Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; Blum S, 1999, J NEUROSCI, V19, P3535; BOULANGER LM, 1995, J NEUROSCI, V15, P1532; Bult A, 1996, J NEUROSCI, V16, P7821; Camps M, 2000, FASEB J, V14, P6, DOI 10.1096/fasebj.14.1.6; Cepeda C, 1998, DEV NEUROSCI-BASEL, V20, P1, DOI 10.1159/000017294; Charpier S, 1997, P NATL ACAD SCI USA, V94, P7036, DOI 10.1073/pnas.94.13.7036; Coogan AN, 1999, J NEUROPHYSIOL, V81, P103, DOI 10.1152/jn.1999.81.1.103; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; Greengard P, 1999, NEURON, V23, P435, DOI 10.1016/S0896-6273(00)80798-9; Grewal SS, 1999, CURR OPIN NEUROBIOL, V9, P544, DOI 10.1016/S0959-4388(99)00010-0; Grewal SS, 2000, J BIOL CHEM, V275, P3722, DOI 10.1074/jbc.275.5.3722; Groom LA, 1996, EMBO J, V15, P3621, DOI 10.1002/j.1460-2075.1996.tb00731.x; Han BH, 2000, J NEUROSCI, V20, P5775, DOI 10.1523/jneurosci.20-15-05775.2000; Hardingham GE, 1999, NEURON, V22, P789, DOI 10.1016/S0896-6273(00)80737-0; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; Kornhauser JM, 1997, NEURON, V18, P839, DOI 10.1016/S0896-6273(00)80322-0; KOTTER R, 1994, PROG NEUROBIOL, V44, P163, DOI 10.1016/0301-0082(94)90037-X; Kuroki Y, 2001, EUR J NEUROSCI, V13, P472, DOI 10.1046/j.0953-816x.2000.01409.x; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Muda M, 1996, J BIOL CHEM, V271, P27205, DOI 10.1074/jbc.271.44.27205; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Nguyen TH, 2002, J BIOL CHEM, V277, P24274, DOI 10.1074/jbc.M111683200; Nicola SM, 2000, ANNU REV NEUROSCI, V23, P185, DOI 10.1146/annurev.neuro.23.1.185; Paul S, 2000, J NEUROSCI, V20, P5630, DOI 10.1523/JNEUROSCI.20-15-05630.2000; Pelkey KA, 2002, NEURON, V34, P127, DOI 10.1016/S0896-6273(02)00633-5; Pulido R, 1998, EMBO J, V17, P7337, DOI 10.1093/emboj/17.24.7337; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; Runden E, 1998, J NEUROSCI, V18, P7296; Sala C, 2000, J NEUROSCI, V20, P3529, DOI 10.1523/JNEUROSCI.20-10-03529.2000; Saxena M, 1999, NAT CELL BIOL, V1, P305, DOI 10.1038/13024; Schwarzschild MA, 1999, J NEUROCHEM, V72, P2248, DOI 10.1046/j.1471-4159.1999.0722248.x; Sgambato V, 1998, J NEUROSCI, V18, P8814; Stanciu M, 2002, J BIOL CHEM, V277, P4010, DOI 10.1074/jbc.M104479200; Stanciu M, 2000, J BIOL CHEM, V275, P12200, DOI 10.1074/jbc.275.16.12200; Vanhoutte P, 1999, MOL CELL BIOL, V19, P136; Vincent SR, 1998, SYNAPSE, V29, P29, DOI 10.1002/(SICI)1098-2396(199805)29:1<29::AID-SYN3>3.3.CO;2-T; Wu GY, 2001, P NATL ACAD SCI USA, V98, P2808, DOI 10.1073/pnas.051634198; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Xia ZG, 1996, J NEUROSCI, V16, P5425; Yan Z, 1999, P NATL ACAD SCI USA, V96, P11607, DOI 10.1073/pnas.96.20.11607; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451; Yun HY, 1999, DIABETES RES CLIN PR, V45, P113, DOI 10.1016/S0168-8227(99)00039-X; Zanassi P, 2001, J BIOL CHEM, V276, P11487, DOI 10.1074/jbc.M007631200; Zhou B, 2002, J BIOL CHEM, V277, P31818, DOI 10.1074/jbc.M203969200	49	260	268	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2003	6	1					34	42		10.1038/nn989	http://dx.doi.org/10.1038/nn989			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	630CE	12483215				2022-12-17	WOS:000180089300013
J	Connolly, JD; Goodale, MA; Menon, RS; Munoz, DP				Connolly, JD; Goodale, MA; Menon, RS; Munoz, DP			Human fMRI evidence for the neural correlates of preparatory set	NATURE NEUROSCIENCE			English	Article							FRONTAL EYE-FIELD; POSITRON EMISSION TOMOGRAPHY; MOVEMENT-RELATED ACTIVITY; LATERAL INTRAPARIETAL AREA; SUPPLEMENTARY MOTOR AREA; EVENT-RELATED FMRI; ANTI-SACCADE TASK; PREMOTOR CORTEX; NEURONAL-ACTIVITY; SUPERIOR COLLICULUS	We used functional magnetic resonance imaging (fMRI) to study readiness and intention signals in frontal and parietal areas that have been implicated in planning saccadic eye movements-the frontal eye fields (FEF) and intraparietal sulcus (IPS). To track fMRI signal changes correlated with readiness to act, we used an event-related design with variable gap periods between disappearance of the fixation point and appearance of the target. To track changes associated with intention, subjects were instructed before the gap period to make either a pro-saccade (look at target) or an anti-saccade (look away from target). FEF activation increased during the gap period and was higher for anti- than for pro-saccade trials. No signal increases were observed during the gap period in the IPS. Our findings suggest that within the frontoparietal networks that control saccade generation, the human FEF, but not the IPS, is critically involved in preparatory set, coding both the readiness and intention to perform a particular movement.	Univ Western Ontario, Dept Psychol, CIHR Grp Act & Percept, London, ON N6C 5C2, Canada; John P Robarts Res Inst, London, ON N6A 5K8, Canada; Queens Univ, Dept Physiol, Ctr Neurosci Studies, Kingston, ON K7L 3N6, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Queens University - Canada	Goodale, MA (corresponding author), Univ Western Ontario, Dept Psychol, CIHR Grp Act & Percept, London, ON N6C 5C2, Canada.		Menon, Ravi/ABA-8654-2020; Menon, Ravi S/K-5500-2013; Goodale, Melvyn A/M-5907-2013	Menon, Ravi/0000-0002-7916-0263; Menon, Ravi S/0000-0002-7916-0263; Goodale, Melvyn A/0000-0001-6748-0561				Ben Hamed S, 2002, EXP BRAIN RES, V142, P512, DOI 10.1007/s00221-001-0954-z; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Colby CL, 1996, J NEUROPHYSIOL, V76, P2841, DOI 10.1152/jn.1996.76.5.2841; Connolly JD, 2000, J NEUROPHYSIOL, V84, P1645, DOI 10.1152/jn.2000.84.3.1645; DIAS EC, 1994, J NEUROPHYSIOL, V72, P2532, DOI 10.1152/jn.1994.72.5.2532; Doricchi F, 1997, EXP BRAIN RES, V116, P50, DOI 10.1007/PL00005744; DORRIS MC, 1995, J NEUROPHYSIOL, V73, P2558, DOI 10.1152/jn.1995.73.6.2558; Dorris MC, 1997, J NEUROSCI, V17, P8566; EVARTS EV, 1984, NEUROPHYSIOLOGICAL A; Everling S, 1998, NEUROPSYCHOLOGIA, V36, P885, DOI 10.1016/S0028-3932(98)00020-7; Everling S, 2000, J NEUROSCI, V20, P387, DOI 10.1523/JNEUROSCI.20-01-00387.2000; Everling S, 1999, J NEUROSCI, V19, P2740; Everling S, 1998, J NEUROPHYSIOL, V80, P1584, DOI 10.1152/jn.1998.80.3.1584; FISCHER B, 1993, BEHAV BRAIN SCI, V16, P553, DOI 10.1017/S0140525X00031575; FISCHER B, 1992, EXP BRAIN RES, V89, P415; FUNAHASHI S, 1993, NATURE, V365, P753, DOI 10.1038/365753a0; Gaymard B, 1998, EXP BRAIN RES, V123, P159, DOI 10.1007/s002210050557; Gaymard B, 1999, EXP BRAIN RES, V129, P288, DOI 10.1007/s002210050899; Gottlieb J, 1999, NAT NEUROSCI, V2, P906, DOI 10.1038/13209; GUITTON D, 1985, EXP BRAIN RES, V58, P455; HALLETT PE, 1978, VISION RES, V18, P1279, DOI 10.1016/0042-6989(78)90218-3; Hebb D. O., 1972, TXB PHYSL, P77; Kollias SS, 2000, NEURORADIOLOGY, V42, P591, DOI 10.1007/s002340000355; Kurata K, 2000, J NEUROPHYSIOL, V84, P1667, DOI 10.1152/jn.2000.84.3.1667; KURATA K, 1993, J NEUROPHYSIOL, V69, P187, DOI 10.1152/jn.1993.69.1.187; KURATA K, 1994, J NEUROPHYSIOL, V71, P1151, DOI 10.1152/jn.1994.71.3.1151; Lee KM, 1999, NEUROIMAGE, V9, P117, DOI 10.1006/nimg.1998.0393; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Luna B, 2001, NEUROIMAGE, V13, P786, DOI 10.1006/nimg.2000.0743; Munoz DP, 2000, CAN J PHYSIOL PHARM, V78, P934, DOI 10.1139/cjpp-78-11-934; Munoz DP, 1998, EXP BRAIN RES, V121, P391, DOI 10.1007/s002210050473; ODRISCOLL GA, 1995, P NATL ACAD SCI USA, V92, P925, DOI 10.1073/pnas.92.3.925; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; Passingham RE., 1993, FRONTAL LOBES VOLUNT; Paus T, 1996, NEUROPSYCHOLOGIA, V34, P475, DOI 10.1016/0028-3932(95)00134-4; Pierrot-Deseilligny C., 1991, BRAIN, V114, P1472, DOI 10.1093/brain/114.3.1473; Pollmann S, 2000, HUM BRAIN MAPP, V9, P26, DOI 10.1002/(SICI)1097-0193(2000)9:1<26::AID-HBM3>3.0.CO;2-2; RIVAUD S, 1994, EXP BRAIN RES, V102, P110; SASLOW MG, 1967, J OPT SOC AM, V57, P1024, DOI 10.1364/JOSA.57.001024; Schall JD, 2001, NAT REV NEUROSCI, V2, P33, DOI 10.1038/35049054; SCHALL JD, 1995, J NEUROSCI, V15, P4464; SchlagRey M, 1997, NATURE, V390, P398, DOI 10.1038/37114; Schluter ND, 1999, NEUROPSYCHOLOGIA, V37, P233; Sereno MI, 2001, SCIENCE, V294, P1350, DOI 10.1126/science.1063695; Snyder LH, 2000, VISION RES, V40, P1433, DOI 10.1016/S0042-6989(00)00052-3; STANTON GB, 1995, J COMP NEUROL, V353, P291, DOI 10.1002/cne.903530210; Sweeney JA, 1996, J NEUROPHYSIOL, V75, P454, DOI 10.1152/jn.1996.75.1.454; Toni I, 1999, CEREB CORTEX, V9, P35, DOI 10.1093/cercor/9.1.35; Umeno MM, 2001, J NEUROPHYSIOL, V86, P2344, DOI 10.1152/jn.2001.86.5.2344; WISE SP, 1989, SOMATOSENS MOT RES, V6, P455, DOI 10.3109/08990228909144687	50	260	263	0	13	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2002	5	12					1345	1352		10.1038/nn969	http://dx.doi.org/10.1038/nn969			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	618ZE	12411958				2022-12-17	WOS:000179447500019
J	Thoenen, H; Sendtner, M				Thoenen, H; Sendtner, M			Neurotrophins: from enthusiastic expectations through sobering experiences to rational therapeutic approaches	NATURE NEUROSCIENCE			English	Review							NERVE GROWTH-FACTOR; PLACEBO-CONTROLLED TRIAL; FACTOR-I; GENE-EXPRESSION; SURVIVAL; EXERCISE; DELIVERY; CELLS; BDNF; NEURODEGENERATION	Despite high enthusiasm, early attempts to develop clinical treatments based on animal research with neurotrophins were not successful. Here we survey clinical trials with neurotrophins, compared with neurotrophic factors of other gene families, and delineate the most likely reasons for their failure. We then suggest improved methods for regulated local supply of NTs to specific populations of neurons and discuss future therapeutic procedures evolving from the more detailed knowledge of the signal transduction pathways activated by neurotrophins via their receptors.	Max Planck Inst Neurobiol, D-82152 Martinsried, Germany; Inst Clin Neurobiol, D-97080 Wurzburg, Germany	Max Planck Society; University of Wurzburg	Thoenen, H (corresponding author), Max Planck Inst Neurobiol, Klopferspitz 18A, D-82152 Martinsried, Germany.		Sendtner, Michael/M-8137-2014; Sendtner, Michael/J-1542-2012	Sendtner, Michael/0000-0002-4737-2974; Sendtner, Michael/0000-0002-4737-2974				Aebischer P, 1996, NAT MED, V2, P696, DOI 10.1038/nm0696-696; Apfel SC, 2000, JAMA-J AM MED ASSOC, V284, P2215, DOI 10.1001/jama.284.17.2215; Apfel SC, 1998, NEUROLOGY, V51, P695, DOI 10.1212/WNL.51.3.695; Bachoud-Levi AC, 2000, HUM GENE THER, V11, P1723, DOI 10.1089/10430340050111377; Baekelandt V, 2000, CURR OPIN MOL THER, V2, P540; BARDE Y-A, 1990, Progress in Growth Factor Research, V2, P237, DOI 10.1016/0955-2235(90)90021-B; Berardi N, 2000, CURR OPIN NEUROBIOL, V10, P138, DOI 10.1016/S0959-4388(99)00047-1; Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400; Binder DK, 2001, TRENDS NEUROSCI, V24, P47, DOI 10.1016/S0166-2236(00)01682-9; Borasio GD, 1998, NEUROLOGY, V51, P583, DOI 10.1212/WNL.51.2.583; Carro E, 2001, J NEUROSCI, V21, P5678, DOI 10.1523/JNEUROSCI.21-15-05678.2001; Carro E, 2000, J NEUROSCI, V20, P2926; CEDARBAUM JM, 1995, CLIN NEUROPHARMACOL, V18, P515; Chaudhry V, 2000, MUSCLE NERVE, V23, P189, DOI 10.1002/(SICI)1097-4598(200002)23:2<189::AID-MUS7>3.3.CO;2-#; Cheng L, 2002, J NEUROSCI, V22, P3977, DOI 10.1523/JNEUROSCI.22-10-03977.2002; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; Dittrich F, 1996, EXP NEUROL, V141, P225, DOI 10.1006/exnr.1996.0157; Donovan MJ, 2000, DEVELOPMENT, V127, P4531; FISCHER W, 1987, NATURE, V329, P65, DOI 10.1038/329065a0; Gravel C, 1997, NAT MED, V3, P765, DOI 10.1038/nm0797-765; HEFTI F, 1986, ANN NEUROL, V20, P275, DOI 10.1002/ana.410200302; Hefti F, 1997, ANNU REV PHARMACOL, V37, P239, DOI 10.1146/annurev.pharmtox.37.1.239; Hempstead BL, 2002, CURR OPIN NEUROBIOL, V12, P260, DOI 10.1016/S0959-4388(02)00321-5; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Jonhagen ME, 1998, DEMENT GERIATR COGN, V9, P246, DOI 10.1159/000017069; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Kasarskis EJ, 1999, NEUROLOGY, V52, P1427; KERSCHENSTEINER M, IN PRESS ANN NEUROL; Knusel B, 1997, NEUROSCIENCE, V78, P851, DOI 10.1016/S0306-4522(96)00616-1; Kordower JH, 2000, SCIENCE, V290, P767, DOI 10.1126/science.290.5492.767; Lai EC, 1997, NEUROLOGY, V49, P1621, DOI 10.1212/WNL.49.6.1621; Lee FS, 2002, CYTOKINE GROWTH F R, V13, P11, DOI 10.1016/S1359-6101(01)00024-7; LEVIMONTALCINI R, 1987, EMBO J, V6, P1145, DOI 10.1002/j.1460-2075.1987.tb02347.x; LINDSAY RM, 1994, TRENDS NEUROSCI, V17, P182, DOI 10.1016/0166-2236(94)90099-X; Lotz B, 1996, NEUROLOGY, V46, P1244; Lowenstein PR, 1996, PROTOCOLS GENE TRANS; Mansuy IM, 2000, CURR OPIN NEUROBIOL, V10, P593, DOI 10.1016/S0959-4388(00)00127-6; MCALLISTER AK, 2001, NAT NEUROSCI S, V4, P1207; McArthur JC, 2000, NEUROLOGY, V54, P1080, DOI 10.1212/WNL.54.5.1080; McKay R, 2000, NATURE, V406, P361, DOI 10.1038/35019186; Miller RG, 1996, ANN NEUROL, V39, P256, DOI 10.1002/ana.410390215; MITSUMOTO H, 1994, SCIENCE, V265, P1107, DOI 10.1126/science.8066451; Ochs G, 2000, AMYOTROPH LATERAL SC, V1, P201, DOI 10.1080/14660820050515197; Penn RD, 1997, NEUROSURGERY, V40, P94, DOI 10.1097/00006123-199701000-00021; Rossi FMV, 1998, CURR OPIN BIOTECH, V9, P451, DOI 10.1016/S0958-1669(98)80028-1; Schifitto G, 2001, NEUROLOGY, V57, P1313, DOI 10.1212/WNL.57.7.1313; SENDTNER M, 1992, NATURE, V358, P502, DOI 10.1038/358502a0; Sendtner M, 1996, NEUROCHEM RES, V21, P831, DOI 10.1007/BF02532307; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; Swain C, 1999, HANDB EXP PHARM, V134, P281; THOENEN H, 2000, AXONAL REGENERATION, P675; Venters HD, 2000, TRENDS NEUROSCI, V23, P175, DOI 10.1016/S0166-2236(99)01533-7; Vigna E, 2002, MOL THER, V5, P252, DOI 10.1006/mthe.2002.0542; Wellmer A, 2001, J PERIPHER NERV SYST, V6, P204, DOI 10.1046/j.1529-8027.2001.01019.x	54	260	292	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5			S			1046	1050		10.1038/nn938	http://dx.doi.org/10.1038/nn938			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	611WT	12403983				2022-12-17	WOS:000179041300011
J	Furmanski, CS; Engel, SA				Furmanski, CS; Engel, SA			An oblique effect in human primary visual cortex	NATURE NEUROSCIENCE			English	Article							ORIENTATION DISCRIMINATION; PERCEPTION; STRIATE; CELLS; AREAS		Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Furmanski, CS (corresponding author), Univ Calif Los Angeles, Dept Psychol, Box 951563,Franz Hall, Los Angeles, CA 90095 USA.							BUCHANANSMITH HM, 1993, PERCEPTION, V22, P1389, DOI 10.1068/p221389; CAMPBELL FW, 1966, J PHYSIOL-LONDON, V187, P427, DOI 10.1113/jphysiol.1966.sp008100; Coppola DM, 1998, P NATL ACAD SCI USA, V95, P2621, DOI 10.1073/pnas.95.5.2621; DEVALOIS RL, 1982, VISION RES, V22, P531, DOI 10.1016/0042-6989(82)90112-2; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; ENGEL SA, 1994, NATURE, V369, P525, DOI 10.1038/369525a0; FINLAY BL, 1976, J NEUROPHYSIOL, V39, P1352, DOI 10.1152/jn.1976.39.6.1352; HEELEY DW, 1988, VISION RES, V28, P337, DOI 10.1016/0042-6989(88)90162-9; LEVITT JB, 1994, J NEUROPHYSIOL, V71, P2517, DOI 10.1152/jn.1994.71.6.2517; MAFFEI L, 1970, SCIENCE, V167, P386, DOI 10.1126/science.167.3917.386; MANSFIELD RJ, 1974, SCIENCE, V186, P1133, DOI 10.1126/science.186.4169.1133; MATIN E, 1984, PERCEPT PSYCHOPHYS, V35, P589, DOI 10.3758/BF03205959; ORBAN GA, 1984, VISION RES, V24, P121, DOI 10.1016/0042-6989(84)90097-X; Orban GA, 1997, EUR J NEUROSCI, V9, P246, DOI 10.1111/j.1460-9568.1997.tb01395.x; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376	15	260	267	2	40	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2000	3	6					535	536		10.1038/75702	http://dx.doi.org/10.1038/75702			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	317WG	10816307				2022-12-17	WOS:000087249500007
J	Genovese, G; Fromer, M; Stahl, EA; Ruderfer, DM; Chambert, K; Landen, M; Moran, JL; Purcell, SM; Sklar, P; Sullivan, PF; Hultman, CM; McCarroll, SA				Genovese, Giulio; Fromer, Menachem; Stahl, Eli A.; Ruderfer, Douglas M.; Chambert, Kimberly; Landen, Mikael; Moran, Jennifer L.; Purcell, Shaun M.; Sklar, Pamela; Sullivan, Patrick F.; Hultman, Christina M.; McCarroll, Steven A.			Increased burden of ultra-rare protein-altering variants among 4,877 individuals with schizophrenia	NATURE NEUROSCIENCE			English	Article							AUTISM SPECTRUM DISORDERS; OF-FUNCTION VARIANTS; DE-NOVO; BRAIN-DEVELOPMENT; BIPOLAR DISORDER; GENES; MUTATIONS; ASSOCIATION; TRANSLOCATION; HERITABILITY	By analyzing the exomes of 12,332 unrelated Swedish individuals, including 4,877 individuals affected with schizophrenia, in ways informed by exome sequences from 45,376 other individuals, we identified 244,246 coding-sequence and splice-site ultra-rare variants (URVs) that were unique to individual Swedes. We found that gene-disruptive and putatively protein-damaging URVs (but not synonymous URVs) were more abundant among individuals with schizophrenia than among controls (P = 1.3 x 10(-10)). This elevation of protein-compromising URVs was several times larger than an analogously elevated rate for de novo mutations, suggesting that most rare-variant effects on schizophrenia risk are inherited. Among individuals with schizophrenia, the elevated frequency of protein-compromising URVs was concentrated in brain-expressed genes, particularly in neuronally expressed genes; most of this elevation arose from large sets of genes whose RNAs have been found to interact with synaptically localized proteins. Our results suggest that synaptic dysfunction may mediate a large fraction of strong, individually rare genetic influences on schizophrenia risk.	[Genovese, Giulio; Chambert, Kimberly; Moran, Jennifer L.; McCarroll, Steven A.] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [Genovese, Giulio; McCarroll, Steven A.] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Genovese, Giulio; McCarroll, Steven A.] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Fromer, Menachem; Stahl, Eli A.; Ruderfer, Douglas M.; Purcell, Shaun M.; Sklar, Pamela] Icahn Sch Med Mt Sinai, Dept Psychiat, Div Psychiat Genom, New York, NY 10029 USA; [Fromer, Menachem; Stahl, Eli A.; Ruderfer, Douglas M.; Purcell, Shaun M.; Sklar, Pamela] Icahn Sch Med Mt Sinai, Inst Genom & Multiscale Biol, New York, NY 10029 USA; [Landen, Mikael] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci Physiol, Dept Psychiat & Neurochem, Gothenburg, Sweden; [Sullivan, Patrick F.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Sullivan, Patrick F.] Univ N Carolina, Dept Psychiat, Chapel Hill, NC USA; [Sullivan, Patrick F.; Hultman, Christina M.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Gothenburg; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Karolinska Institutet	Genovese, G; McCarroll, SA (corresponding author), Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA.; Genovese, G; McCarroll, SA (corresponding author), Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA.; Genovese, G; McCarroll, SA (corresponding author), Harvard Med Sch, Dept Genet, Boston, MA 02115 USA.	giulio.genovese@gmail.com; mccarroll@genetics.med.harvard.edu	Landen, Mikael/AAD-7917-2020	Sullivan, Patrick F/0000-0002-6619-873X; Moran, Jennifer/0000-0002-5664-4716; Genovese, Giulio/0000-0003-3066-5575	National Human Genome Research Institute [U54 HG003067, R01 HG006855]; National Institute of Mental Health [R01 MH077139, R01 MH095034, RC2 MH089905]; Stanley Center for Psychiatric Research; Alexander and Margaret Stewart Trust; Sylvan C. Herman Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006855, U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH077139, RC2MH089905, R01MH095034, R01MH105554, U01MH109528] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Stanley Center for Psychiatric Research; Alexander and Margaret Stewart Trust; Sylvan C. Herman Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank C. Usher for comments on the manuscript and work on the figures. This study was supported by grants from the National Human Genome Research Institute (U54 HG003067, R01 HG006855 to S.A.M.), the National Institute of Mental Health (R01 MH077139 to P.F.S., R01 MH095034 to P.S., and RC2 MH089905 to S.M.P. and P.S.), the Stanley Center for Psychiatric Research, the Alexander and Margaret Stewart Trust, and the Sylvan C. Herman Foundation.	Bayes A, 2011, NAT NEUROSCI, V14, P19, DOI 10.1038/nn.2719; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Bundy H, 2011, ACTA PSYCHIAT SCAND, V123, P98, DOI 10.1111/j.1600-0447.2010.01623.x; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Gecz J, 2009, TRENDS GENET, V25, P308, DOI 10.1016/j.tig.2009.05.002; Hamada N, 2013, J NEUROSCI RES, V91, P1303, DOI 10.1002/jnr.23266; Ionita-Laza I, 2013, AM J HUM GENET, V92, P841, DOI 10.1016/j.ajhg.2013.04.015; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Jensen LR, 2005, AM J HUM GENET, V76, P227, DOI 10.1086/427563; Kirov G, 2012, MOL PSYCHIATR, V17, P142, DOI 10.1038/mp.2011.154; Lee JA, 2016, NEURON, V89, P113, DOI 10.1016/j.neuron.2015.11.025; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Matsumoto M, 1996, NATURE, V379, P168, DOI 10.1038/379168a0; McGrath J, 2008, EPIDEMIOL REV, V30, P67, DOI 10.1093/epirev/mxn001; McRae J. F., 2016, BIORXIV; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; Mo A, 2015, NEURON, V86, P1369, DOI 10.1016/j.neuron.2015.05.018; Moeschler JB, 2008, SEMIN PEDIATR NEUROL, V15, P2, DOI 10.1016/j.spen.2008.01.002; Pinto D, 2014, AM J HUM GENET, V94, P677, DOI 10.1016/j.ajhg.2014.03.018; Pirooznia M, 2012, BIOINFORMATICS, V28, P897, DOI 10.1093/bioinformatics/bts040; Power RA, 2013, JAMA PSYCHIAT, V70, P22, DOI 10.1001/jamapsychiatry.2013.268; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Richards AL, 2016, HUM MOL GENET, V25, P1001, DOI 10.1093/hmg/ddv620; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Robinson EB, 2016, NAT GENET, V48, P552, DOI 10.1038/ng.3529; Robinson EB, 2015, CURR OPIN PEDIATR, V27, P685, DOI 10.1097/MOP.0000000000000278; Robinson EB, 2014, P NATL ACAD SCI USA, V111, P15161, DOI 10.1073/pnas.1409204111; Rujescu D, 2009, HUM MOL GENET, V18, P988, DOI 10.1093/hmg/ddn351; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Singh T, 2016, NAT NEUROSCI, V19, P571, DOI 10.1038/nn.4267; Stefansson H, 2014, NATURE, V505, P361, DOI 10.1038/nature12818; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Takata A, 2014, NEURON, V82, P773, DOI 10.1016/j.neuron.2014.04.043; Wagnon JL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003067; Weyn-Vanhentenryck SM, 2014, CELL REP, V6, P1139, DOI 10.1016/j.celrep.2014.02.005; Xiang Y, 2007, P NATL ACAD SCI USA, V104, P19226, DOI 10.1073/pnas.0700735104; Xu B, 2012, NAT GENET, V44, P1365, DOI 10.1038/ng.2446; Zuk O, 2014, P NATL ACAD SCI USA, V111, pE455, DOI 10.1073/pnas.1322563111	49	259	259	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2016	19	11					1433	1441		10.1038/nn.4402	http://dx.doi.org/10.1038/nn.4402			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EA3WL	27694994	Green Submitted, Green Accepted			2022-12-17	WOS:000386539900013
J	Kording, KP; Tenenbaum, JB; Shadmehr, R				Kording, Konrad P.; Tenenbaum, Joshua B.; Shadmehr, Reza			The dynamics of memory as a consequence of optimal adaptation to a changing body	NATURE NEUROSCIENCE			English	Article							SACCADIC EYE-MOVEMENTS; CEREBELLAR CORTEX; SHORT-TERM; MONKEY; CONSOLIDATION; PLASTICITY; LESIONS; SHIFTS; TASK; SIZE	There are many causes for variation in the responses of the motor apparatus to neural commands. Fast-timescale disturbances occur when muscles fatigue. Slow-timescale disturbances occur when muscles are damaged or when limb dynamics change as a result of development. To maintain performance, motor commands need to adapt. Computing the best adaptation in response to any performance error results in a credit assignment problem: which timescale is responsible for this disturbance? Here we show that a Bayesian solution to this problem accounts for numerous behaviors of animals during both short- and long-term training. Our analysis focused on characteristics of the oculomotor system during learning, including the effects of time passage. However, we suggest that learning and memory in other paradigms, such as reach adaptation, adaptation of visual neurons and retrieval of declarative memories, largely follow similar rules.	Rehabil Inst Chicago, Chicago, IL 60611 USA; MIT, Cambridge, MA 02139 USA; Johns Hopkins Sch Med, Baltimore, MD 21205 USA	Shirley Ryan AbilityLab; Massachusetts Institute of Technology (MIT); Johns Hopkins University; Johns Hopkins Medicine	Kording, KP (corresponding author), Rehabil Inst Chicago, 446 E Ontario St,Rm 922, Chicago, IL 60611 USA.	kk@northwestern.edu	Kording, Konrad P/A-1233-2007	Kording, Konrad P/0000-0001-8408-4499	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057814] Funding Source: NIH RePORTER; NIGMS NIH HHS [T32 GM007057] Funding Source: Medline; NINDS NIH HHS [R01 NS057814, R01 NS057814-02] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anderson J. R., 1990, ADAPTIVE CHARACTER T; Bahcall DO, 1999, NATURE, V400, P864, DOI 10.1038/23693; BAHRICK HP, 1993, PSYCHOL SCI, V4, P316, DOI 10.1111/j.1467-9280.1993.tb00571.x; Barash S, 1999, J NEUROSCI, V19, P10931, DOI 10.1523/JNEUROSCI.19-24-10931.1999; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; BARTON JJS, 1995, NEUROLOGY, V45, P2065, DOI 10.1212/WNL.45.11.2065; Becker W., 1989, NEUROBIOLOGY SACCADI, P13; Catz N, 2005, CURR BIOL, V15, P2179, DOI 10.1016/j.cub.2005.11.037; Cheng S, 2006, NEURAL COMPUT, V18, P760, DOI 10.1162/089976606775774651; Dempster Frank N., 1996, MEMORY, P317, DOI DOI 10.1016/B978-012102570-0/50011-2; DEUBEL H, 1995, VISION RES, V35, P3529, DOI 10.1016/0042-6989(95)00058-M; EBBINGHAUS H, 1885, UBER GEDACHTNIS INTE; ERKELENS CJ, 1993, EXP BRAIN RES, V93, P157; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; Fitzgibbon E. J., 1986, ADAPTIVE PROCESSES V, P329; Fuchs AF, 1996, J NEUROPHYSIOL, V76, P2522, DOI 10.1152/jn.1996.76.4.2522; Fusi S, 2005, NEURON, V45, P599, DOI 10.1016/j.neuron.2005.02.001; Gancarz G, 1999, VISION RES, V39, P3123, DOI 10.1016/S0042-6989(99)00049-8; GLENBERG AM, 1977, J EXP PSYCHOL-HUM L, V3, P282, DOI 10.1037/0278-7393.3.3.282; HAYKIN S, 2001, KALMAN FILTERIN NEUR; Hinton G.E., 1987, P 9 ANN C COGNITIVE, P177; Hopp J, 2004, PROG NEUROBIOL, V72, P27, DOI 10.1016/j.pneurobio.2003.12.002; Jost A., 1897, Z PSYCHOL PHYSIOL SI, V16, P436; Kalman R. E., 1960, J BASIC ENG-T ASME, V82, P35, DOI [10.1115/1.3662552, DOI 10.1115/1.3662552]; Kojima Y, 2004, J NEUROSCI, V24, P7531, DOI 10.1523/JNEUROSCI.1741-04.2004; Krakauer JW, 2006, PLOS BIOL, V4, P1798, DOI 10.1371/journal.pbio.0040316; Krakauer JW, 2005, J NEUROSCI, V25, P473, DOI 10.1523/JNEUROSCI.4218-04.2005; LEWIS RF, 1993, REV NEUROL, V149, P665; MCLAUGHLIN SC, 1967, PERCEPT PSYCHOPHYS, V2, P359, DOI 10.3758/BF03210071; NEWELL KM, 1991, ANNU REV PSYCHOL, V42, P213, DOI 10.1146/annurev.ps.42.020191.001241; Rescorla RA, 2004, LEARN BEHAV, V32, P401; Robinson FR, 2006, J NEUROPHYSIOL, V96, P1030, DOI 10.1152/jn.01151.2005; RUDERMAN DL, 1994, PHYS REV LETT, V73, P814, DOI 10.1103/PhysRevLett.73.814; Scudder CA, 1998, J NEUROPHYSIOL, V79, P704, DOI 10.1152/jn.1998.79.2.704; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Shutoh F, 2006, NEUROSCIENCE, V139, P767, DOI 10.1016/j.neuroscience.2005.12.035; Smith MA, 2006, PLOS BIOL, V4, P1035, DOI 10.1371/journal.pbio.0040179; Thoroughman KA, 2000, NATURE, V407, P742, DOI 10.1038/35037588; Wallman J, 1998, J NEUROPHYSIOL, V80, P2405, DOI 10.1152/jn.1998.80.5.2405; WHITTEN WB, 1977, J VERB LEARN VERB BE, V16, P465, DOI 10.1016/S0022-5371(77)80040-6; Wixted JT, 2004, ANNU REV PSYCHOL, V55, P235, DOI 10.1146/annurev.psych.55.090902.141555; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026	42	259	261	1	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2007	10	6					779	786		10.1038/nn1901	http://dx.doi.org/10.1038/nn1901			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	172JI	17496891	Green Accepted			2022-12-17	WOS:000246799800021
J	Moriceau, S; Sullivan, RM				Moriceau, Stephanie; Sullivan, Regina M.			Maternal presence serves as a switch between learning fear and attraction in infancy	NATURE NEUROSCIENCE			English	Article							MALTREATMENT; NEUROBIOLOGY; BEHAVIOR; AMYGDALA; EVENTS; STRESS	Odor-shock conditioning produces either olfactory preference or aversion in preweanling (12-15 days old) rats, depending on the context. In the mother's absence, odor-shock conditioning produces amygdala activation and learned odor avoidance. With maternal presence, this same conditioning yields an odor preference without amygdala activation. Maternal presence acts through modulation of pup corticosterone and corticosterone's regulation of amygdala activity. Over-riding maternal suppression of corticosterone through intra-amygdala corticosterone infusions permits fear conditioning and amygdala activation.	Univ Oklahoma, Dept Zool, Norman, OK 73019 USA	University of Oklahoma System; University of Oklahoma - Norman	Sullivan, RM (corresponding author), Univ Oklahoma, Dept Zool, Norman, OK 73019 USA.	rsullivan@ou.edu		Moriceau, Stephanie/0000-0002-1413-9359; Sullivan, Regina Marie/0000-0002-2406-8857	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD033402] Funding Source: NIH RePORTER; NICHD NIH HHS [HD33402, R01 HD033402] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Barr G A, 1995, NIDA Res Monogr, V158, P172; CAMP LL, 1988, DEV PSYCHOBIOL, V21, P25, DOI 10.1002/dev.420210103; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; HAROUTUNIAN V, 1979, SCIENCE, V205, P927, DOI 10.1126/science.472715; Heim C, 2001, BIOL PSYCHIAT, V49, P1023, DOI 10.1016/S0006-3223(01)01157-X; Levine S, 2000, EUR J PHARMACOL, V405, P149, DOI 10.1016/S0014-2999(00)00548-3; Maestripieri D, 2005, NEUROSCI BIOBEHAV R, V29, P51, DOI 10.1016/j.neubiorev.2004.05.004; Moriceau S, 2004, BEHAV NEUROSCI, V118, P274, DOI 10.1037/0735-7044.118.2.274; MORICEAU S, J NEUROSCI, V26, P6737; Pollak SD, 2002, P NATL ACAD SCI USA, V99, P9072, DOI 10.1073/pnas.142165999; Roth TL, 2005, BIOL PSYCHIAT, V57, P823, DOI 10.1016/j.biopsych.2005.01.032; STANTON ME, 1990, DEV PSYCHOBIOL, V23, P411, DOI 10.1002/dev.420230504; Sullivan RM, 2000, NATURE, V407, P38, DOI 10.1038/35024156; Sullivan RM, 2003, ANN NY ACAD SCI, V1008, P122, DOI 10.1196/annals.1301.013; Teicher MH, 2003, NEUROSCI BIOBEHAV R, V27, P33, DOI 10.1016/S0149-7634(03)00007-1	15	259	263	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2006	9	8					1004	1006		10.1038/nn1733	http://dx.doi.org/10.1038/nn1733			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	078CZ	16829957	Green Accepted			2022-12-17	WOS:000240080300011
J	Maimon, G; Straw, AD; Dickinson, MH				Maimon, Gaby; Straw, Andrew D.; Dickinson, Michael H.			Active flight increases the gain of visual motion processing in Drosophila	NATURE NEUROSCIENCE			English	Article							LOBULA PLATE; OLFACTORY REPRESENTATIONS; COLLISION-AVOIDANCE; RESPONSE PROPERTIES; INTERNEURONS; SYSTEM; FLY; NEURONS; LOCUST; ORGANIZATION	We developed a technique for performing whole-cell patch-clamp recordings from genetically identified neurons in behaving Drosophila. We focused on the properties of visual interneurons during tethered flight, but this technique generalizes to different cell types and behaviors. We found that the peak-to-peak responses of a class of visual motion-processing interneurons, the vertical-system visual neurons ( VS cells), doubled when flies were flying compared with when they were at rest. Thus, the gain of the VS cells is not fixed, but is instead behaviorally flexible and changes with locomotor state. Using voltage clamp, we found that the passive membrane resistance of VS cells was reduced during flight, suggesting that the elevated gain was a result of increased synaptic drive from upstream motion-sensitive inputs. The ability to perform patch-clamp recordings in behaving Drosophila promises to help unify the understanding of behavior at the gene, cell and circuit levels.	[Maimon, Gaby] CALTECH, Div Biol, Pasadena, CA 91125 USA; CALTECH, Div Engn & Appl Sci, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Maimon, G (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	maimon@caltech.edu	Straw, Andrew D/A-1244-2007	Straw, Andrew D/0000-0001-8381-0858	National Science Foundation [0623527]; Caltech Della Martin	National Science Foundation(National Science Foundation (NSF)); Caltech Della Martin	We thank J. Assad, V. Bhandawat, G. Card, C. Chiu, M. Do, T. Herrington, W. Korff, G. Laurent, M. Murthy, P. Polidoro, G. Turner and R. Wilson for helpful discussion, comments and aid in developing the preparation. We are grateful to L. Luo for the Gal4-3a fly line. This work was supported by a National Science Foundation Frontiers in Integrative Biological Research 0623527 award (M. H. D.) and a Caltech Della Martin fellowship (G. M.).	Balint CN, 2001, J EXP BIOL, V204, P4213; BARRY PH, 1991, J MEMBRANE BIOL, V121, P101, DOI 10.1007/BF01870526; BENZER S, 1967, P NATL ACAD SCI USA, V58, P1112, DOI 10.1073/pnas.58.3.1112; Borst A, 2002, J COMP PHYSIOL A, V188, P419, DOI 10.1007/s00359-002-0316-8; Brembs B, 2007, J NEUROSCI, V27, P11122, DOI 10.1523/JNEUROSCI.2704-07.2007; Budick SA, 2006, J EXP BIOL, V209, P3001, DOI 10.1242/jeb.02305; Busch S, 2009, J COMP NEUROL, V513, P643, DOI 10.1002/cne.21966; Fetcho JR, 2008, BRAIN RES REV, V57, P86, DOI 10.1016/j.brainresrev.2007.06.018; Fry SN, 2003, SCIENCE, V300, P495, DOI 10.1126/science.1081944; FRYE MA, 2007, AVANCES INVERTEBRATE; Gordon S, 2006, P NATL ACAD SCI USA, V103, P4311, DOI 10.1073/pnas.0510109103; GOTZ KG, 1968, KYBERNETIK, V4, P199, DOI 10.1007/BF00272517; GOTZ KG, 1987, J EXP BIOL, V128, P35; Graetzel CF, 2006, P IEEE RAS-EMBS INT, P1, DOI 10.1109/ISTAS.2006.4375883; Haag J, 2004, NAT NEUROSCI, V7, P628, DOI 10.1038/nn1245; Haag J, 1997, J COMPUT NEUROSCI, V4, P349, DOI 10.1023/A:1008804117334; Harris RA, 2000, NEURON, V28, P595, DOI 10.1016/S0896-6273(00)00136-7; Hausen K., 1984, PHOTORECEPTION VISIO; Hausen Klaus, 1993, Reviews of Oculomotor Research, V5, P203; HEISENBERG M, 1978, J COMP PHYSIOL, V124, P287, DOI 10.1007/BF00661379; HENGSTENBERG R, 1982, J COMP PHYSIOL, V149, P179, DOI 10.1007/BF00619212; HENGSTENBERG R, 1977, NATURE, V270, P338, DOI 10.1038/270338a0; Joesch M, 2008, CURR BIOL, V18, P368, DOI 10.1016/j.cub.2008.02.022; Krapp HG, 1998, J NEUROPHYSIOL, V79, P1902, DOI 10.1152/jn.1998.79.4.1902; Krapp HG, 1996, NATURE, V384, P463, DOI 10.1038/384463a0; KRAPP HG, 2008, SENSES COMPREHENSIVE, P131; Liu G, 2006, NATURE, V439, P551, DOI 10.1038/nature04381; Longden KD, 2009, J NEUROPHYSIOL, V102, P3606, DOI 10.1152/jn.00395.2009; Maimon G, 2008, CURR BIOL, V18, P464, DOI 10.1016/j.cub.2008.02.054; Neuser K, 2008, NATURE, V453, P1244, DOI 10.1038/nature07003; Niven JE, 2008, J EXP BIOL, V211, P1792, DOI 10.1242/jeb.017574; NORTH RA, 1989, J PHYSIOL-LONDON, V417, P1; ORCHARD I, 1993, ANNU REV ENTOMOL, V38, P227, DOI 10.1146/annurev.en.38.010193.001303; RAMIREZ JM, 1993, J NEUROPHYSIOL, V70, P2148, DOI 10.1152/jn.1993.70.5.2148; Reiser MB, 2008, J NEUROSCI METH, V167, P127, DOI 10.1016/j.jneumeth.2007.07.019; Rind FC, 2008, J NEUROPHYSIOL, V100, P670, DOI 10.1152/jn.01055.2007; Rosner R, 2010, J EXP BIOL, V213, P331, DOI 10.1242/jeb.035386; ROWELL CHF, 1971, J EXP BIOL, V55, P727; Schmidt MF, 1998, NAT NEUROSCI, V1, P513, DOI 10.1038/2232; Scott EK, 2002, J COMP NEUROL, V454, P470, DOI 10.1002/cne.10467; STRAUSFELD N J, 1976, P214; Strausfeld NJ, 2007, DEV NEUROBIOL, V67, P1267, DOI 10.1002/dneu.20396; Straw AD, 2009, SOURCE CODE BIOL MED, V4, DOI 10.1186/1751-0473-4-5; Tammero LF, 2002, J EXP BIOL, V205, P2785; Taylor GK, 2007, ADV INSECT PHYSIOL, V34, P231, DOI 10.1016/S0065-2806(07)34005-8; TOMIOKA K, 1984, ZOOL SCI, V1, P169; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; Turner GC, 2008, J NEUROPHYSIOL, V99, P734, DOI 10.1152/jn.01283.2007; Wilson RI, 2005, J NEUROSCI, V25, P9069, DOI 10.1523/JNEUROSCI.2070-05.2005; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782	50	258	258	1	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2010	13	3					393	U29		10.1038/nn.2492	http://dx.doi.org/10.1038/nn.2492			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	559WW	20154683				2022-12-17	WOS:000274860100023
J	Beuming, T; Kniazeff, J; Bergmann, ML; Shi, L; Gracia, L; Raniszewska, K; Newman, AH; Javitch, JA; Weinstein, H; Gether, U; Loland, CJ				Beuming, Thijs; Kniazeff, Julie; Bergmann, Marianne L.; Shi, Lei; Gracia, Luis; Raniszewska, Klaudia; Newman, Amy Hauck; Javitch, Jonathan A.; Weinstein, Harel; Gether, Ulrik; Loland, Claus J.			The binding sites for cocaine and dopamine in the dopamine transporter overlap	NATURE NEUROSCIENCE			English	Article							TRANSMEMBRANE DOMAIN-I; HUMAN SEROTONIN TRANSPORTERS; NEUROTRANSMITTER TRANSPORTERS; SUBSTRATE TRANSPORT; BACTERIAL HOMOLOG; UPTAKE INHIBITORS; RECOGNITION; MODEL; ACID; IDENTIFICATION	Cocaine is a widely abused substance with psychostimulant effects that are attributed to inhibition of the dopamine transporter (DAT). We present molecular models for DAT binding of cocaine and cocaine analogs constructed from the high-resolution structure of the bacterial transporter homolog LeuT. Our models suggest that the binding site for cocaine and cocaine analogs is deeply buried between transmembrane segments 1, 3, 6 and 8, and overlaps with the binding sites for the substrates dopamine and amphetamine, as well as for benztropine-like DAT inhibitors. We validated our models by detailed mutagenesis and by trapping the radiolabeled cocaine analog [H-3] CFT in the transporter, either by cross-linking engineered cysteines or with an engineered Zn2+-binding site that was situated extracellularly to the predicted common binding pocket. Our data demonstrate the molecular basis for the competitive inhibition of dopamine transport by cocaine.	[Kniazeff, Julie; Bergmann, Marianne L.; Raniszewska, Klaudia; Gether, Ulrik; Loland, Claus J.] Univ Copenhagen, Panum Inst 18 6, Fac Hlth Sci, Dept Neurosci & Pharmacol,Mol Neuropharmacol Grp, DK-2200 Copenhagen, Denmark; [Beuming, Thijs; Shi, Lei; Gracia, Luis; Weinstein, Harel] Cornell Univ, Weill Med Coll, Dept Physiol & Biophys, New York, NY 10021 USA; [Shi, Lei; Weinstein, Harel] Cornell Univ, Weill Med Coll, Inst Computat Biomed, New York, NY 10021 USA; [Newman, Amy Hauck] Natl Inst Drug Abuse, Med Chem Sect, Medicat Discovery Res Branch,NIH, Intramural Res Program,Dept Hlth & Human Servs, Baltimore, MD 21224 USA; [Javitch, Jonathan A.] Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY 10023 USA; [Javitch, Jonathan A.] Columbia Univ, Coll Phys & Surg, Dept Pharmacol, New York, NY 10023 USA; [Javitch, Jonathan A.] Columbia Univ, Coll Phys & Surg, Ctr Mol Recognit, New York, NY 10023 USA	University of Copenhagen; Cornell University; Cornell University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); Columbia University; Columbia University; Columbia University	Gether, U (corresponding author), Univ Copenhagen, Panum Inst 18 6, Fac Hlth Sci, Dept Neurosci & Pharmacol,Mol Neuropharmacol Grp, Blegdamsvej 3, DK-2200 Copenhagen, Denmark.	gether@sund.ku.dk	Loland, Claus/E-5975-2014; Shi, Lei/AAV-1321-2020; WEINSTEIN, HAREL/O-8245-2019	Loland, Claus/0000-0002-1773-1446; Shi, Lei/0000-0002-4137-096X; WEINSTEIN, HAREL/0000-0003-3473-9818; Javitch, Jonathan/0000-0001-7395-2967; Kniazeff, Julie/0000-0002-0426-0999; Gracia, Luis/0000-0001-5412-6563; Gether, Ulrik/0000-0002-0020-3807	NATIONAL INSTITUTE ON DRUG ABUSE [P01DA012408, K05DA022413, Z01DA000389] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 DA000389-12] Funding Source: Medline; NIDA NIH HHS [K05 DA022413, DA 22413, P01 DA012408, P01 DA12408] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Aguayo LG, 2006, MINI-REV MED CHEM, V6, P997, DOI 10.2174/138955706778195144; Barker EL, 1999, J NEUROSCI, V19, P4705; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Beuming T, 2006, MOL PHARMACOL, V70, P1630, DOI 10.1124/mol.106.026120; Bismuth Y, 1997, J BIOL CHEM, V272, P16096, DOI 10.1074/jbc.272.26.16096; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; CARROLL FI, 1992, J MED CHEM, V35, P969, DOI 10.1021/jm00084a001; Chen JG, 1997, J BIOL CHEM, V272, P28321, DOI 10.1074/jbc.272.45.28321; Chen NH, 2004, PFLUG ARCH EUR J PHY, V447, P519, DOI 10.1007/s00424-003-1064-5; Chen R, 2005, J NEUROCHEM, V94, P352, DOI 10.1111/j.1471-4159.2005.03199.x; Chen R, 2006, P NATL ACAD SCI USA, V103, P9333, DOI 10.1073/pnas.0600905103; Desai RI, 2005, J NEUROSCI, V25, P1889, DOI 10.1523/JNEUROSCI.4778-04.2005; EDVARDSEN O, 1994, MOL BRAIN RES, V27, P265, DOI 10.1016/0169-328X(94)90009-4; Gether U, 2006, TRENDS PHARMACOL SCI, V27, P375, DOI 10.1016/j.tips.2006.05.003; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Henry LK, 2006, J BIOL CHEM, V281, P2012, DOI 10.1074/jbc.M505055200; Henry LK, 2003, J BIOL CHEM, V278, P37052, DOI 10.1074/jbc.M305514200; Huang X, 2007, BIOPHYS J, V93, P3627, DOI 10.1529/biophysj.107.110924; Iversen L, 2006, BRIT J PHARMACOL, V147, pS82, DOI 10.1038/sj.bjp.0706428; Katz JL, 2004, J PHARMACOL EXP THER, V309, P650, DOI 10.1124/jpet.103.060525; KITAYAMA S, 1992, P NATL ACAD SCI USA, V89, P7782, DOI 10.1073/pnas.89.16.7782; Lee SH, 2000, MOL PHARMACOL, V57, P883; Lin ZC, 1999, MOL PHARMACOL, V56, P434, DOI 10.1124/mol.56.2.434; Lin ZC, 2002, MOL PHARMACOL, V61, P885, DOI 10.1124/mol.61.4.885; Loland CJ, 2004, J BIOL CHEM, V279, P3228, DOI 10.1074/jbc.M304755200; Loland CJ, 2002, P NATL ACAD SCI USA, V99, P1683, DOI 10.1073/pnas.032386299; Loland CJ, 1999, J BIOL CHEM, V274, P36928, DOI 10.1074/jbc.274.52.36928; Loland CJ, 2008, MOL PHARMACOL, V73, P813, DOI 10.1124/mol.107.039800; Newman AH, 2002, MED RES REV, V22, P429, DOI 10.1002/med.10014; Niv MY, 2005, J AM CHEM SOC, V127, P14072, DOI 10.1021/ja054195s; Nnadi Charles U, 2005, J Natl Med Assoc, V97, P1504; Ravna AW, 2003, J COMPUT AID MOL DES, V17, P367, DOI 10.1023/A:1026116017725; RITZ MC, 1987, SCIENCE, V237, P1219, DOI 10.1126/science.2820058; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Sen N, 2005, NEUROPHARMACOLOGY, V49, P780, DOI 10.1016/j.neuropharm.2005.08.014; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Torres GE, 2007, CURR OPIN NEUROBIOL, V17, P304, DOI 10.1016/j.conb.2007.05.002; Uhl GR, 2003, EUR J PHARMACOL, V479, P71, DOI 10.1016/j.ejphar.2003.08.058; Ukairo OT, 2005, J PHARMACOL EXP THER, V314, P575, DOI 10.1124/jpet.105.085829; Vaughan RA, 2007, J BIOL CHEM, V282, P8915, DOI 10.1074/jbc.M610633200; Volz TJ, 2005, SYNAPSE, V58, P72, DOI 10.1002/syn.20183; White KJ, 2006, PROTEIN SCI, V15, P2411, DOI 10.1110/ps.062386106; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhou YG, 2004, J BIOL CHEM, V279, P13800, DOI 10.1074/jbc.M311579200; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614; Zomot E, 2005, J BIOL CHEM, V280, P25512, DOI 10.1074/jbc.M503864200; Zomot E, 2007, NATURE, V449, P726, DOI 10.1038/nature06133	47	258	267	4	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2008	11	7					780	789		10.1038/nn.2146	http://dx.doi.org/10.1038/nn.2146			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	318KD	18568020	Green Accepted			2022-12-17	WOS:000257089400015
J	Williams, SR; Mitchell, SJ				Williams, Stephen R.; Mitchell, Simon J.			Direct measurement of somatic voltage clamp errors in central neurons	NATURE NEUROSCIENCE			English	Article							NEOCORTICAL PYRAMIDAL NEURONS; CAT SPINAL MOTONEURONES; ACTION-POTENTIAL OUTPUT; DENDRITIC SPINES; SYNAPSE LOCATION; TIME-COURSE; FEEDFORWARD INHIBITION; FLUCTUATION ANALYSIS; EXCITATORY SYNAPSES; QUANTAL ANALYSIS	The somatic voltage clamp technique has revolutionized understanding of synaptic physiology and the excitability of neurons. Although computer simulations have indicated that the somatic voltage clamp poorly controls voltage in the dendritic tree of neurons, where the majority of synaptic contacts are made, there has not been an experimental description of the performance of the somatic voltage clamp. Here, we directly quantify errors in the measurement of dendritic synaptic input by the somatic voltage clamp using simultaneous whole-cell recordings from the soma and apical dendrite of rat neocortical pyramidal neurons. The somatic voltage clamp did not control voltage at sites other than the soma and distorted measurement of the amplitude, kinetics, slope conductance and reversal potential of synaptic inputs in a dendritic distance-dependent manner. These errors question the use of the somatic voltage clamp as a quantitative tool in dendritic neurons.	[Williams, Stephen R.; Mitchell, Simon J.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Williams, SR (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	srw@mrc-lmb.cam.ac.uk		Williams, Stephen/0000-0001-5352-7947	Medical Research Council [MC_U105170644] Funding Source: Medline; MRC [MC_U105170644] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Araya R, 2006, P NATL ACAD SCI USA, V103, P17961, DOI 10.1073/pnas.0608755103; ARMSTRONG CM, 1992, METHOD ENZYMOL, V207, P100; BEKKERS JM, 1989, NATURE, V341, P230, DOI 10.1038/341230a0; Berger T, 2001, J NEUROPHYSIOL, V85, P855, DOI 10.1152/jn.2001.85.2.855; BLANTON MG, 1989, J NEUROSCI METH, V30, P203, DOI 10.1016/0165-0270(89)90131-3; Bloodgood BL, 2005, SCIENCE, V310, P866, DOI 10.1126/science.1114816; Borg-Graham LJ, 2001, NAT NEUROSCI, V4, P176, DOI 10.1038/84007; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; BUHL EH, 1994, NATURE, V368, P823, DOI 10.1038/368823a0; Cruikshank SJ, 2007, NAT NEUROSCI, V10, P462, DOI 10.1038/nn1861; EDWARDS FA, 1990, J PHYSIOL-LONDON, V430, P213, DOI 10.1113/jphysiol.1990.sp018289; FINKEL AS, 1983, J PHYSIOL-LONDON, V342, P615, DOI 10.1113/jphysiol.1983.sp014872; Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; Hasenstaub A, 2007, J NEUROSCI, V27, P9607, DOI 10.1523/JNEUROSCI.2184-07.2007; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Hausser M, 1997, J NEUROSCI, V17, P7606; JACK JJB, 1990, COLD SPRING HARB SYM, V55, P57; Jaffe DB, 1999, J NEUROPHYSIOL, V82, P3268, DOI 10.1152/jn.1999.82.6.3268; JOHNSTON D, 1983, J NEUROPHYSIOL, V50, P464, DOI 10.1152/jn.1983.50.2.464; JOHNSTON D, 1980, NATURE, V286, P391, DOI 10.1038/286391a0; kandel, 1977, NERVOUS SYSTEM, V1; Kennedy MB, 2005, NAT REV NEUROSCI, V6, P423, DOI 10.1038/nrn1685; Kole MHP, 2006, J NEUROSCI, V26, P1677, DOI 10.1523/JNEUROSCI.3664-05.2006; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; Migliore M, 2005, NAT REV NEUROSCI, V6, P810, DOI 10.1038/nrn1769; Nevian T, 2007, NAT NEUROSCI, V10, P206, DOI 10.1038/nn1826; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; REDMAN S, 1983, J PHYSIOL-LONDON, V343, P117, DOI 10.1113/jphysiol.1983.sp014884; REDMAN S, 1990, PHYSIOL REV, V70, P165, DOI 10.1152/physrev.1990.70.1.165; Sabatini BL, 2000, NATURE, V408, P589, DOI 10.1038/35046076; Sabatini BL, 1999, ANNU REV PHYSIOL, V61, P521, DOI 10.1146/annurev.physiol.61.1.521; Sakmann B., 1995, SINGLE CHANNEL RECOR; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; Silver RA, 2003, SCIENCE, V302, P1981, DOI 10.1126/science.1087160; Silver RA, 1998, J PHYSIOL-LONDON, V510, P881, DOI 10.1111/j.1469-7793.1998.881bj.x; SMITH TG, 1984, VOLTAGE PATCH CLAMPI; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; SPRUSTON N, 1993, J NEUROPHYSIOL, V70, P781, DOI 10.1152/jn.1993.70.2.781; Stuart G, 1998, J NEUROSCI, V18, P3501; Svoboda K, 1996, SCIENCE, V272, P716, DOI 10.1126/science.272.5262.716; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Williams SR, 2000, J NEUROPHYSIOL, V83, P3177, DOI 10.1152/jn.2000.83.5.3177; Williams SR, 2004, NAT NEUROSCI, V7, P961, DOI 10.1038/nn1305; Williams SR, 2003, J NEUROSCI, V23, P7358; Williams SR, 2003, TRENDS NEUROSCI, V26, P147, DOI 10.1016/S0166-2236(03)00035-3; Williams SR, 2002, SCIENCE, V295, P1907, DOI 10.1126/science.1067903; Zhang SJ, 2007, NEURON, V53, P549, DOI 10.1016/j.neuron.2007.01.025	50	258	262	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2008	11	7					790	798		10.1038/nn.2137	http://dx.doi.org/10.1038/nn.2137			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	318KD	18552844				2022-12-17	WOS:000257089400016
J	Padoa-Schioppa, C; Assad, JA				Padoa-Schioppa, Camillo; Assad, John A.			The representation of economic value in the orbitofrontal cortex is invariant for changes of menu	NATURE NEUROSCIENCE			English	Article							VENTROMEDIAL PREFRONTAL CORTEX; NEURONAL-ACTIVITY; REWARD VALUE; FRONTOTEMPORAL DEMENTIA; DECISION-MAKING; PARIETAL CORTEX; CHOICE; TRANSITIVITY; PREFERENCE; MONKEYS	Economic choice entails assigning values to the available options and is impaired by lesions to the orbitofrontal cortex (OFC). Recent results show that some neurons in the OFC encode the values that monkeys (Macaca mulatta) assign to different goods when they choose between them. A broad and fundamental question is how this neuronal representation of value depends on the behavioral context. Here we show that neuronal responses in the OFC are typically invariant for changes of menu. In other words, the activity of a neuron in response to one particular good usually does not depend on what other goods are available at the same time. Neurons in the OFC encode economic value, not relative preference. The fact that their responses are menu invariant suggests that transitivity, a fundamental trait of economic choice, may be rooted in the activity of individual neurons.	[Padoa-Schioppa, Camillo; Assad, John A.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Padoa-Schioppa, C (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	camillo@alum.mit.edu		Padoa-Schioppa, Camillo/0000-0002-7519-8790	NATIONAL INSTITUTE OF MENTAL HEALTH [K99MH080852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041000] Funding Source: NIH RePORTER; NIMH NIH HHS [K99 MH080852-01, K99 MH 080852, K99 MH080852] Funding Source: Medline; NINDS NIH HHS [R01 NS 41000, R01 NS041000-05, R01 NS041000] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALLINGHAM M, 2002, CHOICE THEORY VERY S, V125; Arana FS, 2003, J NEUROSCI, V23, P9632; Bechara A, 1996, CEREB CORTEX, V6, P215, DOI 10.1093/cercor/6.2.215; Blair K, 2006, J NEUROSCI, V26, P11379, DOI 10.1523/JNEUROSCI.1640-06.2006; CAMPIONE JC, 1969, J EXP CHILD PSYCHOL, V7, P387, DOI 10.1016/0022-0965(69)90001-0; Carmichael ST, 1995, J COMP NEUROL, V363, P642, DOI 10.1002/cne.903630409; CHOI S, IN PRESS AM EC REV; Critchley HD, 2005, J COMP NEUROL, V493, P154, DOI 10.1002/cne.20749; Cromwell HC, 2005, EXP BRAIN RES, V162, P520, DOI 10.1007/s00221-005-2223-z; Dorris MC, 2004, NEURON, V44, P365, DOI 10.1016/j.neuron.2004.09.009; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Fellows LK, 2007, CEREB CORTEX, V17, P2669, DOI 10.1093/cercor/bhl176; Fellows Lesley K, 2004, Behav Cogn Neurosci Rev, V3, P159; Glimcher PW, 2005, GAME ECON BEHAV, V52, P213, DOI 10.1016/j.geb.2004.06.011; GRACE RC, 1993, J EXP ANAL BEHAV, V60, P185, DOI 10.1901/jeab.1993.60-185; Hodges JR, 2001, NEUROLOGY, V56, pS6, DOI 10.1212/WNL.56.suppl_4.S6; Hosokawa T, 2007, NEUROSCI RES, V57, P434, DOI 10.1016/j.neures.2006.12.003; Izquierdo A, 2004, J NEUROSCI, V24, P7540, DOI 10.1523/JNEUROSCI.1921-04.2004; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; Knutson B, 2005, J NEUROSCI, V25, P4806, DOI 10.1523/JNEUROSCI.0642-05.2005; Koenigs M, 2007, J NEUROSCI, V27, P951, DOI 10.1523/JNEUROSCI.4606-06.2007; KREPS DM, 1990, COURSE MICROECONOMIC, V850; LOGAN FA, 1965, J COMP PHYSIOL PSYCH, V59, P1, DOI 10.1037/h0021633; Luce R, 1959, INDIVIDUAL CHOICE BE; MAZUR JE, 1987, J EXP ANAL BEHAV, V47, P287, DOI 10.1901/jeab.1987.47-287; Montague PR, 2002, NEURON, V36, P265, DOI 10.1016/S0896-6273(02)00974-1; NAVARICK DJ, 1972, J EXP ANAL BEHAV, V18, P389, DOI 10.1901/jeab.1972.18-389; O'Doherty JP, 2004, CURR OPIN NEUROBIOL, V14, P769, DOI 10.1016/j.conb.2004.10.016; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Padoa-Schioppa C, 2006, COGNITION, V99, pB1, DOI 10.1016/j.cognition.2005.04.008; PADOASCHIOPPA C, 2007, ANN NY ACAD SCI, DOI DOI 10.1196/ANNALS.1404.011; Pasquier F, 1997, EUR NEUROL, V38, P1, DOI 10.1159/000112894; Price JL, 1999, ANN NY ACAD SCI, V877, P383, DOI 10.1111/j.1749-6632.1999.tb09278.x; Pritchard TC, 2005, J NEUROSCI, V25, P6047, DOI 10.1523/JNEUROSCI.0430-05.2005; Rahman S, 1999, BRAIN, V122, P1469, DOI 10.1093/brain/122.8.1469; Roesch MR, 2005, J NEUROPHYSIOL, V94, P1469, DOI 10.1152/jn.00064.2005; Roesch MR, 2004, SCIENCE, V304, P307, DOI 10.1126/science.1093223; ROLLS ET, 1989, EUR J NEUROSCI, V1, P53, DOI 10.1111/j.1460-9568.1989.tb00774.x; Shafir S, 2002, BEHAV ECOL SOCIOBIOL, V51, P180, DOI 10.1007/s00265-001-0420-8; SHAFIR S, 1994, ANIM BEHAV, V48, P55, DOI 10.1006/anbe.1994.1211; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; TVERSKY A, 1969, PSYCHOL REV, V76, P31, DOI 10.1037/h0026750; TVERSKY A, 1993, MANAGE SCI, V39, P1179, DOI 10.1287/mnsc.39.10.1179; Wallis JD, 2003, EUR J NEUROSCI, V18, P2069, DOI 10.1046/j.1460-9568.2003.02922.x	47	258	262	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2008	11	1					95	102		10.1038/nn2020	http://dx.doi.org/10.1038/nn2020			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	247YG	18066060	Green Accepted			2022-12-17	WOS:000252117900017
J	Gothelf, D; Eliez, S; Thompson, T; Hinard, C; Penniman, L; Feinstein, C; Kwon, H; Jin, ST; Jo, B; Antonarakis, SE; Morris, MA; Reiss, AL				Gothelf, D; Eliez, S; Thompson, T; Hinard, C; Penniman, L; Feinstein, C; Kwon, H; Jin, ST; Jo, B; Antonarakis, SE; Morris, MA; Reiss, AL			COMT genotype predicts longitudinal cognitive decline and psychosis in 22q11.2 deletion syndrome	NATURE NEUROSCIENCE			English	Article							CARDIO-FACIAL SYNDROME; GENETIC-VARIATION; SCHIZOPHRENIA; BRAIN	Although schizophrenia is strongly hereditary, there are limited data regarding biological risk factors and pathophysiological processes. In this longitudinal study of adolescents with 22q11.2 deletion syndrome, we identified the catechol-O-methyltransferase low-activity allele (COMTL) as a risk factor for decline in prefrontal cortical volume and cognition, as well as for the consequent development of psychotic symptoms during adolescence. The 22q11.2 deletion syndrome is a promising model for identifying biomarkers related to the development of schizophrenia.	Stanford Univ, Sch Med, Ctr Interdisciplinary Brain Sci Res, Stanford, CA 94305 USA; Tel Aviv Univ, Sackler Fac Med, Ramat Aviv, Israel; Univ Geneva, Sch Med, Dept Psychiat, CH-1206 Geneva, Switzerland; Univ Hosp Geneva, Med Genet Serv, CH-1211 Geneva, Switzerland; Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98104 USA; Ctr Med Univ Geneva, Univ Med Sch, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland	Stanford University; Tel Aviv University; Sackler Faculty of Medicine; University of Geneva; University of Geneva; University of Washington; University of Washington Seattle; University of Geneva	Reiss, AL (corresponding author), Stanford Univ, Sch Med, Ctr Interdisciplinary Brain Sci Res, 401 Quarry Rd, Stanford, CA 94305 USA.	reiss@stanford.edu	Antonarakis, Stylianos E/N-8866-2014	Antonarakis, Stylianos E/0000-0001-8907-5823	NICHD NIH HHS [HD31715] Funding Source: Medline; NIMH NIH HHS [MH50047, MH19908] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD031715] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH050047] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bearden CE, 2004, AM J PSYCHIAT, V161, P1700, DOI 10.1176/appi.ajp.161.9.1700; Blasi G, 2005, J NEUROSCI, V25, P5038, DOI 10.1523/JNEUROSCI.0476-05.2005; Chen JS, 2004, AM J HUM GENET, V75, P807, DOI 10.1086/425589; Fuller R, 2002, AM J PSYCHIAT, V159, P1183, DOI 10.1176/appi.ajp.159.7.1183; Gogos JA, 1998, P NATL ACAD SCI USA, V95, P9991, DOI 10.1073/pnas.95.17.9991; KARYIORGOU M, 1995, P NATL ACAD SCI USA, V92, P7612; Liu H, 2002, P NATL ACAD SCI USA, V99, P3717, DOI 10.1073/pnas.042700699; Mattay VS, 2003, P NATL ACAD SCI USA, V100, P6186, DOI 10.1073/pnas.0931309100; Maynard TM, 2003, P NATL ACAD SCI USA, V100, P14433, DOI 10.1073/pnas.2235651100; Murphy KC, 1999, ARCH GEN PSYCHIAT, V56, P940, DOI 10.1001/archpsyc.56.10.940; PULVER AE, 1994, J NERV MENT DIS, V182, P476, DOI 10.1097/00005053-199408000-00010; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; Shifman S, 2002, AM J HUM GENET, V71, P1296, DOI 10.1086/344514; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; WEINBERGER DR, 1995, LANCET, V346, P552, DOI 10.1016/S0140-6736(95)91386-6	15	258	265	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2005	8	11					1500	1502		10.1038/nn1572	http://dx.doi.org/10.1038/nn1572			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	979TB	16234808				2022-12-17	WOS:000232966600023
J	Viana, F; de la Pena, E; Belmonte, C				Viana, F; de la Pena, E; Belmonte, C			Specificity of cold thermotransduction is determined by differential ionic channel expression	NATURE NEUROSCIENCE			English	Article							ACTIVATED CATION CURRENT; NEURONS; HEAT; RECEPTORS; MENTHOL; RAT; CAPSAICIN; CORNEA; FIBERS	Sensations of cold are mediated by specific thermoreceptor nerve endings excited by low temperature and menthol. Here we identify a population of cold-sensitive cultured mouse trigeminal ganglion neurons with a unique set of biophysical properties. Their impulse activity during cooling and menthol application was similar to that of cold thermoreceptor fibers in vivo. We show that cooling closes a background K+ channel, causing depolarization and firing that is limited by the slower reduction of a cationic inward current (I-h). In cold-insensitive neurons, firing is prevented by a slow, transient, 4-AP-sensitive K+ current (IKD) that acts as an excitability brake. In addition, pharmacological blockade of IKD induced thermosensitivity in cold-insensitive neurons, a finding that may explain cold allodynia in neuropathic pain. These results suggest that cold sensitivity is not associated to a specific transduction molecule but instead results from a favorable blend of ionic channels expressed in a small subset of sensory neurons.	Univ Miguel Hernandez, Inst Neurociencias, CSIC, San Juan De Alicante 03550, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN)	Viana, F (corresponding author), Univ Miguel Hernandez, Inst Neurociencias, CSIC, Apartado 18, San Juan De Alicante 03550, Spain.		Elvira, De la Pena/O-7380-2015; Viana, Felix/U-8533-2017	Elvira, De la Pena/0000-0001-5961-5067; Viana, Felix/0000-0003-1439-949X				BEVAN S, 1990, TRENDS PHARMACOL SCI, V11, P330; BRAUN HA, 1980, PFLUG ARCH EUR J PHY, V386, P1, DOI 10.1007/BF00584180; Brock JA, 2001, J PHYSIOL-LONDON, V533, P493, DOI 10.1111/j.1469-7793.2001.0493a.x; Brock JA, 1998, J PHYSIOL-LONDON, V512, P211, DOI 10.1111/j.1469-7793.1998.211bf.x; CARPENTER DO, 1981, FED PROC, V40, P2808; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cesare P, 1996, P NATL ACAD SCI USA, V93, P15435, DOI 10.1073/pnas.93.26.15435; Craig AD, 2001, J NEUROPHYSIOL, V86, P1459, DOI 10.1152/jn.2001.86.3.1459; Craig AD, 2000, NAT NEUROSCI, V3, P184, DOI 10.1038/72131; ECCLES R, 1994, J PHARM PHARMACOL, V46, P618, DOI 10.1111/j.2042-7158.1994.tb03871.x; GALLAR J, 1993, J PHYSIOL-LONDON, V468, P609, DOI 10.1113/jphysiol.1993.sp019791; GarciaAnoveros J, 1997, ANNU REV NEUROSCI, V20, P567, DOI 10.1146/annurev.neuro.20.1.567; Goldstein SAN, 2001, NAT REV NEUROSCI, V2, P175, DOI 10.1038/35058574; Grafe P, 1997, J NEUROPHYSIOL, V77, P421, DOI 10.1152/jn.1997.77.1.421; GREEN BG, 1992, SOMATOSENS MOT RES, V9, P235, DOI 10.3109/08990229209144774; Hamill OP, 2001, PHYSIOL REV, V81, P685, DOI 10.1152/physrev.2001.81.2.685; Han ZS, 1998, NAT NEUROSCI, V1, P218, DOI 10.1038/665; HENSEL H, 1951, ACTA PHYSIOL SCAND, V22, P96, DOI 10.1111/j.1748-1716.1951.tb00758.x; HENSEL H, 1960, J PHYSIOL-LONDON, V153, P113, DOI 10.1113/jphysiol.1960.sp006522; Hensel H, 1976, Prog Brain Res, V43, P105; HENSEL H, 1974, PFLUG ARCH EUR J PHY, V352, P1, DOI 10.1007/BF01061945; HENSEL H, 1971, PFLUG ARCH EUR J PHY, V329, P1, DOI 10.1007/BF00586896; Hervieu GJ, 2001, NEUROSCIENCE, V103, P899, DOI 10.1016/S0306-4522(01)00030-6; IGGO A, 1975, SOMATOSENSORY SYSTEM, P5; KENSHALO DR, 1967, SCIENCE, V158, P1064, DOI 10.1126/science.158.3804.1064; Koerber HR, 1992, SENSORY NEURONS DIVE, P77; LAMOTTE RH, 1982, BRAIN RES, V244, P279, DOI 10.1016/0006-8993(82)90086-5; Lesage F, 2000, AM J PHYSIOL-RENAL, V279, pF793, DOI 10.1152/ajprenal.2000.279.5.F793; Maingret F, 2000, EMBO J, V19, P2483, DOI 10.1093/emboj/19.11.2483; McCleskey EW, 1997, CURR BIOL, V7, pR679, DOI 10.1016/S0960-9822(06)00354-X; Moosmang S, 2001, EUR J BIOCHEM, V268, P1646, DOI 10.1046/j.1432-1327.2001.02036.x; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.physiol.58.1.299; PIERAU FK, 1975, PFLUG ARCH EUR J PHY, V359, P349, DOI 10.1007/BF00581445; Rasband MN, 2001, P NATL ACAD SCI USA, V98, P13373, DOI 10.1073/pnas.231376298; Reid G, 2001, NATURE, V413, P480, DOI 10.1038/35097164; Reid G, 2001, NEUROSCI LETT, V297, P171, DOI 10.1016/S0304-3940(00)01694-3; SCHAFER K, 1986, J GEN PHYSIOL, V88, P757, DOI 10.1085/jgp.88.6.757; SCHAFER K, 1988, PFLUG ARCH EUR J PHY, V412, P188, DOI 10.1007/BF00583749; SCROGGS RS, 1994, J NEUROPHYSIOL, V71, P271, DOI 10.1152/jn.1994.71.1.271; SPRAY DC, 1986, ANNU REV PHYSIOL, V48, P625; SPRAY DC, 1974, BRAIN RES, V72, P354, DOI 10.1016/0006-8993(74)90881-6; STANSFELD CE, 1986, NEUROSCI LETT, V64, P299, DOI 10.1016/0304-3940(86)90345-9; STORM JF, 1988, NATURE, V336, P379, DOI 10.1038/336379a0; Takigawa T, 1998, NEUROSCIENCE, V82, P631; Viana F, 2001, EUR J NEUROSCI, V13, P722, DOI 10.1046/j.0953-816x.2000.01441.x; Waldmann R, 1998, CURR OPIN NEUROBIOL, V8, P418, DOI 10.1016/S0959-4388(98)80070-6; YARNITSKY D, 1991, BRAIN, V114, P1819, DOI 10.1093/brain/114.4.1819	47	258	271	0	15	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2002	5	3					254	260		10.1038/nn809	http://dx.doi.org/10.1038/nn809			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	526TP	11836533				2022-12-17	WOS:000174146000016
J	Hodge, CW; Mehmert, KK; Kelley, SP; McMahon, T; Haywood, A; Olive, MF; Wang, D; Sanchez-Perez, AM; Messing, RO				Hodge, CW; Mehmert, KK; Kelley, SP; McMahon, T; Haywood, A; Olive, MF; Wang, D; Sanchez-Perez, AM; Messing, RO			Supersensitivity to allosteric GABA(A) receptor modulators and alcohol in mice lacking PKC epsilon	NATURE NEUROSCIENCE			English	Article							PROTEIN-KINASE-C; WHOLE-CELL CURRENTS; A RECEPTOR; ETHANOL SENSITIVITY; RAT-BRAIN; GABAERGIC TRANSMISSION; CHLORIDE CHANNELS; NEURONS; PHOSPHORYLATION; ENHANCEMENT	Several of the actions of ethanol are mediated by gamma-aminobutyrate type A (GABA(A)) receptors. Here we demonstrated that mutant mice lacking protein kinase C epsilon (PKC epsilon) were more sensitive than wildtype littermates to the acute behavioral effects of ethanol and other drugs that allosterically activate GABA(A) receptors. GABA(A) receptors in membranes isolated from the frontal cortex of PKC epsilon null mice were also supersensitive to allosteric activation by ethanol and flunitrazepam. In addition, these mutant mice showed markedly reduced ethanol self-administration. These findings indicate that inhibition of PKC epsilon increases sensitivity of GABA(A) receptors to ethanol and allosteric modulators. Pharmacological agents that inhibit PKC epsilon may be useful for treatment of alcoholism and may provide a non-sedating alternative for enhancing GABA(A) receptor function to treat other disorders such as anxiety and epilepsy.	Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94110 USA; Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, San Francisco, CA 94110 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center	Hodge, CW (corresponding author), Univ Calif San Francisco, Dept Neurol, 1001 Potrero Ave,Bldg 1,Room 101, San Francisco, CA 94110 USA.		Sánchez-Pérez, Ana María M/N-2731-2017; Sánchez-Pérez, Ana María/AAB-4454-2019; Messing, Robert/D-3642-2015	Sánchez-Pérez, Ana María M/0000-0002-5811-0005; Messing, Robert/0000-0002-5345-4431; Hodge, Clyde/0000-0002-6860-7955; Olive, Foster/0000-0002-2517-0351				ALLAN AM, 1987, PHARMACOL BIOCHEM BE, V27, P665, DOI 10.1016/0091-3057(87)90192-4; Coe IR, 1996, J BIOL CHEM, V271, P29468, DOI 10.1074/jbc.271.46.29468; Crabbe JC, 1996, NAT GENET, V14, P98, DOI 10.1038/ng0996-98; DEITRICH RA, 1989, PHARMACOL REV, V41, P489; DIETRICH RA, 1989, PHARMACOL REV, V41, P489; FINN DA, 1994, ALCOHOL CLIN EXP RES, V18, P382, DOI 10.1111/j.1530-0277.1994.tb00029.x; FRYE GD, 1981, PSYCHOPHARMACOLOGY, V75, P372, DOI 10.1007/BF00435856; GIVENS BS, 1990, J PHARMACOL EXP THER, V254, P528; Gordon AS, 1997, MOL PHARMACOL, V52, P554, DOI 10.1124/mol.52.4.554; GUIDOTTI A, 1983, NEUROPHARMACOLOGY, V22, P1471, DOI 10.1016/0028-3908(83)90115-6; HARRIS RA, 1995, P NATL ACAD SCI USA, V92, P3658, DOI 10.1073/pnas.92.9.3658; HODGE C, 1996, ALCOHOL CLIN EXP RES, V21, P250; Hodge CW, 1995, ALCOHOL CLIN EXP RES, V19, P1486, DOI 10.1111/j.1530-0277.1995.tb01012.x; Hodge CW, 1998, PSYCHOPHARMACOLOGY, V139, P95, DOI 10.1007/s002130050694; Homanics GE, 1999, NEUROPHARMACOLOGY, V38, P253, DOI 10.1016/S0028-3908(98)00177-4; Hundle B, 1997, J BIOL CHEM, V272, P15028, DOI 10.1074/jbc.272.23.15028; Johnson JA, 1996, J BIOL CHEM, V271, P24962, DOI 10.1074/jbc.271.40.24962; KELLENBERGER S, 1992, J BIOL CHEM, V267, P25660; KHASAR S, IN PRESS NEURON; KRISHEK BJ, 1994, NEURON, V12, P1081, DOI 10.1016/0896-6273(94)90316-6; LEIDENHEIMER NJ, 1992, ADV BIOCHEM PSYCHOPH, V47, P269; LEIDENHEIMER NJ, 1992, MOL PHARMACOL, V41, P1116; LIN YF, 1994, NEURON, V13, P1421, DOI 10.1016/0896-6273(94)90427-8; Lin YF, 1996, MOL PHARMACOL, V50, P185; LOVINGER DM, 1989, SCIENCE, V243, P1721, DOI 10.1126/science.2467382; MARSZALEC W, 1994, J PHARMACOL EXP THER, V269, P157; MEHTA AK, 1988, J PHARMACOL EXP THER, V246, P558; MESSING RO, 1991, J BIOL CHEM, V266, P23428; Miyakawa T, 1997, SCIENCE, V278, P698, DOI 10.1126/science.278.5338.698; Mochly-Rosen D, 1998, FASEB J, V12, P35; Moss SJ, 1996, INT REV NEUROBIOL, V39, P1, DOI 10.1016/S0074-7742(08)60662-5; OLSEN RW, 1982, ANNU REV PHARMACOL, V22, P245, DOI 10.1146/annurev.pa.22.040182.001333; Phillips TJ, 1998, NAT NEUROSCI, V1, P610, DOI 10.1038/2843; Poisbeau P, 1999, J NEUROSCI, V19, P674; PROCTOR WR, 1992, BRAIN RES, V595, P220, DOI 10.1016/0006-8993(92)91053-H; SAITO N, 1993, BRAIN RES, V607, P241, DOI 10.1016/0006-8993(93)91512-Q; Sapp DW, 1998, J PHARMACOL EXP THER, V284, P768; SCHUCKIT MA, 1994, AM J PSYCHIAT, V151, P184; SIGEL E, 1993, FEBS LETT, V324, P140, DOI 10.1016/0014-5793(93)81380-I; SIGGINS GR, 1987, BRAIN RES, V414, P22, DOI 10.1016/0006-8993(87)91323-0; SUZDAK PD, 1986, P NATL ACAD SCI USA, V83, P4071, DOI 10.1073/pnas.83.11.4071; TANAKA C, 1994, ANNU REV NEUROSCI, V17, P551, DOI 10.1146/annurev.ne.17.030194.003003; Thiele TE, 1998, NATURE, V396, P366, DOI 10.1038/24614; WAFFORD KA, 1991, NEURON, V7, P27, DOI 10.1016/0896-6273(91)90071-7; WEINER JL, 1994, J PHARMACOL EXP THER, V268, P1388; Weiner JL, 1997, J NEUROCHEM, V68, P1949	46	258	269	1	16	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	1999	2	11					997	1002		10.1038/14795	http://dx.doi.org/10.1038/14795			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259FF	10526339				2022-12-17	WOS:000083883300017
J	Sanes, JR; Lichtman, JW				Sanes, JR; Lichtman, JW			Can molecules explain long-term potentiation?	NATURE NEUROSCIENCE			English	Editorial Material							RAT HIPPOCAMPAL SLICES; CELL-ADHESION MOLECULE; DEPENDENT PROTEIN-KINASE; LATERAL PERFORANT PATH; NITRIC-OXIDE SYNTHASE; MOSSY FIBER SYNAPSES; CA1 PYRAMIDAL CELLS; MICE LACKING; SYNAPTIC PLASTICITY; NMDA RECEPTOR	Although over 100 molecules have been Implicated in long-term potentiation and depression, no consensus on their underlying molecular mechanisms has emerged. Here we discuss the difficulties of providing molecular explanations for cellular neurobiological phenomena.	Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Sanes, JR (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, 660 S Euclid Ave,Campus Box 8108, St Louis, MO 63110 USA.							Abe K, 1996, J NEUROSCI, V16, P1066; ABELIOVICH A, 1993, CELL, V75, P1253, DOI 10.1016/0092-8674(93)90613-U; AIBA A, 1994, CELL, V79, P365, DOI 10.1016/0092-8674(94)90204-6; Aizawa M, 1997, BIOL PHARM BULL, V20, P1066; ANDREASSON K, 1995, NEUROSCIENCE, V69, P781, DOI 10.1016/0306-4522(95)00245-E; APPLEYARD ME, 1995, NEUROSCI LETT, V190, P25, DOI 10.1016/0304-3940(95)11491-E; Auerbach JM, 1996, J PHYSIOL-LONDON, V492, P479, DOI 10.1113/jphysiol.1996.sp021323; Bahr BA, 1997, J NEUROSCI, V17, P1320; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Bear M F, 1993, Curr Opin Neurobiol, V3, P197, DOI 10.1016/0959-4388(93)90210-P; Becker CG, 1996, J NEUROSCI RES, V45, P143, DOI 10.1002/(SICI)1097-4547(19960715)45:2<143::AID-JNR6>3.0.CO;2-A; Beilharz EJ, 1998, J NEUROSCI, V18, P9780; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Blitzer RD, 1998, SCIENCE, V280, P1940, DOI 10.1126/science.280.5371.1940; BONHOEFFER T, 1990, COLD SH Q B, V55, P137; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Bramham CR, 1997, NEUROREPORT, V8, P719, DOI 10.1097/00001756-199702100-00028; Bramham CR, 1996, J NEUROSCI, V16, P8123; Bronzino JD, 1996, BRAIN RES BULL, V41, P175, DOI 10.1016/S0361-9230(96)00166-9; Castillo PE, 1997, NATURE, V388, P590, DOI 10.1038/41574; Cavus I, 1998, HIPPOCAMPUS, V8, P373, DOI 10.1002/(SICI)1098-1063(1998)8:4<373::AID-HIPO5>3.0.CO;2-I; Chen SJ, 1997, BRAIN RES, V749, P181, DOI 10.1016/S0006-8993(96)01159-6; Chen W, 1996, P NATL ACAD SCI USA, V93, P8688, DOI 10.1073/pnas.93.16.8688; Chiang MY, 1998, NEURON, V21, P1353, DOI 10.1016/S0896-6273(00)80654-6; CLAIBORNE BJ, 1993, HIPPOCAMPUS, V3, P115, DOI 10.1002/hipo.450030202; COTMAN CW, 1988, ANNU REV NEUROSCI, V11, P61, DOI 10.1146/annurev.ne.11.030188.000425; Cremer H, 1998, P NATL ACAD SCI USA, V95, P13242, DOI 10.1073/pnas.95.22.13242; CREPEL V, 1993, J NEUROPHYSIOL, V69, P1774, DOI 10.1152/jn.1993.69.5.1774; DAVIES CH, 1991, NATURE, V349, P609, DOI 10.1038/349609a0; Drew GM, 1998, NEUROREPORT, V9, P1827, DOI 10.1097/00001756-199806010-00029; DUDEL J, 1961, J PHYSIOL-LONDON, V155, P543, DOI 10.1113/jphysiol.1961.sp006646; Eilam R, 1998, P NATL ACAD SCI USA, V95, P1888, DOI 10.1073/pnas.95.4.1888; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; Furuse H, 1998, EXP BRAIN RES, V123, P307, DOI 10.1007/s002210050573; Gao WQ, 1998, MOL CELL NEUROSCI, V11, P247, DOI 10.1006/mcne.1998.0696; Gerlai R, 1996, TRENDS NEUROSCI, V19, P177, DOI 10.1016/S0166-2236(96)20020-7; GRANT SGN, 1992, SCIENCE, V258, P1903, DOI 10.1126/science.1361685; Henning RH, 1997, PHARMACOL THERAPEUT, V74, P115, DOI 10.1016/S0163-7258(97)00015-6; Hicks A, 1997, NEUROSCIENCE, V79, P329, DOI 10.1016/S0306-4522(96)00700-2; HODGKIN AL, 1976, J PHYSIOL-LONDON, V263, P1; Huang AM, 1998, J NEUROSCI, V18, P4305; Huang YY, 1995, CELL, V83, P1211, DOI 10.1016/0092-8674(95)90146-9; Huang YY, 1996, P NATL ACAD SCI USA, V93, P8699, DOI 10.1073/pnas.93.16.8699; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; ISHIYAMA J, 1991, NEUROSCI RES, V12, P403, DOI 10.1016/0168-0102(91)90071-6; Izumi Y, 1997, NEUROSCI LETT, V232, P17, DOI 10.1016/S0304-3940(97)00567-3; Jia ZP, 1996, NEURON, V17, P945, DOI 10.1016/S0896-6273(00)80225-1; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Jun KS, 1998, LEARN MEMORY, V5, P317; Kang HJ, 1997, NEURON, V19, P653, DOI 10.1016/S0896-6273(00)80378-5; Kantor DB, 1996, SCIENCE, V274, P1744, DOI 10.1126/science.274.5293.1744; Kapur A, 1998, J NEUROPHYSIOL, V79, P2181, DOI 10.1152/jn.1998.79.4.2181; Kato A, 1997, FEBS LETT, V412, P183, DOI 10.1016/S0014-5793(97)00775-8; KATO K, 1994, NATURE, V367, P175, DOI 10.1038/367175a0; Katz B, 1996, J NEUROCYTOL, V25, P677, DOI 10.1007/BF02284834; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kessey K, 1997, BRAIN RES, V756, P184, DOI 10.1016/S0006-8993(97)00148-0; Kirov SA, 1999, J NEUROSCI, V19, P2876; Kiyama Y, 1998, J NEUROSCI, V18, P6704; Klann E, 1998, J BIOL CHEM, V273, P4516, DOI 10.1074/jbc.273.8.4516; Kojima N, 1997, P NATL ACAD SCI USA, V94, P4761, DOI 10.1073/pnas.94.9.4761; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Kullmann DM, 1998, TRENDS NEUROSCI, V21, P8, DOI 10.1016/S0166-2236(97)01150-8; KULLMANN DM, 1995, NEURON, V15, P997, DOI 10.1016/0896-6273(95)90089-6; Lauri SE, 1998, EUR J NEUROSCI, V10, P188; LISMAN J, 1994, TRENDS NEUROSCI, V17, P406, DOI 10.1016/0166-2236(94)90014-0; Lledo PM, 1998, SCIENCE, V279, P399, DOI 10.1126/science.279.5349.399; Lu YM, 1998, SCIENCE, V279, P1363, DOI 10.1126/science.279.5355.1363; Lu YM, 1997, J NEUROSCI, V17, P5196; Luthi A, 1996, J NEUROSCI RES, V46, P1; Luthi A, 1997, J NEUROSCI, V17, P4688; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Manabe T, 1998, NATURE, V394, P577, DOI 10.1038/29073; MANAHANVAUGHAN D, 1995, NEUROPHARMACOLOGY, V34, P991, DOI 10.1016/0028-3908(95)00081-G; Matthies H, 1997, NEUROREPORT, V8, P3533, DOI 10.1097/00001756-199711100-00023; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; McCall MA, 1996, P NATL ACAD SCI USA, V93, P6361, DOI 10.1073/pnas.93.13.6361; McGahon B, 1998, HIPPOCAMPUS, V8, P48, DOI 10.1002/(SICI)1098-1063(1998)8:1<48::AID-HIPO5>3.3.CO;2-N; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; MILLER B, 1992, NATURE, V355, P722, DOI 10.1038/355722a0; Mizutani A, 1996, BRAIN RES, V739, P276, DOI 10.1016/S0006-8993(96)00834-7; Mullany PM, 1998, NEUROREPORT, V9, P2489, DOI 10.1097/00001756-199808030-00012; MULLER D, 1995, SYNAPSE, V19, P37, DOI 10.1002/syn.890190106; Nakic M, 1998, J NEUROBIOL, V37, P393; NostenBertrand M, 1996, NATURE, V379, P826, DOI 10.1038/379826a0; Okabe S, 1998, J NEUROSCI, V18, P4177; Osten P, 1996, J NEUROSCI, V16, P2444; Parent A, 1998, J NEUROPHYSIOL, V79, P3295, DOI 10.1152/jn.1998.79.6.3295; Qi M, 1996, P NATL ACAD SCI USA, V93, P1571, DOI 10.1073/pnas.93.4.1571; Roberts LA, 1998, NEUROREPORT, V9, P33, DOI 10.1097/00001756-199801050-00007; Roder JK, 1996, PHYSIOL BEHAV, V60, P611, DOI 10.1016/S0031-9384(96)80038-2; Sakurai E, 1998, NEUROREPORT, V9, P881, DOI 10.1097/00001756-199803300-00022; Schneider H, 1998, P NATL ACAD SCI USA, V95, P7778, DOI 10.1073/pnas.95.13.7778; SCHUMAN EM, 1994, P NATL ACAD SCI USA, V91, P11958, DOI 10.1073/pnas.91.25.11958; Schurmans S, 1997, P NATL ACAD SCI USA, V94, P10415, DOI 10.1073/pnas.94.19.10415; Shankar S, 1998, J NEUROPHYSIOL, V79, P334, DOI 10.1152/jn.1998.79.1.334; SPILLANE DM, 1995, NEUROPHARMACOLOGY, V34, P1573, DOI 10.1016/0028-3908(95)00107-H; STAUBLI U, 1995, J NEUROSCI, V15, P2445, DOI 10.1523/JNEUROSCI.15-03-02445.1995; Steel M, 1998, HIPPOCAMPUS, V8, P444, DOI 10.1002/(SICI)1098-1063(1998)8:5<444::AID-HIPO5>3.0.CO;2-X; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; TANCREDI V, 1993, NEUROREPORT, V4, P147, DOI 10.1097/00001756-199302000-00008; Tang LX, 1998, NEURON, V20, P1165, DOI 10.1016/S0896-6273(00)80497-3; TERRANOVA JP, 1995, N-S ARCH PHARMACOL, V352, P576, DOI 10.1007/BF00169393; Tokuda M, 1997, BRAIN RES, V755, P162, DOI 10.1016/S0006-8993(97)00189-3; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; UMEMORI H, 1994, NATURE, V367, P572, DOI 10.1038/367572a0; VANDERKLISH P, 1995, MOL BRAIN RES, V32, P25, DOI 10.1016/0169-328X(95)00057-Y; Vizi ES, 1998, HIPPOCAMPUS, V8, P566, DOI 10.1002/(SICI)1098-1063(1998)8:6<566::AID-HIPO2>3.0.CO;2-W; Walther T, 1998, J BIOL CHEM, V273, P11867, DOI 10.1074/jbc.273.19.11867; WANG JH, 1995, NEURON, V15, P443, DOI 10.1016/0896-6273(95)90048-9; Wang JH, 1997, J NEUROSCI, V17, P4600; Warren SG, 1995, BRAIN RES, V703, P26, DOI 10.1016/0006-8993(95)01059-9; WILLIAMS J, 1995, MOL BRAIN RES, V28, P87, DOI 10.1016/0169-328X(94)00187-J; WILLIAMS JH, 1993, NEURON, V11, P877, DOI 10.1016/0896-6273(93)90117-A; Winder DG, 1998, CELL, V92, P25, DOI 10.1016/S0092-8674(00)80896-X; Wolf MJ, 1995, FEBS LETT, V377, P358, DOI 10.1016/0014-5793(95)01371-7; Wu J, 1997, NEUROSCIENCE, V78, P393, DOI 10.1016/S0306-4522(97)84911-1; WU ZL, 1995, P NATL ACAD SCI USA, V92, P220, DOI 10.1073/pnas.92.1.220; ZHUO M, 1994, NATURE, V368, P635, DOI 10.1038/368635a0; ZHUO M, 1993, SCIENCE, V260, P1946, DOI 10.1126/science.8100368	122	258	265	1	11	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	1999	2	7					597	604		10.1038/10154	http://dx.doi.org/10.1038/10154			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259EY	10404178				2022-12-17	WOS:000083882600009
J	Schuller, AGP; King, MA; Zhang, JW; Bolan, E; Pan, YX; Morgan, DJ; Chang, A; Czick, ME; Unterwald, EM; Pasternak, GW; Pintar, JE				Schuller, AGP; King, MA; Zhang, JW; Bolan, E; Pan, YX; Morgan, DJ; Chang, A; Czick, ME; Unterwald, EM; Pasternak, GW; Pintar, JE			Retention of heroin and morphine-6 beta-glucuronide analgesia in a new line of mice lacking exon 1 of MOR-1	NATURE NEUROSCIENCE			English	Article							MORPHINE-INDUCED ANALGESIA; PROTEIN ALPHA-SUBUNITS; NITRIC-OXIDE SYNTHASE; OPIOID-RECEPTOR; ANTISENSE OLIGODEOXYNUCLEOTIDES; DIFFERENTIAL BLOCKADE; MOLECULAR-BIOLOGY; MU-RECEPTOR; EXPRESSION; BINDING	Morphine produces analgesia by activating mu opioid receptors encoded by the MOR-1 gene. Although morphine-6 beta-glucuronide (M6G), heroin and 6-acetylmorphine also are considered mu opioids, recent evidence suggests that they act through a distinct receptor mechanism. We examined this question in knockout mice containing disruptions of either the first or second coding exon of MOR-1. Mice homozygous for either MOR-1 mutation were insensitive to morphine. Heroin, 6-acetylmorphine and M6G still elicited analgesia in the exon-l MOR-1 mutant, which also showed specific M6G binding, whereas M6G and 6-acetylmorphine were inactive in the exon-2 MOR-1 mutant. These results provide genetic evidence for a unique receptor site for M6G and heroin analgesia.	Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, CABM, Dept Neurosci & Cell Biol, Piscataway, NJ 08854 USA; Mem Sloan Kettering Canc Ctr, Cotzias Lab Neurooncol, New York, NY 10021 USA; NYU, Med Ctr, Dept Psychiat, New York, NY 10016 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Memorial Sloan Kettering Cancer Center; New York University	Pintar, JE (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, CABM, Dept Neurosci & Cell Biol, RM 326,675 Hoes Lane, Piscataway, NJ 08854 USA.	pintar@mbcl.rutgers.edu		Morgan, Daniel/0000-0002-9467-4019	NIDA NIH HHS [DA-08622, DA-09040, R56 DA002615, DA-00296, R01 DA007242] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA008622, R01DA007242, R56DA002615, R01DA009040] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		BARE LA, 1994, FEBS LETT, V354, P213, DOI 10.1016/0014-5793(94)01129-X; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Brown GP, 1997, J PHARMACOL EXP THER, V282, P1291; Brown GP, 1997, FEBS LETT, V412, P35, DOI 10.1016/S0014-5793(97)00710-2; CHEN XH, 1995, EUR J PHARMACOL, V275, P105, DOI 10.1016/0014-2999(95)00012-A; HUANG PL, 1993, CELL, V75, P1273, DOI 10.1016/0092-8674(93)90615-W; INTURRISI CE, 1984, NEW ENGL J MED, V310, P1213, DOI 10.1056/NEJM198405103101902; INTURRISI CE, 1983, LIFE SCI, V33, P773, DOI 10.1016/0024-3205(83)90616-1; Joyner AL, 1993, GENE TARGETING PRACT; Loh HH, 1998, MOL BRAIN RES, V54, P321, DOI 10.1016/S0169-328X(97)00353-7; Matthes HWD, 1996, NATURE, V383, P819, DOI 10.1038/383819a0; MOSKOWITZ AS, 1985, BRAIN RES, V360, P117, DOI 10.1016/0006-8993(85)91227-2; OLDENDORF WH, 1972, SCIENCE, V178, P984, DOI 10.1126/science.178.4064.984; PASTERNAK GW, 1995, TRENDS PHARMACOL SCI, V16, P344, DOI 10.1016/S0165-6147(00)89068-9; PASTERNAK GW, 1993, CLIN NEUROPHARMACOL, V16, P1, DOI 10.1097/00002826-199302000-00001; PAUL D, 1989, J PHARMACOL EXP THER, V251, P477; PICK CG, 1993, J PHARMACOL EXP THER, V265, P166; REISINE T, 1993, TRENDS NEUROSCI, V16, P506, DOI 10.1016/0166-2236(93)90194-Q; ROSSI G, 1994, LIFE SCI, V54, pPL375, DOI 10.1016/0024-3205(94)90038-8; ROSSI GC, 1995, NEUROSCI LETT, V198, P99, DOI 10.1016/0304-3940(95)11977-5; ROSSI GC, 1995, FEBS LETT, V369, P192, DOI 10.1016/0014-5793(95)00757-Z; Rossi GC, 1996, NEUROSCI LETT, V216, P1; Rossi GC, 1997, J PHARMACOL EXP THER, V281, P109; Sora I, 1997, P NATL ACAD SCI USA, V94, P1544, DOI 10.1073/pnas.94.4.1544; Standifer KM, 1996, MOL PHARMACOL, V50, P293; Tian MT, 1997, J EXP MED, V185, P1517, DOI 10.1084/jem.185.8.1517; UHL GR, 1994, TRENDS NEUROSCI, V17, P89, DOI 10.1016/0166-2236(94)90110-4; WAY EL, 1960, J PHARMACOL EXP THER, V129, P144; WAY EL, 1965, B NARCOTICS, V17, P25; ZIMPRICH A, 1995, FEBS LETT, V359, P142, DOI 10.1016/0014-5793(95)00028-8	30	258	264	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	1999	2	2					151	156		10.1038/5706	http://dx.doi.org/10.1038/5706			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	160LF	10195199				2022-12-17	WOS:000078231600014
J	Wang, DH; Buckner, RL; Fox, MD; Holt, DJ; Holmes, AJ; Stoecklein, S; Langs, G; Pan, RQ; Qian, TY; Li, KC; Baker, JT; Stufflebeam, SM; Wang, K; Wang, XM; Hong, B; Liu, HS				Wang, Danhong; Buckner, Randy L.; Fox, Michael D.; Holt, Daphne J.; Holmes, Avram J.; Stoecklein, Sophia; Langs, Georg; Pan, Ruiqi; Qian, Tianyi; Li, Kuncheng; Baker, Justin T.; Stufflebeam, Steven M.; Wang, Kai; Wang, Xiaomin; Hong, Bo; Liu, Hesheng			Parcellating cortical functional networks in individuals	NATURE NEUROSCIENCE			English	Article							RESTING-STATE FMRI; HUMAN-BRAIN; CONNECTIVITY ARCHITECTURE; INTERSUBJECT VARIABILITY; CEREBRAL-CORTEX; ORGANIZATION; STIMULATION; IDENTIFICATION; ALIGNMENT; SYSTEM	The capacity to identify the unique functional architecture of an individual's brain is a crucial step toward personalized medicine and understanding the neural basis of variation in human cognition and behavior. Here we developed a cortical parcellation approach to accurately map functional organization at the individual level using resting-state functional magnetic resonance imaging (fMRI). A population-based functional atlas and a map of inter-individual variability were employed to guide the iterative search for functional networks in individual subjects. Functional networks mapped by this approach were highly reproducible within subjects and effectively captured the variability across subjects, including individual differences in brain lateralization. The algorithm performed well across different subject populations and data types, including task fMRI data. The approach was then validated by invasive cortical stimulation mapping in surgical patients, suggesting potential for use in clinical applications.	[Wang, Danhong; Buckner, Randy L.; Fox, Michael D.; Holt, Daphne J.; Stoecklein, Sophia; Pan, Ruiqi; Qian, Tianyi; Stufflebeam, Steven M.; Liu, Hesheng] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Radiol,Athinoula A Martinos Ctr Biomed Imagi, Charlestown, MA 02129 USA; [Wang, Danhong; Buckner, Randy L.; Holt, Daphne J.; Holmes, Avram J.; Baker, Justin T.; Liu, Hesheng] Harvard Univ, Sch Med, Dept Psychiat, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Buckner, Randy L.] Harvard Univ, Dept Psychol, Ctr Brain Sci, Cambridge, MA 02138 USA; [Fox, Michael D.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Berenson Allen Ctr Noninvas Brain Stimulat,Dept N, Boston, MA 02215 USA; [Fox, Michael D.] Harvard Univ, Sch Med, Dept Neurol, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Holmes, Avram J.] Yale Univ, Dept Psychol, New Haven, CT 06520 USA; [Stoecklein, Sophia] Univ Munich, Inst Clin Radiol, Munich, Germany; [Langs, Georg] Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, Computat Imaging Res Lab, Vienna, Austria; [Langs, Georg] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Qian, Tianyi; Hong, Bo] Tsinghua Univ, Sch Med, Dept Biomed Engn, Beijing 100084, Peoples R China; [Qian, Tianyi] Siemens Healthcare, MR Collaborat Nebraska Asia, Beijing, Peoples R China; [Li, Kuncheng] Capital Med Univ, Xuanwu Hosp, Dept Radiol, Beijing, Peoples R China; [Baker, Justin T.] McLean Hosp, Psychot Disorders Div, Belmont, MA 02178 USA; [Stufflebeam, Steven M.] Harvard MIT Hlth Sci & Technol, Inst Med Engn & Sci, Cambridge, MA USA; [Wang, Kai] Anhui Med Univ, Affiliated Hosp 1, Dept Neurol, Hefei, Peoples R China; [Wang, Xiaomin] Capital Med Univ, Beijing Inst Brain Disorders, Beijing, Peoples R China	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Yale University; University of Munich; Medical University of Vienna; Massachusetts Institute of Technology (MIT); Tsinghua University; Siemens AG; Capital Medical University; Harvard University; McLean Hospital; Harvard University; Anhui Medical University; Capital Medical University	Liu, HS (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Radiol,Athinoula A Martinos Ctr Biomed Imagi, Charlestown, MA 02129 USA.	hongbo@tsinghua.edu.cn; hesheng@nmr.mgh.harvard.edu	Holt, Daphne J/O-2201-2017; Fox, Michael D./AAZ-3928-2020; Liu, Hesheng/D-1115-2018	Holt, Daphne J/0000-0002-6428-9603; Fox, Michael D./0000-0001-8848-6399; Liu, Hesheng/0000-0002-7233-1509; Baker, Justin/0000-0002-6629-2195; Langs, Georg/0000-0002-5536-6873	Human Connectome Project, WU-Minn Consortium - 16 NIH Institutes and Centers, NIH Blueprint for Neuroscience Research [1U54MH091657]; McDonnell Center for Systems Neuroscience at Washington University; Center for Brain Science Neuroinformatics Research group; Athinoula A. Martinos Center for Biomedical Imaging; Center for Human Genetic Research; NIH [K25NS069805, R01NS091604, P50MH106435, K01MH099232, R0IHD067312, P41EB015902]; OeNB [15929]; Medical Imaging Cluster of the Medical University of Vienna; National Basic Research Program of China [2011CB504100]; National Science Foundation of China [61473169]; National Program on Key Basic Research Projects of China [2011CB933204]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD067312] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015902] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH091657, K23MH104515, K01MH099232, P50MH106435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K25NS069805, R01NS091604, K23NS083741, R01NS069696] Funding Source: NIH RePORTER	Human Connectome Project, WU-Minn Consortium - 16 NIH Institutes and Centers, NIH Blueprint for Neuroscience Research; McDonnell Center for Systems Neuroscience at Washington University; Center for Brain Science Neuroinformatics Research group; Athinoula A. Martinos Center for Biomedical Imaging; Center for Human Genetic Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OeNB; Medical Imaging Cluster of the Medical University of Vienna; National Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Program on Key Basic Research Projects of China(National Basic Research Program of China); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank X. Peng and M. Li for technical assistance. Data set II was provided by the Human Connectome Project, WU-Minn Consortium (principal investigators, D. Van Essen and K. Ugurbil; 1U54MH091657) funded by the 16 NIH Institutes and Centers that support the NIH Blueprint for Neuroscience Research; and by the McDonnell Center for Systems Neuroscience at Washington University. Data set III was provided by the Brain Genomics Superstruct Project of Harvard University and the Massachusetts General Hospital (principal investigators, R.L.B., J. Roffman and J. Smoller), with support from the Center for Brain Science Neuroinformatics Research group, the Athinoula A. Martinos Center for Biomedical Imaging, and the Center for Human Genetic Research. Twenty investigators at Harvard and MGH contributed data to the overall project. This work was supported by NIH grants K25NS069805 (H.L.), R01NS091604 (H.L.), P50MH106435 (R.L.B. and H.L.), K01MH099232 (A.J.H.), R0IHD067312 (G.L.), P41EB015902 (G.L.), OeNB Nr. 15929 (G.L.), Medical Imaging Cluster of the Medical University of Vienna (G.L.), National Basic Research Program of China Grant 2011CB504100 (X.W.), National Science Foundation of China Grant 61473169 (B.H.) and National Program on Key Basic Research Projects of China Grant 2011CB933204 (B.H.).	Amunts K, 1999, J COMP NEUROL, V412, P319, DOI 10.1002/(SICI)1096-9861(19990920)412:2<319::AID-CNE10>3.0.CO;2-7; Arslan Salim, 2015, Inf Process Med Imaging, V24, P85, DOI 10.1007/978-3-319-19992-4_7; Barch DM, 2013, NEUROIMAGE, V80, P169, DOI 10.1016/j.neuroimage.2013.05.033; Bennett CM, 2010, ANN NY ACAD SCI, V1191, P133, DOI 10.1111/j.1749-6632.2010.05446.x; Binder JR, 2011, EPILEPSY BEHAV, V20, P214, DOI 10.1016/j.yebeh.2010.08.004; Binder JR, 2008, EPILEPSIA, V49, P1980, DOI 10.1111/j.1528-1167.2008.01683.x; Binder JR, 1997, J NEUROSCI, V17, P353, DOI 10.1523/JNEUROSCI.17-01-00353.1997; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Blumensath T, 2013, NEUROIMAGE, V76, P313, DOI 10.1016/j.neuroimage.2013.03.024; Brodmann K., 2006, BRODMANNS LOCALISATI, DOI DOI 10.1016/j.bbadis.2017.07.008; Cole MW, 2014, NEURON, V83, P238, DOI 10.1016/j.neuron.2014.05.014; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Craddock RC, 2012, HUM BRAIN MAPP, V33, P1914, DOI 10.1002/hbm.21333; Curtis AT, 2014, NEUROIMAGE, V100, P51, DOI 10.1016/j.neuroimage.2014.05.079; Fedorenko E, 2010, J NEUROPHYSIOL, V104, P1177, DOI 10.1152/jn.00032.2010; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fox MD, 2006, NAT NEUROSCI, V9, P23, DOI 10.1038/nn1616; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2014, P NATL ACAD SCI USA, V111, pE4367, DOI 10.1073/pnas.1405003111; Fox MD, 2013, NEUROIMAGE, V66, P151, DOI 10.1016/j.neuroimage.2012.10.082; Fox MD, 2010, FRONT SYST NEUROSCI, V4, DOI [10.3389/fnsys.2010.00019, 10.3389/fnsys.2010.0001]; Frost MA, 2012, NEUROIMAGE, V59, P1369, DOI 10.1016/j.neuroimage.2011.08.035; Gao W, 2014, J NEUROSCI, V34, P11288, DOI 10.1523/JNEUROSCI.5072-13.2014; Giussani C, 2010, NEUROSURGERY, V66, P113, DOI 10.1227/01.NEU.0000360392.15450.C9; GOLDMANRAKIC PS, 1988, ANNU REV NEUROSCI, V11, P137, DOI 10.1146/annurev.neuro.11.1.137; Gordon EM, 2016, CEREB CORTEX, V26, P288, DOI 10.1093/cercor/bhu239; Goulas A, 2012, J NEUROSCI, V32, P10238, DOI 10.1523/JNEUROSCI.5852-11.2012; Hacker CD, 2013, NEUROIMAGE, V82, P616, DOI 10.1016/j.neuroimage.2013.05.108; KAAS JH, 1987, ANNU REV PSYCHOL, V38, P129, DOI 10.1146/annurev.ps.38.020187.001021; Krienen FM, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0526; Laumann TO, 2015, NEURON, V87, P657, DOI 10.1016/j.neuron.2015.06.037; Mueller S, 2013, NEURON, V77, P586, DOI 10.1016/j.neuron.2012.12.028; OJEMANN G, 1989, J NEUROSURG, V71, P316, DOI 10.3171/jns.1989.71.3.0316; Penfield W, 1954, EPILEPSY FUNCTIONAL; Poldrack RA, 2014, NAT NEUROSCI, V17, P1510, DOI 10.1038/nn.3818; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Robinson EC, 2014, NEUROIMAGE, V100, P414, DOI 10.1016/j.neuroimage.2014.05.069; Sabuncu MR, 2010, CEREB CORTEX, V20, P130, DOI 10.1093/cercor/bhp085; Shen X, 2013, NEUROIMAGE, V82, P403, DOI 10.1016/j.neuroimage.2013.05.081; Sohn WS, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00280; SWAAB DF, 1984, PROG BRAIN RES, V61, P361; Toga AW, 2006, NAT REV NEUROSCI, V7, P952, DOI 10.1038/nrn2012; Wang DH, 2014, J NEUROSCI, V34, P12341, DOI 10.1523/JNEUROSCI.0787-14.2014; Wang DH, 2014, NEUROSCIENTIST, V20, P432, DOI 10.1177/1073858414543290; Wig GS, 2014, CEREB CORTEX, V24, P2036, DOI 10.1093/cercor/bht056; Wig GS, 2014, NEUROIMAGE, V93, P276, DOI 10.1016/j.neuroimage.2013.07.035; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Zilles K, 2010, NAT REV NEUROSCI, V11, P139, DOI 10.1038/nrn2776	50	257	259	13	147	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2015	18	12					1853	1860		10.1038/nn.4164	http://dx.doi.org/10.1038/nn.4164			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CX1LV	26551545	Green Accepted, Green Submitted			2022-12-17	WOS:000365458600024
J	Wang, WY; Pan, L; Su, SC; Quinn, EJ; Sasaki, M; Jimenez, JC; Mackenzie, IRA; Huang, EJ; Tsai, LH				Wang, Wen-Yuan; Pan, Ling; Su, Susan C.; Quinn, Emma J.; Sasaki, Megumi; Jimenez, Jessica C.; Mackenzie, Ian R. A.; Huang, Eric J.; Tsai, Li-Huei			Interaction of FUS and HDAC1 regulates DNA damage response and repair in neurons	NATURE NEUROSCIENCE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; PRO-ONCOPROTEIN TLS/FUS; STRAND BREAK REPAIR; RNA-BINDING PROTEIN; GENOMIC STABILITY; DENDRITIC SPINES; MAMMALIAN-CELLS; DISEASE; CHROMATIN; MICE	Defects in DNA repair have been extensively linked to neurodegenerative diseases, but the exact mechanisms remain poorly understood. We found that FUS, an RNA/DNA-binding protein that has been linked to amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration, is important for the DNA damage response (DDR). The function of FUS in DDR involved a direct interaction with histone deacetylase 1 (HDAC1), and the recruitment of FUS to double-stranded break sites was important for proper DDR signaling. Notably, FUS proteins carrying familial ALS mutations were defective in DDR and DNA repair and showed a diminished interaction with HDAC1. Moreover, we observed increased DNA damage in human ALS patients harboring FUS mutations. Our findings suggest that an impaired DDR and DNA repair may contribute to the pathogenesis of neurodegenerative diseases linked to FUS mutations.	[Wang, Wen-Yuan; Pan, Ling; Su, Susan C.; Quinn, Emma J.; Sasaki, Megumi; Jimenez, Jessica C.; Tsai, Li-Huei] MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Wang, Wen-Yuan; Pan, Ling; Su, Susan C.; Quinn, Emma J.; Sasaki, Megumi; Jimenez, Jessica C.; Tsai, Li-Huei] Howard Hughes Med Inst, Chevy Chase, MD USA; [Mackenzie, Ian R. A.] Univ British Columbia, Dept Pathol, Vancouver, BC, Canada; [Huang, Eric J.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Huang, Eric J.] VA Med Ctr, Pathol Serv, San Francisco, CA USA	Massachusetts Institute of Technology (MIT); Northwell Health; Howard Hughes Medical Institute; University of British Columbia; University of California System; University of California San Francisco	Tsai, LH (corresponding author), MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, E25-618, Cambridge, MA 02139 USA.	lhtsai@mit.edu	Huang, Eric J./AAH-7997-2019; Pan, Ling/K-9333-2013	Huang, Eric J./0000-0002-5381-3801; Pan, Ling/0000-0001-9947-9071	Simons Foundation; Howard Hughes Medical Institute Exceptional Research Opportunities Program; National Institute of Neurological Disorders and Stroke [NS078839]; Department of Veterans Affairs [BX001108]; Muscular Dystrophy Association [MDA217592]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078839] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R21OD011915] Funding Source: NIH RePORTER; Veterans Affairs [I21BX001625, I01BX001108] Funding Source: NIH RePORTER	Simons Foundation; Howard Hughes Medical Institute Exceptional Research Opportunities Program; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Department of Veterans Affairs(US Department of Veterans Affairs); Muscular Dystrophy Association(Muscular Dystrophy Association); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs)	We thank T. Misteli (National Cancer Institute) for kindly providing the NIH2/4 cell line and Lac-R constructs, M. Dobbin (Massachusetts Institute of Technology) for technical assistance on microirradiation experiments, A. Mungenast, R. Madabhushi, A. Bero, J. Penney and A. Nott for critical reading of the manuscript, and other members of the Tsai and Huang laboratories for helpful discussions. We also thank R.H. Brown Jr and L.J. Hayward for insightful discussions. W.-Y.W. was supported by a Postdoctoral Fellowship from the Simons Foundation, J.C.J. was supported by the Howard Hughes Medical Institute Exceptional Research Opportunities Program. This work is also supported by grants from National Institute of Neurological Disorders and Stroke (NS078839 to L.-H.T.), the Department of Veterans Affairs (BX001108 to E.J.H.) and the Muscular Dystrophy Association (MDA217592 to E.J.H.). L.-H.T. is a member of the Neurodegeneration Consortium. E.J.H. is a member of the Consortium for Frontotemporal Dementia Research. L.-H.T. receives funding from the Howard Hughes Medical Institute.	Anderson AJ, 1996, J NEUROSCI, V16, P1710, DOI 10.1523/jneurosci.16-05-01710.1996; Anderson L, 2001, MOL CELL BIOL, V21, P1719, DOI 10.1128/MCB.21.5.1719-1729.2001; Baechtold H, 1999, J BIOL CHEM, V274, P34337, DOI 10.1074/jbc.274.48.34337; Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769; Bertrand P, 1999, ONCOGENE, V18, P4515, DOI 10.1038/sj.onc.1203048; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Collins AR, 2004, MOL BIOTECHNOL, V26, P249, DOI 10.1385/MB:26:3:249; CROZAT A, 1993, NATURE, V363, P640, DOI 10.1038/363640a0; de Waard MC, 2010, ACTA NEUROPATHOL, V120, P461, DOI 10.1007/s00401-010-0715-9; Dinant C, 2008, EPIGENET CHROMATIN, V1, DOI 10.1186/1756-8935-1-9; Dobbin MM, 2013, NAT NEUROSCI, V16, P1008, DOI 10.1038/nn.3460; Ferguson DO, 2000, P NATL ACAD SCI USA, V97, P6630, DOI 10.1073/pnas.110152897; Ferrante RJ, 1997, J NEUROCHEM, V69, P2064; Fillingham J, 2006, BIOCHEM CELL BIOL, V84, P568, DOI 10.1139/O06-072; Fujii R, 2005, J CELL SCI, V118, P5755, DOI 10.1242/jcs.02692; Fujii R, 2005, CURR BIOL, V15, P587, DOI 10.1016/j.cub.2005.01.058; Gao J, 2010, NATURE, V466, P1105, DOI 10.1038/nature09271; Gardiner M, 2008, BIOCHEM J, V415, P297, DOI 10.1042/BJ20081135; Graff J, 2012, NATURE, V483, P222, DOI 10.1038/nature10849; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Hande KR, 1998, EUR J CANCER, V34, P1514, DOI 10.1016/S0959-8049(98)00228-7; Hicks GG, 2000, NAT GENET, V24, P175, DOI 10.1038/72842; Huang EJ, 2010, BRAIN PATHOL, V20, P1069, DOI 10.1111/j.1750-3639.2010.00413.x; Keramaris E, 2003, J BIOL CHEM, V278, P37782, DOI 10.1074/jbc.M304049200; Kim D, 2008, NEURON, V60, P803, DOI 10.1016/j.neuron.2008.10.015; Kruhlak Michael J., 2009, V523, P125, DOI 10.1007/978-1-59745-190-1_9; Kuroda M, 2000, EMBO J, V19, P453, DOI 10.1093/emboj/19.3.453; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Lukas J, 2011, NAT CELL BIOL, V13, P1161, DOI 10.1038/ncb2344; McKinnon PJ, 2009, NAT REV NEUROSCI, V10, P100, DOI 10.1038/nrn2559; Millecamps S, 2012, J MED GENET, V49, P258, DOI 10.1136/jmedgenet-2011-100699; Miller KM, 2010, NAT STRUCT MOL BIOL, V17, P1144, DOI 10.1038/nsmb.1899; Patel KJ, 1998, MOL CELL, V1, P347, DOI 10.1016/S1097-2765(00)80035-0; Pegoraro G, 2009, NAT CELL BIOL, V11, P1261, DOI 10.1038/ncb1971; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Pilch DR, 2003, BIOCHEM CELL BIOL, V81, P123, DOI 10.1139/o03-042; Rass U, 2007, CELL, V130, P991, DOI 10.1016/j.cell.2007.08.043; Seluanov A, 2004, P NATL ACAD SCI USA, V101, P7624, DOI 10.1073/pnas.0400726101; Sharma S, 2007, BRAIN RES BULL, V73, P48, DOI 10.1016/j.brainresbull.2007.02.001; Soutoglou E, 2008, SCIENCE, V320, P1507, DOI [10.1126/science.1159051, 10.1126/science.ll59051]; Stark JM, 2002, J BIOL CHEM, V277, P20185, DOI 10.1074/jbc.M112132200; Tan AY, 2009, J MOL CELL BIOL, V1, P82, DOI 10.1093/jmcb/mjp025; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Wang WY, 2007, NAT NEUROSCI, V10, P1063, DOI 10.1038/nn1932; Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992; Weinstock DM, 2006, METHOD ENZYMOL, V409, P524, DOI 10.1016/S0076-6879(05)09031-2; Xu Y, 1996, GENE DEV, V10, P2411, DOI 10.1101/gad.10.19.2411	50	257	260	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2013	16	10					1383	+		10.1038/nn.3514	http://dx.doi.org/10.1038/nn.3514			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	223HM	24036913	Green Accepted			2022-12-17	WOS:000324795300010
J	Lieberman, MD; Hariri, A; Jarcho, JM; Eisenberger, NI; Bookheimer, SY				Lieberman, MD; Hariri, A; Jarcho, JM; Eisenberger, NI; Bookheimer, SY			An fMRI investigation of race-related amygdala activity in African-American and Caucasian-American individuals	NATURE NEUROSCIENCE			English	Article							NEURAL COMPONENTS; INHIBITION; STIMULI; SYSTEM	Functional magnetic resonance imaging ( fMRI) was used to examine the nature of amygdala sensitivity to race. Both African-American and Caucasian-American individuals showed greater amygdala activity to African-American targets than to Caucasian-American targets, suggesting that race-related amygdala activity may result from cultural learning rather than from the novelty of other races. Additionally, verbal encoding of African-American targets produced significantly less amygdala activity than perceptual encoding of African-American targets.	Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA; Univ Pittsburgh, Sch Med, Western Psychiat Inst & Clin, Dept Psychiat, Pittsburgh, PA 15213 USA; Univ Calif Los Angeles, Sch Med, Brain Mapping Ctr, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Western Psychiatric Institute & Clinic of UPMC; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Lieberman, MD (corresponding author), Univ Calif Los Angeles, Dept Psychol, Franz Hall, Los Angeles, CA 90095 USA.	lieber@ucla.edu	Lieberman, Matthew/ABD-8197-2020; Jarcho, Johanna/N-8862-2017	Lieberman, Matthew/0000-0002-4447-7359; Jarcho, Johanna/0000-0001-9075-6968; Bookheimer, Susan/0000-0002-3417-5891	NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR012169, P41RR013642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH066709] Funding Source: NIH RePORTER; NCRR NIH HHS [RR08655, RR13642, RR12169] Funding Source: Medline; NIMH NIH HHS [MH66709] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Cunningham WA, 2004, PSYCHOL SCI, V15, P806, DOI 10.1111/j.0956-7976.2004.00760.x; Cunningham WA, 2003, J PERS SOC PSYCHOL, V85, P639, DOI 10.1037/0022-3514.85.4.639; Eberhardt JL, 2005, AM PSYCHOL, V60, P181, DOI 10.1037/0003-066X.60.2.181; Ghashghaei HT, 2002, NEUROSCIENCE, V115, P1261, DOI 10.1016/S0306-4522(02)00446-3; Hariri AR, 2000, NEUROREPORT, V11, P43, DOI 10.1097/00001756-200001170-00009; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Macrae CN, 2000, ANNU REV PSYCHOL, V51, P93, DOI 10.1146/annurev.psych.51.1.93; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; PERDUE CW, 1990, J PERS SOC PSYCHOL, V59, P475, DOI 10.1037/0022-3514.59.3.475; Phelps EA, 2000, J COGNITIVE NEUROSCI, V12, P729, DOI 10.1162/089892900562552; Rosenkranz JA, 2002, J NEUROSCI, V22, P324, DOI 10.1523/JNEUROSCI.22-01-00324.2002; Taylor SF, 2003, NEUROIMAGE, V18, P650, DOI 10.1016/S1053-8119(02)00051-4; WILSON TD, 1991, J PERS SOC PSYCHOL, V60, P181, DOI 10.1037/0022-3514.60.2.181; Zald DH, 2003, BRAIN RES REV, V41, P88, DOI 10.1016/S0165-0173(02)00248-5	15	257	268	1	22	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2005	8	6					720	722		10.1038/nn1465	http://dx.doi.org/10.1038/nn1465			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	929KP	15880106				2022-12-17	WOS:000229345300010
J	Zhang, KY; McQuibban, GA; Silva, C; Butler, GS; Johnston, JB; Holden, J; Clark-Lewis, I; Overall, CM; Power, C				Zhang, KY; McQuibban, GA; Silva, C; Butler, GS; Johnston, JB; Holden, J; Clark-Lewis, I; Overall, CM; Power, C			HIV-induced metalloproteinase processing of the chemokine stromal cell derived factor-1 causes neurodegeneration	NATURE NEUROSCIENCE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; GENE-MEDIATED NEUROVIRULENCE; MATRIX-METALLOPROTEINASE; NERVOUS-SYSTEM; INTRACEREBRAL HEMORRHAGE; NEURONAL INJURY; GELATINASE-A; EXPRESSION; DEMENTIA; BRAIN	The mechanisms of neurodegeneration that result in human immunodeficiency virus (HIV) type 1 dementia have not yet been identified. Here, we report that HIV-infected macrophages secrete the zymogen matrix metalloproteinase-2 (MMP-2), which is activated by exposure to MT1-MMP on neurons. Stromal cell-derived factor 1 (SDF-1), a chemokine overexpressed by astrocytes during HIV infection, was converted to a highly neurotoxic protein after precise proteolytic processing by active MMP-2, which removed the N-terminal tetrapeptide. Implantation of cleaved SDF-1(5-67) into the basal ganglia of mice resulted in neuronal death and inflammation with ensuing neurobehavioral deficits that were abrogated by neutralizing antibodies to SDF-1 and an MMP inhibitor drug. Hence, this study identifies a new in vivo neurotoxic pathway in which cleavage of a chemokine by an induced metalloproteinase results in neuronal apoptosis that leads to neurodegeneration.	Univ Calgary, Dept Clin Neurosci, Calgary, AB T2N 4N1, Canada; Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Dept Oral Biol & Med Sci, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Dept Pathol, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Biomed Res Ctr, Vancouver, BC V6T 1Z3, Canada; Univ Calgary, Dept Microbiol & Infect Dis, Calgary, AB T2N 4N1, Canada	University of Calgary; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of Calgary	Overall, CM (corresponding author), Univ Calgary, Dept Clin Neurosci, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.		Power, Christopher/C-7181-2013; Butler, Georgina/GQP-7553-2022	Butler, Georgina/0000-0003-1172-1578; Power, Christopher/0000-0002-5131-9711; Zhang, Kunyan/0000-0003-1078-6011				Anthony DC, 1998, J NEUROIMMUNOL, V87, P62, DOI 10.1016/S0165-5728(98)00046-0; Asensio VC, 1999, TRENDS NEUROSCI, V22, P504, DOI 10.1016/S0166-2236(99)01453-8; Berman NEJ, 1999, NEUROBIOL DIS, V6, P486, DOI 10.1006/nbdi.1999.0261; Bigg HF, 2001, CANCER RES, V61, P3610; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Catani MV, 2000, J NEUROCHEM, V74, P2373, DOI 10.1046/j.1471-4159.2000.0742373.x; CHESEBRO B, 1991, J VIROL, V65, P5782, DOI 10.1128/JVI.65.11.5782-5789.1991; Conant K, 1999, ANN NEUROL, V46, P391, DOI 10.1002/1531-8249(199909)46:3<391::AID-ANA15>3.0.CO;2-0; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; EPSTEIN LG, 1993, ANN NEUROL, V33, P429, DOI 10.1002/ana.410330502; GLASS JD, 1995, ANN NEUROL, V38, P755, DOI 10.1002/ana.410380510; GONG JH, 1995, J EXP MED, V181, P631, DOI 10.1084/jem.181.2.631; Gonzalez-Scarano F, 1999, ANNU REV NEUROSCI, V22, P219, DOI 10.1146/annurev.neuro.22.1.219; HOIOK YH, 2000, MOL MECH NEURODEGENE, P111; Horuk R, 1998, NATURE, V393, P524, DOI 10.1038/31116; Imai Y, 1996, BIOCHEM BIOPH RES CO, V224, P855, DOI 10.1006/bbrc.1996.1112; Johnston JB, 2000, J VIROL, V74, P7211, DOI 10.1128/JVI.74.16.7211-7220.2000; Johnston JB, 2002, J VIROL, V76, P2622, DOI 10.1128/JVI.76.6.2622-2633.2002; Johnston JB, 2001, ANN NEUROL, V49, P230, DOI 10.1002/1531-8249(20010201)49:2<230::AID-ANA43>3.0.CO;2-O; Kaul M, 2001, NATURE, V410, P988, DOI 10.1038/35073667; Kaul M, 1999, P NATL ACAD SCI USA, V96, P8212, DOI 10.1073/pnas.96.14.8212; Langford D, 2002, J NEUROIMMUNOL, V127, P115, DOI 10.1016/S0165-5728(02)00068-1; LIPTON SA, 1995, NEW ENGL J MED, V332, P934, DOI 10.1056/NEJM199504063321407; Lopez-Otin C, 2002, NAT REV MOL CELL BIO, V3, P509, DOI 10.1038/nrm858; Mayne M, 2001, STROKE, V32, P240, DOI 10.1161/01.STR.32.1.240; McCawley LJ, 2001, CURR OPIN CELL BIOL, V13, P534, DOI 10.1016/S0955-0674(00)00248-9; McQuibban GA, 2000, SCIENCE, V289, P1202, DOI 10.1126/science.289.5482.1202; McQuibban GA, 2001, J BIOL CHEM, V276, P43503, DOI 10.1074/jbc.M107736200; Miller RJ, 1999, TRENDS NEUROSCI, V22, P471, DOI 10.1016/S0166-2236(99)01408-3; Nagasawa T, 1999, Adv Immunol, V71, P211; Nath A, 1999, SEMIN NEUROL, V19, P113, DOI 10.1055/s-2008-1040830; OBERLEY LW, 1982, SUPEROXIDE DISMUTASE, V1, P1; Ohtani Y, 1998, NEUROSCI LETT, V249, P163, DOI 10.1016/S0304-3940(98)00425-X; Opdenakker G, 2001, J LEUKOCYTE BIOL, V69, P851; Overall CM, 2002, NAT REV CANCER, V2, P657, DOI 10.1038/nrc884; Patrick MK, 2002, J VIROL, V76, P7923, DOI 10.1128/JVI.76.16.7923-7931.2002; Power C, 1998, J VIROL, V72, P9045, DOI 10.1128/JVI.72.11.9045-9053.1998; Power C, 2003, ANN NEUROL, V53, P731, DOI 10.1002/ana.10553; Power C, 2001, TRENDS NEUROSCI, V24, P162, DOI 10.1016/S0166-2236(00)01737-9; Ransohoff RM, 1998, TRENDS NEUROSCI, V21, P154, DOI 10.1016/S0166-2236(97)01198-3; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; Sanders VJ, 1998, AIDS, V12, P1021, DOI 10.1097/00002030-199809000-00008; Shrikant P, 1996, J IMMUNOL, V156, P1307; Sisodia SS, 1999, J CLIN INVEST, V104, P1169, DOI 10.1172/JCI8508; UNGERSTEDT U, 1970, Brain Research, V24, P485, DOI 10.1016/0006-8993(70)90187-3; Yong VW, 2001, NAT REV NEUROSCI, V2, P502, DOI 10.1038/35081571; Zhang KY, 2001, VIROLOGY, V283, P19, DOI 10.1006/viro.2001.0876	47	257	268	0	1	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2003	6	10					1064	1071		10.1038/nn1127	http://dx.doi.org/10.1038/nn1127			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	727AK	14502291				2022-12-17	WOS:000185633600018
J	Romo, R; Hernandez, A; Zainos, A; Lemus, L; Brody, CD				Romo, R; Hernandez, A; Zainos, A; Lemus, L; Brody, CD			Neuronal correlates of decision-making in secondary somatosensory cortex	NATURE NEUROSCIENCE			English	Article							POSTERIOR PARIETAL CORTEX; PREFRONTAL CORTEX; PSYCHOPHYSICAL MEASUREMENTS; SENSORY DISCRIMINATION; VISUAL RESPONSES; MONKEY PRIMARY; CONNECTIONS; AREAS; PREMOTOR; CHOICE	The ability to discriminate between two sequential stimuli requires evaluation of current sensory information in reference to stored information. Where and how does this evaluation occur? We trained monkeys to compare two mechanical vibrations applied sequentially to the fingertips and to report which of the two had the higher frequency. We recorded single neurons in secondary somatosensory cortex (S2) while the monkeys performed the task. During the first stimulus period, the firing rate of S2 neurons encoded the stimulus frequency. During the second stimulus period, however, some S2 neurons did not merely encode the stimulus frequency. The responses of these neurons were a function of both the remembered (first) and current (second) stimulus. Moreover, a few hundred milliseconds after the presentation of the second stimulus, these responses were correlated with the monkey's decision. This suggests that some S2 neurons may combine past and present sensory information for decision-making.	Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Mexico City 04510, DF, Mexico; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Universidad Nacional Autonoma de Mexico; Cold Spring Harbor Laboratory	Romo, R (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Apartado Postal 70-253, Mexico City 04510, DF, Mexico.	rromo@ifisiol.unam.mx	Lemus, Luis/E-6760-2019	Lemus, Luis/0000-0002-6608-3684; zainos, antonio/0000-0001-6137-1794; romo, ranulfo/0000-0003-3529-3635				Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; Burton H., 1996, PAIN AND TOUCH, P105; Carmichael ST, 1995, J COMP NEUROL, V363, P642, DOI 10.1002/cne.903630409; CAVADA C, 1989, J COMP NEUROL, V287, P393, DOI 10.1002/cne.902870402; CHAPMAN CE, 1988, EXP BRAIN RES, V72, P316; CHAPMAN CE, 1994, CAN J PHYSIOL PHARM, V72, P558, DOI 10.1139/y94-080; Dodd JV, 2001, J NEUROSCI, V21, P4809, DOI 10.1523/JNEUROSCI.21-13-04809.2001; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; GODSCHALK M, 1984, EXP BRAIN RES, V56, P410; Hernandez A, 1997, J NEUROSCI, V17, P6391; Hernandez A, 2000, P NATL ACAD SCI USA, V97, P6191, DOI 10.1073/pnas.120018597; Hernandez A, 2002, NEURON, V33, P959, DOI 10.1016/S0896-6273(02)00613-X; Horwitz GD, 2001, J NEUROPHYSIOL, V86, P2527, DOI 10.1152/jn.2001.86.5.2527; HSIAO SS, 1993, J NEUROPHYSIOL, V70, P444, DOI 10.1152/jn.1993.70.1.444; Jiang W, 1997, J NEUROPHYSIOL, V77, P1656, DOI 10.1152/jn.1997.77.3.1656; JOHNSON KO, 1980, J NEUROPHYSIOL, V43, P1793, DOI 10.1152/jn.1980.43.6.1793; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; LEICHNETZ GR, 1986, J COMP NEUROL, V254, P460, DOI 10.1002/cne.902540403; LUPPINO G, 1993, J COMP NEUROL, V338, P114, DOI 10.1002/cne.903380109; MILLER EK, 1993, J NEUROSCI, V13, P1460; MISHKIN M, 1979, NEUROPSYCHOLOGIA, V17, P139, DOI 10.1016/0028-3932(79)90005-8; MOUNTCASTLE VB, 1990, J NEUROSCI, V10, P3032; MURRAY EA, 1984, BEHAV BRAIN RES, V11, P67, DOI 10.1016/0166-4328(84)90009-3; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; PREUSS TM, 1989, J COMP NEUROL, V282, P293, DOI 10.1002/cne.902820210; Pruett JR, 2001, J NEUROPHYSIOL, V86, P2069, DOI 10.1152/jn.2001.86.4.2069; Ro JY, 2000, EXP BRAIN RES, V135, P1, DOI 10.1007/s002210000496; Romo R, 1998, NATURE, V392, P387, DOI 10.1038/32891; Romo R, 2000, NEURON, V26, P273, DOI 10.1016/S0896-6273(00)81156-3; Romo R, 1999, NATURE, V399, P470, DOI 10.1038/20939; Salinas E, 2000, J NEUROSCI, V20, P5503, DOI 10.1523/JNEUROSCI.20-14-05503.2000; Schall JD, 2001, NAT REV NEUROSCI, V2, P33, DOI 10.1038/35049054; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; SINCLAIR RJ, 1993, J NEUROPHYSIOL, V70, P331, DOI 10.1152/jn.1993.70.1.331; TOKUNO H, 1993, J COMP NEUROL, V333, P199, DOI 10.1002/cne.903330206; Tomita H, 1999, NATURE, V401, P699, DOI 10.1038/44372; [No title captured]	37	257	262	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5	11					1217	1225		10.1038/nn950	http://dx.doi.org/10.1038/nn950			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	609CG	12368806				2022-12-17	WOS:000178884600026
J	Nunn, JA; Gregory, LJ; Brammer, M; Williams, SCR; Parslow, DM; Morgan, MJ; Morris, RG; Bullmore, ET; Baron-Cohen, S; Gray, JA				Nunn, JA; Gregory, LJ; Brammer, M; Williams, SCR; Parslow, DM; Morgan, MJ; Morris, RG; Bullmore, ET; Baron-Cohen, S; Gray, JA			Functional magnetic resonance imaging of synesthesia: activation of V4/V8 by spoken words	NATURE NEUROSCIENCE			English	Article							GENERIC BRAIN ACTIVATION; VERBAL MEMORY; VISUAL-MOTION; COLOR-CENTER; SYNAESTHESIA; CORTEX; FMRI; INFORMATION; PERCEPTION; ANATOMY	In 'colored-hearing' synesthesia, individuals report color experiences when they hear spoken words. If the synesthetic color experience resembles that of normal color perception, one would predict activation of parts of the visual system specialized for such perception, namely the human 'color center', referred to as either V4 or V8. Using functional magnetic resonance imaging (fMRI), we here locate the region activated by speech in synesthetes to area V4/V8 in the left hemisphere, and demonstrate overlap with V4/V8 activation in normal controls in response to color. No activity was detected in areas V1 or V2, suggesting that activity in primary visual cortex is not necessary for such experience. Control subjects showed no activity in V4/V8 when imagining colors in response to spoken words, despite over-training on word-color associations similar to those spontaneously reported by synesthetes.	Univ London Goldsmiths Coll, Dept Psychol, London SE14 6NW, England; Inst Psychiat, Brain Image Anal Unit, London SE5 8AF, England; Inst Psychiat, Dept Psychol, London SE5 8AF, England; City Univ London, Appl Vis Res Ctr, London EC1V 0HB, England; Univ Cambridge, Addenbrookes Hosp, Dept Psychiat, Cambridge CB2 2QQ, England; Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England; Univ Manchester, Manchester M13 9PL, Lancs, England	University of London; Goldsmiths University London; University of London; King's College London; University of London; King's College London; City University London; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; University of Manchester	Nunn, JA (corresponding author), Univ London Goldsmiths Coll, Dept Psychol, London SE14 6NW, England.		Williams, Steve C/D-6979-2011; Bullmore, Ed/C-1706-2012; Brammer, Michael J/B-7128-2012	Williams, Steve C/0000-0003-4299-1941; Bullmore, Ed/0000-0002-8955-8283; Brammer, Michael J/0000-0001-9800-2052; opoku, anita/0000-0001-7243-8157	Medical Research Council [G0600977] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ANDREASEN NC, 1995, AM J PSYCHIAT, V152, P1576; Bailey M. E. S., 1997, SYNAESTHESIA CLASSIC, P182; BARBUR JL, 1993, BRAIN, V116, P1293, DOI 10.1093/brain/116.6.1293; Barnes J, 1999, NEUROREPORT, V10, P195, DOI 10.1097/00001756-199901180-00037; BARONCOHEN S, 1987, PERCEPTION, V16, P761, DOI 10.1068/p160761; BARONCOHEN S, 1993, PERCEPTION, V22, P419, DOI 10.1068/p220419; BaronCohen S, 1996, PERCEPTION, V25, P1073, DOI 10.1068/p251073; Bartels A, 2000, EUR J NEUROSCI, V12, P172, DOI 10.1046/j.1460-9568.2000.00905.x; Brammer MJ, 1997, MAGN RESON IMAGING, V15, P763, DOI 10.1016/S0730-725X(97)00135-5; Bullmore ET, 1999, HUM BRAIN MAPP, V7, P38, DOI 10.1002/(SICI)1097-0193(1999)7:1<38::AID-HBM4>3.3.CO;2-H; Bullmore ET, 2001, HUM BRAIN MAPP, V12, P61, DOI 10.1002/1097-0193(200102)12:2<61::AID-HBM1004>3.0.CO;2-W; CRICK F, 1995, NATURE, V375, P121, DOI 10.1038/375121a0; Cytowic Richard, 1997, SYNAESTHESIA CLASSIC, P17; DEHAY C, 1984, EXP BRAIN RES, V57, P208; Ffytche DH, 1998, NAT NEUROSCI, V1, P738, DOI 10.1038/3738; FLETCHER PC, 1995, BRAIN, V118, P401, DOI 10.1093/brain/118.2.401; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; GRASBY PM, 1993, BRAIN, V116, P1, DOI 10.1093/brain/116.1.1; Gray J. A., 1997, SYNAESTHESIA CLASSIC, P173; GRAY JA, 1999, NEURONAL BASES PSYCH, V8, P450; Grossenbacher P. G., 1997, SYNAESTHESIA CLASSIC, P148; Grossenbacher PG, 2001, TRENDS COGN SCI, V5, P36, DOI 10.1016/S1364-6613(00)01571-0; Hadjikhani N, 1998, NAT NEUROSCI, V1, P235, DOI 10.1038/681; Hadjikhani N, 1998, J NEUROSCI, V18, P1072; Howard RJ, 1998, NEUROREPORT, V9, P1019, DOI 10.1097/00001756-199804200-00012; JOHANSSON S, 1982, FREQUENCY ANAL ENGLI; Kiehl KA, 1999, HUM BRAIN MAPP, V7, P225, DOI 10.1002/(SICI)1097-0193(1999)7:4<225::AID-HBM1>3.0.CO;2-P; Maddock RJ, 1997, PSYCHIAT RES-NEUROIM, V75, P1, DOI 10.1016/S0925-4927(97)00018-8; Milner A. D., 1995, VISUAL BRAIN ACTION; Nelson H. E., 1991, NATL ADULT READING T; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; PAULESU E, 1995, BRAIN, V118, P661, DOI 10.1093/brain/118.3.661; Ramachandran VS, 2001, P ROY SOC B-BIOL SCI, V268, P979, DOI 10.1098/rspb.2000.1576; Talairach I., 1988, COPLANAR STEREOTACTI; Tong F, 2001, NATURE, V411, P195, DOI 10.1038/35075583; TOOTELL RBH, 1995, NATURE, V375, P139, DOI 10.1038/375139a0; Zeki S, 1998, BRAIN, V121, P1669, DOI 10.1093/brain/121.9.1669; ZEKI S, 1991, J NEUROSCI, V11, P641; ZEKI S, 1993, P ROY SOC B-BIOL SCI, V252, P215, DOI 10.1098/rspb.1993.0068; [No title captured]	41	257	260	0	131	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2002	5	4					371	375		10.1038/nn818	http://dx.doi.org/10.1038/nn818			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	534UQ	11914723				2022-12-17	WOS:000174606900018
J	Romanski, LM; Goldman-Rakic, PS				Romanski, LM; Goldman-Rakic, PS			An auditory domain in primate prefrontal cortex	NATURE NEUROSCIENCE			English	Article							MONKEY FRONTAL-CORTEX; CONNECTIONS; NEURONS; SULCUS; UNIT		Yale Univ, Sch Med, Neurobiol Sect, New Haven, CT 06510 USA; Univ Rochester, Dept Neurobiol & Anat, Rochester, NY 14642 USA	Yale University; University of Rochester	Romanski, LM (corresponding author), Yale Univ, Sch Med, Neurobiol Sect, New Haven, CT 06510 USA.				NIDCD NIH HHS [R01 DC004845-01, R01 DC004845] Funding Source: Medline; NIMH NIH HHS [MH-38546, R01 MH038546, R37 MH038546] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH038546, R37MH038546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004845] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		AZUMA M, 1984, BRAIN RES, V298, P343, DOI 10.1016/0006-8993(84)91434-3; BENEVENTO LA, 1977, EXP NEUROL, V57, P849, DOI 10.1016/0014-4886(77)90112-1; DEACON TW, 1992, BRAIN RES, V573, P8, DOI 10.1016/0006-8993(92)90109-M; Gabrieli JDE, 1998, P NATL ACAD SCI USA, V95, P906, DOI 10.1073/pnas.95.3.906; GoldmanRakic PS, 1996, PHILOS T ROY SOC B, V351, P1445, DOI 10.1098/rstb.1996.0129; Hackett TA, 1999, BRAIN RES, V817, P45, DOI 10.1016/S0006-8993(98)01182-2; NEWMAN JD, 1976, EXP BRAIN RES, V25, P169; OScalaidhe SP, 1997, SCIENCE, V278, P1135, DOI 10.1126/science.278.5340.1135; Price CJ, 1998, TRENDS COGN SCI, V2, P281, DOI 10.1016/S1364-6613(98)01201-7; RAUSCHECKER JP, 1995, SCIENCE, V268, P111, DOI 10.1126/science.7701330; Romanski LM, 1999, NAT NEUROSCI, V2, P1131, DOI 10.1038/16056; Romanski LM, 1999, J COMP NEUROL, V403, P141, DOI 10.1002/(SICI)1096-9861(19990111)403:2<141::AID-CNE1>3.0.CO;2-V; TANILA H, 1993, BEHAV BRAIN RES, V53, P63, DOI 10.1016/S0166-4328(05)80266-9; VAADIA E, 1986, J NEUROPHYSIOL, V56, P934, DOI 10.1152/jn.1986.56.4.934; WILSON FAW, 1993, SCIENCE, V260, P1955, DOI 10.1126/science.8316836	15	257	264	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2002	5	1					15	16		10.1038/nn781	http://dx.doi.org/10.1038/nn781			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	507MG	11753413	Green Accepted			2022-12-17	WOS:000173031800008
J	Huang, LQ; Shanker, YG; Dubauskaite, J; Zheng, JZ; Yan, WT; Rosenzweig, S; Spielman, AI; Max, M; Margolskee, RF				Huang, LQ; Shanker, YG; Dubauskaite, J; Zheng, JZ; Yan, WT; Rosenzweig, S; Spielman, AI; Max, M; Margolskee, RF			G gamma 13 colocalizes with gustducin in taste receptor cells and mediates IP3 responses to bitter denatonium	NATURE NEUROSCIENCE			English	Article							BETA-GAMMA-SUBUNITS; G-PROTEIN; CHROMOSOME LOCALIZATION; GENE STRUCTURE; ALPHA-SUBUNIT; TRANSDUCTION; RAT; KINASE; CDNA; BUDS	Gustducin is a transducin-like G protein selectively expressed in taste receptor cells. The alpha subunit of gustducin (alpha-gustducin) is critical for transduction of responses to bitter or sweet compounds. We identified a G-protein gamma subunit (G gamma 13) that colocalized with alpha-gustducin in taste receptor cells. Of 19 alpha-gustducin/Gy13-positive taste receptor cells profiled, all expressed the G protein beta 3 subunit (G beta 3); similar to 80% also expressed G beta 1. Gustducin heterotrimers (alpha-gustducin/G beta 1/G gamma 13) were activated by taste cell membranes plus bitter denatonium. Antibodies against G gamma 13 blocked the denatonium-induced increase of inositol trisphosphate (IP3) in taste tissue. We conclude that gustducin heterotrimers transduce responses to bitter and sweet compounds via alpha-gustducin's regulation of phosphodiesterase (PDE) and G beta gamma's activation of phospholipase C (PLC).	NYU, Mt Sinai Sch Med, Howard Hughes Med Inst, New York, NY 10029 USA; NYU, Mt Sinai Sch Med, Dept Physiol & Biophys, New York, NY 10029 USA; NYU, Coll Dent, Div Basic Sci, New York, NY 10010 USA	Howard Hughes Medical Institute; Icahn School of Medicine at Mount Sinai; New York University; Icahn School of Medicine at Mount Sinai; New York University; New York University	Margolskee, RF (corresponding author), NYU, Mt Sinai Sch Med, Howard Hughes Med Inst, Box 1677,1 Gustave L Levy Pl, New York, NY 10029 USA.	margolskee@msvax.mssm.edu	Spielman, Andrew I./ABG-1150-2021	Spielman, Andrew I./0000-0002-7052-3689; Margolskee, Robert/0000-0002-9572-2887; Huang, Liquan/0000-0003-3400-0685	NIDCD NIH HHS [DC03155] Funding Source: Medline; NIDCR NIH HHS [DE10754] Funding Source: Medline; NIMH NIH HHS [MH57241] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R29DE010754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH057241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003155] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ABE K, 1993, J BIOL CHEM, V268, P12033; AKABAS MH, 1988, SCIENCE, V242, P1047, DOI 10.1126/science.3194756; AVENET P, 1988, NATURE, V331, P351, DOI 10.1038/331351a0; Boughter JD, 1997, J NEUROSCI, V17, P2852; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRADY G, 1993, METHOD ENZYMOL, V225, P611; Chaudhari N, 1996, J NEUROSCI, V16, P3817; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; FISHER KJ, 1992, MOL CELL BIOL, V12, P1585, DOI 10.1128/MCB.12.4.1585; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; HAGA K, 1994, J BIOL CHEM, V269, P12594; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; Hoon MA, 1999, CELL, V96, P541, DOI 10.1016/S0092-8674(00)80658-3; HURLEY JB, 1984, P NATL ACAD SCI-BIOL, V81, P6948, DOI 10.1073/pnas.81.22.6948; HWANG PM, 1990, P NATL ACAD SCI USA, V87, P7395, DOI 10.1073/pnas.87.19.7395; Kalyanaraman S, 1998, GENOMICS, V49, P147, DOI 10.1006/geno.1998.5223; Kinnamon SC, 1996, CURR OPIN NEUROBIOL, V6, P506, DOI 10.1016/S0959-4388(96)80057-2; KISSELEV OG, 1994, J BIOL CHEM, V269, P21399; KLEUSS C, 1993, SCIENCE, V259, P832, DOI 10.1126/science.8094261; KOLESNIKOV SS, 1995, NATURE, V376, P85, DOI 10.1038/376085a0; Lefkowitz RJ, 1998, J BIOL CHEM, V273, P18677, DOI 10.1074/jbc.273.30.18677; Lindemann B, 1996, PHYSIOL REV, V76, P719, DOI 10.1152/physrev.1996.76.3.719; MATSUOKA I, 1993, BIOCHEM BIOPH RES CO, V194, P504, DOI 10.1006/bbrc.1993.1848; MCLAUGHLIN SK, 1992, NATURE, V357, P563, DOI 10.1038/357563a0; Ming D, 1998, P NATL ACAD SCI USA, V95, P8933, DOI 10.1073/pnas.95.15.8933; Misaka T, 1997, J BIOL CHEM, V272, P22623, DOI 10.1074/jbc.272.36.22623; MORISHITA R, 1995, J BIOL CHEM, V270, P29469, DOI 10.1074/jbc.270.49.29469; Ong OC, 1997, GENOMICS, V44, P101, DOI 10.1006/geno.1997.4814; PALMER S, 1990, METHODS INOSITIDE RE, P127; PITCHER JA, 1992, SCIENCE, V257, P1264, DOI 10.1126/science.1325672; Pumplin DW, 1997, J COMP NEUROL, V378, P389, DOI 10.1002/(SICI)1096-9861(19970217)378:3<389::AID-CNE7>3.0.CO;2-#; RAHMATULLAH M, 1994, J BIOL CHEM, V269, P3574; RAHMATULLAH M, 1995, J BIOL CHEM, V270, P2946, DOI 10.1074/jbc.270.7.2946; RAY K, 1995, J BIOL CHEM, V270, P21765, DOI 10.1074/jbc.270.37.21765; ROPER SD, 1989, ANNU REV NEUROSCI, V12, P329, DOI 10.1146/annurev.ne.12.030189.001553; Rossler P, 1998, EUR J CELL BIOL, V77, P253; Ruiz C, 1995, EXPT CELL BIOL TASTE, P79; RUIZAVILA L, 1995, NATURE, V376, P80, DOI 10.1038/376080a0; RYBA NJP, 1995, J BIOL CHEM, V270, P6757, DOI 10.1074/jbc.270.12.6757; Scherer SW, 1996, GENOMICS, V35, P241, DOI 10.1006/geno.1996.0346; SCHMIDT CJ, 1992, J BIOL CHEM, V267, P13807; Spielman AI, 1996, AM J PHYSIOL-CELL PH, V270, pC926, DOI 10.1152/ajpcell.1996.270.3.C926; SPIELMAN AI, 1994, PHYSIOL BEHAV, V56, P1149, DOI 10.1016/0031-9384(94)90359-X; Spielman AI., 1995, EXPT CELL BIOL TASTE, P25; STRIEM JB, 1991, CELL PHYSIOL BIOCHEM, V1, P46; TAREILUS E, 1995, EXPT CELL BIOL TASTE, P193; Wong GT, 1996, NATURE, V381, P796, DOI 10.1038/381796a0; Wong GT, 1999, J NEUROSCI, V19, P5802, DOI 10.1523/JNEUROSCI.19-14-05802.1999	50	257	279	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	1999	2	12					1055	1062		10.1038/15981	http://dx.doi.org/10.1038/15981			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292TA	10570481				2022-12-17	WOS:000085810100008
J	Xiao, L; Ohayon, D; McKenzie, IA; Sinclair-Wilson, A; Wright, JL; Fudge, AD; Emery, B; Li, HL; Richardson, WD				Xiao, Lin; Ohayon, David; McKenzie, Ian A.; Sinclair-Wilson, Alexander; Wright, Jordan L.; Fudge, Alexander D.; Emery, Ben; Li, Huiliang; Richardson, William D.			Rapid production of new oligodendrocytes is required in the earliest stages of motor-skill learning	NATURE NEUROSCIENCE			English	Article							GENE REGULATORY FACTOR; WHITE-MATTER; PREMYELINATING OLIGODENDROCYTES; MYELIN; PROGENITORS; DYNAMICS; DIFFERENTIATION; NEURONS; LINEAGE; NUMBER	We identified mRNA encoding the ecto-enzyme Enpp6 as a marker of newly forming oligodendrocytes, and used Enpp6 in situ hybridization to track oligodendrocyte differentiation in adult mice as they learned a motor skill (running on a wheel with unevenly spaced rungs). Within just 2.5 h of exposure to the complex wheel, production of Enpp6-expressing immature oligodendrocytes was accelerated in subcortical white matter; within 4 h, it was accelerated in motor cortex. Conditional deletion of myelin regulatory factor (Myrf) in oligodendrocyte precursors blocked formation of new Enpp6(+) oligodendrocytes and impaired learning within the same similar to 2-3 h time frame. This very early requirement for oligodendrocytes suggests a direct and active role in learning, closely linked to synaptic strengthening. Running performance of normal mice continued to improve over the following week accompanied by secondary waves of oligodendrocyte precursor proliferation and differentiation. We concluded that new oligodendrocytes contribute to both early and late stages of motor skill learning.	[Xiao, Lin; Ohayon, David; McKenzie, Ian A.; Sinclair-Wilson, Alexander; Wright, Jordan L.; Fudge, Alexander D.; Li, Huiliang; Richardson, William D.] UCL, Wolfson Inst Biomed Res, London, England; [Xiao, Lin] Second Mil Med Univ, Inst Neurosci, Shanghai, Peoples R China; [Emery, Ben] Oregon Hlth & Sci Univ, Jungers Ctr Neurosci Res, Portland, OR 97201 USA; [Ohayon, David] Univ Paul Sabatier, Ctr Dev Biol, Toulouse, France	University of London; University College London; Naval Medical University; Oregon Health & Science University; Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Richardson, WD (corresponding author), UCL, Wolfson Inst Biomed Res, London, England.	w.richardson@ucl.ac.uk	Richardson FMedSci FRS, William D/C-1762-2008	Richardson FMedSci FRS, William D/0000-0001-7261-2485; OHAYON, David/0000-0003-3545-3774; Emery, Ben/0000-0002-9132-3045; Wright, Jordan/0000-0001-8532-612X	European Research Council [293544]; Wellcome Trust [100269/Z/12/Z]; Biotechnology and Biological Sciences Research Council [BB/L003236/1]; National Natural Science Foundation of China [31471013]; BBSRC [BB/L003236/1] Funding Source: UKRI; MRC [G0800575] Funding Source: UKRI; Medical Research Council [G0800575] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank our colleagues at University College London, especially S. Jolly, U. Grazini and L. Magno, for advice and reagents, and M. Grist and U. Dennehy for technical help. We thank M. Wegner (University of Erlangen, Germany) for the Sox10 antibody. This work was supported by the European Research Council (grant agreement 293544 to W.D.R.), the Wellcome Trust (100269/Z/12/Z to W.D.R.) and the Biotechnology and Biological Sciences Research Council (BB/L003236/1 to H.L.). L.X. was supported by the National Natural Science Foundation of China (grant 31471013). Pdgfra-CreER<SUP>T2</SUP> mice can be obtained through http://www.e-lucid.com/ with a material transfer agreement. Myrf<SUP>loxP</SUP> mice are available from Jackson Labs, strain 010607.	Bellesi Michele, 2015, Curr Sleep Med Rep, V1, P20; Bergles D.E., 2015, GLIA COLD SPRING HAR, P139; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Chang A, 2002, NEW ENGL J MED, V346, P165, DOI 10.1056/NEJMoa010994; Dimou L, 2008, J NEUROSCI, V28, P10434, DOI 10.1523/JNEUROSCI.2831-08.2008; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Emery B, 2009, CELL, V138, P172, DOI 10.1016/j.cell.2009.04.031; Freeman SA, 2015, P NATL ACAD SCI USA, V112, pE321, DOI 10.1073/pnas.1419099112; Funfschilling U, 2012, NATURE, V485, P517, DOI 10.1038/nature11007; Gibson EM, 2014, SCIENCE, V344, P487, DOI 10.1126/science.1252304; Greiner-Tollersrud L, 2013, NEUROCHEM RES, V38, P300, DOI 10.1007/s11064-012-0921-z; Hines JH, 2015, NAT NEUROSCI, V18, P683, DOI 10.1038/nn.3992; Ho VM, 2011, SCIENCE, V334, P623, DOI 10.1126/science.1209236; Hornig J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003907; Hu YZ, 2011, HUM BRAIN MAPP, V32, P10, DOI 10.1002/hbm.20996; Hughes EG, 2013, NAT NEUROSCI, V16, P668, DOI 10.1038/nn.3390; Kang SH, 2010, NEURON, V68, P668, DOI 10.1016/j.neuron.2010.09.009; Koenning M, 2012, J NEUROSCI, V32, P12528, DOI 10.1523/JNEUROSCI.1069-12.2012; Kole K, 2015, J NEUROPHYSIOL, V114, P2077, DOI 10.1152/jn.00972.2014; Lasiene J, 2009, AGING CELL, V8, P201, DOI 10.1111/j.1474-9726.2009.00462.x; Lee KJ, 2014, REV NEUROSCIENCE, V25, P223, DOI 10.1515/revneuro-2013-0068; Lee YJ, 2012, NATURE, V487, P443, DOI 10.1038/nature11314; Li Q, 2010, NEUROSCI LETT, V479, P128, DOI 10.1016/j.neulet.2010.05.043; Makinodan M, 2012, SCIENCE, V337, P1357, DOI 10.1126/science.1220845; Mangin JM, 2012, NAT NEUROSCI, V15, P1192, DOI 10.1038/nn.3190; Matsumoto Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027628; McKenzie IA, 2014, SCIENCE, V346, P318, DOI 10.1126/science.1254960; Mensch S, 2015, NAT NEUROSCI, V18, P628, DOI 10.1038/nn.3991; Milner B, 1998, NEURON, V20, P445, DOI 10.1016/S0896-6273(00)80987-3; Morita J, 2016, SCI REP-UK, V6, DOI 10.1038/srep20995; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; Sagi Y, 2012, NEURON, V73, P1195, DOI 10.1016/j.neuron.2012.01.025; Sakagami H, 2005, J BIOL CHEM, V280, P23084, DOI 10.1074/jbc.M413438200; Sampaio-Baptista C, 2013, J NEUROSCI, V33, P19499, DOI 10.1523/JNEUROSCI.3048-13.2013; Scholz J, 2009, NAT NEUROSCI, V12, P1370, DOI 10.1038/nn.2412; Simon C, 2011, GLIA, V59, P869, DOI 10.1002/glia.21156; STURROCK RR, 1980, NEUROPATH APPL NEURO, V6, P415, DOI 10.1111/j.1365-2990.1980.tb00219.x; Trapp BD, 1997, J CELL BIOL, V137, P459, DOI 10.1083/jcb.137.2.459; van Heyningen P, 2001, CURR BIOL, V11, P232, DOI 10.1016/S0960-9822(01)00075-6; VOLKMAR FR, 1972, SCIENCE, V176, P1445, DOI 10.1126/science.176.4042.1445; Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8; Xu TH, 2009, NATURE, V462, P915, DOI 10.1038/nature08389; Yeung MSY, 2014, CELL, V159, P766, DOI 10.1016/j.cell.2014.10.011; Young KM, 2013, NEURON, V77, P873, DOI 10.1016/j.neuron.2013.01.006; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]; Zhu XQ, 2011, DEVELOPMENT, V138, P745, DOI 10.1242/dev.047951	46	256	258	4	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2016	19	9					1210	1217		10.1038/nn.4351	http://dx.doi.org/10.1038/nn.4351			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DU5SA	27455109	Green Submitted, Green Accepted			2022-12-17	WOS:000382270400020
J	Stuber, GD; Wise, RA				Stuber, Garret D.; Wise, Roy A.			Lateral hypothalamic circuits for feeding and reward	NATURE NEUROSCIENCE			English	Review							MELANIN-CONCENTRATING HORMONE; BRAIN-STIMULATION REWARD; MEDIAL FOREBRAIN-BUNDLE; PIMOZIDE-INDUCED EXTINCTION; MESOLIMBIC DOPAMINE SYSTEM; CONDITIONED TASTE-AVERSION; NUCLEUS-ACCUMBENS SHELL; VENTRAL TEGMENTAL AREA; ELECTRICAL-STIMULATION; SELF-STIMULATION	In experiments conducted over 60 years ago, the lateral hypothalamic area (LHA) was identified as a critical neuroanatomical substrate for motivated behavior. Electrical stimulation of the LHA induces voracious feeding even in well-fed animals. In the absence of food, animals will work tirelessly, often lever-pressing thousands of times per hour, for electrical stimulation at the same site that provokes feeding, drinking and other species-typical motivated behaviors. Here we review the classic findings from electrical stimulation studies and integrate them with more recent work that has used contemporary circuit-based approaches to study the LHA. We identify specific anatomically and molecularly defined LHA elements that integrate diverse information arising from cortical, extended amygdala and basal forebrain networks to ultimately generate a highly specified and invigorated behavioral state conveyed via LHA projections to downstream reward and feeding-specific circuits.	[Stuber, Garret D.] Univ N Carolina, Dept Psychiat, Chapel Hill, NC USA; [Stuber, Garret D.] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC USA; [Stuber, Garret D.] Univ N Carolina, Neurosci Ctr, Chapel Hill, NC USA; [Wise, Roy A.] NIDA, Intramural Res Program, US Natl Inst Hlth, Dept Hlth & Human Serv, Baltimore, MD USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Stuber, GD (corresponding author), Univ N Carolina, Dept Psychiat, Chapel Hill, NC USA.; Stuber, GD (corresponding author), Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC USA.; Stuber, GD (corresponding author), Univ N Carolina, Neurosci Ctr, Chapel Hill, NC USA.	gstuber@med.unc.edu	Stuber, Garret/E-1160-2011	Stuber, Garret/0000-0003-1730-4855	Klarman Family Foundation; Brain and Behavior Research Foundation; Foundation for Prader-Willi Research; Foundation of Hope; National Institute on Drug Abuse [DA032750, DA038168]; Department of Psychiatry at UNC Chapel Hill; Intramural Research Program at the National Institute on Drug Abuse; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056350] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA032750, R01DA032750, ZIADA000471, R01DA038168] Funding Source: NIH RePORTER	Klarman Family Foundation; Brain and Behavior Research Foundation; Foundation for Prader-Willi Research; Foundation of Hope; National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Department of Psychiatry at UNC Chapel Hill; Intramural Research Program at the National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank J. Jennings for input on the manuscript and members of the Stuber laboratory for helpful discussion. This work was supported by the Klarman Family Foundation, the Brain and Behavior Research Foundation, the Foundation for Prader-Willi Research, the Foundation of Hope, the National Institute on Drug Abuse (DA032750 and DA038168), and the Department of Psychiatry at UNC Chapel Hill (G.D.S.). R.A.W. was supported by the Intramural Research Program at the National Institute on Drug Abuse.	Acuna-Goycolea C, 2005, J NEUROSCI, V25, P7406, DOI 10.1523/JNEUROSCI.1008-05.2005; Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; ALLEN GV, 1995, NEUROSCIENCE, V69, P533, DOI 10.1016/0306-4522(95)00261-G; Alon T, 2006, J NEUROSCI, V26, P389, DOI 10.1523/JNEUROSCI.1203-05.2006; ANAND BK, 1951, P SOC EXP BIOL MED, V77, P323, DOI 10.3181/00379727-77-18766; ANDERSSON B, 1957, ACTA PHYSIOL SCAND, V41, P194, DOI 10.1111/j.1748-1716.1957.tb01520.x; Anthony TE, 2014, CELL, V156, P522, DOI 10.1016/j.cell.2013.12.040; BEHBEHANI MM, 1995, PROG NEUROBIOL, V46, P575, DOI 10.1016/0301-0082(95)00009-K; BERK ML, 1982, BRAIN RES BULL, V8, P511, DOI 10.1016/0361-9230(82)90009-0; BERNARDIS LL, 1993, NEUROSCI BIOBEHAV R, V17, P141, DOI 10.1016/S0149-7634(05)80149-6; Berthoud HR, 2011, PHYSIOL BEHAV, V104, P29, DOI 10.1016/j.physbeh.2011.04.051; Betley JN, 2013, CELL, V155, P1337, DOI 10.1016/j.cell.2013.11.002; Bielajew C, 2000, BRAIN RES, V881, P112, DOI 10.1016/S0006-8993(00)02565-8; BITTENCOURT JC, 1992, J COMP NEUROL, V319, P218, DOI 10.1002/cne.903190204; BOWER GH, 1958, J COMP PHYSIOL PSYCH, V51, P669, DOI 10.1037/h0038925; Broberger C, 1998, J COMP NEUROL, V402, P460; Brown JA, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00009; Burdakov D, 2005, J CELL MOL MED, V9, P795, DOI 10.1111/j.1582-4934.2005.tb00380.x; CAGGIULA AR, 1966, SCIENCE, V153, P1284, DOI 10.1126/science.153.3741.1284; CANTERAS NS, 1994, J COMP NEUROL, V348, P41, DOI 10.1002/cne.903480103; Carter ME, 2015, J NEUROSCI, V35, P4582, DOI 10.1523/JNEUROSCI.3729-14.2015; Carter ME, 2013, NATURE, V503, P111, DOI 10.1038/nature12596; Collin M, 2003, EUR J NEUROSCI, V18, P1265, DOI 10.1046/j.1460-9568.2003.02840.x; Cooke JH, 2009, OBESITY, V17, P1135, DOI 10.1038/oby.2008.652; COONS EE, 1965, SCIENCE, V150, P1320, DOI 10.1126/science.150.3701.1320; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; DELGADO JMR, 1953, AM J PHYSIOL, V172, P162, DOI 10.1152/ajplegacy.1952.172.1.162; DEWIT H, 1977, CAN J PSYCHOL, V31, P195, DOI 10.1037/h0081662; Elias CF, 1998, J COMP NEUROL, V402, P442, DOI 10.1002/(SICI)1096-9861(19981228)402:4<442::AID-CNE2>3.0.CO;2-R; FLYNN JP, 1969, ANN NY ACAD SCI, V159, P1008, DOI 10.1111/j.1749-6632.1969.tb12993.x; FOURIEZOS G, 1976, BRAIN RES, V103, P377, DOI 10.1016/0006-8993(76)90809-X; FOURIEZOS G, 1978, J COMP PHYSIOL PSYCH, V92, P661, DOI 10.1037/h0077500; FRANKLIN KBJ, 1979, PHARMACOL BIOCHEM BE, V11, P71, DOI 10.1016/0091-3057(79)90299-5; FRANKLIN KBJ, 1978, PHARMACOL BIOCHEM BE, V9, P813, DOI 10.1016/0091-3057(78)90361-1; FUKUDA M, 1986, BRAIN RES BULL, V17, P879, DOI 10.1016/0361-9230(86)90102-4; Fulton S, 2000, SCIENCE, V287, P125, DOI 10.1126/science.287.5450.125; Fulton S, 2006, BEHAV BRAIN RES, V174, P56, DOI 10.1016/j.bbr.2006.07.009; GALLISTEL CR, 1981, PSYCHOL REV, V88, P228, DOI 10.1037/0033-295X.88.3.228; GALLISTEL CR, 1982, PHARMACOL BIOCHEM BE, V17, P769, DOI 10.1016/0091-3057(82)90360-4; GLICKMAN SE, 1967, PSYCHOL REV, V74, P81, DOI 10.1037/h0024290; Goforth PB, 2014, J NEUROSCI, V34, P11405, DOI 10.1523/JNEUROSCI.5167-13.2014; GRATTON A, 1985, SCIENCE, V227, P545, DOI 10.1126/science.2981439; GRATTON A, 1988, BRAIN RES, V438, P264, DOI 10.1016/0006-8993(88)91345-5; GRATTON A, 1988, BRAIN RES, V438, P256, DOI 10.1016/0006-8993(88)91344-3; GREER MA, 1955, P SOC EXP BIOL MED, V89, P59, DOI 10.3181/00379727-89-21716; Griffond B, 2009, PEPTIDES, V30, P2045, DOI 10.1016/j.peptides.2009.07.008; GROSSMAN SP, 1978, SCIENCE, V202, P537, DOI 10.1126/science.705344; GROSSMAN SP, 1982, PHYSIOL BEHAV, V29, P553, DOI 10.1016/0031-9384(82)90281-5; GROVE EA, 1988, J COMP NEUROL, V277, P347, DOI 10.1002/cne.902770303; Hara J, 2001, NEURON, V30, P345, DOI 10.1016/S0896-6273(01)00293-8; Harris GC, 2005, NATURE, V437, P556, DOI 10.1038/nature04071; Harrison TA, 1999, NEUROSCI LETT, V273, P17, DOI 10.1016/S0304-3940(99)00611-4; Harthoorn LF, 2005, CELL MOL NEUROBIOL, V25, P1209, DOI 10.1007/s10571-005-8184-8; Haynes AC, 2002, REGUL PEPTIDES, V104, P153, DOI 10.1016/S0167-0115(01)00358-5; HEIMER L, 1991, NEUROSCIENCE, V41, P89, DOI 10.1016/0306-4522(91)90202-Y; Hess WR, 1957, FUNCTIONAL ORG DIENC; Hetherington AW, 1940, ANAT REC, V78, P149, DOI 10.1002/ar.1090780203; HOEBEL BG, 1962, SCIENCE, V135, P375, DOI 10.1126/science.135.3501.375; Horvath TL, 1999, J NEUROSCI, V19, P1072; HUTCHINSON RR, 1966, J COMP PHYSIOL PSYCH, V61, P360, DOI 10.1037/h0023250; Jego S, 2013, NAT NEUROSCI, V16, P1637, DOI 10.1038/nn.3522; Jennings JH, 2015, CELL, V160, P516, DOI 10.1016/j.cell.2014.12.026; Jennings JH, 2013, SCIENCE, V341, P1517, DOI 10.1126/science.1241812; Jennings JH, 2013, NATURE, V496, P224, DOI 10.1038/nature12041; JONES BE, 1977, BRAIN RES, V127, P23, DOI 10.1016/0006-8993(77)90378-X; KAHN D, 1980, ENDOCRINOLOGY, V107, P47, DOI 10.1210/endo-107-1-47; KAPATOS G, 1973, Pharmacology Biochemistry and Behavior, V1, P81, DOI 10.1016/0091-3057(73)90060-9; Karnani MM, 2013, J PHYSIOL-LONDON, V591, P933, DOI 10.1113/jphysiol.2012.243493; KELLY J, 1979, PHYSIOL BEHAV, V23, P1123, DOI 10.1016/0031-9384(79)90306-8; Kempadoo KA, 2013, J NEUROSCI, V33, P7618, DOI 10.1523/JNEUROSCI.2588-12.2013; Kim ER, 2008, BEHAV BRAIN RES, V194, P66, DOI 10.1016/j.bbr.2008.06.024; KITA H, 1981, BRAIN RES, V213, P1, DOI 10.1016/0006-8993(81)91244-0; Knight ZA, 2012, CELL, V151, P1126, DOI 10.1016/j.cell.2012.10.039; Lammel S, 2012, NATURE, V491, P212, DOI 10.1038/nature11527; Laque A, 2013, AM J PHYSIOL-ENDOC M, V304, pE999, DOI 10.1152/ajpendo.00643.2012; Lee H, 2014, NATURE, V509, P627, DOI 10.1038/nature13169; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Leinninger GM, 2011, CELL METAB, V14, P313, DOI 10.1016/j.cmet.2011.06.016; Leinninger GM, 2009, CELL METAB, V10, P89, DOI 10.1016/j.cmet.2009.06.011; Ludwig DS, 2001, J CLIN INVEST, V107, P379, DOI 10.1172/JCI10660; LUITEN PGM, 1987, PROG NEUROBIOL, V28, P1, DOI 10.1016/0301-0082(87)90004-9; MACDONNELL M, 1966, ANIM BEHAV, V14, P399, DOI 10.1016/S0003-3472(66)80036-2; MACDONNELL MF, 1966, SCIENCE, V152, P1406, DOI 10.1126/science.152.3727.1406; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; MALDONADOIRIZARRY CS, 1995, J NEUROSCI, V15, P6779; MARGULES DL, 1962, SCIENCE, V135, P374, DOI 10.1126/science.135.3501.374; Martini L., 2013, NEUROENDOCRINOLOGY; MENDELSO.J, 1966, J COMP PHYSIOL PSYCH, V62, P341, DOI 10.1037/h0023933; MENDELSON J, 1973, BEHAV BIOL, V8, P619, DOI 10.1016/S0091-6773(73)80147-6; MENDELSON J, 1965, SCIENCE, V149, P559, DOI 10.1126/science.149.3683.559; MILLHOUSE OE, 1969, BRAIN RES, V15, P341, DOI 10.1016/0006-8993(69)90161-9; MOGENSON GJ, 1971, BRAIN RES, V33, P127, DOI 10.1016/0006-8993(71)90311-8; MOGENSON GJ, 1967, EXP NEUROL, V17, P119, DOI 10.1016/0014-4886(67)90139-2; MONTEMURRO DG, 1957, CAN J BIOCHEM PHYS, V35, P31; MOORE RY, 1978, J COMP NEUROL, V180, P417, DOI 10.1002/cne.901800302; MORGANE PJ, 1961, NATURE, V191, P672, DOI 10.1038/191672a0; NAUTA WJH, 1958, BRAIN, V81, P319, DOI 10.1093/brain/81.3.319; Nieh EH, 2015, CELL, V160, P528, DOI 10.1016/j.cell.2015.01.003; NIEUWENHUYS R, 1982, J COMP NEUROL, V206, P49, DOI 10.1002/cne.902060106; O'Connor EC, 2015, NEURON, V88, P553, DOI 10.1016/j.neuron.2015.09.038; OLDS J, 1956, SCI AM, V195, P105, DOI 10.1038/scientificamerican1056-105; OLDS J, 1954, J COMP PHYSIOL PSYCH, V47, P419, DOI 10.1037/h0058775; OLDS J, 1958, SCIENCE, V127, P315, DOI 10.1126/science.127.3294.315; ONO T, 1992, J NEUROPHYSIOL, V67, P265, DOI 10.1152/jn.1992.67.2.265; ONO T, 1986, J NEUROPHYSIOL, V56, P63, DOI 10.1152/jn.1986.56.1.63; PALKOVITS M, 1980, BRAIN RES BULL, V5, P643, DOI 10.1016/0361-9230(80)90199-9; PHILLIPS AG, 1975, NATURE, V258, P750, DOI 10.1038/258750a0; Poller WC, 2013, BRAIN RES, V1507, P45, DOI 10.1016/j.brainres.2013.01.029; Puelles L, 2003, TRENDS NEUROSCI, V26, P469, DOI 10.1016/S0166-2236(03)00234-0; Qu DQ, 1996, NATURE, V380, P243, DOI 10.1038/380243a0; RANCK JB, 1975, BRAIN RES, V98, P417, DOI 10.1016/0006-8993(75)90364-9; ROBERTS WW, 1965, J COMP PHYSIOL PSYCH, V59, P317, DOI 10.1037/h0022030; Root DH, 2015, PROG NEUROBIOL, V130, P29, DOI 10.1016/j.pneurobio.2015.03.005; Rosin DL, 2003, J COMP NEUROL, V465, P593, DOI 10.1002/cne.10860; Sakurai T, 1999, REGUL PEPTIDES, V85, P25, DOI 10.1016/S0167-0115(99)00076-2; Sakurai T, 2014, NAT REV NEUROSCI, V15, P719, DOI 10.1038/nrn3837; Saper CB, 2002, NEURON, V36, P199, DOI 10.1016/S0896-6273(02)00969-8; SCHWARTZBAUM JS, 1988, PHYSIOL BEHAV, V44, P507, DOI 10.1016/0031-9384(88)90313-7; Shabel SJ, 2012, NEURON, V74, P475, DOI 10.1016/j.neuron.2012.02.037; Shimada M, 1998, NATURE, V396, P670, DOI 10.1038/25341; SHIZGAL P, 1980, J COMP PHYSIOL PSYCH, V94, P227, DOI 10.1037/h0077668; Stamatakis A. M., J NEUROSCI IN PRESS; STANLEY BG, 1993, BRAIN RES, V613, P88; Stratford TR, 2013, BRAIN RES, V1490, P128, DOI 10.1016/j.brainres.2012.10.043; Stratford TR, 1999, J NEUROSCI, V19, P11040, DOI 10.1523/JNEUROSCI.19-24-11040.1999; STRICKER EM, 1978, BRAIN RES, V158, P470, DOI 10.1016/0006-8993(78)90692-3; Swaab DF, 1992, HUMAN HYPOTHALAMUS H; Tan KR, 2012, NEURON, V73, P1173, DOI 10.1016/j.neuron.2012.02.015; TENEN SS, 1964, J COMP PHYSIOL PSYCH, V58, P55, DOI 10.1037/h0043359; UNGERSTEDT U, 1971, ACTA PHYSIOL SCAND, P95; VALENSTEIN ES, 1968, SCIENCE, V159, P1119, DOI 10.1126/science.159.3819.1119; van Zessen R, 2012, NEURON, V73, P1184, DOI 10.1016/j.neuron.2012.02.016; Vong L, 2011, NEURON, V71, P142, DOI 10.1016/j.neuron.2011.05.028; WISE RA, 1981, PROG NEURO-PSYCHOPHA, V5, P467, DOI 10.1016/0364-7722(81)90028-X; WISE RA, 1968, SCIENCE, V162, P377, DOI 10.1126/science.162.3851.377; WISE RA, 1971, PHYSIOL BEHAV, V6, P569, DOI 10.1016/0031-9384(71)90207-1; WISE RA, 1978, BRAIN RES, V152, P215, DOI 10.1016/0006-8993(78)90253-6; WISE RA, 1978, SCIENCE, V201, P262, DOI 10.1126/science.566469; WISE RA, 1974, BRAIN RES, V67, P187, DOI 10.1016/0006-8993(74)90272-8; WISE RA, 1973, BEHAV BIOL, V9, P289, DOI 10.1016/S0091-6773(73)80179-8; Wise RA, 2013, BIOL PSYCHIAT, V73, P819, DOI 10.1016/j.biopsych.2012.09.001; Wu ZF, 2015, J NEUROSCI, V35, P3312, DOI 10.1523/JNEUROSCI.3720-14.2015; YEOMANS JS, 1979, PHYSIOL BEHAV, V22, P911, DOI 10.1016/0031-9384(79)90336-6; YEOMANS JS, 1982, NEURAL BASIS FEEDING, P405; YOKEL RA, 1975, SCIENCE, V187, P547, DOI 10.1126/science.1114313; Yoshida K, 2006, J COMP NEUROL, V494, P845, DOI 10.1002/cne.20859; ZAHM DS, 1992, NEUROSCIENCE, V50, P751, DOI 10.1016/0306-4522(92)90202-D; Ziegler DR, 2002, J COMP NEUROL, V448, P217, DOI 10.1002/cne.10257	148	256	260	2	91	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2016	19	2					198	205		10.1038/nn.4220	http://dx.doi.org/10.1038/nn.4220			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DC4EG	26814589	Green Submitted, Green Accepted			2022-12-17	WOS:000369172600007
J	Rosenzweig, ES; Courtine, G; Jindrich, DL; Brock, JH; Ferguson, AR; Strand, SC; Nout, YS; Roy, RR; Miller, DM; Beattie, MS; Havton, LA; Bresnahan, JC; Edgerton, VR; Tuszynski, MH				Rosenzweig, Ephron S.; Courtine, Gregoire; Jindrich, Devin L.; Brock, John H.; Ferguson, Adam R.; Strand, Sarah C.; Nout, Yvette S.; Roy, Roland R.; Miller, Darren M.; Beattie, Michael S.; Havton, Leif A.; Bresnahan, Jacqueline C.; Edgerton, V. Reggie; Tuszynski, Mark H.			Extensive spontaneous plasticity of corticospinal projections after primate spinal cord injury	NATURE NEUROSCIENCE			English	Article							SAMPLE-SIZE; BROWN-SEQUARD; MOTOR CORTEX; RECOVERY; REGENERATION; AXONS; ORGANIZATION; CONNECTIONS; SYSTEM; GROWTH	Although axonal regeneration after CNS injury is limited, partial injury is frequently accompanied by extensive functional recovery. To investigate mechanisms underlying spontaneous recovery after incomplete spinal cord injury, we administered C7 spinal cord hemisections to adult rhesus monkeys and analyzed behavioral, electrophysiological and anatomical adaptations. We found marked spontaneous plasticity of corticospinal projections, with reconstitution of fully 60% of pre-lesion axon density arising from sprouting of spinal cord midline-crossing axons. This extensive anatomical recovery was associated with improvement in coordinated muscle recruitment, hand function and locomotion. These findings identify what may be the most extensive natural recovery of mammalian axonal projections after nervous system injury observed to date, highlighting an important role for primate models in translational disease research.	[Rosenzweig, Ephron S.; Brock, John H.; Miller, Darren M.; Tuszynski, Mark H.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Courtine, Gregoire; Jindrich, Devin L.; Roy, Roland R.; Havton, Leif A.; Edgerton, V. Reggie] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA; [Courtine, Gregoire; Jindrich, Devin L.; Roy, Roland R.; Havton, Leif A.; Edgerton, V. Reggie] Univ Calif Los Angeles, Dept Physiol Sci, Los Angeles, CA 90024 USA; [Courtine, Gregoire] Univ Zurich, Dept Neurol, Zurich, Switzerland; [Ferguson, Adam R.; Nout, Yvette S.; Beattie, Michael S.; Bresnahan, Jacqueline C.] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA; [Strand, Sarah C.] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA; [Tuszynski, Mark H.] Vet Adm Med Ctr, La Jolla, CA 90034 USA	University of California System; University of California San Diego; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Zurich; University of California System; University of California San Francisco; University of California System; University of California Davis; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Tuszynski, MH (corresponding author), Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA.	mtuszynski@ucsd.edu	courtine, gregoire/AAJ-1694-2020; Rosenzweig, Ephron/AAI-7541-2020	courtine, gregoire/0000-0002-5744-4142; Ferguson, Adam/0000-0001-7102-1608; Rosenzweig, Ephron/0000-0002-0370-9643	US National Institutes of Health [NS42291, NS049881, NS053059]; Veterans Administration; California Roman-Reed funds; Bernard and Anne Spitzer Charitable Trust; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042291, R01NS049041, R01NS067092, F32NS053059, R01NS049881] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Administration(US Department of Veterans Affairs); California Roman-Reed funds; Bernard and Anne Spitzer Charitable Trust; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank H. Yang, S. Zdunowski, M. Culbertson, H. Zhong, R. Moseanko, S. Hawbecker, H. McKay and T. Bernot for valuable experimental assistance. This work was supported by the US National Institutes of Health (NS42291, NS049881 and NS053059), the Veterans Administration, California Roman-Reed funds, the Bernard and Anne Spitzer Charitable Trust and the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation.	Anderson KD, 2005, EXP NEUROL, V194, P161, DOI 10.1016/j.expneurol.2005.02.006; Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195; Blesch A, 2009, TRENDS NEUROSCI, V32, P41, DOI 10.1016/j.tins.2008.09.008; Bradbury EJ, 2006, NAT REV NEUROSCI, V7, P644, DOI 10.1038/nrn1964; Brock JH, 2010, J NEUROSCI, V30, P9728, DOI 10.1523/JNEUROSCI.1924-10.2010; Brus-Ramer M, 2007, J NEUROSCI, V27, P13793, DOI 10.1523/JNEUROSCI.3489-07.2007; BUNGE RP, 1993, ADV NEUROL, V59, P75; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; CATTELL RB, 1969, EDUC PSYCHOL MEAS, V29, P781, DOI 10.1177/001316446902900405; Courtine G, 2005, BRAIN, V128, P2338, DOI 10.1093/brain/awh604; Courtine G, 2008, NAT MED, V14, P69, DOI 10.1038/nm1682; Courtine G, 2007, NAT MED, V13, P561, DOI 10.1038/nm1595; Courtine G, 2009, NAT NEUROSCI, V12, P1333, DOI 10.1038/nn.2401; Dancause N, 2005, J NEUROSCI, V25, P10167, DOI 10.1523/JNEUROSCI.3256-05.2005; Fawcett JW, 2007, SPINAL CORD, V45, P190, DOI 10.1038/sj.sc.3102007; Ghosh A, 2009, J NEUROSCI, V29, P12210, DOI 10.1523/JNEUROSCI.1828-09.2009; GUADAGNOLI E, 1988, PSYCHOL BULL, V103, P265, DOI 10.1037/0033-2909.103.2.265; HAVTON L, 1987, NATURE, V325, P711, DOI 10.1038/325711a0; HEPPREYMOND MC, 1974, EXP BRAIN RES, V21, P519; Hogarty KY, 2005, EDUC PSYCHOL MEAS, V65, P202, DOI 10.1177/0013164404267287; Hollis ER, 2009, EXP NEUROL, V215, P53, DOI 10.1016/j.expneurol.2008.09.014; Isa T, 2007, PHYSIOLOGY, V22, P145, DOI 10.1152/physiol.00045.2006; JENNY AB, 1983, J NEUROSCI, V3, P567; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; Kakulas B A, 1999, J Spinal Cord Med, V22, P119; Lacroix S, 2004, J COMP NEUROL, V473, P147, DOI 10.1002/cne.20051; LAWRENCE DG, 1968, BRAIN, V91, P1, DOI 10.1093/brain/91.1.1; LITTLE JW, 1985, PARAPLEGIA, V23, P39, DOI 10.1038/sc.1985.7; MacCallum RC, 1999, PSYCHOL METHODS, V4, P84, DOI 10.1037/1082-989x.4.1.84; Maier IC, 2008, J NEUROSCI, V28, P9386, DOI 10.1523/JNEUROSCI.1697-08.2008; NATHAN PW, 1973, BRAIN, V96, P471, DOI 10.1093/brain/96.3.471; RAISMAN G, 1969, BRAIN RES, V14, P25, DOI 10.1016/0006-8993(69)90029-8; Reader TA, 1999, NEUROCHEM INT, V34, P1, DOI 10.1016/S0197-0186(98)00048-5; Rosenzweig ES, 2009, J COMP NEUROL, V513, P151, DOI 10.1002/cne.21940; ROTH EJ, 1991, PARAPLEGIA, V29, P582, DOI 10.1038/sc.1991.86; Sasaki S, 2004, J NEUROPHYSIOL, V92, P3142, DOI 10.1152/jn.00342.2004; Steward O, 2008, EXP NEUROL, V209, P446, DOI 10.1016/j.expneurol.2007.12.010; Turner W.A., 1891, BRAIN, V14, P496; Weidner N, 2001, P NATL ACAD SCI USA, V98, P3513, DOI 10.1073/pnas.051626798	39	256	261	1	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2010	13	12					1505	U90		10.1038/nn.2691	http://dx.doi.org/10.1038/nn.2691			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	684CW	21076427	Green Submitted, Green Accepted			2022-12-17	WOS:000284525800015
J	Petkov, CI; Kang, XJ; Alho, K; Bertrand, O; Yund, EW; Woods, DL				Petkov, CI; Kang, XJ; Alho, K; Bertrand, O; Yund, EW; Woods, DL			Attentional modulation of human auditory cortex	NATURE NEUROSCIENCE			English	Article							INTERMODAL SELECTIVE ATTENTION; LEVEL-DEPENDENT REPRESENTATION; EVENT-RELATED FMRI; TONOTOPIC ORGANIZATION; VISUAL-CORTEX; NEURAL MECHANISMS; CORTICAL AREAS; STIMULI; FREQUENCY; MEMORY	Attention powerfully influences auditory perception, but little is understood about the mechanisms whereby attention sharpens responses to unattended sounds. We used high-resolution surface mapping techniques (using functional magnetic resonance imaging, fMRI) to examine activity in human auditory cortex during an intermodal selective attention task. Stimulus-dependent activations (SDAs), evoked by unattended sounds during demanding visual tasks, were maximal over mesial auditory cortex. They were tuned to sound frequency and location, and showed rapid adaptation to repeated sounds. Attention-related modulations (ARMs) were isolated as response enhancements that occurred when subjects performed pitch-discrimination tasks. In contrast to SDAs, ARMs were localized to lateral auditory cortex, showed broad frequency and location tuning, and increased in amplitude with sound repetition. The results suggest a functional dichotomy of auditory cortical fields: stimulus-determined mesial fields that faithfully transmit acoustic information, and attentionally labile lateral fields that analyze acoustic features of behaviorally relevant sounds.	Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; VANCHCS, Martinez, CA 95553 USA; Univ Calif Davis, Human Cognit Neurophysiol Lab, Martinez, CA USA; Univ Helsinki, Dept Psychol, FIN-00014 Helsinki, Finland; INSERM, U280, Mental Proc & Brain Activat Lab, F-69424 Lyon 03, France; Univ Calif Davis, Dept Neurol, Sacramento, CA 95817 USA; Univ Calif Davis, Ctr Mind & Brain, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of Helsinki; Institut National de la Sante et de la Recherche Medicale (Inserm); University of California System; University of California Davis; University of California System; University of California Davis	Woods, DL (corresponding author), Univ Calif Davis, Ctr Neurosci, 1544 Newton Court, Davis, CA 95616 USA.	dlwoods@ucdavis.edu	Petkov, Christopher/O-5318-2015; Alho, Kimmo/G-2997-2013; Bertrand, Olivier/B-6165-2008	Petkov, Christopher/0000-0002-4932-7907; Alho, Kimmo/0000-0001-8563-2792; Bertrand, Olivier/0000-0003-0733-7979; Woods, David/0000-0002-8804-3587; Yund, E./0000-0002-6833-0052	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005814] Funding Source: NIH RePORTER; NIDCD NIH HHS [DC005814] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Alain C, 2001, P NATL ACAD SCI USA, V98, P12301, DOI 10.1073/pnas.211209098; ALCAINI M, 1994, PSYCHOPHYSIOLOGY, V31, P611, DOI 10.1111/j.1469-8986.1994.tb02354.x; ALHO K, 1992, ELECTROEN CLIN NEURO, V82, P356, DOI 10.1016/0013-4694(92)90005-3; Alho K, 1999, COGNITIVE BRAIN RES, V7, P335, DOI 10.1016/S0926-6410(98)00036-6; Bilecen D, 2002, NEUROIMAGE, V17, P710, DOI 10.1006/nimg.2002.1133; Bilecen D, 1998, HEARING RES, V126, P19, DOI 10.1016/S0378-5955(98)00139-7; Binder JR, 2000, CEREB CORTEX, V10, P512, DOI 10.1093/cercor/10.5.512; Brechmann A, 2002, J NEUROPHYSIOL, V87, P423, DOI 10.1152/jn.00187.2001; Celsis P, 1999, NEUROIMAGE, V9, P135, DOI 10.1006/nimg.1998.0389; COWAN N, 1988, PSYCHOL BULL, V104, P163, DOI 10.1037/0033-2909.104.2.163; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Desimone R, 1998, PHILOS T R SOC B, V353, P1245, DOI 10.1098/rstb.1998.0280; Desimone R, 1996, P NATL ACAD SCI USA, V93, P13494, DOI 10.1073/pnas.93.24.13494; Downar J, 2001, NEUROIMAGE, V14, P1256, DOI 10.1006/nimg.2001.0946; Escera C, 1998, J COGNITIVE NEUROSCI, V10, P590, DOI 10.1162/089892998562997; Formisano E, 2003, NEURON, V40, P859, DOI 10.1016/S0896-6273(03)00669-X; Gaab N, 2003, J COGNITIVE NEUROSCI, V15, P810, DOI 10.1162/089892903322370735; Grady CL, 1997, NEUROREPORT, V8, P2511, DOI 10.1097/00001756-199707280-00019; Hackett TA, 2001, J COMP NEUROL, V441, P197, DOI 10.1002/cne.1407; Jancke L, 1999, COGNITIVE BRAIN RES, V8, P117, DOI 10.1016/S0926-6410(99)00012-9; Jancke L, 1999, NEUROSCI LETT, V266, P125, DOI 10.1016/S0304-3940(99)00288-8; Jancke L, 1998, NEUROPSYCHOLOGIA, V36, P875, DOI 10.1016/S0028-3932(98)00019-0; Jancke L, 2003, COGNITIVE BRAIN RES, V16, P257, DOI 10.1016/S0926-6410(02)00281-1; Kaas JH, 1999, CURR OPIN NEUROBIOL, V9, P164, DOI 10.1016/S0959-4388(99)80022-1; Kiehl KA, 2001, PSYCHOPHYSIOLOGY, V38, P133, DOI 10.1017/S0048577201981867; Kosaki H, 1997, J COMP NEUROL, V386, P304; KOSSLYN SM, 1995, NATURE, V378, P496, DOI 10.1038/378496a0; Martinez A, 1999, NAT NEUROSCI, V2, P364, DOI 10.1038/7274; Murray SO, 2004, NAT NEUROSCI, V7, P70, DOI 10.1038/nn1161; Opitz B, 2002, NEUROIMAGE, V15, P167, DOI 10.1006/nimg.2001.0970; PHILLIPS DP, 1994, EXP BRAIN RES, V102, P210; Pugh KR, 1996, NEUROIMAGE, V4, P159, DOI 10.1006/nimg.1996.0067; Rademacher J, 2001, NEUROIMAGE, V13, P669, DOI 10.1006/nimg.2000.0714; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; Rauschecker JP, 1998, CURR OPIN NEUROBIOL, V8, P516, DOI 10.1016/S0959-4388(98)80040-8; Recanzone GH, 2000, P NATL ACAD SCI USA, V97, P11829, DOI 10.1073/pnas.97.22.11829; Rivier F, 1997, NEUROIMAGE, V6, P288, DOI 10.1006/nimg.1997.0304; Schonwiesner M, 2002, NEUROIMAGE, V17, P1144, DOI 10.1006/nimg.2002.1250; Talavage TM, 2004, J NEUROPHYSIOL, V91, P1282, DOI 10.1152/jn.01125.2002; Talavage TM, 2000, HEARING RES, V150, P225, DOI 10.1016/S0378-5955(00)00203-3; Tzourio N, 1997, NEUROIMAGE, V5, P63, DOI 10.1006/nimg.1996.0252; Wallace MN, 2002, EXP BRAIN RES, V143, P499, DOI 10.1007/s00221-002-1014-z; Warren JD, 2003, J NEUROSCI, V23, P5799; Wessinger CM, 2001, J COGNITIVE NEUROSCI, V13, P1, DOI 10.1162/089892901564108; WOLDORFF MG, 1993, P NATL ACAD SCI USA, V90, P8722, DOI 10.1073/pnas.90.18.8722; Woodruff PWR, 1996, NEUROREPORT, V7, P1909, DOI 10.1097/00001756-199608120-00007; WOODS DL, 1992, ELECTROEN CLIN NEURO, V82, P341, DOI 10.1016/0013-4694(92)90004-2; WOODS DL, 1980, SCIENCE, V207, P655, DOI 10.1126/science.7352278; Woods DL, 2001, J COGNITIVE NEUROSCI, V13, P492, DOI 10.1162/08989290152001916; WOODS DL, 1990, EVENT RELATED BRAIN, P178	50	256	257	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2004	7	6					658	663		10.1038/nn1256	http://dx.doi.org/10.1038/nn1256			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	823VA	15156150				2022-12-17	WOS:000221640300021
J	Zhang, H; Sulzer, D				Zhang, H; Sulzer, D			Frequency-dependent modulation of dopamine release by nicotine	NATURE NEUROSCIENCE			English	Article							CHOLINERGIC MODULATION; RAT; RECEPTORS; STRIATUM; ADDICTION; NEURONS	Although nicotine activation of dopamine release is implicated in addiction, it also desensitizes nicotinic acetylcholine receptors (nAChRs), leading to a prolonged depression of evoked dopamine release. Here we show that nicotine's effects depend on the firing pattern of dopamine neurons, so that while desensitization of nAChRs indeed curbs dopamine released by stimuli emulating tonic firing, it allows a rapid rise in dopamine from stimuli emulating phasic firing patterns associated with incentive/salience paradigms. Nicotine may thus enhance the contrast of dopamine signals associated with behavioral cues.	Columbia Univ, Dept Neurol, New York, NY 10032 USA; Columbia Univ, Dept Psychiat, New York, NY 10032 USA; New York State Psychiat Inst & Hosp, Dept Neurosci, New York, NY 10032 USA	Columbia University; Columbia University; New York State Psychiatry Institute	Sulzer, D (corresponding author), Columbia Univ, Dept Neurol, 650 W 168th St, New York, NY 10032 USA.	ds43@columbia.edu						Cragg SJ, 2003, J NEUROSCI, V23, P4378; Di Chiara G, 2000, EUR J PHARMACOL, V393, P295, DOI 10.1016/S0014-2999(00)00122-9; GRENHOFF J, 1986, ACTA PHYSIOL SCAND, V128, P351, DOI 10.1111/j.1748-1716.1986.tb07988.x; Hyland BI, 2002, NEUROSCIENCE, V114, P475, DOI 10.1016/S0306-4522(02)00267-1; Jones IW, 2001, J COMP NEUROL, V439, P235, DOI 10.1002/cne.1345; KUDERNATSCH M, 1994, NEUROSCI LETT, V181, P107, DOI 10.1016/0304-3940(94)90571-1; Kulak JM, 2001, J NEUROCHEM, V77, P1581, DOI 10.1046/j.1471-4159.2001.00357.x; Levin ED, 2002, CNS NEUROL DISORD-DR, V1, P423, DOI 10.2174/1568007023339102; Mansvelder HD, 2003, EUR J PHARMACOL, V480, P117, DOI 10.1016/j.ejphar.2003.08.099; Phillips PEM, 2003, NATURE, V422, P614, DOI 10.1038/nature01566; Schilstrom B, 1998, NEUROSCIENCE, V85, P1005, DOI 10.1016/S0306-4522(98)00114-6; Schmitz Y, 2003, J NEUROCHEM, V87, P273, DOI 10.1046/j.1471-4159.2003.02050.x; SCHULTZ W, 1986, J NEUROPHYSIOL, V56, P1439, DOI 10.1152/jn.1986.56.5.1439; Zhang H, 2003, J NEUROSCI, V23, P10585; Zhou FM, 2001, NAT NEUROSCI, V4, P1224, DOI 10.1038/nn769	15	256	262	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2004	7	6					581	582		10.1038/nn1243	http://dx.doi.org/10.1038/nn1243			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	823VA	15146187				2022-12-17	WOS:000221640300008
J	Kakei, S; Hoffman, DS; Strick, PL				Kakei, S; Hoffman, DS; Strick, PL			Direction of action is represented in the ventral premotor cortex	NATURE NEUROSCIENCE			English	Article							PRIMARY MOTOR CORTEX; MOVEMENT-RELATED ACTIVITY; STEP-TRACKING MOVEMENTS; POST-ARCUATE AREA; MACAQUE MONKEYS; INFERIOR AREA-6; FUNCTIONAL-ORGANIZATION; PERIARCUATE NEURONS; 3-DIMENSIONAL SPACE; AFFERENT PROPERTIES	The ventral premotor area (PMv) is a major source of input to the primary motor cortex (M1). To examine the potential hierarchical processing between these motor areas, we recorded the activity of PMv neurons in a monkey trained to perform wrist movements in different directions with the wrist in three different postures. The task dissociated three major variables of wrist movement: muscle activity, direction of joint movement and direction of movement in space. Many PMv neurons were directionally tuned. Nearly all of these neurons (61/65, 94%) were 'extrinsic-like'; they seemed to encode the direction of movement in space independent of forearm posture. These results are strikingly different from results from M1 of the same animal, and suggest that intracortical processing between PMv and M1 may contribute to a sensorimotor transformation between extrinsic and intrinsic coordinate frames.	Univ Pittsburgh, Sch Med, Vet Affairs Med Ctr, Res Serv, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Sch Med, Dept Neurobiol, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Sch Med, Ctr Neural Basis Cognit, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Strick, PL (corresponding author), Univ Pittsburgh, Sch Med, Vet Affairs Med Ctr, Res Serv, W1640 Biomed Sci Tower,200 Lothrop St, Pittsburgh, PA 15261 USA.	strickp@pitt.edu		Kakei, Shinji/0000-0001-5111-5789				ALEXANDER GE, 1990, J NEUROPHYSIOL, V64, P133, DOI 10.1152/jn.1990.64.1.133; BOUSSAOUD D, 1993, EXP BRAIN RES, V95, P28; Crammond DJ, 1996, EXP BRAIN RES, V108, P45; DUM RP, 1991, LIFE SCI R, V50, P383; FOGARTY TJ, 1996, ADV VASC SURG, V4, P1; Fogassi L, 2001, BRAIN, V124, P571, DOI 10.1093/brain/124.3.571; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; GENTILUCCI M, 1988, EXP BRAIN RES, V71, P475, DOI 10.1007/BF00248741; GODSCHALK M, 1981, EXP BRAIN RES, V44, P113; Graziano MSA, 1997, J NEUROPHYSIOL, V77, P2268, DOI 10.1152/jn.1997.77.5.2268; HOFFMAN DS, 1986, J NEUROSCI, V6, P3309; Hoffman DS, 1999, J NEUROPHYSIOL, V81, P319, DOI 10.1152/jn.1999.81.1.319; Kakei S, 1999, SCIENCE, V285, P2136, DOI 10.1126/science.285.5436.2136; KALASKA JF, 1992, SCIENCE, V255, P1517, DOI 10.1126/science.1549781; KUBOTA K, 1978, J PHYSIOL-PARIS, V74, P297; KURATA K, 1986, J NEUROSCI, V6, P403; KURATA K, 1989, EXP BRAIN RES, V77, P245, DOI 10.1007/BF00274982; KURATA K, 1993, J NEUROPHYSIOL, V69, P187, DOI 10.1152/jn.1993.69.1.187; KURATA K, 1991, NEUROSCI RES, V12, P263, DOI 10.1016/0168-0102(91)90116-G; LU MT, 1994, J COMP NEUROL, V341, P375, DOI 10.1002/cne.903410308; Luppino G, 1999, EXP BRAIN RES, V128, P181, DOI 10.1007/s002210050833; MATELLI M, 1986, J COMP NEUROL, V251, P281, DOI 10.1002/cne.902510302; MATSUMURA M, 1979, NEUROSCI LETT, V11, P241, DOI 10.1016/0304-3940(79)90001-6; MOLL L, 1977, SCIENCE, V198, P317, DOI 10.1126/science.410103; MUAKKASSA KF, 1979, BRAIN RES, V177, P176, DOI 10.1016/0006-8993(79)90928-4; Murata A, 1997, J NEUROPHYSIOL, V78, P2226, DOI 10.1152/jn.1997.78.4.2226; Rizzolatti G, 1998, ELECTROEN CLIN NEURO, V106, P283, DOI 10.1016/S0013-4694(98)00022-4; RIZZOLATTI G, 1988, EXP BRAIN RES, V71, P491, DOI 10.1007/BF00248742; RIZZOLATTI G, 1981, BEHAV BRAIN RES, V2, P147, DOI 10.1016/0166-4328(81)90053-X; RIZZOLATTI G, 1981, BEHAV BRAIN RES, V2, P125, DOI 10.1016/0166-4328(81)90052-8; SCHWARTZ AB, 1988, J NEUROSCI, V8, P2913; Shen LM, 1997, J NEUROPHYSIOL, V77, P1171, DOI 10.1152/jn.1997.77.3.1171; SOECHTING JF, 1992, ANNU REV NEUROSCI, V15, P167, DOI 10.1146/annurev.ne.15.030192.001123; WEINRICH M, 1982, J NEUROSCI, V2, P1329; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582	35	256	256	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2001	4	10					1020	1025		10.1038/nn726	http://dx.doi.org/10.1038/nn726			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	478CR	11547338				2022-12-17	WOS:000171325800016
J	Lotze, M; Grodd, W; Birbaumer, N; Erb, M; Huse, E; Flor, H				Lotze, M; Grodd, W; Birbaumer, N; Erb, M; Huse, E; Flor, H			Does use of a myoelectric prosthesis prevent cortical reorganization and phantom limb pain?	NATURE NEUROSCIENCE			English	Article							OWL MONKEYS; REPRESENTATION; STIMULATION; AMPUTATION; HAND		Univ Tubingen, Dept Neuroradiol, Sect Expt NMR CNS, D-72076 Tubingen, Germany; Univ Tubingen, Inst Med Psychol & Behav Neurobiol, D-72074 Tubingen, Germany; Univ Padua, Dipartimento Psicol, I-35100 Padua, Italy; Humboldt Univ, Dept Psychol, Berlin, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Padua; Humboldt University of Berlin	Lotze, M (corresponding author), Univ Tubingen, Dept Neuroradiol, Sect Expt NMR CNS, Hoppe Seyler Str 3, D-72076 Tubingen, Germany.		Lotze, Martin/D-2964-2012	Lotze, Martin/0000-0003-4519-4956; Birbaumer, Niels/0000-0002-6786-5127; Erb, Michael/0000-0002-9311-4693; Flor, Herta/0000-0003-4809-5398				Birbaumer N, 1997, J NEUROSCI, V17, P5503; COHEN LG, 1991, BRAIN, V114, P615, DOI 10.1093/brain/114.1.615; ELBERT T, 1995, SCIENCE, V270, P305, DOI 10.1126/science.270.5234.305; FLOR H, 1995, NATURE, V375, P482, DOI 10.1038/375482a0; JENKINS WM, 1990, J NEUROPHYSIOL, V63, P82, DOI 10.1152/jn.1990.63.1.82; PONS TP, 1991, SCIENCE, V252, P1857, DOI 10.1126/science.1843843; RAMACHANDRAN VS, 1995, NATURE, V377, P489, DOI 10.1038/377489a0; RECANZONE GH, 1992, J NEUROPHYSIOL, V67, P1031, DOI 10.1152/jn.1992.67.5.1031; Sherman RA, 1997, PHANTOM PAIN	9	256	261	0	36	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	1999	2	6					501	502		10.1038/9145	http://dx.doi.org/10.1038/9145			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	273YA	10448212				2022-12-17	WOS:000084735900007
J	Marschallinger, J; Iram, T; Zardeneta, M; Lee, SE; Lehallier, B; Haney, MS; Pluvinage, JV; Mathur, V; Hahn, O; Morgens, DW; Kim, J; Tevini, J; Felder, TK; Wolinski, H; Bertozzi, CR; Bassik, MC; Aigner, L; Wyss-Coray, T				Marschallinger, Julia; Iram, Tal; Zardeneta, Macy; Lee, Song E.; Lehallier, Benoit; Haney, Michael S.; Pluvinage, John V.; Mathur, Vidhu; Hahn, Oliver; Morgens, David W.; Kim, Justin; Tevini, Julia; Felder, Thomas K.; Wolinski, Heimo; Bertozzi, Carolyn R.; Bassik, Michael C.; Aigner, Ludwig; Wyss-Coray, Tony			Lipid-droplet-accumulating microglia represent a dysfunctional and proinflammatory state in the aging brain	NATURE NEUROSCIENCE			English	Article							FOAM CELLS; MOUSE; EXPRESSION; NEURODEGENERATION; PHAGOCYTOSIS; TRAFFICKING; ACTIVATION; SCLEROSIS; TARGET	Microglia become progressively activated and seemingly dysfunctional with age, and genetic studies have linked these cells to the pathogenesis of a growing number of neurodegenerative diseases. Here we report a striking buildup of lipid droplets in microglia with aging in mouse and human brains. These cells, which we call 'lipid-droplet-accumulating microglia' (LDAM), are defective in phagocytosis, produce high levels of reactive oxygen species and secrete proinflammatory cytokines. RNA-sequencing analysis of LDAM revealed a transcriptional profile driven by innate inflammation that is distinct from previously reported microglial states. An unbiased CRISPR-Cas9 screen identified genetic modifiers of lipid droplet formation; surprisingly, variants of several of these genes, including progranulin (GRN), are causes of autosomal-dominant forms of human neurodegenerative diseases. We therefore propose that LDAM contribute to age-related and genetic forms of neurodegeneration. Microglia in the aging hippocampus accumulate lipid droplets, and are functionally impaired and inflamed. Lipid droplet formation in microglia is regulated by genes linked to neurodegeneration such as progranulin.	[Marschallinger, Julia; Iram, Tal; Zardeneta, Macy; Lee, Song E.; Lehallier, Benoit; Haney, Michael S.; Pluvinage, John V.; Mathur, Vidhu; Hahn, Oliver; Wyss-Coray, Tony] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Marschallinger, Julia; Iram, Tal; Zardeneta, Macy; Lee, Song E.; Lehallier, Benoit; Pluvinage, John V.; Mathur, Vidhu; Hahn, Oliver; Wyss-Coray, Tony] Stanford Univ, Sch Med, Paul F Glenn Ctr Biol Aging, Stanford, CA 94305 USA; [Marschallinger, Julia; Bassik, Michael C.; Aigner, Ludwig] Paracelsus Med Univ, Spinal Cord Injury & Tissue Regenerat Ctr Salzbur, Inst Mol Regenerat Med, Salzburg, Austria; [Haney, Michael S.; Morgens, David W.; Bassik, Michael C.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Haney, Michael S.; Morgens, David W.; Bassik, Michael C.] Stanford Univ, Sch Med, Chem Engn & Med Human Hlth ChEM H, Stanford, CA 94305 USA; [Pluvinage, John V.] Stanford Univ, Sch Med, Med Scientist Training Program, Stanford, CA 94305 USA; [Kim, Justin; Bertozzi, Carolyn R.] Stanford Univ, Dept Chem, Stanford ChEM H, Stanford, CA 94305 USA; [Kim, Justin; Bertozzi, Carolyn R.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Tevini, Julia; Felder, Thomas K.] Paracelsus Med Univ, Dept Lab Med, Salzburg, Austria; [Felder, Thomas K.] Paracelsus Med Univ, Obes Res Unit, Salzburg, Austria; [Wolinski, Heimo] Graz Univ, BioTechMed Graz, Inst Mol Biosci, Graz, Austria; [Wyss-Coray, Tony] Stanford Univ, Stanford Neurosci Inst, Stanford, CA 94305 USA; [Wyss-Coray, Tony] US Dept Vet Affairs, Palo Alto, CA 94304 USA	Stanford University; Stanford University; Paracelsus Private Medical University; Stanford University; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Paracelsus Private Medical University; Paracelsus Private Medical University; University of Graz; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Wyss-Coray, T (corresponding author), Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA.; Wyss-Coray, T (corresponding author), Stanford Univ, Sch Med, Paul F Glenn Ctr Biol Aging, Stanford, CA 94305 USA.; Wyss-Coray, T (corresponding author), Stanford Univ, Stanford Neurosci Inst, Stanford, CA 94305 USA.; Wyss-Coray, T (corresponding author), US Dept Vet Affairs, Palo Alto, CA 94304 USA.	twc@stanford.edu	Iram, Tal/GSE-3876-2022; Hahn, Oliver/G-7518-2017; Felder, Thomas K/A-8342-2017; Hahn, Oliver/AAK-1468-2020	Hahn, Oliver/0000-0001-9015-4545; Felder, Thomas K/0000-0001-8266-5513; Wolinski, Heimo/0000-0002-1583-6092; Wyss-Coray, Tony/0000-0001-5893-0831; LEE, SONG EUN/0000-0002-6839-7724; Aigner, Ludwig/0000-0002-1653-8046; Zardeneta, Macy/0000-0003-3771-6662; Lehallier, Benoit/0000-0001-7452-3785	FWF Hertha-Firnberg Postdoctoral program [T736-B24]; NIH [R37 GM058867]; Stanford Neuroscience Institute Brain Rejuvenation Project Award [1DP2HD084069-01]; NIH Director's New Innovator Award [1DP2HD084069-01]; Department of Veterans Affairs; National Institute on Aging [DP1-AG053015]; NOMIS Foundation; Glenn Foundation for Medical Research; Cure Alzheimer's Fund; Nan Fung Life Sciences Aging Research Fund; PMU-FFF [E-16/23/117-FEA]	FWF Hertha-Firnberg Postdoctoral program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford Neuroscience Institute Brain Rejuvenation Project Award; NIH Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NOMIS Foundation; Glenn Foundation for Medical Research; Cure Alzheimer's Fund; Nan Fung Life Sciences Aging Research Fund; PMU-FFF	The authors thank the members of the Wyss-Coray laboratory for feedback and support throughout the study, W. Stoiber (University of Salzburg, Austria) and the Division of Optical and Electron Microscopy, University of Salzburg, Austria, for excellent assistance with EM images, and D. Channappa from the Department of Neurology and E. Plowey from the Department of Pathology, Stanford University, for providing human postmortem brain samples. CARS imaging was performed at the Microscopy Core Facility of the Institute of Molecular Biosciences, University of Graz, Austria. They also thank A. Enejder, the Heilshorn Biomaterials Group, Stanford University, for discussion and for reviewing the manuscript. This work was supported by the FWF Hertha-Firnberg Postdoctoral program no. T736-B24 (to J.M.), the PMU-FFF E-16/23/117-FEA (to T.K.F), the NIH grant R37 GM058867 (to C.R.B), the Stanford Neuroscience Institute Brain Rejuvenation Project Award and NIH Director's New Innovator Award (1DP2HD084069-01) to M.C.B., the Department of Veterans Affairs (to T.W.-C.), the National Institute on Aging (DP1-AG053015 to T.W.-C.), the NOMIS Foundation (to T.W.-C.), the Glenn Foundation for Medical Research (to T.W.-C.), the Cure Alzheimer's Fund (to T.W.-C.) and the Nan Fung Life Sciences Aging Research Fund (to T.W.-C.).	Aguzzi A, 2013, SCIENCE, V339, P156, DOI 10.1126/science.1227901; Alzheimer A., 1907, ALL PSYCHIATR PSYCHI, V64, P146, DOI DOI 10.1002/CA.980080612; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett ML, 2016, P NATL ACAD SCI USA, V113, pE1738, DOI 10.1073/pnas.1525528113; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bohlen CJ, 2017, NEURON, V94, P759, DOI 10.1016/j.neuron.2017.04.043; Bozza PT, 2010, PROSTAG LEUKOTR ESS, V82, P243, DOI 10.1016/j.plefa.2010.02.005; Burke AC, 2017, CURR OPIN LIPIDOL, V28, P193, DOI 10.1097/MOL.0000000000000390; Cantuti-Castelvetri L, 2018, SCIENCE, V359, P684, DOI 10.1126/science.aan4183; Castejon O. J., 2005, Journal of Submicroscopic Cytology and Pathology, V37, P43; Chandak PG, 2010, J BIOL CHEM, V285, P20192, DOI 10.1074/jbc.M110.107854; Chang PKY, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0244-5; Chen ZH, 2012, J NEUROSCI, V32, P11706, DOI 10.1523/JNEUROSCI.0730-12.2012; Childs BG, 2016, SCIENCE, V354, P472, DOI 10.1126/science.aaf6659; Chinetti-Gbaguidi G, 2011, CIRC RES, V108, P985, DOI 10.1161/CIRCRESAHA.110.233775; Chiu IM, 2013, CELL REP, V4, P385, DOI 10.1016/j.celrep.2013.06.018; Currie E, 2013, CELL METAB, V18, P153, DOI 10.1016/j.cmet.2013.05.017; Deans RM, 2016, NAT CHEM BIOL, V12, P361, DOI [10.1038/NCHEMBIO.2050, 10.1038/nchembio.2050]; den Brok MH, 2018, TRENDS IMMUNOL, V39, P380, DOI 10.1016/j.it.2018.01.012; Evers BM, 2017, CELL REP, V20, P2565, DOI 10.1016/j.celrep.2017.08.056; Foley P, 2010, BBA-MOL CELL BIOL L, V1801, P750, DOI 10.1016/j.bbalip.2010.05.004; FOWLER SD, 1985, ANN NY ACAD SCI, V454, P79, DOI 10.1111/j.1749-6632.1985.tb11846.x; Ghoshal N, 2012, NEUROBIOL DIS, V45, P395, DOI 10.1016/j.nbd.2011.08.029; GilPerotin S, 2009, ADV ANAT EMBRYOL CEL, V203, P1, DOI 10.1007/978-3-540-88719-5; Hahn O, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1187-1; Hammond TR, 2019, IMMUNITY, V50, P253, DOI 10.1016/j.immuni.2018.11.004; Harris LALS, 2013, METHOD CELL BIOL, V116, P213, DOI 10.1016/B978-0-12-408051-5.00011-5; Holtman IR, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0203-5; Hu XR, 2017, NEUROCHEM RES, V42, P3140, DOI 10.1007/s11064-017-2351-4; Huey ED, 2006, ANN NEUROL, V60, P374, DOI 10.1002/ana.20969; Jaitin DA, 2019, CELL, V178, P686, DOI 10.1016/j.cell.2019.05.054; Kamkaew A, 2013, CHEM SOC REV, V42, P77, DOI 10.1039/c2cs35216h; Kawabe K, 2015, NEUROIMMUNOMODULAT, V22, P243, DOI 10.1159/000365484; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Khatchadourian A, 2012, BBA-MOL CELL BIOL L, V1821, P607, DOI 10.1016/j.bbalip.2012.01.007; Krasemann S, 2017, IMMUNITY, V47, P566, DOI 10.1016/j.immuni.2017.08.008; Lee JY, 2008, J BIOL CHEM, V283, P11501, DOI 10.1074/jbc.M800642200; LEE SC, 1990, J NEUROPATH EXP NEUR, V49, P122, DOI 10.1097/00005072-199003000-00005; Lee SJ, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/327167; Li QY, 2019, NEURON, V101, P207, DOI 10.1016/j.neuron.2018.12.006; Liu L, 2015, CELL, V160, P177, DOI 10.1016/j.cell.2014.12.019; Liu PT, 2017, DIS MODEL MECH, V10, P53, DOI 10.1242/dmm.026880; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Morgens DW, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15178; Mosher KI, 2014, BIOCHEM PHARMACOL, V88, P594, DOI 10.1016/j.bcp.2014.01.008; Nadjar A, 2018, PROSTAG LEUKOTR ESS, V135, P63, DOI 10.1016/j.plefa.2018.07.006; Namatame I, 1999, J BIOCHEM-TOKYO, V125, P319, DOI 10.1093/oxfordjournals.jbchem.a022289; Nguyen AD, 2018, ATHEROSCLEROSIS, V277, P145, DOI 10.1016/j.atherosclerosis.2018.08.042; Pluvinage JV, 2019, NATURE, V568, P187, DOI 10.1038/s41586-019-1088-4; Rambold AS, 2015, DEV CELL, V32, P678, DOI 10.1016/j.devcel.2015.01.029; Shimabukuro MK, 2016, SCI REP-UK, V6, DOI 10.1038/srep23795; Tsika E, 2014, HUM MOL GENET, V23, P4621, DOI 10.1093/hmg/ddu178; Vieira-de-Abreu A, 2011, AM J RESP CELL MOL, V44, P509, DOI 10.1165/rcmb.2010-0004OC; Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049; Yin FF, 2010, FASEB J, V24, P4639, DOI 10.1096/fj.10-161471; Yousef H, 2019, NAT MED, V25, P988, DOI 10.1038/s41591-019-0440-4; Yu Y, 2014, BBA-MOL CELL BIOL L, V1841, P1120, DOI 10.1016/j.bbalip.2014.02.003	57	255	257	33	149	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2020	23	2					194	+		10.1038/s41593-019-0566-1	http://dx.doi.org/10.1038/s41593-019-0566-1		JAN 2020	30	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KI4YI	31959936	Green Accepted, Green Submitted			2022-12-17	WOS:000508325100005
J	Grubman, A; Chew, G; Ouyang, JF; Sun, GZ; Choo, XY; McLean, C; Simmons, RK; Buckberry, S; Vargas-Landin, DB; Poppe, D; Pflueger, J; Lister, R; Rackham, OJL; Petretto, E; Polo, JM				Grubman, Alexandra; Chew, Gabriel; Ouyang, John F.; Sun, Guizhi; Choo, Xin Yi; McLean, Catriona; Simmons, Rebecca K.; Buckberry, Sam; Vargas-Landin, Dulce B.; Poppe, Daniel; Pflueger, Jahnvi; Lister, Ryan; Rackham, Owen J. L.; Petretto, Enrico; Polo, Jose M.			A single-cell atlas of entorhinal cortex from individuals with Alzheimer's disease reveals cell-type-specific gene expression regulation	NATURE NEUROSCIENCE			English	Article							RNA-SEQ; COGNITIVE DECLINE; MYELIN BREAKDOWN; R PACKAGE; MICROGLIA; BIN1; ASSOCIATION; INHIBITION; DIVERSITY; COMPLEX	There is currently little information available about how individual cell types contribute to Alzheimer's disease. Here we applied single-nucleus RNA sequencing to entorhinal cortex samples from control and Alzheimer's disease brains (n = 6 per group), yielding a total of 13,214 high-quality nuclei. We detail cell-type-specific gene expression patterns, unveiling how transcriptional changes in specific cell subpopulations are associated with Alzheimer's disease. We report that the Alzheimer's disease risk gene APOE is specifically repressed in Alzheimer's disease oligodendrocyte progenitor cells and astrocyte subpopulations and upregulated in an Alzheimer's disease-specific microglial subopulation. Integrating transcription factor regulatory modules with Alzheimer's disease risk loci revealed drivers of cell-type-specific state transitions towards Alzheimer's disease. For example, transcription factor EB, a master regulator of lysosomal function, regulates multiple disease genes in a specific Alzheimer's disease astrocyte subpopulation. These results provide insights into the coordinated control of Alzheimer's disease risk genes and their cell-type-specific contribution to disease susceptibility. These results are available at http://adsn.ddnetbio.com.	[Grubman, Alexandra; Sun, Guizhi; Choo, Xin Yi; Polo, Jose M.] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia; [Grubman, Alexandra; Sun, Guizhi; Choo, Xin Yi; Polo, Jose M.] Monash Biomed Discovery Inst, Dev & Stem Cells Program, Clayton, Vic, Australia; [Grubman, Alexandra; Sun, Guizhi; Choo, Xin Yi; Polo, Jose M.] Monash Univ, Australian Regenerat Med Inst, Clayton, Vic, Australia; [Chew, Gabriel; Ouyang, John F.; Rackham, Owen J. L.; Petretto, Enrico] Duke Natl Univ Singapore, Sch Med, Program Cardiovasc & Metab Disorders, Singapore, Singapore; [Choo, Xin Yi] Univ Melbourne, Dept Pathol, Melbourne, Vic, Australia; [McLean, Catriona] Florey Inst Neurosci, Victorian Brain Bank, Parkville, Vic, Australia; [Simmons, Rebecca K.; Buckberry, Sam; Vargas-Landin, Dulce B.; Poppe, Daniel; Pflueger, Jahnvi; Lister, Ryan] Univ Western Australia, ARC Ctr Excellence Plant Energy Biol, Perth, Australia; [Simmons, Rebecca K.; Buckberry, Sam; Vargas-Landin, Dulce B.; Poppe, Daniel; Pflueger, Jahnvi; Lister, Ryan] Harry Perkins Inst Med Res, Perth, WA, Australia	Monash University; Monash University; Australian Regenerative Medicine Institute; Monash University; National University of Singapore; University of Melbourne; University of Western Australia; Harry Perkins Institute of Medical Research	Polo, JM (corresponding author), Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia.; Polo, JM (corresponding author), Monash Biomed Discovery Inst, Dev & Stem Cells Program, Clayton, Vic, Australia.; Polo, JM (corresponding author), Monash Univ, Australian Regenerat Med Inst, Clayton, Vic, Australia.; Rackham, OJL; Petretto, E (corresponding author), Duke Natl Univ Singapore, Sch Med, Program Cardiovasc & Metab Disorders, Singapore, Singapore.	owen.rackham@duke-nus.edu.sg; enrico.petretto@duke-nus.edu.sg; jose.polo@monash.edu	Buckberry, Sam/H-5774-2019; Grubman, Alexandra/AAD-3109-2019; Rackham, Owen/AAM-3108-2021; Lister, Ryan/B-5168-2012	Buckberry, Sam/0000-0003-2388-6046; Grubman, Alexandra/0000-0003-4408-4499; Rackham, Owen/0000-0002-4390-0872; Lister, Ryan/0000-0001-6637-7239; Petretto, Enrico/0000-0003-2163-5921; Ouyang, John/0000-0002-1239-1577; McLean, Catriona/0000-0002-0302-5727; Choo, Xin Yi/0000-0002-1783-0102; Simmons, Rebecca/0000-0003-2230-5393; Poppe, Daniel/0000-0002-6674-8420; Vargas Landin, Dulce/0000-0002-4773-9406	Florey Institute of Neuroscience and Mental Health; Alfred; Victorian Institute of Forensic Medicine; Parkinson's Victoria; MND Victoria; State Government of Victoria; Australian Government; Dementia Australia Research Foundation Grant; Monash Network of Excellence grant; Yulgilbar Foundation grant; National Health and Medical Research Council (NHMRC); Australian Research Council (ARC) Dementia Research Development Fellowship [GNT1097461, GNT1111206]; Sylvia-Charles Viertel Fellowship; Singapore National Research Foundation Competitive Research Programme [NRF-CRP20-2017-0002]; Sylvia and Charles Viertel Senior Medical Research Fellowship; Howard Hughes Medical Institute International Research Scholarship; MRC [MC_U120097112] Funding Source: UKRI	Florey Institute of Neuroscience and Mental Health; Alfred; Victorian Institute of Forensic Medicine; Parkinson's Victoria(Parkinson's UK); MND Victoria; State Government of Victoria; Australian Government(Australian GovernmentCGIAR); Dementia Australia Research Foundation Grant; Monash Network of Excellence grant; Yulgilbar Foundation grant; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC) Dementia Research Development Fellowship(Australian Research Council); Sylvia-Charles Viertel Fellowship; Singapore National Research Foundation Competitive Research Programme(National Research Foundation, Singapore); Sylvia and Charles Viertel Senior Medical Research Fellowship; Howard Hughes Medical Institute International Research Scholarship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors acknowledge Flowcore and Micromon, Monash University, for the provision of instrumentation, training, and technical support. Tissues were received from the Victorian Brain Bank, supported by The Florey Institute of Neuroscience and Mental Health, The Alfred and the Victorian Institute of Forensic Medicine, and funded in part by Parkinson's Victoria and MND Victoria. The Australian Regenerative Medicine Institute is supported by grants from the State Government of Victoria and the Australian Government. This work was supported by a Dementia Australia Research Foundation Grant to A.G., J.M.P., and E.P., a Monash Network of Excellence grant to J.M.P., E.P., and O.J.L.R., and a Yulgilbar Foundation grant to A.G. and G.S. A.G. was supported by a National Health and Medical Research Council (NHMRC) and Australian Research Council (ARC) Dementia Research Development Fellowship (GNT1097461). J.M.P. was supported by a Sylvia-Charles Viertel Fellowship. O.J.L.R. and J.F.O. were supported by a Singapore National Research Foundation Competitive Research Programme (NRF-CRP20-2017-0002). S.B. was supported by a National Health and Medical Research Council (NHMRC) and Australian Research Council (ARC) Dementia Research Development Fellowship (GNT1111206). This work was supported by a Sylvia and Charles Viertel Senior Medical Research Fellowship to R.L. and and a Howard Hughes Medical Institute International Research Scholarship to R.L. We acknowledge S. Freytag (University of Western Australia) for her advice regarding disentangling individuals from mixed-individual libraries.	Alzheimer's Association, 2016, Alzheimers Dement, V12, P459; [Anonymous], 2012, PHEATMAP PRETTY HEAT; Bartzokis G, 2006, ARCH GEN PSYCHIAT, V63, P63, DOI 10.1001/archpsyc.63.1.63; Bartzokis G, 2004, NEUROBIOL AGING, V25, P5, DOI 10.1016/j.neurobiolaging.2003.03.001; Behrendt G, 2013, GLIA, V61, P273, DOI 10.1002/glia.22432; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bis JC, 2020, MOL PSYCHIATR, V25, P1859, DOI 10.1038/s41380-018-0112-7; Blalock EM, 2011, J CHEM NEUROANAT, V42, P118, DOI 10.1016/j.jchemneu.2011.06.007; Buniello A, 2019, NUCLEIC ACIDS RES, V47, pD1005, DOI 10.1093/nar/gky1120; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Chapuis J, 2013, MOL PSYCHIATR, V18, P1225, DOI 10.1038/mp.2013.1; Conway JR, 2017, BIOINFORMATICS, V33, P2938, DOI 10.1093/bioinformatics/btx364; Darmanis S, 2015, P NATL ACAD SCI USA, V112, P7285, DOI 10.1073/pnas.1507125112; De Rossi P, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0124-1; De Strooper B, 2016, CELL, V164, P603, DOI 10.1016/j.cell.2015.12.056; De Toledo-Morrell L, 2000, ANN NY ACAD SCI, V911, P240, DOI 10.1111/j.1749-6632.2000.tb06730.x; Diener HC, 1996, J NEUROL SCI, V143, P1, DOI 10.1016/S0022-510X(96)00308-5; Ebermann I, 2009, J MED GENET, V46, P277, DOI 10.1136/jmg.2008.059626; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Fallin MD, 2005, AM J HUM GENET, V77, P918, DOI 10.1086/497703; Fuger P, 2017, NAT NEUROSCI, V20, P1371, DOI 10.1038/nn.4631; Grubman A., 2019, PREPRINT, DOI [10.1101/639054v1, DOI 10.1101/639054V1]; Habib N, 2017, NAT METHODS, V14, P955, DOI [10.1038/NMETH.4407, 10.1038/nmeth.4407]; Hall CN, 2012, J NEUROSCI, V32, P8940, DOI 10.1523/JNEUROSCI.0026-12.2012; Hokama M, 2014, CEREB CORTEX, V24, P2476, DOI 10.1093/cercor/bht101; Huang KL, 2017, NAT NEUROSCI, V20, P1052, DOI 10.1038/nn.4587; Kajiho H, 2011, J BIOL CHEM, V286, P24364, DOI 10.1074/jbc.M110.172445; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Krasemann S, 2017, IMMUNITY, V47, P566, DOI 10.1016/j.immuni.2017.08.008; Lake BB, 2016, SCIENCE, V352, P1586, DOI 10.1126/science.aaf1204; Lambert JC, 2013, MOL PSYCHIATR, V18, P461, DOI 10.1038/mp.2012.14; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Lambert SA, 2018, CELL, V175, P598, DOI 10.1016/j.cell.2018.09.045; Li HP, 2017, NAT GENET, V49, P708, DOI 10.1038/ng.3818; Li L, 2018, NEURAL REGEN RES, V13, P463, DOI 10.4103/1673-5374.228729; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Lin CCJ, 2017, NAT NEUROSCI, V20, P396, DOI 10.1038/nn.4493; Lin YT, 2018, NEURON, V98, P1294, DOI 10.1016/j.neuron.2018.06.011; Lummertz Da Rocha E., 2018, NAT COMMUN, V9, P892, DOI DOI 10.1038/S41467-018-03214-Y; Martini-Stoica H, 2018, J EXP MED, V215, P2355, DOI 10.1084/jem.20172158; Mathys H, 2019, NATURE, V570, P332, DOI 10.1038/s41586-019-1195-2; Maynard MA, 2005, FASEB J, V19, P1396, DOI 10.1096/fj.05-3788com; McKenzie AT, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27293-5; McKenzie AT, 2016, BMC SYST BIOL, V10, DOI 10.1186/s12918-016-0349-1; Mi S, 2005, NAT NEUROSCI, V8, P745, DOI 10.1038/nn1460; Miceli F., 2014, GENE REV; Paris D, 1999, EXP NEUROL, V157, P211, DOI 10.1006/exnr.1999.7055; Raj T, 2018, NAT GENET, V50, P1584, DOI 10.1038/s41588-018-0238-1; Romito-DiGiacomo RR, 2007, J NEUROSCI, V27, P8496, DOI 10.1523/JNEUROSCI.1008-07.2007; Santoro M, 2016, J MOL NEUROSCI, V59, P18, DOI 10.1007/s12031-016-0741-8; Savvaki M, 2010, J NEUROSCI, V30, P13943, DOI 10.1523/JNEUROSCI.2574-10.2010; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shijo M, 2018, BRAIN PATHOL, V28, P58, DOI 10.1111/bpa.12475; Sims R, 2017, NAT GENET, V49, P1373, DOI 10.1038/ng.3916; Skene NG, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00016; Tan MG, 2010, J NEUROSCI RES, V88, P1157, DOI 10.1002/jnr.22290; Tirosh I, 2016, NATURE, V539, P309, DOI 10.1038/nature20123; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Veereshwarayya V, 2006, J BIOL CHEM, V281, P29468, DOI 10.1074/jbc.M602533200; WHITEHOUSE PJ, 1982, SCIENCE, V215, P1237, DOI 10.1126/science.7058341; Wickham H, 2016, GGPLOT2 ELEGANT GRAP; Wilhelmsson U, 2017, CEREB CORTEX, V27, P3360, DOI 10.1093/cercor/bhx069; Xie H, 2013, P NATL ACAD SCI USA, V110, P7904, DOI 10.1073/pnas.1217938110; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Yu L, 2015, JAMA NEUROL, V72, P15, DOI 10.1001/jamaneurol.2014.3049; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030; Zhong SJ, 2018, NATURE, V555, P524, DOI 10.1038/nature25980; Zhu YZ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05882-0	69	255	260	36	170	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2019	22	12					2087	+		10.1038/s41593-019-0539-4	http://dx.doi.org/10.1038/s41593-019-0539-4			24	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JR5CX	31768052				2022-12-17	WOS:000499644100017
J	Lelieveld, SH; Reijnders, MRF; Pfundt, R; Yntema, HG; Kamsteeg, EJ; de Vries, P; de Vries, BBA; Willemsen, MH; Kleefstra, T; Lohner, K; Vreeburg, M; Stevens, SJC; van der Burgt, I; Bongers, EMHF; Stegmann, APA; Rump, P; Rinne, T; Nelen, MR; Veltman, JA; Vissers, LELM; Brunner, HG; Gilissen, C				Lelieveld, Stefan H.; Reijnders, Margot R. F.; Pfundt, Rolph; Yntema, Helger G.; Kamsteeg, Erik-Jan; de Vries, Petra; de Vries, Bert B. A.; Willemsen, Marjolein H.; Kleefstra, Tjitske; Lohner, Katharina; Vreeburg, Maaike; Stevens, Servi J. C.; van der Burgt, Ineke; Bongers, Ernie M. H. F.; Stegmann, Alexander P. A.; Rump, Patrick; Rinne, Tuula; Nelen, Marcel R.; Veltman, Joris A.; Vissers, Lisenka E. L. M.; Brunner, Han G.; Gilissen, Christian			Meta-analysis of 2,104 trios provides support for 10 new genes for intellectual disability	NATURE NEUROSCIENCE			English	Article							DE-NOVO MUTATIONS; AUTISM	To identify candidate genes for intellectual disability, we performed a meta-analysis on 2,637 de novo mutations, identified from the exomes of 2,104 patient-parent trios. Statistical analyses identified 10 new candidate ID genes: DLG4, PPM1D, RAC1, SMAD6, SON, SOX5, SYNCRIP, TCF20, TLK2 and TRIP12. In addition, we show that these genes are intolerant to nonsynonymous variation and that mutations in these genes are associated with specific clinical ID phenotypes.	[Lelieveld, Stefan H.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Human Genet, Nijmegen, Netherlands; [Reijnders, Margot R. F.; Pfundt, Rolph; Yntema, Helger G.; Kamsteeg, Erik-Jan; de Vries, Petra; de Vries, Bert B. A.; Willemsen, Marjolein H.; Kleefstra, Tjitske; van der Burgt, Ineke; Bongers, Ernie M. H. F.; Rinne, Tuula; Nelen, Marcel R.; Veltman, Joris A.; Vissers, Lisenka E. L. M.; Brunner, Han G.; Gilissen, Christian] Radboud Univ Nijmegen, Med Ctr, Donders Ctr Neurosci, Dept Human Genet, Nijmegen, Netherlands; [Lohner, Katharina; Rump, Patrick] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Vreeburg, Maaike; Stevens, Servi J. C.; Stegmann, Alexander P. A.; Veltman, Joris A.; Brunner, Han G.] Maastricht Univ, Med Ctr, Dept Clin Genet, Maastricht, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; University of Groningen; Maastricht University	Gilissen, C (corresponding author), Radboud Univ Nijmegen, Med Ctr, Donders Ctr Neurosci, Dept Human Genet, Nijmegen, Netherlands.	christian.gilissen@radboudumc.nl	Kamsteeg, Erik-Jan/L-4421-2015; Rinne, Tuula/B-6339-2018; Vissers, Lisenka ELM/A-2598-2015; Yntema, H.G./L-4771-2015; Kleefstra, Tjitske/G-2619-2012; Nelen, Marcel R./L-4542-2015; Pfundt, Rolph/L-4576-2015; Stevens, Servi/P-8450-2015; Willemsen, Marjolein/R-5958-2019; Gilissen, Christian/E-5246-2012; Veltman, Joris A/F-5128-2010	Vissers, Lisenka ELM/0000-0001-6470-5497; Stevens, Servi/0000-0001-8769-3150; Gilissen, Christian/0000-0003-1693-9699; Veltman, Joris A/0000-0002-3218-8250; Stegmann, Alexander/0000-0002-9736-7137	Netherlands Organization for Scientific Research [912-12-109, 916-14-043, SH-271-13, 907-00-365]; European Research Council (ERC Starting Grant) [DENOVO 281964]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Research Council (ERC Starting Grant)(European Research Council (ERC))	The authors would like to thank the Exome Aggregation Consortium and the groups that provided exome variant data for comparison. A full list of contributing groups can be found at http://exac.broadinstitute.org/about. We thank all clinicians involved for referring individuals with ID for diagnostic exome sequencing. We thank J. Goeman for statistical advice and M. Hurles for discussions. We would also like to thank the participating individuals and their families. This work was in part financially supported by grants from the Netherlands Organization for Scientific Research (912-12-109 to J.A.V., A.S. and B.B.A.d.V.; 916-14-043 to C.G.; 907-00-365 to T.K. and SH-271-13 to C.G. and J.A.V.) and the European Research Council (ERC Starting Grant DENOVO 281964 to J.A.V.).	Fitzgerald TW, 2015, NATURE, V519, P223, DOI 10.1038/nature14135; Gilissen C, 2014, NATURE, V511, P344, DOI [10.1038/nature13394, 10.3389/fnhum.2013.00444]; Gulsuner S, 2013, CELL, V154, P518, DOI 10.1016/j.cell.2013.06.049; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Krumm N, 2014, TRENDS NEUROSCI, V37, P95, DOI 10.1016/j.tins.2013.11.005; Lek M., 2016, PREPRINT AT BIORXIV; Lumish HS, 2015, J AUTISM DEV DISORD, V45, P3764, DOI 10.1007/s10803-015-2484-8; Luscan A, 2014, J MED GENET, V51, P512, DOI 10.1136/jmedgenet-2014-102402; McRae J.F., 2016, PREPRINT AT BIORXIV; O'Roak BJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6595; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050	11	255	264	2	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2016	19	9					1194	1196		10.1038/nn.4352	http://dx.doi.org/10.1038/nn.4352			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DU5SA	27479843	Green Submitted			2022-12-17	WOS:000382270400017
J	Cho, H; Yang, YD; Lee, J; Lee, B; Kim, T; Jang, Y; Back, SK; Na, HS; Harfe, BD; Wang, F; Raouf, R; Wood, JN; Oh, U				Cho, Hawon; Yang, Young Duk; Lee, Jesun; Lee, Byeongjoon; Kim, Tahnbee; Jang, Yongwoo; Back, Seung Keun; Na, Heung Sik; Harfe, Brian D.; Wang, Fan; Raouf, Ramin; Wood, John N.; Oh, Uhtaek			The calcium-activated chloride channel anoctamin 1 acts as a heat sensor in nociceptive neurons	NATURE NEUROSCIENCE			English	Article							CAPSAICIN-RECEPTOR; NOXIOUS HEAT; ION CHANNELS; PAIN PATHWAY; IN-VITRO; MEMBRANE; CURRENTS; TMEM16A; TRPV1; RAT	Nociceptors are a subset of small primary afferent neurons that respond to noxious chemical, thermal and mechanical stimuli. Ion channels in nociceptors respond differently to noxious stimuli and generate electrical signals in different ways. Anoctamin 1 (ANO1 also known as TMEM16A) is a Ca2+-activated chloride channel that is essential for numerous physiological functions. We found that ANO1 was activated by temperatures over 44 degrees C with steep heat sensitivity. ANO1 was expressed in small sensory neurons and was highly colocalized with nociceptor markers, which suggests that it may be involved in nociception. Application of heat ramps to dorsal root ganglion (DRG) neurons elicited robust ANO1-dependent depolarization. Furthermore, knockdown or deletion of ANO1 in DRG neurons substantially reduced nociceptive behavior in thermal pain models. These results indicate that ANO1 is a heat sensor that detects nociceptive thermal stimuli in sensory neurons and possibly mediates nociception.	[Cho, Hawon; Lee, Jesun; Lee, Byeongjoon; Kim, Tahnbee; Jang, Yongwoo; Oh, Uhtaek] Seoul Natl Univ, Coll Pharm, Creat Res Initiat, Sensory Res Ctr, Seoul, South Korea; [Yang, Young Duk] CHA Univ, Coll Pharm, Dept Pharm, Gyeonggi Do, South Korea; [Back, Seung Keun; Na, Heung Sik] Korea Univ, Coll Med, Dept Physiol, Seoul 136705, South Korea; [Harfe, Brian D.] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL USA; [Harfe, Brian D.] Univ Florida, Coll Med, Genet Inst, Gainesville, FL USA; [Wang, Fan] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Raouf, Ramin; Wood, John N.] UCL, Wolfson Inst Biomed Res, Mol Nocicept Grp, London, England; [Oh, Uhtaek] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Dept Mol Med & Biopharmaceut Sci, Seoul, South Korea	Seoul National University (SNU); Pochon Cha University; Korea University; Korea University Medicine (KU Medicine); State University System of Florida; University of Florida; State University System of Florida; University of Florida; Duke University; University of London; University College London; Seoul National University (SNU)	Oh, U (corresponding author), Seoul Natl Univ, Coll Pharm, Creat Res Initiat, Sensory Res Ctr, Seoul, South Korea.	utoh@snu.ac.kr	Jang, Yongwoo/Y-9854-2018	Jang, Yongwoo/0000-0003-1574-9009; Raouf, Ramin/0000-0002-5890-2221; Kim, Tahnbee/0000-0001-8090-4269	World Class University [R31-2011-00101030]; Creative Research Initiatives Program [20120001246]; Brain Research Center [2011K000275]; Ministry of Education and Science and Technology; National Research Foundation of the Republic of Korea; Biotechnology and Biological Sciences Research Council [BB/F000227/1] Funding Source: researchfish; Medical Research Council [G0901905] Funding Source: researchfish; BBSRC [BB/F000227/1] Funding Source: UKRI; MRC [G0901905] Funding Source: UKRI	World Class University; Creative Research Initiatives Program; Brain Research Center; Ministry of Education and Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation of the Republic of Korea(National Research Foundation of Korea); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the World Class University project (R31-2011-00101030), the Creative Research Initiatives Program (20120001246) and a grant (2011K000275) from the Brain Research Center of the 21st Century Frontier Research Program funded by of the Ministry of Education and Science and Technology and the National Research Foundation of the Republic of Korea.	Alvarez-Leefmans FJ, 2009, PHYSIOLOGY AND PATHOLOGY OF CHLORIDE TRANSPORTERS AND CHANNELS IN THE NERVOUS SYSTEM: FROM MOLECULES TO DISEASES, P439; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Caterina MJ, 2007, AM J PHYSIOL-REG I, V292, pR64, DOI 10.1152/ajpregu.00446.2006; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Cia D, 2005, J NEUROPHYSIOL, V93, P1468, DOI 10.1152/jn.00874.2004; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Dhaka A, 2006, ANNU REV NEUROSCI, V29, P135, DOI 10.1146/annurev.neuro.29.051605.112958; Frings S, 2000, PROG NEUROBIOL, V60, P247, DOI 10.1016/S0301-0082(99)00027-1; Hans G, 2008, NEUROPEPTIDES, V42, P119, DOI 10.1016/j.npep.2007.12.001; Hartzell C, 2005, ANNU REV PHYSIOL, V67, P719, DOI 10.1146/annurev.physiol.67.032003.154341; Hasegawa H, 2007, J NEUROSCI, V27, P14404, DOI 10.1523/JNEUROSCI.4908-07.2007; Hu HZ, 2004, J BIOL CHEM, V279, P35741, DOI 10.1074/jbc.M404164200; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Kaneko H, 2002, CURR TOP MEMBR, V53, P167, DOI 10.1016/S1063-5823(02)53033-7; Karashima Y, 2009, P NATL ACAD SCI USA, V106, P1273, DOI 10.1073/pnas.0808487106; Kleene SJ, 1997, BIOPHYS J, V73, P1110, DOI 10.1016/S0006-3495(97)78143-8; Labrakakis C, 2003, J PHYSIOL-LONDON, V549, P131, DOI 10.1113/jphysiol.2002.031963; Lalonde MR, 2008, CHANNELS, V2, P252, DOI 10.4161/chan.2.4.6704; Lang PM, 2003, J NEUROPHYSIOL, V90, P3295, DOI 10.1152/jn.00512.2003; Large WA, 1996, AM J PHYSIOL-CELL PH, V271, pC435; LOWE G, 1993, NATURE, V366, P283, DOI 10.1038/366283a0; Macpherson LJ, 2005, CURR BIOL, V15, P929, DOI 10.1016/j.cub.2005.04.018; Perl ER, 2007, NAT REV NEUROSCI, V8, P71, DOI 10.1038/nrn2042; Price TJ, 2009, BRAIN RES REV, V60, P149, DOI 10.1016/j.brainresrev.2008.12.015; Rocha-Gonzalez HI, 2008, J NEUROPHYSIOL, V100, P169, DOI 10.1152/jn.01007.2007; Rock JR, 2008, DEV BIOL, V321, P141, DOI 10.1016/j.ydbio.2008.06.009; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; SCOTT RH, 1995, PHARMACOL THERAPEUT, V66, P535, DOI 10.1016/0163-7258(95)00018-C; Shibata M, 2004, J BIOL CHEM, V279, P40084, DOI 10.1074/jbc.M403844200; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Talavera K, 2008, TRENDS NEUROSCI, V31, P287, DOI 10.1016/j.tins.2008.03.002; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Voets T, 2003, J MEMBRANE BIOL, V192, P1, DOI 10.1007/s00232-002-1059-8; Vriens J, 2011, NEURON, V70, P482, DOI 10.1016/j.neuron.2011.02.051; Vyklicky L, 1999, J PHYSIOL-LONDON, V517, P181, DOI 10.1111/j.1469-7793.1999.0181z.x; Willis EF, 2004, CLIN EXP ALLERGY, V34, P450, DOI 10.1111/j.1365-2222.2004.01898.x; Willis WD, 2006, PROG NEUROBIOL, V78, P189, DOI 10.1016/j.pneurobio.2006.02.007; Woodbury CJ, 2004, J NEUROSCI, V24, P6410, DOI 10.1523/JNEUROSCI.1421-04.2004; Xiao BL, 2011, NAT CHEM BIOL, V7, P351, DOI [10.1038/NCHEMBIO.558, 10.1038/nchembio.558]; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zholos A, 2005, J GEN PHYSIOL, V125, P197, DOI 10.1085/jgp.200409161	45	255	264	0	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2012	15	7					1015	1021		10.1038/nn.3111	http://dx.doi.org/10.1038/nn.3111			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	966EE	22634729				2022-12-17	WOS:000305819600020
J	Marder, E; Taylor, AL				Marder, Eve; Taylor, Adam L.			Multiple models to capture the variability in biological neurons and networks	NATURE NEUROSCIENCE			English	Article							ACTIVITY-DEPENDENT REGULATION; RHYTHMICALLY ACTIVE NEURONS; CENTRAL PATTERN GENERATOR; CIRCUIT PARAMETERS; CONDUCTANCES; EXPRESSION; SINGLE; CURRENTS; DYNAMICS; CONSTRUCTION	How tightly tuned are the synaptic and intrinsic properties that give rise to neuron and circuit function? Experimental work shows that these properties vary considerably across identified neurons in different animals. Given this variability in experimental data, this review describes some of the complications of building computational models to aid in understanding how system dynamics arise from the interaction of system components. We argue that instead of trying to build a single model that captures the generic behavior of a neuron or circuit, it is beneficial to construct a population of models that captures the behavior of the population that provided the experimental data. Studying a population of models with different underlying structure and similar behaviors provides opportunities to discover unsuspected compensatory mechanisms that contribute to neuron and network function.	[Marder, Eve; Taylor, Adam L.] Brandeis Univ, Dept Biol, Waltham, MA 02254 USA; [Marder, Eve; Taylor, Adam L.] Brandeis Univ, Volen Ctr, Waltham, MA 02254 USA	Brandeis University; Brandeis University	Marder, E (corresponding author), Brandeis Univ, Dept Biol, Waltham, MA 02254 USA.	marder@brandeis.edu	Marder, Eve/A-5713-2012		US National Institutes of Health [NS17813, MH46742]; James D. McDonnell Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH046742, R01MH046742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017813, R37NS017813] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James D. McDonnell Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by US National Institutes of Health grants NS17813 and MH46742, and by the James D. McDonnell Foundation.	Beer RD, 1999, J COMPUT NEUROSCI, V7, P119, DOI 10.1023/A:1008920021246; BHALLA US, 1993, J NEUROPHYSIOL, V69, P1948, DOI 10.1152/jn.1993.69.6.1948; Bucher D, 2005, J NEUROSCI, V25, P1611, DOI 10.1523/JNEUROSCI.3679-04.2005; Butera RJ, 1999, J NEUROPHYSIOL, V82, P398, DOI 10.1152/jn.1999.82.1.398; CONNOR JA, 1977, BIOPHYS J, V18, P81, DOI 10.1016/S0006-3495(77)85598-7; Davis GW, 2006, ANNU REV NEUROSCI, V29, P307, DOI 10.1146/annurev.neuro.28.061604.135751; Demarque M, 2010, NEURON, V67, P321, DOI 10.1016/j.neuron.2010.06.006; Desai NS, 1999, NEUROCOMPUTING, V26-7, P101, DOI 10.1016/S0925-2312(99)00004-1; Edelman GM, 2001, P NATL ACAD SCI USA, V98, P13763, DOI 10.1073/pnas.231499798; Goaillard JM, 2009, NAT NEUROSCI, V12, P1424, DOI 10.1038/nn.2404; Goldman MS, 2001, J NEUROSCI, V21, P5229, DOI 10.1523/JNEUROSCI.21-14-05229.2001; Golowasch J, 2002, J NEUROPHYSIOL, V87, P1129, DOI 10.1152/jn.00412.2001; Grashow R, 2010, J NEUROSCI, V30, P9145, DOI 10.1523/JNEUROSCI.0980-10.2010; Grashow R, 2009, P NATL ACAD SCI USA, V106, P11742, DOI 10.1073/pnas.0905614106; GUCKENHEIMER J, 1993, PHILOS T ROY SOC B, V341, P345, DOI 10.1098/rstb.1993.0121; Gunay C, 2008, J NEUROSCI, V28, P7476, DOI 10.1523/JNEUROSCI.4198-07.2008; HAGIWARA SUSUMU, 1958, JAPANESE JOUR PHYSIOL, V8, P234; Hobbs KH, 2008, J NEUROPHYSIOL, V99, P1871, DOI 10.1152/jn.00032.2008; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hudson AE, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000838; Jaeger D, 1997, J NEUROSCI, V17, P91, DOI 10.1523/JNEUROSCI.17-01-00091.1997; Jezzini SH, 2004, J NEUROPHYSIOL, V91, P958, DOI 10.1152/jn.00656.2003; Khorkova O, 2007, J NEUROSCI, V27, P8709, DOI 10.1523/JNEUROSCI.1274-07.2007; Korobkova E, 2004, NATURE, V428, P574, DOI 10.1038/nature02404; LEMASSON G, 1993, SCIENCE, V259, P1915, DOI 10.1126/science.8456317; Liu Z, 1998, J NEUROSCI, V18, P2309; MacLean JN, 2005, J NEUROPHYSIOL, V94, P3601, DOI 10.1152/jn.00281.2005; MacLean JN, 2003, NEURON, V37, P109, DOI 10.1016/S0896-6273(02)01104-2; Maffei A, 2009, CURR OPIN NEUROBIOL, V19, P168, DOI 10.1016/j.conb.2009.05.012; Marder E, 1996, PHYSIOL REV, V76, P687, DOI 10.1152/physrev.1996.76.3.687; Marder E, 2006, NAT REV NEUROSCI, V7, P563, DOI 10.1038/nrn1949; Nerbonne JM, 2008, J PHYSIOL-LONDON, V586, P1565, DOI 10.1113/jphysiol.2007.146597; Norris BJ, 2007, J NEUROPHYSIOL, V98, P2992, DOI 10.1152/jn.00877.2007; Olypher AV, 2007, J NEUROPHYSIOL, V98, P3749, DOI 10.1152/jn.00842.2007; Olypher AV, 2010, J COMPUT NEUROSCI, V28, P361, DOI 10.1007/s10827-010-0213-z; Padmanabhan K, 2010, NAT NEUROSCI, V13, P1276, DOI 10.1038/nn.2630; Prinz AA, 2004, NAT NEUROSCI, V7, P1345, DOI 10.1038/nn1352; Prinz AA, 2003, J NEUROPHYSIOL, V90, P3998, DOI 10.1152/jn.00641.2003; ROBERT CP, 2004, MONTE CARLO STAT MET; Schulz DJ, 2007, P NATL ACAD SCI USA, V104, P13187, DOI 10.1073/pnas.0705827104; Schulz DJ, 2006, NAT NEUROSCI, V9, P356, DOI 10.1038/nn1639; Sobie EA, 2009, BIOPHYS J, V96, P1264, DOI 10.1016/j.bpj.2008.10.056; Swensen AM, 2005, J NEUROSCI, V25, P3509, DOI 10.1523/JNEUROSCI.3929-04.2005; Tang LS, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000469; Taylor AL, 2006, J NEUROPHYSIOL, V96, P891, DOI 10.1152/jn.00367.2006; Taylor AL, 2009, J NEUROSCI, V29, P5573, DOI 10.1523/JNEUROSCI.4438-08.2009; Tobin AE, 2006, J NEUROPHYSIOL, V96, P2089, DOI 10.1152/jn.00025.2006; TRAUB RD, 1991, J NEUROPHYSIOL, V66, P635, DOI 10.1152/jn.1991.66.2.635; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Vanier MC, 1999, J COMPUT NEUROSCI, V7, P149, DOI 10.1023/A:1008972005316	50	255	256	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2011	14	2					133	138		10.1038/nn.2735	http://dx.doi.org/10.1038/nn.2735			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	711MJ	21270780	Green Accepted			2022-12-17	WOS:000286595400007
J	Asplund, CL; Todd, JJ; Snyder, AP; Marois, R				Asplund, Christopher L.; Todd, J. Jay; Snyder, Andy P.; Marois, Rene			A central role for the lateral prefrontal cortex in goal-directed and stimulus-driven attention	NATURE NEUROSCIENCE			English	Article							POSTERIOR PARIETAL CORTEX; HUMAN BRAIN; COGNITIVE CONTROL; FUNCTIONAL NEUROANATOMY; INATTENTIONAL BLINDNESS; SPATIAL ATTENTION; VISUAL-ATTENTION; CORTICAL NETWORK; TARGET DETECTION; EYE-MOVEMENTS	Attention is the process that selects which sensory information is preferentially processed and ultimately reaches our awareness. Attention, however, is not a unitary process; it can be captured by unexpected or salient events (stimulus driven) or it can be deployed under voluntary control (goal directed), and these two forms of attention are implemented by largely distinct ventral and dorsal parieto-frontal networks. For coherent behavior and awareness to emerge, stimulus-driven and goal-directed behavior must ultimately interact. We found that the ventral, but not dorsal, network can account for stimulus-driven attentional limits to conscious perception, and that stimulus-driven and goal-directed attention converge in the lateral prefrontal component of that network. Although these results do not rule out dorsal network involvement in awareness when goal-directed task demands are present, they suggest to a general role for the lateral prefrontal cortex in the control of attention and awareness.	[Asplund, Christopher L.; Todd, J. Jay; Snyder, Andy P.; Marois, Rene] Vanderbilt Univ, Dept Psychol, Vanderbilt Vis Res Ctr, Nashville, TN 37240 USA; [Todd, J. Jay] Univ Chicago, Dept Psychol, Chicago, IL 60637 USA	Vanderbilt University; University of Chicago	Asplund, CL (corresponding author), Vanderbilt Univ, Dept Psychol, Vanderbilt Vis Res Ctr, Nashville, TN 37240 USA.	chris.asplund@vanderbilt.edu; rene.marois@vanderbilt.edu		Asplund, Christopher/0000-0001-5708-6966	National Science Foundation [0094992]; National Institute of Mental Health [R01 MH70776]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070776] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank B. Rogers, J. Swisher and E. Conser. This work was supported by National Science Foundation grant 0094992 and National Institute of Mental Health grant R01 MH70776 (R. M.).	ASPLUND CL, J EXP PSYCH IN PRESS; Baars B. J., 1997, J CONSCIOUSNESS STUD, V4, P292; Beck DM, 2001, NAT NEUROSCI, V4, P645, DOI 10.1038/88477; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brass M, 2005, TRENDS COGN SCI, V9, P314, DOI 10.1016/j.tics.2005.05.001; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Chiu YC, 2009, J NEUROSCI, V29, P3930, DOI 10.1523/JNEUROSCI.5737-08.2009; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; COURCHESNE E, 1975, ELECTROEN CLIN NEURO, V39, P131, DOI 10.1016/0013-4694(75)90003-6; Davison A. C., 1998, BOOTSTRAP METHODS TH; Dehaene S, 2006, TRENDS COGN SCI, V10, P204, DOI 10.1016/j.tics.2006.03.007; Downar J, 2002, J NEUROPHYSIOL, V87, P615, DOI 10.1152/jn.00636.2001; Downar J, 2000, NAT NEUROSCI, V3, P277, DOI 10.1038/72991; Egeth HE, 1997, ANNU REV PSYCHOL, V48, P269, DOI 10.1146/annurev.psych.48.1.269; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Gottlieb J, 2007, NEURON, V53, P9, DOI 10.1016/j.neuron.2006.12.009; He BJ, 2007, NEURON, V53, P905, DOI 10.1016/j.neuron.2007.02.013; Heilman K M, 1977, Adv Neurol, V18, P93; Hoffman EA, 2000, NAT NEUROSCI, V3, P80, DOI 10.1038/71152; Horovitz SG, 2002, MAGN RESON IMAGING, V20, P319, DOI 10.1016/S0730-725X(02)00496-4; Huettel SA, 2001, J COGNITIVE NEUROSCI, V13, P1006, DOI 10.1162/089892901753165908; Husain M, 2007, TRENDS COGN SCI, V11, P30, DOI 10.1016/j.tics.2006.10.011; Karnath H. O., 2002, COGNITIVE NEURAL BAS; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; Kastner S, 2007, J NEUROPHYSIOL, V97, P3494, DOI 10.1152/jn.00010.2007; KNIGHT RT, 1984, ELECTROEN CLIN NEURO, V59, P9, DOI 10.1016/0168-5597(84)90016-9; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Konen CS, 2008, J NEUROSCI, V28, P8361, DOI 10.1523/JNEUROSCI.1930-08.2008; Linden DEJ, 1999, CEREB CORTEX, V9, P815, DOI 10.1093/cercor/9.8.815; Lumer ED, 1998, SCIENCE, V280, P1930, DOI 10.1126/science.280.5371.1930; Marois R, 2000, NEURON, V28, P299, DOI 10.1016/S0896-6273(00)00104-5; Marois R, 2005, TRENDS COGN SCI, V9, P296, DOI 10.1016/j.tics.2005.04.010; Marois R, 2004, NEURON, V41, P465, DOI 10.1016/S0896-6273(04)00012-1; Marois R, 2000, NEURON, V25, P717, DOI 10.1016/S0896-6273(00)81073-9; Opitz B, 1999, CEREB CORTEX, V9, P379, DOI 10.1093/cercor/9.4.379; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; Rees G, 1999, SCIENCE, V286, P2504, DOI 10.1126/science.286.5449.2504; Rees G, 2002, NAT REV NEUROSCI, V3, P261, DOI 10.1038/nrn783; Serences JT, 2005, PSYCHOL SCI, V16, P114, DOI 10.1111/j.0956-7976.2005.00791.x; Sheskin D. J., 2000, HDB PARAMETRIC NONPA; Shulman GL, 2007, CEREB CORTEX, V17, P2625, DOI 10.1093/cercor/bhl170; Talairach J., 1988, COPLANAR STEREOTAXIC; Todd JJ, 2005, PSYCHOL SCI, V16, P965, DOI 10.1111/j.1467-9280.2005.01645.x; Yamaguchi S, 2004, J NEUROSCI, V24, P5356, DOI 10.1523/JNEUROSCI.4587-03.2004; Yantis S, 2002, NAT NEUROSCI, V5, P995, DOI 10.1038/nn921	50	255	268	2	68	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2010	13	4					507	U136		10.1038/nn.2509	http://dx.doi.org/10.1038/nn.2509			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	575NI	20208526	Green Accepted			2022-12-17	WOS:000276073500022
J	Santello, M; Toni, N; Volterra, A				Santello, Mirko; Toni, Nicolas; Volterra, Andrea			Astrocyte function from information processing to cognition and cognitive impairment	NATURE NEUROSCIENCE			English	Review							LONG-TERM POTENTIATION; NECROSIS-FACTOR-ALPHA; D-SERINE; ALZHEIMERS-DISEASE; TNF-ALPHA; GLUTAMATE RELEASE; MAMMALIAN-CELLS; CHOLINERGIC MODULATION; INTRACELLULAR CALCIUM; SYNAPTIC-TRANSMISSION	Astrocytes serve important roles that affect recruitment and function of neurons at the local and network levels. Here we review the contributions of astrocyte signaling to synaptic plasticity, neuronal network oscillations, and memory function. The roles played by astrocytes are not fully understood, but astrocytes seem to contribute to memory consolidation and seem to mediate the effects of vigilance and arousal on memory performance. Understanding the role of astrocytes in cognitive processes may also advance our understanding of how these processes go awry in pathological conditions. Indeed, abnormal astrocytic signaling can cause or contribute to synaptic and network imbalances, leading to cognitive impairment. We discuss evidence for this from animal models of Alzheimer's disease and multiple sclerosis and from animal studies of sleep deprivation and drug abuse and addiction. Understanding the emerging roles of astrocytes in cognitive function and dysfunction will open up a large array of new therapeutic opportunities.	[Santello, Mirko] Univ Zurich, Inst Pharmacol & Toxicol, Zurich, Switzerland; [Santello, Mirko] Univ Zurich, Neurosci Ctr Zurich, Zurich, Switzerland; [Santello, Mirko] Swiss Fed Inst Technol, Zurich, Switzerland; [Toni, Nicolas] Lausanne Univ Hosp, Dept Psychiat, Ctr Psychiat Neurosci, Prilly, Switzerland; [Volterra, Andrea] Univ Lausanne, Dept Fundamental Neurosci, Lausanne, Switzerland	University of Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Lausanne	Volterra, A (corresponding author), Univ Lausanne, Dept Fundamental Neurosci, Lausanne, Switzerland.	andrea.volterra@unil.ch	Toni, Nicolas/M-2057-2014; Santello, Mirko/F-9007-2014	Toni, Nicolas/0000-0001-5585-268X; Santello, Mirko/0000-0002-7709-4127; Volterra, Andrea/0000-0003-1069-1602	ERC [340368]; Swiss National Science Foundation [31003A 173124/1, 31003A-173128]; NCCR "Synapsy" [51NF40-158776]; NCCR "Transcure" [51NF40-160620]; Synapsis Foundation; Swiss National Science Foundation "Ambizione" grant [PP00P3_176838]; Novartis Foundation [17C157]	ERC(European Research Council (ERC)European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NCCR "Synapsy"; NCCR "Transcure"; Synapsis Foundation; Swiss National Science Foundation "Ambizione" grant; Novartis Foundation(Novartis)	The authors thank I. Savtchouk for helpful discussions and support in figure preparation and S. Berry for proofreading the manuscript. Research in the Volterra laboratory is supported by the ERC Advanced grant 340368 "Astromnesis", by Swiss National Science Foundation grants 31003A 173124/1, NCCR "Synapsy" (51NF40-158776) and NCCR "Transcure" (51NF40-160620), and by Synapsis Foundation. M.S. is supported by the Swiss National Science Foundation "Ambizione" grant PP00P3_176838 and by the Novartis Foundation for medical-biological Research grant #17C157. N.T. is supported by the Swiss National Science Foundation, grant 31003A-173128.	Abel T, 2013, CURR BIOL, V23, pR774, DOI 10.1016/j.cub.2013.07.025; Abramov AY, 2003, J NEUROSCI, V23, P5088; Adamsky A, 2018, CELL, V174, P59, DOI 10.1016/j.cell.2018.05.002; Agulhon C, 2010, SCIENCE, V327, P1250, DOI 10.1126/science.1184821; Amiri M, 2013, J COMPUT NEUROSCI, V34, P489, DOI 10.1007/s10827-012-0432-6; Andrade-Talavera Y, 2016, CEREB CORTEX, V26, P3637, DOI 10.1093/cercor/bhw172; Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Araque A, 2002, J NEUROSCI, V22, P2443, DOI 10.1523/JNEUROSCI.22-07-02443.2002; Araque A, 2017, NEUROPHARMACOLOGY, V124, P13, DOI 10.1016/j.neuropharm.2017.06.017; Araque A, 2014, NEURON, V81, P728, DOI 10.1016/j.neuron.2014.02.007; Ashhad S, 2016, P NATL ACAD SCI USA, V113, pE3280, DOI 10.1073/pnas.1522180113; Basheer R, 2004, PROG NEUROBIOL, V73, P379, DOI 10.1016/j.pneurobio.2004.06.004; Benneyworth MA, 2012, CELL MOL NEUROBIOL, V32, P613, DOI 10.1007/s10571-012-9808-4; Bernardinelli Y, 2014, CURR BIOL, V24, P1679, DOI 10.1016/j.cub.2014.06.025; Bindocci E, 2017, SCIENCE, V356, DOI 10.1126/science.aai8185; Bittner KC, 2015, NAT NEUROSCI, V18, P1133, DOI 10.1038/nn.4062; Boury-Jamot B, 2016, MOL PSYCHIATR, V21, P1070, DOI 10.1038/mp.2015.157; Busche MA, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0429; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Cavanagh C, 2016, NEUROBIOL AGING, V47, P41, DOI 10.1016/j.neurobiolaging.2016.07.009; Chai H, 2017, NEURON, V95, P531, DOI 10.1016/j.neuron.2017.06.029; Chen NY, 2012, P NATL ACAD SCI USA, V109, pE2832, DOI 10.1073/pnas.1206557109; Chever O, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad3066; Chung WS, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020370; Clasadonte J, 2017, NEURON, V95, P1365, DOI 10.1016/j.neuron.2017.08.022; Covelo A, 2018, ELIFE, V7, DOI 10.7554/eLife.32237; Curcio L, 2013, BRAIN, V136, P1216, DOI 10.1093/brain/awt036; D'Ascenzo Marcello, 2014, Front Synaptic Neurosci, V6, P16, DOI 10.3389/fnsyn.2014.00016; Delekate A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6422; Di Castro MA, 2011, NAT NEUROSCI, V14, P1276, DOI 10.1038/nn.2929; Dong JH, 2017, BIOL PSYCHIAT, V81, P654, DOI 10.1016/j.biopsych.2016.09.025; Fellin T, 2004, NEURON, V43, P729, DOI 10.1016/j.neuron.2004.08.011; Fellin T, 2009, P NATL ACAD SCI USA, V106, P15037, DOI 10.1073/pnas.0906419106; Fiacco TA, 2007, NEURON, V54, P611, DOI 10.1016/j.neuron.2007.04.032; Fields RD, 2014, NEUROSCIENTIST, V20, P426, DOI 10.1177/1073858413504465; Filosa A, 2009, NAT NEUROSCI, V12, P1285, DOI 10.1038/nn.2394; Fischer R, 2015, ANTIBODIES, V4, P48, DOI 10.3390/antib4010048; Florian C, 2011, J NEUROSCI, V31, P6956, DOI 10.1523/JNEUROSCI.5761-10.2011; Fogel H, 2014, CELL REP, V7, P1560, DOI 10.1016/j.celrep.2014.04.024; Fujita T, 2014, J NEUROSCI, V34, P16594, DOI 10.1523/JNEUROSCI.2585-14.2014; Gao V, 2016, P NATL ACAD SCI USA, V113, P8526, DOI 10.1073/pnas.1605063113; Gebara E, 2016, STEM CELLS, V34, P997, DOI 10.1002/stem.2266; Genoud C, 2006, PLOS BIOL, V4, P2057, DOI 10.1371/journal.pbio.0040343; Genzel L, 2014, TRENDS NEUROSCI, V37, P10, DOI 10.1016/j.tins.2013.10.002; Ghezali G, 2016, BRAIN STRUCT FUNCT, V221, P2427, DOI 10.1007/s00429-015-1070-3; Gomez-Gonzalo M, 2017, GLIA, V65, P569, DOI 10.1002/glia.23112; Gomez-Gonzalo M, 2015, CEREB CORTEX, V25, P3699, DOI 10.1093/cercor/bhu231; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Habbas S, 2015, CELL, V163, P1730, DOI 10.1016/j.cell.2015.11.023; Halassa MM, 2007, J NEUROSCI, V27, P6473, DOI 10.1523/JNEUROSCI.1419-07.2007; Halassa MM, 2009, NEURON, V61, P213, DOI 10.1016/j.neuron.2008.11.024; Hamby ME, 2012, J NEUROSCI, V32, P14489, DOI 10.1523/JNEUROSCI.1256-12.2012; Hammond S, 2013, NEUROPHARMACOLOGY, V64, P464, DOI 10.1016/j.neuropharm.2012.06.022; Han J, 2012, CELL, V148, P1039, DOI 10.1016/j.cell.2012.01.037; Hardt O, 2013, TRENDS COGN SCI, V17, P111, DOI 10.1016/j.tics.2013.01.001; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; HERKENHAM M, 1990, P NATL ACAD SCI USA, V87, P1932, DOI 10.1073/pnas.87.5.1932; Hirrlinger PG, 2006, GLIA, V54, P11, DOI 10.1002/glia.20342; Jahn HM, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00310; Jensen CJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164721; Jo S, 2014, NAT MED, V20, P886, DOI 10.1038/nm.3639; Jourdain P, 2007, NAT NEUROSCI, V10, P331, DOI 10.1038/nn1849; Kandel ER, 2014, CELL, V157, P163, DOI 10.1016/j.cell.2014.03.001; Kelamangalath L, 2010, NEUROSCIENCE, V169, P1127, DOI 10.1016/j.neuroscience.2010.06.006; Kuchibhotla KV, 2009, SCIENCE, V323, P1211, DOI 10.1126/science.1169096; Lalo U, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001747; Lee HS, 2014, P NATL ACAD SCI USA, V111, pE3343, DOI 10.1073/pnas.1410893111; Lewitus GM, 2014, J NEUROSCI, V34, P6146, DOI 10.1523/JNEUROSCI.3481-13.2014; Li SM, 2009, NEURON, V62, P788, DOI 10.1016/j.neuron.2009.05.012; Lim D, 2013, GLIA, V61, P1134, DOI 10.1002/glia.22502; Liu ZQ, 2016, PHARMACOL BIOCHEM BE, V143, P44, DOI 10.1016/j.pbb.2016.02.002; Lushnikova I, 2009, HIPPOCAMPUS, V19, P753, DOI 10.1002/hipo.20551; Magistretti PJ, 2018, NAT REV NEUROSCI, V19, P235, DOI 10.1038/nrn.2018.19; Makitani K, 2017, J PHARMACOL SCI, V134, P37, DOI 10.1016/j.jphs.2017.03.008; Mariotti L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02642-6; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; Martin R, 2015, SCIENCE, V349, P730, DOI 10.1126/science.aaa7945; Martin-Fernandez M, 2017, NAT NEUROSCI, V20, P1540, DOI 10.1038/nn.4649; Matos M, 2015, BIOL PSYCHIAT, V78, P763, DOI 10.1016/j.biopsych.2015.02.026; METZGER D, 1995, P NATL ACAD SCI USA, V92, P6991, DOI 10.1073/pnas.92.15.6991; Min R, 2012, NAT NEUROSCI, V15, P746, DOI 10.1038/nn.3075; Mitew S, 2013, NEUROBIOL AGING, V34, P2341, DOI 10.1016/j.neurobiolaging.2013.04.010; Mori T, 2006, GLIA, V54, P21, DOI 10.1002/glia.20350; Murai KK, 2003, NAT NEUROSCI, V6, P153, DOI 10.1038/nn994; Navarrete M, 2008, NEURON, V57, P883, DOI 10.1016/j.neuron.2008.01.029; Navarrete M, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001259; Navarrete M, 2010, NEURON, V68, P113, DOI 10.1016/j.neuron.2010.08.043; Newman LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028427; Norimoto H, 2018, SCIENCE, V359, P1524, DOI 10.1126/science.aao0702; Orr AG, 2018, NEUROBIOL DIS, V110, P29, DOI 10.1016/j.nbd.2017.10.014; Orr AG, 2015, NAT NEUROSCI, V18, P423, DOI 10.1038/nn.3930; Ostroff LE, 2014, J COMP NEUROL, V522, P2152, DOI 10.1002/cne.23523; Otte DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067131; Pabst M, 2016, NEURON, V90, P853, DOI 10.1016/j.neuron.2016.04.003; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051; Panatier A, 2011, CELL, V146, P785, DOI 10.1016/j.cell.2011.07.022; Pankratov Y, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00230; Pannasch U, 2014, NAT NEUROSCI, V17, P549, DOI 10.1038/nn.3662; Pannasch U, 2013, TRENDS NEUROSCI, V36, P405, DOI 10.1016/j.tins.2013.04.004; Papouin T, 2017, NEURON, V94, P840, DOI 10.1016/j.neuron.2017.04.021; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; Paukert M, 2014, NEURON, V82, P1263, DOI 10.1016/j.neuron.2014.04.038; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Perea G, 2005, J NEUROSCI, V25, P2192, DOI 10.1523/JNEUROSCI.3965-04.2005; Perea G, 2007, SCIENCE, V317, P1083, DOI 10.1126/science.1144640; Perea G, 2016, ELIFE, V5, DOI 10.7554/eLife.20362; Perez-Alvarez A, 2014, J NEUROSCI, V34, P12738, DOI 10.1523/JNEUROSCI.2401-14.2014; Petravicz J, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00384; Pirttimaki TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081828; Porto-Pazos AB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019109; Poskanzer KE, 2016, P NATL ACAD SCI USA, V113, pE2675, DOI 10.1073/pnas.1520759113; Poskanzer KE, 2011, P NATL ACAD SCI USA, V108, P18453, DOI 10.1073/pnas.1112378108; Reichenbach N, 2018, J EXP MED, V215, P1649, DOI 10.1084/jem.20171487; Robin LM, 2018, NEURON, V98, P935, DOI 10.1016/j.neuron.2018.04.034; Saab AS, 2012, SCIENCE, V337, P749, DOI 10.1126/science.1221140; Sakers K, 2017, P NATL ACAD SCI USA, V114, pE3830, DOI 10.1073/pnas.1617782114; Santello M, 2012, TRENDS NEUROSCI, V35, P638, DOI 10.1016/j.tins.2012.06.001; Santello M, 2011, NEURON, V69, P988, DOI 10.1016/j.neuron.2011.02.003; Sardinha VM, 2017, GLIA, V65, P1944, DOI 10.1002/glia.23205; Sasaki T, 2011, SCIENCE, V331, P599, DOI 10.1126/science.1197598; SAUER B, 1988, P NATL ACAD SCI USA, V85, P5166, DOI 10.1073/pnas.85.14.5166; Savtchouk I, 2018, J NEUROSCI, V38, P14, DOI 10.1523/JNEUROSCI.0017-17.2017; Schmitt LI, 2012, J NEUROSCI, V32, P4417, DOI 10.1523/JNEUROSCI.5689-11.2012; Scofield MD, 2015, BIOL PSYCHIAT, V78, P441, DOI 10.1016/j.biopsych.2015.02.016; Seif T, 2015, NEUROPSYCHOPHARMACOL, V40, P2357, DOI 10.1038/npp.2015.84; Sharma K, 2015, NAT NEUROSCI, V18, P1819, DOI 10.1038/nn.4160; Slezak M, 2012, NEURON, V74, P504, DOI 10.1016/j.neuron.2012.03.027; Srinivasan R, 2016, NEURON, V92, P1181, DOI 10.1016/j.neuron.2016.11.030; Steinman MQ, 2016, FRONT INTEGR NEUROSC, V10, DOI [10.3389/fnint.2016.00010, 10.3389/fnint.2010.00010]; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Stobart JL, 2018, NEURON, V98, P726, DOI 10.1016/j.neuron.2018.03.050; Sultan S, 2015, NEURON, V88, DOI 10.1016/j.neuron.2015.10.037; Suzuki A, 2011, CELL, V144, P810, DOI 10.1016/j.cell.2011.02.018; Takata N, 2011, J NEUROSCI, V31, P18155, DOI 10.1523/JNEUROSCI.5289-11.2011; Talantova M, 2013, P NATL ACAD SCI USA, V110, pE2518, DOI 10.1073/pnas.1306832110; Tan ZB, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13772; Tanaka M, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-6; Teaktong T, 2003, GLIA, V41, P207, DOI 10.1002/glia.10132; Tewari S, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00145; Toni N, 2015, COLD SPRING HARB PER, V8, DOI DOI 10.1101/CSHPERSPECT.A018903; Verret L, 2012, CELL, V149, P708, DOI 10.1016/j.cell.2012.02.046; Volterra A, 2014, NAT REV NEUROSCI, V15, P327, DOI 10.1038/nrn3725; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; Winchenbach Jan, 2016, F1000Res, V5, P2934, DOI 10.12688/f1000research.10509.1; Wu J, 2017, ADDICT BIOL, V22, P1289, DOI 10.1111/adb.12417; Wu Z, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5159; Yang S, 2014, CEREB CORTEX, V24, P1956, DOI 10.1093/cercor/bht053; Yang YL, 2003, P NATL ACAD SCI USA, V100, P15194, DOI 10.1073/pnas.2431073100; Zhang Y, 2016, BIOL PSYCHIAT, V79, P928, DOI 10.1016/j.biopsych.2015.07.007	150	254	262	17	142	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2019	22	2					154	166		10.1038/s41593-018-0325-8	http://dx.doi.org/10.1038/s41593-018-0325-8			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HI9BQ	30664773	Green Accepted			2022-12-17	WOS:000456750100003
J	Safaiyan, S; Kannaiyan, N; Snaidero, N; Brioschi, S; Biber, K; Yona, S; Edinger, AL; Jung, S; Rossner, MJ; Simons, M				Safaiyan, Shima; Kannaiyan, Nirmal; Snaidero, Nicolas; Brioschi, Simone; Biber, Knut; Yona, Simon; Edinger, Aimee L.; Jung, Steffen; Rossner, Moritz J.; Simons, Mikael			Age-related myelin degradation burdens the clearance function of microglia during aging	NATURE NEUROSCIENCE			English	Article							NERVE-FIBERS; DYNAMICS; CELLS; MICE; DELETION	Myelin is synthesized as a multilamellar membrane, but the mechanisms of membrane turnover are unknown. We found that myelin pieces were gradually released from aging myelin sheaths and were subsequently cleared by microglia. Myelin fragmentation increased with age and led to the formation of insoluble, lipofuscin-like lysosomal inclusions in microglia. Thus, age-related myelin fragmentation is substantial, leading to lysosomal storage and contributing to microglial senescence and immune dysfunction in aging.	[Safaiyan, Shima; Snaidero, Nicolas; Rossner, Moritz J.; Simons, Mikael] Max Planck Inst Expt Med, Gottingen, Germany; [Kannaiyan, Nirmal; Rossner, Moritz J.] Univ Munich, Dept Psychiat, Munich, Germany; [Snaidero, Nicolas; Simons, Mikael] Tech Univ Munich, Inst Neuronal Cell Biol, Munich, Germany; [Brioschi, Simone; Biber, Knut] Dept Psychiat & Psychotherapy, Freiburg, Germany; [Biber, Knut] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, Groningen, Netherlands; [Yona, Simon; Jung, Steffen] Weizmann Inst Sci, Dept Immunol, Rehovot, Israel; [Edinger, Aimee L.] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92717 USA; [Simons, Mikael] German Ctr Neurodegenerat Dis DZNE, Munich, Germany; [Simons, Mikael] Munich Cluster Syst Neurol SyNergy, Munich, Germany	Max Planck Society; University of Munich; Technical University of Munich; University of Groningen; Weizmann Institute of Science; University of California System; University of California Irvine; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munich	Simons, M (corresponding author), Max Planck Inst Expt Med, Gottingen, Germany.; Simons, M (corresponding author), Tech Univ Munich, Inst Neuronal Cell Biol, Munich, Germany.; Simons, M (corresponding author), German Ctr Neurodegenerat Dis DZNE, Munich, Germany.; Simons, M (corresponding author), Munich Cluster Syst Neurol SyNergy, Munich, Germany.	msimons@gwdg.de	Jung, Steffen/K-1409-2012; Yona, Simon/ABE-6572-2020	Jung, Steffen/0000-0003-4290-5716; Brioschi, Simone/0000-0002-3849-3926; Simons, Mikael/0000-0001-5329-192X; Yona, Simon/0000-0002-3984-2008; Snaidero, Nicolas/0000-0003-1148-6926; Kannaiyan, Nirmal Raman/0000-0002-7408-6842	ERC (Axoglia); German Research Foundation [FOR-1756, SFB-TRR43, RO 4076/3-1, RO 4076/5-1, FOR-1336, BI 668/5-1]; ERC; Tschira-Stiftung; INSENS/ FP7-PEOPLE [607616]	ERC (Axoglia); German Research Foundation(German Research Foundation (DFG)); ERC(European Research Council (ERC)European Commission); Tschira-Stiftung; INSENS/ FP7-PEOPLE	We thank K.-A. Nave for providing PLP transgenic mice and W. Mobius for electron microscopy support, which was financed by an ERC Advanced Investigator Grant (Axoglia). The work was supported grants from the German Research Foundation (FOR-1756, SFB-TRR43 and SyNergy Excellence Cluster to M.S.; RO 4076/3-1 and RO 4076/5-1 to M.R.; FOR-1336 and BI 668/5-1 to K.B.), an ERC-Consolidator Grant (to M.S.) and the Tschira-Stiftung (to M.S.). N.K. is a recipient of a Marie-Curie fellowship from the INSENS/ FP7-PEOPLE-2013 (607616) framework.	Aguzzi A, 2013, SCIENCE, V339, P156, DOI 10.1126/science.1227901; Bartzokis G, 2004, NEUROBIOL AGING, V25, P5, DOI 10.1016/j.neurobiolaging.2003.03.001; Goldmann T, 2013, NAT NEUROSCI, V16, P1618, DOI 10.1038/nn.3531; Grabert K, 2016, NAT NEUROSCI, V19, P504, DOI 10.1038/nn.4222; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hellwig S, 2015, SCI REP-UK, V5, DOI 10.1038/srep14624; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; HILDEBRAND C, 1993, PROG NEUROBIOL, V40, P319, DOI 10.1016/0301-0082(93)90015-K; Hoyos HC, 2014, NEUROBIOL DIS, V62, P441, DOI 10.1016/j.nbd.2013.10.023; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Masuch A, 2016, GLIA, V64, P76, DOI 10.1002/glia.22904; Mobius W, 2010, METHOD CELL BIOL, V96, P475, DOI 10.1016/S0091-679X(10)96020-2; Mouton PR, 2002, BRAIN RES, V956, P30, DOI 10.1016/S0006-8993(02)03475-3; Nave KA, 2014, ANNU REV CELL DEV BI, V30, P503, DOI 10.1146/annurev-cellbio-100913-013101; Norton W. T., 2007, CURR PROTOC CELL BIO, V3, P25; NUKINA N, 1985, J BIOCHEM-TOKYO, V98, P1715, DOI 10.1093/oxfordjournals.jbchem.a135443; Peters A, 2002, J NEUROCYTOL, V31, P581, DOI 10.1023/A:1025731309829; Poliani PL, 2015, J CLIN INVEST, V125, P2161, DOI 10.1172/JCI77983; Prinz M, 2011, NAT NEUROSCI, V14, P1227, DOI 10.1038/nn.2923; READHEAD C, 1994, NEURON, V12, P583, DOI 10.1016/0896-6273(94)90214-3; Roy SG, 2013, AUTOPHAGY, V9, P1009, DOI 10.4161/auto.24468; Schnell SA, 1999, J HISTOCHEM CYTOCHEM, V47, P719, DOI 10.1177/002215549904700601; Sierra A, 2007, GLIA, V55, P412, DOI 10.1002/glia.20468; Snaidero N, 2014, CELL, V156, P277, DOI 10.1016/j.cell.2013.11.044; Streit WJ, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0142-6; Toyama BH, 2013, CELL, V154, P971, DOI 10.1016/j.cell.2013.07.037; Yeung MSY, 2014, CELL, V159, P766, DOI 10.1016/j.cell.2014.10.011; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Young KM, 2013, NEURON, V77, P873, DOI 10.1016/j.neuron.2013.01.006	29	254	255	8	66	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2016	19	8					995	+		10.1038/nn.4325	http://dx.doi.org/10.1038/nn.4325			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DS4TB	27294511	Green Submitted, Green Accepted			2022-12-17	WOS:000380773200006
J	Singh, T; Kurki, MI; Curtis, D; Purcell, SM; Crooks, L; Mcrae, J; Suvisaari, J; Chheda, H; Blackwood, D; Breen, G; Pietilainen, O; Gerety, SS; Ayub, M; Blyth, M; Cole, T; Collier, D; Coomber, EL; Craddock, N; Daly, MJ; Danesh, J; DiForti, M; Foster, A; Freimer, NB; Geschwind, D; Johnstone, M; Joss, S; Kirov, G; Korkko, J; Kuismin, O; Holmans, P; Hultman, CM; Iyegbe, C; Lonnqvist, J; Mannikko, M; McCarroll, SA; McGuffin, P; McIntosh, AM; McQuillin, A; Moilanen, JS; Moore, C; Murray, RM; Newbury-Ecob, R; Ouwehand, W; Paunio, T; Prigmore, E; Rees, E; Roberts, D; Sambrook, J; Sklar, P; St Clair, D; Veijola, J; Walters, JTR; Williams, H; Sullivan, PF; Hurles, ME; O'Donovan, MC; Palotie, A; Owen, MJ; Barrett, JC				Singh, Tarjinder; Kurki, Mitja I.; Curtis, David; Purcell, Shaun M.; Crooks, Lucy; Mcrae, Jeremy; Suvisaari, Jaana; Chheda, Himanshu; Blackwood, Douglas; Breen, Gerome; Pietilainen, Olli; Gerety, Sebastian S.; Ayub, Muhammad; Blyth, Moira; Cole, Trevor; Collier, David; Coomber, Eve L.; Craddock, Nick; Daly, Mark J.; Danesh, John; DiForti, Marta; Foster, Alison; Freimer, Nelson B.; Geschwind, Daniel; Johnstone, Mandy; Joss, Shelagh; Kirov, Georg; Korkko, Jarmo; Kuismin, Outi; Holmans, Peter; Hultman, Christina M.; Iyegbe, Conrad; Lonnqvist, Jouko; Mannikko, Minna; McCarroll, Steve A.; McGuffin, Peter; McIntosh, Andrew M.; McQuillin, Andrew; Moilanen, Jukka S.; Moore, Carmel; Murray, Robin M.; Newbury-Ecob, Ruth; Ouwehand, Willem; Paunio, Tiina; Prigmore, Elena; Rees, Elliott; Roberts, David; Sambrook, Jennifer; Sklar, Pamela; St Clair, David; Veijola, Juha; Walters, James T. R.; Williams, Hywel; Sullivan, Patrick F.; Hurles, Matthew E.; O'Donovan, Michael C.; Palotie, Aarno; Owen, Michael J.; Barrett, Jeffrey C.		Swedish Schizophrenia Study; INTERVAL Study; DDD Study; UK 10 K Consortium	Rare loss-of-function variants in SETD1A are associated with schizophrenia and developmental disorders	NATURE NEUROSCIENCE			English	Article							DE-NOVO MUTATIONS; CLINICAL-FEATURES; FRAMEWORK; SPECTRUM; AUTISM; RISK; PHENOTYPE; INSIGHTS; COMPLEX; BIOLOGY	By analyzing the whole-exome sequences of 4,264 schizophrenia cases, 9,343 controls and 1,077 trios, we identified a genome-wide significant association between rare loss-of-function (LoF) variants in SETD1A and risk for schizophrenia (P = 3.3 x 10(-9)). We found only two heterozygous LoF variants in 45,376 exomes from individuals without a neuropsychiatric diagnosis, indicating that SETD1A is substantially depleted of LoF variants in the general population. Seven of the ten individuals with schizophrenia carrying SETD1A LoF variants also had learning difficulties. We further identified four SETD1A LoF carriers among 4,281 children with severe developmental disorders and two more carriers in an independent sample of 5,720 Finnish exomes, both with notable neuropsychiatric phenotypes. Together, our observations indicate that LoF variants in SETD1A cause a range of neurodevelopmental disorders, including schizophrenia. Combining these data with previous common variant evidence, we suggest that epigenetic dysregulation, specifically in the histone H3K4 methylation pathway, is an important mechanism in the pathogenesis of schizophrenia.	[Singh, Tarjinder; Crooks, Lucy; Mcrae, Jeremy; Pietilainen, Olli; Gerety, Sebastian S.; Coomber, Eve L.; Danesh, John; Ouwehand, Willem; Prigmore, Elena; Hurles, Matthew E.; Palotie, Aarno; Owen, Michael J.; Barrett, Jeffrey C.] Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge, England; [Kurki, Mitja I.; Chheda, Himanshu; Pietilainen, Olli; Palotie, Aarno] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland; [Kurki, Mitja I.; Daly, Mark J.; Palotie, Aarno] Broad Inst MIT & Harvard, Program Med & Populat Genet & Genet Anal Platfor, Cambridge, MA USA; [Curtis, David] UCL, Genet Inst, London, England; [Purcell, Shaun M.; Sklar, Pamela] Icahn Sch Med Mt Sinai, Dept Psychiat, Div Psychiat Genom, New York, NY 10029 USA; [Crooks, Lucy] Sheffield Childrens NHS Fdn Trust, Sheffield Diagnost Genet Serv, Sheffield, S Yorkshire, England; [Suvisaari, Jaana; Pietilainen, Olli; Lonnqvist, Jouko] Natl Inst Hlth & Welf THL, Helsinki, Finland; [Blackwood, Douglas; Johnstone, Mandy; McIntosh, Andrew M.] Univ Edinburgh, Royal Edinburgh Hosp, Dept Psychiat, Edinburgh EH10 5HF, Midlothian, Scotland; [Breen, Gerome; DiForti, Marta; Iyegbe, Conrad; McGuffin, Peter; Murray, Robin M.] Kings Coll London, Inst Psychiat, London WC2R 2LS, England; [Breen, Gerome; Murray, Robin M.] Kings Coll London, Inst Psychiat, NIHR BRC Mental Hlth, London WC2R 2LS, England; [Breen, Gerome; Murray, Robin M.] Kings Coll London, SLaM NHS Trust, London WC2R 2LS, England; [Ayub, Muhammad] Queens Univ, Dept Psychiat, Div Dev Disabil, Kingston, ON K7L 3N6, Canada; [Blyth, Moira] Chapel Allerton Hosp, Dept Clin Genet, Chapeltown Rd, Leeds, W Yorkshire, England; [Cole, Trevor] Birmingham Womens Hosp, Birmingham, W Midlands, England; [Collier, David] Kings Coll London, Inst Psychiat, Social Genet & Dev Psychiat Ctr, London WC2R 2LS, England; [Collier, David] Eli Lilly & Co Ltd, Lilly Res Labs, Windlesham, Surrey, England; [Craddock, Nick; Kirov, Georg; Holmans, Peter; Rees, Elliott; Walters, James T. R.; Williams, Hywel; O'Donovan, Michael C.] Cardiff Univ, Sch Med, Inst Psychol Med & Clin Neurosci, MRC Ctr Neuropsychiatr Genet & Genom, Cardiff CF10 3AX, S Glam, Wales; [Daly, Mark J.; McCarroll, Steve A.] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA USA; [Danesh, John; Moore, Carmel; Ouwehand, Willem; Roberts, David] Univ Cambridge, Dept Publ Hlth & Primary Care, NIHR Blood & Transplant Res Unit Donor Hlth & Gen, Cambridge, England; [Danesh, John; Moore, Carmel; Sambrook, Jennifer] Univ Cambridge, Dept Publ Hlth & Primary Care, INTERVAL Coordinating Ctr, Cambridge, England; [Foster, Alison] Birmingham Womens NHS Fdn Trust, Clin Genet Unit, Birmingham, W Midlands, England; [Freimer, Nelson B.] Univ Calif Los Angeles, Ctr Neurobehav Genet, Los Angeles, CA USA; [Geschwind, Daniel] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Joss, Shelagh] South Glasgow Univ Hosp, West Scotland Genet Serv, Glasgow, Lanark, Scotland; [Korkko, Jarmo] Oulu Univ Hosp, Ctr Intellectual Disabil Care, Oulu, Finland; [Korkko, Jarmo; Kuismin, Outi; Moilanen, Jukka S.; Veijola, Juha] Univ Oulu, Oulu, Finland; [Kuismin, Outi; Moilanen, Jukka S.] Oulu Univ Hosp, Med Res Ctr Oulu, PEDEGO Res Unit, Oulu, Finland; [Hultman, Christina M.; Sullivan, Patrick F.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Mannikko, Minna] Univ Oulu, Ctr Life Course Epidemiol & Syst Med, Oulu, Finland; [McCarroll, Steve A.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [McQuillin, Andrew] UCL, Mol Psychiat Lab, Div Psychiat, London, England; [Newbury-Ecob, Ruth] St Michaels Hosp, Univ Hosp Bristol NHS Fdn Trust, Dept Clin Genet, Bristol, Avon, England; [Ouwehand, Willem; Sambrook, Jennifer] Univ Cambridge, Dept Haemotol, Cambridge, England; [Ouwehand, Willem] NHS Blood & Transplant, Cambridge, England; [Paunio, Tiina] Natl Inst Hlth & Welf THL, Helsinki, Finland; [Paunio, Tiina] Univ Helsinki, Dept Psychiat, SF-00180 Helsinki, Finland; [Roberts, David] John Radcliffe Hosp, NHS Blood & Transplant Oxford Ctr, Oxford OX3 9DU, England; [Roberts, David] Univ Oxford, John Radcliffe Hosp, Radcliffe Dept Med, Oxford OX3 9DU, England; [St Clair, David] Univ Aberdeen, Inst Med Sci, Aberdeen, Scotland; [Veijola, Juha] Oulu Univ Hosp, Med Res Ctr Oulu, Oulu, Finland; [Sullivan, Patrick F.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Sullivan, Patrick F.] Univ N Carolina, Dept Psychiat, Chapel Hill, NC USA	Wellcome Trust Sanger Institute; University of Helsinki; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of London; University College London; Icahn School of Medicine at Mount Sinai; Sheffield Children's NHS Foundation Trust; Finland National Institute for Health & Welfare; Royal Infirmary of Edinburgh; University of Edinburgh; University of London; King's College London; University of London; King's College London; South London & Maudsley NHS Trust; University of London; King's College London; Queens University - Canada; Chapel Allerton Hospital; Birmingham Women's Hospital; University of London; King's College London; Eli Lilly; Cardiff University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Cambridge; University of Cambridge; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Oulu; University of Oulu; University of Oulu; Karolinska Institutet; University of Oulu; Harvard University; Harvard Medical School; University of London; University College London; University of Bristol; University of Cambridge; Finland National Institute for Health & Welfare; University of Helsinki; University of Oxford; University of Oxford; University of Aberdeen; University of Oulu; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Barrett, JC (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge, England.	barrett@sanger.ac.uk	Walters, James/HCH-8835-2022; Curtis, David/HGB-3921-2022; St Clair, David/AAN-2412-2021; Williams, Hywel/AAL-2440-2021; blackwood, douglas/AIB-8874-2022; Breen, Gerome/Y-2706-2019; Breen, Gerome D/A-5540-2010; O'Donovan, Michael C/P-7005-2018; Kurki, Mitja/GWM-5671-2022; McIntosh, Andrew M/B-9379-2008; Moilanen, Jukka S/G-2604-2012; Johnstone, Mandy/AAI-1952-2019; Daly, Mark J/B-2453-2017; McQuillin, Andrew/C-1623-2008; murray, robin/F-8658-2012; Collier, David/D-1649-2011; Holmans, Peter/F-4518-2015	Curtis, David/0000-0002-4089-9183; Williams, Hywel/0000-0001-7758-0312; Breen, Gerome/0000-0003-2053-1792; Breen, Gerome D/0000-0003-2053-1792; O'Donovan, Michael C/0000-0001-7073-2379; McIntosh, Andrew M/0000-0002-0198-4588; Moilanen, Jukka S/0000-0002-8041-3205; Johnstone, Mandy/0000-0002-8398-0862; Daly, Mark J/0000-0002-0949-8752; McQuillin, Andrew/0000-0003-1567-2240; Walters, James/0000-0002-6980-4053; Owen, Michael/0000-0003-4798-0862; murray, robin/0000-0003-0829-0519; Kirov, George/0000-0002-3427-3950; Rees, Elliott/0000-0002-6168-9222; Ouwehand, Willem/0000-0002-7744-1790; Gerety, Sebastian/0000-0002-6126-5040; Kuismin, Outi/0000-0002-0157-8985; Palotie, Aarno/0000-0002-2527-5874; Collier, David/0000-0003-4087-1559; Holmans, Peter/0000-0003-0870-9412; Blackwood, Douglas/0000-0002-4076-9346; Blyth, Moira/0000-0002-4312-413X; Singh, Tarjinder/0000-0003-0601-6815; Barrett, Jeffrey/0000-0002-1152-370X	Wellcome Trust [WT091310, WT098051]; Williams College Dr. Herchel Smith Fellowship; NIH [R01 MH077139]; Academy of Finland [251704, 286500]; NIMH [U01MH105666]; Sigrid Juselius Foundation; Medical Research Council (MRC) Centre [G0801418, G0800509]; National Institute of Health Research (NIHR) [RP-PG-0310-1004]; NIHR BioResource; NIHR Cambridge Biomedical Research Centre; NIHR Blood and Transplant Research Unit in Donor Health and Genomics; UK Medical Research Council [G0800270]; British Heart Foundation [SP/09/002]; Instrumentarium Science Foundation, Finland; Finnish Foundation for Cardiovascular Research; Orion Research Foundation; University of Eastern Finland, Saastamoinen Foundation;  [HICF-1009-003]; MRC [G1100583, MR/K013807/1, G0600972, G0700995, G0800509, G0801418, MR/P005748/1, G0800270] Funding Source: UKRI; British Heart Foundation [RG/09/012/28096] Funding Source: researchfish; Medical Research Council [G0800270, G0801418, MR/L010305/1, G0800509, G0700995, MR/P005748/1, G1100583, G0600972, MR/K013807/1, MR/K026992/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10151, RP-PG-0310-1002, NF-SI-0510-10214, NF-SI-0512-10110, RP-PG-0606-1049] Funding Source: researchfish; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH077139, U01MH105666] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Williams College Dr. Herchel Smith Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Academy of Finland(Academy of Finland); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Medical Research Council (MRC) Centre(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute of Health Research (NIHR)(National Institute for Health Research (NIHR)); NIHR BioResource; NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); NIHR Blood and Transplant Research Unit in Donor Health and Genomics; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Instrumentarium Science Foundation, Finland; Finnish Foundation for Cardiovascular Research; Orion Research Foundation; University of Eastern Finland, Saastamoinen Foundation; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank the thousands of patients who participated in these studies. We thank H. Firth and D. FitzPatrick for discussions. The UK10K project was funded by Wellcome Trust grant WT091310. The DDD Study is funded by HICF-1009-003. The DDD and the INTERVAL sequencing studies are funded by Wellcome Trust grant WT098051. T.S. is supported by the Williams College Dr. Herchel Smith Fellowship. P.F.S. is supported by NIH R01 MH077139. A.P. is supported by Academy of Finland grants 251704 and 286500, NIMH U01MH105666 and the Sigrid Juselius Foundation. The work at Cardiff University was funded by Medical Research Council (MRC) Centre (G0801418) and Program Grants (G0800509). The key groups of the Sequencing Initiative Suomi (SISu) project are from the Universities of Eastern Finland, Oulu and Helsinki and The Institute for Health and Welfare, Finland, Lund University, The Wellcome Trust Sanger Institute, University of Oxford, The Broad Institute, University of Michigan, Washington University in St. Louis and University of California, Los Angeles (UCLA). The SiSu project is coordinated in the Institute for Molecular Medicine Finland at the University of Helsinki. Participants in INTERVAL were recruited with the active collaboration of NHS Blood and Transplant England, which has supported fieldwork and other elements of the trial. DNA extraction and genotyping was funded by the National Institute of Health Research (NIHR RP-PG-0310-1004), the NIHR BioResource and the NIHR Cambridge Biomedical Research Centre. The academic coordinating center for INTERVAL was supported by core funding from NIHR Blood and Transplant Research Unit in Donor Health and Genomics, UK Medical Research Council (G0800270) and British Heart Foundation (SP/09/002). M.I.K. was supported by Instrumentarium Science Foundation, Finland; Finnish Foundation for Cardiovascular Research; Orion Research Foundation and the University of Eastern Finland, Saastamoinen Foundation.	Bassett AS, 2005, AM J MED GENET A, V138A, P307, DOI 10.1002/ajmg.a.30984; Butcher NJ, 2012, GENET MED, V14, P836, DOI 10.1038/gim.2012.66; Consortium TU., 2014, NUCLEIC ACIDS RES, V43, P204; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dincer A, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.169; Do R, 2015, NATURE, V518, P102, DOI 10.1038/nature13917; Exome Aggregation Consortium, 2015, PREPRINT; Fahrner JA, 2014, ANNU REV GENOM HUM G, V15, P269, DOI 10.1146/annurev-genom-090613-094245; Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010; Fitzgerald TW, 2015, NATURE, V519, P223, DOI 10.1038/nature14135; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Genovese G, 2014, NEW ENGL J MED, V371, P2477, DOI 10.1056/NEJMoa1409405; Girard SL, 2011, NAT GENET, V43, P860, DOI 10.1038/ng.886; Guipponi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112745; Gulsuner S, 2013, CELL, V154, P518, DOI 10.1016/j.cell.2013.06.049; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; He X, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003671; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Jun G, 2012, AM J HUM GENET, V91, P839, DOI 10.1016/j.ajhg.2012.09.004; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kirov G, 2012, MOL PSYCHIATR, V17, P142, DOI 10.1038/mp.2011.154; Kirov G, 2014, BIOL PSYCHIAT, V75, P378, DOI 10.1016/j.biopsych.2013.07.022; Kleefstra T, 2009, J MED GENET, V46, P598, DOI 10.1136/jmg.2008.062950; Kohler S, 2014, NUCLEIC ACIDS RES, V42, pD966, DOI 10.1093/nar/gkt1026; Lee JH, 2008, MOL CELL BIOL, V28, P609, DOI 10.1128/MCB.01356-07; Lee JH, 2007, J BIOL CHEM, V282, P13419, DOI 10.1074/jbc.M609809200; Li H, 2014, BIOINFORMATICS, V30, P2843, DOI 10.1093/bioinformatics/btu356; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; Malhotra D, 2012, CELL, V148, P1223, DOI 10.1016/j.cell.2012.02.039; McCarthy SE, 2014, MOL PSYCHIATR, V19, P652, DOI 10.1038/mp.2014.29; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Moore C, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-363; O'Dushlaine C, 2015, NAT NEUROSCI, V18, P199, DOI 10.1038/nn.3922; Perala J, 2007, ARCH GEN PSYCHIAT, V64, P19, DOI 10.1001/archpsyc.64.1.19; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Rajji TK, 2009, BRIT J PSYCHIAT, V195, P286, DOI 10.1192/bjp.bp.108.060723; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Rees E, 2014, BRIT J PSYCHIAT, V204, P108, DOI 10.1192/bjp.bp.113.131052; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Ryan AK, 1997, J MED GENET, V34, P798, DOI 10.1136/jmg.34.10.798; Saha S, 2007, ARCH GEN PSYCHIAT, V64, P1123, DOI 10.1001/archpsyc.64.10.1123; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Sanders SJ, 2015, NEURON, V87, P1215, DOI 10.1016/j.neuron.2015.09.016; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Takata A, 2014, NEURON, V82, P773, DOI 10.1016/j.neuron.2014.04.043; Thornton T, 2012, AM J HUM GENET, V91, P122, DOI 10.1016/j.ajhg.2012.05.024; van Os J, 2009, LANCET, V374, P635, DOI [10.1016/S0140-6736(09)60995-8, 10.1016/S0140-6736(15)01121-6]; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Xu B, 2012, NAT GENET, V44, P1365, DOI 10.1038/ng.2446	57	254	258	2	64	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2016	19	4					571	+		10.1038/nn.4267	http://dx.doi.org/10.1038/nn.4267			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DH6OI	26974950	Green Published, Green Submitted, Green Accepted			2022-12-17	WOS:000372909800014
J	Xu, M; Chung, SJ; Zhang, SY; Zhong, P; Ma, CY; Chang, WC; Weissbourd, B; Sakai, N; Luo, LQ; Nishino, SJ; Dan, Y				Xu, Min; Chung, Shinjae; Zhang, Siyu; Zhong, Peng; Ma, Chenyan; Chang, Wei-Cheng; Weissbourd, Brandon; Sakai, Noriaki; Luo, Liqun; Nishino, Seiji; Dan, Yang			Basal forebrain circuit for sleep-wake control	NATURE NEUROSCIENCE			English	Article							VENTROLATERAL PREOPTIC NUCLEUS; POSTERIOR HYPOTHALAMUS; DISCHARGE PROPERTIES; WAKING DISCHARGE; NEURONS; LESIONS; ACTIVATION; RATS; WAKEFULNESS; MODULATION	The mammalian basal forebrain (BF) has important roles in controlling sleep and wakefulness, but the underlying neural circuit remains poorly understood. We examined the BF circuit by recording and optogenetically perturbing the activity of four genetically defined cell types across sleep-wake cycles and by comprehensively mapping their synaptic connections. Recordings from channelrhodopsin-2 (ChR2)-tagged neurons revealed that three BF cell types, cholinergic, glutamatergic and parvalbumin-positive (PV+) GABAergic neurons, were more active during wakefulness and rapid eye movement (REM) sleep (wake/REM active) than during non-REM (NREM) sleep, and activation of each cell type rapidly induced wakefulness. By contrast, activation of somatostatin-positive (SOM+) GABAergic neurons promoted NREM sleep, although only some of them were NREM active. Synaptically, the wake-promoting neurons were organized hierarchically by glutamatergic -> cholinergic -> PV+ neuron excitatory connections, and they all received inhibition from SOM+ neurons. Together, these findings reveal the basic organization of the BF circuit for sleep-wake control.	[Xu, Min; Chung, Shinjae; Zhang, Siyu; Zhong, Peng; Ma, Chenyan; Chang, Wei-Cheng; Dan, Yang] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Helen Wills Neurosci Inst,Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Weissbourd, Brandon; Luo, Liqun] Stanford Univ, Howard Hughes Med Inst, Dept Biol, Stanford, CA 94305 USA; [Sakai, Noriaki; Nishino, Seiji] Stanford Univ, Sch Med, Sleep & Circadian Neurobiol Lab, Psychiat & Behav Sci, Palo Alto, CA 94304 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; Howard Hughes Medical Institute; Stanford University; Stanford University	Dan, Y (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Helen Wills Neurosci Inst,Howard Hughes Med Inst, Berkeley, CA 94720 USA.	ydan@berkeley.edu	Core, Vector/CAF-4832-2022; Ma, Chenyan/AAM-3918-2021; Xu, Min/AGD-5135-2022	Xu, Min/0000-0002-6936-7543; Zhang, Siyu/0000-0001-7298-1475; Dan, Yang/0000-0002-3818-877X; Luo, Liqun/0000-0001-5467-9264; Zhang, Siyu/0000-0003-1745-2532	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Alam MN, 1997, BRAIN RES, V752, P81; Anikeeva P, 2012, NAT NEUROSCI, V15, P163, DOI 10.1038/nn.2992; Brown RE, 2012, PHYSIOL REV, V92, P1087, DOI 10.1152/physrev.00032.2011; BUZSAKI G, 1988, J NEUROSCI, V8, P4007; Deurveilher S, 2011, SLEEP BIOL RHYTHMS, V9, P65, DOI 10.1111/j.1479-8425.2010.00465.x; Duque A, 2000, J NEUROPHYSIOL, V84, P1627, DOI 10.1152/jn.2000.84.3.1627; Economo CV, 1930, J NERV MENT DIS, V71, P249, DOI 10.1097/00005053-193003000-00001; Eggermann E, 2014, CELL REP, V9, P1654, DOI 10.1016/j.celrep.2014.11.005; Everitt BJ, 1997, ANNU REV PSYCHOL, V48, P649, DOI 10.1146/annurev.psych.48.1.649; FREUND TF, 1992, P NATL ACAD SCI USA, V89, P738, DOI 10.1073/pnas.89.2.738; Fu Y, 2014, CELL, V156, P1139, DOI 10.1016/j.cell.2014.01.050; Fuller P, 2011, J COMP NEUROL, V519, P933, DOI 10.1002/cne.22559; Goard M, 2009, NAT NEUROSCI, V12, P1444, DOI 10.1038/nn.2402; Han Y, 2014, CURR BIOL, V24, P693, DOI 10.1016/j.cub.2014.02.011; Hassani OK, 2009, J NEUROSCI, V29, P11828, DOI 10.1523/JNEUROSCI.1259-09.2009; Irmak SO, 2014, SLEEP, V37, P1941, DOI 10.5665/sleep.4246; Jones Barbara E, 2011, Handb Clin Neurol, V98, P131, DOI 10.1016/B978-0-444-52006-7.00009-5; JONES BE, 1993, PROG BRAIN RES, V98, P61; Kaur S, 2008, J NEUROSCI, V28, P491, DOI 10.1523/JNEUROSCI.1585-07.2008; Kim T, 2015, P NATL ACAD SCI USA, V112, P3535, DOI 10.1073/pnas.1413625112; Lee MG, 2005, J NEUROSCI, V25, P4365, DOI 10.1523/JNEUROSCI.0178-05.2005; Lee MG, 2004, J NEUROPHYSIOL, V92, P1182, DOI 10.1152/jn.01003.2003; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; LIN JS, 1989, BRAIN RES, V479, P225, DOI 10.1016/0006-8993(89)91623-5; Lu J, 2000, J NEUROSCI, V20, P3830, DOI 10.1523/JNEUROSCI.20-10-03830.2000; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; MCGINTY DJ, 1968, SCIENCE, V160, P1253, DOI 10.1126/science.160.3833.1253; Modirrousta M, 2004, NEUROSCIENCE, V129, P803, DOI 10.1016/j.neuroscience.2004.07.028; MORUZZI G, 1949, ELECTROEN CLIN NEURO, V1, P455, DOI 10.1016/0013-4694(49)90219-9; NAUTA WJH, 1946, J NEUROPHYSIOL, V9, P285, DOI 10.1152/jn.1946.9.4.285; NISHINO S, 1995, J NEUROSCI, V15, P4806; Pinto L, 2013, NAT NEUROSCI, V16, P1857, DOI 10.1038/nn.3552; SALLANON M, 1989, NEUROSCIENCE, V32, P669, DOI 10.1016/0306-4522(89)90289-3; Saper CB, 2010, NEURON, V68, P1023, DOI 10.1016/j.neuron.2010.11.032; Sarter M, 2005, BRAIN RES REV, V48, P98, DOI 10.1016/j.brainresrev.2004.08.006; Sherin JE, 1998, J NEUROSCI, V18, P4705; Sherin JE, 1996, SCIENCE, V271, P216, DOI 10.1126/science.271.5246.216; Siegel JM, 2009, NAT REV NEUROSCI, V10, P747, DOI 10.1038/nrn2697; Steininger TL, 2001, J COMP NEUROL, V429, P638; Steriade M. M., 2005, BRAIN CONTROL WAKEFU; SZYMUSIAK R, 1989, BRAIN RES BULL, V22, P423, DOI 10.1016/0361-9230(89)90069-5; Szymusiak R, 1998, BRAIN RES, V803, P178, DOI 10.1016/S0006-8993(98)00631-3; SZYMUSIAK R, 1986, EXP NEUROL, V94, P598, DOI 10.1016/0014-4886(86)90240-2; Szymusiak R, 2007, SLEEP MED, V8, P291, DOI 10.1016/j.sleep.2007.03.013; Takahashi K, 2009, NEUROSCIENCE, V161, P269, DOI 10.1016/j.neuroscience.2009.02.075; Xu XM, 2010, J COMP NEUROL, V518, P389, DOI 10.1002/cne.22229; Zaborszky L, 2000, BEHAV BRAIN RES, V115, P143, DOI 10.1016/S0166-4328(00)00255-2	48	254	273	11	90	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2015	18	11					1641	1647		10.1038/nn.4143	http://dx.doi.org/10.1038/nn.4143			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CU8YT	26457552	Green Accepted			2022-12-17	WOS:000363830700022
J	Gratten, J; Wray, NR; Keller, MC; Visscher, PM				Gratten, Jacob; Wray, Naomi R.; Keller, Matthew C.; Visscher, Peter M.			Large-scale genomics unveils the genetic architecture of psychiatric disorders	NATURE NEUROSCIENCE			English	Review							DE-NOVO MUTATIONS; DEFICIT HYPERACTIVITY DISORDER; AUTISM SPECTRUM DISORDERS; WIDE ASSOCIATION; BIPOLAR DISORDER; COMMON SNPS; ALZHEIMERS-DISEASE; RARE VARIANTS; COMPLEX TRAIT; PATERNAL AGE	Family study results are consistent with genetic effects making substantial contributions to risk of psychiatric disorders such as schizophrenia, yet robust identification of specific genetic variants that explain variation in population risk had been disappointing until the advent of technologies that assay the entire genome in large samples. We highlight recent progress that has led to a better understanding of the number of risk variants in the population and the interaction of allele frequency and effect size. The emerging genetic architecture implies a large number of contributing loci (that is, a high genome-wide mutational target) and suggests that genetic risk of psychiatric disorders involves the combined effects of many common variants of small effect, as well as rare and de novo variants of large effect. The capture of a substantial proportion of genetic risk facilitates new study designs to investigate the combined effects of genes and the environment.	[Gratten, Jacob; Wray, Naomi R.; Visscher, Peter M.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Keller, Matthew C.] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA; [Visscher, Peter M.] Univ Queensland, Diamantina Inst, Translat Res Inst, Brisbane, Qld, Australia	University of Queensland; University of Colorado System; University of Colorado Boulder; University of Queensland	Visscher, PM (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia.	peter.visscher@uq.edu.au	Wray, Naomi/C-8639-2015; Gratten, Jacob/G-1485-2011; Visscher, Peter/ABB-6151-2020	Wray, Naomi/0000-0001-7421-3357; Gratten, Jacob/0000-0003-1293-409X; Visscher, Peter/0000-0002-2143-8760; KELLER, MATTHEW/0000-0002-6075-9882	US National Institutes of Health [GM099568, GM075091]; National Institute of Mental Health [K01MH085812, R01MH100141]; Australian Research Council [FT0991360]; Australian National Health and Medical Research Council [APP1011506, APP1048853, APP1067795, APP1047956]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099568, R01GM075091] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH100141, K01MH085812] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Australian Research Council(Australian Research Council); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the US National Institutes of Health (GM099568 and GM075091 to P.M.V.), the National Institute of Mental Health (K01MH085812 and R01MH100141 to M.C.K.), the Australian Research Council (FT0991360 to N.R.W.) and the Australian National Health and Medical Research Council (APP1011506, APP1048853 and APP1067795 to P.M.V., APP1011506 and APP1047956 to N.R.W., APP1067795 to J.G.).	Allardyce J, 2007, INT J METH PSYCH RES, V16, pS34, DOI 10.1002/mpr.214; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Anderson-Schmidt H, 2013, AM J MED GENET B, V162B, P96, DOI 10.1002/ajmg.b.32132; Anney R., 2013, 21 WORLD C PSYCH GEN; Bergen SE, 2012, MOL PSYCHIATR, V17, P880, DOI 10.1038/mp.2012.73; Bromet EJ, 2011, AM J PSYCHIAT, V168, P1186, DOI 10.1176/appi.ajp.2011.11010048; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Charney A.W., 2013, 21 WORLD C PSYCH GEN; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Corvin A, 2010, PSYCHOL MED, V40, P1063, DOI 10.1017/S0033291709991723; Crespi B, 2010, P NATL ACAD SCI USA, V107, P1736, DOI 10.1073/pnas.0906080106; Davis LK, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003864; de Candia TR, 2013, AM J HUM GENET, V93, P463, DOI 10.1016/j.ajhg.2013.07.007; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Duncan LE, 2011, AM J PSYCHIAT, V168, P1041, DOI 10.1176/appi.ajp.2011.11020191; Eyre-Walker A, 2010, P NATL ACAD SCI USA, V107, P1752, DOI 10.1073/pnas.0906182107; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Gilman SR, 2011, NEURON, V70, P898, DOI 10.1016/j.neuron.2011.05.021; Gratten J, 2013, NAT GENET, V45, P234, DOI 10.1038/ng.2555; Hill WG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000008; Hoischen A, 2014, NAT NEUROSCI, V17, P764, DOI 10.1038/nn.3703; Ionita-Laza I, 2014, P NATL ACAD SCI USA, V111, P343, DOI 10.1073/pnas.1309475110; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Ji JG, 2013, SCHIZOPHRENIA BULL, V39, P527, DOI 10.1093/schbul/sbs065; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kapur S, 2012, MOL PSYCHIATR, V17, P1174, DOI 10.1038/mp.2012.105; Keller MC, 2006, BEHAV BRAIN SCI, V29, P385, DOI 10.1017/S0140525X06009095; Kendler KS, 1997, PSYCHOL MED, V27, P411, DOI 10.1017/S003329179600445X; Kirov G, 2012, MOL PSYCHIATR, V17, P142, DOI 10.1038/mp.2011.154; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Laursen TM, 2009, J CLIN PSYCHIAT, V70, P1432, DOI 10.4088/JCP.08m04807; Lee SH, 2012, BIOINFORMATICS, V28, P2540, DOI 10.1093/bioinformatics/bts474; Lee SH, 2013, NAT GENET, V45, P984, DOI 10.1038/ng.2711; Lee SH, 2013, HUM MOL GENET, V22, P832, DOI 10.1093/hmg/dds491; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; Levinson DF, 2011, AM J PSYCHIAT, V168, P302, DOI 10.1176/appi.ajp.2010.10060876; Levy D, 2011, NEURON, V70, P886, DOI 10.1016/j.neuron.2011.05.015; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; Lichtenstein P, 2010, AM J PSYCHIAT, V167, P1357, DOI 10.1176/appi.ajp.2010.10020223; Liu L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003443; Lynch M, 1998, GENETICS ANAL QUANTI; Malhotra D, 2011, NEURON, V72, P951, DOI 10.1016/j.neuron.2011.11.007; McCarro SA, 2014, NAT NEUROSCI, V17, P756, DOI 10.1038/nn.3716; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; McGrath JJ, 2014, JAMA PSYCHIAT, V71, P301, DOI 10.1001/jamapsychiatry.2013.4081; McGrath JJ, 2013, SCHIZOPHRENIA BULL, V39, P955, DOI 10.1093/schbul/sbt108; Medland SE, 2014, NAT NEUROSCI, V17, P791, DOI 10.1038/nn.3718; Michaelson JJ, 2012, CELL, V151, P1431, DOI 10.1016/j.cell.2012.11.019; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Neale BM, 2010, J AM ACAD CHILD PSY, V49, P906, DOI 10.1016/j.jaac.2010.06.007; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; Perrin MC, 2007, SCHIZOPHRENIA BULL, V33, P1270, DOI 10.1093/schbul/sbm093; Petersen L, 2011, AM J PSYCHIAT, V168, P82, DOI 10.1176/appi.ajp.2010.10020252; Plenge RM, 2013, NAT REV DRUG DISCOV, V12, P581, DOI 10.1038/nrd4051; Psychiatric Genomics Consortium Schizophrenia Working Group, 2013, 21 WORLD C PSYCH GEN; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Ronald A, 2011, AM J MED GENET B, V156B, P255, DOI 10.1002/ajmg.b.31159; Samocha K.E., 2013, 21 WORLD C PSYCH GEN; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Sanseau P, 2012, NAT BIOTECHNOL, V30, P317, DOI 10.1038/nbt.2151; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sebat J, 2009, TRENDS GENET, V25, P528, DOI 10.1016/j.tig.2009.10.004; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Sullivan P, 2012, MOL PSYCHIATR, V17, P2, DOI 10.1038/mp.2011.94; Sullivan PF, 2013, MOL PSYCHIATR, V18, P497, DOI 10.1038/mp.2012.21; Sullivan PF, 2010, NEURON, V68, P182, DOI 10.1016/j.neuron.2010.10.003; Sullivan PF, 2005, PLOS MED, V2, P614, DOI 10.1371/journal.pmed.0020212; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Turner MR, 2013, LANCET NEUROL, V12, P310, DOI 10.1016/S1474-4422(13)70036-X; Vacic V, 2011, NATURE, V471, P499, DOI 10.1038/nature09884; Visscher PM, 2012, MOL PSYCHIATR, V17, P474, DOI 10.1038/mp.2011.65; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Wang K, 2011, MOL PSYCHIATR, V16, P949, DOI 10.1038/mp.2010.107; Williams NM, 2012, AM J PSYCHIAT, V169, P195, DOI 10.1176/appi.ajp.2011.11060822; Williams NM, 2010, LANCET, V376, P1401, DOI 10.1016/S0140-6736(10)61109-9; World Health Organization, 2008, GLOB BURD DIS 2004 U; Wray NR, 2012, MOL PSYCHIATR, V17, P36, DOI 10.1038/mp.2010.109; Wray Naomi R., 2012, Frontiers in Genetics, V3, P118, DOI 10.3389/fgene.2012.00118; Wray NR, 2012, EUR J HUM GENET, V20, P668, DOI 10.1038/ejhg.2011.257; Xu B, 2008, NAT GENET, V40, P880, DOI 10.1038/ng.162; Xu B, 2012, NAT GENET, V44, P1365, DOI 10.1038/ng.2446; Yang J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003355; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yang JA, 2010, EUR J HUM GENET, V18, P1039, DOI 10.1038/ejhg.2009.177; Yang L, 2013, AM J MED GENET B, V162B, P419, DOI 10.1002/ajmg.b.32169	96	254	256	2	85	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2014	17	6					782	790		10.1038/nn.3708	http://dx.doi.org/10.1038/nn.3708			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AI1TO	24866044	Green Accepted			2022-12-17	WOS:000336638000011
J	Bello, EP; Mateo, Y; Gelman, DM; Noain, D; Shin, JH; Low, MJ; Alvarez, VA; Lovinger, DM; Rubinstein, M				Bello, Estefania P.; Mateo, Yolanda; Gelman, Diego M.; Noain, Daniela; Shin, Jung H.; Low, Malcolm J.; Alvarez, Veronica A.; Lovinger, David M.; Rubinstein, Marcelo			Cocaine supersensitivity and enhanced motivation for reward in mice lacking dopamine D-2 autoreceptors	NATURE NEUROSCIENCE			English	Article							RECEPTOR-DEFICIENT MICE; CONDITIONED PLACE PREFERENCE; D2 RECEPTORS; FEEDBACK MECHANISM; LOCOMOTOR-ACTIVITY; MUTANT MICE; RELEASE; MOUSE; TRANSPORTER; ABSENCE	Dopamine (DA) D-2 receptors expressed in DA neurons (D-2 autoreceptors) exert a negative feedback regulation that reduces DA neuron firing, DA synthesis and DA release. As D-2 receptors are mostly expressed in postsynaptic neurons, pharmacological and genetic approaches have been unable to definitively address the in vivo contribution of D-2 autoreceptors to DA-mediated behaviors. We found that midbrain DA neurons from mice deficient in D-2 autoreceptors (Drd2(loxP/loxP); Dat(+/IRES-cre), referred to as autoDrd2KO mice) lacked DA-mediated somatodendritic synaptic responses and inhibition of DA release. AutoDrd2KO mice displayed elevated DA synthesis and release, hyperlocomotion and supersensitivity to the psychomotor effects of cocaine. The mice also exhibited increased place preference for cocaine and enhanced motivation for food reward. Our results highlight the importance of D-2 autoreceptors in the regulation of DA neurotransmission and demonstrate that D-2 autoreceptors are important for normal motor function, food-seeking behavior, and sensitivity to the locomotor and rewarding properties of cocaine.	[Bello, Estefania P.; Gelman, Diego M.; Noain, Daniela; Rubinstein, Marcelo] Consejo Nacl Invest Cient & Tecn, Inst Invest Ingn Genet & Biol, Buenos Aires, DF, Argentina; [Mateo, Yolanda; Lovinger, David M.] NIAAA, Sect Synapt Pharmacol, Lab Integrat Neurosci, US Natl Inst Hlth, Bethesda, MD USA; [Shin, Jung H.; Alvarez, Veronica A.] NIAAA, Sect Neuronal Struct, Lab Integrat Neurosci, US Natl Inst Hlth, Bethesda, MD USA; [Low, Malcolm J.] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI USA; [Rubinstein, Marcelo] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); University of Michigan System; University of Michigan; University of Buenos Aires	Rubinstein, M (corresponding author), Consejo Nacl Invest Cient & Tecn, Inst Invest Ingn Genet & Biol, Buenos Aires, DF, Argentina.	mrubins@dna.uba.ar	Alvarez, Veronica A/E-9745-2015	Alvarez, Veronica A/0000-0003-2611-8675; Low, Malcolm/0000-0002-9900-3708; Noain, Daniela/0000-0001-5482-7933	Howard Hughes Medical Institute; Universidad de Buenos Aires; Agencia Nacional de Promocion Cientifica y Tecnologica; National Science Foundation [INT-9901278]; US National Institutes of Health [R01-MH61326]; Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina; Division of Intramural Clinical and Biological Research of the National Institute on Alcohol Abuse and Alcoholism; National Institute of Neurological Disorders and Stroke; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061326] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000416, ZIAAA000421] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Universidad de Buenos Aires(University of Buenos Aires); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); National Science Foundation(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Division of Intramural Clinical and Biological Research of the National Institute on Alcohol Abuse and Alcoholism; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank J. Sztein, G. Levin, C. Backman, V. Rodriguez, R. Lorenzo, S. Nemirovsky, M. Peper, S. Merani, C. Carbone, F. Maschi and M. Baetscher for their scientific and technical assistance. This work was supported in part by an International Research Scholar Grant of the Howard Hughes Medical Institute (M.R.), Universidad de Buenos Aires (M.R.) and Agencia Nacional de Promocion Cientifica y Tecnologica (M.R.), National Science Foundation grant INT-9901278 (M.J.L. and M.R.) and US National Institutes of Health grant R01-MH61326 (M.J.L.). E.P.B., D.N. and D.M.G. received doctoral fellowships from the Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina. Y.M., J.H.S., V.A.A. and D.M.L. were supported by the Division of Intramural Clinical and Biological Research of the National Institute on Alcohol Abuse and Alcoholism. J.H.S. and V.A.A. received support from the Intramural Program of the National Institute of Neurological Disorders and Stroke.	Avale ME, 2004, MOL PSYCHIATR, V9, P718, DOI 10.1038/sj.mp.4001474; Backman CM, 2006, GENESIS, V44, P383, DOI 10.1002/dvg.20228; BAIK JH, 1995, NATURE, V377, P424, DOI 10.1038/377424a0; Benoit-Marand M, 2001, J NEUROSCI, V21, P9134, DOI 10.1523/JNEUROSCI.21-23-09134.2001; Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; Buckholtz JW, 2010, SCIENCE, V329, P532, DOI 10.1126/science.1185778; BUNNEY BS, 1973, NATURE-NEW BIOL, V245, P123, DOI 10.1038/newbio245123a0; Chausmer AL, 2002, PSYCHOPHARMACOLOGY, V163, P54, DOI 10.1007/s00213-002-1142-y; CUBEDDU LX, 1982, J PHARMACOL EXP THER, V223, P497; Cunningham CL, 2006, NAT PROTOC, V1, P1662, DOI 10.1038/nprot.2006.279; Cunningham CL, 2000, PHARMACOL BIOCHEM BE, V67, P693, DOI 10.1016/S0091-3057(00)00414-7; Diaz-Torga G, 2002, ENDOCRINOLOGY, V143, P1270, DOI 10.1210/en.143.4.1270; Dickinson SD, 1999, J NEUROCHEM, V72, P148, DOI 10.1046/j.1471-4159.1999.0720148.x; Falzone TL, 2002, EUR J NEUROSCI, V15, P158, DOI 10.1046/j.0953-816x.2001.01842.x; Ford CP, 2010, J NEUROSCI, V30, P6975, DOI 10.1523/JNEUROSCI.1020-10.2010; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Goto Y, 2007, NEUROPHARMACOLOGY, V53, P583, DOI 10.1016/j.neuropharm.2007.07.007; Pellizzari EH, 2008, LIFE SCI, V83, P413, DOI 10.1016/j.lfs.2008.07.004; Hidalgo-Sanchez M, 2005, J COMP NEUROL, V483, P17, DOI 10.1002/cne.20402; John CE, 2006, J NEUROCHEM, V96, P267, DOI 10.1111/j.1471-4159.2005.03557.x; Jones SR, 1999, NAT NEUROSCI, V2, P649, DOI 10.1038/10204; Joseph JD, 2002, NEUROSCIENCE, V112, P39, DOI 10.1016/S0306-4522(02)00067-2; KEHR W, 1972, J PHARM PHARMACOL, V24, P744, DOI 10.1111/j.2042-7158.1972.tb09104.x; Kelly MA, 1998, J NEUROSCI, V18, P3470; KENNEDY RT, 1992, J NEUROCHEM, V59, P449, DOI 10.1111/j.1471-4159.1992.tb09391.x; Kenny PJ, 2011, NEURON, V69, P664, DOI 10.1016/j.neuron.2011.02.016; Koeltzow TE, 1998, J NEUROSCI, V18, P2231; Maina FK, 2010, ACS CHEM NEUROSCI, V1, P450, DOI 10.1021/cn100003u; Maldonado R, 1997, NATURE, V388, P586, DOI 10.1038/41567; Mercuri NB, 1997, NEUROSCIENCE, V79, P323; Morgan D, 2002, NAT NEUROSCI, V5, P169, DOI 10.1038/nn798; Nemirovsky SI, 2009, SYNAPSE, V63, P991, DOI 10.1002/syn.20680; Paladini CA, 2003, P NATL ACAD SCI USA, V100, P2866, DOI 10.1073/pnas.0138018100; Phillips PEM, 2002, SYNAPSE, V44, P15, DOI 10.1002/syn.10049; Phillips TJ, 1998, NAT NEUROSCI, V1, P610, DOI 10.1038/2843; Salamone JD, 2002, BEHAV BRAIN RES, V137, P3, DOI 10.1016/S0166-4328(02)00282-6; Sano H, 2003, J NEUROSCI, V23, P9078; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Schmitz Y, 2003, J NEUROCHEM, V87, P273, DOI 10.1046/j.1471-4159.2003.02050.x; Schmitz Y, 2002, J NEUROSCI, V22, P8002; Schultz W, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-24; Sulzer D, 2011, NEURON, V69, P628, DOI 10.1016/j.neuron.2011.02.010; Thanos PK, 2001, J NEUROCHEM, V78, P1094, DOI 10.1046/j.1471-4159.2001.00492.x; Volkow ND, 2009, NEUROPHARMACOLOGY, V56, P3, DOI 10.1016/j.neuropharm.2008.05.022; Volkow ND, 1999, AM J PSYCHIAT, V156, P1440; Volkow ND, 2002, SYNAPSE, V46, P79, DOI 10.1002/syn.10137; Welter M, 2007, P NATL ACAD SCI USA, V104, P6840, DOI 10.1073/pnas.0610790104; WOLF ME, 1990, ANN NY ACAD SCI, V604, P323, DOI 10.1111/j.1749-6632.1990.tb32003.x; Zhuang XX, 2001, P NATL ACAD SCI USA, V98, P1982, DOI 10.1073/pnas.98.4.1982	50	254	258	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2011	14	8					1033	U128		10.1038/nn.2862	http://dx.doi.org/10.1038/nn.2862			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	797KC	21743470	Green Accepted, Green Published			2022-12-17	WOS:000293123700017
J	Fancy, SPJ; Harrington, EP; Yuen, TJ; Silbereis, JC; Zhao, C; Baranzini, SE; Bruce, CC; Otero, JJ; Huang, EJ; Nusse, R; Franklin, RJM; Rowitch, DH				Fancy, Stephen P. J.; Harrington, Emily P.; Yuen, Tracy J.; Silbereis, John C.; Zhao, Chao; Baranzini, Sergio E.; Bruce, Charlotte C.; Otero, Jose J.; Huang, Eric J.; Nusse, Roel; Franklin, Robin J. M.; Rowitch, David H.			Axin2 as regulatory and therapeutic target in newborn brain injury and remyelination	NATURE NEUROSCIENCE			English	Article							WHITE-MATTER INJURY; BETA-CATENIN; MULTIPLE-SCLEROSIS; CNS REMYELINATION; FUNCTIONAL INTERACTION; NEGATIVE REGULATOR; SIGNALING PATHWAY; DIFFERENTIATION; TRANSCRIPTION; MYELINATION	Permanent damage to white matter tracts, comprising axons and myelinating oligodendrocytes, is an important component of brain injuries of the newborn that cause cerebral palsy and cognitive disabilities, as well as multiple sclerosis in adults. However, regulatory factors relevant in human developmental myelin disorders and in myelin regeneration are unclear. We found that AXIN2 was expressed in immature oligodendrocyte progenitor cells (OLPs) in white matter lesions of human newborns with neonatal hypoxic-ischemic and gliotic brain damage, as well as in active multiple sclerosis lesions in adults. Axin2 is a target of Wnt transcriptional activation that negatively feeds back on the pathway, promoting beta-catenin degradation. We found that Axin2 function was essential for normal kinetics of remyelination. The small molecule inhibitor XAV939, which targets the enzymatic activity of tankyrase, acted to stabilize Axin2 levels in OLPs from brain and spinal cord and accelerated their differentiation and myelination after hypoxic and demyelinating injury. Together, these findings indicate that Axin2 is an essential regulator of remyelination and that it might serve as a pharmacological checkpoint in this process.	[Fancy, Stephen P. J.; Harrington, Emily P.; Yuen, Tracy J.; Silbereis, John C.; Otero, Jose J.; Rowitch, David H.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Fancy, Stephen P. J.; Harrington, Emily P.; Yuen, Tracy J.; Silbereis, John C.; Otero, Jose J.; Rowitch, David H.] Univ Calif San Francisco, Dept Neurosurg, Eli & Edythe Broad Inst Stem Cell Res & Regenerat, San Francisco, CA USA; [Fancy, Stephen P. J.; Harrington, Emily P.; Yuen, Tracy J.; Silbereis, John C.; Otero, Jose J.; Rowitch, David H.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA USA; [Harrington, Emily P.] Univ Calif San Francisco, Med Scientist Training Program, San Francisco, CA 94143 USA; [Zhao, Chao; Bruce, Charlotte C.; Franklin, Robin J. M.] Univ Cambridge, MRC Ctr Stem Cell Biol & Regenerat Med, Cambridge, England; [Zhao, Chao; Bruce, Charlotte C.; Franklin, Robin J. M.] Univ Cambridge, Dept Vet Med, Cambridge, England; [Baranzini, Sergio E.] Univ Cambridge, Dept Neurol, Cambridge, England; [Otero, Jose J.; Huang, Eric J.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Nusse, Roel] Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA; [Nusse, Roel] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Rowitch, David H.] Univ Calif San Francisco, Div Neonatol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Cambridge; University of Cambridge; University of Cambridge; University of California System; University of California San Francisco; Stanford University; Howard Hughes Medical Institute; Stanford University; University of California System; University of California San Francisco	Rowitch, DH (corresponding author), Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA.	rowitchd@peds.ucsf.edu	Otero, Jose Javier/B-8955-2013; Baranzini, Sergio/A-9422-2013; Otero, Jose/AAI-4891-2020; Huang, Eric J./AAH-7997-2019	Baranzini, Sergio/0000-0003-0067-194X; Otero, Jose/0000-0003-0680-4520; Huang, Eric J./0000-0002-5381-3801; Harrington, Emily P/0000-0001-6352-8687; Rowitch, David/0000-0002-0079-0060; Franklin, Robin/0000-0001-6522-2104; Yuen, Tracy/0000-0002-3451-9279	National Multiple Sclerosis Society; United Kingdom Multiple Sclerosis Society; US National Institutes of Health [NS040511, NS047572]; University of California, San Francisco; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS047572, R01NS040511] Funding Source: NIH RePORTER	National Multiple Sclerosis Society(National Multiple Sclerosis Society); United Kingdom Multiple Sclerosis Society; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California, San Francisco(University of California System); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank W. Birchmeier for Axin2-lacZ mice. This work was supported by a Promise 2010 grant from the National Multiple Sclerosis Society (to R.J.M.F. and D.H.R.), the United Kingdom Multiple Sclerosis Society (to R.J.M.F.), the US National Institutes of Health (NS040511 and NS047572 to D.H.R.) and the Medical Scientist Training Program at the University of California, San Francisco (to E.P.H.). S.E.B. is a Harry Weaver Neuroscience Scholar of the National Multiple Sclerosis Society. R.N. and D.H.R. are Howard Hughes Medical Institute Investigators.	Arnett HA, 2004, SCIENCE, V306, P2111, DOI 10.1126/science.1103709; Back SA, 2002, J NEUROSCI, V22, P455, DOI 10.1523/JNEUROSCI.22-02-00455.2002; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Billiards SS, 2008, BRAIN PATHOL, V18, P153, DOI 10.1111/j.1750-3639.2007.00107.x; Birgbauer E, 2004, J NEUROSCI RES, V78, P157, DOI 10.1002/jnr.20248; Chang A, 2002, NEW ENGL J MED, V346, P165, DOI 10.1056/NEJMoa010994; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Dao DY, 2010, J ORTHOP RES, V28, P89, DOI 10.1002/jor.20954; Dessaud E, 2008, DEVELOPMENT, V135, P2489, DOI 10.1242/dev.009324; Duncan ID, 2009, P NATL ACAD SCI USA, V106, P6832, DOI 10.1073/pnas.0812500106; Emery B, 2009, CELL, V138, P172, DOI 10.1016/j.cell.2009.04.031; Fancy SPJ, 2009, GENE DEV, V23, P1571, DOI 10.1101/gad.1806309; Feigenson K, 2009, MOL CELL NEUROSCI, V42, P255, DOI 10.1016/j.mcn.2009.07.010; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Harrington EP, 2010, ANN NEUROL, V68, P703, DOI 10.1002/ana.22090; Huang JK, 2011, NAT NEUROSCI, V14, P45, DOI 10.1038/nn.2702; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Karadottir R, 2005, NATURE, V438, P1162, DOI 10.1038/nature04302; Khwaja O, 2008, ARCH DIS CHILD-FETAL, V93, pF153, DOI 10.1136/adc.2006.108837; Kotter MR, 2006, J NEUROSCI, V26, P328, DOI 10.1523/JNEUROSCI.2615-05.2006; Kuhlmann T, 2008, BRAIN, V131, P1749, DOI 10.1093/brain/awn096; Lock C, 2002, NAT MED, V8, P500, DOI 10.1038/nm0502-500; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Mi S, 2005, NAT NEUROSCI, V8, P745, DOI 10.1038/nn1460; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Schuller U, 2008, CANCER CELL, V14, P123, DOI 10.1016/j.ccr.2008.07.005; Segovia KN, 2008, ANN NEUROL, V63, P520, DOI 10.1002/ana.21359; Silbereis JC, 2010, DIS MODEL MECH, V3, P678, DOI 10.1242/dmm.002915; Watkins TA, 2008, NEURON, V60, P555, DOI 10.1016/j.neuron.2008.09.011; Woodward LJ, 2006, NEW ENGL J MED, V355, P685, DOI 10.1056/NEJMoa053792; Ye F, 2009, NAT NEUROSCI, V12, P829, DOI 10.1038/nn.2333; Zeng YA, 2010, CELL STEM CELL, V6, P568, DOI 10.1016/j.stem.2010.03.020; Zhang Y, 2009, P NATL ACAD SCI USA, V106, P19162, DOI 10.1073/pnas.0902834106	37	254	270	1	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2011	14	8					1009	U99		10.1038/nn.2855	http://dx.doi.org/10.1038/nn.2855			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	797KC	21706018	Green Accepted, Green Submitted			2022-12-17	WOS:000293123700014
J	Grueter, BA; Brasnjo, G; Malenka, RC				Grueter, Brad A.; Brasnjo, Gabor; Malenka, Robert C.			Postsynaptic TRPV1 triggers cell type-specific long-term depression in the nucleus accumbens	NATURE NEUROSCIENCE			English	Article							COCAINE-INDUCED REINSTATEMENT; CENTRAL-NERVOUS-SYSTEM; IN-VIVO EXPOSURE; SYNAPTIC PLASTICITY; BEHAVIORAL SENSITIZATION; RECEPTORS; CHANNELS; ANANDAMIDE; EXPRESSION; ADDICTION	Synaptic modifications in the nucleus accumbens (NAc) are important for adaptive and pathological reward-dependent learning. Medium spiny neurons (MSNs), the major cell type in the NAc, participate in two parallel circuits that subserve distinct behavioral functions, yet little is known about differences in their electrophysiological and synaptic properties. Using bacterial artificial chromosome transgenic mice, we found that synaptic activation of group I metabotropic glutamate receptors in NAc MSNs in the indirect, but not direct, pathway led to the production of endocannabinoids, which activated presynaptic CB1 receptors to trigger endocannabinoid-mediated long-term depression (eCB-LTD) as well as postsynaptic transient receptor potential vanilloid 1 (TRPV1) channels to trigger a form of LTD resulting from endocytosis of AMPA receptors. These results reveal a previously unknown action of TRPV1 channels and indicate that the postsynaptic generation of endocannabinoids can modulate synaptic strength in a cell type-specific fashion by activating distinct pre- and postsynaptic targets.	[Grueter, Brad A.; Brasnjo, Gabor; Malenka, Robert C.] Stanford Univ, Sch Med, Nancy Pritzker Lab, Dept Psychiat & Behav Sci, Palo Alto, CA 94304 USA	Stanford University	Malenka, RC (corresponding author), Stanford Univ, Sch Med, Nancy Pritzker Lab, Dept Psychiat & Behav Sci, Palo Alto, CA 94304 USA.	malenka@stanford.edu		Grueter, Brad/0000-0002-4224-3866	National Institute on Drug Abuse [DA009264, DA008227, 5F32DA023741-2]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA009264, F32DA023741, P01DA008227] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank members of the Malenka lab for their comments. This work was supported by grants from the National Institute on Drug Abuse (DA009264, DA008227 to R.C.M.; 5F32DA023741-2 to B.A.G.).	Brebner K, 2005, SCIENCE, V310, P1340, DOI 10.1126/science.1116894; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Chavez AE, 2010, NAT NEUROSCI, V13, P1511, DOI 10.1038/nn.2684; Conrad KL, 2008, NATURE, V454, P118, DOI 10.1038/nature06995; de Lago E, 2004, BRAIN RES, V1007, P152, DOI 10.1016/j.brainres.2004.02.016; Di Marzo V, 2001, EUR J PHARMACOL, V420, P123, DOI 10.1016/S0014-2999(01)01012-3; Durieux PF, 2009, NAT NEUROSCI, V12, P393, DOI 10.1038/nn.2286; Fourgeaud L, 2004, J NEUROSCI, V24, P6939, DOI 10.1523/JNEUROSCI.0671-04.2004; Gibson HE, 2008, NEURON, V57, P746, DOI 10.1016/j.neuron.2007.12.027; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Grueter BA, 2006, J NEUROSCI, V26, P3210, DOI 10.1523/JNEUROSCI.0170-06.2006; Heifets BD, 2009, ANNU REV PHYSIOL, V71, P283, DOI 10.1146/annurev.physiol.010908.163149; Hikida T, 2010, NEURON, V66, P896, DOI 10.1016/j.neuron.2010.05.011; Hoffman AF, 2003, J NEUROSCI, V23, P4815; Kalivas PW, 2009, NAT REV NEUROSCI, V10, P561, DOI 10.1038/nrn2515; Kasanetz F, 2010, SCIENCE, V328, P1709, DOI 10.1126/science.1187801; Kauer JA, 2007, NAT REV NEUROSCI, V8, P844, DOI 10.1038/nrn2234; Kauer JA, 2009, TRENDS NEUROSCI, V32, P215, DOI 10.1016/j.tins.2008.12.006; Kourrich S, 2007, J NEUROSCI, V27, P7921, DOI 10.1523/JNEUROSCI.1859-07.2007; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Kreitzer AC, 2007, NATURE, V445, P643, DOI 10.1038/nature05506; Kreitzer AC, 2008, NEURON, V60, P543, DOI 10.1016/j.neuron.2008.11.005; Lee J, 2006, NEUROPHARMACOLOGY, V51, P557, DOI 10.1016/j.neuropharm.2006.04.016; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Maccarrone M, 2008, NAT NEUROSCI, V11, P152, DOI 10.1038/nn2042; Maione S, 2009, J PHYSIOL-LONDON, V587, P2521, DOI 10.1113/jphysiol.2009.171900; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Marsch R, 2007, J NEUROSCI, V27, P832, DOI 10.1523/JNEUROSCI.3303-06.2007; Mato S, 2004, NAT NEUROSCI, V7, P585, DOI 10.1038/nn1251; McFarland K, 2001, J NEUROSCI, V21, P8655; Micale V, 2009, NEUROPSYCHOPHARMACOL, V34, P593, DOI 10.1038/npp.2008.98; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Robbe D, 2002, P NATL ACAD SCI USA, V99, P8384, DOI 10.1073/pnas.122149199; Roberts JC, 2004, BRAIN RES, V995, P176, DOI 10.1016/j.brainres.2003.10.001; Schoch S, 2002, NATURE, V415, P321, DOI 10.1038/415321a; Sesack SR, 2010, NEUROPSYCHOPHARMACOL, V35, P27, DOI 10.1038/npp.2009.93; Starowicz K, 2008, CURR PHARM DESIGN, V14, P42; Szumlinski KK, 2006, CURR OPIN NEUROBIOL, V16, P251, DOI 10.1016/j.conb.2006.05.002; Tang XC, 2005, J NEUROSCI, V25, P4512, DOI 10.1523/JNEUROSCI.0685-05.2005; Thomas MJ, 2001, NAT NEUROSCI, V4, P1217, DOI 10.1038/nn757; Torregrossa MM, 2008, NEUROSCI LETT, V438, P142, DOI 10.1016/j.neulet.2008.04.016; Tzavara ET, 2006, BIOL PSYCHIAT, V59, P508, DOI 10.1016/j.biopsych.2005.08.019; van der Stelt M, 2005, EMBO J, V24, P3026, DOI 10.1038/sj.emboj.7600784; Vezina P, 2009, NEUROPHARMACOLOGY, V56, P160, DOI 10.1016/j.neuropharm.2008.06.070; Wettschureck N, 2006, MOL CELL BIOL, V26, P5888, DOI 10.1128/MCB.00397-06; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	46	254	257	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2010	13	12					1519	U107		10.1038/nn.2685	http://dx.doi.org/10.1038/nn.2685			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	684CW	21076424	Green Accepted			2022-12-17	WOS:000284525800017
J	Vilchez, D; Ros, S; Cifuentes, D; Pujadas, L; Valles, J; Garcia-Fojeda, B; Criado-Garcia, O; Fernandez-Sanchez, E; Medrano-Fernandez, I; Dominguez, J; Garcia-Rocha, M; Soriano, E; De Cordoba, SR; Guinovart, JJ				Vilchez, David; Ros, Susana; Cifuentes, Daniel; Pujadas, Lluis; Valles, Jordi; Garcia-Fojeda, Belen; Criado-Garcia, Olga; Fernandez-Sanchez, Elena; Medrano-Fernandez, Iria; Dominguez, Jorge; Garcia-Rocha, Mar; Soriano, Eduardo; De Cordoba, Santiago Rodriguez; Guinovart, Joan J.			Mechanism suppressing glycogen synthesis in neurons and its demise in progressive myoclonus epilepsy	NATURE NEUROSCIENCE			English	Article							LAFORA-DISEASE; PHOSPHORYLATION SITES; CORPORA-AMYLACEA; SYNTHASE; PROTEIN; PHOSPHATASE; GLUCOSE-6-PHOSPHATE; ACTIVATION; MUTATIONS; CELLS	Glycogen synthesis is normally absent in neurons. However, inclusion bodies resembling abnormal glycogen accumulate in several neurological diseases, particularly in progressive myoclonus epilepsy or Lafora disease. We show here that mouse neurons have the enzymatic machinery for synthesizing glycogen, but that it is suppressed by retention of muscle glycogen synthase (MGS) in the phosphorylated, inactive state. This suppression was further ensured by a complex of laforin and malin, which are the two proteins whose mutations cause Lafora disease. The laforin-malin complex caused proteasome-dependent degradation both of the adaptor protein targeting to glycogen, PTG, which brings protein phosphatase 1 to MGS for activation, and of MGS itself. Enforced expression of PTG led to glycogen deposition in neurons and caused apoptosis. Therefore, the malin-laforin complex ensures a blockade of neuronal glycogen synthesis even under intense glycogenic conditions. Here we explain the formation of polyglucosan inclusions in Lafora disease by demonstrating a crucial role for laforin and malin in glycogen synthesis.	Univ Barcelona, E-08028 Barcelona, Spain; Inst Res Biomed, E-08028 Barcelona, Spain; CSIC, Ctr Invest Biol, E-28040 Madrid, Spain	University of Barcelona; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	De Cordoba, SR (corresponding author), Univ Barcelona, Barcelona Sci Pk,Josep Samitier 1-5, E-08028 Barcelona, Spain.	SRdeCordoba@cib.csic.es	Medraño-Fernandez, Iria/AAN-4357-2020; Vilchez, David/A-8446-2008; Pujadas, Lluís/O-7442-2015; de Cordoba, Santiago Rodriguez/K-6727-2014; Ros, Susana/B-6350-2019; García-Fojeda, Belén/G-4214-2015; Soriano, Eduardo/AAB-3216-2019; PUJADAS, LLUÍS/AAE-1595-2020	Medraño-Fernandez, Iria/0000-0002-7956-9915; Vilchez, David/0000-0002-0801-0743; Pujadas, Lluís/0000-0003-3890-8279; de Cordoba, Santiago Rodriguez/0000-0001-6401-1874; García-Fojeda, Belén/0000-0002-9558-3020; Soriano, Eduardo/0000-0002-3204-9285; PUJADAS, LLUÍS/0000-0003-3890-8279; Cifuentes Buira, Daniel/0000-0001-5442-4843; Garcia-Rocha, Mar/0000-0003-2467-2090; Ros, Susana/0000-0002-5451-1880; Criado, Olga/0000-0003-1200-6365; Fernandez Sanchez, Maria Elena/0000-0001-8083-8863				ACHARYA JN, 1995, EPILEPSIA, V36, P429, DOI 10.1111/j.1528-1157.1995.tb00482.x; Allaman I, 2000, GLIA, V30, P382, DOI 10.1002/(SICI)1098-1136(200006)30:4<382::AID-GLIA70>3.0.CO;2-0; Baba O, 1993, Kokubyo Gakkai Zasshi, V60, P264; BECKER TC, 1994, METHOD CELL BIOL, V43, P161; BERKOVIC SF, 1986, NEW ENGL J MED, V315, P296, DOI 10.1056/NEJM198607313150506; BERKOVIC SF, 1993, EPILEPSIA, V34, pS19; Berman HK, 1998, J BIOL CHEM, V273, P26421, DOI 10.1074/jbc.273.41.26421; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown AM, 2004, J NEUROCHEM, V89, P537, DOI 10.1111/j.1471-4159.2004.02421.x; Cavanagh JB, 1999, BRAIN RES REV, V29, P265, DOI 10.1016/S0165-0173(99)00003-X; Chan EM, 2003, NAT GENET, V35, P125, DOI 10.1038/ng1238; CHAN TM, 1976, ANAL BIOCHEM, V71, P96, DOI 10.1016/0003-2697(76)90014-2; Cid E, 2005, FEBS J, V272, P3197, DOI 10.1111/j.1742-4658.2005.04738.x; COLLINS GH, 1968, ARCH PATHOL, V86, P239; Fernandez-Sanchez ME, 2003, HUM MOL GENET, V12, P3161, DOI 10.1093/hmg/ddg340; Ferrer JC, 1997, FEBS LETT, V415, P249, DOI 10.1016/S0014-5793(97)01136-8; Ferrer JC, 2003, FEBS LETT, V546, P127, DOI 10.1016/S0014-5793(03)00565-9; Fong NM, 2000, J BIOL CHEM, V275, P35034, DOI 10.1074/jbc.M005541200; Ganesh S, 2006, J HUM GENET, V51, P1, DOI 10.1007/s10038-005-0321-1; Gentry MS, 2005, P NATL ACAD SCI USA, V102, P8501, DOI 10.1073/pnas.0503285102; Gomis RR, 2002, J BIOL CHEM, V277, P23246, DOI 10.1074/jbc.M111208200; GUINOVART JJ, 1979, FEBS LETT, V106, P284, DOI 10.1016/0014-5793(79)80515-3; Hojlund K, 2003, DIABETES, V52, P1393, DOI 10.2337/diabetes.52.6.1393; KOBAYASHI K, 1990, EPILEPSIA, V31, P194, DOI 10.1111/j.1528-1167.1990.tb06306.x; Lafora GR, 1911, Z GESAMTE NEUROL PSY, V6, P1, DOI 10.1007/BF02863929; Lafora GR, 1911, VIRCHOWS ARCH A, V205, P295, DOI 10.1007/BF01989438; LANG G, 1974, METHOD ENZYMAT AN, V6, P1238; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; MacAulay K, 2003, EUR J BIOCHEM, V270, P3829, DOI 10.1046/j.1432-1033.2003.03777.x; MCGRORY WJ, 1988, VIROLOGY, V163, P614, DOI 10.1016/0042-6822(88)90302-9; Minassian BA, 1998, NAT GENET, V20, P171, DOI 10.1038/2470; Minassian BA, 2000, NEUROLOGY, V55, P341, DOI 10.1212/WNL.55.3.341; Minassian BA, 2001, PEDIATR NEUROL, V25, P21, DOI 10.1016/S0887-8994(00)00276-9; Printen JA, 1997, SCIENCE, V275, P1475, DOI 10.1126/science.275.5305.1475; SAKAI M, 1970, NEUROLOGY, V20, P160, DOI 10.1212/WNL.20.2.160; SCHLAMOWITZ M, 1951, J BIOL CHEM, V190, P519; Seoane J, 1996, J BIOL CHEM, V271, P23756, DOI 10.1074/jbc.271.39.23756; Serratosa JM, 1999, HUM MOL GENET, V8, P345, DOI 10.1093/hmg/8.2.345; Shahwan A, 2005, LANCET NEUROL, V4, P239, DOI 10.1016/S1474-4422(05)70043-0; Simo S, 2007, CEREB CORTEX, V17, P294, DOI 10.1093/cercor/bhj147; SKURAT AV, 1994, J BIOL CHEM, V269, P25534; Skurat AV, 2000, DIABETES, V49, P1096, DOI 10.2337/diabetes.49.7.1096; THOMAS JA, 1968, ANAL BIOCHEM, V25, P486, DOI 10.1016/0003-2697(68)90127-9; VANHEYCOP TH, 1974, CLIN NEUROL, V15, P382; VillarPalasi C, 1997, FASEB J, V11, P544, DOI 10.1096/fasebj.11.7.9212078; Wang JY, 2002, J BIOL CHEM, V277, P2377, DOI 10.1074/jbc.C100686200	46	254	255	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2007	10	11					1407	1413		10.1038/nn1998	http://dx.doi.org/10.1038/nn1998			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	225HT	17952067	Green Submitted			2022-12-17	WOS:000250508400018
J	Okuda, T; Haga, T; Kanai, Y; Endou, H; Ishihara, T; Katsura, I				Okuda, T; Haga, T; Kanai, Y; Endou, H; Ishihara, T; Katsura, I			Identification and characterization of the high-affinity choline transporter	NATURE NEUROSCIENCE			English	Article							VESICULAR ACETYLCHOLINE TRANSPORTER; RAT-BRAIN SYNAPTOSOMES; ALZHEIMERS-DISEASE; H-3 HEMICHOLINIUM-3; GENE; ACETYLTRANSFERASE; EXPRESSION; ELEGANS; BINDING; NEURONS	In cholinergic neurons, high-affinity choline uptake in presynaptic terminals is the rate-limiting step in acetylcholine synthesis. Using information provided by the Caenorhabditis elegans Genome Project, we cloned a cDNA encoding the high-affinity choline transporter from C. elegans (cho-1). We subsequently used this clone to isolate the corresponding cDNA from rat (CHT1). CHT1 is not homologous to neurotransmitter transporters, but is homologous to members of the Na+-dependent glucose transporter family. Expression of CHT1 mRNA is restricted to cholinergic neurons. The characteristics of CHT1-mediated choline uptake essentially match those of high-affinity choline uptake in rat brain synaptosomes.	Univ Tokyo, Fac Med, Dept Neurochem, Bunkyo Ku, Tokyo 1130033, Japan; Japan Sci & Technol Corp, CREST, Bunkyo Ku, Tokyo 1130033, Japan; Kyorin Univ, Sch Med, Dept Pharmacol & Toxicol, Tokyo 1818611, Japan; Japan Sci & Technol Corp, PRESTO, Tokyo 1818611, Japan; Grad Univ Adv Studies, Sch Life Sci, Dept Genet, Mishima, Shizuoka 4118540, Japan; Grad Univ Adv Studies, Natl Inst Genet, Struct Biol Ctr, Mishima, Shizuoka 4118540, Japan	University of Tokyo; Japan Science & Technology Agency (JST); Kyorin University; Japan Science & Technology Agency (JST); Graduate University for Advanced Studies - Japan; Graduate University for Advanced Studies - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Okuda, T (corresponding author), Univ Tokyo, Fac Med, Dept Neurochem, Bunkyo Ku, Tokyo 1130033, Japan.	okuda@m.u-tokyo.ac.jp						ALFONSO A, 1993, SCIENCE, V261, P617, DOI 10.1126/science.8342028; BARKER LA, 1975, J PHARMACOL EXP THER, V192, P86; Beeri R, 1997, J NEUROCHEM, V69, P2441; BEJANIN S, 1994, J BIOL CHEM, V269, P21944; BERRARD S, 1987, P NATL ACAD SCI USA, V84, P9280, DOI 10.1073/pnas.84.24.9280; BIERER LM, 1995, J NEUROCHEM, V64, P749; Bissette G, 1996, ANN NY ACAD SCI, V777, P197, DOI 10.1111/j.1749-6632.1996.tb34419.x; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Cassata G, 1998, GENE, V212, P127, DOI 10.1016/S0378-1119(98)00137-1; DUTAR P, 1995, PHYSIOL REV, V75, P393, DOI 10.1152/physrev.1995.75.2.393; ERICKSON JD, 1994, J BIOL CHEM, V269, P21929; HAGA T, 1971, J NEUROCHEM, V18, P781, DOI 10.1111/j.1471-4159.1971.tb12008.x; HAGA T, 1973, BIOCHIM BIOPHYS ACTA, V291, P564, DOI 10.1016/0005-2736(73)90508-7; HAPPE HK, 1993, J NEUROCHEM, V60, P1191, DOI 10.1111/j.1471-4159.1993.tb03277.x; HEDIGER MA, 1994, PHYSIOL REV, V74, P993, DOI 10.1152/physrev.1994.74.4.993; KANAI Y, 1992, NATURE, V360, P467, DOI 10.1038/360467a0; Kar S, 1998, J NEUROCHEM, V70, P2179; KUHAR MJ, 1978, J NEUROCHEM, V31, P251, DOI 10.1111/j.1471-4159.1978.tb12456.x; KUHAR MJ, 1973, J NEUROCHEM, V20, P581, DOI 10.1111/j.1471-4159.1973.tb12157.x; KUHAR MJ, 1978, J NEUROCHEM, V30, P15, DOI 10.1111/j.1471-4159.1978.tb07029.x; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; MURRIN LC, 1976, MOL PHARMACOL, V12, P1082; Nelson N, 1998, J NEUROCHEM, V71, P1785; NIKAWA J, 1990, J BIOL CHEM, V265, P15996; OH JD, 1992, NEUROSCIENCE, V47, P807, DOI 10.1016/0306-4522(92)90031-V; PASCUAL J, 1991, BRAIN RES, V552, P170, DOI 10.1016/0006-8993(91)90676-M; ROGHANI A, 1994, P NATL ACAD SCI USA, V91, P10620, DOI 10.1073/pnas.91.22.10620; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SANDBERG K, 1985, BRAIN RES, V348, P321, DOI 10.1016/0006-8993(85)90451-2; SCHLOSS P, 1994, BIOCHEM BIOPH RES CO, V198, P637, DOI 10.1006/bbrc.1994.1093; SIMON JR, 1975, NATURE, V255, P162, DOI 10.1038/255162a0; TUCEK S, 1985, J NEUROCHEM, V44, P11, DOI 10.1111/j.1471-4159.1985.tb07106.x; VICKROY TW, 1984, LIFE SCI, V35, P2335, DOI 10.1016/0024-3205(84)90525-3; Vogelsberg V, 1997, J NEUROCHEM, V68, P1062; WINKLER J, 1995, NATURE, V375, P484, DOI 10.1038/375484a0; WURTMAN RJ, 1992, TRENDS NEUROSCI, V15, P117, DOI 10.1016/0166-2236(92)90351-8; YAMAMURA HI, 1972, SCIENCE, V178, P626, DOI 10.1126/science.178.4061.626	37	254	271	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2000	3	2					120	125		10.1038/72059	http://dx.doi.org/10.1038/72059			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292TC	10649566				2022-12-17	WOS:000085810300008
J	Zhao, Z; Sagare, AP; Ma, QG; Halliday, MR; Kong, P; Kisler, K; Winkler, EA; Ramanathan, A; Kanekiyo, T; Bu, G; Owens, NC; Rege, SV; Si, G; Ahuja, A; Zhu, DH; Miller, CA; Schneider, JA; Maeda, M; Maeda, T; Sugawara, T; Ichida, JK; Zlokovic, BV				Zhao, Zhen; Sagare, Abhay P.; Ma, Qingyi; Halliday, Matthew R.; Kong, Pan; Kisler, Kassandra; Winkler, Ethan A.; Ramanathan, Anita; Kanekiyo, Takahisa; Bu, Guojun; Owens, Nelly Chuqui; Rege, Sanket V.; Si, Gabriel; Ahuja, Ashim; Zhu, Donghui; Miller, Carol A.; Schneider, Julie A.; Maeda, Manami; Maeda, Takahiro; Sugawara, Tohru; Ichida, Justin K.; Zlokovic, Berislav V.			Central role for PICALM in amyloid-beta blood-brain barrier transcytosis and clearance	NATURE NEUROSCIENCE			English	Article							GENOME-WIDE ASSOCIATION; ALZHEIMERS-DISEASE; ENDOCYTIC TRAFFICKING; SUSCEPTIBILITY LOCI; IDENTIFIES VARIANTS; IN-VIVO; CLATHRIN; CELLS; PROTEIN; RECEPTOR	PICALM is a highly validated genetic risk factor for Alzheimer's disease (AD). We found that reduced expression of PICALM in AD and murine brain endothelium correlated with amyloid-beta (A beta) pathology and cognitive impairment. Moreover, Picalm deficiency diminished A beta clearance across the murine blood-brain barrier (BBB) and accelerated A beta pathology in a manner that was reversible by endothelial PICALM re-expression. Using human brain endothelial monolayers, we found that PICALM regulated PICALM/clathrin-dependent internalization of A beta bound to the low density lipoprotein receptor related protein-1, a key A beta clearance receptor, and guided A beta trafficking to Rab5 and Rab11, leading to A beta endothelial transcytosis and clearance. PICALM levels and A beta clearance were reduced in AD-derived endothelial monolayers, which was reversible by adenoviral-mediated PICALM transfer. Inducible pluripotent stem cell-derived human endothelial cells carrying the rs3851179 protective allele exhibited higher PICALM levels and enhanced A beta clearance. Thus, PICALM regulates A beta BBB transcytosis and clearance, which has implications for A beta brain homeostasis and clearance therapy.	[Zhao, Zhen; Sagare, Abhay P.; Ma, Qingyi; Halliday, Matthew R.; Kong, Pan; Kisler, Kassandra; Winkler, Ethan A.; Ramanathan, Anita; Owens, Nelly Chuqui; Rege, Sanket V.; Si, Gabriel; Ahuja, Ashim; Zlokovic, Berislav V.] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA; [Zhao, Zhen; Sagare, Abhay P.; Ma, Qingyi; Halliday, Matthew R.; Kong, Pan; Kisler, Kassandra; Winkler, Ethan A.; Ramanathan, Anita; Owens, Nelly Chuqui; Rege, Sanket V.; Si, Gabriel; Ahuja, Ashim; Zlokovic, Berislav V.] Univ So Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA 90033 USA; [Winkler, Ethan A.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA; [Kanekiyo, Takahisa; Bu, Guojun] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Zhu, Donghui] N Carolina Agr & Tech State Univ, Dept Chem Biol & Bioengn, Greensboro, NC 27411 USA; [Miller, Carol A.] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA; [Schneider, Julie A.] Rush Univ, Med Ctr, Alzheimers Dis Ctr, Chicago, IL 60612 USA; [Maeda, Manami; Maeda, Takahiro] City Hope Natl Med Ctr, Div Hematopoiet Stem Cell & Leukemia Res, Beckman Res Inst, Duarte, CA USA; [Maeda, Manami; Maeda, Takahiro] Harvard Univ, Sch Med, Div Hematol, Dept Med,Brigham & Womens Hospital, Boston, MA USA; [Sugawara, Tohru; Ichida, Justin K.] Univ So Calif, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA USA; [Sugawara, Tohru; Ichida, Justin K.] Univ So Calif, Dept Stem Cell Biol & Regenerat Med, Los Angeles, CA USA	University of Southern California; University of Southern California; University of California System; University of California San Francisco; Mayo Clinic; University of North Carolina; North Carolina A&T State University; University of Southern California; Rush University; City of Hope; Beckman Research Institute of City of Hope; Harvard University; Harvard Medical School; University of Southern California; University of Southern California	Zlokovic, BV (corresponding author), Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA.	zlokovic@usc.edu	Ma, Qingyi/AAC-9203-2022; zhao, zhen/A-2080-2012; Zhu, Donghui/H-9058-2017; Sagare, Abhay/Y-3273-2019; Maeda, Takahiro/AAC-4563-2019; Sugawara, Tohru/W-5304-2019	Ma, Qingyi/0000-0002-3499-0992; zhao, zhen/0000-0001-8967-5570; Zhu, Donghui/0000-0002-3057-1889; Sagare, Abhay/0000-0002-8178-3785; Maeda, Takahiro/0000-0003-4530-6460; Kisler, Kassandra/0000-0002-4161-2498	US National Institutes of Health [R37NS34467, R37AG23084, R01AG039452, R01AG035355, R01AG027924, R00NS07743]; Cure for Alzheimer Fund; American Cancer Society [RSG-13-379-01-LIB]; Rainwater Charitable Foundation; Donald E. and Delia B. Baxter Foundation; Daiichi Sankyo Foundation of Life Science; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS074969, R37NS034467, SC2NS082475] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG023084, RF1AG046205, P50AG005142, RF1AG039452, R01AG039452, P50AG016574, R01AG035355, P01AG030128, R01AG046205, R01AG027924] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cure for Alzheimer Fund; American Cancer Society(American Cancer Society); Rainwater Charitable Foundation; Donald E. and Delia B. Baxter Foundation; Daiichi Sankyo Foundation of Life Science; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by US National Institutes of Health grants R37NS34467 (B.V.Z.), R37AG23084 (B.V.Z.), R01AG039452 (B.V.Z.), R01AG035355 (G.B.), R01AG027924 (G.B.) and R00NS07743 (J.K.I.), the Cure for Alzheimer Fund (B.V.Z.), the American Cancer Society (grant RSG-13-379-01-LIB to T.M.), the Rainwater Charitable Foundation (J.K.I.), the Donald E. and Delia B. Baxter Foundation (J.K.I.), and the Daiichi Sankyo Foundation of Life Science (T.S.).	Adams WJ, 2013, STEM CELL REP, V1, P105, DOI 10.1016/j.stemcr.2013.06.007; Ando K, 2013, ACTA NEUROPATHOL, V125, P861, DOI 10.1007/s00401-013-1111-z; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Baig S, 2010, J NEUROPATH EXP NEUR, V69, P1071, DOI 10.1097/NEN.0b013e3181f52e01; Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Bell RD, 2009, NAT CELL BIOL, V11, P143, DOI 10.1038/ncb1819; Bushlin I, 2008, J NEUROSCI, V28, P10257, DOI 10.1523/JNEUROSCI.2471-08.2008; Carrasquillo MM, 2014, NEUROLOGY, V82, P1455, DOI 10.1212/WNL.0000000000000335; Cirrito JR, 2005, J CLIN INVEST, V115, P3285, DOI 10.1172/JCI25247; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Deane R, 2004, NEURON, V43, P333, DOI 10.1016/j.neuron.2004.07.017; Deane R, 2003, NAT MED, V9, P907, DOI 10.1038/nm890; Dreyling MH, 1996, P NATL ACAD SCI USA, V93, P4804, DOI 10.1073/pnas.93.10.4804; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Grimm D, 2008, J VIROL, V82, P5887, DOI 10.1128/JVI.00254-08; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harel A, 2011, NEUROMOL MED, V13, P88, DOI 10.1007/s12017-010-8142-6; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Ishikawa Y, 2015, HAEMATOLOGICA, V100, P442, DOI 10.3324/haematol.2014.119537; Kanatsu K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4386; Kanekiyo T, 2013, J NEUROSCI, V33, P19276, DOI 10.1523/JNEUROSCI.3487-13.2013; Kanekiyo T, 2012, J NEUROSCI, V32, P16458, DOI 10.1523/JNEUROSCI.3987-12.2012; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Lapierre LA, 2012, MOL BIOL CELL, V23, P2302, DOI 10.1091/mbc.E11-08-0681; Li J, 2012, J BIOL CHEM, V287, P44593, DOI 10.1074/jbc.M112.420224; Li YH, 2001, J BIOL CHEM, V276, P18000, DOI 10.1074/jbc.M101589200; Mackic JB, 1998, J CLIN INVEST, V102, P734, DOI 10.1172/JCI2029; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marsh M, 1999, SCIENCE, V285, P215, DOI 10.1126/science.285.5425.215; Miller SE, 2011, CELL, V147, P1118, DOI 10.1016/j.cell.2011.10.038; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Parikh I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091242; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Raj T, 2012, AM J HUM GENET, V90, P720, DOI 10.1016/j.ajhg.2012.02.022; Sagare AP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3932; Shibata M, 2000, J CLIN INVEST, V106, P1489, DOI 10.1172/JCI10498; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Takahashi S, 2012, J CELL SCI, V125, P4049, DOI 10.1242/jcs.102913; Tanzi Rudolph E, 2012, Cold Spring Harb Perspect Med, V2, DOI 10.1101/cshperspect.a006296; Tebar F, 1999, MOL BIOL CELL, V10, P2687, DOI 10.1091/mbc.10.8.2687; Tian Y, 2013, P NATL ACAD SCI USA, V110, P17071, DOI 10.1073/pnas.1315110110; Treusch S, 2011, SCIENCE, V334, P1241, DOI 10.1126/science.1213210; Vecchi M, 2001, J CELL BIOL, V153, P1511, DOI 10.1083/jcb.153.7.1511; Winkler EA, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-32; Wu ZH, 2005, NAT MED, V11, P959, DOI 10.1038/nm1287; Wu ZH, 2003, J NEUROSCI METH, V130, P53, DOI 10.1016/S0165-0270(03)00206-1; Xiao QL, 2012, J BIOL CHEM, V287, P21279, DOI 10.1074/jbc.M111.338376; Xu S, 2011, J CELL SCI, V124, P3503, DOI 10.1242/jcs.088906; Yui N, 2013, AM J PHYSIOL-CELL PH, V304, pC38, DOI 10.1152/ajpcell.00109.2012; Zeigerer A, 2012, NATURE, V485, P465, DOI 10.1038/nature11133; Zhu DH, 2010, BLOOD, V115, P4963, DOI 10.1182/blood-2010-01-262386; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114; ZLOKOVIC BV, 1993, J BIOL CHEM, V268, P8019	57	253	254	2	81	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2015	18	7					978	+		10.1038/nn.4025	http://dx.doi.org/10.1038/nn.4025			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CL3QU	26005850	Green Accepted, Green Submitted			2022-12-17	WOS:000356866200013
J	Jego, S; Glasgow, SD; Herrera, CG; Ekstrand, M; Reed, SJ; Boyce, R; Friedman, J; Burdakov, D; Adamantidis, AR				Jego, Sonia; Glasgow, Stephen D.; Herrera, Carolina Gutierrez; Ekstrand, Mats; Reed, Sean J.; Boyce, Richard; Friedman, Jeffrey; Burdakov, Denis; Adamantidis, Antoine R.			Optogenetic identification of a rapid eye movement sleep modulatory circuit in the hypothalamus	NATURE NEUROSCIENCE			English	Article							MELANIN-CONCENTRATING HORMONE; PARADOXICAL REM SLEEP; STEM GABAERGIC NEURONS; LOCUS-COERULEUS; GLUTAMATERGIC TRANSMISSION; OREXIN NEURONS; WAKING CYCLE; RAT-BRAIN; IN-SITU; MICE	Rapid-eye movement (REM) sleep correlates with neuronal activity in the brainstem, basal forebrain and lateral hypothalamus. Lateral hypothalamus melanin-concentrating hormone (MCH)-expressing neurons are active during sleep, but their effects on REM sleep remain unclear. Using optogenetic tools in newly generated Tg(Pmch-cre) mice, we found that acute activation of MCH neurons (ChETA, SSFO) at the onset of REM sleep extended the duration of REM, but not non-REM, sleep episodes. In contrast, their acute silencing (eNpHR3.0, archaerhodopsin) reduced the frequency and amplitude of hippocampal theta rhythm without affecting REM sleep duration. In vitro activation of MCH neuron terminals induced GABA(A)-mediated inhibitory postsynaptic currents in wake-promoting histaminergic neurons of the tuberomammillary nucleus (TMN), and in vivo activation of MCH neuron terminals in TMN or medial septum also prolonged REM sleep episodes. Collectively, these results suggest that activation of MCH neurons maintains REM sleep, possibly through inhibition of arousal circuits in the mammalian brain.	[Jego, Sonia; Glasgow, Stephen D.; Herrera, Carolina Gutierrez; Reed, Sean J.; Boyce, Richard; Adamantidis, Antoine R.] McGill Univ, Dept Psychiat, Douglas Inst, Montreal, PQ, Canada; [Ekstrand, Mats; Friedman, Jeffrey] Rockefeller Univ, Howard Hughes Med Inst, Mol Genet Lab, New York, NY 10021 USA; [Burdakov, Denis] Natl Inst Med Res, MRC, London NW7 1AA, England; [Burdakov, Denis] Kings Coll London, London WC2R 2LS, England	McGill University; Howard Hughes Medical Institute; Rockefeller University; MRC National Institute for Medical Research; University of London; King's College London	Adamantidis, AR (corresponding author), McGill Univ, Dept Psychiat, Douglas Inst, Montreal, PQ, Canada.	antoine.adamantidis@mcgill.ca		Adamantidis, Antoine/0000-0003-2531-5175; Gutierrez Herrera, Carolina/0000-0002-7916-3341; Burdakov, Denis/0000-0002-9134-9165; Glasgow, Stephen/0000-0002-9809-4812	Fonds de la Recherche du Quebec - Sante; Human Frontier Science Program; Douglas Foundation; McGill University; Canadian Fund for Innovation; Canadian Research Chair (Tier 2); Canadian Institute for Health Research; Natural Science and Engineering Council of Canada; MRC [MC_UP_1202/2] Funding Source: UKRI; Medical Research Council [MC_UP_1202/2] Funding Source: researchfish	Fonds de la Recherche du Quebec - Sante(Fonds de la Recherche en Sante du Quebec); Human Frontier Science Program(Human Frontier Science Program); Douglas Foundation; McGill University; Canadian Fund for Innovation; Canadian Research Chair (Tier 2); Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Natural Science and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank B. Jones, M.E. Carter and L. de Lecea for helpful comments on a previous version of the manuscript. We thank the members of the Adamantidis laboratory for their technical help and comments. Optogenetic plasmids were kindly provided by K. Deisseroth (Stanford University). S.D.G. was supported by the Fonds de la Recherche du Quebec - Sante. D.B. and A.R.A. were supported by the Human Frontier Science Program. A.R.A. was supported by the Douglas Foundation, McGill University, Canadian Fund for Innovation, Canadian Research Chair (Tier 2), Canadian Institute for Health Research and the Natural Science and Engineering Council of Canada.	Adamantidis A, 2005, EUR J NEUROSCI, V21, P2837, DOI 10.1111/j.1460-9568.2005.04100.x; Adamantidis A, 2008, EUR J NEUROSCI, V27, P1793, DOI 10.1111/j.1460-9568.2008.06129.x; ASTONJONES G, 1981, J NEUROSCI, V1, P876; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; BITTENCOURT JC, 1992, J COMP NEUROL, V319, P218, DOI 10.1002/cne.903190204; Boissard R, 2003, EUR J NEUROSCI, V18, P1627, DOI 10.1046/j.1460-9568.2003.02861.x; Burdakov D, 2005, J NEUROSCI, V25, P2429, DOI 10.1523/JNEUROSCI.4925-04.2005; Chee MJS, 2013, J COMP NEUROL, V521, P2208, DOI 10.1002/cne.23273; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Clement O, 2012, J NEUROSCI, V32, P16763, DOI 10.1523/JNEUROSCI.1885-12.2012; del Cid-Pellitero E, 2012, NEUROSCIENCE, V223, P269, DOI 10.1016/j.neuroscience.2012.07.072; Elias CF, 2001, J COMP NEUROL, V432, P1, DOI 10.1002/cne.1085; Fort P, 2008, NEUROSCIENCE, V155, P174, DOI 10.1016/j.neuroscience.2008.05.035; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; Han X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000299; Hanriot L, 2007, J COMP NEUROL, V505, P147, DOI 10.1002/cne.21482; Hassani OK, 2009, P NATL ACAD SCI USA, V106, P2418, DOI 10.1073/pnas.0811400106; HOBSON JA, 1975, SCIENCE, V189, P55, DOI 10.1126/science.1094539; JOUVET M, 1962, Arch Ital Biol, V100, P125; Konadhode RR, 2013, J NEUROSCI, V33, P10257, DOI 10.1523/JNEUROSCI.1225-13.2013; Lagos P, 2011, BRAIN RES, V1369, P112, DOI 10.1016/j.brainres.2010.11.027; Lee MG, 2005, J NEUROSCI, V25, P6716, DOI 10.1523/JNEUROSCI.1887-05.2005; Lu J, 2002, J NEUROSCI, V22, P4568, DOI 10.1523/JNEUROSCI.22-11-04568.2002; Lu J, 2006, NATURE, V441, P589, DOI 10.1038/nature04767; Lu ZH, 2013, PEPTIDES, V44, P32, DOI 10.1016/j.peptides.2013.03.015; Luppi P.-H., 2013, CURR OPIN NEUROBIOL, DOI [10.1016/j.conb.2013.02.006, DOI 10.1016/J.C0NB.2013.02.006]; MCCARLEY RW, 1975, SCIENCE, V189, P58, DOI 10.1126/science.1135627; MCGINTY DJ, 1976, BRAIN RES, V101, P569, DOI 10.1016/0006-8993(76)90480-7; Mileykovskiy BY, 2005, NEURON, V46, P787, DOI 10.1016/j.neuron.2005.04.035; Modirrousta M, 2005, EUR J NEUROSCI, V21, P2807, DOI 10.1111/j.1460-9568.2005.04104.x; Monti JM, 2013, SLEEP MED REV, V17, P293, DOI 10.1016/j.smrv.2012.10.002; Pace-Schott EF, 2002, NAT REV NEUROSCI, V3, P591, DOI 10.1038/nrn895; Pachoud B, 2010, J NEUROPHYSIOL, V104, P1417, DOI 10.1152/jn.01052.2009; Saito Y, 2001, J COMP NEUROL, V435, P26, DOI 10.1002/cne.1191; Saper CB, 2010, NEURON, V68, P1023, DOI 10.1016/j.neuron.2010.11.032; Sapin E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011766; Sapin E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004272; Schone C, 2012, J NEUROSCI, V32, P12437, DOI 10.1523/JNEUROSCI.0706-12.2012; Takahashi K, 2006, J NEUROSCI, V26, P10292, DOI 10.1523/JNEUROSCI.2341-06.2006; Tan CP, 2002, GENOMICS, V79, P785, DOI 10.1006/geno.2002.6771; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; van den Pol AN, 2004, NEURON, V42, P635, DOI 10.1016/S0896-6273(04)00251-X; van den Pol AN, 2012, NEURON, V76, P98, DOI 10.1016/j.neuron.2012.09.014; Verret L, 2006, J COMP NEUROL, V495, P573, DOI 10.1002/cne.20891; Verret L, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-19; Willie JT, 2008, NEUROSCIENCE, V156, P819, DOI 10.1016/j.neuroscience.2008.08.048; Wu M, 2009, P NATL ACAD SCI USA, V106, P17217, DOI 10.1073/pnas.0908200106; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	50	253	260	0	69	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2013	16	11					1637	1643		10.1038/nn.3522	http://dx.doi.org/10.1038/nn.3522			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241YX	24056699	Green Accepted			2022-12-17	WOS:000326205700021
J	Kennedy, DP; Glascher, J; Tyszka, JM; Adolphs, R				Kennedy, Daniel P.; Glaescher, Jan; Tyszka, J. Michael; Adolphs, Ralph			Personal space regulation by the human amygdala	NATURE NEUROSCIENCE			English	Article							ANIMAL GROUPS; MULATTA	The amygdala plays key roles in emotion and social cognition, but how this translates to face-to-face interactions involving real people remains unknown. We found that an individual with complete amygdala lesions lacked any sense of personal space. Furthermore, healthy individuals showed amygdala activation upon close personal proximity. The amygdala may be required to trigger the strong emotional reactions normally following personal space violations, thus regulating interpersonal distance in humans.	[Kennedy, Daniel P.; Glaescher, Jan; Adolphs, Ralph] CALTECH, Div Humanities & Social Sci, Pasadena, CA 91125 USA; [Tyszka, J. Michael; Adolphs, Ralph] CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Kennedy, DP (corresponding author), CALTECH, Div Humanities & Social Sci, Pasadena, CA 91125 USA.	kennedy@caltech.edu	Gläscher, Jan/H-2930-2019; Tyszka, Julian/O-3498-2014	Gläscher, Jan/0000-0002-1020-7115; Tyszka, Julian/0000-0001-9342-9014	US National Institute of Mental Health; Simons Foundation; Della Martin Foundation; Japanese Ministry of Education, Culture, Sports and Technology; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080721] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS019632] Funding Source: NIH RePORTER	US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Simons Foundation; Della Martin Foundation; Japanese Ministry of Education, Culture, Sports and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank C. Holcomb for behavioral data collection, R. Nair and V. Chib for help with the fMRI study, and M. Spezio for discussions. Supported by US National Institute of Mental Health and the Simons Foundation ( R. A.), the Della Martin Foundation ( D. P. K.) and the Tamagawa University global Centers of Excellence program of the Japanese Ministry of Education, Culture, Sports and Technology.	Adolphs R, 1998, NATURE, V393, P470, DOI 10.1038/30982; Buchanan T., 2009, HUMAN AMYGDALA, P289; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Couzin ID, 2002, J THEOR BIOL, V218, P1, DOI 10.1006/jtbi.2002.3065; Emery NJ, 2001, BEHAV NEUROSCI, V115, P515, DOI 10.1037/0735-7044.115.3.515; Hall E. T., 1966, HIDDEN DIMENSION, V609; HAYDUK LA, 1978, PSYCHOL BULL, V85, P117, DOI 10.1037/0033-2909.85.1.117; HAYDUK LA, 1983, PSYCHOL BULL, V94, P293, DOI 10.1037/0033-2909.94.2.293; Kluaver H., 1937, AM J PHYSIOL, V119, P352; Mason WA, 2006, EMOTION, V6, P73, DOI 10.1037/1528-3542.6.1.73; Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463	11	253	256	0	75	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2009	12	10					1226	1227		10.1038/nn.2381	http://dx.doi.org/10.1038/nn.2381			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	498US	19718035	Green Accepted, Green Submitted			2022-12-17	WOS:000270170200010
J	Lin, DT; Makino, Y; Sharma, K; Hayashi, T; Neve, R; Takamiya, K; Huganir, RL				Lin, Da-Ting; Makino, Yuichi; Sharma, Kamal; Hayashi, Takashi; Neve, Rachael; Takamiya, Kogo; Huganir, Richard L.			Regulation of AMPA receptor extrasynaptic insertion by 4.1N, phosphorylation and palmitoylation	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; DOMAIN-CONTAINING PROTEINS; SYNAPTIC PLASTICITY; GLUTAMATE RECEPTORS; SURFACE TRAFFICKING; LATERAL MOVEMENTS; SUBUNIT GLUR2; SYNAPSES; TRANSMISSION; LTP	The insertion of AMPA receptors (AMPARs) into the plasma membrane is an important step in the synaptic delivery of AMPARs during the expression of synaptic plasticity. However, the molecular mechanisms regulating AMPAR insertion remain elusive. By directly visualizing individual insertion events of the AMPAR subunit GluR1 in rodents, we found that the protein 4.1N was required for activity-dependent GluR1 insertion. Protein kinase C (PKC) phosphorylation of the serine 816 (S816) and S818 residues of GluR1 enhanced 4.1N binding to GluR1 and facilitated GluR1 insertion. In addition, palmitoylation of GluR1 C811 residue modulated PKC phosphorylation and GluR1 insertion. Finally, disrupting 4.1N-dependent GluR1 insertion decreased surface expression of GluR1 and the expression of long-term potentiation. Our study uncovers a previously unknown mechanism that governs activity-dependent GluR1 trafficking, reveals an interaction between AMPAR palmitoylation and phosphorylation, and underscores the functional importance of 4.1N in AMPAR trafficking and synaptic plasticity.	[Lin, Da-Ting; Makino, Yuichi; Sharma, Kamal; Hayashi, Takashi; Takamiya, Kogo; Huganir, Richard L.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Lin, Da-Ting; Makino, Yuichi; Sharma, Kamal; Hayashi, Takashi; Takamiya, Kogo; Huganir, Richard L.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Neve, Rachael] MIT, Picower Inst, Cambridge, MA 02139 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Massachusetts Institute of Technology (MIT)	Huganir, RL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.	rhuganir@jhmi.edu	Lin, Da-Ting/D-1699-2018	Lin, Da-Ting/0000-0003-0538-7892; Takamiya, Kogo/0000-0001-7240-6307; Hayashi, Takashi/0000-0003-3591-2109	US National Institutes of Health [R01NS036715]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036715] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank M. Dai in the Monoclonal Antibody Core Facility of the Johns Hopkins University School of Medicine Department of Neuroscience for generating the monoclonal antibody to GluR1 N terminus, M. Coulter, R. Johnson and Y. Yu for their outstanding technical assistance and B. Bowman and R. M. E. Chalmers- Redman from the Carl Zeiss Micro- Imaging Group for their excellent technical support. This work is funded by US National Institutes of Health grant R01NS036715 and by the Howard Hughes Medical Institute.	Ashby MC, 2004, J NEUROSCI, V24, P5172, DOI 10.1523/JNEUROSCI.1042-04.2004; Ashby MC, 2006, J NEUROSCI, V26, P7046, DOI 10.1523/JNEUROSCI.1235-06.2006; Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030; Boehm J, 2006, NEURON, V51, P213, DOI 10.1016/j.neuron.2006.06.013; Borgdorff AJ, 2002, NATURE, V417, P649, DOI 10.1038/nature00780; Chen K, 2005, J NEUROSCI, V25, P6667, DOI 10.1523/JNEUROSCI.1527-05.2005; Chung HJ, 2000, J NEUROSCI, V20, P7258; Chung HJ, 2003, SCIENCE, V300, P1751, DOI 10.1126/science.1082915; Coleman SK, 2003, J NEUROSCI, V23, P798; DeSouza S, 2002, J NEUROSCI, V22, P3493; Diakowski W, 2006, FOLIA HISTOCHEM CYTO, V44, P231; Dingledine R, 1999, PHARMACOL REV, V51, P7; Ehlers MD, 2007, NEURON, V54, P447, DOI 10.1016/j.neuron.2007.04.010; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; Gardner SM, 2005, NEURON, V45, P903, DOI 10.1016/j.neuron.2005.02.026; Groc L, 2004, NAT NEUROSCI, V7, P695, DOI 10.1038/nn1270; Groc L, 2008, NAT NEUROSCI, V11, P868, DOI 10.1038/nn.2150; Hayashi T, 2005, NEURON, V47, P709, DOI 10.1016/j.neuron.2005.06.035; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Heine M, 2008, SCIENCE, V320, P201, DOI 10.1126/science.1152089; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Hoover KB, 2000, CURR OPIN CELL BIOL, V12, P229, DOI 10.1016/S0955-0674(99)00080-0; Huang K, 2005, CURR OPIN NEUROBIOL, V15, P527, DOI 10.1016/j.conb.2005.08.001; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; Kim CH, 1999, J NEUROSCI, V19, P4314; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; Krucker T, 2000, P NATL ACAD SCI USA, V97, P6856, DOI 10.1073/pnas.100139797; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Lin DT, 2007, J NEUROSCI, V27, P13903, DOI 10.1523/JNEUROSCI.1750-07.2007; Liu SQJ, 2005, NAT NEUROSCI, V8, P768, DOI 10.1038/nn1468; Man HY, 2007, P NATL ACAD SCI USA, V104, P3579, DOI 10.1073/pnas.0611698104; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Moffett S, 1996, J BIOL CHEM, V271, P21490, DOI 10.1074/jbc.271.35.21490; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Rathenberg J, 2004, MOL CELL NEUROSCI, V26, P251, DOI 10.1016/j.mcn.2004.01.012; Sekine-Aizawa Y, 2004, P NATL ACAD SCI USA, V101, P17114, DOI 10.1073/pnas.0407563101; Shen L, 2000, J NEUROSCI, V20, P7932; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Steinberg JP, 2006, NEURON, V49, P845, DOI 10.1016/j.neuron.2006.02.025; Tardin C, 2003, EMBO J, V22, P4656, DOI 10.1093/emboj/cdg463; Thomas GM, 2008, EMBO J, V27, P361, DOI 10.1038/sj.emboj.7601969; Walensky LD, 1999, J NEUROSCI, V19, P6457; Washbourne P, 2004, NEURON, V44, P901, DOI 10.1016/S0896-6273(04)00799-8; Wozny C, 2009, J CELL SCI, V122, P735, DOI 10.1242/jcs.037382; Xia J, 2000, NEURON, V28, P499, DOI 10.1016/S0896-6273(00)00128-8; Yudowski GA, 2007, J NEUROSCI, V27, P11112, DOI 10.1523/JNEUROSCI.2465-07.2007; Zhou Q, 2001, P NATL ACAD SCI USA, V98, P1261, DOI 10.1073/pnas.031573798	50	253	259	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2009	12	7					879	U95		10.1038/nn.2351	http://dx.doi.org/10.1038/nn.2351			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	462OA	19503082	Green Submitted, Green Accepted			2022-12-17	WOS:000267362900015
J	Pascual, A; Hidalgo-Figueroa, M; Piruat, JI; Pintado, CO; Gomez-Diaz, R; Lopez-Barneo, J				Pascual, Alberto; Hidalgo-Figueroa, Maria; Piruat, Jose I.; Pintado, C. Oscar; Gomez-Diaz, Raquel; Lopez-Barneo, Jose			Absolute requirement of GDNF for adult catecholaminergic neuron survival	NATURE NEUROSCIENCE			English	Article							NEUROTROPHIC FACTOR; DOPAMINERGIC-NEURONS; SUBCOMMISSURAL ORGAN; FUNCTIONAL RECOVERY; PARKINSON-DISEASE; SUBSTANTIA-NIGRA; LOCUS-COERULEUS; MOUSE MODEL; MICE; DEGENERATION	GDNF is a potent neurotrophic factor that protects catecholaminergic neurons from toxic damage and induces fiber outgrowth. However, the actual role of endogenous GDNF in the normal adult brain is unknown, even though GDNF-based therapies are considered promising for neurodegenerative disorders. We have generated a conditional GDNF-null mouse to suppress GDNF expression in adulthood, hence avoiding the developmental compensatory modifications masking its true physiologic action. After Gdnf ablation, mice showed a progressive hypokinesia and a selective decrease of brain tyrosine hydroxylase (Th) mRNA, accompanied by pronounced catecholaminergic cell death, affecting most notably the locus coeruleus, which practically disappears; the substantia nigra; and the ventral tegmental area. These data unequivocally demonstrate that GDNF is indispensable for adult catecholaminergic neuron survival and also show that, under physiologic conditions, downregulation of a single trophic factor can produce massive neuronal death.	[Pascual, Alberto; Hidalgo-Figueroa, Maria; Piruat, Jose I.; Pintado, C. Oscar; Gomez-Diaz, Raquel; Lopez-Barneo, Jose] Univ Seville, Hosp Univ Virgen Rocio, Inst Biomed Sevilla, Consejo Super Invest Cient, Seville 41013, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital	Lopez-Barneo, J (corresponding author), Univ Seville, Hosp Univ Virgen Rocio, Inst Biomed Sevilla, Consejo Super Invest Cient, Ave Manuel Siurot S-N, Seville 41013, Spain.	lbarneo@us.es	Gómez-Díaz, Raquel/D-9886-2013; IBIS, NEUROBIOLOGIA/O-9922-2015; Pascual, Alberto/L-2014-2019; Pintado, Carmelo Oscar/M-2219-2018; Pascual, Alberto P/E-9609-2015; Hidalgo-Figueroa, Maria/AAA-9529-2019; IBIS, NEURONAL/O-9910-2015	Gómez-Díaz, Raquel/0000-0002-1423-1315; Pascual, Alberto/0000-0001-5459-6207; Pascual, Alberto P/0000-0001-5459-6207; Hidalgo-Figueroa, Maria/0000-0001-5241-0931; 				Akerud P, 2001, J NEUROSCI, V21, P8108, DOI 10.1523/JNEUROSCI.21-20-08108.2001; Arenas E, 1995, NEURON, V15, P1465, DOI 10.1016/0896-6273(95)90024-1; Arjona V, 2003, NEUROSURGERY, V53, P321, DOI 10.1227/01.NEU.0000073315.88827.72; BJORKLUND A, 1984, HDB CHEM NEUROANAT 1, P123; Boger HA, 2006, EXP NEUROL, V202, P336, DOI 10.1016/j.expneurol.2006.06.006; Boger HA, 2007, J NEUROSCI, V27, P8816, DOI 10.1523/JNEUROSCI.1067-07.2007; Chao CC, 2003, NEUROBIOL AGING, V24, P105, DOI 10.1016/S0197-4580(02)00047-7; Check E, 2007, NAT MED, V13, P770, DOI 10.1038/nm0707-770; ChoiLundberg DL, 1997, SCIENCE, V275, P838, DOI 10.1126/science.275.5301.838; Espejo EF, 1998, NEURON, V20, P197, DOI 10.1016/S0896-6273(00)80449-3; Fleming SM, 2004, J NEUROSCI, V24, P9434, DOI 10.1523/JNEUROSCI.3080-04.2004; Franklin BJ, 1996, MOUSE BRAIN STEREOTA; Galarza M, 2002, NEUROSURG REV, V25, P205, DOI 10.1007/s10143-002-0208-y; Gash DM, 1996, NATURE, V380, P252, DOI 10.1038/380252a0; Gill SS, 2003, NAT MED, V9, P589, DOI 10.1038/nm850; Granholm AC, 2000, J NEUROSCI, V20, P3182, DOI 10.1523/JNEUROSCI.20-09-03182.2000; Guo CY, 2002, GENESIS, V32, P8, DOI 10.1002/gene.10021; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Jain S, 2006, J NEUROSCI, V26, P11230, DOI 10.1523/JNEUROSCI.1876-06.2006; Kirik D, 2004, NAT NEUROSCI, V7, P105, DOI 10.1038/nn1175; Kordower JH, 2000, SCIENCE, V290, P767, DOI 10.1126/science.290.5492.767; Kramer ER, 2007, PLOS BIOL, V5, P616, DOI 10.1371/journal.pbio.0050039; Lang AE, 2006, ANN NEUROL, V59, P459, DOI 10.1002/ana.20737; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; LINDVALL O, 1978, CELL TISSUE RES, V190, P383; MATZUK MM, 1985, ANN NEUROL, V18, P552, DOI 10.1002/ana.410180507; Mejias R, 2006, J NEUROSCI, V26, P4500, DOI 10.1523/JNEUROSCI.0122-06.2006; Meredith GE, 2006, MOVEMENT DISORD, V21, P1595, DOI 10.1002/mds.21010; Minguez-Castellanos A, 2007, J NEUROL NEUROSUR PS, V78, P825, DOI 10.1136/jnnp.2006.106021; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; Paratcha G, 2003, CELL, V113, P867, DOI 10.1016/S0092-8674(03)00435-5; Pichel JG, 1996, NATURE, V382, P73, DOI 10.1038/382073a0; Rosenblad C, 1998, NEUROSCIENCE, V82, P129; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; Sedelis M, 2001, BEHAV BRAIN RES, V125, P109, DOI 10.1016/S0166-4328(01)00309-6; Slevin JT, 2005, J NEUROSURG, V102, P216, DOI 10.3171/jns.2005.102.2.0216; Srinivasan J, 2003, EUR J NEUROSCI, V17, P2586, DOI 10.1046/j.1460-9568.2003.02684.x; Toledo-Aral JJ, 2003, J NEUROSCI, V23, P141; TOMAC A, 1995, NATURE, V373, P335, DOI 10.1038/373335a0; Tome M, 2004, CELL TISSUE RES, V317, P65, DOI 10.1007/s00441-004-0900-z; Trupp M, 1997, J NEUROSCI, V17, P3554; Villadiego J, 2005, J NEUROSCI, V25, P4091, DOI 10.1523/JNEUROSCI.4312-04.2005; Zarow C, 2003, ARCH NEUROL-CHICAGO, V60, P337, DOI 10.1001/archneur.60.3.337; Zhou QY, 1995, CELL, V83, P1197, DOI 10.1016/0092-8674(95)90145-0	44	253	259	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2008	11	7					755	761		10.1038/nn.2136	http://dx.doi.org/10.1038/nn.2136			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	318KD	18536709	Green Submitted			2022-12-17	WOS:000257089400012
J	Adams, WJ; Graf, EW; Ernst, MO				Adams, WJ; Graf, EW; Ernst, MO			Experience can change the 'light-from-above' prior	NATURE NEUROSCIENCE			English	Article								To interpret complex and ambiguous input, the human visual system uses prior knowledge or assumptions about the world. We show that the `light-from-above' prior, used to extract information about shape from shading is modified in response to active experience with the scene. The resultant adaptation is not specific to the learned scene but generalizes to a different task, demonstrating that priors are constantly adapted by interactive experience with the environment.	Univ Southampton, Dept Psychol, Southampton SO17 1BJ, Hants, England; Max Planck Inst Biol Cybernet, Tubingen, Germany	University of Southampton; Max Planck Society	Adams, WJ (corresponding author), Univ Southampton, Dept Psychol, Southampton SO17 1BJ, Hants, England.	w.adams@soton.ac.uk		Graf, Erich/0000-0002-3162-4233; Ernst, Marc/0000-0003-4197-8569				ADELSON EH, 1993, SCIENCE, V262, P2042, DOI 10.1126/science.8266102; Brewster D., 1826, EDINBURGH J SCI, V4, P99; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; HERSHBERGER W, 1970, J COMP PHYSIOL PSYCH, V73, P407, DOI 10.1037/h0030223; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; Kersten D, 2004, ANNU REV PSYCHOL, V55, P271, DOI 10.1146/annurev.psych.55.090902.142005; Langer MS, 2001, PERCEPTION, V30, P403, DOI 10.1068/p3178; Sun J, 1998, NAT NEUROSCI, V1, P183, DOI 10.1038/630; van Ee R, 2003, J OPT SOC AM A, V20, P1398, DOI 10.1364/JOSAA.20.001398; Weiss Y, 2002, NAT NEUROSCI, V5, P598, DOI 10.1038/nn858	10	253	255	1	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2004	7	10					1057	1058		10.1038/nn1312	http://dx.doi.org/10.1038/nn1312			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	857YQ	15361877				2022-12-17	WOS:000224156900014
J	Reddy, GD; Kelleher, K; Fink, R; Saggau, P				Reddy, Gaddum Duemani; Kelleher, Keith; Fink, Rudy; Saggau, Peter			Three-dimensional random access multiphoton microscopy for functional imaging of neuronal activity	NATURE NEUROSCIENCE			English	Article							FLUORESCENCE MICROSCOPY; HIGH-SPEED; 2-PHOTON EXCITATION; TEMPORAL DISPERSION; OBLIQUE DENDRITES; CA2+ SIGNALS; SPINES; COMPENSATION; DEPTH; DYNAMICS	The dynamic ability of neuronal dendrites to shape and integrate synaptic responses is the hallmark of information processing in the brain. Effectively studying this phenomenon requires concurrent measurements at multiple sites on live neurons. Substantial progress has been made by optical imaging systems that combine confocal and multiphoton microscopy with inertia-free laser scanning. However, all of the systems developed so far restrict fast imaging to two dimensions. This severely limits the extent to which neurons can be studied, as they represent complex three-dimensional structures. Here we present a new imaging system that utilizes a unique arrangement of acousto-optic deflectors to steer a focused, ultra-fast laser beam to arbitrary locations in three-dimensional space without moving the objective lens. As we demonstrate, this highly versatile random-access multiphoton microscope supports functional imaging of complex three-dimensional cellular structures such as neuronal dendrites or neural populations at acquisition rates on the order of tens of kilohertz.	[Reddy, Gaddum Duemani; Saggau, Peter] Rice Univ, Dept Bioengn, Houston, TX 77005 USA; [Reddy, Gaddum Duemani; Fink, Rudy; Saggau, Peter] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Kelleher, Keith] Univ Houston, Dept Biol & Biochem, Houston, TX 77004 USA	Rice University; Baylor College of Medicine; University of Houston System; University of Houston	Saggau, P (corresponding author), Rice Univ, Dept Bioengn, 6100 Main St,Suite 116 Keck Hall, Houston, TX 77005 USA.	psaggau@bcm.edu			NIA NIH HHS [R01 AG027577-02, R01 AG027577-03, R01 AG027577-01] Funding Source: Medline; NIBIB NIH HHS [R01 EB001048-01, R01 EB001048-03, T32 EB006350-02, T32 EB006350-01A1, R01 EB001048-02] Funding Source: Medline; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB006350, R01EB001048] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027577] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ambros-Ingerson J, 2005, HIPPOCAMPUS, V15, P302, DOI 10.1002/hipo.20051; Babin AA, 2002, QUANTUM ELECTRON+, V32, P308, DOI 10.1070/QE200203204ABEH002189; Bansal V, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2209562; Bullen A, 1997, BIOPHYS J, V73, P477, DOI 10.1016/S0006-3495(97)78086-X; Bullen A, 1999, BIOPHYS J, V76, P2272, DOI 10.1016/S0006-3495(99)77383-2; CHANG IC, 1994, ELECTRON LETT, V30, P1190, DOI 10.1049/el:19940787; Dufour P, 2006, APPL OPTICS, V45, P9246, DOI 10.1364/AO.45.009246; Durst ME, 2006, OPT EXPRESS, V14, P12243, DOI 10.1364/OE.14.012243; Escobar I, 2006, J OPT SOC AM A, V23, P3150, DOI 10.1364/JOSAA.23.003150; Frick A, 2003, J NEUROSCI, V23, P3243; Gobel W, 2007, NAT METHODS, V4, P73, DOI 10.1038/NMETH989; GOTTLIEB M, 1983, ELECTROOPITIC ACOUST; Helmchen F, 1999, NAT NEUROSCI, V2, P989, DOI 10.1038/14788; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Hoogland TM, 2004, J NEUROSCI, V24, P8416, DOI 10.1523/JNEUROSCI.1677-04.2004; Hopt A, 2001, BIOPHYS J, V80, P2029, DOI 10.1016/S0006-3495(01)76173-5; Iyer V, 2006, J NEUROPHYSIOL, V95, P535, DOI 10.1152/jn.00865.2005; Iyer V, 2003, J BIOMED OPT, V8, P460, DOI 10.1117/1.1580827; Kam Z., 1997, Bioimaging, V5, P40, DOI 10.1002/1361-6374(199703)5:1<40::AID-BIO4>3.3.CO;2-N; Kaplan A, 2001, OPT LETT, V26, P1078, DOI 10.1364/OL.26.001078; Koester HJ, 1999, BIOPHYS J, V77, P2226, DOI 10.1016/S0006-3495(99)77063-3; Kovalchuk Y, 2000, J NEUROSCI, V20, P1791; Lechleiter JD, 2002, BIOPHYS J, V83, P2292, DOI 10.1016/S0006-3495(02)73989-1; Losonczy A, 2006, NEURON, V50, P291, DOI 10.1016/j.neuron.2006.03.016; Lv XH, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2190047; Mainen ZF, 1999, METHODS, V18, P231, DOI 10.1006/meth.1999.0776; MARKRAM H, 1995, J PHYSIOL-LONDON, V485, P1; McConnell G, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2360593; Megias M, 2001, NEUROSCIENCE, V102, P527, DOI 10.1016/S0306-4522(00)00496-6; Mogilevtsev D, 1998, OPT LETT, V23, P1662, DOI 10.1364/OL.23.001662; Oku H, 2004, OPT EXPRESS, V12, P2138, DOI 10.1364/OPEX.12.002138; Oron D, 2005, OPT EXPRESS, V13, P1468, DOI 10.1364/OPEX.13.001468; Reddy GD, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2141504; Sabatini BL, 2000, NATURE, V408, P589, DOI 10.1038/35046076; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Saggau P, 2006, CURR OPIN NEUROBIOL, V16, P543, DOI 10.1016/j.conb.2006.08.011; Salome R, 2006, J NEUROSCI METH, V154, P161, DOI 10.1016/j.jneumeth.2005.12.010; SHEPPARD CJR, 1991, APPL OPTICS, V30, P3563, DOI 10.1364/AO.30.003563; Shoham S, 2005, NAT METHODS, V2, P837, DOI 10.1038/nmeth793; Siegman A. E., 1986, LASERS; TREACY EB, 1969, IEEE J QUANTUM ELECT, VQE 5, P454, DOI 10.1109/JQE.1969.1076303; Vucinic D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000699; Xu J., 1992, ACOUSTO OPTIC DEVICE; Xu JP, 1996, P SOC PHOTO-OPT INS, V2754, P104, DOI 10.1117/12.243118; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; Yuste R, 1999, J NEUROSCI, V19, P1976; Zeng SQ, 2006, OPT LETT, V31, P1091, DOI 10.1364/OL.31.001091; Zhu LJ, 1999, APPL OPTICS, V38, P5350, DOI 10.1364/AO.38.005350	48	252	260	4	63	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2008	11	6					713	720		10.1038/nn.2116	http://dx.doi.org/10.1038/nn.2116			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	304UD	18432198	Green Accepted			2022-12-17	WOS:000256133700018
J	Petkov, CI; Kayser, C; Steudel, T; Whittingstall, K; Augath, M; Logothetis, NK				Petkov, Christopher I.; Kayser, Christoph; Steudel, Thomas; Whittingstall, Kevin; Augath, Mark; Logothetis, Nikos K.			A voice region in the monkey brain	NATURE NEUROSCIENCE			English	Article							HUMAN AUDITORY-CORTEX; RHESUS-MONKEY; TEMPORAL-LOBE; INFEROTEMPORAL CORTEX; MACACA-MULATTA; MACAQUE; FACE; VOCALIZATIONS; ADAPTATION; PRIMATES	For vocal animals, recognizing species-specific vocalizations is important for survival and social interactions. In humans, a voice region has been identified that is sensitive to human voices and vocalizations. As this region also strongly responds to speech, it is unclear whether it is tightly associated with linguistic processing and is thus unique to humans. Using functional magnetic resonance imaging of macaque monkeys (Old World primates, Macaca mulatta) we discovered a high-level auditory region that prefers species-specific vocalizations over other vocalizations and sounds. This region not only showed sensitivity to the 'voice' of the species, but also to the vocal identify of conspecific individuals. The monkey voice region is located on the superior-temporal plane and belongs to an anterior auditory 'what' pathway. These results establish functional relationships with the human voice region and support the notion that, for different primate species, the anterior temporal regions of the brain are adapted for recognizing communication signals from conspecifics.	[Petkov, Christopher I.; Kayser, Christoph; Steudel, Thomas; Whittingstall, Kevin; Augath, Mark; Logothetis, Nikos K.] Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany; [Logothetis, Nikos K.] Univ Manchester, Imaging Sci & Biomed Engn, Manchester N13 9PT, Lancs, England	Max Planck Society; University of Manchester	Petkov, CI (corresponding author), Max Planck Inst Biol Cybernet, Spemannstr 38, D-72076 Tubingen, Germany.		Kayser, Christoph/A-3203-2012; Petkov, Christopher/O-5318-2015; Logothetis, Nikos/U-9282-2019	Kayser, Christoph/0000-0001-7362-5704; Petkov, Christopher/0000-0002-4932-7907; 				Alain C, 2001, P NATL ACAD SCI USA, V98, P12301, DOI 10.1073/pnas.211209098; Altmann CF, 2007, CEREB CORTEX, V17, P2601, DOI 10.1093/cercor/bhl167; Belin P, 2003, NEUROREPORT, V14, P2105, DOI 10.1097/00001756-200311140-00019; Belin P, 2002, COGNITIVE BRAIN RES, V13, P17, DOI 10.1016/S0926-6410(01)00084-2; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; Belin P, 2006, PHILOS T R SOC B, V361, P2091, DOI 10.1098/rstb.2006.1933; Fecteau S, 2004, NEUROIMAGE, V23, P840, DOI 10.1016/j.neuroimage.2004.09.019; Formisano E, 2003, NEURON, V40, P859, DOI 10.1016/S0896-6273(03)00669-X; Fullerton BC, 2007, J COMP NEUROL, V504, P470, DOI 10.1002/cne.21432; Ghazanfar AA, 2005, J NEUROSCI, V25, P5004, DOI 10.1523/JNEUROSCI.0799-05.2005; Ghazanfar AA, 2007, CURR BIOL, V17, P425, DOI 10.1016/j.cub.2007.01.029; Ghazanfar AA, 2006, CURR BIOL, V16, pR879, DOI 10.1016/j.cub.2006.09.026; Gil-Da-Costa R, 2004, P NATL ACAD SCI USA, V101, P17516, DOI 10.1073/pnas.0408077101; Gil-Da-Costa R, 2006, NAT NEUROSCI, V9, P1064, DOI 10.1038/nn1741; Grill-Spector K, 2001, ACTA PSYCHOL, V107, P293, DOI 10.1016/S0001-6918(01)00019-1; Hackett TA, 1998, J COMP NEUROL, V394, P475, DOI 10.1002/(SICI)1096-9861(19980518)394:4<475::AID-CNE6>3.0.CO;2-Z; Hackett TA, 2001, J COMP NEUROL, V441, P197, DOI 10.1002/cne.1407; HAUSER MD, 1993, BEHAV ECOL, V4, P194, DOI 10.1093/beheco/4.3.194; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; Kaas JH, 2000, P NATL ACAD SCI USA, V97, P11793, DOI 10.1073/pnas.97.22.11793; Kaas JH, 1999, NAT NEUROSCI, V2, P1045, DOI 10.1038/15967; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kayser C, 2005, NEURON, V48, P373, DOI 10.1016/j.neuron.2005.09.018; Kayser C, 2007, J NEUROSCI, V27, P1824, DOI 10.1523/JNEUROSCI.4737-06.2007; Leopold DA, 2006, NATURE, V442, P572, DOI 10.1038/nature04951; MASATAKA N, 1985, DEV PSYCHOBIOL, V18, P107, DOI 10.1002/dev.420180203; Mullette-Gillman OA, 2005, J NEUROPHYSIOL, V94, P2331, DOI 10.1152/jn.00021.2005; Obleser J, 2006, HUM BRAIN MAPP, V27, P562, DOI 10.1002/hbm.20201; PANDYA DN, 1973, Z ANAT ENTWICKLUNGS, V139, P127, DOI 10.1007/BF00523634; Petkov CI, 2006, PLOS BIOL, V4, P1213, DOI 10.1371/journal.pbio.0040215; Poremba A, 2004, NATURE, V427, P448, DOI 10.1038/nature02268; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; Rauschecker JP, 1998, AUDIOL NEURO-OTOL, V3, P86, DOI 10.1159/000013784; RAUSCHECKER JP, 1995, SCIENCE, V268, P111, DOI 10.1126/science.7701330; Rendall D, 1998, J ACOUST SOC AM, V103, P602, DOI 10.1121/1.421104; Romanski LM, 1999, NAT NEUROSCI, V2, P1131, DOI 10.1038/16056; Schroeder CE, 2005, CURR OPIN NEUROBIOL, V15, P454, DOI 10.1016/j.conb.2005.06.008; Scott SK, 2000, BRAIN, V123, P2400, DOI 10.1093/brain/123.12.2400; Sereno MI, 2005, CURR OPIN NEUROBIOL, V15, P135, DOI 10.1016/j.conb.2005.03.014; SERGENT J, 1992, BRAIN, V115, P15, DOI 10.1093/brain/115.1.15; SUGA N, 1987, J NEUROPHYSIOL, V58, P643, DOI 10.1152/jn.1987.58.4.643; TANAKA K, 1991, J NEUROPHYSIOL, V66, P170, DOI 10.1152/jn.1991.66.1.170; Tian B, 2001, SCIENCE, V292, P290, DOI 10.1126/science.1058911; Tsao DY, 2006, SCIENCE, V311, P670, DOI 10.1126/science.1119983; Uppenkamp S, 2006, NEUROIMAGE, V31, P1284, DOI 10.1016/j.neuroimage.2006.01.004; Van Lancker D R, 1982, Brain Cogn, V1, P185, DOI 10.1016/0278-2626(82)90016-1; VANLANCKER DR, 1988, CORTEX, V24, P195, DOI 10.1016/S0010-9452(88)80029-7; Wang XQ, 2001, J NEUROPHYSIOL, V86, P2616, DOI 10.1152/jn.2001.86.5.2616; Wessinger CM, 2001, J COGNITIVE NEUROSCI, V13, P1, DOI 10.1162/089892901564108; WINTER P, 1973, EXP BRAIN RES, V18, P489	50	252	258	0	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2008	11	3					367	374		10.1038/nn2043	http://dx.doi.org/10.1038/nn2043			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	267ZS	18264095				2022-12-17	WOS:000253548300021
J	Li, Z; Van Aelst, L; Cline, HT				Li, Z; Van Aelst, L; Cline, HT			Rho GTPases regulate distinct aspects of dendritic arbor growth in Xenopus central neurons in vivo	NATURE NEUROSCIENCE			English	Article							IN-VIVO; CEREBRAL-CORTEX; AXON GUIDANCE; RAC; KINASE; FAMILY; PHOSPHORYLATION; SYNAPTOGENESIS; FILOPODIA; DYNAMICS	The development and structural plasticity of dendritic arbors are governed by several factors, including synaptic activity, neurotrophins and other growth-regulating molecules. The signal transduction pathways leading to dendritic structural changes are unknown, but likely include cytoskeleton regulatory components. To test whether GTPases regulate dendritic arbor development, we collected time-lapse images of single optic tectal neurons in albino Xenopus tadpoles expressing dominant negative or constitutively active forms of Rac, Cdc42 or RhoA. Analysis of images collected at two-hour intervals over eight hours indicated that enhanced Rac activity selectively increased branch additions and retractions, as did Cdc42 to a lesser extent. Activation of endogenous RhoA decreased branch extension without affecting branch additions and retractions, whereas dominant-negative RhoA increased branch extension. Finally, we provide data suggesting that RhoA mediates the promotion of normal dendritic arbor development by NMDA receptor activation.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Cline, HT (corresponding author), Cold Spring Harbor Lab, Beckman Bldg,1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	cline@cshl.org	Li, Zheng/I-8016-2014	Li, Zheng/0000-0002-2978-2531				Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Bentley David, 1994, Current Opinion in Neurobiology, V4, P43, DOI 10.1016/0959-4388(94)90030-2; Billuart P, 1998, NATURE, V392, P923, DOI 10.1038/31940; Chen HJ, 1998, NEURON, V20, P895, DOI 10.1016/S0896-6273(00)80471-7; CLINE HT, 1999, IMAGING LAB MANUAL; Fannon AM, 1996, NEURON, V17, P423, DOI 10.1016/S0896-6273(00)80175-0; Fiala JC, 1998, J NEUROSCI, V18, P8900; Gebbink MFBG, 1997, J CELL BIOL, V137, P1603, DOI 10.1083/jcb.137.7.1603; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hirose M, 1998, J CELL BIOL, V141, P1625, DOI 10.1083/jcb.141.7.1625; JALINK K, 1994, J CELL BIOL, V126, P801, DOI 10.1083/jcb.126.3.801; Jin Z, 1997, J NEUROSCI, V17, P6256; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kaufmann N, 1998, DEVELOPMENT, V125, P453; Kim JH, 1998, NEURON, V20, P683, DOI 10.1016/S0896-6273(00)81008-9; KOESTER SE, 1994, PROG BRAIN RES, V102, P207; Kozma R, 1997, MOL CELL BIOL, V17, P1201, DOI 10.1128/MCB.17.3.1201; Kuhn TB, 1998, J NEUROBIOL, V37, P524, DOI 10.1002/(SICI)1097-4695(199812)37:4<524::AID-NEU3>3.0.CO;2-H; Kuhn TB, 1999, J NEUROSCI, V19, P1965; LEE T, IN PRESS NEURON; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Luo LQ, 1996, NATURE, V379, P837, DOI 10.1038/379837a0; MACKETT M, 1985, DNA CLONING PRACTICA; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; Miki H, 1998, NATURE, V391, P93, DOI 10.1038/34208; Miskevich F, 1998, MOL CELL NEUROSCI, V12, P240, DOI 10.1006/mcne.1998.0718; Narumiya S, 1996, J BIOCHEM-TOKYO, V120, P215; Obermeier A, 1998, EMBO J, V17, P4328, DOI 10.1093/emboj/17.15.4328; OROURKE NA, 1994, NEURON, V12, P921, DOI 10.1016/0896-6273(94)90343-3; PURPURA DP, 1975, ADV NEUROL, V12, P91; Rajan I, 1998, J NEUROSCI, V18, P7836; Rajan I, 1999, J NEUROBIOL, V38, P357, DOI 10.1002/(SICI)1097-4695(19990215)38:3<357::AID-NEU5>3.0.CO;2-#; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Ruchhoeft ML, 1999, J NEUROSCI, V19, P8454; Stuart G., 1999, DENDRITES; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; vanLeeuwen FN, 1997, J CELL BIOL, V139, P797, DOI 10.1083/jcb.139.3.797; Witte S, 1996, J NEUROBIOL, V31, P219, DOI 10.1002/(SICI)1097-4695(199610)31:2<219::AID-NEU7>3.0.CO;2-E; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; Wu GY, 1999, J NEUROSCI, V19, P4472; WU GY, 1995, NEURON, V14, P681, DOI 10.1016/0896-6273(95)90211-2; Wu GY, 1998, SCIENCE, V279, P222, DOI 10.1126/science.279.5348.222; Yamashita T, 1999, NEURON, V24, P585, DOI 10.1016/S0896-6273(00)81114-9; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Zipkin ID, 1997, CELL, V90, P883, DOI 10.1016/S0092-8674(00)80353-0; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	48	252	255	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2000	3	3					217	225		10.1038/72920	http://dx.doi.org/10.1038/72920			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292TE	10700252				2022-12-17	WOS:000085810500009
J	McNamara, CG; Tejero-Cantero, A; Trouche, S; Campo-Urriza, N; Dupret, D				McNamara, Colin G.; Tejero-Cantero, Alvaro; Trouche, Stephanie; Campo-Urriza, Natalia; Dupret, David			Dopaminergic neurons promote hippocampal reactivation and spatial memory persistence	NATURE NEUROSCIENCE			English	Article							VENTRAL TEGMENTAL AREA; REWARD; EXPERIENCE; STABILITY; EXPOSURE; CONTEXT; MAPS; RAT	We found that optogenetic burst stimulation of hippocampal dopaminergic fibers from midbrain neurons in mice exploring novel environments enhanced the reactivation of pyramidal cell assemblies during subsequent sleep/rest. When applied during spatial learning of new goal locations, dopaminergic photostimulation improved the later recall of neural representations of space and stabilized memory performance. These findings reveal that midbrain dopaminergic neurons promote hippocampal network dynamics associated with memory persistence.	[McNamara, Colin G.; Tejero-Cantero, Alvaro; Trouche, Stephanie; Campo-Urriza, Natalia; Dupret, David] Univ Oxford, Dept Pharmacol, MRC, Anat Neuropharmacol Unit, Oxford OX1 3QT, England	University of Oxford	Dupret, D (corresponding author), Univ Oxford, Dept Pharmacol, MRC, Anat Neuropharmacol Unit, S Parks Rd, Oxford OX1 3QT, England.	colin.mcnamara@pharm.ox.ac.uk; david.dupret@pharm.ox.ac.uk		Dupret, David/0000-0002-0040-1766; Trouche, Stephanie/0000-0003-1708-8435; McNamara, Colin/0000-0001-8266-9266	Medical Research Council UK [MC_UU_12020/7]; Medical Research Foundation [C0443]; MRC [MC_UU_12020/7] Funding Source: UKRI; Medical Research Council [1310807, MC_UU_12020/7] Funding Source: researchfish	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Foundation(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank J. Csicsvari, P. Somogyi and P.J. Magill for their comments on a previous version of the manuscript, C. Etienne for her assistance with axon reconstruction, S. Cuell for his initial contribution with the crossword maze, S. Threfell and L. Norman for their assistance with the DAT-IRES-Cre mice, and K. Deisseroth (Stanford University) for sharing the DIO-ChR2-eYFP and DIO-eYFP constructs. C.G.M. is funded by a Medical Research Council Doctoral Training Award. This work was supported by the Medical Research Council UK (award MC_UU_12020/7) and a Mid-Career Researchers Equipment Grant from the Medical Research Foundation (award C0443) to D.D.	Bethus I, 2010, J NEUROSCI, V30, P1610, DOI 10.1523/JNEUROSCI.2721-09.2010; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Cohen JY, 2012, NATURE, V482, P85, DOI 10.1038/nature10754; Dupret D, 2010, NAT NEUROSCI, V13, P995, DOI 10.1038/nn.2599; Frank LM, 2004, J NEUROSCI, V24, P7681, DOI 10.1523/JNEUROSCI.1958-04.2004; Girardeau G, 2009, NAT NEUROSCI, V12, P1222, DOI 10.1038/nn.2384; Kentros C, 1998, SCIENCE, V280, P2121, DOI 10.1126/science.280.5372.2121; Kentros CG, 2004, NEURON, V42, P283, DOI 10.1016/S0896-6273(04)00192-8; Li SM, 2003, NAT NEUROSCI, V6, P526, DOI 10.1038/nn1049; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Luo AH, 2011, SCIENCE, V333, P353, DOI 10.1126/science.1204622; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; O'Neill J, 2008, NAT NEUROSCI, V11, P209, DOI 10.1038/nn2037; OKEEFE J, 1976, EXP NEUROL, V51, P78, DOI 10.1016/0014-4886(76)90055-8; SCATTON B, 1980, NEUROSCI LETT, V18, P125, DOI 10.1016/0304-3940(80)90314-6; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Singer AC, 2009, NEURON, V64, P910, DOI 10.1016/j.neuron.2009.11.016; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520	20	251	266	1	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2014	17	12					1658	1660		10.1038/nn.3843	http://dx.doi.org/10.1038/nn.3843			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AU2ZY	25326690	Green Accepted, Green Submitted			2022-12-17	WOS:000345484000011
J	Beggs, S; Trang, T; Salter, MW				Beggs, Simon; Trang, Tuan; Salter, Michael W.			P2X4R(+) microglia drive neuropathic pain	NATURE NEUROSCIENCE			English	Article							PERIPHERAL-NERVE INJURY; LAMINA-I NEURONS; RECEPTOR UP-REGULATION; CNS GLIAL MODULATOR; SPINAL MICROGLIA; P2X(4) RECEPTORS; DIFFERENTIAL RESPONSES; RODENT MICROGLIA; ANION GRADIENT; VITRO EVIDENCE	Neuropathic pain, the most debilitating of all clinical pain syndromes, may be a consequence of trauma, infection or pathology from diseases that affect peripheral nerves. Here we provide a framework for understanding the spinal mechanisms of neuropathic pain as distinct from those of acute pain or inflammatory pain. Recent work suggests that a specific microglia response phenotype characterized by de novo expression of the purinergic receptor P2X4 is critical for the pathogenesis of pain hypersensitivity caused by injury to peripheral nerves. Stimulating P2X4 receptors initiates a core pain signaling pathway mediated by release of brain-derived neurotrophic factor, which produces a disinhibitory increase in intracellular chloride in nociceptive (pain-transmitting) neurons in the spinal dorsal horn. The changes caused by signaling from P2X4R(+) microglia to nociceptive transmission neurons may account for the main symptoms of neuropathic pain in humans, and they point to specific interventions to alleviate this debilitating condition.	[Beggs, Simon; Trang, Tuan; Salter, Michael W.] Hosp Sick Children, Neurosci & Mental Hlth Program, Toronto, ON M5G 1X8, Canada; [Beggs, Simon; Trang, Tuan; Salter, Michael W.] Univ Toronto, Ctr Study Pain, Toronto, ON, Canada; [Beggs, Simon; Salter, Michael W.] Univ Toronto, Fac Dent, Toronto, ON, Canada; [Trang, Tuan; Salter, Michael W.] Univ Turin, Fac Med, Dept Phys, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Turin	Salter, MW (corresponding author), Hosp Sick Children, Neurosci & Mental Hlth Program, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	mike.salter@utoronto.ca	Beggs, Simon/AAI-4438-2021	Beggs, Simon/0000-0002-1582-8391	Canadian Institutes of Health Research [MT-11219]; Krembil Foundation; Ontario Research Fund Research Excellence Program; Canada Research Chair (Tier I) in Neuroplasticity and Pain; Anne and Max Tanenbaum Chair in Molecular Medicine at the Hospital for Sick Children; Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Krembil Foundation; Ontario Research Fund Research Excellence Program; Canada Research Chair (Tier I) in Neuroplasticity and Pain; Anne and Max Tanenbaum Chair in Molecular Medicine at the Hospital for Sick Children; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	The work of the authors is supported by grants from the Canadian Institutes of Health Research (MT-11219), the Krembil Foundation and the Ontario Research Fund Research Excellence Program. M. W. S. is supported by a Canada Research Chair (Tier I) in Neuroplasticity and Pain, and the Anne and Max Tanenbaum Chair in Molecular Medicine at the Hospital for Sick Children. T. T. was supported by a Canadian Institutes of Health Research fellowship.	Abbadie C, 2009, BRAIN RES REV, V60, P125, DOI 10.1016/j.brainresrev.2008.12.002; Asiedu M, 2010, PAIN, V148, P302, DOI 10.1016/j.pain.2009.11.015; Beggs S, 2012, BRAIN, V135, P404, DOI 10.1093/brain/awr288; Biber K, 2011, EMBO J, V30, P1864, DOI 10.1038/emboj.2011.89; Cammermeyer J, 1965, Ergeb Anat Entwicklungsgesch, V38, P1; Clark AK, 2007, EUR J PAIN, V11, P223, DOI 10.1016/j.ejpain.2006.02.003; Coull JAM, 2005, NATURE, V438, P1017, DOI 10.1038/nature04223; Coull JAM, 2003, NATURE, V424, P938, DOI 10.1038/nature01868; de Jong EK, 2008, FASEB J, V22, P4136, DOI 10.1096/fj.07-101907; de Jong EK, 2005, J NEUROSCI, V25, P7548, DOI 10.1523/JNEUROSCI.1019-05.2005; ERIKSSON NP, 1993, EXP BRAIN RES, V96, P19, DOI 10.1007/BF00230435; Fam SR, 2000, J NEUROSCI, V20, P2800; Foley JC, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-93; GEHRMANN J, 1991, RESTOR NEUROL NEUROS, V2, P181, DOI 10.3233/RNN-1991-245605; GRAEBER MB, 1988, NEUROSCI LETT, V85, P317, DOI 10.1016/0304-3940(88)90585-X; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Honore P, 2000, NEUROSCIENCE, V98, P585, DOI 10.1016/S0306-4522(00)00110-X; JAHR CE, 1983, NATURE, V304, P730, DOI 10.1038/304730a0; Keller AF, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-27; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Knabl J, 2008, NATURE, V451, P330, DOI 10.1038/nature06493; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Landry RP, 2012, EXP NEUROL, V234, P340, DOI 10.1016/j.expneurol.2011.11.006; Lin T, 2007, J NEUROIMMUNOL, V192, P40, DOI 10.1016/j.jneuroim.2007.09.003; Liu L, 1998, GLIA, V23, P221, DOI 10.1002/(SICI)1098-1136(199807)23:3<221::AID-GLIA5>3.0.CO;2-7; Milligan ED, 2009, NAT REV NEUROSCI, V10, P23, DOI 10.1038/nrn2533; Nasu-Tada K, 2006, GLIA, V53, P769, DOI 10.1002/glia.20339; Nissl F., 1899, ARCH PSYCHIAT NERVEN, V32, P656; Penfield W., 1965, CYTOLOGY CELLULAR PA; Prescott SA, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-32; Rezaie Payam, 2002, J Hist Neurosci, V11, P325, DOI 10.1076/jhin.11.4.325.8531; Rivest S, 2009, NAT REV IMMUNOL, V9, P429, DOI 10.1038/nri2565; SALTER MW, 1993, PROG NEUROBIOL, V41, P125, DOI 10.1016/0301-0082(93)90006-E; Sorge RE, 2011, J NEUROSCI, V31, P15450, DOI 10.1523/JNEUROSCI.3859-11.2011; Suleman S., 2008, P 12 WORLD C PAIN; Suter MR, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-53; SVENSSON M, 1994, NEUROPATH APPL NEURO, V20, P185; Toyomitsu E, 2012, PURINERG SIGNAL, V8, P301, DOI 10.1007/s11302-011-9288-x; Tozaki-Saitoh H, 2008, J NEUROSCI, V28, P4949, DOI 10.1523/JNEUROSCI.0323-08.2008; Trang T, 2009, J NEUROSCI, V29, P3518, DOI 10.1523/JNEUROSCI.5714-08.2009; Tsuda M, 2003, NATURE, V424, P778, DOI 10.1038/nature01786; Tsuda M, 2008, GLIA, V56, P579, DOI 10.1002/glia.20641; Tsuda M, 2008, GLIA, V56, P50, DOI 10.1002/glia.20591; Tsuda M, 2009, J CELL MOL MED, V13, P3251, DOI 10.1111/j.1582-4934.2009.00719.x; Tsuda M, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-28; Tsuda M, 2009, P NATL ACAD SCI USA, V106, P8032, DOI 10.1073/pnas.0810420106; Ulmann L, 2008, J NEUROSCI, V28, P11263, DOI 10.1523/JNEUROSCI.2308-08.2008; Watkins LR, 2012, EXP NEUROL, V234, P351, DOI 10.1016/j.expneurol.2012.01.006; Yuan HB, 2010, J NEUROSCI RES, V88, P1348, DOI 10.1002/jnr.22304; Zhang J, 2007, J NEUROSCI, V27, P12396, DOI 10.1523/JNEUROSCI.3016-07.2007	50	251	265	2	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2012	15	8					1068	1073		10.1038/nn.3155	http://dx.doi.org/10.1038/nn.3155			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	979UE	22837036	Green Accepted			2022-12-17	WOS:000306844500007
J	Newman-Norlund, RD; van Schie, HT; van Zuijlen, AMJ; Bekkering, H				Newman-Norlund, Roger D.; van Schie, Hein T.; van Zuijlen, Alexander M. J.; Bekkering, Harold			The mirror neuron system is more active during complementary compared with imitative action	NATURE NEUROSCIENCE			English	Editorial Material							MOTOR	We assessed the role of the human mirror neuron system (MNS) in complementary actions using functional magnetic resonance imaging while participants prepared to execute imitative or complementary actions. The BOLD signal in the right inferior frontal gyrus and bilateral inferior parietal lobes was greater during preparation of complementary than during imitative actions, suggesting that the MNS may be essential in dynamically coupling action observation to action execution.	Radboud Univ Nijmegen, Nijmegen Inst Cognit Res & Informat, NL-6500 HE Nijmegen, Netherlands; Radboud Univ Nijmegen, FC Donders Ctr Cognit Neuroimaging, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Newman-Norlund, RD (corresponding author), Radboud Univ Nijmegen, Nijmegen Inst Cognit Res & Informat, PO Box 9104, NL-6500 HE Nijmegen, Netherlands.	rogern@nici.ru.nl	Galantucci, Bruno/E-5770-2010; van Schie, Hein T/D-2281-2010; Bekkering, Harold/A-6357-2009					Brass M, 2005, TRENDS COGN SCI, V9, P489, DOI 10.1016/j.tics.2005.08.007; Buccino G, 2004, NEURON, V42, P323, DOI 10.1016/S0896-6273(04)00181-3; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Hamilton AFD, 2006, J NEUROSCI, V26, P1133, DOI 10.1523/JNEUROSCI.4551-05.2006; Heiser M, 2003, EUR J NEUROSCI, V17, P1123, DOI 10.1046/j.1460-9568.2003.02530.x; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Iacoboni M, 2006, NAT REV NEUROSCI, V7, P942, DOI 10.1038/nrn2024; Koski L, 2002, CEREB CORTEX, V12, P847, DOI 10.1093/cercor/12.8.847; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Schutz-Bosbach S, 2006, CURR BIOL, V16, P1830, DOI 10.1016/j.cub.2006.07.048	13	251	254	2	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2007	10	7					817	818		10.1038/nn1911	http://dx.doi.org/10.1038/nn1911			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	183GH	17529986				2022-12-17	WOS:000247560200010
J	Rasin, MR; Gazula, VR; Breunig, JJ; Kwan, KY; Johnson, MB; Liu-Chen, S; Li, HS; Jan, LY; Jan, YN; Rakic, P; Sestan, N				Rasin, Mladen-Roko; Gazula, Valeswara-Rao; Breunig, Joshua J.; Kwan, Kenneth Y.; Johnson, Matthew B.; Liu-Chen, Susan; Li, Hua-Shun; Jan, Lily Yeh; Jan, Yuh-Nung; Rakic, Pasko; Sestan, Nenad			Numb and Numbl are required for maintenance of cadherin-based adhesion and polarity of neural progenitors	NATURE NEUROSCIENCE			English	Article							ASYMMETRIC CELL-DIVISION; FATE DETERMINANT NUMB; RADIAL GLIA; NEUROEPITHELIAL CELLS; CEREBRAL-CORTEX; CORTICAL NEUROGENESIS; ADHERENS JUNCTIONS; ENDOCYTIC PROTEIN; STEM-CELLS; BRAIN	The polarity and adhesion of radial glial cells (RGCs), which function as progenitors and migrational guides for neurons, are critical for morphogenesis of the cerebral cortex. These characteristics largely depend on cadherin-based adherens junctions, which anchor apical end-feet of adjacent RGCs to each other at the ventricular surface. Here, we show that mouse numb and numb-like are required for maintaining radial glial adherens junctions. Numb accumulates in the apical end-feet, where it localizes to adherens junction-associated vesicles and interacts with cadherins. Numb and Numbl inactivation in RGCs decreases proper basolateral insertion of cadherins and disrupts adherens junctions and polarity, leading to progenitor dispersion and disorganized cortical lamination. Conversely, overexpression of Numb prolongs RGC polarization, in a cadherin-dependent manner, beyond the normal neurogenic period. Thus, by regulating RGC adhesion and polarity, Numb and Numbl are required for the tissue architecture of neurogenic niches and the cerebral cortex.	Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol & Biochem, San Francisco, CA 94143 USA; Coll Med, Inst Mol Med & Genet, Dev Neurobiol Program, Augusta, GA 30912 USA	Yale University; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Sestan, N (corresponding author), Yale Univ, Sch Med, Dept Neurobiol, 333 Cedar St, New Haven, CT 06510 USA.	nenad.sestan@yale.edu	Breunig, Joshua/F-8490-2012; Kwan, Kenneth/AAI-2841-2021; Kwan, Kenneth Y/F-8489-2011	Kwan, Kenneth/0000-0003-4711-071X; Kwan, Kenneth Y/0000-0003-4711-071X; Breunig, Joshua/0000-0002-3735-3390; Jan, Yuh Nung/0000-0003-1367-6299; Jan, Lily/0000-0003-3938-8498	NIA NIH HHS [AG019394] Funding Source: Medline; NICHD NIH HHS [HD045481] Funding Source: Medline; NINDS NIH HHS [NS047200] Funding Source: Medline; Autism Speaks [AS1672] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019394] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Autism Speaks; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Berdnik D, 2002, DEV CELL, V3, P221, DOI 10.1016/S1534-5807(02)00215-0; Bryant DM, 2004, TRENDS CELL BIOL, V14, P427, DOI 10.1016/j.tcb.2004.07.007; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Cayouette M, 2002, NAT NEUROSCI, V5, P1265, DOI 10.1038/nn1202-1265; Chen JG, 2005, P NATL ACAD SCI USA, V102, P17792, DOI 10.1073/pnas.0509032102; CHENN, 1998, MOL CELL NEUOSCI, V11, P183; Doe CQ, 1998, J NEUROBIOL, V36, P111, DOI 10.1002/(SICI)1097-4695(199808)36:2<111::AID-NEU2>3.3.CO;2-2; Fishell G, 2003, CURR OPIN NEUROBIOL, V13, P34, DOI 10.1016/S0959-4388(03)00013-8; Forni PE, 2006, J NEUROSCI, V26, P9593, DOI 10.1523/JNEUROSCI.2815-06.2006; Gaiano N, 2002, ANNU REV NEUROSCI, V25, P471, DOI 10.1146/annurev.neuro.25.030702.130823; Ganzler-Odenthal SII, 1998, J NEUROSCI, V18, P5415; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Huang EJ, 2005, GENE DEV, V19, P138, DOI 10.1101/gad.1246005; Imai F, 2006, DEVELOPMENT, V133, P1735, DOI 10.1242/dev.02330; Jan YN, 2001, NAT REV NEUROSCI, V2, P772, DOI 10.1038/35097516; Kadowaki M, 2007, DEV BIOL, V304, P22, DOI 10.1016/j.ydbio.2006.12.014; Khan OH, 2006, EXP NEUROL, V200, P311, DOI 10.1016/j.expneurol.2006.02.113; Klezovitch O, 2004, GENE DEV, V18, P559, DOI 10.1101/gad.1178004; Kosodo Y, 2004, EMBO J, V23, P2314, DOI 10.1038/sj.emboj.7600223; Kuo CT, 2006, CELL, V127, P1253, DOI 10.1016/j.cell.2006.10.041; LANGFORD LA, 1986, ACTA NEUROPATHOL, V71, P136, DOI 10.1007/BF00687975; Li HS, 2003, NEURON, V40, P1105, DOI 10.1016/S0896-6273(03)00755-4; Lien WH, 2006, SCIENCE, V311, P1609, DOI 10.1126/science.1121449; Lock JG, 2005, MOL BIOL CELL, V16, P1744, DOI 10.1091/mbc.E04-10-0867; Machon O, 2003, NEUROSCIENCE, V122, P129, DOI 10.1016/S0306-4522(03)00519-0; Masai I, 2003, DEVELOPMENT, V130, P2479, DOI 10.1242/dev.00465; Mashayekhi F, 2002, BRAIN, V125, P1859, DOI 10.1093/brain/awf182; MISSON JP, 1991, GLIA, V4, P138, DOI 10.1002/glia.440040205; Nishimura T, 2006, MOL BIOL CELL, V17, P1273, DOI 10.1091/mbc.E05-07-0700; Osanai Makoto, 2004, Medical Electron Microscopy, V37, P193; Paterson AD, 2003, J BIOL CHEM, V278, P21050, DOI 10.1074/jbc.M300082200; Pece S, 2004, J CELL BIOL, V167, P215, DOI 10.1083/jcb.200406140; Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9; Petersen PH, 2004, NAT NEUROSCI, V7, P803, DOI 10.1038/nn1289; Rakic P, 2003, CEREB CORTEX, V13, P541, DOI 10.1093/cercor/13.6.541; Roncarati R, 2002, P NATL ACAD SCI USA, V99, P7102, DOI 10.1073/pnas.102192599; Santolini E, 2000, J CELL BIOL, V151, P1345, DOI 10.1083/jcb.151.6.1345; Schmid RS, 2003, P NATL ACAD SCI USA, V100, P4251, DOI 10.1073/pnas.0630496100; Sestan N, 1999, SCIENCE, V286, P741, DOI 10.1126/science.286.5440.741; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Smith CA, 2004, MOL BIOL CELL, V15, P3698, DOI 10.1091/mbc.E04-01-0026; Smith CA, 2007, EMBO J, V26, P468, DOI 10.1038/sj.emboj.7601495; Smith KM, 2006, NAT NEUROSCI, V9, P787, DOI 10.1038/nn1705; Takeichi M, 2007, NAT REV NEUROSCI, V8, P11, DOI 10.1038/nrn2043; Taylor MD, 2005, CANCER CELL, V8, P323, DOI 10.1016/j.ccr.2005.09.001; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Wakamatsu Y, 1999, NEURON, V23, P71, DOI 10.1016/S0896-6273(00)80754-0; Yang XD, 2004, DEV BIOL, V269, P81, DOI 10.1016/j.ydbio.2004.01.014; Zhong WM, 1996, NEURON, V17, P43, DOI 10.1016/S0896-6273(00)80279-2	50	251	268	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2007	10	7					819	827		10.1038/nn1924	http://dx.doi.org/10.1038/nn1924			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	183GH	17589506				2022-12-17	WOS:000247560200011
J	Tanda, G; Munzar, P; Goldberg, SR				Tanda, G; Munzar, P; Goldberg, SR			Self-administration behavior is maintained by the psychoactive ingredient of marijuana in squirrel monkeys	NATURE NEUROSCIENCE			English	Article							RHESUS-MONKEYS; RECEPTOR; CANNABINOIDS		NIDA, Preclin Pharmacol Sect, Behav Neurosci Branch, NIH, Baltimore, MD 21224 USA; Georgetown Univ, Sch Med, Dept Pharmacol, Washington, DC 20007 USA; Univ Cagliari, Dept Toxicol, I-09126 Cagliari, Italy; Univ Cagliari, CNR, Ctr Neuropharmacol, I-09126 Cagliari, Italy	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); Georgetown University; University of Cagliari; Consiglio Nazionale delle Ricerche (CNR); University of Cagliari	Goldberg, SR (corresponding author), NIDA, Preclin Pharmacol Sect, Behav Neurosci Branch, NIH, 5500 Nathan Shock Dr, Baltimore, MD 21224 USA.		Tanda, Gianluigi/Q-4976-2019; Tanda, Gianluigi/B-3318-2009	Tanda, Gianluigi/0000-0001-9526-9878; Tanda, Gianluigi/0000-0001-9526-9878	NATIONAL INSTITUTE ON DRUG ABUSE [ZIFDA000001, ZIADA000001, Z01DA000001, Z02DA000001] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		AGURELL S, 1986, PHARMACOL REV, V38, P21; CARNEY JM, 1977, PHARMACOL BIOCHEM BE, V7, P357, DOI 10.1016/0091-3057(77)90232-5; GOLDBERG SR, 1981, SCIENCE, V214, P573; HARRIS RT, 1974, PSYCHOPHARMACOLOGIA, V37, P23, DOI 10.1007/BF00426679; KAYMAKCALAN S, 1973, B NARCOTICS, V25, P39; Ledent C, 1999, SCIENCE, V283, P401, DOI 10.1126/science.283.5400.401; MANSBACH RS, 1994, BEHAV PHARMACOL, V5, P219, DOI 10.1097/00008877-199404000-00014; MANTILLAPLATA B, 1975, TOXICOL APPL PHARM, V34, P292, DOI 10.1016/0041-008X(75)90034-4; OLSEN JL, 1973, J PHARM PHARMACOL, V25, P344, DOI 10.1111/j.2042-7158.1973.tb10023.x; PICKENS R, 1973, BAYER S, V4, P78; RINALDICARMONA M, 1994, FEBS LETT, V350, P240, DOI 10.1016/0014-5793(94)00773-X; SPEAR DJ, 1991, PHARMACOL BIOCHEM BE, V38, P411, DOI 10.1016/0091-3057(91)90300-Q; Tanda G, 1997, SCIENCE, V276, P2048, DOI 10.1126/science.276.5321.2048; Young A. M., 1986, BEHAVIORAL ANAL DRUG, P9	14	251	262	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2000	3	11					1073	1074		10.1038/80577	http://dx.doi.org/10.1038/80577			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TX	11036260				2022-12-17	WOS:000167177600008
J	Frerking, M; Malenka, RC; Nicoll, RA				Frerking, M; Malenka, RC; Nicoll, RA			Synaptic activation of kainate receptors on hippocampal interneurons	NATURE NEUROSCIENCE			English	Article							KAINIC ACID; GLUTAMATE RECEPTORS; EPILEPTIFORM ACTIVITY; RAT HIPPOCAMPUS; INHIBITION; NEURONS; AMPA; RESPONSES; CHANNELS; CELLS	Although kainate receptor activation has been known to evoke epileptiform activity, little is known about the role of kainate receptors in synaptic transmission. Here we report that kainate (KA) receptors are present on interneurons and, when activated, cause a large increase in the frequency of spontaneous inhibitory postsynaptic currents (IPSCs) driven by action potentials. Stimulation of excitatory afferents generates a pharmacologically identifiable synaptic current mediated by KA receptors in interneurons. This synaptic current is similar to that mediated by AM PA receptors in its response to short stimulus trains, current-voltage relations and coefficient of variation, but it is much smaller in peak amplitude and much slower. KA application also considerably depresses evoked IPSCs. This depression seems to be in large part an indirect consequence of the repetitive firing evoked by the activation of the interneuronal somatic/dendritic KA receptors.	Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Nicoll, RA (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.				NINDS NIH HHS [T32NS07067] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007067] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alger BE, 1996, J PHYSIOL-LONDON, V496, P197, DOI 10.1113/jphysiol.1996.sp021677; ALGER BE, 1980, BRAIN RES, V200, P195, DOI 10.1016/0006-8993(80)91108-7; Ali AB, 1998, J PHYSIOL-LONDON, V507, P201, DOI 10.1111/j.1469-7793.1998.201bu.x; BEKKERS JM, 1994, ADV SEC MESS PHOSPH, V29, P261; BENARI Y, 1985, NEUROSCIENCE, V14, P375, DOI 10.1016/0306-4522(85)90299-4; BETTLER B, 1995, NEUROPHARMACOLOGY, V34, P123, DOI 10.1016/0028-3908(94)00141-E; Burnashev N, 1996, J PHYSIOL-LONDON, V496, P165, DOI 10.1113/jphysiol.1996.sp021674; Castillo PE, 1997, NATURE, V388, P182, DOI 10.1038/40645; Chittajallu R, 1996, NATURE, V379, P78, DOI 10.1038/379078a0; Clarke VRJ, 1997, NATURE, V389, P599, DOI 10.1038/39315; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; CORNISH SM, 1989, NEUROSCIENCE, V28, P563, DOI 10.1016/0306-4522(89)90005-5; FISHER RS, 1984, J NEUROSCI, V4, P1312; FRANCK JE, 1988, J NEUROSCI, V8, P1991; Geiger JRP, 1997, NEURON, V18, P1009, DOI 10.1016/S0896-6273(00)80339-6; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Howe JR, 1996, J NEUROPHYSIOL, V76, P510, DOI 10.1152/jn.1996.76.1.510; HUETTNER JE, 1990, NEURON, V5, P255, DOI 10.1016/0896-6273(90)90163-A; JONES MV, 1995, NEURON, V15, P181, DOI 10.1016/0896-6273(95)90075-6; Kamiya H, 1998, J PHYSIOL-LONDON, V509, P833, DOI 10.1111/j.1469-7793.1998.833bm.x; LANCASTER B, 1984, BRAIN RES, V295, P317, DOI 10.1016/0006-8993(84)90980-6; LERMA J, 1993, P NATL ACAD SCI USA, V90, P11688, DOI 10.1073/pnas.90.24.11688; Lerma J, 1997, NEURON, V19, P1155, DOI 10.1016/S0896-6273(00)80407-9; Mayer M, 1997, NATURE, V389, P542, DOI 10.1038/39177; OTIS TS, 1991, BRAIN RES, V545, P142, DOI 10.1016/0006-8993(91)91280-E; PATERNAIN AV, 1995, NEURON, V14, P185, DOI 10.1016/0896-6273(95)90253-8; PATNEAU DK, 1994, NEURON, V12, P357, DOI 10.1016/0896-6273(94)90277-1; ROBINSON JH, 1981, BRAIN RES, V221, P117, DOI 10.1016/0006-8993(81)91067-2; Rodriguez-Moreno A, 1998, NEURON, V20, P1211, DOI 10.1016/S0896-6273(00)80501-2; RodriguezMoreno A, 1997, NEURON, V19, P893, DOI 10.1016/S0896-6273(00)80970-8; RUANO D, 1995, NEURON, V14, P1009, DOI 10.1016/0896-6273(95)90339-9; Scanziani M, 1997, NATURE, V385, P630, DOI 10.1038/385630a0; SIK A, 1993, EUR J NEUROSCI, V5, P1719, DOI 10.1111/j.1460-9568.1993.tb00239.x; SOMMER B, 1992, TRENDS PHARMACOL SCI, V13, P91; Swanson GT, 1996, J PHYSIOL-LONDON, V492, P129, DOI 10.1113/jphysiol.1996.sp021295; Vignes M, 1997, NATURE, V388, P179, DOI 10.1038/40639; WATKINS JC, 1981, ANNU REV PHARMACOL, V21, P165, DOI 10.1146/annurev.pa.21.040181.001121; WESTBROOK GL, 1983, BRAIN RES, V273, P97, DOI 10.1016/0006-8993(83)91098-3; Wilding TJ, 1997, J NEUROSCI, V17, P2713; WILDING TJ, 1995, MOL PHARMACOL, V47, P582; WYLLIE DJA, 1994, NEURON, V12, P127, DOI 10.1016/0896-6273(94)90158-9	42	251	253	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	1998	1	6					479	486		10.1038/2194	http://dx.doi.org/10.1038/2194			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	128LE	10196545				2022-12-17	WOS:000076406900012
J	Bittner, KC; Grienberger, C; Vaidya, SP; Milstein, AD; Macklin, JJ; Suh, J; Tonegawa, S; Magee, JC				Bittner, Katie C.; Grienberger, Christine; Vaidya, Sachin P.; Milstein, Aaron D.; Macklin, John J.; Suh, Junghyup; Tonegawa, Susumu; Magee, Jeffrey C.			Conjunctive input processing drives feature selectivity in hippocampal CA1 neurons	NATURE NEUROSCIENCE			English	Article							PYRAMIDAL NEURONS; PLACE CELLS; SYNAPTIC PLASTICITY; ENTORHINAL CORTEX; IN-VIVO; DENDRITIC INTEGRATION; CELLULAR MECHANISM; DISTAL DENDRITES; CA2+ SPIKES; GRID CELLS	Feature-selective firing allows networks to produce representations of the external and internal environments. Despite its importance, the mechanisms generating neuronal feature selectivity are incompletely understood. In many cortical microcircuits the integration of two functionally distinct inputs occurs nonlinearly through generation of active dendritic signals that drive burst firing and robust plasticity. To examine the role of this processing in feature selectivity, we recorded CA1 pyramidal neuron membrane potential and local field potential in mice running on a linear treadmill. We found that dendritic plateau potentials were produced by an interaction between properly timed input from entorhinal cortex and hippocampal CA3. These conjunctive signals positively modulated the firing of previously established place fields and rapidly induced new place field formation to produce feature selectivity in CA1 that is a function of both entorhinal cortex and CA3 input. Such selectivity could allow mixed network level representations that support context-dependent spatial maps.	[Bittner, Katie C.; Grienberger, Christine; Vaidya, Sachin P.; Milstein, Aaron D.; Macklin, John J.; Magee, Jeffrey C.] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Suh, Junghyup; Tonegawa, Susumu] MIT, RIKEN Ctr Neural Circuit Genet, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Suh, Junghyup; Tonegawa, Susumu] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Northwell Health; RIKEN; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Magee, JC (corresponding author), Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA.	mageej@janelia.hhmi.org	Suh, Junghyup/AAO-8265-2020; Vaidya, Sachin/V-8570-2018	Vaidya, Sachin/0000-0002-4773-0487; Milstein, Aaron/0000-0002-7186-5779; Bittner, Katie/0000-0002-2554-2637; Grienberger, Christine/0000-0002-7774-4062	Howard Hughes Medical Institute; RIKEN, Wako-shi Japan	Howard Hughes Medical Institute(Howard Hughes Medical Institute); RIKEN, Wako-shi Japan	We thank S. Royer, M. Karlsson, J. Osborne, J. Chen and S. Sawtelle for assistance in designing the experimental setup; J. Cohen and A. Lee for technical assistance; W.L. Sun for fiber etching; B. Shields and M. Copeland for histology; M. Lengyel, E. Pastalkova, Y. Wang and B. Lustig for discussions; and M. Mehta, J. Dudman, A. Lee and N. Spruston for comments on the manuscript. This work was supported by Howard Hughes Medical Institute and in part by RIKEN, Wako-shi Japan and the Howard Hughes Medical Institute to the Massachusetts Institute of Technology (S.T.).	Anderson JS, 2000, SCIENCE, V290, P1968, DOI 10.1126/science.290.5498.1968; BRANKACK J, 1993, BRAIN RES, V615, P310, DOI 10.1016/0006-8993(93)90043-M; BUZSAKI G, 1983, BRAIN RES REV, V6, P139, DOI 10.1016/0165-0173(83)90037-1; BUZSAKI G, 1992, SCIENCE, V256, P1025, DOI 10.1126/science.1589772; Cauller LJ, 1998, J COMP NEUROL, V390, P297; Epsztein J, 2011, NEURON, V70, P109, DOI 10.1016/j.neuron.2011.03.006; Frank LM, 2000, NEURON, V27, P169, DOI 10.1016/S0896-6273(00)00018-0; Frank LM, 2004, J NEUROSCI, V24, P7681, DOI 10.1523/JNEUROSCI.1958-04.2004; Gambino F, 2014, NATURE, V515, P116, DOI 10.1038/nature13664; Grienberger C, 2014, NEURON, V81, P1274, DOI 10.1016/j.neuron.2014.01.014; Harnett MT, 2013, NEURON, V79, P516, DOI 10.1016/j.neuron.2013.06.005; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; HILL AJ, 1978, EXP NEUROL, V62, P282, DOI 10.1016/0014-4886(78)90058-4; Jarsky T, 2005, NAT NEUROSCI, V8, P1667, DOI 10.1038/nn1599; Jiang XL, 2013, NAT NEUROSCI, V16, P210, DOI 10.1038/nn.3305; Kamondi A, 1998, J NEUROSCI, V18, P3919; Kentros C, 1998, SCIENCE, V280, P2121, DOI 10.1126/science.280.5372.2121; Kuhn A, 2004, J NEUROSCI, V24, P2345, DOI 10.1523/JNEUROSCI.3349-03.2004; Larkum M, 2013, TRENDS NEUROSCI, V36, P141, DOI 10.1016/j.tins.2012.11.006; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Leutgeb S, 2005, SCIENCE, V309, P619, DOI 10.1126/science.1114037; Lovett-Barron M, 2014, SCIENCE, V343, P857, DOI 10.1126/science.1247485; MARKUS EJ, 1995, J NEUROSCI, V15, P7079; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; McHugh TJ, 1996, CELL, V87, P1339, DOI 10.1016/S0092-8674(00)81828-0; Megias M, 2001, NEUROSCIENCE, V102, P527, DOI 10.1016/S0306-4522(00)00496-6; Mehta MR, 2000, NEURON, V25, P707, DOI 10.1016/S0896-6273(00)81072-7; Mizuseki K, 2009, NEURON, V64, P267, DOI 10.1016/j.neuron.2009.08.037; Monaco JD, 2014, NAT NEUROSCI, V17, P725, DOI 10.1038/nn.3687; O'Keefe J, 2005, HIPPOCAMPUS, V15, P853, DOI 10.1002/hipo.20115; O'Neill J, 2006, NEURON, V49, P143, DOI 10.1016/j.neuron.2005.10.037; Palmer L, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00026; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Pouget A, 2002, NAT REV NEUROSCI, V3, P741, DOI 10.1038/nrn914; Rolls ET, 2006, NETWORK-COMP NEURAL, V17, P447, DOI 10.1080/09548980601064846; Royer S, 2012, NAT NEUROSCI, V15, P769, DOI 10.1038/nn.3077; Salinas E, 2001, NEUROSCIENTIST, V7, P430, DOI 10.1177/107385840100700512; Shepherd G.M., 2004, NEUROBIOLOGY; Sjostrom PJ, 2006, NEURON, V51, P227, DOI 10.1016/j.neuron.2006.06.017; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; STEWARD O, 1976, J COMP NEUROL, V169, P347, DOI 10.1002/cne.901690306; Suh J, 2011, SCIENCE, V334, P1415, DOI 10.1126/science.1210125; Sullivan D, 2011, J NEUROSCI, V31, P8605, DOI 10.1523/JNEUROSCI.0294-11.2011; Takahashi H, 2009, NEURON, V62, P102, DOI 10.1016/j.neuron.2009.03.007; Thomson AM, 2000, TRENDS NEUROSCI, V23, P305, DOI 10.1016/S0166-2236(00)01580-0; Tsay D, 2007, NEURON, V56, P1076, DOI 10.1016/j.neuron.2007.11.015; Witter MP, 2000, HIPPOCAMPUS, V10, P398; Wood ER, 2000, NEURON, V27, P623, DOI 10.1016/S0896-6273(00)00071-4; Xu NL, 2012, NATURE, V492, P247, DOI 10.1038/nature11601; Xu W, 2012, NEURON, V73, P990, DOI 10.1016/j.neuron.2011.12.036	50	250	250	4	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2015	18	8					1133	+		10.1038/nn.4062	http://dx.doi.org/10.1038/nn.4062			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CN7HO	26167906	Green Accepted, Green Submitted			2022-12-17	WOS:000358605400015
J	Rudebeck, PH; Saunders, RC; Prescott, AT; Chau, LS; Murray, EA				Rudebeck, Peter H.; Saunders, Richard C.; Prescott, Anna T.; Chau, Lily S.; Murray, Elisabeth A.			Prefrontal mechanisms of behavioral flexibility, emotion regulation and value updating	NATURE NEUROSCIENCE			English	Article							PRIMATE ORBITOFRONTAL CORTEX; DECISION-MAKING; RHESUS-MONKEYS; BASOLATERAL AMYGDALA; FRONTAL-CORTEX; FIBER PATHWAYS; REWARD VALUE; REVERSAL; LESIONS; NEURONS	Two ideas have dominated neuropsychology concerning the orbitofrontal cortex (OFC). One holds that OFC regulates emotion and enhances behavioral flexibility through inhibitory control. The other ascribes to OFC a role in updating valuations on the basis of current motivational states. Neuroimaging, neurophysiological and clinical observations are consistent with either or both hypotheses. Although these hypotheses are compatible in principle, we present results supporting the latter view of OFC function and arguing against the former. We found that excitotoxic, fiber-sparing lesions confined to OFC in monkeys did not alter either behavioral flexibility, as measured by object reversal learning, or emotion regulation, as assessed by fear of snakes. A follow-up experiment indicated that a previously reported loss of inhibitory control resulted from damage to nearby fiber tracts and not from OFC dysfunction. Thus, OFC has a more specialized role in reward-guided behavior and emotion than has been thought, a function that includes value updating.	[Rudebeck, Peter H.; Saunders, Richard C.; Prescott, Anna T.; Chau, Lily S.; Murray, Elisabeth A.] NIMH, Sect Neurobiol Learning & Memory, Neuropsychol Lab, US Natl Inst Hlth, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Rudebeck, PH (corresponding author), NIMH, Sect Neurobiol Learning & Memory, Neuropsychol Lab, US Natl Inst Hlth, Bethesda, MD 20892 USA.	rudebeckp@mail.nih.gov	Murray, Elisabeth A./X-2051-2019	Murray, Elisabeth/0000-0003-1450-1642; Rudebeck, Peter/0000-0002-1411-7555	Intramural Research Program of the US National Institute of Mental Health; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002887] Funding Source: NIH RePORTER	Intramural Research Program of the US National Institute of Mental Health; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank D. Lundgren and E. Howland for assistance with data collection and R. Reoli for help performing surgery. We also thank S. Wise and M. Walton for comments on an earlier version of the manuscript. This work was supported by the Intramural Research Program of the US National Institute of Mental Health.	Baxter MG, 2009, EUR J NEUROSCI, V29, P2049, DOI 10.1111/j.1460-9568.2009.06740.x; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Blair RJR, 2010, BRIT J PSYCHOL, V101, P383, DOI 10.1348/000712609X418480; Burke KA, 2008, NATURE, V454, P340, DOI 10.1038/nature06993; Bush EC, 2004, ANAT REC PART A, V281A, P1083, DOI 10.1002/ar.a.20113; BUTTER CM, 1969, PHYSIOL BEHAV, V4, P163, DOI 10.1016/0031-9384(69)90075-4; CARMICHAEL ST, 1994, J COMP NEUROL, V346, P366, DOI 10.1002/cne.903460305; Chudasama Y, 2003, J NEUROSCI, V23, P8771; Chudasama Y., 2012, CEREB, DOI DOI 10.1093/CERC0R/BHS266; Chudasama Y, 2009, EUR J NEUROSCI, V30, P2327, DOI 10.1111/j.1460-9568.2009.07012.x; Clark L, 2004, BRAIN COGNITION, V55, P41, DOI 10.1016/s0278-2626(03)00284-7; Croxson PL, 2005, J NEUROSCI, V25, P8854, DOI 10.1523/JNEUROSCI.1311-05.2005; Davidson RJ, 2000, SCIENCE, V289, P591, DOI 10.1126/science.289.5479.591; Dias R, 1996, NATURE, V380, P69, DOI 10.1038/380069a0; Fellows LK, 2003, BRAIN, V126, P1830, DOI 10.1093/brain/awg180; Frank MJ, 2006, PSYCHOL REV, V113, P300, DOI 10.1037/0033-295X.113.2.300; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; Haber SN, 2006, J NEUROSCI, V26, P8368, DOI 10.1523/JNEUROSCI.0271-06.2006; Holland PC, 2004, CURR OPIN NEUROBIOL, V14, P148, DOI 10.1016/j.conb.2004.03.007; Hornak J, 2004, J COGNITIVE NEUROSCI, V16, P463, DOI 10.1162/089892904322926791; IVERSEN SD, 1970, EXP BRAIN RES, V11, P376; Izquierdo A, 2005, J NEUROSCI, V25, P8534, DOI 10.1523/JNEUROSCI.1232-05.2005; Izquierdo A, 2004, J NEUROSCI, V24, P7540, DOI 10.1523/JNEUROSCI.1921-04.2004; Izquierdo A, 2007, J NEUROSCI, V27, P1054, DOI 10.1523/JNEUROSCI.3616-06.2007; Kazama A, 2009, J NEUROSCI, V29, P2794, DOI 10.1523/JNEUROSCI.4655-08.2009; KITT CA, 1987, BRAIN RES, V406, P192, DOI 10.1016/0006-8993(87)90783-9; Mineka S., 1987, THEORETICAL FDN BEHA; Mishkin M., 1964, FRONTAL GRANULAR COR, P219; Morrison SE, 2009, J NEUROSCI, V29, P11471, DOI 10.1523/JNEUROSCI.1815-09.2009; Murray EA, 1998, BEHAV NEUROSCI, V112, P1291, DOI 10.1037/0735-7044.112.6.1291; Murray EA, 2007, J NEUROSCI, V27, P8166, DOI 10.1523/JNEUROSCI.1556-07.2007; Murray EA, 2011, BIOL PSYCHIAT, V69, pE43, DOI 10.1016/j.biopsych.2010.09.041; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Passingham R.E.P., 2012, NEUROBIOLOGY PREFRON; Roberts AC, 2000, CEREB CORTEX, V10, P252, DOI 10.1093/cercor/10.3.252; ROLLS ET, 1994, J NEUROL NEUROSUR PS, V57, P1518, DOI 10.1136/jnnp.57.12.1518; ROLLS ET, 1999, BRAIN EMOTION; Rudebeck PH, 2006, SCIENCE, V313, P1310, DOI 10.1126/science.1128197; Rudebeck PH, 2011, J NEUROSCI, V31, P10569, DOI 10.1523/JNEUROSCI.0091-11.2011; SAVER JL, 1991, NEUROPSYCHOLOGIA, V29, P1241, DOI 10.1016/0028-3932(91)90037-9; Schmahmann JD, 2007, BRAIN, V130, P630, DOI 10.1093/brain/awl359; Schoenbaum G, 2003, LEARN MEMORY, V10, P129, DOI 10.1101/lm.55203; Schoenbaum G, 1999, J NEUROSCI, V19, P1876; Schoenbaum G, 2009, NAT REV NEUROSCI, V10, P885, DOI 10.1038/nrn2753; Stevens JR, 2005, BIOL LETTERS, V1, P223, DOI 10.1098/rsbl.2004.0285; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Wallis JD, 2007, ANNU REV NEUROSCI, V30, P31, DOI 10.1146/annurev.neuro.30.051606.094334; Walton ME, 2010, NEURON, V65, P927, DOI 10.1016/j.neuron.2010.02.027; Watson KK, 2012, CURR BIOL, V22, P2268, DOI 10.1016/j.cub.2012.10.016	49	250	254	1	66	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2013	16	8					1140	U225		10.1038/nn.3440	http://dx.doi.org/10.1038/nn.3440			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190EV	23792944	Green Accepted			2022-12-17	WOS:000322323000026
J	Fetsch, CR; Pouget, A; DeAngelis, GC; Angelaki, DE				Fetsch, Christopher R.; Pouget, Alexandre; DeAngelis, Gregory C.; Angelaki, Dora E.			Neural correlates of reliability-based cue weighting during multisensory integration	NATURE NEUROSCIENCE			English	Article							STOCHASTIC MOTION SIGNALS; SUPERIOR TEMPORAL AREA; MACAQUE MONKEY; OPTIC FLOW; BAYESIAN INTEGRATION; HEADING PERCEPTION; POPULATION CODES; CORTICAL AREAS; SELF-MOTION; MST NEURONS	Integration of multiple sensory cues is essential for precise and accurate perception and behavioral performance, yet the reliability of sensory signals can vary across modalities and viewing conditions. Human observers typically employ the optimal strategy of weighting each cue in proportion to its reliability, but the neural basis of this computation remains poorly understood. We trained monkeys to perform a heading discrimination task from visual and vestibular cues, varying cue reliability randomly. The monkeys appropriately placed greater weight on the more reliable cue, and population decoding of neural responses in the dorsal medial superior temporal area closely predicted behavioral cue weighting, including modest deviations from optimality. We found that the mathematical combination of visual and vestibular inputs by single neurons is generally consistent with recent theories of optimal probabilistic computation in neural circuits. These results provide direct evidence for a neural mechanism mediating a simple and widespread form of statistical inference.	[Fetsch, Christopher R.; DeAngelis, Gregory C.; Angelaki, Dora E.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [Pouget, Alexandre; DeAngelis, Gregory C.] Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY USA; [Pouget, Alexandre] Univ Geneva, Dept Basic Neurosci, Geneva, Switzerland; [Angelaki, Dora E.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA	Washington University (WUSTL); University of Rochester; University of Geneva; Baylor College of Medicine	Fetsch, CR (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA.	crfetsch@u.washington.edu		Pouget, Alexandre/0000-0003-3054-6365; DeAngelis, Gregory/0000-0002-1635-1273	US National Institutes of Health [EY019087, EY016178]; US National Institutes of Health Institutional National Research Service [5-T32-EY13360-07]; National Science Foundation [BCS0446730]; Multidisciplinary University Research Initiative [N00014-07-1-0937]; James McDonnell Foundation; NATIONAL EYE INSTITUTE [R01EY016178, R01EY019087, T32EY013360] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institutes of Health Institutional National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Multidisciplinary University Research Initiative(MURI); James McDonnell Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank A. Turner, J. Arand, H. Schoknecht, B. Adeyemo and J. Lin for animal care and technical help, and V. Rao, S. Nelson and M. Jazayeri for discussions and comments on the manuscript. We are indebted to Y. Guan and S. Liu for generously contributing data to this project. This work was supported by grants from the US National Institutes of Health (EY019087 to D. E. A. and EY016178 to G. C. D.) and a US National Institutes of Health Institutional National Research Service Award (5-T32-EY13360-07 supporting C. R. F.). A. P. was supported by grants from the National Science Foundation (BCS0446730), Multidisciplinary University Research Initiative (N00014-07-1-0937) and the James McDonnell Foundation.	Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; Battaglia PW, 2003, J OPT SOC AM A, V20, P1391, DOI 10.1364/JOSAA.20.001391; Bremmer F, 2002, EUR J NEUROSCI, V16, P1569, DOI 10.1046/j.1460-9568.2002.02206.x; BRITTEN KH, 1993, VISUAL NEUROSCI, V10, P1157, DOI 10.1017/S0952523800010269; Chen AH, 2011, J NEUROSCI, V31, P12036, DOI 10.1523/JNEUROSCI.0395-11.2011; Cheng K, 2007, PSYCHOL BULL, V133, P625, DOI 10.1037/0033-2909.133.4.625; Clark J.J., 1990, DATA FUSION SENSORY; COCHRAN W. G., 1937, J. Roy. Statist. Soc. 1937., (Suppl.), V4, P102; Dayan P., 2001, THEORETICAL NEUROSCI; Duffy CJ, 1998, J NEUROPHYSIOL, V80, P1816, DOI 10.1152/jn.1998.80.4.1816; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Fetsch CR, 2010, J NEUROPHYSIOL, V104, P1506, DOI 10.1152/jn.91247.2008; Fetsch CR, 2009, J NEUROSCI, V29, P15601, DOI 10.1523/JNEUROSCI.2574-09.2009; FOLDIAK P, 1993, COMPUTATION AND NEURAL SYSTEMS, P55; Fukushima K, 1997, EXP BRAIN RES, V117, P1, DOI 10.1007/PL00005786; Fukushima K, 2008, NEURAL NETWORKS, V21, P774, DOI 10.1016/j.neunet.2007.12.049; Gu Y, 2006, J NEUROSCI, V26, P73, DOI 10.1523/JNEUROSCI.2356-05.2006; Gu Y, 2008, NAT NEUROSCI, V11, P1201, DOI 10.1038/nn.2191; Gu Y, 2007, NAT NEUROSCI, V10, P1038, DOI 10.1038/nn1935; Gu Y, 2010, NEURON, V66, P596, DOI 10.1016/j.neuron.2010.04.026; Heuer HW, 2007, J NEUROPHYSIOL, V98, P1115, DOI 10.1152/jn.00083.2007; Hillis JM, 2004, J VISION, V4, P967, DOI 10.1167/4.12.1; Jacobs RA, 1999, VISION RES, V39, P3621, DOI 10.1016/S0042-6989(99)00088-7; Jazayeri M, 2006, NAT NEUROSCI, V9, P690, DOI 10.1038/nn1691; Knill DC, 2007, J VISION, V7, DOI 10.1167/7.5.i; Knill DC, 2003, VISION RES, V43, P2539, DOI 10.1016/S0042-6989(03)00458-9; Knill DC, 2004, TRENDS NEUROSCI, V27, P712, DOI 10.1016/j.tins.2004.10.007; Knill DC, 1996, PERCEPTION BAYESIAN; Kording KP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000943; KOMATSU H, 1988, J NEUROPHYSIOL, V60, P580, DOI 10.1152/jn.1988.60.2.580; Landy M.S., 2011, SENSORY CUE INTEGRAT, P5, DOI [10.1093/acprof:oso/9780195387247.003.0001, DOI 10.1093/ACPROF:OSO/9780195387247.003.0001]; LANDY MS, 1995, VISION RES, V35, P389, DOI 10.1016/0042-6989(94)00176-M; Lappe M, 1996, J NEUROSCI, V16, P6265; Lewis JW, 2000, J COMP NEUROL, V428, P112, DOI 10.1002/1096-9861(20001204)428:1<112::AID-CNE8>3.0.CO;2-9; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; MAUNSELL JHR, 1983, J NEUROSCI, V3, P2563; Morgan ML, 2008, NEURON, V59, P662, DOI 10.1016/j.neuron.2008.06.024; Ohshiro T, 2011, NAT NEUROSCI, V14, P775, DOI 10.1038/nn.2815; Perrone JA, 1998, J NEUROSCI, V18, P5958; Rosas P, 2005, J OPT SOC AM A, V22, P801, DOI 10.1364/JOSAA.22.000801; Sanger TD, 1996, J NEUROPHYSIOL, V76, P2790, DOI 10.1152/jn.1996.76.4.2790; STANTON GB, 1995, J COMP NEUROL, V353, P291, DOI 10.1002/cne.903530210; Stein BE., 1993, MERGING SENSES; Takahashi K, 2007, J NEUROSCI, V27, P9742, DOI 10.1523/JNEUROSCI.0817-07.2007; TANAKA K, 1989, J NEUROPHYSIOL, V62, P626, DOI 10.1152/jn.1989.62.3.626; van Beers RJ, 2002, CURR BIOL, V12, P834, DOI 10.1016/S0960-9822(02)00836-9; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Xiao Q, 2006, VISUAL NEUROSCI, V23, P49, DOI 10.1017/S0952523806231055; YOUNG MJ, 1993, VISION RES, V33, P2685, DOI 10.1016/0042-6989(93)90228-O	50	250	252	1	67	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2012	15	1					146	U185		10.1038/nn.2983	http://dx.doi.org/10.1038/nn.2983			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866VO	22101645	Green Accepted			2022-12-17	WOS:000298414400025
J	Brill, MS; Ninkovic, J; Winpenny, E; Hodge, RD; Ozen, I; Yang, R; Lepier, A; Gascon, S; Erdelyi, F; Szabo, G; Parras, C; Guillemot, F; Frotscher, M; Berninger, B; Hevner, RF; Raineteau, O; Gotz, M				Brill, Monika S.; Ninkovic, Jovica; Winpenny, Eleanor; Hodge, Rebecca D.; Ozen, Ilknur; Yang, Roderick; Lepier, Alexandra; Gascon, Sergio; Erdelyi, Ferenc; Szabo, Gabor; Parras, Carlos; Guillemot, Francois; Frotscher, Michael; Berninger, Benedikt; Hevner, Robert F.; Raineteau, Olivier; Goetz, Magdalena			Adult generation of glutamatergic olfactory bulb interneurons	NATURE NEUROSCIENCE			English	Article							NEURAL STEM-CELLS; CORTICAL INTERNEURONS; PRONEURAL GENES; CEREBRAL-CORTEX; NEUROGENESIS; NEURONS; BRAIN; SPECIFICATION; PROGENITORS; MICE	The adult mouse subependymal zone (SEZ) harbors neural stem cells that are thought to exclusively generate GABAergic interneurons of the olfactory bulb. We examined the adult generation of glutamatergic juxtaglomerular neurons, which had dendritic arborizations that projected into adjacent glomeruli, identifying them as short-axon cells. Fate mapping revealed that these originate from Neurog2- and Tbr2-expressing progenitors located in the dorsal region of the SEZ. Examination of the progenitors of these glutamatergic interneurons allowed us to determine the sequential expression of transcription factors in these cells that are thought to be hallmarks of glutamatergic neurogenesis in the developing cerebral cortex and adult hippocampus. Indeed, the molecular specification of these SEZ progenitors allowed for their recruitment into the cerebral cortex after a lesion was induced. Taken together, our data indicate that SEZ progenitors not only produce a population of adult-born glutamatergic juxtaglomerular neurons, but may also provide a previously unknown source of progenitors for endogenous repair.	[Hodge, Rebecca D.; Yang, Roderick; Hevner, Robert F.] Univ Washington, Seattle Childrens Hosp, Res Inst, Dept Neurol Surg, Seattle, WA 98195 USA; [Hodge, Rebecca D.; Yang, Roderick; Hevner, Robert F.] Univ Washington, Seattle Childrens Hosp, Res Inst, Dept Pathol, Seattle, WA 98195 USA; [Brill, Monika S.; Lepier, Alexandra; Gascon, Sergio; Berninger, Benedikt; Goetz, Magdalena] Univ Munich, Inst Physiol, Dept Physiol Genom, D-8000 Munich, Germany; [Brill, Monika S.; Ninkovic, Jovica; Gascon, Sergio; Berninger, Benedikt; Goetz, Magdalena] German Res Ctr Environm Hlth, Inst Stem Cell Res, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Brill, Monika S.; Ninkovic, Jovica; Goetz, Magdalena] Munich Ctr Integrated Prot Sci CiPSM, Munich, Germany; [Winpenny, Eleanor; Ozen, Ilknur; Raineteau, Olivier] Cambridge Ctr Brain Repair, Cambridge, England; [Erdelyi, Ferenc; Szabo, Gabor] Hungarian Acad Sci, Inst Expt Med, Lab Mol Biol & Genet, Budapest, Hungary; [Parras, Carlos; Guillemot, Francois] Natl Inst Med Res, Div Mol Neurobiol, MRC, London NW7 1AA, England; [Frotscher, Michael] Univ Freiburg, Inst Anat & Cell Biol, Freiburg, Germany	Seattle Children's Hospital; University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Cambridge; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; MRC National Institute for Medical Research; University of Freiburg	Hevner, RF (corresponding author), Univ Washington, Seattle Childrens Hosp, Res Inst, Dept Neurol Surg, Seattle, WA 98195 USA.	rhevner@u.washington.edu; raineteau@hifo.uzh.ch; magdalena.goetz@helmholtz-meunchen.de	Raineteau, Olivier/I-1190-2014; Szabo, Gabor/A-5087-2008; Berninger, Benedikt/H-4098-2019; Guillemot, Francois/AAV-1482-2021; Parras, Carlos/G-6611-2017; Ninkovic, Jovica/AAH-5220-2019	Raineteau, Olivier/0000-0003-4294-2496; Szabo, Gabor/0000-0001-5438-5151; Berninger, Benedikt/0000-0003-2652-2782; Parras, Carlos/0000-0003-0248-1752; Ninkovic, Jovica/0000-0002-4381-0041; Gascon, Sergio/0000-0001-8756-7082; Brill, Monika/0000-0001-5422-9175; Winpenny, Eleanor/0000-0003-1933-0168	Deutsche Forschungsgemeinschaft,; European Union; Bundesministerium fur Bildung und Forschung; Bavarian State Ministry of Sciences, Research and the Arts; Medical Research Council; John & Lucille van Geest Foundation; Dr. Scholl Foundation; European Commission Research and Technological Development program; Institut national de la sante et de la recherche medicale and Fondation de France; Canada Research Fellowship; US National Institutes of Health [R01 NS050248, R01 MH080766]; MRC [MC_U117570528] Funding Source: UKRI; Medical Research Council [MC_U117570528] Funding Source: researchfish; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080766] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050248] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft,(German Research Foundation (DFG)); European Union(European Commission); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Bavarian State Ministry of Sciences, Research and the Arts; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); John & Lucille van Geest Foundation; Dr. Scholl Foundation; European Commission Research and Technological Development program(European CommissionEuropean Commission Joint Research Centre); Institut national de la sante et de la recherche medicale and Fondation de France(Institut National de la Sante et de la Recherche Medicale (Inserm)); Canada Research Fellowship; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank F. Bedogni for invaluable advice on methods and we are particularly grateful to Y. Yanagawa for the Gad67::gfp mice. We would also like to thank T. Simon-Ebert, A. Steiner, T. Ozturk and S. Nestel for excellent technical assistance and S. Bauer for retroviral production. We would also like to thank A. Saghatelyan for invaluable discussions and comments on the manuscript. This work was supported by grants from the Deutsche Forschungsgemeinschaft, including the excellence cluster Center for Integrated Protein Science Munich, by European Transcriptome, Regulome and Cellular Commitment Consortium from the European Union and the Bundesministerium fur Bildung und Forschung to M. G., and the Bavarian State Ministry of Sciences, Research and the Arts (ForNeuroCell) to B. B. and M. G. E. W. was supported by a fellowship from the Medical Research Council, I. O. by a fellowship from the John & Lucille van Geest Foundation and O. R. by a grant from the Dr. Scholl Foundation. Research in the laboratory of F. G. is supported by funds from the Medical Research Council and grants from the European Commission Research and Technological Development program. C. P. is presently supported by an AVENIR-contract from Institut national de la sante et de la recherche medicale and Fondation de France. R. D. H. is supported by a Heart and Stroke Fund of Canada Research Fellowship. Work done in the laboratory of R. F. H. was supported by grants from the US National Institutes of Health (R01 NS050248 and R01 MH080766).	Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Aungst JL, 2003, NATURE, V426, P623, DOI 10.1038/nature02185; Berger J, 2004, GENESIS, V40, P195, DOI 10.1002/gene.20081; Berninger B, 2007, EUR J NEUROSCI, V25, P2581, DOI 10.1111/j.1460-9568.2007.05509.x; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Brill MS, 2008, J NEUROSCI, V28, P6439, DOI 10.1523/JNEUROSCI.0700-08.2008; Chen JH, 2004, P NATL ACAD SCI USA, V101, P16357, DOI 10.1073/pnas.0406795101; Dellovade TL, 1998, J COMP NEUROL, V402, P402; Eyre MD, 2009, EUR J NEUROSCI, V29, P1397, DOI 10.1111/j.1460-9568.2009.06703.x; Faiz M, 2008, MOL CELL NEUROSCI, V38, P170, DOI 10.1016/j.mcn.2008.02.002; Gabellec MM, 2007, EUR J NEUROSCI, V25, P1373, DOI 10.1111/j.1460-9568.2007.05400.x; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gascon S, 2008, J NEUROSCI METH, V168, P104, DOI 10.1016/j.jneumeth.2007.09.023; Geschwind D, 2004, LANCET NEUROL, V3, P82, DOI 10.1016/S1474-4422(03)00658-6; Goings GE, 2004, BRAIN RES, V996, P213, DOI 10.1016/j.brainres.2003.10.034; Hack MA, 2005, NAT NEUROSCI, V8, P865, DOI 10.1038/nn1479; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; Hevner RF, 2006, NEUROSCI RES, V55, P223, DOI 10.1016/j.neures.2006.03.004; Israsena N, 2004, DEV BIOL, V268, P220, DOI 10.1016/j.ydbio.2003.12.024; Jessberger S, 2007, J NEUROSCI, V27, P9400, DOI 10.1523/JNEUROSCI.2002-07.2007; Kohwi M, 2007, J NEUROSCI, V27, P6878, DOI 10.1523/JNEUROSCI.0254-07.2007; Kokaia Z, 2003, CURR OPIN NEUROBIOL, V13, P127, DOI 10.1016/S0959-4388(03)00017-5; Kowalczyk T, 2009, CEREB CORTEX, V19, P2439, DOI 10.1093/cercor/bhn260; Kroll TT, 2005, P NATL ACAD SCI USA, V102, P7374, DOI 10.1073/pnas.0500819102; Liu XX, 2005, NAT NEUROSCI, V8, P1179, DOI 10.1038/nn1522; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Lopez-Bendito G, 2004, CEREB CORTEX, V14, P1122, DOI 10.1093/cercor/bhh072; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Magavi SSP, 2005, J NEUROSCI, V25, P10729, DOI 10.1523/JNEUROSCI.2250-05.2005; Merkle FT, 2007, SCIENCE, V317, P381, DOI 10.1126/science.1144914; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Mori T, 2006, GLIA, V54, P21, DOI 10.1002/glia.20350; Mouret A, 2008, J NEUROSCI, V28, P11511, DOI 10.1523/JNEUROSCI.2954-08.2008; Murphy GJ, 2003, NEURON, V37, P639, DOI 10.1016/S0896-6273(03)00057-6; Nikoletopoulou V, 2007, CELL STEM CELL, V1, P529, DOI 10.1016/j.stem.2007.08.011; Ninkovic J, 2007, J NEUROSCI, V27, P10906, DOI 10.1523/JNEUROSCI.2572-07.2007; Ohmomo H, 2009, NEUROSCIENCE, V160, P419, DOI 10.1016/j.neuroscience.2009.02.048; Parras CM, 2004, EMBO J, V23, P4495, DOI 10.1038/sj.emboj.7600447; Parras CM, 2002, GENE DEV, V16, P324, DOI 10.1101/gad.940902; PINCHING AJ, 1971, J CELL SCI, V9, P305; Roybon L, 2009, EUR J NEUROSCI, V29, P232, DOI 10.1111/j.1460-9568.2008.06595.x; Scardigli R, 2003, DEVELOPMENT, V130, P3269, DOI 10.1242/dev.00539; Schuurmans C, 2004, EMBO J, V23, P2892, DOI 10.1038/sj.emboj.7600278; Seibt J, 2003, NEURON, V39, P439, DOI 10.1016/S0896-6273(03)00435-5; Sohur US, 2006, PHILOS T R SOC B, V361, P1477, DOI 10.1098/rstb.2006.1887; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Waclaw RR, 2006, NEURON, V49, P503, DOI 10.1016/j.neuron.2006.01.018; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954; Young KM, 2007, J NEUROSCI, V27, P8286, DOI 10.1523/JNEUROSCI.0476-07.2007	50	250	257	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2009	12	12					1524	U69		10.1038/nn.2416	http://dx.doi.org/10.1038/nn.2416			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	523II	19881504	Green Accepted			2022-12-17	WOS:000272065600012
J	Karadottir, R; Hamilton, NB; Bakiri, Y; Attwell, D				Karadottir, Ragnhildur; Hamilton, Nicola B.; Bakiri, Yamina; Attwell, David			Spiking and nonspiking classes of oligodendrocyte precursor glia in CNS white matter	NATURE NEUROSCIENCE			English	Article							RAT SPINAL-CORD; PROGENITOR CELLS; NG2 PROTEOGLYCAN; PHYSIOLOGICAL-PROPERTIES; NG2-POSITIVE CELLS; ALPHA-RECEPTOR; ADULT CNS; AREA CA1; BRAIN; GLUTAMATE	A defining feature of glial cells has been their inability to generate action potentials. We show here that there are two distinct types of morphologically identical oligodendrocyte precursor glial cells (OPCs) in situ in rat CNS white matter. One type expresses voltage-gated sodium and potassium channels, generates action potentials when depolarized and senses its environment by receiving excitatory and inhibitory synaptic input from axons. The other type lacks action potentials and synaptic input. We found that when OPCs suffered glutamate-mediated damage, as occurs in cerebral palsy, stroke and spinal cord injury, the action potential-generating OPCs were preferentially damaged, as they expressed more glutamate receptors, and received increased spontaneous glutamatergic synaptic input in ischemia. These data challenge the idea that only neurons generate action potentials in the CNS and imply that the development of therapies for demyelinating disorders will require defining which OPC type can carry out remyelination.	[Karadottir, Ragnhildur; Hamilton, Nicola B.; Bakiri, Yamina; Attwell, David] UCL, Dept Physiol, London WC1E 6BT, England	University of London; University College London	Karadottir, R (corresponding author), Univ Cambridge, Dept Vet Med, Madingley Rd, Cambridge CB3 0ES, England.	rk385@cam.ac.uk	Hamilton, Nicola/C-2108-2008; Messier, Claude/A-2322-2008; Attwell, David/ABE-6750-2020; Hamilton-Whitaker, Nicola/H-8867-2012	Messier, Claude/0000-0002-4791-1763; Hamilton-Whitaker, Nicola/0000-0002-0168-8068; Karadottir, Ragnhildur Thora/0000-0001-9675-2722	Medical Research Council [G0300723, G0800784] Funding Source: Medline; Wellcome Trust [065424, 075232] Funding Source: Medline; MRC [G0300723] Funding Source: UKRI; Medical Research Council [G0300723B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Allen NJ, 2004, J PHYSIOL-LONDON, V561, P485, DOI 10.1113/jphysiol.2004.070490; Allen NJ, 2005, J NEUROSCI, V25, P848, DOI 10.1523/JNEUROSCI.4157-04.2005; Alonso G, 2005, GLIA, V49, P318, DOI 10.1002/glia.20121; Back SA, 2001, J NEUROSCI, V21, P1302; BARRES BA, 1990, NEURON, V4, P507, DOI 10.1016/0896-6273(90)90109-S; Chittajallu R, 2005, J NEUROSCI, V25, P8601, DOI 10.1523/JNEUROSCI.2122-05.2005; Chittajallu R, 2004, J PHYSIOL-LONDON, V561, P109, DOI 10.1113/jphysiol.2004.074252; Dawson MRL, 2003, MOL CELL NEUROSCI, V24, P476, DOI 10.1016/S1044-7431(03)00210-0; Dawson MRL, 2000, J NEUROSCI RES, V61, P471, DOI 10.1002/1097-4547(20000901)61:5<471::AID-JNR1>3.0.CO;2-N; Dayer AG, 2005, J CELL BIOL, V168, P415, DOI 10.1083/jcb.200407053; Follett PL, 2000, J NEUROSCI, V20, P9235; Fukuda A, 1998, J NEUROPHYSIOL, V79, P430, DOI 10.1152/jn.1998.79.1.430; Gensert JM, 1997, NEURON, V19, P197, DOI 10.1016/S0896-6273(00)80359-1; GROVES AK, 1993, NATURE, V362, P453, DOI 10.1038/362453a0; Horner PJ, 2000, J NEUROSCI, V20, P2218; Horner PJ, 2002, J NEUROCYTOL, V31, P469, DOI 10.1023/A:1025739630398; Karadottir R, 2007, NEUROSCIENCE, V145, P1426, DOI 10.1016/j.neuroscience.2006.08.070; Karadottir R, 2005, NATURE, V438, P1162, DOI 10.1038/nature04302; Karadottir R, 2006, NAT PROTOC, V1, P1977, DOI 10.1038/nprot.2006.261; KAWASAKI K, 1990, J NEUROPHYSIOL, V63, P385, DOI 10.1152/jn.1990.63.3.385; Keirstead HS, 1998, GLIA, V22, P161, DOI 10.1002/(SICI)1098-1136(199802)22:2<161::AID-GLIA7>3.0.CO;2-A; Kondo RP, 2000, J MOL CELL CARDIOL, V32, P1859, DOI 10.1006/jmcc.2000.1220; Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754; Kukley M, 2007, NAT NEUROSCI, V10, P311, DOI 10.1038/nn1850; LEVINE JM, 1994, J NEUROSCI, V14, P4716; Levine JM, 2001, TRENDS NEUROSCI, V24, P39, DOI 10.1016/S0166-2236(00)01691-X; Li S, 1999, J Neurosci, V19, pRC16; Ligon KL, 2006, P NATL ACAD SCI USA, V103, P7853, DOI 10.1073/pnas.0511001103; Ligon KL, 2004, J NEUROPATH EXP NEUR, V63, P499, DOI 10.1093/jnen/63.5.499; Marie Y, 2001, LANCET, V358, P298, DOI 10.1016/S0140-6736(01)05499-X; McTigue DM, 2001, J NEUROSCI, V21, P3392, DOI 10.1523/JNEUROSCI.21-10-03392.2001; Newell EW, 2005, J PHYSIOL-LONDON, V567, P869, DOI 10.1113/jphysiol.2005.092056; Nishiyama A, 1996, J NEUROSCI RES, V43, P299, DOI 10.1002/(SICI)1097-4547(19960201)43:3<299::AID-JNR5>3.0.CO;2-E; Nishiyama A, 2002, J NEUROCYTOL, V31, P437, DOI 10.1023/A:1025783412651; Patt S, 1996, NEUROSCIENCE, V71, P601, DOI 10.1016/0306-4522(95)00468-8; Peppiatt CM, 2006, NATURE, V443, P700, DOI 10.1038/nature05193; Stallcup WB, 2002, J NEUROCYTOL, V31, P423, DOI 10.1023/A:1025731428581; Volpe JJ, 2001, PEDIATR RES, V50, P553, DOI 10.1203/00006450-200111000-00003; VORNOV JJ, 1991, EXP NEUROL, V114, P11, DOI 10.1016/0014-4886(91)90079-R; Ziskin JL, 2007, NAT NEUROSCI, V10, P321, DOI 10.1038/nn1854	40	250	253	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2008	11	4					450	456		10.1038/nn2060	http://dx.doi.org/10.1038/nn2060			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	279MM	18311136	Green Accepted			2022-12-17	WOS:000254359300017
J	Brincat, SL; Connor, CE				Brincat, SL; Connor, CE			Underlying principles of visual shape selectivity in posterior inferotemporal cortex	NATURE NEUROSCIENCE			English	Article							INFERIOR TEMPORAL NEURONS; OBJECT RECOGNITION; 3-DIMENSIONAL SHAPES; RECEPTIVE-FIELDS; TERM-MEMORY; AREA V4; MACAQUE; RESPONSES; VISION; FEATURES	Object perception depends on shape processing in the ventral visual pathway, which in monkeys culminates in inferotemporal cortex (IT). Here we provide a description of fundamental quantitative principles governing neural selectivity for complex shape in IT. By measuring responses to large, parametric sets of two-dimensional (2D) silhouette shapes, we found that neurons in posterior IT (Brodmann's areas TEO and posterior TE) integrate information about multiple contour elements (straight and curved edge fragments of the type represented in lower-level areas) using both linear and nonlinear mechanisms. This results in complex, distributed response patterns that cannot be characterized solely in terms of example stimuli. We explained these response patterns with tuning functions in multidimensional shape space and accurately predicted neural responses to the widely varying shapes in our stimulus set. Integration of contour element information in earlier stages of IT represents an important step in the transformation from low-level shape signals to complex object representation.	Johns Hopkins Univ, Zanvyl Krieger Mind Brain Inst, Baltimore, MD 21218 USA; Johns Hopkins Univ, Dept Neurosci, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University	Connor, CE (corresponding author), Johns Hopkins Univ, Zanvyl Krieger Mind Brain Inst, Baltimore, MD 21218 USA.	connor@jhu.edu						ALBRIGHT TD, 1990, P INT C FUZZY LOGIC, V2, P375; Baker CI, 2002, NAT NEUROSCI, V5, P1210, DOI 10.1038/nn960; Barlow H, 2001, NETWORK-COMP NEURAL, V12, P241, DOI 10.1088/0954-898X/12/3/301; BIEDERMAN I, 1987, PSYCHOL REV, V94, P115, DOI 10.1037/0033-295X.94.2.115; Booth MCA, 1998, CEREB CORTEX, V8, P510, DOI 10.1093/cercor/8.6.510; Carandini M, 1997, J NEUROSCI, V17, P8621; Conner CE, 1997, J NEUROSCI, V17, P3201; DiCarlo JJ, 2003, J NEUROPHYSIOL, V89, P3264, DOI 10.1152/jn.00358.2002; Edelman S, 2003, COGNITIVE SCI, V27, P73, DOI 10.1207/s15516709cog2701_3; FUJITA I, 1992, NATURE, V360, P343, DOI 10.1038/360343a0; GALLANT JL, 1993, SCIENCE, V259, P100, DOI 10.1126/science.8418487; GOCHIN PM, 1994, J NEUROPHYSIOL, V71, P2325, DOI 10.1152/jn.1994.71.6.2325; GROSS CG, 1972, J NEUROPHYSIOL, V35, P96, DOI 10.1152/jn.1972.35.1.96; HOFFMAN DD, 1984, COGNITION, V18, P65, DOI 10.1016/0010-0277(84)90022-2; ITO M, 1995, J NEUROPHYSIOL, V73, P218, DOI 10.1152/jn.1995.73.1.218; Janssen P, 1999, P NATL ACAD SCI USA, V96, P8217, DOI 10.1073/pnas.96.14.8217; JONES JP, 1987, J NEUROPHYSIOL, V58, P1187, DOI 10.1152/jn.1987.58.6.1187; Kapadia MK, 2000, J NEUROPHYSIOL, V84, P2048, DOI 10.1152/jn.2000.84.4.2048; Kimia BB, 2003, J PHYSIOL-PARIS, V97, P155, DOI 10.1016/j.jphysparis.2003.09.003; KOBATAKE E, 1994, J NEUROPHYSIOL, V71, P856, DOI 10.1152/jn.1994.71.3.856; Kovacs G, 2003, CEREB CORTEX, V13, P178, DOI 10.1093/cercor/13.2.178; LEYTON M, 1998, GENERATIVE THEORY SH; MARR D, 1978, PROC R SOC SER B-BIO, V200, P269, DOI 10.1098/rspb.1978.0020; Mechler F, 2002, VISION RES, V42, P1017, DOI 10.1016/S0042-6989(02)00025-1; Mel BW, 2000, NEURAL COMPUT, V12, P731, DOI 10.1162/089976600300015574; MILLER EK, 1994, SCIENCE, V263, P520, DOI 10.1126/science.8290960; Olshausen BA, 1997, VISION RES, V37, P3311, DOI 10.1016/S0042-6989(97)00169-7; OLSON CR, 1995, SCIENCE, V269, P985, DOI 10.1126/science.7638625; Op de Beeck H, 2001, NAT NEUROSCI, V4, P1244, DOI 10.1038/nn767; Op De Beeck H, 2000, J COMP NEUROL, V426, P505, DOI 10.1002/1096-9861(20001030)426:4<505::AID-CNE1>3.0.CO;2-M; OPTICAN LM, 1987, J NEUROPHYSIOL, V57, P162, DOI 10.1152/jn.1987.57.1.162; Pasupathy A, 2002, NAT NEUROSCI, V5, P1332, DOI 10.1038/nn972; Polat U, 1998, NATURE, V391, P580, DOI 10.1038/35372; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; Ringach DL, 1997, VISION RES, V37, P2455, DOI 10.1016/S0042-6989(96)00247-7; Rolls ET, 1997, EXP BRAIN RES, V114, P149, DOI 10.1007/PL00005615; SAKAI K, 1991, NATURE, V354, P152, DOI 10.1038/354152a0; Salinas E, 1997, J NEUROPHYSIOL, V77, P3267, DOI 10.1152/jn.1997.77.6.3267; SCHWARTZ EL, 1983, P NATL ACAD SCI-BIOL, V80, P5776, DOI 10.1073/pnas.80.18.5776; Sigala N, 2002, NATURE, V415, P318, DOI 10.1038/415318a; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Theunissen FE, 2001, NETWORK-COMP NEURAL, V12, P289, DOI 10.1088/0954-898X/12/3/304; Tsunoda K, 2001, NAT NEUROSCI, V4, P832, DOI 10.1038/90547; Ullman S, 1998, COGNITION, V67, P21, DOI 10.1016/S0010-0277(98)00013-4; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; Wang Y, 2000, NAT NEUROSCI, V3, P807, DOI 10.1038/77712; Wilson HR, 1997, VISION RES, V37, P2325, DOI 10.1016/S0042-6989(97)00104-1; WOLFE JM, 1992, PERCEPTION, V21, P465, DOI 10.1068/p210465; YOUNG MP, 1992, SCIENCE, V256, P1327, DOI 10.1126/science.1598577; Zhou H, 2000, J NEUROSCI, V20, P6594, DOI 10.1523/JNEUROSCI.20-17-06594.2000	50	250	252	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2004	7	8					880	886		10.1038/nn1278	http://dx.doi.org/10.1038/nn1278			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841LH	15235606				2022-12-17	WOS:000222930800019
J	Sivasankaran, R; Pei, J; Wang, KC; Zhang, YP; Shields, CB; Xu, XM; He, ZG				Sivasankaran, R; Pei, J; Wang, KC; Zhang, YP; Shields, CB; Xu, XM; He, ZG			PKC mediates inhibitory effects of myelin and chondroitin sulfate proteoglycans on axonal regeneration	NATURE NEUROSCIENCE			English	Article							SPINAL-CORD-INJURY; PROTEIN-KINASE-C; NEURITE GROWTH-INHIBITORS; NOGO RECEPTOR; GLYCOPROTEIN INTERACTS; CONE COLLAPSE; CELL-ADHESION; RHO-GTPASES; CYCLIC-AMP; OUTGROWTH	Successful axon regeneration in the mammalian central nervous system (CNS) is at least partially compromised due to the inhibitors associated with myelin and glial scar. However, the intracellular signaling mechanisms underlying these inhibitory activities are largely unknown. Here we provide biochemical and functional evidence that conventional isoforms of protein kinase C (PKC) are key components in the signaling pathways that mediate the inhibitory activities of myelin components and chondroitin sulfate proteoglycans (CSPGs), the major class of inhibitors in the glial scar. Both the myelin inhibitors and CSPGs induce PKC activation. Blocking PKC activity pharmacologically and genetically attenuates the ability of CNS myelin and CSPGs to activate Rho and inhibit neurite outgrowth. Intrathecal infusion of a PKC inhibitor, Go6976, into the site of dorsal hemisection promotes regeneration of dorsal column axons across and beyond the lesion site in adult rats. Thus, perturbing PKC activity could represent a therapeutic approach to stimulating axon regeneration after brain and spinal cord injuries.	Childrens Hosp, Div Neurosci, Boston, MA 02115 USA; Univ Louisville, Sch Med, Dept Neurol Surg, Kentucky Spinal Cord Injury Res Ctr, Louisville, KY 40292 USA; Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; University of Louisville; Harvard University; Harvard Medical School	He, ZG (corresponding author), Childrens Hosp, Div Neurosci, 320 Longwood Ave, Boston, MA 02115 USA.	xmxu0001@louisville.edu; zhigang.he@tch.harvard.edu		Wang, Kevin/0000-0002-5305-6791; Xu, Xiao-ming/0000-0002-7229-0081	NINDS NIH HHS [NS36350] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036350] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bamber NI, 2001, EUR J NEUROSCI, V13, P257, DOI 10.1046/j.1460-9568.2001.01387.x; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; BREGMAN BS, 1995, NATURE, V378, P498, DOI 10.1038/378498a0; BRITTIS PA, 1992, SCIENCE, V255, P733, DOI 10.1126/science.1738848; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Cai D, 2001, J NEUROSCI, V21, P4731, DOI 10.1523/JNEUROSCI.21-13-04731.2001; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; Dergham P, 2002, J NEUROSCI, V22, P6570; Domeniconi M, 2002, NEURON, V35, P283, DOI 10.1016/S0896-6273(02)00770-5; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559; Huang DW, 1999, NEURON, V24, P639, DOI 10.1016/S0896-6273(00)81118-6; Jaken S, 1996, CURR OPIN CELL BIOL, V8, P168, DOI 10.1016/S0955-0674(96)80062-7; Kaneto H, 2002, J BIOL CHEM, V277, P3680, DOI 10.1074/jbc.M109647200; Kottis V, 2002, J NEUROCHEM, V82, P1566, DOI 10.1046/j.1471-4159.2002.01146.x; Kuhn TB, 1999, J NEUROSCI, V19, P1965; Laux T, 2000, J CELL BIOL, V149, P1455, DOI 10.1083/jcb.149.7.1455; Lehmann M, 1999, J NEUROSCI, V19, P7537, DOI 10.1523/JNEUROSCI.19-17-07537.1999; Liu BP, 2002, SCIENCE, V297, P1190, DOI 10.1126/science.1073031; McGee AW, 2003, TRENDS NEUROSCI, V26, P193, DOI 10.1016/S0166-2236(03)00062-6; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; Ming GI, 1999, NEURON, V23, P139, DOI 10.1016/S0896-6273(00)80760-6; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; Neumann S, 2002, NEURON, V34, P885, DOI 10.1016/S0896-6273(02)00702-X; Neumann S, 1999, NEURON, V23, P83, DOI 10.1016/S0896-6273(00)80755-2; Prang P, 2001, EXP NEUROL, V169, P135, DOI 10.1006/exnr.2001.7648; Prinjha R, 2000, NATURE, V403, P383, DOI 10.1038/35000287; Qiu J, 2002, NEURON, V34, P895, DOI 10.1016/S0896-6273(02)00730-4; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; SAVIO T, 1989, J NEUROSCI, V9, P1126; SCHNELL L, 1990, NATURE, V343, P269, DOI 10.1038/343269a0; SCHWAB ME, 1988, J NEUROSCI, V8, P2381; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Slater SJ, 2001, BIOCHEMISTRY-US, V40, P4437, DOI 10.1021/bi001654n; SNOW DM, 1994, DEV BIOL, V166, P87, DOI 10.1006/dbio.1994.1298; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Spencer T, 2003, CURR OPIN NEUROBIOL, V13, P133, DOI 10.1016/S0959-4388(03)00012-6; Ughrin YM, 2003, J NEUROSCI, V23, P175; Vinson M, 2001, J BIOL CHEM, V276, P20280, DOI 10.1074/jbc.M100345200; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Winton MJ, 2002, J BIOL CHEM, V277, P32820, DOI 10.1074/jbc.M201195200; Wong K, 2001, CELL, V107, P209, DOI 10.1016/S0092-8674(01)00530-X; Wong ST, 2002, NAT NEUROSCI, V5, P1302, DOI 10.1038/nn975; Xu XM, 1999, EUR J NEUROSCI, V11, P1723, DOI 10.1046/j.1460-9568.1999.00591.x; Yiu G, 2003, CURR OPIN NEUROBIOL, V13, P545, DOI 10.1016/j.conb.2003.09.006	50	250	261	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2004	7	3					261	268		10.1038/nn1193	http://dx.doi.org/10.1038/nn1193			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	777UU	14770187				2022-12-17	WOS:000189197900016
J	Tate, S; Benn, S; Hick, C; Trezise, D; John, V; Mannion, RJ; Costigan, M; Plumpton, C; Grose, D; Gladwell, Z; Kendall, G; Dale, K; Bountra, C; Woolf, CJ				Tate, S; Benn, S; Hick, C; Trezise, D; John, V; Mannion, RJ; Costigan, M; Plumpton, C; Grose, D; Gladwell, Z; Kendall, G; Dale, K; Bountra, C; Woolf, CJ			Two sodium channels contribute to the TTX-R sodium current in primary sensory neurons	NATURE NEUROSCIENCE			English	Article							ROOT GANGLION NEURONS		Glaxo Wellcome Res & Dev Ltd, Med Res Ctr, Gene Funct Unit, Stevenage SG1 2NY, Herts, England; Glaxo Wellcome Res & Dev Ltd, Neurosci Unit, Stevenage SG1 2NY, Herts, England; Massachusetts Gen Hosp, Dept Anesthesia & Crit Care, Neural Plast Res Grp, Boston, MA 02129 USA; Harvard Univ, Sch Med, Boston, MA 02129 USA; Univ London Univ Coll, Dept Anat & Dev Biol, London WC1E 6BT, England	GlaxoSmithKline; GlaxoSmithKline; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of London; University College London	Tate, S (corresponding author), Glaxo Wellcome Res & Dev Ltd, Med Res Ctr, Gene Funct Unit, Stevenage SG1 2NY, Herts, England.		Woolf, Clifford/A-9784-2010		Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Akopian AN, 1996, NATURE, V379, P257, DOI 10.1038/379257a0; CAFFREY JM, 1992, BRAIN RES, V592, P283, DOI 10.1016/0006-8993(92)91687-A; CATTERALL WA, 1992, PHYSIOL REV, V72, P15; Dib-Hajj SD, 1998, P NATL ACAD SCI USA, V95, P8963, DOI 10.1073/pnas.95.15.8963; England S, 1996, J PHYSIOL-LONDON, V495, P429, DOI 10.1113/jphysiol.1996.sp021604; Gold MS, 1996, P NATL ACAD SCI USA, V93, P1108, DOI 10.1073/pnas.93.3.1108; Novakovic SD, 1998, J NEUROSCI, V18, P2174; RIZZO MA, 1994, J NEUROPHYSIOL, V72, P2796, DOI 10.1152/jn.1994.72.6.2796; ROY ML, 1992, J NEUROSCI, V12, P2104; Rush AM, 1997, NEUROSCI LETT, V226, P95, DOI 10.1016/S0304-3940(97)00258-9; Sangameswaran L, 1996, J BIOL CHEM, V271, P5953, DOI 10.1074/jbc.271.11.5953; Scholz A, 1998, EUR J NEUROSCI, V10, P2547, DOI 10.1046/j.1460-9568.1998.t01-1-00268.x; Sivilotti L, 1997, FEBS LETT, V409, P49, DOI 10.1016/S0014-5793(97)00479-1	13	250	258	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	1998	1	8					653	655		10.1038/3652	http://dx.doi.org/10.1038/3652			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	144PR	10196578				2022-12-17	WOS:000077323400006
J	Klinzing, JG; Niethard, N; Born, J				Klinzing, Jens G.; Niethard, Niels; Born, Jan			Mechanisms of systems memory consolidation during sleep	NATURE NEUROSCIENCE			English	Review							COMPLEMENTARY LEARNING-SYSTEMS; CLOSED-LOOP STIMULATION; SLOW-WAVE-SLEEP; REM-SLEEP; FALSE MEMORY; RIPPLE OSCILLATIONS; THETA-OSCILLATIONS; HUMAN HIPPOCAMPUS; PREFRONTAL THETA; VISUAL-CORTEX	Long-term memory formation is a major function of sleep. Based on evidence from neurophysiological and behavioral studies mainly in humans and rodents, we consider the formation of long-term memory during sleep as an active systems consolidation process that is embedded in a process of global synaptic downscaling. Repeated neuronal replay of representations originating from the hippocampus during slow-wave sleep leads to a gradual transformation and integration of representations in neocortical networks. We highlight three features of this process: (i) hippocampal replay that, by capturing episodic memory aspects, drives consolidation of both hippocampus-dependent and non-hippocampus-dependent memory; (ii) brain oscillations hall-marking slow-wave and rapid-eye movement sleep that provide mechanisms for regulating both information flow across distant brain networks and local synaptic plasticity; and (iii) qualitative transformations of memories during systems consolidation resulting in abstracted, gist-like representations.	[Klinzing, Jens G.; Niethard, Niels; Born, Jan] Univ Tubingen, Inst Med Psychol & Behav Neurobiol, Tubingen, Germany; [Klinzing, Jens G.; Born, Jan] Univ Tubingen, Ctr Integrat Neurosci, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen	Born, J (corresponding author), Univ Tubingen, Inst Med Psychol & Behav Neurobiol, Tubingen, Germany.; Born, J (corresponding author), Univ Tubingen, Ctr Integrat Neurosci, Tubingen, Germany.	jan.born@uni-tuebingen.de	Born, Jan/K-2596-2016; Niethard, Niels/AAQ-8372-2020	Born, Jan/0000-0002-1847-6248; Niethard, Niels/0000-0001-7939-1021; Klinzing, Jens/0000-0002-7012-096X	Deutsche Forschungsgemeinschaft [Tr-SFB 654, SFB 1233]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank E. Bolinger for proof-reading a previous version of the manuscript. This work was supported by grants from the Deutsche Forschungsgemeinschaft (Tr-SFB 654 "Sleep and Plasticity", SFB 1233 "Robust Vision"). We apologize to all authors whose work, although relevant, we did not mention due to space limitations.	Ahissar M, 2004, TRENDS COGN SCI, V8, P457, DOI 10.1016/j.tics.2004.08.011; Almeida DG, 2018, CELL MOL LIFE SCI, V75, P3715, DOI 10.1007/s00018-018-2886-9; Atherton LA, 2015, TRENDS NEUROSCI, V38, P560, DOI 10.1016/j.tins.2015.07.004; Bal T, 1996, NEURON, V17, P297, DOI 10.1016/S0896-6273(00)80161-0; Batterink LJ, 2014, NEUROPSYCHOLOGIA, V65, P169, DOI 10.1016/j.neuropsychologia.2014.10.024; Benchenane K, 2010, NEURON, V66, P921, DOI 10.1016/j.neuron.2010.05.013; Bendor D, 2012, NAT NEUROSCI, V15, P1439, DOI 10.1038/nn.3203; Bergmann TO, 2012, NEUROIMAGE, V59, P2733, DOI 10.1016/j.neuroimage.2011.10.036; Boyce R, 2016, SCIENCE, V352, P812, DOI 10.1126/science.aad5252; Brodt S, 2018, SCIENCE, V362, P1045, DOI 10.1126/science.aau2528; Brodt S, 2018, SLEEP, V41, DOI 10.1093/sleep/zsy155; Buzsaki G, 1996, CEREB CORTEX, V6, P81, DOI 10.1093/cercor/6.2.81; Buzsaki G, 2015, HIPPOCAMPUS, V25, P1073, DOI 10.1002/hipo.22488; Cai DJ, 2009, P NATL ACAD SCI USA, V106, P10130, DOI 10.1073/pnas.0900271106; Cairney SA, 2011, EXP BRAIN RES, V214, P83, DOI 10.1007/s00221-011-2808-7; Cantero JL, 2003, J NEUROSCI, V23, P10897; Chauvette S, 2012, NEURON, V75, P1105, DOI 10.1016/j.neuron.2012.08.034; Chen SX, 2015, NAT NEUROSCI, V18, P1109, DOI 10.1038/nn.4049; Chen Z, 2016, FRONT NEURAL CIRCUIT, V9, DOI 10.3389/fncir.2015.00083; Cheng S, 2008, NEURON, V57, P303, DOI 10.1016/j.neuron.2007.11.035; Cichon J, 2015, NATURE, V520, P180, DOI 10.1038/nature14251; Clemente-Perez A, 2017, CELL REP, V19, P2130, DOI 10.1016/j.celrep.2017.05.044; Cohen N, 2015, NEUROSCI BIOBEHAV R, V50, P128, DOI 10.1016/j.neubiorev.2014.11.002; Crunelli V, 2018, NAT REV NEUROSCI, V19, P106, DOI 10.1038/nrn.2017.151; de Lavilleon G, 2015, NAT NEUROSCI, V18, P493, DOI 10.1038/nn.3970; de Vivo L, 2017, SCIENCE, V355, P507, DOI 10.1126/science.aah5982; Deliens G, 2014, COGNITION EMOTION, V28, P698, DOI 10.1080/02699931.2013.844105; Diba K, 2007, NAT NEUROSCI, V10, P1241, DOI 10.1038/nn1961; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Diering GH, 2017, SCIENCE, V355, P511, DOI 10.1126/science.aai8355; Dudai Y, 2012, ANNU REV NEUROSCI, V35, P227, DOI 10.1146/annurev-neuro-062111-150500; Durkin J, 2017, P NATL ACAD SCI USA, V114, P10485, DOI 10.1073/pnas.1710613114; Ellenbogen JM, 2007, P NATL ACAD SCI USA, V104, P7723, DOI 10.1073/pnas.0700094104; Fenn KM, 2009, LEARN MEMORY, V16, P509, DOI 10.1101/lm.1500808; Frank MG, 2017, CURR OPIN NEUROBIOL, V44, P8, DOI 10.1016/j.conb.2017.01.001; Friedrich M, 2017, CURR BIOL, V27, P2374, DOI 10.1016/j.cub.2017.06.070; Friedrich M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7004; Gais S, 2002, J NEUROSCI, V22, P6830; Gais S, 2007, P NATL ACAD SCI USA, V104, P18778, DOI 10.1073/pnas.0705454104; Girardeau G, 2017, NAT NEUROSCI, V20, P1634, DOI 10.1038/nn.4637; Girardeau G, 2009, NAT NEUROSCI, V12, P1222, DOI 10.1038/nn.2384; Giri B, 2019, J NEUROSCI, V39, P866, DOI 10.1523/JNEUROSCI.1950-18.2018; GIUDITTA A, 1995, BEHAV BRAIN RES, V69, P157, DOI 10.1016/0166-4328(95)00012-I; Gomez RL, 2006, PSYCHOL SCI, V17, P670, DOI 10.1111/j.1467-9280.2006.01764.x; Gomperts SN, 2015, ELIFE, V4, DOI 10.7554/eLife.05360; Gonzalez-Rueda A, 2018, NEURON, V97, P1244, DOI 10.1016/j.neuron.2018.01.047; Grosmark AD, 2012, NEURON, V75, P1001, DOI 10.1016/j.neuron.2012.08.015; Gulati T, 2014, NAT NEUROSCI, V17, P1107, DOI 10.1038/nn.3759; Halassa MM, 2017, NAT NEUROSCI, V20, P1669, DOI 10.1038/s41593-017-0020-1; Halassa MM, 2014, CELL, V158, P808, DOI 10.1016/j.cell.2014.06.025; Hasselmo ME, 2004, PROG BRAIN RES, V145, P207, DOI 10.1016/S0079-6123(03)45015-2; Helfrich RF, 2018, NEURON, V97, P221, DOI 10.1016/j.neuron.2017.11.020; Hoffman KL, 2002, SCIENCE, V297, P2070, DOI 10.1126/science.1073538; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Huber R, 2006, NAT NEUROSCI, V9, P1169, DOI 10.1038/nn1758; Huber R, 2013, CEREB CORTEX, V23, P1, DOI 10.1093/cercor/bhs014; Inostroza M, 2013, BEHAV BRAIN RES, V237, P15, DOI 10.1016/j.bbr.2012.09.011; Jenkins JG, 1924, AM J PSYCHOL, V35, P605, DOI 10.2307/1414040; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Kastellakis G, 2015, PROG NEUROBIOL, V126, P19, DOI 10.1016/j.pneurobio.2014.12.002; Khazipov R, 2004, NATURE, V432, P758, DOI 10.1038/nature03132; Khodagholy D, 2017, SCIENCE, V358, P369, DOI 10.1126/science.aan6203; King BR, 2017, NEUROSCI BIOBEHAV R, V80, P1, DOI 10.1016/j.neubiorev.2017.04.026; Klinzing JG, 2016, NEUROIMAGE, V134, P607, DOI 10.1016/j.neuroimage.2016.04.031; Kudrimoti HS, 1999, J NEUROSCI, V19, P4090; Kuhn M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12455; Kumaran D, 2016, TRENDS COGN SCI, V20, P512, DOI 10.1016/j.tics.2016.05.004; Ladenbauer J, 2017, J NEUROSCI, V37, P7111, DOI 10.1523/JNEUROSCI.0260-17.2017; Lansink CS, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000173; Latchoumane CFV, 2017, NEURON, V95, P424, DOI 10.1016/j.neuron.2017.06.025; Lewis PA, 2011, TRENDS COGN SCI, V15, P343, DOI 10.1016/j.tics.2011.06.004; Li W, 2017, NAT NEUROSCI, V20, P427, DOI 10.1038/nn.4479; Lisman J, 2001, NATURE, V411, P248, DOI 10.1038/35077185; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; Lutz ND, 2018, J NEUROSCI, V38, P8989, DOI 10.1523/JNEUROSCI.1352-18.2018; Maingret N, 2016, NAT NEUROSCI, V19, P959, DOI 10.1038/nn.4304; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; Massimini M, 2004, J NEUROSCI, V24, P6862, DOI 10.1523/JNEUROSCI.1318-04.2004; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; McNamara CG, 2014, NAT NEUROSCI, V17, P1658, DOI 10.1038/nn.3843; Miyawaki H, 2016, CURR BIOL, V26, P893, DOI 10.1016/j.cub.2016.02.024; Molle M, 2011, SLEEP, V34, P1411, DOI 10.5665/SLEEP.1290; Nadel L, 1997, CURR OPIN NEUROBIOL, V7, P217, DOI 10.1016/S0959-4388(97)80010-4; Ngo HVV, 2015, J NEUROSCI, V35, P6630, DOI 10.1523/JNEUROSCI.3133-14.2015; Ngo HVV, 2013, NEURON, V78, P545, DOI 10.1016/j.neuron.2013.03.006; Ngo HVV, 2013, J SLEEP RES, V22, P22, DOI 10.1111/j.1365-2869.2012.01039.x; Niethard N, 2018, P NATL ACAD SCI USA, V115, pE9220, DOI 10.1073/pnas.1805517115; Niethard N, 2016, CURR BIOL, V26, P2739, DOI 10.1016/j.cub.2016.08.035; Nir Y, 2011, NEURON, V70, P153, DOI 10.1016/j.neuron.2011.02.043; Nishida M, 2009, CEREB CORTEX, V19, P1158, DOI 10.1093/cercor/bhn155; Norimoto H, 2018, SCIENCE, V359, P1524, DOI 10.1126/science.aao0702; O'Neill J, 2017, SCIENCE, V355, P184, DOI 10.1126/science.aag2787; O'Neill J, 2008, NAT NEUROSCI, V11, P209, DOI 10.1038/nn2037; O'Neill J, 2010, TRENDS NEUROSCI, V33, P220, DOI 10.1016/j.tins.2010.01.006; Ognjanovski N, 2018, CEREB CORTEX, V28, P3711, DOI 10.1093/cercor/bhy174; Pardilla-Delgado E, 2017, NEUROBIOL LEARN MEM, V137, P123, DOI 10.1016/j.nlm.2016.11.016; PAVLIDES C, 1989, J NEUROSCI, V9, P2907; Perrault AA, 2019, CURR BIOL, V29, P402, DOI 10.1016/j.cub.2018.12.028; Peyrache A, 2009, NAT NEUROSCI, V12, P919, DOI 10.1038/nn.2337; Piantoni G, 2015, HUM BRAIN MAPP, V36, P67, DOI 10.1002/hbm.22613; Poe GR, 2000, BRAIN RES, V855, P176, DOI 10.1016/S0006-8993(99)02310-0; Popa D, 2010, P NATL ACAD SCI USA, V107, P6516, DOI 10.1073/pnas.0913016107; Puentes-Mestril C, 2017, FRONT NEURAL CIRCUIT, V11, DOI 10.3389/fncir.2017.00061; Qin YL, 1997, PHILOS T R SOC B, V352, P1525, DOI 10.1098/rstb.1997.0139; Rasch B, 2013, PHYSIOL REV, V93, P681, DOI 10.1152/physrev.00032.2012; Rasch BH, 2006, J COGNITIVE NEUROSCI, V18, P793, DOI 10.1162/jocn.2006.18.5.793; Redondo RL, 2011, NAT REV NEUROSCI, V12, P17, DOI 10.1038/nrn2963; Ribeiro S, 2007, FRONT NEUROSCI-SWITZ, V1, P43, DOI 10.3389/neuro.01.1.1.003.2007; Rosanova M, 2005, J NEUROSCI, V25, P9398, DOI 10.1523/JNEUROSCI.2149-05.2005; Rothschild G, 2017, NAT NEUROSCI, V20, P251, DOI 10.1038/nn.4457; Sawangjit A, 2018, NATURE, V564, P109, DOI 10.1038/s41586-018-0716-8; Schapiro AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12884-5; Schonauer M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15404; Schonauer M, 2018, FRONT HUM NEUROSCI, V12, DOI 10.3389/fnhum.2018.00072; Scholle S, 2007, CLIN NEUROPHYSIOL, V118, P1525, DOI 10.1016/j.clinph.2007.03.007; Seibt J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00735-w; Shaw JJ, 2017, NEUROPSYCHOLOGIA, V107, P60, DOI 10.1016/j.neuropsychologia.2017.11.002; Siegel M, 2012, NAT REV NEUROSCI, V13, P121, DOI 10.1038/nrn3137; Singer AC, 2009, NEURON, V64, P910, DOI 10.1016/j.neuron.2009.11.016; Sirota A, 2003, P NATL ACAD SCI USA, V100, P2065, DOI 10.1073/pnas.0437938100; Skaggs WE, 1996, SCIENCE, V271, P1870, DOI 10.1126/science.271.5257.1870; Sopp MR, 2017, COGN AFFECT BEHAV NE, V17, P1186, DOI 10.3758/s13415-017-0542-8; Squire L. R., 1984, MEMORY CONSOLIDATION, P185; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Staresina BP, 2015, NAT NEUROSCI, V18, P1679, DOI 10.1038/nn.4119; Steriade M, 2006, NEUROSCIENCE, V137, P1087, DOI 10.1016/j.neuroscience.2005.10.029; Takashima A, 2009, J NEUROSCI, V29, P10087, DOI 10.1523/JNEUROSCI.0799-09.2009; Tempesta D, 2018, SLEEP MED REV, V40, P183, DOI 10.1016/j.smrv.2017.12.005; Tononi G, 2014, NEURON, V81, P12, DOI 10.1016/j.neuron.2013.12.025; Tse D, 2007, SCIENCE, V316, P76, DOI 10.1126/science.1135935; Valdes JL, 2015, J NEUROPHYSIOL, V114, P1183, DOI 10.1152/jn.00758.2014; Varela C, 2014, BRAIN STRUCT FUNCT, V219, P911, DOI 10.1007/s00429-013-0543-5; Vaz AP, 2019, SCIENCE, V363, P975, DOI 10.1126/science.aau8956; Vyazovskiy VV, 2008, NAT NEUROSCI, V11, P200, DOI 10.1038/nn2035; Vyazovskiy VV, 2009, NEURON, V63, P865, DOI 10.1016/j.neuron.2009.08.024; Wagner U, 2004, NATURE, V427, P352, DOI 10.1038/nature02223; Wang DV, 2016, J NEUROSCI, V36, P10663, DOI 10.1523/JNEUROSCI.1042-16.2016; Watson BO, 2016, NEURON, V90, P839, DOI 10.1016/j.neuron.2016.03.036; Weber FD, 2014, LEARN MEMORY, V21, P190, DOI 10.1101/lm.033530.113; Wei YN, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006322; Wierzynski CM, 2009, NEURON, V61, P587, DOI 10.1016/j.neuron.2009.01.011; Wilber AA, 2017, NEURON, V95, P1406, DOI 10.1016/j.neuron.2017.08.033; Wilhelm I, 2013, NAT NEUROSCI, V16, P391, DOI 10.1038/nn.3343; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Wimmer RD, 2015, NATURE, V526, P705, DOI 10.1038/nature15398; Winocur G, 2010, NEUROPSYCHOLOGIA, V48, P2339, DOI 10.1016/j.neuropsychologia.2010.04.016; Yang G, 2014, SCIENCE, V344, P1173, DOI 10.1126/science.1249098; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577; Zhang H, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06553-y	150	249	258	24	187	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2019	22	10					1598	1610		10.1038/s41593-019-0467-3	http://dx.doi.org/10.1038/s41593-019-0467-3			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	JI3VE	31451802				2022-12-17	WOS:000493396200008
J	Musall, S; Kaufman, MT; Juavinett, AL; Gluf, S; Churchland, AK				Musall, Simon; Kaufman, Matthew T.; Juavinett, Ashley L.; Gluf, Steven; Churchland, Anne K.			Single-trial neural dynamics are dominated by richly varied movements	NATURE NEUROSCIENCE			English	Article							MEDIAL PREFRONTAL CORTEX; PERCEPTUAL DECISION; MOTOR CORTEX; SIGNALS; LOCOMOTION; NEURONS; MODELS; REPRESENTATION; INTEGRATION; MODULATION	When experts are immersed in a task, do their brains prioritize task-related activity? Most efforts to understand neural activity during well-learned tasks focus on cognitive computations and task-related movements. We wondered whether task-performing animals explore a broader movement landscape and how this impacts neural activity. We characterized movements using video and other sensors and measured neural activity using widefield and two-photon imaging. Cortex-wide activity was dominated by movements, especially uninstructed movements not required for the task. Some uninstructed movements were aligned to trial events. Accounting for them revealed that neurons with similar trial-averaged activity often reflected utterly different combinations of cognitive and movement variables. Other movements occurred idiosyncratically, accounting for trial-by-trial fluctuations that are often considered 'noise'. This held true throughout task-learning and for extracellular Neuropixels recordings that included subcortical areas. Our observations argue that animals execute expert decisions while performing richly varied, uninstructed movements that profoundly shape neural activity.	[Musall, Simon; Kaufman, Matthew T.; Juavinett, Ashley L.; Gluf, Steven; Churchland, Anne K.] Cold Spring Harbor Lab, Neurosci, POB 100, Cold Spring Harbor, NY 11724 USA; [Kaufman, Matthew T.] Univ Chicago, Dept Organismal Biol & Anat, 1025 E 57Th St, Chicago, IL 60637 USA; [Kaufman, Matthew T.] Univ Chicago, Grossman Inst Neurosci Quantitat Biol & Human Beh, Chicago, IL 60637 USA; [Juavinett, Ashley L.] Univ Calif San Diego, Div Biol Sci, San Diego, CA 92103 USA	Cold Spring Harbor Laboratory; University of Chicago; University of Chicago; University of California System; University of California San Diego	Churchland, AK (corresponding author), Cold Spring Harbor Lab, Neurosci, POB 100, Cold Spring Harbor, NY 11724 USA.	churchland@cshl.edu	Kaufman, Matthew/AAK-2860-2020; Musall, Simon/AAE-5335-2019	Kaufman, Matthew/0000-0002-8072-023X; Musall, Simon/0000-0002-9461-1042; Churchland, Anne/0000-0002-3205-3794	Swiss National Science foundation [P2ZHP3_161770]; Pew Charitable Trusts; Simons Collaboration on the Global Brain; NIH [EY R01EY022979]; Army Research Office [W911NF-16-1-0368]; US DOD; UK MOD; UK Engineering and Physical Research Council under the Multidisciplinary University Research Initiative; NATIONAL EYE INSTITUTE [R01EY022979] Funding Source: NIH RePORTER	Swiss National Science foundation(Swiss National Science Foundation (SNSF)European Commission); Pew Charitable Trusts; Simons Collaboration on the Global Brain; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Army Research Office; US DOD(United States Department of Defense); UK MOD; UK Engineering and Physical Research Council under the Multidisciplinary University Research Initiative; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank O. Odoemene, S. Pisupati and H. Nguyen for technical assistance and scientific discussions; H. Zeng for providing Ai93 mice; J. Tucciarone and F. Marbach for breeding assistance; A. Mills and P. Shrestha for providing GFP mice; T. Harris, S. Caddick and the Allen Institute for Brain Sciences for assistance with the Neuropixels probes; and N. Steinmetz, M. Pachitariu and K. Harris for widefield analysis code. Financial support was received from the Swiss National Science foundation (S.M., grant no. P2ZHP3_161770), the Pew Charitable Trusts (A.K.C.), the Simons Collaboration on the Global Brain (A.K.C., M.T.K.), the NIH (grant no. EY R01EY022979) and the Army Research Office under contract no. W911NF-16-1-0368 as part of the collaboration between the US DOD, the UK MOD and the UK Engineering and Physical Research Council under the Multidisciplinary University Research Initiative (A.K.C.).	Allen WE, 2017, NEURON, V94, P891, DOI 10.1016/j.neuron.2017.04.017; Ayaz A, 2013, CURR BIOL, V23, P890, DOI 10.1016/j.cub.2013.04.012; Caballero-Gaudes C, 2017, NEUROIMAGE, V154, P128, DOI 10.1016/j.neuroimage.2016.12.018; Chen TW, 2017, NEURON, V94, P866, DOI 10.1016/j.neuron.2017.05.005; Churchland AK, 2008, NAT NEUROSCI, V11, P693, DOI 10.1038/nn.2123; Coddington LT, 2018, NAT NEUROSCI, V21, P1563, DOI 10.1038/s41593-018-0245-7; Engel TA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7454; Erlich JC, 2015, ELIFE, V4, DOI 10.7554/eLife.05457; Erlich JC, 2011, NEURON, V72, P330, DOI 10.1016/j.neuron.2011.07.010; Euston DR, 2006, J NEUROSCI, V26, P13143, DOI 10.1523/JNEUROSCI.3803-06.2006; Garrett ME, 2014, J NEUROSCI, V34, P12587, DOI 10.1523/JNEUROSCI.1124-14.2014; Gilad A, 2018, NEURON, V99, P814, DOI 10.1016/j.neuron.2018.07.029; Gold JI, 2003, J NEUROSCI, V23, P632, DOI 10.1523/JNEUROSCI.23-02-00632.2003; Guo ZCV, 2017, NATURE, V545, P181, DOI 10.1038/nature22324; Guo ZCV, 2014, NEURON, V81, P179, DOI 10.1016/j.neuron.2013.10.020; Hanks TD, 2015, NATURE, V520, P220, DOI 10.1038/nature14066; Horwitz GD, 2004, J NEUROPHYSIOL, V91, P2281, DOI 10.1152/jn.00872.2003; Horwitz GD, 1999, SCIENCE, V284, P1158, DOI 10.1126/science.284.5417.1158; Jia HB, 2011, NAT PROTOC, V6, P28, DOI 10.1038/nprot.2010.169; Juavinett AL, 2019, ELIFE, V8, DOI 10.7554/eLife.47188; Jun JJ, 2017, NATURE, V551, P232, DOI 10.1038/nature24636; Karabatsos G., 2017, COMMUN STAT SIMULAT; Kawai R, 2015, NEURON, V86, P800, DOI 10.1016/j.neuron.2015.03.024; Keller GB, 2012, NEURON, V74, P809, DOI 10.1016/j.neuron.2012.03.040; Le Merre P, 2018, NEURON, V97, P83, DOI 10.1016/j.neuron.2017.11.031; Lerner TN, 2015, CELL, V162, P635, DOI 10.1016/j.cell.2015.07.014; Li N, 2015, NATURE, V519, P51, DOI 10.1038/nature14178; Maimon G, 2006, NAT NEUROSCI, V9, P948, DOI 10.1038/nn1716; Mathis A, 2018, NAT NEUROSCI, V21, P1281, DOI 10.1038/s41593-018-0209-y; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; Mumford JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126255; Niell CM, 2010, NEURON, V65, P472, DOI 10.1016/j.neuron.2010.01.033; Pachitariu M., 2017, BIORXIV, DOI DOI 10.1101/061507; Pachitariu M., 2016, ADV NEURAL INF P SYS, V29, P6326; Pereira TD, 2019, NAT METHODS, V16, P117, DOI 10.1038/s41592-018-0234-5; Polack PO, 2013, NAT NEUROSCI, V16, P1331, DOI 10.1038/nn.3464; Powell K, 2015, ELIFE, V4, DOI 10.7554/eLife.07290; Raposo D, 2014, NAT NEUROSCI, V17, P1784, DOI 10.1038/nn.3865; RATZLAFF EH, 1991, J NEUROSCI METH, V36, P127, DOI 10.1016/0165-0270(91)90038-2; Reimer J, 2014, NEURON, V84, P355, DOI 10.1016/j.neuron.2014.09.033; Roitman JD, 2002, J NEUROSCI, V22, P9475; Runyan CA, 2017, NATURE, V548, P92, DOI 10.1038/nature23020; Saleem AB, 2013, NAT NEUROSCI, V16, P1864, DOI 10.1038/nn.3567; Salkoff D. B., CEREB CORTEX; Schmitt LI, 2017, NATURE, V545, P219, DOI 10.1038/nature22073; Schultz W, 1997, CURR OPIN NEUROBIOL, V7, P191, DOI 10.1016/S0959-4388(97)80007-4; Scott BB, 2017, NEURON, V95, P385, DOI 10.1016/j.neuron.2017.06.013; Shadlen MN, 1996, P NATL ACAD SCI USA, V93, P628, DOI 10.1073/pnas.93.2.628; Shimaoka D, 2018, CELL REP, V22, P3160, DOI 10.1016/j.celrep.2018.02.092; Sommer MA, 2008, ANNU REV NEUROSCI, V31, P317, DOI 10.1146/annurev.neuro.31.060407.125627; Steinmetz NA, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0207-17.2017; Stringer C, 2019, SCIENCE, V364, P255, DOI 10.1126/science.aav7893; Vinck M, 2015, NEURON, V86, P740, DOI 10.1016/j.neuron.2015.03.028; Wang LP, 2018, NEURON, V97, P1369, DOI 10.1016/j.neuron.2018.01.049; Wekselblatt JB, 2016, J NEUROPHYSIOL, V115, P2852, DOI 10.1152/jn.01056.2015; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Wolpert DM, 1998, NEURAL NETWORKS, V11, P1317, DOI 10.1016/S0893-6080(98)00066-5; Wolpert DM, 1998, TRENDS COGN SCI, V2, P338, DOI 10.1016/S1364-6613(98)01221-2; Zhang J, 2017, ELIFE, V6, DOI 10.7554/eLife.18372	59	249	250	7	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2019	22	10					1677	+		10.1038/s41593-019-0502-4	http://dx.doi.org/10.1038/s41593-019-0502-4			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JI3VE	31551604	Green Submitted, Green Accepted			2022-12-17	WOS:000493396200018
J	Kupchik, YM; Brown, RM; Heinsbroek, JA; Lobo, MK; Schwartz, DJ; Kalivas, PW				Kupchik, Yonatan M.; Brown, Robyn M.; Heinsbroek, Jasper A.; Lobo, Mary Kay; Schwartz, Danielle J.; Kalivas, Peter W.			Coding the direct/indirect pathways by D1 and D2 receptors is not valid for accumbens projections	NATURE NEUROSCIENCE			English	Article							VENTRAL PALLIDAL NEURONS; NUCLEUS-ACCUMBENS; DISTINCT ROLES; STRIATAL NEURONS; DOPAMINE NEURONS; TEGMENTAL AREA; BASAL GANGLIA; D-2 RECEPTOR; COCAINE; CONNECTIVITY	It is widely accepted that D1 dopamine receptor-expressing striatal neurons convey their information directly to the output nuclei of the basal ganglia, whereas D2-expressing neurons do so indirectly via pallidal neurons. Combining optogenetics and electrophysiology, we found that this architecture does not apply to mouse nucleus accumbens projections to the ventral pallidum. Thus, current thinking attributing D1 and D2 selectivity to accumbens projections akin to dorsal striatal pathways needs to be reconsidered.	[Kupchik, Yonatan M.; Brown, Robyn M.; Heinsbroek, Jasper A.; Schwartz, Danielle J.; Kalivas, Peter W.] Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA; [Kupchik, Yonatan M.] Hebrew Univ Jerusalem, Inst Med Res Israel Canada, Dept Med Neurobiol, Jerusalem, Israel; [Brown, Robyn M.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3052, Australia; [Lobo, Mary Kay] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA	Medical University of South Carolina; Hebrew University of Jerusalem; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University System of Maryland; University of Maryland Baltimore	Kalivas, PW (corresponding author), Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA.	yonatank@ekmd.huji.ac.il; kalivasp@musc.edu	Core, Vector/CAF-4832-2022; Lobo, Mary Kay/K-7734-2015; Kupchik, Yonatan/O-5998-2019; Brown, Robyn M/AAO-3694-2021	Lobo, Mary Kay/0000-0002-9419-2079; Kupchik, Yonatan/0000-0003-3732-4933; Brown, Robyn M/0000-0003-4167-3634; Heinsbroek, Jasper/0000-0003-4641-6899	US Public Health Service [DA03906, DA12513, DA015369]; Neuroscience Institute, Medical University of South Carolina; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA015369, R37DA003906, R01DA038613, R01DA003906, R01DA012513] Funding Source: NIH RePORTER	US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Neuroscience Institute, Medical University of South Carolina; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank T.C. Jhou and R.J. Smith for their assistance with the histology experiments. We thank E.J. Nestler (Mount Sinai School of Medicine) for providing D1-Cre and D2-Cre breeding pairs, and R. Gregory and J. Hyang for genotyping the mice. This work was supported by US Public Health Service grants DA03906, DA12513 and DA015369, and a fellowship from the Neuroscience Institute, Medical University of South Carolina.	Bengtson CP, 2000, J NEUROPHYSIOL, V83, P2649, DOI 10.1152/jn.2000.83.5.2649; Bertran-Gonzalez J, 2008, J NEUROSCI, V28, P5671, DOI 10.1523/JNEUROSCI.1039-08.2008; Bock R, 2013, NAT NEUROSCI, V16, P632, DOI 10.1038/nn.3369; Bocklisch C, 2013, SCIENCE, V341, P1521, DOI 10.1126/science.1237059; Cazorla M, 2014, NEURON, V81, P153, DOI 10.1016/j.neuron.2013.10.041; Gerfen CR, 2011, ANNU REV NEUROSCI, V34, P441, DOI 10.1146/annurev-neuro-061010-113641; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; Kravitz AV, 2012, NAT NEUROSCI, V15, P816, DOI 10.1038/nn.3100; Kupchik YM, 2013, BRAIN STRUCT FUNCT, V218, P1487, DOI 10.1007/s00429-012-0471-9; Leung BK, 2015, J NEUROSCI, V35, P4953, DOI 10.1523/JNEUROSCI.4837-14.2015; Lobo MK, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00041; Lu XY, 1998, NEUROSCIENCE, V82, P767; MacAskill AF, 2014, NAT NEUROSCI, V17, P1198, DOI 10.1038/nn.3783; MacAskill AF, 2012, NAT NEUROSCI, V15, P1624, DOI 10.1038/nn.3254; MOGENSON GJ, 1980, PROG NEUROBIOL, V14, P69, DOI 10.1016/0301-0082(80)90018-0; Saunders A, 2015, NATURE, V521, P85, DOI 10.1038/nature14179; Smith RJ, 2013, CURR OPIN NEUROBIOL, V23, P546, DOI 10.1016/j.conb.2013.01.026; Stefanik MT, 2013, J NEUROSCI, V33, P13654, DOI 10.1523/JNEUROSCI.1570-13.2013; Thibault D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067219; Tripathi A, 2013, BRAIN STRUCT FUNCT, V218, P1133, DOI 10.1007/s00429-012-0451-0; Watabe-Uchida M, 2012, NEURON, V74, P858, DOI 10.1016/j.neuron.2012.03.017; Yawata S, 2012, P NATL ACAD SCI USA, V109, P12764, DOI 10.1073/pnas.1210797109; ZAHM DS, 1987, J COMP NEUROL, V255, P592, DOI 10.1002/cne.902550410	24	249	249	2	66	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2015	18	9					1230	+		10.1038/nn.4068	http://dx.doi.org/10.1038/nn.4068			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CQ0NI	26214370	Green Accepted			2022-12-17	WOS:000360292600010
J	Agetsuma, M; Aizawa, H; Aoki, T; Nakayama, R; Takahoko, M; Goto, M; Sassa, T; Amo, R; Shiraki, T; Kawakami, K; Hosoya, T; Higashijima, S; Okamoto, H				Agetsuma, Masakazu; Aizawa, Hidenori; Aoki, Tazu; Nakayama, Ryoko; Takahoko, Mikako; Goto, Midori; Sassa, Takayuki; Amo, Ryunosuke; Shiraki, Toshiyuki; Kawakami, Koichi; Hosoya, Toshihiko; Higashijima, Shin-ichi; Okamoto, Hitoshi			The habenula is crucial for experience-dependent modification of fear responses in zebrafish	NATURE NEUROSCIENCE			English	Article							NUCLEUS; CONNECTIONS; EXPRESSION	The zebrafish dorsal habenula (dHb) shows conspicuous asymmetry in its connection with the interpeduncular nucleus (IPN) and is equivalent to the mammalian medial habenula. Genetic inactivation of the lateral subnucleus of dHb (dHbL) biased fish towards freezing rather than the normal flight response to a conditioned fear stimulus, suggesting that the dHbL-IPN pathway is important for controlling experience-dependent modification of fear responses.	[Nakayama, Ryoko; Takahoko, Mikako; Shiraki, Toshiyuki] RIKEN Brain Sci Inst, Res Resource Ctr, Wako, Saitama, Japan; [Amo, Ryunosuke] Waseda Univ, Grad Sch Adv Sci & Engn, Dept Life Sci & Med Biosci, Shinjuku Ku, Tokyo, Japan; [Kawakami, Koichi] Natl Inst Genet, Div Mol & Dev Biol, Shizuoka, Japan; [Kawakami, Koichi] Grad Univ Adv Studies, Dept Genet, Shizuoka, Japan; [Higashijima, Shin-ichi] Natl Inst Physiol Sci, Okazaki Inst Integrat Biosci, Natl Inst Nat Sci, Aichi, Japan; [Okamoto, Hitoshi] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Chiyoda Ku, Tokyo, Japan	RIKEN; Waseda University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Okazaki Institute for Integrative Bioscience (OIIB); Japan Science & Technology Agency (JST)	Okamoto, H (corresponding author), RIKEN Brain Sci Inst, Res Resource Ctr, Wako, Saitama, Japan.	hitoshi@brain.riken.jp	Hosoya, Toshihiko/Q-2514-2018; SASSA, Takayuki/B-2519-2012; Kawakami, Koichi/AAF-1380-2019; Okamoto, Hitoshi/P-9767-2015; Aoki, Tazu/F-5051-2011; Agetsuma, Masakazu/AAD-1654-2019	Hosoya, Toshihiko/0000-0001-8559-8344; SASSA, Takayuki/0000-0003-3145-9829; Okamoto, Hitoshi/0000-0002-7512-8549; Agetsuma, Masakazu/0000-0002-8606-4886; Aizawa, Hidenori/0000-0002-2896-1298; Amo, Ryunosuke/0000-0001-8644-2296; Higashijima, Shin-ichi/0000-0001-6350-4992	Ministry of Education, Culture, Sports, Science and Technology of Japan; Core Research for Evolutional Science and Technology of Japan Science and Technology Agency; Okamoto laboratory	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Core Research for Evolutional Science and Technology of Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Okamoto laboratory	We thank Y. Yoshihara, T. Koide and other members of the Yoshihara laboratory for transgenic fish and advice on the behavioral experiments, S. Watanabe for help in setting up the behavioral experiments, N. Copeland for the BAC homologous recombination system, S. Fraser for GAL4VP16 and UAS plasmids, M. Parsons for the UAS:nfsB-mCherry plasmid, A. Thomson for correction of the manuscript and S. Jesuthasan for communication of unpublished data. We are grateful to all of the members of the Okamoto laboratory for support and advice, the Research Resource Center of RIKEN BSI for animal care and the National BioResource Project of Japan for fish strains. This work was supported by Grant-in-Aids from the Ministry of Education, Culture, Sports, Science and Technology of Japan to H.O. and H. A. and by the Core Research for Evolutional Science and Technology of Japan Science and Technology Agency to H.O.	Aizawa H, 2005, CURR BIOL, V15, P238, DOI 10.1016/j.cub.2005.01.014; Amo R, 2010, J NEUROSCI, V30, P1566, DOI 10.1523/JNEUROSCI.3690-09.2010; Bandler R, 2000, BRAIN RES BULL, V53, P95, DOI 10.1016/S0361-9230(00)00313-0; Bianco IH, 2009, PHILOS T R SOC B, V364, P1005, DOI 10.1098/rstb.2008.0213; Curado S, 2007, DEV DYNAM, V236, P1025, DOI 10.1002/dvdy.21100; Eisenberg M, 2003, SCIENCE, V301, P1102, DOI 10.1126/science.1086881; Goto M, 2001, J COMP NEUROL, V438, P86, DOI 10.1002/cne.1303; HERKENHAM M, 1979, J COMP NEUROL, V187, P19, DOI 10.1002/cne.901870103; Hikosaka O, 2010, NAT REV NEUROSCI, V11, P503, DOI 10.1038/nrn2866; Maier SF, 2005, NEUROSCI BIOBEHAV R, V29, P829, DOI 10.1016/j.neubiorev.2005.03.021; Mongeau R, 2003, J NEUROSCI, V23, P3855; Ressler KJ, 2002, J NEUROSCI, V22, P7892; Reti IM, 2002, J NEUROCHEM, V82, P935, DOI 10.1046/j.1471-4159.2002.01051.x; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Wullimann MF, 1996, NEUROANATOMY ZEBRAFI, DOI 10.1007/978-3-0348-8979-7_6	15	249	253	1	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2010	13	11					1354	1356		10.1038/nn.2654	http://dx.doi.org/10.1038/nn.2654			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	673KI	20935642				2022-12-17	WOS:000283658200015
J	Deneve, S; Latham, PE; Pouget, A				Deneve, S; Latham, PE; Pouget, A			Efficient computation and cue integration with noisy population codes	NATURE NEUROSCIENCE			English	Article							RECEPTIVE-FIELDS; CORTEX; INFORMATION; GAZE	The brain represents sensory and motor variables through the activity of large populations of neurons. It is not understood how the nervous system computes with these population codes, given that individual neurons are noisy and thus unreliable. We focus here on two general types of computation, function approximation and cue integration, as these are powerful enough to handle a range of tasks, including sensorimotor transformations, feature extraction in sensory systems and multisensory integration. We demonstrate that a particular class of neural networks, basis function networks with multidimensional attractors, can perform both types of computation optimally with noisy neurons. Moreover, neurons in the intermediate layers of our model show response properties similar to those observed in several multimodal cortical areas. Thus, basis function networks with multidimensional attractors may be used by the brain to compute efficiently with population codes.	Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA; Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA	University of Rochester; University of California System; University of California Los Angeles	Pouget, A (corresponding author), Univ Rochester, Dept Brain & Cognit Sci, 601 Elmwood Ave, Rochester, NY 14627 USA.	alex@bcs.rochester.edu		Pouget, Alexandre/0000-0003-3054-6365	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062447, R29MH057823] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ANDERSEN RA, 1985, SCIENCE, V230, P456, DOI 10.1126/science.4048942; BOUSSAOUD D, 1993, EXP BRAIN RES, V93, P423; Braitenberg V, 1991, ANATOMY CORTEX; Bremmer F, 1997, J NEUROPHYSIOL, V77, P944, DOI 10.1152/jn.1997.77.2.944; Deneve S, 1999, NAT NEUROSCI, V2, P740, DOI 10.1038/11205; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; Duhamel JR, 1997, NATURE, V389, P845, DOI 10.1038/39865; GRAZIANO MSA, 1994, SCIENCE, V266, P1054, DOI 10.1126/science.7973661; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; JAY MF, 1987, J NEUROPHYSIOL, V57, P22, DOI 10.1152/jn.1987.57.1.22; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; Papoulis A., 1991, COMMUNICATIONS SIGNA, V3; PARADISO MA, 1988, BIOL CYBERN, V58, P35, DOI 10.1007/BF00363954; POGGIO T, 1990, COLD SPRING HARB SYM, V55, P899; Pouget A, 1997, J COGNITIVE NEUROSCI, V9, P222, DOI 10.1162/jocn.1997.9.2.222; Pouget A, 2000, NAT NEUROSCI, V3, P1192, DOI 10.1038/81469; SALINAS E, 1995, J NEUROSCI, V15, P6461; SEUNG HS, 1993, P NATL ACAD SCI USA, V90, P10749, DOI 10.1073/pnas.90.22.10749; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; Trotter Y, 1999, NATURE, V398, P239, DOI 10.1038/18444; WESTHEIMER G, 1956, J OPT SOC AM, V46, P116, DOI 10.1364/JOSA.46.000116; Yuille A. L., 1996, PERCEPTION BAYESIAN, P123, DOI DOI 10.1017/CBO9780511984037.006	22	249	252	0	21	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2001	4	8					826	831		10.1038/90541	http://dx.doi.org/10.1038/90541			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	457KY	11477429				2022-12-17	WOS:000170137300016
J	Martinez-Conde, S; Macknik, SL; Hubel, DH				Martinez-Conde, S; Macknik, SL; Hubel, DH			Microsaccadic eye movements and firing of single cells in the striate cortex of macaque monkeys	NATURE NEUROSCIENCE			English	Article							VISUAL-CORTEX; AREA MT; NEURONS; V1	When viewing a stationary object, we unconsciously make small, involuntary eye movements or 'microsaccades'. If displacements of the retinal image are prevented, the image quickly fades from perception. To understand how microsaccades sustain perception, we studied their relationship to the firing of cells in primary visual cortex (V1). We tracked eye movements and recorded from V1 cells as macaque monkeys fixated. When an optimally oriented line was centered over a cell's receptive field, activity increased after microsaccades. Moreover, microsaccades were better correlated with bursts of spikes than with either single spikes or instantaneous firing rate. These findings may help explain maintenance of perception during normal visual fixation.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Martinez-Conde, S (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.		Macknik, Stephen L./H-7704-2019	Macknik, Stephen L./0000-0002-3143-9230				Bair W, 1998, VISUAL NEUROSCI, V15, P779, DOI 10.1017/S0952523898154160; BAIR W, 1994, J NEUROSCI, V14, P2870; BRIDGEMAN B, 1975, VISION RES, V15, P719, DOI 10.1016/0042-6989(75)90290-4; Coppola D, 1996, P NATL ACAD SCI USA, V93, P8001, DOI 10.1073/pnas.93.15.8001; Day EC, 1915, AM J PHYSIOL, V38, P369, DOI 10.1152/ajplegacy.1915.38.3.369; Dodge R, 1900, PSYCHOL REV, V7, P454, DOI 10.1037/h0067215; GERRITS HJM, 1974, VISION RES, V14, P175, DOI 10.1016/0042-6989(74)90098-4; Gur M, 1997, J NEUROSCI, V17, P2914; HUBEL DH, 1958, AM J OPHTHALMOL, V46, P110, DOI 10.1016/0002-9394(58)90060-6; HUBEL DH, 1959, J PHYSIOL-LONDON, V148, P574, DOI 10.1113/jphysiol.1959.sp006308; Leopold DA, 1998, EXP BRAIN RES, V123, P341, DOI 10.1007/s002210050577; Livingstone MS, 1996, COLD SPRING HARB SYM, V61, P27; MACKNIK SL, 1991, VISION RES, V31, P2057, DOI 10.1016/0042-6989(91)90163-Y; MAGLEBY KL, 1987, SYNAPTIC FUNCTION, P21; RIGGS LA, 1952, J OPT SOC AM, V42, P872; SANSBURY RV, 1973, J OPT SOC AM, V63, P612, DOI 10.1364/JOSA.63.000612; STEINMAN RM, 1973, SCIENCE, V181, P810, DOI 10.1126/science.181.4102.810; Usrey WM, 1998, NATURE, V395, P384, DOI 10.1038/26487; WURTZ RH, 1969, J NEUROPHYSIOL, V32, P975, DOI 10.1152/jn.1969.32.6.975; WURTZ RH, 1968, SCIENCE, V162, P1148, DOI 10.1126/science.162.3858.1148; WURTZ RH, 1969, J NEUROPHYSIOL, V32, P987, DOI 10.1152/jn.1969.32.6.987; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.ne.12.030189.000305	23	249	255	1	13	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2000	3	3					251	258		10.1038/72961	http://dx.doi.org/10.1038/72961			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292TE	10700257				2022-12-17	WOS:000085810500014
J	Tonnesen, J; Katona, G; Rozsa, B; Nagerl, UV				Tonnesen, Jan; Katona, Gergely; Rozsa, Balazs; Naegerl, U. Valentin			Spine neck plasticity regulates compartmentalization of synapses	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; DENDRITIC SPINES; MORPHOLOGICAL PLASTICITY; STRUCTURAL PLASTICITY; PYRAMIDAL NEURONS; RAT HIPPOCAMPUS; CA1; MICROSCOPY; MEMBRANE; DIMENSIONS	Dendritic spines have been proposed to transform synaptic signals through chemical and electrical compartmentalization. However, the quantitative contribution of spine morphology to synapse compartmentalization and its dynamic regulation are still poorly understood. We used time-lapse super-resolution stimulated emission depletion (STED) imaging in combination with fluorescence recovery after photobleaching (FRAP) measurements, two-photon glutamate uncaging, electrophysiology and simulations to investigate the dynamic link between nanoscale anatomy and compartmentalization in live spines of CA1 neurons in mouse brain slices. We report a diversity of spine morphologies that argues against common categorization schemes and establish a close link between compartmentalization and spine morphology, wherein spine neck width is the most critical morphological parameter. We demonstrate that spine necks are plastic structures that become wider and shorter after long-term potentiation. These morphological changes are predicted to lead to a substantial drop in spine head excitatory postsynaptic potential (EPSP) while preserving overall biochemical compartmentalization.	[Tonnesen, Jan; Naegerl, U. Valentin] Univ Bordeaux, Interdisciplinary Inst Neurosci IINS, Bordeaux, France; [Tonnesen, Jan; Naegerl, U. Valentin] CNRS, UMR 5297, Bordeaux, France; [Katona, Gergely; Rozsa, Balazs] Hungarian Acad Sci, Inst Expt Med, Photon Imaging Ctr 2, Budapest, Hungary	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine	Nagerl, UV (corresponding author), Univ Bordeaux, Interdisciplinary Inst Neurosci IINS, Bordeaux, France.	valentin.nagerl@u-bordeaux.fr	Tonnesen, Jan/C-7464-2011; Nägerl, Valentin/AAD-2575-2022; Balazs, Rozsa/C-6306-2015	Tonnesen, Jan/0000-0003-3663-8463; Nägerl, Valentin/0000-0001-6831-9008; Balazs, Rozsa/0000-0003-1427-7003; Katona, Gergely/0000-0002-4173-0355	postdoctoral fellowships from the Marie-Curie Program [272351]; European Molecular Biology Organization (EMBO) [1518-2010]; grants from the French Institute of Health and Medical Research (INSERM); Agence Nationale de la Recherche (ANR); Human Frontiers Science program (HFSP); France-BioImaging [ANR-10-INSB-04]	postdoctoral fellowships from the Marie-Curie Program; European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); grants from the French Institute of Health and Medical Research (INSERM); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Human Frontiers Science program (HFSP)(Human Frontier Science Program); France-BioImaging(French National Research Agency (ANR))	We thank D. DiGregorio (Pasteur Institute) and all members of the Nagerl laboratory for comments on the manuscript, and J. Angibaud for excellent technical support. This work was supported by postdoctoral fellowships from the Marie-Curie Program (grant 272351) and the European Molecular Biology Organization (EMBO; grant 1518-2010) to J.T. and by grants from the French Institute of Health and Medical Research (INSERM), Agence Nationale de la Recherche (ANR), the Human Frontiers Science program (HFSP) and France-BioImaging (ANR-10-INSB-04) to U.V.N.	Alevra M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039628; Alvarez VA, 2007, ANNU REV NEUROSCI, V30, P79, DOI 10.1146/annurev.neuro.30.051606.094222; Araya R, 2006, P NATL ACAD SCI USA, V103, P17961, DOI 10.1073/pnas.0608755103; Arellano JI, 2007, FRONT NEUROSCI-SWITZ, V1, P131, DOI 10.3389/neuro.01.1.1.010.2007; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; Bittner KC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046652; CHANG HT, 1952, COLD SPRING HARB SYM, V17, P189, DOI 10.1101/SQB.1952.017.01.019; CRICK F, 1982, TRENDS NEUROSCI, V5, P44, DOI 10.1016/0166-2236(82)90020-0; Einstein A, 1905, ANN PHYS-BERLIN, V17, P549, DOI 10.1002/andp.19053220806; FIFKOVA E, 1981, EXP NEUROL, V74, P621, DOI 10.1016/0014-4886(81)90197-7; Fonseca R, 2004, NEURON, V44, P1011, DOI 10.1016/j.neuron.2004.10.033; GAHWILER BH, 1984, EXPERIENTIA, V40, P235, DOI 10.1007/BF01947561; Gasparini S, 2004, J NEUROSCI, V24, P11046, DOI 10.1523/JNEUROSCI.2520-04.2004; Grunditz A, 2008, J NEUROSCI, V28, P13457, DOI 10.1523/JNEUROSCI.2702-08.2008; Gulledge AT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036007; Harnett MT, 2012, NATURE, V491, P599, DOI 10.1038/nature11554; HARRIS KM, 1989, J NEUROSCI, V9, P2982; HARRIS KM, 1992, J NEUROSCI, V12, P2685; Harvey CD, 2007, NATURE, V450, P1195, DOI 10.1038/nature06416; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; Heyman NS, 2008, BIOPHYS J, V94, P840, DOI 10.1529/biophysj.107.115634; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; JONES EG, 1969, J CELL SCI, V5, P509; Klar TA, 2000, P NATL ACAD SCI USA, V97, P8206, DOI 10.1073/pnas.97.15.8206; KOCH C, 1993, J NEUROSCI, V13, P413; Kumar M, 2010, BIOPHYS J, V98, P552, DOI 10.1016/j.bpj.2009.11.002; Lang C, 2004, P NATL ACAD SCI USA, V101, P16665, DOI 10.1073/pnas.0407581101; Majewska A, 2000, J NEUROSCI, V20, P8262, DOI 10.1523/JNEUROSCI.20-22-08262.2000; MAJOR G, 1994, J NEUROSCI, V14, P4613; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Nagerl UV, 2008, P NATL ACAD SCI USA, V105, P18982, DOI 10.1073/pnas.0810028105; Nagerl UV, 2004, NEURON, V44, P759, DOI 10.1016/j.neuron.2004.11.016; Nevian T, 2007, NAT NEUROSCI, V10, P206, DOI 10.1038/nn1826; Noguchi J, 2005, NEURON, V46, P609, DOI 10.1016/j.neuron.2005.03.015; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; Oh WC, 2013, P NATL ACAD SCI USA, V110, pE305, DOI 10.1073/pnas.1214705110; Oray S, 2006, CEREB CORTEX, V16, P730, DOI 10.1093/cercor/bhj019; Palmer LM, 2009, J NEUROSCI, V29, P6897, DOI 10.1523/JNEUROSCI.5847-08.2009; Parnass Z, 2000, HIPPOCAMPUS, V10, P561, DOI 10.1002/1098-1063(2000)10:5<561::AID-HIPO6>3.3.CO;2-O; Peebles CL, 2010, P NATL ACAD SCI USA, V107, P18173, DOI 10.1073/pnas.1006546107; PETERS A, 1970, AM J ANAT, V127, P321, DOI 10.1002/aja.1001270402; Petrasek Z, 2008, BIOPHYS J, V94, P1437, DOI 10.1529/biophysj.107.108811; Scheuss V, 2014, CEREB CORTEX, V24, P3142, DOI 10.1093/cercor/bht171; SPACEK J, 1983, ANAT EMBRYOL, V167, P289, DOI 10.1007/BF00298517; Stewart MG, 2005, EUR J NEUROSCI, V21, P3368, DOI 10.1111/j.1460-9568.2005.04174.x; Svoboda K, 1996, SCIENCE, V272, P716, DOI 10.1126/science.272.5262.716; Tanaka JI, 2008, SCIENCE, V319, P1683, DOI 10.1126/science.1152864; Tonnesen Jan, 2013, Methods Mol Biol, V950, P65, DOI 10.1007/978-1-62703-137-0_5; Tonnesen J, 2011, BIOPHYS J, V101, P2545, DOI 10.1016/j.bpj.2011.10.011; Trommald M, 1997, J COMP NEUROL, V377, P15, DOI 10.1002/(SICI)1096-9861(19970106)377:1<15::AID-CNE3>3.0.CO;2-M; Urban NT, 2011, BIOPHYS J, V101, P1277, DOI 10.1016/j.bpj.2011.07.027; WILSON CJ, 1984, J NEUROSCI, V4, P281; WONG RKS, 1979, P NATL ACAD SCI USA, V76, P986, DOI 10.1073/pnas.76.2.986; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Yuste R, 2013, ANNU REV NEUROSCI, V36, P429, DOI 10.1146/annurev-neuro-062111-150455	56	248	251	2	108	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2014	17	5					678	+		10.1038/nn.3682	http://dx.doi.org/10.1038/nn.3682			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AF9DS	24657968	Green Accepted			2022-12-17	WOS:000335016200011
J	Griffiths, TD; Buchel, C; Frackowiak, RSJ; Patterson, RD				Griffiths, TD; Buchel, C; Frackowiak, RSJ; Patterson, RD			Analysis of temporal structure in sound by the human brain	NATURE NEUROSCIENCE			English	Article							PRIMARY AUDITORY-CORTEX; ITERATED RIPPLED NOISE; PERCEPTION; PITCH; REPRESENTATION; MECHANISMS; COMPONENTS; STRENGTH	For over a century, models of pitch perception have been based on the frequency composition of the sound. Pitch phenomena can also be explained, however in terms of the time structure, or temporal regularity of sounds. To locate the mechanism for the detection of temporal regularity in humans, we used functional imaging and a 'delay-and-add' noise, which activates all frequency regions uniformly, like noise, but which nevertheless produces strong pitch perceptions and tuneful melodies. This stimulus has temporal regularity that can be systematically altered. We found that the activity of primary auditory cortex increased with the regularity of the sound. Moreover, a melody composed of delay-and-add 'notes' produced a distinct pattern of activation in two areas of the temporal lobe distinct from primary auditory cortex. These results suggest a hierarchical analysis of time structure in the human brain.	Univ Cambridge, Dept Physiol, Ctr Neural Basis Hearing, Cambridge CB2 3EG, England; Inst Neurol, Wellcome Dept Cognit Neurol, London WC1N 3BG, England; Newcastle Univ, Sch Med, Dept Physiol Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	University of Cambridge; University of London; University College London; Newcastle University - UK	Griffiths, TD (corresponding author), Univ Cambridge, Dept Physiol, Ctr Neural Basis Hearing, Downing St, Cambridge CB2 3EG, England.	t.griffiths@fil.ion.ucl.ac.uk	Frackowiak, Richard S/I-1809-2013; Frackowiak, Richard/H-4383-2011	Frackowiak, Richard/0000-0002-3151-822X; Griffiths, Timothy/0000-0001-8066-4381	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		COHEN FS, 1995, IEEE T IMAGE PROCESS, V4, P1, DOI 10.1109/83.350818; EVANS AC, 1994, NATO ADV SCI INST SE, V264, P263; Friston K.J., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Friston KJ, 1997, HUM BRAIN MAPP, V5, P133, DOI 10.1002/(SICI)1097-0193(1997)5:2<133::AID-HBM7>3.0.CO;2-4; FRISTON KJ, 1995, HUMAN BRAIN MAPPING, V2, P165; Griffiths TD, 1997, BRAIN, V120, P785, DOI 10.1093/brain/120.5.785; Langner G, 1997, J COMP PHYSIOL A, V181, P665, DOI 10.1007/s003590050148; LANGNER G, 1988, J NEUROPHYSIOL, V60, P1799, DOI 10.1152/jn.1988.60.6.1799; LAUTER JL, 1985, HEARING RES, V20, P199, DOI 10.1016/0378-5955(85)90024-3; MERZENICH MM, 1973, J NEUROPHYSIOL, V24, P193; PANDYA DN, 1995, REV NEUROL, V151, P486; PANTEV C, 1989, SCIENCE, V246, P486, DOI 10.1126/science.2814476; Patterson RD, 1996, J ACOUST SOC AM, V100, P3286, DOI 10.1121/1.417212; PATTERSON RD, 1994, J ACOUST SOC AM, V96, P1409, DOI 10.1121/1.410285; PATTERSON RD, 1995, J ACOUST SOC AM, V98, P1890, DOI 10.1121/1.414456; Penhune VB, 1996, CEREB CORTEX, V6, P661, DOI 10.1093/cercor/6.5.661; PERETZ I, 1994, BRAIN, V117, P1283, DOI 10.1093/brain/117.6.1283; PHILLIPS DP, 1990, BEHAV BRAIN RES, V40, P85, DOI 10.1016/0166-4328(90)90001-U; Platel H, 1997, BRAIN, V120, P229, DOI 10.1093/brain/120.2.229; Rauschecker JP, 1997, J COMP NEUROL, V382, P89; ROSE JE, 1967, J NEUROPHYSIOL, V30, P769, DOI 10.1152/jn.1967.30.4.769; ROUILLY E, 1979, HEARING RES, P213; Talairach P., 1988, STEREOTACTIC COPLANA; TALAVAGE TM, 1997, NEUROIMAGE, V5, pS8; Wessinger CM, 1997, HUM BRAIN MAPP, V5, P18, DOI 10.1002/(SICI)1097-0193(1997)5:1<18::AID-HBM3>3.0.CO;2-Q; Yost WA, 1996, J ACOUST SOC AM, V99, P1066, DOI 10.1121/1.414593; ZATORRE RJ, 1994, J NEUROSCI, V14, P1908, DOI 10.1523/jneurosci.14-04-01908.1994; ZATORRE RJ, 1992, SCIENCE, V256, P846, DOI 10.1126/science.1589767; ZATORRE RJ, 1993, NEUROPSYCHOLOGIA, V31, P221, DOI 10.1016/0028-3932(93)90086-F	29	248	251	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	1998	1	5					422	427		10.1038/1637	http://dx.doi.org/10.1038/1637			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QE	10196534				2022-12-17	WOS:000076361400022
J	Walters, RK; Polimanti, R; Johnson, EC; McClintick, JN; Adams, MJ; Adkins, AE; Aliev, F; Bacanu, SA; Batzler, A; Bertelsen, S; Biernacka, JM; Bigdeli, TB; Chen, LS; Clarke, TK; Chou, YL; Degenhardt, F; Docherty, AR; Edwards, AC; Fontanillas, P; Foo, JC; Fox, L; Frank, J; Giegling, I; Gordon, S; Hack, LM; Hartmann, AM; Hartz, SM; Heilmann-Heimbach, S; Herms, S; Hodgkinson, C; Hoffmann, P; Hottenga, JJ; Kennedy, MA; Alanne-Kinnunen, M; Konte, B; Lahti, J; Lahti-Pulkkinen, M; Lai, DB; Ligthart, L; Loukola, A; Maher, BS; Mbarek, H; McIntosh, AM; McQueen, MB; Meyers, JL; Milaneschi, Y; Palviainen, T; Pearson, JF; Peterson, RE; Ripatti, S; Ryu, E; Saccone, NL; Salvatore, JE; Sanchez-Roige, S; Schwandt, M; Sherva, R; Streit, F; Strohmaier, J; Thomas, N; Wang, JC; Webb, BT; Wedow, R; Wetherill, L; Wills, AG; Boardman, JD; Chen, DF; Choi, DS; Copeland, WE; Culverhouse, RC; Dahmen, N; Degenhardt, L; Domingue, BW; Elson, SL; Frye, MA; Gabel, W; Hayward, C; Ising, M; Keyes, M; Kiefer, F; Kramer, J; Kuperman, S; Lucae, S; Lynskey, MT; Maier, W; Mann, K; Mannisto, S; Muller-Myhsok, B; Murray, AD; Nurnberger, JI; Palotie, A; Preuss, U; Raikkonen, K; Reynolds, MD; Ridinger, M; Scherbaum, N; Schuckit, MA; Soyka, M; Treutlein, J; Witt, S; Wodarz, N; Zill, P; Adkins, DE; Boden, JM; Boomsma, DI; Bierut, LJ; Brown, SA; Bucholz, KK; Cichon, S; Costello, EJ; De Wit, H; Diazgranados, N; Dick, DM; Eriksson, JG; Farrer, LA; Foroud, TM; Gillespie, NA; Goate, AM; Goldman, D; Grucza, RA; Hancock, DB; Harris, KM; Heath, AC; Hesselbrock, V; Hewitt, JK; Hopfer, CJ; Horwood, J; Iacono, W; Johnson, EO; Kaprio, JA; Karpyak, VM; Kendler, KS; Kranzler, HR; Krauter, K; Lichtenstein, P; Lind, PA; McGue, M; MacKillop, J; Madden, PAF; Maes, HH; Magnusson, P; Martin, NG; Medland, SE; Montgomery, GW; Nelson, EC; Nothen, MM; Palmer, AA; Pedersen, NL; Penninx, BWJH; Porjesz, B; Rice, JP; Rietschel, M; Riley, BP; Rose, R; Rujescu, D; Shen, PH; Silberg, J; Stallings, MC; Tarter, RE; Vanyukov, MM; Vrieze, S; Wall, TL; Whitfield, JB; Zhao, HY; Neale, BM; Gelernter, J; Edenberg, HJ; Agrawal, A				Walters, Raymond K.; Polimanti, Renato; Johnson, Emma C.; McClintick, Jeanette N.; Adams, Mark J.; Adkins, Amy E.; Aliev, Fazil; Bacanu, Silviu-Alin; Batzler, Anthony; Bertelsen, Sarah; Biernacka, Joanna M.; Bigdeli, Tim B.; Chen, Li-Shiun; Clarke, Toni-Kim; Chou, Yi-Ling; Degenhardt, Franziska; Docherty, Anna R.; Edwards, Alexis C.; Fontanillas, Pierre; Foo, Jerome C.; Fox, Louis; Frank, Josef; Giegling, Ina; Gordon, Scott; Hack, Laura M.; Hartmann, Annette M.; Hartz, Sarah M.; Heilmann-Heimbach, Stefanie; Herms, Stefan; Hodgkinson, Colin; Hoffmann, Per; Hottenga, Jouke Jan; Kennedy, Martin A.; Alanne-Kinnunen, Mervi; Konte, Bettina; Lahti, Jari; Lahti-Pulkkinen, Marius; Lai, Dongbing; Ligthart, Lannie; Loukola, Anu; Maher, Brion S.; Mbarek, Hamdi; McIntosh, Andrew M.; McQueen, Matthew B.; Meyers, Jacquelyn L.; Milaneschi, Yuri; Palviainen, Teemu; Pearson, John F.; Peterson, Roseann E.; Ripatti, Samuli; Ryu, Euijung; Saccone, Nancy L.; Salvatore, Jessica E.; Sanchez-Roige, Sandra; Schwandt, Melanie; Sherva, Richard; Streit, Fabian; Strohmaier, Jana; Thomas, Nathaniel; Wang, Jen-Chyong; Webb, Bradley T.; Wedow, Robbee; Wetherill, Leah; Wills, Amanda G.; Boardman, Jason D.; Chen, Danfeng; Choi, Doo-Sup; Copeland, William E.; Culverhouse, Robert C.; Dahmen, Norbert; Degenhardt, Louisa; Domingue, Benjamin W.; Elson, Sarah L.; Frye, Mark A.; Gaebel, Wolfgang; Hayward, Caroline; Ising, Marcus; Keyes, Margaret; Kiefer, Falk; Kramer, John; Kuperman, Samuel; Lucae, Susanne; Lynskey, Michael T.; Maier, Wolfgang; Mann, Karl; Mannisto, Satu; Muller-Myhsok, Bertram; Murray, Alison D.; Nurnberger, John I.; Palotie, Aarno; Preuss, Ulrich; Raikkonen, Katri; Reynolds, Maureen D.; Ridinger, Monika; Scherbaum, Norbert; Schuckit, Marc A.; Soyka, Michael; Treutlein, Jens; Witt, Stephanie; Wodarz, Norbert; Zill, Peter; Adkins, Daniel E.; Boden, Joseph M.; Boomsma, Dorret I.; Bierut, Laura J.; Brown, Sandra A.; Bucholz, Kathleen K.; Cichon, Sven; Costello, E. Jane; De Wit, Harriet; Diazgranados, Nancy; Dick, Danielle M.; Eriksson, Johan G.; Farrer, Lindsay A.; Foroud, Tatiana M.; Gillespie, Nathan A.; Goate, Alison M.; Goldman, David; Grucza, Richard A.; Hancock, Dana B.; Harris, Kathleen Mullan; Heath, Andrew C.; Hesselbrock, Victor; Hewitt, John K.; Hopfer, Christian J.; Horwood, John; Iacono, William; Johnson, Eric O.; Kaprio, Jaakko A.; Karpyak, Victor M.; Kendler, Kenneth S.; Kranzler, Henry R.; Krauter, Kenneth; Lichtenstein, Paul; Lind, Penelope A.; McGue, Matt; MacKillop, James; Madden, Pamela A. F.; Maes, Hermine H.; Magnusson, Patrik; Martin, Nicholas G.; Medland, Sarah E.; Montgomery, Grant W.; Nelson, Elliot C.; Noethen, Markus M.; Palmer, Abraham A.; Pedersen, Nancy L.; Penninx, Brenda W. J. H.; Porjesz, Bernice; Rice, John P.; Rietschel, Marcella; Riley, Brien P.; Rose, Richard; Rujescu, Dan; Shen, Pei-Hong; Silberg, Judy; Stallings, Michael C.; Tarter, Ralph E.; Vanyukov, Michael M.; Vrieze, Scott; Wall, Tamara L.; Whitfield, John B.; Zhao, Hongyu; Neale, Benjamin M.; Gelernter, Joel; Edenberg, Howard J.; Agrawal, Arpana		23Andme Res Team	Transancestral GWAS of alcohol dependence reveals common genetic underpinnings with psychiatric disorders	NATURE NEUROSCIENCE			English	Article							GENOME-WIDE ASSOCIATION; NATIONAL EPIDEMIOLOGIC SURVEY; LD SCORE REGRESSION; RISK; METAANALYSIS; HERITABILITY; CONSUMPTION; ADH1B; PARTICIPANTS; COMORBIDITY	Liability to alcohol dependence (AD) is heritable, but little is known about its complex polygenic architecture or its genetic relationship with other disorders. To discover loci associated with AD and characterize the relationship between AD and other psychiatric and behavioral outcomes, we carried out the largest genome-wide association study to date of DSM-IV-diagnosed AD. Genome-wide data on 14,904 individuals with AD and 37,944 controls from 28 case-control and family-based studies were meta-analyzed, stratified by genetic ancestry (European, n = 46,568; African, n = 6,280). Independent, genome-wide significant effects of different ADH1B variants were identified in European (rs1229984; P = 9.8 x 10(-13)) and African ancestries (rs2066702; P = 2.2 x 10(-9)). Significant genetic correlations were observed with 17 phenotypes, including schizophrenia, attention deficit-hyperactivity disorder, depression, and use of cigarettes and cannabis. The genetic underpinnings of AD only partially overlap with those for alcohol consumption, underscoring the genetic distinction between pathological and nonpathological drinking behaviors.	[Walters, Raymond K.; Ripatti, Samuli; Wedow, Robbee; Palotie, Aarno; Neale, Benjamin M.] Massachusetts Gen Hosp, Dept Med, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Walters, Raymond K.; Ripatti, Samuli; Wedow, Robbee; Palotie, Aarno; Neale, Benjamin M.] Harvard Med Sch, Boston, MA 02114 USA; [Walters, Raymond K.; Ripatti, Samuli; Wedow, Robbee; Chen, Danfeng; Palotie, Aarno; Neale, Benjamin M.] Broad Inst & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA USA; [Polimanti, Renato] Yale Sch Med, Dept Psychiat, West Haven, CT USA; [Polimanti, Renato] Vet Affairs Connecticut Healthcare Ctr, West Haven, CT USA; [Johnson, Emma C.; Chen, Li-Shiun; Chou, Yi-Ling; Fox, Louis; Hartz, Sarah M.; Bierut, Laura J.; Bucholz, Kathleen K.; Grucza, Richard A.; Heath, Andrew C.; Madden, Pamela A. F.; Nelson, Elliot C.; Rice, John P.; Agrawal, Arpana] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO USA; [McClintick, Jeanette N.; Edenberg, Howard J.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN USA; [Adams, Mark J.; Clarke, Toni-Kim] Univ Edinburgh, Div Psychiat, Edinburgh, Midlothian, Scotland; [Adkins, Amy E.; Thomas, Nathaniel; Dick, Danielle M.] Virginia Commonwealth Univ, Dept Psychol, Richmond, VA USA; [Adkins, Amy E.; Thomas, Nathaniel; Dick, Danielle M.] Virginia Commonwealth Univ, Coll Behav & Emot Hlth Inst, Richmond, VA USA; [Aliev, Fazil; Salvatore, Jessica E.] Virginia Commonwealth Univ, Dept Psychol, Richmond, VA USA; [Bacanu, Silviu-Alin; Webb, Bradley T.; Kendler, Kenneth S.; Riley, Brien P.] Virginia Commonwealth Univ, Alcohol Res Ctr, Virginia Inst Psychiat & Behav Genet, Dept Psychiat, Richmond, VA USA; [Batzler, Anthony] Mayo Clin, Psychiat Genom & Pharmacogen Program, Rochester, MN USA; [Bertelsen, Sarah; Wang, Jen-Chyong; Goate, Alison M.] Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY USA; [Biernacka, Joanna M.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Biernacka, Joanna M.] Mayo Clin, Dept Psychiat & Psychol, Rochester, MN USA; [Bigdeli, Tim B.] State Univ New York, Dept Psychiat & Behav Sci, Downstate Med Ctr, Brooklyn, NY USA; [Degenhardt, Franziska; Heilmann-Heimbach, Stefanie; Herms, Stefan; Hoffmann, Per] Univ Bonn, Inst Human Genet, Bonn, Germany; [Degenhardt, Franziska; Heilmann-Heimbach, Stefanie; Herms, Stefan; Hoffmann, Per] Univ Bonn, Dept Gen, Life & Brain Ctr, Bonn, Germany; [Docherty, Anna R.; Adkins, Daniel E.] Univ Utah, Dept Psychiat, Salt Lake City, UT USA; [Edwards, Alexis C.; Peterson, Roseann E.; Salvatore, Jessica E.; Gillespie, Nathan A.; Silberg, Judy] Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Dept Psychiat, Richmond, VA USA; [Fontanillas, Pierre; Elson, Sarah L.] 23andMe Inc, Mountain View, CA USA; [Foo, Jerome C.; Frank, Josef; Streit, Fabian; Strohmaier, Jana; Treutlein, Jens; Witt, Stephanie; Rietschel, Marcella] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Genet Epidemiol Psychiat, Mannheim, Germany; [Giegling, Ina; Hartmann, Annette M.; Konte, Bettina; Preuss, Ulrich; Rujescu, Dan] Martin Luther Univ Halle Wittenberg, Dept Psychiat Psychotherapy & Psychosomat, Halle, Germany; [Gordon, Scott; Lind, Penelope A.; Martin, Nicholas G.; Medland, Sarah E.; Whitfield, John B.] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia; [Hack, Laura M.] Emory Univ, Dept Psychiat & Behav Sci, Sch Med, Atlanta, GA 30322 USA; [Herms, Stefan; Hoffmann, Per; Cichon, Sven] Univ Basel Hosp, Inst Med Genet & Pathol, Univ Basel, Human Genom Res Grp,Dept Biomed, Basel, Switzerland; [Hodgkinson, Colin; Goldman, David; Shen, Pei-Hong] NIH NIAAA, Neurogenet Lab, Bethesda, MD USA; [Hottenga, Jouke Jan; Ligthart, Lannie; Mbarek, Hamdi; Boomsma, Dorret I.] Vrije Univ Amsterdam, Amsterdam Publ Hlth Res Inst, Dept Biol Psychol, Amsterdam, Netherlands; [Kennedy, Martin A.; Boden, Joseph M.; Horwood, John] Univ Otago, Christchurch, New Zealand; [Alanne-Kinnunen, Mervi; Loukola, Anu; Palviainen, Teemu; Ripatti, Samuli; Palotie, Aarno; Kaprio, Jaakko A.] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland; [Lahti, Jari] Univ Helsinki, Helsinki Collegium Adv Studies, Helsinki, Finland; [Lahti, Jari; Lahti-Pulkkinen, Marius; Raikkonen, Katri] Univ Helsinki, Dept Psychol & Logoped, Helsinki, Finland; [Lai, Dongbing; Wetherill, Leah; Nurnberger, John I.; Foroud, Tatiana M.; Edenberg, Howard J.] Indiana Univ, Dept Med & Mol Genet, Sch Med, Indianapolis, IN 46204 USA; [Maher, Brion S.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [McIntosh, Andrew M.] Univ Edinburgh, Div Psychiat, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [McQueen, Matthew B.] Univ Colorado, Dept Integrat Physiol, Boulder, CO USA; [Meyers, Jacquelyn L.; Porjesz, Bernice] Suny Downstate Med Ctr, Dept Psychiat & Behav Sci, Henri Begleiter Neurodynam Lab, Brooklyn, NY 11203 USA; [Milaneschi, Yuri; Penninx, Brenda W. J. H.] Vrije Univ Amsterdam, Med Ctr GGz inGeest, Amsterdam Publ Hlth Res Inst, Dept Psychiat, Amsterdam, Netherlands; [Pearson, John F.] Univ Otago, Biostat & Computat Biol Unit, Christchurch, New Zealand; [Ripatti, Samuli; Kaprio, Jaakko A.] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland; [Ryu, Euijung] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Saccone, Nancy L.] Washington Univ, Sch Med, Dept Genet, St Louis, MO USA; [Sanchez-Roige, Sandra; Schuckit, Marc A.; Brown, Sandra A.; Palmer, Abraham A.; Wall, Tamara L.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Schwandt, Melanie; Goldman, David] NIAAA, Off Clin Director, NIH, Bethesda, MD USA; [Sherva, Richard; Farrer, Lindsay A.] Boston Univ, Dept Med Biomed Genet, Sch Med, Boston, MA USA; [Wedow, Robbee] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Wedow, Robbee] Harvard Univ, Dept Sociol, Cambridge, MA USA; [Wills, Amanda G.] Univ Colorado, Sch Med, Dept Pharmacol, Aurora, CO USA; [Boardman, Jason D.] Univ Colorado, Inst Behav Sci, Boulder, CO USA; [Boardman, Jason D.] Univ Colorado, Dept Sociol, Boulder, CO USA; [Choi, Doo-Sup] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN USA; [Copeland, William E.; Costello, E. Jane] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA; [Culverhouse, Robert C.] Washington Univ, Sch Med, Dept Med, St Louis, MO USA; [Culverhouse, Robert C.] Washington Univ, Div Biostat, St Louis, MO USA; [Dahmen, Norbert] Johannes Gutenberg Univ Mainz, Dept Psychiat, Mainz, Germany; [Degenhardt, Louisa] Univ New South Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW, Australia; [Domingue, Benjamin W.] Stanford Univ, Grad Sch Educ, Stanford, CA USA; [Frye, Mark A.; Karpyak, Victor M.] Mayo Clin, Dept Psychiat & Psychol, Rochester, MN USA; [Gaebel, Wolfgang] Univ Dusseldorf, Dept Psychiat & Psychotherapy, Dusseldorf, Germany; [Hayward, Caroline] Univ Edinburgh, Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh, Midlothian, Scotland; [Ising, Marcus; Lucae, Susanne] Max Planck Inst Psychiat, Munich, Germany; [Keyes, Margaret; Iacono, William; McGue, Matt; Vrieze, Scott] Univ Minnesota, Dept Psychol, Minneapolis, MN USA; [Kiefer, Falk; Mann, Karl] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Addict Behav & Addict Med, Heidelberg, Germany; [Kramer, John; Kuperman, Samuel] Univ Iowa, Roy J & Lucille Carver Coll Med, Dept Psychiat, Iowa City, IA USA; [Lynskey, Michael T.] Kings Coll London, Inst Psychiat Psychol & Neurosci, Addict Dept, London, England; [Maier, Wolfgang] Univ Bonn, Dept Psychiat, Bonn, Germany; [Mannisto, Satu] Inst Hlth & Welf, Helsinki, Finland; [Muller-Myhsok, Bertram] Max Planck Inst Psychiat, Dept Stat Genet, Munich, Germany; [Murray, Alison D.] Univ Aberdeen, Aberdeen Biomed Imaging Ctr, Inst Med Sci, Aberdeen, Scotland; [Nurnberger, John I.] Indiana Univ, Dept Psychiat, Sch Med, Indianapolis, IN 46204 USA; [Palotie, Aarno] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Palotie, Aarno] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Palotie, Aarno] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Preuss, Ulrich] Vitos Hosp Herborn, Dept Psychiat & Psychotherapy, Herborn, Germany; [Reynolds, Maureen D.; Tarter, Ralph E.; Vanyukov, Michael M.] Univ Pittsburgh, Sch Pharm, Pittsburgh, PA USA; [Ridinger, Monika] Univ Regensburg Psychiat Hlth Care Aargau, Dept Psychiat & Psychotherapy, Regensburg, Germany; [Scherbaum, Norbert] Univ Duisburg Essen, Fac Med, Dept Addict Behav & Addict Med, LVR Hosp Essen,Dept Psychiat & Psychotherapy, Duisburg, Germany; [Soyka, Michael] Med Pk Chiemseeblick Bernau Felden, Chiemsee, Germany; [Soyka, Michael; Zill, Peter] Ludwig Maximilians Univ Munchen, Psychiatr Hosp, Munich, Germany; [Wodarz, Norbert] Univ Regensburg, Dept Psychiat & Psychotherapy, Regensburg, Germany; [Adkins, Daniel E.] Univ Utah, Dept Sociol, Salt Lake City, UT USA; [Brown, Sandra A.] Univ Calif San Diego, Sch Med, Dept Psychol, San Diego, CA USA; [De Wit, Harriet; Diazgranados, Nancy] NIAAA, Intramural Res Program, Bethesda, MD USA; [Dick, Danielle M.] Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA USA; [Eriksson, Johan G.] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki, Finland; [Eriksson, Johan G.] Natl Inst Hlth & Welf, Helsinki, Finland; [Farrer, Lindsay A.] Boston Univ, Dept Neurol Ophthalmol Epidemiol & Biostat, Sch Med, Boston, MA 02215 USA; [Farrer, Lindsay A.] Boston Univ, Schs Med & Publ Hlth, Boston, MA 02215 USA; [Hancock, Dana B.] RTI Int, Behav Hlth Res Div, Ctr Omics Discovery & Epidemiol, Res Triangle Pk, NC USA; [Harris, Kathleen Mullan] Univ N Carolina, Dept Sociol & Carolina Populat Ctr, Chapel Hill, NC USA; [Hesselbrock, Victor] Univ Connecticut, Sch Med, Dept Psychiat, Farmington, CT USA; [Hewitt, John K.; Stallings, Michael C.] Univ Colorado Boulder, Inst Behav Genet, Boulder, CO USA; [Hopfer, Christian J.] Univ Colorado Denver, Sch Med, Denver, CO USA; [Johnson, Eric O.] RTI Int, Fellows Program, Res Triangle Pk, NC USA; [Kranzler, Henry R.] Univ Penn, Perelman Sch Med, Ctr Studies Addict, Dept Psychiat, Philadelphia, PA 19104 USA; [Kranzler, Henry R.] Univ Penn, VISN 4 MIRECC, Crescenz VAMC, Philadelphia, PA 19104 USA; [Krauter, Kenneth] Univ Colorado Boulder, Dept Mol Cellular & Dev Biol, Boulder, CO USA; [Lichtenstein, Paul; Magnusson, Patrik; Pedersen, Nancy L.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [MacKillop, James] McMaster Univ, Michael G DeGroote Ctr Med Cannabis Res, St Josephs Healthcare Hamilton, Peter Boris Ctr Addict Res, Hamilton, ON, Canada; [Maes, Hermine H.] Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Richmond, VA USA; [Montgomery, Grant W.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Noethen, Markus M.] Univ Bonn, Sch Med, Inst Human Genet, Bonn, Germany; [Noethen, Markus M.] Univ Hosp Bonn, Bonn, Germany; [Palmer, Abraham A.] Univ Calif San Diego, Inst Genom Med, San Diego, CA USA; [Rose, Richard] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN USA; [Zhao, Hongyu] Yale Univ, Dept Biostat, Yale Sch Publ Hlth, New Haven, CT USA; [Gelernter, Joel] Yale Univ, Dept Psychiat Genet & Neurosci, Sch Med, Vet Affairs Connecticut Healthcare Syst, New Haven, CT USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Washington University (WUSTL); Indiana University System; Indiana University Bloomington; University of Edinburgh; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Mayo Clinic; Icahn School of Medicine at Mount Sinai; Mayo Clinic; Mayo Clinic; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; SUNY Delhi; University of Bonn; University of Bonn; Utah System of Higher Education; University of Utah; Virginia Commonwealth University; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Martin Luther University Halle Wittenberg; QIMR Berghofer Medical Research Institute; Emory University; University of Basel; Vrije Universiteit Amsterdam; University of Otago; University of Helsinki; University of Helsinki; University of Helsinki; Indiana University System; Indiana University-Purdue University Indianapolis; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Edinburgh; University of Colorado System; University of Colorado Boulder; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Vrije Universiteit Amsterdam; University of Otago; University of Helsinki; Mayo Clinic; Washington University (WUSTL); University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Boston University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Mayo Clinic; Duke University; Washington University (WUSTL); Washington University (WUSTL); Johannes Gutenberg University of Mainz; University of New South Wales Sydney; Stanford University; Mayo Clinic; Heinrich Heine University Dusseldorf; University of Edinburgh; Max Planck Society; University of Minnesota System; University of Minnesota Twin Cities; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; University of Iowa; University of London; King's College London; University of Bonn; Max Planck Society; University of Aberdeen; Indiana University System; Indiana University-Purdue University Indianapolis; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Duisburg Essen; University of Munich; University of Regensburg; Utah System of Higher Education; University of Utah; University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Virginia Commonwealth University; University of Helsinki; Finland National Institute for Health & Welfare; Boston University; Boston University; Research Triangle Institute; University of North Carolina; University of North Carolina Chapel Hill; University of Connecticut; University of Colorado System; University of Colorado Boulder; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Research Triangle Institute; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Colorado System; University of Colorado Boulder; Karolinska Institutet; McMaster University; Virginia Commonwealth University; University of Queensland; University of Bonn; University of Bonn; University of California System; University of California San Diego; Indiana University System; Indiana University Bloomington; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University	Agrawal, A (corresponding author), Washington Univ, Sch Med, Dept Psychiat, St Louis, MO USA.; Edenberg, HJ (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN USA.; Edenberg, HJ (corresponding author), Indiana Univ, Dept Med & Mol Genet, Sch Med, Indianapolis, IN 46204 USA.; Gelernter, J (corresponding author), Yale Univ, Dept Psychiat Genet & Neurosci, Sch Med, Vet Affairs Connecticut Healthcare Syst, New Haven, CT USA.	joel.gelernter@yale.edu; edenberg@iu.edu; Arpana@wustl.edu	Bigdeli, Tim B./AAX-7761-2020; Hartz, Sarah/AAD-4073-2019; McIntosh, Andrew M/B-9379-2008; Brown, Sandra A/S-8789-2019; Copeland, William E/N-5413-2014; Sanchez-Roige, Sandra/GPK-6281-2022; Hartmann, Annette/AAS-6331-2021; Bierut, Laura Jean/W-6806-2019; Wetherill, Leah/AAJ-2791-2020; Docherty, Anna/AAW-6640-2021; Webb, Bradley T/B-1459-2009; Giegling, Ina/ABA-3677-2021; Hartz, Sarah M/AAD-7662-2020; kranzler, henry/AAS-1113-2020; Stallings, Michael C/R-3808-2018; Boomsma, Dorret I/AAX-4470-2020; Farrer, Lindsay/AAS-1035-2020; Lahti, Jari/P-2283-2019; Clarke, Toni/AAE-7069-2019; Magnusson, Patrik KE/C-4458-2017; McQueen, Matthew/X-5845-2019; Kennedy, Martin A/A-4942-2008; Karpyak, Victor M./AGJ-2595-2022; Docherty, Anna/AGG-6400-2022; Kendler, Kenneth/AAF-2876-2019; Rujescu, Dan/GRS-3875-2022; Kaprio, Jaakko/A-1820-2008; Wodarz, Norbert/E-1805-2011; Herms, Stefan/J-1949-2014; Medland, Sarah/AAT-7595-2020; Diazgranados, Nancy/M-1781-2019; Lind, Penelope A/B-2553-2009; Hoffmann, Per/A-5149-2010; Aliev, Fazil/D-7172-2013; , James/ABI-3641-2020; Pearson, John F/D-7428-2012; Konte, Bettina/AAT-1142-2021; Lind, Penelope A/ABC-5341-2021; Lahti, Jari/P-7987-2018; Goldman, David/F-9772-2010; Penninx, Brenda WJH/S-7627-2017; Boden, Joseph/C-3316-2009; Lahti-Pulkkinen, Marius/Q-2472-2017	Bigdeli, Tim B./0000-0003-2215-5946; Hartz, Sarah/0000-0002-5429-3799; McIntosh, Andrew M/0000-0002-0198-4588; Copeland, William E/0000-0002-1348-7781; Sanchez-Roige, Sandra/0000-0001-6137-5699; Bierut, Laura Jean/0000-0002-9952-4810; Wetherill, Leah/0000-0003-2888-9051; Docherty, Anna/0000-0001-7139-7007; Webb, Bradley T/0000-0002-0576-5366; kranzler, henry/0000-0002-1018-0450; Stallings, Michael C/0000-0002-8231-9159; Lahti, Jari/0000-0002-4310-5297; Clarke, Toni/0000-0002-7745-6351; Magnusson, Patrik KE/0000-0002-7315-7899; Kennedy, Martin A/0000-0002-6445-8526; Karpyak, Victor M./0000-0002-9552-6130; Docherty, Anna/0000-0001-7139-7007; Kaprio, Jaakko/0000-0002-3716-2455; Herms, Stefan/0000-0002-2786-8200; Medland, Sarah/0000-0003-1382-380X; Diazgranados, Nancy/0000-0002-7415-8455; Lind, Penelope A/0000-0002-3887-2598; Hoffmann, Per/0000-0002-6573-983X; Aliev, Fazil/0000-0001-8357-4699; , James/0000-0002-8695-1071; Pearson, John F/0000-0001-5607-4517; Konte, Bettina/0000-0001-5287-308X; Lind, Penelope A/0000-0002-3887-2598; Lahti, Jari/0000-0002-4310-5297; Hodgkinson, Colin/0000-0002-5365-8119; Murray, Alison/0000-0003-4915-4847; Kuperman, Samuel/0000-0002-5995-1981; Sherva, Richard/0000-0003-2133-1493; Raikkonen, Katri/0000-0003-3124-3470; Alipanahi, Babak/0000-0001-8216-7178; Bacanu, Silviu-Alin/0000-0002-4364-1583; Goldman, David/0000-0002-1724-5405; Penninx, Brenda WJH/0000-0001-7779-9672; Hancock, Dana/0000-0003-2240-3604; Johnson, Emma/0000-0003-0394-777X; Mbarek, Hamdi/0000-0002-1108-0371; Foo, Jerome Clifford/0000-0003-1067-5725; Loukola, Anu-Maria/0000-0003-0542-5967; Johnson, Eric Otto/0000-0002-8870-1949; Kinnunen, Mervi/0000-0002-2448-8763; Adams, Mark James/0000-0002-3599-6018; Polimanti, Renato/0000-0003-0745-6046; Shen, Pei-Hong/0000-0002-8031-9374; Palotie, Aarno/0000-0002-2527-5874; Boden, Joseph/0000-0003-1502-1608; Palviainen, Teemu/0000-0002-7847-8384; Lahti-Pulkkinen, Marius/0000-0002-5244-5525; Lynskey, Michael/0000-0001-9989-737X; Ligthart, Lannie/0000-0002-6570-3319; Edwards, Alexis/0000-0002-4006-9710; Pedersen, Nancy/0000-0001-8057-3543	National Institute of Mental Health [R01-MH-083094, MH109532, R01MH063970, R01MH063671, R01MH048085, K01MH093731, K23MH080230, R01MH045268, R01MH055557, R01MH068521]; Academy of Finland [265240, 263278, 213506, 129680, 100499, 205585, 118555, 141054, 264146]; Juselius Foundation; National Institutes of Health (NIH) [AA009367, MH066140, AA07728, AA14041, AA17688, DA019951, RC2 DA028909, R01 DA12690, R01 DA12849, R01 DA18432, R01 AA11330, R01 AA017535, U01-DK 066134]; National Institute on Alcohol Abuse and Alcoholism (NIAAA) [P20 AA017830, R21 AA25214, P20-AA-017828, P50-AA-022537, AA-12502, AA-00145, AA-09203, AA15416, K02AA018755]; German Government BMBF [01EB0130, 01EB0410]; NHMRC [GNT1078399, NHMRC]; D.F.G.; B.M.B.F.; Health Research Council of New Zealand [11/792, 16/600]; Sigrid Juselius Foundation; Australian NHMRC Principal Research Fellowship; NIH/NIAAA [P20AA017830]; CSAT/SAMHSA [1H79T1026423, 1H79T1026446]; AHRQ [1R18HS024208]; NSF GRFP [DGE 1144083]; Peter Boris Chair in Addictions Research; Frontiers of Innovation Scholars Program (FISP); Interdisciplinary Research Fellowship in NeuroAIDS (IRFN); BMBF [01ZX1314A, 01ZX1311A]; DFG; Integrated Network IntegraMent [01ZX1314A, 01ZX1314G]; SysMedAlcoholism [01ZX1311A]; University of Helsinki; Wellcome Trust [104036/Z/14/Z]; National Institute on Drug Abuse [R01 DA17305, P50 DA005605]; Health Research Council of New Zealand; National Child Health Research Foundation (Cure Kids); Canterbury Medical Research Foundation; New Zealand Lottery Grants Board; University of Otago; Carney Centre for Pharmacogenomics; James Hume Bequest Fund; US NIH [MH077874]; National Institute on Drug Abuse (NIDA) [R01DA024413, U01DA024413, R01DA11301, R00DA023549, R01DA025109]; NIH from the NIAAA [U10AA008401]; NIH GEI [U01HG004438]; NIH Genes, Environment and Health Initiative (GEI) [U01 HG004422]; GWAS as part of the Gene Environment Association Studies (GENEVA) under GEI; COGA [U10 AA008401]; Collaborative Genetic Study of Nicotine Dependence (COGEND) [P01 CA089392]; Family Study of Cocaine Dependence [R01 DA013423, R01 DA019963]; German Federal Ministry of Education and Research (BMBF) [01ZX1314A, 01ZX1314G, BMBF 01ZX1311A]; NARSAD; William T. Grant Foundation; Virginia Commonwealth University from the National Institute on Alcohol Abuse and Alcoholism [K02AA018755, P20 AA017828, R37AA011408, P50 AA022537]; National Center for Research Resources [UL1RR031990]; National Institutes of Health Roadmap for Medical Research; NIAAA Intramural Research Program (IRP); Mayo CTSA [UL1TR000135]; SC Johnson Genomics of Addiction Program; Mayo Clinic Center for Individualized Medicine; Virginia Tobacco Settlement Foundation [8520012]; Swedish Twin Registry; Swedish Research Council [2017-00641, M-2005-1112]; GenomEUtwin [EU/QLRT-2001-01254, QLG2-CT-2002-01254]; Swedish Foundation for Strategic Research (SSF); Heart and Lung Foundation [20070481]; Veterans Affairs Connecticut and Philadelphia Veterans Affairs Mental Illness Research, Educational, and Clinical Centers; Australian National Health and Medical Research Council [241944, 339462, 389927, 389875, 389891, 389892, 389938, 442915, 442981, 496739, 552485, 552498]; Australian Research Council [A7960034, A79906588, A79801419, DP0770096, DP0212016, DP0343921, DP0664638, 464914, 619667, FT110100548]; 5th Framework Programme (FP-5) GenomEUtwin Project [QLG2-CT-2002-01254]; Wellcome Trust Case Control Consortium 2 grant [WTCCC-084710]; Netherlands Organization for Scientific Research (NWO); MagW/ZonMW [NWO-48015-001/674]; Netherlands Twin Registry Repository: researching the interplay between genome and environment; Geestkracht program of the Netherlands Organization for Health Research and Development [Zon-MW 10-000-1002]; Genetic determinants of risk behavior in relation to alcohol use and alcohol use disorder [ZonMWAddiction-31160008]; Biobanking and Biomolecular Resources Research Infrastructure (BBMRI-NL) [184.021.007]; Amsterdam Public Health research institute (APH); Neuroscience Campus Amsterdam (NCA); European Science Council [ERC-230374, ERC-284167]; NWO/SPI [56-46414192]; Genetic Association Information Network (GAIN) of the Foundation for the National Institutes of Health; Rutgers University Cell and DNA Repository [NIMH U24 MH068457-06]; Avera Institute for Human Genetics, Sioux Falls, South Dakota (USA); Global Research Award for Nicotine Dependence/Pfizer Inc.; Wellcome Trust Sanger Institute, UK; European Community's Seventh Framework Programme ENGAGE Consortium [HEALTH-F4-2007-201413]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [P01-HD31921]; Finnish Diabetes Research Society; Folkhalsan Research Foundation; Novo Nordisk Foundation; Finska Lakaresallskapet; Juho Vainio Foundation; Signe and Ane Gyllenberg Foundation; Ministry of Education, Ahokas Foundation; Emil Aaltonen Foundation; UK Medical Research Council; Wellcome [102215/2/13/2]; University of Bristol; Chief Scientist Office of the Scottish Government Health Directorates [CZD/16/6]; Scottish Funding Council [HR03006]; Medical Research Council UK; Wellcome Trust (Wellcome Trust Strategic Award 'STratifying Resilience and Depression Longitudinally' (STRADL) [104036/Z/14/Z];  [480-05-003];  [DA005147];  [AA017444];  [DA011015];  [DA012845];  [DA021913];  [DA021905];  [DA032555];  [DA035804];  [R01 DA019157];  [AA13320];  [R01-AA-011408];  [HHSN268200782096C];  [N01-HG-65403];  [P50DA037844];  [AA022717];  [U01 MH094432];  [K01MH113848];  [R21DA043735];  [R01 HD060726];  [R01 HD073342];  [P01 HD031921];  [DA012854];  [R25DA027995];  [AA07535];  [AA07729];  [AA13321];  [AA11998];  [1K01MH109765-01];  [3T32AA7464-38 S1];  [U01 MH109539];  [R01 MH107649];  [AA011408];  [R01DA036525];  [R01DA039408];  [R01DA036628];  [DA038076];  [AA25214];  [K01DA037914];  [DA025109];  [DA016977];  [K01 AA024152];  [R01HD060726];  [MH100549];  [R01 DA021905];  [R01 DA035804];  [U10 AA08401];  [R01HD093651];  [R01DA036523];  [P30DA023026];  [K02DA32573];  [R01 AA017444];  [R01 HD042157-01A1];  [MH081802];  [1RC2 MH089951];  [1RC2 MH089995];  [DA12854];  [AA021399];  [DA12690];  [R01DA036583];  [R01AA015416];  [P50AA0022537];  [DA023026];  [DA011301];  [DA024413];  [R01 DA044014];  [R21AA024888];  [K08DA032680];  [AA017828];  [AA022537];  [AA018779];  [DA013240];  [DA024417];  [DA036216];  [DA02812];  [DA042755];  [DA037904];  [DA040177];  [HG008983]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD050924, P2CHD066613, P01HD031921, R01HD073342, R01HD093651] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG008983] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH109539, R01MH107649, U24MH068457, K01MH109765, U01MH109532, U01MH109536, K01MH113848] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000130, K02AA018755, T32AA007464, U10AA008401, R37AA011408, R01AA015416, K01AA024152, R21AA025214, R37AA009367, P50AA022537, K05AA017688, R01AA012502, ZIAAA000301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA038076, R01DA036583, R01DA039408, R21DA043735, R01DA036523, R37DA005147, R01DA002812, R01DA036628, K02DA032573, K24DA032555, K08DA032680, R01DA042755, R21DA040177, R01DA012690, R01DA037904, P50DA037844, P30DA023026, R01DA035804, R01DA036216, R21DA041883, R33DA041883, R01DA046436, R01DA042620, R25DA027995] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Academy of Finland(Academy of Finland); Juselius Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Alcohol Abuse and Alcoholism (NIAAA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); German Government BMBF(Federal Ministry of Education & Research (BMBF)); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); D.F.G.(German Research Foundation (DFG)); B.M.B.F.(Federal Ministry of Education & Research (BMBF)); Health Research Council of New Zealand(Health Research Council of New Zealand); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Australian NHMRC Principal Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NIH/NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); CSAT/SAMHSA; AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NSF GRFP(National Science Foundation (NSF)NSF - Office of the Director (OD)); Peter Boris Chair in Addictions Research; Frontiers of Innovation Scholars Program (FISP); Interdisciplinary Research Fellowship in NeuroAIDS (IRFN); BMBF(Federal Ministry of Education & Research (BMBF)); DFG(German Research Foundation (DFG)); Integrated Network IntegraMent; SysMedAlcoholism; University of Helsinki; Wellcome Trust(Wellcome Trust); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Health Research Council of New Zealand(Health Research Council of New Zealand); National Child Health Research Foundation (Cure Kids); Canterbury Medical Research Foundation; New Zealand Lottery Grants Board; University of Otago; Carney Centre for Pharmacogenomics; James Hume Bequest Fund; US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIH from the NIAAA; NIH GEI; NIH Genes, Environment and Health Initiative (GEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GWAS as part of the Gene Environment Association Studies (GENEVA) under GEI; COGA; Collaborative Genetic Study of Nicotine Dependence (COGEND); Family Study of Cocaine Dependence; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); NARSAD(NARSAD); William T. Grant Foundation; Virginia Commonwealth University from the National Institute on Alcohol Abuse and Alcoholism; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAAA Intramural Research Program (IRP); Mayo CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); SC Johnson Genomics of Addiction Program; Mayo Clinic Center for Individualized Medicine; Virginia Tobacco Settlement Foundation; Swedish Twin Registry; Swedish Research Council(Swedish Research CouncilEuropean Commission); GenomEUtwin; Swedish Foundation for Strategic Research (SSF)(Swedish Foundation for Strategic Research); Heart and Lung Foundation(Swedish Heart-Lung Foundation); Veterans Affairs Connecticut and Philadelphia Veterans Affairs Mental Illness Research, Educational, and Clinical Centers; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); 5th Framework Programme (FP-5) GenomEUtwin Project(European Commission); Wellcome Trust Case Control Consortium 2 grant; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); MagW/ZonMW; Netherlands Twin Registry Repository: researching the interplay between genome and environment; Geestkracht program of the Netherlands Organization for Health Research and Development; Genetic determinants of risk behavior in relation to alcohol use and alcohol use disorder; Biobanking and Biomolecular Resources Research Infrastructure (BBMRI-NL); Amsterdam Public Health research institute (APH); Neuroscience Campus Amsterdam (NCA); European Science Council; NWO/SPI(Netherlands Organization for Scientific Research (NWO)); Genetic Association Information Network (GAIN) of the Foundation for the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rutgers University Cell and DNA Repository; Avera Institute for Human Genetics, Sioux Falls, South Dakota (USA); Global Research Award for Nicotine Dependence/Pfizer Inc.; Wellcome Trust Sanger Institute, UK(Wellcome Trust); European Community's Seventh Framework Programme ENGAGE Consortium; Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Finnish Diabetes Research Society; Folkhalsan Research Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Finska Lakaresallskapet; Juho Vainio Foundation; Signe and Ane Gyllenberg Foundation; Ministry of Education, Ahokas Foundation; Emil Aaltonen Foundation; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome; University of Bristol; Chief Scientist Office of the Scottish Government Health Directorates; Scottish Funding Council; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust (Wellcome Trust Strategic Award 'STratifying Resilience and Depression Longitudinally' (STRADL); ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank A. Morris for providing code implementing the MANTRA Bayesian model. We thank A. Martin, A. Bloemendal, and H. Finucane for helpful conversations about the analysis protocol for admixed cohorts. We thank D. Hughes for her assistance with editorial contributions to the manuscript. We thank R. Spanagel for significant contributions as a founding member of the German Study of the Genetics of Alcoholism (GESGA). The PGC-SUD Working Group receives support from the National Institute on Drug Abuse and the National Institute of Mental Health via MH109532. We gratefully acknowledge prior support from the National Institute on Alcohol Abuse and Alcoholism. Statistical analyses for the PGC were carried out on the Genetic Cluster Computer (http://www.geneticcluster.org) hosted by SURFsara and financially supported by the 480-05-003), along with a supplement from the Dutch Brain Foundation and the VU University Amsterdam. We thank the 23 and Me research participants and employees for making this work possible. A.P. is supported by the Academy of Finland, Juselius Foundation; D.E.A. acknowledges 1K01MH093731; R. R. acknowledges AA-12502, AA-09203, AA-00145; M.K. is supported by AA009367, DA005147; M.M. is supported by AA009367, MH066140; R.A.G. is supported by AA017444; K.R. is supported by Academy of Finland; A.C.H. is supported by NIH AA07535, AA07729, AA13320, AA13321, and AA11998; A. R. D. is supported by NIH 1K01MH109765-01; A.E.A. is supported by NIH AA011408 and AA017828; A.G.W. is supported by NIH 3T32AA7464-38 S1; B.M.N. is supported by NIH U01 MH109539 and R01 MH107649; B.P.R. is supported by NIH AA011408, AA017828, and AA022537; B.S.M. is supported by NIH R01DA036525 and R01DA039408; B.T.W. is supported by NIH AA011408, AA017828, and AA022537; C. Hodgkinson. is supported by NIH and National Institute on Alcohol Abuse and Alcoholism (NIAAA) Intramural program; C.J.H. is supported by NIH DA032555, DA035804, DA011015, and DA042755; D.-S.C. is supported by NIH P20AA017830 and AA018779; W.I. is supported by NIH DA005147, DA013240, DA024417, and DA036216; S.A.B. is supported by NIH DA021905; H.d.W. is supported by NIH DA02812; M.C.S. is supported by NIH DA035804; S.V. is supported by NIH DA042755, DA037904, DA040177, and HG008983; R.P. is supported by NIH DA12690; J.G. is supported by NIH DA12690; D.B.H. is supported by NIH R01DA036583; D.G. is supported by the NIAAA Intramural program; D.M.D. is supported by NIH R01AA015416, K02AA018755, U10AA008401, and P50AA0022537; E.J.C. is supported by NIH DA023026, DA011301, and DA024413; E.O.J. is supported by NIH R01 DA044014; N.S. is supported by German Government BMBF #01EB0130; K.M. is supported by German Government BMBF #01EB0410; G.W.M. is supported by an NHMRC fellowship by GNT1078399; N.W. is supported by D.F.G. and B.M.B.F.; N. Dahmen is supported by D.F.G. and B.M.B.F.; J.D.B. is supported by NIH R01HD060726; M.A.K. is supported by Health Research Council of New Zealand 11/792, 16/600; J.M. Boden is supported by Health Research Council of New Zealand 11/792, 16/600; J. H. is supported by Health Research Council of New Zealand 11/792, 16/600; J.F.P. is supported by Health Research Council of New Zealand 11/792, 16/600; H.H.M. is supported by NIH DA025109, DA024413, and DA016977; J.E.S. is supported by NIH K01 AA024152; J.A.K. is supported by Academy of Finland 265240, 263278, and Sigrid Juselius Foundation; J.K.H. is supported by NIH DA011015; J.L.M. is supported by NIH K01DA037914; J.M. Biernaka is supported by NIH P20AA017830 and AA25214; K.K. is supported by NIH DA011015; K.S.K.; is supported by NIH P50AA0022537; L.-S.C. is supported by NIH DA038076; L.J.B. is supported by NIH R01DA036583; L.M.H. is supported by NIH AA011408 and AA017828; L.D. is supported by an Australian NHMRC Principal Research Fellowship; M.A.F. is supported by NIH/NIAAA P20AA017830; M.D.R. is supported by CSAT/SAMHSA 1H79T1026423, 1H79T1026446, AHRQ 1R18HS024208, and NIH R01DA036628; N.A.G. is supported by NIH R00DA023549; P.-H.S. is supported by NIAAA Intramural Research Program; N. Diazgranados is supported by NIAAA Intramural Research Program; M. Schwandt is supported by NIAAA Intramural Research Program; R. W. is supported by NSF GRFP DGE 1144083; P.A.F.M. is supported by NIH DA012854 and R25DA027995; J. M. is supported by Peter Boris Chair in Addictions Research; K. M. H is supported by NIH R01 HD060726, R01 HD073342, and P01 HD031921; M. B. M. is supported by NIH R01HD060726; R. K. W. is supported by NIH U01 MH094432; R. C. C. is supported by NIH R01DA036583; R.E.P. is supported by NIH K01MH113848; R.E.T. is supported by NIH R21DA043735; S.S.-R. is supported by the Frontiers of Innovation Scholars Program (FISP) and the Interdisciplinary Research Fellowship in NeuroAIDS (IRFN) and by NIH P50DA037844; S.-A. B. is supported by NIH AA011408, AA017828, AA022537, and AA022717; S.E.M. is supported by NHMRC 1103623; S.M.H. is supported by NIH R21AA024888 and K08DA032680; T.B.B. is supported by NIH MH100549; M. M. N. is supported by The BMBF-funded e: Med consortium IntegraMent 01ZX1314A, SysMedAlcoholism 01ZX1311A, and DFG-funded Excellence-Cluster ImmunoSensation; S. C. is supported by The Integrated Network IntegraMent 01ZX1314A; M. Rietschel is supported by The Integrated Network IntegraMent 01ZX1314G and SysMedAlcoholism 01ZX1311A; T. L. W. is supported by NIH R01 DA021905 and R01 DA035804; A. M. G. is supported by NIH U10 AA08401; M. L.-P. is supported by University of Helsinki, Academy of Finland; J. L. is supported by University of Helsinki, Academy of Finland; V. M. K. is supported by NIH P20AA017830 and AA25214; W. E. C. is supported by NIH R01HD093651, R01DA036523, and P30DA023026; T.-K. C. is supported by Wellcome Trust (STRADL) 104036/Z/14/Z; M. J. A. is supported by Wellcome Trust (STRADL) 104036/Z/14/Z; A. M. M. is supported by Wellcome Trust (STRADL) 104036/Z/14/Z. A. A. is supported by NIH K02DA32573. Funding support for the Comorbidity and Trauma Study (dbGAP accession number: phs000277.v1.p1) was provided by the National Institute on Drug Abuse (R01 DA17305); GWAS genotyping services at the CIDR at The Johns Hopkins University were supported by the National Institutes of Health (contract N01-HG-65403). Funding support for the Center for Education and Drug Abuse Research (dbGAP accession number: phs001649.v1.p1) was provided by the National Institute on Drug Abuse (P50 DA005605). The Christchurch Health and Development Study (dbGAP in progress) has been supported by funding from the Health Research Council of New Zealand, the National Child Health Research Foundation (Cure Kids), the Canterbury Medical Research Foundation, the New Zealand Lottery Grants Board, the University of Otago, the Carney Centre for Pharmacogenomics, the James Hume Bequest Fund, US NIH grant MH077874, and NIDA grant "A developmental model of gene-environment interplay in SUDs" (R01DA024413) 2007-2012. COGA is supported by NIH Grant U10AA008401 from the NIAAA and the National Institute on Drug Abuse (NIDA).; Funding support for this GWAS genotyping, which was performed at the Johns Hopkins University Center for Inherited Disease Research, was provided by the National Institute on Alcohol Abuse and Alcoholism, the NIH GEI (U01HG004438) and the NIH contract " High throughput genotyping for studying the genetic contributions to human disease" (HHSN268200782096C). COGA Principal Investigators: B. Porjesz, V. Hesselbrock, H. Edenberg, L. Bierut; includes eleven different centers: University of Connecticut (V. Hesselbrock); Indiana University (H. J. Edenberg, J. Nurnberger Jr., T. Foroud); University of Iowa (S. Kuperman, J. Kramer); SUNY Downstate (B. Porjesz); Washington University in St. Louis (L. Bierut, J. Rice, K. Bucholz, A. Agrawal); University of California at San Diego (M. Schuckit); Rutgers University (J. Tischfield, A. Brooks); Department of Biomedical and Health Informatics, The Children's Hospital of Philadelphia; Department of Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia PA (L. Almasy), Virginia Commonwealth University (D. Dick), Icahn School of Medicine at Mount Sinai (A. Goate), and Howard University (R. Taylor). Other COGA collaborators include: L. Bauer (University of Connecticut); J. McClintick, L. Wetherill, X. Xuei, Y. Liu, D. Lai, S. O'Connor, M. Plawecki, S. Lourens (Indiana University); G. Chan (University of Iowa; University of Connecticut); J. Meyers, D. Chorlian, C. Kamarajan, A. Pandey, J. Zhang (SUNY Downstate); J.-C. Wang, M. Kapoor, S. Bertelsen (Icahn School of Medicine at Mount Sinai); A. Anokhin, V. McCutcheon, S. Saccone (Washington University); J. Salvatore, F. Aliev, B. Cho (Virginia Commonwealth University); and Mark Kos (University of Texas Rio Grande Valley). A. Parsian is an NIAAA Staff Collaborator. M. Reilly was an NIAAA staff collaborator. We continue to be inspired by our memories of Henri Begleiter and Theodore Reich, founding PI and Co-PI of COGA, and also owe a debt of gratitude to other past organizers of COGA, including T. -K. Li, currently a consultant with COGA, as well as P. M. Conneally, R. Crowe, and W. Reich, for their critical contributions. The authors thank K. Doheny and E. Pugh from CIDR and J. Paschall from the NCBI dbGaP staff for valuable assistance with genotyping and quality control in developing the dataset available at dbGaP (phs000125.v1.p1, phs000763.v1.p1, and phs000976.v1.p1). Support for the Study of Addiction: Genetics and Environment (SAGE) was provided through the NIH Genes, Environment and Health Initiative (GEI; U01 HG004422; dbGaP study accession phs000092.v1.p1). SAGE is one of the GWAS funded as part of the Gene Environment Association Studies (GENEVA) under GEI. Assistance with phenotype harmonization and genotype cleaning, as well as with general study coordination, was provided by the GENEVA Coordinating Center (U01 HG004446). Assistance with data cleaning was provided by the National Center for Biotechnology Information. Support for collection of datasets and samples was provided by COGA (U10 AA008401), the Collaborative Genetic Study of Nicotine Dependence (COGEND; P01 CA089392; see also phs000404.v1.p1), and the Family Study of Cocaine Dependence (R01 DA013423, R01 DA019963).; Funding support for genotyping, which was performed at the Johns Hopkins University Center for Inherited Disease Research (CIDR), was provided by the NIH GEI (U01HG004438), the National Institute on Alcohol Abuse and Alcoholism, the National Institute on Drug Abuse, and the NIH contract "High throughput genotyping for studying the genetic contributions to human disease" (HHSN268200782096C). For GESGA, M. R. and M. M. N. were supported by the German Federal Ministry of Education and Research (BMBF) through grants BMBF 01ZX1311A (to M. R. and M. M. N.), and through grants 01ZX1314A (to M. M. N.) and 01ZX1314G (to M. R.) within the e:Med research program. The GSMS project (phs000852. v1. p1) was supported by the National Institute on Drug Abuse (U01DA024413 and R01DA11301), the National Institute of Mental Health (R01MH063970, R01MH063671, R01MH048085, K01MH093731, and K23MH080230), NARSAD, and the William T. Grant Foundation. We are grateful to all the GSMS and CCC study participants who contributed to this work. The following grants supported data collection and analysis of the Center on Antisocial Drug Dependence (CADD; dbGAP in progress): DA011015, DA012845, DA021913, DA021905, DA032555, and DA035804. Funding support for Spit for Science (dbGAP in progress) has been provided by Virginia Commonwealth University, P20 AA017828, R37AA011408, K02AA018755, and P50 AA022537 from the National Institute on Alcohol Abuse and Alcoholism, and UL1RR031990 from the National Center for Research Resources and National Institutes of Health Roadmap for Medical Research. We would like to thank the Spit for Science participants for making this study a success, as well as the many University faculty, students, and staff who contributed to the design and implementation of the project. In particular we acknowledge the contributions of the many individuals who have played a critical role data collection, generation, and cleaning, including A. Adkins, F. Aliev, E. Caraway, S. B. Cho, J. Clifford, M. Cooke, E. Do, A. Edwards, N. Goyal, L. Halberstadt, S. Hawn, R. Holloway, J. Lent, M. Lind, E. Long, J. Meyers, J. Myers, A. Moore, A. Moscati, Z. Neale, J. Opalesky, C. Overstreet, K. Pedersen, L. Rappa, B. Riley, J. Salvatore, J. Savage, C. Sun, N. Thomas, B. Webb, and J. Yan. The NIAAA data (https://btris.nih.gov/) were supported by the NIAAA Intramural Research Program (IRP). Data collection, genotyping, and analysis of the Mayo Clinic Center for Individualized Treatment of Addiction (CITA) data was supported by grants from the National Institute on Alcohol Abuse and Alcoholism (P20 AA017830, and R21 AA25214), as well as the Mayo CTSA Grant Number UL1TR000135 and SC Johnson Genomics of Addiction Program. The Mayo Clinic Biobank, which served as the source of controls for the CITA cases, was supported by Mayo Clinic Center for Individualized Medicine. Alcohol Dependence in African Americans was funded by NIH grant R01 AA017444. Brisbane Longitudinal Twin Study was supported by the United States National Institute on Drug Abuse (R00DA023549) and by the Australian Research Council (DP0343921, DP0664638, 464914, 619667, and FT110100548). Gene-Environment-Development Initiative (GEDI) -Virginia Commonwealth University (VTSABD; dbGAP in progress) was supported by the National Institute on Drug Abuse (U01DA024413 and R01DA025109), the National Institute of Mental Health (R01MH045268, R01MH055557, and R01MH068521), and the Virginia Tobacco Settlement Foundation grant 8520012. We are grateful to all the VTSABD-YAFU-TSA study participants who contributed to this work.; Minnesota Center for Twin and Family Research (phs000620. v1. p1) support contributing to this publication was supported by the National Institutes of Health under award numbers DA005147, DA013240, DA024417, DA036216, AA009367, and MH066140. Funding for TwinGene is a substudy of the Swedish Twin Registry, managed by Karolinska Institutet and supported by the Swedish Research Council under grant no 2017-00641. Additional funding was provided by the Swedish Research Council (M-2005-1112), GenomEUtwin (EU/QLRT-2001-01254 and QLG2-CT-2002-01254), National Institutes of Health U01-DK 066134, the Swedish Foundation for Strategic Research (SSF), and the Heart and Lung Foundation (20070481). Substance Use Disorder Liability: Candidate System Genes study was supported by R01 DA019157 and P50 DA005605. Yale-Penn (phs000425. v1. p1 and phs000952. v1. p1) was supported by National Institutes of Health Grants RC2 DA028909, R01 DA12690, R01 DA12849, R01 DA18432, R01 AA11330, and R01 AA017535 and by the Veterans Affairs Connecticut and Philadelphia Veterans Affairs Mental Illness Research, Educational, and Clinical Centers. Australian Alcohol and Nicotine studies (phs000181. v1. p1) were supported by National Institutes of Health Grants AA07535, AA07728, AA13320, AA13321, AA14041, AA11998, AA17688, DA012854, and DA019951; by grants from the Australian National Health and Medical Research Council (241944, 339462, 389927,389875, 389891, 389892, 389938, 442915, 442981, 496739, 552485, and 552498); by grants from the Australian Research Council(A7960034, A79906588, A79801419, DP0770096, DP0212016, and DP0343921); and by the 5th Framework Programme (FP-5) GenomEUtwin Project (QLG2-CT-2002-01254). GWAS genotyping at Center for Inherited Disease Research was supported by a grant to the late Richard Todd, former Principal Investigator of grant AA13320. Irish Affected Sib-Pair Study of Alcohol Dependence GWAS data collection and analysis was supported by National Institute on Alcohol Abuse and Alcoholism grants P20-AA-017828 and P50-AA-022537. Sample collection was supported by R01-AA-011408. Control genotyping was supported by National Institute of Mental Health grant R01-MH-083094 and Wellcome Trust Case Control Consortium 2 grant WTCCC-084710. Netherland Twin Register (NTR) and Netherlands Study of Depression and Anxiety funding was obtained from multiple grants from the Netherlands Organization for Scientific Research (NWO) and MagW/ZonMW, including NWO-48015-001/674: Netherlands Twin Registry Repository: researching the interplay between genome and environment; Geestkracht program of the Netherlands Organization for Health Research and Development (Zon-MW 10-000-1002), Genetic determinants of risk behavior in relation to alcohol use and alcohol use disorder (ZonMWAddiction-31160008); Biobanking and Biomolecular Resources Research Infrastructure (BBMRI -NL, 184.021.007), Amsterdam Public Health research institute (APH) and Neuroscience Campus Amsterdam (NCA); and the European Science Council (ERC-230374 and ERC-284167). Part of the genotyping was funded by NWO/SPI 56-46414192; the Genetic Association Information Network (GAIN) of the Foundation for the National Institutes of Health, Rutgers University Cell and DNA Repository (NIMH U24 MH068457-06), the Avera Institute for Human Genetics, Sioux Falls, South Dakota (USA), and the National Institutes of Health (NIH R01 HD042157-01A1, MH081802, and Grand Opportunity grants 1RC2 MH089951 and 1RC2 MH089995).; The Finnish Twin Cohort/Nicotine Addiction Genetics-Finland study was supported by Academy of Finland (grants #213506 and 129680 to J. K.), NIH DA12854 (PAFM), Global Research Award for Nicotine Dependence/Pfizer Inc. (J. K.), Wellcome Trust Sanger Institute, UK and the European Community's Seventh Framework Programme ENGAGE Consortium (HEALTH-F4-2007-201413). In Finntwin12, support for data collection and genotyping has come from National Institute of Alcohol Abuse and Alcoholism (grants AA-12502, AA-00145, and AA-09203 to R. J. R. and AA15416 and K02AA018755 to D. M. D.), the Academy of Finland (grants 100499, 205585, 118555, 141054, and 264146 to J. K.), and Wellcome Trust Sanger Institute, UK. This research uses data from Add Health, a program project directed by K. Mullan Harris and designed by J. R. Udry, P. S. Bearman, and K. Mullan Harris at the University of North Carolina at Chapel Hill, and funded by grant P01-HD31921 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, with cooperative funding from 23 other federal agencies and foundations. Information on how to obtain the Add Health data files is available on the Add Health website (http://www.cpc.unc.edu/addhealth).No direct support was received from grant P01-HD31921 for this analysis. The Helsinki Birth Cohort Study thanks all study participants as well as everybody involved in the Helsinki Birth Cohort Study. Helsinki Birth Cohort Study has been supported by grants from the Academy of Finland, the Finnish Diabetes Research Society, Folkhalsan Research Foundation, Novo Nordisk Foundation, Finska Lakaresallskapet, Juho Vainio Foundation, Signe and Ane Gyllenberg Foundation, University of Helsinki, Ministry of Education, Ahokas Foundation, and Emil Aaltonen Foundation. The Avon Longitudinal Study of Parents and Children (ALSPAC) is extremely grateful to all the families who took part in the ALSPAC study, the midwives for their help in recruiting them, and the whole ALSPAC team, which includes interviewers, computer and laboratory technicians, clerical workers, research scientists, volunteers, managers, receptionists, and nurses. Funding/support was from The UK Medical Research Council and Wellcome (grant ref: 102215/2/13/2) and the University of Bristol provide core support for ALSPAC. This publication is the work of the authors and A. C. E. will serve as guarantor for the contents of this paper. A comprehensive list of grants funding is available on the ALSPAC website (http://www.bristol.ac.uk/alspac/external/documents/grant-acknowledgements.pdf).This research was specifically funded by NIH grants AA021399. GWAS data were generated by Sample Logistics and Genotyping Facilities at Wellcome Sanger Institute and LabCorp (Laboratory Corporation of America) using support from 23andMe. Generation Scotland is grateful to the families who took part in GS, the GPs and Scottish School of Primary Care for their help in recruiting them, and the whole GS team that includes academic researchers, clinic staff, laboratory technicians, clerical workers, IT staff, statisticians, and research managers. Generation Scotland received core support from the Chief Scientist Office of the Scottish Government Health Directorates (CZD/16/6) and the Scottish Funding Council (HR03006).; Genotyping of the GS samples was carried out by the Genetics Core Laboratory at the Wellcome Trust Clinical Research Facility, Edinburgh, Scotland, and was funded by the Medical Research Council UK and the Wellcome Trust (Wellcome Trust Strategic Award 'STratifying Resilience and Depression Longitudinally' (STRADL) Reference 104036/Z/14/Z). LD Hub (http://ldsc.broadinstitute.org/) is grateful to the following GWAS studies, databases and consortia who have kindly made their summary data available: ADIPOGen (Adiponectin genetics consortium), C4D (Coronary Artery Disease Genetics Consortium), CARDIoGRAM (Coronary ARtery DIsease Genome wide Replication and Meta-analysis), CKDGen (Chronic Kidney Disease Genetics consortium), dbGAP (database of Genotypes and Phenotypes), DIAGRAM (DIAbetes Genetics Replication And Meta-analysis), ENIGMA (Enhancing Neuro Imaging Genetics through Meta Analysis), EAGLE (EArly Genetics & Lifecourse Epidemiology Consortium, excluding 23andMe), EGG (Early Growth Genetics Consortium), GABRIEL (A Multidisciplinary Study to Identify the Genetic and Environmental Causes of Asthma in the European Community), GCAN (Genetic Consortium for Anorexia Nervosa), GEFOS (GEnetic Factors for OSteoporosis Consortium), GIANT (Genetic Investigation of ANthropometric Traits), GIS (Genetics of Iron Status consortium), GLGC (Global Lipids Genetics Consortium), GPC (Genetics of Personality Consortium), GUGC (Global Urate and Gout consortium), HaemGen (hematological and platelet traits genetics consortium), HRgene (Heart Rate consortium), IIBDGC (International Inflammatory Bowel Disease Genetics Consortium), ILCCO (International Lung Cancer Consortium), IMSGC (International Multiple Sclerosis Genetic Consortium), MAGIC (Meta-Analyses of Glucose and Insulin-related traits Consortium), MESA (Multi-Ethnic Study of Atherosclerosis), PGC (Psychiatric Genomics Consortium), Project MinE consortium, ReproGen (Reproductive Genetics Consortium), SSGAC (Social Science Genetics Association Consortium), TAG (Tobacco and Genetics Consortium), TRICL (Transdisciplinary Research in Cancer of the Lung consortium), and UK Biobank. We additionally thank the groups who directly shared GWAS results. We would like to acknowledge all participating groups of the International Cannabis Consortium, and in particular the members of the working group including S. Stringer, C. Minica, K. Verweij, H. Mbarek, E. Derks, N. Gillespie, and J. Vink. Thanks also to the ENIGMA consortium for providing GWAS results on subcortical brain volumes (available from http://enigma.ini.usc.edu/research/download-enigma-gwas-results/).Finally, we acknowledge the valuable contribution of groups who have publicly released summary statistics from their respective GWAS. Specifically, thanks to researchers from Schumann et al. 16 including the CHARGE+ and AlcGen consortia (results available at https://grasp.nhlbi.nih.gov/FullResults.aspx) and to all members of Psychiatric Genomics Consortium (PGC; results available for download at http://www.med.unc.edu/pgc/results-and-downloads), in particular the working groups on attention deficit/hyperactivity disorder (ADHD; chaired by S. Faraone), autism spectrum disorder (ASD; chaired by M. Daly and B. Devlin), and eating disorders (ED; chaired by C. Bulik and G. Breen). Similar thanks to all of the participating groups in the Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH) consortium for their participation in the ADHD and ASD meta-analyses.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; American Psychiatric Association, 1987, DIAGN STAT MAN MENT; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Andersen AM, 2017, JAMA PSYCHIAT, V74, P1153, DOI 10.1001/jamapsychiatry.2017.2269; Anney RJL, 2017, MOL AUTISM, V8, DOI 10.1186/s13229-017-0137-9; Berndt SI, 2013, NAT GENET, V45, P501, DOI 10.1038/ng.2606; Bierut LJ, 2012, MOL PSYCHIATR, V17, P445, DOI 10.1038/mp.2011.124; Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Chambers JC, 2011, NAT GENET, V43, P1131, DOI 10.1038/ng.970; Chen MH, 2010, BIOINFORMATICS, V26, P580, DOI 10.1093/bioinformatics/btp710; Clarke TK, 2017, MOL PSYCHIATR, V22, P1376, DOI 10.1038/mp.2017.153; Dawson DA, 2006, ADDICTION, V101, P824, DOI 10.1111/j.1360-0443.2006.01433.x; de Leeuw CA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004219; Demontis D., 2017, BIORXIV, DOI [10.1101/145581, DOI 10.1038/s41588-019-0344-8]; Derks EM, 2017, BEHAV GENET, V47, P360, DOI 10.1007/s10519-017-9837-3; Dudbridge F, 2008, GENET EPIDEMIOL, V32, P227, DOI 10.1002/gepi.20297; Duncan LE, 2018, MOL PSYCHIATR, V23, P666, DOI 10.1038/mp.2017.77; Duncan L, 2017, AM J PSYCHIAT, V174, P850, DOI 10.1176/appi.ajp.2017.16121402; Evans LM, 2018, NAT GENET, V50, P737, DOI 10.1038/s41588-018-0108-x; FIRTH D, 1993, BIOMETRIKA, V80, P27, DOI 10.2307/2336755; Frank J, 2012, ADDICT BIOL, V17, P171, DOI 10.1111/j.1369-1600.2011.00395.x; Fraser A, 2013, INT J EPIDEMIOL, V42, P97, DOI 10.1093/ije/dys066; Fry A, 2017, AM J EPIDEMIOL, V186, P1026, DOI 10.1093/aje/kwx246; Grant BF, 2015, JAMA PSYCHIAT, V72, P757, DOI 10.1001/jamapsychiatry.2015.0584; Han B, 2011, AM J HUM GENET, V88, P586, DOI 10.1016/j.ajhg.2011.04.014; Hancock DB, 2018, MOL PSYCHIATR, V23, DOI 10.1038/mp.2017.193; Hancock DB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050610; Hart AB, 2015, ALCOHOL CLIN EXP RES, V39, P1312, DOI 10.1111/acer.12792; Hasin DS, 2007, ARCH GEN PSYCHIAT, V64, P830, DOI 10.1001/archpsyc.64.7.830; Hibar DP, 2015, NATURE, V520, P224, DOI 10.1038/nature14101; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Hurley TD, 2012, ALCOHOL RES-CURR REV, V34, P339; Jaffee S, 2001, DEV PSYCHOPATHOL, V13, P377, DOI 10.1017/S0954579401002103; Kendler KS, 2003, ARCH GEN PSYCHIAT, V60, P929, DOI 10.1001/archpsyc.60.9.929; Koob GF, 2016, LANCET PSYCHIAT, V3, P760, DOI 10.1016/S2215-0366(16)00104-8; Kreek MJ, 2005, NAT NEUROSCI, V8, P1450, DOI 10.1038/nn1583; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; Li DW, 2012, HUM GENET, V131, P725, DOI 10.1007/s00439-011-1116-4; Li DW, 2011, BIOL PSYCHIAT, V70, P504, DOI 10.1016/j.biopsych.2011.02.024; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Luczak SE, 2006, PSYCHOL BULL, V132, P607, DOI 10.1037/0033-2909.132.4.607; Martin J, 2018, PSYCHOL MED, V48, P1759, DOI 10.1017/S0033291717003440; Mbarek H, 2015, AM J MED GENET B, V168, P739, DOI 10.1002/ajmg.b.32379; Morris AP, 2011, GENET EPIDEMIOL, V35, P809, DOI 10.1002/gepi.20630; Munafo MR, 2018, INT J EPIDEMIOL, V47, P226, DOI 10.1093/ije/dyx206; O'Connell J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004234; Palmer RHC, 2015, ADDICTION, V110, P1922, DOI 10.1111/add.13070; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; Polimanti Renato, 2019, Psychol Med, V49, P1218, DOI 10.1017/S0033291719000667; Polimanti R, 2017, ADDICT BIOL, V22, P535, DOI 10.1111/adb.12317; Polimanti R, 2017, NEUROPSYCHOPHARMACOL, V42, P598, DOI 10.1038/npp.2016.153; Pratt DS, 2000, NEW ENGL J MED, V342, P1266, DOI 10.1056/NEJM200004273421707; Prescott CA, 2000, ARCH GEN PSYCHIAT, V57, P803, DOI 10.1001/archpsyc.57.8.803; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Sanchez-Roige S., 2018, GENOME WIDE ASS STUD, DOI [10.1101/275917, DOI 10.1101/275917]; Sanchez-Roige S, 2019, ADDICT BIOL, V24, P121, DOI 10.1111/adb.12574; Sanchez-Roige S, 2018, NAT NEUROSCI, V21, P16, DOI 10.1038/s41593-017-0032-x; Schumann G, 2016, P NATL ACAD SCI USA, V113, P14372, DOI 10.1073/pnas.1611243113; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Smith BH, 2013, INT J EPIDEMIOL, V42, P689, DOI 10.1093/ije/dys084; Stringer S, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.36; Sullivan PF, 2018, AM J PSYCHIAT, V175, P15, DOI 10.1176/appi.ajp.2017.17030283; Traversy G, 2015, CURR OBES REP, V4, P122, DOI 10.1007/s13679-014-0129-4; Verhulst B, 2015, PSYCHOL MED, V45, P1061, DOI 10.1017/S0033291714002165; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wray NR, 2018, NAT GENET, V50, P668, DOI 10.1038/s41588-018-0090-3; Wray NR., 2014, CURR EPIDEMIOL REP, V1, P220, DOI DOI 10.1007/S40471-014-0023-3; Zerbino DR, 2018, NUCLEIC ACIDS RES, V46, pD754, DOI 10.1093/nar/gkx1098; Zheng J, 2017, BIOINFORMATICS, V33, P272, DOI 10.1093/bioinformatics/btw613; Zhou H, 2017, JAMA PSYCHIAT, V74, P1234, DOI 10.1001/jamapsychiatry.2017.3275	74	247	252	4	87	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2018	21	12					1656	+		10.1038/s41593-018-0275-1	http://dx.doi.org/10.1038/s41593-018-0275-1			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	HB8GE	30482948	Green Submitted, Green Published, Green Accepted			2022-12-17	WOS:000451324700005
J	Pavlov, VA; Tracey, KJ				Pavlov, Valentin A.; Tracey, Kevin J.			Neural regulation of immunity: molecular mechanisms and clinical translation	NATURE NEUROSCIENCE			English	Review							VAGUS NERVE-STIMULATION; SPINAL-CORD-INJURY; CHOLINERGIC ANTIINFLAMMATORY PATHWAY; SYSTEMIC INFLAMMATORY RESPONSE; IMPROVES SURVIVAL; T-CELLS; LETHAL ENDOTOXEMIA; BRAIN-STIMULATION; SENSORY NEURONS; ACTIVATION	Studies bridging neuroscience and immunology have identified neural pathways that regulate immunity and inflammation. Recent research using methodological advances in molecular genetics has improved our understanding of the neural control of immunity. Here we outline mechanistic insights, focusing on translational relevance and conceptual developments. We also summarize findings from recent clinical studies of bioelectronic neuromodulation in inflammatory and autoimmune diseases.	[Pavlov, Valentin A.; Tracey, Kevin J.] Northwell Hlth, Feinstein Inst Med Res, Ctr Biomed Sci, Manhasset, NY USA; [Pavlov, Valentin A.; Tracey, Kevin J.] Northwell Hlth, Feinstein Inst Med Res, Ctr Bioelect Med, Manhasset, NY USA	Northwell Health; Northwell Health	Pavlov, VA; Tracey, KJ (corresponding author), Northwell Hlth, Feinstein Inst Med Res, Ctr Biomed Sci, Manhasset, NY USA.; Pavlov, VA; Tracey, KJ (corresponding author), Northwell Hlth, Feinstein Inst Med Res, Ctr Bioelect Med, Manhasset, NY USA.	vpavlov@northwell.edu; kjtracey@northwell.edu		Pavlov, Valentin/0000-0002-1994-2853; Tracey, Kevin J/0000-0003-1884-6314	National Institute of General Medical Sciences, National Institutes of Health [R01GM089807, R01GM057226]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118182, R01GM089807, R01GM057226] Funding Source: NIH RePORTER	National Institute of General Medical Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank S. Kerath, B. Sherry and S. Chavan for critically reading the manuscript. This work was supported by the following grants from the National Institute of General Medical Sciences, National Institutes of Health: R01GM089807 (to V.A.P. and K.J.T.) and R01GM057226 (to K.J.T.).	AKERT K, 1962, ELECTROEN CLIN NEURO, V14, P904, DOI 10.1016/0013-4694(62)90141-4; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; [Anonymous], 2011, COMPR PHYSIOL; Arima Y, 2012, CELL, V148, P447, DOI 10.1016/j.cell.2012.01.022; Ballinger EC, 2016, NEURON, V91, P1199, DOI 10.1016/j.neuron.2016.09.006; BARNES PJ, 1986, LANCET, V1, P242; Bastard JP, 2006, EUR CYTOKINE NETW, V17, P4; Ben-Shaanan TL, 2016, NAT MED, V22, P940, DOI 10.1038/nm.4133; BENARROCH EE, 1993, MAYO CLIN PROC, V68, P988, DOI 10.1016/S0025-6196(12)62272-1; Benedetti F, 2005, J NEUROSCI, V25, P10390, DOI 10.1523/JNEUROSCI.3458-05.2005; Bernik TR, 2002, J EXP MED, V195, P781, DOI 10.1084/jem.20011714; Berthoud HR, 2000, AUTON NEUROSCI-BASIC, V85, P1, DOI 10.1016/S1566-0702(00)00215-0; Bonaz B, 2016, NEUROGASTROENT MOTIL, V28, P948, DOI 10.1111/nmo.12792; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Bouton CE, 2016, NATURE, V533, P247, DOI 10.1038/nature17435; Brommer B, 2016, BRAIN, V139, P692, DOI 10.1093/brain/awv375; Burke RE, 2007, BRAIN, V130, P887, DOI 10.1093/brain/awm022; Cabrera LY, 2014, BRAIN TOPOGR, V27, P33, DOI 10.1007/s10548-013-0296-8; Cao XO, 2016, CURR BIOL, V26, P2329, DOI 10.1016/j.cub.2016.06.036; Carnevale D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13035; Carvalheira JBC, 2014, NAT MED, V20, P472, DOI 10.1038/nm.3556; Chamorro A, 2007, STROKE, V38, P1097, DOI 10.1161/01.STR.0000258346.68966.9d; Chan AC, 2013, NAT IMMUNOL, V14, P106, DOI 10.1038/ni.2473; Chang RB, 2015, CELL, V161, P622, DOI 10.1016/j.cell.2015.03.022; Cheung GWC, 2009, CELL METAB, V10, P99, DOI 10.1016/j.cmet.2009.07.005; Chiu IM, 2014, ELIFE, V3, DOI 10.7554/eLife.04660; Chiu IM, 2013, NATURE, V501, P52, DOI 10.1038/nature12479; Chiu IM, 2012, NAT NEUROSCI, V15, P1063, DOI 10.1038/nn.3144; Conner JM, 2005, NEURON, V46, P173, DOI 10.1016/j.neuron.2005.03.003; Cornier MA, 2008, ENDOCR REV, V29, P777, DOI 10.1210/er.2008-0024; Cosentino M, 2000, LIFE SCI, V68, P283, DOI 10.1016/S0024-3205(00)00937-1; Dampney RAL, 2016, ADV PHYSIOL EDUC, V40, P283, DOI 10.1152/advan.00027.2016; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; de Jonge WJ, 2005, NAT IMMUNOL, V6, P844, DOI 10.1038/ni1229; de la Fuente-Fernandez R, 2001, SCIENCE, V293, P1164, DOI 10.1126/science.1060937; de Lartigue G, 2011, AM J PHYSIOL-ENDOC M, V301, pE187, DOI 10.1152/ajpendo.00056.2011; Deisseroth K, 2015, NAT NEUROSCI, V18, P1213, DOI 10.1038/nn.4091; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Elenkov IJ, 2000, PHARMACOL REV, V52, P595; Fregni F, 2007, NAT CLIN PRACT NEURO, V3, P383, DOI 10.1038/ncpneuro0530; Gabanyi I, 2016, CELL, V164, P378, DOI 10.1016/j.cell.2015.12.023; Gautron L, 2015, CELL, V161, P133, DOI 10.1016/j.cell.2015.02.023; Ghia JE, 2006, GASTROENTEROLOGY, V131, P1122, DOI 10.1053/j.gastro.2006.08.016; Ghia JE, 2007, AM J PHYSIOL-GASTR L, V293, pG560, DOI 10.1152/ajpgi.00098.2007; Goebel MU, 2002, FASEB J, V16, P1869, DOI 10.1096/fj.02-0389com; Goehler LE, 2000, AUTON NEUROSCI-BASIC, V85, P49, DOI 10.1016/S1566-0702(00)00219-8; Goehler LE, 1999, J NEUROSCI, V19, P2799; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Guarini S, 2003, CIRCULATION, V107, P1189, DOI 10.1161/01.CIR.0000050627.90734.ED; Haas HS, 1997, PROG NEUROBIOL, V51, P195, DOI 10.1016/S0301-0082(96)00055-X; Hoebe K, 2004, NAT IMMUNOL, V5, P971, DOI 10.1038/ni1004-971; Hosoi T, 2005, AUTON NEUROSCI-BASIC, V120, P104, DOI 10.1016/j.autneu.2004.11.012; Houghton BL, 2006, J PHYSIOL-LONDON, V572, P811, DOI 10.1113/jphysiol.2005.104067; Huston JM, 2006, J EXP MED, V203, P1623, DOI 10.1084/jem.20052362; Inoue T, 2016, J CLIN INVEST, V126, P1939, DOI 10.1172/JCI83658; Inskip JA, 2009, SPINAL CORD, V47, P2, DOI 10.1038/sc.2008.61; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Ji H, 2014, MUCOSAL IMMUNOL, V7, P335, DOI 10.1038/mi.2013.52; Katsnelson A, 2013, NAT MED, V19, P249, DOI 10.1038/nm0313-249; Kawashima K, 2012, LIFE SCI, V91, P1027, DOI 10.1016/j.lfs.2012.05.006; Kelley KW, 2014, SEMIN IMMUNOL, V26, P389, DOI 10.1016/j.smim.2014.01.011; Koopman FA, 2016, P NATL ACAD SCI USA, V113, P8284, DOI 10.1073/pnas.1605635113; LAWRENCE AJ, 1995, J HYPERTENS, V13, P631, DOI 10.1097/00004872-199506000-00009; Lee ST, 2010, BRAIN RES, V1309, P164, DOI 10.1016/j.brainres.2009.10.076; Levine YA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104530; Li M, 2005, ACTA PHARMACOL SIN, V26, P192, DOI 10.1111/j.1745-7254.2005.00522.x; Longo DL, 1999, CLIN IMMUNOL, V90, P173, DOI 10.1006/clim.1998.4637; Lu B, 2014, MOL MED, V20, P350, DOI 10.2119/molmed.2013.00117; Lucin KM, 2007, EXP NEUROL, V207, P75, DOI 10.1016/j.expneurol.2007.05.019; Lucin KM, 2009, J NEUROCHEM, V110, P1409, DOI 10.1111/j.1471-4159.2009.06232.x; Luyer MD, 2005, J EXP MED, V202, P1023, DOI 10.1084/jem.20042397; Ma F, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-31; MACQUEEN G, 1989, SCIENCE, V243, P83, DOI 10.1126/science.2911721; Mayer EA, 2011, NAT REV NEUROSCI, V12, P453, DOI 10.1038/nrn3071; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Miksa M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005504; Mina-Osorio P, 2012, MOL MED, V18, P618, DOI 10.2119/molmed.2012.00027; Mirakaj V, 2014, J EXP MED, V211, P1037, DOI 10.1084/jem.20132103; Montgomery KL, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7577; Morgan K, 2004, J BIOL CHEM, V279, P31139, DOI 10.1074/jbc.M400458200; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B; Nakai A, 2014, J EXP MED, V211, P2583, DOI 10.1084/jem.20141132; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Nieuwenhoff MD, 2016, MICROVASC RES, V106, P1, DOI 10.1016/j.mvr.2016.03.001; Niijima A, 1996, J AUTONOM NERV SYST, V61, P287, DOI 10.1016/S0165-1838(96)00098-7; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Olofsson PS., 2015, BIOELECTRON MED, V2, P37, DOI [10.15424/bioelectronmed.2015., DOI 10.15424/BIOELECTRONMED.2015, 10.15424/bioelectronmed.2015.00006, DOI 10.15424/BI0ELECTR0NMED.2015.00006]; Ordovas-Montanes J, 2015, TRENDS IMMUNOL, V36, P578, DOI 10.1016/j.it.2015.08.007; Owyang C, 2011, J NEUROGASTROENTEROL, V17, P338, DOI 10.5056/jnm.2011.17.4.338; Pacheco-Lopez G, 2005, J NEUROSCI, V25, P2330, DOI 10.1523/JNEUROSCI.4230-04.2005; Pacheco-Lopez G, 2006, BRAIN BEHAV IMMUN, V20, P430, DOI 10.1016/j.bbi.2006.05.003; Pardo JV, 2007, INT J OBESITY, V31, P1756, DOI 10.1038/sj.ijo.0803666; Parrish WR, 2008, MOL MED, V14, P567, DOI 10.2119/2008-00079.Parrish; Pavlov IP, 2010, ANN NEUROSCI, V17, P136, DOI 10.5214/ans.0972-7531.1017309; Pavlov V. A., 2016, J IMMUNOL, V196; Pavlov VA, 2006, P NATL ACAD SCI USA, V103, P5219, DOI 10.1073/pnas.0600506103; Pavlov VA, 2003, MOL MED, V9, P125, DOI 10.1007/BF03402177; Pavlov VA, 2007, CRIT CARE MED, V35, P1139, DOI 10.1097/01.CCM.0000259381.56526.96; Pavlov VA, 2015, IMMUNOL RES, V63, P38, DOI 10.1007/s12026-015-8718-1; Pavlov VA, 2012, NAT REV ENDOCRINOL, V8, P743, DOI 10.1038/nrendo.2012.189; Pavlov VA, 2009, BRAIN BEHAV IMMUN, V23, P41, DOI 10.1016/j.bbi.2008.06.011; Pearce JMS, 2004, J NEUROL NEUROSUR PS, V75, P544; Picciotto MR, 2012, NEURON, V76, P116, DOI 10.1016/j.neuron.2012.08.036; Poulin JF, 2016, NAT NEUROSCI, V19, P1131, DOI 10.1038/nn.4366; Prass K, 2003, J EXP MED, V198, P725, DOI 10.1084/jem.20021098; RESCORLA RA, 1988, AM PSYCHOL, V43, P151, DOI 10.1037/0003-066X.43.3.151; Rosas-Ballina M, 2008, P NATL ACAD SCI USA, V105, P11008, DOI 10.1073/pnas.0803237105; Rosas-Ballina M, 2015, BRAIN BEHAV IMMUN, V44, P19, DOI 10.1016/j.bbi.2014.07.010; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Sabharwal L, 2014, J BIOCHEM, V156, P299, DOI 10.1093/jb/mvu057; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sanz E, 2009, P NATL ACAD SCI USA, V106, P13939, DOI 10.1073/pnas.0907143106; Satapathy SK, 2011, MOL MED, V17, P599, DOI 10.2119/molmed.2011.00083; Schedlowski M, 2010, BRAIN BEHAV IMMUN, V24, P176, DOI 10.1016/j.bbi.2009.08.007; SCHREURS J, 1986, J NEUROCHEM, V46, P294, DOI 10.1111/j.1471-4159.1986.tb12961.x; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; SHIPLEY MT, 1982, BRAIN RES BULL, V8, P139, DOI 10.1016/0361-9230(82)90040-5; Song JG, 2012, ANESTHESIOLOGY, V116, P406, DOI 10.1097/ALN.0b013e3182426ebd; Steinberg BE, 2014, NEW ENGL J MED, V371, P2131, DOI 10.1056/NEJMcibr1412003; Steinman L, 2015, BRAIN BEHAV IMMUN, V44, P17, DOI 10.1016/j.bbi.2014.09.013; Steinman L, 2012, NAT MED, V18, P59, DOI 10.1038/nm.2625; Sun JR, 2011, SCIENCE, V332, P729, DOI 10.1126/science.1203411; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tomer R, 2014, NAT PROTOC, V9, P1682, DOI 10.1038/nprot.2014.123; Torres-Rosas R, 2014, NAT MED, V20, P291, DOI 10.1038/nm.3479; Tracey KJ, 2007, J CLIN INVEST, V117, P289, DOI 10.1172/JCI30555; Tracey KJ, 2015, SCI AM, V312, P28, DOI 10.1038/scientificamerican0315-28; Tracey KJ, 2010, NAT IMMUNOL, V11, P561, DOI 10.1038/ni0710-561; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; Trakhtenberg EF, 2011, SCIENCE, V334, P47, DOI 10.1126/science.1213099; Travagli RA, 2006, ANNU REV PHYSIOL, V68, P279, DOI 10.1146/annurev.physiol.68.040504.094635; Ueno M, 2016, NAT NEUROSCI, V19, P784, DOI 10.1038/nn.4289; Urban DJ, 2015, ANNU REV PHARMACOL, V55, P399, DOI 10.1146/annurev-pharmtox-010814-124803; Van Westerloo DJ, 2006, GASTROENTEROLOGY, V130, P1822, DOI 10.1053/j.gastro.2006.02.022; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wang LY, 2014, NAT MED, V20, P488, DOI 10.1038/nm.3527; Williams EK, 2016, CELL, V166, P209, DOI 10.1016/j.cell.2016.05.011; Wong CHY, 2011, SCIENCE, V334, P101, DOI 10.1126/science.1210301; Wood JD, 2004, PHYSIOLOGY, V19, P326, DOI 10.1152/physiol.00034.2004; Wrona D, 2006, J NEUROIMMUNOL, V172, P38, DOI 10.1016/j.jneuroim.2005.10.017; Yaprak M., 2008, NEUROANATOMY, V7, P17	147	247	256	12	142	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2017	20	2					156	166		10.1038/nn.4477	http://dx.doi.org/10.1038/nn.4477			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EJ5PU	28092663				2022-12-17	WOS:000393271000008
J	Schmidt, R; Leventhal, DK; Mallet, N; Chen, FJ; Berke, JD				Schmidt, Robert; Leventhal, Daniel K.; Mallet, Nicolas; Chen, Fujun; Berke, Joshua D.			Canceling actions involves a race between basal ganglia pathways	NATURE NEUROSCIENCE			English	Article							NIGRA PARS RETICULATA; CHOICE-REACTION-TIME; FAST-SPIKING INTERNEURONS; MONKEY SUBSTANTIA-NIGRA; SUBTHALAMIC NUCLEUS; RESPONSE-INHIBITION; STOP-SIGNAL; SUPERIOR COLLICULUS; SACCADE INITIATION; DECISION THRESHOLD	Salient cues can prompt the rapid interruption of planned actions. It has been proposed that fast, reactive behavioral inhibition involves specific basal ganglia pathways, and we tested this by comparing activity in multiple rat basal ganglia structures during performance of a stop-signal task. Subthalamic nucleus (STN) neurons exhibited low-latency responses to 'Stop' cues, irrespective of whether actions were canceled or not. By contrast, neurons downstream in the substantia nigra pars reticulata (SNr) only responded to Stop cues in trials with successful cancellation. Recordings and simulations together indicate that this sensorimotor gating arises from the relative timing of two distinct inputs to neurons in the SNr dorsolateral 'core' subregion: cue-related excitation from STN and movement-related inhibition from striatum. Our results support race models of action cancellation, with stopping requiring Stop-cue information to be transmitted from STN to SNr before increased striatal input creates a point of no return.	[Schmidt, Robert; Mallet, Nicolas; Chen, Fujun; Berke, Joshua D.] Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA; [Leventhal, Daniel K.] Univ Michigan, Dept Neurol, Ann Arbor, MI USA; [Mallet, Nicolas] Univ Victor Segalen, Inst Malad Neurodegenerat, CNRS, Bordeaux, France	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux	Berke, JD (corresponding author), Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA.	jdberke@umich.edu	Schmidt, Robert/H-6125-2017	Schmidt, Robert/0000-0002-2474-3744; Leventhal, Daniel/0000-0001-8174-5933	Deutsche Forschungsgemeinschaft [SCHM 2745/1-1]; US National Institute on Drug Abuse, National Institute on Neurological Disorders and Stroke; University of Michigan; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA014318] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); US National Institute on Drug Abuse, National Institute on Neurological Disorders and Stroke; University of Michigan(University of Michigan System); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank V. Stuphorn, D. Weissman, A. Aron, G. Morris, M. Churchland, M. Bevan and D. Meyer for their helpful comments. J. Pettibone and A. Case provided valuable assistance. This work was supported by Deutsche Forschungsgemeinschaft grant SCHM 2745/1-1, the US National Institute on Drug Abuse, National Institute on Neurological Disorders and Stroke, and the University of Michigan.	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Aron AR, 2011, BIOL PSYCHIAT, V69, pE55, DOI 10.1016/j.biopsych.2010.07.024; Aron AR, 2006, J NEUROSCI, V26, P2424, DOI 10.1523/JNEUROSCI.4682-05.2006; Ballanger B, 2009, ANN NEUROL, V66, P817, DOI 10.1002/ana.21795; Basso MA, 2011, NEUROSCIENCE, V198, P205, DOI 10.1016/j.neuroscience.2011.08.026; Baunez C, 2001, EUR J NEUROSCI, V13, P1609, DOI 10.1046/j.0953-816x.2001.01521.x; BERGMAN H, 1990, SCIENCE, V249, P1436, DOI 10.1126/science.2402638; Berke JD, 2008, J NEUROSCI, V28, P10075, DOI 10.1523/JNEUROSCI.2192-08.2008; BEVAN MD, 1994, EUR J NEUROSCI, V6, P320, DOI 10.1111/j.1460-9568.1994.tb00275.x; BLOMFIELD S, 1974, BRAIN RES, V69, P115, DOI 10.1016/0006-8993(74)90375-8; Boucher L, 2007, PSYCHOL REV, V114, P376, DOI 10.1037/0033-295X.114.2.376; Brown JW, 2008, EXP BRAIN RES, V190, P135, DOI 10.1007/s00221-008-1455-0; Cavanagh JF, 2011, NAT NEUROSCI, V14, P1462, DOI 10.1038/nn.2925; Cheruel F, 1996, EXP BRAIN RES, V108, P206; Connelly WM, 2010, J NEUROSCI, V30, P14854, DOI 10.1523/JNEUROSCI.3895-10.2010; Cui GH, 2013, NATURE, V494, P238, DOI 10.1038/nature11846; Deniau JM, 2007, PROG BRAIN RES, V160, P151, DOI 10.1016/S0079-6123(06)60009-5; Deschenes M, 1996, EUR J NEUROSCI, V8, P329, DOI 10.1111/j.1460-9568.1996.tb01217.x; Ding JB, 2010, NEURON, V67, P294, DOI 10.1016/j.neuron.2010.06.017; Eagle DM, 2008, CEREB CORTEX, V18, P178, DOI 10.1093/cercor/bhm044; Frank MJ, 2007, SCIENCE, V318, P1309, DOI 10.1126/science.1146157; Frank MJ, 2006, NEURAL NETWORKS, V19, P1120, DOI 10.1016/j.neunet.2006.03.006; Gage GJ, 2010, NEURON, V67, P466, DOI 10.1016/j.neuron.2010.06.034; Gerstner W., 2002, SPIKING NEURON MODEL; Handel A, 1999, J NEUROPHYSIOL, V82, P3458, DOI 10.1152/jn.1999.82.6.3458; Hanes DP, 1996, SCIENCE, V274, P427, DOI 10.1126/science.274.5286.427; HIKOSAKA O, 1983, J NEUROPHYSIOL, V49, P1230; HIKOSAKA O, 1983, BRAIN RES, V272, P368, DOI 10.1016/0006-8993(83)90586-3; Humphries MD, 2006, J NEUROSCI, V26, P12921, DOI 10.1523/JNEUROSCI.3486-06.2006; Humphries MD, 2001, NEURAL NETWORKS, V14, P845, DOI 10.1016/S0893-6080(01)00060-0; Jahfari S, 2011, J NEUROSCI, V31, P6891, DOI 10.1523/JNEUROSCI.5253-10.2011; Kimura M, 2004, NEUROSCI RES, V48, P355, DOI 10.1016/j.neures.2003.12.002; Kita T, 2011, EUR J NEUROSCI, V33, P433, DOI 10.1111/j.1460-9568.2010.07537.x; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Leventhal DK, 2012, NEURON, V73, P523, DOI 10.1016/j.neuron.2011.11.032; Levy BJ, 2011, ANN NY ACAD SCI, V1224, P40, DOI 10.1111/j.1749-6632.2011.05958.x; Lo CC, 2006, NAT NEUROSCI, V9, P956, DOI 10.1038/nn1722; LOGAN GD, 1984, J EXP PSYCHOL HUMAN, V10, P276, DOI 10.1037/0096-1523.10.2.276; Majid DSA, 2012, CEREB CORTEX, V22, P363, DOI 10.1093/cercor/bhr112; Matsumoto N, 2001, J NEUROPHYSIOL, V85, P960, DOI 10.1152/jn.2001.85.2.960; McHaffie JG, 2005, TRENDS NEUROSCI, V28, P401, DOI 10.1016/j.tins.2005.06.006; OSMAN A, 1986, J EXP PSYCHOL HUMAN, V12, P243, DOI 10.1037/0096-1523.12.3.243; Pan WX, 2005, J NEUROSCI, V25, P4725, DOI 10.1523/JNEUROSCI.0277-05.2005; Pare M, 2003, J NEUROSCI, V23, P6480; Paxinos G, 2005, RAT BRAIN STEREOTAXI, DOI 10.1016/c2009-0-63235-9; Robbins TW, 2012, TRENDS COGN SCI, V16, P81, DOI 10.1016/j.tics.2011.11.009; SCHULTZ W, 1986, J NEUROPHYSIOL, V55, P660, DOI 10.1152/jn.1986.55.4.660; Segev I., 1998, HDB BRAIN THEORY NEU, P282; Sharp DJ, 2010, P NATL ACAD SCI USA, V107, P6106, DOI 10.1073/pnas.1000175107; Shulman GL, 2009, J NEUROSCI, V29, P4392, DOI 10.1523/JNEUROSCI.5609-08.2009; Stuphorn V, 2010, J NEUROPHYSIOL, V103, P801, DOI 10.1152/jn.00221.2009; Verbruggen F, 2009, NEUROSCI BIOBEHAV R, V33, P647, DOI 10.1016/j.neubiorev.2008.08.014; Watanabe M, 2009, EUR J NEUROSCI, V30, P2165, DOI 10.1111/j.1460-9568.2009.06998.x; Wiecki TV, 2013, PSYCHOL REV, V120, P329, DOI 10.1037/a0031542; Wiltschko AB, 2008, J NEUROSCI METH, V173, P34, DOI 10.1016/j.jneumeth.2008.05.016; Zandbelt BB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013848	56	247	247	2	76	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2013	16	8					1118	U194		10.1038/nn.3456	http://dx.doi.org/10.1038/nn.3456			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190EV	23852117	Green Accepted			2022-12-17	WOS:000322323000023
J	Williams, DW; Kondo, S; Krzyzanowska, A; Hiromi, Y; Truman, JW				Williams, Darren W.; Kondo, Shu; Krzyzanowska, Agnieszka; Hiromi, Yasushi; Truman, James W.			Local caspase activity directs engulfment of dendrites during pruning	NATURE NEUROSCIENCE			English	Article							DROSOPHILA METAMORPHOSIS; SENSORY NEURONS; AXON; DEGENERATION; SYSTEM; CELLS	Pruning is important for sculpting neural circuits, as it removes excessive or inaccurate projections. Here we show that the removal of sensory neuron dendrites during pruning in Drosophila melanogaster is directed by local caspase activity. Suppressing caspase activity prevented dendrite removal, whereas a global activation of caspases within a neuron caused cell death. A new genetically encoded caspase probe revealed that caspase activity is confined to the degenerating dendrites of pruning neurons.	Kings Coll London, MRC Ctr Dev Neurobiol, London SE1 1UL, England; Univ Washington, Dept Biol, Seattle, WA 98195 USA; Natl Inst Genet, CREST, Japan Sci & Technol Agcy, Shizuoka 4118540, Japan; SOKENDAI, Dept Genet, Shizuoka 4118540, Japan; Jikei Univ, Sch Med, Div Morphol & Organogenesis, Inst DNA Med, Tokyo 1058461, Japan	University of London; King's College London; University of Washington; University of Washington Seattle; Japan Science & Technology Agency (JST); Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan; Jikei University	Williams, DW (corresponding author), Kings Coll London, MRC Ctr Dev Neurobiol, London SE1 1UL, England.	darren.williams@kcl.ac.uk	Williams, Darren/C-5356-2009; Kondo, Shu/AAH-8921-2020	Williams, Darren/0000-0001-5917-4935; Kondo, Shu/0000-0002-4625-8379; krzyzanowska, agnieszka/0000-0002-1288-7054	Medical Research Council [G9900989B] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029971] Funding Source: NIH RePORTER; Medical Research Council [G0600182] Funding Source: Medline; NINDS NIH HHS [NS-029971] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Awasaki T, 2006, NEURON, V50, P855, DOI 10.1016/j.neuron.2006.04.027; Awasaki T, 2004, CURR BIOL, V14, P668, DOI 10.1016/j.cub.2004.04.001; Freeman MR, 2003, NEURON, V38, P567, DOI 10.1016/S0896-6273(03)00289-7; Grueber WB, 2002, DEVELOPMENT, V129, P2867; KONDO S, IN PRESS MOL CELL BI; KUMAR S, 2004, SCI STKE, pPE49; Kuo CT, 2006, NEURON, V51, P283, DOI 10.1016/j.neuron.2006.07.014; Lauber K, 2004, MOL CELL, V14, P277, DOI 10.1016/S1097-2765(04)00237-0; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; OLEARY DDM, 1993, NEURON, V10, P991, DOI 10.1016/0896-6273(93)90049-W; TRUMAN JW, 1990, J NEUROBIOL, V21, P1072, DOI 10.1002/neu.480210711; Watts RJ, 2003, NEURON, V38, P871, DOI 10.1016/S0896-6273(03)00295-2; Watts RJ, 2004, CURR BIOL, V14, P678, DOI 10.1016/j.cub.2004.03.035; Williams DW, 2005, DEVELOPMENT, V132, P3631, DOI 10.1242/dev.01928	15	247	250	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2006	9	10					1234	1236		10.1038/nn1774	http://dx.doi.org/10.1038/nn1774			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	098BB	16980964				2022-12-17	WOS:000241493900014
J	Gordon, GRJ; Baimoukhametova, DV; Hewitt, SA; Rajapaksha, WRAKJS; Fisher, TE; Bains, JS				Gordon, GRJ; Baimoukhametova, DV; Hewitt, SA; Rajapaksha, WRAKJS; Fisher, TE; Bains, JS			Norepinephrine triggers release of glial ATP to increase postsynaptic efficacy	NATURE NEUROSCIENCE			English	Article							CULTURED HIPPOCAMPAL-NEURONS; LONG-TERM POTENTIATION; SYNAPTIC-TRANSMISSION; P2X RECEPTORS; MOLECULAR PHYSIOLOGY; SUPRAOPTIC NEURONS; ASTROCYTES; GLUTAMATE; HYPOTHALAMUS; VASOPRESSIN	Glial cells actively participate in synaptic transmission. They clear molecules from the synaptic cleft, receive signals from neurons and, in turn, release molecules that can modulate signaling between neuronal elements. Whether glial-derived transmitters can contribute to enduring changes in postsynaptic efficacy, however, remains to be established. In rat hypothalamic paraventricular nucleus, we demonstrate an increase in the amplitude of miniature excitatory postsynaptic currents in response to norepinephrine that requires the release of ATP from glial cells. The increase in quantal efficacy, which likely results from an insertion of AMPA receptors, is secondary to the activation of P2X7 receptors, an increase in postsynaptic calcium and the activation of phosphatidylinositol 3-kinase. The gliotransmitter ATP, therefore, contributes directly to the regulation of postsynaptic efficacy at glutamatergic synapses in the CNS.	Univ Calgary, Hotchkiss Brain Inst, Calgary, AB T2N 4N1, Canada; Univ Calgary, Dept Physiol & Biophys, Calgary, AB T2N 4N1, Canada; Univ Saskatchewan, Coll Med, Dept Physiol, Saskatoon, SK S7N 5E5, Canada	University of Calgary; University of Calgary; University of Saskatchewan	Bains, JS (corresponding author), Univ Calgary, Hotchkiss Brain Inst, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	jsbains@ucalgary.ca		Bains, Jaideep/0000-0002-3634-6463; Fisher, Thomas/0000-0003-3890-2774				Anderson CM, 2004, J NEUROCHEM, V88, P246, DOI 10.1046/j.1471-4159.2003.02204.x; Araque A, 1998, EUR J NEUROSCI, V10, P2129, DOI 10.1046/j.1460-9568.1998.00221.x; Armstrong JN, 2002, J NEUROSCI, V22, P5938; ARMSTRONG WE, 1986, BRAIN RES, V365, P192, DOI 10.1016/0006-8993(86)90739-0; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; Bekar LK, 2005, J NEUROPHYSIOL, V93, P1699, DOI 10.1152/jn.00850.2004; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; Bezzi P, 2001, CURR OPIN NEUROBIOL, V11, P387, DOI 10.1016/S0959-4388(00)00223-3; Carter AG, 2002, NAT NEUROSCI, V5, P1309, DOI 10.1038/nn970; CLARKE DD, 1991, NEUROCHEM RES, V16, P1055, DOI 10.1007/BF00965850; Coco S, 2003, J BIOL CHEM, V278, P1354, DOI 10.1074/jbc.M209454200; Cotrina ML, 2000, J NEUROSCI, V20, P2835; Daftary SS, 1998, J NEUROSCI, V18, P10619; DAY TA, 1993, BRAIN RES, V607, P341, DOI 10.1016/0006-8993(93)91528-Z; Di S, 2003, J NEUROSCI, V23, P4850; DUFFY S, 1995, J NEUROSCI, V15, P5535; EDWARDS FA, 1992, NATURE, V359, P144, DOI 10.1038/359144a0; Fellin T, 2004, NEURON, V43, P729, DOI 10.1016/j.neuron.2004.08.011; Gordon GRJ, 2003, J NEUROSCI, V23, P6223; Guthrie PB, 1999, J NEUROSCI, V19, P520, DOI 10.1523/jneurosci.19-02-00520.1999; Jacques-Silva MC, 2004, BRIT J PHARMACOL, V141, P1106, DOI 10.1038/sj.bjp.0705685; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; Kapoor JR, 2000, J NEUROSCI, V20, P8868; Khakh BS, 2001, NAT REV NEUROSCI, V2, P165, DOI 10.1038/35058521; Kombian SB, 2000, J NEUROPHYSIOL, V83, P2542, DOI 10.1152/jn.2000.83.5.2542; Leybaert L, 1998, GLIA, V24, P398, DOI 10.1002/(SICI)1098-1136(199812)24:4<398::AID-GLIA5>3.0.CO;2-R; Lin CH, 2001, NEURON, V31, P841, DOI 10.1016/S0896-6273(01)00433-0; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Man HY, 2003, NEURON, V38, P611, DOI 10.1016/S0896-6273(03)00228-9; MIYATA S, 1994, BRAIN RES BULL, V34, P169, DOI 10.1016/0361-9230(94)90057-4; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; OConnor V, 1997, P NATL ACAD SCI USA, V94, P12186, DOI 10.1073/pnas.94.22.12186; Oliet SHR, 2001, SCIENCE, V292, P923, DOI 10.1126/science.1059162; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; RANDLE JCR, 1986, AM J PHYSIOL, V251, pR569, DOI 10.1152/ajpregu.1986.251.3.R569; Raymond CR, 2002, NEUROSCIENCE, V109, P531, DOI 10.1016/S0306-4522(01)00500-0; Robitaille R, 1998, NEURON, V21, P847, DOI 10.1016/S0896-6273(00)80600-5; Sanna PP, 2002, J NEUROSCI, V22, P3359; SAWYER CH, 1980, FED PROC, V39, P2889; Sharma G, 2003, NEURON, V38, P929, DOI 10.1016/S0896-6273(03)00322-2; Shibuya I, 1999, J PHYSIOL-LONDON, V514, P351, DOI 10.1111/j.1469-7793.1999.351ae.x; Shigetomi E, 2004, J NEUROSCI, V24, P3125, DOI 10.1523/JNEUROSCI.0090-04.2004; Stern JE, 1999, J NEUROSCI, V19, P3367; THEODOSIS DT, 1993, NEUROSCIENCE, V57, P501, DOI 10.1016/0306-4522(93)90002-W; TRAYNELIS SF, 1993, NEURON, V11, P279, DOI 10.1016/0896-6273(93)90184-S; TWEEDLE CD, 1987, NEUROSCIENCE, V20, P241, DOI 10.1016/0306-4522(87)90016-9; TWEEDLE CD, 1977, CELL TISSUE RES, V181, P59; Wang ZQ, 2000, ANAL CHEM, V72, P2001, DOI 10.1021/ac9912146; Zhang JM, 2003, NEURON, V40, P971, DOI 10.1016/S0896-6273(03)00717-7; Zucker RS, 2003, NEURON, V38, P845, DOI 10.1016/S0896-6273(03)00363-5	50	247	257	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2005	8	8					1078	1086		10.1038/nn1498	http://dx.doi.org/10.1038/nn1498			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	949BP	15995701				2022-12-17	WOS:000230760200020
J	Wei, F; Wang, GD; Kerchner, GA; Kim, SJ; Xu, HM; Chen, ZF; Zhuo, M				Wei, F; Wang, GD; Kerchner, GA; Kim, SJ; Xu, HM; Chen, ZF; Zhuo, M			Genetic enhancement of inflammatory pain by forebrain NR2B overexpression	NATURE NEUROSCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; NMDA RECEPTORS; FORMALIN TEST; GLUTAMATE RECEPTORS; VISUAL-CORTEX; RAT; BRAIN; STIMULATION; RESPONSES; MICE	N-methyl-D-aspartate (NMDA) receptors contribute to many brain functions. We studied the effect of forebrain-targeted overexpression of the NMDA receptor subunit NR2B on the response of mice to tissue injury and inflammation. Transgenic mice exhibited prominent NR2B expression and enhanced NMDA receptor-mediated synaptic responses in two pain-related forebrain areas, the anterior cingulate cortex and insular cortex, but not in the spinal cord. Although transgenic and wild type mice were indistinguishable in tests of acute pain, transgenic mice exhibited enhanced responsiveness to peripheral injection of two inflammatory stimuli, formalin and complete Freund's adjuvant. Genetic modification of forebrain NMDA receptors can therefore influence pain perception, which suggests that forebrain-selective NMDA receptor antagonists, including NR2B-selective agents, may be useful analgesics for persistent pain.	Washington Univ, Sch Med, Pain Ctr, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Zhuo, M (corresponding author), Washington Univ, Sch Med, Pain Ctr, Campus Box 8054,660 S Euclid Ave, St Louis, MO 63110 USA.	zhuom@morpheus.wustl.edu	Zhuo, Min/A-2072-2008; Xu, Haiming/A-2238-2014	Zhuo, Min/0000-0001-9062-3241; 				BIRREN SJ, 1993, DEVELOPMENT, V119, P597; Calejesan AA, 2000, EUR J PAIN, V4, P83, DOI 10.1053/eujp.1999.0158; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; Casey KL, 1999, P NATL ACAD SCI USA, V96, P7668, DOI 10.1073/pnas.96.14.7668; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.ne.13.030190.001131; CODERRE TJ, 1993, PAIN, V52, P259, DOI 10.1016/0304-3959(93)90161-H; COLLINGRIDGE GL, 1995, TRENDS NEUROSCI, V18, P54, DOI 10.1016/0166-2236(95)93868-X; DUBUISSON D, 1977, PAIN, V4, P161, DOI 10.1016/0304-3959(77)90130-0; FRANKLIN KBJ, 1997, MOUSE BRAINS TEREOTA; HALEY JE, 1990, BRAIN RES, V518, P218, DOI 10.1016/0006-8993(90)90975-H; Herrera DG, 1996, PROG NEUROBIOL, V50, P83, DOI 10.1016/S0301-0082(96)00021-4; HESTRIN S, 1992, NATURE, V357, P686, DOI 10.1038/357686a0; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; KATO N, 1991, DEV BRAIN RES, V60, P43, DOI 10.1016/0165-3806(91)90153-A; Kim SJ, 1999, BRAIN RES, V829, P185, DOI 10.1016/S0006-8993(99)01353-0; Lee DE, 1999, BRAIN RES, V845, P117, DOI 10.1016/S0006-8993(99)01956-3; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; Munglani R, 1995, PROG BRAIN RES, V104, P283; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; SAH P, 1991, J PHYSIOL-LONDON, V433, P615, DOI 10.1113/jphysiol.1991.sp018446; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; TAYLOR BK, 1995, J NEUROSCI, V15, P7575; Teng CJ, 1998, PAIN, V76, P337, DOI 10.1016/S0304-3959(98)00065-7; TJOLSEN A, 1992, PAIN, V51, P5, DOI 10.1016/0304-3959(92)90003-T; Treede RD, 1999, PAIN, V79, P105, DOI 10.1016/S0304-3959(98)00184-5; Wei F, 1999, J NEUROSCI, V19, P9346; Woolf CJ, 1999, P NATL ACAD SCI USA, V96, P7723, DOI 10.1073/pnas.96.14.7723; YAKSH TL, 1993, CURR OPIN NEUROL NEU, V6, P250	31	247	260	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2001	4	2					164	169		10.1038/83993	http://dx.doi.org/10.1038/83993			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UC	11175877				2022-12-17	WOS:000167178100015
J	Stuart, GJ; Hausser, M				Stuart, GJ; Hausser, M			Dendritic coincidence detection of EPSDs and action potentials	NATURE NEUROSCIENCE			English	Article							NEOCORTICAL PYRAMIDAL NEURONS; TERM SYNAPTIC PLASTICITY; EXCITATORY POSTSYNAPTIC POTENTIALS; RABBIT FOLLOWING STIMULATION; LONG-LASTING POTENTIATION; HIPPOCAMPAL-NEURONS; CALCIUM INFLUX; NMDA RECEPTORS; PERFORANT PATH; DENTATE AREA	We describe a mechanism for coincidence detection mediated by the interaction between backpropagating action potentials and EPSPs in neocortical pyramidal neurons. At distal dendritic locations, appropriately timed EPSPs or oscillations could increase the amplitude of backpropagating action potentials by three- to fourfold. This amplification was greatest when action potentials occurred at the peak of EPSPs or dendritic oscillations and could lead to somatic burst firing. The increase in amplitude required sodium channel activation but not potassium channel inactivation. The temporal characteristics of this amplification are similar to those required for changes in synaptic strength, suggesting that this mechanism may be involved in the induction of synaptic plasticity.	Australian Natl Univ, John Curtin Sch Med Res, Div Neurosci, Canberra, ACT 0200, Australia; UCL, Dept Physiol, London WC1E 6BT, England	Australian National University; John Curtin School of Medical Research; University of London; University College London	Stuart, GJ (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Div Neurosci, Canberra, ACT 0200, Australia.	greg.stuart@anu.edu.au	Hausser, Michael/AAW-6827-2020; stuart, greg j/F-7328-2011	Hausser, Michael/0000-0002-2673-8957; stuart, greg/0000-0001-9395-2219				[Anonymous], 1949, CLIN PSYCHOL-UK, DOI DOI 10.4324/9781410612403; Bekkers JM, 2000, J PHYSIOL-LONDON, V525, P611, DOI 10.1111/j.1469-7793.2000.t01-2-00611.x; Bekkers JM, 2000, J PHYSIOL-LONDON, V525, P593, DOI 10.1111/j.1469-7793.2000.t01-1-00593.x; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P357, DOI 10.1113/jphysiol.1973.sp010274; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; Gray C M, 1994, J Comput Neurosci, V1, P11, DOI 10.1007/BF00962716; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; HUERTA PT, 1995, NEURON, V15, P1053, DOI 10.1016/0896-6273(95)90094-2; HUERTA PT, 1993, NATURE, V364, P723, DOI 10.1038/364723a0; Johnston D, 1996, ANNU REV NEUROSCI, V19, P165, DOI 10.1146/annurev.ne.19.030196.001121; Kamondi A, 1998, J NEUROSCI, V18, P3919; Koester HJ, 1998, P NATL ACAD SCI USA, V95, P9596, DOI 10.1073/pnas.95.16.9596; Korngreen A, 2000, J PHYSIOL-LONDON, V525, P621, DOI 10.1111/j.1469-7793.2000.00621.x; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Linden DJ, 1999, NEURON, V22, P661, DOI 10.1016/S0896-6273(00)80726-6; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Mainen ZF, 1995, NEURON, V15, P1427, DOI 10.1016/0896-6273(95)90020-9; Mainen ZF, 1996, NATURE, V382, P363, DOI 10.1038/382363a0; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; Migliore M, 1999, J COMPUT NEUROSCI, V7, P5, DOI 10.1023/A:1008906225285; Nakamura T, 1999, NEURON, V24, P727, DOI 10.1016/S0896-6273(00)81125-3; Neville KR, 1999, NEUROREPORT, V10, P3711, DOI 10.1097/00001756-199911260-00045; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Paulsen O, 2000, CURR OPIN NEUROBIOL, V10, P172, DOI 10.1016/S0959-4388(00)00076-3; Schiller J, 1998, NAT NEUROSCI, V1, P114, DOI 10.1038/363; Schiller J, 1997, J PHYSIOL-LONDON, V505, P605, DOI 10.1111/j.1469-7793.1997.605ba.x; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.ne.18.030195.003011; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; Sourdet V, 1999, LEARN MEMORY, V6, P422, DOI 10.1101/lm.6.5.422; SPRUSTON N, 1995, J PHYSIOL-LONDON, V482, P325, DOI 10.1113/jphysiol.1995.sp020521; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; Stuart G, 1998, J NEUROSCI, V18, P3501; Stuart G, 1997, J PHYSIOL-LONDON, V505, P617, DOI 10.1111/j.1469-7793.1997.617ba.x; STUART GJ, 1993, PFLUG ARCH EUR J PHY, V423, P511, DOI 10.1007/BF00374949; VETTER P, IN PRESS J NEUROPHYS; Wang SSH, 2000, NAT NEUROSCI, V3, P1266, DOI 10.1038/81792; Whittington MA, 1997, P NATL ACAD SCI USA, V94, P12198, DOI 10.1073/pnas.94.22.12198; Yuste R, 1999, J NEUROSCI, V19, P1976	45	247	249	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2001	4	1					63	71		10.1038/82910	http://dx.doi.org/10.1038/82910			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UB	11135646				2022-12-17	WOS:000167178000015
J	Mensch, S; Baraban, M; Almeida, R; Czopka, T; Ausborn, J; El Manira, A; Lyons, DA				Mensch, Sigrid; Baraban, Marion; Almeida, Rafael; Czopka, Tim; Ausborn, Jessica; El Manira, Abdeljabbar; Lyons, David A.			Synaptic vesicle release regulates myelin sheath number of individual oligodendrocytes in vivo	NATURE NEUROSCIENCE			English	Article							RETICULOSPINAL NEURONS; ELECTRICAL-ACTIVITY; ZEBRAFISH; SYSTEM; BRAIN; MORPHOGENESIS; MATURATION; GENERATION; DYNAMICS; BEHAVIOR	The myelination of axons by oligodendrocytes markedly affects CNS function, but how this is regulated by neuronal activity in vivo is not known. We found that blocking synaptic vesicle release impaired CNS myelination by reducing the number of myelin sheaths made by individual oligodendrocytes during their short period of formation. We also found that stimulating neuronal activity increased myelin sheath formation by individual oligodendrocytes. These data indicate that neuronal activity regulates the myelinating capacity of single oligodendrocytes.	[Mensch, Sigrid; Baraban, Marion; Almeida, Rafael; Czopka, Tim; Lyons, David A.] Univ Edinburgh, Euan MacDonald Ctr Motor Neurone Dis Res, Ctr Multiple Sclerosis Res, Ctr Neuroregenerat, Edinburgh, Midlothian, Scotland; [Ausborn, Jessica; El Manira, Abdeljabbar] Karolinska Inst, Dept Neurosci, Stockholm, Sweden	University of Edinburgh; Karolinska Institutet	Lyons, DA (corresponding author), Univ Edinburgh, Euan MacDonald Ctr Motor Neurone Dis Res, Ctr Multiple Sclerosis Res, Ctr Neuroregenerat, Edinburgh, Midlothian, Scotland.	david.lyons@ed.ac.uk	Czopka, Tim/N-4970-2015	Czopka, Tim/0000-0002-6824-8112; Lyons, David/0000-0003-1166-4454; Almeida, Rafael/0000-0003-3563-5463; El Manira, Abdel/0000-0001-5920-9384; Baraban, Marion/0000-0002-6642-2041	Wellcome Trust Senior Research Fellowship; BBSRC David Phillips Fellowship; Lister Research Prize; BBSRC [BB/F023243/1] Funding Source: UKRI; MRC [MR/K015710/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F023243/1] Funding Source: researchfish; Medical Research Council [MR/K015710/1] Funding Source: researchfish; Wellcome Trust [102836/Z/13/Z] Funding Source: researchfish	Wellcome Trust Senior Research Fellowship(Wellcome Trust); BBSRC David Phillips Fellowship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Lister Research Prize; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	We thank M. Meyer (King's College London) for reagents and C. Tucker and staff for fish care. This work was supported by a Wellcome Trust Senior Research Fellowship, a BBSRC David Phillips Fellowship and a Lister Research Prize to D.A.L.	Almeida RG, 2014, NEUROSCIENCE, V276, P98, DOI 10.1016/j.neuroscience.2013.08.062; Almeida RG, 2011, DEVELOPMENT, V138, P4443, DOI 10.1242/dev.071001; Asakawa K, 2008, P NATL ACAD SCI USA, V105, P1255, DOI 10.1073/pnas.0704963105; Baraban SC, 2005, NEUROSCIENCE, V131, P759, DOI 10.1016/j.neuroscience.2004.11.031; BARRES BA, 1993, NATURE, V361, P258, DOI 10.1038/361258a0; Ben Fredj N, 2010, J NEUROSCI, V30, P10939, DOI 10.1523/JNEUROSCI.1556-10.2010; Czopka T, 2013, DEV CELL, V25, P599, DOI 10.1016/j.devcel.2013.05.013; Czopka T, 2011, METHOD CELL BIOL, V105, P25, DOI 10.1016/B978-0-12-381320-6.00002-3; de Hoz L, 2015, BIOESSAYS, V37, P60, DOI 10.1002/bies.201400127; Demerens C, 1996, P NATL ACAD SCI USA, V93, P9887, DOI 10.1073/pnas.93.18.9887; Feldmann A, 2011, J NEUROSCI, V31, P5659, DOI 10.1523/JNEUROSCI.6638-10.2011; Fields RD, 2010, SCIENCE, V330, P768, DOI 10.1126/science.1199139; Gahtan E, 2003, J COMP NEUROL, V459, P186, DOI 10.1002/cne.10621; Gibson EM, 2014, SCIENCE, V344, P487, DOI 10.1126/science.1252304; Hines JH, 2015, NAT NEUROSCI, V18, P683, DOI 10.1038/nn.3992; Huang RQ, 2001, J PHARMACOL EXP THER, V298, P986; Kirby BB, 2006, NAT NEUROSCI, V9, P1506, DOI 10.1038/nn1803; Korn H, 2005, NEURON, V47, P13, DOI 10.1016/j.neuron.2005.05.019; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Makinodan M, 2012, SCIENCE, V337, P1357, DOI 10.1126/science.1220845; McKenzie IA, 2014, SCIENCE, V346, P318, DOI 10.1126/science.1254960; Nakayama H, 2004, J NEUROSCI, V24, P3199, DOI 10.1523/JNEUROSCI.4419-03.2004; Ng ANY, 2005, DEV BIOL, V286, P114, DOI 10.1016/j.ydbio.2005.07.013; Reimer MM, 2013, DEV CELL, V25, P478, DOI 10.1016/j.devcel.2013.04.012; Shin Jimann, 2003, Methods in Cell Science, V25, P7, DOI 10.1023/B:MICS.0000006847.09037.3a; Sloane JA, 2007, J NEUROSCI, V27, P11366, DOI 10.1523/JNEUROSCI.2326-07.2007; Wake H, 2011, SCIENCE, V333, P1647, DOI 10.1126/science.1206998; Wang S, 2014, NEUROSCIENCE, V276, P148, DOI 10.1016/j.neuroscience.2013.10.018; Watkins TA, 2008, NEURON, V60, P555, DOI 10.1016/j.neuron.2008.09.011; Yeung MSY, 2014, CELL, V159, P766, DOI 10.1016/j.cell.2014.10.011; Young KM, 2013, NEURON, V77, P873, DOI 10.1016/j.neuron.2013.01.006; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045	32	246	252	1	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2015	18	5					628	+		10.1038/nn.3991	http://dx.doi.org/10.1038/nn.3991			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CG9LN	25849985	Green Accepted			2022-12-17	WOS:000353636900008
J	Anikeeva, P; Andalman, AS; Witten, I; Warden, M; Goshen, I; Grosenick, L; Gunaydin, LA; Frank, LM; Deisseroth, K				Anikeeva, Polina; Andalman, Aaron S.; Witten, Ilana; Warden, Melissa; Goshen, Inbal; Grosenick, Logan; Gunaydin, Lisa A.; Frank, Loren M.; Deisseroth, Karl			Optetrode: a multichannel readout for optogenetic control in freely moving mice	NATURE NEUROSCIENCE			English	Article							NEURAL CIRCUITRY; IN-VIVO; CRE RECOMBINASE; TRANSGENIC MICE; NEURONS; LIGHT; RECORDINGS; CORTEX; HIPPOCAMPUS; POPULATIONS	Recent advances in optogenetics have improved the precision with which defined circuit elements can be controlled optically in freely moving mammals; in particular, recombinase-dependent opsin viruses, used with a growing pool of transgenic mice expressing recombinases, allow manipulation of specific cell types. However, although optogenetic control has allowed neural circuits to be manipulated in increasingly powerful ways, combining optogenetic stimulation with simultaneous multichannel electrophysiological readout of isolated units in freely moving mice remains a challenge. We designed and validated the optetrode, a device that allows for colocalized multi-tetrode electrophysiological recording and optical stimulation in freely moving mice. Optetrode manufacture employs a unique optical fiber-centric coaxial design approach that yields a lightweight (2 g), compact and robust device that is suitable for behaving mice. This low-cost device is easy to construct (2.5 h to build without specialized equipment). We found that the drive design produced stable high-quality recordings and continued to do so for at least 6 weeks following implantation. We validated the optetrode by quantifying, for the first time, the response of cells in the medial prefrontal cortex to local optical excitation and inhibition, probing multiple different genetically defined classes of cells in the mouse during open field exploration.	[Anikeeva, Polina; Andalman, Aaron S.; Witten, Ilana; Warden, Melissa; Goshen, Inbal; Grosenick, Logan; Gunaydin, Lisa A.; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Frank, Loren M.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; University of California System; University of California San Francisco; Stanford University; Howard Hughes Medical Institute; Stanford University	Deisseroth, K (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	deissero@stanford.edu	Warden, Melissa R/M-9300-2016; Goshen, Inbal/GQI-2230-2022; Andalman, Aaron S/C-7694-2011	Warden, Melissa R/0000-0003-2240-3997; Goshen, Inbal/0000-0001-7578-2615; Frank, Loren/0000-0002-1752-5677	Stanford University School of Medicine; Helen Hay Whitney Foundation; Machiah fellowship; Weizmann Institute Women in Science award; National Science Foundation; Stanford University; National Institute of Neurological Disorders and Stroke; Gatsby Charitable Foundation; Defense Advanced Research Projects Agency; California Institute for Regenerative Medicine; McKnight Foundation; National Institute of Mental Health; National Institute on Drug Abuse; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086373, R01MH075957] Funding Source: NIH RePORTER	Stanford University School of Medicine; Helen Hay Whitney Foundation; Machiah fellowship; Weizmann Institute Women in Science award; National Science Foundation(National Science Foundation (NSF)); Stanford University(Stanford University); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Gatsby Charitable Foundation; Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); McKnight Foundation; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank S. Arber for the PV::Cre transgenic mouse line. P. A. thanks D. G. Walker for advice on mechanical design. P. A. was supported by a Dean's fellowship from Stanford University School of Medicine, I. W. was supported by the Helen Hay Whitney Foundation, I. G. was supported by a Machiah fellowship and the Weizmann Institute Women in Science award, L. G. was supported by a National Science Foundation Integrative Graduate Education and Research Traineeship Award, and L. A. G. was supported by a BioX fellowship from Stanford University. L. M. F. and K. D. received support from a GO grant from the National Institute of Neurological Disorders and Stroke. Full funding information for K. D. is listed at http://www.stanford.edu/group/dlab/optogenetics/funding/ and includes the Gatsby Charitable Foundation, the Defense Advanced Research Projects Agency Reorganization and Plasticity to Accelerate Injury Recovery Program, the California Institute for Regenerative Medicine, the McKnight Foundation, the National Institute of Mental Health, and the National Institute on Drug Abuse.	Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Bacon SJ, 1996, BRAIN RES, V720, P211, DOI 10.1016/0006-8993(96)00155-2; Benabid AL, 2009, LANCET NEUROL, V8, P67, DOI 10.1016/S1474-4422(08)70291-6; Bjorklund A, 2010, PROG BRAIN RES, V184, P311, DOI [10.1016/S0079-6123(16)8401-6, 10.1016/S0079-6123(10)84016-6]; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; BRITTON DR, 1981, PHARMACOL BIOCHEM BE, V15, P577, DOI 10.1016/0091-3057(81)90212-4; Brown EN, 2011, ANNU REV NEUROSCI, V34, P601, DOI 10.1146/annurev-neuro-060909-153200; Chawla MK, 2007, PROG BRAIN RES, V163, P661, DOI 10.1016/S0079-6123(07)63036-2; Costa RM, 2002, NATURE, V415, P526, DOI 10.1038/nature711; Diester I, 2011, NAT NEUROSCI, V14, P387, DOI 10.1038/nn.2749; Gerrard JL, 2008, J NEUROSCI, V28, P7883, DOI 10.1523/JNEUROSCI.1265-08.2008; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; Gradinaru V, 2007, J NEUROSCI, V27, P14231, DOI 10.1523/JNEUROSCI.3578-07.2007; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Gray CM, 1995, J NEUROSCI METH, V63, P43, DOI 10.1016/0165-0270(95)00085-2; Halassa MM, 2011, NAT NEUROSCI, V14, P1118, DOI 10.1038/nn.2880; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Histed MH, 2009, NEURON, V63, P508, DOI 10.1016/j.neuron.2009.07.016; Huang ZJ, 2002, GENESIS, V32, P209, DOI 10.1002/gene.10054; Jeantet Y, 2003, J NEUROSCI METH, V129, P129, DOI 10.1016/S0165-0270(03)00172-9; Jog MS, 2002, J NEUROSCI METH, V117, P141, DOI 10.1016/S0165-0270(02)00092-4; Leypold BG, 2002, P NATL ACAD SCI USA, V99, P6376, DOI 10.1073/pnas.082127599; Lindeberg J, 2004, GENESIS, V40, P67, DOI 10.1002/gene.20065; Mayberg HS, 2009, J CLIN INVEST, V119, P717, DOI 10.1172/JCI38454; McHugh TJ, 1996, CELL, V87, P1339, DOI 10.1016/S0092-8674(00)81828-0; MCNAUGHTON BL, 1983, J NEUROSCI METH, V8, P391, DOI 10.1016/0165-0270(83)90097-3; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; Nestler EJ, 2010, NAT NEUROSCI, V13, P1161, DOI 10.1038/nn.2647; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Royer S, 2010, EUR J NEUROSCI, V31, P2279, DOI 10.1111/j.1460-9568.2010.07250.x; Scanziani M, 2009, NATURE, V461, P930, DOI 10.1038/nature08540; Schmitzer-Torbert N, 2005, NEUROSCIENCE, V131, P1, DOI 10.1016/j.neuroscience.2004.09.066; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; THIEL G, 1991, P NATL ACAD SCI USA, V88, P3431, DOI 10.1073/pnas.88.8.3431; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Wiltgen BJ, 2004, NEURON, V44, P101, DOI 10.1016/j.neuron.2004.09.015; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Young P, 2008, NAT NEUROSCI, V11, P721, DOI 10.1038/nn.2118; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	43	246	255	0	101	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2012	15	1					163	U204		10.1038/nn.2992	http://dx.doi.org/10.1038/nn.2992			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866VO	22138641	Green Accepted			2022-12-17	WOS:000298414400027
J	Shusterman, R; Smear, MC; Koulakov, AA; Rinberg, D				Shusterman, Roman; Smear, Matthew C.; Koulakov, Alexei A.; Rinberg, Dmitry			Precise olfactory responses tile the sniff cycle	NATURE NEUROSCIENCE			English	Article							BULB UNIT-ACTIVITY; ODOR REPRESENTATIONS; TEMPORAL PRECISION; SPIKE TRAINS; TUFTED CELLS; CORTEX; RAT; INFORMATION; INHIBITION; ACCURACY	In terrestrial vertebrates, sniffing controls odorant access to receptors, and therefore sets the timescale of olfactory stimuli. We found that odorants evoked precisely sniff-locked activity in mitral/tufted cells in the olfactory bulb of awake mouse. The trial-to-trial response jitter averaged 12 ms, a precision comparable to other sensory systems. Individual cells expressed odor-specific temporal patterns of activity and, across the population, onset times tiled the duration of the sniff cycle. Responses were more tightly time-locked to the sniff phase than to the time after inhalation onset. The spikes of single neurons carried sufficient information to discriminate odors. In addition, precise locking to sniff phase may facilitate ensemble coding by making synchrony relationships across neurons robust to variation in sniff rate. The temporal specificity of mitral/tufted cell output provides a potentially rich source of information for downstream olfactory areas.	[Shusterman, Roman; Smear, Matthew C.; Rinberg, Dmitry] Howard Hughes Med Inst, Ashburn, VA USA; [Smear, Matthew C.] Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; [Koulakov, Alexei A.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Howard Hughes Medical Institute; Northwestern University; Cold Spring Harbor Laboratory	Rinberg, D (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus, Ashburn, VA USA.	rinbergd@janelia.hhmi.org	Shusterman, Roman/B-9514-2008	Shusterman, Roman/0000-0002-1081-2884	Howard Hughes Medical Institute; US National Institutes of Health [R01 EY018068]; NATIONAL EYE INSTITUTE [R01EY018068] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank J. Osborne and T. Tabachnik for design and fabrication of experimental equipment, S. Royer for help with electrophysiological setup, J. Nunez-Iglesias for help with statistical analysis, P. Ahammad, D.B. Chklovskii and S. Druckmann for discussions and A. Resulaj, J.T. Dudman, V. Jayaraman, E. Pastalkova and K. Svoboda for comments on the manuscript. R.S., M.C.S. and D.R. are supported by the Howard Hughes Medical Institute. A.A.K. was supported by US National Institutes of Health grant R01 EY018068.	Abraham NM, 2004, NEURON, V44, P865, DOI 10.1016/S0896-6273(04)00753-6; ADRIAN ED, 1950, ELECTROEN CLIN NEURO, V2, P377, DOI 10.1016/0013-4694(50)90075-7; Assisi C, 2007, NAT NEUROSCI, V10, P1176, DOI 10.1038/nn1947; Bair W, 1996, NEURAL COMPUT, V8, P1185, DOI 10.1162/neco.1996.8.6.1185; Barlow H B, 1972, Perception, V1, P371, DOI 10.1068/p010371; Bathellier B, 2008, NEURON, V57, P586, DOI 10.1016/j.neuron.2008.02.011; Berry MJ, 1997, P NATL ACAD SCI USA, V94, P5411, DOI 10.1073/pnas.94.10.5411; Bhalla US, 1997, J COMPUT NEUROSCI, V4, P221, DOI 10.1023/A:1008819818970; Bishop, 2016, PATTERN RECOGN; Brody CD, 2003, NEURON, V37, P843, DOI 10.1016/S0896-6273(03)00120-X; Buonviso N, 2003, EUR J NEUROSCI, V17, P1811, DOI 10.1046/j.1460-9568.2003.02619.x; Butts DA, 2007, NATURE, V449, P92, DOI [10.1038/nature06105, 10.1038/natureO6105]; Cang JH, 2003, J NEUROSCI, V23, P4108; Cassenaer S, 2007, NATURE, V448, P709, DOI 10.1038/nature05973; CHAPUT MA, 1986, PHYSIOL BEHAV, V36, P319, DOI 10.1016/0031-9384(86)90023-5; Cury KM, 2010, NEURON, V68, P570, DOI 10.1016/j.neuron.2010.09.040; Doucette W, 2008, PLOS BIOL, V6, P2266, DOI 10.1371/journal.pbio.0060258; Fantana AL, 2008, NEURON, V59, P802, DOI 10.1016/j.neuron.2008.07.039; Franks KM, 2006, NEURON, V49, P357, DOI 10.1016/j.neuron.2005.12.026; Fuentes RA, 2008, J NEUROPHYSIOL, V100, P422, DOI 10.1152/jn.00095.2008; HABERLY LB, 1977, BRAIN RES, V129, P152, DOI 10.1016/0006-8993(77)90978-7; HOPFIELD JJ, 1995, NATURE, V376, P33, DOI 10.1038/376033a0; Kay LM, 1999, NAT NEUROSCI, V2, P1003, DOI 10.1038/14801; Kepecs A, 2006, CHEM SENSES, V31, P167, DOI 10.1093/chemsce/bjj016; Laurent G, 1996, J NEUROSCI, V16, P3837; Laurent G, 2002, NAT REV NEUROSCI, V3, P884, DOI 10.1038/nrn964; Margrie TW, 2003, J PHYSIOL-LONDON, V546, P363, DOI 10.1113/jphysiol.2002.031245; Miyamichi K, 2011, NATURE, V472, P191, DOI 10.1038/nature09714; Nagel KI, 2011, NAT NEUROSCI, V14, P208, DOI 10.1038/nn.2725; PAGER J, 1985, BEHAV BRAIN RES, V16, P81, DOI 10.1016/0166-4328(85)90084-1; Perez-Orive J, 2002, SCIENCE, V297, P359, DOI 10.1126/science.1070502; Poo C, 2009, NEURON, V62, P850, DOI 10.1016/j.neuron.2009.05.022; Raman B, 2010, J NEUROSCI, V30, P1994, DOI 10.1523/JNEUROSCI.5639-09.2010; Rieke F., 1997, SPIKES EXPLORING NEU; Rinberg D, 2006, J NEUROSCI, V26, P8857, DOI 10.1523/JNEUROSCI.0884-06.2006; Rinberg D, 2006, NEURON, V51, P351, DOI 10.1016/j.neuron.2006.07.013; Shepherd G.M., 2004, NEUROBIOLOGY; SOBEL EC, 1993, J NEUROPHYSIOL, V69, P1331, DOI 10.1152/jn.1993.69.4.1331; Spors H, 2006, J NEUROSCI, V26, P1247, DOI 10.1523/JNEUROSCI.3100-05.2006; Stettler DD, 2009, NEURON, V63, P854, DOI 10.1016/j.neuron.2009.09.005; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; Verhagen JV, 2007, NAT NEUROSCI, V10, P631, DOI 10.1038/nn1892; Vetter RS, 2006, CHEM SENSES, V31, P359, DOI 10.1093/chemse/bjj040; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116	44	246	251	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2011	14	8					1039	U136		10.1038/nn.2877	http://dx.doi.org/10.1038/nn.2877			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	797KC	21765422				2022-12-17	WOS:000293123700018
J	Mak, GK; Enwere, EK; Gregg, C; Pakarainen, T; Poutanen, M; Huhtaniemi, I; Weiss, S				Mak, Gloria K.; Enwere, Emeka K.; Gregg, Christopher; Pakarainen, Tomi; Poutanen, Matti; Huhtaniemi, Ilpo; Weiss, Samuel			Male pheromone-stimulated neurogenesis in the adult female brain: possible role in mating behavior	NATURE NEUROSCIENCE			English	Article							MAIN OLFACTORY EPITHELIUM; NEWLY GENERATED NEURONS; DENTATE GYRUS; HIPPOCAMPAL NEUROGENESIS; LUTEINIZING-HORMONE; MAMMALIAN BRAIN; ENRICHED ENVIRONMENT; PROLACTIN PRL; MICE; RECEPTOR	The regulation of female reproductive behaviors may involve memories of male pheromone signatures, formed in part by neural circuitry involving the olfactory bulb and hippocampus. These neural structures are the principal sites of adult neurogenesis; however, previous studies point to their independent regulation by sensory and physiological stimuli. Here we report that the pheromones of dominant (but not subordinate) males stimulate neuronal production in both the olfactory bulb and hippocampus of female mice, which are independently mediated by prolactin and luteinizing hormone, respectively. Neurogenesis induced by dominant-male pheromones correlates with a female preference for dominant males over subordinate males, whereas blocking neurogenesis with the mitotic inhibitor cytosine arabinoside eliminated this preference. These results suggest that male pheromones are involved in regulating neurogenesis in both the olfactory bulb and hippocampus, which may be important for female reproductive success.	Univ Calgary, Fac Med, Hotchkiss Brain Inst, Dept Cell Biol & Anat, Calgary, AB T2N 4N1, Canada; Univ Turku, Inst Biomed, Dept Physiol, FIN-20520 Turku, Finland; Univ London Imperial Coll Sci & Technol, Inst Reprod & Dev Biol, London W12 0NN, England; Childrens Hosp Eastern Ontario, Res Inst 2, Apoptosis Res Ctr, Ottawa, ON K1H 8L1, Canada; Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	University of Calgary; University of Turku; Imperial College London; University of Ottawa; Children's Hospital of Eastern Ontario; Harvard University; Howard Hughes Medical Institute	Weiss, S (corresponding author), Univ Calgary, Fac Med, Hotchkiss Brain Inst, Dept Cell Biol & Anat, Calgary, AB T2N 4N1, Canada.	weiss@ucalgary.ca	Poutanen, Matti/I-1700-2018; Oka, Yoshitaka/C-9670-2010	Poutanen, Matti/0000-0002-8953-1734; Oka, Yoshitaka/0000-0002-3482-3051				Bakker J, 2003, J NEUROENDOCRINOL, V15, P615, DOI 10.1046/j.1365-2826.2003.01036.x; Becker JB, 2005, ENDOCRINOLOGY, V146, P1650, DOI 10.1210/en.2004-1142; Bedard A, 2004, DEV BRAIN RES, V151, P159, DOI 10.1016/j.devbrainres.2004.03.021; Bigiani A, 2005, REV PHYSIOL BIOCH P, V154, P1, DOI 10.1007/s10254-004-0038-0; Boehm U, 2005, CELL, V123, P683, DOI 10.1016/j.cell.2005.09.027; Bole-Feysot C, 1998, ENDOCR REV, V19, P225, DOI 10.1210/edrv.19.3.0334; Brennan PA, 2004, CURR BIOL, V14, pR81, DOI 10.1016/j.cub.2003.12.052; Brennan PA, 2004, HORM BEHAV, V46, P231, DOI 10.1016/j.yhbeh.2004.01.010; Brown J, 2003, EUR J NEUROSCI, V17, P2042, DOI 10.1046/j.1460-9568.2003.02647.x; Davis RL, 2004, NEURON, V44, P31, DOI 10.1016/j.neuron.2004.09.008; Doetsch F, 1999, P NATL ACAD SCI USA, V96, P11619, DOI 10.1073/pnas.96.20.11619; Doetsch F, 2005, CURR OPIN NEUROBIOL, V15, P121, DOI 10.1016/j.conb.2005.01.018; Drickamer LC, 2000, ANIM BEHAV, V59, P371, DOI 10.1006/anbe.1999.1316; Dulac C, 2003, NAT REV NEUROSCI, V4, P551, DOI 10.1038/nrn1140; Dupret D, 2005, EUR J NEUROSCI, V22, P778, DOI 10.1111/j.1460-9568.2005.04262.x; Enwere E, 2004, J NEUROSCI, V24, P8354, DOI 10.1523/JNEUROSCI.2751-04.2004; Foster D L., 1994, PHYSL REPROD, V2; Ganem G, 2005, BIOL J LINN SOC, V84, P461, DOI 10.1111/j.1095-8312.2005.00447.x; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Grammer K, 2005, EUR J OBSTET GYN R B, V118, P135, DOI 10.1016/j.ejogrb.2004.08.010; GRANT E. C, 1963, BEHAVIOUR, V21, P246, DOI 10.1163/156853963X00185; Huhtaniemi I, 2002, MOL CELL ENDOCRINOL, V187, P49, DOI 10.1016/S0303-7207(01)00698-0; Kavaliers M, 2005, NEUROSCI BIOBEHAV R, V29, P1347, DOI 10.1016/j.neubiorev.2005.04.011; Keller M, 2006, CHEM SENSES, V31, P315, DOI 10.1093/chemse/bjj035; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kero J, 2000, J CLIN INVEST, V105, P633, DOI 10.1172/JCI7716; Kokoeva MV, 2005, SCIENCE, V310, P679, DOI 10.1126/science.1115360; Liberles SD, 2006, NATURE, V442, P645, DOI 10.1038/nature05066; Ling C, 2000, ENDOCRINOLOGY, V141, P3564, DOI 10.1210/en.141.10.3564; Lledo PM, 2005, PHYSIOL REV, V85, P281, DOI 10.1152/physrev.00008.2004; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Meshi D, 2006, NAT NEUROSCI, V9, P729, DOI 10.1038/nn1696; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Mossman CA, 1996, J COMP PSYCHOL, V110, P131, DOI 10.1037/0735-7036.110.2.131; Mucignat-Caretta C, 1999, BEHAVIOUR, V136, P331, DOI 10.1163/156853999501351; Rao CV, 2002, MOL CELL ENDOCRINOL, V187, P57, DOI 10.1016/S0303-7207(01)00694-3; Rao MS, 2004, EUR J NEUROSCI, V19, P234, DOI 10.1111/j.0953-816X.2003.03123.x; Rochefort C, 2002, J NEUROSCI, V22, P2679, DOI 10.1523/JNEUROSCI.22-07-02679.2002; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Savic I, 2001, NEURON, V31, P661, DOI 10.1016/S0896-6273(01)00390-7; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Shingo T, 2003, SCIENCE, V299, P117, DOI 10.1126/science.1076647; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Simerly RB, 2002, ANNU REV NEUROSCI, V25, P507, DOI 10.1146/annurev.neuro.25.112701.142745; Slotnick B, 2001, TRENDS COGN SCI, V5, P216, DOI 10.1016/S1364-6613(00)01625-9; Trinh K, 2003, NAT NEUROSCI, V6, P519, DOI 10.1038/nn1039; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Wojtowicz JM, 2006, HIPPOCAMPUS, V16, P261, DOI 10.1002/hipo.20158; Yoon HY, 2005, CELL, V123, P669, DOI 10.1016/j.cell.2005.08.039; Zhang FP, 2001, MOL ENDOCRINOL, V15, P172, DOI 10.1210/me.15.1.172	50	246	252	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2007	10	8					1003	1011		10.1038/nn1928	http://dx.doi.org/10.1038/nn1928			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	194PY	17603480				2022-12-17	WOS:000248357500014
J	Ben Mamou, C; Gamache, K; Nader, K				Ben Mamou, Cyrinne; Gamache, Karine; Nader, Karim			NMDA receptors are critical for unleashing consolidated auditory fear memories	NATURE NEUROSCIENCE			English	Article							POTENTIATED STARTLE; AMYGDALA; RECONSOLIDATION; EXPRESSION; ACQUISITION; EXTINCTION; RETRIEVAL	Memories are dynamic and can change when recalled. The process that returns memories to a labile state during remembering is unclear. We found that the presence of NMDA, but not AMPA, receptor antagonists in the amygdala prior to recall prevented the consolidated fear memory from returning to a labile state. These findings suggest that NMDA receptors in the amygdala are critical for transforming a memory from a fixed to a labile state.	McGill Univ, Dept Psychol, Montreal, PQ H3A 1B1, Canada	McGill University	Nader, K (corresponding author), McGill Univ, Dept Psychol, 1205 Dr Penfield Ave, Montreal, PQ H3A 1B1, Canada.	karim.nader@mcgill.ca						Dudai Y, 2000, BRAIN, PERCEPTION, MEMORY, P149; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; KIM M, 1993, BEHAV NEURAL BIOL, V59, P5, DOI 10.1016/0163-1047(93)91075-X; MISERENDINO MJD, 1990, NATURE, V345, P716, DOI 10.1038/345716a0; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Przybyslawski J, 1997, BEHAV BRAIN RES, V84, P241, DOI 10.1016/S0166-4328(96)00153-2; Rodrigues SM, 2001, J NEUROSCI, V21, P6889, DOI 10.1523/JNEUROSCI.21-17-06889.2001; SPEAR NE, 1973, PSYCHOL REV, V80, P163, DOI 10.1037/h0034326; Suzuki A, 2004, J NEUROSCI, V24, P4787, DOI 10.1523/JNEUROSCI.5491-03.2004; Walker DL, 2002, PHARMACOL BIOCHEM BE, V71, P379, DOI 10.1016/S0091-3057(01)00698-0	10	246	248	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2006	9	10					1237	1239		10.1038/nn1778	http://dx.doi.org/10.1038/nn1778			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	098BB	16998481				2022-12-17	WOS:000241493900015
J	Zhao, LX; Ma, QL; Calon, F; Harris-White, ME; Yang, FS; Lim, GP; Morihara, T; Ubeda, OJ; Ambegaokar, S; Hansen, JE; Weisbart, RH; Teter, B; Frautschy, SA; Cole, GM				Zhao, LX; Ma, QL; Calon, F; Harris-White, ME; Yang, FS; Lim, GP; Morihara, T; Ubeda, OJ; Ambegaokar, S; Hansen, JE; Weisbart, RH; Teter, B; Frautschy, SA; Cole, GM			Role of p21-activated kinase pathway defects in the cognitive deficits of Alzheimer disease	NATURE NEUROSCIENCE			English	Article							AMYLOID PRECURSOR PROTEIN; MENTAL-RETARDATION; SYNAPTIC PLASTICITY; MISSENSE MUTATION; DENDRITIC SPINES; ACTIN DYNAMICS; DOWN-SYNDROME; MEMORY LOSS; LIM-KINASE; DREBRIN	Defects in dendritic spines are common to several forms of cognitive deficits, including mental retardation and Alzheimer disease. Because mutation of p21-activated kinase ( PAK) can lead to mental retardation and because PAK-cofilin signaling is critical in dendritic spine morphogenesis and actin dynamics, we hypothesized that the PAK pathway is involved in synaptic and cognitive deficits in Alzheimer disease. Here, we show that PAK and its activity are markedly reduced in Alzheimer disease and that this is accompanied by reduced and redistributed phosphoPAK, prominent cofilin pathology and downstream loss of the spine actin-regulatory protein drebrin, which cofilin removes from actin. We found that beta-amyloid ( A beta) was directly involved in PAK signaling deficits and drebrin loss in A beta oligomer-treated hippocampal neurons and in the Appswe transgenic mouse model bearing a double mutation leading to higher A beta production. In addition, pharmacological PAK inhibition in adult mice was sufficient to cause similar cofilin pathology, drebrin loss and memory impairment, consistent with a potential causal role of PAK defects in cognitive deficits in Alzheimer disease.	Greater Los Angeles Vet Affairs Healthcare Syst, Sepulveda, CA 91343 USA; Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA; Univ Laval, Med Ctr, Mol Endocrinol & Oncol Res Ctr, Quebec City, PQ G1V 4G2, Canada; Univ Laval, Fac Pharm, Ste Foy, PQ G1K 7P4, Canada; Educ & Clin Ctr, Sepulveda, CA 91343 USA; Osaka Univ, Sch Med, Div Psychiat & Behav Proteom, Dept Post Genom & Dis, Suita, Osaka 565, Japan; Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; Laval University; Laval University; Osaka University; University of California System; University of California Los Angeles	Cole, GM (corresponding author), Greater Los Angeles Vet Affairs Healthcare Syst, Sepulveda, CA 91343 USA.	gmcole@ucla.edu	Calon, Frederic/AAF-4390-2020; Morihara, Takashi/AAK-2709-2021	Calon, Frederic/0000-0002-4203-0887; Frautschy, Sally A./0000-0003-0194-0363	NIA NIH HHS [AG10685, R01 AG13741, P01 AG16570, P50 AG05142, AG16793, P50 AG 16570, AG10415, R01 AG010685, AG022080, R01 AG013741, P50 AG016570] Funding Source: Medline; NINDS NIH HHS [NS43946] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043946] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005142, R01AG013741, P60AG010415, R01AG016793, P50AG016570, R01AG010685, R01AG022080] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Allen KM, 1998, NAT GENET, V20, P25, DOI 10.1038/1675; Aoki C, 2005, J COMP NEUROL, V483, P383, DOI 10.1002/cne.20449; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Bamburg JR, 2002, TRENDS CELL BIOL, V12, P598, DOI 10.1016/S0962-8924(02)02404-2; Bienvenu T, 2000, AM J MED GENET, V93, P294, DOI 10.1002/1096-8628(20000814)93:4<294::AID-AJMG8>3.0.CO;2-F; Blanpied TA, 2004, BIOL PSYCHIAT, V55, P1121, DOI 10.1016/j.biopsych.2003.10.006; Calon F, 2004, NEURON, V43, P633, DOI 10.1016/j.neuron.2004.08.013; Cataldo AM, 2004, NEUROBIOL AGING, V25, P1263, DOI 10.1016/j.neurobiolaging.2004.02.027; Chelly J, 2001, NAT REV GENET, V2, P669, DOI 10.1038/35088558; Chong C, 2001, J BIOL CHEM, V276, P17347, DOI 10.1074/jbc.M009316200; Coleman P, 2004, NEUROLOGY, V63, P1155, DOI 10.1212/01.WNL.0000140626.48118.0A; FERRER I, 1990, ACTA NEUROPATHOL, V79, P680, DOI 10.1007/BF00294247; Fiala JC, 2002, BRAIN RES REV, V39, P29, DOI 10.1016/S0165-0173(02)00158-3; Frautschy SA, 2001, NEUROBIOL AGING, V22, P993, DOI 10.1016/S0197-4580(01)00300-1; Gedeon AK, 2003, AM J MED GENET A, V120A, P509, DOI 10.1002/ajmg.a.20131; Harigaya Y, 1996, J NEUROSCI RES, V43, P87, DOI 10.1002/jnr.490430111; Hatanpaa K, 1999, J NEUROPATH EXP NEUR, V58, P637, DOI 10.1097/00005072-199906000-00008; Hayashi K, 1996, J NEUROSCI, V16, P7161; Hayashi ML, 2004, NEURON, V42, P773, DOI 10.1016/j.neuron.2004.05.003; Ichetovkin I, 2000, CELL MOTIL CYTOSKEL, V45, P293, DOI 10.1002/(SICI)1097-0169(200004)45:4<293::AID-CM5>3.0.CO;2-1; Janz R, 1999, NEURON, V24, P687, DOI 10.1016/S0896-6273(00)81122-8; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kogan JH, 2000, HIPPOCAMPUS, V10, P47, DOI 10.1002/(SICI)1098-1063(2000)10:1<47::AID-HIPO5>3.0.CO;2-6; Kotilinek LA, 2002, J NEUROSCI, V22, P6331; Kuo YM, 1996, J BIOL CHEM, V271, P4077; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; Lappalainen P, 1998, MOL BIOL CELL, V9, P1951, DOI 10.1091/mbc.9.8.1951; MA QL, 2005, IN PRESS J NEUROSCI, V83; Maruta Hiroshi, 2002, Methods Mol Biol, V189, P75; McGough A, 1997, J CELL BIOL, V138, P771, DOI 10.1083/jcb.138.4.771; McPhie DL, 2003, J NEUROSCI, V23, P6914; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; Minamide LS, 2000, NAT CELL BIOL, V2, P628, DOI 10.1038/35023579; Mitake Shigehisa, 1997, Kaohsiung Journal of Medical Sciences, V13, P10; Moolman DL, 2004, J NEUROCYTOL, V33, P377, DOI 10.1023/B:NEUR.0000044197.83514.64; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; Ong WY, 2002, EXP BRAIN RES, V144, P189, DOI 10.1007/s00221-002-1016-x; PURPURA DP, 1974, SCIENCE, V186, P1126, DOI 10.1126/science.186.4169.1126; Ramakers GJA, 2002, TRENDS NEUROSCI, V25, P191, DOI 10.1016/S0166-2236(00)02118-4; Rossiter JP, 2000, NEUROPATH APPL NEURO, V26, P342, DOI 10.1046/j.1365-2990.2000.00252.x; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shim KS, 2002, NEUROSCI LETT, V324, P209, DOI 10.1016/S0304-3940(02)00210-0; Simic G, 1997, J COMP NEUROL, V379, P482, DOI 10.1002/(SICI)1096-9861(19970324)379:4<482::AID-CNE2>3.0.CO;2-Z; Singh RR, 2005, J BIOL CHEM, V280, P18130, DOI 10.1074/jbc.M412607200; TAKAI E, 1986, J IMMUNOL METHODS, V95, P23, DOI 10.1016/0022-1759(86)90313-3; WISNIEWSKI KE, 1985, ANN NEUROL, V17, P278, DOI 10.1002/ana.410170310; YANG AJ, 1995, J BIOL CHEM, V270, P14786, DOI 10.1074/jbc.270.24.14786; Yang FS, 1998, AM J PATHOL, V152, P379; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Zhao LX, 2004, J NEUROSCI, V24, P11120, DOI 10.1523/JNEUROSCI.2860-04.2004	50	246	261	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2006	9	2					234	242		10.1038/nn1630	http://dx.doi.org/10.1038/nn1630			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	007SN	16415866				2022-12-17	WOS:000234990100019
J	Williams, ZM; Bush, G; Rauch, SL; Cosgrove, GR; Eskandar, EN				Williams, ZM; Bush, G; Rauch, SL; Cosgrove, GR; Eskandar, EN			Human anterior cingulate neurons and the integration of monetary reward with motor responses	NATURE NEUROSCIENCE			English	Article							CORTEX; CINGULOTOMY; SELECTION; STIMULUS	The human dorsal anterior cingulate cortex (dACC) has been implicated in cognitive processes that have been proposed to play a role in integrating contextual information needed to select or modify appropriate motor responses. In humans, however, there has been little direct evidence tying the dACC to the integration of contextual information and behavioral response. We used single-neuron recordings from human subjects to evaluate the role of the dACC in reward-based decision making. Subjects undergoing planned surgical cingulotomy performed a task where they were instructed to make specific movements in response to changing monetary rewards. In many neurons, activity increased in response to a diminished reward, and was also predictive of the movement ultimately made. After dACC ablation, subjects made selectively more errors when they were required to change movement based on reward reduction. These findings suggest that the dACC in humans plays an important role in linking reward-related information with alternative actions.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurosurg, Boston, MA 02114 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Psychiat, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Eskandar, EN (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurosurg, Boston, MA 02114 USA.	eeskandar@partners.org						Ahlfors SP, 2004, NEUROIMAGE, V22, P323, DOI 10.1016/j.neuroimage.2003.12.044; Almeida R, 2002, NEUROIMAGE, V17, P1065, DOI 10.1006/nimg.2002.1234; Badre D, 2004, NEURON, V41, P473, DOI 10.1016/S0896-6273(03)00851-1; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Bush G, 2002, P NATL ACAD SCI USA, V99, P523, DOI 10.1073/pnas.012470999; Deiber MP, 1997, J NEUROPHYSIOL, V78, P977, DOI 10.1152/jn.1997.78.2.977; Dougherty DD, 2002, AM J PSYCHIAT, V159, P269, DOI 10.1176/appi.ajp.159.2.269; Downar J, 2002, J NEUROPHYSIOL, V87, P615, DOI 10.1152/jn.00636.2001; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Ebert D, 1996, BIOL PSYCHIAT, V39, P1044, DOI 10.1016/0006-3223(95)00320-7; Ernst M, 2002, NEUROPSYCHOPHARMACOL, V26, P682, DOI 10.1016/S0893-133X(01)00414-6; Gehring WJ, 2002, SCIENCE, V295, P2279, DOI 10.1126/science.1066893; Holroyd CB, 1998, NEUROSCI LETT, V242, P65, DOI 10.1016/S0304-3940(98)00035-4; Ito S, 2003, SCIENCE, V302, P120, DOI 10.1126/science.1087847; JENKINS IH, 1994, J NEUROSCI, V14, P3775; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Mayr U, 2003, NAT NEUROSCI, V6, P450, DOI 10.1038/nn1051; Miltner WHR, 2003, BIOL PSYCHOL, V64, P157, DOI 10.1016/S0301-0511(03)00107-8; O'Doherty J, 2003, J NEUROSCI, V23, P7931; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; PAUS T, 1993, J NEUROPHYSIOL, V70, P453, DOI 10.1152/jn.1993.70.2.453; Paus T, 1996, CEREB CORTEX, V6, P207, DOI 10.1093/cercor/6.2.207; Saxena S, 1998, BRIT J PSYCHIAT, V173, P26; Sheth SA, 2004, NEURON, V42, P347, DOI 10.1016/S0896-6273(04)00221-1; Shidara M, 2002, SCIENCE, V296, P1709, DOI 10.1126/science.1069504; Shima K, 1998, SCIENCE, V282, P1335, DOI 10.1126/science.282.5392.1335; Spangler WJ, 1996, NEUROSURGERY, V38, P1071, DOI 10.1227/00006123-199606000-00001; Williams ZM, 2003, NAT NEUROSCI, V6, P616, DOI 10.1038/nn1055; Zhang HZH, 1999, COGNITIVE PSYCHOL, V38, P386, DOI 10.1006/cogp.1998.0703	31	246	247	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2004	7	12					1370	1375		10.1038/nn1354	http://dx.doi.org/10.1038/nn1354			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	874MG	15558064				2022-12-17	WOS:000225353900018
J	Pouget, A; Snyder, LH				Pouget, Alexandre; Snyder, Lawrence H.			Computational approaches to sensorimotor transformations	NATURE NEUROSCIENCE			English	Review							NEURAL-NETWORK MODEL; PARIETAL CORTEX; ARM MOVEMENTS; VISUAL SPACE; NEURONS; GAZE; REPRESENTATION; ORIENTATION; INTENTION; RESPONSES	Behaviors such as sensing an object and then moving your eyes or your hand toward it require that sensory information be used to help generate a motor command, a process known as a sensorimotor transformation. Here we review models of sensorimotor transformations that use a flexible intermediate representation that relies on basis functions. The use of basis functions as an intermediate is borrowed from the theory of nonlinear function approximation. We show that this approach provides a unifying insight into the neural basis of three crucial aspects of sensorimotor transformations, namely, computation, learning and short-term memory. This mathematical formalism is consistent with the responses of cortical neurons and provides a fresh perspective on the issue of frames of reference in spatial representations.	[Pouget, Alexandre] Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA; [Snyder, Lawrence H.] Washington Univ, Dept Anat & Neurobiol, St Louis, MO 63110 USA	University of Rochester; Washington University (WUSTL)	Pouget, A (corresponding author), Univ Rochester, Dept Brain & Cognit Sci, 601 Elmwood Ave, Rochester, NY 14627 USA.	alex@bcs.rochester.edu	Snyder, Lawrence H/A-4593-2017	Pouget, Alexandre/0000-0003-3054-6365	ONR; Sloan Foundation; McDonnell-Pew foundation; Klingenstein foundation; NEI	ONR(Office of Naval Research); Sloan Foundation(Alfred P. Sloan Foundation); McDonnell-Pew foundation; Klingenstein foundation(Klingenstein Philanthropies); NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	A.P. is supported by a Young Investigator Award from ONR and fellowships from the Sloan Foundation and the McDonnell-Pew foundation. L. H. S. is supported by fellowships from the Sloan and Klingenstein foundations, and by NEI. We thank Daphne Bavelier and Suliann Ben Hamed for comments on earlier versions of this manuscript.	AMIT DJ, 1995, BEHAV BRAIN SCI, V18, P617, DOI 10.1017/S0140525X00040164; ANDERSEN RA, 1985, SCIENCE, V230, P456, DOI 10.1126/science.4048942; BOUSSAOUD D, 1993, EXP BRAIN RES, V93, P423; Bremmer F, 1997, J NEUROPHYSIOL, V77, P944, DOI 10.1152/jn.1997.77.2.944; BURNOD Y, 1992, J NEUROSCI, V12, P1435; Cumming BG, 1999, J NEUROSCI, V19, P5602; David E. R., 1987, TECHNICAL REPORT, P318, DOI 10.1016/b978-1-4832-1446-7.50035-2; Deneve S, 1999, NAT NEUROSCI, V2, P740, DOI 10.1038/11205; Desmurget M, 1999, NAT NEUROSCI, V2, P563, DOI 10.1038/9219; DOMINEY PF, 1992, CEREB CORTEX, V2, P153, DOI 10.1093/cercor/2.2.153; DROULEZ J, 1991, P NATL ACAD SCI USA, V88, P9653, DOI 10.1073/pnas.88.21.9653; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; FUNAHASHI S, 1993, J NEUROSCI, V13, P1479; Fuster JM, 1995, MEMORY CEREBRAL CORT; GALLETTI C, 1989, J NEUROSCI, V9, P1112; GNADT JW, 1995, J NEUROPHYSIOL, V73, P280, DOI 10.1152/jn.1995.73.1.280; GOLDBERG ME, 1990, J NEUROPHYSIOL, V64, P489, DOI 10.1152/jn.1990.64.2.489; Graziano MSA, 1997, SCIENCE, V277, P239, DOI 10.1126/science.277.5323.239; GROH JM, 1992, BIOL CYBERN, V67, P291, DOI 10.1007/BF02414885; Hinton GE, 2000, ADV NEUR IN, V12, P122; JORDAN MI, 1992, COGNITIVE SCI, V16, P307, DOI 10.1207/s15516709cog1603_1; KUPERSTEIN M, 1988, SCIENCE, V239, P1308, DOI 10.1126/science.3344437; Mazzoni P, 1996, J NEUROPHYSIOL, V76, P1439, DOI 10.1152/jn.1996.76.3.1439; Moody J, 1989, NEURAL COMPUT, V1, P281, DOI 10.1162/neco.1989.1.2.281; Olshausen BA, 1997, VISION RES, V37, P3311, DOI 10.1016/S0042-6989(97)00169-7; Piaget J., 1952, ORIGINS INTELLIGENCE; POGGIO T, 1990, COLD SPRING HARB SYM, V55, P899; Pouget A, 1997, J COGNITIVE NEUROSCI, V9, P222, DOI 10.1162/jocn.1997.9.2.222; POUGET A, 1994, CEREB CORTEX, V4, P314, DOI 10.1093/cercor/4.3.314; Pouget A, 1999, Prog Brain Res, V121, P81; Salinas E, 1996, P NATL ACAD SCI USA, V93, P11956, DOI 10.1073/pnas.93.21.11956; SALINAS E, 1995, J NEUROSCI, V15, P6461; Seung HS, 1996, P NATL ACAD SCI USA, V93, P13339, DOI 10.1073/pnas.93.23.13339; Snyder LH, 1998, NATURE, V394, P887, DOI 10.1038/29777; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; SOMERS DC, 1995, J NEUROSCI, V15, P5448; Squatrito S, 1996, VISUAL NEUROSCI, V13, P385, DOI 10.1017/S0952523800007628; Todorov E, 2000, NAT NEUROSCI, V3, P391, DOI 10.1038/73964; Tresch MC, 1999, NAT NEUROSCI, V2, P162, DOI 10.1038/5721; Trotter Y, 1999, NATURE, V398, P239, DOI 10.1038/18444; Trotter Y, 1996, J NEUROPHYSIOL, V76, P2872, DOI 10.1152/jn.1996.76.5.2872; Vallar G, 1998, TRENDS COGN SCI, V2, P87, DOI 10.1016/S1364-6613(98)01145-0; WALKER MF, 1995, J NEUROPHYSIOL, V73, P1988, DOI 10.1152/jn.1995.73.5.1988; WIDROW B, 1960, C P WESCON, P96; Wolpert DM, 1998, NAT NEUROSCI, V1, P529, DOI 10.1038/2245; Zhang K, 1996, J NEUROSCI, V16, P2112; ZIPSER D, 1988, NATURE, V331, P679, DOI 10.1038/331679a0	47	246	246	0	10	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2000	3	11		S			1192	1198		10.1038/81469	http://dx.doi.org/10.1038/81469			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	V18OV	11127837				2022-12-17	WOS:000208015000015
J	Waxman, SG; Zamponi, GW				Waxman, Stephen G.; Zamponi, Gerald W.			Regulating excitability of peripheral afferents: emerging ion channel targets	NATURE NEUROSCIENCE			English	Review							DORSAL-ROOT GANGLION; ACTIVATED POTASSIUM CHANNELS; CA2+-ACTIVATED K+ CHANNELS; RESISTANT SODIUM-CHANNEL; GATED CATION CHANNELS; RAT SENSORY NEURONS; NEUROPATHIC PAIN; NERVE INJURY; INFLAMMATORY PAIN; NA CHANNELS	The transmission and processing of pain signals relies critically on the activities of ion channels that are expressed in afferent pain fibers. This includes voltage-gated channels, as well as background (or leak) channels that collectively regulate resting membrane potential and action potential firing properties. Dysregulated ion channel expression in response to nerve injury And inflammation results in enhanced neuronal excitability that underlies chronic neuropathic and inflammatory pain. Pharmacological modulators of ion channels, particularly those that target channels on peripheral neurons, are being pursued as possible analgesics. Over the past few years, a number of different types of ion channels have been implicated in afferent pain signaling. Here we give an overview of recent advances on sodium, calcium, potassium and chloride channels that are emerging as especially attractive targets for the treatment of pain.	[Waxman, Stephen G.] Yale Univ, Sch Med, Ctr Neurosci & Regenerat Res, New Haven, CT USA; [Waxman, Stephen G.] Vet Affairs Med Ctr, West Haven, CT USA; [Zamponi, Gerald W.] Univ Calgary, Dept Physiol & Pharmacol, Hotchkiss Brain Inst, Calgary, AB, Canada	Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; University of Calgary	Zamponi, GW (corresponding author), Univ Calgary, Dept Physiol & Pharmacol, Hotchkiss Brain Inst, Calgary, AB, Canada.	zamponi@ucalgary.ca	Waxman, Stephen/Z-2507-2019	Waxman, Stephen/0000-0001-5718-7177; Zamponi, Gerald W./0000-0002-0644-9066	Canada Research Chair award; Alberta Innovates - Health Solutions Scientist award; Canadian Institutes of Health Research; Bridget M. Flaherty Professorship in Neurology, Neurobiology and Pharmacology at Yale; Rehabilitation Research Service and Biomedical Laboratory Research Service, US Department of Veterans Affairs	Canada Research Chair award(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Alberta Innovates - Health Solutions Scientist award; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Bridget M. Flaherty Professorship in Neurology, Neurobiology and Pharmacology at Yale; Rehabilitation Research Service and Biomedical Laboratory Research Service, US Department of Veterans Affairs(US Department of Veterans Affairs)	We thank C. Midgley for editorial assistance. G.W.Z. is supported by a Canada Research Chair award, an Alberta Innovates - Health Solutions Scientist award and grants from the Canadian Institutes of Health Research. S.G.W. is supported by the Bridget M. Flaherty Professorship in Neurology, Neurobiology and Pharmacology at Yale and is supported by grants from the Rehabilitation Research Service and Biomedical Laboratory Research Service, US Department of Veterans Affairs.	Acosta C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050442; Akopian AN, 1999, NAT NEUROSCI, V2, P541, DOI 10.1038/9195; Akopian AN, 1996, NATURE, V379, P257, DOI 10.1038/379257a0; Alloui A, 2006, EMBO J, V25, P2368, DOI 10.1038/sj.emboj.7601116; Amaya F, 2006, J NEUROSCI, V26, P12852, DOI 10.1523/JNEUROSCI.4015-06.2006; Andre S, 2003, J NEUROPHYSIOL, V90, P3764, DOI 10.1152/jn.00449.2003; Bagriantsev SN, 2013, ACS CHEM BIOL, V8, P1841, DOI 10.1021/cb400289x; Bahia PK, 2005, J NEUROSCI, V25, P3489, DOI 10.1523/JNEUROSCI.0597-05.2005; Benarroch EE, 2013, NEUROLOGY, V80, P304, DOI 10.1212/WNL.0b013e31827dec42; Berkefeld H, 2010, PHYSIOL REV, V90, P1437, DOI 10.1152/physrev.00049.2009; Bhattacharjee A, 2005, TRENDS NEUROSCI, V28, P422, DOI 10.1016/j.tins.2005.06.003; Binshtok AM, 2008, J NEUROSCI, V28, P14062, DOI 10.1523/JNEUROSCI.3795-08.2008; Black JA, 1999, J NEUROPHYSIOL, V82, P2776, DOI 10.1152/jn.1999.82.5.2776; Black JA, 2008, ANN NEUROL, V64, P644, DOI 10.1002/ana.21527; Boettger MK, 2002, BRAIN, V125, P252, DOI 10.1093/brain/awf026; Bourinet E, 2005, EMBO J, V24, P315, DOI 10.1038/sj.emboj.7600515; Bourinet E, 2014, PHYSIOL REV, V94, P81, DOI 10.1152/physrev.00023.2013; Cao XH, 2012, J NEUROCHEM, V121, P944, DOI 10.1111/j.1471-4159.2012.07736.x; Cao XH, 2010, J NEUROCHEM, V114, P1460, DOI 10.1111/j.1471-4159.2010.06863.x; Chen SR, 2009, J NEUROCHEM, V110, P352, DOI 10.1111/j.1471-4159.2009.06138.x; Cho H, 2012, NAT NEUROSCI, V15, P1015, DOI 10.1038/nn.3111; Cohen A, 2009, MOL CELL NEUROSCI, V40, P382, DOI 10.1016/j.mcn.2008.12.004; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Craner MJ, 2002, ANN NEUROL, V52, P786, DOI 10.1002/ana.10364; Cummins TR, 2001, J NEUROSCI, V21, P5952, DOI 10.1523/JNEUROSCI.21-16-05952.2001; Cummins TR, 2004, J NEUROSCI, V24, P8232, DOI 10.1523/JNEUROSCI.2695-04.2004; Descoeur J, 2011, EMBO MOL MED, V3, P266, DOI 10.1002/emmm.201100134; Dib-Hajj S, 2002, TRENDS NEUROSCI, V25, P253, DOI 10.1016/S0166-2236(02)02150-1; Dib-Hajj SD, 2005, BRAIN, V128, P1847, DOI 10.1093/brain/awh514; Dib-Hajj SD, 2013, NAT REV NEUROSCI, V14, P49, DOI 10.1038/nrn3404; Dobler T, 2007, J PHYSIOL-LONDON, V585, P867, DOI 10.1113/jphysiol.2007.145649; Emery EC, 2011, SCIENCE, V333, P1462, DOI 10.1126/science.1206243; Estacion M, 2009, ANN NEUROL, V66, P862, DOI 10.1002/ana.21895; Faber CG, 2012, P NATL ACAD SCI USA, V109, P19444, DOI 10.1073/pnas.1216080109; Faber CG, 2012, ANN NEUROL, V71, P26, DOI 10.1002/ana.22485; Fertleman CR, 2006, NEURON, V52, P767, DOI 10.1016/j.neuron.2006.10.006; Francois A, 2013, PAIN, V154, P283, DOI 10.1016/j.pain.2012.10.023; Gao SB, 2008, ACTA PHARMACOL SIN, V29, P899, DOI 10.1111/j.1745-7254.2008.00842.x; Goldberg YP, 2012, PAIN, V153, P80, DOI 10.1016/j.pain.2011.09.008; Hains BC, 2004, J NEUROSCI, V24, P4832, DOI 10.1523/JNEUROSCI.0300-04.2004; Hao JZ, 2013, NEURON, V77, P899, DOI 10.1016/j.neuron.2012.12.035; Hartzell C, 2005, ANNU REV PHYSIOL, V67, P719, DOI 10.1146/annurev.physiol.67.032003.154341; Heppenstall PA, 2006, CELL CALCIUM, V40, P165, DOI 10.1016/j.ceca.2006.04.021; Hildebrand ME, 2011, PAIN, V152, P833, DOI 10.1016/j.pain.2010.12.035; Hoeijmakers JGJ, 2012, BRAIN, V135, P345, DOI 10.1093/brain/awr349; Honore E, 2007, NAT REV NEUROSCI, V8, P251, DOI 10.1038/nrn2117; Huang F, 2013, NAT NEUROSCI, V16, P1284, DOI 10.1038/nn.3468; Hudmon A, 2008, J NEUROSCI, V28, P3190, DOI 10.1523/JNEUROSCI.4403-07.2008; Jacus MO, 2012, J NEUROSCI, V32, P9374, DOI 10.1523/JNEUROSCI.0068-12.2012; Jagodic MM, 2007, J NEUROSCI, V27, P3305, DOI 10.1523/JNEUROSCI.4866-06.2007; Jarvis MF, 2007, P NATL ACAD SCI USA, V104, P8520, DOI 10.1073/pnas.0611364104; Kang D, 2005, J PHYSIOL-LONDON, V564, P103, DOI 10.1113/jphysiol.2004.081059; Kang D, 2006, AM J PHYSIOL-CELL PH, V291, pC138, DOI 10.1152/ajpcell.00629.2005; Kenyon JL, 2000, NEUROSCI LETT, V296, P9, DOI 10.1016/S0304-3940(00)01610-4; Klein CJ, 2012, NEUROLOGY, V79, P1136, DOI 10.1212/WNL.0b013e3182698cab; Kuisle M, 2006, J PHYSIOL-LONDON, V575, P83, DOI 10.1113/jphysiol.2006.110486; La JH, 2011, AM J PHYSIOL-GASTR L, V301, pG165, DOI 10.1152/ajpgi.00417.2010; Lafreniere RG, 2010, NAT MED, V16, P1157, DOI 10.1038/nm.2216; Lai J, 2002, PAIN, V95, P143, DOI 10.1016/S0304-3959(01)00391-8; Li W, 2007, J CELL PHYSIOL, V212, P348, DOI 10.1002/jcp.21007; Lindia JA, 2005, PAIN, V117, P145, DOI 10.1016/j.pain.2005.05.027; Liu BY, 2010, J CLIN INVEST, V120, P1240, DOI 10.1172/JCI41084; Liu XJ, 2008, NAT MED, V14, P1325, DOI 10.1038/nm.1883; Maljevic S, 2013, J NEUROL, V260, P2201, DOI 10.1007/s00415-012-6727-8; Marsh B, 2012, MOL CELL NEUROSCI, V49, P375, DOI 10.1016/j.mcn.2012.01.002; Matsuyoshi H, 2006, BRAIN RES, V1119, P115, DOI 10.1016/j.brainres.2006.08.052; Mongan LC, 2005, NEUROSCIENCE, V131, P161, DOI 10.1016/j.neuroscience.2004.09.062; Nassar MA, 2004, P NATL ACAD SCI USA, V101, P12706, DOI 10.1073/pnas.0404915101; Nockemann D, 2013, EMBO MOL MED, V5, P1263, DOI 10.1002/emmm.201201980; Noel J, 2009, EMBO J, V28, P1308, DOI 10.1038/emboj.2009.57; Nuwer MO, 2010, J NEUROSCI, V30, P14165, DOI 10.1523/JNEUROSCI.3150-10.2010; Okuse K, 2002, NATURE, V417, P653, DOI 10.1038/nature00781; Papp I, 2010, EUR J NEUROSCI, V32, P1193, DOI 10.1111/j.1460-9568.2010.07370.x; Priest BT, 2005, P NATL ACAD SCI USA, V102, P9382, DOI 10.1073/pnas.0501549102; Rasband MN, 2001, P NATL ACAD SCI USA, V98, P13373, DOI 10.1073/pnas.231376298; Rehak R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061844; Reimann F, 2010, P NATL ACAD SCI USA, V107, P5148, DOI 10.1073/pnas.0913181107; Renganathan M, 2001, J NEUROPHYSIOL, V86, P629, DOI 10.1152/jn.2001.86.2.629; Rose KE, 2013, NEUROSCIENCE, V250, P263, DOI 10.1016/j.neuroscience.2013.07.005; Rush AM, 2006, P NATL ACAD SCI USA, V103, P8245, DOI 10.1073/pnas.0602813103; Samad OA, 2013, MOL THER, V21, P49, DOI 10.1038/mt.2012.169; Shields SD, 2012, J NEUROSCI, V32, P10819, DOI 10.1523/JNEUROSCI.0304-12.2012; ToledoAral JJ, 1997, P NATL ACAD SCI USA, V94, P1527, DOI 10.1073/pnas.94.4.1527; Tringham E, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003120; Tsantoulas C, 2012, J NEUROSCI, V32, P17502, DOI 10.1523/JNEUROSCI.3561-12.2012; Tulleuda A, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-30; Wan You, 2008, Shengli Xuebao, V60, P579; Waxman SG, 1999, P NATL ACAD SCI USA, V96, P7635, DOI 10.1073/pnas.96.14.7635; WAXMAN SG, 1994, J NEUROPHYSIOL, V72, P466, DOI 10.1152/jn.1994.72.1.466; Weiss J, 2011, NATURE, V472, P186, DOI 10.1038/nature09975; Weiss N, 2012, J BIOL CHEM, V287, P2810, DOI 10.1074/jbc.M111.290882; Weng XC, 2012, PAIN, V153, P900, DOI 10.1016/j.pain.2012.01.019; Wickenden AD, 2009, CURR PHARM DESIGN, V15, P2149, DOI 10.2174/138161209788489122; Xu W, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-49; Yang Y, 2004, J MED GENET, V41, P171, DOI 10.1136/jmg.2003.012153; Yang Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2184; Zhang XL, 2010, EUR J NEUROSCI, V31, P450, DOI 10.1111/j.1460-9568.2009.07060.x; Zhao XL, 2013, NAT NEUROSCI, V16, P1024, DOI 10.1038/nn.3438; Zheng Q, 2013, PAIN, V154, P434, DOI 10.1016/j.pain.2012.12.005; Zhou J, 2013, NEUROREPORT, V24, P131, DOI 10.1097/WNR.0b013e32835d8431	100	245	253	19	138	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2014	17	2					153	163		10.1038/nn.3602	http://dx.doi.org/10.1038/nn.3602			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AA2FH	24473263				2022-12-17	WOS:000330910000007
J	Verhagen, JV; Wesson, DW; Netoff, TI; White, JA; Wachowiak, M				Verhagen, Justus V.; Wesson, Daniel W.; Netoff, Theoden I.; White, John A.; Wachowiak, Matt			Sniffing controls an adaptive filter of sensory input to the olfactory bulb	NATURE NEUROSCIENCE			English	Article							RECEPTOR NEURON INPUT; MUCOSAL ACTIVITY PATTERNS; RESPONSE PROPERTIES; GLOMERULAR LAYER; UNIT-ACTIVITY; MITRAL CELLS; ODOR; RATS; REPRESENTATIONS; CORTEX	Most sensory stimuli are actively sampled, yet the role of sampling behavior in shaping sensory codes is poorly understood. Mammals sample odors by sniffing, a complex behavior that controls odorant access to receptor neurons. Whether sniffing shapes the neural code for odors remains unclear. We addressed this question by imaging receptor input to the olfactory bulb of awake rats performing odor discriminations that elicited different sniffing behaviors. High- frequency sniffing of an odorant attenuated inputs encoding that odorant, whereas lower sniff frequencies caused little attenuation. Odorants encountered later in a sniff bout were encoded as the combination of that odorant and the background odorant during low- frequency sniffing, but were encoded as the difference between the two odorants during high- frequency sniffing. Thus, sniffing controls an adaptive filter for detecting changes in the odor landscape. These data suggest an unexpected functional role for sniffing and show that sensory codes can be transformed by sampling behavior alone.	Boston Univ, Dept Biol, Boston, MA 02215 USA; Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA	Boston University; Boston University	Wachowiak, M (corresponding author), Boston Univ, Dept Biol, 24 Cummington St, Boston, MA 02215 USA.	dmattw@bu.edu	Wesson, Daniel/AAJ-6719-2020	Wesson, Daniel/0000-0002-3192-3866; White, John/0000-0003-1073-2638; Netoff, Theoden/0000-0002-0115-1930	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC008197] Funding Source: NIH RePORTER; NIDCD NIH HHS [R03 DC008197] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ADRIAN ED, 1951, J PHYSIOL-LONDON, V114, pP4; ADRIAN ED, 1950, BRIT MED BULL, V6, P330, DOI 10.1093/oxfordjournals.bmb.a073625; Bhalla US, 1997, J COMPUT NEUROSCI, V4, P221, DOI 10.1023/A:1008819818970; CHAPUT MA, 1986, PHYSIOL BEHAV, V36, P319, DOI 10.1016/0031-9384(86)90023-5; Duchamp-Viret P, 2000, J NEUROSCI, V20, P2383; Eliades SJ, 2003, J NEUROPHYSIOL, V89, P2194, DOI 10.1152/jn.00627.2002; Hayar A, 2004, J NEUROSCI, V24, P1190, DOI 10.1523/JNEUROSCI.4714-03.2004; HOPFIELD JJ, 1995, NATURE, V376, P33, DOI 10.1038/376033a0; Johnson BA, 1998, J COMP NEUROL, V393, P457, DOI 10.1002/(SICI)1096-9861(19980420)393:4<457::AID-CNE5>3.0.CO;2-#; Johnson BA, 2000, J COMP NEUROL, V422, P496, DOI 10.1002/1096-9861(20000710)422:4<496::AID-CNE2>3.0.CO;2-4; Kadohisa M, 2006, J NEUROPHYSIOL, V95, P1888, DOI 10.1152/jn.00812.2005; Katz DB, 2001, J NEUROSCI, V21, P4478, DOI 10.1523/JNEUROSCI.21-12-04478.2001; Kay LM, 1999, NAT NEUROSCI, V2, P1003, DOI 10.1038/14801; Kent PF, 1996, J NEUROSCI, V16, P345; KENT PF, 1992, J NEUROPHYSIOL, V68, P1804, DOI 10.1152/jn.1992.68.5.1804; Kepecs A, 2006, CHEM SENSES, V31, P167, DOI 10.1093/chemsce/bjj016; Linster C, 2001, J NEUROSCI, V21, P9837, DOI 10.1523/JNEUROSCI.21-24-09837.2001; MACRIDES F, 1982, J NEUROSCI, V2, P1705; MACRIDES F, 1975, BEHAV BIOL, V14, P295, DOI 10.1016/S0091-6773(75)90419-8; MACRIDES F, 1972, SCIENCE, V175, P84, DOI 10.1126/science.175.4017.84; Mainland J, 2006, CHEM SENSES, V31, P181, DOI 10.1093/chemse/bjj012; Margrie TW, 2003, J PHYSIOL-LONDON, V546, P363, DOI 10.1113/jphysiol.2002.031245; McGann JP, 2005, NEURON, V48, P1039, DOI 10.1016/j.neuron.2005.10.031; PAGER J, 1985, BEHAV BRAIN RES, V16, P81, DOI 10.1016/0166-4328(85)90084-1; Reid RC, 1996, CURR OPIN NEUROBIOL, V6, P475, DOI 10.1016/S0959-4388(96)80052-3; Reisert J, 2001, J PHYSIOL-LONDON, V530, P113, DOI 10.1111/j.1469-7793.2001.0113m.x; SCHMITT BC, 1979, SCIENCE, V205, P204, DOI 10.1126/science.205.4402.204; Schoenfeld TA, 2005, TRENDS NEUROSCI, V28, P620, DOI 10.1016/j.tins.2005.09.005; Schoppa NE, 2006, NEURON, V49, P271, DOI 10.1016/j.neuron.2005.11.038; Schoppa NE, 2001, NEURON, V31, P639, DOI 10.1016/S0896-6273(01)00389-0; SOBEL EC, 1993, J NEUROPHYSIOL, V69, P1331, DOI 10.1152/jn.1993.69.4.1331; Sobel N, 2000, CHEM SENSES, V25, P1, DOI 10.1093/chemse/25.1.1; Spors H, 2006, J NEUROSCI, V26, P1247, DOI 10.1523/JNEUROSCI.3100-05.2006; Tabor R, 2004, J NEUROSCI, V24, P6611, DOI 10.1523/JNEUROSCI.1834-04.2004; Uchida N, 2000, NAT NEUROSCI, V3, P1035, DOI 10.1038/79857; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; VANDERWOLF CH, 1987, PHARMACOL BIOCHEM BE, V26, P299, DOI 10.1016/0091-3057(87)90122-5; Wachowiak M, 2005, J NEUROPHYSIOL, V94, P2700, DOI 10.1152/jn.00286.2005; Wachowiak M, 2001, NEURON, V32, P723, DOI 10.1016/S0896-6273(01)00506-2; Walker JKL, 1997, RESP PHYSIOL, V107, P241, DOI 10.1016/S0034-5687(96)02520-0; Welker W. I., 1964, Behaviour, V22, P223, DOI 10.1163/156853964X00030; Wilson DA, 1998, J NEUROPHYSIOL, V79, P1425, DOI 10.1152/jn.1998.79.3.1425; Wilson RI, 2006, ANNU REV NEUROSCI, V29, P163, DOI 10.1146/annurev.neuro.29.051605.112950; Yaksi E, 2006, NAT METHODS, V3, P377, DOI 10.1038/NMETH874; YOUNGENTOB SL, 1987, PHYSIOL BEHAV, V41, P59, DOI 10.1016/0031-9384(87)90131-4; Zhao K, 2006, CHEM SENSES, V31, P107, DOI 10.1093/chemse/bjj008	46	245	246	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2007	10	5					631	639		10.1038/nn1892	http://dx.doi.org/10.1038/nn1892			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	160NB	17450136				2022-12-17	WOS:000245948000020
J	Liegeois, F; Baldeweg, T; Connelly, A; Gadian, DG; Mishkin, M; Vargha-Khadem, F				Liegeois, F; Baldeweg, T; Connelly, A; Gadian, DG; Mishkin, M; Vargha-Khadem, F			Language fMRI abnormalities associated with FOXP2 gene mutation	NATURE NEUROSCIENCE			English	Article							INHERITED SPEECH; BRAIN ABNORMALITIES; COGNITIVE DEFICITS; PREFRONTAL CORTEX; WORD GENERATION; FRONTAL LESIONS; VERB GENERATION; BASAL GANGLIA; MRI-ANALYSIS; DISORDER	Half the members of the KE family suffer from a speech and language disorder caused by a mutation in the FOXP2 gene. We examined functional brain abnormalities associated with this mutation using two fMRI language experiments, one involving covert (silent) verb generation and the other overt (spoken) verb generation and word repetition. The unaffected family members showed a typical left-dominant distribution of activation involving Broca's area in the generation tasks and a more bilateral distribution in the repetition task, whereas the affected members showed a more posterior and more extensively bilateral pattern of activation in all tasks. Consistent with previously reported bilateral morphological abnormalities, the affected members showed significant underactivation relative to the unaffected members in Broca's area and its right homolog, as well as in other cortical language-related regions and in the putamen. Our findings suggest that the FOXP2 gene is critically involved in the development of the neural systems that mediate speech and language.	UCL, Inst Child Hlth, Dev Cognit Neurosci Unit, Wolfson Ctr, London WC1N 2AP, England; Great Ormond St Hosp Sick Children, London WC1N 3JH, England; UCL, Inst Child Hlth, Radiol & Phys Unit, London WC1N 1EH, England; NIMH, Neuropsychol Lab, Bethesda, MD 20892 USA	University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Liegeois, F (corresponding author), UCL, Inst Child Hlth, Dev Cognit Neurosci Unit, Wolfson Ctr, Mecklenburgh Sq, London WC1N 2AP, England.	F.Liegeois@ich.ucl.ac.uk	Vargha-Khadem, Faraneh/C-2558-2008; Gadian, David G/C-4961-2008; Connelly, Alan/A-9065-2013; Liegeois, Frederique/A-6351-2009	Connelly, Alan/0000-0001-7159-8079; Liegeois, Frederique/0000-0002-8640-6217; vargha-khadem, faraneh/0000-0003-4890-8379				Alcock KJ, 2000, BRAIN LANG, V75, P17, DOI 10.1006/brln.2000.2322; ALEXANDER GE, 1994, J CLIN NEUROPHYSIOL, V11, P420, DOI 10.1097/00004691-199407000-00004; Arbib MA, 2002, FROM ANIM ANIMAT, P229; Belton E, 2003, HUM BRAIN MAPP, V18, P194, DOI 10.1002/hbm.10093; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; Dronkers NF, 1996, NATURE, V384, P159, DOI 10.1038/384159a0; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Fisher SE, 1998, NAT GENET, V18, P168, DOI 10.1038/ng0298-168; Friedman L, 1998, BRAIN LANG, V64, P231, DOI 10.1006/brln.1998.1953; Herholz K, 1996, NEUROIMAGE, V3, P185, DOI 10.1006/nimg.1996.0020; HURST JA, 1990, DEV MED CHILD NEUROL, V32, P352; Jueptner M, 1998, BRAIN, V121, P1437, DOI 10.1093/brain/121.8.1437; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Liegeois F, 2002, NEUROIMAGE, V17, P1861, DOI 10.1006/nimg.2002.1327; Martin A, 2001, CURR OPIN NEUROBIOL, V11, P194, DOI 10.1016/S0959-4388(00)00196-3; PAULESU E, 1993, NATURE, V362, P342, DOI 10.1038/362342a0; Paulesu E, 1997, NEUROREPORT, V8, P2011, DOI 10.1097/00001756-199705260-00042; Pickett ER, 1998, NEUROPSYCHOLOGIA, V36, P173, DOI 10.1016/S0028-3932(97)00065-1; Poldrack RA, 1999, NEUROIMAGE, V10, P15, DOI 10.1006/nimg.1999.0441; Price CJ, 2000, J ANAT, V197, P335, DOI 10.1046/j.1469-7580.2000.19730335.x; Price CJ, 1996, BRAIN, V119, P919, DOI 10.1093/brain/119.3.919; Rizzolatti G, 1998, TRENDS NEUROSCI, V21, P188, DOI 10.1016/S0166-2236(98)01260-0; Salmond CH, 2000, HUM BRAIN MAPP, V11, P223; Thierry G, 1999, NEUROREPORT, V10, P2599, DOI 10.1097/00001756-199908200-00029; Thompson-Schill SL, 1999, NEURON, V23, P513, DOI 10.1016/S0896-6273(00)80804-1; Thompson-Schill SL, 1998, P NATL ACAD SCI USA, V95, P15855, DOI 10.1073/pnas.95.26.15855; Tomaiuolo F, 1999, EUR J NEUROSCI, V11, P3033, DOI 10.1046/j.1460-9568.1999.00718.x; Ullman MT, 2001, NAT REV NEUROSCI, V2, P717, DOI 10.1038/35094573; Vargha-Khadem F, 1998, P NATL ACAD SCI USA, V95, P12695, DOI 10.1073/pnas.95.21.12695; VARGHAKHADEM F, 1995, P NATL ACAD SCI USA, V92, P930, DOI 10.1073/pnas.92.3.930; VARGHAKHADEM F, 1985, BRAIN LANG, V25, P167, DOI 10.1016/0093-934X(85)90128-2; Warburton E, 1996, BRAIN, V119, P159, DOI 10.1093/brain/119.1.159; Watkins KE, 2002, BRAIN, V125, P452, DOI 10.1093/brain/awf058; Watkins KE, 2002, BRAIN, V125, P465, DOI 10.1093/brain/awf057	34	245	252	1	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2003	6	11					1230	1237		10.1038/nn1138	http://dx.doi.org/10.1038/nn1138			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	737KH	14555953				2022-12-17	WOS:000186229200024
J	Musso, M; Moro, A; Glauche, V; Rijntjes, M; Reichenbach, J; Buchel, C; Weiller, C				Musso, M; Moro, A; Glauche, V; Rijntjes, M; Reichenbach, J; Buchel, C; Weiller, C			Broca's area and the language instinct	NATURE NEUROSCIENCE			English	Article							PREFRONTAL CORTEX; EPISODIC MEMORY; SPEECH; ACQUISITION; RETRIEVAL; BRAIN	Language acquisition in humans relies on abilities like abstraction and use of syntactic rules, which are absent in other animals. The neural correlate of acquiring new linguistic competence was investigated with two functional magnetic resonance imaging (fMRI) studies. German native speakers learned a sample of 'real' grammatical rules of different languages (Italian or Japanese), which, although parametrically different, follow the universal principles of grammar (UG). Activity during this task was compared with that during a task that involved learning 'unreal' rules of language. 'Unreal' rules were obtained manipulating the original two languages; they used the same lexicon as Italian or Japanese, but were linguistically illegal, as they violated the principles of UG. Increase of activation over time in Broca's area was specific for 'real' language acquisition only, independent of the kind of language. Thus, in Broca's area, biological constraints and language experience interact to enable linguistic competence for a new language.	Univ Hamburg, Dept Neurol, D-20246 Hamburg, Germany; Univ Vita Salute San Raffaele, Milan, Italy; Univ Jena, Inst Diagnost & Intervent Radiol, D-6900 Jena, Germany	University of Hamburg; Vita-Salute San Raffaele University; Friedrich Schiller University of Jena	Musso, M (corresponding author), Univ Hamburg, Dept Neurol, Martinistr 52, D-20246 Hamburg, Germany.	musso@uke.uni-hamburg.de	Reichenbach, Jürgen R./B-4333-2011; moro, andrea/ABG-9796-2020	Reichenbach, Jürgen R./0000-0002-2640-0630; moro, andrea/0000-0002-6602-5871				Alcock KJ, 2000, BRAIN LANG, V75, P34, DOI 10.1006/brln.2000.2323; Allan K, 2000, NEUROIMAGE, V11, P217, DOI 10.1006/nimg.2000.0531; Anderson M., 1992, INTELLIGENCE DEV COG; Breitenstein C, 2002, J NEUROSCI METH, V114, P173, DOI 10.1016/S0165-0270(01)00525-8; BUCKNER RL, 2000, NEW COGNITIVE NEUROS, P817; Cantalupo C, 2001, NATURE, V414, P505, DOI 10.1038/35107134; Chomsky N., 1986, KNOWLEDGE LANGUAGE I; Chomsky Noam, 1957, SYNTACTIC STRUCTURES; Chomsky Noam., 1981, UCLA LECT; Chomsky Noam., 1986, BARRIERS; Darwin C, 1871, ORIGIN SPECIES DESCE; Delis K, 1987, CALIFORNIA VERBAL LE; Embick D, 2000, P NATL ACAD SCI USA, V97, P6150, DOI 10.1073/pnas.100098897; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Friederici AD, 2002, P NATL ACAD SCI USA, V99, P529, DOI 10.1073/pnas.012611199; Friederici AD, 2000, BRAIN LANG, V74, P289, DOI 10.1006/brln.2000.2313; Glitter G., 1998, INTELLIGENZ STRUKTUR; GOPNIK M, 1990, NATURE, V344, P715, DOI 10.1038/344715a0; Hahne A, 1999, J COGNITIVE NEUROSCI, V11, P194, DOI 10.1162/089892999563328; Henson RNA, 1999, BRAIN, V122, P1367, DOI 10.1093/brain/122.7.1367; HOLMES AP, 1998, NEUROIMAGE, V7, pS574; Illes J, 1999, BRAIN LANG, V70, P347, DOI 10.1006/brln.1999.2186; Jensvold MLA, 2000, J COMP PSYCHOL, V114, P335, DOI 10.1037/0735-7036.114.4.335; Kim KHS, 1997, NATURE, V388, P171, DOI 10.1038/40623; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Lepage M, 2000, P NATL ACAD SCI USA, V97, P506, DOI 10.1073/pnas.97.1.506; Maess B, 2001, NAT NEUROSCI, V4, P540, DOI 10.1038/87502; Markson L, 1997, NATURE, V385, P813, DOI 10.1038/385813a0; MORO A, 2002, LINGUE LINGUAGGIO, V1, P39; MORO A, 2000, DYNAMICS ANTISYMMETR; Ni W, 2000, J COGNITIVE NEUROSCI, V12, P120, DOI 10.1162/08989290051137648; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Owen AM, 2000, EXP BRAIN RES, V133, P33, DOI 10.1007/s002210000398; Patel AD, 1998, J COGNITIVE NEUROSCI, V10, P717, DOI 10.1162/089892998563121; Petrides M, 2000, EXP BRAIN RES, V133, P44, DOI 10.1007/s002210000399; PETRIDES M, 1994, HDB NEUROPSYCHOLOGY, V9; Piattelli-Palmarini M., 1980, LANGUAGE LEARNING DE; Pinker S, 2001, NATURE, V413, P465, DOI 10.1038/35097173; Rizzolatti G, 1998, TRENDS NEUROSCI, V21, P188, DOI 10.1016/S0166-2236(98)01260-0; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Rose M, 2002, NEURON, V36, P1221, DOI 10.1016/S0896-6273(02)01105-4; Sakai KL, 2002, NEURON, V35, P1177, DOI 10.1016/S0896-6273(02)00873-5; Seger CA, 1997, CONSCIOUS COGN, V6, P108, DOI 10.1006/ccog.1996.0285; SHALLICE T, 1994, NATURE, V368, P633, DOI 10.1038/368633a0; SMITH N, 1996, MIND SAVANT; Tettamanti M, 2002, NEUROIMAGE, V17, P700, DOI 10.1006/nimg.2002.1201; TULVING E, 1994, P NATL ACAD SCI USA, V91, P2016, DOI 10.1073/pnas.91.6.2016; Ullman MT, 2001, NAT REV NEUROSCI, V2, P717, DOI 10.1038/35094573; Vargha-Khadem F, 1998, P NATL ACAD SCI USA, V95, P12695, DOI 10.1073/pnas.95.21.12695; WALKER AE, 1940, J COMP NEUROL, V262, P256	50	245	247	0	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2003	6	7					774	781		10.1038/nn1077	http://dx.doi.org/10.1038/nn1077			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	694NJ	12819784				2022-12-17	WOS:000183780400027
J	Sankaranarayanan, S; Atluri, PP; Ryan, TA				Sankaranarayanan, S; Atluri, PP; Ryan, TA			Actin has a molecular scaffolding, not propulsive, role in presynaptic function	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; BRAIN MYOSIN-V; SYNAPTIC VESICLES; NEUROTRANSMITTER RELEASE; CELLS; SYNAPSES; PROTEIN; POLYMERIZATION; ARCHITECTURE; CYTOSKELETON	We used actin tagged with enhanced green fluorescent protein (EGFP-actin) to characterize the distribution and dynamics of actin in living presynaptic terminals in rat CNS neurons. Actin was preferentially concentrated around-and appeared to surround-the presynaptic vesicle cluster. In resting terminals, similar to30% of actin was found to be in a polymerized but dynamic state, with a remodeling time scale of similar to20 s. During electrical activity, actin was further polymerized and recruited from nearby axonal regions to the regions surrounding vesicles. Treatment of terminals with the actin monomer-sequestering agent latrunculin-A completely dispersed the actin network and abolished activity-dependent actin dynamics. We used a variety of methods to examine the role of actin in the presynaptic vesicle cycle. These data rule out a propulsive role for actin, either in maintaining the vesicle cluster or in guiding vesicle recycling. Instead, we propose that actin acts as a scaffolding system for regulatory molecules in the nerve terminal.	Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA	Cornell University	Ryan, TA (corresponding author), Cornell Univ, Weill Med Coll, Dept Biochem, 1300 York Ave, New York, NY 10021 USA.	taryan@med.cornell.edu	Ryan, Timothy/AAO-8286-2020	Ryan, Timothy/0000-0003-2533-9548; Atluri, Pradeep/0000-0002-0871-8311	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM061925] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM61925] Funding Source: Medline; NINDS NIH HHS [NS24692] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Allison DW, 1998, J NEUROSCI, V18, P2423; Ballestrem C, 1998, J CELL SCI, V111, P1649; Benfenati F, 1999, PHILOS T R SOC B, V354, P243, DOI 10.1098/rstb.1999.0376; Bernstein BW, 1998, MOL BRAIN RES, V53, P236, DOI 10.1016/S0169-328X(97)00319-7; Betz WJ, 1998, ANNU REV PHYSIOL, V60, P347, DOI 10.1146/annurev.physiol.60.1.347; CANO M, 1995, J CELL BIOL, V115, P677; Chan AY, 2000, J CELL BIOL, V148, P531, DOI 10.1083/jcb.148.3.531; Chi P, 2001, NAT NEUROSCI, V4, P1187, DOI 10.1038/nn756; Cole JC, 2000, J PHYSIOL-LONDON, V525, P579, DOI 10.1111/j.1469-7793.2000.t01-2-00579.x; Colicos MA, 2001, CELL, V107, P605, DOI 10.1016/S0092-8674(01)00579-7; COUE M, 1987, FEBS LETT, V213, P316, DOI 10.1016/0014-5793(87)81513-2; Dresbach T, 2001, CELL MOL LIFE SCI, V58, P94, DOI 10.1007/PL00000781; Evans LL, 1998, J CELL SCI, V111, P2055; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Gautier I, 2001, BIOPHYS J, V80, P3000, DOI 10.1016/S0006-3495(01)76265-0; Goldberg MB, 2001, MICROBIOL MOL BIOL R, V65, P595, DOI 10.1128/MMBR.65.4.595-626.2001; GOTOW T, 1991, NEUROSCIENCE, V40, P587, DOI 10.1016/0306-4522(91)90143-C; HIROKAWA N, 1989, J CELL BIOL, V108, P111, DOI 10.1083/jcb.108.1.111; Holzinger A, 2001, METH MOL B, V161, P109; Job C, 1998, J CELL BIOL, V143, P1661, DOI 10.1083/jcb.143.6.1661; Kuromi H, 1998, NEURON, V20, P917, DOI 10.1016/S0896-6273(00)80473-0; LANDIS DMD, 1988, NEURON, V1, P201, DOI 10.1016/0896-6273(88)90140-7; Lee E, 2002, P NATL ACAD SCI USA, V99, P161, DOI 10.1073/pnas.012607799; May RC, 2001, J CELL SCI, V114, P1061; Merrifield CJ, 1999, NAT CELL BIOL, V1, P72, DOI 10.1038/9048; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Morales M, 2000, NEURON, V27, P539, DOI 10.1016/S0896-6273(00)00064-7; Mounier N, 1997, J CELL SCI, V110, P839; Prekeris R, 1997, J CELL BIOL, V137, P1589, DOI 10.1083/jcb.137.7.1589; Qualmann B, 1999, MOL BIOL CELL, V10, P501, DOI 10.1091/mbc.10.2.501; Roos J, 1999, CURR BIOL, V9, P1411, DOI 10.1016/S0960-9822(00)80087-1; RYAN TA, 1995, NEURON, V14, P983, DOI 10.1016/0896-6273(95)90336-4; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Schafer DA, 2002, CURR OPIN CELL BIOL, V14, P76, DOI 10.1016/S0955-0674(01)00297-6; Shupliakov O, 2002, P NATL ACAD SCI USA, V99, P14476, DOI 10.1073/pnas.212381799; SPECTOR I, 1989, CELL MOTIL CYTOSKEL, V13, P127, DOI 10.1002/cm.970130302; Wang XH, 1996, J PHYSIOL-LONDON, V491, P187, DOI 10.1113/jphysiol.1996.sp021206; Zhang WD, 2001, J NEUROSCI, V21, P5169, DOI 10.1523/JNEUROSCI.21-14-05169.2001	40	245	250	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2003	6	2					127	135		10.1038/nn1002	http://dx.doi.org/10.1038/nn1002			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	640CL	12536209				2022-12-17	WOS:000180669100012
J	Dantzker, JL; Callaway, EM				Dantzker, JL; Callaway, EM			Laminar sources of synaptic input to cortical inhibitory interneurons and pyramidal neurons	NATURE NEUROSCIENCE			English	Article							PRIMARY VISUAL-CORTEX; RAT FRONTAL-CORTEX; DUAL INTRACELLULAR-RECORDINGS; SPINY STELLATE NEURONS; GABAERGIC INTERNEURONS; AXONAL PROJECTIONS; LOCAL CIRCUITS; MACAQUE MONKEY; STRIATE CORTEX; BASKET CELLS	The functional role of an individual neuron within a cortical circuit is largely determined by that neuron's synaptic input. We examined the laminar sources of local input to subtypes of cortical neurons in layer 2/3 of rat visual cortex using laser scanning photostimulation. We identified three distinct laminar patterns of excitatory input that correspond to physiological and morphological subtypes of neurons. Fast-spiking inhibitory basket cells and excitatory pyramidal neurons received strong excitatory input from middle cortical layers. In contrast, adapting inhibitory interneurons received their strongest excitatory input either from deep layers or laterally from within layer 2/3. Thus, differential laminar sources of excitatory inputs contribute to the functional diversity of cortical inhibitory interneurons.	Salk Inst Biol Studies, Syst Neurobiol Labs, La Jolla, CA 92037 USA; Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA	Salk Institute; University of California System; University of California San Diego	Dantzker, JL (corresponding author), Salk Inst Biol Studies, Syst Neurobiol Labs, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	dantzker@salk.edu	Callaway, Edward/D-4336-2011	Callaway, Edward/0000-0002-6366-5267				Ahmed B, 1997, J COMP NEUROL, V380, P230; ANDERSON JC, 1994, J COMP NEUROL, V341, P25, DOI 10.1002/cne.903410104; Braitenberg V, 1991, ANATOMY CORTEX; BURKHALTER A, 1989, J COMP NEUROL, V279, P171, DOI 10.1002/cne.902790202; CALLAWAY EM, 1993, P NATL ACAD SCI USA, V90, P7661, DOI 10.1073/pnas.90.16.7661; Callaway EM, 1998, ANNU REV NEUROSCI, V21, P47, DOI 10.1146/annurev.neuro.21.1.47; Cauli B, 1997, J NEUROSCI, V17, P3894; CONNORS BW, 1990, TRENDS NEUROSCI, V13, P99, DOI 10.1016/0166-2236(90)90185-D; DeFelipe J, 1999, J COMP NEUROL, V412, P515, DOI 10.1002/(SICI)1096-9861(19990927)412:3<515::AID-CNE10>3.0.CO;2-1; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; FREUND TF, 1986, NEUROSCIENCE, V19, P1133, DOI 10.1016/0306-4522(86)90129-6; FREUND TF, 1991, J COMP NEUROL, V314, P187, DOI 10.1002/cne.903140117; Galarreta M, 1998, NAT NEUROSCI, V1, P587, DOI 10.1038/2822; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; GILBERT CD, 1983, ANNU REV NEUROSCI, V6, P217, DOI 10.1146/annurev.ne.06.030183.001245; Gonchar Y, 1997, CEREB CORTEX, V7, P347, DOI 10.1093/cercor/7.4.347; Gonchar Y, 1999, CEREB CORTEX, V9, P683, DOI 10.1093/cercor/9.7.683; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; HORNUNG JP, 1992, J COMP NEUROL, V320, P457, DOI 10.1002/cne.903200404; JONES EG, 1984, CEREB CORTEX, V1, P309, DOI DOI 10.1007/978-1-4615-6610-6; KATZ LC, 1994, J NEUROSCI METH, V54, P205, DOI 10.1016/0165-0270(94)90194-5; KAWABATA TT, 1995, FUND APPL TOXICOL, V26, P8, DOI 10.1006/faat.1995.1070; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Kawaguchi Y, 1998, NEUROSCIENCE, V85, P677, DOI 10.1016/S0306-4522(97)00685-4; KAWAGUCHI Y, 1993, J NEUROPHYSIOL, V69, P416, DOI 10.1152/jn.1993.69.2.416; KIM HG, 1995, J NEUROPHYSIOL, V74, P1810, DOI 10.1152/jn.1995.74.4.1810; KISVARDAY ZF, 1985, J COMP NEUROL, V241, P111, DOI 10.1002/cne.902410202; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; Meskenaite V, 1997, J COMP NEUROL, V379, P113; PARNAVELAS JG, 1992, PROG BRAIN RES, V90, P523; Parra P, 1998, NEURON, V20, P983, DOI 10.1016/S0896-6273(00)80479-1; PETERS A, 1981, J COMP NEUROL, V203, P685, DOI 10.1002/cne.902030408; Reyes A, 1999, J NEUROSCI, V19, P3827; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; Rockland KS, 1998, CURR OPIN NEUROBIOL, V8, P545, DOI 10.1016/S0959-4388(98)80044-5; SOMOGYI P, 1977, BRAIN RES, V136, P345, DOI 10.1016/0006-8993(77)90808-3; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; SOMOGYI P, 1983, NEUROSCIENCE, V10, P261, DOI 10.1016/0306-4522(83)90133-1; Staiger JF, 1996, EUR J NEUROSCI, V8, P2273, DOI 10.1111/j.1460-9568.1996.tb01191.x; STEVENS CF, 1995, NEURON, V14, P795, DOI 10.1016/0896-6273(95)90223-6; Tamas G, 1998, J NEUROSCI, V18, P4255; Tarczy-Hornoch K, 1999, CEREB CORTEX, V9, P833, DOI 10.1093/cercor/9.8.833; Thomson AM, 1998, NEUROSCIENCE, V84, P669, DOI 10.1016/S0306-4522(97)00557-5; Thomson AM, 1997, CEREB CORTEX, V7, P510, DOI 10.1093/cercor/7.6.510; Zhang ZW, 1997, J NEUROSCI, V17, P6365	46	245	247	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2000	3	7					701	707		10.1038/76656	http://dx.doi.org/10.1038/76656			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TT	10862703				2022-12-17	WOS:000167177200017
J	Eckel-Mahan, KL; Phan, T; Han, S; Wang, HB; Chan, GCK; Scheiner, ZS; Storm, DR				Eckel-Mahan, Kristin L.; Phan, Trongha; Han, Sung; Wang, Hongbing; Chan, Guy C-K; Scheiner, Zachary S.; Storm, Daniel R.			Circadian oscillation of hippocampal MAPK activity and cAMP: implications for memory persistence	NATURE NEUROSCIENCE			English	Article							LONG-TERM-MEMORY; DEPENDENT PROTEIN-KINASE; SIGNAL-REGULATED KINASE; SLOW-WAVE SLEEP; SYNAPTIC PLASTICITY; ADENYLYL CYCLASES; PASSIVE-AVOIDANCE; NMDA RECEPTOR; LATE-PHASE; ACTIVATION	The mitogen-activated protein kinase (MAPK) and cyclic adenosine monophosphate (cAMP) signal transduction pathways have critical roles in the consolidation of hippocampus-dependent memory. We found that extracellular regulated kinase 1/2 MAPK phosphorylation and cAMP underwent a circadian oscillation in the hippocampus that was paralleled by changes in Ras activity and the phosphorylation of MAPK kinase and cAMP response element-binding protein (CREB). The nadir of this activation cycle corresponded with severe deficits in hippocampus-dependent fear conditioning under both light-dark and free-running conditions. Circadian oscillations in cAMP and MAPK activity were absent in memory-deficient transgenic mice that lacked Ca(2+)-stimulated adenylyl cyclases. Furthermore, physiological and pharmacological interference with oscillations in MAPK phosphorylation after the cellular memory consolidation period impaired the persistence of hippocampus-dependent memory. These data suggest that the persistence of long-term memories may depend on reactivation of the cAMP/MAPK/CREB transcriptional pathway in the hippocampus during the circadian cycle.	[Eckel-Mahan, Kristin L.; Phan, Trongha; Han, Sung; Chan, Guy C-K; Scheiner, Zachary S.; Storm, Daniel R.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Wang, Hongbing] Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA	University of Washington; University of Washington Seattle; Michigan State University	Storm, DR (corresponding author), Univ Washington, Dept Pharmacol, 1959 NE Pacific St, Seattle, WA 98195 USA.	dstorm@u.washington.edu		Eckel-Mahan, Kristin/0000-0001-8201-1675	US National Institutes of Health [NS 20498]; Ruth L. Kirschstein US National Institutes of Health Research [1 F31 MH075489-01A1]; Korea Research Foundation Grant for Young Scientists [KRF-2005-213-C00036]; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH075489] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020498] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein US National Institutes of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korea Research Foundation Grant for Young Scientists(National Research Foundation of Korea); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank H. de la Iglesia for valuable advice concerning some of the circadian procedures. We also would like to thank several members of the Storm lab for insightful discussions and critical readings of this manuscript. This work was supported by a grant from the US National Institutes of Health (NS 20498), a predoctoral Ruth L. Kirschstein US National Institutes of Health Research Award (1 F31 MH075489-01A1) to K. L. E.-M. and a Korea Research Foundation Grant for Young Scientists to S. H. (KRF-2005-213-C00036).	Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; ASCHOFF J, 1979, Z TIERPSYCHOL, V49, P225; Athos J, 2002, NAT NEUROSCI, V5, P1119, DOI 10.1038/nn951; Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; Bekinschtein P, 2007, NEURON, V53, P261, DOI 10.1016/j.neuron.2006.11.025; Bernabeu R, 1997, P NATL ACAD SCI USA, V94, P7041, DOI 10.1073/pnas.94.13.7041; Born J, 2006, NEUROSCIENTIST, V12, P410, DOI 10.1177/1073858406292647; BRANDON EP, 1995, P NATL ACAD SCI USA, V92, P8851, DOI 10.1073/pnas.92.19.8851; Chaudhury D, 2002, BEHAV BRAIN RES, V133, P95, DOI 10.1016/S0166-4328(01)00471-5; Cui ZZ, 2004, NEURON, V41, P781, DOI 10.1016/S0896-6273(04)00072-8; Devan BD, 2001, NEUROBIOL LEARN MEM, V75, P51, DOI 10.1006/nlme.1999.3957; Duvarci S, 2005, EUR J NEUROSCI, V21, P283, DOI 10.1111/j.1460-9568.2004.03824.x; Ferguson GD, 2004, PHYSIOLOGY, V19, P271, DOI 10.1152/physiol.00010.2004; Fernandez RI, 2003, P NATL ACAD SCI USA, V100, P14415, DOI 10.1073/pnas.2336172100; FOLKARD S, 1983, NATURE, V305, P223, DOI 10.1038/305223a0; Gais S, 2000, NAT NEUROSCI, V3, P1335, DOI 10.1038/81881; Granados-Fuentes D, 2004, J NEUROSCI, V24, P615, DOI 10.1523/JNEUROSCI.4002-03.2004; Graves LA, 2003, LEARN MEMORY, V10, P168, DOI 10.1101/lm.48803; Hauber W, 2001, BEHAV BRAIN RES, V118, P43, DOI 10.1016/S0166-4328(00)00307-7; Hetman M, 2004, EUR J BIOCHEM, V271, P2050, DOI 10.1111/j.1432-1033.2004.04133.x; HOLLOWAY FA, 1973, BEHAV BIOL, V9, P1, DOI 10.1016/S0091-6773(73)80164-6; Huang YY, 1995, CELL, V83, P1211, DOI 10.1016/0092-8674(95)90146-9; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Impey S, 1999, NEURON, V23, P11, DOI 10.1016/S0896-6273(00)80747-3; Keiper M, 2004, J BIOL CHEM, V279, P46497, DOI 10.1074/jbc.M403604200; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; Kelly A, 2003, J NEUROSCI, V23, P5354; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; LEIRER VO, 1994, EXP AGING RES, V20, P127, DOI 10.1080/03610739408253958; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; MAURY P, 1992, BRIT J PSYCHOL, V83, P249, DOI 10.1111/j.2044-8295.1992.tb02439.x; Mednick S, 2003, NAT NEUROSCI, V6, P697, DOI 10.1038/nn1078; Obrietan K, 1998, NAT NEUROSCI, V1, P693, DOI 10.1038/3695; Ohta H, 2005, NAT NEUROSCI, V8, P267, DOI 10.1038/nn1395; Peigneux P, 2004, NEURON, V44, P535, DOI 10.1016/j.neuron.2004.10.007; Schafe GE, 2000, J NEUROSCI, V20, P8177; Scott R, 2002, J MOL NEUROSCI, V19, P171, DOI 10.1007/s12031-002-0029-z; Selcher JC, 1999, LEARN MEMORY, V6, P478, DOI 10.1101/lm.6.5.478; Shalin SC, 2004, J NEUROSCI RES, V75, P760, DOI 10.1002/jnr.20052; Sharma SK, 2004, LEARN MEMORY, V11, P373, DOI 10.1101/lm.81104; Shimizu E, 2000, SCIENCE, V290, P1170, DOI 10.1126/science.290.5494.1170; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Sindreu CB, 2007, NEURON, V53, P79, DOI 10.1016/j.neuron.2006.11.024; STEPHAN FK, 1978, BEHAV BIOL, V22, P456, DOI 10.1016/S0091-6773(78)92565-8; Sweatt JD, 2004, CURR OPIN NEUROBIOL, V14, P311, DOI 10.1016/j.conb.2004.04.001; TAPP WN, 1981, SCIENCE, V211, P1056, DOI 10.1126/science.7193351; Valentinuzzi VS, 2000, PHYSIOL BEHAV, V69, P269, DOI 10.1016/S0031-9384(00)00219-5; Wang HB, 2003, MOL PHARMACOL, V63, P463, DOI 10.1124/mol.63.3.463; Wong ST, 1999, NEURON, V23, P787, DOI 10.1016/S0896-6273(01)80036-2; WU ZL, 1995, P NATL ACAD SCI USA, V92, P220, DOI 10.1073/pnas.92.1.220	50	244	249	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2008	11	9					1074	1082		10.1038/nn.2174	http://dx.doi.org/10.1038/nn.2174			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	341NA	19160506	Green Accepted			2022-12-17	WOS:000258720000018
J	Zhao, XL; Tang, ZX; Zhang, HK; Atianjoh, FE; Zhao, JY; Liang, LL; Wang, W; Guan, XW; Kao, SC; Tiwari, V; Gao, YJ; Hoffman, PN; Cui, HM; Li, M; Dong, XZ; Tao, YX				Zhao, Xiuli; Tang, Zongxiang; Zhang, Hongkang; Atianjoh, Fidelis E.; Zhao, Jian-Yuan; Liang, Lingli; Wang, Wei; Guan, Xiaowei; Kao, Sheng-Chin; Tiwari, Vinod; Gao, Yong-Jing; Hoffman, Paul N.; Cui, Hengmi; Li, Min; Dong, Xinzhong; Tao, Yuan-Xiang			A long noncoding RNA contributes to neuropathic pain by silencing Kcna2 in primary afferent neurons	NATURE NEUROSCIENCE			English	Article							ROOT GANGLION NEURONS; PRIMARY SENSORY NEURONS; ALPHA-GENE EXPRESSION; POTASSIUM CHANNELS; DOWN-REGULATION; MESSENGER-RNA; NERVE INJURY; DORSAL-HORN; RAT; CONDUCTANCE	Neuropathic pain is a refractory disease characterized by maladaptive changes in gene transcription and translation in the sensory pathway. Long noncoding RNAs (lncRNAs) are emerging as new players in gene regulation, but how lncRNAs operate in the development of neuropathic pain is unclear. Here we identify a conserved lncRNA, named Kcna2 antisense RNA, for a voltage-dependent potassium channel mRNA, Kcna2, in first-order sensory neurons of rat dorsal root ganglion (DRG). Peripheral nerve injury increased Kcna2 antisense RNA expression in injured DRG through activation of myeloid zinc finger protein 1, a transcription factor that binds to the Kcna2 antisense RNA gene promoter. Mimicking this increase downregulated Kcna2, reduced total voltage-gated potassium current, increased excitability in DRG neurons and produced neuropathic pain symptoms. Blocking this increase reversed nerve injury-induced downregulation of DRG Kcna2 and attenuated development and maintenance of neuropathic pain. These findings suggest endogenous Kcna2 antisense RNA as a therapeutic target for the treatment of neuropathic pain.	[Zhao, Xiuli; Atianjoh, Fidelis E.; Zhao, Jian-Yuan; Liang, Lingli; Wang, Wei; Guan, Xiaowei; Kao, Sheng-Chin; Tiwari, Vinod; Tao, Yuan-Xiang] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Tang, Zongxiang] Nanjing Univ Chinese Med, Coll Basic Med, Nanjing, Jiangsu, Peoples R China; [Zhang, Hongkang; Li, Min; Dong, Xinzhong] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Gao, Yong-Jing] Nantong Univ, Jiangsu Key Lab Neuroregenerat, Inst Naut Med, Nantong, Peoples R China; [Hoffman, Paul N.] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; [Cui, Hengmi] Yangzhou Univ, Biomed Innovat Inst, Yangzhou, Peoples R China; [Dong, Xinzhong] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Nanjing University of Chinese Medicine; Johns Hopkins University; Nantong University; Johns Hopkins University; Yangzhou University; Howard Hughes Medical Institute; Johns Hopkins University	Tao, YX (corresponding author), Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA.	ytao1@jhmi.edu	TIWARI, VINOD K/L-9595-2019; Gao, Yong-Jing/E-6939-2015; Core, Vector/CAF-4832-2022	TIWARI, VINOD K/0000-0001-9244-8889; Gao, Yong-Jing/0000-0002-7432-7458; Zhao, Jian-Yuan/0000-0001-9861-0330; Tiwari, Vinod/0000-0002-8491-2255	Howard Hughes Medical Institute; US National Institutes of Health (NIH) [NS054791, GM087369]; NIH [MH084691, GM078579, DA033390, NS072206]; Rita Allen Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078579, R01GM087369] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH084691] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072206, R01NS094664, R01NS054791] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA033390] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rita Allen Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank R.J. Samulski (University of North Carolina) for the rAAV5 plasmid, J. Zhou (Institute of Biochemistry of Cell Biology, Chinese Academy of Sciences) for the full-length EGFP-MZF1 plasmid and D.Y.H. Tuan (Georgia Health Sciences University) for MZF1 antibody. We thank C. F. Levine for editorial assistance. This work was supported by the Howard Hughes Medical Institute and US National Institutes of Health (NIH) grants (NS054791 and GM087369) to X. D., by NIH grants (MH084691 and GM078579) to M. L. and by NIH grants (DA033390, NS072206) and the grants from the Rita Allen Foundation to Y.-X.T.	BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Campbell JN, 2006, NEURON, V52, P77, DOI 10.1016/j.neuron.2006.09.021; Cardenas CG, 1999, J PHYSIOL-LONDON, V518, P507, DOI 10.1111/j.1469-7793.1999.0507p.x; Castle NA, 2003, MOL PHARMACOL, V63, P409, DOI 10.1124/mol.63.2.409; CHABAL C, 1989, PAIN, V36, P321, DOI 10.1016/0304-3959(89)90091-2; Chien LY, 2007, J NEUROSCI, V27, P9855, DOI 10.1523/JNEUROSCI.0604-07.2007; Chung Jin Mo, 2002, Pain Pract, V2, P87, DOI 10.1046/j.1533-2500.2002.02011.x; Coggeshall RE, 1996, J COMP NEUROL, V364, P6, DOI 10.1002/(SICI)1096-9861(19960101)364:1<6::AID-CNE2>3.0.CO;2-9; Costa FF, 2008, GENE, V410, P9, DOI 10.1016/j.gene.2007.12.008; Costigan M, 2009, ANNU REV NEUROSCI, V32, P1, DOI 10.1146/annurev.neuro.051508.135531; DEVOR M, 1983, NEUROSCI LETT, V40, P181, DOI 10.1016/0304-3940(83)90299-9; Devor M, 2009, EXP BRAIN RES, V196, P115, DOI 10.1007/s00221-009-1724-6; Dodson PD, 2002, J NEUROSCI, V22, P6953; Dong XZ, 2001, CELL, V106, P619, DOI 10.1016/S0092-8674(01)00483-4; Esumi S, 2006, NAT PROTOC, V1, P2143, DOI 10.1038/nprot.2006.343; Everill B, 2000, NEUROSCIENCE, V100, P417, DOI 10.1016/S0306-4522(00)00263-3; Faghihi MA, 2009, NAT REV MOL CELL BIO, V10, P637, DOI 10.1038/nrm2738; Fulton S, 2011, J BIOL CHEM, V286, P9360, DOI 10.1074/jbc.M110.153262; Gallagher PE, 2001, METH MOLEC MED, V51, P205, DOI 10.1385/1-59259-087-X:205; Gibb EA, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-38; Guan XW, 2009, N-S ARCH PHARMACOL, V380, P459, DOI 10.1007/s00210-009-0451-7; Han PJ, 2004, EXP NEUROL, V189, P293, DOI 10.1016/j.expneurol.2004.03.010; Hsieh YH, 2006, BIOCHEM BIOPH RES CO, V339, P217, DOI 10.1016/j.bbrc.2005.11.015; Ishikawa K, 1999, MUSCLE NERVE, V22, P502, DOI 10.1002/(SICI)1097-4598(199904)22:4<502::AID-MUS12>3.0.CO;2-K; Kim DS, 2002, MOL BRAIN RES, V105, P146, DOI 10.1016/S0169-328X(02)00388-1; Kim YI, 1998, NEUROSCIENCE, V86, P301, DOI 10.1016/S0306-4522(98)00022-0; Lavorgna G, 2004, TRENDS BIOCHEM SCI, V29, P88, DOI 10.1016/j.tibs.2003.12.002; Liang LL, 2013, J PAIN, V14, P638, DOI 10.1016/j.jpain.2013.01.778; Liu CN, 2000, PAIN, V85, P503, DOI 10.1016/S0304-3959(00)00251-7; Luo JL, 2011, J PAIN, V12, P600, DOI 10.1016/j.jpain.2010.11.005; Luo XY, 2009, J NEUROCHEM, V108, P952, DOI 10.1111/j.1471-4159.2008.05845.x; Nehme B, 2011, J NEUROSCI METH, V196, P281, DOI 10.1016/j.jneumeth.2011.01.018; Nicol GD, 1997, J NEUROPHYSIOL, V77, P167, DOI 10.1152/jn.1997.77.1.167; Park JS, 2009, J NEUROSCI, V29, P3206, DOI 10.1523/JNEUROSCI.4514-08.2009; Park SY, 2003, MOL CELLS, V16, P256; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Rasband MN, 2001, P NATL ACAD SCI USA, V98, P13373, DOI 10.1073/pnas.231376298; REHM H, 1991, FASEB J, V5, P164, DOI 10.1096/fasebj.5.2.2004663; Rinke I, 2010, J NEUROSCI, V30, P4776, DOI 10.1523/JNEUROSCI.6299-09.2010; Robbins CA, 2012, EPILEPSIA, V53, P134, DOI 10.1111/j.1528-1167.2012.03484.x; Singh OV, 2009, PROTEOMICS, V9, P1241, DOI 10.1002/pmic.200800636; Tal M, 1999, BRAIN RES, V824, P218, DOI 10.1016/S0006-8993(99)01190-7; TARG EF, 1986, BRAIN RES, V363, P1, DOI 10.1016/0006-8993(86)90652-9; Vacher H, 2011, PFLUG ARCH EUR J PHY, V462, P631, DOI 10.1007/s00424-011-1004-8; Visan V, 2004, MOL PHARMACOL, V66, P1103, DOI 10.1124/mol.104.002774; Wapinski O, 2011, TRENDS CELL BIOL, V21, P354, DOI 10.1016/j.tcb.2011.04.001; Weissner W, 2006, J COMP NEUROL, V497, P78, DOI 10.1002/cne.20981; Xu JT, 2010, BRAIN RES, V1336, P46, DOI 10.1016/j.brainres.2010.04.010; Xu Y, 2003, P NATL ACAD SCI USA, V100, P6204, DOI 10.1073/pnas.0930324100; Yang EK, 2004, NEUROSCIENCE, V123, P867, DOI 10.1016/j.neuroscience.2003.11.014; Zhang BS, 2003, PAIN, V106, P187, DOI 10.1016/j.pain.2003.08.003; Zheng Q, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-24	52	243	256	2	74	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2013	16	8					1024	U76		10.1038/nn.3438	http://dx.doi.org/10.1038/nn.3438			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190EV	23792947	Green Accepted			2022-12-17	WOS:000322323000012
J	Jo, J; Whitcomb, DJ; Olsen, KM; Kerrigan, TL; Lo, SC; Bru-Mercier, G; Dickinson, B; Scullion, S; Sheng, MG; Collingridge, G; Cho, K				Jo, Jihoon; Whitcomb, Daniel J.; Olsen, Kimberly Moore; Kerrigan, Talitha L.; Lo, Shih-Ching; Bru-Mercier, Gilles; Dickinson, Bryony; Scullion, Sarah; Sheng, Morgan; Collingridge, Graham; Cho, Kwangwook			A beta(1-42) inhibition of LTP is mediated by a signaling pathway involving caspase-3, Akt1 and GSK-3 beta	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; ALZHEIMERS-DISEASE; SYNAPTIC PLASTICITY; PROTEIN-KINASE; BETA; ACTIVATION; DEPRESSION; OLIGOMERS; MEMORY	Amyloid-beta(1-42) (A beta) is thought to be a major mediator of the cognitive deficits in Alzheimer's disease. The ability of A. to inhibit hippocampal long-term potentiation provides a cellular correlate of this action, but the underlying molecular mechanism is only partially understood. We found that a signaling pathway involving caspase-3, Akt1 and glycogen synthase kinase-3b is an important mediator of this effect in rats and mice.	[Jo, Jihoon; Whitcomb, Daniel J.; Kerrigan, Talitha L.; Bru-Mercier, Gilles; Dickinson, Bryony; Scullion, Sarah; Cho, Kwangwook] Univ Bristol, Sch Clin Sci, Fac Med & Dent, Henry Wellcome Labs Integrat Neurosci & Endocrino, Bristol, Avon, England; [Olsen, Kimberly Moore; Lo, Shih-Ching; Sheng, Morgan] Genentech Inc, Dept Neurosci, San Francisco, CA 94080 USA; [Scullion, Sarah; Collingridge, Graham; Cho, Kwangwook] Univ Bristol, MRC Ctr Synapt Plast, Bristol, Avon, England; [Collingridge, Graham] Univ Bristol, Sch Physiol & Pharmacol, Bristol, Avon, England	University of Bristol; Roche Holding; Genentech; University of Bristol; University of Bristol	Cho, K (corresponding author), Univ Bristol, Sch Clin Sci, Fac Med & Dent, Henry Wellcome Labs Integrat Neurosci & Endocrino, Bristol, Avon, England.	kei.cho@bristol.ac.uk	Kerrigan, Talitha/C-3759-2016; Collingridge, Graham L/C-4605-2015; collingridge, graham/AAI-8362-2020	Collingridge, Graham L/0000-0002-9572-5359; Whitcomb, Daniel/0000-0003-2703-1643; Lo, Shih-Ching/0000-0002-5187-0730; Kerrigan, Talitha/0000-0003-2158-567X; Cho, Kwangwook/0000-0001-6724-7073	UK Alzheimer's Research Trust; Biotechnology and Biological Sciences Research Council; Medical Research Council; Royal Society; BBSRC [BB/G003963/1] Funding Source: UKRI; MRC [MC_G1000734] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G003963/1] Funding Source: researchfish; Medical Research Council [MC_G1000734, G0601841B] Funding Source: researchfish	UK Alzheimer's Research Trust; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society(Royal Society of London); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the UK Alzheimer's Research Trust (K. C.), Biotechnology and Biological Sciences Research Council (K. C.), Medical Research Council (G. L. C.) and The Royal Society (J.J.). G. L. C. is a World Class University International Scholar and D.J.W. is an UK Alzheimer's Research Trust-funded Ph.D. student.	Allen JW, 2001, J NEUROSCI RES, V65, P45, DOI 10.1002/jnr.1126; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Cho JH, 2004, J BIOL CHEM, V279, P54716, DOI 10.1074/jbc.M403364200; Chong YH, 2006, J BIOL CHEM, V281, P20315, DOI 10.1074/jbc.M601016200; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Kotilinek LA, 2008, BRAIN, V131, P651, DOI 10.1093/brain/awn008; Li SM, 2009, NEURON, V62, P788, DOI 10.1016/j.neuron.2009.05.012; Li Z, 2010, CELL, V141, P859, DOI 10.1016/j.cell.2010.03.053; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Peineau S, 2007, NEURON, V53, P703, DOI 10.1016/j.neuron.2007.01.029; Phiel CJ, 2003, NATURE, V423, P435, DOI 10.1038/nature01640; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang QW, 2004, J NEUROSCI, V24, P3370, DOI 10.1523/JNEUROSCI.1633-03.2004	15	243	252	1	56	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2011	14	5					545	547		10.1038/nn.2785	http://dx.doi.org/10.1038/nn.2785			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	754VU	21441921				2022-12-17	WOS:000289886600007
J	Vogels, TP; Abbott, LF				Vogels, Tim P.; Abbott, L. F.			Gating multiple signals through detailed balance of excitation and inhibition in spiking networks	NATURE NEUROSCIENCE			English	Article							MUSCARINIC ACETYLCHOLINE-RECEPTORS; SYNCHRONOUS SPIKING; NEURAL-NETWORKS; FIRING RATES; MACAQUE V1; NEURONS; MODEL; SCHIZOPHRENIA; PROPAGATION; TRANSMISSION	Recent theoretical work has provided a basic understanding of signal propagation in networks of spiking neurons, but mechanisms for gating and controlling these signals have not been investigated previously. Here we introduce an idea for the gating of multiple signals in cortical networks that combines principles of signal propagation with aspects of balanced networks. Specifically, we studied networks in which incoming excitatory signals are normally cancelled by locally evoked inhibition, leaving the targeted layer unresponsive. Transmission can be gated 'on' by modulating excitatory and inhibitory gains to upset this detailed balance. We illustrate gating through detailed balance in large networks of integrate-and-fire neurons. We show successful gating of multiple signals and study failure modes that produce effects reminiscent of clinically observed pathologies. Provided that the individual signals are detectable, detailed balance has a large capacity for gating multiple signals.	[Vogels, Tim P.; Abbott, L. F.] Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; [Vogels, Tim P.] Brandeis Univ, Dept Biol, Volen Ctr Complex Syst, Waltham, MA 02254 USA	Columbia University; Brandeis University	Vogels, TP (corresponding author), Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, Dept Physiol & Cellular Biophys, 722 W 168th St, New York, NY 10032 USA.	timvogels@columbia.edu			US National Science Foundation [IBN-0235463]; Swartz Foundation; Patterson Trust; US National Institutes of Health (NIH) [5-DP1-OD114-02]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000114] Funding Source: NIH RePORTER	US National Science Foundation(National Science Foundation (NSF)); Swartz Foundation; Patterson Trust; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The idea of detailed balance was originally suggested to us by G. Turrigiano. Research supported by the US National Science Foundation (IBN-0235463), the Swartz Foundation, the Patterson Trust Fellowship Program in Brain Circuitry and a US National Institutes of Health (NIH) Director's Pioneer Award, part of the NIH Roadmap for Medical Research, through grant number 5-DP1-OD114-02. Thanks to J. Peelle, M. Schiff, P. Jercog and R. Yuste for suggestions.	Abbott LF, 2008, NEURON, V60, P489, DOI 10.1016/j.neuron.2008.10.019; Abeles M, 1991, CORTICONICS NEURAL C, DOI DOI 10.1017/CBO9780511574566; Aertsen A, 1996, J PHYSIOLOGY-PARIS, V90, P243, DOI 10.1016/S0928-4257(97)81432-5; Amit DJ, 1997, CEREB CORTEX, V7, P237, DOI 10.1093/cercor/7.3.237; ANDERSON CH, 1987, P NATL ACAD SCI USA, V84, P6297, DOI 10.1073/pnas.84.17.6297; Aviel Y, 2003, NEURAL COMPUT, V15, P1321, DOI 10.1162/089976603321780290; Baca SM, 2008, NEURON, V57, P276, DOI 10.1016/j.neuron.2007.11.028; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Brunel N, 2000, J PHYSIOLOGY-PARIS, V94, P445, DOI 10.1016/S0928-4257(00)01084-6; Destexhe A, 2006, SCIENCE, V314, P85, DOI 10.1126/science.1127241; Diesmann M, 1999, NATURE, V402, P529, DOI 10.1038/990101; Disney AA, 2008, J COMP NEUROL, V507, P1748, DOI 10.1002/cne.21616; Disney AA, 2007, NEURON, V56, P701, DOI 10.1016/j.neuron.2007.09.034; Disney AA, 2006, J COMP NEUROL, V499, P49, DOI 10.1002/cne.21096; Germuska M, 2006, CEREB CORTEX, V16, P865, DOI 10.1093/cercor/bhj030; Gil Z, 1997, NEURON, V19, P679, DOI 10.1016/S0896-6273(00)80380-3; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; Jackson ME, 2004, P NATL ACAD SCI USA, V101, P8467, DOI 10.1073/pnas.0308455101; Kumar A, 2008, J NEUROSCI, V28, P5268, DOI 10.1523/JNEUROSCI.2542-07.2008; Kumar A, 2008, NEURAL COMPUT, V20, P1, DOI 10.1162/neco.2008.20.1.1; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Mitchell JF, 2007, NEURON, V55, P131, DOI 10.1016/j.neuron.2007.06.018; Moore H, 1999, BIOL PSYCHIAT, V46, P40, DOI 10.1016/S0006-3223(99)00078-5; Morrison A, 2007, NEURAL COMPUT, V19, P1437, DOI 10.1162/neco.2007.19.6.1437; Okun M, 2008, NAT NEUROSCI, V11, P535, DOI 10.1038/nn.2105; OLSHAUSEN BA, 1993, J NEUROSCI, V13, P4700; POSNER M, 2004, COGNITIVE NEUROSCIEN; Pouille F, 2004, NATURE, V429, P717, DOI 10.1038/nature02615; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Salinas E, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-47; SEEMAN P, 1987, SYNAPSE, V1, P133, DOI 10.1002/syn.890010203; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; Tamminga CA, 1998, CRIT REV NEUROBIOL, V12, P21, DOI 10.1615/CritRevNeurobiol.v12.i1-2.20; Troyer TW, 1997, NEURAL COMPUT, V9, P971, DOI 10.1162/neco.1997.9.5.971; van Rossum MCW, 2002, J NEUROSCI, V22, P1956, DOI 10.1523/JNEUROSCI.22-05-01956.2002; vanVreeswijk C, 1996, SCIENCE, V274, P1724, DOI 10.1126/science.274.5293.1724; Vogels TP, 2005, J NEUROSCI, V25, P10786, DOI 10.1523/JNEUROSCI.3508-05.2005; Vogels TP, 2005, ANNU REV NEUROSCI, V28, P357, DOI 10.1146/annurev.neuro.28.061604.135637; Xiang ZX, 1998, SCIENCE, V281, P985, DOI 10.1126/science.281.5379.985	42	243	246	1	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2009	12	4					483	491		10.1038/nn.2276	http://dx.doi.org/10.1038/nn.2276			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	424JN	19305402	Green Accepted			2022-12-17	WOS:000264563100023
J	Remage-Healey, L; Maidment, NT; Schlinger, BA				Remage-Healey, Luke; Maidment, Nigel T.; Schlinger, Barney A.			Forebrain steroid levels fluctuate rapidly during social interactions	NATURE NEUROSCIENCE			English	Article							ZEBRA FINCH BRAIN; NEUROSTEROID BIOSYNTHESIS; ESTROGEN SYNTHESIS; BIRDSONG MEMORY; AROMATASE; HORMONES; HIPPOCAMPUS; MODULATION; PLASTICITY; ESTRADIOL	Neurosteroids are powerful modulators of brain function and behavior, yet their dynamics in the brain have remained elusive. Using in vivo microdialysis in male zebra finches, we found that local estradiol levels increased rapidly in the forebrain during social interactions with females. Furthermore, when males were exposed to other males' songs, local estradiol levels also increased and testosterone levels dropped in a cortical/pallial auditory region that is analogous to mammalian auditory cortex. We also found that local estradiol and testosterone levels were differentially regulated in this same region by the conventional neurotransmitters glutamate and GABA, respectively. This study provides direct evidence that forebrain steroid levels are acutely and differentially regulated during social behavior in a region-specific manner and in a rapid time course similar to that of traditional neuromodulators.	[Remage-Healey, Luke; Schlinger, Barney A.] Univ Calif Los Angeles, Dept Physiol Sci, Los Angeles, CA 90095 USA; [Remage-Healey, Luke; Schlinger, Barney A.] Univ Calif Los Angeles, Neuroendocrinol Lab, Brain Res Inst, Los Angeles, CA 90095 USA; [Maidment, Nigel T.] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Dept Psychiat & Behav Sci, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Remage-Healey, L (corresponding author), Univ Calif Los Angeles, Dept Physiol Sci, 621 Charles E Young Dr S, Los Angeles, CA 90095 USA.	healey@ucla.edu			US National Institute of Neurological Disorders and Stroke [F32NS058009-01]; US National Institute of Mental Health [061994]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS058009] Funding Source: NIH RePORTER	US National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	H. Lam provided technical support for microdialysis. M. Konishi provided the sound-attenuation chambers. I. Teramitsu and J. Goodson demonstrated surgical techniques. A. Briedbach, K. Faull and the staff of the University of California Los Angeles Pasarow GC/MS Core Facility (support from the National Science Foundation, CHE 0078299) provided technical support. N. Tillakaratne provided an ELISA plate reader. S. Cho assisted with tissue processing. C. I. M. Healey provided comments on the manuscript. This work was supported by the US National Institute of Neurological Disorders and Stroke (National Research Service Award F32NS058009-01) and the US National Institute of Mental Health (061994).	Agis-Balboa RC, 2006, P NATL ACAD SCI USA, V103, P14602, DOI 10.1073/pnas.0606544103; Amateau SK, 2004, ENDOCRINOLOGY, V145, P2906, DOI 10.1210/en.2003-1363; Balthazart J, 2006, TRENDS NEUROSCI, V29, P241, DOI 10.1016/j.tins.2006.03.004; Barbaccia ML, 1996, PHARMACOL BIOCHEM BE, V54, P205, DOI 10.1016/0091-3057(95)02133-7; Baulieu EE, 1998, PSYCHONEUROENDOCRINO, V23, P963, DOI 10.1016/S0306-4530(98)00071-7; Bixo M, 1995, J STEROID BIOCHEM, V55, P297, DOI 10.1016/0960-0760(95)00179-4; Boehning D, 2003, ANNU REV NEUROSCI, V26, P105, DOI 10.1146/annurev.neuro.26.041002.131047; Bolhuis JJ, 2006, NAT REV NEUROSCI, V7, P347, DOI 10.1038/nrn1904; Bottjer SW, 1997, J NEUROBIOL, V33, P602, DOI 10.1002/(SICI)1097-4695(19971105)33:5<602::AID-NEU8>3.0.CO;2-8; Cornil CA, 2006, BRAIN RES, V1126, P2, DOI 10.1016/j.brainres.2006.07.098; FLORES F, 1973, SCIENCE, V180, P1074, DOI 10.1126/science.180.4090.1074; Frye CA, 2007, NEUROBIOL LEARN MEM, V88, P208, DOI 10.1016/j.nlm.2007.04.003; Gibbs TT, 2006, PHARMACOL BIOCHEM BE, V84, P555, DOI 10.1016/j.pbb.2006.07.031; Gobes SMH, 2007, CURR BIOL, V17, P789, DOI 10.1016/j.cub.2007.03.059; Hojo Y, 2004, P NATL ACAD SCI USA, V101, P865, DOI 10.1073/pnas.2630225100; Holloway CC, 2001, NAT NEUROSCI, V4, P170, DOI 10.1038/84001; Hultcrantz M, 2006, ACTA OTO-LARYNGOL, V126, P10, DOI 10.1080/00016480510038617; Lambert JJ, 2003, PROG NEUROBIOL, V71, P67, DOI 10.1016/j.pneurobio.2003.09.001; Livingston FS, 2000, NAT NEUROSCI, V3, P482, DOI 10.1038/74857; London SE, 2008, NAT NEUROSCI, V11, P579, DOI 10.1038/nn.2103; London SE, 2006, ENDOCRINOLOGY, V147, P5975, DOI 10.1210/en.2006-0154; London SE, 2003, J COMP NEUROL, V467, P496, DOI 10.1002/cne.10936; Maney DL, 2006, EUR J NEUROSCI, V23, P1523, DOI 10.1111/j.1460-9568.2006.04673.x; MARLER P, 1988, NATURE, V336, P770, DOI 10.1038/336770a0; Mathieu M, 2001, J COMP NEUROL, V438, P123, DOI 10.1002/cne.1304; Meitzen J, 2007, J NEUROSCI, V27, P12045, DOI 10.1523/JNEUROSCI.3289-07.2007; Mello CV, 2004, ANN NY ACAD SCI, V1016, P263, DOI 10.1196/annals.1298.021; Mukai H, 2006, NEUROENDOCRINOLOGY, V84, P255, DOI 10.1159/000097747; Murphy NP, 2001, J NEUROCHEM, V79, P626, DOI 10.1046/j.1471-4159.2001.00599.x; Oberlander JG, 2004, HORM BEHAV, V45, P250, DOI 10.1016/j.yhbeh.2003.12.003; Packard MG, 1998, HORM BEHAV, V34, P126, DOI 10.1006/hbeh.1998.1464; Peterson RS, 2001, J NEUROENDOCRINOL, V13, P317, DOI 10.1046/j.1365-2826.2001.00647.x; Peterson RS, 2005, P ROY SOC B-BIOL SCI, V272, P2089, DOI 10.1098/rspb.2005.3181; Pinaud R, 2006, J NEUROBIOL, V66, P182, DOI 10.1002/neu.20211; Reddy DS, 2004, NEUROSCIENCE, V129, P195, DOI 10.1016/j.neuroscience.2004.08.002; Remage-Healey L, 2007, J NEUROSCI, V27, P1114, DOI 10.1523/JNEUROSCI.4282-06.2007; Remage-Healey L, 2006, BRAIN RES, V1126, P27, DOI 10.1016/j.brainres.2006.06.049; Saalmann YB, 2006, J NEUROPHYSIOL, V96, P3064, DOI 10.1152/jn.00786.2006; Saldanha CJ, 2000, J COMP NEUROL, V423, P619, DOI 10.1002/1096-9861(20000807)423:4<619::AID-CNE7>3.0.CO;2-U; Sasaki A, 2006, J NEUROSCI, V26, P9010, DOI 10.1523/JNEUROSCI.1335-06.2006; SCHLINGER BA, 1991, P NATL ACAD SCI USA, V88, P4191, DOI 10.1073/pnas.88.10.4191; Schlinger Barney A., 2002, P799; Sisneros JA, 2004, SCIENCE, V305, P404, DOI 10.1126/science.1097218; Soma KK, 2004, ENDOCRINOLOGY, V145, P1668, DOI 10.1210/en.2003-0883; Stoffel-Wagner B, 2003, ANN NY ACAD SCI, V1007, P64, DOI 10.1196/annals.1286.007; Tsutsui K, 2006, J EXP ZOOL PART A, V305A, P733, DOI 10.1002/jez.a.302; Woolley CS, 2007, ANNU REV PHARMACOL, V47, P657, DOI 10.1146/annurev.pharmtox.47.120505.105219; Yague JG, 2006, NEUROSCIENCE, V138, P389, DOI 10.1016/j.neuroscience.2005.11.054	48	243	243	1	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2008	11	11					1327	1334		10.1038/nn.2200	http://dx.doi.org/10.1038/nn.2200			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	366HZ	18820691	Green Accepted			2022-12-17	WOS:000260472700022
J	Fu, WY; Chen, Y; Sahin, M; Zhao, XS; Shi, L; Bikoff, JB; Lai, KO; Yung, WH; Fu, AKY; Greenberg, ME; Ip, NY				Fu, Wing-Yu; Chen, Yu; Sahin, Mustafa; Zhao, Xiao-Su; Shi, Lei; Bikoff, Jay B.; Lai, Kwok-On; Yung, Wing-Ho; Fu, Amy K. Y.; Greenberg, Michael E.; Ip, Nancy Y.			Cdk5 regulates EphA4-mediated dendritic spine retraction through an ephexin1-dependent mechanism	NATURE NEUROSCIENCE			English	Article							NUCLEOTIDE EXCHANGE FACTOR; GROWTH CONE DYNAMICS; LONG-TERM DEPRESSION; EPH RECEPTORS; NEURAL DEVELOPMENT; AXON GUIDANCE; TYROSINE PHOSPHORYLATION; NEUROMUSCULAR-JUNCTION; HIPPOCAMPAL-NEURONS; NEURITE OUTGROWTH	The development of dendritic spines is thought to be crucial for synaptic plasticity. Dendritic spines are retracted upon Eph receptor A4 ( EphA4) activation, but the mechanisms that control this process are not well understood. Here we report an important function of cyclin-dependent kinase 5 (Cdk5) in EphA4-dependent spine retraction in mice. We found that blocking Cdk5 activity inhibits ephrin-A1- triggered spine retraction and reduction of mEPSC frequency at hippocampal synapses. The activation of EphA4 resulted in the recruitment of Cdk5 to EphA4, leading to the tyrosine phosphorylation and activation of Cdk5. EphA4 and Cdk5 then enhanced the activation of ephexin1, a guanine-nucleotide exchange factor that regulates activation of the small Rho GTPase RhoA. The association between EphA4 and ephexin1 was significantly reduced in Cdk5(-/-) brains and Cdk5-dependent phosphorylation of ephexin1 was required for the ephrin-A1- mediated regulation of spine density. These findings suggest that ephrin-A1 promotes EphA4-dependent spine retraction through the activation of Cdk5 and ephexin1, which in turn modulates actin cytoskeletal dynamics.	Hong Kong Univ Sci & Technol, Dept Biochem, Biotechnol Res Inst, Hong Kong, Hong Kong, Peoples R China; Hong Kong Univ Sci & Technol, Mol Neurosci Ctr, Hong Kong, Hong Kong, Peoples R China; Childrens Hosp, Neurobiol Program, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Chinese Univ Hong Kong, Dept Physiol, Shatin, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Chinese University of Hong Kong	Ip, NY (corresponding author), Hong Kong Univ Sci & Technol, Dept Biochem, Biotechnol Res Inst, Clear Water Bay, Hong Kong, Hong Kong, Peoples R China.	boip@ust.hk	Lai, Kwok-On/E-5182-2011; Lai, Kwok On/ABC-8046-2021; SAHIN, MUSTAFA/I-8653-2019; Lai, Kwok-On/L-7468-2019; Yung, Ho/R-6161-2018; Bikoff, Jay/N-8107-2018	SAHIN, MUSTAFA/0000-0001-7044-2953; Lai, Kwok-On/0000-0002-4069-054X; Yung, Ho/0000-0002-5542-8173; Ip, Nancy Yuk-Yu/0000-0002-2763-8907; Shi, Lei/0000-0001-8695-3432; Fu, Kit Yu/0000-0003-4085-6201	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K08HD001384] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045500] Funding Source: NIH RePORTER; NICHD NIH HHS [HD18655, K08 HD01384] Funding Source: Medline; NINDS NIH HHS [R01 NS045500, NS045500] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bryan B, 2004, J BIOL CHEM, V279, P45824, DOI 10.1074/jbc.M406216200; Chen JX, 2003, COMPUT SCI ENG, V5, P12, DOI 10.1109/MCISE.2003.1182957; Cheng Q, 2003, MOL CELL NEUROSCI, V24, P632, DOI 10.1016/S1044-7431(03)00220-3; Cheung ZH, 2006, NEURON, V50, P13, DOI 10.1016/j.neuron.2006.02.024; Ching YP, 2000, GENE, V242, P285, DOI 10.1016/S0378-1119(99)00499-0; Contractor A, 2002, SCIENCE, V296, P1864, DOI 10.1126/science.1069081; Cowan CW, 2005, NEURON, V46, P205, DOI 10.1016/j.neuron.2005.03.019; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Egea J, 2005, NEURON, V47, P515, DOI 10.1016/j.neuron.2005.06.029; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Ethell IM, 2005, PROG NEUROBIOL, V75, P161, DOI 10.1016/j.pneurobio.2005.02.003; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Fu AKY, 2005, P NATL ACAD SCI USA, V102, P15224, DOI 10.1073/pnas.0507678102; Fu AKY, 2001, NAT NEUROSCI, V4, P374, DOI 10.1038/86019; Fu WY, 2002, NEUROREPORT, V13, P243, DOI 10.1097/00001756-200202110-00014; Gerlai R, 1999, J NEUROSCI, V19, P9538; Gerlai R, 2001, NAT REV NEUROSCI, V2, P205, DOI 10.1038/35058582; Grunwald IC, 2004, NAT NEUROSCI, V7, P33, DOI 10.1038/nn1164; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Henderson JT, 2001, NEURON, V32, P1041, DOI 10.1016/S0896-6273(01)00553-0; Henkemeyer M, 2003, J CELL BIOL, V163, P1313, DOI 10.1083/jcb.200306033; IP NY, 1993, J NEUROSCI, V13, P3394; Irie F, 2002, NAT NEUROSCI, V5, P1117, DOI 10.1038/nn964; Kennedy MB, 2005, NAT REV NEUROSCI, V6, P423, DOI 10.1038/nrn1685; Knoll B, 2004, J NEUROSCI, V24, P6248, DOI 10.1523/JNEUROSCI.0985-04.2004; Lai KO, 2001, MOL CELL NEUROSCI, V17, P1034, DOI 10.1006/mcne.2001.0997; Morabito MA, 2004, J NEUROSCI, V24, P865, DOI 10.1523/JNEUROSCI.4582-03.2004; Muller D, 2000, HIPPOCAMPUS, V10, P596, DOI 10.1002/1098-1063(2000)10:5<596::AID-HIPO10>3.3.CO;2-P; Murai KK, 2005, NEURON, V46, P161, DOI 10.1016/j.neuron.2005.04.004; Murai KK, 2003, NAT NEUROSCI, V6, P153, DOI 10.1038/nn994; Nagerl UV, 2004, NEURON, V44, P759, DOI 10.1016/j.neuron.2004.11.016; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; O'Leary DDM, 1999, CURR OPIN NEUROBIOL, V9, P65, DOI 10.1016/S0959-4388(99)80008-7; Ohshima T, 2005, J NEUROCHEM, V94, P917, DOI 10.1111/j.1471-4159.2005.03233.x; Penzes P, 2003, NEURON, V37, P263, DOI 10.1016/S0896-6273(02)01168-6; Ryan XZP, 2005, NEURON, V47, P85, DOI 10.1016/j.neuron.2005.05.013; Sahin M, 2005, NEURON, V46, P191, DOI 10.1016/j.neuron.2005.01.030; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Sasaki Y, 2002, NEURON, V35, P907, DOI 10.1016/S0896-6273(02)00857-7; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Tolias KF, 2005, NEURON, V45, P525, DOI 10.1016/j.neuron.2005.01.024; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; Yamaguchi Y, 2004, CURR OPIN NEUROBIOL, V14, P288, DOI 10.1016/j.conb.2004.04.003; Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300; Zhang HY, 2005, J NEUROSCI, V25, P3379, DOI 10.1523/JNEUROSCI.3553-04.2005; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011; Zukerberg LR, 2000, NEURON, V26, P633, DOI 10.1016/S0896-6273(00)81200-3	50	243	262	1	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2007	10	1					67	76		10.1038/nn1811	http://dx.doi.org/10.1038/nn1811			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	120PC	17143272				2022-12-17	WOS:000243096100017
J	Galaburda, AM; LoTurco, J; Ramus, F; Fitch, RH; Rosen, GD				Galaburda, Albert M.; LoTurco, Joseph; Ramus, Franck; Fitch, R. Holly; Rosen, Glenn D.			From genes to behavior in developmental dyslexia	NATURE NEUROSCIENCE			English	Article							DOUBLECORTIN-LIKE-KINASE; NEURONAL MIGRATION; READING-DISABILITY; LANGUAGE IMPAIRMENT; INDUCED MICROGYRIA; SEX-DIFFERENCES; CANDIDATE GENE; AXON GUIDANCE; RATS; BRAIN	All four genes thus far linked to developmental dyslexia participate in brain development, and abnormalities in brain development are increasingly reported in dyslexia. Comparable abnormalities induced in young rodent brains cause auditory and cognitive deficits, underscoring the potential relevance of these brain changes to dyslexia. Our perspective on dyslexia is that some of the brain changes cause phonological processing abnormalities as well as auditory processing abnormalities; the latter, we speculate, resolve in a proportion of individuals during development, but contribute early on to the phonological disorder in dyslexia. Thus, we propose a tentative pathway between a genetic effect, developmental brain changes, and perceptual and cognitive deficits associated with dyslexia.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Neurol,Div Behav Neurol, Boston, MA 02215 USA; Univ Connecticut, Dept Physiol & Neurobiol, Storrs, CT 06269 USA; Ecole Normale Super, Lab Sci Cognit & Psycholinguist, F-75230 Paris 05, France; Univ Connecticut, Dept Psychol Behav Neurosci, Storrs, CT 06269 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Connecticut; University of Connecticut	Galaburda, AM (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Neurol,Div Behav Neurol, 330 Brookline Ave, Boston, MA 02215 USA.	agalabur@bidmc.harvard.edu	Fitch, Roslyn Holly/A-2562-2014; Ramus, Franck/A-1755-2009	Ramus, Franck/0000-0002-1122-5913; Rosen, Glenn/0000-0001-8281-5446	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD057853] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD020806] Funding Source: NIH RePORTER; NICHD NIH HHS [HD20806, P01 HD057853, P01 HD020806] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Allen KM, 1998, GENOMICS, V52, P214, DOI 10.1006/geno.1998.5424; Bishop DVM, 2004, PSYCHOL BULL, V130, P858, DOI 10.1037/0033-2909.130.6.858; Butterworth B., 2005, HDB MATH COGNITION, V1st, P455; CARDON LR, 1994, SCIENCE, V266, P276, DOI 10.1126/science.7939663; Chang BS, 2005, NEUROLOGY, V64, P799, DOI 10.1212/01.WNL.0000152874.57180.AF; Chapman NH, 2004, AM J MED GENET B, V131B, P67, DOI 10.1002/ajmg.b.30018; Clark MG, 2000, BRAIN RES, V871, P94, DOI 10.1016/S0006-8993(00)02447-1; Cope N, 2005, AM J HUM GENET, V76, P581, DOI 10.1086/429131; Coquelle FM, 2006, CELL CYCLE, V5, P976, DOI 10.4161/cc.5.9.2715; DENENBERG VH, 1991, BRAIN RES, V562, P98, DOI 10.1016/0006-8993(91)91192-4; des Portes V, 1998, HUM MOL GENET, V7, P1063, DOI 10.1093/hmg/7.7.1063; Deuel TAS, 2006, NEURON, V49, P41, DOI 10.1016/j.neuron.2005.10.038; DRAKE WE, 1968, J LEARN DISABIL-US, V1, P486, DOI 10.1177/002221946800100901; Eckert M, 2004, NEUROSCIENTIST, V10, P362, DOI 10.1177/1073858404263596; Erskine L, 2000, J NEUROSCI, V20, P4975; FISHER SE, IN PRESS TRENDS COGN; FITCH RH, 1994, CEREB CORTEX, V4, P260, DOI 10.1093/cercor/4.3.260; GALABURDA AM, 1985, ANN NEUROL, V18, P222, DOI 10.1002/ana.410180210; GALABURDA AM, 1994, P NATL ACAD SCI USA, V91, P8010, DOI 10.1073/pnas.91.17.8010; Hage SRD, 2006, ARQ NEURO-PSIQUIAT, V64, P173, DOI 10.1590/S0004-282X2006000200001; Hannula-Jouppi K, 2005, PLOS GENET, V1, P467, DOI 10.1371/journal.pgen.0010050; Hill EL, 2001, INT J LANG COMM DIS, V36, P149, DOI 10.1080/13682820010019874; Hinshelwood J., 1917, CONGENITAL WORD BLIN; Koizumi H, 2006, NEURON, V49, P55, DOI 10.1016/j.neuron.2005.10.040; Leonard CM, 2002, J COMMUN DISORD, V35, P501, DOI 10.1016/S0021-9924(02)00120-X; LoTurco JJ, 2006, EXTRAORDINARY BRAIN, P119; Marino C, 2005, EUR J HUM GENET, V13, P491, DOI 10.1038/sj.ejhg.5201356; Meng HY, 2005, P NATL ACAD SCI USA, V102, P17053, DOI 10.1073/pnas.0508591102; Nicolson RI, 2001, TRENDS NEUROSCI, V24, P508, DOI 10.1016/S0166-2236(00)01896-8; Paracchini S, 2006, HUM MOL GENET, V15, P1659, DOI 10.1093/hmg/ddl089; Peiffer AM, 2004, DEV BRAIN RES, V152, P93, DOI 10.1016/j.devbrainres.2004.06.003; PENNINGTON BF, 1991, JAMA-J AM MED ASSOC, V266, P1527, DOI 10.1001/jama.266.11.1527; Ramus F, 2003, CURR OPIN NEUROBIOL, V13, P212, DOI 10.1016/S0959-4388(03)00035-7; Rosen GD, 2000, J COMP NEUROL, V418, P423; ROSEN GD, 1995, BRAIN RES, V681, P177, DOI 10.1016/0006-8993(95)00312-E; Rosen GD, 1999, CEREB CORTEX, V9, P27, DOI 10.1093/cercor/9.1.27; Rutter M, 2004, JAMA-J AM MED ASSOC, V291, P2007, DOI 10.1001/jama.291.16.2007; SMITH SD, 1983, SCIENCE, V219, P1345, DOI 10.1126/science.6828864; Snowling M., 2000, DYSLEXIA; Stein J, 1997, TRENDS NEUROSCI, V20, P147, DOI 10.1016/S0166-2236(96)01005-3; Taipale M, 2003, P NATL ACAD SCI USA, V100, P11553, DOI 10.1073/pnas.1833911100; Valdois S, 2004, DYSLEXIA, V10, P339, DOI 10.1002/dys.284; WAGNER RK, 1987, PSYCHOL BULL, V101, P192, DOI 10.1037/0033-2909.101.2.192; WANG Y, 2003, ANN DYSLEXIA, V53, P1; White S, 2006, COGN NEUROPSYCHOL, V23, P748, DOI 10.1080/02643290500438607; Wigg KG, 2004, MOL PSYCHIATR, V9, P1111, DOI 10.1038/sj.mp.4001543; Yuan WL, 1999, DEV BIOL, V212, P290, DOI 10.1006/dbio.1999.9371; Zhu Y, 1999, NEURON, V23, P473, DOI 10.1016/S0896-6273(00)80801-6	48	243	248	6	56	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2006	9	10					1213	1217		10.1038/nn1772	http://dx.doi.org/10.1038/nn1772			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	098BB	17001339				2022-12-17	WOS:000241493900009
J	Dong, Y; Green, T; Saal, D; Marie, H; Neve, R; Nestler, EJ; Malenka, RC				Dong, Y; Green, T; Saal, D; Marie, H; Neve, R; Nestler, EJ; Malenka, RC			CREB modulates excitability of nucleus accumbens neurons	NATURE NEUROSCIENCE			English	Article							COCAINE; ADDICTION	Drugs of abuse cause activation of the cyclic AMP response element binding protein (CREB) in the nucleus accumbens (NAc). Expression of active CREB in rat NAc medium spiny neurons (MSNs) increased their excitability, whereas dominant-negative CREB had the opposite effect. Decreasing excitability of NAc MSNs in vivo by overexpression of potassium channels enhanced locomotor responses to cocaine, suggesting that the increased NAc MSN excitability caused by CREB helped to limit behavioral sensitivity to cocaine.	Stanford Univ, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, Palo Alto, CA 94304 USA; Univ Texas, SW Med Ctr, Dept Psychiat, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dallas, TX 75390 USA; Harvard Univ, Dept Genet, Cambridge, MA 02478 USA; Harvard Univ, McClean Hosp, Cambridge, MA 02478 USA	Stanford University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Harvard University; Harvard University	Malenka, RC (corresponding author), Stanford Univ, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, Palo Alto, CA 94304 USA.	malenka@stanford.edu	Dong, Yan/A-4154-2016; Marie, Hélène/F-1404-2011	Dong, Yan/0000-0003-0016-9028; Marie, Hélène/0000-0003-2310-6097				Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005; Hu XT, 2004, J NEUROPHYSIOL, V92, P1597, DOI 10.1152/jn.00217.2004; Johns DC, 1999, J NEUROSCI, V19, P1691; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; McClung CA, 2003, NAT NEUROSCI, V6, P1208, DOI 10.1038/nn1143; Nestler EJ, 2004, TRENDS PHARMACOL SCI, V25, P210, DOI 10.1016/j.tips.2004.02.005; Nicola SM, 2000, ANNU REV NEUROSCI, V23, P185, DOI 10.1146/annurev.neuro.23.1.185; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; Robinson TE, 2003, ANNU REV PSYCHOL, V54, P25, DOI 10.1146/annurev.psych.54.101601.145237; Vezina P, 2004, NEUROSCI BIOBEHAV R, V27, P827, DOI 10.1016/j.neubiorev.2003.11.001; Yu CR, 2004, NEURON, V42, P553, DOI 10.1016/S0896-6273(04)00224-7; Zhang XF, 2002, J PHARMACOL EXP THER, V301, P1119, DOI 10.1124/jpet.301.3.1119; Zhang XF, 1998, J NEUROSCI, V18, P488	13	243	247	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2006	9	4					475	477		10.1038/nn1661	http://dx.doi.org/10.1038/nn1661			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	026BC	16520736				2022-12-17	WOS:000236310700010
J	Purushothaman, G; Bradley, DC				Purushothaman, G; Bradley, DC			Neural population code for fine perceptual decisions in area MT	NATURE NEUROSCIENCE			English	Article							SPATIAL-FREQUENCY DISCRIMINATION; SUPERIOR TEMPORAL SULCUS; VISUAL AREA; FUNCTIONAL-ORGANIZATION; NEURONS; ORIENTATION; DIRECTION; MOTION; RESPONSES; MONKEY	In the middle temporal (MT) area of primates, many motion-sensitive neurons with a wide range of preferred directions respond to a stimulus moving in a single direction. These neurons are involved in direction perception, but it is not clear how perceptual decisions are related to the population response. We recorded the activities of MT neurons in rhesus monkeys while they discriminated closely related directions, and examined the relationship between the activities of neurons tuned to different directions and the monkeys' choices. Perceptual decisions were significantly correlated with the activities of the highest-precision neurons but not with those of the lowest-precision neurons. The combined performance of the high-precision neurons matched the monkeys' behavior, whereas the ability to predict behavior based on the entire active population was poor. These results suggest that fine discrimination decisions are crucially dependent on the activities of the most informative neurons.	Univ Chicago, Dept Psychol, Chicago, IL 60637 USA	University of Chicago	Bradley, DC (corresponding author), Univ Chicago, Dept Psychol, 5848 S Univ Ave,Green 320, Chicago, IL 60637 USA.	bradley@uchicago.edu			NATIONAL EYE INSTITUTE [R01EY013138] Funding Source: NIH RePORTER	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALBRIGHT TD, 1984, J NEUROPHYSIOL, V52, P1106, DOI 10.1152/jn.1984.52.6.1106; Albright TD, 2000, NEURON, V25, pS1, DOI 10.1016/S0896-6273(00)80912-5; ALLMAN JM, 1971, BRAIN RES, V31, P85, DOI 10.1016/0006-8993(71)90635-4; ASH R, 1965, INFORMATION THEORY; Barlow H B, 1972, Perception, V1, P371, DOI 10.1068/p010371; Barlow Horace, 1995, P415; BRADLEY A, 1987, J NEUROPHYSIOL, V57, P755, DOI 10.1152/jn.1987.57.3.755; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Cook EP, 2002, NAT NEUROSCI, V5, P985, DOI 10.1038/nn924; deCharms RC, 2000, ANNU REV NEUROSCI, V23, P613, DOI 10.1146/annurev.neuro.23.1.613; DEVALOIS RL, 1967, J NEUROPHYSIOL, V30, P415, DOI 10.1152/jn.1967.30.3.415; DUBNER R, 1971, BRAIN RES, V35, P528, DOI 10.1016/0006-8993(71)90494-X; Erickson R P, 2001, Prog Brain Res, V130, P9, DOI 10.1016/S0079-6123(01)30003-1; Gilbert CD, 2001, NEURON, V31, P681, DOI 10.1016/S0896-6273(01)00424-X; Green DM., 1966, SIGNAL DETECTION THE; Hol K, 2001, VISION RES, V41, P685, DOI 10.1016/S0042-6989(00)00314-X; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; Liu J, 2003, J NEUROPHYSIOL, V89, P246, DOI 10.1152/jn.00097.2002; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1127, DOI 10.1152/jn.1983.49.5.1127; Mazurek ME, 2003, CEREB CORTEX, V13, P1257, DOI 10.1093/cercor/bhg097; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; OHZAWA I, 1990, SCIENCE, V249, P1037, DOI 10.1126/science.2396096; Osborne LC, 2004, J NEUROSCI, V24, P3210, DOI 10.1523/JNEUROSCI.5305-03.2004; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; PELLI DG, 1985, J OPT SOC AM A, V2, P1508, DOI 10.1364/JOSAA.2.001508; Poggio T, 2000, SPATIAL VISION, V13, P287, DOI 10.1163/156856800741108; QUICK RF, 1974, KYBERNETIK, V16, P65, DOI 10.1007/BF00271628; REGAN D, 1983, J OPT SOC AM, V73, P1684, DOI 10.1364/JOSA.73.001684; REGAN D, 1985, J OPT SOC AM A, V2, P147, DOI 10.1364/JOSAA.2.000147; REZA FM, 1994, INTRO INFORMATION TH; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; SEKULER R, 2002, STEVENS HDB EXPT PSY, V1, P121; SEUNG HS, 1993, P NATL ACAD SCI USA, V90, P10749, DOI 10.1073/pnas.90.22.10749; Shadlen MN, 1996, J NEUROSCI, V16, P1486; SNOWDEN RJ, 1992, EXP BRAIN RES, V88, P389, DOI 10.1007/BF02259114; Treue S, 2000, NAT NEUROSCI, V3, P270, DOI 10.1038/72985; VOGELS R, 1990, J NEUROSCI, V10, P3543; WATAMANIUK SNJ, 1989, VISION RES, V29, P47, DOI 10.1016/0042-6989(89)90173-9; WATAMANIUK SNJ, 1992, VISION RES, V32, P2341, DOI 10.1016/0042-6989(92)90097-3; WILSON HR, 1984, J OPT SOC AM A, V1, P1091, DOI 10.1364/JOSAA.1.001091; Young T., 1802, PHILOS T R SOC LOND, V92, P12, DOI [10.1098/rstl.1802.0004, DOI 10.1098/RSTL.1802.0004]; ZEKI SM, 1974, J PHYSIOL-LONDON, V236, P549, DOI 10.1113/jphysiol.1974.sp010452; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	45	243	247	0	9	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2005	8	1					99	106		10.1038/nn1373	http://dx.doi.org/10.1038/nn1373			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882VO	15608633				2022-12-17	WOS:000225967600022
J	Galizia, CG; Sachse, S; Rappert, A; Menzel, R				Galizia, CG; Sachse, S; Rappert, A; Menzel, R			The glomerular code for odor representation is species specific in the honeybee Apis mellifera	NATURE NEUROSCIENCE			English	Article							RAT OLFACTORY-BULB; ANTENNAL LOBES; 2-DEOXYGLUCOSE METHOD; NEURONAL-ACTIVITY; BEE; BRAIN; DISCRIMINATION; COMBINATORIAL; STIMULATION; INFORMATION	Odors are coded by glomerular activity patterns in the insect antennal lobe (AL) and in the mammalian olfactory bulb. We measured glomerular responses to 30 different odors in the AL of honeybees using calcium-sensitive dyes. By subsequently staining glomeruli and identifying individual glomerular outlines, we were able to compare the patterns between animals. Regardless of whether the odors were mixtures or pure substances, environmental odors or pheromones, their representations were highly conserved among individuals. Therefore, it may be possible to create a functional atlas of the AL in which particular molecular receptive ranges are attributed to each glomerulus.	Free Univ Berlin, Inst Neurobiol, D-14195 Berlin, Germany	Free University of Berlin	Galizia, CG (corresponding author), Free Univ Berlin, Inst Neurobiol, Konigin Luise Str 28-30, D-14195 Berlin, Germany.	galizia@zedat.fu-berlin.de	Galizia, C Giovanni/A-1771-2009; Sachse, Silke/M-8484-2014	Galizia, C Giovanni/0000-0001-8292-6031; Sachse, Silke/0000-0002-9769-8067				Bhagavan S, 1997, PHYSIOL BEHAV, V61, P107, DOI 10.1016/S0031-9384(96)00357-5; Burrows M, 1996, NEUROBIOLOGY INSECT; CINELLI AR, 1995, J NEUROPHYSIOL, V73, P2053, DOI 10.1152/jn.1995.73.5.2053; Distler PG, 1998, BRAIN RES, V805, P263, DOI 10.1016/S0006-8993(98)00715-X; Faber T, 1999, NAT NEUROSCI, V2, P74, DOI 10.1038/4576; FLANAGAN D, 1989, INT J INSECT MORPHOL, V18, P145, DOI 10.1016/0020-7322(89)90023-8; Friedrich RW, 1998, J NEUROSCI, V18, P9977; Friedrich RW, 1997, NEURON, V18, P737, DOI 10.1016/S0896-6273(00)80314-1; Galizia CG, 1998, EUR J NEUROSCI, V10, P2964, DOI 10.1111/j.1460-9568.1998.00303.x; Galizia CG, 1999, CELL TISSUE RES, V295, P383, DOI 10.1007/s004410051245; Galizia CG, 1997, J NEUROSCI METH, V76, P61, DOI 10.1016/S0165-0270(97)00080-0; Hildebrand JG, 1996, J COMP PHYSIOL A, V178, P5, DOI 10.1007/BF00189586; Joerges J, 1997, NATURE, V387, P285, DOI 10.1038/387285a0; Johnson BA, 1996, J COMP NEUROL, V376, P557, DOI 10.1002/(SICI)1096-9861(19961223)376:4<557::AID-CNE5>3.0.CO;2-0; Johnson BA, 1998, J COMP NEUROL, V393, P457, DOI 10.1002/(SICI)1096-9861(19980420)393:4<457::AID-CNE5>3.0.CO;2-#; KRAMER E, 1976, PHYSIOL ENTOMOL, V1, P27, DOI 10.1111/j.1365-3032.1976.tb00883.x; Lu XCM, 1998, NEUROSCIENCE, V84, P849, DOI 10.1016/S0306-4522(97)00520-4; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; MORI K, 1992, J NEUROPHYSIOL, V67, P786, DOI 10.1152/jn.1992.67.3.786; RODRIGUES V, 1988, BRAIN RES, V453, P299, DOI 10.1016/0006-8993(88)90170-9; ROSPARS JP, 1988, INT J INSECT MORPHOL, V17, P243, DOI 10.1016/0020-7322(88)90041-4; SHEPHERD GM, 1994, NEURON, V13, P771, DOI 10.1016/0896-6273(94)90245-3; Sigg D, 1997, J NEUROSCI, V17, P7148; SLOTNICK BM, 1987, ANN NY ACAD SCI, V510, P630; STEWART WB, 1979, J COMP NEUROL, V185, P715, DOI 10.1002/cne.901850407; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; TEICHER MH, 1980, BRAIN RES, V194, P530, DOI 10.1016/0006-8993(80)91237-8; Winnington AP, 1996, J COMP NEUROL, V365, P479, DOI 10.1002/(SICI)1096-9861(19960212)365:3<479::AID-CNE10>3.0.CO;2-M; YOKOI M, 1995, P NATL ACAD SCI USA, V92, P3371, DOI 10.1073/pnas.92.8.3371	29	243	243	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	1999	2	5					473	478		10.1038/8144	http://dx.doi.org/10.1038/8144			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	271TK	10321253	Green Published			2022-12-17	WOS:000084609400019
J	Hahamy, A; Behrmann, M; Malach, R				Hahamy, Avital; Behrmann, Marlene; Malach, Rafael			The idiosyncratic brain: distortion of spontaneous connectivity patterns in autism spectrum disorder	NATURE NEUROSCIENCE			English	Article							FUNCTIONAL CONNECTIVITY; SYMPTOM SEVERITY; DEFAULT MODE; CORTEX; NETWORK; SYNCHRONIZATION; COMMUNICATION; ACTIVATION; CHILDREN; FACE	Autism spectrum disorder (ASD) has been associated with a reduction in resting state functional connectivity, though this assertion has recently been challenged by reports of increased connectivity in ASD. To address these contradictory findings, we examined both inter- and intrahemispheric functional connectivity in several resting state data sets acquired from adults with high-functioning ASD and matched control participants. Our results reveal areas of both increased and decreased connectivity in multiple ASD groups as compared to control groups. We propose that this heterogeneity stems from a previously unrecognized ASD characteristic: idiosyncratic distortions of the functional connectivity pattern relative to the typical, canonical template. The magnitude of an individual's pattern distortion in homotopic interhemispheric connectivity correlated significantly with behavioral symptoms of ASD. We propose that individualized alterations in functional connectivity organization are a core characteristic of high-functioning ASD, and that this may account for previous discrepant findings.	[Hahamy, Avital; Malach, Rafael] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Behrmann, Marlene] Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA	Weizmann Institute of Science; Carnegie Mellon University	Malach, R (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	rafi.malach@gmail.com		Behrmann, Marlene/0000-0002-3814-1015; Hahamy, Avital/0000-0001-5862-851X	Israeli Presidential Bursary for outstanding PhD students in brain research; Simons Foundation [298640]; Pennsylvania Department of Health SAP [4100047862]; European Union Future Emerging Technologies -7-Virtual Embodiment and Robotic Re-Embodiment; Israeli Science Foundation; Israeli Center of Research Excellence [51/11]; European Union Flagship The Human Brain Project; Helen and Martin Kimmel award	Israeli Presidential Bursary for outstanding PhD students in brain research; Simons Foundation; Pennsylvania Department of Health SAP; European Union Future Emerging Technologies -7-Virtual Embodiment and Robotic Re-Embodiment; Israeli Science Foundation(Israel Science Foundation); Israeli Center of Research Excellence; European Union Flagship The Human Brain Project; Helen and Martin Kimmel award	The authors would like to thank H. Dubossarsky and T. Golan for numerous discussions and suggestions that contributed greatly to this work, and Y. Cohen for assistance with illustrations. This study was supported by the Israeli Presidential Bursary for outstanding PhD students in brain research (A.H.); the Simons Foundation SFARI award 298640 and the Pennsylvania Department of Health SAP grant 4100047862 (M.B.); and a European Union Future Emerging Technologies -7-Virtual Embodiment and Robotic Re-Embodiment, Israeli Science Foundation, and Israeli Center of Research Excellence grant 51/11, European Union Flagship The Human Brain Project and the Helen and Martin Kimmel award (R.M.). Funding sources for the ABIDE data sets are listed at http://fcon_1000.projects. nitrc.org/indi/abide/index.html.	Anagnostou E, 2011, MOL AUTISM, V2, DOI 10.1186/2040-2392-2-4; Anderson JS, 2011, CEREB CORTEX, V21, P1134, DOI 10.1093/cercor/bhq190; [Anonymous], 2000, DSM 4 TR DIAGN STAT; Belmonte MK, 2010, J CHILD PSYCHOL PSYC, V51, P259, DOI 10.1111/j.1469-7610.2009.02153.x; Belmonte MK, 2004, J NEUROSCI, V24, P9228, DOI 10.1523/JNEUROSCI.3340-04.2004; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Carper RA, 2005, BIOL PSYCHIAT, V57, P126, DOI 10.1016/j.biopsych.2004.11.005; Di Martino A, 2014, MOL PSYCHIATR, V19, P659, DOI 10.1038/mp.2013.78; Dinstein I, 2012, NEURON, V75, P981, DOI 10.1016/j.neuron.2012.07.026; Dinstein I, 2011, NEURON, V70, P1218, DOI 10.1016/j.neuron.2011.04.018; Hahamy A, 2015, ELIFE, V4, DOI 10.7554/eLife.04605; Harmelech T, 2013, TRENDS COGN SCI, V17, P606, DOI 10.1016/j.tics.2013.09.014; Hasson U, 2009, AUTISM RES, V2, P220, DOI 10.1002/aur.89; He BYJ, 2008, P NATL ACAD SCI USA, V105, P16039, DOI 10.1073/pnas.0807010105; Just MA, 2004, BRAIN, V127, P1811, DOI 10.1093/brain/awh199; Keown CL, 2013, CELL REP, V5, P567, DOI 10.1016/j.celrep.2013.10.003; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Lynch CJ, 2013, BIOL PSYCHIAT, V74, P212, DOI 10.1016/j.biopsych.2012.12.013; Markram H, 2007, FRONT NEUROSCI-SWITZ, V1, P77, DOI 10.3389/neuro.01.1.1.006.2007; Muller RA, 2011, CEREB CORTEX, V21, P2233, DOI 10.1093/cercor/bhq296; Muller RA, 2003, AM J PSYCHIAT, V160, P1847, DOI 10.1176/appi.ajp.160.10.1847; Muller RA, 2001, BIOL PSYCHIAT, V49, P665, DOI 10.1016/S0006-3223(00)01004-0; Nir Y, 2008, NAT NEUROSCI, V11, P1100, DOI 10.1038/nn.2177; Pierce K, 2001, BRAIN, V124, P2059, DOI 10.1093/brain/124.10.2059; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Sadaghiani S, 2013, NEUROIMAGE, V80, P379, DOI 10.1016/j.neuroimage.2013.04.100; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Scherf KS, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00026; Schipul SE, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00010; Stark DE, 2008, J NEUROSCI, V28, P13754, DOI 10.1523/JNEUROSCI.4544-08.2008; Supekar K, 2013, CELL REP, V5, P738, DOI 10.1016/j.celrep.2013.10.001; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; Tyszka JM, 2014, CEREB CORTEX, V24, P1894, DOI 10.1093/cercor/bht040; Uddin LQ, 2013, JAMA PSYCHIAT, V70, P869, DOI 10.1001/jamapsychiatry.2013.104	36	242	246	10	88	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2015	18	2					302	309		10.1038/nn.3919	http://dx.doi.org/10.1038/nn.3919			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CA0UM	25599222				2022-12-17	WOS:000348631800021
J	Ousman, SS; Kubes, P				Ousman, Shalina S.; Kubes, Paul			Immune surveillance in the central nervous system	NATURE NEUROSCIENCE			English	Review							WEST-NILE-VIRUS; BLOOD-BRAIN-BARRIER; T-CELL TRAFFICKING; MHC CLASS-II; DENDRITIC CELLS; CEREBROSPINAL-FLUID; CHOROID-PLEXUS; MICROGLIAL CELLS; BONE-MARROW; PERIVASCULAR CELLS	The CNS, which consists of the brain and spinal cord, is continuously monitored by resident microglia and blood-borne immune cells such as macrophages, dendritic cells and T cells to detect for damaging agents that would disrupt homeostasis and optimal functioning of these vital organs. Further, the CNS must balance between vigilantly detecting for potentially harmful factors and resolving any immunological responses that in themselves can create damage if left unabated. We discuss the physiological roles of the immune sentinels that patrol the CNS, the molecular markers that underlie their surveillance duties, and the consequences of interrupting their functions following injury and infection by viruses such as JC virus, human immunodeficiency virus, herpes simplex virus and West Nile virus.	[Kubes, Paul] Univ Calgary, Dept Crit Care Med, Calgary, AB, Canada; [Kubes, Paul] Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB, Canada; [Kubes, Paul] Univ Calgary, Snyder Inst Chron Dis, Calgary, AB, Canada; [Ousman, Shalina S.] Univ Calgary, Dept Clin Neurol Sci, Calgary, AB, Canada; [Ousman, Shalina S.] Univ Calgary, Dept Cell Biol & Anat, Calgary, AB, Canada; [Ousman, Shalina S.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary	Kubes, P (corresponding author), Univ Calgary, Dept Crit Care Med, Calgary, AB, Canada.	sousman@ucalgary.ca; pkubes@ucalgary.ca			Canadian Institutes of Health Research; Alberta Innovates-Health Solutions; Canada Foundation for Innovation; Multiple Sclerosis Society of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates-Health Solutions; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Multiple Sclerosis Society of Canada	This work was supported by the Canadian Institutes of Health Research, Alberta Innovates-Health Solutions, Canada Foundation for Innovation and the Multiple Sclerosis Society of Canada.	AKIYAMA H, 1990, J NEUROIMMUNOL, V30, P81, DOI 10.1016/0165-5728(90)90055-R; AKIYAMA H, 1988, J NEUROSCI RES, V20, P147, DOI 10.1002/jnr.490200202; ALLIOT F, 1991, P NATL ACAD SCI USA, V88, P1541, DOI 10.1073/pnas.88.4.1541; Aloisi F, 1997, J IMMUNOL, V159, P1604; Arima Y, 2012, CELL, V148, P447, DOI 10.1016/j.cell.2012.01.022; Bechmann I, 2001, EXP NEUROL, V168, P242, DOI 10.1006/exnr.2000.7618; Campbell GL, 2002, LANCET INFECT DIS, V2, P519, DOI 10.1016/S1473-3099(02)00368-7; Carrithers MD, 2002, J NEUROIMMUNOL, V129, P51, DOI 10.1016/S0165-5728(02)00172-8; Carson KR, 2009, LANCET ONCOL, V10, P816, DOI 10.1016/S1470-2045(09)70161-5; Carvalho-Tavares J, 2000, CIRC RES, V87, P1141, DOI 10.1161/01.RES.87.12.1141; Celum Connie L, 2004, Herpes, V11 Suppl 1, p36A; Chen SK, 2010, CELL, V141, P775, DOI 10.1016/j.cell.2010.03.055; Cheng PY, 2009, INFECT IMMUN, V77, P4284, DOI 10.1128/IAI.00628-09; Conrady CD, 2010, J NEUROIMMUNOL, V220, P1, DOI 10.1016/j.jneuroim.2009.09.013; Damani MR, 2011, AGING CELL, V10, P263, DOI 10.1111/j.1474-9726.2010.00660.x; Davis LE, 2006, ANN NEUROL, V60, P286, DOI 10.1002/ana.20959; Elhofy A, 2009, J NEUROIMMUNOL, V213, P91, DOI 10.1016/j.jneuroim.2009.05.011; Fischer HG, 2000, J IMMUNOL, V164, P4826, DOI 10.4049/jimmunol.164.9.4826; Flugel A, 2000, BRAIN PATHOL, V10, P353; Ford AL, 1996, J EXP MED, V184, P1737, DOI 10.1084/jem.184.5.1737; Gasser O, 2007, PLOS MED, V4, P556, DOI 10.1371/journal.pmed.0040096; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Glass WG, 2005, J EXP MED, V202, P1087, DOI 10.1084/jem.20042530; GRAEBER MB, 1992, J NEUROPATH EXP NEUR, V51, P303, DOI 10.1097/00005072-199205000-00009; Grovit-Ferbas K, 2010, IMMUNOL RES, V48, P40, DOI 10.1007/s12026-010-8166-x; HARLINGBERG C, 1989, J NEUROIMMUNOL, V25, P185, DOI 10.1016/0165-5728(89)90136-7; Hatterer E, 2006, BLOOD, V107, P806, DOI 10.1182/blood-2005-01-0154; Hawkes CA, 2009, P NATL ACAD SCI USA, V106, P1261, DOI 10.1073/pnas.0805453106; HAYES GM, 1987, J NEUROL SCI, V80, P25, DOI 10.1016/0022-510X(87)90218-8; Henkel JS, 2004, ANN NEUROL, V55, P221, DOI 10.1002/ana.10805; Hickey WF, 1999, SEMIN IMMUNOL, V11, P125, DOI 10.1006/smim.1999.0168; Hickey WF, 2001, GLIA, V36, P118, DOI 10.1002/glia.1101; HICKEY WF, 1991, J NEUROSCI RES, V28, P254, DOI 10.1002/jnr.490280213; HICKEY WF, 1988, SCIENCE, V239, P290, DOI 10.1126/science.3276004; Hoek RM, 2000, SCIENCE, V290, P1768, DOI 10.1126/science.290.5497.1768; HOUFF SA, 1988, NEW ENGL J MED, V318, P301, DOI 10.1056/NEJM198802043180507; Inungu J, 2002, AIDS PATIENT CARE ST, V16, P107, DOI 10.1089/108729102317330445; Kaminski M, 2012, J LEUKOCYTE BIOL, V92, P31, DOI 10.1189/jlb.0511241; Kerschensteiner M, 1999, J EXP MED, V189, P865, DOI 10.1084/jem.189.5.865; Khanna KM, 2004, CURR OPIN IMMUNOL, V16, P463, DOI 10.1016/j.coi.2004.05.003; KIDA SY, 1993, ACTA NEUROPATHOL, V85, P646, DOI 10.1007/BF00334675; Kivisakk P, 2002, CLIN EXP IMMUNOL, V129, P510, DOI 10.1046/j.1365-2249.2002.01947.x; Kivisakk P, 2004, ANN NEUROL, V55, P627, DOI 10.1002/ana.20049; Kivisakk P, 2003, P NATL ACAD SCI USA, V100, P8389, DOI 10.1073/pnas.1433000100; Kleine TO, 2006, CYTOM PART A, V69A, P147, DOI 10.1002/cyto.a.20225; Knickelbein JE, 2008, SCIENCE, V322, P268, DOI 10.1126/science.1164164; KOVACS JA, 1985, ANN INTERN MED, V103, P533, DOI 10.7326/0003-4819-103-4-533; KULKARNI AB, 1991, IMMUNOL CELL BIOL, V69, P71, DOI 10.1038/icb.1991.12; Langmann T, 2007, J LEUKOCYTE BIOL, V81, P1345, DOI 10.1189/jlb.0207114; Laschinger M, 2002, EUR J IMMUNOL, V32, P3598, DOI 10.1002/1521-4141(200212)32:12<3598::AID-IMMU3598>3.0.CO;2-6; Li WW, 2005, J NEUROIMMUNOL, V158, P58, DOI 10.1016/j.jneuroim.2004.08.011; Loeffler C, 2011, NEUROPATHOLOGY, V31, P230, DOI 10.1111/j.1440-1789.2010.01167.x; Mack CL, 2003, J NEUROIMMUNOL, V144, P68, DOI 10.1016/j.jneuroim.2003.08.032; Malone KE, 2008, GLIA, V56, P426, DOI 10.1002/glia.20625; Matyszak MK, 1998, J NEUROIMMUNOL, V82, P73, DOI 10.1016/S0165-5728(97)00190-2; McCandless EE, 2008, P NATL ACAD SCI USA, V105, P11270, DOI 10.1073/pnas.0800898105; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; McGavern DB, 2011, NAT REV IMMUNOL, V11, P318, DOI 10.1038/nri2971; McMahon EJ, 2005, NAT MED, V11, P335, DOI 10.1038/nm1202; McMenamin PG, 1999, J COMP NEUROL, V405, P553, DOI 10.1002/(SICI)1096-9861(19990322)405:4<553::AID-CNE8>3.0.CO;2-6; Mildner A, 2011, J NEUROSCI, V31, P11159, DOI 10.1523/JNEUROSCI.6209-10.2011; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Neumann H, 1998, P NATL ACAD SCI USA, V95, P5779, DOI 10.1073/pnas.95.10.5779; Neumann H, 2001, GLIA, V36, P191, DOI 10.1002/glia.1108; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Pashenkov M, 2001, BRAIN, V124, P480, DOI 10.1093/brain/124.3.480; Poluektova LY, 2002, J IMMUNOL, V168, P3941, DOI 10.4049/jimmunol.168.8.3941; Ponzoni M, 2007, BRIT J HAEMATOL, V138, P316, DOI 10.1111/j.1365-2141.2007.06661.x; Popovich PG, 2008, NAT REV NEUROSCI, V9, P481, DOI 10.1038/nrn2398; Prinz M, 2011, NAT NEUROSCI, V14, P1227, DOI 10.1038/nn.2923; Raivich G, 2005, TRENDS NEUROSCI, V28, P571, DOI 10.1016/j.tins.2005.09.001; Ransohoff RM, 2005, NAT NEUROSCI, V8, P1275, DOI 10.1038/nn1005-1275; Ransohoff RM, 2003, NAT REV IMMUNOL, V3, P569, DOI 10.1038/nri1130; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Reichmann G, 2002, J NEUROIMMUNOL, V129, P125, DOI 10.1016/S0165-5728(02)00184-4; ROSENBLUM ML, 1988, ANN NEUROL, V23, pS13, DOI 10.1002/ana.410230707; Schleich A, 2004, ACTA NEUROPATHOL, V108, P366; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Schwartz Michal, 2003, J Spinal Cord Med, V26 Suppl 1, pS6; Shaked I, 2005, J NEUROCHEM, V92, P997, DOI 10.1111/j.1471-4159.2004.02954.x; Shrestha B, 2006, J VIROL, V80, P119, DOI 10.1128/JVI.80.1.119-129.2006; Shrikant P, 1996, J IMMUNOL, V157, P1819; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; Sitati EM, 2006, J VIROL, V80, P12060, DOI 10.1128/JVI.01650-06; Sparano JA, 1999, J ACQ IMMUN DEF SYND, V21, pS18; Svenningsson A, 1995, J NEUROIMMUNOL, V63, P39, DOI 10.1016/0165-5728(95)00126-3; Tanner J E, 2001, Transpl Infect Dis, V3, P60, DOI 10.1034/j.1399-3062.2001.003002060.x; Town T, 2008, NAT MED, V14, P681, DOI 10.1038/nm1781; Tran EH, 1998, J IMMUNOL, V161, P3767; Tremblay ME, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000527; UNGER ER, 1993, J NEUROPATH EXP NEUR, V52, P460, DOI 10.1097/00005072-199309000-00004; Villares R, 2009, EUR J IMMUNOL, V39, P1671, DOI 10.1002/eji.200839123; Vincent VAM, 1997, GLIA, V19, P190, DOI 10.1002/(SICI)1098-1136(199703)19:3<190::AID-GLIA2>3.0.CO;2-3; Wang T, 2003, J IMMUNOL, V171, P2524, DOI 10.4049/jimmunol.171.5.2524; Wei RT, 1999, J NEUROIMMUNOL, V95, P8, DOI 10.1016/S0165-5728(98)00248-3; WELCH K, 1984, JAMA-J AM MED ASSOC, V252, P1152, DOI 10.1001/jama.252.9.1152; Wojcik E, 2011, NEUROSCI LETT, V495, P115, DOI 10.1016/j.neulet.2011.03.051; Wyss-Coray T, 2001, NAT MED, V7, P612, DOI 10.1038/87945; Zhang B, 2008, J IMMUNOL, V180, P2641, DOI 10.4049/jimmunol.180.4.2641; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522	100	242	247	0	62	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2012	15	8					1096	1101		10.1038/nn.3161	http://dx.doi.org/10.1038/nn.3161			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	979UE	22837040	Green Published, Bronze			2022-12-17	WOS:000306844500011
J	Ma, DKK; Marchetto, MC; Guo, JJU; Ming, GL; Gage, FH; Song, HJ				Ma, Dengke K.; Marchetto, Maria Carolina; Guo, Junjie U.; Ming, Guo-li; Gage, Fred H.; Song, Hongjun			Epigenetic choreographers of neurogenesis in the adult mammalian brain	NATURE NEUROSCIENCE			English	Review							NEURAL STEM-CELLS; METHYL-CPG BINDING-PROTEIN-1; CENTRAL-NERVOUS-SYSTEM; SELF-RENEWAL; HIPPOCAMPAL NEUROGENESIS; DNA METHYLATION; PROGENITOR CELLS; GENE-EXPRESSION; L1 RETROTRANSPOSITION; STEM/PROGENITOR CELLS	Epigenetic mechanisms regulate cell differentiation during embryonic development and also serve as important interfaces between genes and the environment in adulthood. Neurogenesis in adults, which generates functional neural cell types from adult neural stem cells, is dynamically regulated by both intrinsic state-specific cell differentiation cues and extrinsic neural niche signals. Epigenetic regulation by DNA and histone modifiers, non-coding RNAs and other self-sustained mechanisms can lead to relatively long-lasting biological effects and maintain functional neurogenesis throughout life in discrete regions of the mammalian brain. Here, we review recent evidence that epigenetic mechanisms carry out diverse roles in regulating specific aspects of adult neurogenesis and highlight the implications of such epigenetic regulation for neural plasticity and disorders.	[Guo, Junjie U.; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ Sch Med, Inst Cell Engn, Baltimore, MD USA; [Marchetto, Maria Carolina; Gage, Fred H.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; [Ma, Dengke K.] MIT, Dept Biol, Cambridge, MA USA; [Guo, Junjie U.; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ Sch Med, Solomon Snyder Dept Neurosci, Baltimore, MD USA; [Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ Sch Med, Dept Neurol, Baltimore, MD USA	Johns Hopkins University; Salk Institute; Massachusetts Institute of Technology (MIT); Johns Hopkins University; Johns Hopkins University	Song, HJ (corresponding author), Johns Hopkins Univ Sch Med, Inst Cell Engn, Baltimore, MD USA.	shongju1@jhmi.edu	Ming, Guo-li/J-7880-2013	Ming, Guo-li/0000-0002-2517-6075	National Institutes of Health [NS048271, HD069184, MH088485, MH090258, AG024984, NS047344, MH087874]; Brain Science Institute at Johns Hopkins; National Alliance for Research on Schizophrenia and Depression; Mathers Foundation; Lookout Fund; J.S.McDonnell Foundation; Helen Hay Whitney Foundation; Foundation for Advanced Research in the Medical Sciences; Dr. Richard and Mavis Fowler; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069184] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH088485, R01MH090258, R21MH087874, R33MH087874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048271, R01NS047344] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024984] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brain Science Institute at Johns Hopkins; National Alliance for Research on Schizophrenia and Depression(NARSAD); Mathers Foundation; Lookout Fund; J.S.McDonnell Foundation; Helen Hay Whitney Foundation; Foundation for Advanced Research in the Medical Sciences; Dr. Richard and Mavis Fowler; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank M. L. Gage and K. Christian for comments on the manuscript and J. Simon for illustrations. This work was supported by the National Institutes of Health grants NS048271 and HD069184 (G.-l. M.), MH088485 and MH090258 (F. H. G.), and AG024984, NS047344 and MH087874 (H. S.), the Brain Science Institute at Johns Hopkins and National Alliance for Research on Schizophrenia and Depression (G.-l. M.), the Mathers Foundation, the Lookout Fund and the J.S.McDonnell Foundation (F. H. G.), a Helen Hay Whitney Foundation postdoctoral fellowship (D. K. M.), and the Dr. Richard and Mavis Fowler and the Foundation for Advanced Research in the Medical Sciences Fellowship (J.U.G.).	Allan AM, 2008, HUM MOL GENET, V17, P2047, DOI 10.1093/hmg/ddn102; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Banasr Mounira, 2007, CNS & Neurological Disorders-Drug Targets, V6, P311, DOI 10.2174/187152707783220929; Bath KG, 2008, J NEUROSCI, V28, P2383, DOI 10.1523/JNEUROSCI.4387-07.2008; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Caballero IM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004315; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chen ZY, 2006, SCIENCE, V314, P140, DOI 10.1126/science.1129663; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Christian K, 2010, CELL CYCLE, V9, P636, DOI 10.4161/cc.9.4.10932; Coufal NG, 2009, NATURE, V460, P1127, DOI 10.1038/nature08248; Covic M, 2010, HEREDITY, V105, P122, DOI 10.1038/hdy.2010.27; Crepaldi L, 2009, EPIGENETICS-US, V4, P23, DOI 10.4161/epi.4.1.7604; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Dirks P, 2007, CANCER CELL, V12, P295, DOI 10.1016/j.ccr.2007.10.003; Duan X, 2008, CURR OPIN NEUROBIOL, V18, P108, DOI 10.1016/j.conb.2008.04.001; Encinas JM, 2008, METHOD CELL BIOL, V85, P243, DOI 10.1016/S0091-679X(08)85011-X; Episkopou V, 2005, TRENDS NEUROSCI, V28, P219, DOI 10.1016/j.tins.2005.03.003; Fasano CA, 2007, CELL STEM CELL, V1, P87, DOI 10.1016/j.stem.2007.04.001; Fasano CA, 2009, GENE DEV, V23, P561, DOI 10.1101/gad.1743709; Feng J, 2010, NAT NEUROSCI, V13, P423, DOI 10.1038/nn.2514; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Goren A, 2010, NAT METHODS, V7, P47, DOI [10.1038/NMETH.1404, 10.1038/nmeth.1404]; He DY, 2010, J BIOL CHEM, V285, P19043, DOI 10.1074/jbc.M110.100693; He S, 2009, DEV BIOL, V328, P257, DOI 10.1016/j.ydbio.2009.01.020; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Hobert O, 2008, SCIENCE, V319, P1785, DOI 10.1126/science.1151651; Holliday R, 1993, EXS, V64, P452; HOLLIDAY R, 1990, BIOL REV, V65, P431, DOI 10.1111/j.1469-185X.1990.tb01233.x; Holliday R, 2006, EPIGENETICS-US, V1, P76, DOI 10.4161/epi.1.2.2762; Hsieh J, 2004, P NATL ACAD SCI USA, V101, P16659, DOI 10.1073/pnas.0407643101; Hsieh J, 2010, NEUROBIOL DIS, V39, P73, DOI 10.1016/j.nbd.2010.01.008; Hu QK, 2010, STEM CELLS, V28, P279, DOI 10.1002/stem.246; Iorio MV, 2010, BBA-GENE REGUL MECH, V1799, P694, DOI 10.1016/j.bbagrm.2010.05.005; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jawerka M, 2010, NEURON GLIA BIOL, V6, P93, DOI 10.1017/S1740925X10000049; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jepsen K, 2007, NATURE, V450, P415, DOI 10.1038/nature06270; Jin SG, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq223; Juliandi B, 2010, CURR OPIN NEUROBIOL, V20, P408, DOI 10.1016/j.conb.2010.04.001; Kanki H, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-5; Kempermann G, 2004, CURR OPIN NEUROBIOL, V14, P186, DOI 10.1016/j.conb.2004.03.001; Kitabatake Y, 2007, NEUROSURG CLIN N AM, V18, P105, DOI 10.1016/j.nec.2006.10.008; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Kuwabara T, 2004, CELL, V116, P779, DOI 10.1016/S0092-8674(04)00248-X; Kuwabara T, 2009, NAT NEUROSCI, V12, P1097, DOI 10.1038/nn.2360; KUZUMAKI N, 2010, HIPPOCAMPUS     0315, DOI DOI 10.1002/HIPO.20775; Li XK, 2008, J BIOL CHEM, V283, P27644, DOI 10.1074/jbc.M804899200; Li Y, 2008, NEURON, V59, P399, DOI 10.1016/j.neuron.2008.06.023; Lim DA, 2009, NATURE, V458, P529, DOI 10.1038/nature07726; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Liu CM, 2010, CELL STEM CELL, V6, P433, DOI 10.1016/j.stem.2010.02.017; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Ma DKK, 2009, ANN NY ACAD SCI, V1170, P664, DOI 10.1111/j.1749-6632.2009.04373.x; Ma DK, 2009, CELL RES, V19, P672, DOI 10.1038/cr.2009.56; Ma DKK, 2009, CELL CYCLE, V8, P1526, DOI 10.4161/cc.8.10.8500; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Ma DK, 2005, CURR OPIN NEUROBIOL, V15, P514, DOI 10.1016/j.conb.2005.08.003; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Morris KV, 2009, RNA BIOL, V6, P242, DOI 10.4161/rna.6.3.8353; Mu YL, 2010, CURR OPIN NEUROBIOL, V20, P416, DOI 10.1016/j.conb.2010.04.010; Muotri AR, 2006, NATURE, V441, P1087, DOI 10.1038/nature04959; Muotri AR, 2009, HIPPOCAMPUS, V19, P1002, DOI 10.1002/hipo.20564; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Nagarajan RP, 2009, SEMIN CANCER BIOL, V19, P188, DOI 10.1016/j.semcancer.2009.02.005; Nelson ED, 2008, J NEUROSCI, V28, P395, DOI 10.1523/JNEUROSCI.3796-07.2008; Ng RK, 2008, CELL CYCLE, V7, P1173, DOI 10.4161/cc.7.9.5791; O'Neill LP, 2006, NAT GENET, V38, P835, DOI 10.1038/ng1820; Pastrana E, 2009, P NATL ACAD SCI USA, V106, P6387, DOI 10.1073/pnas.0810407106; Ptashne M, 2007, CURR BIOL, V17, pR233, DOI 10.1016/j.cub.2007.02.030; Qiu Z, 2008, NEURON, V60, P775, DOI 10.1016/j.neuron.2008.09.040; Ringrose L, 2007, DEVELOPMENT, V134, P223, DOI 10.1242/dev.02723; Roh TY, 2004, NAT BIOTECHNOL, V22, P1013, DOI 10.1038/nbt990; Roth TL, 2011, HORM BEHAV, V59, P315, DOI 10.1016/j.yhbeh.2010.05.005; Sahay A, 2007, NAT NEUROSCI, V10, P1110, DOI 10.1038/nn1969; Serio TR, 2000, TRENDS CELL BIOL, V10, P98, DOI 10.1016/S0962-8924(99)01711-0; Smrt RD, 2007, NEUROBIOL DIS, V27, P77, DOI 10.1016/j.nbd.2007.04.005; Smrt RD, 2010, STEM CELLS, V28, P1060, DOI 10.1002/stem.431; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Sun GQ, 2007, P NATL ACAD SCI USA, V104, P15282, DOI 10.1073/pnas.0704089104; Szulwach KE, 2010, J CELL BIOL, V189, P127, DOI 10.1083/jcb.200908151; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Waddington C. R., 1966, PRINCIPLES DEV DIFFE; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Yoo AS, 2009, NATURE, V460, P642, DOI 10.1038/nature08139; Zhang TY, 2010, ANNU REV PSYCHOL, V61, P439, DOI 10.1146/annurev.psych.60.110707.163625; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhao XY, 2003, P NATL ACAD SCI USA, V100, P6777, DOI 10.1073/pnas.1131928100; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037; Zocchi L, 2010, CURR OPIN NEUROBIOL, V20, P432, DOI 10.1016/j.conb.2010.04.005	100	242	250	0	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2010	13	11					1338	1344		10.1038/nn.2672	http://dx.doi.org/10.1038/nn.2672			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	673KI	20975758	Green Accepted			2022-12-17	WOS:000283658200011
J	Clapper, JR; Moreno-Sanz, G; Russo, R; Guijarro, A; Vacondio, F; Duranti, A; Tontini, A; Sanchini, S; Sciolino, NR; Spradley, JM; Hohmann, AG; Calignano, A; Mor, M; Tarzia, G; Piomelli, D				Clapper, Jason R.; Moreno-Sanz, Guillermo; Russo, Roberto; Guijarro, Ana; Vacondio, Federica; Duranti, Andrea; Tontini, Andrea; Sanchini, Silvano; Sciolino, Natale R.; Spradley, Jessica M.; Hohmann, Andrea G.; Calignano, Antonio; Mor, Marco; Tarzia, Giorgio; Piomelli, Daniele			Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism	NATURE NEUROSCIENCE			English	Article							ACID AMIDE HYDROLASE; CANNABINOID RECEPTORS; CB2 RECEPTORS; RAT MODEL; ANALGESIA; SYSTEM; FAAH; LOCALIZATION; ACTIVATION; INHIBITORS	Peripheral cannabinoid receptors exert a powerful inhibitory control over pain initiation, but the endocannabinoid signal that normally engages this intrinsic analgesic mechanism is unknown. To address this question, we developed a peripherally restricted inhibitor (URB937) of fatty acid amide hydrolase (FAAH), the enzyme responsible for the degradation of the endocannabinoid anandamide. URB937 suppressed FAAH activity and increased anandamide levels outside the rodent CNS. Despite its inability to access brain and spinal cord, URB937 attenuated behavioral responses indicative of persistent pain in rodent models of peripheral nerve injury and inflammation and prevented noxious stimulus-evoked neuronal activation in spinal cord regions implicated in nociceptive processing. CB1 cannabinoid receptor blockade prevented these effects. These results suggest that anandamide-mediated signaling at peripheral CB1 receptors controls the access of pain-related inputs to the CNS. Brain-impenetrant FAAH inhibitors, which strengthen this gating mechanism, might offer a new approach to pain therapy.	[Clapper, Jason R.; Moreno-Sanz, Guillermo; Guijarro, Ana; Piomelli, Daniele] Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92717 USA; [Moreno-Sanz, Guillermo] Univ Complutense, Dept Biochem & Mol Biol 3, E-28040 Madrid, Spain; [Russo, Roberto; Calignano, Antonio] Univ Naples Federico II, Dept Expt Pharmacol, Naples, Italy; [Vacondio, Federica; Mor, Marco] Univ Parma, Dept Pharmaceut, I-43100 Parma, Italy; [Duranti, Andrea; Tontini, Andrea; Sanchini, Silvano; Tarzia, Giorgio] Univ Urbino Carlo Bo, Dept Hlth & Drug Sci, Urbino, Italy; [Sciolino, Natale R.; Hohmann, Andrea G.] Univ Georgia, Dept Psychol, Neurosci & Behav Program, Athens, GA 30602 USA; [Spradley, Jessica M.; Hohmann, Andrea G.] Univ Georgia, Program Neurosci, Biomed Hlth Sci Inst, Athens, GA 30602 USA; [Piomelli, Daniele] Italian Inst Technol, Genoa, Italy	University of California System; University of California Irvine; Complutense University of Madrid; University of Naples Federico II; University of Parma; University of Urbino; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Istituto Italiano di Tecnologia - IIT	Piomelli, D (corresponding author), Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92717 USA.	daniele.piomelli@iit.it	russo, roberto/A-3193-2012; Vacondio, Federica/C-1295-2009; Calignano, Antonio/K-2542-2018; Mor, Marco/D-2394-2009	russo, roberto/0000-0001-5950-1617; Mor, Marco/0000-0003-0199-1849; Sciolino, Natale/0000-0003-2794-1989; CALIGNANO, Antonio/0000-0002-1742-3179; Vacondio, Federica/0000-0002-0729-4385; GUIJARRO ANTON, Ana Isabel/0000-0002-1595-2173	National Institutes on Drug Abuse; University of Parma; Italian Ministry for Public Education, University and Research; Fulbright Commission; University of California; Agilent Foundation; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012413] Funding Source: NIH RePORTER	National Institutes on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); University of Parma; Italian Ministry for Public Education, University and Research; Fulbright Commission; University of California(University of California System); Agilent Foundation; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank E. Dotsey for help with experiments. This research was supported by grants from the National Institutes on Drug Abuse (D.P. and A.G.H.), the University of Parma (M.M.) and the Italian Ministry for Public Education, University and Research (G.T., A.D and A.T.). G.M.-S. was partially supported by the Fulbright Commission and the Exchange Abroad Program, University of California. The support of the Agilent Foundation is gratefully acknowledged.	Agarwal N, 2007, NAT NEUROSCI, V10, P870, DOI 10.1038/nn1916; Ahluwalia J, 2003, J NEUROCHEM, V84, P585, DOI 10.1046/j.1471-4159.2003.01550.x; Alexander JP, 2005, CHEM BIOL, V12, P1179, DOI 10.1016/j.chembiol.2005.08.011; Anand P, 2009, BRAIN RES REV, V60, P255, DOI 10.1016/j.brainresrev.2008.12.003; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Calignano A, 1998, NATURE, V394, P277, DOI 10.1038/28393; Clapper JR, 2009, CHEMMEDCHEM, V4, P1505, DOI 10.1002/cmdc.200900210; CODERRE TJ, 1992, J NEUROSCI, V12, P3665; Cravatt BF, 2001, P NATL ACAD SCI USA, V98, P9371, DOI 10.1073/pnas.161191698; Cravatt BF, 2004, P NATL ACAD SCI USA, V101, P10821, DOI 10.1073/pnas.0401292101; Dziadulewicz EK, 2007, J MED CHEM, V50, P3851, DOI 10.1021/jm070317a; Guindon J, 2008, BRIT J PHARMACOL, V153, P319, DOI 10.1038/sj.bjp.0707531; Hohmann AG, 1999, NEUROSCIENCE, V92, P1171, DOI 10.1016/S0306-4522(99)00220-1; Hohmann AG, 1999, NEUROSCIENCE, V90, P923, DOI 10.1016/S0306-4522(98)00524-7; Imai Y, 2003, MOL PHARMACOL, V64, P610, DOI 10.1124/mol.64.3.610; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; Kaufmann I, 2009, EUR SURG RES, V43, P325, DOI 10.1159/000235870; Kunos G, 2009, TRENDS PHARMACOL SCI, V30, P1, DOI 10.1016/j.tips.2008.10.001; Lever IJ, 2009, J NEUROSCI, V29, P3766, DOI 10.1523/JNEUROSCI.4071-08.2009; Liu J, 2006, P NATL ACAD SCI USA, V103, P13345, DOI 10.1073/pnas.0601832103; Loscher Wolfgang, 2005, NeuroRx, V2, P86, DOI 10.1007/BF03206645; LoVerme J, 2005, LIFE SCI, V77, P1685, DOI 10.1016/j.lfs.2005.05.012; LoVerme J, 2006, J PHARMACOL EXP THER, V319, P1051, DOI 10.1124/jpet.106.111385; Mitrirattanakul S, 2006, PAIN, V126, P102, DOI 10.1016/j.pain.2006.06.016; Nackley AG, 2003, NEUROSCIENCE, V117, P659, DOI 10.1016/S0306-4522(02)00870-9; Piomelli D, 2006, CNS DRUG REV, V12, P21, DOI 10.1111/j.1527-3458.2006.00021.x; Puig S, 1996, PAIN, V64, P345, DOI 10.1016/0304-3959(95)00121-2; Richardson D, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2401; Richardson JD, 1998, PAIN, V75, P111, DOI 10.1016/S0304-3959(97)00213-3; Russo R, 2007, J PHARMACOL EXP THER, V322, P236, DOI 10.1124/jpet.107.119941; Russo R, 2007, EUR J PHARMACOL, V566, P117, DOI 10.1016/j.ejphar.2007.03.007; Sagar DR, 2008, BRIT J PHARMACOL, V155, P1297, DOI 10.1038/bjp.2008.335; Schlosburg JE, 2009, AAPS J, V11, P39, DOI 10.1208/s12248-008-9075-y; Starowicz K, 2007, PHARMACOL THERAPEUT, V114, P13, DOI 10.1016/j.pharmthera.2007.01.005; Stein C, 2003, NAT MED, V9, P1003, DOI 10.1038/nm908; Stein Christoph, 2009, Handb Exp Pharmacol, P495, DOI 10.1007/978-3-540-79090-7_14; Tegeder I, 2003, BRAIN, V126, P1092, DOI 10.1093/brain/awg115	37	242	248	2	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2010	13	10					1265	1270		10.1038/nn.2632	http://dx.doi.org/10.1038/nn.2632			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	654MB	20852626	Green Accepted, Green Submitted			2022-12-17	WOS:000282171300019
J	Rothschild, G; Nelken, I; Mizrahi, A				Rothschild, Gideon; Nelken, Israel; Mizrahi, Adi			Functional organization and population dynamics in the mouse primary auditory cortex	NATURE NEUROSCIENCE			English	Article							IN-VIVO; VISUAL-CORTEX; TONOTOPIC ORGANIZATION; SINGLE NEURONS; FREQUENCY; RAT; REPRESENTATION; RECORDINGS; RESPONSES; MICROARCHITECTURE	Cortical processing of auditory stimuli involves large populations of neurons with distinct individual response profiles. However, the functional organization and dynamics of local populations in the auditory cortex have remained largely unknown. Using in vivo two-photon calcium imaging, we examined the response profiles and network dynamics of layer 2/3 neurons in the primary auditory cortex (A1) of mice in response to pure tones. We found that local populations in A1 were highly heterogeneous in the large-scale tonotopic organization. Despite the spatial heterogeneity, the tendency of neurons to respond together ( measured as noise correlation) was high on average. This functional organization and high levels of noise correlations are consistent with the existence of partially overlapping cortical subnetworks. Our findings may account for apparent discrepancies between ordered large-scale organization and local heterogeneity.	[Rothschild, Gideon; Nelken, Israel; Mizrahi, Adi] Hebrew Univ Jerusalem, Inst Life Sci, Dept Neurobiol, IL-91904 Jerusalem, Israel; [Rothschild, Gideon; Nelken, Israel; Mizrahi, Adi] Hebrew Univ Jerusalem, Interdisciplinary Ctr Neural Computat, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Mizrahi, A (corresponding author), Hebrew Univ Jerusalem, Inst Life Sci, Dept Neurobiol, IL-91904 Jerusalem, Israel.	mizrahia@cc.huji.ac.il	Nelken, Israel/B-7753-2011	Nelken, Israel/0000-0002-6645-107X	Citizens United for Research in Epilepsy; European Research Council [203994]; European Union	Citizens United for Research in Epilepsy; European Research Council(European Research Council (ERC)European Commission); European Union(European Commission)	We thank H. Sompolinsky and E. Zohary for critically commenting on early versions of this manuscript. We thank N. Taaseh and A. Yaron-Jakoubovitch for their kind technical assistance during the early stages of this project. We thank Y. Rubin and J. Schiller for the software module of the line scan. We thank J. Linden for her help on cortical recordings in mice. We thank all the members of the Mizrahi laboratory and A. Eban-Rothschild for their helpful comments and discussions. This work was supported in part by a grant from Citizens United for Research in Epilepsy and by a European Research Council grant to A. M. (#203994), and by a grant of the European Union FP6 to I. N. (NOVELTUNE consortium).	ABELES M, 1970, J NEUROPHYSIOL, V33, P172, DOI 10.1152/jn.1970.33.1.172; Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; Bizley JK, 2005, CEREB CORTEX, V15, P1637, DOI 10.1093/cercor/bhi042; Chakraborty S, 2007, EXP BRAIN RES, V182, P491, DOI 10.1007/s00221-007-1008-y; Chechik G, 2006, NEURON, V51, P359, DOI 10.1016/j.neuron.2006.06.030; Cohen MR, 2008, NEURON, V60, P162, DOI 10.1016/j.neuron.2008.08.007; DeWeese MR, 2003, J NEUROSCI, V23, P7940; EVANS EF, 1965, J PHYSIOL-LONDON, V179, P238, DOI 10.1113/jphysiol.1965.sp007659; GOLDSTEIN MH, 1970, J NEUROPHYSIOL, V33, P188, DOI 10.1152/jn.1970.33.1.188; Greenberg DS, 2008, NAT NEUROSCI, V11, P749, DOI 10.1038/nn.2140; Henze DA, 2000, J NEUROPHYSIOL, V84, P390, DOI 10.1152/jn.2000.84.1.390; Holmgren C, 2003, J PHYSIOL-LONDON, V551, P139, DOI 10.1113/jphysiol.2003.044784; Houweling AR, 2008, NATURE, V451, P65, DOI 10.1038/nature06447; Hromadka T, 2008, PLOS BIOL, V6, P124, DOI 10.1371/journal.pbio.0060016; Kerr JND, 2005, P NATL ACAD SCI USA, V102, P14063, DOI 10.1073/pnas.0506029102; Kilgard MP, 1999, HEARING RES, V134, P16, DOI 10.1016/S0378-5955(99)00061-1; Kisley MA, 1999, J NEUROSCI, V19, P10451; Komai S, 2006, NAT PROTOC, V1, P648, DOI 10.1038/nprot.2006.100; Linden JF, 2003, J NEUROPHYSIOL, V90, P2660, DOI 10.1152/jn.00751.2002; Llano DA, 2008, J COMP NEUROL, V507, P1209, DOI 10.1002/cne.21602; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; MERZENICH MM, 1975, J NEUROPHYSIOL, V38, P231, DOI 10.1152/jn.1975.38.2.231; Moshitch D, 2006, J NEUROPHYSIOL, V95, P3756, DOI 10.1152/jn.00822.2005; Mrsic-Flogel TD, 2006, EUR J NEUROSCI, V23, P780, DOI 10.1111/j.1460-9568.2006.04609.x; Mrsic-Flogel TD, 2007, NEURON, V54, P961, DOI 10.1016/j.neuron.2007.05.028; Nelken I, 2004, J NEUROPHYSIOL, V92, P2574, DOI 10.1152/jn.00276.2004; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Ohki K, 2006, NATURE, V442, P925, DOI 10.1038/nature05019; Philibert B, 2005, J COMP NEUROL, V487, P391, DOI 10.1002/cne.20581; REALE RA, 1980, J COMP NEUROL, V192, P265, DOI 10.1002/cne.901920207; Recanzone GH, 2000, J NEUROPHYSIOL, V83, P2315, DOI 10.1152/jn.2000.83.4.2315; Sadagopan S, 2008, J NEUROSCI, V28, P3415, DOI 10.1523/JNEUROSCI.2743-07.2008; Sadagopan S, 2009, J NEUROSCI, V29, P11192, DOI 10.1523/JNEUROSCI.1286-09.2009; SALLY SL, 1988, J NEUROPHYSIOL, V59, P1627, DOI 10.1152/jn.1988.59.5.1627; Sato TR, 2007, PLOS BIOL, V5, P1440, DOI 10.1371/journal.pbio.0050189; Schneidman E, 2006, NATURE, V440, P1007, DOI 10.1038/nature04701; SCHREINER CE, 1992, J NEUROPHYSIOL, V68, P1487, DOI 10.1152/jn.1992.68.5.1487; Schulze H, 1997, J COMP PHYSIOL A, V181, P651, DOI 10.1007/s003590050147; Sohya K, 2007, J NEUROSCI, V27, P2145, DOI 10.1523/JNEUROSCI.4641-06.2007; Sompolinsky H, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.051904; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Stiebler I, 1997, J COMP PHYSIOL A, V181, P559, DOI 10.1007/s003590050140; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Thomson AM, 2002, CEREB CORTEX, V12, P936, DOI 10.1093/cercor/12.9.936; Wallace DJ, 2008, NAT METHODS, V5, P797, DOI 10.1038/NMETH.1242; Wang XQ, 2005, NATURE, V435, P341, DOI 10.1038/nature03565; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0; ZURITA P, 1994, NEUROSCI RES, V19, P303, DOI 10.1016/0168-0102(94)90043-4	49	242	246	2	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2010	13	3					353	U21		10.1038/nn.2484	http://dx.doi.org/10.1038/nn.2484			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	559WW	20118927				2022-12-17	WOS:000274860100018
J	Maccarrone, M; Rossi, S; Bari, M; De Chiara, V; Fezza, F; Musella, A; Gasperi, V; Prosperetti, C; Bernardi, G; Finazzi-Agro, A; Cravatt, BF; Centonze, D				Maccarrone, Mauro; Rossi, Silvia; Bari, Monica; De Chiara, Valentina; Fezza, Filomena; Musella, Alessandra; Gasperi, Valeria; Prosperetti, Chiara; Bernardi, Giorgio; Finazzi-Agro, Alessandro; Cravatt, Benjamin F.; Centonze, Diego			Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; ENDOGENOUS CANNABINOIDS; METABOTROPIC GLUTAMATE; PHOSPHOLIPASE-D; ENDOCANNABINOID RELEASE; RECEPTOR; ACTIVATION; STIMULATION; MODULATION; 2-ARACHIDONOYL-GLYCEROL	Of the endocannabinoids (eCBs), anandamide (AEA) and 2-arachidonoylglycerol (2-AG) have received the most study. A functional interaction between these molecules has never been described. Using mouse brain slices, we found that stimulation of metabotropic glutamate 5 receptors by 3,5-dihydroxyphenylglycine (DHPG) depressed inhibitory transmission in the striatum through selective involvement of 2-AG metabolism and stimulation of presynaptic CB1 receptors. Elevation of AEA concentrations by pharmacological or genetic inhibition of AEA degradation reduced the levels, metabolism and physiological effects of 2-AG. Exogenous AEA and the stable AEA analog methanandamide inhibited basal and DHPG-stimulated 2-AG production, confirming that AEA is responsible for the downregulation of the other eCB. AEA is an endovanilloid substance, and the stimulation of transient receptor potential vanilloid 1 (TRPV1) channels mimicked the effects of endogenous AEA on 2-AG metabolism through a previously unknown glutathione-dependent pathway. Consistently, the interaction between AEA and 2-AG was lost after pharmacological and genetic inactivation of TRPV1 channels.	[Maccarrone, Mauro; Gasperi, Valeria] Univ Teramo, Dipartimento Sci Biomed, I-64100 Teramo, Italy; [Maccarrone, Mauro; Rossi, Silvia; De Chiara, Valentina; Fezza, Filomena; Musella, Alessandra; Prosperetti, Chiara; Bernardi, Giorgio; Centonze, Diego] CERC, Fdn Santa Lucia, I-00143 Rome, Italy; [Rossi, Silvia; De Chiara, Valentina; Musella, Alessandra; Prosperetti, Chiara; Bernardi, Giorgio; Cravatt, Benjamin F.; Centonze, Diego] Univ Roma Tor Vergata, Dipartimento Neurosci, Neurol Clin, I-00133 Rome, Italy; [Bari, Monica; Fezza, Filomena; Finazzi-Agro, Alessandro] Univ Roma Tor Vergata, Dipartimento Med Sperimentale & Sci Biochim, I-00133 Rome, Italy; [Cravatt, Benjamin F.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Cravatt, Benjamin F.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	University of Teramo; IRCCS Santa Lucia; University of Rome Tor Vergata; University of Rome Tor Vergata; Scripps Research Institute; Scripps Research Institute	Maccarrone, M (corresponding author), Univ Teramo, Dipartimento Sci Biomed, Piazza Aldo Moro 45, I-64100 Teramo, Italy.	mmaccarrone@unite.it; centonze@uniroma2.it	gasperi, valeria/AGO-4500-2022; Gasperi, Valeria/AAN-9210-2021; musella, alessandra/K-6372-2016; Maccarrone, Mauro/K-5398-2012; Centonze, Diego/J-7767-2016	gasperi, valeria/0000-0003-3200-8093; musella, alessandra/0000-0001-7889-9253; Maccarrone, Mauro/0000-0002-3990-2963; Centonze, Diego/0000-0002-8390-8545; Rossi, Silvia/0000-0003-3257-8248; Prosperetti, Chiara/0000-0001-8069-2163				Bari M, 2006, MINI-REV MED CHEM, V6, P257, DOI 10.2174/138955706776073466; Barinaga M, 2001, SCIENCE, V291, P2530, DOI 10.1126/science.291.5513.2530; Bisogno T, 2003, J CELL BIOL, V163, P463, DOI 10.1083/jcb.200305129; Bisogno T, 2006, BBA-MOL CELL BIOL L, V1761, P205, DOI 10.1016/j.bbalip.2005.12.009; Bisogno T, 1999, BIOCHEM BIOPH RES CO, V256, P377, DOI 10.1006/bbrc.1999.0254; Cartoni A, 2004, TETRAHEDRON LETT, V45, P2723, DOI 10.1016/j.tetlet.2004.02.045; Centonze D, 2005, BIOL PSYCHIAT, V57, P1583, DOI 10.1016/j.biopsych.2005.03.008; Chevaleyre V, 2006, ANNU REV NEUROSCI, V29, P37, DOI 10.1146/annurev.neuro.29.051605.112834; Cravatt BF, 2001, P NATL ACAD SCI USA, V98, P9371, DOI 10.1073/pnas.161191698; Cristino L, 2006, NEUROSCIENCE, V139, P1405, DOI 10.1016/j.neuroscience.2006.02.074; de Lago E, 2005, BIOCHEM PHARMACOL, V70, P446, DOI 10.1016/j.bcp.2005.05.011; Di Marzo V, 2000, FASEB J, V14, P1432, DOI 10.1096/fj.14.10.1432; Dinh TP, 2002, P NATL ACAD SCI USA, V99, P10819, DOI 10.1073/pnas.152334899; Evans RM, 2004, BRIT J PHARMACOL, V141, P1223, DOI 10.1038/sj.bjp.0705723; Fezza F, 2005, ANAL BIOCHEM, V339, P113, DOI 10.1016/j.ab.2004.12.005; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; Gerdeman GL, 2002, NAT NEUROSCI, V5, P446, DOI 10.1038/nn832; Glaser ST, 2005, LIFE SCI, V77, P1584, DOI 10.1016/j.lfs.2005.05.007; Gubellini P, 2002, J NEUROSCI, V22, P6900; Guo Y, 2005, J BIOL CHEM, V280, P23429, DOI 10.1074/jbc.C500168200; Hermann A, 2006, AAPS J, V8, pE409, DOI 10.1007/BF02854913; Jhaveri MD, 2006, J NEUROSCI, V26, P13318, DOI 10.1523/JNEUROSCI.3326-06.2006; Jung KM, 2005, MOL PHARMACOL, V68, P1196, DOI 10.1124/mol.105.013961; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; Kim J, 2004, NAT NEUROSCI, V7, P697, DOI 10.1038/nn1262; Kreitzer AC, 2001, NEURON, V29, P717, DOI 10.1016/S0896-6273(01)00246-X; Kreitzer AC, 2005, J NEUROSCI, V25, P10537, DOI 10.1523/JNEUROSCI.2959-05.2005; Kushmerick C, 2004, J NEUROSCI, V24, P5955, DOI 10.1523/JNEUROSCI.0768-04.2004; Maejima T, 2001, NEURON, V31, P463, DOI 10.1016/S0896-6273(01)00375-0; Maione S, 2006, J PHARMACOL EXP THER, V316, P969, DOI 10.1124/jpet.105.093286; Makara JK, 2005, NAT NEUROSCI, V8, P1139, DOI 10.1038/nn1521; McKinney MK, 2005, ANNU REV BIOCHEM, V74, P411, DOI 10.1146/annurev.biochem.74.082803.133450; Melis M, 2004, J NEUROSCI, V24, P10707, DOI 10.1523/JNEUROSCI.3502-04.2004; Melis M, 2006, NEUROBIOL DIS, V24, P15, DOI 10.1016/j.nbd.2006.04.010; Ohno-Shosaku T, 2002, EUR J NEUROSCI, V15, P953, DOI 10.1046/j.1460-9568.2002.01929.x; Okamoto Y, 2004, J BIOL CHEM, V279, P5298, DOI 10.1074/jbc.M306642200; PELLMAR TC, 1992, BRAIN RES, V583, P194, DOI 10.1016/S0006-8993(10)80024-1; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Pisani A, 2001, NEUROPHARMACOLOGY, V40, P460, DOI 10.1016/S0028-3908(00)00184-2; Rouach N, 2003, EUR J NEUROSCI, V18, P1017, DOI 10.1046/j.1460-9568.2003.02823.x; Sagara Y, 1998, J NEUROSCI, V18, P6662; Sarnataro D, 2005, FEBS LETT, V579, P6343, DOI 10.1016/j.febslet.2005.10.016; Soler-Llavina GJ, 2006, NAT NEUROSCI, V9, P798, DOI 10.1038/nn1698; Starowicz K, 2007, PHARMACOL THERAPEUT, V114, P13, DOI 10.1016/j.pharmthera.2007.01.005; SUGIURA T, 2002, FATTY ACIDS, V66, P173; Szabo B, 2006, J PHYSIOL-LONDON, V577, P263, DOI 10.1113/jphysiol.2006.119362; Uchigashima M, 2007, J NEUROSCI, V27, P3663, DOI 10.1523/JNEUROSCI.0448-07.2007; Valenti M, 2004, CELL MOL LIFE SCI, V61, P945, DOI 10.1007/s00018-003-3453-5; Wang Y, 2001, ANAL BIOCHEM, V294, P73, DOI 10.1006/abio.2001.5015; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076	50	242	244	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2008	11	2					152	159		10.1038/nn2042	http://dx.doi.org/10.1038/nn2042			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	256FC	18204441				2022-12-17	WOS:000252712100009
J	Murray, SO; Wojciulik, E				Murray, SO; Wojciulik, E			Attention increases neural selectivity in the human lateral occipital complex	NATURE NEUROSCIENCE			English	Article							EVENT-RELATED FMRI; INFERIOR TEMPORAL CORTEX; SURFACE-BASED ANALYSIS; MACAQUE VISUAL-CORTEX; EXTRASTRIATE CORTEX; SPATIAL-RESOLUTION; OBJECT RECOGNITION; AREA V4; SHAPE; PERFORMANCE	It is well established that attention increases the efficiency of information processing, but the neural mechanisms underlying this improvement are not fully understood. Evidence indicates that neural firing rates increase for attended stimuli, but another possibility is that attention could increase the selectivity of the neural population representing an attended stimulus. We tested this latter hypothesis by using functional magnetic resonance imaging (fMRI) to measure population selectivity for object views under different attention conditions in the human lateral occipital complex (LOC). Our data not only show increased neural activity (or 'gain') with attention, consistent with existing models, but also increased population selectivity that cannot be accounted for by gain mechanisms alone. Our results suggest that attention increases the specificity of the neural population representing an attended object.	Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; Univ Calif Davis, Dept Psychol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Murray, SO (corresponding author), Univ Minnesota, Dept Psychol, 75 E River Rd, Minneapolis, MN 55455 USA.	somurray@umn.edu						Boynton GM, 2003, J NEUROSCI, V23, P8781; Buckner RL, 1998, NEURON, V20, P285, DOI 10.1016/S0896-6273(00)80456-0; BULTHOFF HH, 1992, P NATL ACAD SCI USA, V89, P60, DOI 10.1073/pnas.89.1.60; Buracas GT, 2002, NEUROIMAGE, V16, P801, DOI 10.1006/nimg.2002.1116; CORBETTA M, 1990, SCIENCE, V248, P1556, DOI 10.1126/science.2360050; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Grill-Spector K, 2001, ACTA PSYCHOL, V107, P293, DOI 10.1016/S0001-6918(01)00019-1; Grill-Spector K, 1998, NEURON, V21, P191, DOI 10.1016/S0896-6273(00)80526-7; HAENNY PE, 1988, EXP BRAIN RES, V69, P225, DOI 10.1007/BF00247569; Hillyard SA, 1998, PHILOS T ROY SOC B, V353, P1257, DOI 10.1098/rstb.1998.0281; James TW, 2002, NEURON, V35, P793, DOI 10.1016/S0896-6273(02)00803-6; Kanwisher N, 1997, J COGNITIVE NEUROSCI, V9, P133, DOI 10.1162/jocn.1997.9.1.133; Kourtzi Z, 2000, J NEUROSCI, V20, P3310, DOI 10.1523/JNEUROSCI.20-09-03310.2000; Kourtzi Z, 2001, SCIENCE, V293, P1506, DOI 10.1126/science.1061133; LOGOTHETIS NK, 1995, CEREB CORTEX, V5, P270, DOI 10.1093/cercor/5.3.270; LOGOTHETIS NK, 1995, CURR BIOL, V5, P552, DOI 10.1016/S0960-9822(95)00108-4; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Maunsell JHR, 2002, PHILOS T ROY SOC B, V357, P1063, DOI 10.1098/rstb.2002.1107; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; MILLER EK, 1991, SCIENCE, V254, P1377, DOI 10.1126/science.1962197; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; OCraven KM, 1997, NEURON, V18, P591, DOI 10.1016/S0896-6273(00)80300-1; Pasupathy A, 2002, NAT NEUROSCI, V5, P1332, DOI 10.1038/nn972; Rensink RA, 1997, PSYCHOL SCI, V8, P368, DOI 10.1111/j.1467-9280.1997.tb00427.x; Reynolds JH, 2000, NEURON, V26, P703, DOI 10.1016/S0896-6273(00)81206-4; Simons DJ, 2000, TRENDS COGN SCI, V4, P147, DOI 10.1016/S1364-6613(00)01455-8; SPITZER H, 1988, SCIENCE, V240, P338, DOI 10.1126/science.3353728; Tarr MJ, 1998, NAT NEUROSCI, V1, P275, DOI 10.1038/1089; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Treue S, 1999, J NEUROSCI, V19, P7591, DOI 10.1523/JNEUROSCI.19-17-07591.1999; Vuilleumier P, 2002, NAT NEUROSCI, V5, P491, DOI 10.1038/nn839; Wojciulik E, 1998, J NEUROPHYSIOL, V79, P1574, DOI 10.1152/jn.1998.79.3.1574; Yeshurun Y, 1999, VISION RES, V39, P293, DOI 10.1016/S0042-6989(98)00114-X; Yeshurun Y, 1998, NATURE, V396, P72, DOI 10.1038/23936	37	242	246	1	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2004	7	1					70	74		10.1038/nn1161	http://dx.doi.org/10.1038/nn1161			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	758LN	14647291				2022-12-17	WOS:000187636000015
J	Hack, I; Bancila, M; Loulier, K; Carroll, P; Cremer, H				Hack, I; Bancila, M; Loulier, K; Carroll, P; Cremer, H			Reelin is a detachment signal in tangential chain-migration during postnatal neurogenesis	NATURE NEUROSCIENCE			English	Article							MESSENGER-RNA EXPRESSION; CAJAL-RETZIUS CELLS; RADIAL GLIAL-CELLS; NEURONAL MIGRATION; OLFACTORY-BULB; SUBVENTRICULAR ZONE; NERVOUS-SYSTEM; VLDL RECEPTOR; ADULT-MOUSE; FOREBRAIN	During development, Reelin acts on migrating neuronal precursors and controls correct cell positioning in the cortex and other brain structures by a hitherto unidentified mechanism. Here we show that in the postnatal mouse brain, Reelin acts as a detachment signal for chain-migrating interneuron precursors in the olfactory bulb. Neuronal precursors cultured in Matrigel detached from chains and migrated individually in the presence of exogenously added Reelin protein or Reelin-expressing brain tissues. Furthermore, we found that in reeler mutant mice, neuronal precursors accumulated in the olfactory bulb and remained in clusters, indicating that they did not change from tangential chain-migration to radial individual migration. Our data provide direct evidence that Reelin acts as a detachment signal, but not a stop or guidance cue. We propose that Reelin may have comparable functions during development.	Univ Mediterranee, INSERM, CNRS, NMDA,IBDM, F-13288 Marseille 9, France; CNRS, UPR 9040, F-91198 Gif Sur Yvette, France; Univ Montpellier 2, INSERM, U432, F-34095 Montpellier 05, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Cremer, H (corresponding author), Univ Mediterranee, INSERM, CNRS, NMDA,IBDM, Campus Luminy, F-13288 Marseille 9, France.		Loulier, Karine/E-5529-2017; Carroll, Patrick/AAL-7773-2021	Loulier, Karine/0000-0001-6216-2708; Cremer, Harold/0000-0002-8673-5176				Alcantara S, 1998, J NEUROSCI, V18, P7779; Alvarez-Buylla A, 1998, J NEUROBIOL, V36, P105, DOI 10.1002/(SICI)1097-4695(199808)36:2<105::AID-NEU1>3.0.CO;2-5; Braids OC, 2001, ENVIRON FORENSICS, V2, P189, DOI 10.1006/enfo.2000.0040; Carroll P, 2001, MOL CELL NEUROSCI, V17, P611, DOI 10.1006/mcne.2001.0966; Chazal G, 2000, J NEUROSCI, V20, P1446; Conover JC, 2000, NAT NEUROSCI, V3, P1091, DOI 10.1038/80606; COROTTO FS, 1994, NEUROSCIENCE, V61, P739, DOI 10.1016/0306-4522(94)90397-2; Cremer H, 1998, P NATL ACAD SCI USA, V95, P13242, DOI 10.1073/pnas.95.22.13242; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; DArcangelo G, 1997, J NEUROSCI, V17, P23, DOI 10.1523/JNEUROSCI.17-01-00023.1997; deBergeyck V, 1997, MOL BRAIN RES, V50, P85, DOI 10.1016/S0169-328X(97)00166-6; Derer P, 2001, J COMP NEUROL, V440, P136, DOI 10.1002/cne.1375; Dulabon L, 2000, NEURON, V27, P33, DOI 10.1016/S0896-6273(00)00007-6; Frotscher M, 1998, CURR OPIN NEUROBIOL, V8, P570, DOI 10.1016/S0959-4388(98)80082-2; GALILEO DS, 1992, NEURON, V9, P1117, DOI 10.1016/0896-6273(92)90070-T; Gilmore EC, 2000, CURR BIOL, V10, pR162, DOI 10.1016/S0960-9822(00)00332-8; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2; Hong SE, 2000, NAT GENET, V26, P93, DOI 10.1038/79246; Hu HY, 2000, J NEUROSCI RES, V61, P480, DOI 10.1002/1097-4547(20000901)61:5<480::AID-JNR2>3.0.CO;2-M; Hu HY, 1999, NEURON, V23, P703, DOI 10.1016/S0896-6273(01)80029-5; JACOBOWITZ DM, 1991, J COMP NEUROL, V304, P198, DOI 10.1002/cne.903040205; Jacques TS, 1998, DEVELOPMENT, V125, P3167; Kim HM, 2002, P NATL ACAD SCI USA, V99, P4020, DOI 10.1073/pnas.062698299; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Magdaleno S, 2002, NEURON, V33, P573, DOI 10.1016/S0896-6273(02)00582-2; Malatesta P, 2000, DEVELOPMENT, V127, P5253; Miyata T, 1997, J NEUROSCI, V17, P3599; Murase S, 2002, J NEUROSCI, V22, P3568; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; OGAWA M, 1995, NEURON, V14, P899, DOI 10.1016/0896-6273(95)90329-1; ORourke NA, 1996, NEURON, V16, P1061, DOI 10.1016/S0896-6273(00)80130-0; Quattrocchi CC, 2002, J BIOL CHEM, V277, P303, DOI 10.1074/jbc.M106996200; Rice DS, 2001, ANNU REV NEUROSCI, V24, P1005, DOI 10.1146/annurev.neuro.24.1.1005; Rochefort C, 2002, J NEUROSCI, V22, P2679, DOI 10.1523/JNEUROSCI.22-07-02679.2002; Schiffmann SN, 1997, EUR J NEUROSCI, V9, P1055, DOI 10.1111/j.1460-9568.1997.tb01456.x; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Wichterle H, 1997, NEURON, V18, P779, DOI 10.1016/S0896-6273(00)80317-7; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; WYSS JM, 1980, BRAIN RES, V188, P566, DOI 10.1016/0006-8993(80)90056-6	42	242	260	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2002	5	10					939	945		10.1038/nn923	http://dx.doi.org/10.1038/nn923			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	597VV	12244323				2022-12-17	WOS:000178242200012
J	Inoue, K; Ozaki, S; Shiga, T; Ito, K; Masuda, T; Okado, N; Iseda, T; Kawaguchi, S; Ogawa, M; Bae, SC; Yamashita, N; Itohara, S; Kudo, N; Ito, Y				Inoue, K; Ozaki, S; Shiga, T; Ito, K; Masuda, T; Okado, N; Iseda, T; Kawaguchi, S; Ogawa, M; Bae, SC; Yamashita, N; Itohara, S; Kudo, N; Ito, Y			Runx3 controls the axonal projection of proprioceptive dorsal root ganglion neurons	NATURE NEUROSCIENCE			English	Article							SPINAL-CORD; NERVOUS-SYSTEM; SENSORY AFFERENTS; CELL-DEATH; GROUP-IA; EXPRESSION; GROWTH; RAT; RECEPTORS; MUSCLES	Dorsal root ganglion (DRG) neurons specifically project axons to central and peripheral targets according to their sensory modality. The Runt-related genes Runx1 and Runx3 are expressed in DRG neuronal subpopulations, suggesting that they may regulate the trajectories of specific axons. Here we report that Runx3-deficient (Runx3(-/-)) mice displayed severe motor discoordination and that few DRG neurons synthesized the proprioceptive neuronal marker parvalbumin. Proprioceptive afferent axons failed to project to their targets in the spinal cord as well as those in the muscle. NT-3-responsive Runx3(-/-) DRG neurons showed less neurite outgrowth in vitro. However, we found no changes in the fate specification of Runx3(-/-) DRG neurons or in the number of DRG neurons that expressed trkC. Our data demonstrate that Runx3 is critical in regulating the axonal projections of a specific subpopulation of DRG neurons.	Kyoto Univ, Inst Virus Res, Dept Viral Oncol, Lab Cell Regulat,Sakyo Ku, Kyoto 6068507, Japan; Univ Tsukuba, Inst Basic Med Sci, Dept Physiol, Tsukuba, Ibaraki 3058575, Japan; Univ Tsukuba, Inst Basic Med Sci, Dept Anat, Tsukuba, Ibaraki 3058575, Japan; Kyoto Univ, Grad Sch Med, Dept Integrat Brain Sci, Kyoto 6068501, Japan; RIKEN, Brain Sci Inst, Lab Cell Culture Dev, Wako, Saitama 3510198, Japan; Chungbuk Natl Univ, Inst Med Res, Coll Med, Dept Biochem, Cheongju 361763, South Korea; RIKEN, Brain Sci Inst, Lab Behav Genet, Wako, Saitama 3510198, Japan; Inst Mol & Cell Biol, Singapore 117609, Singapore	Kyoto University; University of Tsukuba; University of Tsukuba; Kyoto University; RIKEN; Chungbuk National University; RIKEN; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Ito, Y (corresponding author), Kyoto Univ, Inst Virus Res, Dept Viral Oncol, Lab Cell Regulat,Sakyo Ku, Kyoto 6068507, Japan.		Itohara, Shigeyoshi/I-8769-2012	Itohara, Shigeyoshi/0000-0002-2410-9989				AKINTUNDE A, 1992, BRAIN RES, V575, P86, DOI 10.1016/0006-8993(92)90427-B; Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; Brown AG, 1981, ORG SPINAL CORD; BRUHN S, 1998, CELLS LAB MANUAL, V3; CELIO MR, 1990, NEUROSCIENCE, V35, P375, DOI 10.1016/0306-4522(90)90091-H; Chen ZF, 2001, NEURON, V31, P59, DOI 10.1016/S0896-6273(01)00341-5; COPRAY JCVM, 1994, DEV BRAIN RES, V81, P57, DOI 10.1016/0165-3806(94)90068-X; Fyffe RE, 1992, SENSORY NEURONS DIVE, P131; GERGEN JP, 1986, CELL, V45, P289, DOI 10.1016/0092-8674(86)90393-4; HONGO T, 1987, J COMP NEUROL, V262, P159, DOI 10.1002/cne.902620202; Huang EJ, 1999, DEVELOPMENT, V126, P2191; Kalev-Zylinska ML, 2002, DEVELOPMENT, V129, P2015; Kaminker JS, 2002, NAT NEUROSCI, V5, P746, DOI 10.1038/nn889; Krieglstein K, 2000, NAT NEUROSCI, V3, P1085, DOI 10.1038/80598; Kuhn TB, 2000, J NEUROBIOL, V44, P126, DOI 10.1002/1097-4695(200008)44:2<126::AID-NEU4>3.0.CO;2-Z; Levanon D, 2001, MECH DEVELOP, V109, P413, DOI 10.1016/S0925-4773(01)00537-8; Levanon D, 2002, EMBO J, V21, P3454, DOI 10.1093/emboj/cdf370; Li QL, 2002, CELL, V109, P113, DOI 10.1016/S0092-8674(02)00690-6; Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5; MARTINOU JC, 1994, NEURON, V13, P1017, DOI 10.1016/0896-6273(94)90266-6; Masuda T, 2000, DEV BIOL, V224, P112, DOI 10.1006/dbio.2000.9813; Matsumoto I, 2001, MOL BRAIN RES, V93, P105, DOI 10.1016/S0169-328X(01)00129-2; Nakayama K, 1998, J COMP NEUROL, V398, P459; OLEARY DDM, 1988, NEURON, V1, P901, DOI 10.1016/0896-6273(88)90147-X; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.neuro.14.1.453; Ozaki S, 1997, J COMP NEUROL, V380, P215; Perrin FE, 2001, NEURON, V30, P707, DOI 10.1016/S0896-6273(01)00315-4; Price SR, 2002, CELL, V109, P205, DOI 10.1016/S0092-8674(02)00695-5; Senti KA, 2000, DEVELOPMENT, V127, P2291; Sharma K, 1998, DEVELOPMENT, V125, P635; SIMEONE A, 1995, DEV DYNAM, V203, P61, DOI 10.1002/aja.1002030107; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; Suter DM, 2000, J NEUROBIOL, V44, P97, DOI 10.1002/1097-4695(200008)44:2<97::AID-NEU2>3.3.CO;2-L; White FA, 1998, J NEUROSCI, V18, P1428; Zelena J, 1994, NERVES MECHANORECEPT; [No title captured]	36	242	248	1	11	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2002	5	10					946	954		10.1038/nn925	http://dx.doi.org/10.1038/nn925			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	597VV	12352981	Green Submitted			2022-12-17	WOS:000178242200013
J	Ahmadi, S; Lippross, S; Neuhuber, WL; Zeilhofer, HU				Ahmadi, S; Lippross, S; Neuhuber, WL; Zeilhofer, HU			PGE(2) selectively blocks inhibitory glycinergic neurotransmission onto rat superficial dorsal horn neurons	NATURE NEUROSCIENCE			English	Article							DEPENDENT PROTEIN-KINASE; CYCLOOXYGENASE-2 MESSENGER-RNA; SPINAL-CORD; PROSTAGLANDIN E-2; AMINO-ACIDS; PERIPHERAL INFLAMMATION; SYNAPTIC TRANSMISSION; PROSTANOID RECEPTORS; PAIN ALLODYNIA; DEFICIENT MICE	Despite the crucial role that prostaglandins (PGs) have in the sensitization of the central nervous system to pain, their cellular and molecular targets leading to increased pain perception have remained elusive. Here we investigated the effects of PGE(2) on fast synaptic transmission onto neurons in the rat spinal cord dorsal horn, the first site of synaptic integration in the pain pathway. We identified the inhibitory (strychnine-sensitive) glycine receptor as a specific target of PGE(2). PGE(2), but not PGF(2 alpha), PGD(2) or PGI(2), reduced inhibitory glycinergic synaptic transmission in low nanomolar concentrations, whereas GABA(A), AMPA and NMDA receptor-mediated transmission remained unaffected. Inhibition of glycine receptors occurred via a postsynaptic mechanism involving the activation of EP2 receptors, cholera-toxin-sensitive G-proteins and cAMP-dependent protein kinase. Via this mechanism, PGE(2) may facilitate the transmission of nociceptive input through the spinal cord dorsal horn to higher brain areas where pain becomes conscious.	Emil Fischer Zentrum, Inst Expt & Klin Pharmakol & Toxikol, D-91054 Erlangen, Germany; Univ Erlangen Nurnberg, Inst Anat, D-91054 Erlangen, Germany	University of Erlangen Nuremberg	Zeilhofer, HU (corresponding author), Emil Fischer Zentrum, Inst Expt & Klin Pharmakol & Toxikol, Fahrstr 17, D-91054 Erlangen, Germany.		Zeilhofer, Hanns Ulrich/A-4600-2008	Zeilhofer, Hanns Ulrich/0000-0001-6954-4629				ARENA JM, 1979, POISONING TOXICITY S; Baba H, 2001, J NEUROSCI, V21, P1750, DOI 10.1523/JNEUROSCI.21-05-01750.2001; Becker C.-M., 1992, HDB EXPT PHARM, V102, P539; Beiche F, 1998, J NEUROIMMUNOL, V89, P26, DOI 10.1016/S0165-5728(98)00061-7; Beiche F, 1996, FEBS LETT, V390, P165, DOI 10.1016/0014-5793(96)00604-7; BEYER C, 1985, LIFE SCI, V37, P875, DOI 10.1016/0024-3205(85)90523-5; Boie Y, 1997, EUR J PHARMACOL, V340, P227, DOI 10.1016/S0014-2999(97)01383-6; BRANDON EP, 1995, P NATL ACAD SCI USA, V92, P8851, DOI 10.1073/pnas.92.19.8851; Ceranik K, 1997, J NEUROSCI, V17, P5380; DODT HU, 1994, TRENDS NEUROSCI, V17, P453, DOI 10.1016/0166-2236(94)90130-9; Donaldson LF, 2001, PROSTAG OTH LIPID M, V63, P109, DOI 10.1016/S0090-6980(00)00101-5; Doubell TP, 1999, TXB PAIN, V4, P165; Eguchi N, 1999, P NATL ACAD SCI USA, V96, P726, DOI 10.1073/pnas.96.2.726; Fuxe K, 1991, VOLUME TRANSMISSION; Gosselin RE, 1976, CLIN TOXICOLOGY COMM; Guhring H, 2000, J NEUROSCI, V20, P6714, DOI 10.1523/JNEUROSCI.20-17-06714.2000; Ichitani Y, 1997, NEUROREPORT, V8, P2949, DOI 10.1097/00001756-199709080-00028; KASLOW HR, 1992, FASEB J, V6, P2684, DOI 10.1096/fasebj.6.9.1612292; Kawamura T, 1997, LIFE SCI, V61, P2111, DOI 10.1016/S0024-3205(97)00884-9; Kiriyama M, 1997, BRIT J PHARMACOL, V122, P217, DOI 10.1038/sj.bjp.0701367; KUHSE J, 1995, CURR OPIN NEUROBIOL, V5, P318, DOI 10.1016/0959-4388(95)80044-1; KUMAZAWA T, 1993, BRAIN RES, V632, P321, DOI 10.1016/0006-8993(93)91169-S; Liebel JT, 1997, BRIT J PHARMACOL, V121, P425, DOI 10.1038/sj.bjp.0701149; MALMBERG AB, 1995, J NEUROSCI, V15, P2768; Malmberg AB, 1997, J NEUROSCI, V17, P7462; MATSUMURA K, 1992, BRAIN RES, V581, P292, DOI 10.1016/0006-8993(92)90720-T; MINAMI T, 1992, PAIN, V50, P223, DOI 10.1016/0304-3959(92)90166-9; Minami T, 1997, BRIT J PHARMACOL, V122, P605, DOI 10.1038/sj.bjp.0701421; Minami T, 1999, EUR J NEUROSCI, V11, P1849, DOI 10.1046/j.1460-9568.1999.00602.x; Nakamura K, 2000, J COMP NEUROL, V421, P543, DOI 10.1002/(SICI)1096-9861(20000612)421:4<543::AID-CNE6>3.0.CO;2-3; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; NISHIHARA I, 1995, NEUROSCI LETT, V196, P57, DOI 10.1016/0304-3940(95)11839-O; O'Banion MK, 1999, CRIT REV NEUROBIOL, V13, P45, DOI 10.1615/CritRevNeurobiol.v13.i1.30; Okuda-Ashitaka E, 1998, NATURE, V392, P286, DOI 10.1038/32660; PERPER JA, 1985, J FORENSIC SCI, V30, P1248; RIBEIRONETO FAP, 1985, METHOD ENZYMOL, V109, P566; Samad TA, 2001, NATURE, V410, P471, DOI 10.1038/35068566; Smart TG, 1997, CURR OPIN NEUROBIOL, V7, P358, DOI 10.1016/S0959-4388(97)80063-3; VAELLO ML, 1994, J BIOL CHEM, V269, P2002; Vane JR, 1998, ANNU REV PHARMACOL, V38, P97, DOI 10.1146/annurev.pharmtox.38.1.97; Vanegas HN, 2001, PROG NEUROBIOL, V64, P327, DOI 10.1016/S0301-0082(00)00063-0; YAKSH TL, 1989, PAIN, V37, P111, DOI 10.1016/0304-3959(89)90160-7; Yaksh TL, 1999, P NATL ACAD SCI USA, V96, P7680, DOI 10.1073/pnas.96.14.7680; YAKSH TL, 1994, TXB PAIN, P165; Yang LC, 1996, PAIN, V67, P345, DOI 10.1016/0304-3959(96)03106-5; Zeilhofer HU, 2000, J NEUROSCI, V20, P4922; ZIEGLGANSBERGER W, 1971, EXP BRAIN RES, V13, P111	47	242	254	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2002	5	1					34	40		10.1038/nn778	http://dx.doi.org/10.1038/nn778			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	507MG	11740501				2022-12-17	WOS:000173031800012
J	Ji, YY; Lu, Y; Yang, F; Shen, WH; Tang, TTT; Feng, LY; Duan, SM; Lu, B				Ji, Yuanyuan; Lu, Yuan; Yang, Feng; Shen, Wanhua; Tang, Tina Tze-Tsang; Feng, Linyin; Duan, Shumin; Lu, Bai			Acute and gradual increases in BDNF concentration elicit distinct signaling and functions in neurons	NATURE NEUROSCIENCE			English	Article							NERVE GROWTH-FACTOR; HIGH-FREQUENCY STIMULATION; NEUROTROPHIC FACTOR BDNF; LONG-TERM POTENTIATION; SYNAPTIC-TRANSMISSION; HIPPOCAMPAL-NEURONS; DIFFERENTIAL REGULATION; KINASE ACTIVATION; ADULT HIPPOCAMPUS; PC12 CELLS	Extracellular factors may act on cells in two distinct modes: an acute increase in concentration as a result of regulated secretion, or a gradual increase in concentration when secreted constitutively or from a distant source. We found that cellular responses to brain-derived neurotrophic factor ( BDNF) differed markedly depending on how BDNF was delivered. In cultured rat hippocampal neurons, acute and gradual increases in BDNF elicited transient and sustained activation of TrkB receptor and its downstream signaling, respectively, leading to differential expression of Homer1 and Arc. Transient TrkB activation promoted neurite elongation and spine head enlargement, whereas sustained TrkB activation facilitated neurite branch and spine neck elongation. In hippocampal slices, fast and slow increases in BDNF enhanced basal synaptic transmission and LTP, respectively. Thus, the kinetics of TrkB activation is critical for cell signaling and functions. This temporal dimension in cellular signaling may also have implications for the therapeutic drug design.	[Ji, Yuanyuan; Lu, Yuan; Yang, Feng; Lu, Bai] NIMH, Gene Cognit & Psychosis Program, Bethesda, MD 20892 USA; [Ji, Yuanyuan; Shen, Wanhua; Feng, Linyin; Duan, Shumin] Chinese Acad Sci, Inst Neurosci, Shanghai, Peoples R China; [Tang, Tina Tze-Tsang] Natl Inst Neurol Disorders & Stroke, Receptor Biol Unit, Bethesda, MD USA; [Tang, Tina Tze-Tsang] Univ Bristol, Sch Med Sci, Dept Anat, MRC,Ctr Synapt Plast, Bristol BS8 1TD, Avon, England; [Ji, Yuanyuan; Lu, Yuan; Yang, Feng; Lu, Bai] NICHHD, Sect Neural Dev & Plast, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Chinese Academy of Sciences; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Bristol; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Lu, B (corresponding author), GlaxoSmithKline Inc, R&D China, Shanghai, Peoples R China.	bai.b.lu@gsk.com	Shen, Wanhua/B-5554-2011; Lu, Bai/A-4018-2012; tang, tina/GRX-7859-2022; Yang, Feng/C-9530-2011	Shen, Wanhua/0000-0002-5178-9561; Lu, Bai/0000-0001-5418-9759; Yang, Feng/0000-0003-1275-6641	National Institute on Child Health and Human Development; National Institute of Mental Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000714] Funding Source: NIH RePORTER	National Institute on Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank the National Cancer Institute, Center for Cancer Research Fellows Editorial Board and G. Nagappan for the thoughtful comments and suggestions. We thank W. H. Wilson for his innovative research in cancer therapy that helped us conceive this work. This work was supported by the Intramural Research Programs of the National Institute on Child Health and Human Development and the National Institute of Mental Health.	Balkowiec A, 2002, J NEUROSCI, V22, P10399; Canossa M, 1997, P NATL ACAD SCI USA, V94, P13279, DOI 10.1073/pnas.94.24.13279; CARTER BD, 1995, J BIOL CHEM, V270, P21751, DOI 10.1074/jbc.270.37.21751; CHAO MV, 1992, CELL, V68, P995, DOI 10.1016/0092-8674(92)90068-N; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; Finkbeiner S, 1997, NEURON, V19, P1031, DOI 10.1016/S0896-6273(00)80395-5; Frerking M, 1998, J NEUROPHYSIOL, V80, P3383, DOI 10.1152/jn.1998.80.6.3383; Goodman LJ, 1996, MOL CELL NEUROSCI, V7, P222, DOI 10.1006/mcne.1996.0017; Griesbeck O, 1999, MICROSC RES TECHNIQ, V45, P262, DOI 10.1002/(SICI)1097-0029(19990515/01)45:4/5<262::AID-JEMT10>3.0.CO;2-K; Haapasalo A, 2002, J BIOL CHEM, V277, P43160, DOI 10.1074/jbc.M205202200; Hartmann M, 2001, EMBO J, V20, P5887, DOI 10.1093/emboj/20.21.5887; Hering H, 2003, J NEUROSCI, V23, P11759; Huang YZ, 2000, NEURON, V26, P443, DOI 10.1016/S0896-6273(00)81176-9; Ji YY, 2005, NAT NEUROSCI, V8, P164, DOI 10.1038/nn1381; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; Kang HJ, 1996, LEARN MEMORY, V3, P188, DOI 10.1101/lm.3.2-3.188; Kao SC, 2001, J BIOL CHEM, V276, P18169, DOI 10.1074/jbc.M008870200; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Lessmann V, 2003, PROG NEUROBIOL, V69, P341, DOI 10.1016/S0301-0082(03)00019-4; LESSMANN V, 1994, NEUROREPORT, V6, P21; LEVINE ES, 1995, P NATL ACAD SCI USA, V92, P8074, DOI 10.1073/pnas.92.17.8074; Levine ES, 1998, P NATL ACAD SCI USA, V95, P10235, DOI 10.1073/pnas.95.17.10235; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; Mei L, 2008, NAT REV NEUROSCI, V9, P437, DOI 10.1038/nrn2392; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; Sato M, 2001, J NEUROSCI, V21, P3797, DOI 10.1523/JNEUROSCI.21-11-03797.2001; Schuman EM, 1999, CURR OPIN NEUROBIOL, V9, P105, DOI 10.1016/S0959-4388(99)80013-0; Segal RA, 2003, ANNU REV NEUROSCI, V26, P299, DOI 10.1146/annurev.neuro.26.041002.131421; Shimada A, 1998, J NEUROSCI, V18, P8559; Sommerfeld MT, 2000, J BIOL CHEM, V275, P8982, DOI 10.1074/jbc.275.12.8982; Tanaka T, 1997, J NEUROSCI, V17, P2959; TRAVERSE S, 1992, BIOCHEM J, V288, P351, DOI 10.1042/bj2880351; Tyler WJ, 2003, J PHYSIOL-LONDON, V553, P497, DOI 10.1113/jphysiol.2003.052639; Yin Y, 2002, P NATL ACAD SCI USA, V99, P2368, DOI 10.1073/pnas.042693699; Ying SW, 2002, J NEUROSCI, V22, P1532, DOI 10.1523/JNEUROSCI.22-05-01532.2002; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451	37	241	252	1	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2010	13	3					302	U7		10.1038/nn.2505	http://dx.doi.org/10.1038/nn.2505			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	559WW	20173744	Green Accepted			2022-12-17	WOS:000274860100011
J	Leucht, C; Stigloher, C; Wizenmann, A; Klafke, R; Folchert, A; Bally-Cuif, L				Leucht, Christoph; Stigloher, Christian; Wizenmann, Andrea; Klafke, Ruth; Folchert, Anja; Bally-Cuif, Laure			MicroRNA-9 directs late organizer activity of the midbrain-hindbrain boundary	NATURE NEUROSCIENCE			English	Article							ZEBRAFISH GENE; BINDING-SITES; EXPRESSION; NEUROGENESIS; REVEALS; TRANSCRIPTION; FGF8; IDENTIFICATION; MAINTENANCE; INHIBITION	The midbrain-hindbrain boundary (MHB) is a long-lasting organizing center in the vertebrate neural tube that is both necessary and sufficient for the ordered development of midbrain and anterior hindbrain (midbrain-hindbrain domain, MH). The MHB also coincides with a pool of progenitor cells that contributes neurons to the entire MH. Here we show that the organizing activity and progenitor state of the MHB are co-regulated by a single microRNA, miR-9, during late embryonic development in zebrafish. Endogenous miR-9 expression, initiated at late stages, selectively spares the MHB. Gain-and loss-of-function studies, in silico predictions and sensor assays in vivo demonstrate that miR-9 targets several components of the Fgf signaling pathway, thereby delimiting the organizing activity of the MHB. In addition, miR-9 promotes progression of neurogenesis in the MH, defining the MHB progenitor pool. Together, these findings highlight a previously unknown mechanism by which a single microRNA fine-tunes late MHB coherence via its co-regulation of patterning activities and neurogenesis.	[Leucht, Christoph; Stigloher, Christian; Folchert, Anja; Bally-Cuif, Laure] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Dev Genet, Dept Zebrafish Neurogenet, D-85764 Neuherberg, Germany; [Wizenmann, Andrea] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Stem Cell Res, D-85764 Neuherberg, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Leucht, C (corresponding author), Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Dev Genet, Dept Zebrafish Neurogenet, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany.	leucht@topforscher.de; bally@helmholtz-muenchen.de	Stigloher, Christian/E-4762-2015	Stigloher, Christian/0000-0001-6941-2669; Bally-Cuif, Laure/0000-0001-6611-6274				Bae YK, 2005, DEVELOPMENT, V132, P1375, DOI 10.1242/dev.01710; BALLYCUIF L, 1993, DEVELOPMENT, V117, P543; Brand M, 1996, DEVELOPMENT, V123, P179; Cheesman SE, 2004, DEVELOPMENT, V131, P5221, DOI 10.1242/dev.01397; Choi WY, 2007, SCIENCE, V318, P271, DOI 10.1126/science.1147535; Conaco C, 2006, P NATL ACAD SCI USA, V103, P2422, DOI 10.1073/pnas.0511041103; Darnell DK, 2006, DEV DYNAM, V235, P3156, DOI 10.1002/dvdy.20956; EKKER M, 1992, DEVELOPMENT, V116, P1001; Enright AJ, 2004, GENOME BIOL, V5; Fjose Anders, 2006, Birth Defects Research, V78, P150, DOI 10.1002/bdrc.20069; Geling A, 2004, DEVELOPMENT, V131, P1993, DOI 10.1242/dev.01093; Geling A, 2003, DEVELOPMENT, V130, P1591, DOI 10.1242/dev.00375; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Hammerschmidt M, 1996, GENE DEV, V10, P647, DOI 10.1101/gad.10.6.647; Hans S, 2004, DEVELOPMENT, V131, P2957, DOI 10.1242/dev.01167; Hirata H, 2001, EMBO J, V20, P4454, DOI 10.1093/emboj/20.16.4454; Hirate Y, 2006, CURR BIOL, V16, P421, DOI 10.1016/j.cub.2006.01.055; Kapsimali M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r173; Kawakami Y, 2003, NAT CELL BIOL, V5, P513, DOI 10.1038/ncb989; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kloosterman WP, 2006, NAT METHODS, V3, P27, DOI 10.1038/NMETH843; KRAUSS S, 1991, EMBO J, V10, P3609, DOI 10.1002/j.1460-2075.1991.tb04927.x; Leaman D, 2005, CELL, V121, P1097, DOI 10.1016/j.cell.2005.04.016; Li Y, 2006, GENE DEV, V20, P2793, DOI 10.1101/gad.1466306; Lun K, 1998, DEVELOPMENT, V125, P3049; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; MOLVEN A, 1991, EMBO J, V10, P799, DOI 10.1002/j.1460-2075.1991.tb08012.x; Mueller T, 2003, DEV BRAIN RES, V140, P137, DOI 10.1016/S0165-3806(02)00583-7; Muller M, 1996, DEV GENES EVOL, V206, P153, DOI 10.1007/s004270050041; Munchberg SR, 1999, MECH DEVELOP, V88, P233, DOI 10.1016/S0925-4773(99)00179-3; Nakamura Y, 2000, J NEUROSCI, V20, P283, DOI 10.1523/JNEUROSCI.20-01-00283.2000; Ninkovic J, 2005, DEVELOPMENT, V132, P75, DOI 10.1242/dev.01525; OXTOBY E, 1993, NUCLEIC ACIDS RES, V21, P1087, DOI 10.1093/nar/21.5.1087; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Reifers F, 1998, DEVELOPMENT, V125, P2381; Rusinov V, 2005, NUCLEIC ACIDS RES, V33, pW696, DOI 10.1093/nar/gki364; Scholpp S, 2004, DEV GENES EVOL, V214, P285, DOI 10.1007/s00427-004-0409-1; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Stigloher C, 2008, BRAIN RES BULL, V75, P266, DOI 10.1016/j.brainresbull.2007.10.032; STRAHLE U, 1993, GENE DEV, V7, P1436, DOI 10.1101/gad.7.7b.1436; Tallafuss A, 2003, DEVELOPMENT, V130, P4307, DOI 10.1242/dev.00662; Tonou-Fujimori N, 2002, MECH DEVELOP, V119, pS173, DOI 10.1016/S0925-4773(03)00112-6; Vaage S, 1969, Ergeb Anat Entwicklungsgesch, V41, P3; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Wu J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r85; Wurst W, 2001, NAT REV NEUROSCI, V2, P99, DOI 10.1038/35053516; Yan XQ, 2007, FEBS LETT, V581, P1587, DOI 10.1016/j.febslet.2007.03.022	49	241	254	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2008	11	6					641	648		10.1038/nn.2115	http://dx.doi.org/10.1038/nn.2115			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	304UD	18454145				2022-12-17	WOS:000256133700010
J	Chung, MK; Guler, AD; Caterina, MJ				Chung, Man-Kyo; Gueler, Ali D.; Caterina, Michael J.			TRPV1 shows dynamic ionic selectivity during agonist stimulation	NATURE NEUROSCIENCE			English	Article							P2X(2) CHANNEL PERMEABILITY; CAPSAICIN RECEPTOR TRPV1; PRIMARY SENSORY NEURONS; GATED CATION CHANNELS; VANILLOID RECEPTOR; GANGLION NEURONS; PROTEIN; KINASE; CELLS; ACTIVATION	Transient receptor potential vanilloid 1 (TRPV1) is an ion channel that is gated by noxious heat, capsaicin and other diverse stimuli. It is a nonselective cation channel that prefers Ca2+ over Na+. These permeability characteristics, as in most channels, are widely presumed to be static. On the contrary, we found that activation of native or recombinant rat TRPV1 leads to time- and agonist concentration-dependent increases in relative permeability to large cations and changes in Ca2+ permeability. Using the substituted cysteine accessibility method, we saw that these changes were attributable to alterations in the TRPV1 selectivity filter. TRPV1 agonists showed different capabilities for evoking ionic selectivity changes. Furthermore, protein kinase C-dependent phosphorylation of Ser800 in the TRPV1 C terminus potentiated agonist-evoked ionic selectivity changes. Thus, the qualitative signaling properties of TRPV1 are dynamically modulated during channel activation, a process that probably shapes TRPV1 participation in pain, cytotoxicity and neurotransmitter release.	[Chung, Man-Kyo; Gueler, Ali D.; Caterina, Michael J.] Johns Hopkins Sch Med, Ctr Sensory Biol, Dept Biol Chem & Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine	Caterina, MJ (corresponding author), Johns Hopkins Sch Med, Ctr Sensory Biol, Dept Biol Chem & Neurosci, 725 N Wolfe St, Baltimore, MD 21205 USA.	caterina@jhmi.edu	Chung, Man-Kyo/S-7433-2019	Chung, Man-Kyo/0000-0001-7637-1148; Guler, Ali Deniz/0000-0001-8218-850X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051551, R01NS054902] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS051551, R01 NS054902] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahern GP, 2006, J BIOL CHEM, V281, P8991, DOI 10.1074/jbc.M513429200; Ahern GP, 2005, J NEUROSCI, V25, P5109, DOI 10.1523/JNEUROSCI.0237-05.2005; AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; Alam A, 2007, P NATL ACAD SCI USA, V104, P15334, DOI 10.1073/pnas.0707324104; Bhave G, 2003, P NATL ACAD SCI USA, V100, P12480, DOI 10.1073/pnas.2032100100; Binshtok AM, 2007, NATURE, V449, P607, DOI 10.1038/nature06191; BLEAKMAN D, 1990, BRIT J PHARMACOL, V101, P423, DOI 10.1111/j.1476-5381.1990.tb12725.x; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Chancellor MB, 1999, J UROLOGY, V162, P3, DOI 10.1097/00005392-199907000-00002; Chung MK, 2005, J BIOL CHEM, V280, P15928, DOI 10.1074/jbc.M500596200; Docherty RJ, 1996, PFLUG ARCH EUR J PHY, V431, P828, DOI 10.1007/BF02332166; DWYER TM, 1980, J GEN PHYSIOL, V75, P469, DOI 10.1085/jgp.75.5.469; Eickhorst AN, 2002, J GEN PHYSIOL, V120, P119, DOI 10.1085/jgp.20028535; Evans AR, 1996, BRAIN RES, V712, P265, DOI 10.1016/0006-8993(95)01447-0; Flynn GE, 2001, NAT REV NEUROSCI, V2, P643, DOI 10.1038/35090015; Garcia-Martinez C, 2000, J BIOL CHEM, V275, P32552, DOI 10.1074/jbc.M002391200; Hellwig N, 2004, J BIOL CHEM, V279, P34553, DOI 10.1074/jbc.M402966200; Huang SM, 2002, P NATL ACAD SCI USA, V99, P8400, DOI 10.1073/pnas.122196999; JANCSO G, 1992, EXP PHYSIOL, V77, P405, DOI 10.1113/expphysiol.1992.sp003603; Khakh BS, 2000, NATURE, V406, P405, DOI 10.1038/35019066; Khakh BS, 1999, NEURON, V23, P653, DOI 10.1016/S0896-6273(01)80025-8; Khakh BS, 2005, J BIOL CHEM, V280, P6118, DOI 10.1074/jbc.M411324200; Khakh BS, 1999, NAT NEUROSCI, V2, P322, DOI 10.1038/7233; Kiss L, 1999, BIOPHYS J, V76, P253, DOI 10.1016/S0006-3495(99)77194-8; LEWIS CA, 1979, J PHYSIOL-LONDON, V286, P417, DOI 10.1113/jphysiol.1979.sp012629; Liu L, 1996, J NEUROPHYSIOL, V76, P1858, DOI 10.1152/jn.1996.76.3.1858; Liu L, 1997, J NEUROSCI, V17, P4101; Marinelli S, 2002, J PHYSIOL-LONDON, V543, P531, DOI 10.1113/jphysiol.2002.022863; McNamara FN, 2005, BRIT J PHARMACOL, V144, P781, DOI 10.1038/sj.bjp.0706040; Meyers JR, 2003, J NEUROSCI, V23, P4054; Myrdal SE, 2005, HEARING RES, V204, P170, DOI 10.1016/j.heares.2005.02.005; Numazaki M, 2002, J BIOL CHEM, V277, P13375, DOI 10.1074/jbc.C200104200; Owsianik G, 2006, ANNU REV PHYSIOL, V68, P685, DOI 10.1146/annurev.physiol.68.040204.101406; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Skeberdis VA, 2006, NAT NEUROSCI, V9, P501, DOI 10.1038/nn1664; Sobczyk A, 2007, NEURON, V53, P17, DOI 10.1016/j.neuron.2006.11.016; SUPRENANT A, 1996, SCIENCE, V272, P735; SZALLASI A, 1994, GEN PHARMACOL-VASC S, V25, P223, DOI 10.1016/0306-3623(94)90049-3; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Vellani V, 2001, J PHYSIOL-LONDON, V534, P813, DOI 10.1111/j.1469-7793.2001.00813.x; Virginio C, 1999, J PHYSIOL-LONDON, V519, P335, DOI 10.1111/j.1469-7793.1999.0335m.x; Virginio C, 1999, NAT NEUROSCI, V2, P315, DOI 10.1038/7225; Welch JM, 2000, P NATL ACAD SCI USA, V97, P13889, DOI 10.1073/pnas.230146497; Xu HX, 2005, J NEUROSCI, V25, P8924, DOI 10.1523/JNEUROSCI.2574-05.2005; Yeh BI, 2005, EMBO J, V24, P3224, DOI 10.1038/sj.emboj.7600795; Zhuang ZY, 2004, J NEUROSCI, V24, P8300, DOI 10.1523/JNEUROSCI.2893-04.2004	47	241	246	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2008	11	5					555	564		10.1038/nn.2102	http://dx.doi.org/10.1038/nn.2102			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	293HV	18391945				2022-12-17	WOS:000255327300014
J	Robbe, D; Montgomery, SM; Thome, A; Rueda-Orozco, PE; McNaughton, BL; Buzsaki, G				Robbe, David; Montgomery, Sean M.; Thome, Alexander; Rueda-Orozco, Pavel E.; McNaughton, Bruce L.; Buzsaki, Gyoergy			Cannabinoids reveal importance of spike timing coordination in hippocampal function	NATURE NEUROSCIENCE			English	Article							IMPAIRS SPATIAL MEMORY; NETWORK OSCILLATIONS; THETA-OSCILLATIONS; ENDOCANNABINOID SYSTEM; ACETYLCHOLINE-RELEASE; WORKING-MEMORY; PHASE-LOCKING; BEHAVING RAT; IN-VITRO; EEG	Cannabinoids impair hippocampus-dependent memory in both humans and animals, but the network mechanisms responsible for this effect are unknown. Here we show that the cannabinoids Delta(9)-tetrahydrocannabinol and CP55940 decreased the power of theta, gamma and ripple oscillations in the hippocampus of head-restrained and freely moving rats. These effects were blocked by a CB1 antagonist. The decrease in theta power correlated with memory impairment in a hippocampus-dependent task. By simultaneously recording from large populations of single units, we found that CP55940 severely disrupted the temporal coordination of cell assemblies in short time windows (< 100 ms) yet only marginally affected population firing rates of pyramidal cells and interneurons. The decreased power of local field potential oscillations correlated with reduced temporal synchrony but not with firing rate changes. We hypothesize that reduced spike timing coordination and the associated impairment of physiological oscillations are responsible for cannabinoid-induced memory deficits.	Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA; Univ Arizona, Div Neural Syst Mem & Aging, Tucson, AZ 85724 USA	Rutgers State University Newark; Rutgers State University New Brunswick; University of Arizona	Buzsaki, G (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA.	buzsaki@axon.rutgers.edu	Rueda, Pavel/GPP-1112-2022; robbe, david/O-5439-2016	robbe, david/0000-0002-9450-0553; Montgomery, Sean/0000-0001-7370-0938; Rueda-Orozco, Pavel/0000-0002-2801-803X; Buzsaki, Gyorgy/0000-0002-3100-4800	NIMH NIH HHS [MH54671] Funding Source: Medline; NINDS NIH HHS [NS20331, NS34994, NS43157] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034994, R01NS020331, R37NS020331, R01NS043157] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ameri A, 1999, PROG NEUROBIOL, V58, P315, DOI 10.1016/S0301-0082(98)00087-2; Behrens CJ, 2005, NAT NEUROSCI, V8, P1560, DOI 10.1038/nn1571; Bernard C, 2005, P NATL ACAD SCI USA, V102, P9388, DOI 10.1073/pnas.0409641102; BLAND BH, 1986, PROG NEUROBIOL, V26, P1, DOI 10.1016/0301-0082(86)90019-5; BUONAMICI M, 1982, NEUROPHARMACOLOGY, V21, P825, DOI 10.1016/0028-3908(82)90071-5; Buzsaki G, 1996, CEREB CORTEX, V6, P81, DOI 10.1093/cercor/6.2.81; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Buzsaki G., 2003, CURRENT PRACTICE CLI, P1; Chrobak JJ, 1996, J NEUROSCI, V16, P3056; CONSROE PF, 1975, PHARMACOL BIOCHEM BE, V3, P173, DOI 10.1016/0091-3057(75)90144-6; Csicsvari J, 2000, NEURON, V28, P585, DOI 10.1016/S0896-6273(00)00135-5; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; Curran HV, 2002, PSYCHOPHARMACOLOGY, V164, P61, DOI 10.1007/s00213-002-1169-0; Destexhe A, 2003, NAT REV NEUROSCI, V4, P739, DOI 10.1038/nrn1198; Egashira N, 2002, EUR J PHARMACOL, V445, P221, DOI 10.1016/S0014-2999(02)01755-7; Fisahn A, 1998, NATURE, V394, P186, DOI 10.1038/28179; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; GIVENS BS, 1990, BEHAV NEUROSCI, V104, P849, DOI 10.1037/0735-7044.104.6.849; Hajos N, 2000, EUR J NEUROSCI, V12, P3239, DOI 10.1046/j.1460-9568.2000.00217.x; Hampson RE, 1998, NEUROBIOL DIS, V5, P474, DOI 10.1006/nbdi.1998.0223; Hampson RE, 2000, J NEUROSCI, V20, P8932; Harris KD, 2001, NEURON, V32, P141, DOI 10.1016/S0896-6273(01)00447-0; Hasselmo ME, 2002, NEURAL COMPUT, V14, P793, DOI 10.1162/089976602317318965; Hazan L, 2006, J NEUROSCI METH, V155, P207, DOI 10.1016/j.jneumeth.2006.01.017; Hoffman AF, 2003, EUR J NEUROSCI, V18, P524, DOI 10.1046/j.1460-9568.2003.02773.x; Ilan AB, 2004, PSYCHOPHARMACOLOGY, V176, P214, DOI 10.1007/s00213-004-1868-9; Katona I, 2006, J NEUROSCI, V26, P5628, DOI 10.1523/JNEUROSCI.0309-06.2006; Kawamura Y, 2006, J NEUROSCI, V26, P2991, DOI 10.1523/JNEUROSCI.4872-05.2006; Klausberger T, 2005, J NEUROSCI, V25, P9782, DOI 10.1523/JNEUROSCI.3269-05.2005; Konig P, 1996, TRENDS NEUROSCI, V19, P130, DOI 10.1016/S0166-2236(96)80019-1; Kudrimoti HS, 1999, J NEUROSCI, V19, P4090; Lee H, 2005, NEURON, V45, P147, DOI 10.1016/j.neuron.2004.12.025; Lichtman AH, 1996, PSYCHOPHARMACOLOGY, V126, P125, DOI 10.1007/BF02246347; LICHTMAN AH, 1995, PSYCHOPHARMACOLOGY, V119, P282, DOI 10.1007/BF02246292; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; MILLER LL, 1983, PSYCHOL BULL, V93, P441, DOI 10.1037/0033-2909.93.3.441; MIZUMORI SJY, 1990, BRAIN RES, V528, P12, DOI 10.1016/0006-8993(90)90188-H; Monory K, 2006, NEURON, V51, P455, DOI 10.1016/j.neuron.2006.07.006; Nunez PL, 1997, ELECTROEN CLIN NEURO, V103, P499, DOI 10.1016/S0013-4694(97)00066-7; OLPE HR, 1980, BRAIN RES BULL, V5, P507, DOI 10.1016/0361-9230(80)90082-9; Pisanu A, 2006, NEUROPHARMACOLOGY, V50, P661, DOI 10.1016/j.neuropharm.2005.11.023; Robson P, 2001, BRIT J PSYCHIAT, V178, P107, DOI 10.1192/bjp.178.2.107; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Takahashi KA, 2006, NEUROSCIENCE, V139, P795, DOI 10.1016/j.neuroscience.2006.01.024; Traub RD, 1996, NATURE, V383, P621, DOI 10.1038/383621a0; Tzavara ET, 2003, J NEUROSCI, V23, P9374; WILLINSKY MD, 1975, PSYCHOPHARMACOLOGIA, V41, P123, DOI 10.1007/BF00421068	50	241	247	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2006	9	12					1526	1533		10.1038/nn1801	http://dx.doi.org/10.1038/nn1801			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TP	17115043				2022-12-17	WOS:000242404000017
J	Neuhaus, EM; Gisselmann, G; Zhang, WY; Dooley, R; Stortkuhl, K; Hatt, H				Neuhaus, EM; Gisselmann, G; Zhang, WY; Dooley, R; Stortkuhl, K; Hatt, H			Odorant receptor heterodimerization in the olfactory system of Drosophila melanogaster	NATURE NEUROSCIENCE			English	Article							DIMERIZATION; EXPRESSION; ANTENNA; MAP	Despite increasing knowledge about dimerization of G-protein-coupled receptors, nothing is known about dimerization in the largest subfamily, odorant receptors. Using a combination of biochemical and electrophysiological approaches, we demonstrate here that odorant receptors can dimerize. DOR83b, an odorant receptor that is ubiquitously expressed in olfactory neurons from Drosophila melanogaster and highly conserved among insect species, forms heterodimeric complexes with other odorant-receptor proteins, which strongly increases their functionality.	Ruhr Univ Bochum, Lehrstuhl Zellphysiol, D-44780 Bochum, Germany; Ruhr Univ Bochum, AG Sinnesphysiol, D-44780 Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum	Neuhaus, EM (corresponding author), Ruhr Univ Bochum, Lehrstuhl Zellphysiol, Univ Str 150, D-44780 Bochum, Germany.	eva.neuhaus@rub.de	Dooley, Ruth/A-5480-2010; Neuhaus, Eva M./L-1428-2015	Neuhaus, Eva M./0000-0003-3363-1231				Angers S, 2000, P NATL ACAD SCI USA, V97, P3684, DOI 10.1073/pnas.060590697; Angers S, 2002, ANNU REV PHARMACOL, V42, P409, DOI 10.1146/annurev.pharmtox.42.091701.082314; Elmore T, 2003, J NEUROSCI, V23, P9906; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Kennerdell JR, 2000, NAT BIOTECHNOL, V18, P896, DOI 10.1038/78531; Krieger J, 2003, J COMP PHYSIOL A, V189, P519, DOI 10.1007/s00359-003-0427-x; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Mombaerts P, 2004, CURR OPIN NEUROBIOL, V14, P31, DOI 10.1016/j.conb.2004.01.014; Mombaerts P, 1999, SCIENCE, V286, P707, DOI 10.1126/science.286.5440.707; Pitts RJ, 2004, P NATL ACAD SCI USA, V101, P5058, DOI 10.1073/pnas.0308146101; Spehr M, 2003, SCIENCE, V299, P2054, DOI 10.1126/science.1080376; Stortkuhl KF, 2001, P NATL ACAD SCI USA, V98, P9381, DOI 10.1073/pnas.151105698; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wetzel CH, 2001, P NATL ACAD SCI USA, V98, P9377, DOI 10.1073/pnas.151103998	15	241	265	2	37	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2005	8	1					15	17		10.1038/nn1371	http://dx.doi.org/10.1038/nn1371			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882VO	15592462				2022-12-17	WOS:000225967600007
J	Zakharenko, SS; Zablow, L; Siegelbaum, SA				Zakharenko, SS; Zablow, L; Siegelbaum, SA			Visualization of changes in presynaptic function during long-term synaptic plasticity	NATURE NEUROSCIENCE			English	Article							INDIVIDUAL HIPPOCAMPAL SYNAPSES; RAT HIPPOCAMPUS; NERVE-TERMINALS; AMPA RECEPTORS; AREA CA1; POTENTIATION; LTP; TRANSMISSION; BOUTONS; DEPRESSION	Controversy exists regarding the site of modification of synaptic transmission during long-term plasticity in the mammalian hippocampus. Here we used a fluorescent marker of presynaptic activity, FM 1-43, to directly image changes in presynaptic function during both short-term and long-term forms of plasticity at presynaptic boutons of CA3-CA1 excitatory synapses in acute hippocampal slices. We demonstrated enhanced presynaptic function during long-term potentiation (LTP) induced either chemically (with tetraethylammonium), or by high-frequency (200-Hz) electrical stimulation. Both of these forms of LTP required activation of L-type voltage-gated calcium channels and NMDA receptors in the postsynaptic CA1 neuron. These results thus implied that a long-lasting increase in the efficacy of synaptic transmission is likely to depend, at least in part, on enhanced transmitter release from the presynaptic neuron.	Columbia Univ, Howard Hughes Med Inst, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ, Howard Hughes Med Inst, Dept Pharmacol, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute; Columbia University; Howard Hughes Medical Institute	Siegelbaum, SA (corresponding author), Columbia Univ, Howard Hughes Med Inst, Ctr Neurobiol & Behav, 722 W 168th St, New York, NY 10032 USA.		Zakharenko, Stanislav/D-3287-2013	Zakharenko, Stanislav/0000-0001-8115-202X				ANIKSZTEJN L, 1991, NATURE, V349, P67, DOI 10.1038/349067a0; Bear MF, 1999, P NATL ACAD SCI USA, V96, P9457, DOI 10.1073/pnas.96.17.9457; BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; BOLSHAKOV VY, 1995, SCIENCE, V269, P1730, DOI 10.1126/science.7569903; Bozdagi O, 2000, NEURON, V28, P245, DOI 10.1016/S0896-6273(00)00100-8; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Choi S, 2000, NAT NEUROSCI, V3, P330, DOI 10.1038/73895; Cunha RA, 2000, NEUROPHARMACOLOGY, V39, P1156, DOI 10.1016/S0028-3908(99)00237-3; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; DUNWIDDIE TV, 1981, N-S ARCH PHARMACOL, V316, P326, DOI 10.1007/BF00501365; Engert F, 1997, NATURE, V388, P279, DOI 10.1038/40870; GROVER LM, 1990, NATURE, V347, P477, DOI 10.1038/347477a0; HANSE E, 1994, J NEUROSCI, V14, P5028; HARRIS EW, 1984, BRAIN RES, V323, P132, DOI 10.1016/0006-8993(84)90275-0; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Hawkins RD, 1998, PROG BRAIN RES, V118, P155; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Hiscock JJ, 2000, J NEUROSCI METH, V95, P1, DOI 10.1016/S0165-0270(99)00163-6; Huang YY, 1996, LEARN MEMORY, V3, P74, DOI 10.1101/lm.3.2-3.74; HUANG YY, 1993, J NEUROSCI, V13, P568; Kay AR, 1999, NEURON, V24, P809, DOI 10.1016/S0896-6273(00)81029-6; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; KULLMANN DM, 1995, NEURON, V15, P997, DOI 10.1016/0896-6273(95)90089-6; LAMBERT NA, 1991, NEUROSCI LETT, V122, P50, DOI 10.1016/0304-3940(91)90190-5; LIU GS, 1995, NATURE, V375, P404, DOI 10.1038/375404a0; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Ma L, 1999, NAT NEUROSCI, V2, P24, DOI 10.1038/4525; Mainen ZF, 1999, METHODS, V18, P231, DOI 10.1006/meth.1999.0776; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Maletic-Savatic M, 1998, J NEUROSCI, V18, P6814; MALGAROLI A, 1995, SCIENCE, V268, P1624, DOI 10.1126/science.7777862; Malinow R, 2000, CURR OPIN NEUROBIOL, V10, P352, DOI 10.1016/S0959-4388(00)00099-4; MALINOW R, 1991, SCIENCE, V252, P722, DOI 10.1126/science.1850871; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Milner B, 1998, NEURON, V20, P445, DOI 10.1016/S0896-6273(00)80987-3; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; Nicoll RA, 1999, ANN NY ACAD SCI, V868, P515, DOI 10.1111/j.1749-6632.1999.tb11320.x; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Ryan TA, 1996, NEURON, V17, P125, DOI 10.1016/S0896-6273(00)80286-X; RYAN TA, 1995, NEURON, V14, P983, DOI 10.1016/0896-6273(95)90336-4; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; SCHUMAN EM, 1994, SCIENCE, V263, P532, DOI 10.1126/science.8290963; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; STEVENS CF, 1995, NEURON, V14, P795, DOI 10.1016/0896-6273(95)90223-6; STEVENS CF, 1994, NATURE, V371, P704, DOI 10.1038/371704a0; Stricker C, 1999, J PHYSIOL-LONDON, V520, P513, DOI 10.1111/j.1469-7793.1999.00513.x; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; YOON KW, 1991, J NEUROSCI, V11, P1375	49	241	242	0	19	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2001	4	7					711	717		10.1038/89498	http://dx.doi.org/10.1038/89498			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	448HK	11426227				2022-12-17	WOS:000169621300016
J	Chen, J; Leong, YC; Honey, CJ; Yong, CH; Norman, KA; Hasson, U				Chen, Janice; Leong, Yuan Chang; Honey, Christopher J.; Yong, Chung H.; Norman, Kenneth A.; Hasson, Uri			Shared memories reveal shared structure in neural activity across individuals	NATURE NEUROSCIENCE			English	Article							CORTICAL ACTIVITY; TEMPORAL CORTEX; EPISODIC MEMORY; DEFAULT MODE; BRAIN; RETRIEVAL; PATTERNS; EVENTS; REPRESENTATIONS; REINSTATEMENT	Our lives revolve around sharing experiences and memories with others. When different people recount the same events, how similar are their underlying neural representations? Participants viewed a 50-min movie, then verbally described the events during functional MRI, producing unguided detailed descriptions lasting up to 40 min. As each person spoke, event-specific spatial patterns were reinstated in default-network, medial-temporal, and high-level visual areas. Individual event patterns were both highly discriminable from one another and similar among people, suggesting consistent spatial organization. In many high-order areas, patterns were more similar between people recalling the same event than between recall and perception, indicating systematic reshaping of percept into memory. These results reveal the existence of a common spatial organization for memories in highlevel cortical areas, where encoded information is largely abstracted beyond sensory constraints, and that neural patterns during perception are altered systematically across people into shared memory representations for real-life events.	[Chen, Janice; Norman, Kenneth A.; Hasson, Uri] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA; [Chen, Janice; Norman, Kenneth A.; Hasson, Uri] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; [Chen, Janice; Honey, Christopher J.] Johns Hopkins Univ, Dept Psychol & Brain Sci, Baltimore, MD 21218 USA; [Leong, Yuan Chang] Stanford Univ, Dept Psychol, Bldg 420, Stanford, CA 94305 USA; [Honey, Christopher J.; Yong, Chung H.] Univ Toronto, Dept Psychol, Toronto, ON, Canada	Princeton University; Princeton University; Johns Hopkins University; Stanford University; University of Toronto	Chen, J (corresponding author), Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA.; Chen, J (corresponding author), Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA.; Chen, J (corresponding author), Johns Hopkins Univ, Dept Psychol & Brain Sci, Baltimore, MD 21218 USA.	janice@princeton.edu	Honey, Christopher/AAF-3616-2021	Honey, Christopher/0000-0002-0745-5089; chen, janice/0000-0003-4511-4725; Leong, Yuan Chang/0000-0003-2499-2393	US National Institutes of Health [R01-MH094480, 2T32MH065214-11]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH094480, T32MH065214] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank M. Aly, C. Baldassano, M. Arcaro and E. Simony for scientific discussions and comments on earlier versions of the manuscript; J. Edgren for help with transcription; M. Arcaro for advice regarding visual area topography; P. Johnson for improving the classification analysis; P.-H. Chen and H. Zhang for development of the SRM code; and other members of the Hasson and Norman laboratories for their comments and support. This work was supported by the US National Institutes of Health (R01-MH094480, U.H.; 2T32MH065214-11, J.C.).	ALBA JW, 1983, PSYCHOL BULL, V93, P203, DOI 10.1037/0033-2909.93.2.203; Ames DL, 2015, J COGNITIVE NEUROSCI, V27, P655, DOI 10.1162/jocn_a_00728; [Anonymous], 2009, PSYCHOL SCI, V20, P1364, DOI 10.1111/j.1467-9280.2009.02460.x; Baldassano C., 2016, BIORXIV; Benson NC, 2012, CURR BIOL, V22, P2081, DOI 10.1016/j.cub.2012.09.014; Bird CM, 2015, J NEUROSCI, V35, P14426, DOI 10.1523/JNEUROSCI.1774-15.2015; Borges Jorge L., 1942, NACION; Buchsbaum BR, 2012, J COGNITIVE NEUROSCI, V24, P1867, DOI 10.1162/jocn_a_00253; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buzsaki G, 2013, NAT NEUROSCI, V16, P130, DOI 10.1038/nn.3304; Charest I, 2014, P NATL ACAD SCI USA, V111, P14565, DOI 10.1073/pnas.1402594111; Coman A, 2012, J EXP PSYCHOL GEN, V141, P321, DOI 10.1037/a0025247; Danker JF, 2010, PSYCHOL BULL, V136, P87, DOI 10.1037/a0017937; Formisano E, 2003, NEURON, V40, P859, DOI 10.1016/S0896-6273(03)00669-X; Halbwachs Maurice, 1980, COLLECTIVE MEMORY; Hassabis D, 2007, TRENDS COGN SCI, V11, P299, DOI 10.1016/j.tics.2007.05.001; Hasson U, 2004, SCIENCE, V303, P1634, DOI 10.1126/science.1089506; Hasson U, 2012, TRENDS COGN SCI, V16, P114, DOI 10.1016/j.tics.2011.12.007; Hasson U, 2010, TRENDS COGN SCI, V14, P40, DOI 10.1016/j.tics.2009.10.011; Honey CJ, 2012, J NEUROSCI, V32, P15277, DOI 10.1523/JNEUROSCI.1800-12.2012; Honey CJ, 2012, NEURON, V76, P423, DOI 10.1016/j.neuron.2012.08.011; Isola P, 2011, PROC CVPR IEEE, P145, DOI 10.1109/CVPR.2011.5995721; Jaaskelainen Iiro P, 2008, Open Neuroimag J, V2, P14, DOI 10.2174/1874440000802010014; Johnson JD, 2009, NEURON, V63, P697, DOI 10.1016/j.neuron.2009.08.011; Kaplan JT, 2012, NEUROIMAGE, V60, P204, DOI 10.1016/j.neuroimage.2011.12.059; Kriegeskorte N, 2008, FRONT SYST NEUROSCI, V2, DOI 10.3389/neuro.06.004.2008; Kriegeskorte N, 2008, NEURON, V60, P1126, DOI 10.1016/j.neuron.2008.10.043; Kuhl BA, 2011, P NATL ACAD SCI USA, V108, P5903, DOI 10.1073/pnas.1016939108; Kurby CA, 2008, TRENDS COGN SCI, V12, P72, DOI 10.1016/j.tics.2007.11.004; Lahnakoski JM, 2014, NEUROIMAGE, V100, P316, DOI 10.1016/j.neuroimage.2014.06.022; Lerner Y, 2011, J NEUROSCI, V31, P2906, DOI 10.1523/JNEUROSCI.3684-10.2011; Mitchell TM, 2004, MACH LEARN, V57, P145, DOI 10.1023/B:MACH.0000035475.85309.1b; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; OKEEFE J, 1978, EXP BRAIN RES, V31, P573; Polyn SM, 2005, SCIENCE, V310, P1963, DOI 10.1126/science.1117645; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ranganath C, 2012, NAT REV NEUROSCI, V13, P713, DOI 10.1038/nrn3338; Regev M, 2013, J NEUROSCI, V33, P15978, DOI 10.1523/JNEUROSCI.1580-13.2013; Rice GE, 2014, J NEUROSCI, V34, P8837, DOI 10.1523/JNEUROSCI.5265-13.2014; Roediger HL, 2015, TRENDS COGN SCI, V19, P359, DOI 10.1016/j.tics.2015.04.003; Rugg MD, 2013, CURR OPIN NEUROBIOL, V23, P255, DOI 10.1016/j.conb.2012.11.005; Shinkareva SV, 2011, NEUROIMAGE, V54, P2418, DOI 10.1016/j.neuroimage.2010.10.042; Simony E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12141; Sperber D., 1996, EXPLAINING CULTURE N; Wandell BA, 2007, NEURON, V56, P366, DOI 10.1016/j.neuron.2007.10.012; Wang MG, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00945; Wheeler ME, 2000, P NATL ACAD SCI USA, V97, P11125, DOI 10.1073/pnas.97.20.11125; Wilson SM, 2008, CEREB CORTEX, V18, P230, DOI 10.1093/cercor/bhm049; Wing EA, 2015, J COGNITIVE NEUROSCI, V27, P679, DOI 10.1162/jocn_a_00740; Zadbood A., 2016, BIORXIV	50	240	241	9	75	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2017	20	1					115	125		10.1038/nn.4450	http://dx.doi.org/10.1038/nn.4450			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	EG5LO	27918531	Green Submitted, Green Accepted			2022-12-17	WOS:000391085500019
J	Liston, C; Cichon, JM; Jeanneteau, F; Jia, ZP; Chao, MV; Gan, WB				Liston, Conor; Cichon, Joseph M.; Jeanneteau, Freddy; Jia, Zhengping; Chao, Moses V.; Gan, Wen-Biao			Circadian glucocorticoid oscillations promote learning-dependent synapse formation and maintenance	NATURE NEUROSCIENCE			English	Article							MEDIAL PREFRONTAL CORTEX; BASOLATERAL AMYGDALA; GENE-EXPRESSION; IN-VIVO; NORADRENERGIC ACTIVATION; PYRAMIDAL NEURONS; MEMORY STORAGE; STRESS; RECEPTOR; PLASTICITY	Excessive glucocorticoid exposure during chronic stress causes synapse loss and learning impairment. Under normal physiological conditions, glucocorticoid activity oscillates in synchrony with the circadian rhythm. Whether and how endogenous glucocorticoid oscillations modulate synaptic plasticity and learning is unknown. Here we show that circadian glucocorticoid peaks promote postsynaptic dendritic spine formation in the mouse cortex after motor skill learning, whereas troughs are required for stabilizing newly formed spines that are important for long-term memory retention. Conversely, chronic and excessive exposure to glucocorticoids eliminates learning-associated new spines and disrupts previously acquired memories. Furthermore, we show that glucocorticoids promote rapid spine formation through a non-transcriptional mechanism by means of the LIM kinase-cofilin pathway and increase spine elimination through transcriptional mechanisms involving mineralocorticoid receptor activation. Together, these findings indicate that tightly regulated circadian glucocorticoid oscillations are important for learning-dependent synaptic formation and maintenance. They also delineate a new signaling mechanism underlying these effects.	[Liston, Conor; Cichon, Joseph M.; Chao, Moses V.; Gan, Wen-Biao] NYU, Sch Med, Mol Neurobiol Program, Dept Physiol & Neurosci,Skirball Inst, New York, NY 10012 USA; [Liston, Conor] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Jeanneteau, Freddy] CNRS, INSERM, Inst Genom Fonct, UMR 5203,U661, Montpellier, France; [Jia, Zhengping] Hosp Sick Children, Program Brain & Behav, Toronto, ON M5G 1X8, Canada	New York University; Stanford University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Liston, C (corresponding author), NYU, Sch Med, Mol Neurobiol Program, Dept Physiol & Neurosci,Skirball Inst, New York, NY 10012 USA.	cliston@stanford.edu; gan@saturn.med.nyu.edu	Jia, zhengping/AAZ-4190-2021; Jeanneteau, Freddy/AAC-7052-2021; , Conor Liston/GQH-8931-2022	Chao, Moses/0000-0002-6969-3744; Jeanneteau, freddy/0000-0002-9606-2892	US National Institutes of Health [R01 NS047325, R01MH085324, MH086651, NS21072]; US National Institute of Mental Health [K99 MH097822]; DeWitt Wallace Reader's Digest Foundation at Weill Cornell Medical College; NATIONAL INSTITUTE OF MENTAL HEALTH [R00MH097822, R01MH085324, K99MH097822, R01MH086651] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS021072, R01NS021072, R01NS047325] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); DeWitt Wallace Reader's Digest Foundation at Weill Cornell Medical College; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank B.S. McEwen and Gan laboratory members for critical comments on this manuscript. This work was supported by grants from the US National Institutes of Health (R01 NS047325 and a subcontract of R01MH085324) to W.-B.G.C.L. is supported by grants from the US National Institute of Mental Health (K99 MH097822) and the DeWitt Wallace Reader's Digest Foundation at Weill Cornell Medical College. F.J. and M.V.C. are supported by grants from the US National Institutes of Health (MH086651 and NS21072).	Atkinson G, 1996, SPORTS MED, V21, P292, DOI 10.2165/00007256-199621040-00005; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; Bangasser DA, 2007, NAT NEUROSCI, V10, P1401, DOI 10.1038/nn1973; Bellugi U, 1999, TRENDS NEUROSCI, V22, P197, DOI 10.1016/S0166-2236(99)01397-1; Binder DK, 2004, J NEUROSCI, V24, P8049, DOI 10.1523/JNEUROSCI.2294-04.2004; Buffelli M, 2003, NATURE, V424, P430, DOI 10.1038/nature01844; Buitrago MM, 2004, NEUROBIOL LEARN MEM, V81, P211, DOI 10.1016/j.nlm.2004.01.001; Campolongo P, 2009, P NATL ACAD SCI USA, V106, P4888, DOI 10.1073/pnas.0900835106; Chaudhury D, 2002, BEHAV BRAIN RES, V133, P95, DOI 10.1016/S0166-4328(01)00471-5; Colman H, 1997, SCIENCE, V275, P356, DOI 10.1126/science.275.5298.356; Dailey ME, 1996, J NEUROSCI, V16, P2983; Datson NA, 2001, EUR J NEUROSCI, V14, P675, DOI 10.1046/j.0953-816x.2001.01685.x; De Kloet ER, 1998, ENDOCR REV, V19, P269, DOI 10.1210/er.19.3.269; de Quervain DJF, 1998, NATURE, V394, P787, DOI 10.1038/29542; Di S, 2003, J NEUROSCI, V23, P4850; Dias-Ferreira E, 2009, SCIENCE, V325, P621, DOI 10.1126/science.1171203; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Gu JP, 2010, NAT NEUROSCI, V13, P1208, DOI 10.1038/nn.2634; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Hill MN, 2011, J NEUROSCI, V31, P10506, DOI 10.1523/JNEUROSCI.0496-11.2011; Holsboer F, 2000, NEUROPSYCHOPHARMACOL, V23, P477, DOI 10.1016/S0893-133X(00)00159-7; Hubener M, 2010, NEURON, V67, P363, DOI 10.1016/j.neuron.2010.06.033; Jeanneteau F, 2008, P NATL ACAD SCI USA, V105, P4862, DOI 10.1073/pnas.0709102105; Jeanneteau F, 2010, NAT NEUROSCI, V13, P1373, DOI 10.1038/nn.2655; Jiang M, 2006, NAT PROTOC, V1, P695, DOI 10.1038/nprot.2006.86; Karssen AM, 2005, ENDOCRINOLOGY, V146, P5587, DOI 10.1210/en.2005-0501; Karst H, 2005, P NATL ACAD SCI USA, V102, P19204, DOI 10.1073/pnas.0507572102; Knott GW, 2006, NAT NEUROSCI, V9, P1117, DOI 10.1038/nn1747; Lai CSW, 2012, NATURE, V483, P87, DOI 10.1038/nature10792; LI CX, 1991, CAN J NEUROL SCI, V18, P28, DOI 10.1017/S0317167100031267; Liston C, 2006, J NEUROSCI, V26, P7870, DOI 10.1523/JNEUROSCI.1184-06.2006; Liston C, 2011, P NATL ACAD SCI USA, V108, P16074, DOI 10.1073/pnas.1110444108; Lohmann C, 2008, NEURON, V59, P253, DOI 10.1016/j.neuron.2008.05.025; Losel R, 2003, NAT REV MOL CELL BIO, V4, P46, DOI 10.1038/nrm1009; Lupien SJ, 1998, NAT NEUROSCI, V1, P69, DOI 10.1038/271; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; Miller NL, 2012, SLEEP, V35, P1123, DOI 10.5665/sleep.2002; Morsink MC, 2006, J NEUROENDOCRINOL, V18, P239, DOI 10.1111/j.1365-2826.2006.01413.x; Popoli M, 2012, NAT REV NEUROSCI, V13, P22, DOI 10.1038/nrn3138; Quirarte GL, 1997, P NATL ACAD SCI USA, V94, P14048, DOI 10.1073/pnas.94.25.14048; Radley JJ, 2006, CEREB CORTEX, V16, P313, DOI 10.1093/cercor/bhi104; Renthal W, 2007, NEURON, V56, P517, DOI 10.1016/j.neuron.2007.09.032; REUL JMHM, 1985, ENDOCRINOLOGY, V117, P2505, DOI 10.1210/endo-117-6-2505; Roozendaal B, 2006, P NATL ACAD SCI USA, V103, P6741, DOI 10.1073/pnas.0601874103; Ruby NF, 2008, P NATL ACAD SCI USA, V105, P15593, DOI 10.1073/pnas.0808259105; SHORS TJ, 1992, SCIENCE, V257, P537, DOI 10.1126/science.1636089; Stavreva DA, 2009, NAT CELL BIOL, V11, P1093, DOI 10.1038/ncb1922; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; WATANABE Y, 1992, BRAIN RES, V588, P341, DOI 10.1016/0006-8993(92)91597-8; Wellman CL, 2001, J NEUROBIOL, V49, P245, DOI 10.1002/neu.1079; Wright KP, 2006, J COGNITIVE NEUROSCI, V18, P508, DOI 10.1162/jocn.2006.18.4.508; Xu TH, 2009, NATURE, V462, P915, DOI 10.1038/nature08389; Yang G, 2010, NAT PROTOC, V5, P201, DOI 10.1038/nprot.2009.222; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577; Yuen EY, 2009, P NATL ACAD SCI USA, V106, P14075, DOI 10.1073/pnas.0906791106	60	240	242	1	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2013	16	6					698	+		10.1038/nn.3387	http://dx.doi.org/10.1038/nn.3387			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	152DE	23624512	Green Accepted			2022-12-17	WOS:000319509600011
J	Couey, JJ; Witoelar, A; Zhang, SJ; Zheng, K; Ye, J; Dunn, B; Czajkowski, R; Moser, MB; Moser, EI; Roudi, Y; Witter, MP				Couey, Jonathan J.; Witoelar, Aree; Zhang, Sheng-Jia; Zheng, Kang; Ye, Jing; Dunn, Benjamin; Czajkowski, Rafal; Moser, May-Britt; Moser, Edvard I.; Roudi, Yasser; Witter, Menno P.			Recurrent inhibitory circuitry as a mechanism for grid formation	NATURE NEUROSCIENCE			English	Article							MEDIAL ENTORHINAL CORTEX; LAYER-II; PATH-INTEGRATION; DISYNAPTIC INHIBITION; RAT; NEURONS; CELLS; MODEL; DIRECTION; DYNAMICS	Grid cells in layer II of the medial entorhinal cortex form a principal component of the mammalian neural representation of space. The firing pattern of a single grid cell has been hypothesized to be generated through attractor dynamics in a network with a specific local connectivity including both excitatory and inhibitory connections. However, experimental evidence supporting the presence of such connectivity among grid cells in layer II is limited. Here we report recordings from more than 600 neuron pairs in rat entorhinal slices, demonstrating that stellate cells, the principal cell type in the layer II grid network, are mainly interconnected via inhibitory interneurons. Using a model attractor network, we demonstrate that stable grid firing can emerge from a simple recurrent inhibitory network. Our findings thus suggest that the observed inhibitory microcircuitry between stellate cells is sufficient to generate grid-cell firing patterns in layer II of the medial entorhinal cortex.	[Couey, Jonathan J.; Witoelar, Aree; Zhang, Sheng-Jia; Zheng, Kang; Ye, Jing; Dunn, Benjamin; Czajkowski, Rafal; Moser, May-Britt; Moser, Edvard I.; Roudi, Yasser; Witter, Menno P.] Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, N-7034 Trondheim, Norway; [Couey, Jonathan J.; Witoelar, Aree; Zhang, Sheng-Jia; Zheng, Kang; Ye, Jing; Dunn, Benjamin; Czajkowski, Rafal; Moser, May-Britt; Moser, Edvard I.; Roudi, Yasser; Witter, Menno P.] Norwegian Univ Sci & Technol, Ctr Biol Memory, Norwegian Brain Ctr, N-7034 Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Witter, MP (corresponding author), Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, N-7034 Trondheim, Norway.	yasser.roudi@ntnu.no; menno.witter@ntnu.no	Ye, Jing/M-3366-2017; Couey, Jonathan/GXG-6340-2022	Ye, Jing/0000-0002-6364-4124; Couey, Jonathan/0000-0003-2658-692X; Czajkowski, Rafal/0000-0002-9793-5421; Roudi, Yasser/0000-0002-6989-3420	Kavli Foundation; EU [200873]; Centre of Excellence from Norwegian Research Council [145993, 181676, 191929]; European Research Council ('CIRCUIT') [232608]	Kavli Foundation; EU(European Commission); Centre of Excellence from Norwegian Research Council; European Research Council ('CIRCUIT')	We thank K. Deisseroth (Stanford University) for providing the ChR2(H134R) plasmid, I.E.J. Assebo for histological reconstructions, P. Gird for programming and A. Treves for comments on the manuscript. This work was supported by the Kavli Foundation, an EU 7th framework grant ('Spacebrain' grant agreement 200873), and Centre of Excellence (145993), equipment (181676) and research (191929) grants from the Norwegian Research Council, and an Advanced Investigator Grant from the European Research Council ('CIRCUIT', grant 232608).	Acsady L, 1998, J NEUROSCI, V18, P3386; ALONSO A, 1993, J NEUROPHYSIOL, V70, P128, DOI 10.1152/jn.1993.70.1.128; AMARI SI, 1977, BIOL CYBERN, V27, P77, DOI 10.1007/BF00337259; Beed P, 2010, NEURON, V68, P1059, DOI 10.1016/j.neuron.2010.12.009; BENYISHAI R, 1995, P NATL ACAD SCI USA, V92, P3844, DOI 10.1073/pnas.92.9.3844; Berger TK, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000473; Berger TK, 2009, J PHYSIOL-LONDON, V587, P5411, DOI 10.1113/jphysiol.2009.176552; Boccara CN, 2010, NAT NEUROSCI, V13, P987, DOI 10.1038/nn.2602; Bonnevie T, 2013, NAT NEUROSCI, V16, P309, DOI 10.1038/nn.3311; Boucheny C, 2005, J COMPUT NEUROSCI, V18, P205, DOI 10.1007/s10827-005-6559-y; Brun VH, 2008, HIPPOCAMPUS, V18, P1200, DOI 10.1002/hipo.20504; Burak Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000291; Burgalossi A, 2011, NEURON, V70, P773, DOI 10.1016/j.neuron.2011.04.003; Burgess N, 2007, HIPPOCAMPUS, V17, P801, DOI 10.1002/hipo.20327; Canto CB, 2012, HIPPOCAMPUS, V22, P1277, DOI 10.1002/hipo.20993; Compte A, 2000, CEREB CORTEX, V10, P910, DOI 10.1093/cercor/10.9.910; Danglot L, 2006, HIPPOCAMPUS, V16, P1032, DOI 10.1002/hipo.20225; Dhillon A, 2000, NEUROSCIENCE, V99, P413, DOI 10.1016/S0306-4522(00)00225-6; Fuhs MC, 2006, J NEUROSCI, V26, P4266, DOI 10.1523/JNEUROSCI.4353-05.2006; Gatome CW, 2010, NEUROSCIENCE, V170, P156, DOI 10.1016/j.neuroscience.2010.06.048; Giocomo LM, 2008, J NEUROSCI, V28, P9414, DOI 10.1523/JNEUROSCI.3196-08.2008; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; JONES RSG, 1993, NEUROSCI LETT, V149, P35, DOI 10.1016/0304-3940(93)90341-H; Kang KJ, 2003, P NATL ACAD SCI USA, V100, P2848, DOI 10.1073/pnas.0138051100; Kapfer C, 2007, NAT NEUROSCI, V10, P743, DOI 10.1038/nn1909; Klink R, 1997, HIPPOCAMPUS, V7, P571; Kloosterman F, 2003, EUR J NEUROSCI, V18, P3037, DOI 10.1111/j.1460-9568.2003.03046.x; Kropff E, 2008, HIPPOCAMPUS, V18, P1256, DOI 10.1002/hipo.20520; Kumar SS, 2007, J NEUROSCI, V27, P1239, DOI 10.1523/JNEUROSCI.3182-06.2007; Langston RF, 2010, SCIENCE, V328, P1576, DOI 10.1126/science.1188210; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Morgan RJ, 2007, PROG BRAIN RES, V163, P639, DOI 10.1016/S0079-6123(07)63035-0; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Quilichini P, 2010, J NEUROSCI, V30, P11128, DOI 10.1523/JNEUROSCI.1327-10.2010; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Silberberg G, 2007, NEURON, V53, P735, DOI 10.1016/j.neuron.2007.02.012; Sills JB, 2012, HIPPOCAMPUS, V22, P1912, DOI 10.1002/hipo.22026; Song PC, 2005, J NEUROSCI, V25, P1002, DOI 10.1523/JNEUROSCI.4172-04.2005; TAMAMAKI N, 1993, HIPPOCAMPUS, V3, P471, DOI 10.1002/hipo.450030408; van Haeften T, 2003, HIPPOCAMPUS, V13, P943, DOI 10.1002/hipo.10144; Varga C, 2010, NAT NEUROSCI, V13, P822, DOI 10.1038/nn.2570; Witter MP, 2007, PROG BRAIN RES, V163, P43, DOI 10.1016/S0079-6123(07)63003-9; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Zhang K, 1996, J NEUROSCI, V16, P2112; Zilli EA, 2010, J NEUROSCI, V30, P13850, DOI 10.1523/JNEUROSCI.0547-10.2010	46	240	244	0	65	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2013	16	3					318	324		10.1038/nn.3310	http://dx.doi.org/10.1038/nn.3310			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	097LE	23334580				2022-12-17	WOS:000315474800014
J	Kim, MS; Pak, YK; Jang, PG; Namkoong, C; Choi, YS; Won, JC; Kim, KS; Kim, SW; Kim, HS; Park, JY; Kim, YB; Lee, KU				Kim, Min-Seon; Pak, Youngmi K.; Jang, Pil-Geum; Namkoong, Cherl; Choi, Yon-Sik; Won, Jong-Chul; Kim, Kyung-Sup; Kim, Seung-Whan; Kim, Hyo-Soo; Park, Joong-Yeol; Kim, Young-Bum; Lee, Ki-Up			Role of hypothalamic Foxo1 in the regulation of food intake and energy homeostasis	NATURE NEUROSCIENCE			English	Article						t	GENE-EXPRESSION; PROTEASOMAL DEGRADATION; RAT HYPOTHALAMUS; INDUCED ANOREXIA; ARCUATE NUCLEUS; BODY-WEIGHT; FAT-BODY; INSULIN; LEPTIN; BRAIN	Insulin signaling in the hypothalamus plays a role in maintaining body weight. Studies suggest that the forkhead transcription factor Foxo1 is an important mediator of insulin signaling in peripheral tissues. Here we demonstrate that in normal mice, hypothalamic Foxo1 expression is reduced by the anorexigenic hormones insulin and leptin. These hormones' effects on feeding are inhibited when hypothalamic Foxo1 is activated, establishing a new signaling pathway through which insulin and leptin regulate food intake in hypothalamic neurons. Moreover, activation of Foxo1 in the hypothalamus increases food intake and body weight, whereas inhibition of Foxo1 decreases both. Foxo1 stimulates the transcription of the orexigenic neuropeptide Y and Agouti-related protein through the phosphatidylinositol-3-kinase ( PI3K)/Akt signaling pathway, but suppresses the transcription of anorexigenic proopiomelanocortin by antagonizing the activity of signal transducer-activated transcript-3 ( STAT3). Our data suggest that hypothalamic Foxo1 is an important regulator of food intake and energy balance.	Univ Ulsan, Coll Med, Dept Internal Med, Seoul 138736, South Korea; Univ Ulsan, Coll Med, Asan Inst Life Sci, Seoul 138736, South Korea; Yonsei Univ, Sch Med, Dept Biochem & Mol Biol, Seoul 120752, South Korea; Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 110744, South Korea; Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA	University of Ulsan; University of Ulsan; Yonsei University; Seoul National University (SNU); Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Lee, KU (corresponding author), Univ Ulsan, Coll Med, Dept Internal Med, 138-736 Pungnapdong, Seoul 138736, South Korea.	kulee@amc.seoul.kr	Pak, Youngmi Kim/AAI-1091-2020; Kim, Hyo Soo/J-2753-2012; Choi, Hyung Jin/AAU-9629-2020	Pak, Youngmi Kim/0000-0001-7424-3484; Kim, Kyung-sup/0000-0001-8483-8537; NamKoong, Cherl/0000-0002-1869-4405; Won, Jong Chul/0000-0002-2219-4083; Kim, Seung-Whan/0000-0001-6983-0481				Aoki M, 2004, P NATL ACAD SCI USA, V101, P13613, DOI 10.1073/pnas.0405454101; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Burks DJ, 2000, NATURE, V407, P377, DOI 10.1038/35030105; CANICK JA, 1986, BRAIN RES, V372, P277, DOI 10.1016/0006-8993(86)91135-2; Furukawa N, 2005, CELL METAB, V2, P119, DOI 10.1016/j.cmet.2005.06.011; Furuyama T, 2003, BIOCHEM J, V375, P365, DOI 10.1042/BJ20030022; Giannakou ME, 2004, SCIENCE, V305, P361, DOI 10.1126/science.1098219; Hall RK, 2000, J BIOL CHEM, V275, P30169, DOI 10.1074/jbc.M004898200; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Kim MS, 2004, NAT MED, V10, P727, DOI 10.1038/nm1061; Kim MS, 2000, J CLIN INVEST, V105, P1005, DOI 10.1172/JCI8857; Kitamura T, 2002, J CLIN INVEST, V110, P1839, DOI 10.1172/JCI200216857; Matsuzaki H, 2003, P NATL ACAD SCI USA, V100, P11285, DOI 10.1073/pnas.1934283100; Morton GJ, 2003, ENDOCRINOLOGY, V144, P2016, DOI 10.1210/en.2002-0115; Munzberg H, 2003, ENDOCRINOLOGY, V144, P2121, DOI 10.1210/en.2002-221037; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Niswender KD, 2003, DIABETES, V52, P227, DOI 10.2337/diabetes.52.2.227; Niswender KD, 2001, NATURE, V413, P794, DOI 10.1038/35101657; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Schwartz MW, 1996, J CLIN INVEST, V98, P1101, DOI 10.1172/JCI118891; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Spiegel A, 2005, NAT NEUROSCI, V8, P552, DOI 10.1038/nn0505-552; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Wolak ML, 2003, J COMP NEUROL, V464, P285, DOI 10.1002/cne.10823; WOODS SC, 1979, NATURE, V282, P503, DOI 10.1038/282503a0; Xu AW, 2005, J CLIN INVEST, V115, P951, DOI 10.1172/JCI200524301; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	27	240	251	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2006	9	7					901	906		10.1038/nn1731	http://dx.doi.org/10.1038/nn1731			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	057IZ	16783365				2022-12-17	WOS:000238590800016
J	McPeek, RM; Keller, EL				McPeek, RM; Keller, EL			Deficits in saccade target selection after inactivation of superior colliculus	NATURE NEUROSCIENCE			English	Article							DORSOLATERAL PREFRONTAL CORTEX; LATERAL INTRAPARIETAL AREA; REVERSIBLE INACTIVATION; EYE-MOVEMENTS; NEURONAL-ACTIVITY; MONKEY; FIELD; DISCRIMINATION; INVOLVEMENT; GENERATION	Saccades are rapid eye movements that orient gaze toward areas of interest in the visual scene. Neural activity correlated with saccade target selection has been identified in several brain regions, including the superior colliculus (SC), but it is not known whether the SC is directly involved in target selection, or whether the SC merely receives selection-related signals from cortex in preparation for the execution of eye movements. In monkeys, we used focal reversible inactivation to test the functional contributions of the SC to target selection during visual search, and found that inactivation resulted in clear deficits. When a target appeared in the inactivated field, saccades were often misdirected to distractor stimuli. Control tasks showed that this deficit was not caused by low-level visual or motor impairments. Our results indicate that, in addition to its well-established involvement in movement execution, the SC has an important functional role in target selection.	Smith Kettlewell Eye Res Inst, San Francisco, CA 94115 USA	The Smith-Kettlewell Eye Research Institute	McPeek, RM (corresponding author), Smith Kettlewell Eye Res Inst, 2318 Fillmore St, San Francisco, CA 94115 USA.	rmm@ski.org			NATIONAL EYE INSTITUTE [R01EY014885] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY014885-01, R01 EY014885, R01-EY014885, R01-EY08060] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Aizawa H, 1998, J NEUROPHYSIOL, V79, P2082, DOI 10.1152/jn.1998.79.4.2082; Basso MA, 1997, NATURE, V389, P66, DOI 10.1038/37975; BURMAN DD, 1994, J NEUROPHYSIOL, V71, P1266, DOI 10.1152/jn.1994.71.3.1266; Chen LTL, 2001, J NEUROSCI METH, V107, P81, DOI 10.1016/S0165-0270(01)00354-5; Chimoto S, 1996, J NEUROPHYSIOL, V75, P2658, DOI 10.1152/jn.1996.75.6.2658; Chou IH, 1999, VISION RES, V39, P4200, DOI 10.1016/S0042-6989(99)00133-9; Clark JJ, 1999, VISION RES, V39, P585, DOI 10.1016/S0042-6989(98)00190-4; Findlay JM, 1999, BEHAV BRAIN SCI, V22, P661, DOI 10.1017/S0140525X99002150; GLIMCHER PW, 1992, NATURE, V355, P542, DOI 10.1038/355542a0; Goldberg ME, 2002, ANN NY ACAD SCI, V956, P205, DOI 10.1111/j.1749-6632.2002.tb02820.x; Green DM., 1966, SIGNAL DETECTION THE; Hasegawa RP, 2000, J NEUROPHYSIOL, V84, P1692, DOI 10.1152/jn.2000.84.3.1692; HIKOSAKA O, 1986, EXP BRAIN RES, V61, P531; HIKOSAKA O, 1985, J NEUROPHYSIOL, V53, P266, DOI 10.1152/jn.1985.53.1.266; Horwitz GD, 1999, SCIENCE, V284, P1158, DOI 10.1126/science.284.5417.1158; Iba M, 2003, J NEUROPHYSIOL, V89, P587, DOI 10.1152/jn.00148.2002; Itti L, 2000, VISION RES, V40, P1489, DOI 10.1016/S0042-6989(99)00163-7; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; KOCH C, 1985, HUM NEUROBIOL, V4, P219; Krauzlis RJ, 2002, NEURON, V35, P355, DOI 10.1016/S0896-6273(02)00756-0; Lomber SG, 1999, J NEUROSCI METH, V86, P109, DOI 10.1016/S0165-0270(98)00160-5; McPeek RM, 2003, J NEUROPHYSIOL, V89, P2577, DOI 10.1152/jn.00657.2002; McPeek RM, 2002, J NEUROPHYSIOL, V88, P2019, DOI 10.1152/jn.2002.88.4.2019; Miyashita N, 1996, EXP BRAIN RES, V112, P187; MOHLER CW, 1973, BRAIN RES, V61, P385, DOI 10.1016/0006-8993(73)90543-X; MOHLER CW, 1977, J NEUROPHYSIOL, V40, P74, DOI 10.1152/jn.1977.40.1.74; Olson CR, 2000, J NEUROPHYSIOL, V84, P1369, DOI 10.1152/jn.2000.84.3.1369; OTTES FP, 1987, EXP BRAIN RES, V66, P465, DOI 10.1007/BF00270679; Platt ML, 1997, J NEUROPHYSIOL, V78, P1574, DOI 10.1152/jn.1997.78.3.1574; Port NL, 2003, J NEUROPHYSIOL, V90, P1887, DOI 10.1152/jn.01151.2002; Quaia C, 1998, J NEUROPHYSIOL, V79, P2097, DOI 10.1152/jn.1998.79.4.2097; RAYBOURN MS, 1977, J NEUROPHYSIOL, V40, P861, DOI 10.1152/jn.1977.40.4.861; ROVAMO J, 1979, EXP BRAIN RES, V37, P495, DOI 10.1007/bf00236819; Schall JD, 1999, ANNU REV NEUROSCI, V22, P241, DOI 10.1146/annurev.neuro.22.1.241; Schiller PH, 2003, EUR J NEUROSCI, V18, P3127, DOI 10.1111/j.1460-9568.2003.03036.x; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; SOLOMON SJ, 1981, EXP BRAIN RES, V44, P259; Sparks D L, 1989, Rev Oculomot Res, V3, P213; SPARKS DL, 1990, COLD SPRING HARB SYM, V55, P805; Stanford TR, 1996, J NEUROPHYSIOL, V76, P3360, DOI 10.1152/jn.1996.76.5.3360; VETTER RJ, 1975, INT J NEUROSCI, V6, P215, DOI 10.3109/00207457509149495; Wardak C, 2002, J NEUROSCI, V22, P9877; WOLFE JM, 1994, PSYCHON B REV, V1, P202, DOI 10.3758/BF03200774; WURTZ RH, 1980, PROGR PSYCHOBIOLOGY, V9, P43	44	240	244	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2004	7	7					757	763		10.1038/nn1269	http://dx.doi.org/10.1038/nn1269			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	832NO	15195099				2022-12-17	WOS:000222274400018
J	Engblom, D; Saha, S; Engstrom, L; Westman, M; Audoly, LP; Jakobsson, PJ; Blomqvist, A				Engblom, D; Saha, S; Engstrom, L; Westman, M; Audoly, LP; Jakobsson, PJ; Blomqvist, A			Microsomal prostaglandin E synthase-1 is the central switch during immune-induced pyresis	NATURE NEUROSCIENCE			English	Article							MICE LACKING; IDENTIFICATION; INDUCTION; CELLS	We studied the febrile response in mice deficient in microsomal prostaglandin E synthase-1 (mPGES-1), an inducible terminal isomerase expressed in cytokine-sensitive brain endothelial cells. These animals showed no fever and no central prostaglandin (PG) E-2 synthesis after peripheral injection of bacterial-wall lipopolysaccharide, but their pyretic capacity in response to centrally administered PGE(2) was intact. Our findings identify mPGES-1 as the central switch during immune-induced pyresis and as a target for the treatment of fever and other PGE(2)-dependent acute phase reactions elicited by the brain.	Linkoping Univ, Fac Hlth Sci, Div Cell Biol, S-58185 Linkoping, Sweden; Karolinska Inst, Ctr Struct Biochem, S-14157 Huddinge, Sweden; Karolinska Inst, Dept Biochem & Biophys, S-17177 Stockholm, Sweden; Pfizer Inc, Global Res & Dev, Groton Labs, Inflammat Unit, Groton, CT 06340 USA	Linkoping University; Karolinska Institutet; Karolinska Institutet; Pfizer	Blomqvist, A (corresponding author), Linkoping Univ, Fac Hlth Sci, Div Cell Biol, S-58185 Linkoping, Sweden.	andbl@ibk.liu.se	Blomqvist, Anders/K-3990-2019; Jakobsson, Per-Johan/ABC-5594-2021	Blomqvist, Anders/0000-0002-6928-4473; Engstrom Ruud, Linda/0000-0002-3924-5844				Dinarello CA, 1999, CURR BIOL, V9, pR147, DOI 10.1016/S0960-9822(99)80085-2; Ek M, 2001, NATURE, V410, P430, DOI 10.1038/35068632; Elmquist JK, 1997, TRENDS NEUROSCI, V20, P565, DOI 10.1016/S0166-2236(97)01138-7; Engblom D, 2002, J COMP NEUROL, V452, P205, DOI 10.1002/cne.10380; Engblom D, 2002, J MOL MED, V80, P5, DOI 10.1007/s00109-001-0289-z; Inoue W, 2002, NEUROSCI RES, V44, P51, DOI 10.1016/S0168-0102(02)00083-4; Jakobsson PJ, 1999, P NATL ACAD SCI USA, V96, P7220, DOI 10.1073/pnas.96.13.7220; Laflamme N, 1999, J NEUROSCI, V19, P10923, DOI 10.1523/JNEUROSCI.19-24-10923.1999; Tanikawa N, 2002, BIOCHEM BIOPH RES CO, V291, P884, DOI 10.1006/bbrc.2002.6531; Tanioka T, 2000, J BIOL CHEM, V275, P32775, DOI 10.1074/jbc.M003504200; Trebino CE, 2003, P NATL ACAD SCI USA, V100, P9044, DOI 10.1073/pnas.1332766100; Ushikubi F, 1998, NATURE, V395, P281, DOI 10.1038/26233; Wang JP, 1997, NEUROIMMUNOMODULAT, V4, P230, DOI 10.1159/000097341; Yamagata K, 2001, J NEUROSCI, V21, P2669, DOI 10.1523/JNEUROSCI.21-08-02669.2001	14	240	259	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2003	6	11					1137	1138		10.1038/nn1137	http://dx.doi.org/10.1038/nn1137			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	737KH	14566340				2022-12-17	WOS:000186229200009
J	Yan, Z; Hsieh-Wilson, L; Feng, JA; Tomizawa, K; Allen, PB; Fienberg, AA; Nairn, AC; Greengard, P				Yan, Z; Hsieh-Wilson, L; Feng, JA; Tomizawa, K; Allen, PB; Fienberg, AA; Nairn, AC; Greengard, P			Protein phosphatase 1 modulation of neostriatal AMPA channels: regulation by DARPP-32 and spinophilin	NATURE NEUROSCIENCE			English	Article							TERM SYNAPTIC DEPRESSION; REDUCE N-TYPE; GLUTAMATE RECEPTORS; HIPPOCAMPAL-NEURONS; BASAL GANGLIA; CHOLINERGIC INTERNEURONS; DOPAMINE-RECEPTORS; DENDRITIC SPINES; CA2+ CURRENTS; KINASE	Modulation of AMPA-type glutamate channels is important for synaptic plasticity. Here we provide physiological evidence that the activity of AMPA channels is regulated by protein phosphatase 1 (PP-1) in neostriatal neurons and identify two distinct molecular mechanisms of this regulation. One mechanism involves control of PP-1 catalytic activity by DARPP-32, a dopamine- and cAMP-regulated phosphoprotein highly enriched in neostriatum. The other involves binding of PP-1 to spinophilin, a protein that colocalizes PP-1 with AMPA receptors in postsynaptic densities. The results suggest that regulation of anchored PP-1 is important for AMPA-receptor-mediated synaptic transmission and plasticity.	Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA	Rockefeller University	Greengard, P (corresponding author), Rockefeller Univ, Mol & Cellular Neurosci Lab, 1230 York Ave, New York, NY 10021 USA.			Nairn, Angus/0000-0002-7075-0195	NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH040899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010044] Funding Source: NIH RePORTER; NIDA NIH HHS [DA 10044, P01 DA010044] Funding Source: Medline; NIMH NIH HHS [MH 40899] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Allen PB, 1997, P NATL ACAD SCI USA, V94, P9956, DOI 10.1073/pnas.94.18.9956; Beal M F, 1992, Curr Opin Neurobiol, V2, P657, DOI 10.1016/0959-4388(92)90035-J; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; CALABRESI P, 1992, J NEUROSCI, V12, P4224; Calabresi P, 1996, TRENDS NEUROSCI, V19, P19, DOI 10.1016/0166-2236(96)81862-5; CEPEDA C, 1993, P NATL ACAD SCI USA, V90, P9576, DOI 10.1073/pnas.90.20.9576; COHEN P, 1988, METHOD ENZYMOL, V159, P390; CRAIG AM, 1993, NEURON, V10, P1055, DOI 10.1016/0896-6273(93)90054-U; DAVIS KL, 1991, AM J PSYCHIAT, V148, P1474; Egloff MP, 1997, EMBO J, V16, P1876, DOI 10.1093/emboj/16.8.1876; Fienberg AA, 1998, SCIENCE, V281, P838, DOI 10.1126/science.281.5378.838; Gao TY, 1997, NEURON, V19, P185, DOI 10.1016/S0896-6273(00)80358-X; GERFEN CR, 1992, ANNU REV NEUROSCI, V15, P285, DOI 10.1146/annurev.neuro.15.1.285; Goslin K., 1991, CULTURING NERVE CELL, P251; Gotz T, 1997, J NEUROSCI, V17, P204; GREENGARD P, 1991, SCIENCE, V253, P1135, DOI 10.1126/science.1716001; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HEMMINGS HC, 1984, NATURE, V310, P503, DOI 10.1038/310503a0; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; HUBBARD MJ, 1993, TRENDS BIOCHEM SCI, V18, P172, DOI 10.1016/0968-0004(93)90109-Z; Kwon YG, 1997, P NATL ACAD SCI USA, V94, P3536, DOI 10.1073/pnas.94.8.3536; LINDEN DJ, 1994, NEURON, V12, P457, DOI 10.1016/0896-6273(94)90205-4; MANABE T, 1992, NATURE, V355, P50, DOI 10.1038/355050a0; MCGLADEMCCULLOH E, 1993, NATURE, V362, P640, DOI 10.1038/362640a0; OUIMET CC, 1995, P NATL ACAD SCI USA, V92, P3396, DOI 10.1073/pnas.92.8.3396; PATERNAIN AV, 1995, NEURON, V14, P185, DOI 10.1016/0896-6273(95)90253-8; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; PETRALIA RS, 1992, J COMP NEUROL, V318, P329, DOI 10.1002/cne.903180309; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; ROSENMUND C, 1993, NEURON, V10, P805, DOI 10.1016/0896-6273(93)90197-Y; ROSENMUND C, 1994, NATURE, V368, P853, DOI 10.1038/368853a0; SEEBURG PH, 1993, TRENDS NEUROSCI, V16, P359, DOI 10.1016/0166-2236(93)90093-2; SURMEIER DJ, 1995, NEURON, V14, P385, DOI 10.1016/0896-6273(95)90294-5; Surmeier DJ, 1996, J NEUROSCI, V16, P6579, DOI 10.1523/jneurosci.16-20-06579.1996; WALAAS SI, 1983, NATURE, V301, P69; WANG LY, 1991, SCIENCE, V253, P1132, DOI 10.1126/science.1653455; Yan Z, 1996, J NEUROSCI, V16, P2592; Yan Z, 1997, J NEUROPHYSIOL, V77, P1003, DOI 10.1152/jn.1997.77.2.1003; Yan Z, 1997, NEURON, V19, P1115, DOI 10.1016/S0896-6273(00)80402-X	40	240	248	0	15	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	1999	2	1					13	17		10.1038/4516	http://dx.doi.org/10.1038/4516			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	163MK	10195174				2022-12-17	WOS:000078409300007
J	Lyst, MJ; Ekiert, R; Ebert, DH; Merusi, C; Nowak, J; Selfridge, J; Guy, J; Kastan, NR; Robinson, ND; Alves, FD; Rappsilber, J; Greenberg, ME; Bird, A				Lyst, Matthew J.; Ekiert, Robert; Ebert, Daniel H.; Merusi, Cara; Nowak, Jakub; Selfridge, Jim; Guy, Jacky; Kastan, Nathaniel R.; Robinson, Nathaniel D.; Alves, Flavia de Lima; Rappsilber, Juri; Greenberg, Michael E.; Bird, Adrian			Rett syndrome mutations abolish the interaction of MeCP2 with the NCoR/SMRT co-repressor	NATURE NEUROSCIENCE			English	Article							CPG-BINDING PROTEIN-2; EMBRYONIC STEM-CELLS; TRANSCRIPTIONAL REPRESSION; METHYLATED DNA; CHROMATIN; BRAIN; MICE; PHOSPHORYLATION; GENERATION; NEURONS	Rett syndrome (RTT) is a severe neurological disorder that is caused by mutations in the MECP2 gene. Many missense mutations causing RTT are clustered in the DNA-binding domain of MeCP2, suggesting that association with chromatin is critical for its function. We identified a second mutational cluster in a previously uncharacterized region of MeCP2. We found that RTT mutations in this region abolished the interaction between MeCP2 and the NCoR/SMRT co-repressor complexes. Mice bearing a common missense RTT mutation in this domain exhibited severe RTT-like phenotypes. Our data are compatible with the hypothesis that brain dysfunction in RTT is caused by a loss of the MeCP2 'bridge' between the NCoR/SMRT co-repressors and chromatin.	[Lyst, Matthew J.; Ekiert, Robert; Merusi, Cara; Nowak, Jakub; Selfridge, Jim; Guy, Jacky; Alves, Flavia de Lima; Rappsilber, Juri; Bird, Adrian] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh, Midlothian, Scotland; [Ebert, Daniel H.; Kastan, Nathaniel R.; Robinson, Nathaniel D.; Greenberg, Michael E.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	University of Edinburgh; Harvard University; Harvard Medical School	Bird, A (corresponding author), Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh, Midlothian, Scotland.	a.bird@ed.ac.uk	Rappsilber, Juri/ABF-3328-2020; Nowak, Jakub Stanislaw/AFZ-0547-2022; Rappsilber, Juri/B-7265-2015	Nowak, Jakub Stanislaw/0000-0001-6536-2940; Rappsilber, Juri/0000-0001-5999-1310; Lyst, Matthew/0000-0001-9018-4138; Guy, Jacky/0000-0002-8440-5667; Bird, Adrian/0000-0002-8600-0372; SELFRIDGE, JIM/0000-0003-2473-4386; Ekiert, Robert/0000-0002-8879-0646	Rett Syndrome Research Trust; Wellcome Trust; NIH [R01NS048276, K08MH90306]; NIHP30-HD [18655]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH090306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048276] Funding Source: NIH RePORTER	Rett Syndrome Research Trust; Wellcome Trust(Wellcome TrustEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIHP30-HD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Harrison Gabel for advice and materials, and Martha Koerner, Thomas Clouaire and Sabine Lagger for comments on the manuscript. The work was supported by a grant to A.B. and M.E.G. from the Rett Syndrome Research Trust and by grants from the Wellcome Trust (to A.B.) and the NIH R01NS048276 (to M.E.G.). D.H.E. was supported by NIH grant K08MH90306. The Mouse Gene Manipulation Facility of the Boston Children's Hospital Intellectual and Developmental Disabilities Research Center (IDDRC) was supported by grant NIHP30-HD 18655. R.E. and J.N. were funded by Wellcome Trust 4 year PhD studentships and J.R. holds a Wellcome Trust Senior Fellowship.	Agarwal N, 2011, HUM MOL GENET, V20, P4187, DOI 10.1093/hmg/ddr346; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; ARAKI K, 1995, P NATL ACAD SCI USA, V92, P160, DOI 10.1073/pnas.92.1.160; BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Christodoulou J, 2003, HUM MUTAT, V21, P466, DOI 10.1002/humu.10194; Cohen S, 2011, NEURON, V72, P72, DOI 10.1016/j.neuron.2011.08.022; COOPER DN, 1990, HUM GENET, V85, P55; Dragatsis I, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.3.e10; Drewell RA, 2002, NUCLEIC ACIDS RES, V30, P1139, DOI 10.1093/nar/30.5.1139; Ebert DH, 2013, NATURE, V499, P341, DOI 10.1038/nature12348; Fyfe S, 2003, J CHILD NEUROL, V18, P709, DOI 10.1177/08830738030180100301; Goffin D, 2012, NAT NEUROSCI, V15, P274, DOI 10.1038/nn.2997; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Guy J, 2011, ANNU REV CELL DEV BI, V27, P631, DOI 10.1146/annurev-cellbio-092910-154121; Horike S, 2005, NAT GENET, V37, P31, DOI 10.1038/ng1491; Jiang Y, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-42; Klose RJ, 2004, J BIOL CHEM, V279, P46490, DOI 10.1074/jbc.M408284200; Kokura K, 2001, J BIOL CHEM, V276, P34115, DOI 10.1074/jbc.M105747200; Kudo S, 2003, J MED GENET, V40, P487, DOI 10.1136/jmg.40.7.487; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; Li M, 1998, CURR BIOL, V8, P971, DOI 10.1016/S0960-9822(98)70399-9; Muotri AR, 2010, NATURE, V468, P443, DOI 10.1038/nature09544; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Ricciardi S, 2011, HUM MOL GENET, V20, P1182, DOI 10.1093/hmg/ddq563; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; Schanen C, 2004, AM J MED GENET A, V126A, P129, DOI 10.1002/ajmg.a.20571; Schmiedeberg L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004636; Shahbazian MD, 2002, NEURON, V35, P243, DOI 10.1016/S0896-6273(02)00768-7; Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030; Stancheva I, 2003, MOL CELL, V12, P425, DOI 10.1016/S1097-2765(03)00276-4; Watson PJ, 2012, MOL CELL ENDOCRINOL, V348, P440, DOI 10.1016/j.mce.2011.08.033; Young JI, 2005, P NATL ACAD SCI USA, V102, P17551, DOI 10.1073/pnas.0507856102; Yusufzai TM, 2000, NUCLEIC ACIDS RES, V28, P4172, DOI 10.1093/nar/28.21.4172; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037	38	239	243	2	65	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2013	16	7					898	U268		10.1038/nn.3434	http://dx.doi.org/10.1038/nn.3434			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174UM	23770565	Green Accepted			2022-12-17	WOS:000321180900023
J	Orr, AG; Orr, AL; Li, XJ; Gross, RE; Traynelis, SF				Orr, Anna G.; Orr, Adam L.; Li, Xiao-Jiang; Gross, Robert E.; Traynelis, Stephen F.			Adenosine A(2A) receptor mediates microglial process retraction	NATURE NEUROSCIENCE			English	Article							NERVOUS-SYSTEM; RAT MICROGLIA; EXTRACELLULAR NUCLEOTIDES; PARKINSONS-DISEASE; CULTURED MICROGLIA; SIGNALING PATHWAYS; GENE-EXPRESSION; PROTEIN-KINASE; IN-VIVO; CELLS	Cell motility drives many biological processes, including immune responses and embryonic development. In the brain, microglia are immune cells that survey and scavenge brain tissue using elaborate and motile cell processes. The motility of these processes is guided by the local release of chemoattractants. However, most microglial processes retract during prolonged brain injury or disease. This hallmark of brain inflammation remains unexplained. We identified a molecular pathway in mouse and human microglia that converted ATP-driven process extension into process retraction during inflammation. This chemotactic reversal was driven by upregulation of the A(2A) adenosine receptor coincident with P2Y(12) downregulation. Thus, A(2A) receptor stimulation by adenosine, a breakdown product of extracellular ATP, caused activated microglia to assume their characteristic amoeboid morphology during brain inflammation. Our results indicate that purine nucleotides provide an opportunity for context-dependent shifts in receptor signaling. Thus, we reveal an unexpected chemotactic switch that generates a hallmark feature of CNS inflammation.	[Orr, Anna G.; Traynelis, Stephen F.] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA; [Orr, Adam L.; Li, Xiao-Jiang] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; [Gross, Robert E.] Emory Univ, Sch Med, Dept Neurosurg, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University	Orr, AG (corresponding author), Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA.	anna.orr@gladstone.ucsf.edu; strayne@emory.edu		Orr, Anna/0000-0002-4036-4277	US National Institutes of Health National Research Service; US National Institutes of Health [P01 ES016731]; National Parkinson's Foundation; US National Institutes of Health funding; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES012870, P01ES016731] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS054515] Funding Source: NIH RePORTER	US National Institutes of Health National Research Service; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Parkinson's Foundation; US National Institutes of Health funding; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank B. D. Shur, R. Dingledine and J. M. Boss for discussions on the manuscript, J. Olson for assistance in the studies of human microglia, and E. R. Weeks and D. Semwogerere in the Emory University Department of Physics for useful discussions of image analysis techniques. We are also grateful to K. M. Vellano, A. G. Almonte and J. B. Revennaugh for excellent technical assistance with cell cultures, imaging equipment and animal maintenance. This work was supported by a US National Institutes of Health National Research Service Award fellowship to A. G. O., a pilot grant from the US National Institutes of Health (P01 ES016731), the National Parkinson's Foundation (S. F. T.) and US National Institutes of Health funding for S. F.	Angulo E, 2003, BRAIN PATHOL, V13, P440; Bianco F, 2005, BRAIN RES REV, V48, P144, DOI 10.1016/j.brainresrev.2004.12.004; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Braun N, 1997, BRAIN RES, V766, P213, DOI 10.1016/S0006-8993(97)00559-3; Braun N, 2000, EUR J NEUROSCI, V12, P4357, DOI 10.1046/j.1460-9568.2000.01342.x; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Bystrova MF, 2006, CELL TISSUE RES, V323, P377, DOI 10.1007/s00441-005-0098-8; Chen Y, 2004, J LEUKOCYTE BIOL, V76, P245, DOI 10.1189/jlb.0204066; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Farber K, 2008, GLIA, V56, P331, DOI 10.1002/glia.20606; Feng CL, 2004, J IMMUNOL, V173, P7539, DOI 10.4049/jimmunol.173.12.7539; Fiebich BL, 1996, GLIA, V18, P152, DOI 10.1002/(SICI)1098-1136(199610)18:2<152::AID-GLIA7>3.0.CO;2-2; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Grijelmo C, 2007, CELL SIGNAL, V19, P1722, DOI 10.1016/j.cellsig.2007.03.008; Guthrie PB, 1999, J NEUROSCI, V19, P520, DOI 10.1523/jneurosci.19-02-00520.1999; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hashmi AZ, 2007, AM J PHYSIOL-GASTR L, V292, pG395, DOI 10.1152/ajpgi.00208.2006; Haynes SE, 2006, NAT NEUROSCI, V9, P1512, DOI 10.1038/nn1805; Heese K, 1997, NEUROSCI LETT, V231, P83, DOI 10.1016/S0304-3940(97)00545-4; Honda S, 2001, J NEUROSCI, V21, P1975, DOI 10.1523/JNEUROSCI.21-06-01975.2001; Hoskin DW, 2002, INT J CANCER, V99, P386, DOI 10.1002/ijc.10325; JAKOB A, 1927, HDB PSYCHIAT, V1, P268; Klegeris A, 2005, NEUROBIOL AGING, V26, P673, DOI 10.1016/j.neurobiolaging.2004.06.012; Koizumi S, 2003, P NATL ACAD SCI USA, V100, P11023, DOI 10.1073/pnas.1834448100; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Kust BM, 1999, GLIA, V25, P120; Kyrkanides S, 2002, MOL BRAIN RES, V104, P159, DOI 10.1016/S0169-328X(02)00353-4; Magasawa SY, 2005, BIOCHEM J, V385, P737, DOI 10.1042/BJ20041060; Min KJ, 2004, EXP MOL MED, V36, P461, DOI 10.1038/emm.2004.58; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; Moller T, 2000, BRAIN RES, V853, P49, DOI 10.1016/S0006-8993(99)02244-1; Murphree LJ, 2005, BIOCHEM J, V391, P575, DOI 10.1042/BJ20050888; Nasu-Tada K, 2005, GLIA, V52, P98, DOI 10.1002/glia.20224; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Nolte C, 1996, NEUROSCIENCE, V73, P1091, DOI 10.1016/0306-4522(96)00106-6; Ongini E, 1996, TRENDS PHARMACOL SCI, V17, P364, DOI 10.1016/S0165-6147(96)10045-6; Park JS, 2005, J NEUROIMMUNOL, V168, P56, DOI 10.1016/j.jneuroim.2005.07.003; Pedata F, 2001, ANN NY ACAD SCI, V939, P74; Popoli P, 2007, PROG NEUROBIOL, V81, P331, DOI 10.1016/j.pneurobio.2006.12.005; Rodriguez-Nunez A, 2001, J CHILD NEUROL, V16, P704, DOI 10.1177/088307380101600918; SCHOEN SW, 1992, GLIA, V6, P314, DOI 10.1002/glia.440060410; Schwarzschild MA, 2006, TRENDS NEUROSCI, V29, P647, DOI 10.1016/j.tins.2006.09.004; Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.3.CO;2-A; Tha KK, 2000, BRAIN RES, V885, P25, DOI 10.1016/S0006-8993(00)02883-3; TOMOZAWA Y, 1995, NEUROSCI RES, V22, P399, DOI 10.1016/0168-0102(95)00922-G; Verderio C, 2001, J IMMUNOL, V166, P6383, DOI 10.4049/jimmunol.166.10.6383; Wang CX, 2002, PROG NEUROBIOL, V67, P161, DOI 10.1016/S0301-0082(02)00010-2; Wittendorp MC, 2004, GLIA, V46, P410, DOI 10.1002/glia.20016; Xu K, 2005, PHARMACOL THERAPEUT, V105, P267, DOI 10.1016/j.pharmthera.2004.10.007; Zhang B, 2002, NEUROPHARMACOLOGY, V42, P262, DOI 10.1016/S0028-3908(01)00174-5	50	239	250	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2009	12	7					872	U84		10.1038/nn.2341	http://dx.doi.org/10.1038/nn.2341			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	462OA	19525944	Green Accepted			2022-12-17	WOS:000267362900014
J	Wallace, DL; Han, MH; Graham, DL; Green, TA; Vialou, V; Iniguez, SD; Cao, JL; Kirk, A; Chakravarty, S; Kumar, A; Krishnan, V; Neve, RL; Cooper, DC; Bolanos, CA; Barrot, M; McClung, CA; Nestler, EJ				Wallace, Deanna L.; Han, Ming-Hu; Graham, Danielle L.; Green, Thomas A.; Vialou, Vincent; Iniguez, Sergio D.; Cao, Jun-Li; Kirk, Anne; Chakravarty, Sumana; Kumar, Arvind; Krishnan, Vaishnav; Neve, Rachael L.; Cooper, Don C.; Bolanos, Carlos A.; Barrot, Michel; McClung, Colleen A.; Nestler, Eric J.			CREB regulation of nucleus accumbens excitability mediates social isolation-induced behavioral deficits	NATURE NEUROSCIENCE			English	Article							ELEMENT-BINDING PROTEIN; ANTIDEPRESSANT TREATMENT; GENE-TRANSCRIPTION; SEXUAL-BEHAVIOR; EMOTIONAL STIMULI; MOOD DISORDERS; COCAINE REWARD; RATS; EXPRESSION; STRESS	Here, we characterized behavioral abnormalities induced by prolonged social isolation in adult rodents. Social isolation induced both anxiety- and anhedonia-like symptoms and decreased cAMP response element-binding protein (CREB) activity in the nucleus accumbens shell (NAcSh). All of these abnormalities were reversed by chronic, but not acute, antidepressant treatment. However, although the anxiety phenotype and its reversal by antidepressant treatment were CREB-dependent, the anhedonia-like symptoms were not mediated by CREB in NAcSh. We found that decreased CREB activity in NAcSh correlated with increased expression of certain K+ channels and reduced electrical excitability of NAcSh neurons, which was sufficient to induce anxiety-like behaviors and was reversed by chronic antidepressant treatment. Together, our results describe a model that distinguishes anxiety- and depression-like behavioral phenotypes, establish a selective role of decreased CREB activity in NAcSh in anxiety- like behavior, and provide a mechanism by which antidepressant treatment alleviates anxiety symptoms after social isolation.	[Wallace, Deanna L.; Han, Ming-Hu; Graham, Danielle L.; Green, Thomas A.; Vialou, Vincent; Cao, Jun-Li; Kirk, Anne; Chakravarty, Sumana; Kumar, Arvind; Krishnan, Vaishnav; Cooper, Don C.; McClung, Colleen A.; Nestler, Eric J.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Wallace, Deanna L.; Han, Ming-Hu; Graham, Danielle L.; Green, Thomas A.; Vialou, Vincent; Cao, Jun-Li; Kirk, Anne; Chakravarty, Sumana; Kumar, Arvind; Krishnan, Vaishnav; Cooper, Don C.; McClung, Colleen A.; Nestler, Eric J.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Vialou, Vincent; Nestler, Eric J.] Mt Sinai Sch Med, Fishberg Dept Neurosci, Boston, MA 02115 USA; [Iniguez, Sergio D.; Bolanos, Carlos A.] Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA; [Neve, Rachael L.] Harvard Univ, McLean Hosp, Sch Med, Dept Psychiat, Belmont, MA 02178 USA; [Barrot, Michel] CNRS, UMR7168, Inst Neurosci Cellulaires & Integrat, F-67084 Strasbourg, France; [Barrot, Michel] Univ Strasbourg, F-67084 Strasbourg, France	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Icahn School of Medicine at Mount Sinai; State University System of Florida; Florida State University; Harvard University; McLean Hospital; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Nestler, EJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Psychiat, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	eric.nestler@mssm.edu	Iniguez, Sergio D/J-2410-2015; Kumar, Arvind/B-6094-2009; Chakravarty, Sumana/AAW-2823-2021; Graham, Danielle L/K-8459-2014; vialou, vincent/F-2968-2013; Yan, Shuo/B-8381-2009; McClung, Colleen/AAA-5943-2019; Han, Ming-Hu/G-8836-2012	Iniguez, Sergio D/0000-0001-5748-4219; vialou, vincent/0000-0002-8212-751X; Cao, Jun-Li/0000-0002-8932-4743; Krishnan, Vaishnav/0000-0002-2847-0069; Kumar, Arvind/0000-0003-2879-3826	National Institute of Mental Health; National Alliance of Research for Schizophrenia and Depression; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH051399, P50MH066172] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA008227, K01DA017750] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Alliance of Research for Schizophrenia and Depression; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from the National Institute of Mental Health (E.J.N.) and National Alliance of Research for Schizophrenia and Depression (M.-H.H.).	AHMED SH, 1995, PSYCHOPHARMACOLOGY, V117, P116, DOI 10.1007/BF02245106; Balfour ME, 2004, NEUROPSYCHOPHARMACOL, V29, P718, DOI 10.1038/sj.npp.1300350; Barrot M, 2002, P NATL ACAD SCI USA, V99, P11435, DOI 10.1073/pnas.172091899; Barrot M, 2005, P NATL ACAD SCI USA, V102, P8357, DOI 10.1073/pnas.0500587102; Bell TJ, 2008, P NATL ACAD SCI USA, V105, P1901, DOI 10.1073/pnas.0711796105; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Berton O, 2006, NAT REV NEUROSCI, V7, P137, DOI 10.1038/nrn1846; Blendy JA, 2006, BIOL PSYCHIAT, V59, P1144, DOI 10.1016/j.biopsych.2005.11.003; Bolanos CA, 2003, BIOL PSYCHIAT, V54, P1317, DOI 10.1016/S0006-3223(03)00570-5; Brown ES, 1999, NEUROPSYCHOPHARMACOL, V21, P474, DOI 10.1016/S0893-133X(99)00054-8; Carlezon WA, 1998, SCIENCE, V282, P2272, DOI 10.1126/science.282.5397.2272; Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005; Chen ACH, 2001, BIOL PSYCHIAT, V49, P753, DOI 10.1016/S0006-3223(00)01114-8; Conti AC, 2004, MOL NEUROBIOL, V30, P143, DOI 10.1385/MN:30:2:143; Costello J, 2000, J ADV NURS, V32, P1374, DOI 10.1046/j.1365-2648.2000.01625.x; de Jong TR, 2006, NEUROSCI BIOBEHAV R, V30, P893, DOI 10.1016/j.neubiorev.2006.01.001; DEROCHE V, 1994, BRAIN RES, V640, P136, DOI 10.1016/0006-8993(94)91867-8; Dong Y, 2006, NAT NEUROSCI, V9, P475, DOI 10.1038/nn1661; Dulawa SC, 2005, NEUROSCI BIOBEHAV R, V29, P771, DOI 10.1016/j.neubiorev.2005.03.017; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Ehlers CL, 2007, BEHAV NEUROSCI, V121, P111, DOI 10.1037/0735-7044.121.1.111; Ferguson JM, 2001, J CLIN PSYCHIAT, V62, P22; GRECO AM, 1990, PHYSIOL BEHAV, V48, P67, DOI 10.1016/0031-9384(90)90262-3; Grippo AJ, 2007, PSYCHOSOM MED, V69, P149, DOI 10.1097/PSY.0b013e31802f054b; Hall FS, 1998, CRIT REV NEUROBIOL, V12, P129, DOI 10.1615/CritRevNeurobiol.v12.i1-2.50; Heinrich LA, 2006, CLIN PSYCHOL REV, V26, P695, DOI 10.1016/j.cpr.2006.04.002; Hull EM, 2007, HORM BEHAV, V52, P45, DOI 10.1016/j.yhbeh.2007.03.030; Impey S, 1998, NAT NEUROSCI, V1, P595, DOI 10.1038/2830; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Kumar A, 2005, NEURON, V48, P303, DOI 10.1016/j.neuron.2005.09.023; McClung CA, 2003, NAT NEUROSCI, V6, P1208, DOI 10.1038/nn1143; Meisel RL, 2006, BRAIN RES, V1126, P56, DOI 10.1016/j.brainres.2006.08.050; MENDELSON SD, 1991, NEUROENDOCRINOLOGY, V54, P454, DOI 10.1159/000125951; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Newton SS, 2002, J NEUROSCI, V22, P10883; Nibuya M, 1996, J NEUROSCI, V16, P2365; Pandey SC, 2005, ALCOHOL CLIN EXP RES, V29, P176, DOI 10.1097/01.ALC.0000153550.31168.1D; Pandey SC, 2004, PHARMACOL THERAPEUT, V104, P47, DOI 10.1016/j.pharmthera.2004.08.002; Pliakas AM, 2001, J NEUROSCI, V21, P7397, DOI 10.1523/JNEUROSCI.21-18-07397.2001; Rothschild AJ, 2000, J CLIN PSYCHIAT, V61, P28; Salkoff L, 2006, NAT REV NEUROSCI, V7, P921, DOI 10.1038/nrn1992; Stranahan AM, 2006, NAT NEUROSCI, V9, P526, DOI 10.1038/nn1668; Thome J, 2000, J NEUROSCI, V20, P4030; Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132; Warner-Schmidt JL, 2006, HIPPOCAMPUS, V16, P239, DOI 10.1002/hipo.20156; Yirmiya R, 1996, BRAIN RES, V711, P163, DOI 10.1016/0006-8993(95)01415-2	46	239	241	1	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2009	12	2					200	209		10.1038/nn.2257	http://dx.doi.org/10.1038/nn.2257			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	404VV	19151710	Green Accepted			2022-12-17	WOS:000263182000021
J	Reyes, AD				Reyes, AD			Synchrony-dependent propagation of firing rate in iteratively constructed networks in vitro	NATURE NEUROSCIENCE			English	Article							CAT NEOCORTICAL NEURONS; CORTICAL-NEURONS; IN-VIVO; PYRAMIDAL NEURONS; BEHAVING MONKEYS; NEURAL NETWORKS; CORTEX NEURONS; VISUAL-CORTEX; MOTOR CORTEX; MODULATION	The precise role of synchronous neuronal firing in signal encoding remains unclear. To examine what kinds of signals can be carried by synchrony, I reproduced a multilayer feedforward network of neurons in an in vitro slice preparation of rat cortex using an iterative procedure. When constant and time-varying frequency signals were delivered to the network, the firing of neurons in successive layers became progressively more synchronous. Notably, synchrony in the in vitro network developed even with uncorrelated input, persisted under a wide range of physiological conditions and was crucial for the stable propagation of rate signals. The firing rate was represented by a classical rate code in the initial layers, but switched to a synchrony-based code in the deeper layers.	NYU, Ctr Neural Sci, New York, NY 10003 USA	New York University	Reyes, AD (corresponding author), NYU, Ctr Neural Sci, 4 Washington Pl, New York, NY 10003 USA.	reyes@cns.nyu.edu						ABELES M, 1993, J NEUROPHYSIOL, V70, P1629, DOI 10.1152/jn.1993.70.4.1629; Azouz R, 2003, NEURON, V37, P513, DOI 10.1016/S0896-6273(02)01186-8; Azouz R, 1999, J NEUROSCI, V19, P2209; Baker SN, 2001, J NEUROPHYSIOL, V85, P869, DOI 10.1152/jn.2001.85.2.869; Baker SN, 1999, EXP BRAIN RES, V128, P109, DOI 10.1007/s002210050825; Baker SN, 1997, J PHYSIOL-LONDON, V504P, pP116; Barlow H B, 1972, Perception, V1, P371, DOI 10.1068/p010371; Borst A, 1999, NAT NEUROSCI, V2, P947, DOI 10.1038/14731; Cateau H, 2001, NEURAL NETWORKS, V14, P675, DOI 10.1016/S0893-6080(01)00065-X; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; CONNORS BW, 1990, TRENDS NEUROSCI, V13, P99, DOI 10.1016/0166-2236(90)90185-D; Conway BA, 1995, J PHYSIOL-LONDON, V489, P917, DOI 10.1113/jphysiol.1995.sp021104; deCharms RC, 2000, ANNU REV NEUROSCI, V23, P613, DOI 10.1146/annurev.neuro.23.1.613; Diesmann M, 1999, NATURE, V402, P529, DOI 10.1038/990101; DIESMANN M, 2001, NEUROCOMPUTING, V565, P38; Feige B, 2000, J NEUROPHYSIOL, V84, P2622, DOI 10.1152/jn.2000.84.5.2622; FERSTER D, 1995, SCIENCE, V270, P756, DOI 10.1126/science.270.5237.756; FETZ E, 1991, CEREB CORTEX, V9, P1; Gewaltig MO, 2001, NEURAL NETWORKS, V14, P657, DOI 10.1016/S0893-6080(01)00070-3; Hatsopoulos NG, 1998, P NATL ACAD SCI USA, V95, P15706, DOI 10.1073/pnas.95.26.15706; Holt GR, 1996, J NEUROPHYSIOL, V75, P1806, DOI 10.1152/jn.1996.75.5.1806; Litvak V, 2003, J NEUROSCI, V23, P3006; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Markram H, 1998, P NATL ACAD SCI USA, V95, P5323, DOI 10.1073/pnas.95.9.5323; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; Matsumura M, 1996, J NEUROSCI, V16, P7757; Mazurek ME, 2002, NAT NEUROSCI, V5, P463, DOI 10.1038/nn836; Meister M, 1999, NEURON, V22, P435, DOI 10.1016/S0896-6273(00)80700-X; MURTHY VN, 1992, P NATL ACAD SCI USA, V89, P5670, DOI 10.1073/pnas.89.12.5670; Oviedo H, 2002, NAT NEUROSCI, V5, P261, DOI 10.1038/nn807; Panzeri S, 2001, NEURON, V29, P769, DOI 10.1016/S0896-6273(01)00251-3; PERKEL DH, 1967, BIOPHYS J, V7, P419, DOI 10.1016/S0006-3495(67)86597-4; PINSKY PF, 1995, BIOL CYBERN, V73, P129, DOI 10.1007/BF00204051; Prut Y, 1998, J NEUROPHYSIOL, V79, P2857, DOI 10.1152/jn.1998.79.6.2857; Reyes A, 1999, J NEUROSCI, V19, P3827; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; Reyes AD, 1996, J NEUROSCI, V16, P993; REYES AD, 1993, J NEUROPHYSIOL, V69, P1661, DOI 10.1152/jn.1993.69.5.1661; REYES AD, 1993, J NEUROPHYSIOL, V69, P1673, DOI 10.1152/jn.1993.69.5.1673; Riehle A, 1997, SCIENCE, V278, P1950, DOI 10.1126/science.278.5345.1950; SCHWARTZ K, 1984, EUR HEART J, V5, P77, DOI 10.1093/eurheartj/5.suppl_F.77; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; Shadlen MN, 1999, NEURON, V24, P67, DOI 10.1016/S0896-6273(00)80822-3; Shadlen MN, 1998, J NEUROSCI, V18, P3870; SHARP AA, 1993, TRENDS NEUROSCI, V16, P389, DOI 10.1016/0166-2236(93)90004-6; SOFTKY WR, 1993, J NEUROSCI, V13, P334; Stevens CF, 1998, NAT NEUROSCI, V1, P210, DOI 10.1038/659; van Rossum MCW, 2002, J NEUROSCI, V22, P1956, DOI 10.1523/JNEUROSCI.22-05-01956.2002; Van Rullen R, 2001, NEURAL COMPUT, V13, P1255, DOI 10.1162/08997660152002852	49	239	243	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2003	6	6					593	599		10.1038/nn1056	http://dx.doi.org/10.1038/nn1056			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	683GQ	12730700				2022-12-17	WOS:000183140400016
J	Carlson, G; Wang, Y; Alger, BE				Carlson, G; Wang, Y; Alger, BE			Endocannabinoids facilitate the induction of LTP in the hippocampus	NATURE NEUROSCIENCE			English	Article							DEPOLARIZATION-INDUCED SUPPRESSION; PYRAMIDAL CELLS; CANNABINOIDS; INHIBITION; GABA; POTENTIATION; TERMINALS; NEURONS		Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Alger, BE (corresponding author), Univ Maryland, Sch Med, Dept Physiol, 655 W Baltimore St, Baltimore, MD 21201 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030219, R01NS036612] Funding Source: NIH RePORTER; NINDS NIH HHS [NS30219, NS36612] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Di Marzo V, 1998, TRENDS NEUROSCI, V21, P521, DOI 10.1016/S0166-2236(98)01283-1; Ekstrom AD, 2001, NEURON, V31, P631, DOI 10.1016/S0896-6273(01)00401-9; Hajos N, 2001, NEUROSCIENCE, V106, P1, DOI 10.1016/S0306-4522(01)00287-1; KANDEL ER, 1961, J NEUROPHYSIOL, V24, P243, DOI 10.1152/jn.1961.24.3.243; Katona I, 1999, J NEUROSCI, V19, P4544; Le Beau FEN, 1998, J NEUROPHYSIOL, V79, P659, DOI 10.1152/jn.1998.79.2.659; Lenz RA, 1999, J PHYSIOL-LONDON, V521, P147, DOI 10.1111/j.1469-7793.1999.00147.x; LLANO I, 1991, NEURON, V6, P565, DOI 10.1016/0896-6273(91)90059-9; MALINOW R, 1990, NATURE, V346, P177, DOI 10.1038/346177a0; Ohno-Shosaku T, 2001, NEURON, V29, P729, DOI 10.1016/S0896-6273(01)00247-1; PITLER TA, 1992, J NEUROSCI, V12, P4122; Sullivan JM, 2000, LEARN MEMORY, V7, P132, DOI 10.1101/lm.7.3.132; Wagner JJ, 1996, J PHYSIOL-LONDON, V495, P107, DOI 10.1113/jphysiol.1996.sp021577; WIGSTROM H, 1985, ACTA PHYSIOL SCAND, V125, P159, DOI 10.1111/j.1748-1716.1985.tb07703.x; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076	15	239	246	0	14	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2002	5	8					723	724		10.1038/nn879	http://dx.doi.org/10.1038/nn879			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	577XT	12080342				2022-12-17	WOS:000177088900011
J	Longden, TA; Dabertrand, F; Koide, M; Gonzales, AL; Tykocki, NR; Brayden, JE; Hill-Eubanks, D; Nelson, MT				Longden, Thomas A.; Dabertrand, Fabrice; Koide, Masayo; Gonzales, Albert L.; Tykocki, Nathan R.; Brayden, Joseph E.; Hill-Eubanks, David; Nelson, Mark T.			Capillary K+-sensing initiates retrograde hyperpolarization to increase local cerebral blood flow	NATURE NEUROSCIENCE			English	Article							SMOOTH-MUSCLE-CELLS; RECTIFYING POTASSIUM CHANNELS; BRAIN PARENCHYMAL ARTERIOLES; BK CHANNELS; MICROVASCULATURE; CONSTRICTION; VASODILATION; MICROVESSELS; ARCHITECTURE; MODULATION	Blood flow into the brain is dynamically regulated to satisfy the changing metabolic requirements of neurons, but how this is accomplished has remained unclear. Here we demonstrate a central role for capillary endothelial cells in sensing neural activity and communicating it to upstream arterioles in the form of an electrical vasodilatory signal. We further demonstrate that this signal is initiated by extracellular K+-a byproduct of neural activity-which activates capillary endothelial cell inward-rectifier K+ (K(IR)2.1) channels to produce a rapidly propagating retrograde hyperpolarization that causes upstream arteriolar dilation, increasing blood flow into the capillary bed. Our results establish brain capillaries as an active sensory web that converts changes in external K+ into rapid, 'inside-out' electrical signaling to direct blood flow to active brain regions.	[Longden, Thomas A.; Dabertrand, Fabrice; Koide, Masayo; Gonzales, Albert L.; Tykocki, Nathan R.; Brayden, Joseph E.; Hill-Eubanks, David; Nelson, Mark T.] Univ Vermont, Dept Pharmacol, Burlington, VT 05405 USA; [Nelson, Mark T.] Univ Manchester, Inst Cardiovasc Sci, Manchester, Lancs, England	University of Vermont; University of Manchester	Nelson, MT (corresponding author), Univ Vermont, Dept Pharmacol, Burlington, VT 05405 USA.; Nelson, MT (corresponding author), Univ Manchester, Inst Cardiovasc Sci, Manchester, Lancs, England.	mark.nelson@uvm.edu	Tykocki, Nathan R./AAE-6393-2019	Tykocki, Nathan R./0000-0001-5432-7656; Longden, Thomas/0000-0002-7950-7677; Dabertrand, Fabrice/0000-0003-2541-9185; Nelson, Mark/0000-0002-6608-8784	American Heart Association [14POST20480144, 14SDG20150027]; United Leukodystrophy Foundation; Totman Medical Research Trust; Fondation Leducq; European Union [666881]; National Institutes of Health [R01-HL-136636, T32HL-007594, K01-DK103840, P30-GM-103498, P01-HL-095488, R01-HL-121706, R37-DK-053832, 7UM-HL-1207704, R01-HL-131181]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL136636, P01HL095488, T32HL007594, R01HL131181, R01HL121706, UM1HL120877] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK053832, K01DK103840] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103498] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); United Leukodystrophy Foundation; Totman Medical Research Trust; Fondation Leducq(Leducq Foundation); European Union(European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors gratefully acknowledge J. Barry for assistance with local field potential recordings and analysis, and S. O'Dwyer and M. Ross for technical assistance. This study was supported by a postdoctoral fellowship (14POST20480144 to T.A.L.) and a scientist development grant (14SDG20150027 to M.K.) from the American Heart Association, and grants from the United Leukodystrophy Foundation (to F.D.), the Totman Medical Research Trust (to M.T.N.), Fondation Leducq (to M.T.N.), European Union's Horizon 2020 research and innovation programme (grant agreement No 666881, SVDs@target, to M.T.N.), and National Institutes of Health (R01-HL-136636 to F.D.; T32HL-007594 to A.L.G.; K01-DK103840 to N.R.T.; P30-GM-103498 to the COBRE imaging facility at UVM College of Medicine; P01-HL-095488, R01-HL-121706, R37-DK-053832, 7UM-HL-1207704 and R01-HL-131181 to M.T.N.).	Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Ayata C, 2015, PHYSIOL REV, V95, P953, DOI 10.1152/physrev.00027.2014; AYDIN F, 1991, STROKE, V22, P1592, DOI 10.1161/01.STR.22.12.1592; Ballanyi K, 1996, J PHYSIOL-LONDON, V495, P769, DOI 10.1113/jphysiol.1996.sp021632; Barry JM, 2016, EBIOMEDICINE, V7, P175, DOI 10.1016/j.ebiom.2016.03.039; Beach JM, 1998, AM J PHYSIOL-HEART C, V275, pH1489, DOI 10.1152/ajpheart.1998.275.4.H1489; Blinder P, 2013, NAT NEUROSCI, V16, P889, DOI 10.1038/nn.3426; Cauli B, 2004, J NEUROSCI, V24, P8940, DOI 10.1523/JNEUROSCI.3065-04.2004; Chen BR, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000787; Dabertrand F, 2015, P NATL ACAD SCI USA, V112, pE796, DOI 10.1073/pnas.1420765112; Dabertrand F, 2013, J CEREBR BLOOD F MET, V33, P479, DOI 10.1038/jcbfm.2013.9; Dabertrand F, 2012, CIRC RES, V110, P285, DOI 10.1161/CIRCRESAHA.111.258145; DAUT J, 1994, J CARDIOVASC ELECTR, V5, P154, DOI 10.1111/j.1540-8167.1994.tb01156.x; Figueroa XF, 2009, ANTIOXID REDOX SIGN, V11, P251, DOI 10.1089/ars.2008.2117; Filosa JA, 2006, NAT NEUROSCI, V9, P1397, DOI 10.1038/nn1779; Garcia-Amado M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038692; Girouard H, 2010, P NATL ACAD SCI USA, V107, P3811, DOI 10.1073/pnas.0914722107; Hall CN, 2014, NATURE, V508, P55, DOI 10.1038/nature13165; Hannah RM, 2011, J CEREBR BLOOD F MET, V31, P1175, DOI 10.1038/jcbfm.2010.214; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Iadecola C, 2007, NAT NEUROSCI, V10, P1369, DOI 10.1038/nn2003; Knot HJ, 1996, J PHYSIOL-LONDON, V492, P419, DOI 10.1113/jphysiol.1996.sp021318; KUSCHINSKY W, 1972, CIRC RES, V31, P240, DOI 10.1161/01.RES.31.2.240; Ledoux J, 2006, PHYSIOLOGY, V21, P69, DOI 10.1152/physiol.00040.2005; Ledoux J, 2008, P NATL ACAD SCI USA, V105, P9627, DOI 10.1073/pnas.0801963105; Leithner C, 2010, J CEREBR BLOOD F MET, V30, P311, DOI 10.1038/jcbfm.2009.211; Longden TA, 2015, MICROCIRCULATION, V22, P183, DOI 10.1111/micc.12190; Masamoto K, 2015, SCI REP-UK, V5, DOI 10.1038/srep11455; Matsushita K, 2006, J PHYSIOL-LONDON, V573, P483, DOI 10.1113/jphysiol.2006.107102; Mitra P., 2008, OBSERVED BRAIN DYNAM; NELSON MT, 1990, AM J PHYSIOL, V259, pC3; Nishimura N, 2007, P NATL ACAD SCI USA, V104, P365, DOI 10.1073/pnas.0609551104; Nystoriak MA, 2011, AM J PHYSIOL-HEART C, V300, pH803, DOI 10.1152/ajpheart.00760.2010; QUAYLE JM, 1993, AM J PHYSIOL, V265, pC1363, DOI 10.1152/ajpcell.1993.265.5.C1363; Quayle JM, 1997, PHYSIOL REV, V77, P1165, DOI 10.1152/physrev.1997.77.4.1165; Shih AY, 2015, MICROCIRCULATION, V22, P204, DOI 10.1111/micc.12195; Simard M, 2003, J NEUROSCI, V23, P9254; Sonkusare SK, 2016, J PHYSIOL-LONDON, V594, P3271, DOI 10.1113/JP271652; Strobaek D, 2004, BBA-BIOMEMBRANES, V1665, P1, DOI 10.1016/j.bbamem.2004.07.006; Toussay X, 2013, J NEUROSCI, V33, P3390, DOI 10.1523/JNEUROSCI.3346-12.2013; Tsai PS, 2009, J NEUROSCI, V29, P14553, DOI 10.1523/JNEUROSCI.3287-09.2009; Uhlirova H, 2016, ELIFE, V5, DOI [10.7554/elife.14315, 10.7554/eLife.14315]; Vetri F, 2012, AM J PHYSIOL-HEART C, V302, pH1274, DOI 10.1152/ajpheart.01067.2011; Wei HS, 2016, NEURON, V91, P851, DOI 10.1016/j.neuron.2016.07.016; Westcott EB, 2012, J PHYSIOL-LONDON, V590, P1849, DOI 10.1113/jphysiol.2011.222083; Wu DM, 2006, MICROCIRCULATION, V13, P353, DOI 10.1080/10739680600745778; Ye WL, 2016, P NATL ACAD SCI USA, V113, pE229, DOI 10.1073/pnas.1514282112; Zaritsky JJ, 2000, CIRC RES, V87, P160, DOI 10.1161/01.RES.87.2.160; Zhang T, 2011, J PHYSIOL-LONDON, V589, P2383, DOI 10.1113/jphysiol.2010.202937; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]	50	238	239	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2017	20	5					717	+		10.1038/nn.4533	http://dx.doi.org/10.1038/nn.4533			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ET1CU	28319610	Green Accepted			2022-12-17	WOS:000400004300013
J	Raposo, D; Kaufman, MT; Churchland, AK				Raposo, David; Kaufman, Matthew T.; Churchland, Anne K.			A category-free neural population supports evolving demands during decision-making	NATURE NEUROSCIENCE			English	Article							LATERAL INTRAPARIETAL AREA; VISUAL RESPONSE PROPERTIES; PARIETAL CORTEX; V1 NEURONS; INFORMATION; CHOICE; SELECTIVITY; MOVEMENTS; DISCHARGE; RATS	The posterior parietal cortex (PPC) receives diverse inputs and is involved in a dizzying array of behaviors. These many behaviors could rely on distinct categories of neurons specialized to represent particular variables or could rely on a single population of PPC neurons that is leveraged in different ways. To distinguish these possibilities, we evaluated rat PPC neurons recorded during multisensory decisions. Newly designed tests revealed that task parameters and temporal response features were distributed randomly across neurons, without evidence of categories. This suggests that PPC neurons constitute a dynamic network that is decoded according to the animal's present needs. To test for an additional signature of a dynamic network, we compared moments when behavioral demands differed: decision and movement. Our new state-space analysis revealed that the network explored different dimensions during decision and movement. These observations suggest that a single network of neurons can support the evolving behavioral demands of decision-making.	[Raposo, David; Kaufman, Matthew T.; Churchland, Anne K.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Raposo, David; Kaufman, Matthew T.] Champalimaud Neurosci Programme, Lisbon, Portugal	Cold Spring Harbor Laboratory; Fundacao Champalimaud	Churchland, AK (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	churchland@cshl.edu	Kaufman, Matthew/AAK-2860-2020	Kaufman, Matthew/0000-0002-8072-023X; Churchland, Anne/0000-0002-3205-3794	US National Institutes of Health [EY019072, EY022979]; John Merck Fund; McKnight Foundation; Marie Robertson Memorial Fund of Cold Spring Harbor Laboratory; Swartz Foundation fellowship; NATIONAL EYE INSTITUTE [R00EY019072, K99EY019072, R01EY022979] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John Merck Fund; McKnight Foundation; Marie Robertson Memorial Fund of Cold Spring Harbor Laboratory; Swartz Foundation fellowship; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank P. Znamenskiy, S. Jaramillo and T. Zador for technical advice, K. Rockland and A. Licata for help with histology, J. Sheppard and M. Ryan for help with electrophysiology and neural clustering, and M. Carandini and A. Rangel for providing input to early versions of the manuscript. Funding for this work was provided by US National Institutes of Health grants EY019072 and EY022979, the John Merck Fund, the McKnight Foundation, the Marie Robertson Memorial Fund of Cold Spring Harbor Laboratory, and a Swartz Foundation fellowship.	Angelaki DE, 2009, CURR OPIN NEUROBIOL, V19, P452, DOI 10.1016/j.conb.2009.06.008; Arimura N, 2013, J NEUROSCI, V33, P13639, DOI 10.1523/JNEUROSCI.1620-13.2013; Balan PF, 2009, J NEUROSCI, V29, P8166, DOI 10.1523/JNEUROSCI.0243-09.2009; Balan PF, 2008, PLOS BIOL, V6, P1443, DOI 10.1371/journal.pbio.0060158; BARLOW HB, 1953, J PHYSIOL-LONDON, V119, P69, DOI 10.1113/jphysiol.1953.sp004829; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; Brunton BW, 2013, SCIENCE, V340, P95, DOI 10.1126/science.1233912; Chen JL, 2013, NATURE, V499, P336, DOI 10.1038/nature12236; Churchland AK, 2005, J NEUROPHYSIOL, V94, P1084, DOI 10.1152/jn.00196.2005; Churchland AK, 2008, NAT NEUROSCI, V11, P693, DOI 10.1038/nn.2123; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1007/BF00994018; El-Shamayleh Y, 2013, J NEUROSCI, V33, P16594, DOI 10.1523/JNEUROSCI.2753-13.2013; Freedman DJ, 2009, J NEUROSCI, V29, P5671, DOI 10.1523/JNEUROSCI.2878-08.2009; Ganguli S, 2012, ANNU REV NEUROSCI, V35, P485, DOI 10.1146/annurev-neuro-062111-150410; GEORGOPOULOS AP, 1982, J NEUROSCI, V2, P1527; Ghazanfar AA, 2005, J NEUROSCI, V25, P5004, DOI 10.1523/JNEUROSCI.0799-05.2005; Glickfeld LL, 2013, J NEUROSCI, V33, P19416, DOI 10.1523/JNEUROSCI.3560-13.2013; Harvey CD, 2012, NATURE, V484, P62, DOI 10.1038/nature10918; Indyk P., 1998, Proceedings of the Thirtieth Annual ACM Symposium on Theory of Computing, P604, DOI 10.1145/276698.276876; Kaufman MT, 2014, NAT NEUROSCI, V17, P440, DOI 10.1038/nn.3643; Kiani R, 2009, SCIENCE, V324, P759, DOI 10.1126/science.1169405; KUFFLER SW, 1953, J NEUROPHYSIOL, V16, P37, DOI 10.1152/jn.1953.16.1.37; Li CSR, 1999, J NEUROPHYSIOL, V81, P1827, DOI 10.1152/jn.1999.81.4.1827; Linden JF, 1999, J NEUROPHYSIOL, V82, P343, DOI 10.1152/jn.1999.82.1.343; Mante V, 2013, NATURE, V503, P78, DOI 10.1038/nature12742; Meister MLR, 2013, J NEUROSCI, V33, P2254, DOI 10.1523/JNEUROSCI.2984-12.2013; Movshon JA, 1996, J NEUROSCI, V16, P7733; Mullette-Gillman OA, 2005, J NEUROPHYSIOL, V94, P2331, DOI 10.1152/jn.00021.2005; Nienborg H, 2006, J NEUROSCI, V26, P9567, DOI 10.1523/JNEUROSCI.2256-06.2006; Pagan M, 2013, NAT NEUROSCI, V16, P1132, DOI 10.1038/nn.3433; Pare M, 2001, J NEUROPHYSIOL, V85, P2545, DOI 10.1152/jn.2001.85.6.2545; Park IM, 2014, NAT NEUROSCI, V17, P1395, DOI 10.1038/nn.3800; Pouget A, 1997, J COGNITIVE NEUROSCI, V9, P222, DOI 10.1162/jocn.1997.9.2.222; Raposo D, 2012, J NEUROSCI, V32, P3726, DOI 10.1523/JNEUROSCI.4998-11.2012; REEP RL, 1994, EXP BRAIN RES, V100, P67; Rigotti M, 2013, NATURE, V497, P585, DOI 10.1038/nature12160; Rishel CA, 2013, NEURON, V77, P969, DOI 10.1016/j.neuron.2013.01.007; Rogan SC, 2011, PHARMACOL REV, V63, P291, DOI 10.1124/pr.110.003020; Roitman JD, 2002, J NEUROSCI, V22, P9475; Roth ED, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036035; Russo GS, 2002, J NEUROPHYSIOL, V88, P2612, DOI 10.1152/jn.00306.2002; Rust NC, 2010, J NEUROSCI, V30, P12978, DOI 10.1523/JNEUROSCI.0179-10.2010; Salinas E, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-47; SEGRAVES MA, 1992, J NEUROPHYSIOL, V68, P1967, DOI 10.1152/jn.1992.68.6.1967; Shams L, 2002, COGNITIVE BRAIN RES, V14, P147, DOI 10.1016/S0926-6410(02)00069-1; Sheppard JP, 2013, J VISION, V13, DOI 10.1167/13.6.4; Sussillo D, 2009, NEURON, V63, P544, DOI 10.1016/j.neuron.2009.07.018; Viswanathan P, 2013, P NATL ACAD SCI USA, V110, P11187, DOI 10.1073/pnas.1308141110	48	238	240	1	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2014	17	12					1784	1792		10.1038/nn.3865	http://dx.doi.org/10.1038/nn.3865			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AU2ZY	25383902	Green Accepted			2022-12-17	WOS:000345484000027
J	Eldar, E; Cohen, JD; Niv, Y				Eldar, Eran; Cohen, Jonathan D.; Niv, Yael			The effects of neural gain on attention and learning	NATURE NEUROSCIENCE			English	Article							BRAIN NETWORKS; NORADRENERGIC MODULATION; INSTRUMENTAL BEHAVIOR; PUPILLARY DILATION; RECONFIGURATION; NOREPINEPHRINE; RESPONSES; SIGNALS; INDEX	Attention is commonly thought to be manifest through local variations in neural gain. However, what would be the effects of brain-wide changes in gain? We hypothesized that global fluctuations in gain modulate the breadth of attention and the degree to which processing is focused on aspects of the environment to which one is predisposed to attend. We found that measures of pupil diameter, which are thought to track levels of locus coeruleus norepinephrine activity and neural gain, were correlated with the degree to which learning was focused on stimulus dimensions that individual human participants were more predisposed to process. In support of our interpretation of this effect in terms of global changes in gain, we found that the measured pupillary and behavioral variables were strongly correlated with global changes in the strength and clustering of functional connectivity, as brain-wide fluctuations of gain would predict.	[Eldar, Eran; Cohen, Jonathan D.; Niv, Yael] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA; [Cohen, Jonathan D.; Niv, Yael] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA	Princeton University; Princeton University	Eldar, E (corresponding author), Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA.	eeldar@princeton.edu			US National Institutes of Health [R03 DA029073, R01 MH098861]; Howard Hughes Medical Institute International Student Research fellowship; Sloan Research Fellowship; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH098861] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA029073] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute International Student Research fellowship(Howard Hughes Medical Institute); Sloan Research Fellowship(Alfred P. Sloan Foundation); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank N. Turk-Browne and P. Dayan for helpful comments on earlier versions of the manuscript. This research was funded by US National Institutes of Health grants R03 DA029073 and R01 MH098861, a Howard Hughes Medical Institute International Student Research fellowship to E.E. and a Sloan Research Fellowship to Y.N. The authors also wish to thank the generous support of the Regina and John Scully Center for the Neuroscience of Mind and Behavior in the Princeton Neuroscience Institute.	Alexander JK, 2007, J COGNITIVE NEUROSCI, V19, P468, DOI 10.1162/jocn.2007.19.3.468; Bassett DS, 2011, P NATL ACAD SCI USA, V108, P7641, DOI 10.1073/pnas.1018985108; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Campbell HL, 2008, PHARMACOL BIOCHEM BE, V88, P222, DOI 10.1016/j.pbb.2007.08.003; Coffield F., 2004, LEARNING STYLES PEDA; Dayan P, 2006, ADV NEURAL INFORM PR, V18, P243; Dias-Ferreira E, 2009, SCIENCE, V325, P621, DOI 10.1126/science.1171203; EASTERBROOK JA, 1959, PSYCHOL REV, V66, P183, DOI 10.1037/h0047707; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; Einhauser W, 2008, P NATL ACAD SCI USA, V105, P1704, DOI 10.1073/pnas.0707727105; Felder RM, 2005, INT J ENG EDUC, V21, P103; FELDER RM, 1988, ENG EDUC, V78, P674; Fisher R.A., 1921, METRON, V1, P3, DOI DOI 10.1093/BIOMET/9.1-2.22; Gilzenrat MS, 2010, COGN AFFECT BEHAV NE, V10, P252, DOI 10.3758/CABN.10.2.252; Haider B, 2009, NEURON, V62, P171, DOI 10.1016/j.neuron.2009.04.008; HOEKS B, 1993, BEHAV RES METH INSTR, V25, P16, DOI 10.3758/BF03204445; Jepma M, 2011, J COGNITIVE NEUROSCI, V23, P1587, DOI 10.1162/jocn.2010.21548; Kitzbichler MG, 2011, J NEUROSCI, V31, P8259, DOI 10.1523/JNEUROSCI.0440-11.2011; KOSS MC, 1986, J PHARMACOL METHOD, V15, P1, DOI 10.1016/0160-5402(86)90002-1; Lambert A, 2003, PERCEPT PSYCHOPHYS, V65, P495, DOI 10.3758/BF03194578; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; Luce R. D., 1949, PSYCHOMETRIKA, V14, P95; Maier A, 2008, NAT NEUROSCI, V11, P1193, DOI 10.1038/nn.2173; McClelland J. L., 1988, EXPLORATIONS PARALLE; Murphy PR, 2011, PSYCHOPHYSIOLOGY, V48, P1531, DOI 10.1111/j.1469-8986.2011.01226.x; Nicol RM, 2012, J NEUROPHYSIOL, V107, P1421, DOI 10.1152/jn.00817.2011; Reas C., 2014, PROCESSING PROGRAMMI, V2nd ed., P642; Salinas E, 2004, J NEUROSCI, V24, P1113, DOI 10.1523/JNEUROSCI.4569-03.2004; Salinas E, 2009, SPR SER COMPUT NEURO, V3, P121, DOI 10.1007/978-1-4419-0389-1_7; Schwabe L, 2011, J NEUROSCI, V31, P17317, DOI 10.1523/JNEUROSCI.3304-11.2011; Schwabe L, 2011, BEHAV BRAIN RES, V219, P321, DOI 10.1016/j.bbr.2010.12.038; Schwabe L, 2010, J NEUROSCI, V30, P8190, DOI 10.1523/JNEUROSCI.0734-10.2010; SERVANSCHREIBER D, 1990, SCIENCE, V249, P892, DOI 10.1126/science.2392679; Sirotin YB, 2009, NATURE, V457, P475, DOI 10.1038/nature07664; Staal MA, 2004, STRESS COGNITION HUM; WATERHOUSE BD, 1980, EXP NEUROL, V69, P30, DOI 10.1016/0014-4886(80)90141-7; WATERHOUSE BD, 1980, EXP NEUROL, V67, P11, DOI 10.1016/0014-4886(80)90159-4; WATERHOUSE BD, 1984, J PHARMACOL EXP THER, V228, P257	40	238	239	2	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2013	16	8					1146	U236		10.1038/nn.3428	http://dx.doi.org/10.1038/nn.3428			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190EV	23770566	Green Accepted			2022-12-17	WOS:000322323000027
J	Anderson, SM; Famous, KR; Sadri-Vakili, G; Kumaresan, V; Schmidt, HD; Bass, CE; Terwilliger, EF; Cha, JHJ; Pierce, RC				Anderson, Sharon M.; Famous, Katie R.; Sadri-Vakili, Ghazaleh; Kumaresan, Vidhya; Schmidt, Heath D.; Bass, Caroline E.; Terwilliger, Ernest F.; Cha, Jang-Ho J.; Pierce, R. Christopher			CaMKII: a biochemical bridge linking accumbens dopamine and glutamate systems in cocaine seeking	NATURE NEUROSCIENCE			English	Article							DEPENDENT PROTEIN-KINASE; VENTRAL TEGMENTAL AREA; RECEPTOR STIMULATION INCREASES; INDUCED BEHAVIORAL SENSITIZATION; PRIMING-INDUCED REINSTATEMENT; NUCLEUS-ACCUMBENS; AMPA RECEPTOR; SYNAPTIC PLASTICITY; DRUG-SEEKING; SURFACE EXPRESSION	Increases in dopamine and glutamate transmission in the nucleus accumbens independently promote the reinstatement of cocaine seeking, an animal model of relapse. Here we have tested whether cocaine reinstatement in rats depends on interactions between accumbal dopamine and glutamate systems that are mediated by Ca2+/calmodulin-mediated kinase II (CaMKII). We show that stimulation of D1-like dopamine receptors in the nucleus accumbens shell reinstates cocaine seeking by activating L-type Ca2+ channels and CaMKII. Cocaine reinstatement is associated with D1-like dopamine receptor-dependent increases in accumbens shell CaMKII phosphorylated on Thr286 and glutamate receptor 1 (GluR1) phosphorylated on Ser831 (a known CaMKII phosphorylation site), in addition to increases in cell-surface expression of GluR1-containing AMPA receptors in the shell. Consistent with these findings, cocaine reinstatement is attenuated by intra-shell administration of AAV10-GluR1-C99, a vector that impairs the transport of GluR1-containing AMPA receptors. Thus, CaMKII may be an essential link between accumbens shell dopamine and glutamate systems involved in the neuronal plasticity underlying cocaine craving and relapse.	[Anderson, Sharon M.; Famous, Katie R.; Kumaresan, Vidhya; Schmidt, Heath D.; Pierce, R. Christopher] Boston Univ, Sch Med, Dept Pharmacol, Boston, MA 02118 USA; [Pierce, R. Christopher] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; [Sadri-Vakili, Ghazaleh] Massachusetts Gen Hosp, Dept Neurol, MassGen Inst Neurodegenerat Dis, Charlestown, MA 02129 USA; [Bass, Caroline E.; Terwilliger, Ernest F.] Beth Israel Deaconess Med Ctr, Harvard Inst Med, Div Expt Med, Boston, MA 02115 USA; [Terwilliger, Ernest F.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Boston University; Boston University; Harvard University; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School	Pierce, RC (corresponding author), Boston Univ, Sch Med, Dept Pharmacol, 715 Albany St, Boston, MA 02118 USA.	rcpierce@bu.edu	Kumaresan, Vidhya/ABD-6847-2020	Kumaresan, Vidhya/0000-0002-3374-5741; Bass, Caroline/0000-0002-5856-6387	NIDA NIH HHS [K02 DA18678, R21 DA18333, R01 DA15214, F30 DA19304, DA16824, F32 DA017543] Funding Source: Medline; NIGMS NIH HHS [T32 GM008541-7] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015214, F32DA017543, R21DA018333, K02DA018678, F31DA016824, F30DA019304] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Anderson SM, 2003, PSYCHOPHARMACOLOGY, V168, P132, DOI 10.1007/s00213-002-1298-5; Bachtell RK, 2005, PSYCHOPHARMACOLOGY, V183, P41, DOI 10.1007/s00213-005-0133-1; Beurrier C, 2002, J NEUROSCI, V22, P5817; Boehm J, 2005, BIOCHEM SOC T, V33, P1354, DOI 10.1042/BST0331354; Boudreau AC, 2005, J NEUROSCI, V25, P9144, DOI 10.1523/JNEUROSCI.2252-05.2005; Boudreau AC, 2007, J NEUROSCI, V27, P10621, DOI 10.1523/JNEUROSCI.2163-07.2007; Chao SZ, 2002, J NEUROCHEM, V81, P984, DOI 10.1046/j.1471-4159.2002.00877.x; Chao SZ, 2002, J NEUROCHEM, V83, P704, DOI 10.1046/j.1471-4159.2002.01164.x; Chartoff EH, 2006, BIOL PSYCHIAT, V59, P1236, DOI 10.1016/j.biopsych.2005.09.024; Churchill L, 1999, J NEUROCHEM, V72, P2397, DOI 10.1046/j.1471-4159.1999.0722397.x; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Cooper DC, 2000, BRAIN RES, V880, P212, DOI 10.1016/S0006-8993(00)02868-7; Cornish JL, 1999, NEUROSCIENCE, V93, P1359, DOI 10.1016/S0306-4522(99)00214-6; Cornish JL, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-15-j0006.2000; Edwards S, 2007, EUR J NEUROSCI, V25, P2201, DOI 10.1111/j.1460-9568.2007.05473.x; Fitzgerald LW, 1996, J NEUROSCI, V16, P274; Frenkel MY, 2006, NEURON, V51, P339, DOI 10.1016/j.neuron.2006.06.026; Galarraga E, 1997, NEUROREPORT, V8, P2183, DOI 10.1097/00001756-199707070-00019; Gnegy ME, 2000, CRIT REV NEUROBIOL, V14, P91; Gonzalez-Islas C, 2003, J NEUROSCI, V23, P867; HernandezLopez S, 1997, J NEUROSCI, V17, P3334; Kalivas PW, 2005, NEURON, V45, P647, DOI 10.1016/j.neuron.2005.02.005; Kauer JA, 2007, NAT REV NEUROSCI, V8, P844, DOI 10.1038/nrn2234; Kourrich S, 2007, J NEUROSCI, V27, P7921, DOI 10.1523/JNEUROSCI.1859-07.2007; Licata SC, 2003, J NEUROCHEM, V85, P14, DOI 10.1046/j.1471-4159.2003.01662.x; Licata SC, 2004, EUR J NEUROSCI, V19, P405, DOI 10.1111/j.0953-816X.2003.03110.x; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Lu L, 2003, J NEUROCHEM, V85, P1604, DOI 10.1046/j.1471-4159.2003.01824.x; Lynch WJ, 2005, EUR J NEUROSCI, V22, P1214, DOI 10.1111/j.1460-9568.2005.04305.x; Mangiavacchi S, 2004, J NEUROCHEM, V88, P1261, DOI 10.1046/j.1471-4159.2003.02248.x; Martin M, 2006, NAT NEUROSCI, V9, P868, DOI 10.1038/nn1713; McFarland K, 2003, J NEUROSCI, V23, P3531; Park WK, 2002, J NEUROSCI, V22, P2916, DOI 10.1523/JNEUROSCI.22-07-02916.2002; Pierce RC, 1998, J PHARMACOL EXP THER, V286, P1171; Pierce RC, 2006, NEUROSCI BIOBEHAV R, V30, P215, DOI 10.1016/j.neubiorev.2005.04.016; Scheggi S, 2002, NEUROSCIENCE, V109, P267, DOI 10.1016/S0306-4522(01)00483-3; Schmidt HD, 2006, NEUROSCIENCE, V142, P451, DOI 10.1016/j.neuroscience.2006.06.004; Schmidt HD, 2006, EUR J NEUROSCI, V23, P219, DOI 10.1111/j.1460-9568.2005.04524.x; Schmidt HD, 2005, EUR J PHARMACOL, V526, P65, DOI 10.1016/j.ejphar.2005.09.068; Self DW, 1998, J NEUROSCI, V18, P1848; Snyder GL, 2000, J NEUROSCI, V20, P4480, DOI 10.1523/JNEUROSCI.20-12-04480.2000; Suemaru J, 2000, SYNAPSE, V36, P155, DOI 10.1002/(SICI)1098-2396(20000601)36:3<155::AID-SYN1>3.0.CO;2-N; SURMEIER DJ, 1995, NEURON, V14, P385, DOI 10.1016/0896-6273(95)90294-5; Suto N, 2004, NEUROPSYCHOPHARMACOL, V29, P2149, DOI 10.1038/sj.npp.1300533; Sutton MA, 2003, NATURE, V421, P70, DOI 10.1038/nature01249; Takahashi T, 2003, SCIENCE, V299, P1585, DOI 10.1126/science.1079886; Thomas MJ, 2001, NAT NEUROSCI, V4, P1217, DOI 10.1038/nn757; Wolf ME, 2004, NEUROPHARMACOLOGY, V47, P61, DOI 10.1016/j.neuropharm.2004.07.006; Yan Z, 1999, NAT NEUROSCI, V2, P13, DOI 10.1038/4516; Yao WD, 2004, NEURON, V41, P625, DOI 10.1016/S0896-6273(04)00048-0	50	238	245	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2008	11	3					344	353		10.1038/nn2054	http://dx.doi.org/10.1038/nn2054			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	267ZS	18278040				2022-12-17	WOS:000253548300018
J	Trehub, SE				Trehub, SE			The developmental origins of musicality	NATURE NEUROSCIENCE			English	Review							ABSOLUTE PITCH; INFANTS PERCEPTION; LANGUAGE; ADULTS; PREFERENCES; CONSONANCE; MOTHERESE; FACULTY	The study of musical abilities and activities in infancy has the potential to shed light on musical biases or dispositions that are rooted in nature rather than nurture. The available evidence indicates that infants are sensitive to a number of sound features that are fundamental to music across cultures. Their discrimination of pitch and timing differences and their perception of equivalence classes are similar, in many respects, to those of listeners who have had many years of exposure to music. Whether these perceptual skills are unique to human listeners is not known. What is unique is the intense human interest in music, which is evident from the early days of life. Also unique is the importance of music in social contexts. Current ideas about musical timing and interpersonal synchrony are considered here, along with proposals for future research.	Univ Toronto, Dept Psychol, Mississauga, ON L5L 1C6, Canada	University of Toronto; University Toronto Mississauga	Trehub, SE (corresponding author), Univ Toronto, Dept Psychol, Mississauga, ON L5L 1C6, Canada.	sandra.trehub@utoronto.ca						[Anonymous], 1998, ADV INFANCY RES; [Anonymous], 1995, KEEPING TOGETHER TIM; Benzon W, 2001, BEETHOVENS ANVIL MUS; Bergeson TR, 2002, PSYCHOL SCI, V13, P72, DOI 10.1111/1467-9280.00413; Besson M, 2001, ANN NY ACAD SCI, V930, P232, DOI 10.1111/j.1749-6632.2001.tb05736.x; Burns EdwardM., 1999, PSYCHOL MUSIC, V2nd, P215, DOI DOI 10.1016/B978-012213564-4/50008-1; Csikszentmihalyi M., 2008, FLOW PSYCHOL OPTIMAL; DAVIDSON L, 1985, MUSIC PERCEPT, V2, P361; Dissanayake, 1992, HOMO AESTHETICUS ART; Dowling W. J., 1986, MUSIC COGNITION; Fernald A., 1991, ANN CHILD DEV, V8, P43; Freeman W, 2000, ORIGINS OF MUSIC, P411; Hauser MD, 2003, NAT NEUROSCI, V6, P663, DOI 10.1038/nn1080; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; Hockett C.F., 1966, UNIVERSALS LANG, P1; HULSE SH, 1985, J COMP PSYCHOL, V99, P176, DOI 10.1037/0735-7036.99.2.176; HURLY TA, 1992, J COMP PSYCHOL, V106, P388, DOI 10.1037/0735-7036.106.4.388; Jusczyk P.W., 1997, DISCOVERY SPOKEN LAN; JUSLIN Patrik N., 2001, MUSIC EMOTION THEORY, P309; KRUMHANSL CL, 1982, MEM COGNITION, V10, P243, DOI 10.3758/BF03197636; LYNCH MP, 1990, PSYCHOL SCI, V1, P272, DOI 10.1111/j.1467-9280.1990.tb00213.x; MacDougallShackleton SA, 1996, J COMP PSYCHOL, V110, P139, DOI 10.1037/0735-7036.110.2.139; Mache FB, 2000, ORIGINS OF MUSIC, P473; MARLER P, 1990, DEV PSYCHOBIOL, V23, P557, DOI 10.1002/dev.420230703; Masataka N, 1996, DEV PSYCHOL, V32, P874, DOI 10.1037/0012-1649.32.5.874; Masataka N, 1998, DEV PSYCHOL, V34, P241, DOI 10.1037/0012-1649.34.2.241; Masataka N, 1999, DEV PSYCHOL, V35, P1001, DOI 10.1037/0012-1649.35.4.1001; Merker B, 2000, ORIGINS OF MUSIC, P315; Merriam AlanP., 1964, ANTHR MUSIC; Moody D. B., 1990, COMP PERCEPTION, VII, P311; Nettl B, 2000, ORIGINS OF MUSIC, P463; Patel AD, 2003, NAT NEUROSCI, V6, P674, DOI 10.1038/nn1082; Peretz I, 2002, NEURON, V33, P185, DOI 10.1016/S0896-6273(01)00580-3; Pinker S., 1997, MIND WORKS; Rubin David C., 1995, MEMORY ORAL TRADITIO; Sachs J., 2022, STEEP RISE GAG ORDER; Saffran JR, 2003, DEVELOPMENTAL SCI, V6, P35, DOI 10.1111/1467-7687.00250; Saffran JR, 2000, COGNITION, V77, pB15, DOI 10.1016/S0010-0277(00)00095-0; Schellenberg EG, 1996, PSYCHOL SCI, V7, P272, DOI 10.1111/j.1467-9280.1996.tb00373.x; Scherer K. R., 2001, MUSIC EMOTION THEORY, DOI DOI 10.1016/j.jsams.2011.06.003; SIOBODA JA, 2001, MUSIC EMOTION THEORY, P415; SMITH JD, 1994, COGNITION, V52, P23; Trainor LJ, 1998, INFANT BEHAV DEV, V21, P77, DOI 10.1016/S0163-6383(98)90055-8; Trainor LJ, 2002, MUSIC PERCEPT, V20, P187, DOI 10.1525/mp.2002.20.2.187; Trainor LJ, 1996, INFANT BEHAV DEV, V19, P83, DOI 10.1016/S0163-6383(96)90046-6; TRAINOR LJ, 1992, J EXP PSYCHOL HUMAN, V18, P394, DOI 10.1037/0096-1523.18.2.394; TRAINOR LJ, 1993, J EXP PSYCHOL HUMAN, V19, P615, DOI 10.1037/0096-1523.19.3.615; TRAINOR LJ, 1993, MUSIC PERCEPT, V11, P185; TRAINOR LJ, 1994, PERCEPT PSYCHOPHYS, V56, P125, DOI 10.3758/BF03213891; Trehub S, 2000, ORIGINS OF MUSIC, P427; Trehub SE, 2001, ANN NY ACAD SCI, V930, P1; TREHUB SE, 1995, J ACOUST SOC AM, V98, P2532, DOI 10.1121/1.414396; Trehub SE, 1999, J EXP PSYCHOL HUMAN, V25, P965, DOI 10.1037/0096-1523.25.4.965; TREHUB SE, 1987, CHILD DEV, V58, P741, DOI 10.1111/j.1467-8624.1987.tb01414.x; TREHUB SE, 1993, INFANT BEHAV DEV, V16, P193, DOI 10.1016/0163-6383(93)80017-3; TREHUB SE, 1990, PSYCHOMUSICOLOGY, V0009, P00005; TREHUB SE, 2001, MUSIC SCI, P37; WalkerAndrews AS, 1997, PSYCHOL BULL, V121, P437, DOI 10.1037/0033-2909.121.3.437; Wallin Nils., 1991, BIOMUSICOLOGY; Werker JF, 1999, ANNU REV PSYCHOL, V50, P509, DOI 10.1146/annurev.psych.50.1.509; WERNER LA, 1992, DEV PSYCHOACOUSTICS, P47; Wright AA, 2000, J EXP PSYCHOL GEN, V129, P291, DOI 10.1037/0096-3445.129.3.291; Zentner MR, 1996, NATURE, V383, P29, DOI 10.1038/383029a0	63	238	244	3	79	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2003	6	7					669	673		10.1038/nn1084	http://dx.doi.org/10.1038/nn1084			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Neurosciences & Neurology	694NJ	12830157				2022-12-17	WOS:000183780400010
J	Faber, T; Joerges, J; Menzel, R				Faber, T; Joerges, J; Menzel, R			Associative learning modifies neural representations of odors in the insect brain	NATURE NEUROSCIENCE			English	Article							MUSHROOM BODIES; APIS-MELLIFERA; IDENTIFIED NEURON; HONEYBEE BRAIN; MEMORY; DISCRIMINATION; INFORMATION; ASSEMBLIES; MODULATION; BEHAVIOR	Recording brain activity in vivo during learning is fundamental to understanding how memories are formed. We used functional calcium imaging to track odor representations in the primary chemosensory center of the honeybee, the antennal robe, while training animals to discriminate a rewarded odor from an unrewarded one. Our results show that associative learning transforms odor representations and decorrelates activity patterns for the rewarded versus the unrewarded odor, making them less similar. Additionally, activity for the rewarded but not for the unrewarded odor is increased. These results indicate that neural representations of the environment may be modified through associative learning.	Free Univ Berlin, Inst Neurobiol, D-14195 Berlin, Germany	Free University of Berlin	Faber, T (corresponding author), Free Univ Berlin, Inst Neurobiol, Konigin Luise Str 28-30, D-14195 Berlin, Germany.	faber@zedat.fu-berlin.de						BITTERMAN ME, 1983, J COMP PSYCHOL, V97, P107, DOI 10.1037/0735-7036.97.2.107; Brennan PA, 1998, NEUROSCIENCE, V87, P583, DOI 10.1016/S0306-4522(98)00182-1; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; DAVIS RL, 1993, NEURON, V11, P1, DOI 10.1016/0896-6273(93)90266-T; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; FLANAGAN D, 1989, INT J INSECT MORPHOL, V18, P145, DOI 10.1016/0020-7322(89)90023-8; Galizia CG, 1998, EUR J NEUROSCI, V10, P2964, DOI 10.1111/j.1460-9568.1998.00303.x; Galizia CG, 1997, J NEUROSCI METH, V76, P61, DOI 10.1016/S0165-0270(97)00080-0; GALIZIA G, IN PRESS CELL TISSUE; HAMMER M, 1995, J NEUROSCI, V15, P1617, DOI 10.1523/JNEUROSCI.15-03-01617.1995; Hammer M, 1998, LEARN MEMORY, V5, P146; HAMMER M, 1994, BEHAV NEURAL BIOL, V62, P210, DOI 10.1016/S0163-1047(05)80019-6; HAMMER M, 1993, NATURE, V366, P59, DOI 10.1038/366059a0; HAWKINS RD, 1983, SCIENCE, V219, P400, DOI 10.1126/science.6294833; HAWKINS RD, 1993, ANNU REV NEUROSCI, V16, P625, DOI 10.1146/annurev.ne.16.030193.003205; HEISENBERG M, 1985, J NEUROGENET, V2, P1, DOI 10.3109/01677068509100140; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Joerges J, 1997, NATURE, V387, P285, DOI 10.1038/387285a0; KARNI A, 1995, NATURE, V377, P155; LAURENT G, 1994, SCIENCE, V265, P1872, DOI 10.1126/science.265.5180.1872; Laurent G, 1996, J NEUROSCI, V16, P3837; Linster C, 1997, BEHAV BRAIN RES, V84, P117, DOI 10.1016/S0166-4328(97)83331-1; MAUELSHAGEN J, 1993, J NEUROPHYSIOL, V69, P609, DOI 10.1152/jn.1993.69.2.609; Menzel R, 1996, ANNU REV NEUROSCI, V19, P379, DOI 10.1146/annurev.ne.19.030196.002115; Menzel R., 1990, NEUROBIOLOGY COMP CO, P237; Menzel Randolf, 1994, Progress in Zoology, V39, P81; RECANZONE GH, 1992, J NEUROPHYSIOL, V67, P1031, DOI 10.1152/jn.1992.67.5.1031; REHDER V, 1987, J INSECT PHYSIOL, V33, P501, DOI 10.1016/0022-1910(87)90115-6; Rescorla RA, 1972, CLASSICAL CONDITION, P64, DOI [10.1177/0269881120954052, DOI 10.1101/GR.110528.110, DOI 10.1016/J.COGPSYCH.2004.11.001]; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; SCHOENBAUM G, 1995, J NEUROPHYSIOL, V74, P733, DOI 10.1152/jn.1995.74.2.733; Shadmehr R, 1997, SCIENCE, V277, P821, DOI 10.1126/science.277.5327.821; SMITH BH, 1991, J EXP BIOL, V161, P367; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0	36	238	243	0	30	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	1999	2	1					74	78		10.1038/4576	http://dx.doi.org/10.1038/4576			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	163MK	10195183				2022-12-17	WOS:000078409300016
J	Guan, ZH; Kuhn, JA; Wang, XD; Colquitt, B; Solorzano, C; Vaman, S; Guan, AK; Evans-Reinsch, Z; Braz, J; Devor, M; Abboud-Werner, SL; Lanier, LL; Lomvardas, S; Basbaum, AI				Guan, Zhonghui; Kuhn, Julia A.; Wang, Xidao; Colquitt, Bradley; Solorzano, Carlos; Vaman, Smitha; Guan, Andrew K.; Evans-Reinsch, Zoe; Braz, Joao; Devor, Marshall; Abboud-Werner, Sherry L.; Lanier, Lewis L.; Lomvardas, Stavros; Basbaum, Allan I.			Injured sensory neuron-derived CSF1 induces microglial proliferation and DAP12-dependent pain	NATURE NEUROSCIENCE			English	Article							COLONY-STIMULATING FACTOR; CENTRAL-NERVOUS-SYSTEM; NEUROPATHIC PAIN; SPINAL MICROGLIA; TRANSCRIPTION FACTOR; P2X(4) RECEPTORS; ANION GRADIENT; MYELOID CELLS; MODEL; MOUSE	Although microglia have been implicated in nerve injury-induced neuropathic pain, the manner by which injured sensory neurons engage microglia remains unclear. We found that peripheral nerve injury induced de novo expression of colony-stimulating factor 1 (CSF1) in injured sensory neurons. CSF1 was transported to the spinal cord, where it targeted the microglial CSF1 receptor (CSF1R). Cre-mediated sensory neuron deletion of Csf1 completely prevented nerve injury-induced mechanical hypersensitivity and reduced microglial activation and proliferation. In contrast, intrathecal injection of CSF1 induced mechanical hypersensitivity and microglial proliferation. Nerve injury also upregulated CSF1 in motoneurons, where it was required for ventral horn microglial activation and proliferation. Downstream of CSF1R, we found that the microglial membrane adaptor protein DAP12 was required for both nerve injury- and intrathecal CSF1-induced upregulation of pain-related microglial genes and the ensuing pain, but not for microglial proliferation. Thus, both CSF1 and DAP12 are potential targets for the pharmacotherapy of neuropathic pain.	[Guan, Zhonghui] Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA; [Kuhn, Julia A.; Wang, Xidao; Colquitt, Bradley; Solorzano, Carlos; Vaman, Smitha; Guan, Andrew K.; Evans-Reinsch, Zoe; Braz, Joao; Lomvardas, Stavros; Basbaum, Allan I.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Devor, Marshall] Hebrew Univ Jerusalem, Inst Life Sci, Dept Cell & Anim Biol, IL-91904 Jerusalem, Israel; [Abboud-Werner, Sherry L.] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA; [Lanier, Lewis L.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Hebrew University of Jerusalem; University of Texas System; University of Texas Health San Antonio; University of California System; University of California San Francisco	Guan, ZH (corresponding author), Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA.	zhonghui.guan@ucsf.edu; allan.basbaum@ucsf.edu	Colquitt, Bradley/AAR-7838-2021; Lanier, Lewis L/E-2139-2014	Colquitt, Bradley/0000-0001-5819-7924; Lanier, Lewis L/0000-0003-1308-3952	Foundation for Anesthesia Education and Research (FAER) [MRTG-BS-02/15/2010-G]; US National Institutes of Health [K08NS078050]; DFG [KU 3039/1-1]; Wellcome Trust;  [NIH-DE022001];  [NIH-NS14627];  [NIH-AG045040];  [NIH-AI068129]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068129] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS014627, R01NS014627, K08NS078050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG045040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA036985] Funding Source: NIH RePORTER	Foundation for Anesthesia Education and Research (FAER); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DFG(German Research Foundation (DFG)); Wellcome Trust(Wellcome Trust); ; ; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank N. Shah (University of California, San Francisco) for providing Nestin-Cre mice, and D.L. Davies (University of Southern California) and F. Rassendren (Inst. Genomique Functionnelle) for providing the P2X4<SUP>-/-</SUP> mice. We also thank E.K. Unger for illustrating Supplementary Figure 13 and J. Leff for technical support. This work was supported by grants from the Foundation for Anesthesia Education and Research (FAER) MRTG-BS-02/15/2010-G and the US National Institutes of Health (K08NS078050) to Z.G., the DFG (KU 3039/1-1) to J.A.K., NIH-DE022001 to A.I.B. and S.L., NIH-NS14627 and the Wellcome Trust to A.I.B., NIH-AG045040 to S.L.A.-W. and NIH-AI068129 to L.L.L.	Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Backonja M, 2010, ONCOLOGIST, V15, P24, DOI 10.1634/theoncologist.2009-S502; Bakker ABH, 2000, IMMUNITY, V13, P345, DOI 10.1016/S1074-7613(00)00034-0; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Bedard A, 2007, GLIA, V55, P777, DOI 10.1002/glia.20477; Beggs S, 2012, NAT NEUROSCI, V15, P1068, DOI 10.1038/nn.3155; Biber K, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00210; Biber K, 2011, EMBO J, V30, P1864, DOI 10.1038/emboj.2011.89; Braz JM, 2012, NEURON, V74, P663, DOI 10.1016/j.neuron.2012.02.033; Burnett SH, 2004, J LEUKOCYTE BIOL, V75, P612, DOI 10.1189/jlb.0903442; Calvo M, 2010, J NEUROSCI, V30, P5437, DOI 10.1523/JNEUROSCI.5169-09.2010; Cavanaugh DJ, 2009, P NATL ACAD SCI USA, V106, P9075, DOI 10.1073/pnas.0901507106; Clark AK, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00121; Colburn RW, 1999, EXP NEUROL, V157, P289, DOI 10.1006/exnr.1999.7065; Coull JAM, 2005, NATURE, V438, P1017, DOI 10.1038/nature04223; Coull JAM, 2003, NATURE, V424, P938, DOI 10.1038/nature01868; DEVOR M, 1990, PAIN, V42, P51, DOI 10.1016/0304-3959(90)91092-W; Dubois NC, 2006, GENESIS, V44, P355, DOI 10.1002/dvg.20226; Echeverry S, 2008, PAIN, V135, P37, DOI 10.1016/j.pain.2007.05.002; Elmore MRP, 2014, NEURON, V82, P380, DOI 10.1016/j.neuron.2014.02.040; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Grace PM, 2014, NAT REV IMMUNOL, V14, P217, DOI 10.1038/nri3621; Harris SE, 2012, BONE, V50, P42, DOI 10.1016/j.bone.2011.09.038; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Hokfelt T, 2007, PEPTIDES, V28, P365, DOI 10.1016/j.peptides.2006.07.024; Ji RR, 2013, PAIN, V154, pS10, DOI 10.1016/j.pain.2013.06.022; Jung HS, 2009, J NEUROSCI, V29, P8051, DOI 10.1523/JNEUROSCI.0485-09.2009; Kobayashi M, 2015, GLIA, V63, P1073, DOI 10.1002/glia.22802; LaCroix-Fralish ML, 2011, PAIN, V152, P1888, DOI 10.1016/j.pain.2011.04.014; Masuda T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4771; Masuda T, 2012, CELL REP, V1, P334, DOI 10.1016/j.celrep.2012.02.014; Old EA, 2012, CURR OPIN PHARMACOL, V12, P67, DOI 10.1016/j.coph.2011.10.015; Otero K, 2009, NAT IMMUNOL, V10, P734, DOI 10.1038/ni.1744; Perkins JR, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-7; Priller J, 2001, NAT MED, V7, P1356, DOI 10.1038/nm1201-1356; Raivich G, 1998, J COMP NEUROL, V395, P342, DOI 10.1002/(SICI)1096-9861(19980808)395:3<342::AID-CNE6>3.0.CO;2-2; RAIVICH G, 1994, EUR J NEUROSCI, V6, P1615, DOI 10.1111/j.1460-9568.1994.tb00552.x; Ransohoff RM, 2010, NATURE, V468, P253, DOI 10.1038/nature09615; Salter MW, 2014, CELL, V158, P15, DOI 10.1016/j.cell.2014.06.008; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Shields SD, 2003, J PAIN, V4, P465, DOI 10.1067/S1526-5900(03)00781-8; Sieweke MH, 2013, SCIENCE, V342, P946, DOI 10.1126/science.1242974; Sim JA, 2006, J NEUROSCI, V26, P9006, DOI 10.1523/JNEUROSCI.2370-06.2006; Solorzano C, 2015, J NEUROSCI, V35, P648, DOI 10.1523/JNEUROSCI.2955-14.2015; SUZUMURA A, 1990, J NEUROIMMUNOL, V30, P111, DOI 10.1016/0165-5728(90)90094-4; Tsuda M, 2003, NATURE, V424, P778, DOI 10.1038/nature01786; Tsujino H, 2000, MOL CELL NEUROSCI, V15, P170, DOI 10.1006/mcne.1999.0814; Ulmann L, 2008, J NEUROSCI, V28, P11263, DOI 10.1523/JNEUROSCI.2308-08.2008; von Hehn CA, 2012, NEURON, V73, P638, DOI 10.1016/j.neuron.2012.02.008; Wang XD, 2013, NEURON, V78, P312, DOI 10.1016/j.neuron.2013.03.001; Wang YM, 2012, NAT IMMUNOL, V13, P753, DOI 10.1038/ni.2360; Yamamoto S, 2010, J NEUROCHEM, V115, P1057, DOI 10.1111/j.1471-4159.2010.06996.x; YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0; Zhuang ZY, 2007, BRAIN BEHAV IMMUN, V21, P642, DOI 10.1016/j.bbi.2006.11.003; Zurborg S, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-66	55	237	243	4	97	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2016	19	1					94	+		10.1038/nn.4189	http://dx.doi.org/10.1038/nn.4189			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CZ7BH		Green Submitted, Green Published, Green Accepted			2022-12-17	WOS:000367254400017
J	Laje, R; Buonomano, DV				Laje, Rodrigo; Buonomano, Dean V.			Robust timing and motor patterns by taming chaos in recurrent neural networks	NATURE NEUROSCIENCE			English	Article							TEMPORAL INFORMATION; TRANSIENT DYNAMICS; TIME; MODEL; CEREBELLUM; SEQUENCES; VARIABILITY; MECHANISMS; SYSTEMS; MEMORY	The brain's ability to tell time and produce complex spatiotemporal motor patterns is critical for anticipating the next ring of a telephone or playing a musical instrument. One class of models proposes that these abilities emerge from dynamically changing patterns of neural activity generated in recurrent neural networks. However, the relevant dynamic regimes of recurrent networks are highly sensitive to noise; that is, chaotic. We developed a firing rate model that tells time on the order of seconds and generates complex spatiotemporal patterns in the presence of high levels of noise. This is achieved through the tuning of the recurrent connections. The network operates in a dynamic regime that exhibits coexisting chaotic and locally stable trajectories. These stable patterns function as 'dynamic attractors' and provide a feature that is characteristic of biological systems: the ability to 'return' to the pattern being generated in the face of perturbations.	[Laje, Rodrigo; Buonomano, Dean V.] Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90024 USA; [Buonomano, Dean V.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA; [Buonomano, Dean V.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA; [Buonomano, Dean V.] Univ Calif Los Angeles, Integrat Ctr Learning & Memory, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Buonomano, DV (corresponding author), Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90024 USA.	dbuono@ucla.edu	Laje, Rodrigo/AAI-9793-2020	Laje, Rodrigo/0000-0003-1481-303X	US National Institutes of Health [NS077340]; National Science Foundation [II-1114833]; Pew Charitable Trusts; Consejo Nacional de Investigaciones Cientificas y Tecnicas (Argentina); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R03NS077340] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Pew Charitable Trusts; Consejo Nacional de Investigaciones Cientificas y Tecnicas (Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. Garfinkel and R. Huerta for helpful discussions and comments on the manuscript. This work was supported by the US National Institutes of Health (NS077340), the National Science Foundation (II-1114833), the Pew Charitable Trusts, and Consejo Nacional de Investigaciones Cientificas y Tecnicas (Argentina).	Ahrens MB, 2011, CURR BIOL, V21, P200, DOI 10.1016/j.cub.2010.12.043; Banerjee A, 2008, NEURAL COMPUT, V20, P974, DOI 10.1162/neco.2008.05-06-206; Boffetta G, 2001, PHYSICA D, V159, P58, DOI 10.1016/S0167-2789(01)00330-X; Brunel N, 2000, J PHYSIOLOGY-PARIS, V94, P445, DOI 10.1016/S0928-4257(00)01084-6; Bueti D, 2012, NEURON, V75, P725, DOI 10.1016/j.neuron.2012.07.019; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Buonomano DV, 2010, TRENDS COGN SCI, V14, P520, DOI 10.1016/j.tics.2010.09.002; Buonomano DV, 2009, NAT REV NEUROSCI, V10, P113, DOI 10.1038/nrn2558; BUONOMANO DV, 1995, SCIENCE, V267, P1028, DOI 10.1126/science.7863330; BUONOMANO DV, 1994, NEURAL COMPUT, V6, P38, DOI 10.1162/neco.1994.6.1.38; Buonomano DV, 2000, J NEUROSCI, V20, P1129, DOI 10.1523/JNEUROSCI.20-03-01129.2000; CHURCH RM, 1994, J EXP PSYCHOL ANIM B, V20, P135, DOI 10.1037/0097-7403.20.2.135; Churchland MM, 2010, NAT NEUROSCI, V13, P369, DOI 10.1038/nn.2501; Coull JT, 2008, CURR OPIN NEUROBIOL, V18, P137, DOI 10.1016/j.conb.2008.07.011; Crowe DA, 2010, J NEUROSCI, V30, P11640, DOI 10.1523/JNEUROSCI.0954-10.2010; DOYA K, 1992, 1992 IEEE INTERNATIONAL SYMPOSIUM ON CIRCUITS AND SYSTEMS, VOLS 1-6, P2777, DOI 10.1109/ISCAS.1992.230622; Durstewitz D, 2003, J NEUROSCI, V23, P5342; Durstewitz D, 2008, EUR J NEUROSCI, V27, P217, DOI 10.1111/j.1460-9568.2007.05976.x; Fagiolo G, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.026107; Ganguli S, 2008, P NATL ACAD SCI USA, V105, P18970, DOI 10.1073/pnas.0804451105; Goldman MS, 2009, NEURON, V61, P621, DOI 10.1016/j.neuron.2008.12.012; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; Haykin S., 2002, ADAPTIVE FILTER THEO; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; IVRY RB, 1988, EXP BRAIN RES, V73, P167, DOI 10.1007/BF00279670; Ivry RB, 2008, TRENDS COGN SCI, V12, P273, DOI 10.1016/j.tics.2008.04.002; Izhikevich EM, 2008, P NATL ACAD SCI USA, V105, P3593, DOI 10.1073/pnas.0712231105; Jaeger H, 2004, SCIENCE, V304, P78, DOI 10.1126/science.1091277; Jaeger H, 2001, BONN GER GER NATL RE, V148, P13; Jaeger H, 2007, NEURAL NETWORKS, V20, P287, DOI 10.1016/j.neunet.2007.04.001; Janssen P, 2005, NAT NEUROSCI, V8, P234, DOI 10.1038/nn1386; KANTZ H, 1994, PHYS LETT A, V185, P77, DOI 10.1016/0375-9601(94)90991-1; Li JX, 2011, NEURON, V69, P159, DOI 10.1016/j.neuron.2010.11.043; Litwin-Kumar A, 2012, NAT NEUROSCI, V15, P1498, DOI 10.1038/nn.3220; Liu JK, 2009, J NEUROSCI, V29, P13172, DOI 10.1523/JNEUROSCI.2358-09.2009; London M, 2010, NATURE, V466, P123, DOI 10.1038/nature09086; Long MA, 2010, NATURE, V468, P394, DOI 10.1038/nature09514; Matell MS, 2003, BEHAV NEUROSCI, V117, P760, DOI 10.1037/0735-7044.117.4.760; Mauk MD, 2004, ANNU REV NEUROSCI, V27, P307, DOI 10.1146/annurev.neuro.27.070203.144247; Medina JF, 2000, NAT NEUROSCI, V3, P1205, DOI 10.1038/81486; Medina JF, 2000, J NEUROSCI, V20, P5516, DOI 10.1523/JNEUROSCI.20-14-05516.2000; Merchant H, 2011, P NATL ACAD SCI USA, V108, P19784, DOI 10.1073/pnas.1112933108; Miall C, 1989, NEURAL COMPUT, V1, P359, DOI 10.1162/neco.1989.1.3.359; Monteforte M, 2012, PHYS REV X, V2, DOI 10.1103/PhysRevX.2.041007; Pastalkova E, 2008, SCIENCE, V321, P1322, DOI 10.1126/science.1159775; Rajan K, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.011903; Simen P, 2011, J NEUROSCI, V31, P9238, DOI 10.1523/JNEUROSCI.3121-10.2011; SKARDA CA, 1987, BEHAV BRAIN SCI, V10, P161, DOI 10.1017/S0140525X00047336; SOMPOLINSKY H, 1988, PHYS REV LETT, V61, P259, DOI 10.1103/PhysRevLett.61.259; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Sussillo D, 2009, NEURON, V63, P544, DOI 10.1016/j.neuron.2009.07.018; vanVreeswijk C, 1996, SCIENCE, V274, P1724, DOI 10.1126/science.274.5293.1724; Wang XJ, 2001, TRENDS NEUROSCI, V24, P455, DOI 10.1016/S0166-2236(00)01868-3; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	55	237	237	2	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2013	16	7					925	U196		10.1038/nn.3405	http://dx.doi.org/10.1038/nn.3405			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174UM	23708144	Green Submitted, Green Accepted			2022-12-17	WOS:000321180900027
J	Wei, W; Nguyen, LN; Kessels, HW; Hagiwara, H; Sisodia, S; Malinow, R				Wei, Wei; Nguyen, Louis N.; Kessels, Helmut W.; Hagiwara, Hiroaki; Sisodia, Sangram; Malinow, Roberto			Amyloid beta from axons and dendrites reduces local spine number and plasticity	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; NICOTINIC ACETYLCHOLINE-RECEPTORS; PROTEIN TRANSGENIC MICE; ALZHEIMERS-DISEASE; A-BETA; SYNAPTIC PLASTICITY; PRECURSOR PROTEIN; IN-VIVO; HIPPOCAMPAL-NEURONS; RAT HIPPOCAMPUS	Excessive synaptic loss is thought to be one of the earliest events in Alzheimer's disease. Amyloid beta (A beta), a peptide secreted in an activity-modulated manner by neurons, has been implicated in the pathogenesis of Alzheimer's disease by removing dendritic spines, sites of excitatory synaptic transmission. However, issues regarding the subcellular source of A beta, as well as the mechanisms of its production and actions that lead to synaptic loss, remain poorly understood. In rat organotypic slices, we found that acute overproduction of either axonal or dendritic A beta reduced spine density and plasticity at nearby (similar to 5-10 mu m) dendrites. The production of A beta and its effects on spines were sensitive to blockade of action potentials or nicotinic receptors; the effects of A beta (but not its production) were sensitive to NMDA receptor blockade. Notably, only 30-60 min blockade of A beta overproduction permitted induction of plasticity. Our results indicate that continuous overproduction of A beta at dendrites or axons acts locally to reduce the number and plasticity of synapses.	[Wei, Wei; Malinow, Roberto] Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Nguyen, Louis N.; Kessels, Helmut W.; Hagiwara, Hiroaki; Malinow, Roberto] Univ Calif San Diego, Ctr Neural Circuits & Behav, Dept Neurosci, La Jolla, CA 92093 USA; [Nguyen, Louis N.; Kessels, Helmut W.; Hagiwara, Hiroaki; Malinow, Roberto] Univ Calif San Diego, Ctr Neural Circuits & Behav, Dept Biol, La Jolla, CA 92093 USA; [Sisodia, Sangram] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA	Cold Spring Harbor Laboratory; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Chicago	Malinow, R (corresponding author), Cold Spring Harbor Lab, Watson Sch Biol Sci, POB 100, Cold Spring Harbor, NY 11724 USA.	rmalinow@ucsd.edu		Kessels, Helmut/0000-0002-1122-745X	US National Institutes of Health; Cure Alzheimer's Fund; Eisai; Leslie C. Quick Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008444] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH049159, R29MH049159, R01MH049159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG032132] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cure Alzheimer's Fund; Eisai(Eisai Co Ltd); Leslie C. Quick Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank members of the Malinow laboratory for helpful discussions, J. Huang for careful reading of the manuscript and N. Dawkins and I. Hunton for expert technical assistance. This work was supported by grants from the US National Institutes of Health (R.M.), the Cure Alzheimer's Fund (R.M.), Eisai (H.H.) and the Leslie C. Quick Fellowship (W.W.).	Almeida CG, 2005, NEUROBIOL DIS, V20, P187, DOI 10.1016/j.nbd.2005.02.008; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Buxbaum JD, 1998, J NEUROSCI, V18, P9629; Calabrese B, 2007, MOL CELL NEUROSCI, V35, P183, DOI 10.1016/j.mcn.2007.02.006; CHANGEUX JP, 1970, P NATL ACAD SCI USA, V67, P1241, DOI 10.1073/pnas.67.3.1241; Chapman PF, 1999, NAT NEUROSCI, V2, P271, DOI 10.1038/6374; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; COAN EJ, 1989, NEUROSCI LETT, V105, P205, DOI 10.1016/0304-3940(89)90038-4; Dani JA, 2007, ANNU REV PHARMACOL, V47, P699, DOI 10.1146/annurev.pharmtox.47.120505.105214; Dineley KT, 2002, J BIOL CHEM, V277, P25056, DOI 10.1074/jbc.M200066200; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Evans NA, 2008, J NEUROSCI METH, V175, P96, DOI 10.1016/j.jneumeth.2008.08.001; Fabian-Fine R, 2001, J NEUROSCI, V21, P7993, DOI 10.1523/JNEUROSCI.21-20-07993.2001; FERREIRA A, 1993, J NEUROSCI, V13, P3112; Hartman RE, 2005, J NEUROSCI, V25, P6213, DOI 10.1523/JNEUROSCI.0664-05.2005; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Jacobsen JS, 2006, P NATL ACAD SCI USA, V103, P5161, DOI 10.1073/pnas.0600948103; Jones IW, 2004, J NEUROSCI METH, V134, P65, DOI 10.1016/j.jneumeth.2003.11.001; Kaether C, 2000, MOL BIOL CELL, V11, P1213, DOI 10.1091/mbc.11.4.1213; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Klyubin I, 2005, NAT MED, V11, P556, DOI 10.1038/nm1234; Klyubin I, 2008, J NEUROSCI, V28, P4231, DOI 10.1523/JNEUROSCI.5161-07.2008; KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; Lanz TA, 2003, NEUROBIOL DIS, V13, P246, DOI 10.1016/S0969-9961(03)00079-2; Lazarov O, 2002, J NEUROSCI, V22, P9785; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Molnar Z, 2004, NEUROREPORT, V15, P1649, DOI 10.1097/01.wnr.0000134471.06244.d2; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; Otmakhov N, 2004, J NEUROPHYSIOL, V91, P1955, DOI 10.1152/jn.00941.2003; Raschetti R, 2007, PLOS MED, V4, P1818, DOI 10.1371/journal.pmed.0040338; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Sheng JG, 2002, J NEUROSCI, V22, P9794; Shrestha BR, 2006, MOL CELL NEUROSCI, V33, P274, DOI 10.1016/j.mcn.2006.07.011; SISODIA SS, 1993, J NEUROSCI, V13, P3136; Small SA, 2006, NEURON, V52, P15, DOI 10.1016/j.neuron.2006.09.001; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Spires TL, 2005, J NEUROSCI, V25, P7278, DOI 10.1523/JNEUROSCI.1879-05.2005; Stephan A, 2001, J NEUROSCI, V21, P5703, DOI 10.1523/JNEUROSCI.21-15-05703.2001; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Ting JT, 2007, P NATL ACAD SCI USA, V104, P353, DOI 10.1073/pnas.0608807104; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Walsh DM, 2005, J NEUROSCI, V25, P2455, DOI 10.1523/JNEUROSCI.4391-04.2005; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Xia WM, 2009, ARCH NEUROL-CHICAGO, V66, P190, DOI 10.1001/archneurol.2008.565	50	237	247	0	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2010	13	2					190	U71		10.1038/nn.2476	http://dx.doi.org/10.1038/nn.2476			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	548SE	20037574	Green Accepted			2022-12-17	WOS:000273985800014
J	Ozdinler, PH; Macklis, JD				Ozdinler, P. Hande; Macklis, Jeffrey D.			IGF-I specifically enhances axon outgrowth of corticospinal motor neurons	NATURE NEUROSCIENCE			English	Article							GROWTH-FACTOR-I; RETINAL GANGLION-CELLS; NEUROTROPHIC FACTOR; PROJECTION NEURONS; SURVIVAL; EXPRESSION; ALS; PROMOTE; GENES; NEUROGENESIS	Corticospinal motor neurons ( CSMN) are among the most complex CNS neurons; they control voluntary motor function and are prototypical projection neurons. In amyotrophic lateral sclerosis ( ALS), both spinal motor neurons and CSMN degenerate; their damage contributes centrally to the loss of motor function in spinal cord injury. Direct investigation of CSMN is severely limited by inaccessibility in the heterogeneous cortex. Here, using new CSMN purification and culture approaches, and in vivo analyses, we report that insulin-like growth factor-1 ( IGF-I) specifically enhances the extent and rate of murine CSMN axon outgrowth, mediated via the IGF-I receptor and downstream signaling pathways; this is distinct from IGF-I support of neuronal survival. In contrast, brain-derived neurotrophic factor ( BDNF) enhances branching and arborization, but not axon outgrowth. These experiments define specific controls over directed differentiation of CSMN, indicate a distinct role of IGF-I in CSMN axon outgrowth during development, and might enable control over CSMN derived from neural precursors.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, MGH HMS Ctr Nervous Syst Repair,Dept Neurosurg, Boston, MA 02114 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, MGH HMS Ctr Nervous Syst Repair,Dept Neurol, Boston, MA 02114 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Program Neurosci, Boston, MA 02114 USA; Harvard Univ, Harvard Stem Cell Inst, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University	Macklis, JD (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, MGH HMS Ctr Nervous Syst Repair,Dept Neurosurg, Boston, MA 02114 USA.	jeffrey_macklis@hms.harvard.edu			NINDS NIH HHS [NS49553, NS45523, NS41590] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045523, R37NS041590, R01NS049553, R01NS041590] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O; BECK KD, 1995, NEURON, V14, P717, DOI 10.1016/0896-6273(95)90216-3; BLOCHGALLEGO E, 1991, DEVELOPMENT, V111, P221; BONDY CA, 1991, J NEUROSCI, V11, P3442; BONDY CA, 1993, ANN NY ACAD SCI, V692, P33; Borasio GD, 1998, NEUROLOGY, V51, P583, DOI 10.1212/WNL.51.2.583; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Catapano LA, 2004, EUR J NEUROSCI, V19, P2421, DOI 10.1111/j.0953-816X.2004.03303.x; Catapano LA, 2001, J NEUROSCI, V21, P8863, DOI 10.1523/JNEUROSCI.21-22-08863.2001; Chen JH, 2004, P NATL ACAD SCI USA, V101, P16357, DOI 10.1073/pnas.0406795101; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Clemmons D. R., 1995, Progress in Growth Factor Research, V6, P357, DOI 10.1016/0955-2235(95)00013-5; DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034; Deckwerth TL, 1996, NEURON, V17, P401, DOI 10.1016/S0896-6273(00)80173-7; Dobrowolny G, 2005, J CELL BIOL, V168, P193, DOI 10.1083/jcb.200407021; FRANTZ GD, 1994, J NEUROSCI, V14, P472; Fryer RH, 1996, J COMP NEUROL, V374, P21, DOI 10.1002/(SICI)1096-9861(19961007)374:1<21::AID-CNE2>3.0.CO;2-P; Giehl KM, 2001, REV NEUROSCIENCE, V12, P79; Giehl KM, 2001, J NEUROSCI, V21, P3492, DOI 10.1523/JNEUROSCI.21-10-03492.2001; Goldberg JL, 1998, CURR BIOL, V8, pR310, DOI 10.1016/S0960-9822(98)70195-2; Goldberg JL, 2002, NEURON, V33, P689, DOI 10.1016/S0896-6273(02)00602-5; Hains BC, 2003, J COMP NEUROL, V462, P328, DOI 10.1002/cne.10733; Harrington AW, 2004, P NATL ACAD SCI USA, V101, P6226, DOI 10.1073/pnas.0305755101; Hevner RF, 2003, DEV NEUROSCI-BASEL, V25, P139, DOI 10.1159/000072263; Horch HW, 2002, NAT NEUROSCI, V5, P1177, DOI 10.1038/nn927; Huang EJ, 1999, DEVELOPMENT, V126, P2191; Junger H, 1997, BRAIN RES, V762, P56, DOI 10.1016/S0006-8993(97)00347-8; Kasarskis EJ, 1999, NEUROLOGY, V52, P1427; Kaspar BK, 2003, SCIENCE, V301, P839, DOI 10.1126/science.1086137; Lai EC, 1997, NEUROLOGY, V49, P1621, DOI 10.1212/WNL.49.6.1621; LI SL, 1993, BIOCHEM BIOPH RES CO, V196, P92, DOI 10.1006/bbrc.1993.2220; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; Liu RY, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-17-j0003.2001; Liu YB, 2005, NAT NEUROSCI, V8, P1151, DOI 10.1038/nn1520; Lotz B, 1996, NEUROLOGY, V46, P1244; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; Molyneaux BJ, 2005, NEURON, V47, P817, DOI 10.1016/j.neuron.2005.08.030; NEFF NT, 1993, J NEUROBIOL, V24, P1578, DOI 10.1002/neu.480241203; O'Kusky JR, 2000, J NEUROSCI, V20, P8435, DOI 10.1523/JNEUROSCI.20-22-08435.2000; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; PIETRZKOWSKI Z, 1992, CANCER RES, V52, P6447; Popken GJ, 2004, EUR J NEUROSCI, V19, P2056, DOI 10.1111/j.0953-816X.2004.03320.x; Rosler KM, 2000, CLIN NEUROPHYSIOL, V111, P2208, DOI 10.1016/S1388-2457(00)00481-8; ROTWEIN P, 1988, P NATL ACAD SCI USA, V85, P265, DOI 10.1073/pnas.85.1.265; Schwab ME, 2004, CURR OPIN NEUROBIOL, V14, P118, DOI 10.1016/j.conb.2004.01.004; Schwab ME, 2002, SCIENCE, V295, P1029, DOI 10.1126/science.1067840; Sosa L, 2006, NAT NEUROSCI, V9, P993, DOI 10.1038/nn1742; Wilkins A, 2001, GLIA, V36, P48, DOI 10.1002/glia.1094; Winhammar JMC, 2005, LANCET NEUROL, V4, P229, DOI 10.1016/S1474-4422(05)70042-9	50	237	245	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2006	9	11					1371	1381		10.1038/nn1789	http://dx.doi.org/10.1038/nn1789			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TN	17057708				2022-12-17	WOS:000242403800014
J	Ji, YY; Pang, PT; Feng, LY; Lu, B				Ji, YY; Pang, PT; Feng, LY; Lu, B			Cyclic AMP controls BDNF-induced TrkB phosphorylation and dendritic spine formation in mature hippocampal neurons	NATURE NEUROSCIENCE			English	Article							NEUROTROPHIC FACTOR; EXCITATORY SYNAPSES; POSTSYNAPTIC DENSITIES; SYNAPTIC-TRANSMISSION; SURFACE EXPRESSION; PRIMARY CULTURES; FULL-LENGTH; CAMP; POTENTIATION; RELEASE	Synaptic actions of brain-derived neurotrophic factor (BDNF) are 'gated' by cyclic AMP (cAMP), but the underlying molecular mechanisms remain unclear. Here we report that cAMP regulates BDNF function in mature hippocampal neurons by modulating the signaling and trafficking of its receptor TrkB. cAMP gated the TrkB tyrosine kinase with three characteristic features: BDNF-induced TrkB phosphorylation was attenuated by inhibitors of cAMP signaling, it was potentiated by cAMP analogs, and activation of the cAMP pathway alone had no effect. In addition, cAMP facilitated trafficking of TrkB to dendritic spines, possibly by promoting its interaction with synaptic scaffolding protein PSD-95. Norepinephrinergic and dopaminergic agonists, which elevate intracellular cAMP concentration, also enhanced TrkB phosphorylation and its translocation to spines. cAMP gated long-term modulation by BDNF of spine density, but not the number of primary dendrites. These results reveal a specific role of cAMP in controlling BDNF actions in the brain, and provide new insights into the molecular mechanism underlying cAMP gating.	NICHHD, NIH, Sect Neural Dev & Plast, Bethesda, MD 20892 USA; Chinese Acad Sci, Grad Sch, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai, Peoples R China; Chinese Univ Hong Kong, Dept Physiol, Shatin, Hong Kong, Peoples R China	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese University of Hong Kong	Lu, B (corresponding author), NICHHD, NIH, Sect Neural Dev & Plast, 35 Lincoln Dr, Bethesda, MD 20892 USA.	bailu@mail.nih.gov	Lu, Bai/A-4018-2012	Lu, Bai/0000-0001-5418-9759	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000714] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Blitzer RD, 1995, NEURON, V15, P1403, DOI 10.1016/0896-6273(95)90018-7; Blitzer RD, 1998, SCIENCE, V280, P1940, DOI 10.1126/science.280.5371.1940; Boulanger L, 1999, SCIENCE, V284, P1982, DOI 10.1126/science.284.5422.1982; BREWER GJ, 1995, J NEUROSCI RES, V42, P674, DOI 10.1002/jnr.490420510; Brinton RD, 2000, EUR J PHARMACOL, V405, P73, DOI 10.1016/S0014-2999(00)00543-4; CABELLI RJ, 1995, SCIENCE, V267, P1662, DOI 10.1126/science.7886458; CHEN JH, 1994, SCIENCE, V263, P1278, DOI 10.1126/science.8122111; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; Drake CT, 1999, J NEUROSCI, V19, P8009; Du J, 2000, J CELL BIOL, V150, P1423, DOI 10.1083/jcb.150.6.1423; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; Gaiddon C, 1996, J NEUROCHEM, V66, P2279; Gallo G, 1998, J NEUROSCI, V18, P5403, DOI 10.1523/JNEUROSCI.18-14-05403.1998; Gottschalk W, 1998, J NEUROSCI, V18, P6830; Haapasalo A, 2002, J BIOL CHEM, V277, P43160, DOI 10.1074/jbc.M205202200; HARRIS KM, 1992, J NEUROSCI, V12, P2685; Hu BR, 1998, J NEUROSCI, V18, P625; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Iyengar R, 1996, SCIENCE, V271, P461, DOI 10.1126/science.271.5248.461; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Kryl D, 1999, J NEUROSCI, V19, P5823, DOI 10.1523/JNEUROSCI.19-14-05823.1999; LESSMANN V, 1994, NEUROREPORT, V6, P21; Lezcano N, 2002, J NEUROPHYSIOL, V87, P2167, DOI 10.1152/jn.00541.2001; Lu B, 2004, PROG BRAIN RES, V146, P137, DOI 10.1016/S0079-6123(03)46010-X; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; Meyer-Franke A, 1998, NEURON, V21, P681, DOI 10.1016/S0896-6273(00)80586-3; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; O'Brien RJ, 1998, CURR OPIN NEUROBIOL, V8, P364, DOI 10.1016/S0959-4388(98)80062-7; PAPA M, 1995, J NEUROSCI, V15, P1; Patterson SL, 2001, NEURON, V32, P123, DOI 10.1016/S0896-6273(01)00443-3; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Scannevin RH, 2000, NAT REV NEUROSCI, V1, P133, DOI 10.1038/35039075; Sheng M, 2001, P NATL ACAD SCI USA, V98, P7058, DOI 10.1073/pnas.111146298; Shimada A, 1998, J NEUROSCI, V18, P8559; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; Takei N, 1997, J NEUROCHEM, V68, P370; Tartaglia N, 2001, J BIOL CHEM, V276, P37585, DOI 10.1074/jbc.M101683200; Tyler WJ, 2001, J NEUROSCI, V21, P4249, DOI 10.1523/JNEUROSCI.21-12-04249.2001; Wu K, 1996, MOL BRAIN RES, V43, P286, DOI 10.1016/S0169-328X(96)00211-2; Wyneken U, 2001, NEUROSCIENCE, V102, P65, DOI 10.1016/S0306-4522(00)00469-3; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	43	237	251	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2005	8	2					164	172		10.1038/nn1381	http://dx.doi.org/10.1038/nn1381			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	892GN	15665879				2022-12-17	WOS:000226638200015
J	Loewenstein, Y; Mahon, S; Chadderton, P; Kitamura, K; Sompolinsky, H; Yarom, Y; Hausser, MH				Loewenstein, Y; Mahon, S; Chadderton, P; Kitamura, K; Sompolinsky, H; Yarom, Y; Hausser, MH			Bistability of cerebellar Purkinje cells modulated by sensory stimulation	NATURE NEUROSCIENCE			English	Article							CLIMBING FIBER AFFERENTS; ELECTRO-PHYSIOLOGICAL PROPERTIES; IN-VIVO; PREFRONTAL CORTEX; CORTICAL ACTIVITY; FIRING PATTERNS; MOSSY FIBER; NEURONS; DENDRITES; MODEL	A persistent change in neuronal activity after brief stimuli is a common feature of many neuronal microcircuits. This persistent activity can be sustained by ongoing reverberant network activity or by the intrinsic biophysical properties of individual cells. Here we demonstrate that rat and guinea pig cerebellar Purkinje cells in vivo show bistability of membrane potential and spike output on the time scale of seconds. The transition between membrane potential states can be bidirectionally triggered by the same brief current pulses. We also show that sensory activation of the climbing fiber input can switch Purkinje cells between the two states. The intrinsic nature of Purkinje cell bistability and its control by sensory input can be explained by a simple biophysical model. Purkinje cell bistability may have a key role in the short-term processing and storage of sensory information in the cerebellar cortex.	Hebrew Univ Jerusalem, Dept Neurobiol, IL-91904 Jerusalem, Israel; Hebrew Univ Jerusalem, Interdisciplinary Ctr Neural Computat, IL-91904 Jerusalem, Israel; Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England; UCL, Dept Physiol, London WC1E 6BT, England	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Massachusetts Institute of Technology (MIT); University of London; University College London; University of London; University College London	Loewenstein, Y (corresponding author), Hebrew Univ Jerusalem, Dept Neurobiol, IL-91904 Jerusalem, Israel.	yonatanl@mit.edu; s.mahon@ucl.ac.uk	Kitamura, Kazuo/F-3379-2013; Sompolinsky, Haim/ABB-8398-2021; mahon, severine/AAG-9225-2021; Mahon, Severine/E-7195-2017; Hausser, Michael/AAW-6827-2020	Kitamura, Kazuo/0000-0002-8956-4122; mahon, severine/0000-0001-8339-9034; Hausser, Michael/0000-0002-2673-8957; Chadderton, Paul/0000-0002-6276-1011				ARMSTRONG DM, 1979, J PHYSIOL-LONDON, V289, P425, DOI 10.1113/jphysiol.1979.sp012745; BAUSWEIN E, 1984, PFLUG ARCH EUR J PHY, V402, P292, DOI 10.1007/BF00585512; BELL CC, 1969, J NEUROPHYSIOL, V32, P1044, DOI 10.1152/jn.1969.32.6.1044; BROOKHART JM, 1950, J NEUROPHYSIOL, V13, P465, DOI 10.1152/jn.1950.13.6.465; Brown IE, 2001, J COMP NEUROL, V429, P59, DOI 10.1002/1096-9861(20000101)429:1<59::AID-CNE5>3.0.CO;2-3; Camperi M, 1998, J COMPUT NEUROSCI, V5, P383, DOI 10.1023/A:1008837311948; Chadderton P, 2004, NATURE, V428, P856, DOI 10.1038/nature02442; CHANG W, 1993, BRAIN RES, V614, P335, DOI 10.1016/0006-8993(93)91052-T; EBNER TJ, 1981, J NEUROPHYSIOL, V45, P962, DOI 10.1152/jn.1981.45.5.962; EDGLEY SA, 1988, J PHYSIOL-LONDON, V401, P399, DOI 10.1113/jphysiol.1988.sp017169; Egorov AV, 2002, NATURE, V420, P173, DOI 10.1038/nature01171; EKEROT CF, 1985, BRAIN RES, V342, P357, DOI 10.1016/0006-8993(85)91136-9; FUSTER JM, 1973, J NEUROPHYSIOL, V36, P61, DOI 10.1152/jn.1973.36.1.61; Genet S, 2002, J NEUROPHYSIOL, V88, P2430, DOI 10.1152/jn.00839.2001; Goldman MS, 2003, CEREB CORTEX, V13, P1185, DOI 10.1093/cercor/bhg095; GRANIT R, 1956, J PHYSIOL-LONDON, V133, P520, DOI 10.1113/jphysiol.1956.sp005606; HARTIGAN JA, 1985, ANN STAT, V13, P70, DOI 10.1214/aos/1176346577; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; Heyward P, 2001, J NEUROSCI, V21, P5311, DOI 10.1523/JNEUROSCI.21-14-05311.2001; Hirata Y, 2000, PROG BRAIN RES, V124, P221; HOUNSGAARD J, 1988, J PHYSIOL-LONDON, V402, P731, DOI 10.1113/jphysiol.1988.sp017231; ITO M, 1984, CEREBELLIUM NEURAL C; Jorntell H, 2003, J NEUROSCI, V23, P9620; Kobayashi Y, 1998, J NEUROPHYSIOL, V80, P832, DOI 10.1152/jn.1998.80.2.832; Koulakov AA, 2002, NAT NEUROSCI, V5, P775, DOI 10.1038/nn893; Lee RH, 1998, J NEUROPHYSIOL, V80, P583, DOI 10.1152/jn.1998.80.2.583; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P171, DOI 10.1113/jphysiol.1980.sp013357; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P197, DOI 10.1113/jphysiol.1980.sp013358; Loewenstein Y, 2003, NAT NEUROSCI, V6, P961, DOI 10.1038/nn1109; Mahon S, 2001, CEREB CORTEX, V11, P360, DOI 10.1093/cercor/11.4.360; Mann-Metzer P, 1999, J NEUROSCI, V19, P3298; Marder E, 1996, P NATL ACAD SCI USA, V93, P13481, DOI 10.1073/pnas.93.24.13481; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; MCCARLEY RW, 1972, ELECTROEN CLIN NEURO, V33, P471, DOI 10.1016/0013-4694(72)90211-8; McCormick DA, 2003, CEREB CORTEX, V13, P1219, DOI 10.1093/cercor/bhg104; MCDEVITT CJ, 1982, BRAIN RES, V237, P484, DOI 10.1016/0006-8993(82)90460-7; MIDTGAARD J, 1993, J NEUROPHYSIOL, V70, P2455, DOI 10.1152/jn.1993.70.6.2455; NACIMIENTO RC, 1969, NEUROBIOLOGY CEREBEL, P373; RAPP M, 1994, J PHYSIOL-LONDON, V474, P101, DOI 10.1113/jphysiol.1994.sp020006; RAWSON JA, 1981, NEUROSCI LETT, V25, P131, DOI 10.1016/0304-3940(81)90320-7; RAWSON JA, 1981, NEUROSCI LETT, V25, P125, DOI 10.1016/0304-3940(81)90319-0; RINZEL J, 1998, METHODS NEURONAL MOD, P251; SATO Y, 1992, J NEUROPHYSIOL, V68, P2051, DOI 10.1152/jn.1992.68.6.2051; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; Wang SSH, 2000, NAT NEUROSCI, V3, P1266, DOI 10.1038/81792; Williams SR, 1997, J PHYSIOL-LONDON, V505, P689, DOI 10.1111/j.1469-7793.1997.689ba.x; Williams SR, 2002, J PHYSIOL-LONDON, V539, P469, DOI 10.1113/jphysiol.2001.013136; YUEN GL, 1995, BIOL CYBERN, V73, P375, DOI 10.1007/BF00199473	48	237	240	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2005	8	2					202	211		10.1038/nn1393	http://dx.doi.org/10.1038/nn1393			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	892GN	15665875				2022-12-17	WOS:000226638200020
J	Heynen, AJ; Yoon, BJ; Liu, CH; Chung, HJ; Huganir, RL; Bear, MF				Heynen, AJ; Yoon, BJ; Liu, CH; Chung, HJ; Huganir, RL; Bear, MF			Molecular mechanism for loss of visual cortical responsiveness following brief monocular deprivation	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; OCULAR DOMINANCE PLASTICITY; KITTEN STRIATE CORTEX; RECEPTIVE-FIELD PROPERTIES; SOURCE DENSITY ANALYSIS; HIPPOCAMPUS IN-VIVO; SYNAPTIC PLASTICITY; GLUTAMATE RECEPTORS; POSTNATAL-DEVELOPMENT; PROTEIN-KINASE	A dramatic form of experience-dependent synaptic plasticity is revealed in visual cortex when one eye is temporarily deprived of vision during early postnatal life. Monocular deprivation (MD) alters synaptic transmission such that cortical neurons cease to respond to stimulation of the deprived eye, but how this occurs is poorly understood. Here we show in rat visual cortex that brief MD sets in motion the same molecular and functional changes as the experimental model of homosynaptic long-term depression (LTD), and that prior synaptic depression by MD occludes subsequent induction of LTD. The mechanisms of LTD, about which there is now a detailed understanding, therefore contribute to visual cortical plasticity.	MIT, Picower Ctr Learning & Memory, Howard Hughes Med Inst, Cambridge, MA 02139 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University	Bear, MF (corresponding author), MIT, Picower Ctr Learning & Memory, Howard Hughes Med Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA.		Yoon, Bong June/L-7126-2017	Chung, Hee Jung/0000-0002-5555-9907; Bear, Mark/0000-0002-9903-2541				Allen CB, 2003, NAT NEUROSCI, V6, P291, DOI 10.1038/nn1012; Antonini A, 1999, J NEUROSCI, V19, P4388; Banke TG, 2000, J NEUROSCI, V20, P89, DOI 10.1523/JNEUROSCI.20-01-00089.2000; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Bear MF, 1999, J NEUROBIOL, V41, P83, DOI 10.1002/(SICI)1097-4695(199910)41:1<83::AID-NEU11>3.0.CO;2-Z; BEAR MF, 1987, SCIENCE, V237, P42, DOI 10.1126/science.3037696; BEAR MF, 1990, J NEUROSCI, V10, P909; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; Blais BS, 1999, P NATL ACAD SCI USA, V96, P1083, DOI 10.1073/pnas.96.3.1083; Chung HJ, 2000, J NEUROSCI, V20, P7258; Colman H, 1997, SCIENCE, V275, P356, DOI 10.1126/science.275.5298.356; Dodt HU, 1999, SCIENCE, V286, P110, DOI 10.1126/science.286.5437.110; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; DUDEK SM, 1996, NEURON, V16, P1; Edelman GM, 2001, P NATL ACAD SCI USA, V98, P13763, DOI 10.1073/pnas.231499798; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; FAGIOLINI M, 1994, VISION RES, V34, P709, DOI 10.1016/0042-6989(94)90210-0; FREEMAN RD, 1981, J NEUROPHYSIOL, V45, P1074, DOI 10.1152/jn.1981.45.6.1074; GUILLERY RW, 1972, J COMP NEUROL, V144, P117, DOI 10.1002/cne.901440106; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Heynen AJ, 2000, NEURON, V28, P527, DOI 10.1016/S0896-6273(00)00130-6; Heynen AJ, 2001, J NEUROSCI, V21, P9801, DOI 10.1523/JNEUROSCI.21-24-09801.2001; Heynen AJ, 1996, NATURE, V381, P163, DOI 10.1038/381163a0; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Kameyama K, 1998, NEURON, V21, P1163, DOI 10.1016/S0896-6273(00)80633-9; Kandler K, 1998, NAT NEUROSCI, V1, P119, DOI 10.1038/368; KENANVAKNIN G, 1994, BRAIN RES, V635, P37, DOI 10.1016/0006-8993(94)91421-4; Kim CH, 2001, P NATL ACAD SCI USA, V98, P11725, DOI 10.1073/pnas.211132798; KIRKWOOD A, 1994, J NEUROSCI, V14, P3404; Kirkwood A, 1996, NATURE, V381, P526, DOI 10.1038/381526a0; Kirkwood A, 1999, J NEUROSCI, V19, P1599; KOSSUT M, 1991, EXP BRAIN RES, V85, P519; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Mammen AL, 1997, J BIOL CHEM, V272, P32528, DOI 10.1074/jbc.272.51.32528; MIOCHE L, 1989, J NEUROPHYSIOL, V62, P185, DOI 10.1152/jn.1989.62.1.185; Mitchell DE, 2001, P NATL ACAD SCI USA, V98, P11662, DOI 10.1073/pnas.201392698; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Philpot BD, 2003, J NEUROSCI, V23, P5583; Philpot BD, 2001, NEURON, V29, P157, DOI 10.1016/S0896-6273(01)00187-8; Prusky GT, 2003, EUR J NEUROSCI, V17, P167, DOI 10.1046/j.1460-9568.2003.02420.x; RAMOA AS, 1988, EXP BRAIN RES, V73, P285; Rittenhouse CD, 1999, NATURE, V397, P347, DOI 10.1038/16922; Rozas C, 2001, J NEUROSCI, V21, P6791, DOI 10.1523/JNEUROSCI.21-17-06791.2001; Sawtell NB, 2003, NEURON, V38, P977, DOI 10.1016/S0896-6273(03)00323-4; Trachtenberg JT, 2000, SCIENCE, V287, P2029, DOI 10.1126/science.287.5460.2029; WIESEL TN, 1982, NATURE, V299, P583, DOI 10.1038/299583a0; YINON U, 1973, EXP NEUROL, V38, P231, DOI 10.1016/0014-4886(73)90148-9	50	237	246	1	13	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2003	6	8					854	862		10.1038/nn1100	http://dx.doi.org/10.1038/nn1100			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	705UP	12886226				2022-12-17	WOS:000184413700015
J	Oertner, TG; Sabatini, BL; Nimchinsky, EA; Svoboda, K				Oertner, TG; Sabatini, BL; Nimchinsky, EA; Svoboda, K			Facilitation at single synapses probed with optical quantal analysis	NATURE NEUROSCIENCE			English	Article							METHYL-D-ASPARTATE; CULTURED HIPPOCAMPAL-NEURONS; DENDRITIC SPINES; MULTIVESICULAR RELEASE; SILENT SYNAPSES; NMDA RECEPTORS; SYNAPTIC TRANSMISSION; EXCITATORY SYNAPSES; PYRAMIDAL NEURONS; CA1 SYNAPSES	Many synapses can change their strength rapidly in a use-dependent manner, but the mechanisms of such short-term plasticity remain unknown. To understand these mechanisms, measurements of neurotransmitter release at single synapses are required. We probed transmitter release by imaging transient increases in [Ca2+] mediated by synaptic N-methyl-D-aspartate receptors (NMDARs) in individual dendritic spines of CA1 pyramidal neurons in rat brain slices, enabling quantal analysis at single synapses. We found that changes in release probability, produced by paired-pulse facilitation (PPF) or by manipulation of presynaptic adenosine receptors, were associated with changes in glutamate concentration in the synaptic cleft, indicating that single synapses can release a variable amount of glutamate per action potential. The relationship between release probability and response size is consistent with a binomial model of vesicle release with several (> 5) independent release sites per active zone, suggesting that multivesicular release contributes to facilitation at these synapses.	Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute	Svoboda, K (corresponding author), Cold Spring Harbor Lab, Howard Hughes Med Inst, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.		Oertner, Thomas/F-2214-2010; Nimchinsky, Esther/GXF-5277-2022	Oertner, Thomas/0000-0002-2312-7528; 				Arnth-Jensen N, 2002, NAT NEUROSCI, V5, P325, DOI 10.1038/nn825; Asztely F, 1997, NEURON, V18, P281, DOI 10.1016/S0896-6273(00)80268-8; Auger C, 1998, J NEUROSCI, V18, P4532; Auger C, 2000, J PHYSIOL-LONDON, V526, P3, DOI 10.1111/j.1469-7793.2000.t01-3-00003.x; Barbour B, 2001, J NEUROSCI, V21, P7969, DOI 10.1523/JNEUROSCI.21-20-07969.2001; BEKKERS JM, 1990, P NATL ACAD SCI USA, V87, P5359, DOI 10.1073/pnas.87.14.5359; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Choi S, 2000, NAT NEUROSCI, V3, P330, DOI 10.1038/73895; CLEMENTS JD, 1991, NEURON, V7, P605, DOI 10.1016/0896-6273(91)90373-8; Denk W, 1997, NEURON, V18, P351, DOI 10.1016/S0896-6273(00)81237-4; Diamond JS, 2001, J NEUROSCI, V21, P8328, DOI 10.1523/JNEUROSCI.21-21-08328.2001; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; Emptage N, 1999, NEURON, V22, P115, DOI 10.1016/S0896-6273(00)80683-2; FABER DS, 1992, SCIENCE, V258, P1494, DOI 10.1126/science.1279813; Hanse E, 2001, J PHYSIOL-LONDON, V531, P467, DOI 10.1111/j.1469-7793.2001.0467i.x; HARRIS KM, 1989, J NEUROSCI, V9, P2982; HARRIS KM, 1995, NEUROPHARMACOLOGY, V34, P1387, DOI 10.1016/0028-3908(95)00142-S; Isaac JTR, 1998, NEUROPHARMACOLOGY, V37, P1399, DOI 10.1016/S0028-3908(98)00140-3; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Katz B., 1969, RELEASE NEURAL TRANS; KORN H, 1981, SCIENCE, V213, P898, DOI 10.1126/science.6266015; Kovalchuk Y, 2000, J NEUROSCI, V20, P1791; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; Mainen ZF, 1999, METHODS, V18, P231, DOI 10.1006/meth.1999.0776; Mainen ZF, 1999, NATURE, V399, P151, DOI 10.1038/20187; McAllister AK, 2000, P NATL ACAD SCI USA, V97, P6173, DOI 10.1073/pnas.100126497; NEHER E, 1995, NEUROPHARMACOLOGY, V34, P1423, DOI 10.1016/0028-3908(95)00144-U; PATNEAU DK, 1990, J NEUROSCI, V10, P2385; REDMAN S, 1990, PHYSIOL REV, V70, P165, DOI 10.1152/physrev.1990.70.1.165; Regehr WG, 2001, SYNAPSES, P135; Renger JJ, 2001, NEURON, V29, P469, DOI 10.1016/S0896-6273(01)00219-7; Rusakov DA, 1998, J NEUROSCI, V18, P3158; Sabatini BL, 2000, NATURE, V408, P589, DOI 10.1038/35046076; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Sabatini BL, 2001, CURR OPIN NEUROBIOL, V11, P349, DOI 10.1016/S0959-4388(00)00218-X; SATHER W, 1992, J PHYSIOL-LONDON, V450, P643, DOI 10.1113/jphysiol.1992.sp019148; Schikorski T, 1997, J NEUROSCI, V17, P5858; Spacek J, 1997, J NEUROSCI, V17, P190, DOI 10.1523/JNEUROSCI.17-01-00190.1997; SPRUSTON N, 1995, J PHYSIOL-LONDON, V482, P325, DOI 10.1113/jphysiol.1995.sp020521; STEVENS CF, 1995, NEURON, V14, P795, DOI 10.1016/0896-6273(95)90223-6; Stuart G, 1998, J NEUROSCI, V18, P3501; TONG G, 1994, NEURON, V12, P51, DOI 10.1016/0896-6273(94)90151-1; Umemiya M, 1999, J PHYSIOL-LONDON, V521, P113, DOI 10.1111/j.1469-7793.1999.00113.x; Wadiche JI, 2001, NEURON, V32, P301, DOI 10.1016/S0896-6273(01)00488-3; Williams SR, 2002, SCIENCE, V295, P1907, DOI 10.1126/science.1067903; WU LG, 1994, NEURON, V12, P1139, DOI 10.1016/0896-6273(94)90321-2; Wu LG, 1997, TRENDS NEUROSCI, V20, P204, DOI 10.1016/S0166-2236(96)01015-6; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.ne.12.030189.000305	50	237	242	0	16	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2002	5	7					657	664		10.1038/nn867	http://dx.doi.org/10.1038/nn867			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	566EP	12055631				2022-12-17	WOS:000176414300015
J	Koushika, SP; Richmond, JE; Hadwiger, G; Weimer, RM; Jorgensen, EM; Nonet, ML				Koushika, SP; Richmond, JE; Hadwiger, G; Weimer, RM; Jorgensen, EM; Nonet, ML			A post-docking role for active zone protein Rim	NATURE NEUROSCIENCE			English	Article							SYNAPTIC VESICLES; FUSION-COMPETENCE; MUTANTS; UNC-13; SYNTAXIN; RAB3; SYNAPTOTAGMIN; ORGANIZATION; EXOCYTOSIS; EFFECTOR	Rim1 was previously identified as a Rab3 effector localized to the presynaptic active zone in vertebrates. Here we demonstrate that C. elegans unc-10 mutants lacking Rim are viable, but exhibit behavioral and physiological defects that are more severe than those of Rab3 mutants. Rim is localized to synaptic sites in C. elegans, but the ultrastructure of the presynaptic densities is normal in Rim mutants. Moreover, normal levels of docked synaptic vesicles were observed in mutants, suggesting that Rim is not involved in the docking process. The level of fusion competent vesicles at release sites was reduced fivefold in Rim mutants, but calcium sensitivity of release events was unchanged. Furthermore, expression of a constitutively open form of syntaxin suppressed the physiological defects of Rim mutants, suggesting Rim normally acts to regulate conformational changes in syntaxin. These data suggest Rim acts after vesicle docking likely via regulating priming.	Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Washington University (WUSTL); Utah System of Higher Education; University of Utah	Nonet, ML (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, 660 S Euclid Ave, St Louis, MO 63110 USA.	nonetm@thalamus.wustl.edu		Koushika, Sandhya/0000-0002-1742-7356	NIMH NIH HHS [R03 MH059820-02, R03 MH059820-01] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH059820] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aravamudan B, 1999, NAT NEUROSCI, V2, P965, DOI 10.1038/14764; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Bailey CH, 1996, P NATL ACAD SCI USA, V93, P13445, DOI 10.1073/pnas.93.24.13445; Betz A, 2001, NEURON, V30, P183, DOI 10.1016/S0896-6273(01)00272-0; BRENNER S, 1974, GENETICS, V77, P71; BURNS ME, 1995, CELL, V83, P187, DOI 10.1016/0092-8674(95)90160-4; Chen YA, 2001, NEURON, V30, P161, DOI 10.1016/S0896-6273(01)00270-7; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; DIXON D, 1989, J NEUROSCI, V9, P4246; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Garner CC, 2000, CURR OPIN NEUROBIOL, V10, P321, DOI 10.1016/S0959-4388(00)00093-3; Geppert M, 1998, ANNU REV NEUROSCI, V21, P75, DOI 10.1146/annurev.neuro.21.1.75; GEPPERT M, 1994, NATURE, V369, P493, DOI 10.1038/369493a0; HALL DH, 1991, CELL, V65, P837, DOI 10.1016/0092-8674(91)90391-B; Harris TW, 2000, J CELL BIOL, V150, P589, DOI 10.1083/jcb.150.3.589; HEUSER JE, 1973, HDB PHYSL, V1, P261; Iwasaki K, 1997, NEURON, V18, P613, DOI 10.1016/S0896-6273(00)80302-5; JORGENSEN EM, 1995, NATURE, V378, P196, DOI 10.1038/378196a0; Klenchin VA, 2000, BIOCHIMIE, V82, P399, DOI 10.1016/S0300-9084(00)00208-X; Kohn RE, 2000, MOL BIOL CELL, V11, P3441, DOI 10.1091/mbc.11.10.3441; LANDIS DMD, 1988, NEURON, V1, P201, DOI 10.1016/0896-6273(88)90140-7; Miller KG, 1996, P NATL ACAD SCI USA, V93, P12593, DOI 10.1073/pnas.93.22.12593; NGUYEN M, 1995, GENETICS, V140, P527; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; Nonet ML, 1997, J NEUROSCI, V17, P8061; Nonet ML, 1999, MOL BIOL CELL, V10, P2343, DOI 10.1091/mbc.10.7.2343; Nonet ML, 1998, J NEUROSCI, V18, P70; NONET ML, 1993, CELL, V73, P1291, DOI 10.1016/0092-8674(93)90357-V; Ozaki N, 2000, NAT CELL BIOL, V2, P805, DOI 10.1038/35041046; Rand James B., 1997, Cold Spring Harbor Monograph Series, V33, P611; Richmond JE, 2001, NATURE, V412, P338, DOI 10.1038/35085583; Richmond JE, 1999, NAT NEUROSCI, V2, P959, DOI 10.1038/12160; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; Saifee O, 1998, MOL BIOL CELL, V9, P1235, DOI 10.1091/mbc.9.6.1235; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; SHIRATAKI H, 1993, MOL CELL BIOL, V13, P2061, DOI 10.1128/MCB.13.4.2061; STAUNTON J, IN PRESS J NEUROSCI; Sulston J.E., 1988, NEMATODE CAENORHABDI, P587; VONMOLLARD GF, 1990, P NATL ACAD SCI USA, V87, P1988, DOI 10.1073/pnas.87.5.1988; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; Wang Y, 2000, J BIOL CHEM, V275, P20033, DOI 10.1074/jbc.M909008199; ZHONG Y, 1991, SCIENCE, V251, P198, DOI 10.1126/science.1670967	42	237	249	0	17	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2001	4	10					997	1005		10.1038/nn732	http://dx.doi.org/10.1038/nn732			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	478CR	11559854	Green Accepted			2022-12-17	WOS:000171325800013
J	Bolkan, SS; Stujenske, JM; Parnaudeau, S; Spellman, TJ; Rauffenbart, C; Abbas, AI; Harris, AZ; Gordon, JA; Kellendonk, C				Bolkan, Scott S.; Stujenske, Joseph M.; Parnaudeau, Sebastien; Spellman, Timothy J.; Rauffenbart, Caroline; Abbas, Atheir I.; Harris, Alexander Z.; Gordon, Joshua A.; Kellendonk, Christoph			Thalamic projections sustain prefrontal activity during working memory maintenance	NATURE NEUROSCIENCE			English	Article							MEDIODORSAL THALAMUS; POPULATION CODE; UNIT-ACTIVITY; CORTEX; SCHIZOPHRENIA; COGNITION; DYNAMICS; BEHAVIOR; NUCLEUS; NEURONS	The mediodorsal thalamus (MD) shares reciprocal connectivity with the prefrontal cortex (PFC), and decreased MD-PFC connectivity is observed in schizophrenia patients. Patients also display cognitive deficits including impairments in working memory, but a mechanistic link between thalamo-prefrontal circuit function and working memory is missing. Using pathway-specific inhibition, we found directional interactions between mouse MD and medial PFC (mPFC), with MD-to-mPFC supporting working memory maintenance and mPFC-to-MD supporting subsequent choice. We further identify mPFC neurons that display elevated spiking during the delay, a feature that was absent on error trials and required MD inputs for sustained maintenance. Strikingly, delay-tuned neurons had minimal overlap with spatially tuned neurons, and each mPFC population exhibited mutually exclusive dependence on MD and hippocampal inputs. These findings indicate a role for MD in sustaining prefrontal activity during working memory maintenance. Consistent with this idea, we found that enhancing MD excitability was sufficient to enhance task performance.	[Bolkan, Scott S.; Stujenske, Joseph M.] Columbia Univ, Coll Phys & Surg, Grad Program Neurobiol & Behav, New York, NY USA; [Parnaudeau, Sebastien] UPMC Paris 06, Sorbonne Univ, UMR8246,INSERM,U1130,CNRS, Inst Biol Paris Seine,UM119,Neurosci Paris Seine, F-UM119 Paris, France; [Spellman, Timothy J.] Weill Cornell Med Coll, Feil Family Brain & Mind Res Inst, New York, NY USA; [Rauffenbart, Caroline; Abbas, Atheir I.; Harris, Alexander Z.; Gordon, Joshua A.; Kellendonk, Christoph] Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY 10027 USA; [Rauffenbart, Caroline; Kellendonk, Christoph] Columbia Univ, Coll Phys & Surg, Dept Pharmacol, New York, NY 10027 USA; [Abbas, Atheir I.; Harris, Alexander Z.; Gordon, Joshua A.] New York State Psychiat Inst & Hosp, Div Integrat Neurosci, New York, NY 10032 USA; [Rauffenbart, Caroline; Kellendonk, Christoph] New York State Psychiat Inst & Hosp, Div Mol Therapeut, New York, NY 10032 USA; [Gordon, Joshua A.] NIMH, Off Director, Bethesda, MD 20892 USA	Columbia University; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Cornell University; Columbia University; Columbia University; New York State Psychiatry Institute; New York State Psychiatry Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Gordon, JA; Kellendonk, C (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY 10027 USA.; Kellendonk, C (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Pharmacol, New York, NY 10027 USA.; Gordon, JA (corresponding author), New York State Psychiat Inst & Hosp, Div Integrat Neurosci, New York, NY 10032 USA.; Kellendonk, C (corresponding author), New York State Psychiat Inst & Hosp, Div Mol Therapeut, New York, NY 10032 USA.; Gordon, JA (corresponding author), NIMH, Off Director, Bethesda, MD 20892 USA.	joshua.gordon@nih.gov; ck491@cumc.columbia.edu	Harris, Alexander/GPT-0688-2022; Abbas, Atheir/AAI-2158-2019; Kellendonk, Christoph/O-7229-2018; Core, Vector/CAF-4832-2022	Harris, Alexander/0000-0001-9089-0366; Kellendonk, Christoph/0000-0003-3302-2188; Abbas, Atheir/0000-0002-7080-3509	NIMH [R01 MH096274, F31 MH102041, F30 MH107204]; Hope for Depression Research Foundation; Irma Hirschl Trust; NATIONAL INSTITUTE OF MENTAL HEALTH [F30MH107204, F31MH102041, T32MH018870, R01MH096274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS064928] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Hope for Depression Research Foundation; Irma Hirschl Trust; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of the Gordon and Kellendonk labs for technical assistance and discussions. We also thank M. Halassa for discussions and commentary on an initial draft of the manuscript. This work was supported by grants from the NIMH (R01 MH096274 to J.A.G., F31 MH102041 to S.S.B. and F30 MH107204 to J.M.S.); by the Hope for Depression Research Foundation (to J.A.G.); and by the Irma Hirschl Trust (to C.K.). This article was prepared while J.A.G. was employed at the Department of Psychiatry at Columbia University and NYSPI. The opinions expressed in this article are the author's own and do not reflect the view of the National Institutes of Health, the Department of Health and Human Services or the United States government.	Adhikari A, 2010, J NEUROSCI METH, V191, P191, DOI 10.1016/j.jneumeth.2010.06.019; Akhlaghpour H, 2016, ELIFE, V5, DOI 10.7554/eLife.19507; Alcaraz F, 2016, EUR J NEUROSCI, V44, P1972, DOI 10.1111/ejn.13316; Andrews J, 2006, AM J PSYCHIAT, V163, P463, DOI 10.1176/appi.ajp.163.3.463; Anticevic A, 2015, JAMA PSYCHIAT, V72, P882, DOI 10.1001/jamapsychiatry.2015.0566; Anticevic A, 2014, CEREB CORTEX, V24, P3116, DOI 10.1093/cercor/bht165; Baeg EH, 2003, NEURON, V40, P177, DOI 10.1016/S0896-6273(03)00597-X; Bailey KR, 2005, BEHAV NEUROSCI, V119, P410, DOI 10.1037/0735-7044.119.2.410; Baxter MG, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00038; Bolkan SS, 2016, NEUROSCIENCE, V321, P77, DOI 10.1016/j.neuroscience.2015.05.055; Browning PGF, 2015, CEREB CORTEX, V25, P4519, DOI 10.1093/cercor/bhv093; Byne W, 2009, ACTA NEUROPATHOL, V117, P347, DOI 10.1007/s00401-008-0404-0; Cromer JA, 2010, NEURON, V66, P796, DOI 10.1016/j.neuron.2010.05.005; Delevich K, 2015, J NEUROSCI, V35, P5743, DOI 10.1523/JNEUROSCI.4565-14.2015; Durstewitz D, 2010, NEURON, V66, P438, DOI 10.1016/j.neuron.2010.03.029; Fujisawa S, 2008, NAT NEUROSCI, V11, P823, DOI 10.1038/nn.2134; Funahashi S, 2013, PROG NEUROBIOL, V103, P131, DOI 10.1016/j.pneurobio.2012.04.002; Fuster J., 1989, DISSERT ABSTRACTS IN, V60, P255; FUSTER JM, 1973, J NEUROPHYSIOL, V36, P61, DOI 10.1152/jn.1973.36.1.61; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; GROENEWEGEN HJ, 1988, NEUROSCIENCE, V24, P379, DOI 10.1016/0306-4522(88)90339-9; Harvey CD, 2012, NATURE, V484, P62, DOI 10.1038/nature10918; Hunnicutt BJ, 2014, NAT NEUROSCI, V17, P1276, DOI 10.1038/nn.3780; Johansson JD, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3495719; Jones E. G., 2007, THALAMUS, V2; Jung MW, 1998, CEREB CORTEX, V8, P437, DOI 10.1093/cercor/8.5.437; Kellendonk C, 2006, NEURON, V49, P603, DOI 10.1016/j.neuron.2006.01.023; Mattis J, 2012, NAT METHODS, V9, P159, DOI [10.1038/NMETH.1808, 10.1038/nmeth.1808]; Matyas F, 2014, EUR J NEUROSCI, V39, P1810, DOI 10.1111/ejn.12610; Mello GBM, 2015, CURR BIOL, V25, P1113, DOI 10.1016/j.cub.2015.02.036; Minzenberg MJ, 2009, ARCH GEN PSYCHIAT, V66, P811, DOI 10.1001/archgenpsychiatry.2009.91; Mitchell AS, 2015, NEUROSCI BIOBEHAV R, V54, P76, DOI 10.1016/j.neubiorev.2015.03.001; Narayanan NS, 2006, NEURON, V52, P921, DOI 10.1016/j.neuron.2006.10.021; NIKI H, 1974, BRAIN RES, V70, P346, DOI 10.1016/0006-8993(74)90324-2; NIKI H, 1974, BRAIN RES, V68, P185, DOI 10.1016/0006-8993(74)90388-6; Oh SW, 2014, NATURE, V508, P207, DOI 10.1038/nature13186; Padilla-Coreano N, 2016, NEURON, V89, P857, DOI 10.1016/j.neuron.2016.01.011; Parnaudeau S, 2015, BIOL PSYCHIAT, V77, P445, DOI 10.1016/j.biopsych.2014.03.020; Parnaudeau S, 2013, NEURON, V77, P1151, DOI 10.1016/j.neuron.2013.01.038; Paxinos G., 2012, MOUSE BRAIN STEREOTA, V2nd; Perlstein WM, 2001, AM J PSYCHIAT, V158, P1105, DOI 10.1176/appi.ajp.158.7.1105; Rao SC, 1997, SCIENCE, V276, P821, DOI 10.1126/science.276.5313.821; RAY JP, 1993, J COMP NEUROL, V337, P1, DOI 10.1002/cne.903370102; Rich EL, 2009, J NEUROSCI, V29, P7208, DOI 10.1523/JNEUROSCI.6068-08.2009; Saalmann YB, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00083; Schmitt L. I., 2017, NATURE; Sherman SM, 2002, PHILOS T R SOC B, V357, P1695, DOI 10.1098/rstb.2002.1161; Spellman T, 2015, NATURE, V522, P309, DOI 10.1038/nature14445; Stujenske JM, 2015, CELL REP, V12, P525, DOI 10.1016/j.celrep.2015.06.036; Vinck M, 2010, NEUROIMAGE, V51, P112, DOI 10.1016/j.neuroimage.2010.01.073; Wallis JD, 2001, NATURE, V411, P953, DOI 10.1038/35082081; Weinberger DR, 1996, PHILOS T R SOC B, V351, P1495, DOI 10.1098/rstb.1996.0135; Woodward ND, 2012, AM J PSYCHIAT, V169, P1092, DOI 10.1176/appi.ajp.2012.12010056; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Yoon T, 2008, LEARN MEMORY, V15, P97, DOI 10.1101/lm.850808	55	236	240	6	84	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2017	20	7					987	+		10.1038/nn.4568	http://dx.doi.org/10.1038/nn.4568			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EY6TB	28481349	Green Accepted			2022-12-17	WOS:000404115100015
J	Chung, WS; Welsh, CA; Barres, BA; Stevens, B				Chung, Won-Suk; Welsh, Christina A.; Barres, Ben A.; Stevens, Beth			Do glia drive synaptic and cognitive impairment in disease?	NATURE NEUROSCIENCE			English	Article							ASTROCYTE-SECRETED PROTEINS; ALZHEIMERS-DISEASE; MOUSE MODELS; COMPLEMENT ACTIVATION; MICROGLIAL RESPONSE; CNS SYNAPTOGENESIS; CELLS; TREM2; PATHOLOGY; DEMENTIA	Synaptic dysfunction is a hallmark of many neurodegenerative and psychiatric brain disorders, yet we know little about the mechanisms that underlie synaptic vulnerability. Although neuroinflammation and reactive gliosis are prominent in virtually every CNS disease, glia are largely viewed as passive responders to neuronal damage rather than drivers of synaptic dysfunction. This perspective is changing with the growing realization that glia actively signal with neurons and influence synaptic development, transmission and plasticity through an array of secreted and contact-dependent signals. We propose that disruptions in neuron-glia signaling contribute to synaptic and cognitive impairment in disease. Illuminating the mechanisms by which glia influence synapse function may lead to the development of new therapies and biomarkers for synaptic dysfunction.	[Chung, Won-Suk; Barres, Ben A.] Stanford Univ, Sch Med, Dept Neurobiol, Palo Alto, CA 94304 USA; [Welsh, Christina A.; Stevens, Beth] Harvard Univ, Sch Med, Dept Neurol, FM Kirby Neurobiol Ctr,Boston Childrens Hosp, Boston, MA 02115 USA	Stanford University; Harvard University; Boston Children's Hospital; Harvard Medical School	Stevens, B (corresponding author), Harvard Univ, Sch Med, Dept Neurol, FM Kirby Neurobiol Ctr,Boston Childrens Hosp, Boston, MA 02115 USA.	beth.stevens@childrens.harvard.edu	Chung, Won-Suk/B-9011-2016	Chung, Won-Suk/0000-0003-1060-9007; Welsh, Christina/0000-0001-9802-725X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000222] Funding Source: NIH RePORTER; NIA NIH HHS [T32 AG000222] Funding Source: Medline; NINDS NIH HHS [R01 NS071008] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aida T, 2015, NEUROPSYCHOPHARMACOL, V40, P1569, DOI 10.1038/npp.2015.26; Allen NJ, 2012, NATURE, V486, P410, DOI 10.1038/nature11059; Castellano JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002156; Chen XN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006875; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Chung WS, 2013, NATURE, V504, P394, DOI 10.1038/nature12776; Clarke LE, 2013, NAT REV NEUROSCI, V14, P311, DOI 10.1038/nrn3484; Colonna M, 2003, NAT REV IMMUNOL, V3, P445, DOI 10.1038/nri1106; DeKosky ST, 1996, NEURODEGENERATION, V5, P417, DOI 10.1006/neur.1996.0056; Derecki NC, 2012, NATURE, V484, P105, DOI 10.1038/nature10907; Dumanis SB, 2013, J NEUROCHEM, V124, P4, DOI 10.1111/j.1471-4159.2012.07908.x; Eroglu C, 2009, CELL, V139, P380, DOI 10.1016/j.cell.2009.09.025; FEINBERG I, 1983, J PSYCHIAT RES, V17, P319, DOI 10.1016/0022-3956(82)90038-3; Fonseca MI, 2004, J NEUROSCI, V24, P6457, DOI 10.1523/JNEUROSCI.0901-04.2004; Fujita T, 2014, J NEUROSCI, V34, P16594, DOI 10.1523/JNEUROSCI.2585-14.2014; Genoud C, 2006, PLOS BIOL, V4, P2057, DOI 10.1371/journal.pbio.0040343; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Goudriaan A, 2014, SCHIZOPHRENIA BULL, V40, P925, DOI 10.1093/schbul/sbt109; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Haber M, 2006, J NEUROSCI, V26, P8881, DOI 10.1523/JNEUROSCI.1302-06.2006; Halassa MM, 2010, ANNU REV PHYSIOL, V72, P335, DOI 10.1146/annurev-physiol-021909-135843; Han XN, 2013, CELL STEM CELL, V12, P342, DOI 10.1016/j.stem.2012.12.015; Harrison JK, 1998, P NATL ACAD SCI USA, V95, P10896, DOI 10.1073/pnas.95.18.10896; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Hughes EG, 2010, MOL CELL NEUROSCI, V43, P136, DOI 10.1016/j.mcn.2009.10.004; Jay TR, 2015, J EXP MED, V212, P287, DOI 10.1084/jem.20142322; Jo S, 2014, NAT MED, V20, P886, DOI 10.1038/nm.3639; Jones EV, 2011, J NEUROSCI, V31, P4154, DOI 10.1523/JNEUROSCI.4757-10.2011; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Kierdorf K, 2013, NAT NEUROSCI, V16, P273, DOI 10.1038/nn.3318; Kucukdereli H, 2011, P NATL ACAD SCI USA, V108, pE440, DOI 10.1073/pnas.1104977108; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Li HF, 2012, NEUROBIOL DIS, V48, P429, DOI 10.1016/j.nbd.2012.06.019; Liu CC, 2013, NAT REV NEUROL, V9, P106, DOI 10.1038/nrneurol.2012.263; Ma TM, 2013, MOL PSYCHIATR, V18, P557, DOI 10.1038/mp.2012.97; Matsuno H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116319; Matute C, 2005, GLIA, V49, P451, DOI 10.1002/glia.20119; Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Orr AG, 2015, NAT NEUROSCI, V18, P423, DOI 10.1038/nn.3930; Paloneva J, 2002, AM J HUM GENET, V71, P656, DOI 10.1086/342259; Paloneva J, 2000, NAT GENET, V25, P357, DOI 10.1038/77153; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Pasca SP, 2014, ANNU REV NEUROSCI, V37, P479, DOI 10.1146/annurev-neuro-062012-170328; Patterson PH, 2011, TRENDS MOL MED, V17, P389, DOI 10.1016/j.molmed.2011.03.001; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Rayaprolu S, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-19; ROGERS J, 1992, RES IMMUNOL, V143, P624, DOI 10.1016/0923-2494(92)80046-N; Rogers JT, 2011, J NEUROSCI, V31, P16241, DOI 10.1523/JNEUROSCI.3667-11.2011; Roumier A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002595; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Shen Y, 2001, NEUROSCI LETT, V305, P165, DOI 10.1016/S0304-3940(01)01842-0; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Stephan AH, 2013, J NEUROSCI, V33, P13460, DOI 10.1523/JNEUROSCI.1333-13.2013; Stephan AH, 2012, ANNU REV NEUROSCI, V35, P369, DOI 10.1146/annurev-neuro-061010-113810; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Tani H, 2014, NEURON, V81, P888, DOI 10.1016/j.neuron.2013.12.026; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Thrane VR, 2013, NAT MED, V19, P1643, DOI 10.1038/nm.3400; Tremblay ME, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000527; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; Ulrich JD, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-20; van Berckel BN, 2008, BIOL PSYCHIAT, V64, P820, DOI 10.1016/j.biopsych.2008.04.025; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Wang JQ, 2015, NATURE, V521, pE1, DOI 10.1038/nature14444; Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049; Williamson LL, 2013, BRAIN BEHAV IMMUN, V30, P186, DOI 10.1016/j.bbi.2013.01.077; Witcher MR, 2010, GLIA, V58, P572, DOI 10.1002/glia.20946; Wyss-Coray T, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006346; Zhan Y, 2014, NAT NEUROSCI, V17, P400, DOI 10.1038/nn.3641; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030; Zhang JF, 2014, NEURON, V82, P195, DOI 10.1016/j.neuron.2014.01.043; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]	77	236	244	3	86	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2015	18	11					1539	1545		10.1038/nn.4142	http://dx.doi.org/10.1038/nn.4142			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CU8YT	26505565	Green Accepted			2022-12-17	WOS:000363830700006
J	Kageyama, R; Ohtsuka, T; Shimojo, H; Imayoshi, I				Kageyama, Ryoichiro; Ohtsuka, Toshiyuki; Shimojo, Hiromi; Imayoshi, Itaru			Dynamic Notch signaling in neural progenitor cells and a revised view of lateral inhibition	NATURE NEUROSCIENCE			English	Article							HES1 EXPRESSION; STEM-CELLS; PRONEURAL BHLH; DELTA-HOMOLOG; GENES; NUMB; DIFFERENTIATION; PROLIFERATION; NEUROGENESIS; NEURONS	In the developing mammalian nervous system, neural progenitor cells first express the Notch effector Hes1 at variable levels and then proneural genes and Notch ligands in salt-and-pepper patterns. Recent real-time imaging analysis indicates that Hes1 expression in these cells oscillates with a period of about 2-3 h. Furthermore, the proneural gene Neurogenin-2 (Ngn2) and the Notch ligand gene Deltalike-1 (Dll1) are expressed cyclically in neural progenitor cells under the control of Hes1 oscillation but are expressed continuously in postmitotic neurons, which lose Hes1 expression. Hes1-driven Ngn2 and Dll1 oscillations seem to be advantageous for maintenance of a group of cells in an undifferentiated state by mutual activation of Notch signaling. This dynamic mode of gene expression would require a revision of the traditional view of how Notch-mediated lateral inhibition operates in the developing mammalian nervous system.	[Kageyama, Ryoichiro] Kyoto Univ, Inst Virus Res, Sakyo Ku, Kyoto 6068507, Japan; Japan Sci & Technol Agcy, CREST, Sakyo Ku, Kyoto 6068507, Japan	Kyoto University; Japan Science & Technology Agency (JST)	Kageyama, R (corresponding author), Kyoto Univ, Inst Virus Res, Sakyo Ku, Shogoin Kawahara, Kyoto 6068507, Japan.	rkageyam@virus.kyoto-u.ac.jp		Shimojo, Hiromi/0000-0001-5455-4218	Ministry of Education, Culture, Sports, Science and Technology of Japan; Uehara Memorial Foundation; Japan Society for the Promotion of Science for Young Scientists	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan and the Uehara Memorial Foundation. H. S. and I. I. were supported by the 21st Century Center of Excellence Program of the Ministry of Education, Culture, Sports, Science and Technology of Japan and Research Fellowships of the Japan Society for the Promotion of Science for Young Scientists.	Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Baek JH, 2006, DEVELOPMENT, V133, P2467, DOI 10.1242/dev.02403; Bai G, 2007, DEV CELL, V13, P283, DOI 10.1016/j.devcel.2007.05.014; BETTENHAUSEN B, 1995, DEVELOPMENT, V121, P2407; Breunig JJ, 2007, P NATL ACAD SCI USA, V104, P20558, DOI 10.1073/pnas.0710156104; Castella P, 2000, MOL CELL BIOL, V20, P6170, DOI 10.1128/MCB.20.16.6170-6183.2000; Castro DS, 2006, DEV CELL, V11, P831, DOI 10.1016/j.devcel.2006.10.006; Cayouette M, 2002, NAT NEUROSCI, V5, P1265, DOI 10.1038/nn1202-1265; Doetsch F, 2003, NAT NEUROSCI, V6, P1127, DOI 10.1038/nn1144; Dunwoodie SL, 1997, DEVELOPMENT, V124, P3065; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gaiano N, 2002, ANNU REV NEUROSCI, V25, P471, DOI 10.1146/annurev.neuro.25.030702.130823; GUILLEMOT F, 1993, MECH DEVELOP, V42, P171, DOI 10.1016/0925-4773(93)90006-J; Hammerle B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001169; Hartman J, 2004, ONCOGENE, V23, P8826, DOI 10.1038/sj.onc.1208139; Hatakeyama J, 2004, DEVELOPMENT, V131, P5539, DOI 10.1242/dev.01436; Hatakeyama J, 2006, CEREB CORTEX, V16, pI132, DOI 10.1093/cercor/bhj166; Heng JIT, 2008, NATURE, V455, P114, DOI 10.1038/nature07198; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Hirata H, 2002, SCIENCE, V298, P840, DOI 10.1126/science.1074560; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Irvine KD, 2001, ANNU REV CELL DEV BI, V17, P189, DOI 10.1146/annurev.cellbio.17.1.189; Johnson JE, 2003, TRENDS NEUROSCI, V26, P395, DOI 10.1016/S0166-2236(03)00166-8; Kabos P, 2002, J BIOL CHEM, V277, P8763, DOI 10.1074/jbc.C100758200; Kamakura S, 2004, NAT CELL BIOL, V6, P547, DOI 10.1038/ncb1138; Kiecker C, 2005, NAT REV NEUROSCI, V6, P553, DOI 10.1038/nrn1702; Lindsell CE, 1996, MOL CELL NEUROSCI, V8, P14, DOI 10.1006/mcne.1996.0040; Masamizu Y, 2006, P NATL ACAD SCI USA, V103, P1313, DOI 10.1073/pnas.0508658103; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; Murata K, 2005, MOL CELL BIOL, V25, P4262, DOI 10.1128/MCB.25.10.4262-4271.2005; Myat A, 1996, DEV BIOL, V174, P233, DOI 10.1006/dbio.1996.0069; Nelson BR, 2008, DEV DYNAM, V237, P1565, DOI 10.1002/dvdy.21550; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; Ohtsuka T, 2006, MOL CELL NEUROSCI, V31, P109, DOI 10.1016/j.mcn.2005.09.006; Oya S, 2008, NEUROREPORT, V19, P805, DOI 10.1097/WNR.0b013e3282ff8641; Parras CM, 2004, EMBO J, V23, P4495, DOI 10.1038/sj.emboj.7600447; Politis PK, 2007, P NATL ACAD SCI USA, V104, P17861, DOI 10.1073/pnas.0610973104; Rasin MR, 2007, NAT NEUROSCI, V10, P819, DOI 10.1038/nn1924; Sang LY, 2008, SCIENCE, V321, P1095, DOI 10.1126/science.1155998; Selkoe D, 2003, ANNU REV NEUROSCI, V26, P565, DOI 10.1146/annurev.neuro.26.041002.131334; Shen Q, 2002, DEVELOPMENT, V129, P4843; Shimojo H, 2008, NEURON, V58, P52, DOI 10.1016/j.neuron.2008.02.014; Simeone A, 2002, TRENDS NEUROSCI, V25, P119, DOI 10.1016/S0166-2236(00)02095-6; Sommer L, 1996, MOL CELL NEUROSCI, V8, P221, DOI 10.1006/mcne.1996.0060; Strom A, 2000, ONCOGENE, V19, P5951, DOI 10.1038/sj.onc.1203990; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Yoshiura S, 2007, P NATL ACAD SCI USA, V104, P11292, DOI 10.1073/pnas.0701837104	48	236	248	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2008	11	11					1247	1251		10.1038/nn.2208	http://dx.doi.org/10.1038/nn.2208			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	366HZ	18956012				2022-12-17	WOS:000260472700009
J	Choi, JT; Bastian, AJ				Choi, Julia T.; Bastian, Amy J.			Adaptation reveals independent control networks for human walking	NATURE NEUROSCIENCE			English	Article							CENTRAL PATTERN GENERATOR; LOW SPINAL CAT; INTERLIMB COORDINATION; SPINOCEREBELLAR TRACT; LOCOMOTOR ADAPTATIONS; FICTIVE LOCOMOTION; CORD; CEREBELLUM; NEURONS; DELETIONS	Human walking is remarkably adaptable on short and long timescales. We can immediately transition between directions and gait patterns, and we can adaptively learn accurate calibrations for different walking contexts. Here we studied the degree to which different motor patterns can adapt independently. We used a split-belt treadmill to adapt the right and left legs to different speeds and in different directions (forward versus backward). To our surprise, adults could easily walk with their legs moving in opposite directions. Analysis of aftereffects showed that walking adaptations are stored independently for each leg and do not transfer across directions. Thus, there are separate functional networks controlling forward and backward walking in humans, and the circuits controlling the right and left legs can be trained individually. Such training could provide a new therapeutic approach for correcting various walking asymmetries.	Kennedy Krieger Inst, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurol & Neurosurg, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Phys Med & Rehabil, Baltimore, MD 21205 USA	Kennedy Krieger Institute; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Bastian, AJ (corresponding author), Kennedy Krieger Inst, 707 N Broadway, Baltimore, MD 21205 USA.	julia.choi@jhu.edu; bastian@kennedykrieger.org	Hoogkamer, Wouter/G-4498-2010	Choi, Julia/0000-0003-4963-9094	NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015488] Funding Source: NIH RePORTER; NCRR NIH HHS [C06RR15488] Funding Source: Medline; NICHD NIH HHS [R01HD048740] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ARSHAVSKY YI, 1978, BRAIN RES, V151, P493, DOI 10.1016/0006-8993(78)91082-X; Bastian AJ, 2006, CURR OPIN NEUROBIOL, V16, P645, DOI 10.1016/j.conb.2006.08.016; Batschelet E., 1981, CIRCULAR STAT BIOL; BERKOWITZ A, 1994, J NEUROSCI, V14, P5105; Bosco G, 2006, EXP BRAIN RES, V175, P83, DOI 10.1007/s00221-006-0530-7; Bosco G, 2005, EXP BRAIN RES, V167, P394, DOI 10.1007/s00221-005-0033-y; Bosco G, 2000, J NEUROPHYSIOL, V83, P2931, DOI 10.1152/jn.2000.83.5.2931; CALANCIE B, 1994, BRAIN, V117, P1143, DOI 10.1093/brain/117.5.1143; DIETZ V, 1994, EXP BRAIN RES, V101, P513; Dimitrijevic MR, 1998, ANN NY ACAD SCI, V860, P360, DOI 10.1111/j.1749-6632.1998.tb09062.x; FORSSBERG H, 1980, ACTA PHYSIOL SCAND, V108, P283, DOI 10.1111/j.1748-1716.1980.tb06534.x; Grasso R, 1998, J NEUROPHYSIOL, V80, P1868, DOI 10.1152/jn.1998.80.4.1868; GRILLNER S, 1979, EXP BRAIN RES, V34, P241; Hammar I, 2004, EUR J NEUROSCI, V19, P1305, DOI 10.1111/j.1460-9568.2004.03239.x; HORAK FB, 1994, J NEUROPHYSIOL, V72, P479, DOI 10.1152/jn.1994.72.2.479; Kiehn O, 2006, ANNU REV NEUROSCI, V29, P279, DOI 10.1146/annurev.neuro.29.051605.112910; Krakauer JW, 2006, PLOS BIOL, V4, P1798, DOI 10.1371/journal.pbio.0040316; Kullander K, 2003, SCIENCE, V299, P1889, DOI 10.1126/science.1079641; Lafreniere-Roula M, 2005, J NEUROPHYSIOL, V94, P1120, DOI 10.1152/jn.00216.2005; Lam T, 2006, J NEUROPHYSIOL, V95, P766, DOI 10.1152/jn.00473.2005; Lam T, 2000, J NEUROPHYSIOL, V83, P2814, DOI 10.1152/jn.2000.83.5.2814; Lang CE, 1999, J NEUROPHYSIOL, V82, P2108, DOI 10.1152/jn.1999.82.5.2108; MORTIN LI, 1989, J NEUROSCI, V9, P2285; Morton SM, 2004, J NEUROPHYSIOL, V92, P2497, DOI 10.1152/jn.00129.2004; Morton SM, 2006, J NEUROSCI, V26, P9107, DOI 10.1523/JNEUROSCI.2622-06.2006; ORLOVSKY GN, 1972, BRAIN RES, V46, P85, DOI 10.1016/0006-8993(72)90007-8; ORLOVSKY GN, 1972, BRAIN RES, V40, P359, DOI 10.1016/0006-8993(72)90139-4; Pearson KG, 2000, ANNU REV PHYSIOL, V62, P723, DOI 10.1146/annurev.physiol.62.1.723; Poppele RE, 2003, EXP BRAIN RES, V149, P361, DOI 10.1007/s00221-003-1378-8; Reisman DS, 2005, J NEUROPHYSIOL, V94, P2403, DOI 10.1152/jn.00089.2005; REISMAN DS, 2007, BRAIN           0402, DOI DOI 10.1093/BRAIN/AWM035; Reynolds RF, 2004, J NEUROPHYSIOL, V91, P92, DOI 10.1152/jn.00495.2003; Rybak IA, 2006, J PHYSIOL-LONDON, V577, P617, DOI 10.1113/jphysiol.2006.118703; Smith MA, 2005, J NEUROPHYSIOL, V93, P2809, DOI 10.1152/jn.00943.2004; Yanagihara D, 1996, P NATL ACAD SCI USA, V93, P13292, DOI 10.1073/pnas.93.23.13292; Yang JF, 2005, J NEUROSCI, V25, P6869, DOI 10.1523/JNEUROSCI.1765-05.2005; Yang JF, 2004, CAN J PHYSIOL PHARM, V82, P662, DOI 10.1139/Y04-070; Zar JH., 1999, BIOSTATISTICAL ANAL	38	236	243	1	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2007	10	8					1055	1062		10.1038/nn1930	http://dx.doi.org/10.1038/nn1930			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	194PY	17603479				2022-12-17	WOS:000248357500020
J	Hawasli, AH; Benavides, DR; Nguyen, C; Kansy, JW; Hayashi, K; Chambon, P; Greengard, P; Powell, CM; Cooper, DC; Bibb, JA				Hawasli, Ammar H.; Benavides, David R.; Nguyen, Chan; Kansy, Janice W.; Hayashi, Kanehiro; Chambon, Pierre; Greengard, Paul; Powell, Craig M.; Cooper, Donald C.; Bibb, James A.			Cyclin-dependent kinase 5 governs learning and synaptic plasticity via control of NMDAR degradation	NATURE NEUROSCIENCE			English	Article							LONG-TERM-POTENTIATION; NR2B SUBUNIT; CDK5 ACTIVITY; RECEPTOR; MEMORY; ROLES; MICE; P25; EXPRESSION; CLEAVAGE	Learning is accompanied by modulation of postsynaptic signal transduction pathways in neurons. Although the neuronal protein kinase cyclin-dependent kinase 5 (Cdk5) has been implicated in cognitive disorders, its role in learning has been obscured by the perinatal lethality of constitutive knockout mice. Here we report that conditional knockout of Cdk5 in the adult mouse brain improved performance in spatial learning tasks and enhanced hippocampal long-term potentiation and NMDA receptor ( NMDAR)mediated excitatory postsynaptic currents. Enhanced synaptic plasticity in Cdk5 knockout mice was attributed to reduced NR2B degradation, which caused elevations in total, surface and synaptic NR2B subunit levels and current through NR2B-containing NMDARs. Cdk5 facilitated the degradation of NR2B by directly interacting with both it and its protease, calpain. These findings reveal a previously unknown mechanism by which Cdk5 facilitates calpain-mediated proteolysis of NR2B and may control synaptic plasticity and learning.	Univ Texas, SW Med Ctr, Dept Psychiat, Dallas, TX 75390 USA; Ctr Univ Strasbourg, Inst Genet & Biol Mol & Cellular, F-67404 Strasbourg, France; Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA; Univ Texas, SW Med Ctr, Dept Neurol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Rockefeller University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Bibb, JA (corresponding author), Univ Texas, SW Med Ctr, Dept Psychiat, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	james.bibb@utsouthwestern.edu	Hayashi, Kanehiro/L-2777-2013	Powell, Craig/0000-0001-5451-2165; Greengard, Paul/0000-0002-4437-0893	NIDA NIH HHS [F31 DA020199, K01 DA017750] Funding Source: Medline; NIMH NIH HHS [K08 MH065975-04, K08 MH065975-05, K08 MH065975] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH065975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA017750] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Angelo M, 2003, EUR J NEUROSCI, V18, P423, DOI 10.1046/j.1460-9568.2003.02746.x; BERNASCONIGUASTALLA S, 1994, HIPPOCAMPUS, V4, P53, DOI 10.1002/hipo.450040107; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Bibb JA, 1999, NATURE, V402, P669, DOI 10.1038/45251; Bibb JA, 2001, NATURE, V410, P376, DOI 10.1038/35066591; Chenard BL, 1999, CURR PHARM DESIGN, V5, P381; Cheung ZH, 2006, NEURON, V50, P13, DOI 10.1016/j.neuron.2006.02.024; Chung HJ, 2004, J NEUROSCI, V24, P10248, DOI 10.1523/JNEUROSCI.0546-04.2004; Cooper DC, 2005, PLOS BIOL, V3, P1123, DOI 10.1371/journal.pbio.0030175; Costa-Mattioli M, 2005, NATURE, V436, P1166, DOI 10.1038/nature03897; Dong YN, 2004, J NEUROSCI, V24, P11035, DOI 10.1523/JNEUROSCI.3722-04.2004; Fischer A, 2005, NEURON, V48, P825, DOI 10.1016/j.neuron.2005.10.033; Fischer A, 2002, J NEUROSCI, V22, P3700; Gilmore EC, 1998, J NEUROSCI, V18, P6370; Gold SJ, 1997, J NEUROSCI, V17, P8024; Guttmann RP, 2002, J PHARMACOL EXP THER, V302, P1023, DOI 10.1124/jpet.102.036962; Guttmann RP, 2001, J NEUROCHEM, V78, P1083, DOI 10.1046/j.1471-4159.2001.00493.x; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Itoh K, 2005, MOL CELL NEUROSCI, V29, P245, DOI 10.1016/j.mcn.2005.02.014; Kiyama Y, 1998, J NEUROSCI, V18, P6704; Kutsuwada T, 1996, NEURON, V16, P333, DOI 10.1016/S0896-6273(00)80051-3; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Liu MC, 2006, BIOCHEM J, V394, P715, DOI 10.1042/BJ20050905; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Morabito MA, 2004, J NEUROSCI, V24, P865, DOI 10.1523/JNEUROSCI.4582-03.2004; Nakazawa K, 2003, NEURON, V38, P305, DOI 10.1016/S0896-6273(03)00165-X; Nishi A, 2002, J NEUROCHEM, V81, P832, DOI 10.1046/j.1471-4159.2002.00876.x; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Ohshima T, 2005, J NEUROCHEM, V94, P917, DOI 10.1111/j.1471-4159.2005.03233.x; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Picconi B, 2006, STROKE, V37, P1895, DOI 10.1161/01.STR.0000226981.57777.b0; Powell CM, 2004, NEURON, V42, P143, DOI 10.1016/S0896-6273(04)00146-1; Simpkins KL, 2003, J NEUROSCI, V23, P11322; Sweatt JD, 2003, MECH MEMORY; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Wattler S, 1999, BIOTECHNIQUES, V26, P1150, DOI 10.2144/99266rr02; Weber P, 2001, EUR J NEUROSCI, V14, P1777, DOI 10.1046/j.0953-816x.2001.01803.x; Wei FY, 2005, J NEUROCHEM, V93, P502, DOI 10.1111/j.1471-4159.2005.03058.x; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Yan Z, 2002, J PHYSIOL-LONDON, V540, P761; Zhao MG, 2005, NEURON, V47, P859, DOI 10.1016/j.neuron.2005.08.014	43	236	257	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2007	10	7					880	886		10.1038/nn1914	http://dx.doi.org/10.1038/nn1914			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	183GH	17529984	Green Accepted			2022-12-17	WOS:000247560200018
J	Hanchar, HJ; Dodson, PD; Olsen, RW; Otis, TS; Wallner, M				Hanchar, HJ; Dodson, PD; Olsen, RW; Otis, TS; Wallner, M			Alcohol-induced motor impairment caused by increased extrasynaptic GABA(A) receptor activity	NATURE NEUROSCIENCE			English	Article							CEREBELLAR GRANULE CELLS; TONIC INHIBITION; SUBUNIT GENE; NEURONAL EXCITABILITY; HIPPOCAMPAL-NEURONS; A RECEPTORS; RAT BRAIN; ETHANOL; EXPRESSION; MICE	Neuronal mechanisms underlying alcohol intoxication are unclear. We find that alcohol impairs motor coordination by enhancing tonic inhibition mediated by a specific subtype of extrasynaptic GABA(A) receptor (GABAR), alpha6beta3delta, expressed exclusively in cerebellar granule cells. In recombinant studies, we characterize a naturally occurring single-nucleotide polymorphism that causes a single amino acid change (R100Q) in alpha6 (encoded in rats by the Gabra6 gene). We show that this change selectively increases alcohol sensitivity of alpha6beta3delta GABARs. Behavioral and electrophysiological comparisons of Gabra6(100R/100R) and Gabra6(100Q/100Q) rats strongly suggest that alcohol impairs motor coordination by enhancing granule cell tonic inhibition. These findings identify extrasynaptic GABARs as critical targets underlying low-dose alcohol intoxication and demonstrate that subtle changes in tonic inhibition in one class of neurons can alter behavior.	Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Otis, TS (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.	otist@ucla.edu	Wallner, Martin/B-8322-2009	Wallner, Martin/0000-0003-4134-8946; Dodson, Paul/0000-0003-0858-6088	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS035985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [F31AA015460, R37AA007680, R01AA007680] Funding Source: NIH RePORTER; NIAAA NIH HHS [R37 AA007680-16, AA07680, R01 AA007680, AA015460, R37 AA007680, F31 AA015460, F31 AA015460-02] Funding Source: Medline; NINDS NIH HHS [NS41651, P01 NS035985-090004, P01 NS035985, P01 NS035985-05, NS35985] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Brickley SG, 2001, NATURE, V409, P88, DOI 10.1038/35051086; Campos ML, 2001, NEUROSCIENCE, V102, P625, DOI 10.1016/S0306-4522(00)00525-X; Carta M, 2004, J NEUROSCI, V24, P3746, DOI 10.1523/JNEUROSCI.0067-04.2004; Chadderton P, 2004, NATURE, V428, P856, DOI 10.1038/nature02442; Choi DS, 2004, NAT NEUROSCI, V7, P855, DOI 10.1038/nn1288; Davies AG, 2003, CELL, V115, P655, DOI 10.1016/S0092-8674(03)00979-6; FARRANT M, 1993, NATURE, V361, P302, DOI 10.1038/361302a0; Hodge CW, 1999, NAT NEUROSCI, V2, P997, DOI 10.1038/14795; Homanics GE, 1997, MOL PHARMACOL, V51, P588, DOI 10.1124/mol.51.4.588; Homanics GE, 1997, P NATL ACAD SCI USA, V94, P4143, DOI 10.1073/pnas.94.8.4143; Jones A, 1997, J NEUROSCI, V17, P1350; Jurd R, 2002, FASEB J, V16, P250, DOI 10.1096/fj.02-0611fje; KANEDA M, 1995, J PHYSIOL-LONDON, V485, P419, DOI 10.1113/jphysiol.1995.sp020739; Kobayashi T, 1999, NAT NEUROSCI, V2, P1091, DOI 10.1038/16019; KORPI ER, 1993, NATURE, V361, P356, DOI 10.1038/361356a0; Korpi ER, 1999, EUR J NEUROSCI, V11, P233, DOI 10.1046/j.1460-9568.1999.00421.x; KORPI ER, 1992, ALCOHOL, V9, P225, DOI 10.1016/0741-8329(92)90058-I; Lewohl JM, 1999, NAT NEUROSCI, V2, P1084, DOI 10.1038/16012; LOVINGER DM, 1989, SCIENCE, V243, P1721, DOI 10.1126/science.2467382; Low K, 2000, SCIENCE, V290, P131, DOI 10.1126/science.290.5489.131; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.ne.17.030194.003033; McKernan RM, 2000, NAT NEUROSCI, V3, P587, DOI 10.1038/75761; Mihic SJ, 1997, NATURE, V389, P385, DOI 10.1038/38738; Mitchell SJ, 2003, NEURON, V38, P433, DOI 10.1016/S0896-6273(03)00200-9; Mohler H, 2001, Curr Opin Pharmacol, V1, P22, DOI 10.1016/S1471-4892(01)00008-X; Nusser Z, 1999, EUR J NEUROSCI, V11, P1685, DOI 10.1046/j.1460-9568.1999.00581.x; Nusser Z, 1998, J NEUROSCI, V18, P1693; Nusser Z, 2002, J NEUROPHYSIOL, V87, P2624, DOI 10.1152/jn.2002.87.5.2624; Overstreet LS, 2001, J NEUROPHYSIOL, V86, P596, DOI 10.1152/jn.2001.86.2.596; Peng Z, 2002, J COMP NEUROL, V446, P179, DOI 10.1002/cne.10210; Pirker S, 2000, NEUROSCIENCE, V101, P815, DOI 10.1016/S0306-4522(00)00442-5; Poltl A, 2003, J NEUROCHEM, V87, P1444, DOI 10.1046/j.1471-4159.2003.02135.x; Radcliffe RA, 2004, BEHAV GENET, V34, P453, DOI 10.1023/B:BEGE.0000023650.32243.39; Rossi DJ, 1998, NEURON, V20, P783, DOI 10.1016/S0896-6273(00)81016-8; Rudolph U, 1999, NATURE, V401, P796, DOI 10.1038/44579; Saba L, 2001, MOL BRAIN RES, V87, P263, DOI 10.1016/S0169-328X(01)00003-1; Saxena NC, 1996, MOL PHARMACOL, V49, P567; Semyanov A, 2004, TRENDS NEUROSCI, V27, P262, DOI 10.1016/j.tins.2004.03.005; Semyanov A, 2003, NAT NEUROSCI, V6, P484, DOI 10.1038/nn1043; Stell BM, 2003, P NATL ACAD SCI USA, V100, P14439, DOI 10.1073/pnas.2435457100; Sundram FX, 2002, WORLD J NUCL MED, V1, P5; SUZDAK PD, 1986, SCIENCE, V234, P1243, DOI 10.1126/science.3022383; Uusi-Oukari M, 2000, MOL CELL NEUROSCI, V16, P34, DOI 10.1006/mcne.2000.0856; Vallee BL, 1998, SCI AM, V278, P80, DOI 10.1038/scientificamerican0698-80; Vekovischeva OY, 1999, BRAIN RES, V837, P184, DOI 10.1016/S0006-8993(99)01691-1; Wallner M, 2003, P NATL ACAD SCI USA, V100, P15218, DOI 10.1073/pnas.2435171100; Wei WZ, 2004, J NEUROSCI, V24, P8379, DOI 10.1523/JNEUROSCI.2040-04.2004; Wisden W, 1996, NEUROPHARMACOLOGY, V35, P1139, DOI 10.1016/S0028-3908(96)00076-7	48	236	241	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2005	8	3					339	345		10.1038/nn1398	http://dx.doi.org/10.1038/nn1398			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	902KL	15696164	Green Accepted			2022-12-17	WOS:000227354600019
J	Min, R; Nevian, T				Min, Rogier; Nevian, Thomas			Astrocyte signaling controls spike timing-dependent depression at neocortical synapses	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; RAT SOMATOSENSORY CORTEX; SYNAPTIC-TRANSMISSION; D-SERINE; NEUROTRANSMITTER RELEASE; INHIBITORY SYNAPSES; PRESYNAPTIC NMDA; PYRAMIDAL CELLS; GLIAL-CELLS; PLASTICITY	Endocannabinoid mediated spike timing dependent depression (t-LTD) is crucially involved in the development of the sensory neocortex. t-LTD at excitatory synapses in the developing rat barrel cortex requires cannabinoid CBI receptor (CB1R) activation, as well as activation of NMDA receptors located on the presynaptic terminal, but the exact signaling cascade leading to t-LTD remains unclear. We found that astrocytes are critically involved in t-LTD. Astrocytes gradually increased their Ca2+ signaling specifically during the induction of t-LTD in a CB1R-dependent manner. In this way, astrocytes might act as a memory buffer for previous coincident neuronal activity. Following activation, astrocytes released glutamate, which activated presynaptic NMDA receptors to induce t-LTD. Astrocyte stimulation coincident with afferent activity resulted in long-term depression, indicating that astrocyte activation is sufficient for the induction of synaptic depression. Taken together, our findings describe the retrograde signaling cascade underlying neocortical t-LTD. The critical involvement of astrocytes in this process highlights their importance for experience-dependent sensory remodeling.	[Min, Rogier; Nevian, Thomas] Univ Bern, Dept Physiol, CH-3012 Bern, Switzerland	University of Bern	Nevian, T (corresponding author), Univ Bern, Dept Physiol, Buhlpl 5, CH-3012 Bern, Switzerland.	nevian@pyl.unibe.ch	Min, Rogier/C-7137-2012	Min, Rogier/0000-0002-3574-7599; Nevian, Thomas/0000-0001-9804-608X	Swiss National Science Foundation [3100A0-118395]; Berne University Research Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Berne University Research Foundation	We thank A. Volterra, H.D. Mansvelder, H.-R. Luscher, M. Santello, L.M. Palmer and E. Perez-Garci for their comments on the manuscript. This work was supported by the Swiss National Science Foundation (T.N., grant 3100A0-118395) and an Equipment grant of the Berne University Research Foundation.	Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Bellocchio EE, 2000, SCIENCE, V289, P957, DOI 10.1126/science.289.5481.957; Bender KJ, 2006, J NEUROSCI, V26, P4155, DOI 10.1523/JNEUROSCI.0175-06.2006; Bender VA, 2006, J NEUROSCI, V26, P4166, DOI 10.1523/JNEUROSCI.0176-06.2006; Bezzi P, 2004, NAT NEUROSCI, V7, P613, DOI 10.1038/nn1246; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bodor AL, 2005, J NEUROSCI, V25, P6845, DOI 10.1523/JNEUROSCI.0442-05.2005; Castillo PE, 1997, NATURE, V388, P590, DOI 10.1038/41574; Castillo PE, 2002, NATURE, V415, P327, DOI 10.1038/415327a; Chevaleyre V, 2003, NEURON, V38, P461, DOI 10.1016/S0896-6273(03)00235-6; Chevaleyre V, 2007, NEURON, V54, P801, DOI 10.1016/j.neuron.2007.05.020; Corlew R, 2007, J NEUROSCI, V27, P9835, DOI 10.1523/JNEUROSCI.5494-06.2007; Dan Y, 2006, PHYSIOL REV, V86, P1033, DOI 10.1152/physrev.00030.2005; Duguid I, 2006, CURR OPIN NEUROBIOL, V16, P312, DOI 10.1016/j.conb.2006.05.008; Feldman DE, 2005, SCIENCE, V310, P810, DOI 10.1126/science.1115807; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; Fortin DA, 2007, CEREB CORTEX, V17, P163, DOI 10.1093/cercor/bhj133; Fourcaudot E, 2008, P NATL ACAD SCI USA, V105, P15130, DOI 10.1073/pnas.0806938105; Froemke RC, 2005, NATURE, V434, P221, DOI 10.1038/nature03366; Genoud C, 2006, PLOS BIOL, V4, P2057, DOI 10.1371/journal.pbio.0040343; Gordon GRJ, 2009, NEURON, V64, P391, DOI 10.1016/j.neuron.2009.10.021; Grosche J, 1999, NAT NEUROSCI, V2, P139, DOI 10.1038/5692; Halassa MM, 2007, J NEUROSCI, V27, P6473, DOI 10.1523/JNEUROSCI.1419-07.2007; Harkany T, 2004, J NEUROSCI, V24, P4978, DOI 10.1523/JNEUROSCI.4884-03.2004; Harvey CD, 2008, SCIENCE, V321, P136, DOI 10.1126/science.1159675; Hashimotodani Y, 2005, NEURON, V45, P257, DOI 10.1016/j.neuron.2005.01.004; Haydon PG, 2006, PHYSIOL REV, V86, P1009, DOI 10.1152/physrev.00049.2005; Heifets BD, 2008, P NATL ACAD SCI USA, V105, P10250, DOI 10.1073/pnas.0711880105; Heifets BD, 2009, ANNU REV PHYSIOL, V71, P283, DOI 10.1146/annurev.physiol.010908.163149; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Hill EL, 2007, J NEUROPHYSIOL, V97, P2580, DOI 10.1152/jn.00603.2006; Huang Y, 2008, J NEUROSCI, V28, P7074, DOI 10.1523/JNEUROSCI.0899-08.2008; Jourdain P, 2007, NAT NEUROSCI, V10, P331, DOI 10.1038/nn1849; Kakegawa W, 2011, NAT NEUROSCI, V14, P603, DOI 10.1038/nn.2791; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; Larsen RS, 2011, NAT NEUROSCI, V14, P338, DOI 10.1038/nn.2750; Li L, 2009, NEURON, V64, P537, DOI 10.1016/j.neuron.2009.10.005; Navarrete M, 2008, NEURON, V57, P883, DOI 10.1016/j.neuron.2008.01.029; Navarrete M, 2010, NEURON, V68, P113, DOI 10.1016/j.neuron.2010.08.043; Nevian T, 2006, J NEUROSCI, V26, P11001, DOI 10.1523/JNEUROSCI.1749-06.2006; Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Perea G, 2007, SCIENCE, V317, P1083, DOI 10.1126/science.1144640; Rodriguez-Moreno A, 2008, NAT NEUROSCI, V11, P744, DOI 10.1038/nn.2125; Santello M, 2011, NEURON, V69, P988, DOI 10.1016/j.neuron.2011.02.003; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Sjostrom PJ, 2003, NEURON, V39, P641, DOI 10.1016/S0896-6273(03)00476-8; Tsetsenis T, 2011, P NATL ACAD SCI USA, V108, P14300, DOI 10.1073/pnas.1112237108; Verkhratsky A, 1996, TRENDS NEUROSCI, V19, P346, DOI 10.1016/0166-2236(96)10048-5; Zilberter M, 2009, CEREB CORTEX, V19, P2308, DOI 10.1093/cercor/bhn247	50	235	236	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2012	15	5					746	753		10.1038/nn.3075	http://dx.doi.org/10.1038/nn.3075			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	932DI	22446881				2022-12-17	WOS:000303270200019
J	Chavez, AE; Chiu, CQ; Castillo, PE				Chavez, Andres E.; Chiu, Chiayu Q.; Castillo, Pablo E.			TRPV1 activation by endogenous anandamide triggers postsynaptic long-term depression in dentate gyrus	NATURE NEUROSCIENCE			English	Article							VANILLOID RECEPTOR; SYNAPTIC-TRANSMISSION; CAPSAICIN RECEPTOR; IMMUNOHISTOCHEMICAL LOCALIZATION; SYNAPSES; RAT; CHANNELS; PLASTICITY; ENDOCANNABINOIDS; POTENTIATION	The transient receptor potential TRPV1 is a nonselective cation channel that mediates pain sensations and is commonly activated by a wide variety of exogenous and endogenous, physical and chemical stimuli. Although TRPV1 receptors are mainly found in nociceptive neurons of the peripheral nervous system, these receptors have also been found in the brain, where their role is far less understood. Activation of TRPV1 reportedly regulates neurotransmitter release at several central synapses. However, we found that TRPV1 suppressed excitatory transmission in rat and mouse dentate gyrus by regulating postsynaptic function in an input-specific manner. This suppression was a result of Ca2+-calcineurin and clathrin-dependent internalization of AMPA receptors. Moreover, synaptic activation of TRPV1 triggered a form of long-term depression (TRPV1-LTD) mediated by the endocannabinoid anandamide in a type 1 cannabinoid receptor-independent manner. Thus, our findings reveal a previously unknown form of endocannabinoid- and TRPV1-mediated regulation of synaptic strength at central synapses.	[Chavez, Andres E.; Chiu, Chiayu Q.; Castillo, Pablo E.] Albert Einstein Coll Med, Dept Neurosci, New York, NY USA	Yeshiva University	Castillo, PE (corresponding author), Albert Einstein Coll Med, Dept Neurosci, New York, NY USA.	pablo.castillo@einstein.yu.edu		Chiu, Chiayu/0000-0001-5809-6306; Castillo, Pablo/0000-0002-9834-1801	US National Institutes of Health [DA017392, MH081935]; Ruth L. Kirschstein Award [F32 NS071821]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081935] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS053059, F32NS071821] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017392] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank all members of the Castillo laboratory for comments on the manuscript, B. Connors and S. Nawy for kindly providing Trpv1<SUP>-/-</SUP> mice, and R. Carroll and A. Rodenas-Ruano for providing DGC cultures. This work was supported by US National Institutes of Health grants to P.E.C. (DA017392, MH081935). A.E.C. was partially supported by a Ruth L. Kirschstein Award (F32 NS071821).	Bacci A, 2004, NATURE, V431, P312, DOI 10.1038/nature02913; Benninger F, 2008, NEUROCHEM INT, V52, P89, DOI 10.1016/j.neuint.2007.06.008; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chevaleyre V, 2003, NEURON, V38, P461, DOI 10.1016/S0896-6273(03)00235-6; Chevaleyre V, 2006, ANNU REV NEUROSCI, V29, P37, DOI 10.1146/annurev.neuro.29.051605.112834; Chiu CYQ, 2008, NEUROPHARMACOLOGY, V54, P68, DOI 10.1016/j.neuropharm.2007.06.026; Cristino L, 2008, NEUROSCIENCE, V151, P955, DOI 10.1016/j.neuroscience.2007.11.047; Cristino L, 2006, NEUROSCIENCE, V139, P1405, DOI 10.1016/j.neuroscience.2006.02.074; DIMARZO V, 1994, NATURE, V372, P686, DOI 10.1038/372686a0; Doyle MW, 2002, J NEUROSCI, V22, P8222; ERRINGTON ML, 1987, NEUROSCIENCE, V20, P279, DOI 10.1016/0306-4522(87)90019-4; Fagni L, 2000, TRENDS NEUROSCI, V23, P80, DOI 10.1016/S0166-2236(99)01492-7; Gibson HE, 2008, NEURON, V57, P746, DOI 10.1016/j.neuron.2007.12.027; Golech SA, 2004, MOL BRAIN RES, V132, P87, DOI 10.1016/j.molbrainres.2004.08.025; Grueter BA, 2010, NAT NEUROSCI, V13, P1519, DOI 10.1038/nn.2685; Hu HJ, 2002, J NEUROSCI, V22, P7444; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Kauer JA, 2009, TRENDS NEUROSCI, V32, P215, DOI 10.1016/j.tins.2008.12.006; Kim J, 2010, NAT NEUROSCI, V13, P592, DOI 10.1038/nn.2517; Kim YH, 2009, J NEUROSCI, V29, P10000, DOI 10.1523/JNEUROSCI.5030-08.2009; Li H, 2008, ACTA CRYSTALLOGR E, V64, pM770, DOI 10.1107/S1600536808011793; Maccarrone M, 2008, NAT NEUROSCI, V11, P152, DOI 10.1038/nn2042; Maione S, 2009, J PHYSIOL-LONDON, V587, P2521, DOI 10.1113/jphysiol.2009.171900; Marinelli S, 2003, J NEUROSCI, V23, P3136; Marinelli S, 2002, J PHYSIOL-LONDON, V543, P531, DOI 10.1113/jphysiol.2002.022863; Marsch R, 2007, J NEUROSCI, V27, P832, DOI 10.1523/JNEUROSCI.3303-06.2007; Marsden KC, 2007, J NEUROSCI, V27, P14326, DOI 10.1523/JNEUROSCI.4433-07.2007; Mezey E, 2000, P NATL ACAD SCI USA, V97, P3655, DOI 10.1073/pnas.060496197; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Musella A, 2009, MOL CELL NEUROSCI, V40, P89, DOI 10.1016/j.mcn.2008.09.001; Pingle S. C., 2007, V179, P155; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Regehr WG, 2009, NEURON, V63, P154, DOI 10.1016/j.neuron.2009.06.021; Roberts JC, 2004, BRAIN RES, V995, P176, DOI 10.1016/j.brainres.2003.10.001; Ross RA, 2003, BRIT J PHARMACOL, V140, P790, DOI 10.1038/sj.bjp.0705467; Sanchez JF, 2001, NEUROSCIENCE, V107, P373, DOI 10.1016/S0306-4522(01)00373-6; Sasamura T, 1998, NEUROREPORT, V9, P2045, DOI 10.1097/00001756-199806220-00025; Smart D, 2000, BRIT J PHARMACOL, V129, P227, DOI 10.1038/sj.bjp.0703050; Starowicz K, 2007, PHARMACOL THERAPEUT, V114, P13, DOI 10.1016/j.pharmthera.2007.01.005; TATH A, 2005, BRAIN RES MOL BRAIN, V135, P162; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; van der Stelt M, 2005, EMBO J, V24, P3026, DOI 10.1038/sj.emboj.7600784; Winder DG, 2001, NAT REV NEUROSCI, V2, P461, DOI 10.1038/35081514; Wong GY, 2009, BRAIN RES REV, V60, P267, DOI 10.1016/j.brainresrev.2008.12.006; Yang K, 1998, NEUROSCI LETT, V255, P135, DOI 10.1016/S0304-3940(98)00730-7; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	50	235	241	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2010	13	12					1511	U99		10.1038/nn.2684	http://dx.doi.org/10.1038/nn.2684			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	684CW	21076423	Green Accepted			2022-12-17	WOS:000284525800016
J	Yasuda, H; Barth, AL; Stellwagen, D; Malenka, RC				Yasuda, H; Barth, AL; Stellwagen, D; Malenka, RC			A developmental switch in the signaling cascades for LTP induction	NATURE NEUROSCIENCE			English	Article							CALMODULIN-KINASE-II; ADENYLATE-CYCLASE; AREA CA1; BRAIN; ACTIVATION		Stanford Univ, Sch Med, Nancy Pritzker Lab, Dept Psychiat & Behav Sci, Stanford, CA 94304 USA	Stanford University	Malenka, RC (corresponding author), Stanford Univ, Sch Med, Nancy Pritzker Lab, Dept Psychiat & Behav Sci, Stanford, CA 94304 USA.			Yasuda, Hiroki/0000-0001-5911-609X				Adams JP, 2002, ANNU REV PHARMACOL, V42, P135, DOI 10.1146/annurev.pharmtox.42.082701.145401; Blitzer RD, 1995, NEURON, V15, P1403, DOI 10.1016/0896-6273(95)90018-7; Chang BH, 1998, P NATL ACAD SCI USA, V95, P10890, DOI 10.1073/pnas.95.18.10890; CHAVEZNORIEGA LE, 1994, J NEUROSCI, V14, P310; CHETKOVICH DM, 1993, J NEUROCHEM, V61, P1933, DOI 10.1111/j.1471-4159.1993.tb09836.x; Constantine-Paton M, 1998, CURR OPIN NEUROBIOL, V8, P139, DOI 10.1016/S0959-4388(98)80017-2; Fiala JC, 1998, J NEUROSCI, V18, P8900; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KELLY PT, 1985, DEV BRAIN RES, V18, P211, DOI 10.1016/0165-3806(85)90265-2; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; ROSENBERG GB, 1987, METHOD ENZYMOL, V139, P776; Tao HZW, 2001, NEURON, V31, P569, DOI 10.1016/S0896-6273(01)00393-2	15	235	249	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2003	6	1					15	16		10.1038/nn985	http://dx.doi.org/10.1038/nn985			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	630CE	12469130				2022-12-17	WOS:000180089300008
J	Hintiryan, H; Foster, NN; Bowman, I; Bay, M; Song, MY; Gou, L; Yamashita, S; Bienkowski, MS; Zingg, B; Zhu, MY; Yang, XW; Shih, JC; Toga, AW; Dong, HW				Hintiryan, Houri; Foster, Nicholas N.; Bowman, Ian; Bay, Maxwell; Song, Monica Y.; Gou, Lin; Yamashita, Seita; Bienkowski, Michael S.; Zingg, Brian; Zhu, Muye; Yang, X. William; Shih, Jean C.; Toga, Arthur W.; Dong, Hong-Wei			The mouse cortico-striatal projectome	NATURE NEUROSCIENCE			English	Article							PHASEOLUS-VULGARIS-LEUKOAGGLUTININ; BASAL GANGLIA; BARREL CORTEX; CORTICOSTRIATAL PROJECTIONS; SOMATOSENSORY CORTEX; DORSAL STRIATUM; ORGANIZATION; RAT; PARALLEL; ARCHITECTURE	Different cortical areas are organized into distinct intracortical subnetworks. The manner in which descending pathways from the entire cortex interact subcortically as a network remains unclear. We developed an open-access comprehensive mesoscale mouse cortico-striatal projectome: a detailed connectivity projection map from the entire cerebral cortex to the dorsal striatum or caudoputamen (CP) in rodents. On the basis of these projections, we used new computational neuroanatomical tools to identify 29 distinct functional striatal domains. Furthermore, we characterized different cortico-striatal networks and how they reconfigure across the rostral-caudal extent of the CP. The workflow was also applied to select cortico-striatal connections in two different mouse models of disconnection syndromes to demonstrate its utility for characterizing circuitry-specific connectopathies. Together, our results provide the structural basis for studying the functional diversity of the dorsal striatum and disruptions of cortico-basal ganglia networks across a broad range of disorders.	[Hintiryan, Houri; Foster, Nicholas N.; Bowman, Ian; Bay, Maxwell; Song, Monica Y.; Gou, Lin; Yamashita, Seita; Bienkowski, Michael S.; Zhu, Muye; Toga, Arthur W.; Dong, Hong-Wei] Univ Southern Calif, USC Stevens Neuroimaging & Informat Inst, Lab Neuro Imaging LONI, Keck Sch Med, Los Angeles, CA 90089 USA; [Zingg, Brian; Dong, Hong-Wei] Univ Southern Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90089 USA; [Yang, X. William] Univ Calif Los Angeles, David Geffen Sch Med, Ctr Neurobehav Genet, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA; [Shih, Jean C.] Univ Southern Calif, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA 90089 USA; [Dong, Hong-Wei] Univ Southern Calif, Keck Sch Med, Dept Neurol, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Southern California; University of Southern California	Hintiryan, H; Dong, HW (corresponding author), Univ Southern Calif, USC Stevens Neuroimaging & Informat Inst, Lab Neuro Imaging LONI, Keck Sch Med, Los Angeles, CA 90089 USA.; Dong, HW (corresponding author), Univ Southern Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90089 USA.; Dong, HW (corresponding author), Univ Southern Calif, Keck Sch Med, Dept Neurol, Los Angeles, CA 90089 USA.	houri.hintiryan@loni.usc.edu; hongwei.dong@loni.usc.edu		Bienkowski, Michael/0000-0002-8231-8893; Song, Monica/0000-0002-3320-5550; Foster, Nicholas/0000-0003-1740-9788	NIH/NIMH [MH094360-01A1, U01MH106008]; NIH/NCI [U01CA198932-01]; CHDI Foundation [A-7601]; LONIR [P41 EB015922]; NATIONAL CANCER INSTITUTE [U01CA198932] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH107071, U01MH106008, R01MH094360] Funding Source: NIH RePORTER	NIH/NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CHDI Foundation; LONIR; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors are grateful to L.W. Swanson and H. Karten for serving on the Advisory Council for the Mouse Connectome Project (http://www.mouseconnectome.org). This work was supported by NIH/NIMH MH094360-01A1 (H.-W.D.), NIH/NCI U01CA198932-01 (H.-W.D.), the CHDI Foundation A-7601 (H.-W.D.), NIH/NIMH U01MH106008 (X.W.Y.) and LONIR P41 EB015922 (A.W.T.).	ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; ALLEN GV, 1991, J COMP NEUROL, V311, P1, DOI 10.1002/cne.903110102; Alloway KD, 1999, J NEUROSCI, V19, P10908, DOI 10.1523/JNEUROSCI.19-24-10908.1999; Averbeck BB, 2014, J NEUROSCI, V34, P9497, DOI 10.1523/JNEUROSCI.5806-12.2014; Balleine BW, 2010, NEUROPSYCHOPHARMACOL, V35, P48, DOI 10.1038/npp.2009.131; BERENDSE HW, 1992, J COMP NEUROL, V316, P314, DOI 10.1002/cne.903160305; Biag J, 2012, J COMP NEUROL, V520, P6, DOI 10.1002/cne.22698; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Bortolato M, 2013, INT J NEUROPSYCHOPH, V16, P869, DOI 10.1017/S1461145712000715; Bota M, 2015, P NATL ACAD SCI USA, V112, pE2093, DOI 10.1073/pnas.1504394112; Brown LL, 1998, J COMP NEUROL, V392, P468; Cerkevich CM, 2014, J COMP NEUROL, V522, P546, DOI 10.1002/cne.23426; Cohen YE, 2002, NAT REV NEUROSCI, V3, P553, DOI 10.1038/nrn873; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Cromwell HC, 1996, J NEUROSCI, V16, P3444; Devan BD, 1999, J NEUROSCI, V19, P2789; Dong H.W., 2007, ALLEN REFERENCE ATLA; dos Santos LM, 2012, PHYSIOL BEHAV, V105, P893, DOI 10.1016/j.physbeh.2011.10.021; FABRI M, 1991, BRAIN RES, V538, P351, DOI 10.1016/0006-8993(91)90455-5; Fanselow MS, 2005, ANNU REV PSYCHOL, V56, P207, DOI 10.1146/annurev.psych.56.091103.070213; FLAHERTY AW, 1991, J NEUROPHYSIOL, V66, P1249; GERFEN CR, 1984, BRAIN RES, V290, P219, DOI 10.1016/0006-8993(84)90940-5; Geschwind DH, 2007, CURR OPIN NEUROBIOL, V17, P103, DOI 10.1016/j.conb.2007.01.009; Graybiel AM, 2008, ANNU REV NEUROSCI, V31, P359, DOI 10.1146/annurev.neuro.29.051605.112851; Griffiths KR, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00101; Groenewegen HJ, 1999, ANN NY ACAD SCI, V877, P49, DOI 10.1111/j.1749-6632.1999.tb09260.x; Haber SN, 2003, J CHEM NEUROANAT, V26, P317, DOI 10.1016/j.jchemneu.2003.10.003; Heikkinen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050717; Hikosaka O, 2006, J NEUROPHYSIOL, V95, P567, DOI 10.1152/jn.00458.2005; Hintiryan H, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00030; HOOGLAND PV, 1987, EXP BRAIN RES, V68, P73, DOI 10.1007/BF00255235; Joel D, 2001, MOVEMENT DISORD, V16, P407, DOI 10.1002/mds.1096; LI XG, 1990, SOMATOSENS MOT RES, V7, P315, DOI 10.3109/08990229009144711; Liao CC, 2010, J COMP NEUROL, V518, P2592, DOI 10.1002/cne.22354; Mailly P, 2013, J NEUROSCI, V33, P5718, DOI 10.1523/JNEUROSCI.5248-12.2013; MALACH R, 1986, J NEUROSCI, V6, P3436; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; Nambu A, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00026; Nelson AB, 2014, ANNU REV NEUROSCI, V37, P117, DOI 10.1146/annurev-neuro-071013-013916; Oh SW, 2014, NATURE, V508, P207, DOI 10.1038/nature13186; Pan WXX, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00147; PARENT A, 1995, BRAIN RES REV, V20, P91, DOI 10.1016/0165-0173(94)00007-C; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; PISA M, 1988, BEHAV BRAIN RES, V27, P21, DOI 10.1016/0166-4328(88)90106-4; Reep RL, 2003, J COMP NEUROL, V467, P271, DOI 10.1002/cne.10868; Reep RL, 2009, NEUROBIOL LEARN MEM, V91, P104, DOI 10.1016/j.nlm.2008.08.010; Remple MS, 2003, J COMP NEUROL, V467, P105, DOI 10.1002/cne.10909; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Shepherd GMG, 2013, NAT REV NEUROSCI, V14, P278, DOI 10.1038/nrn3469; Smith KS, 2013, NEURON, V79, P361, DOI 10.1016/j.neuron.2013.05.038; Song HF, 2014, P NATL ACAD SCI USA, V111, P16580, DOI 10.1073/pnas.1414153111; Sporns O, 2014, NAT NEUROSCI, V17, P652, DOI 10.1038/nn.3690; Steinberg EE, 2015, CURR OPIN NEUROBIOL, V30, P9, DOI 10.1016/j.conb.2014.08.004; Swanson LW, 2000, BRAIN RES, V886, P113, DOI 10.1016/S0006-8993(00)02905-X; Swanson LW, 1998, TRENDS NEUROSCI, V21, P323, DOI 10.1016/S0166-2236(98)01265-X; Swanson LW., 2004, BRAIN MAPS STRUCTURE, V3rd edition; Taube JS, 1998, PROG NEUROBIOL, V55, P225, DOI 10.1016/S0301-0082(98)00004-5; Thakkar KN, 2014, J NEUROSCI, V34, P8918, DOI 10.1523/JNEUROSCI.0732-14.2014; Voorn P, 2004, TRENDS NEUROSCI, V27, P468, DOI 10.1016/j.tins.2004.06.006; Voronoi G, 1908, J REINE ANGEW MATH, V134, P198, DOI 10.1515/crll.1908.134.198; WELKER E, 1988, EXP BRAIN RES, V73, P411, DOI 10.1007/BF00248234; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919; Zahm DS, 2000, NEUROSCI BIOBEHAV R, V24, P85, DOI 10.1016/S0149-7634(99)00065-2; Zingg B, 2014, CELL, V156, P1096, DOI 10.1016/j.cell.2014.02.023	64	234	236	1	34	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2016	19	8					1100	+		10.1038/nn.4332	http://dx.doi.org/10.1038/nn.4332			19	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DS4TB	27322419	Green Accepted			2022-12-17	WOS:000380773200019
J	Wallis, JD				Wallis, Jonathan D.			Cross-species studies of orbitofrontal cortex and value-based decision-making	NATURE NEUROSCIENCE			English	Review							MEDIAL PREFRONTAL CORTEX; NEURONAL-ACTIVITY; WORKING-MEMORY; REWARD VALUE; NEURAL BASIS; ARCHITECTONIC SUBDIVISION; ENCODES RESPONSE; SUBJECTIVE VALUE; HUMAN AMYGDALA; GOAL VALUES	Recent work has emphasized the role that orbitofrontal cortex (OFC) has in value-based decision-making. However, it is also clear that a number of discrepancies have arisen when comparing the findings from animal models to those from humans. Here, we examine several possibilities that might explain these discrepancies, including anatomical difference between species, the behavioral tasks used to probe decision-making and the methodologies used to assess neural function. Understanding how these differences affect the interpretation of experimental results will help us to better integrate future results from animal models. This will enable us to fully realize the benefits of using multiple approaches to understand OFC function.	[Wallis, Jonathan D.] Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA; [Wallis, Jonathan D.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Wallis, JD (corresponding author), Univ Calif Berkeley, Dept Psychol, 3210 Tolman Hall, Berkeley, CA 94720 USA.	wallis@berkeley.edu		Wallis, Joni/0000-0001-7262-7417	National Institute on Drug Abuse [R01DA19028]; National Institute of Neurological Disorders and Stroke [P01NS04081]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS040813] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA019028] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	I would like to thank R. Cools, E. Murray, C. Padoa-Schioppa, E. Rich, G. Schoenbaum and S. Wise for their valuable comments on an earlier draft of this manuscript. The preparation of this manuscript was supported by grants from the National Institute on Drug Abuse (R01DA19028) and the National Institute of Neurological Disorders and Stroke (P01NS04081).	Abe H, 2011, NEURON, V70, P731, DOI 10.1016/j.neuron.2011.03.026; Arana FS, 2003, J NEUROSCI, V23, P9632; Ballard K, 2009, NEUROIMAGE, V45, P143, DOI 10.1016/j.neuroimage.2008.11.004; Bartels A, 2004, NEUROIMAGE, V21, P1155, DOI 10.1016/j.neuroimage.2003.11.003; Basten U, 2010, P NATL ACAD SCI USA, V107, P21767, DOI 10.1073/pnas.0908104107; Baxter MG, 2000, J NEUROSCI, V20, P4311; Bechara A, 1998, J NEUROSCI, V18, P428; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Blake R, 2002, NAT REV NEUROSCI, V3, P13, DOI 10.1038/nrn701; Bouret S, 2010, J NEUROSCI, V30, P8591, DOI 10.1523/JNEUROSCI.0049-10.2010; Burke KA, 2008, NATURE, V454, P340, DOI 10.1038/nature06993; Buzsaki G, 2007, NEURON, V56, P771, DOI 10.1016/j.neuron.2007.11.008; Canolty RT, 2010, P NATL ACAD SCI USA, V107, P17356, DOI 10.1073/pnas.1008306107; CARMICHAEL ST, 1994, J COMP NEUROL, V346, P366, DOI 10.1002/cne.903460305; Carmichael ST, 1996, J COMP NEUROL, V371, P179, DOI 10.1002/(SICI)1096-9861(19960722)371:2<179::AID-CNE1>3.0.CO;2-#; Carmichael ST, 1995, J COMP NEUROL, V363, P642, DOI 10.1002/cne.903630409; Carmichael ST, 1995, J COMP NEUROL, V363, P615, DOI 10.1002/cne.903630408; Cavada C, 2000, CEREB CORTEX, V10, P220, DOI 10.1093/cercor/10.3.220; Cavada C, 2000, CEREB CORTEX, V10, P205, DOI 10.1093/cercor/10.3.205; Chaudhry AM, 2009, EUR J NEUROSCI, V29, P1047, DOI 10.1111/j.1460-9568.2009.06646.x; Croxson PL, 2009, J NEUROSCI, V29, P4531, DOI 10.1523/JNEUROSCI.4515-08.2009; Croxson PL, 2005, J NEUROSCI, V25, P8854, DOI 10.1523/JNEUROSCI.1311-05.2005; Damasio A.R., 1994, DESCARTES ERROR EMOT; Elston G.N., 2007, EVOLUTION NERVOUS SY, P191, DOI DOI 10.1016/B0-12-370878-8/00164-6; Feierstein CE, 2006, NEURON, V51, P495, DOI 10.1016/j.neuron.2006.06.032; Fellows LK, 2007, CEREB CORTEX, V17, P2669, DOI 10.1093/cercor/bhl176; FitzGerald THB, 2009, J NEUROSCI, V29, P8388, DOI 10.1523/JNEUROSCI.0717-09.2009; Furuyashiki T, 2008, J NEUROSCI, V28, P5127, DOI 10.1523/JNEUROSCI.0319-08.2008; Gallagher M, 1999, J NEUROSCI, V19, P6610; Glover GH, 2001, MAGNET RESON MED, V46, P515, DOI 10.1002/mrm.1222; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; HABER SN, 1995, J NEUROSCI, V15, P4851; Hare TA, 2008, J NEUROSCI, V28, P5623, DOI 10.1523/JNEUROSCI.1309-08.2008; Haynes JD, 2006, NAT REV NEUROSCI, V7, P523, DOI 10.1038/nrn1931; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; Kahnt T, 2010, P NATL ACAD SCI USA, V107, P6010, DOI 10.1073/pnas.0912838107; Kennerley SW, 2009, J NEUROPHYSIOL, V102, P3352, DOI 10.1152/jn.00273.2009; Kennerley SW, 2009, EUR J NEUROSCI, V29, P2061, DOI 10.1111/j.1460-9568.2009.06743.x; Kennerley SW, 2009, J COGNITIVE NEUROSCI, V21, P1162, DOI 10.1162/jocn.2009.21100; Kepecs A, 2008, NATURE, V455, P227, DOI 10.1038/nature07200; King-Casas B, 2005, SCIENCE, V308, P78, DOI 10.1126/science.1108062; Lara AH, 2009, J NEUROSCI, V29, P765, DOI 10.1523/JNEUROSCI.4637-08.2009; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Mackey S, 2009, NEUROSCIENCE, V159, P1089, DOI 10.1016/j.neuroscience.2009.01.036; Mackey S, 2010, EUR J NEUROSCI, V32, P1940, DOI 10.1111/j.1460-9568.2010.07465.x; Manes F, 2002, BRAIN, V125, P624, DOI 10.1093/brain/awf049; Morrison SE, 2009, J NEUROSCI, V29, P11471, DOI 10.1523/JNEUROSCI.1815-09.2009; Murray EA, 2007, J NEUROSCI, V27, P8166, DOI 10.1523/JNEUROSCI.1556-07.2007; Noonan MP, 2010, P NATL ACAD SCI USA, V107, P20547, DOI 10.1073/pnas.1012246107; Noonan MP, 2010, EUR J NEUROSCI, V31, P2341, DOI 10.1111/j.1460-9568.2010.07271.x; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; Ongur D, 1998, J COMP NEUROL, V401, P480; Ongur D, 2003, J COMP NEUROL, V460, P425, DOI 10.1002/cne.10609; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Padoa-Schioppa C, 2011, ANNU REV NEUROSCI, V34, P333, DOI 10.1146/annurev-neuro-061010-113648; Padoa-Schioppa C, 2009, J NEUROSCI, V29, P14004, DOI 10.1523/JNEUROSCI.3751-09.2009; Palomero-Gallagher N, 2004, RAT NERVOUS SYSTEM, P729; Peters J, 2009, J NEUROSCI, V29, P15727, DOI 10.1523/JNEUROSCI.3489-09.2009; Petrides M., 1994, HDB NEUROPSYCHOLOGY, V9, P17; Plassmann H, 2007, J NEUROSCI, V27, P9984, DOI 10.1523/JNEUROSCI.2131-07.2007; Plassmann H, 2010, J NEUROSCI, V30, P10799, DOI 10.1523/JNEUROSCI.0788-10.2010; Price JL, 2007, ANN NY ACAD SCI, V1121, P54, DOI 10.1196/annals.1401.008; Rangel A, 2008, NAT REV NEUROSCI, V9, P545, DOI 10.1038/nrn2357; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; Roesch MR, 2006, NEURON, V51, P509, DOI 10.1016/j.neuron.2006.06.027; Roesch MR, 2005, J NEUROPHYSIOL, V94, P2457, DOI 10.1152/jn.00373.2005; Roesch MR, 2004, SCIENCE, V304, P307, DOI 10.1126/science.1093223; Romanski LM, 1999, J COMP NEUROL, V403, P141, DOI 10.1002/(SICI)1096-9861(19990111)403:2<141::AID-CNE1>3.0.CO;2-V; Rudebeck PH, 2006, SCIENCE, V313, P1310, DOI 10.1126/science.1128197; Rudebeck PH, 2006, NAT NEUROSCI, V9, P1161, DOI 10.1038/nn1756; Rudebeck PH, 2011, J NEUROSCI, V31, P10569, DOI 10.1523/JNEUROSCI.0091-11.2011; Schoenbaum G, 1998, NAT NEUROSCI, V1, P155, DOI 10.1038/407; Sescousse G, 2010, J NEUROSCI, V30, P13095, DOI 10.1523/JNEUROSCI.3501-10.2010; Sirotin YB, 2009, NATURE, V457, P475, DOI 10.1038/nature07664; Smith DV, 2010, J NEUROSCI, V30, P2490, DOI 10.1523/JNEUROSCI.3319-09.2010; Talmi D, 2009, J NEUROSCI, V29, P14617, DOI 10.1523/JNEUROSCI.2026-09.2009; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Tsuchida A, 2010, J NEUROSCI, V30, P16868, DOI 10.1523/JNEUROSCI.1958-10.2010; Tsujimoto S, 2009, J NEUROSCI, V29, P2569, DOI 10.1523/JNEUROSCI.5777-08.2009; Valentin VV, 2007, J NEUROSCI, V27, P4019, DOI 10.1523/JNEUROSCI.0564-07.2007; van Duuren E, 2007, LEARN MEMORY, V14, P446, DOI 10.1101/lm.546207; van Duuren E, 2009, J NEUROSCI, V29, P8965, DOI 10.1523/JNEUROSCI.0005-09.2009; van Wingerden M, 2010, J NEUROSCI, V30, P10025, DOI 10.1523/JNEUROSCI.0222-10.2010; Wallis JD, 2003, EUR J NEUROSCI, V18, P2069, DOI 10.1046/j.1460-9568.2003.02922.x; Wallis JD, 2007, ANN NY ACAD SCI, V1121, P447, DOI 10.1196/annals.1401.009; Wallis JD, 2007, ANNU REV NEUROSCI, V30, P31, DOI 10.1146/annurev.neuro.30.051606.094334; Walton ME, 2010, NEURON, V65, P927, DOI 10.1016/j.neuron.2010.02.027; Wise SP, 2008, TRENDS NEUROSCI, V31, P599, DOI 10.1016/j.tins.2008.08.008	92	234	236	0	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2012	15	1					13	19		10.1038/nn.2956	http://dx.doi.org/10.1038/nn.2956			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866VO	22101646	Green Accepted			2022-12-17	WOS:000298414400007
J	Gu, JP; Lee, CW; Fan, YJ; Komlos, D; Tang, X; Sun, CC; Yu, KA; Hartzell, HC; Chen, G; Bamburg, JR; Zheng, JQ				Gu, Jiaping; Lee, Chi Wai; Fan, Yanjie; Komlos, Daniel; Tang, Xin; Sun, Chicheng; Yu, Kuai; Hartzell, H. Criss; Chen, Gong; Bamburg, James R.; Zheng, James Q.			ADF/cofilin-mediated actin dynamics regulate AMPA receptor trafficking during synaptic plasticity	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; DENDRITIC SPINE MORPHOGENESIS; HIPPOCAMPAL SYNAPSES; RECYCLING ENDOSOMES; LIM-KINASE; F-ACTIN; COFILIN; LTP; PHOSPHORYLATION; MORPHOLOGY	Dendritic spines undergo actin-based growth and shrinkage during synaptic plasticity, in which the actin depolymerizing factor (ADF)/cofilin family of actin-associated proteins are important. Elevated ADF/cofilin activities often lead to reduced spine size and immature spine morphology but can also enhance synaptic potentiation in some cases. Thus, ADF/cofilin may have distinct effects on postsynaptic structure and function. We found that ADF/cofilin-mediated actin dynamics regulated AMPA receptor (AMPAR) trafficking during synaptic potentiation, which was distinct from actin's structural role in spine morphology. Specifically, elevated ADF/cofilin activity markedly enhanced surface addition of AMPARs after chemically induced long-term potentiation (LTP), whereas inhibition of ADF/cofilin abolished AMPAR addition. We found that chemically induced LTP elicited a temporal sequence of ADF/cofilin dephosphorylation and phosphorylation that underlies AMPAR trafficking and spine enlargement. These findings suggest that temporally regulated ADF/cofilin activities function in postsynaptic modifications of receptor number and spine size during synaptic plasticity.	[Gu, Jiaping; Lee, Chi Wai; Fan, Yanjie; Yu, Kuai; Hartzell, H. Criss; Zheng, James Q.] Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA; [Gu, Jiaping; Lee, Chi Wai; Fan, Yanjie; Yu, Kuai; Hartzell, H. Criss; Zheng, James Q.] Emory Univ, Sch Med, Dept Neurol, Ctr Neurodegenerat Dis, Atlanta, GA 30322 USA; [Komlos, Daniel] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ USA; [Tang, Xin; Sun, Chicheng; Chen, Gong] Penn State Univ, Dept Biol, Huck Inst Life Sci, University Pk, PA 16802 USA; [Bamburg, James R.] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA	Emory University; Emory University; Rutgers State University New Brunswick; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Colorado State University	Zheng, JQ (corresponding author), Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA.	james.zheng@emory.edu	Lee, Chi Wai/D-3186-2013; Tang, Xin/E-8191-2016; Sun, Chicheng/C-9980-2016; Lee, Chi Wai/G-5098-2013	Sun, Chicheng/0000-0003-3837-2267; Lee, Chi Wai/0000-0002-9384-2308; Lee, Chi Wai/0000-0003-4619-3189; Chen JNU, Gong/0000-0002-1857-3670	US National Institutes of Health [GM083889 GM084363, HD023315, NS40371, NS054858, EY014852, GM60448]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD023315] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY014852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060448, R01GM083889, R01GM084363] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS054858, R01NS040371] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by grants from the US National Institutes of Health to J.Q.Z. (GM083889 GM084363, and HD023315), J.R.B. (NS40371), G.C. (NS054858) and H.C.H. (EY014852 and GM60448).	Aizawa H, 2001, NAT NEUROSCI, V4, P367, DOI 10.1038/86011; Allison DW, 1998, J NEUROSCI, V18, P2423; ANIKSZTEJN L, 1991, NATURE, V349, P67, DOI 10.1038/349067a0; Ashby MC, 2006, J NEUROSCI, V26, P7046, DOI 10.1523/JNEUROSCI.1235-06.2006; AUNIS D, 1988, J EXP BIOL, V139, P253; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; BUBB MR, 1994, J BIOL CHEM, V269, P14869; Chen LY, 2007, J NEUROSCI, V27, P5363, DOI 10.1523/JNEUROSCI.0164-07.2007; Cingolani LA, 2008, NAT REV NEUROSCI, V9, P344, DOI 10.1038/nrn2373; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Eitzen G, 2003, BBA-MOL CELL RES, V1641, P175, DOI 10.1016/S0167-4889(03)00087-9; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Han L, 2007, EMBO J, V26, P4189, DOI 10.1038/sj.emboj.7601852; Heine M, 2008, SCIENCE, V320, P201, DOI 10.1126/science.1152089; Heredia L, 2006, J NEUROSCI, V26, P6533, DOI 10.1523/JNEUROSCI.5567-05.2006; Hoogenraad SC, 2004, BIOESSAYS, V26, P141, DOI 10.1002/bies.10402; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Hotulainen P, 2009, J CELL BIOL, V185, P323, DOI 10.1083/jcb.200809046; Kim CH, 1999, J NEUROSCI, V19, P4314; Lanzetti L, 2007, CURR OPIN CELL BIOL, V19, P453, DOI 10.1016/j.ceb.2007.04.017; Lee CW, 2009, NAT NEUROSCI, V12, P848, DOI 10.1038/nn.2322; Lin DT, 2007, J NEUROSCI, V27, P13903, DOI 10.1523/JNEUROSCI.1750-07.2007; Makino H, 2009, NEURON, V64, P381, DOI 10.1016/j.neuron.2009.08.035; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Onuma H, 1998, NEUROSCI RES, V30, P313, DOI 10.1016/S0168-0102(98)00012-1; Park M, 2006, NEURON, V52, P817, DOI 10.1016/j.neuron.2006.09.040; Racz B, 2006, NEUROSCIENCE, V138, P447, DOI 10.1016/j.neuroscience.2005.11.025; Rex CS, 2009, J CELL BIOL, V186, P85, DOI 10.1083/jcb.200901084; Rust MB, 2010, EMBO J, V29, P1889, DOI 10.1038/emboj.2010.72; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Schulz TW, 2004, J NEUROSCI, V24, P8584, DOI 10.1523/JNEUROSCI.2100-04.2004; Segal M, 2005, NAT REV NEUROSCI, V6, P277, DOI 10.1038/nrn1649; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; SPECTOR I, 1983, SCIENCE, V219, P493, DOI 10.1126/science.6681676; Tada T, 2006, CURR OPIN NEUROBIOL, V16, P95, DOI 10.1016/j.conb.2005.12.001; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Van Troys M, 2008, EUR J CELL BIOL, V87, P649, DOI 10.1016/j.ejcb.2008.04.001; Wang ZP, 2008, CELL, V135, P535, DOI 10.1016/j.cell.2008.09.057; Yuen EY, 2010, J PHYSIOL-LONDON, V588, P2361, DOI 10.1113/jphysiol.2009.186353; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011	46	234	245	2	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2010	13	10					1208	1215		10.1038/nn.2634	http://dx.doi.org/10.1038/nn.2634			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	654MB	20835250	Green Accepted			2022-12-17	WOS:000282171300012
J	Tain, LS; Mortiboys, H; Tao, RN; Ziviani, E; Bandmann, O; Whitworth, AJ				Tain, Luke S.; Mortiboys, Heather; Tao, Ran N.; Ziviani, Elena; Bandmann, Oliver; Whitworth, Alexander J.			Rapamycin activation of 4E-BP prevents parkinsonian dopaminergic neuron loss	NATURE NEUROSCIENCE			English	Article							MITOCHONDRIAL PATHOLOGY; LIFE-SPAN; OXIDATIVE STRESS; DROSOPHILA; PHOSPHORYLATION; TRANSLATION; DISEASE; PINK1; INITIATION; DOWNSTREAM	Mutations in PINK1 and PARK2 cause autosomal recessive parkinsonism, a neurodegenerative disorder that is characterized by the loss of dopaminergic neurons. To discover potential therapeutic pathways, we identified factors that genetically interact with Drosophila park and Pink1. We found that overexpression of the translation inhibitor Thor (4E-BP) can suppress all of the pathologic phenotypes, including degeneration of dopaminergic neurons in Drosophila. 4E-BP is activated in vivo by the TOR inhibitor rapamycin, which could potently suppress pathology in Pink1 and park mutants. Rapamycin also ameliorated mitochondrial defects in cells from individuals with PARK2 mutations. Recently, 4E-BP was shown to be inhibited by the most common cause of parkinsonism, dominant mutations in LRRK2. We also found that loss of the Drosophila LRRK2 homolog activated 4E-BP and was also able to suppress Pink1 and park pathology. Thus, in conjunction with recent findings, our results suggest that pharmacologic stimulation of 4E-BP activity may represent a viable therapeutic approach for multiple forms of parkinsonism.	[Tain, Luke S.; Mortiboys, Heather; Tao, Ran N.; Ziviani, Elena; Bandmann, Oliver; Whitworth, Alexander J.] Univ Sheffield, MRC, Ctr Dev & Biomed Genet, Sheffield, S Yorkshire, England; [Tain, Luke S.; Tao, Ran N.; Ziviani, Elena; Whitworth, Alexander J.] Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England; [Mortiboys, Heather; Bandmann, Oliver] Univ Sheffield, Acad Neurol Unit, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield; University of Sheffield; University of Sheffield	Whitworth, AJ (corresponding author), Univ Sheffield, MRC, Ctr Dev & Biomed Genet, Sheffield, S Yorkshire, England.	a.whitworth@sheffield.ac.uk	tain, luke/A-6388-2009; Whitworth, Alexander/D-3969-2009; Mortiboys, Heather/E-8838-2010	Mortiboys, Heather/0000-0001-6439-0579; Tain, Luke/0000-0002-5845-7383; Bandmann, Oliver/0000-0003-3149-0252; Ziviani, Elena/0000-0002-0864-8309; Whitworth, Alexander/0000-0002-1154-6629	Parkinson's Disease Society UK [G-4063, G-0713, G-0715]; Royal Society and Wellcome Trust [081987]; MRC Centre for Developmental and Biomedical Genetics [G070091]; Wellcome Trust [GR077544AIA]; Light Microscopy Facility; Medical Research Council [G0700091B] Funding Source: researchfish; Parkinson&quot;s UK [G-0715, G-0713] Funding Source: researchfish	Parkinson's Disease Society UK(Parkinson's UK); Royal Society and Wellcome Trust; MRC Centre for Developmental and Biomedical Genetics(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Light Microscopy Facility; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Parkinson&quot;s UK(Parkinson&apos;s UK)	We would like to thank L. Pallanck, P. Ingham and L. Partridge for critical reading of the manuscript and discussions. We would also like to thank J. Chung, S. Birman, L. Partridge, N. Sonenberg and T. Neufeld for Drosophila lines, H. Benes. for the antibody to GstS1 and I. Bjedov for Atg5 qPCR primer sequences. We also acknowledge the Department of Biomedical Science Centre for Electron Microscopy for technical assistance. This work was supported by grants from the Parkinson's Disease Society UK (G-4063 and G-0713 to A. J. W. and G-0715 to O. B.) and the Royal Society and Wellcome Trust ( 081987) to A. J. W. The MRC Centre for Developmental and Biomedical Genetics is supported by grant G070091. The Wellcome Trust ( grant number GR077544AIA) supports the Light Microscopy Facility.	Abou-Sleiman PM, 2006, NAT REV NEUROSCI, V7, P207, DOI 10.1038/nrn1868; Beretta L, 1996, EMBO J, V15, P658, DOI 10.1002/j.1460-2075.1996.tb00398.x; Bernal A, 2000, P NATL ACAD SCI USA, V97, P6019, DOI 10.1073/pnas.100391597; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Clemens MJ, 2001, J CELL MOL MED, V5, P221, DOI 10.1111/j.1582-4934.2001.tb00157.x; De Vos KJ, 2007, METHOD CELL BIOL, V80, P627, DOI 10.1016/S0091-679X(06)80030-0; Exner N, 2007, J NEUROSCI, V27, P12413, DOI 10.1523/JNEUROSCI.0719-07.2007; Farrer MJ, 2006, NAT REV GENET, V7, P306, DOI 10.1038/nrg1831; Giannakou ME, 2004, SCIENCE, V305, P361, DOI 10.1126/science.1098219; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Gingras AC, 2001, GENE DEV, V15, P2852; Gloeckner CJ, 2006, HUM MOL GENET, V15, P223, DOI 10.1093/hmg/ddi439; Greene JC, 2005, HUM MOL GENET, V14, P799, DOI 10.1093/hmg/ddi074; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; Holcik M, 2000, TRENDS GENET, V16, P469, DOI 10.1016/S0168-9525(00)02106-5; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Imai Y, 2008, EMBO J, V27, P2432, DOI 10.1038/emboj.2008.163; Junger Martin A, 2003, J Biol, V2, P20, DOI 10.1186/1475-4924-2-20; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; King MA, 2008, MOL PHARMACOL, V73, P1052, DOI 10.1124/mol.107.043398; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Li YP, 2009, NAT NEUROSCI, V12, P826, DOI 10.1038/nn.2349; McElwee JJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r132; Miron M, 2001, NAT CELL BIOL, V3, P596, DOI 10.1038/35078571; Mortiboys H, 2008, ANN NEUROL, V64, P555, DOI 10.1002/ana.21492; Muftuoglu M, 2004, MOVEMENT DISORD, V19, P544, DOI 10.1002/mds.10695; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Singh SP, 2001, EUR J BIOCHEM, V268, P2912, DOI 10.1046/j.1432-1327.2001.02179.x; Southgate RJ, 2007, J BIOL CHEM, V282, P21176, DOI 10.1074/jbc.M702039200; Tain LS, 2009, CELL DEATH DIFFER, V16, P1118, DOI 10.1038/cdd.2009.23; Teleman AA, 2005, GENE DEV, V19, P1844, DOI 10.1101/gad.341505; Tettweiler G, 2005, GENE DEV, V19, P1840, DOI 10.1101/gad.1311805; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; Whitworth AJ, 2006, DRUG DISCOV TODAY, V11, P119, DOI 10.1016/S1359-6446(05)03693-7; Whitworth AJ, 2005, P NATL ACAD SCI USA, V102, P8024, DOI 10.1073/pnas.0501078102; Whitworth AJ, 2008, DIS MODEL MECH, V1, P168, DOI 10.1242/dmm.000109; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Wyttenbach A, 2008, AUTOPHAGY, V4, P542, DOI 10.4161/auto.6059; Yamaguchi S, 2008, CELL METAB, V7, P269, DOI 10.1016/j.cmet.2008.01.008; Yang YF, 2008, P NATL ACAD SCI USA, V105, P7070, DOI 10.1073/pnas.0711845105; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103	50	234	242	0	15	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2009	12	9					1129	U13		10.1038/nn.2372	http://dx.doi.org/10.1038/nn.2372			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	487ZD	19684592	Green Accepted			2022-12-17	WOS:000269317300014
J	Naeini, RS; Witty, MF; Seguela, P; Bourque, CW				Naeini, RS; Witty, MF; Seguela, P; Bourque, CW			An N-terminal variant of Trpv1 channel is required for osmosensory transduction	NATURE NEUROSCIENCE			English	Article							RAT SUPRAOPTIC NEURONS; NONSELECTIVE CATION CHANNEL; VANILLOID RECEPTOR; CAPSAICIN RECEPTOR; MICE LACKING; VASOPRESSIN SECRETION; MAGNOCELLULAR NEURONS; OSMOTIC REGULATION; LAMINA TERMINALIS; BLOOD OSMOLALITY	Body fluid homeostasis requires the release of arginine-vasopressin (AVP, an antidiuretic hormone) from the neurohypophysis. This release is controlled by specific and highly sensitive 'osmoreceptors' in the hypothalamus. Indeed, AVP-releasing neurons in the supraoptic nucleus (SON) are directly osmosensitive, and this osmosensitivity is mediated by stretch-inhibited cation channels. However, the molecular nature of these channels remains unknown. Here we show that SON neurons express an N-terminal splice variant of the transient receptor potential vanilloid type-1 (Trpv1), also known as the capsaicin receptor, but not full-length Trpv1. Unlike their wild-type counterparts, SON neurons in Trpv1 knockout (Trpv1(-/-)) mice could not generate ruthenium red-sensitive increases in membrane conductance and depolarizing potentials in response to hyperosmotic stimulation. Moreover, Trpv1(-/-) mice showed a pronounced serum hyperosmolality under basal conditions and severely compromised AVP responses to osmotic stimulation in vivo. These results suggest that the Trpv1 gene may encode a central component of the osmoreceptor.	McGill Univ, Neurosci Res Ctr, Montreal, PQ H3G 1A4, Canada; McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada	McGill University; McGill University	Bourque, CW (corresponding author), McGill Univ, Neurosci Res Ctr, 1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada.	charles.bourque@mcgill.ca	Naeini, Reza Sharif/K-2402-2019	Naeini, Reza Sharif/0000-0001-8896-5306; Bourque, Charles/0000-0002-1594-742X				Alessandri-Haber N, 2003, NEURON, V39, P497, DOI 10.1016/S0896-6273(03)00462-8; Birder LA, 2002, NAT NEUROSCI, V5, P856, DOI 10.1038/nn902; Bourque CW, 1998, PROG BRAIN RES, V119, P59; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chakfe Y, 2000, NAT NEUROSCI, V3, P572, DOI 10.1038/75744; DICKENSON AH, 1991, BRIT J PHARMACOL, V104, P1045, DOI 10.1111/j.1476-5381.1991.tb12547.x; DUNN FL, 1973, J CLIN INVEST, V52, P3212, DOI 10.1172/JCI107521; Goldin AL, 2000, NEURON, V28, P365, DOI 10.1016/S0896-6273(00)00116-1; Grob M, 2004, J NEUROSCI, V24, P3974, DOI 10.1523/JNEUROSCI.3720-03.2004; Hellwig N, 2005, J CELL SCI, V118, P917, DOI 10.1242/jcs.01675; Hiyama TY, 2002, NAT NEUROSCI, V5, P511, DOI 10.1038/nn856; Hussy N, 2000, PROG NEUROBIOL, V62, P113, DOI 10.1016/S0301-0082(99)00071-4; Jung J, 2002, J BIOL CHEM, V277, P44448, DOI 10.1074/jbc.M207103200; Kung C, 2005, NATURE, V436, P647, DOI 10.1038/nature03896; Leng G, 1999, PROG NEUROBIOL, V57, P625, DOI 10.1016/S0301-0082(98)00072-0; Li Z, 1996, NEUROSCIENCE, V71, P133, DOI 10.1016/0306-4522(95)00434-3; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P13698, DOI 10.1073/pnas.1735416100; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P14531, DOI 10.1073/pnas.2235619100; Lu G, 2005, MOL PHARMACOL, V67, P1119, DOI 10.1124/mol.104.009852; McKinley MJ, 2004, J NEUROENDOCRINOL, V16, P340, DOI 10.1111/j.0953-8194.2004.01184.x; Mizuno A, 2003, AM J PHYSIOL-CELL PH, V285, pC96, DOI 10.1152/ajpcell.00559.2002; Muraki K, 2003, CIRC RES, V93, P829, DOI 10.1161/01.RES.0000097263.10220.0C; NAGATOMO T, 1995, J PHYSIOL-LONDON, V485, P87, DOI 10.1113/jphysiol.1995.sp020714; OLIET SHR, 1993, AM J PHYSIOL, V265, pR1475, DOI 10.1152/ajpregu.1993.265.6.R1475; Oliet SHR, 1996, NEURON, V16, P175, DOI 10.1016/S0896-6273(00)80034-3; OLIET SHR, 1993, NATURE, V364, P341, DOI 10.1038/364341a0; POULAIN DA, 1982, NEUROSCIENCE, V7, P773, DOI 10.1016/0306-4522(82)90044-6; Richard D, 1995, J PHYSIOL-LONDON, V489, P567, DOI 10.1113/jphysiol.1995.sp021073; ROBERTSON GL, 1976, KIDNEY INT, V10, P25, DOI 10.1038/ki.1976.76; ROBERTSON GL, 1976, J CLIN ENDOCR METAB, V42, P613, DOI 10.1210/jcem-42-4-613; SCHRIER RW, 1979, AM J PHYSIOL, V236, P321; Schumacher MA, 2000, J BIOL CHEM, V275, P2756, DOI 10.1074/jbc.275.4.2756; Shibuya I, 1998, J NEUROENDOCRINOL, V10, P759, DOI 10.1046/j.1365-2826.1998.00260.x; Ster J, 2005, J NEUROSCI, V25, P2267, DOI 10.1523/JNEUROSCI.4053-04.2005; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Suzuki M, 1999, J BIOL CHEM, V274, P6330, DOI 10.1074/jbc.274.10.6330; SZALLASI A, 1989, NEUROSCIENCE, V30, P515, DOI 10.1016/0306-4522(89)90269-8; Tobin DM, 2002, NEURON, V35, P307, DOI 10.1016/S0896-6273(02)00757-2; VANDESANDE F, 1975, CELL TISSUE RES, V164, P153; Voisin DL, 2002, TRENDS NEUROSCI, V25, P199, DOI 10.1016/S0166-2236(02)02142-2; Vriens J, 2004, P NATL ACAD SCI USA, V101, P396, DOI 10.1073/pnas.0303329101; Wainwright A, 2004, J COMP NEUROL, V474, P24, DOI 10.1002/cne.20100; Wang CB, 2004, J BIOL CHEM, V279, P37423, DOI 10.1074/jbc.M407205200; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; WEISINGER RS, 1979, NATURE, V280, P490, DOI 10.1038/280490a0; Xue Q, 2001, GENOMICS, V76, P14, DOI 10.1006/geno.2001.6582	48	234	245	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2006	9	1					93	98		10.1038/nn1614	http://dx.doi.org/10.1038/nn1614			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	997ZQ	16327782				2022-12-17	WOS:000234288000022
J	Medina, JF; Mauk, MD				Medina, Javier F.; Mauk, Michael D.			Computer simulation of cerebellar information processing	NATURE NEUROSCIENCE			English	Review								Although many functions have been ascribed to the cerebellum, the uniformity of its synaptic organization suggests that a single, characteristic computation may be common to all. Computer simulations are useful in examining this cerebellar computation, as they inherently address function at the level of information processing. Progress is facilitated by factors that make the cerebellum particularly amenable to such analysis. We review progress from two contrasting approaches. Top-down simulations begin with hypotheses about computational mechanisms and then ask how such mechanisms might operate within the cerebellum. Bottom-up simulations attempt to build a representation of the cerebellum that reflects known cellular and synaptic components as accurately as possible. We describe recent advances from these two approaches that are leading to an understanding of what information the cerebellum processes and how its neurons and synapses accomplish this task.	[Medina, Javier F.; Mauk, Michael D.] Univ Texas Med Sch, Dept Neurobiol & Anat, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Mauk, MD (corresponding author), Univ Texas Med Sch, Dept Neurobiol & Anat, 6431 Fannin, Houston, TX 77030 USA.	mmauk@nba19.med.uth.tmc.edu		Medina, Javier/0000-0001-8708-5315	 [MH57051];  [MH46904]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH057051, R01MH046904, R29MH046904] Funding Source: NIH RePORTER	; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Supported by MH57051 and MH46904.	AITKIN LM, 1978, HEARING RES, V1, P67, DOI 10.1016/0378-5955(78)90010-2; Aizenman CD, 1999, J NEUROPHYSIOL, V82, P1697, DOI 10.1152/jn.1999.82.4.1697; BLOEDEL JR, 1992, BEHAV BRAIN SCI, V15, P666; Bower JM, 1997, INT REV NEUROBIOL, V41, P489, DOI 10.1016/S0074-7742(08)60367-0; BULLOCK D, 1994, NEURAL NETWORKS, V7, P1101, DOI 10.1016/S0893-6080(05)80161-3; BUONOMANO DV, 1994, NEURAL COMPUT, V6, P38, DOI 10.1162/neco.1994.6.1.38; Courchesne E, 1997, LEARN MEMORY, V4, P1, DOI 10.1101/lm.4.1.1; Eccles JC, 1967, CEREBELLUM NEURONAL; Fiala JC, 1996, J NEUROSCI, V16, P3760; Gluck MA, 1990, NEUROSCIENCE CONNECT, P131; HESSLOW G, 1994, NEUROREPORT, V5, P649, DOI 10.1097/00001756-199401000-00030; HIRANO T, 1990, NEUROSCI LETT, V119, P141, DOI 10.1016/0304-3940(90)90818-T; Hull C.L., 1943, PRINCIPLES BEHAV INT, DOI DOI 10.2307/1416955; Ito M, 1984, CEREBELLUM NEURAL CO; Ivry RB, 1996, CURR OPIN NEUROBIOL, V6, P851, DOI 10.1016/S0959-4388(96)80037-7; Kim JJ, 1997, TRENDS NEUROSCI, V20, P177, DOI 10.1016/S0166-2236(96)10081-3; Koch C, 2000, NAT NEUROSCI, V3, P1171, DOI 10.1038/81444; LEWIS JL, 1987, BEHAV NEUROSCI, V101, P151, DOI 10.1037/0735-7044.101.2.151; Llinas R, 1993, Curr Opin Neurobiol, V3, P958, DOI 10.1016/0959-4388(93)90168-X; Llinas RR, 1981, HDB PHYSL NERVOUS SY, VII, P831; MAUK MD, 1992, BEHAV NEUROSCI, V106, P666, DOI 10.1037/0735-7044.106.4.666; Mauk MD, 1997, NEURON, V18, P343, DOI 10.1016/S0896-6273(00)81235-0; MAUK MD, 1986, P NATL ACAD SCI USA, V83, P5349, DOI 10.1073/pnas.83.14.5349; MCCORMICK DA, 1984, SCIENCE, V223, P296, DOI 10.1126/science.6701513; MCCORMICK DA, 1985, BRAIN RES, V359, P120, DOI 10.1016/0006-8993(85)91419-2; MCCORMICK DA, 1982, P NATL ACAD SCI-BIOL, V79, P2731, DOI 10.1073/pnas.79.8.2731; Medina JF, 2000, J NEUROSCI, V20, P5516, DOI 10.1523/JNEUROSCI.20-14-05516.2000; MILLENSON JR, 1977, LEARN MOTIV, V8, P351, DOI 10.1016/0023-9690(77)90057-1; Moore JW, 1997, LEARN MEMORY, V4, P116, DOI 10.1101/lm.4.1.116; MOORE JW, 1989, BIOL CYBERN, V62, P17, DOI 10.1007/BF00217657; RACINE RJ, 1986, EXP BRAIN RES, V63, P158; Raymond JL, 1996, SCIENCE, V272, P1126, DOI 10.1126/science.272.5265.1126; SAKURAI M, 1989, OLIVOCEREBELLAR SYST, P221; Schmahmann J.D., 1997, INT REV NEUROBIOLOGY; SCHNEIDERMAN N, 1964, J COMP PHYSIOL PSYCH, V57, P188, DOI 10.1037/h0043419; SCHNEIDERMAN N, 1962, SCIENCE, V136, P650, DOI 10.1126/science.136.3516.650; SEARS LL, 1991, BRAIN RES, V545, P114, DOI 10.1016/0006-8993(91)91276-7; SMITH MC, 1969, J COMP PHYSIOL PSYCH, V69, P226, DOI 10.1037/h0028212; STEINMETZ JE, 1985, B PSYCHONOMIC SOC, V28, P245; STEINMETZ JE, 1988, CELLULAR MECH CONDIT, P143; THACH WT, 1992, ANNU REV NEUROSCI, V15, P403, DOI 10.1146/annurev.ne.15.030192.002155; Voogd J, 1998, TRENDS NEUROSCI, V21, P370, DOI 10.1016/S0166-2236(98)01318-6	42	234	236	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2000	3	11		S			1205	1211		10.1038/81486	http://dx.doi.org/10.1038/81486			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	V18OV	11127839				2022-12-17	WOS:000208015000019
J	Kilgard, MP; Merzenich, MM				Kilgard, MP; Merzenich, MM			Plasticity of temporal information processing in the primary auditory cortex	NATURE NEUROSCIENCE			English	Article							NEOCORTICAL PYRAMIDAL NEURONS; FREQUENCY-DISCRIMINATION TASK; RECEPTIVE-FIELD PLASTICITY; ADULT OWL MONKEYS; CORTICAL-NEURONS; VISUAL-CORTEX; CONTRAST SENSITIVITY; NUCLEUS BASALIS; GUINEA-PIG; RAT	Neurons in the rat primary auditory cortex (Al) generally cannot respond to tone sequences faster than 12 pulses per second (pps). To test whether experience can modify this maximum following rate in adult rats, trains of brief tones with random carrier frequency but fixed repetition rate were paired with electrical stimulation of the nucleus basalis (NB) 300 to 400 times per day for 20-25 days. Pairing NE stimulation with 5-pps stimuli markedly decreased the cortical response to rapidly presented stimuli, whereas pairing with 15-pps stimuli significantly increased the maximum cortical following rate. In contrast, pairing with fixed carrier frequency 15-pps trains did not significantly increase the mean maximum following rate. Thus this protocol elicits extensive cortical remodeling of temporal response properties and demonstrates that simple differences in spectral and temporal features of the sensory input can drive very different cortical reorganizations.	Univ Calif San Francisco, Dept Otolaryngol, Coleman Lab, Keck Ctr Integrat Neurosci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, Coleman Lab, Keck Ctr Integrat Neurosci, San Francisco, CA 94143 USA; Sci Learning Corp, Berkeley, CA 94104 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Kilgard, MP (corresponding author), Univ Calif San Francisco, Dept Otolaryngol, Coleman Lab, Keck Ctr Integrat Neurosci, San Francisco, CA 94143 USA.	kilgard@phy.ucsf.edu		Kilgard, Michael/0000-0002-6699-1818	NINDS NIH HHS [NS-10414, R01 NS010414-27, R01 NS010414, F32 NS010414] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS010414, R01NS010414] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; AHISSAR M, 1993, P NATL ACAD SCI USA, V90, P5718, DOI 10.1073/pnas.90.12.5718; BAKIN JS, 1990, BRAIN RES, V536, P271, DOI 10.1016/0006-8993(90)90035-A; Bakin JS, 1996, BEHAV NEUROSCI, V110, P905, DOI 10.1037/0735-7044.110.5.905; Bakin JS, 1996, P NATL ACAD SCI USA, V93, P11219, DOI 10.1073/pnas.93.20.11219; BEAULIEU C, 1990, DEV BRAIN RES, V53, P82, DOI 10.1016/0165-3806(90)90126-J; Bjordahl TS, 1998, BEHAV NEUROSCI, V112, P467, DOI 10.1037/0735-7044.112.3.467; Brosch M, 1997, J NEUROPHYSIOL, V77, P923, DOI 10.1152/jn.1997.77.2.923; Buonomano DV, 1997, P NATL ACAD SCI USA, V94, P10403, DOI 10.1073/pnas.94.19.10403; BUONOMANO DV, 1995, SCIENCE, V267, P1028, DOI 10.1126/science.7863330; Cartling B, 1997, BIOL CYBERN, V76, P383, DOI 10.1007/s004220050352; Chance FS, 1998, J NEUROSCI, V18, P4785; CHARPIER S, 1995, P NATL ACAD SCI USA, V92, P117, DOI 10.1073/pnas.92.1.117; De Ribaupierre F, 1972, Brain Res, V48, P185, DOI 10.1016/0006-8993(72)90178-3; Dinse HR, 1997, INT J PSYCHOPHYSIOL, V26, P205, DOI 10.1016/S0167-8760(97)00765-4; EGGERMONT JJ, 1995, J NEUROPHYSIOL, V73, P227, DOI 10.1152/jn.1995.73.1.227; Fischer TM, 1997, NATURE, V389, P860, DOI 10.1038/39892; GAESE BH, 1995, EUR J NEUROSCI, V7, P438, DOI 10.1111/j.1460-9568.1995.tb00340.x; Grabauskas G, 1998, J NEUROPHYSIOL, V79, P595, DOI 10.1152/jn.1998.79.2.595; Hawken MJ, 1996, VISUAL NEUROSCI, V13, P477, DOI 10.1017/S0952523800008154; Hollrigel GS, 1998, P ROY SOC B-BIOL SCI, V265, P63, DOI 10.1098/rspb.1998.0265; JimenezCapdeville ME, 1997, J COMP NEUROL, V381, P53, DOI 10.1002/(SICI)1096-9861(19970428)381:1<53::AID-CNE5>3.0.CO;2-J; KELLY JB, 1977, J COMP PHYSIOL PSYCH, V91, P930, DOI 10.1037/h0077356; Kenmochi M, 1997, NEUROREPORT, V8, P1589, DOI 10.1097/00001756-199705060-00008; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Markram H, 1996, NATURE, V382, P807, DOI 10.1038/382807a0; MCKENNA TM, 1989, SYNAPSE, V4, P30, DOI 10.1002/syn.890040105; Merzenich MM, 1996, SCIENCE, V271, P77, DOI 10.1126/science.271.5245.77; MESULAM MM, 1983, NEUROSCIENCE, V10, P1185, DOI 10.1016/0306-4522(83)90108-2; METHERATE R, 1989, BRAIN RES, V480, P372, DOI 10.1016/0006-8993(89)90210-2; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P101, DOI 10.1113/jphysiol.1978.sp012490; Nagarajan SS, 1998, J NEUROSCI, V18, P1559; NEISSER U, 1974, PERCEPT PSYCHOPHYS, V15, P391, DOI 10.3758/BF03213964; Pizzorusso T, 1997, VISION RES, V37, P389, DOI 10.1016/S0042-6989(96)00172-1; RASMUSSON DD, 1992, BRAIN RES, V594, P150, DOI 10.1016/0006-8993(92)91041-C; RECANZONE GH, 1993, J NEUROSCI, V13, P87; RECANZONE GH, 1992, J NEUROPHYSIOL, V67, P1071, DOI 10.1152/jn.1992.67.5.1071; RECANZONE GH, 1992, J NEUROPHYSIOL, V67, P1015, DOI 10.1152/jn.1992.67.5.1015; RECANZONE GH, 1992, J NEUROPHYSIOL, V67, P1057, DOI 10.1152/jn.1992.67.5.1057; RECANZONE GH, 1992, J NEUROPHYSIOL, V67, P1031, DOI 10.1152/jn.1992.67.5.1031; RIBAUPIERRE FD, 1972, BRAIN RES, V48, P205, DOI 10.1016/0006-8993(72)90179-5; Schreiner CE, 1997, ACTA OTO-LARYNGOL, P54; SCHREINER CE, 1988, HEARING RES, V32, P49, DOI 10.1016/0378-5955(88)90146-3; SCHREINER CE, 1986, AUDITORY FUNCTION, P337; TOLHURST DJ, 1975, NATURE, V257, P674, DOI 10.1038/257674a0; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Weinberger N M, 1993, Curr Opin Neurobiol, V3, P570, DOI 10.1016/0959-4388(93)90058-7; Woodrow H, 1935, PSYCHOL REV, V42, P127, DOI 10.1037/h0063696; Wright BA, 1997, J NEUROSCI, V17, P3956; Xerri C, 1996, J PHYSIOLOGY-PARIS, V90, P277, DOI 10.1016/S0928-4257(97)81438-6	50	234	235	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	1998	1	8					727	731		10.1038/3729	http://dx.doi.org/10.1038/3729			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	144PR	10196590	Green Accepted			2022-12-17	WOS:000077323400018
J	Huang, YB; Xu, Z; Xiong, SS; Sun, FF; Qin, GR; Hu, GL; Wang, JJ; Zhao, L; Liang, YX; Wu, TZ; Lu, ZH; Humayun, MS; So, KF; Pan, YH; Li, NN; Yuan, TF; Rao, YX; Peng, B				Huang, Yubin; Xu, Zhen; Xiong, Shanshan; Sun, Fangfang; Qin, Guangrong; Hu, Guanglei; Wang, Jingjing; Zhao, Lei; Liang, Yu-Xiang; Wu, Tianzhun; Lu, Zhonghua; Humayun, Mark S.; So, Kwok-Fai; Pan, Yihang; Li, Ningning; Yuan, Ti-Fei; Rao, Yanxia; Peng, Bo			Repopulated microglia are solely derived from the proliferation of residual microglia after acute depletion	NATURE NEUROSCIENCE			English	Article							NERVOUS-SYSTEM; MYELOID CELLS; ADULT BRAIN; STEM-CELLS; REVEALS; MACROPHAGES; MONOCYTES; RECEPTOR; SEQ; NEUROGENESIS	Newborn microglia rapidly replenish the whole brain after selective elimination of most microglia (>99%) in adult mice. Previous studies reported that repopulated microglia were largely derived from microglial progenitor cells expressing nestin in the brain. However, the origin of these repopulated microglia has been hotly debated. In this study, we investigated the origin of repopulated microglia by a series of fate-mapping approaches. We first excluded the blood origin of repopulated microglia via parabiosis. With different transgenic mouse lines, we then demonstrated that all repopulated microglia were derived from the proliferation of the few surviving microglia (<1%). Despite a transient pattern of nestin expression in newly forming microglia, none of repopulated microglia were derived from nestin-positive non-microglial cells. In summary, we conclude that repopulated microglia are solely derived from residual microglia rather than de novo progenitors, suggesting the absence of microglial progenitor cells in the adult brain.	[Huang, Yubin; Xu, Zhen; Xiong, Shanshan; Sun, Fangfang; Hu, Guanglei; Wang, Jingjing; Zhao, Lei; Wu, Tianzhun; Lu, Zhonghua; Peng, Bo] Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China; [Qin, Guangrong] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China; [Wang, Jingjing] Nanjing Normal Univ, Sch Psychol, Nanjing, Jiangsu, Peoples R China; [Liang, Yu-Xiang; So, Kwok-Fai; Rao, Yanxia] Univ Hong Kong, State Key Lab Brain & Cognit Sci, Hong Kong, Hong Kong, Peoples R China; [Humayun, Mark S.] Univ Southern Calif, Keck Sch Med, Dept Ophthalmol, Los Angeles, CA USA; [So, Kwok-Fai] Jinan Univ, Guangdong Hong Kong Macau Inst CNS Regenerat, Guangzhou, Guangdong, Peoples R China; [Pan, Yihang; Li, Ningning] Sun Yat Sen Univ, Affiliated Hosp 7, Shenzhen, Peoples R China; [Yuan, Ti-Fei] Shanghai Jiao Tong Univ, Sch Med, Shanghai Key Lab Psychot Disorders, Shanghai Mental Hlth Ctr, Shanghai, Peoples R China; [Yuan, Ti-Fei] Nantong Univ, Coinnovat Ctr Neuroregenerat, Nantong, Peoples R China; [Rao, Yanxia] Univ Hong Kong, Li Ka Shing Fac Med, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China	Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Chinese Academy of Sciences; Nanjing Normal University; University of Hong Kong; University of Southern California; Jinan University; Sun Yat Sen University; Shanghai Jiao Tong University; Nantong University; University of Hong Kong	Peng, B (corresponding author), Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China.; Rao, YX (corresponding author), Univ Hong Kong, State Key Lab Brain & Cognit Sci, Hong Kong, Hong Kong, Peoples R China.; Yuan, TF (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Key Lab Psychot Disorders, Shanghai Mental Hlth Ctr, Shanghai, Peoples R China.; Yuan, TF (corresponding author), Nantong Univ, Coinnovat Ctr Neuroregenerat, Nantong, Peoples R China.; Rao, YX (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China.	ytf0707@126.com; yanxiarao@connect.hku.hk; bopeng@connect.hku.hk	Peng, Bo/A-7125-2017; xu, zhen/ABG-7393-2020; Peng, Bo/AAU-3941-2021; Peng, Bo/W-5129-2019	Peng, Bo/0000-0003-4183-5939; xu, zhen/0000-0002-5674-9067; Peng, Bo/0000-0003-4183-5939; Peng, Bo/0000-0003-4183-5939; So, Kwok-Fai/0000-0003-4039-4246; QIN, GUANGRONG/0000-0001-8836-1246; Li, Ningning/0000-0002-0414-5878; Rao, Yanxia/0000-0001-5292-2056	National Key R&D Program of China [2017YFC0111202]; National Natural Science Foundation of China [31600839]; Shenzhen Science and Technology Research Program [JCYJ20170307171222692]; Guangdong Innovative and Entrepreneurial Research Team Program [2013S046]; Shenzhen Peacock Plan; NSFC [31771215, 81501164, 81611130224]; CAST	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Science and Technology Research Program; Guangdong Innovative and Entrepreneurial Research Team Program; Shenzhen Peacock Plan; NSFC(National Natural Science Foundation of China (NSFC)); CAST	The authors wish to thank C. Ren, K. Wang and L. Huang (Jinan University), J. Chang, P. Ren, J. Zhang, Z. Yao and W. Zhan (Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences), and Q. Gao, L. Yang, H. Zhong, C. Zhang, W. Zhao, Z. Dong, B. Chen, W. Wu, F. Fan, Z. Liu and M. Xie (BGI) for technical support. They thank C. Liu (Zhejiang University) for donating NG2-CreER mice. They also thank H. Zheng for supporting the establishment of Bo Peng's laboratory. The authors thank P. Lin, B. West, P. Singh and A. Rymar (Plexxikon Inc.) for kindly providing the PLX5622 compound and formulated chow diet. Last but not least, the authors show their gratitude and respect to all animals sacrificed in this study. This study was supported by National Key R&D Program of China (2017YFC0111202; B.P.), National Natural Science Foundation of China (31600839; B. P.), Shenzhen Science and Technology Research Program (JCYJ20170307171222692; B.P.), Guangdong Innovative and Entrepreneurial Research Team Program (2013S046; B.P.) and Shenzhen Peacock Plan (B. P.). This study was also supported by NSFC Grants (31771215, 81501164 and 81611130224; T.-F.Y.) and Young Elite Scientists Sponsorship Program by CAST (YESS; T.Y.).	Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Ajami B, 2011, NAT NEUROSCI, V14, P1142, DOI 10.1038/nn.2887; Alliot F, 1999, DEV BRAIN RES, V117, P145, DOI 10.1016/S0165-3806(99)00113-3; Amat JA, 1996, GLIA, V16, P368, DOI 10.1002/(SICI)1098-1136(199604)16:4<368::AID-GLIA9>3.0.CO;2-W; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Beggs S, 2016, CELL, V165, P1294, DOI 10.1016/j.cell.2016.05.036; Bruttger J, 2015, IMMUNITY, V43, P92, DOI 10.1016/j.immuni.2015.06.012; Chapman AR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120889; Chen K, 2017, CELL, V170, P492, DOI 10.1016/j.cell.2017.06.042; Chitu V, 2016, TRENDS NEUROSCI, V39, P378, DOI 10.1016/j.tins.2016.03.005; del Rio Hortega P, 1932, MICROGLIA; Del Rio-Hortega P, 1927, B JOHNS HOPKINS HOSP, V41, P278; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Elmore MRP, 2014, NEURON, V82, P380, DOI 10.1016/j.neuron.2014.02.040; Erblich B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026317; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kamran P, 2013, JOVE-J VIS EXP, DOI 10.3791/50556; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kierdorf K, 2013, NAT NEUROSCI, V16, P273, DOI 10.1038/nn.3318; Lagace DC, 2007, J NEUROSCI, V27, P12623, DOI 10.1523/JNEUROSCI.3812-07.2007; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mathys H, 2017, CELL REP, V21, P366, DOI 10.1016/j.celrep.2017.09.039; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Miron VE, 2013, NAT NEUROSCI, V16, P1211, DOI 10.1038/nn.3469; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Peng B, 2014, J NEUROSCI, V34, P8139, DOI 10.1523/JNEUROSCI.5200-13.2014; Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122; Pitulescu ME, 2010, NAT PROTOC, V5, P1518, DOI 10.1038/nprot.2010.113; Prinz M, 2014, NAT REV NEUROSCI, V15, P300, DOI 10.1038/nrn3722; Radu M, 2013, JOVE-J VIS EXP, DOI 10.3791/50062; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Sheng KW, 2017, NAT METHODS, V14, P267, DOI [10.1038/NMETH.4145, 10.1038/nmeth.4145]; Tay TL, 2017, NAT NEUROSCI, V20, P793, DOI 10.1038/nn.4547; Valdearcos M, 2017, CELL METAB, V26, P185, DOI 10.1016/j.cmet.2017.05.015; Valdearcos M, 2014, CELL REP, V9, P2124, DOI 10.1016/j.celrep.2014.11.018; Varvel NH, 2012, P NATL ACAD SCI USA, V109, P18150, DOI 10.1073/pnas.1210150109; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Yuan TF, 2015, SCI REP-UK, V5, DOI 10.1038/srep10788	43	233	235	10	144	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2018	21	4					530	+		10.1038/s41593-018-0090-8	http://dx.doi.org/10.1038/s41593-018-0090-8			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GB1FG	29472620				2022-12-17	WOS:000428796000012
J	Li, W; Ma, L; Yang, G; Gan, WB				Li, Wei; Ma, Lei; Yang, Guang; Gan, Wen-Biao			REM sleep selectively prunes and maintains new synapses in development and learning	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; EYE-MOVEMENT SLEEP; NEURONS IN-VIVO; MEMORY CONSOLIDATION; DENDRITIC SPIKES; SYNAPTIC PLASTICITY; PYRAMIDAL NEURONS; VISUAL-CORTEX; BARREL CORTEX; MECHANISM	The functions and underlying mechanisms of rapid eye movement (REM) sleep remain unclear. Here we show that REM sleep prunes newly formed postsynaptic dendritic spines of layer 5 pyramidal neurons in the mouse motor cortex during development and motor learning. This REM sleep-dependent elimination of new spines facilitates subsequent spine formation during development and when a new motor task is learned, indicating a role for REM sleep in pruning to balance the number of new spines formed over time. Moreover, REM sleep also strengthens and maintains newly formed spines, which are critical for neuronal circuit development and behavioral improvement after learning. We further show that dendritic calcium spikes arising during REM sleep are important for pruning and strengthening new spines. Together, these findings indicate that REM sleep has multifaceted functions in brain development, learning and memory consolidation by selectively eliminating and maintaining newly formed synapses via dendritic calcium spike-dependent mechanisms.	[Li, Wei; Ma, Lei; Gan, Wen-Biao] Peking Univ, Shenzhen Grad Sch, Key Lab Chem Gen, Ctr Drug Discovery, Shenzhen, Peoples R China; [Li, Wei; Ma, Lei; Gan, Wen-Biao] NYU, Sch Med, Dept Neurosci & Physiol, Skirball Inst, New York, NY 10003 USA; [Yang, Guang] NYU, Sch Med, Dept Anesthesiol, New York, NY USA	Peking University; University Town of Shenzhen; New York University; New York University	Gan, WB (corresponding author), Peking Univ, Shenzhen Grad Sch, Key Lab Chem Gen, Ctr Drug Discovery, Shenzhen, Peoples R China.; Gan, WB (corresponding author), NYU, Sch Med, Dept Neurosci & Physiol, Skirball Inst, New York, NY 10003 USA.	gan@saturn.med.nyu.edu	ma, Lei/GOV-5903-2022	Yang, Guang/0000-0002-5739-9126; ma, lei/0000-0001-9673-0224	NIH [R01 NS047325, R01 MH111486, R01 GM107469, R21 AG048410]; National Natural Science Foundation of China [81100839]; Shenzhen Science and Technology Innovation Funds [GJHS20120628101219327, JC201105170726A, JCYJ20160428154351820, JSGG20140703163838793, ZDSYS201504301539161, KQTD2015032709315529]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107469] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH111486] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047325] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG048410] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Science and Technology Innovation Funds; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank J. Cichon for technical help and all the members of the Gan laboratory for comments on the manuscript. This study was supported by funding from the NIH (R01 NS047325 and R01 MH111486 to W-B.G., R01 GM107469 and R21 AG048410 to G.Y.), by the National Natural Science Foundation of China (81100839 to W.L.) and by Shenzhen Science and Technology Innovation Funds (GJHS20120628101219327, JC201105170726A, JCYJ20160428154351820, JSGG20140703163838793, ZDSYS201504301539161 and KQTD2015032709315529 to W.L. and L.M.).	Abel T, 2013, CURR BIOL, V23, pR774, DOI 10.1016/j.cub.2013.07.025; Bridi MCD, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500105; CHANGEUX JP, 1976, NATURE, V264, P705, DOI 10.1038/264705a0; Cichon J, 2015, NATURE, V520, P180, DOI 10.1038/nature14251; CRICK F, 1995, BEHAV BRAIN RES, V69, P147, DOI 10.1016/0166-4328(95)00006-F; CRICK F, 1983, NATURE, V304, P111, DOI 10.1038/304111a0; Datta S, 2004, J NEUROSCI, V24, P1416, DOI 10.1523/JNEUROSCI.4111-03.2004; Frank MG, 2001, NEURON, V30, P275, DOI 10.1016/S0896-6273(01)00279-3; GAARDER K, 1966, ARCH GEN PSYCHIAT, V14, P253; Golding NL, 2002, NATURE, V418, P326, DOI 10.1038/nature00854; Grosmark AD, 2012, NEURON, V75, P1001, DOI 10.1016/j.neuron.2012.08.015; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Hayashi-Takagi A, 2015, NATURE, V525, P333, DOI 10.1038/nature15257; Hobson JA, 2009, NAT REV NEUROSCI, V10, P803, DOI 10.1038/nrn2716; Holthoff K, 2004, J PHYSIOL-LONDON, V560, P27, DOI 10.1113/jphysiol.2004.072678; HOPFIELD JJ, 1983, NATURE, V304, P158, DOI 10.1038/304158a0; Jouvet M, 1980, Prog Brain Res, V53, P331, DOI 10.1016/S0079-6123(08)60073-4; Kampa BM, 2006, J PHYSIOL-LONDON, V574, P283, DOI 10.1113/jphysiol.2006.111062; KARNI A, 1994, SCIENCE, V265, P679, DOI 10.1126/science.8036518; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Larkum ME, 2009, SCIENCE, V325, P756, DOI 10.1126/science.1171958; LAVIE P, 1984, NEUROLOGY, V34, P118, DOI 10.1212/WNL.34.1.118; Lavzin M, 2012, NATURE, V490, P397, DOI 10.1038/nature11451; Lichtman JW, 2000, NEURON, V25, P269, DOI 10.1016/S0896-6273(00)80893-4; Liston C, 2013, NAT NEUROSCI, V16, P698, DOI 10.1038/nn.3387; LLINAS RR, 1991, NEUROSCIENCE, V44, P521, DOI 10.1016/0306-4522(91)90075-Y; MARKS GA, 1995, BEHAV BRAIN RES, V69, P1, DOI 10.1016/0166-4328(95)00018-O; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; MIRMIRAN M, 1995, BEHAV BRAIN RES, V69, P13, DOI 10.1016/0166-4328(95)00019-P; Nelson AB, 2013, BRAIN SCI, V3, P318, DOI 10.3390/brainsci3010318; Nevian T, 2004, J NEUROSCI, V24, P1689, DOI 10.1523/JNEUROSCI.3332-03.2004; NEWMAN EA, 1965, NATURE, V206, P534, DOI 10.1038/206534a0; Rasch B, 2013, PHYSIOL REV, V93, P681, DOI 10.1152/physrev.00032.2012; Rasch B, 2009, NAT NEUROSCI, V12, P396, DOI 10.1038/nn.2206; Ravassard P, 2009, SLEEP, V32, P227, DOI 10.1093/sleep/32.2.227; Ribeiro S, 1999, LEARN MEMORY, V6, P500, DOI 10.1101/lm.6.5.500; ROFFWARG HP, 1966, SCIENCE, V152, P604, DOI 10.1126/science.152.3722.604; Sheffield MEJ, 2015, NATURE, V517, P200, DOI 10.1038/nature13871; Siegel JM, 2001, SCIENCE, V294, P1058, DOI 10.1126/science.1063049; SMITH C, 1991, SLEEP, V14, P325, DOI 10.1093/sleep/14.4.325; Smith SL, 2013, NATURE, V503, P115, DOI 10.1038/nature12600; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; Ulloor J, 2005, J NEUROCHEM, V95, P418, DOI 10.1111/j.1471-4159.2005.03378.x; Vertes R.P., 2000, BEHAV BRAIN SCI, V23, P904; Vertes RP, 2004, NEURON, V44, P135, DOI 10.1016/j.neuron.2004.08.034; Vertes RP, 2005, SLEEP, V28, P1232, DOI 10.1093/sleep/28.10.1232; Vertes RP, 2000, BEHAV BRAIN SCI, V23, P867, DOI 10.1017/S0140525X00004003; Vertes RP, 2005, SLEEP, V28, P1228, DOI 10.1093/sleep/28.10.1228; Xu NL, 2012, NATURE, V492, P247, DOI 10.1038/nature11601; Yang G, 2014, SCIENCE, V344, P1173, DOI 10.1126/science.1249098; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577	52	233	239	13	162	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2017	20	3					427	437		10.1038/nn.4479	http://dx.doi.org/10.1038/nn.4479			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EL9DU	28092659	Green Accepted			2022-12-17	WOS:000394920400020
J	Garfield, AS; Li, C; Madara, JC; Shah, BP; Webber, E; Steger, JS; Campbell, JN; Gavrilova, O; Lee, CE; Olson, DP; Elmquist, JK; Tannous, BA; Krashes, MJ; Lowell, BB				Garfield, Alastair S.; Li, Chia; Madara, Joseph C.; Shah, Bhavik P.; Webber, Emily; Steger, Jennifer S.; Campbell, John N.; Gavrilova, Oksana; Lee, Charlotte E.; Olson, David P.; Elmquist, Joel K.; Tannous, Bakhos A.; Krashes, Michael J.; Lowell, Bradford B.			A neural basis for melanocortin-4 receptor-regulated appetite	NATURE NEUROSCIENCE			English	Article							HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; MELANOCYTE-STIMULATING HORMONE; PROTEIN-COUPLED RECEPTORS; AGOUTI-RELATED PROTEIN; PARABRACHIAL NUCLEUS; FEEDING-BEHAVIOR; AGRP NEURONS; RNA-SEQ; LATERAL HYPOTHALAMUS; FRAMESHIFT MUTATION	Pro-opiomelanocortin (POMC)- and agouti-related peptide (AgRP)-expressing neurons of the arcuate nucleus of the hypothalamus (ARC) are oppositely regulated by caloric depletion and coordinately stimulate and inhibit homeostatic satiety, respectively. This bimodality is principally underscored by the antagonistic actions of these ligands at downstream melanocortin-4 receptors (MC4R) in the paraventricular nucleus of the hypothalamus (PVH). Although this population is critical to energy balance, the underlying neural circuitry remains unknown. Using mice expressing Cre recombinase in MC4R neurons, we demonstrate bidirectional control of feeding following real-time activation and inhibition of PVHMC4R neurons and further identify these cells as a functional exponent of ARC(AgRP) neuron-driven hunger. Moreover, we reveal this function to be mediated by a PVHMC4R -> lateral parabrachial nucleus (LPBN) pathway. Activation of this circuit encodes positive valence, but only in calorically depleted mice. Thus, the satiating and appetitive nature of PVHMC4R -> LPBN neurons supports the principles of drive reduction and highlights this circuit as a promising target for antiobesity drug development.	[Garfield, Alastair S.; Madara, Joseph C.; Shah, Bhavik P.; Steger, Jennifer S.; Campbell, John N.; Olson, David P.; Lowell, Bradford B.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Endocrinol Diabet & Metab,Dept Med, Boston, MA 02215 USA; [Garfield, Alastair S.] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland; [Li, Chia; Webber, Emily; Krashes, Michael J.] NIDDK, Diabet Endocrinol & Obes Branch, NIH, Bethesda, MD 20892 USA; [Li, Chia; Webber, Emily; Krashes, Michael J.] NIDA, NIH, Baltimore, MD USA; [Gavrilova, Oksana] NIDDK, Mouse Metab Core, NIH, Bethesda, MD 20892 USA; [Lee, Charlotte E.; Elmquist, Joel K.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Hypothalam Res, Dallas, TX 75390 USA; [Tannous, Bakhos A.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Neurol, Charlestown, MA USA; [Lowell, Bradford B.] Harvard Univ, Sch Med, Neurosci Program, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Edinburgh; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Lowell, BB (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Endocrinol Diabet & Metab,Dept Med, Boston, MA 02215 USA.	agarfiel@staffmail.ed.ac.uk; michael.krashes@nih.gov; blowell@bidmc.harvard.edu	Core, Vector/CAF-4832-2022; Krashes, Michael/P-7677-2019	Webber, Emily/0000-0003-2893-7164; Garfield, Alastair/0000-0002-9628-6140	Boston Area Diabetes Endocrinology Research Center [BADERC P30 DK057521]; University of Edinburgh; US National Institutes of Health [R01 DK096010, R01 DK089044, R01 DK071051, R01 DK075632, R37 DK053477, F32 DK089710, K08 DK071561, R01 DK088423, R37 DK0053301]; US National Institutes of Health (BNORC Transgenic Core) [P30 DK046200]; US National Institutes of Health (BADERC Transgenic Core) [P30 DK057521]; American Heart Association [14POST20100011]; viral vector production core [P30 NS045776]; American Diabetes Association; NIH, NIDDK [DK075087, DK075088]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK053301, R01DK075632, ZICDK070002, P30DK046200, F32DK089710, R01DK096010, R37DK053477, ZIADK075090, K08DK071561, R01DK088423, P30DK020572, R01DK089044, ZIADK075087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045776] Funding Source: NIH RePORTER	Boston Area Diabetes Endocrinology Research Center; University of Edinburgh; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institutes of Health (BNORC Transgenic Core)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institutes of Health (BADERC Transgenic Core)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); viral vector production core; American Diabetes Association(American Diabetes Association); NIH, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors gratefully acknowledge the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Mouse Metabolism Core for technical support, V. Petkova and the Beth Israel Deaconess Medical Center Molecular Medicine Core Facility for assistance with quantitative PCR and sample preparation, and D. Morse for the production of the rabies virus. Sequencing and initial data processing were performed at Massachusetts General Hospital's Next-Gen Sequencing Core. Sequencing was supported in part by funding from the Boston Area Diabetes Endocrinology Research Center (BADERC P30 DK057521). This work was supported by the University of Edinburgh Chancellor's Fellowship (A.S.G.); US National Institutes of Health grants to B.B.L. (R01 DK096010, R01 DK089044, R01 DK071051, R01 DK075632, R37 DK053477, BNORC Transgenic Core P30 DK046200, BADERC Transgenic Core P30 DK057521), to M.J.K. (F32 DK089710), to D.P.O. (K08 DK071561) and to J.K.E. (R01 DK088423 and R37 DK0053301); American Heart Association Postdoctoral Fellowship 14POST20100011 to J.N.C.; viral vector production core P30 NS045776 to B.A.T.; and an American Diabetes Association Mentor-Based Fellowship to B.P.S. and B.B.L. This research was supported, in part, by the Intramural Research Program of the NIH, NIDDK (DK075087, DK075088).	ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; Alexander GM, 2009, NEURON, V63, P27, DOI 10.1016/j.neuron.2009.06.014; Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Atasoy D, 2014, NAT NEUROSCI, V17, P1830, DOI 10.1038/nn.3854; Atasoy D, 2012, NATURE, V488, P172, DOI 10.1038/nature11270; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Berridge KC, 2004, PHYSIOL BEHAV, V81, P179, DOI 10.1016/j.physbeh.2004.02.004; Betley JN, 2013, CELL, V155, P1337, DOI 10.1016/j.cell.2013.11.002; Cai HJ, 2014, NAT NEUROSCI, V17, P1240, DOI 10.1038/nn.3767; Cannon W.B., 1932, WISDOM BODY, VXV; Carter ME, 2015, J NEUROSCI, V35, P4582, DOI 10.1523/JNEUROSCI.3729-14.2015; Carter ME, 2013, NATURE, V503, P111, DOI 10.1038/nature12596; Cowley MA, 1999, NEURON, V24, P155, DOI 10.1016/S0896-6273(00)80829-6; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Franklin K. B. J., 2008, MOUSE BRAIN STEREOTA; Garfield AS, 2014, CELL METAB, V20, P1030, DOI 10.1016/j.cmet.2014.11.006; Garfield AS, 2009, TRENDS ENDOCRIN MET, V20, P203, DOI 10.1016/j.tem.2009.02.002; Hempel CM, 2007, NAT PROTOC, V2, P2924, DOI 10.1038/nprot.2007.416; Hull C.L., 1943, PRINCIPLES BEHAV INT, VX, P421; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Jennings JH, 2015, CELL, V160, P516, DOI 10.1016/j.cell.2014.12.026; Jennings JH, 2013, SCIENCE, V341, P1517, DOI 10.1126/science.1241812; Keys Ancel, 1946, JOUR AMER DIETETIC ASSOC, V22, P582; Kim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018556; KIRCHGESSNER AL, 1988, PHYSIOL BEHAV, V42, P517, DOI 10.1016/0031-9384(88)90153-9; Krashes MJ, 2014, NATURE, V507, P238, DOI 10.1038/nature12956; Krashes MJ, 2013, CELL METAB, V18, P588, DOI 10.1016/j.cmet.2013.09.009; Krashes MJ, 2011, J CLIN INVEST, V121, P1424, DOI 10.1172/JCI46229; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; LEIBOWITZ SF, 1981, PHYSIOL BEHAV, V27, P1031, DOI 10.1016/0031-9384(81)90366-8; Liu TM, 2012, NEURON, V73, P511, DOI 10.1016/j.neuron.2011.11.027; Lu XY, 2003, J NEUROSCI, V23, P7863; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; MARGULES DL, 1962, SCIENCE, V135, P374, DOI 10.1126/science.135.3501.374; MCCABE JT, 1984, BRAIN RES, V309, P85, DOI 10.1016/0006-8993(84)91013-8; NAGAI K, 1987, J CLIN BIOCHEM NUTR, V3, P103, DOI 10.3164/jcbn.3.103; Paues J, 2006, NEUROSCIENCE, V141, P287, DOI 10.1016/j.neuroscience.2006.03.041; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Rossi J, 2011, CELL METAB, V13, P195, DOI 10.1016/j.cmet.2011.01.010; Rossi M, 1998, ENDOCRINOLOGY, V139, P4428, DOI 10.1210/en.139.10.4428; Saxena A, 2012, BIOTECHNIQUES, V52, P381, DOI 10.2144/0000113878; Shah BP, 2014, P NATL ACAD SCI USA, V111, P13193, DOI 10.1073/pnas.1407843111; Small CJ, 2001, DIABETES, V50, P248, DOI 10.2337/diabetes.50.2.248; Song H, 2012, P NATL ACAD SCI USA, V109, P17531, DOI 10.1073/pnas.1207238109; Stachniak TJ, 2014, NEURON, V82, P797, DOI 10.1016/j.neuron.2014.04.008; Stamatakis AM, 2012, NAT NEUROSCI, V15, P1105, DOI 10.1038/nn.3145; Sternson SM, 2013, NEURON, V77, P810, DOI 10.1016/j.neuron.2013.02.018; Sutton AK, 2014, J NEUROSCI, V34, P15306, DOI 10.1523/JNEUROSCI.0226-14.2014; Tang FC, 2010, NAT PROTOC, V5, P516, DOI 10.1038/nprot.2009.236; Tong QC, 2008, NAT NEUROSCI, V11, P998, DOI 10.1038/nn.2167; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vaisse C, 1998, NAT GENET, V20, P113, DOI 10.1038/2407; Vong L, 2011, NEURON, V71, P142, DOI 10.1016/j.neuron.2011.05.028; Wu Q, 2012, NATURE, V483, P594, DOI 10.1038/nature10899; Wu Q, 2009, CELL, V137, P1225, DOI 10.1016/j.cell.2009.04.022; Wu ZF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045167; Xi D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036453; Yaswen L, 1999, NAT MED, V5, P1066, DOI 10.1038/12506; Yeo GSH, 1998, NAT GENET, V20, P111, DOI 10.1038/2404; Zhan C, 2013, J NEUROSCI, V33, P3624, DOI 10.1523/JNEUROSCI.2742-12.2013	63	233	240	6	84	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2015	18	6					863	U299		10.1038/nn.4011	http://dx.doi.org/10.1038/nn.4011			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CJ1CB	25915476	Green Accepted			2022-12-17	WOS:000355218300014
J	Mahler, SV; Moorman, DE; Smith, RJ; James, MH; Aston-Jones, G				Mahler, Stephen V.; Moorman, David E.; Smith, Rachel J.; James, Morgan H.; Aston-Jones, Gary			Motivational activation: a unifying hypothesis of orexin/hypocretin function	NATURE NEUROSCIENCE			English	Article							HYPOTHALAMIC OREXIN NEURONS; LATERAL HYPOTHALAMUS; PREFRONTAL CORTEX; HOMEOSTATIC REGULATION; HYPOCRETIN; REWARD; AROUSAL; SLEEP; NARCOLEPSY; SYSTEM	Orexins (hypocretins) are two peptides (orexin A and B) produced from the pre-pro-orexin precursor and expressed in a limited region of dorsolateral hypothalamus. Orexins were originally thought to specifically mediate feeding and promote wakefulness, but it is now clear that they participate in a wide range of behavioral and physiological processes under select circumstances. Orexins primarily mediate behavior under situations of high motivational relevance, such as during physiological need states, exposure to threats or reward opportunities. We hypothesize that many behavioral functions of orexins (including regulation of sleep/wake cycling) reflect a fundamentally integrated function for orexins in translating motivational activation into organized suites of psychological and physiological processes supporting adaptive behaviors. We also discuss how numerous forms of neural heterogeneity modulate this function, allowing orexin neurons to organize diverse, adaptive responses in a variety of motivationally relevant situations. Thus, the involvement of orexins in diverse behaviors may reflect a common underlying function for this peptide system.	[Mahler, Stephen V.; Moorman, David E.; Smith, Rachel J.; James, Morgan H.; Aston-Jones, Gary] Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA; [Moorman, David E.] Univ Massachusetts, Dept Psychol & Brain Sci, Amherst, MA 01003 USA	Medical University of South Carolina; University of Massachusetts System; University of Massachusetts Amherst	Aston-Jones, G (corresponding author), Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA.	astong@musc.edu	James, Morgan/AEM-8428-2022; Mahler, Stephen V/P-8594-2018	James, Morgan/0000-0001-9298-8607; Mahler, Stephen V/0000-0002-8698-0905; Moorman, David/0000-0002-5755-0789	US National Institutes of Health [F32 DA026692, K99 DA035251, R01-DA006214, P50 DA015369, R21 DA037744, R21 DA032005, C06 RR015455]; National Health and Medical Research Council CJ Martin Fellowship [1072706]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA026692, R01DA006214, K99DA035251, P50DA015369, R21DA037744, R21DA032005] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council CJ Martin Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank E. Vought for assistance with figure art and design, and A. Koller for helpful comments. Funding was provided by US National Institutes of Health grants F32 DA026692, K99 DA035251, R01-DA006214, P50 DA015369, R21 DA037744, R21 DA032005 and C06 RR015455, and National Health and Medical Research Council CJ Martin Fellowship 1072706.	Akbari E, 2006, BEHAV BRAIN RES, V173, P47, DOI 10.1016/j.bbr.2006.05.028; Alexandre C, 2013, CURR OPIN NEUROBIOL, V23, P752, DOI 10.1016/j.conb.2013.04.008; Appelbaum L, 2010, NEURON, V68, P87, DOI 10.1016/j.neuron.2010.09.006; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Bayardand S, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00050; Belle MDC, 2014, J NEUROSCI, V34, P3607, DOI 10.1523/JNEUROSCI.3388-13.2014; Berridge CW, 2010, BRAIN RES, V1314, P91, DOI 10.1016/j.brainres.2009.09.019; Berthoud HR, 2011, PHYSIOL BEHAV, V104, P29, DOI 10.1016/j.physbeh.2011.04.051; Blouin AM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2461; Borbely A A, 1982, Hum Neurobiol, V1, P195; Borgland SL, 2010, BRAIN RES, V1314, P139, DOI 10.1016/j.brainres.2009.10.068; Borgland SL, 2009, J NEUROSCI, V29, P11215, DOI 10.1523/JNEUROSCI.6096-08.2009; Boutrel B, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00059; Bromberg-Martin ES, 2010, NEURON, V68, P815, DOI 10.1016/j.neuron.2010.11.022; Burdakov D, 2013, PHYSIOL BEHAV, V121, P117, DOI 10.1016/j.physbeh.2013.03.023; Burgess CR, 2013, J NEUROSCI, V33, P9734, DOI 10.1523/JNEUROSCI.5632-12.2013; Calipari ES, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00054; Carrive P, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00257; Cason AM, 2010, PHYSIOL BEHAV, V100, P419, DOI 10.1016/j.physbeh.2010.03.009; Chase MH, 2013, J APPL PHYSIOL, V115, P954, DOI 10.1152/japplphysiol.00700.2012; Chou TC, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-19-j0003.2001; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; Deutch AY, 2007, SCHIZOPHRENIA BULL, V33, P1277, DOI 10.1093/schbul/sbm096; Fadel J, 2010, BRAIN RES, V1314, P112, DOI 10.1016/j.brainres.2009.08.046; Gao XB, 2014, ANNU REV NEUROSCI, V37, P101, DOI 10.1146/annurev-neuro-071013-013855; Harris GC, 2005, NATURE, V437, P556, DOI 10.1038/nature04071; Harris GC, 2006, TRENDS NEUROSCI, V29, P571, DOI 10.1016/j.tins.2006.08.002; James MH, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00244; Johnson PL, 2012, PROG BRAIN RES, V198, P133, DOI 10.1016/B978-0-444-59489-1.00009-4; Khatami R, 2007, J SLEEP RES, V16, P226, DOI 10.1111/j.1365-2869.2007.00587.x; Kilduff TS, 2000, TRENDS NEUROSCI, V23, P359, DOI 10.1016/S0166-2236(00)01594-0; Kukkonen JP, 2014, BRIT J PHARMACOL, V171, P314, DOI 10.1111/bph.12324; Kuwaki T, 2010, RESP PHYSIOL NEUROBI, V174, P43, DOI 10.1016/j.resp.2010.04.018; Lambe EK, 2005, J NEUROSCI, V25, P5225, DOI 10.1523/JNEUROSCI.0719-05.2005; Lee MG, 2005, J NEUROSCI, V25, P6716, DOI 10.1523/JNEUROSCI.1887-05.2005; Li JC, 2014, BRIT J PHARMACOL, V171, P332, DOI 10.1111/bph.12415; Liu RJ, 2008, P NATL ACAD SCI USA, V105, P359, DOI 10.1073/pnas.0706679105; Lutter M, 2008, J NEUROSCI, V28, P3071, DOI 10.1523/JNEUROSCI.5584-07.2008; Mahler SV, 2013, PSYCHOPHARMACOLOGY, V226, P687, DOI 10.1007/s00213-012-2681-5; Mahler SV, 2012, PROG BRAIN RES, V198, P79, DOI 10.1016/B978-0-444-59489-1.00007-0; Mahlios J, 2013, CURR OPIN NEUROBIOL, V23, P767, DOI 10.1016/j.conb.2013.04.013; Marchant NJ, 2012, CELL MOL LIFE SCI, V69, P581, DOI 10.1007/s00018-011-0817-0; Mignot E, 2004, SLEEP MED, V5, pS2, DOI 10.1016/S1389-9457(04)90001-9; Mileykovskiy BY, 2005, NEURON, V46, P787, DOI 10.1016/j.neuron.2005.04.035; Mochizuki T, 2004, J NEUROSCI, V24, P6291, DOI 10.1523/JNEUROSCI.0586-04.2004; Morein-Zamir S, 2007, SCHIZOPHRENIA BULL, V33, P1298, DOI 10.1093/schbul/sbm090; Muschamp JW, 2014, P NATL ACAD SCI USA, V111, pE1648, DOI 10.1073/pnas.1315542111; Oishi Y, 2013, J NEUROSCI, V33, P9743, DOI 10.1523/JNEUROSCI.0499-13.2013; Overeem Sebastiaan, 2002, Sleep Med, V3, P471, DOI 10.1016/S1389-9457(02)00037-0; Perello M, 2010, BIOL PSYCHIAT, V67, P880, DOI 10.1016/j.biopsych.2009.10.030; Ponz A, 2010, ANN NEUROL, V67, P394, DOI 10.1002/ana.21881; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Sakurai T, 2007, NAT REV NEUROSCI, V8, P171, DOI 10.1038/nrn2092; Salomon RM, 2003, BIOL PSYCHIAT, V54, P96, DOI 10.1016/S0006-3223(02)01740-7; Saper CB, 2010, NEURON, V68, P1023, DOI 10.1016/j.neuron.2010.11.032; Schoene C, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00081; Sears RM, 2013, P NATL ACAD SCI USA, V110, P20260, DOI 10.1073/pnas.1320325110; Sheng ZY, 2014, MOL CELL NEUROSCI, V62, P30, DOI 10.1016/j.mcn.2014.08.001; SIEGEL JM, 1991, SCIENCE, V252, P1315, DOI 10.1126/science.1925546; Siegel JM, 1999, CELL, V98, P409, DOI 10.1016/S0092-8674(00)81969-8; Smith RJ, 2009, EUR J NEUROSCI, V30, P493, DOI 10.1111/j.1460-9568.2009.06844.x; Tabuchi S, 2014, J NEUROSCI, V34, P6495, DOI 10.1523/JNEUROSCI.0073-14.2014; Takahashi K, 2008, NEUROSCIENCE, V153, P860, DOI 10.1016/j.neuroscience.2008.02.058; Thompson JL, 2011, BEHAV BRAIN RES, V217, P446, DOI 10.1016/j.bbr.2010.09.028; Tsujino N, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00028; Tupone D, 2011, J NEUROSCI, V31, P15944, DOI 10.1523/JNEUROSCI.3909-11.2011; Wheeler DS, 2014, EUR J NEUROSCI, V40, P2359, DOI 10.1111/ejn.12592; Winsky-Sommerer R, 2004, J NEUROSCI, V24, P11439, DOI 10.1523/JNEUROSCI.3459-04.2004; Wu MF, 2011, ARCH ITAL BIOL, V149, P492, DOI 10.4449/aib.v149i4.1315; Yamanaka A, 2003, NEURON, V38, P701, DOI 10.1016/S0896-6273(03)00331-3; Yeoh JW, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00036; Yoshida K, 2006, J COMP NEUROL, V494, P845, DOI 10.1002/cne.20859; Zeitzer JM, 2003, J NEUROSCI, V23, P3555	73	233	235	1	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2014	17	10					1298	1303		10.1038/nn.3810	http://dx.doi.org/10.1038/nn.3810			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AP8KD	25254979	Green Accepted			2022-12-17	WOS:000342327000007
J	Mahler, SV; Vazey, EM; Beckley, JT; Keistler, CR; McGlinchey, EM; Kaufling, J; Wilson, SP; Deisseroth, K; Woodward, JJ; Aston-Jones, G				Mahler, Stephen V.; Vazey, Elena M.; Beckley, Jacob T.; Keistler, Colby R.; McGlinchey, Ellen M.; Kaufling, Jennifer; Wilson, Steven P.; Deisseroth, Karl; Woodward, John J.; Aston-Jones, Gary			Designer receptors show role for ventral pallidum input to ventral tegmental area in cocaine seeking	NATURE NEUROSCIENCE			English	Article							NUCLEUS-ACCUMBENS; INDUCED REINSTATEMENT; DOPAMINE NEURONS; RAT; REWARD; PROJECTION; ACTIVATION; AFFERENTS; BEHAVIOR; CIRCUITRY	The ventral pallidum is centrally positioned within mesocorticolimbic reward circuits, and its dense projection to the ventral tegmental area (VTA) regulates neuronal activity there. However, the ventral pallidum is a heterogeneous structure, and how this complexity affects its role within wider reward circuits is unclear. We found that projections to VTA from the rostral ventral pallidum (RVP), but not the caudal ventral pallidum (CVP), were robustly Fos activated during cue-induced reinstatement of cocaine seeking-a rat model of relapse in addiction. Moreover, designer receptor-mediated transient inactivation of RVP neurons, their terminals in VTA or functional connectivity between RVP and VTA dopamine neurons blocked the ability of drug-associated cues (but not a cocaine prime) to reinstate cocaine seeking. In contrast, CVP neuronal inhibition blocked cocaine-primed, but not cue-induced, reinstatement. This double dissociation in ventral pallidum subregional roles in drug seeking is likely to be important for understanding the mesocorticolimbic circuits underlying reward seeking and addiction.	[Mahler, Stephen V.; Vazey, Elena M.; Beckley, Jacob T.; Keistler, Colby R.; McGlinchey, Ellen M.; Kaufling, Jennifer; Woodward, John J.; Aston-Jones, Gary] Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA; [Wilson, Steven P.] Univ S Carolina, Sch Med, Dept Pharmacol Physiol & Neurosci, Columbia, SC USA; [Deisseroth, Karl] Stanford Univ, Dept Bioengn & Psychiat & Behav Sci, Stanford, CA 94305 USA	Medical University of South Carolina; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Stanford University	Mahler, SV (corresponding author), Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA.	mahler@musc.edu	Core, Vector/CAF-4832-2022; Mahler, Stephen V/P-8594-2018	Mahler, Stephen V/0000-0002-8698-0905; Wilson, Steven/0000-0001-8778-946X; /0000-0003-3311-9414; kaufling, jennifer/0000-0001-8115-6039; Beckley, Jacob/0000-0003-2950-6462	US National Institutes of Health (NIH) National Cancer Institute (NCI) [NS064882-01]; NIH [F32 DA026692, K99 DA035251, F31 DA030891, R21 DA025837, R01 DA013951, R37 DA006214, P50 DA015369]; National Center for Research Resources; Office of the Director of the National Institutes of Health [C06 RR015455]; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA026692, R37DA006214, P50DA015369, R01DA013951, R00DA035251, F31DA030891, R21DA025837, K99DA035251, R01DA006214] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of the Director of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank P. Do, M.J. Gilstrap and E.C. Lin for assistance with behavioral testing and immunohistochemistry and B.L. Roth (Department of Pharmacology, University of North Carolina) for DREADD constructs and consultation on DREADDs. CNO was supplied by US National Institutes of Health (NIH) National Cancer Institute (NCI) under the auspices of NS064882-01 and by the National Institute of Mental Health (NIMH) Chemical Synthesis and Drug Supply Program. Research was supported by NIH grants F32 DA026692, K99 DA035251 (S.V.M.), F31 DA030891 (J.T.B.), R21 DA025837 (G.A.-J. and S.P.W.), R01 DA013951 (J.J.W.), R37 DA006214 and P50 DA015369 (G.A.-J.). This project was supported by the National Center for Research Resources and the Office of the Director of the National Institutes of Health through grant number C06 RR015455.	[Anonymous], [No title captured]; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Beckley JT, 2013, J NEUROSCI, V33, P804, DOI 10.1523/JNEUROSCI.3729-12.2013; Bengtson CP, 2000, J NEUROPHYSIOL, V83, P2649, DOI 10.1152/jn.2000.83.5.2649; Calder AJ, 2007, EUR J NEUROSCI, V25, P3422, DOI 10.1111/j.1460-9568.2007.05604.x; Childress AR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001506; CHURCHILL L, 1994, J COMP NEUROL, V345, P579, DOI 10.1002/cne.903450408; Colussi-Mas J, 2007, EUR J NEUROSCI, V26, P1011, DOI 10.1111/j.1460-9568.2007.05738.x; Farrar AM, 2008, NEUROSCIENCE, V152, P321, DOI 10.1016/j.neuroscience.2007.12.034; Ferguson SM, 2012, NEUROPSYCHOPHARMACOL, V37, P296, DOI 10.1038/npp.2011.179; Fields HL, 2007, ANNU REV NEUROSCI, V30, P289, DOI 10.1146/annurev.neuro.30.051606.094341; Floresco SB, 2003, NAT NEUROSCI, V6, P968, DOI 10.1038/nn1103; Geisler S, 2008, NEUROPSYCHOPHARMACOL, V33, P2688, DOI 10.1038/sj.npp.1301650; Geisler S, 2007, J NEUROSCI, V27, P5730, DOI 10.1523/JNEUROSCI.0012-07.2007; Grace AA, 2007, TRENDS NEUROSCI, V30, P220, DOI 10.1016/j.tins.2007.03.003; HABER SN, 1983, NEUROSCIENCE, V9, P245, DOI 10.1016/0306-4522(83)90291-9; HEIMER L, 1991, NEUROSCIENCE, V41, P89, DOI 10.1016/0306-4522(91)90202-Y; Hjelmstad GO, 2013, J NEUROSCI, V33, P6454, DOI 10.1523/JNEUROSCI.0178-13.2013; Ikemoto S, 2007, BRAIN RES REV, V56, P27, DOI 10.1016/j.brainresrev.2007.05.004; JOHNSON PI, 1993, NEUROPHARMACOLOGY, V32, P1305, DOI 10.1016/0028-3908(93)90025-X; KALIVAS PW, 1993, NEUROSCIENCE, V57, P1047, DOI 10.1016/0306-4522(93)90048-K; Kupchik YM, 2013, BRAIN STRUCT FUNCT, V218, P1487, DOI 10.1007/s00429-012-0471-9; Lammel S, 2008, NEURON, V57, P760, DOI 10.1016/j.neuron.2008.01.022; Leung BK, 2013, J NEUROSCI, V33, P13848, DOI 10.1523/JNEUROSCI.1697-13.2013; Luo AH, 2008, EUR J NEUROSCI, V27, P408, DOI 10.1111/j.1460-9568.2007.05985.x; Mahler SV, 2012, J NEUROSCI, V32, P13309, DOI 10.1523/JNEUROSCI.2277-12.2012; McBride WJ, 1999, BEHAV BRAIN RES, V101, P129, DOI 10.1016/S0166-4328(99)00022-4; McFarland K, 2004, J NEUROSCI, V24, P1551, DOI 10.1523/JNEUROSCI.4177-03.2004; McFarland K, 2001, J NEUROSCI, V21, P8655; Morales M, 2012, ANN NY ACAD SCI, V1248, P71, DOI 10.1111/j.1749-6632.2011.06299.x; PANAGIS G, 1995, BEHAV BRAIN RES, V68, P165, DOI 10.1016/0166-4328(94)00169-G; Paxinos G., 2006, RAT BRAIN STEREOTAXI; Robinson MJF, 2013, CURR BIOL, V23, P282, DOI 10.1016/j.cub.2013.01.016; Robinson TE, 2003, ANNU REV PSYCHOL, V54, P25, DOI 10.1146/annurev.psych.54.101601.145237; ROBLEDO P, 1993, BEHAV BRAIN RES, V55, P159, DOI 10.1016/0166-4328(93)90112-4; Root DH, 2013, J COMP NEUROL, V521, P558, DOI 10.1002/cne.23191; Smith KS, 2005, J NEUROSCI, V25, P8637, DOI 10.1523/JNEUROSCI.1902-05.2005; Smith KS, 2009, BEHAV BRAIN RES, V196, P155, DOI 10.1016/j.bbr.2008.09.038; Stamatakis AM, 2013, NEURON, V80, P1039, DOI 10.1016/j.neuron.2013.08.023; Tachibana Y, 2012, NEURON, V76, P826, DOI 10.1016/j.neuron.2012.09.030; Tindell AJ, 2004, J NEUROSCI, V24, P1058, DOI 10.1523/JNEUROSCI.1437-03.2004; Tripathi A, 2013, BRAIN STRUCT FUNCT, V218, P1133, DOI 10.1007/s00429-012-0451-0; Ungless MA, 2012, TRENDS NEUROSCI, V35, P422, DOI 10.1016/j.tins.2012.02.003; van Zessen R, 2012, NEURON, V73, P1184, DOI 10.1016/j.neuron.2012.02.016; Witten IB, 2011, NEURON, V72, P721, DOI 10.1016/j.neuron.2011.10.028; YANG CR, 1989, BRAIN RES, V489, P237, DOI 10.1016/0006-8993(89)90856-1; ZAHM DS, 1990, J COMP NEUROL, V302, P437, DOI 10.1002/cne.903020302; ZAHM DS, 1988, J COMP NEUROL, V272, P516, DOI 10.1002/cne.902720406; Zahm DS, 1998, CRIT REV NEUROBIOL, V12, P245, DOI 10.1615/CritRevNeurobiol.v12.i3.50; Zahm DS, 1996, J COMP NEUROL, V364, P340, DOI 10.1002/(SICI)1096-9861(19960108)364:2<340::AID-CNE11>3.0.CO;2-T	50	233	234	3	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2014	17	4					577	U136		10.1038/nn.3664	http://dx.doi.org/10.1038/nn.3664			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AD6XR	24584054	Green Submitted, Green Accepted			2022-12-17	WOS:000333405300018
J	Jossin, Y; Cooper, JA				Jossin, Yves; Cooper, Jonathan A.			Reelin, Rap1 and N-cadherin orient the migration of multipolar neurons in the developing neocortex	NATURE NEUROSCIENCE			English	Article							CELL-CELL ADHESION; CEREBRAL-CORTEX; CORTICAL-NEURONS; RADIAL MIGRATION; INTERCELLULAR-JUNCTIONS; LAMINAR ORGANIZATION; SMALL GTPASES; MOUSE-BRAIN; ACTIVATION; POLARITY	Projection neurons migrate from the ventricular zone to the neocortical plate during the development of the mouse brain. Their overall movement is radial, but they become multipolar and move nonradially in the intermediate zone. Here we show that Reelin, the Rap1 GTPase and N-cadherin (NCad) are important for multipolar neurons to polarize their migration toward the cortical plate. Inhibition and rescue experiments indicated that Reelin regulates migration through Rap1 and Akt, and that the Rap1-regulated GTPases RalA, RalB, Rac1 and Cdc42 are also involved. We found that Rap1 regulated the plasma membrane localization of NCad and NCad rescued radial polarization when Rap1 was inhibited. However, inhibition of Rap1 or NCad had little effect on glia-dependent locomotion. We propose a multistep mechanism in which Reelin activates Rap1, Rap1 upregulates NCad, and NCad is needed to orient cell migration.	[Jossin, Yves; Cooper, Jonathan A.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98104 USA	Fred Hutchinson Cancer Center	Jossin, Y (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1124 Columbia St, Seattle, WA 98104 USA.	yves.jossin@uclouvain.be; jcooper@fhcrc.org	Roussel, Nathalie A/A-1267-2012; cagnie, barbara/D-9830-2017; Kregel, Jeroen/J-7849-2015	Roussel, Nathalie A/0000-0002-7409-878X; cagnie, barbara/0000-0003-4342-4519; Kregel, Jeroen/0000-0002-5692-1461; Jossin, Yves/0000-0001-8466-7432	Fonds National de la Recherche Scientifique, Belgium; European Commission through the Universite Catholique de Louvain; National Institutes of Health [CA41072]; NATIONAL CANCER INSTITUTE [R37CA041072, R01CA041072] Funding Source: NIH RePORTER	Fonds National de la Recherche Scientifique, Belgium(Fonds de la Recherche Scientifique - FNRS); European Commission through the Universite Catholique de Louvain; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank L. Buck for the use of her confocal microscope, W. Arthur, R. Hevner, F. Polleux, K. Sanada, L.-H. Tsai, V. Vasioukhin, A. Puschel, Y. Gotoh, P. Phelps and M. White for reagents, J. Wang and E. Jhingan for technical assistance, A. Goffinet and F. Polleux for helpful discussions, and V. Vasioukhin, S. Parkhurst, B. Edgar and S. Simo for comments on the manuscript. This work was supported by the Fonds National de la Recherche Scientifique, Belgium (Y.J.), the European Commission under the Marie Curie International Outgoing Fellowship Program through the Universite Catholique de Louvain (Y.J.) and National Institutes of Health grant CA41072 (J.A.C.).	Arnaud L, 2003, MOL CELL BIOL, V23, P9293, DOI 10.1128/MCB.23.24.9293-9302.2003; Arthur WT, 2004, J CELL BIOL, V167, P111, DOI 10.1083/jcb.200404068; Ballif BA, 2004, CURR BIOL, V14, P606, DOI 10.1016/j.cub.2004.03.038; Beffert U, 2002, J BIOL CHEM, V277, P49958, DOI 10.1074/jbc.M209205200; Belvindrah R, 2007, J NEUROSCI, V27, P13854, DOI 10.1523/JNEUROSCI.4494-07.2007; Bielas S, 2004, ANNU REV CELL DEV BI, V20, P593, DOI 10.1146/annurev.cellbio.20.082503.103047; Bivona TG, 2004, J CELL BIOL, V164, P461, DOI 10.1083/jcb.200311093; Boettner B, 2009, CURR OPIN CELL BIOL, V21, P684, DOI 10.1016/j.ceb.2009.06.004; Chen G, 2008, NAT NEUROSCI, V11, P36, DOI 10.1038/nn2018; Chen XY, 2003, J CELL BIOL, V163, P547, DOI 10.1083/jcb.200305137; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; de Anda FC, 2010, J NEUROSCI, V30, P10391, DOI 10.1523/JNEUROSCI.0381-10.2010; Elias LAB, 2007, NATURE, V448, P901, DOI 10.1038/nature06063; Franco SJ, 2011, NEURON, V69, P482, DOI 10.1016/j.neuron.2011.01.003; Fulga TA, 2002, NAT CELL BIOL, V4, P715, DOI 10.1038/ncb848; GOFFINET AM, 1979, ANAT EMBRYOL, V157, P205, DOI 10.1007/BF00305160; Grindstaff KK, 1998, CELL, V93, P731, DOI 10.1016/S0092-8674(00)81435-X; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Jossin Y, 2003, J NEUROSCI, V23, P9953; Jossin Y, 2004, MOL NEUROBIOL, V30, P225, DOI 10.1385/MN:30:3:225; Jossin Y, 2007, MOL CELL BIOL, V27, P7113, DOI 10.1128/MCB.00928-07; Jossin Y, 2007, J NEUROSCI, V27, P4243, DOI 10.1523/JNEUROSCI.0023-07.2007; Kadowaki M, 2007, DEV BIOL, V304, P22, DOI 10.1016/j.ydbio.2006.12.014; Kawauchi T, 2010, NEURON, V67, P588, DOI 10.1016/j.neuron.2010.07.007; Kooistra MRH, 2007, J CELL SCI, V120, P17, DOI 10.1242/jcs.03306; Kuroda S, 1998, SCIENCE, V281, P832, DOI 10.1126/science.281.5378.832; Liu C, 2008, MOL CELL BIOL, V28, P7109, DOI 10.1128/MCB.01060-08; Morimura T, 2009, BRAIN RES, V1304, P26, DOI 10.1016/j.brainres.2009.09.087; Moskalenko S, 2002, NAT CELL BIOL, V4, P66, DOI 10.1038/ncb728; Nadarajah B, 2001, NAT NEUROSCI, V4, P143, DOI 10.1038/83967; Nelson WJ, 2008, BIOCHEM SOC T, V36, P149, DOI 10.1042/BST0360149; Nichols AJ, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-50; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; OGAWA M, 1995, NEURON, V14, P899, DOI 10.1016/0896-6273(95)90329-1; Park HO, 2007, MICROBIOL MOL BIOL R, V71, P48, DOI 10.1128/MMBR.00028-06; Qin Y, 2005, J CELL BIOL, V171, P1061, DOI 10.1083/jcb.200506094; Rice DS, 1998, DEVELOPMENT, V125, P3719; Rieger S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000240; RUBINFELD B, 1991, CELL, V65, P1033, DOI 10.1016/0092-8674(91)90555-D; Schwamborn JC, 2004, NAT NEUROSCI, V7, P923, DOI 10.1038/nn1295; Simo S, 2010, J NEUROSCI, V30, P5668, DOI 10.1523/JNEUROSCI.0035-10.2010; Tabata H, 2003, J NEUROSCI, V23, P9996; Tabata H, 2001, NEUROSCIENCE, V103, P865, DOI 10.1016/S0306-4522(01)00016-1; Takai Y, 2003, J CELL SCI, V116, P17, DOI 10.1242/jcs.00167; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; Taniguchi H, 2006, DEVELOPMENT, V133, P1923, DOI 10.1242/dev.02354; Tsai JW, 2005, J CELL BIOL, V170, P935, DOI 10.1083/jcb.200505166; Uchida T, 2009, J NEUROSCI, V29, P10653, DOI 10.1523/JNEUROSCI.0345-09.2009; Yang XS, 2008, DEVELOPMENT, V135, P3521, DOI 10.1242/dev.023416; Zhang JN, 2010, DEV CELL, V18, P472, DOI 10.1016/j.devcel.2009.12.025	50	233	241	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2011	14	6					697	U289		10.1038/nn.2816	http://dx.doi.org/10.1038/nn.2816			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	768SH	21516100	Green Accepted			2022-12-17	WOS:000290958000011
J	Yashiro, K; Riday, TT; Condon, KH; Roberts, AC; Bernardo, DR; Prakash, R; Weinberg, RJ; Ehlers, MD; Philpot, BD				Yashiro, Koji; Riday, Thorfinn T.; Condon, Kathryn H.; Roberts, Adam C.; Bernardo, Danilo R.; Prakash, Rohit; Weinberg, Richard J.; Ehlers, Michael D.; Philpot, Benjamin D.			Ube3a is required for experience-dependent maturation of the neocortex	NATURE NEUROSCIENCE			English	Article							MOUSE VISUAL-CORTEX; LONG-TERM POTENTIATION; ANGELMAN SYNDROME GENE; SYNAPTIC PLASTICITY; MUTANT MICE; UBIQUITIN LIGASE; DIFFERENT LAYERS; KINASE-II; PROTEIN; DEPRIVATION	Experience-dependent maturation of neocortical circuits is required for normal sensory and cognitive abilities, which are distorted in neurodevelopmental disorders. We tested whether experience-dependent neocortical modifications require Ube3a, an E3 ubiquitin ligase whose dysregulation has been implicated in autism and Angelman syndrome. Using visual cortex as a model, we found that experience-dependent maturation of excitatory cortical circuits was severely impaired in Angelman syndrome model mice deficient in Ube3a. This developmental defect was associated with profound impairments in neocortical plasticity. Normal plasticity was preserved under conditions of sensory deprivation, but was rapidly lost by sensory experiences. The loss of neocortical plasticity is reversible, as late-onset visual deprivation restored normal synaptic plasticity. Furthermore, Ube3a-deficient mice lacked ocular dominance plasticity in vivo when challenged with monocular deprivation. We conclude that Ube3a is necessary for maintaining plasticity during experience-dependent neocortical development and suggest that the loss of neocortical plasticity contributes to deficits associated with Angelman syndrome.	[Condon, Kathryn H.; Ehlers, Michael D.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Yashiro, Koji; Riday, Thorfinn T.; Roberts, Adam C.; Bernardo, Danilo R.; Prakash, Rohit; Philpot, Benjamin D.] Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC USA; [Riday, Thorfinn T.; Philpot, Benjamin D.] Univ N Carolina, Curriculum Neurobiol, Chapel Hill, NC USA; [Roberts, Adam C.; Weinberg, Richard J.; Philpot, Benjamin D.] Univ N Carolina, Ctr Neurosci, Chapel Hill, NC USA; [Roberts, Adam C.; Philpot, Benjamin D.] Univ N Carolina, Neurodev Disorders Res Ctr, Chapel Hill, NC USA; [Weinberg, Richard J.] Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC USA; [Ehlers, Michael D.] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA	Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Duke University; Howard Hughes Medical Institute	Ehlers, MD (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.	ehlers@neuro.duke.edu; bphilpot@med.unc.edu	Weinberg, Richard/AAC-1898-2020; , Histology Research Core Facility/ABF-6317-2021; , UNC Neuroscience Microscopy Core/AAE-8305-2022	Roberts, Adam/0000-0001-8596-8552; Weinberg, Richard/0000-0001-9689-7278	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD040127] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY018323] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039402, R01NS035527] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024492] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NEI NIH HHS [R01 EY018323, R01 EY018323-02, R01EY018323] Funding Source: Medline; NIA NIH HHS [R01 AG024492, R01 AG024492-05, AG024492] Funding Source: Medline; NICHD NIH HHS [T32-HD40127, T32 HD040127, T32 HD040127-09] Funding Source: Medline; NINDS NIH HHS [R01 NS035527, R01 NS039402, NS039402, NS035527, R01 NS039402-10, R01 NS035527-09] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Albrecht U, 1997, NAT GENET, V17, P75, DOI 10.1038/ng0997-75; Clayton-Smith J, 2003, J MED GENET, V40, P87, DOI 10.1136/jmg.40.2.87; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; Crozier RA, 2007, P NATL ACAD SCI USA, V104, P1383, DOI 10.1073/pnas.0609596104; Desai NS, 2002, NAT NEUROSCI, V5, P783, DOI 10.1038/nn878; Dindot SV, 2008, HUM MOL GENET, V17, P111, DOI 10.1093/hmg/ddm288; Fagiolini M, 2003, P NATL ACAD SCI USA, V100, P2854, DOI 10.1073/pnas.0536089100; Fonseca R, 2006, NEURON, V52, P239, DOI 10.1016/j.neuron.2006.08.015; Frankland PW, 2001, NATURE, V411, P309, DOI 10.1038/35077089; GATENBY J, 1950, MICROSCOPISTS VADE M; Gianfranceschi L, 2003, P NATL ACAD SCI USA, V100, P12486, DOI 10.1073/pnas.1934836100; Goel A, 2007, J NEUROSCI, V27, P6692, DOI 10.1523/JNEUROSCI.5038-06.2007; Gordon JA, 1996, J NEUROSCI, V16, P3274; He HY, 2006, J NEUROSCI, V26, P2951, DOI 10.1523/JNEUROSCI.5554-05.2006; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Heynen AJ, 2003, NAT NEUROSCI, V6, P854, DOI 10.1038/nn1100; JAY V, 1991, NEUROLOGY, V41, P416, DOI 10.1212/WNL.41.3.416; Jiang B, 2007, J NEUROSCI, V27, P9648, DOI 10.1523/JNEUROSCI.2655-07.2007; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Jordan C, 2006, HUM MOL GENET, V15, P2210, DOI 10.1093/hmg/ddl146; Kirkwood A, 1997, P NATL ACAD SCI USA, V94, P3380, DOI 10.1073/pnas.94.7.3380; Kirkwood A, 1996, NATURE, V381, P526, DOI 10.1038/381526a0; Li Y, 2006, NAT NEUROSCI, V9, P676, DOI 10.1038/nn1684; Majdan M, 2006, NAT NEUROSCI, V9, P650, DOI 10.1038/nn1674; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Philpot BD, 2001, NEURON, V29, P157, DOI 10.1016/S0896-6273(01)00187-8; Philpot BD, 2007, NEURON, V53, P495, DOI 10.1016/j.neuron.2007.01.027; Rougeulle C, 1997, NAT GENET, V17, P14, DOI 10.1038/ng0997-14; Schroer RJ, 1998, AM J MED GENET, V76, P327, DOI 10.1002/(SICI)1096-8628(19980401)76:4<327::AID-AJMG8>3.0.CO;2-M; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; Thompson DA, 1999, DEV MED CHILD NEUROL, V41, P633, DOI 10.1017/S0012162299001292; TORII N, 1995, NEUROSCI LETT, V185, P1, DOI 10.1016/0304-3940(94)11210-A; Tropea D, 2006, NAT NEUROSCI, V9, P660, DOI 10.1038/nn1689; Van Splunder J, 2003, EUR J OPHTHALMOL, V13, P566, DOI 10.1177/112067210301300610; van Woerden GM, 2007, NAT NEUROSCI, V10, P280, DOI 10.1038/nn1845; Vu TH, 1997, NAT GENET, V17, P12, DOI 10.1038/ng0997-12; Wallace W, 2004, J NEUROSCI, V24, P6928, DOI 10.1523/JNEUROSCI.1110-04.2004; Walz NC, 2006, AM J OCCUP THER, V60, P472, DOI 10.5014/ajot.60.4.472; Weeber EJ, 2003, J NEUROSCI, V23, P2634; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; Williams CA, 2006, AM J MED GENET A, V140A, P413, DOI 10.1002/ajmg.a.31074; Xia ZG, 2005, NAT REV NEUROSCI, V6, P267, DOI 10.1038/nrn1647; Yasuda H, 2003, NAT NEUROSCI, V6, P15, DOI 10.1038/nn985; Yi JJ, 2007, PHARMACOL REV, V59, P14, DOI 10.1124/pr.59.1.4; Yi JJ, 2005, NEURON, V47, P629, DOI 10.1016/j.neuron.2005.07.008; Zoghbi HY, 2003, SCIENCE, V302, P826, DOI 10.1126/science.1089071	48	233	242	1	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2009	12	6					777	U132		10.1038/nn.2327	http://dx.doi.org/10.1038/nn.2327			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	450DJ	19430469	Green Accepted, Green Submitted			2022-12-17	WOS:000266380900022
J	Hanks, TD; Ditterich, J; Shadlen, MN				Hanks, TD; Ditterich, J; Shadlen, MN			Microstimulation of macaque area LIP affects decision-making in a motion discrimination task	NATURE NEUROSCIENCE			English	Article							LATERAL INTRAPARIETAL AREA; POSTERIOR PARIETAL CORTEX; PERCEPTION FOLLOWING LESIONS; SACCADIC EYE-MOVEMENTS; SUPERIOR COLLICULUS; ELECTRICAL-STIMULATION; TARGET SELECTION; RESPONSE-TIMES; VISUAL-MOTION; MONKEY	A central goal of cognitive neuroscience is to elucidate the neural mechanisms underlying decision-making. Recent physiological studies suggest that neurons in association areas may be involved in this process. To test this, we measured the effects of electrical microstimulation in the lateral intraparietal area ( LIP) while monkeys performed a reaction-time motion discrimination task with a saccadic response. In each experiment, we identified a cluster of LIP cells with overlapping response fields (RFs) and sustained activity during memory-guided saccades. Microstimulation of this cluster caused an increase in the proportion of choices toward the RF of the stimulated neurons. Choices toward the stimulated RF were faster with microstimulation, while choices in the opposite direction were slower. Microstimulation never directly evoked saccades, nor did it change reaction times in a simple saccade task. These results demonstrate that the discharge of LIP neurons is causally related to decision formation in the discrimination task.	Univ Washington, Howard Hughes Med Inst, Natl Primate Res Ctr, Seattle, WA 98195 USA; Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California Davis	Shadlen, MN (corresponding author), Univ Washington, Howard Hughes Med Inst, Natl Primate Res Ctr, Seattle, WA 98195 USA.	shadlen@u.washington.edu	Shadlen, Michael Neil/AAL-1870-2020	Shadlen, Michael/0000-0002-2002-2210	Howard Hughes Medical Institute Funding Source: Medline; NCRR NIH HHS [P51 RR000166, P51 RR000166-390015] Funding Source: Medline; NEI NIH HHS [R01 EY011378, R01 EY011378-11A1] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000166] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011378] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Andersen RA, 2002, ANNU REV NEUROSCI, V25, P189, DOI 10.1146/annurev.neuro.25.112701.142922; Bisley JW, 2003, SCIENCE, V299, P81, DOI 10.1126/science.1077395; Bisley JW, 2001, J NEUROPHYSIOL, V85, P187, DOI 10.1152/jn.2001.85.1.187; Born RT, 2005, ANNU REV NEUROSCI, V28, P157, DOI 10.1146/annurev.neuro.26.041002.131052; Brainard D. H., 1997, SPATIAL VISION, V10, P443, DOI DOI 10.1163/156856897X00357; BRITTEN KH, 1993, VISUAL NEUROSCI, V10, P1157, DOI 10.1017/S0952523800010269; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Burman DD, 1997, J NEUROPHYSIOL, V77, P2252, DOI 10.1152/jn.1997.77.5.2252; Butovas S, 2003, J NEUROPHYSIOL, V90, P3024, DOI 10.1152/jn.00245.2003; Carello CD, 2004, NEURON, V43, P575, DOI 10.1016/j.neuron.2004.07.026; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; de Lafuente V, 2005, NAT NEUROSCI, V8, P1698, DOI 10.1038/nn1587; Ditterich J, 2003, NAT NEUROSCI, V6, P891, DOI 10.1038/nn1094; Eskandar EN, 1999, NAT NEUROSCI, V2, P88, DOI 10.1038/4594; Glimcher PW, 2003, ANNU REV NEUROSCI, V26, P133, DOI 10.1146/annurev.neuro.26.010302.081134; Gold JI, 2003, J NEUROSCI, V23, P632, DOI 10.1523/JNEUROSCI.23-02-00632.2003; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; Gottlieb J, 1999, NAT NEUROSCI, V2, P906, DOI 10.1038/13209; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; Holmes P, 2005, IEICE T FUND ELECTR, VE88A, P2496, DOI [10.1093/ietfec/e88-a.10.2496, 10.1093/ietfec/e88.a.10.2496]; Horwitz GD, 2001, J NEUROPHYSIOL, V86, P2543, DOI 10.1152/jn.2001.86.5.2543; Huk AC, 2005, J NEUROSCI, V25, P10420, DOI 10.1523/JNEUROSCI.4684-04.2005; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; Leon MI, 2003, NEURON, V38, P317, DOI 10.1016/S0896-6273(03)00185-5; Lewis JW, 2000, J COMP NEUROL, V428, P112, DOI 10.1002/1096-9861(20001204)428:1<112::AID-CNE8>3.0.CO;2-9; Link SW, 1992, WAVE THEORY DIFFEREN; Mazurek ME, 2003, CEREB CORTEX, V13, P1257, DOI 10.1093/cercor/bhg097; NEWSOME WT, 1988, J NEUROSCI, V8, P2201; Opris I, 2005, VISION RES, V45, P3414, DOI 10.1016/j.visres.2005.03.014; Palmer J, 2005, J VISION, V5, P376, DOI 10.1167/5.5.1; Pare M, 2001, J NEUROPHYSIOL, V85, P2545, DOI 10.1152/jn.2001.85.6.2545; PASTERNAK T, 1994, CEREB CORTEX, V4, P247, DOI 10.1093/cercor/4.3.247; Platt ML, 1997, J NEUROPHYSIOL, V78, P1574, DOI 10.1152/jn.1997.78.3.1574; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Press W. H., 1988, NUMERICAL RECIPES C, P735; Ratcliff R, 2004, PSYCHOL REV, V111, P333, DOI 10.1037/0033-295X.111.2.333; Ratcliff R, 1998, PSYCHOL SCI, V9, P347, DOI 10.1111/1467-9280.00067; Roitman JD, 2002, J NEUROSCI, V22, P9475; Romo R, 2003, NAT REV NEUROSCI, V4, P203, DOI 10.1038/nrn1058; Romo R, 2004, NEURON, V41, P165, DOI 10.1016/S0896-6273(03)00817-1; SALZMAN CD, 1992, J NEUROSCI, V12, P2331; Schall JD, 1999, ANNU REV NEUROSCI, V22, P241, DOI 10.1146/annurev.neuro.22.1.241; Schiller PH, 2001, PROG BRAIN RES, V134, P127; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; SMITH PL, 1990, J MATH PSYCHOL, V34, P445, DOI 10.1016/0022-2496(90)90023-3; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Tehovnik EJ, 1996, J NEUROSCI METH, V65, P1, DOI 10.1016/0165-0270(95)00131-X; Thier P, 1998, J NEUROPHYSIOL, V80, P1713, DOI 10.1152/jn.1998.80.4.1713; Van Essen DC, 2001, J AM MED INFORM ASSN, V8, P443, DOI 10.1136/jamia.2001.0080443; Wardak C, 2004, NEURON, V42, P501, DOI 10.1016/S0896-6273(04)00185-0	50	233	235	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2006	9	5					682	689		10.1038/nn1683	http://dx.doi.org/10.1038/nn1683			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	040YI	16604069	Green Accepted			2022-12-17	WOS:000237417200020
J	Govek, EE; Newey, SE; Akerman, CJ; Cross, JR; Van der Veken, L; Van Aelst, L				Govek, EE; Newey, SE; Akerman, CJ; Cross, JR; Van der Veken, L; Van Aelst, L			The X-linked mental retardation protein oligophrenin-1 is required for dendritic spine morphogenesis	NATURE NEUROSCIENCE			English	Article							RHO-ASSOCIATED KINASE; CEREBELLAR HYPOPLASIA; SYNAPTIC PLASTICITY; SMALL GTPASES; MORPHOLOGY; RECEPTOR; CALCIUM; ACTIN; HOMER; COMPLEX	Of 11 genes involved in nonspecific X-linked mental retardation (MRX), three encode regulators or effectors of the Rho GTPases, suggesting an important role for Rho signaling in cognitive function. It remains unknown, however, how mutations in Rho-linked genes lead to MRX. Here we report that oligophrenin-1, a Rho-GTPase activating protein that is absent in a family affected with MRX, is required for dendritic spine morphogenesis. Using RNA interference and antisense RNA approaches, we show that knock-down of oligophrenin-1 levels in CA1 neurons in rat hippocampal slices significantly decreases spine length. This phenotype can be recapitulated using an activated form of RhoA and rescued by inhibiting Rho-kinase, indicating that reduced oligophrenin-1 levels affect spine length by increasing RhoA and Rho-kinase activities. We further demonstrate an interaction between oligophrenin-1 and the postsynaptic adaptor protein Homer. Our findings provide the first insight into how mutations in a Rho-linked MRX gene may compromise neuronal function.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; SUNY Stony Brook, Mol & Cellular Biol Program, Stony Brook, NY 11794 USA	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Van Aelst, L (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	vanaelst@cshl.org		Cross, Justin/0000-0002-6356-057X				Ackermann M, 2003, NAT NEUROSCI, V6, P1194, DOI 10.1038/nn1135; Allen KM, 1998, NAT GENET, V20, P25, DOI 10.1038/1675; Amano M, 2000, EXP CELL RES, V261, P44, DOI 10.1006/excr.2000.5046; Beneken J, 2000, NEURON, V26, P143, DOI 10.1016/S0896-6273(00)81145-9; Bergmann C, 2003, BRAIN, V126, P1537, DOI 10.1093/brain/awg173; Billuart P, 2001, CELL, V107, P195, DOI 10.1016/S0092-8674(01)00522-0; Billuart P, 1998, NATURE, V392, P923, DOI 10.1038/31940; Chelly J, 2001, NAT REV GENET, V2, P669, DOI 10.1038/35088558; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Comery TA, 1997, P NATL ACAD SCI USA, V94, P5401, DOI 10.1073/pnas.94.10.5401; Comery TA, 1996, NEUROBIOL LEARN MEM, V66, P93, DOI 10.1006/nlme.1996.0049; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; FAGNI L, 2002, SCI STKE, V137, P1; Fauchereau F, 2003, MOL CELL NEUROSCI, V23, P574, DOI 10.1016/S1044-7431(03)00078-2; Fiala JC, 2002, BRAIN RES REV, V39, P29, DOI 10.1016/S0165-0173(02)00158-3; Fischer M, 2000, NAT NEUROSCI, V3, P887, DOI 10.1038/78791; Frints SGM, 2002, CLIN GENET, V62, P423, DOI 10.1034/j.1399-0004.2002.620601.x; Harris KM, 1999, CURR OPIN NEUROBIOL, V9, P343, DOI 10.1016/S0959-4388(99)80050-6; Hayashi K, 1996, J NEUROSCI, V16, P7161; Hering H, 2001, NAT REV NEUROSCI, V2, P880, DOI 10.1038/35104061; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Joneson T, 1996, SCIENCE, V274, P1374, DOI 10.1126/science.274.5291.1374; Kaufmann WE, 2000, CEREB CORTEX, V10, P981, DOI 10.1093/cercor/10.10.981; Korkotian E, 1999, P NATL ACAD SCI USA, V96, P12068, DOI 10.1073/pnas.96.21.12068; Kutsche K, 2000, NAT GENET, V26, P247, DOI 10.1038/80002; Lau LF, 1996, J BIOL CHEM, V271, P21622, DOI 10.1074/jbc.271.35.21622; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Majewska A, 2000, J NEUROSCI, V20, P8262, DOI 10.1523/JNEUROSCI.20-22-08262.2000; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Nimchinsky EA, 2001, J NEUROSCI, V21, P5139, DOI 10.1523/JNEUROSCI.21-14-05139.2001; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; Philip N, 2003, J MED GENET, V40, P441, DOI 10.1136/jmg.40.6.441; PURPURA DP, 1974, SCIENCE, V186, P1126, DOI 10.1126/science.186.4169.1126; Ramakers GJA, 2002, TRENDS NEUROSCI, V25, P191, DOI 10.1016/S0166-2236(00)02118-4; Sala C, 2003, J NEUROSCI, V23, P6327; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Sin WC, 2002, NATURE, V419, P475, DOI 10.1038/nature00987; Star EN, 2002, NAT NEUROSCI, V5, P239, DOI 10.1038/nn811; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Tashiro A, 2000, CEREB CORTEX, V10, P927, DOI 10.1093/cercor/10.10.927; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; VAN AL, 1997, GENE DEV, V11, P2295; Xiao B, 2000, CURR OPIN NEUROBIOL, V10, P370, DOI 10.1016/S0959-4388(00)00087-8; Yamaguchi Y, 2001, J BIOL CHEM, V276, P18977, DOI 10.1074/jbc.M100254200; Yuan JP, 2003, CELL, V114, P777, DOI 10.1016/S0092-8674(03)00716-5; Yuste R, 2000, NAT NEUROSCI, V3, P653, DOI 10.1038/76609	50	233	244	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2004	7	4					364	372		10.1038/nn1210	http://dx.doi.org/10.1038/nn1210			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	807DP	15034583				2022-12-17	WOS:000220482500015
J	Bhave, G; Karim, F; Carlton, SM; Gereau, RW				Bhave, G; Karim, F; Carlton, SM; Gereau, RW			Peripheral group I metabotropic glutamate receptors modulate nociception in mice	NATURE NEUROSCIENCE			English	Article							RAT SPINAL-CORD; FORMALIN TEST; PAIN RESPONSE; HYPERALGESIA; AXONS; NEURONS; RELEASE; NMDA; LOCALIZATION; INFLAMMATION	The metabotropic glutamate receptors (mGluRs) are found throughout the central nervous system, where they modulate neuronal excitability and synaptic transmission. Here we report the presence of phospholipase C-coupled group I mGluRs (mGluR1 and mGluR5) outside the central nervous system on peripheral unmyelinated sensory afferents. Given their localization on predominantly nociceptive afferents, we investigated whether these receptors modulate nociceptive signaling, and found that agonist-induced activation of peripheral group I mGluRs leads to increased sensitivity to noxious heat, a phenomenon termed thermal hyperalgesia. Furthermore, group I mGluR antagonists not only prevent, but also attenuate established formalin-induced pain. Taken together, these results suggest that peripheral mGluRs mediate a component of hyperalgesia and may be therapeutically targeted to prevent and treat inflammatory pain.	Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA; Inst Marine Biomed, Dept Anat & Neurosci, Galveston, TX 77555 USA	Baylor College of Medicine; University of Texas System; University of Texas Medical Branch Galveston	Gereau, RW (corresponding author), Baylor Coll Med, Div Neurosci, 1 Baylor Plaza,Room S636, Houston, TX 77030 USA.				NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060230] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS027910, R01NS027910, P01NS011255] Funding Source: NIH RePORTER; NIMH NIH HHS [MH60230] Funding Source: Medline; NINDS NIH HHS [NS27910, NS11255] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABBOTT FV, 1995, PAIN, V60, P91, DOI 10.1016/0304-3959(94)00095-V; Annoura H, 1996, BIOORG MED CHEM LETT, V6, P763, DOI 10.1016/0960-894X(96)00104-7; BAKER SR, 1995, BIOORG MED CHEM LETT, V5, P223; Carlton SM, 1998, NEUROSCIENCE, V83, P601, DOI 10.1016/S0306-4522(97)00406-5; Carlton SM, 1998, BRAIN RES, V790, P160, DOI 10.1016/S0006-8993(97)01471-6; CARLTON SM, 1995, NEUROSCI LETT, V197, P25, DOI 10.1016/0304-3940(95)11889-5; Clark BP, 1997, BIOORG MED CHEM LETT, V7, P2777, DOI 10.1016/S0960-894X(97)10071-3; CODERRE TJ, 1990, BRAIN RES, V535, P155, DOI 10.1016/0006-8993(90)91835-5; Coggeshall RE, 1997, BRAIN RES, V764, P126, DOI 10.1016/S0006-8993(97)00446-0; Coggeshall RE, 1998, J COMP NEUROL, V391, P78; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Contractor A, 1998, P NATL ACAD SCI USA, V95, P8969, DOI 10.1073/pnas.95.15.8969; Crawford JH, 2000, NEUROPHARMACOLOGY, V39, P621, DOI 10.1016/S0028-3908(99)00167-7; Davidson EM, 1997, NEUROREPORT, V8, P941, DOI 10.1097/00001756-199703030-00025; de Groot J, 2000, NEUROREPORT, V11, P497, DOI 10.1097/00001756-200002280-00014; Fisher K, 1998, PAIN, V77, P59, DOI 10.1016/S0304-3959(98)00082-7; Fisher K, 1998, NEUROREPORT, V9, P1169, DOI 10.1097/00001756-199804200-00038; Fisher K, 1996, NEUROREPORT, V7, P2743, DOI 10.1097/00001756-199611040-00067; Fisher K, 1996, PAIN, V68, P255, DOI 10.1016/S0304-3959(96)03212-5; Gasparini F, 1999, NEUROPHARMACOLOGY, V38, P1493, DOI 10.1016/S0028-3908(99)00082-9; GEREAU RW, 1995, J NEUROPHYSIOL, V74, P122, DOI 10.1152/jn.1995.74.1.122; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; JACKSON DL, 1995, EUR J PHARMACOL, V284, P321, DOI 10.1016/0014-2999(95)00449-U; Jia H, 1999, J COMP NEUROL, V410, P627; Lawand NB, 2000, PAIN, V86, P69, DOI 10.1016/S0304-3959(99)00311-5; Litschig S, 1999, MOL PHARMACOL, V55, P453; McCall WD, 1996, NEUROSCI LETT, V208, P45, DOI 10.1016/0304-3940(96)12552-0; McNearney T, 2000, J RHEUMATOL, V27, P739; NEUGEBAUER V, 1994, EUR J NEUROSCI, V6, P1179, DOI 10.1111/j.1460-9568.1994.tb00616.x; Neugebauer V, 1999, J NEUROPHYSIOL, V82, P272, DOI 10.1152/jn.1999.82.1.272; Omote K, 1998, BRAIN RES, V787, P161, DOI 10.1016/S0006-8993(97)01568-0; Peng YB, 1999, J NEUROPHYSIOL, V82, P1164, DOI 10.1152/jn.1999.82.3.1164; Puig S, 1996, PAIN, V64, P345, DOI 10.1016/0304-3959(95)00121-2; SCHOEPP DD, 1994, J NEUROCHEM, V63, P769; TAYLOR BK, 1995, J NEUROSCI, V15, P7575; TJOLSEN A, 1992, PAIN, V51, P5, DOI 10.1016/0304-3959(92)90003-T; Valerio A, 1997, NEUROREPORT, V8, P2695, DOI 10.1097/00001756-199708180-00012; Valerio A, 1997, NEUROSCI RES, V28, P49, DOI 10.1016/S0168-0102(97)01175-9; VIDNYANSZKY Z, 1994, NEUROREPORT, V6, P209, DOI 10.1097/00001756-199412300-00053; Walker K, 2001, NEUROPHARMACOLOGY, V40, P10, DOI 10.1016/S0028-3908(00)00114-3; Young MR, 1997, BRAIN RES, V777, P161; Zhou ST, 1996, NEUROREPORT, V7, P895, DOI 10.1097/00001756-199603220-00012	42	233	239	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2001	4	4					417	423		10.1038/86075	http://dx.doi.org/10.1038/86075			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	433MB	11276233				2022-12-17	WOS:000168762200023
J	Diekelmann, S; Buchel, C; Born, J; Rasch, B				Diekelmann, Susanne; Buechel, Christian; Born, Jan; Rasch, Bjoern			Labile or stable: opposing consequences for memory when reactivated during waking and sleep	NATURE NEUROSCIENCE			English	Article							LONG-TERM-MEMORY; SLOW-WAVE SLEEP; PROTEIN-SYNTHESIS; DECLARATIVE MEMORY; PREFRONTAL CORTEX; FEAR MEMORIES; RECONSOLIDATION; CONSOLIDATION; HIPPOCAMPUS; RETRIEVAL	Memory consolidation is a dynamic process. Reconsolidation theory assumes that reactivation during wakefulness transiently destabilizes memories, requiring them to reconsolidate in order to persist. Memory reactivation also occurs during slow-wave sleep (SWS) and is assumed to underlie the consolidating effect of sleep. Here, we tested whether the same principle of transient destabilization applies to memory reactivation during SWS. We reactivated memories in humans by presenting associated odor cues either during SWS or wakefulness. Reactivation was followed by an interference task to probe memory stability. As we expected, reactivation during waking destabilized memories. In contrast, reactivation during SWS immediately stabilized memories, thereby directly increasing their resistance to interference. Functional magnetic resonance imaging revealed that reactivation during SWS mainly activated hippocampal and posterior cortical regions, whereas reactivation during wakefulness primarily activated prefrontal cortical areas. Our results show that reactivation of memory serves distinct functions depending on the brain state of wakefulness or sleep.	[Diekelmann, Susanne; Born, Jan; Rasch, Bjoern] Univ Tubingen, Dept Med Psychol & Neurobiol, Tubingen, Germany; [Diekelmann, Susanne; Born, Jan] Med Univ Lubeck, Dept Neuroendocrinol, D-23538 Lubeck, Germany; [Buechel, Christian] Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, Hamburg, Germany; [Rasch, Bjoern] Univ Basel, Div Cognit Neurosci, Basel, Switzerland	Eberhard Karls University of Tubingen; University of Lubeck; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Basel	Rasch, B (corresponding author), Univ Tubingen, Dept Med Psychol & Neurobiol, Tubingen, Germany.	born@kfg.mu-luebeck.de; bjoern.rasch@unibas.ch	Born, Jan/K-2596-2016; Rasch, Bjorn/A-3119-2015	Born, Jan/0000-0002-1847-6248; Rasch, Bjorn/0000-0001-7607-3415	Deutsche Forschungsgemeinschaft [SFB 654, SFB TR 58]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank I. Wilhelm for helpful discussions and J. Martens, F. Hobrack, M. Palm and K. Muller for assistance with data collection. This work was supported by grants from the Deutsche Forschungsgemeinschaft (SFB 654 and SFB TR 58).	Alberini CM, 2005, TRENDS NEUROSCI, V28, P51, DOI 10.1016/j.tins.2004.11.001; Bozon B, 2003, NEURON, V40, P695, DOI 10.1016/S0896-6273(03)00674-3; Buzsaki G, 1998, J SLEEP RES, V7, P17, DOI 10.1046/j.1365-2869.7.s1.3.x; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Doyere V, 2007, NAT NEUROSCI, V10, P414, DOI 10.1038/nn1871; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Euston DR, 2007, SCIENCE, V318, P1147, DOI 10.1126/science.1148979; Fonseca R, 2006, NAT NEUROSCI, V9, P478, DOI 10.1038/nn1667; Forcato C, 2007, LEARN MEMORY, V14, P295, DOI 10.1101/lm.486107; Foricato C, 2009, NEUROBIOL LEARN MEM, V91, P50, DOI 10.1016/j.nlm.2008.09.011; Gais S, 2007, P NATL ACAD SCI USA, V104, P18778, DOI 10.1073/pnas.0705454104; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Hupbach A, 2007, LEARN MEMORY, V14, P47, DOI 10.1101/lm.365707; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Kuhl BA, 2010, NAT NEUROSCI, V13, P501, DOI 10.1038/nn.2498; Lee JLC, 2009, TRENDS NEUROSCI, V32, P413, DOI 10.1016/j.tins.2009.05.002; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Milekic MH, 2002, NEURON, V36, P521, DOI 10.1016/S0896-6273(02)00976-5; MISANIN JR, 1968, SCIENCE, V160, P554, DOI 10.1126/science.160.3827.554; Morris RGM, 2006, NEURON, V50, P479, DOI 10.1016/j.neuron.2006.04.012; Nader K, 2003, TRENDS NEUROSCI, V26, P65, DOI 10.1016/S0166-2236(02)00042-5; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Nader K, 2009, NAT REV NEUROSCI, V10, P224, DOI 10.1038/nrn2590; Payne JD, 2009, NEUROBIOL LEARN MEM, V92, P327, DOI 10.1016/j.nlm.2009.03.007; Pedreira ME, 2003, NEURON, V38, P863, DOI 10.1016/S0896-6273(03)00352-0; Pedreira ME, 2002, J NEUROSCI, V22, P8305; Peigneux P, 2004, NEURON, V44, P535, DOI 10.1016/j.neuron.2004.10.007; Petrides M, 2005, PHILOS T ROY SOC B, V360, P781, DOI 10.1098/rstb.2005.1631; Polyn SM, 2008, TRENDS COGN SCI, V12, P24, DOI 10.1016/j.tics.2007.10.010; Rasch B, 2007, CURR OPIN NEUROBIOL, V17, P698, DOI 10.1016/j.conb.2007.11.007; Rasch B, 2007, SCIENCE, V315, P1426, DOI 10.1126/science.1138581; Rodriguez WA, 1999, PROG NEURO-PSYCHOPH, V23, P1285, DOI 10.1016/S0278-5846(99)00063-9; Rudoy JD, 2009, SCIENCE, V326, P1079, DOI 10.1126/science.1179013; Sara SJ, 2000, LEARN MEMORY, V7, P73, DOI 10.1101/lm.7.2.73; Schacter DL, 1999, AM PSYCHOL, V54, P182, DOI 10.1037/0003-066X.54.3.182; Schiller D, 2010, NATURE, V463, P49, DOI 10.1038/nature08637; Schwabe L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007519; Simons JS, 2003, NAT REV NEUROSCI, V4, P637, DOI 10.1038/nrn1178; Stickgold R, 2007, NAT NEUROSCI, V10, P540, DOI 10.1038/nn0507-540; Takashima A, 2006, P NATL ACAD SCI USA, V103, P756, DOI 10.1073/pnas.0507774103; Tse D, 2007, SCIENCE, V316, P76, DOI 10.1126/science.1135935; Walker MP, 2003, NATURE, V425, P616, DOI 10.1038/nature01930; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517	46	232	239	3	64	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2011	14	3					381	386		10.1038/nn.2744	http://dx.doi.org/10.1038/nn.2744			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	725MW	21258327				2022-12-17	WOS:000287650100020
J	Roitman, MF; Wheeler, RA; Wightman, RM; Carelli, RM				Roitman, Mitchell F.; Wheeler, Robert A.; Wightman, R. Mark; Carelli, Regina M.			Real-time chemical responses in the nucleus accumbens differentiate rewarding and aversive stimuli	NATURE NEUROSCIENCE			English	Article							DOPAMINE NEURONS; ACTIVATION; RAT	Rewarding and aversive stimuli evoke very different patterns of behavior and are rapidly discriminated. Here taste stimuli of opposite hedonic valence evoked opposite patterns of dopamine and metabolic activity within milliseconds in the nucleus accumbens. This rapid encoding may serve to guide ongoing behavioral responses and promote plastic changes in underlying circuitry.	[Roitman, Mitchell F.] Univ Illinois, Dept Psychol, Chicago, IL 60607 USA; [Wheeler, Robert A.; Carelli, Regina M.] Univ N Carolina, Dept Psychol, Chapel Hill, NC 27599 USA; [Wightman, R. Mark] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA; [Wightman, R. Mark; Carelli, Regina M.] Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA; [Wightman, R. Mark; Carelli, Regina M.] Univ N Carolina, Curriculum Neurobiol, Chapel Hill, NC 27599 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Roitman, MF (corresponding author), Univ Illinois, Dept Psychol, 1007 W Harrison St, Chicago, IL 60607 USA.	mroitman@uic.edu			US National Institute on Drug Abuse [DA018298, DA10900, DA17318]; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA018298, R01DA010900, R01DA017318, F32DA021055] Funding Source: NIH RePORTER	US National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors wish to thank M. L. A. V. Heien for programming assistance, S. Ng-Evans and S. A. Wescott for technical assistance, and B.J. Aragona for review of this manuscript. This work was supported by US National Institute on Drug Abuse grants (DA018298 to M. F. R., DA10900 to R. M. W. and DA17318 to R. M. C.).	Arbuthnott GW, 2007, TRENDS NEUROSCI, V30, P62, DOI 10.1016/j.tins.2006.12.003; Berridge KC, 2003, TRENDS NEUROSCI, V26, P507, DOI 10.1016/S0166-2236(03)00233-9; Calabresi P, 2007, TRENDS NEUROSCI, V30, P211, DOI 10.1016/j.tins.2007.03.001; Carlezon WA, 2009, NEUROPHARMACOLOGY, V56, P122, DOI 10.1016/j.neuropharm.2008.06.075; Coizet V, 2006, NEUROSCIENCE, V139, P1479, DOI 10.1016/j.neuroscience.2006.01.030; Cooper JC, 2008, NEUROIMAGE, V39, P538, DOI 10.1016/j.neuroimage.2007.08.009; Mirenowicz J, 1996, NATURE, V379, P449, DOI 10.1038/379449a0; Roitman MF, 2005, NEURON, V45, P587, DOI 10.1016/j.neuron.2004.12.055; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Stuber GD, 2005, NEUROPSYCHOPHARMACOL, V30, P853, DOI 10.1038/sj.npp.1300619; Ungless MA, 2004, TRENDS NEUROSCI, V27, P702, DOI 10.1016/j.tins.2004.10.001; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360; Venton BJ, 2003, J NEUROCHEM, V84, P373, DOI 10.1046/j.1471-4159.2003.01527.x; Waelti P, 2001, NATURE, V412, P43, DOI 10.1038/35083500; Wheeler RA, 2008, NEURON, V57, P774, DOI 10.1016/j.neuron.2008.01.024	15	232	232	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2008	11	12					1376	1377		10.1038/nn.2219	http://dx.doi.org/10.1038/nn.2219			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	375JF	18978779	Green Accepted, Green Published			2022-12-17	WOS:000261109300008
J	Sereno, MI; Huang, RS				Sereno, Martin I.; Huang, Ruey-Song			A human parietal face area contains aligned head-centered visual and tactile maps	NATURE NEUROSCIENCE			English	Article							VENTRAL INTRAPARIETAL AREA; FUNCTIONAL-ORGANIZATION; RESPONSE PROPERTIES; POSTERIOR PARIETAL; MACAQUE MONKEY; CORTEX; SPACE; FMRI; CONNECTIONS; ACTIVATION	Visually guided eating, biting and kissing, and avoiding objects moving toward the face and toward which the face moves require prompt, coordinated processing of spatial visual and somatosensory information in order to protect the face and the brain. Single-cell recordings in parietal cortex have identified multisensory neurons with spatially restricted, aligned visual and somatosensory receptive fields, but so far, there has been no evidence for a topographic map in this area. Here we mapped the organization of a multisensory parietal face area in humans by acquiring functional magnetic resonance images while varying the polar angle of facial air puffs and close-up visual stimuli. We found aligned maps of tactile and near-face visual stimuli at the highest level of human association cortex-namely, in the superior part of the postcentral sulcus. We show that this area may code the location of visual stimuli with respect to the face, not with respect to the retina.	Univ Calif San Diego, Dept Cognit Sci, Inst Neural Computat, La Jolla, CA 92093 USA; Univ Calif San Diego, Swartz Ctr Computat Neurosci, Inst Neural Computat, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Sereno, MI (corresponding author), Univ Calif San Diego, Dept Cognit Sci, Inst Neural Computat, La Jolla, CA 92093 USA.	sereno@cogsci.ucsd.edu	Huang, Ruey-Song/GZL-0985-2022; Sereno, Martin I/F-7657-2012	Sereno, Martin I/0000-0002-7598-7829; Huang, Ruey-Song/0000-0003-0385-9358	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD041581] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036722, R01NS041925] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD041581] Funding Source: Medline; NINDS NIH HHS [R01 NS36722, R01 NS41925] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Astafiev SV, 2003, J NEUROSCI, V23, P4689; Avillac M, 2005, NAT NEUROSCI, V8, P941, DOI 10.1038/nn1480; Beauchamp MS, 2005, CURR OPIN NEUROBIOL, V15, P145, DOI 10.1016/j.conb.2005.03.011; Bremmer F, 2005, J PHYSIOL-LONDON, V566, P29, DOI 10.1113/jphysiol.2005.082552; Bremmer F, 2002, EUR J NEUROSCI, V16, P1554, DOI 10.1046/j.1460-9568.2002.02207.x; Bremmer F, 2001, NEURON, V29, P287, DOI 10.1016/S0896-6273(01)00198-2; Calvert G., 2004, HDB MULTISENSORY PRO; Colby CL, 1996, J NEUROPHYSIOL, V76, P2841, DOI 10.1152/jn.1996.76.5.2841; COLBY CL, 1993, J NEUROPHYSIOL, V69, P902, DOI 10.1152/jn.1993.69.3.902; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Cook EP, 2002, J NEUROSCI, V22, P1994, DOI 10.1523/JNEUROSCI.22-05-01994.2002; Cooke DF, 2004, NEURON, V43, P585, DOI 10.1016/j.neuron.2004.07.029; Cooke DF, 2003, P NATL ACAD SCI USA, V100, P6163, DOI 10.1073/pnas.1031751100; Culham JC, 2001, CURR OPIN NEUROBIOL, V11, P157, DOI 10.1016/S0959-4388(00)00191-4; Culham JC, 1998, J NEUROPHYSIOL, V80, P2657, DOI 10.1152/jn.1998.80.5.2657; Duhamel JR, 1998, J NEUROPHYSIOL, V79, P126, DOI 10.1152/jn.1998.79.1.126; ENGEL SA, 1994, NATURE, V369, P525, DOI 10.1038/369525a0; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; Gattass R, 2005, PHILOS T R SOC B, V360, P709, DOI 10.1098/rstb.2005.1629; Grefkes C, 2005, J ANAT, V207, P3, DOI 10.1111/j.1469-7580.2005.00426.x; Grunewald A, 1999, J NEUROPHYSIOL, V82, P330, DOI 10.1152/jn.1999.82.1.330; Hagler DJ, 2006, NEUROIMAGE, V29, P567, DOI 10.1016/j.neuroimage.2005.08.058; HAGLER DJ, IN PRESS NEURIMAGE; Hasson U, 2004, SCIENCE, V303, P1634, DOI 10.1126/science.1089506; HUANG RS, IN PRESS NEURIMAGE; Lewis JW, 2000, J COMP NEUROL, V428, P112, DOI 10.1002/1096-9861(20001204)428:1<112::AID-CNE8>3.0.CO;2-9; Medendorp WP, 2003, J NEUROSCI, V23, P6209; Merriam EP, 2003, NEURON, V39, P361, DOI 10.1016/S0896-6273(03)00393-3; Monteiro GA, 2003, NEUROREPORT, V14, P2139, DOI 10.1097/00001756-200312020-00002; MORI A, 1991, NEUROSCI RES, V11, P198, DOI 10.1016/0168-0102(91)90043-X; Orban GA, 2003, NEUROPSYCHOLOGIA, V41, P1757, DOI 10.1016/S0028-3932(03)00177-5; Pitzalis S, 2006, J NEUROSCI, V26, P7962, DOI 10.1523/JNEUROSCI.0178-06.2006; Schluppeck D, 2005, J NEUROPHYSIOL, V94, P1372, DOI 10.1152/jn.01290.2004; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Sereno MI, 2005, CURR OPIN NEUROBIOL, V15, P135, DOI 10.1016/j.conb.2005.03.014; Sereno MI, 2001, SCIENCE, V294, P1350, DOI 10.1126/science.1063695; Spence C., 2004, CROSSMODAL SPACE CRO; THOMAS HC, 1987, BRAIN RES, V417, P214, DOI 10.1016/0006-8993(87)90445-8; Tootell RBH, 1996, TRENDS NEUROSCI, V19, P481, DOI 10.1016/S0166-2236(96)10053-9	39	232	235	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2006	9	10					1337	1343		10.1038/nn1777	http://dx.doi.org/10.1038/nn1777			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	098BB	16998482				2022-12-17	WOS:000241493900028
J	Fries, P; Neuenschwander, S; Engel, AK; Goebel, R; Singer, W				Fries, P; Neuenschwander, S; Engel, AK; Goebel, R; Singer, W			Rapid feature selective neuronal synchronization through correlated latency shifting	NATURE NEUROSCIENCE			English	Article							LOCAL-FIELD POTENTIALS; PRIMARY VISUAL-CORTEX; CORTICAL-NEURONS; RESPONSE VARIABILITY; NEOCORTICAL NEURONS; SHORT-RANGE; CAT; OSCILLATIONS; FLUCTUATIONS; DISCHARGE	Spontaneous brain activity could affect processing if it were structured,. We show that neuron pairs in cat primary visual cortex exhibited correlated fluctuations in response latency, particularly when they had overlapping receptive fields or similar orientation preferences. Correlations occurred within and across hemispheres, but only when local field potentials (LFPs) oscillated in the gamma-frequency range (40-70 Hz). In this range, LFP fluctuations preceding response onset predicted response latencies; negative (positive) LFPs were associated with early (late) responses. Oscillations below 10 Hz caused covariations in response amplitude, but exhibited no columnar selectivity or coordinating effect on latencies. Thus, during high gamma activity, spontaneous activity exhibits distinct, column-specific correlation patterns. Consequently, cortical cells undergo coherent fluctuations in excitability that enhance temporal coherence of responses to contours that are spatially contiguous or have similar orientation. Because synchronized responses are more likely than dispersed responses to undergo rapid and joint processing, spontaneous activity may be important in early visual processes.	Max Planck Inst Brain Res, D-60528 Frankfurt, Germany; Univ Frankfurt, Dept Psychiat, D-60528 Frankfurt, Germany	Max Planck Society; Goethe University Frankfurt	Singer, W (corresponding author), Max Planck Inst Brain Res, Deutschcordenstr 46, D-60528 Frankfurt, Germany.		Fries, Pascal/E-3196-2010; Engel, Andreas K./AAH-6384-2019; Singer, Wolf/D-6874-2012; Engel, Andreas K/C-7781-2012	Fries, Pascal/0000-0002-4270-1468; Engel, Andreas K./0000-0003-4899-8466; Engel, Andreas K/0000-0003-4899-8466; NEUENSCHWANDER, Sergio/0000-0001-7493-121X				Alonso JM, 1996, NATURE, V383, P815, DOI 10.1038/383815a0; AMZICA F, 1995, J NEUROPHYSIOL, V73, P20, DOI 10.1152/jn.1995.73.1.20; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Azouz R, 1999, J NEUROSCI, V19, P2209; BOUYER JJ, 1981, ELECTROEN CLIN NEURO, V51, P244, DOI 10.1016/0013-4694(81)90138-3; Brecht M, 1998, J NEUROPHYSIOL, V79, P2394, DOI 10.1152/jn.1998.79.5.2394; Contreras D, 1997, NEUROSCIENCE, V76, P25; Das A, 1999, NATURE, V399, P655, DOI 10.1038/21371; Diesmann M, 1999, NATURE, V402, P529, DOI 10.1038/990101; ENGEL AK, 1991, SCIENCE, V252, P1177, DOI 10.1126/science.252.5009.1177; FRIES P, IN PRESS SCIENCE; Gawne TJ, 1996, J NEUROPHYSIOL, V76, P1356, DOI 10.1152/jn.1996.76.2.1356; Gur M, 1997, J NEUROSCI, V17, P2914; Herculano-Houzel S, 1999, J NEUROSCI, V19, P3992; Lampl I, 1999, NEURON, V22, P361, DOI 10.1016/S0896-6273(00)81096-X; LAMPL I, 1993, J NEUROPHYSIOL, V70, P2181, DOI 10.1152/jn.1993.70.5.2181; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Makeig S, 1996, COGNITIVE BRAIN RES, V4, P15, DOI 10.1016/0926-6410(95)00042-9; MITZDORF U, 1985, PHYSIOL REV, V65, P37, DOI 10.1152/physrev.1985.65.1.37; Murthy VN, 1996, J NEUROPHYSIOL, V76, P3949, DOI 10.1152/jn.1996.76.6.3949; Nowak LG, 1997, CEREB CORTEX, V7, P487, DOI 10.1093/cercor/7.6.487; Roelfsema PR, 1997, NATURE, V385, P157, DOI 10.1038/385157a0; SANES JN, 1993, P NATL ACAD SCI USA, V90, P4470, DOI 10.1073/pnas.90.10.4470; Schmidt KE, 1997, J NEUROSCI, V17, P5480; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; Stevens CF, 1998, NAT NEUROSCI, V1, P210, DOI 10.1038/659; Swindale NV, 1998, BIOL CYBERN, V78, P45, DOI 10.1007/s004220050411; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Tsodyks M, 1999, SCIENCE, V286, P1943, DOI 10.1126/science.286.5446.1943; Volgushev M, 1998, NEUROSCIENCE, V83, P15, DOI 10.1016/S0306-4522(97)00380-1	31	232	236	0	17	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2001	4	2					194	200		10.1038/84032	http://dx.doi.org/10.1038/84032			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UC	11175881				2022-12-17	WOS:000167178100019
J	Aravamudan, B; Fergestad, T; Davis, WS; Rodesch, CK; Broadie, K				Aravamudan, B; Fergestad, T; Davis, WS; Rodesch, CK; Broadie, K			Drosophila Unc-13 is essential for synaptic transmission	NATURE NEUROSCIENCE			English	Article							PROTEIN-KINASE-C; CAENORHABDITIS-ELEGANS; NEUROTRANSMITTER RELEASE; NEUROMUSCULAR-JUNCTION; EXPRESSION; GENE; SYNAPTOBREVIN; SYNAPTOTAGMIN; MELANOGASTER; CA2+	The UNC-13 protein family has been suggested to be critical for synaptic vesicle dynamics based on its interactions with Syntaxin, Munc-18 and Doc 2 alpha. We cloned the Drosophila homolog (Dunc-13) and characterized its function using a combination of electrophysiology and ultrastructural analyses. Dunc-13 contained a C1 lipid-binding motif and two C2 calcium-binding domains, and its expression was restricted to neurons. Elimination of dune-13 expression abolished synaptic transmission, an effect comparable only to removal of the core complex proteins Syntaxin and Synaptobrevin. Transmitter release remained impaired under elevated calcium influx or application of hyperosmotic saline. Ultrastructurally, mutant terminals accumulated docked vesicles at presynaptic release sites. We conclude that Dunc-13 is essential for a stage of neurotransmission following vesicle docking and before fusion.	Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Broadie, K (corresponding author), Univ Utah, Dept Biol, 257 South 1400 East, Salt Lake City, UT 84112 USA.				NICHD NIH HHS [5T32 HD07491] Funding Source: Medline; NIGMS NIH HHS [GM54544] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054544] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON WB, 1985, CURR TOP CELL REGUL, V27, P455; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Bennett MK, 1997, CURR OPIN NEUROBIOL, V7, P316, DOI 10.1016/S0959-4388(97)80058-X; Betz A, 1997, J BIOL CHEM, V272, P2520; Betz A, 1998, NEURON, V21, P123, DOI 10.1016/S0896-6273(00)80520-6; BRENNER S, 1974, GENETICS, V77, P71; BROADIE K, 1995, NEURON, V15, P663, DOI 10.1016/0896-6273(95)90154-X; BROADIE K, 1993, DEVELOPMENT, V119, P533; BROADIE KS, 1995, J PHYSIOLOGY-PARIS, V89, P59, DOI 10.1016/0928-4257(96)80552-3; BROADIE KS, 1993, J NEUROSCI, V13, P167; BROADIE KS, 1993, J NEUROSCI, V13, P144; BROSE N, 1995, J BIOL CHEM, V270, P25273, DOI 10.1074/jbc.270.42.25273; Chavez RA, 1996, J CELL BIOL, V133, P1177, DOI 10.1083/jcb.133.6.1177; Chen YA, 1999, CELL, V97, P165, DOI 10.1016/S0092-8674(00)80727-8; CHIN AC, 1993, GENE, V131, P175, DOI 10.1016/0378-1119(93)90291-A; CURRIE DA, 1995, DEV DYNAM, V203, P311, DOI 10.1002/aja.1002030303; Deitcher DL, 1998, J NEUROSCI, V18, P2028; EGEA G, 1991, J NEUROCHEM, V57, P1593, DOI 10.1111/j.1471-4159.1991.tb06356.x; Fergestad T, 1999, J NEUROSCI, V19, P5847, DOI 10.1523/JNEUROSCI.19-14-05847.1999; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; JAN LY, 1982, P NATL ACAD SCI-BIOL, V79, P2700, DOI 10.1073/pnas.79.8.2700; Keshishian H, 1996, ANNU REV NEUROSCI, V19, P545, DOI 10.1146/annurev.ne.19.030196.002553; LEHMANN R, 1994, METHOD CELL BIOL, V44, P575, DOI 10.1016/S0091-679X(08)60933-4; Li J, 1999, PHILOS T ROY SOC B, V354, P299, DOI 10.1098/rstb.1999.0381; LITTLETON JT, 1993, DEVELOPMENT, V118, P1077; MARUYAMA IN, 1991, P NATL ACAD SCI USA, V88, P5729, DOI 10.1073/pnas.88.13.5729; Mochida S, 1998, P NATL ACAD SCI USA, V95, P11418, DOI 10.1073/pnas.95.19.11418; Orita S, 1997, J BIOL CHEM, V272, P16081, DOI 10.1074/jbc.272.26.16081; Prokop A, 1996, NEURON, V17, P617, DOI 10.1016/S0896-6273(00)80195-6; Richmond JE, 1999, NAT NEUROSCI, V2, P959, DOI 10.1038/12160; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Sakaguchi G, 1998, BIOCHEM BIOPH RES CO, V248, P846, DOI 10.1006/bbrc.1998.9067; Sassa T, 1999, J NEUROSCI, V19, P4772; SCHULZE KL, 1995, CELL, V80, P311, DOI 10.1016/0092-8674(95)90414-X; Sutton RB, 1998, STRUCTURE, V6, P1395, DOI 10.1016/S0969-2126(98)00139-7; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Valtorta Flavia, 1994, Seminars in Cell Biology, V5, P211, DOI 10.1006/scel.1994.1027; Xu XZS, 1998, J BIOL CHEM, V273, P31297, DOI 10.1074/jbc.273.47.31297; Yoshihara M, 1999, J NEUROSCI, V19, P2432	40	232	237	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	1999	2	11					965	971		10.1038/14764	http://dx.doi.org/10.1038/14764			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259FF	10526334				2022-12-17	WOS:000083883300012
J	Bichot, NP; Schall, JD				Bichot, NP; Schall, JD			Effects of similarity and history on neural mechanisms of visual selection	NATURE NEUROSCIENCE			English	Article							FRONTAL EYE FIELD; SACCADE TARGET SELECTION; FEATURE CONJUNCTIONS; SPATIAL ATTENTION; GUIDED SEARCH; NEURONS; PARALLEL; MACAQUE; MOVEMENTS; CORTEX	To investigate how the brain combines knowledge with visual processing to locate eye movement targets, we trained monkeys to search for a target defined by a conjunction of color and shape. On successful trials, neurons in the frontal eye field not only discriminated the target from distracters, but also discriminated distracters that shared a target feature as well as distracters that had been the search target during the previous session. Likewise, occasional errant saccades tended to direct gaze to distracters that either resembled the current target or had been the previous target. These findings show that the frontal eye field is involved in visual and not just motor selection and that visual selection is influenced by long-term priming. The data support the hypothesis that visual selection can be accomplished by parallel processing of objects based on their elementary features.	Vanderbilt Univ, Dept Psychol, Vanderbilt Vis Res Ctr, Nashville, TN 37240 USA	Vanderbilt University	Schall, JD (corresponding author), Vanderbilt Univ, Dept Psychol, Vanderbilt Vis Res Ctr, 301 Wilson Hall, Nashville, TN 37240 USA.				NATIONAL EYE INSTITUTE [P30EY008126, T32EY007135] Funding Source: NIH RePORTER; NEI NIH HHS [P30-EY08126, T32-EY07135] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BAIZER JS, 1991, J NEUROSCI, V11, P168; Bichot NP, 1999, VISUAL NEUROSCI, V16, P81, DOI 10.1017/S0952523899161042; Bichot NP, 1996, NATURE, V381, P697, DOI 10.1038/381697a0; BRUCE CJ, 1985, J NEUROPHYSIOL, V54, P714, DOI 10.1152/jn.1985.54.3.714; BUTTNERENNEVER JA, 1988, J COMP NEUROL, V267, P307, DOI 10.1002/cne.902670302; CAVE KR, 1990, COGNITIVE PSYCHOL, V22, P225, DOI 10.1016/0010-0285(90)90017-X; CAVE KR, IN PRESS PSYCHOL RES; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.neuro.18.1.193; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037/0033-295X.96.3.433; Findlay JM, 1997, VISION RES, V37, P617, DOI 10.1016/S0042-6989(96)00218-0; Kim MS, 1995, PSYCHOL SCI, V6, P376, DOI 10.1111/j.1467-9280.1995.tb00529.x; KOWLER E, 1995, VISION RES, V35, P1897, DOI 10.1016/0042-6989(94)00279-U; Kustov AA, 1996, NATURE, V384, P74, DOI 10.1038/384074a0; MALJKOVIC V, 1994, MEM COGNITION, V22, P657, DOI 10.3758/BF03209251; MCLEOD P, 1988, NATURE, V332, P154, DOI 10.1038/332154a0; MOHLER CW, 1973, BRAIN RES, V61, P385, DOI 10.1016/0006-8993(73)90543-X; NAKAYAMA K, 1986, NATURE, V320, P264, DOI 10.1038/320264a0; SAYER RJ, 1990, J NEUROSCI, V10, P826; Schall JD, 1998, CURR OPIN NEUROBIOL, V8, P211, DOI 10.1016/S0959-4388(98)80142-6; SCHALL JD, 1995, J NEUROSCI, V15, P6905; Schall JD, 1997, CEREBR CORT, V12, P527; SCHALL JD, 1995, J NEUROSCI, V15, P4464; SEGRAVES MA, 1992, J NEUROPHYSIOL, V68, P1967, DOI 10.1152/jn.1992.68.6.1967; SHELIGA BM, 1995, EXP BRAIN RES, V105, P261; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; Thompson KG, 1997, J NEUROPHYSIOL, V77, P1046, DOI 10.1152/jn.1997.77.2.1046; Thompson KG, 1996, J NEUROPHYSIOL, V76, P4040, DOI 10.1152/jn.1996.76.6.4040; THOMPSON KG, IN PRESS BEHAV BRAIN; TOWNSEND JT, 1990, PSYCHOL SCI, V1, P46, DOI 10.1111/j.1467-9280.1990.tb00067.x; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; TREISMAN AM, 1990, J EXPT PSYCHOL HUMAN, V16, P456; WILLIAMS LG, 1967, ACTA PSYCHOL, V27, P355, DOI 10.1016/0001-6918(67)90080-7; WOLFE JM, 1989, J EXP PSYCHOL HUMAN, V15, P419, DOI 10.1037/0096-1523.15.3.419; WOLFE JM, 1994, PSYCHON B REV, V1, P202, DOI 10.3758/BF03200774; Yarbus A. L., 1967, EYE MOVEMENTS VISION, P171	36	232	236	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	1999	2	6					549	554		10.1038/9205	http://dx.doi.org/10.1038/9205			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	273YA	10448220				2022-12-17	WOS:000084735900015
J	Li, SL; Overman, JJ; Katsman, D; Kozlov, SV; Donnelly, CJ; Twiss, JL; Giger, RJ; Coppola, G; Geschwind, DH; Carmichael, ST				Li, Songlin; Overman, Justine J.; Katsman, Diana; Kozlov, Serguei V.; Donnelly, Christopher J.; Twiss, Jeffery L.; Giger, Roman J.; Coppola, Giovanni; Geschwind, Daniel H.; Carmichael, S. Thomas			An age-related sprouting transcriptome provides molecular control of axonal sprouting after stroke	NATURE NEUROSCIENCE			English	Article							GROWTH-ASSOCIATED GENE; NEURITE OUTGROWTH; DNA METHYLATION; NOGO RECEPTOR; FACTOR-I; EXPRESSION; REGENERATION; NEURONS; BRAIN; REVEALS	Stroke is an age-related disease. Recovery after stroke is associated with axonal sprouting in cortex adjacent to the infarct. The molecular program that induces a mature cortical neuron to sprout a new connection after stroke is not known. We selectively isolated neurons that sprout a new connection in cortex after stroke and compared their whole-genome expression profile to that of adjacent, non-sprouting neurons. This 'sprouting transcriptome' identified a neuronal growth program that consists of growth factor, cell adhesion, axonal guidance and cytoskeletal modifying molecules that differed by age and time point. Gain and loss of function in three distinct functional classes showed new roles for these proteins in epigenetic regulation of axonal sprouting, growth factor-dependent survival of neurons and, in the aged mouse, paradoxical upregulation of myelin and ephrin receptors in sprouting neurons. This neuronal growth program may provide new therapeutic targets and suggest mechanisms for age-related differences in functional recovery.	[Li, Songlin; Overman, Justine J.; Katsman, Diana; Coppola, Giovanni; Geschwind, Daniel H.; Carmichael, S. Thomas] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Kozlov, Serguei V.] NCI, Canc & Dev Biol Lab, Frederick, MD 21701 USA; [Donnelly, Christopher J.; Twiss, Jeffery L.] Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA; [Giger, Roman J.] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Giger, Roman J.] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Drexel University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Carmichael, ST (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA.	scarmichael@mednet.ucla.edu	LI, Songlin/O-8512-2016; Li, Songlin/D-7768-2011; Donnelly, Christopher/AGI-7461-2022	Donnelly, Christopher/0000-0002-2383-9015; Carmichael, S Thomas/0000-0002-1169-9203; Li, Songlin/0000-0002-1073-9779	US National Institutes of Health [NS045729, NS04733, NS049041, AHA 09SDG2310180, 0525144Y]; US Department of Veterans Affairs; Larry L Hillblom Foundation; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; American Federation of Aging Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049041, R01NS045729, R01NS041596] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Veterans Affairs(US Department of Veterans Affairs); Larry L Hillblom Foundation; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; American Federation of Aging Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank S. Raike (University of Michigan) for help with obtaining NgR2 mutant mice. This research was funded by US National Institutes of Health NS045729, NS04733, NS049041, AHA 09SDG2310180 and 0525144Y; the US Department of Veterans Affairs; the Larry L Hillblom Foundation; the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation and the American Federation of Aging Research.	Atwal JK, 2008, SCIENCE, V322, P967, DOI 10.1126/science.1161151; Berube NG, 2005, J CLIN INVEST, V115, P258, DOI 10.1172/JCI200522329; Boulanger LM, 2009, NEURON, V64, P93, DOI 10.1016/j.neuron.2009.09.001; Brown CE, 2009, J NEUROSCI, V29, P1719, DOI 10.1523/JNEUROSCI.4249-08.2009; CALLAWAY EM, 1990, J NEUROSCI, V10, P1134; CALLAWAY EM, 1992, J NEUROSCI, V12, P570; Cao Y, 2003, J CEREBR BLOOD F MET, V23, P739, DOI 10.1097/01.WCB.0000067720.12805.6F; Carmichael ST, 2001, NEUROBIOL DIS, V8, P910, DOI 10.1006/nbdi.2001.0425; Carmichael ST, 2005, EXP NEUROL, V193, P291, DOI 10.1016/j.expneurol.2005.01.004; Carmichael ST, 2006, ANN NEUROL, V59, P735, DOI 10.1002/ana.20845; Case LC, 2005, CURR BIOL, V15, pR749, DOI 10.1016/j.cub.2005.09.008; Chklovskii DB, 2004, NATURE, V431, P782, DOI 10.1038/nature03012; Costigan M, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-16; Dalva MB, 2007, NEURON, V55, P681, DOI 10.1016/j.neuron.2007.08.015; Dancause N, 2005, J NEUROSCI, V25, P10167, DOI 10.1523/JNEUROSCI.3256-05.2005; Du J, 2007, CURR PHARM DESIGN, V13, P2507; Fan GP, 2005, DEVELOPMENT, V132, P3345, DOI 10.1242/dev.01912; Fischer D, 2004, J NEUROSCI, V24, P8726, DOI 10.1523/JNEUROSCI.2774-04.2004; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Ikegami K, 2006, J BIOL CHEM, V281, P30707, DOI 10.1074/jbc.M603984200; Ji B, 2006, MOL CELL NEUROSCI, V33, P311, DOI 10.1016/j.mcn.2006.08.003; Kooijman R, 2009, STROKE, V40, pE83, DOI 10.1161/STROKEAHA.108.528356; Lee JK, 2004, J NEUROSCI, V24, P6209, DOI 10.1523/JNEUROSCI.1643-04.2004; Lemons ML, 2008, EXP NEUROL, V209, P343, DOI 10.1016/j.expneurol.2007.05.027; Li SL, 2006, NEUROBIOL DIS, V23, P362, DOI 10.1016/j.nbd.2006.03.011; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Liu BP, 2006, PHILOS T R SOC B, V361, P1593, DOI 10.1098/rstb.2006.1891; MacDonald JL, 2009, PROG NEUROBIOL, V88, P170, DOI 10.1016/j.pneurobio.2009.04.002; Ohab JJ, 2006, J NEUROSCI, V26, P13007, DOI 10.1523/JNEUROSCI.4323-06.2006; Ozdinler PH, 2006, NAT NEUROSCI, V9, P1371, DOI 10.1038/nn1789; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Paxinos G., 2012, MOUSE BRAIN STEREOTA, V2nd; Pertz OC, 2008, P NATL ACAD SCI USA, V105, P1931, DOI 10.1073/pnas.0706545105; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Rosenstein JM, 2003, J NEUROSCI, V23, P11036; Salie R, 2005, INT J DEV NEUROSCI, V23, P587, DOI 10.1016/j.ijdevneu.2005.07.003; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Stowe AM, 2007, J CEREBR BLOOD F MET, V27, P76, DOI 10.1038/sj.jcbfm.9600320; Tanabe K, 2003, J NEUROSCI, V23, P9675; Topalli I, 2004, BRAIN RES, V1030, P116, DOI 10.1016/j.brainres.2004.09.057; Venkatesh K, 2005, J NEUROSCI, V25, P808, DOI 10.1523/JNEUROSCI.4464-04.2005; Venkatesh K, 2007, J CELL BIOL, V177, P393, DOI 10.1083/jcb.200702102; Wang F, 2007, NEUROSCI LETT, V417, P255, DOI 10.1016/j.neulet.2007.02.080; Xiao HS, 2002, P NATL ACAD SCI USA, V99, P8360, DOI 10.1073/pnas.122231899; Zai LL, 2009, J NEUROSCI, V29, P8187, DOI 10.1523/JNEUROSCI.0414-09.2009; Zheng BH, 2005, P NATL ACAD SCI USA, V102, P1205, DOI 10.1073/pnas.0409026102; Zheng JQ, 2001, J NEUROSCI, V21, P9291, DOI 10.1523/JNEUROSCI.21-23-09291.2001; Zhu ML, 2008, ENDOCR-RELAT CANCER, V15, P841, DOI 10.1677/ERC-08-0084; Zujovic V, 2005, J NEUROSCI RES, V82, P581, DOI 10.1002/jnr.20676	50	231	236	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2010	13	12					1496	U82		10.1038/nn.2674	http://dx.doi.org/10.1038/nn.2674			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	684CW	21057507	Green Accepted, Green Submitted			2022-12-17	WOS:000284525800014
J	Theyel, BB; Llano, DA; Sherman, M				Theyel, Brian B.; Llano, Daniel A.; Sherman, Murray			The corticothalamocortical circuit drives higher-order cortex in the mouse	NATURE NEUROSCIENCE			English	Article							LATERAL GENICULATE-NUCLEUS; AUDITORY-CORTEX; IN-VITRO; FLAVOPROTEIN AUTOFLUORESCENCE; LASER PHOTOSTIMULATION; ANTEROGRADE TRACER; VISUAL-SYSTEM; BARREL CORTEX; RAT THALAMUS; SINGLE-FIBER	An unresolved question in neuroscience relates to the extent to which corticothalamocortical circuits emanating from layer 5B are involved in information transfer through the cortical hierarchy. Using a new form of optical imaging in a brain slice preparation, we found that the corticothalamocortical pathway drove robust activity in higher-order somatosensory cortex. When the direct corticocortical pathway was interrupted, secondary somatosensory cortex showed robust activity in response to stimulation of the barrel field in primary somatosensory cortex (S1BF), which was eliminated after subsequently cutting the somatosensory thalamus, suggesting a highly efficacious corticothalamocortical circuit. Furthermore, after chemically inhibiting the thalamus, activation in secondary somatosensory cortex was eliminated, with a subsequent return after washout. Finally, stimulation of layer 5B in S1BF, and not layer 6, drove corticothalamocortical activation. These findings suggest that the corticothalamocortical circuit is a physiologically viable candidate for information transfer to higher-order cortical areas.	[Theyel, Brian B.; Sherman, Murray] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA; [Llano, Daniel A.] Univ Chicago, Dept Neurol, Med Ctr, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago Medical Center	Theyel, BB (corresponding author), Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA.	btheyel@uchicago.edu	Llano, Daniel/X-8184-2019	Llano, Daniel/0000-0003-0933-1837	US Public Health Service; US National Institutes of Health [DC008320, EY03038, DC008794]; NATIONAL EYE INSTITUTE [R01EY003038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008794, K08DC008320] Funding Source: NIH RePORTER	US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank N. Issa, T. Husson and A. Mallik for technical assistance with flavoprotein autofluorescence imaging. This work was supported by the US Public Health Service and US National Institutes of Health grants DC008320 ( D. A. L.), EY03038 and DC008794 ( S. M. S.).	AGMON A, 1991, NEUROSCIENCE, V41, P365, DOI 10.1016/0306-4522(91)90333-J; BAJO VM, 1995, HEARING RES, V83, P161, DOI 10.1016/0378-5955(94)00199-Z; BENDER DB, 1983, BRAIN RES, V279, P258, DOI 10.1016/0006-8993(83)90188-9; BOURASSA J, 1995, EUR J NEUROSCI, V7, P19, DOI 10.1111/j.1460-9568.1995.tb01016.x; BOURASSA J, 1995, NEUROSCIENCE, V66, P253, DOI 10.1016/0306-4522(95)00009-8; CALLAWAY EM, 1993, P NATL ACAD SCI USA, V90, P7661, DOI 10.1073/pnas.90.16.7661; Cox CL, 2000, NEURON, V27, P597, DOI 10.1016/S0896-6273(00)00069-6; Cruikshank SJ, 2002, J NEUROPHYSIOL, V87, P361, DOI 10.1152/jn.00549.2001; DIAMOND ME, 1992, J COMP NEUROL, V319, P66, DOI 10.1002/cne.903190108; Franklin K. B. J., 2008, MOUSE BRAIN STEREOTA; Groh A, 2008, J NEUROSCI, V28, P9652, DOI 10.1523/JNEUROSCI.1554-08.2008; Guillery RW, 2003, J NEUROPHYSIOL, V90, P539, DOI 10.1152/jn.00337.2003; Guillery RW, 2002, PHILOS T R SOC B, V357, P1809, DOI 10.1098/rstb.2002.1171; Guillery RW, 2002, NEURON, V33, P163, DOI 10.1016/S0896-6273(01)00582-7; Guillery RW, 2001, J COMP NEUROL, V438, P66, DOI 10.1002/cne.1302; Hazama M, 2004, NEUROSCIENCE, V124, P655, DOI 10.1016/j.neuroscience.2003.12.027; KAAS JH, 1987, ANNU REV PSYCHOL, V38, P129, DOI 10.1146/annurev.ps.38.020187.001021; KATO N, 1990, BRAIN RES, V509, P150, DOI 10.1016/0006-8993(90)90323-4; Lam YW, 2007, J NEUROPHYSIOL, V98, P2903, DOI 10.1152/jn.00782.2007; Lam YW, 2006, J NEUROPHYSIOL, V96, P2593, DOI 10.1152/jn.00555.2006; Lam YW, 2005, J NEUROPHYSIOL, V94, P2472, DOI 10.1152/jn.00206.2005; Lee CC, 2008, J NEUROPHYSIOL, V100, P317, DOI 10.1152/jn.90391.2008; Llano DA, 2009, J NEUROPHYSIOL, V101, P3325, DOI 10.1152/jn.91291.2008; Llano DA, 2008, J COMP NEUROL, V507, P1209, DOI 10.1002/cne.21602; MacLean JN, 2006, NAT METHODS, V3, P129, DOI 10.1038/NMETH849; MATHERS LH, 1972, J COMP NEUROL, V146, P43, DOI 10.1002/cne.901460104; OJIMA H, 1994, CEREB CORTEX, V4, P646, DOI 10.1093/cercor/4.6.646; OLSHAUSEN BA, 1993, J NEUROSCI, V13, P4700; Reichova I, 2004, J NEUROPHYSIOL, V92, P2185, DOI 10.1152/jn.00322.2004; Reinert KC, 2004, J NEUROPHYSIOL, V92, P199, DOI 10.1152/jn.01275.2003; ROUILLER EM, 1991, HEARING RES, V56, P179, DOI 10.1016/0378-5955(91)90168-9; Shepherd GMG, 2003, NEURON, V38, P277, DOI 10.1016/S0896-6273(03)00152-1; Sherer DM, 2001, GYNECOL OBSTET INVES, V51, P69, DOI 10.1159/000052896; Sherman S.M., 2006, EXPLORING THALAMUS I, V2nd; Sherman SM, 1996, J NEUROPHYSIOL, V76, P1367, DOI 10.1152/jn.1996.76.3.1367; Sherman SM, 2002, PHILOS T R SOC B, V357, P1695, DOI 10.1098/rstb.2002.1161; Sherman SM, 1998, P NATL ACAD SCI USA, V95, P7121, DOI 10.1073/pnas.95.12.7121; Shibuki K, 2003, J PHYSIOL-LONDON, V549, P919, DOI 10.1113/jphysiol.2003.040709; SPREAFICO R, 1987, SOMATOSENS MOT RES, V4, P359, DOI 10.3109/07367228709144614; Staiger JF, 1999, ANAT EMBRYOL, V199, P357, DOI 10.1007/s004290050234; Van Horn SC, 2004, J COMP NEUROL, V475, P406, DOI 10.1002/cne.20187; VANESSEN DC, 1992, SCIENCE, V255, P419, DOI 10.1126/science.1734518; WILSON JR, 1984, PROC R SOC SER B-BIO, V221, P411, DOI 10.1098/rspb.1984.0042; Winer JA, 1999, J COMP NEUROL, V413, P181	44	231	233	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2010	13	1					84	U246		10.1038/nn.2449	http://dx.doi.org/10.1038/nn.2449			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	536PM	19966840	Green Accepted			2022-12-17	WOS:000273056300017
J	Woodhoo, A; Alonso, MBD; Droggiti, A; Turmaine, M; D'Antonio, M; Parkinson, DB; Wilton, DK; Al-Shawi, R; Simons, P; Shen, J; Guillemot, F; Radtke, F; Meijer, D; Feltri, ML; Wrabetz, L; Mirsky, R; Jessen, KR				Woodhoo, Ashwin; Alonso, Maria B. Duran; Droggiti, Anna; Turmaine, Mark; D'Antonio, Maurizio; Parkinson, David B.; Wilton, Daniel K.; Al-Shawi, Raya; Simons, Paul; Shen, Jie; Guillemot, Francois; Radtke, Freddy; Meijer, Dies; Feltri, M. Laura; Wrabetz, Lawrence; Mirsky, Rhona; Jessen, Kristjan R.			Notch controls embryonic Schwann cell differentiation, postnatal myelination and adult plasticity	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; NEURAL CREST; NEGATIVE REGULATION; FATE DETERMINATION; GROWTH-FACTOR; IN-VIVO; ACTIVATION; AXONS; MICE; GENE	Notch signaling is central to vertebrate development, and analysis of Notch has provided important insights into pathogenetic mechanisms in the CNS and many other tissues. However, surprisingly little is known about the role of Notch in the development and pathology of Schwann cells and peripheral nerves. Using transgenic mice and cell cultures, we found that Notch has complex and extensive regulatory functions in Schwann cells. Notch promoted the generation of Schwann cells from Schwann cell precursors and regulated the size of the Schwann cell pool by controlling proliferation. Notch inhibited myelination, establishing that myelination is subject to negative transcriptional regulation that opposes forward drives such as Krox20. Notably, in the adult, Notch dysregulation resulted in demyelination; this finding identifies a signaling pathway that induces myelin breakdown in vivo. These findings are relevant for understanding the molecular mechanisms that control Schwann cell plasticity and underlie nerve pathology, including demyelinating neuropathies and tumorigenesis.	[Woodhoo, Ashwin; Alonso, Maria B. Duran; Droggiti, Anna; Turmaine, Mark; Wilton, Daniel K.; Mirsky, Rhona; Jessen, Kristjan R.] UCL, Dept Cell & Dev Biol, London, England; [D'Antonio, Maurizio; Feltri, M. Laura; Wrabetz, Lawrence] Ist Sci San Raffaele, DIBIT, I-20132 Milan, Italy; [Parkinson, David B.] Peninsula Med Sch, Plymouth, Devon, England; [Al-Shawi, Raya; Simons, Paul] UCL, Dept Med, London, England; [Shen, Jie] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA; [Guillemot, Francois] Natl Inst Med Res, London NW7 1AA, England; [Radtke, Freddy] Univ Lausanne, Ludwig Inst Canc Res, CH-1066 Epalinges, Switzerland; [Meijer, Dies] Erasmus MC, Dept Cell Biol & Genet, Rotterdam, Netherlands	University of London; University College London; Vita-Salute San Raffaele University; University of Plymouth; University of London; University College London; Harvard University; Brigham & Women's Hospital; Harvard Medical School; MRC National Institute for Medical Research; Ludwig Institute for Cancer Research; University of Lausanne; Erasmus University Rotterdam; Erasmus MC	Jessen, KR (corresponding author), UCL, Dept Cell & Dev Biol, London, England.	k.jessen@ucl.ac.uk	Shen, Jie/GXH-9449-2022; Radtke, Freddy/Q-3198-2017; Simons, Paul/ABG-2628-2021; Guillemot, Francois/AAV-1482-2021; Alonso, M. Beatriz Durán/L-5858-2017; Meijer, Dies/C-7786-2012; Feltri, Maria Laura/J-5286-2018; D'Antonio, Maurizio/AHI-1781-2022; Simons, Paul/A-9960-2009; Messier, Claude/A-2322-2008; woodhoo, ashwin/A-4904-2015	Radtke, Freddy/0000-0003-4315-4045; Simons, Paul/0000-0002-5007-6674; Alonso, M. Beatriz Durán/0000-0001-7784-0591; Meijer, Dies/0000-0002-8461-6341; D'Antonio, Maurizio/0000-0003-0637-8971; Simons, Paul/0000-0002-5007-6674; Messier, Claude/0000-0002-4791-1763; woodhoo, ashwin/0000-0002-8395-2837	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045630, R01NS042818, R01NS055256] Funding Source: NIH RePORTER; Medical Research Council [MC_U117570528, G0601943] Funding Source: Medline; NINDS NIH HHS [R01 NS042818-07, R01 NS042818, R01 NS045630-07, R01 NS045630-08, R01 NS045630-09, R01 NS055256, R01 NS045630, R01 NS045630-06] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [G0601943, MC_U117570528] Funding Source: UKRI	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Arias AM, 2002, CURR OPIN GENET DEV, V12, P524, DOI 10.1016/S0959-437X(02)00336-2; Birchmeier C, 2008, GLIA, V56, P1491, DOI 10.1002/glia.20753; Bothwell M, 2000, CELL, V102, P271, DOI 10.1016/S0092-8674(00)00032-5; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Brennan A, 2000, DEV BIOL, V227, P545, DOI 10.1006/dbio.2000.9887; Chen ZL, 2007, ANNU REV NEUROSCI, V30, P209, DOI 10.1146/annurev.neuro.30.051606.094337; D'Antonio M, 2006, GLIA, V53, P501, DOI 10.1002/glia.20309; D'Antonio M, 2006, J NEUROSCI, V26, P8417, DOI 10.1523/JNEUROSCI.1578-06.2006; DONG Z, 1995, NEURON, V15, P585, DOI 10.1016/0896-6273(95)90147-7; Feltri ML, 1999, ANN NY ACAD SCI, V883, P116, DOI 10.1111/j.1749-6632.1999.tb08574.x; Givogri MI, 2002, J NEUROSCI RES, V67, P309, DOI 10.1002/jnr.10128; Hatakeyama J, 2004, DEVELOPMENT, V131, P5539, DOI 10.1242/dev.01436; Jaegle M, 2003, GENE DEV, V17, P1380, DOI 10.1101/gad.258203; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; JESSEN KR, 1990, DEVELOPMENT, V109, P91; JESSEN KR, 1985, J CELL BIOL, V101, P1135, DOI 10.1083/jcb.101.3.1135; Jessen KR, 2008, GLIA, V56, P1552, DOI 10.1002/glia.20761; John GR, 2002, NAT MED, V8, P1115, DOI 10.1038/nm781; Kubu CJ, 2002, DEV BIOL, V244, P199, DOI 10.1006/dbio.2002.0568; Lasky JL, 2005, PEDIATR RES, V57, p104R, DOI 10.1203/01.PDR.0000159632.70510.3D; LEMKE G, 1988, DEVELOPMENT, V102, P499; Li YW, 2004, ONCOGENE, V23, P1146, DOI 10.1038/sj.onc.1207068; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Luo D, 2005, SEMIN CELL DEV BIOL, V16, P612, DOI 10.1016/j.semcdb.2005.07.002; Meier C, 1999, J NEUROSCI, V19, P3847; MORGAN L, 1994, DEVELOPMENT, V120, P1399; MORGAN L, 1991, J CELL BIOL, V112, P457, DOI 10.1083/jcb.112.3.457; Morrison SJ, 2000, CELL, V101, P499, DOI 10.1016/S0092-8674(00)80860-0; Muller HW, 1998, CURR OPIN NEUROL, V11, P557; Nave KA, 2007, NAT CLIN PRACT NEURO, V3, P453, DOI 10.1038/ncpneuro0583; Parkinson DB, 2008, J CELL BIOL, V181, P625, DOI 10.1083/jcb.200803013; Parkinson DB, 2003, MOL CELL NEUROSCI, V23, P13, DOI 10.1016/S1044-7431(03)00024-1; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Rangarajan A, 2001, EMBO J, V20, P3427, DOI 10.1093/emboj/20.13.3427; SCHERER SS, 2001, GLIAL CELL DEV, P299; Sharghi-Namini S, 2006, J NEUROSCI, V26, P6364, DOI 10.1523/JNEUROSCI.0157-06.2006; STEWART HJS, 1993, EUR J NEUROSCI, V5, P1136, DOI 10.1111/j.1460-9568.1993.tb00968.x; Suter U, 2003, NAT REV NEUROSCI, V4, P714, DOI 10.1038/nrn1196; Svaren J, 2008, GLIA, V56, P1541, DOI 10.1002/glia.20767; Tanigakik K, 2002, NAT IMMUNOL, V3, P443, DOI 10.1038/ni793; Taylor MK, 2007, DEVELOPMENT, V134, P2435, DOI 10.1242/dev.005520; TOPILKO P, 1994, NATURE, V371, P796, DOI 10.1038/371796a0; Wakamatsu Y, 2000, DEVELOPMENT, V127, P2811; Wang SL, 1998, NEURON, V21, P63, DOI 10.1016/S0896-6273(00)80515-2; WEBSTER HDF, 1973, DEV BIOL, V32, P401, DOI 10.1016/0012-1606(73)90250-9; Winseck AK, 2006, EUR J NEUROSCI, V24, P2105, DOI 10.1111/j.1460-9568.2006.05107.x; Woodhoo A, 2008, GLIA, V56, P1481, DOI 10.1002/glia.20723; Yang XD, 2004, DEV BIOL, V269, P81, DOI 10.1016/j.ydbio.2004.01.014; Yoon K, 2005, NAT NEUROSCI, V8, P709, DOI 10.1038/nn1475; Yu WM, 2005, J NEUROSCI, V25, P4463, DOI 10.1523/JNEUROSCI.5032-04.2005	50	231	235	1	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2009	12	7					839	U46		10.1038/nn.2323	http://dx.doi.org/10.1038/nn.2323			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	462OA	19525946	Green Accepted			2022-12-17	WOS:000267362900010
J	Skeberdis, VA; Chevaleyre, V; Lau, CG; Goldberg, JH; Pettit, DL; Suadicani, SO; Lin, Y; Bennett, MVL; Yuste, R; Castillo, PE; Zukin, RS				Skeberdis, VA; Chevaleyre, V; Lau, CG; Goldberg, JH; Pettit, DL; Suadicani, SO; Lin, Y; Bennett, MVL; Yuste, R; Castillo, PE; Zukin, RS			Protein kinase A regulates calcium permeability of NMDA receptors	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; CULTURED HIPPOCAMPAL-NEURONS; D-ASPARTATE RECEPTOR; DENDRITIC SPINES; VISUAL-CORTEX; CA1 REGION; LATE-PHASE; CHANNELS; LTP; EXPRESSION	Calcium (Ca2+) influx through NMDA receptors (NMDARs) is essential for synaptogenesis, experience-dependent synaptic remodeling and plasticity. The NMDAR-mediated rise in postsynaptic Ca2+ activates a network of kinases and phosphatases that promote persistent changes in synaptic strength, such as long-term potentiation (LTP). Here we show that the Ca2+ permeability of neuronal NMDARs is under the control of the cyclic AMP-protein kinase A (cAMP-PKA) signaling cascade. PKA blockers reduced the relative fractional Ca2+ influx through NMDARs as determined by reversal potential shift analysis and by a combination of electrical recording and Ca2+ influx measurements in rat hippocampal neurons in culture and hippocampal slices from mice. In slices, PKA blockers markedly inhibited NMDAR-mediated Ca21 rises in activated dendritic spines, with no significant effect on synaptic current. Consistent with this, PKA blockers depressed the early phase of NMDAR-dependent LTP at hippocampal Schaffer collateral-CA1 (Sch-CA1) synapses. Our data link PKA-dependent synaptic plasticity to Ca2+ signaling in spines and thus provide a new mechanism whereby PKA regulates the induction of LTP.	Yeshiva Univ Albert Einstein Coll Med, Dept Neurosci, Rose F Kennedy Ctr Res Mental Retardat & Dev Disa, Bronx, NY 10461 USA; Columbia Univ, Dept Biol Sci, Howard Hughes Med Inst, New York, NY 10027 USA	Yeshiva University; Albert Einstein College of Medicine; Columbia University; Howard Hughes Medical Institute	Zukin, RS (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Neurosci, Rose F Kennedy Ctr Res Mental Retardat & Dev Disa, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	zukin@aecom.yu.edu	Bennett, Michael/A-6958-2009; Lau, C. Geoffrey/G-4036-2014	Lau, C. Geoffrey/0000-0001-9750-2514; Castillo, Pablo/0000-0002-9834-1801; Goldberg, Jesse/0000-0003-0422-8902; Skeberdis, Vytenis Arvydas/0000-0001-7137-3187; Chevaleyre, Vivien/0000-0002-3679-4856	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065495] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020752, R01NS045287] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017392] Funding Source: NIH RePORTER; NIDA NIH HHS [DA17392] Funding Source: Medline; NIMH NIH HHS [MH65495] Funding Source: Medline; NINDS NIH HHS [NS45287, NS20752] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Beaver CJ, 2001, NAT NEUROSCI, V4, P159, DOI 10.1038/83985; Blank T, 1997, P NATL ACAD SCI USA, V94, P14859, DOI 10.1073/pnas.94.26.14859; Blitzer RD, 1998, SCIENCE, V280, P1940, DOI 10.1126/science.280.5371.1940; BURNASHEV N, 1995, J PHYSIOL-LONDON, V485, P403, DOI 10.1113/jphysiol.1995.sp020738; Carroll RC, 2002, TRENDS NEUROSCI, V25, P571, DOI 10.1016/S0166-2236(02)02272-5; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Cull-Candy Stuart G, 2004, Sci STKE, V2004, pre16, DOI 10.1126/stke.2552004re16; Cummings JA, 1996, NEURON, V16, P825, DOI 10.1016/S0896-6273(00)80102-6; Garaschuk O, 1996, J PHYSIOL-LONDON, V491, P757, DOI 10.1113/jphysiol.1996.sp021255; Hille B., 2001, ION CHANNELS EXCITAB; Hoffmann H, 2000, J NEUROCHEM, V75, P1590, DOI 10.1046/j.1471-4159.2000.0751590.x; Huang Y Y, 1994, Learn Mem, V1, P74; KACZMAREK LK, 1982, BRAIN RES, V238, P105, DOI 10.1016/0006-8993(82)90774-0; Lan JY, 2001, NAT NEUROSCI, V4, P382, DOI 10.1038/86028; LEGENDRE P, 1993, J NEUROSCI, V13, P674; Leonard AS, 1997, J BIOL CHEM, V272, P12107, DOI 10.1074/jbc.272.18.12107; LIEBERMAN DN, 1994, NATURE, V369, P235, DOI 10.1038/369235a0; Lin Y, 2004, J NEUROSCI, V24, P10138, DOI 10.1523/JNEUROSCI.3159-04.2004; Majewska A, 2000, PFLUG ARCH EUR J PHY, V441, P398, DOI 10.1007/s004240000435; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; MALENKA RC, 1991, NEURON, V6, P53, DOI 10.1016/0896-6273(91)90121-F; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; MAYER ML, 1987, J PHYSIOL-LONDON, V394, P501, DOI 10.1113/jphysiol.1987.sp016883; Otmakhova NA, 2000, J NEUROSCI, V20, P4446, DOI 10.1523/JNEUROSCI.20-12-04446.2000; Otmakhova NA, 1996, J NEUROSCI, V16, P7478; Qi M, 1996, P NATL ACAD SCI USA, V93, P1571, DOI 10.1073/pnas.93.4.1571; Quinlan EM, 1999, NAT NEUROSCI, V2, P352, DOI 10.1038/7263; Raman IM, 1996, NEURON, V16, P415, DOI 10.1016/S0896-6273(00)80059-8; ROGERS M, 1995, BIOPHYS J, V68, P501, DOI 10.1016/S0006-3495(95)80211-0; Scannevin RH, 2000, NAT REV NEUROSCI, V1, P133, DOI 10.1038/35039075; Scemes E, 2000, J NEUROSCI, V20, P1435; SCHNEGGENBURGER R, 1993, NEURON, V11, P133, DOI 10.1016/0896-6273(93)90277-X; Schneider MC, 1996, MOL MED TODAY, V2, P70, DOI 10.1016/1357-4310(96)88741-7; Sheng M, 2001, P NATL ACAD SCI USA, V98, P7058, DOI 10.1073/pnas.111146298; Snyder GL, 1998, J NEUROSCI, V18, P10297; Sobczyk A, 2005, J NEUROSCI, V25, P6037, DOI 10.1523/JNEUROSCI.1221-05.2005; Thomas MJ, 1996, NEURON, V17, P475, DOI 10.1016/S0896-6273(00)80179-8; Tingley WG, 1997, J BIOL CHEM, V272, P5157, DOI 10.1074/jbc.272.8.5157; TONG G, 1995, SCIENCE, V267, P1510, DOI 10.1126/science.7878472; WANG LY, 1994, NATURE, V369, P230, DOI 10.1038/369230a0; WANG SSH, 1995, NEURON, V15, P755, DOI 10.1016/0896-6273(95)90167-1; Westphal RS, 1999, SCIENCE, V285, P93, DOI 10.1126/science.285.5424.93; Winder DG, 2001, NAT REV NEUROSCI, V2, P461, DOI 10.1038/35081514; Wong ST, 1999, NEURON, V23, P787, DOI 10.1016/S0896-6273(01)80036-2; Yasuda H, 2003, NAT NEUROSCI, V6, P15, DOI 10.1038/nn985; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; Yuste R, 1999, J NEUROSCI, V19, P1976; ZHONG J, 1994, MOL PHARMACOL, V45, P846; ZORUMSKI CF, 1989, CELL MOL NEUROBIOL, V9, P95, DOI 10.1007/BF00711446	50	231	238	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2006	9	4					501	510		10.1038/nn1664	http://dx.doi.org/10.1038/nn1664			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	026BC	16531999				2022-12-17	WOS:000236310700017
J	Yu, X; Wadghiri, YZ; Sanes, DH; Turnbull, DH				Yu, X; Wadghiri, YZ; Sanes, DH; Turnbull, DH			In vivo auditory brain mapping in mice with Mn-enhanced MRI	NATURE NEUROSCIENCE			English	Article							RESONANCE-IMAGING MEMRI; INFERIOR COLLICULUS; OTITIS-MEDIA; MOUSE-BRAIN; ACTIVATION; RESPONSES; NEURONS; HEARING; NUCLEI	There are currently no noninvasive imaging methods available for auditory brain mapping in mice, despite the increasing use of genetically engineered mice to study auditory brain development and hearing loss. We developed a manganese-enhanced MRI (MEMRI) method to map regions of accumulated sound-evoked activity in awake, normally behaving mice. To demonstrate its utility for high-resolution (100-mu m) brain mapping, we used MEMRI to show the tonotopic organization of the mouse inferior colliculus. To test its efficacy in an experimental setting, we acquired data from mice experiencing unilateral conductive hearing loss at different ages. Larger and persistent changes in auditory brainstem activity resulted when hearing loss occurred before the onset of hearing, showing that early hearing loss biases the response toward the functional ear. Thus, MEMRI provides a sensitive and effective method for mapping the mouse auditory brainstem and has great potential for a range of functional neuroimaging studies in normal and mutant mice.	NYU, Sch Med, Skirball Inst Biomol Med, New York, NY 10016 USA; NYU, Sch Med, Grad Program Neurosci & Physiol, New York, NY 10016 USA; NYU, Sch Med, Dept Radiol, New York, NY 10016 USA; NYU, Ctr Neural Sci, New York, NY 10003 USA; NYU, Sch Med, Dept Pathol, New York, NY 10016 USA	New York University; New York University; New York University; New York University; New York University	Turnbull, DH (corresponding author), NYU, Sch Med, Skirball Inst Biomol Med, 540 1st Ave, New York, NY 10016 USA.	turnbull@saturn.med.nyu.edu	Wadghiri, Youssef Zaim/Q-5110-2019; Wadghiri, Youssef/E-6848-2016	Wadghiri, Youssef Zaim/0000-0001-7175-9397; Wadghiri, Youssef/0000-0001-7175-9397; Turnbull, Daniel/0000-0003-0889-5155	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006864, R21DC006892] Funding Source: NIH RePORTER; NIDCD NIH HHS [R21 DC006892, DC06892, R01 DC006864-03, R01 DC006864] Funding Source: Medline; NINDS NIH HHS [NS38461, R01 NS038461] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aoki I, 2004, NEUROIMAGE, V22, P1046, DOI 10.1016/j.neuroimage.2004.03.031; Aoki I, 2004, NMR BIOMED, V17, P569, DOI 10.1002/nbm.941; Bozza T, 2004, NEURON, V42, P9, DOI 10.1016/S0896-6273(04)00144-8; Duong TQ, 2000, MAGN RESON MED, V43, P383, DOI 10.1002/(SICI)1522-2594(200003)43:3<383::AID-MRM10>3.0.CO;2-Q; Ehret G, 1976, J Am Audiol Soc, V1, P179; Emmorey K, 2003, P NATL ACAD SCI USA, V100, P10049, DOI 10.1073/pnas.1730169100; HALL JW, 1995, ARCH OTOLARYNGOL, V121, P847; Kalatsky VA, 2003, NEURON, V38, P529, DOI 10.1016/S0896-6273(03)00286-1; KENNEDY C, 1975, SCIENCE, V187, P850, DOI 10.1126/science.1114332; Lin YJ, 1997, MAGN RESON MED, V38, P378, DOI 10.1002/mrm.1910380305; NARITA K, 1990, BRAIN RES, V510, P289, DOI 10.1016/0006-8993(90)91379-U; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Pautler RG, 2002, NEUROIMAGE, V16, P441, DOI 10.1006/nimg.2002.1075; Pautler RG, 1998, MAGNET RESON MED, V40, P740, DOI 10.1002/mrm.1910400515; ROMAND R, 1990, DEV BRAIN RES, V54, P221, DOI 10.1016/0165-3806(90)90145-O; RYUGO DK, 1981, BRAIN RES, V210, P342, DOI 10.1016/0006-8993(81)90907-0; Saleem KS, 2002, NEURON, V34, P685, DOI 10.1016/S0896-6273(02)00718-3; SANES DH, 1985, J NEUROSCI, V5, P1152; SCHILDER AGM, 1993, CLIN OTOLARYNGOL, V18, P234; Sharma Anu, 2002, Ear and Hearing, V23, P532, DOI 10.1097/00003446-200212000-00004; Shnerson A, 1983, AUDITORY PSYCHOBIOLO, P395; Shukakidze A, 2003, Neurosci Behav Physiol, V33, P263; Sterbing SJ, 2003, HEARING RES, V177, P91, DOI 10.1016/S0378-5955(02)00805-5; Tai YC, 2003, PHYS MED BIOL, V48, P1519, DOI 10.1088/0031-9155/48/11/303; Tindemans I, 2003, EUR J NEUROSCI, V18, P3352, DOI 10.1111/j.1460-9568.2003.03056.x; Tucci DL, 1999, LARYNGOSCOPE, V109, P1359, DOI 10.1097/00005537-199909000-00001; Wadghiri YZ, 2004, NMR BIOMED, V17, P613, DOI 10.1002/nbm.932; Watanabe T, 2002, MAGN RESON MED, V48, P852, DOI 10.1002/mrm.10276; WEBSTER DB, 1977, ARCH OTOLARYNGOL, V103, P392; WILLOTT JF, 1978, J COMP PHYSIOL, V127, P175, DOI 10.1007/BF01352302	30	231	236	1	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2005	8	7					961	968		10.1038/nn1477	http://dx.doi.org/10.1038/nn1477			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	940IK	15924136	Green Accepted			2022-12-17	WOS:000230137100025
J	Kohn, A; Movshon, JA				Kohn, A; Movshon, JA			Adaptation changes the direction tuning of macaque MT neurons	NATURE NEUROSCIENCE			English	Article							UNDERLYING CONTRAST ADAPTATION; TEMPORAL VISUAL AREA; ORIENTATION SELECTIVITY; CORTICAL PLASTICITY; TRANSPARENT MOTION; SINGLE UNITS; V1 NEURONS; CORTEX; MONKEY; PERCEPTION	Prolonged exposure to a stimulus, called 'adaptation', reduces cortical responsiveness. Adaptation has been studied extensively in primary visual cortex (V1), where responsivity is usually reduced most when the adapting and test stimuli are well matched. Theories about the functional benefits of adaptation have relied on this specificity, but the resultant changes in neuronal tuning are of the wrong type to account for well-documented perceptual aftereffects. Here we have used moving sinusoidal gratings to study the effect of adaptation on the direction tuning of neurons in area MT in macaques. Responsivity in MT is maintained best in the adapted direction and is strongly reduced for nearby directions. Consequently, adaptation in the preferred direction reduces the direction-tuning bandwidth, whereas adaptation at near-preferred directions causes tuning to shift toward the adapted direction. This previously unknown effect of adaptation is consistent with perceptual aftereffects and indicates that different cortical regions may adjust to constant sensory input in distinct ways.	NYU, Ctr Neural Sci, New York, NY 10003 USA	New York University	Kohn, A (corresponding author), NYU, Ctr Neural Sci, 4 Washington Pl,Room 809, New York, NY 10003 USA.	adamk@cns.nyu.edu			NATIONAL EYE INSTITUTE [R01EY002017] Funding Source: NIH RePORTER; NEI NIH HHS [EY02017] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALBRECHT DG, 1984, J PHYSIOL-LONDON, V347, P713, DOI 10.1113/jphysiol.1984.sp015092; BARLOW H, 1989, COMP NEUR S, P54; BLAKEMORE C, 1970, J PHYSIOL-LONDON, V210, P727, DOI 10.1113/jphysiol.1970.sp009238; Blakemore C., 2010, VISION CODING EFFICI, P363, DOI 10.1017/cbo9780511626197.034; Carandini M, 1997, SCIENCE, V276, P949, DOI 10.1126/science.276.5314.949; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2530, DOI 10.1152/jn.00692.2001; CHANDLER JP, 1969, BEHAV SCI, V14, P81; CHANDRAN PKG, 1985, ADV CAPD, V1, P18; CHAUDHURI A, 1990, NATURE, V344, P60, DOI 10.1038/344060a0; Clifford CWG, 2002, TRENDS COGN SCI, V6, P136, DOI 10.1016/S1364-6613(00)01856-8; Dragoi V, 2000, NEURON, V28, P287, DOI 10.1016/S0896-6273(00)00103-3; Dragoi V, 2002, NAT NEUROSCI, V5, P883, DOI 10.1038/nn900; Dragoi V, 2001, NATURE, V411, P80, DOI 10.1038/35075070; Felsen G, 2002, NEURON, V36, P945, DOI 10.1016/S0896-6273(02)01011-5; Fu YX, 2002, SCIENCE, V296, P1999, DOI 10.1126/science.1070521; Gibson JJ, 1937, J EXP PSYCHOL, V20, P453, DOI 10.1037/h0059826; Gibson JJ, 1933, J EXP PSYCHOL, V16, P1, DOI 10.1037/h0074626; GILBERT CD, 1990, VISION RES, V30, P1689, DOI 10.1016/0042-6989(90)90153-C; Kohler Wolfgang, 1944, PROC AMER PHIL SOC, V88, P269; Kohn A, 2003, NEURON, V39, P681, DOI 10.1016/S0896-6273(03)00438-0; LEHMKUHLE SW, 1975, VISION RES, V15, P855, DOI 10.1016/0042-6989(75)90266-7; LEVENTHAL AG, 1995, J NEUROSCI, V15, P1808, DOI 10.1523/JNEUROSCI.15-03-01808.1995; LEVINSON E, 1976, VISION RES, V16, P779, DOI 10.1016/0042-6989(76)90189-9; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1127, DOI 10.1152/jn.1983.49.5.1127; MAUNSELL JHR, 1983, J NEUROSCI, V3, P2563; Movshon A, 1985, PATTERN RECOGN, V54, P117; MOVSHON JA, 1979, NATURE, V278, P850, DOI 10.1038/278850a0; Movshon JA, 1996, J NEUROSCI, V16, P7733; Muller JR, 1999, SCIENCE, V285, P1405, DOI 10.1126/science.285.5432.1405; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; OHZAWA I, 1985, J NEUROPHYSIOL, V54, P651, DOI 10.1152/jn.1985.54.3.651; Patterson R, 1996, VISION RES, V36, P1773, DOI 10.1016/0042-6989(95)00239-1; PETERSEN SE, 1985, BRAIN RES, V346, P146, DOI 10.1016/0006-8993(85)91105-9; QIAN N, 1994, J NEUROSCI, V14, P7367; SALZMAN CD, 1992, J NEUROSCI, V12, P2331; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4267; SAUL AB, 1989, VISUAL NEUROSCI, V2, P593, DOI 10.1017/S0952523800003527; SAUL AB, 1989, VISUAL NEUROSCI, V2, P609, DOI 10.1017/S0952523800003539; Schrater PR, 1998, VISION RES, V38, P3899, DOI 10.1016/S0042-6989(98)00088-1; SNOWDEN RJ, 1991, J NEUROSCI, V11, P2768; STONER GR, 1992, NATURE, V358, P412, DOI 10.1038/358412a0; Sur M, 2002, CURR BIOL, V12, pR168, DOI 10.1016/S0960-9822(02)00733-9; Teich AF, 2003, J NEUROPHYSIOL, V89, P2086, DOI 10.1152/jn.00970.2002; Thiele A, 2000, NEURON, V26, P715, DOI 10.1016/S0896-6273(00)81207-6; Thomson AM, 1997, CEREB CORTEX, V7, P510, DOI 10.1093/cercor/7.6.510; Van Wezel RJA, 2002, J NEUROPHYSIOL, V88, P3469, DOI 10.1152/jn.00276.2002; Wainwright MJ, 1999, VISION RES, V39, P3960, DOI 10.1016/S0042-6989(99)00101-7; Wainwright MJ, 2002, NEURAL INF PROCESS S, P203; WIESENFELDER H, 1990, J NEUROSCI, V10, P3880, DOI 10.1523/JNEUROSCI.10-12-03880.1990; ZEKI SM, 1974, J PHYSIOL-LONDON, V236, P549, DOI 10.1113/jphysiol.1974.sp010452	50	231	231	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2004	7	7					764	772		10.1038/nn1267	http://dx.doi.org/10.1038/nn1267			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	832NO	15195097				2022-12-17	WOS:000222274400019
J	Amateau, SK; McCarthy, MM				Amateau, SK; McCarthy, MM			Induction of PGE(2) by estradiol mediates developmental masculinization of sex behavior	NATURE NEUROSCIENCE			English	Article							SEXUALLY DIMORPHIC NUCLEUS; PREOPTIC AREA; CLINICAL PHARMACOKINETICS; DENDRITIC SPINES; ARCUATE NUCLEUS; BINDING PROTEIN; RECEPTOR-ALPHA; MALE-RATS; DIFFERENTIATION; BRAIN	Adult male sexual behavior in mammals requires the neuronal organizing effects of gonadal steroids during a sensitive perinatal period. During development, estradiol differentiates the rat preoptic area (POA), an essential brain region in the male copulatory circuit. Here we report that increases in prostaglandin-E-2 (PGE(2)), resulting from changes in cyclooxygenase-2 (COX-2) regulation induced by perinatal exposure to estradiol, are necessary and sufficient to organize the crucial neural substrate that mediates male sexual behavior. Briefly preventing prostaglandin synthesis in newborn males with the COX inhibitor indomethacin permanently downregulates markers of dendritic spines in the POA and severely impairs male sexual behavior. Developmental exposure to the COX inhibitor aspirin results in mild impairment of sexual behavior. Conversely, administration of PGE(2) to newborn females masculinizes the POA and leads to male sex behavior in adults, thereby highlighting the pathway of steroid-independent brain masculinization. Our findings show that PGE(2) functions as a downstream effector of estradiol to permanently masculinize the brain.	Univ Maryland, Sch Med, Program Neurosci, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Amateau, SK (corresponding author), Univ Maryland, Sch Med, Program Neurosci, Baltimore, MD 21201 USA.	samat001@umaryland.edu	McCarthy, Margaret/O-2059-2017	McCarthy, Margaret/0000-0003-2243-4726	NICHD NIH HHS [U54 HD28934] Funding Source: Medline; NIMH NIH HHS [MH52716, MH12862] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD028934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F30MH012862, R01MH052716, R29MH052716] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Amateau SK, 2004, ENDOCRINOLOGY, V145, P2906, DOI 10.1210/en.2003-1363; Amateau SK, 2002, J NEUROSCI, V22, P8586; Auger AP, 2002, ENDOCRINOLOGY, V143, P3009, DOI 10.1210/en.143.8.3009; Baum B.M., 2002, BEHAV ENDOCRINOLOGY, P153; BEACH FA, 1946, J EXP ZOOL, V101, P91, DOI 10.1002/jez.1401010107; BREDER CD, 1995, J COMP NEUROL, V355, P296, DOI 10.1002/cne.903550208; Calizo LH, 2000, J NEUROSCI, V20, P1589; CHRISTENSEN LW, 1977, BRAIN RES BULL, V2, P137, DOI 10.1016/0361-9230(77)90010-7; Davis AM, 2000, BEHAV NEUROSCI, V114, P923, DOI 10.1037/0735-7044.114.5.923; Davis EC, 1996, BRAIN RES, V734, P10, DOI 10.1016/0006-8993(96)00298-3; de Vries G.J., 2002, HORMONES BRAIN BEHAV, P137, DOI [10.1016/B978, DOI 10.1016/B978-012532104-4/50066-4]; DEWSBURY DA, 1969, ANIM BEHAV, V17, P217, DOI 10.1016/0003-3472(69)90004-9; Emmons SW, 2003, J NEUROBIOL, V54, P93, DOI 10.1002/neu.10163; Feng J, 2000, P NATL ACAD SCI USA, V97, P9287, DOI 10.1073/pnas.97.16.9287; Feng PF, 2001, DEV BRAIN RES, V129, P107, DOI 10.1016/S0165-3806(01)00158-4; Forger NG, 1998, J NEUROSCI, V18, P8720; GEORGE FW, 1982, ENDOCRINOLOGY, V111, P522, DOI 10.1210/endo-111-2-522; GLASER EM, 1981, J NEUROSCI METH, V4, P117, DOI 10.1016/0165-0270(81)90045-5; Goldin M, 2001, J NEUROSCI, V21, P186, DOI 10.1523/JNEUROSCI.21-01-00186.2001; GORSKI RA, 1978, BRAIN RES, V148, P333, DOI 10.1016/0006-8993(78)90723-0; GORSKI RA, 1980, J COMP NEUROL, V193, P529, DOI 10.1002/cne.901930214; GREEN GA, 2001, CLIN CORNERSTONE, V3, P5; HARRIS KM, 1992, J NEUROSCI, V12, P2685; HELLEBERG L, 1981, CLIN PHARMACOKINET, V6, P245, DOI 10.2165/00003088-198106040-00001; Herrmann K, 1996, J COMP NEUROL, V375, P1; HOUTSMULLER EJ, 1994, PHYSIOL BEHAV, V56, P535, DOI 10.1016/0031-9384(94)90298-4; Hull EM, 2002, HORMONES BRAIN BEHAV, P3, DOI DOI 10.1016/B978-012532104-4/50003-2; LARRIVASAHD J, 1991, NEUROENDOCRINOLOGY, V54, P416, DOI 10.1159/000125923; LEVY G, 1978, PEDIATRICS, V62, P867; MALENKA RC, 1991, MOL NEUROBIOL, V5, P289, DOI 10.1007/BF02935552; MCMULLEN NT, 1981, AM J ANAT, V161, P323, DOI 10.1002/aja.1001610306; Meisel Robert L., 1994, P3; Mong JA, 1999, J NEUROSCI, V19, P1464; Mong JA, 2001, J COMP NEUROL, V432, P259, DOI 10.1002/cne.1101; Murphy AZ, 2001, J COMP NEUROL, V438, P191, DOI 10.1002/cne.1309; PEREZ J, 1990, BRAIN RES, V527, P116, DOI 10.1016/0006-8993(90)91068-R; PFAFF DW, 1966, J ENDOCRINOL, V36, P415, DOI 10.1677/joe.0.0360415; PFAUS JG, 1990, BRAIN RES, V530, P345, DOI 10.1016/0006-8993(90)91309-5; PHOENIX CH, 1959, ENDOCRINOLOGY, V65, P369, DOI 10.1210/endo-65-3-369; Powell WS, 2003, BEHAV NEUROSCI, V117, P69, DOI 10.1037/0735-7044.117.1.69; RAISMAN G, 1971, SCIENCE, V173, P731, DOI 10.1126/science.173.3998.731; Roselli CE, 2003, HORM BEHAV, V44, P146, DOI 10.1016/S0018-506X(03)00123-5; Ryner LC, 1996, CELL, V87, P1079, DOI 10.1016/S0092-8674(00)81802-4; Shughrue PJ, 1997, J COMP NEUROL, V388, P507, DOI 10.1002/(SICI)1096-9861(19971201)388:4<507::AID-CNE1>3.0.CO;2-6; Simerly RB, 2002, ANNU REV NEUROSCI, V25, P507, DOI 10.1146/annurev.neuro.25.112701.142745; Sorra KE, 2000, HIPPOCAMPUS, V10, P501, DOI 10.1002/1098-1063(2000)10:5<501::AID-HIPO1>3.0.CO;2-T; Stephens DJ, 2000, BIOCHEM J, V345, P185, DOI 10.1042/0264-6021:3450185; Truitt WA, 2002, SCIENCE, V297, P1566, DOI 10.1126/science.1073885; WEISZ J, 1980, ENDOCRINOLOGY, V106, P306, DOI 10.1210/endo-106-1-306; WOOLLEY CS, 1992, J NEUROSCI, V12, P2549	50	231	232	2	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2004	7	6					643	650		10.1038/nn1254	http://dx.doi.org/10.1038/nn1254			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	823VA	15156148				2022-12-17	WOS:000221640300019
J	Andersen, SL; Arvanitogiannis, A; Pliakas, AM; LeBlanc, C; Carlezon, WA				Andersen, SL; Arvanitogiannis, A; Pliakas, AM; LeBlanc, C; Carlezon, WA			Altered responsiveness to cocaine in rats exposed to methylphenidate during development	NATURE NEUROSCIENCE			English	Article							EXPRESSION; DOPAMINE		Harvard Univ, Sch Med, Dept Psychiat, Belmont, MA 02478 USA; McLean Hosp, Belmont, MA 02478 USA	Harvard University; Harvard University; McLean Hospital	Andersen, SL (corresponding author), Harvard Univ, Sch Med, Dept Psychiat, 115 Mill St, Belmont, MA 02478 USA.	andersen@mclean.org			NIDA NIH HHS [DA12736] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012736] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		ANDERSEN SL, IN PRESS BEHAV BRAIN; BALSKUBIK R, 1989, PSYCHOPHARMACOLOGY, V98, P203, DOI 10.1007/BF00444692; Biederman J, 1999, PEDIATRICS, V104, part. no., DOI 10.1542/peds.104.2.e20; Brandon CL, 2001, NEUROPSYCHOPHARMACOL, V25, P651, DOI 10.1016/S0893-133X(01)00281-0; Carlezon WA, 1998, SCIENCE, V282, P2272, DOI 10.1126/science.282.5397.2272; COLE RL, 1995, NEURON, V14, P813, DOI 10.1016/0896-6273(95)90225-2; DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274; Kelz MB, 1999, NATURE, V401, P272, DOI 10.1038/45790; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Pliakas AM, 2001, J NEUROSCI, V21, P7397, DOI 10.1523/JNEUROSCI.21-18-07397.2001; Robinson TE, 2000, ADDICTION, V95, pS91; ROSENGARTEN H, 1979, SCIENCE, V203, P1133, DOI 10.1126/science.570724; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; WARGIN W, 1983, J PHARMACOL EXP THER, V226, P382; WISE RA, 1987, PSYCHOL REV, V94, P469, DOI 10.1037/0033-295X.94.4.469	15	231	233	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2002	5	1					13	14		10.1038/nn777	http://dx.doi.org/10.1038/nn777			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	507MG	11731802				2022-12-17	WOS:000173031800007
J	Sankaranarayanan, S; Ryan, TA				Sankaranarayanan, S; Ryan, TA			Calcium accelerates endocytosis of vSNAREs at hippocampal synapses	NATURE NEUROSCIENCE			English	Article							FROG NEUROMUSCULAR-JUNCTION; SYNAPTIC VESICLE MEMBRANE; ADRENAL CHROMAFFIN CELLS; TRANSMITTER RELEASE; RAPID ENDOCYTOSIS; V-ATPASES; DYNAMIN; TRANSMISSION; EXOCYTOSIS; INHIBITION	A pH-sensitive form of green-fluorescent protein (GFP) fused to the lumenal domain of VAMP (synapto-pHluorin) provides a sensitive optical probe to track the net balance between exocytosis and endocytosis of this protein at small synaptic terminals of the central nervous system. Here we used a reversible proton-pump blocker that prevents vesicle re-acidification upon endocytosis to trap vesicles in the alkaline state during recycling. In combination with optical measurements of synapto-pHluorin, we used alkaline trapping to examine the kinetic components of exocytosis and endocytosis separately at synaptic terminals. Using this approach, we show that, in addition to controlling exocytosis, intracellular calcium levels tightly regulate the speed of endocytosis, increasing it to a maximal speed of approximately one vesicle per second.	Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA	Cornell University	Ryan, TA (corresponding author), Cornell Univ, Weill Med Coll, Dept Biochem, 1300 York Ave, New York, NY 10021 USA.		Ryan, Timothy/AAO-8286-2020	Ryan, Timothy/0000-0003-2533-9548	NINDS NIH HHS [NS24692] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Artalejo CR, 1996, NEURON, V16, P195, DOI 10.1016/S0896-6273(00)80036-7; ARTALEJO CR, 1995, P NATL ACAD SCI USA, V92, P8328, DOI 10.1073/pnas.92.18.8328; AUGUSTINE GJ, 1986, J PHYSIOL-LONDON, V381, P619, DOI 10.1113/jphysiol.1986.sp016347; BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; Cousin MA, 1997, J NEUROCHEM, V69, P1927; Drose S, 1997, J EXP BIOL, V200, P1; Haupts U, 1998, P NATL ACAD SCI USA, V95, P13573, DOI 10.1073/pnas.95.23.13573; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; KOENIG JH, 1989, J NEUROSCI, V9, P3844; LIU JP, 1994, SCIENCE, V265, P970, DOI 10.1126/science.8052858; Marks B, 1998, CURR BIOL, V8, P740, DOI 10.1016/S0960-9822(98)70297-0; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; NELSON N, 1992, J EXP BIOL, V172, P149; Pyle JL, 2000, NEURON, V28, P221, DOI 10.1016/S0896-6273(00)00098-2; RAMASWAMI M, 1994, NEURON, V13, P363, DOI 10.1016/0896-6273(94)90353-0; Ryan TA, 1996, P NATL ACAD SCI USA, V93, P5567, DOI 10.1073/pnas.93.11.5567; RYAN TA, 1995, NEURON, V14, P983, DOI 10.1016/0896-6273(95)90336-4; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Slepnev VI, 1998, SCIENCE, V281, P821, DOI 10.1126/science.281.5378.821; Takahashi T, 1996, SCIENCE, V274, P594, DOI 10.1126/science.274.5287.594; Takei K, 1996, J CELL BIOL, V133, P1237, DOI 10.1083/jcb.133.6.1237; Wu LG, 1996, NEURON, V17, P769, DOI 10.1016/S0896-6273(00)80208-1; WYTHRICH K, 1986, NMR PROTEINS NUCL AC; Zhou Q, 2000, J PHYSIOL-LONDON, V525, P195, DOI 10.1111/j.1469-7793.2000.t01-1-00195.x	28	231	238	2	15	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2001	4	2					129	136		10.1038/83949	http://dx.doi.org/10.1038/83949			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UC	11175872				2022-12-17	WOS:000167178100010
J	Xie, Q; Wu, QL; Horbinski, CM; Flavahan, WA; Yang, KL; Zhou, WC; Dombrowski, SM; Huang, Z; Fang, XG; Shi, Y; Ferguson, AN; Kashatus, DF; Bao, SD; Rich, JN				Xie, Qi; Wu, Qiulian; Horbinski, Craig M.; Flavahan, William A.; Yang, Kailin; Zhou, Wenchao; Dombrowski, Stephen M.; Huang, Zhi; Fang, Xiaoguang; Shi, Yu; Ferguson, Ashley N.; Kashatus, David F.; Bao, Shideng; Rich, Jeremy N.			Mitochondrial control by DRP1 in brain tumor initiating cells	NATURE NEUROSCIENCE			English	Article							GLIOBLASTOMA STEM-CELLS; OXIDATIVE-PHOSPHORYLATION; GROWTH-FACTOR; GLIOMA-CELLS; FISSION; DYNAMICS; CANCER; INHIBITION; PATHWAY; FUSION	Brain tumor initiating cells (BTICs) co-opt the neuronal high affinity glucose transporter, GLUT3, to withstand metabolic stress. We investigated another mechanism critical to brain metabolism, mitochondrial morphology, in BTICs. BTIC mitochondria were fragmented relative to non-BTIC tumor cell mitochondria, suggesting that BTICs increase mitochondrial fission. The essential mediator of mitochondrial fission, dynamin-related protein 1 (DRP1), showed activating phosphorylation in BTICs and inhibitory phosphorylation in non-BTIC tumor cells. Targeting DRP1 using RNA interference or pharmacologic inhibition induced BTIC apoptosis and inhibited tumor growth. Downstream, DRP1 activity regulated the essential metabolic stress sensor, AMP-activated protein kinase (AMPK), and targeting AMPK rescued the effects of DRP1 disruption. Cyclin-dependent kinase 5 (CDK5) phosphorylated DRP1 to increase its activity in BTICs, whereas Ca2+-calmodulin-dependent protein kinase 2 (CAMK2) inhibited DRP1 in non-BTIC tumor cells, suggesting that tumor cell differentiation induces a regulatory switch in mitochondrial morphology. DRP1 activation correlated with poor prognosis in glioblastoma, suggesting that mitochondrial dynamics may represent a therapeutic target for BTICs.	[Xie, Qi; Wu, Qiulian; Flavahan, William A.; Yang, Kailin; Zhou, Wenchao; Huang, Zhi; Fang, Xiaoguang; Shi, Yu; Bao, Shideng; Rich, Jeremy N.] Lerner Res Inst, Dept Stem Cell Biol & Regenerat Med, Cleveland, OH 44195 USA; [Horbinski, Craig M.] Univ Kentucky, Dept Pathol, Lexington, KY USA; [Yang, Kailin; Bao, Shideng; Rich, Jeremy N.] Case Western Reserve Univ, Lerner Coll Med, Cleveland Clin, Dept Mol Med, Cleveland, OH 44106 USA; [Dombrowski, Stephen M.] Cleveland Clin, Dept Neurol Surg, Cleveland, OH 44106 USA; [Ferguson, Ashley N.; Kashatus, David F.] Univ Virginia, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA USA	Cleveland Clinic Foundation; University of Kentucky; Case Western Reserve University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of Virginia	Rich, JN (corresponding author), Lerner Res Inst, Dept Stem Cell Biol & Regenerat Med, Cleveland, OH 44195 USA.	drjeremyrich@gmail.com	Rich, Jeremy/AAM-1445-2021; Kashatus, David F/D-8299-2012; Zhou, Wenchao/ABE-9015-2020; Yang, Kailin/L-2205-2013	Kashatus, David F/0000-0001-8007-0612; Yang, Kailin/0000-0001-5968-6738; Xie, Qi/0000-0002-2370-2078; Ferguson, Ashley/0000-0002-9133-6735	US National Institutes of Health [CA154130, CA169117, CA171652, NS087913, NS089272, CA155764, 2P20 RR020171, NS070315]; Research Programs Committees of Cleveland Clinic; James S. McDonnell Foundation; Peter and Carmen Lucia Buck Training Program in Translational Clinical Oncology; University of Kentucky College of Medicine Physician Scientist Program; University of Kentucky Markey Cancer Center [P30CA177558]; NATIONAL CANCER INSTITUTE [P30CA177558, R01CA154130, K08CA155764, R01CA169117, R01CA171652] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070315, R01NS087913, R01NS089272] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Programs Committees of Cleveland Clinic; James S. McDonnell Foundation; Peter and Carmen Lucia Buck Training Program in Translational Clinical Oncology; University of Kentucky College of Medicine Physician Scientist Program; University of Kentucky Markey Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We appreciate flow cytometry assistance from C. Shemo and S. O'Bryant, and the tissue provided by M. McGraw, the Cleveland Clinic Foundation Tissue Procurement Service and A.E. Sloan (University Hospitals). I. Nakano (Ohio State University) kindly provided the IN528 model. We thank members of the Rich laboratory for critical reading of the manuscript and discussions. We thank A. Janocha for help with using the Seahorse XF Extracellular Flux Analyzer. Special thanks to D. Napier for her histologic expertise. Finally, we thank our funding sources: US National Institutes of Health grants CA154130, CA169117, CA171652, NS087913, NS089272 (J.N.R.), and CA155764, 2P20 RR020171 COBRE pilot grant (C.M.H.) and NS070315 (S.B.); the Research Programs Committees of Cleveland Clinic (J.N.R.); and the James S. McDonnell Foundation (J.N.R.). C.M.H. was supported by the Peter and Carmen Lucia Buck Training Program in Translational Clinical Oncology and the University of Kentucky College of Medicine Physician Scientist Program. The Markey Biospecimen and Tissue Procurement (BSTP) Shared Resource Facility facilitated the construction of tissue microarrays and immunohistochemical studies. The BSTP Shared Resource Facility is supported by the University of Kentucky Markey Cancer Center (P30CA177558).	Anido J, 2010, CANCER CELL, V18, P655, DOI 10.1016/j.ccr.2010.10.023; Archer SL, 2013, NEW ENGL J MED, V369, P2236, DOI 10.1056/NEJMra1215233; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Catania A, 2001, NEURO-ONCOLOGY, V3, P89, DOI 10.1093/neuonc/3.2.89; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Cheng L, 2013, CELL, V153, P139, DOI 10.1016/j.cell.2013.02.021; Cribbs JT, 2007, EMBO REP, V8, P939, DOI 10.1038/sj.embor.7401062; Eramo A, 2006, CELL DEATH DIFFER, V13, P1238, DOI 10.1038/sj.cdd.4401872; Eyler CE, 2011, CELL, V146, P53, DOI 10.1016/j.cell.2011.06.006; Flavahan WA, 2013, NAT NEUROSCI, V16, P1373, DOI 10.1038/nn.3510; Frattini V, 2013, NAT GENET, V45, P1141, DOI 10.1038/ng.2734; Gage FH, 2013, NEURON, V80, P588, DOI 10.1016/j.neuron.2013.10.037; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gao C, 2001, J CELL SCI, V114, P1145; Gharanei M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077713; Gilbert MR, 2014, ACTA NEUROPATHOL, V127, P221, DOI 10.1007/s00401-013-1194-6; Gunther HS, 2008, ONCOGENE, V27, P2897, DOI 10.1038/sj.onc.1210949; Guido C, 2012, ONCOTARGET, V3, P798, DOI 10.18632/oncotarget.574; Guo X, 2013, J CLIN INVEST, V123, P5371, DOI 10.1172/JCI70911; Han XJ, 2008, J CELL BIOL, V182, P573, DOI 10.1083/jcb.200802164; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Janiszewska M, 2012, GENE DEV, V26, P1926, DOI 10.1101/gad.188292.112; Kasahara A, 2013, SCIENCE, V342, P734, DOI 10.1126/science.1241359; Kashatus DF, 2011, NAT CELL BIOL, V13, P1108, DOI 10.1038/ncb2310; Kathagen A, 2013, ACTA NEUROPATHOL, V126, P763, DOI 10.1007/s00401-013-1173-y; Lagadinou ED, 2013, CELL STEM CELL, V12, P329, DOI 10.1016/j.stem.2012.12.013; Liu R, 2008, P NATL ACAD SCI USA, V105, P7570, DOI 10.1073/pnas.0712306105; Marin-Valencia I, 2012, CELL METAB, V15, P827, DOI 10.1016/j.cmet.2012.05.001; Ochocki JD, 2013, J CELL BIOL, V203, P23, DOI 10.1083/jcb.201303110; Palorini R, 2013, ONCOGENE, V32, P352, DOI 10.1038/onc.2012.50; Rehman J, 2012, FASEB J, V26, P2175, DOI 10.1096/fj.11-196543; Sarkar S, 2014, NAT NEUROSCI, V17, P46, DOI 10.1038/nn.3597; Sato A, 2012, STEM CELL TRANSL MED, V1, P811, DOI 10.5966/sctm.2012-0058; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Son MJ, 2009, CELL STEM CELL, V4, P440, DOI 10.1016/j.stem.2009.03.003; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Tanaka A, 2008, MOL CELL, V29, P409, DOI 10.1016/j.molcel.2008.02.005; Thomas KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045319; Todd LR, 2010, AUTOPHAGY, V6, P821, DOI 10.1091/mbc.E09-11-0937; Todd LR, 2010, MOL BIOL CELL, V21, P1225, DOI 10.1091/mbc.E09-11-0937; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; Vlashi E, 2011, P NATL ACAD SCI USA, V108, P16062, DOI 10.1073/pnas.1106704108; Wan YY, 2014, ONCOL REP, V32, P619, DOI 10.3892/or.2014.3235; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Zhao J, 2013, ONCOGENE, V32, P4814, DOI 10.1038/onc.2012.494; Zhou BBS, 2009, NAT REV DRUG DISCOV, V8, P806, DOI 10.1038/nrd2137	50	230	237	9	75	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2015	18	4					501	+		10.1038/nn.3960	http://dx.doi.org/10.1038/nn.3960			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CE4DL	25730670	Green Accepted			2022-12-17	WOS:000351780900011
J	Kokaia, Z; Martino, G; Schwartz, M; Lindvall, O				Kokaia, Zaal; Martino, Gianvito; Schwartz, Michal; Lindvall, Olle			Cross-talk between neural stem cells and immune cells: the key to better brain repair?	NATURE NEUROSCIENCE			English	Review							ADULT HIPPOCAMPAL NEUROGENESIS; SPINAL-CORD-INJURY; PROMOTES NEURONAL DIFFERENTIATION; OLIGODENDROCYTE PRECURSOR CELLS; ENDOTHELIAL GROWTH-FACTOR; PROGENITOR-CELLS; SUBVENTRICULAR ZONE; MULTIPLE-SCLEROSIS; IN-VITRO; AUTOIMMUNE ENCEPHALOMYELITIS	Systemic or intracerebral delivery of neural stem and progenitor cells (NSPCs) and activation of endogenous NSPCs hold much promise as potential treatments for diseases in the human CNS. Recent studies have shed new light on the interaction between the NSPCs and cells belonging to the innate and adaptive arms of the immune system. According to these studies, the immune cells can be both beneficial and detrimental for cell genesis from grafted and endogenous NSPCs in the CNS, and the NSPCs exert their beneficial effects not only by cell replacement but also by immunomodulation and trophic support. The crosstalk between immune cells and NSPCs and their progeny seems to determine both the efficacy of endogenous regenerative responses and the mechanism of action as well as the fate and functional integration of grafted NSPCs. Better understanding of the dialog between NSPCs and innate and adaptive immune cells is crucial for further development of effective strategies for CNS repair.	[Kokaia, Zaal; Lindvall, Olle] Univ Hosp, Lund Stem Cell Ctr, Lund, Sweden; [Martino, Gianvito] Hosp San Raffaele, Div Neurosci, I-20132 Milan, Italy; [Schwartz, Michal] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel	Lund University; Skane University Hospital; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Weizmann Institute of Science	Lindvall, O (corresponding author), Univ Hosp, Lund Stem Cell Ctr, Lund, Sweden.	olle.lindvall@med.lu.se	martino, gianvito/AAL-2682-2020; Kokaia, Zaal/AAL-6009-2020	martino, gianvito/0000-0003-1295-9131; Kokaia, Zaal/0000-0003-2296-2449	European Union [279017]	European Union(European Commission)	All authors are supported by European Union FP7 collaborative grant TargetBraIn (no. 279017).	Aberg MAI, 2003, MOL CELL NEUROSCI, V24, P23, DOI 10.1016/S1044-7431(03)00082-4; AHMED S, 1995, J NEUROSCI, V15, P5765; Bachoud-Levi A, 2000, LANCET, V356, P1975, DOI 10.1016/S0140-6736(00)03310-9; Bacigaluppi M, 2009, BRAIN, V132, P2239, DOI 10.1093/brain/awp174; Batchelor PE, 1999, J NEUROSCI, V19, P1708; Ben-Hur T, 2003, MOL CELL NEUROSCI, V24, P623, DOI 10.1016/S1044-7431(03)00218-5; Bernaudin M, 1999, J CEREBR BLOOD F MET, V19, P643, DOI 10.1097/00004647-199906000-00007; Blakemore WF, 2008, CURR TOP MICROBIOL, V318, P193; Bonde S, 2006, EUR J NEUROSCI, V23, P965, DOI 10.1111/j.1460-9568.2006.04635.x; Butovsky O, 2006, MOL CELL NEUROSCI, V31, P149, DOI 10.1016/j.mcn.2005.10.006; Butovsky O, 2006, P NATL ACAD SCI USA, V103, P11784, DOI 10.1073/pnas.0604681103; Cacci E, 2008, GLIA, V56, P412, DOI 10.1002/glia.20616; Cao W, 2011, IMMUNITY, V35, P273, DOI 10.1016/j.immuni.2011.06.011; Cho YK, 2012, BIOCHEM BIOPH RES CO, V417, P753, DOI 10.1016/j.bbrc.2011.12.029; Chu K, 2004, BRAIN RES, V1016, P145, DOI 10.1016/j.brainres.2004.04.038; Curtis MA, 2007, SCIENCE, V315, P1243, DOI 10.1126/science.1136281; Cusimano M, 2012, BRAIN, V135, P447, DOI 10.1093/brain/awr339; Darsalia V, 2011, J CEREBR BLOOD F MET, V31, P235, DOI 10.1038/jcbfm.2010.81; Derecki NC, 2010, J EXP MED, V207, P1067, DOI 10.1084/jem.20091419; Einstein O, 2003, MOL CELL NEUROSCI, V24, P1074, DOI 10.1016/j.mcn.2003.08.009; Einstein O, 2007, ANN NEUROL, V61, P209, DOI 10.1002/ana.21033; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Emsley JG, 2003, EXP NEUROL, V183, P298, DOI 10.1016/S0014-4886(03)00129-8; Erblich B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026317; Erlandsson A, 2001, J NEUROSCI, V21, P3483, DOI 10.1523/JNEUROSCI.21-10-03483.2001; Gaughwin PM, 2006, EUR J NEUROSCI, V23, P945, DOI 10.1111/j.1460-9568.2006.04625.x; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Gomez-Nicola D, 2011, MOL BIOL CELL, V22, P1960, DOI 10.1091/mbc.E11-01-0053; Gomi M, 2011, J NEUROSCI RES, V89, P1388, DOI 10.1002/jnr.22667; Guan YT, 2008, EXP MOL PATHOL, V85, P232, DOI 10.1016/j.yexmp.2008.07.003; Hauben E, 2001, P NATL ACAD SCI USA, V98, P15173, DOI 10.1073/pnas.011585298; Hoehn BD, 2005, STROKE, V36, P2718, DOI 10.1161/01.STR.0000190020.30282.cc; Horie N, 2011, STEM CELLS, V29, P274, DOI 10.1002/stem.584; Hsieh J, 2004, J CELL BIOL, V164, P111, DOI 10.1083/jcb.200308101; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Iosif RE, 2008, J CEREBR BLOOD F MET, V28, P1574, DOI 10.1038/jcbfm.2008.47; Iosif RE, 2006, J NEUROSCI, V26, P9703, DOI 10.1523/JNEUROSCI.2723-06.2006; Jakubs K, 2006, NEURON, V52, P1047, DOI 10.1016/j.neuron.2006.11.004; Jakubs K, 2008, J NEUROSCI, V28, P12477, DOI 10.1523/JNEUROSCI.3240-08.2008; Joannides A, 2004, LANCET, V364, P172, DOI 10.1016/S0140-6736(04)16630-0; Kelly S, 2004, P NATL ACAD SCI USA, V101, P11839, DOI 10.1073/pnas.0404474101; Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754; Koo JW, 2008, P NATL ACAD SCI USA, V105, P751, DOI 10.1073/pnas.0708092105; Kordower JH, 1996, J COMP NEUROL, V370, P203; Krathwohl MD, 2004, STEM CELLS, V22, P109, DOI 10.1634/stemcells.22-1-109; Lee ST, 2008, BRAIN, V131, P616, DOI 10.1093/brain/awm306; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Lindvall O, 2010, J CLIN INVEST, V120, P29, DOI 10.1172/JCI40543; Lindvall O, 2009, TRENDS PHARMACOL SCI, V30, P260, DOI 10.1016/j.tips.2009.03.001; London A, 2011, J EXP MED, V208, P23, DOI 10.1084/jem.20101202; Lu P, 2003, EXP NEUROL, V181, P115, DOI 10.1016/S0014-4886(03)00037-2; Martino G, 2006, NAT REV NEUROSCI, V7, P395, DOI 10.1038/nrn1908; Martino G, 2004, LANCET NEUROL, V3, P372, DOI 10.1016/S1474-4422(04)00771-9; Martino G, 2011, PHYSIOL REV, V91, P1281, DOI 10.1152/physrev.00032.2010; McBride JL, 2004, J COMP NEUROL, V475, P211, DOI 10.1002/cne.20176; Moalem G, 1999, NAT MED, V5, P49, DOI 10.1038/4734; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Moriyama M, 2011, J NEUROSCI, V31, P3981, DOI 10.1523/JNEUROSCI.3617-10.2011; Oki K, 2012, STEM CELLS, V30, P1120, DOI 10.1002/stem.1104; Ourednik J, 2002, NAT BIOTECHNOL, V20, P1103, DOI 10.1038/nbt750; Payne NL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035093; Pluchino S, 2005, NATURE, V436, P266, DOI 10.1038/nature03889; Pluchino S, 2003, NATURE, V422, P688, DOI 10.1038/nature01552; Pluchino S, 2008, BRAIN, V131, P2564, DOI 10.1093/brain/awn198; Pluchino S, 2009, ANN NEUROL, V66, P343, DOI 10.1002/ana.21745; Pluchino S, 2009, NEUROSCI LETT, V456, P101, DOI 10.1016/j.neulet.2008.03.097; Rafuse VF, 2005, NEUROSCIENCE, V131, P899, DOI 10.1016/j.neuroscience.2004.11.048; Ramos-Cabrer P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012779; Redmond DE, 2007, P NATL ACAD SCI USA, V104, P12175, DOI 10.1073/pnas.0704091104; Reiss K, 2002, NEUROSCIENCE, V115, P295, DOI 10.1016/S0306-4522(02)00307-X; Rolls A, 2007, NAT CELL BIOL, V9, P1081, DOI 10.1038/ncb1629; Ron-Hare N, 2011, BRAIN BEHAV IMMUN, V25, P1036, DOI 10.1016/j.bbi.2010.12.011; Roussa E, 2004, NEUROSCI LETT, V361, P52, DOI 10.1016/j.neulet.2003.12.106; Ryu JK, 2004, NEUROBIOL DIS, V16, P68, DOI 10.1016/j.nbd.2004.01.016; Saino O, 2010, J NEUROSCI RES, V88, P2385, DOI 10.1002/jnr.22410; Sanai N, 2011, NATURE, V478, P382, DOI 10.1038/nature10487; Schanzer A, 2004, BRAIN PATHOL, V14, P237; Schmidt NO, 2005, NEOPLASIA, V7, P623, DOI 10.1593/neo.04781; Seminatore C, 2010, STROKE, V41, P153, DOI 10.1161/STROKEAHA.109.563015; Shechter R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027969; Shechter R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000113; Shingo T, 2001, J NEUROSCI, V21, P9733, DOI 10.1523/JNEUROSCI.21-24-09733.2001; Sierra A, 2010, CELL STEM CELL, V7, P483, DOI 10.1016/j.stem.2010.08.014; Skihar V, 2009, P NATL ACAD SCI USA, V106, P17992, DOI 10.1073/pnas.0909607106; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Stipursky J, 2007, GLIA, V55, P1023, DOI 10.1002/glia.20522; Takata M, 2012, CELL DEATH DIFFER, V19, P756, DOI 10.1038/cdd.2011.145; Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899; Tepavcevic V, 2011, J CLIN INVEST, V121, P4722, DOI 10.1172/JCI59145; Thored P, 2009, GLIA, V57, P835, DOI 10.1002/glia.20810; Thored P, 2006, STEM CELLS, V24, P739, DOI 10.1634/stemcells.2005-0281; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357; Walton NM, 2006, GLIA, V54, P815, DOI 10.1002/glia.20419; Wolf SA, 2009, FASEB J, V23, P3121, DOI 10.1096/fj.08-113944; Wood JC, 2011, EXP NEUROL, V229, P484, DOI 10.1016/j.expneurol.2011.03.019; Yan YP, 2009, NEUROCHEM INT, V55, P826, DOI 10.1016/j.neuint.2009.08.007; Yan YP, 2009, J NEUROCHEM, V109, P1624, DOI 10.1111/j.1471-4159.2009.06059.x; Yang JX, 2009, J CLIN INVEST, V119, P3678, DOI 10.1172/JCI37914; Ziv Y, 2006, NAT NEUROSCI, V9, P268, DOI 10.1038/nn1629; Ziv Y, 2006, P NATL ACAD SCI USA, V103, P13174, DOI 10.1073/pnas.0603747103	100	230	237	1	68	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2012	15	8					1078	1087		10.1038/nn.3163	http://dx.doi.org/10.1038/nn.3163			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	979UE	22837038				2022-12-17	WOS:000306844500009
J	Miyata, S; Komatsu, Y; Yoshimura, Y; Taya, C; Kitagawa, H				Miyata, Shinji; Komatsu, Yukio; Yoshimura, Yumiko; Taya, Choji; Kitagawa, Hiroshi			Persistent cortical plasticity by upregulation of chondroitin 6-sulfation	NATURE NEUROSCIENCE			English	Article							EXPERIENCE-DEPENDENT PLASTICITY; OCULAR DOMINANCE PLASTICITY; ADULT VISUAL-CORTEX; CENTRAL-NERVOUS-SYSTEM; RAT FRONTAL-CORTEX; PERINEURONAL NETS; CRITICAL PERIOD; INHIBITORY NEURONS; SULFATE; PARVALBUMIN	Cortical plasticity is most evident during a critical period in early life, but the mechanisms that restrict plasticity after the critical period are poorly understood. We found that a developmental increase in the 4- sulfation/6-sulfation (4S/6S) ratio of chondroitin sulfate proteoglycans (CSPGs), which are components of the brain extracellular matrix, leads to the termination of the critical period for ocular dominance plasticity in the mouse visual cortex. Condensation of CSPGs into perineuronal nets that enwrapped synaptic contacts on parvalbumin-expressing interneurons was prevented by cell-autonomous overexpression of chondroitin 6-sulfation, which maintains a low 4S/6S ratio. Furthermore, the increase in the 4S/6S ratio was required for the accumulation of Otx2, a homeoprotein that activates the development of parvalbumin-expressing interneurons, and for functional maturation of the electrophysiological properties of these cells. Our results indicate that the critical period for cortical plasticity is regulated by the 4S/6S ratio of CSPGs, which determines the maturation of parvalbumin-expressing interneurons.	[Miyata, Shinji; Kitagawa, Hiroshi] Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, Kobe, Hyogo 658, Japan; [Miyata, Shinji; Kitagawa, Hiroshi] Kobe Univ, Global Ctr Excellence, Program Signal Transduct Med, Grad Sch Med,Chuo Ku, Kobe, Hyogo 657, Japan; [Komatsu, Yukio] Nagoya Univ, Environm Med Res Inst, Dept Neurosci, Nagoya, Aichi 464, Japan; [Yoshimura, Yumiko] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Natl Inst Physiol Sci, Div Dev Neurophysiol, Okazaki, Aichi 4448787, Japan; [Taya, Choji] Tokyo Metropolitan Inst Med Sci, Lab Transgen Technol, Tokyo 113, Japan	Kobe Pharmaceutical University; Kobe University; Nagoya University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Okazaki Institute for Integrative Bioscience (OIIB); Tokyo Metropolitan Institute of Medical Science	Kitagawa, H (corresponding author), Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, Kobe, Hyogo 658, Japan.	kitagawa@kobepharma-u.ac.jp	Kitagawa, Hiroshi/AAJ-1344-2020; Miyata, Shinji/S-6000-2019	Kitagawa, Hiroshi/0000-0002-9307-7079; Miyata, Shinji/0000-0001-6635-1645; Yoshimura, Yumiko/0000-0002-7526-4153	Ministry of Education, Culture, Sports, Science & Technology, Japan [21390025, 23110003, 23110004, 21890286]	Ministry of Education, Culture, Sports, Science & Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank T. Maruyama and F. Murakami for technical advises on the VEP recordings and in utero electroporation, respectively. This work was funded by a Grant-in-Aid for Scientific Research-B 21390025 (to H. K.), grants from the Scientific Research on Innovative Areas (23110003 and 23110004 to H.K. and Y.K.), and a Young Scientists grant (21890286 to S.M.) from Ministry of Education, Culture, Sports, Science & Technology, Japan.	Bavelier D, 2010, J NEUROSCI, V30, P14964, DOI 10.1523/JNEUROSCI.4812-10.2010; Borrell V, 2005, J NEUROSCI METH, V143, P151, DOI 10.1016/j.jneumeth.2004.09.027; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Carulli D, 2006, J COMP NEUROL, V494, P559, DOI 10.1002/cne.20822; Carulli D, 2010, BRAIN, V133, P2331, DOI 10.1093/brain/awq145; Celio MR, 1998, TRENDS NEUROSCI, V21, P510, DOI 10.1016/S0166-2236(98)01298-3; Chang MC, 2010, NAT NEUROSCI, V13, P1090, DOI 10.1038/nn.2621; CONNORS BW, 1990, TRENDS NEUROSCI, V13, P99, DOI 10.1016/0166-2236(90)90185-D; Erisir A, 2005, J COMP NEUROL, V485, P11, DOI 10.1002/cne.20507; Fox K, 2005, NEURON, V48, P465, DOI 10.1016/j.neuron.2005.10.013; Frenkel MY, 2004, NEURON, V44, P917, DOI 10.1016/j.neuron.2004.12.003; Galtrey CM, 2007, BRAIN RES REV, V54, P1, DOI 10.1016/j.brainresrev.2006.09.006; Gama CI, 2006, NAT CHEM BIOL, V2, P467, DOI 10.1038/nchembio810; GODEMENT P, 1984, J COMP NEUROL, V230, P552, DOI 10.1002/cne.902300406; Goldberg EM, 2011, CEREB CORTEX, V21, P666, DOI 10.1093/cercor/bhq138; Gordon JA, 1996, J NEUROSCI, V16, P3274; Harauzov A, 2010, J NEUROSCI, V30, P361, DOI 10.1523/JNEUROSCI.2233-09.2010; HARTIG W, 1992, NEUROREPORT, V3, P869; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Jiang B, 2005, BRAIN RES REV, V50, P126, DOI 10.1016/j.brainresrev.2005.05.007; KAWAGUCHI Y, 1995, J NEUROSCI, V15, P2638; Kawaguchi Y, 2002, J NEUROCYTOL, V31, P277, DOI 10.1023/A:1024126110356; Kitagawa H, 1997, J BIOL CHEM, V272, P31377, DOI 10.1074/jbc.272.50.31377; KITAGAWA H, 1995, ANAL BIOCHEM, V232, P114, DOI 10.1006/abio.1995.9952; Lander C, 1998, J NEUROSCI, V18, P174; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Maeda N, 2003, J BIOL CHEM, V278, P35805, DOI 10.1074/jbc.M305530200; Marin O, 2001, NAT REV NEUROSCI, V2, P780, DOI 10.1038/35097509; Matthews RT, 2002, J NEUROSCI, V22, P7536; McGee AW, 2005, SCIENCE, V309, P2222, DOI 10.1126/science.1114362; Mikami T, 2009, J BIOL CHEM, V284, P4494, DOI 10.1074/jbc.M809227200; Miyata S, 2005, NEUROSCIENCE, V136, P95, DOI 10.1016/j.neuroscience.2005.07.031; Morishita H, 2010, SCIENCE, V330, P1238, DOI 10.1126/science.1195320; Nadanaka S, 2008, J BIOL CHEM, V283, P27333, DOI 10.1074/jbc.M802997200; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Pantazopoulos H, 2010, ARCH GEN PSYCHIAT, V67, P155, DOI 10.1001/archgenpsychiatry.2009.196; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Properzi F, 2005, EUR J NEUROSCI, V21, P378, DOI 10.1111/j.1460-9568.2005.03876.x; Rudy B, 2001, TRENDS NEUROSCI, V24, P517, DOI 10.1016/S0166-2236(00)01892-0; Sato M, 2008, J NEUROSCI, V28, P10278, DOI 10.1523/JNEUROSCI.2451-08.2008; Schwaller B, 2004, MOL CELL NEUROSCI, V25, P650, DOI 10.1016/j.mcn.2003.12.006; Sugahara K, 2007, CURR OPIN STRUC BIOL, V17, P536, DOI 10.1016/j.sbi.2007.08.015; Sugiyama S, 2008, CELL, V134, P508, DOI 10.1016/j.cell.2008.05.054; Tanaka DH, 2009, J NEUROSCI, V29, P1300, DOI 10.1523/JNEUROSCI.5446-08.2009; Tropea D, 2006, NAT NEUROSCI, V9, P660, DOI 10.1038/nn1689; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; Yazaki-Sugiyama Y, 2009, NATURE, V462, P218, DOI 10.1038/nature08485; Yoshimura Y, 2008, EUR J NEUROSCI, V28, P730, DOI 10.1111/j.1460-9568.2008.06384.x	49	230	236	3	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2012	15	3					414	U100		10.1038/nn.3023	http://dx.doi.org/10.1038/nn.3023			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	899CY	22246436				2022-12-17	WOS:000300793100015
J	Meyer, AC; Frank, T; Khimich, D; Hoch, G; Riedel, D; Chapochnikov, NM; Yarin, YM; Harke, B; Hell, SW; Egner, A; Moser, T				Meyer, Alexander C.; Frank, Thomas; Khimich, Darina; Hoch, Gerhard; Riedel, Dietmar; Chapochnikov, Nikolai M.; Yarin, Yury M.; Harke, Benjamin; Hell, Stefan W.; Egner, Alexander; Moser, Tobias			Tuning of synapse number, structure and function in the cochlea	NATURE NEUROSCIENCE			English	Article							CELL RIBBON SYNAPSE; AUDITORY-NERVE FIBERS; INNER HAIR-CELLS; PRESYNAPTIC ACTIVE ZONES; PLACE-FREQUENCY MAP; CALCIUM-DEPENDENCE; AFFERENT SYNAPSE; TRANSMITTER RELEASE; CA(V)1.3 CHANNELS; CA2+ CHANNELS	Cochlear inner hair cells (IHCs) transmit acoustic information to spiral ganglion neurons through ribbon synapses. Here we have used morphological and physiological techniques to ask whether synaptic mechanisms differ along the tonotopic axis and within IHCs in the mouse cochlea. We show that the number of ribbon synapses per IHC peaks where the cochlea is most sensitive to sound. Exocytosis, measured as membrane capacitance changes, scaled with synapse number when comparing apical and midcochlear IHCs. Synapses were distributed in the subnuclear portion of IHCs. High-resolution imaging of IHC synapses provided insights into presynaptic Ca2+ channel clusters and Ca2+ signals, synaptic ribbons and postsynaptic glutamate receptor clusters and revealed subtle differences in their average properties along the tonotopic axis. However, we observed substantial variability for presynaptic Ca2+ signals, even within individual IHCs, providing a candidate presynaptic mechanism for the divergent dynamics of spiral ganglion neuron spiking.	[Meyer, Alexander C.; Frank, Thomas; Khimich, Darina; Hoch, Gerhard; Chapochnikov, Nikolai M.; Yarin, Yury M.; Moser, Tobias] Univ Gottingen, InnerEar Lab, Dept Otolaryngol, Gottingen, Germany; [Meyer, Alexander C.; Frank, Thomas; Khimich, Darina; Hoch, Gerhard; Chapochnikov, Nikolai M.; Yarin, Yury M.; Moser, Tobias] Univ Gottingen, Ctr Mol Physiol Brain, Gottingen, Germany; [Riedel, Dietmar] Max Planck Inst Biophys Chem, Electron Microscopy Lab, D-37077 Gottingen, Germany; [Chapochnikov, Nikolai M.; Moser, Tobias] Univ Gottingen, Bernstein Ctr Computat Neurosci, Gottingen, Germany; [Yarin, Yury M.] Tech Univ Dresden, Otorhinolaryngol Clin, Dept Med, Dresden, Germany; [Harke, Benjamin; Hell, Stefan W.; Egner, Alexander] Max Planck Inst Biophys Chem, Dept NanoBiophoton, D-37077 Gottingen, Germany	University of Gottingen; University of Gottingen; Max Planck Society; University of Gottingen; Technische Universitat Dresden; Max Planck Society	Moser, T (corresponding author), Univ Gottingen, InnerEar Lab, Dept Otolaryngol, Gottingen, Germany.	aegner@gwdg.de; tmoser@gwdg.de	Meyer, Alexander/F-2479-2010; Frank, Thomas/F-5273-2012; Moser, Tobias/L-5068-2014	Frank, Thomas/0000-0002-5113-176X; Moser, Tobias/0000-0001-7145-0533; Yarin, Yury/0000-0002-1710-1567; Chapochnikov, Nikolai/0000-0001-8491-0017; Egner, Alexander/0000-0001-5248-3858	Deutsche Forschungsgemeinschaft (Center for Molecular Physiology of the Brain); state of Lower Saxony; European Commission; Max-Planck-Society; BMBF (Bernstein Center for Computational Neuroscience Gottingen); University of Gottingen Medical School	Deutsche Forschungsgemeinschaft (Center for Molecular Physiology of the Brain)(German Research Foundation (DFG)); state of Lower Saxony(European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Max-Planck-Society(Max Planck SocietyFoundation CELLEX); BMBF (Bernstein Center for Computational Neuroscience Gottingen)(Federal Ministry of Education & Research (BMBF)); University of Gottingen Medical School	We thank E. Neher, M. Gopfert, R. Nouvian, N. Strenzke, M. Muller and A. Lysakowski for comments on the manuscript; K. Wadel and C. Henrich for participation in an early stage of the project; A. Neef for image analysis support; J. Hegerman and S. Eimer for support with high-pressure rapid freeze and freeze substitution; and C. Rudiger and M. Koppler for technical assistance. This work was supported by grants from the Deutsche Forschungsgemeinschaft (Center for Molecular Physiology of the Brain; T. M., A. E. and S. W. H), a Lichtenberg Fellowship from the state of Lower Saxony (T. F.), the European Commission (Eurohear, T. M.), the Max-Planck-Society (Tandemproject, T. M.), BMBF (Bernstein Center for Computational Neuroscience Gottingen, T. M.) and an intramural grant from the University of Gottingen Medical School (A. C. M.).	Beutner D, 2001, NEURON, V29, P681, DOI 10.1016/S0896-6273(01)00243-4; Brandt A, 2005, J NEUROSCI, V25, P11577, DOI 10.1523/JNEUROSCI.3411-05.2005; Brandt A, 2003, J NEUROSCI, V23, P10832; Egner A, 2002, P NATL ACAD SCI USA, V99, P3370, DOI 10.1073/pnas.052545099; EHRET G, 1974, NATURWISSENSCHAFTEN, V61, P506, DOI 10.1007/BF00622976; Ehret Guenter, 2006, P85; Francis HW, 2004, BRAIN RES, V1016, P182, DOI 10.1016/j.brainres.2004.05.016; FRANK T, 2002, P NATL ACAD IN PRESS; Fuchs PA, 2005, J PHYSIOL-LONDON, V566, P7, DOI 10.1113/jphysiol.2004.082214; Fuchs PA, 2003, CURR OPIN NEUROBIOL, V13, P452, DOI 10.1016/S0959-4388(03)00098-9; Glowatzki E, 2002, NAT NEUROSCI, V5, P147, DOI 10.1038/nn796; Goutman JD, 2007, P NATL ACAD SCI USA, V104, P16341, DOI 10.1073/pnas.0705756104; Griesinger CB, 2005, NATURE, V435, P212, DOI 10.1038/nature03567; Harke B, 2008, OPT EXPRESS, V16, P4154, DOI 10.1364/OE.16.004154; HELL S, 1992, J OPT SOC AM A, V9, P2159, DOI 10.1364/JOSAA.9.002159; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; ISSA NP, 1994, P NATL ACAD SCI USA, V91, P7578, DOI 10.1073/pnas.91.16.7578; Johnson SL, 2008, J NEUROSCI, V28, P7670, DOI 10.1523/JNEUROSCI.0785-08.2008; Johnson SL, 2008, J PHYSIOL-LONDON, V586, P1029, DOI 10.1113/jphysiol.2007.145219; Khimich D, 2005, NATURE, V434, P889, DOI 10.1038/nature03418; LIBERMAN MC, 1982, SCIENCE, V216, P1239, DOI 10.1126/science.7079757; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; LIBERMAN MC, 1980, HEARING RES, V3, P45, DOI 10.1016/0378-5955(80)90007-6; LIBERMAN MC, 1991, J COMP NEUROL, V304, P341; LIBERMAN MC, 1990, J COMP NEUROL, V301, P443, DOI 10.1002/cne.903010309; LIBERMAN MC, 1982, J ACOUST SOC AM, V72, P1441, DOI 10.1121/1.388677; MartinezDunst C, 1997, J NEUROSCI, V17, P9133; Masugi-Tokita M, 2007, J NEUROSCI, V27, P2135, DOI 10.1523/JNEUROSCI.2861-06.2007; Matsubara A, 1996, J NEUROSCI, V16, P4457; MerchanPerez A, 1996, J COMP NEUROL, V371, P208, DOI 10.1002/(SICI)1096-9861(19960722)371:2<208::AID-CNE2>3.0.CO;2-6; Moser T, 2000, P NATL ACAD SCI USA, V97, P883, DOI 10.1073/pnas.97.2.883; Moser T, 2006, J PHYSIOL-LONDON, V576, P55, DOI 10.1113/jphysiol.2006.114835; Muller M, 2005, HEARING RES, V202, P63, DOI 10.1016/j.heares.2004.08.011; Muller M, 1996, HEARING RES, V94, P148, DOI 10.1016/0378-5955(95)00230-8; Nouvian R, 2006, J MEMBRANE BIOL, V209, P153, DOI 10.1007/s00232-005-0854-4; Nusser Z, 2000, CURR OPIN NEUROBIOL, V10, P337, DOI 10.1016/S0959-4388(00)00086-6; Platzer J, 2000, CELL, V102, P89, DOI 10.1016/S0092-8674(00)00013-1; ROBERTS WM, 1990, J NEUROSCI, V10, P3664; Rodriguez-Contreras A, 2001, J PHYSIOL-LONDON, V534, P669, DOI 10.1111/j.1469-7793.2001.00669.x; Rostaing P, 2004, J HISTOCHEM CYTOCHEM, V52, P1, DOI 10.1177/002215540405200101; Ruel J, 2001, EUR J NEUROSCI, V14, P977, DOI 10.1046/j.0953-816x.2001.01721.x; RUTHERFORD MA, 2006, P NATL ACAD SCI US; Schnee ME, 2005, NEURON, V47, P243, DOI 10.1016/j.neuron.2005.06.004; Slepecky NB, 2000, HEARING RES, V144, P124, DOI 10.1016/S0378-5955(00)00055-1; Sterling P, 2005, TRENDS NEUROSCI, V28, P20, DOI 10.1016/j.tins.2004.11.009; Taberner AM, 2005, J NEUROPHYSIOL, V93, P557, DOI 10.1152/jn.00574.2004; Tokuoka H, 2008, P NATL ACAD SCI USA, V105, P14656, DOI 10.1073/pnas.0805705105; Tsuji J, 1997, J COMP NEUROL, V381, P188; Tucker T, 1995, NEURON, V15, P1323, DOI 10.1016/0896-6273(95)90011-X; Wu YC, 1996, BIOPHYS J, V71, P2256, DOI 10.1016/S0006-3495(96)79429-8; Zenisek D, 2003, J NEUROSCI, V23, P2538	51	230	239	2	56	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2009	12	4					444	453		10.1038/nn.2293	http://dx.doi.org/10.1038/nn.2293			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	424JN	19270686	Green Published			2022-12-17	WOS:000264563100019
J	Thomas, C; Avidan, G; Humphreys, K; Jung, KJ; Gao, FQ; Behrmann, M				Thomas, Cibu; Avidan, Galia; Humphreys, Kate; Jung, Kwan-jin; Gao, Fuqiang; Behrmann, Marlene			Reduced structural connectivity in ventral visual cortex in congenital prosopagnosia	NATURE NEUROSCIENCE			English	Article							FACE PERCEPTION	Using diffusion tensor imaging and tractography, we found that a disruption in structural connectivity in ventral occipitotemporal cortex may be the neurobiological basis for the lifelong impairment in face recognition that is experienced by individuals who suffer from congenital prosopagnosia. Our findings suggest that white-matter fibers in ventral occipitotemporal cortex support the integrated function of a distributed cortical network that subserves normal face processing.	[Thomas, Cibu; Behrmann, Marlene] Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA; [Thomas, Cibu; Behrmann, Marlene] Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA; [Avidan, Galia] Ben Gurion Univ Negev, Dept Behav Sci, IL-84105 Beer Sheva, Israel; [Humphreys, Kate] Kings Coll London, Inst Psychiat, London SE5 8AF, England; [Jung, Kwan-jin] Carnegie Mellon Univ, Pittsburgh, PA 15203 USA; [Jung, Kwan-jin] Univ Pittsburgh, Brain Imaging Res Ctr, Pittsburgh, PA 15203 USA; [Gao, Fuqiang] Univ Toronto, Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada	Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Ben Gurion University; University of London; King's College London; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Thomas, C (corresponding author), Carnegie Mellon Univ, Dept Psychol, 5000 Forbes Ave, Pittsburgh, PA 15213 USA.	cibut@nmr.mgh.harvard.edu	Avidan, Galia/B-9347-2011	Avidan, Galia/0000-0003-2293-3859; Behrmann, Marlene/0000-0002-3814-1015	US National Institute of Mental Health [MH54246]; National Alliance for Autism Research (Autism Speaks); Cure Autism Now foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH054246, R29MH054246] Funding Source: NIH RePORTER	US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Alliance for Autism Research (Autism Speaks); Cure Autism Now foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We are grateful to S. Mori and H. Jiang of Johns Hopkins University who provided advice and guidance at various stages of this project regarding the development of the DTI protocol and method of analysis. We thank S. Kurdilla and D. Viszlay of the Brain Imaging Research Center for their help in the acquisition of the imaging data and B. Frye and T. Keller for their help with the computation and analyses of fractional anisotropy maps. This study was funded by grants from the US National Institute of Mental Health (MH54246) to M. B. and by awards from the National Alliance for Autism Research (Autism Speaks) to C. T. and K. H. and from the Cure Autism Now foundation to K. H.	Avidan G, 2005, J COGNITIVE NEUROSCI, V17, P1150, DOI 10.1162/0898929054475145; Bar M, 2006, P NATL ACAD SCI USA, V103, P449, DOI 10.1073/pnas.0507062103; Behrmann M, 2005, TRENDS COGN SCI, V9, P180, DOI 10.1016/j.tics.2005.02.011; Behrmann M, 2007, CEREB CORTEX, V17, P2354, DOI 10.1093/cercor/bhl144; Grueter M, 2007, CORTEX, V43, P734, DOI 10.1016/S0010-9452(08)70502-1; Hadjikhani N, 2002, HUM BRAIN MAPP, V16, P176, DOI 10.1002/hbm.10043; Harris AM, 2005, NEUROPSYCHOLOGIA, V43, P2125, DOI 10.1016/j.neuropsychologia.2005.03.017; Hasson U, 2003, J COGNITIVE NEUROSCI, V15, P419, DOI 10.1162/089892903321593135; Ishai A, 2005, BRAIN RES BULL, V67, P87, DOI 10.1016/j.brainresbull.2005.05.027; Minnebusch DA, 2007, EUR J NEUROSCI, V25, P2234, DOI 10.1111/j.1460-9568.2007.05451.x; Mori S, 2002, MAGN RESON MED, V47, P215, DOI 10.1002/mrm.10074; Summerfield C, 2006, SCIENCE, V314, P1311, DOI 10.1126/science.1132028; Thomas C, 2008, J COGNITIVE NEUROSCI, V20, P268, DOI 10.1162/jocn.2008.20025; Tsao DY, 2008, NAT NEUROSCI, V11, P877, DOI 10.1038/nn.2158; Yamasaki T, 2004, J NEUROL SCI, V221, P53, DOI 10.1016/j.jns.2004.03.024	15	230	232	2	116	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2009	12	1					29	31		10.1038/nn.2224	http://dx.doi.org/10.1038/nn.2224			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	388HL	19029889	Green Accepted, Green Published			2022-12-17	WOS:000262010800011
J	Lazarus, M; Yoshida, K; Coppari, R; Bass, CE; Mochizuki, T; Lowell, BB; Saper, CB				Lazarus, Michael; Yoshida, Kyoko; Coppari, Roberto; Bass, Caroline E.; Mochizuki, Takatoshi; Lowell, Bradford B.; Saper, Clifford B.			EP3 prostaglandin receptors in the median preoptic nucleus are critical for fever responses	NATURE NEUROSCIENCE			English	Review							BROWN ADIPOSE-TISSUE; FEBRILE RESPONSE; MICE; LIPOPOLYSACCHARIDE; THERMOGENESIS; TEMPERATURE; RAPHE	Fever is a result of the action of prostaglandin E2 ( PGE2) on the brain and appears to require EP3 prostaglandin receptors ( EP3Rs), but the specific neurons on which PGE2 acts to produce fever have not been definitively established. Here we report that selective genetic deletion of the EP3Rs in the median preoptic nucleus of mice resulted in abrogation of the fever response. These observations demonstrate that the EP3R-bearing neurons in the median preoptic nucleus are required for fever responses.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Program Neurosci, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Div Endocrinol, Boston, MA 02215 USA; Univ Texas, SW Med Ctr, Dept Internal Med, Div Hypothalam Res, Dallas, TX 75390 USA; Wake Forest Univ Hlth Sci, Dept Physiol & Pharmacol, Winston Salem, NC 27157 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Wake Forest University; Wake Forest University School of Medicine	Saper, CB (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Neurol, 330 Brookline Ave, Boston, MA 02215 USA.	csaper@bidmc.harvard.edu	Saper, Clifford/L-3815-2019; Mochizuki, Takatoshi/AAB-2522-2020; Coppari, Roberto/B-4799-2014; Lazarus, Michael/G-3130-2010	Lazarus, Michael/0000-0003-3863-4474; Yoshida-Court, Kyoko/0000-0002-7558-9943; Mochizuki, Takatoshi/0000-0001-6976-7240; Lazarus, Michael/0000-0003-4700-7894; COPPARI, Roberto/0000-0003-1288-6948; Bass, Caroline/0000-0002-5856-6387	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL060292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA017543] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL60292] Funding Source: Medline; NIDA NIH HHS [F32 DA017543] Funding Source: Medline; NINDS NIH HHS [NS33987] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ek M, 2001, NATURE, V410, P430, DOI 10.1038/35068632; Engblom D, 2003, NAT NEUROSCI, V6, P1137, DOI 10.1038/nn1137; Li S, 1999, BRAIN RES, V825, P86, DOI 10.1016/S0006-8993(99)01225-1; Lu J, 2001, J NEUROSCI, V21, P4864, DOI 10.1523/JNEUROSCI.21-13-04864.2001; Madden CJ, 2004, AM J PHYSIOL-REG I, V286, pR320, DOI 10.1152/ajpregu.00515.2003; Morrison SR, 2004, NEWS PHYSIOL SCI, V19, P67, DOI 10.1152/nips.01502.2003; Nakamura K, 2002, J NEUROSCI, V22, P4600, DOI 10.1523/JNEUROSCI.22-11-04600.2002; Oka T, 2000, J COMP NEUROL, V428, P20, DOI 10.1002/1096-9861(20001204)428:1<20::AID-CNE3>3.0.CO;2-X; Oka T, 2003, J PHYSIOL-LONDON, V551, P945, DOI 10.1113/jphysiol.2003.048140; Oka T, 2003, BRAIN RES, V968, P256, DOI 10.1016/S0006-8993(03)02268-6; Romanovsky AA, 2003, AM J PHYSIOL-REG I, V285, pR420, DOI 10.1152/ajpregu.00757.2002; Scammell TE, 1998, AM J PHYSIOL-REG I, V274, pR783, DOI 10.1152/ajpregu.1998.274.3.R783; Tanaka M, 2005, AM J PHYSIOL-REG I, V289, pR1592, DOI 10.1152/ajpregu.00141.2005; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Ushikubi F, 1998, NATURE, V395, P281, DOI 10.1038/26233	15	230	238	2	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2007	10	9					1131	1133		10.1038/nn1949	http://dx.doi.org/10.1038/nn1949			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	205VZ	17676060				2022-12-17	WOS:000249144000013
J	Scott, EK; Luo, LQ				Scott, EK; Luo, LQ			How do dendrites take their shape?	NATURE NEUROSCIENCE			English	Review							RETINAL GANGLION-CELLS; ACTIN-BASED PLASTICITY; RHO-ASSOCIATED KINASE; ABL TYROSINE KINASE; AXON GUIDANCE; IN-VIVO; HIPPOCAMPAL-NEURONS; SYMPATHETIC NEURONS; CEREBELLAR CORTEX; GENE-EXPRESSION	Recent technical advances have made possible the visualization and genetic manipulation of individual dendritic trees. These studies have led to the identification and characterization of molecules that are important for different aspects of dendritic development. Although much remains to be learned, the existing knowledge has allowed us to take initial steps toward a comprehensive understanding of how complex dendritic trees are built. In this review, we describe recent advances in our understanding of the molecular mechanisms underlying dendritic morphogenesis, and discuss their cell-biological implications.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Neurosci Program, Stanford, CA 94305 USA	Stanford University; Stanford University	Luo, LQ (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	lluo@stanford.edu		Luo, Liqun/0000-0001-5467-9264; Scott, Ethan/0000-0003-3150-9216				ALTMAN J, 1972, J COMP NEUROL, V146, P355, DOI 10.1002/cne.901460305; ARNOLD D, 1994, P NATL ACAD SCI USA, V91, P9970, DOI 10.1073/pnas.91.21.9970; Atwal JK, 2000, NEURON, V27, P265, DOI 10.1016/S0896-6273(00)00035-0; BANKER GA, 1979, J COMP NEUROL, V187, P469, DOI 10.1002/cne.901870302; BAPTISTA CA, 1994, NEURON, V12, P243, DOI 10.1016/0896-6273(94)90268-2; BARBACID M, 1995, CURR OPIN CELL BIOL, V7, P148, DOI 10.1016/0955-0674(95)80022-0; Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; Bito H, 2000, NEURON, V26, P431, DOI 10.1016/S0896-6273(00)81175-7; Bradke F, 2000, CURR OPIN NEUROBIOL, V10, P574, DOI 10.1016/S0959-4388(00)00124-0; BRAND AH, 1993, DEVELOPMENT, V118, P401; BRAY D, 1973, J CELL BIOL, V56, P702, DOI 10.1083/jcb.56.3.702; CACERES A, 1992, NEURON, V9, P607, DOI 10.1016/0896-6273(92)90025-9; Cantallops I, 2000, NAT NEUROSCI, V3, P1004, DOI 10.1038/79823; Cowan WM, 1998, NEURON, V20, P413, DOI 10.1016/S0896-6273(00)80985-X; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; Dailey ME, 1996, J NEUROSCI, V16, P2983; Davies AM, 2000, CURR BIOL, V10, pR198, DOI 10.1016/S0960-9822(00)00351-1; DOE CQ, 1991, CELL, V65, P451, DOI 10.1016/0092-8674(91)90463-9; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Fryer RH, 1996, J COMP NEUROL, V374, P21, DOI 10.1002/(SICI)1096-9861(19961007)374:1<21::AID-CNE2>3.0.CO;2-P; Fuchs E, 1999, CELL, V98, P547, DOI 10.1016/S0092-8674(00)80041-0; Gao FB, 1999, GENE DEV, V13, P2549, DOI 10.1101/gad.13.19.2549; Gao FB, 2000, NEURON, V28, P91, DOI 10.1016/S0896-6273(00)00088-X; Gertler FB, 1996, CELL, V87, P227, DOI 10.1016/S0092-8674(00)81341-0; GERTLER FB, 1995, GENE DEV, V9, P521, DOI 10.1101/gad.9.5.521; Giger RJ, 1996, J COMP NEUROL, V375, P378, DOI 10.1002/(SICI)1096-9861(19961118)375:3<378::AID-CNE3>3.0.CO;2-#; Giniger E, 1998, NEURON, V20, P667, DOI 10.1016/S0896-6273(00)81007-7; Gregory SL, 1998, J CELL BIOL, V143, P1271, DOI 10.1083/jcb.143.5.1271; GUNDERSEN RW, 1979, SCIENCE, V206, P1079, DOI 10.1126/science.493992; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Hirai H, 2000, J NEUROSCI, V20, P5217, DOI 10.1523/JNEUROSCI.20-14-05217.2000; Hirose M, 1998, J CELL BIOL, V141, P1625, DOI 10.1083/jcb.141.7.1625; Horch HW, 1999, NEURON, V23, P353; Ichinose T, 2000, J NEUROSCI RES, V59, P365, DOI 10.1002/(SICI)1097-4547(20000201)59:3<365::AID-JNR10>3.0.CO;2-I; Jontes JD, 2000, NEURON, V27, P11, DOI 10.1016/S0896-6273(00)00003-9; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; KOLODZIEJ PA, 1995, NEURON, V15, P273, DOI 10.1016/0896-6273(95)90033-0; Lanier LM, 2000, CURR OPIN NEUROBIOL, V10, P80, DOI 10.1016/S0959-4388(99)00058-6; Le Roux P, 1999, EXP NEUROL, V160, P151, DOI 10.1006/exnr.1999.7194; Lee S, 2000, J NEUROSCI, V20, P1096, DOI 10.1523/JNEUROSCI.20-03-01096.2000; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lee TM, 2000, NEURON, V25, P307, DOI 10.1016/S0896-6273(00)80896-X; LEIN P, 1995, NEURON, V15, P597, DOI 10.1016/0896-6273(95)90148-5; Li Z, 2000, NAT NEUROSCI, V3, P217, DOI 10.1038/72920; Liu Z, 2000, NAT CELL BIOL, V2, P776, DOI 10.1038/35041011; LO DC, 1994, NEURON, V13, P1263, DOI 10.1016/0896-6273(94)90412-X; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Luo LQ, 1996, NATURE, V379, P837, DOI 10.1038/379837a0; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; McAllister AK, 1997, NEURON, V18, P767, DOI 10.1016/S0896-6273(00)80316-5; McAllister AK, 1996, NEURON, V17, P1057, DOI 10.1016/S0896-6273(00)80239-1; McAllister AK, 2000, CEREB CORTEX, V10, P963, DOI 10.1093/cercor/10.10.963; MESSERSMITH EK, 1995, NEURON, V14, P949, DOI 10.1016/0896-6273(95)90333-X; Morrison ME, 1998, J NEUROSCI, V18, P3563; Nakamura F, 2000, J NEUROBIOL, V44, P219, DOI 10.1002/1097-4695(200008)44:2<219::AID-NEU11>3.0.CO;2-W; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Nedivi E, 1998, SCIENCE, V281, P1863, DOI 10.1126/science.281.5384.1863; Niethammer M, 2000, NEURON, V28, P697, DOI 10.1016/S0896-6273(00)00147-1; Nikolic M, 1998, NATURE, V395, P194, DOI 10.1038/26034; OLEARY DDM, 1988, NEURON, V1, P901, DOI 10.1016/0896-6273(88)90147-X; Peters A, 1991, FINE STRUCTURE NERVO; Pfister KK, 1999, MOL NEUROBIOL, V20, P81, DOI 10.1007/BF02742435; Polleux F, 1998, SCIENCE, V282, P1904, DOI 10.1126/science.282.5395.1904; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; Prokop A, 1998, J CELL BIOL, V143, P1283, DOI 10.1083/jcb.143.5.1283; RAKIC P, 1973, J COMP NEUROL, V152, P133, DOI 10.1002/cne.901520203; Ramon y Cajal S., 1897, HISTOLOGY NERVOUS SY, V1; Redmond L, 2000, NAT NEUROSCI, V3, P30, DOI 10.1038/71104; Redmond L, 2001, CURR OPIN NEUROBIOL, V11, P111, DOI 10.1016/S0959-4388(00)00181-1; REINHARD M, 1995, EMBO J, V14, P1583, DOI 10.1002/j.1460-2075.1995.tb07146.x; Ruchhoeft ML, 1999, J NEUROSCI, V19, P8454; Sasaki S, 2000, NEURON, V28, P681, DOI 10.1016/S0896-6273(00)00146-X; Segal M, 2000, TRENDS NEUROSCI, V23, P53, DOI 10.1016/S0166-2236(99)01499-X; Sestan N, 1999, SCIENCE, V286, P741, DOI 10.1126/science.286.5440.741; Sharp DJ, 1997, J CELL BIOL, V138, P833, DOI 10.1083/jcb.138.4.833; Smith DS, 2000, NAT CELL BIOL, V2, P767, DOI 10.1038/35041000; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Strumpf D, 1998, J CELL BIOL, V143, P1259, DOI 10.1083/jcb.143.5.1259; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; Usui T, 1999, CELL, V98, P585, DOI 10.1016/S0092-8674(00)80046-X; VAESSIN H, 1991, CELL, V67, P941, DOI 10.1016/0092-8674(91)90367-8; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5; Wang KH, 1999, CELL, V96, P771, DOI 10.1016/S0092-8674(00)80588-7; WASSLE H, 1981, NATURE, V292, P344, DOI 10.1038/292344a0; Wills Z, 1999, NEURON, V22, P301, DOI 10.1016/S0896-6273(00)81091-0; WINTER CG, IN PRESS CELL; Wong WT, 2000, J NEUROSCI, V20, P5024; Wu GY, 1998, SCIENCE, V279, P222, DOI 10.1126/science.279.5348.222; Yacoubian TA, 2000, NAT NEUROSCI, V3, P342, DOI 10.1038/73911; Yu WQ, 2000, J NEUROSCI, V20, P5782, DOI 10.1523/JNEUROSCI.20-15-05782.2000; YU WQ, 1994, J NEUROSCI, V14, P5872; Zakharenko S, 1998, J CELL BIOL, V143, P1077, DOI 10.1083/jcb.143.4.1077; Zou DJ, 1999, J NEUROSCI, V19, P8909, DOI 10.1523/JNEUROSCI.19-20-08909.1999	98	230	233	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2001	4	4					359	365		10.1038/86006	http://dx.doi.org/10.1038/86006			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	433MB	11276225				2022-12-17	WOS:000168762200015
J	Stuart, GJ; Spruston, N				Stuart, Greg J.; Spruston, Nelson			Dendritic integration: 60 years of progress	NATURE NEUROSCIENCE			English	Review							CA1 PYRAMIDAL NEURONS; ACTION-POTENTIAL INITIATION; CEREBELLAR PURKINJE-CELLS; RAT BARREL CORTEX; DISTAL APICAL DENDRITES; RETINAL GANGLION-CELLS; LONG-TERM POTENTIATION; MOUSE VISUAL-CORTEX; IN-VIVO; HIPPOCAMPAL-NEURONS	Understanding how individual neurons integrate the thousands of synaptic inputs they receive is critical to understanding how the brain works. Modeling studies in silico and experimental work in vitro, dating back more than half a century, have revealed that neurons can perform a variety of different passive and active forms of synaptic integration on their inputs. But how are synaptic inputs integrated in the intact brain? With the development of new techniques, this question has recently received substantial attention, with new findings suggesting that many of the forms of synaptic integration observed in vitro also occur in vivo, including in awake animals. Here we review six decades of progress, which collectively highlights the complex ways that single neurons integrate their inputs, emphasizing the critical role of dendrites in information processing in the brain.	[Stuart, Greg J.] Australian Natl Univ, John Curtin Sch Med Res, Eccles Inst Neurosci, Canberra, ACT 2601, Australia; [Stuart, Greg J.] Australian Natl Univ, John Curtin Sch Med Res, ARC Ctr Excellence Integrat Brain Funct, Canberra, ACT 2601, Australia; [Spruston, Nelson] Howard Hughes Med Inst, Ashburn, VA USA	Australian National University; John Curtin School of Medical Research; Australian National University; John Curtin School of Medical Research; Howard Hughes Medical Institute	Stuart, GJ (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Eccles Inst Neurosci, Canberra, ACT 2601, Australia.	greg.stuart@anu.edu.au		Spruston, Nelson/0000-0003-3118-1636; stuart, greg/0000-0001-9395-2219	John Curtin School of Medical Research; National Health and Medical Research Council of Australia; Australia Research Council (ARC) Centre of Excellence for Integrative Brain Function; Howard Hughes Medical Institute	John Curtin School of Medical Research(Australian National University); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australia Research Council (ARC) Centre of Excellence for Integrative Brain Function(Australian Research Council); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	The authors wish to thank the following funding sources: The John Curtin School of Medical Research (G.J.S.), the National Health and Medical Research Council of Australia (G.J.S.), the Australia Research Council (ARC) Centre of Excellence for Integrative Brain Function (G.J.S.) and the Howard Hughes Medical Institute (N.S.).	AMITAI Y, 1993, CEREB CORTEX, V3, P26, DOI 10.1093/cercor/3.1.26; Angelo K, 2007, J NEUROSCI, V27, P8643, DOI 10.1523/JNEUROSCI.5284-06.2007; BENARDO LS, 1982, J NEUROSCI, V2, P1614; Bereshpolova Y, 2007, J NEUROSCI, V27, P9392, DOI 10.1523/JNEUROSCI.2218-07.2007; Berger T, 2001, J NEUROPHYSIOL, V85, P855, DOI 10.1152/jn.2001.85.2.855; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Bittner KC, 2015, NAT NEUROSCI, V18, P1133, DOI 10.1038/nn.4062; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Bloodgood BL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000190; BURKE RE, 1967, J NEUROPHYSIOL, V30, P1114, DOI 10.1152/jn.1967.30.5.1114; Buzsaki G, 1996, P NATL ACAD SCI USA, V93, P9921, DOI 10.1073/pnas.93.18.9921; Buzsaki G, 1998, J NEUROPHYSIOL, V79, P1587, DOI 10.1152/jn.1998.79.3.1587; Chen XW, 2011, NATURE, V475, P501, DOI 10.1038/nature10193; Cichon J, 2015, NATURE, V520, P180, DOI 10.1038/nature14251; Colbert CM, 1997, J NEUROSCI, V17, P6512; COOMBS JS, 1957, J PHYSIOL-LONDON, V139, P198, DOI 10.1113/jphysiol.1957.sp005887; DODT HU, 1990, BRAIN RES, V537, P333, DOI 10.1016/0006-8993(90)90380-T; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Dombeck DA, 2010, NAT NEUROSCI, V13, P1433, DOI 10.1038/nn.2648; Druckmann S, 2014, NEURON, V81, P629, DOI 10.1016/j.neuron.2013.11.026; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; Fannella M., 2014, PLOS COMPUT BIOL, V10; FATT P, 1957, J NEUROPHYSIOL, V20, P27, DOI 10.1152/jn.1957.20.1.27; Frick A, 2005, J NEUROBIOL, V64, P100, DOI 10.1002/neu.20148; Frick A, 2004, NAT NEUROSCI, V7, P126, DOI 10.1038/nn1178; Fu M, 2012, NATURE, V483, P92, DOI 10.1038/nature10844; FUORTES MGF, 1957, J GEN PHYSIOL, V40, P735, DOI 10.1085/jgp.40.5.735; Gambino F, 2014, NATURE, V515, P116, DOI 10.1038/nature13664; Gasparini S, 2004, J NEUROSCI, V24, P11046, DOI 10.1523/JNEUROSCI.2520-04.2004; Ghosh KK, 2011, NAT METHODS, V8, P871, DOI [10.1038/NMETH.1694, 10.1038/nmeth.1694]; Gidon A, 2012, NEURON, V75, P330, DOI 10.1016/j.neuron.2012.05.015; Golding NL, 1999, J NEUROSCI, V19, P8789, DOI 10.1523/JNEUROSCI.19-20-08789.1999; Golding NL, 2002, NATURE, V418, P326, DOI 10.1038/nature00854; Golding NL, 1998, NEURON, V21, P1189, DOI 10.1016/S0896-6273(00)80635-2; Grienberger C, 2014, NEURON, V81, P1274, DOI 10.1016/j.neuron.2014.01.014; Haider B, 2013, NATURE, V493, P97, DOI 10.1038/nature11665; Harnett MT, 2015, J NEUROSCI, V35, P1024, DOI 10.1523/JNEUROSCI.2813-14.2015; Harnett MT, 2013, NEURON, V79, P516, DOI 10.1016/j.neuron.2013.06.005; Harnett MT, 2012, NATURE, V491, P599, DOI 10.1038/nature11554; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; HAUSSER M, 1995, NEURON, V15, P637, DOI 10.1016/0896-6273(95)90152-3; Helmchen F, 1999, NAT NEUROSCI, V2, P989, DOI 10.1038/14788; Helmchen Fritjof, 2013, Cold Spring Harb Protoc, V2013, P904, DOI 10.1101/pdb.top078147; HERRERAS O, 1990, J NEUROPHYSIOL, V64, P1429, DOI 10.1152/jn.1990.64.5.1429; Higley MJ, 2003, J NEUROSCI, V23, P10190; Hill DN, 2013, P NATL ACAD SCI USA, V110, P13618, DOI 10.1073/pnas.1312599110; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; JAFFE DB, 1992, NATURE, V357, P244, DOI 10.1038/357244a0; Jarsky T, 2005, NAT NEUROSCI, V8, P1667, DOI 10.1038/nn1599; Jia HB, 2014, P NATL ACAD SCI USA, V111, P9277, DOI 10.1073/pnas.1408525111; Jia HB, 2010, NATURE, V464, P1307, DOI 10.1038/nature08947; Jung HY, 1997, J NEUROSCI, V17, P6639; Kamondi A, 1998, J NEUROSCI, V18, P3919; Katz Y, 2009, NEURON, V63, P171, DOI 10.1016/j.neuron.2009.06.023; Kleindienst T, 2011, NEURON, V72, P1012, DOI 10.1016/j.neuron.2011.10.015; KOCH C, 1983, P NATL ACAD SCI-BIOL, V80, P2799, DOI 10.1073/pnas.80.9.2799; KOCH C, 1992, SCIENCE, V256, P973, DOI 10.1126/science.1589781; Larkum ME, 2009, SCIENCE, V325, P756, DOI 10.1126/science.1171958; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Larkum ME, 2002, J NEUROSCI, V22, P6991; Larkum ME, 2001, J PHYSIOL-LONDON, V533, P447, DOI 10.1111/j.1469-7793.2001.0447a.x; Larkum ME, 1999, P NATL ACAD SCI USA, V96, P14600, DOI 10.1073/pnas.96.25.14600; LASSERROSS N, 1992, P ROY SOC B-BIOL SCI, V247, P35, DOI 10.1098/rspb.1992.0006; Lavzin M, 2012, NATURE, V490, P397, DOI 10.1038/nature11451; Lee SH, 2012, NEURON, V76, P209, DOI 10.1016/j.neuron.2012.09.012; Leger JF, 2005, J NEUROPHYSIOL, V93, P281, DOI 10.1152/jn.00067.2003; Letzkus JJ, 2006, J NEUROSCI, V26, P10420, DOI 10.1523/JNEUROSCI.2650-06.2006; LLINAS R, 1976, P NATL ACAD SCI USA, V73, P2520, DOI 10.1073/pnas.73.7.2520; LLINAS R, 1968, SCIENCE, V160, P1132, DOI 10.1126/science.160.3832.1132; LLINAS R, 1971, J NEUROPHYSIOL, V34, P532, DOI 10.1152/jn.1971.34.4.532; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P171, DOI 10.1113/jphysiol.1980.sp013357; Longordo F, 2013, NAT NEUROSCI, V16, P714, DOI 10.1038/nn.3394; Losonczy A, 2006, NEURON, V50, P291, DOI 10.1016/j.neuron.2006.03.016; Losonczy A, 2008, NATURE, V452, P436, DOI 10.1038/nature06725; Lovett-Barron M, 2014, SCIENCE, V343, P857, DOI 10.1126/science.1247485; Magee JC, 1999, J NEUROPHYSIOL, V82, P1895, DOI 10.1152/jn.1999.82.4.1895; MAGEE JC, 1995, J PHYSIOL-LONDON, V487, P67, DOI 10.1113/jphysiol.1995.sp020862; Magee JC, 1998, J NEUROSCI, V18, P7613; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Magee JC, 2000, NAT REV NEUROSCI, V1, P181, DOI 10.1038/35044552; Major G, 2013, ANNU REV NEUROSCI, V36, P1, DOI 10.1146/annurev-neuro-062111-150343; Makino H, 2011, NEURON, V72, P1001, DOI 10.1016/j.neuron.2011.09.036; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; Migliore M, 2002, NAT REV NEUROSCI, V3, P362, DOI 10.1038/nrn810; Murayama M, 2007, J NEUROPHYSIOL, V98, P1791, DOI 10.1152/jn.00082.2007; Murayama M, 2009, P NATL ACAD SCI USA, V106, P20482, DOI 10.1073/pnas.0910379106; Murayama M, 2009, NATURE, V457, P1137, DOI 10.1038/nature07663; Nevian T, 2007, NAT NEUROSCI, V10, P206, DOI 10.1038/nn1826; Niell CM, 2010, NEURON, V65, P472, DOI 10.1016/j.neuron.2010.01.033; Oesch N, 2005, NEURON, V47, P739, DOI 10.1016/j.neuron.2005.06.036; Palmer LM, 2006, J NEUROSCI, V26, P1854, DOI 10.1523/JNEUROSCI.4812-05.2006; Palmer LM, 2014, NAT NEUROSCI, V17, P383, DOI 10.1038/nn.3646; Palmer LM, 2012, SCIENCE, V335, P989, DOI 10.1126/science.1217276; Palmer LM, 2010, J PHYSIOL-LONDON, V588, P1709, DOI 10.1113/jphysiol.2010.188300; Palmer LM, 2009, J NEUROSCI, V29, P6897, DOI 10.1523/JNEUROSCI.5847-08.2009; Pawlak V, 2013, ELIFE, V2, DOI 10.7554/eLife.00012; Perez-Garci E, 2013, J PHYSIOL-LONDON, V591, P1599, DOI 10.1113/jphysiol.2012.245464; Petreanu L, 2012, NATURE, V489, P299, DOI 10.1038/nature11321; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; POCKBERGER H, 1991, BRAIN RES, V539, P181, DOI 10.1016/0006-8993(91)91619-C; Poirazi P, 2003, NEURON, V37, P989, DOI 10.1016/S0896-6273(03)00149-1; Polsky A, 2004, NAT NEUROSCI, V7, P621, DOI 10.1038/nn1253; Potez S, 2008, J NEUROPHYSIOL, V99, P1394, DOI 10.1152/jn.01126.2007; Priebe NJ, 2010, NATURE, V464, P1290, DOI 10.1038/4641290b; RALL W, 1968, J NEUROPHYSIOL, V31, P884, DOI 10.1152/jn.1968.31.6.884; Rall W, 1964, NEURAL THEORY MODELI, P122; Rapp M, 1996, P NATL ACAD SCI USA, V93, P11985, DOI 10.1073/pnas.93.21.11985; Remy S, 2007, P NATL ACAD SCI USA, V104, P17192, DOI 10.1073/pnas.0707919104; Remy S, 2009, NEURON, V61, P906, DOI 10.1016/j.neuron.2009.01.032; Schiller J, 2000, NATURE, V404, P285, DOI 10.1038/35005094; Schiller J, 1997, J PHYSIOL-LONDON, V505, P605, DOI 10.1111/j.1469-7793.1997.605ba.x; Schmidt-Hieber C, 2008, J PHYSIOL-LONDON, V586, P1849, DOI 10.1113/jphysiol.2007.150151; Sheffield MEJ, 2015, NATURE, V517, P200, DOI 10.1038/nature13871; Shu YS, 2007, J NEUROPHYSIOL, V97, P746, DOI 10.1152/jn.00922.2006; Sivyer B, 2013, NAT NEUROSCI, V16, P1848, DOI 10.1038/nn.3565; Sjostrom PJ, 2006, NEURON, V51, P227, DOI 10.1016/j.neuron.2006.06.017; Smith SL, 2013, NATURE, V503, P115, DOI 10.1038/nature12600; SPENCER WA, 1961, J NEUROPHYSIOL, V24, P272, DOI 10.1152/jn.1961.24.3.272; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; STUART G, 1994, NEURON, V13, P703, DOI 10.1016/0896-6273(94)90037-X; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; Stuart G, 1998, J NEUROSCI, V18, P3501; Stuart G, 1997, J PHYSIOL-LONDON, V505, P617, DOI 10.1111/j.1469-7793.1997.617ba.x; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; Stuart GJ, 2001, NAT NEUROSCI, V4, P63, DOI 10.1038/82910; STUART GJ, 1993, PFLUG ARCH EUR J PHY, V423, P511, DOI 10.1007/BF00374949; Sun Q, 2014, ELIFE, V3, DOI 10.7554/eLife.04551; Svoboda K, 1999, NAT NEUROSCI, V2, P65, DOI 10.1038/4569; Takahashi H, 2009, NEURON, V62, P102, DOI 10.1016/j.neuron.2009.03.007; Takahashi N, 2012, SCIENCE, V335, P353, DOI 10.1126/science.1210362; TANK DW, 1988, SCIENCE, V242, P773, DOI 10.1126/science.2847315; TURNER RW, 1989, J NEUROPHYSIOL, V62, P1375, DOI 10.1152/jn.1989.62.6.1375; Varga Z, 2011, P NATL ACAD SCI USA, V108, P15420, DOI 10.1073/pnas.1112355108; Velte TJ, 1999, J NEUROPHYSIOL, V81, P1412, DOI 10.1152/jn.1999.81.3.1412; Vetter P, 2001, J NEUROPHYSIOL, V85, P926, DOI 10.1152/jn.2001.85.2.926; Waters J, 2004, J NEUROSCI, V24, P11127, DOI 10.1523/JNEUROSCI.2933-04.2004; Waters J, 2003, J NEUROSCI, V23, P8558; Waters J, 2006, J NEUROSCI, V26, P8267, DOI 10.1523/JNEUROSCI.2152-06.2006; Williams SR, 2002, SCIENCE, V295, P1907, DOI 10.1126/science.1067903; Williams SR, 1999, J PHYSIOL-LONDON, V521, P467, DOI 10.1111/j.1469-7793.1999.00467.x; WONG RKS, 1979, P NATL ACAD SCI USA, V76, P986, DOI 10.1073/pnas.76.2.986; Xu NL, 2012, NATURE, V492, P247, DOI 10.1038/nature11601; YAMAMOTO C, 1966, NATURE, V210, P1055, DOI 10.1038/2101055a0; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; YUSTE R, 1994, NEURON, V13, P23, DOI 10.1016/0896-6273(94)90457-X; Zhao XY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3088; Zhu JJ, 1999, J NEUROPHYSIOL, V81, P1171, DOI 10.1152/jn.1999.81.3.1171	150	229	234	9	68	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2015	18	12					1713	1721		10.1038/nn.4157	http://dx.doi.org/10.1038/nn.4157			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CX1LV	26605882				2022-12-17	WOS:000365458600006
J	de Lafuente, V; Romo, R				de Lafuente, V; Romo, R			Neuronal correlates of subjective sensory experience	NATURE NEUROSCIENCE			English	Article							EARLY VISUAL-CORTEX; PREFRONTAL CORTEX; DECISION-MAKING; PREMOTOR CORTEX; PSYCHOPHYSICAL PERFORMANCE; CORTICAL MICROSTIMULATION; SOMATOSENSORY CORTEX; NEURAL CODES; DISCRIMINATION; MACAQUE	When a near-threshold stimulus is presented, a sensory percept may or may not be produced. The unpredictable outcome of such perceptual judgment is believed to be determined by the activity of neurons in early sensory cortex. We analyzed the responses of neurons in primary somatosensory cortex, recorded while monkeys judged the presence or absence of threshold stimuli. We found that these responses did not covary with the monkeys' perceptual reports. In contrast, the activity of frontal lobe neurons did covary with trial-by-trial judgments. Further control and microstimulation experiments indicated that frontal lobe neurons are closely related to the monkeys' subjective experiences during sensory detection.	Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico	Romo, R (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Mexico City 04510, DF, Mexico.	rromo@ifc.unam.mx	de la Fuente, Javier/GQP-6328-2022	de Lafuente, Victor/0000-0002-1047-1354; romo, ranulfo/0000-0003-3529-3635				Bair W, 2001, J NEUROSCI, V21, P1676, DOI 10.1523/JNEUROSCI.21-05-01676.2001; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; Cisek P, 2005, NEURON, V45, P801, DOI 10.1016/j.neuron.2005.01.027; Fries P, 2001, NAT NEUROSCI, V4, P194, DOI 10.1038/84032; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; HANES DP, 1995, EXP BRAIN RES, V103, P85; Hernandez A, 2000, P NATL ACAD SCI USA, V97, P6191, DOI 10.1073/pnas.120018597; Hernandez A, 2002, NEURON, V33, P959, DOI 10.1016/S0896-6273(02)00613-X; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; Leopold DA, 1996, NATURE, V379, P549, DOI 10.1038/379549a0; Leopold DA, 1999, TRENDS COGN SCI, V3, P254, DOI 10.1016/S1364-6613(99)01332-7; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; MOUNTCASTLE VB, 1969, J NEUROPHYSIOL, V32, P452, DOI 10.1152/jn.1969.32.3.452; Ress D, 2003, NAT NEUROSCI, V6, P414, DOI 10.1038/nn1024; Rizzolatti G, 2001, NEURON, V31, P889, DOI 10.1016/S0896-6273(01)00423-8; Romo R, 2003, NAT REV NEUROSCI, V4, P203, DOI 10.1038/nrn1058; Romo R, 1998, NATURE, V392, P387, DOI 10.1038/32891; Romo R, 2000, NEURON, V26, P273, DOI 10.1016/S0896-6273(00)81156-3; Romo R, 1999, NATURE, V399, P470, DOI 10.1038/20939; Romo R, 2004, NEURON, V41, P165, DOI 10.1016/S0896-6273(03)00817-1; Romo R, 2003, NEURON, V38, P649, DOI 10.1016/S0896-6273(03)00287-3; Romo R, 2002, NAT NEUROSCI, V5, P1217, DOI 10.1038/nn950; Salinas E, 2000, J NEUROSCI, V20, P5503, DOI 10.1523/JNEUROSCI.20-14-05503.2000; Schall JD, 2001, NAT REV NEUROSCI, V2, P33, DOI 10.1038/35049054; Shulman GL, 2001, P NATL ACAD SCI USA, V98, P313, DOI 10.1073/pnas.021381198; Tanji J, 2001, ANNU REV NEUROSCI, V24, P631, DOI 10.1146/annurev.neuro.24.1.631; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	27	229	232	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2005	8	12					1698	1703		10.1038/nn1587	http://dx.doi.org/10.1038/nn1587			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	988FC	16286929				2022-12-17	WOS:000233576200018
J	Nguyen, QT; Sanes, JR; Lichtman, JW				Nguyen, QT; Sanes, JR; Lichtman, JW			Pre-existing pathways promote precise projection patterns	NATURE NEUROSCIENCE			English	Article							PERIPHERAL-NERVE REGENERATION; DIFFERENT SEGMENTAL LEVELS; GROWTH CONE GUIDANCE; NEUROMUSCULAR-JUNCTIONS; SELECTIVE REINNERVATION; INVIVO VISUALIZATION; POSTSYNAPTIC CHANGES; INTERCOSTAL MUSCLES; SYNAPSE ELIMINATION; TRANSGENIC MICE	A large body of evidence shows that molecular cues promote specific synapse formation by guiding axons and by mediating their association with targets, but much less is known about the contribution of physical cues (such as mechanical constraints) to these processes. Here we used the peripheral motor system to investigate the latter issue. In living mice, we viewed individual motor axons bearing a fluorescent reporter, and mapped the cohort of muscle fibers that they innervated both before and after nerve damage. When gross trauma was minimized (by a nerve-crushing rather than nerve-cutting procedure), regenerating axons retraced their former pathways, bifurcated at original branch points, and formed neuromuscular junctions on the same fibers that they originally innervated. Axonal growth through tubes of non-neural cells seemed to account for this specificity, and specificity degraded when the tubes were cut. These results suggest that nonspecific guidance cues can be sufficient to generate specific synaptic circuitry.	Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Lichtman, JW (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA.							Akaaboune M, 1999, SCIENCE, V286, P503, DOI 10.1126/science.286.5439.503; [Anonymous], [No title captured]; BALICEGORDON RJ, 1990, J NEUROSCI, V10, P894; BALICEGORDON RJ, 1993, J NEUROSCI, V13, P834; Bastmeyer M, 1998, J COMP NEUROL, V392, P1, DOI 10.1002/(SICI)1096-9861(19980302)392:1<1::AID-CNE1>3.0.CO;2-6; Benson DL, 2001, NAT REV NEUROSCI, V2, P899, DOI 10.1038/35104078; BERNSTEIN J, 1961, EXP NEUROL, V4, P262, DOI 10.1016/0014-4886(61)90047-4; BROWN MC, 1987, BRAIN, V110, P695, DOI 10.1093/brain/110.3.695; BROWN MC, 1981, ANNU REV NEUROSCI, V4, P17, DOI 10.1146/annurev.ne.04.030181.000313; BRUSHART TM, 1980, SCIENCE, V208, P603, DOI 10.1126/science.7367884; BRUSHART TM, 1981, NEUROSCIENCE, V6, P2053, DOI 10.1016/0306-4522(81)90043-9; CAJAL SRY, 1928, DEGENERATION REGENER, V1, P66; Carlstedt T, 2000, CURR OPIN NEUROL, V13, P683, DOI 10.1097/00019052-200012000-00012; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; DESANTIS M, 1992, EXP NEUROL, V116, P229, DOI 10.1016/0014-4886(92)90002-8; DESANTIS M, 1993, J COMP NEUROL, V336, P66, DOI 10.1002/cne.903360106; DIAMOND J, 1992, J NEUROSCI, V12, P1467; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Feng GP, 2000, NEURON, V25, P295, DOI 10.1016/S0896-6273(00)80895-8; Fu SY, 1997, MOL NEUROBIOL, V14, P67, DOI 10.1007/BF02740621; Gutmann E, 1944, J ANAT, V78, P15; HARDMAN VJ, 1987, J NEUROSCI, V7, P1031; HENDRY IA, 1986, BRAIN RES, V376, P292, DOI 10.1016/0006-8993(86)90192-7; Ide C, 1996, NEUROSCI RES, V25, P101; Keller-Peck CR, 2001, NEURON, V31, P381, DOI 10.1016/S0896-6273(01)00383-X; Keller-Peck CR, 2001, J NEUROSCI, V21, P6136, DOI 10.1523/JNEUROSCI.21-16-06136.2001; Kiefer R, 2001, PROG NEUROBIOL, V64, P109, DOI 10.1016/S0301-0082(00)00060-5; KUGELBERG E, 1970, J NEUROL NEUROSUR PS, V33, P319, DOI 10.1136/jnnp.33.3.319; Langley J N, 1897, J Physiol, V22, P215; Laskowski MB, 1998, J NEUROSCI, V18, P7328; LASKOWSKI MB, 1988, J NEUROSCI, V8, P3094; LINGLE CJ, 1988, INT ANESTHESIOL CLIN, V26, P288, DOI 10.1097/00004311-198802640-00007; Melancon E, 1997, J NEUROSCI, V17, P7796; Mueller BK, 1999, ANNU REV NEUROSCI, V22, P351, DOI 10.1146/annurev.neuro.22.1.351; NJA A, 1977, J PHYSIOL-LONDON, V272, P633, DOI 10.1113/jphysiol.1977.sp012064; RICH MM, 1989, J NEUROSCI, V9, P1781, DOI 10.1523/jneurosci.09-05-01781.1989; SALONEN V, 1988, ACTA NEUROPATHOL, V75, P331, DOI 10.1007/BF00687785; SANES JR, 1978, J CELL BIOL, V78, P176, DOI 10.1083/jcb.78.1.176; SCHERER SS, 1984, J NEUROCYTOL, V13, P519, DOI 10.1007/BF01148079; Stankovic N, 1996, CELL TISSUE RES, V284, P161, DOI 10.1007/s004410050576; Sunderland S, 1978, NERVES NERVE INJURIE, P69; THOMAS GJ, 1993, ADV BIOPHYS CHEM, V3, P1; Wang KH, 1999, CELL, V96, P771, DOI 10.1016/S0092-8674(00)80588-7; Weiss P, 1934, J EXP ZOOL, V68, P393, DOI 10.1002/jez.1400680304; WESTERFIELD M, 1987, J EXP BIOL, V132, P161; WIGSTON DJ, 1985, J NEUROSCI, V5, P1208; WIGSTON DJ, 1982, NATURE, V299, P464, DOI 10.1038/299464a0; WIGSTON DJ, 1986, J NEUROSCI, V6, P2757; Young JZ, 1942, PHYSIOL REV, V22, P0318, DOI 10.1152/physrev.1942.22.4.318	49	229	236	0	14	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2002	5	9					861	867		10.1038/nn905	http://dx.doi.org/10.1038/nn905			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	587RL	12172551				2022-12-17	WOS:000177656300016
J	Richards, BA; Lillicrap, TP; Beaudoin, P; Bengio, Y; Bogacz, R; Christensen, A; Clopath, C; Costa, RP; de Berker, A; Ganguli, S; Gillon, CJ; Hafner, D; Kepecs, A; Kriegeskorte, N; Latham, P; Lindsay, GW; Miller, KD; Naud, R; Pack, CC; Poirazi, P; Roelfsema, P; Sacramento, J; Saxe, A; Scellier, B; Schapiro, AC; Senn, W; Wayne, G; Yamins, D; Zenke, F; Zylberberg, J; Therien, D; Kording, KP				Richards, Blake A.; Lillicrap, Timothy P.; Beaudoin, Philippe; Bengio, Yoshua; Bogacz, Rafal; Christensen, Amelia; Clopath, Claudia; Costa, Rui Ponte; de Berker, Archy; Ganguli, Surya; Gillon, Colleen J.; Hafner, Danijar; Kepecs, Adam; Kriegeskorte, Nikolaus; Latham, Peter; Lindsay, Grace W.; Miller, Kenneth D.; Naud, Richard; Pack, Christopher C.; Poirazi, Panayiota; Roelfsema, Pieter; Sacramento, Joao; Saxe, Andrew; Scellier, Benjamin; Schapiro, Anna C.; Senn, Walter; Wayne, Greg; Yamins, Daniel; Zenke, Friedemann; Zylberberg, Joel; Therien, Denis; Kording, Konrad P.			A deep learning framework for neuroscience	NATURE NEUROSCIENCE			English	Article							SYNAPTIC PLASTICITY; NEURON; REPRESENTATIONS; GRADIENT; NETWORK; CHALLENGES; MODELS	Systems neuroscience seeks explanations for how the brain implements a wide variety of perceptual, cognitive and motor tasks. Conversely, artificial intelligence attempts to design computational systems based on the tasks they will have to solve. In artificial neural networks, the three components specified by design are the objective functions, the learning rules and the architectures. With the growing success of deep learning, which utilizes brain-inspired architectures, these three designed components have increasingly become central to how we model, engineer and optimize complex artificial learning systems. Here we argue that a greater focus on these components would also benefit systems neuroscience. We give examples of how this optimization-based framework can drive theoretical and experimental progress in neuroscience. We contend that this principled perspective on systems neuroscience will help to generate more rapid progress.	[Richards, Blake A.; Bengio, Yoshua; Scellier, Benjamin] Mila, Montreal, PQ, Canada; [Richards, Blake A.] McGill Univ, Sch Comp Sci, Montreal, PQ, Canada; [Richards, Blake A.; Pack, Christopher C.] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada; [Richards, Blake A.; Bengio, Yoshua; Zylberberg, Joel; Kording, Konrad P.] Canadian Inst Adv Res, Toronto, ON, Canada; [Lillicrap, Timothy P.; Wayne, Greg] DeepMind Inc, London, England; [Lillicrap, Timothy P.] UCL, Ctr Computat Math & Phys Life Sci & Expt Biol, London, England; [Beaudoin, Philippe; de Berker, Archy; Therien, Denis] Element AI, Montreal, PQ, Canada; [Bengio, Yoshua; Scellier, Benjamin] Univ Montreal, Montreal, PQ, Canada; [Bogacz, Rafal] Univ Oxford, MRC Brain Network Dynam Unit, Oxford, England; [Christensen, Amelia] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; [Clopath, Claudia] Imperial Coll London, Dept Bioengn, London, England; [Costa, Rui Ponte] Univ Bristol, Sch Comp Sci Elect & Elect Engn, Computat Neurosci Unit, Bristol, Avon, England; [Costa, Rui Ponte] Univ Bristol, Engn Maths, Bristol, Avon, England; [Costa, Rui Ponte; Senn, Walter] Univ Bern, Dept Physiol, Bern, Switzerland; [Ganguli, Surya] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [Ganguli, Surya; Hafner, Danijar] Google Brain, Mountain View, CA USA; [Gillon, Colleen J.] Univ Toronto Scarborough, Dept Biol Sci, Toronto, ON, Canada; [Gillon, Colleen J.] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada; [Hafner, Danijar] Univ Toronto, Dept Comp Sci, Toronto, ON, Canada; [Hafner, Danijar] Vector Inst, Toronto, ON, Canada; [Kepecs, Adam] Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA; [Kriegeskorte, Nikolaus] Columbia Univ, Dept Psychol & Neurosci, New York, NY USA; [Kriegeskorte, Nikolaus; Lindsay, Grace W.; Miller, Kenneth D.] Columbia Univ, Zuckerman Mind Brain Behav Inst, New York, NY USA; [Latham, Peter] UCL, Gatsby Computat Neurosci Unit, London, England; [Lindsay, Grace W.; Miller, Kenneth D.] Columbia Univ, Ctr Theoret Neurosci, New York, NY USA; [Miller, Kenneth D.] Columbia Univ, Coll Phys & Surg, Dept Neurosci, New York, NY USA; [Naud, Richard] Univ Ottawa, Brain & Mind Inst, Ottawa, ON, Canada; [Naud, Richard] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Poirazi, Panayiota] Fdn Res & Technol Hellas FORTH, IMBB, Iraklion, Greece; [Roelfsema, Pieter] Netherlands Inst Neurosci, Dept Vis & Cognit, Amsterdam, Netherlands; [Sacramento, Joao] Swiss Fed Inst Technol, Inst Neuroinformat, Zurich, Switzerland; [Sacramento, Joao] Univ Zurich, Zurich, Switzerland; [Saxe, Andrew] Univ Oxford, Dept Expt Psychol, Oxford, England; [Schapiro, Anna C.] Univ Penn, Dept Psychol, 3815 Walnut St, Philadelphia, PA 19104 USA; [Yamins, Daniel] Stanford Univ, Dept Psychol, Stanford, CA USA; [Yamins, Daniel] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Yamins, Daniel] Stanford Univ, Wu Tsai Neurosci Inst, Stanford, CA 94305 USA; [Zenke, Friedemann] Friedrich Miescher Inst Biomed Res, Basel, Switzerland; [Zenke, Friedemann] Univ Oxford, Ctr Neural Circuits & Behav, Oxford, England; [Zylberberg, Joel] York Univ, Dept Phys & Astron, Toronto, ON, Canada; [Zylberberg, Joel] York Univ, Ctr Vis Res, Toronto, ON, Canada; [Kording, Konrad P.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Kording, Konrad P.] Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA	McGill University; McGill University; Canadian Institute for Advanced Research (CIFAR); University of London; University College London; Universite de Montreal; University of Oxford; Stanford University; Imperial College London; University of Bristol; University of Bristol; University of Bern; Stanford University; Google Incorporated; University of Toronto; University of Toronto; University of Toronto; Cold Spring Harbor Laboratory; Columbia University; Columbia University; University of London; University College London; Columbia University; Columbia University; University of Ottawa; University of Ottawa; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University of Oxford; University of Pennsylvania; Stanford University; Stanford University; Stanford University; Friedrich Miescher Institute for Biomedical Research; University of Oxford; York University - Canada; York University - Canada; University of Pennsylvania; University of Pennsylvania	Richards, BA (corresponding author), Mila, Montreal, PQ, Canada.; Richards, BA (corresponding author), McGill Univ, Sch Comp Sci, Montreal, PQ, Canada.; Richards, BA (corresponding author), McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada.; Richards, BA (corresponding author), Canadian Inst Adv Res, Toronto, ON, Canada.	blake.richards@mcgill.ca	; Kording, Konrad/A-1233-2007	Ganguli, Surya/0000-0002-9264-7551; Kording, Konrad/0000-0001-8408-4499; Costa, Rui Ponte/0000-0003-2595-2027; Kepecs, Adam/0000-0003-0049-8120; Naud, Richard/0000-0001-7383-3095; Saxe, Andrew/0000-0002-9831-8812; Lillicrap, Timothy/0000-0001-8918-486X; Gillon, Colleen/0000-0002-2253-7816; Poirazi, Panayiota/0000-0001-6152-595X; Christensen, Amelia/0000-0002-0082-4822	Canadian Institute for Advanced Research Learning in Machines and Brains Program; BBSRC [BB/P018785/1] Funding Source: UKRI; MRC [MC_UU_12024/5] Funding Source: UKRI	Canadian Institute for Advanced Research Learning in Machines and Brains Program; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This article emerged from a workshop on optimization in the brain that took place February 24-28, 2019 at the Bellairs Research Institute of McGill University. We thank Element AI and Bellairs Research Institute for their critical support in organizing this workshop. This work was also supported by the Canadian Institute for Advanced Research Learning in Machines and Brains Program.	Advani M. S., 2017, HIGH DIMENSIONAL DYN; Akrout M., 2019, USING WEIGHT MIRRORS; Amit Y, 2019, FRONT COMPUT NEUROSC, V13, DOI 10.3389/fncom.2019.00018; [Anonymous], 1995, HDB BRAIN THEORY NEU; Banino A, 2018, NATURE, V557, P429, DOI 10.1038/s41586-018-0102-6; Bartunov S., 2018, ARXIV180704587; Bashivan P, 2019, SCIENCE, V364, P453, DOI 10.1126/science.aav9436; Bengio Y., 2007, LARGE SCALE KERNEL M; Bittner KC, 2017, SCIENCE, V357, P1033, DOI 10.1126/science.aan3846; Botvinick M, 2019, TRENDS COGN SCI, V23, P408, DOI 10.1016/j.tics.2019.02.006; Cadieu CF, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003963; Chalk M., 2019, INFERRING FUNCTION P, DOI [10.1101/598086, DOI 10.1101/598086]; Chorowski Jan K, 2015, P NIPS, DOI DOI 10.1016/0167-739X(94)90007-8; Cichy RM, 2016, SCI REP-UK, V6, DOI 10.1038/srep27755; Costa RP, 2017, NEURON, V96, P177, DOI 10.1016/j.neuron.2017.09.021; Cullen KE, 2012, TRENDS NEUROSCI, V35, P185, DOI 10.1016/j.tins.2011.12.001; Finn C, 2016, ADV NEUR IN, V29; Fiser A, 2016, NAT NEUROSCI, V19, P1658, DOI 10.1038/nn.4385; FUKUSHIMA K, 1980, BIOL CYBERN, V36, P193, DOI 10.1007/BF00344251; Gao Y, 2016, IEEE INT CONF ROBOT, P536, DOI 10.1109/ICRA.2016.7487176; Goel V., 2018, ADV NEURAL INFORM PR, P5683; Golub MD, 2018, NAT NEUROSCI, V21, P607, DOI 10.1038/s41593-018-0095-3; Goodfellow I, 2016, ADAPT COMPUT MACH LE, P1; Guclu U, 2015, J NEUROSCI, V35, P10005, DOI 10.1523/JNEUROSCI.5023-14.2015; Guerguiev J, 2017, ELIFE, V6, DOI 10.7554/eLife.22901; Hannun A., 2014, ABS1412556; Houthooft R., 2016, ADV NEURAL INFORM PR, P1109; Huang YP, 2011, WIRES COGN SCI, V2, P580, DOI 10.1002/wcs.142; Hyvarinen A, 1996, INT J NEURAL SYST, V7, P671, DOI 10.1142/S0129065796000646; INTRATOR N, 1992, NEURAL NETWORKS, V5, P3, DOI 10.1016/S0893-6080(05)80003-6; Kebschull JM, 2016, NEURON, V91, P975, DOI 10.1016/j.neuron.2016.07.036; Kell AJE, 2018, NEURON, V98, P630, DOI 10.1016/j.neuron.2018.03.044; Kepecs A, 2014, NATURE, V505, P318, DOI 10.1038/nature12983; Khaligh-Razavi SM, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003915; Kim JS, 2014, NATURE, V509, P331, DOI 10.1038/nature13240; Klyubin AS, 2005, IEEE C EVOL COMPUTAT, P128; Kording KP, 2001, J COMPUT NEUROSCI, V11, P207, DOI 10.1023/A:1013776130161; Koren V, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005355; Kornfeld J, 2018, CURR OPIN NEUROBIOL, V50, P261, DOI 10.1016/j.conb.2018.04.030; Krakauer JW, 2017, NEURON, V93, P480, DOI 10.1016/j.neuron.2016.12.041; Kriegeskorte N, 2018, NAT NEUROSCI, V21, P1148, DOI 10.1038/s41593-018-0210-5; Krizhevsky A., 2012, COMMUN ACM, P1097, DOI DOI 10.1145/3065386; Kwag J, 2009, NAT NEUROSCI, V12, P1219, DOI 10.1038/nn.2388; Lacefield CO, 2019, CELL REP, V26, P2000, DOI 10.1016/j.celrep.2019.01.093; Lansdell B. J., 2019, SPIKING ALLOWS NEURO, DOI [10.1101/253351, DOI 10.1101/253351]; Lillicrap T. P., 2019, WHAT DOES IT MEAN UN; Lillicrap TP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13276; Lim S, 2015, NAT NEUROSCI, V18, P1804, DOI 10.1038/nn.4158; Lindsey J, 2019, INT C LEARN REPR ICL; Maass, 2018, ADV NEURAL INFORM PR, P787; MacKay David JC, 2003, INFORM THEORY INFERE; Marblestone AH, 2016, FRONT COMPUT NEUROSC, V10, DOI 10.3389/fncom.2016.00094; Marder E, 2001, CURR BIOL, V11, pR986, DOI 10.1016/S0960-9822(01)00581-4; Mathis A, 2018, NAT NEUROSCI, V21, P1281, DOI 10.1038/s41593-018-0209-y; Momennejad I, 2017, NAT HUM BEHAV, V1, P680, DOI 10.1038/s41562-017-0180-8; Nayebi A., 2018, ADV NEURAL INFORM PR, P5290; Newell A., 1961, GPS PROGRAM SIMULATE; Neyshabur B., 2014, SEARCH REAL INDUCTIV; Neyshabur B., 2019, INT C LEARN REPR ICL; Nguyen A., 2019, UNDERSTANDING NEURAL; OJA E, 1982, J MATH BIOL, V15, P267, DOI 10.1007/BF00275687; Olshausen BA, 1996, NETWORK-COMP NEURAL, V7, P333, DOI 10.1088/0954-898X/7/2/014; Olshausen BA, 2006, 23 PROBLEMS SYSTEMS, P182, DOI [DOI 10.1093/ACPROF:OSO/9780195148220.001.0001, 10.1093/acprof:oso/9780195148220.003.0010]; Poirazi P, 2003, NEURON, V37, P989, DOI 10.1016/S0896-6273(03)00149-1; Pospisil DA, 2018, ELIFE, V7, DOI 10.7554/eLife.38242; Pozzi I., 2018, BIOL PLAUSIBLE LEARN; Radford Alec, 2019, BETTER LANGUAGE MODE; Raman DV, 2019, P NATL ACAD SCI USA, V116, P10537, DOI 10.1073/pnas.1813416116; Ravi S., 2017, P INT C LEARN REPR, P1; Richards BA, 2019, CURR OPIN NEUROBIOL, V54, P28, DOI 10.1016/j.conb.2018.08.003; Roelfsema PR, 2018, NAT REV NEUROSCI, V19, P166, DOI 10.1038/nrn.2018.6; Roelfsema PR, 2005, NEURAL COMPUT, V17, P2176, DOI 10.1162/0899766054615699; Rumelhart DE, 1988, PARALLEL DISTRIBUTED; Sacramento J, 2018, ADV NEUR IN, V31; Salge C, 2014, EMERGENCE COMPLEX CO, V9, P67, DOI 10.1007/978-3-642-53734-9_4; Samadi A, 2017, NEURAL COMPUT, V29, P578, DOI 10.1162/NECO_a_00929; Santoro A., 2017, ADV NEURAL INFORM PR, P4967; Scellier B, 2017, FRONT COMPUT NEUROSC, V11, DOI 10.3389/fncom.2017.00024; Schrimpf M., 2020, BIORXIV, DOI 10.1101/407007; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Scott SH, 2004, NAT REV NEUROSCI, V5, P534, DOI 10.1038/nrn1427; Silver D, 2017, NATURE, V550, P354, DOI 10.1038/nature24270; Singer Y, 2018, ELIFE, V7, DOI 10.7554/eLife.31557; Snell Jake, 2017, ADV NEURAL INFORM PR, P4077; Steinmetz NA, 2018, CURR OPIN NEUROBIOL, V50, P92, DOI 10.1016/j.conb.2018.01.009; THOMPSON LT, 1989, J NEUROSCI, V9, P2382; Van Essen D. C., 1995, INTRO NEURAL ELECT N, V2nd, P45; Vogels TP, 2005, ANNU REV NEUROSCI, V28, P357, DOI 10.1146/annurev.neuro.28.061604.135637; Wang JX, 2018, NAT NEUROSCI, V21, P860, DOI 10.1038/s41593-018-0147-8; Watanabe E, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00345; Werfel J, 2004, ADV NEUR IN, V16, P1197; Whittington JCR, 2017, NEURAL COMPUT, V29, P1229, DOI 10.1162/NECO_a_00949; Williams LE, 2019, NEURON, V101, P91, DOI 10.1016/j.neuron.2018.10.049; WILLIAMS RJ, 1992, MACH LEARN, V8, P229, DOI 10.1007/BF00992696; Wolpert D. H., 1997, IEEE Transactions on Evolutionary Computation, V1, P67, DOI 10.1109/4235.585893; Yagishita S, 2014, SCIENCE, V345, P1616, DOI 10.1126/science.1255514; Yamins DLK, 2016, NAT NEUROSCI, V19, P356, DOI 10.1038/nn.4244; Zador AM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11786-6; Zolnik TA, 2017, J PHYSIOL-LONDON, V595, P1465, DOI 10.1113/JP273116; Zylberberg J, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002250	100	228	230	34	175	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2019	22	11					1761	1770		10.1038/s41593-019-0520-2	http://dx.doi.org/10.1038/s41593-019-0520-2			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JI3VI	31659335	Green Submitted, Green Accepted			2022-12-17	WOS:000493396600005
J	Poldrack, RA; Gorgolewski, KJ				Poldrack, Russell A.; Gorgolewski, Krzysztof J.			Making big data open: data sharing in neuroimaging	NATURE NEUROSCIENCE			English	Review							HUMAN CONNECTOME PROJECT; CIRCULAR ANALYSIS; BRAIN; FMRI; NEUROSCIENCE; FLEXIBILITY; PSYCHOLOGY; FRAMEWORK; TIME	In the last decade, major advances have been made in the availability of shared neuroimaging data, such that there are more than 8,000 shared MRI (magnetic resonance imaging) data sets available online. Here we outline the state of data sharing for task-based functional MRI (fMRI) data, with a focus on various forms of data and their relative utility for subsequent analyses. We also discuss challenges to the future success of data sharing and highlight the ethical argument that data sharing may be necessary to maximize the contribution of human subjects.	[Poldrack, Russell A.; Gorgolewski, Krzysztof J.] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; [Gorgolewski, Krzysztof J.] Max Planck Inst Human Cognit & Brain Sci, Max Planck Res Grp Neuroanat & Connect, Leipzig, Germany	Stanford University; Max Planck Society	Poldrack, RA (corresponding author), Stanford Univ, Dept Psychol, Stanford, CA 94305 USA.	poldrack@stanford.edu	Gorgolewski, Krzysztof Jacek/A-7883-2010	Gorgolewski, Krzysztof Jacek/0000-0003-3321-7583; Poldrack, Russell/0000-0001-6755-0259	US National Science Foundation [OCI-1131441]; US National Institute of Drug Abuse [1R21DA034316-S1]; Max Planck Society; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA034316] Funding Source: NIH RePORTER; Direct For Computer & Info Scie & Enginr [1532231] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); US National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Max Planck Society(Max Planck Society); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	Thanks to T. Schonberg, D.S. Margulies and K. Heuer for comments on an early draft. Preparation of this paper was supported by the US National Science Foundation (OCI-1131441) and US National Institute of Drug Abuse (1R21DA034316-S1) to R.A.P. and Max Planck Society to K.J.G.	Acuna C, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00062; [Anonymous], 2009, PSYCHOL SCI, V20, P1364, DOI 10.1111/j.1467-9280.2009.02460.x; [Anonymous], 2014, USING SOMEONE ELSES; [Anonymous], 2013, ADV NEURAL INFORM PR; [Anonymous], 2013, ECONOMIST; Bellec P, 2012, FRONT NEUROINFORM, V6, DOI 10.3389/fninf.2012.00007; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Brakewood B, 2013, NEUROIMAGE, V82, P671, DOI 10.1016/j.neuroimage.2013.02.040; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Carp J, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00149; Das S, 2012, FRONT NEUROINFORM, V5, DOI 10.3389/fninf.2011.00037; David SP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070104; Dinov I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013070; Gadde S, 2012, NEUROINFORMATICS, V10, P19, DOI 10.1007/s12021-011-9119-9; Gardner D, 2008, NEUROINFORMATICS, V6, P149, DOI 10.1007/s12021-008-9024-z; Gauthier CJ, 2012, NEUROIMAGE, V63, P1353, DOI 10.1016/j.neuroimage.2012.07.065; Gorgolewski Krzysztof, 2011, Front Neuroinform, V5, P13, DOI 10.3389/fninf.2011.00013; Gorgolewski KJ, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-6; Gorgolewski KJ, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00009; Guyon, 2004, ADV NEURAL INF PROCE, V17, P545; Hanke M, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.3; Hoge RD, 2012, NEUROIMAGE, V62, P930, DOI 10.1016/j.neuroimage.2012.02.022; Hurko O, 2012, NEUROIMAGE, V59, P4196, DOI 10.1016/j.neuroimage.2011.10.085; Ioannidis JPA, 2008, EPIDEMIOLOGY, V19, P640, DOI 10.1097/EDE.0b013e31818131e7; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Keator DB, 2013, NEUROIMAGE, V82, P647, DOI 10.1016/j.neuroimage.2013.05.094; Kriegeskorte N, 2010, J CEREBR BLOOD F MET, V30, P1551, DOI 10.1038/jcbfm.2010.86; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Laird AR, 2005, NEUROINFORMATICS, V3, P65, DOI 10.1385/NI:3:1:065; Langille MGI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010071; Lloyd D, 2002, J COGNITIVE NEUROSCI, V14, P818, DOI 10.1162/089892902760191027; MacKenzie-Graham AJ, 2008, NEUROIMAGE, V42, P178, DOI 10.1016/j.neuroimage.2008.04.186; Marcus DS, 2007, NEUROINFORMATICS, V5, P11, DOI 10.1385/NI:5:1:11; Marcus DS, 2013, NEUROIMAGE, V80, P202, DOI 10.1016/j.neuroimage.2013.05.077; Marenco L, 2008, NEUROINFORMATICS, V6, P219, DOI 10.1007/s12021-008-9025-y; Marques JP, 2010, NEUROIMAGE, V49, P1271, DOI 10.1016/j.neuroimage.2009.10.002; Marshall E, 2001, SCIENCE, V291, P1192, DOI 10.1126/science.291.5507.1192; Medland SE, 2014, NAT NEUROSCI, V17, P791, DOI 10.1038/nn.3718; MEEHL PE, 1967, PHILOS SCI, V34, P103, DOI 10.1086/288135; Mennes M, 2013, NEUROIMAGE, V82, P683, DOI 10.1016/j.neuroimage.2012.10.064; Monogan JE, 2013, POLIT ANAL, V21, P21, DOI 10.1093/pan/mps022; Poldrack RA, 2013, FRONT NEUROINFORM, V7, DOI 10.3389/fninf.2013.00012; Poldrack RA, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002707; Poldrack Russell A, 2011, Front Neuroinform, V5, P17, DOI 10.3389/fninf.2011.00017; Poldrack RA, 2010, PERSPECT PSYCHOL SCI, V5, P753, DOI 10.1177/1745691610388777; Poline JB, 2012, FRONT NEUROINFORM, V6, DOI 10.3389/fninf.2012.00009; POSNER MI, 1988, SCIENCE, V240, P1627, DOI 10.1126/science.3289116; Rex DE, 2003, NEUROIMAGE, V19, P1033, DOI 10.1016/S1053-8119(03)00185-X; Rohlfing T, 2012, NEUROIMAGE, V59, P4189, DOI 10.1016/j.neuroimage.2011.09.080; Rubinov M, 2011, NEUROIMAGE, V56, P2068, DOI 10.1016/j.neuroimage.2011.03.069; Salimi-Khorshidi G, 2009, NEUROIMAGE, V45, P810, DOI 10.1016/j.neuroimage.2008.12.039; Scott Adam, 2011, Front Neuroinform, V5, P33, DOI 10.3389/fninf.2011.00033; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Tomasi D, 2010, P NATL ACAD SCI USA, V107, P9885, DOI 10.1073/pnas.1001414107; Turner JA, 2012, NEUROINFORMATICS, V10, P57, DOI 10.1007/s12021-011-9126-x; Van Essen DC, 2013, NEUROIMAGE, V80, P62, DOI 10.1016/j.neuroimage.2013.05.041; Van Horn JD, 2001, PHILOS T R SOC B, V356, P1323, DOI 10.1098/rstb.2001.0916; Van Horn JD, 2013, NEUROIMAGE, V82, P677, DOI 10.1016/j.neuroimage.2012.11.010; Van Horn JD, 2009, NEUROIMAGE, V47, P1720, DOI 10.1016/j.neuroimage.2009.03.086; Vul E, 2009, PERSPECT PSYCHOL SCI, V4, P274, DOI 10.1111/j.1745-6924.2009.01125.x; Webb JT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084279; Wicherts JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026828; Yan CG, 2013, NEUROIMAGE, V80, P246, DOI 10.1016/j.neuroimage.2013.04.081; Yarkoni T, 2011, NAT METHODS, V8, P665, DOI [10.1038/NMETH.1635, 10.1038/nmeth.1635]; Yeo BTT, 2014, NEUROIMAGE, V88, P212, DOI 10.1016/j.neuroimage.2013.10.046; Zalesky A, 2014, P NATL ACAD SCI USA, V111, P10341, DOI 10.1073/pnas.1400181111; Zuo XN, 2012, CEREB CORTEX, V22, P1862, DOI 10.1093/cercor/bhr269; 2013, NATURE, V496, P398	68	228	233	2	97	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2014	17	11					1510	1517		10.1038/nn.3818	http://dx.doi.org/10.1038/nn.3818			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AS0LT	25349916				2022-12-17	WOS:000343969300015
J	Tissir, F; Qu, YB; Montcouquiol, M; Zhou, LB; Komatsu, K; Shi, DB; Fujimori, T; Labeau, J; Tyteca, D; Courtoy, P; Poumay, Y; Uemura, T; Goffinet, AM				Tissir, Fadel; Qu, Yibo; Montcouquiol, Mireille; Zhou, Libing; Komatsu, Kouji; Shi, Dongbo; Fujimori, Toshihiko; Labeau, Jason; Tyteca, Donatienne; Courtoy, Pierre; Poumay, Yves; Uemura, Tadashi; Goffinet, Andre M.			Lack of cadherins Celsr2 and Celsr3 impairs ependymal ciliogenesis, leading to fatal hydrocephalus	NATURE NEUROSCIENCE			English	Article							PLANAR CELL POLARITY; NEURAL STEM-CELLS; TISSUE POLARITY; GENES; EXPRESSION; CILIA; POLARIZATION; MUTATION; DEFECTS; MORPHOGENESIS	Ependymal cells form the epithelial lining of cerebral ventricles. Their apical surface is covered by cilia that beat in a coordinated fashion to facilitate circulation of the cerebrospinal fluid (CSF). The genetic factors that govern the development and function of ependymal cilia remain poorly understood. We found that the planar cell polarity cadherins Celsr2 and Celsr3 control these processes. In Celsr2-deficient mice, the development and planar organization of ependymal cilia are compromised, leading to defective CSF dynamics and hydrocephalus. In Celsr2 and Celsr3 double mutant ependyma, ciliogenesis is markedly impaired, resulting in lethal hydrocephalus. The membrane distribution of Vangl2 and Fzd3, two key planar cell polarity proteins, was disturbed in Celsr2 mutants, and even more so in Celsr2 and Celsr3 double mutants. Our findings suggest that planar cell polarity signaling is involved in ependymal cilia development and in the pathophysiology of hydrocephalus, with possible implications in other ciliopathies.	[Tissir, Fadel; Qu, Yibo; Zhou, Libing; Labeau, Jason; Goffinet, Andre M.] Catholic Univ Louvain, Inst Neurosci, B-1200 Brussels, Belgium; [Montcouquiol, Mireille] Neuroctr Magendie, INSERM, U862, Mol Basis Planar Polar Grp, Bordeaux, France; [Komatsu, Kouji; Fujimori, Toshihiko] Natl Inst Basic Biol, Div Embryol, Okazaki, Japan; [Komatsu, Kouji; Shi, Dongbo; Fujimori, Toshihiko; Uemura, Tadashi] Japan Sci & Technol Agcy, CREST, Tokyo, Japan; [Shi, Dongbo; Uemura, Tadashi] Kyoto Univ, Grad Sch Biostudies, Kyoto, Japan; [Tyteca, Donatienne; Courtoy, Pierre] Catholic Univ Louvain, de Duve Inst, B-1200 Brussels, Belgium; [Poumay, Yves] Fac Univ Notre Dame Paix, B-5000 Namur, Belgium	Universite Catholique Louvain; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Japan Science & Technology Agency (JST); Kyoto University; Universite Catholique Louvain; University of Namur	Tissir, F (corresponding author), Catholic Univ Louvain, Inst Neurosci, B-1200 Brussels, Belgium.	fadel.tissir@uclouvain.be; andre.goffinet@uclouvain.be	Komatsu, Kouji/R-6087-2019; Shi, Dongbo/AAB-9994-2020; montcouquiol, mireille/L-6199-2017; Fujimori, Toshihiko/L-7711-2016; Poumay, Yves/G-4525-2016	Shi, Dongbo/0000-0002-4408-3042; montcouquiol, mireille/0000-0001-8739-6519; Fujimori, Toshihiko/0000-0001-5200-4634; Poumay, Yves/0000-0001-5200-3367; Komatsu, Kouji/0000-0003-3137-4569; Tissir, Fadel/0000-0002-9292-6622; Zhou, Libing/0000-0002-8975-5228; UEMURA, Tadashi/0000-0001-7204-3606	Actions de Recherches Concertees [ARC-186]; FRFC [2.1501.01]; FRSM [3.4501.07]; Fondation medicale Reine Elisabeth; Wallonne and Bruxelloise regions; Japan Science and Technology Corporation; Interuniversity Poles of Attraction (SSTC) [PAI p6/20]	Actions de Recherches Concertees; FRFC(Fonds de la Recherche Scientifique - FNRS); FRSM(Fonds de la Recherche Scientifique - FNRS); Fondation medicale Reine Elisabeth; Wallonne and Bruxelloise regions; Japan Science and Technology Corporation(Japan Science & Technology Agency (JST)); Interuniversity Poles of Attraction (SSTC)	We thank K. Jones for Emx1-Cre mice, G. Meyer for the antibody to SCO-spondin, and K.-A. Nave for NEX-Cre mice. We also thank V. Bonte, I. Lambermont and E. Paitre for technical assistance and M. F. Boulanger, Y. Houbion, M.- J. Vertez and R. Vigneron for help with electron microscopy. This work was supported by grants from the Actions de Recherches Concertees (ARC-186), FRFC 2.1501.01, FRSM 3.4501.07, Interuniversity Poles of Attraction (SSTC, PAI p6/20), the Fondation medicale Reine Elisabeth, the Wallonne and Bruxelloise regions from Belgium and from the Japan Science and Technology Corporation. F.T. is a research associate at the Belgian Fonds National de la Recherche Scientifique.	Banizs B, 2005, DEVELOPMENT, V132, P5329, DOI 10.1242/dev.02153; BOISVIEUXULRICH E, 1987, CELL MOTIL CYTOSKEL, V8, P333, DOI 10.1002/cm.970080406; BOISVIEUXULRICH E, 1990, CELL TISSUE RES, V259, P443, DOI 10.1007/BF01740770; BOISVIEUXULRICH E, 1991, BIOL CELL, V72, P3, DOI 10.1016/0248-4900(91)90072-U; Brody SL, 2000, AM J RESP CELL MOL, V23, P45, DOI 10.1165/ajrcmb.23.1.4070; Chen JC, 1998, J CLIN INVEST, V102, P1077, DOI 10.1172/JCI4786; Curtin JA, 2003, CURR BIOL, V13, P1129, DOI 10.1016/S0960-9822(03)00374-9; Danilov AI, 2009, GLIA, V57, P136, DOI 10.1002/glia.20741; Davenport JR, 2005, AM J PHYSIOL-RENAL, V289, pF1159, DOI 10.1152/ajprenal.00118.2005; Davy BE, 2003, HUM MOL GENET, V12, P1163, DOI 10.1093/hmg/ddg122; Dawe HR, 2007, J CELL SCI, V120, P7, DOI 10.1242/jcs.03305; Devenport D, 2008, NAT CELL BIOL, V10, P1257, DOI 10.1038/ncb1784; Formstone CJ, 2001, MECH DEVELOP, V109, P91, DOI 10.1016/S0925-4773(01)00515-9; Goebbels S, 2006, GENESIS, V44, P611, DOI 10.1002/dvg.20256; Gomperts BN, 2004, J CELL SCI, V117, P1329, DOI 10.1242/jcs.00978; Guo N, 2004, P NATL ACAD SCI USA, V101, P9277, DOI 10.1073/pnas.0402802101; Ibanez-Tallon I, 2004, HUM MOL GENET, V13, P2133, DOI 10.1093/hmg/ddh219; Jones C, 2008, NAT GENET, V40, P69, DOI 10.1038/ng.2007.54; Kibar Z, 2001, NAT GENET, V28, P251, DOI 10.1038/90081; Lechtreck KF, 2008, J CELL BIOL, V180, P633, DOI 10.1083/jcb.200710162; Marshall WF, 2008, CURR OPIN CELL BIOL, V20, P48, DOI 10.1016/j.ceb.2007.11.009; Marshall WF, 2008, J CELL BIOL, V180, P17, DOI 10.1083/jcb.200710085; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; Mirzadeh Z, 2010, J NEUROSCI, V30, P2600, DOI 10.1523/JNEUROSCI.3744-09.2010; Mitchell B, 2007, NATURE, V447, P97, DOI 10.1038/nature05771; Montcouquiol M, 2006, J NEUROSCI, V26, P5265, DOI 10.1523/JNEUROSCI.4680-05.2006; Pan JH, 2007, J CELL SCI, V120, P1868, DOI 10.1242/jcs.005306; Park TJ, 2008, NAT GENET, V40, P871, DOI 10.1038/ng.104; Park TJ, 2006, NAT GENET, V38, P303, DOI 10.1038/ng1753; Ravni A, 2009, J INVEST DERMATOL, V129, P2507, DOI 10.1038/jid.2009.84; Ropper A.H. a.B., 2005, ADAMS VICTORS PRINCI; Ross AJ, 2005, NAT GENET, V37, P1135, DOI 10.1038/ng1644; Salathe M, 2007, ANNU REV PHYSIOL, V69, P401, DOI 10.1146/annurev.physiol.69.040705.141253; Sawamoto K, 2006, SCIENCE, V311, P629, DOI 10.1126/science.1119133; Sharma N, 2008, CURR TOP DEV BIOL, V85, P371, DOI 10.1016/S0070-2153(08)00813-2; Shima Y, 2002, DEV DYNAM, V223, P321, DOI 10.1002/dvdy.10054; Shima Y, 2007, NAT NEUROSCI, V10, P963, DOI 10.1038/nn1933; Simons M, 2008, ANNU REV GENET, V42, P517, DOI 10.1146/annurev.genet.42.110807.091432; Spassky N, 2005, J NEUROSCI, V25, P10, DOI 10.1523/JNEUROSCI.1108-04.2005; Strutt DI, 1997, NATURE, V387, P292, DOI 10.1038/387292a0; Tissir F, 2006, EUR J NEUROSCI, V23, P597, DOI 10.1111/j.1460-9568.2006.04596.x; Tissir F, 2005, NAT NEUROSCI, V8, P451, DOI 10.1038/nn1428; Tissir F, 2002, MECH DEVELOP, V112, P157, DOI 10.1016/S0925-4773(01)00623-2; Town T, 2008, P NATL ACAD SCI USA, V105, P2853, DOI 10.1073/pnas.0712385105; Voronina VA, 2009, J CELL BIOL, V185, P225, DOI 10.1083/jcb.200809144; Wang YS, 2007, DEVELOPMENT, V134, P647, DOI 10.1242/dev.02772; Wang YH, 2006, J NEUROSCI, V26, P2147, DOI 10.1523/JNEUROSCI.4698-05.2005; Wang YS, 2002, J NEUROSCI, V22, P8563; WONG LL, 1993, J CELL BIOL, V123, P209, DOI 10.1083/jcb.123.1.209; Zhou LB, 2008, SCIENCE, V320, P946, DOI 10.1126/science.1155244	50	228	233	2	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2010	13	6					700	U71		10.1038/nn.2555	http://dx.doi.org/10.1038/nn.2555			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	600QY	20473291				2022-12-17	WOS:000278003300014
J	Sternson, SM; Shepherd, GMG; Friedman, JM				Sternson, SM; Shepherd, GMG; Friedman, JM			Topographic mapping of VMH -> arcuate nucleus microcircuits and their reorganization by fasting	NATURE NEUROSCIENCE			English	Article							VENTROMEDIAL NUCLEUS; HYPOTHALAMIC CONTROL; NEUROPEPTIDE-Y; FOOD-INTAKE; NEURONS; LESIONS; LEPTIN; RAT; OBESITY; ORGANIZATION	In the hypothalamic arcuate nucleus ( ARC), pro-opiomelanocortin ( POMC) neurons inhibit feeding and neuropeptide-Y (NPY) neurons stimulate feeding. We tested whether neurons in the ventromedial hypothalamic nucleus (VMH), a known satiety center, activate anorexigenic neuronal pathways in the ARC by projecting either excitatory synaptic inputs to POMC neurons and/or inhibitory inputs to NPY neurons. Using laser scanning photostimulation in brain slices from transgenic mice, we found that POMC and NPY neurons, which are interspersed in the ARC, are nevertheless regulated by anatomically distinct synaptic inputs. POMC neurons received strong excitatory input from the medial VMH (mVMH), whereas NPY neurons did not and, instead, received weak inhibitory input only from within the ARC. The strength of the excitatory input from the mVMH to POMC neurons was diminished by fasting. These data identify a new molecularly defined circuit that is dynamically regulated by nutritional state in a manner consistent with the known role of the VMH as a satiety center.	Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; Rockefeller Univ, Mol Genet Lab, New York, NY 10021 USA; Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Howard Hughes Medical Institute; Rockefeller University; Rockefeller University; Howard Hughes Medical Institute; Cold Spring Harbor Laboratory	Friedman, JM (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, 1230 York Ave, New York, NY 10021 USA.	friedj@rockefeller.edu	Shepherd, Gordon/F-2679-2010	Sternson, Scott/0000-0002-0835-444X				Ahima RS, 1996, NATURE, V382, P250, DOI 10.1038/382250a0; ANAND BK, 1951, YALE J BIOL MED, V24, P123; Bouret SG, 2004, SCIENCE, V304, P108, DOI 10.1126/science.1095004; Brivanlou IH, 2004, P NATL ACAD SCI USA, V101, P2560, DOI 10.1073/pnas.0308577100; CALLAWAY EM, 1993, P NATL ACAD SCI USA, V90, P7661, DOI 10.1073/pnas.90.16.7661; Callaway EM, 2002, J NEUROCYTOL, V31, P231, DOI 10.1023/A:1024165824469; CANTERAS NS, 1994, J COMP NEUROL, V348, P41, DOI 10.1002/cne.903480103; CHRISTENSEN LW, 1977, BRAIN RES BULL, V2, P137, DOI 10.1016/0361-9230(77)90010-7; CLARK JT, 1984, ENDOCRINOLOGY, V115, P427, DOI 10.1210/endo-115-1-427; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Dantzker JL, 2000, NAT NEUROSCI, V3, P701, DOI 10.1038/76656; DeFalco J, 2001, SCIENCE, V291, P2608, DOI 10.1126/science.1056602; Elmquist JK, 1999, NEURON, V22, P221, DOI 10.1016/S0896-6273(00)81084-3; Elmquist JK, 1998, J COMP NEUROL, V395, P535; Faletti AG, 1999, P NATL ACAD SCI USA, V96, P1722, DOI 10.1073/pnas.96.4.1722; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Hetherington AW, 1940, ANAT REC, V78, P149, DOI 10.1002/ar.1090780203; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; KENNEDY GC, 1950, PROC R SOC SER B-BIO, V137, P535, DOI 10.1098/rspb.1950.0065; Kreek MJ, 2000, ANN NY ACAD SCI, V909, P186; Lechner HAE, 2002, J NEUROSCI, V22, P5287; Majdic G, 2002, ENDOCRINOLOGY, V143, P607, DOI 10.1210/en.143.2.607; ONO T, 1982, BRAIN RES, V232, P494, DOI 10.1016/0006-8993(82)90295-5; PFAFF DW, 1979, J PHYSIOL-LONDON, V288, P203; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Sawatari A, 1996, NATURE, V380, P442, DOI 10.1038/380442a0; Shepherd GMG, 2005, NAT NEUROSCI, V8, P782, DOI 10.1038/nn1447; Shepherd GMG, 2003, NEURON, V38, P277, DOI 10.1016/S0896-6273(03)00152-1; SHIMIZU N, 1987, BRAIN RES, V416, P153, DOI 10.1016/0006-8993(87)91508-3; Slimko EM, 2002, J NEUROSCI, V22, P7373; STENGER J, 1991, PHYSIOL BEHAV, V50, P1209, DOI 10.1016/0031-9384(91)90584-B; THEODOSIS DT, 1993, NEUROSCIENCE, V57, P501, DOI 10.1016/0306-4522(93)90002-W; VANDENPOL AN, 1982, J COMP NEUROL, V204, P65, DOI 10.1002/cne.902040108; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252; ZARJEVSKI N, 1993, ENDOCRINOLOGY, V133, P1753, DOI 10.1210/en.133.4.1753	35	228	236	1	17	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2005	8	10					1356	1363		10.1038/nn1550	http://dx.doi.org/10.1038/nn1550			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	968EY	16172601				2022-12-17	WOS:000232145900020
J	Akten, B; Jauch, E; Genova, GK; Kim, EY; Edery, I; Raabe, T; Jackson, FR				Akten, B; Jauch, E; Genova, GK; Kim, EY; Edery, I; Raabe, T; Jackson, FR			A role for CK2 in the Drosophila circadian oscillator	NATURE NEUROSCIENCE			English	Article							PROTEIN-KINASE CK2; GENE-EXPRESSION; PERIOD PROTEIN; REGULATORY SUBUNIT; CRYSTAL-STRUCTURE; CLOCK PROTEINS; DOUBLE-TIME; RHYTHMS; MELANOGASTER; LIGHT	The posttranslational modification of clock proteins is critical for the function of circadian oscillators. By genetic analysis of a Drosophila melanogaster circadian clock mutant known as Andante, which has abnormally long circadian periods, we show that casein kinase 2 (CK2) has a role in determining period length. Andante is a mutation of the gene encoding the beta subunit of CK2 and is predicted to perturb CK2beta subunit dimerization. It is associated with reduced beta subunit levels, indicative of a defect in alpha:beta association and production of the tetrameric alpha2:beta2 holoenzyme. Consistent with a direct action on the clock mechanism, we show that CK2beta is localized within clock neurons and that the clock proteins Period (Per) and Timeless (Tim) accumulate to abnormally high levels in the Andante mutant. Furthermore, the nuclear translocation of Per and Tim is delayed in Andante, and this defect accounts for the long-period phenotype of the mutant. These results suggest a function for CK2-dependent phosphorylation in the molecular oscillator.	Tufts Univ, Sch Med, Dept Neurosci, Boston, MA 01211 USA; Univ Wurzburg, Inst Med Strahlenkunde & Zellforsch, D-97078 Wurzburg, Germany; Rutgers State Univ, Dept Mol Biol & Biochem, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA	Tufts University; University of Wurzburg; Rutgers State University New Brunswick	Jackson, FR (corresponding author), Tufts Univ, Sch Med, Dept Neurosci, 136 Harrison Ave, Boston, MA 01211 USA.			Jauch, Edward/0000-0002-3533-4364				Bidwai A P, 1999, Mol Cell Biol Res Commun, V1, P21, DOI 10.1006/mcbr.1999.0103; BIDWAI AP, 1993, ARCH BIOCHEM BIOPHYS, V300, P265, DOI 10.1006/abbi.1993.1037; Chantalat L, 1999, EMBO J, V18, P2930, DOI 10.1093/emboj/18.11.2930; Claridge-Chang A, 2001, NEURON, V32, P657, DOI 10.1016/S0896-6273(01)00515-3; CURTIN KD, 1995, NEURON, V14, P365, DOI 10.1016/0896-6273(95)90292-9; DiBartolomeis SM, 2002, MOL GENET GENOMICS, V267, P564, DOI 10.1007/s00438-002-0700-7; EDERY I, 1994, P NATL ACAD SCI USA, V91, P2260, DOI 10.1073/pnas.91.6.2260; Helfrich-Forster C, 2000, J NEUROSCI, V20, P3339, DOI 10.1523/JNEUROSCI.20-09-03339.2000; HELFRICHFORSTER C, 1995, P NATL ACAD SCI USA, V92, P612, DOI 10.1073/pnas.92.2.612; HunterEnsor M, 1996, CELL, V84, P677, DOI 10.1016/S0092-8674(00)81046-6; Jauch E, 2002, GENE, V298, P29, DOI 10.1016/S0378-1119(02)00921-6; Kloss B, 2001, NEURON, V30, P699, DOI 10.1016/S0896-6273(01)00320-8; KONOPKA RJ, 1991, J NEUROGENET, V7, P103, DOI 10.3109/01677069109066214; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lee CG, 1996, SCIENCE, V271, P1740, DOI 10.1126/science.271.5256.1740; LEVINE JD, 1994, NEURON, V13, P967, DOI 10.1016/0896-6273(94)90262-3; Lin Y, 2002, P NATL ACAD SCI USA, V99, P9562, DOI 10.1073/pnas.132269699; LUSCHER B, 1994, EUR J BIOCHEM, V220, P521, DOI 10.1111/j.1432-1033.1994.tb18651.x; Martinek S, 2001, CELL, V105, P769, DOI 10.1016/S0092-8674(01)00383-X; McDonald MJ, 2001, CELL, V107, P567, DOI 10.1016/S0092-8674(01)00545-1; Myers MP, 1996, SCIENCE, V271, P1736, DOI 10.1126/science.271.5256.1736; NEWBY LM, 1995, DEV GENET, V16, P85, DOI 10.1002/dvg.1020160112; NEWBY LM, 1991, GENETICS, V128, P571; Niefind K, 2001, EMBO J, V20, P5320, DOI 10.1093/emboj/20.19.5320; ORR D, 1982, THESIS CALTECH; Park JH, 2000, P NATL ACAD SCI USA, V97, P3608, DOI 10.1073/pnas.070036197; Price JL, 1998, CELL, V94, P83, DOI 10.1016/S0092-8674(00)81224-6; Shafer OT, 2002, J NEUROSCI, V22, P5946; Sidote D, 1998, MOL CELL BIOL, V18, P2004, DOI 10.1128/MCB.18.4.2004; Sugano S, 1999, P NATL ACAD SCI USA, V96, P12362, DOI 10.1073/pnas.96.22.12362; Ueda HR, 2002, J BIOL CHEM, V277, P14048, DOI 10.1074/jbc.C100765200; Yang YH, 2002, GENE DEV, V16, P994, DOI 10.1101/gad.965102; Yang ZH, 2001, NEURON, V29, P453, DOI 10.1016/S0896-6273(01)00218-5; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576; Zeng HK, 1996, NATURE, V380, P129, DOI 10.1038/380129a0	35	228	232	0	27	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2003	6	3					251	257		10.1038/nn1007	http://dx.doi.org/10.1038/nn1007			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	648YB	12563262				2022-12-17	WOS:000181178300013
J	Corbin, JG; Nery, S; Fishell, G				Corbin, JG; Nery, S; Fishell, G			Telencephalic cells take a tangent: non-radial migration in the mammalian forebrain	NATURE NEUROSCIENCE			English	Review							DEVELOPING CEREBRAL-CORTEX; LATERAL GANGLIONIC EMINENCE; NEURONAL MIGRATION; SUBVENTRICULAR ZONE; INTERMEDIATE ZONE; CORTICAL-NEURONS; NERVOUS-SYSTEM; SPINAL-CORD; DLX GENES; ORIGIN	During development of the mammalian telencephalon, cells migrate via diverse pathways to reach their final destinations. In the developing neocortex, projection neurons are generated from cells that migrate radially from the underlying ventricular zone. In contrast, subsets of cells that populate the ventral piriform cortex and olfactory bulb reach these sites by migrating long distances. Additionally, it has been recently established that cells migrate tangentially from the ventral ganglionic eminences to the developing cortex. These tangentially migrating cells are a significant source of cortical interneurons and possibly other cell types such as oligodendrocytes. Here we summarize the known routes of migration in the developing telencephalon, with a particular focus on tangential migration. We also review recent genetic and transplantation studies that have given greater insight into the understanding of these processes and the molecular cues that may guide these migrating cells.	NYU Med Ctr, Dev Genet Program, New York, NY 10016 USA; NYU Med Ctr, Dept Cell Biol, Skirball Inst Biomol Med, New York, NY 10016 USA	New York University; New York University	Fishell, G (corresponding author), NYU Med Ctr, Dev Genet Program, 540 1st Ave, New York, NY 10016 USA.		Nery, Susana Vaz/P-4518-2014	Vaz Nery, Susana/0000-0002-2399-7785; Fishell, Gordon/0000-0002-9640-9278				ALTMAN J, 1969, J COMP NEUROL, V137, P433, DOI 10.1002/cne.901370404; AlvarezBuylla A, 1997, SEMIN CELL DEV BIOL, V8, P207, DOI 10.1006/scdb.1996.0134; Anderson S, 1999, CEREB CORTEX, V9, P646, DOI 10.1093/cercor/9.6.646; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Anderson SA, 2001, DEVELOPMENT, V128, P353; ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; BAYER SA, 1991, NEOCORTICAL DEV, P116; Brodmann K., 1909, VERGLEICHENDE LOKALI; Brose K, 2000, CURR OPIN NEUROBIOL, V10, P95, DOI 10.1016/S0959-4388(99)00066-5; Brunstrom JE, 1997, NEURON, V18, P505, DOI 10.1016/S0896-6273(00)81250-7; Casarosa S, 1999, DEVELOPMENT, V126, P525; Conover JC, 2000, NAT NEUROSCI, V3, P1091, DOI 10.1038/80606; Corbin JG, 2000, DEVELOPMENT, V127, P5007; DEACON TW, 1994, BRAIN RES, V668, P211, DOI 10.1016/0006-8993(94)90526-6; DeCarlos JA, 1996, J NEUROSCI, V16, P6146; DEDIEGO I, 1994, EUR J NEUROSCI, V6, P983, DOI 10.1111/j.1460-9568.1994.tb00593.x; EDWARDS MA, 1990, NEUROSCIENCE, V36, P121, DOI 10.1016/0306-4522(90)90356-9; Fishell G, 1997, CURR OPIN NEUROBIOL, V7, P62, DOI 10.1016/S0959-4388(97)80121-3; FISHELL G, 1993, NATURE, V362, P636, DOI 10.1038/362636a0; GADISSEUX JF, 1992, J COMP NEUROL, V324, P94, DOI 10.1002/cne.903240108; Gaiano N, 1999, NAT NEUROSCI, V2, P812, DOI 10.1038/12186; Goldman SA, 1998, TRENDS NEUROSCI, V21, P107, DOI 10.1016/S0166-2236(97)01191-0; Gonchar Y, 1997, CEREB CORTEX, V7, P347, DOI 10.1093/cercor/7.4.347; GOTZ M, 1994, EUR J NEUROSCI, V6, P18, DOI 10.1111/j.1460-9568.1994.tb00244.x; Gross RE, 1996, NEURON, V17, P595, DOI 10.1016/S0896-6273(00)80193-2; HATTEN ME, 1990, TRENDS NEUROSCI, V13, P179, DOI 10.1016/0166-2236(90)90044-B; HICKS SP, 1968, ANAT REC, V160, P619, DOI 10.1002/ar.1091600311; Lavdas AA, 1999, J NEUROSCI, V19, P7881; LEBER SM, 1990, J NEUROSCI, V10, P2451; Letinic K, 1997, J COMP NEUROL, V384, P373; Lim DA, 2000, NEURON, V28, P713, DOI 10.1016/S0896-6273(00)00148-3; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Marin O, 2000, J NEUROSCI, V20, P6063; Marin O, 2001, SCIENCE, V293, P872, DOI 10.1126/science.1061891; McCarthy M, 2001, J NEUROSCI, V21, P6772, DOI 10.1523/JNEUROSCI.21-17-06772.2001; Meyer G, 1998, J COMP NEUROL, V397, P493; Miller RH, 1996, TRENDS NEUROSCI, V19, P92, DOI 10.1016/S0166-2236(96)80036-1; MIONE MC, 1994, J NEUROSCI, V14, P107; Misson JP, 1991, CEREB CORTEX, V1, P221, DOI 10.1093/cercor/1.3.221; MISSON JP, 1988, DEV BRAIN RES, V44, P95, DOI 10.1016/0165-3806(88)90121-6; Nery S, 2001, DEVELOPMENT, V128, P527; Olivier C, 2001, DEVELOPMENT, V128, P1757; OROURKE NA, 1992, SCIENCE, V258, P299, DOI 10.1126/science.1411527; OROURKE NA, 1995, DEVELOPMENT, V121, P2165; Parnavelas JG, 1991, CEREB CORTEX, V1, P463, DOI 10.1093/cercor/1.6.463; Parnavelas JG, 2000, TRENDS NEUROSCI, V23, P126, DOI 10.1016/S0166-2236(00)01553-8; Pleasure SJ, 2000, NEURON, V28, P727, DOI 10.1016/S0896-6273(00)00149-5; Powell EM, 2001, NEURON, V30, P79, DOI 10.1016/S0896-6273(01)00264-1; PRICE J, 1988, DEVELOPMENT, V104, P473; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAKIC P, 1969, Z ANAT ENTWICKLUNGS, V129, P53, DOI 10.1007/BF00521955; RAKIC P, 1972, J COMP NEUROL, V145, P173; Richardson WD, 2000, GLIA, V29, P136, DOI 10.1002/(SICI)1098-1136(20000115)29:2<136::AID-GLIA6>3.0.CO;2-G; Richardson WD, 1997, DEV NEUROSCI-BASEL, V19, P58, DOI 10.1159/000111186; Rubenstein JLR, 1998, ANNU REV NEUROSCI, V21, P445, DOI 10.1146/annurev.neuro.21.1.445; SMART IHM, 1979, NEOSTRIATUM, P127; Spassky N, 1998, J NEUROSCI, V18, P8331; Sussel L, 1999, DEVELOPMENT, V126, P3359; Tamamaki N, 1997, J NEUROSCI, V17, P8313; TAN SS, 1993, NATURE, V362, P638, DOI 10.1038/362638a0; Tan SS, 1998, NEURON, V21, P295, DOI 10.1016/S0896-6273(00)80539-5; TIMSIT S, 1995, J NEUROSCI, V15, P1012; Toresson H, 2000, DEVELOPMENT, V127, P4361; VANEDEN CG, 1989, J COMP NEUROL, V289, P213, DOI 10.1002/cne.902890204; Ware ML, 1999, CEREB CORTEX, V9, P636, DOI 10.1093/cercor/9.6.636; Wichterle H, 1997, NEURON, V18, P779, DOI 10.1016/S0896-6273(00)80317-7; Wichterle H, 2001, DEVELOPMENT, V128, P3759; Wichterle H, 1999, NAT NEUROSCI, V2, P461, DOI 10.1038/8131; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; Wynshaw-Boris A, 2001, GENE DEV, V15, P639, DOI 10.1101/gad.886801; Yuan WL, 1999, DEV BIOL, V212, P290, DOI 10.1006/dbio.1999.9371; Yun K, 2001, DEVELOPMENT, V128, P193; Zhu Y, 1999, NEURON, V23, P473, DOI 10.1016/S0896-6273(00)80801-6	75	228	231	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2001	4			S			1177	1182		10.1038/nn749	http://dx.doi.org/10.1038/nn749			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	490GF	11687827				2022-12-17	WOS:000172041500009
J	Marrs, GS; Green, SH; Dailey, ME				Marrs, GS; Green, SH; Dailey, ME			Rapid formation and remodeling of postsynaptic densities in developing dendrites	NATURE NEUROSCIENCE			English	Article							SYNAPSE FORMATION; SLICE CULTURES; PLASTICITY; SPINE; RAT; ACTIN; FILOPODIA; CORTEX; AREA; CA1	The dynamics of postsynaptic density (PSD) formation and remodeling were investigated in live developing hippocampal tissue slices. Time lapse imaging of transfected neurons expressing GFP-tagged PSD95, a prominent PSD protein, revealed that up to 40% of PSDs in developing dendrites are structurally dynamic; they rapidly (<15 min) appear or disappear, but also grow, shrink and move within shafts and spines. New spines containing Ms were formed by conversion of dynamic filopodia-like spine precursors in which PSDs appeared de novo, or by direct extension of spines or spine precursors carrying preformed PSDs from the shaft. Ms are therefore highly dynamic structures that can undergo rapid structural alteration within dendrite shafts, spines and spine precursors, permitting rapid formation and remodeling of synaptic connections in developing CNS tissues.	Univ Iowa, Dept Biol Sci, Iowa City, IA 52242 USA; Univ Iowa, Program Neurosci, Med Labs 1178, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Dailey, ME (corresponding author), Univ Iowa, Dept Biol Sci, 335 Biol Bldg, Iowa City, IA 52242 USA.	michael-e-dailey@uiowa.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS037159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002961] Funding Source: NIH RePORTER; NIDCD NIH HHS [DC02961, R01 DC002961] Funding Source: Medline; NINDS NIH HHS [NS37159, R29 NS037159] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Arnold DB, 1999, NEURON, V23, P149, DOI 10.1016/S0896-6273(00)80761-8; BLUE ME, 1983, J NEUROCYTOL, V12, P599, DOI 10.1007/BF01181526; Boyer C, 1998, J NEUROSCI, V18, P5294, DOI 10.1523/JNEUROSCI.18-14-05294.1998; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; COTMAN C, 1973, BRAIN RES, V63, P205, DOI 10.1016/0006-8993(73)90089-9; Dailey ME, 1996, J NEUROSCI, V16, P2983; DAILEY ME, 1999, IMAGING NEURONS LAB; DECAMILLI P, 1983, J CELL BIOL, V96, P1337, DOI 10.1083/jcb.96.5.1337; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; El-Hussein AE, 2000, SCIENCE, V290, P1364; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fiala JC, 1998, J NEUROSCI, V18, P8900; Friedman HV, 2000, NEURON, V27, P57, DOI 10.1016/S0896-6273(00)00009-X; FROTSCHER M, 1995, PROG NEUROBIOL, V45, P143, DOI 10.1016/0301-0082(94)00040-O; Gahwiler BH, 1997, TRENDS NEUROSCI, V20, P471, DOI 10.1016/S0166-2236(97)01122-3; Halpain S, 2000, TRENDS NEUROSCI, V23, P141, DOI 10.1016/S0166-2236(00)01576-9; Harris KM, 1999, CURR OPIN NEUROBIOL, V9, P343, DOI 10.1016/S0959-4388(99)80050-6; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; Harris KM., 1989, HIPPOCAMPUS NEW VIST, P33; HINDS JW, 1976, J COMP NEUROL, V169, P41, DOI 10.1002/cne.901690104; Jontes JD, 2000, NEURON, V27, P11, DOI 10.1016/S0896-6273(00)00003-9; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; KISTNER U, 1993, J BIOL CHEM, V268, P4580; Korkotian E, 1999, NEUROREPORT, V10, P2875, DOI 10.1097/00001756-199909090-00032; Krucker T, 2000, P NATL ACAD SCI USA, V97, P6856, DOI 10.1073/pnas.100139797; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; LO DC, 1994, NEURON, V13, P1263, DOI 10.1016/0896-6273(94)90412-X; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; MOREST DK, 1969, Z ANAT ENTWICKLUNGS, V128, P271, DOI 10.1007/BF00522528; Naisbitt S, 2000, J NEUROSCI, V20, P4524, DOI 10.1523/JNEUROSCI.20-12-04524.2000; Okabe S, 1999, NAT NEUROSCI, V2, P804, DOI 10.1038/12175; Parnass Z, 2000, HIPPOCAMPUS, V10, P561, DOI 10.1002/1098-1063(2000)10:5<561::AID-HIPO6>3.3.CO;2-O; Passafaro M, 1999, NAT NEUROSCI, V2, P1063, DOI 10.1038/15990; POKORNY J, 1981, BRAIN RES BULL, V7, P121, DOI 10.1016/0361-9230(81)90076-9; PURPURA DP, 1975, ADV NEUROL, V12, P91; Rao A, 2000, HIPPOCAMPUS, V10, P527, DOI 10.1002/1098-1063(2000)10:5<527::AID-HIPO3>3.0.CO;2-B; Rao A, 1998, J NEUROSCI, V18, P1217; SAITO Y, 1992, NEUROSCI LETT, V147, P81, DOI 10.1016/0304-3940(92)90779-7; SMITH SJ, 1991, NERVE GROWTH CONE, P19; Sorra KE, 2000, HIPPOCAMPUS, V10, P501, DOI 10.1002/1098-1063(2000)10:5<501::AID-HIPO1>3.0.CO;2-T; STEWARD O, 1988, MOL NEUROBIOL, V2, P227, DOI 10.1007/BF02935634; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Walikonis RS, 2000, J NEUROSCI, V20, P4069; Wong WT, 2001, NAT NEUROSCI, V4, P351, DOI 10.1038/85987; Wong WT, 2000, CURR OPIN NEUROBIOL, V10, P118, DOI 10.1016/S0959-4388(99)00059-8; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	49	228	233	2	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2001	4	10					1006	1013		10.1038/nn717	http://dx.doi.org/10.1038/nn717			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	478CR	11574832				2022-12-17	WOS:000171325800014
J	Habib, N; McCabe, C; Medina, S; Varshavsky, M; Kitsberg, D; Dvir-Szternfeld, R; Green, G; Dionne, D; Nguyen, L; Marshall, JL; Chen, F; Zhang, F; Kaplan, T; Regev, A; Schwartz, M				Habib, Naomi; McCabe, Cristin; Medina, Sedi; Varshavsky, Miriam; Kitsberg, Daniel; Dvir-Szternfeld, Raz; Green, Gilad; Dionne, Danielle; Nguyen, Lan; Marshall, Jamie L.; Chen, Fei; Zhang, Feng; Kaplan, Tommy; Regev, Aviv; Schwartz, Michal			Disease-associated astrocytes in Alzheimer's disease and aging	NATURE NEUROSCIENCE			English	Article							NUCLEUS RNA-SEQ; EXPRESSION; PATHOLOGY; BETA	The role of non-neuronal cells in Alzheimer's disease progression has not been fully elucidated. Using single-nucleus RNA sequencing, we identified a population of disease-associated astrocytes in an Alzheimer's disease mouse model. These disease-associated astrocytes appeared at early disease stages and increased in abundance with disease progression. We discovered that similar astrocytes appeared in aged wild-type mice and in aging human brains, suggesting their linkage to genetic and age-related factors. A new subset of disease-associated astrocytes (DAAs) is identified in a mouse model of Alzheimer's disease by single-nucleus RNA sequencing. DAAs are also found in aged wild-type mice, suggesting a link to genetic and age-related factors.	[Habib, Naomi; Varshavsky, Miriam; Kitsberg, Daniel; Green, Gilad] Hebrew Univ Jerusalem, Edmond & Lily Safra Ctr Brain Sci, Jerusalem, Israel; [Habib, Naomi; McCabe, Cristin; Dionne, Danielle; Nguyen, Lan; Marshall, Jamie L.; Chen, Fei; Zhang, Feng; Regev, Aviv; Schwartz, Michal] Broad Inst MIT & Harvard, Klarman Cell Observ, Cambridge, MA 02142 USA; [Medina, Sedi; Dvir-Szternfeld, Raz; Schwartz, Michal] Weizmann Inst Sci, Dept Neurobiol, Rehovot, Israel; [Zhang, Feng] MIT, Howard Hughes Med Inst, McGovern Inst Brain Res, Dept Brain & Cognit Sci, Cambridge, MA USA; [Zhang, Feng] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Kaplan, Tommy] Hebrew Univ Jerusalem, Sch Comp Sci & Engn, Jerusalem, Israel; [Regev, Aviv] MIT, Howard Hughes Med Inst, Koch Inst Integrat Canc Res, Dept Biol, Cambridge, MA USA	Hebrew University of Jerusalem; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Weizmann Institute of Science; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Hebrew University of Jerusalem; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Habib, N (corresponding author), Hebrew Univ Jerusalem, Edmond & Lily Safra Ctr Brain Sci, Jerusalem, Israel.; Habib, N; Regev, A; Schwartz, M (corresponding author), Broad Inst MIT & Harvard, Klarman Cell Observ, Cambridge, MA 02142 USA.; Schwartz, M (corresponding author), Weizmann Inst Sci, Dept Neurobiol, Rehovot, Israel.; Regev, A (corresponding author), MIT, Howard Hughes Med Inst, Koch Inst Integrat Canc Res, Dept Biol, Cambridge, MA USA.	naomi.habib@mail.huji.ac.il; regev@broadinstitute.org; michal.schwartz@weizmann.ac.il	Kaplan, Tommy/T-2528-2017; Chen, Fei/HGE-5690-2022	Kaplan, Tommy/0000-0002-1892-5461; Chen, Fei/0000-0003-2308-3649; Dionne, Danielle/0000-0002-8338-4323; Marshall, Jamie/0000-0002-2364-391X	NIH BRAIN Initiative grant [U19MH114821]; Klarman Incubator and Klarman Cell Observatory; HHMI; MOST-IL flagship grant; Advanced European Research Council [232835]; Israel Science Foundation (ISF) [991/16, 913/15, 1250/18]; ISF-Legacy Heritage Biomedical Science Partnership research grant [1354/15]; Adelis Foundation; Thompson Foundation; Alon Fellowship; MOST-IL-China [3-15687]	NIH BRAIN Initiative grant; Klarman Incubator and Klarman Cell Observatory; HHMI(Howard Hughes Medical Institute); MOST-IL flagship grant; Advanced European Research Council(European Research Council (ERC)); Israel Science Foundation (ISF)(Israel Science Foundation); ISF-Legacy Heritage Biomedical Science Partnership research grant; Adelis Foundation; Thompson Foundation; Alon Fellowship; MOST-IL-China	We thank R. Herbst, I. Avraham-Davidi and members of the Habib laboratory for discussions and helpful suggestions, and L. Gaffney for graphics and J. Rood for editing. We thank I. Shif and M. Bronstein for help with library preparation and sequencing. This work was supported by the NIH BRAIN Initiative grant (grant no. U19MH114821 for A.R.), the Klarman Incubator and Klarman Cell Observatory (A.R.), the HHMI (A.R.) and a MOST-IL flagship grant (for N.H.). M.S. holds the Maurice and Ilse Katz Professorial Chair in Neuroimmunology, and N.H. holds the Goren-Khazzam Chair in Neurobiology. The work was supported in part by Advanced European Research Council grant no. 232835 (M.S.); Israel Science Foundation (ISF) research grants no. 991/16 (M.S.), no. 913/15 (T.K.) and no. 1250/18 (T.K.); ISF-Legacy Heritage Biomedical Science Partnership research grant no. 1354/15 (M.S.); the Adelis Foundation and the Thompson Foundation (M.S.); the MOST-IL-China research grant no. 3-15687 (N.H.); and the Alon Fellowship (N.H.).	Angerer P, 2016, BIOINFORMATICS, V32, P1241, DOI 10.1093/bioinformatics/btv715; Baruch K, 2016, NAT MED, V22, P135, DOI 10.1038/nm.4022; Baruch K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8967; Bates KA, 2002, NEUROSCIENCE, V113, P785, DOI 10.1016/S0306-4522(02)00230-0; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Clarke LE, 2018, P NATL ACAD SCI USA, V115, pE1896, DOI 10.1073/pnas.1800165115; De Strooper B, 2016, CELL, V164, P603, DOI 10.1016/j.cell.2015.12.056; Gaublomme JT, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10756-2; Haber AL, 2017, NATURE, V551, P333, DOI 10.1038/nature24489; Habib N, 2017, NAT METHODS, V14, P955, DOI [10.1038/NMETH.4407, 10.1038/nmeth.4407]; Habib N, 2016, SCIENCE, V353, P925, DOI 10.1126/science.aad7038; James Melville, 2020, Arxiv, DOI arXiv:1802.03426; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Lancichinetti A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016118; Leitao RA, 2018, MOL NEUROBIOL, V55, P2056, DOI 10.1007/s12035-017-0439-0; Liao MC, 2016, J NEUROSCI, V36, P1730, DOI 10.1523/JNEUROSCI.2735-15.2016; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Mathys H, 2019, NATURE, V570, P332, DOI 10.1038/s41586-019-1195-2; Matias I, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00059; Mucke L, 2000, AM J PATHOL, V157, P2003, DOI 10.1016/S0002-9440(10)64839-0; MUNKRES J, 1957, J SOC IND APPL MATH, V5, P32, DOI 10.1137/0105003; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Rodriguez-Arellano JJ, 2016, NEUROSCIENCE, V323, P170, DOI 10.1016/j.neuroscience.2015.01.007; Rothhammer V, 2018, NATURE, V557, P724, DOI 10.1038/s41586-018-0119-x; Roussotte FF, 2014, J NEUROSCI, V34, P6537, DOI 10.1523/JNEUROSCI.5236-13.2014; Smillie CS, 2019, CELL, V178, P714, DOI 10.1016/j.cell.2019.06.029; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; von Bohlen und Halbach O, 2011, CELL TISSUE RES, V345, P1, DOI 10.1007/s00441-011-1196-4; Wang C, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.371641; Wolock SL, 2019, CELL SYST, V8, P281, DOI 10.1016/j.cels.2018.11.005; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zeisel A, 2018, CELL, V174, P999, DOI 10.1016/j.cell.2018.06.021	35	227	231	25	168	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2020	23	6					701	+		10.1038/s41593-020-0624-8	http://dx.doi.org/10.1038/s41593-020-0624-8		APR 2020	25	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LT6YQ	32341542	Green Accepted			2022-12-17	WOS:000528993700003
J	Prudencio, M; Belzil, VV; Batra, R; Ross, CA; Gendron, TF; Pregent, LJ; Murray, ME; Overstreet, KK; Piazza-Johnston, AE; Desaro, P; Bieniek, KF; DeTure, M; Lee, WC; Biendarra, SM; Davis, MD; Baker, MC; Perkerson, RB; van Blitterswijk, M; Stetler, CT; Rademakers, R; Link, CD; Dickson, DW; Boylan, KB; Li, H; Petrucelli, L				Prudencio, Mercedes; Belzil, Veronique V.; Batra, Ranjan; Ross, Christian A.; Gendron, Tania F.; Pregent, Luc J.; Murray, Melissa E.; Overstreet, Karen K.; Piazza-Johnston, Amelia E.; Desaro, Pamela; Bieniek, Kevin F.; DeTure, Michael; Lee, Wing C.; Biendarra, Sherri M.; Davis, Mary D.; Baker, Matthew C.; Perkerson, Ralph B.; van Blitterswijk, Marka; Stetler, Caroline T.; Rademakers, Rosa; Link, Christopher D.; Dickson, Dennis W.; Boylan, Kevin B.; Li, Hu; Petrucelli, Leonard			Distinct brain transcriptome profiles in C9orf72-associated and sporadic ALS	NATURE NEUROSCIENCE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; HEXANUCLEOTIDE REPEAT EXPANSION; ALTERNATIVE POLYADENYLATION; RNA FOCI; FRONTOTEMPORAL DEMENTIA; C9ORF72 EXPANSION; GGGGCC REPEAT; GENE; MUTATIONS; PROTEINS	Increasing evidence suggests that defective RNA processing contributes to the development of amyotrophic lateral sclerosis (ALS). This may be especially true for ALS caused by a repeat expansion in C9orf72 (c9ALS), in which the accumulation of RNA foci and dipeptide-repeat proteins are expected to modify RNA metabolism. We report extensive alternative splicing (AS) and alternative polyadenylation (APA) defects in the cerebellum of c9ALS subjects (8,224 AS and 1,437 APA), including changes in ALS-associated genes (for example, ATXN2 and FUS), and in subjects with sporadic ALS (sALS; 2,229 AS and 716 APA). Furthermore, heterogeneous nuclear ribonucleoprotein H (hnRNPH) and other RNA-binding proteins are predicted to be potential regulators of cassette exon AS events in both c9ALS and sALS. Co-expression and gene-association network analyses of gene expression and AS data revealed divergent pathways associated with c9ALS and sALS.	[Prudencio, Mercedes; Belzil, Veronique V.; Batra, Ranjan; Gendron, Tania F.; Pregent, Luc J.; Murray, Melissa E.; Bieniek, Kevin F.; DeTure, Michael; Lee, Wing C.; Davis, Mary D.; Baker, Matthew C.; Perkerson, Ralph B.; van Blitterswijk, Marka; Stetler, Caroline T.; Rademakers, Rosa; Dickson, Dennis W.; Petrucelli, Leonard] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Ross, Christian A.] Mayo Clin, Informat Technol, Jacksonville, FL 32224 USA; [Overstreet, Karen K.; Piazza-Johnston, Amelia E.; Desaro, Pamela; Boylan, Kevin B.] Mayo Clin, Dept Neurol, Jacksonville, FL 32224 USA; [Bieniek, Kevin F.] Mayo Clin, Coll Med, Mayo Grad Sch, Rochester, MN USA; [Biendarra, Sherri M.; Li, Hu] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN USA; [Link, Christopher D.] Univ Colorado, Inst Behav Genet, Integrat Physiol, Boulder, CO 80309 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; University of Colorado System; University of Colorado Boulder	Petrucelli, L (corresponding author), Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA.	li.hu@mayo.edu; petrucelli.leonard@mayo.edu	van Blitterswijk, Marka/AAL-4126-2021; van Blitterswijk, Marka/H-7274-2012; Murray, Melissa E/C-2763-2015; Batra, Ranjan/N-3443-2014	van Blitterswijk, Marka/0000-0002-3054-7053; van Blitterswijk, Marka/0000-0002-3054-7053; Murray, Melissa E/0000-0001-7379-2545; Ross, Paige/0000-0002-4157-3951; Prudencio, Mercedes/0000-0002-4894-4858; Batra, Ranjan/0000-0002-6668-2505; Lee, Chris/0000-0001-9068-5274; Bieniek, Kevin/0000-0003-4922-864X	National Institutes of Health/National Institute on Aging [R01AG026251, P50AG016574]; National Institutes of Health/National Institute of Neurological Disorders and Stroke [R21NS089979, R21NS084528, R01NS088689, R01NS077402, R01NS063964, P01NS084974]; National Institute of Environmental Health Sciences [R01ES20395]; Department of Defense [ALSRP AL130125]; Mayo Clinic Foundation; Mayo Clinic Center for Individualized Medicine; ALS Association; Robert Packard Center for ALS Research at Johns Hopkins; Canadian Institutes of Health Research; Siragusa Foundation; Robert and Clarice Smith & Abigail Van Buren Alzheimer's Disease Research Foundation; Donors Cure Foundation; Target ALS; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES020395] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM072474] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063964, R01NS088689, R01NS077402, R21NS089979, P01NS084974, R21NS084528] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG016574, R01AG026251] Funding Source: NIH RePORTER	National Institutes of Health/National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Department of Defense(United States Department of Defense); Mayo Clinic Foundation; Mayo Clinic Center for Individualized Medicine; ALS Association; Robert Packard Center for ALS Research at Johns Hopkins; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Siragusa Foundation; Robert and Clarice Smith & Abigail Van Buren Alzheimer's Disease Research Foundation; Donors Cure Foundation; Target ALS; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are extremely grateful to all individuals who agreed to donate their brains to research. This work was supported by the National Institutes of Health/National Institute on Aging (R01AG026251 and P50AG016574 to L.P.), the National Institutes of Health/National Institute of Neurological Disorders and Stroke (R21NS089979 to T.F.G. and K.B.B.; R21NS084528, R01NS088689 and R01NS077402 to L.P.; R01NS063964 to L.P. and C.D.L.; P01NS084974 to L.P., D.W.D., R.R. and K.B.B.), the National Institute of Environmental Health Sciences (R01ES20395 to L.P.), the Department of Defense (ALSRP AL130125 to L.P.), the Mayo Clinic Foundation (L.P.), the Mayo Clinic Center for Individualized Medicine (L.P. and K.B.B.), the ALS Association (K.B.B., L.P., M.P. and T.F.G.), the Robert Packard Center for ALS Research at Johns Hopkins (L.P.), Target ALS (L.P.), the ALS Association (Milton Safenowitz postdoctoral fellowships to V.V.B. and M.P.), the Canadian Institutes of Health Research (postdoctoral fellowship to V.V.B.), the Siragusa Foundation (Career Development Award for Young Investigators to V.V.B.), and the Robert and Clarice Smith & Abigail Van Buren Alzheimer's Disease Research Foundation (postdoctoral fellowship to V.V.B.). H.L. and M.E.M. are supported by the Mayo Clinic Center for Individualized Medicine and the Donors Cure Foundation.	Affaitati A, 2001, GENE, V267, P89, DOI 10.1016/S0378-1119(01)00402-4; Ash PEA, 2013, NEURON, V77, P639, DOI 10.1016/j.neuron.2013.02.004; Batra R, 2014, MOL CELL, V56, P311, DOI 10.1016/j.molcel.2014.08.027; Bede P, 2015, J NEUROL NEUROSUR PS, V86, P468, DOI 10.1136/jnnp-2014-308172; Boeve BF, 2012, BRAIN, V135, P765, DOI 10.1093/brain/aws004; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; BROOKS BR, 1994, J NEUROL SCI, V124, P96, DOI 10.1016/0022-510X(94)90191-0; Charizanis K, 2012, NEURON, V75, P437, DOI 10.1016/j.neuron.2012.05.029; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Cooper-Knock J, 2014, BRAIN, V137, P2040, DOI 10.1093/brain/awu120; Couthouis J, 2012, HUM MOL GENET, V21, P2899, DOI 10.1093/hmg/dds116; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Donnelly CJ, 2013, NEURON, V80, P415, DOI 10.1016/j.neuron.2013.10.015; Elden AC, 2010, NATURE, V466, P1069, DOI 10.1038/nature09320; Emig D, 2010, NUCLEIC ACIDS RES, V38, pW755, DOI 10.1093/nar/gkq405; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Gendron TF, 2010, NEUROPATH APPL NEURO, V36, P97, DOI [10.1111/j.1365-2990.2009.01060.x, 10.1111/j.1365-2990.2010.01060.x]; Gendron TF, 2013, ACTA NEUROPATHOL, V126, P829, DOI 10.1007/s00401-013-1192-8; Geser F, 2008, ARCH NEUROL-CHICAGO, V65, P636, DOI 10.1001/archneur.65.5.636; Gothie E, 2000, J BIOL CHEM, V275, P6922, DOI 10.1074/jbc.275.10.6922; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huelga SC, 2012, CELL REP, V1, P167, DOI 10.1016/j.celrep.2012.02.001; Irwin DJ, 2013, J NEUROL NEUROSUR PS, V84, P163, DOI 10.1136/jnnp-2012-303507; Jenal M, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.022; Johnson JO, 2014, NAT NEUROSCI, V17, P664, DOI 10.1038/nn.3688; Kalari KR, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-224; Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922; Kremerskothen J, 2002, BIOCHEM BIOPH RES CO, V295, P678, DOI 10.1016/S0006-291X(02)00734-9; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Kwon I, 2014, SCIENCE, V345, P1139, DOI 10.1126/science.1254917; Lagier-Tourenne C, 2013, P NATL ACAD SCI USA, V110, pE4530, DOI 10.1073/pnas.1318835110; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lee YB, 2013, CELL REP, V5, P1178, DOI 10.1016/j.celrep.2013.10.049; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Mahoney CJ, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt144; Masamha CP, 2014, NATURE, V510, P412, DOI 10.1038/nature13261; May S, 2014, ACTA NEUROPATHOL, V128, P485, DOI 10.1007/s00401-014-1329-4; Mizielinska S, 2014, SCIENCE, V345, P1192, DOI 10.1126/science.1256800; Mori K, 2013, ACTA NEUROPATHOL, V126, P881, DOI 10.1007/s00401-013-1189-3; Mori K, 2013, SCIENCE, V339, P1335, DOI 10.1126/science.1232927; Mori K, 2013, ACTA NEUROPATHOL, V125, P413, DOI 10.1007/s00401-013-1088-7; Murray ME, 2011, ACTA NEUROPATHOL, V122, P673, DOI 10.1007/s00401-011-0907-y; Murray ME, 2011, LANCET NEUROL, V10, P785, DOI 10.1016/S1474-4422(11)70156-9; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Ray D, 2013, NATURE, V499, P172, DOI 10.1038/nature12311; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sareen D, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007529; Seeley WW, 2008, ARCH NEUROL-CHICAGO, V65, P249, DOI 10.1001/archneurol.2007.38; Shi YS, 2012, RNA, V18, P2105, DOI 10.1261/rna.035899.112; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Tan RH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105632; Tao ZT, 2015, HUM MOL GENET, V24, P2426, DOI 10.1093/hmg/ddv005; Thivard L, 2007, J NEUROL NEUROSUR PS, V78, P889, DOI 10.1136/jnnp.2006.101758; Ticozzi N, 2011, AM J MED GENET B, V156B, P285, DOI 10.1002/ajmg.b.31158; Tuncel H, 2012, INT J ONCOL, V41, P2079, DOI 10.3892/ijo.2012.1652; Van Blitterswijk M, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.04.016; van Blitterswijk M, 2012, CURR OPIN NEUROL, V25, P689, DOI 10.1097/WCO.0b013e32835a3efb; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Wen XM, 2014, NEURON, V84, P1213, DOI 10.1016/j.neuron.2014.12.010; Wu J, 2013, NUCLEIC ACIDS RES, V41, P5149, DOI 10.1093/nar/gkt216; Xia Z, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6274; Yamakawa M, 2015, HUM MOL GENET, V24, P1630, DOI 10.1093/hmg/ddu576; Yen SH, 1999, BRAIN PATHOL, V9, P695; Zhang YJ, 2014, ACTA NEUROPATHOL, V128, P505, DOI 10.1007/s00401-014-1336-5; Zhang YJ, 2009, P NATL ACAD SCI USA, V106, P7607, DOI 10.1073/pnas.0900688106	68	227	229	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2015	18	8					1175	+		10.1038/nn.4065	http://dx.doi.org/10.1038/nn.4065			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CN7HO	26192745	Green Accepted			2022-12-17	WOS:000358605400020
J	Bonnevie, T; Dunn, B; Fyhn, M; Hafting, T; Derdikman, D; Kubie, JL; Roudi, Y; Moser, EI; Moser, MB				Bonnevie, Tora; Dunn, Benjamin; Fyhn, Marianne; Hafting, Torkel; Derdikman, Dori; Kubie, John L.; Roudi, Yasser; Moser, Edvard I.; Moser, May-Britt			Grid cells require excitatory drive from the hippocampus	NATURE NEUROSCIENCE			English	Article							MEDIAL ENTORHINAL CORTEX; SPATIAL REPRESENTATION SYSTEM; PLACE CELLS; THETA OSCILLATIONS; PHASE PRECESSION; PATH-INTEGRATION; COGNITIVE MAP; RAT; NEURONS; FIELDS	To determine how hippocampal backprojections influence spatially periodic firing in grid cells, we recorded neural activity in the medial entorhinal cortex (MEC) of rats after temporary inactivation of the hippocampus. We report two major changes in entorhinal grid cells. First, hippocampal inactivation gradually and selectively extinguished the grid pattern. Second, the same grid cells that lost their grid fields acquired substantial tuning to the direction of the rat's head. This transition in firing properties was contingent on a drop in the average firing rate of the grid cells and could be replicated by the removal of an external excitatory drive in an attractor network model in which grid structure emerges by velocity-dependent translation of activity across a network with inhibitory connections. These results point to excitatory drive from the hippocampus, and possibly other regions, as one prerequisite for the formation and translocation of grid patterns in the MEC.	[Bonnevie, Tora; Dunn, Benjamin; Fyhn, Marianne; Hafting, Torkel; Derdikman, Dori; Roudi, Yasser; Moser, Edvard I.; Moser, May-Britt] Norwegian Univ Sci & Technol NTNU, Kavli Inst Syst Neurosci, Trondheim, Norway; [Bonnevie, Tora; Dunn, Benjamin; Fyhn, Marianne; Hafting, Torkel; Derdikman, Dori; Roudi, Yasser; Moser, Edvard I.; Moser, May-Britt] Norwegian Univ Sci & Technol NTNU, Ctr Biol Memory, Norwegian Brain Ctr, Trondheim, Norway; [Kubie, John L.] Suny Downstate Med Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Moser, MB (corresponding author), Norwegian Univ Sci & Technol NTNU, Kavli Inst Syst Neurosci, Trondheim, Norway.	edvard.moser@ntnu.no; maybm@ntnu.no		Hafting, Torkel/0000-0002-0928-3487; Roudi, Yasser/0000-0002-6989-3420	Kavli Foundation; Faculty of Medicine at NTNU; Centre of Excellence from Research Council of Norway; European Research Council ('CIRCUIT') [232608]	Kavli Foundation; Faculty of Medicine at NTNU; Centre of Excellence from Research Council of Norway; European Research Council ('CIRCUIT')	We thank R. Skjerpeng for programming, M.P. Witter and C.B. Boccara for advice on tetrode locations, M. Mehta and M.P. Witter for discussion, N. Burgess for sharing code for dynamic autocorrelation analyses and A.M. Amundsgard, K. Haugen, K. Jenssen; E. Krakvik and H. Waade for technical assistance. This work was supported by the Kavli Foundation, a studentship to T.B. from the Faculty of Medicine at NTNU, a Centre of Excellence grant from the Research Council of Norway and an Advanced Investigator Grant to E.I.M. from the European Research Council ('CIRCUIT', grant agreement 232608).	Allen TA, 2008, J NEUROSCI METH, V171, P30, DOI 10.1016/j.jneumeth.2008.01.033; ALONSO A, 1993, J NEUROPHYSIOL, V70, P128, DOI 10.1152/jn.1993.70.1.128; Boccara CN, 2010, NAT NEUROSCI, V13, P987, DOI 10.1038/nn.2602; Brandon MP, 2011, SCIENCE, V332, P595, DOI 10.1126/science.1201652; Burak Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000291; Burgess N, 2007, HIPPOCAMPUS, V17, P801, DOI 10.1002/hipo.20327; Burwell RD, 2003, NEUROSCIENCE, V119, P577, DOI 10.1016/S0306-4522(03)00160-X; Couey JJ, 2013, NAT NEUROSCI, V16, P318, DOI 10.1038/nn.3310; de Almeida L, 2009, J NEUROSCI, V29, P7504, DOI 10.1523/JNEUROSCI.6048-08.2009; Fuhs MC, 2006, J NEUROSCI, V26, P4266, DOI 10.1523/JNEUROSCI.4353-05.2006; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Fyhn M, 2007, NATURE, V446, P190, DOI 10.1038/nature05601; Giocomo LM, 2011, NEURON, V71, P589, DOI 10.1016/j.neuron.2011.07.023; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hafting T, 2008, NATURE, V453, P1248, DOI 10.1038/nature06957; Kloosterman F, 2003, EUR J NEUROSCI, V18, P3037, DOI 10.1111/j.1460-9568.2003.03046.x; Koenig J, 2011, SCIENCE, V332, P592, DOI 10.1126/science.1201685; Kropff E, 2008, HIPPOCAMPUS, V18, P1256, DOI 10.1002/hipo.20520; Langston RF, 2010, SCIENCE, V328, P1576, DOI 10.1126/science.1188210; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Molter C, 2008, HIPPOCAMPUS, V18, P919, DOI 10.1002/hipo.20450; Monaco JD, 2011, J NEUROSCI, V31, P11096; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; O'Keefe J, 2005, HIPPOCAMPUS, V15, P853, DOI 10.1002/hipo.20115; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Rolls ET, 2006, NETWORK-COMP NEURAL, V17, P447, DOI 10.1080/09548980601064846; Samu D, 2009, BIOL CYBERN, V101, P19, DOI 10.1007/s00422-009-0311-z; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Savelli F, 2010, J NEUROPHYSIOL, V103, P3167, DOI 10.1152/jn.00932.2009; Savelli F, 2008, HIPPOCAMPUS, V18, P1270, DOI 10.1002/hipo.20511; Si B, 2009, COGN NEURODYNAMICS, V3, P177, DOI 10.1007/s11571-009-9079-z; Solstad T, 2006, HIPPOCAMPUS, V16, P1026, DOI 10.1002/hipo.20244; Solstad T, 2008, SCIENCE, V322, P1865, DOI 10.1126/science.1166466; Sreenivasan S, 2011, NAT NEUROSCI, V14, P1330, DOI 10.1038/nn.2901; Stensola H, 2012, NATURE, V492, P72, DOI 10.1038/nature11649; TAUBE JS, 1990, J NEUROSCI, V10, P420; van Haeften T, 2003, HIPPOCAMPUS, V13, P943, DOI 10.1002/hipo.10144; Wills TJ, 2010, SCIENCE, V328, P1573, DOI 10.1126/science.1188224; Yartsev MM, 2011, NATURE, V479, P103, DOI 10.1038/nature10583; Yoshida M, 2011, J NEUROSCI, V31, P12683, DOI 10.1523/JNEUROSCI.1654-11.2011; Zilli EA, 2010, J NEUROSCI, V30, P13850, DOI 10.1523/JNEUROSCI.0547-10.2010	42	227	232	1	98	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2013	16	3					309	317		10.1038/nn.3311	http://dx.doi.org/10.1038/nn.3311			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	097LE	23334581				2022-12-17	WOS:000315474800013
J	Mizuseki, K; Diba, K; Pastalkova, E; Buzsaki, G				Mizuseki, Kenji; Diba, Kamran; Pastalkova, Eva; Buzsaki, Gyoergy			Hippocampal CA1 pyramidal cells form functionally distinct sublayers	NATURE NEUROSCIENCE			English	Article							PHASE PRECESSION; ENTORHINAL CORTEX; CORTICAL-NEURONS; RAT HIPPOCAMPUS; BEHAVING RAT; FIELD CA1; OSCILLATIONS; MORPHOLOGY; NEOCORTEX; NETWORKS	Hippocampal CA1 pyramidal neurons have frequently been regarded as a homogeneous cell population in biophysical, pharmacological and modeling studies. We found robust differences between pyramidal neurons residing in the deep and superficial CA1 sublayers in rats. Compared with their superficial peers, deep pyramidal cells fired at higher rates, burst more frequently, were more likely to have place fields and were more strongly modulated by slow oscillations of sleep. Both deep and superficial pyramidal cells fired preferentially at the trough of theta oscillations during maze exploration, whereas deep pyramidal cells shifted their preferred phase of firing to the peak of theta during rapid eye movement (REM) sleep. Furthermore, although the majority of REM theta phase-shifting cells fired at the ascending phase of gamma oscillations during waking, nonshifting cells preferred the trough. Thus, CA1 pyramidal cells in adjacent sublayers can address their targets jointly or differentially, depending on brain states.	[Mizuseki, Kenji; Diba, Kamran; Pastalkova, Eva; Buzsaki, Gyoergy] Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA	Rutgers State University Newark; Rutgers State University New Brunswick	Buzsaki, G (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA.	buzsaki@axon.rutgers.edu	Mizuseki, Kenji/A-9214-2011	Mizuseki, Kenji/0000-0002-1456-2149; Diba, Kamran/0000-0001-5128-4478; Buzsaki, Gyorgy/0000-0002-3100-4800	US National Institutes of Health [NS034994, MH54671]; National Science Foundation; J.D. McDonnell Foundation; Uehara Memorial Foundation; Astellas Foundation for Research on Metabolic Disorders; Japan Society of Promotion for Sciences; Robert Leet and Clara Guthrie Patterson Trust; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH054671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034994] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009947] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); J.D. McDonnell Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Astellas Foundation for Research on Metabolic Disorders; Japan Society of Promotion for Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Robert Leet and Clara Guthrie Patterson Trust; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank E. Cela, S. Fujisawa, P. M. Hiche, S. Ozen, A. Sirota, E. Stark and Y. Wang for comments on the manuscript, and D. Sullivan for valuable suggestions. This work was supported by the US National Institutes of Health (NS034994, MH54671), the National Science Foundation, the J.D. McDonnell Foundation, the Uehara Memorial Foundation, the Astellas Foundation for Research on Metabolic Disorders, the Japan Society of Promotion for Sciences, and the Robert Leet and Clara Guthrie Patterson Trust.	Amaral D, 2007, HIPPOCAMPUS BOOK, P37; BAIMBRIDGE KG, 1991, SYNAPSE, V7, P269, DOI 10.1002/syn.890070404; BANNISTER NJ, 1995, J COMP NEUROL, V360, P150, DOI 10.1002/cne.903600111; BILKEY DK, 1990, BRAIN RES, V514, P77, DOI 10.1016/0006-8993(90)90437-G; BRAGIN A, 1995, J NEUROSCI, V15, P47; CHAGNACAMITAL Y, 1990, J COMP NEUROL, V296, P598, DOI 10.1002/cne.902960407; CONNORS BW, 1982, J NEUROPHYSIOL, V48, P1302, DOI 10.1152/jn.1982.48.6.1302; Csicsvari J, 2003, J NEUROPHYSIOL, V90, P1314, DOI 10.1152/jn.00116.2003; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; de No RL, 1934, J PSYCHOL NEUROL, V46, P113; Deguchi Y, 2011, NAT NEUROSCI, V14, P495, DOI 10.1038/nn.2768; Dong HW, 2009, P NATL ACAD SCI USA, V106, P11794, DOI 10.1073/pnas.0812608106; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Golding NL, 2001, J NEUROPHYSIOL, V86, P2998, DOI 10.1152/jn.2001.86.6.2998; Hafting T, 2008, NATURE, V453, P1248, DOI 10.1038/nature06957; Harris KD, 2002, NATURE, V417, P738, DOI 10.1038/nature00808; Harris KD, 2001, NEURON, V32, P141, DOI 10.1016/S0896-6273(01)00447-0; Henriksen EJ, 2010, NEURON, V68, P127, DOI 10.1016/j.neuron.2010.08.042; Isomura Y, 2006, NEURON, V52, P871, DOI 10.1016/j.neuron.2006.10.023; Jarsky T, 2008, J COMP NEUROL, V506, P535, DOI 10.1002/cne.21564; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; MARKUS EJ, 1994, HIPPOCAMPUS, V4, P410, DOI 10.1002/hipo.450040404; MASON A, 1990, J NEUROSCI, V10, P1415; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; Mizuseki K, 2009, NEURON, V64, P267, DOI 10.1016/j.neuron.2009.08.037; Molinari S, 1996, P NATL ACAD SCI USA, V93, P8028, DOI 10.1073/pnas.93.15.8028; MULLER RU, 1989, J NEUROSCI, V9, P4101; Nelson SB, 2006, TRENDS NEUROSCI, V29, P339, DOI 10.1016/j.tins.2006.05.004; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Pace-Schott EF, 2002, NAT REV NEUROSCI, V3, P591, DOI 10.1038/nrn895; PETERS S, 1987, SCIENCE, V236, P589, DOI 10.1126/science.2883728; Poe GR, 2000, BRAIN RES, V855, P176, DOI 10.1016/S0006-8993(99)02310-0; Senior TJ, 2008, J NEUROSCI, V28, P2274, DOI 10.1523/JNEUROSCI.4669-07.2008; Skaggs W., 1993, ADV NEURAL INFORM PR, V5, P1030; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; SLOMIANKA L, 1992, NEUROSCIENCE, V48, P325, DOI 10.1016/0306-4522(92)90494-M; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; SORENSEN JC, 1993, ANAT EMBRYOL, V188, P107; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; TAMAMAKI N, 1995, J COMP NEUROL, V353, P379, DOI 10.1002/cne.903530306; Thompson CL, 2008, NEURON, V60, P1010, DOI 10.1016/j.neuron.2008.12.008; Thomson AM, 2002, CEREB CORTEX, V12, P936, DOI 10.1093/cercor/12.9.936; Varga C, 2010, NAT NEUROSCI, V13, P822, DOI 10.1038/nn.2570; Wang Y, 2006, NAT NEUROSCI, V9, P534, DOI 10.1038/nn1670; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; YLINEN A, 1995, J NEUROSCI, V15, P30; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252; Yu YC, 2009, NATURE, V458, P501, DOI 10.1038/nature07722	50	227	231	2	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2011	14	9					1174	U235		10.1038/nn.2894	http://dx.doi.org/10.1038/nn.2894			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	812ID	21822270	Green Accepted, Green Published			2022-12-17	WOS:000294284900018
J	Soucy, ER; Albeanu, DF; Fantana, AL; Murthy, VN; Meister, M				Soucy, Edward R.; Albeanu, Dinu F.; Fantana, Antoniu L.; Murthy, Venkatesh N.; Meister, Markus			Precision and diversity in an odor map on the olfactory bulb	NATURE NEUROSCIENCE			English	Article							INTRINSIC OPTICAL SIGNALS; RECEPTOR NEURON INPUT; STRUCTURAL FEATURES; MOLECULAR-FEATURES; MITRAL CELLS; MOUSE; SYSTEM; REPRESENTATION; ORGANIZATION; COMBINATORIAL	We explored the map of odor space created by glomeruli on the olfactory bulb of both rat and mouse. Identified glomeruli could be matched across animals by their response profile to hundreds of odors. Their layout in different individuals varied by only similar to 1 glomerular spacing, corresponding to a precision of 1 part in 1,000. Across species, mouse and rat share many glomeruli with apparently identical odor tuning, arranged in a similar layout. In mapping the position of a glomerulus to its odor tuning, we found only a coarse relationship with a precision of similar to 5 spacings. No chemotopic order was apparent on a finer scale and nearby glomeruli were almost as diverse in their odor sensitivity as distant ones. This local diversity of sensory tuning stands in marked distinction from other brain maps. Given the reliable placement of the glomeruli, it represents a feature, not a flaw, of the olfactory bulb.	[Soucy, Edward R.; Albeanu, Dinu F.; Fantana, Antoniu L.; Murthy, Venkatesh N.; Meister, Markus] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Soucy, Edward R.; Albeanu, Dinu F.; Fantana, Antoniu L.; Murthy, Venkatesh N.; Meister, Markus] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA	Harvard University; Harvard University	Meister, M (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 52 Oxford St, Cambridge, MA 02138 USA.	vnmurthy@fas.harvard.edu; meister@fas.harvard.edu		Albeanu, Dinu/0000-0001-7825-7744; Meister, Markus/0000-0003-2136-6506; Murthy, Venkatesh/0000-0003-2443-4252				Albeanu DF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002146; Belluscio L, 2001, J NEUROSCI, V21, P2113, DOI 10.1523/JNEUROSCI.21-06-02113.2001; Bozza T, 2004, NEURON, V42, P9, DOI 10.1016/S0896-6273(04)00144-8; BUONVISO N, 1990, J NEUROPHYSIOL, V63, P447, DOI 10.1152/jn.1990.63.3.447; Chklovskii DB, 2004, ANNU REV NEUROSCI, V27, P369, DOI 10.1146/annurev.neuro.27.070203.144226; Cleland TA, 2007, P NATL ACAD SCI USA, V104, P1953, DOI 10.1073/pnas.0608564104; DUCHAMP A, 1974, CHEM SENS FLAV, V1, P213, DOI 10.1093/chemse/1.2.213; Egana JI, 2005, NEUROSCIENCE, V134, P1069, DOI 10.1016/j.neuroscience.2005.04.027; Egger V, 2006, SEMIN CELL DEV BIOL, V17, P424, DOI 10.1016/j.semcdb.2006.04.006; Fantana AL, 2008, NEURON, V59, P802, DOI 10.1016/j.neuron.2008.07.039; Friedrich RW, 1997, NEURON, V18, P737, DOI 10.1016/S0896-6273(00)80314-1; Gurden H, 2006, NEURON, V52, P335, DOI 10.1016/j.neuron.2006.07.022; Imai T, 2007, CURR OPIN NEUROBIOL, V17, P507, DOI 10.1016/j.conb.2007.08.002; Johnson BA, 2002, J COMP NEUROL, V449, P180, DOI 10.1002/cne.10284; Johnson BA, 2007, J COMP NEUROL, V503, P1, DOI 10.1002/cne.21396; Kaas JH, 1997, BRAIN RES BULL, V44, P107, DOI 10.1016/S0361-9230(97)00094-4; KNUDSEN EI, 1987, ANNU REV NEUROSCI, V10, P41, DOI 10.1146/annurev.ne.10.030187.000353; Luo M, 2001, NEURON, V32, P1165, DOI 10.1016/S0896-6273(01)00537-2; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Meister M, 2001, J NEUROSCI, V21, P1351; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Mombaerts P, 1999, ANNU REV NEUROSCI, V22, P487, DOI 10.1146/annurev.neuro.22.1.487; Mombaerts P, 2006, ANNU REV CELL DEV BI, V22, P713, DOI 10.1146/annurev.cellbio.21.012804.093915; Mori K, 2006, PHYSIOL REV, V86, P409, DOI 10.1152/physrev.00021.2005; Mori Kensaku, 1994, Seminars in Cell Biology, V5, P65, DOI 10.1006/scel.1994.1009; Oka Y, 2006, NEURON, V52, P857, DOI 10.1016/j.neuron.2006.10.019; Pimentel DO, 2008, J PHYSIOL-LONDON, V586, P2107, DOI 10.1113/jphysiol.2007.149575; Potter SM, 2001, J NEUROSCI, V21, P9713, DOI 10.1523/JNEUROSCI.21-24-09713.2001; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Schaefer ML, 2001, J COMP NEUROL, V436, P351; Serizawa SU, 2004, TRENDS GENET, V20, P648, DOI 10.1016/j.tig.2004.09.006; Shepherd GM, 1998, SYNAPTIC ORG BRAIN, DOI [10.1093/acprof:oso/9780195159561.001.1, DOI 10.1093/ACPROF:OSO/9780195159561.001.1]; SICARD G, 1984, BRAIN RES, V292, P283, DOI 10.1016/0006-8993(84)90764-9; STEWART WB, 1979, J COMP NEUROL, V185, P715, DOI 10.1002/cne.901850407; Strotmann J, 2000, J NEUROSCI, V20, P6927, DOI 10.1523/JNEUROSCI.20-18-06927.2000; Takahashi YK, 2004, J NEUROPHYSIOL, V92, P2413, DOI 10.1152/jn.00236.2004; Uchida N, 2000, NAT NEUROSCI, V3, P1035, DOI 10.1038/79857; Wachowiak M, 2001, NEURON, V32, P723, DOI 10.1016/S0896-6273(01)00506-2; Wachowiak M, 2003, J NEUROPHYSIOL, V89, P1623, DOI 10.1152/jn.00747.2002; Wachowiak M, 2006, SEMIN CELL DEV BIOL, V17, P411, DOI 10.1016/j.semcdb.2006.04.007; Willhite DC, 2006, P NATL ACAD SCI USA, V103, P12592, DOI 10.1073/pnas.0602032103; YOKOI M, 1995, P NATL ACAD SCI USA, V92, P3371, DOI 10.1073/pnas.92.8.3371; Zhang XH, 2007, GENOMICS, V89, P441, DOI 10.1016/j.ygeno.2007.01.002	44	227	231	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2009	12	2					210	220		10.1038/nn.2262	http://dx.doi.org/10.1038/nn.2262			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	404VV	19151709				2022-12-17	WOS:000263182000022
J	Fan, W; Ellacott, KLJ; Halatchev, IG; Takahashi, K; Yu, PX; Cone, RD				Fan, W; Ellacott, KLJ; Halatchev, IG; Takahashi, K; Yu, PX; Cone, RD			Cholecystokinin-mediated suppression of feeding involves the brainstem melanocortin system	NATURE NEUROSCIENCE			English	Article							POMC NEURONS; LEPTIN; OBESITY; NUCLEUS; MICE; RAT	Hypothalamic pro-opiomelanocortin (POMC) neurons help regulate long-term energy stores. POMC neurons are also found in the nucleus tractus solitarius (NTS), a region regulating satiety. We show here that mouse brainstem NTS POMC neurons are activated by cholecystokinin (CCK) and feeding-induced satiety and that activation of the neuronal melanocortin-4 receptor (MC4-R) is required for CCK-induced suppression of feeding; the melanocortin system thus provides a potential substrate for integration of long-term adipostatic and short-term satiety signals.	Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA	Oregon Health & Science University	Cone, RD (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA.	fanw@ohsu.edu; cone@ohsu.edu		Ellacott, Kate/0000-0001-5261-7465	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK055819, R01DK062179] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK55819, DK62179] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Azzara AV, 2002, PHYSIOL BEHAV, V77, P411, DOI 10.1016/S0031-9384(02)00883-1; Butler AA, 2000, ENDOCRINOLOGY, V141, P3518, DOI 10.1210/en.141.9.3518; Cheung CC, 1997, ENDOCRINOLOGY, V138, P4489, DOI 10.1210/en.138.10.4489; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Elias CF, 1999, NEURON, V23, P775, DOI 10.1016/S0896-6273(01)80035-0; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Farooqi I.S., 2003, NEW ENGL J MED, V348, P1160, DOI DOI 10.1056/NEJM0A002050; Grill HJ, 1998, J NEUROSCI, V18, P10128; HRUBY VJ, 1995, J MED CHEM, V38, P3454, DOI 10.1021/jm00018a005; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; JOSEPH SA, 1983, NEUROSCI LETT, V38, P221, DOI 10.1016/0304-3940(83)90372-5; LUCKMAN SM, 1992, J NEUROENDOCRINOL, V4, P149, DOI 10.1111/j.1365-2826.1992.tb00152.x; Rinaman L, 1999, AM J PHYSIOL-REG I, V277, pR582, DOI 10.1152/ajpregu.1999.277.2.R582; Wang L, 1998, BRAIN RES, V791, P157, DOI 10.1016/S0006-8993(98)00091-2; Williams DL, 2002, PSYCHOPHARMACOLOGY, V161, P47, DOI 10.1007/s00213-002-1022-5	15	227	236	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2004	7	4					335	336		10.1038/nn1214	http://dx.doi.org/10.1038/nn1214			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	807DP	15034587				2022-12-17	WOS:000220482500009
J	Staal, RGW; Mosharov, EV; Sulzer, D				Staal, RGW; Mosharov, EV; Sulzer, D			Dopamine neurons release transmitter via a flickering fusion pore	NATURE NEUROSCIENCE			English	Article							PROTEIN-KINASE-C; SYNAPTIC VESICLES; CHROMAFFIN CELLS; HORSE EOSINOPHILS; SUBSTANTIA-NIGRA; QUANTAL SIZE; SINGLE; EXOCYTOSIS; TRANSMISSION; MIDBRAIN	A key question in understanding mechanisms of neurotransmitter release is whether the fusion pore of a synaptic vesicle regulates the amount of transmitter released during exocytosis. We measured dopamine release from small synaptic vesicles of rat cultured ventral midbrain neurons using carbon fiber amperometry. Our data indicate that small synaptic vesicle fusion pores flicker either once or multiple times in rapid succession, with each flicker releasing similar to25-30% of vesicular dopamine. The incidence of events with multiple flickers was reciprocally regulated by phorbol esters and staurosporine. Thus, dopamine neurons regulate the amount of neurotransmitter released by small synaptic vesicles by controlling the number of fusion pore flickers per exocytotic event. This mode of exocytosis is a potential mechanism whereby neurons can rapidly reuse vesicles without undergoing the comparatively slow process of recycling.	Columbia Univ, Dept Neurol, New York, NY 10032 USA; Columbia Univ, Dept Psychiat, New York, NY 10032 USA; New York State Psychiat Inst & Hosp, Dept Neurosci, New York, NY 10032 USA	Columbia University; Columbia University; New York State Psychiatry Institute	Sulzer, D (corresponding author), Columbia Univ, Dept Neurol, Black 305,650 W 168th St, New York, NY 10032 USA.	ds43@columbia.edu		Staal, Roland/0000-0002-2857-2241				Albillos A, 1997, NATURE, V389, P509, DOI 10.1038/39081; Aravanis AM, 2003, NATURE, V423, P643, DOI 10.1038/nature01686; Berg H.C., 1983, RANDOM WALKS BIOL, P152; Betz A, 1998, NEURON, V21, P123, DOI 10.1016/S0896-6273(00)80520-6; Bittner MA, 2000, BIOCHIMIE, V82, P447, DOI 10.1016/S0300-9084(00)00222-4; BRUNS D, 1995, NATURE, V377, P62, DOI 10.1038/377062a0; CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; CHEN GY, 1995, J NEUROSCI, V15, P7747; Colliver TL, 2000, J NEUROCHEM, V74, P1086; Colquhoun David, 1995, P483; Cragg SJ, 2001, J NEUROPHYSIOL, V85, P1761, DOI 10.1152/jn.2001.85.4.1761; Cremona O, 1997, CURR OPIN NEUROBIOL, V7, P323, DOI 10.1016/S0959-4388(97)80059-1; DETOLEDO GA, 1993, NATURE, V363, P554, DOI 10.1038/363554a0; Gandhi SP, 2003, NATURE, V423, P607, DOI 10.1038/nature01677; GARRIS PA, 1994, J NEUROSCI, V14, P6084; Gillis KD, 1996, NEURON, V16, P1209, DOI 10.1016/S0896-6273(00)80147-6; GIROD R, 1993, J PHYSIOL-LONDON, V471, P129, DOI 10.1113/jphysiol.1993.sp019894; Gonon F, 2000, PROG BRAIN RES, V125, P291; Graham ME, 2000, BIOCHIMIE, V82, P469, DOI 10.1016/S0300-9084(00)00196-6; Hafez I, 2003, J BIOL CHEM, V278, P44921, DOI 10.1074/jbc.M306013200; HARTMANN J, 1995, J PHYSIOL-LONDON, V483, P201, DOI 10.1113/jphysiol.1995.sp020578; Henkel AW, 1995, J NEUROSCI, V15, P8246; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Hochstetler SE, 2000, ANAL CHEM, V72, P489, DOI 10.1021/ac991119x; Jaffe EH, 1998, J NEUROSCI, V18, P3548; Jeremic A, 2003, BIOPHYS J, V85, P2035, DOI 10.1016/S0006-3495(03)74631-1; Klyachko VA, 2002, NATURE, V418, P89, DOI 10.1038/nature00852; Levant B, 1997, PHARMACOL REV, V49, P231; LOLLIKE K, 1995, J CELL BIOL, V129, P99, DOI 10.1083/jcb.129.1.99; NICHOLSON C, 1999, MONITORING MOL NEURO, V8, P71; Pickel VM, 1996, J NEUROCYTOL, V25, P843, DOI 10.1007/BF02284846; Pothos EN, 1998, J NEUROSCI, V18, P5575; Pothos EN, 1998, J NEUROSCI, V18, P4106; Pothos EN, 2000, J NEUROSCI, V20, P7297; Rhee JS, 2002, CELL, V108, P121, DOI 10.1016/S0092-8674(01)00635-3; RICE ME, 1994, EXP BRAIN RES, V100, P395, DOI 10.1007/BF02738400; Scepek S, 1998, EMBO J, V17, P4340, DOI 10.1093/emboj/17.15.4340; Schmitz Y, 2003, J NEUROCHEM, V87, P273, DOI 10.1046/j.1471-4159.2003.02050.x; Schmitz Y, 2001, J NEUROSCI, V21, P5916, DOI 10.1523/JNEUROSCI.21-16-05916.2001; Stiles JR, 1996, P NATL ACAD SCI USA, V93, P5747, DOI 10.1073/pnas.93.12.5747; Sulzer D, 2000, REV NEUROSCIENCE, V11, P159; Sun JY, 2002, NATURE, V417, P555, DOI 10.1038/417555a; Valtorta F, 2001, TRENDS CELL BIOL, V11, P324, DOI 10.1016/S0962-8924(01)02058-X; Wang P, 2003, J BIOL CHEM, V278, P47030, DOI 10.1074/jbc.M306728200; WIGHTMAN RM, 1991, P NATL ACAD SCI USA, V88, P10754, DOI 10.1073/pnas.88.23.10754; Yang Y, 2002, P NATL ACAD SCI USA, V99, P17060, DOI 10.1073/pnas.242624699; Zhou Z, 1996, BIOPHYS J, V70, P1543, DOI 10.1016/S0006-3495(96)79718-7; Zhu HL, 2002, P NATL ACAD SCI USA, V99, P17055, DOI 10.1073/pnas.232588899	48	227	231	0	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2004	7	4					341	346		10.1038/nn1205	http://dx.doi.org/10.1038/nn1205			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	807DP	14990933				2022-12-17	WOS:000220482500012
J	Critchley, HD; Mathias, CT; Dolan, RJ				Critchley, HD; Mathias, CT; Dolan, RJ			Neuroanatomical basis for first- and second-order representations of bodily states	NATURE NEUROSCIENCE			English	Article							MULTIPLE-SYSTEM ATROPHY; PURE AUTONOMIC FAILURE; CINGULATE CORTEX; ACTIVATION; RESPONSES; CONJUNCTION; ATTENTION; EMOTIONS; MEMORY; RAT	Changes in bodily states, particularly those mediated by the autonomic nervous system, are crucial to ongoing emotional experience. A theoretical model proposes a first-order autoregulatory representation of bodily state at the level of dorsal pens, and a second-order experience-dependent re-mapping of changes in bodily state within structures such as cingulate and medial parietal cortices. We tested these anatomical predictions using positron emission tomography and a human neurological model (pure autonomic failure), in which peripheral autonomic denervation prevents the emergence of autonomic responses. Compared to controls, we observed task-independent differences in activity of dorsal pens and context-induced differences in cingulate and medial parietal activity in PAF patients. An absence of afferent feedback concerning autonomically generated bodily states was associated with subtle impairments of emotional responses in PAF patients. Our findings provide empirical support for a theory proposing a hierarchical representation of bodily states.	UCL, Inst Neurol, Wellcome Dept Cognit Neurol, London WC1N 3BG, England; UCL, Natl Hosp Neurol & Neurosurg, Autonom Unit, London WC1N 3BG, England; St Marys Hosp, ICSM, Neurovasc Med Unit, London W2 1NY, England	University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; Imperial College London	Dolan, RJ (corresponding author), UCL, Inst Neurol, Wellcome Dept Cognit Neurol, 12 Queen Sq, London WC1N 3BG, England.	r.dolan@fil.ion.ucl.ac.uk	critchley, hugo d/G-9267-2011	critchley, hugo d/0000-0002-2445-9284; Dolan, Ray/0000-0001-9356-761X				Adolphs R, 2000, J NEUROSCI, V20, P2683; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; Bouscein W., 1992, ELECTRODERMAL ACTIVI; Cahill L, 1997, ANN NY ACAD SCI, V821, P238, DOI 10.1111/j.1749-6632.1997.tb48283.x; CECHETTO DF, 1987, J COMP NEUROL, V262, P27, DOI 10.1002/cne.902620104; CHAMBERLIN NL, 1992, J COMP NEUROL, V326, P245, DOI 10.1002/cne.903260207; CLARK CV, 1988, DOC OPHTHALMOL, V70, P309, DOI 10.1007/BF00157061; Cohen RA, 1999, NEUROLOGY, V53, P819, DOI 10.1212/WNL.53.4.819; COLEBATCH JG, 1991, J NEUROPHYSIOL, V65, P1392, DOI 10.1152/jn.1991.65.6.1392; Collet C, 1997, J AUTONOM NERV SYST, V62, P45, DOI 10.1016/S0165-1838(96)00108-7; Craig AD, 2000, NAT NEUROSCI, V3, P184, DOI 10.1038/72131; Critchley HD, 2000, J PHYSIOL-LONDON, V523, P259, DOI 10.1111/j.1469-7793.2000.t01-1-00259.x; Critchley HD, 2000, J NEUROSCI, V20, P3033; Damasio A.R., 1994, DESCARTES ERROR EMOT; Damasio A.R., 1999, FEELING WHAT HAPPENS; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Friston K.J., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Friston KJ, 1999, NEUROIMAGE, V10, P385, DOI 10.1006/nimg.1999.0484; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Hamilton M., 1969, BRIT J PSYCHIAT, V3, P76, DOI DOI 10.1037/T04100-000; JAMES W, 1994, PSYCHOL REV, V101, P205, DOI 10.1037/0033-295X.101.2.205; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Kimber JR, 1997, LANCET, V349, P1877, DOI 10.1016/S0140-6736(96)10168-9; Lane RD, 1997, NEUROREPORT, V8, P3969, DOI 10.1097/00001756-199712220-00024; Magnifico F, 1998, CLIN AUTON RES, V8, P133, DOI 10.1007/BF02281117; Mathias CJ, 1999, J NEUROL, V246, P893, DOI 10.1007/s004150050479; Mathias CJ, 1999, AUTONOMIC FAILURE TX, V4, P169; MATHIAS CJ, 2000, NEUROLOGY CLIN PRACT, P2131; MATTHEWS M, 1999, AUTONOMIC FAILURE TX, P169; PAULESU E, 1993, NATURE, V362, P342, DOI 10.1038/362342a0; Price CJ, 1997, NEUROIMAGE, V5, P261, DOI 10.1006/nimg.1997.0269; Saleh TM, 1997, AM J PHYSIOL-REG I, V272, pR1631, DOI 10.1152/ajpregu.1997.272.5.R1631; SPYER KM, 1909, AUTONOMIC FAILURE TX, P45; Talairach J., 1988, COPLANAR STEREOTAXIC; VANDERPLAS J, 1995, BRAIN RES BULL, V38, P447, DOI 10.1016/0361-9230(95)02012-G; VOGT BA, 1992, CEREB CORTEX, V2, P435, DOI 10.1093/cercor/2.6.435-a; Xi MC, 1999, J NEUROPHYSIOL, V82, P2015, DOI 10.1152/jn.1999.82.4.2015	38	227	228	2	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2001	4	2					207	212		10.1038/84048	http://dx.doi.org/10.1038/84048			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UC	11175883	Green Published			2022-12-17	WOS:000167178100021
J	Marino, J; Schummers, J; Lyon, DC; Schwabe, L; Beck, O; Wiesing, P; Obermayer, K; Sur, M				Marino, J; Schummers, J; Lyon, DC; Schwabe, L; Beck, O; Wiesing, P; Obermayer, K; Sur, M			Invariant computations in local cortical networks with balanced excitation and inhibition	NATURE NEUROSCIENCE			English	Article							PRIMARY VISUAL-CORTEX; ORIENTATION SELECTIVITY; DIRECTION SELECTIVITY; SIMPLE CELLS; CONNECTIONS; DYNAMICS; NEURONS; TOPOGRAPHY; PLASTICITY; CONDUCTANCE	Cortical computations critically involve local neuronal circuits. The computations are often invariant across a cortical area yet are carried out by networks that can vary widely within an area according to its functional architecture. Here we demonstrate a mechanism by which orientation selectivity is computed invariantly in cat primary visual cortex across an orientation preference map that provides a wide diversity of local circuits. Visually evoked excitatory and inhibitory synaptic conductances are balanced exquisitely in cortical neurons and thus keep the spike response sharply tuned at all map locations. This functional balance derives from spatially isotropic local connectivity of both excitatory and inhibitory cells. Modeling results demonstrate that such covariation is a signature of recurrent rather than purely feed-forward processing and that the observed isotropic local circuit is sufficient to generate invariant spike tuning.	MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; MIT, Picower Ctr Learning & Memory, Cambridge, MA 02139 USA; Berlin Univ Technol, Dept Comp Sci & Elect Engn, D-10587 Berlin, Germany	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Technical University of Berlin	Sur, M (corresponding author), MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA.	msur@mit.edu		Schummers, James/0000-0002-1030-824X; Lyon, David C./0000-0002-4367-5636				Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; Angelucci A, 2002, J NEUROSCI, V22, P8633; Azouz R, 2003, NEURON, V37, P513, DOI 10.1016/S0896-6273(02)01186-8; BENYISHAI R, 1995, P NATL ACAD SCI USA, V92, P3844, DOI 10.1073/pnas.92.9.3844; BONHOEFFER T, 1991, NATURE, V353, P429, DOI 10.1038/353429a0; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; Bosking WH, 1997, J NEUROSCI, V17, P2112; Carandini M, 2000, J NEUROSCI, V20, P470, DOI 10.1523/JNEUROSCI.20-01-00470.2000; Crook JM, 1997, VISUAL NEUROSCI, V14, P141, DOI 10.1017/S095252380000883X; Das A, 1999, NATURE, V399, P655, DOI 10.1038/21371; Desai NS, 2002, NAT NEUROSCI, V5, P783, DOI 10.1038/nn878; Destexhe A, 2001, NEUROSCIENCE, V107, P13, DOI 10.1016/S0306-4522(01)00344-X; Dragoi V, 2002, NAT NEUROSCI, V5, P883, DOI 10.1038/nn900; Dragoi V, 2001, NATURE, V411, P80, DOI 10.1038/35075070; DRAGOI V, 2003, VISUAL NEUROSCIENCES, P1654; FAGIOLINI M, 2003, EXCITATORY INHIBITOR, P269; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; Hirsch JA, 2003, NAT NEUROSCI, V6, P1300, DOI 10.1038/nn1152; Hirsch JA, 2002, J PHYSIOL-LONDON, V540, P335, DOI 10.1113/jphysiol.2001.012777; Kisvarday ZF, 1997, CEREB CORTEX, V7, P605, DOI 10.1093/cercor/7.7.605; Lampl I, 2001, NEURON, V30, P263, DOI 10.1016/S0896-6273(01)00278-1; Lauritzen TZ, 2003, J NEUROSCI, V23, P10201; Liu GS, 2004, NAT NEUROSCI, V7, P373, DOI 10.1038/nn1206; Maldonado PE, 1997, SCIENCE, V276, P1551, DOI 10.1126/science.276.5318.1551; Martin KAC, 2002, CURR OPIN NEUROBIOL, V12, P418, DOI 10.1016/S0959-4388(02)00343-4; Martinez LM, 2002, J PHYSIOL-LONDON, V540, P321, DOI 10.1113/jphysiol.2001.012776; Mazer JA, 2002, P NATL ACAD SCI USA, V99, P1645, DOI 10.1073/pnas.022638499; McLaughlin D, 2000, P NATL ACAD SCI USA, V97, P8087, DOI 10.1073/pnas.110135097; Monier C, 2003, NEURON, V37, P663, DOI 10.1016/S0896-6273(03)00064-3; Mooser F, 2004, NAT NEUROSCI, V7, P872, DOI 10.1038/nn1287; Mountcastle V.B., 1998, PERCEPTUAL NEUROSCIE; NELSON S, 1994, SCIENCE, V265, P774, DOI 10.1126/science.8047882; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Ringach DL, 2002, J NEUROPHYSIOL, V87, P1018, DOI 10.1152/jn.00614.2001; Roerig B, 2002, CEREB CORTEX, V12, P187, DOI 10.1093/cercor/12.2.187; SCHULTE F J, 1969, Neuropaediatrie, V1, P36, DOI 10.1055/s-0028-1091862; Shapley R, 2003, NEURON, V38, P689, DOI 10.1016/S0896-6273(03)00332-5; Sharon D, 2002, SCIENCE, V295, P512, DOI 10.1126/science.1065916; SOMERS DC, 1995, J NEUROSCI, V15, P5448; SUAREZ H, 1995, J NEUROSCI, V15, P6700; Troyer TW, 1998, J NEUROSCI, V18, P5908; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Volgushev M, 2003, EUR J NEUROSCI, V17, P1768, DOI 10.1046/j.1460-9568.2003.02609.x; Volgushev M, 2000, EUR J NEUROSCI, V12, P257, DOI 10.1046/j.1460-9568.2000.00909.x; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Wielaard DJ, 2001, J NEUROSCI, V21, P5203, DOI 10.1523/JNEUROSCI.21-14-05203.2001; Williams SR, 2004, NAT NEUROSCI, V7, P961, DOI 10.1038/nn1305; Yao HS, 2001, NEURON, V32, P315, DOI 10.1016/S0896-6273(01)00460-3; Yousef T, 2001, NEUROREPORT, V12, P1693, DOI 10.1097/00001756-200106130-00035; Zhang LI, 2003, NATURE, V424, P201, DOI 10.1038/nature01796	50	226	235	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2005	8	2					194	201		10.1038/nn1391	http://dx.doi.org/10.1038/nn1391			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	892GN	15665876				2022-12-17	WOS:000226638200019
J	Kirik, D; Georgievska, B; Bjorklund, A				Kirik, D; Georgievska, B; Bjorklund, A			Localized striatal delivery of GDNF as a treatment for Parkinson disease	NATURE NEUROSCIENCE			English	Article							MIDBRAIN DOPAMINERGIC-NEURONS; NEUROTROPHIC FACTOR GDNF; AGED RHESUS-MONKEYS; PARTIAL LESION MODEL; SUBSTANTIA-NIGRA; IN-VIVO; GENE-TRANSFER; FUNCTIONAL RECOVERY; GROWTH-FACTOR; INTRAPUTAMENAL INFUSION		Lund Univ, Dept Physiol Sci, Wallenberg Neurosci Ctr, S-22184 Lund, Sweden	Lund University	Kirik, D (corresponding author), Lund Univ, Dept Physiol Sci, Wallenberg Neurosci Ctr, BMC A11, S-22184 Lund, Sweden.	Deniz.Kirik@mphy.lu.se	Björklund, Anders/ABA-1326-2020; Kirik, Deniz/E-5156-2011	Bjorklund, Anders/0000-0002-5676-6203				Aebischer P, 2001, TRENDS NEUROSCI, V24, P533, DOI 10.1016/S0166-2236(00)01899-3; Ai Y, 2003, J COMP NEUROL, V461, P250, DOI 10.1002/cne.10689; Bensadoun JC, 2000, EXP NEUROL, V164, P15, DOI 10.1006/exnr.2000.7409; Bjorklund A, 2000, BRAIN RES, V886, P82, DOI 10.1016/S0006-8993(00)02915-2; ChoiLundberg DL, 1997, SCIENCE, V275, P838, DOI 10.1126/science.275.5301.838; Connor B, 1999, GENE THER, V6, P1936, DOI 10.1038/sj.gt.3301033; Costa S, 2001, EUR J PHARMACOL, V412, P45, DOI 10.1016/S0014-2999(00)00933-X; Deglon N, 2000, HUM GENE THER, V11, P179, DOI 10.1089/10430340050016256; Gash DM, 1995, J COMP NEUROL, V363, P345, DOI 10.1002/cne.903630302; Gash DM, 1996, NATURE, V380, P252, DOI 10.1038/380252a0; Georgievska B, 2002, EXP NEUROL, V177, P461, DOI 10.1006/exnr.2002.8006; Gerhardt GA, 1999, BRAIN RES, V817, P163, DOI 10.1016/S0006-8993(98)01244-X; Gill SS, 2003, NAT MED, V9, P589, DOI 10.1038/nm850; Grondin R, 2003, J NEUROSCI, V23, P1974; Grondin R, 2002, BRAIN, V125, P2191, DOI 10.1093/brain/awf234; Hebert MA, 1997, J PHARMACOL EXP THER, V282, P760; Hebert MA, 1996, J PHARMACOL EXP THER, V279, P1181; HOFFER BJ, 1994, NEUROSCI LETT, V182, P107, DOI 10.1016/0304-3940(94)90218-6; Hoffman AF, 1997, EXP NEUROL, V147, P130, DOI 10.1006/exnr.1997.6571; Horger BA, 1998, J NEUROSCI, V18, P4929; HUDSON J, 1995, BRAIN RES BULL, V36, P425, DOI 10.1016/0361-9230(94)00224-O; Iravani MM, 2001, EUR J NEUROSCI, V13, P597, DOI 10.1046/j.1460-9568.2001.01408.x; Kearns CM, 1997, J NEUROSCI, V17, P7111; Kimpinski K, 1997, J NEUROBIOL, V33, P395, DOI 10.1002/(SICI)1097-4695(199710)33:4<395::AID-NEU5>3.0.CO;2-5; Kirik D, 2000, EUR J NEUROSCI, V12, P3871, DOI 10.1046/j.1460-9568.2000.00274.x; Kirik D, 2000, J NEUROSCI, V20, P4686, DOI 10.1523/JNEUROSCI.20-12-04686.2000; Kirik D, 2001, EUR J NEUROSCI, V13, P1589, DOI 10.1046/j.0953-816x.2001.01534.x; Kobayashi S, 1998, EXP NEUROL, V154, P302, DOI 10.1006/exnr.1998.6952; Kordower JH, 2000, SCIENCE, V290, P767, DOI 10.1126/science.290.5492.767; Lapchak PA, 1997, NEUROSCIENCE, V78, P61, DOI 10.1016/S0306-4522(97)83045-X; Mandel RJ, 1997, P NATL ACAD SCI USA, V94, P14083, DOI 10.1073/pnas.94.25.14083; Martin D, 1996, EUR J PHARMACOL, V317, P247, DOI 10.1016/S0014-2999(96)00756-X; Martin D, 1996, EUR J NEUROSCI, V8, P1249, DOI 10.1111/j.1460-9568.1996.tb01293.x; Maswood N, 2002, NEUROBIOL AGING, V23, P881, DOI 10.1016/S0197-4580(02)00022-2; Miyoshi Y, 1997, ANN NEUROL, V42, P208, DOI 10.1002/ana.410420212; Nutt JG, 2003, NEUROLOGY, V60, P69, DOI 10.1212/WNL.60.1.69; Obeso JA, 2001, NEW ENGL J MED, V345, P956, DOI 10.1056/nejmoa000827; Pothos EN, 2000, J NEUROSCI, V20, P7297; Rosenblad C, 2000, EXP NEUROL, V161, P503, DOI 10.1006/exnr.1999.7296; Rosenblad C, 1999, EUR J NEUROSCI, V11, P1554, DOI 10.1046/j.1460-9568.1999.00566.x; Rosenblad C, 1998, NEUROSCIENCE, V82, P129; SAUER H, 1994, NEUROSCIENCE, V59, P401, DOI 10.1016/0306-4522(94)90605-X; SAUER H, 1995, P NATL ACAD SCI USA, V92, P8935, DOI 10.1073/pnas.92.19.8935; Sullivan AM, 1998, EUR J NEUROSCI, V10, P57; Tuszynski MH, 2002, LANCET NEUROL, V1, P51, DOI 10.1016/S1474-4422(02)00006-6; Wang J, 2003, NEUROSIGNALS, V12, P78, DOI 10.1159/000071817; Winkler C, 1996, J NEUROSCI, V16, P7206; Yang F, 2001, NAT NEUROSCI, V4, P1071, DOI 10.1038/nn734; Zhang ZM, 1997, J PHARMACOL EXP THER, V282, P1396	49	226	247	0	11	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2004	7	2					105	110		10.1038/nn1175	http://dx.doi.org/10.1038/nn1175			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	767TJ	14747832				2022-12-17	WOS:000188468500006
J	Hardingham, GE; Arnold, FJL; Bading, H				Hardingham, GE; Arnold, FJL; Bading, H			A calcium microdomain near NMDA receptors: on switch for ERK-dependent synapse-to-nucleus communication	NATURE NEUROSCIENCE			English	Article							DENDRITIC SPINES; GENE-EXPRESSION; PHOSPHORYLATION; NEURONS		MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Bading, H (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.			Hardingham, Giles/0000-0002-7629-5314				BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; BADING H, 1991, SCIENCE, V253, P912, DOI 10.1126/science.1715095; Chawla S, 1998, SCIENCE, V281, P1505, DOI 10.1126/science.281.5382.1505; Cruzalegui FH, 2000, CELL MOL LIFE SCI, V57, P402, DOI 10.1007/PL00000702; Deisseroth K, 1996, NEURON, V16, P89, DOI 10.1016/S0896-6273(00)80026-4; GUTHRIE PB, 1991, NATURE, V354, P76, DOI 10.1038/354076a0; Hardingham GE, 1997, NATURE, V385, P260, DOI 10.1038/385260a0; Hardingham GE, 2001, NAT NEUROSCI, V4, P261, DOI 10.1038/85109; LEREA LS, 1992, J NEUROSCI, V12, P2973, DOI 10.1523/JNEUROSCI.12-08-02973.1992; MULLER W, 1991, NATURE, V354, P73, DOI 10.1038/354073a0; Shibasaki F, 1996, NATURE, V382, P370, DOI 10.1038/382370a0; STERN MD, 1992, CELL CALCIUM, V13, P183, DOI 10.1016/0143-4160(92)90046-U; Wu GY, 2001, P NATL ACAD SCI USA, V98, P2808, DOI 10.1073/pnas.051634198; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0	14	226	237	0	14	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2001	4	6					565	566		10.1038/88380	http://dx.doi.org/10.1038/88380			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	438PG	11369935				2022-12-17	WOS:000169061800007
J	Procyk, E; Tanaka, YL; Joseph, JP				Procyk, E; Tanaka, YL; Joseph, JP			Anterior cingulate activity during routine and non-routine sequential behaviors in macaques	NATURE NEUROSCIENCE			English	Article							MOTOR AREA CELLS; FRONTAL-CORTEX; PREFRONTAL CORTEX; MONKEY; SUPPLEMENTARY; ATTENTION; MOVEMENTS; ORDER	Anterior cingulate cortex is important in monitoring action for new challenges. We recorded neuron activity in the anterior cingulate sulcus of macaques while they performed a sequential problem-solving task. By trial and error, animals determined the correct sequence for touching three fixed spatial targets. After the sequence was repeated three times, we then changed the correct solution order, requiring a new search. Irrespective of component movements or their kinematics, task-related neurons encoded the serial order of the sequence. Neurons activated with sequence components (68%) differed in activity between search and repetition. Search-related activity occurred when behavioral flexibility was required and ended as soon as the animal accumulated enough information to infer the solution, but had not yet tested it. Repetition-related activity occurred in a regime of memory-based motor performance in which attention to action is less necessary.	Espace & Act, INSERM, U94, F-69676 Bron, France; Nihon Univ, Sch Med, Dept Physiol, Itabashi Ku, Tokyo 173, Japan	Institut National de la Sante et de la Recherche Medicale (Inserm); Nihon University	Procyk, E (corresponding author), Yale Univ, Sch Med, Neurobiol Sect, 333 Cedar St,SHM B413, New Haven, CT 06510 USA.		procyk, emmanuel/H-3037-2014	procyk, emmanuel/0000-0001-7486-4993				BARONE P, 1989, EXP BRAIN RES, V78, P447; Carpenter AF, 1999, SCIENCE, V283, P1752, DOI 10.1126/science.283.5408.1752; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Clower WT, 1998, J NEUROPHYSIOL, V80, P1562, DOI 10.1152/jn.1998.80.3.1562; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; DUM RP, 1991, J NEUROSCI, V11, P667; Gabbott PLA, 1996, J COMP NEUROL, V364, P567; HANES DP, 1995, EXP BRAIN RES, V103, P85; Jueptner M, 1997, J NEUROPHYSIOL, V77, P1313, DOI 10.1152/jn.1997.77.3.1313; KERMADI I, 1995, J NEUROPHYSIOL, V74, P911, DOI 10.1152/jn.1995.74.3.911; MATTELLI M, 1991, J COMP NEUROL, V311, P445; MILLER GA, 1986, PLANS STRUCT BEHAV, P159; Nakamura K, 1998, J NEUROPHYSIOL, V80, P2671, DOI 10.1152/jn.1998.80.5.2671; Passingham RE, 1996, PHILOS T ROY SOC B, V351, P1473, DOI 10.1098/rstb.1996.0132; PAUS T, 1993, J NEUROPHYSIOL, V70, P453, DOI 10.1152/jn.1993.70.2.453; Picard N, 1996, CEREB CORTEX, V6, P342, DOI 10.1093/cercor/6.3.342; Posner MI, 1998, ATTENTIVE BRAIN, P401; Procyk E, 1996, BEHAV BRAIN RES, V82, P67, DOI 10.1016/S0166-4328(97)81109-6; SCHULTZ W, 1997, ASS CORTEX STRUCTURE, P67; Shallice T., 1988, NEUROPSYCHOLOGY MENT, DOI DOI 10.1017/IPM.2020.45; Shidara M, 1998, J NEUROSCI, V18, P2613; Shima K, 1996, P NATL ACAD SCI USA, V93, P8694, DOI 10.1073/pnas.93.16.8694; Shima K, 1998, SCIENCE, V282, P1335, DOI 10.1126/science.282.5392.1335; SHIMA K, 1991, J NEUROPHYSIOL, V65, P188, DOI 10.1152/jn.1991.65.2.188; TANJI J, 1994, NATURE, V371, P413, DOI 10.1038/371413a0; Wise SP, 1996, CRIT REV NEUROBIOL, V10, P317, DOI 10.1615/CritRevNeurobiol.v10.i3-4.30; Zilles K, 1995, J ANAT, V187, P515	27	226	228	0	14	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2000	3	5					502	508		10.1038/74880	http://dx.doi.org/10.1038/74880			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	309DG	10769392	Green Submitted			2022-12-17	WOS:000086752000021
J	Lisman, J; Buzsaki, G; Eichenbaum, H; Nadel, L; Rangananth, C; Redish, AD				Lisman, John; Buzsaki, Gyorgy; Eichenbaum, Howard; Nadel, Lynn; Rangananth, Charan; Redish, A. David			Viewpoints: how the hippocampus contributes to memory, navigation and cognition	NATURE NEUROSCIENCE			English	Letter							MEDIAL TEMPORAL-LOBE; PLACE CELLS; TIME CELLS; THETA OSCILLATIONS; ACTIVITY PATTERNS; GRID CELLS; ENTORHINAL CORTEX; ENSEMBLE ACTIVITY; CA2 REGION; SEQUENCES	The hippocampus serves a critical function in memory, navigation, and cognition. Nature Neuroscience asked John Lisman to lead a group of researchers in a dialog on shared and distinct viewpoints on the hippocampus.	[Lisman, John] Brandeis Univ, Dept Biol, Waltham, MA 02254 USA; [Buzsaki, Gyorgy] NYU, NYU Neurosci Inst, New York, NY USA; [Eichenbaum, Howard] Boston Univ, Ctr Memory & Brain, Boston, MA 02215 USA; [Nadel, Lynn] Univ Arizona, Dept Psychol, Tucson, AZ 85721 USA; [Nadel, Lynn] Univ Arizona, Cognit Sci Program, Tucson, AZ USA; [Rangananth, Charan] Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; [Rangananth, Charan] Univ Calif Davis, Dept Psychol, Davis, CA 95616 USA; [Redish, A. David] Univ Minnesota, Dept Neurosci, Minneapolis, MN USA	Brandeis University; New York University; Boston University; University of Arizona; University of Arizona; University of California System; University of California Davis; University of California System; University of California Davis; University of Minnesota System; University of Minnesota Twin Cities	Lisman, J (corresponding author), Brandeis Univ, Dept Biol, Waltham, MA 02254 USA.	Lisman@brandeis.edu		Buzsaki, Gyorgy/0000-0002-3100-4800	NIH [U19NS104590, MH080318, MH112688, MH54671, NS 090583, NS090526, NS074015]; Vanneavar Bush Faculty Fellowship (Office of Naval Research) [N00014-15-1-0033]; NIH/NIMH [R01 MH051570, R01 MH095297, R01 MH052090]; Simons Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH051570, R01MH095297, R56MH080318, R01MH112688, R01MH054671, R01MH052090, R01MH080318, R01MH110391] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS074015, U01NS090526, U19NS104590, U01NS090583] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA043195] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanneavar Bush Faculty Fellowship (Office of Naval Research)(Office of Naval Research); NIH/NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Simons Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The editors are extremely grateful to Dr. Karen Shedlack (Howard Eichenbaum's widow), Denise Parisi (Assistant Director, Center for Memory and Brain at Boston University), and Dr. Neal Cohen (Department of Psychology at University of Illinois) for their efforts in ensuring that Dr. Eichenbaum's final revisions were located, revised, and included in this publication. J.L. was supported by NIH grant U19NS104590. C.R. was supported by a Vanneavar Bush Faculty Fellowship (Office of Naval Research Grant N00014-15-1-0033). Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the Office of Naval Research or the U.S. Department of Defense. H.E. was supported by NIH/NIMH grants R01 MH051570, R01 MH095297 and R01 MH052090. A.D.R. was supported by NIH grants MH080318 and MH112688. G.B. was supported by the Simons Foundation and by NIH grants MH54671, NS 090583, NS090526 and NS074015.	Aggleton JP, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0565; Alexander GM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10300; Aly M, 2013, NEURON, V78, P1127, DOI 10.1016/j.neuron.2013.04.018; Aronov D, 2017, NATURE, V543, P719, DOI 10.1038/nature21692; Benchenane K, 2010, NEURON, V66, P921, DOI 10.1016/j.neuron.2010.05.013; Berke JD, 2009, J NEUROPHYSIOL, V101, P1575, DOI 10.1152/jn.91106.2008; Bohbot VD, 1998, NEUROPSYCHOLOGIA, V36, P1217, DOI 10.1016/S0028-3932(97)00161-9; Bohbot VD, 2000, ANN NY ACAD SCI, V911, P355; Brown TI, 2016, SCIENCE, V352, P1323, DOI 10.1126/science.aaf0784; Brown TI, 2014, HIPPOCAMPUS, V24, P819, DOI 10.1002/hipo.22273; Burak Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000291; Burke SN, 2011, HIPPOCAMPUS, V21, P783, DOI 10.1002/hipo.20929; Buzsaki G., 2006, RHYTHMS BRAIN; Buzsaki G., SCIENCE IN PRESS; Buzsaki G, 2013, NAT NEUROSCI, V16, P130, DOI 10.1038/nn.3304; Buzsaki G, 2010, NEURON, V68, P362, DOI 10.1016/j.neuron.2010.09.023; Buzsaki G, 2014, COLD SH Q B, V79, P41, DOI 10.1101/sqb.2014.79.024679; Chen GF, 2016, CURR BIOL, V26, P2335, DOI 10.1016/j.cub.2016.06.043; Cohen N.J., 1993, MEMORY AMNESIA HIPPO, DOI DOI 10.1136/JNNP.58.1.128-A; Colgin LL, 2016, NAT REV NEUROSCI, V17, P239, DOI 10.1038/nrn.2016.21; Colgin LL, 2009, NATURE, V462, P353, DOI 10.1038/nature08573; Constantinescu AO, 2016, SCIENCE, V352, P1464, DOI 10.1126/science.aaf0941; Czurko A, 1999, EUR J NEUROSCI, V11, P344, DOI 10.1046/j.1460-9568.1999.00446.x; Davidson TJ, 2009, NEURON, V63, P497, DOI 10.1016/j.neuron.2009.07.027; de Lavilleon G, 2015, NAT NEUROSCI, V18, P493, DOI 10.1038/nn.3970; DeCoteau WE, 2007, P NATL ACAD SCI USA, V104, P5644, DOI 10.1073/pnas.0700818104; Dede AJO, 2016, P NATL ACAD SCI USA, V113, P13480, DOI 10.1073/pnas.1617025113; DENNETT DC, 1992, BEHAV BRAIN SCI, V15, P183, DOI 10.1017/S0140525X00068229; Deuker L, 2016, ELIFE, V5, DOI 10.7554/eLife.16534; Diehl GW, 2017, NEURON, V94, P83, DOI 10.1016/j.neuron.2017.03.004; Doeller CF, 2010, NATURE, V463, P657, DOI 10.1038/nature08704; Dongaonkar B, 2013, PSYCHOPHARMACOLOGY, V226, P769, DOI 10.1007/s00213-013-2998-8; Dragoi G, 2006, NEURON, V50, P145, DOI 10.1016/j.neuron.2006.02.023; Dudek SM, 2016, NAT REV NEUROSCI, V17, P89, DOI 10.1038/nrn.2015.22; Eichenbaum H, 2017, J NEUROPHYSIOL, V117, P1785, DOI 10.1152/jn.00005.2017; Eichenbaum H, 2014, NAT REV NEUROSCI, V15, P732, DOI 10.1038/nrn3827; Ekstrom AD, 2017, HIPPOCAMPUS; Ferbinteanu J, 2003, NEURON, V40, P1227, DOI 10.1016/S0896-6273(03)00752-9; Fernandez-Ruiz A, 2017, NEURON, V93, P1213, DOI 10.1016/j.neuron.2017.02.017; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; Frank LM, 2000, NEURON, V27, P169, DOI 10.1016/S0896-6273(00)00018-0; Fuhs MC, 2007, NEURAL COMPUT, V19, P3173, DOI 10.1162/neco.2007.19.12.3173; Gallistel C. R., 1993, ORG LEARNING; Garvert MM, 2017, ELIFE, V6, DOI 10.7554/eLife.17086; Geisler C, 2007, P NATL ACAD SCI USA, V104, P8149, DOI 10.1073/pnas.0610121104; GOLANI I, 1993, BEHAV BRAIN RES, V53, P21, DOI 10.1016/S0166-4328(05)80263-3; Gothard KM, 2001, J NEUROSCI, V21, P7284, DOI 10.1523/JNEUROSCI.21-18-07284.2001; Gothard KM, 1996, J NEUROSCI, V16, P823; Gupta AS, 2010, NEURON, V65, P695, DOI 10.1016/j.neuron.2010.01.034; Guzman SJ, 2016, SCIENCE, V353, P1117, DOI 10.1126/science.aaf1836; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hannula DE, 2007, J COGNITIVE NEUROSCI, V19, P1690, DOI 10.1162/jocn.2007.19.10.1690; Hannula DE, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00166; Hannula DE, 2009, NEURON, V63, P592, DOI 10.1016/j.neuron.2009.08.025; Hardcastle K, 2017, NAT NEUROSCI, V20, P1474, DOI 10.1038/nn.4654; Hartley T, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2012.0510; Hassabis D, 2007, P NATL ACAD SCI USA, V104, P1726, DOI 10.1073/pnas.0610561104; Hasselmo ME, 2002, NEURAL COMPUT, V14, P793, DOI 10.1162/089976602317318965; Hitti FL, 2014, NATURE, V508, P88, DOI 10.1038/nature13028; Hsieh LT, 2014, NEURON, V81, P1165, DOI 10.1016/j.neuron.2014.01.015; Hsieh LT, 2014, NEUROIMAGE, V85, P721, DOI 10.1016/j.neuroimage.2013.08.003; Hupbach A, 2008, LEARN MEMORY, V15, P574, DOI 10.1101/lm.1022308; Hupbach A, 2011, PSYCHON B REV, V18, P787, DOI 10.3758/s13423-011-0117-6; Hupbach A, 2009, MEMORY, V17, P502, DOI 10.1080/09658210902882399; Huth J. E., 2013, LOST ART FINDING OUR; Jadhav SP, 2012, SCIENCE, V336, P1454, DOI 10.1126/science.1217230; Jeffery KJ, 2003, HIPPOCAMPUS, V13, P175, DOI 10.1002/hipo.10047; Johnson A, 2007, J NEUROSCI, V27, P12176, DOI 10.1523/JNEUROSCI.3761-07.2007; Jung MW, 1998, CEREB CORTEX, V8, P437, DOI 10.1093/cercor/8.5.437; Jutras MJ, 2010, P NATL ACAD SCI USA, V107, P401, DOI 10.1073/pnas.0908378107; Keene CS, 2016, J NEUROSCI, V36, P3660, DOI 10.1523/JNEUROSCI.4368-15.2016; Kelemen E, 2016, NEUROBIOL LEARN MEM, V129, P50, DOI 10.1016/j.nlm.2015.12.011; Kraus BJ, 2015, NEURON, V88, P578, DOI 10.1016/j.neuron.2015.09.031; Kraus BJ, 2013, NEURON, V78, P1090, DOI 10.1016/j.neuron.2013.04.015; Kravitz DJ, 2011, NAT REV NEUROSCI, V12, P217, DOI 10.1038/nrn3008; Krupic J, 2015, NATURE, V518, P232, DOI 10.1038/nature14153; Lee ACH, 2005, Q J EXP PSYCHOL-B, V58, P300, DOI 10.1080/02724990444000168; Lee JLC, 2017, TRENDS COGN SCI, V21, P531, DOI 10.1016/j.tics.2017.04.006; Leutgeb JK, 2005, NEURON, V48, P345, DOI 10.1016/j.neuron.2005.09.007; Levy WB, 1996, HIPPOCAMPUS, V6, P579, DOI 10.1002/(SICI)1098-1063(1996)6:6<579::AID-HIPO3>3.0.CO;2-C; Lisman JE, 2001, HIPPOCAMPUS, V11, P551; Lisman JE, 2005, NEURAL NETWORKS, V18, P1191, DOI 10.1016/j.neunet.2005.08.008; LISMAN JE, 1995, SCIENCE, V267, P1512, DOI 10.1126/science.7878473; Lisman JE, 1999, NEURON, V22, P233, DOI 10.1016/S0896-6273(00)81085-5; Lisman J, 2008, SCHIZOPHRENIA BULL, V34, P974, DOI 10.1093/schbul/sbn060; Lisman JE, 2007, PROG BRAIN RES, V163, P615, DOI 10.1016/S0079-6123(07)63033-7; Liu ZX, 2017, J NEUROSCI, V37, P599, DOI [10.1523/JNEUROSCI.2610-16.2017, 10.1523/JNEUROSCI.2610-16.2016]; Lubenov EV, 2009, NATURE, V459, P534, DOI 10.1038/nature08010; MacDonald CJ, 2013, J NEUROSCI, V33, P14607, DOI 10.1523/JNEUROSCI.1537-13.2013; MacDonald CJ, 2011, NEURON, V71, P737, DOI 10.1016/j.neuron.2011.07.012; Maguire EA, 2006, BRAIN, V129, P2894, DOI 10.1093/brain/awl286; Mankin EA, 2015, NEURON, V85, P190, DOI 10.1016/j.neuron.2014.12.001; Manns JR, 2009, LEARN MEMORY, V16, P616, DOI 10.1101/lm.1484509; Maurer AP, 2012, HIPPOCAMPUS, V22, P737, DOI 10.1002/hipo.20936; McKenzie S, 2014, NEURON, V83, P202, DOI 10.1016/j.neuron.2014.05.019; McKenzie S, 2013, J NEUROSCI, V33, P10243, DOI 10.1523/JNEUROSCI.0879-13.2013; MCNAUGHTON BL, 1983, EXP BRAIN RES, V52, P41; Mittelstaedt H, 1982, AVIAN NAVIGATION; Muller RU, 1996, J GEN PHYSIOL, V107, P663, DOI 10.1085/jgp.107.6.663; MULLER RU, 1987, J NEUROSCI, V7, P1951; Nadel L, 2013, J EXP PSYCHOL GEN, V142, P1242, DOI 10.1037/a0033690; Nielson DM, 2015, P NATL ACAD SCI USA, V112, P11078, DOI 10.1073/pnas.1507104112; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Pastalkova E, 2008, SCIENCE, V321, P1322, DOI 10.1126/science.1159775; Patel J, 2012, NEURON, V75, P410, DOI 10.1016/j.neuron.2012.07.015; Peters J, 2010, NEURON, V66, P138, DOI 10.1016/j.neuron.2010.03.026; Pfeiffer BE, 2015, SCIENCE, V349, P180, DOI 10.1126/science.aaa9633; Pfeiffer BE, 2013, NATURE, V497, P74, DOI 10.1038/nature12112; Place R, 2016, NAT NEUROSCI, V19, P992, DOI 10.1038/nn.4327; Powell NJ, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00120; Ramirez S, 2013, SCIENCE, V341, P387, DOI 10.1126/science.1239073; Ranganath C, 2016, ANN NY ACAD SCI, V1369, P93, DOI 10.1111/nyas.13043; Ranganath C, 2012, NAT REV NEUROSCI, V13, P713, DOI 10.1038/nrn3338; Redish A. D., 1999, COGNITIVE MAP PLACE, DOI DOI 10.1038/nature14445; Redish AD, 1997, HIPPOCAMPUS, V7, P15; Redish AD, 2000, J NEUROSCI, V20, P9298; Redondo RL, 2014, NATURE, V513, P426, DOI 10.1038/nature13725; Robbe D, 2009, J NEUROSCI, V29, P12597, DOI 10.1523/JNEUROSCI.2407-09.2009; Robinson NTM, 2017, NEURON, V94, P677, DOI 10.1016/j.neuron.2017.04.003; Rosenzweig ES, 2003, NAT NEUROSCI, V6, P609, DOI 10.1038/nn1053; Royer S, 2010, J NEUROSCI, V30, P1777, DOI 10.1523/JNEUROSCI.4681-09.2010; Ryan JD, 2000, PSYCHOL SCI, V11, P454, DOI 10.1111/1467-9280.00288; Salz DM, 2016, J NEUROSCI, V36, P7476, DOI 10.1523/JNEUROSCI.0087-16.2016; Sanders H, 2015, TRENDS NEUROSCI, V38, P763, DOI 10.1016/j.tins.2015.10.004; Schlesiger MI, 2015, NAT NEUROSCI, V18, P1123, DOI 10.1038/nn.4056; Schlichting ML, 2015, CURR OPIN BEHAV SCI, V1, P1, DOI 10.1016/j.cobeha.2014.07.005; Schmitzer-Torbert NC, 2008, NEUROSCIENCE, V153, P349, DOI 10.1016/j.neuroscience.2008.01.081; Spiers HJ, 2007, HIPPOCAMPUS, V17, P618, DOI 10.1002/hipo.20298; Stevenson EL, 2014, EUR J NEUROSCI, V40, P3294, DOI 10.1111/ejn.12689; Tavares RM, 2015, NEURON, V87, P231, DOI 10.1016/j.neuron.2015.06.011; TOLMAN EC, 1948, PSYCHOL REV, V55, P189, DOI 10.1037/h0061626; Touretzky DS, 1996, HIPPOCAMPUS, V6, P247; Tulving E., 1972, ORG MEMORY, P423; van der Meer M, 2012, NEUROSCIENTIST, V18, P342, DOI 10.1177/1073858411435128; VarghaKhadem F, 1997, SCIENCE, V277, P376, DOI 10.1126/science.277.5324.376; Viard A, 2011, J NEUROSCI, V31, P4613, DOI 10.1523/JNEUROSCI.4640-10.2011; Voss JL, 2017, TRENDS COGN SCI, V21, P577, DOI 10.1016/j.tics.2017.05.008; Wallenstein GV, 1998, TRENDS NEUROSCI, V21, P317, DOI 10.1016/S0166-2236(97)01220-4; Wang YX, 2015, NAT NEUROSCI, V18, P282, DOI 10.1038/nn.3904; Wikenheiser AM, 2015, NAT NEUROSCI, V18, P289, DOI 10.1038/nn.3909; Wills TJ, 2005, SCIENCE, V308, P873, DOI 10.1126/science.1108905; Wittlinger M, 2007, J EXP BIOL, V210, P198, DOI 10.1242/jeb.02657; Wood ER, 2000, NEURON, V27, P623, DOI 10.1016/S0896-6273(00)00071-4; Wood ER, 1999, NATURE, V397, P613, DOI 10.1038/17605; Wood F., 1975, SHORT TERM MEMORY, P257	147	225	230	10	106	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2017	20	11					1434	1447		10.1038/nn.4661	http://dx.doi.org/10.1038/nn.4661			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FL0QV	29073641	Green Accepted			2022-12-17	WOS:000413916800003
J	Lafourcade, M; Larrieu, T; Mato, S; Duffaud, A; Sepers, M; Matias, I; De Smedt-Peyrusse, V; Labrousse, VF; Bretillon, L; Matute, C; Rodriguez-Puertas, R; Laye, S; Manzoni, OJ				Lafourcade, Mathieu; Larrieu, Thomas; Mato, Susana; Duffaud, Anais; Sepers, Marja; Matias, Isabelle; De Smedt-Peyrusse, Veronique; Labrousse, Virginie F.; Bretillon, Lionel; Matute, Carlos; Rodriguez-Puertas, Rafael; Laye, Sophie; Manzoni, Olivier J.			Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions	NATURE NEUROSCIENCE			English	Article							POLYUNSATURATED FATTY-ACIDS; LONG-TERM DEPRESSION; NUCLEUS-ACCUMBENS; SYNAPTIC PLASTICITY; PREFRONTAL CORTEX; MOOD DISORDERS; BEHAVIOR; MICE; RECEPTORS; BRAIN	The corollaries of the obesity epidemic that plagues developed societies are malnutrition and resulting biochemical imbalances. Low levels of essential n-3 polyunsaturated fatty acids (n-3 PUFAs) have been linked to neuropsychiatric diseases, but the underlying synaptic alterations are mostly unknown. We found that lifelong n-3 PUFAs dietary insufficiency specifically ablates long-term synaptic depression mediated by endocannabinoids in the prelimbic prefrontal cortex and accumbens. In n-3-deficient mice, presynaptic cannabinoid CB1 receptors (CB(1)Rs) normally responding to endocannabinoids were uncoupled from their effector G(i/o) proteins. Finally, the dietary-induced reduction of CB1R functions in mood-controlling structures was associated with impaired emotional behavior. These findings identify a plausible synaptic substrate for the behavioral alterations caused by the n-3 PUFAs deficiency that is often observed in western diets.	[Lafourcade, Mathieu; Larrieu, Thomas; Duffaud, Anais; Sepers, Marja; Matias, Isabelle; De Smedt-Peyrusse, Veronique; Labrousse, Virginie F.; Laye, Sophie; Manzoni, Olivier J.] INRA, CNRS, UMR 1286, UMR 5226, Bordeaux, France; [Lafourcade, Mathieu; Sepers, Marja; Matias, Isabelle; Manzoni, Olivier J.] INSERM, U862, Physiopathol Synapt Plast Grp, Neuroctr Magendie, Bordeaux, France; [Larrieu, Thomas; Duffaud, Anais; De Smedt-Peyrusse, Veronique; Labrousse, Virginie F.; Laye, Sophie] Univ Bordeaux, Bordeaux, France; [Mato, Susana; Matute, Carlos] Univ Basque Country, Dept Neurosci, Bizkaia, Spain; [Bretillon, Lionel] INRA, CGSA, UMR1324, F-21034 Dijon, France; [Rodriguez-Puertas, Rafael] Univ Basque Country, Dept Pharmacol, Bizkaia, Spain; [Manzoni, Olivier J.] INSERM, U901, F-13258 Marseille, France; [Manzoni, Olivier J.] Univ Aix Marseille 2, UMR S901, Marseille, France; [Manzoni, Olivier J.] INMED, Marseille, France	Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; University of Basque Country; INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne; University of Basque Country; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Laye, S (corresponding author), INRA, CNRS, UMR 1286, UMR 5226, Bordeaux, France.	sophie.laye@bordeaux.inra.fr; olivier.manzoni@inserm.fr	Lafourcade, Mathieu/GQZ-7267-2022; Manzoni, Olivier/M-7899-2016; Rodriguez-Puertas, Rafael/A-1127-2010; Mato, Susana/AAU-3129-2020; Matute, Carlos/N-5559-2014; Laye, Sophie/AAX-2501-2020	Manzoni, Olivier/0000-0002-5579-6208; Rodriguez-Puertas, Rafael/0000-0003-4517-5114; Mato, Susana/0000-0002-2005-9793; Matute, Carlos/0000-0001-8672-711X; Laye, Sophie/0000-0002-3843-1012; Larrieu, Thomas/0000-0003-2406-356X; Bretillon, Lionel/0000-0002-6957-100X; Lafourcade, Mathieu/0000-0001-6117-1194; Sepers, Marja/0000-0002-6510-2804	INSERM; Institut National de la Recherche Agronomique; Region Aquitaine; Centro de Investigacion Biomedica en Red en Enfermedades Neurodegenerativas (CIBERNED); Spanish Ministry of Health [FIS 070628]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Institut National de la Recherche Agronomique; Region Aquitaine(Region Nouvelle-Aquitaine); Centro de Investigacion Biomedica en Red en Enfermedades Neurodegenerativas (CIBERNED); Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government)	The authors thank O. Lassalle for helping with illustrations, P. Chavis and M. Darnaudery for helpful discussions, P. Birac and C. Tridon for taking care of the mice and S. Gregoire for technical help. This work was supported by INSERM (O.J.M.), Institut National de la Recherche Agronomique (S.L.), Region Aquitaine (O.J.M. and S.L.), Centro de Investigacion Biomedica en Red en Enfermedades Neurodegenerativas (CIBERNED) and the Spanish Ministry of Health (FIS 070628, ISCIII, C.M.M., R.R.P. and S.M.).	Bambico FR, 2007, J NEUROSCI, V27, P11700, DOI 10.1523/JNEUROSCI.1636-07.2007; Berger A, 2001, P NATL ACAD SCI USA, V98, P6402, DOI 10.1073/pnas.101119098; Bourre JM, 2005, J NUTR HEALTH AGING, V9, P31; Chalon S, 2006, PROSTAG LEUKOTR ESS, V75, P259, DOI 10.1016/j.plefa.2006.07.005; DeMar JC, 2006, J LIPID RES, V47, P172, DOI 10.1194/jlr.M500362-JLR200; Evans DL, 2005, BIOL PSYCHIAT, V58, P175, DOI 10.1016/j.biopsych.2005.05.001; Haller J, 2004, EUR J NEUROSCI, V19, P1906, DOI 10.1111/j.1460-9568.2004.03293.x; Hayton SJ, 2010, J NEUROSCI, V30, P11493, DOI 10.1523/JNEUROSCI.1550-10.2010; Heifets BD, 2009, ANNU REV PHYSIOL, V71, P283, DOI 10.1146/annurev.physiol.010908.163149; Hill MN, 2009, TRENDS PHARMACOL SCI, V30, P484, DOI 10.1016/j.tips.2009.06.006; Jacob W, 2009, GENES BRAIN BEHAV, V8, P685, DOI 10.1111/j.1601-183X.2009.00512.x; Kauer JA, 2006, NAT NEUROSCI, V9, P593, DOI 10.1038/nn0506-593; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Lafourcade M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000709; Lauritzen L, 2001, PROG LIPID RES, V40, P1, DOI 10.1016/S0163-7827(00)00017-5; Leweke FM, 2008, ADDICT BIOL, V13, P264, DOI 10.1111/j.1369-1600.2008.00106.x; Liperoti R, 2009, CURR PHARM DESIGN, V15, P4165, DOI 10.2174/138161209789909683; Lutz B, 2009, CURR OPIN PHARMACOL, V9, P46, DOI 10.1016/j.coph.2008.12.001; Mackie K, 2008, MOL CELL ENDOCRINOL, V286, pS60, DOI 10.1016/j.mce.2008.01.022; Martin BR, 2004, TRENDS PHARMACOL SCI, V25, P325, DOI 10.1016/j.tips.2004.04.005; Matias I, 2008, BBA-MOL CELL BIOL L, V1781, P52, DOI 10.1016/j.bbalip.2007.11.001; Mato S, 2005, J NEUROSCI, V25, P11619, DOI 10.1523/JNEUROSCI.2294-05.2005; Mato S, 2004, NAT NEUROSCI, V7, P585, DOI 10.1038/nn1251; Mato S, 2008, NEUROPHARMACOLOGY, V54, P87, DOI 10.1016/j.neuropharm.2007.04.014; Mikasova L, 2008, P NATL ACAD SCI USA, V105, P18596, DOI 10.1073/pnas.0805959105; Mingam R, 2008, EUR J NEUROSCI, V28, P1877, DOI 10.1111/j.1460-9568.2008.06470.x; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; Parker G, 2006, AM J PSYCHIAT, V163, P969, DOI 10.1176/appi.ajp.163.6.969; PORSOLT RD, 2001, CURR PROTOC NEUROSCI, V10; Rapoport SI, 2007, PROSTAG LEUKOTR ESS, V77, P251, DOI 10.1016/j.plefa.2007.10.023; Robbe D, 2002, P NATL ACAD SCI USA, V99, P8384, DOI 10.1073/pnas.122149199; Robbe D, 2002, J NEUROSCI, V22, P4346, DOI 10.1523/JNEUROSCI.22-11-04346.2002; SAMAT A, 2008, DRUG DISCOV, V3, P187; Schlosburg JE, 2010, NAT NEUROSCI, V13, P1113, DOI 10.1038/nn.2616; SIMON P, 1994, BEHAV BRAIN RES, V61, P59, DOI 10.1016/0166-4328(94)90008-6; Simopoulos AP, 2009, WORLD REV NUTR DIET, V100, P1, DOI 10.1159/000235706; Steiner MA, 2008, PHARMACOGENOMICS J, V8, P196, DOI 10.1038/sj.tpj.6500466; Steiner MA, 2008, PSYCHONEUROENDOCRINO, V33, P1165, DOI 10.1016/j.psyneuen.2008.06.004; Uriguen L, 2004, NEUROPHARMACOLOGY, V46, P966, DOI 10.1016/j.neuropharm.2004.01.003; Vinod KY, 2006, TRENDS PHARMACOL SCI, V27, P539, DOI 10.1016/j.tips.2006.08.006; Watanabe S, 2003, PROSTAG LEUKOTR ESS, V69, P51, DOI 10.1016/S0952-3278(03)00056-5	41	225	233	3	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2011	14	3					345	350		10.1038/nn.2736	http://dx.doi.org/10.1038/nn.2736			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	725MW	21278728	Green Submitted			2022-12-17	WOS:000287650100015
J	Rolfs, M; Jonikaitis, D; Deubel, H; Cavanagh, P				Rolfs, Martin; Jonikaitis, Donatas; Deubel, Heiner; Cavanagh, Patrick			Predictive remapping of attention across eye movements	NATURE NEUROSCIENCE			English	Article							PRIMARY VISUAL-CORTEX; SPATIAL ATTENTION; PSYCHOPHYSICS TOOLBOX; PARIETAL CORTEX; SELECTION; SACCADES; SYSTEM; REPRESENTATION; PERCEPTION	Many cells in retinotopic brain areas increase their activity when saccades (rapid eye movements) are about to bring stimuli into their receptive fields. Although previous work has attempted to look at the functional correlates of such predictive remapping, no study has explicitly tested for better attentional performance at the future retinal locations of attended targets. We found that, briefly before the eyes start moving, attention drawn to the targets of upcoming saccades also shifted to those retinal locations that the targets would cover once the eyes had moved, facilitating future movements. This suggests that presaccadic visual attention shifts serve to both improve presaccadic perceptual processing at the target locations and speed subsequent eye movements to their new postsaccadic locations. Predictive remapping of attention provides a sparse, efficient mechanism for keeping track of relevant parts of the scene when frequent rapid eye movements provoke retinal smear and temporal masking.	[Rolfs, Martin; Cavanagh, Patrick] Univ Paris 05, Lab Psychol Percept, Paris, France; [Rolfs, Martin] NYU, Dept Psychol, New York, NY 10003 USA; [Jonikaitis, Donatas; Deubel, Heiner] Univ Munich, Dept Psychol, Munich, Germany	UDICE-French Research Universities; Universite Paris Cite; New York University; University of Munich	Rolfs, M (corresponding author), Univ Paris 05, Lab Psychol Percept, Paris, France.	martin.rolfs@gmail.com; patrick.cavanagh@parisdescartes.fr	Jonikaitis, Donatas/K-6782-2019; Rolfs, Martin/A-7214-2008	Rolfs, Martin/0000-0002-8214-8556; Jonikaitis, Donatas/0000-0001-9851-0903	European Commission [235625]; Deutsche Forschungsgemeinschaft [GRK 1091]; Chaire d'Excellence grant	European Commission(European CommissionEuropean Commission Joint Research Centre); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Chaire d'Excellence grant	We thank C. Buss for help with data acquisition. This work was supported by the 7th Framework Program of the European Commission (Marie Curie International Outgoing Fellowship 235625 awarded to M. R.), by Deutsche Forschungsgemeinschaft (GRK 1091, as a fellowship to D.J.) and by a Chaire d'Excellence grant to P. C.	Awh E, 2006, TRENDS COGN SCI, V10, P124, DOI 10.1016/j.tics.2006.01.001; Baldauf D, 2008, EXP BRAIN RES, V184, P411, DOI 10.1007/s00221-007-1114-x; BECKER W, 1979, VISION RES, V19, P967, DOI 10.1016/0042-6989(79)90222-0; Berman R, 2009, VISION RES, V49, P1233, DOI 10.1016/j.visres.2008.06.017; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Castet E, 2002, P NATL ACAD SCI USA, V99, P15159, DOI 10.1073/pnas.232377199; Cavanagh P, 2010, TRENDS COGN SCI, V14, P147, DOI 10.1016/j.tics.2010.01.007; Chen Y, 2008, NAT NEUROSCI, V11, P974, DOI 10.1038/nn.2147; Collins T, 2009, J VISION, V9, DOI 10.1167/9.5.29; Cornelissen FW, 2002, BEHAV RES METH INS C, V34, P613, DOI 10.3758/BF03195489; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; Deubel H, 2008, PSYCHOL RES-PSYCH FO, V72, P630, DOI 10.1007/s00426-008-0165-3; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; Engbert R, 2006, P NATL ACAD SCI USA, V103, P7192, DOI 10.1073/pnas.0509557103; Gersch TM, 2006, VIS COGN, V14, P104; Godijn R, 2003, J EXP PSYCHOL HUMAN, V29, P882, DOI 10.1037/0096-1523.29.5.882; Golomb JD, 2008, J NEUROSCI, V28, P10654, DOI 10.1523/JNEUROSCI.2525-08.2008; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; GUTHRIE BL, 1983, SCIENCE, V221, P1193, DOI 10.1126/science.6612334; HALLETT PE, 1976, VISION RES, V16, P107, DOI 10.1016/0042-6989(76)90084-5; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; Knapen T, 2010, J VISION, V10, DOI 10.1167/10.1.8; KOWLER E, 1995, VISION RES, V35, P1897, DOI 10.1016/0042-6989(94)00279-U; Mack A., 1998, INATTENTIONAL BLINDN; Macknik S. L., 2009, COGNITIVE NEUROSCIEN; Mathot S, 2010, EXP BRAIN RES, V200, P117, DOI 10.1007/s00221-009-2055-3; Melcher D, 2007, NAT NEUROSCI, V10, P903, DOI 10.1038/nn1917; Melcher D, 2008, TRENDS COGN SCI, V12, P466, DOI 10.1016/j.tics.2008.09.003; Montagnini A, 2007, J VISION, V7, DOI 10.1167/7.14.8; O'Regan JK, 1999, NATURE, V398, P34, DOI 10.1038/17953; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; POLAT U, 1993, VISION RES, V33, P993, DOI 10.1016/0042-6989(93)90081-7; Rolfs M, 2005, EXP BRAIN RES, V166, P427, DOI 10.1007/s00221-005-2382-y; Solomon JA, 2004, VISION RES, V44, P1209, DOI 10.1016/j.visres.2003.12.003; Sommer MA, 2002, SCIENCE, V296, P1480, DOI 10.1126/science.1069590; Sommer MA, 2006, NATURE, V444, P374, DOI 10.1038/nature05279; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; Wurtz RH, 2008, VISION RES, V48, P2070, DOI 10.1016/j.visres.2008.03.021	38	225	227	3	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2011	14	2					252	U347		10.1038/nn.2711	http://dx.doi.org/10.1038/nn.2711			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	711MJ	21186360				2022-12-17	WOS:000286595400024
J	Logothetis, NK; Augath, M; Murayama, Y; Rauch, A; Sultan, F; Goense, J; Oeltermann, A; Merkle, H				Logothetis, Nikos K.; Augath, Mark; Murayama, Yusuke; Rauch, Alexander; Sultan, Fahad; Goense, Jozien; Oeltermann, Axel; Merkle, Hellmut			The effects of electrical microstimulation on cortical signal propagation	NATURE NEUROSCIENCE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; CAT VISUAL-CORTEX; FRONTAL EYE FIELD; STRIATE CORTEX; INTRACORTICAL MICROSTIMULATION; FUNCTIONAL MRI; RAT NEOCORTEX; MOTOR CORTEX; FMRI SIGNAL; AREA MT	Electrical stimulation has been used in animals and humans to study potential causal links between neural activity and specific cognitive functions. Recently, it has found increasing use in electrotherapy and neural prostheses. However, the manner in which electrical stimulation-elicited signals propagate in brain tissues remains unclear. We used combined electrostimulation, neurophysiology, microinjection and functional magnetic resonance imaging (fMRI) to study the cortical activity patterns elicited during stimulation of cortical afferents in monkeys. We found that stimulation of a site in the lateral geniculate nucleus (LGN) increased the fMRI signal in the regions of primary visual cortex (V1) that received input from that site, but suppressed it in the retinotopically matched regions of extrastriate cortex. Consistent with previous observations, intracranial recordings indicated that a short excitatory response occurring immediately after a stimulation pulse was followed by a long-lasting inhibition. Following microinjections of GABA antagonists in V1, LGN stimulation induced positive fMRI signals in all of the cortical areas. Taken together, our findings suggest that electrical stimulation disrupts cortico-cortical signal propagation by silencing the output of any neocortical area whose afferents are electrically stimulated.	[Logothetis, Nikos K.; Augath, Mark; Murayama, Yusuke; Rauch, Alexander; Goense, Jozien; Oeltermann, Axel] Max Planck Inst Biol Cybernet, Tubingen, Germany; [Logothetis, Nikos K.] Univ Manchester, Manchester, Lancs, England; [Sultan, Fahad] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Cognit Neurol, Tubingen, Germany; [Merkle, Hellmut] NINDS, Lab Funct & Mol Imaging, US NIH, Bethesda, MD 20892 USA	Max Planck Society; University of Manchester; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Logothetis, NK (corresponding author), Max Planck Inst Biol Cybernet, Tubingen, Germany.	nikos.logothetis@tuebingen.mpg.de	Logothetis, Nikos/U-9282-2019		Max Planck Society; German Research Foundation [DFG SFB-A9]; US National Institutes of Health (National Institute Neurological Disorders and Stroke)	Max Planck Society(Max Planck Society); German Research Foundation(German Research Foundation (DFG)); US National Institutes of Health (National Institute Neurological Disorders and Stroke)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank C. Kayser, O. Eschenko and M. Munk for reading the manuscript and for useful suggestions. Many thanks also go to D. Blaurock for editing, S. Weber for fine-mechanic work and T. Steudel and P. Douay for help with the alert monkey experiments. This research was supported by the Max Planck Society, the German Research Foundation (DFG SFB-A9) and by the intramural research program of the US National Institutes of Health (National Institute Neurological Disorders and Stroke, H.M.).	Allen EA, 2007, SCIENCE, V317, P1918, DOI 10.1126/science.1146426; Armstrong KM, 2006, NEURON, V50, P791, DOI 10.1016/j.neuron.2006.05.010; Berger TK, 2009, J PHYSIOL-LONDON, V587, P5411, DOI 10.1113/jphysiol.2009.176552; BERMAN NJ, 1991, J PHYSIOL-LONDON, V440, P697, DOI 10.1113/jphysiol.1991.sp018731; Brewer AA, 2002, J NEUROSCI, V22, P10416; BULLIER J, 1979, J NEUROPHYSIOL, V42, P1271, DOI 10.1152/jn.1979.42.5.1271; Butovas S, 2003, J NEUROPHYSIOL, V90, P3024, DOI 10.1152/jn.00245.2003; Butovas S, 2007, EUR J NEUROSCI, V25, P2161, DOI 10.1111/j.1460-9568.2007.05449.x; Butovas S, 2006, J NEUROPHYSIOL, V96, P1227, DOI 10.1152/jn.01170.2005; Chung S, 1998, NEURON, V20, P1177, DOI 10.1016/S0896-6273(00)80498-5; Cowey A, 2005, PHILOS T R SOC B, V360, P1185, DOI 10.1098/rstb.2005.1658; DEFELIPE J, 1986, J NEUROSCI, V6, P3749, DOI 10.1523/jneurosci.06-12-03749.1986; DOUGLAS RJ, 1991, J PHYSIOL-LONDON, V440, P735, DOI 10.1113/jphysiol.1991.sp018733; DOUGLAS RJ, 1991, J PHYSIOL-LONDON, V440, P659, DOI 10.1113/jphysiol.1991.sp018730; Douglas RJ, 2007, CURR BIOL, V17, pR496, DOI 10.1016/j.cub.2007.04.024; Driver J, 2009, TRENDS COGN SCI, V13, P319, DOI 10.1016/j.tics.2009.04.007; Ekstrom LB, 2008, SCIENCE, V321, P414, DOI 10.1126/science.1153276; Ekstrom LB, 2009, J NEUROSCI, V29, P10683, DOI 10.1523/JNEUROSCI.0673-09.2009; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; FRIES W, 1983, PROC R SOC SER B-BIO, V219, P53, DOI 10.1098/rspb.1983.0058; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Goense JBM, 2008, CURR BIOL, V18, P631, DOI 10.1016/j.cub.2008.03.054; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Guillery RW, 1995, J ANAT, V187, P583; Hallett M, 2007, NEURON, V55, P187, DOI 10.1016/j.neuron.2007.06.026; Kara P, 2002, P NATL ACAD SCI USA, V99, P16261, DOI 10.1073/pnas.242625499; KELLER A, 1993, CEREB CORTEX, V3, P430, DOI 10.1093/cercor/3.5.430; LEHKY SR, 1988, NATURE, V333, P452, DOI 10.1038/333452a0; LI C, 1963, J CELL COMPAR PHYSL, V61, P165, DOI 10.1002/jcp.1030610207; Logothetis NK, 2007, NEURON, V55, P809, DOI 10.1016/j.neuron.2007.07.027; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Moeller S, 2008, SCIENCE, V320, P1355, DOI 10.1126/science.1157436; Moore T, 2003, NEURON, V40, P671, DOI 10.1016/S0896-6273(03)00716-5; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; Murphey DK, 2007, CURR BIOL, V17, P862, DOI 10.1016/j.cub.2007.03.066; Okun M, 2008, NAT NEUROSCI, V11, P535, DOI 10.1038/nn.2105; Pezaris JS, 2007, P NATL ACAD SCI USA, V104, P7670, DOI 10.1073/pnas.0608563104; Rauch A, 2008, P NATL ACAD SCI USA, V105, P6759, DOI 10.1073/pnas.0800312105; Ruff CC, 2006, CURR BIOL, V16, P1479, DOI 10.1016/j.cub.2006.06.057; SALZMAN CD, 1992, J NEUROSCI, V12, P2331; SCHALL JD, 1995, J NEUROSCI, V15, P4464; Sherman SM, 2007, CURR OPIN NEUROBIOL, V17, P417, DOI 10.1016/j.conb.2007.07.003; Shipp S, 2003, PHILOS T R SOC B, V358, P1605, DOI 10.1098/rstb.2002.1213; Shmuel A, 2006, NAT NEUROSCI, V9, P569, DOI 10.1038/nn1675; Sincich LC, 2004, NAT NEUROSCI, V7, P1123, DOI 10.1038/nn1318; STANTON GB, 1995, J COMP NEUROL, V353, P291, DOI 10.1002/cne.903530210; Sultan F, 2007, MAGN RESON IMAGING, V25, P754, DOI 10.1016/j.mri.2007.03.014; Tehovnik EJ, 2005, J NEUROPHYSIOL, V93, P1, DOI 10.1152/jn.00736.2004; Tolias AS, 2005, NEURON, V48, P901, DOI 10.1016/j.neuron.2005.11.034	50	225	230	1	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2010	13	10					1283	1291		10.1038/nn.2631	http://dx.doi.org/10.1038/nn.2631			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	654MB	20818384				2022-12-17	WOS:000282171300022
J	Munch, TA; da Silveira, RA; Siegert, S; Viney, TJ; Awatramani, GB; Roska, B				Muench, Thomas A.; da Silveira, Rava Azeredo; Siegert, Sandra; Viney, Tim James; Awatramani, Gautam B.; Roska, Botond			Approach sensitivity in the retina processed by a multifunctional neural circuit	NATURE NEUROSCIENCE			English	Article							AII AMACRINE CELLS; LOOMING VISUAL-STIMULI; MAMMALIAN RETINA; GANGLION-CELLS; RABBIT RETINA; MOUSE RETINA; ELECTRICAL SYNAPSES; OBJECT APPROACH; BIPOLAR CELLS; CAT RETINA	The detection of approaching objects, such as looming predators, is necessary for survival. Which neurons and circuits mediate this function? We combined genetic labeling of cell types, two-photon microscopy, electrophysiology and theoretical modeling to address this question. We identify an approach-sensitive ganglion cell type in the mouse retina, resolve elements of its afferent neural circuit, and describe how these confer approach sensitivity on the ganglion cell. The circuit's essential building block is a rapid inhibitory pathway: it selectively suppresses responses to non-approaching objects. This rapid inhibitory pathway, which includes All amacrine cells connected to bipolar cells through electrical synapses, was previously described in the context of night-time vision. In the daytime conditions of our experiments, the same pathway conveys signals in the reverse direction. The dual use of a neural pathway in different physiological conditions illustrates the efficiency with which several functions can be accommodated in a single circuit.	[Muench, Thomas A.; Siegert, Sandra; Viney, Tim James; Awatramani, Gautam B.; Roska, Botond] Friedrich Miescher Inst Biomed Res, Neural Circuit Labs, Basel, Switzerland; [da Silveira, Rava Azeredo] Ecole Normale Super, Dept Phys, F-75231 Paris, France; [da Silveira, Rava Azeredo] Ecole Normale Super, Dept Cognit Studies, F-75231 Paris, France	Friedrich Miescher Institute for Biomedical Research; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Roska, B (corresponding author), Friedrich Miescher Inst Biomed Res, Neural Circuit Labs, Basel, Switzerland.	botond.roska@fmi.ch	Roska, Botond/AAD-7268-2021; Siegert, Sandra/GWC-4507-2022	Siegert, Sandra/0000-0001-8635-0877; Munch, Thomas/0000-0002-8884-6961; Viney, Tim/0000-0001-6444-1188	Friedrich Miescher Institute; US Office of Naval Research Naval International Cooperative Opportunities in Science and Technology; Marie Curie Excellence Grant, a Human Frontier Science Program; National Centers of Competence in Research in Genetics; European Union [HEALTH-F2-223156]; Marie Curie Postdoctoral Fellowship; Centre National de la Recherche Scientifique through the Unite Mixte de Recherche [8550]	Friedrich Miescher Institute; US Office of Naval Research Naval International Cooperative Opportunities in Science and Technology; Marie Curie Excellence Grant, a Human Frontier Science Program; National Centers of Competence in Research in Genetics; European Union(European Commission); Marie Curie Postdoctoral Fellowship(European Commission); Centre National de la Recherche Scientifique through the Unite Mixte de Recherche(Centre National de la Recherche Scientifique (CNRS))	We are grateful to S. Arber ( Friedrich Miescher Institute), D. Paul ( Harvard Medical School) and J. Sanes ( Harvard University) for providing mouse lines and Robert Margolskee ( Mount Sinai School of Medicine) for providing the G.13 antibody. We are grateful for the technical assistance of S. Djaffer, B. Gross Scherf and Y. Shimada. We thank members of the Roska lab, P. Lagali, P. Caroni, R. Friedrich and A. Luthi for comments on the manuscript. The study was supported by Friedrich Miescher Institute funds, a US Office of Naval Research Naval International Cooperative Opportunities in Science and Technology program grant, a Marie Curie Excellence Grant, a Human Frontier Science Program Young Investigator grant, a National Centers of Competence in Research in Genetics grant and a European Union HEALTH-F2-223156 grant to B. R., a Marie Curie Postdoctoral Fellowship to T. A. M., the Centre National de la Recherche Scientifique through the Unite Mixte de Recherche 8550 to R.A.d.S.	BALL W, 1971, SCIENCE, V171, P818, DOI 10.1126/science.171.3973.818; BELGUM JH, 1987, J PHYSIOL-LONDON, V388, P233, DOI 10.1113/jphysiol.1987.sp016612; Bloomfield SA, 2001, PROG RETIN EYE RES, V20, P351, DOI 10.1016/S1350-9462(00)00031-8; Bradley DC, 2008, NAT REV NEUROSCI, V9, P686, DOI 10.1038/nrn2472; Buffelli M, 2003, NATURE, V424, P430, DOI 10.1038/nature01844; Cohen ED, 1999, BRAIN RES, V831, P206, DOI 10.1016/S0006-8993(99)01448-1; Deans MR, 2001, NEURON, V31, P477, DOI 10.1016/S0896-6273(01)00373-7; Feigenspan A, 2001, J NEUROSCI, V21, P230, DOI 10.1523/JNEUROSCI.21-01-00230.2001; Franconeri SL, 2003, PERCEPT PSYCHOPHYS, V65, P999, DOI 10.3758/BF03194829; Fried SI, 2002, NATURE, V420, P411, DOI 10.1038/nature01179; Gabbiani F, 2005, J NEUROPHYSIOL, V94, P2150, DOI 10.1152/jn.00411.2005; Gabbiani F, 1999, J NEUROSCI, V19, P1122; Geraghty RJ, 1998, SCIENCE, V280, P1618, DOI 10.1126/science.280.5369.1618; GREFERATH U, 1990, J COMP NEUROL, V301, P433, DOI 10.1002/cne.903010308; HATSOPOULOS N, 1995, SCIENCE, V270, P1000, DOI 10.1126/science.270.5238.1000; Haverkamp S, 2000, J COMP NEUROL, V424, P1; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Huang LQ, 2003, J COMP NEUROL, V455, P1, DOI 10.1002/cne.10396; Huberman AD, 2008, NEURON, V59, P425, DOI 10.1016/j.neuron.2008.07.018; Ishikane H, 2005, NAT NEUROSCI, V8, P1087, DOI 10.1038/nn1497; Kim IJ, 2008, NATURE, V452, P478, DOI 10.1038/nature06739; King JG, 1999, BRAIN RES, V841, P20, DOI 10.1016/S0006-8993(99)01764-3; KING SM, 1992, NEUROPSYCHOLOGIA, V30, P1017, DOI 10.1016/0028-3932(92)90053-O; KING SM, 1992, PERCEPTION, V21, P245, DOI 10.1068/p210245; Manookin MB, 2008, J NEUROSCI, V28, P4136, DOI 10.1523/JNEUROSCI.4274-07.2008; Massey SC, 2003, CELL COMMUN ADHES, V10, P425, DOI 10.1080/15419060390264343; MCGUIRE BA, 1986, J NEUROSCI, V6, P907; Metzger D, 1999, CURR OPIN BIOTECH, V10, P470, DOI 10.1016/S0958-1669(99)00012-9; Mills SL, 2001, J COMP NEUROL, V436, P336; Murphy GJ, 2008, NAT NEUROSCI, V11, P318, DOI 10.1038/nn2045; Olveczky BP, 2003, NATURE, V423, P401, DOI 10.1038/nature01652; OYSTER CW, 1968, J PHYSIOL-LONDON, V199, P613, DOI 10.1113/jphysiol.1968.sp008671; Pang JJ, 2007, J PHYSIOL-LONDON, V580, P397, DOI 10.1113/jphysiol.2006.120790; POURCHO RG, 1985, J COMP NEUROL, V233, P473, DOI 10.1002/cne.902330406; Rice DS, 2000, J COMP NEUROL, V424, P327, DOI 10.1002/1096-9861(20000821)424:2<327::AID-CNE10>3.0.CO;2-6; Roska B, 1998, J NEUROSCI, V18, P3451; Roska B, 2001, NATURE, V410, P583, DOI 10.1038/35069068; Roska B, 2006, J NEUROPHYSIOL, V95, P3810, DOI 10.1152/jn.00113.2006; SCHIFF W, 1962, SCIENCE, V136, P982, DOI 10.1126/science.136.3520.982; SLAUGHTER MM, 1981, SCIENCE, V211, P182, DOI 10.1126/science.6255566; Sun HJ, 1998, NAT NEUROSCI, V1, P296, DOI 10.1038/1110; Veruki ML, 2002, J NEUROSCI, V22, P10558; Volgyi B, 2002, J PHYSIOL-LONDON, V539, P603, DOI 10.1013/jphysiol.2001.013133; WALDECK RF, 1995, BRAIN BEHAV EVOLUT, V46, P84, DOI 10.1159/000113261; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; Xin DY, 1999, VISUAL NEUROSCI, V16, P653, DOI 10.1017/S0952523899164058	46	225	226	0	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2009	12	10					1308	U135		10.1038/nn.2389	http://dx.doi.org/10.1038/nn.2389			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	498US	19734895				2022-12-17	WOS:000270170200020
J	Nauhaus, I; Busse, L; Carandini, M; Ringach, DL				Nauhaus, Ian; Busse, Laura; Carandini, Matteo; Ringach, Dario L.			Stimulus contrast modulates functional connectivity in visual cortex	NATURE NEUROSCIENCE			English	Article							MACAQUE V1 NEURONS; ORIENTATION SELECTIVITY; HORIZONTAL CONNECTIONS; RECEPTIVE-FIELD; SIMPLE CELLS; CROSS-CORRELATION; THALAMIC INPUT; SPIKE TRAINS; INTEGRATION; INHIBITION	Neurons in visual cortex are linked by an extensive network of lateral connections. To study the effect of these connections on neural responses, we recorded spikes and local field potentials (LFPs) from multi-electrode arrays that were implanted in monkey and cat primary visual cortex. Spikes at each location generated outward traveling LFP waves. When the visual stimulus was absent or had low contrast, these LFP waves had large amplitudes and traveled over long distances. Their effect was strong: LFP traces at any site could be predicted by the superposition of waves that were evoked by spiking in a similar to 1.5- mm radius. As stimulus contrast increased, both the magnitude and the distance traveled by the waves progressively decreased. We conclude that the relative weight of feedforward and lateral inputs in visual cortex is not fixed, but rather depends on stimulus contrast. Lateral connections dominate at low contrast, when spatial integration of signals is perhaps most beneficial.	[Nauhaus, Ian; Ringach, Dario L.] Univ Calif Los Angeles, Dept Biomed Engn, Los Angeles, CA 90095 USA; [Busse, Laura; Carandini, Matteo] Smith Kettlewell Eye Res Inst, San Francisco, CA 94115 USA; [Carandini, Matteo] UCL, Inst Ophthalmol, London EC1V 9EL, England; [Ringach, Dario L.] Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA; [Ringach, Dario L.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; The Smith-Kettlewell Eye Research Institute; University of London; University College London; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Nauhaus, I (corresponding author), Univ Calif Los Angeles, Dept Biomed Engn, 405 Hilgard Ave, Los Angeles, CA 90095 USA.	inauhaus@gmail.com	Carandini, Matteo/ABD-8296-2021	Carandini, Matteo/0000-0003-4880-7682	US National Institutes of Health [EY-17396, EY-12816, EY-18322]; DARPA [FA8650-06-C-7633]; Oppenheimer/Stein Endowment Award; McKnight Endowment Fund; Leopoldina [BMBF-LPD9901/8165]; NATIONAL EYE INSTITUTE [R01EY017396, R01EY018322, R01EY012816] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Oppenheimer/Stein Endowment Award; McKnight Endowment Fund; Leopoldina; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We are grateful to B. Malone, A. Benucci and S. Katzner for help with data collection and valuable discussions. This work was supported by grants from the US National Institutes of Health (EY-17396 to M. C., EY-12816 and EY-18322 to D. L. R.) and DARPA (FA8650-06-C-7633 to D. L. R.), an Oppenheimer/Stein Endowment Award (D. L. R.), a Scholar Award from the McKnight Endowment Fund for Neuroscience (M. C.) and a Leopoldina fellowship (BMBF-LPD9901/8165 to L. B.). M. C. holds the GlaxoSmithKline/Fight for Sight Chair in Visual Neuroscience.	AERTSEN AMHJ, 1985, BRAIN RES, V340, P341, DOI 10.1016/0006-8993(85)90931-X; ALLMAN J, 1985, ANNU REV NEUROSCI, V8, P407, DOI 10.1146/annurev.ne.08.030185.002203; Angelucci A, 2002, J NEUROSCI, V22, P8633; Benucci A, 2007, NEURON, V55, P103, DOI 10.1016/j.neuron.2007.06.017; BERNANDER O, 1991, P NATL ACAD SCI USA, V88, P11569, DOI 10.1073/pnas.88.24.11569; Bosking WH, 1997, J NEUROSCI, V17, P2112; Bringuier V, 1999, SCIENCE, V283, P695, DOI 10.1126/science.283.5402.695; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2530, DOI 10.1152/jn.00692.2001; Chen YZ, 2006, NAT NEUROSCI, V9, P1412, DOI 10.1038/nn1792; Chung S, 1998, NEURON, V20, P1177, DOI 10.1016/S0896-6273(00)80498-5; de la Rocha J, 2007, NATURE, V448, P802, DOI 10.1038/nature06028; Destexhe A, 1999, J NEUROPHYSIOL, V81, P1531, DOI 10.1152/jn.1999.81.4.1531; Dorn JD, 2003, J NEUROPHYSIOL, V89, P2271, DOI 10.1152/jn.000889.2002; Douglas RJ, 2007, CURR BIOL, V17, pR496, DOI 10.1016/j.cub.2007.04.024; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; Ferster D, 1996, NATURE, V380, P249, DOI 10.1038/380249a0; Finn IM, 2007, NEURON, V54, P137, DOI 10.1016/j.neuron.2007.02.029; GILBERT CD, 1983, J NEUROSCI, V3, P1116; GRINVALD A, 1994, J NEUROSCI, V14, P2545; HIRSCH JA, 1991, J NEUROSCI, V11, P1800; HOFFMANN KP, 1971, BRAIN RES, V32, P460, DOI 10.1016/0006-8993(71)90340-4; Jin JZ, 2008, NAT NEUROSCI, V11, P88, DOI 10.1038/nn2029; KATZNER S, NEURON IN PRESS; Kenet T, 2003, NATURE, V425, P954, DOI 10.1038/nature02078; KITANO M, 1994, VISUAL NEUROSCI, V11, P953, DOI 10.1017/S0952523800003904; Kohn A, 2005, J NEUROSCI, V25, P3661, DOI 10.1523/JNEUROSCI.5106-04.2005; Lampl I, 1999, NEURON, V22, P361, DOI 10.1016/S0896-6273(00)81096-X; Levitt JB, 1997, NATURE, V387, P73, DOI 10.1038/387073a0; Nowak LG, 1999, J NEUROPHYSIOL, V81, P1057, DOI 10.1152/jn.1999.81.3.1057; Polat U, 1998, NATURE, V391, P580, DOI 10.1038/35372; Priebe NJ, 2008, NEURON, V57, P482, DOI 10.1016/j.neuron.2008.02.005; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Ringach DL, 1997, NATURE, V387, P281, DOI 10.1038/387281a0; Sceniak MP, 1999, NAT NEUROSCI, V2, P733, DOI 10.1038/11197; Shapley R, 2003, NEURON, V38, P689, DOI 10.1016/S0896-6273(03)00332-5; Sompolinsky H, 1997, CURR OPIN NEUROBIOL, V7, P514, DOI 10.1016/S0959-4388(97)80031-1; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Tsodyks M, 1999, SCIENCE, V286, P1943, DOI 10.1126/science.286.5446.1943; WELIKY M, 1995, NEURON, V15, P541, DOI 10.1016/0896-6273(95)90143-4	39	225	225	1	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2009	12	1					70	76		10.1038/nn.2232	http://dx.doi.org/10.1038/nn.2232			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	388HL	19029885	Green Accepted			2022-12-17	WOS:000262010800017
J	Ofen, N; Kao, YC; Sokol-Hessner, P; Kim, H; Whitfield-Gabrieli, S; Gabrieli, JDE				Ofen, Noa; Kao, Yun-Ching; Sokol-Hessner, Peter; Kim, Heesoo; Whitfield-Gabrieli, Susan; Gabrieli, John D. E.			Development of the declarative memory system in the human brain	NATURE NEUROSCIENCE			English	Article							CEREBRAL FUNCTIONAL-ORGANIZATION; COMMON STEREOTACTIC SPACE; TEMPORAL-LOBE; CORTICAL DEVELOPMENT; STRUCTURAL MRI; FRONTAL-CORTEX; BOLD FMRI; CHILDREN; CHILDHOOD; ADULTS	Brain regions that are involved in memory formation, particularly medial temporal lobe ( MTL) structures and lateral prefrontal cortex ( PFC), have been identified in adults, but not in children. We investigated the development of brain regions involved in memory formation in 49 children and adults ( ages 8-24), who studied scenes during functional magnetic resonance imaging. Recognition memory for vividly recollected scenes improved with age. There was greater activation for subsequently remembered scenes than there was for forgotten scenes in MTL and PFC regions. These activations increased with age in specific PFC, but not in MTL, regions. PFC, but not MTL, activations correlated with developmental gains in memory for details of experiences. Voxel-based morphometry indicated that gray matter volume in PFC, but not in MTL, regions reduced with age. These results suggest that PFC regions that are important for the formation of detailed memories for experiences have a prolonged maturational trajectory.	Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; NYU, Dept Psychol, New York, NY 10003 USA; Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	Stanford University; Harvard University; New York University; University of California System; University of California Berkeley	Ofen, N (corresponding author), Stanford Univ, Dept Psychol, Jordan Hall,Bldg 420, Stanford, CA 94305 USA.	noa@mit.edu	Gabrieli, John/AAJ-2869-2020	Ofen, Noa/0000-0003-3927-8408				Aguirre GK, 1998, NEUROIMAGE, V8, P360, DOI 10.1006/nimg.1998.0369; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Billingsley RL, 2002, J EXP CHILD PSYCHOL, V82, P251, DOI 10.1016/S0022-0965(02)00007-3; Brewer JB, 1998, SCIENCE, V281, P1185, DOI 10.1126/science.281.5380.1185; Brown TT, 2005, CEREB CORTEX, V15, P275, DOI 10.1093/cercor/bhh129; Buckner RL, 1999, NAT NEUROSCI, V2, P311, DOI 10.1038/7221; Buckner RL, 2000, J COGNITIVE NEUROSCI, V12, P24, DOI 10.1162/089892900564046; Bunge SA, 2002, NEURON, V33, P301, DOI 10.1016/S0896-6273(01)00583-9; Burgund ED, 2002, NEUROIMAGE, V17, P184, DOI 10.1006/nimg.2002.1174; Casey BJ, 2005, CURR OPIN NEUROBIOL, V15, P239, DOI 10.1016/j.conb.2005.03.012; Chiu CYP, 2006, DEV NEUROPSYCHOL, V29, P321, DOI 10.1207/s15326942dn2902_3; Cycowicz YM, 2003, J COGNITIVE NEUROSCI, V15, P759, DOI 10.1162/jocn.2003.15.5.759; Cycowicz YM, 2001, NEUROPSYCHOLOGIA, V39, P255, DOI 10.1016/S0028-3932(00)00108-1; Czernochowski D, 2005, COGN AFFECT BEHAV NE, V5, P417, DOI 10.3758/CABN.5.4.417; D'Esposito M, 2003, NAT REV NEUROSCI, V4, P863, DOI 10.1038/nrn1246; Davachi L, 2003, P NATL ACAD SCI USA, V100, P2157, DOI 10.1073/pnas.0337195100; Davis TL, 1998, P NATL ACAD SCI USA, V95, P1834, DOI 10.1073/pnas.95.4.1834; DIRKS J, 1977, J EXP CHILD PSYCHOL, V23, P315, DOI 10.1016/0022-0965(77)90108-4; Drummey AB, 2002, DEVELOPMENTAL SCI, V5, P502, DOI 10.1111/1467-7687.00243; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Giedd JN, 1996, J COMP NEUROL, V366, P223, DOI 10.1002/(SICI)1096-9861(19960304)366:2<223::AID-CNE3>3.0.CO;2-7; Glover GH, 2001, MAGNET RESON MED, V46, P515, DOI 10.1002/mrm.1222; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Gogtay N, 2006, HIPPOCAMPUS, V16, P664, DOI 10.1002/hipo.20193; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Goswami U, 2006, NAT REV NEUROSCI, V7, P406, DOI 10.1038/nrn1907; HUTTENLOCHER PR, 1979, BRAIN RES, V163, P195; JANOWSKY JS, 1989, NEUROPSYCHOLOGIA, V27, P1043, DOI 10.1016/0028-3932(89)90184-X; Kang HC, 2003, NEUROIMAGE, V19, P16, DOI 10.1016/S1053-8119(03)00038-7; KNOWLTON BJ, 1995, J EXP PSYCHOL LEARN, V21, P699, DOI 10.1037/0278-7393.21.3.699; MANDLER JM, 1978, J EXP CHILD PSYCHOL, V26, P122, DOI 10.1016/0022-0965(78)90114-5; Menon V, 2005, COGNITIVE BRAIN RES, V25, P379, DOI 10.1016/j.cogbrainres.2005.07.007; Miezin FM, 2000, NEUROIMAGE, V11, P735, DOI 10.1006/nimg.2000.0568; Ranganath C, 2004, NEUROPSYCHOLOGIA, V42, P2, DOI 10.1016/j.neuropsychologia.2003.07.006; SCHACTER DL, 1984, J VERB LEARN VERB BE, V23, P593, DOI 10.1016/S0022-5371(84)90373-6; Schlaggar BL, 2002, SCIENCE, V296, P1476, DOI 10.1126/science.1069464; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Shaw P, 2006, NATURE, V440, P676, DOI 10.1038/nature04513; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; Sowell ER, 1998, DEV NEUROPSYCHOL, V14, P599, DOI 10.1080/87565649809540731; Sowell ER, 2004, J NEUROSCI, V24, P8223, DOI 10.1523/JNEUROSCI.1798-04.2004; Sowell ER, 2002, DEV MED CHILD NEUROL, V44, P4, DOI 10.1017/S0012162201001591; Sowell ER, 2001, J INT NEUROPSYCH SOC, V7, P312, DOI 10.1017/S135561770173305X; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Stern CE, 1996, P NATL ACAD SCI USA, V93, P8660, DOI 10.1073/pnas.93.16.8660; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; Wig GS, 2004, J COGNITIVE NEUROSCI, V16, P139, DOI 10.1162/089892904322755629; Wilke M, 2003, MAGN RESON MED, V50, P749, DOI 10.1002/mrm.10606; YONELINAS AP, 1995, PSYCHOL RES-PSYCH FO, V57, P156, DOI 10.1007/BF00431277	49	225	228	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2007	10	9					1198	1205		10.1038/nn1950	http://dx.doi.org/10.1038/nn1950			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	205VZ	17676059				2022-12-17	WOS:000249144000023
J	Hirai, H; Pang, Z; Bao, DH; Miyazaki, T; Li, LY; Miura, E; Parris, J; Rong, YQ; Watanabe, M; Yuzaki, M; Morgan, JI				Hirai, H; Pang, Z; Bao, DH; Miyazaki, T; Li, LY; Miura, E; Parris, J; Rong, YQ; Watanabe, M; Yuzaki, M; Morgan, JI			Cbln1 is essential for synaptic integrity and plasticity in the cerebellum	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; CLIMBING FIBER INNERVATION; GLUTAMATE-RECEPTOR DELTA-2; GAMMA MUTANT MICE; PURKINJE-CELLS; MOTOR COORDINATION; MULTIPLE INNERVATION; PRECEREBELLIN; LACKING; GLUR-DELTA-2	Cbln1 is a cerebellum-specific protein of previously unknown function that is structurally related to the C1q and tumor necrosis factor families of proteins. We show that Cbln1 is a glycoprotein secreted from cerebellar granule cells that is essential for three processes in cerebellar Purkinje cells: the matching and maintenance of pre- and postsynaptic elements at parallel fiber-Purkinje cell synapses, the establishment of the proper pattern of climbing fiber-Purkinje cell innervation, and induction of long-term depression at parallel fiber-Purkinje cell synapses. Notably, the phenotype of cbln1-null mice mimics loss-of-function mutations in the orphan glutamate receptor, GluR delta 2, a gene selectively expressed in Purkinje neurons. Therefore, Cbln1 secreted from presynaptic granule cells may be a component of a transneuronal signaling pathway that controls synaptic structure and plasticity.	St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; Hokkaido Univ, Sch Med, Dept Anat, Sapporo, Hokkaido 0608638, Japan	St Jude Children's Research Hospital; Hokkaido University	Yuzaki, M (corresponding author), Keio Univ, Sch Med, Dept Physiol, Tokyo 1608582, Japan.	myuzaki@sc.itc.keio.ac.jp; jim.morgan@stjude.org	Hirai, Hirokazu/ABP-1143-2022; Yuzaki, Michisuke/K-5328-2013; Morgan, James/GRO-2905-2022; WATANABE, Masahiko/A-4055-2012; Watanabe, Masahiko/S-3614-2019; Morgan, James/N-8104-2018; Miyazaki, Taisuke/C-8685-2012	Yuzaki, Michisuke/0000-0002-5750-3544; Morgan, James/0000-0002-8920-1065; WATANABE, Masahiko/0000-0001-5037-7138; Watanabe, Masahiko/0000-0001-5037-7138; Hirai, Hirokazu/0000-0002-0721-4293	NCI NIH HHS [CA 21765] Funding Source: Medline; NIEHS NIH HHS [ES10772] Funding Source: Medline; NINDS NIH HHS [NS040749, NS042828, NS040361] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010772] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040749, R01NS040361] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; BENOIT P, 1984, DEV BRAIN RES, V14, P310, DOI 10.1016/0165-3806(84)90320-1; Chen C, 1995, CELL, V83, P1233, DOI 10.1016/0092-8674(95)90148-5; CREPEL F, 1976, J NEUROBIOL, V7, P567, DOI 10.1002/neu.480070609; Furuya S, 1998, BRAIN RES PROTOC, V3, P192, DOI 10.1016/S1385-299X(98)00040-3; Hashimoto K, 2001, J NEUROSCI, V21, P9701, DOI 10.1523/JNEUROSCI.21-24-09701.2001; Hawkes R, 1995, J MOL NEUROSCI, V6, P147, DOI 10.1007/BF02736761; Ichikawa R, 2002, J NEUROSCI, V22, P8487; ITO M, 1989, ANNU REV NEUROSCI, V12, P85, DOI 10.1146/annurev.neuro.12.1.85; Kano M, 1995, CELL, V83, P1223, DOI 10.1016/0092-8674(95)90147-7; Kano M, 1997, NEURON, V18, P71, DOI 10.1016/S0896-6273(01)80047-7; KASHIWABUCHI N, 1995, CELL, V81, P245, DOI 10.1016/0092-8674(95)90334-8; KAVETY B, 1994, MOL BRAIN RES, V27, P152, DOI 10.1016/0169-328X(94)90196-1; Kishore U, 2004, TRENDS IMMUNOL, V25, P551, DOI 10.1016/j.it.2004.08.006; Kohda K, 2000, NAT NEUROSCI, V3, P315, DOI 10.1038/73877; Kurihara H, 1997, J NEUROSCI, V17, P9613; Lalouette A, 2001, NEUROSCIENCE, V105, P443, DOI 10.1016/S0306-4522(01)00193-2; LevRam V, 1997, NEURON, V18, P1025, DOI 10.1016/S0896-6273(00)80340-2; LOMELI H, 1993, FEBS LETT, V315, P318, DOI 10.1016/0014-5793(93)81186-4; Matsumoto M, 2000, INORG REACT MECH, V2, P19; Morando L, 2001, P NATL ACAD SCI USA, V98, P9954, DOI 10.1073/pnas.171098398; MORGAN JI, 1988, SYNAPSE, V2, P117, DOI 10.1002/syn.890020203; MUGNAINI E, 1988, SYNAPSE, V2, P125, DOI 10.1002/syn.890020204; OBERDICK J, 1990, SCIENCE, V248, P223, DOI 10.1126/science.2109351; Pang Z, 2000, J NEUROSCI, V20, P6333, DOI 10.1523/JNEUROSCI.20-17-06333.2000; Rhyu IJ, 1999, NEUROSCIENCE, V90, P717, DOI 10.1016/S0306-4522(98)00518-1; SLEMMON JR, 1984, P NATL ACAD SCI-BIOL, V81, P6866, DOI 10.1073/pnas.81.21.6866; SOTELO C, 1990, J EXP BIOL, V153, P225; URADE Y, 1991, P NATL ACAD SCI USA, V88, P1069, DOI 10.1073/pnas.88.3.1069; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; Watanabe D, 1998, CELL, V95, P17, DOI 10.1016/S0092-8674(00)81779-1; Yuzaki M, 2003, NEUROSCI RES, V46, P11, DOI 10.1016/S0168-0102(03)00036-1; ZIAI MR, 1988, J NEUROCHEM, V51, P1771, DOI 10.1111/j.1471-4159.1988.tb01158.x	33	225	236	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2005	8	11					1534	1541		10.1038/nn1576	http://dx.doi.org/10.1038/nn1576			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	979TB	16234806				2022-12-17	WOS:000232966600028
J	Pegan, S; Arrabit, C; Zhou, W; Kwiatkowski, W; Collins, A; Slesinger, PA; Choe, S				Pegan, S; Arrabit, C; Zhou, W; Kwiatkowski, W; Collins, A; Slesinger, PA; Choe, S			Cytoplasmic domain structures of Kir2.1 and Kir3.1 show sites for modulating gating and rectification	NATURE NEUROSCIENCE			English	Article							RECTIFIER K+ CHANNELS; INWARD-RECTIFIER; POTASSIUM CHANNEL; ANDERSENS-SYNDROME; INTRACELLULAR VESTIBULE; SELECTIVITY FILTER; C-TERMINUS; PORE; PERMEATION; MECHANISM	N- and C-terminal cytoplasmic domains of inwardly rectifying K (Kir) channels control the ion-permeation pathway through diverse interactions with small molecules and protein ligands in the cytoplasm. Two new crystal structures of the cytoplasmic domains of Kir2.1 (Kir2.1(L)) and the G protein-sensitive Kir3.1 (Kir3.1(S)) channels in the absence of PIP2 show the cytoplasmic ion-permeation pathways occluded by four cytoplasmic loops that form a girdle around the central pore (G-loop). Significant flexibility of the pore-facing G-loop of Kir2.1(L) and Kir3.1(S) suggests a possible role as a diffusion barrier between cytoplasmic and transmembrane pores. Consistent with this, mutations of the G-loop disrupted gating or inward rectification. Structural comparison shows a di-aspartate cluster on the distal end of the cytoplasmic pore of Kir2.1(L) that is important for modulating inward rectification. Taken together, these results suggest the cytoplasmic domains of Kir channels undergo structural changes to modulate gating and inward rectification.	Salk Inst Biol Studies, Struct Biol Lab, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Peptide Biol Lab, La Jolla, CA 92037 USA; Oregon State Univ, Coll Pharm, Dept Pharmaceut Sci, Corvallis, OR 97331 USA	Salk Institute; Salk Institute; Oregon State University	Choe, S (corresponding author), Salk Inst Biol Studies, Struct Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	slesinger@salk.edu; choe@salk.edu						Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; Bendahhou S, 2003, J BIOL CHEM, V278, P51779, DOI 10.1074/jbc.M310278200; Chang HK, 2005, BIOPHYS J, V88, P243, DOI 10.1529/biophysj.104.052217; Chen L, 2002, P NATL ACAD SCI USA, V99, P8430, DOI 10.1073/pnas.122682899; Clancy SM, 2005, MOL CELL NEUROSCI, V28, P375, DOI 10.1016/j.mcn.2004.10.009; Cohen NA, 1996, NEURON, V17, P759, DOI 10.1016/S0896-6273(00)80207-X; Corey S, 1998, J BIOL CHEM, V273, P27499, DOI 10.1074/jbc.273.42.27499; Derst C, 1997, BIOCHEM BIOPH RES CO, V230, P641, DOI 10.1006/bbrc.1996.6024; Doring F, 1998, J NEUROSCI, V18, P8625; Fakler B, 1996, PFLUG ARCH EUR J PHY, V433, P77, DOI 10.1007/s004240050251; Garneau L, 2003, BIOPHYS J, V84, P3717, DOI 10.1016/S0006-3495(03)75100-5; Guo Y, 2002, J BIOL CHEM, V277, P48289, DOI 10.1074/jbc.M207987200; Hilgemann Donald W., 1995, P307; Hosaka Y, 2003, J MOL CELL CARDIOL, V35, P409, DOI 10.1016/S0022-2828(03)00046-4; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; HUANG CL, 1995, NEURON, V15, P1133, DOI 10.1016/0896-6273(95)90101-9; Inanobe A, 1999, J NEUROSCI, V19, P1006; Ishihara K, 2004, J PHYSIOL-LONDON, V556, P61, DOI 10.1113/jphysiol.2003.055434; Ivanina T, 2004, J BIOL CHEM, V279, P17260, DOI 10.1074/jbc.M313425200; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; John SA, 2004, J GEN PHYSIOL, V123, P623, DOI 10.1085/jgp.200409017; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; Kubo Y, 2001, J PHYSIOL-LONDON, V531, P645, DOI 10.1111/j.1469-7793.2001.0645h.x; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; Lopes CMB, 2002, NEURON, V34, P933, DOI 10.1016/S0896-6273(02)00725-0; Lu T, 1999, P NATL ACAD SCI USA, V96, P9926, DOI 10.1073/pnas.96.17.9926; Lu T, 1999, NEURON, V22, P571, DOI 10.1016/S0896-6273(00)80711-4; Lu T, 2001, NAT NEUROSCI, V4, P239, DOI 10.1038/85080; LU Z, 1994, NATURE, V371, P243, DOI 10.1038/371243a0; MATSUDA H, 1987, NATURE, V325, P156, DOI 10.1038/325156a0; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; Nishida M, 2002, CELL, V111, P957, DOI 10.1016/S0092-8674(02)01227-8; Pearson WL, 1998, J GEN PHYSIOL, V112, P351, DOI 10.1085/jgp.112.3.351; Phillips LR, 2003, NEURON, V37, P953, DOI 10.1016/S0896-6273(03)00155-7; Plaster NM, 2001, CELL, V105, P511, DOI 10.1016/S0092-8674(01)00342-7; Preisig-Muller R, 2002, P NATL ACAD SCI USA, V99, P7774, DOI 10.1073/pnas.102609499; Proks P, 2003, EMBO REP, V4, P70, DOI 10.1038/embor708; Riven I, 2003, NEURON, V38, P225, DOI 10.1016/S0896-6273(03)00193-4; Roosild TP, 2004, TRENDS BIOCHEM SCI, V29, P39, DOI 10.1016/j.tibs.2003.11.008; Roosild TP, 2002, CELL, V109, P781, DOI 10.1016/S0092-8674(02)00768-7; Schulte U, 1998, J BIOL CHEM, V273, P34575, DOI 10.1074/jbc.273.51.34575; Shyng SL, 2000, J GEN PHYSIOL, V116, P599, DOI 10.1085/jgp.116.5.599; SIESINGER PA, 1996, NEURON, V16, P321; Signorini S, 1997, P NATL ACAD SCI USA, V94, P923, DOI 10.1073/pnas.94.3.923; Wickman K, 1998, NEURON, V20, P103, DOI 10.1016/S0896-6273(00)80438-9; Xiao J, 2003, NAT NEUROSCI, V6, P811, DOI 10.1038/nn1090; YANG J, 1995, NEURON, V14, P1047, DOI 10.1016/0896-6273(95)90343-7; Zhou W, 2004, NEURON, V41, P573, DOI 10.1016/S0896-6273(04)00045-5	50	225	234	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2005	8	3					279	287		10.1038/nn1411	http://dx.doi.org/10.1038/nn1411			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	902KL	15723059				2022-12-17	WOS:000227354600012
J	Rong, R; Ahn, JY; Huang, HL; Nagata, E; Kalman, D; Kapp, JA; Tu, JC; Worley, PF; Snyder, SH; Ye, KQ				Rong, R; Ahn, JY; Huang, HL; Nagata, E; Kalman, D; Kapp, JA; Tu, JC; Worley, PF; Snyder, SH; Ye, KQ			PI3 kinase enhancer-Homer complex couples mGluRI to PI3 kinase, preventing neuronal apoptosis	NATURE NEUROSCIENCE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; LONG-TERM POTENTIATION; GROUP-I; PHOSPHOINOSITIDE 3-KINASE; PHOSPHOLIPASE C-GAMMA-1; INOSITOL TRISPHOSPHATE; NUCLEAR GTPASE; PROTEIN; ACTIVATION; FAMILY	Phosphoinositide 3 kinase enhancer (PIKE) is a recently identified nuclear GTPase that activates nuclear phosphoinositide 3-kinase (PI3 kinase). We have identified, cloned and characterized a new form of PIKE, designated PIKE-L, which, unlike the nuclear PIKE-S, localizes to both the cytoplasm and the nucleus. We demonstrate physiologic binding of PIKE-L to Homer, an adaptor protein known to link metabotropic glutamate receptors to multiple intracellular targets including the inositol 1,4,5-trisphosphate receptor (IP3R). We show that activation of group I metabotropic glutamate receptors (mGluRIs) enhances formation of an mGluRI-Homer-PIKE-L complex, leading to activation of PI3 kinase activity and prevention of neuronal apoptosis. Our findings indicate that this complex mediates the well-known ability of agonists of mGluRI to prevent neuronal apoptosis.	Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Emory University; Johns Hopkins University	Ye, KQ (corresponding author), Emory Univ, Sch Med, Dept Pathol & Lab Med, Room 145,Whitehead Bldg,615 Michael St, Atlanta, GA 30322 USA.	kye@emory.edu	huang, Honglian/E-8679-2010		NINDS NIH HHS [R01 NS045627] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045627] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AIBA A, 1994, CELL, V79, P365, DOI 10.1016/0092-8674(94)90204-6; AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; Allen JW, 1999, NEUROPHARMACOLOGY, V38, P1243, DOI 10.1016/S0028-3908(99)00044-1; Allen JW, 2000, CELL DEATH DIFFER, V7, P470, DOI 10.1038/sj.cdd.4400678; Ango F, 2001, NATURE, V411, P962, DOI 10.1038/35082096; Anneser JMH, 1998, NEUROREPORT, V9, P2039; Beneken J, 2000, NEURON, V26, P143, DOI 10.1016/S0896-6273(00)81145-9; Bernstein HG, 1998, CELL MOL BIOL, V44, P973; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; CONQUET F, 1994, NATURE, V372, P237, DOI 10.1038/372237a0; COPANI A, 1995, J NEUROCHEM, V64, P101; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; De Blasi A, 2001, TRENDS PHARMACOL SCI, V22, P114, DOI 10.1016/S0165-6147(00)01635-7; Fagni L, 2000, TRENDS NEUROSCI, V23, P80, DOI 10.1016/S0166-2236(99)01492-7; Fagni Laurent, 2002, Sci STKE, V2002, pre8, DOI 10.1126/stke.2002.137.re8; Ferraguti F, 1999, EUR J NEUROSCI, V11, P2073, DOI 10.1046/j.1460-9568.1999.00626.x; Finch EA, 1998, NATURE, V396, P753, DOI 10.1038/25541; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; HUANG PS, 1995, FEBS LETT, V358, P287, DOI 10.1016/0014-5793(94)01453-8; Inoue T, 1998, J NEUROSCI, V18, P5366, DOI 10.1523/JNEUROSCI.18-14-05366.1998; Jackson TR, 2000, TRENDS BIOCHEM SCI, V25, P489, DOI 10.1016/S0968-0004(00)01644-3; Kandel ES, 1999, EXP CELL RES, V253, P210, DOI 10.1006/excr.1999.4690; KASONO K, 1995, NEUROREPORT, V6, P569, DOI 10.1097/00001756-199502000-00040; Khodakhah K, 1997, BIOPHYS J, V73, P3349, DOI 10.1016/S0006-3495(97)78359-0; Leopoldt D, 1998, J BIOL CHEM, V273, P7024, DOI 10.1074/jbc.273.12.7024; LopezIlasaca M, 1997, SCIENCE, V275, P394, DOI 10.1126/science.275.5298.394; Lu YM, 1997, J NEUROSCI, V17, P5196; Maiese K, 1999, NEUROSCI LETT, V264, P17, DOI 10.1016/S0304-3940(99)00199-8; Maiese K, 2000, J NEUROSCI RES, V62, P257, DOI 10.1002/1097-4547(20001015)62:2<257::AID-JNR10>3.0.CO;2-H; Naisbitt S, 1999, NEURON, V23, P569, DOI 10.1016/S0896-6273(00)80809-0; PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1, DOI 10.1016/0028-3908(94)00129-G; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; SMITH MR, 1994, P NATL ACAD SCI USA, V91, P6554, DOI 10.1073/pnas.91.14.6554; Stoyanova S, 1997, BIOCHEM J, V324, P489, DOI 10.1042/bj3240489; Tang XW, 1997, J BIOL CHEM, V272, P14193, DOI 10.1074/jbc.272.22.14193; Troy CM, 2001, J NEUROSCI, V21, P5007, DOI 10.1523/JNEUROSCI.21-14-05007.2001; Tu JC, 1998, NEURON, V21, P717, DOI 10.1016/S0896-6273(00)80589-9; Tu JC, 1999, NEURON, V23, P583, DOI 10.1016/S0896-6273(00)80810-7; Vincent AM, 2000, EXP NEUROL, V166, P65, DOI 10.1006/exnr.2000.7487; Xia CZ, 2003, MOL CELL BIOL, V23, P2476, DOI 10.1128/MCB.23.7.2476-2488.2003; Xiao B, 1998, NEURON, V21, P707, DOI 10.1016/S0896-6273(00)80588-7; Xiao B, 2000, CURR OPIN NEUROBIOL, V10, P370, DOI 10.1016/S0959-4388(00)00087-8; Ye KQ, 2000, CELL, V103, P919, DOI 10.1016/S0092-8674(00)00195-1; Ye KQ, 2002, NATURE, V415, P541, DOI 10.1038/415541a; Ye KQ, 1998, P NATL ACAD SCI USA, V95, P1601, DOI 10.1073/pnas.95.4.1601; Ye KQ, 1999, J NEUROSCI, V19, P10747, DOI 10.1523/JNEUROSCI.19-24-10747.1999	46	225	242	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2003	6	11					1153	1161		10.1038/nn1134	http://dx.doi.org/10.1038/nn1134			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	737KH	14528310				2022-12-17	WOS:000186229200014
J	Baker, CI; Behrmann, M; Olson, CR				Baker, CI; Behrmann, M; Olson, CR			Impact of learning on representation of parts and wholes in monkey inferotemporal cortex	NATURE NEUROSCIENCE			English	Article							INFERIOR TEMPORAL CORTEX; SHAPE REPRESENTATION; RECOGNITION MEMORY; PERIRHINAL NEURONS; ADULT MONKEYS; VISUAL IMAGES; MACAQUE; OBJECTS; FAMILIARITY; RESPONSES	Here we investigated the impact of visual discrimination training on neuronal responses to parts of images and to whole images in inferotemporal (IT) cortex. Monkeys were trained to discriminate among 'baton' stimuli consisting of discrete top and bottom parts joined by a vertical stem. With separate features at each end, we were able to manipulate the two parts of each baton independently. After training the monkeys, we used single-cell recording to compare neuronal responses to learned and unlearned batons. Responses to learned batons, though not enhanced in strength, were enhanced in selectivity for both individual parts and for whole batons. Whole-baton selectivity arose from a form of conjunctive encoding whereby two parts together exerted a greater influence on neuronal activity than predicted by the additive influence of each part considered individually. These results indicate a possible neural mechanism for holistic or configural effects in expert versus novice observers.	Ctr Neural Basis Cognit, Mellon Inst 115, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA; Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Carnegie Mellon University	Baker, CI (corresponding author), Ctr Neural Basis Cognit, Mellon Inst 115, 4400 5th Ave, Pittsburgh, PA 15213 USA.		Baker, Chris/P-8442-2019	Baker, Chris/0000-0001-6861-8964; Behrmann, Marlene/0000-0002-3814-1015	NATIONAL EYE INSTITUTE [R01EY011831] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY11831] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BAYLIS GC, 1987, EXP BRAIN RES, V65, P614; Bussey TJ, 2002, EUR J NEUROSCI, V15, P355, DOI 10.1046/j.0953-816x.2001.01850.x; Bussey TJ, 2002, EUR J NEUROSCI, V15, P365, DOI 10.1046/j.0953-816x.2001.01851.x; Desimone R, 1998, PHILOS T R SOC B, V353, P1245, DOI 10.1098/rstb.1998.0280; Desimone R, 1996, P NATL ACAD SCI USA, V93, P13494, DOI 10.1073/pnas.93.24.13494; DESIMONE R, 1984, J NEUROSCI, V4, P2051; Erickson CA, 1999, J NEUROSCI, V19, P10404; Erickson CA, 2000, NAT NEUROSCI, V3, P1143, DOI 10.1038/80664; Freedman DJ, 2001, SCIENCE, V291, P312, DOI 10.1126/science.291.5502.312; Freedman DJ, 2002, J NEUROPHYSIOL, V88, P929, DOI 10.1152/jn.2002.88.2.929; Gauthier I, 2002, J EXP PSYCHOL HUMAN, V28, P431, DOI 10.1037//0096-1523.28.2.431; Goldstone RL, 2000, J EXP PSYCHOL HUMAN, V26, P86, DOI 10.1037/0096-1523.26.1.86; Goldstone RL, 1998, ANNU REV PSYCHOL, V49, P585, DOI 10.1146/annurev.psych.49.1.585; Hasegawa I, 2002, NAT NEUROSCI, V5, P90, DOI 10.1038/nn0202-90; Kobatake E, 1998, J NEUROPHYSIOL, V80, P324, DOI 10.1152/jn.1998.80.1.324; LI L, 1993, J NEUROPHYSIOL, V69, P1918, DOI 10.1152/jn.1993.69.6.1918; LOGOTHETIS NK, 1995, CURR BIOL, V5, P552, DOI 10.1016/S0960-9822(95)00108-4; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; LOGOTHETIS NK, 1995, CEREB CORTEX, V3, P270; Messinger A, 2001, P NATL ACAD SCI USA, V98, P12239, DOI 10.1073/pnas.211431098; MILLER EK, 1991, SCIENCE, V254, P1377, DOI 10.1126/science.1962197; MIYASHITA Y, 1993, NEUROPSYCHOLOGIA, V31, P1119, DOI 10.1016/0028-3932(93)90036-Y; Murray EA, 1999, TRENDS COGN SCI, V3, P142, DOI 10.1016/S1364-6613(99)01303-0; Op de Beeck H, 2001, NAT NEUROSCI, V4, P1244, DOI 10.1038/nn767; Op De Beeck H, 2000, J COMP NEUROL, V426, P505, DOI 10.1002/1096-9861(20001030)426:4<505::AID-CNE1>3.0.CO;2-M; Pasupathy A, 2001, J NEUROPHYSIOL, V86, P2505, DOI 10.1152/jn.2001.86.5.2505; PERRETT DI, 1982, EXP BRAIN RES, V47, P329; SAKAI K, 1994, NEUROREPORT, V5, P829, DOI 10.1097/00001756-199403000-00023; SAKAI K, 1991, NATURE, V354, P152, DOI 10.1038/354152a0; Sheinberg DL, 2002, PERCEPTUAL LEARNING, P95; Sigala N, 2002, NATURE, V415, P318, DOI 10.1038/415318a; Tanaka J. W., 1997, PSYCHOL LEARN MOTIV, V36, P83, DOI DOI 10.1016/S0079-7421(08)60282-0; TANAKA JW, IN PRESS ANAL HOLIST; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; TANAKA K, 1991, J NEUROPHYSIOL, V66, P170, DOI 10.1152/jn.1991.66.1.170; Tsunoda K, 2001, NAT NEUROSCI, V4, P832, DOI 10.1038/90547; Vogels R, 1999, EUR J NEUROSCI, V11, P1239, DOI 10.1046/j.1460-9568.1999.00531.x; VOGELS R, 1994, EUR J NEUROSCI, V6, P1680, DOI 10.1111/j.1460-9568.1994.tb00560.x; Wallis G, 1999, TRENDS COGN SCI, V3, P22, DOI 10.1016/S1364-6613(98)01261-3; Xiang JZ, 1999, EUR J NEUROSCI, V11, P3715, DOI 10.1046/j.1460-9568.1999.00790.x; Xiang JZ, 1998, NEUROPHARMACOLOGY, V37, P657, DOI 10.1016/S0028-3908(98)00030-6; YAMANE S, 1988, EXP BRAIN RES, V73, P209, DOI 10.1007/BF00279674; Zar JH., 1999, BIOSTATISTICAL ANAL	43	225	227	0	17	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5	11					1210	1216		10.1038/nn960	http://dx.doi.org/10.1038/nn960			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	609CG	12379864	Green Published			2022-12-17	WOS:000178884600025
J	Mohajerani, MH; Chan, AW; Mohsenvand, M; LeDue, J; Liu, R; McVea, DA; Boyd, JD; Wang, YT; Reimers, M; Murphy, TH				Mohajerani, Majid H.; Chan, Allen W.; Mohsenvand, Mostafa; LeDue, Jeffrey; Liu, Rui; McVea, David A.; Boyd, Jamie D.; Wang, Yu Tian; Reimers, Mark; Murphy, Timothy H.			Spontaneous cortical activity alternates between motifs defined by regional axonal projections	NATURE NEUROSCIENCE			English	Article							MONKEY VISUAL-CORTEX; FUNCTIONAL ARCHITECTURE; DYNAMICS; STATE; FLUCTUATIONS; INTEGRATION; RESOLUTION; RESPONSES; NETWORKS; WAVES	Using millisecond-timescale voltage-sensitive dye imaging in lightly anesthetized or awake adult mice, we show that a palette of sensory-evoked and hemisphere-wide activity motifs are represented in spontaneous activity. These motifs can reflect multiple modes of sensory processing, including vision, audition and touch. We found similar cortical networks with direct cortical activation using channelrhodopsin-2. Regional analysis of activity spread indicated modality-specific sources, such as primary sensory areas, a common posterior-medial cortical sink where sensory activity was extinguished within the parietal association area and a secondary anterior medial sink within the cingulate and secondary motor cortices for visual stimuli. Correlation analysis between functional circuits and intracortical axonal projections indicated a common framework corresponding to long-range monosynaptic connections between cortical regions. Maps of intracortical monosynaptic structural connections predicted hemisphere-wide patterns of spontaneous and sensory-evoked depolarization. We suggest that an intracortical monosynaptic connectome shapes the ebb and flow of spontaneous cortical activity.	[Mohajerani, Majid H.; Chan, Allen W.; Mohsenvand, Mostafa; LeDue, Jeffrey; Liu, Rui; McVea, David A.; Boyd, Jamie D.; Murphy, Timothy H.] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; [Mohajerani, Majid H.; Chan, Allen W.; Mohsenvand, Mostafa; LeDue, Jeffrey; McVea, David A.; Boyd, Jamie D.; Wang, Yu Tian; Murphy, Timothy H.] Univ British Columbia, Brain Res Ctr, Vancouver, BC, Canada; [Chan, Allen W.; Wang, Yu Tian] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Chan, Allen W.; Wang, Yu Tian] Univ British Columbia, Vancouver Coastal Hlth Res Inst, Vancouver, BC, Canada; [Reimers, Mark] Virginia Commonwealth Univ, Dept Psychiat, Richmond, VA USA; [Murphy, Timothy H.] Univ British Columbia, Dep Cellular & Physiol Sci, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; Vancouver Coastal Health Research Institute; Virginia Commonwealth University; University of British Columbia	Murphy, TH (corresponding author), Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada.	thmurphy@mail.ubc.ca	Murphy, Timothy H/I-4982-2014; LeDue, Jeffrey/C-9230-2012; Murphy, Timothy/AAW-1975-2021; Chan, Allen/AAF-4718-2020; Wang, Yu Tian/J-8255-2015; Liu, Rui/AAC-5111-2020	Murphy, Timothy H/0000-0002-0093-4490; Murphy, Timothy/0000-0002-0093-4490; Liu, Rui/0000-0002-3634-0344; Mohajerani, Majid H./0000-0003-0964-2977	Canadian Institutes of Health Research (CIHR) [MOP-12675]; Human Frontier Science Program; Michael Smith Foundation for Health Research postdoctoral fellowships; Heart and Stroke Foundation of Canada postdoctoral fellowships; CIHR Focus on Stroke postdoctoral fellowship	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Human Frontier Science Program(Human Frontier Science Program); Michael Smith Foundation for Health Research postdoctoral fellowships; Heart and Stroke Foundation of Canada postdoctoral fellowships; CIHR Focus on Stroke postdoctoral fellowship(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research (CIHR) Operating Grant MOP-12675 (T.H.M.), a Human Frontier Science Program grant (T.H.M.), Michael Smith Foundation for Health Research postdoctoral fellowships (M.H.M. and A.W.C.), a CIHR Operating Grant (Y.T.W.), Heart and Stroke Foundation of Canada postdoctoral fellowships (M.H.M. and A.W.C.) and a CIHR Focus on Stroke postdoctoral fellowship (M.H.M.). We thank the Allen Institute for Brain Science for providing a database of axonal projections. We thank P. Wang and C. Jiang for surgical assistance.	Akemann W, 2012, J NEUROPHYSIOL, V108, P2323, DOI 10.1152/jn.00452.2012; Alivisatos AP, 2012, NEURON, V74, P970, DOI 10.1016/j.neuron.2012.06.006; Allen Institute for Brain Science, 2012, ALL MOUS BRAIN CONN; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Azin M, 2011, IEEE T BIO-MED ENG, V58, P2589, DOI 10.1109/TBME.2011.2159603; Beier KT, 2011, P NATL ACAD SCI USA, V108, P15414, DOI 10.1073/pnas.1110854108; Bohland JW, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000334; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; BUZSAKI G, 1988, J NEUROSCI, V8, P4007; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; de Pasquale F, 2012, NEURON, V74, P753, DOI 10.1016/j.neuron.2012.03.031; Destexhe A, 2006, SCIENCE, V314, P85, DOI 10.1126/science.1127241; Douglas RJ, 2007, NEURON, V56, P226, DOI 10.1016/j.neuron.2007.10.017; Euston DR, 2007, SCIENCE, V318, P1147, DOI 10.1126/science.1148979; Ferezou I, 2007, NEURON, V56, P907, DOI 10.1016/j.neuron.2007.10.007; Frostig RD, 2008, J NEUROSCI, V28, P13274, DOI 10.1523/JNEUROSCI.4074-08.2008; Grandy TH, 2012, J NEUROPHYSIOL, V108, P2931, DOI 10.1152/jn.00512.2011; Grienberger C, 2012, J PHYSIOL-LONDON, V590, P899, DOI 10.1113/jphysiol.2011.222513; Grinvald A, 2004, NAT REV NEUROSCI, V5, P874, DOI 10.1038/nrn1536; Haider B, 2013, NATURE, V493, P97, DOI 10.1038/nature11665; Han F, 2008, NEURON, V60, P321, DOI 10.1016/j.neuron.2008.08.026; Harris KD, 2011, NAT REV NEUROSCI, V12, P509, DOI 10.1038/nrn3084; Hipp JF, 2012, NAT NEUROSCI, V15, P884, DOI 10.1038/nn.3101; Huang XY, 2010, NEURON, V68, P978, DOI 10.1016/j.neuron.2010.11.007; Kenet T, 2003, NATURE, V425, P954, DOI 10.1038/nature02078; Kleinfeld D, 1996, J COMP NEUROL, V375, P89, DOI 10.1002/(SICI)1096-9861(19961104)375:1<89::AID-CNE6>3.0.CO;2-K; Kleinfeld D, 2011, J NEUROSCI, V31, P16125, DOI 10.1523/JNEUROSCI.4077-11.2011; Leopold DA, 2003, CEREB CORTEX, V13, P422, DOI 10.1093/cercor/13.4.422; Li AA, 2010, SCIENCE, V330, P1404, DOI 10.1126/science.1191776; Lim DH, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00011; Liu C., 2009, PIXELS EXPLORING NEW; Lu HB, 2012, P NATL ACAD SCI USA, V109, P3979, DOI [10.1073/pnas.1200506109, 10.1073/pnas.1101934108]; Luczak A, 2009, NEURON, V62, P413, DOI 10.1016/j.neuron.2009.03.014; Mao TY, 2011, NEURON, V72, P111, DOI 10.1016/j.neuron.2011.07.029; Mohajerani MH, 2010, J NEUROSCI, V30, P3745, DOI 10.1523/JNEUROSCI.6437-09.2010; Niell CM, 2010, NEURON, V65, P472, DOI 10.1016/j.neuron.2010.01.033; Osakada F, 2011, NEURON, V71, P617, DOI 10.1016/j.neuron.2011.07.005; Paxinos G., 2019, PAXINOS FRANKLINS MO, DOI [10.3390/ijms20225729, DOI 10.3390/IJMS20225729]; Polack PO, 2012, J NEUROSCI, V32, P11120, DOI 10.1523/JNEUROSCI.6304-11.2012; Poulet JFA, 2008, NATURE, V454, P881, DOI 10.1038/nature07150; Reid RC, 2012, NEURON, V75, P209, DOI 10.1016/j.neuron.2012.06.031; Sato TK, 2012, NEURON, V75, P218, DOI 10.1016/j.neuron.2012.06.029; Shmuel A, 2008, HUM BRAIN MAPP, V29, P751, DOI 10.1002/hbm.20580; Shoham D, 1999, NEURON, V24, P791, DOI 10.1016/S0896-6273(00)81027-2; Takagaki K, 2011, J NEUROSCI METH, V200, P207, DOI 10.1016/j.jneumeth.2011.05.023; Tamamaki N, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00202; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Waters J, 2006, J NEUROSCI, V26, P8267, DOI 10.1523/JNEUROSCI.2152-06.2006; Wedeen VJ, 2008, NEUROIMAGE, V41, P1267, DOI 10.1016/j.neuroimage.2008.03.036; White BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016322; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198	52	224	228	0	49	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2013	16	10					1426	+		10.1038/nn.3499	http://dx.doi.org/10.1038/nn.3499			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	223HM	23974708	Green Accepted			2022-12-17	WOS:000324795300015
J	Packer, AM; Roska, B; Hausser, M				Packer, Adam M.; Roska, Botond; Haeusser, Michael			Targeting neurons and photons for optogenetics	NATURE NEUROSCIENCE			English	Review							SINGLE-CELL ELECTROPORATION; IN-VIVO; GENE-EXPRESSION; NEURAL CIRCUITS; OPTICAL CONTROL; HIGH-SPEED; SYNAPTIC CONNECTIVITY; MILLISECOND-TIMESCALE; 2-PHOTON EXCITATION; TRANSGENIC MICE	Optogenetic approaches promise to revolutionize neuroscience by using light to manipulate neural activity in genetically or functionally defined neurons with millisecond precision. Harnessing the full potential of optogenetic tools, however, requires light to be targeted to the right neurons at the right time. Here we discuss some barriers and potential solutions to this problem. We review methods for targeting the expression of light-activatable molecules to specific cell types, under genetic, viral or activity-dependent control. Next we explore new ways to target light to individual neurons to allow their precise activation and inactivation. These techniques provide a precision in the temporal and spatial activation of neurons that was not achievable in previous experiments. In combination with simultaneous recording and imaging techniques, these strategies will allow us to mimic the natural activity patterns of neurons in vivo, enabling previously impossible 'dream experiments'.	[Packer, Adam M.; Haeusser, Michael] UCL, Wolfson Inst Biomed Res, London, England; [Packer, Adam M.; Haeusser, Michael] UCL, Dept Neurosci Physiol & Pharmacol, London, England; [Roska, Botond] Friedrich Miescher Inst Biomed Res, Neural Circuit Labs, Basel, Switzerland	University of London; University College London; University of London; University College London; Friedrich Miescher Institute for Biomedical Research	Roska, B (corresponding author), Friedrich Miescher Inst Biomed Res, Neural Circuit Labs, Basel, Switzerland.	botond.roska@fmi.ch; m.hausser@ucl.ac.uk	Roska, Botond/AAD-7268-2021; Hausser, Michael/AAW-6827-2020	Hausser, Michael/0000-0002-2673-8957; Packer, Adam/0000-0001-5884-794X	EMBO Long-Term Fellowship; Friedrich Miescher Institute; Alcon; European Research Council; European Union; Wellcome Trust; ERC; Gatsby Charitable Foundation	EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO)); Friedrich Miescher Institute; Alcon(Novartis); European Research Council(European Research Council (ERC)European Commission); European Union(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); ERC(European Research Council (ERC)European Commission); Gatsby Charitable Foundation	We are grateful to B. Clark, B. Judkewitz, D. Peterka, A. Roth, T. Sato, S. Smith, D. Sosulski, C. Wilms, K. Yonehara, R. Yuste and F. Zhang for discussions and for comments on the manuscript. We thank B. Judkewitz for help with Figure 4. This work was supported by an EMBO Long-Term Fellowship (A.M.P.) and by grants from the Friedrich Miescher Institute, Alcon, European Research Council and the European Union (B.R.) and from the Wellcome Trust, ERC and Gatsby Charitable Foundation (M.H.).	Akerboom J, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00002; Andrasfalvy BK, 2010, P NATL ACAD SCI USA, V107, P11981, DOI 10.1073/pnas.1006620107; Anikeeva P, 2012, NAT NEUROSCI, V15, P163, DOI 10.1038/nn.2992; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Bamann C, 2010, CURR OPIN NEUROBIOL, V20, P610, DOI 10.1016/j.conb.2010.07.003; Beier KT, 2013, J NEUROSCI, V33, P35, DOI 10.1523/JNEUROSCI.0245-12.2013; Beier KT, 2011, P NATL ACAD SCI USA, V108, P15414, DOI 10.1073/pnas.1110854108; Blumhagen F, 2011, NATURE, V479, P493, DOI 10.1038/nature10633; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Busskamp V, 2012, GENE THER, V19, P169, DOI 10.1038/gt.2011.155; Busskamp V, 2010, SCIENCE, V329, P413, DOI 10.1126/science.1190897; Calame M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023782; CALLAWAY EM, 1993, P NATL ACAD SCI USA, V90, P7661, DOI 10.1073/pnas.90.16.7661; Cardin JA, 2010, NAT PROTOC, V5, P247, DOI 10.1038/nprot.2009.228; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Cavanaugh J, 2012, NEURON, V76, P901, DOI 10.1016/j.neuron.2012.10.016; Cohen JY, 2012, NATURE, V482, P85, DOI 10.1038/nature10754; Cronin J, 2005, CURR GENE THER, V5, P387, DOI 10.2174/1566523054546224; DeFelipe J., 2013, NAT REV NEUROSCI; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Diester I, 2011, NAT NEUROSCI, V14, P387, DOI 10.1038/nn.2749; Dymecki SM, 2010, METHOD ENZYMOL, V477, P183, DOI 10.1016/S0076-6879(10)77011-7; Enquist LW, 2003, CURR OPIN NEUROBIOL, V13, P603, DOI 10.1016/j.conb.2003.08.001; Farrow K, 2013, NEURON, V78, P325, DOI 10.1016/j.neuron.2013.02.014; Flusberg BA, 2008, NAT METHODS, V5, P935, DOI 10.1038/nmeth.1256; Foutz TJ, 2012, J NEUROPHYSIOL, V107, P3235, DOI 10.1152/jn.00501.2011; Fried SI, 2002, NATURE, V420, P411, DOI 10.1038/nature01179; Gerits A, 2012, CURR BIOL, V22, P1722, DOI 10.1016/j.cub.2012.07.023; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Grewe BF, 2010, NAT METHODS, V7, P399, DOI 10.1038/nmeth.1453; Guo ZV, 2009, NAT METHODS, V6, P891, DOI 10.1038/nmeth.1397; Han X, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00018; Han X, 2009, NEURON, V62, P191, DOI 10.1016/j.neuron.2009.03.011; Helmchen F, 2001, NEURON, V31, P903, DOI 10.1016/S0896-6273(01)00421-4; Hirase H, 2002, J NEUROBIOL, V51, P237, DOI 10.1002/neu.10056; Houweling AR, 2008, NATURE, V451, P65, DOI 10.1038/nature06447; Huber D, 2008, NATURE, V451, P61, DOI 10.1038/nature06445; Iwai Y, 2011, NEUROSCI RES, V70, P124, DOI 10.1016/j.neures.2011.01.007; Jazayeri M, 2012, NAT NEUROSCI, V15, P1368, DOI 10.1038/nn.3210; Jia N, 2012, P NATL ACAD SCI USA, V109, P22, DOI 10.1073/pnas.1109202108; Judkewitz B, 2009, NAT PROTOC, V4, P862, DOI 10.1038/nprot.2009.56; Katona G, 2012, NAT METHODS, V9, P201, DOI [10.1038/nmeth.1851, 10.1038/NMETH.1851]; Kienle E., 2012, JOVE-J VIS EXP, V62, P3819; Kirkby PA, 2010, OPT EXPRESS, V18, P13720, DOI 10.1364/OE.18.013720; Kitamura K, 2008, NAT METHODS, V5, P61, DOI 10.1038/NMETH1150; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; LeChasseur Y, 2011, NAT METHODS, V8, P319, DOI 10.1038/NMETH.1572; Lee SH, 2012, NATURE, V488, P379, DOI 10.1038/nature11312; Leifer AM, 2011, NAT METHODS, V8, P147, DOI 10.1038/NMETH.1554; Lim DH, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00011; Lima SQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006099; Little JP, 2012, J NEUROSCI, V32, P12808, DOI 10.1523/JNEUROSCI.1616-12.2012; Liu X, 2012, NATURE, V484, P381, DOI 10.1038/nature11028; Lo LC, 2011, NEURON, V72, P938, DOI 10.1016/j.neuron.2011.12.002; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; Marshel JH, 2010, NEURON, V67, P562, DOI 10.1016/j.neuron.2010.08.001; Mattis J, 2012, NAT METHODS, V9, P159, DOI [10.1038/NMETH.1808, 10.1038/nmeth.1808]; Miesenbock G, 2009, SCIENCE, V326, P395, DOI 10.1126/science.1174520; Miyashita T, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00008; Munch TA, 2009, NAT NEUROSCI, V12, P1308, DOI 10.1038/nn.2389; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nikolenko V, 2008, FRONT NEURAL CIRCUIT, V2, DOI 10.3389/neuro.04.005.2008; Osakada F, 2011, NEURON, V71, P617, DOI 10.1016/j.neuron.2011.07.005; Packer AM, 2012, NAT METHODS, V9, P1202, DOI [10.1038/NMETH.2249, 10.1038/nmeth.2249]; Papagiakoumou E, 2013, NAT PHOTONICS, V7, P274, DOI [10.1038/NPHOTON.2013.9, 10.1038/nphoton.2013.9]; Papagiakoumou E, 2010, NAT METHODS, V7, P848, DOI [10.1038/nmeth.1505, 10.1038/NMETH.1505]; Peron S, 2011, NAT METHODS, V8, P30, DOI [10.1038/nmeth.f.325, 10.1038/NMETH.F.325]; Petreanu L., 2007, FRONT SYST NEUROSCI, V10, P663; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Prakash R, 2012, NAT METHODS, V9, P1171, DOI 10.1038/NMETH.2215; Reddy GD, 2008, NAT NEUROSCI, V11, P713, DOI 10.1038/nn.2116; Reijmers L, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.027.2009; Reutsky-Gefen I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2500; Rickgauer JP, 2009, P NATL ACAD SCI USA, V106, P15025, DOI 10.1073/pnas.0907084106; Royer S, 2012, NAT NEUROSCI, V15, P769, DOI 10.1038/nn.3077; Royer S, 2010, EUR J NEUROSCI, V31, P2279, DOI 10.1111/j.1460-9568.2010.07250.x; Scanziani M, 2009, NATURE, V461, P930, DOI 10.1038/nature08540; Schoenenberger P, 2011, EXP PHYSIOL, V96, P34, DOI 10.1113/expphysiol.2009.051219; Shepherd GMG, 2003, NEURON, V38, P277, DOI 10.1016/S0896-6273(03)00152-1; Siegert S, 2012, NAT NEUROSCI, V15, P487, DOI 10.1038/nn.3032; Stirman JN, 2011, NAT METHODS, V8, P153, DOI 10.1038/NMETH.1555; Stroh A, 2013, NEURON, V77, P1136, DOI 10.1016/j.neuron.2013.01.031; Theer P, 2006, J OPT SOC AM A, V23, P3139, DOI 10.1364/JOSAA.23.003139; Toledo-Rodriguez M, 2004, CEREB CORTEX, V14, P1310, DOI 10.1093/cercor/bhh092; Tripodi M, 2011, NATURE, V479, P61, DOI 10.1038/nature10538; Tye KM, 2012, NAT REV NEUROSCI, V13, P251, DOI 10.1038/nrn3171; Wall NR, 2010, P NATL ACAD SCI USA, V107, P21848, DOI 10.1073/pnas.1011756107; Wang H, 2007, P NATL ACAD SCI USA, V104, P8143, DOI 10.1073/pnas.0700384104; Wang X, 2012, NAT METHODS, V9, P266, DOI [10.1038/NMETH.1892, 10.1038/nmeth.1892]; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Wilson NR, 2012, NATURE, V488, P343, DOI 10.1038/nature11347; Xu W, 2013, SCIENCE, V339, P1290, DOI 10.1126/science.1229534; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Yonehara K, 2011, NATURE, V469, P407, DOI 10.1038/nature09711; Zhang F, 2010, NAT PROTOC, V5, P439, DOI 10.1038/nprot.2009.226; Zhu PX, 2012, NAT PROTOC, V7, P1410, DOI 10.1038/nprot.2012.072; Zhu PX, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.021.2009	98	224	260	6	263	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2013	16	7					805	815		10.1038/nn.3427	http://dx.doi.org/10.1038/nn.3427			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174UM	23799473	Green Accepted			2022-12-17	WOS:000321180900010
J	Belmonte, MK; Bourgeron, T				Belmonte, Matthew K.; Bourgeron, Thomas			Fragile X syndrome and autism at the intersection of genetic and neural networks	NATURE NEUROSCIENCE			English	Article							MENTAL-RETARDATION PROTEIN; SEROTONIN TRANSPORTER; NEURODEVELOPMENTAL DISORDERS; SOCIAL-INTERACTION; NEUROLIGIN GENES; MUTATIONS; BRAIN; SUSCEPTIBILITY; INDIVIDUALS; EXPRESSION	Autism, an entirely behavioral diagnosis with no largely understood etiologies and no population-wide biomarkers, contrasts with fragile X syndrome (FXS), a single-gene disorder with definite alterations of gene expression and neuronal morphology. Nevertheless, the behavioral overlap between autism and FXS suggests some overlapping mechanisms. Understanding how the single-gene alteration in FXS plays out within complex genetic and neural network processes may suggest targets for autism research and illustrate strategies for relating autism to more singular genetic syndromes.	Cornell Univ, Dept Human Dev, Ithaca, NY 14853 USA; Inst Pasteur, Lab Genet Humaine & Fonct Cognit, F-75015 Paris 15, France; Univ Paris 07, F-75251 Paris 05, France	Cornell University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite	Belmonte, MK (corresponding author), Cornell Univ, Dept Human Dev, Martha Van Rensselaer Hall, Ithaca, NY 14853 USA.	belmonte@mit.edu	; Belmonte, Matthew/G-1170-2015	Bourgeron, Thomas/0000-0001-8164-9220; Belmonte, Matthew/0000-0002-4633-9400				BASU TN, 1992, NATURE, V356, P713, DOI 10.1038/356713a0; Bauman ML, 2005, INT J DEV NEUROSCI, V23, P183, DOI 10.1016/j.ijdevneu.2004.09.006; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Beckel-Mitchener A, 2004, MENT RETARD DEV D R, V10, P53, DOI 10.1002/mrdd.20009; Belmonte MK, 2004, J NEUROSCI, V24, P9228, DOI 10.1523/JNEUROSCI.3340-04.2004; Bertone A, 2005, BRAIN, V128, P2430, DOI 10.1093/brain/awh561; Blasi F, 2006, AM J MED GENET B, V141B, P220, DOI 10.1002/ajmg.b.30287; Butler MG, 2005, J MED GENET, V42, P318, DOI 10.1136/jmg.2004.024646; Casanova MF, 2002, NEUROLOGY, V58, P428, DOI 10.1212/WNL.58.3.428; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; CLIFFORD S, IN PRESS J AUTISM DE; Comoletti D, 2004, J NEUROSCI, V24, P4889, DOI 10.1523/JNEUROSCI.0468-04.2004; Costa RM, 2002, NATURE, V415, P526, DOI 10.1038/nature711; COURCHESNE E, 1994, AM J ROENTGENOL, V162, P123, DOI 10.2214/ajr.162.1.8273650; Delorme R, 2005, MOL PSYCHIATR, V10, P1059, DOI 10.1038/sj.mp.4001728; Devlin B, 2005, MOL PSYCHIATR, V10, P1110, DOI 10.1038/sj.mp.4001724; Eliez S, 2001, BRAIN, V124, P1610, DOI 10.1093/brain/124.8.1610; Feinstein C, 1998, J AUTISM DEV DISORD, V28, P393, DOI 10.1023/A:1026000404855; FILIPEK PA, 2005, HDB AUTISM PERVASIVE, P534; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; Gauthier J, 2005, AM J MED GENET B, V132B, P74, DOI 10.1002/ajmg.b.30066; Hagerman RJ, 2006, J DEV BEHAV PEDIATR, V27, P63, DOI 10.1097/00004703-200602000-00012; Hagerman RJ, 2002, FRAGILE X SYNDROME D, P3; Hollander E, 2005, BIOL PSYCHIAT, V58, P226, DOI 10.1016/j.biopsych.2005.03.040; Hollander E, 2003, PSYCHIAT RES, V117, P11, DOI 10.1016/S0165-1781(02)00304-9; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Johnson MH, 2002, DEV PSYCHOPATHOL, V14, P521, DOI 10.1017/S0954579402003073; Kaufmann WE, 2004, AM J MED GENET A, V129A, P225, DOI 10.1002/ajmg.a.30229; Kaufmann WE, 2003, J CHILD NEUROL, V18, P463, DOI 10.1177/08830738030180070501; Kogan CS, 2004, NEUROLOGY, V63, P1634, DOI 10.1212/01.WNL.0000142987.44035.3B; Kogan CS, 2004, BRAIN, V127, P591, DOI 10.1093/brain/awh069; Kwiatkowski DJ, 2005, HUM MOL GENET, V14, pR251, DOI 10.1093/hmg/ddi260; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Laumonnier F, 2004, AM J HUM GENET, V74, P552, DOI 10.1086/382137; Pellicano E, 2005, NEUROPSYCHOLOGIA, V43, P1044, DOI 10.1016/j.neuropsychologia.2004.10.003; Persico AM, 2006, TRENDS NEUROSCI, V29, P349, DOI 10.1016/j.tins.2006.05.010; Pickett J, 2005, J NEUROPATH EXP NEUR, V64, P925, DOI 10.1097/01.jnen.0000186921.42592.6c; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; REISCHMANN T, 1995, S AFR J GEOL, V1, P1; Rogers SJ, 2001, J DEV BEHAV PEDIATR, V22, P409, DOI 10.1097/00004703-200112000-00008; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Samaco RC, 2005, HUM MOL GENET, V14, P483, DOI 10.1093/hmg/ddi045; Sears LL, 1999, PROG NEURO-PSYCHOPH, V23, P613, DOI 10.1016/S0278-5846(99)00020-2; Sutcliffe JS, 2005, AM J HUM GENET, V77, P265, DOI 10.1086/432648; Todd PK, 2003, P NATL ACAD SCI USA, V100, P14374, DOI 10.1073/pnas.2336265100; Vincent JB, 2004, AM J MED GENET B, V129B, P82, DOI 10.1002/ajmg.b.30069; Weiler IJ, 1997, P NATL ACAD SCI USA, V94, P5395, DOI 10.1073/pnas.94.10.5395; Yan J, 2005, MOL PSYCHIATR, V10, P329, DOI 10.1038/sj.mp.4001629; Ylisaukko-oja T, 2005, EUR J HUM GENET, V13, P1285, DOI 10.1038/sj.ejhg.5201474; Zoghbi HY, 2003, SCIENCE, V302, P826, DOI 10.1126/science.1089071	50	224	268	1	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2006	9	10					1221	1225		10.1038/nn1765	http://dx.doi.org/10.1038/nn1765			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	098BB	17001341				2022-12-17	WOS:000241493900011
J	Lorenzo, A; Yuan, ML; Zhang, ZH; Paganetti, PA; Sturchler-Pierrat, C; Staufenbiel, M; Mautino, J; Sol Vigo, F; Sommer, B; Yankner, BA				Lorenzo, A; Yuan, ML; Zhang, ZH; Paganetti, PA; Sturchler-Pierrat, C; Staufenbiel, M; Mautino, J; Sol Vigo, F; Sommer, B; Yankner, BA			Amyloid beta interacts with the amyloid precursor protein: a potential toxic mechanism in Alzheimer's disease	NATURE NEUROSCIENCE			English	Article							WILD-TYPE; INTRACELLULAR ACCUMULATION; OXIDATIVE STRESS; IN-VIVO; NEUROTOXICITY; PEPTIDE; CELL; ADHESION; NEURONS; DEGENERATION	Amyloid beta protein (A beta) deposition in the brain is a hallmark of Alzheimer's disease (AD). The fibrillar form of A beta is neurotoxic, although the mechanism of its toxicity is unknown. We showed that conversion of A beta to the fibrillar form markedly increased binding to specific neuronal membrane proteins, including amyloid precursor protein (APP). Nanomolar concentrations of fibrillar A beta bound cell-surface holo-APP in cortical neurons. Reduced vulnerability of cultured APP-null neurons to A beta neurotoxicity suggested that AP neurotoxicity involves APP. Thus A beta toxicity may be mediated by the interaction of fibrillar AP with neuronal membrane proteins, notably APP. An A beta-APP interaction reminiscent of the pathogenic mechanism of prions may thus contribute to neuronal degeneration in AD.	Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; Childrens Hosp, Div Neurosci, Boston, MA 02115 USA; Inst Invest Med Mercedes & Martin Ferreyra, RA-5000 Cordoba, Argentina; Novartis Pharma Ltd, Preclin Res, CH-4002 Basel, Switzerland	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Novartis	Yankner, BA (corresponding author), Harvard Univ, Sch Med, Dept Neurol, Enders 260,300 Longwood Ave, Boston, MA 02115 USA.		Paganetti, Paolo/AAF-8039-2020	Paganetti, Paolo/0000-0003-1896-6324	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030352, R01NS033325] Funding Source: NIH RePORTER; NINDS NIH HHS [NS30352, NS33325] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7; BREEN KC, 1991, J NEUROSCI RES, V28, P90, DOI 10.1002/jnr.490280109; Brown DR, 1996, NATURE, V380, P345, DOI 10.1038/380345a0; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; Bursztajn S, 1998, J NEUROSCI, V18, P9790; BUSCIGLIO J, 1995, NEURON, V14, P879, DOI 10.1016/0896-6273(95)90232-5; BUSCIGLIO J, 1992, NEUROBIOL AGING, V13, P609, DOI 10.1016/0197-4580(92)90065-6; CHEN M, 1991, NEUROSCI LETT, V125, P223, DOI 10.1016/0304-3940(91)90034-Q; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; CONDRESCU M, 1984, BIOCHIM BIOPHYS ACTA, V769, P261, DOI 10.1016/0005-2736(84)90031-2; DAVISSALINAS J, 1995, J NEUROCHEM, V65, P931; Geula C, 1998, NAT MED, V4, P827, DOI 10.1038/nm0798-827; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Hegde RS, 1999, NATURE, V402, P822, DOI 10.1038/45574; HENSLEY K, 1994, P NATL ACAD SCI USA, V91, P3270, DOI 10.1073/pnas.91.8.3270; HOWLETT DR, 1995, NEURODEGENERATION, V4, P23, DOI 10.1006/neur.1995.0003; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KIBBEY MC, 1993, P NATL ACAD SCI USA, V90, P10150, DOI 10.1073/pnas.90.21.10150; LEDERMANN B, 1991, EXP CELL RES, V197, P254, DOI 10.1016/0014-4827(91)90430-3; LORENZO A, 1994, NATURE, V368, P756, DOI 10.1038/368756a0; LORENZO A, 1994, P NATL ACAD SCI USA, V91, P12243, DOI 10.1073/pnas.91.25.12243; MATTSON MP, 1993, NEURON, V10, P243, DOI 10.1016/0896-6273(93)90315-I; MATTSON MP, 1993, BRAIN RES, V621, P35, DOI 10.1016/0006-8993(93)90295-X; MAY PC, 1993, J NEUROCHEM, V61, P2330, DOI 10.1111/j.1471-4159.1993.tb07480.x; MILWARD EA, 1992, NEURON, V9, P129, DOI 10.1016/0896-6273(92)90228-6; Nishimura I, 1998, J NEUROSCI, V18, P2387, DOI 10.1523/jneurosci.18-07-02387.1998; Paganetti PA, 1996, J NEUROSCI RES, V46, P283, DOI 10.1002/(SICI)1097-4547(19961101)46:3<283::AID-JNR1>3.0.CO;2-G; Perez RG, 1997, J NEUROSCI, V17, P9407; PIKE CJ, 1991, BRAIN RES, V563, P311, DOI 10.1016/0006-8993(91)91553-D; PIKE CJ, 1993, J NEUROSCI, V13, P1676; Russo T, 1998, FEBS LETT, V434, P1, DOI 10.1016/S0014-5793(98)00941-7; SAITOH T, 1989, CELL, V58, P615, DOI 10.1016/0092-8674(89)90096-2; Savage MJ, 1998, J NEUROSCI, V18, P1743; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; SCHUBERT D, 1993, BRAIN RES, V629, P275, DOI 10.1016/0006-8993(93)91331-L; SCHUBERT D, 1989, NEURON, V3, P689, DOI 10.1016/0896-6273(89)90237-7; Selkoe DJ, 1997, SCIENCE, V275, P630, DOI 10.1126/science.275.5300.630; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Uetsuki T, 1999, J NEUROSCI, V19, P6955, DOI 10.1523/JNEUROSCI.19-16-06955.1999; White AR, 1999, J NEUROSCI, V19, P9170; White AR, 1998, J NEUROSCI, V18, P6207; Xu X, 1999, P NATL ACAD SCI USA, V96, P7547, DOI 10.1073/pnas.96.13.7547; Yamatsuji T, 1996, SCIENCE, V272, P1349, DOI 10.1126/science.272.5266.1349; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Yang AJ, 1999, J BIOL CHEM, V274, P20650, DOI 10.1074/jbc.274.29.20650; YANKNER BA, 1990, SCIENCE, V250, P279, DOI 10.1126/science.2218531; Yankner BA, 1996, NEURON, V16, P921, DOI 10.1016/S0896-6273(00)80115-4; YOSHIKAWA K, 1992, NATURE, V359, P64, DOI 10.1038/359064a0; ZHANG C, 1994, J BIOL CHEM, V269, P25247; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X	50	224	241	1	17	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2000	3	5					460	464		10.1038/74833	http://dx.doi.org/10.1038/74833			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	309DG	10769385				2022-12-17	WOS:000086752000014
J	Yacoubian, TA; Lo, DC				Yacoubian, TA; Lo, DC			Truncated and full-length TrkB receptors regulate distinct modes of dendritic growth	NATURE NEUROSCIENCE			English	Article							VISUAL CORTICAL-NEURONS; NEUROTROPHIC FACTOR; GENE-EXPRESSION; KINASE-ACTIVITY; IN-VIVO; ISOFORMS; CELLS; CORTEX; RAT; MORPHOLOGY	Neurotrophin regulation of neuronal morphology is complex and may involve differential action of alternative Trk receptor isoforms. We transfected ferret visual cortical slices with full-length and truncated TrkB receptors to examine their roles in regulating cortical dendrite development. These TrkB isoforms had differential effects on dendritic arborization: whereas full-length TrkB increased proximal dendritic branching, truncated TrkB promoted net elongation of distal dendrites. The morphological effects of each receptor isoform were distinct, yet their actions inhibited one another. Actions of the truncated TrkB receptor did not involve unmasking of endogenous TrkC signaling. These results suggest that TrkB receptors do not regulate dendritic growth per se but, rather, the mode of such growth.	Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Duke University	Lo, DC (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Box 3209, Durham, NC 27710 USA.				NATIONAL EYE INSTITUTE [R01EY011553] Funding Source: NIH RePORTER; NEI NIH HHS [EY11553] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALLENDOERFER KL, 1994, J NEUROSCI, V14, P1795; ARMANINI MP, 1995, EUR J NEUROSCI, V7, P1403, DOI 10.1111/j.1460-9568.1995.tb01132.x; ARNOLD D, 1994, P NATL ACAD SCI USA, V91, P9970, DOI 10.1073/pnas.91.21.9970; BARBACID M, 1994, J NEUROBIOL, V25, P1386, DOI 10.1002/neu.480251107; Barker PA, 1998, CELL DEATH DIFFER, V5, P346, DOI 10.1038/sj.cdd.4400375; Baxter GT, 1997, J NEUROSCI, V17, P2683; BERG MM, 1992, J BIOL CHEM, V267, P13; BIFFO S, 1995, DEVELOPMENT, V121, P2461; Boeshore KL, 1999, J NEUROSCI, V19, P4739; Bonhoeffer T, 1996, CURR OPIN NEUROBIOL, V6, P119, DOI 10.1016/S0959-4388(96)80017-1; Cabelli RJ, 1997, NEURON, V19, P63, DOI 10.1016/S0896-6273(00)80348-7; Cellerino A, 1996, PROG NEUROBIOL, V49, P53, DOI 10.1016/0301-0082(96)00008-1; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Dechant G, 1997, CURR OPIN NEUROBIOL, V7, P413, DOI 10.1016/S0959-4388(97)80071-2; Eide FF, 1996, J NEUROSCI, V16, P3123; ESCANDON E, 1994, J NEUROSCI, V14, P2054; FRISEN J, 1993, P NATL ACAD SCI USA, V90, P4971, DOI 10.1073/pnas.90.11.4971; Fryer RH, 1997, EXP NEUROL, V148, P616, DOI 10.1006/exnr.1997.6699; Fryer RH, 1996, J COMP NEUROL, V374, P21, DOI 10.1002/(SICI)1096-9861(19961007)374:1<21::AID-CNE2>3.0.CO;2-P; Galuske RAW, 1996, EUR J NEUROSCI, V8, P1554, DOI 10.1111/j.1460-9568.1996.tb01618.x; Garner AS, 1996, J NEUROSCI, V16, P1740; Haapasalo A, 1999, ONCOGENE, V18, P1285, DOI 10.1038/sj.onc.1202401; HOLTZMAN DM, 1992, NEURON, V9, P465, DOI 10.1016/0896-6273(92)90184-F; JACKSON CA, 1989, J NEUROSCI, V9, P1242; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; KNUSEL B, 1994, J NEUROSCI, V14, P1542, DOI 10.1523/JNEUROSCI.14-03-01542.1994; Kryl D, 1999, J NEUROSCI, V19, P5823, DOI 10.1523/JNEUROSCI.19-14-05823.1999; LAMBALLE F, 1993, EMBO J, V12, P3083, DOI 10.1002/j.1460-2075.1993.tb05977.x; Lentz SI, 1999, J NEUROSCI, V19, P1038; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; LO DC, 1994, NEURON, V13, P1263, DOI 10.1016/0896-6273(94)90412-X; Lom B, 1999, J NEUROSCI, V19, P9928; MAFFEI L, 1992, J NEUROSCI, V12, P4651; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; McAllister AK, 1997, NEURON, V18, P767, DOI 10.1016/S0896-6273(00)80316-5; Ninkina N, 1997, J BIOL CHEM, V272, P13019, DOI 10.1074/jbc.272.20.13019; Ninkina N, 1996, EMBO J, V15, P6385, DOI 10.1002/j.1460-2075.1996.tb01029.x; PURVES D, 1988, NATURE, V336, P123, DOI 10.1038/336123a0; RUDGE JS, 1994, EUR J NEUROSCI, V6, P693, DOI 10.1111/j.1460-9568.1994.tb00981.x; Shimada A, 1998, J NEUROSCI, V18, P8559; SHOLL DA, 1953, J ANAT, V87, P387; SNIDER WD, 1988, J NEUROSCI, V8, P2628; Strohmaier C, 1996, EMBO J, V15, P3332, DOI 10.1002/j.1460-2075.1996.tb00698.x; TAPLEY P, 1992, ONCOGENE, V7, P371; Tsoulfas P, 1996, J BIOL CHEM, V271, P5691, DOI 10.1074/jbc.271.10.5691; VALENZUELA DM, 1993, NEURON, V10, P963, DOI 10.1016/0896-6273(93)90211-9; WETMORE C, 1995, J COMP NEUROL, V353, P143, DOI 10.1002/cne.903530113; Wu GY, 1999, J NEUROSCI, V19, P4472; Zervas M, 1999, J COMP NEUROL, V413, P429, DOI 10.1002/(SICI)1096-9861(19991025)413:3<429::AID-CNE6>3.0.CO;2-7	50	224	227	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2000	3	4					342	349		10.1038/73911	http://dx.doi.org/10.1038/73911			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	330CN	10725923				2022-12-17	WOS:000087945400014
J	Donoghue, T; Haller, M; Peterson, EJ; Varma, P; Sebastian, P; Gao, R; Noto, T; Lara, AH; Wallis, JD; Knight, RT; Shestyuk, A; Voytek, B				Donoghue, Thomas; Haller, Matar; Peterson, Erik J.; Varma, Paroma; Sebastian, Priyadarshini; Gao, Richard; Noto, Torben; Lara, Antonio H.; Wallis, Joni D.; Knight, Robert T.; Shestyuk, Avgusta; Voytek, Bradley			Parameterizing neural power spectra into periodic and aperiodic components	NATURE NEUROSCIENCE			English	Article							BRAIN ACTIVITY; ALPHA-OSCILLATIONS; ARTIFACT REJECTION; FIELD POTENTIALS; EEG; MEG; DYNAMICS; MODEL; COMMUNICATION; INFORMATION	Electrophysiological signals exhibit both periodic and aperiodic properties. Periodic oscillations have been linked to numerous physiological, cognitive, behavioral and disease states. Emerging evidence demonstrates that the aperiodic component has putative physiological interpretations and that it dynamically changes with age, task demands and cognitive states. Electrophysiological neural activity is typically analyzed using canonically defined frequency bands, without consideration of the aperiodic (1/f-like) component. We show that standard analytic approaches can conflate periodic parameters (center frequency, power, bandwidth) with aperiodic ones (offset, exponent), compromising physiological interpretations. To overcome these limitations, we introduce an algorithm to parameterize neural power spectra as a combination of an aperiodic component and putative periodic oscillatory peaks. This algorithm requires no a priori specification of frequency bands. We validate this algorithm on simulated data, and demonstrate how it can be used in applications ranging from analyzing age-related changes in working memory to large-scale data exploration and analysis. A method for parameterizing electrophysiological neural power spectra into periodic and aperiodic components is introduced, addressing limitations of common approaches. The method is validated in simulation and demonstrated on real data applications.	[Donoghue, Thomas; Peterson, Erik J.; Sebastian, Priyadarshini; Gao, Richard; Noto, Torben; Voytek, Bradley] Univ Calif San Diego, Dept Cognit Sci, La Jolla, CA 92093 USA; [Haller, Matar; Varma, Paroma; Lara, Antonio H.; Wallis, Joni D.; Knight, Robert T.; Shestyuk, Avgusta] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Wallis, Joni D.; Knight, Robert T.] Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA; [Voytek, Bradley] Univ Calif San Diego, Neurosci Grad Program, La Jolla, CA 92093 USA; [Voytek, Bradley] Univ Calif San Diego, Halicioglu Data Sci Inst, La Jolla, CA 92093 USA; [Voytek, Bradley] Univ Calif San Diego, Kavli Inst Brain & Mind, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Donoghue, T; Voytek, B (corresponding author), Univ Calif San Diego, Dept Cognit Sci, La Jolla, CA 92093 USA.; Voytek, B (corresponding author), Univ Calif San Diego, Neurosci Grad Program, La Jolla, CA 92093 USA.; Voytek, B (corresponding author), Univ Calif San Diego, Halicioglu Data Sci Inst, La Jolla, CA 92093 USA.; Voytek, B (corresponding author), Univ Calif San Diego, Kavli Inst Brain & Mind, La Jolla, CA 92093 USA.	tdonoghue.research@gmail.com; bradley.voytek@gmail.com	Voytek, Bradley/K-3305-2016	Voytek, Bradley/0000-0003-1640-2525; Donoghue, Thomas/0000-0001-5911-0472	NIGMS NIH HHS [R01 GM134363] Funding Source: Medline; NIMH NIH HHS [R01 MH121448, R01 MH117763, F32 MH075317, P50 MH109429] Funding Source: Medline; NINDS NIH HHS [R01 NS021135, U19 NS107609, R37 NS021135] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Baillet S, 2001, PHYS MED BIOL, V46, P77, DOI 10.1088/0031-9155/46/1/306; Bartoli E, 2019, CURR BIOL, V29, P3345, DOI 10.1016/j.cub.2019.08.004; Becker R, 2018, J NEUROSCI, V38, P755, DOI 10.1523/JNEUROSCI.0831-17.2017; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Bullock TH, 2003, NEUROSCIENCE, V121, P233, DOI 10.1016/S0306-4522(03)00208-2; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Buzsaki G, 2013, NEURON, V80, P751, DOI 10.1016/j.neuron.2013.10.002; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; Canolty RT, 2010, TRENDS COGN SCI, V14, P506, DOI 10.1016/j.tics.2010.09.001; Caplan JB, 2015, NEUROIMAGE, V112, P341, DOI 10.1016/j.neuroimage.2015.03.001; Cole S., 2019, J OPEN SOURCE SOFTW, V4, P1272, DOI [10.21105/joss.01272, DOI 10.21105/JOSS.01272]; Cole S, 2019, J NEUROPHYSIOL, V122, P849, DOI 10.1152/jn.00273.2019; Cole SR, 2017, TRENDS COGN SCI, V21, P137, DOI 10.1016/j.tics.2016.12.008; Crone NE, 1998, BRAIN, V121, P2271, DOI 10.1093/brain/121.12.2271; Demirtas M, 2019, NEURON, V101, P1181, DOI 10.1016/j.neuron.2019.01.017; DUSTMAN RE, 1993, PROG NEUROBIOL, V41, P369, DOI 10.1016/0301-0082(93)90005-D; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Fonov V., 2009, NEUROIMAGE, V47, pS102, DOI [10.1016/s1053-8119(09)70884-5, DOI 10.1016/S1053-8119(09)70884-5, 10.1016/S1053-8119(09)70884-5]; Frauscher B, 2018, BRAIN, V141, DOI 10.1093/brain/awy035; Freeman WJ, 2009, COGN NEURODYNAMICS, V3, P97, DOI 10.1007/s11571-008-9064-y; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Gao R., 2020, NEURONAL TIMESCALES, DOI [10.1101/2020.05.25.115378, DOI 10.1101/2020.05.25.115378]; Gao R, 2017, NEUROIMAGE, V158, P70, DOI 10.1016/j.neuroimage.2017.06.078; Gao R, 2016, J NEUROPHYSIOL, V115, P628, DOI 10.1152/jn.00722.2015; Gramfort A, 2014, NEUROIMAGE, V86, P446, DOI 10.1016/j.neuroimage.2013.10.027; Groppe DM, 2013, NEUROIMAGE, V79, P223, DOI 10.1016/j.neuroimage.2013.04.044; Gross J, 2013, NEUROIMAGE, V65, P349, DOI 10.1016/j.neuroimage.2012.10.001; Haegens S, 2014, NEUROIMAGE, V92, P46, DOI 10.1016/j.neuroimage.2014.01.049; Haegens S, 2011, P NATL ACAD SCI USA, V108, P19377, DOI 10.1073/pnas.1117190108; He BYJ, 2014, TRENDS COGN SCI, V18, P480, DOI 10.1016/j.tics.2014.04.003; He BYJ, 2010, NEURON, V66, P353, DOI 10.1016/j.neuron.2010.04.020; He W., 2019, BIORXIV, DOI DOI 10.1101/839258; Huang MX, 1999, PHYS MED BIOL, V44, P423, DOI 10.1088/0031-9155/44/2/010; Hughes AM, 2012, HIPPOCAMPUS, V22, P1417, DOI 10.1002/hipo.20979; Izhikevich L, 2018, MEASURING AVERAGE PO, DOI [10.1101/441626, DOI 10.1101/441626]; Jas M, 2017, NEUROIMAGE, V159, P417, DOI 10.1016/j.neuroimage.2017.06.030; Jasper H, 1949, ARCH PSYCHIAT NERVEN, V83, P163, DOI [DOI 10.1007/BF01062488, 10.1007/BF01062488]; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Kopell NJ, 2014, NEURON, V83, P1319, DOI 10.1016/j.neuron.2014.08.016; Lansbergen MM, 2011, PROG NEURO-PSYCHOPH, V35, P47, DOI 10.1016/j.pnpbp.2010.08.004; Lara AH, 2014, NAT NEUROSCI, V17, P876, DOI 10.1038/nn.3702; Lim S, 2013, NAT NEUROSCI, V16, P1306, DOI 10.1038/nn.3492; Manning JR, 2009, J NEUROSCI, V29, P13613, DOI 10.1523/JNEUROSCI.2041-09.2009; Mierau A, 2017, NEUROSCIENCE, V360, P146, DOI 10.1016/j.neuroscience.2017.07.037; Miller KJ, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002655; Miller KJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000609; Mizuseki K, 2009, NEURON, V64, P267, DOI 10.1016/j.neuron.2009.08.037; Molina JL, 2020, BIOL PSYCHIAT-COGN N, V5, P562, DOI 10.1016/j.bpsc.2020.02.004; Mukamel R, 2005, SCIENCE, V309, P951, DOI 10.1126/science.1110913; Muthukumaraswamy SD, 2018, NEUROIMAGE, V179, P582, DOI 10.1016/j.neuroimage.2018.06.068; Muthukumaraswamy SD, 2010, NEUROIMAGE, V49, P3349, DOI 10.1016/j.neuroimage.2009.11.045; Niso G, 2016, NEUROIMAGE, V124, P1182, DOI 10.1016/j.neuroimage.2015.04.028; Nolte G, 1999, IEEE T BIO-MED ENG, V46, P400, DOI 10.1109/10.752937; PASCUALMARQUI RD, 1988, INT J NEUROSCI, V40, P89, DOI 10.3109/00207458808985730; Podvalny E, 2015, J NEUROPHYSIOL, V114, P505, DOI 10.1152/jn.00943.2014; Reimann MW, 2013, NEURON, V79, P375, DOI 10.1016/j.neuron.2013.05.023; Robertson MM, 2019, J NEUROPHYSIOL, V122, P2427, DOI 10.1152/jn.00388.2019; Tadel F, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/879716; Tran TT, 2020, J COGNITIVE NEUROSCI, V32, P1813, DOI 10.1162/jocn_a_01584; Tran TT, 2016, NEUROIMAGE, V143, P196, DOI 10.1016/j.neuroimage.2016.08.052; van der Meij R, 2012, J NEUROSCI, V32, P111, DOI 10.1523/JNEUROSCI.4816-11.2012; Van Essen DC, 2012, NEUROIMAGE, V62, P2222, DOI 10.1016/j.neuroimage.2012.02.018; Van Essen DC, 2013, NEUROIMAGE, V80, P62, DOI 10.1016/j.neuroimage.2013.05.041; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447; Voytek B, 2015, J NEUROSCI, V35, P13257, DOI 10.1523/JNEUROSCI.2332-14.2015; Voytek B, 2015, NAT NEUROSCI, V18, P1318, DOI 10.1038/nn.4071; Voytek B, 2015, BIOL PSYCHIAT, V77, P1089, DOI 10.1016/j.biopsych.2015.04.016; Voytek B, 2010, P NATL ACAD SCI USA, V107, P18167, DOI 10.1073/pnas.1007277107; WELCH PD, 1967, IEEE T ACOUST SPEECH, VAU15, P70, DOI 10.1109/TAU.1967.1161901; Wen HG, 2016, BRAIN TOPOGR, V29, P13, DOI 10.1007/s10548-015-0448-0; Winawer J, 2013, CURR BIOL, V23, P1145, DOI 10.1016/j.cub.2013.05.001	72	223	223	41	91	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2020	23	12					1655	U288		10.1038/s41593-020-00744-x	http://dx.doi.org/10.1038/s41593-020-00744-x			24	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PC2QZ	33230329	Green Accepted			2022-12-17	WOS:000596853000022
J	Hughes, EG; Orthmann-Murphy, JL; Langseth, AJ; Bergles, DE				Hughes, Ethan G.; Orthmann-Murphy, Jennifer L.; Langseth, Abraham J.; Bergles, Dwight E.			Myelin remodeling through experience-dependent oligodendrogenesis in the adult somatosensory cortex	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; SYNAPTIC VESICLE RELEASE; IN-VIVO; WHITE-MATTER; PREMYELINATING OLIGODENDROCYTES; INDIVIDUAL OLIGODENDROCYTES; MULTIPLE-SCLEROSIS; AXONAL INTEGRITY; BRAIN; PROGENITORS	Oligodendrocyte generation in the adult CNS provides a means to adapt the properties of circuits to changes in life experience. However, little is known about the dynamics of oligodendrocytes and the extent of myelin remodeling in the mature brain. Using longitudinal in vivo two-photon imaging of oligodendrocytes and their progenitors in the mouse cerebral cortex, we show that myelination is an inefficient and extended process, with half of the final complement of oligodendrocytes generated after 4 months of age. Oligodendrocytes that successfully integrated formed new sheaths on unmyelinated and sparsely myelinated axons, and they were extremely stable, gradually changing the pattern of myelination. Sensory enrichment robustly increased oligodendrocyte integration, but did not change the length of existing sheaths. This experience-dependent enhancement of myelination in the mature cortex may accelerate information transfer in these circuits and strengthen the ability of axons to sustain activity by providing additional metabolic support.	[Hughes, Ethan G.; Orthmann-Murphy, Jennifer L.; Langseth, Abraham J.; Bergles, Dwight E.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21218 USA; [Hughes, Ethan G.] Univ Colorado, Sch Med, Dept Cell & Dev Biol, Aurora, CO 80045 USA; [Orthmann-Murphy, Jennifer L.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA	Johns Hopkins University; University of Colorado System; University of Colorado Anschutz Medical Campus; Johns Hopkins University	Hughes, EG; Bergles, DE (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21218 USA.; Hughes, EG (corresponding author), Univ Colorado, Sch Med, Dept Cell & Dev Biol, Aurora, CO 80045 USA.	ethan.hughes@ucdenver.edu; dbergles@jhmi.edu	Bergles, Dwight/U-8343-2019	Bergles, Dwight/0000-0002-7133-7378; Hughes, Ethan/0000-0003-3243-7429	NRSA grant from the NIH [F32NS076098]; Boettcher Foundation; Whitehall Foundation; Conrad N. Hilton Foundation [17324, 17314]; National Multiple Sclerosis Society [RG-1701-26733]; National Multiple Sclerosis Society Postdoctoral Fellowship [FG 2092-A-1, FG 20114-A-1]; NIH [NS051509, NS050274]; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation, a National MS Society Collaborative Center Award; Brain Science Institute at Johns Hopkins University; Johns Hopkins Medicine Discovery Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS076098, R01NS051509, P30NS050274] Funding Source: NIH RePORTER	NRSA grant from the NIH; Boettcher Foundation; Whitehall Foundation; Conrad N. Hilton Foundation; National Multiple Sclerosis Society(National Multiple Sclerosis Society); National Multiple Sclerosis Society Postdoctoral Fellowship(National Multiple Sclerosis Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dr. Miriam and Sheldon G. Adelson Medical Research Foundation, a National MS Society Collaborative Center Award; Brain Science Institute at Johns Hopkins University; Johns Hopkins Medicine Discovery Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Pucak, N. Ye, H. Hsieh, and A. Doreswamy for technical assistance; T. Shelly for machining expertise; and members of the Bergles laboratory for discussions. We thank T. McCown (University of North Carolina) for the kind gift of AAV9-MBP-eGFP virus. E.G.H. was supported by a NRSA grant from the NIH (F32NS076098), the Boettcher Foundation, the Whitehall Foundation, the Conrad N. Hilton Foundation (17324), and the National Multiple Sclerosis Society (RG-1701-26733). J.O.M. was supported by a National Multiple Sclerosis Society Postdoctoral Fellowship (FG 2092-A-1) and the Conrad N. Hilton Foundation (17314). A.J.L. was supported by a National Multiple Sclerosis Society Postdoctoral Fellowship (FG 20114-A-1). Funding was provided by grants from the NIH (NS051509, NS050274), the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation, a National MS Society Collaborative Center Award, the Brain Science Institute at Johns Hopkins University, and the Johns Hopkins Medicine Discovery Fund to D.E.B.	BARRES BA, 1992, CELL, V70, P31, DOI 10.1016/0092-8674(92)90531-G; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Bengtsson SL, 2005, NAT NEUROSCI, V8, P1148, DOI 10.1038/nn1516; Bryson-Richardson R. J., 2014, JOVE-J VIS EXP, V85; Cerghet M, 2006, J NEUROSCI, V26, P1439, DOI 10.1523/JNEUROSCI.2219-05.2006; Chang A, 2002, NEW ENGL J MED, V346, P165, DOI 10.1056/NEJMoa010994; Chong SYC, 2012, P NATL ACAD SCI USA, V109, P1299, DOI 10.1073/pnas.1113540109; Czopka T, 2013, DEV CELL, V25, P599, DOI 10.1016/j.devcel.2013.05.013; del Rio Hortega P., 1921, B REAL SOC ESPAN BIO, V9, P69; Dimou L, 2008, J NEUROSCI, V28, P10434, DOI 10.1523/JNEUROSCI.2831-08.2008; Exner S., 1881, UNTERSUCHUNGEN LOCAL; Funfschilling U, 2012, NATURE, V485, P517, DOI 10.1038/nature11007; Gibson EM, 2014, SCIENCE, V344, P487, DOI 10.1126/science.1252304; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Green AJ, 2017, LANCET, V390, P2481, DOI 10.1016/S0140-6736(17)32346-2; Hines JH, 2015, NAT NEUROSCI, V18, P683, DOI 10.1038/nn.3992; Holz A, 1996, J NEUROSCI, V16, P467; Hughes EG, 2013, NAT NEUROSCI, V16, P668, DOI 10.1038/nn.3390; Kang SH, 2013, NAT NEUROSCI, V16, P571, DOI 10.1038/nn.3357; Kang SH, 2010, NEURON, V68, P668, DOI 10.1016/j.neuron.2010.09.009; Koudelka S, 2016, CURR BIOL, V26, P1447, DOI 10.1016/j.cub.2016.03.070; Lasiene J, 2009, AGING CELL, V8, P201, DOI 10.1111/j.1474-9726.2009.00462.x; Lee YJ, 2012, NATURE, V487, P443, DOI 10.1038/nature11314; Liu J, 2012, NAT NEUROSCI, V15, P1621, DOI 10.1038/nn.3263; Longair MH, 2011, BIOINFORMATICS, V27, P2453, DOI 10.1093/bioinformatics/btr390; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Makinodan M, 2012, SCIENCE, V337, P1357, DOI 10.1126/science.1220845; Marques S, 2016, SCIENCE, V352, P1326, DOI 10.1126/science.aaf6463; McKenzie IA, 2014, SCIENCE, V346, P318, DOI 10.1126/science.1254960; Mensch S, 2015, NAT NEUROSCI, V18, P628, DOI 10.1038/nn.3991; Micheva KD, 2016, ELIFE, V5, DOI 10.7554/eLife.15784; Murtie JC, 2007, J NEUROSCI RES, V85, P2080, DOI 10.1002/jnr.21339; Nave KA, 2010, NATURE, V468, P244, DOI 10.1038/nature09614; Ouzounov DG, 2017, NAT METHODS, V14, P388, DOI 10.1038/nmeth.4183; Peters A, 2012, NEUROBIOL AGING, V33, P2357, DOI 10.1016/j.neurobiolaging.2011.11.015; Redmond SA, 2016, NEURON, V91, P824, DOI 10.1016/j.neuron.2016.07.021; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; Schain AJ, 2014, NAT MED, V20, P443, DOI 10.1038/nm.3495; Scholz J, 2009, NAT NEUROSCI, V12, P1370, DOI 10.1038/nn.2412; Shen SM, 2008, NAT NEUROSCI, V11, P1024, DOI 10.1038/nn.2172; Takebayashi H, 2002, CURR BIOL, V12, P1157, DOI 10.1016/S0960-9822(02)00926-0; Tomassy GS, 2014, SCIENCE, V344, P319, DOI 10.1126/science.1249766; Trapp BD, 1997, J CELL BIOL, V137, P459, DOI 10.1083/jcb.137.2.459; Tripathi RB, 2017, CELL REP, V21, P316, DOI 10.1016/j.celrep.2017.09.050; Watkins TA, 2008, NEURON, V60, P555, DOI 10.1016/j.neuron.2008.09.011; Xiao L, 2016, NAT NEUROSCI, V19, P1210, DOI 10.1038/nn.4351; Yakovlev PL, 1967, REGIONAL DEV BRAIN E, P3; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577; Yeung MSY, 2014, CELL, V159, P766, DOI 10.1016/j.cell.2014.10.011; Young KM, 2013, NEURON, V77, P873, DOI 10.1016/j.neuron.2013.01.006	50	223	224	3	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2018	21	5					696	+		10.1038/s41593-018-0121-5	http://dx.doi.org/10.1038/s41593-018-0121-5			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GE4EB	29556025	Green Accepted			2022-12-17	WOS:000431166100009
J	Herb, BR; Wolschin, F; Hansen, KD; Aryee, MJ; Langmead, B; Irizarry, R; Amdam, GV; Feinberg, AP				Herb, Brian R.; Wolschin, Florian; Hansen, Kasper D.; Aryee, Martin J.; Langmead, Ben; Irizarry, Rafael; Amdam, Gro V.; Feinberg, Andrew P.			Reversible switching between epigenetic states in honeybee behavioral subcastes	NATURE NEUROSCIENCE			English	Article							GENE-EXPRESSION; DNA METHYLATION; ENCODES; MEMORY; SYSTEM; FAMILY	In honeybee societies, distinct caste phenotypes are created from the same genotype, suggesting a role for epigenetics in deriving these behaviorally different phenotypes. We found no differences in DNA methylation between irreversible worker and queen castes, but substantial differences between nurses and forager subcastes. Reverting foragers back to nurses reestablished methylation levels for a majority of genes and provides, to the best of our knowledge, the first evidence in any organism of reversible epigenetic changes associated with behavior.	[Wolschin, Florian; Amdam, Gro V.] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, As, Norway; [Herb, Brian R.; Hansen, Kasper D.; Aryee, Martin J.; Feinberg, Andrew P.] Johns Hopkins Univ, Sch Med, Ctr Epigenet, Baltimore, MD USA; [Herb, Brian R.; Feinberg, Andrew P.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Wolschin, Florian; Amdam, Gro V.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Hansen, Kasper D.; Langmead, Ben; Irizarry, Rafael; Feinberg, Andrew P.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [Aryee, Martin J.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Feinberg, Andrew P.] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA	Norwegian University of Life Sciences; Johns Hopkins University; Johns Hopkins University; Arizona State University; Arizona State University-Tempe; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University	Amdam, GV (corresponding author), Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, As, Norway.	gro.amdam@asu.edu; afeinberg@jhu.edu	Aryee, Martin/AAC-8113-2020; Langmead, Ben/F-4218-2012; Feinberg, Andrew/AAY-7666-2020; Hansen, Kasper D/E-6094-2011	Langmead, Ben/0000-0003-2437-1976; Hansen, Kasper D/0000-0003-0086-0687; Feinberg, Andrew/0000-0002-8364-1991	Research Council of Norway [191699]; PEW Charitable Trust [2009-000068001]; US National Institutes of Health [1DPIOD008324]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [DP1ES022579] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD008324] Funding Source: NIH RePORTER	Research Council of Norway(Research Council of Norway); PEW Charitable Trust; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank E. Fennern, N. Baker, K. Flores and O. Kaftanoglu for assistance with colonies, bees and brain dissections, and A. Doi for reviewing the manuscript. We thank G. Klein for serving as scientific schadchen to AYE and G.V.A. after hearing them lecture on different occasions at I. Ernberg's "What is Life" series at the Karolinska Institute, without which this research would not have taken place. G.V.A. was funded by the Research Council of Norway #191699 and the PEW Charitable Trust #2009-000068001. A.P.F. was funded by US National Institutes of Health grant 1DPIOD008324.	Amdam GV, 2011, AGING CELL, V10, P18, DOI 10.1111/j.1474-9726.2010.00647.x; Barak O, 2003, EMBO J, V22, P6089, DOI 10.1093/emboj/cdg582; Elango N, 2009, P NATL ACAD SCI USA, V106, P11206, DOI 10.1073/pnas.0900301106; GoldmanLevi R, 1996, NUCLEIC ACIDS RES, V24, P3121, DOI 10.1093/nar/24.16.3121; Guo JJU, 2011, NAT NEUROSCI, V14, P1345, DOI 10.1038/nn.2900; Ji H, 2010, NATURE, V467, P338, DOI 10.1038/nature09367; Linder P, 2006, NUCLEIC ACIDS RES, V34, P4168, DOI 10.1093/nar/gkl468; Lyko F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000506; Melicharek DJ, 2010, HUM MOL GENET, V19, P4253, DOI 10.1093/hmg/ddq348; Miller CA, 2007, NEURON, V53, P857, DOI 10.1016/j.neuron.2007.02.022; Parsyan A, 2011, NAT REV MOL CELL BIO, V12, P235, DOI 10.1038/nrm3083; ROBINSON GE, 1992, ETHOLOGY, V90, P336, DOI 10.1111/j.1439-0310.1992.tb00844.x; Suganuma T, 2008, NAT STRUCT MOL BIOL, V15, P364, DOI 10.1038/nsmb.1397; Terriente-Felix A, 2011, DEV BIOL, V350, P382, DOI 10.1016/j.ydbio.2010.12.003; TSUKIYAMA T, 1995, CELL, V83, P1021, DOI 10.1016/0092-8674(95)90217-1; Wang Y, 2006, SCIENCE, V314, P645, DOI 10.1126/science.1135213; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Whitfield CW, 2003, SCIENCE, V302, P296, DOI 10.1126/science.1086807; Winston M.L., 1991, BIOL HONEY BEE; Wolf C, 2012, GENES BRAIN BEHAV, V11, P3, DOI 10.1111/j.1601-183X.2011.00752.x	20	223	228	1	151	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2012	15	10					1371	1373		10.1038/nn.3218	http://dx.doi.org/10.1038/nn.3218			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	013VZ	22983211	Green Accepted			2022-12-17	WOS:000309335300016
J	Scott, CE; Wynn, SL; Sesay, A; Cruz, C; Cheung, M; Gaviro, MVG; Booth, S; Gao, B; Cheah, KSE; Lovell-Badge, R; Briscoe, J				Scott, Charlotte E.; Wynn, Sarah L.; Sesay, Abdul; Cruz, Catarina; Cheung, Martin; Gaviro, Maria-Victoria Gomez; Booth, Sarah; Gao, Bo; Cheah, Kathryn S. E.; Lovell-Badge, Robin; Briscoe, James			SOX9 induces and maintains neural stem cells	NATURE NEUROSCIENCE			English	Article							SONIC HEDGEHOG; SELF-RENEWAL; GENE-EXPRESSION; EPENDYMAL CELLS; CNS PRECURSOR; GLIAL-CELLS; IN-VITRO; MOUSE; DIFFERENTIATION; PROLIFERATION	Neural stem cells (NSCs) are uncommitted cells of the CNS defined by their multipotentiality and ability to self renew. We found these cells to not be present in substantial numbers in the CNS until after embryonic day (E) 10.5 in mouse and E5 in chick. This coincides with the induction of SOX9 in neural cells. Gain- and loss-of-function studies indicated that SOX9 was essential for multipotent NSC formation. Moreover, Sonic Hedgehog was able to stimulate precocious generation of NSCs by inducing Sox9 expression. SOX9 was also necessary for the maintenance of multipotent NSCs, as shown by in vivo fate mapping experiments in the adult subependymal zone and olfactory bulbs. In addition, loss of SOX9 led ependymal cells to adopt a neuroblast identity. These data identify a functional link between extrinsic and intrinsic mechanisms of NSCs specification and maintenance, and establish a central role for SOX9 in the process.	[Scott, Charlotte E.; Wynn, Sarah L.; Sesay, Abdul; Gaviro, Maria-Victoria Gomez; Booth, Sarah; Lovell-Badge, Robin] Natl Inst Med Res, Div Stem Cell Biol & Dev Genet, MRC, London NW7 1AA, England; [Scott, Charlotte E.; Cruz, Catarina; Cheung, Martin; Briscoe, James] Natl Inst Med Res, Div Dev Neurobiol, MRC, London NW7 1AA, England; [Wynn, Sarah L.; Cheung, Martin; Gao, Bo; Cheah, Kathryn S. E.] Univ Hong Kong, Dept Biochem, Hong Kong, Hong Kong, Peoples R China	MRC National Institute for Medical Research; MRC National Institute for Medical Research; University of Hong Kong	Lovell-Badge, R (corresponding author), Natl Inst Med Res, Div Stem Cell Biol & Dev Genet, MRC, Mill Hill, London NW7 1AA, England.	rlovell@nimr.mrc.ac.uk; jbrisco@nimr.mrc.ac.uk	cruz, catarina/I-1387-2013; Cheung, Martin Chi Hang/C-4235-2009	cruz, catarina/0000-0001-9139-8453; Lovell-Badge, Robin/0000-0001-9364-4179; Cheung, Martin Chi Hang/0000-0002-3471-8534; Briscoe, James/0000-0002-1020-5240; Gao, Bo/0000-0002-8684-5199; Gomez-Gaviro, Maria Victoria/0000-0002-8683-5150	UK Medical Research Council; US National Institutes of Health (National Institute of Biomedical Imaging and Bioengineering) [U117512772]; Hong Kong Research Grants Council; MRC [MC_U117562207] Funding Source: UKRI; Medical Research Council [MC_U117562207] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); US National Institutes of Health (National Institute of Biomedical Imaging and Bioengineering); Hong Kong Research Grants Council(Hong Kong Research Grants Council); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank A. Schedl (INSERM U636, Nice) for the conditional Sox9 mutant mice, A. Nagy (Samuel Lunenfeld Research Institute) for the pCall2 vector, W.C.W. Chan for blastocyst injections and production of Z/Sox9 mice and T. Caspary (Emory University) for the Arl13b antibody. The CMV:cre construct was a gift from S.O'Gorman (Salk Institute). Thank you to S. Guioli, F. Guillemot and L. Reynard for critical reading of the manuscript, to C. Andoniadou for advice and training in the ways of neurosphere cultures, to W. Han Yau in the photographics department at NIMR for help with illustrations, to T. Matabanadzo and other biological services staff at NIMR for help with the mouse colonies and other members of our laboratories for discussion and encouragement. This work was supported by the UK Medical Research Council (U117512772), a US National Institutes of Health (National Institute of Biomedical Imaging and Bioengineering) Quantum Grant (R.L.-B. and C.E.S.), and grants from the Hong Kong Research Grants Council and the Hong Kong University Grants Council Area of Excellence Scheme (S.L.W. and K.S.E.C.).	Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Akiyama H, 2004, P NATL ACAD SCI USA, V101, P6502, DOI 10.1073/pnas.0401711101; ANTON M, 1995, J VIROL, V69, P4600, DOI 10.1128/JVI.69.8.4600-4606.1995; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bien-Willner GA, 2007, HUM MOL GENET, V16, P1143, DOI 10.1093/hmg/ddm061; Bonaguidi MA, 2008, J NEUROSCI, V28, P9194, DOI 10.1523/JNEUROSCI.3314-07.2008; Carlen M, 2009, NAT NEUROSCI, V12, P259, DOI 10.1038/nn.2268; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Cheung M, 2003, DEVELOPMENT, V130, P5681, DOI 10.1242/dev.00808; Cheung M, 2005, DEV CELL, V8, P179, DOI 10.1016/j.devcel.2004.12.010; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Doetsch F, 2003, NAT NEUROSCI, V6, P1127, DOI 10.1038/nn1144; Favaro R, 2009, NAT NEUROSCI, V12, P1248, DOI 10.1038/nn.2397; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gulacsi AA, 2008, NAT NEUROSCI, V11, P1383, DOI 10.1038/nn.2226; HOUSTON CS, 1983, AM J MED GENET, V15, P3, DOI 10.1002/ajmg.1320150103; Kalani MYS, 2008, P NATL ACAD SCI USA, V105, P16970, DOI 10.1073/pnas.0808616105; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kordes U, 2006, J NEURO-ONCOL, V80, P151, DOI 10.1007/s11060-006-9180-7; Kordes U, 2005, DEV BRAIN RES, V157, P209, DOI 10.1016/j.devbrainres.2005.03.009; Lai K, 2003, NAT NEUROSCI, V6, P21, DOI 10.1038/nn983; Machold R, 2003, NEURON, V39, P937, DOI 10.1016/S0896-6273(03)00561-0; Miller SJ, 2006, CANCER RES, V66, P2584, DOI 10.1158/0008-5472.CAN-05-3330; Mizutani K, 2007, NATURE, V449, P351, DOI 10.1038/nature06090; Nowak JA, 2008, CELL STEM CELL, V3, P33, DOI 10.1016/j.stem.2008.05.009; Okubo T, 2005, DEVELOPMENT, V132, P1363, DOI 10.1242/dev.01678; Palma V, 2004, DEVELOPMENT, V131, P337, DOI 10.1242/dev.00930; Pevny L, 2005, CURR OPIN NEUROBIOL, V15, P7, DOI 10.1016/j.conb.2005.01.016; Poche RA, 2008, J COMP NEUROL, V510, P237, DOI 10.1002/cne.21746; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; Rowitch DH, 1999, J NEUROSCI, V19, P8954, DOI 10.1523/JNEUROSCI.19-20-08954.1999; Shi YH, 2008, CRIT REV ONCOL HEMAT, V65, P43, DOI 10.1016/j.critrevonc.2007.06.004; Sottile V, 2006, BRAIN RES, V1099, P8, DOI 10.1016/j.brainres.2006.04.127; Spassky N, 2005, J NEUROSCI, V25, P10, DOI 10.1523/JNEUROSCI.1108-04.2005; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stamataki D, 2005, GENE DEV, V19, P626, DOI 10.1101/gad.325905; Stolt CC, 2010, INT J BIOCHEM CELL B, V42, P437, DOI 10.1016/j.biocel.2009.07.014; Stolt CC, 2003, GENE DEV, V17, P1677, DOI 10.1101/gad.259003; Takaki M, 2006, STEM CELLS, V24, P1414, DOI 10.1634/stemcells.2005-0394; Takanaga H, 2009, STEM CELLS, V27, P165, DOI 10.1634/stemcells.2008-0580; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Vidal VPI, 2005, CURR BIOL, V15, P1340, DOI 10.1016/j.cub.2005.06.064; Wood HB, 1999, MECH DEVELOP, V86, P197, DOI 10.1016/S0925-4773(99)00116-1	45	223	230	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2010	13	10					1181	1189		10.1038/nn.2646	http://dx.doi.org/10.1038/nn.2646			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	654MB	20871603	Green Submitted			2022-12-17	WOS:000282171300009
J	Bhandawat, V; Olsen, SR; Gouwens, NW; Schlief, ML; Wilson, RI				Bhandawat, Vikas; Olsen, Shawn R.; Gouwens, Nathan W.; Schlief, Michelle L.; Wilson, Rachel I.			Sensory processing in the Drosophila antennal lobe increases reliability and separability of ensemble odor representations	NATURE NEUROSCIENCE			English	Article							OLFACTORY NETWORK DYNAMICS; PRIMARY VISUAL-CORTEX; RESPONSE VARIABILITY; CORTICAL-NEURONS; SYSTEM; MELANOGASTER; ORGANIZATION; INFORMATION; BULB; FLY	Here we describe several fundamental principles of olfactory processing in the Drosophila melanogaster antennal lobe (the analog of the vertebrate olfactory bulb), through the systematic analysis of input and output spike trains of seven identified glomeruli. Repeated presentations of the same odor elicit more reproducible responses in second-order projection neurons (PNs) than in their presynaptic olfactory receptor neurons (ORNs). PN responses rise and accommodate rapidly, emphasizing odor onset. Furthermore, weak ORN inputs are amplified in the PN layer but strong inputs are not. This nonlinear transformation broadens PN tuning and produces more uniform distances between odor representations in PN coding space. In addition, portions of the odor response profile of a PN are not systematically related to their direct ORN inputs, which probably indicates the presence of lateral connections between glomeruli. Finally, we show that a linear discriminator classifies odors more accurately using PN spike trains than using an equivalent number of ORN spike trains.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Wilson, RI (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	rachel_wilson@hms.harvard.edu	Wilson, Rachel/E-2227-2012	Wilson, Rachel/0000-0001-8573-9266; Olsen, Shawn/0000-0002-9568-7057	NIDCD NIH HHS [1F32DC008471-01A1, R01 DC008174-02, R01 DC008174, F32 DC008741] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008174, F32DC008741] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Alonso JM, 2001, J NEUROSCI, V21, P4002, DOI 10.1523/JNEUROSCI.21-11-04002.2001; Armstrong-Gold CE, 2003, J NEUROSCI, V23, P3796; Bargmann CI, 2006, NATURE, V444, P295, DOI 10.1038/nature05402; Bazhenov M, 2005, NEURON, V46, P483, DOI 10.1016/j.neuron.2005.03.022; Berry MJ, 1997, P NATL ACAD SCI USA, V94, P5411, DOI 10.1073/pnas.94.10.5411; Berry MJ, 1998, J NEUROSCI, V18, P2200; Budick SA, 2006, J EXP BIOL, V209, P3001, DOI 10.1242/jeb.02305; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; de Bruyne M, 1999, J NEUROSCI, V19, P4520; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; DERBY CD, 1984, J NEUROPHYSIOL, V51, P906, DOI 10.1152/jn.1984.51.5.906; DUCHAMP A, 1982, CHEM SENSES, V7, P191, DOI 10.1093/chemse/7.2.191; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2004, TRENDS GENET, V20, P453, DOI 10.1016/j.tig.2004.06.015; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Kara P, 2000, NEURON, V27, P635, DOI 10.1016/S0896-6273(00)00072-6; Laissue PP, 1999, J COMP NEUROL, V405, P543; LAUGHLIN S, 1981, Z NATURFORSCH C, V36, P910; LAUGHLIN SB, 1987, PROC R SOC SER B-BIO, V231, P437, DOI 10.1098/rspb.1987.0054; Laurent G, 2002, NAT REV NEUROSCI, V3, P884, DOI 10.1038/nrn964; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; MATHEWS DF, 1972, J GEN PHYSIOL, V60, P166; Mazor O, 2005, NEURON, V48, P661, DOI 10.1016/j.neuron.2005.09.032; Mombaerts P, 2004, NAT REV NEUROSCI, V5, P263, DOI 10.1038/nrn1365; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; Nozawa M, 2007, P NATL ACAD SCI USA, V104, P7122, DOI 10.1073/pnas.0702133104; Olsen SR, 2007, NEURON, V54, P89, DOI 10.1016/j.neuron.2007.03.010; Perez-Orive J, 2002, SCIENCE, V297, P359, DOI 10.1126/science.1070502; Pologruto TA, 2004, J NEUROSCI, V24, P9572, DOI 10.1523/JNEUROSCI.2854-04.2004; Schlief ML, 2007, NAT NEUROSCI, V10, P623, DOI 10.1038/nn1881; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Shanbhag SR, 1999, INT J INSECT MORPHOL, V28, P377, DOI 10.1016/S0020-7322(99)00039-2; Shang YH, 2007, CELL, V128, P601, DOI 10.1016/j.cell.2006.12.034; Simoncelli EP, 2003, CURR OPIN NEUROBIOL, V13, P144, DOI 10.1016/S0959-4388(03)00047-3; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; Stopfer M, 1999, NATURE, V402, P664, DOI 10.1038/45244; Stopfer M, 2003, NEURON, V39, P991, DOI 10.1016/j.neuron.2003.08.011; Tanaka NK, 2004, CURR BIOL, V14, P449, DOI 10.1016/j.cub.2004.03.006; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; Vogel A, 2005, J NEUROPHYSIOL, V93, P3548, DOI 10.1152/jn.01288.2004; Wachowiak M, 2005, J NEUROPHYSIOL, V94, P2700, DOI 10.1152/jn.00286.2005; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wilson RI, 2005, J NEUROSCI, V25, P9069, DOI 10.1523/JNEUROSCI.2070-05.2005; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9	48	223	225	0	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2007	10	11					1474	1482		10.1038/nn1976	http://dx.doi.org/10.1038/nn1976			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	225HT	17922008	Green Accepted			2022-12-17	WOS:000250508400026
J	Wilent, WB; Contreras, D				Wilent, WB; Contreras, D			Dynamics of excitation and inhibition underlying stimulus selectivity in rat somatosensory cortex	NATURE NEUROSCIENCE			English	Article							HIPPOCAMPAL PYRAMIDAL NEURONS; BARREL CORTEX; RESPONSE TRANSFORMATION; NEOCORTICAL NEURONS; THALAMIC BARRELOIDS; WHISKER DEFLECTIONS; TRIGEMINAL GANGLION; RECEPTIVE-FIELDS; SYNAPSE LOCATION; AUDITORY-CORTEX	Neurons in sensory systems respond to stimuli within their receptive fields, but the magnitude of the response depends on specific stimulus features. In the rodent whisker system, the response magnitude to the deflection of a particular whisker is, in most cells, dependent on the direction of deflection. Here we use in vivo intracellular recordings from thalamorecipient neurons in layers 3 and 4 of the rat barrel cortex to elucidate the dynamics of the synaptic inputs underlying direction selectivity. We show that cells are direction selective despite a broadly tuned excitatory and inhibitory synaptic input. Selectivity emerges from a direction-dependent temporal shift of excitation relative to inhibition. For preferred direction deflections, excitation precedes inhibition, but as the direction diverges from the preferred, this separation decreases. Our results illustrate a mechanism by which the timing of the synaptic inputs, and not their relative peak amplitudes, primarily determine feature selectivity.	Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19106 USA	University of Pennsylvania	Contreras, D (corresponding author), Univ Penn, Sch Med, Dept Neurosci, 215 Stemmler Hall, Philadelphia, PA 19106 USA.	diegoc@mail.med.upenn.edu						Bruno RM, 2003, J NEUROSCI, V23, P9565; Bruno RM, 2002, J NEUROSCI, V22, P10966; Carandini M, 2000, J NEUROSCI, V20, P470, DOI 10.1523/JNEUROSCI.20-01-00470.2000; Castro-Alamancos MA, 2002, J NEUROPHYSIOL, V87, P946, DOI 10.1152/jn.00426.2001; CONNORS BW, 1990, TRENDS NEUROSCI, V13, P99, DOI 10.1016/0166-2236(90)90185-D; CONNORS BW, 1982, J PHARMACOL EXP THER, V220, P476; Contreras D, 2004, NEURAL NETWORKS, V17, P633, DOI 10.1016/j.neunet.2004.04.003; Deschenes M, 2003, J NEUROSCI, V23, P6778; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Feldmeyer D, 1999, J PHYSIOL-LONDON, V521, P169, DOI 10.1111/j.1469-7793.1999.00169.x; Higley MJ, 2003, J NEUROSCI, V23, P10190; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; JENSEN KF, 1987, J NEUROSCI, V7, P3529; Johnston D, 1996, FDN CELLULAR NEUROPH; Lee SH, 2004, J NEUROPHYSIOL, V91, P223, DOI 10.1152/jn.00541.2003; Leventhal AG, 2003, SCIENCE, V300, P812, DOI 10.1126/science.1082874; LICHTENSTEIN SH, 1990, SOMATOSENS MOT RES, V7, P47, DOI 10.3109/08990229009144697; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; Martinez LM, 2002, J PHYSIOL-LONDON, V540, P321, DOI 10.1113/jphysiol.2001.012776; MILLER W, 1988, CABIOS, V4, P11; Minnery BS, 2003, J NEUROPHYSIOL, V90, P1556, DOI 10.1152/jn.00111.2003; Monier C, 2003, NEURON, V37, P663, DOI 10.1016/S0896-6273(03)00064-3; Moore CI, 1998, J NEUROPHYSIOL, V80, P2882, DOI 10.1152/jn.1998.80.6.2882; MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P408, DOI 10.1152/jn.1957.20.4.408; Mountcastle VB, 2003, CEREB CORTEX, V13, P2, DOI 10.1093/cercor/13.1.2; MULLE C, 1985, BRAIN RES, V333, P350, DOI 10.1016/0006-8993(85)91591-4; Petersen CCH, 2000, J NEUROSCI, V20, P7579; Pinto DJ, 2003, CEREB CORTEX, V13, P33, DOI 10.1093/cercor/13.1.33; Pinto DJ, 2000, J NEUROPHYSIOL, V83, P1158, DOI 10.1152/jn.2000.83.3.1158; Schmolesky MT, 2000, NAT NEUROSCI, V3, P384, DOI 10.1038/73957; SCHULTE F J, 1969, Neuropaediatrie, V1, P36, DOI 10.1055/s-0028-1091862; Shoykhet M, 2000, SOMATOSENS MOT RES, V17, P171; SIMONS DJ, 1992, EXP BRAIN RES, V91, P259; SIMONS DJ, 1989, J NEUROPHYSIOL, V61, P311, DOI 10.1152/jn.1989.61.2.311; Staiger JF, 2004, CEREB CORTEX, V14, P690, DOI 10.1093/cercor/bhh029; Swadlow HA, 2002, J NEUROSCI, V22, P7766; Swadlow HA, 2000, J NEUROPHYSIOL, V83, P2802, DOI 10.1152/jn.2000.83.5.2802; Tan AYY, 2004, J NEUROPHYSIOL, V92, P630, DOI 10.1152/jn.01020.2003; Temereanca S, 2003, J NEUROPHYSIOL, V89, P2137, DOI 10.1152/jn.00582.2002; Timofeeva E, 2003, J NEUROSCI, V23, P10717; Veinante P, 1999, J NEUROSCI, V19, P5085; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Wilent WB, 2005, J NEUROSCI, V25, P2983, DOI 10.1523/JNEUROSCI.4906-04.2005; Wilent WB, 2004, J NEUROSCI, V24, P3985, DOI 10.1523/JNEUROSCI.5782-03.2004; WILLIAMS MN, 1994, EUR J NEUROSCI, V6, P429, DOI 10.1111/j.1460-9568.1994.tb00286.x; Williams SR, 2002, SCIENCE, V295, P1907, DOI 10.1126/science.1067903; ZUCKER E, 1969, BRAIN RES, V12, P138, DOI 10.1016/0006-8993(69)90061-4	47	223	229	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2005	8	10					1364	1370		10.1038/nn1545	http://dx.doi.org/10.1038/nn1545			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	968EY	16158064				2022-12-17	WOS:000232145900021
J	Dombrowski, Y; O'Hagan, T; Dittmer, M; Penalva, R; Mayoral, SR; Bankhead, P; Fleville, S; Eleftheriadis, G; Zhao, C; Naughton, M; Hassan, R; Moffat, J; Falconer, J; Boyd, A; Hamilton, P; Allen, IV; Kissenpfennig, A; Moynagh, PN; Evergren, E; Perbal, B; Williams, AC; Ingram, RJ; Chan, JR; Franklin, RJM; Fitzgerald, DC				Dombrowski, Yvonne; O'Hagan, Thomas; Dittmer, Marie; Penalva, Rosana; Mayoral, Sonia R.; Bankhead, Peter; Fleville, Samara; Eleftheriadis, George; Zhao, Chao; Naughton, Michelle; Hassan, Rachel; Moffat, Jill; Falconer, John; Boyd, Amanda; Hamilton, Peter; Allen, Ingrid V.; Kissenpfennig, Adrien; Moynagh, Paul N.; Evergren, Emma; Perbal, Bernard; Williams, Anna C.; Ingram, Rebecca J.; Chan, Jonah R.; Franklin, Robin J. M.; Fitzgerald, Denise C.			Regulatory T cells promote myelin regeneration in the central nervous system	NATURE NEUROSCIENCE			English	Article							MOUSE SPINAL-CORD; CNS REMYELINATION; DIFFERENTIAL EXPRESSION; INDUCED DEMYELINATION; MULTIPLE-SCLEROSIS; CCN FAMILY; MICE; REPAIR; MACROPHAGES; ACTIVATION	Regeneration of CNS myelin involves differentiation of oligodendrocytes from oligodendrocyte progenitor cells. In multiple sclerosis, remyelination can fail despite abundant oligodendrocyte progenitor cells, suggesting impairment of oligodendrocyte differentiation. T cells infiltrate the CNS in multiple sclerosis, yet little is known about T cell functions in remyelination. We report that regulatory T cells (T-reg) promote oligodendrocyte differentiation and (re) myelination. T-reg-deficient mice exhibited substantially impaired remyelination and oligodendrocyte differentiation, which was rescued by adoptive transfer of T-reg. In brain slice cultures, T-reg accelerated developmental myelination and remyelination, even in the absence of overt inflammation. T-reg directly promoted oligodendrocyte progenitor cell differentiation and myelination in vitro. We identified CCN3 as a T-reg-derived mediator of oligodendrocyte differentiation and myelination in vitro. These findings reveal a new regenerative function of T-reg in the CNS, distinct from immunomodulation. Although the cells were originally named 'T-reg' to reflect immunoregulatory roles, this also captures emerging, regenerative T-reg functions.	[Dombrowski, Yvonne; O'Hagan, Thomas; Dittmer, Marie; Penalva, Rosana; Fleville, Samara; Eleftheriadis, George; Naughton, Michelle; Hassan, Rachel; Moffat, Jill; Falconer, John; Allen, Ingrid V.; Kissenpfennig, Adrien; Moynagh, Paul N.; Ingram, Rebecca J.; Fitzgerald, Denise C.] Queens Univ Belfast, Ctr Expt Med, Sch Med Dent & Biomed Sci, Belfast, North Ireland; [Mayoral, Sonia R.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Mayoral, Sonia R.] Univ Calif San Francisco, Program Neurosci, San Francisco, CA 94143 USA; [Bankhead, Peter; Hamilton, Peter; Evergren, Emma] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Sch Med Dent & Biomed Sci, Belfast, North Ireland; [Zhao, Chao; Franklin, Robin J. M.] Univ Cambridge, Cambridge Stem Cell Inst, Wellcome Trust Med Res Council, Clifford Allbutt Bldg,Cambridge Biomedical Campus, Cambridge, England; [Boyd, Amanda; Williams, Anna C.] Univ Edinburgh, Ctr Regenerat Med, Edinburgh, Midlothian, Scotland; [Moynagh, Paul N.] Natl Univ Ireland Maynooth, Inst Immunol, Dept Biol, Maynooth, Kildare, Ireland; [Perbal, Bernard] Univ Cote Azur, CNRS, GREDEG, Nice, France; [Perbal, Bernard] Int CCN Soc, Paris, France	Queens University Belfast; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Queens University Belfast; University of Cambridge; University of Edinburgh; Maynooth University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Fitzgerald, DC (corresponding author), Queens Univ Belfast, Ctr Expt Med, Sch Med Dent & Biomed Sci, Belfast, North Ireland.	d.fitzgerald@qub.ac.uk	Evergren, Emma/X-3677-2019; Bankhead, Peter/AAA-7915-2020; Dombrowski, Yvonne/N-7020-2019; Ingram, Rebecca J/F-9711-2013	Bankhead, Peter/0000-0003-4851-8813; Dombrowski, Yvonne/0000-0003-1732-6288; Ingram, Rebecca J/0000-0003-1832-2457; Moynagh, Paul/0000-0002-4139-3061; Kissenpfennig, Adrien/0000-0002-9633-3111; Evergren, Emma/0000-0002-0775-2921; Zhao, Chao/0000-0003-1144-1621; , denise/0000-0002-8608-430X; Franklin, Robin/0000-0001-6522-2104; Williams, Anna/0000-0002-6329-382X; Naughton, Michelle/0000-0002-7233-913X	Biotechnology and Biological Sciences Research Council [BB/J01026X/1, BB/N003721/1]; Leverhulme Trust [ECF-2014-390]; QUB (QUB - Lucy McGuigan Bequest); UK Multiple Sclerosis Society [941, 50]; MRC UK Regenerative Medicine platform [MR/KO26666/1]; University of Edinburgh Wellcome Trust [WT104915MA]; Wellcome Trust [097922/Z/11/Z, 110138/Z/15/Z]; MRC [097922/Z/11/Z]; Dept. for the Economy (Northern Ireland); British Pathological Society; US National Multiple Sclerosis Society [RG5203A4]; NIH/NINDS [NS095889]; NIH/NIGMS [K12GM081266]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM081266] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS095889] Funding Source: NIH RePORTER; Medical Research Council [MR/K017047/1, MC_PC_12009] Funding Source: researchfish; Rosetrees Trust [M144] Funding Source: researchfish; BBSRC [BB/J01026X/1, BB/N003721/1] Funding Source: UKRI; MRC [MR/K017047/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Leverhulme Trust(Leverhulme Trust); QUB (QUB - Lucy McGuigan Bequest); UK Multiple Sclerosis Society; MRC UK Regenerative Medicine platform(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Edinburgh Wellcome Trust; Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Dept. for the Economy (Northern Ireland); British Pathological Society; US National Multiple Sclerosis Society(National Multiple Sclerosis Society); NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Rosetrees Trust(Rosetrees Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank A. Rudensky (Memorial Sloan Kettering Cancer Centre) for providing Foxp3-DTR mice and B. Malissen (Aix Marseille Universite) for the provision of Foxp3-eGFP mice. We acknowledge extensive technical support from S. Leech, S. Peoples, N. de la Vega Gallardo, S. Mitchell, J. Brown, R. Blain and the staff of the animal facility. This work was supported by the Biotechnology and Biological Sciences Research Council (BB/J01026X/1 and BB/N003721/1, to D.C.F.), The Leverhulme Trust (ECF-2014-390, to Y.D.), QUB (QUB - Lucy McGuigan Bequest, to D.C.F.), The UK Multiple Sclerosis Society (941 and 50, to R.J.M.F. and C.Z.), MRC UK Regenerative Medicine platform (MR/KO26666/1, to A.C.W.), University of Edinburgh Wellcome Trust Multi User Equipment Grant (WT104915MA, to A.C.W.), by a core support grant from the Wellcome Trust and MRC to the Wellcome Trust - Medical Research Council Cambridge Stem Cell Institute (097922/Z/11/Z to R.J.M.F.), studentship support from Dept. for the Economy (Northern Ireland) and British Pathological Society, US National Multiple Sclerosis Society (RG5203A4, to J.R.C.), NIH/NINDS (NS095889, to J.R.C.), NIH/NIGMS IRACDA Postdoctoral Fellowship (K12GM081266, to S.R.M.) and Wellcome Trust (110138/Z/15/Z, to D.C.F.).	Arnett HA, 2004, SCIENCE, V306, P2111, DOI 10.1126/science.1103709; Arpaia N, 2015, CELL, V162, P1078, DOI 10.1016/j.cell.2015.08.021; Bieber AJ, 2003, ANN NEUROL, V53, P680, DOI 10.1002/ana.10578; Birgbauer E, 2004, J NEUROSCI RES, V78, P157, DOI 10.1002/jnr.20248; Burzyn D, 2013, CELL, V155, P1282, DOI 10.1016/j.cell.2013.10.054; Chevalier G, 1998, AM J PATHOL, V152, P1563; Christiaansen AF, 2014, J IMMUNOL METHODS, V406, P58, DOI 10.1016/j.jim.2014.03.005; Funfschilling U, 2012, NATURE, V485, P517, DOI 10.1038/nature11007; HALL SM, 1972, J CELL SCI, V10, P535; HILD W, 1956, Verh Anat Ges, V53, P315; Horste GMZ, 2010, J IMMUNOL METHODS, V354, P80, DOI 10.1016/j.jim.2010.01.012; Huang JK, 2011, NAT NEUROSCI, V14, P45, DOI 10.1038/nn.2702; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Kim Jun, 2013, Exp Neurobiol, V22, P38, DOI 10.5607/en.2013.22.1.38; Kotter MR, 2001, GLIA, V35, P204, DOI 10.1002/glia.1085; Le Dreau G, 2010, MOL CELL NEUROSCI, V43, P60, DOI 10.1016/j.mcn.2009.02.011; Leask A, 2006, J CELL SCI, V119, P4803, DOI 10.1242/jcs.03270; Lee YJ, 2012, NATURE, V487, P443, DOI 10.1038/nature11314; Lin CG, 2003, J BIOL CHEM, V278, P24200, DOI 10.1074/jbc.M302028200; Ling CY, 2008, J IMMUNOL, V180, P8393, DOI 10.4049/jimmunol.180.12.8393; Liu J, 2012, NAT NEUROSCI, V15, P1621, DOI 10.1038/nn.3263; Mayer CT, 2014, IMMUN INFLAMM DIS, V2, P162, DOI 10.1002/iid3.33; Mei F, 2014, NAT MED, V20, P954, DOI 10.1038/nm.3618; Miron VE, 2013, NAT NEUROSCI, V16, P1211, DOI 10.1038/nn.3469; Ousman SS, 2000, GLIA, V30, P92, DOI 10.1002/(SICI)1098-1136(200003)30:1<92::AID-GLIA10>3.0.CO;2-W; Perbal B, 2001, J CLIN PATHOL-MOL PA, V54, P57, DOI 10.1136/mp.54.2.57; Perbal B, 2013, J CELL COMMUN SIGNAL, V7, P169, DOI 10.1007/s12079-013-0193-7; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Raposo C, 2014, J NEUROSCI, V34, P10141, DOI 10.1523/JNEUROSCI.0076-14.2014; Ruckh JM, 2012, CELL STEM CELL, V10, P96, DOI 10.1016/j.stem.2011.11.019; Saxena A, 2014, AM J PHYSIOL-HEART C, V307, pH1233, DOI 10.1152/ajpheart.00328.2014; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sheridan GK, 2012, GLIA, V60, P382, DOI 10.1002/glia.22272; Su BY, 2001, J CLIN PATHOL-MOL PA, V54, P184, DOI 10.1136/mp.54.3.184; Wang XF, 2014, BIOMATERIALS, V35, P2720, DOI 10.1016/j.biomaterials.2013.12.029; Wang Y, 2008, J IMMUNOL, V180, P1565, DOI 10.4049/jimmunol.180.3.1565; Weirather J, 2014, CIRC RES, V115, P55, DOI 10.1161/CIRCRESAHA.115.303895; Woodruff RH, 2004, MOL CELL NEUROSCI, V25, P252, DOI 10.1016/j.mcn.2003.10.014; Xin LW, 1996, J CLIN PATHOL-CL MOL, V49, pM91; Zhang H, 2011, EXP NEUROL, V230, P138, DOI 10.1016/j.expneurol.2011.04.009; Zhao C, 2006, NEUROBIOL AGING, V27, P1298, DOI 10.1016/j.neurobiolaging.2005.06.008	41	222	228	8	97	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2017	20	5					674	+		10.1038/nn.4528	http://dx.doi.org/10.1038/nn.4528			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ET1CU	28288125	Green Submitted, Green Accepted			2022-12-17	WOS:000400004300008
J	Rideout, EJ; Dornan, AJ; Neville, MC; Eadie, S; Goodwin, SF				Rideout, Elizabeth J.; Dornan, Anthony J.; Neville, Megan C.; Eadie, Suzanne; Goodwin, Stephen F.			Control of sexual differentiation and behavior by the doublesex gene in Drosophila melanogaster	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; MALE COURTSHIP BEHAVIOR; REPRODUCTIVE-BEHAVIOR; SENSORY NEURONS; FRUITLESS GENE; EXPRESSION; CELL; SWITCH; SONG; DIMORPHISM	Doublesex proteins, which are part of the structurally and functionally conserved Dmrt gene family, are important for sex determination throughout the animal kingdom. We inserted Gal4 into the doublesex (dsx) locus of Drosophila melanogaster, allowing us to visualize and manipulate cells expressing dsx in various tissues. In the nervous system, we detected differences between the sexes in dsx-positive neuronal numbers, axonal projections and synaptic density. We found that dsx was required for the development of male-specific neurons that coexpressed fruitless (fru), a regulator of male sexual behavior. We propose that dsx and fru act together to form the neuronal framework necessary for male sexual behavior. We found that disrupting dsx neuronal function had profound effects on male sexual behavior. Furthermore, our results suggest that dsx-positive neurons are involved in pre- to post-copulatory female reproductive behaviors.	[Rideout, Elizabeth J.; Dornan, Anthony J.; Neville, Megan C.; Eadie, Suzanne; Goodwin, Stephen F.] Univ Glasgow, Fac Biomed & Life Sci Integrat & Syst Biol, Glasgow, Lanark, Scotland; [Neville, Megan C.; Goodwin, Stephen F.] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England	University of Glasgow; University of Oxford	Goodwin, SF (corresponding author), Univ Glasgow, Fac Biomed & Life Sci Integrat & Syst Biol, Glasgow, Lanark, Scotland.	stephen.goodwin@dpag.ox.ac.uk	Goodwin, Megan/ABA-9239-2021	Goodwin, Megan/0000-0001-8506-9944; Dornan, Anthony/0000-0002-5228-2893; Goodwin, Stephen/0000-0002-0552-4140; Rideout, Elizabeth/0000-0003-0012-2828	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	We thank T. Aigaki, P. Breslin, B. Dickson, J.-F. Ferveur, F. Hirth, G. Lee, R. Renkawitz-Pohl, Y. Rong and S. Sweeney for providing valuable reagents and protocols, and J.-C. Billeter, J. Hall, J. Levine, B. Oliver and S. Waddell for comments on the manuscript. We also thank members of the Goodwin laboratory for helpful discussions. This work was supported by grants from the Wellcome Trust.	BAKER BS, 1980, GENETICS, V94, P383; BELOTE JM, 1987, P NATL ACAD SCI USA, V84, P8026, DOI 10.1073/pnas.84.22.8026; BERNSTEIN AS, 1992, J INSECT BEHAV, V5, P15, DOI 10.1007/BF01049155; Billeter JC, 2004, J COMP NEUROL, V475, P270, DOI 10.1002/cne.20177; Billeter JC, 2006, CURR BIOL, V16, pR766, DOI 10.1016/j.cub.2006.08.025; Billeter JC, 2006, CURR BIOL, V16, P1063, DOI 10.1016/j.cub.2006.04.039; Broughton SJ, 2004, CURR BIOL, V14, pR290, DOI 10.1016/j.cub.2004.03.037; Camara N, 2008, CURR TOP DEV BIOL, V83, P65, DOI 10.1016/S0070-2153(08)00403-1; Clyne JD, 2008, CELL, V133, P354, DOI 10.1016/j.cell.2008.01.050; Dauwalder B, 2008, CURR GENOMICS, V9, P517, DOI 10.2174/138920208786847980; Demir E, 2005, CELL, V121, P785, DOI 10.1016/j.cell.2005.04.027; Dickson BJ, 2008, SCIENCE, V322, P904, DOI 10.1126/science.1159276; Ferveur J F, 1998, J Neurogenet, V12, P205; HALL JC, 1977, BEHAV GENET, V7, P291, DOI 10.1007/BF01066800; HALL JC, 1979, GENETICS, V92, P437; HAY BA, 1994, DEVELOPMENT, V120, P2121; Kimura K, 2008, NEURON, V59, P759, DOI 10.1016/j.neuron.2008.06.007; Kimura KI, 2005, NATURE, V438, P229, DOI 10.1038/nature04229; Lazareva AA, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030016; Lee G, 2002, J NEUROGENET, V16, P229, DOI 10.1080/01677060216292; Lee G, 2000, J NEUROBIOL, V43, P404, DOI 10.1002/1097-4695(20000615)43:4<404::AID-NEU8>3.0.CO;2-D; MacDonald JM, 2006, NEURON, V50, P869, DOI 10.1016/j.neuron.2006.04.028; Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859; Manoli DS, 2004, NATURE, V430, P564, DOI 10.1038/nature02713; Montell C, 2009, CURR OPIN NEUROBIOL, V19, P345, DOI 10.1016/j.conb.2009.07.001; Ng CS, 2008, BEHAV GENET, V38, P195, DOI 10.1007/s10519-008-9190-7; POSSIDENTE DR, 1989, DEV BIOL, V132, P448, DOI 10.1016/0012-1606(89)90241-8; Rideout EJ, 2007, CURR BIOL, V17, P1473, DOI 10.1016/j.cub.2007.07.047; Rong YS, 2000, SCIENCE, V288, P2013, DOI 10.1126/science.288.5473.2013; Sanders LE, 2008, DEV BIOL, V320, P378, DOI 10.1016/j.ydbio.2008.05.543; Santel A, 1997, MECH DEVELOP, V64, P19, DOI 10.1016/S0925-4773(97)00031-2; Shirangi TR, 2006, NAT GENET, V38, P1435, DOI 10.1038/ng1908; Shirangi TR, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000168; Siwicki KK, 2009, CURR OPIN NEUROBIOL, V19, P200, DOI 10.1016/j.conb.2009.04.001; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Villella A, 1996, GENETICS, V143, P331; Villella A, 2006, J COMP PHYSIOL A, V192, P1253, DOI 10.1007/s00359-006-0154-1; Villella A, 2008, ADV GENET, V62, P67, DOI 10.1016/S0065-2660(08)00603-2; VONSCHILCHER F, 1979, J COMP PHYSIOL, V129, P85, DOI 10.1007/BF00679915; Waterbury JA, 1999, GENETICS, V152, P1653; Williams TM, 2008, CELL, V134, P610, DOI 10.1016/j.cell.2008.06.052; Yang CH, 2009, NEURON, V61, P519, DOI 10.1016/j.neuron.2008.12.021; Zarkower D, 2002, NOVART FDN SYMP, V244, P115	44	222	226	5	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2010	13	4					458	U79		10.1038/nn.2515	http://dx.doi.org/10.1038/nn.2515			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	575NI	20305646	Green Accepted			2022-12-17	WOS:000276073500015
J	Bajo, VM; Nodal, FR; Moore, DR; King, AJ				Bajo, Victoria M.; Nodal, Fernando R.; Moore, David R.; King, Andrew J.			The descending corticocollicular pathway mediates learning-induced auditory plasticity	NATURE NEUROSCIENCE			English	Article							CORTICAL MAP REORGANIZATION; SOUND-LOCALIZATION BEHAVIOR; CORTICOFUGAL MODULATION; INFERIOR COLLICULUS; BRAIN-STEM; SUPERIOR COLLICULUS; RECEPTIVE-FIELDS; CORTEX; PROJECTIONS; MIDBRAIN	Descending projections from sensory areas of the cerebral cortex are among the largest pathways in the brain, suggesting that they are important for subcortical processing. Although corticofugal inputs have been shown to modulate neuronal responses in the thalamus and midbrain, the behavioral importance of these changes remains unknown. In the auditory system, one of the major descending pathways is from cortical layer V pyramidal cells to the inferior colliculus in the midbrain. We examined the role of these neurons in experience-dependent recalibration of sound localization in adult ferrets by selectively killing the neurons using chromophore-targeted laser photolysis. When provided with appropriate training, animals normally relearn to localize sound accurately after altering the spatial cues available by reversibly occluding one ear. However, this ability was lost after eliminating corticocollicular neurons, whereas normal sound-localization accuracy was unaffected. The integrity of this descending pathway is therefore critical for learning-induced localization plasticity.	[Bajo, Victoria M.; Nodal, Fernando R.; Moore, David R.; King, Andrew J.] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England	University of Oxford	King, AJ (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Oxford, England.	andrew.king@dpag.ox.ac.uk	Nodal, Fernando/U-5700-2019; King, Andrew J/M-6708-2013	Nodal, Fernando/0000-0002-1039-6032; King, Andrew J/0000-0001-5180-7179; Bajo, Victoria/0000-0002-3612-2048	Wellcome Trust through a Principal Research Fellowship [WT076508AIA];  [WT069600/Z/02/Z]; MRC [MC_U135079236] Funding Source: UKRI; Medical Research Council [MC_U135079236] Funding Source: researchfish	Wellcome Trust through a Principal Research Fellowship(Wellcome Trust); ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to J.D. Macklis and R.Fricker-Gates for helping us to set up the chromophore-targeted laser photolysis technique and to B. Willmore for statistical advice. K. Allen and A. Fieger assisted with the early stages of the project, and J. Bizley, R. Campbell, D. Kumpik and S. Spires contributed to the behavioral testing and provided valuable discussion. This work was supported by the Wellcome Trust through a Principal Research Fellowship to A. J. K. (WT076508AIA) and a project grant to A.J.K. and D.R.M. (WT069600/Z/02/Z).	Alvarado JC, 2007, J NEUROSCI, V27, P12775, DOI 10.1523/JNEUROSCI.3524-07.2007; Bajo VM, 2007, CEREB CORTEX, V17, P475, DOI 10.1093/cercor/bhj164; BAUER RW, 1966, J ACOUST SOC AM, V40, P441, DOI 10.1121/1.1910093; Chase SM, 2008, J NEUROPHYSIOL, V99, P1672, DOI 10.1152/jn.00644.2007; Dahmen JC, 2007, CURR OPIN NEUROBIOL, V17, P456, DOI 10.1016/j.conb.2007.07.004; Davis KA, 1999, J NEUROPHYSIOL, V82, P164, DOI 10.1152/jn.1999.82.1.164; EDELINE JM, 1991, BEHAV NEUROSCI, V105, P618, DOI 10.1037/0735-7044.105.5.618; Eyding D, 2003, J NEUROSCI, V23, P7021, DOI 10.1523/JNEUROSCI.23-18-07021.2003; Florentine M, 1976, J Am Audiol Soc, V1, P243; Gilbert CD, 2009, J PHYSIOL-LONDON, V587, P2743, DOI 10.1113/jphysiol.2009.171488; HEFFNER HE, 1990, J NEUROPHYSIOL, V64, P915, DOI 10.1152/jn.1990.64.3.915; Hofman PM, 2003, EXP BRAIN RES, V148, P458, DOI 10.1007/s00221-002-1320-5; JENKINS WM, 1984, J NEUROPHYSIOL, V52, P819, DOI 10.1152/jn.1984.52.5.819; Jiang W, 2002, J COGNITIVE NEUROSCI, V14, P1240, DOI 10.1162/089892902760807230; Jin C, 2004, J ACOUST SOC AM, V115, P3124, DOI 10.1121/1.1736649; Kacelnik O, 2006, PLOS BIOL, V4, P627, DOI 10.1371/journal.pbio.0040071; KAVANAGH GL, 1987, J NEUROPHYSIOL, V57, P1746, DOI 10.1152/jn.1987.57.6.1746; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; King AJ, 2001, TRENDS COGN SCI, V5, P261, DOI 10.1016/S1364-6613(00)01660-0; King AJ, 1998, J COMP NEUROL, V390, P342; King AJ, 2000, P NATL ACAD SCI USA, V97, P11821, DOI 10.1073/pnas.97.22.11821; KNUDSEN EI, 1984, J NEUROSCI, V4, P1001; Krupa DJ, 1999, P NATL ACAD SCI USA, V96, P8200, DOI 10.1073/pnas.96.14.8200; Lomber SG, 2001, J COMP NEUROL, V441, P44, DOI 10.1002/cne.1396; Luo F, 2008, J NEUROSCI, V28, P11615, DOI 10.1523/JNEUROSCI.3972-08.2008; Ma XF, 2001, P NATL ACAD SCI USA, V98, P14060, DOI 10.1073/pnas.241517098; Ma XF, 2001, J NEUROPHYSIOL, V85, P1078, DOI 10.1152/jn.2001.85.3.1078; MACKLIS JD, 1993, J NEUROSCI, V13, P3848; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Mrsic-Flogel TD, 2005, J NEUROPHYSIOL, V93, P3489, DOI 10.1152/jn.00748.2004; Nakamoto KT, 2008, J NEUROPHYSIOL, V99, P2347, DOI 10.1152/jn.01326.2007; Nodal FR, 2008, NEUROSCIENCE, V154, P397, DOI 10.1016/j.neuroscience.2007.12.022; Oliver DL, 2005, INFERIOR COLLICULUS, P69, DOI 10.1007/0-387-27083-3_2; Perrot X, 2006, CEREB CORTEX, V16, P941, DOI 10.1093/cercor/bhj035; Pollak GD, 2002, HEARING RES, V168, P60, DOI 10.1016/S0378-5955(02)00362-3; Polley DB, 2006, J NEUROSCI, V26, P4970, DOI 10.1523/JNEUROSCI.3771-05.2006; SILLITO AM, 1994, NATURE, V369, P479, DOI 10.1038/369479a0; Spierer L, 2007, J NEUROSCI, V27, P5474, DOI 10.1523/JNEUROSCI.0764-07.2007; Suga N, 2003, NAT REV NEUROSCI, V4, P783, DOI 10.1038/nrn1222; Suga N, 2008, J COMP PHYSIOL A, V194, P169, DOI 10.1007/s00359-007-0274-2; THOMPSON GC, 1978, J NEUROPHYSIOL, V41, P1183, DOI 10.1152/jn.1978.41.5.1183; Tzounopoulos T, 2009, NEURON, V62, P463, DOI 10.1016/j.neuron.2009.05.002; Van Wanrooij MM, 2007, J NEUROPHYSIOL, V97, P715, DOI 10.1152/jn.00260.2006; Weinberger NM, 2004, NAT REV NEUROSCI, V5, P279, DOI 10.1038/nrn1366; Winer JA, 1998, J COMP NEUROL, V400, P147; Woods TM, 2006, J NEUROPHYSIOL, V96, P3323, DOI 10.1152/jn.00392.2006; Xiao ZJ, 2002, NAT NEUROSCI, V5, P57, DOI 10.1038/nn786; Yan J, 2002, EUR J NEUROSCI, V16, P119, DOI 10.1046/j.1460-9568.2002.02046.x; Yan J, 2005, J NEUROPHYSIOL, V93, P71, DOI 10.1152/jn.00348.2004; Zhou XM, 2005, HEARING RES, V203, P201, DOI 10.1016/j.heares.2004.12.008	50	222	224	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2010	13	2					253	U146		10.1038/nn.2466	http://dx.doi.org/10.1038/nn.2466			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	548SE	20037578	Green Accepted			2022-12-17	WOS:000273985800022
J	Yoshii, A; Constantine-Paton, M				Yoshii, Akira; Constantine-Paton, Martha			BDNF induces transport of PSD-95 to dendrites through PI3K-AKT signaling after NMDA receptor activation	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; ENDOPLASMIC-RETICULUM; HIPPOCAMPAL-NEURONS; CALCIUM CHANNELS; LIPID RAFTS; SYNAPSES; PROTEINS; NEUROTROPHINS; TRANSMISSION	The N-methyl-D-aspartate receptor (NMDAR), brain-derived neurotrophic factor (BDNF), postsynaptic density protein 95 (PSD-95) and phosphatidylinositol 3-kinase (PI3K) have all been implicated in long-term potentiation. Here we show that these molecules are involved in a single pathway for synaptic potentiation. In visual cortical neurons in young rodents, the neurotrophin receptor TrkB is associated with PSD-95. When BDNF is applied to cultured visual cortical neurons, PSD-95-labeled synaptic puncta enlarge, and fluorescent recovery after photobleaching (FRAP) reveals increased delivery of green fluorescent protein-tagged PSD-95 to the dendrites. The recovery of fluorescence requires TrkB, signaling through PI3K and the serine-threonine kinase Akt, and an intact Golgi apparatus. Stimulation of NMDARs mimics the PSD-95 trafficking that is induced by BDNF but requires active BDNF and PI3K. Furthermore, local dendritic contact with a BDNF-coated microsphere induces PSD-95 FRAP throughout the dendrites of the stimulated neuron, suggesting that this mechanism induces rapid neuron-wide synaptic increases in PSD-95 and refinement whenever a few robust inputs activate the NMDAR-BDNF-PI3K pathway.	MIT, Dept Biol, Cambridge, MA 02139 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital	Yoshii, A (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	ayoshii@mit.edu			NEI NIH HHS [R01EY014074, R01EY006039] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY006039, R01EY014074] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AELD EH, 2002, CELL, V108, P849; Alarcon JM, 2006, J NEUROSCI, V26, P256, DOI 10.1523/JNEUROSCI.3196-05.2006; BANKERG, 1991, CULTURING NERVE CELL; Beique JC, 2003, J PHYSIOL-LONDON, V546, P859, DOI 10.1113/jphysiol.2002.031369; Bhattacharyya A, 1997, J NEUROSCI, V17, P7007; CABELLI RJ, 1995, SCIENCE, V267, P1662, DOI 10.1126/science.7886458; Chen HK, 2003, CELL, V113, P457, DOI 10.1016/S0092-8674(03)00349-0; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; Du JL, 2004, NATURE, V429, P878, DOI 10.1038/nature02618; Ehrlich I, 2004, J NEUROSCI, V24, P916, DOI 10.1523/JNEUROSCI.4733-03.2004; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Hanover JL, 1999, J NEUROSCI, V19, part. no.; Hering H, 2003, J NEUROSCI, V23, P3262; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Itami C, 2003, P NATL ACAD SCI USA, V100, P13069, DOI 10.1073/pnas.2131948100; Jaworski J, 2005, J NEUROSCI, V25, P11300, DOI 10.1523/JNEUROSCI.2270-05.2005; Ji YY, 2005, NAT NEUROSCI, V8, P164, DOI 10.1038/nn1381; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; Kau TR, 2003, CANCER CELL, V4, P463, DOI 10.1016/S1535-6108(03)00303-9; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Kovalchuk Y, 2002, SCIENCE, V295, P1729, DOI 10.1126/science.1067766; Kumar V, 2005, J NEUROSCI, V25, P11288, DOI 10.1523/JNEUROSCI.2284-05.2005; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Lessmann V, 2003, PROG NEUROBIOL, V69, P341, DOI 10.1016/S0301-0082(03)00019-4; Lu W, 2004, NEURON, V43, P237, DOI 10.1016/j.neuron.2004.06.031; Ma DK, 2001, SCIENCE, V291, P316, DOI 10.1126/science.291.5502.316; Man HY, 2003, NEURON, V38, P611, DOI 10.1016/S0896-6273(03)00228-9; Martin KC, 2002, NAT REV NEUROSCI, V3, P813, DOI 10.1038/nrn942; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; Michelsen K, 2005, EMBO REP, V6, P717, DOI 10.1038/sj.embor.7400480; O'Kelly I, 2002, CELL, V111, P577, DOI 10.1016/S0092-8674(02)01040-1; Okabe S, 2001, J NEUROSCI, V21, P9561, DOI 10.1523/JNEUROSCI.21-24-09561.2001; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Parker MJ, 2004, J NEUROSCI, V24, P378, DOI 10.1523/JNEUROSCI.3865-03.2004; Penzes P, 2001, NEURON, V29, P229, DOI 10.1016/S0896-6273(01)00193-3; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Sans N, 2000, J NEUROSCI, V20, P1260, DOI 10.1523/JNEUROSCI.20-03-01260.2000; Stein V, 2003, J NEUROSCI, V23, P5503; Suzuki S, 2004, J CELL BIOL, V167, P1205, DOI 10.1083/jcb.200404106; Tang SJ, 2002, P NATL ACAD SCI USA, V99, P467, DOI 10.1073/pnas.012605299; TURNER TJ, 1992, SCIENCE, V258, P310, DOI 10.1126/science.1357749; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Viard P, 2004, NAT NEUROSCI, V7, P939, DOI 10.1038/nn1300; Washbourne P, 2004, NEURON, V44, P901, DOI 10.1016/S0896-6273(04)00799-8; Wu K, 1996, MOL BRAIN RES, V43, P286, DOI 10.1016/S0169-328X(96)00211-2; Yoshii A, 2003, P NATL ACAD SCI USA, V100, P1334, DOI 10.1073/pnas.0335785100	50	222	229	2	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2007	10	6					702	711		10.1038/nn1903	http://dx.doi.org/10.1038/nn1903			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	172JI	17515902				2022-12-17	WOS:000246799800012
J	Haeseleer, F; Imanishi, Y; Maeda, T; Possin, DE; Maeda, A; Lee, A; Rieke, F; Palczewski, K				Haeseleer, F; Imanishi, Y; Maeda, T; Possin, DE; Maeda, A; Lee, A; Rieke, F; Palczewski, K			Essential role of Ca2+-binding protein 4, a Ca(v)1.4 channel regulator, in photoreceptor synaptic function	NATURE NEUROSCIENCE			English	Article							STATIONARY NIGHT BLINDNESS; SENSITIVE CALCIUM-CHANNEL; CA2+ CHANNELS; CA2+-DEPENDENT INACTIVATION; BIPOLAR CELLS; HIPPOCAMPAL-NEURONS; CONE PHOTORECEPTORS; PLEXIFORM LAYER; RIBBON SYNAPSE; RETINA	CaBP1-8 are neuronal Ca2+-binding proteins with similarity to calmodulin (CaM). Here we show that CaBP4 is specifically expressed in photoreceptors, where it is localized to synaptic terminals. The outer plexiform layer, which contains the photoreceptor synapses with secondary neurons, was thinner in the Cabp4(-/-) mice than in control mice. Cabp4(-/-) retinas also had ectopic synapses originating from rod bipolar and horizontal cells tha HJt extended into the outer nuclear layer. Responses of Cabp4(-/-) rod bipolars were reduced in sensitivity about 100-fold. Electroretinograms (ERGs) indicated a reduction in cone and rod synaptic function. The phenotype of Cabp4(-/-) mice shares similarities with that of incomplete congenital stationary night blindness (CSNB2) patients. CaBP4 directly associated with the C-terminal domain of the Ca(v)1.4 alpha(1)-subunit and shifted the activation of Ca(v)1.4 to hyperpolarized voltages in transfected cells. These observations indicate that CaBP4 is important for normal synaptic function, probably through regulation of Ca2+ influx and neurotransmitter release in photoreceptor synaptic terminals.	Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA; Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Ctr Neurodegenerat Dis, Atlanta, GA 30322 USA; Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; Univ Washington, Dept Chem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Emory University; Emory University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Haeseleer, F (corresponding author), Univ Washington, Dept Ophthalmol, Box 356485, Seattle, WA 98195 USA.	fanfan@u.washington.edu; palczews@u.washington.edu	Imanishi, Yoshikazu/E-8178-2010	Imanishi, Yoshikazu/0000-0003-4696-4836; Lee, Amy/0000-0001-8021-0443	NEI NIH HHS [R03 EY014561, P30 EY001730, R01 EY009339, R01 EY011850, EY014561, EY11850, EY09339] Funding Source: Medline; NINDS NIH HHS [NS044922, R01 NS044922] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY009339, R03EY014561, R01EY011850] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044922] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; Ball SL, 2002, INVEST OPHTH VIS SCI, V43, P1595; BARNES S, 2002, CALCIUM, V514, P465; Batten ML, 2004, J BIOL CHEM, V279, P10422, DOI 10.1074/jbc.M312410200; Baumann L, 2004, INVEST OPHTH VIS SCI, V45, P708, DOI 10.1167/iovs.03-0937; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P613; BAYLOR DA, 1970, J PHYSIOL-LONDON, V207, P77, DOI 10.1113/jphysiol.1970.sp009049; Bech-Hansen NT, 2000, NAT GENET, V26, P319, DOI 10.1038/81619; Bech-Hansen NT, 1998, NAT GENET, V19, P264, DOI 10.1038/947; Berntson A, 2003, J NEUROSCI RES, V71, P146, DOI 10.1002/jnr.10459; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; Dick O, 2003, NEURON, V37, P775, DOI 10.1016/S0896-6273(03)00086-2; Dolmetsch Ricardo, 2003, Sci STKE, V2003, pPE4; ELLIS SB, 1988, SCIENCE, V241, P1661, DOI 10.1126/science.2458626; Erickson MG, 2001, NEURON, V31, P973, DOI 10.1016/S0896-6273(01)00438-X; Field GD, 2002, NEURON, V34, P773, DOI 10.1016/S0896-6273(02)00700-6; Grunert U, 2002, J COMP NEUROL, V447, P138, DOI 10.1002/cne.10220; Haeseleer F, 1999, J BIOL CHEM, V274, P6526, DOI 10.1074/jbc.274.10.6526; Haeseleer F, 2000, J BIOL CHEM, V275, P1247, DOI 10.1074/jbc.275.2.1247; Haeseleer F, 2001, INVEST OPHTH VIS SCI, V42, P3294; Haynes LP, 2004, J BIOL CHEM, V279, P547, DOI 10.1074/jbc.M309617200; Imanishi Y, 2002, EUR J NEUROSCI, V15, P63, DOI 10.1046/j.0953-816x.2001.01835.x; Koschak A, 2003, J NEUROSCI, V23, P6041, DOI 10.1523/JNEUROSCI.23-14-06041.2003; Koulen P, 1998, J NEUROSCI, V18, P10136; Lee A, 2002, NAT NEUROSCI, V5, P210, DOI 10.1038/nn805; Maeda T, 2003, J NEUROCHEM, V85, P944, DOI 10.1046/j.1471-4159.2003.01741.x; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; McRory JE, 2004, J NEUROSCI, V24, P1707, DOI 10.1523/JNEUROSCI.4846-03.2004; Morgans CW, 1998, J NEUROSCI, V18, P2467; Morgans CW, 1999, EUR J NEUROSCI, V11, P2989, DOI 10.1046/j.1460-9568.1999.00719.x; Morgans CW, 2001, INVEST OPHTH VIS SCI, V42, P2414; Nachman-Clewner M, 1999, J COMP NEUROL, V415, P1, DOI 10.1002/(SICI)1096-9861(19991206)415:1<1::AID-CNE1>3.0.CO;2-G; NAKATANI K, 1988, J PHYSIOL-LONDON, V395, P695, DOI 10.1113/jphysiol.1988.sp016942; NOMURA A, 1994, CELL, V77, P361, DOI 10.1016/0092-8674(94)90151-1; Pate P, 2000, J BIOL CHEM, V275, P39786, DOI 10.1074/jbc.M007158200; PEREZREYES E, 1992, J BIOL CHEM, V267, P1792; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Pitt GS, 2001, J BIOL CHEM, V276, P30794, DOI 10.1074/jbc.M104959200; RIEKE F, 1994, NEURON, V13, P863, DOI 10.1016/0896-6273(94)90252-6; Sampath AP, 2004, NEURON, V41, P431, DOI 10.1016/S0896-6273(04)00005-4; Schmitz F, 2000, NEURON, V28, P857, DOI 10.1016/S0896-6273(00)00159-8; Schmitz Y, 1997, NEUROSCIENCE, V78, P1209, DOI 10.1016/S0306-4522(96)00678-1; Seidenbecher CI, 2002, ADV EXP MED BIOL, V514, P451; SLAUGHTER MM, 1981, SCIENCE, V211, P182, DOI 10.1126/science.6255566; Strom TM, 1998, NAT GENET, V19, P260, DOI 10.1038/940; Van Hooser JP, 2000, P NATL ACAD SCI USA, V97, P8623, DOI 10.1073/pnas.150236297; Yang J, 2002, P NATL ACAD SCI USA, V99, P7711, DOI 10.1073/pnas.102006299; Zhang N, 2002, J NEUROSCI, V22, P7065; Zhou H, 2004, J NEUROSCI, V24, P4698, DOI 10.1523/JNEUROSCI.5523-03.2004; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	50	222	232	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2004	7	10					1079	1087		10.1038/nn1320	http://dx.doi.org/10.1038/nn1320			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	857YQ	15452577	Green Accepted			2022-12-17	WOS:000224156900017
J	Rousselet, GA; Fabre-Thorpe, M; Thorpe, SJ				Rousselet, GA; Fabre-Thorpe, M; Thorpe, SJ			Parallel processing in high-level categorization of natural images	NATURE NEUROSCIENCE			English	Article							VISUAL-SEARCH; PERCEPTION; STIMULI; ATTENTION; CORTEX		Fac Med Rangueil, UPS, CNRS, UMR 5549,Ctr Rech Cerveau & Cognit, F-31062 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Rousselet, GA (corresponding author), Fac Med Rangueil, UPS, CNRS, UMR 5549,Ctr Rech Cerveau & Cognit, 133 Route Narbonne, F-31062 Toulouse, France.	guillau@cerco.ups-tlse.fr	Rousselet, Guillaume/B-4701-2009; THORPE, Simon J/A-5661-2008; Fabre-Thorpe, Michèle/B-2698-2008; Rousselet, Guillaume/AAV-1151-2020	Rousselet, Guillaume/0000-0003-0006-8729; THORPE, Simon J/0000-0003-4997-3367; Rousselet, Guillaume/0000-0003-0006-8729				BIEDERMA.I, 1972, SCIENCE, V177, P77, DOI 10.1126/science.177.4043.77; CHUN MM, 1995, J EXP PSYCHOL HUMAN, V21, P109; DUNCAN J, 1980, PSYCHOL REV, V87, P272, DOI 10.1037/0033-295X.87.3.272; Fize D, 2000, NEUROIMAGE, V11, P634, DOI 10.1006/nimg.2000.0585; Freedman DJ, 2001, SCIENCE, V291, P312, DOI 10.1126/science.291.5502.312; KINCHLA RA, 1992, ANNU REV PSYCHOL, V43, P711, DOI 10.1146/annurev.ps.43.020192.003431; LI FF, IN PRESS P NATL ACAD; McElree B, 1999, J EXP PSYCHOL HUMAN, V25, P1517, DOI 10.1037/0096-1523.25.6.1517; POTTER MC, 1976, J EXP PSYCHOL-HUM L, V2, P509, DOI 10.1037/0278-7393.2.5.509; SASAKI K, 1993, NEUROSCI RES, V18, P249, DOI 10.1016/0168-0102(93)90062-U; Schall JD, 2001, NAT REV NEUROSCI, V2, P33, DOI 10.1038/35049054; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Treisman A, 1998, PHILOS T ROY SOC B, V353, P1295, DOI 10.1098/rstb.1998.0284; VanRullen R, 2001, J COGNITIVE NEUROSCI, V13, P454, DOI 10.1162/08989290152001880; WOLFE JM, 1994, VISION RES, V34, P1187, DOI 10.1016/0042-6989(94)90300-X	15	222	224	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2002	5	7					629	630		10.1038/nn866	http://dx.doi.org/10.1038/nn866			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	566EP	12032544				2022-12-17	WOS:000176414300010
J	Trotti, D; Rolfs, A; Danbolt, NC; Brown, RH; Hediger, MA				Trotti, D; Rolfs, A; Danbolt, NC; Brown, RH; Hediger, MA			SOD1 mutants linked to amyotrophic lateral sclerosis selectively inactivate a glial glutamate transporter	NATURE NEUROSCIENCE			English	Article							CU,ZN-SUPEROXIDE DISMUTASE MUTANT; CU,ZN SUPEROXIDE-DISMUTASE; OXYGEN RADICALS; PROTEIN DAMAGE; HYDROGEN-PEROXIDE; SPINAL-CORD; MOTOR CORTEX; RAT-BRAIN; K-M; DEGRADATION	The mechanism by which Cu2+/Zn2+ superoxide dismutase (SOD1) mutants lead to motor neuron degeneration in familial amyotrophic lateral sclerosis (FALS) is unknown. We show that oxidative reactions triggered by hydrogen peroxide and catalyzed by A4V and I113T mutant but not wild-type SOD1 inactivated the glutamate transporter human GLT1. Chelation of the copper ion of the prosthetic group of A4V prevented GLT1 inhibition. GLT1 was a selective target of oxidation mediated by SOD1 mutants, and its reactivity was confined to the intracellular carboxyl-terminal domain. The antioxidant Mn(III)TBAP rescued GLT1 from inhibition. Because inactivation of GLT1 results in neuronal degeneration, we propose that toxic properties of SOD1 mutants lead to neuronal death via an excitotoxic mechanism in SOD1-linked FALS.	Harvard Univ, Brigham & Womens Hosp, Sch Med,Dept Med, Membrane Biol Program, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Renal, Boston, MA 02115 USA; Univ Oslo, Inst Basic Med Sci, Dept Anat, N-0317 Oslo, Norway; Harvard Univ, Massachusetts Gen Hosp E, Sch Med, Day Neuromuscular Res Lab, Charlestown, MA 02129 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Oslo; Harvard University	Hediger, MA (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med,Dept Med, Membrane Biol Program, HIM Bldg,77 Ave Louis Pasteur, Boston, MA 02115 USA.	dtrotti@rics.bwh.harvard.edu; mhediger@rics.bwh.harvard.edu	Danbolt, Niels Christian/A-1907-2014	Danbolt, Niels Christian/0000-0003-4227-4520; Hediger, Matthias/0000-0003-1946-027X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032001, P01NS031248] Funding Source: NIH RePORTER; AHRQ HHS [5F32HS10064] Funding Source: Medline; NINDS NIH HHS [NS32001, 1PO1NS31248-05] Funding Source: Medline; Telethon [754] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Telethon(Fondazione Telethon)		Aoki M, 1998, ANN NEUROL, V43, P645, DOI 10.1002/ana.410430514; ARRIZA JL, 1994, J NEUROSCI, V14, P5559; BatinicHaberle I, 1997, ARCH BIOCHEM BIOPHYS, V343, P225, DOI 10.1006/abbi.1997.0157; BENSIMON G, 1994, NEW ENGL J MED, V330, P585, DOI 10.1056/NEJM199403033300901; Bogdanov MB, 1998, J NEUROCHEM, V71, P1321; BORCHELT DR, 1995, J BIOL CHEM, V270, P3234, DOI 10.1074/jbc.270.7.3234; BORCHELT DR, 1994, P NATL ACAD SCI USA, V91, P8292, DOI 10.1073/pnas.91.17.8292; Bristol LA, 1996, ANN NEUROL, V39, P676, DOI 10.1002/ana.410390519; BROWN RH, 1995, CELL, V80, P687, DOI 10.1016/0092-8674(95)90346-1; BROWN RH, 1995, CURR OPIN NEUROL, V8, P373, DOI 10.1097/00019052-199510000-00009; Bruijn LI, 1997, P NATL ACAD SCI USA, V94, P7606, DOI 10.1073/pnas.94.14.7606; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Canton T, 1998, NEUROREPORT, V9, P775, DOI 10.1097/00001756-199803300-00001; DAVIES KJA, 1987, J BIOL CHEM, V262, P9895; DAVIES KJA, 1987, J BIOL CHEM, V262, P9908; DAVIES KJA, 1987, J BIOL CHEM, V262, P9902; DAVIES KJA, 1987, J BIOL CHEM, V262, P9914; Day BJ, 1997, ARCH BIOCHEM BIOPHYS, V347, P256, DOI 10.1006/abbi.1997.0341; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; EISEN A, 1995, MUSCLE NERVE, V18, P741, DOI 10.1002/mus.880180711; Ferrante RJ, 1997, J NEUROCHEM, V69, P2064; Grunewald M, 1998, NEURON, V21, P623, DOI 10.1016/S0896-6273(00)80572-3; Gurney ME, 1998, NEUROLOGY, V50, P62, DOI 10.1212/WNL.50.1.62; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Haugeto O, 1996, J BIOL CHEM, V271, P27715, DOI 10.1074/jbc.271.44.27715; Lacomblez L, 1996, LANCET, V347, P1425, DOI 10.1016/S0140-6736(96)91680-3; Lehre KP, 1998, J NEUROSCI, V18, P8751, DOI 10.1523/jneurosci.18-21-08751.1998; Lin CLG, 1998, NEURON, V20, P589, DOI 10.1016/S0896-6273(00)80997-6; Mu XJ, 1996, ANN NEUROL, V40, P379, DOI 10.1002/ana.410400307; Pedersen WA, 1998, ANN NEUROL, V44, P819, DOI 10.1002/ana.410440518; ROBBERECHT W, 1994, J NEUROCHEM, V62, P384; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; ROTHSTEIN JD, 1992, NEW ENGL J MED, V326, P1464, DOI 10.1056/NEJM199205283262204; ROTHSTEIN JD, 1995, ANN NEUROL, V38, P73, DOI 10.1002/ana.410380114; Siddique T, 1996, HUM MOL GENET, V5, P1465, DOI 10.1093/hmg/5.Supplement_1.1465; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Taylor PM, 1996, J EXP BIOL, V199, P923; Trotti D, 1996, J BIOL CHEM, V271, P5976, DOI 10.1074/jbc.271.11.5976; Trotti D, 1998, TRENDS PHARMACOL SCI, V19, P328, DOI 10.1016/S0165-6147(98)01230-9; Trotti D, 1997, EUR J NEUROSCI, V9, P2207, DOI 10.1111/j.1460-9568.1997.tb01388.x; Tu PH, 1997, LAB INVEST, V76, P441; VANIWAARDEN PR, 1992, BIOCHIM BIOPHYS ACTA, V1113, P161, DOI 10.1016/0304-4157(92)90037-B; WiedauPazos M, 1996, SCIENCE, V271, P515, DOI 10.1126/science.271.5248.515; Yim HS, 1997, J BIOL CHEM, V272, P8861; Yim MB, 1996, P NATL ACAD SCI USA, V93, P5709, DOI 10.1073/pnas.93.12.5709; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0	48	222	229	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	1999	2	5					427	433		10.1038/8091	http://dx.doi.org/10.1038/8091			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	271TK	10321246				2022-12-17	WOS:000084609400012
J	Ransohoff, RM				Ransohoff, Richard M.			Animal models of multiple sclerosis: the good, the bad and the bottom line	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; ENVIRONMENTAL RISK-FACTORS; CD8(+) T-CELLS; DEMYELINATING DISEASE; AXONAL DAMAGE; MOUSE MODELS; SPINAL-CORD; REMYELINATION	Multiple sclerosis (MS) is a spontaneous, acquired, inflammatory demyelinating disease of the human CNS. Because it involves a complex interaction between two of the most intricate biological systems, immune system and CNS, animal modeling has been critical for addressing MS pathogenesis. MS models were originally developed serendipitously more than 75 years ago. Immune-mediated, toxic, viral and genetic models of demyelination are now used to understand the manifold aspects of MS. MS treatments evolved in part from animal model research, and further progress is envisaged in large part because these systems have been continually refined and their use focused on questions whose relevance was established by studying the human disease.	Cleveland Clin, Lerner Res Inst, Neuroinflammat Res Ctr, Cleveland, OH 44106 USA	Cleveland Clinic Foundation	Ransohoff, RM (corresponding author), Cleveland Clin, Lerner Res Inst, Neuroinflammat Res Ctr, Cleveland, OH 44106 USA.	ransohr@ccf.org			US National Institutes of Health; National Multiple Sclerosis Society; Williams Family Fund for MS Research	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); Williams Family Fund for MS Research	Research in the Ransohoff laboratory is supported by the US National Institutes of Health, the National Multiple Sclerosis Society and the Williams Family Fund for MS Research. The invaluable aid of other philanthropic donors is gratefully recognized.	Aboul-Enein F, 2005, ACTA NEUROPATHOL, V109, P49, DOI 10.1007/s00401-004-0954-8; Arnett HA, 2001, NAT NEUROSCI, V4, P1116, DOI 10.1038/nn738; Ascherio A, 2007, ANN NEUROL, V61, P504, DOI 10.1002/ana.21141; Ascherio A, 2007, ANN NEUROL, V61, P288, DOI 10.1002/ana.21117; Babbe H, 2000, J EXP MED, V192, P393, DOI 10.1084/jem.192.3.393; Berer K, 2011, MOL IMMUNOL, V48, P1332, DOI 10.1016/j.molimm.2010.10.025; Bergmann CC, 2006, NAT REV MICROBIOL, V4, P121, DOI 10.1038/nrmicro1343; BERNARD CCA, 1976, EUR J IMMUNOL, V6, P655, DOI 10.1002/eji.1830060912; Blakemore WF, 2008, CURR TOP MICROBIOL, V318, P193; BLAKEMORE WF, 1977, J NEUROL SCI, V33, P31, DOI 10.1016/0022-510X(77)90179-4; Croxford AL, 2011, BBA-MOL BASIS DIS, V1812, P177, DOI 10.1016/j.bbadis.2010.06.010; DALCANTO MC, 1995, MICROSC RES TECHNIQ, V32, P215, DOI 10.1002/jemt.1070320305; Ferguson B, 1997, BRAIN, V120, P393, DOI 10.1093/brain/120.3.393; Foote AK, 2005, BRAIN, V128, P528, DOI 10.1093/brain/awh417; Frohman EM, 2006, NEW ENGL J MED, V354, P942, DOI 10.1056/NEJMra052130; Fugger L, 2009, NAT REV IMMUNOL, V9, P408, DOI 10.1038/nri2554; Furtado GD, 2001, IMMUNOL REV, V182, P122; Hauser SL, 2008, NEW ENGL J MED, V358, P676, DOI 10.1056/NEJMoa0706383; Huseby ES, 2001, J EXP MED, V194, P669, DOI 10.1084/jem.194.5.669; Kornek B, 2000, AM J PATHOL, V157, P267, DOI 10.1016/S0002-9440(10)64537-3; Lassmann H, 2004, TRENDS IMMUNOL, V25, P132, DOI 10.1016/j.it.2004.01.007; Linares D, 2006, J NEUROSCI, V26, P12672, DOI 10.1523/JNEUROSCI.0294-06.2006; LIPTON HL, 1975, INFECT IMMUN, V11, P1147, DOI 10.1128/IAI.11.5.1147-1155.1975; Liu LP, 2010, NAT NEUROSCI, V13, P319, DOI 10.1038/nn.2491; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; Lucchinetti CF, 2011, NEW ENGL J MED, V365, P2188, DOI 10.1056/NEJMoa1100648; LUDWIN SK, 1978, LAB INVEST, V39, P597; Matsushima GK, 2001, BRAIN PATHOL, V11, P107; Miller RH, 2010, DIS MODEL MECH, V3, P535, DOI 10.1242/dmm.001958; Miller SD, 1997, NAT MED, V3, P1133, DOI 10.1038/nm1097-1133; PATERSON PY, 1979, REV INFECT DIS, V1, P468; Patrikios P, 2006, BRAIN, V129, P3165, DOI 10.1093/brain/awl217; Pelletier D, 2012, NEW ENGL J MED, V366, P339, DOI 10.1056/NEJMct1101691; Pohl HBF, 2011, J NEUROSCI, V31, P1069, DOI 10.1523/JNEUROSCI.5035-10.2011; PRINEAS JW, 1981, ANN NEUROL, V10, P149, DOI 10.1002/ana.410100205; Ransohoff RM, 2006, J CLIN INVEST, V116, P2313, DOI 10.1172/JCI29834; Ransohoff RM, 2002, TRENDS IMMUNOL, V23, P512, DOI 10.1016/S1471-4906(02)02321-9; Rivera-Quinones C, 1998, NAT MED, V4, P187, DOI 10.1038/nm0298-187; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Skripuletz T, 2011, HISTOL HISTOPATHOL, V26, P1585, DOI 10.14670/HH-26.1585; Steinman L, 2006, ANN NEUROL, V60, P12, DOI 10.1002/ana.20913; 't Hart BA, 1998, AM J PATHOL, V153, P649, DOI 10.1016/S0002-9440(10)65606-4; Traka M, 2010, BRAIN, V133, P3017, DOI 10.1093/brain/awq247; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Uccelli A, 2003, Int MS J, V10, P6; Waksman BH, 1999, NEUROCHEM RES, V24, P491, DOI 10.1023/A:1022527628192; WAKSMAN BH, 1962, AM J PATHOL, V41, P135; YASUDA T, 1975, JPN J EXP MED, V45, P423; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0; Zhang GX, 2000, MULT SCLER J, V6, P3, DOI 10.1191/135245800678827446	50	221	258	4	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2012	15	8					1074	1077		10.1038/nn.3168	http://dx.doi.org/10.1038/nn.3168			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	979UE	22837037	Green Published			2022-12-17	WOS:000306844500008
J	Khalsa, SS; Rudrauf, D; Feinstein, JS; Tranel, D				Khalsa, Sahib S.; Rudrauf, David; Feinstein, Justin S.; Tranel, Daniel			The pathways of interoceptive awareness	NATURE NEUROSCIENCE			English	Article							FEEL	A network of cortical brain regions, including the insula and anterior cingulate cortex (ACC), has been proposed as the critical and sole substrate for interoceptive awareness. Combining lesion and pharmacological approaches in humans, we found that the insula and ACC were not critical for awareness of heartbeat sensations. Instead, this awareness was mediated by both somatosensory afferents from the skin and a network that included the insula and ACC. Together, these pathways enable the core human experience of the cardiovascular state of the body.	[Khalsa, Sahib S.; Rudrauf, David; Tranel, Daniel] Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA; [Khalsa, Sahib S.; Rudrauf, David; Tranel, Daniel] Univ Iowa, Neurosci Program, Iowa City, IA 52242 USA; [Khalsa, Sahib S.] Univ Iowa, Med Sci Training Program, Iowa City, IA 52242 USA; [Feinstein, Justin S.; Tranel, Daniel] Univ Iowa, Dept Psychol, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa	Khalsa, SS (corresponding author), Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA.	skhalsa@mednet.ucla.edu	Khalsa, Sahib S./ABA-8359-2020; Khalsa, Sahib S. S/Q-1434-2018	Khalsa, Sahib S./0000-0003-2124-8585; Khalsa, Sahib S. S/0000-0003-2124-8585; Tranel, Daniel/0000-0002-1338-1389	US National Center for Complementary & Alternative Medicine [F31-AT003061]; US National Institute on Drug Abuse [R01-DA022549]; US National Center for Research Resources, General Clinical Research Center Program [M01-RR-59]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [F31AT003061] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA022549] Funding Source: NIH RePORTER	US National Center for Complementary & Alternative Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); US National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); US National Center for Research Resources, General Clinical Research Center Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank J. Bruss for figure assistance, S. Schubert and M. Bosch for isoproterenol administration, C. Sandesara, E. St. Louis, B. Olshansky and H. Shim for medical supervision, T. Grabowski for neurological expertise and J. Martins for safety monitoring. This work was supported by the US National Center for Complementary & Alternative Medicine (F31-AT003061), the US National Institute on Drug Abuse (R01-DA022549) and the US National Center for Research Resources, General Clinical Research Center Program (M01-RR-59).	Bechara A, 2004, NAT NEUROSCI, V7, P102, DOI 10.1038/nn0204-102; Cameron OG, 2001, PSYCHOSOM MED, V63, P697, DOI 10.1097/00006842-200109000-00001; Cameron OG, 2002, PSYCHOSOM MED, V64, P851, DOI 10.1097/01.PSY.0000038939.33335.32; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Damasio A.R., 1999, FEELING WHAT HAPPENS; Dworkin BR, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P482, DOI 10.1017/CBO9780511546396.021; Feinstein JS, 2010, J CLIN EXP NEUROPSYC, V32, P88, DOI 10.1080/13803390903066873; Jones G.E., 1994, PERCEPTION VISCERAL; KHALSA S, 2009, PSYCHOPHYSIOLOG 0706, DOI DOI 10.1111/J.1469-8986.2009.00859.X; Khalsa SS, 2009, INT J PSYCHOPHYSIOL, V72, P34, DOI 10.1016/j.ijpsycho.2008.08.010; Pollatos O, 2007, BRAIN RES, V1141, P178, DOI 10.1016/j.brainres.2007.01.026; Rudrauf D, 2009, INT J PSYCHOPHYSIOL, V72, P13, DOI 10.1016/j.ijpsycho.2008.03.015; Van Oudenhove L, 2004, BEST PRACT RES CL GA, V18, P663, DOI 10.1016/j.bpg.2004.04.010	15	221	223	1	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2009	12	12					1494	1496		10.1038/nn.2411	http://dx.doi.org/10.1038/nn.2411			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	523II	19881506	Green Accepted			2022-12-17	WOS:000272065600008
J	Wang, SH; Alvares, LD; Nader, K				Wang, Szu-Han; Alvares, Lucas de Oliveira; Nader, Karim			Cellular and systems mechanisms of memory strength as a constraint on auditory fear reconsolidation	NATURE NEUROSCIENCE			English	Article							RETROGRADE-AMNESIA; PROTEIN-SYNTHESIS; NMDA RECEPTORS; ELECTROCONVULSIVE SHOCK; HIPPOCAMPAL-FORMATION; BASOLATERAL AMYGDALA; SPATIAL MEMORY; CONSOLIDATION; REACTIVATION; EXTINCTION	Memory reconsolidation has been demonstrated in various tasks and species, suggesting it is a fundamental process. However, there are experimental parameters that can inhibit reconsolidation from occurring (boundary conditions). These conditions and their mechanisms remain poorly defined. Here, we characterize the ability of strong training to inhibit reconsolidation at the behavioral, systems and molecular levels. We demonstrate that strong memories in rats initially are resistant to reconsolidation, but after sufficient time will undergo reconsolidation, suggesting that boundary conditions can be transient. At the systems level, we show that the hippocampus is necessary for inhibiting reconsolidation in the amygdala. At the molecular level, we demonstrate that NR2B NMDA-receptor subunits which are critical for the induction of reconsolidation of auditory memories in the amygdala, are downregulated only under conditions when strong memories do not undergo reconsolidation. This suggests that one molecular mechanism for mediating boundary conditions is through downregulation of reconsolidation induction mechanisms.	[Wang, Szu-Han; Alvares, Lucas de Oliveira; Nader, Karim] McGill Univ, Dept Psychol, Montreal, PQ, Canada	McGill University	Nader, K (corresponding author), McGill Univ, Dept Psychol, Montreal, PQ, Canada.	karim.nader@mcgill.ca	Wang, Szu-Han/AAR-1137-2021; De Oliveira Alvares, Lucas/AGY-7473-2022	De Oliveira Alvares, Lucas/0000-0002-0472-903X; Wang, Szu-Han/0000-0003-0500-0352	Natural Sciences and Engineering Research Council (Canada); Canadian Institutes of Health Research; Canada Foundation for Innovation; Volkswagen Foundation; E. W. R. Steacie Memorial Fellowship	Natural Sciences and Engineering Research Council (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Volkswagen Foundation(Volkswagen); E. W. R. Steacie Memorial Fellowship(Natural Sciences and Engineering Research Council of Canada (NSERC))	We thank S. Kusher for detailed suggestions and comments on the manuscript. We thank various people in the lab who have helped us with these experiments. L. d. O. A. was supported by the Brazilian Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior. The study was supported by Natural Sciences and Engineering Research Council (Canada), Canadian Institutes of Health Research, Canada Foundation for Innovation, Volkswagen Foundation and E. W. R. Steacie Memorial Fellowship.	Alberini CM, 2005, TRENDS NEUROSCI, V28, P51, DOI 10.1016/j.tins.2004.11.001; Ben Mamou C, 2006, NAT NEUROSCI, V9, P1237, DOI 10.1038/nn1778; BLANCHARD RJ, 1976, B PSYCHONOMIC SOC, V8, P129, DOI 10.3758/BF03335103; BLANCHARD RJ, 1969, J COMP PHYSIOL PSYCH, V67, P370, DOI 10.1037/h0026779; Bozon B, 2003, NEURON, V40, P695, DOI 10.1016/S0896-6273(03)00674-3; Debiec J, 2002, NEURON, V36, P527, DOI 10.1016/S0896-6273(02)01001-2; Debiec J, 2006, P NATL ACAD SCI USA, V103, P3428, DOI 10.1073/pnas.0507168103; Debiec J, 2004, NEUROSCIENCE, V129, P267, DOI 10.1016/j.neuroscience.2004.08.018; DEVIETTI TL, 1972, PSYCHON SCI, V29, P137; Dudai Y, 2006, CURR OPIN NEUROBIOL, V16, P174, DOI 10.1016/j.conb.2006.03.010; Duvarci S, 2004, J NEUROSCI, V24, P9269, DOI 10.1523/JNEUROSCI.2971-04.2004; Duvarci S, 2006, EUR J NEUROSCI, V24, P249, DOI 10.1111/j.1460-9568.2006.04907.x; Eisenberg M, 2003, SCIENCE, V301, P1102, DOI 10.1126/science.1086881; Fanselow MS, 2003, ANN NY ACAD SCI, V985, P125; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Frankland PW, 2004, SCIENCE, V304, P881, DOI 10.1126/science.1094804; Franks KM, 2005, NEURON, V47, P101, DOI 10.1016/j.neuron.2005.05.024; Joshi I, 2002, J PHYSIOL-LONDON, V540, P861; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Lee JLC, 2005, NEURON, V47, P795, DOI 10.1016/j.neuron.2005.08.007; Lee SH, 2008, SCIENCE, V319, P1253, DOI 10.1126/science.1150541; Lengyel I, 2004, EUR J NEUROSCI, V20, P3063, DOI 10.1111/j.1460-9568.2004.03748.x; Lorenzini CGA, 1999, NEUROBIOL LEARN MEM, V71, P1; Maren S, 1999, J NEUROSCI, V19, P8696; McDonald AJ, 1998, PROG NEUROBIOL, V55, P257, DOI 10.1016/S0301-0082(98)00003-3; Milekic MH, 2002, NEURON, V36, P521, DOI 10.1016/S0896-6273(02)00976-5; Milton AL, 2008, J NEUROSCI, V28, P8230, DOI 10.1523/JNEUROSCI.1723-08.2008; MISANIN JR, 1968, SCIENCE, V160, P554, DOI 10.1126/science.160.3827.554; Morris RGM, 2006, NEURON, V50, P479, DOI 10.1016/j.neuron.2006.04.012; Moscovitch M, 2006, CURR OPIN NEUROBIOL, V16, P179, DOI 10.1016/j.conb.2006.03.013; Muller G. E, 1900, Z PSYCHOL S, V1, P300; Nader K, 2003, TRENDS NEUROSCI, V26, P65, DOI 10.1016/S0166-2236(02)00042-5; Nader K, 2000, NAT REV NEUROSCI, V1, P216, DOI 10.1038/35044580; Nader K, 2009, NAT REV NEUROSCI, V10, P224, DOI 10.1038/nrn2590; Pedreira ME, 2003, NEURON, V38, P863, DOI 10.1016/S0896-6273(03)00352-0; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Pitkanen A, 2000, ANN NY ACAD SCI, V911, P369; Przybyslawski J, 1999, J NEUROSCI, V19, P6623; Reijmers LG, 2007, SCIENCE, V317, P1230, DOI 10.1126/science.1143839; Richter-Levin G, 2000, MOL NEUROBIOL, V22, P11, DOI 10.1385/MN:22:1-3:011; Rudy JW, 2006, LEARN MEMORY, V13, P1, DOI 10.1101/lm.157806; Sara SJ, 2000, LEARN MEMORY, V7, P73, DOI 10.1101/lm.7.2.73; Schafe GE, 2001, TRENDS NEUROSCI, V24, P540, DOI 10.1016/S0166-2236(00)01969-X; SCHNEIDER AM, 1968, SCIENCE, V159, P219, DOI 10.1126/science.159.3811.219; Stollhoff N, 2005, J NEUROSCI, V25, P4485, DOI 10.1523/JNEUROSCI.0117-05.2005; Suzuki A, 2004, J NEUROSCI, V24, P4787, DOI 10.1523/JNEUROSCI.5491-03.2004; Suzuki A, 2008, LEARN MEMORY, V15, P426, DOI 10.1101/lm.888808; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; Zinebi F, 2003, J NEUROSCI, V23, P10283; ZOLAMORGAN SM, 1990, SCIENCE, V250, P288, DOI 10.1126/science.2218534	50	221	223	2	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2009	12	7					905	U116		10.1038/nn.2350	http://dx.doi.org/10.1038/nn.2350			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	462OA	19543280				2022-12-17	WOS:000267362900018
J	Sirigu, A; Daprati, E; Ciancia, S; Giraux, P; Nighoghossian, N; Posada, A; Haggard, P				Sirigu, A; Daprati, E; Ciancia, S; Giraux, P; Nighoghossian, N; Posada, A; Haggard, P			Altered awareness of voluntary action after damage to the parietal cortex	NATURE NEUROSCIENCE			English	Article							GRIP-FORCE ADJUSTMENTS; SENSORIMOTOR INTEGRATION; MOVEMENTS; ABNORMALITIES	A central question in the study of human behavior is the origin of willed action. EEG recordings of surface brain activity from human subjects performing a self-initiated movement show that the subjective experience of wanting to move follows, rather than precedes, the 'readiness potential'-an electrophysiological mark of motor preparation. This raises the issue of how conscious experience of willed action is generated. Here we show that patients with parietal lesions can report when they started moving, but not when they first became aware of their intention to move. This stands in contrast with the performance of cerebellar patients who behaved as normal subjects. We thus propose that when a movement is planned, activity in the parietal cortex, as part of a cortico-cortical sensorimotor processing loop, generates a predictive internal model of the upcoming movement. This model might form the neural correlate of motor awareness.	Inst Cognit Sci, CNRS, F-69675 Bron, France; IRCCS, Fdn Santa Lucia, I-00179 Rome, Italy; Hop Neurol, Cerebrovasc Unit, F-69394 Lyon, France; UCL, Inst Cognit Neurosci, London, England	Centre National de la Recherche Scientifique (CNRS); IRCCS Santa Lucia; CHU Lyon; University of London; University College London	Sirigu, A (corresponding author), Inst Cognit Sci, CNRS, 67 Blv Pinel, F-69675 Bron, France.	sirigu@isc.cnrs.fr	Sirigu, Angela/L-4683-2017; Giraux, Pascal/D-8105-2018; Nighoghossian, Norbert/H-7492-2014; Haggard, Patrick/A-5081-2010; daprati, elena/AAA-2224-2019	Giraux, Pascal/0000-0002-8581-1472; Haggard, Patrick/0000-0001-7798-793X				Babin-Ratte S, 1999, EXP BRAIN RES, V128, P81, DOI 10.1007/s002210050821; BERTRAND O, 1985, ELECTROEN CLIN NEURO, V62, P462, DOI 10.1016/0168-5597(85)90058-9; Blakemore SJ, 2002, TRENDS COGN SCI, V6, P237, DOI 10.1016/S1364-6613(02)01907-1; Blakemore SJ, 2001, NEUROREPORT, V12, P1879, DOI 10.1097/00001756-200107030-00023; BLAKEMORE SJ, IN PRESS EXP BRAIN R; Buxbaum LJ, 2003, NEUROPSYCHOLOGIA, V41, P1091, DOI 10.1016/S0028-3932(02)00314-7; Desmurget M, 2000, TRENDS COGN SCI, V4, P423, DOI 10.1016/S1364-6613(00)01537-0; Flanagan JR, 1997, J NEUROSCI, V17, P1519; Frith CD, 2000, PHILOS T R SOC B, V355, P1771, DOI 10.1098/rstb.2000.0734; Haggard P, 2002, NAT NEUROSCI, V5, P382, DOI 10.1038/nn827; Kawagoe A, 1999, IEEE T APPL SUPERCON, V9, P727, DOI 10.1109/77.783398; KORNHUBE.HH, 1965, PFLUG ARCH GES PHYS, V284, P1, DOI 10.1007/BF00412364; Leiguarda RC, 2000, BRAIN, V123, P860, DOI 10.1093/brain/123.5.860; LIBET B, 1985, BEHAV BRAIN SCI, V8, P529, DOI 10.1017/S0140525X00044903; LIBET B, 1983, BRAIN, V106, P623, DOI 10.1093/brain/106.3.623; McCallum W., 1988, HDB ELECTROENCEPHALO, V3, P427; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Sirigu A, 1996, SCIENCE, V273, P1564, DOI 10.1126/science.273.5281.1564; Sirigu A, 1999, BRAIN, V122, P1867, DOI 10.1093/brain/122.10.1867; Weinstein E.A., 1955, DENIAL ILLNESS SYMBO; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Wolpert DM, 2001, TRENDS COGN SCI, V5, P487, DOI 10.1016/S1364-6613(00)01773-3	24	221	224	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2004	7	1					80	84		10.1038/nn1160	http://dx.doi.org/10.1038/nn1160			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	758LN	14647290				2022-12-17	WOS:000187636000017
J	Mignot, E; Taheri, S; Nishino, S				Mignot, E; Taheri, S; Nishino, S			Sleeping with the hypothalamus: emerging therapeutic targets for sleep disorders	NATURE NEUROSCIENCE			English	Review							CIRCADIAN-RHYTHM; WAKEFULNESS; RAT; HUMANS; ACID	Delineating the basic mechanisms that regulate sleep will likely result in the development of better treatments for sleep disorders. The hypothalamus is now recognized as a key center for sleep regulation, with hypothalamic neurotransmitter systems providing the framework for therapeutic advances. An increased awareness of the close interaction between sleep and homeostatic systems is also emerging. Progress has occurred in the understanding of narcolepsy-molecular techniques have identified the lateral hypothalamic hypocretin (orexin) neuropeptide system as key to the disorder. Other sleep disorders are now being tackled in the same way and are likely to yield to efforts combining basic and clinical research. Here we highlight the role of the hypothalamus in sleep physiology and discuss neurotransmitter systems, such as adenosine, dopamine, GABA, histamine and hypocretin, that may have therapeutic applications for sleep disorders.	Stanford Univ, Ctr Narcolepsy, Palo Alto, CA 94304 USA	Stanford University	Mignot, E (corresponding author), Stanford Univ, Ctr Narcolepsy, 701 Welch Rd B,Room 145, Palo Alto, CA 94304 USA.	mignot@stanford.edu	Taheri, Shahrad/O-9721-2016	Taheri, Shahrad/0000-0001-8314-1500				Bernardis LL, 1996, NEUROSCI BIOBEHAV R, V20, P189, DOI 10.1016/0149-7634(95)00015-1; Bernasconi R, 1999, TRENDS PHARMACOL SCI, V20, P135, DOI 10.1016/S0165-6147(99)01341-3; Beuckmann CT, 2002, J MOL MED, V80, P329, DOI 10.1007/s00109-002-0322-x; Cheng MY, 2002, NATURE, V417, P405, DOI 10.1038/417405a; Crestani F, 2000, BRIT J PHARMACOL, V131, P1251, DOI 10.1038/sj.bjp.0703717; DIJK DJ, 1994, NEUROSCI LETT, V166, P63, DOI 10.1016/0304-3940(94)90841-9; Dugovic C, 2002, SLEEP, V25, pA114; EDGAR DM, 1993, J NEUROSCI, V13, P1065; Kiyashchenko LI, 2002, J NEUROSCI, V22, P5282; Kramer A, 2001, SCIENCE, V294, P2511, DOI 10.1126/science.1067716; Kubin L, 1996, SLEEP, V19, P187; Lu J, 2002, SLEEP, V25, pA290; Marcus JN, 2001, J COMP NEUROL, V435, P6, DOI 10.1002/cne.1190; MILLR JD, 1983, BRAIN RES, V273, P133, DOI 10.1016/0006-8993(83)91101-0; Mitler M.M., 2000, PRINCIPLES PRACTICE; MORUZZI G, 1949, ELECTROEN CLIN NEURO, V1, P455, DOI 10.1016/0013-4694(49)90219-9; Naylor E, 2000, J NEUROSCI, V20, P8138; Pace-Schott EF, 2002, NAT REV NEUROSCI, V3, P591, DOI 10.1038/nrn895; Parmentier R, 2002, J NEUROSCI, V22, P7695; Porkka-Heiskanen T, 1997, SCIENCE, V276, P1265, DOI 10.1126/science.276.5316.1265; Rechtschaffen A, 2002, SLEEP, V25, p68B, DOI 10.1093/sleep/25.1.68; Rye DB, 2002, NEUROLOGY, V58, P341, DOI 10.1212/WNL.58.3.341; Saper CB, 2001, TRENDS NEUROSCI, V24, P726, DOI 10.1016/S0166-2236(00)02002-6; Shaw PJ, 2002, NATURE, V417, P287, DOI 10.1038/417287a; Smith TAD, 2001, BRIT J BIOMED SCI, V58, P111; Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8; Steriade M, 1996, SCIENCE, V272, P225, DOI 10.1126/science.272.5259.225; Strecker RE, 2002, NEUROSCIENCE, V113, P663, DOI 10.1016/S0306-4522(02)00158-6; Suntsova N, 2002, J PHYSIOL-LONDON, V543, P665, DOI 10.1113/jphysiol.2002.023085; Taheri S, 2002, ANNU REV NEUROSCI, V25, P283, DOI 10.1146/annurev.neuro.25.112701.142826; Tobler I, 2001, P NATL ACAD SCI USA, V98, P6464, DOI 10.1073/pnas.111055398; VANECONOMO C, 1930, J NERV MENT DIS, V71, P249; Wager-Smith K, 2000, NAT GENET, V26, P23, DOI 10.1038/79134; Wisor JP, 2001, J NEUROSCI, V21, P1787, DOI 10.1523/JNEUROSCI.21-05-01787.2001; Yamanaka A, 2002, BIOCHEM BIOPH RES CO, V290, P1237, DOI 10.1006/bbrc.2001.6318; Yoshida Y, 2001, EUR J NEUROSCI, V14, P1075, DOI 10.1046/j.0953-816x.2001.01725.x	36	221	235	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5			S			1071	1075		10.1038/nn944	http://dx.doi.org/10.1038/nn944			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	611WT	12403989				2022-12-17	WOS:000179041300017
J	Huettel, SA; Mack, PB; McCarthy, G				Huettel, SA; Mack, PB; McCarthy, G			Perceiving patterns in random series: dynamic processing of sequence in prefrontal cortex	NATURE NEUROSCIENCE			English	Article							EVENT-RELATED FMRI; WORKING-MEMORY; FUNCTIONAL MRI; VISUAL TARGET; ACTIVATION; TASK; STIMULI; SELECTION; NETWORK; BRAIN	We demonstrate that regions within human prefrontal cortex develop moment-to-moment models for patterns of events occurring in the sensory environment. Subjects viewed a random binary sequence of images, each presented singly and each requiring a different button press response. Patterns occurred by chance within the presented series of images. Using functional magnetic resonance imaging (fMRI), we identified activity evoked by viewing a stimulus that interrupted a pattern. Prefrontal activation was evoked by violations of both repeating and alternating patterns, and the amplitude of this activation increased with increasing pattern length. Violations of repeating patterns, but not of alternating patterns, activated the basal ganglia.	Duke Univ, Med Ctr, Brain Imaging & Anal Ctr, Durham, NC 27710 USA	Duke University	McCarthy, G (corresponding author), Duke Univ, Med Ctr, Brain Imaging & Anal Ctr, Box 3918, Durham, NC 27710 USA.			Mack, Peter/0000-0002-0627-5334	NIMH NIH HHS [MH-05286, MH-12541] Funding Source: Medline; NINDS NIH HHS [NS-41328] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS041328] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alain C, 1998, BRAIN RES, V812, P23, DOI 10.1016/S0006-8993(98)00851-8; BAUDENA P, 1995, ELECTROEN CLIN NEURO, V94, P251, DOI 10.1016/0013-4694(95)98476-O; BERTELSON P, 1961, Q J EXP PSYCHOL, V13, P90, DOI 10.1080/17470216108416478; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; CANFIELD RL, 1991, DEV PSYCHOL, V27, P198, DOI 10.1037/0012-1649.27.2.198; Clark VP, 2000, J NEUROPHYSIOL, V83, P3133, DOI 10.1152/jn.2000.83.5.3133; COHEN A, 1990, J EXP PSYCHOL LEARN, V16, P17, DOI 10.1037/0278-7393.16.1.17; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; Comerchero MD, 1998, COGNITIVE BRAIN RES, V7, P41, DOI 10.1016/S0926-6410(98)00009-3; COURCHESNE E, 1975, ELECTROEN CLIN NEURO, V39, P131, DOI 10.1016/0013-4694(75)90003-6; CURRAN T, 1993, J EXP PSYCHOL LEARN, V19, P189, DOI 10.1037/0278-7393.19.1.189; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Grafton ST, 1998, J NEUROPHYSIOL, V79, P1092, DOI 10.1152/jn.1998.79.2.1092; Gray Jeffrey A., 1995, P1165; Hardoon KK, 2001, J CLIN PSYCHOL, V57, P749, DOI 10.1002/jclp.1047; Harrington DL, 2000, J COGNITIVE NEUROSCI, V12, P56, DOI 10.1162/08989290051137602; HIKOSAKA O, 1999, NEW COGNITIVE NEUROS, P553; HOLLAND MK, 1968, PERCEPT PSYCHOPHYS, V3, P409, DOI 10.3758/BF03205747; Huettel SA, 1999, PERCEPT PSYCHOPHYS, V61, P1624, DOI 10.3758/BF03213123; HYMAN R, 1953, J EXP PSYCHOL, V45, P188, DOI 10.1037/h0056940; Katayama J, 1998, PSYCHOPHYSIOLOGY, V35, P23, DOI 10.1017/S0048577298961479; Kirino E, 2000, J NEUROSCI, V20, P6612, DOI 10.1523/JNEUROSCI.20-17-06612.2000; Levy R, 1997, J NEUROSCI, V17, P3870; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; McCarthy G, 1997, J NEUROPHYSIOL, V77, P1630, DOI 10.1152/jn.1997.77.3.1630; Middleton FA, 2000, BRAIN RES REV, V31, P236, DOI 10.1016/S0165-0173(99)00040-5; NISSEN MJ, 1987, COGNITIVE PSYCHOL, V19, P1, DOI 10.1016/0010-0285(87)90002-8; SCHVANEV.RW, 1969, J EXP PSYCHOL, V80, P1, DOI 10.1037/h0027144; SELEMON LD, 1988, J NEUROSCI, V8, P4049; Sohn MH, 2000, P NATL ACAD SCI USA, V97, P13448, DOI 10.1073/pnas.240460497; SQUIRES KC, 1976, SCIENCE, V193, P1142, DOI 10.1126/science.959831; SQUIRES N, 1975, ELECTROENCEPHALOGR C, V38; Stevens AA, 2000, MAGN RESON IMAGING, V18, P495, DOI 10.1016/S0730-725X(00)00128-4; Tervaniemi M, 2000, HUM BRAIN MAPP, V10, P74, DOI 10.1002/(SICI)1097-0193(200006)10:2<74::AID-HBM30>3.0.CO;2-2; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; WILLINGHAM DB, 1989, J EXP PSYCHOL LEARN, V15, P1047, DOI 10.1037/0278-7393.15.6.1047; Xiong JH, 1995, HUM BRAIN MAPP, V3, P287, DOI 10.1002/hbm.460030404; ZATORRE RJ, 1992, SCIENCE, V256, P846, DOI 10.1126/science.1589767	38	221	223	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2002	5	5					485	490		10.1038/nn841	http://dx.doi.org/10.1038/nn841			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	546JY	11941373				2022-12-17	WOS:000175272000021
J	Cho, KW				Cho, KW			Chronic 'jet lag' produces temporal lobe atrophy and spatial cognitive deficits	NATURE NEUROSCIENCE			English	Article							MEMORY IMPAIRMENT; PERFORMANCE		Univ Bristol, Sch Med, Dept Anat, MRC,Ctr Synapt Plast, Bristol BS8 1TD, Avon, England	University of Bristol	Cho, KW (corresponding author), Univ Bristol, Sch Med, Dept Anat, MRC,Ctr Synapt Plast, Bristol BS8 1TD, Avon, England.	kei.cho@bris.ac.uk		Cho, Kwangwook/0000-0001-6724-7073				Abrahams S, 1999, BRAIN COGNITION, V41, P39, DOI 10.1006/brcg.1999.1095; Brown MW, 2001, NAT REV NEUROSCI, V2, P51, DOI 10.1038/35049064; Cho K, 2000, J NEUROSCI, V20, part. no.; Deacon S, 1996, PHYSIOL BEHAV, V59, P665, DOI 10.1016/0031-9384(95)02147-7; Lupien SJ, 1997, J CLIN ENDOCR METAB, V82, P2070, DOI 10.1210/jc.82.7.2070; Lupien SJ, 1998, NAT NEUROSCI, V1, P69, DOI 10.1038/271; Newcomer JW, 1999, ARCH GEN PSYCHIAT, V56, P527, DOI 10.1001/archpsyc.56.6.527; Nunn JA, 1999, BRAIN, V122, P47, DOI 10.1093/brain/122.1.47; Porter NM, 1998, NAT NEUROSCI, V1, P3, DOI 10.1038/196; Sapolsky RM, 1992, STRESS AGING BRAIN M; SQUIRE LR, 1990, J NEUROSCI, V10, P3106; WINGET CM, 1984, AVIAT SPACE ENVIR MD, V55, P1085	12	221	226	1	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2001	4	6					567	568		10.1038/88384	http://dx.doi.org/10.1038/88384			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	438PG	11369936				2022-12-17	WOS:000169061800008
J	Dawson, TM; Golde, TE; Lagier-Tourenne, C				Dawson, Ted M.; Golde, Todd E.; lagier-Tourenne, Clotilde			Animal models of neurodegenerative diseases	NATURE NEUROSCIENCE			English	Review							AMYOTROPHIC-LATERAL-SCLEROSIS; MOTOR-NEURON DEGENERATION; EARLY ALZHEIMERS-DISEASE; TAU-TRANSGENIC MICE; PARKINSONS-DISEASE; ALPHA-SYNUCLEIN; MOUSE MODELS; A-BETA; HEXANUCLEOTIDE REPEAT; NEUROFIBRILLARY TANGLES	Animal models of adult-onset neurodegenerative diseases have enhanced the understanding of the molecular pathogenesis of Alzheimer's disease, Parkinson's disease, frontotemporal dementia, and amyotrophic lateral sclerosis. Nevertheless, our understanding of these disorders and the development of mechanistically designed therapeutics can still benefit from more rigorous use of the models and from generation of animals that more faithfully recapitulate human disease. Here we review the current state of rodent models for Alzheimer's disease, Parkinson's disease, frontotemporal dementia, and amyotrophic lateral sclerosis. We discuss the limitations and utility of current models, issues regarding translatability, and future directions for developing animal models of these human disorders.	[Dawson, Ted M.] Johns Hopkins Univ, Sch Med, Dept Neurol, Neuroregenerat Program,Inst Cell Engn, Baltimore, MD 21205 USA; [Dawson, Ted M.] Johns Hopkins Univ, Sch Med, Dept Neurol, Stem Cell Program,Inst Cell Engn, Baltimore, MD 21205 USA; [Dawson, Ted M.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Dawson, Ted M.] Adrienne Helis Malvin Med Res Fdn, New Orleans, LA 70130 USA; [Golde, Todd E.] Univ Florida, Dept Neurosci & Neurol, Ctr Translat Res Neurodegenerat Dis, McKnight Brain Inst, Gainesville, FL 32611 USA; [lagier-Tourenne, Clotilde] Massachusetts Gen Hosp, Dept Neurol, MIND, Boston, MA 02114 USA; [lagier-Tourenne, Clotilde] Harvard Med Sch, Boston, MA 02115 USA; [lagier-Tourenne, Clotilde] Broad Inst Harvard Univ & MIT, Cambridge, MA 02142 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; State University System of Florida; University of Florida; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Dawson, TM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol, Neuroregenerat Program,Inst Cell Engn, Baltimore, MD 21205 USA.; Dawson, TM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol, Stem Cell Program,Inst Cell Engn, Baltimore, MD 21205 USA.; Dawson, TM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.; Dawson, TM (corresponding author), Adrienne Helis Malvin Med Res Fdn, New Orleans, LA 70130 USA.; Golde, TE (corresponding author), Univ Florida, Dept Neurosci & Neurol, Ctr Translat Res Neurodegenerat Dis, McKnight Brain Inst, Gainesville, FL 32611 USA.; Lagier-Tourenne, C (corresponding author), Massachusetts Gen Hosp, Dept Neurol, MIND, Boston, MA 02114 USA.; Lagier-Tourenne, C (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Lagier-Tourenne, C (corresponding author), Broad Inst Harvard Univ & MIT, Cambridge, MA 02142 USA.	tdawson@jhmi.edu; tgold@mbi.ufl.edu; clagier-tourenne@mgh.harvard.edu	lagier-Tourenne, Clotilde/ABE-6303-2020	lagier-Tourenne, Clotilde/0000-0002-3058-8322	NIH/NINDS [NS38377, NS082205, NS098006]; JPB Foundation; Michael J. Fox Foundation; Abramson Professorship; NIH [P01CA166009, U01AG046139, R01AG018454, P50AG047266, R01NS087227]; ALS Association; Target ALS Foundation; ALS Finding a Cure; Association Francaise contre les Myopathies; Pape Adams Charitable Foundation; NATIONAL CANCER INSTITUTE [P01CA166009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS098006, R01NS087227, R01NS082205, P50NS038377] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG018454, P50AG047266, U01AG046139] Funding Source: NIH RePORTER	NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); JPB Foundation; Michael J. Fox Foundation; Abramson Professorship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ALS Association; Target ALS Foundation; ALS Finding a Cure; Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Pape Adams Charitable Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the NIH/NINDS NS38377 Morris K. Udall Parkinson's Disease Research Center, NIH/NINDS NS082205, NIH/NINDS NS098006, the JPB Foundation and Michael J. Fox Foundation. T.M.D. is supported by the Abramson Professorship. T.M.D. acknowledges joint participation by the Adrienne Helis Malvin Medical Research Foundation through its direct engagement in the continuous active conduct of medical research in conjunction with The Johns Hopkins Hospital, the Johns Hopkins University School of Medicine, and the Foundation's Parkinson's Disease Program M-1, M-2, M-2015. Supported by grants from the NIH to T.E.G. (P01CA166009, U01AG046139 R01AG018454, P50AG047266) and to C.L.T. (R01NS087227). C.L.-T. was supported by grants from the ALS Association, the Target ALS Foundation, ALS Finding a Cure, the Association Francaise contre les Myopathies, and the Pape Adams Charitable Foundation.	Ahmed RM, 2017, NEUROSCI BIOBEHAV R, V74, P126, DOI 10.1016/j.neubiorev.2017.01.004; Andersen PM, 2011, NAT REV NEUROL, V7, P603, DOI 10.1038/nrneurol.2011.150; Andorfer C, 2005, J NEUROSCI, V25, P5446, DOI 10.1523/JNEUROSCI.4637-04.2005; Arnold ES, 2013, P NATL ACAD SCI USA, V110, pE736, DOI 10.1073/pnas.1222809110; Ashe KH, 2010, NEURON, V66, P631, DOI 10.1016/j.neuron.2010.04.031; Atanasio A, 2016, SCI REP-UK, V6, DOI 10.1038/srep23204; Athauda D, 2016, PARKINSONISM RELAT D, V32, P1, DOI 10.1016/j.parkreldis.2016.07.019; Bateman RJ, 2017, ALZHEIMERS DEMENT, V13, P8, DOI 10.1016/j.jalz.2016.07.005; Berry JD, 2014, AMYOTROPH LAT SCL FR, V15, P1, DOI 10.3109/21678421.2013.838969; Bezard E, 2013, MOVEMENT DISORD, V28, P61, DOI 10.1002/mds.25108; Bilen J, 2005, ANNU REV GENET, V39, P153, DOI 10.1146/annurev.genet.39.110304.095804; Blesa J, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00155; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Bolmont T, 2007, AM J PATHOL, V171, P2012, DOI 10.2353/ajpath.2007.070403; Braak H, 2017, J PARKINSON DIS, V7, pS73, DOI 10.3233/JPD-179001; Breschi A, 2017, NAT REV GENET, V18, P425, DOI 10.1038/nrg.2017.19; Brettschneider J, 2015, NAT REV NEUROSCI, V16, P109, DOI 10.1038/nrn3887; Brundin P, 2010, NAT REV MOL CELL BIO, V11, P301, DOI 10.1038/nrm2873; Burberry A, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf6038; CARLSSON A, 1957, NATURE, V180, P1200, DOI 10.1038/1801200a0; Carmona Susana, 2018, Handb Clin Neurol, V148, P395, DOI 10.1016/B978-0-444-64076-5.00026-0; Chang D, 2017, NAT GENET, V49, P1511, DOI 10.1038/ng.3955; Chew J, 2015, SCIENCE, V348, P1151, DOI 10.1126/science.aaa9344; Collinge J, 2016, NATURE, V539, P217, DOI 10.1038/nature20415; Daniel G, 2015, CURR TOP BEHAV NEURO, V22, P331, DOI 10.1007/7854_2014_311; Dawson TM, 2010, NEURON, V66, P646, DOI 10.1016/j.neuron.2010.04.034; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Devoy A, 2017, BRAIN, V140, P2797, DOI 10.1093/brain/awx248; Eisele YS, 2010, SCIENCE, V330, P980, DOI 10.1126/science.1194516; Fil D, 2017, HUM MOL GENET, V26, P686, DOI 10.1093/hmg/ddw429; Fu HJ, 2017, NEURON, V93, P533, DOI 10.1016/j.neuron.2016.12.023; Giaime E, 2017, NEURON, V96, P796, DOI 10.1016/j.neuron.2017.09.036; Goedert M, 2017, ANNU REV NEUROSCI, V40, P189, DOI 10.1146/annurev-neuro-072116-031153; Golde TE, 2013, J CLIN INVEST, V123, P1847, DOI 10.1172/JCI66029; Golde TE, 2011, NEURON, V69, P203, DOI 10.1016/j.neuron.2011.01.002; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Greenland S, 2016, EUR J EPIDEMIOL, V31, P337, DOI 10.1007/s10654-016-0149-3; Guo JL, 2014, NAT MED, V20, P130, DOI 10.1038/nm.3457; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Gurney ME, 1996, ANN NEUROL, V39, P147, DOI 10.1002/ana.410390203; Haass C, 1999, SCIENCE, V286, P916, DOI 10.1126/science.286.5441.916; Hatami A, 2015, CURR TOP BEHAV NEURO, V22, P303, DOI 10.1007/7854_2014_355; He ZH, 2018, NAT MED, V24, P29, DOI 10.1038/nm.4443; Heuer E, 2012, CURR PHARM DESIGN, V18, P1159, DOI 10.2174/138161212799315885; Holtzman DM, 2016, ALZHEIMERS DEMENT, V12, P1033, DOI 10.1016/j.jalz.2016.03.018; Holtzman DM, 2011, SCI TRANSL MED, V3; Hutton M, 2001, TRENDS MOL MED, V7, P467, DOI 10.1016/S1471-4914(01)02123-2; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Irwin DJ, 2013, JAMA NEUROL, V70, P462, DOI 10.1001/jamaneurol.2013.1933; Ito H, 2008, EXP NEUROL, V213, P448, DOI 10.1016/j.expneurol.2008.07.017; Ittner LM, 2015, NAT REV NEUROL, V11, P360, DOI 10.1038/nrneurol.2015.65; Jack CR, 2016, NEUROLOGY, V87, P539, DOI 10.1212/WNL.0000000000002923; Jiang J, 2016, NEURON, V90, P535, DOI 10.1016/j.neuron.2016.04.006; Kaufman SK, 2016, NEURON, V92, P796, DOI 10.1016/j.neuron.2016.09.055; Kim J, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-15; Kitada T, 2009, J NEUROCHEM, V111, P696, DOI 10.1111/j.1471-4159.2009.06350.x; Klein C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a008888; Koprich JB, 2017, NAT REV NEUROSCI, V18, P515, DOI 10.1038/nrn.2017.75; Kraemer BC, 2010, ACTA NEUROPATHOL, V119, P409, DOI 10.1007/s00401-010-0659-0; LaFerla FM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006320; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Le NTT, 2016, P NATL ACAD SCI USA, V113, pE7580, DOI 10.1073/pnas.1608432113; Lee BD, 2010, NAT MED, V16, P998, DOI 10.1038/nm.2199; Lee SJ, 2010, NAT REV NEUROL, V6, P702, DOI 10.1038/nrneurol.2010.145; Lee Y, 2017, CELL REP, V18, P918, DOI 10.1016/j.celrep.2016.12.090; Lee Y, 2013, NAT NEUROSCI, V16, P1392, DOI 10.1038/nn.3500; Lee Y, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009324; Lees AJ, 2015, MOVEMENT DISORD, V30, P19, DOI 10.1002/mds.26120; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Li J, 2013, EXP NEUROL, V250, P94, DOI 10.1016/j.expneurol.2013.09.024; Lin X, 2012, J NEUROSCI, V32, P9248, DOI 10.1523/JNEUROSCI.1731-12.2012; Link CD, 2005, GENES BRAIN BEHAV, V4, P147, DOI 10.1111/j.1601-183X.2004.00105.x; Liu C, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.156166; Liu ET, 2017, EMBO REP, V18, P187, DOI 10.15252/embr.201643717; Liu YJ, 2016, NEURON, V90, P521, DOI 10.1016/j.neuron.2016.04.005; Low BE, 2016, METHODS MOL BIOL, V1438, P19, DOI 10.1007/978-1-4939-3661-8_2; Lu XH, 2009, J NEUROSCI, V29, P1962, DOI 10.1523/JNEUROSCI.5351-08.2009; Ludolph AC, 2010, AMYOTROPH LATERAL SC, V11, P38, DOI 10.3109/17482960903545334; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Lutz C, 2018, BRAIN RES, V1693, P1, DOI 10.1016/j.brainres.2018.03.024; Martin I, 2011, ANNU REV GENOM HUM G, V12, P301, DOI 10.1146/annurev-genom-082410-101440; McDowell K, 2012, NEUROBIOL DIS, V46, P597, DOI 10.1016/j.nbd.2011.12.040; McGowan E, 2005, NEURON, V47, P191, DOI 10.1016/j.neuron.2005.06.030; McGowan E, 2006, TRENDS GENET, V22, P281, DOI 10.1016/j.tig.2006.03.007; Miller TM, 2013, LANCET NEUROL, V12, P435, DOI 10.1016/S1474-4422(13)70061-9; Moehle MS, 2012, J NEUROSCI, V32, P1602, DOI 10.1523/JNEUROSCI.5601-11.2012; Muqit MMK, 2002, NAT REV NEUROSCI, V3, P237, DOI 10.1038/nrn751; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nicholson KA, 2015, NEUROTHERAPEUTICS, V12, P376, DOI 10.1007/s13311-015-0341-2; Nolan M, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0358-8; O'Rourke JG, 2016, SCIENCE, V351, P1324, DOI 10.1126/science.aaf1064; O'Rourke JG, 2015, NEURON, V88, P892, DOI 10.1016/j.neuron.2015.10.027; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Olanow CW, 2017, EXP NEUROL, V298, P246, DOI 10.1016/j.expneurol.2017.06.018; Onos KD, 2016, BRAIN RES BULL, V122, P1, DOI 10.1016/j.brainresbull.2015.12.003; Peters OM, 2015, NEURON, V88, P902, DOI 10.1016/j.neuron.2015.11.018; Philips Thomas, 2015, Curr Protoc Pharmacol, V69, DOI 10.1002/0471141755.ph0567s69; Picher-Martel V, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0340-5; Price DL, 1998, ANNU REV GENET, V32, P461, DOI 10.1146/annurev.genet.32.1.461; Prussing K, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-35; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Reaume AG, 1996, NAT GENET, V13, P43, DOI 10.1038/ng0596-43; Reiman EM, 2010, BIOMARK MED, V4, P3, DOI [10.2217/bmm.09.91, 10.2217/BMM.09.91]; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Sacino AN, 2016, ACTA NEUROPATHOL, V131, P151, DOI 10.1007/s00401-015-1505-1; Saito T, 2014, NAT NEUROSCI, V17, P661, DOI 10.1038/nn.3697; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Sasaguri H, 2017, EMBO J, V36, P2473, DOI 10.15252/embj.201797397; Savitt JM, 2006, J CLIN INVEST, V116, P1744, DOI 10.1172/JCI29178; Scekic-Zahirovic J, 2017, ACTA NEUROPATHOL, V133, P887, DOI 10.1007/s00401-017-1687-9; Schludi MH, 2017, ACTA NEUROPATHOL, V134, P241, DOI 10.1007/s00401-017-1711-0; Scott L, 2017, EXP NEUROL, V298, P191, DOI 10.1016/j.expneurol.2017.04.008; Scott S, 2008, AMYOTROPH LATERAL SC, V9, P4, DOI 10.1080/17482960701856300; Sephton CF, 2010, J BIOL CHEM, V285, P6826, DOI 10.1074/jbc.M109.061846; Shi YX, 2018, NAT MED, V24, P313, DOI 10.1038/nm.4490; Shin JH, 2011, CELL, V144, P689, DOI 10.1016/j.cell.2011.02.010; Sloan M, 2012, BIOCHEM SOC T, V40, P1080, DOI 10.1042/BST20120151; Sperling RA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007941; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Spiller KJ, 2018, NAT NEUROSCI, V21, P329, DOI 10.1038/s41593-018-0083-7; Spires TL, 2004, REV NEUROSCIENCE, V15, P267, DOI 10.1515/REVNEURO.2004.15.4.267; Stopschinski BE, 2017, LANCET NEUROL, V16, P323, DOI 10.1016/S1474-4422(17)30037-6; Strang KH, 2018, J BIOL CHEM, V293, P2408, DOI 10.1074/jbc.M117.815357; Swarup V, 2011, BRAIN, V134, P2610, DOI 10.1093/brain/awr159; Tansey KE, 2018, GENOME MED, V10, DOI 10.1186/s13073-018-0523-8; Taylor JP, 2016, NATURE, V539, P197, DOI 10.1038/nature20413; Tofaris GK, 2006, J NEUROSCI, V26, P3942, DOI 10.1523/JNEUROSCI.4965-05.2006; Tsika E, 2015, NEUROBIOL DIS, V77, P49, DOI 10.1016/j.nbd.2015.02.019; Van der Perren A, 2015, CURR TOP BEHAV NEURO, V22, P271, DOI 10.1007/7854_2014_310; Vingill S, 2018, BEHAV BRAIN RES, V352, P133, DOI 10.1016/j.bbr.2017.10.021; Visanji NP, 2016, TRENDS NEUROSCI, V39, P750, DOI 10.1016/j.tins.2016.09.003; Volta M, 2017, BIOCHEM SOC T, V45, P113, DOI 10.1042/BST20160238; Walker AK, 2015, ACTA NEUROPATHOL, V130, P643, DOI 10.1007/s00401-015-1460-x; Walker LC, 2015, ANNU REV NEUROSCI, V38, P87, DOI 10.1146/annurev-neuro-071714-033828; Walker LC, 2013, JAMA NEUROL, V70, P304, DOI 10.1001/jamaneurol.2013.1453; Watts JC, 2014, P NATL ACAD SCI USA, V111, P10323, DOI 10.1073/pnas.1408900111; Wen XM, 2017, NEUROSCI LETT, V636, P16, DOI 10.1016/j.neulet.2016.09.007; White MA, 2018, NAT NEUROSCI, V21, P552, DOI 10.1038/s41593-018-0113-5; Winderickx J, 2008, BBA-MOL CELL RES, V1783, P1381, DOI 10.1016/j.bbamcr.2008.01.020; Wu LS, 2010, GENESIS, V48, P56, DOI 10.1002/dvg.20584; Xiong YL, 2018, P NATL ACAD SCI USA, V115, P1635, DOI 10.1073/pnas.1712648115; Xiong Y, 2017, ADV NEUROBIOL, V14, P163, DOI 10.1007/978-3-319-49969-7_9; Yang CX, 2016, P NATL ACAD SCI USA, V113, pE6209, DOI 10.1073/pnas.1605964113; Yun SP, 2018, NAT MED, V24, P931, DOI 10.1038/s41591-018-0051-5; Zhang YJ, 2018, NAT MED, V24, P1136, DOI 10.1038/s41591-018-0071-1; Zhang YJ, 2016, NAT NEUROSCI, V19, P668, DOI 10.1038/nn.4272	149	220	224	19	143	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2018	21	10					1370	1379		10.1038/s41593-018-0236-8	http://dx.doi.org/10.1038/s41593-018-0236-8			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GU9FY	30250265	Green Accepted			2022-12-17	WOS:000445651600012
J	Pasman, JA; Verweij, KJH; Gerring, Z; Stringer, S; Sanchez-Roige, S; Treur, JL; Abdellaoui, A; Nivard, MG; Baselmans, BML; Ong, JS; Ip, HF; van der Zee, MD; Bartels, M; Day, FR; Fontanillas, P; Elson, SL; de Wit, H; Davis, LK; MacKillop, J; Derringer, JL; Branje, SJT; Hartman, CA; Heath, AC; van Lier, PAC; Madden, PAF; Magi, R; Meeus, W; Montgomery, GW; Oldehinkel, AJ; Pausova, Z; Ramos-Quiroga, JA; Paus, T; Ribases, M; Kaprio, J; Boks, MPM; Bell, JT; Spector, TD; Gelernter, J; Boomsma, DI; Martin, NG; MacGregor, S; Perry, JRB; Palmer, AA; Posthuma, D; Munafo, MR; Gillespie, NA; Derks, EM; Vink, JM				Pasman, Joelle A.; Verweij, Karin J. H.; Gerring, Zachary; Stringer, Sven; Sanchez-Roige, Sandra; Treur, Jorien L.; Abdellaoui, Abdel; Nivard, Michel G.; Baselmans, Bart M. L.; Ong, Jue-Sheng; Ip, Hill F.; van der Zee, Matthijs D.; Bartels, Meike; Day, Felix R.; Fontanillas, Pierre; Elson, Sarah L.; de Wit, Harriet; Davis, Lea K.; MacKillop, James; Derringer, Jaime L.; Branje, Susan J. T.; Hartman, Catharina A.; Heath, Andrew C.; van Lier, Pol A. C.; Madden, Pamela A. F.; Maegi, Reedik; Meeus, Wim; Montgomery, Grant W.; Oldehinkel, A. J.; Pausova, Zdenka; Ramos-Quiroga, Josep A.; Paus, Tomas; Ribases, Marta; Kaprio, Jaakko; Boks, Marco P. M.; Bell, Jordana T.; Spector, Tim D.; Gelernter, Joel; Boomsma, Dorret I.; Martin, Nicholas G.; MacGregor, Stuart; Perry, John R. B.; Palmer, Abraham A.; Posthuma, Danielle; Munafo, Marcus R.; Gillespie, Nathan A.; Derks, Eske M.; Vink, Jacqueline M.		23andMe Res Team; Subst Use Disorders Working Grp Ps; Int Cannabis Consortium	GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal influence of schizophrenia	NATURE NEUROSCIENCE			English	Article							GENOME-WIDE ASSOCIATION; CELL-ADHESION MOLECULES; MENDELIAN RANDOMIZATION; USE INITIATION; NICOTINE DEPENDENCE; SUBSTANCE USE; NCAM1; METAANALYSIS; VARIANTS; ALCOHOL	Cannabis use is a heritable trait that has been associated with adverse mental health outcomes. In the largest genome-wide association study (GWAS) for lifetime cannabis use to date (N = 184,765), we identified eight genome-wide significant independent single nucleotide polymorphisms in six regions. All measured genetic variants combined explained 11% of the variance. Gene-based tests revealed 35 significant genes in 16 regions, and S-PrediXcan analyses showed that 21 genes had different expression levels for cannabis users versus nonusers. The strongest finding across the different analyses was CADM2, which has been associated with substance use and risk-taking. Significant genetic correlations were found with 14 of 25 tested sub-stance use and mental health-related traits, including smoking, alcohol use, schizophrenia and risk-taking. Mendelian randomization analysis showed evidence for a causal positive influence of schizophrenia risk on cannabis use. Overall, our study provides new insights into the etiology of cannabis use and its relation with mental health.	[Pasman, Joelle A.; Verweij, Karin J. H.; Vink, Jacqueline M.] Radboud Univ Nijmegen, Behav Sci Inst, Nijmegen, Netherlands; [Verweij, Karin J. H.; Abdellaoui, Abdel] Univ Amsterdam, Amsterdam UMC, Dept Psychiat, Amsterdam, Netherlands; [Gerring, Zachary; Ong, Jue-Sheng; Martin, Nicholas G.; MacGregor, Stuart; Gillespie, Nathan A.; Derks, Eske M.] QIMR Berghofer Med Res Inst, Genet Epidemiol Lab, Brisbane, Qld, Australia; [Gerring, Zachary; Ong, Jue-Sheng; Martin, Nicholas G.; MacGregor, Stuart; Gillespie, Nathan A.; Derks, Eske M.] QIMR Berghofer Med Res Inst, Stat Genet Lab, Brisbane, Qld, Australia; [Gerring, Zachary; Ong, Jue-Sheng; Martin, Nicholas G.; MacGregor, Stuart; Gillespie, Nathan A.; Derks, Eske M.] QIMR Berghofer Med Res Inst, Translat Neurogen Lab, Brisbane, Qld, Australia; [Stringer, Sven; Posthuma, Danielle] Vrije Univ Amsterdam, Ctr Neurogenom & Cognit Res, Dept Complex Trait Genet, Amsterdam, Netherlands; [Sanchez-Roige, Sandra; Palmer, Abraham A.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Treur, Jorien L.; Munafo, Marcus R.] Univ Bristol, MRC Integrat Epidemiol Unit IEU, Bristol, Avon, England; [Nivard, Michel G.; Baselmans, Bart M. L.; Ip, Hill F.; van der Zee, Matthijs D.; Bartels, Meike; Boomsma, Dorret I.] Vrije Univ Amsterdam, Netherlands Twin Register, Dept Biol Psychol, Amsterdam, Netherlands; [Day, Felix R.; Perry, John R. B.] Univ Cambridge, Sch Clin Med, Inst Metab Sci, MRC Epidemiol Unit, Cambridge Biomed Campus, Cambridge, England; [Fontanillas, Pierre; Elson, Sarah L.] 23andMe Inc, Mountain View, CA USA; [de Wit, Harriet] Univ Chicago, Dept Psychiat & Behav Neurosci, Chicago, IL 60637 USA; [Davis, Lea K.] Vanderbilt Univ, Dept Med, Vanderbilt Genet Inst, Div Med Genet, Nashville, TN USA; [MacKillop, James] McMaster Univ, St Josephs Healthcare Hamilton, Peter Boris Ctr Addict Res, Hamilton, ON, Canada; [MacKillop, James] McMaster Univ, St Josephs Healthcare Hamilton, Michael G DeGroote Ctr Med Cannabis Res, Hamilton, ON, Canada; [Derringer, Jaime L.] Univ Illinois, Dept Psychol, Champaign, IL USA; [Branje, Susan J. T.; Meeus, Wim] Univ Utrecht, Dept Youth & Family, Utrecht, Netherlands; [Hartman, Catharina A.; Oldehinkel, A. J.] Univ Groningen, Univ Med Ctr Groningen, Interdisciplinary Ctr Psychopathol & Emot Regulat, Dept Psychiat, Groningen, Netherlands; [Heath, Andrew C.; Madden, Pamela A. F.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [van Lier, Pol A. C.] Vrije Univ Amsterdam, Dept Dev Psychol, Amsterdam, Netherlands; [van Lier, Pol A. C.] Vrije Univ Amsterdam, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Maegi, Reedik] Univ Tartu, Estonian Genome Ctr, Tartu, Estonia; [Montgomery, Grant W.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Pausova, Zdenka] Hosp Sick Children, Toronto, ON, Canada; [Ramos-Quiroga, Josep A.; Ribases, Marta] Univ Autonoma Barcelona, Vall dHebron Res Inst VHIR, Grp Psychiat Mental Hlth & Addict, Psychiat Genet Unit, Barcelona, Spain; [Ramos-Quiroga, Josep A.; Ribases, Marta] Hosp Univ Vall dHebron, Dept Psychiat, Barcelona, Spain; [Ramos-Quiroga, Josep A.; Ribases, Marta] Inst Salud Carlos III, Biomed Network Res Ctr Mental Hlth CIBERSAM, Barcelona, Spain; [Ramos-Quiroga, Josep A.] Univ Autonoma Barcelona, Dept Psychiat & Legal Med, Barcelona, Spain; [Paus, Tomas] Baycrest, Rotman Res Inst, Toronto, ON, Canada; [Paus, Tomas] Univ Toronto, Dept Psychol, Toronto, ON, Canada; [Paus, Tomas] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Kaprio, Jaakko] Univ Helsinki, Inst Mol Med Finland FIMM, HiLIFE Unit, Helsinki, Finland; [Boks, Marco P. M.] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Psychiat, Utrecht, Netherlands; [Bell, Jordana T.; Spector, Tim D.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London, England; [Gelernter, Joel] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; [Palmer, Abraham A.] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA; [Munafo, Marcus R.] Univ Bristol, UK Ctr Tobacco & Alcohol Studies, Bristol, Avon, England; [Munafo, Marcus R.] Univ Bristol, Sch Expt Psychol, Bristol, Avon, England; [Gillespie, Nathan A.] Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Dept Psychiat, Richmond, VA USA	Radboud University Nijmegen; University of Amsterdam; Vrije Universiteit Amsterdam; QIMR Berghofer Medical Research Institute; QIMR Berghofer Medical Research Institute; QIMR Berghofer Medical Research Institute; Vrije Universiteit Amsterdam; University of California System; University of California San Diego; University of Bristol; Vrije Universiteit Amsterdam; University of Cambridge; University of Chicago; Vanderbilt University; McMaster University; McMaster University; University of Illinois System; University of Illinois Urbana-Champaign; Utrecht University; University of Groningen; Washington University (WUSTL); Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Tartu; University of Queensland; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Hospital Universitari Vall d'Hebron; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Instituto de Salud Carlos III; Autonomous University of Barcelona; University of Toronto; University Toronto Affiliates; Baycrest; University of Toronto; University of Toronto; University of Helsinki; Utrecht University; Utrecht University Medical Center; University of London; King's College London; Yale University; University of California System; University of California San Diego; University of Bristol; University of Bristol; Virginia Commonwealth University	Vink, JM (corresponding author), Radboud Univ Nijmegen, Behav Sci Inst, Nijmegen, Netherlands.	j.vink@bsi.ru.nl	Copeland, William E/N-5413-2014; Bell, Jordana/AAH-7312-2019; Boomsma, Dorret I/AAX-4470-2020; Pasman, Joëlle/M-6233-2019; , James/ABI-3641-2020; Ribasés, Marta/B-5309-2019; Baselmans, Bart ML/R-3562-2016; Kaprio, Jaakko/A-1820-2008; Branje, Susan/A-7813-2010; Munafo, Marcus/AAE-2306-2020; Macgregor, Stuart/C-6442-2009; Mägi, Reedik/AAJ-9679-2021; Sanchez-Roige, Sandra/GPK-6281-2022; Ong, Jue Sheng/B-3595-2018; Derks, Eske/A-1652-2017; Bartels, Meike/D-4492-2014	Copeland, William E/0000-0002-1348-7781; Pasman, Joëlle/0000-0001-7558-0482; , James/0000-0002-8695-1071; Ribasés, Marta/0000-0003-1039-1116; Baselmans, Bart ML/0000-0001-9042-1041; Kaprio, Jaakko/0000-0002-3716-2455; Branje, Susan/0000-0002-9999-5313; Munafo, Marcus/0000-0002-4049-993X; Macgregor, Stuart/0000-0001-6731-8142; Sanchez-Roige, Sandra/0000-0001-6137-5699; Ong, Jue Sheng/0000-0002-6062-710X; Gerring, Zachary/0000-0002-2445-1266; Derks, Eske/0000-0002-6292-6883; Derringer, Jaime/0000-0002-7352-9859; Ramos-Quiroga, Josep Antoni/0000-0003-1622-0350; van der Zee, Mattthijs/0000-0003-4076-9167; Bartels, Meike/0000-0002-9667-7555; Bell, Jordana/0000-0002-3858-5986; Posthuma, Danielle/0000-0001-7582-2365; Nivard, Michel/0000-0003-2015-1888	European Research Council (Beyond the Genetics of Addiction) [ERC-284167]; Foundation Volksbond Rotterdam; US National Institutes of Health, National Institute on Drug Abuse [R00DA023549]; Netherlands Organization for Scientific Research (NWO) [446-16009]; Australian Research Council Fellowship; Netherlands Organization for Scientific Research [NWO 480-05-003]; Royal Netherlands Academy of Science Professor Award [PAH/6635]; NWO Exact Sciences; NIDA; NIMH [MH109532]; NIAAA [U01AA008401]; Peter Boris Chair in Addictions Research; Frontiers of Innovation Scholars Program (FISP) [3-P3029]; Interdisciplinary Research Fellowship in NeuroAIDS (IRFN) [MH081482]; pilot award [DA037844]; European Union through the European Regional Development Fund [2014-2020.4.01.15-0012]; European Union's Horizon 2020 Research and Innovation Programme [692065, 692145]; Academy of Finland [263278, 292782]; Instituto de Salud Carlos III, Spain [CP09/00119, CPII15/00023]; MRC [MC_UU_12015/2, MC_UU_00011/7] Funding Source: UKRI; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH109536, U01MH109532, R25MH081482] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U10AA008401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K99DA023549, P50DA037844, R00DA023549] Funding Source: NIH RePORTER	European Research Council (Beyond the Genetics of Addiction); Foundation Volksbond Rotterdam; US National Institutes of Health, National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Australian Research Council Fellowship(Australian Research Council); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Royal Netherlands Academy of Science Professor Award; NWO Exact Sciences; NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Peter Boris Chair in Addictions Research; Frontiers of Innovation Scholars Program (FISP); Interdisciplinary Research Fellowship in NeuroAIDS (IRFN); pilot award; European Union through the European Regional Development Fund(European Commission); European Union's Horizon 2020 Research and Innovation Programme; Academy of Finland(Academy of Finland); Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We would like to thank the research participants and employees of 23 and Me for making this work possible. We gratefully acknowledge the Psychiatric Genomics Consortium contributing studies and the participants in those studies without whom this effort would not have been possible. J.A.P. and J.M.V. are supported by the European Research Council (Beyond the Genetics of Addiction ERC-284167, PI J.M.V.). K.J.H.V. is supported by the Foundation Volksbond Rotterdam. N.A.G. is supported by US National Institutes of Health, National Institute on Drug Abuse R00DA023549. J.L.T. is supported by the Netherlands Organization for Scientific Research (NWO; Rubicon grant 446-16009). S.M. is supported by an Australian Research Council Fellowship. Statistical analyses were partly carried out on the Genetic Cluster Computer (http://www.geneticcluster.org) hosted by SURFsara and financially supported by the Netherlands Organization for Scientific Research (NWO 480-05-003 PI: Posthuma) along with a supplement from the Dutch Brain Foundation and the VU University Amsterdam. M.G.N. is supported by Royal Netherlands Academy of Science Professor Award to D.I.B. (PAH/6635). Part of the computation of this project was funded by NWO Exact Sciences for the application: "Population scale Genetic Analysis" awarded to M.G.N. The genome-wide association analysis on the UK Biobank dataset has been conducted using the UK Biobank resource under application numbers 9905, 16406 and 25331.; The Substance Use Disorders Working Group of the Psychiatric Genomics Consortium (PGC-SUD) is supported by funds from NIDA and NIMH to MH109532 and, previously, with analyst support from NIAAA to U01AA008401 (COGA). J.M.'s contributions were partially supported by the Peter Boris Chair in Addictions Research. S.S.-R. was supported by the Frontiers of Innovation Scholars Program (FISP; #3-P3029), the Interdisciplinary Research Fellowship in NeuroAIDS (IRFN; MH081482) and a pilot award from DA037844. R.M. was supported by the European Union through the European Regional Development Fund (Project No. 2014-2020.4.01.15-0012) and the European Union's Horizon 2020 Research and Innovation Programme under grant agreements No 692065 and 692145. J.K. was supported by Academy Professorship grants by the Academy of Finland (263278, 292782). M.R. is a recipient of a Miguel de Servet contract from the Instituto de Salud Carlos III, Spain (CP09/00119 and CPII15/00023).	Agrawal A, 2005, ADDICT BEHAV, V30, P1043, DOI 10.1016/j.addbeh.2004.09.007; Agrawal A, 2006, ADDICTION, V101, P801, DOI 10.1111/j.1360-0443.2006.01399.x; Agrawal A, 2011, ADDICT BIOL, V16, P514, DOI 10.1111/j.1369-1600.2010.00255.x; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; ANDREASSON S, 1987, LANCET, V2, P1483, DOI 10.1016/s0140-6736(87)92620-1; Atz ME, 2007, PSYCHIAT GENET, V17, P55, DOI 10.1097/YPG.0b013e328012d850; Barbeira A, 2016, BIORXIV, DOI [10.1101/045260, DOI 10.1101/045260]; Bidwell LC, 2015, PSYCHOPHARMACOLOGY, V232, P1177, DOI 10.1007/s00213-014-3748-2; Boutwell B, 2017, HELIYON, V3, DOI 10.1016/j.heliyon.2017.e00349; Bowden J, 2016, INT J EPIDEMIOL, V45, P1961, DOI 10.1093/ije/dyw220; Bowden J, 2016, GENET EPIDEMIOL, V40, P304, DOI 10.1002/gepi.21965; Bowden J, 2015, INT J EPIDEMIOL, V44, P512, DOI 10.1093/ije/dyv080; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Burgess S, 2017, EUR J EPIDEMIOL, V32, P377, DOI 10.1007/s10654-017-0255-x; Burgess S, 2015, EUR J EPIDEMIOL, V30, P543, DOI 10.1007/s10654-015-0011-z; Carithers LJ, 2015, BIOPRESERV BIOBANK, V13, P311, DOI 10.1089/bio.2015.0032; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Clarke TK, 2017, MOL PSYCHIATR, V22, P1376, DOI 10.1038/mp.2017.153; Davey Smith G, 2014, HUM MOL GENET, V23, pR89, DOI 10.1093/hmg/ddu328; Day FR, 2016, NAT GENET, V48, P617, DOI 10.1038/ng.3551; de Leeuw CA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004219; Delaneau O, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4934; Demontis D, 2018, GENOME WIDE ASS STUD, DOI [10.1101/237321, DOI 10.1101/237321]; Donaldson ZR, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2015.226; Ducci F, 2011, BIOL PSYCHIAT, V69, P650, DOI 10.1016/j.biopsych.2010.09.055; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Gage SH, 2017, PSYCHOL MED, V47, P971, DOI 10.1017/S0033291716003172; Gamazon ER, 2015, NAT GENET, V47, P1091, DOI 10.1038/ng.3367; Gatt JM, 2015, J PSYCHIATR RES, V60, P1, DOI 10.1016/j.jpsychires.2014.09.014; Gelernter J, 2006, HUM MOL GENET, V15, P3498, DOI 10.1093/hmg/ddl426; Gonzalez JR, 2014, AM J HUM GENET, V94, P361, DOI 10.1016/j.ajhg.2014.01.015; Hall W, 2009, LANCET, V374, P1383, DOI 10.1016/S0140-6736(09)61037-0; Hartwig FP, 2017, ROBUST INFERENCE 2 S, DOI [10.1101/126102, DOI 10.1101/126102]; Hemani G, 2016, BIORXIV, DOI [10.1101/078972, DOI 10.1101/078972]; Ibrahim-Verbaas CA, 2016, MOL PSYCHIATR, V21, P189, DOI 10.1038/mp.2015.37; Martin CA, 2002, J AM ACAD CHILD PSY, V41, P1495, DOI 10.1097/00004583-200212000-00022; McCarthy S, 2016, NAT GENET, V48, P1279, DOI 10.1038/ng.3643; McCarthy SE, 2009, NAT GENET, V41, P1223, DOI 10.1038/ng.474; Minica CC, 2015, BEHAV GENET, V45, P503, DOI 10.1007/s10519-015-9723-9; Moore THM, 2007, LANCET, V370, P319, DOI 10.1016/S0140-6736(07)61162-3; Muller-Vahl Kirsten R, 2008, Expert Rev Neurother, V8, P1037, DOI 10.1586/14737175.8.7.1037; Nielsen J, 2010, ADV EXP MED BIOL, V663, P23, DOI 10.1007/978-1-4419-1170-4_2; Patrick ME, 2012, J STUD ALCOHOL DRUGS, V73, P772, DOI 10.15288/jsad.2012.73.772; Petrovska J, 2017, J PSYCHIATR RES, V91, P116, DOI 10.1016/j.jpsychires.2017.03.007; Power RA, 2014, MOL PSYCHIATR, V19, P1201, DOI 10.1038/mp.2014.51; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Rubinek T, 2003, J CLIN ENDOCR METAB, V88, P3724, DOI 10.1210/jc.2003-030090; Sherva R, 2016, JAMA PSYCHIAT, V73, P472, DOI 10.1001/jamapsychiatry.2016.0036; Smit F, 2004, ADDICTION, V99, P425, DOI 10.1111/j.1360-0443.2004.00683.x; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Stringer S, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.36; Sul JH, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003491; Takekita Y, 2016, INT J NEUROPSYCHOPH, V19, DOI 10.1093/ijnp/pyv125; Turner SD, 2014, BIORXIV, DOI 10. 1101/005165 , 2014 .; Vaucher J, 2018, MOL PSYCHIATR, V23, P1287, DOI 10.1038/mp.2016.252; Verweij KJH, 2017, DRUG ALCOHOL DEPEN, V171, P117, DOI 10.1016/j.drugalcdep.2016.09.022; Verweij KJH, 2013, ADDICT BIOL, V18, P846, DOI 10.1111/j.1369-1600.2012.00478.x; Verweij KJH, 2010, ADDICTION, V105, P417, DOI 10.1111/j.1360-0443.2009.02831.x; Volkow ND, 2016, JAMA PSYCHIAT, V73, P292, DOI 10.1001/jamapsychiatry.2015.3278; Volkow ND, 2014, NEW ENGL J MED, V371, P879, DOI 10.1056/NEJMc1407928; Walther B, 2012, EUR ADDICT RES, V18, P167, DOI 10.1159/000335662; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Winkler TW, 2014, NAT PROTOC, V9, P1192, DOI 10.1038/nprot.2014.071; Yang BZ, 2007, HUM MOL GENET, V16, P2844, DOI 10.1093/hmg/ddm240; Zhu ZH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02317-2; Zuo LJ, 2013, ALCOHOL CLIN EXP RES, V37, P730, DOI 10.1111/acer.12032	69	220	219	7	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2018	21	9					1161	+		10.1038/s41593-018-0206-1	http://dx.doi.org/10.1038/s41593-018-0206-1			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	GS0DU	30150663	Green Accepted, Green Submitted, Green Published			2022-12-17	WOS:000443157700006
J	Costa-Mattioli, M; Monteggia, LM				Costa-Mattioli, Mauro; Monteggia, Lisa M.			mTOR complexes in neurodevelopmental and neuropsychiatric disorders	NATURE NEUROSCIENCE			English	Review							TUBEROUS SCLEROSIS COMPLEX; TRANSLATION REPRESSOR 4E-BP2; TERM SYNAPTIC PLASTICITY; GIANT-CELL ASTROCYTOMAS; MAMMALIAN TARGET; NEUROTROPHIC FACTOR; MOUSE MODEL; ACTIN CYTOSKELETON; SIGNALING PATHWAY; MICE LACKING	The mechanistic target of rapamycin (mTOR) acts as a highly conserved signaling "hub" that integrates neuronal activity and a variety of synaptic inputs. mTOR is found in two functionally distinct complexes, mTORC1 and mTORC2, that crucially control long-term synaptic efficacy and memory storage. Dysregulation of mTOR signaling is associated with neurodevelopmental and neuropsychiatric disorders. In this Review, we describe the most recent advances in studies of mTOR signaling in the brain and the possible mechanisms underlying the many different functions of the mTOR complexes in neurological diseases. In addition, we discuss the medical relevance of these findings.	[Costa-Mattioli, Mauro] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Monteggia, Lisa M.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA	Baylor College of Medicine; University of Texas System; University of Texas Southwestern Medical Center Dallas	Costa-Mattioli, M (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.	costamat@bcm.edu; lisa.monteggia@utsouthwestern.edu			US National Institutes of Health [NS076708, MH096816, MH070727]; Department of Defense [AR10254]; Searle award [09-SSP-211]; Whitehall Foundation; International Mental Health Research Organization; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070727, R01MH096816] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076708] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Searle award; Whitehall Foundation; International Mental Health Research Organization; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of M.C.-M.'s laboratory, K. Krnjevic and E.T. Kavalali for comments and discussion. The figures were designed by S. Buffington. This work was supported by US National Institutes of Health grants NS076708 (M.C.-M.), MH096816 (M.C.-M.) and MH070727 (L.M.M.), Department of Defense grant AR10254 (M.C.-M.), Searle award grant 09-SSP-211 (M.C.-M.), the Whitehall Foundation (M.C.-M.) and the International Mental Health Research Organization (L.M.M.).	Adachi M, 2008, BIOL PSYCHIAT, V63, P642, DOI 10.1016/j.biopsych.2007.09.019; Antion MD, 2008, LEARN MEMORY, V15, P29, DOI 10.1101/lm.661908; Antion MD, 2008, MOL CELL BIOL, V28, P2996, DOI 10.1128/MCB.00201-08; Auerbach BD, 2011, NATURE, V480, P63, DOI 10.1038/nature10658; Autry AE, 2012, PHARMACOL REV, V64, P238, DOI 10.1124/pr.111.005108; Autry AE, 2011, NATURE, V475, P91, DOI 10.1038/nature10130; Banko JL, 2007, NEUROBIOL LEARN MEM, V87, P248, DOI 10.1016/j.nlm.2006.08.012; Banko JL, 2005, J NEUROSCI, V25, P9581, DOI 10.1523/JNEUROSCI.2423-05.2005; Barak S, 2013, NAT NEUROSCI, V16, P1111, DOI 10.1038/nn.3439; Bateup HS, 2013, NEURON, V78, P510, DOI 10.1016/j.neuron.2013.03.017; Bateup HS, 2011, J NEUROSCI, V31, P8862, DOI 10.1523/JNEUROSCI.1617-11.2011; Bauman ML, 2005, INT J DEV NEUROSCI, V23, P183, DOI 10.1016/j.ijdevneu.2004.09.006; Bidinosti M, 2010, MOL CELL, V37, P797, DOI 10.1016/j.molcel.2010.02.022; Bissler JJ, 2008, NEW ENGL J MED, V358, P140, DOI 10.1056/NEJMoa063564; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; Busquets-Garcia A, 2013, NAT MED, V19, P603, DOI 10.1038/nm.3127; Carson RP, 2013, HUM MOL GENET, V22, P140, DOI 10.1093/hmg/dds414; Carson RP, 2012, NEUROBIOL DIS, V45, P369, DOI 10.1016/j.nbd.2011.08.024; Cingolani LA, 2008, NAT REV NEUROSCI, V9, P344, DOI 10.1038/nrn2373; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Cui YJ, 2008, CELL, V135, P549, DOI 10.1016/j.cell.2008.09.060; Cybulski N, 2009, TRENDS BIOCHEM SCI, V34, P620, DOI 10.1016/j.tibs.2009.09.004; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Ehninger D, 2008, NAT MED, V14, P843, DOI 10.1038/nm1788; Ehninger D, 2008, NEURON, V60, P950, DOI 10.1016/j.neuron.2008.12.007; Emamian ES, 2004, NAT GENET, V36, P131, DOI 10.1038/ng1296; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Fernandez F, 2007, NAT NEUROSCI, V10, P411, DOI 10.1038/nn1860; Fombonne E, 1999, PSYCHOL MED, V29, P769, DOI 10.1017/S0033291799008508; Franz DN, 2013, LANCET, V381, P125, DOI 10.1016/S0140-6736(12)61134-9; Franz DN, 2006, ANN NEUROL, V59, P490, DOI 10.1002/ana.20784; Gkogkas CG, 2013, NATURE, V493, P371, DOI 10.1038/nature11628; Goncharova E, 2004, J CELL BIOL, V167, P1171, DOI 10.1083/jcb.200405130; Goorden SMI, 2007, ANN NEUROL, V62, P648, DOI 10.1002/ana.21317; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Henderson C, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004218; Hernandez-Negrete I, 2007, J BIOL CHEM, V282, P23708, DOI 10.1074/jbc.M703771200; Hou LF, 2004, J NEUROSCI, V24, P6352, DOI 10.1523/JNEUROSCI.0995-04.2004; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Huang W, 2013, NAT NEUROSCI, V16, P441, DOI 10.1038/nn.3351; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Kaizuka T, 2010, J BIOL CHEM, V285, P20109, DOI 10.1074/jbc.M110.121699; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kim JY, 2012, CELL, V148, P1051, DOI 10.1016/j.cell.2011.12.037; Kim JY, 2009, NEURON, V63, P761, DOI 10.1016/j.neuron.2009.08.008; Kirchner GI, 2004, CLIN PHARMACOKINET, V43, P83, DOI 10.2165/00003088-200443020-00002; Koike H, 2011, NEUROPHARMACOLOGY, V61, P1419, DOI 10.1016/j.neuropharm.2011.08.034; Krueger D.A., 2013, ANN NEUROL, DOI [10.1002/ana 23960, DOI 10.1002/ANA]; Krueger DA, 2010, NEW ENGL J MED, V363, P1801, DOI 10.1056/NEJMoa1001671; Kwon CH, 2003, P NATL ACAD SCI USA, V100, P12923, DOI 10.1073/pnas.2132711100; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287; Liliental J, 2000, CURR BIOL, V10, P401, DOI 10.1016/S0960-9822(00)00417-6; Ljungberg MC, 2006, ANN NEUROL, V60, P420, DOI 10.1002/ana.20949; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Max X, 2008, CELL, V133, P303, DOI 10.1016/j.cell.2008.02.031; Mazei-Robison MS, 2011, NEURON, V72, P977, DOI 10.1016/j.neuron.2011.10.012; Mefford HC, 2012, NEW ENGL J MED, V366, P733, DOI 10.1056/NEJMra1114194; Meikle L, 2008, J NEUROSCI, V28, P5422, DOI 10.1523/JNEUROSCI.0955-08.2008; Mita M, 2008, EXPERT OPIN INV DRUG, V17, P1947, DOI [10.1517/13543780802556485, 10.1517/13543780802556485 ]; Monteggia LM, 2004, P NATL ACAD SCI USA, V101, P10827, DOI 10.1073/pnas.0402141101; Nibuya M, 1996, J NEUROSCI, V16, P2365; Nosyreva E, 2013, J NEUROSCI, V33, P6990, DOI 10.1523/JNEUROSCI.4998-12.2013; Oh WJ, 2011, CELL CYCLE, V10, P2305, DOI 10.4161/cc.10.14.16586; Parker WE, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005271; Pearce LR, 2011, BIOCHEM J, V436, P169, DOI 10.1042/BJ20102103; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Punt CJA, 2003, ANN ONCOL, V14, P931, DOI 10.1093/annonc/mdg248; Ran I, 2013, J NEUROSCI, V33, P1872, DOI 10.1523/JNEUROSCI.3264-12.2013; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; SABERS CJ, 1995, J BIOL CHEM, V270, P815, DOI 10.1074/jbc.270.2.815; Santini E, 2013, NATURE, V493, P411, DOI 10.1038/nature11782; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Shirayama Y, 2002, J NEUROSCI, V22, P3251, DOI 10.1523/JNEUROSCI.22-08-03251.2002; Siuta MA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000393; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Stoica L, 2011, P NATL ACAD SCI USA, V108, P3791, DOI 10.1073/pnas.1014715108; Sunnen CN, 2011, EPILEPSIA, V52, P2065, DOI 10.1111/j.1528-1167.2011.03280.x; Tafet GE, 2003, PROG NEURO-PSYCHOPH, V27, P893, DOI 10.1016/S0278-5846(03)00162-3; Takeuchi K, 2013, P NATL ACAD SCI USA, V110, P4738, DOI 10.1073/pnas.1222803110; Tang SJ, 2002, P NATL ACAD SCI USA, V99, P467, DOI 10.1073/pnas.012605299; Thomanetz V, 2013, J CELL BIOL, V201, P293, DOI 10.1083/jcb.201205030; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Tsai PT, 2012, NATURE, V488, P647, DOI 10.1038/nature11310; Uhlmann EJ, 2002, ANN NEUROL, V52, P285, DOI 10.1002/ana.10283; Wang YL, 2007, ANN NEUROL, V61, P139, DOI 10.1002/ana.21058; Wang Y, 2006, NEUROMOL MED, V8, P329, DOI 10.1385/NMM:8:3:329; Way SW, 2012, HUM MOL GENET, V21, P3226, DOI 10.1093/hmg/dds156; Wong M, 2010, EPILEPSIA, V51, P27, DOI 10.1111/j.1528-1167.2009.02341.x; Yang HJ, 2013, NATURE, V497, P217, DOI 10.1038/nature12122; Zeng LH, 2008, ANN NEUROL, V63, P444, DOI 10.1002/ana.21331; Zhou J, 2012, CURR OPIN NEUROBIOL, V22, P873, DOI 10.1016/j.conb.2012.05.004; Zhou J, 2009, J NEUROSCI, V29, P1773, DOI 10.1523/JNEUROSCI.5685-08.2009; Zhou MO, 2013, NEURON, V77, P647, DOI 10.1016/j.neuron.2012.12.033; Zinzalla V, 2011, CELL, V144, P757, DOI 10.1016/j.cell.2011.02.014; Zoghbi HY, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a009886	100	220	229	1	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2013	16	11					1537	1543		10.1038/nn.3546	http://dx.doi.org/10.1038/nn.3546			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241YX	24165680				2022-12-17	WOS:000326205700009
J	Jiang, XL; Wang, GF; Lee, AJ; Stornetta, RL; Zhu, JJ				Jiang, Xiaolong; Wang, Guangfu; Lee, Alice J.; Stornetta, Ruth L.; Zhu, J. Julius			The organization of two new cortical interneuronal circuits	NATURE NEUROSCIENCE			English	Article							LAYER-5 PYRAMIDAL NEURONS; EVOKED SYNAPTIC RESPONSES; VISUAL-CORTEX; BARREL CORTEX; GABAERGIC NEURONS; ACTION-POTENTIALS; AUDITORY-CORTEX; RAT NEOCORTEX; INHIBITION; DENDRITES	Deciphering the interneuronal circuitry is central to understanding brain functions, yet it remains a challenging task in neurobiology. Using simultaneous quadruple-octuple in vitro and dual in vivo whole-cell recordings, we found two previously unknown interneuronal circuits that link cortical layer 1-3 (L1-3) interneurons and L5 pyramidal neurons in the rat neocortex. L1 single-bouquet cells (SBCs) preferentially formed unidirectional inhibitory connections on L2/3 interneurons that inhibited the entire dendritic-somato-axonal axis of similar to 1% of L5 pyramidal neurons located in the same column. In contrast, L elongated neurogliaform cells (ENGCs) frequently formed mutual inhibitory and electric connections with L2/3 interneurons, and these L1-3 interneurons inhibited the distal apical dendrite of >60% of L5 pyramidal neurons across multiple columns. Functionally, SBC -> L2/3 interneuron -> L5 pyramidal neuronal circuits disinhibited and ENGC <-> L2/3 interneuron -> L5 pyramidal neuronal circuits inhibited the initiation of dendritic complex spikes in L5 pyramidal neurons. As dendritic complex spikes can serve coincidence detection, these cortical interneuronal circuits may be essential for salience selection.	[Jiang, Xiaolong; Wang, Guangfu; Lee, Alice J.; Stornetta, Ruth L.; Zhu, J. Julius] Univ Virginia, Sch Med, Dept Pharmacol, Charlottesville, VA 22908 USA; [Lee, Alice J.] Univ Virginia, Dept Biol, Coll Arts & Sci, Charlottesville, VA USA; [Zhu, J. Julius] Univ Virginia, Sch Med, Dept Neurosci, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia	Zhu, JJ (corresponding author), Univ Virginia, Sch Med, Dept Pharmacol, Charlottesville, VA 22908 USA.	jjzhu@virginia.edu		Stornetta, Ruth/0000-0001-7278-8923	Epilepsy Foundation; College of Arts and Sciences of the University of Virginia; US National Institutes of Health; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053570] Funding Source: NIH RePORTER	Epilepsy Foundation; College of Arts and Sciences of the University of Virginia; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank E. Callaway, A. Erisir, J. Huang, J. Kapur and G. Tamas for technical advice and invaluable discussions, and members of the Zhu laboratory for comments and technical assistance. This study was supported in part by a postdoctoral fellowship from the Epilepsy Foundation (X.J.), a small research grant from the College of Arts and Sciences of the University of Virginia (A.J.L.) and the US National Institutes of Health.	Adesnik H, 2012, NATURE, V490, P226, DOI 10.1038/nature11526; Anderson JS, 2000, SCIENCE, V290, P1968, DOI 10.1126/science.290.5498.1968; Antic SD, 2003, J PHYSIOL-LONDON, V550, P35, DOI 10.1113/jphysiol.2002.033746; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Baluchi F, 2011, TRENDS NEUROSCI, V34, P210, DOI 10.1016/j.tins.2011.02.003; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Batista-Brito R, 2009, CURR TOP DEV BIOL, V87, P81, DOI 10.1016/S0070-2153(09)01203-4; Brown SP, 2009, CURR OPIN NEUROBIOL, V19, P415, DOI 10.1016/j.conb.2009.07.011; Burkhalter A, 2008, FRONT NEUROSCI-SWITZ, V2, P155, DOI 10.3389/neuro.01.026.2008; Cauller LJ, 1998, J COMP NEUROL, V390, P297; CAULLER LJ, 1991, EXP BRAIN RES, V84, P607; Chu ZG, 2003, J NEUROSCI, V23, P96; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Foldy C, 2007, NAT NEUROSCI, V10, P1128, DOI 10.1038/nn1952; Gentet LJ, 2012, NAT NEUROSCI, V15, P607, DOI 10.1038/nn.3051; Gilbert CD, 2007, NEURON, V54, P677, DOI 10.1016/j.neuron.2007.05.019; Glickfeld LL, 2006, NAT NEUROSCI, V9, P807, DOI 10.1038/nn1688; Gonchar Y, 2003, J NEUROSCI, V23, P10904; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Kopell N, 2004, P NATL ACAD SCI USA, V101, P15482, DOI 10.1073/pnas.0406343101; Kubota Y, 2011, CEREB CORTEX, V21, P1803, DOI 10.1093/cercor/bhq252; Larkum ME, 2008, CURR OPIN NEUROBIOL, V18, P321, DOI 10.1016/j.conb.2008.08.013; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Larkum ME, 2002, J NEUROSCI, V22, P6991; Larkum ME, 2001, J PHYSIOL-LONDON, V533, P447, DOI 10.1111/j.1469-7793.2001.0447a.x; Letzkus JJ, 2011, NATURE, V480, P331, DOI 10.1038/nature10674; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; McBain CJ, 2001, NAT REV NEUROSCI, V2, P11, DOI 10.1038/35049047; Nevian T, 2007, NAT NEUROSCI, V10, P206, DOI 10.1038/nn1826; Palmer LM, 2012, SCIENCE, V335, P989, DOI 10.1126/science.1217276; Perez-Garci E, 2006, NEURON, V50, P603, DOI 10.1016/j.neuron.2006.04.019; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Purushothaman G, 2012, NAT NEUROSCI, V15, P905, DOI 10.1038/nn.3106; Reyes A, 2001, ANNU REV NEUROSCI, V24, P653, DOI 10.1146/annurev.neuro.24.1.653; ROBINSON DL, 1992, TRENDS NEUROSCI, V15, P127, DOI 10.1016/0166-2236(92)90354-B; Rubio-Garrido P, 2009, CEREB CORTEX, V19, P2380, DOI 10.1093/cercor/bhn259; Sjostrom PJ, 2008, PHYSIOL REV, V88, P769, DOI 10.1152/physrev.00016.2007; Sun YJ, 2010, NATURE, V465, P927, DOI 10.1038/nature09079; Tamas G, 2003, SCIENCE, V299, P1902, DOI 10.1126/science.1082053; Tamas G, 2000, NAT NEUROSCI, V3, P366, DOI 10.1038/73936; Tricoire L, 2010, J NEUROSCI, V30, P2165, DOI 10.1523/JNEUROSCI.5123-09.2010; Wozny C, 2011, CEREB CORTEX, V21, P1818, DOI 10.1093/cercor/bhq257; Wu GYK, 2011, NEUROSCI BIOBEHAV R, V35, P2094, DOI 10.1016/j.neubiorev.2011.05.004; Zhu JJ, 1999, J NEUROPHYSIOL, V81, P1171, DOI 10.1152/jn.1999.81.3.1171; Zhu YH, 2004, J NEUROSCI, V24, P5101, DOI 10.1523/JNEUROSCI.0544-04.2004; Zhu YH, 2004, J NEUROSCI, V24, P1272, DOI 10.1523/JNEUROSCI.4805-03.2004	50	220	224	1	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2013	16	2					210	218		10.1038/nn.3305	http://dx.doi.org/10.1038/nn.3305			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	080RE	23313910	Green Accepted			2022-12-17	WOS:000314260200018
J	Meyer-Lindenberg, A; Tost, H				Meyer-Lindenberg, Andreas; Tost, Heike			Neural mechanisms of social risk for psychiatric disorders	NATURE NEUROSCIENCE			English	Article							OXYTOCIN RECEPTOR GENE; EARLY-LIFE STRESS; ENVIRONMENT INTERACTIONS; DOPAMINE RELEASE; SCHIZOPHRENIA; HUMANS; BRAIN; OXTR; VASOPRESSIN; SYMPTOMS	Mental health and social life are intimately inter-related, as demonstrated by the frequent social deficits of psychiatric patients and the increased rate of psychiatric disorders in people exposed to social environmental adversity. Here, we review emerging evidence that combines epidemiology, social psychology and neuroscience to bring neural mechanisms of social risk factors for mental illness into focus. In doing so, we discuss existing evidence on the effects of common genetic risk factors in social neural pathways and outline the need for integrative approaches to identify the converging mechanisms of social environmental and genetic risk in brain.	[Meyer-Lindenberg, Andreas; Tost, Heike] Heidelberg Univ, Cent Inst Mental Hlth, Med Fac Mannheim, D-6800 Mannheim, Germany	Central Institute of Mental Health; Ruprecht Karls University Heidelberg	Meyer-Lindenberg, A (corresponding author), Heidelberg Univ, Cent Inst Mental Hlth, Med Fac Mannheim, D-6800 Mannheim, Germany.	a.meyer-lindenberg@zi-mannheim.de; heike.tost@zi-mannheim.de	Tost, med. Dr. phil. Heike/AAX-8305-2020; Carroll, Joseph/D-1158-2011; Meyer-Lindenberg, Andreas/H-1076-2011	Carroll, Joseph/0000-0003-2656-1378; Meyer-Lindenberg, Andreas/0000-0001-5619-1123	Deutsche Forschungsgemeinschaft [SFB 636, KFO 256]; German Federal Ministry of Education and Research (BMBF) [01GQ1003B, 01GQ1102]; European Union (NEWMEDS, OPTIMIZE, EU-GEI, EU-AIMS)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); European Union (NEWMEDS, OPTIMIZE, EU-GEI, EU-AIMS)	A.M.-L. gratefully acknowledges grant support by Deutsche Forschungsgemeinschaft (SFB 636, KFO 256), German Federal Ministry of Education and Research (BMBF NGFN-MooDs, Bernstein-Programm funding number 01GQ1003B) and European Union (NEWMEDS, OPTIMIZE, EU-GEI, EU-AIMS) during the preparation of this manuscript. H.T. gratefully acknowledges grant support by the German Federal Ministry of Education and Research (BMBF 01GQ1102).	Adolphs R, 2009, ANNU REV PSYCHOL, V60, P693, DOI 10.1146/annurev.psych.60.110707.163514; [Anonymous], 2010, NATURE, V463, P9, DOI 10.1038/463009a; Armbruster D, 2012, INT J NEUROPSYCHOPH, V15, P1229, DOI 10.1017/S1461145711001763; Bakermans-Kranenburg MJ, 2008, SOC COGN AFFECT NEUR, V3, P128, DOI 10.1093/scan/nsn004; Bigos KL, 2010, ARCH GEN PSYCHIAT, V67, P939, DOI 10.1001/archgenpsychiatry.2010.96; Bourque F, 2011, PSYCHOL MED, V41, P897, DOI 10.1017/S0033291710001406; Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915; Buckholtz JW, 2008, TRENDS NEUROSCI, V31, P120, DOI 10.1016/j.tins.2007.12.006; Caspi A, 2002, SCIENCE, V297, P851, DOI 10.1126/science.1072290; Chen FS, 2011, P NATL ACAD SCI USA, V108, P19937, DOI 10.1073/pnas.1113079108; Coplan JD, 2011, PSYCHONEUROENDOCRINO, V36, P289, DOI 10.1016/j.psyneuen.2010.07.011; Corcoran CM, 2012, SCHIZOPHR RES, V135, P170, DOI 10.1016/j.schres.2011.11.035; Erk S, 2010, ARCH GEN PSYCHIAT, V67, P803, DOI 10.1001/archgenpsychiatry.2010.94; Gillis RF, 2011, MOL AUTISM, V2, DOI 10.1186/2040-2392-2-12; Hammock EAD, 2005, SCIENCE, V308, P1630, DOI 10.1126/science.1111427; Heim C, 2009, MOL PSYCHIATR, V14, P954, DOI 10.1038/mp.2008.112; Heim C, 2012, EXP NEUROL, V233, P102, DOI 10.1016/j.expneurol.2011.10.032; Inoue H, 2010, BIOL PSYCHIAT, V68, P1066, DOI 10.1016/j.biopsych.2010.07.019; Kirsch P, 2005, J NEUROSCI, V25, P11489, DOI 10.1523/JNEUROSCI.3984-05.2005; Knafo A, 2006, DEV PSYCHOL, V42, P771, DOI 10.1037/0012-1649.42.5.771; Krabbendam L, 2005, SCHIZOPHRENIA BULL, V31, P795, DOI 10.1093/schbul/sbi060; Kurth F, 2011, BIOL PSYCHIAT, V70, P278, DOI 10.1016/j.biopsych.2011.03.026; Lederbogen F, 2011, NATURE, V474, P498, DOI 10.1038/nature10190; Martin DJ, 2000, J CONSULT CLIN PSYCH, V68, P438, DOI 10.1037//0022-006X.68.3.438; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; Meyer-Lindenberg A, 2009, MOL PSYCHIATR, V14, P968, DOI 10.1038/mp.2008.54; Meyer-Lindenberg A, 2006, NAT REV NEUROSCI, V7, P818, DOI 10.1038/nrn1993; Meyer-Lindenberg A, 2011, NAT REV NEUROSCI, V12, P524, DOI 10.1038/nrn3044; Miczek KA, 2011, J NEUROSCI, V31, P9848, DOI 10.1523/JNEUROSCI.0637-11.2011; Mizrahi R, 2012, BIOL PSYCHIAT, V71, P561, DOI 10.1016/j.biopsych.2011.10.009; Montague PR, 2002, NEUROIMAGE, V16, P1159, DOI 10.1006/nimg.2002.1150; O'Donovan MC, 2009, HUM GENET, V126, P3, DOI 10.1007/s00439-009-0703-0; Pedersen CB, 2001, ARCH GEN PSYCHIAT, V58, P1039, DOI 10.1001/archpsyc.58.11.1039; Penn DL, 2008, SCHIZOPHRENIA BULL, V34, P408, DOI 10.1093/schbul/sbn014; Pruessner JC, 2004, J NEUROSCI, V24, P2825, DOI 10.1523/JNEUROSCI.3422-03.2004; Ressler KJ, 2010, AM J MED GENET B, V153B, P812, DOI 10.1002/ajmg.b.31052; Selten JP, 2007, BRIT J PSYCHIAT, V191, pS9, DOI 10.1192/bjp.191.51.s9; Szyf M, 2012, CLIN GENET      1213, DOI [10.1111/0399-0004.2012.01843.x, DOI 10.1111/J.0399-0004.2012.01843.X]; Thompson RJ, 2011, PSYCHONEUROENDOCRINO, V36, P144, DOI 10.1016/j.psyneuen.2010.07.003; Tost H, 2012, NEUROIMAGE, V62, P2250, DOI 10.1016/j.neuroimage.2011.11.007; Tost H, 2011, BIOL PSYCHIAT, V70, pE37, DOI 10.1016/j.biopsych.2011.06.034; Tost H, 2010, P NATL ACAD SCI USA, V107, P13936, DOI 10.1073/pnas.1003296107; van Os J, 2008, SCHIZOPHRENIA BULL, V34, P1066, DOI 10.1093/schbul/sbn117; Viviani D, 2011, SCIENCE, V333, P104, DOI 10.1126/science.1201043; Walum H, 2008, P NATL ACAD SCI USA, V105, P14153, DOI 10.1073/pnas.0803081105; WEINBERGER DR, 1987, ARCH GEN PSYCHIAT, V44, P660, DOI 10.1001/archpsyc.1987.01800190080012; Wu SP, 2005, BIOL PSYCHIAT, V58, P74, DOI 10.1016/j.biopsych.2005.03.013; Zammit S, 2010, ARCH GEN PSYCHIAT, V67, P914, DOI 10.1001/archgenpsychiatry.2010.101; Zink CF, 2008, NEURON, V58, P273, DOI 10.1016/j.neuron.2008.01.025; Zink CF, 2010, J NEUROSCI, V30, P7017, DOI 10.1523/JNEUROSCI.4899-09.2010	50	220	225	1	66	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2012	15	5					663	668		10.1038/nn.3083	http://dx.doi.org/10.1038/nn.3083			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	932DI	22504349				2022-12-17	WOS:000303270200007
J	Chen, Y; Wu, H; Wang, SZ; Koito, H; Li, JR; Ye, F; Hoang, J; Escobar, SS; Gow, A; Arnett, HA; Trapp, BD; Karandikar, NJ; Hsieh, J; Lu, QR				Chen, Ying; Wu, Heng; Wang, Shuzong; Koito, Hisami; Li, Jianrong; Ye, Feng; Hoang, Jenny; Escobar, Sabine S.; Gow, Alexander; Arnett, Heather A.; Trapp, Bruce D.; Karandikar, Nitin J.; Hsieh, Jenny; Lu, Q. Richard			The oligodendrocyte-specific G protein-coupled receptor GPR17 is a cell-intrinsic timer of myelination	NATURE NEUROSCIENCE			English	Article							MULTIPLE-SCLEROSIS; PROGENITOR CELLS; PRECURSOR CELLS; CRUCIAL ROLE; STEM-CELLS; DIFFERENTIATION; TRANSCRIPTION; EXPRESSION; LESIONS; BRAIN	The basic helix-loop-helix transcription factor Olig1 promotes oligodendrocyte maturation and is required for myelin repair. We characterized an Olig1-regulated G protein-coupled receptor, GPR17, whose function is to oppose the action of Olig1. Gpr17 was restricted to oligodendrocyte lineage cells, but was downregulated during the peak period of myelination and in adulthood. Transgenic mice with sustained Gpr17 expression in oligodendrocytes exhibited stereotypic features of myelinating disorders in the CNS. Gpr17 overexpression inhibited oligodendrocyte differentiation and maturation both in vivo and in vitro. Conversely, Gpr17 knockout mice showed early onset of oligodendrocyte myelination. The opposing action of Gpr17 on oligodendrocyte maturation reflects, at least partially, upregulation and nuclear translocation of the potent oligodendrocyte differentiation inhibitors ID2/4. Collectively, these findings suggest that GPR17 orchestrates the transition between immature and myelinating oligodendrocytes via an ID protein-mediated negative regulation and may serve as a potential therapeutic target for CNS myelin repair.	[Chen, Ying; Wu, Heng; Wang, Shuzong; Ye, Feng; Hoang, Jenny; Lu, Q. Richard] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA; [Chen, Ying; Wu, Heng; Wang, Shuzong; Ye, Feng; Hoang, Jenny; Lu, Q. Richard] Univ Texas SW Med Ctr Dallas, Kent Waldrep Fdn Ctr Basic Neurosci Res Nerve Gro, Dallas, TX 75390 USA; [Koito, Hisami; Li, Jianrong] Texas A&M Univ, Dept Vet Integrat Biosci, College Stn, TX USA; [Escobar, Sabine S.; Arnett, Heather A.] Amgen Inc, Dept Inflammat, Seattle, WA USA; [Gow, Alexander] Wayne State Univ, Ctr Mol Med & Genet, Detroit, MI USA; [Trapp, Bruce D.] Cleveland Clin, Lerner Res Inst, Dept Neurosci, Cleveland, OH 44106 USA; [Karandikar, Nitin J.; Lu, Q. Richard] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Hsieh, Jenny; Lu, Q. Richard] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Texas A&M University System; Texas A&M University College Station; Amgen; Wayne State University; Cleveland Clinic Foundation; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Lu, QR (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA.	qrichard.lu@utsouthwestern.edu	Li, Jianrong/C-4126-2011	Li, Jianrong/0000-0002-8232-9322; gow, alexander/0000-0001-7446-8990; Karandikar, Nitin/0000-0002-6867-6950	US National Institutes of Health [NS050389, NS060017]; National Multiple Sclerosis Society [RG3978, RG2891]; Harry Weaver Neuroscience Scholar; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI079272] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060017, R01NS050389] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); Harry Weaver Neuroscience Scholar(National Multiple Sclerosis Society); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank C. Stiles, J. Chan, J. Johnson, R. Bassel-Duby, E. Hurlock and T. Hu for critical comments; M. Gravel for the Cnp1 promoter; M. Yanagisawa for ligand analysis; J. Koch for preliminary injury study; J. Cai, T. Hu, X. Xu and T. Yue for technical assistance; L. Cai for microarray analysis; and T. Januszewski and L. Mueller for electron microscopy. This study was funded by grants from the US National Institutes of Health (NS050389 to Q. R. L. and NS060017 to J. L.) and the National Multiple Sclerosis Society (RG3978 to Q. R. L. and RG2891 to A. G.). Q. R. L. is a Harry Weaver Neuroscience Scholar.	Arnett HA, 2004, SCIENCE, V306, P2111, DOI 10.1126/science.1103709; BARRES BA, 1994, DEVELOPMENT, V120, P1097; Berger J, 2001, CURR OPIN NEUROL, V14, P305, DOI 10.1097/00019052-200106000-00007; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Cai J, 2007, DEVELOPMENT, V134, P1887, DOI 10.1242/dev.02847; Campagnoni A.T., 2005, NEUROGLIA, P253; Casaccia-Bonnefil P, 1999, DEVELOPMENT, V126, P4027; CasacciaBonnefil P, 1997, GENE DEV, V11, P2335, DOI 10.1101/gad.11.18.2335; Chang A, 2002, NEW ENGL J MED, V346, P165, DOI 10.1056/NEJMoa010994; Chang A, 2000, J NEUROSCI, V20, P6404, DOI 10.1523/JNEUROSCI.20-17-06404.2000; Chen Y, 2007, NAT PROTOC, V2, P1044, DOI 10.1038/nprot.2007.149; Ciana P, 2006, EMBO J, V25, P4615, DOI 10.1038/sj.emboj.7601341; Dugas JC, 2007, J NEUROSCI, V27, P6185, DOI 10.1523/JNEUROSCI.0628-07.2007; Durand B, 2000, BIOESSAYS, V22, P64; Durand B, 1997, EMBO J, V16, P306, DOI 10.1093/emboj/16.2.306; Franklin RJM, 2002, NAT REV NEUROSCI, V3, P705, DOI 10.1038/nrn917; Gabay L, 2003, NEURON, V40, P485, DOI 10.1016/S0896-6273(03)00637-8; Gokhan S, 2005, J NEUROSCI, V25, P8311, DOI 10.1523/JNEUROSCI.1850-05.2005; GOW A, 1992, J CELL BIOL, V119, P605, DOI 10.1083/jcb.119.3.605; Gravel M, 1998, J NEUROSCI RES, V53, P393; Hsieh J, 2004, J CELL BIOL, V164, P111, DOI 10.1083/jcb.200308101; Hu QD, 2003, CELL, V115, P163, DOI 10.1016/S0092-8674(03)00810-9; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; John GR, 2002, NAT MED, V8, P1115, DOI 10.1038/nm781; Karandikar NJ, 1998, J IMMUNOL, V161, P192; Kondo T, 2000, EMBO J, V19, P1998, DOI 10.1093/emboj/19.9.1998; Lecca D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003579; Levine JM, 1999, EXP NEUROL, V160, P333, DOI 10.1006/exnr.1999.7224; Li HL, 2007, J NEUROSCI, V27, P14375, DOI 10.1523/JNEUROSCI.4456-07.2007; Lu QR, 2000, NEURON, V25, P317, DOI 10.1016/S0896-6273(00)80897-1; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; Marin-Husstege M, 2006, GLIA, V54, P285, DOI 10.1002/glia.20385; Megason SG, 2002, DEVELOPMENT, V129, P2087; Mi S, 2005, NAT NEUROSCI, V8, P745, DOI 10.1038/nn1460; NAVE KA, 1994, J NEUROSCI RES, V38, P607, DOI 10.1002/jnr.490380602; Navel KA, 2006, CURR OPIN NEUROBIOL, V16, P492, DOI 10.1016/j.conb.2006.08.008; Parravicini C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-263; Pfeiffer Steve E., 1993, Trends in Cell Biology, V3, P191, DOI 10.1016/0962-8924(93)90213-K; Ross SE, 2003, NEURON, V39, P13, DOI 10.1016/S0896-6273(03)00365-9; Samanta J, 2004, DEVELOPMENT, V131, P4131, DOI 10.1242/dev.01273; Tokumoto YM, 2002, DEV BIOL, V245, P224, DOI 10.1006/dbio.2002.0626; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Vartanian T, 1997, J CELL BIOL, V137, P211, DOI 10.1083/jcb.137.1.211; Wang SZ, 2006, DEVELOPMENT, V133, P3389, DOI 10.1242/dev.02522; Wang SL, 2001, NEURON, V29, P603, DOI 10.1016/S0896-6273(01)00237-9; Wang SL, 1998, NEURON, V21, P63, DOI 10.1016/S0896-6273(00)80515-2; Xin M, 2005, J NEUROSCI, V25, P1354, DOI 10.1523/JNEUROSCI.3034-04.2005; Yue T, 2006, J NEUROSCI, V26, P1275, DOI 10.1523/JNEUROSCI.4717-05.2006; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3	50	220	234	1	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2009	12	11					1398	1406		10.1038/nn.2410	http://dx.doi.org/10.1038/nn.2410			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	511UE	19838178	Green Accepted			2022-12-17	WOS:000271194100012
J	Keck, T; Mrsic-Flogel, TD; Afonso, MV; Eysel, UT; Bonhoeffer, T; Hubener, M				Keck, Tara; Mrsic-Flogel, Thomas D.; Afonso, Miguel Vaz; Eysel, Ulf T.; Bonhoeffer, Tobias; Huebener, Mark			Massive restructuring of neuronal circuits during functional reorganization of adult visual cortex	NATURE NEUROSCIENCE			English	Article							RETINAL LESIONS; STRIATE CORTEX; TOPOGRAPHIC REORGANIZATION; CORTICAL REORGANIZATION; IN-VIVO; MONOCULAR DEPRIVATION; MAP REORGANIZATION; DENDRITIC SPINES; OCULAR DOMINANCE; CAT	The cerebral cortex has the ability to adapt to altered sensory inputs. In the visual cortex, a small lesion to the retina causes the deprived cortical region to become responsive to adjacent parts of the visual field. This extensive topographic remapping is assumed to be mediated by the rewiring of intracortical connections, but the dynamics of this reorganization process remain unknown. We used repeated intrinsic signal and two-photon imaging to monitor functional and structural alterations in adult mouse visual cortex over a period of months following a retinal lesion. The rate at which dendritic spines were lost and gained increased threefold after a small retinal lesion, leading to an almost complete replacement of spines in the deafferented cortex within 2 months. Because this massive remodeling of synaptic structures did not occur when all visual input was removed, it likely reflects the activity-dependent establishment of new cortical circuits that serve the recovery of visual responses.	[Keck, Tara; Mrsic-Flogel, Thomas D.; Afonso, Miguel Vaz; Bonhoeffer, Tobias; Huebener, Mark] Max Planck Inst Neurobiol, D-82152 Martinsried, Germany; [Eysel, Ulf T.] Ruhr Univ Bochum, Dept Neurophysiol, D-44780 Bochum, Germany	Max Planck Society; Ruhr University Bochum	Hubener, M (corresponding author), Max Planck Inst Neurobiol, Klopfersptiz 18, D-82152 Martinsried, Germany.	mark@neuro.mpg.de	Keck, Tara/C-5408-2009; Bonhoeffer, Tobias/B-9481-2009	Bonhoeffer, Tobias/0000-0001-7897-6634; Eysel, Ulf/0000-0001-6087-957X; Mrsic-Flogel, Tom/0000-0002-8947-408X; Keck, Tara/0000-0001-6623-1037	Max Planck Society; Humboldt Foundation; German Research Foundation [SFB 509]; Fundacao para a Ciencia e Tecnologia, Portugal	Max Planck Society(Max Planck SocietyFoundation CELLEX); Humboldt Foundation(Alexander von Humboldt Foundation); German Research Foundation(German Research Foundation (DFG)); Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	We thank S. Hofer for contributing control data for the Supplementary Discussion. This work was supported by the Max Planck Society (T.K., T.D.M.-F., M.V.A., T.B. and M.H.), the Humboldt Foundation (T.D.M.-F.), the German Research Foundation SFB 509 (U.T.E.) and the Fundacao para a Ciencia e Tecnologia, Portugal (M.V.A.).	Calford MB, 1999, P ROY SOC B-BIOL SCI, V266, P499, DOI 10.1098/rspb.1999.0665; Calford MB, 2003, J NEUROSCI, V23, P6434; CHINO YM, 1995, J NEUROSCI, V15, P2417, DOI 10.1523/JNEUROSCI.15-03-02417.1995; Cnops L, 2007, EUR J NEUROSCI, V25, P1395, DOI 10.1111/j.1460-9568.2007.05395.x; DARIANSMITH C, 1995, J NEUROSCI, V15, P1631, DOI 10.1523/JNEUROSCI.15-03-01631.1995; DARIANSMITH C, 1994, NATURE, V368, P737, DOI 10.1038/368737a0; DAS A, 1995, NATURE, V375, P780, DOI 10.1038/375780a0; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; EYSEL UT, 1982, NATURE, V299, P442, DOI 10.1038/299442a0; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Florence SL, 1998, SCIENCE, V282, P1117, DOI 10.1126/science.282.5391.1117; Giannikopoulos DV, 2006, P NATL ACAD SCI USA, V103, P10805, DOI 10.1073/pnas.0604539103; GILBERT CD, 1979, NATURE, V280, P120, DOI 10.1038/280120a0; GILBERT CD, 1992, NEURON, V9, P1, DOI 10.1016/0896-6273(92)90215-Y; GILBERT CD, 1992, NATURE, V356, P150, DOI 10.1038/356150a0; GILBERT CD, 1983, J NEUROSCI, V3, P1116; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; HEINEN SJ, 1991, EXP BRAIN RES, V83, P670; Heynen AJ, 2003, NAT NEUROSCI, V6, P854, DOI 10.1038/nn1100; HIRSCH JA, 1993, J PHYSIOL-LONDON, V461, P247, DOI 10.1113/jphysiol.1993.sp019512; Hofer SB, 2006, NAT NEUROSCI, V9, P127, DOI 10.1038/nn1610; Holtmaat A, 2006, NATURE, V441, P979, DOI 10.1038/nature04783; Horton JC, 1998, J NEUROSCI, V18, P5433, DOI 10.1523/JNEUROSCI.18-14-05433.1998; HUBEL DH, 1977, PHILOS T ROY SOC B, V278, P377, DOI 10.1098/rstb.1977.0050; KAAS JH, 1990, SCIENCE, V248, P229, DOI 10.1126/science.2326637; Knott GW, 2006, NAT NEUROSCI, V9, P1117, DOI 10.1038/nn1747; Lee WCA, 2006, PLOS BIOL, V4, P271, DOI 10.1371/journal.pbio.0040029; Majewska AK, 2006, J NEUROSCI, V26, P3021, DOI 10.1523/JNEUROSCI.4454-05.2006; MARTIN KAC, 1984, J PHYSIOL-LONDON, V353, P463, DOI 10.1113/jphysiol.1984.sp015347; Mataga N, 2004, NEURON, V44, P1031, DOI 10.1016/j.neuron.2004.11.028; MERZENICH MM, 1983, NEUROSCIENCE, V8, P33, DOI 10.1016/0306-4522(83)90024-6; Mrsic-Flogel TD, 2005, J NEUROSCI, V25, P6921, DOI 10.1523/JNEUROSCI.1555-05.2005; Murakami I, 1997, VISUAL NEUROSCI, V14, P89, DOI 10.1017/S0952523800008798; Nagerl UV, 2007, J NEUROSCI, V27, P8149, DOI 10.1523/JNEUROSCI.0511-07.2007; Obata S, 1999, CEREB CORTEX, V9, P238, DOI 10.1093/cercor/9.3.238; ROBERTSON D, 1989, J COMP NEUROL, V282, P456, DOI 10.1002/cne.902820311; Schuett S, 2002, J NEUROSCI, V22, P6549; SHATZ CJ, 1978, J PHYSIOL-LONDON, V281, P267, DOI 10.1113/jphysiol.1978.sp012421; Smirnakis SM, 2005, NATURE, V435, P300, DOI 10.1038/nature03495; Stepanyants A, 2002, NEURON, V34, P275, DOI 10.1016/S0896-6273(02)00652-9; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; VALVERDE F, 1967, EXP BRAIN RES, V3, P337; Van Den Bergh G, 2003, NEUROSCIENCE, V120, P133, DOI 10.1016/S0306-4522(03)00291-4; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; Young JM, 2007, NAT NEUROSCI, V10, P887, DOI 10.1038/nn1913; Zuo Y, 2005, NATURE, V436, P261, DOI 10.1038/nature03715	46	220	220	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2008	11	10					1162	1167		10.1038/nn.2181	http://dx.doi.org/10.1038/nn.2181			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	352WQ	18758460				2022-12-17	WOS:000259528500013
J	Tan, WB; Janczewski, WA; Yang, P; Shao, XM; Callaway, EM; Feldman, JL				Tan, Wenbin; Janczewski, Wiktor A.; Yang, Paul; Shao, Xuesi M.; Callaway, Edward M.; Feldman, Jack L.			Silencing preBotzinger Complex somatostatin-expressing neurons induces persistent apnea in awake rat	NATURE NEUROSCIENCE			English	Article							PRE-BOTZINGER COMPLEX; MAMMALIAN NEURONS; RECEPTOR; DROSOPHILA; REGION; RHYTHM	Delineating neurons that underlie complex behaviors is of fundamental interest. Using adeno-associated virus 2, we expressed the Drosophila allatostatin receptor in somatostatin (Sst)-expressing neurons in the preBotzinger Complex (preBotC). Rapid silencing of these neurons in awake rats induced a persistent apnea without any respiratory movements to rescue their breathing. We hypothesize that breathing requires preBotC Sst neurons and that their sudden depression can lead to serious, even fatal, respiratory failure.	[Tan, Wenbin; Janczewski, Wiktor A.; Yang, Paul; Shao, Xuesi M.; Feldman, Jack L.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; [Callaway, Edward M.] Salk Inst Biol Studies, Syst Neurobiol Lab, La Jolla, CA 92037 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Salk Institute	Feldman, JL (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Box 951763,650 Charles E Young Dr S, Los Angeles, CA 90095 USA.	feldman@ucla.edu	feldman, jack/AAO-7505-2021; Callaway, Edward/D-4336-2011; Tan, Wenbin/AAM-4661-2020; Tan, Wenbin/AAF-2037-2020	feldman, jack/0000-0003-3692-9412; Callaway, Edward/0000-0002-6366-5267; Tan, Wenbin/0000-0002-2334-8988	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070029, R01HL037941, R37HL037941, R01HL040959] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL37941, R01 HL040959, HL40959, R01 HL070029-05A1, R01 HL070029] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Birgul N, 1999, EMBO J, V18, P5892, DOI 10.1093/emboj/18.21.5892; Callaway EM, 2005, TRENDS NEUROSCI, V28, P196, DOI 10.1016/j.tins.2005.01.007; Chen Maida Lynn, 2004, Paediatr Respir Rev, V5, P182, DOI 10.1016/j.prrv.2004.04.009; Gosgnach S, 2006, NATURE, V440, P215, DOI 10.1038/nature04545; Gray PA, 2001, NAT NEUROSCI, V4, P927, DOI 10.1038/nn0901-927; Gray PA, 1999, SCIENCE, V286, P1566, DOI 10.1126/science.286.5444.1566; Janczewski WA, 2006, J PHYSIOL-LONDON, V570, P407, DOI 10.1113/jphysiol.2005.098848; Lechner HAE, 2002, J NEUROSCI, V22, P5287; McKay LC, 2005, NAT NEUROSCI, V8, P1142, DOI 10.1038/nn1517; Pagliardini S, 2003, J NEUROSCI, V23, P9575; SMITH JC, 1991, SCIENCE, V254, P726, DOI 10.1126/science.1683005; Stornetta RL, 2003, J COMP NEUROL, V455, P499, DOI 10.1002/cne.10504; Tan EM, 2006, NEURON, V51, P157, DOI 10.1016/j.neuron.2006.06.018; Tenenbaum L, 2004, J GENE MED, V6, pS212, DOI 10.1002/jgm.506	14	220	221	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2008	11	5					538	540		10.1038/nn.2104	http://dx.doi.org/10.1038/nn.2104			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	293HV	18391943	Green Accepted			2022-12-17	WOS:000255327300010
J	Benedetti, F; Colloca, L; Torre, E; Lanotte, M; Melcarne, A; Pesare, M; Bergamasco, B; Lopiano, L				Benedetti, F; Colloca, L; Torre, E; Lanotte, M; Melcarne, A; Pesare, M; Bergamasco, B; Lopiano, L			Placebo-responsive Parkinson patients show decreased activity in single neurons of subthalamic nucleus	NATURE NEUROSCIENCE			English	Article							DOPAMINE RELEASE; GLOBUS-PALLIDUS; OPIOID SYSTEMS; EXPECTATION; STIMULATION; APOMORPHINE; ANALGESIA	Placebo administration is known to affect the brain both in pain and in Parkinson disease. Here we show that placebo treatment caused reduced activity in single neurons in the subthalamic nucleus of placebo-responsive Parkinsonian patients. These changes in activity were tightly correlated with clinical improvement; no decrease in activity occurred when the clinical placebo response was absent.	Univ Turin, Sch Med, Dept Neurosci, Clin & Appl Physiol Program, I-10125 Turin, Italy; Univ Turin, Sch Med, Dept Neurosci, Neurol Clin, I-10126 Turin, Italy; CTO Med Ctr, Div Neurosurg, I-10126 Turin, Italy; Maugeri Fdn, I-27100 Pavia, Italy	University of Turin; University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; Istituti Clinici Scientifici Maugeri IRCCS	Benedetti, F (corresponding author), Univ Turin, Sch Med, Dept Neurosci, Clin & Appl Physiol Program, Corso Raffaello 30, I-10125 Turin, Italy.	fabrizio.benedetti@unito.it	Lanotte, Michele M./I-2647-2012; Colloca, Luana/S-1389-2018	Lanotte, Michele M./0000-0002-4184-028X; Colloca, Luana/0000-0002-6503-4709				Amanzio M, 1999, J NEUROSCI, V19, P484, DOI 10.1523/JNEUROSCI.19-01-00484.1999; Benazzouz A, 2000, NEUROLOGY, V55, pS13; Benedetti F, 2003, J NEUROSCI, V23, P4315; Benedetti F, 1999, J NEUROSCI, V19, P3639; Benedetti F, 2003, CURR OPIN ANESTHESIO, V16, P515, DOI 10.1097/00001503-200310000-00012; BERGMAN H, 1994, J NEUROPHYSIOL, V72, P507, DOI 10.1152/jn.1994.72.2.507; Blandini F, 2000, PROG NEUROBIOL, V62, P63, DOI 10.1016/S0301-0082(99)00067-2; de la Fuente-Fernandez R, 2002, BEHAV BRAIN RES, V136, P359, DOI 10.1016/S0166-4328(02)00130-4; de la Fuente-Fernandez R, 2001, SCIENCE, V293, P1164, DOI 10.1126/science.1060937; Hutchison WD, 1998, ANN NEUROL, V44, P622, DOI 10.1002/ana.410440407; Levy R, 2001, J NEUROPHYSIOL, V86, P249, DOI 10.1152/jn.2001.86.1.249; Limousin P, 1998, NEW ENGL J MED, V339, P1105, DOI 10.1056/NEJM199810153391603; Petrovic P, 2002, SCIENCE, V295, P1737, DOI 10.1126/science.1067176; Pollo A, 2002, NEUROREPORT, V13, P1383, DOI 10.1097/00001756-200208070-00006; Stefani A, 2002, CLIN NEUROPHYSIOL, V113, P91, DOI 10.1016/S1388-2457(01)00683-6	15	220	224	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2004	7	6					587	588		10.1038/nn1250	http://dx.doi.org/10.1038/nn1250			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	823VA	15146189				2022-12-17	WOS:000221640300011
J	Irie, F; Yamaguchi, Y				Irie, F; Yamaguchi, Y			EphB receptors regulate dendritic spine development via intersectin, Cdc42 and N-WASP	NATURE NEUROSCIENCE			English	Article							ARP2/3 COMPLEX; ACTIN; MORPHOGENESIS; PROTEINS; NEURONS; GTPASES; RAC; RHO		Burnham Inst, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Yamaguchi, Y (corresponding author), Burnham Inst, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.				NICHD NIH HHS [HD25938] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD025938] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Ethell IM, 2001, NEURON, V31, P1001, DOI 10.1016/S0896-6273(01)00440-8; Halpain S, 2000, TRENDS NEUROSCI, V23, P141, DOI 10.1016/S0166-2236(00)01576-9; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; Hussain NK, 1999, J BIOL CHEM, V274, P15671, DOI 10.1074/jbc.274.22.15671; Hussain NK, 2001, NAT CELL BIOL, V3, P927, DOI 10.1038/ncb1001-927; LANDIS DMD, 1983, J CELL BIOL, V97, P1169, DOI 10.1083/jcb.97.4.1169; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Luo LQ, 1996, NATURE, V379, P837, DOI 10.1038/379837a0; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Takenawa T, 2001, J CELL SCI, V114, P1801	14	220	224	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5	11					1117	1118		10.1038/nn964	http://dx.doi.org/10.1038/nn964			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	609CG	12389031				2022-12-17	WOS:000178884600011
J	Carruth, LL; Reisert, I; Arnold, AP				Carruth, LL; Reisert, I; Arnold, AP			Sex chromosome genes directly affect brain sexual differentiation	NATURE NEUROSCIENCE			English	Article							DOPAMINERGIC-NEURONS; MOUSE-BRAIN; TESTOSTERONE; INVITRO		Univ Calif Los Angeles, Dept Physiol Sci, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Neuroendocrinol Lab, Inst Brain Res, Los Angeles, CA 90095 USA; Univ Ulm, Anat & Zellbiol Abt, D-89081 Ulm, Germany	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Ulm University	Arnold, AP (corresponding author), Univ Calif Los Angeles, Dept Physiol Sci, Los Angeles, CA 90095 USA.			Arnold, Arthur/0000-0002-9908-9767	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059268] Funding Source: NIH RePORTER; NIMH NIH HHS [MH59268] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Arnold AP., 2002, HORMONES BRAIN BEHAV, P105, DOI 10.1016/B978-012532104-4/50065-2; Becker JB, 1999, PHARMACOL BIOCHEM BE, V64, P803, DOI 10.1016/S0091-3057(99)00168-9; BEYER C, 1992, CELL TISSUE RES, V270, P547, DOI 10.1007/BF00645057; DEVRIES GJ, IN PRESS J NEUROSCI; Dluzen D E, 2000, J Gend Specif Med, V3, P36; Lahr Georgia, 1995, Molecular Brain Research, V33, P179, DOI 10.1016/0169-328X(95)00136-G; LOVELLBADGE R, 1990, DEVELOPMENT, V109, P635; Mahadevaiah SK, 1998, HUM MOL GENET, V7, P715, DOI 10.1093/hmg/7.4.715; PICON R, 1976, J ENDOCRINOL, V71, P231, DOI 10.1677/joe.0.0710231; PILGRIM C, 1992, HORM METAB RES, V24, P353, DOI 10.1055/s-2007-1003334; REISERT I, 1991, TRENDS NEUROSCI, V14, P467; Sibug R, 1996, DEV BRAIN RES, V93, P136, DOI 10.1016/0165-3806(96)00024-7; WEISZ J, 1980, ENDOCRINOLOGY, V106, P306, DOI 10.1210/endo-106-1-306; Xu J, 2002, HUM MOL GENET, V11, P1409, DOI 10.1093/hmg/11.12.1409	14	220	224	0	20	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2002	5	10					933	934		10.1038/nn922	http://dx.doi.org/10.1038/nn922			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	597VV	12244322				2022-12-17	WOS:000178242200009
J	Mednick, SC; Nakayama, K; Cantero, JL; Atienza, M; Levin, AA; Pathak, N; Stickgold, R				Mednick, SC; Nakayama, K; Cantero, JL; Atienza, M; Levin, AA; Pathak, N; Stickgold, R			The restorative effect of naps on perceptual deterioration	NATURE NEUROSCIENCE			English	Article							LATE NOCTURNAL SLEEP; MEMORY; PERFORMANCE; DISCRIMINATION; ALERTNESS; IMPROVEMENT; STATES; CAFFEINE; CORTEX; SKILL	Human performance on visual texture discrimination tasks improves slowly (over days) in the absence of additional training. This 'slow learning' requires nocturnal sleep after training and is limited to the region of visual space in which training occurred. Here, we tested human subjects four times in one day and found that with repeated, within-day testing, perceptual thresholds actually increased progressively across the four test sessions. This performance deterioration was prevented either by shifting the target stimuli to an untrained region of visual space or by having the subjects take a mid-day nap between the second and third sessions.	Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Neurophysiol Lab, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Psychiat, Massachusetts Mental Hlth Ctr, Boston, MA 02115 USA	Harvard University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Mednick, SC (corresponding author), Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA.		Cantero, Jose L./ABG-6447-2020; Atienza, Mercedes/L-1805-2014	Atienza, Mercedes/0000-0002-6760-1252; mednick, sara/0000-0002-0906-3097; Pathak, Neha/0000-0002-6078-5482	NIMH NIH HHS [MH 48,832] Funding Source: Medline; NINDS NIH HHS [NS 26,895] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092638] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BALL K, 1987, VISION RES, V27, P953, DOI 10.1016/0042-6989(87)90011-3; BETTINA BL, 1995, VISION RES, V34, P1679; BONNET MH, 1994, PHYSIOL BEHAV, V56, P103, DOI 10.1016/0031-9384(94)90266-6; BONNET MH, 1991, SLEEP, V14, P307, DOI 10.1093/sleep/14.4.307; Cantero JL, 2002, SLEEP, V25, P238, DOI 10.1093/sleep/25.2.238; Contreras D, 1997, J NEUROPHYSIOL, V78, P335, DOI 10.1152/jn.1997.78.1.335; Destexhe A, 1999, J NEUROSCI, V19, P4595, DOI 10.1523/jneurosci.19-11-04595.1999; Dinges D., 1989, SLEEP ALERTNESS CHRO; FAHLE M, 1994, PERCEPTION, V23, P411, DOI 10.1068/p230411; FAHLE M, 1993, VISION RES, V33, P397, DOI 10.1016/0042-6989(93)90094-D; Gais S, 2000, NAT NEUROSCI, V3, P1335, DOI 10.1038/81881; HARMA M, 1989, INT ARCH OCC ENV HEA, V61, P341, DOI 10.1007/BF00409390; HODDES E, 1973, PSYCHOPHYSIOLOGY, V10, P431, DOI 10.1111/j.1469-8986.1973.tb00801.x; Horne JA, 1996, PSYCHOPHYSIOLOGY, V33, P306, DOI 10.1111/j.1469-8986.1996.tb00428.x; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; KARNI A, 1994, SCIENCE, V265, P679, DOI 10.1126/science.8036518; KARNI A, 1995, NEUROIMAGE, V3, pS543; Plihal W, 1997, J COGNITIVE NEUROSCI, V9, P534, DOI 10.1162/jocn.1997.9.4.534; Plihal W, 1999, PSYCHOPHYSIOLOGY, V36, P571, DOI 10.1111/1469-8986.3650571; Rechtschaffen A., 1968, MANUAL STANDARDIZED, V20, P246; ROSA RR, 1993, SLEEP, V16, P727, DOI 10.1093/sleep/16.8.727; Sejnowski TJ, 2000, BRAIN RES, V886, P208, DOI 10.1016/S0006-8993(00)03007-9; SMITH C, 1995, BEHAV BRAIN RES, V69, P137, DOI 10.1016/0166-4328(95)00024-N; Smith Carlyle, 1996, Physiology and Behavior, V59, P93, DOI 10.1016/0031-9384(95)02054-3; Smith CT, 1998, NEUROBIOL LEARN MEM, V69, P211, DOI 10.1006/nlme.1997.3809; Stickgold R, 2000, NAT NEUROSCI, V3, P1237, DOI 10.1038/81756; Stickgold R, 2000, J COGNITIVE NEUROSCI, V12, P246, DOI 10.1162/089892900562075; Stickgold R, 1998, TRENDS COGN SCI, V2, P484, DOI 10.1016/S1364-6613(98)01258-3; STICKGOLD R, 1998, SLEEP S, V21, P256; Takahashi M, 2000, SLEEP, V23, P813; TAUB JM, 1979, INT J NEUROSCI, V9, P97, DOI 10.3109/00207457909147225; Watanabe T, 2001, NATURE, V413, P844, DOI 10.1038/35101601	33	220	223	0	37	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2002	5	7					677	681		10.1038/nn864	http://dx.doi.org/10.1038/nn864			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	566EP	12032542				2022-12-17	WOS:000176414300018
J	Lee, SK; Pfaff, SL				Lee, SK; Pfaff, SL			Transcriptional networks regulating neuronal identity in the developing spinal cord	NATURE NEUROSCIENCE			English	Review							CENTRAL-NERVOUS-SYSTEM; PROGENITOR-CELL IDENTITY; DOMAIN INTERACTOR NLI; VENTRAL NEURAL-TUBE; LIM HOMEOBOX GENES; SONIC HEDGEHOG; MOTOR-NEURON; HOMEODOMAIN PROTEIN; FLOOR PLATE; NEGATIVE MODULATION	The spinal cord is composed of anatomically distinct classes of neurons that perform sensory and motor functions. Because of its relative simplicity, the spinal cord has served as an important system for defining molecular mechanisms that contribute to the assembly of circuits in the central nervous system. At early embryonic stages, the neural tube contains multipotential cells whose identity becomes specified by cell-to-cell signaling. This review will focus on the progress made in understanding the transcriptional networks that become activated by these cell-cell interactions, with particular emphasis on the neurons that contribute to locomotor control. Remarkably, many of the transcription factors implicated in neuronal specification in the spinal cord are found to inhibit transcription, which has led to a 'derepression' model for cell fate specification in the developing spinal cord.	Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA	Salk Institute	Pfaff, SL (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	pfaff@salk.edu						Agulnick AD, 1996, NATURE, V384, P270, DOI 10.1038/384270a0; Allen T, 1999, CELL MOL BIOL, V45, P687; Altaba AR, 1996, INT J DEV BIOL, V40, P1081; Appel B, 1998, DEVELOPMENT, V125, P371; Appel B, 1995, DEVELOPMENT, V121, P4117; Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Bach I, 1997, GENE DEV, V11, P1370, DOI 10.1101/gad.11.11.1370; Bailey P, 1999, MOL ENDOCRINOL, V13, P1155, DOI 10.1210/me.13.7.1155; Bermingham NA, 2001, NEURON, V30, P411, DOI 10.1016/S0896-6273(01)00305-1; BOYD JM, 1993, EMBO J, V12, P469, DOI 10.1002/j.1460-2075.1993.tb05679.x; Briscoe J, 2001, CURR OPIN NEUROBIOL, V11, P43, DOI 10.1016/S0959-4388(00)00172-0; Briscoe J, 1999, SEMIN CELL DEV BIOL, V10, P353, DOI 10.1006/scdb.1999.0295; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Briscoe J, 2001, MOL CELL, V7, P1279, DOI 10.1016/S1097-2765(01)00271-4; Burrill JD, 1997, DEVELOPMENT, V124, P4493; CARRIERE C, 1995, CELL GROWTH DIFFER, V6, P1531; Chen GQ, 2000, GENE, V249, P1, DOI 10.1016/S0378-1119(00)00161-X; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; CHITNIS A, 1995, NATURE, V375, P761, DOI 10.1038/375761a0; Choi CY, 1999, J BIOL CHEM, V274, P31543, DOI 10.1074/jbc.274.44.31543; Ding Q, 1998, DEVELOPMENT, V125, P2533; Edlund T, 1999, CELL, V96, P211, DOI 10.1016/S0092-8674(00)80561-9; Edmondson DG, 1998, METHODS, V15, P355, DOI 10.1006/meth.1998.0639; Edmondson DG, 1996, GENE DEV, V10, P1247, DOI 10.1101/gad.10.10.1247; Eggenschwiler JT, 2001, NATURE, V412, P194, DOI 10.1038/35084089; Ensini M, 1998, DEVELOPMENT, V125, P969; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; Ericson J, 1997, COLD SPRING HARB SYM, V62, P451; Erskine L, 1998, DEV BIOL, V199, P26, DOI 10.1006/dbio.1998.8912; Fickett JW, 2000, CURR OPIN BIOTECH, V11, P19, DOI 10.1016/S0958-1669(99)00049-X; Fisher AL, 1998, GENE DEV, V12, P1931, DOI 10.1101/gad.12.13.1931; Gowan K, 2001, NEURON, V31, P219, DOI 10.1016/S0896-6273(01)00367-1; Heinzel T, 1997, NATURE, V387, P43, DOI 10.1038/387043a0; HERSCHBACH BM, 1994, NATURE, V370, P309, DOI 10.1038/370309a0; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Hynes M, 2000, NAT NEUROSCI, V3, P41, DOI 10.1038/71114; Itasaki N, 1996, NEURON, V16, P487, DOI 10.1016/S0896-6273(00)80069-0; Itoh S, 2000, EUR J BIOCHEM, V267, P6954, DOI 10.1046/j.1432-1327.2000.01828.x; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; JESSELL TM, 1997, MOL CELLULAR APPROAC, P290; Jurata LW, 1998, J BIOL CHEM, V273, P3152, DOI 10.1074/jbc.273.6.3152; Jurata LW, 1996, P NATL ACAD SCI USA, V93, P11693, DOI 10.1073/pnas.93.21.11693; Jurata LW, 1997, MOL CELL BIOL, V17, P5688, DOI 10.1128/MCB.17.10.5688; Kageyama R, 1999, CELL RES, V9, P179, DOI 10.1038/sj.cr.7290016; Kania A, 2000, CELL, V102, P161, DOI 10.1016/S0092-8674(00)00022-2; Krishnan V, 1997, SCIENCE, V278, P1947, DOI 10.1126/science.278.5345.1947; Lance-Jones C, 2001, DEVELOPMENT, V128, P2255; LEBER SM, 1995, J NEUROSCI, V15, P1236; Lee KJ, 1999, ANNU REV NEUROSCI, V22, P261, DOI 10.1146/annurev.neuro.22.1.261; Li Steven Shoei-Lung, 2000, Proceedings of the National Science Council Republic of China Part B Life Sciences, V24, P47; Liem KF, 2000, DEVELOPMENT, V127, P4855; Liem KF, 1997, CELL, V91, P127, DOI 10.1016/S0092-8674(01)80015-5; Livesey FJ, 2000, CURR BIOL, V10, P301, DOI 10.1016/S0960-9822(00)00379-1; Lu QR, 2000, NEURON, V25, P317, DOI 10.1016/S0896-6273(00)80897-1; Lumsden A, 1996, SCIENCE, V274, P1109, DOI 10.1126/science.274.5290.1109; Mannervik M, 1999, SCIENCE, V284, P606, DOI 10.1126/science.284.5414.606; Matise MP, 1998, DEVELOPMENT, V125, P2759; Matise MP, 1997, J NEUROSCI, V17, P7805; Meier BC, 1999, MOL CELL ENDOCRINOL, V147, P65, DOI 10.1016/S0303-7207(98)00213-5; Mizuguchi R, 2001, NEURON, V31, P757, DOI 10.1016/S0896-6273(01)00413-5; Moran-Rivard L, 2001, NEURON, V29, P385, DOI 10.1016/S0896-6273(01)00213-6; Muhr J, 2001, CELL, V104, P861, DOI 10.1016/S0092-8674(01)00283-5; Nagy L, 1997, CELL, V89, P373, DOI 10.1016/S0092-8674(00)80218-4; Nguyen VH, 2000, DEVELOPMENT, V127, P1209; Nibu Y, 1998, SCIENCE, V280, P101, DOI 10.1126/science.280.5360.101; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Palaparti A, 1997, J BIOL CHEM, V272, P26604, DOI 10.1074/jbc.272.42.26604; Pfaff S, 1998, CURR OPIN NEUROBIOL, V8, P27, DOI 10.1016/S0959-4388(98)80005-6; Pierani A, 2001, NEURON, V29, P367, DOI 10.1016/S0896-6273(01)00212-4; Pringle NP, 1998, NEURON, V20, P883, DOI 10.1016/S0896-6273(00)80470-5; Redd MJ, 1997, J BIOL CHEM, V272, P11193; Ren B, 1999, GENE DEV, V13, P125, DOI 10.1101/gad.13.1.125; Richardson WD, 1997, DEV NEUROSCI-BASEL, V19, P58, DOI 10.1159/000111186; Rincon-Limas DE, 2000, EMBO J, V19, P2602, DOI 10.1093/emboj/19.11.2602; ROELINK H, 1995, CELL, V81, P445, DOI 10.1016/0092-8674(95)90397-6; Roelink H, 1996, CURR OPIN NEUROBIOL, V6, P33, DOI 10.1016/S0959-4388(96)80006-7; Roose J, 1998, NATURE, V395, P608, DOI 10.1038/26989; Sander M, 2000, GENE DEV, V14, P2134, DOI 10.1101/gad.820400; Saueressig H, 1999, DEVELOPMENT, V126, P4201; Scardigli R, 2001, NEURON, V31, P203, DOI 10.1016/S0896-6273(01)00358-0; SCHAEPER U, 1995, P NATL ACAD SCI USA, V92, P10467, DOI 10.1073/pnas.92.23.10467; Sharma K, 2000, NATURE, V406, P515, DOI 10.1038/35020078; Sharma K, 2001, NEURON, V29, P321, DOI 10.1016/S0896-6273(01)00208-2; Sharma K, 1998, CELL, V95, P817, DOI 10.1016/S0092-8674(00)81704-3; Smith ST, 1996, DEVELOPMENT, V122, P3141; Soula C, 2001, DEVELOPMENT, V128, P1369; Tanabe Y, 1998, CELL, V95, P67, DOI 10.1016/S0092-8674(00)81783-3; Tanabe Y, 1996, SCIENCE, V274, P1115, DOI 10.1126/science.274.5290.1115; Thaler J, 1999, NEURON, V23, P675, DOI 10.1016/S0896-6273(01)80027-1; Tolkunova EN, 1998, MOL CELL BIOL, V18, P2804, DOI 10.1128/MCB.18.5.2804; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; Vallstedt A, 2001, NEURON, V31, P743, DOI 10.1016/S0896-6273(01)00412-3; van Meyel DJ, 2000, DEVELOPMENT, V127, P1823; van Meyel DJ, 1999, MOL CELL, V4, P259, DOI 10.1016/S1097-2765(00)80373-1; VarelaEchavarria A, 1996, MOL CELL NEUROSCI, V8, P242, DOI 10.1006/mcne.1996.0061; Wenner P, 2000, J NEUROPHYSIOL, V84, P2651, DOI 10.1152/jn.2000.84.5.2651; WOLOSHIN P, 1995, CELL, V82, P611, DOI 10.1016/0092-8674(95)90033-0; Ying LT, 2000, NAT NEUROSCI, V3, P979, DOI 10.1038/79916; Zhou Q, 2001, NEURON, V31, P791, DOI 10.1016/S0896-6273(01)00414-7; Zhou Q, 2000, NEURON, V25, P331, DOI 10.1016/S0896-6273(00)80898-3	103	220	228	3	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2001	4			S			1183	1191		10.1038/nn750	http://dx.doi.org/10.1038/nn750			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	490GF	11687828				2022-12-17	WOS:000172041500010
J	Sapir, A; Soroker, N; Berger, A; Henik, A				Sapir, A; Soroker, N; Berger, A; Henik, A			Inhibition of return in spatial attention: direct evidence for collicular generation	NATURE NEUROSCIENCE			English	Article							NASAL; LOCATIONS; FIELD		Ben Gurion Univ Negev, Dept Behav Sci, IL-84105 Beer Sheva, Israel; Ben Gurion Univ Negev, Zlotowski Ctr Neurosci, IL-84105 Beer Sheva, Israel; Tel Aviv Univ, Loewenstein Rehabil Hosp, IL-69978 Tel Aviv, Israel; Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel	Ben Gurion University; Ben Gurion University; Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine	Henik, A (corresponding author), Ben Gurion Univ Negev, Dept Behav Sci, IL-84105 Beer Sheva, Israel.		Berger, Andrea/F-1427-2012; Soroker, Nachum/V-7094-2019; HENIK, AVISHAI/F-1176-2012	Berger, Andrea/0000-0001-5557-4114; Henik, Avishai/0000-0002-5665-6004; Soroker, Nachum/0000-0003-4909-5576				Danziger S, 1997, CONSCIOUS COGN, V6, P291, DOI 10.1006/ccog.1997.0312; HUBEL DH, 1975, BRAIN RES, V96, P25, DOI 10.1016/0006-8993(75)90567-3; KLEIN RM, IN PRESS PSYCHOL SCI; LEWIS TL, 1985, VISION RES, V25, P943, DOI 10.1016/0042-6989(85)90205-6; Posner M.I., 1980, TUTORIALS MOTOR BEHA, P243; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; POSNER MI, 1985, COGNITIVE NEUROPSYCH, V2, P211, DOI 10.1080/02643298508252866; POSNER MI, 1984, ATTENTION PERFORM, V10, P531; RAFAL RD, 1989, J EXP PSYCHOL HUMAN, V15, P673, DOI 10.1037/0096-1523.15.4.673; SHERMAN SM, 1974, SCIENCE, V185, P355, DOI 10.1126/science.185.4148.355; SIMION F, 1995, INFANT BEHAV DEV, V18, P189, DOI 10.1016/0163-6383(95)90048-9; WILLIAMS C, 1995, NEUROSCIENCE, V65, P577, DOI 10.1016/0306-4522(94)00489-R; WILSON M E, 1970, Brain Research, V24, P395, DOI 10.1016/0006-8993(70)90181-2	13	220	229	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	1999	2	12					1053	1054		10.1038/15977	http://dx.doi.org/10.1038/15977			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	292TA	10570480				2022-12-17	WOS:000085810100007
J	Britten, KH; van Wezel, RJA				Britten, KH; van Wezel, RJA			Electrical microstimulation of cortical area MST biases heading perception in monkeys	NATURE NEUROSCIENCE			English	Article							SUPERIOR TEMPORAL AREA; PURSUIT EYE-MOVEMENTS; OPTIC FLOW STIMULI; MACAQUE MONKEY; VISUAL-CORTEX; EXPANSION CONTRACTION; ROTATION CELLS; IMAGE MOTION; DORSAL PART; NEURONS	As we move through the environment, the pattern of visual motion on the retina provides rich information about our movement through the scene. Human subjects can use this information, often termed "optic flow", to accurately estimate their direction of self movement (heading) from relatively sparse displays. Physiological observations on the motion-sensitive areas of monkey visual cortex suggest that the medial superior temporal area (MST) is well suited for the analysis of optic Row information. To test whether MST is involved in extracting heading from optic flow, we perturbed its activity in monkeys trained on a heading discrimination task. Electrical microstimulation of MST frequently biased the monkeys' decisions about their heading, and these induced biases were often quite large. This result suggests that MST has a direct role in the perception of heading from optic flow.	Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; Univ Calif Davis, Sect Neurobiol Physiol & Behav, Davis, CA 95616 USA; Univ Utrecht, Dept Comparat Physiol, Utrecht, Netherlands	University of California System; University of California Davis; University of California System; University of California Davis; Utrecht University	Britten, KH (corresponding author), Univ Calif Davis, Ctr Neurosci, 1544 Newton Court, Davis, CA 95616 USA.		van Wezel, Richard R J/G-4455-2011	van Wezel, Richard R J/0000-0001-5753-7069	NEI NIH HHS [EY10562] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY010562] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Banks MS, 1996, VISION RES, V36, P431, DOI 10.1016/0042-6989(95)00122-0; Bradley DC, 1996, SCIENCE, V273, P1544, DOI 10.1126/science.273.5281.1544; Bremmer I, 1997, J DEMOCR, V8, P77; BRITTEN KH, 1998, IN PRESS VISUAL NURO; CELEBRINI S, 1995, J NEUROPHYSIOL, V73, P437, DOI 10.1152/jn.1995.73.2.437; CELEBRINI S, 1994, J NEUROSCI, V14, P4109; Doty R W, 1969, Annu Rev Psychol, V20, P289, DOI 10.1146/annurev.ps.20.020169.001445; DUFFY CJ, 1991, J NEUROPHYSIOL, V65, P1329, DOI 10.1152/jn.1991.65.6.1329; DUFFY CJ, 1995, J NEUROSCI, V15, P5192; Duffy CJ, 1997, J NEUROPHYSIOL, V77, P782, DOI 10.1152/jn.1997.77.2.782; Geesaman BJ, 1997, CEREB CORTEX, V7, P749, DOI 10.1093/cercor/7.8.749; Gibson J.J., 1950, PERCEPTION VISUAL WO; GRAZIANO MSA, 1994, J NEUROSCI, V14, P54; HEEGER DJ, 1992, INT J COMPUT VISION, V7, P95, DOI 10.1007/BF00128130; Hoel P. G., 1971, INTRO STAT THEORY; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; KOENDERINK JJ, 1987, BIOL CYBERN, V56, P247, DOI 10.1007/BF00365219; KOMATSU H, 1989, J NEUROPHYSIOL, V62, P31, DOI 10.1152/jn.1989.62.1.31; LAGAE L, 1993, J NEUROPHYSIOL, V69, P19, DOI 10.1152/jn.1993.69.1.19; LAGAE L, 1994, J NEUROPHYSIOL, V71, P1597, DOI 10.1152/jn.1994.71.5.1597; MURASUGI CM, 1993, J NEUROSCI, V13, P1719; NEWSOME WT, 1988, J NEUROPHYSIOL, V60, P604, DOI 10.1152/jn.1988.60.2.604; PERRONE JA, 1994, VISION RES, V34, P2917, DOI 10.1016/0042-6989(94)90060-4; QUICK RF, 1974, KYBERNETIK, V16, P65, DOI 10.1007/BF00271628; RIEGER JH, 1985, J OPT SOC AM A, V2, P354, DOI 10.1364/JOSAA.2.000354; ROYDEN CS, 1994, VISION RES, V34, P3197, DOI 10.1016/0042-6989(94)90084-1; ROYDEN CS, 1992, NATURE, V360, P583, DOI 10.1038/360583a0; SAITO H, 1986, J NEUROSCI, V6, P145; SALZMAN CD, 1992, J NEUROSCI, V12, P2331; Schmidt EM, 1996, BRAIN, V119, P507, DOI 10.1093/brain/119.2.507; Squatrito S, 1997, J NEUROSCI, V17, P3847; TANAKA K, 1989, J NEUROPHYSIOL, V62, P642, DOI 10.1152/jn.1989.62.3.642; TANAKA K, 1989, J NEUROPHYSIOL, V62, P626, DOI 10.1152/jn.1989.62.3.626; TANAKA K, 1986, J NEUROSCI, V6, P134; vandenBerg AV, 1996, VISION RES, V36, P2337, DOI 10.1016/0042-6989(95)00247-2; WARREN WH, 1990, J OPT SOC AM A, V7, P160, DOI 10.1364/JOSAA.7.000160	36	220	227	0	11	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	1998	1	1					59	63		10.1038/259	http://dx.doi.org/10.1038/259			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QA	10195110				2022-12-17	WOS:000076361000019
J	Giandomenico, SL; Mierau, SB; Gibbons, GM; Wenger, LMD; Masullo, L; Sit, T; Sutcliffe, M; Boulanger, J; Tripodi, M; Derivery, E; Paulsen, O; Lakatos, A; Lancaster, MA				Giandomenico, Stefano L.; Mierau, Susanna B.; Gibbons, George M.; Wenger, Lea M. D.; Masullo, Laura; Sit, Timothy; Sutcliffe, Magdalena; Boulanger, Jerome; Tripodi, Marco; Derivery, Emmanuel; Paulsen, Ole; Lakatos, Andras; Lancaster, Madeline A.			Cerebral organoids at the air-liquid interface generate diverse nerve tracts with functional output	NATURE NEUROSCIENCE			English	Article							SELF-ORGANIZATION; AXON GUIDANCE; SPIKE TRAINS; CELL; DYNAMICS; MODEL	Neural organoids have the potential to improve our understanding of human brain development and neurological disorders. However, it remains to be seen whether these tissues can model circuit formation with functional neuronal output. Here we have adapted air-liquid interface culture to cerebral organoids, leading to improved neuronal survival and axon outgrowth. The resulting thick axon tracts display various morphologies, including long-range projection within and away from the organoid, growth-cone turning, and decussation. Single-cell RNA sequencing reveals various cortical neuronal identities, and retrograde tracing demonstrates tract morphologies that match proper molecular identities. These cultures exhibit active neuronal networks, and subcortical projecting tracts can innervate mouse spinal cord explants and evoke contractions of adjacent muscle in a manner dependent on intact organoid-derived innervating tracts. Overall, these results reveal a remarkable self-organization of corticofugal and callosal tracts with a functional output, providing new opportunities to examine relevant aspects of human CNS development and disease.	[Giandomenico, Stefano L.; Masullo, Laura; Sutcliffe, Magdalena; Boulanger, Jerome; Tripodi, Marco; Derivery, Emmanuel; Lancaster, Madeline A.] MRC, Lab Mol Biol, Cambridge Biomed Campus, Cambridge, England; [Mierau, Susanna B.; Sit, Timothy; Paulsen, Ole] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England; [Gibbons, George M.; Wenger, Lea M. D.; Lakatos, Andras] Univ Cambridge, John van Geest Ctr Brain Repair, Cambridge, England; [Gibbons, George M.; Wenger, Lea M. D.; Lakatos, Andras] Univ Cambridge, Div Stem Cell Neurobiol, Dept Clin Neurosci, Cambridge, England; [Lakatos, Andras] Wellcome Trust MRC Cambridge Stem Cell Inst, Cambridge Biomed Campus, Cambridge, England	MRC Laboratory Molecular Biology; University of Cambridge; University of Cambridge; University of Cambridge	Lancaster, MA (corresponding author), MRC, Lab Mol Biol, Cambridge Biomed Campus, Cambridge, England.	mlancast@mrc-lmb.cam.ac.uk	Tripodi, Marco/AGN-5956-2022	Tripodi, Marco/0000-0002-6827-6690; Mierau, Susanna/0000-0002-1220-6423; Giandomenico, Stefano/0000-0003-4235-8353; Boulanger, Jerome/0000-0003-0237-3743; Lakatos, Andras/0000-0002-1301-2292	Medical Research Council [MC_UP_1201/9, MR/P008658/1, MC_UP_1201/2, MC_UP_1201/13]; European Research Council ERC [STG 757710, STG 677029]; Wellcome Trust [ISSF_ RRZC/115_RG89529]; Newton Trust [RRZC/115_RG89305]; MRC Clinician Scientist Fellowship; Biotechnology and Biological Sciences Research Council (BBSRC); ERANET-NEURON Micronet consortium; HFSP CDA; MRC [MC_PC_16036, MC_UP_1201/9, MC_UP_1201/13, MC_U105184326, MC_UP_1201/2, MR/P008658/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council ERC(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome Trust); Newton Trust; MRC Clinician Scientist Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ERANET-NEURON Micronet consortium; HFSP CDA; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors would like to thank members of the Lancaster lab for helpful discussions and D. Jabaudon for insightful comments, as well as members of the LMB mouse facility for help with timed matings and tissue collections. We also thank members of the H. McMahon laboratory for plasmids and the LMB light microscopy facility, in particular B. Sutcliffe, for assistance with imaging. We are grateful to P. Coupland and S. Ballereau (Cancer Research UK) for technical assistance and to M. Galardini and P. Beltrao (European Bioinformatics Institute) for helping with computing resources. This work was supported by the Medical Research Council MC_UP_1201/9 (to M.A.L.), European Research Council ERC STG 757710 (to M.A.L.), Medical Research Council MR/P008658/1 (to A.L.), Wellcome Trust ISSF_ RRZC/115_RG89529 (to A.L.), Newton Trust RRZC/115_RG89305 (to A.L.), MRC Clinician Scientist Fellowship (to A.L.), grants from the Biotechnology and Biological Sciences Research Council (BBSRC) (to O. P.), Medical Research Council MC_UP_1201/2 (to M.T.), European Research Council ERC Starting Grant, STG 677029 (to M.T.), ERANET-NEURON Micronet consortium (to M.T.), Medical Research Council MC_UP_1201/13 (to E.D.), and HFSP CDA (to E.D.).	Bak M, 2003, DEVELOPMENT, V130, P4999, DOI 10.1242/dev.00713; Birey F, 2017, NATURE, V545, P54, DOI 10.1038/nature22330; Camp JG, 2015, P NATL ACAD SCI USA, V112, P15672, DOI 10.1073/pnas.1520760112; Chedotal A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001917; Cotterill E, 2016, J NEUROPHYSIOL, V116, P306, DOI 10.1152/jn.00093.2016; Cutts CS, 2014, J NEUROSCI, V34, P14288, DOI 10.1523/JNEUROSCI.2767-14.2014; Daza R. A. M., 2007, CSH PROTOC, V2007, pt4914; Gahwiler BH, 1997, TRENDS NEUROSCI, V20, P471, DOI 10.1016/S0166-2236(97)01122-3; Gonzalez C, 2018, MOL PSYCHIATR, V23, P2363, DOI 10.1038/s41380-018-0229-8; Kadoshima T, 2013, P NATL ACAD SCI USA, V110, P20284, DOI 10.1073/pnas.1315710110; Keeble TR, 2006, J NEUROSCI, V26, P5840, DOI 10.1523/JNEUROSCI.1175-06.2006; KOH THHG, 1988, ARCH DIS CHILD, V63, P1347, DOI 10.1136/adc.63.11.1347; Lake BB, 2016, SCIENCE, V352, P1586, DOI 10.1126/science.aaf1204; Lancaster MA, 2017, NAT BIOTECHNOL, V35, P659, DOI 10.1038/nbt.3906; Lancaster MA, 2014, NAT PROTOC, V9, P2329, DOI 10.1038/nprot.2014.158; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Mansour AA, 2018, NAT BIOTECHNOL, V36, P432, DOI 10.1038/nbt.4127; Mates L, 2009, NAT GENET, V41, P753, DOI 10.1038/ng.343; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; Piper M, 2009, CEREB CORTEX, V19, pI11, DOI 10.1093/cercor/bhp027; Pollen AA, 2015, CELL, V163, P55, DOI 10.1016/j.cell.2015.09.004; Polleux F, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001925; Preissl S, 2018, NAT NEUROSCI, V21, P432, DOI 10.1038/s41593-018-0079-3; Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032; Quadrato G, 2017, NATURE, V545, P48, DOI 10.1038/nature22047; Renner M, 2017, EMBO J, V36, P1316, DOI 10.15252/embj.201694700; Rezakhaniha R, 2012, BIOMECH MODEL MECHAN, V11, P461, DOI 10.1007/s10237-011-0325-z; Schroeter MS, 2015, J NEUROSCI, V35, P5459, DOI 10.1523/JNEUROSCI.4259-14.2015; Shu TZ, 2001, J NEUROSCI, V21, P2749, DOI 10.1523/JNEUROSCI.21-08-02749.2001; Sorkin R, 2006, J NEURAL ENG, V3, P95, DOI 10.1088/1741-2560/3/2/003; STREIT J, 1991, EUR J NEUROSCI, V3, P1054, DOI 10.1111/j.1460-9568.1991.tb00042.x; Watanabe M, 2017, CELL REP, V21, P517, DOI 10.1016/j.celrep.2017.09.047; Zhong SJ, 2018, NATURE, V555, P524, DOI 10.1038/nature25980	33	219	225	16	128	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2019	22	4					669	+		10.1038/s41593-019-0350-2	http://dx.doi.org/10.1038/s41593-019-0350-2			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HQ1JO	30886407	Green Accepted, Green Submitted			2022-12-17	WOS:000462154300021
J	Bautista, DM; Wilson, SR; Hoon, MA				Bautista, Diana M.; Wilson, Sarah R.; Hoon, Mark A.			Why we scratch an itch: the molecules, cells and circuits of itch	NATURE NEUROSCIENCE			English	Review							PROTEINASE-ACTIVATED RECEPTOR-2; SPINOTHALAMIC TRACT NEURONS; GASTRIN-RELEASING-PEPTIDE; CHRONIC ATOPIC-DERMATITIS; TOLL-LIKE RECEPTORS; SENSORY NEURONS; SPINAL-CORD; BEHAVIORAL-RESPONSES; MOUSE MODEL; DRY SKIN	Itch is described as an irritating sensation that triggers a desire to scratch. However, this definition hardly seems fitting for the millions of people who suffer from intractable itch. Indeed, the Buddhist philosopher Nagarjuna more aptly stated, "There is pleasure when an itch is scratched. But to be without an itch is more pleasurable still." Chronic itch is widespread and very difficult to treat. In this review we focus on the molecules, cells and circuits in the peripheral and central nervous systems that drive acute and chronic itch transmission. Understanding the itch circuitry is critical to developing new therapies for this intractable disease.	[Bautista, Diana M.; Wilson, Sarah R.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Bautista, Diana M.; Wilson, Sarah R.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Hoon, Mark A.] Natl Inst Dent & Craniofacial Res, Mol Genet Unit, Lab Sensory Biol, NIH, Bethesda, MD USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Bautista, DM (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	dbautista@berkeley.edu			US National Institutes of Health (NIH) [AR059385, DOD007123A]; NIH NIDCR; US National Science Foundation Fellowship; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000721] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); US National Science Foundation Fellowship; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We are grateful to M. Pellegrino for critical comments on the manuscript. This work was supported by US National Institutes of Health (NIH) grants AR059385 and DOD007123A (D.M.B.), the intramural research program of the NIH NIDCR (M.A.H.) and a US National Science Foundation Fellowship (S.R.W.).	Abreu MT, 2005, J IMMUNOL, V174, P4453, DOI 10.4049/jimmunol.174.8.4453; Akiyama T, 2010, PAIN, V151, P378, DOI 10.1016/j.pain.2010.07.024; Akiyama T, 2013, NEUROSCIENCE, V250, P697, DOI 10.1016/j.neuroscience.2013.07.035; Akiyama T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022665; Akiyama T, 2010, NEUROSCI LETT, V484, P62, DOI 10.1016/j.neulet.2010.08.020; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Bautista DM, 2013, ANNU REV PHYSIOL, V75, P181, DOI 10.1146/annurev-physiol-030212-183811; Belghiti M, 2013, J BIOL CHEM, V288, P9675, DOI 10.1074/jbc.M113.455162; Brandt EB, 2013, J IMMUNOL, V191, P3519, DOI 10.4049/jimmunol.1300789; Briot A, 2010, J INVEST DERMATOL, V130, P2736, DOI 10.1038/jid.2010.233; Cavanaugh DJ, 2009, P NATL ACAD SCI USA, V106, P9075, DOI 10.1073/pnas.0901507106; Chiu IM, 2013, NATURE, V501, P52, DOI 10.1038/nature12479; D'Almeida JAC, 1999, ARQ NEURO-PSIQUIAT, V57, P746, DOI 10.1590/S0004-282X1999000500004; Davidson S, 2012, J NEUROPHYSIOL, V108, P1711, DOI 10.1152/jn.00206.2012; Davidson S, 2010, TRENDS NEUROSCI, V33, P550, DOI 10.1016/j.tins.2010.09.002; Davidson S, 2009, NAT NEUROSCI, V12, P544, DOI 10.1038/nn.2292; Dey DD, 2005, PAIN, V113, P233, DOI 10.1016/j.pain.2004.09.032; Elmariah SB, 2011, SEMIN CUTAN MED SURG, V30, P118, DOI 10.1016/j.sder.2011.04.008; Fleming MS, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-52; FORSSMANN WG, 1989, ARCH HISTOL CYTOL, V52, P293, DOI 10.1679/aohc.52.Suppl_293; Garibyan L, 2013, DERMATOL THER, V26, P84, DOI 10.1111/dth.12025; Gomes LO, 2012, LIFE SCI, V91, P628, DOI 10.1016/j.lfs.2012.03.020; Grimstad O, 2009, EXP DERMATOL, V18, P35, DOI 10.1111/j.1600-0625.2008.00766.x; Han L, 2013, NAT NEUROSCI, V16, P174, DOI 10.1038/nn.3289; Hansson L, 2002, J INVEST DERMATOL, V118, P444, DOI 10.1046/j.0022-202x.2001.01684.x; Honma Y, 2007, BRIT J DERMATOL, V156, P1178, DOI 10.1111/j.1365-2133.2007.07882.x; Ikoma A, 2006, NAT REV NEUROSCI, V7, P535, DOI 10.1038/nrn1950; Imamachi N, 2009, P NATL ACAD SCI USA, V106, P11330, DOI 10.1073/pnas.0905605106; Inan S, 2006, PHARMACOL BIOCHEM BE, V85, P39, DOI 10.1016/j.pbb.2006.07.004; Jin HL, 2009, J INVEST DERMATOL, V129, P31, DOI 10.1038/jid.2008.106; Johanek LM, 2008, J NEUROSCI, V28, P7659, DOI 10.1523/JNEUROSCI.1760-08.2008; Kim DK, 2008, EUR J PHARMACOL, V579, P390, DOI 10.1016/j.ejphar.2007.11.005; Kim N, 2012, J INVEST DERMATOL, V132, P1169, DOI 10.1038/jid.2011.404; Kim SJ, 2011, P NATL ACAD SCI USA, V108, P3371, DOI 10.1073/pnas.1019755108; Konishi H, 2002, P NATL ACAD SCI USA, V99, P11340, DOI 10.1073/pnas.152337799; Lagerstrom MC, 2010, NEURON, V68, P529, DOI 10.1016/j.neuron.2010.09.016; Li MZ, 2006, DEV BIOL, V292, P555, DOI 10.1016/j.ydbio.2006.01.033; Liang JX, 2011, NEUROSCI LETT, V492, P175, DOI 10.1016/j.neulet.2011.02.009; Liu BY, 2013, FASEB J, V27, P3549, DOI 10.1096/fj.13-229948; Liu Q, 2012, J NEUROSCI, V32, P14532, DOI 10.1523/JNEUROSCI.3509-12.2012; Liu Q, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001925; Liu Q, 2009, CELL, V139, P1353, DOI 10.1016/j.cell.2009.11.034; Liu T, 2012, J CLIN INVEST, V122, P2195, DOI 10.1172/JCI45414; Liu T, 2012, NEUROSCI BULL, V28, P131, DOI 10.1007/s12264-012-1219-5; Liu T, 2010, NAT NEUROSCI, V13, P1460, DOI 10.1038/nn.2683; Liu XY, 2011, CELL, V147, P447, DOI 10.1016/j.cell.2011.08.043; Liu Y, 2010, NEURON, V68, P543, DOI 10.1016/j.neuron.2010.09.008; Maurer M, 2013, NEW ENGL J MED, V368, P924, DOI 10.1056/NEJMoa1215372; McCoy ES, 2013, NEURON, V78, P138, DOI 10.1016/j.neuron.2013.01.030; McNeil B, 2012, NEUROSCI BULL, V28, P100, DOI 10.1007/s12264-012-1202-1; Mishra SK, 2013, SCIENCE, V340, P968, DOI 10.1126/science.1233765; Mishra SK, 2012, J NEUROSCI, V32, P8686, DOI 10.1523/JNEUROSCI.1533-12.2012; Mishra SK, 2011, EMBO J, V30, P582, DOI 10.1038/emboj.2010.325; Miyamoto T, 2002, JPN J PHARMACOL, V88, P285, DOI 10.1254/jjp.88.285; Moser HR, 2013, J NEUROSCI, V33, P6093, DOI 10.1523/JNEUROSCI.0216-13.2013; Mrabet-Dahbi S, 2008, J ALLERGY CLIN IMMUN, V121, P1013, DOI 10.1016/j.jaci.2007.11.029; Nakajima K, 2013, J INVEST DERMATOL, V133, P2555, DOI 10.1038/jid.2013.199; Namer B, 2008, J NEUROPHYSIOL, V100, P2062, DOI 10.1152/jn.90482.2008; Oh MH, 2013, J IMMUNOL, V191, P5371, DOI 10.4049/jimmunol.1300300; Papoiu ADP, 2012, NEUROIMAGE, V59, P3611, DOI 10.1016/j.neuroimage.2011.10.099; Patel T, 2010, EXPERT OPIN PHARMACO, V11, P1673, DOI 10.1517/14656566.2010.484420; Rau KK, 2009, J NEUROSCI, V29, P8612, DOI 10.1523/JNEUROSCI.1057-09.2009; Reddy VB, 2010, J INVEST DERMATOL, V130, P1468, DOI 10.1038/jid.2009.430; Roberson DP, 2013, NAT NEUROSCI, V16, P910, DOI 10.1038/nn.3404; Ross SE, 2011, CURR OPIN NEUROBIOL, V21, P880, DOI 10.1016/j.conb.2011.10.012; Sabroe I, 2002, CLIN EXP ALLERGY, V32, P984, DOI 10.1046/j.1365-2745.2002.01451.x; Salpietro C, 2011, INT J IMMUNOPATH PH, V24, P33, DOI 10.1177/03946320110240S408; Seike M, 2005, EXP DERMATOL, V14, P169, DOI 10.1111/j.0906-6705.2005.00247.x; Shields SD, 2010, PAIN, V151, P422, DOI 10.1016/j.pain.2010.08.001; Shim WS, 2007, J NEUROSCI, V27, P2331, DOI 10.1523/JNEUROSCI.4643-06.2007; Shimada SG, 2006, EUR J PHARMACOL, V530, P281, DOI 10.1016/j.ejphar.2005.11.012; Stebbins KJ, 2010, EUR J PHARMACOL, V638, P142, DOI 10.1016/j.ejphar.2010.04.031; Stefansson K, 2008, J INVEST DERMATOL, V128, P18, DOI 10.1038/sj.jid.5700965; Steinhoff M, 2003, J NEUROSCI, V23, P6176; Steinhoff M, 1999, EXP DERMATOL, V8, P282; Sukhtankar DD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067422; Sun YG, 2007, NATURE, V448, P700, DOI 10.1038/nature06029; Sun YG, 2009, SCIENCE, V325, P1531, DOI 10.1126/science.1174868; TANI E, 1990, Auris Nasus Larynx, V17, P267; Tominaga M, 2004, J NEUROBIOL, V61, P3, DOI 10.1002/neu.20079; Tsujii K, 2008, J PHARMACOL SCI, V108, P385, DOI 10.1254/jphs.08200SC; Turner MJ, 2013, PEDIATR DERMATOL, V30, P574, DOI 10.1111/pde.12187; Wallace K, 2010, J STEROID BIOCHEM, V120, P137, DOI 10.1016/j.jsbmb.2010.04.012; Wang XD, 2013, NEURON, V78, P312, DOI 10.1016/j.neuron.2013.03.001; Wilson SR, 2013, CELL, V155, P285, DOI 10.1016/j.cell.2013.08.057; Wilson SR, 2013, J NEUROSCI, V33, P9283, DOI 10.1523/JNEUROSCI.5318-12.2013; Wilson SR, 2011, NAT NEUROSCI, V14, P595, DOI 10.1038/nn.2789; Xu Y, 2013, J NEUROSCI, V33, P14738, DOI 10.1523/JNEUROSCI.5512-12.2013; Yilinuer H, 2010, ARCH DERMATOL RES, V302, P19, DOI 10.1007/s00403-009-1006-y; Yockey LJ, 2013, J INVEST DERMATOL, V133, P2714, DOI 10.1038/jid.2013.228; Yoo J, 2005, J EXP MED, V202, P541, DOI 10.1084/jem.20041503; Zhang FX, 2010, J NEUROSCI, V30, P10927, DOI 10.1523/JNEUROSCI.0657-10.2010; Zhao ZQ, 2013, J CLIN INVEST, V123, P4769, DOI 10.1172/JCI70528; Zheng T, 2009, J INVEST DERMATOL, V129, P742, DOI 10.1038/jid.2008.295; Zhou ZR, 2002, J NEUROSCI, V22, P6325; Zhu Y, 2009, BIOL PHARM BULL, V32, P1173, DOI 10.1248/bpb.32.1173; Zylka MJ, 2005, NEURON, V45, P17, DOI 10.1016/j.neuron.2004.12.015	98	219	232	1	92	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2014	17	2					175	182		10.1038/nn.3619	http://dx.doi.org/10.1038/nn.3619			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AA2FH	24473265	Green Accepted			2022-12-17	WOS:000330910000009
J	Migues, PV; Hardt, O; Wu, DC; Gamache, K; Sacktor, TC; Wang, YT; Nader, K				Migues, Paola Virginia; Hardt, Oliver; Wu, Dong Chuan; Gamache, Karine; Sacktor, Todd Charlton; Wang, Yu Tian; Nader, Karim			PKM zeta maintains memories by regulating GluR2-dependent AMPA receptor trafficking	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; TYROSINE PHOSPHORYLATION; SYNAPTIC-TRANSMISSION; HIPPOCAMPAL-NEURONS; RETROGRADE-AMNESIA; PROTEIN-KINASE; GLUR2; NSF; PLASTICITY; AMYGDALA	The maintenance of long-term memory in hippocampus, neocortex and amygdala requires the persistent action of the atypical protein kinase C isoform, protein kinase M zeta (PKM zeta). We found that inactivating PKM zeta in the amygdala impaired fear memory in rats and that the extent of the impairment was positively correlated with a decrease in postsynaptic GluR2. Blocking the GluR2-dependent removal of postsynaptic AMPA receptors abolished the behavioral impairment caused by PKM zeta inhibition and the associated decrease in postsynaptic GluR2 expression, which correlated with performance. Similarly, blocking this pathway for removal of GluR2-containing receptors from postsynaptic sites in amygdala slices prevented the reversal of long-term potentiation caused by inactivating PKM zeta. Similar behavioral results were obtained in the hippocampus for unreinforced recognition memory of object location. Together, these findings indicate that PKM zeta maintains long-term memory by regulating the trafficking of GluR2-containing AMPA receptors, the postsynaptic expression of which directly predicts memory retention.	[Migues, Paola Virginia; Hardt, Oliver; Gamache, Karine; Nader, Karim] McGill Univ, Dept Psychol, Montreal, PQ, Canada; [Wu, Dong Chuan; Wang, Yu Tian] Univ British Columbia, Brain Res Ctr, Vancouver, BC V5Z 1M9, Canada; [Wu, Dong Chuan; Wang, Yu Tian] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Sacktor, Todd Charlton] Suny Downstate Med Ctr, Robert Furchgott Ctr Neural & Behav Sci, Dept Physiol & Pharmacol, Brooklyn, NY 11203 USA; [Sacktor, Todd Charlton] Suny Downstate Med Ctr, Robert Furchgott Ctr Neural & Behav Sci, Dept Neurol, Brooklyn, NY 11203 USA	McGill University; University of British Columbia; University of British Columbia; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Migues, PV (corresponding author), McGill Univ, Dept Psychol, Montreal, PQ, Canada.	virginia.migues@mcgill.ca	Wang, Yu Tian/A-4729-2008; Wang, Yu Tian/J-8255-2015; Wu, Dong Chuan/O-3909-2015	WU, DONG CHUAN/0000-0002-9539-5935	Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; E.W.R. Steacie Foundation; US National Institutes of Health [R01 MH53576, MH57068]; German Research Society; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH057068, R01MH053576, R37MH057068] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); E.W.R. Steacie Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Society(German Research Foundation (DFG)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Canadian Institutes of Health Research and the Natural Sciences and Engineering Research Council of Canada (K.N. and Y.T.W.), the E.W.R. Steacie Foundation (K.N.) and by US National Institutes of Health grants R01 MH53576 and MH57068 (T. C. S.). O.H. was supported by the German Research Society (Deutsche Forschungsgemeinschaft).	Ahmadian G, 2004, EMBO J, V23, P1040, DOI 10.1038/sj.emboj.7600126; Brebner K, 2005, SCIENCE, V310, P1340, DOI 10.1126/science.1116894; Gale GD, 2004, J NEUROSCI, V24, P3810, DOI 10.1523/JNEUROSCI.4100-03.2004; Hanley JG, 2002, NEURON, V34, P53, DOI 10.1016/S0896-6273(02)00638-4; HARDT O, 2009, HIPPOCAMPUS     1005, DOI DOI 10.1002/HIPO.20708; Hayashi T, 2004, J NEUROSCI, V24, P6152, DOI 10.1523/JNEUROSCI.0799-04.2004; Huang YY, 2000, J NEUROSCI, V20, P6317, DOI 10.1523/JNEUROSCI.20-17-06317.2000; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Lee SH, 2004, NEURON, V43, P221, DOI 10.1016/j.neuron.2004.06.015; Ling DSF, 2002, NAT NEUROSCI, V5, P295, DOI 10.1038/nn829; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; McCormack SG, 2006, NEURON, V50, P75, DOI 10.1016/j.neuron.2006.02.027; Migues PV, 2006, J NEUROCHEM, V98, P289, DOI 10.1111/j.1471-4159.2006.03876.x; Mumby DG, 2002, LEARN MEMORY, V9, P49, DOI 10.1101/lm.41302; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Noel J, 1999, NEURON, V23, P365, DOI 10.1016/S0896-6273(00)80786-2; Osten P, 1998, NEURON, V21, P99, DOI 10.1016/S0896-6273(00)80518-8; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Saglietti L, 2007, NEURON, V54, P461, DOI 10.1016/j.neuron.2007.04.012; Serrano P, 2008, PLOS BIOL, V6, P2698, DOI 10.1371/journal.pbio.0060318; Shema R, 2007, SCIENCE, V317, P951, DOI 10.1126/science.1144334; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; Takahashi T, 2003, SCIENCE, V299, P1585, DOI 10.1126/science.1079886; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; WINOCUR G, 1990, BEHAV BRAIN RES, V38, P145, DOI 10.1016/0166-4328(90)90012-4; Xu L, 1998, NATURE, V394, P891, DOI 10.1038/29783; Yao YD, 2008, J NEUROSCI, V28, P7820, DOI 10.1523/JNEUROSCI.0223-08.2008; Yu SY, 2008, J NEUROCHEM, V106, P889, DOI 10.1111/j.1471-4159.2008.05461.x	30	219	226	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2010	13	5					630	U147		10.1038/nn.2531	http://dx.doi.org/10.1038/nn.2531			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	588JM	20383136				2022-12-17	WOS:000277065700022
J	Sun, HS; Jackson, MF; Martin, LJ; Jansen, K; Teves, L; Cui, H; Kiyonaka, S; Mori, Y; Jones, M; Forder, JP; Golde, TE; Orser, BA; MacDonald, JF; Tymianski, M				Sun, Hong-Shuo; Jackson, Michael F.; Martin, Loren J.; Jansen, Karen; Teves, Lucy; Cui, Hong; Kiyonaka, Shigeki; Mori, Yasuo; Jones, Michael; Forder, Joan P.; Golde, Todd E.; Orser, Beverley A.; MacDonald, John F.; Tymianski, Michael			Suppression of hippocampal TRPM7 protein prevents delayed neuronal death in brain ischemia	NATURE NEUROSCIENCE			English	Article							CELL-DEATH; CATION CHANNEL; RECEPTORS; DAMAGE; MODULATION; MAGNESIUM; KINASE; MODEL; NMDA	Cardiac arrest victims may experience transient brain hypoperfusion leading to delayed death of hippocampal CA1 neurons and cognitive impairment. We prevented this in adult rats by inhibiting the expression of transient receptor potential melastatin 7 (TRPM7), a transient receptor potential channel that is essential for embryonic development, is necessary for cell survival and trace ion homeostasis in vitro, and whose global deletion in mice is lethal. TRPM7 was suppressed in CA1 neurons by intrahippocampal injections of viral vectors bearing shRNA specific for TRPM7. This had no ill effect on animal survival, neuronal and dendritic morphology, neuronal excitability, or synaptic plasticity, as exemplified by robust long-term potentiation (LTP). However, TRPM7 suppression made neurons resistant to ischemic death after brain ischemia and preserved neuronal morphology and function. Also, it prevented ischemia-induced deficits in LTP and preserved performance in fear-associated and spatial-navigational memory tasks. Thus, regional suppression of TRPM7 is feasible, well tolerated and inhibits delayed neuronal death in vivo.	[Sun, Hong-Shuo; Teves, Lucy; Cui, Hong; Jones, Michael; Forder, Joan P.; Tymianski, Michael] Toronto Western Hosp, Res Inst, Toronto, ON M5T 2S8, Canada; [Jackson, Michael F.; Orser, Beverley A.; MacDonald, John F.; Tymianski, Michael] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Jackson, Michael F.; MacDonald, John F.] Univ Western Ontario, Robarts Res Inst, London, ON, Canada; [Martin, Loren J.; Orser, Beverley A.; Tymianski, Michael] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada; [Jansen, Karen; Golde, Todd E.] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Kiyonaka, Shigeki; Mori, Yasuo] Kyoto Univ, Mol Biol Lab, Dept Synthet Chem & Biol Chem, Grad Sch Engn, Kyoto, Japan; [Orser, Beverley A.] Sunnybrook Hlth Sci Ctr, Dept Anesthesia, Toronto, ON M4N 3M5, Canada; [Tymianski, Michael] Univ Toronto, Dept Surg, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Western University (University of Western Ontario); University of Toronto; Mayo Clinic; Kyoto University; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto	Tymianski, M (corresponding author), Toronto Western Hosp, Res Inst, Toronto, ON M5T 2S8, Canada.	mike.tymianski@uhn.on.ca	Kiyonaka, Shigeki/AAM-7303-2021; Jackson, Mike/H-5573-2012	Jackson, Mike/0000-0002-4730-201X; Martin, Loren/0000-0003-0579-2441; Tymianski, Mike/0000-0002-6311-9565	Canadian Institute of Health Research [MOP68939, MOP89720, MOP15514]; US National Institutes of Health [NS048956]; Canadian Stroke Networks; Krembil Seed fund; Heart and Stroke Foundation of Canada Focus; Grants-in-Aid for Scientific Research [20249015] Funding Source: KAKEN; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048956] Funding Source: NIH RePORTER	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Stroke Networks; Krembil Seed fund; Heart and Stroke Foundation of Canada Focus(Heart & Stroke Foundation of Canada); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Aarts and W. Czerwinski for technical information, J. C. Roder for advice on MWM testing, and A. Fleig, C. Montell, A. Scharenberg and E. Lo for a critical review of the manuscript. This work was supported by grants from the Canadian Institute of Health Research ( MOP68939 and MOP89720 to M. T. and MOP15514 to J. F. M.), the US National Institutes of Health ( NS048956 to M. T.), the Canadian Stroke Networks ( M. T., J. F. M. and M. F. J.) and the Krembil Seed fund ( M. T.). H.- S. S. is a recipient of Postdoctoral Fellowship Awards from the Heart and Stroke Foundation of Canada Focus on Stroke Training Initiative Program.	Aarts M, 2003, CELL, V115, P863, DOI 10.1016/S0092-8674(03)01017-1; Bennett MVL, 1996, COLD SPRING HARB SYM, V61, P373; Besancon E, 2008, TRENDS PHARMACOL SCI, V29, P268, DOI 10.1016/j.tips.2008.02.003; Block F, 1999, PROG NEUROBIOL, V58, P279, DOI 10.1016/S0301-0082(98)00085-9; Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; Cheng VY, 2006, J NEUROSCI, V26, P3713, DOI 10.1523/JNEUROSCI.5024-05.2006; Corish P, 1999, PROTEIN ENG, V12, P1035, DOI 10.1093/protein/12.12.1035; Davis SM, 1997, LANCET, V349, P32, DOI 10.1016/S0140-6736(05)62166-6; FANSELOW MS, 1980, PAVLOVIAN J BIOL SCI, V15, P177; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Hausenloy DJ, 2007, CLIN PHARMACOL THER, V82, P370, DOI 10.1038/sj.clpt.6100352; Ji JZ, 2007, HIPPOCAMPUS, V17, P749, DOI 10.1002/hipo.20331; Jin J, 2008, SCIENCE, V322, P756, DOI 10.1126/science.1163493; Kaneko S, 2006, J PHARMACOL SCI, V101, P66, DOI 10.1254/jphs.FP0060128; Kozak JA, 2002, J GEN PHYSIOL, V120, P221, DOI 10.1085/jgp.20028601; Kumar R, 2001, J NEUROCHEM, V77, P1418, DOI 10.1046/j.1471-4159.2001.00387.x; Lawlor PA, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-11; Lin MC, 2004, J AM COLL NUTR, V23, p556S, DOI 10.1080/07315724.2004.10719403; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Mastakov MY, 2001, MOL THER, V3, P225, DOI 10.1006/mthe.2001.0246; Monteilh-Zoller MK, 2003, J GEN PHYSIOL, V121, P49, DOI 10.1085/jgp.20028740; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; Morris GF, 1999, J NEUROSURG, V91, P737, DOI 10.3171/jns.1999.91.5.0737; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; PETITO CK, 1987, NEUROLOGY, V37, P1281, DOI 10.1212/WNL.37.8.1281; PULSINELLI WA, 1979, STROKE, V10, P267, DOI 10.1161/01.STR.10.3.267; PULSINELLI WA, 1982, ANN NEUROL, V11, P491, DOI 10.1002/ana.410110509; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Saito A, 2005, MOL NEUROBIOL, V31, P105, DOI 10.1385/MN:31:1-3:105; Schmitz C, 2005, J BIOL CHEM, V280, P37763, DOI 10.1074/jbc.M509175200; Schmitz C, 2003, CELL, V114, P191, DOI 10.1016/S0092-8674(03)00556-7; SIESJO BK, 1994, ADV NEUROLOGY CELLUL; SILVER IA, 1990, J GEN PHYSIOL, V95, P837, DOI 10.1085/jgp.95.5.837; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; Stoll G, 1998, PROG NEUROBIOL, V56, P149, DOI 10.1016/S0301-0082(98)00034-3; Sun HS, 2006, J NEUROPHYSIOL, V95, P2590, DOI 10.1152/jn.00970.2005; Thompson RJ, 2006, SCIENCE, V312, P924, DOI 10.1126/science.1126241; VOLPE BT, 1984, STROKE, V15, P558, DOI 10.1161/01.STR.15.3.558; VOLPE BT, 1985, NEUROLOGY, V35, P1793, DOI 10.1212/WNL.35.12.1793; WANG LY, 1995, J PHYSIOL-LONDON, V486, P83, DOI 10.1113/jphysiol.1995.sp020792; Wei WL, 2007, P NATL ACAD SCI USA, V104, P16323, DOI 10.1073/pnas.0701149104; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Xiong ZG, 2001, J NEUROPHYSIOL, V86, P2520, DOI 10.1152/jn.2001.86.5.2520; Xiong ZG, 1997, P NATL ACAD SCI USA, V94, P7012, DOI 10.1073/pnas.94.13.7012	49	219	228	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2009	12	10					1300	U124		10.1038/nn.2395	http://dx.doi.org/10.1038/nn.2395			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	498US	19734892				2022-12-17	WOS:000270170200019
J	Zhang, WW; Luck, SJ				Zhang, Weiwei; Luck, Steven J.			Feature-based attention modulates feedforward visual processing	NATURE NEUROSCIENCE			English	Article							SELECTIVE ATTENTION; NEURAL MECHANISMS; BRAIN POTENTIALS; COLOR; CORTEX; AREAS; LOCATION; MOTION	It is widely believed that attention selects locations at an earlier stage than it selects nonspatial features, but this has been tested only under conditions of minimal competition. We found that, when competition was increased, color-based attention was able to influence the feedforward flow of information in humans within 100 ms of stimulus onset, even for stimuli presented at unattended locations. Thus, color-based attention can operate as early as, and independently from, spatial attention.	[Zhang, Weiwei; Luck, Steven J.] Univ Calif Davis, Ctr Mind & Brain, Davis, CA 95618 USA; [Luck, Steven J.] Univ Calif Davis, Dept Psychol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Zhang, WW (corresponding author), Univ Calif Davis, Ctr Mind & Brain, 267 Cousteau Pl, Davis, CA 95618 USA.	wwzhang@ucdavis.edu	zhang, weiwei/Q-5199-2019; zhang, weiwei/B-9657-2008	zhang, weiwei/0000-0002-0431-5355; 	US National Institute of Mental Health	US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was made possible by a grant from US National Institute of Mental Health to S.J.L.	Anllo-Vento L, 1998, HUM BRAIN MAPP, V6, P216, DOI 10.1002/(SICI)1097-0193(1998)6:4<216::AID-HBM3>3.0.CO;2-6; AnlloVento L, 1996, PERCEPT PSYCHOPHYS, V58, P191, DOI 10.3758/BF03211875; Boynton GM, 2005, CURR OPIN NEUROBIOL, V15, P465, DOI 10.1016/j.conb.2005.06.009; Chawla D, 1999, NAT NEUROSCI, V2, P671, DOI 10.1038/10230; EIMER M, 1995, BIOL PSYCHOL, V41, P167, DOI 10.1016/0301-0511(95)05139-2; Giesbrecht B, 2003, NEUROIMAGE, V19, P496, DOI 10.1016/S1053-8119(03)00162-9; HILLYARD SA, 1984, PERCEPT PSYCHOPHYS, V36, P185, DOI 10.3758/BF03202679; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; Muller MM, 2006, P NATL ACAD SCI USA, V103, P14250, DOI 10.1073/pnas.0606668103; Saenz M, 2002, NAT NEUROSCI, V5, P631, DOI 10.1038/nn876; Saenz M, 2003, VISION RES, V43, P629, DOI 10.1016/S0042-6989(02)00595-3; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Valdes-Sosa M, 1998, J COGNITIVE NEUROSCI, V10, P137, DOI 10.1162/089892998563743; WOLFE JM, 1994, PSYCHON B REV, V1, P202, DOI 10.3758/BF03200774	15	219	224	1	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2009	12	1					24	25		10.1038/nn.2223	http://dx.doi.org/10.1038/nn.2223			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	388HL	19029890				2022-12-17	WOS:000262010800009
J	Ahmed, EI; Zehr, JL; Schulz, KM; Lorenz, BH; DonCarlos, LL; Sisk, CL				Ahmed, Eman I.; Zehr, Julia L.; Schulz, Kalynn M.; Lorenz, Betty H.; DonCarlos, Lydia L.; Sisk, Cheryl L.			Pubertal hormones modulate the addition of new cells to sexually dimorphic brain regions	NATURE NEUROSCIENCE			English	Article							DENTATE GYRUS; ESTROGEN; NEURONS; DIFFERENTIATION; PROLIFERATION; NUCLEUS	New cells, including neurons, arise in several brain regions during puberty in rats. Sex differences in pubertal addition of cells coincide with adult sexual dimorphisms: for each region, the sex that gains more cells during puberty has a larger volume in adulthood. Removing gonadal hormones before puberty eliminates these sex differences, indicating that gonadal steroids direct the addition of new cells during puberty to maintain and accentuate sexual dimorphisms in the adult brain.	[Ahmed, Eman I.; Zehr, Julia L.; Schulz, Kalynn M.; Sisk, Cheryl L.] Michigan State Univ, Neurosci Program, E Lansing, MI 48824 USA; [Schulz, Kalynn M.; Sisk, Cheryl L.] Michigan State Univ, Dept Psychol, E Lansing, MI 48824 USA; [Lorenz, Betty H.; DonCarlos, Lydia L.] Loyola Univ, Stritch Sch Med, Dept Cell Biol Neurobiol & Anat, Maywood, IL 60153 USA; [Lorenz, Betty H.] Loyola Univ, Stritch Sch Med, Neurosci Program, Maywood, IL 60153 USA	Michigan State University; Michigan State University; Loyola University Chicago; Loyola University Chicago	Sisk, CL (corresponding author), Michigan State Univ, Neurosci Program, 108 Giltner Hall, E Lansing, MI 48824 USA.	sisk@msu.edu	Schulz, Kalynn M/O-6740-2018; Sisk, Cheryl L/C-1199-2012	Schulz, Kalynn M/0000-0001-5001-3721; 	US National Institutes of Health (NIH) [R01 MH-068764, F32 MH-068975, F31 MH-070125]; Michigan State University Foundation; NIH [R01 MH-062588]; Schmitt Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062588, F31MH070125, F32MH068975, R01MH068764] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michigan State University Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Schmitt Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The technical support of J. Venier and L. Rogers is gratefully acknowledged. We thank M. Holmes for her technical and intellectual insight during protocol development. This work was supported by US National Institutes of Health (NIH) R01 MH-068764 (C. L. S.), F32 MH-068975 (J. L. Z.) and F31 MH-070125 (K. M. S.), the Michigan State University Foundation (C. L. S., E. I. A.), NIH R01 MH-062588 (L. L. DC.) and the Schmitt Foundation (B. H. L.).	Cahill L, 2006, NAT REV NEUROSCI, V7, P477, DOI 10.1038/nrn1909; Chung WCJ, 2002, J NEUROSCI, V22, P1027, DOI 10.1523/JNEUROSCI.22-03-01027.2002; Davis EC, 1996, NEUROENDOCRINOLOGY, V63, P142, DOI 10.1159/000126950; de Vries G.J., 2002, HORMONES BRAIN BEHAV, P137, DOI [10.1016/B978, DOI 10.1016/B978-012532104-4/50066-4]; Forger NG, 2006, NEUROSCIENCE, V138, P929, DOI 10.1016/j.neuroscience.2005.07.006; Fowler CD, 2005, J COMP NEUROL, V489, P166, DOI 10.1002/cne.20638; Galea LAM, 2008, BRAIN RES REV, V57, P332, DOI 10.1016/j.brainresrev.2007.05.008; Hoffman GE, 2005, BRAIN RES, V1054, P116, DOI 10.1016/j.brainres.2005.06.082; Killgore WDS, 2004, PERCEPT MOTOR SKILL, V99, P371; Kokoeva MV, 2007, J COMP NEUROL, V505, P209, DOI 10.1002/cne.21492; Lenroot RK, 2006, NEUROSCI BIOBEHAV R, V30, P718, DOI 10.1016/j.neubiorev.2006.06.001; Petersen SL, 2003, BIOL REPROD, V69, P1771, DOI 10.1095/biolreprod.103.019745; Pinos H, 2001, BRAIN RES BULL, V56, P73, DOI 10.1016/S0361-9230(01)00540-8; Sisk CL, 2005, FRONT NEUROENDOCRIN, V26, P163, DOI 10.1016/j.yfrne.2005.10.003; Tanapat P, 1999, J NEUROSCI, V19, P5792, DOI 10.1523/JNEUROSCI.19-14-05792.1999	15	219	219	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2008	11	9					995	997		10.1038/nn.2178	http://dx.doi.org/10.1038/nn.2178			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	341NA	19160494	Green Accepted			2022-12-17	WOS:000258720000006
J	Liss, B; Haeckel, O; Wildmann, J; Miki, T; Seino, S; Roeper, J				Liss, B; Haeckel, O; Wildmann, J; Miki, T; Seino, S; Roeper, J			K-ATP channels promote the differential degeneration of dopaminergic midbrain neurons	NATURE NEUROSCIENCE			English	Article							SENSITIVE POTASSIUM CHANNELS; PARKINSONS-DISEASE; MOUSE MODEL; UNCOUPLING PROTEIN-2; SUBSTANTIA-NIGRA; GENE-EXPRESSION; PROTECTIVE ROLE; DEFICIENT MICE; MECHANISMS; 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE	The selective degeneration of dopaminergic (DA) midbrain neurons in the substantia nigra (SN) is a hallmark of Parkinson disease. DA neurons in the neighboring ventral tegmental area (VTA) are significantly less affected. The mechanisms for this differential vulnerability of DA neurons are unknown. We identified selective activation of ATP-sensitive potassium (K-ATP) channels as a potential mechanism. We show that in response to parkinsonism-inducing toxins, electrophysiological activity of SN DA neurons, but not VTA DA neurons, is lost owing to activation of K-ATP channels. This selective K-ATP channel activation is controlled by differences in mitochondrial uncoupling between SN and VTA DA neurons. Genetic inactivation of the K-ATP channel pore-forming subunit Kir6.2 resulted in a selective rescue of SN but not VTA DA neurons in two mechanistically distinct mouse models of dopaminergic degeneration, the neurotoxicological 1-methyl-4-phenyl- 1,2,3,6-tetrahydropyridine ( MPTP) model and the mutant weaver mouse. Thus, K-ATP channel activation has an unexpected role in promoting death of DA neurons in chronic disease.	Univ Marburg, Dept Physiol, D-35037 Marburg, Germany; Univ Oxford, MRC, Anat Neuropharmacol Unit, Oxford OX1 3TH, England; Univ Oxford, Univ Lab Physiol, Oxford OX1 3PT, England; Univ Grad Sch Med, Kobe, Hyogo 6500017, Japan	Philipps University Marburg; University of Oxford; University of Oxford	Liss, B (corresponding author), Univ Marburg, Dept Physiol, Deutschhausstr 2, D-35037 Marburg, Germany.	birgit.liss@staff.uni-marburg.de	MIKI, Takashi/ABD-3995-2020	MIKI, Takashi/0000-0001-5741-1626; Roeper, Jochen/0000-0003-2145-8742; liss, Birgit/0000-0002-6733-9207				ALBURGES ME, 1993, SYNAPSE, V14, P314, DOI 10.1002/syn.890140409; Andrews ZB, 2005, J NEUROSCI, V25, P184, DOI 10.1523/JNEUROSCI.4269-04.2005; Ashcroft F, 2004, HUM MOL GENET, V13, pR21, DOI 10.1093/hmg/ddh066; Avshalumov MV, 2005, J NEUROSCI, V25, P4222, DOI 10.1523/JNEUROSCI.4701-04.2005; Ballanyi K, 2004, J EXP BIOL, V207, P3201, DOI 10.1242/jeb.01106; Baukrowitz T, 1998, SCIENCE, V282, P1141, DOI 10.1126/science.282.5391.1141; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Brookes PS, 2005, FREE RADICAL BIO MED, V38, P12, DOI 10.1016/j.freeradbiomed.2004.10.016; Bryan J, 2004, DIABETES, V53, pS104, DOI 10.2337/diabetes.53.suppl_3.S104; Conti B, 2005, J NEUROCHEM, V93, P493, DOI 10.1111/j.1471-4159.2005.03052.x; Craft S, 2004, LANCET NEUROL, V3, P169, DOI 10.1016/S1474-4422(04)00681-7; Damier P, 1999, BRAIN, V122, P1437, DOI 10.1093/brain/122.8.1437; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Greenamyre JT, 2004, SCIENCE, V304, P1120, DOI 10.1126/science.1098966; Greene JG, 2005, NEUROBIOL DIS, V18, P19, DOI 10.1016/j.nbd.2004.10.003; Hernandez-Sanchez C, 2001, P NATL ACAD SCI USA, V98, P3549, DOI 10.1073/pnas.051012898; Hoglinger GU, 2003, J NEUROCHEM, V86, P1297, DOI 10.1046/j.1471-4159.2003.01952.x; Horvath TL, 2003, ENDOCRINOLOGY, V144, P2757, DOI 10.1210/en.2003-0163; JIANG C, 1994, J NEUROSCI, V14, P5590; Keuker JIH, 2001, BRAIN RES PROTOC, V7, P211, DOI 10.1016/S1385-299X(01)00064-2; Krauss S, 2005, NAT REV MOL CELL BIO, V6, P248, DOI 10.1038/nrm1592; Langston JW, 1996, NEUROLOGY, V47, pS153, DOI 10.1212/WNL.47.6_Suppl_3.153S; Lin YF, 2004, P NATL ACAD SCI USA, V101, P7799, DOI 10.1073/pnas.0402496101; Lin YF, 2000, EMBO J, V19, P942, DOI 10.1093/emboj/19.5.942; Liss B, 2001, MOL MEMBR BIOL, V18, P117; Liss B, 1999, EMBO J, V18, P833, DOI 10.1093/emboj/18.4.833; Liss B, 2004, TRENDS NEUROSCI, V27, P475, DOI 10.1016/j.tins.2004.06.007; Liss B, 1999, J NEUROSCI, V19, P8839, DOI 10.1523/JNEUROSCI.19-20-08839.1999; Liss B, 2001, EMBO J, V20, P5715, DOI 10.1093/emboj/20.20.5715; Liu YP, 2002, CLIN EXP PHARMACOL P, V29, P305, DOI 10.1046/j.1440-1681.2002.03649.x; MERCURI NB, 1994, J NEUROPHYSIOL, V71, P1165, DOI 10.1152/jn.1994.71.3.1165; Miki T, 1998, P NATL ACAD SCI USA, V95, P10402, DOI 10.1073/pnas.95.18.10402; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; MORATALLA R, 1992, P NATL ACAD SCI USA, V89, P3859, DOI 10.1073/pnas.89.9.3859; Morrison BM, 1998, ANN NEUROL, V44, pS32, DOI 10.1002/ana.410440706; Neuhoff H, 2002, J NEUROSCI, V22, P1290, DOI 10.1523/JNEUROSCI.22-04-01290.2002; O'Rahilly S, 2005, SCIENCE, V307, P370, DOI 10.1126/science.1104346; PATIL N, 1995, NAT GENET, V11, P126, DOI 10.1038/ng1095-126; Petroske E, 2001, NEUROSCIENCE, V106, P589, DOI 10.1016/S0306-4522(01)00295-0; Przedborski S, 2003, ANN NY ACAD SCI, V991, P189; ROFFLERTARLOV S, 1984, NATURE, V307, P62, DOI 10.1038/307062a0; Salthun-Lassalle B, 2004, J NEUROSCI, V24, P5922, DOI 10.1523/JNEUROSCI.5668-03.2004; Schapira AHV, 2001, ADV NEUROL, V86, P155; Seino Y, 2004, EUR J HEART FAIL, V6, P295, DOI 10.1016/j.ejheart.2003.12.009; Tarasov A, 2004, DIABETES, V53, pS113, DOI 10.2337/diabetes.53.suppl_3.S113; Testa CM, 2005, MOL BRAIN RES, V134, P109, DOI 10.1016/j.molbrainres.2004.11.007; Yamada K, 2001, SCIENCE, V292, P1543, DOI 10.1126/science.1059829; Zhou QY, 1995, CELL, V83, P1197, DOI 10.1016/0092-8674(95)90145-0; Zingman LV, 2002, P NATL ACAD SCI USA, V99, P13278, DOI 10.1073/pnas.212315199	49	219	233	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2005	8	12					1742	1751		10.1038/nn1570	http://dx.doi.org/10.1038/nn1570			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	988FC	16299504				2022-12-17	WOS:000233576200024
J	Solecki, DJ; Model, L; Gaetz, J; Kapoor, TM; Hatten, ME				Solecki, DJ; Model, L; Gaetz, J; Kapoor, TM; Hatten, ME			Par6 alpha signaling controls glial-guided neuronal migration	NATURE NEUROSCIENCE			English	Article							CEREBELLAR GRANULE NEURONS; CELL POLARITY; MICROTUBULE DYNAMICS; CYTOPLASMIC DYNEIN; MITOTIC SPINDLES; CAENORHABDITIS-ELEGANS; CEREBRAL-CORTEX; MAMMALIAN-CELLS; ANIMAL-CELLS; C-ELEGANS	Neuronal migrations along glial fibers provide a primary pathway for the formation of cortical laminae. To examine the mechanisms underlying glial-guided migration, we analyzed the dynamics of cytoskeletal and signaling components in living neurons. Migration involves the coordinated two-stroke movement of a perinuclear tubulin 'cage' and the centrosome, with the centrosome moving forward before nuclear translocation. Overexpression of mParalpha disrupts the perinuclear tubulin cage, retargets PKCzeta and gamma-tubulin away from the centrosome, and inhibits centrosomal motion and neuronal migration. Thus, we propose that during neuronal migration the centrosome acts to coordinate cytoskeletal dynamics in response to mParalpha-mediated signaling.	Rockefeller Univ, Dev Neurobiol Lab, New York, NY 10021 USA; Rockefeller Univ, Lab Chem & Cell Biol, New York, NY 10021 USA	Rockefeller University; Rockefeller University	Hatten, ME (corresponding author), Rockefeller Univ, Dev Neurobiol Lab, 1230 York Ave, New York, NY 10021 USA.	hatten@rockefeller.edu	Solecki, David/N-8080-2018		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS015429] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS15429-24A1] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahmad FJ, 2000, NAT CELL BIOL, V2, P276, DOI 10.1038/35010544; Burakov A, 2003, J CELL BIOL, V162, P963, DOI 10.1083/jcb.200305082; Busson S, 1998, CURR BIOL, V8, P541, DOI 10.1016/S0960-9822(98)70208-8; Dujardin DL, 2003, J CELL BIOL, V163, P1205, DOI 10.1083/jcb.200310097; Echeverri CJ, 1996, J CELL BIOL, V132, P617, DOI 10.1083/jcb.132.4.617; EDMONDSON JC, 1987, J NEUROSCI, V7, P1928; ETEMADMOGHADAM B, 1995, CELL, V83, P743, DOI 10.1016/0092-8674(95)90187-6; Etienne-Manneville S, 2003, CURR OPIN CELL BIOL, V15, P67, DOI 10.1016/S0955-0674(02)00005-4; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; GASSER UE, 1990, P NATL ACAD SCI USA, V87, P4543, DOI 10.1073/pnas.87.12.4543; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; GREGORY WA, 1988, J NEUROSCI, V8, P1728; Grill SW, 2001, NATURE, V409, P630, DOI 10.1038/35054572; Hatten ME, 1999, ANNU REV NEUROSCI, V22, P511, DOI 10.1146/annurev.neuro.22.1.511; HATTEN ME, 1985, J CELL BIOL, V100, P384, DOI 10.1083/jcb.100.2.384; Hatten ME, 2002, SCIENCE, V297, P1660, DOI 10.1126/science.1074572; HATTEN ME, 1986, J NEUROSCI, V6, P2676; Henrique D, 2003, CURR OPIN GENET DEV, V13, P341, DOI 10.1016/S0959-437X(03)00077-7; Hirotsune S, 1998, NAT GENET, V19, P333, DOI 10.1038/1221; Kaltschmidt JA, 2002, J CELL SCI, V115, P2257; Komuro H, 1998, J NEUROSCI, V18, P1478; Koonce MP, 1999, EMBO J, V18, P6786, DOI 10.1093/emboj/18.23.6786; Labbe JC, 2003, CURR BIOL, V13, P707, DOI 10.1016/S0960-9822(03)00251-3; MORITZ M, 1995, NATURE, V378, P638, DOI 10.1038/378638a0; Nadarajah B, 2001, NAT NEUROSCI, V4, P143, DOI 10.1038/83967; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; OROURKE NA, 1992, SCIENCE, V258, P299, DOI 10.1126/science.1411527; Paddison Patrick J, 2004, Methods Mol Biol, V265, P85; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; Palazzo AF, 2001, CURR BIOL, V11, P1536, DOI 10.1016/S0960-9822(01)00475-4; Paoletti A, 1996, J CELL SCI, V109, P3089; Piel M, 2001, SCIENCE, V291, P1550, DOI 10.1126/science.1057330; Rakic P, 1996, P NATL ACAD SCI USA, V93, P9218, DOI 10.1073/pnas.93.17.9218; RAKIC P, 1971, J COMP NEUROL, V141, P283, DOI 10.1002/cne.901410303; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; RIVAS RJ, 1995, J NEUROSCI, V15, P981; Rosenblatt J, 2004, CELL, V117, P361, DOI 10.1016/S0092-8674(04)00341-1; Salina D, 2002, CELL, V108, P97, DOI 10.1016/S0092-8674(01)00628-6; SAXTON WM, 1984, J CELL BIOL, V99, P2175, DOI 10.1083/jcb.99.6.2175; Schaefer AW, 2002, J CELL BIOL, V158, P139, DOI 10.1083/jcb.200203038; Severson AF, 2003, J CELL BIOL, V161, P21, DOI 10.1083/jcb.200210171; Sheen VL, 2001, HUM MOL GENET, V10, P1775, DOI 10.1093/hmg/10.17.1775; Smith DS, 2000, NAT CELL BIOL, V2, P767, DOI 10.1038/35041000; Solecki DJ, 2001, NEURON, V31, P557, DOI 10.1016/S0896-6273(01)00395-6; STEUER ER, 1990, NATURE, V345, P266, DOI 10.1038/345266a0; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Tsou MFB, 2003, J CELL BIOL, V160, P845, DOI 10.1083/jcb.200209079; WADSWORTH P, 1986, ANN NY ACAD SCI, V466, P580, DOI 10.1111/j.1749-6632.1986.tb38434.x; Yvon AMC, 2002, MOL BIOL CELL, V13, P1871, DOI 10.1091/mbc.01-11-0539; Zmuda JF, 1998, CELL MOTIL CYTOSKEL, V41, P18, DOI 10.1002/(SICI)1097-0169(1998)41:1<18::AID-CM2>3.0.CO;2-B	50	219	221	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2004	7	11					1195	1203		10.1038/nn1332	http://dx.doi.org/10.1038/nn1332			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866CB	15475953				2022-12-17	WOS:000224749400012
J	Tzounopoulos, T; Kim, Y; Oertel, D; Trussell, LO				Tzounopoulos, T; Kim, Y; Oertel, D; Trussell, LO			Cell-specific, spike timing-dependent plasticities in the dorsal cochlear nucleus	NATURE NEUROSCIENCE			English	Article							SYNAPTIC PLASTICITY; PYRAMIDAL CELLS; NEURONS; CARTWHEEL; EFFICACY; LOCALIZATION; COINCIDENCE; EXPRESSION; DEPRESSION; SYNAPSES	In the dorsal cochlear nucleus, long-term synaptic plasticity can be induced at the parallel fiber inputs that synapse onto both fusiform principal neurons and cartwheel feedforward inhibitory interneurons. Here we report that in mouse fusiform cells, spikes evoked 5 ms after parallel-fiber excitatory postsynaptic potentials (EPSPs) led to long-term potentiation (LTP), whereas spikes evoked 5 ms before EPSPs led to long-term depression (LTD) of the synapse. The EPSP-spike protocol led to LTD in cartwheel cells, but no synaptic changes resulted from the reverse sequence (spike-EPSP). Plasticity in fusiform and cartwheel cells therefore followed Hebbian and anti-Hebbian learning rules, respectively. Similarly, spikes generated by summing EPSPs from different groups of parallel fibers produced LTP in fusiform cells, and LTD in cartwheel cells. LTD could also be induced in glutamatergic inputs of cartwheel cells by pairing parallel-fiber EPSPs with depolarizing glycinergic PSPs from neighboring cartwheel cells. Thus, synaptic learning rules vary with the postsynaptic cell, and may require the interaction of different transmitter systems.	Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97239 USA; Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; Univ Wisconsin, Sch Med, Dept Physiol, Madison, WI 53706 USA	Oregon Health & Science University; Oregon Health & Science University; University of Wisconsin System; University of Wisconsin Madison	Tzounopoulos, T (corresponding author), Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	tzounopo@ohsu.edu	Kim, Yuil/AAA-1103-2020	Kim, Yuil/0000-0001-9271-7073; Oertel, Donata/0000-0001-8416-7470	NIDCD NIH HHS [R01 DC000176] Funding Source: Medline; NINDS NIH HHS [NS28901] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS028901, R01NS028901] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000176] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Beierlein M, 2000, NAT NEUROSCI, V3, P904, DOI 10.1038/78809; Bell CC, 2002, BRAIN BEHAV EVOLUT, V59, P312, DOI 10.1159/000063567; Bell CC, 1997, NATURE, V387, P278, DOI 10.1038/387278a0; BERREBI AS, 1991, ANAT EMBRYOL, V183, P427; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Bilak SR, 1998, SYNAPSE, V28, P251; Chavas J, 2003, J NEUROSCI, V23, P2019; Davis KA, 1996, J NEUROPHYSIOL, V76, P3012, DOI 10.1152/jn.1996.76.5.3012; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; Egger V, 1999, NAT NEUROSCI, V2, P1098, DOI 10.1038/16026; Ehrlich I, 1999, J PHYSIOL-LONDON, V520, P121, DOI 10.1111/j.1469-7793.1999.00121.x; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; Fujino K, 2003, P NATL ACAD SCI USA, V100, P265, DOI 10.1073/pnas.0135345100; Golding NL, 1997, J NEUROPHYSIOL, V78, P248, DOI 10.1152/jn.1997.78.1.248; Golding NL, 1996, J NEUROSCI, V16, P2208; Han VZ, 2000, NEURON, V27, P611, DOI 10.1016/S0896-6273(00)00070-2; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; Maccaferri G, 1998, SCIENCE, V279, P1368, DOI 10.1126/science.279.5355.1368; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; MANIS PB, 1994, J COMP NEUROL, V348, P261, DOI 10.1002/cne.903480208; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; May BJ, 2000, HEARING RES, V148, P74, DOI 10.1016/S0378-5955(00)00142-8; Molitor SC, 1999, J NEUROPHYSIOL, V81, P985, DOI 10.1152/jn.1999.81.3.985; Molitor SC, 2003, J NEUROPHYSIOL, V89, P2225, DOI 10.1152/jn.00709.2002; Neveu D, 1996, NEURON, V16, P619, DOI 10.1016/S0896-6273(00)80081-1; Oertel D, 2004, TRENDS NEUROSCI, V27, P104, DOI 10.1016/j.tins.2003.12.001; Pouille F, 2000, J PHYSIOL-LONDON, V527, P265, DOI 10.1111/j.1469-7793.2000.00265.x; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; Roberts PD, 2000, J COMPUT NEUROSCI, V9, P67, DOI 10.1023/A:1008938428112; Rumsey CC, 2004, J NEUROPHYSIOL, V91, P2273, DOI 10.1152/jn.00900.2003; RYUGO DK, 1995, J COMP NEUROL, V358, P102, DOI 10.1002/cne.903580107; Sjostrom PJ, 2002, CURR OPIN NEUROBIOL, V12, P305, DOI 10.1016/S0959-4388(02)00325-2; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/s0896-6273(01)00542-6; Sutherland DP, 1998, BEHAV BRAIN RES, V97, P1, DOI 10.1016/S0166-4328(98)00008-4; Tao HZW, 2001, NEURON, V31, P569, DOI 10.1016/S0896-6273(01)00393-2; Veruki ML, 2002, J NEUROSCI, V22, P10558; Yao HS, 2001, NEURON, V32, P315, DOI 10.1016/S0896-6273(01)00460-3; Young ED, 2002, SPR HDB AUD, V15, P160; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665; ZHANG S, 1993, J NEUROPHYSIOL, V69, P1384, DOI 10.1152/jn.1993.69.5.1384	40	219	224	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2004	7	7					719	725		10.1038/nn1272	http://dx.doi.org/10.1038/nn1272			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	832NO	15208632				2022-12-17	WOS:000222274400013
J	Li, J; Schiller, D; Schoenbaum, G; Phelps, EA; Daw, ND				Li, Jian; Schiller, Daniela; Schoenbaum, Geoffrey; Phelps, Elizabeth A.; Daw, Nathaniel D.			Differential roles of human striatum and amygdala in associative learning	NATURE NEUROSCIENCE			English	Article							HUMAN BRAIN; REWARD; PREDICTION; STIMULI; WORLD	Although the human amygdala and striatum have both been implicated in associative learning, only the striatum's contribution has been consistently computationally characterized. Using a reversal learning task, we found that amygdala blood oxygen level-dependent activity tracked associability as estimated by a computational model, and dissociated it from the striatal representation of reinforcement prediction error. These results extend the computational learning approach from striatum to amygdala, demonstrating their complementary roles in aversive learning.	[Li, Jian; Phelps, Elizabeth A.; Daw, Nathaniel D.] NYU, Dept Psychol, New York, NY 10003 USA; [Li, Jian; Phelps, Elizabeth A.; Daw, Nathaniel D.] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Schiller, Daniela] Mt Sinai Sch Med, Dept Psychiat, New York, NY USA; [Schiller, Daniela] Mt Sinai Sch Med, Dept Neurosci, New York, NY USA; [Schiller, Daniela] Mt Sinai Sch Med, Friedman Brain Inst, New York, NY USA; [Schoenbaum, Geoffrey] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [Schoenbaum, Geoffrey] Univ Maryland, Sch Med, Dept Psychiat, Baltimore, MD 21201 USA; [Schoenbaum, Geoffrey] Natl Inst Drug Abuse, Intramural Res Program, Baltimore, MD USA	New York University; New York University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Li, J (corresponding author), NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA.	lijian@nyu.edu	Schiller, Daniela/Q-2431-2018	Schiller, Daniela/0000-0002-0357-7724	McKnight Foundation; Human Frontiers Science Program [RGP0036/2009-C]; US National Institutes of Health (NIH) [MH087882]; James S. McDonnell Foundation; NIH [MH080756, DA015718, AG027097]; Seaver Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH087882, R01MH080756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027097] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015718, ZIADA000587] Funding Source: NIH RePORTER	McKnight Foundation; Human Frontiers Science Program(Human Frontier Science Program); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James S. McDonnell Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Seaver Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank P. Glimcher, R. Rutledge and E. DeWitt for discussions and comments. This research was supported by a McKnight Foundation Scholar Award, Human Frontiers Science Program grant RGP0036/2009-C, US National Institutes of Health (NIH) grant MH087882 (part of the CRCNS program, to N.D.D.), a James S. McDonnell Foundation grant and NIH grant MH080756 to E. A. P., and NIH grants DA015718 and AG027097 to G. S. This work was also supported by a Seaver Foundation grant to the Center for Brain Imaging.	Baxter MG, 2002, NAT REV NEUROSCI, V3, P563, DOI 10.1038/nrn875; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Belova MA, 2007, NEURON, V55, P970, DOI 10.1016/j.neuron.2007.08.004; Courville AC, 2006, TRENDS COGN SCI, V10, P294, DOI 10.1016/j.tics.2006.05.004; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; Delgado MR, 2008, PHILOS T R SOC B, V363, P3787, DOI 10.1098/rstb.2008.0161; Holland PC, 1999, TRENDS COGN SCI, V3, P65, DOI 10.1016/S1364-6613(98)01271-6; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; PEARCE JM, 1980, PSYCHOL REV, V87, P532, DOI 10.1037/0033-295X.87.6.532; Phelps, 2009, HUMAN AMYGDALA, P204; Preuschoff K, 2007, ANN NY ACAD SCI, V1104, P135, DOI 10.1196/annals.1390.005; ROBBINS TW, 1989, NEUROSCI BIOBEHAV R, V13, P155, DOI 10.1016/S0149-7634(89)80025-9; Roesch MR, 2010, J NEUROSCI, V30, P2464, DOI 10.1523/JNEUROSCI.5781-09.2010; Schiller D, 2008, J NEUROSCI, V28, P11517, DOI 10.1523/JNEUROSCI.2265-08.2008; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593	15	218	220	1	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2011	14	10					1250	1252		10.1038/nn.2904	http://dx.doi.org/10.1038/nn.2904			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	825EQ	21909088	Green Accepted			2022-12-17	WOS:000295254200012
J	Gu, Y; DeAngelis, GC; Angelaki, DE				Gu, Yong; DeAngelis, Gregory C.; Angelaki, Dora E.			A functional link between area MSTd and heading perception based on vestibular signals	NATURE NEUROSCIENCE			English	Article							SUPERIOR TEMPORAL AREA; STEREOSCOPIC DEPTH-PERCEPTION; INNERVATING OTOLITH ORGANS; SELF-MOTION; OPTIC FLOW; SQUIRREL-MONKEY; EYE-MOVEMENTS; PSYCHOPHYSICAL SENSITIVITY; VESTIBULOOCULAR REFLEX; NEURON RESPONSES	Recent findings of vestibular responses in part of the visual cortex - the dorsal medial superior temporal area (MSTd) - indicate that vestibular signals might contribute to cortical processes that mediate the perception of self-motion. We tested this hypothesis in monkeys trained to perform a fine heading discrimination task solely on the basis of inertial motion cues. The sensitivity of the neuronal responses was typically lower than that of psychophysical performance, and only the most sensitive neurons rivaled behavioral performance. Responses recorded in MSTd were significantly correlated with perceptual decisions, and the correlations were strongest for the most sensitive neurons. These results support a functional link between MSTd and heading perception based on inertial motion cues. These cues seem mainly to be of vestibular origin, as labyrinthectomy produced a marked elevation of psychophysical thresholds and abolished MSTd responses. This study provides evidence that links single-unit activity to spatial perception mediated by vestibular signals, and supports the idea that the role of MSTd in self-motion perception extends beyond optic flow processing.	Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Angelaki, DE (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, 660 S Euclid Ave, St Louis, MO 63110 USA.	angelaki@pcg.wustl.edu		DeAngelis, Gregory/0000-0002-1635-1273	NEI NIH HHS [R01 EY016178-03, EY017866, EY016178, R01 EY017866, R01 EY016178] Funding Source: Medline; NIDCD NIH HHS [R01 DC004260, DC04260] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY016178, R01EY017866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004260] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Angelaki DE, 2005, NAT REV NEUROSCI, V6, P966, DOI 10.1038/nrn1804; Angelaki DE, 2004, J NEUROPHYSIOL, V92, P20, DOI 10.1152/jn.00047.2004; Angelaki DE, 2000, J NEUROPHYSIOL, V84, P2113, DOI 10.1152/jn.2000.84.4.2113; Ben Hamed S, 2003, J NEUROPHYSIOL, V90, P549, DOI 10.1152/jn.00639.2002; Bremmer F, 1999, ANN NY ACAD SCI, V871, P272, DOI 10.1111/j.1749-6632.1999.tb09191.x; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; Britten KH, 2002, CEREB CORTEX, V12, P692, DOI 10.1093/cercor/12.7.692; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Britten KH, 1998, NAT NEUROSCI, V1, P59, DOI 10.1038/259; CELEBRINI S, 1994, J NEUROSCI, V14, P4109; Chen-Huang C, 2006, EXP BRAIN RES, V168, P410, DOI 10.1007/s00221-005-0098-7; Duffy CJ, 1998, J NEUROPHYSIOL, V80, P1816, DOI 10.1152/jn.1998.80.4.1816; DUFFY CJ, 1991, J NEUROPHYSIOL, V65, P1329, DOI 10.1152/jn.1991.65.6.1329; FERNANDEZ C, 1976, J NEUROPHYSIOL, V39, P985, DOI 10.1152/jn.1976.39.5.985; FERNANDEZ C, 1971, J NEUROPHYSIOL, V34, P661, DOI 10.1152/jn.1971.34.4.661; FERNANDEZ C, 1976, J NEUROPHYSIOL, V39, P970, DOI 10.1152/jn.1976.39.5.970; Fukushima K, 1997, EXP BRAIN RES, V117, P1, DOI 10.1007/PL00005786; Goldberg JM, 2000, EXP BRAIN RES, V130, P277, DOI 10.1007/s002210050033; GRUSSER OJ, 1990, J PHYSIOL-LONDON, V430, P537; Gu Y, 2006, J NEUROSCI, V26, P73, DOI 10.1523/JNEUROSCI.2356-05.2006; GU Y, 2006, J VIS, V6, pA409; GUEDRY FE, 1974, HDB SENSORY PHYSL, P1; Harris LR, 2000, EXP BRAIN RES, V135, P12, DOI 10.1007/s002210000504; Heuer HW, 2004, J NEUROPHYSIOL, V91, P1314, DOI 10.1152/jn.00637.2003; KARUNARATNE AD, 2006, SOC NEUR ABSTR; KOMATSU H, 1988, J NEUROPHYSIOL, V60, P580, DOI 10.1152/jn.1988.60.2.580; Lappe M, 1999, TRENDS COGN SCI, V3, P329, DOI 10.1016/S1364-6613(99)01364-9; Lappe M, 1996, J NEUROSCI, V16, P6265; Luna R, 2005, NAT NEUROSCI, V8, P1210, DOI 10.1038/nn1513; NASHNER LM, 1976, EXP BRAIN RES, V26, P59; Newlands SD, 2001, EXP BRAIN RES, V140, P25, DOI 10.1007/s002210100810; Ohmi M, 1996, COGNITIVE BRAIN RES, V5, P87, DOI 10.1016/S0926-6410(96)00044-4; Osborne LC, 2004, J NEUROSCI, V24, P3210, DOI 10.1523/JNEUROSCI.5305-03.2004; Page WK, 2003, J NEUROPHYSIOL, V89, P1994, DOI 10.1152/jn.00493.2002; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; PERRONE JA, 1994, VISION RES, V34, P2917, DOI 10.1016/0042-6989(94)90060-4; Prince SJD, 2000, J NEUROSCI, V20, P3387, DOI 10.1523/JNEUROSCI.20-09-03387.2000; Purushothaman G, 2005, NAT NEUROSCI, V8, P99, DOI 10.1038/nn1373; Raphan T, 2002, EXP BRAIN RES, V145, P1, DOI 10.1007/s00221-002-1067-z; SEUNG HS, 1993, P NATL ACAD SCI USA, V90, P10749, DOI 10.1073/pnas.90.22.10749; Shaikh AG, 2005, J NEUROPHYSIOL, V93, P853, DOI 10.1152/jn.00879.2004; SMITH ST, 2002, SOC NEUR ABSTR; TAKAHASHI K, 2006, SOC NEUR ABSTR; TANAKA K, 1989, J NEUROPHYSIOL, V62, P626, DOI 10.1152/jn.1989.62.3.626; TELFORD L, 1995, EXP BRAIN RES, V104, P502; Uka T, 2005, J NEUROSCI, V25, P10796, DOI 10.1523/JNEUROSCI.1637-05.2005; Uka T, 2004, NEURON, V42, P297, DOI 10.1016/S0896-6273(04)00186-2; Uka T, 2003, J NEUROSCI, V23, P3515; Uka T, 2006, J NEUROSCI, V26, P6791, DOI 10.1523/JNEUROSCI.5435-05.2006; XU HPW, 2006, SOC NEUR ASTR	50	218	222	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2007	10	8					1038	1047		10.1038/nn1935	http://dx.doi.org/10.1038/nn1935			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	194PY	17618278	Green Accepted			2022-12-17	WOS:000248357500018
J	Womelsdorf, T; Anton-Erxleben, K; Pieper, F; Treue, S				Womelsdorf, Thilo; Anton-Erxleben, Katharina; Pieper, Florian; Treue, Stefan			Dynamic shifts of visual receptive fields in cortical area MT by spatial attention	NATURE NEUROSCIENCE			English	Article							FOCUSED ATTENTION; PARIETAL CORTEX; EYE-MOVEMENTS; V4; RESOLUTION; NEURONS; SPACE; LOCALIZATION; MECHANISMS; RESPONSES	Voluntary attention is the top-down selection process that focuses cortical processing resources on the most relevant sensory information. Spatial attention - that is, selection based on stimulus position - alters neuronal responsiveness throughout primate visual cortex. It has been hypothesized that it also changes receptive field profiles by shifting their centers toward attended locations and by shrinking them around attended stimuli. Here we examined, at high resolution, receptive fields in cortical area MT of rhesus macaque monkeys when their attention was directed to different locations within and outside these receptive fields. We found a shift of receptive fields, even far from the current location of attention, accompanied by a small amount of shrinkage. Thus, already in early extrastriate cortex, receptive fields are not static entities but are highly modifiable, enabling the dynamic allocation of processing resources to attended locations and supporting enhanced perception within the focus of attention by effectively increasing the local cortical magnification.	Radboud Univ Nijmegen, FC Donders Ctr Cognit Neuroimaging, NL-6525 EN Nijmegen, Netherlands; German Primate Ctr, Cognit Neurosci Lab, D-37077 Gottingen, Germany	Radboud University Nijmegen; Deutsches Primatenzentrum (DPZ)	Womelsdorf, T (corresponding author), Radboud Univ Nijmegen, FC Donders Ctr Cognit Neuroimaging, Kapittelweg 29, NL-6525 EN Nijmegen, Netherlands.	t.womelsdorf@fcdonders.ru.nl	Womelsdorf, Thilo/C-3096-2015	Womelsdorf, Thilo/0000-0001-6921-4187				Britten KH, 1999, J NEUROSCI, V19, P5074; Carrasco M, 2004, NAT NEUROSCI, V7, P308, DOI 10.1038/nn1194; Carrasco M, 2002, J VISION, V2, DOI 10.1167/2.6.4; Conner CE, 1997, J NEUROSCI, V17, P3201; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; Everling S, 2002, NAT NEUROSCI, V5, P671, DOI 10.1038/nn874; Hamed SB, 2002, CEREB CORTEX, V12, P234, DOI 10.1093/cercor/12.3.234; HAWKINS HL, 1990, J EXP PSYCHOL HUMAN, V16, P802, DOI 10.1037/0096-1523.16.4.802; He S, 1996, NATURE, V383, P334, DOI 10.1038/383334a0; Intriligator J, 2001, COGNITIVE PSYCHOL, V43, P171, DOI 10.1006/cogp.2001.0755; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Krekelberg B, 2003, NEURON, V37, P537, DOI 10.1016/S0896-6273(03)00003-5; LaBerge D, 1997, J EXP PSYCHOL HUMAN, V23, P1380, DOI 10.1037/0096-1523.23.5.1380; Martinez-Trujillo JC, 2004, CURR BIOL, V14, P744, DOI 10.1016/j.cub.2004.04.028; Maunsell JHR, 2001, VISUAL ATTENTION AND CORTICAL CIRCUITS, P103; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; Musseler J, 2002, VIS COGN, V9, P120, DOI 10.1080/13506280143000359; Reynolds JH, 1999, NEURON, V24, P19, DOI 10.1016/S0896-6273(00)80819-3; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Salinas E, 1996, P NATL ACAD SCI USA, V93, P11956, DOI 10.1073/pnas.93.21.11956; Simons DJ, 2005, TRENDS COGN SCI, V9, P16, DOI 10.1016/j.tics.2004.11.006; Suzuki S, 1997, J EXP PSYCHOL HUMAN, V23, P443, DOI 10.1037/0096-1523.23.2.443; Tolias AS, 2001, NEURON, V29, P757, DOI 10.1016/S0896-6273(01)00250-1; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Treue S, 1999, J NEUROSCI, V19, P7591, DOI 10.1523/JNEUROSCI.19-17-07591.1999; Treue S, 2001, TRENDS NEUROSCI, V24, P295, DOI 10.1016/S0166-2236(00)01814-2; Tsal Y, 1999, PSYCHON B REV, V6, P292, DOI 10.3758/BF03212332; Yeshurun Y, 1998, NATURE, V396, P72, DOI 10.1038/23936	30	218	220	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2006	9	9					1156	1160		10.1038/nn1748	http://dx.doi.org/10.1038/nn1748			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	078DE	16906153				2022-12-17	WOS:000240080800017
J	Liu, GS				Liu, GS			Local structural balance and functional interaction of excitatory and inhibitory synapses in hippocampal dendrites	NATURE NEUROSCIENCE			English	Article							VISUAL-CORTEX; QUANTITATIVE DISTRIBUTION; DIRECTION SELECTIVITY; SYNAPTIC PLASTICITY; GABAERGIC SYNAPSES; ACTIVE DENDRITES; PYRAMIDAL CELLS; IN-VIVO; NEURONS; TRANSMISSION	Theoretical and experimental studies on the computation of neural networks suggest that neural computation results from a dynamic interplay of excitatory and inhibitory(E/I) synaptic inputs. Precisely how E/I synapses are organized structurally and functionally to facilitate meaningful interaction remains elusive. Here we show that E/I synapses are regulated across dendritic trees to maintain a constant ratio of inputs in cultured rat hippocampal neurons. This structural arrangement is accompanied by an E/I functional balance maintained by a 'push-pull' feedback regulatory mechanism that is capable of adjusting E/I efficacies in a coordinated fashion. We also found that during activity, inhibitory synapses can determine the impact of adjacent excitatory synapses only if they are colocalized on the same dendritic branch and are activated simultaneously. These fundamental relationships among E/I synapses provide organizational principles relevant to deciphering the structural and functional basis for neural computation within dendritic branches.	MIT, Picower Ctr Learning & Memory, RIKEN,MIT Neurosci Res Ctr, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; MIT, Picower Ctr Learning & Memory, RIKEN,MIT Neurosci Res Ctr, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); RIKEN; Massachusetts Institute of Technology (MIT); RIKEN	Liu, GS (corresponding author), MIT, Picower Ctr Learning & Memory, RIKEN,MIT Neurosci Res Ctr, Dept Brain & Cognit Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	liu@mit.edu	babakinejad, babak/G-2674-2012					Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; BEAULIEU C, 1992, CEREB CORTEX, V2, P295, DOI 10.1093/cercor/2.4.295; BEAULIEU C, 1990, EUR J NEUROSCI, V2, P296, DOI 10.1111/j.1460-9568.1990.tb00421.x; BENARI Y, 1989, J PHYSIOL-LONDON, V416, P303, DOI 10.1113/jphysiol.1989.sp017762; Burrone J, 2002, NATURE, V420, P414, DOI 10.1038/nature01242; BUSH PC, 1994, J NEUROPHYSIOL, V71, P2183, DOI 10.1152/jn.1994.71.6.2183; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Cossart R, 2001, NAT NEUROSCI, V4, P52, DOI 10.1038/82900; Davis GW, 1998, CURR OPIN NEUROBIOL, V8, P149, DOI 10.1016/S0959-4388(98)80018-4; Desai NS, 2002, NAT NEUROSCI, V5, P783, DOI 10.1038/nn878; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; Fried SI, 2002, NATURE, V420, P411, DOI 10.1038/nature01179; Gabbiani F, 2002, NATURE, V420, P320, DOI 10.1038/nature01190; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Johnston D, 2003, PHILOS T ROY SOC B, V358, P667, DOI 10.1098/rstb.2002.1248; Kilman V, 2002, J NEUROSCI, V22, P1328, DOI 10.1523/JNEUROSCI.22-04-01328.2002; Knott GW, 2002, NEURON, V34, P265, DOI 10.1016/S0896-6273(02)00663-3; KOCH C, 1983, P NATL ACAD SCI-BIOL, V80, P2799, DOI 10.1073/pnas.80.9.2799; LARKMAN AU, 1991, J COMP NEUROL, V306, P332, DOI 10.1002/cne.903060209; Leinekugel X, 2002, SCIENCE, V296, P2049, DOI 10.1126/science.1071111; Liu GS, 1999, NEURON, V22, P395, DOI 10.1016/S0896-6273(00)81099-5; LIU GS, 1995, NATURE, V375, P404, DOI 10.1038/375404a0; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; McBain CJ, 2001, NAT REV NEUROSCI, V2, P11, DOI 10.1038/35049047; Megias M, 2001, NEUROSCIENCE, V102, P527, DOI 10.1016/S0306-4522(00)00496-6; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; Morales B, 2002, J NEUROSCI, V22, P8084; Murnick JG, 2002, J NEUROSCI METH, V116, P65, DOI 10.1016/S0165-0270(02)00028-6; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; Paradis S, 2001, NEURON, V30, P737, DOI 10.1016/S0896-6273(01)00326-9; Poirazi P, 2001, NEURON, V29, P779, DOI 10.1016/S0896-6273(01)00252-5; RUMSEY CC, 2003, J NEUROPHYSIOL; SCHULTE F J, 1969, Neuropaediatrie, V1, P36, DOI 10.1055/s-0028-1091862; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; Taylor WR, 2000, SCIENCE, V289, P2347, DOI 10.1126/science.289.5488.2347; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Zhang LI, 2003, NATURE, V424, P201, DOI 10.1038/nature01796	40	218	223	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2004	7	4					373	379		10.1038/nn1206	http://dx.doi.org/10.1038/nn1206			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	807DP	15004561				2022-12-17	WOS:000220482500016
J	Griffiths, TD; Rees, G; Rees, A; Green, GGR; Witton, C; Rowe, D; Buchel, C; Turner, R; Frackowiak, RSJ				Griffiths, TD; Rees, G; Rees, A; Green, GGR; Witton, C; Rowe, D; Buchel, C; Turner, R; Frackowiak, RSJ			Right parietal cortex is involved in the perception of sound movement in humans	NATURE NEUROSCIENCE			English	Article							POSITRON EMISSION TOMOGRAPHY; AUDITORY-CORTEX; RIGHT-HEMISPHERE; ATTENTION; LOCATION; NEURONS; BRAIN; TIME; INTENSITY; MOTION	Changes in the delay (phase) and amplitude of sound at the ears are cues for the analysis of sound movement. The detection of these cues depends on the convergence of the inputs to each ear, a process that first occurs in the brainstem. The conscious perception of these cues is likely to involve higher centers. Using novel stimuli that produce different perceptions of movement in the presence of identical phase and amplitude modulation components, we have demonstrated human brain areas that are active specifically during the perception of sound movement. Both functional magnetic resonance imaging (fMRI) and positron emission tomography (PET) demonstrated the involvement of the right parietal cortex in sound movement perception with these stimuli.	Inst Neurol, Wellcome Dept Cognit Neurol, London WC1N 3BG, England; Med Sch Newcastle Upon Tyne, Dept Physiol Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Med Sch Newcastle Upon Tyne, Dept Clin Neurosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; UCL Natl Hosp Neurol, London WC1N 3BG, England	University of London; University College London; Newcastle University - UK; Newcastle University - UK; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust	Griffiths, TD (corresponding author), Inst Neurol, Wellcome Dept Cognit Neurol, 12 Queen Sq, London WC1N 3BG, England.	t.griffiths@fil.ion.ucl.ac.uk	Rees, Adrian/H-2200-2012; Frackowiak, Richard S/I-1809-2013; Rowe, Dominic B/B-6661-2011; Green, Gary GR/D-3543-2009; Frackowiak, Richard/H-4383-2011; Rees, Geraint/C-1493-2008; Turner, Robert/C-1820-2008	Rees, Adrian/0000-0003-3313-8375; Rowe, Dominic B/0000-0003-0912-2146; Green, Gary GR/0000-0003-1977-7509; Frackowiak, Richard/0000-0002-3151-822X; Rees, Geraint/0000-0002-9623-7007; Turner, Robert/0000-0001-5055-9644; Griffiths, Timothy/0000-0001-8066-4381; Witton, Caroline/0000-0002-5610-4234	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AHISSAR M, 1992, J NEUROPHYSIOL, V67, P203, DOI 10.1152/jn.1992.67.1.203; ALTMAN JA, 1986, HEARING RES, V24, P243, DOI 10.1016/0378-5955(86)90023-7; ANDERSEN RA, 1995, CEREB CORTEX, V5, P457, DOI 10.1093/cercor/5.5.457; BANDETTINI PA, 1998, IN PRESS MAG RES MED; BISIACH E, 1984, BRAIN, V107, P37, DOI 10.1093/brain/107.1.37; Bregman A. S., 1990, AUDITORY SCENE ANAL; BRUGGE JF, 1996, ACOUSTICAL SIGNAL PR; CAVADA C, 1989, J COMP NEUROL, V287, P422, DOI 10.1002/cne.902870403; CORBETTA M, 1993, J NEUROSCI, V13, P1202; Friston K, 1995, HUM BRAIN MAPP, V2, P1; Friston K.J., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Friston KJ, 1996, NEUROIMAGE, V4, P223, DOI 10.1006/nimg.1996.0074; GOLDBERG JAY M., 1968, J NEUROPHYSIOL, V31, P639; GREEN GGR, 1976, J PHYSIOL-LONDON, V260, pP49; Griffiths TD, 1997, J NEUROL NEUROSUR PS, V62, P522, DOI 10.1136/jnnp.62.5.522; Griffiths TD, 1997, BRAIN, V120, P785, DOI 10.1093/brain/120.5.785; GRIFFITHS TD, 1994, CURR BIOL, V4, P892, DOI 10.1016/S0960-9822(00)00198-6; Griffiths TD, 1996, NATURE, V383, P425, DOI 10.1038/383425a0; HAFTER ER, 1972, J ACOUST SOC AM, V51, P1852, DOI 10.1121/1.1913044; IRVINE DRF, 1986, AUDITORY BRAINSTEM R, V7; Makela JP, 1996, EXP BRAIN RES, V110, P446; MIDDLEBROOKS JC, 1994, SCIENCE, V264, P842, DOI 10.1126/science.8171339; MIDDLEBROOKS JC, 1991, ANNU REV PSYCHOL, V42, P135, DOI 10.1146/annurev.ps.42.020191.001031; MOUNTCASTLE VB, 1995, CEREB CORTEX, V5, P377, DOI 10.1093/cercor/5.5.377; Owen AM, 1996, CEREB CORTEX, V6, P31, DOI 10.1093/cercor/6.1.31; Paus T, 1996, NEUROPSYCHOLOGIA, V34, P475, DOI 10.1016/0028-3932(95)00134-4; Penhune VB, 1996, CEREB CORTEX, V6, P661, DOI 10.1093/cercor/6.5.661; PETRIDES M, 1984, J COMP NEUROL, V20, P249; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Pugh KR, 1996, NEUROIMAGE, V4, P159, DOI 10.1006/nimg.1996.0067; SHELIGA BM, 1994, EXP BRAIN RES, V98, P507; SPITZER MW, 1993, J NEUROPHYSIOL, V69, P1245, DOI 10.1152/jn.1993.69.4.1245; STRYBEL TZ, 1989, PERCEPT PSYCHOPHYS, V45, P371, DOI 10.3758/BF03204951; STUMPF E, 1992, EXP BRAIN RES, V88, P158, DOI 10.1007/BF02259137; Talairach P., 1988, STEREOTACTIC COPLANA; Tzourio N, 1997, NEUROIMAGE, V5, P63, DOI 10.1006/nimg.1996.0252; WATSON JDG, 1993, CEREB CORTEX, V3, P79, DOI 10.1093/cercor/3.2.79; WIGHTMAN FL, 1989, J ACOUST SOC AM, V85, P868, DOI 10.1121/1.397558; ZAKARAUSKAS P, 1991, HEARING RES, V52, P233, DOI 10.1016/0378-5955(91)90203-L	40	218	230	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	1998	1	1					74	79		10.1038/276	http://dx.doi.org/10.1038/276			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QA	10195113				2022-12-17	WOS:000076361000022
J	Cohen, MX; Schoene-Bake, JC; Elger, CE; Weber, B				Cohen, Michael X.; Schoene-Bake, Jan-Christoph; Elger, Christian E.; Weber, Bernd			Connectivity-based segregation of the human striatum predicts personality characteristics	NATURE NEUROSCIENCE			English	Article							NOVELTY-SEEKING; BASAL GANGLIA; HIPPOCAMPUS; CORTEX; MODEL	We found that personality characteristics are linked to dissociable connectivity streams in the human brain. Whereas fiber tracts between a subcortical network, including the hippocampus and amygdala, and the ventral striatum predicted individual differences in novelty seeking, tracts between prefrontal cortex and the striatum predicted individual differences in reward dependence. These findings suggest that the strength of limbic-striatal connectivity may, in part, underlie human personality traits.	[Cohen, Michael X.; Schoene-Bake, Jan-Christoph; Elger, Christian E.; Weber, Bernd] Univ Bonn, Dept NeuroCognit, Dept Epileptol, D-53105 Bonn, Germany; [Cohen, Michael X.; Schoene-Bake, Jan-Christoph; Elger, Christian E.; Weber, Bernd] Univ Bonn, Dept NeuroCognit, Life & Brain Ctr, D-53105 Bonn, Germany; [Cohen, Michael X.] Univ Arizona, Dept Psychol, Tucson, AZ 85721 USA	University of Bonn; University of Bonn; University of Arizona	Cohen, MX (corresponding author), Univ Bonn, Dept NeuroCognit, Dept Epileptol, Sigmund Freud Str 25, D-53105 Bonn, Germany.	mikexcohen@gmail.com	Cohen, Michael/A-3092-2016; Cohen, Michael X/H-8748-2019; Weber, Bernd/H-5244-2012	Cohen, Michael/0000-0002-1879-3593; Cohen, Michael X/0000-0002-1879-3593; Weber, Bernd/0000-0002-7811-9605				Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Bhatti AS, 2007, HIPPOCAMPUS, V17, P922, DOI 10.1002/hipo.20310; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; Cohen MX, 2008, EUR J NEUROSCI, V27, P1534, DOI 10.1111/j.1460-9568.2008.06117.x; Cohen MX, 2008, NEUROIMAGE, V39, P1396, DOI 10.1016/j.neuroimage.2007.10.004; Draganski B, 2008, J NEUROSCI, V28, P7143, DOI 10.1523/JNEUROSCI.1486-08.2008; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Haber SN, 2006, J NEUROSCI, V26, P8368, DOI 10.1523/JNEUROSCI.0271-06.2006; Hollerman JR, 2000, PROG BRAIN RES, V126, P193; King-Casas B, 2005, SCIENCE, V308, P78, DOI 10.1126/science.1108062; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Peters JR, 2007, BRAIN RES BULL, V74, P232, DOI 10.1016/j.brainresbull.2007.06.016; ROBBINS TW, 1989, NEUROSCI BIOBEHAV R, V13, P155, DOI 10.1016/S0149-7634(89)80025-9; ROLLS ET, 1994, REV NEUROL-FRANCE, V150, P648; Sheth A, 2008, HIPPOCAMPUS, V18, P169, DOI 10.1002/hipo.20380	15	217	221	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2009	12	1					32	34		10.1038/nn.2228	http://dx.doi.org/10.1038/nn.2228			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	388HL	19029888				2022-12-17	WOS:000262010800012
J	Yanai, A; Huang, K; Kang, RJ; Singaraja, RR; Arstikaitis, P; Gan, L; Orban, PC; Mullard, A; Cowan, CM; Raymond, LA; Drisdel, RC; Green, WN; Ravikumar, B; Rubinsztein, DC; El-Husseini, A; Hayden, MR				Yanai, Anat; Huang, Kun; Kang, Rujun; Singaraja, Roshni R.; Arstikaitis, Pamela; Gan, Lu; Orban, Paul C.; Mullard, Asher; Cowan, Catherine M.; Raymond, Lynn A.; Drisdel, Renaldo C.; Green, William N.; Ravikumar, Brinda; Rubinsztein, David C.; El-Husseini, Alaa; Hayden, Michael R.			Palmitoylation of huntingtin by HIP14 is essential for its trafficking and function	NATURE NEUROSCIENCE			English	Article							YAC128 MOUSE MODEL; MUTANT HUNTINGTIN; PROTEIN PALMITOYLATION; NUCLEAR-LOCALIZATION; INCLUSION-BODIES; PLASMA-MEMBRANE; NEURONAL DEATH; IN-VIVO; DISEASE; PHOSPHORYLATION	Post-translational modification by the lipid palmitate is crucial for the correct targeting and function of many proteins. Here we show that huntingtin (htt) is normally palmitoylated at cysteine 214, which is essential for its trafficking and function. The palmitoylation and distribution of htt are regulated by the palmitoyl transferase huntingtin interacting protein 14 (HIP14). Expansion of the polyglutamine tract of htt, which causes Huntington disease, results in reduced interaction between mutant htt and HIP14 and consequently in a marked reduction in palmitoylation. Mutation of the palmitoylation site of htt, making it palmitoylation resistant, accelerates inclusion formation and increases neuronal toxicity. Downregulation of HIP14 in mouse neurons expressing wild-type and mutant htt increases inclusion formation, whereas overexpression of HIP14 substantially reduces inclusions. These results suggest that the expansion of the polyglutamine tract in htt results in decreased palmitoylation, which contributes to the formation of inclusion bodies and enhanced neuronal toxicity.	Univ British Columbia, Ctr Mol Med & Therapeut, Vancouver, BC V5Z 4H4, Canada; Univ British Columbia, Dept Psychiat, Vancouver, BC V6T 1Z3, Canada; Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA; Addenbrookes Hosp, Cambridge Inst Med Res, Dept Med Genet, Cambridge CB2 2XY, England; British Columbia Childrens Hosp, Childrens & Family Res Inst, Vancouver, BC V5Z 4H4, Canada	University of British Columbia; University of British Columbia; University of Chicago; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; BC Childrens Hospital; University of British Columbia	Hayden, MR (corresponding author), Univ British Columbia, Ctr Mol Med & Therapeut, Vancouver, BC V5Z 4H4, Canada.	alaa@interchange.ubc.ca; mrh@cmmt.ubc.ca	Raymond, Lynn A/A-6664-2010; Hayden, Michael R/D-8581-2011; Raymond, Lynn A./R-6707-2016; Rubinsztein, David C/C-3472-2011; Cowan, Catherine/F-4181-2010	Raymond, Lynn A/0000-0002-8610-1042; Hayden, Michael R/0000-0001-5159-1419; Raymond, Lynn A./0000-0002-8610-1042; Yanai, Anat/0000-0002-0792-6901; Singaraja, Roshni/0000-0002-3418-3867	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043782] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS043782, R01 NS043782-03, R01 NS043782-04, R01 NS043782-01A2, R01 NS043782-02, R01 NS043782-05] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome TrustEuropean Commission)		Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; DIFIGLIA M, 1995, NEURON, V14, P1075, DOI 10.1016/0896-6273(95)90346-1; Drenan RM, 2005, J CELL BIOL, V169, P623, DOI 10.1083/jcb.200502007; Drisdel RC, 2004, J NEUROSCI, V24, P10502, DOI 10.1523/JNEUROSCI.3315-04.2004; Drisdel RC, 2004, BIOTECHNIQUES, V36, P276, DOI 10.2144/04362RR02; El-Husseini AE, 2000, J CELL BIOL, V148, P159, DOI 10.1083/jcb.148.1.159; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; El-Husseini AED, 2002, NAT REV NEUROSCI, V3, P791, DOI 10.1038/nrn940; Ferrante RJ, 2003, J NEUROSCI, V23, P9418; Hackam AS, 1998, J CELL BIOL, V141, P1097, DOI 10.1083/jcb.141.5.1097; Huang K, 2005, CURR OPIN NEUROBIOL, V15, P527, DOI 10.1016/j.conb.2005.08.001; Huang K, 2004, NEURON, V44, P977, DOI 10.1016/j.neuron.2004.11.027; Humbert S, 2002, DEV CELL, V2, P831, DOI 10.1016/S1534-5807(02)00188-0; Janas J, 2006, METHOD ENZYMOL, V406, P593, DOI 10.1016/S0076-6879(06)06046-0; Kalchman MA, 1996, J BIOL CHEM, V271, P19385, DOI 10.1074/jbc.271.32.19385; Kegel KB, 2005, J BIOL CHEM, V280, P36464, DOI 10.1074/jbc.M503672200; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mastroberardino P, 2002, CELL DEATH DIFFER, V9, P873, DOI 10.1038/sj.cdd.4401093; Rakhilin S, 1999, J CELL BIOL, V146, P203; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Sapp E, 1997, ANN NEUROL, V42, P604, DOI 10.1002/ana.410420411; Singaraja RR, 2002, HUM MOL GENET, V11, P2815, DOI 10.1093/hmg/11.23.2815; Slow EJ, 2005, P NATL ACAD SCI USA, V102, P11402, DOI 10.1073/pnas.0503634102; Slow EJ, 2003, HUM MOL GENET, V12, P1555, DOI 10.1093/hmg/ddg169; Soyombo AA, 1997, J BIOL CHEM, V272, P27456, DOI 10.1074/jbc.272.43.27456; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Van Raamsdonk JM, 2005, HUM MOL GENET, V14, P3823, DOI 10.1093/hmg/ddi407; Velier J, 1998, EXP NEUROL, V152, P34, DOI 10.1006/exnr.1998.6832; Verkruyse LA, 1996, J BIOL CHEM, V271, P15831, DOI 10.1074/jbc.271.26.15831; Waelter S, 2001, MOL BIOL CELL, V12, P1393, DOI 10.1091/mbc.12.5.1393; Warby SC, 2005, HUM MOL GENET, V14, P1569, DOI 10.1093/hmg/ddi165; Wellington CL, 1998, J BIOL CHEM, V273, P9158, DOI 10.1074/jbc.273.15.9158; Wheeler VC, 2002, HUM MOL GENET, V11, P633, DOI 10.1093/hmg/11.6.633; Wyttenbach A, 2002, HUM MOL GENET, V11, P1137, DOI 10.1093/hmg/11.9.1137; Zeron MM, 2002, NEURON, V33, P849, DOI 10.1016/S0896-6273(02)00615-3	36	217	224	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2006	9	6					824	831		10.1038/nn1702	http://dx.doi.org/10.1038/nn1702			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	047RA	16699508	Green Accepted			2022-12-17	WOS:000237895200023
J	Khalilov, I; Holmes, GL; Ben-Ari, Y				Khalilov, I; Holmes, GL; Ben-Ari, Y			In vitro formation of a secondary epileptogenic mirror focus by interhippocampal propagation of seizures	NATURE NEUROSCIENCE			English	Article							TEMPORAL-LOBE EPILEPSY; CA3 HIPPOCAMPAL-NEURONS; EXCITATORY ACTIONS; DEVELOPING BRAIN; NMDA RECEPTORS; GABAERGIC INHIBITION; NEONATAL SEIZURES; KAINIC ACID; GABA; ANTAGONISTS	We have determined whether seizures generate an epileptogenic focus in distal structures using an in vitro preparation composed of three independent chambers that accommodate two intact hippocampi and their connecting commissures. This enabled us to apply a convulsive agent to one hippocampus, allow the propagation of a given number of seizures to the other side and block the connections reversibly by applying tetrodotoxin (TTX) to the commissural chamber. The propagation of seizures from the kainate-treated side to the naive side transformed the latter into an independent epileptogenic focus that was capable of generating spontaneous and evoked seizures. The induction mechanism required activation of NMDA receptors and the epileptogenic transformation was associated with long-term alterations in GABAergic synapses, which became excitatory because of a shift in the chloride reversal potential, E-Cl. These data indicate that the excitatory actions of GABA may be a fundamental property of epileptogenic structures.	INSERM, INMED, U29, F-13273 Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Ben-Ari, Y (corresponding author), INSERM, INMED, U29, 163 Route Luminy, F-13273 Marseille, France.	ben-ari@inmed.univ-mrs.fr	Khalilov, Ilgam/B-5267-2015	Khalilov, Ilgam/0000-0002-9468-4778; Ben-Ari, Yehezkel/0000-0001-6208-8480				BARBIN G, 1993, NEUROSCI LETT, V152, P150, DOI 10.1016/0304-3940(93)90505-F; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; BENARI Y, 1985, NEUROSCIENCE, V14, P375, DOI 10.1016/0306-4522(85)90299-4; BENARI Y, 1988, J PHYSIOL-LONDON, V404, P365, DOI 10.1113/jphysiol.1988.sp017294; BENARI Y, 1979, CAN J PHYSIOL PHARM, V57, P1462, DOI 10.1139/y79-218; BENARI Y, 1989, J PHYSIOL-LONDON, V416, P303, DOI 10.1113/jphysiol.1989.sp017762; Bittigau P, 2002, P NATL ACAD SCI USA, V99, P15089, DOI 10.1073/pnas.222550499; CENDES F, 1995, NEUROLOGY, V45, P2058, DOI 10.1212/WNL.45.11.2058; Chen K, 1999, NAT MED, V5, P888, DOI 10.1038/11330; CLANCY RR, 1987, EPILEPSIA, V28, P537, DOI 10.1111/j.1528-1157.1987.tb03685.x; Cohen I, 2002, SCIENCE, V298, P1418, DOI 10.1126/science.1076510; CONSTANTINEPATON M, 1990, ANNU REV NEUROSCI, V13, P129, DOI 10.1146/annurev.neuro.13.1.129; Cossart R, 2001, NAT NEUROSCI, V4, P52, DOI 10.1038/82900; Dzhala VI, 2003, J NEUROSCI, V23, P1840; Esclapez M, 1997, P NATL ACAD SCI USA, V94, P12151, DOI 10.1073/pnas.94.22.12151; Esclapez M, 1999, J COMP NEUROL, V408, P449, DOI 10.1002/(SICI)1096-9861(19990614)408:4<449::AID-CNE1>3.0.CO;2-R; Ganguly K, 2001, CELL, V105, P521, DOI 10.1016/S0092-8674(01)00341-5; HAUSER WA, 1995, NEUROSURG CLIN N AM, V6, P419; Hirsch JC, 1999, NAT NEUROSCI, V2, P499, DOI 10.1038/9142; Holmes GL, 1998, NEURON, V21, P1231, DOI 10.1016/S0896-6273(00)80642-X; Houser CR, 1996, EPILEPSY RES, V26, P207, DOI 10.1016/S0920-1211(96)00054-X; Khalilov I, 1997, NEURON, V19, P743, DOI 10.1016/S0896-6273(00)80956-3; Khalilov I, 1999, DEV NEUROSCI-BASEL, V21, P310, DOI 10.1159/000017380; Khazipov R, 1999, J NEUROPHYSIOL, V81, P921, DOI 10.1152/jn.1999.81.2.921; KOMURO H, 1993, SCIENCE, V260, P95, DOI 10.1126/science.8096653; Leinekugel X, 1997, NEURON, V18, P243, DOI 10.1016/S0896-6273(00)80265-2; Lemos T, 1996, Epilepsy Res Suppl, V12, P137; Louvel J, 2001, NEUROSCIENCE, V105, P803, DOI 10.1016/S0306-4522(01)00247-0; MALENKA RC, 1993, TRENDS NEUROSCI, V16, P521, DOI 10.1016/0166-2236(93)90197-T; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; MODY I, 1987, NATURE, V326, P701, DOI 10.1038/326701a0; MOSHE SL, 1983, DEV BRAIN RES, V7, P81, DOI 10.1016/0165-3806(83)90083-4; MOSHE SL, 1982, DEV BRAIN RES, V4, P67, DOI 10.1016/0165-3806(82)90097-9; NEUMAN R, 1988, BRAIN RES, V459, P265, DOI 10.1016/0006-8993(88)90642-7; RAFIQ A, 1993, J NEUROPHYSIOL, V70, P1962, DOI 10.1152/jn.1993.70.5.1962; RAYMOND AA, 1994, NEUROLOGY, V44, P1841, DOI 10.1212/WNL.44.10.1841; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Shinnar S, 1996, PEDIATRICS, V98, P216; SLOVITER RS, 1987, SCIENCE, V235, P73, DOI 10.1126/science.2879352; STASHEFF SF, 1989, SCIENCE, V245, P648, DOI 10.1126/science.2569762; SZENTE MB, 1994, BRAIN RES, V648, P203, DOI 10.1016/0006-8993(94)91119-3; TROMMER BL, 1990, DEV BRAIN RES, V53, P248, DOI 10.1016/0165-3806(90)90014-P; Villeneuve N, 2000, ANN NEUROL, V47, P729, DOI 10.1002/1531-8249(200006)47:6<729::AID-ANA5>3.3.CO;2-3; Wang C, 2002, DEV BRAIN RES, V139, P59, DOI 10.1016/S0165-3806(02)00536-9; Wieser HG, 2003, J NEUROSURG, V98, P751, DOI 10.3171/jns.2003.98.4.0751	45	217	230	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2003	6	10					1079	1085		10.1038/nn1125	http://dx.doi.org/10.1038/nn1125			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	727AK	14502289				2022-12-17	WOS:000185633600020
J	Egger, V; Feldmeyer, D; Sakmann, B				Egger, V; Feldmeyer, D; Sakmann, B			Coincidence detection and changes of synaptic efficacy in spiny stellate neurons in vat barrel cortex	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; METABOTROPIC GLUTAMATE RECEPTORS; VISUAL-CORTEX; ACTION-POTENTIALS; CALCIUM CURRENTS; AREA CA1; HIPPOCAMPUS; INDUCTION; PLASTICITY; LTD	Paired whole-cell voltage recordings were made from synaptically connected spiny stellate neurons in layer 4 of the barrel field in young (P14) rat somatosensory cortex. When postsynaptic action potentials (APs) followed each of 5 presynaptic APs in a 10- or 20-Hz train by less than 25 ms, subsequent unitary EPSP amplitudes were persistently reduced. Induction of long-term depression (LTD) depended on activation of group II metabotropic glutamate receptors, but not on NMDA or AMPA receptors. Reducing postsynaptic increases in intracellular calcium ([Ca2+](i)) by intracellular loading with a fast- (BAPTA) or a slow- (EGTA) acting Ca2+ buffer blocked synaptic depression. Analysis of EPSP failures suggested mediation of LTD by a reduction in release probability. We propose a mechanism by which coincident activity results in long-lasting reduction of synaptic efficacy between synaptically connected neurons.	Max Planck Inst Med Forsch, Abt Zellphysiol, D-69120 Heidelberg, Germany	Max Planck Society	Feldmeyer, D (corresponding author), Max Planck Inst Med Forsch, Abt Zellphysiol, Jahnstr 29, D-69120 Heidelberg, Germany.		Feldmeyer, Dirk/H-5940-2013	Feldmeyer, Dirk/0000-0002-1716-8972				AGMON A, 1991, NEUROSCIENCE, V41, P365, DOI 10.1016/0306-4522(91)90333-J; [Anonymous], 1949, CLIN PSYCHOL-UK, DOI DOI 10.4324/9781410612403; BARRIONUEVO G, 1983, P NATL ACAD SCI-BIOL, V80, P7347, DOI 10.1073/pnas.80.23.7347; Bear MF, 1996, J PHYSIOL-PARIS, V90, P223, DOI 10.1016/S0928-4257(97)81428-3; Bell CC, 1997, NATURE, V387, P278, DOI 10.1038/387278a0; Bevington PR, 1969, DATA REDUCTION ERROR; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOLSHAKOV VY, 1994, SCIENCE, V264, P1148, DOI 10.1126/science.7909958; BROCHER S, 1992, P NATL ACAD SCI USA, V89, P123, DOI 10.1073/pnas.89.1.123; Choi SK, 1997, J NEUROSCI, V17, P8613; CHRISTIE BR, 1997, NEUROPHYSIOLOGY, V225, P189; CRAIR MC, 1995, NATURE, V375, P325, DOI 10.1038/375325a0; Daniel H, 1998, TRENDS NEUROSCI, V21, P401, DOI 10.1016/S0166-2236(98)01304-6; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; Domenici MR, 1998, P NATL ACAD SCI USA, V95, P8310, DOI 10.1073/pnas.95.14.8310; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Dudek SM, 1996, NEURON, V16, P1097, DOI 10.1016/S0896-6273(00)80136-1; Feldman DE, 1998, NEURON, V21, P347, DOI 10.1016/S0896-6273(00)80544-9; Feldmeyer D, 1999, J PHYSIOL-LONDON, V521, P169, DOI 10.1111/j.1469-7793.1999.00169.x; Huang LQ, 1999, NEUROPHARMACOLOGY, V38, P73, DOI 10.1016/S0028-3908(98)00168-3; JANE DE, 1994, BRIT J PHARMACOL, V112, P809; Jane DE, 1996, NEUROPHARMACOLOGY, V35, P1029, DOI 10.1016/S0028-3908(96)00048-2; KELSO SR, 1986, P NATL ACAD SCI USA, V83, P5326, DOI 10.1073/pnas.83.14.5326; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; Lujan R, 1997, J CHEM NEUROANAT, V13, P219, DOI 10.1016/S0891-0618(97)00051-3; LUND JS, 1984, CEREB CORTEX, V1, P255; LYNCH G, 1983, NATURE, V305, P719, DOI 10.1038/305719a0; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; ManahanVaughan D, 1997, J NEUROSCI, V17, P3303; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MARKRAM H, 1995, J PHYSIOL-LONDON, V485, P1; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; Neveu D, 1996, NEURON, V16, P619, DOI 10.1016/S0896-6273(00)80081-1; Otani S, 1998, J PHYSIOL-LONDON, V511, P761, DOI 10.1111/j.1469-7793.1998.761bg.x; Petralia RS, 1996, NEUROSCIENCE, V71, P949, DOI 10.1016/0306-4522(95)00533-1; ROTHE T, 1994, PFLUG ARCH EUR J PHY, V426, P161, DOI 10.1007/BF00374684; Schiller J, 1998, NAT NEUROSCI, V1, P114, DOI 10.1038/363; SCHUMAN EM, 1991, SCIENCE, V254, P1503, DOI 10.1126/science.1720572; Snedecor GW, 1980, STAT METHODS, V7th; STANTON PK, 1989, NATURE, V339, P215, DOI 10.1038/339215a0; STAUBLI U, 1990, BRAIN RES, V513, P113, DOI 10.1016/0006-8993(90)91096-Y; Stefani A, 1996, MOL NEUROBIOL, V13, P81, DOI 10.1007/BF02740753; Stowell JN, 1999, NEURON, V22, P525, DOI 10.1016/S0896-6273(00)80707-2; Stratford KJ, 1996, NATURE, V382, P258, DOI 10.1038/382258a0; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; Torii N, 1997, NEUROSCIENCE, V79, P317; Tzounopoulos T, 1998, NEURON, V21, P837, DOI 10.1016/S0896-6273(00)80599-1; Wang Y, 1997, J NEUROPHYSIOL, V77, P812, DOI 10.1152/jn.1997.77.2.812	50	217	219	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	1999	2	12					1098	1105		10.1038/16026	http://dx.doi.org/10.1038/16026			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292TA	10570487				2022-12-17	WOS:000085810100014
J	Parhizkar, S; Arzberger, T; Brendel, M; Kleinberger, G; Deussing, M; Focke, C; Nuscher, B; Xiong, M; Ghasemigharagoz, A; Katzmarski, N; Krasemann, S; Lichtenthaler, SF; Muller, SA; Colombo, A; Monasor, LS; Tahirovic, S; Herms, J; Willem, M; Pettkus, N; Butovsky, O; Bartenstein, P; Edbauer, D; Rominger, A; Erturk, A; Grathwohl, SA; Neher, JJ; Holtzman, DM; Meyer-Luehmann, M; Haass, C				Parhizkar, Samira; Arzberger, Thomas; Brendel, Matthias; Kleinberger, Gernot; Deussing, Maximilian; Focke, Carola; Nuscher, Brigitte; Xiong, Monica; Ghasemigharagoz, Alireza; Katzmarski, Natalie; Krasemann, Susanne; Lichtenthaler, Stefan F.; Mueller, Stephan A.; Colombo, Alessio; Monasor, Laura Sebastian; Tahirovic, Sabina; Herms, Jochen; Willem, Michael; Pettkus, Nadine; Butovsky, Oleg; Bartenstein, Peter; Edbauer, Dieter; Rominger, Axel; Ertuerk, Ali; Grathwohl, Stefan A.; Neher, Jonas J.; Holtzman, David M.; Meyer-Luehmann, Melanie; Haass, Christian			Loss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE	NATURE NEUROSCIENCE			English	Article							MOUSE MODEL; MICROGLIAL RESPONSE; BETA; PROTEIN; PET; DEFICIENCY; ACTIVATION; BRAIN; TSPO; IDENTIFICATION	Coding variants in the triggering receptor expressed on myeloid cells 2 (TREM2) are associated with late-onset Alzheimer's disease (AD). We demonstrate that amyloid plaque seeding is increased in the absence of functional Trem2. Increased seeding is accompanied by decreased microglial clustering around newly seeded plaques and reduced plaque-associated apolipoprotein E (ApoE). Reduced ApoE deposition in plaques is also observed in brains of AD patients carrying TREM2 coding variants. Proteomic analyses and microglia depletion experiments revealed microglia as one origin of plaque-associated ApoE. Longitudinal amyloid small animal positron emission tomography demonstrates accelerated amyloidogenesis in Trem2 loss-of-function mutants at early stages, which progressed at a lower rate with aging. These findings suggest that in the absence of functional Trem2, early amyloidogenesis is accelerated due to reduced phagocytic clearance of amyloid seeds despite reduced plaque-associated ApoE.	[Parhizkar, Samira; Kleinberger, Gernot; Nuscher, Brigitte; Willem, Michael; Pettkus, Nadine; Haass, Christian] Ludwig Maximilians Univ Munchen, Fac Med, Biomed Ctr BMC, Chair Metab Biochem, Munich, Germany; [Arzberger, Thomas; Kleinberger, Gernot; Lichtenthaler, Stefan F.; Herms, Jochen; Bartenstein, Peter; Edbauer, Dieter; Rominger, Axel; Haass, Christian] Munich Cluster Syst Neurol SyNergy, Munich, Germany; [Arzberger, Thomas; Lichtenthaler, Stefan F.; Mueller, Stephan A.; Colombo, Alessio; Monasor, Laura Sebastian; Tahirovic, Sabina; Herms, Jochen; Edbauer, Dieter; Haass, Christian] German Ctr Neurodegenerat Dis DZNE Munich, Munich, Germany; [Arzberger, Thomas; Herms, Jochen] Ludwig Maximilians Univ Munchen, Ctr Neuropathol & Prion Res, Munich, Germany; [Arzberger, Thomas] Ludwig Maximilians Univ Munchen, Dept Psychiat & Psychotherapy, Munich, Germany; [Brendel, Matthias; Deussing, Maximilian; Focke, Carola; Bartenstein, Peter; Rominger, Axel] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Nucl Med, Munich, Germany; [Xiong, Monica; Holtzman, David M.] Washington Univ, Sch Med, Dept Neurol, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA; [Xiong, Monica; Holtzman, David M.] Washington Univ, Sch Med, Charles F & Joanne Knight Alzheimers Dis Res Ctr, St Louis, MO USA; [Ghasemigharagoz, Alireza; Ertuerk, Ali] Klinikum Univ Munchen, Inst Stroke & Dementia Res, Munich, Germany; [Katzmarski, Natalie; Meyer-Luehmann, Melanie] Univ Freiburg, Med Ctr, Dept Neurol, Freiburg, Germany; [Katzmarski, Natalie; Meyer-Luehmann, Melanie] Univ Freiburg, Fac Med, Freiburg, Germany; [Krasemann, Susanne; Butovsky, Oleg] Harvard Med Sch, Brigham & Womens Hosp, Ann Romney Ctr Neurol Dis, Dept Neurol, Boston, MA USA; [Krasemann, Susanne] Univ Med Ctr Hamburg Eppendorf, Inst Neuropathol, Hamburg, Germany; [Lichtenthaler, Stefan F.; Mueller, Stephan A.] Tech Univ Munich, Sch Med, Klinikum Rechts Isar, Neuroprote, Munich, Germany; [Lichtenthaler, Stefan F.] Tech Univ Munich, Inst Adv Study, Garching, Germany; [Butovsky, Oleg] Harvard Med Sch, Brigham & Womens Hosp, Evergrande Ctr Immunol Dis, Boston, MA USA; [Grathwohl, Stefan A.; Neher, Jonas J.] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Cellular Neurol, Tubingen, Germany; [Neher, Jonas J.] German Ctr Neurodegenerat Dis DZNE Tubingen, Tubingen, Germany; [Rominger, Axel] Univ Hosp Bern, Inselspital, Dept Nucl Med, Bern, Switzerland	University of Munich; University of Munich; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munich; University of Munich; University of Munich; Washington University (WUSTL); Washington University (WUSTL); University of Munich; University of Freiburg; University of Freiburg; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Hamburg; University Medical Center Hamburg-Eppendorf; Technical University of Munich; Technical University of Munich; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Bern; University Hospital of Bern	Haass, C (corresponding author), Ludwig Maximilians Univ Munchen, Fac Med, Biomed Ctr BMC, Chair Metab Biochem, Munich, Germany.; Haass, C (corresponding author), Munich Cluster Syst Neurol SyNergy, Munich, Germany.; Haass, C (corresponding author), German Ctr Neurodegenerat Dis DZNE Munich, Munich, Germany.; Meyer-Luehmann, M (corresponding author), Univ Freiburg, Med Ctr, Dept Neurol, Freiburg, Germany.; Meyer-Luehmann, M (corresponding author), Univ Freiburg, Fac Med, Freiburg, Germany.	melanie.meyer-luehmann@uniklinik-freiburg.de; christian.haass@mail03.med.uni-muenchen.de	Butovsky, Oleg/ABG-9086-2020; Edbauer, Dieter/M-9906-2019; Neher, Jonas/AAQ-4927-2021; Rominger, Axel/K-5891-2019	Butovsky, Oleg/0000-0003-0186-8867; Edbauer, Dieter/0000-0002-7186-4653; Neher, Jonas/0000-0003-1346-8924; Parhizkar, Samira/0000-0001-5807-190X; Muller, Stephan/0000-0003-3414-307X	Deutsche Forschungsgemeinschaft (DFG) [EXC 1010 SyNergy]; DFG [HA1737/16-1]; Helmholtz-Gemeinschaft Zukunftsthema 'Immunology and Inflammation' [ZT-0027]; PET imaging grant [BR4580/1-1, RO5194/1-1]; Innovative Medicines Initiative 2 Joint Undertaking [115976]; LMUexcellent; MetLife award; Cure Alzheimer's fund; Emmy Noether Program of the DFG [ME 3542/1-1]; Hans and Ilse Breuer Foundation; Ono Pharmaceuticals, Japan; NIH [NS090934, AG047644]; JPB Foundation; Centers of Excellence in neurodegeneration; NIH grant NINDS [R01NS088137]; NIH grant NIH-NIA [R01AG051812, R01AG054672]; Weston Foundation; MRC; European Community's Health Seventh Framework Programme [617198]; Helmholtz-Israel program;  [FOR2290]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RF1NS090934, R01NS090934, R01NS088137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG047644, R01AG051812, R01AG054672] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); Helmholtz-Gemeinschaft Zukunftsthema 'Immunology and Inflammation'; PET imaging grant; Innovative Medicines Initiative 2 Joint Undertaking; LMUexcellent; MetLife award; Cure Alzheimer's fund; Emmy Noether Program of the DFG(German Research Foundation (DFG)); Hans and Ilse Breuer Foundation; Ono Pharmaceuticals, Japan; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JPB Foundation; Centers of Excellence in neurodegeneration; NIH grant NINDS; NIH grant NIH-NIA; Weston Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Community's Health Seventh Framework Programme; Helmholtz-Israel program; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) within the framework of the Munich Cluster for Systems Neurology (EXC 1010 SyNergy), a DFG funded Koselleck Project (HA1737/16-1 to C.H.), by the Helmholtz-Gemeinschaft Zukunftsthema 'Immunology and Inflammation' (ZT-0027 to C.H.), the FOR2290 (to S.F.L. and C.H.), and by a dedicated PET imaging grant to M.B. and A.R. (BR4580/1-1 & RO5194/1-1). This project has received additional funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No. 115976. Startup funding for this project came from LMU<SUP>excellent</SUP>. Additional funding came from the general legacy of S. Ammer, the MetLife award, and the Cure Alzheimer's fund. M.M.-L. is supported by the Emmy Noether Program of the DFG (ME 3542/1-1). M.M.-L. and S.F.L. are supported by the Hans and Ilse Breuer Foundation. S.T. got support from Ono Pharmaceuticals, Japan. D.M.H. is supported by NIH grants NS090934 and AG047644, the JPB Foundation, and the Cure Alzheimer's Fund. S.F.L. is supported by the Centers of Excellence in neurodegeneration and the Helmholtz-Israel program. O.B. is supported by NIH grants NINDS (R01NS088137), NIH-NIA (R01AG051812), NIH-NIA (R01AG054672) and the Cure Alzheimer's Fund. The APPPS1 colony was established from a breeding pair kindly provided by M. Jucker (Hertie-Institute for Clinical Brain Research, University of Tubingen and DZNE-Tubingen). The authors thank M. Colonna for the Trem2<SUP>-/-</SUP> mice. Thanks to the Queen Square Brain Bank for access to tissue: this resource is funded in part by the Weston Foundation and the MRC. D.E. is supported by the European Community's Health Seventh Framework Programme under grant agreement 617198 [DPR-MODELS].	Boutin H, 2015, EUR J NUCL MED MOL I, V42, P503, DOI 10.1007/s00259-014-2939-8; Brendel M, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00008; Brendel M, 2016, J NUCL MED, V57, P954, DOI 10.2967/jnumed.115.167858; Bruderer R, 2016, PROTEOMICS, V16, P2246, DOI 10.1002/pmic.201500488; Butovsky O, 2018, NAT REV NEUROSCI, V19, P622, DOI 10.1038/s41583-018-0057-5; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Chau WF, 2015, NUCL MED BIOL, V42, P711, DOI 10.1016/j.nucmedbio.2015.05.004; Cheng-Hathaway PJ, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0262-8; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Daria A, 2017, EMBO J, V36, P583, DOI 10.15252/embj.201694591; Deussing M, 2018, NEUROIMAGE, V165, P83, DOI 10.1016/j.neuroimage.2017.10.006; Dickens AM, 2014, J NUCL MED, V55, P466, DOI 10.2967/jnumed.113.125625; Fagan AM, 2002, NEUROBIOL DIS, V9, P305, DOI 10.1006/nbdi.2002.0483; Feeney C, 2016, EUR J NUCL MED MOL I, V43, P2201, DOI 10.1007/s00259-016-3444-z; Grathwohl SA, 2009, NAT NEUROSCI, V12, P1361, DOI 10.1038/nn.2432; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Guerreiro RJ, 2013, JAMA NEUROL, V70, P78, DOI 10.1001/jamaneurol.2013.579; Heppner FL, 2005, NAT MED, V11, P146, DOI 10.1038/nm1177; Holtman IR, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0203-5; Huynh TPV, 2017, NEURON, V96, P1013, DOI 10.1016/j.neuron.2017.11.014; James ML, 2017, THERANOSTICS, V7, P1422, DOI 10.7150/thno.17666; Jay TR, 2017, J NEUROSCI, V37, P637, DOI [10.1523/JNEUROSCI.2110-16.2017, 10.1523/JNEUROSCI.2110-16.2016]; Jay TR, 2015, J EXP MED, V212, P287, DOI 10.1084/jem.20142322; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Jucker M, 2013, NATURE, V501, P45, DOI 10.1038/nature12481; Kane MD, 2000, J NEUROSCI, V20, P3606, DOI 10.1523/JNEUROSCI.20-10-03606.2000; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Kleinberger G, 2017, EMBO J, V36, P1837, DOI 10.15252/embj.201796516; Kleinberger G, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009093; Krasemann S, 2017, IMMUNITY, V47, P566, DOI 10.1016/j.immuni.2017.08.008; Lavisse S, 2012, J NEUROSCI, V32, P10809, DOI 10.1523/JNEUROSCI.1487-12.2012; Liao F, 2018, J CLIN INVEST, V128, P2144, DOI 10.1172/JCI96429; Liu CC, 2017, NEURON, V96, P1024, DOI 10.1016/j.neuron.2017.11.013; MA JY, 1994, NATURE, V372, P92, DOI 10.1038/372092a0; Mazaheri F, 2017, EMBO REP, V18, P1186, DOI 10.15252/embr.201743922; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Overhoff F, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00045; Page RM, 2008, J BIOL CHEM, V283, P677, DOI 10.1074/jbc.M708754200; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Sevigny J, 2016, NATURE, V537, P50, DOI 10.1038/nature19323; Sims R, 2017, NAT GENET, V49, P1373, DOI 10.1038/ng.3916; Song WM, 2018, NAT IMMUNOL, V19, P1048, DOI 10.1038/s41590-018-0212-1; Song WM, 2018, J EXP MED, V215, P745, DOI 10.1084/jem.20171529; Sperling R, 2014, NEURON, V84, P608, DOI 10.1016/j.neuron.2014.10.038; Styren SC, 2000, J HISTOCHEM CYTOCHEM, V48, P1223, DOI 10.1177/002215540004800906; Suarez-Calvet M, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aag1767; Turnbull IR, 2006, J IMMUNOL, V177, P3520, DOI 10.4049/jimmunol.177.6.3520; Ulland TK, 2017, CELL, V170, P649, DOI 10.1016/j.cell.2017.07.023; Ulrich JD, 2018, J EXP MED, V215, P1047, DOI 10.1084/jem.20171265; Ulrich JD, 2017, NEURON, V94, P237, DOI 10.1016/j.neuron.2017.02.042; Ulrich JD, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-20; Vomacka L, 2017, EJNMMI RES, V7, DOI 10.1186/s13550-017-0340-x; Wang YM, 2016, J EXP MED, V213, P667, DOI 10.1084/jem.20151948; Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Yeh FL, 2016, NEURON, V91, P328, DOI 10.1016/j.neuron.2016.06.015; Zhang Y, 2016, NEURON, V89, P37, DOI 10.1016/j.neuron.2015.11.013; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]; Ziegler-Waldkirch S, 2018, EMBO J, V37, P167, DOI 10.15252/embj.201797021	60	216	221	8	89	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2019	22	2					191	+		10.1038/s41593-018-0296-9	http://dx.doi.org/10.1038/s41593-018-0296-9			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HI9BQ	30617257	Green Accepted, Green Submitted			2022-12-17	WOS:000456750100006
J	Kolling, N; Wittmann, MK; Behrens, TEJ; Boorman, ED; Mars, RB; Rushworth, MFS				Kolling, Nils; Wittmann, Marco K.; Behrens, Tim E. J.; Boorman, Erie D.; Mars, Rogier B.; Rushworth, Matthew F. S.			Value, search, persistence and model updating in anterior cingulate cortex	NATURE NEUROSCIENCE			English	Article							DECISION-MAKING; FRONTAL-CORTEX; PREFRONTAL CORTEX; NEURAL MECHANISMS; DOUBLE DISSOCIATION; CORTICAL ACTIVITY; NEURONAL-ACTIVITY; STIMULUS-VALUE; CHOICE; DORSAL	Dorsal anterior cingulate cortex (dACC) carries a wealth of value-related information necessary for regulating behavioral flexibility and persistence. It signals error and reward events informing decisions about switching or staying with current behavior. During decision-making, it encodes the average value of exploring alternative choices (search value), even after controlling for response selection difficulty, and during learning, it encodes the degree to which internal models of the environment and current task must be updated. dACC value signals are derived in part from the history of recent reward integrated simultaneously over multiple time scales, thereby enabling comparison of experience over the recent and extended past. Such ACC signals may instigate attentionally demanding and difficult processes such as behavioral change via interactions with prefrontal cortex. However, the signal in dACC that instigates behavioral change need not itself be a conflict or difficulty signal.	[Kolling, Nils; Wittmann, Marco K.; Mars, Rogier B.; Rushworth, Matthew F. S.] Univ Oxford, Dept Expt Psychol, Oxford, England; [Behrens, Tim E. J.; Boorman, Erie D.; Mars, Rogier B.; Rushworth, Matthew F. S.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Neurosci, Ctr Funct MRI Brain MRI, Oxford, England; [Mars, Rogier B.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands	University of Oxford; University of Oxford; Radboud University Nijmegen	Kolling, N (corresponding author), Univ Oxford, Dept Expt Psychol, Oxford, England.	nils.kollling@psy.ox.ac.uk	Mars, Rogier/GWZ-9665-2022; Mars, Rogier/G-2312-2018	Mars, Rogier/0000-0001-6302-8631; Behrens, Timothy/0000-0003-0048-1177; Kolling, Nils/0000-0002-0283-6966; Rushworth, Matthew/0000-0002-5578-9884; Wittmann, Marco/0000-0001-5229-7457	Economic and Social Research Council [1501067] Funding Source: researchfish; Medical Research Council [1022152] Funding Source: researchfish; Wellcome Trust [101092/Z/13/Z] Funding Source: researchfish; Medical Research Council [G0700399, G0400593, G0802146, G0902373] Funding Source: Medline; Wellcome Trust [104765, 101092] Funding Source: Medline; MRC [G0802146, G0400593, G0902373, G0700399] Funding Source: UKRI	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Amemori KI, 2012, NAT NEUROSCI, V15, P776, DOI 10.1038/nn.3088; Amiez C, 2014, CEREB CORTEX, V24, P563, DOI 10.1093/cercor/bhs329; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Behrens TEJ, 2013, TRENDS COGN SCI, V17, P2, DOI 10.1016/j.tics.2012.10.010; Bernacchia A, 2011, NAT NEUROSCI, V14, P366, DOI 10.1038/nn.2752; Blanchard TC, 2014, J NEUROSCI, V34, P646, DOI 10.1523/JNEUROSCI.3151-13.2014; Boorman ED, 2013, J NEUROSCI, V33, P2242, DOI 10.1523/JNEUROSCI.3022-12.2013; Boorman ED, 2009, NEURON, V62, P733, DOI 10.1016/j.neuron.2009.05.014; Buckley MJ, 2009, SCIENCE, V325, P52, DOI 10.1126/science.1172377; Cai XY, 2014, NEURON, V81, P1140, DOI 10.1016/j.neuron.2014.01.008; Cai XY, 2012, J NEUROSCI, V32, P3791, DOI 10.1523/JNEUROSCI.3864-11.2012; Camille N, 2011, J NEUROSCI, V31, P15048, DOI 10.1523/JNEUROSCI.3164-11.2011; Cole MW, 2009, TRENDS NEUROSCI, V32, P566, DOI 10.1016/j.tins.2009.07.001; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; De Martino B, 2013, NAT NEUROSCI, V16, P105, DOI 10.1038/nn.3279; Ebitz RB, 2015, NEURON, V85, P628, DOI 10.1016/j.neuron.2014.12.053; EBLEN F, 1995, J NEUROSCI, V15, P5999; Fellows LK, 2005, BRAIN, V128, P788, DOI 10.1093/brain/awh405; Friedman A, 2015, CELL, V161, P1320, DOI 10.1016/j.cell.2015.04.049; Haber SN, 2006, J NEUROSCI, V26, P8368, DOI 10.1523/JNEUROSCI.0271-06.2006; Hare TA, 2011, P NATL ACAD SCI USA, V108, P18120, DOI 10.1073/pnas.1109322108; Hayden BY, 2011, NAT NEUROSCI, V14, P933, DOI 10.1038/nn.2856; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI [10.1037//0033-295X.109.4.679, 10.1037/0033-295X.109.4.679]; Hunt LT, 2012, NAT NEUROSCI, V15, P470, DOI 10.1038/nn.3017; Ito S, 2003, SCIENCE, V302, P120, DOI 10.1126/science.1087847; Karlsson MP, 2012, SCIENCE, V338, P135, DOI 10.1126/science.1226518; Kennerley SW, 2006, NAT NEUROSCI, V9, P940, DOI 10.1038/nn1724; Kennerley SW, 2011, NAT NEUROSCI, V14, P1581, DOI 10.1038/nn.2961; Kennerley SW, 2009, J COGNITIVE NEUROSCI, V21, P1162, DOI 10.1162/jocn.2009.21100; Klein-Flugge MC, 2013, J NEUROSCI, V33, P3202, DOI 10.1523/JNEUROSCI.2532-12.2013; Kolling N, 2014, NEURON, V81, P1190, DOI 10.1016/j.neuron.2014.01.033; Kolling N, 2012, SCIENCE, V336, P95, DOI 10.1126/science.1216930; Lebreton M, 2015, NAT NEUROSCI, V18, P1159, DOI 10.1038/nn.4064; Logiaco L, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002222; Luk CH, 2013, J NEUROSCI, V33, P1864, DOI 10.1523/JNEUROSCI.4920-12.2013; Mansouri FA, 2007, SCIENCE, V318, P987, DOI 10.1126/science.1146384; Mars RB, 2009, J NEUROSCI, V29, P6926, DOI 10.1523/JNEUROSCI.1396-09.2009; McGuire JT, 2015, NAT NEUROSCI, V18, P760, DOI 10.1038/nn.3994; Meder D, 2016, J NEUROSCI, V36, P5417, DOI 10.1523/JNEUROSCI.3191-15.2016; Nakamura K, 2005, J NEUROPHYSIOL, V93, P884, DOI 10.1152/jn.00305.2004; Narayanan NS, 2013, NAT NEUROSCI, V16, P1888, DOI 10.1038/nn.3549; Neubert FX, 2015, P NATL ACAD SCI USA, V112, pE2695, DOI 10.1073/pnas.1410767112; Neubert FX, 2014, NEURON, V81, P700, DOI 10.1016/j.neuron.2013.11.012; O'Reilly JX, 2013, P NATL ACAD SCI USA, V110, pE3660, DOI 10.1073/pnas.1305373110; O'Reilly JX, 2013, P NATL ACAD SCI USA, V110, P13982, DOI 10.1073/pnas.1305062110; Passingham R.E.P., 2012, NEUROBIOLOGY PREFRON; Pearson JM, 2014, NEURON, V82, P950, DOI 10.1016/j.neuron.2014.04.037; Phillips JM, 2014, NEUROIMAGE, V97, P308, DOI 10.1016/j.neuroimage.2014.04.028; PORRINO LJ, 1982, J COMP NEUROL, V205, P63, DOI 10.1002/cne.902050107; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Procyk E, 2016, CEREB CORTEX, V26, P467, DOI 10.1093/cercor/bhu213; Quilodran R, 2008, NEURON, V57, P314, DOI 10.1016/j.neuron.2007.11.031; Rudebeck PH, 2006, NAT NEUROSCI, V9, P1161, DOI 10.1038/nn1756; Rudebeck PH, 2013, NEURON, V80, P1519, DOI 10.1016/j.neuron.2013.09.036; Rushworth MFS, 2003, J COGNITIVE NEUROSCI, V15, P338, DOI 10.1162/089892903321593072; Scholl J, 2015, J NEUROSCI, V35, P11233, DOI 10.1523/JNEUROSCI.0396-15.2015; Seo H, 2007, J NEUROSCI, V27, P8366, DOI 10.1523/JNEUROSCI.2369-07.2007; Shenhav A, 2014, NAT NEUROSCI, V17, P1249, DOI 10.1038/nn.3771; Shenhav A, 2013, NEURON, V79, P217, DOI 10.1016/j.neuron.2013.07.007; Sheth SA, 2012, NATURE, V488, P218, DOI 10.1038/nature11239; Shidara M, 2002, SCIENCE, V296, P1709, DOI 10.1126/science.1069504; Shima K, 1998, SCIENCE, V282, P1335, DOI 10.1126/science.282.5392.1335; Stoll FM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11990; Strait CE, 2014, NEURON, V82, P1357, DOI 10.1016/j.neuron.2014.04.032; Strick PL, 1998, NOVART FDN SYMP, V218, P64; STRICK PL, 1998, NOVART FDN SYMP, V218, P104; STRICK PL, 1998, NOVART FDN SYMP, V218, P75; Tervo DGR, 2014, CELL, V159, P21, DOI 10.1016/j.cell.2014.08.037; THALER D, 1995, EXP BRAIN RES, V102, P445; Van Hoesen G. W. M., 1993, NEUROBIOLOGY CINGULA, P249, DOI DOI 10.1007/978-1-4899-6704-6_9; Vogt B., 2009, CINGULATE NEUROBIOLO; Voloh B, 2015, P NATL ACAD SCI USA, V112, P8457, DOI 10.1073/pnas.1500438112; Wang XJ, 2008, NEURON, V60, P215, DOI 10.1016/j.neuron.2008.09.034; Warren CM, 2015, J PHYSIOL-PARIS, V109, P87, DOI 10.1016/j.jphysparis.2014.08.008; Wittmann MK, 2016, NEURON, V91, P482, DOI 10.1016/j.neuron.2016.06.022; Wittmann MK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12327	77	216	217	4	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2016	19	10					1280	1285		10.1038/nn.4382	http://dx.doi.org/10.1038/nn.4382			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DX7ER	27669988	Green Accepted, Green Submitted			2022-12-17	WOS:000384549900007
J	Deneve, S; Machens, CK				Deneve, Sophie; Machens, Christian K.			Efficient codes and balanced networks	NATURE NEUROSCIENCE			English	Review							SPATIAL WORKING-MEMORY; IN-VIVO; ORIENTATION SELECTIVITY; CORTICAL MICROCIRCUITRY; SYNAPTIC MECHANISMS; INHIBITORY NEURONS; EXCITATION; DYNAMICS; CORTEX; STATE	Recent years have seen a growing interest in inhibitory interneurons and their circuits. A striking property of cortical inhibition is how tightly it balances excitation. Inhibitory currents not only match excitatory currents on average, but track them on a millisecond time scale, whether they are caused by external stimuli or spontaneous fluctuations. We review, together with experimental evidence, recent theoretical approaches that investigate the advantages of such tight balance for coding and computation. These studies suggest a possible revision of the dominant view that neurons represent information with firing rates corrupted by Poisson noise. Instead, tight excitatory/inhibitory balance may be a signature of a highly cooperative code, orders of magnitude more precise than a Poisson rate code. Moreover, tight balance may provide a template that allows cortical neurons to construct high-dimensional population codes and learn complex functions of their inputs.	[Deneve, Sophie] Ecole Normale Super, Cognit Neurosci Lab, 24 Rue Lhomond, F-75231 Paris, France; [Machens, Christian K.] Champalimaud Ctr Unknown, Lisbon, Portugal	UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Fundacao Champalimaud	Deneve, S (corresponding author), Ecole Normale Super, Cognit Neurosci Lab, 24 Rue Lhomond, F-75231 Paris, France.; Machens, CK (corresponding author), Champalimaud Ctr Unknown, Lisbon, Portugal.	sophie.deneve@ens.fr; christian.machens@neuro.fchampalimaud.org		Machens, Christian/0000-0003-1717-1562				Abbott LF, 2016, NAT NEUROSCI, V19, P350, DOI 10.1038/nn.4241; ABELES M, 1982, ISRAEL J MED SCI, V18, P83; Adrian ED, 1926, J PHYSIOL-LONDON, V61, P151, DOI 10.1113/jphysiol.1926.sp002281; Amit DJ, 1997, CEREB CORTEX, V7, P237, DOI 10.1093/cercor/7.3.237; Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; Atallah BV, 2009, NEURON, V62, P566, DOI 10.1016/j.neuron.2009.04.027; Barrett D. G. T., 2015, PREPRINT; Barrett DGT, 2013, ADV NEURAL INFORM PR, V26, P1538; Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; Boerlin M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003258; Boerlin M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001080; Bourdoukan R., ADV NEURAL IN PRESS; Bourdoukan R, 2012, ADV NEURAL INFORM PR, V25, P2285; Brunel N, 2000, J COMPUT NEUROSCI, V8, P183, DOI 10.1023/A:1008925309027; Cardin JA, 2007, J NEUROSCI, V27, P10333, DOI 10.1523/JNEUROSCI.1692-07.2007; Chalk M., 2015, PREPRINT, DOI [10.1101/034736, DOI 10.1101/034736]; Churchland MM, 2012, NATURE, V487, P51, DOI 10.1038/nature11129; Cohen MR, 2011, NAT NEUROSCI, V14, P811, DOI 10.1038/nn.2842; Compte A, 2000, CEREB CORTEX, V10, P910, DOI 10.1093/cercor/10.9.910; D'amour JA, 2015, NEURON, V86, P514, DOI 10.1016/j.neuron.2015.03.014; Dayan P., 2001, THEORETICAL NEUROSCI, P806; Destexhe A, 2003, NAT REV NEUROSCI, V4, P739, DOI 10.1038/nrn1198; Dorrn AL, 2010, NATURE, V465, P932, DOI 10.1038/nature09119; Fino E, 2011, NEURON, V69, P1188, DOI 10.1016/j.neuron.2011.02.025; Fiser J, 2010, TRENDS COGN SCI, V14, P119, DOI 10.1016/j.tics.2010.01.003; Froemke RC, 2007, NATURE, V450, P425, DOI 10.1038/nature06289; Froemke RC, 2013, NAT NEUROSCI, V16, P79, DOI 10.1038/nn.3274; Gentet LJ, 2010, NEURON, V65, P422, DOI 10.1016/j.neuron.2010.01.006; Graupner M, 2013, J NEUROSCI, V33, P15075, DOI 10.1523/JNEUROSCI.0347-13.2013; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; Haider B, 2013, NATURE, V493, P97, DOI 10.1038/nature11665; Hansel D, 2013, J NEUROSCI, V33, P133, DOI 10.1523/JNEUROSCI.3455-12.2013; Harvey CD, 2012, NATURE, V484, P62, DOI 10.1038/nature10918; Hennequin G, 2014, NEURON, V82, P1394, DOI 10.1016/j.neuron.2014.04.045; HOPFIELD JJ, 1995, NATURE, V376, P33, DOI 10.1038/376033a0; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027; Jaeger H., 2001, 148 GMD GERM NAT RES, V148, P13; Kerlin AM, 2010, NEURON, V67, P858, DOI 10.1016/j.neuron.2010.08.002; Lim S, 2014, J NEUROSCI, V34, P6790, DOI 10.1523/JNEUROSCI.4602-13.2014; Lim S, 2013, NAT NEUROSCI, V16, P1306, DOI 10.1038/nn.3492; Liu BH, 2011, NEURON, V71, P542, DOI 10.1016/j.neuron.2011.06.017; Liu BH, 2009, J NEUROSCI, V29, P10520, DOI 10.1523/JNEUROSCI.1915-09.2009; London M, 2010, NATURE, V466, P123, DOI 10.1038/nature09086; Maass W, 2002, NEURAL COMPUT, V14, P2531, DOI 10.1162/089976602760407955; Marlin BJ, 2015, NATURE, V520, P499, DOI 10.1038/nature14402; Martinez LM, 2002, J PHYSIOL-LONDON, V540, P321, DOI 10.1113/jphysiol.2001.012776; Mello GBM, 2015, CURR BIOL, V25, P1113, DOI 10.1016/j.cub.2015.02.036; Monier C, 2008, J NEUROSCI METH, V169, P323, DOI 10.1016/j.jneumeth.2007.11.008; Monier C, 2003, NEURON, V37, P663, DOI 10.1016/S0896-6273(03)00064-3; Monteforte M, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.268104; Moreno-Bote R, 2015, SCI REP-UK, V5, DOI 10.1038/srep17531; Murphy BK, 2009, NEURON, V61, P635, DOI 10.1016/j.neuron.2009.02.005; Niell CM, 2010, NEURON, V65, P472, DOI 10.1016/j.neuron.2010.01.033; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Okun M, 2008, NAT NEUROSCI, V11, P535, DOI 10.1038/nn.2105; Packer AM, 2013, CEREB CORTEX, V23, P2790, DOI 10.1093/cercor/bhs210; Perkel D. H., 1968, NEUROSCI RES PROG B, V6, P220; Poirazi P, 2003, NEURON, V37, P989, DOI 10.1016/S0896-6273(03)00149-1; Poo C, 2009, NEURON, V62, P850, DOI 10.1016/j.neuron.2009.05.022; Ren M, 2007, SCIENCE, V316, P758, DOI 10.1126/science.1135468; Renart A, 2010, SCIENCE, V327, P587, DOI 10.1126/science.1179850; Rieke F., 1997, SPIKES EXPLORING NEU; Runyan CA, 2010, NEURON, V67, P847, DOI 10.1016/j.neuron.2010.08.006; Salkoff DB, 2015, J NEUROSCI, V35, P10236, DOI 10.1523/JNEUROSCI.0828-15.2015; Schwemmer MA, 2015, J NEUROSCI, V35, P10112, DOI 10.1523/JNEUROSCI.4951-14.2015; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; SOFTKY WR, 1993, J NEUROSCI, V13, P334; Stettler DD, 2009, NEURON, V63, P854, DOI 10.1016/j.neuron.2009.09.005; Tan AYY, 2013, NEUROSCIENCE, V247, P364, DOI 10.1016/j.neuroscience.2013.05.037; Tan AYY, 2009, NEUROSCIENCE, V163, P1302, DOI 10.1016/j.neuroscience.2009.07.032; Tan AYY, 2011, J NEUROSCI, V31, P12339, DOI 10.1523/JNEUROSCI.2039-11.2011; Tan AYY, 2004, J NEUROPHYSIOL, V92, P630, DOI 10.1152/jn.01020.2003; Thalmeier D., 2015, PREPRINT; van Vreeswijk C, 1998, NEURAL COMPUT, V10, P1321, DOI 10.1162/089976698300017214; vanVreeswijk C, 1996, SCIENCE, V274, P1724, DOI 10.1126/science.274.5293.1724; Vogels TP, 2011, SCIENCE, V334, P1569, DOI 10.1126/science.1211095; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Wilent WB, 2005, NAT NEUROSCI, V8, P1364, DOI 10.1038/nn1545; Wu GK, 2008, NEURON, V58, P132, DOI 10.1016/j.neuron.2008.01.035; Xue MS, 2014, NATURE, V511, P596, DOI 10.1038/nature13321; Yu JN, 2010, NEURON, V68, P1187, DOI 10.1016/j.neuron.2010.11.027; Zhou M, 2014, NAT NEUROSCI, V17, P841, DOI 10.1038/nn.3701	85	216	218	4	74	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2016	19	3					375	382		10.1038/nn.4243	http://dx.doi.org/10.1038/nn.4243			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DE7MU	26906504				2022-12-17	WOS:000370822200006
J	Bakker, J; De Mees, C; Douhard, Q; Balthazart, J; Gabant, P; Szpirer, J; Szpirer, C				Bakker, J; De Mees, C; Douhard, Q; Balthazart, J; Gabant, P; Szpirer, J; Szpirer, C			Alpha-fetoprotein protects the developing female mouse brain from masculinization and defeminization by estrogens	NATURE NEUROSCIENCE			English	Article							PROGESTERONE-RECEPTOR EXPRESSION; MEDIATING MATING BEHAVIOR; CENTRAL NERVOUS-SYSTEM; TREATED MALE-RATS; SEXUAL-DIFFERENTIATION; FEMININE BEHAVIOR; MICE LACKING; GENE; VASOPRESSIN; ESTRADIOL	Two clearly opposing views exist on the function of alpha-fetoprotein ( AFP), a fetal plasma protein that binds estrogens with high affinity, in the sexual differentiation of the rodent brain. AFP has been proposed to either prevent the entry of estrogens or to actively transport estrogens into the developing female brain. The availability of Afp mutant mice ( Afp(-/-)) now finally allows us to resolve this longstanding controversy concerning the role of AFP in brain sexual differentiation, and thus to determine whether prenatal estrogens contribute to the development of the female brain. Here we show that the brain and behavior of female Afp(-/-) mice were masculinized and defeminized. However, when estrogen production was blocked by embryonic treatment with the aromatase inhibitor 1,4,6-androstatriene-3,17-dione, the feminine phenotype of these mice was rescued. These results clearly demonstrate that prenatal estrogens masculinize and defeminize the brain and that AFP protects the female brain from these effects of estrogens.	Univ Liege, Ctr Cellular & Mol Neurobiol, B-4000 Cointe Ougree, Belgium; Univ Libre Bruxelles, Inst Biol & Med Mol, Dev Biol Lab, B-6041 Gosselies, Belgium	University of Liege; Universite Libre de Bruxelles	Bakker, J (corresponding author), Univ Liege, Ctr Cellular & Mol Neurobiol, Ave Hop 1,B36, B-4000 Cointe Ougree, Belgium.	jbakker@ulg.ac.be			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD044897] Funding Source: NIH RePORTER; NICHD NIH HHS [HD044897] Funding Source: Medline; NIMH NIH HHS [MH50388] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ANDREWS GK, 1982, J BIOL CHEM, V257, P5148; AUSSEL C, 1978, J STEROID BIOCHEM, V9, P547, DOI 10.1016/0022-4731(78)90121-8; Bakker J, 2002, J NEUROSCI, V22, P9104; BAKKER J, 1993, BEHAV NEUROSCI, V107, P480, DOI 10.1037/0735-7044.107.3.480; BAUM MJ, 1979, NEUROSCI BIOBEHAV R, V3, P265, DOI 10.1016/0149-7634(79)90013-7; Bennett JA, 2002, P NATL ACAD SCI USA, V99, P2211, DOI 10.1073/pnas.251667098; BENNO RH, 1978, BRAIN RES, V142, P182; de Vries GJ, 1998, PROG BRAIN RES, V119, P3; De Vries GJ, 2002, J NEUROSCI, V22, P9005; DEMEES C, IN PRESS CELL MOL BI; DOHLER KD, 1984, PROG BRAIN RES, V61, P99; Dominguez-Salazar E, 2004, HORM BEHAV, V46, P482, DOI 10.1016/j.yhbeh.2004.05.006; FEDER HH, 1965, SCIENCE, V147, P306, DOI 10.1126/science.147.3655.306; Fitch RH, 1998, BEHAV BRAIN SCI, V21, P311, DOI 10.1017/S0140525X98001216; Gabant P, 2002, P NATL ACAD SCI USA, V99, P12865, DOI 10.1073/pnas.202215399; GERALL AA, 1973, J COMP PHYSIOL PSYCH, V82, P449, DOI 10.1037/h0034113; Gillespie JR, 2000, BBA-PROTEIN STRUCT M, V1480, P41, DOI 10.1016/S0167-4838(00)00104-7; GRADY KL, 1965, J COMP PHYSIOL PSYCH, V59, P176, DOI 10.1037/h0021824; Han TM, 2003, J NEUROBIOL, V54, P502, DOI 10.1002/neu.10157; Lonstein JS, 1999, J NEUROENDOCRINOL, V11, P441; MACLUSKY NJ, 1981, SCIENCE, V211, P1294, DOI 10.1126/science.6163211; MCCALL AL, 1981, J REPROD FERTIL, V61, P103, DOI 10.1530/jrf.0.0610103; McCarthy MM, 2005, FRONT NEUROENDOCRIN, V26, P85, DOI 10.1016/j.yfrne.2005.06.001; MCEWEN BS, 1975, BRAIN RES, V96, P400, DOI 10.1016/0006-8993(75)90755-6; MEIJSROE.HM, 1973, J ENDOCRINOL, V59, P295, DOI 10.1677/joe.0.0590295; Mesfin FB, 2000, BBA-MOL BASIS DIS, V1501, P33, DOI 10.1016/S0925-4439(00)00008-9; PETRA PH, 1991, J STEROID BIOCHEM, V40, P735, DOI 10.1016/0960-0760(91)90299-K; PHOENIX CH, 1959, ENDOCRINOLOGY, V65, P369, DOI 10.1210/endo-65-3-369; Plumari L, 2002, J NEUROENDOCRINOL, V14, P971, DOI 10.1046/j.1365-2826.2002.00866.x; Quadros PS, 2002, J NEUROENDOCRINOL, V14, P761, DOI 10.1046/j.1365-2826.2002.00827.x; Quadros PS, 2002, ENDOCRINOLOGY, V143, P3727, DOI 10.1210/en.2002-211438; RAYNAUD JP, 1973, STEROIDS, V21, P249, DOI 10.1016/S0039-128X(73)80009-1; SCHACHTER BS, 1982, DEV BRAIN RES, V5, P93, DOI 10.1016/0165-3806(82)90116-X; SIMERLY RB, 1985, NEUROENDOCRINOLOGY, V40, P501, DOI 10.1159/000124122; Simerly RB, 1997, P NATL ACAD SCI USA, V94, P14077, DOI 10.1073/pnas.94.25.14077; TILGHMAN SM, 1982, P NATL ACAD SCI-BIOL, V79, P5254, DOI 10.1073/pnas.79.17.5254; Tobet SA, 1997, CELL MOL NEUROBIOL, V17, P565, DOI 10.1023/A:1022529918810; Toda K, 2001, J ENDOCRINOL, V170, P99, DOI 10.1677/joe.0.1700099; TORANALLERAND CD, 1984, PROG BRAIN RES, V61, P63; TORANALLERAND CD, 1982, DEV BRAIN RES, V5, P213; Wallen K, 2005, FRONT NEUROENDOCRIN, V26, P7, DOI 10.1016/j.yfrne.2005.02.001; Wersinger SR, 1997, HORM BEHAV, V32, P176, DOI 10.1006/hbeh.1997.1419; WHALEN RE, 1967, ANAT RECORD, V157, P173, DOI 10.1002/ar.1091570208; WIEGAND SJ, 1982, NEUROENDOCRINOLOGY, V34, P395, DOI 10.1159/000123335	44	216	220	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2006	9	2					220	226		10.1038/nn1624	http://dx.doi.org/10.1038/nn1624			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	007SN	16388309				2022-12-17	WOS:000234990100017
J	Kins, S; Betz, H; Kirsch, J				Kins, S; Betz, H; Kirsch, J			Collybistin, a newly identified brain-specific GEF, induces submembrane clustering of gephyrin	NATURE NEUROSCIENCE			English	Article							INHIBITORY GLYCINE RECEPTOR; TUBULIN LINKER PROTEIN; RAT SPINAL-CORD; ACTIN CYTOSKELETON; BETA SUBUNIT; EXPRESSION; GTPASES; NEURONS; FAMILY; RHO	The formation of postsynaptic GABA(A) and glycine receptor clusters requires the receptor-associated peripheral membrane protein gephyrin. Here we describe two splice variants of a novel gephyrin-binding protein, termed collybistin I and II, which belong to the family of dbl-like GDP/GTP exchange factors (GEFs). Co-expression of collybistin II with gephyrin induced the formation of submembrane gephyrin aggregates that accumulate hetero-oligomeric glycine receptors. Our data suggest that collybistin II regulates the membrane deposition of gephyrin by activating a GTPase of the Rho/Rac family. Therefore, this protein may be an important determinant of inhibitory postsynaptic membrane formation and plasticity.	Max Planck Inst Brain Res, Dept Neurochem, D-60528 Frankfurt, Germany; Univ Ulm, Dept Anat & Cellular Neurobiol, D-89069 Ulm, Germany	Max Planck Society; Ulm University	Betz, H (corresponding author), Max Planck Inst Brain Res, Dept Neurochem, Deutschordenstr 46, D-60528 Frankfurt, Germany.	neurochemie@mpih-frankfurt.mpg.de						AKAGI H, 1988, SCIENCE, V242, P270, DOI 10.1126/science.2845580; Bechade C, 1996, EUR J NEUROSCI, V8, P429, DOI 10.1111/j.1460-9568.1996.tb01226.x; Brambilla R, 1997, NATURE, V390, P281, DOI 10.1038/36849; Cerione RA, 1996, CURR OPIN CELL BIOL, V8, P216, DOI 10.1016/S0955-0674(96)80068-8; Chen HJ, 1998, NEURON, V20, P895, DOI 10.1016/S0896-6273(00)80471-7; Ehlers MD, 1996, CURR OPIN CELL BIOL, V8, P484, DOI 10.1016/S0955-0674(96)80024-X; Essrich C, 1998, NAT NEUROSCI, V1, P563, DOI 10.1038/2798; Feng GP, 1998, SCIENCE, V282, P1321, DOI 10.1126/science.282.5392.1321; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; FROEHNER SC, 1993, ANNU REV NEUROSCI, V16, P347, DOI 10.1146/annurev.ne.16.030193.002023; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GRENNINGLOH G, 1990, NEURON, V4, P963, DOI 10.1016/0896-6273(90)90149-A; GRENNINGLOH G, 1987, NATURE, V328, P215, DOI 10.1038/328215a0; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HARLAN JE, 1994, NATURE, V372, P375; HARPER JW, 1993, CELL, V75, P805; HART MJ, 1994, J BIOL CHEM, V269, P62; HATEBOER G, 1995, EMBO J, V14, P3159, DOI 10.1002/j.1460-2075.1995.tb07318.x; HENG HHQ, 1992, P NATL ACAD SCI USA, V89, P9509, DOI 10.1073/pnas.89.20.9509; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Kim JH, 1998, NEURON, V20, P683, DOI 10.1016/S0896-6273(00)81008-9; Kins S, 1999, EUR J NEUROSCI, V11, P740, DOI 10.1046/j.1460-9568.1999.00527.x; KIRSCH J, 1993, EUR J NEUROSCI, V5, P1109, DOI 10.1111/j.1460-9568.1993.tb00965.x; KIRSCH J, 1995, MOL CELL NEUROSCI, V6, P450, DOI 10.1006/mcne.1995.1033; Kirsch J, 1998, NATURE, V392, P717, DOI 10.1038/33694; Kirsch J, 1996, MOL CELL NEUROSCI, V8, P93, DOI 10.1006/mcne.1996.0048; KIRSCH J, 1991, J BIOL CHEM, V266, P22242; KIRSCH J, 1993, BRAIN RES, V621, P301, DOI 10.1016/0006-8993(93)90120-C; KIRSCH J, 1993, NATURE, V366, P745, DOI 10.1038/366745a0; KIRSCH J, 1995, J NEUROSCI, V15, P4148; Kneussel M, 1999, J NEUROSCI, V19, P9289, DOI 10.1523/jneurosci.19-21-09289.1999; Kneussel M, 1999, J NEUROCHEM, V72, P1323, DOI 10.1046/j.1471-4159.1999.0721323.x; Krisch J, 1999, CURR OPIN NEUROBIOL, V9, P329, DOI 10.1016/S0959-4388(99)80048-8; KUHSE J, 1995, CURR OPIN NEUROBIOL, V5, P318, DOI 10.1016/0959-4388(95)80044-1; Levi S, 1998, J CELL SCI, V111, P335; LIM WA, 1994, NATURE, V372, P375, DOI 10.1038/372375a0; Mammoto A, 1998, BIOCHEM BIOPH RES CO, V243, P86, DOI 10.1006/bbrc.1997.8068; Manser E, 1998, MOL CELL, V1, P183, DOI 10.1016/S1097-2765(00)80019-2; MEYER G, 1995, NEURON, V15, P563, DOI 10.1016/0896-6273(95)90145-0; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; MUSACCHIO A, 1993, TRENDS BIOCHEM SCI, V18, P343, DOI 10.1016/0968-0004(93)90071-T; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; PFEIFFER F, 1984, P NATL ACAD SCI-BIOL, V81, P7224, DOI 10.1073/pnas.81.22.7224; PRIOR P, 1992, NEURON, V8, P1161, DOI 10.1016/0896-6273(92)90136-2; Sabatini DM, 1999, SCIENCE, V284, P1161, DOI 10.1126/science.284.5417.1161; SASSOEPOGNETTO M, 1995, J COMP NEUROL, V357, P1, DOI 10.1002/cne.903570102; Stallmeyer B, 1999, P NATL ACAD SCI USA, V96, P1333, DOI 10.1073/pnas.96.4.1333; TALEB O, 1994, EMBO J, V13, P1318, DOI 10.1002/j.1460-2075.1994.tb06384.x; Tapon N, 1997, CURR OPIN CELL BIOL, V9, P86, DOI 10.1016/S0955-0674(97)80156-1; Todd AJ, 1996, J NEUROSCI, V16, P974	50	216	222	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2000	3	1					22	29		10.1038/71096	http://dx.doi.org/10.1038/71096			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292TB	10607391				2022-12-17	WOS:000085810200008
J	Hrvatin, S; Hochbaum, DR; Nagy, MA; Cicconet, M; Robertson, K; Cheadle, L; Zilionis, R; Ratner, A; Borges-Monroy, R; Klein, AM; Sabatini, BL; Greenberg, ME				Hrvatin, Sinisa; Hochbaum, Daniel R.; Nagy, M. Aurel; Cicconet, Marcelo; Robertson, Keiramarie; Cheadle, Lucas; Zilionis, Rapolas; Ratner, Alex; Borges-Monroy, Rebeca; Klein, Allon M.; Sabatini, Bernardo L.; Greenberg, Michael E.			Single-cell analysis of experience-dependent transcriptomic states in the mouse visual cortex	NATURE NEUROSCIENCE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; GENE-EXPRESSION; RNA-SEQ; CREB PHOSPHORYLATION; BRAIN; NEURONS; PROTEIN; TAXONOMY; DYNAMICS; NUCLEUS	Activity-dependent transcriptional responses shape cortical function. However, a comprehensive understanding of the diversity of these responses across the full range of cortical cell types, and how these changes contribute to neuronal plasticity and disease, is lacking. To investigate the breadth of transcriptional changes that occur across cell types in the mouse visual cortex after exposure to light, we applied high-throughput single-cell RNA sequencing. We identified significant and divergent transcriptional responses to stimulation in each of the 30 cell types characterized, thus revealing 611 stimulus-responsive genes. Excitatory pyramidal neurons exhibited inter-and intralaminar heterogeneity in the induction of stimulus-responsive genes. Non-neuronal cells showed clear transcriptional responses that may regulate experience-dependent changes in neurovascular coupling and myelination. Together, these results reveal the dynamic landscape of the stimulus-dependent transcriptional changes occurring across cell types in the visual cortex; these changes are probably critical for cortical function and may be sites of deregulation in developmental brain disorders.	[Hrvatin, Sinisa; Nagy, M. Aurel; Cheadle, Lucas; Greenberg, Michael E.] Harvard Med Sch, Dept Neurobiol, Boston, MA 02115 USA; [Hochbaum, Daniel R.] Harvard Univ, Soc Fellows, Cambridge, MA 02138 USA; [Hochbaum, Daniel R.; Robertson, Keiramarie; Sabatini, Bernardo L.] Harvard Med Sch, Howard Hughes Med Inst, Dept Neurobiol, Boston, MA 02115 USA; [Cicconet, Marcelo] Harvard Med Sch, Image & Data Anal Core, Boston, MA USA; [Zilionis, Rapolas; Klein, Allon M.] Harvard Med Sch, Dept Syst Biol, Boston, MA USA; [Zilionis, Rapolas] Vilnius Univ, Inst Biotechnol, Vilnius, Lithuania; [Ratner, Alex] Harvard Med Sch, ICCB L Single Cell Core, Boston, MA USA; [Borges-Monroy, Rebeca] Harvard Univ, Div Med Sci, Grad Sch Arts & Sci, Program Bioinformat & Integrat Genom, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Vilnius University; Harvard University; Harvard Medical School; Harvard University	Greenberg, ME (corresponding author), Harvard Med Sch, Dept Neurobiol, Boston, MA 02115 USA.; Sabatini, BL (corresponding author), Harvard Med Sch, Howard Hughes Med Inst, Dept Neurobiol, Boston, MA 02115 USA.	bernardo_sabatini@hms.harvard.edu; michael_greenberg@hms.harvard.edu		Hochbaum, Daniel/0000-0001-6220-6651; Hrvatin, Sinisa/0000-0001-7303-4218	National Institutes of Health (NIH) [R01 NS028829, R01 NS046579, T32GM007753]; ROADS Program - F. Hoffmann-La Roche Ltd.; William F. Milton Fund; NIH Training Grant in the Molecular Biology of Neurodegeneration [5T32AG000222-23]; Burroughs Wellcome Fund Career award at the scientific interface; Edward J. Mallinckrodt Scholarship; NCI grant [R33CA212697]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD090255] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R33CA212697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS046579, P30NS072030, R01NS028829, R01NS046579, R37NS028829] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000222] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ROADS Program - F. Hoffmann-La Roche Ltd.; William F. Milton Fund; NIH Training Grant in the Molecular Biology of Neurodegeneration; Burroughs Wellcome Fund Career award at the scientific interface(Burroughs Wellcome Fund); Edward J. Mallinckrodt Scholarship; NCI grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank E. Griffith and J. Gray for critical reading of the manuscript; the HMS Single Cell Core for sample processing; and D. Harmin, A. Veres, D. Kotliar, H. Finucane, Y. Reshef, B. Hall, T. Otis, and D. Malhotra for discussions. This work was supported by funding from National Institutes of Health (NIH) grant R01 NS028829 and the ROADS Program funded by F. Hoffmann-La Roche Ltd. to M.E.G.; NIH grant R01 NS046579 to B.L.S.; the William F. Milton Fund to D.R.H.; NIH grant T32GM007753 to M.A.N.; NIH Training Grant in the Molecular Biology of Neurodegeneration 5T32AG000222-23 to S.H.; and a Burroughs Wellcome Fund Career award at the scientific interface, an Edward J. Mallinckrodt Scholarship, and NCI grant R33CA212697 to A.M.K.	Aguet F, 2013, DEV CELL, V26, P279, DOI 10.1016/j.devcel.2013.06.019; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Bading H, 2013, NAT REV NEUROSCI, V14, P593, DOI 10.1038/nrn3531; Baron M, 2016, CELL SYST, V3, P346, DOI 10.1016/j.cels.2016.08.011; Ben-David E, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002556; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Campbell JN, 2017, NAT NEUROSCI, V20, P484, DOI 10.1038/nn.4495; Chacon PJ, 2015, NEUROBIOL AGING, V36, P1057, DOI 10.1016/j.neurobiolaging.2014.11.006; Cicconet M., 2017, BOTS SOFTWARE ASSIST; de Kock CPJ, 2007, J PHYSIOL-LONDON, V581, P139, DOI 10.1113/jphysiol.2006.124321; Fan JL, 1998, PATTERN RECOGN LETT, V19, P425, DOI 10.1016/S0167-8655(98)00028-2; Gibson EM, 2014, SCIENCE, V344, P487, DOI 10.1126/science.1252304; GINTY DD, 1993, SCIENCE, V260, P238, DOI 10.1126/science.8097062; Gokce O, 2016, CELL REP, V16, P1126, DOI 10.1016/j.celrep.2016.06.059; Gurnik S, 2016, ACTA NEUROPATHOL, V131, P753, DOI 10.1007/s00401-016-1551-3; Habib N, 2016, SCIENCE, V353, P925, DOI 10.1126/science.aad7038; Harris KD, 2015, NAT NEUROSCI, V18, P170, DOI 10.1038/nn.3917; Harward SC, 2016, NATURE, V538, P99, DOI 10.1038/nature19766; Hattox AM, 2007, J NEUROPHYSIOL, V98, P3330, DOI 10.1152/jn.00397.2007; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hines JH, 2015, NAT NEUROSCI, V18, P683, DOI 10.1038/nn.3992; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Islam S, 2014, NAT METHODS, V11, P163, DOI [10.1038/NMETH.2772, 10.1038/nmeth.2772]; Klein AM, 2015, CELL, V161, P1187, DOI 10.1016/j.cell.2015.04.044; Kratzer S, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00091; Lacar B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11022; Lacoste B, 2014, NEURON, V83, P1117, DOI 10.1016/j.neuron.2014.07.034; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Li K, 2016, CELL, V167, P60, DOI 10.1016/j.cell.2016.08.067; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; MacManus JP, 2004, J CEREBR BLOOD F MET, V24, P657, DOI 10.1097/01.WCB.0000123141.67811.91; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Majdan M, 2006, NAT NEUROSCI, V9, P650, DOI 10.1038/nn1674; Mardinly AR, 2016, NATURE, V531, P371, DOI 10.1038/nature17187; Marques S, 2016, SCIENCE, V352, P1326, DOI 10.1126/science.aaf6463; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Miyata S, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/492367; Nassi JJ, 2009, NAT REV NEUROSCI, V10, P360, DOI 10.1038/nrn2619; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; Ramilowski JA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8866; Renier N, 2016, CELL, V165, P1789, DOI 10.1016/j.cell.2016.05.007; Richmond D, 2015, LECT NOTES COMPUT SC, V9349, P653, DOI 10.1007/978-3-319-24553-9_80; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rodriguez A, 2014, SCIENCE, V344, P1492, DOI 10.1126/science.1242072; Roy C S, 1890, J Physiol, V11, P85; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Schulz TW, 2004, J NEUROSCI, V24, P8584, DOI 10.1523/JNEUROSCI.2100-04.2004; Shekhar K, 2016, CELL, V166, P1308, DOI 10.1016/j.cell.2016.07.054; Shepherd JD, 2011, NAT NEUROSCI, V14, P279, DOI 10.1038/nn.2708; Spiegel I, 2014, CELL, V157, P1216, DOI 10.1016/j.cell.2014.03.058; Straub AC, 2012, NATURE, V491, P473, DOI 10.1038/nature11626; Su YJ, 2017, NAT NEUROSCI, V20, P476, DOI 10.1038/nn.4494; Tasic B, 2016, NAT NEUROSCI, V19, P335, DOI 10.1038/nn.4216; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tu ZW, 2010, IEEE T PATTERN ANAL, V32, P1744, DOI 10.1109/TPAMI.2009.186; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Wang XH, 2006, NAT NEUROSCI, V9, P816, DOI 10.1038/nn1703; Weinl C, 2013, J CLIN INVEST, V123, P2193, DOI 10.1172/JCI64201; West AE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005744; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; Wu GY, 2001, P NATL ACAD SCI USA, V98, P2808, DOI 10.1073/pnas.051634198; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zhou ZN, 2016, NATURE, V532, P122, DOI 10.1038/nature17178; Zilionis R, 2017, NAT PROTOC, V12, DOI 10.1038/nprot.2016.154; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	72	215	215	4	77	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2018	21	1					120	+		10.1038/s41593-017-0029-5	http://dx.doi.org/10.1038/s41593-017-0029-5			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FT4WL	29230054	Green Accepted, Green Submitted			2022-12-17	WOS:000423155800020
J	Hannon, E; Spiers, H; Viana, J; Pidsley, R; Burrage, J; Murphy, TM; Troakes, C; Turecki, G; O'Donovan, MC; Schalkwyk, LC; Bray, NJ; Mill, J				Hannon, Eilis; Spiers, Helen; Viana, Joana; Pidsley, Ruth; Burrage, Joe; Murphy, Therese M.; Troakes, Claire; Turecki, Gustavo; O'Donovan, Michael C.; Schalkwyk, Leonard C.; Bray, Nicholas J.; Mill, Jonathan			Methylation QTLs in the developing brain and their enrichment in schizophrenia risk loci	NATURE NEUROSCIENCE			English	Article							DNA METHYLATION; HUMAN GENOME; INTERINDIVIDUAL VARIATION; SYSTEMATIC ANNOTATION; GENETIC-VARIATION; EXPRESSION; DISEASE; ASSOCIATION; IDENTIFICATION; IMPUTATION	We characterized DNA methylation quantitative trait loci (mQTLs) in a large collection (n = 166) of human fetal brain samples spanning 56-166 d post-conception, identifying > 16,000 fetal brain mQTLs. Fetal brain mQTLs were primarily cis-acting, enriched in regulatory chromatin domains and transcription factor binding sites, and showed substantial overlap with genetic variants that were also associated with gene expression in the brain. Using tissue from three distinct regions of the adult brain (prefrontal cortex, striatum and cerebellum), we found that most fetal brain mQTLs were developmentally stable, although a subset was characterized by fetal-specific effects. Fetal brain mQTLs were enriched amongst risk loci identified in a recent large-scale genome-wide association study (GWAS) of schizophrenia, a severe psychiatric disorder with a hypothesized neurodevelopmental component. Finally, we found that mQTLs can be used to refine GWAS loci through the identification of discrete sites of variable fetal brain methylation associated with schizophrenia risk variants.	[Hannon, Eilis; Viana, Joana; Burrage, Joe; Murphy, Therese M.; Mill, Jonathan] Univ Exeter, Sch Med, Exeter, Devon, England; [Spiers, Helen; Troakes, Claire; Bray, Nicholas J.; Mill, Jonathan] Kings Coll London, Inst Psychiat Psychol & Neurosci, London WC2R 2LS, England; [Pidsley, Ruth] Garvan Inst Med Res, Sydney, NSW, Australia; [Turecki, Gustavo] McGill Univ, Douglas Mental Hlth Inst, Montreal, PQ, Canada; [O'Donovan, Michael C.; Bray, Nicholas J.] Cardiff Univ, Sch Med, MRC Ctr Neuropsychiat Genet & Genom, Cardiff CF10 3AX, S Glam, Wales; [Schalkwyk, Leonard C.] Univ Essex, Sch Biol Sci, Colchester CO4 3SQ, Essex, England	University of Exeter; University of London; King's College London; Garvan Institute of Medical Research; McGill University; Cardiff University; University of Essex	Mill, J (corresponding author), Univ Exeter, Sch Med, Exeter, Devon, England.	j.mill@exeter.ac.uk	O'Donovan, Michael C/P-7005-2018; Mill, Jonathan S/B-3276-2010; Viana, Joana/B-1957-2013; Hannon, Eilis/T-1349-2019; Schalkwyk, Leonard C/A-2150-2010; Mill, Jonathan/B-5678-2014; Murphy, Therese/C-7481-2014	O'Donovan, Michael C/0000-0001-7073-2379; Mill, Jonathan S/0000-0003-1115-3224; Viana, Joana/0000-0003-2502-6736; Hannon, Eilis/0000-0001-6840-072X; Schalkwyk, Leonard C/0000-0001-7030-5756; Mill, Jonathan/0000-0003-1115-3224; Pidsley, Ruth/0000-0002-1386-1374; Troakes, Claire/0000-0002-1790-7376; Spiers, Helen/0000-0001-7748-7935; Bray, Nicholas/0000-0002-4357-574X; Murphy, Therese/0000-0002-7647-2798; Turecki, Gustavo/0000-0003-4075-2736	UK Medical Research Council (MRC) [MR/K013807/1, MR/L010674/1]; US National Institutes of Health [AG036039]; MRC PhD studentships; Joint MRC/Wellcome Trust [099175/Z/12/Z]; Human Developmental Biology Resource; MRC [G0700089, MR/L010674/2, MR/L010674/1, G1100695, G0800509, G9318379, MC_PC_15004, MR/L016397/1, MR/K013807/1] Funding Source: UKRI; Medical Research Council [G0800509, 1097235, MR/L010674/1, MR/L016397/1, MR/L010674/2, MR/L010305/1, G1100695, G9318379, MR/K013807/1, MC_PC_15004, G0700089] Funding Source: researchfish; NATIONAL INSTITUTE ON AGING [R01AG036039] Funding Source: NIH RePORTER	UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC PhD studentships(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Joint MRC/Wellcome Trust(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Human Developmental Biology Resource; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank M. Weale for providing eQTL data from the BRAINEAC database. This work was supported by grants from the UK Medical Research Council (MRC; MR/K013807/1 to J.M. and MR/L010674/1 to N.J.B.) and the US National Institutes of Health (AG036039) to J.M. R.P. and H.S. were funded by MRC PhD studentships. The human embryonic and fetal material was provided by the Joint MRC/Wellcome Trust (grant #099175/Z/12/Z) Human Developmental Biology Resource.	Teh AL, 2014, GENOME RES, V24, P1064, DOI 10.1101/gr.171439.113; Aryee MJ, 2014, BIOINFORMATICS, V30, P1363, DOI 10.1093/bioinformatics/btu049; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chen YA, 2013, EPIGENETICS-US, V8, P203, DOI 10.4161/epi.23470; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Davis S., 2015, METHYLUMI HANDLE ILL; Dekker J, 2013, NAT REV GENET, V14, P390, DOI 10.1038/nrg3454; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Drong AW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055923; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Elliott G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7363; Ernst J, 2015, NAT BIOTECHNOL, V33, P364, DOI 10.1038/nbt.3157; Fatemi SH, 2009, SCHIZOPHRENIA BULL, V35, P528, DOI 10.1093/schbul/sbn187; Gamazon ER, 2013, MOL PSYCHIATR, V18, P340, DOI 10.1038/mp.2011.174; Giambartolomei C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004383; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Gutierrez-Arcelus M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004958; Gutierrez-Arcelus M, 2013, ELIFE, V2, DOI 10.7554/eLife.00523; Hill MJ, 2012, AM J PSYCHIAT, V169, P1301, DOI 10.1176/appi.ajp.2012.11121845; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Jaffe AE, 2016, NAT NEUROSCI, V19, P40, DOI 10.1038/nn.4181; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Lemire M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7326; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McRae AF, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-5-r73; Meaburn EL, 2010, EPIGENETICS-US, V5, P578, DOI 10.4161/epi.5.7.12960; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Olsson AH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004735; Ong CT, 2014, NAT REV GENET, V15, P234, DOI 10.1038/nrg3663; Pidsley R, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0483-2; Pidsley R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-293; Price EM, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-4; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramasamy A, 2014, NAT NEUROSCI, V17, P1418, DOI 10.1038/nn.3801; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Shabalin AA, 2012, BIOINFORMATICS, V28, P1353, DOI 10.1093/bioinformatics/bts163; Slieker RC, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-26; Spiers H, 2015, GENOME RES, V25, P338, DOI 10.1101/gr.180273.114; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Tao R, 2014, JAMA PSYCHIAT, V71, P1112, DOI 10.1001/jamapsychiatry.2014.1079; van Eijk KR, 2015, EUR J HUM GENET, V23, P1106, DOI 10.1038/ejhg.2014.245; Wagner JR, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r37; Wang H, 2012, GENOME RES, V22, P1680, DOI 10.1101/gr.136101.111; WEINBERGER DR, 1995, LANCET, V346, P552, DOI 10.1016/S0140-6736(95)91386-6; Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433	52	215	216	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2016	19	1					48	+		10.1038/nn.4182	http://dx.doi.org/10.1038/nn.4182			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CZ7BH	26619357	Green Submitted, Green Accepted			2022-12-17	WOS:000367254400012
J	Pannasch, U; Freche, D; Dallerac, G; Ghezali, G; Escartin, C; Ezan, P; Cohen-Salmon, M; Benchenane, K; Abudara, V; Dufour, A; Lubke, JHR; Deglon, N; Knott, G; Holcman, D; Rouach, N				Pannasch, Ulrike; Freche, Dominik; Dallerac, Glenn; Ghezali, Gregory; Escartin, Carole; Ezan, Pascal; Cohen-Salmon, Martine; Benchenane, Karim; Abudara, Veronica; Dufour, Amandine; Luebke, Joachim H. R.; Deglon, Nicole; Knott, Graham; Holcman, David; Rouach, Nathalie			Connexin 30 sets synaptic strength by controlling astroglial synapse invasion	NATURE NEUROSCIENCE			English	Article							ASTROCYTE-DIRECTED INACTIVATION; DENDRITIC SPINE MORPHOLOGY; GLUTAMATE TRANSPORTERS; RAFT MICRODOMAINS; GAP-JUNCTIONS; UP-REGULATION; EXPRESSION; PLASTICITY; NETWORKS; CELLS	Astrocytes play active roles in brain physiology by dynamic interactions with neurons. Connexin 30, one of the two main astroglial gap-junction subunits, is thought to be involved in behavioral and basic cognitive processes. However, the underlying cellular and molecular mechanisms are unknown. We show here in mice that connexin 30 controls hippocampal excitatory synaptic transmission through modulation of astroglial glutamate transport, which directly alters synaptic glutamate levels. Unexpectedly, we found that connexin 30 regulated cell adhesion and migration and that connexin 30 modulation of glutamate transport, occurring independently of its channel function, was mediated by morphological changes controlling insertion of astroglial processes into synaptic clefts. By setting excitatory synaptic strength, connexin 30 plays an important role in long-term synaptic plasticity and in hippocampus-based contextual memory. Taken together, these results establish connexin 30 as a critical regulator of synaptic strength by controlling the synaptic location of astroglial processes.	[Pannasch, Ulrike; Dallerac, Glenn; Ghezali, Gregory; Ezan, Pascal; Cohen-Salmon, Martine; Abudara, Veronica; Rouach, Nathalie] PSL Res Univ, Ctr Interdisciplinary Res Biol, CNRS UMR 7241, Coll France,INSERM U1050,Labex Memolife, Paris, France; [Pannasch, Ulrike; Dallerac, Glenn; Ghezali, Gregory; Ezan, Pascal; Cohen-Salmon, Martine; Abudara, Veronica; Rouach, Nathalie] Univ Paris 06, Doctoral Sch 158, Paris, France; [Freche, Dominik; Holcman, David] Ecole Normale Super, CNRS UMR 8197, INSERM 1024, Inst Biol, F-75231 Paris, France; [Freche, Dominik; Holcman, David] Weizmann Inst Sci, Dept Math, IL-76100 Rehovot, Israel; [Escartin, Carole; Deglon, Nicole] MIRCen, Commissariat Energie Atom & Energies Alternat, CNRS URA2210, Fontenay Aux Roses, France; [Benchenane, Karim] Ecole Super Phys & Chim Ind Ville Paris, CNRS UMR 7637, Paris, France; [Dufour, Amandine; Luebke, Joachim H. R.] Res Ctr Julich, Inst Neurosci & Med INM 2, Julich, Germany; [Luebke, Joachim H. R.] Rheinisch Westfael Tech Hsch Aachen Univ, Dept Psychiat Psychotherapy & Psychosomat, Julich Aachen Res Alliance Translat Brain Med, Aachen, Germany; [Knott, Graham] Ecole Polytech Fed Lausanne, Ctr Interdisciplinary Electron Microscopy, Lausanne, Switzerland	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Weizmann Institute of Science; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Helmholtz Association; Research Center Julich; RWTH Aachen University; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Rouach, N (corresponding author), PSL Res Univ, Ctr Interdisciplinary Res Biol, CNRS UMR 7241, Coll France,INSERM U1050,Labex Memolife, Paris, France.	nathalie.rouach@college-de-france.fr	Escartin, Carole/A-1952-2010; Deglon, Nicole/A-2265-2012; Rouach, Nathalie/L-4767-2017; benchenane, karim/D-8023-2015	Escartin, Carole/0000-0003-3613-4118; Deglon, Nicole/0000-0003-4475-9476; Rouach, Nathalie/0000-0002-5574-888X; benchenane, karim/0000-0001-7118-0748; Knott, Graham W/0000-0002-2956-9052; Cohen-Salmon, Martine/0000-0002-5312-8476; holcman, david/0000-0001-9854-5014	Human Frontier Science Program Organization (Career Development Award); French Research Agency (Programme Jeunes chercheurs and Programme Blanc); City of Paris (Programme Emergence); INSERM; CEA; CNRS; International Brain Research Organization; French Research Ministry; Deutsche Forschungsgemeinschaft; Labex Memolife; doctoral school ED3C, Paris 6 University; Max-Planck Society	Human Frontier Science Program Organization (Career Development Award)(Human Frontier Science Program); French Research Agency (Programme Jeunes chercheurs and Programme Blanc)(French National Research Agency (ANR)); City of Paris (Programme Emergence)(Region Ile-de-France); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CEA(French Atomic Energy Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); International Brain Research Organization; French Research Ministry(Ministry of Research, France); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Labex Memolife; doctoral school ED3C, Paris 6 University; Max-Planck Society(Max Planck SocietyFoundation CELLEX)	We thank R. Nicoll, A. Koulakoff, E. Brouillet, O. Chever, F. Mammano and D. Schmitz for discussions and for technical assistance. This work was supported by grants from the Human Frontier Science Program Organization (Career Development Award), French Research Agency (Programme Jeunes chercheurs and Programme Blanc), City of Paris (Programme Emergence) and INSERM to N.R., from CEA and CNRS to C.E. and N.D., from International Brain Research Organization to V.A., from the French Research Ministry and Deutsche Forschungsgemeinschaft to U.P., from Labex Memolife to G.D., from the doctoral school ED3C, Paris 6 University to G.G. and from the Max-Planck Society to D.F.	Barbour B, 2001, J NEUROSCI, V21, P7969, DOI 10.1523/JNEUROSCI.21-20-07969.2001; Bellesi M, 2009, GLIA, V57, P703, DOI 10.1002/glia.20798; Bernard R, 2011, MOL PSYCHIATR, V16, P634, DOI 10.1038/mp.2010.44; Butchbach MER, 2004, J BIOL CHEM, V279, P34388, DOI 10.1074/jbc.M403938200; Carmona MA, 2009, P NATL ACAD SCI USA, V106, P12524, DOI 10.1073/pnas.0903328106; Cohen-Salmon M, 2007, P NATL ACAD SCI USA, V104, P6229, DOI 10.1073/pnas.0605108104; Colin A, 2009, GLIA, V57, P667, DOI 10.1002/glia.20795; Condorelli DF, 2002, MOL CELL NEUROSCI, V21, P94, DOI 10.1006/mcne.2002.1155; CORNELLBELL AH, 1990, GLIA, V3, P322, DOI 10.1002/glia.440030503; Dere E, 2003, EUR J NEUROSCI, V18, P629, DOI 10.1046/j.1460-9568.2003.02784.x; Elias LAB, 2007, NATURE, V448, P901, DOI 10.1038/nature06063; Ernst C, 2011, BIOL PSYCHIAT, V70, P312, DOI 10.1016/j.biopsych.2011.03.038; Escartin C, 2006, J NEUROSCI, V26, P5978, DOI 10.1523/JNEUROSCI.0302-06.2006; Filosa A, 2009, NAT NEUROSCI, V12, P1285, DOI 10.1038/nn.2394; Frisch C, 2003, EUR J NEUROSCI, V18, P2313, DOI 10.1046/j.1460-9568.2003.02971.x; Geiger JRP, 1999, HANDB EXP PHARM, V141, P363; Genoud C, 2006, PLOS BIOL, V4, P2057, DOI 10.1371/journal.pbio.0040343; Grifa A, 1999, NAT GENET, V23, P16, DOI 10.1038/12612; Gros D, 2010, CARDIOVASC RES, V85, P45, DOI 10.1093/cvr/cvp280; Haber M, 2006, J NEUROSCI, V26, P8881, DOI 10.1523/JNEUROSCI.1302-06.2006; Harris AL, 2001, Q REV BIOPHYS, V34, P325, DOI 10.1017/S0033583501003705; Ji JZ, 2007, HIPPOCAMPUS, V17, P749, DOI 10.1002/hipo.20331; JONAS P, 1993, J PHYSIOL-LONDON, V472, P615, DOI 10.1113/jphysiol.1993.sp019965; Koulakoff A, 2008, GLIA, V56, P1299, DOI 10.1002/glia.20698; Lino M, 2001, SCIENCE, V292, P926, DOI 10.1126/science.1058827; Melone M, 2009, GLIA, V57, P108, DOI 10.1002/glia.20744; Murai KK, 2003, NAT NEUROSCI, V6, P153, DOI 10.1038/nn994; Nagy JI, 1999, NEUROSCIENCE, V88, P447, DOI 10.1016/S0306-4522(98)00191-2; Oliet SHR, 2001, SCIENCE, V292, P923, DOI 10.1126/science.1059162; Omrani A, 2009, J PHYSIOL-LONDON, V587, P4575, DOI 10.1113/jphysiol.2009.177881; Ozog MA, 2002, J NEUROPATH EXP NEUR, V61, P132, DOI 10.1093/jnen/61.2.132; Pannasch U, 2013, TRENDS NEUROSCI, V36, P405, DOI 10.1016/j.tins.2013.04.004; Pannasch U, 2011, P NATL ACAD SCI USA, V108, P8467, DOI 10.1073/pnas.1016650108; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; Princen F, 2001, CARCINOGENESIS, V22, P507, DOI 10.1093/carcin/22.3.507; Qu CY, 2009, EXP CELL RES, V315, P1683, DOI 10.1016/j.yexcr.2009.03.001; Rampon C, 2000, P NATL ACAD SCI USA, V97, P12880, DOI 10.1073/pnas.97.23.12880; Rothstein JD, 2005, NATURE, V433, P73, DOI 10.1038/nature03180; Roux L, 2011, P NATL ACAD SCI USA, V108, P18442, DOI 10.1073/pnas.1107386108; Saab AS, 2012, SCIENCE, V337, P749, DOI 10.1126/science.1221140; Schutz M, 2010, HUM MOL GENET, V19, P4759, DOI 10.1093/hmg/ddq402; Scimemi A, 2009, J NEUROSCI, V29, P14581, DOI 10.1523/JNEUROSCI.4845-09.2009; Singer A, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.051111; Teubner B, 2003, HUM MOL GENET, V12, P13, DOI 10.1093/hmg/ddg001; Theis M, 2003, J NEUROSCI, V23, P766; Theis M, 2005, TRENDS NEUROSCI, V28, P188, DOI 10.1016/j.tins.2005.02.006; Tzingounis AV, 2007, NAT REV NEUROSCI, V8, P935, DOI 10.1038/nrn2274; Witcher MR, 2007, GLIA, V55, P13, DOI 10.1002/glia.20415; Zheng KY, 2008, BIOPHYS J, V95, P4584, DOI 10.1529/biophysj.108.129874	50	215	219	0	63	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2014	17	4					549	U104		10.1038/nn.3662	http://dx.doi.org/10.1038/nn.3662			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AD6XR	24584052				2022-12-17	WOS:000333405300015
J	Sachidhanandam, S; Sreenivasan, V; Kyriakatos, A; Kremer, Y; Petersen, CCH				Sachidhanandam, Shankar; Sreenivasan, Varun; Kyriakatos, Alexandros; Kremer, Yves; Petersen, Carl C. H.			Membrane potential correlates of sensory perception in mouse barrel cortex	NATURE NEUROSCIENCE			English	Article							PRIMARY SOMATOSENSORY CORTEX; AUDITORY-CORTEX; BEHAVING MICE; CORTICAL MICROSTIMULATION; GABAERGIC NEURONS; NEURAL ACTIVITY; VISUAL-CORTEX; SINGLE NEURON; MOTOR CORTEX; LAYER 2/3	Neocortical activity can evoke sensory percepts, but the cellular mechanisms remain poorly understood. We trained mice to detect single brief whisker stimuli and report perceived stimuli by licking to obtain a reward. Pharmacological inactivation and optogenetic stimulation demonstrated a causal role for the primary somatosensory barrel cortex. Whole-cell recordings from barrel cortex neurons revealed membrane potential correlates of sensory perception. Sensory responses depended strongly on prestimulus cortical state, but both slow-wave and desynchronized cortical states were compatible with task performance. Whisker deflection evoked an early (<50 ms) reliable sensory response that was encoded through cell-specific reversal potentials. A secondary late (50-400 ms) depolarization was enhanced on hit trials compared to misses. Optogenetic inactivation revealed a causal role for late excitation. Our data reveal dynamic processing in the sensory cortex during task performance, with an early sensory response reliably encoding the stimulus and later secondary activity contributing to driving the subjective percept.	[Sachidhanandam, Shankar; Sreenivasan, Varun; Kyriakatos, Alexandros; Kremer, Yves; Petersen, Carl C. H.] Ecole Polytech Fed Lausanne, Lab Sensory Proc, Brain Mind Inst, Fac Life Sci, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Petersen, CCH (corresponding author), Ecole Polytech Fed Lausanne, Lab Sensory Proc, Brain Mind Inst, Fac Life Sci, CH-1015 Lausanne, Switzerland.	carl.petersen@epfl.ch	Petersen, Carl/M-5123-2017	Petersen, Carl/0000-0003-3344-4495; Sachidhanandam, Shankar/0000-0002-9359-6653; Sreenivasan, Varun/0000-0003-0559-9713; Kremer, Yves/0000-0002-2319-1394	Swiss National Science Foundation [31003A-116027, 310030-146252, BaCoFun 310030E-147486]; Deutsche Forschungsgemeinschaft [BaCoFun 310030E-147486]; Human Frontier Science Program [RGP0041/2009]; SystemsX.ch (Neurochoice); National Competence Centre for Research (Synapsy); European Research Council [ERC-2011-AdG-293660]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Human Frontier Science Program(Human Frontier Science Program); SystemsX.ch (Neurochoice); National Competence Centre for Research (Synapsy); European Research Council(European Research Council (ERC)European Commission)	This work was funded by grants from the Swiss National Science Foundation (31003A-116027 and 310030-146252), a joint grant between the Swiss National Science Foundation and the Deutsche Forschungsgemeinschaft (BaCoFun 310030E-147486), the Human Frontier Science Program (RGP0041/2009), SystemsX.ch (Neurochoice), the National Competence Centre for Research (Synapsy) and the European Research Council (ERC-2011-AdG-293660 Sensorimotor).	Avermann M, 2012, J NEUROPHYSIOL, V107, P3116, DOI 10.1152/jn.00917.2011; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Branco T, 2010, CURR OPIN NEUROBIOL, V20, P494, DOI 10.1016/j.conb.2010.07.009; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Chen JL, 2013, NATURE, V499, P336, DOI 10.1038/nature12236; Chubykin AA, 2013, NEURON, V77, P723, DOI 10.1016/j.neuron.2012.12.039; Crochet S, 2006, NAT NEUROSCI, V9, P608, DOI 10.1038/nn1690; Crochet S, 2011, NEURON, V69, P1160, DOI 10.1016/j.neuron.2011.02.022; de Kock CPJ, 2009, P NATL ACAD SCI USA, V106, P16446, DOI 10.1073/pnas.0904143106; de Lafuente V, 2006, P NATL ACAD SCI USA, V103, P14266, DOI 10.1073/pnas.0605826103; Dehaene S, 2011, NEURON, V70, P200, DOI 10.1016/j.neuron.2011.03.018; Diamond ME, 2008, NAT REV NEUROSCI, V9, P601, DOI 10.1038/nrn2411; Feldmeyer D, 2013, PROG NEUROBIOL, V103, P3, DOI 10.1016/j.pneurobio.2012.11.002; Ferezou I, 2007, NEURON, V56, P907, DOI 10.1016/j.neuron.2007.10.007; Gdalyahu A, 2012, NEURON, V75, P121, DOI 10.1016/j.neuron.2012.04.035; Gentet LJ, 2012, NAT NEUROSCI, V15, P607, DOI 10.1038/nn.3051; Gentet LJ, 2010, NEURON, V65, P422, DOI 10.1016/j.neuron.2010.01.006; Gilbert CD, 2013, NAT REV NEUROSCI, V14, P350, DOI 10.1038/nrn3476; Haider B, 2013, NATURE, V493, P97, DOI 10.1038/nature11665; Houweling AR, 2008, NATURE, V451, P65, DOI 10.1038/nature06447; Huber D, 2012, NATURE, V484, P473, DOI 10.1038/nature11039; Huber D, 2008, NATURE, V451, P61, DOI 10.1038/nature06445; HUTSON KA, 1986, J NEUROPHYSIOL, V56, P1196, DOI 10.1152/jn.1986.56.4.1196; Larkum ME, 2009, SCIENCE, V325, P756, DOI 10.1126/science.1171958; Lee SH, 2012, NEURON, V76, P209, DOI 10.1016/j.neuron.2012.09.012; Lee SH, 2012, NATURE, V488, P379, DOI 10.1038/nature11312; Lee S, 2013, NAT NEUROSCI, V16, P1662, DOI 10.1038/nn.3544; Letzkus JJ, 2011, NATURE, V480, P331, DOI 10.1038/nature10674; Luna R, 2005, NAT NEUROSCI, V8, P1210, DOI 10.1038/nn1513; Mao TY, 2011, NEURON, V72, P111, DOI 10.1016/j.neuron.2011.07.029; Matyas F, 2010, SCIENCE, V330, P1240, DOI 10.1126/science.1195797; Miyashita T, 2013, CEREB CORTEX, V23, P1655, DOI 10.1093/cercor/bhs155; Nienborg H, 2012, ANNU REV NEUROSCI, V35, P463, DOI 10.1146/annurev-neuro-062111-150403; O'Connor DH, 2013, NAT NEUROSCI, V16, P958, DOI 10.1038/nn.3419; O'Connor DH, 2010, NEURON, V67, P1048, DOI 10.1016/j.neuron.2010.08.026; Okun M, 2010, J NEUROSCI, V30, P4440, DOI 10.1523/JNEUROSCI.5062-09.2010; Otazu GH, 2009, NAT NEUROSCI, V12, P646, DOI 10.1038/nn.2306; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017; Petersen CCH, 2013, NEURON, V78, P28, DOI 10.1016/j.neuron.2013.03.020; Polack PO, 2013, NAT NEUROSCI, V16, P1331, DOI 10.1038/nn.3464; Poulet JFA, 2008, NATURE, V454, P881, DOI 10.1038/nature07150; Poulet JFA, 2012, NAT NEUROSCI, V15, P370, DOI 10.1038/nn.3035; Romo R, 1998, NATURE, V392, P387, DOI 10.1038/32891; SALZMAN CD, 1990, NATURE, V346, P174, DOI 10.1038/346174a0; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Stuttgen MC, 2008, NAT NEUROSCI, V11, P1091, DOI 10.1038/nn.2162; Timofeev I, 2001, P NATL ACAD SCI USA, V98, P1924, DOI 10.1073/pnas.041430398; Xu NL, 2012, NATURE, V492, P247, DOI 10.1038/nature11601; Znamenskiy P, 2013, NATURE, V497, P482, DOI 10.1038/nature12077	50	215	215	2	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2013	16	11					1671	1677		10.1038/nn.3532	http://dx.doi.org/10.1038/nn.3532			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241YX	24097038				2022-12-17	WOS:000326205700025
J	Saleem, AB; Ayaz, A; Jeffery, KJ; Harris, KD; Carandini, M				Saleem, Aman B.; Ayaz, Asli; Jeffery, Kathryn J.; Harris, Kenneth D.; Carandini, Matteo			Integration of visual motion and locomotion in mouse visual cortex	NATURE NEUROSCIENCE			English	Article							CELL ASSEMBLIES; SELF-MOTION; DYNAMICS; AWAKE; FIELD; SELECTIVITY; PERCEPTION; NAVIGATION; RESPONSES; STATE	Successful navigation through the world requires accurate estimation of one's own speed. To derive this estimate, animals integrate visual speed gauged from optic flow and run speed gauged from proprioceptive and locomotor systems. The primary visual cortex (V1) carries signals related to visual speed, and its responses are also affected by run speed. To study how V1 combines these signals during navigation, we recorded from mice that traversed a virtual environment. Nearly half of the V1 neurons were reliably driven by combinations of visual speed and run speed. These neurons performed a weighted sum of the two speeds. The weights were diverse across neurons, and typically positive. As a population, V1 neurons predicted a linear combination of visual and run speeds better than either visual or run speeds alone. These data indicate that V1 in the mouse participates in a multimodal processing system that integrates visual motion and locomotion during navigation.	[Saleem, Aman B.; Ayaz, Asli; Harris, Kenneth D.; Carandini, Matteo] UCL, UCL Inst Ophthalmol, London, England; [Saleem, Aman B.; Jeffery, Kathryn J.] UCL, Dept Cognit Perceptual & Brain Sci, London, England; [Harris, Kenneth D.] UCL, UCL Inst Neurol, London, England; [Harris, Kenneth D.] UCL, Dept Neurosci Physiol & Pharmacol, London, England	University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London	Saleem, AB (corresponding author), UCL, UCL Inst Ophthalmol, Mortimer St, London, England.	aman.saleem@ucl.ac.uk	AYAZ, ASLI/AAL-6577-2020; Carandini, Matteo/ABD-8296-2021; Jeffery, Kate/C-2409-2008	AYAZ, ASLI/0000-0002-6276-2516; Carandini, Matteo/0000-0003-4880-7682; Saleem, Aman/0000-0002-7100-1954; Harris, Kenneth/0000-0002-5930-6456; Jeffery, Kate/0000-0002-9495-0378	Wellcome Trust; BBSRC [BB/J009792/1] Funding Source: UKRI; EPSRC [EP/I005102/1, EP/I005102/2, EP/K015141/1] Funding Source: UKRI; MRC [G0800791, G1100669] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J009792/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/I005102/1, EP/K015141/1, EP/I005102/2] Funding Source: researchfish; Medical Research Council [G1100669, G0800791] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank M. Scholvinck for help with pilot experiments, L. Muessig and F. Cacucci for sharing open-field behavioral data, B. Haider, D. Schulz and other members of the laboratory for helpful discussions, J. O'Keefe, N. Burgess and K.D. Longden for comments on the project. This work was supported by the Medical Research Council and by the European Research Council. M.C. and K.D.H. are jointly funded by the Wellcome Trust. K.J.J. is supported by the Biotechnology and Biological Sciences Research Council. M.C. is supported as a GlaxoSmithKline/Fight for Sight Chair in Visual Neuroscience.	Ahrens MB, 2012, NATURE, V485, P471, DOI 10.1038/nature11057; Angelaki DE, 2011, J PHYSIOL-LONDON, V589, P825, DOI 10.1113/jphysiol.2010.194720; Angelaki DE, 2009, CURR OPIN NEUROBIOL, V19, P452, DOI 10.1016/j.conb.2009.06.008; Ayaz A, 2013, CURR BIOL, V23, P890, DOI 10.1016/j.cub.2013.04.012; Bastos AM, 2012, NEURON, V76, P695, DOI 10.1016/j.neuron.2012.10.038; Bizley JK, 2007, CEREB CORTEX, V17, P2172, DOI 10.1093/cercor/bhl128; Carandini M, 2005, J NEUROSCI, V25, P10577, DOI 10.1523/JNEUROSCI.3726-05.2005; Chen GF, 2013, P NATL ACAD SCI USA, V110, P378, DOI 10.1073/pnas.1215834110; Crochet S, 2006, NAT NEUROSCI, V9, P608, DOI 10.1038/nn1690; DeAngelis GC., 2012, NEURAL BASES MULTISE; Deneve S, 2004, J PHYSIOLOGY-PARIS, V98, P249, DOI 10.1016/j.jphysparis.2004.03.011; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Domnisoru C, 2013, NATURE, V495, P199, DOI 10.1038/nature11973; DUFFY CJ, 1991, J NEUROPHYSIOL, V65, P1329, DOI 10.1152/jn.1991.65.6.1329; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Geisler C, 2007, P NATL ACAD SCI USA, V104, P8149, DOI 10.1073/pnas.0610121104; Ghazanfar AA, 2006, TRENDS COGN SCI, V10, P278, DOI 10.1016/j.tics.2006.04.008; Gu Y, 2011, NEURON, V71, P750, DOI 10.1016/j.neuron.2011.06.015; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; Harris KD, 2011, NAT REV NEUROSCI, V12, P509, DOI 10.1038/nrn3084; Harvey CD, 2012, NATURE, V484, P62, DOI 10.1038/nature10918; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; Israel I, 1997, J NEUROPHYSIOL, V77, P3180, DOI 10.1152/jn.1997.77.6.3180; Itskov V, 2008, NEURAL COMPUT, V20, P644, DOI 10.1162/neco.2007.3179; Iurilli G, 2012, NEURON, V73, P814, DOI 10.1016/j.neuron.2011.12.026; Jeffery KJ, 2007, CURR OPIN NEUROBIOL, V17, P684, DOI 10.1016/j.conb.2007.11.008; Keller GB, 2012, NEURON, V74, P809, DOI 10.1016/j.neuron.2012.03.040; Lappe M, 1999, TRENDS COGN SCI, V3, P329, DOI 10.1016/S1364-6613(99)01364-9; McAdams CJ, 2005, J NEUROSCI, V25, P11023, DOI 10.1523/JNEUROSCI.2904-05.2005; Murayama M, 2009, P NATL ACAD SCI USA, V106, P20482, DOI 10.1073/pnas.0910379106; Niell CM, 2010, NEURON, V65, P472, DOI 10.1016/j.neuron.2010.01.033; Polack P.O., 2013, NAT NEUROSCI; Pouget A, 2002, NAT REV NEUROSCI, V3, P741, DOI 10.1038/nrn914; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; Rigotti M, 2013, NATURE, V497, P585, DOI 10.1038/nature12160; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Schmidt-Hieber C, 2013, NAT NEUROSCI, V16, P325, DOI 10.1038/nn.3340; Shuler MG, 2006, SCIENCE, V311, P1606, DOI 10.1126/science.1123513; Szuts TA, 2011, NAT NEUROSCI, V14, P263, DOI 10.1038/nn.2730; Terrazas A, 2005, J NEUROSCI, V25, P8085, DOI 10.1523/JNEUROSCI.0693-05.2005; Wallace DJ, 2013, NATURE, V498, P65, DOI 10.1038/nature12153; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Xu NL, 2012, NATURE, V492, P247, DOI 10.1038/nature11601; ZIPSER D, 1988, NATURE, V331, P679, DOI 10.1038/331679a0	45	214	214	0	49	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2013	16	12					1864	1869		10.1038/nn.3567	http://dx.doi.org/10.1038/nn.3567			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	257VV	24185423	Green Accepted			2022-12-17	WOS:000327416800025
J	Miller, BR; Press, C; Daniels, RW; Sasaki, Y; Milbrandt, J; DiAntonio, A				Miller, Bradley R.; Press, Craig; Daniels, Richard W.; Sasaki, Yo; Milbrandt, Jeffrey; DiAntonio, Aaron			A dual leucine kinase-dependent axon self-destruction program promotes Wallerian degeneration	NATURE NEUROSCIENCE			English	Article							PROTECTION; MECHANISMS; DISEASE	Axon degeneration underlies many common neurological disorders, but the signaling pathways that orchestrate axon degeneration are unknown. We found that dual leucine kinase promoted degeneration of severed axons in Drosophila and mice, and that its target, c-Jun N-terminal kinase, promoted degeneration locally in axons as they committed to degenerate. This pathway also promoted degeneration after chemotherapy exposure and may be a component of a general axon self-destruction program.	[Miller, Bradley R.; Daniels, Richard W.; DiAntonio, Aaron] Washington Univ, Dept Dev Biol, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO 63130 USA; [Press, Craig; Sasaki, Yo; Milbrandt, Jeffrey] Washington Univ, Dept Pathol, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL)	DiAntonio, A (corresponding author), Washington Univ, Dept Dev Biol, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO 63130 USA.	diantonio@wustl.edu	Press, Craig/K-1307-2019; Miller, Bradley/G-7426-2014	Press, Craig/0000-0003-4435-206X; DiAntonio, Aaron/0000-0002-7262-0968; Milbrandt, Jeffrey/0000-0002-5477-7689	US National Institutes of Health [P30 NS057105, NS040745, AG13730, DA 020812]; Washington University Alzheimer's Disease Research Center National Institute on Aging [NIA P50 AG05681-25]; Hope Center for Neurological Disorders; Keck Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040745, P30NS057105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RF1AG013730, P50AG005681, R01AG013730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA020812] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Washington University Alzheimer's Disease Research Center National Institute on Aging; Hope Center for Neurological Disorders; Keck Foundation(W.M. Keck Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank the members of our laboratories, V. Cavalli and E. M. Johnson. This work was supported by US National Institutes of Health grants P30 NS057105 to Washington University, NS040745 (J. M.), AG13730 (J. M.), DA 020812 (A. D.), Washington University Alzheimer's Disease Research Center National Institute on Aging grant NIA P50 AG05681-25 (A. D.), the Hope Center for Neurological Disorders and the Keck Foundation (A. D.).	Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Bloom AJ, 2007, GENE DEV, V21, P2593, DOI 10.1101/gad.1592107; Cavalli V, 2005, J CELL BIOL, V168, P775, DOI 10.1083/jcb.200410136; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; Collins CA, 2006, NEURON, V51, P57, DOI 10.1016/j.neuron.2006.05.026; Gallo KA, 2002, NAT REV MOL CELL BIO, V3, P663, DOI 10.1038/nrm906; GEORGE EB, 1995, J NEUROSCI, V15, P6445; Hoopfer ED, 2006, NEURON, V50, P883, DOI 10.1016/j.neuron.2006.05.013; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; MacDonald JM, 2006, NEURON, V50, P869, DOI 10.1016/j.neuron.2006.04.028; Mack TGA, 2001, NAT NEUROSCI, V4, P1199, DOI 10.1038/nn770; Saxena S, 2007, PROG NEUROBIOL, V83, P174, DOI 10.1016/j.pneurobio.2007.07.007; Wang J, 2005, J CELL BIOL, V170, P349, DOI 10.1083/jcb.200504028; Wang MS, 2000, J NEUROPATH EXP NEUR, V59, P599, DOI 10.1093/jnen/59.7.599; Zhai QW, 2003, NEURON, V39, P217, DOI 10.1016/S0896-6273(03)00429-X	15	214	221	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2009	12	4					387	389		10.1038/nn.2290	http://dx.doi.org/10.1038/nn.2290			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	424JN	19287387	Green Accepted			2022-12-17	WOS:000264563100010
J	Heintz, N				Heintz, N			Gene expression nervous system atlas (GENSAT)	NATURE NEUROSCIENCE			English	Article									Rockefeller Univ, New York, NY 10021 USA; Howard Hughes Med Inst, New York, NY 10021 USA	Rockefeller University; Howard Hughes Medical Institute	Heintz, N (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.	heintz@rockvax.rockefeller.edu						Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033	1	214	218	0	5	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2004	7	5					483	483		10.1038/nn0504-483	http://dx.doi.org/10.1038/nn0504-483			1	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	816HP	15114362	Bronze			2022-12-17	WOS:000221101300017
J	Moores, E; Laiti, L; Chelazzi, L				Moores, E; Laiti, L; Chelazzi, L			Associative knowledge controls deployment of visual selective attention	NATURE NEUROSCIENCE			English	Article							FIGURE GROUND ORGANIZATION; INFERIOR TEMPORAL CORTEX; OBJECT IDENTIFICATION; NEURAL MECHANISMS; SCENE PERCEPTION; WORKING-MEMORY; SEARCH; RECOGNITION; V4; NEURONS	According to some models of visual selective attention, objects in a scene activate corresponding neural representations, which compete for perceptual awareness and motor behavior. During a visual search for a target object, top-down control exerted by working memory representations of the target's defining properties resolves competition in favor of the target. These models, however, ignore the existence of associative links among object representations. Here we show that such associations can strongly influence deployment of attention in humans. In the context of visual search, objects associated with the target were both recalled more often and recognized more accurately than unrelated distractors. Notably, both target and associated objects competitively weakened recognition of unrelated distractors and slowed responses to a luminance probe. Moreover, in a speeded search protocol, associated objects rendered search both slower and less accurate. Finally, the first saccades after onset of the stimulus array were more often directed toward associated than control items.	Univ Verona, Dept Neurol & Vis Sci, Physiol Sect, I-37134 Verona, Italy; Aston Univ, Neurosci Res Inst, Birmingham B4 7ET, W Midlands, England	University of Verona; Aston University	Chelazzi, L (corresponding author), Univ Verona, Dept Neurol & Vis Sci, Physiol Sect, Strada Le Grazie 8, I-37134 Verona, Italy.	leonardo.chelazzi@univr.it	Chelazzi, Leonardo/B-6084-2011	Chelazzi, Leonardo/0000-0001-8566-0611; moores, elisabeth/0000-0003-3997-0832				Anderson J.R., 1973, HUMAN ASS MEMORY; [Anonymous], 1949, CLIN PSYCHOL-UK, DOI DOI 10.4324/9781410612403; Awh E, 1998, J EXP PSYCHOL HUMAN, V24, P780, DOI 10.1037/0096-1523.24.3.780; BIEDERMAN I, 1982, COGNITIVE PSYCHOL, V14, P143, DOI 10.1016/0010-0285(82)90007-X; BIEDERMAN I, 1973, J EXP PSYCHOL, V97, P22, DOI 10.1037/h0033776; BOYCE SJ, 1989, J EXP PSYCHOL HUMAN, V15, P556, DOI 10.1037/0096-1523.15.3.556; BUNDESEN C, 1990, PSYCHOL REV, V97, P523, DOI 10.1037/0033-295X.97.4.523; Butter CM, 2000, VIS COGN, V7, P769, DOI 10.1080/13506280050144425; CHELAZZI L, 1993, NATURE, V363, P345, DOI 10.1038/363345a0; Chelazzi L, 1998, J NEUROPHYSIOL, V80, P2918, DOI 10.1152/jn.1998.80.6.2918; Chun MM, 2000, TRENDS COGN SCI, V4, P170, DOI 10.1016/S1364-6613(00)01476-5; Chun MM, 1999, PSYCHOL SCI, V10, P360, DOI 10.1111/1467-9280.00168; COLLINS AM, 1975, PSYCHOL REV, V82, P407, DOI 10.1037/0033-295X.82.6.407; Deese J, 1965, STRUCTURE ASS LANGUA; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.neuro.18.1.193; Downing PE, 2000, PSYCHOL SCI, V11, P467, DOI 10.1111/1467-9280.00290; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037/0033-295X.96.3.433; Estes W.K., 1994, CLASSIFICATION COGNI; Findlay JM, 1997, VISION RES, V37, P617, DOI 10.1016/S0042-6989(96)00218-0; Fodor J.A., 1983, MODULARITY MIND; FRIEDMAN A, 1979, J EXP PSYCHOL GEN, V108, P316, DOI 10.1037/0096-3445.108.3.316; GLASER WR, 1992, COGNITION, V42, P61, DOI 10.1016/0010-0277(92)90040-O; Henderson JM, 1999, ANNU REV PSYCHOL, V50, P243, DOI 10.1146/annurev.psych.50.1.243; Hollingworth A, 1998, J EXP PSYCHOL GEN, V127, P398, DOI 10.1037/0096-3445.127.4.398; Humphreys GW, 1997, PHILOS T R SOC B, V352, P1275, DOI 10.1098/rstb.1997.0110; ISHAI A, 1995, SCIENCE, V268, P1712; Laberge D., 1995, ATTENTIONAL PROCESSI; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; McClelland James L, 2000, OXFORD HDB MEMORY, P583; OCHSNER KN, 1994, CURR OPIN NEUROBIOL, V4, P189, DOI 10.1016/0959-4388(94)90071-X; PALMER SE, 1975, MEM COGNITION, V3, P519, DOI 10.3758/BF03197524; Parasuraman R, 2001, VIS COGN, V8, P103, DOI 10.1080/13506280042000045; PETERSON MA, 1994, PERCEPT PSYCHOPHYS, V56, P551, DOI 10.3758/BF03206951; PETERSON MA, 1993, COGNITIVE PSYCHOL, V25, P383, DOI 10.1006/cogp.1993.1010; Peterson MA, 2001, VIS COGN, V8, P329, DOI 10.1080/13506280143000034; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; POSNER MI, 1994, TRENDS NEUROSCI, V17, P75, DOI 10.1016/0166-2236(94)90078-7; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Reynolds JH, 2000, NEURON, V26, P703, DOI 10.1016/S0896-6273(00)81206-4; Roediger H. L., 1993, HANDB NEUR, P63; ROEDIGER HL, 1995, J EXP PSYCHOL LEARN, V21, P803, DOI 10.1037/0278-7393.21.4.803; SPERLING G, 1960, PSYCHOL MONOGR, V74, P1, DOI 10.1037/h0093759; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; TULVING E, 1990, SCIENCE, V247, P301, DOI 10.1126/science.2296719; VANDERHEIDEN AHC, 1992, SELECTIVE ATTENTION; WOLFE JM, 1999, FLEETING MEMORIES; Yantis S., 1998, ATTENTION, V1, P223, DOI DOI 10.1037/0096-1523.16.4.812	48	214	229	4	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2003	6	2					182	189		10.1038/nn996	http://dx.doi.org/10.1038/nn996			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	640CL	12514738				2022-12-17	WOS:000180669100019
J	von Gall, C; Garabette, ML; Kell, CA; Frenzel, S; Dehghani, F; Schumm-Draeger, PM; Weaver, DR; Korf, HW; Hastings, MH; Stehle, JH				von Gall, C; Garabette, ML; Kell, CA; Frenzel, S; Dehghani, F; Schumm-Draeger, PM; Weaver, DR; Korf, HW; Hastings, MH; Stehle, JH			Rhythmic gene expression in pituitary depends on heterologous sensitization by the neurohormone melatonin	NATURE NEUROSCIENCE			English	Article							PARS TUBERALIS; PHOTOPERIODIC REGULATION; CIRCADIAN CLOCK; PINEAL-GLAND; MOUSE SCN; MPER1; ADENOSINE; HAMSTER; CLONING; LIGHT	In mammals, many daily cycles are driven by a central circadian clock, which is based on the cell-autonomous rhythmic expression of clock genes. It is not clear, however, how peripheral cells are able to interpret the rhythmic signals disseminated from this central oscillator. Here we show that cycling expression of the clock gene Period1 in rodent pituitary cells depends on the heterologous sensitization of the adenosine A(2b) receptor, which occurs through the nocturnal activation of melatonin mt1 receptors. Eliminating the impact of the neurohormone melatonin simultaneously suppresses the expression of Period1 and evokes an increase in the release of pituitary prolactin. Our findings expose a mechanism by which two convergent signals interact within a temporal dimension to establish high-amplitude, precise and robust cycles of gene expression.	Goethe Univ Frankfurt, Inst Anat 2, D-60590 Frankfurt, Germany; Goethe Univ Frankfurt, Inst Internal Med, D-60590 Frankfurt, Germany; Univ Cambridge, Dept Anat, Cambridge CB2 3DY, England; Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01655 USA; MRC Ctr, Mol Biol Lab, Div Neurobiol, Cambridge CB2 2QH, England	Goethe University Frankfurt; Goethe University Frankfurt; University of Cambridge; University of Massachusetts System; University of Massachusetts Worcester; MRC Laboratory Molecular Biology	Stehle, JH (corresponding author), Goethe Univ Frankfurt, Inst Anat 2, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	stehle@em.uni-frankfurt.de	Jansen, Heiko T./A-5770-2008; Korf, Horst/ACX-9860-2022; Von+Gall, Charlotte/AAJ-2160-2021	Jansen, Heiko T./0000-0003-0178-396X; Korf, Horst/0000-0002-5051-0303; Von+Gall, Charlotte/0000-0002-5088-3118; Hastings, Michael Harvey/0000-0001-8576-6651; Weaver, David/0000-0001-7941-6719	NATIONAL INSTITUTE ON AGING [P01AG009975] Funding Source: NIH RePORTER; NIA NIH HHS [AG09975] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; CARLSON LL, 1989, ENDOCRINOLOGY, V125, P2670, DOI 10.1210/endo-125-5-2670; Hastings MH, 2001, J BIOL RHYTHM, V16, P424, DOI 10.1177/074873001129002015; HAZLERIGG DG, 1993, ENDOCRINOLOGY, V132, P285, DOI 10.1210/en.132.1.285; Hazlerigg DG, 2001, J ENDOCRINOL, V170, P493, DOI 10.1677/joe.0.1700493; Klein D.C., 1991, SUPRACHIASMATIC NUCL; Korf H.-W., 1998, Advances in Anatomy Embryology and Cell Biology, V146, P1; Li XM, 2000, AM J PHYSIOL-REG I, V278, pR924, DOI 10.1152/ajpregu.2000.278.4.R924; LINCOLN GA, 1995, J NEUROENDOCRINOL, V7, P637, DOI 10.1111/j.1365-2826.1995.tb00802.x; Liu C, 1997, NEURON, V19, P91, DOI 10.1016/S0896-6273(00)80350-5; Maronde E, 1999, J NEUROSCI, V19, P3326; MARQUARDT DL, 1994, J IMMUNOL, V152, P4508; McNulty S, 1996, J NEUROENDOCRINOL, V8, P635; Messager S, 2001, NEUROREPORT, V12, P579, DOI 10.1097/00001756-200103050-00029; Messager S, 1999, P NATL ACAD SCI USA, V96, P9938, DOI 10.1073/pnas.96.17.9938; Morgan PJ, 2000, J NEUROENDOCRINOL, V12, P287; Pfeffer M, 1998, EUR J NEUROSCI, V10, P2896, DOI 10.1111/j.1460-9568.1998.00309.x; Porkka-Heiskanen T, 1997, SCIENCE, V276, P1265, DOI 10.1126/science.276.5316.1265; Rajaratnam SM, 2001, LANCET, V358, P999, DOI 10.1016/S0140-6736(01)06108-6; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Shigeyoshi Y, 1997, CELL, V91, P1043, DOI 10.1016/S0092-8674(00)80494-8; STEHLE JH, 1995, J PINEAL RES, V18, P179, DOI 10.1111/j.1600-079X.1995.tb00158.x; STEHLE JH, 1993, NATURE, V365, P314, DOI 10.1038/365314a0; STEHLE JH, 1992, MOL ENDOCRINOL, V6, P384, DOI 10.1210/me.6.3.384; Stirland JA, 2001, J NEUROENDOCRINOL, V13, P147, DOI 10.1046/j.1365-2826.2001.00611.x; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Sun ZS, 1997, CELL, V90, P1003, DOI 10.1016/S0092-8674(00)80366-9; Takekida S, 2000, EUR J NEUROSCI, V12, P4557, DOI 10.1046/j.0953-816X.2000.01324.x; von Gall C, 1998, J NEUROSCI, V18, P10389; von Gall C, 2000, EUR J NEUROSCI, V12, P964, DOI 10.1046/j.1460-9568.2000.00990.x; von Gall C, 2000, NEUROREPORT, V11, P1803, DOI 10.1097/00001756-200006260-00002; von Gall C, 2001, J NEUROENDOCRINOL, V13, P313, DOI 10.1046/j.1365-2826.2001.00643.x; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682	36	214	217	0	6	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2002	5	3					234	238		10.1038/nn806	http://dx.doi.org/10.1038/nn806			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	526TP	11836530				2022-12-17	WOS:000174146000013
J	Wilson, SI; Edlund, T				Wilson, SI; Edlund, T			Neural induction: toward a unifying mechanism	NATURE NEUROSCIENCE			English	Review							FIBROBLAST-GROWTH-FACTOR; DORSAL-VENTRAL AXIS; XENOPUS EMBRYOS; CHICK-EMBRYO; DORSOVENTRAL PATTERN; SPEMANN ORGANIZER; HEAD INDUCTION; FOREBRAIN DEVELOPMENT; PRIMITIVE ENDODERM; SECRETED PROTEINS	Neural induction constitutes the initial step in the generation of the vertebrate nervous system. In attempting to understand the principles that underlie this process, two key issues need to be resolved. When is neural induction initiated, and what is the cellular source and molecular nature of the neural inducing signal(s)? Currently, these aspects of neural induction seem to be very different in amphibian and amniote embryos. Here we highlight the similarities and the differences, and we propose a possible unifying mechanism.	Umea Univ, Dept Mol Biol, S-90187 Umea, Sweden	Umea University	Edlund, T (corresponding author), Umea Univ, Dept Mol Biol, S-90187 Umea, Sweden.							ANG SL, 1994, CELL, V78, P561, DOI 10.1016/0092-8674(94)90522-3; Bachiller D, 2000, NATURE, V403, P658, DOI 10.1038/35001072; Baker JC, 1999, GENE DEV, V13, P3149, DOI 10.1101/gad.13.23.3149; Barbera JPM, 2000, DEVELOPMENT, V127, P2433; BEDDINGTON RSP, 1994, DEVELOPMENT, V120, P613; CHRISTIAN JL, 1993, GENE DEV, V7, P13, DOI 10.1101/gad.7.1.13; Connolly DJ, 1997, INT J DEV BIOL, V41, P389; Dale JK, 1997, CELL, V90, P257, DOI 10.1016/S0092-8674(00)80334-7; Dale L, 1999, BIOESSAYS, V21, P751, DOI 10.1002/(SICI)1521-1878(199909)21:9<751::AID-BIES6>3.0.CO;2-I; Davidson BP, 1999, DEV BIOL, V211, P11, DOI 10.1006/dbio.1999.9276; Dick A, 2000, DEVELOPMENT, V127, P343; Episkopou V, 2001, NATURE, V410, P825, DOI 10.1038/35071095; FAINSOD A, 1994, EMBO J, V13, P5015, DOI 10.1002/j.1460-2075.1994.tb06830.x; Fekany-Lee K, 2000, DEVELOPMENT, V127, P2333; Foley AC, 2000, DEVELOPMENT, V127, P3839; Fukushima M, 1996, DEVELOPMENT, V122, P905; Gamse JT, 2001, MECH DEVELOP, V104, P21, DOI 10.1016/S0925-4773(01)00358-6; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Glinka A, 1997, NATURE, V389, P517, DOI 10.1038/39092; GRUNZ H, 1989, CELL DIFFER DEV, V28, P211, DOI 10.1016/0922-3371(89)90006-3; Hammerschmidt M, 1996, GENE DEV, V10, P2452, DOI 10.1101/gad.10.19.2452; Hansen CS, 1997, DEVELOPMENT, V124, P483; Harland R, 2000, CURR OPIN GENET DEV, V10, P357, DOI 10.1016/S0959-437X(00)00096-4; HAWLEY SHB, 1995, GENE DEV, V9, P2923, DOI 10.1101/gad.9.23.2923; HEMMATIBRIVANLOU A, 1994, CELL, V77, P283, DOI 10.1016/0092-8674(94)90320-4; HEMMATIBRIVANLOU A, 1995, DEV GENET, V17, P78, DOI 10.1002/dvg.1020170109; HemmatiBrivanlou A, 1997, ANNU REV NEUROSCI, V20, P43, DOI 10.1146/annurev.neuro.20.1.43; HEMMATIBRIVANLOU A, 1992, NATURE, V359, P609, DOI 10.1038/359609a0; Hild M, 1999, DEVELOPMENT, V126, P2149; Holowacz T, 1999, DEV BIOL, V205, P296, DOI 10.1006/dbio.1998.9108; Hongo I, 1999, DEV BIOL, V216, P561, DOI 10.1006/dbio.1999.9515; Hsieh JC, 1999, P NATL ACAD SCI USA, V96, P3546, DOI 10.1073/pnas.96.7.3546; ISAACS HV, 1995, INT J DEV BIOL, V39, P575; Itoh K, 1995, DEVELOPMENT, V121, P3979; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; KENGAKU M, 1995, DEVELOPMENT, V121, P3121; Kimura C, 2000, DEV BIOL, V225, P304, DOI 10.1006/dbio.2000.9835; KINTNER CR, 1991, DEVELOPMENT, V113, P1495; Klingensmith J, 1999, DEV BIOL, V216, P535, DOI 10.1006/dbio.1999.9525; Knoetgen H, 2000, DEV BIOL, V225, P370, DOI 10.1006/dbio.2000.9834; Knoetgen H, 1999, DEVELOPMENT, V126, P815; Kroll KL, 1998, DEVELOPMENT, V125, P3247; Kroll KL, 1996, DEVELOPMENT, V122, P3173; Kurata T, 2001, DIFFERENTIATION, V67, P33, DOI 10.1046/j.1432-0436.2001.067001033.x; LAMB TM, 1995, DEVELOPMENT, V121, P3627; LAMB TM, 1993, SCIENCE, V262, P713, DOI 10.1126/science.8235591; Launay C, 1996, DEVELOPMENT, V122, P869; Levin M, 1998, INT J DEV BIOL, V42, P553; MATZUK MM, 1995, NATURE, V374, P360, DOI 10.1038/374360a0; McMahon JA, 1998, GENE DEV, V12, P1438, DOI 10.1101/gad.12.10.1438; Miller JR, 1999, J CELL BIOL, V146, P427, DOI 10.1083/jcb.146.2.427; Mizuseki K, 1998, NEURON, V21, P77, DOI 10.1016/S0896-6273(00)80516-4; Moon RT, 1997, TRENDS GENET, V13, P157, DOI 10.1016/S0168-9525(97)01093-7; Muhr J, 1999, NEURON, V23, P689, DOI 10.1016/S0896-6273(01)80028-3; Muhr J, 1997, NEURON, V19, P487, DOI 10.1016/S0896-6273(00)80366-9; Nguyen VH, 1998, DEV BIOL, V199, P93, DOI 10.1006/dbio.1998.8927; Niehrs C, 1999, TRENDS GENET, V15, P314, DOI 10.1016/S0168-9525(99)01767-9; NIEUWKOOP PD, 1952, J EXP ZOOL, V120, P1, DOI 10.1002/jez.1401200102; Penzel R, 1997, INT J DEV BIOL, V41, P667; Pera E, 1999, DEVELOPMENT, V126, P63; Pera EM, 2000, MECH DEVELOP, V96, P183, DOI 10.1016/S0925-4773(00)00394-4; Powers CJ, 2000, ENDOCR-RELAT CANCER, V7, P165, DOI 10.1677/erc.0.0070165; Ribisi S, 2000, DEV BIOL, V227, P183, DOI 10.1006/dbio.2000.9889; ROTH S, 1989, CELL, V59, P1189, DOI 10.1016/0092-8674(89)90774-5; SASAI Y, 1995, NATURE, V376, P333, DOI 10.1038/376333a0; Sasai Y, 1996, EMBO J, V15, P4547, DOI 10.1002/j.1460-2075.1996.tb00832.x; Sasai Y, 1997, DEV BIOL, V182, P5, DOI 10.1006/dbio.1996.8445; SATER AK, 1990, DEVELOPMENT, V108, P461; Schier AF, 2001, INT J DEV BIOL, V45, P289; Sheng GJ, 1999, MECH DEVELOP, V87, P213, DOI 10.1016/S0925-4773(99)00150-1; Shibata M, 2000, MECH DEVELOP, V96, P243, DOI 10.1016/S0925-4773(00)00399-3; Shih J, 1996, DEVELOPMENT, V122, P1313; SMITH JL, 1989, J EXP ZOOL, V250, P49, DOI 10.1002/jez.1402500107; Spemann H, 1924, ARCH MIKROSK ANAT EN, V100, P599, DOI 10.1007/BF02108133; Spemann H, 2001, INT J DEV BIOL, V45, P13; Stern CD, 2001, NAT REV NEUROSCI, V2, P92, DOI 10.1038/35053563; STJOHNSTON RD, 1987, EMBO J, V6, P2785, DOI 10.1002/j.1460-2075.1987.tb02574.x; STOREY KG, 1992, DEVELOPMENT, V114, P729; Streit A, 2000, NATURE, V406, P74, DOI 10.1038/35017617; Streit A, 1999, TRENDS GENET, V15, P20, DOI 10.1016/S0168-9525(98)01620-5; Streit A, 1998, DEVELOPMENT, V125, P507; Streit A, 1999, MECH DEVELOP, V82, P51, DOI 10.1016/S0925-4773(99)00013-1; Suzuki A, 1997, DEVELOPMENT, V124, P3037; Thomas P, 1996, CURR BIOL, V6, P1487, DOI 10.1016/S0960-9822(96)00753-1; Umbhauer M, 2000, J CELL SCI, V113, P2865; VINCENT JP, 1986, DEV BIOL, V113, P484, DOI 10.1016/0012-1606(86)90184-3; Waddington C. H., 1937, Archives de Biologie Liege, V48, P273; Waddington CH, 1932, PHILOS T R SOC LON B, V221, P179, DOI 10.1098/rstb.1932.0003; Waddington CH, 1933, J EXP BIOL, V10, P38; Wessely O, 2001, DEV BIOL, V234, P161, DOI 10.1006/dbio.2001.0258; Wilson PA, 1997, DEVELOPMENT, V124, P3177; Wilson PA, 1997, NEURON, V18, P699, DOI 10.1016/S0896-6273(00)80311-6; WILSON PA, 1995, NATURE, V376, P331, DOI 10.1038/376331a0; Wilson SI, 2000, CURR BIOL, V10, P421, DOI 10.1016/S0960-9822(00)00431-0; Wilson SI, 2001, NATURE, V411, P325, DOI 10.1038/35077115; XU RH, 1995, BIOCHEM BIOPH RES CO, V212, P212, DOI 10.1006/bbrc.1995.1958; Yamaguchi TP, 1999, GENE DEV, V13, P3185, DOI 10.1101/gad.13.24.3185; ZHANG J, 1993, DEV DYNAM, V196, P79, DOI 10.1002/aja.1001960202	98	214	218	0	18	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2001	4			S			1161	1168		10.1038/nn747	http://dx.doi.org/10.1038/nn747			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	490GF	11687825				2022-12-17	WOS:000172041500007
J	Phillips, TJ; Brown, KJ; Burkhart-Kasch, S; Wenger, CD; Kelly, MA; Rubinstein, M; Grandy, DK; Low, MJ				Phillips, TJ; Brown, KJ; Burkhart-Kasch, S; Wenger, CD; Kelly, MA; Rubinstein, M; Grandy, DK; Low, MJ			Alcohol preference and sensitivity are markedly reduced in mice lacking dopamine D-2 receptors	NATURE NEUROSCIENCE			English	Article							C57BL/6J INBRED MOUSE; NUCLEUS-ACCUMBENS; MOLECULAR MECHANISMS; D2 RECEPTOR; ETHANOL; GENE; RATS; CONSUMPTION; ASSOCIATION; STRAINS	Although dopaminergic transmission has been strongly implicated in alcohol self-administration, the involvement of specific dopamine receptor subtypes has not been well established. We studied the ethanol preference and sensitivity of D-2-receptor-deficient mice to directly evaluate whether dopamine D-2 receptors contribute to alcohol (ethanol) consumption. We report a marked aversion to ethanol in these mice, relative to the high preference and consumption exhibited by wild-type littermates. Sensitivity to ethanol-induced locomotor impairment was also reduced in these mutant mice, although they showed a normal locomotor depressant response to the dopamine D-1 antagonist SCH-23390, These data demonstrate that dopamine signaling via D-2 receptors is an essential component of the molecular pathway determining ethanol self-administration and sensitivity.	Dept Vet Affairs Med Ctr, Portland, OR 97201 USA; Oregon Hlth Sci Univ, Portland Alcohol Res Ctr, Portland, OR 97201 USA; Oregon Hlth Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA; Oregon Hlth Sci Univ, Vollum Inst, Portland, OR 97201 USA; Oregon Hlth Sci Univ, Dept Cell & Dev Biol, Portland, OR 97201 USA; Oregon Hlth Sci Univ, Dept Physiol & Pharmacol, Portland, OR 97201 USA; CONICET, Inst Invest Ingn Genet & Biol Mol, RA-1033 Buenos Aires, DF, Argentina; Univ Buenos Aires, Dept Biol, Buenos Aires, DF, Argentina	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Phillips, TJ (corresponding author), Dept Vet Affairs Med Ctr, Portland, OR 97201 USA.			Low, Malcolm/0000-0002-9900-3708; Kelly, Michele/0000-0003-1799-055X	NIAAA NIH HHS [P50 AA10760, P60 AA010760, T32 AA07468] Funding Source: Medline; NIDA NIH HHS [T32 DA07262] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P60AA010760, P50AA010760, T32AA007468] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007262] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		BALK JH, 1995, NATURE, V377, P424; BELKNAP JK, 1993, PSYCHOPHARMACOLOGY, V112, P503, DOI 10.1007/BF02244901; BLUM K, 1990, JAMA-J AM MED ASSOC, V263, P2055, DOI 10.1001/jama.263.15.2055; CLONINGER CR, 1991, JAMA-J AM MED ASSOC, V266, P1833; Crabbe JC, 1996, NAT GENET, V14, P98, DOI 10.1038/ng0996-98; CRABBE JC, IN PRESS TRENDS NEUR; CUNNINGHAM CL, 1992, PSYCHOPHARMACOLOGY, V107, P385, DOI 10.1007/BF02245166; DICHIARA G, 1985, EUR J PHARMACOL, V115, P131, DOI 10.1016/0014-2999(85)90598-9; DUDEK BC, 1990, PSYCHOPHARMACOLOGY, V101, P93, DOI 10.1007/BF02253724; DUDEK BC, 1991, ALCOHOL CLIN EXP RES, V15, P262, DOI 10.1111/j.1530-0277.1991.tb01867.x; DUDEK BC, 1994, PHARMACOL BIOCHEM BE, V48, P593, DOI 10.1016/0091-3057(94)90319-0; DYR W, 1993, ALCOHOL, V10, P207, DOI 10.1016/0741-8329(93)90037-O; ERWIN VG, 1993, PHARMACOGENETICS, V3, P189, DOI 10.1097/00008571-199308000-00003; FROEHLICH JC, 1988, PHARMACOL BIOCHEM BE, V31, P215, DOI 10.1016/0091-3057(88)90336-X; GELERNTER J, 1993, JAMA-J AM MED ASSOC, V269, P1673, DOI 10.1001/jama.269.13.1673; GEORGE SR, 1995, J PHARMACOL EXP THER, V273, P373; GOLDMAN D, 1995, CLIN NEUROSCI, V3, P174; GRANDY DK, 1989, AM J HUM GENET, V45, P778; Hodge C. W., 1996, PHARM EFFECTS ETHANO, P203; Hodge CW, 1997, ALCOHOL CLIN EXP RES, V21, P1083, DOI 10.1111/j.1530-0277.1997.tb04257.x; Kelly MA, 1997, NEURON, V19, P103, DOI 10.1016/S0896-6273(00)80351-7; Kelly MA, 1998, J NEUROSCI, V18, P3470; KOOB GF, 1988, SCIENCE, V242, P715, DOI 10.1126/science.2903550; LANCA AJ, 1994, NEUROSCIENCE, V58, P359, DOI 10.1016/0306-4522(94)90043-4; LEVY AD, 1991, ALCOHOL ALCOHOLISM, P417; Low MJ, 1998, MOL PSYCHIATR, V3, P375, DOI 10.1038/sj.mp.4000455; MCBRIDE WJ, 1993, ALCOHOL, V10, P387, DOI 10.1016/0741-8329(93)90025-J; MCCLEARN GE, 1959, Q J STUD ALCOHOL, V20, P691; Melo JA, 1996, NAT GENET, V13, P147, DOI 10.1038/ng0696-147; NG GYK, 1994, EUR J PHARM-MOLEC PH, V269, P349, DOI 10.1016/0922-4106(94)90043-4; NG GYK, 1994, EUR J PHARM-MOLEC PH, V269, P365, DOI 10.1016/0922-4106(94)90044-2; Orr TE, 1997, ALCOHOL CLIN EXP RES, V21, P1491; PATO CN, 1993, AM J MED GENET, V48, P78, DOI 10.1002/ajmg.1320480204; Phillips TJ, 1996, INT REV NEUROBIOL, V39, P243, DOI 10.1016/S0074-7742(08)60669-8; Phillips TJ, 1998, J NEUROSCI, V18, P3023; PHILLIPS TJ, 1994, ALCOHOL CLIN EXP RES, V18, P931, DOI 10.1111/j.1530-0277.1994.tb00062.x; PHILLIPS TJ, 1995, ALCOHOL CLIN EXP RES, V19, P269, DOI 10.1111/j.1530-0277.1995.tb01502.x; RASSNICK S, 1992, PSYCHOPHARMACOLOGY, V109, P92, DOI 10.1007/BF02245485; RODRIGUEZ LA, 1995, ALCOHOL CLIN EXP RES, V19, P367, DOI 10.1111/j.1530-0277.1995.tb01517.x; SCHUCKIT MA, 1994, AM J PSYCHIAT, V151, P184; SELF DW, 1995, ANNU REV NEUROSCI, V18, P463, DOI 10.1146/annurev.neuro.18.1.463; STEFANINI E, 1992, ALCOHOL ALCOHOLISM, V27, P127; SUAREZ BK, 1994, GENOMICS, V19, P12, DOI 10.1006/geno.1994.1005; SYVALAHTI EKG, 1994, ALCOHOL CLIN EXP RES, V18, P1029, DOI 10.1111/j.1530-0277.1994.tb00078.x; Tarantino LM, 1998, ALCOHOL CLIN EXP RES, V22, P1099; TERDAL ES, 1994, ALCOHOL CLIN EXP RES, V18, P542, DOI 10.1111/j.1530-0277.1994.tb00907.x; TURNER E, 1992, BIOL PSYCHIAT, V31, P285, DOI 10.1016/0006-3223(92)90052-2; WEISS F, 1993, J PHARMACOL EXP THER, V267, P250; WISE RA, 1987, PSYCHOL REV, V94, P469, DOI 10.1037/0033-295X.94.4.469	49	214	219	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	1998	1	7					610	615		10.1038/2843	http://dx.doi.org/10.1038/2843			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	146NL	10196569				2022-12-17	WOS:000077437100017
J	Romanov, RA; Zeisel, A; Bakker, J; Girach, F; Hellysaz, A; Tomer, R; Alpar, A; Mulder, J; Clotman, F; Keimpema, E; Hsueh, B; Crow, AK; Martens, H; Schwindling, C; Calvigioni, D; Bains, JS; Mate, Z; Szabo, G; Yanagawa, Y; Zhang, MD; Rendeiro, A; Farlik, M; Uhlen, M; Wulff, P; Bock, C; Broberger, C; Deisseroth, K; Hokfelt, T; Linnarsson, S; Horvath, TL; Harkany, T				Romanov, Roman A.; Zeisel, Amit; Bakker, Joanne; Girach, Fatima; Hellysaz, Arash; Tomer, Raju; Alpar, Alan; Mulder, Jan; Clotman, Frederic; Keimpema, Erik; Hsueh, Brian; Crow, Ailey K.; Martens, Henrik; Schwindling, Christian; Calvigioni, Daniela; Bains, Jaideep S.; Mate, Zoltan; Szabo, Gabor; Yanagawa, Yuchio; Zhang, Ming-Dong; Rendeiro, Andre; Farlik, Matthias; Uhlen, Mathias; Wulff, Peer; Bock, Christoph; Broberger, Christian; Deisseroth, Karl; Hokfelt, Tomas; Linnarsson, Sten; Horvath, Tamas L.; Harkany, Tibor			Molecular interrogation of hypothalamic organization reveals distinct dopamine neuronal subtypes	NATURE NEUROSCIENCE			English	Article							INNERVATE NEUROENDOCRINE CELLS; SUPRACHIASMATIC NUCLEUS; PARAVENTRICULAR NUCLEUS; MESSENGER-RNA; NEUROMEDIN-S; IDENTIFICATION; EXPRESSION; COMPLEX; PITUITARY; CIRCUIT	The hypothalamus contains the highest diversity of neurons in the brain. Many of these neurons can co-release neurotransmitters and neuropeptides in a use-dependent manner. Investigators have hitherto relied on candidate protein-based tools to correlate behavioral, endocrine and gender traits with hypothalamic neuron identity. Here we map neuronal identities in the hypothalamus by single-cell RNA sequencing. We distinguished 62 neuronal subtypes producing glutamatergic, dopaminergic or GABAergic markers for synaptic neurotransmission and harboring the ability to engage in task-dependent neurotransmitter switching. We identified dopamine neurons that uniquely coexpress the Onecut3 and Nmur2 genes, and placed these in the periventricular nucleus with many synaptic afferents arising from neuromedin S+ neurons of the suprachiasmatic nucleus. These neuroendocrine dopamine cells may contribute to the dopaminergic inhibition of prolactin secretion diurnally, as their neuromedin S+ inputs originate from neurons expressing Per2 and Per3 and their tyrosine hydroxylase phosphorylation is regulated in a circadian fashion. Overall, our catalog of neuronal subclasses provides new understanding of. hypothalamic organization and function.	[Romanov, Roman A.; Girach, Fatima; Keimpema, Erik; Calvigioni, Daniela; Harkany, Tibor] Med Univ Vienna, Dept Mol Neurosci, Ctr Brain Res, Vienna, Austria; [Zeisel, Amit; Linnarsson, Sten] Karolinska Inst, Div Mol Neurobiol, Dept Med Biochem & Biophys, Stockholm, Sweden; [Bakker, Joanne; Hellysaz, Arash; Calvigioni, Daniela; Zhang, Ming-Dong; Broberger, Christian; Hokfelt, Tomas; Harkany, Tibor] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Tomer, Raju; Hsueh, Brian; Crow, Ailey K.; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Tomer, Raju; Hsueh, Brian; Crow, Ailey K.; Deisseroth, Karl] Stanford Univ, CNC Program, Stanford, CA 94305 USA; [Alpar, Alan] Hungarian Acad Sci, MTA SE NAP Res Grp Expt Neuroanat & Dev Biol, Budapest, Hungary; [Alpar, Alan] Semmelweis Univ, Dept Anat, Budapest, Hungary; [Mulder, Jan] Karolinska Inst, Dept Neurosci, Sci Life Labs, Stockholm, Sweden; [Clotman, Frederic] Catholic Univ Louvain, Inst Neurosci, Lab Neural Differentiat, Brussels, Belgium; [Martens, Henrik] Synapt Syst GmbH, Gottingen, Germany; [Schwindling, Christian] Carl Zeiss Microscopy GmbH, Microscopy Labs Munich, Global Sales Support Life Sci, Munich, Germany; [Bains, Jaideep S.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Mate, Zoltan; Szabo, Gabor] Hungarian Acad Sci, Inst Expt Med, Budapest, Hungary; [Yanagawa, Yuchio] Gunma Univ, Grad Sch Med, Dept Genet & Behav Neurosci, Maebashi, Gunma, Japan; [Rendeiro, Andre; Farlik, Matthias; Bock, Christoph] Austrian Acad Sci, CeMM Res Ctr Mol Med, Vienna, Austria; [Uhlen, Mathias] Albanova Univ Ctr, Royal Inst Technol, Sci Life Lab, Stockholm, Sweden; [Wulff, Peer] Univ Kiel, Inst Physiol, Kiel, Germany; [Horvath, Tamas L.] Yale Univ, Comparat Med Sect, Program Integrat Cell Signaling & Neurobiol Metab, Sch Med, New Haven, CT 06520 USA	Medical University of Vienna; Karolinska Institutet; Karolinska Institutet; Stanford University; Stanford University; Hungarian Academy of Sciences; Semmelweis University; Karolinska Institutet; Universite Catholique Louvain; Carl Zeiss AG; University of Calgary; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; Gunma University; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Royal Institute of Technology; University of Kiel; Yale University	Harkany, T (corresponding author), Med Univ Vienna, Dept Mol Neurosci, Ctr Brain Res, Vienna, Austria.; Harkany, T (corresponding author), Karolinska Inst, Dept Neurosci, Stockholm, Sweden.; Horvath, TL (corresponding author), Yale Univ, Comparat Med Sect, Program Integrat Cell Signaling & Neurobiol Metab, Sch Med, New Haven, CT 06520 USA.	tamas.horvath@yale.edu; tibor.harkany@meduniwien.ac.at	Bock, Christoph/AAE-7618-2019; Mulder, Jan/G-3909-2011; Uhlen, Mathias/AAV-8746-2021; Linnarsson, Sten/HCH-3909-2022; Rendeiro, André F./AAC-4747-2019; Uhlen, Mathias/B-3262-2016; Mulder, Jan/AAG-9761-2021; Szabo, Gabor/A-5087-2008; Romanov, Roman/J-2349-2015	Bock, Christoph/0000-0001-6091-3088; Mulder, Jan/0000-0003-3717-5018; Rendeiro, André F./0000-0001-9362-5373; Uhlen, Mathias/0000-0002-4858-8056; Szabo, Gabor/0000-0001-5438-5151; Romanov, Roman/0000-0002-3937-518X; Hellysaz, Arash/0000-0003-4512-3795; Harkany, Tibor/0000-0002-6637-5900; Zhang, Mingdong/0000-0002-6348-1994; Keimpema, Erik/0000-0002-7555-6762; Wulff, Peer/0000-0002-0282-7832; Bains, Jaideep/0000-0002-3634-6463	Swedish Research Council; Hjarnfonden; Petrus and Augusta Hedlunds Foundation; Novo Nordisk Foundation; National Brain Research Program of Hungary (MTA-SE NAP B) [KTIA_NAP_13-2014-0013]; European Commission [GA-2012-600394, ALTF 596-2014]; European Research Council; Medical University of Vienna; NIH [AG051459]; Human Frontier Science Program; Austrian Academy of Sciences; NATIONAL INSTITUTE ON AGING [P01AG051459] Funding Source: NIH RePORTER; Alzheimers Research UK [ART-EG2009A-1] Funding Source: researchfish; Novo Nordisk Fonden [NNF15OC0016258, NNF16OC0021482, NNF15OC0015964, NNF17OC0027294, NNF14OC0010695, NNF14OC0011061] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Hjarnfonden; Petrus and Augusta Hedlunds Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); National Brain Research Program of Hungary (MTA-SE NAP B); European Commission(European CommissionEuropean Commission Joint Research Centre); European Research Council(European Research Council (ERC)European Commission); Medical University of Vienna; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program(Human Frontier Science Program); Austrian Academy of Sciences; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Novo Nordisk Fonden(Novo Nordisk Foundation)	The authors thank N.-G. Larsson and L. Olson for providing Dat1-Cre mice for the generation of reporter mice, H. Wong and M. Watanabe for antibodies and K. Meletis for his supervision of viral injections in Dat1-Cre mice. This work was supported by the Swedish Research Council (T. Harkany, T. Hokfelt, S.L., C. Broberger), Hjarnfonden (T. Harkany), the Petrus and Augusta Hedlunds Foundation (T. Harkany), the Novo Nordisk Foundation (T. Harkany, T. Hokfelt, C. Broberger), the National Brain Research Program of Hungary (MTA-SE NAP B, KTIA_NAP_13-2014-0013; A.A.), the European Commission (PAINCAGE grant, T. Harkany, T. Hokfelt), the European Research Council (BRAINCELL; S.L., ENDOSWITCH; C. Broberger and SECRET-CELLS; T. Harkany), intramural funds of the Medical University of Vienna (T. Harkany) and an NIH grant AG051459 (T.L.H.). R.A.R. is an EMBO long-term research fellow (ALTF 596-2014) cofunded by the European Commission FP7 (Marie Curie Actions, EMBOCOFUND2012, GA-2012-600394). A.Z. received support from the Human Frontier Science Program. F.C. is a Research Associate of the Fonds de la Recherche Scientifique-FNRS, Belgium. The single-cell sequencing infrastructure at CeMM was supported by a New Frontiers Research Infrastructure grant from the Austrian Academy of Sciences.	Abizaid A, 2004, EUR J NEUROSCI, V20, P2767, DOI 10.1111/j.1460-9568.2004.03737.x; AJIKA K, 1973, BRAIN RES, V57, P97, DOI 10.1016/0006-8993(73)90571-4; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Ben-Jonathan N, 2001, ENDOCR REV, V22, P724, DOI 10.1210/er.22.6.724; BJORKLUND A, 1973, BRAIN RES, V51, P171, DOI 10.1016/0006-8993(73)90371-5; Boulland JL, 2009, CEREB CORTEX, V19, P241, DOI 10.1093/cercor/bhn077; BRO S, 1977, BEHAV BIOL, V21, P508, DOI 10.1016/S0091-6773(77)92165-4; Clarke IJ, 2015, COMPR PHYSIOL, V5, P217, DOI 10.1002/cphy.c140019; Cristino L, 2013, P NATL ACAD SCI USA, V110, pE2229, DOI 10.1073/pnas.1219485110; DAHLSTROM A, 1964, ACTA PHYSIOL SCAND, V62, P1; DAWSON TM, 1994, J NEUROSCI, V14, P5147; DeMaria JE, 1999, BRAIN RES, V837, P236, DOI 10.1016/S0006-8993(99)01667-4; DU VIGNEAUD V, 1954, Harvey Lect, V50, P1; Dulcis D, 2013, SCIENCE, V340, P449, DOI 10.1126/science.1234152; EVERITT BJ, 1984, NEUROENDOCRINOLOGY, V39, P189, DOI 10.1159/000123977; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; GOUDREAU JL, 1992, NEUROENDOCRINOLOGY, V56, P100, DOI 10.1159/000126214; Henry FE, 2015, ELIFE, V4, DOI 10.7554/eLife.09800; Hokfelt T., 1984, HDB CHEM NEUROANATOM, P277; Holtta M, 2015, J PROTEOME RES, V14, P654, DOI 10.1021/pr501076j; Horvath TL, 1997, ENDOCRINOLOGY, V138, P1312, DOI 10.1210/en.138.3.1312; Horvath TL, 1998, J NEUROSCI, V18, P1546; Irani D, 2009, CEREBROSPINAL FLUID, P69, DOI [10.1016/B978-1-4160-2908-3.X0001-6, DOI 10.1016/B978-141602908-3.50013-3]; Jonas P, 1998, SCIENCE, V281, P419, DOI 10.1126/science.281.5375.419; Krashes MJ, 2014, NATURE, V507, P238, DOI 10.1038/nature12956; LANTOS TA, 1995, BRAIN RES REV, V20, P209, DOI 10.1016/0165-0173(94)00013-F; Lee IT, 2015, NEURON, V85, P1086, DOI 10.1016/j.neuron.2015.02.006; Lee SY, 2011, J NEUROSCI, V31, P10993, DOI 10.1523/JNEUROSCI.1970-11.2011; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; MEISTER B, 1990, CELL TISSUE RES, V260, P279, DOI 10.1007/BF00318631; MEISTER B, 1993, NEUROENDOCRINOLOGY, V58, P388, DOI 10.1159/000126568; Mori K, 2005, EMBO J, V24, P325, DOI 10.1038/sj.emboj.7600526; Moriya R, 2006, ENDOCRINOLOGY, V147, P2916, DOI 10.1210/en.2005-1580; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Romanov RA, 2015, EMBO J, V34, P36, DOI 10.15252/embj.201488977; Scott MM, 2009, J COMP NEUROL, V514, P518, DOI 10.1002/cne.22025; Scott N, 2015, NATURE, V525, P519, DOI 10.1038/nature15378; Sellix MT, 2006, AM J PHYSIOL-REG I, V290, pR1309, DOI 10.1152/ajpregu.00555.2005; Stagkourakis S, 2016, CELL REP, V15, P735, DOI 10.1016/j.celrep.2016.03.062; SWANSON LW, 1980, J COMP NEUROL, V194, P555, DOI 10.1002/cne.901940306; Tekin I, 2014, J NEURAL TRANSM, V121, P1451, DOI 10.1007/s00702-014-1238-7; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Xu XH, 2012, CELL, V148, P596, DOI 10.1016/j.cell.2011.12.018; Yang CF, 2013, CELL, V153, P896, DOI 10.1016/j.cell.2013.04.017; Yang X, 2006, GENOME RES, V16, P995, DOI 10.1101/gr.5217506; Yulyaningsih E, 2014, CELL METAB, V19, P58, DOI 10.1016/j.cmet.2013.11.019; Zagoracz O, 2015, BRAIN RES BULL, V118, P58, DOI 10.1016/j.brainresbull.2015.09.004; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zhang LY, 2016, P NATL ACAD SCI USA, V113, pE1536, DOI 10.1073/pnas.1600039113; Zivraj KH, 2010, J NEUROSCI, V30, P15464, DOI 10.1523/JNEUROSCI.1800-10.2010	50	213	214	3	67	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2017	20	2					176	188		10.1038/nn.4462	http://dx.doi.org/10.1038/nn.4462			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EJ5PU	27991900				2022-12-17	WOS:000393271000012
J	Gupta, VK; Scheunemann, L; Eisenberg, T; Mertel, S; Bhukel, A; Koemans, TS; Kramer, JM; Liu, KSY; Schroeder, S; Stunnenberg, HG; Sinner, F; Magnes, C; Pieber, TR; Dipt, S; Fiala, A; Schenck, A; Schwaerzel, M; Madeo, F; Sigrist, SJ				Gupta, Varun K.; Scheunemann, Lisa; Eisenberg, Tobias; Mertel, Sara; Bhukel, Anuradha; Koemans, Tom S.; Kramer, Jamie M.; Liu, Karen S. Y.; Schroeder, Sabrina; Stunnenberg, Hendrik G.; Sinner, Frank; Magnes, Christoph; Pieber, Thomas R.; Dipt, Shubham; Fiala, Andre; Schenck, Annette; Schwaerzel, Martin; Madeo, Frank; Sigrist, Stephan J.			Restoring polyamines protects from age-induced memory impairment in an autophagy-dependent manner	NATURE NEUROSCIENCE			English	Article							DROSOPHILA-MELANOGASTER; LIFE-SPAN; ORNITHINE-DECARBOXYLASE; DIETARY RESTRICTION; C-ELEGANS; MICE; BRAIN; SPERMIDINE; LONGEVITY; DISEASE	Age-dependent memory impairment is known to occur in several organisms, including Drosophila, mouse and human. However, the fundamental cellular mechanisms that underlie these impairments are still poorly understood, effectively hampering the development of pharmacological strategies to treat the condition. Polyamines are among the substances found to decrease with age in the human brain. We found that levels of polyamines (spermidine, putrescine) decreased in aging fruit flies, concomitant with declining memory abilities. Simple spermidine feeding not only restored juvenile polyamine levels, but also suppressed age-induced memory impairment. Ornithine decarboxylase-1, the rate-limiting enzyme for de novo polyamine synthesis, also protected olfactory memories in aged flies when expressed specifically in Kenyon cells, which are crucial for olfactory memory formation. Spermidine-fed flies showed enhanced autophagy (a form of cellular self-digestion), and genetic deficits in the autophagic machinery prevented spermidine-mediated rescue of memory impairments. Our findings indicate that autophagy is critical for suppression of memory impairments by spermidine and that polyamines, which are endogenously present, are candidates for pharmacological intervention.	[Gupta, Varun K.; Scheunemann, Lisa; Mertel, Sara; Bhukel, Anuradha; Koemans, Tom S.; Liu, Karen S. Y.; Schwaerzel, Martin; Sigrist, Stephan J.] Free Univ Berlin, Inst Biol Genet, Berlin, Germany; [Gupta, Varun K.; Bhukel, Anuradha; Liu, Karen S. Y.; Sigrist, Stephan J.] NeuroCure Charite, Berlin, Germany; [Eisenberg, Tobias; Schroeder, Sabrina; Madeo, Frank] Graz Univ, Inst Mol Biosci, Graz, Austria; [Koemans, Tom S.; Kramer, Jamie M.; Schenck, Annette] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Human Genet,Nijmegen Ctr Mol Life Sci, NL-6525 ED Nijmegen, Netherlands; [Stunnenberg, Hendrik G.] Radboud Univ Nijmegen, Nijmegen Ctr Mol Life Sci, Fac Sci, Dept Mol Biol, NL-6525 ED Nijmegen, Netherlands; [Sinner, Frank; Magnes, Christoph; Pieber, Thomas R.] Joanneum Res Forsch GesmBH, Hlth Inst Biomed & Hlth Sci, Graz, Austria; [Sinner, Frank; Pieber, Thomas R.] Med Univ Graz, Dept Internal Med, Div Endocrinol & Metab, Graz, Austria; [Dipt, Shubham; Fiala, Andre] Univ Gottingen, D-37073 Gottingen, Germany	Free University of Berlin; University of Graz; Radboud University Nijmegen; Radboud University Nijmegen; Medical University of Graz; University of Gottingen	Sigrist, SJ (corresponding author), Free Univ Berlin, Inst Biol Genet, Berlin, Germany.	stephan.sigrist@fu-berlin.de	Gupta, Varun/ABE-1876-2020; Eisenberg, Tobias/AAV-7806-2021; Bhukel, Anuradha/AAU-8586-2020; Schenck, Annette/E-4514-2012; Stunnenberg, Hendrik G./D-6875-2012; Fiala, André/AAA-3852-2019	Bhukel, Anuradha/0000-0002-4269-1466; Schenck, Annette/0000-0002-6918-3314; Stunnenberg, Hendrik G./0000-0002-0066-1576; Fiala, André/0000-0002-9745-5145; Madeo, Frank/0000-0002-5070-1329; Magnes, Christoph/0000-0002-5153-7444; Sinner, Frank Michael/0000-0002-9292-4512; Kramer, Jamie/0000-0002-0924-1279; Pieber, Thomas/0000-0003-3554-0405; Eisenberg, Tobias/0000-0003-3559-1130	Deutsche Forschungsgemeinschaft [Exc257, FOR1363]; DynAge Focus Area (Freie Universitat Berlin); European Union [HEALTH-241995]; Netherlands Organization for Scientific Research [917-96-346]; BMBF (BCCNII) [01GQ1005A]; Emmy Noether Program; FWF [LIPOTOX, P23490, P24381, I1000]; Austrian Academy of Sciences;  [A6/SFB 958]; Austrian Science Fund (FWF) [P 24381, P 23490] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DynAge Focus Area (Freie Universitat Berlin); European Union(European Commission); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); BMBF (BCCNII)(Federal Ministry of Education & Research (BMBF)); Emmy Noether Program(German Research Foundation (DFG)); FWF(Austrian Science Fund (FWF)); Austrian Academy of Sciences; ; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We would like to thank T. Neufeld (University of Minnesota), L. Luo (Stanford University) and the Bloomington Stock Center for fly stocks, and S. Gaumer (University Versailles) for ref(2) P antibody. We are also grateful to M.G. Holt and B. Gerber for critically reading the manuscript. This work was supported by grants from the Deutsche Forschungsgemeinschaft to S.J.S. (Exc257, FOR1363), as well as A6/SFB 958 and DynAge Focus Area (Freie Universitat Berlin) to S.J.S., the European Union (FP7 Gencodys HEALTH-241995) to H.G.S. and A.S., a VIDI grant from the Netherlands Organization for Scientific Research (917-96-346) to A.S., the BMBF (BCCNII, grant number 01GQ1005A) to A.F., and the Emmy Noether Program to M.S. F.M. is grateful to the FWF for grants LIPOTOX, P23490, P24381 and I1000 (DACH). T.E. is recipient of an APART fellowship of the Austrian Academy of Sciences.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bartlett BJ, 2011, AUTOPHAGY, V7, P572, DOI 10.4161/auto.7.6.14943; Bateman JR, 2006, GENETICS, V173, P769, DOI 10.1534/genetics.106.056945; Bishop NA, 2010, NATURE, V464, P529, DOI 10.1038/nature08983; Burger JMS, 2010, AGING CELL, V9, P327, DOI 10.1111/j.1474-9726.2010.00560.x; Byun JA, 2008, BIOMED CHROMATOGR, V22, P73, DOI 10.1002/bmc.898; Chang YY, 2009, MOL BIOL CELL, V20, P2004, DOI 10.1091/mbc.E08-12-1250; DAS R, 1982, EXP GERONTOL, V17, P95, DOI 10.1016/0531-5565(82)90042-0; Davis RL, 2005, ANNU REV NEUROSCI, V28, P275, DOI 10.1146/annurev.neuro.28.061604.135651; Demontis F, 2010, CELL, V143, P813, DOI 10.1016/j.cell.2010.10.007; Dubnau J, 2003, CURR BIOL, V13, P286, DOI 10.1016/S0960-9822(03)00064-2; Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975; Elliott DA, 2010, CLIN LIPIDOL, V5, P555, DOI 10.2217/CLP.10.37; Estes PS, 1996, J NEUROSCI, V16, P5443; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Hansen M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040024; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; HEISENBERG M, 1985, J NEUROGENET, V2, P1, DOI 10.3109/01677068509100140; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Isabel G, 2004, SCIENCE, V304, P1024, DOI 10.1126/science.1094932; Juhasz G, 2007, GENE DEV, V21, P3061, DOI 10.1101/gad.1600707; Keleman K, 2012, NATURE, V489, P145, DOI 10.1038/nature11345; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Lee J.A., 2012, EXP NEUROBIOL, V21, P1, DOI DOI 10.5607/EN.2012.21.1.1; Liu P, 2008, NEUROSCIENCE, V155, P789, DOI 10.1016/j.neuroscience.2008.06.033; Liu X, 2009, NAT NEUROSCI, V12, P53, DOI 10.1038/nn.2235; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; MINOCHA R, 1994, J PLANT GROWTH REGUL, V13, P187, DOI 10.1007/BF00226036; Minois N, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.139; Minois N, 2011, AGING-US, V3, P716, DOI 10.18632/aging.100361; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Morselli E, 2011, J CELL BIOL, V192, P615, DOI 10.1083/jcb.201008167; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Nezis IP, 2008, J CELL BIOL, V180, P1065, DOI 10.1083/jcb.200711108; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pegg AE, 2006, J BIOL CHEM, V281, P14529, DOI 10.1074/jbc.R500031200; Peleg S, 2010, SCIENCE, V328, P753, DOI 10.1126/science.1186088; QUINN WG, 1976, NATURE, V262, P576, DOI 10.1038/262576a0; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Saitoe M, 2005, REV NEUROSCIENCE, V16, P137; Schwartz CE, 2011, METHODS MOL BIOL, V720, P437, DOI 10.1007/978-1-61779-034-8_28; Simonsen A, 2008, AUTOPHAGY, V4, P176, DOI 10.4161/auto.5269; Tamura T, 2003, NEURON, V40, P1003, DOI 10.1016/S0896-6273(03)00732-3; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Tonoki A, 2012, P NATL ACAD SCI USA, V109, P6319, DOI 10.1073/pnas.1118126109; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Vivo M, 2001, NEUROSCI LETT, V304, P107, DOI 10.1016/S0304-3940(01)01776-1; Wang IF, 2012, P NATL ACAD SCI USA, V109, P15024, DOI 10.1073/pnas.1206362109; Xia SZ, 2005, CURR BIOL, V15, P603, DOI 10.1016/j.cub.2005.02.059; Xie ZP, 2008, MOL BIOL CELL, V19, P3290, DOI 10.1091/mbc.E07-12-1292; Yamazaki D, 2007, NAT NEUROSCI, V10, P478, DOI 10.1038/nn1863; Zarnack K, 2013, CELL, V152, P453, DOI 10.1016/j.cell.2012.12.023; Zhou C, 2012, J NEUROSCI, V32, P14281, DOI 10.1523/JNEUROSCI.0517-12.2012	60	213	224	5	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2013	16	10					1453	+		10.1038/nn.3512	http://dx.doi.org/10.1038/nn.3512			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	223HM	23995066				2022-12-17	WOS:000324795300018
J	Burchell, VS; Nelson, DE; Sanchez-Martinez, A; Delgado-Camprubi, M; Ivatt, RM; Pogson, JH; Randle, SJ; Wray, S; Lewis, PA; Houlden, H; Abramov, AY; Hardy, J; Wood, NW; Whitworth, AJ; Laman, H; Plun-Favreau, H				Burchell, Victoria S.; Nelson, David E.; Sanchez-Martinez, Alvaro; Delgado-Camprubi, Marta; Ivatt, Rachael M.; Pogson, Joe H.; Randle, Suzanne J.; Wray, Selina; Lewis, Patrick A.; Houlden, Henry; Abramov, Andrey Y.; Hardy, John; Wood, Nicholas W.; Whitworth, Alexander J.; Laman, Heike; Plun-Favreau, Helene			The Parkinson's disease-linked proteins Fbxo7 and Parkin interact to mediate mitophagy	NATURE NEUROSCIENCE			English	Article							F-BOX PROTEIN; MITOCHONDRIAL PATHOLOGY; MONITORING AUTOPHAGY; TARGETING SEQUENCES; PYRAMIDAL SYNDROME; DROSOPHILA; PINK1; COMPLEX; CELLS; PROTEASOME	Compelling evidence indicates that two autosomal recessive Parkinson's disease genes, PINK1 (PARK6) and Parkin (PARK2), cooperate to mediate the autophagic clearance of damaged mitochondria (mitophagy). Mutations in the F-box domain-containing protein Fbxo7 (encoded by PARK15) also cause early-onset autosomal recessive Parkinson's disease, by an unknown mechanism. Here we show that Fbxo7 participates in mitochondrial maintenance through direct interaction with PINK1 and Parkin and acts in Parkin-mediated mitophagy. Cells with reduced Fbxo7 expression showed deficiencies in translocation of Parkin to mitochondria, ubiquitination of mitofusin 1 and mitophagy. In Drosophila, ectopic overexpression of Fbxo7 rescued loss of Parkin, supporting a functional relationship between the two proteins. Parkinson's disease-causing mutations in Fbxo7 interfered with this process, emphasizing the importance of mitochondrial dysfunction in Parkinson's disease pathogenesis.	[Burchell, Victoria S.; Delgado-Camprubi, Marta; Wray, Selina; Lewis, Patrick A.; Houlden, Henry; Abramov, Andrey Y.; Hardy, John; Wood, Nicholas W.; Plun-Favreau, Helene] UCL, Inst Neurol, Dept Mol Neurosci, London, England; [Nelson, David E.; Randle, Suzanne J.; Laman, Heike] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Sanchez-Martinez, Alvaro; Ivatt, Rachael M.; Pogson, Joe H.; Whitworth, Alexander J.] Ctr Dev & Biomed Genet, MRC, Sheffield, S Yorkshire, England; [Sanchez-Martinez, Alvaro; Ivatt, Rachael M.; Pogson, Joe H.; Whitworth, Alexander J.] Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England	University of London; University College London; University of Cambridge; University of Sheffield	Plun-Favreau, H (corresponding author), UCL, Inst Neurol, Dept Mol Neurosci, London, England.	a.whitworth@sheffield.ac.uk; hl316@cam.ac.uk; h.plun-favreau@ucl.ac.uk	Hardy, John/C-2451-2009; Houlden, Henry J/C-1532-2008; Abramov, Andrey/AAC-6712-2019; Wray, Selina/C-3682-2009; Plun-Favreau, Helene/Q-4111-2016; Abramov, Andrey Y/H-9053-2012; Wood, Nicholas W/C-2505-2009; Sanchez-Martinez, Alvaro/L-3851-2019; Sanchez-Martinez, Alvaro/L-1395-2013; Lewis, Patrick A./C-3674-2009; Nelson, David/AAX-5648-2021	Hardy, John/0000-0002-3122-0423; Houlden, Henry J/0000-0002-2866-7777; Abramov, Andrey/0000-0002-7646-7235; Wray, Selina/0000-0003-3062-7050; Plun-Favreau, Helene/0000-0002-1401-9656; Abramov, Andrey Y/0000-0002-7646-7235; Wood, Nicholas W/0000-0002-9500-3348; Sanchez-Martinez, Alvaro/0000-0002-2728-6251; Nelson, David/0000-0002-5034-0885; Whitworth, Alexander/0000-0002-1154-6629; Laman, Heike/0000-0002-6089-171X; Lewis, Patrick/0000-0003-4537-0489	Wellcome/Medical Research Council (MRC) Parkinson's Disease Consortium grant; MRC Protein Phosphorylation Unit at the University of Dundee [WT089698]; MRC Career Development Award [G0700183]; European Union; ERC Starting Grant [309742]; UK National Institute for Health Research University College London Hospitals Biomedical Research Centre; MRC Doctoral Training Account; Biotechnology and Biological Sciences Research Council [BB/F012764/1, BB/J007846/1]; University of Sheffield;  [G070091]; Medical Research Council [G108/638, G0701075, MC_G1000735, G1001253, G0802760, G0700183, MR/J004758/1, G0700091B] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10376] Funding Source: researchfish; Parkinson&quot;s UK [H-1006, F-1002] Funding Source: researchfish; BBSRC [BB/J007846/1] Funding Source: UKRI; MRC [G108/638, G0802760, G0701075, G1001253, G0700183, MR/J004758/1, MC_G1000735] Funding Source: UKRI	Wellcome/Medical Research Council (MRC) Parkinson's Disease Consortium grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC Protein Phosphorylation Unit at the University of Dundee(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC Career Development Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); ERC Starting Grant(European Research Council (ERC)); UK National Institute for Health Research University College London Hospitals Biomedical Research Centre; MRC Doctoral Training Account(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Sheffield; ; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Parkinson&quot;s UK(Parkinson&apos;s UK); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We would like to thank M. Mehrabian and E. Elahi for obtaining patient biopsies, H. Ardley (Leeds Institute of Molecular Medicine) for donating the Flag-Parkin construct and cell line, K. Holmstrpom and A. Isaacs for discussions and M. Gegg for technical advice. We thank C. Hill for technical assistance within the University of Sheffield Electron Microscopy Facility. We thank the H. Steller (Rockefeller University) laboratory for kind provision of the ntc mutant lines. The work was funded by a Wellcome/Medical Research Council (MRC) Parkinson's Disease Consortium grant to the University College London Institute of Neurology, the University of Sheffield and the MRC Protein Phosphorylation Unit at the University of Dundee (grant number WT089698), an MRC Career Development Award (G0700183; H.P.-F.), the MEFOPA project funded through the European Union FP7 research program (A.J.W.), and an ERC Starting Grant (no. 309742; A.J.W.). This research was supported by the UK National Institute for Health Research University College London Hospitals Biomedical Research Centre. V.S.B. is funded by the MRC Doctoral Training Account. D.E.N. is funded by the Biotechnology and Biological Sciences Research Council (BB/F012764/1; BB/J007846/1). The Wellcome Trust is acknowledged for support of the Sheffield Light Microscopy Facility (GR077544AIA). The MRC Centre for Developmental and Biomedical Genetics is supported by grant G070091.	Ardley HC, 2003, MOL BIOL CELL, V14, P4541, DOI 10.1091/mbc.E03-02-0078; Bader M, 2011, CELL, V145, P371, DOI 10.1016/j.cell.2011.03.021; Bader M, 2010, DEVELOPMENT, V137, P1679, DOI 10.1242/dev.050088; Chang YF, 2006, BIOCHEM BIOPH RES CO, V342, P1022, DOI 10.1016/j.bbrc.2006.02.061; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Deas E, 2011, BBA-MOL CELL RES, V1813, P623, DOI 10.1016/j.bbamcr.2010.08.007; Di Fonzo A, 2009, NEUROLOGY, V72, P240, DOI 10.1212/01.wnl.0000338144.10967.2b; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Ding WX, 2010, J BIOL CHEM, V285, P27879, DOI 10.1074/jbc.M110.119537; Exner N, 2007, J NEUROSCI, V27, P12413, DOI 10.1523/JNEUROSCI.0719-07.2007; Gegg ME, 2010, HUM MOL GENET, V19, P4861, DOI 10.1093/hmg/ddq419; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; Hsu JM, 2004, J BIOL CHEM, V279, P32592, DOI 10.1074/jbc.M404950200; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Kirk R, 2008, J BIOL CHEM, V283, P22325, DOI 10.1074/jbc.M709900200; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kondapalli C, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120080; Kuiken HJ, 2012, J CELL MOL MED, V16, P2140, DOI 10.1111/j.1582-4934.2012.01524.x; Laman H, 2005, EMBO J, V24, P3104, DOI 10.1038/sj.emboj.7600775; Lee SJ, 2010, EMBO REP, V11, P226, DOI 10.1038/embor.2010.7; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Nelson DE, 2011, J BIOL CHEM, V286, P19804, DOI 10.1074/jbc.M111.220079; Paisan-Ruiz C, 2010, MOVEMENT DISORD, V25, P1791, DOI 10.1002/mds.23221; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Plun-Favreau H, 2007, NAT CELL BIOL, V9, P1243, DOI 10.1038/ncb1644; Poole AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010054; Rakovic A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016746; Samali A, 1999, EMBO J, V18, P2040, DOI 10.1093/emboj/18.8.2040; Sarraf SA, 2013, NATURE, V496, P372, DOI 10.1038/nature12043; Shojaee S, 2008, AM J HUM GENET, V82, P1375, DOI 10.1016/j.ajhg.2008.05.005; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; Song S, 2013, J BIOL CHEM, V288, P5660, DOI 10.1074/jbc.M112.430801; Sullivan W., 2000, DROSOPHILA PROTOCOLS, P240; Tain LS, 2009, CELL DEATH DIFFER, V16, P1118, DOI 10.1038/cdd.2009.23; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Tanaka A, 2010, FEBS LETT, V584, P1386, DOI 10.1016/j.febslet.2010.02.060; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Whitworth AJ, 2005, P NATL ACAD SCI USA, V102, P8024, DOI 10.1073/pnas.0501078102; Whitworth AJ, 2008, DIS MODEL MECH, V1, P168, DOI 10.1242/dmm.000109; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107	47	213	219	1	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2013	16	9					1257	U135		10.1038/nn.3489	http://dx.doi.org/10.1038/nn.3489			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	207KN	23933751	Green Accepted, Green Submitted			2022-12-17	WOS:000323597500017
J	Ji, J; Kline, AE; Amoscato, A; Samhan-Arias, AK; Sparvero, LJ; Tyurin, VA; Tyurina, YY; Fink, B; Manole, MD; Puccio, AM; Okonkwo, DO; Cheng, JP; Alexander, H; Clark, RSB; Kochanek, PM; Wipf, P; Kagan, VE; Bayir, H				Ji, Jing; Kline, Anthony E.; Amoscato, Andrew; Samhan-Arias, Alejandro K.; Sparvero, Louis J.; Tyurin, Vladimir A.; Tyurina, Yulia Y.; Fink, Bruno; Manole, Mioara D.; Puccio, Ava M.; Okonkwo, David O.; Cheng, Jeffrey P.; Alexander, Henry; Clark, Robert S. B.; Kochanek, Patrick M.; Wipf, Peter; Kagan, Valerian E.; Bayir, Huelya			Lipidomics identifies cardiolipin oxidation as a mitochondrial target for redox therapy of brain injury	NATURE NEUROSCIENCE			English	Article							CYTOCHROME-C RELEASE; PERMEABILITY TRANSITION; SUPEROXIDE-DISMUTASE; PEROXIDATION; NITROXIDE; DAMAGE; STRESS; LIPIDS; SCAVENGERS; REDUCTION	The brain contains a highly diversified complement of molecular species of a mitochondria-specific phospholipid, cardiolipin, which, because of its polyunsaturation, can readily undergo oxygenation. Using global lipidomics analysis in experimental traumatic brain injury (TBI), we found that TBI was accompanied by oxidative consumption of polyunsaturated cardiolipin and the accumulation of more than 150 new oxygenated molecular species of cardiolipin. RNAi-based manipulations of cardiolipin synthase and cardiolipin levels conferred resistance to mechanical stretch, an in vitro model of traumatic neuronal injury, in primary rat cortical neurons. By applying a brain-permeable mitochondria-targeted electron scavenger, we prevented cardiolipin oxidation in the brain, achieved a substantial reduction in neuronal death both in vitro and in vivo, and markedly reduced behavioral deficits and cortical lesion volume. We conclude that cardiolipin oxygenation generates neuronal death signals and that prevention of it by mitochondria-targeted small molecule inhibitors represents a new target for neuro-drug discovery.	[Ji, Jing; Alexander, Henry; Clark, Robert S. B.; Kochanek, Patrick M.; Bayir, Huelya] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA 15260 USA; [Ji, Jing; Amoscato, Andrew; Samhan-Arias, Alejandro K.; Sparvero, Louis J.; Tyurin, Vladimir A.; Tyurina, Yulia Y.; Kagan, Valerian E.; Bayir, Huelya] Univ Pittsburgh, Dept Environm & Occupat Hlth, Pittsburgh, PA USA; [Ji, Jing; Amoscato, Andrew; Samhan-Arias, Alejandro K.; Sparvero, Louis J.; Tyurin, Vladimir A.; Tyurina, Yulia Y.; Kagan, Valerian E.; Bayir, Huelya] Univ Pittsburgh, Ctr Free Rad & Antioxidant Hlth, Pittsburgh, PA USA; [Ji, Jing; Kline, Anthony E.; Manole, Mioara D.; Cheng, Jeffrey P.; Alexander, Henry; Clark, Robert S. B.; Kochanek, Patrick M.; Bayir, Huelya] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA USA; [Kline, Anthony E.; Cheng, Jeffrey P.] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA USA; [Kline, Anthony E.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA USA; [Fink, Bruno] Noxygen Sci Transfer & Diagnost GmbH, Elzach, Germany; [Manole, Mioara D.; Clark, Robert S. B.; Kochanek, Patrick M.; Bayir, Huelya] Univ Pittsburgh, Childrens Hosp Pittsburgh, Med Ctr, Pittsburgh, PA 15213 USA; [Puccio, Ava M.; Okonkwo, David O.] Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15260 USA; [Wipf, Peter] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Bayir, H (corresponding author), Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA 15260 USA.	bayihx@ccm.upmc.edu	Samhan-Arias, Alejandro/J-3593-2014; Kochanek, Patrick M/D-2371-2015; Ji, J/O-2816-2013; Wipf, Peter/AAG-1771-2021	Samhan-Arias, Alejandro/0000-0001-9602-4848; Kochanek, Patrick M/0000-0002-2627-913X; Wipf, Peter/0000-0001-7693-5863; Tyurina, Yulia/0000-0003-0287-2091; Amoscato, Andrew/0000-0002-1340-9150; Cheng, Jeffrey/0000-0001-8285-3207; Tyurin, Vladimir/0000-0002-3474-1697; Kagan, Valerian E./0000-0002-7245-1885	US National Institutes of Health [NS061817, NS060005, HL070755, ES020693, NS076511, U19AI068021]; US National Institute for Occupational Safety and Health [OH008282]; US Army [W81XWH-09-0187]; La Junta de Extremadura y el Fondo Social Europeo [2010063090]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069620] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [R01OH008282] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI068021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES020693] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060005, R01NS061817, R01NS076511] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institute for Occupational Safety and Health(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); US Army(United States Department of DefenseUnited States Army); La Junta de Extremadura y el Fondo Social Europeo; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors would like to thank J. Lewis for the technical assistance of unbiased stereology for cortical lesion volume, J. Davoren for the preparation of XJB-5-131 and Y.M. Frapart (Laboratoire de Chimie Biochimie Pharmacologique et Toxicologique, Universite Paris Descartes) for providing an L-band EPR spectrometer for in vivo imaging. This study was supported in part by grants from the US National Institutes of Health (NS061817 (H.B.), NS060005 (A.E.K.), HL070755 (V.E.K.), ES020693 (Y.Y.T. and V.E.K.), NS076511 and U19AI068021 (H.B. and V.E.K.)), the US National Institute for Occupational Safety and Health (OH008282 to V.E.K.) and the US Army (W81XWH-09-0187 to P.M.K.). A.K.S.-A. is a recipient of a research fellowship from La Junta de Extremadura y el Fondo Social Europeo (2010063090).	Alessandri B, 2002, J NEUROTRAUM, V19, P829, DOI 10.1089/08977150260190429; Bayir H, 2002, PEDIATR RES, V51, P571, DOI 10.1203/00006450-200205000-00005; Bayir H, 2007, ANN NEUROL, V62, P154, DOI 10.1002/ana.21168; Betaneli V, 2012, BIOPHYS J, V102, P523, DOI 10.1016/j.bpj.2011.12.049; Bobko AA, 2007, FREE RADICAL BIO MED, V42, P404, DOI 10.1016/j.freeradbiomed.2006.11.007; Broadhurst CL, 2002, COMP BIOCHEM PHYS B, V131, P653, DOI 10.1016/S1096-4959(02)00002-7; CHAN PH, 1980, J NEUROCHEM, V35, P1004, DOI 10.1111/j.1471-4159.1980.tb07100.x; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Deng-Bryant Y, 2008, J CEREBR BLOOD F MET, V28, P1114, DOI 10.1038/jcbfm.2008.10; Fan P, 2003, J NEUROTRAUM, V20, P437, DOI 10.1089/089771503765355513; Faul M, 2010, TRAUMATIC BRAIN INJU, DOI DOI 10.15620/CDC.5571; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; Kiebish MA, 2008, J NEUROCHEM, V106, P299, DOI 10.1111/j.1471-4159.2008.05383.x; Kline AE, 2004, J NEUROTRAUM, V21, P1712, DOI 10.1089/neu.2004.21.1712; Korytowski W, 2011, J BIOL CHEM, V286, P26334, DOI 10.1074/jbc.M110.188516; Lewen A, 2001, J CEREBR BLOOD F MET, V21, P914, DOI 10.1097/00004647-200108000-00003; Lo EH, 2001, BRAIN RES REV, V38, P140, DOI 10.1016/S0165-0173(01)00083-2; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; MITCHELL JB, 1990, BIOCHEMISTRY-US, V29, P2802, DOI 10.1021/bi00463a024; MUIZELAAR JP, 1993, J NEUROSURG, V78, P375, DOI 10.3171/jns.1993.78.3.0375; Nakagawa Y, 2004, ANN NY ACAD SCI, V1011, P177, DOI 10.1196/annals.1293.018; Nomura K, 2000, BIOCHEM J, V351, P183, DOI 10.1042/0264-6021:3510183; Ott M, 2002, P NATL ACAD SCI USA, V99, P1259, DOI 10.1073/pnas.241655498; Petrosillo G, 2006, FEBS LETT, V580, P6311, DOI 10.1016/j.febslet.2006.10.036; Petrosillo G, 2010, J PINEAL RES, V48, P340, DOI 10.1111/j.1600-079X.2010.00758.x; Ran QT, 2004, J BIOL CHEM, V279, P55137, DOI 10.1074/jbc.M410387200; RAND, 2011, INV WOUNDS WAR STUD; Rostovtseva TK, 2006, J BIOL CHEM, V281, P37496, DOI 10.1074/jbc.M602548200; Scafidi S, 2010, DEV NEUROSCI-BASEL, V32, P480, DOI 10.1159/000323178; Scheff SW, 1999, J NEUROTRAUM, V16, P783, DOI 10.1089/neu.1999.16.783; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; SIESJO BK, 1981, J CEREBR BLOOD F MET, V1, P155, DOI 10.1038/jcbfm.1981.18; Singh IN, 2007, J NEUROSCI RES, V85, P2216, DOI 10.1002/jnr.21360; Sorice M, 2004, CELL DEATH DIFFER, V11, P1133, DOI 10.1038/sj.cdd.4401457; Soule BP, 2007, FREE RADICAL BIO MED, V42, P1632, DOI 10.1016/j.freeradbiomed.2007.02.030; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Stoyanovsky DA, 1998, FREE RADICAL BIO MED, V25, P536, DOI 10.1016/S0891-5849(98)00081-1; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Trnka J, 2008, FREE RADICAL BIO MED, V44, P1406, DOI 10.1016/j.freeradbiomed.2007.12.036; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; WEI EP, 1981, CIRC RES, V48, P95, DOI 10.1161/01.RES.48.1.95; Wilcox CS, 2008, PHARMACOL REV, V60, P418, DOI 10.1124/pr.108.000240; Wipf P, 2005, J AM CHEM SOC, V127, P12460, DOI 10.1021/ja053679l; Zhang RL, 1999, FREE RADICAL BIO MED, V26, P1245, DOI 10.1016/S0891-5849(98)00328-1; Zhao ZS, 2010, ENDOCRINOLOGY, V151, P3038, DOI 10.1210/en.2010-0016	48	213	223	3	94	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2012	15	10					1407	1413		10.1038/nn.3195	http://dx.doi.org/10.1038/nn.3195			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	013VZ	22922784	Green Accepted			2022-12-17	WOS:000309335300021
J	Futai, K; Kim, MJ; Hashikawa, T; Scheiffele, P; Sheng, M; Hayashi, Y				Futai, Kensuke; Kim, Myung Jong; Hashikawa, Tsutomu; Scheiffele, Peter; Sheng, Morgan; Hayashi, Yasunori			Retrograde modulation of presynaptic release probability through signaling mediated by PSD-95-neuroligin	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; CA3 PYRAMIDAL CELLS; SYNAPTIC-TRANSMISSION; HIPPOCAMPAL SYNAPSES; EXCITATORY SYNAPSES; ALPHA-NEUREXINS; POSTSYNAPTIC MATURATION; GLUTAMATERGIC SYNAPSES; DENDRITIC SPINES; BETA-NEUREXINS	The structure and function of presynaptic and postsynaptic components of the synapse are highly coordinated. How such coordination is achieved and the molecules involved in this process have not been clarified. Several lines of evidence suggest that presynaptic functionalities are regulated by retrograde mechanisms from the postsynaptic side. We therefore sought postsynaptic mechanisms responsible for trans- synaptic regulation of presynaptic function at excitatory synapses in rat hippocampal CA1 pyramidal neurons. We show here that the postsynaptic complex of scaffolding protein PSD- 95 and neuroligin can modulate the release probability of transmitter vesicles at synapse in a retrograde way, resulting in altered presynaptic short- term plasticity. Presynaptic beta- neurexin serves as a likely presynaptic mediator of this effect. Our results indicate that trans- synaptic proteinprotein interactions can link postsynaptic and presynaptic function.	MIT, RIKEN, Neurosci Res Ctr,Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA; RIKEN, Brain Sci Inst, Lab Neural Architecture, Adv Technol Dev Grp, Wako, Saitama 3510198, Japan; Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, Dept Physiol & Cellular Biophys, New York, NY 10032 USA	Massachusetts Institute of Technology (MIT); Northwell Health; RIKEN; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); RIKEN; Columbia University	Hayashi, Y (corresponding author), MIT, RIKEN, Neurosci Res Ctr,Dept Brain & Cognit Sci, Picower Inst Learning & Memory, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	yhayashi@mit.edu	Hayashi, Yasunori/AAF-1408-2019; Hayashi, Yasunori/C-2249-2008	Hayashi, Yasunori/0000-0002-7560-3004; Hayashi, Yasunori/0000-0002-7560-3004; Sheng, Morgan/0000-0002-8703-5366	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045014] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS045014] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Boucard AA, 2005, NEURON, V48, P229, DOI 10.1016/j.neuron.2005.08.026; Chavis P, 2001, NATURE, V411, P317, DOI 10.1038/35077101; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Christie JM, 2006, J NEUROSCI, V26, P210, DOI 10.1523/JNEUROSCI.4307-05.2006; Conti R, 2003, P NATL ACAD SCI USA, V100, P4885, DOI 10.1073/pnas.0630290100; Contractor A, 2002, SCIENCE, V296, P1864, DOI 10.1126/science.1069081; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Dean C, 2006, TRENDS NEUROSCI, V29, P21, DOI 10.1016/j.tins.2005.11.003; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; deKay JGT, 2006, HIPPOCAMPUS, V16, P66, DOI 10.1002/hipo.20132; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; Ehrlich I, 2004, J NEUROSCI, V24, P916, DOI 10.1523/JNEUROSCI.4733-03.2004; El-Hussein AE, 2000, SCIENCE, V290, P1364; FIFKOVA E, 1977, J NEUROCYTOL, V6, P211, DOI 10.1007/BF01261506; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Haghighi AP, 2003, NEURON, V39, P255, DOI 10.1016/S0896-6273(03)00427-6; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511; Jungling K, 2006, J NEUROSCI, V26, P6968, DOI 10.1523/JNEUROSCI.1013-06.2006; Kazama H, 2003, NEUROSCIENCE, V117, P615, DOI 10.1016/S0306-4522(02)00923-5; Koester HJ, 2005, SCIENCE, V308, P863, DOI 10.1126/science.1100815; Liu GS, 1999, NEURON, V22, P395, DOI 10.1016/S0896-6273(00)81099-5; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; Nakagawa T, 2004, NEURON, V44, P453, DOI 10.1016/j.neuron.2004.10.012; Noguchi J, 2005, NEURON, V46, P609, DOI 10.1016/j.neuron.2005.03.015; Oertner TG, 2002, NAT NEUROSCI, V5, P657, DOI 10.1038/nn867; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Pavlidis P, 1999, J NEUROPHYSIOL, V81, P2787, DOI 10.1152/jn.1999.81.6.2787; Petralia RS, 2005, MOL CELL NEUROSCI, V29, P436, DOI 10.1016/j.mcn.2005.03.013; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Pratt KG, 2003, NEURON, V39, P269, DOI 10.1016/S0896-6273(03)00422-7; Regalado MP, 2006, J NEUROSCI, V26, P2343, DOI 10.1523/JNEUROSCI.5247-05.2006; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Schermanz K, 2002, CATALY SCI, V2, P1, DOI 10.1142/9781860949654_0001; Schikorski T, 1997, J NEUROSCI, V17, P5858; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; Shepherd GMG, 1998, J NEUROSCI, V18, P8300; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Sun HY, 2005, J PHYSIOL-LONDON, V568, P815, DOI 10.1113/jphysiol.2005.093948; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Yoshii A, 2003, P NATL ACAD SCI USA, V100, P1334, DOI 10.1073/pnas.0335785100; Zhang WQ, 2005, J NEUROSCI, V25, P4330, DOI 10.1523/JNEUROSCI.0497-05.2005; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	50	213	221	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2007	10	2					186	195		10.1038/nn1837	http://dx.doi.org/10.1038/nn1837			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	135TB	17237775	Green Accepted			2022-12-17	WOS:000244175200013
J	Cook, EP; Maunsell, JHR				Cook, EP; Maunsell, JHR			Dynamics of neuronal responses in macaque MT and VIP during motion detection	NATURE NEUROSCIENCE			English	Article							TEMPORAL VISUAL AREA; SENSITIVE NEURONS; CORTICAL AREA; SINGLE NEURON; MONKEY; CORTEX; DISCRIMINATION; SIGNALS; CHOICE; TIME	We examined how the relationship between neuronal activity and behavior evolved over time during a motion-detection task. Recording from two regions of visual cortex that process motion, the middle temporal (MT) and ventral intraparietal (VIP) areas, we used the time it took subjects to detect a motion stimulus to evaluate the dynamics of the underlying neuronal signals. Single-neuron activity was correlated with stimulus detection and reaction time (RT) in both areas. The rising edge of the population response from both areas was highly predictive of RT using a simple threshold-detection model. The time course of the population responses, however, differed between MT and VIP. For MT, the onset of the neuronal response was relatively constant, whereas for VIP the onset of the neuronal responses increased with RT. In contrast to previous studies, we found that single neurons were not reliable detectors of the motion signal when constrained by realistic detection times.	Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA	Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine	Cook, EP (corresponding author), Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA.		Maunsell, John/G-5702-2010	Maunsell, John/0000-0003-0018-4439	NEI NIH HHS [R01 EY05911] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY005911] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Bair W, 1996, NEURAL COMPUT, V8, P1185, DOI 10.1162/neco.1996.8.6.1185; Bair W, 2001, J NEUROSCI, V21, P1676, DOI 10.1523/JNEUROSCI.21-05-01676.2001; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; BRITTEN KH, 1993, VISUAL NEUROSCI, V10, P1157, DOI 10.1017/S0952523800010269; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Buracas GT, 1998, NEURON, V20, P959, DOI 10.1016/S0896-6273(00)80477-8; CELEBRINI S, 1994, J NEUROSCI, V14, P4109; COLBY CL, 1993, J NEUROPHYSIOL, V69, P902, DOI 10.1152/jn.1993.69.3.902; Cook EP, 2002, J NEUROSCI, V22, P1994, DOI 10.1523/JNEUROSCI.22-05-01994.2002; Croner LJ, 1999, J NEUROSCI, V19, P3935; Dodd JV, 2001, J NEUROSCI, V21, P4809, DOI 10.1523/JNEUROSCI.21-13-04809.2001; Efron B., 1993, INTRO BOOTSTRAP; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Geisler WS, 1997, VISUAL NEUROSCI, V14, P897, DOI 10.1017/S0952523800011627; Gibson JR, 1997, J NEUROPHYSIOL, V78, P1263, DOI 10.1152/jn.1997.78.3.1263; GRATTON G, 1988, J EXP PSYCHOL HUMAN, V14, P331, DOI 10.1037/0096-1523.14.3.331; Hanes DP, 1996, SCIENCE, V274, P427, DOI 10.1126/science.274.5286.427; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; LAMARRE Y, 1981, CAN J PHYSIOL PHARM, V59, P748, DOI 10.1139/y81-111; Luce RD, 1986, RESPONSE TIMES; MAUNSELL JHR, 1983, J NEUROSCI, V3, P2563; Mazurek ME, 2002, NAT NEUROSCI, V5, P463, DOI 10.1038/nn836; MEYER DE, 1988, BIOL PSYCHOL, V26, P3, DOI 10.1016/0301-0511(88)90013-0; MOUNTCASTLE VB, 1990, J NEUROSCI, V10, P3032; PARKER A, 1985, J OPT SOC AM A, V2, P1101, DOI 10.1364/JOSAA.2.001101; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; Prince SJD, 2000, J NEUROSCI, V20, P3387, DOI 10.1523/JNEUROSCI.20-09-03387.2000; RAIGUEL SE, 1989, BRAIN RES, V493, P155, DOI 10.1016/0006-8993(89)91010-X; Reddi BAJ, 2000, NAT NEUROSCI, V3, P827, DOI 10.1038/77739; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; Schall JD, 1999, ANNU REV NEUROSCI, V22, P241, DOI 10.1146/annurev.neuro.22.1.241; Schmolesky MT, 1998, J NEUROPHYSIOL, V79, P3272, DOI 10.1152/jn.1998.79.6.3272; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Shadlen MN, 1996, P NATL ACAD SCI USA, V93, P628, DOI 10.1073/pnas.93.2.628; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Thompson KG, 1996, J NEUROPHYSIOL, V76, P4040, DOI 10.1152/jn.1996.76.6.4040; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; Usher M, 2001, PSYCHOL REV, V108, P550, DOI 10.1037//0033-295X.108.3.550; VANESSEN DC, 1981, J COMP NEUROL, V199, P293, DOI 10.1002/cne.901990302	40	213	215	0	16	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2002	5	10					985	994		10.1038/nn924	http://dx.doi.org/10.1038/nn924			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	597VV	12244324				2022-12-17	WOS:000178242200018
J	Kim, JG; Suyama, S; Koch, M; Lin, SH; Argente-Arizon, P; Argente, J; Liu, ZW; Zimmer, MR; Jeong, JK; Szigeti-Buck, K; Gao, YQ; Garcia-Caceres, C; Yi, CX; Salmaso, N; Vaccarino, FM; Chowen, J; Diano, S; Dietrich, MO; Tschop, MH; Horvath, TL				Kim, Jae Geun; Suyama, Shigetomo; Koch, Marco; Lin, Sungho; Argente-Arizon, Pilar; Argente, Jesus; Liu, Zhong-Wu; Zimmer, Marcelo R.; Jeong, Jin Kwon; Szigeti-Buck, Klara; Gao, Yuanqing; Garcia-Caceres, Cristina; Yi, Chun-Xia; Salmaso, Natalina; Vaccarino, Flora M.; Chowen, Julie; Diano, Sabrina; Dietrich, Marcelo O.; Tschoep, Matthias H.; Horvath, Tamas L.			Leptin signaling in astrocytes regulates hypothalamic neuronal circuits and feeding	NATURE NEUROSCIENCE			English	Article							ARCUATE NUCLEUS; POMC NEURONS; OBESITY; RECEPTORS; GLUTAMATE	We found that leptin receptors were expressed in hypothalamic astrocytes and that their conditional deletion led to altered glial morphology and synaptic inputs onto hypothalamic neurons involved in feeding control. Leptin-regulated feeding was diminished, whereas feeding after fasting or ghrelin administration was elevated in mice with astrocyte-specific leptin receptor deficiency. These data reveal an active role of glial cells in hypothalamic synaptic remodeling and control of feeding by leptin.	[Kim, Jae Geun; Suyama, Shigetomo; Koch, Marco; Lin, Sungho; Liu, Zhong-Wu; Zimmer, Marcelo R.; Jeong, Jin Kwon; Szigeti-Buck, Klara; Diano, Sabrina; Dietrich, Marcelo O.; Horvath, Tamas L.] Yale Univ, Sch Med, Comparat Med Sect, Program Integrat Cell Signaling & Neurobiol Metab, New Haven, CT 06520 USA; [Koch, Marco] Univ Leipzig, Inst Anat, D-04109 Leipzig, Germany; [Argente-Arizon, Pilar; Argente, Jesus; Chowen, Julie] Hosp Infantil Univ Nino Jesus, Inst Invest Princesa, Dept Endocrinol, Madrid, Spain; [Argente-Arizon, Pilar; Argente, Jesus; Chowen, Julie] Inst Salud Carlos III, Ctr Invest Biomed Red Fisiopatol CIBER, Madrid, Spain; [Jeong, Jin Kwon; Diano, Sabrina; Horvath, Tamas L.] Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT USA; [Gao, Yuanqing; Garcia-Caceres, Cristina; Yi, Chun-Xia; Tschoep, Matthias H.] Helmholtz Zentrum Munchen, Inst Diabet & Obes, Munich, Germany; [Gao, Yuanqing; Garcia-Caceres, Cristina; Yi, Chun-Xia; Tschoep, Matthias H.] Tech Univ Munich, D-80290 Munich, Germany; [Salmaso, Natalina; Vaccarino, Flora M.] Yale Univ, Sch Med, Ctr Child Study, New Haven, CT USA; [Vaccarino, Flora M.; Diano, Sabrina; Horvath, Tamas L.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA	Yale University; Leipzig University; Instituto de Salud Carlos III; Yale University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Yale University; Yale University	Horvath, TL (corresponding author), Yale Univ, Sch Med, Comparat Med Sect, Program Integrat Cell Signaling & Neurobiol Metab, New Haven, CT 06520 USA.	tamas.horvath@yale.edu	Argente Arizón, Pilar/K-1153-2014; Argente, Jesús/K-1167-2014; Yi, Chun-Xia/J-4068-2016; García-Cáceres, Cristina/O-6601-2016; Jeong, Jin Kwon/AAU-2951-2020; Chowen, Julie/C-8979-2011; Dietrich, Marcelo/A-9928-2009; Zimmer, Marcelo Rigon/ABB-7993-2020; Argente, Jesús/M-5226-2019	Argente Arizón, Pilar/0000-0002-8013-3828; Argente, Jesús/0000-0001-5826-0276; Yi, Chun-Xia/0000-0003-1184-4615; García-Cáceres, Cristina/0000-0001-6376-9448; Chowen, Julie/0000-0002-4770-2291; Dietrich, Marcelo/0000-0001-9781-2221; Zimmer, Marcelo Rigon/0000-0001-9628-8915; Argente, Jesús/0000-0001-5826-0276; Salmaso, Natalina/0000-0002-9661-5194; Tschoep, Matthias/0000-0002-4744-371X; Vaccarino, Flora/0000-0003-2167-981X; Jeong, Jin Kwon/0000-0002-5261-4915	US National Institutes of Health [DP1 DK098058, R01AG040236, P01NS062686, R01 DK097566]; American Diabetes Association; Helmholtz Society (ICEMED); Klarmann Family Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097566, DP1DK098058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS062686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG040236] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Helmholtz Society (ICEMED); Klarmann Family Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the US National Institutes of Health (DP1 DK098058, R01AG040236, P01NS062686 and R01 DK097566), the American Diabetes Association, the Helmholtz Society (ICEMED) and the Klarmann Family Foundation.	Allaman I, 2011, TRENDS NEUROSCI, V34, P76, DOI 10.1016/j.tins.2010.12.001; Andrews ZB, 2008, NATURE, V454, P846, DOI 10.1038/nature07181; Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; Cowley MA, 2003, NEURON, V37, P649, DOI 10.1016/S0896-6273(03)00063-1; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Diano S, 1998, J NEUROENDOCRINOL, V10, P239, DOI 10.1046/j.1365-2826.1998.00195.x; Fuente-Martin E, 2012, J CLIN INVEST, V122, P3900, DOI 10.1172/JCI64102; Ganat YM, 2006, J NEUROSCI, V26, P8609, DOI 10.1523/JNEUROSCI.2532-06.2006; Gao Q, 2007, ANNU REV NEUROSCI, V30, P367, DOI 10.1146/annurev.neuro.30.051606.094324; Garcia-Caceres C, 2011, ENDOCRINOLOGY, V152, P1809, DOI 10.1210/en.2010-1252; Horvath TL, 2010, P NATL ACAD SCI USA, V107, P14875, DOI 10.1073/pnas.1004282107; Hsuchou H, 2009, BRAIN, V132, P889, DOI 10.1093/brain/awp029; Hung HC, 2009, PEPTIDES, V30, P2275, DOI 10.1016/j.peptides.2009.08.023; SHOLL DA, 1959, J ANAT, V93, P143; Vong L, 2011, NEURON, V71, P142, DOI 10.1016/j.neuron.2011.05.028; WEST MJ, 1990, J COMP NEUROL, V296, P1, DOI 10.1002/cne.902960102; Yang YL, 2011, CELL, V146, P991, DOI 10.1016/j.cell.2011.07.039	17	212	216	0	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2014	17	7					908	910		10.1038/nn.3725	http://dx.doi.org/10.1038/nn.3725			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AK0IX	24880214	Green Accepted			2022-12-17	WOS:000338097200006
J	Bock, R; Shin, JH; Kaplan, AR; Dobi, A; Markey, E; Kramer, PF; Gremel, CM; Christensen, CH; Adrover, MF; Alvarez, VA				Bock, Roland; Shin, J. Hoon; Kaplan, Alanna R.; Dobi, Alice; Markey, Eric; Kramer, Paul F.; Gremel, Christina M.; Christensen, Christine H.; Adrover, Martin F.; Alvarez, Veronica A.			Strengthening the accumbal indirect pathway promotes resilience to compulsive cocaine use	NATURE NEUROSCIENCE			English	Article							D2-LIKE AGONISTS; OPTOGENETIC CONTROL; NUCLEUS-ACCUMBENS; DOPAMINE D1-LIKE; DISTINCT ROLES; D2 RECEPTORS; ADDICTION; REWARD; RATS; IMPULSIVITY	A hallmark of addiction is the loss of control over drug intake, which is seen in only a fraction of those exposed to stimulant drugs such as cocaine. The cellular mechanisms underlying vulnerability or resistance to compulsive drug use remain unknown. We found that individual variability in the development of highly motivated and perseverative behavior toward cocaine is associated with synaptic plasticity in medium spiny neurons expressing dopamine D2 receptors (D2-MSNs) in the nucleus accumbens (NAc) of mice. Potentiation of glutamatergic inputs onto indirect pathway D2-MSNs was associated with resilience toward compulsive cocaine seeking. Inhibition of D2-MSNs using a chemicogenetic approach enhanced the motivation to obtain cocaine, whereas optogenetic activation of D2-MSNs suppressed cocaine self-administration. These results indicate that recruitment of D2-MSNs in NAc functions to restrain cocaine self-administration and serves as a natural protective mechanism in drug-exposed individuals.	[Bock, Roland; Shin, J. Hoon; Kaplan, Alanna R.; Dobi, Alice; Markey, Eric; Kramer, Paul F.; Gremel, Christina M.; Christensen, Christine H.; Adrover, Martin F.; Alvarez, Veronica A.] NIAAA, Lab Integrat Neurosci, US NIH, Bethesda, MD USA; [Alvarez, Veronica A.] NINDS, US NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Alvarez, VA (corresponding author), NIAAA, Lab Integrat Neurosci, US NIH, Bethesda, MD USA.	alvarezva@mail.nih.gov	Core, Vector/CAF-4832-2022; Alvarez, Veronica A/E-9745-2015; Bock, Roland/G-2982-2016	Alvarez, Veronica A/0000-0003-2611-8675; Bock, Roland/0000-0002-8654-1080; Kaplan, Alanna/0000-0002-2612-4736; Kramer, Paul/0000-0002-0095-3712	Intramural Program of the National Institute on Alcohol Abuse and Alcoholism; Intramural Program of the National Institute of Neurological Disorders and Stroke [ZIA-AA000421]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000421] Funding Source: NIH RePORTER	Intramural Program of the National Institute on Alcohol Abuse and Alcoholism; Intramural Program of the National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We are grateful to the staff of Fishers Lane Animal Center and to L. Chedester for technical support. We thank the members of the Alvarez laboratory, J.T. Williams, D.M. Lovinger and B.L. Sabatini for helpful comments on the manuscript. We also thank B. Roth (University of North Carolina) and K. Deisseroth (Stanford University) for their generosity in providing the constructs for hM4Di and ChR2, respectively, and B. Harvey (Optogenetics and Transgenic Technology Core at the National Institute on Drug Abuse) for the viral vector preparation. This study was funded by the Intramural Programs of the National Institute on Alcohol Abuse and Alcoholism and the National Institute of Neurological Disorders and Stroke (ZIA-AA000421).	Alexander GM, 2009, NEURON, V63, P27, DOI 10.1016/j.neuron.2009.06.014; Barrett AC, 2004, NEUROPHARMACOLOGY, V47, P256, DOI 10.1016/j.neuropharm.2004.07.007; Beckmann JS, 2011, BEHAV BRAIN RES, V216, P159, DOI 10.1016/j.bbr.2010.07.022; Belin D, 2008, SCIENCE, V320, P1352, DOI 10.1126/science.1158136; Bello EP, 2011, NAT NEUROSCI, V14, P1033, DOI 10.1038/nn.2862; Caine SB, 2000, PSYCHOPHARMACOLOGY, V148, P41, DOI 10.1007/s002130050023; Caine SB, 1999, J PHARMACOL EXP THER, V291, P353; Corbit LH, 2010, EUR J NEUROSCI, V31, P1312, DOI 10.1111/j.1460-9568.2010.07153.x; Deroche-Gamonet V, 2004, SCIENCE, V305, P1014, DOI 10.1126/science.1099020; Dobi A, 2011, J NEUROSCI, V31, P1895, DOI 10.1523/JNEUROSCI.5375-10.2011; Dong SY, 2010, NAT PROTOC, V5, P561, DOI 10.1038/nprot.2009.239; Durieux PF, 2009, NAT NEUROSCI, V12, P393, DOI 10.1038/nn.2286; Ersche KD, 2011, BRAIN, V134, P2013, DOI 10.1093/brain/awr138; Ferguson SM, 2011, NAT NEUROSCI, V14, P22, DOI 10.1038/nn.2703; Gerfen CR, 2011, ANNU REV NEUROSCI, V34, P441, DOI 10.1146/annurev-neuro-061010-113641; Giessel AJ, 2010, NEURON, V68, P936, DOI 10.1016/j.neuron.2010.09.004; Kasanetz F, 2010, SCIENCE, V328, P1709, DOI 10.1126/science.1187801; Kozorovitskiy Y, 2012, NATURE, V485, P646, DOI 10.1038/nature11052; Kramer PF, 2011, J NEUROSCI, V31, P126, DOI 10.1523/JNEUROSCI.4287-10.2011; Kravitz AV, 2012, NAT NEUROSCI, V15, P816, DOI 10.1038/nn.3100; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Lobo MK, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00041; Lobo MK, 2010, SCIENCE, V330, P385, DOI 10.1126/science.1188472; Nader MA, 2006, NAT NEUROSCI, V9, P1050, DOI 10.1038/nn1737; Napolitano F, 2010, J NEUROSCI, V30, P11043, DOI 10.1523/JNEUROSCI.1682-10.2010; Pascoli V, 2012, NATURE, V481, P71, DOI 10.1038/nature10709; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Ralph RJ, 2005, J PHARMACOL EXP THER, V312, P733, DOI 10.1124/jpet.104.074468; Richardson NR, 1996, J NEUROSCI METH, V66, P1, DOI 10.1016/0165-0270(95)00153-0; Root DH, 2013, J COMP NEUROL, V521, P558, DOI 10.1002/cne.23191; Saunders BT, 2011, NEUROPSYCHOPHARMACOL, V36, P1668, DOI 10.1038/npp.2011.48; Tang XC, 2005, J NEUROSCI, V25, P4512, DOI 10.1523/JNEUROSCI.0685-05.2005; Thomsen Morgane, 2005, Curr Protoc Neurosci, VChapter 9, DOI 10.1002/0471142301.ns0920s32; Torregrossa MM, 2008, NEUROSCI LETT, V438, P142, DOI 10.1016/j.neulet.2008.04.016; Volkow ND, 2009, NEUROPHARMACOLOGY, V56, P3, DOI 10.1016/j.neuropharm.2008.05.022; Volkow ND, 2002, SYNAPSE, V46, P79, DOI 10.1002/syn.10137	36	212	216	1	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2013	16	5					632	+		10.1038/nn.3369	http://dx.doi.org/10.1038/nn.3369			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	131WT	23542690	Green Accepted			2022-12-17	WOS:000318029300020
J	Sanuki, R; Onishi, A; Koike, C; Muramatsu, R; Watanabe, S; Muranishi, Y; Irie, S; Uneo, S; Koyasu, T; Matsui, R; Cherasse, Y; Urade, Y; Watanabe, D; Kondo, M; Yamashita, T; Furukawa, T				Sanuki, Rikako; Onishi, Akishi; Koike, Chieko; Muramatsu, Rieko; Watanabe, Satoshi; Muranishi, Yuki; Irie, Shoichi; Uneo, Shinji; Koyasu, Toshiyuki; Matsui, Ryosuke; Cherasse, Yoan; Urade, Yoshihiro; Watanabe, Dai; Kondo, Mineo; Yamashita, Toshihide; Furukawa, Takahisa			miR-124a is required for hippocampal axogenesis and retinal cone survival through Lhx2 suppression	NATURE NEUROSCIENCE			English	Article							DEVELOPING MOUSE RETINA; HOMEOBOX GENE; CELL FATE; TRANSCRIPTION FACTORS; EARLY NEUROGENESIS; MICRORNA TARGETS; TRANSGENIC MICE; MESSENGER-RNAS; DIFFERENTIATION; EXPRESSION	MicroRNA-124a (miR-124a) is the most abundant microRNA expressed in the vertebrate CNS. Despite past investigations into the role of miR-124a, inconsistent results have left the in vivo function of miR-124a unclear. We examined the in vivo function of miR-124a by targeted disruption of Rncr3 (retinal non-coding RNA 3), the dominant source of miR-124a. Rncr3(-/-) mice exhibited abnormalities in the CNS, including small brain size, axonal mis-sprouting of dentate gyrus granule cells and retinal cone cell death. We found that Lhx2 is an in vivo target mRNA of miR-124a. We also observed that LHX2 downregulation by miR-124a is required for the prevention of apoptosis in the developing retina and proper axonal development of hippocampal neurons. These results suggest that miR-124a is essential for the maturation and survival of dentate gyrus neurons and retinal cones, as it represses Lhx2 translation.	[Sanuki, Rikako; Onishi, Akishi; Koike, Chieko; Watanabe, Satoshi; Muranishi, Yuki; Irie, Shoichi; Furukawa, Takahisa] Osaka Biosci Inst, Dept Dev Biol, Osaka, Japan; [Sanuki, Rikako; Onishi, Akishi; Watanabe, Satoshi; Irie, Shoichi; Furukawa, Takahisa] Japan Sci & Technol Agcy, Osaka Biosci Inst, Osaka, Japan; [Muramatsu, Rieko; Yamashita, Toshihide] Osaka Univ, Grad Sch Med, Dept Mol Neurosci, Osaka, Japan; [Uneo, Shinji; Koyasu, Toshiyuki; Kondo, Mineo] Nagoya Univ, Dept Ophthalmol, Grad Sch Med, Showa Ku, Nagoya, Aichi 4648601, Japan; [Matsui, Ryosuke; Watanabe, Dai] Kyoto Univ, Dept Biol Sci, Fac Med, Grad Sch Biostudies,Sakyo Ku, Kyoto, Japan; [Cherasse, Yoan; Urade, Yoshihiro] Osaka Biosci Inst, Dept Mol Behav Biol, Osaka, Japan	Japan Science & Technology Agency (JST); Osaka University; Nagoya University; Kyoto University	Furukawa, T (corresponding author), Osaka Biosci Inst, Dept Dev Biol, Osaka, Japan.	furukawa@obi.or.jp	Cherasse, Yoan/AAD-6442-2020; Sanuki, Rikako/AAV-7143-2021	Cherasse, Yoan/0000-0002-6139-8193; Sanuki, Rikako/0000-0001-9862-9840; Watanabe, Satoshi/0000-0002-8129-6223; Yamashita, Toshihide/0000-0003-4559-7018	Japan Science and Technology Agency (JST), Core Research for Evolutional Science and Technology (CREST); Ministry of Education, Culture, Sports, Science and Technology; Takeda Science Foundation; Uehara Memorial Foundation; Mochida Memorial Foundation; Naito Foundation; Grants-in-Aid for Scientific Research [23592603] Funding Source: KAKEN	Japan Science and Technology Agency (JST), Core Research for Evolutional Science and Technology (CREST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); Mochida Memorial Foundation; Naito Foundation(Naito Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank T. Maniatis for RIPmiR-124a-2, M. Kilimann for Synapsin 1 promoter, Y. Omori, K. Terada, M. Ueno, N. Nagata, K. Aritake, Y. Oishi, T. Hamasaki, and H. Abe for critical comments and technical advice, and A. Tani, M. Kadowaki, Y. Kawakami, A. Ishimaru, H. Tsujii, T. Saioka, K. Sone, H. Abe, and S. Kennedy for technical assistance. This work was supported by Japan Science and Technology Agency (JST), Core Research for Evolutional Science and Technology (CREST), Grant-in-Aid for Scientific Research (B), Grant-in-Aid for Young Scientists (B), a Grant for Molecular Brain Science from the Ministry of Education, Culture, Sports, Science and Technology, the Takeda Science Foundation, the Uehara Memorial Foundation, the Mochida Memorial Foundation, and the Naito Foundation.	BABB TL, 1991, NEUROSCIENCE, V42, P351, DOI 10.1016/0306-4522(91)90380-7; Baulac S, 2008, ARCH NEUROL-CHICAGO, V65, P943, DOI 10.1001/archneur.65.7.943; Blackshaw S, 2004, PLOS BIOL, V2, P1411, DOI 10.1371/journal.pbio.0020247; Cao XW, 2007, GENE DEV, V21, P531, DOI 10.1101/gad.1519207; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; Chen SM, 1997, NEURON, V19, P1017, DOI 10.1016/S0896-6273(00)80394-3; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Chow RL, 2001, ANNU REV CELL DEV BI, V17, P255, DOI 10.1146/annurev.cellbio.17.1.255; Conaco C, 2006, P NATL ACAD SCI USA, V103, P2422, DOI 10.1073/pnas.0511041103; COTE F, 1993, CELL, V73, P35, DOI 10.1016/0092-8674(93)90158-M; Damiani D, 2008, J NEUROSCI, V28, P4878, DOI 10.1523/JNEUROSCI.0828-08.2008; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Edbauer D, 2010, NEURON, V65, P373, DOI 10.1016/j.neuron.2010.01.005; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Furukawa A, 2002, J NEUROSCI, V22, P1640, DOI 10.1523/JNEUROSCI.22-05-01640.2002; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; Georgi SA, 2010, J NEUROSCI, V30, P4048, DOI 10.1523/JNEUROSCI.4982-09.2010; Glancy M, 2009, EUR J HUM GENET, V17, P37, DOI 10.1038/ejhg.2008.133; Gray PA, 2004, SCIENCE, V306, P2255, DOI 10.1126/science.1104935; Hackler L, 2010, INVEST OPHTH VIS SCI, V51, P1823, DOI 10.1167/iovs.09-4657; He SM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-236; HOESCHE C, 1993, J BIOL CHEM, V268, P26494; Holmes GL, 1999, J COMP NEUROL, V404, P537, DOI 10.1002/(SICI)1096-9861(19990222)404:4<537::AID-CNE9>3.0.CO;2-#; Koike C, 2010, P NATL ACAD SCI USA, V107, P332, DOI 10.1073/pnas.0912730107; Koyama R, 2004, CURR NEUROVASC RES, V1, P3, DOI 10.2174/1567202043480242; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu KL, 2011, NUCLEIC ACIDS RES, V39, P2869, DOI 10.1093/nar/gkq904; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Mangale VS, 2008, SCIENCE, V319, P304, DOI 10.1126/science.1151695; Ng L, 2001, NAT GENET, V27, P94, DOI 10.1038/83829; Nishida A, 2003, NAT NEUROSCI, V6, P1255, DOI 10.1038/nn1155; Ohsawa R, 2008, BRAIN RES, V1192, P90, DOI 10.1016/j.brainres.2007.04.014; OKAZAKI MM, 1995, J COMP NEUROL, V352, P515, DOI 10.1002/cne.903520404; Onishi A, 2009, NEURON, V61, P234, DOI 10.1016/j.neuron.2008.12.006; Porter FD, 1997, DEVELOPMENT, V124, P2935; Qiu R, 2009, MECH DEVELOP, V126, P804, DOI 10.1016/j.mod.2009.08.002; Rajasethupathy P, 2009, NEURON, V63, P803, DOI 10.1016/j.neuron.2009.05.029; Sanuki R, 2010, FEBS LETT, V584, P753, DOI 10.1016/j.febslet.2009.12.030; Siegel G, 2009, NAT CELL BIOL, V11, P705, DOI 10.1038/ncb1876; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Tabares-Seisdedos R, 2009, MOL PSYCHIATR, V14, P563, DOI 10.1038/mp.2009.2; Tonelli DD, 2008, DEVELOPMENT, V135, P3911, DOI 10.1242/dev.025080; Visvanathan J, 2007, GENE DEV, V21, P744, DOI 10.1101/gad.1519107; Weiler IJ, 1997, P NATL ACAD SCI USA, V94, P5395, DOI 10.1073/pnas.94.10.5395; Wilson SI, 2008, NEURON, V59, P413, DOI 10.1016/j.neuron.2008.07.020; Xu XL, 2008, J NEUROSCI, V28, P11883, DOI 10.1523/JNEUROSCI.4114-08.2008; Yoo AS, 2009, NATURE, V460, P642, DOI 10.1038/nature08139	50	212	216	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2011	14	9					1125	U177		10.1038/nn.2897	http://dx.doi.org/10.1038/nn.2897			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	812ID	21857657				2022-12-17	WOS:000294284900012
J	Arnal, LH; Wyart, V; Giraud, AL				Arnal, Luc H.; Wyart, Valentin; Giraud, Anne-Lise			Transitions in neural oscillations reflect prediction errors generated in audiovisual speech	NATURE NEUROSCIENCE			English	Article							SUPERIOR TEMPORAL SULCUS; AUDITORY-CORTEX; TOP-DOWN; COMPUTATIONAL PRINCIPLES; NEURONAL OSCILLATIONS; GAMMA-OSCILLATIONS; VISUAL-CORTEX; INFORMATION; INTEGRATION; SYNCHRONIZATION	According to the predictive coding theory, top-down predictions are conveyed by backward connections and prediction errors are propagated forward across the cortical hierarchy. Using MEG in humans, we show that violating multisensory predictions causes a fundamental and qualitative change in both the frequency and spatial distribution of cortical activity. When visual speech input correctly predicted auditory speech signals, a slow delta regime (3-4 Hz) developed in higher-order speech areas. In contrast, when auditory signals invalidated predictions inferred from vision, a low-beta (14-15 Hz) / high-gamma (60-80 Hz) coupling regime appeared locally in a multisensory area (area STS). This frequency shift in oscillatory responses scaled with the degree of audio-visual congruence and was accompanied by increased gamma activity in lower sensory regions. These findings are consistent with the notion that bottom-up prediction errors are communicated in predominantly high (gamma) frequency ranges, whereas top-down predictions are mediated by slower (beta) frequencies.	[Arnal, Luc H.; Giraud, Anne-Lise] Ecole Normale Super, INSERM, U960, F-75231 Paris, France; [Wyart, Valentin] Univ Paris 06, Ctr Rech, Ctr Natl Rech Sci,Unite Mixte Rech 7225, Inst Cerveau & Moelle Epiniere,INSERM,U975, Paris, France; [Giraud, Anne-Lise] Hop La Pitie Salpetriere, Ctr Neuroimagerie Rech, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Giraud, AL (corresponding author), Ecole Normale Super, INSERM, U960, 24 Rue Lhomond, F-75231 Paris, France.	anne-lise.giraud@ens.fr	Arnal, Luc/AAE-2356-2022	Wyart, Valentin/0000-0001-6522-7837; Arnal, Luc/0000-0002-2226-6497	Centre National de la Recherche Scientifique; Fondation Fyssen	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Fondation Fyssen	We thank the staff of the Centre de Neuroimagerie de Recherche and the Magnetoencephalography Center (Hopital de la Pitie-Salpetriere), in particular J.-D. Lemarechal, A. Ducorps and D. Schwarz, and the colleagues who commented on this work: V. van Wassenhove, B. Morillon, A. Hyafil, S. Deneve, L. Melloni, F. Griffon, A. Kleinschmidt, E. Koechlin, B. Fischer, K. Friston and C. Tallon-Baudry. This work was supported by the Centre National de la Recherche Scientifique (A.-L.G.) and the Fondation Fyssen (V.W.).	Akam T, 2010, NEURON, V67, P308, DOI 10.1016/j.neuron.2010.06.019; Arnal LH, 2009, J NEUROSCI, V29, P13445, DOI 10.1523/JNEUROSCI.3194-09.2009; Beauchamp MS, 2004, NEURON, V41, P809, DOI 10.1016/S0896-6273(04)00070-4; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Chandrasekaran C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000436; Colgin LL, 2009, NATURE, V462, P353, DOI 10.1038/nature08573; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; Fries P, 1997, P NATL ACAD SCI USA, V94, P12699, DOI 10.1073/pnas.94.23.12699; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; Garrido MI, 2007, NEUROIMAGE, V36, P571, DOI 10.1016/j.neuroimage.2007.03.014; George D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000532; Ghazanfar AA, 2008, J NEUROSCI, V28, P4457, DOI 10.1523/JNEUROSCI.0541-08.2008; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Hagoort P, 2004, SCIENCE, V304, P438, DOI 10.1126/science.1095455; Hald LA, 2006, BRAIN LANG, V96, P90, DOI 10.1016/j.bandl.2005.06.007; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Kayser C, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.007.2009; Kayser C, 2009, NEURON, V61, P597, DOI 10.1016/j.neuron.2009.01.008; Koch SP, 2009, J NEUROSCI, V29, P13962, DOI 10.1523/JNEUROSCI.1402-09.2009; Kopell N, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00187; Kramer MA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000169; Lakatos P, 2005, J NEUROPHYSIOL, V94, P1904, DOI 10.1152/jn.00263.2005; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; Mukamel R, 2005, SCIENCE, V309, P951, DOI 10.1126/science.1110913; MUMFORD D, 1992, BIOL CYBERN, V66, P241, DOI 10.1007/BF00198477; Neisser U., 1967, COGNITIVE PSYCHOL; Niessing J, 2005, SCIENCE, V309, P948, DOI 10.1126/science.1110948; Panzeri S, 2010, TRENDS NEUROSCI, V33, P111, DOI 10.1016/j.tins.2009.12.001; Poeppel D, 2008, PHILOS T R SOC B, V363, P1071, DOI 10.1098/rstb.2007.2160; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; ROCKLAND KS, 1979, BRAIN RES, V179, P3, DOI 10.1016/0006-8993(79)90485-2; Roopun AK, 2008, FRONT CELL NEUROSCI, V2, DOI 10.3389/neuro.03.001.2008; Schroeder CE, 2009, BRAIN TOPOGR, V22, P24, DOI 10.1007/s10548-009-0080-y; Schroeder CE, 2009, TRENDS NEUROSCI, V32, P9, DOI 10.1016/j.tins.2008.09.012; Sejnowski TJ, 2006, J NEUROSCI, V26, P1673, DOI 10.1523/JNEUROSCI.3737-05d.2006; Shah AS, 2004, CEREB CORTEX, V14, P476, DOI 10.1093/cercor/bhh009; Spratling MW, 2008, FRONT COMPUT NEUROSC, V2, P1, DOI 10.3389/neuro.10.004.2008; Stevens KN, 1967, MODELS PERCEPTION SP, P88; TallonBaudry C, 1996, J NEUROSCI, V16, P4240; van Wassenhove V, 2005, P NATL ACAD SCI USA, V102, P1181, DOI 10.1073/pnas.0408949102; von Stein A, 2000, P NATL ACAD SCI USA, V97, P14748, DOI 10.1073/pnas.97.26.14748; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]; Wrobel A, 2000, ACTA NEUROBIOL EXP, V60, P247; Wyart V, 2008, J NEUROSCI, V28, P2667, DOI 10.1523/JNEUROSCI.4748-07.2008	50	212	213	2	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2011	14	6					797	U164		10.1038/nn.2810	http://dx.doi.org/10.1038/nn.2810			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	768SH	21552273	Green Published			2022-12-17	WOS:000290958000025
J	Maier, A; Wilke, M; Aura, C; Zhu, C; Ye, FQ; Leopold, DA				Maier, Alexander; Wilke, Melanie; Aura, Christopher; Zhu, Charles; Ye, Frank Q.; Leopold, David A.			Divergence of fMRI and neural signals in V1 during perceptual suppression in the awake monkey	NATURE NEUROSCIENCE			English	Article							PRIMARY VISUAL-CORTEX; LATERAL GENICULATE-NUCLEUS; RESONANCE-IMAGING SIGNAL; BINOCULAR-RIVALRY; FLUCTUATIONS; MODULATION; ATTENTION; AWARENESS; BRAIN; FLASH	The role of primary visual cortex (V1) in determining the contents of perception is controversial. Human functional magnetic resonance imaging (fMRI) studies of perceptual suppression have revealed a robust drop in V1 activity when a stimulus is subjectively invisible. In contrast, monkey single-unit recordings have failed to demonstrate such perception-locked changes in V1. To investigate the basis of this discrepancy, we measured both the blood oxygen level-dependent (BOLD) response and several electrophysiological signals in two behaving monkeys. We found that all signals were in good agreement during conventional stimulus presentation, showing strong visual modulation to presentation and removal of a stimulus. During perceptual suppression, however, only the BOLD response and the low-frequency local field potential (LFP) power showed decreases, whereas the spiking and high-frequency LFP power were unaffected. These results demonstrate that the coupling between the BOLD and electrophysiological signals in V1 is context dependent, with a marked dissociation occurring during perceptual suppression.	[Maier, Alexander; Wilke, Melanie; Aura, Christopher; Leopold, David A.] NIMH, Unit Cognit Neurophysiol & Imaging, Neuropsychol Lab, Bethesda, MD 20892 USA; NEI, Neurophysiol Imaging Facil, NIMH, NINDS,US Natl Inst Hlth,US Dept HHS, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); NIH National Institute of Mental Health (NIMH); NIH National Institute of Neurological Disorders & Stroke (NINDS)	Maier, A (corresponding author), NIMH, Unit Cognit Neurophysiol & Imaging, Neuropsychol Lab, 49 Convent Dr,B2J-45,MSC 4400, Bethesda, MD 20892 USA.	maiera@mail.nih.gov	Maier, Alexander/B-7489-2009	Maier, Alexander/0000-0002-7250-502X; Leopold, David/0000-0002-1345-6360	National Institute of Mental Health; National Institute of Neurological Disorders and Stroke; National Eye Institute; NATIONAL INSTITUTE OF MENTAL HEALTH [ZICMH002888, ZIAMH002838, ZICMH002899, ZIAMH002896] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We would like to thank G. Dold, D. Ide, N. Nichols and T. Talbot, as well as K. Smith, N. Phipps and J. Yu for technical assistance. We also thank H. Merkle for extensive guidance on the design and fabrication of radio frequency coils, R. Cox for assistance with magnetic resonance image alignment, D. Sheinberg for help with the stimulus software, K. King and C. Brewer for auditory testing and ear plug manufacture, W. Vinje for help with the multi- contact electrodes, K. Tanji, A.H. Bell and Z. Saad for help with the fMRI analysis, and S. Guderian, M. Schmid and K.- M. Mueller for discussions. This work was supported by the Intramural Research Programs of the National Institute of Mental Health, the National Institute of Neurological Disorders and Stroke and the National Eye Institute.	Blake R, 2002, NAT REV NEUROSCI, V3, P13, DOI 10.1038/nrn701; Bonneh YS, 2001, NATURE, V411, P798, DOI 10.1038/35081073; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; CRICK F, 1995, NATURE, V375, P121, DOI 10.1038/375121a0; Gail A, 2004, CEREB CORTEX, V14, P300, DOI 10.1093/cercor/bhg129; GAUTHIER C, 2008, INT J BIOMED IM 0302; GRUETTER R, 1993, MAGNET RESON MED, V29, P804, DOI 10.1002/mrm.1910290613; Haynes JD, 2005, NATURE, V438, P496, DOI 10.1038/nature04169; Haynes JD, 2005, CURR BIOL, V15, P1301, DOI 10.1016/j.cub.2005.06.026; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; Lamme VAF, 2000, VISION RES, V40, P1507, DOI 10.1016/S0042-6989(99)00243-6; Lee SH, 2002, J VISION, V2, P618, DOI 10.1167/2.9.4; Lee SH, 2005, NAT NEUROSCI, V8, P22, DOI 10.1038/nn1365; Leopold DA, 1996, NATURE, V379, P549, DOI 10.1038/379549a0; Leopold DA, 2003, CEREB CORTEX, V13, P422, DOI 10.1093/cercor/13.4.422; LEOPOLD DA, 2004, BINOCULAR RIVALRY PE; LOGOTHETIS NK, 1989, SCIENCE, V245, P761, DOI 10.1126/science.2772635; Logothetis NK, 2002, PHILOS T R SOC B, V357, P1003, DOI 10.1098/rstb.2002.1114; Logothetis NK, 2003, J NEUROSCI, V23, P3963; MAIER A, 2007, SOC NEUR ABSTR; Maier A, 2007, P NATL ACAD SCI USA, V104, P5620, DOI 10.1073/pnas.0608489104; MANSFIELD P, 1977, J PHYS C SOLID STATE, V10, pL55, DOI 10.1088/0022-3719/10/3/004; Mitchell JF, 2007, NEURON, V55, P131, DOI 10.1016/j.neuron.2007.06.018; Mitz AR, 2005, J NEUROSCI METH, V148, P19, DOI 10.1016/j.jneumeth.2005.07.012; Mukamel R, 2005, SCIENCE, V309, P951, DOI 10.1126/science.1110913; Niessing J, 2005, SCIENCE, V309, P948, DOI 10.1126/science.1110948; Nir Y, 2007, CURR BIOL, V17, P1275, DOI 10.1016/j.cub.2007.06.066; Polonsky A, 2000, NAT NEUROSCI, V3, P1153, DOI 10.1038/80676; Posner MI, 1999, P NATL ACAD SCI USA, V96, P2585, DOI 10.1073/pnas.96.6.2585; Shmuel A, 2008, HUM BRAIN MAPP, V29, P751, DOI 10.1002/hbm.20580; Super H, 2001, NAT NEUROSCI, V4, P304, DOI 10.1038/85170; Tong F, 2001, NATURE, V411, P195, DOI 10.1038/35075583; Tong F, 2003, NAT REV NEUROSCI, V4, P219, DOI 10.1038/nrn1055; Tong F, 2006, TRENDS COGN SCI, V10, P502, DOI 10.1016/j.tics.2006.09.003; Viswanathan A, 2007, NAT NEUROSCI, V10, P1308, DOI 10.1038/nn1977; Wilke M, 2003, NEURON, V39, P1043, DOI 10.1016/j.neuron.2003.08.003; Wilke M, 2006, P NATL ACAD SCI USA, V103, P17507, DOI 10.1073/pnas.0604673103; WOLFE JM, 1984, VISION RES, V24, P471, DOI 10.1016/0042-6989(84)90044-0; Wunderlich K, 2005, NAT NEUROSCI, V8, P1595, DOI 10.1038/nn1554	40	212	213	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2008	11	10					1193	1200		10.1038/nn.2173	http://dx.doi.org/10.1038/nn.2173			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	352WQ	18711393	Green Accepted			2022-12-17	WOS:000259528500017
J	Grosmaitre, X; Santarelli, LC; Tan, J; Luo, MM; Ma, MH				Grosmaitre, Xavier; Santarelli, Lindsey C.; Tan, Jie; Luo, Minmin; Ma, Minghong			Dual functions of mammalian olfactory sensory neurons as odor detectors and mechanical sensors	NATURE NEUROSCIENCE			English	Article							BULB UNIT-ACTIVITY; EXTERNAL TUFTED CELLS; MOLECULAR-BASIS; RECEPTOR; RAT; INHIBITION; RESPONSES; PATTERNS; CHANNEL	Most sensory systems are primarily specialized to detect one sensory modality. Here we report that olfactory sensory neurons (OSNs) in the mammalian nose can detect two distinct modalities transmitted by chemical and mechanical stimuli. As revealed by patch-clamp recordings, many OSNs respond not only to odorants, but also to mechanical stimuli delivered by pressure ejections of odor-free Ringer solution. The mechanical responses correlate directly with the pressure intensity and show several properties similar to those induced by odorants, including onset latency, reversal potential and adaptation to repeated stimulation. Blocking adenylyl cyclase or knocking out the cyclic nucleotide-gated channel CNGA2 eliminates the odorant and the mechanical responses, suggesting that both are mediated by a shared cAMP cascade. We further show that this mechanosensitivity enhances the firing frequency of individual neurons when they are weakly stimulated by odorants and most likely drives the rhythmic activity (theta oscillation) in the olfactory bulb to synchronize with respiration.	Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA; Natl Inst Biol Sci, Beijing, Peoples R China	University of Pennsylvania; National Institute of Biological Sciences, Beijing	Ma, MH (corresponding author), Univ Penn, Sch Med, Dept Neurosci, 215 Stemmler Hall,3450 Hamilton Walk, Philadelphia, PA 19104 USA.	minghong@mail.med.upenn.edu		Ma, Minghong/0000-0002-5027-9623; Grosmaitre, Xavier/0000-0001-8041-6919; Luo, Minmin/0000-0003-3535-6624	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006213] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC006213-01A2, R01 DC006213-02, R01 DC006213, R01 DC006213-03] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ADRIAN ED, 1951, J PHYSIOL-LONDON, V114, pP4; Balu R, 2004, J NEUROPHYSIOL, V92, P743, DOI 10.1152/jn.00016.2004; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Cang JH, 2003, J NEUROSCI, V23, P4108; Chaput MA, 2000, CHEM SENSES, V25, P695, DOI 10.1093/chemse/25.6.695; Chen S, 2000, J NEUROPHYSIOL, V84, P575, DOI 10.1152/jn.2000.84.1.575; Firestein S, 2001, NATURE, V413, P211, DOI 10.1038/35093026; Fontanini A, 2003, J NEUROSCI, V23, P7993; Grosmaitre X, 2006, P NATL ACAD SCI USA, V103, P1970, DOI 10.1073/pnas.0508491103; Hayar A, 2005, J NEUROSCI, V25, P8197, DOI 10.1523/JNEUROSCI.2374-05.2005; Hayar A, 2004, J NEUROSCI, V24, P1190, DOI 10.1523/JNEUROSCI.4714-03.2004; Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev; Johnson BN, 2003, J NEUROPHYSIOL, V90, P1084, DOI 10.1152/jn.00115.2003; KURAHASHI T, 1990, BRAIN RES, V515, P261, DOI 10.1016/0006-8993(90)90605-B; Lai-Fook SJ, 2005, J APPL PHYSIOL, V98, P2204, DOI 10.1152/japplphysiol.00869.2004; LAING DG, 1983, PERCEPTION, V12, P99, DOI 10.1068/p120099; Lin SY, 2005, CURR OPIN NEUROBIOL, V15, P350, DOI 10.1016/j.conb.2005.05.012; Luo M, 2001, NEURON, V32, P1165, DOI 10.1016/S0896-6273(01)00537-2; Ma MH, 1999, J NEUROSCI METH, V92, P31, DOI 10.1016/S0165-0270(99)00089-8; Ma MH, 2000, P NATL ACAD SCI USA, V97, P12869, DOI 10.1073/pnas.220301797; Ma MH, 2003, J NEUROSCI, V23, P317; MACRIDES F, 1972, SCIENCE, V175, P84, DOI 10.1126/science.175.4017.84; Mainland J, 2006, CHEM SENSES, V31, P181, DOI 10.1093/chemse/bjj012; ONODA N, 1980, J NEUROPHYSIOL, V44, P29, DOI 10.1152/jn.1980.44.1.29; PAOLETTI P, 1994, NEURON, V13, P645, DOI 10.1016/0896-6273(94)90032-9; Philpot BD, 1997, J NEUROBIOL, V33, P374, DOI 10.1002/(SICI)1097-4695(199710)33:4<374::AID-NEU3>3.0.CO;2-7; POTTER H, 1976, BRAIN RES, V116, P417, DOI 10.1016/0006-8993(76)90490-X; RAVEL N, 1987, EXP BRAIN RES, V65, P623; RAVEL N, 1990, NEUROSCI LETT, V115, P213, DOI 10.1016/0304-3940(90)90457-K; Rodolfo-Masera T., 1943, ARCH ITAL ANAT E EMBRIOL, V48, P157; Schoppa NE, 2001, NEURON, V31, P639, DOI 10.1016/S0896-6273(01)00389-0; SOBEL EC, 1993, J NEUROPHYSIOL, V69, P1331, DOI 10.1152/jn.1993.69.4.1331; Spehr M, 2002, NEURON, V33, P731, DOI 10.1016/S0896-6273(02)00610-4; Spors H, 2006, J NEUROSCI, V26, P1247, DOI 10.1523/JNEUROSCI.3100-05.2006; UEKI S, 1961, J NEUROPHYSIOL, V24, P12, DOI 10.1152/jn.1961.24.1.12; Urban NN, 2002, J PHYSIOL-LONDON, V542, P355, DOI 10.1113/jphysiol.2001.013491; Zhao HQ, 2001, CELL, V104, P651, DOI 10.1016/S0092-8674(02)01107-8; ZUFALL F, 1991, P ROY SOC B-BIOL SCI, V246, P225, DOI 10.1098/rspb.1991.0148; Zufall F, 2000, CHEM SENSES, V25, P473, DOI 10.1093/chemse/25.4.473	39	212	214	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2007	10	3					348	354		10.1038/nn1856	http://dx.doi.org/10.1038/nn1856			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	140CM	17310245	Green Accepted			2022-12-17	WOS:000244480300017
J	Urgesi, C; Candidi, M; Ionta, S; Aglioti, SM				Urgesi, Cosimo; Candidi, Matteo; Ionta, Silvio; Aglioti, Salvatore M.			Representation of body identity and body actions in extrastriate body area and ventral premotor cortex	NATURE NEUROSCIENCE			English	Article							PERSPECTIVE	Although inherently linked, body form and body action may be represented in separate neural substrates. Using repetitive transcranial magnetic stimulation in healthy individuals, we show that interference with the extrastriate body area impairs the discrimination of bodily forms, and interference with the ventral premotor cortex impairs the discrimination of bodily actions. This double dissociation suggests that whereas extrastriate body area mainly processes actors' body identity, premotor cortex is crucial for visual discriminations of actions.	Univ Roma La Sapienza, Dipartimento Piscol, I-00185 Rome, Italy; Ist Ricovero & Cura Carattere Sci E Medea, I-33078 San Vito Al Tagliamento, Pordenone, Italy; Ist Ricovero & Cura Carattere Sci Fdn St Lucia, I-00179 Rome, Italy	Sapienza University Rome; IRCCS Eugenio Medea; IRCCS Santa Lucia	Aglioti, SM (corresponding author), Univ Roma La Sapienza, Dipartimento Piscol, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	urgesi@sv.lnf.it; salvatoremaria.aglioti@uniroma1.it	Urgesi, Cosimo/K-4688-2016; Aglioti, Salvatore M/E-9829-2012; Candidi, Matteo/K-9245-2016; ionta, silvio/AGB-3634-2022	Urgesi, Cosimo/0000-0003-0572-1328; ionta, silvio/0000-0003-2078-4861; Aglioti, Salvatore Maria/0000-0001-8175-7563; CANDIDI, MATTEO/0000-0001-8201-7954				Astafiev SV, 2004, NAT NEUROSCI, V7, P542, DOI 10.1038/nn1241; Chan AWY, 2004, NEUROREPORT, V15, P2407, DOI 10.1097/00001756-200410250-00021; Downing PE, 2006, SOC NEUROSCI, V1, P52, DOI 10.1080/17470910600668854; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Gallese V, 2004, TRENDS COGN SCI, V8, P396, DOI 10.1016/j.tics.2004.07.002; Hamilton AFD, 2006, NEUROIMAGE, V29, P524, DOI 10.1016/j.neuroimage.2005.07.037; Heiser M, 2003, EUR J NEUROSCI, V17, P1123, DOI 10.1046/j.1460-9568.2003.02530.x; Peelen MV, 2005, NAT NEUROSCI, V8, P125, DOI 10.1038/nn0205-125a; Peelen MV, 2006, NEURON, V49, P815, DOI 10.1016/j.neuron.2006.02.004; Pobric G, 2006, CURR BIOL, V16, P524, DOI 10.1016/j.cub.2006.01.033; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Ruby P, 2001, NAT NEUROSCI, V4, P546, DOI 10.1038/87510; Saxe R, 2006, CEREB CORTEX, V16, P178, DOI 10.1093/cercor/bhi095; Urgesi C, 2004, CURR BIOL, V14, P2130, DOI 10.1016/j.cub.2004.11.031; Wilson M, 2005, PSYCHOL BULL, V131, P460, DOI 10.1037/0033-2909.131.3.460	15	212	216	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2007	10	1					30	31		10.1038/nn1815	http://dx.doi.org/10.1038/nn1815			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	120PC	17159990	Green Published			2022-12-17	WOS:000243096100012
J	Pegna, AJ; Khateb, A; Lazeyras, F; Seghier, ML				Pegna, AJ; Khateb, A; Lazeyras, F; Seghier, ML			Discriminating emotional faces without primary visual cortices involves the right amygdala	NATURE NEUROSCIENCE			English	Article							BLINDSIGHT; RESPONSES; FIELD; FEAR	Destruction of the brain's primary visual areas leads to blindness of cortical origin. Here we report on a subject who, after bilateral destruction of his visual cortices and ensuing cortical blindness, could nevertheless correctly guess the type of emotional facial expression being displayed, but could not guess other types of emotional or non-emotional stimuli. Functional magnetic resonance imaging showed activation of the right amygdala during the unconscious processing of emotionally expressive faces.	Univ Wales Bangor, Sch Psychol, Ctr Cognit Neurosci, Bangor LL57 2AS, Gwynedd, Wales; Univ Hosp Geneva, Dept Clin Neurosci & Dermatol, Neurol Clin, Neuropsychol Unit, CH-1211 Geneva 14, Switzerland; Univ Hosp Geneva, Dept Radiol, CH-1211 Geneva 14, Switzerland; Univ Med Ctr, Dept Fundamental Neurosci, Lab Neurol & Neuroimaging Cognit, CH-1211 Geneva 4, Switzerland	Bangor University; University of Geneva; University of Geneva; University of Geneva	Pegna, AJ (corresponding author), Univ Wales Bangor, Sch Psychol, Ctr Cognit Neurosci, Penrallt Rd, Bangor LL57 2AS, Gwynedd, Wales.	alan.pegna@hcuge.ch	Khateb, Asaid/AAF-1609-2020; Seghier, Mohamed L/C-6314-2009; Pegna, A J/D-1297-2017; Seghier, Mohamed/O-8634-2019	Khateb, Asaid/0000-0003-4639-1564; Seghier, Mohamed L/0000-0002-1146-8800; Pegna, A J/0000-0001-9920-9290; Seghier, Mohamed/0000-0002-1146-8800				Breiter HC, 1996, NEURON, V17, P875, DOI 10.1016/S0896-6273(00)80219-6; de Gelder B, 1999, NEUROREPORT, V10, P3759, DOI 10.1097/00001756-199912160-00007; Ekman P., 1975, PICTURES FACIAL AFFE; Hamm AO, 2003, BRAIN, V126, P267, DOI 10.1093/brain/awg037; Holmes G, 1918, Br J Ophthalmol, V2, P353, DOI 10.1136/bjo.2.7.353; Lang P.J., 1997, NIMH CENT STUDY EMOT; MARZI CA, 1986, NEUROPSYCHOLOGIA, V24, P749, DOI 10.1016/0028-3932(86)90074-6; Morris JS, 2001, BRAIN, V124, P1241, DOI 10.1093/brain/124.6.1241; Morris JS, 1999, P NATL ACAD SCI USA, V96, P1680, DOI 10.1073/pnas.96.4.1680; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; Pessoa L, 2002, P NATL ACAD SCI USA, V99, P11458, DOI 10.1073/pnas.172403899; WEISKRANTZ L, 1974, BRAIN, V97, P709, DOI 10.1093/brain/97.1.709; WEISKRANTZ L, 2001, DISORDERS VISUAL BEH, V4, P215; Wright CI, 2002, NEUROREPORT, V13, P785, DOI 10.1097/00001756-200205070-00010; Zald DH, 2003, BRAIN RES REV, V41, P88, DOI 10.1016/S0165-0173(02)00248-5	15	212	215	0	28	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2005	8	1					24	25		10.1038/nn1364	http://dx.doi.org/10.1038/nn1364			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882VO	15592466				2022-12-17	WOS:000225967600011
J	Gottfried, JA; Dolan, RJ				Gottfried, JA; Dolan, RJ			Human orbitofrontal cortex mediates extinction learning while accessing conditioned representations of value	NATURE NEUROSCIENCE			English	Article							PREFRONTAL CORTEX; BASOLATERAL AMYGDALA; UCS INFLATION; FEAR; NEURONS; RESPONSES; ACTIVATION; CONTEXT; REWARD; MEMORY	In extinction, an animal learns that a previously conditioned stimulus (CS+) no longer predicts delivery of a salient reinforcer (unconditioned stimulus, UCS). Rodent studies indicate that extinction relies on amygdala-prefrontal interactions and involves formation of memories that inhibit, without actually erasing, the original conditioning trace. Whether extinction learning in humans follows similar neurobiological principles is unknown. We used functional magnetic resonance imaging to measure human brain activity evoked during olfactory aversive conditioning and extinction learning. Neural responses in orbitofrontal cortex and amygdala were preferentially enhanced during extinction, suggesting potential cross-species preservation of learning mechanisms that oppose conditioning. Moreover, by manipulating UCS aversiveness via reinforcer inflation, we showed that a CS+ retains access to representations of UCS value in distinct regions of ventral prefrontal cortex, even as extinction proceeds.	Wellcome Dept Imaging Neurosci, Funct Imaging Lab, London WC1N 3BG, England	University of London; University College London	Gottfried, JA (corresponding author), Cognit Neurol & Alzheimers Dis Ctr, 320 E Super St,Searle 11-453, Chicago, IL 60611 USA.	j-gottfried@northwestern.edu	anand, amit/A-7222-2009					[Anonymous], 1997, ATLAS HUMAN BRAIN; Arana FS, 2003, J NEUROSCI, V23, P9632; Baeg EH, 2001, CEREB CORTEX, V11, P441, DOI 10.1093/cercor/11.5.441; Baxter MG, 2000, J NEUROSCI, V20, P4311; BOUTON ME, 1984, J EXP PSYCHOL ANIM B, V10, P56; BOUTON ME, 1993, PSYCHOL BULL, V114, P80, DOI 10.1037/0033-2909.114.1.80; Buchel C, 1998, NEURON, V20, P947, DOI 10.1016/S0896-6273(00)80476-6; Critchley HD, 2002, NEURON, V33, P653, DOI 10.1016/S0896-6273(02)00588-3; Deichmann R, 2003, NEUROIMAGE, V19, P430, DOI 10.1016/S1053-8119(03)00073-9; Ekman P., 1976, PICTURES FACIAL AFFE; FALLS WA, 1992, J NEUROSCI, V12, P854; Friston K.J., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Gallagher M, 1999, J NEUROSCI, V19, P6610; Garcia R, 2002, LEARN MEMORY, V9, P361, DOI 10.1101/lm.56402; Gottfried JA, 2002, J NEUROSCI, V22, P10829; Gottfried JA, 2002, J NEUROSCI, V22, P10819; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; Hatfield T, 1996, J NEUROSCI, V16, P5256; Herry C, 2002, J NEUROSCI, V22, P577, DOI 10.1523/JNEUROSCI.22-02-00577.2002; Hobin JA, 2003, J NEUROSCI, V23, P8410; Holland PC, 1999, TRENDS COGN SCI, V3, P65, DOI 10.1016/S1364-6613(98)01271-6; Hosoba T, 2001, BEHAV RES THER, V39, P465, DOI 10.1016/S0005-7967(00)00025-5; LaBar KS, 1998, NEURON, V20, P937, DOI 10.1016/S0896-6273(00)80475-4; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Malkova L, 1997, J NEUROSCI, V17, P6011; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; Milad MR, 2002, NATURE, V420, P70, DOI 10.1038/nature01138; MORGAN MA, 1993, NEUROSCI LETT, V163, P109, DOI 10.1016/0304-3940(93)90241-C; Morris JS, 2004, NEUROIMAGE, V22, P372, DOI 10.1016/j.neuroimage.2004.01.012; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; Morrow BA, 1999, NEUROSCIENCE, V92, P553, DOI 10.1016/S0306-4522(99)00014-7; Myers KM, 2002, NEURON, V36, P567, DOI 10.1016/S0896-6273(02)01064-4; O'Doherty J, 2003, J NEUROSCI, V23, P7931; O'Doherty JP, 2002, NEURON, V33, P815, DOI 10.1016/S0896-6273(02)00603-7; PEARCE JM, 1980, PSYCHOL REV, V87, P532, DOI 10.1037/0033-295X.87.6.532; Pickens CL, 2003, J NEUROSCI, V23, P11078; Price CJ, 1997, NEUROIMAGE, V5, P261, DOI 10.1006/nimg.1997.0269; Quirk GJ, 2003, J NEUROSCI, V23, P8800, DOI 10.1523/jneurosci.23-25-08800.2003; Quirk GJ, 2003, ANN NY ACAD SCI, V985, P263; Repa JC, 2001, NAT NEUROSCI, V4, P724, DOI 10.1038/89512; Rescorla RA, 2001, HANDBOOK OF CONTEMPORARY LEARNING THEORIES, P119; RESCORLA RA, 1974, J COMP PHYSIOL PSYCH, V86, P101, DOI 10.1037/h0035964; Rosenkranz JA, 2003, J NEUROSCI, V23, P11054; Rosenkranz JA, 2002, J NEUROSCI, V22, P324, DOI 10.1523/JNEUROSCI.22-01-00324.2002; Royer S, 2002, NEUROSCIENCE, V115, P455, DOI 10.1016/S0306-4522(02)00455-4; Schoenbaum G, 2003, NEURON, V39, P855, DOI 10.1016/S0896-6273(03)00474-4; Schoenbaum G, 2000, J NEUROSCI, V20, P5179; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; WHITE K, 1989, BEHAV RES THER, V27, P161, DOI 10.1016/0005-7967(89)90074-0; WILSON PN, 1992, Q J EXP PSYCHOL-B, V44B, P17; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O	51	212	213	0	16	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2004	7	10					1145	1153		10.1038/nn1314	http://dx.doi.org/10.1038/nn1314			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	857YQ		Green Published			2022-12-17	WOS:000224156900025
J	Koulakov, AA; Raghavachari, S; Kepecs, A; Lisman, JE				Koulakov, AA; Raghavachari, S; Kepecs, A; Lisman, JE			Model for a robust neural integrator	NATURE NEUROSCIENCE			English	Article							OCULOMOTOR SYSTEM; WORKING-MEMORY; PERSISTENT ACTIVITY; EYE-POSITION; PARIETAL CORTEX; HEAD-DIRECTION; NMDA RECEPTORS; NEURONS; NETWORK; CAT	Integrator circuits in the brain show persistent firing that reflects the sum of previous excitatory and inhibitory inputs from external sources. Integrator circuits have been implicated in parametric working memory, decision making and motor control. Previous work has shown that stable integrator function can be achieved by an excitatory recurrent neural circuit, provided synaptic strengths are tuned with extreme precision (better than 1% accuracy). Here we show that integrator circuits can function without fine tuning if the neuronal units have bistable properties. Two specific mechanisms of bistability are analyzed, one based on local recurrent excitation, and the other on the voltage-dependence of the NMDA (N-methyl-D-aspartate) channel. Neither circuit requires fine tuning to perform robust integration, and the latter actually exploits the variability of neuronal conductances.	Salk Inst Biol Studies, La Jolla, CA 92037 USA; Univ Utah, Dept Phys, Salt Lake City, UT 84112 USA; Brandeis Univ, Volen Ctr Complex Syst, Waltham, MA 02454 USA	Salk Institute; Utah System of Higher Education; University of Utah; Brandeis University	Koulakov, AA (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.			Kepecs, Adam/0000-0003-0049-8120	PHS HHS [461434] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Aksay E, 2000, J NEUROPHYSIOL, V84, P1035, DOI 10.1152/jn.2000.84.2.1035; Aksay E, 2001, NAT NEUROSCI, V4, P184, DOI 10.1038/84023; ARNOLD DB, 1991, BIOL CYBERN, V64, P447, DOI 10.1007/BF00202608; BLAIR HT, 1995, J NEUROSCI, V15, P6260; CANNON SC, 1983, BIOL CYBERN, V49, P127, DOI 10.1007/BF00320393; CIMINO A, 1990, FEBS LETT, V263, P199, DOI 10.1016/0014-5793(90)81373-V; DeSouza JFX, 2000, J NEUROSCI, V20, P5835, DOI 10.1523/JNEUROSCI.20-15-05835.2000; FUKUSHIMA K, 1992, PROG NEUROBIOL, V39, P609, DOI 10.1016/0301-0082(92)90016-8; Fuster JM, 1995, MEMORY CEREBRAL CORT; GNADT JW, 1988, EXP BRAIN RES, V70, P216; GODAUX E, 1990, NEUROSCI LETT, V116, P162, DOI 10.1016/0304-3940(90)90403-V; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; KEPECS A, 2002, ADV NEURAL INFORMATI, V14; Koulakov AA, 2001, NETWORK-COMP NEURAL, V12, P47, DOI 10.1088/0954-898X/12/1/304; LISMAN JE, 1985, P NATL ACAD SCI USA, V82, P3055, DOI 10.1073/pnas.82.9.3055; Lisman JE, 1998, NAT NEUROSCI, V1, P273, DOI 10.1038/1086; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; McAdams HH, 1998, ANNU REV BIOPH BIOM, V27, P199, DOI 10.1146/annurev.biophys.27.1.199; METTENS P, 1994, NEUROREPORT, V5, P1333, DOI 10.1097/00001756-199406270-00009; MIYASHITA Y, 1988, NATURE, V331, P68, DOI 10.1038/331068a0; NOVICK A, 1957, P NATL ACAD SCI USA, V43, P553, DOI 10.1073/pnas.43.7.553; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Petersen CCH, 1998, P NATL ACAD SCI USA, V95, P4732, DOI 10.1073/pnas.95.8.4732; Pinsky P F, 1994, J Comput Neurosci, V1, P39, DOI 10.1007/BF00962717; Priesol AJ, 2000, BRAIN RES, V857, P252, DOI 10.1016/S0006-8993(99)02441-5; ROBINSON DA, 1989, ANNU REV NEUROSCI, V12, P33, DOI 10.1146/annurev.ne.12.030189.000341; Romo R, 1999, NATURE, V399, P470, DOI 10.1038/20939; Schiller J, 2001, CURR OPIN NEUROBIOL, V11, P343, DOI 10.1016/S0959-4388(00)00217-8; SEGEL LA, 1995, IMMUNOL TODAY, V16, P80, DOI 10.1016/0167-5699(95)80093-X; Seung HS, 2000, J COMPUT NEUROSCI, V9, P171, DOI 10.1023/A:1008971908649; Seung HS, 1996, P NATL ACAD SCI USA, V93, P13339, DOI 10.1073/pnas.93.23.13339; Seung HS, 2000, NEURON, V26, P259, DOI 10.1016/S0896-6273(00)81155-1; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; TAUBE JS, 1990, J NEUROSCI, V10, P420; Wang XJ, 2001, TRENDS NEUROSCI, V24, P455, DOI 10.1016/S0166-2236(00)01868-3; Wang XJ, 1999, J NEUROSCI, V19, P9587; WILSON HR, 1972, BIOPHYS J, V12, P1, DOI 10.1016/S0006-3495(72)86068-5	38	212	215	1	19	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2002	5	8					775	782		10.1038/nn893	http://dx.doi.org/10.1038/nn893			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	577XT	12134153				2022-12-17	WOS:000177088900021
J	Pouget, A; Drugowitsch, J; Kepecs, A				Pouget, Alexandre; Drugowitsch, Jan; Kepecs, Adam			Confidence and certainty: distinct probabilistic quantities for different goals	NATURE NEUROSCIENCE			English	Article							TEMPORAL VISUAL AREA; FUNCTIONAL-PROPERTIES; DECISION-MAKING; MACAQUE MONKEY; NEURAL BASIS; NEURONS; METACOGNITION; INFORMATION; DISCRIMINATION; REPRESENTATION	When facing uncertainty, adaptive behavioral strategies demand that the brain performs probabilistic computations. In this probabilistic framework, the notion of certainty and confidence would appear to be closely related, so much so that it is tempting to conclude that these two concepts are one and the same. We argue that there are computational reasons to distinguish between these two concepts. Specifically, we propose that confidence should be defined as the probability that a decision or a proposition, overt or covert, is correct given the evidence, a critical quantity in complex sequential decisions. We suggest that the term certainty should be reserved to refer to the encoding of all other probability distributions over sensory and cognitive variables. We also discuss strategies for studying the neural codes for confidence and certainty and argue that clear definitions of neural codes are essential to understanding the relative contributions of various cortical areas to decision making.	[Pouget, Alexandre; Drugowitsch, Jan] Univ Geneva, Dept Basic Neurosci, Geneva, Switzerland; [Pouget, Alexandre] Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY USA; [Pouget, Alexandre] Gatsby Computat Neurosci Unit, London, England; [Kepecs, Adam] Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA	University of Geneva; University of Rochester; University of London; University College London; Cold Spring Harbor Laboratory	Pouget, A (corresponding author), Univ Geneva, Dept Basic Neurosci, Geneva, Switzerland.; Pouget, A (corresponding author), Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY USA.; Pouget, A (corresponding author), Gatsby Computat Neurosci Unit, London, England.	alexandre.pouget@unige.ch		Drugowitsch, Jan/0000-0002-7846-0408; Pouget, Alexandre/0000-0003-3054-6365; Kepecs, Adam/0000-0003-0049-8120	Simons Global Brain Initiative; US National Institutes of Health [R01MH097061]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH097061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS094288] Funding Source: NIH RePORTER	Simons Global Brain Initiative; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors would like to thank Z. Mainen, R. Kiani, P. Latham, P. Dayan, J. Sanders and B. Hangya for stimulating discussions about the definition and utility of the concept of confidence and A. Urai and P. Masset for comments on the manuscript. This work was supported by grants from the Simons Global Brain Initiative ( A. P.) and the US National Institutes of Health (R01MH097061) to A.K.	Aitchison L, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004519; Bang D, 2014, CONSCIOUS COGN, V26, P13, DOI 10.1016/j.concog.2014.02.002; BARANSKI JV, 1994, PERCEPT PSYCHOPHYS, V55, P412, DOI 10.3758/BF03205299; Barthelme S, 2010, P NATL ACAD SCI USA, V107, P20834, DOI 10.1073/pnas.1007704107; Bayes T., 1763, PHILOS T ROY SOC LON, V53, P370, DOI [DOI 10.1098/RSTL.1763.0053, 10.1098/rstl.1763.0053]; Beck JM, 2012, NEURON, V74, P30, DOI 10.1016/j.neuron.2012.03.016; Beck JM, 2011, J NEUROSCI, V31, P15310, DOI 10.1523/JNEUROSCI.1706-11.2011; Beck JM, 2008, NEURON, V60, P1142, DOI 10.1016/j.neuron.2008.09.021; Camerer C, 1999, AM ECON REV, V89, P306, DOI 10.1257/aer.89.1.306; CLARKE FR, 1959, J ACOUST SOC AM, V31, P629, DOI 10.1121/1.1907764; Clifford CWG, 2008, TRENDS COGN SCI, V12, P54, DOI 10.1016/j.tics.2007.11.009; Dayan P, 2000, NAT NEUROSCI, V3, P1218, DOI 10.1038/81504; de Gardelle V, 2014, PSYCHOL SCI, V25, P1286, DOI 10.1177/0956797614528956; De Martino B, 2013, NAT NEUROSCI, V16, P105, DOI 10.1038/nn.3279; DiCarlo JJ, 2007, TRENDS COGN SCI, V11, P333, DOI 10.1016/j.tics.2007.06.010; Drugowitsch J, 2014, ELIFE, V3, DOI 10.7554/eLife.03005; Drugowitsch J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096511; Fetsch CR, 2012, NAT NEUROSCI, V15, P146, DOI 10.1038/nn.2983; Fetsch CR, 2009, J NEUROSCI, V29, P15601, DOI 10.1523/JNEUROSCI.2574-09.2009; Fiser J, 2010, TRENDS COGN SCI, V14, P119, DOI 10.1016/j.tics.2010.01.003; Fleming SM, 2014, BRAIN, V137, P2811, DOI 10.1093/brain/awu221; Fleming SM, 2012, PHILOS T R SOC B, V367, P1338, DOI 10.1098/rstb.2011.0417; Fleming SM, 2010, SCIENCE, V329, P1541, DOI 10.1126/science.1191883; FOLDIAK P, 1993, COMPUTATION AND NEURAL SYSTEMS, P55; Galvin SJ, 2003, PSYCHON B REV, V10, P843, DOI 10.3758/BF03196546; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Grimaldi P, 2015, NEUROSCI BIOBEHAV R, V55, P88, DOI 10.1016/j.neubiorev.2015.04.006; Hangya B., 2015, PREPRINT; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Insabato A, 2010, J NEUROPHYSIOL, V104, P539, DOI 10.1152/jn.01068.2009; Jacobs RA, 1999, VISION RES, V39, P3621, DOI 10.1016/S0042-6989(99)00088-7; Juslin P, 1997, PSYCHOL REV, V104, P344, DOI 10.1037/0033-295X.104.2.344; Kepecs A, 2008, NATURE, V455, P227, DOI 10.1038/nature07200; Kepecs A, 2012, PHILOS T R SOC B, V367, P1322, DOI 10.1098/rstb.2012.0037; Kiani R, 2014, NEURON, V84, P1329, DOI 10.1016/j.neuron.2014.12.015; Kiani R, 2009, SCIENCE, V324, P759, DOI 10.1126/science.1169405; Kneissler J, 2014, EVOL COMPUT, V22, P139, DOI 10.1162/EVCO_a_00108; Komura Y, 2013, NAT NEUROSCI, V16, P749, DOI 10.1038/nn.3393; Konstantinidis E, 2014, J EXP PSYCHOL GEN, V143, P2111, DOI 10.1037/a0037977; Lak A, 2014, NEURON, V84, P190, DOI 10.1016/j.neuron.2014.08.039; Lau H, 2010, SCIENCE, V329, P1478, DOI 10.1126/science.1195983; Lebreton M, 2015, NAT NEUROSCI, V18, P1159, DOI 10.1038/nn.4064; Lichtenstein S., 1982, JUDGMENT UNCERTAINTY, P306; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; Ma WJ, 2014, ANNU REV NEUROSCI, V37, P205, DOI 10.1146/annurev-neuro-071013-014017; MacKay D. J. C., 2003, INFORM THEORY INFERE, P343; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1148, DOI 10.1152/jn.1983.49.5.1148; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1127, DOI 10.1152/jn.1983.49.5.1127; MAUNSELL JHR, 1987, ANNU REV NEUROSCI, V10, P363, DOI 10.1146/annurev.ne.10.030187.002051; Meyniel F, 2015, NEURON, V88, P78, DOI 10.1016/j.neuron.2015.09.039; Meyniel F, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004305; Middlebrooks PG, 2012, NEURON, V75, P517, DOI 10.1016/j.neuron.2012.05.028; Moore DA, 2008, PSYCHOL REV, V115, P502, DOI 10.1037/0033-295X.115.2.502; Olsson H, 1996, PERCEPT PSYCHOPHYS, V58, P374, DOI 10.3758/BF03206813; Persaud N, 2007, NAT NEUROSCI, V10, P257, DOI 10.1038/nn1840; Pleskac TJ, 2010, PSYCHOL REV, V117, P864, DOI 10.1037/a0019737; POGGIO T, 1990, COLD SPRING HARB SYM, V55, P899; Pouget A., 1995, Advances in Neural Information Processing Systems 7, P157; Pouget A, 2013, NAT NEUROSCI, V16, P1170, DOI 10.1038/nn.3495; Pouget A, 2000, NAT NEUROSCI, V3, P1192, DOI 10.1038/81469; Rescorla RA, 1972, CLASSICAL CONDITION, P64, DOI [10.1177/0269881120954052, DOI 10.1101/GR.110528.110, DOI 10.1016/J.COGPSYCH.2004.11.001]; Rutishauser U, 2015, NAT NEUROSCI, V18, P1041, DOI 10.1038/nn.4041; Saleem A. B., 2015, COSYNE ABSTRACTS T, VT-14; SALINAS E, 1995, J NEUROSCI, V15, P6461; Sanders J. I., NEURON IN PRESS; Sanger TD, 1996, J NEUROPHYSIOL, V76, P2790, DOI 10.1152/jn.1996.76.4.2790; Sutton R.S., 1992, P 7 YAL WORKSH AD LE, P161; Teichert T, 2014, J NEUROSCI, V34, P1657, DOI 10.1523/JNEUROSCI.3694-13.2014; van Beers RJ, 1999, J NEUROPHYSIOL, V81, P1355, DOI 10.1152/jn.1999.81.3.1355; Vickers D., 1979, DECISION PROCESSES V; Vo VA, 2014, PSYCHOL SCI, V25, P1712, DOI 10.1177/0956797614538458; Wei ZQ, 2015, J NEUROPHYSIOL, V114, P99, DOI 10.1152/jn.00793.2014; Yeung N, 2012, PHILOS T R SOC B, V367, P1310, DOI 10.1098/rstb.2011.0416; Zylberberg A, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00079	75	211	212	4	65	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2016	19	3					366	374		10.1038/nn.4240	http://dx.doi.org/10.1038/nn.4240			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DE7MU	26906503	Green Accepted			2022-12-17	WOS:000370822200005
J	Rickgauer, JP; Deisseroth, K; Tank, DW				Rickgauer, John Peter; Deisseroth, Karl; Tank, David W.			Simultaneous cellular-resolution optical perturbation and imaging of place cell firing fields	NATURE NEUROSCIENCE			English	Article							NEURONAL-ACTIVITY; 2-PHOTON EXCITATION; OPTOGENETIC CONTROL; SPIKE TRANSMISSION; NEURAL CIRCUITS; IN-VITRO; HIPPOCAMPAL; INTERROGATION; CONNECTIONS; SPECIFICITY	Linking neural microcircuit function to emergent properties of the mammalian brain requires fine-scale manipulation and measurement of neural activity during behavior, where each neuron's coding and dynamics can be characterized. We developed an optical method for simultaneous cellular-resolution stimulation and large-scale recording of neuronal activity in behaving mice. Dual-wavelength two-photon excitation allowed largely independent functional imaging with a green fluorescent calcium sensor (GCaMP3, lambda = 920 +/- 6 nm) and single-neuron photostimulation with a red-shifted optogenetic probe (C1V1, lambda = 1,064 +/- 6 nm) in neurons coexpressing the two proteins. We manipulated task-modulated activity in individual hippocampal CA1 place cells during spatial navigation in a virtual reality environment, mimicking natural place-field activity, or 'biasing', to reveal subthreshold dynamics. Notably, manipulating single place-cell activity also affected activity in small groups of other place cells that were active around the same time in the task, suggesting a functional role for local place cell interactions in shaping firing fields.	[Rickgauer, John Peter; Tank, David W.] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA; [Rickgauer, John Peter; Tank, David W.] Princeton Univ, Bezos Ctr Neural Circuit Dynam, Princeton, NJ 08544 USA; [Rickgauer, John Peter; Tank, David W.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Rickgauer, John Peter; Tank, David W.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, CNC Program, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Princeton University; Princeton University; Princeton University; Princeton University; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Tank, DW (corresponding author), Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA.	dwtank@princeton.edu			US National Institutes of Health [R01-MH083686, P50-GM071508]; National Science Foundation Graduate Research Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083686, R01MH075957, R01MH099647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS090541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA035377] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank D. Kim and C. Guo (Genetically Encoded Neuronal Indicator and Effector Project, Janelia Research Campus) for transgenic mice, D. Aronov for VR software, B. Scott for discussions, and C. Domnisoru, A. Miri, F. Collman and S. Wang for comments on the manuscript. This work was supported by the US National Institutes of Health (R01-MH083686; P50-GM071508) and a National Science Foundation Graduate Research Fellowship to J.P.R.	Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; Akerboom J, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00002; AMARAL DG, 1989, NEUROSCIENCE, V31, P571, DOI 10.1016/0306-4522(89)90424-7; Andrasfalvy BK, 2010, P NATL ACAD SCI USA, V107, P11981, DOI 10.1073/pnas.1006620107; Aronov D, 2014, NEURON, V84, P442, DOI 10.1016/j.neuron.2014.08.042; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; Carter ME, 2010, NAT NEUROSCI, V13, P1526, DOI 10.1038/nn.2682; Chang YF, 2012, NEUROSCI RES, V73, P341, DOI 10.1016/j.neures.2012.05.007; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Dana H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108697; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Deuchars J, 1996, NEUROSCIENCE, V74, P1009, DOI 10.1016/0306-4522(96)00251-5; Dombeck DA, 2010, NAT NEUROSCI, V13, P1433, DOI 10.1038/nn.2648; Fenton AA, 1998, P NATL ACAD SCI USA, V95, P3182, DOI 10.1073/pnas.95.6.3182; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Galarreta M, 2001, SCIENCE, V292, P2295, DOI 10.1126/science.1061395; Greenberg DS, 2008, NAT NEUROSCI, V11, P749, DOI 10.1038/nn.2140; Grienberger C, 2014, NEURON, V81, P1274, DOI 10.1016/j.neuron.2014.01.014; Guo ZV, 2009, NAT METHODS, V6, P891, DOI 10.1038/nmeth.1397; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; Husson SJ, 2012, CURR BIOL, V22, P743, DOI 10.1016/j.cub.2012.02.066; Jonas P, 2004, TRENDS NEUROSCI, V27, P30, DOI 10.1016/j.tins.2003.10.010; Kaifosh P, 2013, NAT NEUROSCI, V16, P1182, DOI 10.1038/nn.3482; Ko H, 2011, NATURE, V473, P87, DOI 10.1038/nature09880; Lee D, 2012, SCIENCE, V337, P849, DOI 10.1126/science.1221489; Lin JY, 2009, BIOPHYS J, V96, P1803, DOI 10.1016/j.bpj.2008.11.034; Losonczy A, 2010, NAT NEUROSCI, V13, P967, DOI 10.1038/nn.2597; Lovett-Barron M, 2014, SCIENCE, V343, P857, DOI 10.1126/science.1247485; Marshall L, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-02-j0001.2002; Mattis J, 2012, NAT METHODS, V9, P159, DOI [10.1038/NMETH.1808, 10.1038/nmeth.1808]; Oheim M, 2001, J NEUROSCI METH, V111, P29, DOI 10.1016/S0165-0270(01)00438-1; Oron D, 2005, OPT EXPRESS, V13, P1468, DOI 10.1364/OPEX.13.001468; Packer AM, 2012, NAT METHODS, V9, P1202, DOI [10.1038/NMETH.2249, 10.1038/nmeth.2249]; Papagiakoumou E, 2013, NAT PHOTONICS, V7, P274, DOI [10.1038/NPHOTON.2013.9, 10.1038/nphoton.2013.9]; Papagiakoumou E, 2010, NAT METHODS, V7, P848, DOI [10.1038/nmeth.1505, 10.1038/NMETH.1505]; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Petreanu L, 2012, NATURE, V489, P299, DOI 10.1038/nature11321; Prakash R, 2012, NAT METHODS, V9, P1171, DOI 10.1038/NMETH.2215; Rickgauer JP, 2009, P NATL ACAD SCI USA, V106, P15025, DOI 10.1073/pnas.0907084106; Royer S, 2012, NAT NEUROSCI, V15, P769, DOI 10.1038/nn.3077; St-Pierre F, 2014, NAT NEUROSCI, V17, P884, DOI 10.1038/nn.3709; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; Wilson NR, 2012, NATURE, V488, P343, DOI 10.1038/nature11347; Yaroslavsky AN, 2002, PHYS MED BIOL, V47, P2059, DOI 10.1088/0031-9155/47/12/305; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhu GH, 2005, OPT EXPRESS, V13, P2153, DOI 10.1364/OPEX.13.002153; Zimmermann T, 2003, FEBS LETT, V546, P87, DOI 10.1016/S0014-5793(03)00521-0; Ziv Y, 2013, NAT NEUROSCI, V16, P264, DOI 10.1038/nn.3329	50	211	214	1	75	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2014	17	12					1816	1824		10.1038/nn.3866	http://dx.doi.org/10.1038/nn.3866			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AU2ZY	25402854	Green Accepted			2022-12-17	WOS:000345484000031
J	Cai, HJ; Haubensak, W; Anthony, TE; Anderson, DJ				Cai, Haijiang; Haubensak, Wulf; Anthony, Todd E.; Anderson, David J.			Central amygdala PKC-delta(+) neurons mediate the influence of multiple anorexigenic signals	NATURE NEUROSCIENCE			English	Article							FOOD-INTAKE; CENTRAL NUCLEUS; CIRCUIT; HYPOTHALAMUS; MECHANISMS; BRAIN; RAT; ORGANIZATION; ACTIVATION; BEHAVIORS	Feeding can be inhibited by multiple cues, including those associated with satiety, sickness or unpalatable food. How such anorexigenic signals inhibit feeding at the neural circuit level is not completely understood. Although some inhibitory circuits have been identified, it is not yet clear whether distinct anorexigenic influences are processed in a convergent or parallel manner. The amygdala central nucleus (CEA) has been implicated in feeding control, but its role is controversial. The lateral subdivision of CEA (CEI) contains a subpopulation of GABAergic neurons that are marked by protein kinase C-delta (PKC-delta). We found that CEI PKC-delta(+) neurons in mice were activated by diverse anorexigenic signals in vivo, were required for the inhibition of feeding by such signals and strongly suppressed food intake when activated. They received presynaptic inputs from anatomically distributed neurons activated by different anorexigenic agents. Our data suggest that CEI PKC-delta(+) neurons constitute an important node that mediates the influence of multiple anorexigenic signals.	[Cai, Haijiang; Haubensak, Wulf; Anthony, Todd E.; Anderson, David J.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Anderson, David J.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute	Anderson, DJ (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	wuwei@caltech.edu		Haubensak, Wulf/0000-0002-2034-9184; Cai, Haijiang/0000-0003-3775-903X	US National Institutes of Health [R01MH085082, MH070053]; Klarman Foundation; Hilda and Preston Davis Foundation; NARSAD; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070053, R01MH085082] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Klarman Foundation; Hilda and Preston Davis Foundation; NARSAD(NARSAD); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank B. Lowell (Beth Israel Deaconess Medical Center) for providing Cre-dependent DREADD constructs and viruses for pilot experiments, C. Saper (Beth Israel Deaconess Medical Center) for providing the original hrGFP construct, Z.J. Huang (Cold Spring Harbor Laboratory) for CRF-Cre mice, the Allen Institute for Brain Science for Tac2-Cre mice, C. Xiao and H. Lester for electrophysiology training and advice, and K. Deisseroth (Stanford University) for providing viruses for optogenetics. We thank J.S. Chang, C. Chiu and A. Chang for technical assistance on histology and behavior scoring, M. Martinez and M. McCardle for tail genotyping, G. Mosconi and C. Chiu for lab management, and G. Mancuso for administrative support. This work was supported by US National Institutes of Health grants R01MH085082 and MH070053, and a grant from the Klarman Foundation to D.J.A. H.C. is supported by a postdoctoral fellowship of the Hilda and Preston Davis Foundation and a NARSAD Young Investigator Award. D.J.A. receives funding from the Howard Hughes Medical Institute.	Beckman TR, 2009, PHYSIOL BEHAV, V96, P568, DOI 10.1016/j.physbeh.2008.12.007; Betley JN, 2013, CELL, V155, P1337, DOI 10.1016/j.cell.2013.11.002; BOVETTO S, 1995, AM J PHYSIOL-REG I, V269, pR781, DOI 10.1152/ajpregu.1995.269.4.R781; BOX BM, 1975, PHYSIOL BEHAV, V15, P679, DOI 10.1016/0031-9384(75)90119-5; Carter ME, 2013, NATURE, V503, P111, DOI 10.1038/nature12596; Ciocchi S, 2010, NATURE, V468, P277, DOI 10.1038/nature09559; Dantzer R, 2001, ANN NY ACAD SCI, V933, P222; Day HEW, 1999, J COMP NEUROL, V413, P113; Fekete E, 2002, BRAIN RES, V955, P55, DOI 10.1016/S0006-8993(02)03362-0; Fekete EM, 2007, BRAIN RES BULL, V71, P386, DOI 10.1016/j.brainresbull.2006.10.007; Gautron L, 2010, J COMP NEUROL, V518, P2090, DOI 10.1002/cne.22323; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Haba R, 2012, BEHAV BRAIN RES, V228, P423, DOI 10.1016/j.bbr.2011.12.027; Haubensak W, 2010, NATURE, V468, P270, DOI 10.1038/nature09553; Jennings JH, 2013, SCIENCE, V341, P1517, DOI 10.1126/science.1241812; Kask A, 2000, BRAIN RES, V887, P460, DOI 10.1016/S0006-8993(00)03034-1; KEMBLE ED, 1979, PHYSIOL BEHAV, V22, P789, DOI 10.1016/0031-9384(79)90250-6; King BM, 2006, AM J PHYSIOL-REG I, V291, pR1201, DOI 10.1152/ajpregu.00199.2006; Kishi T, 2005, MOL PSYCHIATR, V10, P132, DOI 10.1038/sj.mp.4001638; Kovacs A, 2012, BRAIN RES BULL, V88, P589, DOI 10.1016/j.brainresbull.2012.06.001; Krashes MJ, 2011, J CLIN INVEST, V121, P1424, DOI 10.1172/JCI46229; Lee HM, 2014, DRUG DISCOV TODAY, V19, P469, DOI 10.1016/j.drudis.2013.10.018; Lee H, 2014, NATURE, V509, P627, DOI 10.1038/nature13169; LENARD L, 1982, BRAIN RES, V233, P115, DOI 10.1016/0006-8993(82)90934-9; Marchant NJ, 2007, J COMP NEUROL, V504, P702, DOI 10.1002/cne.21464; Maren S, 1996, NEURON, V16, P237, DOI 10.1016/S0896-6273(00)80041-0; Moran TH, 2000, NUTRITION, V16, P858, DOI 10.1016/S0899-9007(00)00419-6; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Neugebauer V, 2004, NEUROSCIENTIST, V10, P221, DOI 10.1177/1073858403261077; Oh SW, 2014, NATURE, V508, P207, DOI 10.1038/nature13186; Panksepp J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021236; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Petrovich GD, 2009, J NEUROSCI, V29, P15205, DOI 10.1523/JNEUROSCI.3656-09.2009; Pitkanen A, 1997, TRENDS NEUROSCI, V20, P517, DOI 10.1016/S0166-2236(97)01125-9; Saper CB, 2002, NEURON, V36, P199, DOI 10.1016/S0896-6273(02)00969-8; Sternson SM, 2013, NEURON, V77, P810, DOI 10.1016/j.neuron.2013.02.018; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; Wall NR, 2010, P NATL ACAD SCI USA, V107, P21848, DOI 10.1073/pnas.1011756107; Watabe-Uchida M, 2012, NEURON, V74, P858, DOI 10.1016/j.neuron.2012.03.017; Woods SC, 1998, SCIENCE, V280, P1378, DOI 10.1126/science.280.5368.1378; Wu Q, 2012, NATURE, V483, P594, DOI 10.1038/nature10899; Yamamoto T, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00076; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	44	211	215	3	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2014	17	9					1240	1248		10.1038/nn.3767	http://dx.doi.org/10.1038/nn.3767			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AO2DJ	25064852	Green Accepted			2022-12-17	WOS:000341125400018
J	Chou, YH; Spletter, ML; Yaksi, E; Leong, JCS; Wilson, RI; Luo, LQ				Chou, Ya-Hui; Spletter, Maria L.; Yaksi, Emre; Leong, Jonathan C. S.; Wilson, Rachel I.; Luo, Liqun			Diversity and wiring variability of olfactory local interneurons in the Drosophila antennal lobe	NATURE NEUROSCIENCE			English	Article							RECEPTOR NEURONS; PRESYNAPTIC INHIBITION; NEUROBLAST LINEAGE; MUSHROOM BODIES; REPRESENTATION; MELANOGASTER; INFORMATION; CIRCUITS; BULB; MAP	Local interneurons are essential in information processing by neural circuits. Here we present a comprehensive genetic, anatomical and electrophysiological analysis of local interneurons (LNs) in the Drosophila melanogaster antennal lobe, the first olfactory processing center in the brain. We found LNs to be diverse in their neurotransmitter profiles, connectivity and physiological properties. Analysis of >1,500 individual LNs revealed principal morphological classes characterized by coarsely stereotyped glomerular innervation patterns. Some of these morphological classes showed distinct physiological properties. However, the finer-scale connectivity of an individual LN varied considerably across brains, and there was notable physiological variability within each morphological or genetic class. Finally, LN innervation required interaction with olfactory receptor neurons during development, and some individual variability also likely reflected LN-LN interactions. Our results reveal an unexpected degree of complexity and individual variation in an invertebrate neural circuit, a result that creates challenges for solving the Drosophila connectome.	[Chou, Ya-Hui; Spletter, Maria L.; Leong, Jonathan C. S.; Luo, Liqun] Stanford Univ, Howard Hughes Med Inst, Dept Biol, Stanford, CA 94305 USA; [Yaksi, Emre; Wilson, Rachel I.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Howard Hughes Medical Institute; Stanford University; Harvard University; Harvard Medical School	Luo, LQ (corresponding author), Stanford Univ, Howard Hughes Med Inst, Dept Biol, Stanford, CA 94305 USA.	lluo@stanford.edu	Spletter, Maria Lynn/T-5917-2018; Wilson, Rachel/E-2227-2012; Chou, Ya-Hui/F-3775-2014; Yaksi, Emre/A-3215-2019	Spletter, Maria Lynn/0000-0002-2068-3350; Chou, Ya-Hui/0000-0001-6552-8728; Yaksi, Emre/0000-0003-3761-0235; Wilson, Rachel/0000-0001-8573-9266; Luo, Liqun/0000-0001-5467-9264	US National Institutes of Health [R01-DC005982, R01-DC008174]; Pew Scholar award; McKnight Scholar award; Sloan Foundation research fellowship; Beckman Young Investigator award; US National Research Service predoctoral award; Human Frontiers Science Program Long Term Fellowship; Stanford University; Howard Hughes Medical Institute; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008174, F31DC008277, R01DC005982] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Scholar award; McKnight Scholar award; Sloan Foundation research fellowship(Alfred P. Sloan Foundation); Beckman Young Investigator award; US National Research Service predoctoral award; Human Frontiers Science Program Long Term Fellowship; Stanford University(Stanford University); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank U. Heberlein (University of California, San Francisco) and E. Marin for respectively providing and screening unpublished Gal4 lines, which lead to identification of line 1 and line 6; J. Simpson (Janelia Farm, Howard Hughes Medical Institute) for providing unpublished LCCH3 (line 7) Gal4; K. Wehner (Stanford University) for mouse anti-HA; A. DiAntonio (Washington University) for rabbit anti-DVGLUT; and the Bloomington Stock Center, Kyoto Stock Center, Drosophila Genetic Resource Center, Gal4 Enhancer Trap Insertion Database (GETDB), and Developmental Studies Hybridoma Bank for other reagents. M. L. S. is grateful for the help of J. Brooks in data collection. We thank the Stanford Department of Statistics Consulting Service for technical help with statistical analyses. We thank T. Clandinin, G. Jefferis and members of the Luo and Wilson laboratories for helpful comments on the manuscript. This work was supported by US National Institutes of Health grants to L. L. (R01-DC005982) and R. I. W. (R01-DC008174), a Pew Scholar award, a McKnight Scholar award, a Sloan Foundation research fellowship, and a Beckman Young Investigator award (to R. I. W). M. L. S. is supported by a US National Research Service predoctoral award. E. Y. is supported by a Human Frontiers Science Program Long Term Fellowship. J. C. S. L. is supported by the Medical Scientist Training Program at Stanford University. L. L. receives investigator support from the Howard Hughes Medical Institute.	Berdnik D, 2006, J NEUROSCI, V26, P3367, DOI 10.1523/JNEUROSCI.4941-05.2006; Bhandawat V, 2007, NAT NEUROSCI, V10, P1474, DOI 10.1038/nn1976; CHRISTENSEN TA, 1993, J COMP PHYSIOL A, V173, P385, DOI 10.1007/BF00193512; Das A, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-33; Dubnau J, 2003, CURR BIOL, V13, P286, DOI 10.1016/S0960-9822(03)00064-2; ERNST KD, 1983, CELL TISSUE RES, V229, P1, DOI 10.1007/BF00217877; FONTA C, 1993, CHEM SENSES, V18, P101, DOI 10.1093/chemse/18.2.101; Gouwens NW, 2009, J NEUROSCI, V29, P6239, DOI 10.1523/JNEUROSCI.0764-09.2009; Grueber WB, 2002, DEVELOPMENT, V129, P2867; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Hayashi S, 2002, GENESIS, V34, P58, DOI 10.1002/gene.10137; Jefferis GSXE, 2007, CELL, V128, P1187, DOI 10.1016/j.cell.2007.01.040; Jefferis GSXE, 2004, DEVELOPMENT, V131, P117, DOI 10.1242/dev.00896; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Kim J, 2003, NATURE, V424, P81, DOI 10.1038/nature01733; Lai SL, 2008, DEVELOPMENT, V135, P2883, DOI 10.1242/dev.024380; Laissue PP, 1999, J COMP NEUROL, V405, P543; Lee T, 1999, DEVELOPMENT, V126, P4065; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lichtman JW, 2008, CURR OPIN NEUROBIOL, V18, P346, DOI 10.1016/j.conb.2008.08.010; Lledo PM, 2008, TRENDS NEUROSCI, V31, P392, DOI 10.1016/j.tins.2008.05.006; Lu J, 2009, PLOS BIOL, V7, P265, DOI 10.1371/journal.pbio.1000032; Luo LQ, 2007, NEURON, V56, P284, DOI 10.1016/j.neuron.2007.10.014; MacLeod K, 1996, SCIENCE, V274, P976, DOI 10.1126/science.274.5289.976; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Martin JR, 1998, LEARN MEMORY, V5, P179; Miles R, 2000, SCIENCE, V287, P244, DOI 10.1126/science.287.5451.244; Murthy M, 2008, NEURON, V59, P1009, DOI 10.1016/j.neuron.2008.07.040; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; Okada R, 2009, J COMP NEUROL, V514, P74, DOI 10.1002/cne.21971; Olsen SR, 2008, TRENDS NEUROSCI, V31, P512, DOI 10.1016/j.tins.2008.07.006; Olsen SR, 2007, NEURON, V54, P89, DOI 10.1016/j.neuron.2007.03.010; Pirez N, 2008, J NEUROSCI, V28, P6360, DOI 10.1523/JNEUROSCI.0793-08.2008; Sachse S, 2007, NEURON, V56, P838, DOI 10.1016/j.neuron.2007.10.035; Schlief ML, 2007, NAT NEUROSCI, V10, P623, DOI 10.1038/nn1881; Seki Y, 2008, J COMP NEUROL, V506, P93, DOI 10.1002/cne.21528; Shang YH, 2007, CELL, V128, P601, DOI 10.1016/j.cell.2006.12.034; Shao Z, 2009, J NEUROPHYSIOL, V101, P1988, DOI 10.1152/jn.91116.2008; Shepherd G.M., 2004, NEUROBIOLOGY; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; STOCKER RF, 1990, CELL TISSUE RES, V262, P9, DOI 10.1007/BF00327741; Sweeney LB, 2007, NEURON, V53, P185, DOI 10.1016/j.neuron.2006.12.022; van Naters WVG, 2007, CURR BIOL, V17, P606, DOI 10.1016/j.cub.2007.02.043; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Wachowiak M, 2006, SEMIN CELL DEV BIOL, V17, P411, DOI 10.1016/j.semcdb.2006.04.007; WASSLE H, 1981, NATURE, V292, P344, DOI 10.1038/292344a0; Wilson RI, 2005, J NEUROSCI, V25, P9069, DOI 10.1523/JNEUROSCI.2070-05.2005; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9	50	211	213	0	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2010	13	4					439	U60		10.1038/nn.2489	http://dx.doi.org/10.1038/nn.2489			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	575NI	20139975	Green Accepted			2022-12-17	WOS:000276073500013
J	Weiler, N; Wood, L; Yu, JI; Solla, SA; Shepherd, GMG				Weiler, Nicholas; Wood, Lydia; Yu, Jianing; Solla, Sara A.; Shepherd, Gordon M. G.			Top-down laminar organization of the excitatory network in motor cortex	NATURE NEUROSCIENCE			English	Article							FUNCTIONAL-ORGANIZATION; PYRAMIDAL NEURONS; CORTICAL COLUMN; LAYER-IV; RAT; CONNECTIVITY; CIRCUITS; PROJECTIONS; INPUT; CELLS	Cortical layering is a hallmark of the mammalian neocortex and a major determinant of local synaptic circuit organization in sensory systems. In motor cortex, the laminar organization of cortical circuits has not been resolved, although their input-output operations are crucial for motor control. Here, we developed a general approach for estimating layer-specific connectivity in cortical circuits and applied it to mouse motor cortex. From these data we computed a laminar presynaptic -> postsynaptic connectivity matrix, W-post,W-pre, revealing a complement of stereotypic pathways dominated by layer 2 outflow to deeper layers. Network modeling predicted, and experiments with disinhibited slices confirmed, that stimuli targeting upper, but not lower, cortical layers effectively evoked network-wide events. Thus, in motor cortex, descending excitation from a preamplifier-like network of upper-layer neurons drives output neurons in lower layers. Our analysis provides a quantitative wiring-diagram framework for further investigation of the excitatory networks mediating cortical mechanisms of motor control.	[Weiler, Nicholas; Yu, Jianing; Solla, Sara A.; Shepherd, Gordon M. G.] Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA; [Solla, Sara A.] Northwestern Univ, Dept Phys & Astron, Evanston, IL 60208 USA	Northwestern University; Feinberg School of Medicine; Northwestern University	Shepherd, GMG (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Physiol, Morton 5-660,303E Chicago Ave, Chicago, IL 60611 USA.	g-shepherd@northwestern.edu	Weiler, Norbert/E-5356-2010; Shepherd, Gordon/F-2679-2010	Weiler, Nicholas/0000-0001-6750-9248	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061963] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS061963-01, R01 NS061963] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alloway KD, 2008, CEREB CORTEX, V18, P979, DOI 10.1093/cercor/bhm138; ARMSTRONGJAMES M, 1992, J NEUROPHYSIOL, V68, P1345, DOI 10.1152/jn.1992.68.4.1345; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Braitenberg VB, 1998, CORTEX STAT GEOMETRY; Brecht M, 2004, J COMP NEUROL, V479, P360, DOI 10.1002/cne.20306; Briggs F, 2005, CEREB CORTEX, V15, P479, DOI 10.1093/cercor/bhh154; Bureau I, 2006, PLOS BIOL, V4, P2361, DOI 10.1371/journal.pbio.0040382; Callaway EM, 2004, NEURAL NETWORKS, V17, P625, DOI 10.1016/j.neunet.2004.04.004; Callaway EM, 1998, ANNU REV NEUROSCI, V21, P47, DOI 10.1146/annurev.neuro.21.1.47; Castro-Alamancos MA, 2000, J NEUROSCI, V20, P9195; CAVINESS VS, 1975, J COMP NEUROL, V164, P247, DOI 10.1002/cne.901640207; CHAGNACAMITAI Y, 1989, J NEUROPHYSIOL, V62, P1149, DOI 10.1152/jn.1989.62.5.1149; CONNORS BW, 1984, NATURE, V310, P685, DOI 10.1038/310685a0; Crick F, 1998, NATURE, V391, P245, DOI 10.1038/34584; Dantzker JL, 2000, NAT NEUROSCI, V3, P701, DOI 10.1038/76656; Donoghue JP, 1986, SENSORY MOTOR AREAS, P243; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Fregnac Y., 2006, MICROCIRCUITS INTERF, P393; Helmstaedter M, 2007, BRAIN RES REV, V55, P193, DOI 10.1016/j.brainresrev.2007.07.011; HIRSCH JA, 1995, J PHYSIOL-LONDON, V483, P183, DOI 10.1113/jphysiol.1995.sp020577; Huber D, 2008, NATURE, V451, P61, DOI 10.1038/nature06445; JONES EG, 1975, J COMP NEUROL, V160, P167, DOI 10.1002/cne.901600203; Kaneko T, 1995, J NEUROSCI, V15, P8362; Kaneko T, 2000, J COMP NEUROL, V423, P52, DOI 10.1002/1096-9861(20000717)423:1<52::AID-CNE5>3.0.CO;2-F; KANEKO T, 1994, J COMP NEUROL, V345, P172, DOI 10.1002/cne.903450203; KELLER A, 1993, CEREB CORTEX, V3, P430, DOI 10.1093/cercor/3.5.430; LEHKY SR, 1988, NATURE, V333, P452, DOI 10.1038/333452a0; Llinas R., 2002, I VORTEX NEURONS SEL; Lubke J, 2003, CEREB CORTEX, V13, P1051, DOI 10.1093/cercor/13.10.1051; Lubke J, 2007, BRAIN STRUCT FUNCT, V212, P3, DOI 10.1007/s00429-007-0144-2; Nelson Sacha B., 2002, Neuron, V36, P19, DOI 10.1016/S0896-6273(02)00944-3; Ohki K, 2007, CURR OPIN NEUROBIOL, V17, P401, DOI 10.1016/j.conb.2007.07.007; Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Pouille F, 2004, NATURE, V429, P717, DOI 10.1038/nature02615; Schieber MH, 2001, J NEUROPHYSIOL, V86, P2125, DOI 10.1152/jn.2001.86.5.2125; Schubert D, 2001, J NEUROSCI, V21, P3580, DOI 10.1523/JNEUROSCI.21-10-03580.2001; Schubert D, 2003, J NEUROSCI, V23, P2961; Schubert D, 2007, BRAIN STRUCT FUNCT, V212, P107, DOI 10.1007/s00429-007-0147-z; Shepherd GMG, 2005, J NEUROSCI, V25, P5670, DOI 10.1523/JNEUROSCI.1173-05.2005; Shepherd GMG, 2005, NAT NEUROSCI, V8, P782, DOI 10.1038/nn1447; Shipp S, 2005, PHILOS T R SOC B, V360, P797, DOI 10.1098/rstb.2005.1630; Silberberg G, 2005, TRENDS NEUROSCI, V28, P541, DOI 10.1016/j.tins.2005.08.004; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Stepanyants A, 2005, TRENDS NEUROSCI, V28, P387, DOI 10.1016/j.tins.2005.05.006; Stepanyants A, 2008, CEREB CORTEX, V18, P13, DOI 10.1093/cercor/bhm027; STRICK PL, 1974, J COMP NEUROL, V153, P77, DOI 10.1002/cne.901530107; Tarczy-Hornoch K, 1999, CEREB CORTEX, V9, P833, DOI 10.1093/cercor/9.8.833; Thomson AM, 2007, FRONT NEUROSCI-SWITZ, V1, P19, DOI 10.3389/neuro.01.1.1.002.2007; Zhang ZW, 1997, J NEUROSCI, V17, P6365	50	211	213	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2008	11	3					360	366		10.1038/nn2049	http://dx.doi.org/10.1038/nn2049			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	267ZS	18246064	Green Accepted			2022-12-17	WOS:000253548300020
J	Jansen, P; Giehl, K; Nyengaard, JR; Teng, K; Lioubinski, O; Sjoegaard, SS; Breiderhoff, T; Gotthardt, M; Lin, F; Eilers, A; Petersen, CM; Lewin, GR; Hempstead, BL; Willnow, TE; Nykjaer, A				Jansen, Pernille; Giehl, Klaus; Nyengaard, Jens R.; Teng, Kenneth; Lioubinski, Oleg; Sjoegaard, Susanne S.; Breiderhoff, Tilman; Gotthardt, Michael; Lin, Fuyu; Eilers, Andreas; Petersen, Claus M.; Lewin, Gary R.; Hempstead, Barbara L.; Willnow, Thomas E.; Nykjaer, Anders			Roles for the pro-neurotrophin receptor sortilin in neuronal development, aging and brain injury	NATURE NEUROSCIENCE			English	Article							NERVE GROWTH-FACTOR; AFFINITY NGF RECEPTOR; GANGLION-CELL NUMBER; SYMPATHETIC NEURONS; IN-VIVO; SPINAL-CORD; DEATH; P75; APOPTOSIS; SURVIVAL	Neurotrophins are essential for development and maintenance of the vertebrate nervous system. Paradoxically, although mature neurotrophins promote neuronal survival by binding to tropomyosin receptor kinases and p75 neurotrophin receptor (p75(NTR)), pro-neurotrophins induce apoptosis in cultured neurons by engaging sortilin and p75(NTR) in a death-signaling receptor complex. Substantial amounts of neurotrophins are secreted in pro-form in vivo, yet their physiological significance remains unclear. We generated a sortilin-deficient mouse to examine the contribution of the p75(NTR)/sortilin receptor complex to neuronal viability. In the developing retina, Sortilin 1 (Sort1)(-/-) mice showed reduced neuronal apoptosis that was indistinguishable from that observed in p75(NTR)-deficient (Ngfr(-/-)) mice. To our surprise, although sortilin deficiency did not affect developmentally regulated apoptosis of sympathetic neurons, it did prevent their age-dependent degeneration. Furthermore, in an injury protocol, lesioned corticospinal neurons in Sort1(-/-) mice were protected from death. Thus, the sortilin pathway has distinct roles in pro-neurotrophin-induced apoptotic signaling in pathological conditions, but also in specific stages of neuronal development and aging.	Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; Aarhus Univ, MIND Ctr, Dept Med Biochem, DK-8000 Aarhus, Denmark; Univ Texas, SW Med Ctr, Dallas, TX 75390 USA; Univ Texas, Dept Cell Biol, Dallas, TX 75390 USA; Aarhus Univ, MIND Ctr, Stereol & Elect Microscopy Res Lab, DK-8000 Aarhus, Denmark; Cornell Univ, Weill Med Coll, New York, NY 10021 USA	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Aarhus University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; Aarhus University; Cornell University	Willnow, TE (corresponding author), Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13125 Berlin, Germany.	willnow@mdc-berlin.de; an@biokemi.au.dk	Breiderhoff, Tilman/X-9364-2019; Lewin, Gary R/B-8028-2011; Gotthardt, Michael/ABE-8274-2021	Breiderhoff, Tilman/0000-0002-1676-7498; Gotthardt, Michael/0000-0003-1788-3172; Teng, Kenneth/0000-0002-9392-2172; Willnow, Thomas/0000-0001-9515-7921; Nykjaer, Anders/0000-0001-6422-6736; Lewin, Gary/0000-0002-2890-6352	NINDS NIH HHS [NS30687] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030687] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDREWS TJ, 1994, J NEUROCYTOL, V23, P234, DOI 10.1007/BF01275527; Bamji SX, 1998, J CELL BIOL, V140, P911, DOI 10.1083/jcb.140.4.911; Beattie MS, 2002, NEURON, V36, P375, DOI 10.1016/S0896-6273(02)01005-X; Bierl MA, 2007, NEUROBIOL AGING, V28, P122, DOI 10.1016/j.neurobiolaging.2005.11.008; Bonatz H, 2000, J NEUROSCI METH, V100, P105, DOI 10.1016/S0165-0270(00)00238-7; Brennan C, 1999, NAT NEUROSCI, V2, P699, DOI 10.1038/11158; Bruno MA, 2006, P NATL ACAD SCI USA, V103, P6735, DOI 10.1073/pnas.0510645103; CasacciaBonnefil P, 1996, NATURE, V383, P716, DOI 10.1038/383716a0; Casademunt E, 1999, EMBO J, V18, P6050, DOI 10.1093/emboj/18.21.6050; CHAKRABARTI S, 1990, BRAIN RES, V523, P11, DOI 10.1016/0006-8993(90)91630-Y; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Chen ZY, 2004, J NEUROSCI, V24, P4401, DOI 10.1523/JNEUROSCI.0348-04.2004; Domeniconi M, 2007, MOL CELL NEUROSCI, V34, P271, DOI 10.1016/j.mcn.2006.11.005; Dorph-Petersen KA, 2001, J MICROSC-OXFORD, V204, P232, DOI 10.1046/j.1365-2818.2001.00958.x; Fahnestock M, 2001, MOL CELL NEUROSCI, V18, P210, DOI 10.1006/mcne.2001.1016; Frade JM, 1999, DEVELOPMENT, V126, P683; Frade JM, 1998, NEURON, V20, P35, DOI 10.1016/S0896-6273(00)80432-8; Gatzinsky KP, 2004, EUR J NEUROSCI, V20, P2848, DOI 10.1111/j.1460-9568.2004.03780.x; Giehl KM, 2001, J NEUROSCI, V21, P3492, DOI 10.1523/JNEUROSCI.21-10-03492.2001; Giehl KM, 1996, EUR J NEUROSCI, V8, P1167, DOI 10.1111/j.1460-9568.1996.tb01284.x; Glebova NO, 2004, J NEUROSCI, V24, P743, DOI 10.1523/JNEUROSCI.4523-03.2004; Glebova NO, 2005, ANNU REV NEUROSCI, V28, P191, DOI 10.1146/annurev.neuro.28.061604.135659; Gonzalez-Hoyuela M, 2001, DEVELOPMENT, V128, P117; Harada C, 2006, DEV BIOL, V290, P57, DOI 10.1016/j.ydbio.2005.08.051; Harrington AW, 2004, P NATL ACAD SCI USA, V101, P6226, DOI 10.1073/pnas.0305755101; Hasan W, 2003, J NEUROBIOL, V57, P38, DOI 10.1002/neu.10250; Hermans-Borgmeyer I, 1999, MOL BRAIN RES, V65, P216, DOI 10.1016/S0169-328X(99)00022-4; HEUMANN R, 1984, EMBO J, V3, P3183, DOI 10.1002/j.1460-2075.1984.tb02277.x; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; JENSEN EBV, 1993, J MICROSC-OXFORD, V170, P35, DOI 10.1111/j.1365-2818.1993.tb03321.x; Kenchappa RS, 2006, NEURON, V50, P219, DOI 10.1016/j.neuron.2006.03.011; Kumar A, 2006, ENDOCRINOLOGY, V147, P4893, DOI 10.1210/en.2006-0027; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; LEE KF, 1994, SCIENCE, V263, P1447, DOI 10.1126/science.8128229; LEE KF, 1994, DEVELOPMENT, V120, P1027; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Linggi MS, 2005, J BIOL CHEM, V280, P13801, DOI 10.1074/jbc.M410435200; Majdan M, 2001, J CELL BIOL, V155, P1275, DOI 10.1083/jcb.200110017; Majdan M, 1997, J NEUROSCI, V17, P6988; Nielsen MS, 2001, EMBO J, V20, P2180, DOI 10.1093/emboj/20.9.2180; NYENGAARD JR, 1992, J MICROSC-OXFORD, V165, P427, DOI 10.1111/j.1365-2818.1992.tb01497.x; Nykjaer A, 2005, CURR OPIN NEUROBIOL, V15, P49, DOI 10.1016/j.conb.2005.01.004; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; Peng SY, 2004, J NEUROPATH EXP NEUR, V63, P641, DOI 10.1093/jnen/63.6.641; Petersen CM, 1997, J BIOL CHEM, V272, P3599, DOI 10.1074/jbc.272.6.3599; RABIZADEH S, 1993, SCIENCE, V261, P345, DOI 10.1126/science.8332899; SCHMIDT RE, 1995, J NEUROCYTOL, V24, P189, DOI 10.1007/BF01181534; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; Volosin M, 2006, J NEUROSCI, V26, P7756, DOI 10.1523/JNEUROSCI.1560-06.2006; Yoon SO, 1998, J NEUROSCI, V18, P3273	50	211	244	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2007	10	11					1449	1457		10.1038/nn2000	http://dx.doi.org/10.1038/nn2000			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	225HT	17934455				2022-12-17	WOS:000250508400023
J	Muller, MM; Teder-Salejarvi, W; Hillyard, SA				Muller, MM; Teder-Salejarvi, W; Hillyard, SA			The time course of cortical facilitation during cued shifts of spatial attention	NATURE NEUROSCIENCE			English	Article							SELECTIVE ATTENTION; NEURAL MECHANISMS; VISUAL-ATTENTION; ALLOCATION; MEMORY; MODEL; BLINK; V4	Adaptive behavior requires the rapid switching of attention among potentially relevant stimuli that appear in the environment. The present study used an electrophysiological approach to continuously measure the time course of visual pathway facilitation in human subjects as attention was shifted from one location to another. Steady-state visual evoked potentials (SSVEPs) were recorded to rapidly flickering lights at attended and unattended locations, and variations in SSVEP amplitude over time were calculated after a cue to shift attention. The build-up of cortical facilitation reflected in SSVEP amplitude was found to bear a close temporal relationship with the emergence of accurate target discriminations at the newly attended location.	Univ Konstanz, Dept Psychol, D-78457 Constance, Germany; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	University of Konstanz; University of California System; University of California San Diego	Muller, MM (corresponding author), Univ Konstanz, Dept Psychol, Fach D25, D-78457 Constance, Germany.				NIMH NIH HHS [MH-25594] Funding Source: Medline; NINDS NIH HHS [NS 17778] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH025594, R37MH025594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS017778, P50NS017778] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		CHEAL ML, 1994, Q J EXP PSYCHOL-A, V47, P699, DOI 10.1080/14640749408401134; Clark V.P., 1994, HUMAN BRAIN MAPPING, V2, P170, DOI [10.1002/hbm.460020306, DOI 10.1002/HBM.460020306]; Corbetta M, 1998, P NATL ACAD SCI USA, V95, P831, DOI 10.1073/pnas.95.3.831; DUNCAN J, 1994, NATURE, V369, P313, DOI 10.1038/369313a0; ERIKSEN CW, 1986, PERCEPT PSYCHOPHYS, V40, P225, DOI 10.3758/BF03211502; Hillyard SA, 1997, HUM BRAIN MAPP, V5, P287, DOI 10.1002/(SICI)1097-0193(1997)5:4<287::AID-HBM14>3.0.CO;2-B; Hillyard SA, 1998, P NATL ACAD SCI USA, V95, P781, DOI 10.1073/pnas.95.3.781; HILLYARD SA, IN PRESS PHIL T R B; LaBerge D, 1997, J EXP PSYCHOL HUMAN, V23, P1380, DOI 10.1037/0096-1523.23.5.1380; Laberge D., 1995, ATTENTIONAL PROCESSI; Luck SJ, 1996, J EXP PSYCHOL HUMAN, V22, P725, DOI 10.1037/0096-1523.22.3.725; Luck SJ, 1996, NATURE, V383, P616, DOI 10.1038/383616a0; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; MANGUN GR, 1995, PSYCHOPHYSIOLOGY, V32, P4, DOI 10.1111/j.1469-8986.1995.tb03400.x; Morgan ST, 1996, P NATL ACAD SCI USA, V93, P4770, DOI 10.1073/pnas.93.10.4770; Motter BC, 1998, ATTENTIVE BRAIN, P51; MOTTER BC, 1994, J NEUROSCI, V14, P2190; Muller MM, 1998, COGNITIVE BRAIN RES, V6, P249, DOI 10.1016/S0926-6410(97)00036-0; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; POSNER MI, 1987, PSYCHOBIOLOGY, V15, P107; REEVES A, 1986, PSYCHOL REV, V93, P180, DOI 10.1037/0033-295X.93.2.180; Regan D., 1989, HUMAN BRAIN ELECTROP, P70; Shapiro K, 1997, PSYCHOL SCI, V8, P95, DOI 10.1111/j.1467-9280.1997.tb00689.x; Shapiro KL, 1997, TRENDS COGN SCI, V1, P291, DOI 10.1016/S1364-6613(97)01094-2; SPERLING G, 1971, SCIENCE, V174, P307, DOI 10.1126/science.174.4006.307; Stelmach LB, 1997, J EXP PSYCHOL HUMAN, V23, P823, DOI 10.1037/0096-1523.23.3.823; TREISMAN A, 1988, Q J EXP PSYCHOL-A, V40, P201, DOI 10.1080/02724988843000104; Ward R, 1996, COGNITIVE PSYCHOL, V30, P79, DOI 10.1006/cogp.1996.0003; YAMAGUCHI S, 1994, BRAIN, V117, P553, DOI 10.1093/brain/117.3.553	29	211	214	0	28	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	1998	1	7					631	634		10.1038/2865	http://dx.doi.org/10.1038/2865			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	146NL	10196572				2022-12-17	WOS:000077437100020
J	Akbarian, S; Liu, CY; Knowles, JA; Vaccarino, FM; Farnham, PJ; Crawford, GE; Jaffe, AE; Pinto, D; Dracheva, S; Geschwind, DH; Mill, J; Nairn, AC; Abyzov, A; Pochareddy, S; Prabhakar, S; Weissman, S; Sullivan, PF; State, MW; Weng, ZP; Peters, MA; White, KP; Gerstein, MB; Amiri, A; Armoskus, C; Ashley-Koch, AE; Bae, T; Beckel-Mitchener, A; Berman, BP; Coetzee, GA; Coppola, G; Francoeur, N; Fromer, M; Gao, R; Grennan, K; Herstein, J; Kavanagh, DH; Ivanov, NA; Jiang, Y; Kitchen, RR; Kozlenkov, A; Kundakovic, M; Li, MF; Li, Z; Liu, S; Mangravite, LM; Mattei, E; Markenscoff-Papadimitriou, E; Navarro, FCP; North, N; Omberg, L; Panchision, D; Parikshak, N; Poschmann, J; Price, AJ; Purcaro, M; Reddy, TE; Roussos, P; Schreiner, S; Scuderri, S; Sebra, R; Shibata, M; Shieh, AW; Skarica, M; Sun, WJ; Swarup, V; Thomas, A; Tsuji, J; van Bakel, H; Wang, DF; Wang, YJ; Wang, K; Werling, DM; Willsey, AJ; Witt, H; Won, H; Wong, CCY; Wray, GA; Wu, EY; Xu, XM; Yao, LJ; Senthil, G; Lehner, T; Sklar, P; Sestan, N				Akbarian, Schahram; Liu, Chunyu; Knowles, James A.; Vaccarino, Flora M.; Farnham, Peggy J.; Crawford, Gregory E.; Jaffe, Andrew E.; Pinto, Dalila; Dracheva, Stella; Geschwind, Daniel H.; Mill, Jonathan; Nairn, Angus C.; Abyzov, Alexej; Pochareddy, Sirisha; Prabhakar, Shyam; Weissman, Sherman; Sullivan, Patrick F.; State, Matthew W.; Weng, Zhiping; Peters, Mette A.; White, Kevin P.; Gerstein, Mark B.; Amiri, Anahita; Armoskus, Chris; Ashley-Koch, Allison E.; Bae, Taejeong; Beckel-Mitchener, Andrea; Berman, Benjamin P.; Coetzee, Gerhard A.; Coppola, Gianfilippo; Francoeur, Nancy; Fromer, Menachem; Gao, Robert; Grennan, Kay; Herstein, Jennifer; Kavanagh, David H.; Ivanov, Nikolay A.; Jiang, Yan; Kitchen, Robert R.; Kozlenkov, Alexey; Kundakovic, Marija; Li, Mingfeng; Li, Zhen; Liu, Shuang; Mangravite, Lara M.; Mattei, Eugenio; Markenscoff-Papadimitriou, Eirene; Navarro, Fabio C. P.; North, Nicole; Omberg, Larsson; Panchision, David; Parikshak, Neelroop; Poschmann, Jeremie; Price, Amanda J.; Purcaro, Michael; Reddy, Timothy E.; Roussos, Panos; Schreiner, Shannon; Scuderri, Soraya; Sebra, Robert; Shibata, Mikihito; Shieh, Annie W.; Skarica, Mario; Sun, Wenjie; Swarup, Vivek; Thomas, Amber; Tsuji, Junko; van Bakel, Harm; Wang, Daifeng; Wang, Yongjun; Wang, Kai; Werling, Donna M.; Willsey, A. Jeremy; Witt, Heather; Won, Hyejung; Wong, Chloe C. Y.; Wray, Gregory A.; Wu, Emily Y.; Xu, Xuming; Yao, Lijing; Senthil, Geetha; Lehner, Thomas; Sklar, Pamela; Sestan, Nenad		PsychENCODE Consortium	The PsychENCODE project	NATURE NEUROSCIENCE			English	Article							NONCODING GENETIC-VARIATION; DE-NOVO MUTATIONS; HUMAN BRAIN; PSYCHIATRIC-DISORDERS; TRANSCRIPTIONAL REGULATION; EXPRESSION VARIATION; REGULATORY NETWORKS; DISEASE MECHANISMS; BIPOLAR DISORDER; DNA METHYLATION	Recent research on disparate psychiatric disorders has implicated rare variants in genes involved in global gene regulation and chromatin modification, as well as many common variants located primarily in regulatory regions of the genome. Understanding precisely how these variants contribute to disease will require a deeper appreciation for the mechanisms of gene regulation in the developing and adult human brain. The PsychENCODE project aims to produce a public resource of multidimensional genomic data using tissue- and cell type specific samples from approximately 1,000 phenotypically well-characterized, high-quality healthy and disease-affected human post-mortem brains, as well as functionally characterize disease-associated regulatory elements and variants in model systems. We are beginning with a focus on autism spectrum disorder, bipolar disorder and schizophrenia, and expect that this knowledge will apply to a wide variety of psychiatric disorders. This paper outlines the motivation and design of PsychENCODE.	[Akbarian, Schahram; Pinto, Dalila; Dracheva, Stella; Francoeur, Nancy; Fromer, Menachem; Kavanagh, David H.; Jiang, Yan; Kozlenkov, Alexey; Kundakovic, Marija; Roussos, Panos; Sebra, Robert; van Bakel, Harm; Sklar, Pamela] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Liu, Chunyu; Grennan, Kay; Shieh, Annie W.; Wang, Yongjun] Univ Illinois, Chicago, IL USA; [Knowles, James A.; Farnham, Peggy J.; Armoskus, Chris; Berman, Benjamin P.; Coetzee, Gerhard A.; Gao, Robert; Herstein, Jennifer; Schreiner, Shannon; Wang, Kai; Witt, Heather; Yao, Lijing] Univ So Calif, Los Angeles, CA USA; [Vaccarino, Flora M.; Nairn, Angus C.; Pochareddy, Sirisha; Weissman, Sherman; Gerstein, Mark B.; Amiri, Anahita; Coppola, Gianfilippo; Kitchen, Robert R.; Li, Mingfeng; Li, Zhen; Liu, Shuang; Navarro, Fabio C. P.; Scuderri, Soraya; Shibata, Mikihito; Skarica, Mario; Wang, Daifeng; Xu, Xuming; Sestan, Nenad] Yale Univ, New Haven, CT USA; [Crawford, Gregory E.; Ashley-Koch, Allison E.; Reddy, Timothy E.; Wray, Gregory A.] Duke Univ, Durham, NC USA; [Jaffe, Andrew E.; Ivanov, Nikolay A.; Price, Amanda J.] Lieber Inst Brain Dev, Baltimore, MD USA; [Geschwind, Daniel H.; Parikshak, Neelroop; Swarup, Vivek; Won, Hyejung; Wu, Emily Y.] Univ Calif Los Angeles, Los Angeles, CA USA; [Mill, Jonathan; Poschmann, Jeremie; Wong, Chloe C. Y.] Kings Coll London, London WC2R 2LS, England; [Mill, Jonathan; Poschmann, Jeremie; Wong, Chloe C. Y.] Univ Exeter, Exeter EX4 4QJ, Devon, England; [Abyzov, Alexej; Bae, Taejeong] Mayo Clin, Rochester, MN USA; [Prabhakar, Shyam; Sun, Wenjie] Genome Inst Singapore, Singapore, Singapore; [Sullivan, Patrick F.] Univ N Carolina, Chapel Hill, NC USA; [State, Matthew W.; Markenscoff-Papadimitriou, Eirene; Werling, Donna M.; Willsey, A. Jeremy] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Weng, Zhiping; Mattei, Eugenio; Purcaro, Michael; Tsuji, Junko] Univ Massachusetts, Sch Med, Worcester, MA USA; [Peters, Mette A.; Mangravite, Lara M.; Omberg, Larsson] Sage Bionetworks, Seattle, WA USA; [White, Kevin P.; Thomas, Amber] Univ Chicago, Chicago, IL 60637 USA; [Beckel-Mitchener, Andrea; North, Nicole; Panchision, David; Senthil, Geetha; Lehner, Thomas] NIMH, Bethesda, MD 20892 USA	Icahn School of Medicine at Mount Sinai; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Southern California; Yale University; Duke University; University of California System; University of California Los Angeles; University of London; King's College London; University of Exeter; Mayo Clinic; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California San Francisco; University of Massachusetts System; University of Massachusetts Worcester; University of Chicago; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Akbarian, S (corresponding author), Icahn Sch Med Mt Sinai, New York, NY 10029 USA.	geetha.senthil2@nih.gov; tlehner@mail.nih.gov; pamela.sklar@mssm.edu; nenad.sestan@yale.edu	Scuderi, Soraya/AAP-6865-2020; Kundakovic, Marija/GQH-6026-2022; Abyzov, Alexej/AAT-4615-2020; Li, Zhen/J-7456-2019; van Bakel, Harm/N-9561-2017; Shibata, Mikihito/S-5405-2019; Pinto, Dalila/C-4218-2016; Mill, Jonathan/B-5678-2014; Coppola, Gianfilippo/A-9754-2009; Yao, Lijing/N-2954-2017; BERMAN, BENJAMIN/AAT-3720-2021; Bae, Taejeong/AAW-6003-2021; Liu, Chunyu/G-7561-2012; Jaffe, Andrew/L-3089-2016; Wang, Daifeng/K-2412-2019; Coetzee, Gerhard/AAG-8439-2019; coetzee, Gerhard/AAT-6203-2020; Jiang, Yan/A-7941-2018; Abyzov, Alexej/M-4284-2013; Jaffe, Andrew/GPF-5693-2022; Wong, Chloe/AAN-9416-2021; Berman, Benjamin P/D-5942-2014; State, Matthew/W-2256-2019; Mill, Jonathan S/B-3276-2010	Scuderi, Soraya/0000-0001-5126-2009; Kundakovic, Marija/0000-0002-6734-4217; Li, Zhen/0000-0002-6418-9485; van Bakel, Harm/0000-0002-1376-6916; Pinto, Dalila/0000-0002-8769-0846; Mill, Jonathan/0000-0003-1115-3224; Coppola, Gianfilippo/0000-0003-2675-783X; BERMAN, BENJAMIN/0000-0002-2099-9005; Bae, Taejeong/0000-0002-4626-3725; Liu, Chunyu/0000-0002-5986-4415; Jaffe, Andrew/0000-0001-6886-1454; Jaffe, Andrew/0000-0001-6886-1454; Wong, Chloe/0000-0003-4886-8506; Berman, Benjamin P/0000-0002-2099-9005; Mill, Jonathan S/0000-0003-1115-3224; Farnham, Peggy/0000-0003-4469-7914; Ashley-Koch, Allison/0000-0001-5409-9155; Baldwin, Amber/0000-0002-7346-3052; Tsuji, Junko/0000-0003-0139-3750; Vaccarino, Flora/0000-0003-2167-981X; Price, Amanda J./0000-0001-7352-3732; Omberg, Larsson/0000-0002-4719-9120; Nairn, Angus/0000-0002-7075-0195; Abyzov, Alexej/0000-0001-5405-6729; Schreiner, Shannon/0000-0002-8458-5362; Mangravite, Lara/0000-0001-7841-3612; Coetzee, Gerhard/0000-0001-8820-8364; Purcaro, Michael/0000-0002-4735-4215; Navarro, Fabio/0000-0002-5640-9070; Parikshak, Neel/0000-0003-2027-1871; Skarica, Mario/0000-0002-2478-014X; State, Matthew/0000-0003-1624-8302; Mattei, Eugenio/0000-0002-8889-658X	US National Institute of Mental Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM107000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH106934, R21MH105881, R01MH094714, U01MH103339, R21MH105853, P50MH096890, U01MH103392, R21MH103877, U01MH116492, U01MH103365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG050986] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002395] Funding Source: NIH RePORTER	US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	The authors would like to acknowledge and thank the tissue donors and their families. We also thank all consortium members for discussions and feedback on this document. The PsychENCODE consortium projects are funded by the US National Institute of Mental Health.	Amaral DG, 2008, TRENDS NEUROSCI, V31, P137, DOI 10.1016/j.tins.2007.12.005; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Bell JT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r10; Brennand KJ, 2012, DIS MODEL MECH, V5, P26, DOI 10.1242/dmm.008268; Buenrostro J.D., 2015, CURR PROTOC MOL BIOL, V109; Darmanis S, 2015, P NATL ACAD SCI USA, V112, P7285, DOI 10.1073/pnas.1507125112; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; Dekker J, 2013, NAT REV GENET, V14, P390, DOI 10.1038/nrg3454; del Rosario RCH, 2015, NAT METHODS, V12, P458, DOI [10.1038/NMETH.3326, 10.1038/nmeth.3326]; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Evgrafov OV, 2011, PSYCHIAT GENET, V21, P217, DOI 10.1097/YPG.0b013e328341a2f0; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Gamazon ER, 2013, MOL PSYCHIATR, V18, P340, DOI 10.1038/mp.2011.174; Gaugler T, 2014, NAT GENET, V46, P881, DOI 10.1038/ng.3039; Geschwind DH, 2015, LANCET NEUROL, V14, P1109, DOI 10.1016/S1474-4422(15)00044-7; Hause RJ, 2014, AM J HUM GENET, V95, P194, DOI 10.1016/j.ajhg.2014.07.005; He X, 2013, AM J HUM GENET, V92, P667, DOI 10.1016/j.ajhg.2013.03.022; Insel TR, 2010, NATURE, V468, P187, DOI 10.1038/nature09552; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Jiang Y, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-42; Johnson MB, 2015, NAT NEUROSCI, V18, P637, DOI 10.1038/nn.3980; Johnson MB, 2009, NEURON, V62, P494, DOI 10.1016/j.neuron.2009.03.027; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Kelly TK, 2012, GENOME RES, V22, P2497, DOI 10.1101/gr.143008.112; Konopka G, 2012, NEURON, V75, P601, DOI 10.1016/j.neuron.2012.05.034; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee SH, 2013, NAT GENET, V45, P984, DOI 10.1038/ng.2711; Lee TI, 2013, CELL, V152, P1237, DOI 10.1016/j.cell.2013.02.014; Levine M, 2005, P NATL ACAD SCI USA, V102, P4936, DOI 10.1073/pnas.0408031102; Liao BY, 2008, P NATL ACAD SCI USA, V105, P6987, DOI [10.1073/pnas.0800387105, 10.1073/pnas.0806419105]; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; Malhotra D, 2012, CELL, V148, P1223, DOI 10.1016/j.cell.2012.02.039; Mariani J, 2015, CELL, V162, P375, DOI 10.1016/j.cell.2015.06.034; McCarthy SE, 2014, MOL PSYCHIATR, V19, P652, DOI 10.1038/mp.2014.29; Meyer-Lindenberg A, 2006, NAT REV NEUROSCI, V7, P818, DOI 10.1038/nrn1993; Miller JA, 2014, NATURE, V508, P199, DOI 10.1038/nature13185; Nord AS, 2015, NEURON, V85, P27, DOI 10.1016/j.neuron.2014.11.011; Richards AL, 2012, MOL PSYCHIATR, V17, P193, DOI 10.1038/mp.2011.11; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Shibata M, 2015, TRENDS GENET, V31, P77, DOI 10.1016/j.tig.2014.12.004; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; Sullivan PF, 2012, NAT REV GENET, V13, P537, DOI 10.1038/nrg3240; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Visel A, 2009, NATURE, V461, P199, DOI 10.1038/nature08451; Vockley CM, 2015, GENOME RES, V25, P1206, DOI 10.1101/gr.190090.115; Ward LD, 2012, NAT BIOTECHNOL, V30, P1095, DOI 10.1038/nbt.2422; West AE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005744; Wray Naomi R., 2012, Frontiers in Genetics, V3, P118, DOI 10.3389/fgene.2012.00118	50	210	211	1	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2015	18	12					1707	1712		10.1038/nn.4156	http://dx.doi.org/10.1038/nn.4156			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CX1LV	26605881	Green Accepted			2022-12-17	WOS:000365458600005
J	Bossert, JM; Stern, AL; Theberge, FRM; Cifani, C; Koya, E; Hope, BT; Shaham, Y				Bossert, Jennifer M.; Stern, Anna L.; Theberge, Florence R. M.; Cifani, Carlo; Koya, Eisuke; Hope, Bruce T.; Shaham, Yavin			Ventral medial prefrontal cortex neuronal ensembles mediate context-induced relapse to heroin	NATURE NEUROSCIENCE			English	Article							NUCLEUS-ACCUMBENS; SEEKING; RATS; REINSTATEMENT; EXTINCTION; FEAR	In a rat model of context-induced relapse to heroin, we identified sparsely distributed ventral medial prefrontal cortex (mPFC) neurons that were activated by the heroin-associated context. Selective pharmacogenetic inactivation of these neurons inhibited context-induced drug relapse. A small subset of ventral mPFC neurons formed neuronal ensembles that encode the learned associations between heroin reward and heroin-associated contexts; re-activation of these neuronal ensembles by drug-associated contexts during abstinence provoked drug relapse.	[Bossert, Jennifer M.; Stern, Anna L.; Theberge, Florence R. M.; Cifani, Carlo; Koya, Eisuke; Hope, Bruce T.; Shaham, Yavin] NIDA, Behav Neurosci Branch, Intramural Res Program, US Natl Inst Hlth,Dept Hlth & Human Serv, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Shaham, Y (corresponding author), NIDA, Behav Neurosci Branch, Intramural Res Program, US Natl Inst Hlth,Dept Hlth & Human Serv, Baltimore, MD USA.	yshaham@intra.nida.nih.gov	shaham, yavin/G-1306-2014; Hope, Bruce T/A-9223-2010; Theberge, Florence/T-2916-2019; Cifani, Carlo/AAC-5456-2022	Hope, Bruce T/0000-0001-5804-7061; Cifani, Carlo/0000-0001-6180-828X; Koya, Eisuke/0000-0002-5039-4875	National Institute on Drug Abuse (US National Institutes of Health, Department of Health and Human Services); NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000467, ZIADA000434] Funding Source: NIH RePORTER	National Institute on Drug Abuse (US National Institutes of Health, Department of Health and Human Services)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank B. Navarre and K. Wihbey for their help in conducting the experiments and thank M. van den Oever for the CamKII and GAD67 immunofluorescence protocol. We also thank M. Heilig for helpful comments on the manuscript. This work was supported by the Intramural Research Program of the National Institute on Drug Abuse (US National Institutes of Health, Department of Health and Human Services).	[Anonymous], 1949, CLIN PSYCHOL-UK, DOI DOI 10.4324/9781410612403; Bossert JM, 2007, J NEUROSCI, V27, P12655, DOI 10.1523/JNEUROSCI.3926-07.2007; BOUTON ME, 1979, LEARN MOTIV, V10, P445, DOI 10.1016/0023-9690(79)90057-2; Celentano M, 2009, PSYCHOPHARMACOLOGY, V204, P349, DOI 10.1007/s00213-009-1467-x; Crombag HS, 2008, PHILOS T R SOC B, V363, P3233, DOI 10.1098/rstb.2008.0090; EICHENBAUM H, 1993, SCIENCE, V261, P993, DOI 10.1126/science.8351525; ETTENBERG A, 1982, PSYCHOPHARMACOLOGY, V78, P204, DOI 10.1007/BF00428151; KASOF GM, 1995, J NEUROSCI, V15, P4238; Koya E, 2009, NAT NEUROSCI, V12, P1069, DOI 10.1038/nn.2364; PENNARTZ CMA, 1994, PROG NEUROBIOL, V42, P719, DOI 10.1016/0301-0082(94)90025-6; Peters J, 2008, J NEUROSCI, V28, P6046, DOI 10.1523/JNEUROSCI.1045-08.2008; Peters J, 2009, LEARN MEMORY, V16, P279, DOI 10.1101/lm.1041309; Rogers JL, 2008, NEUROSCIENCE, V151, P579, DOI 10.1016/j.neuroscience.2007.10.012; Van den Oever MC, 2008, NAT NEUROSCI, V11, P1053, DOI 10.1038/nn.2165; WIKLER A, 1973, ARCH GEN PSYCHIAT, V28, P611	15	210	223	2	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2011	14	4					420	422		10.1038/nn.2758	http://dx.doi.org/10.1038/nn.2758			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	741FQ	21336273	Green Submitted, Green Accepted			2022-12-17	WOS:000288849400010
J	Van Der Werf, YD; Altena, E; Schoonheim, MM; Sanz-Arigita, EJ; Vis, JC; De Rijke, W; Van Someren, EJW				Van Der Werf, Ysbrand D.; Altena, Ellemarije; Schoonheim, Menno M.; Sanz-Arigita, Ernesto J.; Vis, Jose C.; De Rijke, Wim; Van Someren, Eus J. W.			Sleep benefits subsequent hippocampal functioning	NATURE NEUROSCIENCE			English	Article							SLOW OSCILLATIONS; MEMORY; DEPRIVATION	Sleep before learning benefits memory encoding through unknown mechanisms. We found that even a mild sleep disruption that suppressed slow-wave activity and induced shallow sleep, but did not reduce total sleep time, was sufficient to affect subsequent successful encoding-related hippocampal activation and memory performance in healthy human subjects. Implicit learning was not affected. Our results suggest that the hippocampus is particularly sensitive to shallow, but intact, sleep.	[Van Der Werf, Ysbrand D.; Altena, Ellemarije; Sanz-Arigita, Ernesto J.; Vis, Jose C.; Van Someren, Eus J. W.] Inst Royal Netherlands Acad Arts & Sci, Netherlands Inst Neurosci, Dept Sleep & Cognit, NL-1105 BA Amsterdam, Netherlands; [Van Der Werf, Ysbrand D.; De Rijke, Wim; Van Someren, Eus J. W.] Vrije Univ Amsterdam, Med Ctr, Dept Clin Neurophysiol, NL-1007 MB Amsterdam, Netherlands; [Altena, Ellemarije] Vrije Univ Amsterdam, Med Ctr, Dept Neurol, NL-1007 MB Amsterdam, Netherlands; [Schoonheim, Menno M.; Sanz-Arigita, Ernesto J.] Vrije Univ Amsterdam, Med Ctr, Dept Radiol, NL-1007 MB Amsterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Van Der Werf, YD (corresponding author), Inst Royal Netherlands Acad Arts & Sci, Netherlands Inst Neurosci, Dept Sleep & Cognit, Meibergdreef 47, NL-1105 BA Amsterdam, Netherlands.	y.van.der.werf@nin.knaw.nl	Schoonheim, Menno/AAI-6853-2021; Schoonheim, Menno M/X-5398-2018; Van Someren, Eus/AAA-6789-2020	Schoonheim, Menno/0000-0002-2504-6959; Schoonheim, Menno M/0000-0002-2504-6959; van der Werf, Ysbrand/0000-0003-2370-9584; Altena, Ellemarije/0000-0002-8882-7963; Sanz-Arigita, Ernesto J./0000-0001-9858-9666	Netherlands Organization of Scientific Research; Hague; VIDI [016.025.041, 016.095.359]; Integrated Cognition [051-04-010]; Internationale Stichting Alzheimer Onderzoek [05511]; Graduate School Neurosciences Amsterdam	Netherlands Organization of Scientific Research(Netherlands Organization for Scientific Research (NWO)); Hague; VIDI(Netherlands Organization for Scientific Research (NWO)); Integrated Cognition; Internationale Stichting Alzheimer Onderzoek; Graduate School Neurosciences Amsterdam	We wish to thank K. Plugge, I. Beckmann and R. Strijers for assistance in subject screening. This study was funded by the Netherlands Organization of Scientific Research, the Hague, VIDI Innovation Grants 016.025.041 and 016.095.359, Integrated Cognition Project Grant 051-04-010, and by Internationale Stichting Alzheimer Onderzoek grant 05511. Financial support for imaging costs was supplied by the Graduate School Neurosciences Amsterdam.	Buzsaki G., 2006, RHYTHMS BRAIN; Collins DR, 2001, J NEUROPHYSIOL, V85, P1661, DOI 10.1152/jn.2001.85.4.1661; Dolan RJ, 1997, NATURE, V388, P582, DOI 10.1038/41561; Drewes AM, 2000, J MUSCULOSKELET PAIN, V8, P49, DOI 10.1300/J094v08n03_05; Gron G, 2003, NEUROBIOL AGING, V24, P453, DOI 10.1016/S0197-4580(02)00128-8; Isomura Y, 2006, NEURON, V52, P871, DOI 10.1016/j.neuron.2006.10.023; Lubenov EV, 2008, NEURON, V58, P118, DOI 10.1016/j.neuron.2008.01.036; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; McDermott CM, 2003, J NEUROSCI, V23, P9687; Stern CE, 1996, P NATL ACAD SCI USA, V93, P8660, DOI 10.1073/pnas.93.16.8660; Ungerleider Leslie G., 1994, Current Opinion in Neurobiology, V4, P157, DOI 10.1016/0959-4388(94)90066-3; Van Cauter E, 2000, JAMA-J AM MED ASSOC, V284, P861, DOI 10.1001/jama.284.7.861; Yoo SS, 2007, NAT NEUROSCI, V10, P385, DOI 10.1038/nn1851	13	210	212	1	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2009	12	2					122	123		10.1038/nn.2253	http://dx.doi.org/10.1038/nn.2253			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	404VV	19151712				2022-12-17	WOS:000263182000011
J	Wunderlich, K; Schneider, KA; Kastner, S				Wunderlich, K; Schneider, KA; Kastner, S			Neural correlates of binocular rivalry in the human lateral geniculate nucleus	NATURE NEUROSCIENCE			English	Article							PRIMARY VISUAL-CORTEX; ALERT MACAQUE; MONKEY; CAT; PERCEPTION; ORGANIZATION; SUPPRESSION; ATTENTION; RESPONSES; DYNAMICS	When dissimilar images are presented to the two eyes, they compete for perceptual dominance so that only one image is visible at a time while the other one is suppressed. Neural correlates of such binocular rivalry have been found at multiple stages of visual processing, including striate and extrastriate visual cortex. However, little is known about the role of subcortical processing during binocular rivalry. Here we used fMRI to measure neural activity in the human LGN while subjects viewed contrast-modulated gratings presented dichoptically. Neural activity in the LGN correlated strongly with the subjects' reported percepts, such that activity increased when a high-contrast grating was perceived and decreased when a low-contrast grating was perceived. Our results provide evidence for a functional role of the LGN in binocular rivalry and suggest that the LGN, traditionally viewed as the gateway to the visual cortex, may be an early gatekeeper of visual awareness.	Princeton Univ, Dept Psychol, Ctr Study Brain Mind & Behav, Princeton, NJ 08544 USA	Princeton University	Kastner, S (corresponding author), Princeton Univ, Dept Psychol, Ctr Study Brain Mind & Behav, Princeton, NJ 08544 USA.	skastner@princeton.edu		Schneider, Keith/0000-0001-7120-3380; Kastner, Sabine/0000-0002-9742-965X	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064043, T32MH065214, P50MH062196] Funding Source: NIH RePORTER; NIMH NIH HHS [R01MH-64043, P50 MH062196, P50MH-62196, T32 MH065214, R01 MH064043] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BLAKE R, 1989, PSYCHOL REV, V96, P145, DOI 10.1037/0033-295X.96.1.145; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Cohen J, 2003, ANIM COGN, V6, P93, DOI 10.1007/s10071-003-0168-9; Crick F, 1998, CEREB CORTEX, V8, P97, DOI 10.1093/cercor/8.2.97; CRICK F, 1995, NATURE, V375, P121, DOI 10.1038/375121a0; Friston K.J., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Guillery RW, 1998, TRENDS NEUROSCI, V21, P28, DOI 10.1016/S0166-2236(97)01157-0; Kastner S, 2004, J NEUROPHYSIOL, V91, P438, DOI 10.1152/jn.00553.2003; Lee SH, 2002, J VISION, V2, P618, DOI 10.1167/2.9.4; Lee SH, 2005, NAT NEUROSCI, V8, P22, DOI 10.1038/nn1365; Lehky SR, 1991, NEURAL COMPUT, V3, P44, DOI 10.1162/neco.1991.3.1.44; LEHKY SR, 1988, PERCEPTION, V17, P215, DOI 10.1068/p170215; Lehky SR, 1996, VISION RES, V36, P1225, DOI 10.1016/0042-6989(95)00232-4; Leopold DA, 1996, NATURE, V379, P549, DOI 10.1038/379549a0; LEVELT WJM, 1965, BRIT J PSYCHOL, V56, P1, DOI 10.1111/j.2044-8295.1965.tb00939.x; LIVINGSTONE MS, 1987, J NEUROSCI, V7, P3416; LOGOTHETIS NK, 1989, SCIENCE, V245, P761, DOI 10.1126/science.2772635; Logothetis NK, 1999, NAT NEUROSCI, V2, P555, DOI 10.1038/9210; Lumer ED, 1998, SCIENCE, V280, P1930, DOI 10.1126/science.280.5371.1930; LUND JS, 1975, J COMP NEUROL, V159, P305, DOI 10.1002/cne.901590303; MARROCCO RT, 1979, BRAIN RES, V168, P633, DOI 10.1016/0006-8993(79)90319-6; MUELLER TJ, 1989, BIOL CYBERN, V61, P223, DOI 10.1007/BF00198769; O'Connor DH, 2002, NAT NEUROSCI, V5, P1203, DOI 10.1038/nn957; PAPE HC, 1986, EXP BRAIN RES, V61, P265; Polonsky A, 2000, NAT NEUROSCI, V3, P1153, DOI 10.1038/80676; RODIECK RW, 1979, EXP BRAIN RES, V35, P465; SANDERSON KJ, 1971, EXP BRAIN RES, V13, P178; SCHMIELAU F, 1977, BRAIN RES, V120, P354, DOI 10.1016/0006-8993(77)90914-3; Schneider KA, 2005, J NEUROPHYSIOL, V94, P2491, DOI 10.1152/jn.00288.2005; Schneider KA, 2004, J NEUROSCI, V24, P8975, DOI 10.1523/JNEUROSCI.2413-04.2004; SCHROEDER CE, 1990, BRAIN RES, V521, P303, DOI 10.1016/0006-8993(90)91556-V; SENGPIEL F, 1995, VISION RES, V35, P179, DOI 10.1016/0042-6989(94)00125-6; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Shenberg DL, 1997, P NATL ACAD SCI USA, V94, P3408, DOI 10.1073/pnas.94.7.3408; Sherman S.M., 2001, EXPLORING THALAMUS, V1st Edn; SINGER W, 1970, BRAIN RES, V18, P165, DOI 10.1016/0006-8993(70)90463-4; Tong F, 2001, NATURE, V411, P195, DOI 10.1038/35075583; Tong F, 1998, NEURON, V21, P753, DOI 10.1016/S0896-6273(00)80592-9; VARELA FJ, 1987, EXP BRAIN RES, V66, P10	39	210	216	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2005	8	11					1595	1602		10.1038/nn1554	http://dx.doi.org/10.1038/nn1554			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	979TB	16234812	Green Accepted			2022-12-17	WOS:000232966600035
J	Mallamaci, A; Muzio, L; Chan, CH; Parnavelas, J; Boncinelli, E				Mallamaci, A; Muzio, L; Chan, CH; Parnavelas, J; Boncinelli, E			Area identity shifts in the early cerebral cortex of Emx2-/- mutant mice	NATURE NEUROSCIENCE			English	Article							SOMATOSENSORY CORTEX; MEMBRANE-PROTEIN; DENTATE GYRUS; CELL-CYCLE; NEURONS; EXPRESSION; SYSTEM; MOUSE; SPECIFICATION; NEOCORTEX	The specification of area identities in the cerebral cortex is a complex process, primed by intrinsic cortical cues and refined after the arrival of afferent fibers from the thalamus. Little is known about the genetic control of the early steps of this process, but the distinctive expression pattern of the homeogene Emx2 in the developing cortex has prompted suggestions that it is critical in this context. We tested this hypothesis using Emx2(-/-) mice. We found that the normal spectrum of cortical areal identities was encoded in these mutants, but areas with caudal-medial identities were reduced and those with anterior-lateral identities were relatively expanded in the cortex.	Ist Sci H San Raffaele, Dept Biol & Technol Res DIBIT, I-20132 Milan, Italy; UCL, Dept Anat & Dev Biol, London WC1E 6BT, England; Univ Vita Salute San Raffaele, Fac Psychol, I-20132 Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of London; University College London; Vita-Salute San Raffaele University	Mallamaci, A (corresponding author), Ist Sci H San Raffaele, Dept Biol & Technol Res DIBIT, Via Olgettina 58, I-20132 Milan, Italy.	mallamaci.antanio@hsr.it	Mallamaci, Antonello/A-2975-2015; Chan, Chun-Hung/F-5358-2015; Muzio, Luca/AAB-2308-2022	Mallamaci, Antonello/0000-0002-3621-1307; Chan, Chun-Hung/0000-0001-9646-2944; Muzio, Luca/0000-0002-1068-865X	Telethon [D.078] Funding Source: Medline	Telethon(Fondazione Telethon)		ALLENDOERFER KL, 1990, P NATL ACAD SCI USA, V87, P187, DOI 10.1073/pnas.87.1.187; ARIMATSU Y, 1992, P NATL ACAD SCI USA, V89, P8879, DOI 10.1073/pnas.89.19.8879; BARBE MF, 1992, P NATL ACAD SCI USA, V89, P3706, DOI 10.1073/pnas.89.9.3706; BARBE MF, 1991, J NEUROSCI, V11, P519; Bayer S.A., 1991, NEOCORTICAL DEV; Bishop KM, 2000, SCIENCE, V288, P344, DOI 10.1126/science.288.5464.344; Briata P, 1996, MECH DEVELOP, V57, P169, DOI 10.1016/0925-4773(96)00544-8; COHENTANNOUDJI M, 1992, MOL REPROD DEV, V33, P149, DOI 10.1002/mrd.1080330206; COHENTANNOUDJI M, 1994, NATURE, V368, P460, DOI 10.1038/368460a0; Eagleson KL, 1997, DEVELOPMENT, V124, P1623; FERRI RT, 1993, CEREB CORTEX, V3, P187, DOI 10.1093/cercor/3.3.187; Fukuda T, 1997, J COMP NEUROL, V382, P141; Gitton Y, 1999, J NEUROSCI, V19, P4889; Gulisano M, 1996, EUR J NEUROSCI, V8, P1037, DOI 10.1111/j.1460-9568.1996.tb01590.x; LEVITT P, 1984, SCIENCE, V223, P299, DOI 10.1126/science.6199842; Li FZ, 1999, NAT CELL BIOL, V1, P461, DOI 10.1038/70242; Mackarehtschian K, 1999, CEREB CORTEX, V9, P601, DOI 10.1093/cercor/9.6.601; Mallamaci A, 1998, MECH DEVELOP, V77, P165, DOI 10.1016/S0925-4773(98)00141-5; Mallamaci A, 2000, J NEUROSCI, V20, P1109, DOI 10.1523/JNEUROSCI.20-03-01109.2000; Miyashita-Lin EM, 1999, SCIENCE, V285, P906, DOI 10.1126/science.285.5429.906; Molnar Z, 1998, J NEUROSCI, V18, P5723; Nakagawa Y, 1999, J NEUROSCI, V19, P10877, DOI 10.1523/JNEUROSCI.19-24-10877.1999; Pellegrini M, 1996, DEVELOPMENT, V122, P3893; PIMENTA AF, 1995, NEURON, V15, P287, DOI 10.1016/0896-6273(95)90034-9; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RIECHMANN V, 1995, CELL GROWTH DIFFER, V6, P837; Rubenstein JLR, 1999, CEREB CORTEX, V9, P524, DOI 10.1093/cercor/9.6.524; SCHLESSINGER AR, 1978, ANAT EMBRYOL, V154, P153, DOI 10.1007/BF00304660; STANFIELD BB, 1979, J COMP NEUROL, V185, P423, DOI 10.1002/cne.901850303; TAKAHASHI T, 1995, J NEUROSCI, V15, P6058; TAKAHASHI T, 1995, J NEUROSCI, V15, P6046; VANDERLO.H, 1973, SCIENCE, V179, P395, DOI 10.1126/science.179.4071.395; WALTHER C, 1991, DEVELOPMENT, V113, P1435; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; ZACCO A, 1990, J NEUROSCI, V10, P73	35	210	213	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2000	3	7					679	686		10.1038/76630	http://dx.doi.org/10.1038/76630			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TT	10862700				2022-12-17	WOS:000167177200014
J	Hessler, NA; Doupe, AJ				Hessler, NA; Doupe, AJ			Social context modulates singing-related neural activity in the songbird forebrain	NATURE NEUROSCIENCE			English	Article							ZEBRA FINCH; LESIONS; SYSTEM; BIRDS		Univ Calif San Francisco, Keck Ctr Integrat Neurosci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Hessler, NA (corresponding author), Univ Calif San Francisco, Keck Ctr Integrat Neurosci, San Francisco, CA 94143 USA.		hessler, neal/A-7328-2010		NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH055987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS009913] Funding Source: NIH RePORTER; NIMH NIH HHS [MH55987] Funding Source: Medline; NINDS NIH HHS [NS09913] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BOTTJER SW, 1984, SCIENCE, V224, P901, DOI 10.1126/science.6719123; Catchpole C. K., 1995, BIRD SONG BIOL THEME; DOUPE AJ, 1991, P NATL ACAD SCI USA, V88, P11339, DOI 10.1073/pnas.88.24.11339; Dunn AM, 1996, ETHOLOGY, V102, P540; Fox HE, 1997, J NEUROSCI, V17, P6463; Jarvis ED, 1998, NEURON, V21, P775, DOI 10.1016/S0896-6273(00)80594-2; LEWIS JW, 1981, J COMP NEUROL, V196, P347, DOI 10.1002/cne.901960212; MARLER P, 1970, J COMP PHYSIOL PSYCH, V71, P1, DOI 10.1037/h0029144; MCCASLAND JS, 1987, J NEUROSCI, V7, P23; MORRIS D, 1954, BEHAVIOUR, V7, P1, DOI 10.1163/156853955X00012; NOTTEBOHM F, 1976, J COMP NEUROL, V165, P457, DOI 10.1002/cne.901650405; SCHARFF C, 1991, J NEUROSCI, V11, P2896; SOHRABJI F, 1990, BEHAV NEURAL BIOL, V53, P51, DOI 10.1016/0163-1047(90)90797-A; WEST MJ, 1988, NATURE, V334, P244, DOI 10.1038/334244a0; Yu AC, 1996, SCIENCE, V273, P1871, DOI 10.1126/science.273.5283.1871	15	210	211	0	11	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	1999	2	3					209	211		10.1038/6306	http://dx.doi.org/10.1038/6306			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	220TX	10195211				2022-12-17	WOS:000081684500006
J	Mostafavi, S; Gaiteri, C; Sullivan, SE; White, CC; Tasaki, S; Xu, JS; Taga, M; Klein, HU; Patrick, E; Komashko, V; McCabe, C; Smith, R; Bradshaw, EM; Root, DE; Regev, A; Yu, L; Chibnik, LB; Schneider, JA; Young-Pearse, TL; Bennett, DA; De Jager, PL				Mostafavi, Sara; Gaiteri, Chris; Sullivan, Sarah E.; White, Charles C.; Tasaki, Shinya; Xu, Jishu; Taga, Mariko; Klein, Hans-Ulrich; Patrick, Ellis; Komashko, Vitalina; McCabe, Cristin; Smith, Robert; Bradshaw, Elizabeth M.; Root, David E.; Regev, Aviv; Yu, Lei; Chibnik, Lori B.; Schneider, Julie A.; Young-Pearse, Tracy L.; Bennett, David A.; De Jager, Philip L.			A molecular network of the aging human brain provides insights into the pathology and cognitive decline of Alzheimer's disease	NATURE NEUROSCIENCE			English	Article							GENE-EXPRESSION; NEURONS; NEUROPATHOLOGY; DEMENTIA; MEMORY; MOUSE; IMPAIRMENT; ALIGNMENT; DATABASE; VARIANTS	There is a need for new therapeutic targets with which to prevent Alzheimer's disease (AD), a major contributor to aging-related cognitive decline. Here we report the construction and validation of a molecular network of the aging human frontal cortex. Using RNA sequence data from 478 individuals, we first build a molecular network using modules of coexpressed genes and then relate these modules to AD and its neuropathologic and cognitive endophenotypes. We confirm these associations in two independent AD datasets. We also illustrate the use of the network in prioritizing amyloid-and cognition- associated genes for in vitro validation in human neurons and astrocytes. These analyses based on unique cohorts enable us to resolve the role of distinct cortical modules that have a direct effect on the accumulation of AD pathology from those that have a direct effect on cognitive decline, exemplifying a network approach to complex diseases.	[Mostafavi, Sara] Univ British Columbia, Dept Med Genet, Dept Stat, Vancouver, BC, Canada; [Mostafavi, Sara] Canadian Inst Adv Res, Toronto, ON, Canada; [Gaiteri, Chris; Tasaki, Shinya; Komashko, Vitalina; Yu, Lei; Schneider, Julie A.; Bennett, David A.] Rush Univ, Med Ctr, Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA; [Sullivan, Sarah E.; Smith, Robert; Young-Pearse, Tracy L.] Brigham & Womens Hosp, Dept Neurol, 75 Francis St, Boston, MA 02115 USA; [White, Charles C.; Xu, Jishu; Taga, Mariko; Klein, Hans-Ulrich; McCabe, Cristin; Bradshaw, Elizabeth M.; Root, David E.; Regev, Aviv; Chibnik, Lori B.; De Jager, Philip L.] Broad Inst, Cambridge, MA 02142 USA; [Taga, Mariko; Klein, Hans-Ulrich; Bradshaw, Elizabeth M.; De Jager, Philip L.] Columbia Univ, Dept Neurol, Med Ctr, Ctr Translat & Computat Neuroimmunol, New York, NY 10027 USA; [Patrick, Ellis] Univ Sydney, Sydney, NSW, Australia; [Chibnik, Lori B.; Young-Pearse, Tracy L.] Harvard Med Sch, Boston, MA USA; [Chibnik, Lori B.] Harvard TH Chan Sch Publ Hlth, Boston, MA USA	University of British Columbia; Canadian Institute for Advanced Research (CIFAR); Rush University; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Columbia University; University of Sydney; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Bennett, DA (corresponding author), Rush Univ, Med Ctr, Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA.; De Jager, PL (corresponding author), Broad Inst, Cambridge, MA 02142 USA.; De Jager, PL (corresponding author), Columbia Univ, Dept Neurol, Med Ctr, Ctr Translat & Computat Neuroimmunol, New York, NY 10027 USA.	david_a_bennett@rush.edu; pld2115@cumc.columbia.edu	Yu, Lei/AAT-3685-2020; Patrick, Ellis/B-1763-2013; Klein, Hans-Ulrich/O-5118-2019	Patrick, Ellis/0000-0002-5253-4747; Klein, Hans-Ulrich/0000-0002-6382-9428; Chibnik, Lori/0000-0001-6293-806X; Gaiteri, Chris/0000-0001-7838-8664; Young-Pearse, Tracy/0000-0001-7846-1542	NIH [U01AG046152, R01AG036836, P30AG10161, R01AG015819, R01AG017917, R01AG036547]; NATIONAL INSTITUTE ON AGING [P30AG010161, R01AG017917, R01AG057911, R01AG015819, RF1AG015819, U01AG046152] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the participants of ROS and MAP for their essential contributions and the gifts of their brains to these projects. All subjects gave informed consent. This work has been supported by many different NIH grants: U01AG046152, R01AG036836, P30AG10161, R01AG015819, R01AG017917, R01AG036547. This work was done as part of the National Institute of Aging's Accelerating Medicines Partnership for AD (AMP-AD).	Adiconis X, 2013, NAT METHODS, V10, P623, DOI 10.1038/nmeth.2483; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Battle A, 2014, GENOME RES, V24, P14, DOI 10.1101/gr.155192.113; Beckervordersandforth R, 2010, CELL STEM CELL, V7, P744, DOI 10.1016/j.stem.2010.11.017; Beecham GW, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004606; Bennett DA, 2006, NEUROLOGY, V66, P1837, DOI 10.1212/01.wnl.0000219668.47116.e6; Bennett DA, 2012, ANN NEUROL, V72, P599, DOI 10.1002/ana.23654; Bennett DA, 2012, CURR ALZHEIMER RES, V9, P646; Bennett DA, 2012, CURR ALZHEIMER RES, V9, P628; Boyle PA, 2013, ANN NEUROL, V74, P478, DOI 10.1002/ana.23964; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chibnik LB, 2011, ANN NEUROL, V69, P560, DOI 10.1002/ana.22277; Cummings JL, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt269; Dalal J, 2013, GENE DEV, V27, P565, DOI 10.1101/gad.207654.112; De Jager PL, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.09.033; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Farfel JM, 2016, NEUROLOGY, V87, P489, DOI 10.1212/WNL.0000000000002909; Feng JX, 2012, NAT PROTOC, V7, P1728, DOI 10.1038/nprot.2012.101; Fomchenko EI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020605; Gaiteri C, 2014, GENES BRAIN BEHAV, V13, P13, DOI 10.1111/gbb.12106; Gaiteri C, 2016, NAT REV NEUROL, V12, P413, DOI 10.1038/nrneurol.2016.84; Gaiteri C, 2015, SCI REP-UK, V5, DOI 10.1038/srep16361; Galloway JN, 2014, HUM MOL GENET, V23, P5906, DOI 10.1093/hmg/ddu314; Geschwind DH, 2009, NATURE, V461, P908, DOI 10.1038/nature08537; Grzegorczyk M, 2008, MACH LEARN, V71, P265, DOI 10.1007/s10994-008-5057-7; Gustafsson M, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0082-6; Hebert LE, 2013, NEUROLOGY, V80, P1778, DOI 10.1212/WNL.0b013e31828726f5; Heiman M, 2014, P NATL ACAD SCI USA, V111, P4578, DOI 10.1073/pnas.1401819111; Hoeting JA, 1999, STAT SCI, V14, P382, DOI 10.1214/ss/1009212519; Hyman BT, 1997, J NEUROPATH EXP NEUR, V56, P1095, DOI 10.1097/00005072-199710000-00002; Jack CR, 2014, LANCET NEUROL, V13, P997, DOI 10.1016/S1474-4422(14)70194-2; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Koller Daphne, 2009, PROBABILISTICGRAPHIC; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langfelder P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001057; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee PH, 2012, BIOINFORMATICS, V28, P1797, DOI 10.1093/bioinformatics/bts191; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Levin JZ, 2010, NAT METHODS, V7, P709, DOI [10.1038/NMETH.1491, 10.1038/nmeth.1491]; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MANCARCI BO, 2017, ENEURO 4 ENEURO, V0212; Matarin M, 2015, CELL REP, V10, P633, DOI 10.1016/j.celrep.2014.12.041; Maze I, 2014, NAT NEUROSCI, V17, P533, DOI 10.1038/nn.3670; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Miller JA, 2013, GENOME MED, V5, DOI 10.1186/gm452; Mitra K, 2013, NAT REV GENET, V14, P719, DOI 10.1038/nrg3552; Mostafavi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068141; Okaty BW, 2009, J NEUROSCI, V29, P7040, DOI 10.1523/JNEUROSCI.0105-09.2009; Parikshak NN, 2015, NAT REV GENET, V16, P441, DOI 10.1038/nrg3934; Paul A, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00037; Perala N, 2012, DIFFERENTIATION, V83, P77, DOI 10.1016/j.diff.2011.08.001; Perrone-Bizzozero NI, 2011, ASN NEURO, V3, DOI 10.1042/AN20110015; Phani S, 2010, BRAIN RES, V1343, P1, DOI 10.1016/j.brainres.2010.04.061; Raber J, 2004, NEUROBIOL AGING, V25, P641, DOI 10.1016/j.neurobiolaging.2003.12.023; Schmidt EF, 2012, CELL, V149, P1152, DOI 10.1016/j.cell.2012.03.038; Schneider JA, 2012, BRAIN, V135, P3005, DOI 10.1093/brain/aws234; Schneider JA, 2007, NEUROLOGY, V69, P2197, DOI 10.1212/01.wnl.0000271090.28148.24; Schneider JA, 2009, ANN NEUROL, V66, P200, DOI 10.1002/ana.21706; Soeda Y, 2010, MOL ENDOCRINOL, V24, P1965, DOI 10.1210/me.2010-0163; Stegle O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000770; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Stranger BE, 2012, PLOS GENET, V8, P272, DOI 10.1371/journal.pgen.1002639; Sugino K, 2006, NAT NEUROSCI, V9, P99, DOI 10.1038/nn1618; Sugino K, 2014, J NEUROSCI, V34, P12877, DOI 10.1523/JNEUROSCI.2674-14.2014; Suwa A, 2010, EXPERT OPIN THER TAR, V14, P727, DOI 10.1517/14728222.2010.492780; Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903; Tan CL, 2013, SCIENCE, V342, P1254, DOI 10.1126/science.1244193; Tasaki S, 2015, GENETICS, V199, P973, DOI 10.1534/genetics.114.172619; Wilson RS, 2015, PSYCHOL AGING, V30, P74, DOI 10.1037/pag0000013; Wilson RS, 2003, J CLIN EXP NEUROPSYC, V25, P634, DOI 10.1076/jcen.25.5.634.14572; Wilson RS, 2002, PSYCHOL AGING, V17, P179, DOI 10.1037/0882-7974.17.2.179; Wu JJ, 2009, KDD-09: 15TH ACM SIGKDD CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P877; Yan CH, 2006, MOL CELL BIOL, V26, P6357, DOI 10.1128/MCB.00311-06; Yu L, 2014, NEUROBIOL AGING, V35, P819, DOI 10.1016/j.neurobiolaging.2013.10.074; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030	81	209	212	5	85	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2018	21	6					811	+		10.1038/s41593-018-0154-9	http://dx.doi.org/10.1038/s41593-018-0154-9			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GH2LE	29802388	Green Accepted, Green Submitted			2022-12-17	WOS:000433232600010
J	Cole, MW; Ito, T; Bassett, DS; Schultz, DH				Cole, Michael W.; Ito, Takuya; Bassett, Danielle S.; Schultz, Douglas H.			Activity flow over resting-state networks shapes cognitive task activations	NATURE NEUROSCIENCE			English	Article							HUMAN BRAIN; FUNCTIONAL CONNECTIVITY; INDIVIDUAL-DIFFERENCES; HUMAN CONNECTOME; FMRI; CORTEX; COMMUNICATION; ORGANIZATION; FLUCTUATIONS; ARCHITECTURE	Resting-state functional connectivity (FC) has helped reveal the intrinsic network organization of the human brain, yet its relevance to cognitive task activations has been unclear. Uncertainty remains despite evidence that resting-state FC patterns are highly similar to cognitive task activation patterns. Identifying the distributed processes that shape localized cognitive task activations may help reveal why resting-state FC is so strongly related to cognitive task activations. We found that estimating task-evoked activity flow (the spread of activation amplitudes) over resting-state FC networks allowed prediction of cognitive task activations in a large-scale neural network model. Applying this insight to empirical functional MRI data, we found that cognitive task activations can be predicted in held-out brain regions (and held-out individuals) via estimated activity flow over resting-state FC networks. This suggests that task-evoked activity flow over intrinsic networks is a large-scale mechanism explaining the relevance of resting-state FC to cognitive task activations.	[Cole, Michael W.; Ito, Takuya; Schultz, Douglas H.] Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA; [Bassett, Danielle S.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Bassett, Danielle S.] Univ Penn, Dept Elect & Syst Engn, Philadelphia, PA 19104 USA	Rutgers State University Newark; Rutgers State University New Brunswick; University of Pennsylvania; University of Pennsylvania	Cole, MW (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA.	mwcole@mwcole.net	Schultz, Douglas/AAB-2365-2020; Cole, Michael W/G-1056-2010	Schultz, Douglas/0000-0003-0809-9036; Cole, Michael W/0000-0003-4329-438X	16 NIH Institutes and Centers that support the NIH Blueprint for Neuroscience Research [1U54MH091657]; McDonnell Center for Systems Neuroscience at Washington University; US National Institutes of Health [K99-R00 MH096801]; John D. and Catherine T. MacArthur Foundation; Army Research Laboratory; Army Research Office [W911NF-10-2-0022, W911NF-14-1-0679]; National Institute of Mental Health [2-R01-DC-009209-11]; National Institute of Child Health and Human Development [1R01HD086888-01]; Office of Naval Research; National Science Foundation [BCS-1441502, BCS-1430087, PHY-1554488]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD086888] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R00MH096801, U54MH091657, R21MH106799] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009209] Funding Source: NIH RePORTER	16 NIH Institutes and Centers that support the NIH Blueprint for Neuroscience Research; McDonnell Center for Systems Neuroscience at Washington University; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John D. and Catherine T. MacArthur Foundation; Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); Army Research Office; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Office of Naval Research(Office of Naval Research); National Science Foundation(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank B. Biswal, M. Dixon, T. Braver, S. Petersen and J. Power for helpful conversations during preparation of this manuscript. Data were provided by the Human Connectome Project, WU-Minn Consortium (Principal Investigators: D. Van Essen and K. Ugurbil; 1U54MH091657) funded by the 16 NIH Institutes and Centers that support the NIH Blueprint for Neuroscience Research; and by the McDonnell Center for Systems Neuroscience at Washington University. M.W.C. was supported by the US National Institutes of Health under award K99-R00 MH096801. D.S.B. acknowledges support from the John D. and Catherine T. MacArthur Foundation, the Army Research Laboratory and the Army Research Office through contract numbers W911NF-10-2-0022 and W911NF-14-1-0679, the National Institute of Mental Health (2-R01-DC-009209-11), the National Institute of Child Health and Human Development (1R01HD086888-01), the Office of Naval Research and the National Science Foundation (#BCS-1441502, #BCS-1430087, and #PHY-1554488). The content is solely the responsibility of the authors and does not necessarily represent the official views of any of the funding agencies.	Badre D, 2008, TRENDS COGN SCI, V12, P193, DOI 10.1016/j.tics.2008.02.004; Barch DM, 2013, NEUROIMAGE, V80, P169, DOI 10.1016/j.neuroimage.2013.05.033; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Chein JM, 2005, COGNITIVE BRAIN RES, V25, P607, DOI 10.1016/j.cogbrainres.2005.08.013; Cole MW, 2014, NEURON, V83, P238, DOI 10.1016/j.neuron.2014.05.014; Cole MW, 2013, NAT NEUROSCI, V16, P1348, DOI 10.1038/nn.3470; Cole MW, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00142; Curtis CE, 2003, TRENDS COGN SCI, V7, P415, DOI 10.1016/S1364-6613(03)00197-9; Deco G, 2013, J NEUROSCI, V33, P11239, DOI 10.1523/JNEUROSCI.1091-13.2013; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Duncan J, 2010, TRENDS COGN SCI, V14, P172, DOI 10.1016/j.tics.2010.01.004; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2014, P NATL ACAD SCI USA, V111, pE4367, DOI 10.1073/pnas.1405003111; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Friston KJ, 2011, BRAIN CONNECT, V1, P13, DOI 10.1089/brain.2011.0008; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Galan RF, 2008, J NEUROPHYSIOL, V99, P277, DOI 10.1152/jn.00563.2007; Gu S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9414; Handwerker DA, 2004, NEUROIMAGE, V21, P1639, DOI 10.1016/j.neuroimage.2003.11.029; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Haynes JD, 2015, NEURON, V87, P257, DOI 10.1016/j.neuron.2015.05.025; Heinzle J, 2011, NEUROIMAGE, V56, P1426, DOI 10.1016/j.neuroimage.2011.02.077; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; JESSELL TM, 1993, CELL, V72, P1, DOI 10.1016/S0092-8674(05)80025-X; Kannurpatti SS, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00007; Kanwisher N, 2010, P NATL ACAD SCI USA, V107, P11163, DOI 10.1073/pnas.1005062107; Kiebel SJ, 1999, NEUROIMAGE, V10, P756, DOI 10.1006/nimg.1999.0508; Laughlin SB, 2003, SCIENCE, V301, P1870, DOI 10.1126/science.1089662; Lee JH, 2010, NATURE, V465, P788, DOI 10.1038/nature09108; MANDELBROT B, 1967, SCIENCE, V156, P636, DOI 10.1126/science.156.3775.636; Medaglia JD, 2015, J COGNITIVE NEUROSCI, V27, P1471, DOI 10.1162/jocn_a_00810; Mennes M, 2010, NEUROIMAGE, V50, P1690, DOI 10.1016/j.neuroimage.2010.01.002; Misic B, 2015, NEURON, V86, P1518, DOI 10.1016/j.neuron.2015.05.035; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; Osher DE, 2016, CEREB CORTEX, V26, P1668, DOI 10.1093/cercor/bhu303; Power JD, 2014, NEURON, V84, P681, DOI 10.1016/j.neuron.2014.09.007; Power JD, 2013, CURR OPIN NEUROBIOL, V23, P223, DOI 10.1016/j.conb.2012.12.009; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Ramsey JD, 2010, NEUROIMAGE, V49, P1545, DOI 10.1016/j.neuroimage.2009.08.065; Saxe R, 2006, NEUROIMAGE, V30, P1088, DOI 10.1016/j.neuroimage.2005.12.062; Saygin ZM, 2012, NAT NEUROSCI, V15, P321, DOI 10.1038/nn.3001; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P624, DOI 10.1162/jocn.1997.9.5.624; Siero JCW, 2014, NEUROIMAGE, V101, P177, DOI 10.1016/j.neuroimage.2014.07.002; Smith SM, 2011, NEUROIMAGE, V54, P875, DOI 10.1016/j.neuroimage.2010.08.063; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Smith VA, 2006, PLOS COMPUT BIOL, V2, P1436, DOI 10.1371/journal.pcbi.0020161; Tavor I, 2016, SCIENCE, V352, P216, DOI 10.1126/science.aad8127	50	209	214	8	68	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2016	19	12					1718	1726		10.1038/nn.4406	http://dx.doi.org/10.1038/nn.4406			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	ED7BY	27723746	Green Accepted, Green Submitted			2022-12-17	WOS:000389011900032
J	Brickman, AM; Khan, UA; Provenzano, FA; Yeung, LK; Suzuki, W; Schroeter, H; Wall, M; Sloan, RP; Small, SA				Brickman, Adam M.; Khan, Usman A.; Provenzano, Frank A.; Yeung, Lok-Kin; Suzuki, Wendy; Schroeter, Hagen; Wall, Melanie; Sloan, Richard P.; Small, Scott A.			Enhancing dentate gyrus function with dietary flavanols improves cognition in older adults	NATURE NEUROSCIENCE			English	Article							RECOGNITION MEMORY; SPATIAL MEMORY; VISUAL-CORTEX; BLOOD-FLOW; BRAIN; HIPPOCAMPUS; AGE; DECLINE; DISEASE; NEUROGENESIS	The dentate gyrus (DG) is a region in the hippocampal formation whose function declines in association with human aging and is therefore considered to be a possible source of age-related memory decline. Causal evidence is needed, however, to show that DG-associated memory decline in otherwise healthy elders can be improved by interventions that enhance DG function. We addressed this issue by first using a high-resolution variant of functional magnetic resonance imaging (fMRI) to map the precise site of age-related DG dysfunction and to develop a cognitive task whose function localized to this anatomical site. Then, in a controlled randomized trial, we applied these tools to study healthy 50-69-year-old subjects who consumed either a high or low cocoa flavanol containing diet for 3 months. A high-flavanol intervention was found to enhance DG function, as measured by fMRI and by cognitive testing. Our findings establish that DG dysfunction is a driver of age-related cognitive decline and suggest non-pharmacological means for its amelioration.	[Brickman, Adam M.; Khan, Usman A.; Provenzano, Frank A.; Yeung, Lok-Kin; Small, Scott A.] Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10027 USA; [Brickman, Adam M.; Khan, Usman A.; Provenzano, Frank A.; Yeung, Lok-Kin; Small, Scott A.] Columbia Univ, Dept Neurol, New York, NY USA; [Suzuki, Wendy] NYU, Ctr Neurol Sci, New York, NY USA; [Schroeter, Hagen] MARS Inc, Mclean, VA USA; [Wall, Melanie; Sloan, Richard P.; Small, Scott A.] Columbia Univ, Dept Psychiat, New York, NY USA; [Wall, Melanie; Sloan, Richard P.] New York State Psychiat Inst & Hosp, New York, NY 10032 USA; [Small, Scott A.] Columbia Univ, Dept Radiol, New York, NY USA	Columbia University; Columbia University; New York University; Mars; Columbia University; New York State Psychiatry Institute; Columbia University	Small, SA (corresponding author), Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10027 USA.	sas68@columbia.edu	Wall, Melanie/AAE-7828-2019	Schroeter, Hagen/0000-0001-6569-382X; Yeung, Lok-Kin/0000-0002-6687-0282	US National Institutes of Health [AG034618, AG035015, AG025161, AG08702]; James S. McDonnell Foundation; MARS, Inc.; NATIONAL INSTITUTE ON AGING [P50AG008702, R01AG034618, R01AG035015, R01AG025161] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James S. McDonnell Foundation; MARS, Inc.; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank F. Gage for previous discussions and A. Glass for helping with the statistical analysis. This investigation was supported by US National Institutes of Health grants AG034618, AG035015, AG025161 and AG08702, the James S. McDonnell Foundation, and an unrestricted grant by MARS, Inc.	Anastasi A., 1997, PSYCHOL TESTING, V7th; Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004; BELLIVEAU JW, 1991, SCIENCE, V254, P716, DOI 10.1126/science.1948051; BOROWSKY IW, 1989, J COMP NEUROL, V288, P401, DOI 10.1002/cne.902880304; Brickman AM, 2011, HIPPOCAMPUS, V21, P923, DOI 10.1002/hipo.20840; Broadbent NJ, 2004, P NATL ACAD SCI USA, V101, P14515, DOI 10.1073/pnas.0406344101; Erickson CA, 2003, EXP GERONTOL, V38, P61, DOI 10.1016/S0531-5565(02)00160-2; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Fonta C, 2002, CEREB CORTEX, V12, P199, DOI 10.1093/cercor/12.2.199; Gazzaley A, 2005, NAT NEUROSCI, V8, P1298, DOI 10.1038/nn1543; GRADY CL, 1995, SCIENCE, V269, P218, DOI 10.1126/science.7618082; Hara Y, 2012, J NEUROSCI, V32, P7336, DOI 10.1523/JNEUROSCI.0605-12.2012; Jessberger S, 2009, LEARN MEMORY, V16, P147, DOI 10.1101/lm.1172609; Khan UA, 2014, NAT NEUROSCI, V17, P304, DOI 10.1038/nn.3606; Lin WL, 1999, JMRI-J MAGN RESON IM, V9, P44, DOI 10.1002/(SICI)1522-2586(199901)9:1<44::AID-JMRI6>3.0.CO;2-7; Moreno H, 2007, ARCH NEUROL-CHICAGO, V64, P1467, DOI 10.1001/archneur.64.10.1467; Morrison JH, 2012, NAT REV NEUROSCI, V13, P240, DOI 10.1038/nrn3200; MOSS MB, 1988, NEUROBIOL AGING, V9, P495, DOI 10.1016/S0197-4580(88)80103-9; New York State Psychiatric Institute & Mars Inc, 2014, MARS FLAV EX COGN FU; Pavlopoulos E, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006373; Pereira AC, 2007, P NATL ACAD SCI USA, V104, P5638, DOI 10.1073/pnas.0611721104; SCHACTER DL, 1992, PSYCHOL AGING, V7, P299, DOI 10.1037//0882-7974.7.2.299; Schroeter H, 2006, P NATL ACAD SCI USA, V103, P1024, DOI 10.1073/pnas.0510168103; Small SA, 2004, P NATL ACAD SCI USA, V101, P7181, DOI 10.1073/pnas.0400285101; Small SA, 2002, ANN NEUROL, V51, P290, DOI 10.1002/ana.10105; Small SA, 1999, NEUROLOGY, V52, P1392, DOI 10.1212/WNL.52.7.1392; Small SA, 2011, NAT REV NEUROSCI, V12, P585, DOI 10.1038/nrn3085; Sorond FA, 2010, J ULTRAS MED, V29, P1017, DOI 10.7863/jum.2010.29.7.1017; Strauss E, 2006, COMPENDIUM NEUROPSYC; Van Leemput K, 2009, HIPPOCAMPUS, V19, P549, DOI 10.1002/hipo.20615; van Praag H, 2007, J NEUROSCI, V27, P5869, DOI 10.1523/JNEUROSCI.0914-07.2007; Villeda SA, 2014, NAT MED, V20, P659, DOI 10.1038/nm.3569; VOLPE JJ, 1983, PEDIATRICS, V72, P589; Wu W, 2008, ANN NEUROL, V64, P698, DOI 10.1002/ana.21557; Yassa MA, 2011, TRENDS NEUROSCI, V34, P515, DOI 10.1016/j.tins.2011.06.006; Yassa MA, 2011, P NATL ACAD SCI USA, V108, P8873, DOI 10.1073/pnas.1101567108	36	209	216	1	103	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2014	17	12					1798	1803		10.1038/nn.3850	http://dx.doi.org/10.1038/nn.3850			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AU2ZY	25344629	Green Accepted			2022-12-17	WOS:000345484000029
J	Bellocchio, L; Lafenetre, P; Cannich, A; Cota, D; Puente, N; Grandes, P; Chaouloff, F; Piazza, PV; Marsicano, G				Bellocchio, Luigi; Lafenetre, Pauline; Cannich, Astrid; Cota, Daniela; Puente, Nagore; Grandes, Pedro; Chaouloff, Francis; Piazza, Pier Vincenzo; Marsicano, Giovanni			Bimodal control of stimulated food intake by the endocannabinoid system	NATURE NEUROSCIENCE			English	Article							ENERGY; INTEGRATION; NEURONS	Activation of cannabinoid type-1 receptors (CB1) is universally recognized as a powerful endogenous orexigenic signal, but the detailed underlying neuronal mechanisms are not fully understood. Using combined genetic and pharmacological approaches in mice, we found that ventral striatal CB1 receptors exerted a hypophagic action through inhibition of GABAergic transmission. Conversely, brain CB1 receptors modulating excitatory transmission mediated the well-known orexigenic effects of cannabinoids.	[Bellocchio, Luigi; Lafenetre, Pauline; Cannich, Astrid; Chaouloff, Francis; Marsicano, Giovanni] INSERM, U862, NeuroCtr Magendie Endocannabinoids & Neuroadaptat, Bordeaux, France; [Bellocchio, Luigi; Lafenetre, Pauline; Cannich, Astrid; Cota, Daniela; Chaouloff, Francis; Piazza, Pier Vincenzo; Marsicano, Giovanni] Univ Bordeaux, Bordeaux, France; [Cota, Daniela] INSERM, U862, NeuroCtr Magendie Energy Balance & Obes, Bordeaux, France; [Puente, Nagore] Univ Basque Country, Dept Neurosci, Fac Med & Dent, Leioia, Spain; [Piazza, Pier Vincenzo] INSERM, U862, NeuroCtr Magendie, Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; University of Basque Country; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Marsicano, G (corresponding author), INSERM, U862, NeuroCtr Magendie Endocannabinoids & Neuroadaptat, Bordeaux, France.	giovanni.marsicano@inserm.fr	Chaouloff, Francis/N-7003-2017; Grandes, Pedro/H-7494-2015; Grandes, Pedro/AAA-1627-2019; Puente, Nagore/H-7054-2015	Chaouloff, Francis/0000-0001-9036-4067; Grandes, Pedro/0000-0003-3947-4230; Puente, Nagore/0000-0003-0866-5747; Marsicano, Giovanni/0000-0003-3804-1951; Cota, Daniela/0000-0002-6909-2156	AVENIR/INSERMFondation Bettencourt-Schueller; Agence National de la Recherche [ANR-06-NEURO-043-01]; European Foundation; European Union [HEALTH-F2-2008-223713]; European Commission Network of European Neuroscience Institutes (ENINET) [LSHM-CT-2005-19063]; Basque Country Government [GIC07/70-IT-432-07]; Red de Trastornos Adictivos; Instituto de Salud Carlos III; Ministerio de Ciencia e Innovacion; Gobierno de Espana [RD07/0001/2001]; Basque Country University	AVENIR/INSERMFondation Bettencourt-Schueller(Institut National de la Sante et de la Recherche Medicale (Inserm)); Agence National de la Recherche(French National Research Agency (ANR)); European Foundation(European Science Foundation (ESF)); European Union(European Commission); European Commission Network of European Neuroscience Institutes (ENINET); Basque Country Government(Basque Government); Red de Trastornos Adictivos(Instituto de Salud Carlos III); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Gobierno de Espana(Spanish Government); Basque Country University	We thank F. George, P. Ciofi, V. Deroche-Gamonet and O. Moustie for help, D. Gonzales and the Genotyping Platform of the NeuroCentre Magendie for mouse genotyping, S. K. Nave, J. Rubenstein, M. Ekker, G. Schutz, T. Lemberger for providing Cre-expressing mice, and C. T. Wotjak, U. Pagotto, K. Monory, J. Lourenco, M. Vallee, B. Lutz and all the members of the Marsicano laboratory for valuable suggestions. This work was supported by AVENIR/INSERM and Fondation Bettencourt-Schueller (G. M.), Agence National de la Recherche (ANR-06-NEURO-043-01 to G. M.), the European Foundation for the Study of Diabetes (G. M.), European Union Seventh Framework Program (REPROBESITY, HEALTH-F2-2008-223713 to G. M.), European Commission Network of European Neuroscience Institutes (ENINET) (LSHM-CT-2005-19063 to G. M.), the Basque Country Government (GIC07/70-IT-432-07 to P. G.), Red de Trastornos Adictivos, Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion, Gobierno de Espana (RD07/0001/2001 to P. G.) and Basque Country University (N.P.).	Goebbels S, 2006, GENESIS, V44, P611, DOI 10.1002/dvg.20256; Hudson BD, 2010, MOL PHARMACOL, V77, P1, DOI 10.1124/mol.109.060251; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Kelley AE, 2005, PHYSIOL BEHAV, V86, P773, DOI 10.1016/j.physbeh.2005.08.066; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; Marsicano Giovanni, 2008, P161, DOI 10.1007/978-0-387-74349-3_10; Matias I, 2007, TRENDS ENDOCRIN MET, V18, P27, DOI 10.1016/j.tem.2006.11.006; Meena H, 2009, LIFE SCI, V84, P156, DOI 10.1016/j.lfs.2008.11.013; Monory K, 2006, NEURON, V51, P455, DOI 10.1016/j.neuron.2006.07.006; Monory K, 2007, PLOS BIOL, V5, P2354, DOI 10.1371/journal.pbio.0050269; Pagotto U, 2006, ENDOCR REV, V27, P73, DOI 10.1210/er.2005-0009; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Shin AC, 2009, PHYSIOL BEHAV, V97, P572, DOI 10.1016/j.physbeh.2009.02.010; Wiley JL, 2005, BRIT J PHARMACOL, V145, P293, DOI 10.1038/sj.bjp.0706157; Yee CL, 2009, J COMP NEUROL, V517, P37, DOI 10.1002/cne.22132	15	209	216	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2010	13	3					281	283		10.1038/nn.2494	http://dx.doi.org/10.1038/nn.2494			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	559WW	20139974	Green Published			2022-12-17	WOS:000274860100007
J	Liu, YB; Shi, J; Lu, CC; Wang, ZB; Lyuksyutova, AI; Song, XJ; Zou, YM				Liu, YB; Shi, J; Lu, CC; Wang, ZB; Lyuksyutova, AI; Song, XJ; Zou, YM			Ryk-mediated Wnt repulsion regulates posterior-directed growth of corticospinal tract	NATURE NEUROSCIENCE			English	Article							RECEPTOR TYROSINE KINASE; AXON GUIDANCE; MOLECULE; L1	Guidance cues along the longitudinal axis of the CNS are poorly understood. Wnt proteins attract ascending somatosensory axons to project from the spinal cord to the brain. Here we show that Wnt proteins repel corticospinal tract (CST) axons in the opposite direction. Several Wnt genes were found to be expressed in the mouse spinal cord gray matter, cupping the dorsal funiculus, in an anterior-to-posterior decreasing gradient along the cervical and thoracic cord. Wnts repelled CST axons in collagen gel assays through a conserved high-affinity receptor, Ryk, which is expressed in CST axons. Neonatal spinal cord secretes diffusible repellent(s) in an anterior-posterior graded fashion, with anterior cord being stronger, and the repulsive activity was blocked by antibodies to Ryk (anti-Ryk). Intrathecal injection of anti-Ryk blocked the posterior growth of CST axons. Therefore, Wnt proteins may have a general role in anterior-posterior guidance of multiple classes of axons.	Univ Chicago, Dept Neurol Pharmacol & Physiol, Chicago, IL 60637 USA; Univ Chicago, Comm Dev Biol, Chicago, IL 60637 USA; Univ Chicago, Comm Neurobiol, Chicago, IL 60637 USA; Parker Coll Res Inst, Dallas, TX 75229 USA	University of Chicago; University of Chicago; University of Chicago	Zou, YM (corresponding author), Univ Chicago, Dept Neurol Pharmacol & Physiol, Chicago, IL 60637 USA.	yzou@bsd.uchicago.edu	Liu, Yaobo/AFS-0502-2022; shi, jun/C-2389-2011	Liu, Yaobo/0000-0002-7663-5649; 	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047484] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS047484] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Castellani V, 2000, NEURON, V27, P237, DOI 10.1016/S0896-6273(00)00033-7; CHENG HJ, 1994, CELL, V79, P157, DOI 10.1016/0092-8674(94)90408-1; Cohen NR, 1998, CURR BIOL, V8, P26, DOI 10.1016/S0960-9822(98)70017-X; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Dottori M, 1998, P NATL ACAD SCI USA, V95, P13248, DOI 10.1073/pnas.95.22.13248; FROHMAN MA, 1990, DEVELOPMENT, V110, P589; Gianino S, 1999, DEV BRAIN RES, V112, P189, DOI 10.1016/S0165-3806(98)00168-0; Halford MM, 2000, NAT GENET, V25, P414, DOI 10.1038/78099; HOVENS CM, 1992, P NATL ACAD SCI USA, V89, P11818, DOI 10.1073/pnas.89.24.11818; Joosten EAJ, 1996, DEV BRAIN RES, V94, P99, DOI 10.1016/0165-3806(96)00017-X; Lu WG, 2004, CELL, V119, P97, DOI 10.1016/j.cell.2004.09.019; Lyuksyutova AI, 2003, SCIENCE, V302, P1984, DOI 10.1126/science.1089610; Paxinos G, 1995, RAT NERVOUS SYSTEM; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; Yoshikawa S, 2003, NATURE, V422, P583, DOI 10.1038/nature01522; Zoo YM, 2000, CELL, V102, P363, DOI 10.1016/S0092-8674(00)00041-6	17	209	219	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2005	8	9					1151	1159		10.1038/nn1520	http://dx.doi.org/10.1038/nn1520			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	958YJ	16116452				2022-12-17	WOS:000231483800014
J	Deboer, T; Vansteensel, MJ; Detari, L; Meijer, JH				Deboer, T; Vansteensel, MJ; Detari, L; Meijer, JH			Sleep states alter activity of suprachiasmatic nucleus neurons	NATURE NEUROSCIENCE			English	Article							EEG POWER SPECTRA; SLOW-WAVE SLEEP; CIRCADIAN PACEMAKER; CORTICAL TEMPERATURE; DJUNGARIAN HAMSTER; LESIONED RATS; DEPRIVATION; PERIOD; BRAIN; HOMEOSTASIS	The timing of sleep and wakefulness in mammals is governed by a sleep homeostatic process and by the circadian clock of the suprachiasmatic nucleus (SCN), which has a molecular basis for rhythm generation. By combining SCN electrical activity recordings with electroencephalogram (EEG) recordings in the same animal (the Wistar rat), we discovered that changes in vigilance states are paralleled by strong changes in SCN electrophysiological activity. During rapid eye movement (REM) sleep, neuronal activity in the SCN was elevated, and during non-REM (NREM) sleep, it was lowered. We also carried out selective sleep deprivation experiments to confirm that changes in SCN electrical activity are caused by changes in vigilance state. Our results indicate that the 24-hour pattern in electrical activity that is controlled by the molecular machinery of the SCN is substantially modified by afferent information from the central nervous system.	Leiden Univ, Med Ctr, Dept Neurophysiol, NL-2300 RC Leiden, Netherlands; Eotvos Lorand Univ, Dept Physiol & Neurobiol, H-1088 Budapest, Hungary	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Eotvos Lorand University	Meijer, JH (corresponding author), Leiden Univ, Med Ctr, Dept Neurophysiol, Box 9604, NL-2300 RC Leiden, Netherlands.	j.h.meijer@lumc.nl	Vansteensel, Mariska/K-8015-2019	Vansteensel, Mariska/0000-0002-9252-5116				ACHERMANN P, 1994, BIOL CYBERN, V71, P115, DOI 10.1007/BF00197314; Albus H, 2002, CURR BIOL, V12, P1130, DOI 10.1016/S0960-9822(02)00923-5; Antle MC, 2000, J NEUROSCI, V20, P9326; BENINGTON JH, 1994, AM J PHYSIOL, V266, pR1992, DOI 10.1152/ajpregu.1994.266.6.R1992; BENINGTON JH, PROG NEUROBIOL, V45, P347; BINA KG, 1993, J COMP NEUROL, V335, P295, DOI 10.1002/cne.903350212; Borbely A. A., 2000, PRINCIPLES PRACTICE, P377; BORBELY AA, 1984, BEHAV BRAIN RES, V14, P171, DOI 10.1016/0166-4328(84)90186-4; CAMPBELL SS, 1989, PSYCHOPHYSIOLOGY, V26, P580, DOI 10.1111/j.1469-8986.1989.tb00714.x; CRICK F, 1983, NATURE, V304, P111, DOI 10.1038/304111a0; DAAN S, 1984, AM J PHYSIOL, V246, pR161, DOI 10.1152/ajpregu.1984.246.2.R161; Deboer T, 2003, SLEEP, V26, P567, DOI 10.1093/sleep/26.5.567; DEBOER T, 1994, J COMP PHYSIOL A, V174, P145; DEBOER T, 1997, PFLUGERS ARCH, V433, P23; DIJK D J, 1987, Journal of Biological Rhythms, V2, P207, DOI 10.1177/074873048700200304; DIJK DJ, 1995, J NEUROSCI, V15, P3526; DIJK DJ, 1995, BEHAV BRAIN RES, V69, P109, DOI 10.1016/0166-4328(95)00007-G; DIJK DJ, 1987, EUR ARCH PSY CLIN N, V236, P323; DIJK DJ, 1989, AM J PHYSIOL, V156, pR106; EDGAR DM, 1993, J NEUROSCI, V13, P1065; Endo T, 1997, PSYCHIAT RES, V66, P97, DOI 10.1016/S0165-1781(96)03029-6; FRANKEN P, 1991, AM J PHYSIOL, V261, pR198, DOI 10.1152/ajpregu.1991.261.1.R198; Herzog ED, 1998, NAT NEUROSCI, V1, P708, DOI 10.1038/3708; Huber R, 2000, BRAIN RES, V857, P8, DOI 10.1016/S0006-8993(99)02248-9; Jouvet M, 1998, J SLEEP RES, V7, P1, DOI 10.1046/j.1365-2869.7.s1.1.x; King DP, 2000, ANNU REV NEUROSCI, V23, P713, DOI 10.1146/annurev.neuro.23.1.713; KRUEGER JM, 1993, J SLEEP RES, V2, P63, DOI 10.1111/j.1365-2869.1993.tb00064.x; LANCEL M, 1991, BRAIN RES, V548, P206, DOI 10.1016/0006-8993(91)91123-I; Liu C, 1997, CELL, V91, P855, DOI 10.1016/S0092-8674(00)80473-0; MCCARLEY RW, 1992, J SLEEP RES, V1, P132, DOI 10.1111/j.1365-2869.1992.tb00026.x; Meijer JH, 1997, BRAIN RES, V753, P322, DOI 10.1016/S0006-8993(97)00150-9; Meijer JH, 1998, J NEUROSCI, V18, P9078; MISTLBERGER RE, 1983, SLEEP, V6, P217, DOI 10.1093/sleep/6.3.217; Moore, 2001, HDB BEHAV NEUROBIOLO, V12; MOORE RY, 1978, J COMP NEUROL, V180, P417, DOI 10.1002/cne.901800302; MOSES JM, 1975, PSYCHOPHYSIOLOGY, V12, P141, DOI 10.1111/j.1469-8986.1975.tb01264.x; Nakamura W, 2002, NAT NEUROSCI, V5, P399, DOI 10.1038/nn843; Palchykova S, 2002, J SLEEP RES, V11, P313, DOI 10.1046/j.1365-2869.2002.00310.x; SCHWARTZ WJ, 1987, P NATL ACAD SCI USA, V84, P1694, DOI 10.1073/pnas.84.6.1694; Stickgold R, 2001, SCIENCE, V294, P1052, DOI 10.1126/science.1063530; Strijkstra AM, 1998, AM J PHYSIOL-REG I, V275, pR1110, DOI 10.1152/ajpregu.1998.275.4.R1110; TOBLER I, 1986, ELECTROEN CLIN NEURO, V64, P74, DOI 10.1016/0013-4694(86)90044-1; TOBLER I, 1983, NEUROSCI LETT, V42, P49, DOI 10.1016/0304-3940(83)90420-2; TRACHSEL L, 1992, BRAIN RES, V589, P253, DOI 10.1016/0006-8993(92)91284-L; Wisorl JP, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-20	45	209	215	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2003	6	10					1086	1090		10.1038/nn1122	http://dx.doi.org/10.1038/nn1122			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	727AK	12958601				2022-12-17	WOS:000185633600021
J	Meier, J; Vannier, C; Serge, A; Triller, A; Choquet, D				Meier, J; Vannier, C; Serge, A; Triller, A; Choquet, D			Fast and reversible trapping of surface glycine receptors by gephyrin	NATURE NEUROSCIENCE			English	Article							SINGLE-PARTICLE TRACKING; LONG-TERM DEPRESSION; SPINAL NEURONS; NEUROMUSCULAR-JUNCTION; LATERAL DIFFUSION; GABA(A) RECEPTORS; AMPA RECEPTORS; BETA SUBUNIT; SYNAPSES; MEMBRANE	Variations in receptor number at a given synapse are known to contribute to synaptic plasticity, but methods used to establish this idea usually do not allow for the determination of the dynamics of these phenomena. We used single-particle tracking to follow in real time, on the cell surface, movements of the glycine receptor (GlyR) with or without the GlyR stabilizing protein gephyrin. GlyR alternated within seconds between diffusive and confined states. In the absence of gephyrin, GlyR were mostly freely diffusing. Gephyrin induced long confinement periods spatially associated with submembranous clusters of gephyrin. However, even when most receptors were stabilized, they still frequently made transitions through the diffusive state. These data show that receptor number in a cluster results from a dynamic equilibrium between the pools of stabilized and freely mobile receptors. Modification of this equilibrium could be involved in regulation of the number of receptors at synapses.	CNRS, Inst Francois Magendie, UMR 5091, F-33077 Bordeaux, France; Ecole Normale Super, INSERM, U497, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Choquet, D (corresponding author), CNRS, Inst Francois Magendie, UMR 5091, Rue Camille St Saens, F-33077 Bordeaux, France.	dchoquet@u-bordeaux2.fr	Choquet, Daniel/K-7893-2018; Choquet, Daniel/E-4203-2013; Sergé, Arnauld/N-4828-2019; Choquet, Daniel/GOJ-8825-2022; Serge, Aho Glele Ludwig/AAP-8863-2021; Serge, Arnauld/AAP-1525-2020	Choquet, Daniel/0000-0003-4726-9763; Sergé, Arnauld/0000-0003-4271-3706; Choquet, Daniel/0000-0003-4726-9763; Serge, Aho Glele Ludwig/0000-0001-7590-8644; Serge, Arnauld/0000-0002-1280-6277; Meier, Jochen/0000-0001-5574-3336; TRILLER, Antoine/0000-0002-7530-1233				Akaaboune M, 1999, SCIENCE, V286, P503, DOI 10.1126/science.286.5439.503; Bechade C, 1996, EUR J NEUROSCI, V8, P429, DOI 10.1111/j.1460-9568.1996.tb01226.x; BETZ H, 1992, Q REV BIOPHYS, V25, P381, DOI 10.1017/S0033583500004340; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; CHARPIER S, 1995, P NATL ACAD SCI USA, V92, P117, DOI 10.1073/pnas.92.1.117; Choquet D, 1997, CELL, V88, P39, DOI 10.1016/S0092-8674(00)81856-5; Colin I, 1996, J COMP NEUROL, V374, P467, DOI 10.1002/(SICI)1096-9861(19961021)374:3<467::AID-CNE10>3.0.CO;2-S; Colin I, 1998, J COMP NEUROL, V398, P359; CRAIG AM, 1994, P NATL ACAD SCI USA, V91, P12373, DOI 10.1073/pnas.91.26.12373; Dumoulin A, 2000, EUR J NEUROSCI, V12, P3883, DOI 10.1046/j.1460-9568.2000.00271.x; Essrich C, 1998, NAT NEUROSCI, V1, P563, DOI 10.1038/2798; Felsenfeld DP, 1996, NATURE, V383, P438, DOI 10.1038/383438a0; FROEHNER SC, 1993, ANNU REV NEUROSCI, V16, P347, DOI 10.1146/annurev.ne.16.030193.002023; GRENNINGLOH G, 1990, NEURON, V4, P963, DOI 10.1016/0896-6273(90)90149-A; GRENNINGLOH G, 1987, NATURE, V328, P215, DOI 10.1038/328215a0; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Kirsch J, 1998, NATURE, V392, P717, DOI 10.1038/33694; KIRSCH J, 1993, NATURE, V366, P745, DOI 10.1038/366745a0; KIRSCH J, 1995, J NEUROSCI, V15, P4148; Kneussel M, 1999, J NEUROSCI, V19, P9289, DOI 10.1523/jneurosci.19-21-09289.1999; Krisch J, 1999, CURR OPIN NEUROBIOL, V9, P329, DOI 10.1016/S0959-4388(99)80048-8; Kucik DF, 1999, BIOPHYS J, V76, P314, DOI 10.1016/S0006-3495(99)77198-5; KUROMI H, 1985, DEV BIOL, V109, P165, DOI 10.1016/0012-1606(85)90357-4; KUSUMI A, 1993, BIOPHYS J, V65, P2021, DOI 10.1016/S0006-3495(93)81253-0; Levi S, 1998, J CELL SCI, V111, P335; Levi S, 1999, J NEUROSCI, V19, P7434, DOI 10.1523/JNEUROSCI.19-17-07434.1999; Luthi A, 1999, NEURON, V24, P389, DOI 10.1016/S0896-6273(00)80852-1; Meier J, 2000, J CELL SCI, V113, P2783; MeunierDurmort C, 1997, GENE THER, V4, P808, DOI 10.1038/sj.gt.3300450; MEYER G, 1995, NEURON, V15, P563, DOI 10.1016/0896-6273(95)90145-0; Morishita W, 1996, J NEUROPHYSIOL, V76, P59, DOI 10.1152/jn.1996.76.1.59; Nusser Z, 1998, NATURE, V395, P172, DOI 10.1038/25999; ODA Y, 1995, J NEUROPHYSIOL, V74, P1056, DOI 10.1152/jn.1995.74.3.1056; Qian H, 1991, BIOPHYS J, V60, P910, DOI 10.1016/S0006-3495(91)82125-7; SAFFMAN PG, 1976, J FLUID MECH, V73, P593, DOI 10.1017/S0022112076001511; SAKO Y, 1994, J CELL BIOL, V125, P1251, DOI 10.1083/jcb.125.6.1251; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; SAXTON MJ, 1993, BIOPHYS J, V64, P1766, DOI 10.1016/S0006-3495(93)81548-0; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; Scannevin RH, 2000, NAT REV NEUROSCI, V1, P133, DOI 10.1038/35039075; SIMSON R, 1995, BIOPHYS J, V69, P989, DOI 10.1016/S0006-3495(95)79972-6; SONTHEIMER H, 1989, NEURON, V2, P1491, DOI 10.1016/0896-6273(89)90195-5; TODD AJ, 1990, NEUROSCIENCE, V39, P387, DOI 10.1016/0306-4522(90)90275-9; TRILLER A, 1985, J CELL BIOL, V101, P683, DOI 10.1083/jcb.101.2.683; Turrigiano GG, 2000, NEURON, V26, P5, DOI 10.1016/S0896-6273(00)81131-9; Vannier C, 1997, INT REV CYTOL, V176, P201, DOI 10.1016/S0074-7696(08)61611-3; Ziff EB, 1997, NEURON, V19, P1163, DOI 10.1016/S0896-6273(00)80409-2	47	209	215	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2001	4	3					253	260		10.1038/85099	http://dx.doi.org/10.1038/85099			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UE	11224541				2022-12-17	WOS:000167178300012
J	Huang, KL; Marcora, E; Pimenova, AA; Di Narzo, AF; Kapoor, M; Jin, SC; Harari, O; Bertelsen, S; Fairfax, BP; Czajkowski, J; Chouraki, V; Grenier-Boley, B; Bellenguez, C; Deming, Y; McKenzie, A; Raj, T; Renton, AE; Budde, J; Smith, A; Fitzpatrick, A; Bis, JC; DeStefano, A; Adams, HHH; Ikram, MA; van der Lee, S; Del-Aguila, JL; Fernandez, MV; Ibanez, L; Sims, R; Escott-Price, V; Mayeux, R; Haines, JL; Farrer, LA; Pericak-Vance, MA; Lambert, JC; van Duijn, C; Launer, L; Seshadri, S; Williams, J; Amouyel, P; Schellenberg, GD; Zhang, B; Borecki, I; Kauwe, JSK; Cruchaga, C; Hao, K; Goate, AM				Huang, Kuan-lin; Marcora, Edoardo; Pimenova, Anna A.; Di Narzo, Antonio F.; Kapoor, Manav; Jin, Sheng Chih; Harari, Oscar; Bertelsen, Sarah; Fairfax, Benjamin P.; Czajkowski, Jake; Chouraki, Vincent; Grenier-Boley, Benjamin; Bellenguez, Celine; Deming, Yuetiva; McKenzie, Andrew; Raj, Towfique; Renton, Alan E.; Budde, John; Smith, Albert; Fitzpatrick, Annette; Bis, Joshua C.; DeStefano, Anita; Adams, Hieab H. H.; Ikram, M. Arfan; van der Lee, Sven; Del-Aguila, Jorge L.; Fernandez, Maria Victoria; Ibanez, Laura; Sims, Rebecca; Escott-Price, Valentina; Mayeux, Richard; Haines, Jonathan L.; Farrer, Lindsay A.; Pericak-Vance, Margaret A.; Lambert, Jean Charles; van Duijn, Cornelia; Launer, Lenore; Seshadri, Sudha; Williams, Julie; Amouyel, Philippe; Schellenberg, Gerard D.; Zhang, Bin; Borecki, Ingrid; Kauwe, John S. K.; Cruchaga, Carlos; Hao, Ke; Goate, Alison M.		Int Genomics Alzheimer's Project; Alzheimer's Dis Neuroimaging	A common haplotype lowers PU.1 expression in myeloid cells and delays onset of Alzheimer's disease	NATURE NEUROSCIENCE			English	Article							GENOME-WIDE ASSOCIATION; CEREBROSPINAL-FLUID; TRANSCRIPTION FACTORS; REGRESSION-MODELS; LIFETIME RISK; GENETIC-LOCI; FRAMINGHAM; VARIANTS; DEMENTIA; DESIGN	A genome-wide survival analysis of 14,406 Alzheimer's disease (AD) cases and 25,849 controls identified eight previously reported AD risk loci and 14 novel loci associated with age at onset. Linkage disequilibrium score regression of 220 cell types implicated the regulation of myeloid gene expression in AD risk. The minor allele of rs1057233 (G), within the previously reported CELF1 AD risk locus, showed association with delayed AD onset and lower expression of SPI1 in monocytes and macrophages. SPI1 encodes PU.1, a transcription factor critical for myeloid cell development and function. AD heritability was enriched within the PU.1 cistrome, implicating a myeloid PU.1 target gene network in AD. Finally, experimentally altered PU.1 levels affected the expression of mouse orthologs of many AD risk genes and the phagocytic activity of mouse microglial cells. Our results suggest that lower SPI1 expression reduces AD risk by regulating myeloid gene expression and cell function.	[Huang, Kuan-lin; Di Narzo, Antonio F.] Washington Univ, Dept Med, St Louis, MO USA; [Huang, Kuan-lin; Di Narzo, Antonio F.] Washington Univ, McDonnell Genome Inst, St Louis, MO USA; [Marcora, Edoardo; Kapoor, Manav; McKenzie, Andrew; Raj, Towfique; Zhang, Bin; Hao, Ke; Goate, Alison M.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Marcora, Edoardo; Pimenova, Anna A.; Kapoor, Manav; Bertelsen, Sarah; Raj, Towfique; Renton, Alan E.; Goate, Alison M.] Icahn Sch Med Mt Sinai, Dept Neurosci, Ronald M Loeb Ctr Alzheimers Dis, New York, NY 10029 USA; [Jin, Sheng Chih] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Harari, Oscar; Deming, Yuetiva; Budde, John; Del-Aguila, Jorge L.; Fernandez, Maria Victoria; Ibanez, Laura; Cruchaga, Carlos] Washington Univ, Dept Psychol, St Louis, MO 63130 USA; [Fairfax, Benjamin P.] Univ Oxford, Nuffield Dept Med, Wellcome Trust Ctr Human Genet, Oxford, England; [Czajkowski, Jake; Borecki, Ingrid] Washington Univ, Dept Genet, St Louis, MO 63110 USA; [Chouraki, Vincent; Seshadri, Sudha] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Grenier-Boley, Benjamin; Bellenguez, Celine; Lambert, Jean Charles; Amouyel, Philippe] INSERM, U1167, RID AGE Risk Factors & Mol Determinants Aging Rel, Lille, France; [Grenier-Boley, Benjamin; Bellenguez, Celine; Lambert, Jean Charles; Amouyel, Philippe] Univ Lille, Excellence Lab Labex DISTALZ, Lille, France; [Grenier-Boley, Benjamin; Bellenguez, Celine; Lambert, Jean Charles; Amouyel, Philippe] Inst Pasteur, Lille, France; [Smith, Albert] Univ Iceland, Iceland Heart Assoc, Fac Med, Reykjavik, Iceland; [Fitzpatrick, Annette] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Bis, Joshua C.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [DeStefano, Anita; Farrer, Lindsay A.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02215 USA; [Adams, Hieab H. H.; Ikram, M. Arfan; van der Lee, Sven; van Duijn, Cornelia] Erasmus Univ, Med Ctr, Dept Epidemiol, Rotterdam, Netherlands; [Sims, Rebecca; Escott-Price, Valentina; Williams, Julie] Cardiff Univ, MRC, Ctr Neuropsychiat Genet & Genom, Psychol Med & Clin Neurosci, Cardiff, S Glam, Wales; [Mayeux, Richard] Columbia Univ, Case Western H Sergievsky Ctr, Taub Inst Alzheimers Dis & Aging Brain, New York, NY USA; [Mayeux, Richard] Columbia Univ, Dept Neurol, New York, NY 10027 USA; [Haines, Jonathan L.] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Farrer, Lindsay A.] Boston Univ, Sch Med, Dept Ophthalmol, Boston, MA 02118 USA; [Farrer, Lindsay A.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02215 USA; [Farrer, Lindsay A.; Pericak-Vance, Margaret A.] Univ Miami, John P Hussman Inst Human Gen, Miami, FL USA; [Pericak-Vance, Margaret A.] Univ Miami, Macdonald Fdn, Dept Human Genet, Miami, FL USA; [Launer, Lenore] Natl Inst Aging, Lab Epidemiol Populat Sci, Bethesda, MD USA; [Amouyel, Philippe] CHU Lille, U1167, Lille, France; [Schellenberg, Gerard D.] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Kauwe, John S. K.] Brigham Young Univ, Dept Biol, Provo, UT 84602 USA	Washington University (WUSTL); Washington University (WUSTL); Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Yale University; Washington University (WUSTL); University of Oxford; Wellcome Centre for Human Genetics; Washington University (WUSTL); Boston University; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Icelandic Heart Association; University of Iceland; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Boston University; Erasmus University Rotterdam; Erasmus MC; Cardiff University; Case Western Reserve University; Columbia University; Columbia University; Case Western Reserve University; Boston University; Boston University; University of Miami; University of Miami; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Universite de Lille - ISITE; CHU Lille; Universite de Lille; University of Pennsylvania; Pennsylvania Medicine; Brigham Young University	Goate, AM (corresponding author), Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA.; Goate, AM (corresponding author), Icahn Sch Med Mt Sinai, Dept Neurosci, Ronald M Loeb Ctr Alzheimers Dis, New York, NY 10029 USA.	alison.goate@mssm.edu	lambert, jean-charles/F-8787-2013; Haines, Jonathan/C-3374-2012; , beccie/AAM-3770-2021; Adams, Hieab/GLN-6421-2022; Farrer, Lindsay/AAS-1035-2020; Belllenguez, Céline/Y-3183-2018; Cruchaga, Carlos/ABF-4065-2020; Raj, Towfique/ABD-7620-2021; Bellenguez, Céline/X-4004-2019; Lambert, jean-charles/A-9553-2014; Ikram, M. Arfan/AAM-5225-2021; Robles, Yuetiva/AAS-3610-2020; Kauwe, John/AAC-6646-2021; Smith, Albert Vernon/K-5150-2015	lambert, jean-charles/0000-0003-0829-7817; Haines, Jonathan/0000-0002-4351-4728; , beccie/0000-0002-3885-1199; Belllenguez, Céline/0000-0002-1240-7874; Cruchaga, Carlos/0000-0002-0276-2899; Bellenguez, Céline/0000-0002-1240-7874; Lambert, jean-charles/0000-0003-0829-7817; Robles, Yuetiva/0000-0001-7512-5703; Kauwe, John/0000-0001-8641-2468; Pimenova, Anna/0000-0003-3342-8778; Escott-Price, Valentina/0000-0003-1784-5483; Budde, John/0000-0001-7778-7276; Goate, Alison/0000-0002-0576-2472; Farrer, Lindsay/0000-0001-5533-4225; Fairfax, Benjamin/0000-0001-7413-5002; Smith, Albert Vernon/0000-0003-1942-5845; Williams, Julie/0000-0002-4069-0259; McKenzie, Andrew/0000-0001-7462-4340; Van Duijn, Cornelia/0000-0002-2374-9204; Amouyel, Philippe/0000-0001-9088-234X; Jin, Sheng Chih/0000-0002-5777-7262; Chouraki, Vincent/0000-0002-4698-1794; Renton, Alan E./0000-0001-6702-8268; Seshadri, Sudha/0000-0001-6135-2622; Del Aguila, Jorge L./0000-0002-6364-8707; Marcora, Edoardo/0000-0002-3829-4927	Wellcome Trust; MRC; Alzheimer's Research UK (ARUK); Welsh government; US National Institutes of Health, National Institute on Aging (NIH-NIA); Erasmus Medical Center; Erasmus University; Medical Research Council (MRC); Welsh Assembly Government; Alzheimer's Society; Ulster Garden Villages; N. Ireland RD Office; Royal College of Physicians/Dunhill Medical Trust; MRC and Mercer's Institute for Research on Aging; Bristol Research into Alzheimer's and Care of the Elderly; Charles Wolfson Charitable Trust; NIH grants; Barnes Jewish Foundation; Charles and Joanne Knight Alzheimer's Research Initiative; Lundbeck SA; German Federal Ministry of Education and Research (BMBF); Competence Network Dementia; Competence Network Degenerative Dementia; Alfried Krupp von Bohlen und Halbach-Stiftung; Helmholtz Zentrum Munchen; German Research Center for Environmental Health; BMBF; German National Genome Research Network; Munich Center of Health Sciences; Heinz Nixdorf Foundation; NINDS; Intramural Research Program of the National Institute on Aging; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Allergy and Infectious Diseases; National Human Genome Research Institute; National Institute of Child Health and Human Development; Juvenile Diabetes Research Foundation International; Alzheimer's Disease Neuroimaging Initiative (National Institutes of Health Grant) [U01 AG024904]; DOD ADNI (Department of Defense) [W81XWH-12-2-0012]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; Canadian Institutes of Health Research; Cardiogenics (European Project) [LSHM-CT-2006-037593]; National Institutes of Health [U01 AG049508, R01-AG035083, RF-AG054011, R01-AG044546, RF1AG053303]; JPB Foundation; F Prime; NIH [P50 AG05681, P01 AG03991, P01 AG026276]; Ministry of Education in Taiwan; Lucille P. Markey Special Emphasis Pathway in Human Pathobiology; National Natural Science Foundation of China [21477087, 91643201]; Ministry of Science and Technology of China [2016YFC0206507]; Hope Center for Neurological Disorders; Department of Neurology at Washington University School of Medicine; Department of Psychiatry at Washington University School of Medicine;  [U01 AG032984];  [R01 AG033193]; MRC [MR/P005748/1, MR/L023784/2, MR/L023784/1, MC_PC_17112, UKDRI-3003, G0300429] Funding Source: UKRI; Alzheimers Research UK [ARUK-PG2014-1] Funding Source: researchfish; Medical Research Council [G0300429, MR/P005748/1, MC_PC_17112, MR/L023784/1, MR/L023784/2, MR/L010305/1] Funding Source: researchfish; National Institute for Health Research [CL-2012-13-004] Funding Source: researchfish; Wellcome Trust [201488/Z/16/Z] Funding Source: researchfish; NATIONAL INSTITUTE ON AGING [ZIAAG007270, RF1AG054011, R01AG033193, P50AG005138, R01AG044546, U24AG021886, R01AG035083, U01AG049508, U01AG032984, U01AG052411, P01AG003991, RF1AG044546, P01AG026276, P50AG005681, RF1AG053303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R25DA027995] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimer's Research UK (ARUK)(Alzheimer's Research UK (ARUK)); Welsh government; US National Institutes of Health, National Institute on Aging (NIH-NIA); Erasmus Medical Center; Erasmus University; Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Welsh Assembly Government; Alzheimer's Society; Ulster Garden Villages; N. Ireland RD Office; Royal College of Physicians/Dunhill Medical Trust(Dunhill Medical Trust); MRC and Mercer's Institute for Research on Aging(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Bristol Research into Alzheimer's and Care of the Elderly; Charles Wolfson Charitable Trust; NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Barnes Jewish Foundation; Charles and Joanne Knight Alzheimer's Research Initiative; Lundbeck SA(Lundbeck Corporation); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Competence Network Dementia; Competence Network Degenerative Dementia; Alfried Krupp von Bohlen und Halbach-Stiftung; Helmholtz Zentrum Munchen(Helmholtz Association); German Research Center for Environmental Health; BMBF(Federal Ministry of Education & Research (BMBF)); German National Genome Research Network; Munich Center of Health Sciences; Heinz Nixdorf Foundation; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Intramural Research Program of the National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Juvenile Diabetes Research Foundation International(Juvenile Diabetes Research Foundation); Alzheimer's Disease Neuroimaging Initiative (National Institutes of Health Grant)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD ADNI (Department of Defense); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Cardiogenics (European Project); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JPB Foundation; F Prime; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education in Taiwan(Ministry of Education, Taiwan); Lucille P. Markey Special Emphasis Pathway in Human Pathobiology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Hope Center for Neurological Disorders; Department of Neurology at Washington University School of Medicine; Department of Psychiatry at Washington University School of Medicine; ; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	IGAP: This study incorporated imputed summary results from the GERAD1 genome-wide association study. GERAD was supported by the Wellcome Trust, the MRC, Alzheimer's Research UK (ARUK) and the Welsh government. ADGC and CHARGE were supported by the US National Institutes of Health, National Institute on Aging (NIH-NIA), including grants U01 AG032984 and R01 AG033193. CHARGE was also supported by Erasmus Medical Center and Erasmus University.; Cardiff University was supported by the Wellcome Trust, Medical Research Council (MRC), Alzheimer's Research UK (ARUK) and the Welsh Assembly Government. Cambridge University and Kings College London acknowledge support from the MRC. ARUK supported sample collections at the South West Dementia Bank and the Universities of Nottingham, Manchester and Belfast. The Belfast group acknowledges support from the Alzheimer's Society, Ulster Garden Villages, N. Ireland R&D Office and the Royal College of Physicians/Dunhill Medical Trust. The MRC and Mercer's Institute for Research on Aging supported the Trinity College group. The South West Dementia Brain Bank acknowledges support from Bristol Research into Alzheimer's and Care of the Elderly. The Charles Wolfson Charitable Trust supported the OPTIMA group. Washington University was funded by NIH grants, Barnes Jewish Foundation and by the Charles and Joanne Knight Alzheimer's Research Initiative. Patient recruitment for the MRC Prion Unit/UCL Department of Neurodegenerative Disease collection was supported by the UCLH/UCL Biomedical Centre and NIHR Queen Square Dementia Biomedical Research Unit. LASER-AD was funded by Lundbeck SA. The Bonn group was supported by the German Federal Ministry of Education and Research (BMBF), Competence Network Dementia and Competence Network Degenerative Dementia and by the Alfried Krupp von Bohlen und Halbach-Stiftung. The GERAD Consortium also used samples ascertained by the NIMH AD Genetics Initiative.; The KORA F4 studies were financed by Helmholtz Zentrum Munchen; German Research Center for Environmental Health; BMBF; German National Genome Research Network and the Munich Center of Health Sciences. The Heinz Nixdorf Recall cohort was funded by the Heinz Nixdorf Foundation (Dr. jur. G.Schmidt, Chairman) and BMBF. Coriell Cell Repositories is supported by NINDS and the Intramural Research Program of the National Institute on Aging. We acknowledge use of genotype data from the 1958 Birth Cohort collection, funded by the MRC and the Wellcome Trust, which was genotyped by the Wellcome Trust Case Control Consortium and the Type-1 Diabetes Genetics Consortium, sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Allergy and Infectious Diseases, National Human Genome Research Institute, National Institute of Child Health and Human Development and Juvenile Diabetes Research Foundation International.; ADNDNI: Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging and the National Institute of Biomedical Imaging and Bioengineering and through generous contributions from the following: AbbVie, Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; F. Hoffmann-La Roche Ltd and its affiliated company, Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; and Transition Therapeutics. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (https://fnih.org/). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California.; We thank the Cardiogenics (European Project reference LSHM-CT-2006-037593) project for providing summary statistics for the cis-eQTL-based analyses. We also thank the ENCODE Consortium and R. Myers' lab (HAIB) for providing ChIP-seq datasets.; This work was supported by grants from the National Institutes of Health (U01 AG049508, R01-AG035083 and RF-AG054011 (to A.M.G.) and R01-AG044546 and RF1AG053303 (to C.C.)), the JPB Foundation (to A.M.G.) and F Prime (to A.M.G.). The recruitment and clinical characterization of research participants at Washington University were supported by NIH P50 AG05681, P01 AG03991 and P01 AG026276. Kuan-lin Huang received fellowship funding in part from the Ministry of Education in Taiwan and the Lucille P. Markey Special Emphasis Pathway in Human Pathobiology. Ke Hao is partially supported by the National Natural Science Foundation of China (Grant Nos. 21477087 and 91643201) and by the Ministry of Science and Technology of China (Grant No. 2016YFC0206507). This work was supported by access to equipment made possible by the Hope Center for Neurological Disorders and the Departments of Neurology and Psychiatry at Washington University School of Medicine.	Alperovitch A, 2003, NEUROEPIDEMIOLOGY, V22, P316, DOI 10.1159/000072920; Au R, 2004, EXP AGING RES, V30, P333, DOI 10.1080/03610730490484380; BACHMAN DL, 1993, NEUROLOGY, V43, P515, DOI 10.1212/WNL.43.3_Part_1.515; Bajari TM, 2003, FASEB J, V17, P1505, DOI 10.1096/fj.02-1106fje; Beers DR, 2006, P NATL ACAD SCI USA, V103, P16021, DOI 10.1073/pnas.0607423103; Beiser A, 2000, STAT MED, V19, P1495, DOI 10.1002/(SICI)1097-0258(20000615/30)19:11/12<1495::AID-SIM441>3.0.CO;2-E; BENNETT C, 1995, AM J MED GENET, V60, P1, DOI 10.1002/ajmg.1320600102; Bennett ML, 2016, P NATL ACAD SCI USA, V113, pE1738, DOI 10.1073/pnas.1525528113; Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; Bradshaw EM, 2013, NAT NEUROSCI, V16, P848, DOI 10.1038/nn.3435; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Chan G, 2015, NAT NEUROSCI, V18, P1556, DOI 10.1038/nn.4126; COX DR, 1972, J R STAT SOC B, V34, P187; Cruchaga C, 2013, NEURON, V78, P256, DOI 10.1016/j.neuron.2013.02.026; Dagher NN, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0366-9; Daniel B, 2014, GENE DEV, V28, P1562, DOI 10.1101/gad.242685.114; DAWBER TR, 1966, CIRCULATION, V34, P553, DOI 10.1161/01.CIR.34.4.553; DeCarli C, 2005, NEUROBIOL AGING, V26, P491, DOI 10.1016/j.neurobiolaging.2004.05.004; Dreses-Werringloer U, 2008, CELL, V133, P1149, DOI 10.1016/j.cell.2008.05.048; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fagan AM, 2006, ANN NEUROL, V59, P512, DOI 10.1002/ana.20730; Fairfax BP, 2014, SCIENCE, V343, P1118, DOI 10.1126/science.1246949; FARMER ME, 1987, PSYCHOL REP, V60, P1023, DOI 10.2466/pr0.1987.60.3c.1023; FEINLEIB M, 1975, PREV MED, V4, P518, DOI 10.1016/0091-7435(75)90037-7; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Garnier S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003240; Giambartolomei C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004383; Gjoneska E, 2015, NATURE, V518, P365, DOI 10.1038/nature14252; Griffon A, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1280; Grimmer T, 2009, BIOL PSYCHIAT, V65, P927, DOI 10.1016/j.biopsych.2009.01.027; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Gusev A, 2016, NAT GENET, V48, P245, DOI 10.1038/ng.3506; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hikami K, 2011, ARTHRITIS RHEUM-US, V63, P755, DOI 10.1002/art.30188; Hofman A, 2013, EUR J EPIDEMIOL, V28, P889, DOI 10.1007/s10654-013-9866-z; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Jones EL, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2013.03.018; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Kamboh MI, 2012, MOL PSYCHIATR, V17, P1340, DOI 10.1038/mp.2011.135; Kauwe JSK, 2009, NEUROGENETICS, V10, P13, DOI 10.1007/s10048-008-0150-4; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Lopez OL, 2003, NEUROEPIDEMIOLOGY, V22, P1, DOI 10.1159/000067110; Mak Ka Sin, 2011, Int J Cell Biol, V2011, P808524, DOI 10.1155/2011/808524; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; Naj AC, 2014, JAMA NEUROL, V71, P1394, DOI 10.1001/jamaneurol.2014.1491; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Peskind E, 2009, CURR ALZHEIMER RES, V6, P290, DOI 10.2174/156720509788486509; Peskind ER, 2006, ARCH NEUROL-CHICAGO, V63, P936, DOI 10.1001/archneur.63.7.936; PRENTICE RL, 1978, BIOMETRIKA, V65, P153, DOI 10.1093/biomet/65.1.153; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raj T, 2014, SCIENCE, V344, P519, DOI 10.1126/science.1249547; Roe JS, 2015, MOL CELL, V58, P1028, DOI 10.1016/j.molcel.2015.04.011; Sakai K, 2009, BRAIN RES, V1276, P11, DOI 10.1016/j.brainres.2009.04.030; Satoh J, 2014, GENE REGUL SYST BIO, V8, P127, DOI 10.4137/GRSB.S19711; Seshadri S, 2007, LANCET NEUROL, V6, P1106, DOI 10.1016/S1474-4422(07)70291-0; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Sloan CA, 2016, NUCLEIC ACIDS RES, V44, pD726, DOI 10.1093/nar/gkv1160; Slooter AJC, 1998, ARCH NEUROL-CHICAGO, V55, P964, DOI 10.1001/archneur.55.7.964; Smith AM, 2013, GLIA, V61, P929, DOI 10.1002/glia.22486; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Splansky GL, 2007, AM J EPIDEMIOL, V165, P1328, DOI 10.1093/aje/kwm021; Steinberg S, 2015, NAT GENET, V47, P445, DOI 10.1038/ng.3246; Strawbridge RJ, 2011, DIABETES, V60, P2624, DOI 10.2337/db11-0415; Thambisetty M, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2013.05.028; Pham TH, 2012, BLOOD, V119, pE161, DOI 10.1182/blood-2012-01-402453; van der Net JB, 2008, EUR J HUM GENET, V16, P1111, DOI 10.1038/ejhg.2008.59; Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154; Wang YM, 2012, NAT IMMUNOL, V13, P753, DOI 10.1038/ni.2360; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030; Zhang Y, 2016, NEURON, V89, P37, DOI 10.1016/j.neuron.2015.11.013; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]; Zhou X, 2013, NAT METHODS, V10, P375, DOI 10.1038/nmeth.2440; Zhu ZH, 2016, NAT GENET, V48, P481, DOI 10.1038/ng.3538	79	208	210	3	56	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2017	20	8					1052	+		10.1038/nn.4587	http://dx.doi.org/10.1038/nn.4587			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FB7CO	28628103	Green Accepted, Green Submitted			2022-12-17	WOS:000406298900006
J	Pandya, H; Shen, MJ; Ichikawa, DM; Sedlock, AB; Choi, Y; Johnson, KR; Kim, G; Brown, MA; Elkahloun, AG; Maric, D; Sweeney, CL; Gossa, S; Malech, HL; McGavern, DB; Park, JK				Pandya, Hetal; Shen, Michael J.; Ichikawa, David M.; Sedlock, Andrea B.; Choi, Yong; Johnson, Kory R.; Kim, Gloria; Brown, Mason A.; Elkahloun, Abdel G.; Maric, Dragan; Sweeney, Colin L.; Gossa, Selamawit; Malech, Harry L.; McGavern, Dorian B.; Park, John K.			Differentiation of human and murine induced pluripotent stem cells to microglia-like cells	NATURE NEUROSCIENCE			English	Article							IN-VIVO; DOPAMINERGIC NEURODEGENERATION; FRACTALKINE RECEPTOR; PARKINSONS-DISEASE; DELIVERY PROTECTS; BRAIN PARENCHYMA; MACROPHAGES; MICE; PRECURSORS; DERIVATION	Microglia are resident inflammatory cells of the CNS and have important roles in development, homeostasis and a variety of neurologic and psychiatric diseases. Difficulties in procuring human microglia have limited their study and hampered the clinical translation of microglia-based treatments shown to be effective in animal disease models. Here we report the differentiation of human induced pluripotent stem cells (iPSC) into microglia-like cells by exposure to defined factors and co-culture with astrocytes. These iPSC-derived microglia have the phenotype, gene expression profile and functional properties of brain-isolated microglia. Murine iPSC-derived microglia generated using a similar protocol have equivalent efficacy to primary brain-isolated microglia in treatment of murine syngeneic intracranial malignant gliomas. The ability to generate human microglia facilitates the further study of this important CNS cell type and raises the possibility of their use in personalized medicine applications.	[Pandya, Hetal; Shen, Michael J.; Ichikawa, David M.; Sedlock, Andrea B.; Choi, Yong; Johnson, Kory R.; Kim, Gloria; Brown, Mason A.; Maric, Dragan; Gossa, Selamawit; McGavern, Dorian B.; Park, John K.] NINDS, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Elkahloun, Abdel G.] NHGRI, NIH, Bethesda, MD 20892 USA; [Sweeney, Colin L.; Malech, Harry L.] NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Park, John K.] Santa Barbara Neurosci Inst, Santa Barbara, CA 93106 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	McGavern, DB; Park, JK (corresponding author), NINDS, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.; Park, JK (corresponding author), Santa Barbara Neurosci Inst, Santa Barbara, CA 93106 USA.	mcgavernd@ninds.nih.gov; parkjk@ninds.nih.gov	Brown, Mason Anthony/AAY-4397-2020; McGavern, Dorian/HCH-3601-2022	Brown, Mason Anthony/0000-0002-3404-1455; McGavern, Dorian/0000-0001-9568-545X; Malech, Harry/0000-0001-5874-5775	National Institute of Neurological Disorders and Stroke, National Institutes of Health; National Human Genome Research Institute, National Institutes of Health; National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZICHG200365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000988, ZIAAI000644] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003112] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Human Genome Research Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Intramural Research Programs of the National Institute of Neurological Disorders and Stroke, the National Human Genome Research Institute and the National Institute of Allergy and Infectious Diseases, National Institutes of Health.	Aguzzi A, 2013, SCIENCE, V339, P156, DOI 10.1126/science.1227901; Bellin M, 2012, NAT REV MOL CELL BIO, V13, P713, DOI 10.1038/nrm3448; Beutner C, 2013, GENE THER, V20, P797, DOI 10.1038/gt.2012.100; Beutner C, 2010, NAT PROTOC, V5, P1481, DOI 10.1038/nprot.2010.90; Biju KC, 2013, NEUROSCI LETT, V535, P24, DOI 10.1016/j.neulet.2012.12.034; Biju KC, 2010, MOL THER, V18, P1536, DOI 10.1038/mt.2010.107; Brantley EC, 2010, TRANSL ONCOL, V3, P380, DOI 10.1593/tlo.10208; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Butovsky O, 2012, J CLIN INVEST, V122, P3063, DOI 10.1172/JCI62636; Capotondo A, 2012, P NATL ACAD SCI USA, V109, P15018, DOI 10.1073/pnas.1205858109; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/NMETH.1593, 10.1038/nmeth.1593]; Chen SK, 2010, CELL, V141, P775, DOI 10.1016/j.cell.2010.03.055; Chicoine MR, 2007, NEUROSURGERY, V60, P372, DOI 10.1227/01.NEU.0000249280.61761.2E; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Eglitis MA, 1997, P NATL ACAD SCI USA, V94, P4080, DOI 10.1073/pnas.94.8.4080; Gandy S, 2013, NEURON, V78, P575, DOI 10.1016/j.neuron.2013.05.007; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Hambardzumyan D, 2016, NAT NEUROSCI, V19, P20, DOI 10.1038/nn.4185; Hussain SF, 2006, NEURO-ONCOLOGY, V8, P261, DOI 10.1215/15228517-2006-008; Hwang SY, 2009, BBA-MOL CELL RES, V1793, P1656, DOI 10.1016/j.bbamcr.2009.08.011; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kierdorf K, 2013, NAT NEUROSCI, V16, P273, DOI 10.1038/nn.3318; Merling RK, 2013, BLOOD, V121, pE98, DOI 10.1182/blood-2012-03-420273; Mora R, 2009, GLIA, V57, P561, DOI 10.1002/glia.20785; Muffat J, 2016, NAT MED, V22, P1358, DOI 10.1038/nm.4189; Napoli I, 2009, GLIA, V57, P1660, DOI 10.1002/glia.20878; Nayak D, 2014, ANNU REV IMMUNOL, V32, P367, DOI 10.1146/annurev-immunol-032713-120240; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Prinz M, 2011, NAT NEUROSCI, V14, P1227, DOI 10.1038/nn.2923; Pripuzova NS, 2015, STEM CELL RES, V14, P323, DOI 10.1016/j.scr.2015.01.009; Saijo K, 2011, NAT REV IMMUNOL, V11, P775, DOI 10.1038/nri3086; Sarkar S, 2014, NAT NEUROSCI, V17, P46, DOI 10.1038/nn.3597; Sedgwick JD, 1998, J IMMUNOL, V160, P5320; Senju S, 2009, STEM CELLS, V27, P1021, DOI 10.1002/stem.33; Tsuchiya T, 2005, J NEUROIMMUNOL, V160, P210, DOI 10.1016/j.jneuroim.2004.10.025; Van Gool S, 2009, BRAIN PATHOL, V19, P694, DOI 10.1111/j.1750-3639.2009.00316.x; Vodyanik MA, 2006, BLOOD, V108, P2095, DOI 10.1182/blood-2006-02-003327; Yang I, 2010, J CLIN NEUROSCI, V17, P6, DOI 10.1016/j.jocn.2009.05.006	40	208	214	5	99	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2017	20	5					753	+		10.1038/nn.4534	http://dx.doi.org/10.1038/nn.4534			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ET1CU	28253233	Green Accepted			2022-12-17	WOS:000400004300017
J	van Woerden, GM; Harris, KD; Hojjati, MR; Gustin, RM; Qiu, SF; Freire, RDA; Jiang, YH; Elgersma, Y; Weeber, EJ				van Woerden, Geeske M.; Harris, Karen D.; Hojjati, Mohammad Reza; Gustin, Richard M.; Qiu, Shenfeng; Freire, Rogerio de Avila; Jiang, Yong-hui; Elgersma, Ype; Weeber, Edwin J.			Rescue of neurological deficits in a mouse model for Angelman syndrome by reduction of alpha CaMKII inhibitory phosphorylation	NATURE NEUROSCIENCE			English	Article							PROTEIN-KINASE-II; UBE3A; HIPPOCAMPAL; MUTATIONS; LIGASE; GENE; AUTOPHOSPHORYLATION; PLASTICITY; DELETION	Angelman syndrome ( AS) is a severe neurological disorder characterized by mental retardation, motor dysfunction and epilepsy. We show that the molecular and cellular deficits of an AS mouse model can be rescued by introducing an additional mutation at the inhibitory phosphorylation site of alpha CaMKII. Moreover, these double mutants no longer show the behavioral deficits seen in AS mice, suggesting that these deficits are the direct result of increased inhibitory phosphorylation of aCaMKII.	Univ Med Ctr, Erasmus MC, Dept Neurosci, NL-3000 CA Rotterdam, Netherlands; Vanderbilt Univ, Dept Physiol & Mol Biophys, Nashville, TN 37235 USA; Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37235 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Erasmus University Rotterdam; Erasmus MC; Vanderbilt University; Vanderbilt University; Baylor College of Medicine	Elgersma, Y (corresponding author), Univ Med Ctr, Erasmus MC, Dept Neurosci, Dr Molewaterplein 50,POB 2040, NL-3000 CA Rotterdam, Netherlands.	y.elgersma@erasmusmc.nl	Weeber, Edwin J/A-5396-2012; Hojjati, Mohammad reza/B-9941-2013; Elgersma, Ype/F-5164-2013	Hojjati, Mohammad reza/0000-0001-7889-2545; Elgersma, Ype/0000-0002-3758-1297				Albrecht U, 1997, NAT GENET, V17, P75, DOI 10.1038/ng0997-75; CLAYTONSMITH J, 1993, AM J MED GENET, V46, P12, DOI 10.1002/ajmg.1320460105; Elgersma Y, 2004, J NEUROSCI, V24, P8410, DOI 10.1523/JNEUROSCI.3622-04.2004; Elgersma Y, 2002, NEURON, V36, P493, DOI 10.1016/S0896-6273(02)01007-3; Gillessen-Kaesbach G, 1999, EUR J HUM GENET, V7, P638, DOI 10.1038/sj.ejhg.5200362; Hansel C, 2006, NEURON, V51, P835, DOI 10.1016/j.neuron.2006.08.013; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; KNOLL JHM, 1989, AM J MED GENET, V32, P285, DOI 10.1002/ajmg.1320320235; Matsuura T, 1997, NAT GENET, V15, P74, DOI 10.1038/ng0197-74; Moncla A, 1999, J MED GENET, V36, P554; Smith A, 1996, J MED GENET, V33, P107, DOI 10.1136/jmg.33.2.107; Sutcliffe JS, 1997, GENOME RES, V7, P368, DOI 10.1101/gr.7.4.368; Weeber EJ, 2003, J NEUROSCI, V23, P2634; Zhang L, 2005, J NEUROSCI, V25, P7697, DOI 10.1523/JNEUROSCI.2086-05.2005	15	208	215	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2007	10	3					280	282		10.1038/nn1845	http://dx.doi.org/10.1038/nn1845			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	140CM	17259980	Green Submitted			2022-12-17	WOS:000244480300008
J	Porter, J; Craven, B; Khan, RM; Chang, SJ; Kang, I; Judkewitz, B; Volpe, J; Settles, G; Sobel, N				Porter, Jess; Craven, Brent; Khan, Rehan M.; Chang, Shao-Ju; Kang, Irene; Judkewitz, Benjamin; Volpe, Jason; Settles, Gary; Sobel, Noam			Mechanisms of scent-tracking in humans	NATURE NEUROSCIENCE			English	Article							INFORMATION; OLFACTION; BEHAVIOR; PRIMATES; PLUME; SMELL	Whether mammalian scent-tracking is aided by inter-nostril comparisons is unknown. We assessed this in humans and found that (i) humans can scent-track, (ii) they improve with practice, (iii) the human nostrils sample spatially distinct regions separated by similar to 3.5 cm and, critically, (iv) scent-tracking is aided by inter-nostril comparisons. These findings reveal fundamental mechanisms of scent-tracking and suggest that the poor reputation of human olfaction may reflect, in part, behavioral demands rather than ultimate abilities.	Univ Calif Berkeley, Program Biophys, 299 Life Sci Addict,MC 3200, Berkeley, CA 94720 USA; Penn State Univ, Dept Mech & Nucl Engn, University Pk, PA 16802 USA; Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Bioengn Program, Berkeley, CA 94720 USA; Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel	University of California System; University of California Berkeley; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Weizmann Institute of Science	Porter, J (corresponding author), Univ Calif Berkeley, Program Biophys, 299 Life Sci Addict,MC 3200, Berkeley, CA 94720 USA.	jessiep@berkeley.edu; noam.sobel@weizmann.ac.il	Settles, Gary S/D-5260-2009; Khan, Rehan/AAR-4803-2020; Judkewitz, Benjamin/C-3645-2014	Khan, Rehan/0000-0001-8724-5788; Judkewitz, Benjamin/0000-0002-8570-3869; Sobel, Noam/0000-0002-3232-9391; Kang, Irene/0000-0002-9472-3853	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006915, R01DC005958] Funding Source: NIH RePORTER; NIDCD NIH HHS [DC006915, DC005958] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Crimaldi JP, 2001, EXP FLUIDS, V31, P90, DOI 10.1007/s003480000263; Gibbons B., 1986, NATL GEOGRAPHIC, V170, P324; Gilad Y, 2004, PLOS BIOL, V2, P120, DOI 10.1371/journal.pbio.0020005; Koehl MAR, 2001, SCIENCE, V294, P1948, DOI 10.1126/science.1063724; Laska M, 2000, CHEM SENSES, V25, P47, DOI 10.1093/chemse/25.1.47; Mainland J, 2006, CHEM SENSES, V31, P181, DOI 10.1093/chemse/bjj012; MOULTON DG, 1967, AM ZOOL, V7, P421; Porter J, 2005, NEURON, V47, P581, DOI 10.1016/j.neuron.2005.06.028; Rajan R, 2006, SCIENCE, V311, P666, DOI 10.1126/science.1122096; Settles GS, 2005, J FLUID ENG-T ASME, V127, P189, DOI 10.1115/1.1891146; Shepherd GM, 2004, PLOS BIOL, V2, P572, DOI 10.1371/journal.pbio.0020146; Smith Timothy D., 2004, Anatomical Record Part B:The New Anatomist, V279, P24, DOI 10.1002/ar.b.20026; THESEN A, 1993, J EXP BIOL, V180, P247; Vickers NJ, 2006, CHEM SENSES, V31, P155, DOI 10.1093/chemse/bjj011; Wilson DA, 1999, PHYSIOL BEHAV, V66, P41, DOI 10.1016/S0031-9384(98)00269-8	15	208	210	2	56	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2007	10	1					27	29		10.1038/nn1819	http://dx.doi.org/10.1038/nn1819			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	120PC	17173046				2022-12-17	WOS:000243096100011
J	Sperling, AJ; Lu, ZL; Manis, FR; Seidenberg, MS				Sperling, AJ; Lu, ZL; Manis, FR; Seidenberg, MS			Deficits in perceptual noise exclusion in developmental dyslexia	NATURE NEUROSCIENCE			English	Article							READING-DISABILITY; SENSITIVITY; INSIGHTS; CHILDREN	We evaluated signal-noise discrimination in children with and without dyslexia, using magnocellular and parvocellular visual stimuli presented either with or without high noise. Dyslexic children had elevated contrast thresholds when stimuli of either type were presented in high noise, but performed as well as non-dyslexic children when either type was displayed without noise. Our findings suggest that deficits in noise exclusion, not magnocellular processing, contribute to the etiology of dyslexia.	Georgetown Univ, Med Ctr, Washington, DC 20057 USA; Univ So Calif, Los Angeles, CA 90089 USA; Univ Wisconsin, Madison, WI 53706 USA	Georgetown University; University of Southern California; University of Wisconsin System; University of Wisconsin Madison	Sperling, AJ (corresponding author), Georgetown Univ, Med Ctr, 4000 Reservoir Rd NW,Bldg D,Room 207E, Washington, DC 20057 USA.	ajs76@georgetown.edu		Lu, Zhong-Lin/0000-0002-7295-727X	NICHD NIH HHS [HD29891] Funding Source: Medline; NIMH NIH HHS [P50-MH64445, KO2-MH01188] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD029891] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH064445, K02MH001188] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Cornelissen PL, 1998, VISION RES, V38, P471, DOI 10.1016/S0042-6989(97)00199-5; Demb JB, 1998, J NEUROSCI, V18, P6939; Gottardo A, 1996, J EXP CHILD PSYCHOL, V63, P563, DOI 10.1006/jecp.1996.0062; Harm MW, 1999, PSYCHOL REV, V106, P491, DOI 10.1037/0033-295X.106.3.491; LOVEGROVE WJ, 1980, SCIENCE, V210, P439, DOI 10.1126/science.7433985; Lu ZL, 1998, VISION RES, V38, P1183, DOI 10.1016/S0042-6989(97)00273-3; MANIS FR, 2004, CONNECTIONS LANGUAGE; Molfese DL, 2000, BRAIN LANG, V72, P238, DOI 10.1006/brln.2000.2287; OLSON R, 1989, J LEARN DISABIL, V22, P339, DOI 10.1177/002221948902200604; Ramus F, 2003, BRAIN, V126, P841, DOI 10.1093/brain/awg076; READ C, 1986, COGNITION, V24, P31, DOI 10.1016/0010-0277(86)90003-X; Sperling AJ, 2004, ANN DYSLEXIA, V54, P281, DOI 10.1007/s11881-004-0014-z; Willcutt EG, 2000, J CHILD PSYCHOL PSYC, V41, P1039, DOI 10.1017/S0021963099006368	13	208	211	0	34	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2005	8	7					862	863		10.1038/nn1474	http://dx.doi.org/10.1038/nn1474			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	940IK	15924138				2022-12-17	WOS:000230137100012
J	Ackermann, M; Matus, A				Ackermann, M; Matus, A			Activity-induced targeting of profilin and stabilization of dendritic spine morphology	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; EXCITATORY SYNAPTIC TRANSMISSION; DYNAMIC ACTIN-FILAMENTS; SILENT SYNAPSES; AREA CA1; IN-VIVO; VISUAL-CORTEX; ADULT CORTEX; PLASTICITY; LTP	Morphological changes in dendritic spines have been implicated in connective plasticity in brain circuitry, but the underlying pathway leading from synaptic transmission to structural change is unknown. Using primary neurons expressing GFP-tagged proteins, we found that profilin, a regulator of actin polymerization, is targeted to spine heads when postsynaptic NMDA receptors are activated and that actin-based changes in spine shape are concomitantly blocked. Profilin targeting was triggered by electrical stimulation patterns known to induce the long-term changes in synaptic responsiveness associated with memory formation. These results suggest that, in addition to electrophysiological changes, NMDA receptor activation initiates changes in the actin cytoskeleton of dendritic spines that stabilize synaptic structure.	Friedrich Miescher Inst, CH-4002 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research	Ackermann, M (corresponding author), Friedrich Miescher Inst, Box 2543, CH-4002 Basel, Switzerland.							ARTOLA A, 1993, TRENDS NEUROSCI, V16, P480, DOI 10.1016/0166-2236(93)90081-V; Artola A, 1996, J NEUROPHYSIOL, V76, P984, DOI 10.1152/jn.1996.76.2.984; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BUSS F, 1992, CELL MOTIL CYTOSKEL, V22, P51, DOI 10.1002/cm.970220106; CARLSSON L, 1977, J MOL BIOL, V115, P465, DOI 10.1016/0022-2836(77)90166-8; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; CHRISTOFI G, 1993, J NEUROPHYSIOL, V69, P219, DOI 10.1152/jn.1993.69.1.219; CRICK F, 1982, TRENDS NEUROSCI, V5, P44, DOI 10.1016/0166-2236(82)90020-0; Dickinson RB, 2002, BIOPHYS J, V82, P605, DOI 10.1016/S0006-3495(02)75425-8; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; FINKEL T, 1994, P NATL ACAD SCI USA, V91, P1510, DOI 10.1073/pnas.91.4.1510; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; FREY U, 1988, BRAIN RES, V452, P57, DOI 10.1016/0006-8993(88)90008-X; Frey U, 1998, TRENDS NEUROSCI, V21, P181, DOI 10.1016/S0166-2236(97)01189-2; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Geinisman Y, 2001, J NEUROSCI, V21, P5568, DOI 10.1523/JNEUROSCI.21-15-05568.2001; Gertler FB, 1996, CELL, V87, P227, DOI 10.1016/S0092-8674(00)81341-0; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Hajkova L, 2000, EXP CELL RES, V256, P112, DOI 10.1006/excr.1999.4786; Halpain S, 2000, TRENDS NEUROSCI, V23, P141, DOI 10.1016/S0166-2236(00)01576-9; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; HONORE B, 1993, FEBS LETT, V330, P151, DOI 10.1016/0014-5793(93)80262-S; Isaac J, 2001, NEURON, V32, P963, DOI 10.1016/S0896-6273(01)00545-1; Kang F, 1997, BIOCHEMISTRY-US, V36, P8384, DOI 10.1021/bi970065n; Kim CH, 1999, J NEUROSCI, V19, P4314; Knott GW, 2002, NEURON, V34, P265, DOI 10.1016/S0896-6273(02)00663-3; Krucker T, 2000, P NATL ACAD SCI USA, V97, P6856, DOI 10.1073/pnas.100139797; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Liao DH, 1999, NAT NEUROSCI, V2, P37, DOI 10.1038/4540; Martin KC, 2002, NAT REV NEUROSCI, V3, P813, DOI 10.1038/nrn942; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; MATUS A, 1982, P NATL ACAD SCI-BIOL, V79, P7590, DOI 10.1073/pnas.79.23.7590; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; MCGAUGH JL, 1966, SCIENCE, V153, P1351, DOI 10.1126/science.153.3742.1351; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; Ottersen OP, 2002, NATURE, V420, P751, DOI 10.1038/420751a; Petralia RS, 1999, NAT NEUROSCI, V2, P31, DOI 10.1038/4532; REINHARD M, 1995, EMBO J, V14, P1583, DOI 10.1002/j.1460-2075.1995.tb07146.x; ROELANDSE M, IN PRESS NEUROSCIENC; Rothkegel M, 1996, J CELL SCI, V109, P83; Rumpel S, 1998, J NEUROSCI, V18, P8863; Soderling TR, 2000, TRENDS NEUROSCI, V23, P75, DOI 10.1016/S0166-2236(99)01490-3; Star EN, 2002, NAT NEUROSCI, V5, P239, DOI 10.1038/nn811; Suetsugu S, 1998, EMBO J, V17, P6516, DOI 10.1093/emboj/17.22.6516; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Witke W, 2001, P NATL ACAD SCI USA, V98, P3832, DOI 10.1073/pnas.051515498; Yang SN, 1999, J NEUROPHYSIOL, V81, P781, DOI 10.1152/jn.1999.81.2.781	50	208	212	1	4	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2003	6	11					1194	1200		10.1038/nn1135	http://dx.doi.org/10.1038/nn1135			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	737KH	14555951				2022-12-17	WOS:000186229200019
J	Crosio, C; Cermakian, N; Allis, CD; Sassone-Corsi, P				Crosio, C; Cermakian, N; Allis, CD; Sassone-Corsi, P			Light induces chromatin modification in cells of the mammalian circadian clock	NATURE NEUROSCIENCE			English	Article							HAMSTER SUPRACHIASMATIC NUCLEUS; INDUCED PHASE-SHIFTS; C-FOS EXPRESSION; HISTONE H3; SUPRAOPTIC NUCLEUS; PHOTIC REGULATION; GENE-EXPRESSION; PHOSPHORYLATION; RAT; RHYTHMS	The mammalian circadian clock resides in neurons of the hypothalamic suprachiasmatic nucleus (SCN). Light entrains phase resetting of the clock using the retino-hypothalamic tract, via release of glutamate. Nighttime light exposure causes rapid, transient induction of clock and immediate-early genes implicated in phase-shifting the pacemaker. Here we show that a nighttime light pulse caused phosphorylation of Ser10 in histone H3's tail, in SCN clock cells. The effect of light was specific, and the kinetics of H3 phosphorylation were characteristic of the early response, paralleling c-fos and Per1 induction. Using fos-lacZ transgenic mice, we found that H3 phosphorylation and Fos induction occurRed in the same SCN neurons. Systemic treatment with the GABA(B) receptor agonist baclofen prevented light-induced c-fos and Per1 expression and H3 phosphorylation, indicating that one signaling pathway governs both events. Our results suggest that dynamic chromatin remodeling in the SCN occurs in response to a physiological stimulus in vivo.	Univ Strasbourg 1, Inst Genet & Biol Mol & Cellulaire, CNRS, INSERM, F-67404 Illkirch, France; Univ Virginia, Hlth Sci Ctr, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Virginia	Sassone-Corsi, P (corresponding author), Univ Strasbourg 1, Inst Genet & Biol Mol & Cellulaire, CNRS, INSERM, 1 Rue Laurent Fries, F-67404 Illkirch, France.		Sassone-Corsi, Paolo/H-6182-2011; Jansen, Heiko T./A-5770-2008	Jansen, Heiko T./0000-0003-0178-396X; CROSIO, Claudia/0000-0003-2452-1145; Cermakian, Nicolas/0000-0003-4517-9131				Akiyama M, 1999, J NEUROSCI, V19, P1115; Albrecht U, 1997, CELL, V91, P1055, DOI 10.1016/S0092-8674(00)80495-X; Belvin MP, 1999, NEURON, V22, P777, DOI 10.1016/S0896-6273(00)80736-9; Berquin P, 2000, BRAIN RES, V857, P30, DOI 10.1016/S0006-8993(99)02304-5; Bormann J, 2000, TRENDS PHARMACOL SCI, V21, P16, DOI 10.1016/S0165-6147(99)01413-3; Bourque CW, 1997, ANNU REV PHYSIOL, V59, P601, DOI 10.1146/annurev.physiol.59.1.601; CARD JP, 1989, J COMP NEUROL, V284, P135, DOI 10.1002/cne.902840110; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; Cermakian N, 2000, NAT REV MOL CELL BIO, V1, P59, DOI 10.1038/35036078; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; COLWELL CS, 1993, NEUROSCI LETT, V163, P177, DOI 10.1016/0304-3940(93)90376-V; COLWELL CS, 1993, J NEUROSCI, V13, P1454; Cui LN, 1997, J PHYSIOL-LONDON, V502, P149, DOI 10.1111/j.1469-7793.1997.149bl.x; Cui LN, 2000, AM J PHYSIOL-REG I, V278, pR1210, DOI 10.1152/ajpregu.2000.278.5.R1210; DAAN S, 1976, J COMP PHYSIOL, V106, P253, DOI 10.1007/BF01417857; De Cesare D, 1999, TRENDS BIOCHEM SCI, V24, P281, DOI 10.1016/S0968-0004(99)01414-0; De Cesare D, 1998, P NATL ACAD SCI USA, V95, P12202, DOI 10.1073/pnas.95.21.12202; DING JM, 1994, SCIENCE, V266, P1713, DOI 10.1126/science.7527589; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Gillespie CF, 1999, J COMP NEUROL, V411, P683; GINTY DD, 1993, SCIENCE, V260, P238, DOI 10.1126/science.8097062; Harrington M E, 1986, J Biol Rhythms, V1, P309, DOI 10.1177/074873048600100405; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Honrado GI, 1996, J COMP PHYSIOL A, V178, P563; JOHNSON RF, 1988, BRAIN RES, V460, P297, DOI 10.1016/0006-8993(88)90374-5; Klein D.C., 1991, SUPRACHIASMATIC NUCL; KORNHAUSER JM, 1990, NEURON, V5, P127, DOI 10.1016/0896-6273(90)90303-W; Liu C, 2000, NEURON, V25, P123, DOI 10.1016/S0896-6273(00)80876-4; MOORE RY, 1972, J COMP NEUROL, V146, P1, DOI 10.1002/cne.901460102; MOORE RY, 1993, NEUROSCI LETT, V150, P112, DOI 10.1016/0304-3940(93)90120-A; Morris ME, 1998, SCIENCE, V279, P1544, DOI 10.1126/science.279.5356.1544; Obrietan K, 1998, NAT NEUROSCI, V1, P693, DOI 10.1038/3695; Obrietan K, 1999, J BIOL CHEM, V274, P17748, DOI 10.1074/jbc.274.25.17748; Pickard GE, 1997, BIOL CELL, V89, P513, DOI 10.1016/S0248-4900(98)80007-5; ROBERTSON LM, 1995, NEURON, V14, P241, DOI 10.1016/0896-6273(95)90282-1; Sassone-Corsi P, 1999, SCIENCE, V285, P886, DOI 10.1126/science.285.5429.886; Shearman LP, 1997, NEURON, V19, P1261, DOI 10.1016/S0896-6273(00)80417-1; SHIBATA K, 1990, EUR J BIOCHEM, V192, P87, DOI 10.1111/j.1432-1033.1990.tb19199.x; Shinohara K, 2000, NEUROSCIENCE, V96, P591, DOI 10.1016/S0306-4522(99)00556-4; Silver R, 1999, NEUROREPORT, V10, P3165, DOI 10.1097/00001756-199910190-00008; Thomson S, 1999, EMBO J, V18, P4779, DOI 10.1093/emboj/18.17.4779; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Wang K, 1997, BRAIN RES, V746, P117, DOI 10.1016/S0006-8993(96)01216-4; WEBER ET, 1995, BRAIN RES, V692, P137; Whitmore D, 2000, NATURE, V404, P87, DOI 10.1038/35003589; WOLLNIK F, 1995, EUR J NEUROSCI, V7, P388, DOI 10.1111/j.1460-9568.1995.tb00334.x; Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959	50	208	214	1	17	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2000	3	12					1241	1247		10.1038/81767	http://dx.doi.org/10.1038/81767			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UA	11100144	Bronze			2022-12-17	WOS:000167177900009
J	Fu, HJ; Hardy, J; Duff, KE				Fu, Hongjun; Hardy, John; Duff, Karen E.			Selective vulnerability in neurodegenerative diseases	NATURE NEUROSCIENCE			English	Review							MITOCHONDRIAL-DNA DELETIONS; AMYLOID PRECURSOR PROTEIN; NUCLEUS BASALIS NEURONS; ALZHEIMERS-DISEASE; FRONTOTEMPORAL DEMENTIA; PARKINSONS-DISEASE; GENE-EXPRESSION; HUNTINGTONS-DISEASE; SUBSTANTIA-NIGRA; CEREBRAL-CORTEX	Neurodegenerative diseases have two general characteristics that are so fundamental we usually take them for granted. The first is that the pathology associated with the disease only affects particular neurons ('selective neuronal vulnerability'); the second is that the pathology worsens with time and impacts more regions in a stereotypical and predictable fashion. The mechanisms underpinning selective neuronal and regional vulnerability have been difficult to dissect, but the recent application of whole-genome technologies, the development of mouse models that reproduce spatial and temporal features of the pathology, and the identification of intrinsic morphological, electrophysiological, and biochemical properties of vulnerable neurons are beginning to shed some light on these fundamental features of neurodegenerative diseases. Here we detail our emerging understanding of the underlying biology of selective neuronal vulnerability and outline some of the areas in which our understanding is incomplete.	[Fu, Hongjun; Duff, Karen E.] Columbia Univ, Med Ctr, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10027 USA; [Fu, Hongjun; Duff, Karen E.] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY 10027 USA; [Hardy, John] Inst Neurol, Dept Mol Neurosci, London, England; [Hardy, John] Inst Neurol, Reta Lilla Weston Labs, London, England; [Duff, Karen E.] New York State Psychiat Inst & Hosp, Dept Psychiat, Div Integrat Neurosci, New York, NY 10032 USA; [Fu, Hongjun] Ohio State Univ, Dept Neurosci, Wexner Med Ctr, Columbus, OH 43210 USA	Columbia University; Columbia University; University of London; University College London; University of London; University College London; New York State Psychiatry Institute; University System of Ohio; Ohio State University	Duff, KE (corresponding author), Columbia Univ, Med Ctr, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10027 USA.; Duff, KE (corresponding author), Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY 10027 USA.; Duff, KE (corresponding author), New York State Psychiat Inst & Hosp, Dept Psychiat, Div Integrat Neurosci, New York, NY 10032 USA.	ked2115@columbia.edu	Hardy, John/C-2451-2009; Fu, Hongjun/ABB-3558-2021	Hardy, John/0000-0002-3122-0423; Duff, Karen/0000-0002-6177-868X; Fu, Hongjun/0000-0001-5346-7075	NIH [NS074874, AG056151, AG056673]; Cure Alzheimer's Fund; Tau Consortium; Brightfocus Foundation; Alzheimer's Association [AARF-17-505009]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS074874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG056673, RF1AG056151] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cure Alzheimer's Fund; Tau Consortium; Brightfocus Foundation(BrightFocus Foundation); Alzheimer's Association(Alzheimer's Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank D. Dickson for critical reading of the manuscript. K.E.D. acknowledges the support of NIH (NS074874 and AG056151), Cure Alzheimer's Fund, the Tau Consortium, and the Brightfocus Foundation. This work was also supported by a grant from the NIH (AG056673) and the Alzheimer's Association (AARF-17-505009) to H.J.F.	ALEXIANU ME, 1994, ANN NEUROL, V36, P846, DOI 10.1002/ana.410360608; Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769; Bender A, 2008, J NEUROL, V255, P1231, DOI 10.1007/s00415-008-0892-9; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Bolam JP, 2012, MOVEMENT DISORD, V27, P1478, DOI 10.1002/mds.25135; BONDAREFF W, 1982, NEUROLOGY, V32, P164, DOI 10.1212/WNL.32.2.164; Braak H, 1996, ACTA NEUROPATHOL, V92, P197, DOI 10.1007/s004010050508; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Braak H, 2017, J PARKINSON DIS, V7, pS73, DOI 10.3233/JPD-179001; Braak H, 2013, NAT REV NEUROL, V9, P708, DOI 10.1038/nrneurol.2013.221; Brettschneider J, 2015, NAT REV NEUROSCI, V16, P109, DOI 10.1038/nrn3887; Brettschneider J, 2013, ANN NEUROL, V74, P20, DOI 10.1002/ana.23937; Brichta L, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00152; Bussiere T, 2003, J COMP NEUROL, V463, P281, DOI 10.1002/cne.10760; Chan CS, 2009, TRENDS NEUROSCI, V32, P249, DOI 10.1016/j.tins.2009.01.006; Chin J, 2007, J NEUROSCI, V27, P2727, DOI 10.1523/JNEUROSCI.3758-06.2007; CHOI DW, 1987, J NEUROSCI, V7, P369; Chung YH, 2005, BRAIN RES, V1035, P105, DOI 10.1016/j.brainres.2004.12.022; Ciryam P, 2017, P NATL ACAD SCI USA, V114, pE3935, DOI 10.1073/pnas.1613854114; Ciryam P, 2016, P NATL ACAD SCI USA, V113, P4753, DOI 10.1073/pnas.1516604113; Ciryam P, 2015, TRENDS PHARMACOL SCI, V36, P72, DOI 10.1016/j.tips.2014.12.004; Ciryam P, 2013, CELL REP, V5, P781, DOI 10.1016/j.celrep.2013.09.043; DAVIES P, 1976, LANCET, V2, P1403; Di Giovannantonio LG, 2013, DEV BIOL, V373, P176, DOI 10.1016/j.ydbio.2012.10.022; Dickson D, 2011, J MOL NEUROSCI, V45, P384, DOI 10.1007/s12031-011-9589-0; Double Kay L, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS52, DOI 10.1016/S1353-8020(11)70018-9; Fimia GM, 2007, NATURE, V447, P1121, DOI 10.1038/nature05925; Fitzpatrick AWP, 2017, NATURE, V547, P185, DOI 10.1038/nature23002; Fombonne J, 2009, ANN NEUROL, V65, P294, DOI 10.1002/ana.21578; Freer R, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600947; Fu HJ, 2017, NEURON, V93, P533, DOI 10.1016/j.neuron.2016.12.023; Galvan L, 2012, J HUNTINGTONS DIS, V1, P17, DOI 10.3233/JHD-2012-120009; Gamazon ER, 2015, NAT GENET, V47, P1091, DOI 10.1038/ng.3367; Gerschutz A, 2014, J ALZHEIMERS DIS, V40, P135, DOI 10.3233/JAD-131280; Ghetti B, 2015, NEUROPATH APPL NEURO, V41, P24, DOI 10.1111/nan.12213; Ginsberg SD, 2017, HIPPOCAMPUS; Ginsberg Stephen D, 2006, NeuroRx, V3, P302, DOI 10.1016/j.nurx.2006.05.007; Goedert M, 2017, ANNU REV NEUROSCI, V40, P189, DOI 10.1146/annurev-neuro-072116-031153; Gotz J, 2009, J ALZHEIMERS DIS, V18, P243, DOI 10.3233/JAD-2009-1143; Gosselin D, 2017, SCIENCE, V356, DOI 10.1126/science.aal3222; GREENAMYRE JT, 1989, NEUROBIOL AGING, V10, P593, DOI 10.1016/0197-4580(89)90143-7; Greene JG, 2005, NEUROBIOL DIS, V18, P19, DOI 10.1016/j.nbd.2004.10.003; Gremer L, 2017, SCIENCE, V358, P116, DOI 10.1126/science.aao2825; Guedes-Dias P, 2016, NEUROBIOL DIS, V90, P51, DOI 10.1016/j.nbd.2015.09.008; Habib N, 2017, NAT METHODS, V14, P955, DOI [10.1038/NMETH.4407, 10.1038/nmeth.4407]; HALLIDAY GM, 1990, ANN NEUROL, V27, P373, DOI 10.1002/ana.410270405; Han I, 2010, J NEUROCHEM, V113, P1073, DOI 10.1111/j.1471-4159.2010.06672.x; Harding AJ, 2002, BRAIN, V125, P2431, DOI 10.1093/brain/awf251; Hardy J, 2005, BIOCHEM SOC T, V33, P578, DOI 10.1042/BST0330578; Hardy J, 2016, BIOCHEM SOC T, V44, P659, DOI 10.1042/BST20150287; Henderson JM, 2000, ANN NEUROL, V47, P345, DOI 10.1002/1531-8249(200003)47:3<345::AID-ANA10>3.3.CO;2-M; Hirsch EC, 2013, MOVEMENT DISORD, V28, P24, DOI 10.1002/mds.25032; HOF PR, 1993, NEUROSCI LETT, V152, P145, DOI 10.1016/0304-3940(93)90504-E; HYMAN BT, 1984, SCIENCE, V225, P1168, DOI 10.1126/science.6474172; Imamura K, 2016, SCI REP-UK, V6, DOI 10.1038/srep34904; IWAMOTO N, 1991, NEUROSCI LETT, V128, P81, DOI 10.1016/0304-3940(91)90764-K; Jellinger KA, 1999, J NEURAL TRANSM-SUPP, P1; Johnson NR, 2017, P NATL ACAD SCI USA, V114, pE11029, DOI 10.1073/pnas.1717193114; Josephs KA, 2014, ACTA NEUROPATHOL, V127, P441, DOI 10.1007/s00401-013-1211-9; Jucker M, 2013, NATURE, V501, P45, DOI 10.1038/nature12481; Kanning KC, 2010, ANNU REV NEUROSCI, V33, P409, DOI 10.1146/annurev.neuro.051508.135722; Kaushik S, 2015, NAT MED, V21, P1406, DOI 10.1038/nm.4001; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Kihira T, 1997, J NEUROL SCI, V147, P81, DOI 10.1016/S0022-510X(96)05313-0; Kingsbury AE, 2010, MOVEMENT DISORD, V25, P2508, DOI 10.1002/mds.23305; Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778; Kundra R, 2017, P NATL ACAD SCI USA, V114, pE5703, DOI 10.1073/pnas.1618417114; Kuppenbender KD, 2000, J COMP NEUROL, V419, P407, DOI 10.1002/(SICI)1096-9861(20000417)419:4<407::AID-CNE1>3.0.CO;2-I; Labbadia J, 2015, ANNU REV BIOCHEM, V84, P435, DOI 10.1146/annurev-biochem-060614-033955; Lake BB, 2016, SCIENCE, V352, P1586, DOI 10.1126/science.aaf1204; LANDWEHRMEYER GB, 1995, J NEUROSCI, V15, P5297; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Laslo P, 2001, NEUROREPORT, V12, P1903, DOI 10.1097/00001756-200107030-00027; Le Grand JN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063133; Lee H, 2004, ACTA NEUROPATHOL, V107, P365, DOI 10.1007/s00401-004-0820-8; Lee JH, 2014, SCIENCE, V343, P1360, DOI 10.1126/science.1250212; Liang WS, 2008, PHYSIOL GENOMICS, V33, P240, DOI 10.1152/physiolgenomics.00242.2007; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lorenzo LE, 2006, EUR J NEUROSCI, V23, P3161, DOI 10.1111/j.1460-9568.2006.04863.x; Magnusson KR, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00011; Matarin M, 2015, CELL REP, V10, P633, DOI 10.1016/j.celrep.2014.12.041; Mattson MP, 2006, NAT REV NEUROSCI, V7, P278, DOI 10.1038/nrn1886; Mattsson N, 2016, J NEUROL NEUROSUR PS, V87, P1000, DOI 10.1136/jnnp-2015-311321; McKeever PM, 2017, NEUROBIOL AGING, V57, P104, DOI 10.1016/j.neurobiolaging.2017.05.014; Mendez I, 2005, BRAIN, V128, P1498, DOI 10.1093/brain/awh510; Miller JD, 2013, CELL STEM CELL, V13, P691, DOI 10.1016/j.stem.2013.11.006; Mills KR, 2003, BRAIN, V126, P2558, DOI 10.1093/brain/awg260; Milnerwood AJ, 2010, NEURON, V65, P178, DOI 10.1016/j.neuron.2010.01.008; Mishizen-Eberz AJ, 2004, NEUROBIOL DIS, V15, P80, DOI 10.1016/j.nbd.2003.09.016; Morigaki R, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7060063; Morrison BM, 1998, ANN NEUROL, V44, pS32, DOI 10.1002/ana.410440706; Morrison JH, 2002, PROG BRAIN RES, V136, P467; MORRISON JH, 1987, BRAIN RES, V416, P331, DOI 10.1016/0006-8993(87)90914-0; MORRISON JH, 1993, NEUROBIOL AGING, V14, P51, DOI 10.1016/0197-4580(93)90021-3; Mudher A, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0488-7; Muratore CR, 2017, STEM CELL REP, V9, P1868, DOI 10.1016/j.stemcr.2017.10.015; Nichterwitz S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12139; Nitrini Ricardo, 2008, Dement Neuropsychol, V2, P164; Okamoto SI, 2009, NAT MED, V15, P1407, DOI 10.1038/nm.2056; Oliveira MAP, 2017, NPJ PARKINSONS DIS, V3, DOI 10.1038/s41531-017-0022-4; Osborne PB, 2005, NEUROSCIENCE, V131, P671, DOI 10.1016/j.neuroscience.2004.11.043; Perez SE, 2012, AM J PATHOL, V180, P526, DOI 10.1016/j.ajpath.2011.10.027; Rabinovici G D, 2007, Am J Alzheimers Dis Other Demen, V22, P474, DOI 10.1177/1533317507308779; REINER A, 1988, P NATL ACAD SCI USA, V85, P5733, DOI 10.1073/pnas.85.15.5733; Richfield EK, 1995, ANN NEUROL, V38, P852, DOI 10.1002/ana.410380605; RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465; ROBERTS GW, 1993, NEUROREPORT, V4, P7, DOI 10.1097/00001756-199301000-00001; Roessler R, 2013, STEM CELL REV REP, V9, P505, DOI 10.1007/s12015-012-9369-4; Roselli F, 2015, NEURON, V85, P901, DOI 10.1016/j.neuron.2014.12.063; Ryan BJ, 2015, TRENDS BIOCHEM SCI, V40, P200, DOI 10.1016/j.tibs.2015.02.003; Sarter M, 2002, EUR J NEUROSCI, V15, P1867, DOI 10.1046/j.1460-9568.2002.02004.x; Saxena S, 2011, NEURON, V71, P35, DOI 10.1016/j.neuron.2011.06.031; SCHAPIRA AHV, 1992, ANN NEUROL, V32, pS116, DOI 10.1002/ana.410320720; Schmidt M, 2015, P NATL ACAD SCI USA, V112, P11858, DOI 10.1073/pnas.1503455112; Seeley WW, 2007, ALZ DIS ASSOC DIS, V21, pS50, DOI 10.1097/WAD.0b013e31815c0f14; Seeley WW, 2006, ANN NEUROL, V60, P660, DOI 10.1002/ana.21055; Seeley WW, 2008, CURR OPIN NEUROL, V21, P701, DOI 10.1097/WCO.0b013e3283168e2d; Shaw PJ, 2000, J NEUROL, V247, P17; Shu S, 2016, J NEUROSCI, V36, P10843, DOI 10.1523/JNEUROSCI.2258-16.2016; Silva MC, 2016, STEM CELL REP, V7, P325, DOI 10.1016/j.stemcr.2016.08.001; SIMONIAN NA, 1995, NEUROBIOL AGING, V16, P305, DOI 10.1016/0197-4580(95)00034-C; Soreq L, 2017, CELL REP, V18, P557, DOI 10.1016/j.celrep.2016.12.011; Spina S, 2008, BRAIN, V131, P72, DOI 10.1093/brain/awm280; Squier TC, 2001, EXP GERONTOL, V36, P1539, DOI 10.1016/S0531-5565(01)00139-5; Stranahan AM, 2010, NEURAL PLAST, V2010, DOI 10.1155/2010/108190; Sulzer D, 2007, TRENDS NEUROSCI, V30, P244, DOI 10.1016/j.tins.2007.03.009; Sun AX, 2016, CELL REP, V16, P1942, DOI 10.1016/j.celrep.2016.07.035; Sun SY, 2015, P NATL ACAD SCI USA, V112, pE6993, DOI 10.1073/pnas.1520639112; Sundberg M, 2013, STEM CELLS, V31, P1548, DOI 10.1002/stem.1415; Surmeier DJ, 2010, CELL CALCIUM, V47, P175, DOI 10.1016/j.ceca.2009.12.003; Surmeier J, 2017, J NEUROSCI, V37, P9799, DOI 10.1523/JNEUROSCI.1787-16.2017; Swistowski A, 2010, STEM CELLS, V28, P1893, DOI 10.1002/stem.499; Taylor RC, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004440; Tiernan CT, 2016, NEUROBIOL AGING, V42, P80, DOI 10.1016/j.neurobiolaging.2016.02.031; Tomiyama M, 2001, J NEUROL SCI, V189, P65, DOI 10.1016/S0022-510X(01)00561-5; Tsvetkov AS, 2013, NAT CHEM BIOL, V9, P586, DOI [10.1038/nchembio.1308, 10.1038/NCHEMBIO.1308]; Varrone A, 2002, EUR J NUCL MED MOL I, V29, P1447, DOI 10.1007/s00259-002-0883-5; Victor MB, 2018, NAT NEUROSCI, V21, P341, DOI 10.1038/s41593-018-0075-7; von Lewinski F, 2005, TRENDS NEUROSCI, V28, P494, DOI 10.1016/j.tins.2005.07.001; Walker DG, 2013, EXP NEUROL, V240, P190, DOI 10.1016/j.expneurol.2012.11.020; Walker LC, 2016, ANNU REV GENET, V50, P329, DOI 10.1146/annurev-genet-120215-034943; Walker LC, 2015, ANNU REV NEUROSCI, V38, P87, DOI 10.1146/annurev-neuro-071714-033828; Wang C, 2017, STEM CELL REP, V9, P1221, DOI 10.1016/j.stemcr.2017.08.019; Wang Y, 2014, NEUROBIOL AGING, V35, P88, DOI 10.1016/j.neurobiolaging.2013.07.007; WHITEHOUSE PJ, 1982, SCIENCE, V215, P1237, DOI 10.1126/science.7058341; Wojda U, 2008, IUBMB LIFE, V60, P575, DOI 10.1002/iub.91; Yang N, 2017, NAT METHODS, V14, P621, DOI [10.1038/nmeth.4291, 10.1038/NMETH.4291]; Zeron MM, 2002, NEURON, V33, P849, DOI 10.1016/S0896-6273(02)00615-3; Zhang YS, 2013, NEURON, V78, P785, DOI 10.1016/j.neuron.2013.05.029	150	207	207	8	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2018	21	10					1350	1358		10.1038/s41593-018-0221-2	http://dx.doi.org/10.1038/s41593-018-0221-2			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GU9FY	30250262	Green Accepted, Green Submitted			2022-12-17	WOS:000445651600010
J	Dimidschstein, J; Chen, Q; Tremblay, R; Rogers, SL; Saldi, GA; Guo, LH; Xu, Q; Liu, RP; Lu, CY; Chu, JH; Avery, MC; Rashid, MS; Baek, M; Jacob, AL; Smith, GB; Wilson, DE; Kosche, G; Kruglikov, I; Rusielewicz, T; Kotak, VC; Mowery, TM; Anderson, SA; Callaway, EM; Dasen, JS; Fitzpatrick, D; Fossati, V; Long, MA; Noggle, S; Reynolds, JH; Sanes, DH; Rudy, B; Feng, GP; Fishell, G				Dimidschstein, Jordane; Chen, Qian; Tremblay, Robin; Rogers, Stephanie L.; Saldi, Giuseppe-Antonio; Guo, Lihua; Xu, Qing; Liu, Runpeng; Lu, Congyi; Chu, Jianhua; Avery, Michael C.; Rashid, Mohammad S.; Baek, Myungin; Jacob, Amanda L.; Smith, Gordon B.; Wilson, Daniel E.; Kosche, Georg; Kruglikov, Illya; Rusielewicz, Tomasz; Kotak, Vibhakar C.; Mowery, Todd M.; Anderson, Stewart A.; Callaway, Edward M.; Dasen, Jeremy S.; Fitzpatrick, David; Fossati, Valentina; Long, Michael A.; Noggle, Scott; Reynolds, John H.; Sanes, Dan H.; Rudy, Bernardo; Feng, Guoping; Fishell, Gord			A viral strategy for targeting and manipulating interneurons across vertebrate species	NATURE NEUROSCIENCE			English	Article							PROTEIN-COUPLED RECEPTORS; TRANSGENE EXPRESSION; CORTICAL INTERNEURONS; GANGLIONIC EMINENCE; GABAERGIC NEURONS; DLX GENES; ENHANCER; BRAIN; FOREBRAIN; SEIZURES	A fundamental impediment to understanding the brain is the availability of inexpensive and robust methods for targeting and manipulating specific neuronal populations. The need to overcome this barrier is pressing because there are considerable anatomical, physiological, cognitive and behavioral differences between mice and higher mammalian species in which it is difficult to specifically target and manipulate genetically defined functional cell types. In particular, it is unclear the degree to which insights from mouse models can shed light on the neural mechanisms that mediate cognitive functions in higher species, including humans. Here we describe a novel recombinant adeno-associated virus that restricts gene expression to GABAergic interneurons within the telencephalon. We demonstrate that the viral expression is specific and robust, allowing for morphological visualization, activity monitoring and functional manipulation of interneurons in both mice and non-genetically tractable species, thus opening the possibility to study GABAergic function in virtually any vertebrate species.	[Dimidschstein, Jordane; Tremblay, Robin; Rogers, Stephanie L.; Saldi, Giuseppe-Antonio; Guo, Lihua; Xu, Qing; Baek, Myungin; Kosche, Georg; Dasen, Jeremy S.; Long, Michael A.; Rudy, Bernardo; Fishell, Gord] NYU, Langone Med Ctr, Inst Neurosci, New York, NY 10003 USA; [Dimidschstein, Jordane; Tremblay, Robin; Rogers, Stephanie L.; Saldi, Giuseppe-Antonio; Guo, Lihua; Xu, Qing; Baek, Myungin; Dasen, Jeremy S.; Rudy, Bernardo; Fishell, Gord] NYU, Smilow Res Ctr, Langone Med Ctr, Dept Neurosci & Physiol, New York, NY 10003 USA; [Dimidschstein, Jordane; Guo, Lihua; Xu, Qing; Fishell, Gord] New York Univ, Ctr Genom & Syst Biol, Abu Dhabi, U Arab Emirates; [Chen, Qian; Liu, Runpeng; Lu, Congyi; Feng, Guoping] MIT, Dept Brain & Cognit Sci, McGovern Inst Brain Res, E25-618, Cambridge, MA 02139 USA; [Chu, Jianhua; Anderson, Stewart A.] Childrens Hosp Philadelphia, Dept Psychiat, Philadelphia, PA 19104 USA; [Chu, Jianhua; Anderson, Stewart A.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Avery, Michael C.; Rashid, Mohammad S.; Callaway, Edward M.; Reynolds, John H.] Salk Inst Biol Studies, Syst Neurobiol Labs, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Jacob, Amanda L.; Smith, Gordon B.; Wilson, Daniel E.; Fitzpatrick, David] Max Planck Florida Inst Neurosci, Dept Funct Architecture & Dev Cerebral Cortex, Jupiter, FL USA; [Kosche, Georg; Long, Michael A.] NYU, Dept Otolaryngol, Langone Med Ctr, Smilow Res Ctr, 550 1St Ave, New York, NY 10016 USA; [Kruglikov, Illya; Rusielewicz, Tomasz; Fossati, Valentina; Noggle, Scott] New York Stem Cell Fdn, New York, NY USA; [Kotak, Vibhakar C.; Mowery, Todd M.; Sanes, Dan H.] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Feng, Guoping] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA USA	New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; Massachusetts Institute of Technology (MIT); University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Salk Institute; Max Planck Society; New York University; NYU Langone Medical Center; The New York Stem Cell Foundation; New York University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Fishell, G (corresponding author), NYU, Langone Med Ctr, Inst Neurosci, New York, NY 10003 USA.; Fishell, G (corresponding author), NYU, Smilow Res Ctr, Langone Med Ctr, Dept Neurosci & Physiol, New York, NY 10003 USA.; Fishell, G (corresponding author), New York Univ, Ctr Genom & Syst Biol, Abu Dhabi, U Arab Emirates.	gordon.fishell@med.nyu.edu	Feng, Guoping/Y-2827-2019; Kruglikov, Ilya/AAC-9131-2020	Kruglikov, Ilya/0000-0002-1575-4636; fossati, valentina/0000-0003-1825-9371; rogers, stephanie/0000-0002-5969-0590; Noggle, Scott/0000-0002-0374-2240; Fishell, Gordon/0000-0002-9640-9278; Dimidschstein, Jordane/0000-0001-6289-6891; Mowery, Todd/0000-0001-7727-6353; Rudy, Bernardo/0000-0001-5748-6900	National Institutes of Health (NIH) [MH071679, NS08297, NS074972, MH095147]; Simons Foundation (SFARI) [MH066912, EY022577, MH063912]; NATIONAL EYE INSTITUTE [R01EY011488, R01EY022577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066912, R01MH063912, R01MH071679, T32MH096331, R01MH095147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS074972, R21NS093987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011284] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation (SFARI); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank S. Gerard, L. Sjulson and T. Petros for discussions and comments on the manuscript. Plasmids AAV-CaMKIIa-GCaMP6f-P2A-nls-dTomato and AAV-hSyn1-GCaMP6s-P2A-nls-dTomato were a gift from J. Ting (Allen Institute for Brain Science). Plasmid pNeuroD-Ires-GFP was a gift from F. Polleux (Department of Neuroscience, Mortimer B. Zuckerman Mind Brain Behavior Institute, Columbia University Medical Center). Plasmid pGP-CMV-GCaMP6f was a gift from D. Kim (Janelia Research Canipus, Howard Hughes Medical Institute). Plasmid pAAV-Efla-DIO hChR2(E123T/T159C)-EYFP was a gift from K. Deisseroth (Department of Bioengineering, Stanford University). Plasmid pAAV-hSyn-DIO-hM3D(Gq)-mCherry was a gift from B. Roth (Department of Pharmacology, UNC Chapel Hill Medical School).This work was supported by grants from the National Institutes of Health (NIH): MH071679, NS08297, NS074972, MH095147, as well as support from the Simons Foundation (SFARI) (to G.F.); MH066912 (to S.S.A.); and EY022577 and MH063912 (to E.M.C.).	Alexander GM, 2009, NEURON, V63, P27, DOI 10.1016/j.neuron.2009.06.014; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Chen YJJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061956; Choi JH, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-17; Cobos I, 2006, CEREB CORTEX, V16, pI82, DOI 10.1093/cercor/bhk003; Delzor A, 2012, HUM GENE THER METHOD, V23, P242, DOI 10.1089/hgtb.2012.073; Dittgen T, 2004, P NATL ACAD SCI USA, V101, P18206, DOI 10.1073/pnas.0407976101; Fenno LE, 2014, NAT METHODS, V11, P763, DOI [10.1038/NMETH.2996, 10.1038/nmeth.2996]; Ghanem N, 2003, GENOME RES, V13, P533, DOI 10.1101/gr.716103; Ghanem N, 2008, DEV BIOL, V322, P415, DOI 10.1016/j.ydbio.2008.07.029; Han X, 2009, NEURON, V62, P191, DOI 10.1016/j.neuron.2009.03.011; Katzel D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4847; Kepecs A, 2014, NATURE, V505, P318, DOI 10.1038/nature12983; Kotterman MA, 2014, NAT REV GENET, V15, P445, DOI 10.1038/nrg3742; Krook-Magnuson E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2376; Kugler S, 2003, GENE THER, V10, P337, DOI 10.1038/sj.gt.3301905; Marik SA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000395; Marin O, 2012, NAT REV NEUROSCI, V13, P107, DOI 10.1038/nrn3155; Miyoshi G, 2010, J NEUROSCI, V30, P1582, DOI 10.1523/JNEUROSCI.4515-09.2010; Monory K, 2006, NEURON, V51, P455, DOI 10.1016/j.neuron.2006.07.006; Nassi JJ, 2015, NEURON, V86, P1504, DOI 10.1016/j.neuron.2015.05.040; Nathanson JL, 2009, NEUROSCIENCE, V161, P441, DOI 10.1016/j.neuroscience.2009.03.032; Nord AS, 2015, NEURON, V85, P27, DOI 10.1016/j.neuron.2014.11.011; Punnakkal P, 2014, J PHYSIOL-LONDON, V592, P759, DOI 10.1113/jphysiol.2013.264937; Roth BL, 2016, NEURON, V89, P683, DOI 10.1016/j.neuron.2016.01.040; Rudy B, 2011, DEV NEUROBIOL, V71, P45, DOI 10.1002/dneu.20853; Stbhmer T., 2002, CEREB CORTEX, V12, P75; Stenman J, 2003, J NEUROSCI, V23, P167; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Urban DJ, 2015, ANNU REV PHARMACOL, V55, P399, DOI 10.1146/annurev-pharmtox-010814-124803; Visel A, 2013, CELL, V152, P895, DOI 10.1016/j.cell.2012.12.041; Whalen S, 2016, NAT GENET, V48, P488, DOI 10.1038/ng.3539; Wu ZJ, 2010, MOL THER, V18, P80, DOI 10.1038/mt.2009.255; Xu XM, 2006, J COMP NEUROL, V499, P144, DOI 10.1002/cne.21101; Zerucha T, 2000, J NEUROSCI, V20, P709, DOI 10.1523/JNEUROSCI.20-02-00709.2000; Zou D, 2016, CURR MOL MED, V16, P91, DOI 10.2174/1566524016666151222150024	36	207	215	1	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2016	19	12					1743	1749		10.1038/nn.4430	http://dx.doi.org/10.1038/nn.4430			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ED7BY	27798629	Green Published, Green Accepted			2022-12-17	WOS:000389011900035
J	Langfelder, P; Cantle, JP; Chatzopoulou, D; Wang, N; Gao, FY; Al-Ramahi, I; Lu, XH; Ramos, EM; El-Zein, K; Zhao, YN; Deverasetty, S; Tebbe, A; Schaab, C; Lavery, DJ; Howland, D; Kwak, S; Botas, J; Aaronson, JS; Rosinski, J; Coppola, G; Horvath, S; Yang, XW				Langfelder, Peter; Cantle, Jeffrey P.; Chatzopoulou, Doxa; Wang, Nan; Gao, Fuying; Al-Ramahi, Ismael; Lu, Xiao-Hong; Ramos, Eliana Marisa; El-Zein, Karla; Zhao, Yining; Deverasetty, Sandeep; Tebbe, Andreas; Schaab, Christoph; Lavery, Daniel J.; Howland, David; Kwak, Seung; Botas, Juan; Aaronson, Jeffrey S.; Rosinski, Jim; Coppola, Giovanni; Horvath, Steve; Yang, X. William			Integrated genomics and proteomics define huntingtin CAG length-dependent networks in mice	NATURE NEUROSCIENCE			English	Article							GENE-EXPRESSION CHANGES; MOUSE MODEL; EARLY MOTOR; DISEASE; NORMALIZATION; DYSFUNCTION; MECHANISMS; ACCURATE; PLATFORM; STRESS	To gain insight into how mutant huntingtin (mHtt) CAG repeat length modifies Huntington's disease (HD) pathogenesis, we profiled mRNA in over 600 brain and peripheral tissue samples from HD knock-in mice with increasing CAG repeat lengths. We found repeat length-dependent transcriptional signatures to be prominent in the striatum, less so in cortex, and minimal in the liver. Coexpression network analyses revealed 13 striatal and 5 cortical modules that correlated highly with CAG length and age, and that were preserved in HD models and sometimes in patients. Top striatal modules implicated mHtt CAG length and age in graded impairment in the expression of identity genes for striatal medium spiny neurons and in dysregulation of cyclic AMP signaling, cell death and protocadherin genes. We used proteomics to confirm 790 genes and 5 striatal modules with CAG length-dependent dysregulation at the protein level, and validated 22 striatal module genes as modifiers of mHtt toxicities in vivo.	[Langfelder, Peter; Horvath, Steve] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Cantle, Jeffrey P.; Chatzopoulou, Doxa; Wang, Nan; Gao, Fuying; Lu, Xiao-Hong; Ramos, Eliana Marisa; Zhao, Yining; Deverasetty, Sandeep; Coppola, Giovanni; Yang, X. William] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Ctr Neurobehav Genet, Los Angeles, CA 90024 USA; [Cantle, Jeffrey P.; Wang, Nan; Gao, Fuying; Lu, Xiao-Hong; Ramos, Eliana Marisa; Coppola, Giovanni; Yang, X. William] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Cantle, Jeffrey P.; Wang, Nan; Lu, Xiao-Hong; Coppola, Giovanni; Yang, X. William] Univ Calif Los Angeles, UCLA Brain Res Inst, Los Angeles, CA USA; [Al-Ramahi, Ismael; El-Zein, Karla; Botas, Juan] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Al-Ramahi, Ismael; El-Zein, Karla; Botas, Juan] Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA; [Tebbe, Andreas; Schaab, Christoph] Evotec Munich GmbH, Martinsried, Germany; [Lavery, Daniel J.; Howland, David; Kwak, Seung; Aaronson, Jeffrey S.; Rosinski, Jim] CHDI Management Inc, CHDI Fdn, Princeton, NJ USA; [Coppola, Giovanni] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Horvath, Steve] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biostat, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; Baylor College of Medicine; Baylor College of Medicine; Evotec; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Horvath, S (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA.; Yang, XW (corresponding author), Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Ctr Neurobehav Genet, Los Angeles, CA 90024 USA.; Yang, XW (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA.; Yang, XW (corresponding author), Univ Calif Los Angeles, UCLA Brain Res Inst, Los Angeles, CA USA.; Horvath, S (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Biostat, Los Angeles, CA 90095 USA.	shorvath@mednet.ucla.edu; xwyang@mednet.ucla.edu	Lu, Xiao-Hong/AAI-9661-2020; Al-Ramahi, Ismael/B-4000-2017	Al-Ramahi, Ismael/0000-0002-1275-1114; Lavery, Daniel J./0000-0002-4218-0527; Merz, Karla/0000-0003-0094-9382	CHDI Foundation, Inc.; NINDS US National Institutes of Health [R01NS074312, R01NS049501, R01NS084298]; David Weill fund from Semel Institute; Carol Moss Spivak Scholarship in Neuroscience from the Brain Research Institute at UCLA; Leslie Gehry Brenner Prize from the Hereditary Disease Foundation; NINDS Informatics Center for Neurogenetics and Neurogenomics [P30 NS062691]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049501, R01NS074312, R01NS084298, P30NS062691] Funding Source: NIH RePORTER	CHDI Foundation, Inc.; NINDS US National Institutes of Health; David Weill fund from Semel Institute; Carol Moss Spivak Scholarship in Neuroscience from the Brain Research Institute at UCLA; Leslie Gehry Brenner Prize from the Hereditary Disease Foundation; NINDS Informatics Center for Neurogenetics and Neurogenomics; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank PsychoGenics for help in breeding the knock-in allelic series and dissecting the tissues as part of a contract research agreement with CHDI. The research was supported by CHDI Foundation, Inc. HD research in the Yang laboratory is also supported by NINDS US National Institutes of Health grants (R01NS074312, R01NS049501 and R01NS084298). X.W.Y is also supported by the David Weill fund from Semel Institute, the Carol Moss Spivak Scholarship in Neuroscience from the Brain Research Institute at UCLA, and the Leslie Gehry Brenner Prize from the Hereditary Disease Foundation. We acknowledge the support of the NINDS Informatics Center for Neurogenetics and Neurogenomics (P30 NS062691).	Al-Ramahi I, 2006, J BIOL CHEM, V281, P26714, DOI 10.1074/jbc.M601603200; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Aylward EH, 2013, J HUNTINGTONS DIS, V2, P477, DOI 10.3233/JHD-130076; Becanovic K, 2010, HUM MOL GENET, V19, P1438, DOI 10.1093/hmg/ddq018; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Biagioli M, 2015, HUM MOL GENET, V24, P2442, DOI 10.1093/hmg/ddv006; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Chen WV, 2013, DEVELOPMENT, V140, P3297, DOI 10.1242/dev.090621; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2009, NAT PROTOC, V4, P698, DOI 10.1038/nprot.2009.36; Deneris ES, 2014, NAT NEUROSCI, V17, P899, DOI 10.1038/nn.3731; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dowen JM, 2014, CELL, V159, P374, DOI 10.1016/j.cell.2014.09.030; Durrenberger PF, 2015, J NEURAL TRANSM, V122, P1055, DOI 10.1007/s00702-014-1293-0; Fishell G, 2013, NEURON, V80, P602, DOI 10.1016/j.neuron.2013.10.035; Geiger T, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014050; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Giles P, 2012, BRAIN RES BULL, V88, P199, DOI 10.1016/j.brainresbull.2011.10.001; Grange P, 2014, P NATL ACAD SCI USA, V111, P5397, DOI 10.1073/pnas.1312098111; Gu XF, 2015, NEURON, V85, P726, DOI 10.1016/j.neuron.2015.01.008; Guo Y, 2012, P NATL ACAD SCI USA, V109, P21081, DOI 10.1073/pnas.1219280110; Gusella JF, 2006, TRENDS BIOCHEM SCI, V31, P533, DOI 10.1016/j.tibs.2006.06.009; Gusella JF, 2000, NAT REV NEUROSCI, V1, P109, DOI 10.1038/35039051; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Hodges A, 2006, HUM MOL GENET, V15, P965, DOI 10.1093/hmg/ddl013; Horvath S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000117; Jacobsen JC, 2011, HUM MOL GENET, V20, P2846, DOI 10.1093/hmg/ddr195; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kaltenbach LS, 2007, PLOS GENET, V3, P689, DOI 10.1371/journal.pgen.0030082; Kuhn A, 2007, HUM MOL GENET, V16, P1845, DOI 10.1093/hmg/ddm133; Labbadia J, 2013, TRENDS BIOCHEM SCI, V38, P378, DOI 10.1016/j.tibs.2013.05.003; Langfelder P, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-54; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langfelder P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061505; Langfelder P, 2012, J STAT SOFTW, V46, P1; Lee JM, 2015, CELL, V162, P516, DOI 10.1016/j.cell.2015.07.003; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lobo MK, 2006, NAT NEUROSCI, V9, P443, DOI 10.1038/nn1654; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu T, 2014, NATURE, V507, P448, DOI 10.1038/nature13163; Lu XH, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3010523; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mann M, 2013, MOL CELL, V49, P583, DOI 10.1016/j.molcel.2013.01.029; Menalled LB, 2003, J COMP NEUROL, V465, P11, DOI 10.1002/cne.10776; Menalled LB, 2002, J NEUROSCI, V22, P8266; Menalled LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049838; Mielcarek M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004550; Miller JA, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-322; Monahan K, 2012, P NATL ACAD SCI USA, V109, P9125, DOI 10.1073/pnas.1205074109; Oldham MC, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-63; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Pal A, 2006, J CELL BIOL, V172, P605, DOI 10.1083/jcb.200509091; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Pouladi MA, 2013, NAT REV NEUROSCI, V14, P708, DOI 10.1038/nrn3570; REINER A, 1988, P NATL ACAD SCI USA, V85, P5733, DOI 10.1073/pnas.85.15.5733; Ross CA, 2014, NAT REV NEUROL, V10, P204, DOI 10.1038/nrneurol.2014.24; Seong IS, 2005, HUM MOL GENET, V14, P2871, DOI 10.1093/hmg/ddi319; Sharma K, 2015, NAT NEUROSCI, V18, P1819, DOI 10.1038/nn.4160; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Shirasaki DI, 2012, NEURON, V75, P41, DOI 10.1016/j.neuron.2012.05.024; Smith GA, 2014, HUM MOL GENET, V23, P4510, DOI 10.1093/hmg/ddu166; Stouffer S. A., 1949, THE AM SOLDIER; Toyoda S, 2014, NEURON, V82, P94, DOI 10.1016/j.neuron.2014.02.005; Valencia A, 2013, J HUNTINGTONS DIS, V2, P459, DOI 10.3233/JHD-130080; Van Raamsdonk JM, 2007, NEUROBIOL DIS, V26, P512, DOI 10.1016/j.nbd.2007.01.006; Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369; Wang N, 2014, NAT MED, V20, P540, DOI 10.1038/nm.3514; Wang YX, 2011, PROTEOMICS, V11, P2019, DOI 10.1002/pmic.201000722; Zaykin DV, 2011, J EVOLUTION BIOL, V24, P1836, DOI 10.1111/j.1420-9101.2011.02297.x; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030; Zuccato C, 2003, NAT GENET, V35, P76, DOI 10.1038/ng1219	74	207	209	2	79	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2016	19	4					623	+		10.1038/nn.4256	http://dx.doi.org/10.1038/nn.4256			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DH6OI	26900923	Green Accepted, Green Submitted			2022-12-17	WOS:000372909800020
J	Lee, BR; Ma, YY; Huang, YHH; Wang, XS; Otaka, M; Ishikawa, M; Neumann, PA; Graziane, NM; Brown, TE; Suska, A; Guo, CY; Lobo, MK; Sesack, SR; Wolf, ME; Nestler, EJ; Shaham, Y; Schluter, OM; Dong, Y				Lee, Brian R.; Ma, Yao-Ying; Huang, Yanhua H.; Wang, Xiusong; Otaka, Mami; Ishikawa, Masago; Neumann, Peter A.; Graziane, Nicholas M.; Brown, Travis E.; Suska, Anna; Guo, Changyong; Lobo, Mary Kay; Sesack, Susan R.; Wolf, Marina E.; Nestler, Eric J.; Shaham, Yavin; Schlueter, Oliver M.; Dong, Yan			Maturation of silent synapses in amygdala-accumbens projection contributes to incubation of cocaine craving	NATURE NEUROSCIENCE			English	Article							PERMEABLE AMPA RECEPTORS; NUCLEUS-ACCUMBENS; REINSTATEMENT MODEL; DRUG RELAPSE; EXPOSURE; TRANSMISSION; PLASTICITY; WITHDRAWAL; SEEKING; ADAPTATIONS	In rat models of drug relapse and craving, cue-induced cocaine seeking progressively increases after withdrawal from the drug. This 'incubation of cocaine craving' is partially mediated by time-dependent adaptations at glutamatergic synapses in nucleus accumbens (NAc). However, the circuit-level adaptations mediating this plasticity remain elusive. We studied silent synapses, often regarded as immature synapses that express stable NMDA receptors with AMPA receptors being either absent or labile, in the projection from the basolateral amygdala to the NAc in incubation of cocaine craving. Silent synapses were detected in this projection during early withdrawal from cocaine. As the withdrawal period progressed, these silent synapses became unsilenced, a process that involved synaptic insertion of calcium-permeable AMPA receptors (CP-AMPARs). In vivo optogenetic stimulation-induced downregulation of CP-AMPARs at amygdala-to-NAc synapses, which re-silenced some of the previously silent synapses after prolonged withdrawal, decreased incubation of cocaine craving. Our findings indicate that silent synapse-based reorganization of the amygdala-to-NAc projection is critical for persistent cocaine craving and relapse after withdrawal.	[Lee, Brian R.] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL USA; [Lee, Brian R.; Brown, Travis E.; Dong, Yan] Washington State Univ, Program Neurosci, Pullman, WA 99164 USA; [Ma, Yao-Ying; Otaka, Mami; Ishikawa, Masago; Neumann, Peter A.; Graziane, Nicholas M.; Guo, Changyong; Sesack, Susan R.; Dong, Yan] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA USA; [Huang, Yanhua H.; Wang, Xiusong] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA USA; [Suska, Anna; Schlueter, Oliver M.] European Neurosci Inst, Gottingen, Germany; [Lobo, Mary Kay; Nestler, Eric J.] Mt Sinai Sch Med, Fishberg Dept Neurosci, New York, NY USA; [Lobo, Mary Kay; Nestler, Eric J.] Mt Sinai Sch Med, Friedman Brain Inst, New York, NY USA; [Wolf, Marina E.] Rosalind Franklin Univ Med & Sci, Dept Neurosci, N Chicago, IL USA; [Shaham, Yavin] NIDA, Behav Neurosci Branch, Intramural Res Program, US NIH, Baltimore, MD USA	Scripps Research Institute; Washington State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Rosalind Franklin University Medical & Science; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Dong, Y (corresponding author), Washington State Univ, Program Neurosci, Pullman, WA 99164 USA.	yandong@pitt.edu	Dong, Yan/A-4154-2016; Huang, Yanhua/P-1583-2015; Beroun, Anna/P-6322-2016; Sesack, Susan R/H-8013-2018; shaham, yavin/G-1306-2014; Lobo, Mary Kay/K-7734-2015	Dong, Yan/0000-0003-0016-9028; Huang, Yanhua/0000-0003-1770-0196; Beroun, Anna/0000-0003-4376-5241; Sesack, Susan R/0000-0002-2852-7440; Lobo, Mary Kay/0000-0002-9419-2079; Lee, Brian/0000-0002-3210-5638; Graziane, Nicholas/0000-0002-7055-7029	National Institute on Drug Abuse [DA028020, DA029565, DA036303, DA030379, DA009621, DA029099, DA007359, DA014133, DA023206, DA031551, DA034856]; German Research Foundation through the Cluster of Excellence "Nanoscale Microscopy and Molecular Physiology of the Brain"; Gottingen University Medical School; Max Planck Society;  [SCHL592/4]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA014133, R37DA007359, R01DA009621, ZIADA000434, F31DA028020, R00DA029565, R01DA015835, R21DA036303, R37DA015835, P01DA008227, K05DA029099, R01DA007359, R01DA030379, R01DA023206, K99DA029565, R21DA031551, R01DA034856] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); German Research Foundation through the Cluster of Excellence "Nanoscale Microscopy and Molecular Physiology of the Brain"; Gottingen University Medical School; Max Planck Society(Max Planck SocietyFoundation CELLEX); ; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank B. Sorg, D. Dietz, R.L. Brown and H. Jansen for technical consultations. This research was supported by the Intramural Research Program of the National Institute on Drug Abuse (Y.S.), extramural funds DA028020 (B.R.L.), DA029565 and DA036303 (Y.H.H.), DA030379 (M.E.W. and Y.D.), DA009621 and DA029099 (M.E.W.), DA007359 and DA014133 (E.J.N.), DA023206, DA031551 and DA034856 (Y.D.) from the National Institute on Drug Abuse, the German Research Foundation through the Cluster of Excellence "Nanoscale Microscopy and Molecular Physiology of the Brain" and grant SCHL592/4 (O.M.S.). The European Neuroscience Institute Gottingen is jointly funded by the Gottingen University Medical School and the Max Planck Society.	Barria A, 2002, NEURON, V35, P345, DOI 10.1016/S0896-6273(02)00776-6; Belin D, 2009, BEHAV BRAIN RES, V199, P89, DOI 10.1016/j.bbr.2008.09.027; Bossert JM, 2013, PSYCHOPHARMACOLOGY, V229, P453, DOI 10.1007/s00213-013-3120-y; Brown TE, 2011, J NEUROSCI, V31, P8163, DOI 10.1523/JNEUROSCI.0016-11.2011; Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005; Carroll RC, 2001, NAT REV NEUROSCI, V2, P315, DOI 10.1038/35072500; Conrad KL, 2008, NATURE, V454, P118, DOI 10.1038/nature06995; Cull-Candy S, 2006, CURR OPIN NEUROBIOL, V16, P288, DOI 10.1016/j.conb.2006.05.012; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; Ferrario CR, 2011, NEUROPHARMACOLOGY, V61, P1141, DOI 10.1016/j.neuropharm.2011.01.021; GAWIN FH, 1986, ARCH GEN PSYCHIAT, V43, P107; Grimm JW, 2001, NATURE, V412, P141, DOI 10.1038/35084134; Hollander JA, 2005, NEUROPSYCHOPHARMACOL, V30, P1464, DOI 10.1038/sj.npp.1300748; Hollander JA, 2007, J NEUROSCI, V27, P3535, DOI 10.1523/JNEUROSCI.3667-06.2007; Huang YHH, 2009, NEURON, V63, P40, DOI 10.1016/j.neuron.2009.06.007; HUNT WA, 1971, J CLIN PSYCHOL, V27, P455, DOI 10.1002/1097-4679(197110)27:4<455::AID-JCLP2270270412>3.0.CO;2-R; Isaac JTR, 1997, NEURON, V18, P269, DOI 10.1016/S0896-6273(00)80267-6; Kalivas PW, 2009, NAT REV NEUROSCI, V10, P561, DOI 10.1038/nrn2515; Kerchner GA, 2008, NAT REV NEUROSCI, V9, P813, DOI 10.1038/nrn2501; Koya E, 2012, NAT NEUROSCI, V15, P1556, DOI 10.1038/nn.3232; Lee BR, 2011, NEUROPHARMACOLOGY, V61, P1060, DOI 10.1016/j.neuropharm.2010.12.033; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Loweth JA, 2013, CURR OPIN NEUROBIOL, V23, P500, DOI 10.1016/j.conb.2013.01.009; Lu L, 2004, NEUROPHARMACOLOGY, V47, P214, DOI 10.1016/j.neuropharm.2004.06.027; Lu L, 2004, PSYCHOPHARMACOLOGY, V176, P101, DOI 10.1007/s00213-004-1860-4; Lu L, 2009, BIOL PSYCHIAT, V66, P137, DOI 10.1016/j.biopsych.2009.02.009; Mameli M, 2009, NAT NEUROSCI, V12, P1036, DOI 10.1038/nn.2367; Marchant NJ, 2013, CURR OPIN NEUROBIOL, V23, P675, DOI 10.1016/j.conb.2013.01.003; Martin M, 2006, NAT NEUROSCI, V9, P868, DOI 10.1038/nn1713; McCutcheon JE, 2011, J NEUROSCI, V31, P14536, DOI 10.1523/JNEUROSCI.3625-11.2011; McCutcheon JE, 2011, J NEUROSCI, V31, P5737, DOI 10.1523/JNEUROSCI.0350-11.2011; Mu P, 2010, J NEUROSCI, V30, P3689, DOI 10.1523/JNEUROSCI.4063-09.2010; Otaka M, 2013, J NEUROSCI, V33, P6753, DOI 10.1523/JNEUROSCI.4577-12.2013; Pickens CL, 2011, TRENDS NEUROSCI, V34, P411, DOI 10.1016/j.tins.2011.06.001; Pitkanen A., 2000, AMYGDALA FUNCTIONAL; Purgianto A, 2013, NEUROPSYCHOPHARMACOL, V38, P1789, DOI 10.1038/npp.2013.78; Robinson TE, 2004, NEUROPHARMACOLOGY, V47, P33, DOI 10.1016/j.neuropharm.2004.06.025; Russo SJ, 2010, TRENDS NEUROSCI, V33, P267, DOI 10.1016/j.tins.2010.02.002; Setlow B, 2002, BEHAV NEUROSCI, V116, P267, DOI 10.1037//0735-7044.116.2.267; Shaham Y, 2003, PSYCHOPHARMACOLOGY, V168, P3, DOI 10.1007/s00213-002-1224-x; Sorge RE, 2005, PSYCHOPHARMACOLOGY, V183, P210, DOI 10.1007/s00213-005-0160-y; Stuber GD, 2011, NATURE, V475, P377, DOI 10.1038/nature10194; Suska A, 2013, P NATL ACAD SCI USA, V110, P713, DOI 10.1073/pnas.1206287110; Theberge FR, 2013, BIOL PSYCHIAT, V73, P729, DOI 10.1016/j.biopsych.2012.12.019; Thomas MJ, 2001, NAT NEUROSCI, V4, P1217, DOI 10.1038/nn757; Voorn P, 2004, TRENDS NEUROSCI, V27, P468, DOI 10.1016/j.tins.2004.06.006; Waites CL, 2005, ANNU REV NEUROSCI, V28, P251, DOI 10.1146/annurev.neuro.27.070203.144336; Wolf ME, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00072; Wolf ME, 2010, NEUROSCI BIOBEHAV R, V35, P185, DOI 10.1016/j.neubiorev.2010.01.013	50	207	207	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2013	16	11					1644	1651		10.1038/nn.3533	http://dx.doi.org/10.1038/nn.3533			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241YX	24077564	Green Accepted			2022-12-17	WOS:000326205700022
J	Tai, LH; Lee, AM; Benavidez, N; Bonci, A; Wilbrecht, L				Tai, Lung-Hao; Lee, A. Moses; Benavidez, Nora; Bonci, Antonello; Wilbrecht, Linda			Transient stimulation of distinct subpopulations of striatal neurons mimics changes in action value	NATURE NEUROSCIENCE			English	Article							MEDIUM SPINY NEURONS; BASAL GANGLIA; DECISION-MAKING; DORSOMEDIAL STRIATUM; SUPERIOR COLLICULUS; MATCHING BEHAVIOR; PREFRONTAL CORTEX; PRIMATE STRIATUM; TRANSGENIC MICE; MOTOR PROGRAMS	In changing environments, animals must adaptively select actions to achieve their goals. In tasks involving goal-directed action selection, striatal neural activity has been shown to represent the value of competing actions. Striatal representations of action value could potentially bias responses toward actions of higher value. However, no study to date has demonstrated the direct effect of distinct striatal pathways in goal-directed action selection. We found that transient optogenetic stimulation of dorsal striatal dopamine D1 and D2 receptor-expressing neurons during decision-making in mice introduced opposing biases in the distribution of choices. The effect of stimulation on choice was dependent on recent reward history and mimicked an additive change in the action value. Although stimulation before and during movement initiation produced a robust bias in choice behavior, this bias was substantially diminished when stimulation was delayed after response initiation. Together, our data suggest that striatal activity is involved in goal-directed action selection.	[Tai, Lung-Hao; Lee, A. Moses; Benavidez, Nora; Wilbrecht, Linda] Ernest Gallo Clin & Res Ctr, Emeryville, CA USA; [Lee, A. Moses] Univ Calif San Francisco, Neurosci Grad Program, Med Scientist Training Program, San Francisco, CA 94143 USA; [Benavidez, Nora] Univ Calif Berkeley, Cognit Sci Program, Berkeley, CA 94720 USA; [Bonci, Antonello; Wilbrecht, Linda] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Bonci, Antonello] Natl Inst Drug Abuse, Intramural Program, Baltimore, MD USA; [Bonci, Antonello] Johns Hopkins Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); Johns Hopkins University; Johns Hopkins Medicine	Wilbrecht, L (corresponding author), Ernest Gallo Clin & Res Ctr, Emeryville, CA USA.	lwilbrecht@gallo.ucsf.edu	Lee, A Moses/GPP-4361-2022; Wilbrecht, Linda/J-7988-2013		State of California; US National Institutes of Health [1RC2NS069350, R01MH087542, R01DA029150]; P. Royer and K. Clayton Family; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH087542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC2NS069350] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA029150] Funding Source: NIH RePORTER	State of California; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); P. Royer and K. Clayton Family; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank G. Stuber, F. Ambroggi, D. Niell, K. Berger, C. Wu and H. Peckler for assistance with experiments, V. Kharazia for immunostaining and histological quantification, K. Deisseroth (Stanford University) for advice and reagents, and C. Niell for comments on the manuscript. This work was supported by the State of California, the US National Institutes of Health (1RC2NS069350; R01MH087542 and R01DA029150), and the P. Royer and K. Clayton Family.	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Ariano MA, 2005, J NEUROPHYSIOL, V93, P2565, DOI 10.1152/jn.00791.2004; Balleine BW, 2007, J NEUROSCI, V27, P8161, DOI 10.1523/JNEUROSCI.1554-07.2007; Barnes TD, 2005, NATURE, V437, P1158, DOI 10.1038/nature04053; Brainard MS, 2000, NATURE, V404, P762, DOI 10.1038/35008083; Castane A, 2010, BEHAV BRAIN RES, V210, P74, DOI 10.1016/j.bbr.2010.02.017; Cromwell HC, 2003, J NEUROPHYSIOL, V89, P2823, DOI 10.1152/jn.01014.2002; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; Desmurget M, 2010, J NEUROSCI, V30, P7685, DOI 10.1523/JNEUROSCI.0163-10.2010; Felsen G, 2008, NEURON, V60, P137, DOI 10.1016/j.neuron.2008.09.019; GERFEN CR, 1992, TRENDS NEUROSCI, V15, P133, DOI 10.1016/0166-2236(92)90355-C; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Grillner S, 2005, TRENDS NEUROSCI, V28, P364, DOI 10.1016/j.tins.2005.05.004; Grillner S, 2008, BRAIN RES REV, V57, P2, DOI 10.1016/j.brainresrev.2007.06.027; Hikosaka O, 2006, J NEUROPHYSIOL, V95, P567, DOI 10.1152/jn.00458.2005; Hikosaka O, 2010, TRENDS COGN SCI, V14, P154, DOI 10.1016/j.tics.2010.01.006; Ikeda T, 2003, NEURON, V39, P693, DOI 10.1016/S0896-6273(03)00464-1; Isoda M, 2011, EUR J NEUROSCI, V33, P2058, DOI 10.1111/j.1460-9568.2011.07698.x; Jiang H, 2003, NATURE, V423, P982, DOI 10.1038/nature01698; Jin X, 2010, NATURE, V466, P457, DOI 10.1038/nature09263; Kable JW, 2009, NEURON, V63, P733, DOI 10.1016/j.neuron.2009.09.003; KAWAGUCHI Y, 1995, TRENDS NEUROSCI, V18, P527, DOI 10.1016/0166-2236(95)98374-8; Kim H, 2009, J NEUROSCI, V29, P14701, DOI 10.1523/JNEUROSCI.2728-09.2009; Kimchi EY, 2009, J NEUROSCI, V29, P14891, DOI 10.1523/JNEUROSCI.4060-09.2009; Kravitz AV, 2012, NAT NEUROSCI, V15, P816, DOI 10.1038/nn.3100; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Kreitzer AC, 2011, NEUROSCIENCE, V198, P19, DOI 10.1016/j.neuroscience.2011.08.018; Kreitzer AC, 2008, NEURON, V60, P543, DOI 10.1016/j.neuron.2008.11.005; Kubota Y, 2009, J NEUROPHYSIOL, V102, P2142, DOI 10.1152/jn.00522.2009; Lau B, 2005, J EXP ANAL BEHAV, V84, P555, DOI 10.1901/jeab.2005.110-04; Lau B, 2008, NEURON, V58, P451, DOI 10.1016/j.neuron.2008.02.021; Lauwereyns J, 2002, NATURE, V418, P413, DOI 10.1038/nature00892; Lo CC, 2006, NAT NEUROSCI, V9, P956, DOI 10.1038/nn1722; Lobo MK, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00041; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; Pasupathy A, 2005, NATURE, V433, P873, DOI 10.1038/nature03287; Ragozzino ME, 2007, ANN NY ACAD SCI, V1121, P355, DOI 10.1196/annals.1401.013; Rangel A, 2008, NAT REV NEUROSCI, V9, P545, DOI 10.1038/nrn2357; Redgrave P, 1999, TRENDS NEUROSCI, V22, P146, DOI 10.1016/S0166-2236(98)01373-3; Redgrave P, 1999, NEUROSCIENCE, V89, P1009, DOI 10.1016/S0306-4522(98)00319-4; Rymar VV, 2004, J COMP NEUROL, V469, P325, DOI 10.1002/cne.11008; SALZMAN CD, 1990, NATURE, V346, P174, DOI 10.1038/346174a0; Samejima K, 2005, SCIENCE, V310, P1337, DOI 10.1126/science.1115270; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schwarting RKW, 1996, PROG NEUROBIOL, V50, P275, DOI 10.1016/S0301-0082(96)00040-8; Shuen JA, 2008, J NEUROSCI, V28, P2681, DOI 10.1523/JNEUROSCI.5492-07.2008; Sparta DR, 2012, NAT PROTOC, V7, P12, DOI 10.1038/nprot.2011.413; Sugrue LP, 2005, NAT REV NEUROSCI, V6, P363, DOI 10.1038/nrn1666; Sutton Richard S, 1998, INTRO REINFORCEMENT, V2; Thorn CA, 2010, NEURON, V66, P781, DOI 10.1016/j.neuron.2010.04.036; Turner RS, 2010, CURR OPIN NEUROBIOL, V20, P704, DOI 10.1016/j.conb.2010.08.022; Watanabe K, 2005, J NEUROPHYSIOL, V94, P1879, DOI 10.1152/jn.00012.2005	52	207	206	1	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2012	15	9					1281	U152		10.1038/nn.3188	http://dx.doi.org/10.1038/nn.3188			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	996GJ	22902719	Green Submitted, Green Accepted			2022-12-17	WOS:000308072600019
J	Rossi, S; Cappa, SF; Babiloni, C; Pasqualetti, P; Miniussi, C; Carducci, F; Babiloni, F; Rossini, PM				Rossi, S; Cappa, SF; Babiloni, C; Pasqualetti, P; Miniussi, C; Carducci, F; Babiloni, F; Rossini, PM			Prefontal cortex in long-term memory: an "interference" approach using magnetic stimulation	NATURE NEUROSCIENCE			English	Article							POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; EPISODIC MEMORY; WORKING-MEMORY; RECOGNITION MEMORY; FUNCTIONAL NEUROANATOMY; COGNITIVE NEUROSCIENCE; FALSE RECOGNITION; RETRIEVAL; FMRI	Neuroimaging has consistently shown engagement of the prefrontal cortex during episodic memory tasks, but the functional relevance of this metabolic/hemodynamic activation in memory processing is still to be determined. We used repetitive transcranial magnetic stimulation (rTMS) to transiently interfere with either left or right prefrontal brain activity during the encoding or retrieval of pictures showing complex scenes. We found that the right dorsolateral prefrontal cortex (DLPFC) was crucial for the retrieval of the encoded pictorial information, whereas the left DLPFC was involved in encoding operations. This 'interference' approach allowed us to establish whether a cortical area activated by a memory task actually contributes to behavioral performance.	IRCCS S Giovanni di Dio, I-25125 Brescia, Italy; Policlin Le Scotte, UO Neurofisiopatol, Dipartimento Neurosci, Sez Neurol, I-53100 Siena, Italy; Univ Salute Vita S Raffaele, Ctr Neurosci Cognit, I-20132 Milan, Italy; Univ Roma La Sapienza, Dipartimento Fisiol Umana & Farmacol, I-00185 Rome, Italy; AFaR, Dipartimento Neurosci, Fatebenefratelli Isola Tiberina, I-00186 Rome, Italy	IRCCS Fatebenefratelli; University of Siena; Vita-Salute San Raffaele University; Sapienza University Rome	Rossi, S (corresponding author), IRCCS S Giovanni di Dio, Via Pilastroni 4, I-25125 Brescia, Italy.		Babiloni, Claudio/AAC-5324-2022; Miniussi, Carlo/E-7602-2010; Cappa, Stefano/B-1874-2014; Pasqualetti, Patrizio/D-4496-2013; Miniussi, Carlo/P-5610-2019; Rossini, Paolo M./D-4994-2013; Rossi, Simone/AAC-6067-2022; Babiloni, Fabio/E-5169-2015	Babiloni, Claudio/0000-0002-5245-9839; Miniussi, Carlo/0000-0002-5436-4745; Cappa, Stefano/0000-0003-1003-3925; Pasqualetti, Patrizio/0000-0001-5560-1979; Miniussi, Carlo/0000-0002-5436-4745; Rossini, Paolo M./0000-0003-2665-534X; Rossi, Simone/0000-0001-6697-9459; Babiloni, Fabio/0000-0002-4962-176X; carducci, filippo/0000-0003-4795-0970	Telethon [E.C0985] Funding Source: Medline	Telethon(Fondazione Telethon)		AMASSIAN VE, 1990, ELECTROEN CLIN NEURO, V77, P390, DOI 10.1016/0168-5597(90)90061-H; Brandt SA, 1998, EXP BRAIN RES, V118, P197, DOI 10.1007/s002210050272; Buckner RL, 1998, NEUROIMAGE, V7, P151, DOI 10.1006/nimg.1998.0327; Cabeza Roberto, 2000, Current Opinion in Neurology, V13, P415, DOI 10.1097/00019052-200008000-00008; Callicott JH, 1999, CEREB CORTEX, V9, P20, DOI 10.1093/cercor/9.1.20; Curran T, 1997, NEUROPSYCHOLOGIA, V35, P1035, DOI 10.1016/S0028-3932(97)00029-8; Desgranges B, 1998, NEUROIMAGE, V8, P198, DOI 10.1006/nimg.1998.0359; Fletcher PC, 2001, BRAIN, V124, P849, DOI 10.1093/brain/124.5.849; Fletcher PC, 1997, TRENDS NEUROSCI, V20, P213, DOI 10.1016/S0166-2236(96)01013-2; Flitman SS, 1998, NEUROLOGY, V50, P175, DOI 10.1212/WNL.50.1.175; Hallett M, 2000, NATURE, V406, P147, DOI 10.1038/35018000; Haxby JV, 2000, NEUROIMAGE, V11, P380, DOI 10.1006/nimg.2000.0592; ILLMONIEMI RJ, 1997, NEUROREPORT, V8, P3537; Jahanshahi M, 1998, BRAIN, V121, P1533, DOI 10.1093/brain/121.8.1533; JANOWSKY JS, 1989, BEHAV NEUROSCI, V103, P548, DOI 10.1037/0735-7044.103.3.548; KAMMAN R, 1970, WORKBOOK GEN PSYCHOL, P228; Kirchhoff BA, 2000, J NEUROSCI, V20, P6173, DOI 10.1523/JNEUROSCI.20-16-06173.2000; Lepage M, 2000, P NATL ACAD SCI USA, V97, P506, DOI 10.1073/pnas.97.1.506; McDermott KB, 1999, J COGNITIVE NEUROSCI, V11, P631, DOI 10.1162/089892999563698; MILNER B, 1991, NEUROPSYCHOLOGIA, V29, P601, DOI 10.1016/0028-3932(91)90013-X; MILNER B, 1964, FRONTAL AGRANULAR CO; Mottaghy FM, 2000, NEUROSCI LETT, V280, P167, DOI 10.1016/S0304-3940(00)00798-9; NICKERSON RS, 1973, PSYCHOL REV, V80, P489, DOI 10.1037/h0035437; Nyberg L, 1995, NEUROREPORT, V7, P249, DOI 10.1097/00001756-199512000-00060; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oliveri M, 2000, BRAIN, V123, P1939, DOI 10.1093/brain/123.9.1939; Pascual-Leone A, 2000, CURR OPIN NEUROBIOL, V10, P232, DOI 10.1016/S0959-4388(00)00081-7; PascualLeone A, 1996, EXP BRAIN RES, V107, P479; Paus T, 1997, J NEUROSCI, V17, P3178; Rossi S, 2000, CEREB CORTEX, V10, P802, DOI 10.1093/cercor/10.8.802; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Rossini PM, 1998, ELECTROEN CLIN NEURO, V106, P180, DOI 10.1016/S0013-4694(97)00097-7; Rowe JB, 2000, SCIENCE, V288, P1656, DOI 10.1126/science.288.5471.1656; Rugg MD, 1999, NEUROIMAGE, V10, P520, DOI 10.1006/nimg.1999.0488; Schacter DL, 1997, NEUROIMAGE, V6, P259, DOI 10.1006/nimg.1997.0305; Schacter DL, 1996, NEURON, V17, P267, DOI 10.1016/S0896-6273(00)80158-0; Schacter DL, 1999, HIPPOCAMPUS, V9, P7, DOI 10.1002/(SICI)1098-1063(1999)9:1<7::AID-HIPO2>3.0.CO;2-K; SHALLICE T, 1994, NATURE, V368, P633, DOI 10.1038/368633a0; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Swick D, 1999, NEUROPSYCHOLOGY, V13, P155, DOI 10.1037/0894-4105.13.2.155; TULVING E, 1994, P NATL ACAD SCI USA, V91, P2016, DOI 10.1073/pnas.91.6.2016; Wagner AD, 1999, NEURON, V22, P19, DOI 10.1016/S0896-6273(00)80674-1; Walsh V, 2000, NAT REV NEUROSCI, V1, P73, DOI 10.1038/35036239; Wheeler M A, 1995, J Int Neuropsychol Soc, V1, P525	44	207	212	0	28	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2001	4	9					948	952		10.1038/nn0901-948	http://dx.doi.org/10.1038/nn0901-948			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	467JL	11528428	Green Published			2022-12-17	WOS:000170698600023
J	Elson, GCA; Lelievre, E; Guillet, C; Chevalier, S; Plun-Favreau, H; Froger, J; Suard, I; de Coignac, AB; Delneste, Y; Bonnefoy, JY; Gauchat, JF; Gascan, H				Elson, GCA; Lelievre, E; Guillet, C; Chevalier, S; Plun-Favreau, H; Froger, J; Suard, I; de Coignac, AB; Delneste, Y; Bonnefoy, JY; Gauchat, JF; Gascan, H			CLF associates with CLC to form a functional heteromeric ligand for the CNTF receptor complex	NATURE NEUROSCIENCE			English	Article							CILIARY NEUROTROPHIC FACTOR; AMYOTROPHIC-LATERAL-SCLEROSIS; LEUKEMIA INHIBITORY FACTOR; MOTOR-NEURONS; MICE LACKING; LIFR-BETA; CYTOKINE; FAMILY; SURVIVAL; DISEASE	Ciliary neurotrophic factor (CNTF) is a cytokine supporting the differentiation and survival of various cell types in the peripheral and central nervous systems. Its receptor complex consists of a non-signaling alpha chain, CNTFR, and two signaling beta chains, gp130 and the leukemia inhibitory factor receptor (LIFR). Striking phenotypic differences between CNTF- and CNTFR-deficient mice suggest that CNTFR serves as a receptor for a second, developmentally important ligand. We have identified this factor as a stable secreted complex of cardiotrophin-like cytokine (CLC) and the soluble receptor cytokine-like factor-1 (CLF). CLF expression was required for CLC secretion, and the complex acted only on cells expressing functional CNTF receptors. The CLF/CLC complex activated gp130, LIFR and signal transducer and activator of transcription 3 (STAT3) and supported motor neuron survival. Our results indicate that the CLF/CLC complex is a second ligand for CNTFR with potentially important implications in nervous system development.	Ctr Immunol Pierre Fabre, F-74164 St Julien Genevois, France; CHU Angers, INSERM, E9928, F-49033 Angers, France	Centre d'Immunologie Pierre Fabre; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Centre Hospitalier Universitaire d'Angers	Gauchat, JF (corresponding author), Ctr Immunol Pierre Fabre, 5 Ave Napoleon III, F-74164 St Julien Genevois, France.		Lelievre, Eric/M-2878-2015; DELNESTE, Yves/K-7367-2015; Plun-Favreau, Helene/Q-4111-2016; Delneste, Yves/O-3956-2016; PLUN-FAVREAU, Helene/C-8513-2009	DELNESTE, Yves/0000-0002-2142-596X; Plun-Favreau, Helene/0000-0002-1401-9656; lelievre, eric/0000-0002-4132-4023				Aebischer P, 1996, NAT MED, V2, P696, DOI 10.1038/nm0696-696; Alexander WS, 1999, CURR BIOL, V9, P605, DOI 10.1016/S0960-9822(99)80266-8; Anderson KD, 1996, P NATL ACAD SCI USA, V93, P7346, DOI 10.1073/pnas.93.14.7346; ARAKAWA Y, 1990, J NEUROSCI, V10, P3507; Arce V, 1999, J NEUROSCI RES, V55, P119, DOI 10.1002/(SICI)1097-4547(19990101)55:1<119::AID-JNR13>3.3.CO;2-Y; CURTIS R, 1993, NATURE, V365, P253, DOI 10.1038/365253a0; DAVIS S, 1993, SCIENCE, V260, P1805, DOI 10.1126/science.8390097; DAVIS S, 1991, SCIENCE, V253, P59, DOI 10.1126/science.1648265; DECHIARA TM, 1995, CELL, V83, P313, DOI 10.1016/0092-8674(95)90172-8; Elson GCA, 1998, J IMMUNOL, V161, P1371; Guillet C, 1999, J NEUROSCI, V19, P1257; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; HELGREN ME, 1994, CELL, V76, P493, DOI 10.1016/0092-8674(94)90113-9; IP NY, 1993, NEURON, V10, P89, DOI 10.1016/0896-6273(93)90245-M; Kallen KJ, 1999, J BIOL CHEM, V274, P11859, DOI 10.1074/jbc.274.17.11859; LI M, 1995, NATURE, V378, P724, DOI 10.1038/378724a0; MASU Y, 1993, NATURE, V365, P27, DOI 10.1038/365027a0; Miller RG, 1996, ANN NEUROL, V39, P256, DOI 10.1002/ana.410390215; MITSUMOTO H, 1994, SCIENCE, V265, P1107, DOI 10.1126/science.8066451; Mittoux V, 2000, HUM GENE THER, V11, P1177, DOI 10.1089/10430340050015220; OPPENHEIM RW, 1991, SCIENCE, V251, P1616, DOI 10.1126/science.2011743; Penn RD, 1997, NEUROSURGERY, V40, P94, DOI 10.1097/00006123-199701000-00021; Robledo O, 1997, J BIOL CHEM, V272, P4855, DOI 10.1074/jbc.272.8.4855; Robledo O, 1996, J NEUROCHEM, V66, P1391; Senaldi G, 1999, P NATL ACAD SCI USA, V96, P11458, DOI 10.1073/pnas.96.20.11458; SENDTNER M, 1992, NATURE, V358, P502, DOI 10.1038/358502a0; SENDTNER M, 1994, J NEUROBIOL, V25, P1436, DOI 10.1002/neu.480251110; Shi Y, 1999, BIOCHEM BIOPH RES CO, V262, P132, DOI 10.1006/bbrc.1999.1181; STOCKLI KA, 1989, NATURE, V342, P920, DOI 10.1038/342920a0; Taga T, 1997, ANNU REV IMMUNOL, V15, P797, DOI 10.1146/annurev.immunol.15.1.797; TAKAHASHI R, 1994, NAT GENET, V7, P79, DOI 10.1038/ng0594-79; TRINCHIERI G, 1995, ANNU REV IMMUNOL, V13, P251, DOI 10.1146/annurev.immunol.13.1.251; Zurn AD, 1996, J NEUROSCI RES, V44, P133, DOI 10.1002/(SICI)1097-4547(19960415)44:2<133::AID-JNR5>3.0.CO;2-E	33	207	220	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2000	3	9					867	872		10.1038/78765	http://dx.doi.org/10.1038/78765			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TV	10966616				2022-12-17	WOS:000167177400012
J	Comoli, E; Coizet, V; Boyes, J; Bolam, JP; Canteras, NS; Quirk, RH; Overton, PG; Redgrave, P				Comoli, E; Coizet, V; Boyes, J; Bolam, JP; Canteras, NS; Quirk, RH; Overton, PG; Redgrave, P			A direct projection from superior colliculus to substantia nigra for detecting salient visual events	NATURE NEUROSCIENCE			English	Article							VENTRAL TEGMENTAL AREA; DOPAMINERGIC-NEURONS; BASAL GANGLIA; REWARD; RAT; RESPONSES; CORTEX; BRAIN; CAT; ORGANIZATION	Midbrain dopaminergic neurons respond to unexpected and biologically salient events, but little is known about the sensory systems underlying this response. Here we describe, in the rat, a direct projection from a primary visual structure, the midbrain superior colliculus (SC), to the substantia nigra pars compacta (SNc) where direct synaptic contacts are made with both dopaminergic and non-dopaminergic neurons. Complementary electrophysiological data reveal that short-latency visual responses in the SNc are abolished by ipsilateral lesions of the SC and increased by local collicular stimulation. These results show that the tectonigral projection is ideally located to relay short-latency visual information to dopamine-containing regions of the ventral midbrain. We conclude that it is within this afferent sensory circuitry that the critical perceptual discriminations that identify stimuli as both unpredicted and biologically salient are made.	Univ Sheffield, Dept Psychol, Sheffield S10 2TP, S Yorkshire, England; Univ Oxford, MRC, Anat Neuropharmacol Unit, Oxford OX1 3TH, England; Univ Sao Paulo, Dept Physiol & Biophys, Inst Biomed Sci, BR-05508900 Sao Paulo, Brazil	University of Sheffield; University of Oxford; Universidade de Sao Paulo	Redgrave, P (corresponding author), Univ Sheffield, Dept Psychol, Sheffield S10 2TP, S Yorkshire, England.		Coizet, Véronique/T-1601-2019; Comoli, Eliane/D-4405-2012; Canteras, Newton/F-2402-2013	Coizet, Véronique/0000-0001-5192-6610; Overton, Paul/0000-0003-4334-261X; Comoli, Eliane/0000-0002-3254-7487; Bolam, J Paul/0000-0002-5008-8405; Canteras, Newton/0000-0002-7205-5372				ADAMS JC, 1992, J HISTOCHEM CYTOCHEM, V40, P1457, DOI 10.1177/40.10.1527370; Bar-Gad I, 2001, CURR OPIN NEUROBIOL, V11, P689, DOI 10.1016/S0959-4388(01)00270-7; Basso MA, 1998, NEURON, V21, P665, DOI 10.1016/S0896-6273(00)80583-8; BOLAM JP, 1992, EXPT NEUROANATOMY PR, P1; CAMERON AA, 1995, J COMP NEUROL, V351, P568, DOI 10.1002/cne.903510407; Ciaramitaro VM, 1997, J COMP NEUROL, V387, P568, DOI 10.1002/(SICI)1096-9861(19971103)387:4<568::AID-CNE7>3.0.CO;2-0; Clarke NP, 1996, EUR J NEUROSCI, V8, P1363, DOI 10.1111/j.1460-9568.1996.tb01599.x; Coizet V, 2003, EUR J NEUROSCI, V17, P28, DOI 10.1046/j.1460-9568.2003.02415.x; DEAN P, 1989, TRENDS NEUROSCI, V12, P137, DOI 10.1016/0166-2236(89)90052-0; Dreher JC, 2002, EUR J NEUROSCI, V16, P1609, DOI 10.1046/j.1460-9568.2002.02212.x; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; FREEMAN AS, 1985, LIFE SCI, V36, P1983, DOI 10.1016/0024-3205(85)90448-5; Gonzalez-Hernandez T, 2000, J COMP NEUROL, V421, P107, DOI 10.1002/(SICI)1096-9861(20000522)421:1<107::AID-CNE7>3.0.CO;2-F; GOODALE MA, 1973, EXP BRAIN RES, V17, P75; Guarraci FA, 1999, BEHAV BRAIN RES, V99, P169, DOI 10.1016/S0166-4328(98)00102-8; HARDY SC, 1988, J COMP NEUROL, V273, P527, DOI 10.1002/cne.902730408; Heilman K, 1994, NEUROPSYCHOLOGY, P139; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P814, DOI 10.1152/jn.1989.61.4.814; Horvitz JC, 2000, NEUROSCIENCE, V96, P651, DOI 10.1016/S0306-4522(00)00019-1; Horvitz JC, 1997, BRAIN RES, V759, P251, DOI 10.1016/S0006-8993(97)00265-5; HSU SM, 1981, AM J CLIN PATHOL, V75, P816, DOI 10.1093/ajcp/75.6.816; JAY MF, 1987, J NEUROPHYSIOL, V57, P22, DOI 10.1152/jn.1987.57.1.22; Mana S, 2001, NEUROSCIENCE, V103, P673, DOI 10.1016/S0306-4522(01)00026-4; Matsuura T, 1999, JPN J PHYSIOL, V49, P289, DOI 10.2170/jjphysiol.49.289; Overton PG, 1997, BRAIN RES REV, V25, P312, DOI 10.1016/S0165-0173(97)00039-8; Paxinos G, 1986, RAT BRAIN STEREOTAXI; Redgrave P, 1999, TRENDS NEUROSCI, V22, P146, DOI 10.1016/S0166-2236(98)01373-3; REDGRAVE P, 1993, PROG BRAIN RES, V95, P69, DOI 10.1016/S0079-6123(08)60358-1; Redgrave P, 1999, NEUROSCIENCE, V89, P1009, DOI 10.1016/S0306-4522(98)00319-4; SAGAR SM, 1988, SCIENCE, V240, P1328, DOI 10.1126/science.3131879; SCHNEIDER GE, 1969, SCIENCE, V163, P895, DOI 10.1126/science.163.3870.895; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; SPRAGUE JM, 1966, SCIENCE, V153, P1544, DOI 10.1126/science.153.3743.1544; Stein BE., 1993, MERGING SENSES; Thorpe SJ, 2001, SCIENCE, V291, P260, DOI 10.1126/science.1058249; Tsumori T, 2001, BRAIN RES, V903, P168, DOI 10.1016/S0006-8993(01)02437-4; Waelti P, 2001, NATURE, V412, P43, DOI 10.1038/35083500; WEINBERG RJ, 1991, J HISTOCHEM CYTOCHEM, V39, P1143, DOI 10.1177/39.8.1906909; Wittmann M, 1999, CHRONOBIOL INT, V16, P17, DOI 10.3109/07420529908998709; WURTZ RH, 1972, INVEST OPHTH VISUAL, V11, P441; ZILLES K, 1990, CEREBRAL CORTEX RAT, P77	43	206	209	0	19	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2003	6	9					974	980		10.1038/nn1113	http://dx.doi.org/10.1038/nn1113			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	715KH	12925855				2022-12-17	WOS:000184970400017
J	Aizenman, CD; Linden, DJ				Aizenman, CD; Linden, DJ			Rapid, synaptically driven increases in the intrinsic excitability of cerebellar deep nuclear neurons	NATURE NEUROSCIENCE			English	News Item							EPSP-SPIKE POTENTIATION; LONG-TERM POTENTIATION; RAT HIPPOCAMPAL SLICES; PYRAMIDAL NEURONS; CA1 REGION; CONDUCTANCE		Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University	Linden, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, 725 N Wolfe St, Baltimore, MD 21205 USA.				NIMH NIH HHS [MH01590] Funding Source: Medline	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ABRAHAM WC, 1987, J PHYSIOL-LONDON, V394, P367, DOI 10.1113/jphysiol.1987.sp016875; Aizenman CD, 1999, J NEUROPHYSIOL, V82, P1697, DOI 10.1152/jn.1999.82.4.1697; Aizenman CD, 1998, NEURON, V21, P827, DOI 10.1016/S0896-6273(00)80598-X; ALKON DL, 1984, J EXP BIOL, V112, P95; BARABAN JM, 1985, P NATL ACAD SCI USA, V82, P2538, DOI 10.1073/pnas.82.8.2538; Cull-Candy SG, 1998, NEUROPHARMACOLOGY, V37, P1369, DOI 10.1016/S0028-3908(98)00119-1; DEJONGE MC, 1990, EXP BRAIN RES, V80, P456, DOI 10.1007/BF00227987; Desai NS, 1999, NAT NEUROSCI, V2, P515, DOI 10.1038/9165; HESS G, 1990, NEUROSCIENCE, V37, P61, DOI 10.1016/0306-4522(90)90192-7; JESTER JM, 1995, J PHYSIOL-LONDON, V484, P689, DOI 10.1113/jphysiol.1995.sp020696; MADISON DV, 1986, J PHYSIOL-LONDON, V372, P221, DOI 10.1113/jphysiol.1986.sp016006; MURI R, 1994, J NEUROPHYSIOL, V71, P420, DOI 10.1152/jn.1994.71.1.420; PUGLIESE AM, 1994, NEUROSCIENCE, V62, P1021, DOI 10.1016/0306-4522(94)90340-9; Raymond JL, 1996, SCIENCE, V272, P1126, DOI 10.1126/science.272.5265.1126; TURRIGIANO G, 1994, SCIENCE, V264, P974, DOI 10.1126/science.8178157	15	206	207	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2000	3	2					109	111		10.1038/72049	http://dx.doi.org/10.1038/72049			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292TC	10649564				2022-12-17	WOS:000085810300006
J	Toth, K; McBain, CJ				Toth, K; McBain, CJ			Afferent-specific innervation of two distinct AMPA receptor subtypes on single hippocampal interneurons	NATURE NEUROSCIENCE			English	Article							GUINEA-PIG HIPPOCAMPUS; MOSSY FIBER SYNAPSES; GLUTAMATE RECEPTORS; RAT HIPPOCAMPUS; CA2+ PERMEABILITY; SUBUNIT COMPOSITION; KAINATE RECEPTORS; SYNAPTIC TRANSMISSION; INWARD RECTIFICATION; SELECTIVE ANTAGONISM	Using the polyamine toxin philanthotoxin, which selectively blocks calcium-permeable AMPA receptors, we show that synaptic transmission onto single hippocampal interneurons occurs by afferent-specific activation of philanthotoxin-sensitive and -insensitive AMPA receptors, Calcium-permeable AMPA receptors are found exclusively at synapses from mossy fibers. In contrast, synaptic responses evoked by stimulation of CA3 pyramidal neurons are mediated by calcium-impermeable AMPA receptors. Both pathways converge onto single interneurons and can be discriminated with Group II mGluR agonists. Thus, single interneurons target AMPA receptors of different subunit composition to specific postsynaptic sites, providing a mechanism to increase the synapse-specific computational properties of hippocampal interneurons.	NICHD, Lab Cellular & Mol Neurophysiol, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	McBain, CJ (corresponding author), NICHD, Lab Cellular & Mol Neurophysiol, Rm 5A72,Bldg 49,49 Convent Dr, Bethesda, MD 20892 USA.							Acsady L, 1998, J NEUROSCI, V18, P3386; AMARAL DG, 1981, J COMP NEUROL, V195, P51, DOI 10.1002/cne.901950106; Angulo MC, 1997, J NEUROSCI, V17, P6685; Bahring R, 1998, J PHYSIOL-LONDON, V509, P635, DOI 10.1111/j.1469-7793.1998.635bm.x; BLASCHKE M, 1993, P NATL ACAD SCI USA, V90, P6528, DOI 10.1073/pnas.90.14.6528; BOWIE D, 1995, NEURON, V15, P453, DOI 10.1016/0896-6273(95)90049-7; BRACKLEY PTH, 1993, J PHARMACOL EXP THER, V266, P1573; Castillo PE, 1997, NATURE, V388, P182, DOI 10.1038/40645; DONEVAN SD, 1995, P NATL ACAD SCI USA, V92, P9298, DOI 10.1073/pnas.92.20.9298; FROTSCHER M, 1985, J NEUROCYTOL, V14, P245, DOI 10.1007/BF01258450; Geiger JRP, 1997, NEURON, V18, P1009, DOI 10.1016/S0896-6273(00)80339-6; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; GU YP, 1991, NEURON, V6, P777, DOI 10.1016/0896-6273(91)90174-X; GULYAS AI, 1992, NEUROSCIENCE, V48, P1, DOI 10.1016/0306-4522(92)90334-X; GULYAS AI, 1993, NATURE, V366, P683, DOI 10.1038/366683a0; HERLITZE S, 1993, NEURON, V10, P1131, DOI 10.1016/0896-6273(93)90061-U; HIGUCHI M, 1993, CELL, V75, P1361, DOI 10.1016/0092-8674(93)90622-W; HOLLMANN M, 1991, SCIENCE, V252, P851, DOI 10.1126/science.1709304; Howe JR, 1996, J NEUROPHYSIOL, V76, P510, DOI 10.1152/jn.1996.76.1.510; HSU M, 1993, J NEUROSCI, V13, P3964; HUME RI, 1991, SCIENCE, V253, P1028, DOI 10.1126/science.1653450; Iino M, 1996, J PHYSIOL-LONDON, V496, P431, DOI 10.1113/jphysiol.1996.sp021696; Isa T, 1996, J PHYSIOL-LONDON, V491, P719, DOI 10.1113/jphysiol.1996.sp021252; Isa T, 1996, NEUROREPORT, V7, P689, DOI 10.1097/00001756-199602290-00002; JONAS P, 1995, NEURON, V15, P987, DOI 10.1016/0896-6273(95)90087-X; JONAS P, 1994, NEURON, V12, P1281, DOI 10.1016/0896-6273(94)90444-8; KAMBOJ SK, 1995, J PHYSIOL-LONDON, V486, P297, DOI 10.1113/jphysiol.1995.sp020812; Kamiya H, 1996, J PHYSIOL-LONDON, V493, P447, DOI 10.1113/jphysiol.1996.sp021395; KOH DS, 1995, J PHYSIOL-LONDON, V486, P305, DOI 10.1113/jphysiol.1995.sp020813; Landsend AS, 1997, J NEUROSCI, V17, P834, DOI 10.1523/jneurosci.17-02-00834.1997; Maccaferri G, 1998, SCIENCE, V279, P1368, DOI 10.1126/science.279.5355.1368; MACCAFERRI G, 1995, NEURON, V15, P137, DOI 10.1016/0896-6273(95)90071-3; MAGLOCZKY Z, 1995, NEUROSCIENCE, V66, P847, DOI 10.1016/0306-4522(94)00613-A; Mahanty NK, 1998, NATURE, V394, P683, DOI 10.1038/29312; MANZONI OJ, 1995, NEUROPHARMACOLOGY, V34, P965, DOI 10.1016/0028-3908(95)00060-J; MCBAIN CJ, 1993, J PHYSIOL-LONDON, V462, P373, DOI 10.1113/jphysiol.1993.sp019560; Nusser Z, 1998, J NEUROSCI, V18, P1693; Nusser Z, 1996, P NATL ACAD SCI USA, V93, P11939, DOI 10.1073/pnas.93.21.11939; OTIS TS, 1995, J PHYSIOL-LONDON, V482, P309, DOI 10.1113/jphysiol.1995.sp020519; PATERNAIN AV, 1995, NEURON, V14, P185, DOI 10.1016/0896-6273(95)90253-8; Racca C, 1996, EUR J NEUROSCI, V8, P1580, DOI 10.1111/j.1460-9568.1996.tb01303.x; Rozov A, 1998, J PHYSIOL-LONDON, V511, P361, DOI 10.1111/j.1469-7793.1998.361bh.x; Rubio ME, 1997, NEURON, V18, P939, DOI 10.1016/S0896-6273(00)80333-5; Shigemoto R, 1997, J NEUROSCI, V17, P7503, DOI 10.1523/jneurosci.17-19-07503.1997; Spruston N, 1997, J COMP NEUROL, V385, P427; Swanson GT, 1997, J NEUROSCI, V17, P58, DOI 10.1523/JNEUROSCI.17-01-00058.1997; Vignes M, 1997, NATURE, V388, P179, DOI 10.1038/40639; Vissavajjhala P, 1996, EXP NEUROL, V142, P296, DOI 10.1006/exnr.1996.0199; Washburn MS, 1997, J NEUROSCI, V17, P9393; Washburn MS, 1996, J PHARMACOL EXP THER, V278, P669	50	206	208	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	1998	1	7					572	578		10.1038/2807	http://dx.doi.org/10.1038/2807			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	146NL	10196564				2022-12-17	WOS:000077437100012
J	Wang, Y; Li, Y; Yue, MH; Wang, J; Kumar, S; Wechsler-Reya, RJ; Zhang, ZL; Ogawa, Y; Kellis, M; Duester, G; Zhao, JC				Wang, Yang; Li, Yue; Yue, Minghui; Wang, Jun; Kumar, Sandeep; Wechsler-Reya, Robert J.; Zhang, Zhaolei; Ogawa, Yuya; Kellis, Manolis; Duester, Gregg; Zhao, Jing Crystal			N-6-methyladenosine RNA modification regulates embryonic neural stem cell self-renewal through histone modifications	NATURE NEUROSCIENCE			English	Article							MESSENGER-RNA; NUCLEAR-RNA; DEVELOPMENTAL REGULATORS; METHYLATION; GENE; DIFFERENTIATION; FTO; CHROMATIN; PROLIFERATION; TRANSLATION	Internal N-6-methyladenosine (m(6)A) modification is widespread in messenger RNAs (mRNAs) and is catalyzed by heterodimers of methyltransferase-like protein 3 (Mettl3) and Mettl14. To understand the role of m(6)A in development, we deleted Mettl14 in embryonic neural stem cells (NSCs) in a mouse model. Phenotypically, NSCs lacking Mett114 displayed markedly decreased proliferation and premature differentiation, suggesting that m(6)A modification enhances NSC self-renewal. Decreases in the NSC pool led to a decreased number of late-born neurons during cortical neurogenesis. Mechanistically, we discovered a genome-wide increase in specific histone modifications in Mett114 knockout versus control NSCs. These changes correlated with altered gene expression and observed cellular phenotypes, suggesting functional significance of altered histone modifications in knockout cells. Finally, we found that m(6)A regulates histone modification in part by destabilizing transcripts that encode histone-modifying enzymes. Our results suggest an essential role for m(6)A in development and reveal m(6)A-regulated histone modifications as a previously unknown mechanism of gene regulation in mammalian cells.	[Wang, Yang; Wang, Jun; Wechsler-Reya, Robert J.; Zhao, Jing Crystal] Sanford Burnham Prebys Med Discovery Inst, NCI Designated Canc Ctr, Tumor Initiat & Maintenance Program, La Jolla, CA 92037 USA; [Li, Yue; Kellis, Manolis] MIT, Comp Sci & Artificial Intelligence Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Yue, Minghui; Ogawa, Yuya] Cincinnati Childrens Hosp Med Ctr, Perinatal Inst, Div Dev Biol, Div Reprod Sci, Cincinnati, OH 45229 USA; [Yue, Minghui; Ogawa, Yuya] Univ Cincinnati, Dept Pediat, Cincinnati, OH USA; [Kumar, Sandeep; Duester, Gregg] Sanford Burnham Prebys Med Discovery Inst, Dev Aging & Regenerat Program, La Jolla, CA USA; [Zhang, Zhaolei] Univ Toronto, Dept Mol Genet, Donnelly Ctr, Toronto, ON, Canada	Sanford Burnham Prebys Medical Discovery Institute; Massachusetts Institute of Technology (MIT); Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Sanford Burnham Prebys Medical Discovery Institute; University of Toronto	Zhao, JC (corresponding author), Sanford Burnham Prebys Med Discovery Inst, NCI Designated Canc Ctr, Tumor Initiat & Maintenance Program, La Jolla, CA 92037 USA.	czhao@sbpdiscovery.org	Kellis, Manolis/ABE-7385-2020; Yue, Minghui/ABH-7143-2020	Kellis, Manolis/0000-0001-7113-9630; Li, Yue/0000-0002-1163-3634; Yue, Minghui/0000-0001-8325-4222; Duester, Gregg/0000-0003-4335-3650	CIHR Operating grant [115194]; NSERC Discovery Grant [327612]; NCI [CA159859]; CIRM (California Institute for Regenerative Medicine) Leadership Award [LA1-01747]; NIGMS grant [GM062848]; NIH R01 awards [MH109978, HG008155]; NIH RF1 award [AG054012]; NIH U01 award [HG007610]; CIRM Training Grant [TG2-01162]; NIH R01 award [R01 GM110090]; SBP Cancer Center Pilot grant [5P30 CA030199]; NATIONAL CANCER INSTITUTE [P30CA030199, R01CA159859] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007610, R01HG008155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM113708, R01GM062848, R01GM110090] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH109978] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RF1AG054012] Funding Source: NIH RePORTER	CIHR Operating grant(Canadian Institutes of Health Research (CIHR)); NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CIRM (California Institute for Regenerative Medicine) Leadership Award; NIGMS grant; NIH R01 awards(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH RF1 award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH U01 award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIRM Training Grant; NIH R01 award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SBP Cancer Center Pilot grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank L. Wang and V. Ylis from the Sanford-Burnham-Prebys Medical Discovery Institute (SBP) Animal Resources Facility for blastocyst injection and mouse maintenance; G. Garcia from the SBP Histopathology core for preparing coronal sections from frozen and paraffin-embedded mouse brains; the SBP Cell Imaging core for confocal microscopy; the SBP flow cytometry core for apoptosis analysis; B. James from the Genomics DNA Analysis Facility at SBP for high-throughput sequencing analysis; and A. Bang for critical reading of the manuscript. This work is supported by a CIHR Operating grant (No. 115194) and an NSERC Discovery Grant (327612) to Z.Z., an NCI grant (CA159859) and a CIRM (California Institute for Regenerative Medicine) Leadership Award (LA1-01747) to R.W.R., an NIGMS grant (GM062848) to G.D., NIH R01 awards (MH109978 and HG008155), an NIH RF1 award (AG054012), and an NIH U01 award (HG007610) to M.K., a CIRM Training Grant (TG2-01162) to Y.W., an NIH R01 award (R01 GM110090) and an SBP Cancer Center Pilot grant (5P30 CA030199) to J.C.Z.	Alarcon CR, 2015, CELL, V162, P1299, DOI 10.1016/j.cell.2015.08.011; Arai Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1155; Avgustinova A, 2016, NAT REV MOL CELL BIO, V17, P643, DOI 10.1038/nrm.2016.76; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Batista PJ, 2014, CELL STEM CELL, V15, P707, DOI 10.1016/j.stem.2014.09.019; Ben-Haim MS, 2015, CELL RES, V25, P3, DOI 10.1038/cr.2014.162; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bodi Z, 2010, NUCLEIC ACIDS RES, V38, P5327, DOI 10.1093/nar/gkq266; Boissel S, 2009, AM J HUM GENET, V85, P106, DOI 10.1016/j.ajhg.2009.06.002; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Caglayan AO, 2016, J HUM GENET, V61, P395, DOI 10.1038/jhg.2015.160; Castelo-Branco G, 2014, STEM CELL REP, V3, P502, DOI 10.1016/j.stemcr.2014.07.008; cIshino Y, 2014, J NEUROSCI, V34, P3067; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Daikoku T, 2014, ENDOCRINOLOGY, V155, P2718, DOI 10.1210/en.2014-1265; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; George SHL, 2007, P NATL ACAD SCI USA, V104, P4455, DOI 10.1073/pnas.0609277104; Geula S, 2015, SCIENCE, V347, P1002, DOI 10.1126/science.1261417; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Hardwick LJA, 2014, TRENDS GENET, V30, P254, DOI 10.1016/j.tig.2014.04.001; Hess ME, 2013, NAT NEUROSCI, V16, P1042, DOI 10.1038/nn.3449; Hu WF, 2014, ANNU REV GENOM HUM G, V15, P195, DOI 10.1146/annurev-genom-090413-025600; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Ju YT, 1998, P NATL ACAD SCI USA, V95, P11423, DOI 10.1073/pnas.95.19.11423; Karatas H, 2013, J AM CHEM SOC, V135, P669, DOI 10.1021/ja306028q; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Li SL, 2012, IMMUNITY, V37, P685, DOI 10.1016/j.immuni.2012.08.001; Lim DA, 2009, NATURE, V458, P529, DOI 10.1038/nature07726; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; Martynoga B, 2005, DEV BIOL, V283, P113, DOI 10.1016/j.ydbio.2005.04.005; Mauer J, 2017, NATURE, V541, P371, DOI 10.1038/nature21022; Meyer KD, 2015, CELL, V163, P999, DOI 10.1016/j.cell.2015.10.012; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Nakashima K, 1999, SCIENCE, V284, P479, DOI 10.1126/science.284.5413.479; Ogawa Y, 2003, MOL CELL, V11, P731, DOI 10.1016/S1097-2765(03)00063-7; Pereira JD, 2010, P NATL ACAD SCI USA, V107, P15957, DOI 10.1073/pnas.1002530107; Qiao YB, 2015, J BIOL CHEM, V290, P2508, DOI 10.1074/jbc.M114.603761; Roman-Trufero M, 2009, STEM CELLS, V27, P1559, DOI 10.1002/stem.82; Roopra A, 2004, MOL CELL, V14, P727, DOI 10.1016/j.molcel.2004.05.026; Sledz P, 2016, ELIFE, V5, DOI 10.7554/eLife.18434; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Voncken JW, 2003, P NATL ACAD SCI USA, V100, P2468, DOI 10.1073/pnas.0434312100; Wang J, 2010, DEV CELL, V18, P114, DOI 10.1016/j.devcel.2009.10.023; Wang P, 2016, MOL CELL, V63, P306, DOI 10.1016/j.molcel.2016.05.041; Wang X, 2016, NATURE, V534, P575, DOI 10.1038/nature18298; Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Wang Y, 2016, TRENDS GENET, V32, P763, DOI 10.1016/j.tig.2016.09.006; Wang Y, 2014, NAT CELL BIOL, V16, P191, DOI 10.1038/ncb2902; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Williams BP, 1997, NEURON, V18, P553, DOI 10.1016/S0896-6273(00)80297-4; Xiao W, 2016, MOL CELL, V61, P507, DOI 10.1016/j.molcel.2016.01.012; Yamada N, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005430; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015; Zhou RY, 2009, CELL, V139, P802, DOI 10.1016/j.cell.2009.10.023	57	205	217	5	92	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2018	21	2					195	+		10.1038/s41593-017-0057-1	http://dx.doi.org/10.1038/s41593-017-0057-1			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FV0TB	29335608	Green Accepted, hybrid, Green Published			2022-12-17	WOS:000424269900011
J	Denk, F; McMahon, SB; Tracey, I				Denk, Franziska; McMahon, Stephen B.; Tracey, Irene			Pain vulnerability: a neurobiological perspective	NATURE NEUROSCIENCE			English	Review							GENOME-WIDE ASSOCIATION; IRRITABLE-BOWEL-SYNDROME; CPG-BINDING PROTEIN-2; NEUROPATHIC PAIN; DNA METHYLATION; SPINAL-CORD; CENTRAL SENSITIZATION; FIBROMYALGIA PATIENTS; POSTSURGICAL PAIN; BRAIN-FUNCTION	There are many known risk factors for chronic pain conditions, yet the biological underpinnings that link these factors to abnormal processing of painful signals are only just beginning to be explored. This Review will discuss the potential mechanisms that have been proposed to underlie vulnerability and resilience toward developing chronic pain. Particular focus will be given to genetic and epigenetic processes, priming effects on a cellular level, and alterations in brain networks concerned with reward, motivation/learning and descending modulatory control. Although research in this area is still in its infancy, a better understanding of how pain vulnerability emerges has the potential to help identify individuals at risk and may open up new therapeutic avenues.	[Denk, Franziska; McMahon, Stephen B.] Kings Coll London, Wolfson Ctr Age Related Dis, London, England; [Tracey, Irene] Univ Oxford, Oxford Ctr Funct Magnet Resonance Imaging Brain, Oxford, England; [Tracey, Irene] Univ Oxford, Nuffield Dept Clin Neurosci, Nuffield Div Anaesthet, Oxford, England	University of London; King's College London; University of Oxford; University of Oxford	McMahon, SB (corresponding author), Kings Coll London, Wolfson Ctr Age Related Dis, London, England.	stephen.mcmahon@kci.ac.uk	Denk, Franziska/A-4212-2010	Denk, Franziska/0000-0003-4883-4234; Tracey, Irene/0000-0003-4134-6115; McMahon, Stephen/0000-0003-4656-5536	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	The authors are supported by grants from the Wellcome Trust.	Abbott CA, 2011, DIABETES CARE, V34, P2220, DOI 10.2337/dc11-1108; Balague F, 2012, LANCET, V379, P482, DOI 10.1016/S0140-6736(11)60610-7; Baliki MN, 2012, NAT NEUROSCI, V15, P1117, DOI 10.1038/nn.3153; Baliki MN, 2010, NEURON, V66, P149, DOI 10.1016/j.neuron.2010.03.002; Becerra L, 2001, NEURON, V32, P927, DOI 10.1016/S0896-6273(01)00533-5; Beggs S, 2012, BRAIN, V135, P404, DOI 10.1093/brain/awr288; Bell JT, 2012, PLOS GENET, V8, P189, DOI 10.1371/journal.pgen.1002629; Bishop S., 2013, CAMBRIDGE HDB HUMAN; Bogen O, 2012, J NEUROSCI, V32, P2018, DOI 10.1523/JNEUROSCI.5138-11.2012; Buchen L, 2010, NATURE, V467, P146, DOI 10.1038/467146a; Bushnell MC, 2013, NAT REV NEUROSCI, V14, P502, DOI 10.1038/nrn3516; Chen JYW, 2011, BRAIN RES, V1392, P121, DOI 10.1016/j.brainres.2011.03.069; Chesler EJ, 2002, NAT NEUROSCI, V5, P1101, DOI 10.1038/nn1102-1101; Coggon DIW, 2005, LANCET, V365, P1434, DOI 10.1016/S0140-6736(05)66380-5; Coghill RC, 2003, P NATL ACAD SCI USA, V100, P8538, DOI 10.1073/pnas.1430684100; Coutinho SV, 2002, AM J PHYSIOL-GASTR L, V282, pG307, DOI 10.1152/ajpgi.00240.2001; Covington HE, 2011, NEURON, V71, P656, DOI 10.1016/j.neuron.2011.06.007; Cox JJ, 2013, NAT GENET, V45, P1271, DOI 10.1038/ng.2810; Crow M, 2013, GENOME MED, V5, DOI 10.1186/gm416; De Felice M, 2011, PAIN, V152, P2701, DOI 10.1016/j.pain.2011.06.008; Denk F, 2013, PAIN, V154, P1668, DOI 10.1016/j.pain.2013.05.021; Denk F, 2012, NEURON, V73, P435, DOI 10.1016/j.neuron.2012.01.012; Dieppe PA, 2005, LANCET, V365, P965, DOI 10.1016/S0140-6736(05)71086-2; Doehring A, 2013, PAIN, V154, P15, DOI 10.1016/j.pain.2012.06.011; Doesburg SM, 2013, PAIN, V154, P1946, DOI 10.1016/j.pain.2013.04.009; Downs J, 2010, AM J MED GENET A, V152A, P1197, DOI 10.1002/ajmg.a.33314; Dulac C, 2010, NATURE, V465, P728, DOI 10.1038/nature09231; Eijkelkamp N, 2012, BRAIN, V135, P2585, DOI 10.1093/brain/aws225; Eippert F, 2009, SCIENCE, V326, P404, DOI 10.1126/science.1180142; Erpelding N, 2013, PAIN, V154, P2060, DOI 10.1016/j.pain.2013.06.030; Erpelding N, 2012, PAIN, V153, P1602, DOI 10.1016/j.pain.2012.03.012; Esserlind AL, 2013, EUR J NEUROL, V20, P765, DOI 10.1111/ene.12055; Filippini N, 2011, NEUROIMAGE, V54, P602, DOI 10.1016/j.neuroimage.2010.08.009; Fillingim RB, 2005, J PAIN, V6, P159, DOI 10.1016/j.jpain.2004.11.008; Foerster BR, 2012, ARTHRITIS RHEUM-US, V64, P579, DOI 10.1002/art.33339; Garcia-Larrea L., PAIN IN PRESS; Geuter S, 2013, J NEUROSCI, V33, P13784, DOI 10.1523/JNEUROSCI.2191-13.2013; Graur D, 2013, GENOME BIOL EVOL, V5, P578, DOI 10.1093/gbe/evt028; Gwilym SE, 2009, ARTHRIT RHEUM-ARTHR, V61, P1226, DOI 10.1002/art.24837; Hashmi JA, 2013, BRAIN, V136, P2751, DOI 10.1093/brain/awt211; Hathway GJ, 2009, J PHYSIOL-LONDON, V587, P2927, DOI 10.1113/jphysiol.2008.168013; Hathway GJ, 2012, PAIN, V153, P775, DOI 10.1016/j.pain.2011.11.011; Heinricher MM, 2009, BRAIN RES REV, V60, P214, DOI 10.1016/j.brainresrev.2008.12.009; Henikoff S, 2011, TRENDS GENET, V27, P389, DOI 10.1016/j.tig.2011.06.006; Hocking LJ, 2012, EUR J PAIN, V16, P1053, DOI 10.1002/j.1532-2149.2011.00095.x; Hohmeister J, 2010, PAIN, V150, P257, DOI 10.1016/j.pain.2010.04.004; Johansen-Berg H, 2010, CURR OPIN NEUROL, V23, P351, DOI 10.1097/WCO.0b013e32833b7631; Kehlet H, 2006, LANCET, V367, P1618, DOI 10.1016/S0140-6736(06)68700-X; Kim H, 2009, PHARMACOGENOMICS, V10, P171, DOI 10.2217/14622416.10.2.171; Kuchinad A, 2007, J NEUROSCI, V27, P4004, DOI 10.1523/JNEUROSCI.0098-07.2007; Labus JS, 2013, PAIN, V154, P2088, DOI 10.1016/j.pain.2013.06.024; Lee M, 2013, CURR OPIN NEUROBIOL, V23, P127, DOI 10.1016/j.conb.2012.11.007; Lee MC, 2008, J NEUROSCI, V28, P11642, DOI 10.1523/JNEUROSCI.2638-08.2008; Leknes S, 2013, PAIN, V154, P402, DOI 10.1016/j.pain.2012.11.018; Loram LC, 2011, BRAIN BEHAV IMMUN, V25, P1408, DOI 10.1016/j.bbi.2011.04.013; Low LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034316; Malfait AM, 2012, ANN RHEUM DIS, V71, P1042, DOI 10.1136/annrheumdis-2011-200300; Mansour AR, 2013, PAIN, V154, P2160, DOI 10.1016/j.pain.2013.06.044; McMahon SB, 1996, PHILOS T R SOC B, V351, P431, DOI 10.1098/rstb.1996.0039; Moayedi M, 2011, NEUROIMAGE, V55, P277, DOI 10.1016/j.neuroimage.2010.12.013; Mogil JS, 2012, TRENDS GENET, V28, P258, DOI 10.1016/j.tig.2012.02.004; Moloney RD, 2012, NEUROSCI LETT, V512, P99, DOI 10.1016/j.neulet.2012.01.066; Mouraux A, 2011, NEUROIMAGE, V54, P2237, DOI 10.1016/j.neuroimage.2010.09.084; Nishizawa D, 2014, MOL PSYCHIATR, V19, P55, DOI 10.1038/mp.2012.164; Nyholt DR, 2012, NAT GENET, V44, P1355, DOI 10.1038/ng.2445; Peters MJ, 2013, ANN RHEUM DIS, V72, P427, DOI 10.1136/annrheumdis-2012-201742; Ploghaus A, 1999, SCIENCE, V284, P1979, DOI 10.1126/science.284.5422.1979; Ploner M, 2010, P NATL ACAD SCI USA, V107, P355, DOI 10.1073/pnas.0906186106; Reichling DB, 2009, TRENDS NEUROSCI, V32, P611, DOI 10.1016/j.tins.2009.07.007; Schweinhardt P, 2009, J NEUROSCI, V29, P4882, DOI 10.1523/JNEUROSCI.5634-08.2009; Segerdahl AR, 2012, PAIN, V153, P1122, DOI 10.1016/j.pain.2011.12.012; Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030; Smith YR, 2006, J NEUROSCI, V26, P5777, DOI 10.1523/JNEUROSCI.5223-05.2006; Sorge RE, 2012, NAT MED, V18, P595, DOI 10.1038/nm.2710; Stresemann C, 2006, CANCER RES, V66, P2794, DOI 10.1158/0008-5472.CAN-05-2821; Tajerian M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055259; Tajerian M, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-65; Telese F, 2013, NEURON, V77, P606, DOI 10.1016/j.neuron.2013.01.034; Tochiki KK, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-14; Tracey I, 2002, J NEUROSCI, V22, P2748, DOI 10.1523/JNEUROSCI.22-07-02748.2002; Tracey I, 2012, CELL, V148, P1308, DOI 10.1016/j.cell.2012.03.004; Tsantoulas C, 2012, J NEUROSCI, V32, P17502, DOI 10.1523/JNEUROSCI.3561-12.2012; Tu CH, 2013, PAIN, V154, P1718, DOI 10.1016/j.pain.2013.05.022; Vega-Avelaira D, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-30; Villemure C., 2013, CEREB CORTEX, DOI [10.1093/cercor/bht123, DOI 10.1093/CERC0R/BHT123]; Vincent K, 2013, PAIN, V154, P515, DOI 10.1016/j.pain.2012.11.016; Vincent K, 2011, PAIN, V152, P1966, DOI 10.1016/j.pain.2011.03.029; Wager TD, 2013, NEW ENGL J MED, V368, P1388, DOI 10.1056/NEJMoa1204471; Wang RZ, 2013, J PAIN, V14, P845, DOI 10.1016/j.jpain.2013.02.011; Wang Y, 2011, BRAIN RES, V1418, P64, DOI 10.1016/j.brainres.2011.08.040; Wanigasekera V, 2012, P NATL ACAD SCI USA, V109, P17705, DOI 10.1073/pnas.1120201109; Weissman-Fogel I, 2009, J PAIN, V10, P628, DOI 10.1016/j.jpain.2008.12.009; Williams FMK, 2013, ANN RHEUM DIS, V72, P1141, DOI 10.1136/annrheumdis-2012-201551; Williams FMK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003095; Wood PB, 2007, EUR J NEUROSCI, V25, P3576, DOI 10.1111/j.1460-9568.2007.05623.x; Wu H, 2011, GENE DEV, V25, P2436, DOI 10.1101/gad.179184.111; Yarnitsky D, 2008, PAIN, V138, P22, DOI 10.1016/j.pain.2007.10.033; Yarnitsky D, 2012, PAIN, V153, P1193, DOI 10.1016/j.pain.2012.02.021; Yarnitsky D, 2010, CURR OPIN ANESTHESIO, V23, P611, DOI 10.1097/ACO.0b013e32833c348b; Zeggini E, 2012, LANCET, V380, P815, DOI 10.1016/S0140-6736(12)60681-3	100	205	208	0	101	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2014	17	2					192	200		10.1038/nn.3628	http://dx.doi.org/10.1038/nn.3628			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AA2FH	24473267	Green Submitted			2022-12-17	WOS:000330910000011
J	Sato, S; Omori, Y; Katoh, K; Kondo, M; Kanagawa, M; Miyata, K; Funabiki, K; Koyasu, T; Kajimura, N; Miyoshi, T; Sawai, H; Kobayashi, K; Tani, A; Toda, T; Usukura, J; Tano, Y; Fujikado, T; Furukawa, T				Sato, Shigeru; Omori, Yoshihiro; Katoh, Kimiko; Kondo, Mineo; Kanagawa, Motoi; Miyata, Kentaro; Funabiki, Kazuo; Koyasu, Toshiyuki; Kajimura, Naoko; Miyoshi, Tomomitsu; Sawai, Hajime; Kobayashi, Kazuhiro; Tani, Akiko; Toda, Tatsushi; Usukura, Jiro; Tano, Yasuo; Fujikado, Takashi; Furukawa, Takahisa			Pikachurin, a dystroglycan ligand, is essential for photoreceptor ribbon synapse formation	NATURE NEUROSCIENCE			English	Article							DYSTROPHIN-GLYCOPROTEIN COMPLEX; BETA-DYSTROGLYCAN; ALPHA-DYSTROGLYCAN; MOUSE RETINA; LOCALIZATION; PERLECAN; LAMININ; BINDING; MATRIX; IDENTIFICATION	Exquisitely precise synapse formation is crucial for the mammalian CNS to function correctly. Retinal photoreceptors transfer information to bipolar and horizontal cells at a specialized synapse, the ribbon synapse. We identified pikachurin, an extracellular matrix-like retinal protein, and observed that it localized to the synaptic cleft in the photoreceptor ribbon synapse. Pikachurin null-mutant mice showed improper apposition of the bipolar cell dendritic tips to the photoreceptor ribbon synapses, resulting in alterations in synaptic signal transmission and visual function. Pikachurin colocalized with both dystrophin and dystroglycan at the ribbon synapses. Furthermore, we observed direct biochemical interactions between pikachurin and dystroglycan. Together, our results identify pikachurin as a dystroglycan-interacting protein and demonstrate that it has an essential role in the precise interactions between the photoreceptor ribbon synapse and the bipolar dendrites. This may also advance our understanding of the molecular mechanisms underlying the retinal electrophysiological abnormalities observed in muscular dystrophy patients.	Osaka Biosci Inst, Dept Dev Biol, Osaka 5650874, Japan; Osaka Univ, Grad Sch Med, Dept Ophthalmol, Suita, Osaka 5650871, Japan; Osaka Univ, Grad Sch Med, Dept Visual Sci, Suita, Osaka 5650871, Japan; Nagoya Univ, Grad Sch Med, Dept Ophthalmol, Showa Ku, Nagoya, Aichi 4668550, Japan; Osaka Univ, Grad Sch Med, Dept Med Genet, Div Clin Genet, Suita, Osaka 5650871, Japan; Osaka Biosci Inst, Dept Syst Biol, Osaka 5650874, Japan; Osaka Univ, Res Ctr Ultrahigh Voltage Elect Microscopy, Osaka 5670047, Japan; Osaka Univ, Grad Sch Med, Dept Physiol, Suita, Osaka 5650871, Japan; Nagoya Univ, Grad Sch Engn, Dept Mat Phys & Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan	Osaka University; Osaka University; Nagoya University; Osaka University; Osaka University; Osaka University; Nagoya University	Furukawa, T (corresponding author), Osaka Biosci Inst, Dept Dev Biol, 6-2-4 Furuedai, Osaka 5650874, Japan.	furukawa@obi.or.jp	Kajimura, Naoko/R-9267-2019; Kobayashi, Kazuhiro/AAH-8638-2021	Kobayashi, Kazuhiro/0000-0001-7801-147X; Usukura, Jiro/0000-0003-2286-5403; Kanagawa, Motoi/0000-0003-0984-6398; Toda, Tatsushi/0000-0002-0717-1123				BOWE MA, 1994, NEURON, V12, P1173, DOI 10.1016/0896-6273(94)90324-7; Bozdagi O, 2004, MOL CELL NEUROSCI, V27, P509, DOI 10.1016/j.mcn.2004.08.008; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; CIBIS GW, 1993, INVEST OPHTH VIS SCI, V34, P3646; Dalloz C, 2001, MOL CELL NEUROSCI, V17, P908, DOI 10.1006/mcne.2001.0978; Deng CX, 1996, CELL, V84, P911, DOI 10.1016/S0092-8674(00)81069-7; Dick O, 2003, NEURON, V37, P775, DOI 10.1016/S0896-6273(03)00086-2; Dieck ST, 2006, CELL TISSUE RES, V326, P339, DOI 10.1007/s00441-006-0234-0; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; FITZGERALD KM, 1994, J CLIN INVEST, V93, P2425, DOI 10.1172/JCI117250; GEE SH, 1994, CELL, V77, P675, DOI 10.1016/0092-8674(94)90052-3; Henry MD, 1999, CURR OPIN CELL BIOL, V11, P602, DOI 10.1016/S0955-0674(99)00024-1; Hohenester E, 1999, MOL CELL, V4, P783, DOI 10.1016/S1097-2765(00)80388-3; Holzfeind PJ, 2002, HUM MOL GENET, V11, P2673, DOI 10.1093/hmg/11.21.2673; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; IWASAKI M, 1992, J COMP NEUROL, V319, P277, DOI 10.1002/cne.903190207; Jastrow H, 2006, INVEST OPHTH VIS SCI, V47, P17, DOI 10.1167/iovs.05-0597; Kanagawa M, 2005, FEBS LETT, V579, P4792, DOI 10.1016/j.febslet.2005.07.059; Koike C, 2007, MOL CELL BIOL, V27, P8318, DOI 10.1128/MCB.01209-07; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Nishida A, 2003, NAT NEUROSCI, V6, P1255, DOI 10.1038/nn1155; NOMURA A, 1994, CELL, V77, P361, DOI 10.1016/0092-8674(94)90151-1; Pillers DAM, 1999, MOL GENET METAB, V68, P304, DOI 10.1006/mgme.1999.2929; PILLERS DAM, 1993, NAT GENET, V4, P82, DOI 10.1038/ng0593-82; Prakash S, 2005, NAT NEUROSCI, V8, P443, DOI 10.1038/nn1415; RAO MR, 1995, NEURON, V14, P561; ROBSON JG, 1995, VISUAL NEUROSCI, V12, P837, DOI 10.1017/S0952523800009408; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Schmitz F, 1997, HISTOCHEM CELL BIOL, V108, P249, DOI 10.1007/s004180050165; Schmitz F, 2000, NEURON, V28, P857, DOI 10.1016/S0896-6273(00)00159-8; SIGESMUND DA, 1994, OPHTHALMOLOGY, V101, P856; Sterling P, 2005, TRENDS NEUROSCI, V28, P20, DOI 10.1016/j.tins.2004.11.009; Straub V, 1997, CURR OPIN NEUROL, V10, P168, DOI 10.1097/00019052-199704000-00016; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sugita S, 2001, J CELL BIOL, V154, P435, DOI 10.1083/jcb.200105003; SUGIYAMA J, 1994, NEURON, V13, P103, DOI 10.1016/0896-6273(94)90462-6; Talts JF, 1999, EMBO J, V18, P863, DOI 10.1093/emboj/18.4.863; Ueda H, 1998, J HISTOCHEM CYTOCHEM, V46, P185, DOI 10.1177/002215549804600207; Waites CL, 2005, ANNU REV NEUROSCI, V28, P251, DOI 10.1146/annurev.neuro.27.070203.144336; Winder SJ, 2001, TRENDS BIOCHEM SCI, V26, P118, DOI 10.1016/S0968-0004(00)01731-X; Zaccaria ML, 2001, NEUROSCIENCE, V104, P311, DOI 10.1016/S0306-4522(01)00092-6	42	205	210	0	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2008	11	8					923	931		10.1038/nn.2160	http://dx.doi.org/10.1038/nn.2160			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	330UU	18641643				2022-12-17	WOS:000257969100018
J	Adler, CE; Fetter, RD; Bargmann, CI				Adler, CE; Fetter, RD; Bargmann, CI			UNC-6/Netrin induces neuronal asymmetry and defines the site of axon formation	NATURE NEUROSCIENCE			English	Article							CAENORHABDITIS-ELEGANS; C-ELEGANS; NETRIN RECEPTOR; EXPRESSION PATTERNS; HIPPOCAMPAL-NEURONS; ACTIN CYTOSKELETON; ENA/VASP PROTEINS; COLORECTAL-CANCER; CELL-MIGRATION; PI 3-KINASE	UNC-6/Netrin and its receptor UNC-40/DCC are conserved regulators of growth cone guidance. By directly observing developing neurons in vivo, we show that UNC-6 and UNC-40 also function during axon formation to initiate, maintain and orient asymmetric neuronal growth. The immature HSN neuron of Caenorhabditis elegans breaks spherical symmetry to extend a leading edge toward ventral UNC-6. In unc-6 and unc-40 mutants, leading edge formation fails, the cell remains symmetrical until late in development and the axon that eventually forms is misguided. Thus netrin has two activities: one that breaks neuronal symmetry and one that guides the future axon. As the axon forms, UNC-6, UNC-40 and the lipid modulators AGE-1/phosphoinositide 3-kinase (PI3K) and DAF-18/PTEN drive the actin-regulatory pleckstrin homology (PH) domain protein MIG-10/lamellipodin ventrally in HSN to promote asymmetric growth. The coupling of a directional netrin cue to sustained asymmetric growth via PI3K signaling is reminiscent of polarization in chemotaxing cells.	Rockefeller Univ, Howard Hughes Med Inst, Lab Naeural Circuits & Behav, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	Bargmann, CI (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Naeural Circuits & Behav, 1230 York Ave, New York, NY 10021 USA.	cori@rockefeller.edu		Bargmann, Cornelia/0000-0002-8484-0618	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM084661] Funding Source: NIH RePORTER; NIGMS NIH HHS [F32 GM084661, F32 GM084661-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baumeister R, 1996, GENE DEV, V10, P1395, DOI 10.1101/gad.10.11.1395; BRENNER S, 1974, GENETICS, V77, P71; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Chan SSY, 1996, CELL, V87, P187, DOI 10.1016/S0092-8674(00)81337-9; Colavita A, 1998, SCIENCE, V281, P706, DOI 10.1126/science.281.5377.706; Da Silva JS, 2002, NAT REV NEUROSCI, V3, P694, DOI 10.1038/nrn918; Deiner MS, 1997, NEURON, V19, P575, DOI 10.1016/S0896-6273(00)80373-6; DESAI C, 1988, NATURE, V336, P638, DOI 10.1038/336638a0; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Funamoto S, 2002, CELL, V109, P611, DOI 10.1016/S0092-8674(02)00755-9; Gad JM, 2000, EXP EYE RES, V70, P711, DOI 10.1006/exer.2000.0823; GARRIGA G, 1993, DEVELOPMENT, V117, P1071; Gil EB, 1999, P NATL ACAD SCI USA, V96, P2925, DOI 10.1073/pnas.96.6.2925; Gitai Z, 2003, NEURON, V37, P53, DOI 10.1016/S0896-6273(02)01149-2; Goldberg JL, 2002, NEURON, V33, P689, DOI 10.1016/S0896-6273(02)00602-5; HALFTER W, 1985, J COMP NEUROL, V232, P466, DOI 10.1002/cne.902320405; HAMELIN M, 1993, NATURE, V364, P327, DOI 10.1038/364327a0; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Hiramoto M, 2000, NATURE, V406, P886, DOI 10.1038/35022571; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; Iijima M, 2002, CELL, V109, P599, DOI 10.1016/S0092-8674(02)00745-6; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; Jiang H, 2005, CELL, V120, P123, DOI 10.1016/j.cell.2004.12.033; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Kishi M, 2005, SCIENCE, V307, P929, DOI 10.1126/science.1107403; Knobel KM, 1999, DEVELOPMENT, V126, P4489; Krause M, 2004, DEV CELL, V7, P571, DOI 10.1016/j.devcel.2004.07.024; Krause M, 2003, ANNU REV CELL DEV BI, V19, P541, DOI 10.1146/annurev.cellbio.19.050103.103356; Lebrand C, 2004, NEURON, V42, P37, DOI 10.1016/S0896-6273(04)00108-4; LEFCORT F, 1989, J CELL BIOL, V108, P1737, DOI 10.1083/jcb.108.5.1737; Lieberam I, 2005, NEURON, V47, P667, DOI 10.1016/j.neuron.2005.08.011; Manser J, 1997, DEV BIOL, V184, P150, DOI 10.1006/dbio.1997.8516; Mello C, 1995, METHOD CELL BIOL, V48, P451; Menager C, 2004, J NEUROCHEM, V89, P109, DOI 10.1046/j.1471-4159.2004.02302.x; Ming GI, 1999, NEURON, V23, P139, DOI 10.1016/S0896-6273(00)80760-6; Morris JZ, 1996, NATURE, V382, P536, DOI 10.1038/382536a0; Polleux F, 1998, SCIENCE, V282, P1904, DOI 10.1126/science.282.5395.1904; Sato T, 1968, J Electron Microsc (Tokyo), V17, P158; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Shi SH, 2004, CURR BIOL, V14, P2025, DOI 10.1016/j.cub.2004.11.009; STRINGHAM EG, 1992, MOL BIOL CELL, V3, P221, DOI 10.1091/mbc.3.2.221; Van Haastert PJM, 2004, NAT REV MOL CELL BIO, V5, P626, DOI 10.1038/nrm1435; Wadsworth WG, 1996, NEURON, V16, P35, DOI 10.1016/S0896-6273(00)80021-5; Weiner OD, 2002, NAT CELL BIOL, V4, P509, DOI 10.1038/ncb811; Weiner OD, 2002, CURR OPIN CELL BIOL, V14, P196, DOI 10.1016/S0955-0674(02)00310-1; Xie Y, 2005, NAT CELL BIOL, V7, P1124, DOI 10.1038/ncb1321	47	205	217	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2006	9	4					511	518		10.1038/nn1666	http://dx.doi.org/10.1038/nn1666			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	026BC	16520734	Green Accepted			2022-12-17	WOS:000236310700018
J	Liu, GF; Beggs, H; Jurgensen, C; Park, HT; Tang, H; Gorski, J; Jones, KR; Reichardt, LF; Wu, J; Rao, Y				Liu, GF; Beggs, H; Jurgensen, C; Park, HT; Tang, H; Gorski, J; Jones, KR; Reichardt, LF; Wu, J; Rao, Y			Netrin requires focal adhesion kinase and Src family kinases for axon outgrowth and attraction	NATURE NEUROSCIENCE			English	Article							PROTEIN-TYROSINE KINASE; GROWTH CONE GUIDANCE; C-ELEGANS; COLORECTAL-CANCER; SPINAL-CORD; FLOOR PLATE; CAENORHABDITIS-ELEGANS; COMMISSURAL AXONS; RECEPTOR DCC; SIGNAL-TRANSDUCTION	Although netrins are an important family of neuronal guidance proteins, intracellular mechanisms that mediate netrin function are not well understood. Here we show that netrin-1 induces tyrosine phosphorylation of proteins including focal adhesion kinase (FAK) and the Src family kinase Fyn. Blockers of Src family kinases inhibited FAK phosphorylation and axon outgrowth and attraction by netrin. Dominant-negative FAK and Fyn mutants inhibited the attractive turning response to netrin. Axon outgrowth and attraction induced by netrin-1 were significantly reduced in neurons lacking the FAK gene. Our results show the biochemical and functional links between netrin, a prototypical neuronal guidance cue, and FAK, a central player in intracellular signaling that is crucial for cell migration.	Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Dong A Univ, Coll Med, Dept Physiol, Pusan 602714, South Korea; Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37232 USA; Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	Washington University (WUSTL); University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Dong A University; Vanderbilt University; University of Colorado System; University of Colorado Boulder	Rao, Y (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, 660 S Euclid Ave, St Louis, MO 63110 USA.	raoyi@pcg.wustl.edu	Tang, Hao/G-9841-2011	JONES, KEVIN/0000-0002-3802-7562	NCI NIH HHS [R01 CA107193-03, CA107193, R01 CA107193] Funding Source: Medline; NINDS NIH HHS [NS19090, R01 NS019090] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA107193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019090] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ackerman SL, 1997, NATURE, V386, P838, DOI 10.1038/386838a0; Beggs HE, 2003, NEURON, V40, P501, DOI 10.1016/S0896-6273(03)00666-4; BERNHARDT RR, 1992, NEURON, V8, P869, DOI 10.1016/0896-6273(92)90201-N; BOVOLENTA P, 1990, DEVELOPMENT, V109, P435; BOVOLENTA P, 1991, DEVELOPMENT, V113, P625; Campbell DS, 2003, NEURON, V37, P939, DOI 10.1016/S0896-6273(03)00158-2; Chan SSY, 1996, CELL, V87, P187, DOI 10.1016/S0092-8674(00)81337-9; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; Colavita A, 1998, DEV BIOL, V194, P72, DOI 10.1006/dbio.1997.8790; de la Torre JR, 1997, NEURON, V19, P1211, DOI 10.1016/S0896-6273(00)80413-4; Engelkamp D, 2002, MECH DEVELOP, V118, P191, DOI 10.1016/S0925-4773(02)00248-4; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; Forcet C, 2002, NATURE, V417, P443, DOI 10.1038/nature748; GUAN JL, 1991, CELL REGUL, V2, P951, DOI 10.1091/mbc.2.11.951; GUAN JL, 1992, NATURE, V358, P690, DOI 10.1038/358690a0; HAMELIN M, 1993, NATURE, V364, P327, DOI 10.1038/364327a0; HANKS SK, 1992, P NATL ACAD SCI USA, V89, P8487, DOI 10.1073/pnas.89.18.8487; Harris R, 1996, NEURON, V17, P217, DOI 10.1016/S0896-6273(00)80154-3; HEDGECOCK EM, 1987, DEVELOPMENT, V100, P365; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; Huang X, 2002, NEURON, V34, P563, DOI 10.1016/S0896-6273(02)00672-4; ISHII N, 1992, NEURON, V9, P873, DOI 10.1016/0896-6273(92)90240-E; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Killeen M, 2002, DEV BIOL, V251, P348, DOI 10.1006/dbio.2002.0825; Koch M, 2000, J CELL BIOL, V151, P221, DOI 10.1083/jcb.151.2.221; Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0; KORNBERG LJ, 1991, P NATL ACAD SCI USA, V88, P8392, DOI 10.1073/pnas.88.19.8392; Leonardo ED, 1997, NATURE, V386, P833, DOI 10.1038/386833a0; LEUNGHAGESTEIJN CY, 1992, CELL, V71, P289, DOI 10.1016/0092-8674(92)90357-I; Li WQ, 2004, NAT NEUROSCI, V7, P1213, DOI 10.1038/nn1329; Li XD, 2002, J BIOL CHEM, V277, P15207, DOI 10.1074/jbc.M109913200; Merz DC, 2001, GENETICS, V158, P1071; Merz DC, 2000, J NEUROBIOL, V44, P281, DOI 10.1002/1097-4695(200008)44:2&lt;281::AID-NEU16&gt;3.0.CO;2-4; Ming GI, 1999, NEURON, V23, P139, DOI 10.1016/S0896-6273(00)80760-6; Ming GL, 2002, NATURE, V417, P411, DOI 10.1038/nature745; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; PLACZEK M, 1990, DEVELOPMENT, V110, P19; Przyborski SA, 1998, DEVELOPMENT, V125, P41; Ren XR, 2004, NAT NEUROSCI, V7, P1204, DOI 10.1038/nn1330; Richards LJ, 1997, J NEUROSCI, V17, P2445; SCHALLER MD, 1992, P NATL ACAD SCI USA, V89, P5192, DOI 10.1073/pnas.89.11.5192; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Shekarabi M, 2002, MOL CELL NEUROSCI, V19, P1, DOI 10.1006/mcne.2001.1075; TESSIERLAVIGNE M, 1988, NATURE, V336, P775, DOI 10.1038/336775a0; Tong JF, 2001, J BIOL CHEM, V276, P40917, DOI 10.1074/jbc.M103872200; Wang H, 1999, J NEUROSCI, V19, P4938; Wong K, 2001, CELL, V107, P209, DOI 10.1016/S0092-8674(01)00530-X	50	205	215	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2004	7	11					1222	1232		10.1038/nn1331	http://dx.doi.org/10.1038/nn1331			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866CB	15494732	Green Accepted			2022-12-17	WOS:000224749400015
J	Grunwald, IC; Korte, M; Adelmann, G; Plueck, A; Kullander, K; Adams, RH; Frotscher, M; Bonhoeffer, T; Klein, R				Grunwald, IC; Korte, M; Adelmann, G; Plueck, A; Kullander, K; Adams, RH; Frotscher, M; Bonhoeffer, T; Klein, R			Hippocampal plasticity requires postsynaptic ephrinBs	NATURE NEUROSCIENCE			English	Article							RECEPTOR TYROSINE KINASE; LONG-TERM DEPRESSION; EPHB RECEPTORS; CORTICOSPINAL TRACT; SYNAPSE FORMATION; DENSITY FRACTION; NERVOUS-SYSTEM; AMPA RECEPTORS; MULTIPLE ROLES; AREA CA1	Chemical synapses contain specialized pre- and postsynaptic structures that regulate synaptic transmission and plasticity. EphB receptor tyrosine kinases are important molecular components in this process. Previously, EphB receptors were shown to act postsynaptically, whereas their transmembrane ligands, the ephrinBs, were presumed to act presynaptically. Here we show that in mouse hippocampal CA1 neurons, the Eph/ephrin system is used in an inverted manner: ephrinBs are predominantly localized postsynaptically and are required for synaptic plasticity. We further demonstrate that EphA4, a candidate receptor, is also critically involved in long-term plasticity independent of its cytoplasmic domain, suggesting that ephrinBs are the active signaling partner. This work raises the intriguing possibility that depending on the type of synapse, Eph/ephrins can be involved in activity-dependent plasticity in converse ways, with ephrinBs on the pre- or the postsynaptic side.	Max Planck Inst Neurobiol, Dept Cellular & Syst Neurobiol, D-82152 Munich, Germany; Max Planck Inst Neurobiol, Dept Mol Neurobiol, D-82152 Munich, Germany; Univ Freiburg, Inst Anat & Cell Biol, D-79001 Freiburg, Germany; Univ Cologne, Inst Genet, D-50931 Cologne, Germany; Univ Gothenburg, Dept Med Biochem, S-40530 Gothenburg, Sweden; Canc Res UK, London Res Inst, London WC2A 3PX, England	Max Planck Society; Max Planck Society; University of Freiburg; University of Cologne; University of Gothenburg; Cancer Research UK	Bonhoeffer, T (corresponding author), Max Planck Inst Neurobiol, Dept Cellular & Syst Neurobiol, D-82152 Munich, Germany.		Adams, Ralf H/AAE-9274-2019; Grunwald, Iris/AAY-2521-2021; Bonhoeffer, Tobias/B-9481-2009; Klein, Ruediger/C-6147-2008	Grunwald, Iris/0000-0002-3404-7590; Bonhoeffer, Tobias/0000-0001-7897-6634; Klein, Ruediger/0000-0002-3109-0163; Grunwald Kadow, Ilona/0000-0002-9085-4274; Kullander, Klas/0000-0001-6418-5460				Adams RH, 1999, GENE DEV, V13, P295, DOI 10.1101/gad.13.3.295; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Buchert M, 1999, J CELL BIOL, V144, P361, DOI 10.1083/jcb.144.2.361; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Contractor A, 2002, SCIENCE, V296, P1864, DOI 10.1126/science.1069081; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Dong HL, 1999, ANN NY ACAD SCI, V868, P535, DOI 10.1111/j.1749-6632.1999.tb11323.x; Dottori M, 1998, P NATL ACAD SCI USA, V95, P13248, DOI 10.1073/pnas.95.22.13248; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Dymecki SM, 1996, GENE, V171, P197, DOI 10.1016/0378-1119(96)00035-2; Ethell IM, 2001, NEURON, V31, P1001, DOI 10.1016/S0896-6273(01)00440-8; Ghosh A, 2002, SCIENCE, V295, P449, DOI 10.1126/science.1069391; Godenschwege TA, 2002, NAT NEUROSCI, V5, P1294, DOI 10.1038/nn976; Grunwald IC, 2001, NEURON, V32, P1027, DOI 10.1016/S0896-6273(01)00550-5; Henderson JT, 2001, NEURON, V32, P1041, DOI 10.1016/S0896-6273(01)00553-0; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; HENKEMEYER M, IN PRESS J CELL BIOL; Kullander K, 2003, SCIENCE, V299, P1889, DOI 10.1126/science.1079641; Kullander K, 2001, GENE DEV, V15, P877, DOI 10.1101/gad.868901; Kullander K, 2001, NEURON, V29, P73, DOI 10.1016/S0896-6273(01)00181-7; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Marston DJ, 2003, NAT CELL BIOL, V5, P879, DOI 10.1038/ncb1044; Mellitzer G, 1999, NATURE, V400, P77, DOI 10.1038/21907; Minichiello L, 1999, NEURON, V24, P401, DOI 10.1016/S0896-6273(00)80853-3; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; Murai KK, 2003, NAT NEUROSCI, V6, P153, DOI 10.1038/nn994; Murai KK, 2002, NEURON, V33, P159, DOI 10.1016/S0896-6273(02)00565-2; Palmer A, 2003, GENE DEV, V17, P1429, DOI 10.1101/gad.1093703; Penzes P, 2003, NEURON, V37, P263, DOI 10.1016/S0896-6273(02)01168-6; Takasu MA, 2002, SCIENCE, V295, P491, DOI 10.1126/science.1065983; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Walikonis RS, 2000, J NEUROSCI, V20, P4069; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; Wyszynski M, 1999, J NEUROSCI, V19, P6528; Yokoyama N, 2001, NEURON, V29, P85, DOI 10.1016/S0896-6273(01)00182-9; Zimmer M, 2003, NAT CELL BIOL, V5, P869, DOI 10.1038/ncb1045	38	205	211	0	8	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2004	7	1					33	40		10.1038/nn1164	http://dx.doi.org/10.1038/nn1164			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	758LN	14699416				2022-12-17	WOS:000187636000010
J	Ding, YQ; Marklund, U; Yuan, WL; Yin, J; Wegman, L; Ericson, J; Deneris, E; Johnson, RL; Chen, ZF				Ding, YQ; Marklund, U; Yuan, WL; Yin, J; Wegman, L; Ericson, J; Deneris, E; Johnson, RL; Chen, ZF			Lmx1b is essential for the development of serotonergic neurons	NATURE NEUROSCIENCE			English	Article							ETS DOMAIN FACTOR; MOUSE-BRAIN; SPECIFICATION; TRANSPORTER; PET-1; TRANSCRIPTION; IDENTITY; SIGNALS; SYSTEM; PLATE	The specification and differentiation of serotonergic (5-HT) neurons require both extrinsic signaling molecules and intrinsic transcription factors to work in concert or in cascade. Here we identify the genetic cascades that control the specification and differentiation of 5-HT neurons in mice. A major determinant in the cascades is an LIM homeodomain-containing gene, Lmx1b, which is required for the development of all 5-HT neurons in the central nervous system. Our results suggest that, during development of 5-HT neurons, Lmx1b is a critical intermediate factor that couples Nkx2-2-mediated early specification with Pet1-mediated terminal differentiation. Moreover, our data indicate that genetic cascades controlling the caudal and rostral 5-HT neurons are distinct, despite their shared components.	Washington Univ, Sch Med, Pain Ctr, Dept Anesthesiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Pain Ctr, Dept Psychiat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Pain Ctr, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden; Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA; Univ Texas, MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Karolinska Institutet; Case Western Reserve University; University of Texas System; UTMD Anderson Cancer Center	Chen, ZF (corresponding author), Washington Univ, Sch Med, Pain Ctr, Dept Anesthesiol, St Louis, MO 63110 USA.		Marklund, Ulrika/I-8814-2012	Marklund, Ulrika/0000-0003-1426-1271; Ding, Yu-Qiang/0000-0003-1202-4635; Ericson, Johan/0000-0002-8019-7127				BASBAUM AI, 1984, ANNU REV NEUROSCI, V7, P309, DOI 10.1146/annurev.ne.07.030184.001521; BLAKELY RD, 1991, NATURE, V354, P66, DOI 10.1038/354066a0; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Bruning G, 1997, CELL TISSUE RES, V289, P211, DOI 10.1007/s004410050868; Chen H, 1998, NAT GENET, V19, P51, DOI 10.1038/ng0598-51; Chen ZF, 2001, NEURON, V31, P59, DOI 10.1016/S0896-6273(01)00341-5; Fyodorov D, 1998, J NEUROBIOL, V34, P151, DOI 10.1002/(SICI)1097-4695(19980205)34:2<151::AID-NEU5>3.0.CO;2-1; Goridis C, 2002, NAT REV NEUROSCI, V3, P531, DOI 10.1038/nrn871; Halliday Glenda, 1995, P929; Hendricks T, 1999, J NEUROSCI, V19, P10348; Hendricks TJ, 2003, NEURON, V37, P233, DOI 10.1016/S0896-6273(02)01167-4; Hynes M, 1999, CURR OPIN NEUROBIOL, V9, P26, DOI 10.1016/S0959-4388(99)80004-X; JACOBS BL, 1992, PHYSIOL REV, V72, P165, DOI 10.1152/physrev.1992.72.1.165; Kania A, 2000, CELL, V102, P161, DOI 10.1016/S0092-8674(00)00022-2; LAUDER JM, 1993, TRENDS NEUROSCI, V16, P233, DOI 10.1016/0166-2236(93)90162-F; LAUDER JM, 1982, BRAIN RES BULL, V9, P605, DOI 10.1016/0361-9230(82)90165-4; MILLS HA, 1974, AGRON J, V66, P355, DOI 10.2134/agronj1974.00021962006600030005x; Nakamoto H, 2000, MOL BRAIN RES, V76, P93, DOI 10.1016/S0169-328X(99)00335-6; Pattyn A, 2003, GENE DEV, V17, P729, DOI 10.1101/gad.255803; Pfaar H, 2002, DEV GENES EVOL, V212, P43, DOI 10.1007/s00427-001-0208-x; Smidt MP, 2000, NAT NEUROSCI, V3, P337, DOI 10.1038/73902; Stockmeier CA, 1997, ANN NY ACAD SCI, V836, P220, DOI 10.1111/j.1749-6632.1997.tb52362.x; van Doorninck J H, 1999, J Neurosci, V19, pRC12; WhitakerAzmitia PM, 1996, BEHAV BRAIN RES, V73, P19; YAMADA T, 1991, CELL, V64, P635, DOI 10.1016/0092-8674(91)90247-V; Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3	27	205	208	0	14	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2003	6	9					933	938		10.1038/nn1104	http://dx.doi.org/10.1038/nn1104			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	715KH	12897786				2022-12-17	WOS:000184970400011
J	Pawlak, R; Magarinos, AM; Melchor, J; McEwen, B; Strickland, S				Pawlak, R; Magarinos, AM; Melchor, J; McEwen, B; Strickland, S			Tissue plasminogen activator in the amygdala is critical for stress-induced anxiety-like behavior	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; HIPPOCAMPAL PLASTICITY; LATE-PHASE; GENE; EXPRESSION; RELEASE; MICE; DEGRADATION; PATHWAY; LAMININ	Although neuronal stress circuits have been identified, little is known about the mechanisms that underlie the stress-induced neuronal plasticity leading to fear and anxiety. Here we found that the serine protease tissue-plasminogen activator (tPA) was upregulated in the central and medial amygdala by acute restraint stress, where it promoted stress-related neuronal remodeling and was subsequently inhibited by plasminogen activator inhibitor-1 (PAI-1). These events preceded stress-induced increases in anxiety-like behavior of mice. Mice in which the tPA gene has been disrupted did not show anxiety after up to three weeks of daily restraint and showed attenuated neuronal remodeling as well as a maladaptive hormonal response. These studies support the idea that tPA is critical for the development of anxiety-like behavior after stress.	Rockefeller Univ, Neurobiol Lab, New York, NY 10021 USA; Rockefeller Univ, Neuroendocrinol Lab, New York, NY 10021 USA	Rockefeller University; Rockefeller University	Strickland, S (corresponding author), Rockefeller Univ, Neurobiol Lab, 1230 York Ave, New York, NY 10021 USA.	strickland@rockefeller.edu	McEwen, Bruce/Z-1630-2019	Strickland, Sidney/0000-0002-3072-9244	NINDS NIH HHS [NS-35704, NS-38472] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038472, R01NS035704] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams JP, 2002, ANNU REV PHARMACOL, V42, P135, DOI 10.1146/annurev.pharmtox.42.082701.145401; ALLEN JP, 1974, NEUROENDOCRINOLOGY, V15, P220, DOI 10.1159/000122310; Baranes D, 1998, NEURON, V21, P813, DOI 10.1016/S0896-6273(00)80597-8; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; CHAPMAN PF, 2000, AMYGDALA FUNCTIONAL, P117; CHEN ZL, 1995, J NEUROSCI, V15, P5088; Chen ZL, 1997, CELL, V91, P917, DOI 10.1016/S0092-8674(00)80483-3; Davis S, 2000, J NEUROSCI, V20, P4563, DOI 10.1523/JNEUROSCI.20-12-04563.2000; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; Frey U, 1996, J NEUROSCI, V16, P2057; GLOWINSKI J, 1966, BIOCHEM PHARMACOL, V15, P977, DOI 10.1016/0006-2952(66)90175-4; GRAY TS, 1989, NEUROENDOCRINOLOGY, V50, P433, DOI 10.1159/000125260; Gualandris A, 1996, J NEUROSCI, V16, P2220; Hastings GA, 1997, J BIOL CHEM, V272, P33062, DOI 10.1074/jbc.272.52.33062; Herman JP, 1996, CRIT REV NEUROBIOL, V10, P371, DOI 10.1615/CritRevNeurobiol.v10.i3-4.50; Holsboer F, 1999, J PSYCHIATR RES, V33, P181, DOI 10.1016/S0022-3956(98)90056-5; Horsell A, 1999, NEUROREPORT, V10, P3003, DOI 10.1097/00001756-199909290-00024; Huang YY, 1996, P NATL ACAD SCI USA, V93, P8699, DOI 10.1073/pnas.93.16.8699; Impey S, 1999, NEURON, V23, P11, DOI 10.1016/S0896-6273(00)80747-3; Kim YH, 1999, SCIENCE, V284, P647, DOI 10.1126/science.284.5414.647; Lisman JE, 1999, NEURON, V22, P233, DOI 10.1016/S0896-6273(00)81085-5; LUITEN PGM, 1985, BRAIN RES, V332, P283, DOI 10.1016/0006-8993(85)90597-9; Madani R, 1999, EMBO J, V18, P3007, DOI 10.1093/emboj/18.11.3007; Magarinos AM, 1997, P NATL ACAD SCI USA, V94, P14002, DOI 10.1073/pnas.94.25.14002; MARS WM, 1993, AM J PATHOL, V143, P949; McEwen BS, 2002, PSYCHIAT CLIN N AM, V25, P469, DOI 10.1016/S0193-953X(01)00009-0; MCEWEN BS, 1994, ANN NY ACAD SCI, V746, P134; MCEWEN BS, 1995, CURR OPIN NEUROBIOL, V5, P205, DOI 10.1016/0959-4388(95)80028-X; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; Nakagami Y, 2000, J NEUROSCI, V20, P2003; Neuhoff H, 1999, EUR J NEUROSCI, V11, P4241, DOI 10.1046/j.1460-9568.1999.00856.x; Nicole O, 2001, NAT MED, V7, P59, DOI 10.1038/83358; Parmer RJ, 1997, J BIOL CHEM, V272, P1976, DOI 10.1074/jbc.272.3.1976; QIAN Z, 1993, NATURE, V361, P453, DOI 10.1038/361453a0; Rogan MT, 1996, CELL, V85, P469, DOI 10.1016/S0092-8674(00)81247-7; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Salles FJ, 2002, J NEUROSCI, V22, P2125, DOI 10.1523/JNEUROSCI.22-06-02125.2002; SAPPINO AP, 1993, J CLIN INVEST, V92, P679, DOI 10.1172/JCI116637; Schafe GE, 2000, J NEUROSCI, V20, P8177; Selye H, 1936, NATURE, V138, P32, DOI 10.1038/138032a0; TSIRKA SE, 1995, NATURE, V377, P340, DOI 10.1038/377340a0; Tsirka SE, 1996, NATURE, V384, P123, DOI 10.1038/384123b0; Vyas A, 2002, J NEUROSCI, V22, P6810; Yamamoto K, 2002, P NATL ACAD SCI USA, V99, P890, DOI 10.1073/pnas.022608799; Yepes M, 2002, J CLIN INVEST, V109, P1571, DOI 10.1172/JCI200214308; Zhuo M, 2000, J NEUROSCI, V20, P542, DOI 10.1523/JNEUROSCI.20-02-00542.2000	46	205	217	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2003	6	2					168	174		10.1038/nn998	http://dx.doi.org/10.1038/nn998			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	640CL	12524546				2022-12-17	WOS:000180669100017
J	Nordstrom, U; Jessell, TM; Edlund, T				Nordstrom, U; Jessell, TM; Edlund, T			Progressive induction of caudal neural character by graded Wnt signaling	NATURE NEUROSCIENCE			English	Article							POSTERIOR NONAXIAL MESODERM; CENTRAL-NERVOUS-SYSTEM; CHICK-EMBRYO; ANTERIOR NEUROECTODERM; DYNAMIC EXPRESSION; PARAXIAL MESODERM; MOUSE EMBRYO; SPINAL-CORD; ZEBRAFISH; XENOPUS	Early in differentiation, all neural cells have a rostral character. Only later do posteriorly positioned neural cells acquire characteristics of caudal forebrain, midbrain and hindbrain cells. Caudalization of neural tissue in the chick embryo apparently involves the convergent actions of (i) fibroblast growth factor (FGF) signaling and (ii) signaling from the caudal paraxial mesoderm, or 'PMC activity', which has not yet been defined molecularly. Here we report evidence that Wnt signaling underlies PMC activity, and show that Wnt signals act directly and in a graded manner on anterior neural cells to induce their progressive differentiation into caudal forebrain, midbrain and hindbrain cells.	Umea Univ, Dept Mol Biol, S-90187 Umea, Sweden; Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Umea University; Columbia University; Howard Hughes Medical Institute	Edlund, T (corresponding author), Umea Univ, Dept Mol Biol, S-90187 Umea, Sweden.	Thomas.Edlund@molbiol.umu.se						Bang AG, 1997, DEVELOPMENT, V124, P2075; Bang AG, 1999, DEV BIOL, V212, P366, DOI 10.1006/dbio.1999.9319; Baranski M, 2000, DEV BIOL, V217, P25, DOI 10.1006/dbio.1999.9516; Bell E, 2001, DEV BIOL, V236, P76, DOI 10.1006/dbio.2001.0301; DAVIS CA, 1988, GENE DEV, V2, P1736, DOI 10.1101/gad.2.12b.1736; Domingos PM, 2001, DEV BIOL, V239, P148, DOI 10.1006/dbio.2001.0431; Eisenberg CA, 1997, DEVELOPMENT, V124, P525; Erter CE, 2001, DEVELOPMENT, V128, P3571; Fekany-Lee K, 2000, DEVELOPMENT, V127, P2333; Foley AC, 2000, DEVELOPMENT, V127, P3839; Foley AC, 1997, DEVELOPMENT, V124, P2983; Fredieu JR, 1997, DEV BIOL, V186, P100, DOI 10.1006/dbio.1997.8566; Gould A, 1998, NEURON, V21, P39, DOI 10.1016/S0896-6273(00)80513-9; Greco TL, 1996, GENE DEV, V10, P313, DOI 10.1101/gad.10.3.313; Heisenberg CP, 2001, GENE DEV, V15, P1427, DOI 10.1101/gad.194301; Hsieh JC, 1999, P NATL ACAD SCI USA, V96, P3546, DOI 10.1073/pnas.96.7.3546; Huelsken J, 2000, J CELL BIOL, V148, P567, DOI 10.1083/jcb.148.3.567; HUME CR, 1993, DEVELOPMENT, V119, P1147; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kiecker C, 2001, DEVELOPMENT, V128, P4189; Lekven AC, 2001, DEV CELL, V1, P103, DOI 10.1016/S1534-5807(01)00007-7; Liu JP, 2001, NEURON, V32, P997, DOI 10.1016/S0896-6273(01)00544-X; Liu PT, 1999, NAT GENET, V22, P361, DOI 10.1038/11932; Lumsden A, 1996, SCIENCE, V274, P1109, DOI 10.1126/science.274.5290.1109; Maden M, 1999, BIOESSAYS, V21, P809, DOI 10.1002/(SICI)1521-1878(199910)21:10<809::AID-BIES2>3.0.CO;2-0; Mallamaci A, 1996, MECH DEVELOP, V58, P165, DOI 10.1016/S0925-4773(96)00571-0; Matsunaga E, 2000, DEVELOPMENT, V127, P2357; McGrew LL, 1997, MECH DEVELOP, V69, P105, DOI 10.1016/S0925-4773(97)00160-3; Muhr J, 1999, NEURON, V23, P689, DOI 10.1016/S0896-6273(01)80028-3; Muhr J, 1997, NEURON, V19, P487, DOI 10.1016/S0896-6273(00)80366-9; Mukhopadhyay M, 2001, DEV CELL, V1, P423, DOI 10.1016/S1534-5807(01)00041-7; NEW DAT, 1955, J EMBRYOL EXP MORPH, V3, P320; Niederreither K, 2000, DEVELOPMENT, V127, P75; Niehrs C, 1999, TRENDS GENET, V15, P314, DOI 10.1016/S0168-9525(99)01767-9; NIETO MA, 1991, DEVELOPMENT, P59; NIEUWKOOP PD, 1952, J EXP ZOOL, V120, P1, DOI 10.1002/jez.1401200102; Popperl H, 1997, DEVELOPMENT, V124, P2997; Rex M, 1997, DEV DYNAM, V209, P323, DOI 10.1002/(SICI)1097-0177(199707)209:3<323::AID-AJA7>3.0.CO;2-K; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Shamim H, 1998, MECH DEVELOP, V76, P157, DOI 10.1016/S0925-4773(98)00102-6; Shibamoto S, 1998, GENES CELLS, V3, P659; Stern CD, 2001, NAT REV NEUROSCI, V2, P92, DOI 10.1038/35053563; Storey KG, 1998, DEVELOPMENT, V125, P473; TAKADA S, 1994, GENE DEV, V8, P174, DOI 10.1101/gad.8.2.174; van de Water S, 2001, DEVELOPMENT, V128, P3877; Wilson SI, 2001, NATURE, V411, P325, DOI 10.1038/35077115; Woo K, 1997, SCIENCE, V277, P254, DOI 10.1126/science.277.5323.254; YAMADA T, 1991, CELL, V64, P635, DOI 10.1016/0092-8674(91)90247-V; Yamaguchi TP, 2001, CURR BIOL, V11, pR713, DOI 10.1016/S0960-9822(01)00417-1; Yoshikawa Y, 1997, DEV BIOL, V183, P234, DOI 10.1006/dbio.1997.8502	50	205	208	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2002	5	6					525	532		10.1038/nn854	http://dx.doi.org/10.1038/nn854			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	556XQ	12006981				2022-12-17	WOS:000175874600011
J	Turken, AU; Swick, D				Turken, AU; Swick, D			Response selection in the human anterior cingulate cortex	NATURE NEUROSCIENCE			English	Article							POSITRON EMISSION TOMOGRAPHY; FUNCTIONAL-ANATOMY; PREFRONTAL CORTEX; WILLED ACTION; MEDIAL WALL; STROOP; INTERFERENCE; ATTENTION; TASK; PET	The anterior cingulate cortex (ACC) has been proposed as part of the brain's attentional control network, but the exact nature of its involvement in cognitive and motor operations is under debate. Assessing effects of human ACC damage directly addresses the problem of ACC function. We report that executive control processes of a patient with a focal right hemisphere anterior cingulate lesion were not compromised. However, her performance level depended on the response modality used. Under the same task requirements, she was impaired when giving manual responses, but not vocal responses. Thus, we provide neuropsychological evidence for functional specialization within the human ACC.	Univ Calif Davis, Dept Neurol, Dept Vet Affairs, Martinez, CA 94553 USA; Univ Calif Santa Barbara, Dept Psychol, Santa Barbara, CA 93106 USA	University of California System; University of California Davis; University of California System; University of California Santa Barbara	Swick, D (corresponding author), Univ Calif Davis, Dept Neurol, Dept Vet Affairs, No Calif Hlth Care Syst 316-127,150 Muir Rd, Martinez, CA 94553 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS017778, P50NS017778] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R29DC003424] Funding Source: NIH RePORTER; NIDCD NIH HHS [DC03424] Funding Source: Medline; NINDS NIH HHS [P0 NS17778] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Baldo JV, 1998, PERCEPT PSYCHOPHYS, V60, P427, DOI 10.3758/BF03206864; BENCH CJ, 1993, NEUROPSYCHOLOGIA, V31, P907, DOI 10.1016/0028-3932(93)90147-R; Brainard D. H., 1997, SPATIAL VISION, V10, P443, DOI DOI 10.1163/156856897X00357; Bush G, 1998, HUM BRAIN MAPP, V6, P270, DOI 10.1002/(SICI)1097-0193(1998)6:4<270::AID-HBM6>3.0.CO;2-0; Carter CS, 1995, NEUROIMAGE, V2, P264, DOI 10.1006/nimg.1995.1034; CORBETTA M, 1991, J NEUROSCI, V11, P2383; Deiber MP, 1996, J NEUROPHYSIOL, V75, P233, DOI 10.1152/jn.1996.75.1.233; Derbyshire SWG, 1998, EXP BRAIN RES, V118, P52, DOI 10.1007/s002210050254; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; DUM RP, 1993, NEUROBIOLOGY LIMBIC, P20; FLETCHER PC, 1995, BRAIN, V118, P401, DOI 10.1093/brain/118.2.401; FRITH CD, 1991, P ROY SOC B-BIOL SCI, V244, P241, DOI 10.1098/rspb.1991.0077; Hyder F, 1997, P NATL ACAD SCI USA, V94, P6989, DOI 10.1073/pnas.94.13.6989; PARDO JV, 1990, P NATL ACAD SCI USA, V87, P256, DOI 10.1073/pnas.87.1.256; Paus T, 1998, NEUROREPORT, V9, pR37, DOI 10.1097/00001756-199806220-00001; PAUS T, 1993, J NEUROPHYSIOL, V70, P453, DOI 10.1152/jn.1993.70.2.453; Paus T, 1996, CEREB CORTEX, V6, P207, DOI 10.1093/cercor/6.2.207; Petit L, 1998, J NEUROSCI, V18, P9429; Picard N, 1996, CEREB CORTEX, V6, P342, DOI 10.1093/cercor/6.3.342; POSNER MI, 1994, P NATL ACAD SCI USA, V91, P7398, DOI 10.1073/pnas.91.16.7398; Posner MI, 1998, ATTENTIVE BRAIN, P401; SHIMA K, 1991, J NEUROPHYSIOL, V65, P188, DOI 10.1152/jn.1991.65.2.188; Talairach J., 1988, COPLANAR STEREOTAXIC; VERFAELLIE M, 1987, ARCH NEUROL-CHICAGO, V44, P1265, DOI 10.1001/archneur.1987.00520240045010; Wechsler D., 1997, WAIS 3 WECHSLER ADUL	25	205	210	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	1999	2	10					920	924		10.1038/13224	http://dx.doi.org/10.1038/13224			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259FE	10491614				2022-12-17	WOS:000083883200019
J	Takenaka, MC; Gabriely, G; Rothhammer, V; Mascanfroni, ID; Wheeler, MA; Chao, CC; Gutierrez-Vazquez, C; Kenison, J; Tjon, EC; Barroso, A; Vandeventer, T; de Lima, KA; Rothweiler, S; Mayo, L; Ghannam, S; Zandee, S; Healy, L; Sherr, D; Farez, MF; Pratt, A; Antel, J; Reardon, DA; Zhang, H; Robson, SC; Getz, G; Weiner, HL; Quintana, FJ				Takenaka, Maisa C.; Gabriely, Galina; Rothhammer, Veit; Mascanfroni, Ivan D.; Wheeler, Michael A.; Chao, Chun-Cheih; Gutierrez-Vazquez, Cristina; Kenison, Jessica; Tjon, Emily C.; Barroso, Andreia; Vandeventer, Tyler; de Lima, Kalil Alves; Rothweiler, Sonja; Mayo, Lior; Ghannam, Soufiene; Zandee, Stephanie; Healy, Luke; Sherr, David; Farez, Mauricio F.; Pratt, Alexandre; Antel, Jack; Reardon, David A.; Zhang, Hailei; Robson, Simon C.; Getz, Gad; Weiner, Howard L.; Quintana, Francisco J.			Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39	NATURE NEUROSCIENCE			English	Article							STRONG PREDICTOR; RECEPTOR; EXPRESSION; POLARIZATION; AUTOIMMUNITY; PROGRESSION; ACTIVATION; PI3K-GAMMA; MICROGLIA; SUPPRESS	Tumor-associated macrophages (TAMs) play an important role in the immune response to cancer, but the mechanisms by which the tumor microenvironment controls TAMs and T cell immunity are not completely understood. Here we report that kynurenine produced by glioblastoma cells activates aryl hydrocarbon receptor (AHR) in TAMs to modulate their function and T cell immunity. AHR promotes CCR2 expression, driving TAM recruitment in response to CCL2. AHR also drives the expression of KLF4 and suppresses NF-kappa B activation in TAMs. Finally, AHR drives the expression of the ectonucleotidase CD39 in TAMs, which promotes CD8(+) T cell dysfunction by producing adenosine in cooperation with CD73. In humans, the expression of AHR and CD39 was highest in grade 4 glioma, and high AHR expression was associated with poor prognosis. In summary, AHR and CD39 expressed in TAMs participate in the regulation of the immune response in glioblastoma and constitute potential targets for immunotherapy.	[Takenaka, Maisa C.; Gabriely, Galina; Rothhammer, Veit; Mascanfroni, Ivan D.; Wheeler, Michael A.; Chao, Chun-Cheih; Gutierrez-Vazquez, Cristina; Kenison, Jessica; Tjon, Emily C.; Barroso, Andreia; Vandeventer, Tyler; de Lima, Kalil Alves; Mayo, Lior; Weiner, Howard L.; Quintana, Francisco J.] Harvard Med Sch, Ann Romney Ctr Neurol Dis, Brigham & Womens Hosp, Boston, MA 02115 USA; [Rothweiler, Sonja; Robson, Simon C.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Div Gastroenterol, Boston, MA 02115 USA; [Rothweiler, Sonja; Robson, Simon C.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Div Hepatol, Boston, MA 02115 USA; [Rothweiler, Sonja; Robson, Simon C.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Div Transplantat, Boston, MA 02115 USA; [Ghannam, Soufiene; Zandee, Stephanie; Pratt, Alexandre] Univ Montreal, Neuroimmunol Res Lab, Ctr Excellence Neur, Dept Neurosci, Montreal, PQ, Canada; [Healy, Luke; Antel, Jack] McGill Univ, Dept Neurol & Neurosurg, Neuroimmunol Unit, Montreal Neurol Inst, Montreal, PQ, Canada; [Sherr, David] Boston Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA; [Farez, Mauricio F.] Raul Carrea Inst Neurol Res FLENI, Ctr Res Neuroimmunol Dis CIEN, Buenos Aires, DF, Argentina; [Farez, Mauricio F.] Raul Carrea Inst Neurol Res FLENI, Ctr Epidemiol Biostat & Publ Hlth CEBES, Buenos Aires, DF, Argentina; [Reardon, David A.] Brigham & Womens Hosp, Dana Farber Canc Inst, Ctr Neurooncol, 75 Francis St, Boston, MA 02115 USA; [Zhang, Hailei; Getz, Gad; Quintana, Francisco J.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Universite de Montreal; McGill University; Boston University; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Quintana, FJ (corresponding author), Harvard Med Sch, Ann Romney Ctr Neurol Dis, Brigham & Womens Hosp, Boston, MA 02115 USA.; Quintana, FJ (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	fquintana@rics.bwh.harvard.edu	Zandee, Stephanie/GQQ-3078-2022; Barroso, Andreia/U-9976-2019; Robson, Simon C./AAA-8537-2021; Quintana, Francisco Javier/AAB-6915-2020; m, Lior/AGK-3671-2022; Healy, Luke/Y-5604-2019	Barroso, Andreia/0000-0002-3188-2785; m, Lior/0000-0002-1296-6692; Healy, Luke/0000-0001-9496-2216; Zandee, Stephanie/0000-0003-0812-676X; antel, jack/0000-0002-5148-0636; Kenison, Jessica/0000-0002-5599-3228; Alves de Lima, Kalil/0000-0002-9149-168X	National Institutes of Health (NIH) [NS087867, ES02530, AI126880, AI093903]; American Cancer Society [RSG-14-198-01-LIB]; Brain Science Foundation; NIH [1F32NS101790]; Dana Farber Cancer Institute [T32CA207201]; German Research Foundation (DFG) [RO4866 1/1]; Mallinkrodt Pharmaceuticals [A219074]; Alfonso Martin Escudero Foundation postdoctoral fellowship; FAPEMIG, Brazil [CBB BDS-00503-16];  [ES07381]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Brain Science Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana Farber Cancer Institute; German Research Foundation (DFG)(German Research Foundation (DFG)); Mallinkrodt Pharmaceuticals; Alfonso Martin Escudero Foundation postdoctoral fellowship; FAPEMIG, Brazil(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); 	This work was supported by the following grants: NS087867, ES02530, AI126880 and AI093903 from the National Institutes of Health (NIH) and RSG-14-198-01-LIB from the American Cancer Society to F.J.Q.; the Brain Science Foundation grant to G. Gabriely and ES07381 to D.S. M.C.T. received support from an educational grant from Mallinkrodt Pharmaceuticals (A219074). M.A.W. was supported by a training grant from the NIH (1F32NS101790) and the Dana Farber Cancer Institute (T32CA207201). V.R. was supported by a fellowship from the German Research Foundation (DFG RO4866 1/1) and an educational grant from Mallinkrodt Pharmaceuticals (A219074). C.G.-V. is supported by an Alfonso Martin Escudero Foundation postdoctoral fellowship. A.B. was supported by a doctoral fellowship (CBB BDS-00503-16) from FAPEMIG, Brazil. We thank T. Seyfried (Biology Department, Boston College, MA, USA) for providing the CT2A cell line.	Bennett ML, 2016, P NATL ACAD SCI USA, V113, pE1738, DOI 10.1073/pnas.1525528113; Bessede A, 2014, NATURE, V511, P184, DOI 10.1038/nature13323; Bowman RL, 2016, CELL REP, V17, P2445, DOI 10.1016/j.celrep.2016.10.052; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Colegio OR, 2014, NATURE, V513, P559, DOI 10.1038/nature13490; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; David BA, 2017, IMMUNOLOGY, V151, P56, DOI 10.1111/imm.12706; De Henau O, 2016, NATURE, V539, P443, DOI 10.1038/nature20554; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Durafourt Bryce A, 2013, Methods Mol Biol, V1041, P199, DOI 10.1007/978-1-62703-520-0_19; Franklin RA, 2014, SCIENCE, V344, P921, DOI 10.1126/science.1252510; Gabriely G, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aaj1738; Gabriely G, 2017, TRENDS ENDOCRIN MET, V28, P428, DOI 10.1016/j.tem.2017.02.009; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Gutierrez-Vazquez C, 2018, IMMUNITY, V48, P19, DOI 10.1016/j.immuni.2017.12.012; Hambardzumyan D, 2016, NAT NEUROSCI, V19, P20, DOI 10.1038/nn.4185; Junttila MR, 2013, NATURE, V501, P346, DOI 10.1038/nature12626; Kaneda MM, 2016, NATURE, V539, P437, DOI 10.1038/nature19834; Karpurapu M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093362; Kohanbash G, 2017, J CLIN INVEST, V127, P1425, DOI 10.1172/JCI90644; Liao XD, 2011, J CLIN INVEST, V121, P2736, DOI 10.1172/JCI45444; Mascanfroni ID, 2015, NAT MED, V21, P638, DOI 10.1038/nm.3868; Mascanfroni ID, 2013, NAT IMMUNOL, V14, P1054, DOI 10.1038/ni.2695; Mayo L, 2014, NAT MED, V20, P1147, DOI 10.1038/nm.3681; Mukthavaram R, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0627-5; Nirschl CJ, 2017, CELL, V170, P127, DOI 10.1016/j.cell.2017.06.016; Noy R, 2014, IMMUNITY, V41, P49, DOI 10.1016/j.immuni.2014.06.010; OKEY AB, 1989, MOL PHARMACOL, V35, P823; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Phillips Roderick J, 2005, J Inflamm (Lond), V2, P14, DOI 10.1186/1476-9255-2-14; Platten M, 2005, SCIENCE, V310, P850, DOI 10.1126/science.1117634; Platten M, 2003, ANN NEUROL, V54, P388, DOI 10.1002/ana.10679; Preusser M, 2015, NAT REV NEUROL, V11, P504, DOI 10.1038/nrneurol.2015.139; Pyonteck SM, 2013, NAT MED, V19, P1264, DOI 10.1038/nm.3337; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Quail DF, 2016, SCIENCE, V352, DOI 10.1126/science.aad3018; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Rothhammer V, 2018, NATURE, V557, P724, DOI 10.1038/s41586-018-0119-x; Rothhammer V, 2016, NAT MED, V22, P586, DOI 10.1038/nm.4106; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Shin S, 2007, MOL CELL BIOL, V27, P7188, DOI 10.1128/MCB.00915-07; Singer M, 2016, CELL, V166, P1500, DOI 10.1016/j.cell.2016.08.052; Sozzani S, 1997, J LEUKOCYTE BIOL, V62, P30, DOI 10.1002/jlb.62.1.30; Takenaka MC, 2016, TRENDS IMMUNOL, V37, P427, DOI 10.1016/j.it.2016.04.009; Thaiss CA, 2016, NATURE, V535, P65, DOI 10.1038/nature18847; Thomas AA, 2015, NEURO-ONCOLOGY, V17, P801, DOI 10.1093/neuonc/nou363; Thota B, 2014, J NEUROSURG, V121, P374, DOI 10.3171/2014.4.JNS131198; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Vetizou M, 2015, SCIENCE, V350, P1079, DOI 10.1126/science.aad1329; Wang QH, 2017, CANCER CELL, V32, P42, DOI 10.1016/j.ccell.2017.06.003; Wen PY, 2016, NAT REV NEUROL, V12, P69, DOI 10.1038/nrneurol.2015.242; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Yeste A, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad0612	57	204	210	15	116	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2019	22	5					729	+		10.1038/s41593-019-0370-y	http://dx.doi.org/10.1038/s41593-019-0370-y			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HU8SN	30962630	Green Accepted			2022-12-17	WOS:000465560800010
J	Krishnan, A; Zhang, R; Yao, V; Theesfeld, CL; Wong, AK; Tadych, A; Volfovsky, N; Packer, A; Lash, A; Troyanskaya, OG				Krishnan, Arjun; Zhang, Ran; Yao, Victoria; Theesfeld, Chandra L.; Wong, Aaron K.; Tadych, Alicja; Volfovsky, Natalia; Packer, Alan; Lash, Alex; Troyanskaya, Olga G.			Genome-wide prediction and functional characterization of the genetic basis of autism spectrum disorder	NATURE NEUROSCIENCE			English	Article							DE-NOVO MUTATIONS; BRAIN-DEVELOPMENT; PROTEIN NETWORK; IMPLICATE; PATHWAYS; REVEALS; DISEASE; TRANSCRIPTION; ASSOCIATION; EVOLUTION	Autism spectrum disorder (ASD) is a complex neurodevelopmental disorder with a strong genetic basis. Yet, only a small fraction of potentially causal genes-about 65 genes out of an estimated several hundred-are known with strong genetic evidence from sequencing studies. We developed a complementary machine-learning approach based on a human brain-specific gene network to present a genome-wide prediction of autism risk genes, including hundreds of candidates for which there is minimal or no prior genetic evidence. Our approach was validated in a large independent case-control sequencing study. Leveraging these genome-wide predictions and the brain-specific network, we demonstrated that the large set of ASD genes converges on a smaller number of key pathways and developmental stages of the brain. Finally, we identified likely pathogenic genes within frequent autism associated copy-number variants and proposed genes and pathways that are likely mediators of ASD across multiple copy-number variants. All predictions and functional insights are available at http://asd.princeton.edu.	[Krishnan, Arjun; Theesfeld, Chandra L.; Tadych, Alicja; Troyanskaya, Olga G.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Zhang, Ran] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Yao, Victoria; Troyanskaya, Olga G.] Princeton Univ, Dept Comp Sci, Princeton, NJ 08544 USA; [Wong, Aaron K.; Volfovsky, Natalia; Packer, Alan; Lash, Alex] Simons Fdn, New York, NY 10010 USA; [Troyanskaya, Olga G.] Simons Fdn, Flatiron Inst, New York, NY 10010 USA	Princeton University; Princeton University; Princeton University	Troyanskaya, OG (corresponding author), Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA.; Troyanskaya, OG (corresponding author), Princeton Univ, Dept Comp Sci, Princeton, NJ 08544 USA.; Lash, A (corresponding author), Simons Fdn, New York, NY 10010 USA.; Troyanskaya, OG (corresponding author), Simons Fdn, Flatiron Inst, New York, NY 10010 USA.	alash@simonsfoundation.org; otroyanskaya@simonsfoundation.org	Yao, Vicky/AAC-6183-2020	Yao, Vicky/0000-0002-3201-9983; Troyanskaya, Olga/0000-0002-5676-5737; Krishnan, Arjun/0000-0002-7980-4110; Wong, Aaron/0000-0002-7294-0646; Lash, Alex/0000-0003-3787-1590; Zhang, Ran/0000-0002-7630-1251	US National Institutes of Health (NIH) [R01 GM071966, R01 HG005998]; US NIH [T32 HG003284, P50 GM071508]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005998, T32HG003284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508, R01GM071966] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to all of the families at the participating Simons Simplex Collection (SSC) sites, as well as the SSC principal investigators. We thank all members of the Troyanskaya lab for valuable discussions. We thank J. Spiro and other members of the Simons Foundation for constant feedback on the work and manuscript. This work was primarily supported by US National Institutes of Health (NIH) grants R01 GM071966 and R01 HG005998 to O.G.T. V.Y. was supported in part by US NIH grant T32 HG003284. This work was supported in part by US NIH grant P50 GM071508. O.G.T. is a senior fellow of the Genetic Networks program of the Canadian Institute for Advanced Research (CIFAR).	Bayes A, 2011, NAT NEUROSCI, V14, P19, DOI 10.1038/nn.2719; Ben-David E, 2013, MOL PSYCHIATR, V18, P1054, DOI 10.1038/mp.2012.148; Bresnahan M, 2015, JAMA PSYCHIAT, V72, P466, DOI 10.1001/jamapsychiatry.2014.3034; Chang J, 2015, NAT NEUROSCI, V18, P191, DOI 10.1038/nn.3907; Cohen S, 2014, J NEURODEV DISORD, V6, DOI 10.1186/1866-1955-6-44; Corominas R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4650; Cotney J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7404; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; Di Martino A, 2014, MOL PSYCHIATR, V19, P659, DOI 10.1038/mp.2013.78; Dinstein I, 2015, TRENDS COGN SCI, V19, P322, DOI 10.1016/j.tics.2015.04.005; Gilman SR, 2011, NEURON, V70, P898, DOI 10.1016/j.neuron.2011.05.021; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Goldberg DS, 2003, P NATL ACAD SCI USA, V100, P4372, DOI 10.1073/pnas.0735871100; Greene CS, 2015, NAT GENET, V47, P569, DOI 10.1038/ng.3259; Haar S, 2016, CEREB CORTEX, V26, P1440, DOI 10.1093/cercor/bhu242; Hazen EP, 2014, HARVARD REV PSYCHIAT, V22, P112, DOI 10.1097/01.HRP.0000445143.08773.58; He X, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003671; Hormozdiari F, 2015, GENOME RES, V25, P142, DOI 10.1101/gr.178855.114; Hus V, 2014, J AUTISM DEV DISORD, V44, P1996, DOI 10.1007/s10803-014-2080-3; Iossifov I, 2015, P NATL ACAD SCI USA, V112, pE5600, DOI 10.1073/pnas.1516376112; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; King IF, 2013, NATURE, V501, P58, DOI 10.1038/nature12504; Kou Y, 2012, AM J MED GENET C, V160C, P130, DOI 10.1002/ajmg.c.31330; Lee TL, 2012, GENE, V496, P88, DOI 10.1016/j.gene.2012.01.020; Li JJ, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145487; Lin GN, 2015, NEURON, V85, P742, DOI 10.1016/j.neuron.2015.01.010; Liu L, 2015, ANN APPL STAT, V9, P1571, DOI 10.1214/15-AOAS844; Martin-Granados C, 2008, INT J BIOCHEM CELL B, V40, P2315, DOI 10.1016/j.biocel.2008.03.021; Masi A, 2015, MOL PSYCHIATR, V20, P440, DOI 10.1038/mp.2014.59; Moreno-De-Luca D, 2013, MOL PSYCHIATR, V18, P1090, DOI 10.1038/mp.2012.138; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Parikshak NN, 2013, CELL, V155, P1008, DOI 10.1016/j.cell.2013.10.031; Peca J, 2011, NATURE, V472, P437, DOI 10.1038/nature09965; Pinto D, 2014, AM J HUM GENET, V94, P677, DOI 10.1016/j.ajhg.2014.03.018; Ronemus M, 2014, NAT REV GENET, V15, P133, DOI 10.1038/nrg3585; Sanders SJ, 2015, NEURON, V87, P1215, DOI 10.1016/j.neuron.2015.09.016; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Stoner R, 2014, NEW ENGL J MED, V370, P1209, DOI 10.1056/NEJMoa1307491; Takahashi T, 2004, BIOL REPROD, V70, P1485, DOI 10.1095/biolreprod.103.026096; Uddin M, 2014, NAT GENET, V46, P742, DOI 10.1038/ng.2980; Vanunu O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000641; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Wang SSH, 2014, NEURON, V83, P518, DOI 10.1016/j.neuron.2014.07.016; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Willsey AJ, 2013, CELL, V155, P997, DOI 10.1016/j.cell.2013.10.020; Winter EE, 2004, GENOME RES, V14, P54, DOI 10.1101/gr.1924004	50	204	208	1	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2016	19	11					1454	1462		10.1038/nn.4353	http://dx.doi.org/10.1038/nn.4353			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EA3WL	27479844	Green Accepted, Green Submitted			2022-12-17	WOS:000386539900015
J	Jbabdi, S; Sotiropoulos, SN; Haber, SN; Van Essen, DC; Behrens, TE				Jbabdi, Saad; Sotiropoulos, Stamatios N.; Haber, Suzanne N.; Van Essen, David C.; Behrens, Timothy E.			Measuring macroscopic brain connections in vivo	NATURE NEUROSCIENCE			English	Review							INTRINSIC FUNCTIONAL CONNECTIVITY; MEDIAL PREFRONTAL CORTEX; HUMAN PARIETAL CORTEX; DIFFUSION MRI; WHITE-MATTER; ARCHITECTONIC SUBDIVISION; THALAMIC SEGMENTATION; IMAGING TRACTOGRAPHY; REWARD PREDICTION; DECISION-MAKING	Decades of detailed anatomical tracer studies in non-human animals point to a rich and complex organization of long-range white matter connections in the brain. State-of-the art in vivo imaging techniques are striving to achieve a similar level of detail in humans, but multiple technical factors can limit their sensitivity and fidelity. In this review, we mostly focus on magnetic resonance imaging of the brain. We highlight some of the key challenges in analyzing and interpreting in vivo connectomics data, particularly in relation to what is known from classical neuroanatomy in laboratory animals. We further illustrate that, despite the challenges, in vivo imaging methods can be very powerful and provide information on connections that is not available by any other means.	[Jbabdi, Saad; Sotiropoulos, Stamatios N.; Behrens, Timothy E.] Univ Oxford, Oxford Ctr Funct Magnet Resonance Imaging Brain F, Oxford, England; [Haber, Suzanne N.] Univ Rochester, Sch Med, Dept Pharmacol & Physiol, Rochester, NY USA; [Van Essen, David C.] Washington Univ, Dept Anat & Neurobiol, St Louis, MO USA; [Behrens, Timothy E.] UCL, Wellcome Trust Ctr Neuroimaging, London, England	University of Oxford; University of Rochester; Washington University (WUSTL); University of London; University College London	Jbabdi, S (corresponding author), Univ Oxford, Oxford Ctr Funct Magnet Resonance Imaging Brain F, Oxford, England.	saad@fmrib.ox.ac.uk	Van Essen, David/ABA-8888-2020; Sotiropoulos, Stamatios/I-1163-2019	Sotiropoulos, Stamatios/0000-0003-4735-5776; Behrens, Timothy/0000-0003-0048-1177; Jbabdi, Saad/0000-0003-3234-5639	UK Medical Research Council [MR/L009013/1]; James S McDonnell Foundation [JSMF220020372]; Wellcome Trust [WT104765MA]; UK EPSRC [EP/L023067/1]; US National Institutes of Health Blueprint for Neuroscience [1U54MH091657-01]; US National Institutes of Health [R01 MH-60974]; National Institute of Mental Health [P50 MH106435]; EPSRC [EP/L023067/1] Funding Source: UKRI; MRC [MR/L009013/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/L023067/1] Funding Source: researchfish; Medical Research Council [MR/L009013/1] Funding Source: researchfish; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH091657, P50MH106435, R01MH060974] Funding Source: NIH RePORTER	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); James S McDonnell Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); UK EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); US National Institutes of Health Blueprint for Neuroscience(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We acknowledge support from the UK Medical Research Council (MR/L009013/1), the James S McDonnell Foundation (JSMF220020372), the Wellcome Trust (WT104765MA), the UK EPSRC EP/L023067/1), the US National Institutes of Health Blueprint for Neuroscience (1U54MH091657-01), the US National Institutes of Health (R01 MH-60974) and the National Institute of Mental Health (P50 MH106435).	Alexander DC, 2008, MAGN RESON MED, V60, P439, DOI 10.1002/mrm.21646; Alexander DC, 2010, NEUROIMAGE, V52, P1374, DOI 10.1016/j.neuroimage.2010.05.043; Aron AR, 2007, J NEUROSCI, V27, P3743, DOI 10.1523/JNEUROSCI.0519-07.2007; Assaf Y, 2008, MAGN RESON MED, V59, P1347, DOI 10.1002/mrm.21577; BARBAS H, 1986, J COMP NEUROL, V252, P415, DOI 10.1002/cne.902520310; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Behrens TEJ, 2005, PHILOS T R SOC B, V360, P903, DOI 10.1098/rstb.2005.1640; Berns GS, 2001, J NEUROSCI, V21, P2793, DOI 10.1523/JNEUROSCI.21-08-02793.2001; Bhatia KD, 2012, STEREOT FUNCT NEUROS, V90, P225, DOI 10.1159/000338083; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Buckner RL, 2011, J NEUROPHYSIOL, V106, P2322, DOI 10.1152/jn.00339.2011; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; CARMICHAEL ST, 1994, J COMP NEUROL, V346, P366, DOI 10.1002/cne.903460305; Caspers S, 2011, NEUROIMAGE, V58, P362, DOI 10.1016/j.neuroimage.2011.06.027; Castellanos FX, 2013, NEUROIMAGE, V80, P527, DOI 10.1016/j.neuroimage.2013.04.083; Catani M, 2002, NEUROIMAGE, V17, P77, DOI 10.1006/nimg.2002.1136; Chowdhury R, 2013, NAT NEUROSCI, V16, P648, DOI 10.1038/nn.3364; Cohen MX, 2011, CURR BIOL, V21, P1900, DOI 10.1016/j.cub.2011.09.036; Cohen MX, 2009, NAT NEUROSCI, V12, P32, DOI 10.1038/nn.2228; Craddock RC, 2013, NAT METHODS, V10, P524, DOI [10.1038/nmeth.2482, 10.1038/NMETH.2482]; Dauguet J, 2007, NEUROIMAGE, V37, P530, DOI 10.1016/j.neuroimage.2007.04.067; Deco G, 2014, J NEUROSCI, V34, P7910, DOI 10.1523/JNEUROSCI.4423-13.2014; DEMETER S, 1990, J COMP NEUROL, V302, P29, DOI 10.1002/cne.903020104; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Donahue C, 2014, HUMAN BRAIN MAPPING, V2014, P3916; Dyrby TB, 2007, NEUROIMAGE, V37, P1267, DOI 10.1016/j.neuroimage.2007.06.022; Elias WJ, 2012, NEUROIMAGE, V59, P2025, DOI 10.1016/j.neuroimage.2011.10.049; Ercsey-Ravasz M, 2013, NEURON, V80, P184, DOI 10.1016/j.neuron.2013.07.036; Forstmann BU, 2010, P NATL ACAD SCI USA, V107, P15916, DOI 10.1073/pnas.1004932107; Fox PT, 2005, HUM BRAIN MAPP, V25, P185, DOI 10.1002/hbm.20141; Fujisawa S, 2011, NEURON, V72, P153, DOI 10.1016/j.neuron.2011.08.018; GOLDMANRAKIC PS, 1984, TRENDS NEUROSCI, V7, P419, DOI 10.1016/S0166-2236(84)80146-0; GOLDMANRAKIC PS, 1982, SCIENCE, V216, P755, DOI 10.1126/science.6177037; Guitart-Masip M, 2013, J NEUROSCI, V33, P442, DOI 10.1523/JNEUROSCI.2573-12.2013; Gutman DA, 2009, BIOL PSYCHIAT, V65, P276, DOI 10.1016/j.biopsych.2008.09.021; Jbabdi S, 2013, ANN NY ACAD SCI, V1305, P83, DOI 10.1111/nyas.12271; Jbabdi S, 2013, J NEUROSCI, V33, P3190, DOI 10.1523/JNEUROSCI.2457-12.2013; Jbabdi S, 2011, BRAIN CONNECT, V1, P169, DOI 10.1089/brain.2011.0033; Johansen-Berg H, 2004, P NATL ACAD SCI USA, V101, P13335, DOI 10.1073/pnas.0403743101; Johansen-Berg H, 2005, CEREB CORTEX, V15, P31, DOI 10.1093/cercor/bhh105; Johansen-Berg H, 2007, NEUROIMAGE, V36, pT16, DOI 10.1016/j.neuroimage.2007.03.041; Jones D. K., 2010, IMAGING MED, V2, P341, DOI DOI 10.2217/IIM.10.21; Kim JH, 2010, NEUROIMAGE, V49, P2375, DOI 10.1016/j.neuroimage.2009.10.016; Klein JC, 2007, NEUROIMAGE, V34, P204, DOI 10.1016/j.neuroimage.2006.08.022; Koch MA, 2008, MAGN RESON MED, V60, P90, DOI 10.1002/mrm.21514; Kolind SH, 2011, MAGN RESON MED, V65, P551, DOI 10.1002/mrm.22634; Le Bihan D, 2007, PHYS MED BIOL, V52, pR57, DOI 10.1088/0031-9155/52/7/R02; LEBIHAN D, 1988, RADIOLOGY, V168, P497, DOI 10.1148/radiology.168.2.3393671; Lehman JF, 2011, J NEUROSCI, V31, P10392, DOI 10.1523/JNEUROSCI.0595-11.2011; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; MacKay A, 2006, MAGN RESON IMAGING, V24, P515, DOI 10.1016/j.mri.2005.12.037; Margulies DS, 2013, J NEUROSCI, V33, P16846, DOI 10.1523/JNEUROSCI.2259-13.2013; Margulies DS, 2009, P NATL ACAD SCI USA, V106, P20069, DOI 10.1073/pnas.0905314106; Markov NT, 2014, CEREB CORTEX, V24, P17, DOI 10.1093/cercor/bhs270; Markov NT, 2014, J COMP NEUROL, V522, P225, DOI 10.1002/cne.23458; Markov NT, 2013, SCIENCE, V342, P578, DOI 10.1126/science.1238406; Mars RB, 2013, P NATL ACAD SCI USA, V110, P10806, DOI 10.1073/pnas.1302956110; Mars RB, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00189; Mars RB, 2011, J NEUROSCI, V31, P4087, DOI 10.1523/JNEUROSCI.5102-10.2011; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Modha DS, 2010, P NATL ACAD SCI USA, V107, P13485, DOI 10.1073/pnas.1008054107; O'Reilly JX, 2013, P NATL ACAD SCI USA, V110, P13982, DOI 10.1073/pnas.1305062110; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Ongur D, 2003, J COMP NEUROL, V460, P425, DOI 10.1002/cne.10609; Owen SLF, 2008, J CLIN NEUROSCI, V15, P801, DOI 10.1016/j.jocn.2007.06.010; Pagnoni G, 2002, NAT NEUROSCI, V5, P97, DOI 10.1038/nn802; Passingham RE, 2002, NAT REV NEUROSCI, V3, P606, DOI 10.1038/nrn893; Petrides M, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000170; Polimeni JR, 2010, NEUROIMAGE, V52, P1334, DOI 10.1016/j.neuroimage.2010.05.005; Pouratian N, 2011, J NEUROSURG, V115, P995, DOI 10.3171/2011.7.JNS11250; Power JD, 2014, NEUROIMAGE, V84, P320, DOI 10.1016/j.neuroimage.2013.08.048; Reisert M, 2011, IEEE T MED IMAGING, V30, P1274, DOI 10.1109/TMI.2011.2112769; Reveley C, 2015, P NATL ACAD SCI USA, V112, pE2820, DOI 10.1073/pnas.1418198112; Rushworth MFS, 2006, CEREB CORTEX, V16, P1418, DOI 10.1093/cercor/bhj079; Sagi Y, 2012, NEURON, V73, P1195, DOI 10.1016/j.neuron.2012.01.025; Salat DH, 2005, ANN NY ACAD SCI, V1064, P37, DOI 10.1196/annals.1340.009; Sallet J, 2011, SCIENCE, V334, P697, DOI 10.1126/science.1210027; Sallet J, 2013, J NEUROSCI, V33, P12255, DOI 10.1523/JNEUROSCI.5108-12.2013; Sampaio-Baptista C, 2013, J NEUROSCI, V33, P19499, DOI 10.1523/JNEUROSCI.3048-13.2013; Saygin ZM, 2012, NAT NEUROSCI, V15, P321, DOI 10.1038/nn.3001; Schmahmann J., 2006, FIBRE PATHWAYS BRAIN; Schmahmann JD, 2007, BRAIN, V130, P630, DOI 10.1093/brain/awl359; Schuz A., 2002, CORTICAL AREAS, P377; Setsompop K, 2013, NEUROIMAGE, V80, P220, DOI 10.1016/j.neuroimage.2013.05.078; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2013, TRENDS COGN SCI, V17, P666, DOI 10.1016/j.tics.2013.09.016; Smith SM, 2012, NEUROIMAGE, V62, P1257, DOI 10.1016/j.neuroimage.2012.01.022; Smith SM, 2011, NEUROIMAGE, V54, P875, DOI 10.1016/j.neuroimage.2010.08.063; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Sotiropoulos SN, 2013, NEUROIMAGE, V80, P125, DOI 10.1016/j.neuroimage.2013.05.057; Sotiropoulos SN, 2013, IEEE T MED IMAGING, V32, P969, DOI 10.1109/TMI.2012.2231873; Sotiropoulos SN, 2012, NEUROIMAGE, V60, P1412, DOI 10.1016/j.neuroimage.2012.01.056; Spanagel R, 1999, TRENDS NEUROSCI, V22, P521, DOI 10.1016/S0166-2236(99)01447-2; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Thomas C, 2014, P NATL ACAD SCI USA, V111, P16574, DOI 10.1073/pnas.1405672111; Thompson PM, 2014, BRAIN IMAGING BEHAV, V8, P153, DOI 10.1007/s11682-013-9269-5; Toro R, 2008, CEREB CORTEX, V18, P2553, DOI 10.1093/cercor/bhn014; Toulmin H, 2015, P NATL ACAD SCI USA, V112, P6485, DOI 10.1073/pnas.1422638112; Tournier JD, 2011, MAGN RESON MED, V65, P1532, DOI 10.1002/mrm.22924; Tyszka JM, 2011, J NEUROSCI, V31, P15154, DOI 10.1523/JNEUROSCI.1453-11.2011; Ugurbil K, 2013, NEUROIMAGE, V80, P80, DOI 10.1016/j.neuroimage.2013.05.012; van Essen D, 2014, DIFFUSION MRI, P337; Van Essen DC, 2013, NEUROIMAGE, V80, P62, DOI 10.1016/j.neuroimage.2013.05.041; Van Essen DC, 2012, CEREB CORTEX, V22, P2241, DOI 10.1093/cercor/bhr291; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Voogd J, 2014, CEREBELLUM, V13, P113, DOI 10.1007/s12311-013-0520-9; Wedeen VJ, 2012, SCIENCE, V335, P1628, DOI 10.1126/science.1215280; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Zhang DY, 2010, CEREB CORTEX, V20, P1187, DOI 10.1093/cercor/bhp182; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072	116	204	206	4	66	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2015	18	11					1546	1555		10.1038/nn.4134	http://dx.doi.org/10.1038/nn.4134			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CU8YT	26505566	Green Accepted, Green Submitted			2022-12-17	WOS:000363830700007
J	Power, RA; Steinberg, S; Bjornsdottir, G; Rietveld, CA; Abdellaoui, A; Nivard, MM; Johannesson, M; Galesloot, TE; Hottenga, JJ; Willemsen, G; Cesarini, D; Benjamin, DJ; Magnusson, PKE; Ullen, F; Tiemeier, H; Hofman, A; Van Rooij, FJA; Walters, GB; Sigurdsson, E; Thorgeirsson, TE; Ingason, A; Helgason, A; Kong, A; Kiemeney, LA; Koellinger, P; Boomsma, DI; Gudbjartsson, D; Stefansson, H; Stefansson, K				Power, Robert A.; Steinberg, Stacy; Bjornsdottir, Gyda; Rietveld, Cornelius A.; Abdellaoui, Abdel; Nivard, Michel M.; Johannesson, Magnus; Galesloot, Tessel E.; Hottenga, Jouke J.; Willemsen, Gonneke; Cesarini, David; Benjamin, Daniel J.; Magnusson, Patrik K. E.; Ullen, Fredrik; Tiemeier, Henning; Hofman, Albert; Van Rooij, Frank J. A.; Walters, G. Bragi; Sigurdsson, Engilbert; Thorgeirsson, Thorgeir E.; Ingason, Andres; Helgason, Agnar; Kong, Augustine; Kiemeney, Lambertus A.; Koellinger, Philipp; Boomsma, Dorret I.; Gudbjartsson, Daniel; Stefansson, Hreinn; Stefansson, Kari			Polygenic risk scores for schizophrenia and bipolar disorder predict creativity	NATURE NEUROSCIENCE			English	Article							MENTAL-ILLNESS; POPULATION; PSYCHOPATHOLOGY; ACHIEVEMENT; ASSOCIATION; PREVALENCE; WRITERS; PEOPLE	We tested whether polygenic risk scores for schizophrenia and bipolar disorder would predict creativity. Higher scores were associated with artistic society membership or creative profession in both Icelandic (P = 5.2 x 10(-6) and 3.8 x 10(-6) for schizophrenia and bipolar disorder scores, respectively) and replication cohorts (P = 0.0021 and 0.00086). This could not be accounted for by increased relatedness between creative individuals and those with psychoses, indicating that creativity and psychosis share genetic roots.	[Power, Robert A.; Steinberg, Stacy; Bjornsdottir, Gyda; Walters, G. Bragi; Thorgeirsson, Thorgeir E.; Helgason, Agnar; Kong, Augustine; Gudbjartsson, Daniel; Stefansson, Hreinn; Stefansson, Kari] deCODE Genet Amgen, Reykjavik, Iceland; [Power, Robert A.] Kings Coll London, Inst Psychiat, Genet & Dev Psychiat Ctr, MRC Social, London WC2R 2LS, England; [Rietveld, Cornelius A.] Erasmus Univ, Erasmus Sch Econ, Rotterdam, Netherlands; [Abdellaoui, Abdel; Nivard, Michel M.; Hottenga, Jouke J.; Willemsen, Gonneke; Boomsma, Dorret I.] Vrije Univ Amsterdam, Dept Biol Psychol, Netherlands Twin Register, Amsterdam, Netherlands; [Johannesson, Magnus] Stockholm Sch Econ, Dept Econ, Stockholm, Sweden; [Galesloot, Tessel E.; Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, Nijmegen, Netherlands; [Cesarini, David] Ctr Expt Social Sci, New York, NY USA; [Benjamin, Daniel J.] Univ So Calif, Ctr Econ & Social Res, Los Angeles, CA USA; [Magnusson, Patrik K. E.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Ullen, Fredrik] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Tiemeier, Henning; Hofman, Albert; Van Rooij, Frank J. A.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Sigurdsson, Engilbert] Landspitali Univ Hosp, Dept Psychiat, Reykjavik, Iceland; [Sigurdsson, Engilbert; Helgason, Agnar; Kiemeney, Lambertus A.] Univ Iceland, Dept Anthropol, Reykjavik, Iceland; [Koellinger, Philipp] Univ Amsterdam, Fac Econ & Business, Amsterdam, Netherlands	University of London; King's College London; Erasmus University Rotterdam; Vrije Universiteit Amsterdam; Stockholm School of Economics; Radboud University Nijmegen; University of Southern California; Karolinska Institutet; Karolinska Institutet; Erasmus University Rotterdam; Erasmus MC; Landspitali National University Hospital; University of Iceland; University of Amsterdam	Stefansson, K (corresponding author), deCODE Genet Amgen, Reykjavik, Iceland.	kstefans@decode.is	Johannesson, Magnus/E-9680-2011; Kiemeney, Lambertus A./D-3357-2009; Sigurdsson, Engilbert/D-2486-2014; Stefansson, Kari/AAE-7187-2019; Magnusson, Patrik KE/C-4458-2017; Boomsma, Dorret I/AAX-4470-2020; Tiemeier, Henning/H-6534-2019; Galesloot, Tessel/P-6667-2015; Helgason, Agnar/K-1522-2015	Johannesson, Magnus/0000-0001-8759-6393; Kiemeney, Lambertus A./0000-0002-2368-1326; Sigurdsson, Engilbert/0000-0001-9404-7982; Magnusson, Patrik KE/0000-0002-7315-7899; Tiemeier, Henning/0000-0002-4395-1397; Galesloot, Tessel/0000-0002-2717-3679; Cesarini, David/0000-0002-0043-009X; Koellinger, Philipp/0000-0001-7413-0412; Willemsen, Gonneke/0000-0003-3755-0236; Stefansson, Hreinn/0000-0002-9331-6666; Helgason, Agnar/0000-0002-8545-3767; Nivard, Michel/0000-0003-2015-1888; Power, Robert/0000-0003-0276-0399; Thorgeirsson, Thorgeir/0000-0002-5149-7040; Kong, Augustine/0000-0001-8193-5438; Bjornsdottir, Gyda/0000-0002-8100-0306	Innovative Medicines Initiative [115008]; European Union [GA 286213]; National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley; NHS Foundation Trust; King's College London; Netherlands Organisation for Scientific Research NWO Investments [175.010.2005.011, 911-03-012]; Research Institute for Diseases in the Elderly [014-93-015, RIDE2]; Netherlands Genomics Initiative (NGI)/Netherlands Consortium for Healthy Aging (NCHA) [050-060-810]; Erasmus Medical Center; Erasmus University, Rotterdam; Netherlands Organization for the Health Research and Development (ZonMw); Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture, and Science; Ministry for Health, Welfare, and Sports; European Commission (DG XII); Municipality of Rotterdam; Netherlands Organization for Scientific Research (NWO); MagW/ZonMW; BBMRI-NL [184.021.007]; VU University Institute for Health and Care Research (EMGO+); Neuroscience Campus Amsterdam; European Science Council (ERC) Genetics of Mental Illness [230374]; Avera Institute for Human Genetics and US National Institute of Mental Health [1RC2MH089951-01, 1RC2 MH089995]; Ragnar Soderberg Foundation [E9/11]; Swedish Research Council [421-2013-1061]; Jan Wallander and Tom Hedelius Foundation [P2012-0002:1]; Sven and Dagmar Salen Foundation; Bank of Sweden Tercentenary Foundation [M11-0451:1]; Karolinska Institutet; Netherlands Scientific Organization [NWO 480-05-003]; NATIONAL INSTITUTE OF MENTAL HEALTH [RC2MH089951, RC2MH089995] Funding Source: NIH RePORTER	Innovative Medicines Initiative; European Union(European Commission); National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley(National Institute for Health Research (NIHR)); NHS Foundation Trust; King's College London; Netherlands Organisation for Scientific Research NWO Investments(Netherlands Organization for Scientific Research (NWO)); Research Institute for Diseases in the Elderly; Netherlands Genomics Initiative (NGI)/Netherlands Consortium for Healthy Aging (NCHA); Erasmus Medical Center; Erasmus University, Rotterdam; Netherlands Organization for the Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture, and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry for Health, Welfare, and Sports; European Commission (DG XII)(European CommissionEuropean Commission Joint Research Centre); Municipality of Rotterdam; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); MagW/ZonMW; BBMRI-NL; VU University Institute for Health and Care Research (EMGO+); Neuroscience Campus Amsterdam; European Science Council (ERC) Genetics of Mental Illness(European Research Council (ERC)); Avera Institute for Human Genetics and US National Institute of Mental Health; Ragnar Soderberg Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Jan Wallander and Tom Hedelius Foundation; Sven and Dagmar Salen Foundation; Bank of Sweden Tercentenary Foundation; Karolinska Institutet(Karolinska Institutet); Netherlands Scientific Organization; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors are grateful to the participants and thank the staff at the Krokhals recruitment center. We thank P. Arp, M. Jhamai, M. Moorhouse, M. Verkerk and S. Bervoets for their assistance in creating the GWAS database. The authors are very grateful to the participants and staff from the Rotterdam Study, participating general practitioners and the pharmacists. The Netherlands Twin Registry thanks all participants. The research leading to these results has received support from the Innovative Medicines Initiative Joint Undertaking under grant agreement 115008, resources of which are composed of European Federation of Pharmaceutical Industries and Associations (EFPIA) in-kind contributions and financial contributions from the European Union's Seventh Framework Programme (FP7/2007-2013) and the European Union-funded FP7-People-2011-IAPP grant PsychDPC (GA 286213). This study presents independent research funded in part by the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley, NHS Foundation Trust and King's College London. The views expressed are those of the authors and not necessarily those of the UK National Health Service, the NIHR or the Department of Health. The Rotterdam Study was funded by the Netherlands Organisation for Scientific Research NWO Investments (175.010.2005.011, 911-03-012), the Research Institute for Diseases in the Elderly (014-93-015; RIDE2) and the Netherlands Genomics Initiative (NGI)/Netherlands Consortium for Healthy Aging (NCHA) project 050-060-810. The Rotterdam Study is funded by the Erasmus Medical Center; Erasmus University, Rotterdam; the Netherlands Organization for the Health Research and Development (ZonMw); the Research Institute for Diseases in the Elderly (RIDE); the Ministry of Education, Culture, and Science; the Ministry for Health, Welfare, and Sports; the European Commission (DG XII); and the Municipality of Rotterdam. Funding for the Netherlands Twin Registry was obtained from the Netherlands Organization for Scientific Research (NWO) and MagW/ZonMW, BBMRI-NL (184.021.007), the VU University Institute for Health and Care Research (EMGO+) and Neuroscience Campus Amsterdam, the European Science Council (ERC) Genetics of Mental Illness (230374), Avera Institute for Human Genetics and US National Institute of Mental Health (1RC2MH089951-01 and 1RC2 MH089995). The Swedish Twin Registry was financially supported by the Ragnar Soderberg Foundation (E9/11), the Swedish Research Council (421-2013-1061), the Jan Wallander and Tom Hedelius Foundation (P2012-0002:1), the Sven and Dagmar Salen Foundation, the Bank of Sweden Tercentenary Foundation (M11-0451:1) and the Karolinska Institutet. Some of the statistical analyses were carried out on the Genetic Cluster Computer (http://www.geneticcluster.org/), which is financially supported by the Netherlands Scientific Organization (NWO 480-05-003 PI: Posthuma) along with a supplement from the Dutch Brain Foundation and the VU University Amsterdam.	ANDREASEN NC, 1987, AM J PSYCHIAT, V144, P1288; Barrantes-Vidal N, 2004, J CONSCIOUSNESS STUD, V11, P58; Benjamin DJ, 2012, P NATL ACAD SCI USA, V109, P8026, DOI 10.1073/pnas.1120666109; Carson SH, 2005, CREATIVITY RES J, V17, P37, DOI 10.1207/s15326934crj1701_4; Ellamil M, 2012, NEUROIMAGE, V59, P1783, DOI 10.1016/j.neuroimage.2011.08.008; Heilman KM, 2003, NEUROCASE, V9, P369, DOI 10.1076/neur.9.5.369.16553; HERBERT PS, 1959, PSYCHIAT QUART, V33, P534, DOI 10.1007/BF01563109; Hofman A, 2013, EUR J EPIDEMIOL, V28, P889, DOI 10.1007/s10654-013-9866-z; Hoogendoorn EH, 2006, CLIN CHEM, V52, P104, DOI 10.1373/clinchem.2005.055194; JAMISON KR, 1989, PSYCHIATRY, V52, P125, DOI 10.1080/00332747.1989.11024436; JUDA A, 1949, AM J PSYCHIAT, V106, P296, DOI 10.1176/ajp.106.4.296; KARLSSON JL, 1970, HEREDITAS-GENETISK A, V66, P177; KARLSSON JL, 1984, HEREDITAS, V100, P83, DOI 10.1111/j.1601-5223.1984.tb00108.x; Kyaga S, 2013, J PSYCHIATR RES, V47, P83, DOI 10.1016/j.jpsychires.2012.09.010; Kyaga S, 2011, BRIT J PSYCHIAT, V199, P373, DOI 10.1192/bjp.bp.110.085316; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Lichtenstein P, 2006, TWIN RES HUM GENET, V9, P875, DOI 10.1375/twin.9.6.875; LUDWIG AM, 1992, AM J PSYCHOTHER, V46, P330, DOI 10.1176/appi.psychotherapy.1992.46.3.330; Minica CC, 2015, EUR J HUM GENET, V23, P388, DOI 10.1038/ejhg.2014.94; Nivard MG, 2014, GENES BRAIN BEHAV, V13, P195, DOI 10.1111/gbb.12095; Owen GS, 2007, BRIT J PSYCHIAT, V191, P453, DOI 10.1192/bjp.bp.107.037309; POST F, 1994, BRIT J PSYCHIAT, V165, P22, DOI 10.1192/bjp.165.1.22; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; Stefansson H, 2014, NATURE, V505, P361, DOI 10.1038/nature12818; Styrkarsdottir U, 2013, NATURE, V497, P517, DOI 10.1038/nature12124; van der Loos MJHM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060542; Willemsen G, 2013, TWIN RES HUM GENET, V16, P271, DOI 10.1017/thg.2012.140; Willemsen G, 2010, TWIN RES HUM GENET, V13, P231, DOI 10.1375/twin.13.3.231	30	204	206	4	123	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2015	18	7					953	+		10.1038/nn.4040	http://dx.doi.org/10.1038/nn.4040			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	CL3QU	26053403				2022-12-17	WOS:000356866200008
J	Shih, AY; Blinder, P; Tsai, PS; Friedman, B; Stanley, G; Lyden, PD; Kleinfeld, D				Shih, Andy Y.; Blinder, Pablo; Tsai, Philbert S.; Friedman, Beth; Stanley, Geoffrey; Lyden, Patrick D.; Kleinfeld, David			The smallest stroke: occlusion of one penetrating vessel leads to infarction and a cognitive deficit	NATURE NEUROSCIENCE			English	Article							RAT BARREL CORTEX; CEREBRAL MICROINFARCTS; BLOOD-FLOW; VASCULAR DEMENTIA; MEMANTINE; BRAIN; MICROCIRCULATION; ORGANIZATION; ANTAGONISTS; ARTERIOLES	Microinfarctions are present in the aged and injured human brain. Their clinical relevance is controversial, with postulated sequelae ranging from cognitive sparing to vascular dementia. To address the consequences of microinfarcts, we used controlled optical methods to create occlusions of individual penetrating arterioles or venules in rat cortex. Single microinfarcts, targeted to encompass all or part of a cortical column, impaired performance in a macrovibrissa-based behavioral task. Furthermore, the targeting of multiple vessels resulted in tissue damage that coalesced across cortex, even though the intervening penetrating vessels were acutely patent. Post-occlusion administration of memantine, a glutamate receptor antagonist that reduces cognitive decline in Alzheimer's disease, ameliorated tissue damage and perceptual deficits. Collectively, these data imply that microinfarcts likely contribute to cognitive decline. Strategies that have received limited success in the treatment of ischemic injury, which include therapeutics against excitotoxicity, may be successful against the progressive nature of vascular dementia.	[Shih, Andy Y.; Blinder, Pablo; Tsai, Philbert S.; Stanley, Geoffrey; Kleinfeld, David] Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; [Friedman, Beth] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Lyden, Patrick D.] Cedars Sinai Med Ctr, Dept Neurol, Los Angeles, CA USA; [Kleinfeld, David] Univ Calif San Diego, Neurobiol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Cedars Sinai Medical Center; University of California System; University of California San Diego	Kleinfeld, D (corresponding author), Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA.	dk@physics.ucsd.edu	Blinder, Pablo/GQI-2237-2022; Blinder, Pablo/AAX-7980-2020; Blinder, Pablo/D-2472-2009	Blinder, Pablo/0000-0002-4042-214X; Stanley, Geoffrey/0000-0003-4911-3279	American Heart Association; US National Institutes of Health [MH085499, EB003832, OD006831]; University of California, San Diego Neuroscience Shared Microscopy Core [NS047101]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB003832] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085499] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006831] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California, San Diego Neuroscience Shared Microscopy Core; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank A. Schweitzer for constructing the behavioral apparatus, S. E. Black, M. Deschenes, M. E. Diamond, F. F. Ebner, E. E. Smith and R. Swanson for discussions, and C. Mateo for comments on an early version of the manuscript. This work was supported by the American Heart Association (Post-doctoral fellowship to A.Y.S.) and the US National Institutes of Health (MH085499, EB003832 and OD006831 to D. K.), which further supported the University of California, San Diego Neuroscience Shared Microscopy Core (NS047101), which was used to image histological tissue.	ARMSTRONGJAMES M, 1992, J NEUROPHYSIOL, V68, P1345, DOI 10.1152/jn.1992.68.4.1345; Arvanitakis Z, 2011, STROKE, V42, P722, DOI 10.1161/STROKEAHA.110.595082; Bar T., 1980, ADV ANAT EMBRYOL CEL, V59, P1, DOI DOI 10.1007/978-3-642-67432-7_1; Blinder P, 2010, P NATL ACAD SCI USA, V107, P12670, DOI 10.1073/pnas.1007239107; Brown WR, 2011, NEUROPATH APPL NEURO, V37, P56, DOI 10.1111/j.1365-2990.2010.01139.x; Brundel M, 2012, J CEREBR BLOOD F MET, V32, P425, DOI 10.1038/jcbfm.2011.200; Calabrese V, 2007, NAT REV NEUROSCI, V8, P766, DOI 10.1038/nrn2214; Carmichael ST, 2003, NEUROSCIENTIST, V9, P64, DOI 10.1177/1073858402239592; Cassot F, 2010, BRAIN RES, V1313, P62, DOI 10.1016/j.brainres.2009.12.007; Cevik IU, 2003, CELL DEATH DIFFER, V10, P928, DOI 10.1038/sj.cdd.4401250; Chen B, 2009, STROKE, V40, pE666, DOI 10.1161/STROKEAHA.109.551341; Drew PJ, 2010, NAT METHODS, V7, P981, DOI 10.1038/NMETH.1530; Friedman B, 2009, STROKE, V40, P2182, DOI 10.1161/STROKEAHA.108.523720; FROSTIG RD, 1990, P NATL ACAD SCI USA, V87, P6082, DOI 10.1073/pnas.87.16.6082; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; HUTSON KA, 1986, J NEUROPHYSIOL, V56, P1196, DOI 10.1152/jn.1986.56.4.1196; Nguyen J, 2011, J CEREBR BLOOD F MET, V31, P2243, DOI 10.1038/jcbfm.2011.95; Jouvent E, 2011, STROKE, V42, pE27, DOI 10.1161/STROKEAHA.110.594218; Kleinfeld D, 1998, P NATL ACAD SCI USA, V95, P15741, DOI 10.1073/pnas.95.26.15741; Kleinfeld D, 1996, J COMP NEUROL, V375, P89, DOI 10.1002/(SICI)1096-9861(19961104)375:1<89::AID-CNE6>3.0.CO;2-K; Kleinfeld D, 2011, NEURON, V72, P455, DOI 10.1016/j.neuron.2011.10.009; Kovari E, 2007, NEUROLOGY, V68, P927, DOI 10.1212/01.wnl.0000257094.10655.9a; Lashley KS, 1931, SCIENCE, V73, P245, DOI 10.1126/science.73.1888.245; Lauwers F, 2008, NEUROIMAGE, V39, P936, DOI 10.1016/j.neuroimage.2007.09.024; MASINO SA, 1993, P NATL ACAD SCI USA, V90, P9998, DOI 10.1073/pnas.90.21.9998; Mehta SB, 2007, PLOS BIOL, V5, P309, DOI 10.1371/journal.pbio.0050015; Mohajerani MH, 2011, P NATL ACAD SCI USA, V108, pE183, DOI 10.1073/pnas.1101914108; Murphy TH, 2008, J NEUROSCI, V28, P1756, DOI 10.1523/JNEUROSCI.5128-07.2008; Nguyen QT, 2009, FRONT NEUROSCI, P117; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Nishimura N, 2006, NAT METHODS, V3, P99, DOI 10.1038/NMETH844; Nishimura N, 2007, P NATL ACAD SCI USA, V104, P365, DOI 10.1073/pnas.0609551104; Nishimura N, 2010, J CEREBR BLOOD F MET, V30, P1914, DOI 10.1038/jcbfm.2010.157; Olivares D, 2012, CURR ALZHEIMER RES, V9, P746; Orgogozo JM, 2002, STROKE, V33, P1834, DOI 10.1161/01.STR.0000020094.08790.49; Reisberg B, 2003, NEW ENGL J MED, V348, P1333, DOI 10.1056/NEJMoa013128; Rosidi NL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026612; Schaffer CB, 2006, PLOS BIOL, V4, P258, DOI 10.1371/journal.pbio.0040022; Shih A.Y., 2011, IMAGING NEUROSCIENCE, P939; Shih AY, 2012, J CEREBR BLOOD F MET, V32, P1277, DOI 10.1038/jcbfm.2011.196; Shih AY, 2009, J CEREBR BLOOD F MET, V29, P738, DOI 10.1038/jcbfm.2008.166; SIESJO BK, 1989, J CEREBR BLOOD F MET, V9, P127, DOI 10.1038/jcbfm.1989.20; Smith EE, 2012, LANCET NEUROL, V11, P272, DOI 10.1016/S1474-4422(11)70307-6; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Soontornniyomkij V, 2010, BRAIN PATHOL, V20, P459, DOI 10.1111/j.1750-3639.2009.00322.x; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Troncoso E, 2004, CEREB CORTEX, V14, P332, DOI 10.1093/cercor/bhg131; Tsai PS, 2009, J NEUROSCI, V29, P14553, DOI 10.1523/JNEUROSCI.3287-09.2009; Tsai PS, 2009, FRONT NEUROSCI, P59; Valmianski I, 2010, J NEUROPHYSIOL, V104, P1803, DOI 10.1152/jn.00484.2010; VILLRINGER A, 1994, J NEURORADIOLOGY, V21, P72; Vinters HV, 2000, J NEUROPATH EXP NEUR, V59, P931, DOI 10.1093/jnen/59.11.931; Weber B, 2008, CEREB CORTEX, V18, P2318, DOI 10.1093/cercor/bhm259; Wilcock GK, 2003, LANCET NEUROL, V2, P503, DOI 10.1016/S1474-4422(03)00486-1; Woolsey TA, 1996, CEREB CORTEX, V6, P647, DOI 10.1093/cercor/6.5.647; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; Yuste, 2011, IMAGING NEUROSCIENCE, P927; Zhang SX, 2007, PLOS BIOL, V5, P1152, DOI 10.1371/journal.pbio.0050119	60	204	209	1	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2013	16	1					55	U88		10.1038/nn.3278	http://dx.doi.org/10.1038/nn.3278			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	058KZ	23242312	Green Accepted			2022-12-17	WOS:000312633900013
J	Ko, HK; Poletti, M; Rucci, M				Ko, Hee-kyoung; Poletti, Martina; Rucci, Michele			Microsaccades precisely relocate gaze in a high visual acuity task	NATURE NEUROSCIENCE			English	Article							FIXATIONAL EYE-MOVEMENTS; MONOCULAR FIXATION; STIMULI; VISION; MEMORY; IMAGE	The image on the retina is never stationary. Microscopic relocations of gaze, known as microsaccades, occur even during steady fixation. It has long been thought that microsaccades enable exploration of small regions in the scene in the same way saccades are normally used to scan larger regions. This hypothesis, however, has remained controversial, as it is believed that microsaccades are suppressed during fine spatial judgments. We examined the eye movements of human observers in a high-acuity visuomotor task, the threading of a needle in a computer-simulated virtual environment. Using a method for gaze-contingent display that enables accurate localization of the line of sight, we found that microsaccades precisely move the eye to nearby regions of interest and are dynamically modulated by the ongoing demands of the task. These results indicate that microsaccades are part of the oculomotor strategy by which the visual system acquires fine spatial detail.	[Ko, Hee-kyoung; Poletti, Martina; Rucci, Michele] Boston Univ, Dept Psychol, Boston, MA 02215 USA; [Rucci, Michele] Boston Univ, Program Neurosci, Boston, MA 02215 USA	Boston University; Boston University	Rucci, M (corresponding author), Boston Univ, Dept Psychol, 64 Cummington St, Boston, MA 02215 USA.	mrucci@bu.edu		Rucci, Michele/0000-0002-3066-1964; Poletti, Martina/0000-0002-4773-8745	US National Institutes of Health [EY018363]; National Science Foundation [BCS-0719849, IOS-0843304]; NATIONAL EYE INSTITUTE [R01EY018363] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors thank A. Casile and D. Richters for helpful comments on the manuscript. This work was supported by a grant from the US National Institutes of Health (EY018363) and grants from the National Science Foundation (BCS-0719849 and IOS-0843304).	Ahissar E, 2001, NEURON, V32, P185, DOI 10.1016/S0896-6273(01)00466-4; BALLARD DH, 1995, J COGNITIVE NEUROSCI, V7, P66, DOI 10.1162/jocn.1995.7.1.66; BRIDGEMAN B, 1980, VISION RES, V20, P813, DOI 10.1016/0042-6989(80)90013-9; Collewijn H, 2008, J VISION, V8, DOI 10.1167/8.14.20; CORNSWEET TN, 1956, J OPT SOC AM, V46, P987, DOI 10.1364/JOSA.46.000987; CUNITZ RJ, 1969, VISION RES, V9, P683, DOI 10.1016/0042-6989(69)90125-4; DITCHBURN RW, 1953, J PHYSIOL-LONDON, V119, P1; DITCHBURN RW, 1959, J PHYSIOL-LONDON, V145, P98, DOI 10.1113/jphysiol.1959.sp006130; Engbert R, 2004, PSYCHOL SCI, V15, P431, DOI 10.1111/j.0956-7976.2004.00697.x; EPELBOIM J, 1995, VISION RES, V35, P3401, DOI 10.1016/0042-6989(95)00080-X; HADDAD GM, 1973, VISION RES, V13, P1075, DOI 10.1016/0042-6989(73)90145-4; Hafed ZM, 2009, SCIENCE, V323, P940, DOI 10.1126/science.1166112; Johansson RS, 2001, J NEUROSCI, V21, P6917, DOI 10.1523/JNEUROSCI.21-17-06917.2001; Kagan I, 2008, J VISION, V8, DOI 10.1167/8.14.19; Land M, 1999, PERCEPTION, V28, P1311, DOI 10.1068/p2935; Martinez-Conde S, 2006, NEURON, V49, P297, DOI 10.1016/j.neuron.2005.11.033; Poletti M, 2010, J VISION, V10, DOI 10.1167/10.3.6; Putnam NM, 2005, J VISION, V5, P632, DOI 10.1167/5.7.3; RATLIFF F, 1950, J EXP PSYCHOL, V40, P687, DOI 10.1037/h0057754; Rolfs M, 2009, VISION RES, V49, P2415, DOI 10.1016/j.visres.2009.08.010; Rucci M, 2003, J VISION, V3, P852, DOI 10.1167/3.11.18; Rucci M, 2007, NATURE, V447, P851, DOI 10.1038/nature05866; Santini F, 2007, BEHAV RES METHODS, V39, P350, DOI 10.3758/BF03193003; SNODDERLY DM, 1987, VISION RES, V27, P401, DOI 10.1016/0042-6989(87)90089-7; STEINMAN RM, 1967, SCIENCE, V155, P1577, DOI 10.1126/science.155.3769.1577; STEINMAN RM, 1965, J OPT SOC AM, V55, P1158, DOI 10.1364/JOSA.55.001158; TIMBERLAKE GT, 1972, VISION RES, V12, P1059, DOI 10.1016/0042-6989(72)90027-2; van Hateren JH, 1998, P ROY SOC B-BIOL SCI, V265, P2315, DOI 10.1098/rspb.1998.0577; WINTERSON BJ, 1976, VISION RES, V16, P1387, DOI 10.1016/0042-6989(76)90156-5	30	204	205	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2010	13	12					1549	U142		10.1038/nn.2663	http://dx.doi.org/10.1038/nn.2663			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	684CW	21037583	Green Accepted			2022-12-17	WOS:000284525800021
J	Tronson, NC; Wiseman, SL; Olausson, P; Taylor, JR				Tronson, NC; Wiseman, SL; Olausson, P; Taylor, JR			Bidirectional behavioral plasticity of memory reconsolidation depends on amygdalar protein kinase A	NATURE NEUROSCIENCE			English	Article							EXTINCTION; CONSOLIDATION; RETRIEVAL	Reconsolidation-the stabilization of a memory after retrieval is hypothesized to be a critical and distinct component of memory processing, the disruption of which results in memory impairment. In the rat, we found that activation of amygdalar protein kinase A ( PKA) was sufficient to enhance memory only when it was retrieved; in contrast, PKA inhibition impaired reconsolidation. This study demonstrates both a selective enhancement and an impairment of memory reconsolidation dependent on amygdalar PKA.	Yale Univ, Sch Med, Connecticut Mental Hlth Ctr, Dept Psychiat,Div Mol Psychiat,Ctr Genes & Behav,, New Haven, CT 06508 USA; Yale Univ, Dept Psychol, New Haven, CT 06520 USA	Yale University; Yale University	Taylor, JR (corresponding author), Yale Univ, Sch Med, Connecticut Mental Hlth Ctr, Dept Psychiat,Div Mol Psychiat,Ctr Genes & Behav,, 34 Pk St, New Haven, CT 06508 USA.	jane.taylor@yale.edu		Tronson, Natalie/0000-0001-5676-1579; Wiseman, Shari/0000-0001-7868-9723	NIDA NIH HHS [DA15222] Funding Source: Medline; NIMH NIH HHS [MH25642] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH025642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015222] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Bahar A, 2004, EUR J NEUROSCI, V19, P1115, DOI 10.1111/j.0953-816X.2004.03215.x; Christensen AE, 2003, J BIOL CHEM, V278, P35394, DOI 10.1074/jbc.M302179200; Duvarci S, 2004, J NEUROSCI, V24, P9269, DOI 10.1523/JNEUROSCI.2971-04.2004; GORDON WC, 1977, PHYSIOL BEHAV, V19, P95; Jentsch JD, 2002, BIOL PSYCHIAT, V52, P111, DOI 10.1016/S0006-3223(02)01358-6; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; PAXINOS G, 1996, RAT BRAIN ATLAS STER; Pedreira ME, 2003, NEURON, V38, P863, DOI 10.1016/S0896-6273(03)00352-0; Sara SJ, 2000, NAT REV NEUROSCI, V1, P212, DOI 10.1038/35044575; Schafe GE, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-18-j0003.2000; Suzuki A, 2004, J NEUROSCI, V24, P4787, DOI 10.1523/JNEUROSCI.5491-03.2004	11	204	206	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2006	9	2					167	169		10.1038/nn1628	http://dx.doi.org/10.1038/nn1628			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	007SN	16415868				2022-12-17	WOS:000234990100009
J	Mandiyan, VS; Coats, JK; Shah, NM				Mandiyan, VS; Coats, JK; Shah, NM			Deficits in sexual and aggressive behaviors in Cnga2 mutant mice	NATURE NEUROSCIENCE			English	Article							DISCRIMINATION; DISRUPTION; ODORANTS; DISTINCT; ANOSMIA	Odors detected by the vomeronasal organ or the main olfactory epithelium (MOE) trigger social behaviors in many animals. It is unknown whether MOE neurons detect cues that initiate mating or aggression. We demonstrate that mice lacking functional CNGA2 ( cyclic nucleotide - gated channel alpha 2), which is required for odor-evoked MOE signaling, fail to mate or fight, suggesting a broad and essential role for the MOE in regulating these behaviors.	Univ Calif San Francisco, Dept Anat, Grad Program Neurosci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Shah, NM (corresponding author), Univ Calif San Francisco, Dept Anat, Grad Program Neurosci, Box 2722, San Francisco, CA 94143 USA.	nms@itsa.ucsf.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049488] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS049488] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Belluscio L, 1998, NEURON, V20, P69, DOI 10.1016/S0896-6273(00)80435-3; Berghard A, 1996, P NATL ACAD SCI USA, V93, P2365, DOI 10.1073/pnas.93.6.2365; Brunet LJ, 1996, NEURON, V17, P681, DOI 10.1016/S0896-6273(00)80200-7; Del Punta K, 2002, NATURE, V419, P70, DOI 10.1038/nature00955; DEVOR M, 1973, BEHAV BIOL, V9, P31, DOI 10.1016/S0091-6773(73)80166-X; Kingston PA, 1999, SYNAPSE, V32, P1, DOI 10.1002/(SICI)1098-2396(199904)32:1<1::AID-SYN1>3.0.CO;2-M; Leypold BG, 2002, P NATL ACAD SCI USA, V99, P6376, DOI 10.1073/pnas.082127599; Lin DY, 2005, NATURE, V434, P470, DOI 10.1038/nature03414; Luo MM, 2003, SCIENCE, V299, P1196, DOI 10.1126/science.1082133; Miczek KA, 2001, BEHAV BRAIN RES, V125, P167, DOI 10.1016/S0166-4328(01)00298-4; Pankevich DE, 2004, J NEUROSCI, V24, P9451, DOI 10.1523/JNEUROSCI.2376-04.2004; Restrepo D, 2004, HORM BEHAV, V46, P247, DOI 10.1016/j.yhbeh.2004.02.009; Sam M, 2001, NATURE, V412, P142, DOI 10.1038/35084137; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; Wong ST, 2000, NEURON, V27, P487, DOI 10.1016/S0896-6273(00)00060-X	15	204	210	2	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2005	8	12					1660	1662		10.1038/nn1589	http://dx.doi.org/10.1038/nn1589			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	988FC	16261133				2022-12-17	WOS:000233576200012
J	George, N; Dolan, RJ; Fink, GR; Baylis, GC; Russell, C; Driver, J				George, N; Dolan, RJ; Fink, GR; Baylis, GC; Russell, C; Driver, J			Contrast polarity and face recognition in the human fusiform gyrus	NATURE NEUROSCIENCE			English	Article							HUMAN EXTRASTRIATE CORTEX; FUNCTIONAL-ORGANIZATION; FACIAL RECOGNITION; RECOGNIZING FACES; TEMPORAL CORTEX; HUMAN BRAIN; MEMORY; PERCEPTION; PROSOPAGNOSIA; NEURONS	Functional imaging has revealed face-responsive visual areas in the human fusiform gyrus, but their role in recognizing familiar individuals remains controversial. Face recognition is particularly impaired by reversing contrast polarity of the image, even though this preserves all edges and spatial frequencies. Here, combined influences of familiarity and priming on face processing were examined as contrast polarity was manipulated. Our fMRI results show that bilateral posterior areas in fusiform gyrus responded more strongly for faces with positive than with negative contrast polarity. An anterior, right-lateralized fusiform region is activated when a given face stimulus becomes recognizable as a well-known individual.	Inst Neurol, Wellcome Dept Cognit Neurol, London WC1N 3BG, England; Univ Dusseldorf, Neurol Klin, D-40001 Dusseldorf, Germany; Univ S Carolina, Dept Psychol, Columbia, SC 29208 USA; UCL, Inst Cognit Neurosci, London WC1N 3AR, England	University of London; University College London; Heinrich Heine University Dusseldorf; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of London; University College London	Dolan, RJ (corresponding author), Inst Neurol, Wellcome Dept Cognit Neurol, 12 Queen Sq, London WC1N 3BG, England.	r.dolan@fil.ion.ucl.ac.uk	Fink, Gereon R./E-1616-2012; Fink, Gereon R./AFW-9377-2022; Driver, Jon/A-4779-2010	Fink, Gereon R./0000-0002-8230-1856; Fink, Gereon R./0000-0002-8230-1856; Russell, Charlotte/0000-0002-8194-8033; BAYLIS, Gordon/0000-0002-4223-9074; Dolan, Ray/0000-0001-9356-761X	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Andreasen NC, 1996, J NEUROPSYCH CLIN N, V8, P139; Biederman I, 1997, PHILOS T ROY SOC B, V352, P1203, DOI 10.1098/rstb.1997.0103; BRUCE V, 1994, PERCEPTION, V23, P803, DOI 10.1068/p230803; Bruce V., 1994, VIS COGN, V1, P141, DOI [DOI 10.1080/13506289408402299, 10.1080/13506289408402299]; BRUNASWAGSTAFF J, 1992, Q J EXP PSYCHOL-A, V44, P423, DOI 10.1080/14640749208401293; BUCKNER RL, 1995, J NEUROSCI, V15, P12; Buckner RL, 1998, NEURON, V20, P285, DOI 10.1016/S0896-6273(00)80456-0; CAVANAGH P, 1989, J EXP PSYCHOL HUMAN, V15, P3, DOI 10.1037/0096-1523.15.1.3; Clark VP, 1998, J NEUROPHYSIOL, V79, P3257, DOI 10.1152/jn.1998.79.6.3257; Courtney SM, 1997, NATURE, V386, P608, DOI 10.1038/386608a0; DAMASIO AR, 1982, NEUROLOGY, V32, P331, DOI 10.1212/WNL.32.4.331; DAMASIO AR, 1990, ANNU REV NEUROSCI, V13, P89, DOI 10.1146/annurev.ne.13.030190.000513; DAVIES G, 1978, J APPL PSYCHOL, V63, P180, DOI 10.1037/0021-9010.63.2.180; DERENZI E, 1994, NEUROPSYCHOLOGIA, V32, P893, DOI 10.1016/0028-3932(94)90041-8; DERENZI E, 1989, HDB RES FACE PROCESS, P27; DESIMONE R, 1984, J NEUROSCI, V4, P2051; Dolan RJ, 1997, NATURE, V389, P596, DOI 10.1038/39309; ELLIS AW, 1990, Q J EXP PSYCHOL-A, V42, P495, DOI 10.1080/14640749008401234; ETTLIN TM, 1992, CORTEX, V28, P129, DOI 10.1016/S0010-9452(13)80171-2; Gauthier I, 1997, CURR BIOL, V7, P645, DOI 10.1016/S0960-9822(06)00291-0; GRADY CL, 1995, SCIENCE, V269, P218, DOI 10.1126/science.7618082; HARRIES MH, 1991, J COGNITIVE NEUROSCI, V3, P9, DOI 10.1162/jocn.1991.3.1.9; Haxby JV, 1996, P NATL ACAD SCI USA, V93, P922, DOI 10.1073/pnas.93.2.922; HAXBY JV, 1991, P NATL ACAD SCI USA, V88, P1621, DOI 10.1073/pnas.88.5.1621; HAXBY JV, 1994, J NEUROSCI, V14, P6336; JOHNSTON A, 1992, PERCEPTION, V21, P365, DOI 10.1068/p210365; Kanwisher N, 1997, J NEUROSCI, V17, P4302; KANWISHER N, IN PRESS COGNITION; KAPUR N, 1995, CORTEX, V31, P99, DOI 10.1016/S0010-9452(13)80108-6; Kemp R, 1996, PERCEPTION, V25, P37, DOI 10.1068/p250037; McCarthy G, 1997, J COGNITIVE NEUROSCI, V9, P605, DOI 10.1162/jocn.1997.9.5.605; MEADOWS JC, 1974, J NEUROL NEUROSUR PS, V37, P489, DOI 10.1136/jnnp.37.5.489; MORTON J, 1969, PSYCHOL REV, V76, P165, DOI 10.1037/h0027366; PERRETT DI, 1984, HUM NEUROBIOL, V3, P197; Puce A, 1996, J NEUROSCI, V16, P5205; RAICHLE ME, 1994, CEREB CORTEX, V4, P8, DOI 10.1093/cercor/4.1.8; RIZZO M, 1987, ANN NEUROL, V22, P41, DOI 10.1002/ana.410220111; ROLLS ET, 1986, EXP BRAIN RES, V65, P38; Schacter DL, 1998, NEURON, V20, P185, DOI 10.1016/S0896-6273(00)80448-1; SCHACTER DL, 1995, NATURE, V376, P587, DOI 10.1038/376587a0; SERGENT J, 1992, BRAIN, V115, P15, DOI 10.1093/brain/115.1.15; SERGENT J, 1989, HDB RES FACE PROCESS, P77; Sinha P, 1996, NATURE, V384, P460, DOI 10.1038/384460a0; SQUIRE LR, 1992, P NATL ACAD SCI USA, V89, P1837, DOI 10.1073/pnas.89.5.1837; SUBRAMANIAM S, 1997, INVEST OPHTHALMOL, V38, P998; Tempini MLG, 1998, BRAIN, V121, P2103, DOI 10.1093/brain/121.11.2103; UNGERLEIDER LG, 1995, SCIENCE, V270, P769, DOI 10.1126/science.270.5237.769; Warrington E., 1967, CORTEX, V3, P317, DOI DOI 10.1016/S0010-9452(67)80020-0; Wiskott L, 1996, NEUROIMAGE, V4, pS14, DOI 10.1006/nimg.1996.0043; YOUNG AW, 1994, BRIT J PSYCHOL, V85, P393, DOI 10.1111/j.2044-8295.1994.tb02531.x	50	204	209	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	1999	2	6					574	580		10.1038/9230	http://dx.doi.org/10.1038/9230			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	273YA	10448224				2022-12-17	WOS:000084735900019
J	Feldmeyer, D; Kask, K; Brusa, R; Kornau, HC; Kolhekar, R; Rozov, A; Burnashev, N; Jensen, V; Hvalby, O; Sprengel, R; Seeburg, PH				Feldmeyer, D; Kask, K; Brusa, R; Kornau, HC; Kolhekar, R; Rozov, A; Burnashev, N; Jensen, V; Hvalby, O; Sprengel, R; Seeburg, PH			Neurological dysfunctions in mice expressing different levels of the Q/R site-unedited AMPAR subunit GluR-B	NATURE NEUROSCIENCE			English	Article							LONG-LASTING POTENTIATION; SINGLE-CHANNEL PROPERTIES; GLUTAMATE-GATED CHANNELS; RECEPTOR CHANNELS; CALCIUM PERMEABILITY; TERM POTENTIATION; GERM-CELLS; NEURONS; DEFICIENT; NMDA	We generated mouse mutants with targeted AMPA receptor (AMPAR) GluR-B subunit alleles, functionally expressed at different levels and deficient in Q/R-site editing. All mutant lines had increased AMPAR calcium permeabilities in pyramidal neurons, and one showed elevated macroscopic conductances of these channels. The AMPAR-mediated calcium influx induced NMDA-receptor-independent long-term potentiation (LTP) in hippocampal pyramidal cell connections. Calcium-triggered neuronal death was not observed, but mutants had mild to severe neurological dysfunctions, including epilepsy and deficits in dendritic architecture. The seizure-prone phenotype correlated with an increase in the macroscopic conductance, as independently revealed by the effect of a transgene for a Q/R-site-altered GluR-B subunit. Thus, changes in GluR-B gene expression and Q/R site editing can affect critical architectural and functional aspects of excitatory principal neurons.	Max Planck Inst Med Res, Dept Mol Neurobiol, D-69120 Heidelberg, Germany; Max Planck Inst Med Res, Dept Mol Cell Physiol, D-69120 Heidelberg, Germany; Univ Oslo, Inst Neurophysiol, N-0317 Oslo, Norway	Max Planck Society; Max Planck Society; University of Oslo	Sprengel, R (corresponding author), Max Planck Inst Med Res, Dept Mol Neurobiol, Jahnstr 29, D-69120 Heidelberg, Germany.		Rozov, Andrei/C-1997-2015; Burnashev, Nail/G-4056-2013; Feldmeyer, Dirk/H-5940-2013	Feldmeyer, Dirk/0000-0002-1716-8972				ANDERSEN P, 1977, NATURE, V266, P736, DOI 10.1038/266736a0; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BRAUN RE, 1990, BIOL REPROD, V43, P684, DOI 10.1095/biolreprod43.4.684; BRUSA R, 1995, SCIENCE, V270, P1677, DOI 10.1126/science.270.5242.1677; BURNASHEV N, 1992, NEURON, V8, P189, DOI 10.1016/0896-6273(92)90120-3; Burnashev N, 1996, CURR OPIN NEUROBIOL, V6, P311, DOI 10.1016/S0959-4388(96)80113-9; BURNASHEV N, 1995, J PHYSIOL-LONDON, V485, P403, DOI 10.1113/jphysiol.1995.sp020738; Cases O, 1996, NEURON, V16, P297, DOI 10.1016/S0896-6273(00)80048-3; CHEN EY, 1989, GENOMICS, V4, P479, DOI 10.1016/0888-7543(89)90271-1; CHOI DW, 1995, TRENDS NEUROSCI, V18, P58; DANIELSON PE, 1988, DNA-J MOLEC CELL BIO, V7, P261, DOI 10.1089/dna.1988.7.261; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; DUNWIDDIE TV, 1979, BRAIN RES, V169, P103, DOI 10.1016/0006-8993(79)90377-9; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Gu JG, 1996, NATURE, V381, P793, DOI 10.1038/381793a0; HIGUCHI M, 1993, CELL, V75, P1361, DOI 10.1016/0092-8674(93)90622-W; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; HORIKAWA K, 1988, J NEUROSCI METH, V25, P1, DOI 10.1016/0165-0270(88)90114-8; HUME RI, 1991, SCIENCE, V253, P1028, DOI 10.1126/science.1653450; Jia ZP, 1996, NEURON, V17, P945, DOI 10.1016/S0896-6273(00)80225-1; JONAS P, 1995, NEURON, V15, P987, DOI 10.1016/0896-6273(95)90087-X; Kamal A, 1998, NEUROSCIENCE, V83, P707, DOI 10.1016/S0306-4522(97)00394-1; KASK K, IN PRESS P NATL ACAD; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kharazia VN, 1996, NEUROSCI LETT, V210, P37, DOI 10.1016/0304-3940(96)12658-6; KOHLER M, 1994, J BIOL CHEM, V269, P17367; KYROZIS A, 1995, J PHYSIOL-LONDON, V485, P373, DOI 10.1113/jphysiol.1995.sp020736; Lin JW, 1998, NEURON, V21, P267, DOI 10.1016/S0896-6273(00)80534-6; LOMELI H, 1994, SCIENCE, V266, P1709, DOI 10.1126/science.7992055; Mahanty NK, 1998, NATURE, V394, P683, DOI 10.1038/29312; MOSBACHER J, 1994, SCIENCE, V266, P1059, DOI 10.1126/science.7973663; Myers SJ, 1998, J NEUROSCI, V18, P6723; Nagy A, 1998, CURR BIOL, V8, P661, DOI 10.1016/S0960-9822(98)70254-4; O'Brien RJ, 1998, CURR OPIN NEUROBIOL, V8, P364, DOI 10.1016/S0959-4388(98)80062-7; Petralia RS, 1997, J COMP NEUROL, V385, P456, DOI 10.1002/(SICI)1096-9861(19970901)385:3<456::AID-CNE9>3.0.CO;2-2; ROTHSTEIN JD, 1995, J NEUROCHEM, V65, P643; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Seeburg PH, 1998, BRAIN RES REV, V26, P217, DOI 10.1016/S0165-0173(97)00062-3; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; Sprengel R, 1998, CELL, V92, P279, DOI 10.1016/S0092-8674(00)80921-6; Swanson GT, 1996, J PHYSIOL-LONDON, V492, P129, DOI 10.1113/jphysiol.1996.sp021295; Swanson GT, 1997, J NEUROSCI, V17, P58, DOI 10.1523/JNEUROSCI.17-01-00058.1997; Washburn MS, 1997, J NEUROSCI, V17, P9393; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; WIGSTROM H, 1979, ACTA PHYSIOL SCAND, V105, P126, DOI 10.1111/j.1748-1716.1979.tb06323.x; WISDEN W, 1994, IN SITU HYBRIDIZATIO, P9	47	204	207	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	1999	2	1					57	64		10.1038/4561	http://dx.doi.org/10.1038/4561			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	163MK	10195181				2022-12-17	WOS:000078409300014
J	Park, S; Guo, YY; Jia, XT; Choe, HK; Grena, B; Kang, J; Park, J; Lu, C; Canales, A; Chen, R; Yim, YS; Choi, GB; Fink, Y; Anikeeva, P				Park, Seongjun; Guo, Yuanyuan; Jia, Xiaoting; Choe, Han Kyoung; Grena, Benjamin; Kang, Jeewoo; Park, Jiyeon; Lu, Chi; Canales, Andres; Chen, Ritchie; Yim, Yeong Shin; Choi, Gloria B.; Fink, Yoel; Anikeeva, Polina			One-step optogenetics with multifunctional flexible polymer fibers	NATURE NEUROSCIENCE			English	Article							IN-VIVO; CONDUCTING POLYMERS; NEURAL INTERFACES; SOCIAL-BEHAVIOR; NEURONS; TISSUE; CHANNELRHODOPSIN-2; INTERROGATION; DISEASE; SYSTEMS	Optogenetic interrogation of neural pathways relies on delivery of light-sensitive opsins into tissue and subsequent optical illumination and electrical recording from the regions of interest. Despite the recent development of multifunctional neural probes, integration of these modalities in a single biocompatible platform remains a challenge. We developed a device composed of an optical waveguide, six electrodes and two microfluidic channels produced via fiber drawing. Our probes facilitated injections of viral vectors carrying opsin genes while providing collocated neural recording and optical stimulation. The miniature (<200 mm) footprint and modest weight (<0.5 g) of these probes allowed for multiple implantations into the mouse brain, which enabled opto-electrophysiological investigation of projections from the basolateral amygdala to the medial prefrontal cortex and ventral hippocampus during behavioral experiments. Fabricated solely from polymers and polymer composites, these flexible probes minimized tissue response to achieve chronic multimodal interrogation of brain circuits with high fidelity.	[Park, Seongjun] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Park, Seongjun; Grena, Benjamin; Lu, Chi; Canales, Andres; Chen, Ritchie; Fink, Yoel; Anikeeva, Polina] MIT, Elect Res Lab, Cambridge, MA 02139 USA; [Guo, Yuanyuan; Grena, Benjamin; Lu, Chi; Canales, Andres; Chen, Ritchie; Fink, Yoel; Anikeeva, Polina] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Guo, Yuanyuan] Tohoku Univ, Dept Biomed Engn, Sendai, Miyagi, Japan; [Guo, Yuanyuan; Jia, Xiaoting] Virginia Polytech Inst & State Univ, Dept Elect & Comp Engn, Blacksburg, VA 24061 USA; [Choe, Han Kyoung; Yim, Yeong Shin; Choi, Gloria B.] MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Choe, Han Kyoung; Yim, Yeong Shin; Choi, Gloria B.] MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA; [Kang, Jeewoo] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Park, Jiyeon] MIT, Dept Mech Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Tohoku University; Virginia Polytechnic Institute & State University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Anikeeva, P (corresponding author), MIT, Elect Res Lab, Cambridge, MA 02139 USA.; Anikeeva, P (corresponding author), MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA.	anikeeva@mit.edu	Guo, Yuanyuan/AAT-8786-2020; Yim, Yeong Shin/HCH-4791-2022; Choe, Han Kyoung/ABD-5083-2020; Core, Vector/CAF-4832-2022; Park, Seongjun/H-2307-2019	Guo, Yuanyuan/0000-0002-9618-7919; Choe, Han Kyoung/0000-0001-7849-7094; Chen, Ritchie/0000-0001-5985-8843	National Institute of Neurological Disorders and Stroke [5R01NS086804]; National Science Foundation under CAREER award [CBET-1253890]; Center for Materials Science and Engineering [DMR-1419807]; Center for Sensorimotor Neural Engineering [EEC-1028725]; McGovern Institute for Brain Research at MIT; Samsung Scholarship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS086804] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Science Foundation under CAREER award; Center for Materials Science and Engineering; Center for Sensorimotor Neural Engineering(National Science Foundation (NSF)); McGovern Institute for Brain Research at MIT; Samsung Scholarship(Samsung); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors are grateful to H.Cho for graphics help during figure preparation. This work was supported in part by the National Institute of Neurological Disorders and Stroke (5R01NS086804, P.A.) National Science Foundation under CAREER award (CBET-1253890, P.A.), Center for Materials Science and Engineering (DMR-1419807, P.A. and Y.F.), Center for Sensorimotor Neural Engineering (EEC-1028725, P.A.) and the McGovern Institute for Brain Research at MIT (P.A. and G.B.C.). S.P. is a recipient of Samsung Scholarship.	Abouraddy AF, 2007, NAT MATER, V6, P336, DOI 10.1038/nmat1889; Anikeeva P, 2012, NAT NEUROSCI, V15, P163, DOI 10.1038/nn.2992; Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Bacon SJ, 1996, BRAIN RES, V720, P211, DOI 10.1016/0006-8993(96)00155-2; Baumer S., 2011, HDB PLASTIC OPTICS; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Canales A, 2015, NAT BIOTECHNOL, V33, P277, DOI 10.1038/nbt.3093; Cardin JA, 2010, NAT PROTOC, V5, P247, DOI 10.1038/nprot.2009.228; Desai M, 2011, J NEUROPHYSIOL, V105, P1393, DOI 10.1152/jn.00828.2010; Farrell MS, 2013, NEUROPSYCHOPHARMACOL, V38, P854, DOI 10.1038/npp.2012.251; Felix-Ortiz AC, 2014, J NEUROSCI, V34, P586, DOI 10.1523/JNEUROSCI.4257-13.2014; Felix-Ortiz AC, 2013, NEURON, V79, P658, DOI 10.1016/j.neuron.2013.06.016; Flecknell P., 2009, LAB ANIMAL ANAESTHES, V3rd ed.; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Green RA, 2008, BIOMATERIALS, V29, P3393, DOI 10.1016/j.biomaterials.2008.04.047; Guimard NK, 2007, PROG POLYM SCI, V32, P876, DOI 10.1016/j.progpolymsci.2007.05.012; Gunaydin LA, 2014, CELL, V157, P1535, DOI 10.1016/j.cell.2014.05.017; Huang JC, 2002, ADV POLYM TECH, V21, P299, DOI 10.1002/adv.10025; Hunt RF, 2013, NAT NEUROSCI, V16, P692, DOI 10.1038/nn.3392; Jeong JW, 2015, CELL, V162, P662, DOI 10.1016/j.cell.2015.06.058; Jukkola P, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-70; Kim BJ, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/4/045002; Kravitz AV, 2012, NAT NEUROSCI, V15, P816, DOI 10.1038/nn.3100; Kuo JTW, 2013, LAB CHIP, V13, P554, DOI 10.1039/c2lc40935f; Lee BR, 2013, NAT NEUROSCI, V16, P1644, DOI 10.1038/nn.3533; Lee H, 2005, J NEURAL ENG, V2, P81, DOI 10.1088/1741-2560/2/4/003; Lind G, 2013, SCI REP-UK, V3, DOI 10.1038/srep02942; Mark J.E., 2009, POLYM DATA HDB; Minev IR, 2015, SCIENCE, V347, P159, DOI 10.1126/science.1260318; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nevian T, 2007, NAT NEUROSCI, V10, P206, DOI 10.1038/nn1826; Park S, 2015, SCI REP-UK, V5, DOI 10.1038/srep09669; Park SI, 2015, NAT BIOTECHNOL, V33, P1280, DOI 10.1038/nbt.3415; Paxinos G., 2019, PAXINOS FRANKLINS MO, DOI [10.3390/ijms20225729, DOI 10.3390/IJMS20225729]; Polikov VS, 2005, J NEUROSCI METH, V148, P1, DOI 10.1016/j.jneumeth.2005.08.015; Roy N, 2012, PROG POLYM SCI, V37, P781, DOI 10.1016/j.progpolymsci.2012.02.002; Saxena T, 2013, BIOMATERIALS, V34, P4703, DOI 10.1016/j.biomaterials.2013.03.007; Schmitzer-Torbert N, 2005, NEUROSCIENCE, V131, P1, DOI 10.1016/j.neuroscience.2004.09.066; Shi PT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098247; Siracusa R, 2015, CNS NEUROL DISORD-DR, V14, P1350, DOI 10.2174/1871527314666150821102823; Tao GM, 2012, INT J APPL GLASS SCI, V3, P349, DOI 10.1111/ijag.12007; Tye KM, 2012, NAT REV NEUROSCI, V13, P251, DOI 10.1038/nrn3171; Vardy E, 2015, NEURON, V86, P936, DOI 10.1016/j.neuron.2015.03.065; Ward MP, 2009, BRAIN RES, V1282, P183, DOI 10.1016/j.brainres.2009.05.052; Wes PD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106050; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192	46	203	205	24	253	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2017	20	4					612	+		10.1038/nn.4510	http://dx.doi.org/10.1038/nn.4510			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EP7LH	28218915	Green Submitted, Green Accepted, Green Published			2022-12-17	WOS:000397558800016
J	Hunt, RF; Girskis, KM; Rubenstein, JL; Alvarez-Buylla, A; Baraban, SC				Hunt, Robert F.; Girskis, Kelly M.; Rubenstein, John L.; Alvarez-Buylla, Arturo; Baraban, Scott C.			GABA progenitors grafted into the adult epileptic brain control seizures and abnormal behavior	NATURE NEUROSCIENCE			English	Article							MEDIAL GANGLIONIC EMINENCE; TEMPORAL-LOBE EPILEPSY; OPTOGENETIC CONTROL; PILOCARPINE MODEL; INHIBITION; PRECURSORS; ORIGINS; NEURONS; MICE	Impaired GABA-mediated neurotransmission has been implicated in many neurologic diseases, including epilepsy, intellectual disability and psychiatric disorders. We found that inhibitory neuron transplantation into the hippocampus of adult mice with confirmed epilepsy at the time of grafting markedly reduced the occurrence of electrographic seizures and restored behavioral deficits in spatial learning, hyperactivity and the aggressive response to handling. In the recipient brain, GABA progenitors migrated up to 1,500 mu m from the injection site, expressed genes and proteins characteristic for interneurons, differentiated into functional inhibitory neurons and received excitatory synaptic input. In contrast with hippocampus, cell grafts into basolateral amygdala rescued the hyperactivity deficit, but did not alter seizure activity or other abnormal behaviors. Our results highlight a critical role for interneurons in epilepsy and suggest that interneuron cell transplantation is a powerful approach to halting seizures and rescuing accompanying deficits in severely epileptic mice.	[Hunt, Robert F.; Girskis, Kelly M.; Baraban, Scott C.] Univ Calif San Francisco, Epilepsy Res Lab, San Francisco, CA 94143 USA; [Hunt, Robert F.; Girskis, Kelly M.; Alvarez-Buylla, Arturo; Baraban, Scott C.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Rubenstein, John L.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Hunt, RF (corresponding author), Univ Calif San Francisco, Epilepsy Res Lab, San Francisco, CA 94143 USA.	robert.huntiii@ucsf.edu; scott.baraban@ucsf.edu	Ritter, Stefanie L/D-9312-2012	Baraban, Scott/0000-0003-1975-9781; Hunt, Robert/0000-0003-4490-8718; Alvarez-Buylla, Arturo/0000-0003-4426-8925	US National Institutes of Health from the National Institute of Neurological Disorders and Stroke [RO1-NS071785, F32-NS077747]; California Institute of Regenerative Medicine [TR2-01749]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS077747, R01NS071785] Funding Source: NIH RePORTER	US National Institutes of Health from the National Institute of Neurological Disorders and Stroke; California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Dinday and W. Hindle-Katel for assistance with pilocarpine injections, J. Sebe for tissue dissection training, G. Hortopan for advice on the single-cell RT-PCR procedure, R. Palmiter for the ZnT3 antibody, and S. Canchola for training on behavior assays. This work was supported by funding from US National Institutes of Health grants from the National Institute of Neurological Disorders and Stroke (RO1-NS071785 to S.C.B., J.L.R. and A.A.-B., and F32-NS077747 to R.F.H.), and a grant from the California Institute of Regenerative Medicine (#TR2-01749 to A.A.-B. and S.C.B.).	Alvarez-Dolado M, 2006, J NEUROSCI, V26, P7380, DOI 10.1523/JNEUROSCI.1540-06.2006; Andrews-Zwilling Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040555; [Anonymous], 2012, EPILEPSY FACT SHEET; BABB TL, 1991, NEUROSCIENCE, V42, P351, DOI 10.1016/0306-4522(91)90380-7; Baraban SC, 2009, P NATL ACAD SCI USA, V106, P15472, DOI 10.1073/pnas.0900141106; Berenyi A, 2012, SCIENCE, V337, P735, DOI 10.1126/science.1223154; Bortel A, 2010, NEUROBIOL DIS, V40, P478, DOI 10.1016/j.nbd.2010.07.015; Butt SJB, 2005, NEURON, V48, P591, DOI 10.1016/j.neuron.2005.09.034; Can A, 2012, JOVE-J VIS EXP, DOI 10.3791/3638; CHAGNACAMITAI Y, 1989, J NEUROPHYSIOL, V61, P747, DOI 10.1152/jn.1989.61.4.747; Clasadonte J., 2012, JASPERS BASIC MECH E; Cossart R, 2001, NAT NEUROSCI, V4, P52, DOI 10.1038/82900; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; Goffin K, 2007, EXP NEUROL, V205, P501, DOI 10.1016/j.expneurol.2007.03.008; Groticke I, 2007, EXP NEUROL, V207, P329, DOI 10.1016/j.expneurol.2007.06.021; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; Han S, 2012, NATURE, V489, P385, DOI 10.1038/nature11356; Hermann B, 2008, LANCET NEUROL, V7, P151, DOI 10.1016/S1474-4422(08)70018-8; Hirsch JC, 1999, NAT NEUROSCI, V2, P499, DOI 10.1038/9142; Kobayashi M, 2003, J NEUROSCI, V23, P2440; Krook-Magnuson E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2376; Lavdas AA, 1999, J NEUROSCI, V19, P7881; Loscher W., 2012, JASPERS BASIC MECH E, Vfourth; LOTHMAN EW, 1991, PROG NEUROBIOL, V37, P1, DOI 10.1016/0301-0082(91)90011-O; Marchenko Steven, 2007, J Vis Exp, P262, DOI 10.3791/262; Mortazavi F, 2005, EPILEPSY BEHAV, V7, P629, DOI 10.1016/j.yebeh.2005.08.019; Palmiter RD, 1996, P NATL ACAD SCI USA, V93, P14934, DOI 10.1073/pnas.93.25.14934; Palop JJ, 2003, P NATL ACAD SCI USA, V100, P9572, DOI 10.1073/pnas.1133381100; Paz JT, 2013, NAT NEUROSCI, V16, P64, DOI 10.1038/nn.3269; Raber J, 2002, J NEUROSCI, V22, P5204, DOI 10.1523/JNEUROSCI.22-12-05204.2002; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Schevon CA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2056; Shibley H, 2002, EPILEPSY RES, V49, P109, DOI 10.1016/S0920-1211(02)00012-8; Southwell DG, 2012, NATURE, V491, P109, DOI 10.1038/nature11523; Trevelyan AJ, 2007, J NEUROSCI, V27, P3383, DOI 10.1523/JNEUROSCI.0145-07.2007; Tricoire L, 2011, J NEUROSCI, V31, P10948, DOI 10.1523/JNEUROSCI.0323-11.2011; Verret L, 2012, CELL, V149, P708, DOI 10.1016/j.cell.2012.02.046; Vignoli T, 2012, BRAIN RES, V1450, P125, DOI 10.1016/j.brainres.2012.02.028; Vucurovic K, 2010, CEREB CORTEX, V20, P2333, DOI 10.1093/cercor/bhp310; Wichterle H, 1999, NAT NEUROSCI, V2, P461, DOI 10.1038/8131; Xu Q, 2004, J NEUROSCI, V24, P2612, DOI 10.1523/JNEUROSCI.5667-03.2004; Zipancic I, 2010, CELL TRANSPLANT, V19, P549, DOI 10.3727/096368910X491383	42	203	205	0	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2013	16	6					692	+		10.1038/nn.3392	http://dx.doi.org/10.1038/nn.3392			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	152DE	23644485	Green Accepted, Green Submitted			2022-12-17	WOS:000319509600010
J	Huang, W; Zhu, PJ; Zhang, SX; Zhou, HY; Stoica, L; Galiano, M; Krnjevic, K; Roman, G; Costa-Mattioli, M				Huang, Wei; Zhu, Ping Jun; Zhang, Shixing; Zhou, Hongyi; Stoica, Loredana; Galiano, Mauricio; Krnjevic, Kresimir; Roman, Gregg; Costa-Mattioli, Mauro			mTORC2 controls actin polymerization required for consolidation of long-term memory	NATURE NEUROSCIENCE			English	Article							SYNAPTIC PLASTICITY; TUBEROUS SCLEROSIS; MAMMALIAN TARGET; AKT; PHOSPHORYLATION; RICTOR; DYNAMICS; REVEALS; DISEASE; GROWTH	A major goal of biomedical research is the identification of molecular and cellular mechanisms that underlie memory storage. Here we report a previously unknown signaling pathway that is necessary for the conversion from short- to long-term memory. The mammalian target of rapamycin (mTOR) complex 2 (mTORC2), which contains the regulatory protein Rictor (rapamycin-insensitive companion of mTOR), was discovered only recently and little is known about its function. We found that conditional deletion of Rictor in the postnatal murine forebrain greatly reduced mTORC2 activity and selectively impaired both long-term memory (LTM) and the late phase of hippocampal long-term potentiation (L-LTP). We also found a comparable impairment of LTM in dTORC2-deficient flies, highlighting the evolutionary conservation of this pathway. Actin polymerization was reduced in the hippocampus of mTORC2-deficient mice and its restoration rescued both L-LTP and LTM. Moreover, a compound that promoted mTORC2 activity converted early LTP into late LTP and enhanced LTM. Thus, mTORC2 could be a therapeutic target for the treatment of cognitive dysfunction.	[Huang, Wei; Zhu, Ping Jun; Zhou, Hongyi; Stoica, Loredana; Galiano, Mauricio; Costa-Mattioli, Mauro] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Huang, Wei; Zhu, Ping Jun; Zhou, Hongyi; Costa-Mattioli, Mauro] Baylor Coll Med, Ctr Addict Learning & Memory, Houston, TX 77030 USA; [Zhang, Shixing; Roman, Gregg] Univ Houston, Dept Biol & Biochem, Houston, TX USA; [Zhang, Shixing; Roman, Gregg] Univ Houston, Biol Behav Inst, Houston, TX USA; [Stoica, Loredana; Costa-Mattioli, Mauro] Baylor Coll Med, Dept Mol & Cell Biol, Houston, TX 77030 USA; [Krnjevic, Kresimir] McGill Univ, Dept Physiol, Montreal, PQ, Canada	Baylor College of Medicine; Baylor College of Medicine; University of Houston System; University of Houston; University of Houston System; University of Houston; Baylor College of Medicine; McGill University	Costa-Mattioli, M (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.	costamat@bcm.edu	Roman, Gregg/W-1586-2019	Roman, Gregg/0000-0003-1519-4699; Galiano, Mauricio/0000-0002-8245-1715	National Institute of Mental Health [MH 096816]; National Institute of Neurological Disorders and Stroke [NS 076708]; Searle award [09-SSP-211]; George and Cynthia Mitchell Foundation; US National Institutes of Health [MH091305]; Texas Norman Hackerman Advanced Research Program award; Whitehall award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH096816] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076708] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Searle award; George and Cynthia Mitchell Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas Norman Hackerman Advanced Research Program award; Whitehall award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Magnuson (Vanderbilt University), I. Dragatsis (University of Tennessee) and K. Tolias (Baylor College of Medicine) who generously provided Rictor<SUP>loxP/loxP</SUP> mice, Camk2a-Cre mice and the Tiam1 constructs, respectively. We also thank A. Placzek and W. Sossin for comments on an early version of the manuscript. This work was supported by grants to M.C.-M. (National Institute of Mental Health grant MH 096816, National Institute of Neurological Disorders and Stroke grant NS 076708, Searle award grant 09-SSP-211, Whitehall award, grants from the George and Cynthia Mitchell Foundation) and G.R. (US National Institutes of Health grant MH091305 and a Texas Norman Hackerman Advanced Research Program award).	BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Carson RP, 2013, HUM MOL GENET, V22, P140, DOI 10.1093/hmg/dds414; Chen LY, 2007, J NEUROSCI, V27, P5363, DOI 10.1523/JNEUROSCI.0164-07.2007; Choe G, 2003, CANCER RES, V63, P2742; Cingolani LA, 2008, NAT REV NEUROSCI, V9, P344, DOI 10.1038/nrn2373; Costa-Mattioli M, 2007, CELL, V129, P195, DOI 10.1016/j.cell.2007.01.050; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Dragatsis I, 2000, GENESIS, V26, P133, DOI 10.1002/(SICI)1526-968X(200002)26:2<133::AID-GENE10>3.0.CO;2-V; Ferris J, 2006, NAT NEUROSCI, V9, P1036, DOI 10.1038/nn1738; Fischer A, 2004, J NEUROSCI, V24, P1962, DOI 10.1523/JNEUROSCI.5112-03.2004; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Griffin RJ, 2005, J NEUROCHEM, V93, P105, DOI 10.1111/j.1471-4159.2004.02949.x; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Han EKH, 2007, ONCOGENE, V26, P5655, DOI 10.1038/sj.onc.1210343; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hietakangas V, 2007, GENE DEV, V21, P632, DOI 10.1101/gad.416307; Holzinger A, 2009, METHODS MOL BIOL, V586, P71, DOI 10.1007/978-1-60761-376-3_4; Humbert S, 2002, DEV CELL, V2, P831, DOI 10.1016/S1534-5807(02)00188-0; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kim CH, 1999, J NEUROSCI, V19, P4314; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; Kramar EA, 2006, P NATL ACAD SCI USA, V103, P5579, DOI 10.1073/pnas.0601354103; Krucker T, 2000, P NATL ACAD SCI USA, V97, P6856, DOI 10.1073/pnas.100139797; Lamprecht R, 2002, NEURON, V36, P727, DOI 10.1016/S0896-6273(02)01047-4; Lamprecht R, 2004, NAT REV NEUROSCI, V5, P45, DOI 10.1038/nrn1301; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lynch G, 2007, NEUROPHARMACOLOGY, V52, P12, DOI 10.1016/j.neuropharm.2006.07.027; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Malagelada C, 2008, J NEUROSCI, V28, P14363, DOI 10.1523/JNEUROSCI.3928-08.2008; Mantzur L, 2009, NEUROBIOL LEARN MEM, V91, P85, DOI 10.1016/j.nlm.2008.09.001; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Mazei-Robison MS, 2011, NEURON, V72, P977, DOI 10.1016/j.neuron.2011.10.012; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Meikle L, 2008, J NEUROSCI, V28, P5422, DOI 10.1523/JNEUROSCI.0955-08.2008; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Oh WJ, 2011, CELL CYCLE, V10, P2305, DOI 10.4161/cc.10.14.16586; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Shiota C, 2006, DEV CELL, V11, P583, DOI 10.1016/j.devcel.2006.08.013; Siarey RJ, 2006, J NEUROCHEM, V98, P1266, DOI 10.1111/j.1471-4159.2006.03971.x; Siuta MA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000393; Stoica L, 2011, P NATL ACAD SCI USA, V108, P3791, DOI 10.1073/pnas.1014715108; Tolias KF, 2005, NEURON, V45, P525, DOI 10.1016/j.neuron.2005.01.024; Tsai V, 2014, CEREB CORTEX, V24, P315, DOI 10.1093/cercor/bhs310; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; Van Horck FPG, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.18pe11; Wang SH, 2010, ANNU REV PSYCHOL, V61, P49, DOI 10.1146/annurev.psych.093008.100523; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zeng LH, 2007, J NEUROSCI, V27, P11604, DOI 10.1523/JNEUROSCI.0983-07.2007; Zhou J, 2009, J NEUROSCI, V29, P1773, DOI 10.1523/JNEUROSCI.5685-08.2009; Zhu PJ, 2011, CELL, V147, P1384, DOI 10.1016/j.cell.2011.11.029	55	203	208	1	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2013	16	4					441	U105		10.1038/nn.3351	http://dx.doi.org/10.1038/nn.3351			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	114EM	23455608	Green Accepted			2022-12-17	WOS:000316723700014
J	Poulet, JFA; Fernandez, LMJ; Crochet, S; Petersen, CCH				Poulet, James F. A.; Fernandez, Laura M. J.; Crochet, Sylvain; Petersen, Carl C. H.			Thalamic control of cortical states	NATURE NEUROSCIENCE			English	Article							BEHAVING MICE; BARREL CORTEX; RESPONSES; MODULATION; MECHANISMS; NETWORKS; DYNAMICS	We investigated the impact of thalamus on ongoing cortical activity in the awake, behaving mouse. We demonstrate that the desynchronized cortical state during active behavior is driven by a centrally generated increase in thalamic action potential firing, which can also be mimicked by optogenetic stimulation of the thalamus. The thalamus therefore is key in controlling cortical states.	[Poulet, James F. A.; Fernandez, Laura M. J.; Crochet, Sylvain; Petersen, Carl C. H.] Ecole Polytech Fed Lausanne EPFL, Fac Life Sci, Brain Mind Inst, Lab Sensory Proc, Lausanne, Switzerland; [Poulet, James F. A.] Max Delbruck Ctr Mol Med MDC, Dept Neurosci, Berlin, Germany; [Poulet, James F. A.] Charite Univ Med Berlin, Neurosci Res Ctr, Berlin, Germany; [Poulet, James F. A.] Charite Univ Med Berlin, Cluster Excellence NeuroCure, Berlin, Germany; [Fernandez, Laura M. J.; Crochet, Sylvain] INSERM, U1028, F-69008 Lyon, France; [Fernandez, Laura M. J.; Crochet, Sylvain] Ctr Natl Rech Sci CNRS, UMR5292, Lyon, France; [Fernandez, Laura M. J.; Crochet, Sylvain] Integrat Physiol Brain Arousal Syst Team, Lyon Neurosci Res Ctr, Lyon, France	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm)	Crochet, S (corresponding author), Ecole Polytech Fed Lausanne EPFL, Fac Life Sci, Brain Mind Inst, Lab Sensory Proc, Lausanne, Switzerland.	sylvain.crochet@univ-lyon1.fr; carl.petersen@epfl.ch	Fernandez, Laura MJ/K-4717-2012; Petersen, Carl/M-5123-2017	Fernandez, Laura MJ/0000-0002-7942-3369; Petersen, Carl/0000-0003-3344-4495; Crochet, Sylvain/0000-0002-2965-8899; Poulet, James/0000-0003-0296-5415	Swiss National Science Foundation; Human Frontiers in Science Program; SystemsX.ch; Deutsche Forschungsgemeinschaft [Exc 257 NeuroCure]; European Research Council; Region Rhone-Alpes Exploradoc; Agence Nationale de la Recherche France [ANR-09-JCJC-0028-01]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Human Frontiers in Science Program(Human Frontier Science Program); SystemsX.ch; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); Region Rhone-Alpes Exploradoc(Region Auvergne-Rhone-Alpes); Agence Nationale de la Recherche France(French National Research Agency (ANR))	We would like to thank K. Svoboda (Howard Hughes Medical Institute Janelia Farm; Addgene plasmid 20071) and C. Luscher (University of Geneva; virus) for AAV-ChR2. This work was funded by grants from the Swiss National Science Foundation (C.C.H.P.), Human Frontiers in Science Program (J.F.A.P. and C. C. H. P.), SystemsX.ch (C. C. H. P.), Deutsche Forschungsgemeinschaft (Exc 257 NeuroCure) (J.F.A.P.), a European Research Council starting grant (J.F.A.P.), Region Rhone-Alpes Exploradoc (L.M.J.F.) and Agence Nationale de la Recherche France (project AWAKE CX, ANR-09-JCJC-0028-01) (S.C.).	Berger H, 1929, ARCH PSYCHIAT NERVEN, V87, P527, DOI 10.1007/BF01797193; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Castro-Alamancos MA, 2004, NEURON, V41, P455, DOI 10.1016/S0896-6273(03)00853-5; Constantinople CM, 2011, NEURON, V69, P1061, DOI 10.1016/j.neuron.2011.02.040; Crochet S, 2006, NAT NEUROSCI, V9, P608, DOI 10.1038/nn1690; Fanselow EE, 1999, J NEUROSCI, V19, P7603, DOI 10.1523/JNEUROSCI.19-17-07603.1999; Fee MS, 1997, J NEUROPHYSIOL, V78, P1144, DOI 10.1152/jn.1997.78.2.1144; Ferezou I, 2007, NEURON, V56, P907, DOI 10.1016/j.neuron.2007.10.007; Haider B, 2009, NEURON, V62, P171, DOI 10.1016/j.neuron.2009.04.008; Niell CM, 2010, NEURON, V65, P472, DOI 10.1016/j.neuron.2010.01.033; Okun M, 2010, J NEUROSCI, V30, P4440, DOI 10.1523/JNEUROSCI.5062-09.2010; Otazu GH, 2009, NAT NEUROSCI, V12, P646, DOI 10.1038/nn.2306; Poulet JFA, 2008, NATURE, V454, P881, DOI 10.1038/nature07150; Steriade M, 2004, PROG BRAIN RES, V145, P179, DOI 10.1016/S0079-6123(03)45013-9	15	203	204	1	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2012	15	3					370	372		10.1038/nn.3035	http://dx.doi.org/10.1038/nn.3035			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	899CY	22267163				2022-12-17	WOS:000300793100009
J	English, DF; Ibanez-Sandoval, O; Stark, E; Tecuapetla, F; Buzsaki, G; Deisseroth, K; Tepper, JM; Koos, T				English, Daniel F.; Ibanez-Sandoval, Osvaldo; Stark, Eran; Tecuapetla, Fatuel; Buzsaki, Gyoergy; Deisseroth, Karl; Tepper, James M.; Koos, Tibor			GABAergic circuits mediate the reinforcement-related signals of striatal cholinergic interneurons	NATURE NEUROSCIENCE			English	Article							TONICALLY ACTIVE NEURONS; FAST-SPIKING INTERNEURONS; NICOTINIC ACH RECEPTORS; MIDBRAIN DOPAMINE; PRIMATES STRIATUM; GABA(A) RECEPTORS; TOURETTE-SYNDROME; RESPONSES; REWARD; DESENSITIZATION	Neostriatal cholinergic interneurons are believed to be important for reinforcement-mediated learning and response selection by signaling the occurrence and motivational value of behaviorally relevant stimuli through precisely timed multiphasic population responses. An important problem is to understand how these signals regulate the functioning of the neostriatum. Here we describe the synaptic organization of a previously unknown circuit that involves direct nicotinic excitation of several classes of GABAergic interneurons, including neuroptide Y-expressing neurogilaform neurons, and enables cholinergic interneurons to exert rapid inhibitory control of the activity of projection neurons. We also found that, in vivo, the dominant effect of an optogenetically reproduced pause-excitation population response of cholinergic interneurons was powerful and rapid inhibition of the firing of projection neurons that is coincident with synchronous cholinergic activation. These results reveal a previously unknown circuit mechanism that transmits reinforcement-related information of ChAT interneurons in the mouse neostriatal network.	[English, Daniel F.; Ibanez-Sandoval, Osvaldo; Stark, Eran; Tecuapetla, Fatuel; Buzsaki, Gyoergy; Tepper, James M.; Koos, Tibor] Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA; [Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	Rutgers State University Newark; Rutgers State University New Brunswick; Stanford University	Koos, T (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA.	tibkoos@yahoo.com	Tepper, James/AAA-3828-2019	Tepper, James/0000-0002-8643-4082; Tecuapetla, Fatuel/0000-0002-9191-6553; Stark, Eran/0000-0002-2446-9140; Buzsaki, Gyorgy/0000-0002-3100-4800; English, Daniel/0000-0003-2284-870X	US National Institutes of Health [NS072950, NS034865]; Rutgers University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS034865, R01NS072950, R01NS034865] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rutgers University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Berlin for confocal microscopy, L. Zaborszky for providing ChAT-EGFP mice, R. Yanez-Munoz for providing integration deficient pCMV-dR8.74-D64V plasmid DNA and for advice regarding virus production, N. Altan-Bonnet, W. Friedman and Haesun Kim for generously providing access to an ultracentrifuge facility and other equipment in their laboratories, C. T. Unal and A. Kreitzer for valuable discussion, A. Berenyi, S. Fujisawa and M. Vandecasteele for advice regarding in vivo recording methods, H. Xenias for help with confocal imaging, F. Shah for help with immunocytochemical procedures and other technical assistance, and I. Tadros for virus injections. The research was supported by US National Institutes of Health grant NS072950 and a Busch Biomedical Research Grant of Rutgers University to T. K., US National Institutes of Health grant NS034865 to J. M. T. and Rutgers University funds.	AOSAKI T, 1995, J NEUROPHYSIOL, V73, P1234, DOI 10.1152/jn.1995.73.3.1234; AOSAKI T, 1994, J NEUROSCI, V14, P3969; Apicella P, 1998, J NEUROPHYSIOL, V80, P3341, DOI 10.1152/jn.1998.80.6.3341; Apicella P, 2007, TRENDS NEUROSCI, V30, P299, DOI 10.1016/j.tins.2007.03.011; Banks MI, 2000, NEURON, V25, P449, DOI 10.1016/S0896-6273(00)80907-1; Banks MI, 1998, J NEUROSCI, V18, P1305; Banks MI, 2000, J NEUROSCI, V20, P937, DOI 10.1523/JNEUROSCI.20-03-00937.2000; Berke JD, 2009, EUR J NEUROSCI, V30, P848, DOI 10.1111/j.1460-9568.2009.06843.x; Berke JD, 2008, J NEUROSCI, V28, P10075, DOI 10.1523/JNEUROSCI.2192-08.2008; Capogna M, 2011, TRENDS NEUROSCI, V34, P101, DOI 10.1016/j.tins.2010.10.005; CHANG HT, 1992, BRAIN RES, V574, P307, DOI 10.1016/0006-8993(92)90830-3; De Rover M, 2005, SYNAPSE, V55, P17, DOI 10.1002/syn.20087; Ding JB, 2010, NEURON, V67, P294, DOI 10.1016/j.neuron.2010.06.017; Giniatullin R, 2005, TRENDS NEUROSCI, V28, P371, DOI 10.1016/j.tins.2005.04.009; Gittis AH, 2010, J NEUROSCI, V30, P2223, DOI 10.1523/JNEUROSCI.4870-09.2010; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Gradinaru V, 2008, BRAIN CELL BIOL, V36, P129, DOI 10.1007/s11068-008-9027-6; Graybiel AM, 1998, NEUROBIOL LEARN MEM, V70, P119, DOI 10.1006/nlme.1998.3843; Han X, 2009, NEURON, V62, P191, DOI 10.1016/j.neuron.2009.03.011; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P814, DOI 10.1152/jn.1989.61.4.814; HILL JA, 1993, J NEUROSCI, V13, P1551; Hyland BI, 2002, NEUROSCIENCE, V114, P475, DOI 10.1016/S0306-4522(02)00267-1; Ibanez-Sandoval O, 2011, J NEUROSCI, V31, P16757, DOI 10.1523/JNEUROSCI.2628-11.2011; Ibanez-Sandoval O, 2010, J NEUROSCI, V30, P6999, DOI 10.1523/JNEUROSCI.5996-09.2010; Jog MS, 2002, J NEUROSCI METH, V117, P141, DOI 10.1016/S0165-0270(02)00092-4; Joshua M, 2008, J NEUROSCI, V28, P11673, DOI 10.1523/JNEUROSCI.3839-08.2008; Karayannis T, 2010, J NEUROSCI, V30, P9898, DOI 10.1523/JNEUROSCI.5883-09.2010; Kataoka Y, 2010, J COMP NEUROL, V518, P277, DOI 10.1002/cne.22206; KIMURA M, 1984, P NATL ACAD SCI-BIOL, V81, P4998, DOI 10.1073/pnas.81.15.4998; Koos T, 1999, NAT NEUROSCI, V2, P467, DOI 10.1038/8138; Koos T, 2002, J NEUROSCI, V22, P529, DOI 10.1523/JNEUROSCI.22-02-00529.2002; KUBOTA Y, 1993, NEUROREPORT, V5, P205, DOI 10.1097/00001756-199312000-00004; Leckman JF, 2006, J CHILD PSYCHOL PSYC, V47, P537, DOI 10.1111/j.1469-7610.2006.01620.x; Matsumoto N, 2001, J NEUROPHYSIOL, V85, P960, DOI 10.1152/jn.2001.85.2.960; MCGEHEE DS, 1995, SCIENCE, V269, P1692, DOI 10.1126/science.7569895; Morris G, 2004, NEURON, V43, P133, DOI 10.1016/j.neuron.2004.06.012; Olah S, 2009, NATURE, V461, P1278, DOI 10.1038/nature08503; Overstreet LS, 2000, J NEUROSCI, V20, P7914; PEARCE RA, 1993, NEURON, V10, P189, DOI 10.1016/0896-6273(93)90310-N; Rice ME, 2004, NAT NEUROSCI, V7, P583, DOI 10.1038/nn1244; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Sullivan MA, 2008, J NEUROSCI, V28, P8682, DOI 10.1523/JNEUROSCI.2411-08.2008; Szabadics J, 2007, P NATL ACAD SCI USA, V104, P14831, DOI 10.1073/pnas.0707204104; Tamas G, 2003, SCIENCE, V299, P1902, DOI 10.1126/science.1082053; Tecuapetla F, 2009, J NEUROSCI, V29, P8977, DOI 10.1523/JNEUROSCI.6145-08.2009; Wilson CJ, 2005, NEURON, V45, P575, DOI 10.1016/j.neuron.2004.12.053; Witten IB, 2010, SCIENCE, V330, P1677, DOI 10.1126/science.1193771; Wonnacott S, 1997, TRENDS NEUROSCI, V20, P92, DOI 10.1016/S0166-2236(96)10073-4; Yanez-Munoz RJ, 2006, NAT MED, V12, P348, DOI 10.1038/nm1365; Zhou FM, 2001, NAT NEUROSCI, V4, P1224, DOI 10.1038/nn769	50	203	205	0	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2012	15	1					123	U155		10.1038/nn.2984	http://dx.doi.org/10.1038/nn.2984			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866VO	22158514	Green Accepted			2022-12-17	WOS:000298414400022
J	State, MW; Levitt, P				State, Matthew W.; Levitt, Pat			The conundrums of understanding genetic risks for autism spectrum disorders	NATURE NEUROSCIENCE			English	Review							COPY-NUMBER VARIATION; RECEPTOR TYROSINE KINASE; RARE DE-NOVO; MET; ASSOCIATION; MUTATIONS; 16P11.2; DELETIONS; VARIANTS; REVEALS	Recent advances in the genetics of autism spectrum disorders (ASDs) are offering new valuable insights into molecular and cellular mechanisms of pathology. At the same time, the emerging data challenge long-standing diagnostic conventions and the notion of phenotypic specificity. This review addresses the particular issues that attend gene discovery in neuropsychiatric and neurodevelopmental disorders and ASDs in particular, summarizes recent findings in human genetics broadly that are driving the reevaluation of the conventional wisdom regarding the allelic architecture of common psychiatric conditions, reviews selected discoveries in ASDs and their relevance to models of pathology, highlights the conceptual and practical issues raised by the observation of a convergence of ASD genetic risks with distinct psychiatric disorders, and considers the important interplay of studies of neurobiology and genetics in clarifying and extending our understanding of social disability syndromes.	[State, Matthew W.] Yale Univ, Sch Med, Dept Child Psychiat, Program Neurogenet, New Haven, CT 06520 USA; [State, Matthew W.] Yale Univ, Sch Med, Dept Psychiat, Program Neurogenet, New Haven, CT USA; [State, Matthew W.] Yale Univ, Sch Med, Dept Genet, Program Neurogenet, New Haven, CT USA; [Levitt, Pat] Univ So Calif, Keck Sch Med, Dept Cell & Neurobiol, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA	Yale University; Yale University; Yale University; University of Southern California	State, MW (corresponding author), Yale Univ, Sch Med, Dept Child Psychiat, Program Neurogenet, New Haven, CT 06520 USA.	matthew.state@yale.edu; plevitt@usc.edu	State, Matthew/W-2256-2019	State, Matthew/0000-0003-1624-8302	Simons Foundation; National Institute of Mental Health [MH067842, MH080759, MH089956, MH081754]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081754, RC2MH089956, R01MH067842, R01MH080759] Funding Source: NIH RePORTER	Simons Foundation; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work has been supported in part by grants from the Simons Foundation (to M.W.S. and P.L.) and the National Institute of Mental Health (MH067842 and MH080759 to P.L. and MH089956 and MH081754 to M.W.S.).	Akil H, 2010, SCIENCE, V327, P1580, DOI 10.1126/science.1188654; Alarcon M, 2008, AM J HUM GENET, V82, P150, DOI 10.1016/j.ajhg.2007.09.005; Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; American Psychiatric Association. American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Anney R, 2010, HUM MOL GENET, V19, P4072, DOI 10.1093/hmg/ddq307; Arking DE, 2008, AM J HUM GENET, V82, P160, DOI 10.1016/j.ajhg.2007.09.015; Ayhan Y, 2009, BEHAV BRAIN RES, V204, P274, DOI 10.1016/j.bbr.2009.04.010; Bachman P, 2008, SCHIZOPHR RES, V103, P293, DOI 10.1016/j.schres.2008.04.006; Bakkaloglu B, 2008, AM J HUM GENET, V82, P165, DOI 10.1016/j.ajhg.2007.09.017; Berkel S, 2010, NAT GENET, V42, P489, DOI 10.1038/ng.589; Bill BR, 2009, CURR OPIN GENET DEV, V19, P271, DOI 10.1016/j.gde.2009.04.004; Bochukova EG, 2010, NATURE, V463, P666, DOI 10.1038/nature08689; Bourgeron T, 2009, CURR OPIN NEUROBIOL, V19, P231, DOI 10.1016/j.conb.2009.06.003; Buie T, 2010, PEDIATRICS, V125, pS1, DOI 10.1542/peds.2009-1878C; Campbell DB, 2007, ANN NEUROL, V62, P243, DOI 10.1002/ana.21180; Campbell DB, 2006, P NATL ACAD SCI USA, V103, P16834, DOI 10.1073/pnas.0605296103; Campbell DB, 2009, PEDIATRICS, V123, P1018, DOI 10.1542/peds.2008-0819; Campbell DB, 2008, AUTISM RES, V1, P159, DOI 10.1002/aur.27; Chakravarti A, 1999, NAT GENET, V21, P56, DOI 10.1038/4482; Ching MSL, 2010, AM J MED GENET B, V153B, P937, DOI 10.1002/ajmg.b.31063; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Devlin B, 2011, BRAIN RES, V1380, P78, DOI 10.1016/j.brainres.2010.11.026; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Ehninger D, 2008, NEURON, V60, P950, DOI 10.1016/j.neuron.2008.12.007; Fernandez T, 2004, AM J HUM GENET, V74, P1286, DOI 10.1086/421474; Fernandez T, 2008, AM J HUM GENET, V82, P1385, DOI 10.1016/j.ajhg.2008.04.021; Friedman JI, 2008, MOL PSYCHIATR, V13, P261, DOI 10.1038/sj.mp.4002049; Gauthier J, 2009, AM J MED GENET B, V150B, P421, DOI 10.1002/ajmg.b.30822; Geschwind DH, 2007, CURR OPIN NEUROBIOL, V17, P103, DOI 10.1016/j.conb.2007.01.009; Geschwind DH, 2009, NATURE, V461, P908, DOI 10.1038/nature08537; Geschwind DH, 2009, ANNU REV MED, V60, P367, DOI 10.1146/annurev.med.60.053107.121225; Gilman SR, 2011, NEURON, V70, P898, DOI 10.1016/j.neuron.2011.05.021; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; Gutierrez H, 2004, DEVELOPMENT, V131, P3717, DOI 10.1242/dev.01209; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Hammock EAD, 2006, HUM DEV, V49, P294, DOI 10.1159/000095581; Hindorff L.A., 2010, CATALOGUE PUBLISHED; Hoekstra RA, 2009, BRIT J PSYCHIAT, V195, P531, DOI 10.1192/bjp.bp.108.060889; Ivleva EI, 2010, NEUROSCI BIOBEHAV R, V34, P897, DOI 10.1016/j.neubiorev.2009.11.022; Jackson PB, 2009, AUTISM RES, V2, P232, DOI 10.1002/aur.87; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Ji WZ, 2008, NAT GENET, V40, P592, DOI 10.1038/ng.118; Judson MC, 2011, J NEURODEV DISORD, V3, P282, DOI 10.1007/s11689-011-9081-8; Judson MC, 2011, CEREB CORTEX, V21, P1613, DOI 10.1093/cercor/bhq223; Judson MC, 2010, J COMP NEUROL, V518, P4463, DOI 10.1002/cne.22467; Judson MC, 2009, J COMP NEUROL, V513, P511, DOI 10.1002/cne.21969; King BH, 2011, BRAIN RES, V1380, P34, DOI 10.1016/j.brainres.2010.11.031; Krab LC, 2008, JAMA-J AM MED ASSOC, V300, P287, DOI 10.1001/jama.300.3.287; Kumar RA, 2008, HUM MOL GENET, V17, P628, DOI 10.1093/hmg/ddm376; Kumar RA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004582; Laumonnier F, 2004, AM J HUM GENET, V74, P552, DOI 10.1086/382137; Levitt P, 2009, J CLIN INVEST, V119, P747, DOI 10.1172/JCI37934; Levy D, 2011, NEURON, V70, P886, DOI 10.1016/j.neuron.2011.05.015; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; McCarthy SE, 2009, NAT GENET, V41, P1223, DOI 10.1038/ng.474; Mefford HC, 2008, NEW ENGL J MED, V359, P1685, DOI 10.1056/NEJMoa0805384; Moreno-De-Luca D, 2010, AM J HUM GENET, V87, P618, DOI 10.1016/j.ajhg.2010.10.004; Moss J, 2009, J INTELL DISABIL RES, V53, P852, DOI 10.1111/j.1365-2788.2009.01197.x; Mukamel Z, 2011, J NEUROSCI, V31, P11437, DOI 10.1523/JNEUROSCI.0181-11.2011; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Pober BR, 2010, NEW ENGL J MED, V362, P239, DOI 10.1056/NEJMra0903074; Qiu SF, 2011, J NEUROSCI, V31, P5855, DOI 10.1523/JNEUROSCI.6569-10.2011; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Roll P, 2010, HUM MOL GENET, V19, P4848, DOI 10.1093/hmg/ddq415; Roohi J, 2009, J MED GENET, V46, P176, DOI 10.1136/jmg.2008.057505; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Scala E, 2007, AM J MED GENET A, V143A, P2775, DOI 10.1002/ajmg.a.32002; Scott-Van Zeeland AA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001344; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sebat J, 2009, TRENDS GENET, V25, P528, DOI 10.1016/j.tig.2009.10.004; Skuse DH, 2007, TRENDS GENET, V23, P387, DOI 10.1016/j.tig.2007.06.003; Sousa I, 2009, EUR J HUM GENET, V17, P749, DOI 10.1038/ejhg.2008.215; State MW, 2010, NEURON, V68, P254, DOI 10.1016/j.neuron.2010.10.004; Stein MB, 2011, BIOL PSYCHIAT, V69, P825, DOI 10.1016/j.biopsych.2010.11.008; Strauss KA, 2006, NEW ENGL J MED, V354, P1370, DOI 10.1056/NEJMoa052773; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Tyndall SJ, 2007, J NEUROSCI RES, V85, P2343, DOI 10.1002/jnr.21390; Vernes SC, 2008, NEW ENGL J MED, V359, P2337, DOI 10.1056/NEJMoa0802828; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Weiss LA, 2009, NATURE, V461, P802, DOI 10.1038/nature08490	86	203	207	1	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2011	14	12					1499	1506		10.1038/nn.2924	http://dx.doi.org/10.1038/nn.2924			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	855EJ	22037497	Green Accepted			2022-12-17	WOS:000297546300006
J	Otazu, GH; Tai, LH; Yang, Y; Zador, AM				Otazu, Gonzalo H.; Tai, Lung-Hao; Yang, Yang; Zador, Anthony M.			Engaging in an auditory task suppresses responses in auditory cortex	NATURE NEUROSCIENCE			English	Article							INFORMATION-PROCESSING STATES; VISUAL-CORTEX; THALAMOCORTICAL SYNAPSES; SYNAPTIC DEPRESSION; SENSORY SUPPRESSION; RECEPTIVE-FIELDS; BARREL CORTEX; ATTENTION; RAT; REPRESENTATION	Although systems that are involved in attentional selection have been studied extensively, much less is known about nonselective systems. To study these preparatory mechanisms, we compared activity in auditory cortex that was elicited by sounds while rats performed an auditory task ('engaged') with activity that was elicited by identical stimuli while subjects were awake but not performing a task ('passive'). We found that engagement suppressed responses, an effect that was opposite in sign to that elicited by selective attention. In the auditory thalamus, however, engagement enhanced spontaneous firing rates but did not affect evoked responses. These results indicate that neural activity in auditory cortex cannot be viewed simply as a limited resource that is allocated in greater measure as the state of the animal passes from somnolent to passively listening to engaged and attentive. Instead, the engaged condition possesses a characteristic and distinct neural signature in which sound-evoked responses are paradoxically suppressed.	[Otazu, Gonzalo H.; Tai, Lung-Hao; Yang, Yang; Zador, Anthony M.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Tai, Lung-Hao; Yang, Yang] SUNY Stony Brook, Grad Program Neurosci, Stony Brook, NY 11794 USA	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Zador, AM (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	zador@cshl.edu		Zador, Anthony/0000-0002-8431-9136; Otazu, Gonzalo/0000-0002-3576-2537	US National Institutes of Health; Swartz Foundation; Marie Robertson Fund; Louis Morin Charitable Trust; Coleman Fung Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005415] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swartz Foundation; Marie Robertson Fund; Louis Morin Charitable Trust; Coleman Fung Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grants from the US National Institutes of Health, the Swartz Foundation, the Marie Robertson Fund, the Louis Morin Charitable Trust and the Coleman Fung Foundation.	Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Boly M, 2007, P NATL ACAD SCI USA, V104, P12187, DOI 10.1073/pnas.0611404104; Castro-Alamancos MA, 2004, PROG NEUROBIOL, V74, P213, DOI 10.1016/j.pneurobio.2004.09.002; Castro-Alamancos MA, 2002, J NEUROSCI, V22, P9651; Castro-Alamancos MA, 2002, J PHYSIOL-LONDON, V541, P319, DOI 10.1113/jphysiol.2002.016857; Castro-Alamancos MA, 2004, NEURON, V41, P455, DOI 10.1016/S0896-6273(03)00853-5; Chung S, 2002, NEURON, V34, P437, DOI 10.1016/S0896-6273(02)00659-1; Cook EP, 2002, NAT NEUROSCI, V5, P985, DOI 10.1038/nn924; Crochet S, 2006, NAT NEUROSCI, V9, P608, DOI 10.1038/nn1690; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.neuro.18.1.193; Deweese MR, 2004, J NEUROPHYSIOL, V92, P1840, DOI 10.1152/jn.00197.2004; Edeline JM, 2001, EUR J NEUROSCI, V14, P1865, DOI 10.1046/j.0953-816x.2001.01821.x; Eliades SJ, 2008, NATURE, V453, P1102, DOI 10.1038/nature06910; Fanselow EE, 1999, J NEUROSCI, V19, P7603, DOI 10.1523/JNEUROSCI.19-17-07603.1999; Feierstein CE, 2006, NEURON, V51, P495, DOI 10.1016/j.neuron.2006.06.032; Ferezou I, 2006, NEURON, V50, P617, DOI 10.1016/j.neuron.2006.03.043; Fritz J, 2003, NAT NEUROSCI, V6, P1216, DOI 10.1038/nn1141; Fritz JB, 2007, HEARING RES, V229, P186, DOI 10.1016/j.heares.2007.01.009; Fritz JB, 2007, J NEUROPHYSIOL, V98, P2337, DOI 10.1152/jn.00552.2007; Ghose GM, 2002, NATURE, V419, P616, DOI 10.1038/nature01057; Hirata A, 2006, J NEUROPHYSIOL, V95, P2479, DOI 10.1152/jn.01145.2005; HOCHERMAN S, 1976, BRAIN RES, V117, P51, DOI 10.1016/0006-8993(76)90555-2; HROMADKA T, 2008, THESIS COLD SPRING H; Hromadka T, 2008, PLOS BIOL, V6, P124, DOI 10.1371/journal.pbio.0060016; HUBEL DH, 1959, SCIENCE, V129, P1279, DOI 10.1126/science.129.3358.1279; Kawai H, 2007, NAT NEUROSCI, V10, P1168, DOI 10.1038/nn1956; Kilgard MP, 1998, NAT NEUROSCI, V1, P727, DOI 10.1038/3729; Martikainen MH, 2005, CEREB CORTEX, V15, P299, DOI 10.1093/cercor/bhh131; Massaux A, 2004, J NEUROPHYSIOL, V91, P2117, DOI 10.1152/jn.00970.2003; Maunsell JHR, 2002, PHILOS T ROY SOC B, V357, P1063, DOI 10.1098/rstb.2002.1107; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; MULLERPREUSS P, 1981, BRAIN RES, V215, P61, DOI 10.1016/0006-8993(81)90491-1; PICTON TW, 1971, SCIENCE, V173, P351, DOI 10.1126/science.173.3994.351; Poulet JFA, 2008, NATURE, V454, P881, DOI 10.1038/nature07150; Raz A, 2006, NAT REV NEUROSCI, V7, P367, DOI 10.1038/nrn1903; Reinagel P, 1999, J NEUROPHYSIOL, V81, P2558, DOI 10.1152/jn.1999.81.5.2558; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Schmitzer-Torbert N, 2005, NEUROSCIENCE, V131, P1, DOI 10.1016/j.neuroscience.2004.09.066; Scott BH, 2007, J NEUROSCI, V27, P6489, DOI 10.1523/JNEUROSCI.0016-07.2007; Sherman SM, 2005, PROG BRAIN RES, V149, P107, DOI 10.1016/S0079-6123(05)49009-3; Shuler MG, 2006, SCIENCE, V311, P1606, DOI 10.1126/science.1123513; SPITZER H, 1988, SCIENCE, V240, P338, DOI 10.1126/science.3353728; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; Swadlow HA, 2001, NAT NEUROSCI, V4, P402, DOI 10.1038/86054; TAI LH, 2008, THESIS STONY BROOK U; Talwar SK, 2001, J NEUROPHYSIOL, V86, P1555, DOI 10.1152/jn.2001.86.4.1555; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; Wehr M, 2005, NEURON, V47, P437, DOI 10.1016/j.neuron.2005.06.009; Yang Y, 2008, NAT NEUROSCI, V11, P1262, DOI 10.1038/nn.2211	50	203	204	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2009	12	5					646	654		10.1038/nn.2306	http://dx.doi.org/10.1038/nn.2306			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	438SJ	19363491	Green Accepted			2022-12-17	WOS:000265575400022
J	Durieux, PF; Bearzatto, B; Guiducci, S; Buch, T; Waisman, A; Zoli, M; Schiffmann, SN; d'Exaerde, ADK				Durieux, Pierre F.; Bearzatto, Bertrand; Guiducci, Stefania; Buch, Thorsten; Waisman, Ari; Zoli, Michele; Schiffmann, Serge N.; d'Exaerde, Alban De Kerchove			D2R striatopallidal neurons inhibit both locomotor and drug reward processes	NATURE NEUROSCIENCE			English	Article							GENE-EXPRESSION; ADDICTION; ABLATION	The specific functions of dopamine D-2 receptor-positive (D2R) striatopallidal neurons remain poorly understood. Using a genetic mouse model, we found that ablation of D2R neurons in the entire striatum induced hyperlocomotion, whereas ablation in the ventral striatum increased amphetamine conditioned place preference. Thus D2R striatopallidal neurons limit both locomotion and, unexpectedly, drug reinforcement.	[Durieux, Pierre F.; Bearzatto, Bertrand; Schiffmann, Serge N.; d'Exaerde, Alban De Kerchove] Univ Libre Bruxelles, Neurophysiol Lab, Brussels, Belgium; [Guiducci, Stefania; Zoli, Michele] Univ Modena & Reggio Emilia, Dept Biomed Sci, Physiol Sect, Modena, Italy; [Buch, Thorsten] Univ Zurich, Dept Pathol, Inst Expt Immunol, CH-8006 Zurich, Switzerland; [Waisman, Ari] Johannes Gutenberg Univ Mainz, Dept Med 1, D-6500 Mainz, Germany	Universite Libre de Bruxelles; Universita di Modena e Reggio Emilia; University of Zurich; Johannes Gutenberg University of Mainz	d'Exaerde, ADK (corresponding author), Univ Libre Bruxelles, Neurophysiol Lab, Brussels, Belgium.	adekerch@ulb.ac.be	Buch, Thorsten/P-1659-2019; de Kerchove d'Exaerde, Alban/R-6984-2019; Zoli, Michele/C-8899-2016; Waisman, Ari/C-7383-2015	Buch, Thorsten/0000-0002-2236-9074; Zoli, Michele/0000-0002-8034-2849; Waisman, Ari/0000-0003-4304-8234; de Kerchove d'Exaerde, Alban/0000-0002-0682-5877; Schiffmann, Serge/0000-0002-0118-9816	Fondation Medicale Reine Elisabeth (Belgium); Fonds de la Recherche Scientifique (Belgium); Fonds d'Encouragement a la Recherche from the Universite Libre de Bruxelles; Action de Recherche Concertee from the Communaute Francaise Wallonie Bruxelles; Ministero Italiano dell'Universitae della Ricerca [PRIN20072BTSR2]	Fondation Medicale Reine Elisabeth (Belgium); Fonds de la Recherche Scientifique (Belgium)(Fonds de la Recherche Scientifique - FNRS); Fonds d'Encouragement a la Recherche from the Universite Libre de Bruxelles; Action de Recherche Concertee from the Communaute Francaise Wallonie Bruxelles; Ministero Italiano dell'Universitae della Ricerca(Ministry of Education, Universities and Research (MIUR))	We thank M. Picciotto for helpful and critical comments on the manuscript and D. Houtteman, S. Laghmiri and L. Cuvelier for expert technical assistance. P. F. D. is Research Fellow of the Fonds de la Recherche Scientifique (bourse de doctorat Fonds de la Recherche Scientifique) and A. d. K. d. E. is a Research Associate of the Fonds de la Recherche Scientifique (Belgium). This study was supported by Fondation Medicale Reine Elisabeth (Belgium), Fonds de la Recherche Scientifique (Belgium), Fonds d'Encouragement a la Recherche from the Universite Libre de Bruxelles, Action de Recherche Concertee from the Communaute Francaise Wallonie Bruxelles and Ministero Italiano dell'Universitae della Ricerca (grant number PRIN20072BTSR2) to M. Z.	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Bertran-Gonzalez J, 2008, J NEUROSCI, V28, P5671, DOI 10.1523/JNEUROSCI.1039-08.2008; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; CHESSELET MF, 1993, PROG BRAIN RES, V99, P143; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Graybiel AM, 2000, CURR BIOL, V10, pR509, DOI 10.1016/S0960-9822(00)00593-5; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Kreitzer AC, 2007, NATURE, V445, P643, DOI 10.1038/nature05506; Lobo MK, 2006, NAT NEUROSCI, V9, P443, DOI 10.1038/nn1654; Sano H, 2003, J NEUROSCI, V23, P9078; SCHIFFMANN SN, 1993, J NEUROSCI, V13, P1080; Self DW, 2004, NEUROPHARMACOLOGY, V47, P242, DOI 10.1016/j.neuropharm.2004.07.005; Shen W, 2007, NAT NEUROSCI, V10, P1458, DOI 10.1038/nn1972	15	203	205	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2009	12	4					393	395		10.1038/nn.2286	http://dx.doi.org/10.1038/nn.2286			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	424JN	19270687				2022-12-17	WOS:000264563100012
J	Zhou, C; Rao, Y; Rao, Y				Zhou, Chuan; Rao, Yong; Rao, Yi			A subset of octopaminergic neurons are important for Drosophila aggression	NATURE NEUROSCIENCE			English	Article							SOCIAL EXPERIENCE; MATING SUCCESS; MELANOGASTER; BEHAVIOR; TERRITORIALITY; SEROTONIN; COURTSHIP; MICE; MODULATION; RESPONSES	Aggression is an innate behavior that is important for animal survival and evolution. We examined the molecular and cellular mechanisms underlying aggression in Drosophila. Reduction of the neurotransmitter octopamine, the insect equivalent of norepinephrine, decreased aggression in both males and females. Mutants lacking octopamine did not initiate fighting and did not fight other flies, although they still provoked other flies to fight themselves. Mutant males lost to the wild-type males in fighting and in competing for copulation with females. Enhanced octopaminergic signaling increased aggression in socially grouped flies, but not in socially isolated flies. We carried out genetic rescue experiments that revealed the functional importance of neuronal octopamine and identified a small subset of octopaminergic neurons in the suboesophageal ganglion as being important for aggression.	[Zhou, Chuan; Rao, Yong; Rao, Yi] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Zhou, Chuan] Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China; [Rao, Yi] Peking Univ, Sch Life Sci, Beijing 100871, Peoples R China; [Rao, Yi] Peking Univ, State Key Lab Biomembrane, Beijing 100871, Peoples R China	National Institute of Biological Sciences, Beijing; Chinese Academy of Sciences; Institute of Biophysics, CAS; Peking University; Peking University	Rao, Y (corresponding author), Natl Inst Biol Sci, 7 Zhongguanchun Life Sci Pk, Beijing 102206, Peoples R China.	yrao@pku.edu.cn		Rao, Yi/0000-0002-0405-5426				ADAMO SA, 1995, J EXP BIOL, V198, P1691; Anholt RRH, 1996, GENETICS, V143, P293; Baier A, 2002, J EXP BIOL, V205, P1233; BRUNNER HG, 1993, SCIENCE, V262, P578, DOI 10.1126/science.8211186; Certel SJ, 2007, P NATL ACAD SCI USA, V104, P4706, DOI 10.1073/pnas.0700328104; Chen S, 2002, P NATL ACAD SCI USA, V99, P5664, DOI 10.1073/pnas.082102599; Cole SH, 2005, J BIOL CHEM, V280, P14948, DOI 10.1074/jbc.M414197200; Darwin C., 1871, P423; Dierick HA, 2007, NAT GENET, V39, P678, DOI 10.1038/ng2029; Dierick HA, 2006, NAT GENET, V38, P1023, DOI 10.1038/ng1864; DOW MA, 1975, NATURE, V254, P511, DOI 10.1038/254511a0; Edwards AC, 2006, PLOS GENET, V2, P1386, DOI 10.1371/journal.pgen.0020154; Edwards DH, 1997, CURR OPIN NEUROBIOL, V7, P812, DOI 10.1016/S0959-4388(97)80140-7; Ganguly-Fitzgerald I, 2006, SCIENCE, V313, P1775, DOI 10.1126/science.1130408; HOFFMANN AA, 1987, ANIM BEHAV, V35, P1899, DOI 10.1016/S0003-3472(87)80085-4; HOFFMANN AA, 1987, ANIM BEHAV, V35, P807, DOI 10.1016/S0003-3472(87)80117-3; HOFFMANN AA, 1990, ANIM BEHAV, V40, P526, DOI 10.1016/S0003-3472(05)80533-0; HOFFMANN AA, 1989, BEHAV GENET, V19, P241, DOI 10.1007/BF01065908; HOFFMANN AA, 1990, J INSECT BEHAV, V3, P1, DOI 10.1007/BF01049191; HOFFMANN AA, 1989, ANIM BEHAV, V38, P23, DOI 10.1016/S0003-3472(89)80062-4; Hoyer SC, 2008, CURR BIOL, V18, P159, DOI 10.1016/j.cub.2007.12.052; JACOBS ME, 1960, ECOLOGY, V41, P182, DOI 10.2307/1931952; JACOBS ME, 1978, BEHAV GENET, V8, P487, DOI 10.1007/BF01067478; Kitamoto T, 2002, P NATL ACAD SCI USA, V99, P13232, DOI 10.1073/pnas.202489099; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; KRAVITZ EA, 1988, SCIENCE, V241, P1775, DOI 10.1126/science.2902685; KULKARNI SJ, 1987, GENETICS, V115, P461; LIVINGSTONE MS, 1980, SCIENCE, V208, P76, DOI 10.1126/science.208.4439.76; Lorenz K., 1963, AGGRESSION; Luan HJ, 2006, J NEUROSCI, V26, P573, DOI 10.1523/JNEUROSCI.3916-05.2006; Marino MD, 2005, BEHAV BRAIN RES, V161, P197, DOI 10.1016/j.bbr.2005.02.005; Monastirioti M, 2003, DEV BIOL, V264, P38, DOI 10.1016/j.ydbio.2003.07.019; Nilsen SP, 2004, P NATL ACAD SCI USA, V101, P12342, DOI 10.1073/pnas.0404693101; Roeder T, 2005, ANNU REV ENTOMOL, V50, P447, DOI 10.1146/annurev.ento.50.071803.130404; Sallinen J, 1998, J NEUROSCI, V18, P3035; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Scott JP, 1942, J HERED, V33, P11, DOI 10.1093/oxfordjournals.jhered.a105080; Stevenson PA, 2000, J NEUROBIOL, V43, P107; Stevenson PA, 2005, J NEUROSCI, V25, P1431, DOI 10.1523/JNEUROSCI.4258-04.2005; Sturtevant A. H., 1915, Journal of Animal Behavior Boston, V5, DOI 10.1037/h0074109; Svetec N, 2005, J EXP BIOL, V208, P891, DOI 10.1242/jeb.01454; Ueda A, 2002, PHYSIOL ENTOMOL, V27, P21, DOI 10.1046/j.1365-3032.2002.00262.x; Valzelli L., 1969, P70; Villella A, 1997, GENETICS, V147, P1107; Vrontou E, 2006, NAT NEUROSCI, V9, P1469, DOI 10.1038/nn1809; Wang LM, 2008, P NATL ACAD SCI USA, V105, P5657, DOI 10.1073/pnas.0801327105	47	203	210	2	97	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2008	11	9					1059	1067		10.1038/nn.2164	http://dx.doi.org/10.1038/nn.2164			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	341NA	19160504				2022-12-17	WOS:000258720000016
J	Sharpe, IA; Gehrmann, J; Loughnan, ML; Thomas, L; Adams, DA; Atkins, A; Palant, E; Craik, DJ; Adams, DJ; Alewood, PF; Lewis, RJ				Sharpe, IA; Gehrmann, J; Loughnan, ML; Thomas, L; Adams, DA; Atkins, A; Palant, E; Craik, DJ; Adams, DJ; Alewood, PF; Lewis, RJ			Two new classes of conopeptides inhibit the alpha 1-adrenoceptor and noradrenaline transporter	NATURE NEUROSCIENCE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; 1.1 ANGSTROM RESOLUTION; CONUS-GEOGRAPHUS VENOM; ALPHA-CONOTOXIN; CRYSTAL-STRUCTURE; SODIUM-CHANNELS; VAS-DEFERENS; NOREPINEPHRINE TRANSPORTER; PEPTIDE; ANTAGONIST	Cone snails use venom containing a cocktail of peptides ('conopeptides') to capture their prey. Many of these peptides also target mammalian receptors, often with exquisite selectivity. Here we report the discovery of two new classes of conopeptides. One class targets alpha (1)-adrenoceptors (rho -TIA from the fish-hunting Conus tulipa), and the second class targets the neuronal noradrenaline transporter (chi -MrIA and chi -MrIB from the mollusk-hunting C. marmoreus). rho -TIA and chi -MrIA selectively modulate these important membrane-bound proteins. Both peptides act as reversible non-competitive inhibitors and provide alternative avenues for the identification of inhibitor drugs.	Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; Univ Queensland, Sch Biomed Sci, Dept Physiol & Pharmacol, Brisbane, Qld 4072, Australia; Xenome Ltd, Brisbane, Qld 4068, Australia	University of Queensland; University of Queensland	Lewis, RJ (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.		Lewis, Richard J/E-8674-2013; Craik, David/B-1695-2010; Adams, David/J-9125-2014; Adams, David John/K-3578-2019; Loughnan, Marion/B-4508-2009; Lewis, Richard/T-8763-2019	Lewis, Richard J/0000-0003-3470-923X; Craik, David/0000-0003-0007-6796; Adams, David/0000-0002-7030-2288; Adams, David John/0000-0002-7030-2288; Lewis, Richard/0000-0003-3470-923X; Atkins, Annette/0000-0003-2558-7058; Alewood, Paul/0000-0001-7454-6522				Adams DJ, 1999, DRUG DEVELOP RES, V46, P219; Balaji RA, 2000, J BIOL CHEM, V275, P39516, DOI 10.1074/jbc.M006354200; Bruss M, 1997, MOL BRAIN RES, V52, P257, DOI 10.1016/S0169-328X(97)00267-2; Craig AG, 1998, BIOCHEMISTRY-US, V37, P16019, DOI 10.1021/bi981690a; Craig AG, 1999, J BIOL CHEM, V274, P13752, DOI 10.1074/jbc.274.20.13752; CRUZ LJ, 1987, J BIOL CHEM, V262, P15821; CRUZ LJ, 1985, J BIOL CHEM, V260, P9280; CUSACK B, 1994, PSYCHOPHARMACOLOGY, V114, P559, DOI 10.1007/BF02244985; England LJ, 1998, SCIENCE, V281, P575, DOI 10.1126/science.281.5376.575; FAINZILBER M, 1994, BIOCHEMISTRY-US, V33, P9523, DOI 10.1021/bi00198a018; FAINZILBER M, 1994, J BIOL CHEM, V269, P2574; Furst S, 1999, BRAIN RES BULL, V48, P129, DOI 10.1016/S0361-9230(98)00159-2; GRAY WR, 1981, J BIOL CHEM, V256, P4734; HOPKINS C, 1995, J BIOL CHEM, V270, P22361, DOI 10.1074/jbc.270.38.22361; Hu SH, 1996, STRUCTURE, V4, P417, DOI 10.1016/S0969-2126(96)00047-0; Hu SH, 1997, BIOCHEMISTRY-US, V36, P11323, DOI 10.1021/bi9713052; Hu SH, 1998, BIOCHEMISTRY-US, V37, P11425, DOI 10.1021/bi9806549; HWA J, 1995, J BIOL CHEM, V270, P23189, DOI 10.1074/jbc.270.39.23189; Kenakin T., 1997, PHARMACOLOGIC ANAL D, Vsecond edition, P137, DOI DOI 10.1097/00007691-198803000-00029; Loughnan M, 1998, J BIOL CHEM, V273, P15667, DOI 10.1074/jbc.273.25.15667; Massot O, 1996, MOL PHARMACOL, V50, P752; MCGRATH JC, 1978, J PHYSIOL-LONDON, V283, P23, DOI 10.1113/jphysiol.1978.sp012486; MCINTOSH JM, 1995, J BIOL CHEM, V270, P16796, DOI 10.1074/jbc.270.28.16796; McIntosh JM, 2000, J BIOL CHEM, V275, P32391, DOI 10.1074/jbc.M003619200; MENA EE, 1990, NEUROSCI LETT, V118, P241, DOI 10.1016/0304-3940(90)90637-O; MINNEMAN KP, 1983, MOL PHARMACOL, V23, P359; Nielsen KJ, 1999, BIOCHEMISTRY-US, V38, P6741, DOI 10.1021/bi982980u; NORTHOVER BJ, 1983, BRIT J PHARMACOL, V80, P85, DOI 10.1111/j.1476-5381.1983.tb11053.x; Olivera BM, 2001, TOXICON, V39, P7, DOI 10.1016/S0041-0101(00)00157-4; OLIVERA BM, 1984, BIOCHEMISTRY-US, V23, P5087, DOI 10.1021/bi00317a001; OLIVERA BM, 1990, SCIENCE, V249, P257, DOI 10.1126/science.2165278; Percy E, 1999, BRIT J PHARMACOL, V128, P774, DOI 10.1038/sj.bjp.0702831; PEREZ O, 1994, BRIT J PHARMACOL, V111, P717, DOI 10.1111/j.1476-5381.1994.tb14796.x; PRZYWARA DA, 1989, CIRC RES, V65, P185, DOI 10.1161/01.RES.65.1.185; Shon KJ, 1997, BIOCHEMISTRY-US, V36, P9581, DOI 10.1021/bi970235w; Shon KJ, 1998, J BIOL CHEM, V273, P33, DOI 10.1074/jbc.273.1.33; SNEDDON P, 1984, J PHYSIOL-LONDON, V347, P561, DOI 10.1113/jphysiol.1984.sp015083; TRENDELENBURG U, 1970, J PHARMACOL EXP THER, V172, P91	38	203	211	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2001	4	9					902	907		10.1038/nn0901-902	http://dx.doi.org/10.1038/nn0901-902			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	467JL	11528421				2022-12-17	WOS:000170698600016
J	Okabe, S; Kim, HD; Miwa, A; Kuriu, T; Okado, H				Okabe, S; Kim, HD; Miwa, A; Kuriu, T; Okado, H			Continual remodeling of postsynaptic density and its regulation by synaptic activity	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; DENDRITIC SPINE DENSITY; HIPPOCAMPAL-NEURONS; NMDA RECEPTOR; RECOMBINANT ADENOVIRUS; AXOSPINOUS SYNAPSES; PROTEIN; RAT; SYNAPTOGENESIS; TRANSMISSION	A postsynaptic density (PSD) protein, PSD-95, was tagged with green fluorescent protein (GFP-PSD-95) and expressed in cultured hippocampal neurons using recombinant adenoviruses. CFP-PSD-95 was selectively localized to excitatory postsynaptic sites. Time-lapse fluorescence imaging of hippocampal neurons revealed that >20% of GFP-PSD-95 clusters turned over within 24 hours. The appearance rate of clusters was higher than the disappearance rate, and this difference accounted for the gradual increase of the cluster density observed in culture. Dynamics of PSD-95 clusters were also inhibited by blockers of excitatory synaptic transmission. Continual PSD turnover and its regulation by synaptic activity may be important in activity-dependent remodeling of neuronal connections.	Tokyo Med & Dent Univ, Sch Med, Dept Anat & Cell Biol, Bunkyo Ku, Tokyo 1138519, Japan; Natl Inst Biosci & Human Technol, Mol Neurobiol Lab, Tsukuba, Ibaraki 3058566, Japan; Tokyo Metropolitan Inst Neurosci, Dept Neurobiol, Tokyo 1838526, Japan	Tokyo Medical & Dental University (TMDU); National Institute of Advanced Industrial Science & Technology (AIST); Tokyo Metropolitan Institute for Neuroscience; Tokyo Metropolitan Institute of Medical Science	Okabe, S (corresponding author), Tokyo Med & Dent Univ, Sch Med, Dept Anat & Cell Biol, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.			Okabe, Shigeo/0000-0003-1216-8890				Arnold DB, 1999, NEURON, V23, P149, DOI 10.1016/S0896-6273(00)80761-8; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; Bolshakov VY, 1997, NEURON, V19, P635, DOI 10.1016/S0896-6273(00)80377-3; Buchs PA, 1996, P NATL ACAD SCI USA, V93, P8040, DOI 10.1073/pnas.93.15.8040; BURNS ME, 1995, CELL, V83, P187, DOI 10.1016/0092-8674(95)90160-4; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Craven SE, 1999, NEURON, V22, P497, DOI 10.1016/S0896-6273(00)80705-9; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Fukaya M, 1999, NEUROSCI RES, V33, P111, DOI 10.1016/S0168-0102(98)00120-5; GEINISMAN Y, 1991, BRAIN RES, V566, P77, DOI 10.1016/0006-8993(91)91683-R; GEINISMAN Y, 1993, HIPPOCAMPUS, V3, P435, DOI 10.1002/hipo.450030405; Geinisman Y, 1996, J COMP NEUROL, V368, P413; GOULD E, 1990, J NEUROSCI, V10, P1286; HEIM R, 1994, P NATL ACAD SCI USA, V91, P12501, DOI 10.1073/pnas.91.26.12501; HOSOKAWA T, 1995, J NEUROSCI, V15, P5560; KANEGAE Y, 1995, NUCLEIC ACIDS RES, V23, P3816, DOI 10.1093/nar/23.19.3816; KANEGAE Y, 1994, JPN J MED SCI BIOL, V47, P157, DOI 10.7883/yoken1952.47.157; Kim E, 1996, NEURON, V17, P103, DOI 10.1016/S0896-6273(00)80284-6; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; KISTNER U, 1993, J BIOL CHEM, V268, P4580; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Ma L, 1999, NAT NEUROSCI, V2, P24, DOI 10.1038/4525; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Miyake S, 1996, P NATL ACAD SCI USA, V93, P1320, DOI 10.1073/pnas.93.3.1320; MULLER M, 1993, P NATL ACAD SCI USA, V90, P257, DOI 10.1073/pnas.90.1.257; Murphy DD, 1996, J NEUROSCI, V16, P4059; Nguyen QT, 1996, CURR OPIN NEUROBIOL, V6, P104, DOI 10.1016/S0959-4388(96)80015-8; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Okabe S, 1998, EUR J NEUROSCI, V10, P2192, DOI 10.1046/j.1460-9568.1998.00233.x; OKABE S, IN PRESS J NEUROSCI; PAPA M, 1995, J NEUROSCI, V15, P1; Rao A, 1998, J NEUROSCI, V18, P1217; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; Sorra KE, 1998, J NEUROSCI, V18, P658; WOOLLEY CS, 1992, J NEUROSCI, V12, P2549; WOOLLEY CS, 1990, J NEUROSCI, V10, P4035, DOI 10.1523/JNEUROSCI.10-12-04035.1990; Ziff EB, 1997, NEURON, V19, P1163, DOI 10.1016/S0896-6273(00)80409-2; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	40	203	213	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	1999	2	9					804	811		10.1038/12175	http://dx.doi.org/10.1038/12175			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259FB	10461219				2022-12-17	WOS:000083882900011
J	Tsivilis, D; Vann, SD; Denby, C; Roberts, N; Mayes, AR; Montaldi, D; Aggleton, JP				Tsivilis, Dimitris; Vann, Seralynne D.; Denby, Christine; Roberts, Neil; Mayes, Andrew R.; Montaldi, Daniela; Aggleton, John P.			A disproportionate role for the fornix and mammillary bodies in recall versus recognition memory	NATURE NEUROSCIENCE			English	Article							MEDIAL TEMPORAL-LOBE; MACAQUE MONKEYS; COLLOID CYST; HIPPOCAMPAL REGION; ANTERIOR FORNIX; AMNESIA; DAMAGE; LESIONS; RECOLLECTION; FAMILIARITY	Uncovering the functional relationship between temporal lobe amnesia and diencephalic amnesia depends on determining the role of the fornix, the major interlinking fiber tract. In this study relating fornix volume with memory, we made magnetic resonance imaging-based volume estimates of 13 brain structures in 38 individuals with surgically removed colloid cysts. Fornix status was assessed directly by overall volume and indirectly by mammillary body volume (which atrophies after fornix damage). Mammillary body volume significantly correlated with 13 out of 14 tests of episodic memory recall, but correlated poorly with recognition memory. Furthermore, as the volumes of the left fornix and the left mammillary bodies decreased, the difference between recall and recognition scores increased. No other structure was consistently associated with memory. These findings support models of diencephalic memory mechanisms that require hippocampal inputs for recall, but not for key elements of recognition.	[Tsivilis, Dimitris; Denby, Christine; Mayes, Andrew R.; Montaldi, Daniela] Univ Manchester, Sch Psychol Sci, Manchester M13 9PL, Lancs, England; [Vann, Seralynne D.; Aggleton, John P.] Cardiff Univ, Sch Psychol, Cardiff CF10 3AT, Wales; [Roberts, Neil] Univ Liverpool, Magnet Resonance & Image Anal Res Ctr, Liverpool L69 3GE, Merseyside, England	University of Manchester; Cardiff University; University of Liverpool	Tsivilis, D (corresponding author), Univ Manchester, Sch Psychol Sci, Zochonis Bldg,Brunswick St, Manchester M13 9PL, Lancs, England.	dimitris.tsivilis@manchester.ac.uk	Vann, Seralynne/A-1601-2010	Aggleton, John/0000-0002-5573-1308; Vann, Seralynne/0000-0002-6709-8773	Medical Research Council [G0001371] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aggleton JP, 2006, TRENDS COGN SCI, V10, P455, DOI 10.1016/j.tics.2006.08.003; Aggleton JP, 2005, EUR J NEUROSCI, V22, P2519, DOI 10.1111/j.1460-9568.2005.04450.x; Aggleton JP, 1999, BEHAV BRAIN SCI, V22, P425; Aggleton JP, 2000, BRAIN, V123, P800, DOI 10.1093/brain/123.4.800; Baddeley A.D., 1994, DOORS PEOPLE TEST TE; Baxter MG, 1999, CURR OPIN NEUROBIOL, V9, P178, DOI 10.1016/S0959-4388(99)80024-5; Bilir E, 1998, NEURORADIOLOGY, V40, P138, DOI 10.1007/s002340050554; Bowles B, 2007, P NATL ACAD SCI USA, V104, P16382, DOI 10.1073/pnas.0705273104; Carlesimo GA, 2007, NEUROPSYCHOLOGIA, V45, P2467, DOI 10.1016/j.neuropsychologia.2007.03.025; COOK MJ, 1992, BRAIN, V115, P1001, DOI 10.1093/brain/115.4.1001; Cruz-Orive LM, 1993, B INT STAT I, V55, P451; DENBY C, 2008, NEUROSCI IM IN PRESS; DESPOSITO M, 1995, NEUROLOGY, V45, P1546, DOI 10.1212/WNL.45.8.1546; Dunn JC, 2004, PSYCHOL REV, V111, P524, DOI 10.1037/0033-295X.111.2.524; DUSOIR H, 1990, BRAIN, V113, P1695, DOI 10.1093/brain/113.6.1695; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; GAFFAN EA, 1991, BRAIN, V114, P1297, DOI 10.1093/brain/114.3.1297; Garcia-Finana M, 2003, NEUROIMAGE, V18, P505, DOI 10.1016/S1053-8119(02)00021-6; GARCIABENGOCHEA F, 1987, SURG NEUROL, V27, P361, DOI 10.1016/0090-3019(87)90012-7; Harding A, 2000, BRAIN, V123, P141, DOI 10.1093/brain/123.1.141; Hildebrandt H, 2001, J CLIN EXP NEUROPSYC, V23, P490, DOI 10.1076/jcen.23.4.490.1234; HODGES JR, 1991, J NEUROL NEUROSUR PS, V54, P633, DOI 10.1136/jnnp.54.7.633; Howard MA, 2003, BRAIN RES PROTOC, V10, P125, DOI 10.1016/S1385-299X(02)00202-7; Insausti R, 1998, AM J NEURORADIOL, V19, P659; Kapur N, 1998, NEUROCASE, V4, P509, DOI 10.1093/neucas/4.6.509; KOPELMAN MD, 1995, BRIT J PSYCHIAT, V166, P154, DOI 10.1192/bjp.166.2.154; Kopelman MD, 2007, NEUROPSYCHOLOGIA, V45, P1232, DOI 10.1016/j.neuropsychologia.2006.10.005; Loftus M, 2000, EXP NEUROL, V163, P180, DOI 10.1006/exnr.2000.7361; Manns JR, 1999, HIPPOCAMPUS, V9, P495, DOI 10.1002/(SICI)1098-1063(1999)9:5<495::AID-HIPO2>3.0.CO;2-O; MAYES AR, 1997, CASE STUDIES NEUROPS; MCMACKIN D, 1995, ACTA NEUROCHIR, V135, P12, DOI 10.1007/BF02307408; Park SA, 2000, NEUROLOGY, V54, P1379, DOI 10.1212/WNL.54.6.1379; POLETTI CE, 1977, J COMP NEUROL, V175, P101, DOI 10.1002/cne.901750107; Poreh A, 2006, NEUROPSYCHOLOGIA, V44, P2241, DOI 10.1016/j.neuropsychologia.2006.05.020; Pruessner JC, 2002, CEREB CORTEX, V12, P1342, DOI 10.1093/cercor/12.12.1342; Saunders RC, 2007, HIPPOCAMPUS, V17, P396, DOI 10.1002/hipo.20276; Squire LR, 2007, NAT REV NEUROSCI, V8, P872, DOI 10.1038/nrn2154; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Van der Werf YD, 2003, NEUROPSYCHOLOGIA, V41, P1330, DOI 10.1016/S0028-3932(03)00059-9; Vann SD, 2004, NAT REV NEUROSCI, V5, P35, DOI 10.1038/nrn1299; Vann SD, 2007, EUR J NEUROSCI, V26, P1575, DOI 10.1111/j.1460-9568.2007.05773.x; Victor M, 1987, Int J Neurol, V21-22, P51; VONCRAMON DY, 1985, BRAIN, V108, P993, DOI 10.1093/brain/108.4.993; Warrington E.K., 1984, RECOGNITION MEMORY T; Wechsler D., 2001, WECHSLER TEST ADULT; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D, 1997, WECHSLER ADULT INTEL; WOOLSEY RM, 1975, ARCH NEUROL-CHICAGO, V32, P566, DOI 10.1001/archneur.1975.00490500086012; Yonelinas AP, 2002, J MEM LANG, V46, P441, DOI 10.1006/jmla.2002.2864; Zahajszky J, 2001, SCHIZOPHR RES, V47, P87, DOI 10.1016/S0920-9964(00)00051-7	50	202	205	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2008	11	7					834	842		10.1038/nn.2149	http://dx.doi.org/10.1038/nn.2149			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	318KD	18552840				2022-12-17	WOS:000257089400021
J	Hall, J; Whalley, HC; Job, DE; Baig, BJ; McIntosh, AM; Evans, KL; Thomson, PA; Porteous, DJ; Cunningham-Owens, DG; Johnstone, EC; Lawrie, SM				Hall, Jeremy; Whalley, Heather C.; Job, Dominic E.; Baig, Ben J.; McIntosh, Andrew M.; Evans, Kathryn L.; Thomson, Pippa A.; Porteous, David J.; Cunningham-Owens, David G.; Johnstone, Eve C.; Lawrie, Stephen M.			A neuregulin 1 variant associated with abnormal cortical function and psychotic symptoms	NATURE NEUROSCIENCE			English	Article							BIPOLAR DISORDER; ENHANCED RISK; SCHIZOPHRENIA; SUSCEPTIBILITY; METAANALYSIS; POPULATION; GENE	NRG1, encoding neuregulin 1, is a susceptibility gene for schizophrenia, but no functional mutation causally related to the disorder has yet been identified. Here we investigate the effects of a variant in the human NRG1 promoter region in subjects at high risk of schizophrenia. We show that this variant is associated with (i) decreased activation of frontal and temporal lobe regions, (ii) increased development of psychotic symptoms and (iii) decreased premorbid IQ.	Univ Edinburgh, Royal Edinburgh Hosp, Div Psychiat, Edinburgh EH10 5HF, Midlothian, Scotland; Univ Edinburgh, Western Gen Hosp, Mol Med Ctr, Med Genet Sect, Edinburgh EH4 2XU, Midlothian, Scotland	Royal Infirmary of Edinburgh; University of Edinburgh; University of Edinburgh	Hall, J (corresponding author), Univ Edinburgh, Royal Edinburgh Hosp, Div Psychiat, Morningside Pk, Edinburgh EH10 5HF, Midlothian, Scotland.	jhall5@staffmail.ed.ac.uk	McIntosh, Andrew M/B-9379-2008; Lawrie, Stephen MacGregor/AAD-1607-2021; Evans, Kathryn KL/I-5910-2012; Whalley, Heather C/N-1886-2019; Porteous, David/AAA-3446-2021; Porteous, David J/C-7289-2013; Baig, Benjamin J/C-6714-2009	McIntosh, Andrew M/0000-0002-0198-4588; Lawrie, Stephen MacGregor/0000-0002-2444-5675; Whalley, Heather C/0000-0002-4505-8869; Porteous, David/0000-0003-1249-6106; Porteous, David J/0000-0003-1249-6106; Job, Dominic/0000-0002-7829-7217; Baig, Benjamin/0000-0003-2766-9014; Hall, Jeremy/0000-0002-0403-3278; Evans, Kathryn/0000-0002-7884-5877	Medical Research Council [G0600429, G0100266] Funding Source: Medline; MRC [G0100266] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Badner JA, 2002, MOL PSYCHIATR, V7, P405, DOI 10.1038/sj.mp.4001012; Corfas G, 2004, NAT NEUROSCI, V7, P575, DOI 10.1038/nn1258; David AS, 1997, PSYCHOL MED, V27, P1311, DOI 10.1017/S0033291797005680; FRISTON KJ, 1995, CLIN NEUROSCI, V3, P89; Green EK, 2005, ARCH GEN PSYCHIAT, V62, P642, DOI 10.1001/archpsyc.62.6.642; Honey GD, 2003, PSYCHOL MED, V33, P1007, DOI 10.1017/S0033291703007864; Johnstone EC, 2000, SCHIZOPHR RES, V46, P1, DOI 10.1016/S0920-9964(99)00225-X; Law AJ, 2006, P NATL ACAD SCI USA, V103, P6747, DOI 10.1073/pnas.0602002103; LAWRIE SM, 2004, SCHIZOPHRENIA IMAGIN; Li DW, 2006, HUM MOL GENET, V15, P1995, DOI 10.1093/hmg/ddl122; Marjoram D, 2006, NEUROIMAGE, V31, P1850, DOI 10.1016/j.neuroimage.2006.02.011; Stefansson H, 2003, AM J HUM GENET, V72, P83, DOI 10.1086/345442; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Whalley HC, 2004, BRAIN, V127, P478, DOI 10.1093/brain/awh070; Williams LM, 2004, AM J PSYCHIAT, V161, P480, DOI 10.1176/appi.ajp.161.3.480	15	202	204	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2006	9	12					1477	1478		10.1038/nn1795	http://dx.doi.org/10.1038/nn1795			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	110TP	17072305				2022-12-17	WOS:000242404000010
J	Zachariou, V; Bolanos, CA; Selley, DE; Theobald, D; Cassidy, MP; Kelz, MB; Shaw-Lutchman, T; Berton, O; Sim-Selley, LJ; Dileone, RJ; Kumar, A; Nestler, EJ				Zachariou, V; Bolanos, CA; Selley, DE; Theobald, D; Cassidy, MP; Kelz, MB; Shaw-Lutchman, T; Berton, O; Sim-Selley, LJ; Dileone, RJ; Kumar, A; Nestler, EJ			An essential role for Delta FosB in the nucleus accumbens in morphine action	NATURE NEUROSCIENCE			English	Article							KAPPA-OPIOID RECEPTORS; CHRONIC COCAINE; WITHDRAWAL SYNDROME; OPIATE WITHDRAWAL; TRANSGENIC MICE; BRAIN; ADDICTION; SYSTEMS; REWARD; EXPRESSION	The transcription factor Delta FosB is induced in the nucleus accumbens ( NAc) and dorsal striatum by the repeated administration of drugs of abuse. Here, we investigated the role of DFosB in the NAc in behavioral responses to opiates. We achieved overexpression of DFosB by using a bitransgenic mouse line that inducibly expresses the protein in the NAc and dorsal striatum and by using viral-mediated gene transfer to specifically express the protein in the NAc. DFosB overexpression in the NAc increased the sensitivity of the mice to the rewarding effects of morphine and led to exacerbated physical dependence, but also reduced their sensitivity to the analgesic effects of morphine and led to faster development of analgesic tolerance. The opioid peptide dynorphin seemed to be one target through which DFosB produced this behavioral phenotype. Together, these experiments demonstrated that DFosB in the NAc, partly through the repression of dynorphin expression, mediates several major features of opiate addiction.	Univ Texas, SW Med Ctr, Dept Psychiat, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dallas, TX 75390 USA; Univ Crete, Fac Med, Dept Basic Sci, Iraklion 71003, Crete, Greece; Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA; Univ Penn, Sch Med, Dept Anesthesia, Philadelphia, PA 19104 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Crete; Virginia Commonwealth University; University of Pennsylvania	Nestler, EJ (corresponding author), Univ Texas, SW Med Ctr, Dept Psychiat, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	eric.nestler@utsouthwestern.edu	Kumar, Arvind/B-6094-2009; Zachariou, Venetia/L-2726-2016; Kelz, Max/E-4054-2010	Kelz, Max/0000-0002-2803-6078; DiLeone, Ralph/0000-0002-4770-2590; Kumar, Arvind/0000-0003-2879-3826				AKIL H, 1994, PROG BRAIN RES, V100, P81; Altier N, 1999, LIFE SCI, V65, P2269, DOI 10.1016/S0024-3205(99)00298-2; Asanuma M, 1998, MOL BRAIN RES, V60, P305, DOI 10.1016/S0169-328X(98)00188-0; Barrot M, 2002, P NATL ACAD SCI USA, V99, P11435, DOI 10.1073/pnas.172091899; BROG JS, 1993, J COMP NEUROL, V338, P255, DOI 10.1002/cne.903380209; Carlezon WA, 1998, SCIENCE, V282, P2272, DOI 10.1126/science.282.5397.2272; Chefer VI, 2005, J NEUROSCI, V25, P5029, DOI 10.1523/JNEUROSCI.0854-05.2005; Chen JS, 1997, J NEUROSCI, V17, P4933; Colby CR, 2003, J NEUROSCI, V23, P2488; COLE RL, 1995, NEURON, V14, P813, DOI 10.1016/0896-6273(95)90225-2; Ehrlich ME, 2002, J NEUROSCI, V22, P9155; Everitt BJ, 2002, J NEUROSCI, V22, P3312; Frenois F, 2002, EUR J NEUROSCI, V16, P1377, DOI 10.1046/j.1460-9568.2002.02187.x; FUNADA M, 1993, NEUROPHARMACOLOGY, V32, P1315; GEAR RW, 1995, J NEUROSCI, V15, P3154; Harris GC, 2003, NEUROPSYCHOPHARMACOL, V28, P865, DOI 10.1038/sj.npp.1300122; HARRIS GC, 1994, NATURE, V371, P155, DOI 10.1038/371155a0; Hiroi N, 1997, P NATL ACAD SCI USA, V94, P10397, DOI 10.1073/pnas.94.19.10397; HOPE BT, 1994, NEURON, V13, P1235, DOI 10.1016/0896-6273(94)90061-2; Hyman SE, 2001, NAT REV NEUROSCI, V2, P695, DOI 10.1038/35094560; Inturrisi CE, 2002, CLIN J PAIN, V18, pS3, DOI 10.1097/00002508-200207001-00002; Kalivas PW, 2004, CURR OPIN PHARMACOL, V4, P23, DOI 10.1016/j.coph.2003.11.002; Kelz MB, 1999, NATURE, V401, P272, DOI 10.1038/45790; Koob GF, 1998, NEURON, V21, P467, DOI 10.1016/S0896-6273(00)80557-7; MALDONADO R, 1992, J PHARMACOL EXP THER, V261, P669; Marinelli M, 2002, EUR J NEUROSCI, V16, P387, DOI 10.1046/j.1460-9568.2002.02089.x; Matthes HWD, 1996, NATURE, V383, P819, DOI 10.1038/383819a0; McClung CA, 2003, NAT NEUROSCI, V6, P1208, DOI 10.1038/nn1143; Moratalla R, 1996, NEURON, V17, P147, DOI 10.1016/S0896-6273(00)80288-3; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Nye HE, 1996, MOL PHARMACOL, V49, P636; NYLANDER I, 1995, PSYCHOPHARMACOLOGY, V118, P391, DOI 10.1007/BF02245939; O'Donovan KJ, 1999, TRENDS NEUROSCI, V22, P167, DOI 10.1016/S0166-2236(98)01343-5; Peakman MC, 2003, BRAIN RES, V970, P73, DOI 10.1016/S0006-8993(03)02230-3; Pich EM, 1997, SCIENCE, V275, P83; Robinson TE, 2000, ADDICTION, V95, pS91; Schmidt BL, 2002, J NEUROSCI, V22, P6773; Shaw-Lutchman TZ, 2002, J NEUROSCI, V22, P3663; Shippenberg TS, 1996, EUR J PHARMACOL, V299, P33, DOI 10.1016/0014-2999(95)00852-7; Shippenberg TS, 1998, EUR J PHARMACOL, V345, P27, DOI 10.1016/S0014-2999(97)01614-2; Shippenberg TS, 2001, ANN NY ACAD SCI, V937, P50; SUZUKI T, 1992, EUR J PHARMACOL, V213, P91, DOI 10.1016/0014-2999(92)90237-X; Svingos AL, 1999, J NEUROSCI, V19, P1804; Wang XM, 1999, MOL BRAIN RES, V66, P184, DOI 10.1016/S0169-328X(99)00021-2; Werme M, 2002, J NEUROSCI, V22, P8133; Willis WD, 1997, J CLIN NEUROPHYSIOL, V14, P2, DOI 10.1097/00004691-199701000-00002; Wise RA, 1998, DRUG ALCOHOL DEPEN, V51, P13, DOI 10.1016/S0376-8716(98)00063-5; Yao WD, 2004, NEURON, V41, P625, DOI 10.1016/S0896-6273(04)00048-0; YUKHANANOV RY, 1993, NEUROPHARMACOLOGY, V32, P703, DOI 10.1016/0028-3908(93)90084-G; Zachariou V, 2003, P NATL ACAD SCI USA, V100, P13656, DOI 10.1073/pnas.2232594100	50	202	209	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2006	9	2					205	211		10.1038/nn1636	http://dx.doi.org/10.1038/nn1636			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	007SN	16415864				2022-12-17	WOS:000234990100015
J	Wang, J; Liu, SH; Fu, YP; Wang, JH; Lu, YM				Wang, J; Liu, SH; Fu, YP; Wang, JH; Lu, YM			Cdk5 activation induces hippocampal CA1 cell death by directly phosphorylating NMDA receptors	NATURE NEUROSCIENCE			English	Article							EXCITATORY AMINO-ACIDS; DELAYED NEURONAL DEATH; NITRIC-OXIDE SYNTHASE; MOLECULAR-MECHANISMS; SYNAPTIC TRANSMISSION; RAT HIPPOCAMPUS; AMPA RECEPTORS; GLUTAMATE; NEUROTOXICITY; CALCIUM	CA1 pyramidal neurons degenerate after transient forebrain ischemia, whereas neurons in other regions of the hippocampus remain intact. Here we show that in rat hippocampal CA1 neurons, forebrain ischemia induces the phosphorylation of the N-methyl-D-aspartate (NMDA) receptor 2A subunit at Ser1232 (phospho-Ser1232). Ser1232 phosphorylation is catalyzed by cyclin-dependent kinase 5 (Cdk5). Inhibiting endogenous Cdk5, or perturbing interactions between Cdk5 and NR2A subunits, abolished NR2A phosphorylation at Ser1232 and protected CA1 pyramidal neurons from ischemic insult. Thus, we conclude that modulation of NMDA receptors by Cdk5 is the primary intracellular event underlying the ischemic injury of CA1 pyramidal neurons.	Univ Calgary, Fac Med, Dept Physiol & Biophys, Calgary, AB T2N 4N1, Canada; Univ Calgary, Fac Med, Neurosci Res Grp, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada	University of Calgary; University of Calgary	Lu, YM (corresponding author), Univ Calgary, Fac Med, Dept Physiol & Biophys, Calgary, AB T2N 4N1, Canada.	luy@ucalgary.ca						Abel T, 2001, CURR OPIN NEUROBIOL, V11, P180, DOI 10.1016/S0959-4388(00)00194-X; Ali DW, 2001, CURR OPIN NEUROBIOL, V11, P336, DOI 10.1016/S0959-4388(00)00216-6; ANDINE P, 1988, J CEREBR BLOOD F MET, V8, P799, DOI 10.1038/jcbfm.1988.135; Barria A, 2002, NEURON, V35, P345, DOI 10.1016/S0896-6273(02)00776-6; BENVENISTE H, 1984, J NEUROCHEM, V43, P1369, DOI 10.1111/j.1471-4159.1984.tb05396.x; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; Carroll RC, 2002, TRENDS NEUROSCI, V25, P571, DOI 10.1016/S0166-2236(02)02272-5; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; CHOI DW, 1988, TRENDS NEUROSCI, V11, P465, DOI 10.1016/0166-2236(88)90200-7; CHOI DW, 1995, TRENDS NEUROSCI, V18, P58; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; DAWSON VL, 1991, P NATL ACAD SCI USA, V88, P6368, DOI 10.1073/pnas.88.14.6368; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Gong XM, 2003, NEURON, V38, P33, DOI 10.1016/S0896-6273(03)00191-0; Gorter JA, 1997, J NEUROSCI, V17, P6179; Greengard P, 1999, NEURON, V23, P435, DOI 10.1016/S0896-6273(00)80798-9; HAGBERG H, 1985, J CEREBR BLOOD F MET, V5, P413, DOI 10.1038/jcbfm.1985.56; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; JONAS P, 1995, NEURON, V15, P987, DOI 10.1016/0896-6273(95)90087-X; Jover T, 2002, J NEUROSCI, V22, P2115, DOI 10.1523/JNEUROSCI.22-06-02115.2002; KIRINO T, 1982, BRAIN RES, V239, P57, DOI 10.1016/0006-8993(82)90833-2; KUTSUWADA T, 1992, NATURE, V358, P36, DOI 10.1038/358036a0; Lee JM, 1999, NATURE, V399, pA7, DOI 10.1038/399a007; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; LEW J, 1992, J BIOL CHEM, V267, P13383; Li BS, 2001, P NATL ACAD SCI USA, V98, P12742, DOI 10.1073/pnas.211428098; Liu HN, 2002, J NEUROCHEM, V82, P398, DOI 10.1046/j.1471-4159.2002.00981.x; Liu SH, 2003, J NEUROSCI, V23, P732; MEGURO H, 1992, NATURE, V357, P70, DOI 10.1038/357070a0; MELDRUM B, 1990, TRENDS PHARMACOL SCI, V11, P379, DOI 10.1016/0165-6147(90)90184-A; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Minger SL, 1998, BRAIN RES, V810, P181, DOI 10.1016/S0006-8993(98)00921-4; Mitani A, 1998, J CEREBR BLOOD F MET, V18, P1088, DOI 10.1097/00004647-199810000-00005; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Neumar RW, 2001, EXP NEUROL, V170, P27, DOI 10.1006/exnr.2001.7708; Nguyen MD, 2001, NEURON, V30, P135, DOI 10.1016/S0896-6273(01)00268-9; Nikolic M, 1996, GENE DEV, V10, P816, DOI 10.1101/gad.10.7.816; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; PellegriniGiampietro DE, 1997, TRENDS NEUROSCI, V20, P464, DOI 10.1016/S0166-2236(97)01100-4; Sattler R, 2001, MOL NEUROBIOL, V24, P107, DOI 10.1385/MN:24:1-3:107; Scannevin RH, 2000, NAT REV NEUROSCI, V1, P133, DOI 10.1038/35039075; SIMON RP, 1984, SCIENCE, V226, P850, DOI 10.1126/science.6093256; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; Wang Fuhu, 2001, Expert Opin Ther Targets, V5, P557; Wang J, 2003, J NEUROSCI, V23, P826; Zhu DY, 2003, J NEUROSCI, V23, P223	50	202	236	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2003	6	10					1039	1047		10.1038/nn1119	http://dx.doi.org/10.1038/nn1119			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	727AK	14502288				2022-12-17	WOS:000185633600015
J	Arnth-Jensen, N; Jabaudon, D; Scanziani, M				Arnth-Jensen, N; Jabaudon, D; Scanziani, M			Cooperation between independent hippocampal synapses is controlled by glutamate uptake	NATURE NEUROSCIENCE			English	Article							EXCITATORY SYNAPTIC CURRENTS; MULTIPLE RELEASE SITES; MOSSY FIBER SYNAPSES; PARALLEL FIBER; TRANSPORTERS; SPILLOVER; RECEPTORS; CELLS; TRANSMISSION; POTENTIATION	Localized action of released neurotransmitters is the basis for synaptic independence. In the hippocampal neuropil, where synapses are densely packed, it has been postulated that released glutamate, by diffusing out of the synaptic cleft, may also activate postsynaptic receptors at neighboring synapses. Here we show that neighboring excitatory synapses on hippocampal CA1 pyramidal cells can cooperate in the activation of postsynaptic receptors through the confluence of released glutamate, and that this cooperation is controlled by glutamate uptake. Furthermore, glutamate transporters control temporal interactions between transmitter transients originating from the same axon. Thus, cooperative interactions between excitatory synapses are modulated in space and time by glutamate uptake.	Univ Zurich, Brain Res Inst, CH-8057 Zurich, Switzerland; Univ Hosp Geneva, Dept Neurol, CH-1211 Geneva, Switzerland	University of Zurich; University of Geneva	Scanziani, M (corresponding author), Univ Zurich, Brain Res Inst, Winterthurerstr 190, CH-8057 Zurich, Switzerland.		Jabaudon, Denis/B-8802-2014	Jabaudon, Denis/0000-0003-2438-4769				Asztely F, 1997, NEURON, V18, P281, DOI 10.1016/S0896-6273(00)80268-8; BARBOUR B, 1994, NEURON, V12, P1331, DOI 10.1016/0896-6273(94)90448-0; Barbour B, 1997, TRENDS NEUROSCI, V20, P377; Bergles DE, 1997, NEURON, V19, P1297, DOI 10.1016/S0896-6273(00)80420-1; Carter AG, 2000, J NEUROSCI, V20, P4423, DOI 10.1523/JNEUROSCI.20-12-04423.2000; Diamond JS, 2001, J NEUROSCI, V21, P8328, DOI 10.1523/JNEUROSCI.21-21-08328.2001; Engert F, 1997, NATURE, V388, P279, DOI 10.1038/40870; FOX SE, 1975, EXP NEUROL, V49, P299, DOI 10.1016/0014-4886(75)90213-7; GAHWILER BH, 1981, J NEUROSCI METH, V4, P329, DOI 10.1016/0165-0270(81)90003-0; Gegelashvili G, 1997, MOL PHARMACOL, V52, P6, DOI 10.1124/mol.52.1.6; Harris KD, 2001, NEURON, V32, P141, DOI 10.1016/S0896-6273(01)00447-0; HARTZELL HC, 1975, J PHYSIOL-LONDON, V251, P427, DOI 10.1113/jphysiol.1975.sp011102; HESTRIN S, 1990, NEURON, V5, P247, DOI 10.1016/0896-6273(90)90162-9; ISAACSON JS, 1993, J NEUROPHYSIOL, V70, P2187, DOI 10.1152/jn.1993.70.5.2187; Jabaudon D, 1999, P NATL ACAD SCI USA, V96, P8733, DOI 10.1073/pnas.96.15.8733; Lehre KP, 1998, J NEUROSCI, V18, P8751, DOI 10.1523/jneurosci.18-21-08751.1998; LI XM, 1994, POTENTIAL ANAL, V3, P339, DOI 10.1007/BF01049807; Lozovaya NA, 1999, NEUROSCIENCE, V91, P1321, DOI 10.1016/S0306-4522(98)00638-1; MALINOW R, 1994, P NATL ACAD SCI USA, V91, P8170, DOI 10.1073/pnas.91.17.8170; MENNERICK S, 1994, NATURE, V368, P59, DOI 10.1038/368059a0; Otis TS, 1996, J NEUROSCI, V16, P1634, DOI 10.1523/jneurosci.16-05-01634.1996; Rusakov DA, 1998, P NATL ACAD SCI USA, V95, P8975, DOI 10.1073/pnas.95.15.8975; SARANTIS M, 1993, NEURON, V11, P541, DOI 10.1016/0896-6273(93)90158-N; Scanziani M, 2000, NEURON, V25, P673, DOI 10.1016/S0896-6273(00)81069-7; Schmitz D, 2000, NEURON, V27, P327, DOI 10.1016/S0896-6273(00)00040-4; Semyanov A, 2000, NEURON, V25, P663, DOI 10.1016/S0896-6273(00)81068-5; Shimamoto K, 1998, MOL PHARMACOL, V53, P195, DOI 10.1124/mol.53.2.195; Silver RA, 1996, J PHYSIOL-LONDON, V494, P231, DOI 10.1113/jphysiol.1996.sp021487; SPRUSTON N, 1995, J PHYSIOL-LONDON, V482, P325, DOI 10.1113/jphysiol.1995.sp020521; TAKAHASHI M, 1995, J NEUROSCI, V15, P5693; TONG G, 1994, NEURON, V13, P1195, DOI 10.1016/0896-6273(94)90057-4; TONG G, 1994, NEURON, V12, P51, DOI 10.1016/0896-6273(94)90151-1; Ventura R, 1999, J NEUROSCI, V19, P6897, DOI 10.1523/JNEUROSCI.19-16-06897.1999; Vogt KE, 1999, P NATL ACAD SCI USA, V96, P1118, DOI 10.1073/pnas.96.3.1118	34	202	205	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2002	5	4					325	331		10.1038/nn825	http://dx.doi.org/10.1038/nn825			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	534UQ	11896395				2022-12-17	WOS:000174606900012
J	Rosenbaum, RS; Priselac, S; Kohler, S; Black, SE; Gao, FQ; Nadel, L; Moscovitch, M				Rosenbaum, RS; Priselac, S; Kohler, S; Black, SE; Gao, FQ; Nadel, L; Moscovitch, M			Remote spatial memory in an amnesic person with extensive bilateral hippocampal lesions	NATURE NEUROSCIENCE			English	Article							PURE TOPOGRAPHICAL DISORIENTATION; RETROGRADE-AMNESIA; COGNITIVE MAPS; PATIENT; RECALL	The hippocampus may have a time-limited role in memory, being needed only until information is permanently stored elsewhere, or this region may permanently represent long-term allocentric spatial information or cognitive maps in memory. To test these ideas, we investigated remote spatial memory in K.C., a patient with bilateral hippocampal lesions and amnesia for autobiographical events. In his spatial knowledge, general aspects were preserved, but details were lost, a pattern that resembled his memory loss in other domains. K.C. performed normally on allocentric spatial tests of his neighborhood and the world. He had difficulty, however, in recognizing and identifying non-salient neighborhood landmarks, and in recognizing city locations on world maps. This suggests that the hippocampus is not crucial for maintenance and retrieval of remotely formed spatial representations of major landmarks, routes, distances and directions, but is necessary for specifying location details, regardless of when they were acquired.	Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; McGill Univ, Montreal Neurol Inst, Cognit Neurosci Unit, Montreal, PQ H3A 2B4, Canada; Sunnybrook & Womens Coll Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada; Univ Arizona, Dept Psychol & Neural Syst, Memory & Aging Div, Tucson, AZ 85721 USA; Baycrest Ctr Geriatr Care, Rotman Res Inst, Toronto, ON M6A 2E1, Canada; Baycrest Ctr Geriatr Care, Dept Psychol, Toronto, ON M6A 2E1, Canada	University of Toronto; McGill University; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Arizona; University of Toronto; University Toronto Affiliates; Baycrest; University of Toronto; University Toronto Affiliates; Baycrest	Rosenbaum, RS (corresponding author), Univ Toronto, Dept Psychol, 100 St George St, Toronto, ON M5S 1A1, Canada.	shayna@psych.utoronot.ca; momos@credit.erin.uto	Black, Sandra E./C-7294-2011	Black, Sandra/0000-0001-7093-8289; Kohler, Stefan/0000-0003-1905-6453				Aguirre GK, 1999, BRAIN, V122, P1613, DOI 10.1093/brain/122.9.1613; BEATTY WW, 1987, PSYCHOL MED, V17, P657, DOI 10.1017/S0033291700025897; BEATTY WW, 1988, J CLIN PSYCHOL, V44, P61, DOI 10.1002/1097-4679(198801)44:1<61::AID-JCLP2270440113>3.0.CO;2-Y; Bohbot VD, 1998, NEUROPSYCHOLOGIA, V36, P1217, DOI 10.1016/S0028-3932(97)00161-9; Camalleri R, 1996, NEUROPSYCHOLOGIA, V34, P321, DOI 10.1016/0028-3932(95)00108-5; DERENZI E, 1985, HDB CLIN NEUROLOGY, V1, P405; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; FUJII T, IN PRESS HDB NEUROPS, V4; Golledge RG, 1985, J ENVIRON PSYCHOL, V5, P125, DOI DOI 10.1016/S0272-4944(85)80014-1; HABIB M, 1987, CORTEX, V23, P73, DOI 10.1016/S0010-9452(87)80020-5; Katayama K, 1999, CORTEX, V35, P279, DOI 10.1016/S0010-9452(08)70801-3; Kubie JL, 1999, PSYCHOBIOLOGY, V27, P313; Maguire EA, 1996, P ROY SOC B-BIOL SCI, V263, P1745, DOI 10.1098/rspb.1996.0255; Maguire EA, 1997, J NEUROSCI, V17, P7103; MILNER B, 1965, NEUROPSYCHOLOGIA, V3, P317, DOI 10.1016/0028-3932(65)90005-9; MILNER B, 1968, NEUROPSYCHOLOGIA, V6, P215, DOI 10.1016/0028-3932(68)90021-3; Moscovitch M, 2000, MEMORY, CONSCIOUSNESS, AND THE BRAIN, P331; Nadel L, 1997, CURR OPIN NEUROBIOL, V7, P217, DOI 10.1016/S0959-4388(97)80010-4; Nadel L, 1998, NEUROPHARMACOLOGY, V37, P431, DOI 10.1016/S0028-3908(98)00057-4; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Pearce JM, 1998, NATURE, V396, P75, DOI 10.1038/23941; Riedel G, 1999, NAT NEUROSCI, V2, P898, DOI 10.1038/13202; SMITH ML, 1981, NEUROPSYCHOLOGIA, V19, P781, DOI 10.1016/0028-3932(81)90090-7; SMITH ML, 1988, BRAIN COGNITION, V7, P178, DOI 10.1016/0278-2626(88)90028-0; Suzuki K, 1998, CORTEX, V34, P589, DOI 10.1016/S0010-9452(08)70516-1; Teng E, 1999, NATURE, V400, P675, DOI 10.1038/23276; TOLMAN EC, 1948, PSYCHOL REV, V55, P189, DOI 10.1037/h0061626; TULVING E, 1991, J EXP PSYCHOL LEARN, V17, P595, DOI 10.1037/0278-7393.17.4.595; TULVING E, 1988, BRAIN COGNITION, V8, P3, DOI 10.1016/0278-2626(88)90035-8; WESTMACOTT R, IN PRESS NEUROCASE; ZOLAMORGAN S, 1986, J NEUROSCI, V6, P2950	31	202	202	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2000	3	10					1044	1048		10.1038/79867	http://dx.doi.org/10.1038/79867			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TW	11017178				2022-12-17	WOS:000167177500023
J	Whitney, D; Murakami, I				Whitney, D; Murakami, I			Latency difference, not spatial extrapolation	NATURE NEUROSCIENCE			English	Article							MOTION EXTRAPOLATION		Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA	Harvard University	Whitney, D (corresponding author), Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA.							Allik J, 1998, PSYCHOL SCI, V9, P135, DOI 10.1111/1467-9280.00025; GRZYWACZ NM, 1993, J NEUROPHYSIOL, V69, P2188, DOI 10.1152/jn.1993.69.6.2188; KHURANA B, 1995, NATURE, V378, P565; Nijhawan R, 1997, NATURE, V386, P66, DOI 10.1038/386066a0; NIJHAWAN R, 1994, NATURE, V370, P256, DOI 10.1038/370256b0; SNOWDEN RJ, 1989, VISION RES, V29, P1621, DOI 10.1016/0042-6989(89)90143-0	6	202	203	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	1998	1	8					656	657		10.1038/3659	http://dx.doi.org/10.1038/3659			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	144PR	10196580				2022-12-17	WOS:000077323400008
J	Ayata, P; Badimon, A; Strasburger, HJ; Duff, MK; Montgomery, SE; Loh, YHE; Ebert, A; Pimenova, AA; Ramirez, BR; Chan, AT; Sullivan, JM; Purushothaman, I; Scarpa, JR; Goate, AM; Busslinger, M; Shen, L; Losic, B; Schaefer, A				Ayata, Pinar; Badimon, Ana; Strasburger, Hayley J.; Duff, Mary Kaye; Montgomery, Sarah E.; Loh, Yong-Hwee E.; Ebert, Anja; Pimenova, Anna A.; Ramirez, Brianna R.; Chan, Andrew T.; Sullivan, Josefa M.; Purushothaman, Immanuel; Scarpa, Joseph R.; Goate, Alison M.; Busslinger, Meinrad; Shen, Li; Losic, Bojan; Schaefer, Anne			Epigenetic regulation of brain region-specific microglia clearance activity	NATURE NEUROSCIENCE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; TRANSLATIONAL PROFILING APPROACH; PURKINJE NEURONS; CELL; RECEPTORS; MOUSE; DEGENERATION; MACROPHAGES; DYNAMICS; PROTEIN	The rapid elimination of dying neurons and nonfunctional synapses in the brain is carried out by microglia, the resident myeloid cells of the brain. Here we show that microglia clearance activity in the adult brain is regionally regulated and depends on the rate of neuronal attrition. Cerebellar, but not striatal or cortical, microglia exhibited high levels of basal clearance activity, which correlated with an elevated degree of cerebellar neuronal attrition. Exposing forebrain microglia to apoptotic cells activated gene-expression programs supporting clearance activity. We provide evidence that the polycomb repressive complex 2 (PRC2) epigenetically restricts the expression of genes that support clearance activity in striatal and cortical microglia. Loss of PRC2 leads to aberrant activation of a microglia clearance phenotype, which triggers changes in neuronal morphology and behavior. Our data highlight a key role of epigenetic mechanisms in preventing microglia-induced neuronal alterations that are frequently associated with neurodegenerative and psychiatric diseases.	[Ayata, Pinar; Badimon, Ana; Strasburger, Hayley J.; Duff, Mary Kaye; Montgomery, Sarah E.; Loh, Yong-Hwee E.; Pimenova, Anna A.; Ramirez, Brianna R.; Chan, Andrew T.; Sullivan, Josefa M.; Purushothaman, Immanuel; Goate, Alison M.; Shen, Li; Schaefer, Anne] Icahn Sch Med Mt Sinai, Friedman Brain Inst, Dept Psychiat, Fishberg Dept Neurosci, New York, NY 10029 USA; [Ayata, Pinar; Pimenova, Anna A.; Goate, Alison M.; Schaefer, Anne] Icahn Sch Med Mt Sinai, Ronald M Loeb Ctr Alzheimers Dis, New York, NY 10029 USA; [Ebert, Anja; Busslinger, Meinrad] Vienna Bioctr, Res Inst Mol Pathol, Vienna, Austria; [Scarpa, Joseph R.; Goate, Alison M.; Losic, Bojan] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Losic, Bojan] Icahn Sch Med Mt Sinai, Tisch Canc Inst, Canc Immunol Program, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Schaefer, A (corresponding author), Icahn Sch Med Mt Sinai, Friedman Brain Inst, Dept Psychiat, Fishberg Dept Neurosci, New York, NY 10029 USA.; Schaefer, A (corresponding author), Icahn Sch Med Mt Sinai, Ronald M Loeb Ctr Alzheimers Dis, New York, NY 10029 USA.	anne.schaefer@mssm.edu	Ramirez, Brianna/GRO-3627-2022; Busslinger, Meinrad/J-1249-2016	Montgomery, Sarah/0000-0002-4189-5416; Chan, Andrew/0000-0001-8477-2566; Ayata, Pinar/0000-0001-7621-832X; Busslinger, Meinrad/0000-0002-9111-9351; Pimenova, Anna/0000-0003-3342-8778	National Institutes of Health (NIH) [DP2 MH100012-01, R01NS091574, R21 MH115353, 1 RF1 AG054011-01]; JPB Foundation; NARSAD Young Investigator Award [25065]; Boehringer Ingelheim; Austrian Industrial Research Promotion Agency [FFG-852936, T32AG049688, F30MH106293]; Ruth L. Kirschstein NRSA fellowship [F31MH111147]; NATIONAL INSTITUTE OF MENTAL HEALTH [DP2MH100012, F31MH111147, F30MH106293, R21MH115353] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS091574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG049688, RF1AG054011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA025962, P01DA008227] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JPB Foundation; NARSAD Young Investigator Award(NARSAD); Boehringer Ingelheim(Boehringer Ingelheim); Austrian Industrial Research Promotion Agency; Ruth L. Kirschstein NRSA fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank D. Littman (NYU School of Medicine, NY) for Cx3cr1<SUP>CreErt2/+(Litt)</SUP> mice; N. Heintz (Rockefeller University, NY) for Tg(Prox1-Cre)SJ39 and Tg(Aldh1l1-eGFPL10a) mice; A. Domingos (Instituto Gulbenkian de Ciencia, PT) and J. Friedman (Rockefeller University, NY) for Eef1a1<SUP>LSL.eGFPL10a/+</SUP> mice; G. Lemke (Salk Institute, CA) for brain tissue from Axl<SUP>-/-</SUP> Mertk<SUP>-/-</SUP> mice; the Flow Cytometry CoRE at Icahn School of Medicine for cytometry assistance; I. Lemischka (Icahn School of Medicine, NY) for Fluidigm C1 use; O. Butovsky (Harvard Medical School, MA) for P2RY12 antibody; and J. W. Murray for ImageJ automation. We are very grateful to D. Schafer, E. Marcora, A. Tarakhovsky, J. W. Murray, and all Schaefer lab and Ronald M. Loeb Center members for helpful discussions and comments on the manuscript. This work was supported by the National Institutes of Health (NIH) Director New Innovator Award DP2 MH100012-01 (A.S.), R01NS091574 (A.S.), R21 MH115353 (A.S.), 1 RF1 AG054011-01 (A.M.G. and A.S.), JPB Foundation (A.M.G.), NARSAD Young Investigator Award #25065 (P.A.), Boehringer Ingelheim and the Austrian Industrial Research Promotion Agency FFG-852936 (M.B.), T32AG049688 (A.B.), F30MH106293 (J.R.S), and Ruth L. Kirschstein NRSA fellowship F31MH111147 (J.M.S).	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bennett ML, 2016, P NATL ACAD SCI USA, V113, pE1738, DOI 10.1073/pnas.1525528113; Bisht K, 2016, GLIA, V64, P826, DOI 10.1002/glia.22966; Blander JM, 2017, IMMUNOL REV, V277, P158, DOI 10.1111/imr.12537; Bohlen CJ, 2017, NEURON, V94, P759, DOI 10.1016/j.neuron.2017.04.043; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Buttgereit A, 2016, NAT IMMUNOL, V17, P1397, DOI 10.1038/ni.3585; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Cunningham CL, 2013, J NEUROSCI, V33, P4216, DOI 10.1523/JNEUROSCI.3441-12.2013; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; Deng L, 2010, AM J PATHOL, V176, P952, DOI 10.2353/ajpath.2010.090622; Denisenko O, 1998, MOL CELL BIOL, V18, P5634, DOI 10.1128/MCB.18.10.5634; Dickstein DL, 2013, NEUROSCIENCE, V251, P21, DOI 10.1016/j.neuroscience.2012.09.077; Dietmar R., 2002, NEUROLOGY, V58, P1791; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Dzhagalov IL, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001566; Elmore MRP, 2014, NEURON, V82, P380, DOI 10.1016/j.neuron.2014.02.040; Fourgeaud L, 2016, NATURE, V532, P240, DOI 10.1038/nature17630; Friedman D, 2012, CNS NEUROSCI THER, V18, P285, DOI 10.1111/j.1755-5949.2011.00251.x; Fujii S, 2012, BIOCHEM BIOPH RES CO, V417, P1074, DOI 10.1016/j.bbrc.2011.12.099; Galluzzi L, 2017, EMBO J, V36, P1811, DOI 10.15252/embj.201796697; GENSAT, 2003, N01NS02331 NINDS GEN; Goldmann T, 2016, NAT IMMUNOL, V17, P797, DOI 10.1038/ni.3423; Grabert K, 2016, NAT NEUROSCI, V19, P504, DOI 10.1038/nn.4222; Gyorffy BA, 2018, P NATL ACAD SCI USA, V115, P6303, DOI 10.1073/pnas.1722613115; Heckmann BL, 2017, J MOL BIOL, V429, P3561, DOI 10.1016/j.jmb.2017.08.012; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Heiman M, 2014, NAT PROTOC, V9, P1282, DOI 10.1038/nprot.2014.085; Holtman IR, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0203-5; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Howe EA, 2011, BIOINFORMATICS, V27, P3209, DOI 10.1093/bioinformatics/btr490; Huntley RP, 2015, NUCLEIC ACIDS RES, V43, pD1057, DOI 10.1093/nar/gku1113; Jadhav U, 2016, CELL, V165, P1389, DOI 10.1016/j.cell.2016.04.031; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kim D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r72; Kohno H, 2013, J BIOL CHEM, V288, P15326, DOI 10.1074/jbc.M112.448712; Krasemann S, 2017, IMMUNITY, V47, P566, DOI 10.1016/j.immuni.2017.08.008; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Kruidenier L, 2012, NATURE, V488, P404, DOI 10.1038/nature11262; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LeComte MD, 2015, P NATL ACAD SCI USA, V112, P8726, DOI 10.1073/pnas.1501029112; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liu X, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1081-0; Liu ZT, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12603; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Madry C, 2015, J BIOL CHEM, V290, P12443, DOI 10.1074/jbc.R115.637157; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Mass E, 2017, NATURE, V549, P389, DOI 10.1038/nature23672; Mass E, 2016, SCIENCE, V353, DOI 10.1126/science.aaf4238; Matcovitch-Natan O, 2016, SCIENCE, V353, DOI 10.1126/science.aad8670; Mathys H, 2017, CELL REP, V21, P366, DOI 10.1016/j.celrep.2017.09.039; Maze I, 2010, SCIENCE, V327, P213, DOI 10.1126/science.1179438; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; MENSAH PL, 1982, EXP BRAIN RES, V47, P57; Miyamoto A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12540; Montgomery ND, 2005, CURR BIOL, V15, P942, DOI 10.1016/j.cub.2005.04.051; Mortera P, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00045; Moyon S, 2016, CELL REP, V15, P748, DOI 10.1016/j.celrep.2016.03.060; Nestler Eric J, 2005, Sci Pract Perspect, V3, P4; Neumann H, 2009, BRAIN, V132, P288, DOI 10.1093/brain/awn109; O'Banion KM, 1994, SEMIN NEUROSCI, V6, P307; Paolicelli Rosa C, 2017, Front Synaptic Neurosci, V9, P9, DOI 10.3389/fnsyn.2017.00009; Paolino A, 2018, J NEUROSCI METH, V293, P45, DOI 10.1016/j.jneumeth.2017.09.004; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Przanowski P, 2014, J MOL MED, V92, P239, DOI 10.1007/s00109-013-1090-5; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Rehli M, 2005, J IMMUNOL, V174, P7111, DOI 10.4049/jimmunol.174.11.7111; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2008, BIOSTATISTICS, V9, P321, DOI 10.1093/biostatistics/kxm030; Robinson MD, 2007, BIOINFORMATICS, V23, P2881, DOI 10.1093/bioinformatics/btm453; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roszer T, 2013, TRENDS ENDOCRIN MET, V24, P460, DOI 10.1016/j.tem.2013.04.004; Rothhammer V, 2018, NATURE, V557, P724, DOI 10.1038/s41586-018-0119-x; Saura J, 2003, GLIA, V44, P183, DOI 10.1002/glia.10274; Schaefer A, 2007, J EXP MED, V204, P1553, DOI 10.1084/jem.20070823; Schaefer A, 2009, NEURON, V64, P678, DOI 10.1016/j.neuron.2009.11.019; Schumacher A, 1996, NATURE, V384, P648, DOI 10.1038/384648a0; Shao N. - Y., 2016, REGION ANAL PYTHON P; Shen L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-284; Song J, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a018937; Souroullas GP, 2016, NAT MED, V22, P632, DOI 10.1038/nm.4092; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stanley S, 2013, CELL METAB, V18, P596, DOI 10.1016/j.cmet.2013.09.002; Stephan AH, 2013, J NEUROSCI, V33, P13460, DOI 10.1523/JNEUROSCI.1333-13.2013; Stowell RD, 2018, DEV NEUROBIOL, V78, P627, DOI 10.1002/dneu.22572; Sullivan JM, 2015, J EXP MED, V212, P1771, DOI 10.1084/jem.20151271; Sun H, 2015, J CELL MOL MED, V19, P836, DOI 10.1111/jcmm.12521; Swigut T, 2007, CELL, V131, P29, DOI 10.1016/j.cell.2007.09.026; Tan CL, 2013, SCIENCE, V342, P1254, DOI 10.1126/science.1244193; Tee WW, 2014, CELL, V156, P678, DOI 10.1016/j.cell.2014.01.009; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Tufail Y, 2017, NEURON, V93, P574, DOI 10.1016/j.neuron.2016.12.021; von Schimmelmann M, 2016, NAT NEUROSCI, V19, P1321, DOI 10.1038/nn.4360; Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049; Wei SW, 2010, J LEUKOCYTE BIOL, V88, P495, DOI 10.1189/jlb.1209822; Willen K, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0203-y; Woodruff-Pak DS, 2010, P NATL ACAD SCI USA, V107, P1624, DOI 10.1073/pnas.0914207107; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao XF, 2018, CELL REP, V22, P2080, DOI 10.1016/j.celrep.2018.02.004; Zhou XB, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku310	107	201	203	3	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2018	21	8					1049	+		10.1038/s41593-018-0192-3	http://dx.doi.org/10.1038/s41593-018-0192-3			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HL5RP	30038282	Green Accepted			2022-12-17	WOS:000458787900001
J	Mahn, M; Prigge, M; Ron, S; Levy, R; Yizhar, O				Mahn, Mathias; Prigge, Matthias; Ron, Shiri; Levy, Rivka; Yizhar, Ofer			Biophysical constraints of optogenetic inhibition at presynaptic terminals	NATURE NEUROSCIENCE			English	Article							SYNAPTIC ACTIVITY; CHLORIDE CHANNEL; INTRACELLULAR PH; CHANNELRHODOPSIN; TRANSMISSION; VECTORS; NEURONS	We investigated the efficacy of optogenetic inhibition at presynaptic terminals using halorhodopsin, archaerhodopsin and chloride-conducting channelrhodopsins. Precisely timed activation of both archaerhodopsin and halorhodpsin at presynaptic terminals attenuated evoked release. However, sustained archaerhodopsin activation was paradoxically associated with increased spontaneous release. Activation of chloride-conducting channelrhodopsins triggered neurotransmitter release upon light onset. Thus, the biophysical properties of presynaptic terminals dictate unique boundary conditions for optogenetic manipulation.	[Mahn, Mathias; Prigge, Matthias; Ron, Shiri; Levy, Rivka; Yizhar, Ofer] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Yizhar, O (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	ofer.yizhar@weizmann.ac.il	YIZHAR, OFER/AAV-8497-2021	Mahn, Mathias/0000-0002-8951-1530; Yizhar, Ofer/0000-0003-4228-1448	Human Frontier Science Program; I-CORE program of the Planning and Budgeting Committee; Israel Science Foundation [51/11, 1351/12]; European Research Council [337637]; Adelis Foundation; Lord Sieff of Brimpton Memorial Fund; Candice Appleton Family Trust; Gertrude and Philip Nollman Career Development Chair	Human Frontier Science Program(Human Frontier Science Program); I-CORE program of the Planning and Budgeting Committee; Israel Science Foundation(Israel Science Foundation); European Research Council(European Research Council (ERC)European Commission); Adelis Foundation; Lord Sieff of Brimpton Memorial Fund; Candice Appleton Family Trust; Gertrude and Philip Nollman Career Development Chair	We thank M. Segal (Weizmann Institute of Science) for discussions and reagents. We thank R. Zwang for help with cloning. We thank Y.Ziv, L. Fenno, I. Lampl, R. Paz and the Yizhar laboratory members for comments on the manuscript. We acknowledge support (to O.Y.) from the Human Frontier Science Program, the I-CORE program of the Planning and Budgeting Committee and the Israel Science Foundation (I-CORE grant no. 51/11, ISF grant no. 1351/12), a European Research Council starting grant (ERC-2013-StG OptoNeuromod 337637), the Adelis Foundation, the Lord Sieff of Brimpton Memorial Fund and the Candice Appleton Family Trust. O.Y. is supported by the Gertrude and Philip Nollman Career Development Chair.	Berndt A, 2014, SCIENCE, V344, P420, DOI 10.1126/science.1252367; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chen YH, 1998, J NEUROSCI, V18, P2982; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Chuong AS, 2014, NAT NEUROSCI, V17, P1123, DOI 10.1038/nn.3752; Cosentino C, 2015, SCIENCE, V348, P707, DOI 10.1126/science.aaa2787; Dreosti E, 2009, NAT METHODS, V6, P883, DOI 10.1038/nmeth.1399; Fenno LE, 2014, NAT METHODS, V11, P763, DOI [10.1038/NMETH.2996, 10.1038/nmeth.2996]; Fino E, 2011, NEURON, V69, P1188, DOI 10.1016/j.neuron.2011.02.025; FLETCHER TL, 1991, J NEUROSCI, V11, P1617; Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022; Govorunova EG, 2015, SCIENCE, V349, P647, DOI 10.1126/science.aaa7484; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Grimm D, 2003, MOL THER, V7, P839, DOI 10.1016/S1525-0016(03)00095-9; Grunwald D, 2008, NAT PROTOC, V3, P1809, DOI 10.1038/nprot.2008.180; Mattis J, 2012, NAT METHODS, V9, P159, DOI [10.1038/NMETH.1808, 10.1038/nmeth.1808]; Price GD, 2006, J NEUROSCI, V26, P11432, DOI 10.1523/JNEUROSCI.1660-06.2006; Pugh JR, 2011, J NEUROSCI, V31, P565, DOI 10.1523/JNEUROSCI.4506-10.2011; Raimondo JV, 2012, NAT NEUROSCI, V15, P1102, DOI 10.1038/nn.3143; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Spellman T, 2015, NATURE, V522, P309, DOI 10.1038/nature14445; Stuber GD, 2011, NATURE, V475, P377, DOI 10.1038/nature10194; Tombaugh GC, 1997, J NEUROPHYSIOL, V77, P639, DOI 10.1152/jn.1997.77.2.639; Turecek R, 2001, NATURE, V411, P587, DOI 10.1038/35079084; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; Wietek J, 2014, SCIENCE, V344, P409, DOI 10.1126/science.1249375; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	27	201	204	2	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2016	19	4					554	+		10.1038/nn.4266	http://dx.doi.org/10.1038/nn.4266			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DH6OI	26950004	Green Accepted			2022-12-17	WOS:000372909800009
J	Wimmer, K; Nykamp, DQ; Constantinidis, C; Compte, A				Wimmer, Klaus; Nykamp, Duane Q.; Constantinidis, Christos; Compte, Albert			Bump attractor dynamics in prefrontal cortex explains behavioral precision in spatial working memory	NATURE NEUROSCIENCE			English	Article							IRREGULAR PERSISTENT ACTIVITY; VISUAL AREA MT; CORTICAL-NEURONS; MACAQUE; INFORMATION; MECHANISMS; MONKEYS; TASKS; REPRESENTATIONS; INTERNEURONS	Prefrontal persistent activity during the delay of spatial working memory tasks is thought to maintain spatial location in memory. A 'bump attractor' computational model can account for this physiology and its relationship to behavior. However, direct experimental evidence linking parameters of prefrontal firing to the memory report in individual trials is lacking, and, to date, no demonstration exists that bump attractor dynamics underlies spatial working memory. We analyzed monkey data and found model-derived predictive relationships between the variability of prefrontal activity in the delay and the fine details of recalled spatial location, as evident in trial-to-trial imprecise oculomotor responses. Our results support a diffusing bump representation for spatial working memory instantiated in persistent prefrontal activity. These findings reinforce persistent activity as a basis for spatial working memory, provide evidence for a continuous prefrontal representation of memorized space and offer experimental support for bump attractor dynamics mediating cognitive tasks in the cortex.	[Wimmer, Klaus; Nykamp, Duane Q.; Compte, Albert] Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain; [Nykamp, Duane Q.] Univ Minnesota, Sch Math, Minneapolis, MN 55455 USA; [Constantinidis, Christos] Wake Forest Sch Med, Winston Salem, NC USA	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Minnesota System; University of Minnesota Twin Cities; Wake Forest University	Compte, A (corresponding author), Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain.	acompte@clinic.ub.es	Constantinidis, Christos/ABB-5760-2021; Wimmer, Klaus/L-1680-2017; Compte, Albert/A-2491-2009	Wimmer, Klaus/0000-0003-2973-3462; Compte, Albert/0000-0001-6594-6946; Constantinidis, Christos/0000-0001-7441-022X	Ministry of Economy and Competitiveness of Spain; European Regional Development Fund [BFU2009-09537]; National Science Foundation [NSF PHY11-25915, DMS-0847749]; German Research Foundation [Wi 3767/1-1]; Generalitat de Catalunya (PIV-DGR program); Tab Williams Family Endowment; Direct For Mathematical & Physical Scien [0847749] Funding Source: National Science Foundation	Ministry of Economy and Competitiveness of Spain(Spanish Government); European Regional Development Fund(European Commission); National Science Foundation(National Science Foundation (NSF)); German Research Foundation(German Research Foundation (DFG)); Generalitat de Catalunya (PIV-DGR program)(Generalitat de Catalunya); Tab Williams Family Endowment; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank M. Goldman, J. de la Rocha and A. Roxin for fruitful discussions. We wish to acknowledge the late P. Goldman-Rakic, in whose laboratory experimental data were collected. This work was funded by the Ministry of Economy and Competitiveness of Spain, the European Regional Development Fund (Ref: BFU2009-09537) and by the National Science Foundation (NSF PHY11-25915 and DMS-0847749). K. W. acknowledges funding from the German Research Foundation (research fellowship Wi 3767/1-1). D.Q.N. was supported by the Generalitat de Catalunya (PIV-DGR 2010 program). C. C. received support from the Tab Williams Family Endowment. The work was carried out at the Esther Koplowitz Centre and partly at the Kavli Institute for Theoretical Physics, and at the Centre de Recerca Matematica.	AMARI SI, 1977, BIOL CYBERN, V27, P77, DOI 10.1007/BF00337259; Amit DJ, 1997, NEURAL COMPUT, V9, P1071, DOI 10.1162/neco.1997.9.5.1071; Bair W, 2001, J NEUROSCI, V21, P1676, DOI 10.1523/JNEUROSCI.21-05-01676.2001; Balaguer-Ballester E, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002057; Barak O, 2010, J NEUROSCI, V30, P9424, DOI 10.1523/JNEUROSCI.1875-10.2010; Barbieri F, 2007, FRONT COMPUT NEUROSC, V1, DOI 10.3389/neuro.10.005.2007; BENYISHAI R, 1995, P NATL ACAD SCI USA, V92, P3844, DOI 10.1073/pnas.92.9.3844; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; Brody CD, 2003, CEREB CORTEX, V13, P1196, DOI 10.1093/cercor/bhg100; Brody CD, 2003, CURR OPIN NEUROBIOL, V13, P204, DOI 10.1016/S0959-4388(03)00050-3; Burak Y, 2012, P NATL ACAD SCI USA, V109, P17645, DOI 10.1073/pnas.1117386109; Churchland AK, 2011, NEURON, V69, P818, DOI 10.1016/j.neuron.2010.12.037; Cohen MR, 2008, NEURON, V60, P162, DOI 10.1016/j.neuron.2008.08.007; Compte A, 2000, CEREB CORTEX, V10, P910, DOI 10.1093/cercor/10.9.910; Compte A, 2003, J NEUROPHYSIOL, V90, P3441, DOI 10.1152/jn.00949.2002; Compte A, 2006, CEREB CORTEX, V16, P761, DOI 10.1093/cercor/bhj021; Constantinidis C, 2004, NEUROSCIENTIST, V10, P553, DOI 10.1177/1073858404268742; Constantinidis C, 2002, J NEUROPHYSIOL, V88, P3487, DOI 10.1152/jn.00188.2002; Constantinidis C, 2002, NAT NEUROSCI, V5, P175, DOI 10.1038/nn799; Constantinidis C, 2001, NAT NEUROSCI, V4, P311, DOI 10.1038/85179; Constantinidis C, 2001, J NEUROSCI, V21, P3646, DOI 10.1523/JNEUROSCI.21-10-03646.2001; Durstewitz D, 2000, NAT NEUROSCI, V3, P1184, DOI 10.1038/81460; Durstewitz D, 2010, NEURON, V66, P438, DOI 10.1016/j.neuron.2010.03.029; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; GNADT JW, 1988, EXP BRAIN RES, V70, P216; Goldman MS, 2009, NEURON, V61, P621, DOI 10.1016/j.neuron.2008.12.012; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Hansel D, 2013, J NEUROSCI, V33, P133, DOI 10.1523/JNEUROSCI.3455-12.2013; Hussar CR, 2012, J NEUROSCI, V32, P2747, DOI 10.1523/JNEUROSCI.5135-11.2012; Jin DZ, 2005, J NEUROPHYSIOL, V94, P4038, DOI 10.1152/jn.00571.2004; Jun JK, 2010, J NEUROSCI, V30, P916, DOI 10.1523/JNEUROSCI.2062-09.2010; Kilpatrick ZP, 2013, J NEUROSCI, V33, P18999, DOI 10.1523/JNEUROSCI.1641-13.2013; Kohn A, 2005, J NEUROSCI, V25, P3661, DOI 10.1523/JNEUROSCI.5106-04.2005; Leutgeb JK, 2005, NEURON, V48, P345, DOI 10.1016/j.neuron.2005.09.007; Machens CK, 2010, J NEUROSCI, V30, P350, DOI 10.1523/JNEUROSCI.3276-09.2010; Meyer T, 2007, CEREB CORTEX, V17, pI70, DOI 10.1093/cercor/bhm063; Meyers EM, 2008, J NEUROPHYSIOL, V100, P1407, DOI 10.1152/jn.90248.2008; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; Miller P, 2006, NEURAL COMPUT, V18, P1268, DOI 10.1162/neco.2006.18.6.1268; Mitchell JF, 2009, NEURON, V63, P879, DOI 10.1016/j.neuron.2009.09.013; Mongillo G, 2008, SCIENCE, V319, P1543, DOI 10.1126/science.1150769; Ploner CJ, 1998, EUR J NEUROSCI, V10, P794, DOI 10.1046/j.1460-9568.1998.00101.x; Ponce-Alvarez A, 2013, P NATL ACAD SCI USA, V110, P13162, DOI 10.1073/pnas.1300098110; Pouget A, 1998, NEURAL COMPUT, V10, P373, DOI 10.1162/089976698300017809; Renart A, 2003, NEURON, V38, P473, DOI 10.1016/S0896-6273(03)00255-1; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Shafi M, 2007, NEUROSCIENCE, V146, P1082, DOI 10.1016/j.neuroscience.2006.12.072; Wang XJ, 2001, TRENDS NEUROSCI, V24, P455, DOI 10.1016/S0166-2236(00)01868-3; WHITE JM, 1994, VISION RES, V34, P79, DOI 10.1016/0042-6989(94)90259-3; Wills TJ, 2005, SCIENCE, V308, P873, DOI 10.1126/science.1108905; WILSON HR, 1973, KYBERNETIK, V13, P55, DOI 10.1007/BF00288786; Wu S, 2008, NEURAL COMPUT, V20, P994, DOI 10.1162/neco.2008.10-06-378; Zaksas D, 2006, J NEUROSCI, V26, P11726, DOI 10.1523/JNEUROSCI.3420-06.2006	54	201	205	3	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2014	17	3					431	439		10.1038/nn.3645	http://dx.doi.org/10.1038/nn.3645			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AB8CA	24487232				2022-12-17	WOS:000332016500017
J	Lien, AD; Scanziani, M				Lien, Anthony D.; Scanziani, Massimo			Tuned thalamic excitation is amplified by visual cortical circuits	NATURE NEUROSCIENCE			English	Article							LATERAL GENICULATE-NUCLEUS; NEURONS IN-VIVO; ORIENTATION SELECTIVITY; SIMPLE CELLS; RECEPTIVE-FIELDS; FUNCTIONAL ARCHITECTURE; STRIATE CORTEX; CONNECTIONS; INPUT; SPECIFICITY	Cortical neurons in thalamic recipient layers receive excitation from the thalamus and the cortex. The relative contribution of these two sources of excitation to sensory tuning is poorly understood. We optogenetically silenced the visual cortex of mice to isolate thalamic excitation onto layer 4 neurons during visual stimulation. Thalamic excitation contributed to a third of the total excitation and was organized in spatially offset, yet overlapping, ON and OFF receptive fields. This receptive field structure predicted the orientation tuning of thalamic excitation. Finally, both thalamic and total excitation were similarly tuned to orientation and direction and had the same temporal phase relationship to the visual stimulus. Our results indicate that tuning of thalamic excitation is unlikely to be imparted by direction- or orientation-selective thalamic neurons and that a principal role of cortical circuits is to amplify tuned thalamic excitation.	[Lien, Anthony D.; Scanziani, Massimo] Univ Calif San Diego, Grad Program Neurosci, La Jolla, CA 92093 USA; [Lien, Anthony D.; Scanziani, Massimo] Univ Calif San Diego, Ctr Neural Circuits & Behav, Neurobiol Sect, La Jolla, CA 92093 USA; [Lien, Anthony D.; Scanziani, Massimo] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Lien, Anthony D.; Scanziani, Massimo] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego	Lien, AD (corresponding author), Univ Calif San Diego, Grad Program Neurosci, La Jolla, CA 92093 USA.	anthony.d.lien@gmail.com; massimo@ucsd.edu		Lien, Anthony/0000-0003-3989-3881	Gatsby charitable foundation; Brain and Behavior Research Foundation; Howard Hughes Medical Institute	Gatsby charitable foundation; Brain and Behavior Research Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank J. Evora for help with genotyping and mouse husbandry, J. Isaacson, E. Chichilnisky and the members of the Scanziani and Isaacson laboratories for helpful discussions of this project, and S. Olsen and K. Reinhold for help with dLGN recordings. This project was supported by the Gatsby charitable foundation, the Brain and Behavior Research Foundation and the Howard Hughes Medical Institute.	Adesnik H, 2012, NATURE, V490, P226, DOI 10.1038/nature11526; Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; Atallah BV, 2012, NEURON, V73, P159, DOI 10.1016/j.neuron.2011.12.013; Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; Bosking WH, 1997, J NEUROSCI, V17, P2112; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brecht M, 2002, J PHYSIOL-LONDON, V543, P49, DOI 10.1113/jphysiol.2002.018465; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; CHAPMAN B, 1991, J NEUROSCI, V11, P1347; Chung S, 1998, NEURON, V20, P1177, DOI 10.1016/S0896-6273(00)80498-5; Cudeiro J, 2006, TRENDS NEUROSCI, V29, P298, DOI 10.1016/j.tins.2006.05.002; Ferster D, 1996, NATURE, V380, P249, DOI 10.1038/380249a0; GILBERT CD, 1989, J NEUROSCI, V9, P2432; Grubb MS, 2003, J NEUROPHYSIOL, V90, P3594, DOI 10.1152/jn.00699.2003; Haider B, 2013, NATURE, V493, P97, DOI 10.1038/nature11665; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Jia HB, 2010, NATURE, V464, P1307, DOI 10.1038/nature08947; Jin JZ, 2011, NAT NEUROSCI, V14, P232, DOI 10.1038/nn.2729; Kitamura K, 2008, NAT METHODS, V5, P61, DOI 10.1038/NMETH1150; Ko H, 2011, NATURE, V473, P87, DOI 10.1038/nature09880; Lampl I, 2001, NEURON, V30, P263, DOI 10.1016/S0896-6273(01)00278-1; Lien AD, 2011, FRONT NEURAL CIRCUIT, V5, DOI 10.3389/fncir.2011.00016; Liu BH, 2007, NAT NEUROSCI, V10, P1594, DOI 10.1038/nn2012; Liu BH, 2011, NEURON, V71, P542, DOI 10.1016/j.neuron.2011.06.017; Liu BH, 2010, NAT NEUROSCI, V13, P89, DOI 10.1038/nn.2443; MALACH R, 1993, P NATL ACAD SCI USA, V90, P10469, DOI 10.1073/pnas.90.22.10469; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; Marshel JH, 2012, NEURON, V76, P713, DOI 10.1016/j.neuron.2012.09.021; Marshel JH, 2010, NEURON, V67, P562, DOI 10.1016/j.neuron.2010.08.001; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; NELSON S, 1994, SCIENCE, V265, P774, DOI 10.1126/science.8047882; Niell CM, 2010, NEURON, V65, P472, DOI 10.1016/j.neuron.2010.01.033; Olsen SR, 2012, NATURE, V483, P47, DOI 10.1038/nature10835; Piscopo DM, 2013, J NEUROSCI, V33, P4642, DOI 10.1523/JNEUROSCI.5187-12.2013; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Ringach DL, 2002, J NEUROSCI, V22, P5639; Swindale NV, 1998, BIOL CYBERN, V78, P45, DOI 10.1007/s004220050411; Usrey WM, 2000, J NEUROSCI, V20, P5461, DOI 10.1523/JNEUROSCI.20-14-05461.2000	39	201	202	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2013	16	9					1315	U207		10.1038/nn.3488	http://dx.doi.org/10.1038/nn.3488			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	207KN	23933748	Green Accepted, Green Submitted			2022-12-17	WOS:000323597500024
J	Huberfeld, G; de la Prida, LM; Pallud, J; Cohen, I; Le Van Quyen, M; Adam, C; Clemenceau, S; Baulac, M; Miles, R				Huberfeld, Gilles; de la Prida, Liset Menendez; Pallud, Johan; Cohen, Ivan; Le Van Quyen, Michel; Adam, Claude; Clemenceau, Stephane; Baulac, Michel; Miles, Richard			Glutamatergic pre-ictal discharges emerge at the transition to seizure in human epilepsy	NATURE NEUROSCIENCE			English	Article							TEMPORAL-LOBE EPILEPSY; RAT HIPPOCAMPAL SLICE; SYSTEM IN-VITRO; EPILEPTIFORM ACTIVITY; MOUSE HIPPOCAMPUS; LIMBIC NETWORKS; DENTATE GYRUS; NEURONS; CORTEX; PROPAGATION	The mechanisms involved in the transition to an epileptic seizure remain unclear. To examine them, we used tissue slices from human subjects with mesial temporal lobe epilepsies. Ictal-like discharges were induced in the subiculum by increasing excitability along with alkalinization or low Mg2+. During the transition, distinct pre-ictal discharges emerged concurrently with interictal events. Intracranial recordings from the mesial temporal cortex of subjects with epilepsy revealed that similar discharges before seizures were restricted to seizure onset sites. In vitro, pre-ictal events spread faster and had larger amplitudes than interictal discharges and had a distinct initiation site. These events depended on glutamatergic mechanisms and were preceded by pyramidal cell firing, whereas interneuron firing preceded interictal events that depended on both glutamatergic and depolarizing GABAergic transmission. Once established, recurrence of these pre-ictal discharges triggered seizures. Thus, the subiculum supports seizure generation, and the transition to seizure involves an emergent glutamatergic population activity.	[Huberfeld, Gilles; de la Prida, Liset Menendez; Pallud, Johan; Cohen, Ivan; Clemenceau, Stephane; Baulac, Michel; Miles, Richard] Univ Paris 06, Inst Cerveau & Moelle Epiniere, Ctr Natl Rech Sci CNRS, Ctr Rech,INSERM,UMRS975,UMR7225, Paris, France; [Huberfeld, Gilles; Adam, Claude; Clemenceau, Stephane; Baulac, Michel] Ctr Hosp Univ Pitie Salpetriere, AP HP, Unite Epileptol, Paris, France; [Huberfeld, Gilles] UPMC, Dept Neurophysiol, Ctr Hosp Univ Pitie Salptriere, Paris, France; [de la Prida, Liset Menendez] CSIC, Lab Circuitos Neuronales, Inst Cajal, Madrid, Spain; [Pallud, Johan] Univ Paris 05, Serv Neurochirurg, Ctr Hosp Ste Anne, Paris, France; [Le Van Quyen, Michel] UPMC, Network Dynam & Cellular Excitabil, Ctr Rech Inst Cerveau & Moelle Epiniere, INSERM,CNRS,UMRS975,UMR7225, Paris, France; [Clemenceau, Stephane] Ctr Hosp Univ Pitie Salpetriere, AP HP, Serv Neurochirurg, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); GHU PARIS Psychiatrie Neurosciences; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Huberfeld, G (corresponding author), Univ Paris 06, Inst Cerveau & Moelle Epiniere, Ctr Natl Rech Sci CNRS, Ctr Rech,INSERM,UMRS975,UMR7225, Paris, France.	gilles.huberfeld@upmc.fr; richard.miles@upmc.fr	de la Prida, Liset M/O-1342-2013	de la Prida, Liset M/0000-0002-0160-6472; Cohen, Ivan/0000-0001-6046-5289; Miles, Richard/0000-0001-7303-0233; Pallud, Johan/0000-0002-1652-9844	INSERM; CNRS; AP-HP; Federation pour la Recherche Medicale; Federation pour la Recherche sur le Cerveau; Agence Nationale de la Recherche; European Community (EPICURE) [LSH-037315]; Spain-France Joint Action [HF2006-0082]; Spanish National Research Council (Consejo Superior de Investigaciones Cientificas) [200720I023]; Spanish Ministry of Innovation and Science [BFU2006-10584-BFI, BFU2009-07989]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); AP-HP; Federation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Federation pour la Recherche sur le Cerveau; Agence Nationale de la Recherche(French National Research Agency (ANR)); European Community (EPICURE)(European Commission); Spain-France Joint Action; Spanish National Research Council (Consejo Superior de Investigaciones Cientificas); Spanish Ministry of Innovation and Science(Spanish Government)	We wish to thank M. Noulhiane for her help with imaging and statistics, M.-L. Tanguy for help with statistical analysis, E. Eugene for his technical assistance, M. Valderrama for software assistance and L. Wittner for participating in initial recordings. We gratefully acknowledge financial support from INSERM, the CNRS, the AP-HP, the Federation pour la Recherche Medicale, the Federation pour la Recherche sur le Cerveau, the Agence Nationale de la Recherche, the European Community (EPICURE, LSH-037315), Spain-France Joint Action (HF2006-0082), the Spanish National Research Council (Consejo Superior de Investigaciones Cientificas 200720I023) and the Spanish Ministry of Innovation and Science (BFU2006-10584-BFI and BFU2009-07989).	ALGER BE, 1982, J PHYSIOL-LONDON, V328, P125, DOI 10.1113/jphysiol.1982.sp014256; Avoli M, 2002, PROG NEUROBIOL, V68, P167, DOI 10.1016/S0301-0082(02)00077-1; Avoli M, 1996, J NEUROSCI, V16, P3912; Bartho P, 2004, J NEUROPHYSIOL, V92, P600, DOI 10.1152/jn.01170.2003; Bartolomei F, 2005, EPILEPSIA, V46, P677, DOI 10.1111/j.1528-1167.2005.43804.x; Bartolomei F, 2004, EPILEPSY RES, V61, P89, DOI 10.1016/j.eplepsyres.2004.06.006; Bartolomei F, 2008, BRAIN, V131, P1818, DOI 10.1093/brain/awn111; Bragin A, 2005, EPILEPSIA, V46, P1592, DOI 10.1111/j.1528-1167.2005.00268.x; Bragin A, 2009, J NEUROSCI, V29, P3660, DOI 10.1523/JNEUROSCI.5309-08.2009; Chabardes S, 2005, BRAIN, V128, P1818, DOI 10.1093/brain/awh512; Chassoux F, 2008, EPILEPSIA, V49, P51, DOI 10.1111/j.1528-1167.2007.01267.x; CLARK KA, 1995, J PHYSIOL-LONDON, V482, P39, DOI 10.1113/jphysiol.1995.sp020498; Cohen I, 2002, SCIENCE, V298, P1418, DOI 10.1126/science.1076510; Cohen I, 2000, J PHYSIOL-LONDON, V524, P485, DOI 10.1111/j.1469-7793.2000.00485.x; D'Antuono M, 2004, BRAIN, V127, P1626, DOI 10.1093/brain/awh181; de Curtis M, 2001, PROG NEUROBIOL, V63, P541, DOI 10.1016/S0301-0082(00)00026-5; de la Prida LM, 2003, HIPPOCAMPUS, V13, P728, DOI 10.1002/hipo.10123; de la Prida LM, 2002, NEUROREPORT, V13, P1421, DOI 10.1097/00001756-200208070-00015; Derchansky M, 2008, J PHYSIOL-LONDON, V586, P477, DOI 10.1113/jphysiol.2007.143065; Derchansky M, 2004, HIPPOCAMPUS, V14, P935, DOI 10.1002/hipo.20007; Dzhala VI, 2003, J NEUROSCI, V23, P7873; Ebersole JS, 1996, EPILEPSIA, V37, P386, DOI 10.1111/j.1528-1157.1996.tb00577.x; Fabo D, 2008, BRAIN, V131, P485, DOI 10.1093/brain/awm297; Gabriel S, 2004, J NEUROSCI, V24, P10416, DOI 10.1523/JNEUROSCI.2074-04.2004; Gavaret M, 2004, J CLIN NEUROPHYSIOL, V21, P267, DOI 10.1097/01.WNP.0000139929.06455.82; Gnatkovsky V, 2008, ANN NEUROL, V64, P674, DOI 10.1002/ana.21519; Henze DA, 2000, J NEUROPHYSIOL, V84, P390, DOI 10.1152/jn.2000.84.1.390; Huberfeld G, 2007, J NEUROSCI, V27, P9866, DOI 10.1523/JNEUROSCI.2761-07.2007; Jandova K, 2006, BRAIN, V129, P3290, DOI 10.1093/brain/awl218; Jensen MS, 1997, J NEUROPHYSIOL, V77, P1224, DOI 10.1152/jn.1997.77.3.1224; Kaila K, 1997, J NEUROSCI, V17, P7662; Khalilov I, 2003, NAT NEUROSCI, V6, P1079, DOI 10.1038/nn1125; Lachaux JP, 2003, J PHYSIOLOGY-PARIS, V97, P613, DOI 10.1016/j.jphysparis.2004.01.018; Le Van Quyen M, 2007, TRENDS NEUROSCI, V30, P365, DOI 10.1016/j.tins.2007.05.006; LEHNERTZ K, 2007, EPILEPSY COMPREHENSI; McGonigal A, 2007, BRAIN, V130, P3169, DOI 10.1093/brain/awm218; MILES R, 1983, NATURE, V306, P371, DOI 10.1038/306371a0; MILES R, 1988, J NEUROPHYSIOL, V60, P1481, DOI 10.1152/jn.1988.60.4.1481; Pinault D, 1996, J NEUROSCI METH, V65, P113, DOI 10.1016/0165-0270(95)00144-1; Spencer SS, 1999, EPILEPSIA, V40, P708, DOI 10.1111/j.1528-1157.1999.tb00767.x; SPENCER SS, 1992, EPILEPSIA, V33, P537, DOI 10.1111/j.1528-1157.1992.tb01706.x; Staba RJ, 2004, ANN NEUROL, V56, P108, DOI 10.1002/ana.20164; STALEY KJ, 1995, SCIENCE, V269, P977, DOI 10.1126/science.7638623; TRAYNELIS SF, 1988, J NEUROPHYSIOL, V59, P259, DOI 10.1152/jn.1988.59.1.259; Trevelyan AJ, 2007, J NEUROSCI, V27, P3383, DOI 10.1523/JNEUROSCI.0145-07.2007; Trevelyan AJ, 2006, J NEUROSCI, V26, P12447, DOI 10.1523/JNEUROSCI.2787-06.2006; Van Quyen ML, 2008, J NEUROSCI, V28, P6104, DOI 10.1523/JNEUROSCI.0437-08.2008; Wennberg R, 2002, EPILEPSIA, V43, P716, DOI 10.1046/j.1528-1157.2002.31101.x; Wittner L, 2007, J PHYSIOL-LONDON, V584, P867, DOI 10.1113/jphysiol.2007.138131; Ziburkus J, 2006, J NEUROPHYSIOL, V95, P3948, DOI 10.1152/jn.01378.2005	50	201	202	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2011	14	5					627	U121		10.1038/nn.2790	http://dx.doi.org/10.1038/nn.2790			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	754VU	21460834	Green Submitted			2022-12-17	WOS:000289886600019
J	Lomber, SG; Malhotra, S				Lomber, Stephen G.; Malhotra, Shveta			Double dissociation of 'what' and 'where' processing in auditory cortex	NATURE NEUROSCIENCE			English	Article							VISUAL WORKING-MEMORY; SOUND-LOCALIZATION; COOLING DEACTIVATION; HEMISPHERIC LESIONS; CORTICAL PATHWAYS; COMPLEX SOUNDS; HUMAN BRAIN; CAT; FIELD; OBJECT	Studies of cortical connections or neuronal function in different cerebral areas support the hypothesis that parallel cortical processing streams, similar to those identified in visual cortex, may exist in the auditory system. However, this model has not yet been behaviorally tested. We used reversible cooling deactivation to investigate whether the individual regions in cat nonprimary auditory cortex that are responsible for processing the pattern of an acoustic stimulus or localizing a sound in space could be doubly dissociated in the same animal. We found that bilateral deactivation of the posterior auditory field resulted in deficits in a sound-localization task, whereas bilateral deactivation of the anterior auditory field resulted in deficits in a pattern-discrimination task, but not vice versa. These findings support a model of cortical organization that proposes that identifying an acoustic stimulus ('what') and its spatial location ('where') are processed in separate streams in auditory cortex.	[Lomber, Stephen G.] Univ Western Ontario, Ctr Brain & Mind, Schulich Sch Med & Dent, Dept Physiol & Pharmacol, London, ON N6A 5K8, Canada; [Lomber, Stephen G.] Univ Western Ontario, Fac Sch Sci, Dept Psychol, London, ON N6A 5C2, Canada; [Lomber, Stephen G.] Univ Western Ontario, Fac Hlth Sci, Natl Ctr Audiol, London, ON N6G 1H1, Canada; [Malhotra, Shveta] Univ Texas Dallas, Sch Behav & Brain Sci, Richardson, TX 75080 USA	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); University of Texas System; University of Texas Dallas	Lomber, SG (corresponding author), Univ Western Ontario, Ctr Brain & Mind, Schulich Sch Med & Dent, Dept Physiol & Pharmacol, London, ON N6A 5K8, Canada.	steve.lomber@uwo.ca	Lomber, Stephen/B-6820-2015	Lomber, Stephen/0000-0002-3001-7909				Ahveninen J, 2006, P NATL ACAD SCI USA, V103, P14608, DOI 10.1073/pnas.0510480103; Alain C, 2001, P NATL ACAD SCI USA, V98, P12301, DOI 10.1073/pnas.211209098; Arnott SR, 2004, NEUROIMAGE, V22, P401, DOI 10.1016/j.neuroimage.2004.01.014; Bullier Jean, 1994, Cerebral Cortex, V10, P301; Cavina-Pratesi C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000424; Clarke S, 2000, NEUROPSYCHOLOGIA, V38, P797, DOI 10.1016/S0028-3932(99)00141-4; Clarke S, 2002, EXP BRAIN RES, V147, P8, DOI 10.1007/s00221-002-1203-9; Courtney SM, 1996, CEREB CORTEX, V6, P39, DOI 10.1093/cercor/6.1.39; De Santis L, 2007, CEREB CORTEX, V17, P9, DOI 10.1093/cercor/bhj119; Goodale MA, 2004, CURR OPIN NEUROBIOL, V14, P203, DOI 10.1016/j.conb.2004.03.002; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; GOODALE MA, 1991, NATURE, V349, P154, DOI 10.1038/349154a0; Griffiths TD, 2004, NAT REV NEUROSCI, V5, P887, DOI 10.1038/nrn1538; Griffiths TD, 1998, NAT NEUROSCI, V1, P422, DOI 10.1038/1637; Heffner HE, 2005, J NEUROPHYSIOL, V94, P3653, DOI 10.1152/jn.00720.2005; Jones EG, 1985, THALAMUS; Kaas JH, 2000, P NATL ACAD SCI USA, V97, P11793, DOI 10.1073/pnas.97.22.11793; KELLY JB, 1971, J NEUROPHYSIOL, V34, P802, DOI 10.1152/jn.1971.34.5.802; KNIGHT PL, 1977, BRAIN RES, V130, P447, DOI 10.1016/0006-8993(77)90108-1; Krumbholz K, 2005, CEREB CORTEX, V15, P317, DOI 10.1093/cercor/bhh133; Lee CC, 2008, J COMP NEUROL, V507, P1879, DOI 10.1002/cne.21611; Loftus WC, 2001, J NEUROPHYSIOL, V86, P475, DOI 10.1152/jn.2001.86.1.475; Lomber SG, 1999, J NEUROSCI METH, V86, P179, DOI 10.1016/S0165-0270(98)00165-4; Lomber SG, 1996, CEREB CORTEX, V6, P673, DOI 10.1093/cercor/6.5.673; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Maeder PP, 2001, NEUROIMAGE, V14, P802, DOI 10.1006/nimg.2001.0888; Malhotra S, 2004, J NEUROPHYSIOL, V92, P1625, DOI 10.1152/jn.01205.2003; MISHKIN M, 1983, TRENDS NEUROSCI, V6, P414, DOI 10.1016/0166-2236(83)90190-X; MOREL A, 1987, J COMP NEUROL, V265, P119, DOI 10.1002/cne.902650109; MOREL A, 1990, VISUAL NEUROSCI, V4, P555, DOI 10.1017/S0952523800005769; Neff WD, 1975, HDB SENSORY PHYSIOLO, P307; Petrides M, 2000, J NEUROSCI, V20, P7496; PHILLIPS DP, 1995, J NEUROPHYSIOL, V73, P674, DOI 10.1152/jn.1995.73.2.674; Populin LC, 1998, J NEUROSCI, V18, P2147; Rauschecker JP, 1997, J COMP NEUROL, V382, P89; Rauschecker JP, 1998, AUDIOL NEURO-OTOL, V3, P86, DOI 10.1159/000013784; Rauschecker JP, 1997, ACTA OTO-LARYNGOL, P34; Rauschecker JP, 1998, CURR OPIN NEUROBIOL, V8, P516, DOI 10.1016/S0959-4388(98)80040-8; REALE RA, 1980, J COMP NEUROL, V192, P265, DOI 10.1002/cne.901920207; REINOSOSUAREZ F, 1961, TOPOGRAPHICAL ATLAS; Romanski LM, 1999, NAT NEUROSCI, V2, P1131, DOI 10.1038/16056; Stecker GC, 2003, J NEUROPHYSIOL, V89, P2889, DOI 10.1152/jn.00980.2002; Teuber HL, 1955, ANNU REV PSYCHOL, V6, P267, DOI 10.1146/annurev.ps.06.020155.001411; TIAN B, 1994, J NEUROPHYSIOL, V71, P1959, DOI 10.1152/jn.1994.71.5.1959; Tian B, 2001, SCIENCE, V292, P290, DOI 10.1126/science.1058911; Ungerleider Leslie G., 1994, Current Opinion in Neurobiology, V4, P157, DOI 10.1016/0959-4388(94)90066-3; UNGERLEIDER LG, 1982, ANAL VISUAL BEHAV, P486; Warrington E K, 1970, Cortex, V6, P87; Winters BD, 2004, J NEUROSCI, V24, P5901, DOI 10.1523/JNEUROSCI.1346-04.2004; Yang XF, 2006, NEUROBIOL DIS, V23, P637, DOI 10.1016/j.nbd.2006.05.006	50	201	203	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2008	11	5					609	616		10.1038/nn.2108	http://dx.doi.org/10.1038/nn.2108			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	293HV	18408717				2022-12-17	WOS:000255327300021
J	Jarsky, T; Roxin, A; Kath, WL; Spruston, N				Jarsky, T; Roxin, A; Kath, WL; Spruston, N			Conditional dendritic spike propagation following distal synaptic activation of hippocampal CA1 pyramidal neurons	NATURE NEUROSCIENCE			English	Article							ACTION-POTENTIAL INITIATION; CORTEX COMBINED SLICE; ENTORHINAL CORTEX; EXCITATORY SYNAPSES; IN-VITRO; AREA CA1; CELLS; RAT; BACKPROPAGATION; INPUTS	The perforant-path projection to the hippocampus forms synapses in the apical tuft of CA1 pyramidal neurons. We used computer modeling to examine the function of these distal synaptic inputs, which led to three predictions that we confirmed in experiments using rat hippocampal slices. First, activation of CA1 neurons by the perforant path is limited, a result of the long distance between these inputs and the soma. Second, activation of CA1 neurons by the perforant path depends on the generation of dendritic spikes. Third, the forward propagation of these spikes is unreliable, but can be facilitated by modest activation of Schaffer-collateral synapses in the upper apical dendrites. This 'gating' of dendritic spike propagation may be an important activation mode of CA1 pyramidal neurons, and its modulation by neurotransmitters or long-term, activity-dependent plasticity may be an important feature of dendritic integration during mnemonic processing in the hippocampus.	Northwestern Univ, Dept Neurobiol & Physiol, Inst Neurosci, Evanston, IL 60208 USA; Northwestern Univ, Dept Engn Sci & Appl Math, Evanston, IL 60208 USA; Univ Paris 05, CNRS, Unite Mixte Rech 8119, F-75270 Paris, France	Northwestern University; Northwestern University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Spruston, N (corresponding author), Northwestern Univ, Dept Neurobiol & Physiol, Inst Neurosci, 2205 Tech Dr, Evanston, IL 60208 USA.	spruston@northwestern.edu	Kath, William/B-6771-2009; Jarsky, Tim/S-1879-2019; Roxin, Alex/F-1742-2013	Spruston, Nelson/0000-0003-3118-1636; Kath, William/0000-0003-3867-4783; Roxin, Alex/0000-0003-1015-8138	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046064, F31NS045437, R01NS035180] Funding Source: NIH RePORTER; NINDS NIH HHS [NS-35180, NS-045437, NS-46064] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Amaral D G, 1993, Curr Opin Neurobiol, V3, P225, DOI 10.1016/0959-4388(93)90214-J; ANDERSEN P, 1987, J PHYSIOL-LONDON, V383, P509; ANDERSEN P, 1966, EXP BRAIN RES, V2, P247; Brun VH, 2002, SCIENCE, V296, P2243, DOI 10.1126/science.1071089; BUZSAKI G, 1995, HIPPOCAMPUS, V5, P141, DOI 10.1002/hipo.450050210; Cauller LJ, 1992, SINGLE NEURON COMPUT, P199; Colbert CM, 1996, J NEUROSCI, V16, P6676; COLBERT CM, 1992, J NEUROPHYSIOL, V68, P1; DESMOND NL, 1994, HIPPOCAMPUS, V4, P594, DOI 10.1002/hipo.450040509; DOLLER HJ, 1982, BRAIN RES, V237, P1, DOI 10.1016/0006-8993(82)90553-4; EMPSON RM, 1995, HIPPOCAMPUS, V5, P104, DOI 10.1002/hipo.450050203; EMPSON RM, 1995, J PHYSIOL-LONDON, V484, P707, DOI 10.1113/jphysiol.1995.sp020697; Fellous JM, 2003, NEUROSCIENCE, V122, P811, DOI 10.1016/j.neuroscience.2003.08.027; Frick A, 2004, NAT NEUROSCI, V7, P126, DOI 10.1038/nn1178; Gasparini S, 2004, J NEUROSCI, V24, P11046, DOI 10.1523/JNEUROSCI.2520-04.2004; Golding NL, 2002, NATURE, V418, P326, DOI 10.1038/nature00854; Golding NL, 2001, J NEUROPHYSIOL, V86, P2998, DOI 10.1152/jn.2001.86.6.2998; Golding NL, 1998, NEURON, V21, P1189, DOI 10.1016/S0896-6273(00)80635-2; GOLDSTEIN SS, 1974, BIOPHYS J, V14, P731, DOI 10.1016/S0006-3495(74)85947-3; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Johnston D, 1999, CURR OPIN NEUROBIOL, V9, P288, DOI 10.1016/S0959-4388(99)80042-7; Johnston D, 1996, ANNU REV NEUROSCI, V19, P165, DOI 10.1146/annurev.ne.19.030196.001121; Kamondi A, 1998, J NEUROSCI, V18, P3919; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Larkum ME, 2004, CEREB CORTEX, V14, P1059, DOI 10.1093/cercor/bhh065; LEVY WB, 1995, HIPPOCAMPUS, V5, P137, DOI 10.1002/hipo.450050209; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; MANOR Y, 1991, BIOPHYS J, V60, P1424, DOI 10.1016/S0006-3495(91)82179-8; MCNAUGHTON BL, 1989, EXP BRAIN RES, V76, P485, DOI 10.1007/BF00248904; Megias M, 2001, NEUROSCIENCE, V102, P527, DOI 10.1016/S0306-4522(00)00496-6; Migliore M, 1999, J COMPUT NEUROSCI, V7, P5, DOI 10.1023/A:1008906225285; PARE D, 1995, HIPPOCAMPUS, V5, P115, DOI 10.1002/hipo.450050205; Poirazi P, 2003, NEURON, V37, P977, DOI 10.1016/S0896-6273(03)00148-X; Remondes M, 2002, NATURE, V416, P736, DOI 10.1038/416736a; SOLTESZ I, 1995, HIPPOCAMPUS, V5, P120, DOI 10.1002/hipo.450050206; SPENCER WA, 1961, J NEUROPHYSIOL, V24, P272, DOI 10.1152/jn.1961.24.3.272; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; Stuart GJ, 2001, NAT NEUROSCI, V4, P63, DOI 10.1038/82910; WONG RKS, 1992, J PHYSIOL-LONDON, V457, P675, DOI 10.1113/jphysiol.1992.sp019401; YECKEL MF, 1995, HIPPOCAMPUS, V5, P108, DOI 10.1002/hipo.450050204; YECKEL MF, 1990, P NATL ACAD SCI USA, V87, P5832, DOI 10.1073/pnas.87.15.5832	44	201	202	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2005	8	12					1667	1676		10.1038/nn1599	http://dx.doi.org/10.1038/nn1599			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	988FC	16299501				2022-12-17	WOS:000233576200014
J	Le Grand, R; Mondloch, CJ; Maurer, D; Brent, HP				Le Grand, R; Mondloch, CJ; Maurer, D; Brent, HP			Expert face processing requires visual input to the right hemisphere during infancy	NATURE NEUROSCIENCE			English	Article							HUMAN FUSIFORM GYRUS; SPATIAL ATTENTION; DEPRIVATION; RECOGNITION; EXPERIENCE; PROSOPAGNOSIA; INFORMATION; INTEGRATION; ASYMMETRIES; PERCEPTION	Adult expertise in face processing is mediated largely by neural networks in the right hemisphere. Here we evaluate the contribution of early visual input in establishing this neural substrate. We compared visually normal individuals to patients for whom visual input had been restricted mainly to one hemisphere during infancy. We show that early deprivation of visual input to the right hemisphere severely impairs the development of expert face processing, whereas deprivation restricted mainly to the left hemisphere does not. Our results indicate that the neural circuitry responsible for adults' face expertise is not pre-specified, but requires early visual experience. However, the two hemispheres are not equipotent: only the right hemisphere is capable of using the early input to develop expertise at face processing.	McMaster Univ, Dept Psychol, Hamilton, ON L8S 4K1, Canada; Hosp Sick Children, Toronto, ON M5G 1X8, Canada	McMaster University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Maurer, D (corresponding author), McMaster Univ, Dept Psychol, 1280 Main St W, Hamilton, ON L8S 4K1, Canada.							Barton JJS, 2002, NEUROLOGY, V58, P71, DOI 10.1212/WNL.58.1.71; Bruce V., 1994, VIS COGN, V1, P141, DOI [DOI 10.1080/13506289408402299, 10.1080/13506289408402299]; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; de Schonen S., 1989, EUROPEAN B COGNITIVE, V9, P3; DERENZI E, 1994, NEUROPSYCHOLOGIA, V32, P893, DOI 10.1016/0028-3932(94)90041-8; Deruelle C, 1998, DEV NEUROPSYCHOL, V14, P535, DOI 10.1080/87565649809540727; DERUELLE C, 1991, BRAIN COGNITION, V16, P151, DOI 10.1016/0278-2626(91)90004-R; DERUELLE C, 1995, INFANT BEHAV DEV, V18, P123, DOI 10.1016/0163-6383(95)90042-X; DESCHONEN S, 1990, CHILD DEV, V61, P1192, DOI 10.2307/1130887; DIAMOND R, 1986, J EXP PSYCHOL GEN, V115, P107, DOI 10.1037/0096-3445.115.2.107; Ellemberg D, 2000, VISION RES, V40, P3283, DOI 10.1016/S0042-6989(00)00165-6; Farah MJ, 2000, COGNITIVE NEUROPSYCH, V17, P117, DOI 10.1080/026432900380526; Freire A, 2000, PERCEPTION, V29, P159, DOI 10.1068/p3012; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Geldart S, 2002, DEVELOPMENTAL SCI, V5, P490, DOI 10.1111/1467-7687.00242; GELDART S, 2000, THESIS MCMASTER U; George N, 1999, NAT NEUROSCI, V2, P574, DOI 10.1038/9230; Gitelman DR, 1999, BRAIN, V122, P1093, DOI 10.1093/brain/122.6.1093; GOLDBERG M, 1998, THESIS MCMASTER U; Goldberg MC, 2001, DEV NEUROPSYCHOL, V19, P53, DOI 10.1207/S15326942DN1901_5; Goldberg MC, 2001, DEVELOPMENTAL SCI, V4, P209, DOI 10.1111/1467-7687.00166; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Le Grand R, 2001, NATURE, V410, P890, DOI 10.1038/35073749; LeGrand R, 2001, NATURE, V412, P786; Lewis TL, 2002, VISION RES, V42, P939, DOI 10.1016/S0042-6989(02)00041-X; LEWIS TL, 1992, VISION RES, V32, P903, DOI 10.1016/0042-6989(92)90033-F; Liegeois F, 1997, NEUROPSYCHOLOGIA, V35, P381, DOI 10.1016/S0028-3932(96)00078-4; Liegeois F, 2000, NEUROPSYCHOLOGIA, V38, P1382, DOI 10.1016/S0028-3932(00)00041-5; MAUER D, 1989, APPL DEV PSYCHOL, V3, P108; Maurer D, 2002, TRENDS COGN SCI, V6, P255, DOI 10.1016/S1364-6613(02)01903-4; McCarthy G, 1997, J COGNITIVE NEUROSCI, V9, P605, DOI 10.1162/jocn.1997.9.5.605; Mondloch CJ, 2002, PERCEPTION, V31, P553, DOI 10.1068/p3339; MONDLOCH CJ, IN PRESS DEV FACE PR; Nobre AC, 1997, BRAIN, V120, P515, DOI 10.1093/brain/120.3.515; PASCALIS O, 1995, INFANT BEHAV DEV, V18, P79, DOI 10.1016/0163-6383(95)90009-8; Rossion B, 2000, J COGNITIVE NEUROSCI, V12, P793, DOI 10.1162/089892900562606; Sergent J., 1988, THOUGHT LANGUAGE, V108-131; Weliky M, 1999, SCIENCE, V285, P599, DOI 10.1126/science.285.5427.599	38	201	202	1	18	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2003	6	10					1108	1112		10.1038/nn1121	http://dx.doi.org/10.1038/nn1121			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	727AK	12958600				2022-12-17	WOS:000185633600024
J	Janata, P; Grafton, ST				Janata, P; Grafton, ST			Swinging in the brain: shared neural substrates for behaviors related to sequencing and music	NATURE NEUROSCIENCE			English	Review							SENSORIMOTOR SYNCHRONIZATION; AUDITORY SEQUENCES; ACTION REPERTOIRES; TEMPORAL PATTERNS; ACCENT PRODUCTION; PHASE CORRECTION; CAUDATE-NUCLEUS; BASAL GANGLIA; MOTOR CONTROL; TIME	Music consists of precisely patterned sequences of both movement and sound that engage the mind in a multitude of experiences. We move in response to music and we move in order to make music. Because of the intimate coupling between perception and action, music provides a panoramic window through which we can examine the neural organization of complex behaviors that are at the core of human nature. Although the cognitive neuroscience of music is still in its infancy, a considerable behavioral and neuroimaging literature has amassed that pertains to neural mechanisms that underlie musical experience. Here we review neuroimaging studies of explicit sequence learning and temporal production-findings that ultimately lay the groundwork for understanding how more complex musical sequences are represented and produced by the brain. These studies are also brought into an existing framework concerning the interaction of attention and time-keeping mechanisms in perceiving complex patterns of information that are distributed in time, such as those that occur in music.	Dartmouth Coll, Dept Psychol & Brain Sci, Ctr Cognit Neurosci, Hanover, NH 03755 USA	Dartmouth College	Janata, P (corresponding author), Dartmouth Coll, Dept Psychol & Brain Sci, Ctr Cognit Neurosci, Hanover, NH 03755 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS017778, R01NS033504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC005146] Funding Source: NIH RePORTER; NIDCD NIH HHS [R03 DC05146] Funding Source: Medline; NINDS NIH HHS [P50 NS17778-18, NS33504-10] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bapi RS, 2000, EXP BRAIN RES, V132, P149, DOI 10.1007/s002219900332; Barnes R, 2000, COGNITIVE PSYCHOL, V41, P254, DOI 10.1006/cogp.2000.0738; BILLON M, 1995, PSYCHOL RES-PSYCH FO, V58, P206, DOI 10.1007/BF00419635; Billon M, 1996, J MOTOR BEHAV, V28, P198, DOI 10.1080/00222895.1996.9941745; BOLTZ MG, 1993, PERCEPT PSYCHOPHYS, V53, P585, DOI 10.3758/BF03211736; Clegg BA, 1998, TRENDS COGN SCI, V2, P275, DOI 10.1016/S1364-6613(98)01202-9; Coull JT, 2000, NEUROPSYCHOLOGIA, V38, P808, DOI 10.1016/S0028-3932(99)00132-3; Coull JT, 1998, J NEUROSCI, V18, P7426; Drake C, 2000, COGNITION, V77, P251, DOI 10.1016/S0010-0277(00)00106-2; Drake C, 1998, MUSIC PERCEPT, V16, P11, DOI 10.2307/40285774; ESSENS PJ, 1985, PERCEPT PSYCHOPHYS, V37, P1, DOI 10.3758/BF03207132; Fuster JM, 2001, NEURON, V30, P319, DOI 10.1016/S0896-6273(01)00285-9; Ghahramani Z, 1997, NATURE, V386, P392, DOI 10.1038/386392a0; Graybiel AM, 1998, NEUROBIOL LEARN MEM, V70, P119, DOI 10.1006/nlme.1998.3843; Graybiel AM, 1995, CURR OPIN NEUROBIOL, V5, P733, DOI 10.1016/0959-4388(95)80100-6; Halpern AR, 1999, CEREB CORTEX, V9, P697, DOI 10.1093/cercor/9.7.697; HAZELTINE E, 2002, COMMON MECH PERCEPTI, V19; Ivry RB, 1996, CURR OPIN NEUROBIOL, V6, P851, DOI 10.1016/S0959-4388(96)80037-7; Ivry RB, 2002, BRAIN COGNITION, V48, P117, DOI 10.1006/brcg.2001.1308; Janata P, 2002, SCIENCE, V298, P2167, DOI 10.1126/science.1076262; Janata P, 2002, COGN AFFECT BEHAV NE, V2, P121, DOI 10.3758/CABN.2.2.121; Jog MS, 1999, SCIENCE, V286, P1745, DOI 10.1126/science.286.5445.1745; JONES MR, 1982, PERCEPT PSYCHOPHYS, V32, P211, DOI 10.3758/BF03206225; Jones MR, 1997, CAN J EXP PSYCHOL, V51, P271, DOI 10.1037/1196-1961.51.4.271; JONES MR, 1987, PERCEPT PSYCHOPHYS, V41, P621, DOI 10.3758/BF03210494; Jones MR, 2002, PSYCHOL SCI, V13, P313, DOI 10.1111/1467-9280.00458; JONES MR, 1989, PSYCHOL REV, V96, P459, DOI 10.1037/0033-295X.96.3.459; JONES MR, 1976, PSYCHOL REV, V83, P323, DOI 10.1037/0033-295x.83.5.323; JONES MR, 1993, THINKING SOUND COGNI, P69; KEELE SW, 1995, J MOTOR BEHAV, V27, P17, DOI 10.1080/00222895.1995.9941696; KERMADI I, 1993, EXP BRAIN RES, V94, P352; KERMADI I, 1995, J NEUROPHYSIOL, V74, P911, DOI 10.1152/jn.1995.74.3.911; Koch I, 2000, PSYCHOL RES-PSYCH FO, V63, P22, DOI 10.1007/PL00008165; Koelsch S, 2002, NEUROIMAGE, V17, P956, DOI 10.1016/S1053-8119(02)91154-7; Krampe RT, 2002, BRAIN COGNITION, V48, P1, DOI 10.1006/brcg.2001.1300; Langheim FJP, 2002, NEUROIMAGE, V16, P901, DOI 10.1006/nimg.2002.1144; Large EW, 2002, COGNITIVE SCI, V26, P1, DOI 10.1207/s15516709cog2601_1; Large EW, 1999, PSYCHOL REV, V106, P119, DOI 10.1037/0033-295X.106.1.119; Large EW, 2000, HUM MOVEMENT SCI, V19, P527, DOI 10.1016/S0167-9457(00)00026-9; Macar F, 2002, EXP BRAIN RES, V142, P475, DOI 10.1007/s00221-001-0953-0; Meck WH, 2002, BRAIN COGNITION, V48, P195, DOI 10.1006/brcg.2001.1313; Munte TF, 2002, NAT REV NEUROSCI, V3, P473, DOI 10.1038/nrn843; Nobre AC, 2001, NEUROSCI BIOBEHAV R, V25, P477, DOI 10.1016/S0149-7634(01)00028-8; Penhune VB, 1998, J COGNITIVE NEUROSCI, V10, P752, DOI 10.1162/089892998563149; POVEL DJ, 1982, ACTA PSYCHOL, V52, P107, DOI 10.1016/0001-6918(82)90029-4; POVEL DJ, 1985, MUSIC PERCEPT, V2, P411; Repp BH, 2002, J MOTOR BEHAV, V34, P291, DOI 10.1080/00222890209601947; Repp BH, 2002, PERCEPT PSYCHOPHYS, V64, P703, DOI 10.3758/BF03194738; Repp BH, 1999, PERCEPT PSYCHOPHYS, V61, P529, DOI 10.3758/BF03211971; Repp BH, 2001, J EXP PSYCHOL HUMAN, V27, P600, DOI 10.1037/0096-1523.27.3.600; Rizzolatti G, 2001, NEURON, V31, P889, DOI 10.1016/S0896-6273(01)00423-8; Sakai K, 2000, J NEUROSCI, V20, P2691; Sakai K, 2002, J NEUROPHYSIOL, V88, P2035, DOI 10.1152/jn.2002.88.4.2035; Satoh M, 2001, COGNITIVE BRAIN RES, V12, P101, DOI 10.1016/S0926-6410(01)00044-1; Schellenberg EG, 2000, MUSIC PERCEPT, V18, P155; SCHMUCKLER MA, 1994, PERCEPT PSYCHOPHYS, V56, P313, DOI 10.3758/BF03209765; Schon D, 2002, NEUROREPORT, V13, P2285, DOI 10.1097/01.wnr.0000044224.79663.f5; Schoner G, 2002, BRAIN COGNITION, V48, P31, DOI 10.1006/brcg.2001.1302; Schubotz RI, 2000, NEUROIMAGE, V11, P1, DOI 10.1006/nimg.1999.0514; Schubotz RI, 2002, NEUROIMAGE, V15, P787, DOI 10.1006/nimg.2001.1043; Schubotz RI, 2001, CEREB CORTEX, V11, P210, DOI 10.1093/cercor/11.3.210; SERGENT J, 1992, SCIENCE, V257, P106, DOI 10.1126/science.1621084; Shin JC, 2002, J EXP PSYCHOL LEARN, V28, P445, DOI 10.1037//0278-7393.28.3.445; SLOBODA JA, 1976, Q J EXP PSYCHOL, V28, P1, DOI 10.1080/14640747608400532; Smith GJ, 1999, PERCEPT MOTOR SKILL, V89, P951, DOI 10.2466/PMS.89.7.951-965; STADLER MA, 1993, MEM COGNITION, V21, P819, DOI 10.3758/BF03202749; Tillmann B, 2003, COGNITIVE BRAIN RES, V16, P145, DOI 10.1016/S0926-6410(02)00245-8; YEE W, 1994, PERCEPT PSYCHOPHYS, V56, P461, DOI 10.3758/BF03206737; ZATORRE RJ, 1994, J NEUROSCI, V14, P1908, DOI 10.1523/jneurosci.14-04-01908.1994; Zatorre RJ, 1996, J COGNITIVE NEUROSCI, V8, P29, DOI 10.1162/jocn.1996.8.1.29	70	201	202	1	41	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2003	6	7					682	687		10.1038/nn1081	http://dx.doi.org/10.1038/nn1081			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Neurosciences & Neurology	694NJ	12830159				2022-12-17	WOS:000183780400012
J	Hosie, AM; Dunne, EL; Harvey, RJ; Smart, TG				Hosie, AM; Dunne, EL; Harvey, RJ; Smart, TG			Zinc-mediated inhibition of GABA(A) receptors: discrete binding sites underlie subtype specificity	NATURE NEUROSCIENCE			English	Article							A RECEPTOR; RAT HIPPOCAMPUS; DENTATE GRANULE; ZN2+ INHIBITION; BETA-SUBUNITS; RELEASED ZINC; CHANNEL; IDENTIFICATION; RECOMBINANT; MODULATION	Zinc ions are concentrated in the central nervous system and regulate GABA(A) receptors, which are pivotal mediators of inhibitory synaptic neurotransmission. Zinc ions inhibit GABA(A) receptor function by an allosteric mechanism that is critically dependent on the receptor subunit composition: alphabeta subunit combinations show the highest sensitivity, and alphabetagamma isoforms are the least sensitive. Here we propose a mechanistic and structural basis for this inhibition and its dependence on the receptor subunit composition. We used molecular modeling to identify three discrete sites that mediate Zn2+ inhibition. One is located within the ion channel, and the other two are on the external amino (N)-terminal face of the receptor at the interfaces between alpha and beta subunits. We found that the characteristically low Zn2+ sensitivity of GABA(A) receptors containing the gamma2 subunit results from disruption to two of the three sites after receptor subunit co-assembly.	UCL, Dept Pharmacol, London WC1E 6BT, England; Univ London Sch Pharm, Dept Pharmacol, London WC1N 1AX, England	University of London; University College London; University of London; University College London; University of London School of Pharmacy	Smart, TG (corresponding author), UCL, Dept Pharmacol, Gower St, London WC1E 6BT, England.	t.smart@ucl.ac.uk	Harvey, Robert J/D-3994-2016	Harvey, Robert J/0000-0001-5956-6664				AMIN J, 1993, NATURE, V366, P565, DOI 10.1038/366565a0; Auld DS, 2001, BIOMETALS, V14, P271, DOI 10.1023/A:1012976615056; BARNARD EA, 1987, TRENDS NEUROSCI, V10, P502, DOI 10.1016/0166-2236(87)90130-5; Boileau AJ, 1999, J NEUROSCI, V19, P10213; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Brickley SG, 1999, J NEUROSCI, V19, P2960; Brooks-Kayal AR, 2001, J NEUROCHEM, V77, P1266, DOI 10.1046/j.1471-4159.2001.00329.x; Buhl EH, 1996, SCIENCE, V271, P369, DOI 10.1126/science.271.5247.369; CELENTANO JJ, 1991, MOL PHARMACOL, V40, P766; Cromer BA, 2002, TRENDS BIOCHEM SCI, V27, P280, DOI 10.1016/S0968-0004(02)02092-3; DRAGUHN A, 1990, NEURON, V5, P781, DOI 10.1016/0896-6273(90)90337-F; Dunne EL, 2002, BRIT J PHARMACOL, V137, P29, DOI 10.1038/sj.bjp.0704835; Farrar SJ, 1999, J BIOL CHEM, V274, P10100, DOI 10.1074/jbc.274.15.10100; Fisher JL, 1998, J NEUROSCI, V18, P2944; FREDERICKSON CJ, 1989, INT REV NEUROBIOL, V31, P145; Frederickson CJ, 2001, BIOMETALS, V14, P353, DOI 10.1023/A:1012934207456; Gibbs JW, 1997, J NEUROPHYSIOL, V77, P1924, DOI 10.1152/jn.1997.77.4.1924; Gingrich KJ, 1998, J PHYSIOL-LONDON, V506, P609, DOI 10.1111/j.1469-7793.1998.609bv.x; Horenstein J, 1998, MOL PHARMACOL, V53, P870; Horenstein J, 2001, NAT NEUROSCI, V4, P477, DOI 10.1038/87425; Krishek BJ, 1998, J PHYSIOL-LONDON, V507, P639, DOI 10.1111/j.1469-7793.1998.639bs.x; LEGENDRE P, 1991, MOL PHARMACOL, V39, P267; Lynch JW, 1997, EMBO J, V16, P110, DOI 10.1093/emboj/16.1.110; Mehta AK, 1999, BRAIN RES REV, V29, P196, DOI 10.1016/S0165-0173(98)00052-6; Molnar P, 2001, J NEUROPHYSIOL, V85, P1932, DOI 10.1152/jn.2001.85.5.1932; Moss SJ, 2001, NAT REV NEUROSCI, V2, P240, DOI 10.1038/35067500; Nagaya N, 2001, J PHYSIOL-LONDON, V532, P17, DOI 10.1111/j.1469-7793.2001.0017g.x; Newell JG, 2002, J BIOL CHEM, V277, P21423, DOI 10.1074/jbc.M110312200; O'Shea SM, 2000, J BIOL CHEM, V275, P22764, DOI 10.1074/jbc.M001299200; Pawelzik H, 1999, EUR J NEUROSCI, V11, P3552, DOI 10.1046/j.1460-9568.1999.00772.x; RABOW LE, 1995, SYNAPSE, V21, P189, DOI 10.1002/syn.890210302; Saxena NC, 1996, MOL PHARMACOL, V49, P567; Sieghart W., 2002, Current Topics in Medicinal Chemistry, V2, P795, DOI 10.2174/1568026023393507; SIEGHART W, 1995, PHARMACOL REV, V47, P181; SMART TG, 1991, BRIT J PHARMACOL, V103, P1837, DOI 10.1111/j.1476-5381.1991.tb12337.x; SMART TG, 1994, PROG NEUROBIOL, V42, P393, DOI 10.1016/0301-0082(94)90082-5; SMART TG, 1992, J PHYSIOL-LONDON, V447, P587, DOI 10.1113/jphysiol.1992.sp019020; SMITH GB, 1995, TRENDS PHARMACOL SCI, V16, P162, DOI 10.1016/S0165-6147(00)89009-4; Taketo M, 2000, NEUROSCIENCE, V96, P507, DOI 10.1016/S0306-4522(99)00574-6; Taylor PM, 2000, J NEUROSCI, V20, P1297; Tretter V, 1997, J NEUROSCI, V17, P2728; VALLEE BL, 1990, BIOCHEMISTRY-US, V29, P5647, DOI 10.1021/bi00476a001; Wagner DA, 2001, J NEUROSCI, V21, P67, DOI 10.1523/JNEUROSCI.21-01-00067.2001; WANG TL, 1995, J NEUROSCI, V15, P7684; Wang ZY, 2002, NEUROSCI LETT, V321, P37, DOI 10.1016/S0304-3940(01)02560-5; Whiting PJ, 1997, J NEUROSCI, V17, P5027; Wooltorton JRA, 1997, EUR J NEUROSCI, V9, P2225, DOI 10.1111/j.1460-9568.1997.tb01641.x; Wooltorton JRA, 1997, J PHYSIOL-LONDON, V505, P633, DOI 10.1111/j.1469-7793.1997.633ba.x; Xu M, 1996, J GEN PHYSIOL, V107, P195, DOI 10.1085/jgp.107.2.195	49	201	204	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2003	6	4					362	369		10.1038/nn1030	http://dx.doi.org/10.1038/nn1030			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	660KV	12640458				2022-12-17	WOS:000181833100013
J	Korin, B; Ben-Shaanan, TL; Schiller, M; Dubovik, T; Azulay-Debby, H; Boshnak, NT; Koren, T; Rolls, A				Korin, Ben; Ben-Shaanan, Tamar L.; Schiller, Maya; Dubovik, Tania; Azulay-Debby, Hilla; Boshnak, Nadia T.; Koren, Tamar; Rolls, Asya			High-dimensional, single-cell characterization of the brain's immune compartment	NATURE NEUROSCIENCE			English	Article							MATURE NK-CELLS; MASS CYTOMETRY; T-CELLS; MICROGLIA; REVEALS; HEALTH; MOUSE; HETEROGENEITY; INFLAMMATION; EXPRESSION	The brain and its borders create a highly dynamic microenvironment populated with immune cells. Yet characterization of immune cells within the naive brain compartment remains limited. In this study, we used CyTOF mass cytometry to characterize the immune populations of the naive mouse brain using 44 cell surface markers. By comparing immune cell composition and cell profiles between the brain compartment and blood, we were able to characterize previously undescribed cell subsets of CD8 T cells, B cells, NK cells and dendritic cells in the naive brain. Using flow cytometry, we show differential distributions of immune populations between meninges, choroid plexus and parenchyma. We demonstrate the phenotypic ranges of resident myeloid cells and identify CD44 as a marker for infiltrating immune populations. This study provides an approach for a system-wide view of immune populations in the brain and is expected to serve as a resource for understanding brain immunity.	[Korin, Ben; Ben-Shaanan, Tamar L.; Schiller, Maya; Dubovik, Tania; Azulay-Debby, Hilla; Boshnak, Nadia T.; Koren, Tamar; Rolls, Asya] Technion Israel Inst Technol, Rappaport Fac Med, Dept Immunol, Haifa, Israel; [Korin, Ben; Ben-Shaanan, Tamar L.; Schiller, Maya; Azulay-Debby, Hilla; Boshnak, Nadia T.; Koren, Tamar; Rolls, Asya] Technion Israel Inst Technol, Rappaport Fac Med, Dept Neurosci, Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Rolls, A (corresponding author), Technion Israel Inst Technol, Rappaport Fac Med, Dept Immunol, Haifa, Israel.; Rolls, A (corresponding author), Technion Israel Inst Technol, Rappaport Fac Med, Dept Neurosci, Haifa, Israel.	rolls.asya@gmail.com		Ben-Shaanan, Tamar L./0000-0001-6519-1715; Rolls, Asya/0000-0001-5862-4287	Israeli Ministry of Science, Technology Space (MOST) [3-12070]; Prince Center for Neurodegenerative Diseases; Israeli Society for Science (ISF) [1862/15]; FP-7-CIG grant [618654]; Adelis Foundation	Israeli Ministry of Science, Technology Space (MOST); Prince Center for Neurodegenerative Diseases; Israeli Society for Science (ISF); FP-7-CIG grant; Adelis Foundation	We thank S. Schwarzbaum and N. Green for editing the paper; M. Schwartz, S. Shen-Orr, I. Strominger and H. Elyahu for their discussions and advice; G. Vildebaum and L. Saadaa for their help with the experiments; and A. Grau, Y. Sakuory, S. Blumenfeld and the Biomedical core facility at the Technion Faculty of Medicine for technical support and remarks. This study was supported by the Israeli Ministry of Science, Technology & Space (MOST; 3-12070), Prince Center for Neurodegenerative Diseases, Israeli Society for Science (ISF; 1862/15), the FP-7-CIG grant (618654) and the Adelis Foundation.	Amir ED, 2013, NAT BIOTECHNOL, V31, P545, DOI 10.1038/nbt.2594; Anderson KG, 2014, NAT PROTOC, V9, P209, DOI 10.1038/nprot.2014.005; Becher B, 2014, NAT IMMUNOL, V15, P1181, DOI 10.1038/ni.3006; Beham AW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002375; Bennett ML, 2016, P NATL ACAD SCI USA, V113, pE1738, DOI 10.1073/pnas.1525528113; Bottcher JP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9306; Bruttger J, 2015, IMMUNITY, V43, P92, DOI 10.1016/j.immuni.2015.06.012; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Derecki N, 2014, PROTOC EXCH; Engelhardt B, 2006, J NEURAL TRANSM, V113, P477, DOI 10.1007/s00702-005-0409-y; Engelhardt B, 2017, NAT IMMUNOL, V18, P123, DOI 10.1038/ni.3666; Filiano AJ, 2017, NAT REV NEUROSCI, V18, P375, DOI 10.1038/nrn.2017.39; Finck R, 2013, CYTOM PART A, V83A, P483, DOI 10.1002/cyto.a.22271; Fuchs T, 2015, BIOCHEM BIOPH RES CO, V456, P59, DOI 10.1016/j.bbrc.2014.11.034; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Grabert K, 2016, NAT NEUROSCI, V19, P504, DOI 10.1038/nn.4222; Guilliams M, 2016, IMMUNITY, V45, P669, DOI 10.1016/j.immuni.2016.08.015; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; Hayakawa Y, 2006, J IMMUNOL, V176, P1517, DOI 10.4049/jimmunol.176.3.1517; Heppner FL, 2015, NAT REV NEUROSCI, V16, P358, DOI 10.1038/nrn3880; Hertwig L, 2016, EUR J IMMUNOL, V46, P1984, DOI 10.1002/eji.201546194; Horowitz A, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006702; Huang D, 2006, FASEB J, V20, P896, DOI 10.1096/fj.05-5465com; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Mildner A, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.MCHD-0033-2016; Mrdjen D, 2017, METHODS MOL BIOL, V1559, P321, DOI 10.1007/978-1-4939-6786-5_22; Mueller SN, 2016, NAT REV IMMUNOL, V16, P79, DOI 10.1038/nri.2015.3; Norden DM, 2013, NEUROPATH APPL NEURO, V39, P19, DOI 10.1111/j.1365-2990.2012.01306.x; Paine A, 2012, J IMMUNOL, V188, P1620, DOI 10.4049/jimmunol.1100181; Peake K, 2015, JOVE-J VIS EXP, DOI 10.3791/52553; Peng H, 2013, J IMMUNOL, V190, P4255, DOI 10.4049/jimmunol.1202395; Pino PA, 2011, JOVE-J VIS EXP, DOI 10.3791/2348; Poli A, 2013, J IMMUNOL, V190, P5355, DOI 10.4049/jimmunol.1203401; Prinz M, 2017, NAT NEUROSCI, V20, P136, DOI 10.1038/nn.4475; Prinz M, 2014, NAT REV NEUROSCI, V15, P300, DOI 10.1038/nrn3722; Prinz M, 2011, NAT NEUROSCI, V14, P1227, DOI 10.1038/nn.2923; Qiu P, 2011, NAT BIOTECHNOL, V29, P886, DOI 10.1038/nbt.1991; Ransohoff RM, 2012, NAT REV IMMUNOL, V12, P623, DOI 10.1038/nri3265; Rose S, 2012, CYTOM PART A, V81A, P343, DOI 10.1002/cyto.a.22012; Schlitzer A, 2014, CURR OPIN IMMUNOL, V26, P90, DOI 10.1016/j.coi.2013.11.002; Schwartz M, 2013, J NEUROSCI, V33, P17587, DOI 10.1523/JNEUROSCI.3241-13.2013; Spitzer MH, 2016, CELL, V165, P780, DOI 10.1016/j.cell.2016.04.019; Stern JNH, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008879; Streit Wolfgang J., 2005, Current Alzheimer Research, V2, P187, DOI 10.2174/1567205053585765; van Unen V, 2016, IMMUNITY, V44, P1227, DOI 10.1016/j.immuni.2016.04.014; Viola A, 2008, ANNU REV PHARMACOL, V48, P171, DOI 10.1146/annurev.pharmtox.48.121806.154841; Wes PD, 2016, GLIA, V64, P197, DOI 10.1002/glia.22866; Willing A, 2012, CURR OPIN NEUROL, V25, P316, DOI 10.1097/WCO.0b013e328352ea8b; Wilson EH, 2010, J CLIN INVEST, V120, P1368, DOI 10.1172/JCI41911; Wu ZQ, 2014, J BIOL CHEM, V289, P22630, DOI 10.1074/jbc.M114.569459; Zheng Y, 2004, J IMMUNOL, V172, P2778, DOI 10.4049/jimmunol.172.5.2778; Ziv Y, 2006, NAT NEUROSCI, V9, P268, DOI 10.1038/nn1629; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	54	200	202	7	72	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2017	20	9					1300	+		10.1038/nn.4610	http://dx.doi.org/10.1038/nn.4610			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FF0JJ	28758994				2022-12-17	WOS:000408587700019
J	Segerdahl, AR; Mezue, M; Okell, TW; Farrar, JT; Tracey, I				Segerdahl, Andrew R.; Mezue, Melvin; Okell, Thomas W.; Farrar, John T.; Tracey, Irene			The dorsal posterior insula subserves a fundamental role in human pain	NATURE NEUROSCIENCE			English	Article							SOMATOTOPIC ORGANIZATION; MACAQUE MONKEY; CORTEX; FMRI; MODEL; HEAT	Several brain regions have been implicated in human painful experiences, but none have been proven to be specific to pain. We exploited arterial spin-labeling quantitative perfusion imaging and a newly developed procedure to identify a specific role for the dorsal posterior insula (dpIns) in pain. Tract tracing studies in animals identify a similar region as fundamental to nociception, which suggests the dpIns is its human homolog and, as such, a potential therapeutic target.	[Segerdahl, Andrew R.; Mezue, Melvin; Okell, Thomas W.; Tracey, Irene] Univ Oxford, Nuffield Dept Clin Neurosci, Oxford Ctr Funct Magnet Resonance Imaging Brain F, Oxford, England; [Segerdahl, Andrew R.; Mezue, Melvin; Tracey, Irene] Univ Oxford, Nuffield Dept Clin Neurosci, Nuffield Div Anesthet, Oxford, England; [Farrar, John T.] Univ Penn, Perelman Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA	University of Oxford; University of Oxford; University of Pennsylvania; Pennsylvania Medicine	Segerdahl, AR (corresponding author), Univ Oxford, Nuffield Dept Clin Neurosci, Oxford Ctr Funct Magnet Resonance Imaging Brain F, Oxford, England.	andrew.segerdahl@ndcn.ox.ac.uk	Farrar, John T/AAP-4788-2021	Farrar, John T/0000-0001-8656-5157; Tracey, Irene/0000-0003-4134-6115; Okell, Thomas/0000-0001-8258-0659; Segerdahl, Andrew/0000-0002-0180-7194	Medical Research Council of Great Britain; National Institute for Health Research Oxford Biomedical Research Centre; Wellcome Trust; Innovative Medicines Initiative [115007]; European Union; European Federation of Pharmaceutical Industries and Associations (EFPIA) companies'; Medical Research Council of Northern Ireland; MRC [G0700399] Funding Source: UKRI; Medical Research Council [G0700399] Funding Source: researchfish	Medical Research Council of Great Britain(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); Innovative Medicines Initiative; European Union(European Commission); European Federation of Pharmaceutical Industries and Associations (EFPIA) companies'; Medical Research Council of Northern Ireland(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We would also like to acknowledge F. Eippert, K. Wiech and M. Chappell for their insights into the work. The research was funded by the Medical Research Council of Great Britain and Northern Ireland, the National Institute for Health Research Oxford Biomedical Research Centre, the Wellcome Trust, and the Innovative Medicines Initiative joint undertaking, under grant agreement no 115007, resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and European Federation of Pharmaceutical Industries and Associations (EFPIA) companies' in-kind contribution.	Baumgartner U, 2010, J NEUROPHYSIOL, V104, P2863, DOI 10.1152/jn.00253.2010; Brooks JCW, 2005, NEUROIMAGE, V27, P201, DOI 10.1016/j.neuroimage.2005.03.041; Buxton RB, 1997, J CEREBR BLOOD F MET, V17, P64, DOI 10.1097/00004647-199701000-00009; Chappell MA, 2009, IEEE T SIGNAL PROCES, V57, P223, DOI 10.1109/TSP.2008.2005752; Craig AD, 2014, J COMP NEUROL, V522, P36, DOI 10.1002/cne.23425; Denk F, 2014, NAT NEUROSCI, V17, P192, DOI 10.1038/nn.3628; Evrard HC, 2014, J COMP NEUROL, V522, P64, DOI 10.1002/cne.23436; Garcia-Larrea L, 2013, PAIN, V154, pS29, DOI 10.1016/j.pain.2013.09.001; Garcia-Larrea L, 2010, BRAIN, V133, P2528, DOI 10.1093/brain/awq220; Greenspan JD, 1999, PAIN, V81, P273, DOI 10.1016/S0304-3959(99)00021-4; Henderson LA, 2007, PAIN, V128, P20, DOI 10.1016/j.pain.2006.08.013; Mazzola L, 2009, PAIN, V146, P99, DOI 10.1016/j.pain.2009.07.014; Mezue M, 2014, J CEREBR BLOOD F MET, V34, P1919, DOI 10.1038/jcbfm.2014.163; Mouraux A, 2011, NEUROIMAGE, V54, P2237, DOI 10.1016/j.neuroimage.2010.09.084; Ploghaus A, 1999, SCIENCE, V284, P1979, DOI 10.1126/science.284.5422.1979; Rainville P, 1997, SCIENCE, V277, P968, DOI 10.1126/science.277.5328.968; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Wager TD, 2013, NEW ENGL J MED, V368, P1388, DOI 10.1056/NEJMoa1204471; Wiech K, 2010, J NEUROSCI, V30, P16324, DOI 10.1523/JNEUROSCI.2087-10.2010	19	200	205	0	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2015	18	4					499	+		10.1038/nn.3969	http://dx.doi.org/10.1038/nn.3969			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CE4DL	25751532	Green Accepted, Green Submitted			2022-12-17	WOS:000351780900009
J	Leao, RN; Mikulovic, S; Leao, KE; Munguba, H; Gezelius, H; Enjin, A; Patra, K; Eriksson, A; Loew, LM; Tort, ABL; Kullander, K				Leao, Richardson N.; Mikulovic, Sanja; Leao, Katarina E.; Munguba, Hermany; Gezelius, Henrik; Enjin, Anders; Patra, Kalicharan; Eriksson, Anders; Loew, Leslie M.; Tort, Adriano B. L.; Kullander, Klas			OLM interneurons differentially modulate CA3 and entorhinal inputs to hippocampal CA1 neurons	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; STRATUM-ORIENS; THETA-RHYTHM; GABAERGIC NEURONS; FAST INHIBITION; CELLS; MODEL; GAMMA; ACETYLCHOLINE; FEEDFORWARD	The vast diversity of GABAergic interneurons is believed to endow hippocampal microcircuits with the required flexibility for memory encoding and retrieval. However, dissection of the functional roles of defined interneuron types has been hampered by the lack of cell-specific tools. We identified a precise molecular marker for a population of hippocampal GABAergic interneurons known as oriens lacunosum-moleculare (OLM) cells. By combining transgenic mice and optogenetic tools, we found that OLM cells are important for gating the information flow in CA1, facilitating the transmission of intrahippocampal information (from CA3) while reducing the influence of extrahippocampal inputs (from the entorhinal cortex). Furthermore, we found that OLM cells were interconnected by gap junctions, received direct cholinergic inputs from subcortical afferents and accounted for the effect of nicotine on synaptic plasticity of the Schaffer collateral pathway. Our results suggest that acetylcholine acting through OLM cells can control the mnemonic processes executed by the hippocampus.	[Leao, Richardson N.; Mikulovic, Sanja; Leao, Katarina E.; Gezelius, Henrik; Enjin, Anders; Patra, Kalicharan; Eriksson, Anders; Kullander, Klas] Uppsala Univ, Dept Neurosci, Uppsala, Sweden; [Leao, Richardson N.; Leao, Katarina E.; Munguba, Hermany; Tort, Adriano B. L.] Univ Fed Rio Grande do Norte, Brain Inst, BR-59072970 Natal, RN, Brazil; [Loew, Leslie M.] UConn Hlth Ctr, RD Berlin Ctr Cell Anal & Modeling, Farmington, CT USA; [Kullander, Klas] Uppsala Univ, Dept Neurosci, Sci Life Lab, Uppsala, Sweden	Uppsala University; Universidade Federal do Rio Grande do Norte; University of Connecticut; Uppsala University	Kullander, K (corresponding author), Uppsala Univ, Dept Neurosci, Uppsala, Sweden.	richardson.leao@neuro.uu.se; klas.kullander@neuro.uu.se	Enjin, Anders/J-9706-2014; Tort, Adriano/A-9945-2009; Leao, Richardson/AAX-4985-2020	Tort, Adriano/0000-0002-9877-7816; Leao, Richardson/0000-0001-8496-1965; Leao, Katarina/0000-0001-7295-1233; Kullander, Klas/0000-0001-6418-5460; Loew, Leslie/0000-0002-1851-4646; Enjin, Anders/0000-0001-7167-9434; Munguba, Hermany/0000-0002-8480-8423; Gezelius, Henrik/0000-0002-6242-6344	foundation of Marta och Kjell Beijer; foundation of Hallsten; foundation of Goran Gustafsson; Swedish Foundation for International Cooperation in Research and Higher Education; Brazilian Federal Agency for Support and Evaluation of Graduate Education; Brazilian National Council of Technological and Scientific Development; Research Support Agency of the State of Rio Grande do Norte, US National Institutes of Health [R01EB001963]; Swedish Medical Research Council; Swedish Brain Foundation; Uppsala University; Knut and Alice Wallenberg Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB001963] Funding Source: NIH RePORTER	foundation of Marta och Kjell Beijer; foundation of Hallsten; foundation of Goran Gustafsson; Swedish Foundation for International Cooperation in Research and Higher Education; Brazilian Federal Agency for Support and Evaluation of Graduate Education; Brazilian National Council of Technological and Scientific Development; Research Support Agency of the State of Rio Grande do Norte, US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Brain Foundation; Uppsala University; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank G. Buzsaki, P. Ascher, B. Lamotte d'Incamps, O. Amaral and E. Hanse for comments on earlier versions of this manuscript. This work was supported by the foundations of Marta och Kjell Beijer, Hallsten and Goran Gustafsson, The Swedish Foundation for International Cooperation in Research and Higher Education, the Brazilian Federal Agency for Support and Evaluation of Graduate Education, the Brazilian National Council of Technological and Scientific Development, the Research Support Agency of the State of Rio Grande do Norte, US National Institutes of Health grant R01EB001963, the Swedish Medical Research Council, the Swedish Brain Foundation, and Uppsala University. K.K. is a Royal Swedish Academy of Sciences Research Fellow supported by a grant from the Knut and Alice Wallenberg Foundation.	Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; BLASCOIBANEZ JM, 1995, EUR J NEUROSCI, V7, P2170, DOI 10.1111/j.1460-9568.1995.tb00638.x; Cardin JA, 2010, NAT PROTOC, V5, P247, DOI 10.1038/nprot.2009.228; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Colom LV, 2006, J NEUROCHEM, V96, P609, DOI 10.1111/j.1471-4159.2005.03630.x; Cutsuridis V, 2010, HIPPOCAMPUS, V20, P423, DOI 10.1002/hipo.20661; Davis Jennifer A, 2008, Curr Drug Abuse Rev, V1, P9; Dugladze T, 2007, P NATL ACAD SCI USA, V104, P17530, DOI 10.1073/pnas.0708301104; Eichenbaum H, 2004, NEURON, V44, P109, DOI 10.1016/j.neuron.2004.08.028; Elfant D, 2008, EUR J NEUROSCI, V27, P104, DOI 10.1111/j.1460-9568.2007.06001.x; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Fuchs EC, 2007, NEURON, V53, P591, DOI 10.1016/j.neuron.2007.01.031; Gloveli T, 2005, P NATL ACAD SCI USA, V102, P13295, DOI 10.1073/pnas.0506259102; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; GULYAS AI, 1990, NEUROSCIENCE, V37, P31, DOI 10.1016/0306-4522(90)90189-B; Gulyas AI, 2010, J NEUROSCI, V30, P15134, DOI 10.1523/JNEUROSCI.4104-10.2010; Hasselmo ME, 1999, TRENDS COGN SCI, V3, P351, DOI 10.1016/S1364-6613(99)01365-0; Ishii K, 2005, J COMP NEUROL, V493, P241, DOI 10.1002/cne.20762; Jia YS, 2010, EUR J NEUROSCI, V31, P463, DOI 10.1111/j.1460-9568.2009.07058.x; Jia YS, 2009, EUR J NEUROSCI, V29, P1588, DOI 10.1111/j.1460-9568.2009.06706.x; Kee MZL, 2008, BRAIN CELL BIOL, V36, P157, DOI 10.1007/s11068-009-9039-x; Kim S, 2012, NAT NEUROSCI, V15, P600, DOI [10.1038/nn.3060, 10.1038/nn.3173]; Klausberger T, 2004, NAT NEUROSCI, V7, P41, DOI 10.1038/nn1159; Korotkova T, 2010, NEURON, V68, P557, DOI 10.1016/j.neuron.2010.09.017; Lovett-Barron M, 2012, NAT NEUROSCI, V15, P423, DOI 10.1038/nn.3024; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Maccaferri G, 2002, J NEUROSCI, V22, P5462; Maccaferri G, 2000, J PHYSIOL-LONDON, V524, P91, DOI 10.1111/j.1469-7793.2000.t01-3-00091.x; MACCAFERRI G, 1995, NEURON, V15, P137, DOI 10.1016/0896-6273(95)90071-3; Maccaferri G, 1996, J PHYSIOL-LONDON, V497, P119, DOI 10.1113/jphysiol.1996.sp021754; Minneci F, 2007, HIPPOCAMPUS, V17, P538, DOI 10.1002/hipo.20291; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Murray AJ, 2011, NAT NEUROSCI, V14, P297, DOI 10.1038/nn.2751; Nakauchi S, 2007, EUR J NEUROSCI, V25, P2666, DOI 10.1111/j.1460-9568.2007.05513.x; Neymotin SA, 2011, J NEUROSCI, V31, P11733, DOI 10.1523/JNEUROSCI.0501-11.2011; Palmer LM, 2006, J NEUROSCI, V26, P1854, DOI 10.1523/JNEUROSCI.4812-05.2006; Paxinos G., 2007, MOUSE BRAIN STEREOTA, DOI 10.1016/B978-0-12-374247-6.50004-3; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Rotstein HG, 2005, J NEUROPHYSIOL, V94, P1509, DOI 10.1152/jn.00957.2004; Somogyi P, 2005, J PHYSIOL-LONDON, V562, P9, DOI 10.1113/jphysiol.2004.078915; Stanley EM, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.12.014; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Tong QC, 2008, NAT NEUROSCI, V11, P998, DOI 10.1038/nn.2167; Tort ABL, 2007, P NATL ACAD SCI USA, V104, P13490, DOI 10.1073/pnas.0705708104; Tu B, 2009, J NEUROSCI, V29, P10436, DOI 10.1523/JNEUROSCI.2580-09.2009; Veruki ML, 2010, J NEUROPHYSIOL, V103, P1456, DOI 10.1152/jn.01105.2009; Wulff P, 2009, P NATL ACAD SCI USA, V106, P3561, DOI 10.1073/pnas.0813176106	47	200	200	0	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2012	15	11					1524	1530		10.1038/nn.3235	http://dx.doi.org/10.1038/nn.3235			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	028LX	23042082	Green Published, Green Accepted			2022-12-17	WOS:000310424900012
J	Saito, T; Suemoto, T; Brouwers, N; Sleegers, K; Funamoto, S; Mihira, N; Matsuba, Y; Yamada, K; Nilsson, P; Takano, J; Nishimura, M; Iwata, N; Van Broeckhoven, C; Ihara, Y; Saido, TC				Saito, Takashi; Suemoto, Takahiro; Brouwers, Nathalie; Sleegers, Kristel; Funamoto, Satoru; Mihira, Naomi; Matsuba, Yukio; Yamada, Kazuyuki; Nilsson, Per; Takano, Jiro; Nishimura, Masaki; Iwata, Nobuhisa; Van Broeckhoven, Christine; Ihara, Yasuo; Saido, Takaomi C.			Potent amyloidogenicity and pathogenicity of A beta 43	NATURE NEUROSCIENCE			English	Article							AMYLOID-BETA-PROTEIN; GAMMA-SECRETASE ACTIVITY; DISEASE-LIKE PATHOLOGY; ALZHEIMERS-DISEASE; A-BETA; PRECURSOR PROTEIN; SENILE PLAQUES; IN-VIVO; PRESENILIN MUTATIONS; TERMINAL FRAGMENT	The amyloid-beta peptide A beta 42 is known to be a primary amyloidogenic and pathogenic agent in Alzheimer's disease. However, the role of A beta 43, which is found just as frequently in the brains of affected individuals, remains unresolved. We generated knock-in mice containing a pathogenic presenilin-1 R278I mutation that causes overproduction of A beta 43. Homozygosity was embryonic lethal, indicating that the mutation involves a loss of function. Crossing amyloid precursor protein transgenic mice with heterozygous mutant mice resulted in elevated A beta 43, impairment of short-term memory and acceleration of amyloid-b pathology, which accompanied pronounced accumulation of A beta 43 in plaque cores similar in biochemical composition to those observed in the brains of affected individuals. Consistently, A beta 43 showed a higher propensity to aggregate and was more neurotoxic than A beta 42. Other pathogenic presenilin mutations also caused overproduction of A beta 43 in a manner correlating with A beta 42 and with the age of disease onset. These findings indicate that A beta 43, an overlooked species, is potently amyloidogenic, neurotoxic and abundant in vivo.	[Saito, Takashi; Suemoto, Takahiro; Mihira, Naomi; Matsuba, Yukio; Nilsson, Per; Takano, Jiro; Iwata, Nobuhisa; Saido, Takaomi C.] RIKEN, Lab Proteolyt Neurosci, Brain Sci Inst, Wako, Saitama, Japan; [Brouwers, Nathalie; Sleegers, Kristel; Van Broeckhoven, Christine] Flanders Interunivers Inst Biotechnol, Neurodegenerat Brain Dis Grp, Dept Mol Genet, Antwerp, Belgium; [Brouwers, Nathalie; Sleegers, Kristel; Van Broeckhoven, Christine] Univ Antwerp, Inst Born Bunge, Lab Neurogenet, B-2020 Antwerp, Belgium; [Funamoto, Satoru; Ihara, Yasuo] Doshisha Univ, Fac Life Sci, Kyoto 602, Japan; [Yamada, Kazuyuki] RIKEN, Brain Sci Inst, Res Resource Ctr, Wako, Saitama, Japan; [Nishimura, Masaki] Shiga Univ Med Sci, Mol Neurosci Res Ctr, Shiga, Japan; [Iwata, Nobuhisa] Nagasaki Univ, Dept Mol Med Sci, Div Biotechnol, Grad Sch Biomed Sci, Nagasaki 852, Japan	RIKEN; University of Antwerp; Doshisha University; RIKEN; Shiga University of Medical Science; Nagasaki University	Saido, TC (corresponding author), RIKEN, Lab Proteolyt Neurosci, Brain Sci Inst, Wako, Saitama, Japan.	saido@brain.riken.jp	Sado, Takaomi/AAN-2759-2021; Saito, Takashi/G-2563-2015; Van Broeckhoven, Christine/M-7853-2019; Van Broeckhoven, Christine/G-8362-2017; Saido, Takaomi C/N-5472-2015; Brouwers, Nathalie/L-2089-2014	Sado, Takaomi/0000-0003-1970-6903; Saito, Takashi/0000-0002-9659-9251; Van Broeckhoven, Christine/0000-0003-0183-7665; Van Broeckhoven, Christine/0000-0003-0183-7665; Saido, Takaomi C/0000-0003-1970-6903; Brouwers, Nathalie/0000-0002-9808-9394	RIKEN Brain Science Institute; Ministry of Education, Culture, Sports, Science and Technology; Ministry of Health, Labor and Welfare of Japan; TAKEDA Science Foundation; Fund for Scientific Research - Flanders (FWO-V); Belgian Federal Science Policy Office [P6/43]; Flemish Government; Grants-in-Aid for Scientific Research [22700379] Funding Source: KAKEN	RIKEN Brain Science Institute; Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); TAKEDA Science Foundation(Takeda Science Foundation (TSF)); Fund for Scientific Research - Flanders (FWO-V)(FWO); Belgian Federal Science Policy Office(Belgian Federal Science Policy Office); Flemish Government(European Commission); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank M.N. Rossor (University College London) for sharing clinical information about the R278I mutation carriers, J.Q. Trojanowski and V.M.-Y. Lee (University of Pennsylvania) for providing postmortem brain tissues, R. Kopan (Washington University) for providing Myc-tagged Delta Notch1 plasmid, A. Takashima (RIKEN Brain Science Institute) for providing antibody to Aph-1, and J. Hardy (University College London) for valuable discussions. This work was supported by research grants from RIKEN Brain Science Institute, the Ministry of Education, Culture, Sports, Science and Technology, the Ministry of Health, Labor and Welfare of Japan, the TAKEDA Science Foundation, the Fund for Scientific Research - Flanders (FWO-V), the Interuniversity Attraction Poles program P6/43 of the Belgian Federal Science Policy Office and a Methusalem Excellence Grant of the Flemish Government to C.V.B. N.B receives a FWO-V postdoctoral fellowship.	Arango D, 2001, AM J MED GENET, V103, P138, DOI 10.1002/1096-8628(20011001)103:2<138::AID-AJMG1529>3.0.CO;2-8; Bentahir M, 2006, J NEUROCHEM, V96, P732, DOI 10.1111/j.1471-4159.2005.03578.x; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Culvenor JG, 2004, EUR J BIOCHEM, V271, P375, DOI 10.1046/j.1432-1033.2003.03936.x; Deng Y, 2006, J NEUROSCI, V26, P3845, DOI 10.1523/JNEUROSCI.5384-05.2006; Enya M, 1999, AM J PATHOL, V154, P271, DOI 10.1016/S0002-9440(10)65273-X; Evin G, 2005, BIOCHEMISTRY-US, V44, P4332, DOI 10.1021/bi0481702; Godbolt AK, 2004, NEUROLOGY, V63, P1702, DOI 10.1212/01.WNL.0000143060.98164.1A; Hama E, 2004, J BIOL CHEM, V279, P30259, DOI 10.1074/jbc.M401891200; Hara H, 2004, J ALZHEIMERS DIS, V6, P483; Huang SM, 2006, J BIOL CHEM, V281, P17941, DOI 10.1074/jbc.M601372200; Huppert SS, 2000, NATURE, V405, P966, DOI 10.1038/35016111; IIZUKA T, 1995, BRAIN RES, V702, P275, DOI 10.1016/0006-8993(95)01163-2; Ikeuchi T, 2003, J BIOL CHEM, V278, P7010, DOI 10.1074/jbc.M209252200; Iwata N, 2004, J NEUROSCI, V24, P991, DOI 10.1523/JNEUROSCI.4792-03.2004; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; Jan A, 2008, J BIOL CHEM, V283, P28176, DOI 10.1074/jbc.M803159200; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Kaneko H, 2007, J NEUROSCI, V27, P13092, DOI 10.1523/JNEUROSCI.4244-07.2007; Keller L, 2010, EUR J HUM GENET, V18, P1202, DOI 10.1038/ejhg.2010.107; Kim J, 2007, J NEUROSCI, V27, P627, DOI 10.1523/JNEUROSCI.4849-06.2007; Kimura N, 2001, EXP ANIM TOKYO, V50, P77, DOI 10.1538/expanim.50.77; Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683; Kumar-Singh S, 2006, HUM MUTAT, V27, P686, DOI 10.1002/humu.20336; Lee MK, 1997, NAT MED, V3, P756, DOI 10.1038/nm0797-756; Maeda J, 2007, J NEUROSCI, V27, P10957, DOI 10.1523/JNEUROSCI.0673-07.2007; McGowan E, 2005, NEURON, V47, P191, DOI 10.1016/j.neuron.2005.06.030; Miravalle L, 2005, BIOCHEMISTRY-US, V44, P10810, DOI 10.1021/bi0508237; Mouri A, 2007, FASEB J, V21, P2135, DOI 10.1096/fj.06-7685com; Nakaya Y, 2005, J BIOL CHEM, V280, P19070, DOI 10.1074/jbc.M501130200; Ono K, 2010, J BIOL CHEM, V285, P23184, DOI 10.1074/jbc.M109.086496; Parvathy S, 2001, ARCH NEUROL-CHICAGO, V58, P2025, DOI 10.1001/archneur.58.12.2025; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Russo C, 2000, NATURE, V405, P531, DOI 10.1038/35014735; Ryan DA, 2010, J NEUROSCI METH, V190, P171, DOI 10.1016/j.jneumeth.2010.05.001; SAIDO TC, 1995, NEURON, V14, P457, DOI 10.1016/0896-6273(95)90301-1; Schilling S, 2008, NAT MED, V14, P1106, DOI 10.1038/nm.1872; Schroeter EH, 2003, P NATL ACAD SCI USA, V100, P13075, DOI 10.1073/pnas.1735338100; Serneels L, 2009, SCIENCE, V324, P639, DOI 10.1126/science.1171176; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; Shimojo M, 2008, J BIOL CHEM, V283, P16488, DOI 10.1074/jbc.M801279200; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Takami M, 2009, J NEUROSCI, V29, P13042, DOI 10.1523/JNEUROSCI.2362-09.2009; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Van Vickle GD, 2007, BIOCHEMISTRY-US, V46, P10317, DOI 10.1021/bi700951u; Wang RS, 2006, J BIOL CHEM, V281, P15330, DOI 10.1074/jbc.M512574200; Welander H, 2009, J NEUROCHEM, V110, P697, DOI 10.1111/j.1471-4159.2009.06170.x; Wong PC, 1997, NATURE, V387, P288, DOI 10.1038/387288a0; Zhang C, 2009, NATURE, V460, P632, DOI 10.1038/nature08177	50	200	204	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2011	14	8					1023	U120		10.1038/nn.2858	http://dx.doi.org/10.1038/nn.2858			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	797KC	21725313	Green Submitted			2022-12-17	WOS:000293123700016
J	Filosa, A; Paixao, S; Honsek, SD; Carmona, MA; Becker, L; Feddersen, B; Gaitanos, L; Rudhard, Y; Schoepfer, R; Klopstock, T; Kullander, K; Rose, CR; Pasquale, EB; Klein, R				Filosa, Alessandro; Paixao, Sonia; Honsek, Silke D.; Carmona, Maria A.; Becker, Lore; Feddersen, Berend; Gaitanos, Louise; Rudhard, York; Schoepfer, Ralf; Klopstock, Thomas; Kullander, Klas; Rose, Christine R.; Pasquale, Elena B.; Klein, Ruediger			Neuron-glia communication via EphA4/ephrin-A3 modulates LTP through glial glutamate transport	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; HIPPOCAMPAL SYNAPTIC PLASTICITY; DENDRITIC SPINE MORPHOLOGY; MICE LACKING; TRANSGENIC MICE; AMPA RECEPTORS; BRAIN; SYNAPSES; EPHA4; PHOSPHORYLATION	Astrocytes are critical participants in synapse development and function, but their role in synaptic plasticity is unclear. Eph receptors and their ephrin ligands have been suggested to regulate neuron-glia interactions, and EphA4-mediated ephrin reverse signaling is required for synaptic plasticity in the hippocampus. Here we show that long-term potentiation (LTP) at the CA3-CA1 synapse is modulated by EphA4 in the postsynaptic CA1 cell and by ephrin-A3, a ligand of EphA4 that is found in astrocytes. Lack of EphA4 increased the abundance of glial glutamate transporters, and ephrin-A3 modulated transporter currents in astrocytes. Pharmacological inhibition of glial glutamate transporters rescued the LTP defects in EphA4 (Epha4) and ephrin-A3 (Efna3) mutant mice. Transgenic overexpression of ephrin-A3 in astrocytes reduces glutamate transporter levels and produces focal dendritic swellings possibly caused by glutamate excitotoxicity. These results suggest that EphA4/ephrin-A3 signaling is a critical mechanism for astrocytes to regulate synaptic function and plasticity.	[Filosa, Alessandro; Paixao, Sonia; Gaitanos, Louise; Klein, Ruediger] Max Planck Inst Neurobiol, Dept Mol Neurobiol, Martinsried, Germany; [Honsek, Silke D.; Rose, Christine R.] Univ Dusseldorf, Inst Neurobiol, Dusseldorf, Germany; [Carmona, Maria A.; Pasquale, Elena B.] Burnham Inst Med Res, La Jolla, CA USA; [Becker, Lore; Klopstock, Thomas] German Res Ctr Environm Hlth GmbH, German Mouse Clin, Inst Expt Genet, Helmholtz Ctr, Munich, Germany; [Becker, Lore; Feddersen, Berend; Klopstock, Thomas] Univ Munich, Dept Neurol, Friedrich Baur Inst, D-8000 Munich, Germany; [Rudhard, York; Schoepfer, Ralf] UCL, Mol Pharmacol Lab, London, England; [Kullander, Klas] Uppsala Univ, Dept Neurosci, Uppsala, Sweden	Max Planck Society; Heinrich Heine University Dusseldorf; Sanford Burnham Prebys Medical Discovery Institute; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of London; University College London; Uppsala University	Klein, R (corresponding author), Max Planck Inst Neurobiol, Dept Mol Neurobiol, Martinsried, Germany.	paixao@neuro.mpg.de; rklein@neuro.mpg.de	Becker, Lore/AAJ-1203-2020; Filosa, Alessandro/A-9448-2008; Klein, Ruediger/C-6147-2008; Becker, Lore/E-3717-2010	Becker, Lore/0000-0002-6890-4984; Klein, Ruediger/0000-0002-3109-0163; Kullander, Klas/0000-0001-6418-5460	Fundacao para a Ciencia e Tecnologia of Portugal; Programa Operacional Ciencia e Inovacao; Fundo Social Europeu; Fundacion Espanola para la Ciencia y la Tecnologia; European Union; Deutsche Forschungsgemeinschaft [SPP1172]; Max-Planck Society; Wellcome Trust; Biotechnology and Biological Sciences Research Council, UK; German National Genome Research Network [01GR0430]; US National Institutes of Health [HD025938]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD025938] Funding Source: NIH RePORTER	Fundacao para a Ciencia e Tecnologia of Portugal(Portuguese Foundation for Science and Technology); Programa Operacional Ciencia e Inovacao; Fundo Social Europeu; Fundacion Espanola para la Ciencia y la Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Union(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max-Planck Society(Max Planck SocietyFoundation CELLEX); Wellcome Trust(Wellcome Trust); Biotechnology and Biological Sciences Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); German National Genome Research Network; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank M. Bsl and the transgenic core facility for generating transgenic mice; E. Kandel ( Columbia University) and F. Kirchhoff ( Max Planck Institute of Experimental Medicine, Gttingen) for transgenic mice; M. Klein and O. Gkce for technical help; K. Deininger, C. Erlacher, V. Staiger, V. Stein and M. Traut for scientific input and suggestions; M. Korte, I. Kadow, V. Stein, J. Egea and R. Fonseca for critical comments on the manuscript. S. P. was supported by a postdoctoral fellowship from Fundacao para a Ciencia e Tecnologia of Portugal, co-funded by Programa Operacional Ciencia e Inovacao 2010 and Fundo Social Europeu. M. A. C. was supported by a fellowship from Fundacion Espanola para la Ciencia y la Tecnologia. This work was in part supported by grants from the European Union ( Endotrack), the Deutsche Forschungsgemeinschaft ( SPP1172) and the Max-Planck Society ( all to R. K.), the Wellcome Trust and the Biotechnology and Biological Sciences Research Council, UK ( R. S.), the German National Genome Research Network ( NGF N grant 01GR0430) ( T. K.), and US National Institutes of Health grant HD025938 ( E. B. P.).	Albensi BC, 2007, EXP NEUROL, V204, P1, DOI 10.1016/j.expneurol.2006.12.009; Allen NJ, 2005, CURR OPIN NEUROBIOL, V15, P542, DOI 10.1016/j.conb.2005.08.006; Barres BA, 2008, NEURON, V60, P430, DOI 10.1016/j.neuron.2008.10.013; Beart PM, 2007, BRIT J PHARMACOL, V150, P5, DOI 10.1038/sj.bjp.0706949; Bergles DE, 1998, J NEUROSCI, V18, P7709; Bouzioukh F, 2007, J NEUROSCI, V27, P11279, DOI 10.1523/JNEUROSCI.3393-07.2007; Carmona MA, 2009, P NATL ACAD SCI USA, V106, P12524, DOI 10.1073/pnas.0903328106; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Diamond JS, 2000, J NEUROPHYSIOL, V83, P2835, DOI 10.1152/jn.2000.83.5.2835; Egea J, 2005, NEURON, V47, P515, DOI 10.1016/j.neuron.2005.06.029; Essmann CL, 2008, NAT NEUROSCI, V11, P1035, DOI 10.1038/nn.2171; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Genoud C, 2006, PLOS BIOL, V4, P2057, DOI 10.1371/journal.pbio.0040343; Greenwood SM, 2007, NEUROPHARMACOLOGY, V53, P891, DOI 10.1016/j.neuropharm.2007.10.003; Grunwald IC, 2004, NAT NEUROSCI, V7, P33, DOI 10.1038/nn1164; Grunwald IC, 2001, NEURON, V32, P1027, DOI 10.1016/S0896-6273(01)00550-5; Halassa MM, 2007, TRENDS MOL MED, V13, P54, DOI 10.1016/j.molmed.2006.12.005; Hasbani MJ, 2001, J NEUROSCI, V21, P2393, DOI 10.1523/JNEUROSCI.21-07-02393.2001; Haugeto O, 1996, J BIOL CHEM, V271, P27715, DOI 10.1074/jbc.271.44.27715; Henderson JT, 2001, NEURON, V32, P1041, DOI 10.1016/S0896-6273(01)00553-0; Kayser MS, 2008, NEURON, V59, P56, DOI 10.1016/j.neuron.2008.05.007; Klein R, 2009, NAT NEUROSCI, V12, P15, DOI 10.1038/nn.2231; Kramer ER, 2007, PLOS BIOL, V5, P616, DOI 10.1371/journal.pbio.0050039; Kullander K, 2001, NEURON, V29, P73, DOI 10.1016/S0896-6273(01)00181-7; Lehre KP, 2002, BIOPHYS J, V83, P125, DOI 10.1016/S0006-3495(02)75154-0; Levenson J, 2002, NAT NEUROSCI, V5, P155, DOI 10.1038/nn791; Liu GS, 1999, NEURON, V22, P395, DOI 10.1016/S0896-6273(00)81099-5; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu YM, 1997, J NEUROSCI, V17, P5196; Luscher C, 1998, NEURON, V21, P435, DOI 10.1016/S0896-6273(00)80552-8; Morris RGM, 2003, PHILOS T R SOC B, V358, P773, DOI 10.1098/rstb.2002.1264; Mulholland PJ, 2008, J NEUROSCI, V28, P8801, DOI 10.1523/JNEUROSCI.2405-08.2008; Murai KK, 2003, NAT NEUROSCI, V6, P153, DOI 10.1038/nn994; Nestor MW, 2007, J NEUROSCI, V27, P12817, DOI 10.1523/JNEUROSCI.2442-07.2007; Nikkuni O, 2007, NEUROSCI RES, V59, P296, DOI 10.1016/j.neures.2007.07.006; Nishida H, 2007, J NEUROSCI, V27, P331, DOI 10.1523/JNEUROSCI.4466-06.2007; Nolte C, 2001, GLIA, V33, P72; Oliet SHR, 2001, SCIENCE, V292, P923, DOI 10.1126/science.1059162; Pita-Almenar JD, 2006, J NEUROSCI, V26, P10461, DOI 10.1523/JNEUROSCI.2579-06.2006; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Tremblay ME, 2007, J COMP NEUROL, V501, P691, DOI 10.1002/cne.21263; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; Tsuda H, 2008, CELL, V133, P963, DOI 10.1016/j.cell.2008.04.039; Tsukada S, 2005, NEUROPHARMACOLOGY, V48, P479, DOI 10.1016/j.neuropharm.2004.11.006; Tzingounis AV, 2007, NAT REV NEUROSCI, V8, P935, DOI 10.1038/nrn2274; Wadiche JI, 2005, NAT NEUROSCI, V8, P1329, DOI 10.1038/nn1539; Watanabe T, 1999, BRAIN RES, V845, P92, DOI 10.1016/S0006-8993(99)01945-9; Weiergraber M, 2006, EPILEPSIA, V47, P839, DOI 10.1111/j.1528-1167.2006.00541.x	50	200	206	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2009	12	10					1285	U106		10.1038/nn.2394	http://dx.doi.org/10.1038/nn.2394			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	498US	19734893	Green Accepted, Green Submitted			2022-12-17	WOS:000270170200017
J	Glykys, J; Peng, ZC; Chandra, D; Homanics, GE; Houser, CR; Mody, I				Glykys, Joseph; Peng, Zechun; Chandra, Dev; Homanics, Gregg E.; Houser, Carolyn R.; Mody, Istvan			A new naturally occurring GABA(A) receptor subunit partnership with high sensitivity to ethanol	NATURE NEUROSCIENCE			English	Article							CA1 PYRAMIDAL NEURONS; DELTA-SUBUNIT; TONIC INHIBITION; DENTATE GYRUS; GRANULE CELLS; A RECEPTORS; ALPHA-1 SUBUNIT; DEFICIENT MICE; KNOCKOUT MICE; RAT-BRAIN	According to the rules of GABA(A) receptor (GABA(A)R) subunit assembly, alpha 4 and alpha 6 subunits are considered to be the natural partners of delta subunits. These GABA(A)Rs are a preferred target of low, sobriety-impairing concentrations of ethanol. Here we demonstrate a new naturally occurring GABAAR subunit partnership: d subunits of hippocampal interneurons are coexpressed and colocalized with alpha 1 subunits, but not with alpha 4, alpha 6 or any other alpha subunits. Ethanol potentiates the tonic inhibition mediated by such native alpha 1/delta GABA(A)Rs in wild-type and in alpha 4 subunit-deficient (Gabra4(-/-)) mice, but not in delta subunit - deficient (Gabrd(-/-)) mice. We also ruled out any compensatory upregulation of alpha 6 subunits that might have accounted for the ethanol effect in Gabra4(-/-) mice. Thus, alpha 1/delta subunit assemblies represent a new neuronal GABA(A)R subunit partnership present in hippocampal interneurons, mediate tonic inhibitory currents and are highly sensitive to low concentrations of ethanol.	Univ Calif Los Angeles, David Geffen Sch Med, Interdept PhD Program Neurosci, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; Univ Pittsburgh, Dept Anesthesiol, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Dept Pharmacol, Pittsburgh, PA 15261 USA; VA Greater Los Angeles Healthcare Syst, Res Serv, Los Angeles, CA 90073 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Mody, I (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Interdept PhD Program Neurosci, Los Angeles, CA 90095 USA.	mody@ucla.edu		Glykys, Joseph/0000-0002-1499-9172; Homanics, Gregg/0000-0003-3641-8153	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS030549, R56NS051311, R01NS051311, R01NS030549] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000404] Funding Source: NIH RePORTER; NIAAA NIH HHS [AA14003] Funding Source: Medline; NINDS NIH HHS [NS051311, NS30549, NS35958] Funding Source: Medline; BLRD VA [I01 BX000404] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Veterans Affairs(US Department of Veterans Affairs); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); BLRD VA		Araujo F, 1998, EUR J PHARMACOL, V347, P347, DOI 10.1016/S0014-2999(98)00122-8; Bianchi MT, 2002, NEUROPHARMACOLOGY, V43, P492, DOI 10.1016/S0028-3908(02)00163-6; Borghese CM, 2006, J PHARMACOL EXP THER, V316, P1360, DOI 10.1124/jpet.105.092452; Brunig I, 2002, J COMP NEUROL, V443, P43, DOI 10.1002/cne.10102; Chandra D, 2006, P NATL ACAD SCI USA, V103, P15230, DOI 10.1073/pnas.0604304103; Cope DW, 2005, J NEUROSCI, V25, P11553, DOI 10.1523/JNEUROSCI.3362-05.2005; Esclapez M, 1996, HIPPOCAMPUS, V6, P225; Essrich C, 1998, NAT NEUROSCI, V1, P563, DOI 10.1038/2798; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; GAO B, 1994, EUR J NEUROSCI, V6, P837, DOI 10.1111/j.1460-9568.1994.tb00994.x; Glykys J, 2006, J NEUROPHYSIOL, V95, P2796, DOI 10.1152/jn.01122.2005; Goldstein PA, 2002, J NEUROPHYSIOL, V88, P3208, DOI 10.1152/jn.00885.2001; Hamann M, 2002, NEURON, V33, P625, DOI 10.1016/S0896-6273(02)00593-7; HAN ZS, 1993, EUR J NEUROSCI, V5, P395, DOI 10.1111/j.1460-9568.1993.tb00507.x; Hanchar HJ, 2004, LIFE SCI, V76, P1, DOI 10.1016/j.lfs.2004.05.035; Hanchar HJ, 2005, NAT NEUROSCI, V8, P339, DOI 10.1038/nn1398; Jia F, 2005, J NEUROPHYSIOL, V94, P4491, DOI 10.1152/jn.00421.2005; Jones A, 1997, J NEUROSCI, V17, P1350; Korpi ER, 2002, NEUROSCIENCE, V109, P733, DOI 10.1016/S0306-4522(01)00527-9; Kralic JE, 2006, J COMP NEUROL, V495, P408, DOI 10.1002/cne.20866; Maguire JL, 2005, NAT NEUROSCI, V8, P797, DOI 10.1038/nn1469; McKernan RM, 1996, TRENDS NEUROSCI, V19, P139, DOI 10.1016/S0166-2236(96)80023-3; Mihalek RM, 1999, P NATL ACAD SCI USA, V96, P12905, DOI 10.1073/pnas.96.22.12905; Mihalek RM, 2001, ALCOHOL CLIN EXP RES, V25, P1708, DOI 10.1111/j.1530-0277.2001.tb02179.x; Mody I, 2004, TRENDS NEUROSCI, V27, P569, DOI 10.1016/j.tins.2004.07.002; Nusser Z, 1998, J NEUROSCI, V18, P1693; Nusser Z, 2002, J NEUROPHYSIOL, V87, P2624, DOI 10.1152/jn.2002.87.5.2624; Ogris W, 2006, J NEUROCHEM, V96, P136, DOI 10.1111/j.1471-4159.2005.03509.x; Peng Z, 2002, J COMP NEUROL, V446, P179, DOI 10.1002/cne.10210; Peng ZC, 2004, J NEUROSCI, V24, P8629, DOI 10.1523/JNEUROSCI.2877-04.2004; Pirker S, 2000, NEUROSCIENCE, V101, P815, DOI 10.1016/S0306-4522(00)00442-5; Poltl A, 2003, J NEUROCHEM, V87, P1444, DOI 10.1046/j.1471-4159.2003.02135.x; Ponomarev I, 2006, J NEUROSCI, V26, P5673, DOI 10.1523/JNEUROSCI.0860-06.2006; QUIRK K, 1995, EUR J PHARM-MOLEC PH, V290, P175, DOI 10.1016/0922-4106(95)00061-5; Scimemi A, 2005, J NEUROSCI, V25, P10016, DOI 10.1523/JNEUROSCI.2520-05.2005; Sieghart W., 2002, Current Topics in Medicinal Chemistry, V2, P795, DOI 10.2174/1568026023393507; Somogyi P, 1996, NEUROPHARMACOLOGY, V35, P1425, DOI 10.1016/S0028-3908(96)00086-X; Sperk G, 1997, NEUROSCIENCE, V80, P987, DOI 10.1016/S0306-4522(97)00146-2; Stell BM, 2003, P NATL ACAD SCI USA, V100, P14439, DOI 10.1073/pnas.2435457100; Sun CS, 2004, BRAIN RES, V1029, P207, DOI 10.1016/j.brainres.2004.09.056; Sundstrom-Poromaa I, 2002, NAT NEUROSCI, V5, P721, DOI 10.1038/nn888; Sur C, 1999, MOL PHARMACOL, V56, P110, DOI 10.1124/mol.56.1.110; Sur C, 2001, J NEUROSCI, V21, P3409, DOI 10.1523/JNEUROSCI.21-10-03409.2001; Wafford KA, 2004, BIOCHEM SOC T, V32, P553, DOI 10.1042/BST0320553; Wall MJ, 2002, NEUROPHARMACOLOGY, V43, P737, DOI 10.1016/S0028-3908(02)00085-0; Wallner M, 2003, P NATL ACAD SCI USA, V100, P15218, DOI 10.1073/pnas.2435171100; Wei WZ, 2004, J NEUROSCI, V24, P8379, DOI 10.1523/JNEUROSCI.2040-04.2004; Wei WZ, 2003, J NEUROSCI, V23, P10650; Weiner JL, 1997, J NEUROPHYSIOL, V77, P1306, DOI 10.1152/jn.1997.77.3.1306; Weiner JL, 1997, J NEUROCHEM, V68, P1949; Whiting PJ, 2003, DRUG DISCOV TODAY, V8, P445, DOI 10.1016/S1359-6446(03)02703-X; Wohlfarth KM, 2002, J NEUROSCI, V22, P1541, DOI 10.1523/JNEUROSCI.22-05-01541.2002	52	200	202	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2007	10	1					40	48		10.1038/nn1813	http://dx.doi.org/10.1038/nn1813			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	120PC	17159992				2022-12-17	WOS:000243096100014
J	Wang, HX; Gerkin, RC; Nauen, DW; Bi, GQ				Wang, HX; Gerkin, RC; Nauen, DW; Bi, GQ			Coactivation and timing-dependent integration of synaptic potentiation and depression	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; ASYMMETRIC HEBBIAN PLASTICITY; PROTEIN-KINASE-II; HIPPOCAMPAL-NEURONS; NMDA RECEPTOR; PYRAMIDAL CELLS; MEMORY; CALMODULIN; LTP; TRANSMISSION	Neuronal synaptic connections can be potentiated or depressed by paired pre- and postsynaptic spikes, depending on the spike timing. We show that in cultured rat hippocampal neurons a calcium/calmodulin-dependent protein kinase II (CaMKII)-mediated potentiation process and a calcineurin-mediated depression process can be activated concomitantly by spike triplets or quadruplets. The integration of the two processes critically depends on their activation timing. Depression can cancel previously activated potentiation, whereas potentiation tends to override previously activated depression. The time window for potentiation to dominate is about 70 ms, beyond which the two processes cancel. These results indicate that the signaling machinery underlying spike timing-dependent plasticity (STDP) may be separated into functional modules that are sensitive to the spatiotemporal dynamics (rather than the amount) of calcium influx. The timing dependence of modular interaction provides a quantitative framework for understanding the temporal integration of STDP.	Univ Pittsburgh, Sch Med, Dept Neurobiol, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Sch Med, Ctr Neurosci, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Sch Med, Ctr Neural Basis Cognit, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Sch Med, Med Scientist Training Program, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Bi, GQ (corresponding author), Univ Pittsburgh, Sch Med, Dept Neurobiol, Pittsburgh, PA 15261 USA.	gqbi@pitt.edu	Gerkin, Richard/B-7683-2008; Bi, Guo-Qiang/E-5075-2013	Gerkin, Richard C/0000-0002-2940-3378; Bi, Guo-Qiang/0000-0001-8735-3818; nauen, david/0000-0002-2652-9944	NIMH NIH HHS [R01 MH066962] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066962] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; [Anonymous], 1949, CLIN PSYCHOL-UK, DOI DOI 10.4324/9781410612403; ARTOLA A, 1993, TRENDS NEUROSCI, V16, P480, DOI 10.1016/0166-2236(93)90081-V; Berninger B, 2002, BIOESSAYS, V24, P212, DOI 10.1002/bies.10060; Bi GQ, 2002, BIOL CYBERN, V87, P319, DOI 10.1007/s00422-002-0349-7; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; CONSTANTINEPATON M, 1990, ANNU REV NEUROSCI, V13, P129, DOI 10.1146/annurev.neuro.13.1.129; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; Froemke RC, 2002, NATURE, V416, P433, DOI 10.1038/416433a; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; Gutig R, 2003, J NEUROSCI, V23, P3697; Hopfield JJ, 2004, P NATL ACAD SCI USA, V101, P337, DOI 10.1073/pnas.2536316100; ITO I, 1991, NEUROSCI LETT, V121, P119, DOI 10.1016/0304-3940(91)90663-E; Izhikevich EM, 2003, NEURAL COMPUT, V15, P1511, DOI 10.1162/089976603321891783; LINDEN DJ, 1995, ANNU REV NEUROSCI, V18, P319, DOI 10.1146/annurev.ne.18.030195.001535; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; MALENKA RC, 1989, NATURE, V340, P554, DOI 10.1038/340554a0; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Mehta MR, 1997, P NATL ACAD SCI USA, V94, P8918, DOI 10.1073/pnas.94.16.8918; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Nishiyama M, 2000, NATURE, V408, P584, DOI 10.1038/35046067; Petersen JD, 2003, J NEUROSCI, V23, P11270; Rubin J, 2001, PHYS REV LETT, V86, P364, DOI 10.1103/PhysRevLett.86.364; RUBIN JE, IN PRESS J NEUROPHYS; Scannevin RH, 2000, NAT REV NEUROSCI, V1, P133, DOI 10.1038/35039075; Schuett S, 2001, NEURON, V32, P325, DOI 10.1016/S0896-6273(01)00472-X; Senn W, 2003, J COMPUT NEUROSCI, V14, P119, DOI 10.1023/A:1021935100586; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Shouval HZ, 2002, P NATL ACAD SCI USA, V99, P10831, DOI 10.1073/pnas.152343099; Sjostrom PJ, 2002, CURR OPIN NEUROBIOL, V12, P305, DOI 10.1016/S0959-4388(02)00325-2; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/s0896-6273(01)00542-6; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Stevens CF, 1996, NATURE, V381, P471, DOI 10.1038/381471a0; van Rossum MCW, 2000, J NEUROSCI, V20, P8812; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Yang SN, 1999, J NEUROPHYSIOL, V81, P781, DOI 10.1152/jn.1999.81.2.781; Yao HS, 2001, NEURON, V32, P315, DOI 10.1016/S0896-6273(01)00460-3; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665; Zhou Q, 2004, TRENDS NEUROSCI, V27, P378, DOI 10.1016/j.tins.2004.05.006; Zhou Q, 2003, SCIENCE, V300, P1953, DOI 10.1126/science.1082212	50	200	205	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2005	8	2					187	193		10.1038/nn1387	http://dx.doi.org/10.1038/nn1387			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	892GN	15657596				2022-12-17	WOS:000226638200018
J	Viard, P; Butcher, AJ; Halet, G; Davies, A; Nurnberg, B; Heblich, F; Dolphin, AC				Viard, P; Butcher, AJ; Halet, G; Davies, A; Nurnberg, B; Heblich, F; Dolphin, AC			PI3K promotes voltage-dependent calcium channel trafficking to the plasma membrane	NATURE NEUROSCIENCE			English	Article							PROTEIN-KINASE-B; G-BETA-GAMMA; GROWTH-FACTOR-I; CA2+ CHANNELS; PHOSPHOINOSITIDE 3-KINASE; PHOSPHATIDYLINOSITOL-3-OH KINASE; SUBUNIT HETEROGENEITY; ENDOPLASMIC-RETICULUM; COUPLED RECEPTORS; ACTIVATION	Phosphatidylinositol 3-kinase (PI3K) has been shown to enhance native voltage-dependent calcium channel (Ca(v)) currents both in myocytes and in neurons; however, the mechanism(s) responsible for this regulation were not known. Here we show that PI3K promotes the translocation of GFP-tagged Ca(v) channels to the plasma membrane in both COS-7 cells and neurons. We show that the effect of PI3K is mediated by Akt/PKB and specifically requires Ca(v)beta(2) subunits. The mutations S574A and S574E in Ca(v)beta(2a) prevented and mimicked, respectively, the effect of PI3K/Akt-PKB, indicating that phosphorylation of Ser574 on Ca(v)beta(2a) is necessary and sufficient to promote Ca(v) channel trafficking.	UCL, Dept Pharmacol, London WC1E 6BT, England; UCL, Dept Physiol, London WC1E 6BT, England; Univ Dusseldorf Klinikum, Inst Biochem & Mol Biol 2, D-40225 Dusseldorf, Germany	University of London; University College London; University of London; University College London; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital	Viard, P (corresponding author), UCL, Dept Pharmacol, Mortimer St, London WC1E 6BT, England.	p.viard@ucl.ac.uk	Dolphin, Annette C/F-7416-2010; halet, guillaume/C-7502-2009; Tuluc, Petronel/C-2527-2011	Dolphin, Annette C/0000-0003-4626-4856; Nurnberg, Bernd/0000-0002-5995-6555; Halet, Guillaume/0000-0002-6204-2105				Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Bertrand L, 1999, J BIOL CHEM, V274, P30927, DOI 10.1074/jbc.274.43.30927; Bichet D, 2000, NEURON, V25, P177, DOI 10.1016/S0896-6273(00)80881-8; Blair LAC, 1997, NEURON, V19, P421, DOI 10.1016/S0896-6273(00)80950-2; Blair LAC, 1999, J NEUROSCI, V19, P1940; Bondeva T, 1998, SCIENCE, V282, P293, DOI 10.1126/science.282.5387.293; Brice NL, 1997, EUR J NEUROSCI, V9, P749, DOI 10.1111/j.1460-9568.1997.tb01423.x; Brock C, 2003, J CELL BIOL, V160, P89, DOI 10.1083/jcb.200210115; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Chien AJ, 1996, J BIOL CHEM, V271, P26465, DOI 10.1074/jbc.271.43.26465; CHIEN AJ, 1995, J BIOL CHEM, V270, P30036; Dolphin AC, 2002, RECEPTOR ION CHANNEL, pOxford; Girard C, 2002, EMBO J, V21, P4439, DOI 10.1093/emboj/cdf469; GRAY A, 1999, BIOCHEM J, V344, P29; Insall RH, 2001, DEV CELL, V1, P743, DOI 10.1016/S1534-5807(01)00086-7; Kanzaki M, 1999, NAT CELL BIOL, V1, P165, DOI 10.1038/11086; Kurosu H, 1997, J BIOL CHEM, V272, P24252, DOI 10.1074/jbc.272.39.24252; Lhuillier L, 2002, J NEUROPHYSIOL, V88, P954, DOI 10.1152/jn.2002.88.2.954; Lie AA, 1999, NEUROSCIENCE, V93, P449, DOI 10.1016/S0306-4522(99)00162-1; LopezIlasaca M, 1997, SCIENCE, V275, P394, DOI 10.1126/science.275.5298.394; Maier U, 1999, J BIOL CHEM, V274, P29311, DOI 10.1074/jbc.274.41.29311; Martin DJ, 2002, NEUROPHARMACOLOGY, V42, P353, DOI 10.1016/S0028-3908(01)00181-2; Murga C, 1998, J BIOL CHEM, V273, P19080, DOI 10.1074/jbc.273.30.19080; O'Kelly I, 2002, CELL, V111, P577, DOI 10.1016/S0092-8674(02)01040-1; Obata T, 2000, J BIOL CHEM, V275, P36108, DOI 10.1074/jbc.M005497200; Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3; Pichler M, 1997, J BIOL CHEM, V272, P13877, DOI 10.1074/jbc.272.21.13877; Raghib A, 2001, J NEUROSCI, V21, P8495, DOI 10.1523/JNEUROSCI.21-21-08495.2001; Rajan S, 2002, J PHYSIOL-LONDON, V545, P13, DOI 10.1113/jphysiol.2002.027052; Rameh LE, 1999, J BIOL CHEM, V274, P8347, DOI 10.1074/jbc.274.13.8347; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; Scott VES, 1996, J BIOL CHEM, V271, P3207, DOI 10.1074/jbc.271.6.3207; Stephens GJ, 1998, J PHYSIOL-LONDON, V509, P15, DOI 10.1111/j.1469-7793.1998.015bo.x; Stephens GJ, 2000, J PHYSIOL-LONDON, V525, P377, DOI 10.1111/j.1469-7793.2000.t01-1-00377.x; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Viard P, 1999, FASEB J, V13, P685, DOI 10.1096/fasebj.13.6.685; Wang QH, 1999, MOL CELL BIOL, V19, P4008; Wu L, 2002, NATURE, V419, P947, DOI 10.1038/nature01118; Yano S, 1998, NATURE, V396, P584, DOI 10.1038/25147	39	200	206	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2004	7	9					939	946		10.1038/nn1300	http://dx.doi.org/10.1038/nn1300			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	849NX	15311280				2022-12-17	WOS:000223546700012
J	Rosoff, WJ; Urbach, JS; Esrick, MA; McAllister, RG; Richards, LJ; Goodhill, GJ				Rosoff, WJ; Urbach, JS; Esrick, MA; McAllister, RG; Richards, LJ; Goodhill, GJ			A new chemotaxis assay shows the extreme sensitivity of axons to molecular gradients	NATURE NEUROSCIENCE			English	Article							NERVE GROWTH-FACTOR; GUIDANCE MOLECULES; CONE; CHEMOATTRACTANT; RECEPTORS; ORIENT; FIBRIN; TRK	Axonal chemotaxis is believed to be important in wiring up the developing and regenerating nervous system, but little is known about how axons actually respond to molecular gradients. We report a new quantitative assay that allows the long-term response of axons to gradients of known and controllable shape to be examined in a three-dimensional gel. Using this assay, we show that axons may be nature's most-sensitive gradient detectors, but this sensitivity exists only within a narrow range of ligand concentrations. This assay should also be applicable to other biological processes that are controlled by molecular gradients, such as cell migration and morphogenesis.	Georgetown Univ, Med Ctr, Dept Neurosci, Washington, DC 20007 USA; Georgetown Univ, Dept Phys, Washington, DC 20057 USA; Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Program Neurosci, Baltimore, MD 21201 USA	Georgetown University; Georgetown University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Goodhill, GJ (corresponding author), Georgetown Univ, Med Ctr, Dept Neurosci, Washington, DC 20007 USA.	geoff@georgetown.edu	Goodhill, Geoffrey J/D-9984-2013; Richards AO, Linda/P-6372-2014	Goodhill, Geoffrey/0000-0001-9789-9355; Richards AO, Linda/0000-0002-7590-7390; Urbach, Jeffrey/0000-0002-1593-520X				Bagnard D, 2000, J NEUROSCI, V20, P1030, DOI 10.1523/JNEUROSCI.20-03-01030.2000; BERG HC, 1977, BIOPHYS J, V20, P193, DOI 10.1016/S0006-3495(77)85544-6; Cao X, 2001, NEUROSCIENCE, V103, P831, DOI 10.1016/S0306-4522(01)00029-X; Caton A, 2000, DEVELOPMENT, V127, P1751; Conti AM, 1997, ANN NEUROL, V42, P838, DOI 10.1002/ana.410420604; Crank J., 1979, MATH DIFFUSION; Dertinger SKW, 2002, P NATL ACAD SCI USA, V99, P12542, DOI 10.1073/pnas.192457199; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Esposito D, 2001, J BIOL CHEM, V276, P32687, DOI 10.1074/jbc.M011674200; Firtel RA, 2000, BIOESSAYS, V22, P603, DOI 10.1002/1521-1878(200007)22:7<603::AID-BIES3>3.0.CO;2-#; Foxman EF, 1997, J CELL BIOL, V139, P1349, DOI 10.1083/jcb.139.5.1349; Gallo G, 1997, J NEUROSCI, V17, P5445; Goodhill GJ, 1998, TRENDS NEUROSCI, V21, P226, DOI 10.1016/S0166-2236(97)01203-4; Goodhill GJ, 1999, J NEUROBIOL, V41, P230, DOI 10.1002/(SICI)1097-4695(19991105)41:2<230::AID-NEU6>3.0.CO;2-9; GUNDERSEN RW, 1979, SCIENCE, V206, P1079, DOI 10.1126/science.493992; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Knapp DM, 1999, EXP CELL RES, V247, P543, DOI 10.1006/excr.1998.4364; LETOURNEAU PC, 1978, DEV BIOL, V66, P183, DOI 10.1016/0012-1606(78)90283-X; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; Ming GL, 2002, NATURE, V417, P411, DOI 10.1038/nature745; MOGHE PV, 1995, J IMMUNOL METHODS, V180, P193, DOI 10.1016/0022-1759(94)00314-M; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; Paves H, 1997, CELL TISSUE RES, V290, P285, DOI 10.1007/s004410050933; Phillips HS, 1996, PHILOS T ROY SOC B, V351, P413, DOI 10.1098/rstb.1996.0036; Rosentreter SM, 1998, J NEUROBIOL, V37, P541, DOI 10.1002/(SICI)1097-4695(199812)37:4<541::AID-NEU4>3.3.CO;2-C; Soeda H, 2002, NEUROSCI LETT, V325, P5, DOI 10.1016/S0304-3940(02)00215-X; Song HJ, 2001, NAT CELL BIOL, V3, pE81, DOI 10.1038/35060164; TESSIERLAVIGNE M, 1991, TRENDS NEUROSCI, V14, P303, DOI 10.1016/0166-2236(91)90142-H; TRANQUILLO RT, 1990, BIOL MOTION, P415; Weaver CM, 2003, J NEUROSCI METH, V124, P197, DOI 10.1016/S0165-0270(03)00017-7; ZHENG JQ, 1994, NATURE, V368, P140, DOI 10.1038/368140a0; ZIGMOND SH, 1977, J CELL BIOL, V75, P606, DOI 10.1083/jcb.75.2.606	32	200	208	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2004	7	6					678	682		10.1038/nn1259	http://dx.doi.org/10.1038/nn1259			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	823VA	15162167				2022-12-17	WOS:000221640300024
J	Halassa, MM; Kastner, S				Halassa, Michael M.; Kastner, Sabine			Thalamic functions in distributed cognitive control	NATURE NEUROSCIENCE			English	Review							LATERAL GENICULATE-NUCLEUS; PRIMARY VISUAL-CORTEX; SPATIAL ATTENTION; ORIENTATION SELECTIVITY; MEDIODORSAL NUCLEUS; PREFRONTAL CORTEX; RECEPTIVE-FIELDS; WORKING-MEMORY; RETINOGENICULATE CONNECTIONS; CORTICAL CONNECTIVITY	Cognition can be conceptualized as a set of algorithmic control functions whose real-time deployment determines how an organism stores and uses information to guide thought and action. A subset of these functions is required for goal-directed selection and amplification of sensory signals-broadly referred to as attention-and for its flexible control and its interaction with processes such as working memory and decision making. While the contribution of recurrent cortical microcircuits to cognition has been extensively studied, the role of the thalamus is just beginning to be elucidated. Here we highlight recent studies across rodents and primates showing how thalamus contributes to attentional control. In addition to high-fidelity information relay to or between cortical regions, thalamic circuits shift and sustain functional interactions within and across cortical areas. This thalamic process enables rapid coordination of spatially segregated cortical computations, thereby constructing task-relevant functional networks. Because such function may be critical for cognitive flexibility, clarifying its mechanisms will likely expand our basic understanding of cognitive control and its perturbation in disease.	[Halassa, Michael M.] MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA; [Halassa, Michael M.] MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Halassa, Michael M.] Broad Inst, Stanley Ctr Psychiat Genet, Cambridge, MA 02142 USA; [Kastner, Sabine] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA; [Kastner, Sabine] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Princeton University; Princeton University	Halassa, MM (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.; Halassa, MM (corresponding author), MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Halassa, MM (corresponding author), Broad Inst, Stanley Ctr Psychiat Genet, Cambridge, MA 02142 USA.	mhalassa@mit.edu		Halassa, Michael/0000-0003-1386-0336; Kastner, Sabine/0000-0002-9742-965X	NIH [R01NS098505, R01MH107680, R00NS078115, R21MH105779, 2R01MH064043-11, 5R01EY017699-09]; NSF [BCS-1328270]; Human Frontiers Science Program; Simons Foundation; Klingenstein Foundation; Sloan Foundation; Feldstein Foundation; Brain & Behavior Research Foundation; Pew Foundation; James S. McDonnell Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Human Frontiers Science Program(Human Frontier Science Program); Simons Foundation; Klingenstein Foundation(Klingenstein Philanthropies); Sloan Foundation(Alfred P. Sloan Foundation); Feldstein Foundation; Brain & Behavior Research Foundation(NARSAD); Pew Foundation; James S. McDonnell Foundation	We gratefully acknowledge funding support from NIH (R01NS098505, R01MH107680, R00NS078115 and R21MH105779 to M.M.H.; 2R01MH064043-11 and 5R01EY017699-09 to S.K.); NSF (BCS-1328270 to S.K.); Human Frontiers Science Program, the Simons Foundation, Klingenstein Foundation, Sloan Foundation, Feldstein Foundation, Brain & Behavior Research Foundation, and Pew Foundation to M.M.H.; and from the James S. McDonnell Foundation to S.K.	Adams MM, 2000, J COMP NEUROL, V419, P377, DOI 10.1002/(SICI)1096-9861(20000410)419:3<377::AID-CNE9>3.0.CO;2-E; Alcaraz F, 2016, EUR J NEUROSCI, V44, P1972, DOI 10.1111/ejn.13316; Allen AE, 2016, J PHYSIOL-LONDON, V594, P1911, DOI 10.1113/JP271707; Alonso JM, 2006, PROG BRAIN RES, V154, P3, DOI 10.1016/S0079-6123(06)54001-4; Arcaro MJ, 2015, J NEUROSCI, V35, P9848, DOI 10.1523/JNEUROSCI.1575-14.2015; Baldwin MKL, 2013, J COMP NEUROL, V521, P1664, DOI 10.1002/cne.23252; Baldwin MKL, 2011, J COMP NEUROL, V519, P1071, DOI 10.1002/cne.22552; Bender DB, 2001, J NEUROPHYSIOL, V85, P219, DOI 10.1152/jn.2001.85.1.219; Bolkan SS, 2017, NAT NEUROSCI, V20, P987, DOI 10.1038/nn.4568; Bridge H, 2016, TRENDS COGN SCI, V20, P146, DOI 10.1016/j.tics.2015.10.003; Buschman TJ, 2015, NEURON, V88, P127, DOI 10.1016/j.neuron.2015.09.017; Buzsaki G, 2012, ANNU REV NEUROSCI, V35, P203, DOI 10.1146/annurev-neuro-062111-150444; Buzsaki Gyorgy, 2012, Dialogues Clin Neurosci, V14, P345; Carandini M, 2012, NAT REV NEUROSCI, V13, P51, DOI 10.1038/nrn3136; Casagrande VA, 2005, PROG BRAIN RES, V149, P11, DOI 10.1016/S0079-6123(05)49002-0; CHALUPA LM, 1989, J NEUROSCI, V9, P347; Chaudhry A, 2015, CLIN GENET, V88, P224, DOI 10.1111/cge.12482; Chen MG, 2014, NEURON, V82, P682, DOI 10.1016/j.neuron.2014.03.023; Cheong SK, 2013, J NEUROSCI, V33, P6864, DOI 10.1523/JNEUROSCI.5208-12.2013; Clasca F, 2012, EUR J NEUROSCI, V35, P1524, DOI 10.1111/j.1460-9568.2012.08033.x; Cossell L, 2015, NATURE, V518, P399, DOI 10.1038/nature14182; CRICK F, 1984, P NATL ACAD SCI-BIOL, V81, P4586, DOI 10.1073/pnas.81.14.4586; Danziger S, 2002, BEHAV NEUROL, V13, P95, DOI 10.1155/2002/917570; Danziger S, 2004, COGN AFFECT BEHAV NE, V4, P89, DOI 10.3758/CABN.4.1.89; DAUM I, 1994, INT J NEUROSCI, V77, P187, DOI 10.3109/00207459408986030; De Weerd P, 1999, NAT NEUROSCI, V2, P753, DOI 10.1038/11234; Dehaene S, 2012, CURR OPIN NEUROBIOL, V22, P937, DOI 10.1016/j.conb.2012.05.006; Denman DJ, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.00020; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Ferster D, 1996, NATURE, V380, P249, DOI 10.1038/380249a0; FitzGerald THB, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005418; FITZPATRICK D, 1983, J NEUROSCI, V3, P673; Friedman-Hill SR, 2003, P NATL ACAD SCI USA, V100, P4263, DOI 10.1073/pnas.0730772100; Fries P, 2015, NEURON, V88, P220, DOI 10.1016/j.neuron.2015.09.034; FUNAHASHI S, 1993, NATURE, V365, P753, DOI 10.1038/365753a0; Fusi S, 2016, CURR OPIN NEUROBIOL, V37, P66, DOI 10.1016/j.conb.2016.01.010; Gallant JL, 2000, NEURON, V27, P227, DOI 10.1016/S0896-6273(00)00032-5; Gambino F, 2014, NATURE, V515, P116, DOI 10.1038/nature13664; Ganguli S, 2008, NEURON, V58, P15, DOI 10.1016/j.neuron.2008.01.038; GIGUERE M, 1988, J COMP NEUROL, V277, P195, DOI 10.1002/cne.902770204; Goldberg JH, 2013, TRENDS NEUROSCI, V36, P695, DOI 10.1016/j.tins.2013.09.001; GOLDMANRAKIC PS, 1985, J COMP NEUROL, V242, P535, DOI 10.1002/cne.902420406; Gottlieb J, 2007, NEURON, V53, P9, DOI 10.1016/j.neuron.2006.12.009; Gottlieb J, 2010, TRENDS COGN SCI, V14, P240, DOI 10.1016/j.tics.2010.03.001; Gregoriou GG, 2009, SCIENCE, V324, P1207, DOI 10.1126/science.1171402; Grieve KL, 2000, TRENDS NEUROSCI, V23, P35, DOI 10.1016/S0166-2236(99)01482-4; Halassa MM, 2016, TRENDS NEUROSCI, V39, P680, DOI 10.1016/j.tins.2016.08.001; Halassa MM, 2014, CELL, V158, P808, DOI 10.1016/j.cell.2014.06.025; Heeger DJ, 2017, P NATL ACAD SCI USA, V114, P1773, DOI 10.1073/pnas.1619788114; Hirsch JA, 2015, ANNU REV NEUROSCI, V38, P309, DOI 10.1146/annurev-neuro-071013-014229; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Jazayeri M, 2017, NEURON, V93, P1003, DOI 10.1016/j.neuron.2017.02.019; Jeffries AM, 2014, J PHYSIOL-PARIS, V108, P3, DOI 10.1016/j.jphysparis.2013.10.001; Jensen O, 2014, TRENDS NEUROSCI, V37, P357, DOI 10.1016/j.tins.2014.04.001; Jonas E, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005268; Jones E G, 1981, Int Rev Physiol, V25, P173; JONES EG, 1991, PROG BRAIN RES, V87, P29; Jones EG, 1998, NEUROSCIENCE, V85, P331, DOI 10.1016/S0306-4522(97)00581-2; Kaas JH, 2007, BRAIN RES REV, V55, P285, DOI 10.1016/j.brainresrev.2007.02.008; Kamigaki T, 2017, NAT NEUROSCI, V20, P854, DOI 10.1038/nn.4554; Karnath HO, 2002, BRAIN, V125, P350, DOI 10.1093/brain/awf032; Kuramoto E, 2017, J COMP NEUROL, V525, P166, DOI 10.1002/cne.24054; Lee WCA, 2016, NATURE, V532, P370, DOI 10.1038/nature17192; Lien AD, 2013, NAT NEUROSCI, V16, P1315, DOI 10.1038/nn.3488; Luckmann HC, 2014, PROG NEUROBIOL, V116, P66, DOI 10.1016/j.pneurobio.2014.02.002; Lundqvist M, 2016, NEURON, V90, P152, DOI 10.1016/j.neuron.2016.02.028; Malpeli JG, 1996, J COMP NEUROL, V375, P363; Marblestone AH, 2016, FRONT COMPUT NEUROSC, V10, DOI 10.3389/fncom.2016.00094; MASON R, 1981, NEUROSCI LETT, V25, P107, DOI 10.1016/0304-3940(81)90316-5; Masterson SP, 2009, J COMP NEUROL, V515, P647, DOI 10.1002/cne.22077; McAlonan K, 2006, J NEUROSCI, V26, P4444, DOI 10.1523/JNEUROSCI.5602-05.2006; McAlonan K, 2008, NATURE, V456, P391, DOI 10.1038/nature07382; Mease RA, 2017, CELL REP, V19, P1130, DOI 10.1016/j.celrep.2017.04.050; Mitchell AS, 2014, J NEUROSCI, V34, P15340, DOI 10.1523/JNEUROSCI.3289-14.2014; Monchi O, 2001, J NEUROSCI, V21, P7733, DOI 10.1523/JNEUROSCI.21-19-07733.2001; Moore T, 2003, NEURON, V40, P671, DOI 10.1016/S0896-6273(03)00716-5; Moore T, 2001, P NATL ACAD SCI USA, V98, P1273, DOI 10.1073/pnas.021549498; Munoz W, 2017, SCIENCE, V355, P954, DOI 10.1126/science.aag2599; Nakajima M, 2017, CURR OPIN NEUROBIOL, V44, P127, DOI 10.1016/j.conb.2017.04.001; Naud R, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002711; Noor A, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001267; O'Connor DH, 2002, NAT NEUROSCI, V5, P1203, DOI 10.1038/nn957; PEI X, 1994, J NEUROSCI, V14, P7130; PETERSEN SE, 1985, J NEUROPHYSIOL, V54, P867, DOI 10.1152/jn.1985.54.4.867; PETERSEN SE, 1987, NEUROPSYCHOLOGIA, V25, P97, DOI 10.1016/0028-3932(87)90046-7; Pinault D, 1998, J COMP NEUROL, V391, P180, DOI 10.1002/(SICI)1096-9861(19980209)391:2<180::AID-CNE3>3.0.CO;2-Z; Pinault D, 2004, BRAIN RES REV, V46, P1, DOI 10.1016/j.brainresrev.2004.04.008; Piscopo DM, 2013, J NEUROSCI, V33, P4642, DOI 10.1523/JNEUROSCI.5187-12.2013; Priebe NJ, 2016, ANNU REV VIS SCI, V2, P85, DOI 10.1146/annurev-vision-111815-114456; Ptak R, 2012, NEUROSCIENTIST, V18, P502, DOI 10.1177/1073858411409051; Purushothaman G, 2012, NAT NEUROSCI, V15, P905, DOI 10.1038/nn.3106; Quang D, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw226; RAFAL RD, 1987, P NATL ACAD SCI USA, V84, P7349, DOI 10.1073/pnas.84.20.7349; Reid RC, 1996, CURR OPIN NEUROBIOL, V6, P475, DOI 10.1016/S0959-4388(96)80052-3; Reynolds JH, 2000, NEURON, V26, P703, DOI 10.1016/S0896-6273(00)81206-4; Reynolds JH, 2009, NEURON, V61, P168, DOI 10.1016/j.neuron.2009.01.002; Rigotti M, 2013, NATURE, V497, P585, DOI 10.1038/nature12160; Rivlin-Etzion M, 2006, CURR OPIN NEUROBIOL, V16, P629, DOI 10.1016/j.conb.2006.10.002; Rockland KS, 1999, J COMP NEUROL, V406, P221, DOI 10.1002/(SICI)1096-9861(19990405)406:2<221::AID-CNE7>3.0.CO;2-K; ROCKLAND KS, 1994, CEREB CORTEX, V4, P300, DOI 10.1093/cercor/4.3.300; Roth MM, 2016, NAT NEUROSCI, V19, P299, DOI 10.1038/nn.4197; Rovo Z, 2012, J NEUROSCI, V32, P17894, DOI 10.1523/JNEUROSCI.2815-12.2012; Saalmann YB, 2012, SCIENCE, V337, P753, DOI 10.1126/science.1223082; Schmitt LI, 2017, MOL PSYCHIATR, V22, P183, DOI 10.1038/mp.2016.183; Schmitt LI, 2017, NATURE, V545, P219, DOI 10.1038/nature22073; Sherman SM, 2016, NAT NEUROSCI, V19, P533, DOI 10.1038/nn.4269; Smith PL, 2009, PSYCHOL REV, V116, P283, DOI 10.1037/a0015156; Snow JC, 2009, P NATL ACAD SCI USA, V106, P4054, DOI 10.1073/pnas.0810086106; Sommer MA, 2006, NATURE, V444, P374, DOI 10.1038/nature05279; TAKAHASHI T, 1985, J COMP NEUROL, V231, P281, DOI 10.1002/cne.902310302; Tohmi M, 2014, CURR BIOL, V24, P587, DOI 10.1016/j.cub.2014.01.061; Usrey WM, 2015, ANNU REV VIS SCI, V1, P351, DOI 10.1146/annurev-vision-082114-035920; Usrey WM, 1999, J NEUROPHYSIOL, V82, P3527, DOI 10.1152/jn.1999.82.6.3527; Van der Werf YD, 2000, NEUROPSYCHOLOGIA, V38, P613, DOI 10.1016/S0028-3932(99)00104-9; Van der Werf YD, 2003, NEUROPSYCHOLOGIA, V41, P1330, DOI 10.1016/S0028-3932(03)00059-9; Wallis JD, 2001, NATURE, V411, P953, DOI 10.1038/35082081; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; Wang XL, 2016, NEURON, V90, P400, DOI 10.1016/j.neuron.2016.02.035; Wang X, 2011, CURR OPIN NEUROBIOL, V21, P726, DOI 10.1016/j.conb.2011.06.004; Warner CE, 2015, CURR BIOL, V25, P424, DOI 10.1016/j.cub.2014.12.028; Watanabe Y, 2004, J NEUROPHYSIOL, V92, P1756, DOI 10.1152/jn.00995.2003; Watanabe Y, 2012, NEUROSCI BIOBEHAV R, V36, P134, DOI 10.1016/j.neubiorev.2011.05.003; Wells MF, 2016, NATURE, V532, P58, DOI 10.1038/nature17427; White AJR, 1998, J NEUROPHYSIOL, V80, P2063, DOI 10.1152/jn.1998.80.4.2063; Wilke M, 2010, J NEUROSCI, V30, P8650, DOI 10.1523/JNEUROSCI.0953-10.2010; Wimmer RD, 2015, NATURE, V526, P705, DOI 10.1038/nature15398; Zeater N., 2015, CURR BIOL; Zhou HH, 2016, NEURON, V89, P209, DOI 10.1016/j.neuron.2015.11.034	128	199	200	6	56	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2017	20	12					1669	1679		10.1038/s41593-017-0020-1	http://dx.doi.org/10.1038/s41593-017-0020-1			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	FO1HT	29184210				2022-12-17	WOS:000416509800005
J	Crotti, A; Benner, C; Kerman, BE; Gosselin, D; Lagier-Tourenne, C; Zuccato, C; Cattaneo, E; Gage, FH; Cleveland, DW; Glass, CK				Crotti, Andrea; Benner, Christopher; Kerman, Bilal E.; Gosselin, David; Lagier-Tourenne, Clotilde; Zuccato, Chiara; Cattaneo, Elena; Gage, Fred H.; Cleveland, Don W.; Glass, Christopher K.			Mutant Huntingtin promotes autonomous microglia activation via myeloid lineage-determining factors	NATURE NEUROSCIENCE			English	Article							GENE-EXPRESSION; MOTOR-NEURONS; MOUSE MODEL; HIPPOCAMPAL NEUROGENESIS; DISEASE; CHROMATIN; REVEALS; ALS; MORPHOLOGY; ASTROCYTES	Huntington's disease (HD) is a fatal neurodegenerative disorder caused by an extended polyglutamine repeat in the N terminus of the Huntingtin protein (HTT). Reactive microglia and elevated cytokine levels are observed in the brains of HD patients, but the extent to which neuroinflammation results from extrinsic or cell-autonomous mechanisms in microglia is unknown. Using genome-wide approaches, we found that expression of mutant Huntingtin (mHTT) in microglia promoted cell-autonomous pro-inflammatory transcriptional activation by increasing the expression and transcriptional activities of the myeloid lineage-determining factors PU.1 and C/EBPs. We observed elevated levels of PU.1 and its target genes in the brains of mouse models and individuals with HD. Moreover, mHTT-expressing microglia exhibited an increased capacity to induce neuronal death ex vivo and in vivo in the presence of sterile inflammation. These findings suggest a cell-autonomous basis for enhanced microglia reactivity that may influence non-cell-autonomous HD pathogenesis.	[Crotti, Andrea; Gosselin, David; Cleveland, Don W.; Glass, Christopher K.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Benner, Christopher] Salk Inst Biol Studies, Razavi Newman Integrat Genom & Bioinformat Core, La Jolla, CA 92037 USA; [Kerman, Bilal E.; Gage, Fred H.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; [Lagier-Tourenne, Clotilde] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Lagier-Tourenne, Clotilde; Cleveland, Don W.] Ludwig Inst Canc Res, La Jolla, CA USA; [Zuccato, Chiara; Cattaneo, Elena] Univ Milan, Dept Biosci, Milan, Italy; [Zuccato, Chiara; Cattaneo, Elena] Univ Milan, Ctr Stem Cell Res, Milan, Italy; [Glass, Christopher K.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Salk Institute; Salk Institute; University of California System; University of California San Diego; Ludwig Institute for Cancer Research; University of Milan; University of Milan; University of California System; University of California San Diego	Glass, CK (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.	ckg@ucsd.edu	Kerman, Bilal Ersen/W-7237-2019; Cleveland, Don/AAN-9783-2021; lagier-Tourenne, Clotilde/ABE-6303-2020; Glass, Christopher/AAI-3933-2021	Kerman, Bilal Ersen/0000-0003-1106-3288; lagier-Tourenne, Clotilde/0000-0002-3058-8322; Glass, Christopher/0000-0003-4344-3592; ZUCCATO, CHIARA/0000-0003-1771-3392; Cleveland, Don/0000-0002-1934-3682; CATTANEO, ELENA/0000-0002-0755-4917; Benner, Christopher/0000-0002-4618-0719	PHS [R24 MH068855]; CHDI Foundation; US National Institutes of Health [DK091183, DK063491, GM 069338, CA17390]; NATIONAL CANCER INSTITUTE [R01CA173903] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491, R01DK091183] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R24MH068855] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS027036] Funding Source: NIH RePORTER	PHS(United States Department of Health & Human ServicesUnited States Public Health Service); CHDI Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank E. Mejia for Fluoro-Jade B staining, H. Kordasiewicz (ISIS Pharmaceuticals) for providing R6/2 mice, M. McAlonis, J. Artates and J. Boubaker for stereotaxic injection, University of California at San Diego (UCSD) Histology Core for PU.1 staining, the UCSD Human Embryonic Stem Cell Core Facility at Sanford Consortium for Regenerative Medicine for assistance with cell sorting, J. Corey-Bloom (Shiley-Marcos Alzheimer's Disease Research Center) for providing blood samples from HD patients, M. Hayden (University of British Columbia) for providing HTT and mHTT N548 aa original cDNA, S. Georges for assistance in quantification of TUNNEL assay, the Harvard Brain Tissue Resource Center (supported in part by PHS R24 MH068855), New York Brain Bank at Columbia University and Massachusetts General Hospital for HD post-mortem samples. C.L.T. and D.W.C. are supported by the CHDI Foundation. These studies were supported by US National Institutes of Health grants DK091183, DK063491, GM 069338 and CA17390 to C.K.G.	Battista D, 2006, EUR J NEUROSCI, V23, P83, DOI 10.1111/j.1460-9568.2005.04539.x; Bjorkqvist M, 2008, J EXP MED, V205, P1869, DOI 10.1084/jem.20080178; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Bonifer C, 2008, SEMIN IMMUNOL, V20, P257, DOI 10.1016/j.smim.2008.05.001; Brykczynska U, 2010, NAT STRUCT MOL BIOL, V17, P679, DOI 10.1038/nsmb.1821; Chepelev I, 2012, CELL RES, V22, P490, DOI 10.1038/cr.2012.15; Crocker SF, 2006, BRAIN RES, V1088, P176, DOI 10.1016/j.brainres.2006.02.102; Diaz-Hernandez M, 2009, FASEB J, V23, P1893, DOI 10.1096/fj.08-122275; Ferrante RJ, 1997, J NEUROSCI, V17, P3052; Franciosi S, 2012, NEUROBIOL DIS, V45, P438, DOI 10.1016/j.nbd.2011.09.003; Gaspard N, 2009, NAT PROTOC, V4, P1454, DOI 10.1038/nprot.2009.157; Ghisletti S, 2010, IMMUNITY, V32, P317, DOI 10.1016/j.immuni.2010.02.008; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Giorgini F, 2005, NAT GENET, V37, P526, DOI 10.1038/ng1542; Gu XF, 2005, NEURON, V46, P433, DOI 10.1016/j.neuron.2005.03.025; Heikkinen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050717; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Huber R, 2012, CELL SIGNAL, V24, P1287, DOI 10.1016/j.cellsig.2012.02.007; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Khoshnan A, 2004, J NEUROSCI, V24, P7999, DOI 10.1523/JNEUROSCI.2675-04.2004; Kierdorf K, 2013, NAT NEUROSCI, V16, P273, DOI 10.1038/nn.3318; Kohl Z, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-114; Kraft AD, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.02.015; LAWSON LJ, 1990, NEUROSCIENCE, V39, P151, DOI 10.1016/0306-4522(90)90229-W; Lehnardt S, 2003, P NATL ACAD SCI USA, V100, P8514, DOI 10.1073/pnas.1432609100; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Marchetto MCN, 2008, CELL STEM CELL, V3, P649, DOI 10.1016/j.stem.2008.10.001; Marullo M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r9; Medzhitov R, 2010, CELL, V140, P771, DOI 10.1016/j.cell.2010.03.006; Menalled LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049838; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Palazuelos J, 2009, BRAIN, V132, P3152, DOI 10.1093/brain/awp239; Pavese N, 2006, NEUROLOGY, V66, P1638, DOI 10.1212/01.wnl.0000222734.56412.17; Politis M, 2011, HUM BRAIN MAPP, V32, P258, DOI 10.1002/hbm.21008; Ransome MI, 2013, MOL CELL NEUROSCI, V54, P93, DOI 10.1016/j.mcn.2013.01.005; Regha K, 2007, MOL CELL, V27, P353, DOI 10.1016/j.molcel.2007.06.024; REINER A, 1988, P NATL ACAD SCI USA, V85, P5733, DOI 10.1073/pnas.85.15.5733; Saijo K, 2009, CELL, V137, P47, DOI 10.1016/j.cell.2009.01.038; Samii A, 2004, LANCET, V363, P1783, DOI 10.1016/S0140-6736(04)16305-8; Sapp E, 2001, J NEUROPATH EXP NEUR, V60, P161, DOI 10.1093/jnen/60.2.161; Schellenberg GD, 2012, ACTA NEUROPATHOL, V124, P305, DOI 10.1007/s00401-012-0996-2; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Silvestroni A, 2009, NEUROREPORT, V20, P1098, DOI 10.1097/WNR.0b013e32832e34ee; Simpson JM, 2011, NEUROBIOL DIS, V41, P249, DOI 10.1016/j.nbd.2010.09.012; Streit WJ, 1999, PROG NEUROBIOL, V57, P563, DOI 10.1016/S0301-0082(98)00069-0; Tai YF, 2007, BRAIN, V130, P1759, DOI 10.1093/brain/awm044; TROTTIER Y, 1995, NAT GENET, V10, P104, DOI 10.1038/ng0595-104; Tsukada J, 2011, CYTOKINE, V54, P6, DOI 10.1016/j.cyto.2010.12.019; van Gool WA, 2010, LANCET, V375, P773, DOI 10.1016/S0140-6736(09)61158-2; Walsh JC, 2002, IMMUNITY, V17, P665, DOI 10.1016/S1074-7613(02)00452-1; Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7	54	199	209	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2014	17	4					513	U58		10.1038/nn.3668	http://dx.doi.org/10.1038/nn.3668			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AD6XR	24584051	Green Accepted			2022-12-17	WOS:000333405300011
J	Cukur, T; Nishimoto, S; Huth, AG; Gallant, JL				Cukur, Tolga; Nishimoto, Shinji; Huth, Alexander G.; Gallant, Jack L.			Attention during natural vision warps semantic representation across the human brain	NATURE NEUROSCIENCE			English	Article							PREFRONTAL CORTEX; SCENE CATEGORIZATION; NEURAL MECHANISMS; SPATIAL ATTENTION; VISUAL-CORTEX; V4 NEURONS; AREA V4; OBJECTS; SEARCH; IMAGES	Little is known about how attention changes the cortical representation of sensory information in humans. On the basis of neurophysiological evidence, we hypothesized that attention causes tuning changes to expand the representation of attended stimuli at the cost of unattended stimuli. To investigate this issue, we used functional magnetic resonance imaging to measure how semantic representation changed during visual search for different object categories in natural movies. We found that many voxels across occipito-temporal and fronto-parietal cortex shifted their tuning toward the attended category. These tuning shifts expanded the representation of the attended category and of semantically related, but unattended, categories, and compressed the representation of categories that were semantically dissimilar to the target. Attentional warping of semantic representation occurred even when the attended category was not present in the movie; thus, the effect was not a target-detection artifact. These results suggest that attention dynamically alters visual representation to optimize processing of behaviorally relevant objects during natural vision.	[Cukur, Tolga; Nishimoto, Shinji; Huth, Alexander G.; Gallant, Jack L.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Gallant, Jack L.] Univ Calif Berkeley, Program Bioengn, Berkeley, CA 94720 USA; [Gallant, Jack L.] Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Gallant, JL (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.	gallant@berkeley.edu	Cukur, Tolga/Z-5452-2019	Cukur, Tolga/0000-0002-2296-851X; Nishimoto, Shinji/0000-0001-8015-340X	National Eye Institute [EY019684, EY022454]; Center for Science of Information; Center for Science of Information, a National Science Foundation Science and Technology Center [CCF-0939370]; NATIONAL EYE INSTITUTE [R01EY019684, R01EY022454] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Center for Science of Information; Center for Science of Information, a National Science Foundation Science and Technology Center; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank D. Whitney for discussions regarding this manuscript. We also thank J. Gao, N. Bilenko, T. Naselaris, A. Vu and M. Oliver for their help in various aspects of this research. This work was supported by the National Eye Institute (EY019684 and EY022454) and the Center for Science of Information, a National Science Foundation Science and Technology Center, under grant agreement CCF-0939370.	Asaad WF, 2000, J NEUROPHYSIOL, V84, P451, DOI 10.1152/jn.2000.84.1.451; Bartels A, 2004, HUM BRAIN MAPP, V21, P75, DOI 10.1002/hbm.10153; Benjamini Y, 2001, ANN STAT, V29, P1165; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Conner CE, 1997, J NEUROSCI, V17, P3201; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; David SV, 2008, NEURON, V59, P509, DOI 10.1016/j.neuron.2008.07.001; David SV, 2005, NETWORK-COMP NEURAL, V16, P239, DOI 10.1080/09548980500464030; Hasson U, 2004, SCIENCE, V303, P1634, DOI 10.1126/science.1089506; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Huth AG, 2012, NEURON, V76, P1210, DOI 10.1016/j.neuron.2012.10.014; Johnston K, 2006, J COGNITIVE NEUROSCI, V18, P749, DOI 10.1162/jocn.2006.18.5.749; Kay KN, 2008, NATURE, V452, P352, DOI 10.1038/nature06713; Li FF, 2002, P NATL ACAD SCI USA, V99, P9596, DOI 10.1073/pnas.092277599; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; Mazer JA, 2003, NEURON, V40, P1241, DOI 10.1016/S0896-6273(03)00764-5; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; MILLER GA, 1995, COMMUN ACM, V38, P39, DOI 10.1145/219717.219748; Mitchell TM, 2008, SCIENCE, V320, P1191, DOI 10.1126/science.1152876; Naselaris T, 2009, NEURON, V63, P902, DOI 10.1016/j.neuron.2009.09.006; Navalpakkam V, 2007, NEURON, V53, P605, DOI 10.1016/j.neuron.2007.01.018; Nishimoto S, 2011, CURR BIOL, V21, P1641, DOI 10.1016/j.cub.2011.08.031; O'Craven KM, 1999, NATURE, V401, P584, DOI 10.1038/44134; OLSHAUSEN BA, 1993, J NEUROSCI, V13, P4700; Peelen MV, 2009, NATURE, V460, P94, DOI 10.1038/nature08103; Reddy L, 2007, CURR BIOL, V17, P2067, DOI 10.1016/j.cub.2007.10.043; Reynolds JH, 2000, NEURON, V26, P703, DOI 10.1016/S0896-6273(00)81206-4; TURIN GL, 1960, IRE T INFORM THEOR, V6, P311, DOI 10.1109/TIT.1960.1057571; Warden MR, 2010, J NEUROSCI, V30, P15801, DOI 10.1523/JNEUROSCI.1569-10.2010; Womelsdorf T, 2006, NAT NEUROSCI, V9, P1156, DOI 10.1038/nn1748	30	199	199	2	59	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2013	16	6					763	+		10.1038/nn.3381	http://dx.doi.org/10.1038/nn.3381			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	152DE	23603707	Green Submitted, Green Accepted			2022-12-17	WOS:000319509600019
J	Murray, AJ; Sauer, JF; Riedel, G; McClure, C; Ansel, L; Cheyne, L; Bartos, M; Wisden, W; Wulff, P				Murray, Andrew J.; Sauer, Jonas-Frederic; Riedel, Gernot; McClure, Christina; Ansel, Laura; Cheyne, Lesley; Bartos, Marlene; Wisden, William; Wulff, Peer			Parvalbumin-positive CA1 interneurons are required for spatial working but not for reference memory	NATURE NEUROSCIENCE			English	Article							HIPPOCAMPAL; SCHIZOPHRENIA; INHIBITION; BEHAVIOR; NEURONS	Parvalbumin-positive GABAergic interneurons in cortical circuits are hypothesized to control cognitive function. To test this idea directly, we functionally removed parvalbumin-positive interneurons selectively from hippocampal CA1 in mice. We found that parvalbumin-positive interneurons are dispensable for spatial reference, but are essential for spatial working memory.	[Murray, Andrew J.; Sauer, Jonas-Frederic; Riedel, Gernot; McClure, Christina; Ansel, Laura; Cheyne, Lesley; Bartos, Marlene; Wisden, William; Wulff, Peer] Univ Aberdeen, Inst Med Sci, Aberdeen, Scotland	University of Aberdeen	Wulff, P (corresponding author), Univ Aberdeen, Inst Med Sci, Foresterhill, Aberdeen, Scotland.	w.wisden@imperial.ac.uk; p.wulff@abdn.ac.uk	Wisden, William/A-4071-2011	Wisden, William/0000-0003-4743-0334; McClure, Christina/0000-0002-8207-450X; Ansel Bollepalli, Laura/0000-0003-2324-7228; Bollepalli, Laura/0000-0001-5902-059X; Bartos, Marlene/0000-0001-9741-1946; Wulff, Peer/0000-0002-0282-7832; Sauer, Jonas-Frederic/0000-0002-6854-7294	Northern Research Partnership; Biotechnology and Biological Sciences Research Council [BB/H001123/1]; Royal Society; University of Aberdeen; J. Ernest Tait Estate; Lichtenberg Award; Medical Research Council [G0800401, G0601498]; BBSRC [BB/H001123/1] Funding Source: UKRI; MRC [G0800401, G0800399, G0601498] Funding Source: UKRI; Medical Research Council [G0800399] Funding Source: researchfish	Northern Research Partnership; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society(Royal Society of London); University of Aberdeen; J. Ernest Tait Estate; Lichtenberg Award; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank M. Klugmann and T. Kuner for AAV plasmids and technical advice, E. Fuchs and H. Monyer for Pvalb-cre mice, R. Yu for tetanus toxin light chain cDNA, D. Kuhl for the Arc/Arg3.1 cDNA, T. Goetz for bringing the FLEX system to our attention, C. Black for participation in the initial cloning of AAV vectors, P. Teismann and the microscopy core facility at the University of Aberdeen for the use of microscopy equipment, and L. Strachan, A. Plano and S. Deiana for help with surgeries and behavioral testing. We were supported by the Northern Research Partnership (J.-F.S.), Biotechnology and Biological Sciences Research Council grant BB/H001123/1 (P. W.), the Royal Society (M. B. and P. W.), the University of Aberdeen (M. B., W. W. and P. W.), the J. Ernest Tait Estate (W. W.), the Lichtenberg Award (M. B.) and Medical Research Council grants G0800401 (G.R.) and G0601498 (W.W. and P.W.).	Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Baude A, 2007, CEREB CORTEX, V17, P2094, DOI 10.1093/cercor/bhl117; Behrens MM, 2007, SCIENCE, V318, P1645, DOI 10.1126/science.1148045; Fuchs EC, 2007, NEURON, V53, P591, DOI 10.1016/j.neuron.2007.01.031; Glickfeld LL, 2008, J NEUROSCI, V28, P1824, DOI 10.1523/JNEUROSCI.4700-07.2008; Hampson RE, 1999, J NEUROSCI, V19, P1492; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Morris BJ, 2005, CURR OPIN PHARMACOL, V5, P101, DOI 10.1016/j.coph.2004.08.008; OLTON DS, 1979, BEHAV BRAIN SCI, V2, P313, DOI 10.1017/S0140525X00062713; Reisel D, 2002, NAT NEUROSCI, V5, P868, DOI 10.1038/nn910; Riedel G, 1999, NAT NEUROSCI, V2, P898, DOI 10.1038/13202; Wulff P, 2009, P NATL ACAD SCI USA, V106, P3561, DOI 10.1073/pnas.0813176106; Yamamoto M, 2003, J NEUROSCI, V23, P6759; Zhang ZJ, 2002, SCHIZOPHR RES, V55, P1, DOI 10.1016/S0920-9964(01)00188-8	15	199	202	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2011	14	3					297	299		10.1038/nn.2751	http://dx.doi.org/10.1038/nn.2751			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	725MW	21278730	Green Submitted, Green Accepted			2022-12-17	WOS:000287650100008
J	Pouille, F; Marin-Burgin, A; Adesnik, H; Atallah, BV; Scanziani, M				Pouille, Frederic; Marin-Burgin, Antonia; Adesnik, Hillel; Atallah, Bassam V.; Scanziani, Massimo			Input normalization by global feedforward inhibition expands cortical dynamic range	NATURE NEUROSCIENCE			English	Article							BARREL CORTEX; SOMATOSENSORY CORTEX; DENDRITIC INHIBITION; PYRAMIDAL CELLS; IN-VITRO; NEURONS; INTERNEURONS; RAT; NEOCORTEX; NETWORKS	The cortex is sensitive to weak stimuli, but responds to stronger inputs without saturating. The mechanisms that enable this wide range of operation are not fully understood. We found that the amplitude of excitatory synaptic currents necessary to fire rodent pyramidal cells, the threshold excitatory current, increased with stimulus strength. Consequently, the relative contribution of individual afferents in firing a neuron was inversely proportional to the total number of active afferents. Feedforward inhibition, acting homogeneously across pyramidal cells, ensured that threshold excitatory currents increased with stimulus strength. In contrast, heterogeneities in the distribution of excitatory currents in the neuronal population determined the specific set of pyramidal cells recruited. Together, these mechanisms expand the range of afferent input strengths that neuronal populations can represent.	[Pouille, Frederic; Marin-Burgin, Antonia; Adesnik, Hillel; Atallah, Bassam V.; Scanziani, Massimo] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Pouille, Frederic; Marin-Burgin, Antonia; Adesnik, Hillel; Atallah, Bassam V.; Scanziani, Massimo] Univ Calif San Diego, Neurobiol Sect, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Scanziani, M (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA.	massimo@ucsd.edu	Marin-Burgin, Antonia/V-6602-2019	Marin-Burgin, Antonia/0000-0003-0684-9796; Atallah, Bassam/0000-0003-2315-7126	US National Institutes of Health [MH71401, NS061521]; Helen Hay Whithney Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH071401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS061521] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helen Hay Whithney Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank P. Abelkop for anatomical reconstructions of biocytin filled neurons, F. Frhlich for developing the initial versions of model, M. Carandini and J. Isaacson for comments and suggestions during the entire course of the project, C. Poo and F. Bertaso for inputs on the manuscript, and all of the members of the Scanziani laboratory for their input on the project and the manuscript. M. S. thanks C. Staub for the original discussions leading to the project. This work was funded in part by the US National Institutes of Health (MH71401 to M. S. and NS061521 to B. V. A.). H. A. is a fellow of the Helen Hay Whithney Foundation. M. S. is an investigator of the Howard Hughes Medical Institute.	AGMON A, 1991, NEUROSCIENCE, V41, P365, DOI 10.1016/0306-4522(91)90333-J; ALGER BE, 1982, J PHYSIOL-LONDON, V328, P105, DOI 10.1113/jphysiol.1982.sp014255; Arabzadeh E, 2005, PLOS BIOL, V3, P155, DOI 10.1371/journal.pbio.0030017; Beierlein M, 2003, J NEUROPHYSIOL, V90, P2987, DOI 10.1152/jn.00283.2003; Blitz DM, 2005, NEURON, V45, P917, DOI 10.1016/j.neuron.2005.01.033; Bruno RM, 2006, SCIENCE, V312, P1622, DOI 10.1126/science.1124593; BUHL EH, 1994, NATURE, V368, P823, DOI 10.1038/368823a0; BUZSAKI G, 1984, PROG NEUROBIOL, V22, P131, DOI 10.1016/0301-0082(84)90023-6; Carvalho TP, 2009, NEURON, V61, P774, DOI 10.1016/j.neuron.2009.01.013; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Cruikshank SJ, 2007, NAT NEUROSCI, V10, P462, DOI 10.1038/nn1861; Csicsvari J, 2000, NEURON, V28, P585, DOI 10.1016/S0896-6273(00)00135-5; Daw MI, 2007, NAT NEUROSCI, V10, P453, DOI 10.1038/nn1866; Diesmann M, 1999, NATURE, V402, P529, DOI 10.1038/990101; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022; Geiger JRP, 1997, NEURON, V18, P1009, DOI 10.1016/S0896-6273(00)80339-6; Glickfeld LL, 2006, NAT NEUROSCI, V9, P807, DOI 10.1038/nn1688; Helmstaedter M, 2008, J NEUROSCI, V28, P8273, DOI 10.1523/JNEUROSCI.5701-07.2008; Holmgren C, 2003, J PHYSIOL-LONDON, V551, P139, DOI 10.1113/jphysiol.2003.044784; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Maccaferri G, 2002, J NEUROSCI, V22, P5462; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Mitchell SJ, 2003, NEURON, V38, P433, DOI 10.1016/S0896-6273(03)00200-9; Mittmann W, 2005, J PHYSIOL-LONDON, V563, P369, DOI 10.1113/jphysiol.2004.075028; Nakamura M, 2007, J NEUROSCI, V27, P1365, DOI 10.1523/JNEUROSCI.4672-06.2007; NICOLL RA, 1980, NATURE, V287, P22, DOI 10.1038/287022a0; OTMAKHOV N, 1993, NEURON, V10, P1101, DOI 10.1016/0896-6273(93)90058-Y; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Poo C, 2009, NEURON, V62, P850, DOI 10.1016/j.neuron.2009.05.022; Porter JT, 2001, J NEUROSCI, V21, P2699, DOI 10.1523/JNEUROSCI.21-08-02699.2001; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; SAYER RJ, 1990, J NEUROSCI, V10, P826; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Shu YS, 2003, J NEUROSCI, V23, P10388; Sneider JT, 2006, NEUROSCIENCE, V141, P1665, DOI 10.1016/j.neuroscience.2006.05.052; Somogyi P, 2005, J PHYSIOL-LONDON, V562, P9, DOI 10.1113/jphysiol.2004.078915; STEIGER JH, 1980, PSYCHOL BULL, V87, P245, DOI 10.1037/0033-2909.87.2.245; Thomson AM, 2002, CEREB CORTEX, V12, P936, DOI 10.1093/cercor/12.9.936; Vaillend C, 2002, J NEUROPHYSIOL, V88, P2963, DOI 10.1152/jn.00244.2002; Vogels TP, 2005, J NEUROSCI, V25, P10786, DOI 10.1523/JNEUROSCI.3508-05.2005; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Winegar BD, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-5	44	199	199	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2009	12	12					1577	U131		10.1038/nn.2441	http://dx.doi.org/10.1038/nn.2441			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	523II	19881502				2022-12-17	WOS:000272065600018
J	Yamane, Y; Carlson, ET; Bowman, KC; Wang, ZH; Connor, CE				Yamane, Yukako; Carlson, Eric T.; Bowman, Katherine C.; Wang, Zhihong; Connor, Charles E.			A neural code for three-dimensional object shape in macaque inferotemporal cortex	NATURE NEUROSCIENCE			English	Article							INFERIOR TEMPORAL CORTEX; AREA V4; CEREBRAL-CORTEX; VISUAL-CORTEX; RECOGNITION; REPRESENTATION; NEURONS; FEATURES; MONKEY; SELECTIVITY	Previous investigations of the neural code for complex object shape have focused on two-dimensional pattern representation. This may be the primary mode for object vision given its simplicity and direct relation to the retinal image. In contrast, three-dimensional shape representation requires higher-dimensional coding derived from extensive computation. We found evidence for an explicit neural code for complex three-dimensional object shape. We used an evolutionary stimulus strategy and linear/nonlinear response models to characterize three-dimensional shape responses in macaque monkey inferotemporal cortex ( IT). We found widespread tuning for three-dimensional spatial configurations of surface fragments characterized by their three-dimensional orientations and joint principal curvatures. Configural representation of three-dimensional shape could provide specific knowledge of object structure to support guidance of complex physical interactions and evaluation of object functionality and utility.	[Yamane, Yukako; Carlson, Eric T.; Bowman, Katherine C.; Wang, Zhihong; Connor, Charles E.] Johns Hopkins Univ, Zanvyl Krieger Mind Brain Inst, Baltimore, MD 21218 USA; [Carlson, Eric T.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Bowman, Katherine C.; Connor, Charles E.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Connor, CE (corresponding author), Johns Hopkins Univ, Zanvyl Krieger Mind Brain Inst, 3400 N Charles St, Baltimore, MD 21218 USA.	connor@jhu.edu		yamane, yukako/0000-0002-3348-1942	US National Institutes of Health; NATIONAL EYE INSTITUTE [R01EY016711] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank B. Nash, B. Quinlan, C. Moses and L. Guruvadoo for technical support, and J. Bastian, A. Bastian, T. Poggio and M. Riesenhuber for comments on the manuscript. This work was supported by a grant from the US National Institutes of Health to C. E. C.	Anzai A, 2007, NAT NEUROSCI, V10, P1313, DOI 10.1038/nn1975; Baker CI, 2002, NAT NEUROSCI, V5, P1210, DOI 10.1038/nn960; Barenholtz E, 2007, PSYCHOL LEARN MOTIV, V47, P157, DOI 10.1016/S0079-7421(06)47005-5; BIEDERMAN I, 1987, PSYCHOL REV, V94, P115, DOI 10.1037/0033-295X.94.2.115; Brincat SL, 2006, NEURON, V49, P17, DOI 10.1016/j.neuron.2005.11.026; Brincat SL, 2004, NAT NEUROSCI, V7, P880, DOI 10.1038/nn1278; BULTHOFF HH, 1995, CEREB CORTEX, V5, P247, DOI 10.1093/cercor/5.3.247; Connor CE, 2007, CURR OPIN NEUROBIOL, V17, P140, DOI 10.1016/j.conb.2007.03.002; Edelman S, 1991, Curr Opin Neurobiol, V1, P270; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Freedman DJ, 2001, SCIENCE, V291, P312, DOI 10.1126/science.291.5502.312; FUJITA I, 1992, NATURE, V360, P343, DOI 10.1038/360343a0; GALLANT JL, 1993, SCIENCE, V259, P100, DOI 10.1126/science.8418487; GROSS CG, 1972, J NEUROPHYSIOL, V35, P96, DOI 10.1152/jn.1972.35.1.96; Hinkle DA, 2002, NAT NEUROSCI, V5, P665, DOI 10.1038/nn875; HOFFMAN DD, 1984, COGNITION, V18, P65, DOI 10.1016/0010-0277(84)90022-2; Ito M, 2004, J NEUROSCI, V24, P3313, DOI 10.1523/JNEUROSCI.4364-03.2004; ITO M, 1995, J NEUROPHYSIOL, V73, P218, DOI 10.1152/jn.1995.73.1.218; Janssen P, 2000, NEURON, V27, P385, DOI 10.1016/S0896-6273(00)00045-3; Janssen P, 2000, SCIENCE, V288, P2054, DOI 10.1126/science.288.5473.2054; Janssen P, 1999, P NATL ACAD SCI USA, V96, P8217, DOI 10.1073/pnas.96.14.8217; KOBATAKE E, 1994, J NEUROPHYSIOL, V71, P856, DOI 10.1152/jn.1994.71.3.856; KOENDERINK JJ, 1984, PERCEPTION, V13, P321, DOI 10.1068/p130321; Kourtzi Z, 2001, SCIENCE, V293, P1506, DOI 10.1126/science.1061133; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; MARR D, 1978, PROC R SOC SER B-BIO, V200, P269, DOI 10.1098/rspb.1978.0020; Pasupathy A, 1999, J NEUROPHYSIOL, V82, P2490, DOI 10.1152/jn.1999.82.5.2490; Pasupathy A, 2001, J NEUROPHYSIOL, V86, P2505, DOI 10.1152/jn.2001.86.5.2505; Pasupathy A, 2002, NAT NEUROSCI, V5, P1332, DOI 10.1038/nn972; Quiroga RQ, 2005, NATURE, V435, P1102, DOI 10.1038/nature03687; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; Roelfsema PR, 2006, ANNU REV NEUROSCI, V29, P203, DOI 10.1146/annurev.neuro.29.051605.112939; Rolls ET, 1990, NETWORK-COMP NEURAL, V1, P407, DOI 10.1088/0954-898X/1/4/002; Rust NC, 2006, NAT NEUROSCI, V9, P1421, DOI 10.1038/nn1786; Sakata H, 1998, PHILOS T ROY SOC B, V353, P1363, DOI 10.1098/rstb.1998.0290; SCHWARTZ EL, 1983, P NATL ACAD SCI-BIOL, V80, P5776, DOI 10.1073/pnas.80.18.5776; Serre T, 2007, P NATL ACAD SCI USA, V104, P6424, DOI 10.1073/pnas.0700622104; TARR MJ, 1989, COGNITIVE PSYCHOL, V21, P233, DOI 10.1016/0010-0285(89)90009-1; Tsao DY, 2003, NAT NEUROSCI, V6, P989, DOI 10.1038/nn1111; Tsunoda K, 2001, NAT NEUROSCI, V4, P832, DOI 10.1038/90547; Uka T, 2000, J NEUROPHYSIOL, V84, P120, DOI 10.1152/jn.2000.84.1.120; Ungerleider LG, 1982, ANAL VISUAL BEHAV, P549; VETTER T, 1995, CEREB CORTEX, V5, P261, DOI 10.1093/cercor/5.3.261; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; Wang G, 2005, NAT NEUROSCI, V8, P1568, DOI 10.1038/nn1600; Watanabe M, 2002, J NEUROPHYSIOL, V87, P1960, DOI 10.1152/jn.00780.2000	46	199	204	0	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2008	11	11					1352	1360		10.1038/nn.2202	http://dx.doi.org/10.1038/nn.2202			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	366HZ	18836443	Green Accepted			2022-12-17	WOS:000260472700025
J	Fiorillo, CD; Newsome, WT; Schultz, W				Fiorillo, Christopher D.; Newsome, William T.; Schultz, Wolfram			The temporal precision of reward prediction in dopamine neurons	NATURE NEUROSCIENCE			English	Article							DELAYED-RESPONSE TASK; PREFRONTAL CORTEX; MIDBRAIN DOPAMINE; SIGNAL; TIME; REPRESENTATION; MACAQUE; MONKEY; ERROR; MODEL	Midbrain dopamine neurons are activated when reward is greater than predicted, and this error signal could teach target neurons both the value of reward and when it will occur. We used the dopamine error signal to measure how the expectation of reward was distributed over time. Animals were trained with fixed-duration intervals of 1-16 s between conditioned stimulus onset and reward. In contrast to the weak responses that have been observed after short intervals (1-2 s), activations to reward increased steeply and linearly with the logarithm of the interval. Results with varied stimulus-reward intervals suggest that the neural expectation was substantial after just half an interval had elapsed. Thus, the neural expectation of reward in these experiments was not highly precise and the precision declined sharply with interval duration. The neural precision of expectation appeared to be at least qualitatively similar to the precision of anticipatory licking behavior.	[Fiorillo, Christopher D.; Newsome, William T.] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA; [Schultz, Wolfram] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3DY, England	Stanford University; University of Cambridge	Fiorillo, CD (corresponding author), Stanford Univ, Dept Neurobiol, Fairchild Bldg,D209,299 Campus Dr W, Stanford, CA 94305 USA.	chris@monkeybiz.stanford.edu	Fiorillo, Christopher Dante/C-1718-2011; Newsome, William T./W-7171-2019; schultz, wolfram/H-8958-2016	Fiorillo, Christopher/0000-0002-7232-9505; schultz, wolfram/0000-0002-8530-4518	Medical Research Council [G0001354B] Funding Source: researchfish; NATIONAL EYE INSTITUTE [R01EY005603, R37EY005603] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; Medical Research Council [G0001354] Funding Source: Medline; NEI NIH HHS [EY 05603] Funding Source: Medline; Wellcome Trust [095495] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Wellcome Trust(Wellcome Trust)		BATESON M, 1995, ANIM BEHAV, V50, P431, DOI 10.1006/anbe.1995.0257; Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Berns GS, 1998, J COGNITIVE NEUROSCI, V10, P108, DOI 10.1162/089892998563815; Brody CD, 2003, CEREB CORTEX, V13, P1196, DOI 10.1093/cercor/bhg100; Brown J, 1999, J NEUROSCI, V19, P10502; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Contreras-Vidal JL, 1999, J COMPUT NEUROSCI, V6, P191, DOI 10.1023/A:1008862904946; Daw ND, 2006, NEURAL COMPUT, V18, P1637, DOI 10.1162/neco.2006.18.7.1637; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Ghose GM, 2002, NATURE, V419, P616, DOI 10.1038/nature01057; Gibbon J, 1997, CURR OPIN NEUROBIOL, V7, P170, DOI 10.1016/S0959-4388(97)80005-0; GROSSBERG S, 1989, NEURAL NETWORKS, V2, P79, DOI 10.1016/0893-6080(89)90026-9; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; Houk JC, 1995, MODELS INFORM PROCES, P249; Janssen P, 2005, NAT NEUROSCI, V8, P234, DOI 10.1038/nn1386; Kacelnik A, 1998, J THEOR BIOL, V194, P289, DOI 10.1006/jtbi.1998.0763; Komura Y, 2001, NATURE, V412, P546, DOI 10.1038/35087595; Leon MI, 2003, NEURON, V38, P317, DOI 10.1016/S0896-6273(03)00185-5; Matell MS, 2004, COGNITIVE BRAIN RES, V21, P139, DOI 10.1016/j.cogbrainres.2004.06.012; Mauk MD, 2004, ANNU REV NEUROSCI, V27, P307, DOI 10.1146/annurev.neuro.27.070203.144247; Meck WH, 1996, COGNITIVE BRAIN RES, V3, P227, DOI 10.1016/0926-6410(96)00009-2; Medina JF, 2002, NATURE, V416, P330, DOI 10.1038/416330a; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Morris G, 2004, NEURON, V43, P133, DOI 10.1016/j.neuron.2004.06.012; Nakahara H, 2004, NEURON, V41, P269, DOI 10.1016/S0896-6273(03)00869-9; Nieder A, 2003, NEURON, V37, P149, DOI 10.1016/S0896-6273(02)01144-3; O'Reilly RC, 2007, BEHAV NEUROSCI, V121, P31, DOI 10.1037/0735-7044.121.1.31; Pan WX, 2005, J NEUROSCI, V25, P6235, DOI 10.1523/JNEUROSCI.1478-05.2005; Rakitin BC, 1998, J EXP PSYCHOL-ANIM B, V24, P15, DOI 10.1037/0097-7403.24.1.15; Rao SM, 2001, NAT NEUROSCI, V4, P317, DOI 10.1038/85191; Renoult L, 2006, EUR J NEUROSCI, V23, P3098, DOI 10.1111/j.1460-9568.2006.04824.x; Satoh T, 2003, J NEUROSCI, V23, P9913; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; SCHULTZ W, 1993, J NEUROSCI, V13, P900; SCHULTZ W, 1987, J NEUROPHYSIOL, V57, P201, DOI 10.1152/jn.1987.57.1.201; Suri RE, 1999, NEUROSCIENCE, V91, P871, DOI 10.1016/S0306-4522(98)00697-6; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370	38	199	203	1	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2008	11	8					966	973		10.1038/nn.2159	http://dx.doi.org/10.1038/nn.2159			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	330UU	18660807				2022-12-17	WOS:000257969100023
J	Rouach, N; Byrd, K; Petralia, RS; Elias, GM; Adesnik, H; Tomita, S; Karimzadegan, S; Kealey, C; Bredt, DS; Nicoll, RA				Rouach, N; Byrd, K; Petralia, RS; Elias, GM; Adesnik, H; Tomita, S; Karimzadegan, S; Kealey, C; Bredt, DS; Nicoll, RA			TARP gamma-8 controls hippocampal AMPA receptor number, distribution and synaptic plasticity	NATURE NEUROSCIENCE			English	Article							CALCIUM-CHANNEL SUBUNITS; LONG-TERM POTENTIATION; EXCITATORY SYNAPSES; ENDOPLASMIC-RETICULUM; GLUTAMATE RECEPTORS; KAINATE RECEPTORS; MOUSE STARGAZER; CA2+ CHANNELS; MUTANT MOUSE; GENE FAMILY	Synaptic plasticity involves activity-dependent trafficking of AMPA-type glutamate receptors. Numerous cytoplasmic scaffolding proteins are postulated to control AMPA receptor trafficking, but the detailed mechanisms remain unclear. Here, we show that the transmembrane AMPA receptor regulatory protein (TARP) gamma-8, which is preferentially expressed in the mouse hippocampus, is important for AMPA receptor protein levels and extrasynaptic surface expression. By controlling the number of AMPA receptors, gamma-8 is also important in long-term potentiation, but not long-term depression. This study establishes gamma-8 as a critical protein for basal AMPA receptor expression and localization at extrasynaptic sites in the hippocampus and raises the possibility that TARP-dependent control of AMPA receptors during synapse development and plasticity may be widespread.	Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Natl Inst Deafness & Other Commun Disorders, Neurochem Lab, NIH, Bethesda, MD 20892 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Nicoll, RA (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA.	nicoll@cmp.ucsf.edu	Rouach, Nathalie/L-4767-2017	Rouach, Nathalie/0000-0002-5574-888X	Intramural NIH HHS Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Andrianopoli L, 2003, J HIGH ENERGY PHYS; Arikkath J, 2003, CURR OPIN NEUROBIOL, V13, P298, DOI 10.1016/S0959-4388(03)00066-7; Barry MF, 2002, CURR OPIN NEUROBIOL, V12, P279, DOI 10.1016/S0959-4388(02)00329-X; Bogdanov Y, 2000, EUR J NEUROSCI, V12, P894, DOI 10.1046/j.1460-9568.2000.00981.x; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Brice NL, 1997, EUR J NEUROSCI, V9, P749, DOI 10.1111/j.1460-9568.1997.tb01423.x; Burgess DL, 2001, GENOMICS, V71, P339, DOI 10.1006/geno.2000.6440; Castillo PE, 1997, NATURE, V388, P182, DOI 10.1038/40645; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Chen L, 1999, P NATL ACAD SCI USA, V96, P12132, DOI 10.1073/pnas.96.21.12132; CHIEN AJ, 1995, J BIOL CHEM, V270, P30036; Chu PJ, 2001, GENE, V280, P37, DOI 10.1016/S0378-1119(01)00738-7; Dingledine R, 1999, PHARMACOL REV, V51, P7; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Fremeau RT, 2004, SCIENCE, V304, P1815, DOI 10.1126/science.1097468; Garner CC, 2000, TRENDS CELL BIOL, V10, P274, DOI 10.1016/S0962-8924(00)01783-9; Hashimoto K, 1999, J NEUROSCI, V19, P6027, DOI 10.1523/JNEUROSCI.19-14-06027.1999; Henze DA, 2000, NEUROSCIENCE, V98, P407, DOI 10.1016/S0306-4522(00)00146-9; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; HOLLMANN M, 1994, NEURON, V13, P1331, DOI 10.1016/0896-6273(94)90419-7; HURTLEY SM, 1989, ANNU REV CELL BIOL, V5, P277, DOI 10.1146/annurev.cb.05.110189.001425; Jensen V, 2003, J PHYSIOL-LONDON, V553, P843, DOI 10.1113/jphysiol.2003.053637; Klugbauer N, 2000, FEBS LETT, V470, P189, DOI 10.1016/S0014-5793(00)01306-5; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Letts VA, 1998, NAT GENET, V19, P340, DOI 10.1038/1228; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Meng YH, 2003, NEURON, V39, P163, DOI 10.1016/S0896-6273(03)00368-4; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; Sans N, 2001, J NEUROSCI, V21, P7506, DOI 10.1523/JNEUROSCI.21-19-07506.2001; Scannevin RH, 2000, NAT REV NEUROSCI, V1, P133, DOI 10.1038/35039075; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; Sheng M, 2001, P NATL ACAD SCI USA, V98, P7058, DOI 10.1073/pnas.111146298; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Tomita S, 2005, NATURE, V435, P1052, DOI 10.1038/nature03624; Tomita S, 2003, J CELL BIOL, V161, P805, DOI 10.1083/jcb.200212116; Tomita S, 2005, NEURON, V45, P269, DOI 10.1016/j.neuron.2005.01.009; Vandenberghe W, 2005, J NEUROSCI, V25, P1095, DOI 10.1523/JNEUROSCI.3568-04.2005; Vignes M, 1997, NATURE, V388, P179, DOI 10.1038/40639; Wisden W, 1993, Curr Opin Neurobiol, V3, P291, DOI 10.1016/0959-4388(93)90120-N; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4	42	199	205	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2005	8	11					1525	1533		10.1038/nn1551	http://dx.doi.org/10.1038/nn1551			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	979TB	16222232				2022-12-17	WOS:000232966600027
J	Seki, K; Perlmutter, SI; Fetz, EE				Seki, K; Perlmutter, SI; Fetz, EE			Sensory input to primate spinal cord is presynaptically inhibited during voluntary movement	NATURE NEUROSCIENCE			English	Article							PRIMARY AFFERENT DEPOLARIZATION; SOMATOSENSORY-EVOKED-POTENTIALS; POSTSYNAPTIC DORSAL COLUMN; FICTIVE LOCOMOTION; EXCITABILITY CHANGES; CENTRAL TERMINALS; REFLEX RESPONSES; CUNEATE NUCLEUS; MOTOR UNITS; CAT	During normal voluntary movements, re-afferent sensory input continuously converges on the spinal circuits that are activated by descending motor commands. This time-varying input must either be synergistically combined with the motor commands or be appropriately suppressed to minimize interference. The earliest suppression could be produced by presynaptic inhibition, which effectively reduces synaptic transmission at the initial synapse. Here we report evidence from awake, behaving monkeys that presynaptic inhibition decreases the ability of afferent impulses to affect postsynaptic neurons in a behaviorally dependent manner. Evidence indicates that cutaneous afferent input to spinal cord interneurons is inhibited presynaptically during active wrist movement, and this inhibition is effectively produced by descending commands. Our results further suggest that this presynaptic inhibition has appropriate functional consequences for movement generation and may underlie increases in perceptual thresholds during active movement.	Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; Univ Washington, Washington Natl Primate Res Ctr, Seattle, WA 98195 USA; Natl Inst Physiol Sci, Dept Integrat Physiol, Aichi 4448585, Japan	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Seki, K (corresponding author), Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA.	kazuseki@nips.ac.jp		Seki, Kazuhiko/0000-0002-4262-9590; Perlmutter, Steve/0000-0002-1149-4152	NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000166] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS012542, R01NS012542, R29NS036781] Funding Source: NIH RePORTER; NCRR NIH HHS [RR00166] Funding Source: Medline; NINDS NIH HHS [NS 12542, NS36781] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSEN P, 1964, J NEUROPHYSIOL, V27, P92, DOI 10.1152/jn.1964.27.1.92; ANGEL RW, 1982, EXP NEUROL, V77, P266, DOI 10.1016/0014-4886(82)90244-8; BALDISSE.F, 1967, EXPERIENTIA, V23, P398, DOI 10.1007/BF02144542; Baldissera F, 1981, HDB PHYSL NERVOUS SY, P509, DOI [10.1002/cphy.cp010212, DOI 10.1002/CPHY.CP010212]; BRINK E, 1984, J NEUROPHYSIOL, V51, P432, DOI 10.1152/jn.1984.51.3.432; BURKE D, 1994, J PHYSIOL-LONDON, V480, P191, DOI 10.1113/jphysiol.1994.sp020352; BURKE RE, 1970, J PHYSIOL-LONDON, V207, P709, DOI 10.1113/jphysiol.1970.sp009090; CAIMS BE, 1996, J NEUROPHYSIOL, V75, P1152; CAPADAY C, 1986, J NEUROSCI, V6, P1308; CARPENTER D, 1963, ACTA PHYSIOL SCAND, V59, P126, DOI 10.1111/j.1748-1716.1963.tb02729.x; CLIFFER KD, 1994, J COMP NEUROL, V345, P84, DOI 10.1002/cne.903450106; Dick SH, 2001, BRAIN RES, V914, P134, DOI 10.1016/S0006-8993(01)02787-1; DUENAS SH, 1988, EXP BRAIN RES, V70, P15; DUYSENS J, 1993, BRAIN RES, V613, P230, DOI 10.1016/0006-8993(93)90903-Z; ECCLES JC, 1963, J NEUROPHYSIOL, V26, P646, DOI 10.1152/jn.1963.26.4.646; ECCLES JC, 1961, J PHYSL, V159, P47; EGGER MD, 1986, BRAIN RES, V383, P68, DOI 10.1016/0006-8993(86)90009-0; EGUIBAR JR, 1994, BRAIN RES, V643, P328, DOI 10.1016/0006-8993(94)90042-6; Ennis M, 2001, J NEUROPHYSIOL, V86, P2986, DOI 10.1152/jn.2001.86.6.2986; FETZ EE, 1968, J NEUROPHYSIOL, V31, P69, DOI 10.1152/jn.1968.31.1.69; FETZ EE, 1980, J NEUROPHYSIOL, V43, P1070, DOI 10.1152/jn.1980.43.4.1070; FETZ EE, 1989, PROG BRAIN RES, V80, P437; FLAMENT D, 1992, J NEUROPHYSIOL, V67, P875, DOI 10.1152/jn.1992.67.4.875; FRANK K, 1959, IRE T MED ELECTRON, V6, P85, DOI 10.1109/IRET-ME.1959.5007923; GARNETT R, 1980, J PHYSIOL-LONDON, V303, P351, DOI 10.1113/jphysiol.1980.sp013290; GOSSARD JP, 1990, BRAIN RES, V537, P14, DOI 10.1016/0006-8993(90)90334-8; Haugland M., 1996, 18 ANN INT C IEEE EN; HONGO T, 1989, BRAIN RES, V505, P167, DOI 10.1016/0006-8993(89)90132-7; HULLIGER M, 1979, J PHYSIOL-LONDON, V291, P233, DOI 10.1113/jphysiol.1979.sp012809; HULTBORN H, 1987, J PHYSIOL-LONDON, V389, P757, DOI 10.1113/jphysiol.1987.sp016681; JANIG W, 1968, EXP BRAIN RES, V6, P116; Jankowska E, 2002, J PHYSIOL-LONDON, V542, P287, DOI 10.1113/jphysiol.2001.014068; JENNER JR, 1982, J PHYSIOL-LONDON, V333, P405, DOI 10.1113/jphysiol.1982.sp014461; JIMENEZ I, 1987, EXP BRAIN RES, V69, P195; KRIZ N, 1974, J PHYSIOL-LONDON, V238, P1; Menard A, 2002, J NEUROPHYSIOL, V88, P163, DOI 10.1152/jn.2002.88.1.163; Miller RJ, 1998, ANNU REV PHARMACOL, V38, P201, DOI 10.1146/annurev.pharmtox.38.1.201; MILNE RJ, 1988, EXP BRAIN RES, V70, P569; MORRISON AR, 1966, NATURE, V210, P201, DOI 10.1038/210201a0; MOSCHOVAKIS AK, 1991, EXP BRAIN RES, V83, P489; NIELSEN J, 1993, J PHYSIOL-LONDON, V464, P575, DOI 10.1113/jphysiol.1993.sp019652; PECCISAA.J, 1966, NATURE, V210, P740, DOI 10.1038/210740a0; Perlmutter SI, 1998, J NEUROPHYSIOL, V80, P2475, DOI 10.1152/jn.1998.80.5.2475; Rudomin P, 1999, EXP BRAIN RES, V129, P1, DOI 10.1007/s002210050933; RUSHTON DN, 1981, BRAIN, V104, P465, DOI 10.1093/brain/104.3.465; RUSTIONI A, 1977, SCIENCE, V196, P656, DOI 10.1126/science.404704; RUSTIONI A, 1979, BRAIN, V102, P95, DOI 10.1093/brain/102.1.95; Shimazu H, 1999, NEUROREPORT, V10, P2457, DOI 10.1097/00001756-199908200-00004; WALL PD, 1958, J PHYSIOL-LONDON, V142, P1; Willis Jr W. D., 1991, SENSORY MECH SPINAL	50	199	202	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2003	6	12					1309	1316		10.1038/nn1154	http://dx.doi.org/10.1038/nn1154			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	746BC	14625555				2022-12-17	WOS:000186725600016
J	Dahanukar, A; Foster, K; van Naters, WMVDG; Carlson, JR				Dahanukar, A; Foster, K; van Naters, WMVDG; Carlson, JR			A Gr receptor is required for response to the sugar trehalose in taste neurons of Drosophila	NATURE NEUROSCIENCE			English	Article							SWEET TASTE; GENE; FAMILY; MELANOGASTER; SENSITIVITY; IDENTIFICATION; PROJECTIONS; MOUTHPARTS; EXPRESSION	We recently identified from the Drosophila genome database a large family of G protein-coupled receptor genes, the Gr genes, and predicted that they encode taste receptors on the basis of their structure and specificity of expression. The expression of Gr genes in gustatory neurons has subsequently been confirmed and 56 family members have been reported. Here we provide functional evidence that one Gr gene, Gr5a, encodes a taste receptor required for response to the sugar trehalose. In two different mutants that carry deletions in Gr5a, electrophysiological and behavioral responses to trehalose were diminished but the response to sucrose was unaffected. Transgenic rescue experiments showed that Gr5a confers response to trehalose. The results correlate a particular taste ligand with a Gr receptor and indicate a role for G protein-mediated signaling in the transduction of sweet taste in Drosophila.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA	Yale University	Carlson, JR (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, POB 208103, New Haven, CT 06520 USA.	john.carlson@yale.edu	van der Goes van Naters, Wynand/A-5868-2010	Dahanukar, Anupama/0000-0003-0534-7700				Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; AMAKAWA T, 1990, J INSECT PHYSIOL, V36, P281, DOI 10.1016/0022-1910(90)90112-S; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Chaudhari N, 2000, NAT NEUROSCI, V3, P113, DOI 10.1038/72053; Clyne PJ, 2000, SCIENCE, V287, P1830, DOI 10.1126/science.287.5459.1830; DAMBLYCHAUDIERE C, 1992, CELL, V69, P159, DOI 10.1016/0092-8674(92)90127-X; Dethier VG, 1976, HUNGRY FLY; Dunipace L, 2001, CURR BIOL, V11, P822, DOI 10.1016/S0960-9822(01)00258-5; GLENDINNING JI, 2000, NEUROBIOLOGY TASTE S, V2, P315; HODGSON ES, 1955, SCIENCE, V122, P417, DOI 10.1126/science.122.3166.417-a; Ishimoto H, 2000, SCIENCE, V289, P116, DOI 10.1126/science.289.5476.116; L'Etoile ND, 2000, NEURON, V25, P575, DOI 10.1016/S0896-6273(00)81061-2; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; Max M, 2001, NAT GENET, V28, P58, DOI 10.1038/ng0501-58; Montmayeur JP, 2001, NAT NEUROSCI, V4, P492, DOI 10.1038/87440; Murakami M, 2000, J GEN PHYSIOL, V115, P455, DOI 10.1085/jgp.115.4.455; NAYAK SV, 1983, INT J INSECT MORPHOL, V12, P273, DOI 10.1016/0020-7322(83)90023-5; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; RAY K, 1993, DEV BIOL, V155, P26, DOI 10.1006/dbio.1993.1003; RODRIGUES V, 1981, MOL GEN GENET, V181, P406, DOI 10.1007/BF00425621; Sainz E, 2001, J NEUROCHEM, V77, P896, DOI 10.1046/j.1471-4159.2001.00292.x; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; SHANBHAG SR, 1992, CELL TISSUE RES, V267, P273, DOI 10.1007/BF00302965; Singh RN, 1997, MICROSC RES TECHNIQ, V39, P547, DOI 10.1002/(SICI)1097-0029(19971215)39:6<547::AID-JEMT7>3.0.CO;2-A; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; STOCKER RF, 1981, CELL TISSUE RES, V216, P513; TANIMURA T, 1988, GENETICS, V119, P399; TANIMURA T, 1982, J COMP PHYSIOL, V147, P433, DOI 10.1007/BF00612007; TANIMURA T, 1981, J COMP PHYSIOL, V141, P265, DOI 10.1007/BF01342672; Ueno K, 2001, CURR BIOL, V11, P1451, DOI 10.1016/S0960-9822(01)00450-X; WIECZOREK H, 1989, J COMP PHYSIOL A, V164, P825, DOI 10.1007/BF00616754	31	199	201	3	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2001	4	12					1182	1186		10.1038/nn765	http://dx.doi.org/10.1038/nn765			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	498RV	11704765				2022-12-17	WOS:000172525000013
J	Takahashi, T; Nakamura, F; Jin, Z; Kalb, RG; Strittmatter, SM				Takahashi, T; Nakamura, F; Jin, Z; Kalb, RG; Strittmatter, SM			Semaphorins A and E act as antagonists of neuropilin-1 and agonists of neuropilin-2 receptors	NATURE NEUROSCIENCE			English	Article							PERIPHERAL-NERVE PROJECTION; GROWTH CONE COLLAPSE; HERPES-SIMPLEX VIRUS; AXON GUIDANCE; DEVELOPING CHICK; FAMILY; EXPRESSION; PROTEIN; MEMBER; SYSTEM	Neuropilin-1 (NP-1) has been identified as a necessary component of a semaphorin D (SemD) receptor; that repulses dorsal root ganglion (DRG) axons during development. SemA and SemE are related to SemD and bind to NP-1, but do not repulse DRG axons. By expressing NP-1 in retinal neurons and NP-2 in DRG neurons, we demonstrate that neuropilins are sufficient to determine the functional specificity of semaphorin responsiveness. SemA and SemE block SemD binding to NP-1 and abolish SemD repulsion in axons expressing NP-1. SemA and SemE seem to have a newly discovered protein antagonist capacity at NP-1 receptors, whereas they act as agonists at receptors containing NP-2.	Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06520 USA	Yale University	Strittmatter, SM (corresponding author), Yale Univ, Sch Med, Dept Neurol, POB 208018,333 Cedar St, New Haven, CT 06520 USA.	stephen_stritmatter@qm.yale.edu	Strittmatter, Stephen/F-5739-2011	Strittmatter, Stephen/0000-0001-8188-3092				Adams RH, 1997, EMBO J, V16, P6077, DOI 10.1093/emboj/16.20.6077; Chen H, 1997, NEURON, V19, P547, DOI 10.1016/S0896-6273(00)80371-2; DODD J, 1995, CELL, V81, P471, DOI 10.1016/0092-8674(95)90066-7; EISENBERG SP, 1990, NATURE, V343, P341, DOI 10.1038/343341a0; Feiner L, 1997, NEURON, V19, P539, DOI 10.1016/S0896-6273(00)80370-0; Furuyama T, 1996, J BIOL CHEM, V271, P33376, DOI 10.1074/jbc.271.52.33376; GOSHIMA Y, 1995, NATURE, V376, P509, DOI 10.1038/376509a0; GUIDOTTI A, 1983, P NATL ACAD SCI-BIOL, V80, P3531, DOI 10.1073/pnas.80.11.3531; HANNUM CH, 1990, NATURE, V343, P336, DOI 10.1038/343336a0; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; IGARASHI M, 1993, SCIENCE, V259, P77, DOI 10.1126/science.8418498; INAGAKI S, 1995, FEBS LETT, V370, P269, DOI 10.1016/0014-5793(95)00850-9; Jin Z, 1997, J NEUROSCI, V17, P6256; Kawakami A, 1996, J NEUROBIOL, V29, P1, DOI 10.1002/(SICI)1097-4695(199601)29:1<1::AID-NEU1>3.0.CO;2-F; Kikuchi K, 1997, MOL BRAIN RES, V51, P229, DOI 10.1016/S0169-328X(97)00251-9; Kitsukawa T, 1997, NEURON, V19, P995, DOI 10.1016/S0896-6273(00)80392-X; Klostermann A, 1998, J BIOL CHEM, V273, P7326, DOI 10.1074/jbc.273.13.7326; Kobayashi H, 1997, J NEUROSCI, V17, P8339; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; Kolodkin AL, 1997, NEURON, V19, P1159, DOI 10.1016/S0896-6273(00)80408-0; Kolodkin AL, 1996, TRENDS CELL BIOL, V6, P15, DOI 10.1016/0962-8924(96)81033-6; Koppel AM, 1997, NEURON, V19, P531, DOI 10.1016/S0896-6273(00)80369-4; Lim F, 1996, BIOTECHNIQUES, V20, P460; LU DS, 1994, NATURE, V371, P799, DOI 10.1038/371799a0; LUO YL, 1995, NEURON, V14, P1131, DOI 10.1016/0896-6273(95)90261-9; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; MCCARTHY AM, 1989, J VIROL, V63, P18, DOI 10.1128/JVI.63.1.18-27.1989; MESSERSMITH EK, 1995, NEURON, V14, P949, DOI 10.1016/0896-6273(95)90333-X; Neve RL, 1997, NEUROSCIENCE, V79, P435, DOI 10.1016/S0306-4522(96)00645-8; Puschel AW, 1996, EUR J NEUROSCI, V8, P1317, DOI 10.1111/j.1460-9568.1996.tb01593.x; PUSCHEL AW, 1995, NEURON, V14, P941, DOI 10.1016/0896-6273(95)90332-1; STRITTMATTER SM, 1994, J NEUROSCI, V14, P5503; TAKAGI S, 1987, DEV BIOL, V122, P90, DOI 10.1016/0012-1606(87)90335-6; TAKAGI S, 1991, NEURON, V7, P295, DOI 10.1016/0896-6273(91)90268-5; TAKAGI S, 1995, DEV BIOL, V170, P207, DOI 10.1006/dbio.1995.1208; Takahashi T, 1997, J NEUROSCI, V17, P9183; Taniguchi M, 1997, NEURON, V19, P519, DOI 10.1016/S0896-6273(00)80368-2; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; VarelaEchavarria A, 1997, NEURON, V18, P193, DOI 10.1016/S0896-6273(00)80261-5; Yamada T, 1997, P NATL ACAD SCI USA, V94, P14713, DOI 10.1073/pnas.94.26.14713	40	199	203	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	1998	1	6					487	493		10.1038/2203	http://dx.doi.org/10.1038/2203			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	128LE	10196546				2022-12-17	WOS:000076406900013
J	Parvizi, J; Kastner, S				Parvizi, Josef; Kastner, Sabine			Promises and limitations of human intracranial electroencephalography	NATURE NEUROSCIENCE			English	Article							LOCAL-FIELD POTENTIALS; COGNITIVE NEURAL PROSTHETICS; NEURONAL POPULATION ACTIVITY; HIGH-FREQUENCY OSCILLATIONS; INFERIOR TEMPORAL CORTEX; ELECTRICAL-STIMULATION; VISUAL-CORTEX; EPILEPTIFORM DISCHARGES; GAMMA-OSCILLATIONS; SENSORY SELECTION	Intracranial electroencephalography (iEEG), also known as electrocorticography when using subdural grid electrodes or stereotactic EEG when using depth electrodes, is blossoming in various fields of human neuroscience. In this article, we highlight the potentials of iEEG in exploring functions of the human brain while also considering its limitations. The iEEG signal provides anatomically precise information about the selective engagement of neuronal populations at the millimeter scale and the temporal dynamics of their engagement at the millisecond scale. If several nodes of a given network are monitored simultaneously with implanted electrodes, the iEEG signals can also reveal information about functional interactions within and across networks during different stages of neural computation. As such, human iEEG can complement other methods of neuroscience beyond simply replicating what is already known, or can be known, from noninvasive lines of research in humans or from invasive recordings in nonhuman mammalian brains.	[Parvizi, Josef] Stanford Univ, Stanford Human Intracranial Cognit Electrophysiol, Lab Behav & Cognit Neurosci, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Kastner, Sabine] Princeton Univ, Princeton Neurosci Inst, Dept Psychol, Princeton, NJ 08544 USA	Stanford University; Princeton University	Parvizi, J (corresponding author), Stanford Univ, Stanford Human Intracranial Cognit Electrophysiol, Lab Behav & Cognit Neurosci, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA.	parvizi@stanford.edu			US National Institute of Health [1R01MH 109954-01, 2RO1MH064043-12, 5RO1EY017699-09, 21560-685]; US National Science Foundation [BCS1358907, BCS-1328270]; James S. McDonnell Foundation; NATIONAL EYE INSTITUTE [R01EY017699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH109954, R01MH064043, P50MH109429] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078396] Funding Source: NIH RePORTER	US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation(National Science Foundation (NSF)); James S. McDonnell Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the following colleagues for their time discussing the promises and limitations of iEEG with us: G. Buszki, S. Dehaene, J. DiCarlo, E. Halgren, R. Kiani, M. Kahana, R. Knight, C. Koch, N. Logotethis, R. Malach, M.-B. Moser, B. Newsome, A. Nieder, U. Rutishauser and A. Wagner. We gratefully acknowledge funding support from the US National Institute of Health (1R01MH109954-01 to J.P.; 2RO1MH064043-12, 5RO1EY017699-09, Silvio O. Conte Center 21560-685 to S.K. and J.P.), the US National Science Foundation (BCS1358907 to JP; BCS-1328270 to S.K.) and the James S. McDonnell Foundation to S.K.	Aldenkamp AP, 2004, EPILEPSY BEHAV, V5, pS25, DOI 10.1016/j.yebeh.2003.11.005; Andersen RA, 2004, TRENDS COGN SCI, V8, P486, DOI 10.1016/j.tics.2004.09.009; Ball T, 2009, NEUROIMAGE, V46, P708, DOI 10.1016/j.neuroimage.2009.02.028; Bassett DS, 2017, NAT NEUROSCI, V20, P353, DOI 10.1038/nn.4502; Bastos AM, 2015, NEURON, V85, P390, DOI 10.1016/j.neuron.2014.12.018; Beauchamp MS, 2012, NAT NEUROSCI, V15, P957, DOI 10.1038/nn.3131; Beck A., 1890, CENTRALBLATT PHYSL, V4, P473; Berger H, 1929, ARCH PSYCHIAT NERVEN, V87, P527, DOI 10.1007/BF01797193; Binnie CD, 2003, LANCET NEUROL, V2, P725, DOI 10.1016/S1474-4422(03)00584-2; Blanke O, 2002, NATURE, V419, P269, DOI 10.1038/419269a; Buffalo EA, 2011, P NATL ACAD SCI USA, V108, P11262, DOI 10.1073/pnas.1011284108; Buzsaki G., 2006, RHYTHMS BRAIN; Canolty RT, 2010, TRENDS COGN SCI, V14, P506, DOI 10.1016/j.tics.2010.09.001; Cash SS, 2009, SCIENCE, V324, P1084, DOI 10.1126/science.1169626; Caton R, 1875, BRIT MED J, V2, P278, DOI DOI 10.1080/00029238.1970.11080764; Chang EF, 2015, NEURON, V86, P68, DOI 10.1016/j.neuron.2015.03.037; Chao Zenas C, 2010, Front Neuroeng, V3, P3, DOI 10.3389/fneng.2010.00003; Cogan GB, 2014, NATURE, V507, P94, DOI 10.1038/nature12935; Daitch AL, 2016, P NATL ACAD SCI USA, V113, pE7277, DOI 10.1073/pnas.1608434113; Desmurget M, 2009, SCIENCE, V324, P811, DOI 10.1126/science.1169896; Elger CE, 2004, LANCET NEUROL, V3, P663, DOI 10.1016/S1474-4422(04)00906-8; Engel AK, 2005, NAT REV NEUROSCI, V6, P35, DOI 10.1038/nrn1585; ENGEL AK, 1990, EUR J NEUROSCI, V2, P588, DOI 10.1111/j.1460-9568.1990.tb00449.x; Engel J, 1996, NEW ENGL J MED, V334, P647, DOI 10.1056/NEJM199603073341008; Famm K, 2013, NATURE, V496, P159, DOI 10.1038/496159a; Flinker A, 2011, BRAIN LANG, V117, P103, DOI 10.1016/j.bandl.2010.09.009; Foster BL, 2015, NEURON, V86, P578, DOI 10.1016/j.neuron.2015.03.018; Foster BL, 2012, P NATL ACAD SCI USA, V109, P15514, DOI 10.1073/pnas.1206580109; Foutz TJ, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/6/066008; Fried I, 1998, NATURE, V391, P650, DOI 10.1038/35536; GAZZANIGA MS, 1975, J NEUROL, V209, P75, DOI 10.1007/BF00314600; Glennon JM, 2016, EPILEPSIA, V57, P1436, DOI 10.1111/epi.13479; Groppe DM, 2017, J NEUROSCI METH, V281, P40, DOI 10.1016/j.jneumeth.2017.01.022; Halgren E, 2015, NEUROPSYCHOLOGIA, V76, P108, DOI 10.1016/j.neuropsychologia.2015.03.021; Hermes D, 2012, HUM BRAIN MAPP, V33, P1689, DOI 10.1002/hbm.21314; Hermes D, 2010, J NEUROSCI METH, V185, P293, DOI 10.1016/j.jneumeth.2009.10.005; Holmes GL, 2006, EPILEPSY BEHAV, V8, P504, DOI 10.1016/j.yebeh.2005.11.014; Holmes MD, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00084; Jacobs J, 2007, J NEUROSCI, V27, P3839, DOI 10.1523/JNEUROSCI.4636-06.2007; Jiruska P, 2017, EPILEPSIA, V58, P1330, DOI 10.1111/epi.13830; JONESGOTMAN M, 1991, EPILEPSIA, V32, pS41; Katzner S, 2009, NEURON, V61, P35, DOI 10.1016/j.neuron.2008.11.016; Keller CJ, 2013, J NEUROSCI, V33, P6333, DOI 10.1523/JNEUROSCI.4837-12.2013; Khodagholy D, 2015, NAT NEUROSCI, V18, P310, DOI 10.1038/nn.3905; Kiani R, 2015, NEURON, V85, P1359, DOI 10.1016/j.neuron.2015.02.014; Kreiman G, 2006, NEURON, V49, P433, DOI 10.1016/j.neuron.2005.12.019; Kriegeskorte N, 2008, NEURON, V60, P1126, DOI 10.1016/j.neuron.2008.10.043; Kwan P, 2011, NEW ENGL J MED, V365, P919, DOI 10.1056/NEJMra1004418; LILLY JC, 1955, SCIENCE, V121, P468, DOI 10.1126/science.121.3144.468; Litt B, 2003, EPILEPSIA, V44, P30, DOI 10.1046/j.1528-1157.44.s7.3.x; Litt B, 2015, NEURON, V86, P16, DOI 10.1016/j.neuron.2015.03.029; Liu J, 2006, J NEUROSCI, V26, P7779, DOI 10.1523/JNEUROSCI.5052-05.2006; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Loring DW, 2015, EPILEPSIA, V56, P1836, DOI 10.1111/epi.13191; Manning JR, 2009, J NEUROSCI, V29, P13613, DOI 10.1523/JNEUROSCI.2041-09.2009; Meador KJ, 2011, NEUROLOGY, V77, P930, DOI 10.1212/WNL.0b013e31822cfcd6; Mesgarani N, 2014, SCIENCE, V343, P1006, DOI 10.1126/science.1245994; Miller KJ, 2007, J NEUROSCI, V27, P2424, DOI 10.1523/JNEUROSCI.3886-06.2007; Miller KJ, 2010, J NEUROSCI, V30, P6477, DOI 10.1523/JNEUROSCI.6401-09.2010; Miller KJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000609; Milner B, 1998, NEURON, V20, P445, DOI 10.1016/S0896-6273(00)80987-3; Morrell MJ, 2011, NEUROLOGY, V77, P1295, DOI 10.1212/WNL.0b013e3182302056; Motamedi G, 2003, EPILEPSY BEHAV, V4, pS25, DOI 10.1016/j.yebeh.2003.07.004; Mukamel R, 2005, SCIENCE, V309, P951, DOI 10.1126/science.1110913; Mukamel R, 2012, ANNU REV PSYCHOL, V63, P511, DOI 10.1146/annurev-psych-120709-145401; Niessing J, 2005, SCIENCE, V309, P948, DOI 10.1126/science.1110948; Nir Y, 2008, NAT NEUROSCI, V11, P523, DOI 10.1038/nn0508-523; Nir Y, 2007, CURR BIOL, V17, P1275, DOI 10.1016/j.cub.2007.06.066; Park SH, 2017, NEURON, V95, P971, DOI 10.1016/j.neuron.2017.07.014; Parvizi J, 2013, NEURON, V80, P1359, DOI 10.1016/j.neuron.2013.10.057; Parvizi J, 2012, J NEUROSCI, V32, P14915, DOI 10.1523/JNEUROSCI.2609-12.2012; Parvizi J, 2009, TRENDS COGN SCI, V13, P354, DOI 10.1016/j.tics.2009.04.008; Pasley BN, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001251; Penfield W, 1937, BRAIN, V60, P389, DOI 10.1093/brain/60.4.389; Pesaran B, 2006, CURR BIOL, V16, pR77, DOI 10.1016/j.cub.2006.01.043; Pinsk MA, 2009, J NEUROPHYSIOL, V101, P2581, DOI 10.1152/jn.91198.2008; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Raichle ME, 2006, SCIENCE, V314, P1249, DOI 10.1126/science.1134405; Rangarajan V, 2014, J NEUROSCI, V34, P12828, DOI 10.1523/JNEUROSCI.0527-14.2014; Ray S, 2008, J NEUROSCI, V28, P11526, DOI 10.1523/JNEUROSCI.2848-08.2008; Ray S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000610; Rosin B, 2011, NEURON, V72, P370, DOI 10.1016/j.neuron.2011.08.023; Rutishauser U, 2010, NATURE, V464, P903, DOI 10.1038/nature08860; Saalmann YB, 2012, SCIENCE, V337, P753, DOI 10.1126/science.1223082; Schalk Gerwin, 2011, IEEE Rev Biomed Eng, V4, P140, DOI 10.1109/RBME.2011.2172408; Schevon CA, 2009, BRAIN, V132, P3047, DOI 10.1093/brain/awp222; Schroeder CE, 2009, TRENDS NEUROSCI, V32, P9, DOI 10.1016/j.tins.2008.09.012; Selimbeyoglu A, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00046; Semah F, 1998, NEUROLOGY, V51, P1256, DOI 10.1212/WNL.51.5.1256; Shum J, 2013, J NEUROSCI, V33, P6709, DOI 10.1523/JNEUROSCI.4558-12.2013; Svoboda E, 2006, NEUROPSYCHOLOGIA, V44, P2189, DOI 10.1016/j.neuropsychologia.2006.05.023; Szczepanski SM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001936; Tang HL, 2014, NEURON, V83, P736, DOI 10.1016/j.neuron.2014.06.017; Tsao DY, 2008, P NATL ACAD SCI USA, V105, P19514, DOI 10.1073/pnas.0809662105; VanRullen R, 2016, TRENDS COGN SCI, V20, P723, DOI 10.1016/j.tics.2016.07.006; Voytek B, 2015, NAT NEUROSCI, V18, P1318, DOI 10.1038/nn.4071; Widge AS, 2017, EXP NEUROL, V287, P461, DOI 10.1016/j.expneurol.2016.07.021; Wimmer RD, 2015, NATURE, V526, P705, DOI 10.1038/nature15398; Winawer J, 2013, CURR BIOL, V23, P1145, DOI 10.1016/j.cub.2013.05.001; Zanos S, 2012, J NEUROPHYSIOL, V107, P1808, DOI 10.1152/jn.00663.2011	100	198	198	5	79	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2018	21	4					474	483		10.1038/s41593-018-0108-2	http://dx.doi.org/10.1038/s41593-018-0108-2			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GB1FG	29507407	Green Accepted			2022-12-17	WOS:000428796000006
J	Root, DH; Mejias-Aponte, CA; Zhang, SL; Wang, HL; Hoffman, AF; Lupica, CR; Morales, M				Root, David H.; Mejias-Aponte, Carlos A.; Zhang, Shiliang; Wang, Hui-Ling; Hoffman, Alexander F.; Lupica, Carl R.; Morales, Marisela			Single rodent mesohabenular axons release glutamate and GABA	NATURE NEUROSCIENCE			English	Article							VENTRAL TEGMENTAL AREA; NEGATIVE REWARD SIGNALS; LATERAL HABENULA; DOPAMINE NEURONS; PATHWAY; RAT; PROJECTIONS; SYNAPSES; STIMULATION; POPULATION	The lateral habenula (LHb) is involved in reward, aversion, addiction and depression through descending interactions with several brain structures, including the ventral tegmental area (VTA). The VTA provides reciprocal inputs to LHb, but their actions are unclear. Here we show that the majority of rat and mouse VTA neurons innervating LHb coexpress markers for both glutamate signaling (vesicular glutamate transporter 2; VGluT2) and GABA signaling (glutamic acid decarboxylase; GAD, and vesicular GABA transporter; VGaT). A single axon from these mesohabenular neurons coexpresses VGluT2 protein and VGaT protein and, surprisingly, establishes symmetric and asymmetric synapses on LHb neurons. In LHb slices, light activation of mesohabenular fibers expressing channelrhodopsin2 driven by VGluT2 (Slc17a6) or VGaT (Slc32a1) promoters elicits release of both glutamate and GABA onto single LHb neurons. In vivo light activation of mesohabenular terminals inhibits or excites LHb neurons. Our findings reveal an unanticipated type of VTA neuron that cotransmits glutamate and GABA and provides the majority of mesohabenular inputs.	[Root, David H.; Mejias-Aponte, Carlos A.; Zhang, Shiliang; Wang, Hui-Ling; Morales, Marisela] NIDA, Neuronal Networks Sect, Integrat Neurosci Res Branch, Baltimore, MD 21224 USA; [Hoffman, Alexander F.; Lupica, Carl R.] NIDA, Electrophysiol Res Sect, Cellular Neurobiol Res Branch, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Morales, M (corresponding author), NIDA, Neuronal Networks Sect, Integrat Neurosci Res Branch, Baltimore, MD 21224 USA.	mmorales@intra.nida.nih.gov	Hoffman, Alexander F/H-3035-2012; Lupica, Carl/AAY-3193-2021; Hoffman, Alex/AIF-4544-2022	Hoffman, Alexander F/0000-0002-2676-0628; Lupica, Carl/0000-0002-5375-3263; Hoffman, Alex/0000-0002-2676-0628; Root, David/0000-0002-1927-2175	Intramural Research Program of the National Institute on Drug Abuse, US National Institutes of Health (IRP/NIDA/NIH); NATIONAL INSTITUTE ON DRUG ABUSE [Z01DA000510] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute on Drug Abuse, US National Institutes of Health (IRP/NIDA/NIH); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank R. Wise, J. Qi and J. Aceves for comments and J. Qi for assistance with viral injections used in ultrastructural experiments. Viruses were packaged by the NIDA IRP Optogenetics and Transgenic Technology Core. The Intramural Research Program of the National Institute on Drug Abuse, US National Institutes of Health (IRP/NIDA/NIH) supported this work.	Boulland JL, 2009, CEREB CORTEX, V19, P241, DOI 10.1093/cercor/bhn077; Bromberg-Martin ES, 2010, J NEUROPHYSIOL, V104, P1068, DOI 10.1152/jn.00158.2010; Bromberg-Martin ES, 2010, NEURON, V67, P144, DOI 10.1016/j.neuron.2010.06.016; Chaudhury D, 2013, NATURE, V493, P532, DOI 10.1038/nature11713; Cohen JY, 2012, NATURE, V482, P85, DOI 10.1038/nature10754; Cruikshank SJ, 2010, NEURON, V65, P230, DOI 10.1016/j.neuron.2009.12.025; Dal Bo G, 2004, J NEUROCHEM, V88, P1398, DOI 10.1046/j.1471-4159.2003.02277.x; Foss SM, 2013, J NEUROSCI, V33, P10647, DOI 10.1523/JNEUROSCI.5662-12.2013; Friedman A, 2010, NEUROPHARMACOLOGY, V59, P452, DOI 10.1016/j.neuropharm.2010.06.008; Gruber C, 2007, NEUROSCI LETT, V427, P165, DOI 10.1016/j.neulet.2007.09.016; Hnasko TS, 2012, J NEUROSCI, V32, P15076, DOI 10.1523/JNEUROSCI.3128-12.2012; Hong S, 2011, J NEUROSCI, V31, P11457, DOI 10.1523/JNEUROSCI.1384-11.2011; Jhou TC, 2013, J NEUROSCI, V33, P7501, DOI 10.1523/JNEUROSCI.3634-12.2013; Jhou TC, 2009, NEURON, V61, P786, DOI 10.1016/j.neuron.2009.02.001; Johnston GAR, 2013, BRIT J PHARMACOL, V169, P328, DOI 10.1111/bph.12127; Lammel S, 2012, NATURE, V491, P212, DOI 10.1038/nature11527; Li B, 2011, NATURE, V470, P535, DOI 10.1038/nature09742; Li XP, 2013, BRAIN STRUCT FUNCT, V218, P1159, DOI 10.1007/s00429-012-0452-z; Maroteaux M, 2012, J NEUROSCI, V32, P12641, DOI 10.1523/JNEUROSCI.2405-12.2012; Matsumoto M, 2007, NATURE, V447, P1111, DOI 10.1038/nature05860; Morales M, 2014, NEUROSCIENCE, V282, P60, DOI 10.1016/j.neuroscience.2014.05.032; Munster-Wandowski A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00210; Nair SG, 2013, BRAIN RES, V1511, P93, DOI 10.1016/j.brainres.2012.10.011; Peters A, 1996, J NEUROCYTOL, V25, P687, DOI 10.1007/BF02284835; Peters A, 1991, FINE STRUCTURE NERVO; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; PHILLIPSON OT, 1982, EXP BRAIN RES, V45, P89; Shabel SJ, 2012, NEURON, V74, P475, DOI 10.1016/j.neuron.2012.02.037; SKAGERBERG G, 1984, BRAIN RES, V307, P99, DOI 10.1016/0006-8993(84)90465-7; Stamatakis AM, 2013, NEURON, V80, P1039, DOI 10.1016/j.neuron.2013.08.023; Stamatakis AM, 2012, NAT NEUROSCI, V15, P1105, DOI 10.1038/nn.3145; Sulzer D, 1998, J NEUROSCI, V18, P4588, DOI 10.1523/jneurosci.18-12-04588.1998; SWANSON LW, 1982, BRAIN RES BULL, V9, P321, DOI 10.1016/0361-9230(82)90145-9; Tan KR, 2012, NEURON, V73, P1173, DOI 10.1016/j.neuron.2012.02.015; Taylor SR, 2014, J COMP NEUROL, V522, P3308, DOI 10.1002/cne.23603; Tritsch NX, 2012, NATURE, V490, P262, DOI 10.1038/nature11466; Tye KM, 2013, NATURE, V493, P537, DOI 10.1038/nature11740; Weiss T, 2011, NEUROSCIENCE, V172, P74, DOI 10.1016/j.neuroscience.2010.10.047; Yamaguchi T, 2011, J NEUROSCI, V31, P8476, DOI 10.1523/JNEUROSCI.1598-11.2011	39	198	199	1	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2014	17	11					1543	1551		10.1038/nn.3823	http://dx.doi.org/10.1038/nn.3823			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AS0LT	25242304	Green Accepted			2022-12-17	WOS:000343969300019
J	Bendor, D; Wilson, MA				Bendor, Daniel; Wilson, Matthew A.			Biasing the content of hippocampal replay during sleep	NATURE NEUROSCIENCE			English	Article							PLACE CELLS; MEMORY; REACTIVATION; SEQUENCES; RIPPLES	The hippocampus is essential for encoding self-experienced events into memory. During sleep, neural activity in the hippocampus related to a recent experience has been observed to spontaneously reoccur, and this 'replay' has been postulated to be important for memory consolidation. Task-related cues can enhance memory consolidation when presented during a post-training sleep session, and, if memories are consolidated by hippocampal replay, a specific enhancement for this replay should be observed. To test this, we trained rats on an auditory-spatial association task while recording from neuronal ensembles in the hippocampus. We found that, during sleep, a task-related auditory cue biased reactivation events toward replaying the spatial memory associated with that cue. These results indicate that sleep replay can be manipulated by external stimulation and provide further evidence for the role of hippocampal replay in memory consolidation.	[Bendor, Daniel; Wilson, Matthew A.] MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Northwell Health	Bendor, D (corresponding author), MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, E25-618, Cambridge, MA 02139 USA.	dbendor@mit.edu		Bendor, Daniel/0000-0001-6621-793X	Merck Award/Helen Hay Whitney Postdoctoral Fellowship; Charles King Trust Postdoctoral Fellowship; US National Institutes of Health grants [1-K99-DC012321-01, 5R01MH061976]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061976] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [K99DC012321] Funding Source: NIH RePORTER	Merck Award/Helen Hay Whitney Postdoctoral Fellowship; Charles King Trust Postdoctoral Fellowship; US National Institutes of Health grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank M. Fee, H. Tanila and members of the Wilson laboratory for their helpful comments and suggestions. We would also like to thank C. Varela, J. Yamamoto, J. Siegle, E. Kuo, A. Hussain and E. Molina for technical assistance. This work was supported by a Merck Award/Helen Hay Whitney Postdoctoral Fellowship (D.B.), a Charles King Trust Postdoctoral Fellowship (D.B.), US National Institutes of Health grants 1-K99-DC012321-01 (D.B.) and 5R01MH061976 (M.A.W.).	Antony JW, 2012, NAT NEUROSCI, V15, P1114, DOI 10.1038/nn.3152; Davidson TJ, 2009, NEURON, V63, P497, DOI 10.1016/j.neuron.2009.07.027; Diba K, 2007, NAT NEUROSCI, V10, P1241, DOI 10.1038/nn1961; Diekelmann S, 2011, NAT NEUROSCI, V14, P381, DOI 10.1038/nn.2744; Dupret D, 2010, NAT NEUROSCI, V13, P995, DOI 10.1038/nn.2599; Ego-Stengel V, 2010, HIPPOCAMPUS, V20, P1, DOI 10.1002/hipo.20707; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; Girardeau G, 2009, NAT NEUROSCI, V12, P1222, DOI 10.1038/nn.2384; Issa EB, 2008, J NEUROSCI, V28, P14467, DOI 10.1523/JNEUROSCI.3086-08.2008; Itskov PM, 2012, J NEUROPHYSIOL, V107, P1822, DOI 10.1152/jn.00404.2011; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Kali S, 2004, NAT NEUROSCI, V7, P286, DOI 10.1038/nn1202; Karlsson MP, 2009, NAT NEUROSCI, V12, P913, DOI 10.1038/nn.2344; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Lesburgueres E, 2011, SCIENCE, V331, P924, DOI 10.1126/science.1196164; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; Marshall U, 2007, TRENDS COGN SCI, V11, P442, DOI 10.1016/j.tics.2007.09.001; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Peigneux P, 2004, NEURON, V44, P535, DOI 10.1016/j.neuron.2004.10.007; Plihal W, 1999, PSYCHOPHYSIOLOGY, V36, P571, DOI 10.1111/1469-8986.3650571; Rasch B, 2007, SCIENCE, V315, P1426, DOI 10.1126/science.1138581; Rudoy JD, 2009, SCIENCE, V326, P1079, DOI 10.1126/science.1179013; Schabus Manuel, 2012, Front Neurol, V3, P40, DOI 10.3389/fneur.2012.00040; Siapas AG, 1998, NEURON, V21, P1123, DOI 10.1016/S0896-6273(00)80629-7; Sirota A, 2003, P NATL ACAD SCI USA, V100, P2065, DOI 10.1073/pnas.0437938100; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Tahvildari B, 2007, HIPPOCAMPUS, V17, P257, DOI 10.1002/hipo.20270; Walker MP, 2004, NEURON, V44, P121, DOI 10.1016/j.neuron.2004.08.031; Wierzynski CM, 2009, NEURON, V61, P587, DOI 10.1016/j.neuron.2009.01.011; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Zhang KC, 1998, J NEUROPHYSIOL, V79, P1017, DOI 10.1152/jn.1998.79.2.1017	33	198	208	0	64	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2012	15	10					1439	1444		10.1038/nn.3203	http://dx.doi.org/10.1038/nn.3203			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	013VZ	22941111	Green Accepted, Green Submitted			2022-12-17	WOS:000309335300025
J	Wunderlich, K; Dayan, P; Dolan, RJ				Wunderlich, Klaus; Dayan, Peter; Dolan, Raymond J.			Mapping value based planning and extensively trained choice in the human brain	NATURE NEUROSCIENCE			English	Article							VENTROMEDIAL PREFRONTAL CORTEX; TEMPORAL DIFFERENCE MODELS; ORBITOFRONTAL CORTEX; BASAL GANGLIA; DECISION-MAKING; PREDICTION ERRORS; STRIATUM; REWARD; REPRESENTATION; COMPUTATIONS	Investigations of the underlying mechanisms of choice in humans have focused on learning from prediction errors, leaving the computational structure of value based planning comparatively underexplored. Using behavioral and neuroimaging analyses of a minimax decision task, we found that the computational processes underlying forward planning are expressed in the anterior caudate nucleus as values of individual branching steps in a decision tree. In contrast, values represented in the putamen pertain solely to values learned during extensive training. During actual choice, both striatal areas showed a functional coupling to ventromedial prefrontal cortex, consistent with this region acting as a value comparator. Our findings point toward an architecture of choice in which segregated value systems operate in parallel in the striatum for planning and extensively trained choices, with medial prefrontal cortex integrating their outputs.	[Wunderlich, Klaus; Dolan, Raymond J.] UCL, Wellcome Trust Ctr Neuroimaging, London, England; [Dayan, Peter] UCL, Gatsby Computat Neurosci Unit, London, England	University of London; University College London; University of London; University College London	Wunderlich, K (corresponding author), UCL, Wellcome Trust Ctr Neuroimaging, London, England.	kwunder@gmail.com		Dayan, Peter/0000-0003-3476-1839; Dolan, Ray/0000-0001-9356-761X	Wellcome Trust [091593/Z/10/Z]; Max Planck Award; Gatsby Charitable Foundation	Wellcome Trust(Wellcome TrustEuropean Commission); Max Planck Award(Max Planck Society); Gatsby Charitable Foundation	We thank W. Yoshida and J. Oberg for help with data acquisition, and N. Daw and M. Guitart Masip for their valuable and insightful comments on the manuscript. This study was supported by a Wellcome Trust Program Grant and Max Planck Award (RID. and KM.) and the Gatsby Charitable Foundation (P.D.). The Wellcome Trust Centre for Neuroimaging is supported by core funding from the Wellcome Trust (091593/Z/10/Z).	Balleine BW, 2010, NEUROPSYCHOPHARMACOL, V35, P48, DOI 10.1038/npp.2009.131; Basten U, 2010, P NATL ACAD SCI USA, V107, P21767, DOI 10.1073/pnas.0908104107; Beiser, 1995, MODELS INFORM PROCES, P215; Berns GS, 2001, J NEUROSCI, V21, P2793, DOI 10.1523/JNEUROSCI.21-08-02793.2001; Boorman ED, 2009, NEURON, V62, P733, DOI 10.1016/j.neuron.2009.05.014; Chib VS, 2009, J NEUROSCI, V29, P12315, DOI 10.1523/JNEUROSCI.2575-09.2009; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Daw ND, 2011, NEURON, V69, P1204, DOI 10.1016/j.neuron.2011.02.027; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Doya K, 1999, NEURAL NETWORKS, V12, P961, DOI 10.1016/S0893-6080(99)00046-5; FitzGerald THB, 2010, CURR BIOL, V20, P1823, DOI 10.1016/j.cub.2010.08.048; FitzGerald THB, 2009, J NEUROSCI, V29, P8388, DOI 10.1523/JNEUROSCI.0717-09.2009; Glascher J, 2010, NEURON, V66, P585, DOI 10.1016/j.neuron.2010.04.016; Hampton AN, 2006, J NEUROSCI, V26, P8360, DOI 10.1523/JNEUROSCI.1010-06.2006; Hare TA, 2008, J NEUROSCI, V28, P5623, DOI 10.1523/JNEUROSCI.1309-08.2008; Jueptner M, 1997, J NEUROPHYSIOL, V77, P1325, DOI 10.1152/jn.1997.77.3.1325; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; Knutson B, 2005, CURR OPIN NEUROL, V18, P411, DOI 10.1097/01.wco.0000173463.24758.f6; Knutson B, 2005, J NEUROSCI, V25, P4806, DOI 10.1523/JNEUROSCI.0642-05.2005; Lau B, 2007, J NEUROSCI, V27, P14502, DOI 10.1523/JNEUROSCI.3060-07.2007; Lehericy S, 2005, P NATL ACAD SCI USA, V102, P12566, DOI 10.1073/pnas.0502762102; Noonan MP, 2010, P NATL ACAD SCI USA, V107, P20547, DOI 10.1073/pnas.1012246107; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Plassmann H, 2007, J NEUROSCI, V27, P9984, DOI 10.1523/JNEUROSCI.2131-07.2007; Redgrave P, 2010, NAT REV NEUROSCI, V11, P760, DOI 10.1038/nrn2915; Samejima K, 2005, SCIENCE, V310, P1337, DOI 10.1126/science.1115270; SAMUEL AL, 1959, IBM J RES DEV, V3, P211, DOI 10.1147/rd.441.0206; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Seymour B, 2004, NATURE, V429, P664, DOI 10.1038/nature02581; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Stephan KE, 2009, NEUROIMAGE, V46, P1004, DOI 10.1016/j.neuroimage.2009.03.025; Sutton Richard S, 1998, INTRO REINFORCEMENT, V2; Sutton RS, 1990, NEURAL NETWORKS CONT, P179; Tanaka SC, 2008, J NEUROSCI, V28, P6750, DOI 10.1523/JNEUROSCI.1808-08.2008; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; Tricomi E, 2009, EUR J NEUROSCI, V29, P2225, DOI 10.1111/j.1460-9568.2009.06796.x; Tricomi EM, 2004, NEURON, V41, P281, DOI 10.1016/S0896-6273(03)00848-1; Valentin VV, 2007, J NEUROSCI, V27, P4019, DOI 10.1523/JNEUROSCI.0564-07.2007; Wunderlich K, 2010, P NATL ACAD SCI USA, V107, P15005, DOI 10.1073/pnas.1002258107; Wunderlich K, 2009, P NATL ACAD SCI USA, V106, P17199, DOI 10.1073/pnas.0901077106; Yin HH, 2005, EUR J NEUROSCI, V22, P513, DOI 10.1111/j.1460-9568.2005.04218.x	43	198	200	2	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2012	15	5					786	791		10.1038/nn.3068	http://dx.doi.org/10.1038/nn.3068			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	932DI	22406551	Green Accepted, Green Published			2022-12-17	WOS:000303270200024
J	Liebe, S; Hoerzer, GM; Logothetis, NK; Rainer, G				Liebe, Stefanie; Hoerzer, Gregor M.; Logothetis, Nikos K.; Rainer, Gregor			Theta coupling between V4 and prefrontal cortex predicts visual short-term memory performance	NATURE NEUROSCIENCE			English	Article							WORKING-MEMORY; PHASE-LOCKING; NEURONAL SYNCHRONIZATION; PARIETAL CORTEX; SPATIAL MEMORY; NEURAL BASIS; OSCILLATIONS; TASK; BRAIN; REPRESENTATION	Short-term memory requires communication between multiple brain regions that collectively mediate the encoding and maintenance of sensory information. It has been suggested that oscillatory synchronization underlies intercortical communication. Yet, whether and how distant cortical areas cooperate during visual memory remains elusive. We examined neural interactions between visual area V4 and the lateral prefrontal cortex using simultaneous local field potential (LFP) recordings and single-unit activity (SUA) in monkeys performing a visual short-term memory task. During the memory period, we observed enhanced between-area phase synchronization in theta frequencies (3-9 Hz) of LFPs together with elevated phase locking of SUA to theta oscillations across regions. In addition, we found that the strength of intercortical locking was predictive of the animals' behavioral performance. This suggests that theta-band synchronization coordinates action potential communication between V4 and prefrontal cortex that may contribute to the maintenance of visual short-term memories.	[Liebe, Stefanie; Logothetis, Nikos K.; Rainer, Gregor] Max Planck Inst Biol Cybernet, Dept Physiol Cognit Proc, Tubingen, Germany; [Hoerzer, Gregor M.] Graz Univ Technol, Inst Theoret Comp Sci, A-8010 Graz, Austria; [Logothetis, Nikos K.] Univ Manchester, Fac Med & Human Sci, Manchester, Lancs, England; [Rainer, Gregor] Univ Fribourg, Dept Med, CH-1700 Fribourg, Switzerland	Max Planck Society; Graz University of Technology; University of Manchester; University of Fribourg	Liebe, S (corresponding author), UCL, Dept Physiol Pharmacol & Neurosci, London, England.	s.liebe@ucl.ac.uk; gregor.rainer@unifr.ch	Rainer, Gregor/B-5876-2012; Logothetis, Nikos/U-9282-2019	Rainer, Gregor/0000-0002-5805-2220	Deutsche Forschungsgemeinschaft [Sonderforschungsbereich 550]; Max Planck Society; European Union [FP7-231267, FP7-506778]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max Planck Society(Max Planck SocietyFoundation CELLEX); European Union(European Commission)	We would like to thank J. Macke for discussions regarding analyses, and T. Mrsic-Flogel and J. Macke for useful comments on the manuscript. We also thank A.-L. Keller for help with histology. S. L. was supported by the Deutsche Forschungsgemeinschaft Sonderforschungsbereich 550 and a doctoral Fellowship of the Max Planck Society. G. M. H. was supported by projects FP7-231267 ("Self-Organized Recurrent Neural Learning for Language Processing", ORGANIC) and FP7-506778 (Pattern Analysis, Statistical Modeling and Computational Learning, PASCAL2) of the European Union. G.R. is a European Science Foundation European Young Investigator.	Akam T, 2010, NEURON, V67, P308, DOI 10.1016/j.neuron.2010.06.019; Azouz R, 2003, NEURON, V37, P513, DOI 10.1016/S0896-6273(02)01186-8; Buzsaki G, 1996, CEREB CORTEX, V6, P81, DOI 10.1093/cercor/6.2.81; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Fell J, 2008, NEUROIMAGE, V43, P410, DOI 10.1016/j.neuroimage.2008.07.021; Fell J, 2011, NAT REV NEUROSCI, V12, P105, DOI 10.1038/nrn2979; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Fuentemilla L, 2010, CURR BIOL, V20, P606, DOI 10.1016/j.cub.2010.01.057; FUSTER JM, 1971, SCIENCE, V173, P652, DOI 10.1126/science.173.3997.652; Graimann B, 2006, PROG BRAIN RES, V159, P79, DOI 10.1016/S0079-6123(06)59006-5; Guderian S, 2005, HIPPOCAMPUS, V15, P901, DOI 10.1002/hipo.20125; Hoerzer GM, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00014; HUERTA PT, 1995, NEURON, V15, P1053, DOI 10.1016/0896-6273(95)90094-2; Jensen O, 2005, TRENDS NEUROSCI, V28, P67, DOI 10.1016/j.tins.2004.12.001; Jones MW, 2005, PLOS BIOL, V3, P2187, DOI 10.1371/journal.pbio.0030402; Kahana MJ, 1999, NATURE, V399, P781, DOI 10.1038/21645; Klimesch W, 1996, INT J PSYCHOPHYSIOL, V24, P61, DOI 10.1016/S0167-8760(96)00057-8; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Lee H, 2005, NEURON, V45, P147, DOI 10.1016/j.neuron.2004.12.025; Liebe S, 2011, J NEUROSCI, V31, P10215, DOI 10.1523/JNEUROSCI.1791-10.2011; Liebe S, 2009, J VISION, V9, DOI 10.1167/9.5.14; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Mehta MR, 2000, NEURON, V25, P707, DOI 10.1016/S0896-6273(00)81072-7; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mongillo G, 2008, SCIENCE, V319, P1543, DOI 10.1126/science.1150769; O'Keefe J, 1993, Curr Opin Neurobiol, V3, P917, DOI 10.1016/0959-4388(93)90163-S; Orban GA, 2008, PHYSIOL REV, V88, P59, DOI 10.1152/physrev.00008.2007; Pasternak T, 2005, NAT REV NEUROSCI, V6, P97, DOI [10.1038/nrn1603, 10.1038/nrn1637]; Pasupathy A, 2006, PROG BRAIN RES, V154, P293, DOI 10.1016/S0079-6121(06)54016-6; PAVLIDES C, 1988, BRAIN RES, V439, P383, DOI 10.1016/0006-8993(88)91499-0; Pesaran B, 2002, NAT NEUROSCI, V5, P805, DOI 10.1038/nn890; Raghavachari S, 2001, J NEUROSCI, V21, P3175, DOI 10.1523/JNEUROSCI.21-09-03175.2001; Rainer G, 2002, EUR J NEUROSCI, V15, P1244, DOI 10.1046/j.1460-9568.2002.01958.x; Rutishauser U, 2010, NATURE, V464, P903, DOI 10.1038/nature08860; Sarnthein J, 1998, P NATL ACAD SCI USA, V95, P7092, DOI 10.1073/pnas.95.12.7092; Schack B, 2002, INT J PSYCHOPHYSIOL, V44, P143, DOI 10.1016/S0167-8760(01)00199-4; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; Siegel M, 2009, P NATL ACAD SCI USA, V106, P21341, DOI 10.1073/pnas.0908193106; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; Tesche CD, 2000, P NATL ACAD SCI USA, V97, P919, DOI 10.1073/pnas.97.2.919; Tiesinga P, 2008, NAT REV NEUROSCI, V9, P97, DOI 10.1038/nrn2315; TOWE AL, 1970, EXP NEUROL, V29, P366, DOI 10.1016/0014-4886(70)90065-8; Volgushev M, 1998, NEUROSCIENCE, V83, P15, DOI 10.1016/S0306-4522(97)00380-1; Weiss S, 2000, NEUROREPORT, V11, P2357, DOI 10.1097/00001756-200008030-00005; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]; ZEKI S, 1980, NATURE, V284, P412, DOI 10.1038/284412a0	49	198	201	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2012	15	3					456	U150		10.1038/nn.3038	http://dx.doi.org/10.1038/nn.3038			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	899CY	22286175	Green Submitted			2022-12-17	WOS:000300793100020
J	Padmanabhan, K; Urban, NN				Padmanabhan, Krishnan; Urban, Nathaniel N.			Intrinsic biophysical diversity decorrelates neuronal firing while increasing information content	NATURE NEUROSCIENCE			English	Article							RAT OLFACTORY-BULB; PYRAMIDAL NEURONS; NEOCORTICAL NEURONS; MITRAL/TUFTED CELLS; ODOR DISCRIMINATION; LATERAL INHIBITION; ANTENNAL LOBE; SENSORY INPUT; RELIABILITY; CIRCUIT	Although examples of variation and diversity exist throughout the nervous system, their importance remains a source of debate. Even neurons of the same molecular type have notable intrinsic differences. Largely unknown, however, is the degree to which these differences impair or assist neural coding. We examined the outputs from a single type of neuron, the mitral cells of the mouse olfactory bulb, to identical stimuli and found that each cell's spiking response was dictated by its unique biophysical fingerprint. Using this intrinsic heterogeneity, diverse populations were able to code for twofold more information than their homogeneous counterparts. In addition, biophysical variability alone reduced pair-wise output spike correlations to low levels. Our results indicate that intrinsic neuronal diversity is important for neural coding and is not simply the result of biological imprecision.	[Padmanabhan, Krishnan; Urban, Nathaniel N.] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA; [Padmanabhan, Krishnan; Urban, Nathaniel N.] Ctr Neural Basis Cognit, Pittsburgh, PA USA; [Urban, Nathaniel N.] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA USA	Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Urban, NN (corresponding author), Carnegie Mellon Univ, Dept Biol Sci, 4400 5th Ave, Pittsburgh, PA 15213 USA.	nurban@cmu.edu	Urban, Nathaniel/A-4974-2008	Urban, Nathaniel/0000-0002-0365-9068	National Institute on Deafness and Other Communication Disorders [R01DC0005798]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011184, R01DC005798] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We wish to thank G.M. LaRocca for assistance with the immunohistochemistry and B. Benedetti, A. Barth, J. Castro and members of the Urban laboratory for helpful comments on this manuscript. Funding was provided by the National Institute on Deafness and Other Communication Disorders (R01DC0005798).	Arevian AC, 2008, NAT NEUROSCI, V11, P80, DOI 10.1038/nn2030; Bazhenov M, 2001, NEURON, V30, P553, DOI 10.1016/S0896-6273(01)00284-7; Brody CD, 2003, NEURON, V37, P843, DOI 10.1016/S0896-6273(03)00120-X; BRYANT HL, 1976, J PHYSIOL-LONDON, V260, P279, DOI 10.1113/jphysiol.1976.sp011516; Chen TW, 2009, P NATL ACAD SCI USA, V106, P2401, DOI 10.1073/pnas.0810151106; Chen WR, 1997, BRAIN RES, V745, P189, DOI 10.1016/S0006-8993(96)01150-X; Chou YH, 2010, NAT NEUROSCI, V13, P439, DOI 10.1038/nn.2489; Day M, 2005, J NEUROSCI, V25, P8776, DOI 10.1523/JNEUROSCI.2650-05.2005; Desai NS, 1999, NAT NEUROSCI, V2, P515, DOI 10.1038/9165; Ecker AS, 2010, SCIENCE, V327, P584, DOI 10.1126/science.1179867; Ermentrout GB, 2008, TRENDS NEUROSCI, V31, P428, DOI 10.1016/j.tins.2008.06.002; Ermentrout GB, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.248103; Friedrich RW, 2001, SCIENCE, V291, P889, DOI 10.1126/science.291.5505.889; Galan RF, 2006, J NEUROSCI, V26, P3646, DOI 10.1523/JNEUROSCI.4605-05.2006; Galan RF, 2008, J NEUROPHYSIOL, V99, P277, DOI 10.1152/jn.00563.2007; Geffen MN, 2009, NEURON, V61, P570, DOI 10.1016/j.neuron.2009.01.021; Goaillard JM, 2009, NAT NEUROSCI, V12, P1424, DOI 10.1038/nn.2404; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Kashiwadani H, 1999, J NEUROPHYSIOL, V82, P1786, DOI 10.1152/jn.1999.82.4.1786; Kazama H, 2009, NAT NEUROSCI, V12, P1136, DOI 10.1038/nn.2376; Laurent G, 2001, ANNU REV NEUROSCI, V24, P263, DOI 10.1146/annurev.neuro.24.1.263; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Mainen ZF, 1996, NATURE, V382, P363, DOI 10.1038/382363a0; Marder E, 2006, NAT REV NEUROSCI, V7, P563, DOI 10.1038/nrn1949; Margrie TW, 2001, P NATL ACAD SCI USA, V98, P319, DOI 10.1073/pnas.011523098; MEISTER M, 1994, J NEUROSCI METH, V51, P95, DOI 10.1016/0165-0270(94)90030-2; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Osborne LC, 2008, J NEUROSCI, V28, P13522, DOI 10.1523/JNEUROSCI.4390-08.2008; Ramon y Cajal S, 1952, B LOS ANGEL NEURO SO, V17, P5; Renart A, 2010, SCIENCE, V327, P587, DOI 10.1126/science.1179850; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; Schaefer AT, 2006, PLOS BIOL, V4, P1010, DOI 10.1371/journal.pbio.0040163; Schaefer AT, 2003, J NEUROPHYSIOL, V89, P3143, DOI 10.1152/jn.00046.2003; Schoppa NE, 1999, NAT NEUROSCI, V2, P1106, DOI 10.1038/16033; Schulz DJ, 2006, NAT NEUROSCI, V9, P356, DOI 10.1038/nn1639; Schwartz O, 2006, J VISION, V6, P484, DOI 10.1167/6.4.13; Stocks NG, 2000, PHYS REV LETT, V84, P2310, DOI 10.1103/PhysRevLett.84.2310; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; Sugino K, 2006, NAT NEUROSCI, V9, P99, DOI 10.1038/nn1618; Taylor AL, 2009, J NEUROSCI, V29, P5573, DOI 10.1523/JNEUROSCI.4438-08.2009; vanSteveninck RRD, 1997, SCIENCE, V275, P1805, DOI 10.1126/science.275.5307.1805; Verhagen JV, 2007, NAT NEUROSCI, V10, P631, DOI 10.1038/nn1892; Wachowiak M, 2004, P NATL ACAD SCI USA, V101, P9097, DOI 10.1073/pnas.0400438101; Wang Y, 2002, CEREB CORTEX, V12, P395, DOI 10.1093/cercor/12.4.395; Wang Y, 2006, NAT NEUROSCI, V9, P534, DOI 10.1038/nn1670; WELLIS DP, 1989, J NEUROPHYSIOL, V61, P1161, DOI 10.1152/jn.1989.61.6.1161; Wesson DW, 2009, J NEUROPHYSIOL, V101, P1089, DOI 10.1152/jn.90981.2008	47	198	199	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2010	13	10					1276	1282		10.1038/nn.2630	http://dx.doi.org/10.1038/nn.2630			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	654MB	20802489	Green Accepted			2022-12-17	WOS:000282171300021
J	Haswell, CC; Izawa, J; Dowell, LR; Mostofsky, SH; Shadmehr, R				Haswell, Courtney C.; Izawa, Jun; Dowell, Lauren R.; Mostofsky, Stewart H.; Shadmehr, Reza			Representation of internal models of action in the autistic brain	NATURE NEUROSCIENCE			English	Article							DIFFERENT ARM ORIENTATIONS; SIMILAR HAND PATHS; MOTOR CORTEX; SPECTRUM DISORDERS; REACHING MOVEMENTS; INDIVIDUAL CELLS; IMITATION; DYSPRAXIA; CHILDREN; DORSAL	Children with autism spectrum disorder (ASD) have deficits in motor control, imitation and social function. Does a dysfunction in the neural basis of representing internal models of action contribute to these problems? We measured patterns of generalization as children learned to control a novel tool and found that the autistic brain built a stronger than normal association between self-generated motor commands and proprioceptive feedback; furthermore, the greater the reliance on proprioception, the greater the child's impairments in social function and imitation.	[Haswell, Courtney C.; Izawa, Jun; Shadmehr, Reza] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Dowell, Lauren R.; Mostofsky, Stewart H.] Johns Hopkins Univ, Sch Med, Kennedy Krieger Inst, Baltimore, MD 21205 USA; [Mostofsky, Stewart H.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Mostofsky, Stewart H.] Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Kennedy Krieger Institute; Johns Hopkins University; Johns Hopkins University	Shadmehr, R (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA.	shadmehr@jhu.edu			NCRR NIH HHS [UL1-RR025005, UL1 RR025005] Funding Source: Medline; NIGMS NIH HHS [T32 GM007057] Funding Source: Medline; NIMH NIH HHS [R01 MH085328, R01 MH078160] Funding Source: Medline; NINDS NIH HHS [R01 NS048527-01A2, K02 NS044850, K02 NS044850-02, R01 NS048527-04, R01 NS048527, R01 NS048527-05, R01 NS048527-06A1, K02 NS044850-01A2, R01 NS048527-03, K02 NS044850-03, K02 NS044850-05, R01 NS048527-02, K02 NS044850-04, R01 NS037422, R01 NS037422-11] Funding Source: Medline; Autism Speaks [AS1739, AS2384, AS2506] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085328, R01MH078160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048527, K02NS044850, R01NS037422] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Autism Speaks; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Dziuk MA, 2007, DEV MED CHILD NEUROL, V49, P734, DOI 10.1111/j.1469-8749.2007.00734.x; Herbert MR, 2004, ANN NEUROL, V55, P530, DOI 10.1002/ana.20032; Hwang EJ, 2005, J NEURAL ENG, V2, DOI 10.1088/1741-2560/2/3/S09; Jansiewicz EM, 2006, J AUTISM DEV DISORD, V36, P613, DOI 10.1007/s10803-006-0109-y; Li CSR, 2001, NEURON, V30, P593, DOI 10.1016/S0896-6273(01)00301-4; Mattar AAG, 2005, NEURON, V46, P153, DOI 10.1016/j.neuron.2005.02.009; Mostofsky SH, 2007, BRAIN, V130, P2117, DOI 10.1093/brain/awm129; Mostofsky SH, 2006, J INT NEUROPSYCH SOC, V12, P314, DOI 10.1017/S1355617706060437; Oztop E, 2006, NEURAL NETWORKS, V19, P254, DOI 10.1016/j.neunet.2006.02.002; Rogers SJ, 1996, CHILD DEV, V67, P2060, DOI 10.2307/1131609; Scott SH, 1997, J NEUROPHYSIOL, V78, P2413, DOI 10.1152/jn.1997.78.5.2413; Scott SH, 1997, J NEUROPHYSIOL, V77, P826, DOI 10.1152/jn.1997.77.2.826; Shadmehr R, 2004, HUM MOVEMENT SCI, V23, P543, DOI 10.1016/j.humov.2004.04.003; Shadmehr R, 2008, EXP BRAIN RES, V185, P359, DOI 10.1007/s00221-008-1280-5; Xiao J, 2006, EXP BRAIN RES, V168, P106, DOI 10.1007/s00221-005-0074-2	15	198	202	3	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2009	12	8					970	972		10.1038/nn.2356	http://dx.doi.org/10.1038/nn.2356			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	475WS	19578379	Green Accepted			2022-12-17	WOS:000268396300009
J	Jessberger, S; Toni, N; Clemenson, GD; Ray, J; Gage, FH				Jessberger, Sebastian; Toni, Nicolas; Clemenson, Gregory D., Jr.; Ray, Jasodhara; Gage, Fred H.			Directed differentiation of hippocampal stem/progenitor cells in the adult brain	NATURE NEUROSCIENCE			English	Article							NEURAL STEM-CELLS; NEWLY GENERATED NEURONS; IN-VIVO ANALYSIS; DENTATE GYRUS; SPINAL-CORD; OLFACTORY-BULB; NEUROGENESIS; PROGENITORS; OLIGODENDROCYTES; MULTIPOTENT	Adult neurogenesis is a lifelong feature of brain plasticity; however, the potency of adult neural stem/progenitor cells in vivo remains unclear. We found that retrovirus-mediated overexpression of a single gene, the bHLH transcription factor Ascl1, redirected the fate of the proliferating adult hippocampal stem/progenitor (AHP) progeny and lead to the exclusive generation of cells of the oligodendrocytic lineage at the expense of newborn neurons, demonstrating that AHPs in the adult mouse brain are not irrevocably specified in vivo. These data indicate that AHPs have substantial plasticity, which might have important implications for the potential use of endogenous AHPs in neurological disease.	[Jessberger, Sebastian; Toni, Nicolas; Clemenson, Gregory D., Jr.; Ray, Jasodhara; Gage, Fred H.] Salk Inst Biol Studies, Lab Genet, La Jolla, CA 92037 USA; [Jessberger, Sebastian] Swiss Fed Inst Technol ETH Zurich, Dept Biol, Inst Cell Biol, CH-8093 Zurich, Switzerland	Salk Institute; Swiss Federal Institutes of Technology Domain; ETH Zurich	Gage, FH (corresponding author), Salk Inst Biol Studies, Lab Genet, 10010 N Torrey Pines, La Jolla, CA 92037 USA.	jessberger@cell.biol.ethz.ch; gage@salk.edu	Jessberger, Sebastian/AAJ-4032-2020; Toni, Nicolas/M-2057-2014	Toni, Nicolas/0000-0001-5585-268X; Jessberger, Sebastian/0000-0002-0056-8275	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050217, R01NS052842] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS052842-03, R01 NS050217-03, R01 NS050217-04, R01 NS050217, R01 NS052842] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Babu H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000388; Back SA, 2002, J NEUROSCI, V22, P455, DOI 10.1523/JNEUROSCI.22-02-00455.2002; Battiste J, 2007, DEVELOPMENT, V134, P285, DOI 10.1242/dev.02727; Bull ND, 2005, J NEUROSCI, V25, P10815, DOI 10.1523/JNEUROSCI.3249-05.2005; Carleton A, 2003, NAT NEUROSCI, V6, P507, DOI 10.1038/nn1048; Consiglio A, 2004, P NATL ACAD SCI USA, V101, P14835, DOI 10.1073/pnas.0404180101; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Duan X, 2007, CELL, V130, P1146, DOI 10.1016/j.cell.2007.07.010; Gabay L, 2003, NEURON, V40, P485, DOI 10.1016/S0896-6273(03)00637-8; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Galichet C, 2008, DEVELOPMENT, V135, P2031, DOI 10.1242/dev.015115; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Hack MA, 2005, NAT NEUROSCI, V8, P865, DOI 10.1038/nn1479; Hsieh J, 2004, J CELL BIOL, V164, P111, DOI 10.1083/jcb.200308101; Jackson EL, 2006, NEURON, V51, P187, DOI 10.1016/j.neuron.2006.06.012; Kim EJ, 2007, J NEUROSCI, V27, P12764, DOI 10.1523/JNEUROSCI.3178-07.2007; Kondo T, 2000, DEVELOPMENT, V127, P2989; Lein ES, 2004, J NEUROSCI, V24, P3879, DOI 10.1523/JNEUROSCI.4710-03.2004; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Liu M, 2000, P NATL ACAD SCI USA, V97, P865, DOI 10.1073/pnas.97.2.865; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; Merkle FT, 2007, SCIENCE, V317, P381, DOI 10.1126/science.1144914; Miyata T, 1999, GENE DEV, V13, P1647, DOI 10.1101/gad.13.13.1647; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; PALMER TD, 1995, MOL CELL NEUROSCI, V6, P474, DOI 10.1006/mcne.1995.1035; Parras CM, 2007, J NEUROSCI, V27, P4233, DOI 10.1523/JNEUROSCI.0126-07.2007; Parras CM, 2004, EMBO J, V23, P4495, DOI 10.1038/sj.emboj.7600447; Petryniak MA, 2007, NEURON, V55, P417, DOI 10.1016/j.neuron.2007.06.036; Pitt D, 2000, NAT MED, V6, P67, DOI 10.1038/71555; Poitras L, 2007, DEVELOPMENT, V134, P1755, DOI 10.1242/dev.02845; Ray J, 2006, MOL CELL NEUROSCI, V31, P560, DOI 10.1016/j.mcn.2005.11.010; Rowitch DH, 2004, NAT REV NEUROSCI, V5, P409, DOI 10.1038/nrn1389; Sahay A, 2007, NAT NEUROSCI, V10, P1110, DOI 10.1038/nn1969; Seaberg RM, 2002, J NEUROSCI, V22, P1784, DOI 10.1523/JNEUROSCI.22-05-01784.2002; Sherman DL, 2005, NAT REV NEUROSCI, V6, P683, DOI 10.1038/nrn1743; SPERK G, 1983, NEUROSCIENCE, V10, P1301, DOI 10.1016/0306-4522(83)90113-6; Sugimori M, 2008, DEVELOPMENT, V135, P1271, DOI 10.1242/dev.015370; Sugimori M, 2007, DEVELOPMENT, V134, P1617, DOI 10.1242/dev.001255; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006	46	198	204	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2008	11	8					888	893		10.1038/nn.2148	http://dx.doi.org/10.1038/nn.2148			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	330UU	18587391	Green Accepted			2022-12-17	WOS:000257969100013
